FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Al Mutair, A
   Amr, A
   Ambani, Z
   Al Salman, K
   Schwebius, D
AF Al Mutair, Abbas
   Amr, Anas
   Ambani, Zainab
   Al Salman, Khulud
   Schwebius, Deborah
TI Nursing Surge Capacity Strategies for Management of Critically Ill
   Adults with COVID-19
SO NURSING REPORTS
LA English
DT Review
DE COVID-19; coronavirus 2019; ICU surge capacity; nursing surge capacity
   and strategies
ID CARE
AB Background: There is a vital need to develop strategies to improve nursing surge capacity for caring of patients with coronavirus (COVID-19) in critical care settings. COVID-19 has spread rapidly, affecting thousands of patients and hundreds of territories. Hospitals, through anticipation and planning, can serve patients and staff by developing strategies to cope with the complications that a surge of COVID-19 places on the provision of adequate intensive care unit (ICU) nursing staff-both in numbers and in training. Aims: The aim is to provide an evidence-based starting point from which to build expanding staffing models dealing with these additional demands. Design/Method: In order to address and develop nursing surge capacity strategies, a five-member expert panel was formed. Multiple questions directed towards nursing surge capacity strategies were posed by the assembled expert panel. Literature review was conducted through accessing various databases including MEDLINE, CINAHL, Cochrane Central, and EMBASE. All studies were appraised by at least two reviewers independently using the Joanna Briggs Institute JBI Critical Appraisal Tools. Results: The expert panel has issued strategies and recommendation statements. These proposals, supported by evidence-based resources in regard to nursing staff augmentation strategies, have had prior success when implemented during the COVID-19 pandemic. Conclusion: The proposed guidelines are intended to provide a basis for the provision of best practice nursing care during times of diminished intensive care unit (ICU) nursing staff capacity and resources due to a surge in critically ill patients. The recommendations and strategies issued are intended to specifically support critical care nurses incorporating COVID-19 patients. As new knowledge evidence becomes available, updates can be issued and strategies, guidelines and/or policies revised. Relevance to Clinical Practice: Through discussion and condensing research, healthcare professionals can create a starting point from which to synergistically develop strategies to combat crises that a pandemic like COVID-19 produces.
C1 [Al Mutair, Abbas; Schwebius, Deborah] Dr Sulaiman Habib Med Grp, Res Ctr, Riyadh 91877, Saudi Arabia.
   [Al Mutair, Abbas] Univ Wollongong, Nursing Sch, Wollongong, NSW 2522, Australia.
   [Amr, Anas] Patient Safety Ctr, Riyadh 9264, Saudi Arabia.
   [Ambani, Zainab] King Saud Ben Abdulaziz Univ Hlth Sci, Nursing Coll, Al Hufuf 32641, Saudi Arabia.
   [Al Salman, Khulud] Minist Hlth, Al Jaber Hosp Ear Nose Throat & Eye, Nursing Dept, Al Hufuf 36422, Saudi Arabia.
RP Al Mutair, A (corresponding author), Dr Sulaiman Habib Med Grp, Res Ctr, Riyadh 91877, Saudi Arabia.; Al Mutair, A (corresponding author), Univ Wollongong, Nursing Sch, Wollongong, NSW 2522, Australia.
EM abbas.almutair@drsulaimanalhabib.com; aamr@spsc.gov.sa;
   ambaniz@ksau-hs.edu.sa; kaalsalman@moh.gov.sa; dg.schwebius@gmail.com
OI Schwebius, Deborah/0000-0002-0071-2812; Amr, Anas/0000-0003-0789-4732;
   Al Mutair, Abbas/0000-0002-9471-2767
FU Sulaiman Al Habib Research Center
FX Authors acknowledge Sulaiman Al Habib Research Center that supported
   this research.
CR Ajao A, 2015, DISASTER MED PUBLIC, V9, P634, DOI 10.1017/dmp.2015.105
   Alhazzani W, 2020, SAUDI CRITICAL CARE, V4, P27, DOI DOI 10.4103/SCCJ.SCCJ_15_20
   American College of Chest Physicians, SURG PRIOR PLANN COV
   Brazil K, 2020, TRIALS, V21, DOI 10.1186/s13063-020-4100-2
   Cho E, 2016, J NURS SCHOLARSHIP, V48, P74, DOI 10.1111/jnu.12183
   Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9
   Chung W, 2018, J CARDIOVASC NURS, V33, P47, DOI 10.1097/JCN.0000000000000415
   Driscoll A, 2018, EUR J CARDIOVASC NUR, V17, P6, DOI 10.1177/1474515117721561
   Kleinpell RM, 2019, CRIT CARE MED, V47, P1442, DOI 10.1097/CCM.0000000000003925
   Kleinpell RM, 2014, CRIT CARE MED, V42, P1291, DOI 10.1097/CCM.0000000000000202
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   Maves RC, 2020, CHEST, V158, P212, DOI 10.1016/j.chest.2020.03.063
   McHugh MD, 2013, MED CARE, V51, P52, DOI [10.1097/MLR.0b013e3182763284, 10.1097/01.NNA.0000435146.46961.d1]
   Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205
   Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633
   North Carolina Healthcare Foundation, STRAT SUPP NURS SURG
   Penoyer DA, 2010, CRIT CARE MED, V38, P1521, DOI 10.1097/CCM.0b013e3181e47888
   Society of Critical Care Medicine, US RES AV COVID 19
   Society of Critical Care Medicine, CRIT CAR STAT
   The University of Toronto Interdepartmental Division of Critical Care Medicine Working Group, PRINC AD CRIT 3 COVI
   World Health Organization, COR
   World Health Organization, 2020, RAT US PERS PRO EQ C
   World Health Organization, COR VIR DIS COVID 19
   World Health Organization, ADV US MASKS CONT CO
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 25
TC 4
Z9 4
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2039-439X
EI 2039-4403
J9 NURS REP
JI Nurs. Rep.
PD SEP
PY 2020
VL 10
IS 1
BP 23
EP 32
DI 10.3390/nursrep10010004
PG 10
WC Nursing
WE Emerging Sources Citation Index (ESCI)
SC Nursing
GA OG8OI
UT WOS:000582135900004
PM 34968261
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Favalli, EG
   Ingegnoli, F
   De Lucia, O
   Cincinelli, G
   Cimaz, R
   Caporali, R
AF Favalli, Ennio Giulio
   Ingegnoli, Francesca
   De Lucia, Orazio
   Cincinelli, Gilberto
   Cimaz, Rolando
   Caporali, Roberto
TI COVID-19 infection and rheumatoid arthritis: Faraway, so close!
SO AUTOIMMUNITY REVIEWS
LA English
DT Review
DE Rheumatoid arthritis; COVID-19; Treatment; DMARDs; Cytokine release
   syndrome; Coronavirus
ID SERIOUS INFECTIONS; KINASE INHIBITORS; CONVERTING ENZYME; SPIKE PROTEIN;
   DOUBLE-BLIND; IN-VITRO; RISK; THERAPY; CORONAVIRUS; TOFACITINIB
AB The outbreak of the new coronavirus infections COVID-19 in December 2019 in China has quickly become a global health emergency. Given the lack of specific anti-viral therapies, the current management of severe acute respiratory syndrome coronaviruses (SARS-CoV-2) is mainly supportive, even though several compounds are now under investigation for the treatment of this life-threatening disease. COVID-19 pandemic is certainly conditioning the treatment strategy of a complex disorder as rheumatoid arthritis (RA), whose infectious risk is increased compared to the general population because of an overall impairment of immune system typical of autoimmune diseases combined with the iatrogenic effect generated by corticosteroids and immunosuppressive drugs. However, the increasing knowledge about the pathophysiology of SARS-CoV-2 infection is leading to consider some anti-rheumatic drugs as potential treatment options for the management of COVID-19. In this review we will critically analyse the evidences on either positive or negative effect of drugs commonly used to treat RA in this particular scenario, in order to optimize the current approach to RA patients.
C1 [Favalli, Ennio Giulio; Ingegnoli, Francesca; De Lucia, Orazio; Caporali, Roberto] ASST Gaetano Pini, Div Clin Rheumatol, CTO Inst, Via Gaetano Pini 9, I-20122 Milan, Italy.
   [Ingegnoli, Francesca; Cincinelli, Gilberto; Cimaz, Rolando; Caporali, Roberto] Univ Milan, Res Ctr Adult & Pediat Rheumat Dis, Dept Clin Sci & Community Hlth, Milan, Italy.
   [Cimaz, Rolando] ASST Gaetano Pini, Div Pediat Rheumatol, CTO Inst, Milan, Italy.
RP Favalli, EG (corresponding author), ASST Gaetano Pini, Div Clin Rheumatol, CTO Inst, Via Gaetano Pini 9, I-20122 Milan, Italy.
EM enniofavalli@me.com
RI Favalli, Ennio G/K-7982-2016
OI Favalli, Ennio G/0000-0003-1471-6467; De Lucia,
   Orazio/0000-0003-2304-6661
CR Accortt NA, 2018, ARTHRIT CARE RES, V70, P679, DOI 10.1002/acr.23426
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2020, CHINESE CLIN TRIAL R
   Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC
   Arleevskaya MI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01725
   Atzeni F, 2013, AUTOIMMUN REV, V12, P1115, DOI 10.1016/j.autrev.2013.06.011
   Atzeni F, 2012, AUTOIMMUN REV, V12, P225, DOI 10.1016/j.autrev.2012.06.008
   Au K, 2011, ANN RHEUM DIS, V70, P785, DOI 10.1136/ard.2010.128637
   Ayllon J, 2015, CURR TOP MICROBIOL, V386, P73, DOI 10.1007/82_2014_400
   Bakker MF, 2012, ANN INTERN MED, V156, P329, DOI 10.7326/0003-4819-156-5-201203060-00004
   Bello S, 2012, REUMATISMO, V64, P299, DOI 10.4081/reumatismo.2012.299
   Biggioggero Martina, 2019, Drugs Context, V8, P212595, DOI 10.7573/dic.212595
   Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7
   Bogdanos DP, 2013, AUTOIMMUN REV, V12, P726, DOI 10.1016/j.autrev.2012.12.005
   Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422
   Caporali R, 2019, CLIN EXP RHEUMATOL, V37, P485
   Chen Y., 2020, CHARACTERISTICS LYMP, DOI [10.1101/2020.02.10.20021832, DOI 10.1101/2020.02.10.20021832]
   Conigliaro P, 2019, AUTOIMMUN REV, V18, P706, DOI 10.1016/j.autrev.2019.05.007
   Curtis JR, 2016, ANN RHEUM DIS, V75, P1843, DOI 10.1136/annrheumdis-2016-209131
   Devaux CA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105938
   Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827
   Dixon WG, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3453
   Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524
   Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223
   Edwards CJ, 2019, AUTOIMMUN REV, V18, DOI [10.1016/j.autrev.2019.102399, 10.1016/j.autrev.2019102399]
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Favalli EG, 2020, LANCET RHEUMATOL, V2, pE65, DOI 10.1016/S2665-9913(20)30001-1
   Favalli EG, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2019.102421
   Favalli EG, 2017, AUTOIMMUN REV, V16, P1185, DOI 10.1016/j.autrev.2017.10.002
   Favalli EG, 2014, AUTOIMMUN REV, V13, P1102, DOI 10.1016/j.autrev.2014.08.026
   Favalli EG, 2009, AUTOIMMUN REV, V8, P266, DOI 10.1016/j.autrev.2008.11.002
   Ferguson FM, 2018, NAT REV DRUG DISCOV, V17, P353, DOI 10.1038/nrd.2018.21
   Fleming SB, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030023
   Franklin J, 2007, ANN RHEUM DIS, V66, P308, DOI 10.1136/ard.2006.057265
   G DS, POS STAT ESC COUNC H
   Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105
   HOFFMANN M, 2020, CELL, DOI DOI 10.1016/J.CELL.2020.02.052
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ibrahim A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010015
   INGLOT AD, 1969, J GEN VIROL, V4, P203, DOI 10.1099/0022-1317-4-2-203
   Jamilloux Y, 2019, AUTOIMMUN REV, V18, DOI 10.1016/j.autrev.2019.102390
   Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927
   Joo YB, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1977-9
   Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085
   KEYSTONE E, 2018, J RHEUMATOL, V45, P1003
   Lacaille D, 2008, ARTHRIT RHEUM-ARTHR, V59, P1074, DOI 10.1002/art.23913
   Lewis SR, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004477.pub3
   Li XW, 2020, J PHARM ANAL, V10, P102, DOI 10.1016/j.jpha.2020.03.001
   Lim JK, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e92
   Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305
   Liu C, 2020, ACS CENTRAL SCI, V6, P315, DOI 10.1021/acscentsci.0c00272
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mathew AJ, 2014, BEST PRACT RES CL RH, V28, P935, DOI 10.1016/j.berh.2015.04.009
   Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Memish ZA, 2020, LANCET, V395, P1063, DOI 10.1016/S0140-6736(19)33221-0
   Michaud K, 2007, BEST PRACT RES CL RH, V21, P885, DOI 10.1016/j.berh.2007.06.002
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   Ni YN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2395-8
   Paton NI, 2011, LANCET INFECT DIS, V11, P677, DOI 10.1016/S1473-3099(11)70065-2
   Pawar A, 2020, LANCET RHEUMATOL, V2, pE84, DOI 10.1016/S2665-9913(19)30137-7
   Pu SY, 2018, ANTIVIR RES, V155, P67, DOI 10.1016/j.antiviral.2018.05.001
   Qiao WL, 2015, CARDIOLOGY, V131, P97, DOI 10.1159/000375362
   Ramiro S, 2017, ANN RHEUM DIS, V76, P1093, DOI 10.1136/annrheumdis-2016-210708
   Ramos-Casals M, 2014, LANCET, V383, P1503, DOI 10.1016/S0140-6736(13)61048-X
   Ranganath VK, 2013, RHEUMATOLOGY, V52, P1809, DOI 10.1093/rheumatology/ket224
   Richardson P, 2020, LANCET, V395, pE30, DOI 10.1016/S0140-6736(20)30304-4
   Roques P, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050268
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Rutherford AI, 2018, ANN RHEUM DIS, V77, P905, DOI 10.1136/annrheumdis-2017-212825
   Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   Schoggins JW, 2015, NATURE, V525, DOI 10.1038/nature14554
   Schrezenmeier E, 2020, NAT REV RHEUMATOL, V16, P155, DOI 10.1038/s41584-020-0372-x
   Seguin A, 2016, CHEST, V149, P1294, DOI 10.1016/j.chest.2015.11.004
   Sepriano A, 2020, ANN RHEUM DIS, V79, P760, DOI 10.1136/annrheumdis-2019-216653
   Shakoory B, 2016, CRIT CARE MED, V44, P275, DOI 10.1097/CCM.0000000000001402
   Shale Matt, 2010, Therap Adv Gastroenterol, V3, P173, DOI 10.1177/1756283X10366368
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Singh JA, 2015, LANCET, V386, P258, DOI 10.1016/S0140-6736(14)61704-9
   Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2
   Smitten AL, 2008, J RHEUMATOL, V35, P387
   Smolen JS, 2020, ANN RHEUM DIS, V79, P685, DOI 10.1136/annrheumdis-2019-216655
   Sorrell FJ, 2016, STRUCTURE, V24, P401, DOI 10.1016/j.str.2015.12.015
   Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Strehl C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01744
   Tang NLS, 2005, CLIN CHEM, V51, P2333, DOI 10.1373/clinchem.2005.054460
   Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036
   Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11
   Tudesq JJ, 2018, AUTOIMMUN REV, V17, P115, DOI 10.1016/j.autrev.2017.11.015
   van Everdingen AA, 2002, ANN INTERN MED, V136, P1, DOI 10.7326/0003-4819-136-1-200201010-00006
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Virtanen AT, 2019, BIODRUGS, V33, P15, DOI 10.1007/s40259-019-00333-w
   Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang W., 2020, DEFINITION RISKS CYT, DOI [10.1101/2020.02.26.20026989, DOI 10.1101/2020.02.26.20026989]
   Wang W, 2007, VIRUS RES, V128, P1, DOI 10.1016/j.virusres.2007.02.007
   Widdifield J, 2013, ARTHRIT CARE RES, V65, P353, DOI 10.1002/acr.21812
   Widjaja I, 2019, EMERG MICROBES INFEC, V8, P516, DOI [10.1080/22221751.2019.1597644, 10.6084/m9.figshare.7937462.v3]
   Winthrop KL, 2017, NAT REV RHEUMATOL, V13, P234, DOI 10.1038/nrrheum.2017.23
   Winthrop KL, 2014, ARTHRITIS RHEUMATOL, V66, P2675, DOI 10.1002/art.38745
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   XU X, 2020, EFFECTIVE TREATMENT, DOI [10.1073/pnas.2005615117, DOI 10.1073/PNAS.2005615117]
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Yildiz Halil, 2020, QJM, DOI 10.1093/qjmed/hcaa011
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
   Zuo, 2020, SINGLE CELL RNA EXPR, DOI 10.1101/2020.01.26.919985
NR 115
TC 224
Z9 232
U1 13
U2 56
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD MAY
PY 2020
VL 19
IS 5
AR 102523
DI 10.1016/j.autrev.2020.102523
PG 7
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA LF3PS
UT WOS:000527333300012
PM 32205186
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Shen, Q
   Hua, YK
   Huang, YX
   Ebstein, R
   Yu, XF
   Wu, ZH
AF Shen, Qiang
   Hua, Yukun
   Huang, Yuxing
   Ebstein, Richard
   Yu, Xiaofen
   Wu, Zhihua
TI Knowledge management and modern digital transformation of the property
   management industry in China
SO JOURNAL OF KNOWLEDGE MANAGEMENT
LA English
DT Article; Early Access
DE Property management; Knowledge management; Digital transformation;
   Knowledge creation; Knowledge updating
ID INNOVATION; COMPANIES; CREATION; TACIT
AB Purpose In the current urban and increasingly digital/information era, the service of property management towards residents is of key importance to the well-being of society, which is especially well reflected in its role during the COVID-19 pandemic in China. However, professional knowledge management (KM) has yet to be applied to the daily operation of the property management companies in this sector. The authors posit that introduction of KM concepts to property management at this time would significantly help facilitate the transition of traditional property management towards a higher and more effective value-added service model. From the perspective of KM, this study aims to offer both a theoretical and practical analysis of such a novel business model for companies in the property management industry. Design/methodology/approach Given the current status quo of property management, the authors integrate theories from both KM and information-digital management to qualitatively analyse the challenges and difficulties companies are facing and importantly offer practical suggestions for the centralization, digital-information platform establishment and service innovation. Findings Following the analysis of KM and digital-information modeling, the authors identify three main challenges facing property management services offered in the current digital society including market fragmentation, lack of digital platforms and the absence of a unitary service model. Therefore, the authors propose strategic solutions to resolve these aforementioned problems. Specifically, the authors suggest centralizing property management service, the establishment of a KM-based digital platform and the upgrading of the service model, towards offering a new impetus for the development of companies in property management. Research limitations/implications The authors offer essential guidelines derived from knowledge and information management and explore their implications both from a theoretical, as well as pragmatic/practical perspective that overall would support property management companies' crucial transition from the traditional service model to a more digital-based foundation, and hence, provide a higher value-added service for the residents. Originality/value The current study is one of the first attempts to analyse property management services from the perspective of KM with digital transformation enabling its transition to an information-based internet of things infrastructure. The study not only offers practical guidance to the business of property management but importantly, also contributes to the theoretical underpinnings of KM especially as related to secure serviceability, well-being, security and efficiency of the residential environment by integrating people, place, process and technology.
C1 [Shen, Qiang; Hua, Yukun; Huang, Yuxing; Ebstein, Richard; Yu, Xiaofen] Zhejiang Univ Technol, Sch Management, Hangzhou, Peoples R China.
   [Yu, Xiaofen] Zhejiang Univ Technol, China Acad Housing & Real Estate, Hangzhou, Peoples R China.
   [Wu, Zhihua] Greentown Serv Grp Co Ltd, Hangzhou, Peoples R China.
RP Yu, XF (corresponding author), Zhejiang Univ Technol, Sch Management, Hangzhou, Peoples R China.
EM yxf@zjut.edu.cn
CR Abidoye RB, 2016, J FACIL MANAG, V14, P283, DOI 10.1108/JFM-02-2016-0003
   Agostini L, 2020, J KNOWL MANAG, V24, P463, DOI 10.1108/JKM-07-2019-0382
   Alwis Ragna Seidler-de, 2008, Journal of Knowledge Management, V12, P133, DOI 10.1108/13673270810852449
   Anderson C., 2006, LONG TAIL WHY FUTURE
   Bican PM, 2017, J KNOWL MANAG, V21, P1384, DOI 10.1108/JKM-11-2016-0509
   Botha A, 2008, CHANDOS KNOWL MANAGE, P1
   Cabrera A, 2002, ORGAN STUD, V23, P687, DOI 10.1177/0170840602235001
   Cepeda-Carrion G, 2019, J KNOWL MANAG, V23, P67, DOI 10.1108/JKM-05-2018-0322
   Chin T, 2021, J KNOWL MANAG, V25, P1, DOI 10.1108/JKM-04-2020-0244
   Chin TC, 2018, INT J CONFL MANAGE, V29, P683, DOI 10.1108/IJCMA-09-2017-0101
   China Index Academy, 2020, CHIN TOP 100 PROP SE
   Choi B, 2002, EXPERT SYST APPL, V23, P173, DOI 10.1016/S0957-4174(02)00038-6
   Crane L, 2014, J KNOWL MANAG, V18, P1127, DOI 10.1108/JKM-02-2014-0061
   Dalkir K., 2011, KNOWLEDGE MANAGEMENT
   DAVENPORT TH, 1994, HARVARD BUS REV, V72, P119
   Del Giudice M, 2016, J KNOWL MANAG, V20, P484, DOI 10.1108/JKM-07-2015-0257
   Del Giudice M, 2014, J KNOWL MANAG, V18, P841, DOI 10.1108/JKM-06-2014-0264
   Deloitte, 2020, SPEC REP PROP MAN CH
   Ferreira J, 2018, J KNOWL MANAG, V24, P121, DOI 10.1108/JKM-07-2018-0461
   Gaviria-Marin M, 2018, J KNOWL MANAG, V22, P1655, DOI 10.1108/JKM-10-2017-0497
   Gold AH, 2001, J MANAGE INFORM SYST, V18, P185, DOI 10.1080/07421222.2001.11045669
   Goswami AK, 2019, J KNOWL MANAG, V24, P172, DOI 10.1108/JKM-09-2018-0561
   Ipe M., 2003, HUM RESOUR DEV REV, V2, P337, DOI DOI 10.1177/1534484303257985
   King WR, 2009, ANN INFORM SYST, V4, P3, DOI 10.1007/978-1-4419-0011-1_1
   Maravilhas S, 2019, J BUS RES, V94, P353, DOI 10.1016/j.jbusres.2018.01.061
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Nonaka I, 2007, HARVARD BUS REV, V85, P162
   Oliva FL, 2019, J KNOWL MANAG, V23, P1838, DOI 10.1108/JKM-06-2018-0361
   Papa A, 2021, J KNOWL MANAG, V25, P669, DOI 10.1108/JKM-04-2020-0300
   Razali MN, 2008, PAC RIM PROP RES J, V14, P412, DOI 10.1080/14445921.2008.11104266
   Razali MN, 2011, FACILITIES, V29, P368, DOI 10.1108/02632771111146305
   Santoro G, 2020, TECHNOVATION, V92-93, DOI 10.1016/j.technovation.2018.06.003
   Santoro G, 2018, TECHNOL FORECAST SOC, V136, P347, DOI 10.1016/j.techfore.2017.02.034
   Sousa MJ, 2019, J BUS RES, V94, P223, DOI 10.1016/j.jbusres.2018.10.016
   Talamo C., 2015, KNOWLEDGE MANAGEMENT
   Verhoef PC, 2021, J BUS RES, V122, P889, DOI 10.1016/j.jbusres.2019.09.022
   Vial G, 2019, J STRATEGIC INF SYST, V28, P118, DOI 10.1016/j.jsis.2019.01.003
   Wang S, 2010, HUM RESOUR MANAGE R, V20, P115, DOI 10.1016/j.hrmr.2009.10.001
   Wang XQ, 2014, LANCET, V383, P870, DOI 10.1016/S0140-6736(14)60443-8
NR 39
TC 0
Z9 0
U1 43
U2 43
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1367-3270
EI 1758-7484
J9 J KNOWL MANAG
JI J. Knowl. Manag.
DI 10.1108/JKM-04-2021-0320
EA DEC 2021
PG 12
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XL4VK
UT WOS:000728142600001
DA 2022-04-20
ER

PT J
AU Jevtic, SD
   Malinowski, AK
   Othman, M
   Kadir, RAA
AF Jevtic, Stefan D.
   Malinowski, Ann Kinga
   Othman, Maha
   Abdul Kadir, Rezan A.
TI Physician experiences in management of COVID-19-associated coagulopathy
   in pregnancy: Communication from the ISTH SSC Subcommittee on Women's
   Health Issues in Thrombosis and Haemostasis
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE anticoagulant; coagulopathy; COVID-19; pregnancy; thrombosis
ID COVID-19; DISEASE; TRIALS
AB Background Coronavirus disease 2019 (COVID-19) occurs following infection with the potentially fatal, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. Infection can be complicated by coagulopathy, at times featuring thrombocytopenia and thrombosis alongside other coagulation abnormalities, also termed COVID-19-associated coagulopathy (CAC). Data concerning CAC in pregnancy are limited. Better understanding of physician experiences is essential to identify current practice patterns and knowledge gaps. Objectives To determine physician experiences and practice patterns regarding CAC in pregnancy. Methods Self-administered survey using the RedCap online platform; supported by the ISTH Subcommittee on Women's Health Issues in Thrombosis and Hemostasis. Results Seventy-five respondents fully or partially completed the survey. Of 1546 reported cases, disease severity was specified in 1298. Sixty-four percent of COVID-19 infections were mild, whereas 4% were severe. Of all cases, 1% developed CAC, with 65% classified as severe. The most frequent abnormalities included thrombocytopenia, elevated C-reactive protein, D-dimer, and lymphopenia. Low molecular weight heparin was the anticoagulant of choice in CAC and was provided by 77% of respondents, with 60% using standard prophylactic dosing. Thrombosis occurred in seven anticoagulated patients who were receiving standard prophylactic (four) or weight-based (three) dosing. Disease severity and additional thrombosis risk factors dictated anticoagulation duration. Conclusion In the select population reported by our survey, CAC appears to be uncommon in pregnancy. Anticoagulation practices vary and may not reflect current guidelines. Venous thromboembolism was observed in some CAC patients despite prophylactic anticoagulation (including standard and weight-adjusted dosing). Urgent research is required to determine appropriate anticoagulant dosing and duration in pregnant women with COVID-19 infection.
C1 [Jevtic, Stefan D.] McMaster Univ, Dept Med, Hamilton, ON, Canada.
   [Malinowski, Ann Kinga] Lunenfeld Tanenbaum Res Inst, Sinai Hlth Syst, Dept Obstet & Gynaecol, Div Maternal Fetal Med, 700 Univ Ave,Suite 3-909, Toronto, ON M5G 1Z5, Canada.
   [Malinowski, Ann Kinga] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada.
   [Othman, Maha] Queens Univ, Sch Med, Dept Biomed & Mol Sci, Kingston, ON, Canada.
   [Othman, Maha] St Lawrence Coll, Sch Baccalaureate Nursing, Sch Baccalaureate Nursing, Kingston, ON, Canada.
   [Abdul Kadir, Rezan A.] Royal Free NHS Fdn Hosp, Dept Obstet & Gynaecol, London, England.
   [Abdul Kadir, Rezan A.] UCL, Inst Womens Hlth, London, England.
RP Malinowski, AK (corresponding author), Lunenfeld Tanenbaum Res Inst, Sinai Hlth Syst, Dept Obstet & Gynaecol, Div Maternal Fetal Med, 700 Univ Ave,Suite 3-909, Toronto, ON M5G 1Z5, Canada.
EM ann.malinowski@sinaihealth.ca
OI Jevtic, Stefan/0000-0002-0806-9833
CR Althaus K., SEVERE COVID 19 INFE, DOI [10.1101/2020.09.03.20187286, DOI 10.1101/2020.09.03.20187286]
   Castaman G, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.052
   CDC, COVID DAT TRACK
   Charbit B, 2007, J THROMB HAEMOST, V5, P266, DOI 10.1111/j.1538-7836.2007.02297.x
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Godoy LC, 2020, CAN MED ASSOC J, V192, pE1156, DOI 10.1503/cmaj.201240
   Goshua G, 2020, LANCET HAEMATOL, V7, pE575, DOI 10.1016/S2352-3026(20)30216-7
   Guan WJ, 2020, NEW ENGL J MED, V382, P1708
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0
   Iba T, 2021, J CLIN MED, V10, DOI 10.3390/jcm10020191
   Kadir RA, 2020, J THROMB HAEMOST, V18, P3086, DOI 10.1111/jth.15072
   Kim MS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003501
   Koumoutsea EV, 2020, J THROMB HAEMOST, V18, P1648, DOI 10.1111/jth.14856
   LaCourse SM, 2020, CLIN INFECT DIS, V71, P879, DOI 10.1093/cid/ciaa444
   Lopes RD, 2021, LANCET, V397, P2253, DOI 10.1016/S0140-6736(21)01203-4
   Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639
   Malinowski AK, 2020, REPROD BIOL, V20, P568, DOI 10.1016/j.repbio.2020.10.005
   Malinowski AK, 2020, CAN MED ASSOC J, V192, pE634, DOI 10.1503/cmaj.75807
   Marik PE, 2008, NEW ENGL J MED, V359, P2025, DOI 10.1056/NEJMra0707993
   McClymont Elisabeth, 2021, J Obstet Gynaecol Can, V43, P165, DOI 10.1016/j.jogc.2020.10.005
   Nazy I., 2020, PLATELET ACTIVATING, DOI [10.1101/2020.11.04.20226076v1, DOI 10.1101/2020.11.04.20226076V1]
   Servante J, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03568-0
   Taylor MM, 2021, LANCET GLOB HEALTH, V9, pE366, DOI 10.1016/S2214-109X(20)30484-8
   Turan O, 2020, INT J GYNECOL OBSTET, V151, P7, DOI 10.1002/ijgo.13329
   Yang XB, 2020, J THROMB HAEMOST, V18, P1469, DOI 10.1111/jth.14848
   Zambrano LD, 2020, MMWR-MORBID MORTAL W, V69, P1641, DOI 10.15585/mmwr.mm6944e3
   Zarychanski R., THERAPEUTIC ANTICOAG, DOI [10.1101/2021.03.10.21252749v1, DOI 10.1101/2021.03.10.21252749V1]
   Zhang J, 2020, REV CARDIOVASC MED, V21, P315, DOI 10.31083/j.rcm.2020.03.126
   Zhang LT, 2020, J THROMB HAEMOST, V18, P1324, DOI 10.1111/jth.14859
NR 31
TC 3
Z9 3
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1538-7933
EI 1538-7836
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
PD OCT
PY 2021
VL 19
IS 10
BP 2539
EP 2545
DI 10.1111/jth.15462
EA AUG 2021
PG 7
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA UU0BW
UT WOS:000681474600001
PM 34260818
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Singh, GP
   Hrishi, AP
   Rath, GP
AF Singh, Gyaninder Pal
   Hrishi, Ajay Prasad
   Rath, Girija Prasad
TI Emergency neurological procedures during COVID-19 pandemic: Practical
   issues
SO JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY
LA English
DT Review
DE Corona Virus Disease 2019 (COVID-19); neuroanesthesia; neuroradiologic
   intervention; neurosurgical emergency
ID ACUTE ISCHEMIC-STROKE; CONSENSUS STATEMENT; ENDOVASCULAR TREATMENT;
   ANESTHETIC MANAGEMENT; ANESTHESIOLOGY; NEUROSCIENCE; SOCIETY;
   GUIDELINES; THERAPY
AB The novel coronavirus disease 2019 (COVID-19) has emerged as a global pandemic. A significant number of these patients would present to hospitals with neurological manifestations and neurosurgical emergencies requiring urgent treatment. The anesthesiologists should be prepared to manage these cases in an efficient and timely manner in the operating room, intensive care units, and interventional neuroradiology suites. The clinical course of the disease is in an evolving stage. As we acquire more knowledge about COVID-19, new recommendations and guidelines are being formulated and regularly updated. This article discusses the anesthetic management of urgent neurosurgical and neurointerventional procedures. In addition, a brief overview of intrahospital transport of neurologically injured patients has been addressed.
C1 [Singh, Gyaninder Pal; Rath, Girija Prasad] All India Inst Med Sci AIIMS, Dept Neuroanaesthesiol & Crit Care, New Delhi, India.
   [Hrishi, Ajay Prasad] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMS, Div Neuroanaesthesia, Thiruvananthapuram, Kerala, India.
RP Rath, GP (corresponding author), All India Inst Med Sci AIIMS, Neurosci Ctr, Dept Neuroanaesthesiol & Crit Care, New Delhi 110029, India.
EM girijarath@aiims.edu
RI SINGH, GYANINDER/T-7976-2017
OI SINGH, GYANINDER/0000-0002-6702-6892
CR Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Bejjani GK, 1998, NEUROSURGERY, V42, P979, DOI 10.1097/00006123-199805000-00013
   Dexter F, 2020, ANESTH ANALG, V131, P37, DOI 10.1213/ANE.0000000000004829
   Filatov A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7352
   Flexman AM, 2020, J NEUROSURG ANESTH, V32, P202, DOI 10.1097/ANA.0000000000000691
   Gupta P, 2020, NEUROL INDIA, V68, P246, DOI 10.4103/0028-3886.283130
   Han H, 2020, CLIN CHEM LAB MED, V58, P1116, DOI 10.1515/cclm-2020-0188
   Hui DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050845
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li SY, 2016, J CLIN ANESTH, V34, P440, DOI 10.1016/j.jclinane.2016.05.034
   Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431
   Liew MF, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2828-4
   Luo MQ, 2020, ANESTHESIOLOGY, V132, P1616, DOI 10.1097/ALN.0000000000003288
   Mao L, 2020, JAMA NEUROL, P1, DOI [10.1001/jamaneurol.2020.1127, 10.2139/ssrn.3544840, 10.1101/ 2020.02.22.20026500, DOI 10.1101/2020.02.22.20026500]
   Meng LZ, 2020, ANESTHESIOLOGY, V132, P1317, DOI 10.1097/ALN.0000000000003296
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Patel ZM, 2020, NEUROSURGERY, V87, pE66, DOI 10.1093/neuros/nyaa125
   Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211
   Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Sharma D, 2020, J NEUROSURG ANESTH, V32, P193, DOI 10.1097/ANA.0000000000000688
   Simonds AK, 2010, HEALTH TECHNOL ASSES, V14, P131, DOI 10.3310/hta14460-02
   Spyropoulos AC, 2011, CHEST, V140, P706, DOI 10.1378/chest.10-1944
   Talke PO, 2014, J NEUROSURG ANESTH, V26, P95, DOI 10.1097/ANA.0000000000000042
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 28
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0970-9185
EI 2231-2730
J9 J ANAESTH CLIN PHARM
JI J. Anaesth. Clin. Pharm.
PD AUG
PY 2020
VL 36
SU 1
BP S104
EP +
DI 10.4103/joacp.JOACP_243_20
PG 6
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA OF9TO
UT WOS:000581540400023
PM 33100657
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Jha, SK
AF Jha, Srirang Kumar
TI Imperatives for open innovation in times of COVID-19
SO INTERNATIONAL JOURNAL OF INNOVATION SCIENCE
LA English
DT Article
DE Open innovation; Collaboration; COVID-19; Creative problem solving
AB Purpose COVID-19 pandemic has triggered an existential crisis amongst the companies, communities, organisations and institutions across the globe. People are facing unusual scenarios characterized by prolonged lockdowns, changes in the work from home compulsions, job losses, disruptions in the supply-chain networks, the slowdown in economies, scarcity of essential commodities and unavailability of medical services due to burgeoning numbers of positive cases with COVID-19. Death rates due to COVID-19 are alarmingly high, which complicate matters all the more. The purpose of this paper is to explore how open innovation can enable the suffering communities overcome the crisis of such magnitude. Design/methodology/approach This paper is based on general understanding and academic insight emerging out of the millennial crisis like COVID-19 that the author witnessed with close quarters. Findings The people's suffering due to COVID-19 pandemic is terrific, almost unparalleled in the history of civilisation. However, the pandemic has also galvanised the people all over the world to come together and work towards collaborative problem solving and open innovation. As such, COVID-19 has presented an unprecedented situation which warrants extra-ordinary responses. The crisis has inadvertently made room for open innovation so that human miseries can be successfully mitigated by leveraging collective wisdom and traditional knowledge of the communities who are more than willing today to collaborate and make a difference in the solutions space in true sense. Originality/value This paper provides fresh insights on the rationale and efficacy of open innovations in overcoming the crisis like a pandemic. Companies across the globe have also come forward to work together with anyone, including their competitors, to explore immediate and practical solutions to the problems caused by COVID-19. The paper also provides a framework of developing as well as strengthening an ecosystem for open innovations in the world inflicted by unique civilizational crisis. The only way to get out of the current mess is to join hands for collaborations and collectively find innovative solutions to the issues plaguing humanity today.
C1 [Jha, Srirang Kumar] Apeejay Sch Management, Dept Gen Management, New Delhi, India.
RP Jha, SK (corresponding author), Apeejay Sch Management, Dept Gen Management, New Delhi, India.
EM jha.srirang@gmail.com
CR Alexy O, 2009, MIT SLOAN MANAGE REV, V51, P71
   [Anonymous], 2020, HINDU BUSINESS LINE
   Arthur WB, 1996, HARVARD BUS REV, V74, P100
   Bertello A, 2022, R&D MANAGE, V52, P178, DOI 10.1111/radm.12456
   Boudreau KJ, 2009, MIT SLOAN MANAGE REV, V50, P69
   Burmakina, 2021, J OPEN INNOV-TECHNOL, V7, P172, DOI [10.3390/joitmc7030172, DOI 10.3390/JOITMC7030172]
   Business World, 2020, BUSINESS WORLD
   Chesbrough H, 2003, CALIF MANAGE REV, V45, P33, DOI 10.2307/41166175
   Chesbrough H., 2007, OPEN BUSINESS MODELS
   Chesbrough H.W., 2006, OPEN INNOVATION NEW
   Chesbrough H, 2020, IND MARKET MANAG, V88, P410, DOI 10.1016/j.indmarman.2020.04.010
   Chesbrough H, 2018, J PROD INNOVAT MANAG, V35, P930, DOI 10.1111/jpim.12471
   Chesbrough H, 2017, RES TECHNOL MANAGE, V60, P35, DOI 10.1080/08956308.2017.1255054
   Chesbrough H, 2011, MIT SLOAN MANAGE REV, V52, P85
   Chesbrough HW, 2009, HARVARD BUS REV, V87, P68
   Di Minin A, 2010, CALIF MANAGE REV, V52, P132, DOI 10.1525/cmr.2010.52.3.132
   Drucker P.F., 1985, DISCIPLINE INNOVATIO, P143
   Felin T, 2014, RES POLICY, V43, P914, DOI 10.1016/j.respol.2013.09.006
   Frazer John Scott, 2020, Journal of Medical Engineering & Technology, V44, DOI 10.1080/03091902.2020.1757772
   Frick W., 2014, HARVARD BUS REV
   Galanakis CM, 2021, TRENDS FOOD SCI TECH, V110, P193, DOI 10.1016/j.tifs.2021.02.002
   Huston L, 2006, HARVARD BUS REV, V84, P58
   Jagtiani T., 2020, INDIA DEV REV
   Jeppesen LB, 2010, ORGAN SCI, V21, P1016, DOI 10.1287/orsc.1090.0491
   Keogh C, 2021, QEIOS
   Law, 2020, HINDU BUSINESS LINE
   Mount M, 2014, CALIF MANAGE REV, V56, P124, DOI 10.1525/cmr.2014.56.4.124
   Oyewole AO, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11020182
   Rauter R, 2019, J INNOV KNOWL, V4, P226, DOI 10.1016/j.jik.2018.03.004
   Saini A.K., 2020, J POLITICS GOVERNANC, V8, P8
   Salter A, 2014, CALIF MANAGE REV, V56, P77, DOI 10.1525/cmr.2014.56.2.77
   Sehan, 2020, COMPETITOR COLLABORA
   Sharma HB, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105052
   Susilo D, 2021, COGENT SOC SCI, V7, DOI 10.1080/23311886.2021.1905919
   Tuttle KR, 2020, NAT REV NEPHROL, V16, P562, DOI 10.1038/s41581-020-00336-9
   Wallin, 2020, HARVARD BUS REV
   West J, 2017, INNOV-ORGAN MANAG, V19, P43, DOI 10.1080/14479338.2016.1258995
   Whelan E, 2011, MIT SLOAN MANAGE REV, V53, P37
   Woolliscroft JO, 2020, ACAD MED, V95, P1140, DOI 10.1097/ACM.0000000000003402
   World Economic Forum, 2020, COV SOC SECT MOB PLA
   Yun JJ, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125076
NR 41
TC 1
Z9 1
U1 3
U2 3
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1757-2223
EI 1757-2231
J9 INT J INOV SCI
JI Int. J. Innov. Sci.
PD MAR 23
PY 2022
VL 14
IS 2
BP 339
EP 350
DI 10.1108/IJIS-02-2021-0030
EA OCT 2021
PG 12
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZZ7QE
UT WOS:000712439200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Trunfio, M
   Pasquinelli, C
AF Trunfio, Mariapina
   Pasquinelli, Cecilia
TI Smart technologies in the Covid-19 crisis: Managing tourism flows and
   shaping visitors' behaviour
SO EUROPEAN JOURNAL OF TOURISM RESEARCH
LA English
DT Article
DE smart technology; COVID-19; overtourism; smart tourism destination;
   tourism flows; visitor behaviour
ID DESTINATIONS; CITY; PERCEPTIONS; MANAGEMENT; ATTITUDES; QUALITY
AB This paper contributes to the academic debate on tourism destination development in the COVID-19 crisis, by investigating the role of smart technology tools for managing tourism flows and shaping visitors' behaviours. Considering tourism in the COVID-19 crisis as an emerging stream of research, the paper assumes a continuity with the overtourism research (pre-COVID-19) and builds on the cross-fertilization between the advances in this field and the smart destination literature. Based on an explorative online news media analysis, the paper provides fresh knowledge on the role of smart technologies in destination management, by proposing the Smart Technology Matrix. This frames the smart-tech tools and provides the conceptual background for opening future paths of inquiry on smart tourism destinations in the Covid-19 context.
C1 [Trunfio, Mariapina; Pasquinelli, Cecilia] Univ Naples Parthenope, Dept Management & Quantitat Studies, Naples, Italy.
RP Trunfio, M (corresponding author), Univ Naples Parthenope, Dept Management & Quantitat Studies, Naples, Italy.
EM mariapina.trunfio@uniparthenope.it
CR Ali A, 2014, J HOSP TOUR TECHNOL, V5, P2, DOI 10.1108/JHTT-12-2012-0034
   Andereck KL, 2005, ANN TOURISM RES, V32, P1056, DOI 10.1016/j.annals.2005.03.001
   Angelidou M, 2017, J URBAN TECHNOL, V24, P3, DOI 10.1080/10630732.2017.1348880
   Baggio R, 2014, INF TECHNOL TOUR, V14, P3, DOI 10.1007/s40558-013-0001-5
   Berg B.R.U.C.E.L., 2001, QUALITATIVE RES METH
   Boes K., 2015, INFORM COMMUNICATION, P391, DOI DOI 10.1007/978-3-319-14343-9_29
   Bramwell B, 2008, J SUSTAIN TOUR, V16, P253, DOI 10.1080/09669580802208201
   Buhalis D, 1998, TOURISM MANAGE, V19, P409, DOI 10.1016/S0261-5177(98)00038-7
   Buhalis D., 2013, INFORM COMMUNICATION, P553, DOI DOI 10.1007/978-3-319-03973-2_40
   Buonincontri P, 2016, INF TECHNOL TOUR, V16, P285, DOI 10.1007/s40558-016-0060-5
   Burrai E, 2019, J SUSTAIN TOUR, V27, P992, DOI 10.1080/09669582.2019.1578365
   Butler R.W., 1999, TOURISM GEOGR, V1, P7, DOI [10.1080/14616689908721291, DOI 10.1080/14616689908721291]
   BUTLER RW, 1980, CAN GEOGR-GEOGR CAN, V24, P5, DOI 10.1111/j.1541-0064.1980.tb00970.x
   Camero A, 2019, CITIES, V93, P84, DOI 10.1016/j.cities.2019.04.014
   Capocchi A, 2020, CURR ISSUES TOUR, V23, P2235, DOI 10.1080/13683500.2019.1638353
   Caragliu A, 2011, J URBAN TECHNOL, V18, P65, DOI 10.1080/10630732.2011.601117
   Cavalheiro G. M. D. C., 2019, TOUR PLAN DEV, V17, P1
   Cheer JM, 2019, J SUSTAIN TOUR, V27, P554, DOI 10.1080/09669582.2019.1578363
   Cheung KS, 2019, J SUSTAIN TOUR, V27, P1197, DOI 10.1080/09669582.2019.1606815
   de Jong M, 2015, J CLEAN PROD, V109, P25, DOI 10.1016/j.jclepro.2015.02.004
   Del Chiappa G, 2015, J DESTIN MARK MANAGE, V4, P145, DOI 10.1016/j.jdmm.2015.02.001
   Desdemoustier J, 2019, CITIES, V92, P175, DOI 10.1016/j.cities.2019.03.021
   Dodds R., 2019, OVERTOURISM ISSUES R
   Dredge D., 2017, OVERTOURISM OLD WINE
   Errichiello L, 2017, BRIDG TOUR THEOR PRA, V8, P147, DOI 10.1108/S2042-144320170000008010
   Errichiello L, 2017, EUR J TOUR RES, V17, P5
   European Cities Marketing, 2014, ECM PRES RES TOUR EU
   Fleishman L., 2004, Tourism Analysis, V9, P23, DOI 10.3727/1083542041437530
   Font X, 2017, J SUSTAIN TOUR, V25, P869, DOI 10.1080/09669582.2017.1301721
   Ford R., 2014, METACOMMUNICATE, V4, P1
   Frey N, 2010, TOURISM MANAGE, V31, P621, DOI 10.1016/j.tourman.2009.06.017
   Fulton H, 2005, NARRATIVE AND MEDIA, P218
   Gajdosik T, 2019, SPR PROC BUS ECON, P15, DOI 10.1007/978-3-030-03910-3_2
   Garcia-Hernandez M, 2019, B ASOC GEOGR ESP, DOI 10.21138/bage.2830
   Goodwin H, 2019, DE GRU STUD TOURISM, V1, P125, DOI 10.1515/9783110607369-009
   Gretzel U., 2000, Journal of Travel Research, V39, P146, DOI 10.1177/004728750003900204
   Gretzel U, 2015, ELECTRON MARK, V25, P179, DOI 10.1007/s12525-015-0196-8
   Gunter B., 2000, MEDIA RES METHODS
   Hall C. M., 2002, Current Issues in Tourism, V5, P458, DOI 10.1080/13683500208667935
   Hall M.C., 2003, E REV TOUR RES, V1, P1
   Higgins-Desbiolles F., 2019, Journal of Sustainable Tourism, V27, P1926
   Ivars-Baidal J. A., 2019, e-Review of Tourism Research, V17, P122
   Ivars-Baidal JA, 2019, CURR ISSUES TOUR, V22, P1581, DOI 10.1080/13683500.2017.1388771
   Jin Q, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8100976
   Jovicic DZ, 2019, CURR ISSUES TOUR, V22, P276, DOI 10.1080/13683500.2017.1313203
   Koens K, 2021, J DESTIN MARK MANAGE, V19, DOI 10.1016/j.jdmm.2019.100376
   Koens K, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124384
   Krippendorff K, 2004, HUM COMMUN RES, V30, P411, DOI 10.1111/j.1468-2958.2004.tb00738.x
   McCool S. F., 2001, Journal of Sustainable Tourism, V9, P372, DOI 10.1080/09669580108667409
   McCool S. F., 1994, Tourism Recreation Research, V19, P51
   McKeever, 2010, P ANN CONV WORLD ASS
   Milano C., 2017, OVERTOURISM TURISMOF
   Milano C, 2019, TOUR PLAN DEV, V16, P353, DOI 10.1080/21568316.2019.1599604
   Mora L, 2019, TECHNOL FORECAST SOC, V142, P70, DOI 10.1016/j.techfore.2018.07.035
   Gonzalez VM, 2018, TOUR REV, V73, P277, DOI [10.1108/tr-08-2017-0138, 10.1108/TR-08-2017-0138]
   Nash D., 1990, TOUR MANAG, V11, P263, DOI [10.1016/0261-5177(90)90051-A, DOI 10.1016/0261-5177(90)90051-A]
   Neuhofer B, 2012, J DESTIN MARK MANAGE, V1, P36, DOI 10.1016/j.jdmm.2012.08.001
   Novy J, 2019, TOUR PLAN DEV, V16, P358, DOI 10.1080/21568316.2019.1577293
   O'Reilly A. M., 1986, Tourism Management, V7, P254, DOI 10.1016/0261-5177(86)90035-X
   Oklevik O, 2019, J SUSTAIN TOUR, V27, P1804, DOI 10.1080/09669582.2018.1533020
   Pasquinelli C, 2020, CITIES, V102, DOI 10.1016/j.cities.2020.102729
   Pasquinelli C, 2020, J SUSTAIN TOUR, V28, P1805, DOI 10.1080/09669582.2020.1760871
   Peeters P., 2018, RES TRAN COMMITTEE O
   Perdue RR, 1999, J BUS RES, V44, P165, DOI 10.1016/S0148-2963(97)00198-7
   Phi GT, 2020, CURR ISSUES TOUR, V23, P2093, DOI 10.1080/13683500.2019.1618249
   Pung JM, 2020, ANN TOURISM RES, V81, DOI 10.1016/j.annals.2020.102885
   Racherla P, 2008, CURR ISSUES TOUR, V11, P407, DOI 10.1080/13683500802316022
   Rasoolimanesh SM, 2017, ANATOLIA, V28, P41, DOI 10.1080/13032917.2016.1247288
   Riganti P, 2008, TOURISM ECON, V14, P25, DOI 10.5367/000000008783554785
   Rosenow J.E., 1979, TOURISM GOOD BAD UGL
   Ruhanen L, 2015, J SUSTAIN TOUR, V23, P517, DOI 10.1080/09669582.2014.978790
   Schweinsberg S, 2017, TOURISM MANAGE, V62, P241, DOI 10.1016/j.tourman.2017.04.011
   Seraphin H, 2019, J HOSP TOUR MANAG, V38, P1, DOI 10.1016/j.jhtm.2018.11.003
   Seraphin H, 2018, J DESTIN MARK MANAGE, V9, P374, DOI 10.1016/j.jdmm.2018.01.011
   Sigala M, 2018, TOUR MANAG PERSPECT, V25, P151, DOI 10.1016/j.tmp.2017.12.003
   Stamboulis Y, 2003, TOURISM MANAGE, V24, P35, DOI 10.1016/S0261-5177(02)00047-X
   Stewart WP, 2001, J LEISURE RES, V33, P106, DOI 10.1080/00222216.2001.11949933
   STOKOLS D, 1972, J AM I PLANNERS, V38, P72, DOI 10.1080/01944367208977409
   Sun YY, 2017, CURR ISSUES TOUR, V20, P1246, DOI 10.1080/13683500.2015.1089845
   Teye V, 2002, ANN TOURISM RES, V29, P668, DOI 10.1016/S0160-7383(01)00074-3
   Trunfio M, 2019, J DESTIN MARK MANAGE, V14, DOI 10.1016/j.jdmm.2019.100370
   Trunfio M, 2019, J HOSP TOUR RES, V43, P349, DOI 10.1177/1096348018807293
   UNWTO, 2019, IMP ASS COVID 19 OUT
   UNWTO, 2018, OV UND MAN URB TOUR
   Williams AM, 2020, ANN TOURISM RES, V83, DOI 10.1016/j.annals.2020.102930
   World Tourism Organization (UNWTO), 2019, INT TOUR HIGHL 2019, DOI 10.18111/9789284421152
   World Travel and Tourism Council, 2017, COP SUCC MAN OV TOUR
   Yeh SS, 2012, ADV HOSP LEISURE, V8, P63, DOI 10.1108/S1745-3542(2012)0000008008
   Zubiaga M, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11247254
NR 89
TC 3
Z9 3
U1 10
U2 10
PU VARNA UNIV MANAGEMENT-VUM
PI VARNA
PA 13 A OBORISHTE STR, VARNA, 9000, BULGARIA
SN 1994-7658
EI 1314-0817
J9 EUR J TOUR RES
JI Eur. J. Tour. Res.
PY 2021
VL 29
PG 20
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA TE2GK
UT WOS:000669833200016
OA gold
DA 2022-04-20
ER

PT J
AU Forouzesh, M
   Behnoush, B
   Sadeghi, A
   Shahnavaz, H
   Barzegar, A
   Bazmi, E
AF Forouzesh, Mehdi
   Behnoush, Behnam
   Sadeghi, Anahita
   Shahnavaz, Hengameh
   Barzegar, Abdolrazagh
   Bazmi, Elham
TI Postmortem Liver Pathology Findings in Patients With COVID-19: A
   Systematic Review
SO INTERNATIONAL JOURNAL OF MEDICAL TOXICOLOGY AND FORENSIC MEDICINE
LA English
DT Review
DE Postmortem; Findings; Liver; Pathology; Coronavirus Disease 2019
   (COVID-19)
ID AUTOPSY
AB Background: The Coronavirus Disease 2019 (COVID-19) pandemic promptly became a significant public health challenge with extra-pulmonary manifestations, including liver damage. Postmortem examination is crucial for gaining a better understanding of these manifestations and improving patient management This study summarized the current knowledge of the postmortem liver pathology of patients with COVID-19.
   Methods: This review was conducted on studies evaluating the postmortem macroscopic and microscopic findings of the liver in patients with COVID-19. Accordingly, we searched 4 electronic databases (PubMed, Scopus, Google Scholar, & Web of Science) until June 2021. From the 317 screened articles, 16 articles examining a total of 332 patients who had died due to COVID-19 were selected.
   Results: The significant findings of the liver were moderate macro and microvesicular steatosis with mild sinusoidal dilation, active lobular and portal vein thrombosis, mildly-increased lymphocyte filtration in sinusoidal space, and multifocal hepatic necrosis. Additionally, the most common comorbidities were hypertension and other metabolic diseases. In conclusion, liver damage due to COVID-19 infection has various manifestations in patients who have expired due to COVID-19.
   Conclusion: Therefore, monitoring liver function during the course and treatment of this disease is necessary for better patient management and to decrease the COVID-19-induced mortality rate COVID.
C1 [Forouzesh, Mehdi; Barzegar, Abdolrazagh; Bazmi, Elham] Legal Med Org, Legal Med Res Ctr, Tehran, Iran.
   [Behnoush, Behnam] Fac Med, Dept Forens Med, Tehran, Iran.
   [Sadeghi, Anahita] Univ Tehran Med Sci, Digest Dis Res Ctr, Digest Dis Res Inst, Tehran, Iran.
   [Shahnavaz, Hengameh] Univ Tehran Med Sci, Sch Med, Dept Pathol, Tehran, Iran.
RP Bazmi, E (corresponding author), Legal Med Org, Legal Med Res Ctr, Tehran, Iran.
EM dr_elbazmi@yahoo.com
CR Bangash MN, 2020, LANCET GASTROENTEROL, V5, P529, DOI 10.1016/S2468-1253(20)30084-4
   Beigee FS, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.153228
   Beigmohammadi MT, 2021, INT J SURG PATHOL, V29, P135, DOI 10.1177/1066896920935195
   Besharat S, 2020, OPEN ACCESS MACED J, V8, P144, DOI [10.3889/ oamjms.2020.5013, DOI 10.3889/OAMJMS.2020.5013]
   Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2
   Buja LM, 2020, CARDIOVASC PATHOL, V48, DOI 10.1016/j.carpath.2020.107233
   Cai QX, 2020, J HEPATOL, V73, P566, DOI 10.1016/j.jhep.2020.04.006
   Chai X, 2020, SPECIFIC ACE2 EXPRES, DOI [10.1101/2020.02.03.931766, DOI 10.1101/2020.02.03.931766]
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2
   D'Amico F, 2020, CLIN GASTROENTEROL H, V18, P1663, DOI 10.1016/j.cgh.2020.04.001
   Duarte-Neto AN, 2020, HISTOPATHOLOGY, V77, P186, DOI 10.1111/his.14160
   Eketunde AO, 2020, CUREUS, V12, DOI 10.7759/cureus.9438
   Elsoukkary SS, 2021, PATHOBIOLOGY, V88, P56, DOI 10.1159/000511325
   Falasca L, 2020, J INFECT DIS, V222, P1807, DOI 10.1093/infdis/jiaa578
   Fan ZY, 2020, CLIN GASTROENTEROL H, V18, P1561, DOI 10.1016/j.cgh.2020.04.002
   Fassan M, 2021, PATHOL RES PRACT, V221, DOI 10.1016/j.prp.2021.153451
   Forouzesh M., 2021, J NEPHROPHARMACOL, V10, DOI [10.34172/npj.2021.06, DOI 10.34172/NPJ.2021.06]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jothimani D, 2020, J HEPATOL, V73, P1231, DOI 10.1016/j.jhep.2020.06.006
   Keten D, 2020, J FORENSIC LEG MED, V73, DOI 10.1016/j.jflm.2020.102000
   Lagana SM, 2020, MODERN PATHOL, V33, P2147, DOI 10.1038/s41379-020-00649-x
   Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566
   Ledford Heidi, 2020, Nature, DOI 10.1038/d41586-020-01355-z
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Martines RB, 2020, EMERG INFECT DIS, V26, P2005, DOI 10.3201/eid2609.202095
   Milroy Christopher M, 2018, Acad Forensic Pathol, V8, P296, DOI 10.1177/1925362118782061
   Murad MH, 2018, BMJ EVID-BASED MED, V23, P60, DOI 10.1136/bmjebm-2017-110853
   Nobel YR, 2020, GASTROENTEROLOGY, V159, P373, DOI 10.1053/j.gastro.2020.04.017
   Rapkiewicz AV, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100434
   Remmelink M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03218-5
   Schmit G, 2021, PATHOBIOLOGY, V88, P88, DOI 10.1159/000512008
   Schurink B, 2020, LANCET MICROBE, V1, pE290, DOI 10.1016/S2666-5247(20)30144-0
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Sonzogni A, 2020, LIVER INT, V40, P2110, DOI 10.1111/liv.14601
   Tombolini A, 2020, INT J LEGAL MED, V134, P2205, DOI 10.1007/s00414-020-02354-5
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   World Health Organization, LIST WHOS RESP COVID
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xu L, 2020, LIVER INT, V40, P998, DOI 10.1111/liv.14435
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zhang YF, 2020, LIVER INT, V40, P2095, DOI 10.1111/liv.14455
   Zhao CL, 2021, HUM PATHOL, V109, DOI 10.1016/j.humpath.2020.11.015
NR 46
TC 0
Z9 0
U1 1
U2 1
PU SHAHEED BEHESHTI MEDICAL UNIV-MEDICAL SCIENCES & HEALTH SERVICES
PI TEHRAN
PA SHAHEED BAHONAR AVE, DARABAD, TEHRAN, 19569, IRAN
SN 2251-8762
EI 2251-8770
J9 INT J MED TOX FORENS
JI Int. J. Med. Toxicol. Forens. Med.
PD FAL
PY 2021
VL 11
IS 4
AR 35042
DI 10.32598/ijmtfm.v11i4.35042
PG 11
WC Medicine, Legal; Toxicology
WE Emerging Sources Citation Index (ESCI)
SC Legal Medicine; Toxicology
GA ZA8SP
UT WOS:000756427300013
OA gold
DA 2022-04-20
ER

PT J
AU McCartney, G
   In, CLC
   Pinto, JSDF
AF McCartney, Glenn
   In, Charlene Lai Chi
   de Albergaria Ferreira Pinto, Jose Soares
TI COVID-19 impact on hospitality retail employees' turnover intentions
SO INTERNATIONAL JOURNAL OF CONTEMPORARY HOSPITALITY MANAGEMENT
LA English
DT Article; Early Access
DE Hospitality retail workforce; COVID-19; Turnover intention; Retention
   strategy
ID JOB-SATISFACTION; ORGANIZATIONAL-COMMITMENT; PLANNED BEHAVIOR; HOTEL
   EMPLOYEES; FRINGE BENEFITS; WORK-LIFE; MANAGEMENT; PERFORMANCE; SUPPORT;
   QUALITY
AB Purpose This study aims to examine effects of the COVID-19-induced lockdown on turnover intentions (TI) for the hospitality retail sector. Design/methodology/approach This study reviews employee TI literature before and during the COVID-19 pandemic. The data for the present study were derived from a sample of 301 hospitality retail workers employed within the integrated resorts on The Cotai Strip, Macao. Data were analysed using structural equation modelling. Findings This study showed a significant positive relationship between job satisfaction (JS) and the two variables of workload and pay (WP) and company support (CS). Co-worker relationship did not influence JS. Furthermore, JS had a significant negative effect on employee TI. WP had the greatest influence on whether to leave the sector or not. Practical implications The suggested framework can assist hospitality retail management in developing an employee-retention strategy as the sector recovers from pandemic restrictions. Originality/value To the best of the authors' knowledge, this is one of the first studies to develop a TI framework for the hospitality retail sector during the pandemic.
C1 [McCartney, Glenn; In, Charlene Lai Chi; de Albergaria Ferreira Pinto, Jose Soares] Univ Macau, Fac Business Adm, Macau, Peoples R China.
RP McCartney, G (corresponding author), Univ Macau, Fac Business Adm, Macau, Peoples R China.
EM glennm@umac.mo
OI SOARES DE ALBERGARIA FERREIRA PINTO, JOSE/0000-0001-8168-3816
CR Agarwal P, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102765
   Aguiar-Quintana T, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2021.102868
   Ahmad R, 2015, TOUR REV, V70, P13, DOI 10.1108/TR-11-2013-0065
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Albashiti B, 2021, INT J CONTEMP HOSP M, V33, P3564, DOI 10.1108/IJCHM-03-2021-0394
   Arndt A, 2006, J RETAILING, V82, P319, DOI 10.1016/j.jretai.2006.08.005
   Arokiasamy A.R.A., 2013, MIDDLE EAST J SCI RE, V16, P1532, DOI DOI 10.5829/idosi.mejsr.2013.16.11.12044
   Artz B, 2010, INT J MANPOWER, V31, P626, DOI 10.1108/01437721011073346
   Bajrami DD, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102754
   Bani-Melhem S, 2021, J HOSP MARKET MANAG, V30, P611, DOI 10.1080/19368623.2021.1860850
   Baum T, 2020, INT J CONTEMP HOSP M, V32, P2813, DOI 10.1108/IJCHM-04-2020-0314
   Beaujean A.A., 2014, LATENT VARIABLE MODE
   Bohdanowicz P, 2009, TOUR HOSP RES, V9, P147, DOI 10.1057/thr.2008.46
   Booth S, 2007, INT J RETAIL DISTRIB, V35, P289, DOI 10.1108/09590550710736210
   Brown TA., 2006, CONFIRMATORY FACTOR, DOI [10.1007/978-3-319-65361-7_8, DOI 10.1007/978-3-319-65361-7_8]
   Bufquin D, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102764
   Bulinska-Stangrecka H, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041903
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Chan SH, 2015, J HOSP MARKET MANAG, V24, P345, DOI 10.1080/19368623.2014.911712
   Chandrasekar K., 2011, INT J ENTERPRISE COM, V1, P1
   Chang W, 2020, INT J CONTEMP HOSP M, V32, P193, DOI 10.1108/IJCHM-10-2018-0831
   Chen CC, 2021, ANN TOURISM RES, V89, DOI 10.1016/j.annals.2020.103080
   Chen HT, 2019, INT J CONTEMP HOSP M, V31, P2034, DOI 10.1108/IJCHM-02-2018-0164
   Choi S.H., 2015, HUMANITIES SOCIAL SC, V3, P6
   Choi Y. S., 2010, Journal of Human Resources in Hospitality & Tourism, V9, P103, DOI 10.1080/15332840903336499
   Choy MWC, 2021, CURR ISSUES TOUR, V24, P1375, DOI 10.1080/13683500.2020.1792853
   Costen W. M., 2011, Journal of Human Resources in Hospitality & Tourism, V10, P273, DOI 10.1080/15332845.2011.555734
   Dean. G., 2021, 3 FORMER HOSPITALITY
   Dess GG, 2001, ACAD MANAGE REV, V26, P446, DOI 10.2307/259187
   Dewanto A, 2018, BMC NURS, V17, DOI 10.1186/s12912-018-0317-8
   Ellickson MC, 2002, PUBLIC PERS MANAGE, V31, P343, DOI 10.1177/009102600203100307
   Fox J., 2012, HDB STRUCTURAL EQUAT, P325
   Gebbels M, 2020, INT J CONTEMP HOSP M, V32, P126, DOI 10.1108/IJCHM-04-2019-0338
   Gupta V, 2019, INT J CONTEMP HOSP M, V31, P4150, DOI 10.1108/IJCHM-10-2018-0859
   Guzzo RF, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102778
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Hassan SB, 2021, J DESTIN MARK MANAGE, V19, DOI 10.1016/j.jdmm.2020.100495
   Hox J.J., 2013, OXFORD HDB QUANTITAT, P281, DOI [DOI 10.1093/OXFORDHB/9780199934898.013.0014, DOI 10.1093/0XF0RDHB/9780199934898.013.0014]
   Hoyle R. H., 2012, HDB STRUCTURAL EQUAT
   Jehanzeb K., 2015, INT BUSINESS RES, V8, P208
   Jiang YY, 2020, INT J CONTEMP HOSP M, V32, P2563, DOI 10.1108/IJCHM-03-2020-0237
   Jimmieson NL, 2008, J APPL BEHAV SCI, V44, P237, DOI 10.1177/0021886307312773
   Jung HS, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102703
   Kamarulzaman N, 2015, PROC ECON FINANC, V31, P896, DOI 10.1016/S2212-5671(15)01187-9
   Kang SE, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031327
   Kapuscinski G, 2016, TOURISM MANAGE, V57, P234, DOI 10.1016/j.tourman.2016.06.017
   Karatepe OM, 2006, TOURISM MANAGE, V27, P547, DOI 10.1016/j.tourman.2005.02.009
   Karatepe OM, 2021, CURR ISSUES TOUR, V24, P934, DOI 10.1080/13683500.2021.1884665
   Khan AN, 2021, INT J CONTEMP HOSP M, V33, P3277, DOI 10.1108/IJCHM-12-2020-1439
   Kilic AF, 2019, INT J ASSESS TOOLS E, V6, P25, DOI 10.21449/ijate.442542
   Kim K. Y., 2010, Journal of Human Resources in Hospitality & Tourism, V9, P318, DOI 10.1080/15332845.2010.487043
   Kline RB, 2010, PRINCIPLES PRACTICE
   Koo B, 2020, J QUAL ASSUR HOSP TO, V21, P371, DOI 10.1080/1528008X.2019.1663572
   Lam T, 2001, TOURISM MANAGE, V22, P157, DOI 10.1016/S0261-5177(00)00039-X
   Lau YL, 2021, HONG KONG MED J, V27, P88, DOI 10.12809/hkmj215114
   Lee C.C., 2012, ASIAN EC FINANCIAL R, V2, P866
   Lee JS, 2015, INT J CONTEMP HOSP M, V27, P768, DOI 10.1108/IJCHM-11-2013-0530
   Lewis H., 2021, INT HOSPITALITY REV, DOI [10.1108/IHR-01-2021-0004, DOI 10.1108/IHR-01-2021-0004]
   Li J, 2017, TOURISM MANAGE, V59, P193, DOI 10.1016/j.tourman.2016.08.006
   Li LZ, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113267
   Macao Statistics and Census Service (2021a), MACAU EC B
   Malik M.I., 2010, S ASIAN J MANAGEMENT, V17, P112
   Marinakou E, 2019, INT J CONTEMP HOSP M, V31, P3855, DOI 10.1108/IJCHM-10-2018-0862
   Mathieu C, 2016, J MANAGE ORGAN, V22, P113, DOI 10.1017/jmo.2015.25
   McCartney. G.J., 2020, ROUTLEDGE COMPANION, P199
   McCartney G, 2021, CITIES, V112, DOI 10.1016/j.cities.2021.103130
   McGinley S, 2020, INT J CONTEMP HOSP M, V32, P2737, DOI 10.1108/IJCHM-12-2019-1002
   MICHAELS CE, 1982, J APPL PSYCHOL, V67, P53, DOI 10.1037/0021-9010.67.1.53
   Mohsin A, 2013, INT J HOSP MANAG, V35, P48, DOI 10.1016/j.ijhm.2013.05.002
   Muthen LK., 2017, MPLUS USERS GUIDE, V8
   Nadiri H, 2010, INT J HOSP MANAG, V29, P33, DOI 10.1016/j.ijhm.2009.05.001
   Ng TWH, 2016, PERS PSYCHOL, V69, P599, DOI 10.1111/peps.12117
   Pan FC, 2015, TOURISM MANAGE, V46, P84, DOI 10.1016/j.tourman.2014.06.004
   Park JY, 2021, INT J HOSP MANAG, V97, DOI 10.1016/j.ijhm.2021.102992
   Perez J., 2013, INT J ACCOUNTING INF, V6, P40
   Quintal V, 2022, CURR ISSUES TOUR, V25, P206, DOI 10.1080/13683500.2021.1880377
   Quintal VA, 2010, TOURISM MANAGE, V31, P797, DOI 10.1016/j.tourman.2009.08.006
   Rhee SY, 2017, J BUS PSYCHOL, V32, P711, DOI 10.1007/s10869-016-9469-2
   Riggle RJ, 2009, J BUS RES, V62, P1027, DOI 10.1016/j.jbusres.2008.05.003
   Saladino V, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.577684
   Salleh R., 2012, WORLD ACAD SCI ENG T, V72, P316
   Sands China Ltd, 2021, COMPANY
   Sang KJC, 2009, ENG CONSTR ARCHIT MA, V16, P288, DOI 10.1108/09699980910951681
   Singh P, 2010, RELAT IND-IND RELAT, V65, P470, DOI 10.7202/044892ar
   Susskind A.M., 2000, INT J HOSP MANAG, V19, P53
   Tian-Foreman W, 2009, CHIN MANAG STUD, V3, P356, DOI 10.1108/17506140911007503
   UNWTO, 2020, IMP COVID 19 TOUR
   Varga S, 2021, INT J CONTEMP HOSP M, V33, P3331, DOI 10.1108/IJCHM-12-2020-1417
   Wang YC, 2015, TOURISM, V63, P67
   Wells JE, 2011, TEAM PERFORM MANAG, V17, P23, DOI 10.1108/13527591111114693
   Westaby JD, 2005, ORGAN BEHAV HUM DEC, V98, P97, DOI 10.1016/j.obhdp.2005.07.003
   Westfall. B., 2017, 5 BENEFITS YES BENEF
   WINSTEAD BA, 1995, J SOC PERS RELAT, V12, P199, DOI 10.1177/0265407595122003
   Wozniak H, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00900-x
   Wu X., 2012, FACTORS INFLUENCING
   Xu S, 2018, CURR ISSUES TOUR, V21, P775, DOI 10.1080/13683500.2015.1076771
   Yang CJ, 2019, INT J CONTEMP HOSP M, V31, P4086, DOI 10.1108/IJCHM-07-2017-0398
   Yang JT, 2008, SERV IND J, V28, P429, DOI 10.1080/02642060801917430
   Yao T, 2019, INT J HOSP MANAG, V76, P1, DOI 10.1016/j.ijhm.2018.03.018
   Yeh SS, 2021, TOUR RECREAT RES, V46, P188, DOI 10.1080/02508281.2020.1805933
   Zeytinoglu IU, 2007, CAN PUBLIC POL, V33, pS31, DOI 10.3138/0560-6GV2-G326-76PT
NR 101
TC 0
Z9 0
U1 2
U2 2
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0959-6119
EI 1757-1049
J9 INT J CONTEMP HOSP M
JI Int. J. Contemp. Hosp. Manag.
DI 10.1108/IJCHM-08-2021-1053
EA MAR 2022
PG 21
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA ZY8EZ
UT WOS:000772815500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Enya, T
   Morimoto, Y
   Oshima, R
   Miyazaki, K
   Miyazawa, T
   Okada, M
   Sugimoto, K
AF Enya, Takuji
   Morimoto, Yuichi
   Oshima, Rina
   Miyazaki, Kohei
   Miyazawa, Tomoki
   Okada, Mitsuru
   Sugimoto, Keisuke
TI Nephrotic syndrome relapse in a boy with COVID-19
SO CEN CASE REPORTS
LA English
DT Article
DE COVID-19; SARS-CoV-2; Nephrotic syndrome; Relapse; Child
AB Clinical data on coronavirus disease-19 (COVID-19) in children during the management of nephrotic syndrome (NS) is lacking. Patients on prednisolone are compromised hosts at the risk of severe infections. Some infections may induce NS relapse. We describe the clinical course of a child with NS and COVID-19. A 3-year-old boy was admitted with clinical and laboratory findings indicative of NS. Induction therapy with prednisolone (2 mg/kg/day) induced complete remission. While tapering the dose, he was infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). He developed a high fever and periorbital edema. Urinalysis revealed proteinuria (protein-creatinine ratio: 6.3 g/gCr). He was transferred to our hospital for the concurrent management of COVID-19 and NS relapse. As proteinuria worsened, the prednisolone dose was increased to 2 mg/kg/day. Proteinuria gradually improved, and remission was noted a week after initiating full-dose steroid treatment. The fever subsided after 2 days without treatment for COVID-19. Anti-SARS-CoV-2 antibody including IgG levels decreased in the early convalescent phase. To the best of our knowledge, this is the first reported case with the recurrence of NS triggered by the SARS-CoV-2 infection in Asia. SARS-CoV-2 infection may induce NS relapse. Daily administration of full-dose of prednisolone may be effective for managing the recurrence of NS associated with SARS-CoV-2 infection.
C1 [Enya, Takuji; Morimoto, Yuichi; Oshima, Rina; Miyazaki, Kohei; Miyazawa, Tomoki; Okada, Mitsuru; Sugimoto, Keisuke] Kindai Univ, Fac Med, Dept Pediat, 377-2 Ohno Higashi, Osaka 5898511, Japan.
RP Enya, T (corresponding author), Kindai Univ, Fac Med, Dept Pediat, 377-2 Ohno Higashi, Osaka 5898511, Japan.
EM enyatakuji@yahoo.co.jp
CR Abeyagunawardena AS, 2008, ARCH DIS CHILD, V93, P226, DOI 10.1136/adc.2007.116079
   Almeida FJ, 2020, PEDIATR INFECT DIS J, V39, pE161, DOI 10.1097/INF.0000000000002737
   Alvarado A, 2021, PEDIATR NEPHROL, V36, P205, DOI 10.1007/s00467-020-04724-y
   D'Antiga L, 2020, LIVER TRANSPLANT, V26, P832, DOI 10.1002/lt.25756
   Derespina KR, 2020, J PEDIATR-US, V226, P55, DOI 10.1016/j.jpeds.2020.07.039
   Gross O, 2020, LANCET, V395, pE87, DOI 10.1016/S0140-6736(20)31041-2
   Gulati A, 2011, CLIN J AM SOC NEPHRO, V6, P63, DOI 10.2215/CJN.01850310
   Liu FF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70387-2
   Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6
   MACDONALD NE, 1986, J PEDIATR-US, V108, P378, DOI 10.1016/S0022-3476(86)80876-9
   Melgosa M, 2020, PEDIATR NEPHROL, V35, P1521, DOI 10.1007/s00467-020-04597-1
   Safadi MAP, 2020, J PEDIAT-BRAZIL, V96, P265, DOI 10.1016/j.jped.2020.04.001
   Perez-Martinez A, 2021, EUR J PEDIATR, V180, P967, DOI 10.1007/s00431-020-03793-3
   Plumb L, 2021, ARCH DIS CHILD, V106, DOI 10.1136/archdischild-2020-319903
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Wang YL, 2020, PEDIATR INFECT DIS J, V39, pE91, DOI 10.1097/INF.0000000000002739
   Xia W, 2020, PEDIATR PULM, V55, P1169, DOI 10.1002/ppul.24718
   Zhang H, 2016, AUTOIMMUN REV, V15, P632, DOI 10.1016/j.autrev.2016.02.007
NR 19
TC 7
Z9 8
U1 0
U2 0
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 2192-4449
J9 CEN CASE REP
JI CEN CASE REP.
PD AUG
PY 2021
VL 10
IS 3
BP 431
EP 434
DI 10.1007/s13730-021-00587-w
EA FEB 2021
PG 4
WC Urology & Nephrology
WE Emerging Sources Citation Index (ESCI)
SC Urology & Nephrology
GA TG7JF
UT WOS:000620403000002
PM 33616881
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Sharma, A
   Bhardwaj, R
AF Sharma, Akriti
   Bhardwaj, Rohit
TI COVID-19 and ENT surgery: a brief review of essential precautions and
   triage
SO EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
LA English
DT Review
DE COVID-19; ENT surgeon; Triage; Precautions
ID RESPIRATORY VIRUSES; MIDDLE-EAR
AB Purpose This study is a brief review of the existing knowledge on the ENT surgeon's approach towards management of patients during the COVID-19 pandemic. While it is being recommended to carry out only the emergent procedures and to postpone the non-urgent ones to a later date, this article is meant to provide an insight into triage of the ENT procedures and the various precautions to be taken into account by the ENT surgeons while carrying out a procedure during the COVID-19 pandemic. Methods The ENT Cochrane, Pubmed and Web of Science databases were searched without a time limit using the terms 'COVID-19 and SARS-CoV-2 in conjunction with ENT surgery. Results Elective and non urgent cases are best avoided during this time. Only absolutely essential and emergent procedures need to be carried out with the use of Personal protective equipment comprising of safety gown, N95 mask, safety goggles, disposable gloves and caps. There is a possibility of transmission of the SARS- CoV-2 through asymptomatic patients and hence all patients, even with an unknown COVID-19 status, need to undergo a preoperative screening. As all procedures under general anesthesia are aerosol generating, the use of Personal protective equipment (PPE) is recommended for all the health care workers present in the operation theater. Conclusion A proper knowledge of triage would be of immense help to the ENT surgeon in minimizing the exposure to health care workers and patients during this pandemic. All patients with an unknown COVID-19 status should be considered suspects and essential precautions for their management be taken accordingly.
C1 [Sharma, Akriti] SGT Med Coll, Hosp & Res Inst, Dept Otorhinolaryngol, Gurugram 122505, Haryana, India.
   [Bhardwaj, Rohit] Safdarjang Hosp, Dept Otorhinolaryngol, New Delhi 110029, India.
   [Bhardwaj, Rohit] Vardhman Mahavir Med Coll, New Delhi 110029, India.
RP Bhardwaj, R (corresponding author), Safdarjang Hosp, Dept Otorhinolaryngol, New Delhi 110029, India.; Bhardwaj, R (corresponding author), Vardhman Mahavir Med Coll, New Delhi 110029, India.
EM drrohitbhardwaj90@gmail.com
RI Sharma, Akriti/AAK-6962-2021; Bhardwaj, Rohit/AAV-1716-2020
OI Bhardwaj, Rohit/0000-0003-4005-4719
CR American Academy of Otolaryngology - Head & Neck Surgery, 2020, COR DIS 2019 RES, P2020
   American-College-of-Surgeons, 2020, COVID 19 GUID TRIAG
   [Anonymous], 2020, OT MAY CONTR COVID 1
   [Anonymous], 2020, GUIDANCE ENT COVID 1
   [Anonymous], 2020, COVID 19 RAT US PERS
   [Anonymous], 2020, S CHINA MORNING POST
   [Anonymous], 2020, BNN
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chang D, 2020, LANCET RESP MED, V8, pE13, DOI 10.1016/S2213-2600(20)30066-7
   Chang L, 2020, TRANSFUS MED REV, V34, P75, DOI 10.1016/j.tmrv.2020.02.003
   Facial Plastic Surgery & Aesthetic Medicine, 2020, FACIAL PLASTIC SURG
   Federal Data Protection and Information Officer, 2020, LATEST NEWS
   Givi B, 2020, JAMA OTOLARYNGOL, V146, P579, DOI 10.1001/jamaoto.2020.0780
   Heikkinen T, 1999, NEW ENGL J MED, V340, P260, DOI 10.1056/NEJM199901283400402
   Institute of Medicine, 2015, US EFF POW PUR RESP, P18990, DOI [10.17226/18990, DOI 10.17226/18990]
   JEWETT DL, 1992, AM IND HYG ASSOC J, V53, P228, DOI 10.1202/0002-8894(1992)053<0228:BAGBST>2.0.CO;2
   King's College London, 2020, SCIENCEDAILY
   Lu D, 2020, J HOSP INFECT, V104, P454, DOI 10.1016/j.jhin.2020.02.018
   Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Saadi RA, 2020, OTOLARYNG HEAD NECK, V162, P797, DOI 10.1177/0194599820919741
   Tay JK, 2020, JAMA OTOLARYNGOL, V146, P517, DOI 10.1001/jamaoto.2020.0764
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Vukkadala N, 2020, LARYNGOSCOPE, V130, P2537, DOI 10.1002/lary.28672
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   Wiertsema SP, 2011, J MED VIROL, V83, P2008, DOI 10.1002/jmv.22221
   Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 29
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0937-4477
EI 1434-4726
J9 EUR ARCH OTO-RHINO-L
JI Eur. Arch. Oto-Rhino-Laryn.
PD MAY
PY 2021
VL 278
IS 5
BP 1301
EP 1305
DI 10.1007/s00405-020-06207-0
EA JUL 2020
PG 5
WC Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Otorhinolaryngology
GA RP7DV
UT WOS:000547352300003
PM 32654024
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Waselewski, E
   Waselewski, M
   Harper, C
   Dickey, S
   Bell, SA
   Chang, T
AF Waselewski, Eric
   Waselewski, Marika
   Harper, Chloe
   Dickey, Sarah
   Bell, Sue Anne
   Chang, Tammy
TI Perspectives of US Youth During Initial Month of the COVID-19 Pandemic
SO ANNALS OF FAMILY MEDICINE
LA English
DT Article
DE adolescent; COVID-19; pandemics
ID SENSITIVITY
AB during the coronavirus disease 2019 (COVID-19) pandemic are an ongoing public health concern, particularly given their depiction as unengaged with recommendations. Our goal was to understand the knowledge, beliefs, and experiences of US youth at the onset of the COVID-19 pandemic.
   METHODS We posed 2 open-ended surveys to the national MyVoice text message cohort of youth, aged 14-24 years. On March 6, 2020, 4 questions were asked regarding knowledge and experiences during the COVID-19 pandemic with 3 questions repeated on March 20, 2020. Qualitative responses were coded using thematic analysis and summarized with descriptive statistics.
   RESULTS Of 1,174 youth, 1,087 responded to at least 1 question (response rate of 88%). The average age of respondents was 19 (SD 2.8) years with 52% female and 56% non-Hispanic White respondents. On March 6, 2020, most (70%) respondents reported knowing about COVID-19 and primarily cited the news (46%) as their source of information. Nearly all (95%) respondents reported impact by March 20, 2020, and respondents expressing worry increased from 25% to 51%. In both surveys, worried youth primarily cited concern for others (26% and 34%). Regarding preparation, respondents primarily reported doing nothing (36%) on March 6, 2020, and practicing social distancing (50%) on March 20, 2020.
   CONCLUSIONS Many youths in our sample are engaged with the COVID-19 pandemic and most are feeling knowledgeable, are concerned about its impacts on others, and are practicing social distancing. Sustained public health efforts should focus on maintaining youth engagement with accurate public information and youth-centered messaging promoting prevention measures to protect the health and well-being of youth and their friends and family.
C1 [Waselewski, Eric] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
   [Waselewski, Marika; Chang, Tammy] Univ Michigan, Dept Family Med, 2800 Plymouth Rd,Bldg 14 G128, Ann Arbor, MI 48109 USA.
   [Harper, Chloe] Skyline High Sch, Ann Arbor, MI USA.
   [Dickey, Sarah; Bell, Sue Anne] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA.
   [Bell, Sue Anne; Chang, Tammy] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.
RP Waselewski, M (corresponding author), Univ Michigan, Dept Family Med, 2800 Plymouth Rd,Bldg 14 G128, Ann Arbor, MI 48109 USA.
EM marikag@med.umich.edu
FU Michigan Institute for Clinical & Health Research; University of
   Michigan MCubed program; University of Michigan Department of Family
   MedicineUniversity of Michigan System
FX This research was funded by the Michigan Institute for Clinical & Health
   Research, the University of Michigan MCubed program, and the University
   of Michigan Department of Family Medicine. These funders had no role in
   the design and conduct of the study; collection, management, analysis,
   and interpretation of the data; preparation, review, or approval of the
   manuscript; or decision to submit the manuscript for publication.
CR American Academy of Pediatrics, NTR
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Cammaerts B, 2014, AM BEHAV SCI, V58, P645, DOI 10.1177/0002764213515992
   Canipe C., REUTERS
   Carpini MXD, 2000, POLIT COMMUN, V17, P341, DOI 10.1080/10584600050178942
   Chokshi N., 2019, NY TIMES
   DeJonckheere M, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.8502
   Galvan A, 2013, CURR DIR PSYCHOL SCI, V22, P88, DOI 10.1177/0963721413480859
   Gordon S., US NEWS
   Gringlas S., NTR
   Grubbs JB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215637
   Harris R., NTR
   Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4
   Huang P, NPR NEWS
   Kelly C., CONVERSATION
   Konrath SH, 2011, PERS SOC PSYCHOL REV, V15, P180, DOI 10.1177/1088868310377395
   Lin R.-G., 2020, LOS ANGELES TIMES
   Muccari R, NBC NEWS
   Nasheed J., TEENVOGUE
   Nebehay S., REUTERS
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Preidt R., U S NEWS
   Saad L., NTR
   Stauffer R., 2020, INSTYLE 0305
   Syvertsen AK, 2011, J RES ADOLESCENCE, V21, P586, DOI 10.1111/j.1532-7795.2010.00706.x
   Telzer EH, 2014, P NATL ACAD SCI USA, V111, P6600, DOI 10.1073/pnas.1323014111
   Van der Graaff J, 2014, DEV PSYCHOL, V50, P881, DOI 10.1037/a0034325
   Wells M., 2004, GUARDIAN
   Wickman Mary E, 2008, J Pediatr Nurs, V23, P460, DOI 10.1016/j.pedn.2008.02.003
NR 29
TC 3
Z9 3
U1 2
U2 2
PU ANNALS FAMILY MEDICINE
PI LEAWOOD
PA 11400 TOMAHAWK CREEK PARKWAY, LEAWOOD, KS 66211-2672 USA
SN 1544-1709
EI 1544-1717
J9 ANN FAM MED
JI Ann. Fam. Med.
PD MAR-APR
PY 2021
VL 19
IS 2
BP 141
EP 147
DI 10.1370/afm.2642
PG 7
WC Primary Health Care; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA QU8XX
UT WOS:000627562800008
PM 33397686
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Brauner, DF
   Reichert, FM
   Janissek-Muniz, R
   Zen, AC
   de Menezes, DC
   Closs, LQ
   Carraro, WBWH
   Ruppenthal, CS
   Muller, FM
   Lubaszewski, MS
   Rhoden, MIS
AF Brauner, Daniela Francisco
   Reichert, Fernanda Maciel
   Janissek-Muniz, Raquel
   Zen, Aurora Carneiro
   de Menezes, Daniela Callegaro
   Closs, Lisiane Quadrado
   Witt Haddad Carraro, Wendy Beatriz
   Ruppenthal, Carla Simone
   Muller, Fernanda Maria
   Lubaszewski, Marcelo Soares
   Rhoden, Marisa Ignez S.
TI An engaged university: Rescuing SMES during the COVID-19 crisis
SO RAE-REVISTA DE ADMINISTRACAO DE EMPRESAS
LA Portuguese
DT Article
DE Engaged university; engagement; COVID-19; SMEs; project management
ID ENTREPRENEURIAL UNIVERSITY; INDUSTRY COLLABORATION;
   ECONOMIC-DEVELOPMENT; COMMERCIALIZATION; IMPACTS; MODELS
AB The economic effects of isolation policies resulting from the COVID-19 pandemic have led small and medium-sized enterprises (SMEs) to look for alternatives to survive. Within this crisis scenario, an engaged university has an important role to play in a regional context in addressing not only health issues, but also any resultant social and economic problems. An engaged university needs to take actions that go beyond its traditional missions of education and research - it has to deliver knowledge to society. This paper analyzes a university-community project in Brazil to identify the necessary elements that help promote a regionally-engaged university: the SOS-PME Advisory Network project, which was originally designed to assist SMEs during the crisis. As a result, we identified elements necessary for promoting the university's third mission - social engagement by way of a university-community project: an engaged team, multidisciplinarity, project management, agility, alliances, a communication strategy, institutional support, and reputation.
C1 [Brauner, Daniela Francisco; Reichert, Fernanda Maciel; Janissek-Muniz, Raquel; Zen, Aurora Carneiro; de Menezes, Daniela Callegaro; Closs, Lisiane Quadrado; Ruppenthal, Carla Simone; Muller, Fernanda Maria; Rhoden, Marisa Ignez S.] Univ Fed Rio Grande do Sul, Escola Adm, Porto Alegre, RS, Brazil.
   [Witt Haddad Carraro, Wendy Beatriz] Univ Fed Rio Grande do Sul, Fac Ciencias Econ, Porto Alegre, RS, Brazil.
   [Lubaszewski, Marcelo Soares] Univ Fed Rio Grande do Sul, Escola Engn, Porto Alegre, RS, Brazil.
RP Brauner, DF (corresponding author), Univ Fed Rio Grande do Sul, Escola Adm, Porto Alegre, RS, Brazil.
EM daniela.brauner@ufrgs.br; fernanda.reichert@ufrgs.br; rjmuniz@ufrgs.br;
   aurora.zen@ufrgs.br; daniela.callegaro@ufrgs.br; lisiane.closs@ufrgs.br;
   wendy.carraro@ufrgs.br; carla.ruppenthal@ufrgs.br;
   fernanda.muller@ufrgs.br; marcelo.lubaszewski@ufrgs.br;
   marisa.rhoden@ufrgs.br
RI Müller, Fernanda/AAB-5245-2022; Janissek-Muniz, Raquel/J-1502-2018;
   Closs, Lisiane/A-5575-2015
OI Janissek-Muniz, Raquel/0000-0002-0657-6559; Ruppenthal, Carla
   Simone/0000-0003-0550-7946; Closs, Lisiane/0000-0003-1971-9341; Brauner,
   Daniela/0000-0002-6379-7825; REICHERT, FERNANDA/0000-0002-5639-5879;
   Lubaszewski, Marcelo/0000-0002-1337-0671; Zen,
   Aurora/0000-0003-4078-4359
CR Audretsch DB, 2014, J TECHNOL TRANSFER, V39, P313, DOI 10.1007/s10961-012-9288-1
   Bardin Laurence, 1977, ANALISE CONTEUDO
   Benneworth P, 2005, EUR PLAN STUD, V13, P537, DOI 10.1080/09654310500107175
   Breznitz SM, 2012, J TECHNOL TRANSFER, V37, P139, DOI 10.1007/s10961-010-9183-6
   Cherrington AM, 2019, EDUC CITIZSH SOC JUS, V14, P165, DOI 10.1177/1746197918779945
   Cohen WM, 2002, MANAGE SCI, V48, P1, DOI 10.1287/mnsc.48.1.1.14273
   DeWalt K.M., 2002, PARTICIPANT OBSERVAT
   Drucker J, 2007, INT REGIONAL SCI REV, V30, P20, DOI 10.1177/0160017606296731
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   Etzkowitz H., 2004, International Journal of Technology and Globalisation, V1, P64
   Guerrero M, 2016, SMALL BUS ECON, V47, P551, DOI 10.1007/s11187-016-9755-4
   Instituto Brasileiro de Geografia e Estatistica, 2020, IND CONJ COVID 19
   Jacoby, 1996, SERVICE LEARNING HIG
   Klofsten M, 2019, TECHNOL FORECAST SOC, V141, P149, DOI 10.1016/j.techfore.2018.12.004
   Lazzeroni M., 2003, LOCAL ECON, V18, P38
   Listo, 2019, LIST TURNS 2 REV REV
   Olmos-Penuela J., 2013, SCI PUBLIC POLICY, V17, DOI [10.1177/1474022214534081, DOI 10.1177/1474022214534081]
   Perkmann M, 2013, RES POLICY, V42, P423, DOI 10.1016/j.respol.2012.09.007
   Ponds R, 2010, J ECON GEOGR, V10, P231, DOI 10.1093/jeg/lbp036
   Renwick K, 2020, HIGH EDUC RES DEV, V39, P1232, DOI 10.1080/07294360.2020.1712680
   Sanchez-Barrioluengo M, 2019, TECHNOL FORECAST SOC, V141, P206, DOI 10.1016/j.techfore.2018.10.017
   Schwaber K., 2002, AGILE SOFTWARE DEV S
   Servico Brasileiro de Apoio as Micro e Pequenas Empresas, 2020, IMP PAND COR NOS PEQ
   Servico Brasileiro de Apoio as Micro e Pequenas Empresas, 2018, PAN DOS PESQ NEG 201
   Trippl M, 2015, EUR PLAN STUD, V23, P1722, DOI 10.1080/09654313.2015.1052782
   TURNER JR, 2006, INT J PROJ MANAG, V24, P93, DOI DOI 10.1016/J.IJPROMAN.2005.11.008
   Universidade Federal do Rio Grande do Sul, 2020, COR FONT IMPR
   Universidade Federal do Rio Grande do Sul, 2020, PRES REC
   Uyarra E, 2010, EUR PLAN STUD, V18, P1227, DOI 10.1080/09654311003791275
   Wadhwani RD, 2017, MANAG ORGAN HIST, V12, P175, DOI 10.1080/17449359.2017.1359903
   Wang YD, 2016, SCIENTOMETRICS, V106, P1037, DOI 10.1007/s11192-015-1818-9
   Watson D, 2011, INT STUD HIGH EDUC, P1
   World Health Organization World Health Organization, 2020, OV PUBL HLTH SOC MEA
   Yin R.K., 2013, CASE STUDY RES DESIG
NR 34
TC 0
Z9 0
U1 2
U2 18
PU FUNDACAO GETULIO VARGAS
PI SAO PAULO SP
PA ESCOLA ADMIN EMPRESAS SAO PAULO, AV 9 DE JULHO, 2-029, BELA VISTA, SAO
   PAULO SP, 01313-902, BRAZIL
SN 2178-938X
J9 RAE-REV ADMIN EMPRES
JI RAE-Rev. Adm. Empres.
PD NOV-DEC
PY 2020
VL 60
IS 6
BP 437
EP 450
DI 10.1590/S0034-759020200607
PG 14
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA PT7YR
UT WOS:000608828400007
OA Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Hankalo, NC
   Alemayehu, A
   Fikre, R
   Shona, E
AF Hankalo, Nana Chea
   Alemayehu, Akalewold
   Fikre, Rekiku
   Shona, Edilu
TI COVID-19 Prevention Practices Among Prisoners, in Southern Ethiopia
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; prevention practice; prison; Sidama; Ethiopia
ID ATTITUDES; RESIDENTS; KNOWLEDGE
AB Background: Coronavirus disease-19 (COVID-19) is a highly contagious disease with high attack and case fatality rate. Since WHO's declaration of disease as pandemic in March 2020, the unprecedented global crises have been happening. To curb and reduce such crises, multi-dimensional international efforts have been made, particularly, infection prevention measures has been developed. However, there was a wide gap of implementing COVID-19 prevention measures from rural to urban, from institution to institution and from person to person. Therefore, the aim of this study was to measure the level of prevention practice towards COVID 19 and associated factors in prison, in Sidama National Regional State, Ethiopia. Methods: A cross-sectional study using quantitative method of data collection was conducted in November, 2020 among 422 prisoners in two prisons. Data were collected by trained nurses using structured questionnaires. We analyzed data using SPSS version 24 software. Descriptive statistics and bivariable and multivariable logistic regression analyses were employed to identify factors associated with prevention practices of COVID-19. Results: More than one-fifth (22%; 95% CI: 19%, 26%) of respondents had good preventive practice. Participants who had a history of alcohol intake were 1.79 times less likely to implement good preventive practice for COVID-19 (AOR = 1.79; 95% CI; 1.09, 2.93). The respondents who had negative attitude towards COVID-19 infection were 1.69 times more likely to have poor prevention practice (AOR = 1.69; 95% CI: 1.02, 2.81). Conclusion and Recommendation: In this study, COVID-19 prevention practice among prisoners was very low. Negative attitude and previous alcohol taking history were factors associated with poor prevention practice. Accordingly, the researchers recommends to the concerned body to design educational intervention to change the attitude towards COVID-19 and other infectious diseases and behaviors of the prisoners.
C1 [Hankalo, Nana Chea; Alemayehu, Akalewold] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia.
   [Fikre, Rekiku] Hawassa Univ, Coll Med & Hlth Sci, Dept Midwifery, Hawassa, Ethiopia.
   [Shona, Edilu] Hawassa Univ, Coll Law & Governance, Sch Law, Hawassa, Ethiopia.
RP Hankalo, NC (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia.
EM nanachea@hu.edu.et
FU Hawassa University
FX Hawassa University.
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Administrative F, 2020, FEDERAL NEGARIT GAZE, P35
   Amsalu B, 2021, J MULTIDISCIP HEALTH, V14, P219, DOI 10.2147/JMDH.S292409
   [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373
   Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3
   Asmelash D, 2020, RISK MANAG HEALTHC P, V13, P2239, DOI 10.2147/RMHP.S277846
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17
   Culp WC, 2020, A A PRACT, V14, DOI 10.1213/XAA.0000000000001218
   Defar A, 2020, KNOWLEDGE PRACTICE A, DOI [10.1101/2020.08.14.20172429, DOI 10.1101/2020.08.14.20172429]
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Fatmi Z, 2020, E MEDITERR HEALTH J, V26, P1446, DOI 10.26719/emhj.20.133
   Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254
   FMOH E, 2020, COVID19 MAN HDB, P7
   Kassa AM, 2020, RES REP TROP MED, V11, P129, DOI 10.2147/RRTM.S283043
   Mola S, 2020, MAGNITUDE ASS FACTOR, P1, DOI [10.21203/rs.3.rs-36120/v1, DOI 10.21203/RS.3.RS-36120/V1]
   Ngwewondo A, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008700
   UNICEF, 2020, SIT NUMB CAS 269 CRI, P1
   World Health Organization, 2020, INT GUID WHO, V2020, DOI [10.13140/RG.2.2.26206.18245, DOI 10.13140/RG.2.2.26206.18245]
   World Health Organization, WHOS RESP COV 19
   World Health Organization, 2020, COVID 19 STRATEGIC P, P19
   Yordi Aguirre I, 2014, PRISONS HLTH PRISONS, P1
NR 22
TC 0
Z9 0
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2022
VL 15
BP 521
EP 528
DI 10.2147/RMHP.S350257
PG 8
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA 0E9ZL
UT WOS:000777030000002
PM 35341026
OA Green Published
DA 2022-04-20
ER

PT J
AU Feroz, AS
   Ali, NA
   Feroz, R
   Akber, N
   Meghani, SN
AF Shahil Feroz, Anam
   Ali, Naureen Akber
   Feroz, Ridah
   Akber, Noshaba
   Nazim Meghani, Salima
TI Exploring community perceptions, attitudes and practices regarding the
   COVID-19 pandemic in Karachi, Pakistan
SO BMJ OPEN
LA English
DT Article
DE COVID-19; public health; public health
AB Background The Government of Pakistan is facing difficulty to contain the surge of COVID-19 due to the country's social, political, economical and cultural context. Experiences from the previous epidemic suggest that community perceptions, social norms and cultural practices can impede COVID-19 containment. To understand social responses towards COVID-19, the study aims to explore the understanding of COVID-19 and the acceptance of control measures among community members. Methods We conducted an exploratory qualitative study using a purposive sampling approach, at two communities of Karachi, Pakistan. In-depth interviews were conducted with community members including, young, middle-aged and older adults of both genders. Study data were analysed manually using the conventional content analysis technique. Results A total of 27 in-depth virtual interviews were conducted, between May and June 2020. Six overarching themes were identified: (1) community knowledge and perceptions around COVID-19; (2) trusted and preferred sources of health information; (3) initial thoughts and feeling towards COVID-19 pandemic; (4) community practices to prevent exposure from COVID-19; (5) perceived risks associated with poor adherence to infection control practices; and (6) future preparedness of community to avoid the second wave of the outbreak. Generally, community members had good knowledge about COVID-19, and positive behaviour and attitude towards using standard precautions. The knowledge is mainly acquired through electronic, print and social media platforms, which have pros and cons. However, some community members including younger individuals had poor adherence to safety measures. This may necessitate concentrated efforts to raise awareness through community mobilisation and sensitisation activities. Conclusion This study provides an initial evidence base of communities' perceptions, and attitudes towards COVID-19 in an early stage of pandemic. The study emphasises that sufficient knowledge and awareness about COVID-19, adequate training and drills, and adherence to safety measures, are necessary to better prepare for the second wave of COVID-19.
C1 [Shahil Feroz, Anam; Ali, Naureen Akber; Akber, Noshaba; Nazim Meghani, Salima] Aga Khan Univ, Commun Hlth Sci Dept, Karachi, Pakistan.
   [Shahil Feroz, Anam] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Feroz, Ridah] Aga Khan Univ, Inst Educ Dev, Karachi, Pakistan.
RP Feroz, AS (corresponding author), Aga Khan Univ, Commun Hlth Sci Dept, Karachi, Pakistan.; Feroz, AS (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
EM anam.shahil@mail.utoronto.ca
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Akhtar H, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/28517
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   Corrigan P., 2020, STIGMA COVID 19 LETS
   Dzigbede KD, 2020, PUBLIC ADMIN REV, V80, P634, DOI 10.1111/puar.13249
   Faulkner SL., 2017, DATA SATURATION INT, P1, DOI [DOI 10.1002/9781118901731.IECRM0060, 10.1002/9781118901731.iecrm0060]
   Government of Pakistan, 2021, COVID 19 DASHB
   Gray N, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006461
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Javed B, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00158
   Klemm C, 2016, J RISK RES, V19, P1, DOI 10.1080/13669877.2014.923029
   Kobayashi M, 2015, MMWR-MORBID MORTAL W, V64, P714
   Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Mahar I., 2020, PAKISTAN COVID 19 RH
   Modarres N., 2015, COMMUNITY PERSPECTIV
   Organization WH, 2020, WHO COR DIS COVID 19
   Organization WH, 2020, ROLL UPD COVID 19 ROLL UPD COVID 19
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Saqlain M, 2020, DRUGS THER PERSPECT, V36, P213, DOI 10.1007/s40267-020-00721-1
   Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8
   Teti M., 2020, METHODS TIME COVID 1
   UNICEF. WHO IFRC, 2020, SOC STIGM ASS COVID SOC STIGM ASS COVID
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Waris A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100681
NR 25
TC 1
Z9 1
U1 4
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PY 2021
VL 11
IS 8
AR e048359
DI 10.1136/bmjopen-2020-048359
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA UA8AW
UT WOS:000685380300023
PM 34389572
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Kumar, K
   Venkitachalam, R
   Varma, B
   Nair, P
   Shanmugham, A
   Jose, R
AF Kumar, Krishna
   Venkitachalam, Ramanarayanan
   Varma, Beena
   Nair, Priya
   Shanmugham, Aravind
   Jose, Renju
TI Oral medicine practice during COVID-19: A scoping review
SO JOURNAL OF INDIAN ACADEMY OF ORAL MEDICINE AND RADIOLOGY
LA English
DT Review
DE COVID-19; infection control; oral lesions; Oral Medicine; practice
   guidelines
AB Oral healthcare providers work near the face of the patients and are at an increased risk of being infected or transmitting the infection to the patients. Standard practice guidelines have to be modified to reorganize Oral Medicine care in the new normality of the COVID-19 pandemic to minimize the negative impacts of the infection on oral and systemic health. This scoping review aims to assess the guidelines for the safe practice of Oral Medicine during the COVID-19 pandemic. The literature search was done using Medline and Pubmed as the database and 23 articles were identified related to 8 domains. Utilization of teledentistry, efficient triaging of the patients with strict adherence to the infection control protocols, knowledge of the possible oral manifestations, and management of patients based on their presenting symptoms can help for the safe practice of Oral Medicine during the COVID-19 pandemic.
C1 [Kumar, Krishna; Venkitachalam, Ramanarayanan] Amrita Sch Dent, Dept Oral Med & Radiol, Kochi, Kerala, India.
   [Varma, Beena; Nair, Priya; Shanmugham, Aravind; Jose, Renju] Amrita Sch Dent, Dept Publ Hlth Dent, Kochi, Kerala, India.
RP Kumar, K (corresponding author), AIMS, Amrita Vishwa Vidyapeetham, Amrita Sch Dent, Dept Oral Med & Radiol, Ponekkara POB, Kochi 682041, Kerala, India.
EM krishna.santhosh32@gmail.com
RI Ramanarayanan, Venkitachalam/AAP-8439-2020
OI Ramanarayanan, Venkitachalam/0000-0002-5587-3453; M.S,
   Aravind/0000-0002-9733-0879
CR AL-Maweri SA, 2020, ORAL ONCOL, V106, DOI 10.1016/j.oraloncology.2020.104760
   Alharbi A, 2020, SAUDI DENT J, V32, P181, DOI 10.1016/j.sdentj.2020.04.001
   Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005
   Bescos R, 2020, J DENT RES, V99, P1113, DOI 10.1177/0022034520932149
   Crighton AJ, 2020, BRIT DENT J, V229, P15, DOI 10.1038/s41415-020-1784-3
   Tapia ROC, 2020, SPEC CARE DENT, V40, P555, DOI 10.1111/scd.12520
   Dang V, 2020, GUIDELINES ORAL MED
   Dar-Odeh N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093151
   dos Santos JA, 2020, INT J INFECT DIS, V97, P326, DOI 10.1016/j.ijid.2020.06.012
   Dziedzic A, 2020, ORAL DIS, DOI DOI 10.1111/ODI.13359.
   Guo YQ, 2021, ORAL DIS, V27, P737, DOI 10.1111/odi.13350
   Hussein H, 2021, OR SURG OR MED OR PA, V131, pE9, DOI 10.1016/j.oooo.2020.06.011
   Jiang SB, 2020, LANCET, V395, P949, DOI 10.1016/S0140-6736(20)30419-0
   Lozada-Nur F, 2020, OR SURG OR MED OR PA, V130, P344, DOI 10.1016/j.oooo.2020.06.016
   Lv N, 2021, J DENT SCI, V16, P493, DOI 10.1016/j.jds.2020.07.016
   Nguyen Long H, 2020, medRxiv, DOI [10.1016/S2468-2667(20)30164-X, 10.1101/2020.04.29.20084111]
   Porter S, 2020, RECOMMENDATIONS ORAL
   Sarode SC, 2020, ORAL ONCOL, V107, DOI 10.1016/j.oraloncology.2020.104811
   Shanti RM, 2020, HEAD NECK-J SCI SPEC, V42, P1497, DOI 10.1002/hed.26258
   Soares CD, 2020, MED ORAL PATOL ORAL, V25, pE563, DOI 10.4317/medoral.24044
   Vinayachandran D, 2020, J DENT SCI, V15, P364, DOI 10.1016/j.jds.2020.04.006
   Wang CX, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109789
   WHO, CONS PROV ESS OR HLT
   World Health Organization, WHO COR DIS COVID 19
   World Health Organization, TRANSM SARS COV2 IMP
NR 25
TC 0
Z9 0
U1 1
U2 6
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0972-1363
EI 0975-1572
J9 J INDIAN ACAD ORAL M
JI J. Indian Acad. Oral Med. Radiol.
PD APR-JUN
PY 2021
VL 33
IS 2
BP 215
EP 221
DI 10.4103/jiaomr.jiaomr_4_21
PG 7
WC Dentistry, Oral Surgery & Medicine
WE Emerging Sources Citation Index (ESCI)
SC Dentistry, Oral Surgery & Medicine
GA TB7YR
UT WOS:000668163800019
OA gold
DA 2022-04-20
ER

PT J
AU Tofani, M
   Berardi, A
   Marceca, M
   Valente, D
   Mazzaccara, A
   Polimeni, A
   Galeoto, G
AF Tofani, Marco
   Berardi, Anna
   Marceca, Maurizio
   Valente, Donatella
   Mazzaccara, Alfonso
   Polimeni, Antonella
   Galeoto, Giovanni
TI Fighting COVID-19 Contagion among University Students of Healthcare
   Professions: An Italian Cross-Sectional Study
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19 prevention; distance learning; health professions; students;
   university
ID KNOWLEDGE
AB During the pandemic, most governments around the world temporarily closed educational institutions to contain the spread of the Coronavirus Disease 2019 (COVID-19). The objective of the present study is to evaluate the efficacy of an e-learning course on COVID-19 transmission for healthcare university students, in order to advance the preparedness of healthcare university students against contracting COVID-19 within the general university population. The e-learning course was run using a free web service for education. Access to the course was limited to participants enrolled in degree courses related to healthcare professions within the Italian university system. A specific and validated questionnaire was administered at two different times (pre-test and post-test). A paired sample t-test was then used to evaluate their knowledge on COVID-19. Furthermore, a questionnaire measuring their satisfaction was distributed. Data were analyzed from a qualitative point of view. The course was made available from March to July 2020. Over 25,000 students from different Italian universities and various backgrounds participated in the course. The analysis of final test scores revealed that approximately 97% of participants acquired new knowledge and skills on COVID-19, with a statistically significant improvement (p < 0.05). Therefore, it is possible to state that most students enrolled in degrees relating to healthcare at Italian universities are adequately trained with respect to COVID-19 knowledge. Furthermore, students declared a high satisfaction rate both with the course content, and with the management of the telematic platform used.
C1 [Tofani, Marco; Marceca, Maurizio] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy.
   [Tofani, Marco] Bambino Gesu Pediat Hosp, Dept Intens Neurorehabil & Robot, I-00165 Rome, Italy.
   [Berardi, Anna; Valente, Donatella; Galeoto, Giovanni] Sapienza Univ Rome, Dept Human Neurosci, I-00185 Rome, Italy.
   [Valente, Donatella; Galeoto, Giovanni] IRCCS, Ist Neurol Mediterraneo Neuromed Neuromed, I-86077 Pozzilli, Italy.
   [Mazzaccara, Alfonso] Ist Super Sanita, I-00185 Rome, Italy.
   [Polimeni, Antonella] Sapienza Univ, Dept Odontostomatol & Maxillo Facial Sci, I-00185 Rome, Italy.
RP Tofani, M (corresponding author), Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy.; Tofani, M (corresponding author), Bambino Gesu Pediat Hosp, Dept Intens Neurorehabil & Robot, I-00165 Rome, Italy.; Galeoto, G (corresponding author), Sapienza Univ Rome, Dept Human Neurosci, I-00185 Rome, Italy.; Galeoto, G (corresponding author), IRCCS, Ist Neurol Mediterraneo Neuromed Neuromed, I-86077 Pozzilli, Italy.
EM anna.berardi@uniroma1.it; maurizio.marceca@uniroma1.it;
   donatella.valente@uniroma1.it; alfonso.mazzaccara@iss.it;
   antonella.polimeni@uniroma1.it; giovanni.galeoto@uniroma1.it
RI TOFANI, Marco/L-9720-2019; Galeoto, Giovanni/M-4922-2016
OI TOFANI, Marco/0000-0003-2071-4513; Galeoto,
   Giovanni/0000-0002-9043-5686; Polimeni, Antonella/0000-0002-2679-7607;
   Berardi, Anna/0000-0003-0670-5303
FU Sapienza University of Rome Bandi dAteneo [CC12117A8682CD95]
FX This research received no external funding. The APC, however, was funded
   by Sapienza University of Rome Bandi dAteneo CC12117A8682CD95.
CR Aker S, 2020, J COMMUN HEALTH, V45, P684, DOI 10.1007/s10900-020-00841-9
   [Anonymous], GU SERIE GEN
   [Anonymous], 2020, DECRETO DIRETTORIALE
   Berardi Anna, 2020, Proceedings of the 14th International Conference e-learning 2020. Part of the Multi Conference on Computer Science and Information Systems MCCSIS 2020, P160
   Cervera-Gasch A, 2020, NURS EDUC TODAY, V92, DOI 10.1016/j.nedt.2020.104473
   Farina I., 2019, P INT C METH INT SYS
   Fernandez-de-las-Penas C, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052621
   Galeoto G, 2021, Clin Ter, V172, P284, DOI 10.7417/CT.2021.2333
   Galeoto G., 2019, LEARNING TECHNOLOGY
   Galeoto G., 2018, P INT C METH INT SYS
   Galle F, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060638
   Gao ZY, 2020, J INFECT PUBLIC HEAL, V13, P1419, DOI 10.1016/j.jiph.2020.06.031
   Gohel KH, 2021, CLIN EPIDEMIOL GLOB, V9, P104, DOI 10.1016/j.cegh.2020.07.008
   ISS COVID-19 Training Working Group, TRAIN PREP COVID 19
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Ministero della Salute, DEF POST DISP IMM CO
   Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514
   Nguyen HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114164
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   World Health Organisation, 2020, 42 WHO
   World Health Organization, 46 WHO
NR 23
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD DEC
PY 2021
VL 18
IS 23
AR 12676
DI 10.3390/ijerph182312676
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA XV5LB
UT WOS:000734982600001
PM 34886401
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Piro, R
   Casalini, E
   Livrieri, F
   Fontana, M
   Ghidoni, G
   Taddei, S
   Facciolongo, N
AF Piro, Roberto
   Casalini, Eleonora
   Livrieri, Francesco
   Fontana, Matteo
   Ghidoni, Giulia
   Taddei, Sofia
   Facciolongo, Nicola
TI Interventional pulmonology during COVID-19 pandemic: current evidence
   and future perspectives
SO JOURNAL OF THORACIC DISEASE
LA English
DT Review
DE Thoracoscopy; bronchoscopy; interventional pulmonology; COVID-19;
   SARS-CoV-2
ID RESPIRATORY-DISTRESS-SYNDROME; LUNG FIBROSIS; CHEST CT; BRONCHOSCOPY;
   INTUBATION; SOCIETY; TRACHEOSTOMY; CRYOBIOPSY; MANAGEMENT; GUIDELINE
AB COVID-19, caused by SARS-CoV-2 infection, has become increasingly prevalent worldwide, reaching a pandemic stage in March 2020. The organization of health care services had to change because of this new disease, with the need to reallocate staff and materials, besides changing management protocols. A very important challenge is not to expose patients and health care workers to the risk of infection and not to waste personal protective equipment (PPE). In the field of interventional pulmonology, various aspects related to COVID-19 must be taken into great consideration. Although bronchoscopy is not a first-line test for patients with suspected SARS-CoV-2 infection, it has a role in selected cases and it can be useful for differential diagnosis. However, bronchoscopy is an aerosol-generating procedure, that's why its unjustified use could contribute to propagate the virus. For this reason, the utility of each procedure must be carefully evaluated, the patient has to be properly investigated before the procedure, which has to be performed with specific precautions, including adequate PPE. In this review, we summarize the knowledge and the principal statements about endoscopic activity in COVID-19 period, in both diagnosis of COVID-19 and management of patients. How to safely perform both bronchoscopic and pleural-related procedures (thoracoscopy, pleural biopsy and drainage of pleural effusions) is described with the aim to help the staff to decide when and how performing a procedure. We also highlight how interventional pulmonology could help in matter of complications related to COVID-19.
C1 [Piro, Roberto; Casalini, Eleonora; Livrieri, Francesco; Fontana, Matteo; Ghidoni, Giulia; Taddei, Sofia; Facciolongo, Nicola] Azienda Unita Sanit Locale IRCCS Reggio Emilia, Pulmonol Unit, Via Amendola 2, I-42122 Reggio Emilia, Italy.
RP Piro, R (corresponding author), Azienda Unita Sanit Locale IRCCS Reggio Emilia, Pulmonol Unit, Via Amendola 2, I-42122 Reggio Emilia, Italy.
EM roberto.piro@ausl.re.it
RI Fontana, Matteo/AAU-4692-2021; Piro, Roberto/AAA-5572-2021
OI Fontana, Matteo/0000-0001-8758-8449; Piro, Roberto/0000-0003-1046-4848
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   AIPO-ITS, RUOL MOD ES BRONC NE
   Alanio A, 2020, LANCET RESP MED, V8, pE48, DOI 10.1016/S2213-2600(20)30237-X
   Asai T, 2020, J ANESTH, V23, P1
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Barisione E, 2021, VIRCHOWS ARCH, V478, P471, DOI 10.1007/s00428-020-02934-1
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Botti C, 2021, ENT-EAR NOSE THROAT, V100, p116S, DOI 10.1177/0145561320965196
   British Thoracic Society, 2020, PLEUR SERV COVID 19, P1
   Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638
   Cabrera-Benitez NE, 2014, ANESTHESIOLOGY, V121, P189, DOI 10.1097/ALN.0000000000000264
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Catanese S, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2020-000804
   Centers for Disease Control and Prevention, TEST COVID 19
   Centers for Disease Control and Prevention, STRAT OPT SUPPL PPE
   Ceylan KC, 2020, EUR J CARDIO-THORAC, V58, P1216, DOI 10.1093/ejcts/ezaa356
   Chakrabarti, 2020, LANCET INFECT DIS
   Charlton CL, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00042-18
   Combet M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01808-2020
   Cooper JD, 2018, THORAC SURG CLIN, V28, P139, DOI 10.1016/j.thorsurg.2018.01.001
   Cordovilla R, 2020, ARCH BRONCONEUMOL, V56, P19, DOI 10.1016/j.arbres.2020.03.017
   Das Karuna M, 2017, Indian J Radiol Imaging, V27, P342, DOI 10.4103/ijri.IJRI_469_16
   de Medeiros GC, 2019, CODAS, V31, DOI 10.1590/2317-1782/20192018228
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dhanasopon AP, 2021, PHYS ASSIST CLIN, V6, P261, DOI 10.1016/j.cpha.2020.11.011
   Dinnes J, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013705
   Elhakim TS, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-239489
   Esteller-More E, 2005, EUR ARCH OTO-RHINO-L, V262, P880, DOI 10.1007/s00405-005-0929-y
   Facciolongo N, 2013, Monaldi Arch Chest Dis, V79, P128
   Falsey AR, 2012, J CLIN MICROBIOL, V50, P2835, DOI 10.1128/JCM.01473-12
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Farzanegan R, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.37574
   Freitas C, 2021, PULMONOLOGY, V27, P296, DOI 10.1016/j.pulmoe.2019.12.004
   Frija-Masson J, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01754-2020
   Galluccio G, 2009, EUR J CARDIO-THORAC, V35, P429, DOI 10.1016/j.ejcts.2008.10.041
   Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10
   George PM, 2020, LANCET RESP MED, V8, P807, DOI 10.1016/S2213-2600(20)30225-3
   Geri P, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01733-2020
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Grillo F, 2020, LANCET INFECT DIS, V21, pE72, DOI 10.1016/S1473-3099(20)30582-X
   Group of Interventional Respiratory Medicine Chinese Thoracic Society, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE006, DOI 10.3760/cma.j.issn.1001-0939.2020.0006
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guler SA, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03690-2020
   Hameed M, 2020, RESPIR MED CASE REP, V31, DOI 10.1016/j.rmcr.2020.101265
   Hernandez-Gonzalez F, 2015, ARCH BRONCONEUMOL, V51, P261, DOI 10.1016/j.arbres.2014.09.009
   Hoffman Tove, 2020, Infection Ecology & Epidemiology, V10, P1754538, DOI 10.1080/20008686.2020.1754538
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
   Joynt GM, 2004, RADIOLOGY, V230, P339, DOI 10.1148/radiol.2303030894
   Kollias A, 2020, BRIT J HAEMATOL, V189, P846, DOI 10.1111/bjh.16727
   Kutsukutsa J, 2019, INT J EVID-BASED HEA, V17, P74, DOI 10.1097/XEB.0000000000000166
   LEE TS, 1995, RESP MED, V89, P571, DOI 10.1016/0954-6111(95)90161-2
   Lentz RJ, 2020, RESPIROLOGY, V25, P574, DOI 10.1111/resp.13824
   Liang T, 2020, EUR RADIOL, V30, P4865, DOI 10.1007/s00330-020-06823-8
   Liu KF, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020175
   Livrieri F, 2020, INT MED CASE REP J, V13, P563, DOI 10.2147/IMCRJ.S277474
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Luo FM, 2020, RESPIRATION, V99, P417, DOI 10.1159/000507898
   MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986
   Maldonado F, 2020, CHEST, V157, P1030, DOI 10.1016/j.chest.2019.10.048
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Mattioli F, 2021, EUR ARCH OTO-RHINO-L, V278, P847, DOI 10.1007/s00405-020-06394-w
   Mattioli F, 2020, EUR ARCH OTO-RHINO-L, V277, P2133, DOI 10.1007/s00405-020-05982-0
   McGrath BA, 2020, LANCET RESP MED, V8, P717, DOI 10.1016/S2213-2600(20)30230-7
   Mo XN, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01217-2020
   Myall KJ, 2021, ANN AM THORAC SOC, V18, P799, DOI 10.1513/AnnalsATS.202008-1002OC
   Ortega R, 2015, NEW ENGL J MED, V372, pE11, DOI 10.1056/NEJMvcm1400705
   OSHA, 2009, ASS PROT FACT REV RE, P1
   Ost DE, 2020, J BRONCHOL INTERN PU, V27, P160, DOI 10.1097/LBR.0000000000000682
   Ost DE, 2016, AM J RESP CRIT CARE, V193, P68, DOI 10.1164/rccm.201507-1332OC
   Piazza C, 2021, EUR ARCH OTO-RHINO-L, V278, P1, DOI 10.1007/s00405-020-06112-6
   Pieracci FM, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2020-000498
   Pritchett MA, 2020, J THORAC DIS, V12, P1781, DOI 10.21037/jtd.2020.04.32
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rintoul R, 2020, BR THORAC SOC
   Rodrigues JCL, 2020, CLIN RADIOL, V75, P323, DOI 10.1016/j.crad.2020.03.003
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Saftic I, 2020, COVID 19 CHEST DRAIN, DOI [10.25373/ctsnet.12089130, DOI 10.25373/CTSNET.12089130]
   Sarper A, 2005, TEX HEART I J, V32, P154
   Scelfo C, 2020, THER CLIN RISK MANAG, V16, P1039, DOI 10.2147/TCRM.S275779
   Schaller T, 2020, JAMA-J AM MED ASSOC, V323, P2518, DOI 10.1001/jama.2020.8907
   Schwensen HF, 2021, J CLIN PATHOL, V74, P400, DOI 10.1136/jclinpath-2020-206879
   Scohy A, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104455
   Shah AS, 2021, THORAX, V76, P402, DOI 10.1136/thoraxjnl-2020-216308
   Sheng GH, 2020, CHEST, V157, P1175, DOI 10.1016/j.chest.2019.10.032
   Sihoe ADL, 2004, CHEST, V125, P2345, DOI 10.1378/chest.125.6.2345
   Simpson Scott, 2020, J Thorac Imaging, V35, P219, DOI [10.1148/ryct.2020200152, 10.1097/RTI.0000000000000524]
   Singh RK, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0234-z
   Spagnolo P, 2020, LANCET RESP MED, V8, P750, DOI 10.1016/S2213-2600(20)30222-8
   Steinfort DP, 2020, RESPIROLOGY, V25, P703, DOI 10.1111/resp.13843
   Sun RH, 2020, KOREAN J RADIOL, V21, P541, DOI 10.3348/kjr.2020.0180
   Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010
   van Arkel ALE, 2020, AM J RESP CRIT CARE, V202, P132, DOI 10.1164/rccm.202004-1038LE
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wahidi MM, 2020, CHEST, V158, P1268, DOI 10.1016/j.chest.2020.04.036
   Wahidi MM, 2020, J BRONCHOL INTERN PU, V27, pE52, DOI 10.1097/LBR.0000000000000681
   Wang J, 2020, Zhonghua Shao Shang Za Zhi, V36, P691, DOI 10.3760/cma.j.cn501120-20200307-00132
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691
   West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9
   World Health Organization, CRIT REL COVID 19 PA
   World Health Organization, 2019, WEEKLY EPIDEMIOLOGIC, P12
   Zamora JE, 2006, CAN MED ASSOC J, V175, P249, DOI 10.1503/cmaj.060094
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zhou CY, 2020, LANCET INFECT DIS, V20, P510, DOI 10.1016/S1473-3099(20)30156-0
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 106
TC 3
Z9 3
U1 1
U2 2
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2072-1439
EI 2077-6624
J9 J THORAC DIS
JI J. Thorac. Dis.
PD APR
PY 2021
VL 13
IS 4
BP 2495
EP 2509
DI 10.21037/jtd-20-2192
PG 15
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA TA8LO
UT WOS:000667497200008
PM 34012596
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Cvetkovic, VM
   Nikolic, N
   Nenadic, UR
   Ocal, A
   Noji, EK
   Zecevic, M
AF Cvetkovic, Vladimir M.
   Nikolic, Neda
   Nenadic, Una Radovanovic
   Ocal, Adem
   Noji, Eric K.
   Zecevic, Miodrag
TI Preparedness and Preventive Behaviors for a Pandemic Disaster Caused by
   COVID-19 in Serbia
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE disaster; epidemic risk; pandemic; citizen preparedness; coronavirus;
   COVID-19; Serbia
ID KNOWLEDGE; ATTITUDES; STUDENTS
AB Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2. The disease was first detected in Wuhan, the capital of China's Hubei province, in December 2019 and has since spread globally, especially to Europe and North America, resulting in the ongoing global coronavirus pandemic disaster of 2019-2020. Although most cases have mild symptoms, there is some progression to viral pneumonia and multi-organ failure and death. More than 4.6 million cases have been registered across 216 countries and territories as of 19 April 2020, resulting in more than 311,000 deaths. Risk to communities with continued widespread disease transmission depends on characteristics of the virus, including how well it spreads between people; the severity of resulting illness; and the medical or other measures available to control the impact of the virus (for example, vaccines or medications that can treat the illness) and the relative success of these. In the absence of vaccines or medications, non-pharmaceutical interventions were the most important response strategy based on community interventions such as person-to-person distancing, mask-wearing, isolation and good personal hygiene (hand-washing)-all of which have been demonstrated can reduce the impact of this seemingly unstoppable globally spreading natural disaster. This paper presents the results of quantitative research regarding the level of citizen preparedness for disasters caused by coronavirus disease (COVID-19) in Serbia. The survey was conducted using a questionnaire that was requested and then collected online among 975 respondents during disaster in April 2020. The questionnaire examined citizens' basic socio-economic and demographic characteristics, their knowledge, preparedness, risk perception and preventive measures taken individually and as a community to prevent the death and widespread transmission of novel coronavirus disease 2019 in the Republic of Serbia. Based on the findings that there are major differences in the public's perception of risks posed by communicable disease threats such as presented by COVID-19, emergency management agencies should use these differences to develop targeted strategies to enhance community and national preparedness by promoting behavioral change and improving risk management decision-making.
C1 [Cvetkovic, Vladimir M.] Univ Belgrade, Fac Secur Studies, Gospodara Vucica 50, Belgrade 11040, Serbia.
   [Nikolic, Neda] Univ Kragujevac, Fac Tehn Sci Cacak, Cacak 32000, Serbia.
   [Nenadic, Una Radovanovic] Sci Profess Soc Disaster Risk Management, Dimitrija Tucovica 121, Belgrade 11040, Serbia.
   [Ocal, Adem] Independent Researcher, TR-06500 Ankara, Turkey.
   [Noji, Eric K.] King Saud Univ Hosp & Coll Med, Riyadh 11564, Saudi Arabia.
   [Zecevic, Miodrag] European Univ, Fac Int Engn Management Belgrade, Belgrade 11000, Serbia.
RP Cvetkovic, VM (corresponding author), Univ Belgrade, Fac Secur Studies, Gospodara Vucica 50, Belgrade 11040, Serbia.
EM vmc@fb.bg.ac.rs; neda.nikolic@ftn.kg.ac.rs; una.radovanovic@gmail.com;
   ocadem@gmail.com; nojie@alumni.stanford.edu; misko.zecevic@gmail.com
RI Öcal, Adem/X-7314-2018; Ertan, Asli/AAE-6201-2021; Cvetković, PhD, Prof.
   dr Vladimir M./J-3501-2015
OI Öcal, Adem/0000-0003-4067-968X; Cvetković, PhD, Prof. dr Vladimir
   M./0000-0002-3450-0658
FU Scientific-Professional Society for Disaster Risk Management, Belgrade,
   Serbia
FX This research was funded by Scientific-Professional Society for Disaster
   Risk Management, Belgrade, Serbia (http://upravljanje-rizicima.com/).
CR Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339
   [Anonymous], 2010, AN EP PAND GRUP AH1N
   Anti-Corruption Council Government of Republic of Serbia [Savet za borbu protiv korupcije Vlada Republike Srbije], 2011, IZV PRIT KONTR MED
   Balicer RD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-99
   Barr M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-117
   Brewer PR, 2004, POLIT BEHAV, V26, P317, DOI 10.1007/s11109-004-0899-6
   Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391
   Cvetkovi V., 2018, BEZBEDNOST, V60, P5, DOI [10.5937/bezbednost1803005C, DOI 10.5937/BEZBEDNOST1803005C]
   Cvetkovic Vladimir., 2019, INT J DISASTER RISK, V1, P81, DOI [10.18485/ijdrm.2019.1.1.5, DOI 10.18485/IJDRM.2019.1.1.5]
   Cvetkovic VM, 2019, ACTA GEOGR SLOV, V59, P27, DOI 10.3986/AGS.5445
   Cvetkovic VM, 2019, INT J DISAST RISK RE, V35, DOI 10.1016/j.ijdrr.2019.101095
   Cvetkovic VM, 2018, REV KRIMINALISTIKO K, V69, P279
   Cvetkovic VM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122761
   Cvetkovic VM, 2018, IRAN J PUBLIC HEALTH, V47, P1213
   Cvetkovic VM, 2015, J GEOGR INST JOVAN C, V65, P323, DOI 10.2298/IJGI1503323C
   Dan A., 2016, STAVOVI GRADANA POLI
   Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6
   Glanz K., 2008, HLTH BEHAV HLTH ED T, V4
   Goodwin R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-166
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hunter W., 1919, P SECT EP STAT MED 2, DOI 10.1177/003591572001301502
   Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296
   Keki D., 2016, UPRAVLJANJE BEZBEDNO
   Krivokapi D., 2017, SHARE WORK 2016 MONI
   Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500
   Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002
   Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857
   Libertarijanski klub [Libertharian Club] Libek, 2015, LIB ISTR POV GRAD ME
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Miki D., 2010, ZARAZNE BOLESTI SRPS
   Montgomery D.C., 2012, INTRO LINEAR REGRESS, V821
   Oliveira ER, 2002, AIDS CARE, V14, P569, DOI 10.1080/09540120220133099
   Park JH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-222
   Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033
   Nenadic UR, 2020, HEALTH SECUR, V18, P29, DOI 10.1089/hs.2019.0046
   Ramzan Musarat, 2015, J Ayub Med Coll Abbottabad, V27, P402
   Ristanovi E., 2015, GAZZETTA SERBIAN MIN, V57, P5, DOI [10.5937/bezbednost1502005R, DOI 10.5937/BEZBEDNOST1502005R]
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99
   Seneviratne K, 2010, INT J STRATEG PROP M, V14, P376, DOI 10.3846/ijspm.2010.28
   Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054
   Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090
   Statistical Office of Serbia, STANOVNITVO
   uki G.J., 2018, ACTA MED MEDIAN, V57, P145
   Wang YB, 2020, J HEALTH PSYCHOL, V25, P733, DOI 10.1177/1359105320919177
   WHO, 2020, NAM COR DIS COVID 19
   WHO, 2020, CRIT PREP READ RESP
   WHO, 2003, SUMM TABL SARS CAS C
   World Health Organization, COR DIS COVID 19 PAN
   Wray R, 2004, BIOSECUR BIOTERROR, V2, P208, DOI 10.1089/15387130460759272
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 51
TC 49
Z9 50
U1 9
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUN
PY 2020
VL 17
IS 11
AR 4124
DI 10.3390/ijerph17114124
PG 23
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA MB5FY
UT WOS:000542629600377
PM 32527056
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Li, HJ
   Zhang, LW
   Wang, L
   Xu, TJ
AF Li, Huijie
   Zhang, Liwei
   Wang, Long
   Xu, Tianjiao
TI Regular COVID-19 Pandemic Containment in Communities: A Risk Governance
   Perspective
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE pandemic control experience; IRGC risk governance framework; China;
   COVID-19
ID HEALTH; DISEASES
AB Post COVID-19, differentiated regular management in place of strict lockdowns is more favored as a feasible option for balancing economic resumption and pandemic control. China's transition experience shows that this stage came not easily, during which regional sporadic outbreaks could re-emerge. Actually, it is an ongoing process of identifying loopholes and refining the management. Based on the IRGC risk governance framework, this article analyzes these challenges in community involvement posed by the transition. The systematic examination of the whole risk chain would be conducive to contain the virus spread, lessen the pressure of communities for the battle and enhance future responses for a possible resurgence. Unlike the emergency mode with mass mobilized, during regular control periods, community becomes the critical frontline for suppressing COVID-19 but with limited manpower and resources. Still, it can serve as a transformation platform to motivate atomized residents to take responsibility or contribute. Notably, the health governance of all people never ends. With the increased knowledge of COVID-19, the progress of pandemic control, and the needed adjustments for behavioral responses, different communities should come up with more suitable options instead of rigid management back to the old days.
C1 [Li, Huijie; Zhang, Liwei; Wang, Long; Xu, Tianjiao] Jilin Univ, Sch Publ Adm, Changchun, Peoples R China.
RP Xu, TJ (corresponding author), Jilin Univ, Changchun, Peoples R China.
EM xtjjlu01@163.com
OI Li, Huijie/0000-0002-6393-1094; Xu, Tianjiao/0000-0002-5825-9002
FU National Social Science Fund for Young Scholars [18CZZ010]; Integrity
   Research Program at Jilin University [2017LZY016]; Seed Funding of Basic
   Research Operating Expense of Jilin University [2021ZZ012]
FX This work was supported by the National Social Science Fund for Young
   Scholars (grant number 18CZZ010) ; the Integrity Research Program at
   Jilin University (grant num-ber 2017LZY016) ; and the Seed Funding of
   Basic Research Operating Expense of Jilin University (grant number
   2021ZZ012) .
CR Ahlqvist V, 2020, OPER SUPPLY CHAIN MA, V13, P382, DOI 10.31387/oscm0430278
   [Anonymous], 2021, LANCET, V397, P1683, DOI 10.1016/S0140-6736(21)01052-7
   [Anonymous], GUARDIAN
   Blizniewska-Kowalska KM, 2021, MED SCI MONITOR, V27, DOI 10.12659/MSM.932220
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   China National Radio, 2021, EXP COMM WHY CHIN CO
   China Youth Network, COMMUNICATION
   Collins A, 2020, J RISK RES, V23, P1073, DOI 10.1080/13669877.2020.1760332
   Hale T, 2021, VARIATION GOVT RESPO
   International Risk Governance Council, 2017, INTR IRGC RISK GOV F, DOI [10.5075/epfl-irgc -233739, DOI 10.5075/EPFL-IRGC-233739]
   International Risk Governance Council, 2005, 1 IRGC
   Jiang SH, 2021, ASIAN J CRIMINOL, V16, P75, DOI 10.1007/s11417-020-09334-z
   Joint Prevention and Control Mechanism of the State Council, 2020, NOT FURTH DIFF REG S
   Joint Prevention and Control Mechanism of the State Council, 2020, GUID REG PREV CONTR
   Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028
   National Health Commission of the People's Republic of China, 2021, REP NAT COV VACC SHO
   National Health Commission of the People's Republic of China, 2020, PROT PREV CONTR COVI
   National Health Commission of the People's Republic of China, 2021, REP NAT COV VACC SHO
   Pang XH, 2020, NATL SCI REV, V7, P1861, DOI 10.1093/nsr/nwaa264
   Rastogi S, 2020, ANN AYU MED, V9, P144, DOI [10.5455/AAM.1603468291, DOI 10.5455/AAM.1603468291]
   Rastogi S, ANN AYU MED, V10, P82, DOI [10.5455/AAM.75790, DOI 10.5455/AAM.75790]
   Renn O, 2008, INT RISK GOV COUNC B, V1, P1, DOI 10.1007/978-1-4020-6799-0
   Renn O., 2008, RISK GOVERNANCE COPI, DOI [10.4324/9781849772440, DOI 10.4324/9781849772440]
   Roodenrijs JCM, 2014, J RISK RES, V17, P1161, DOI 10.1080/13669877.2013.875935
   Schmidt K, 2013, ZOONOSES PUBLIC HLTH, V60, P528, DOI 10.1111/zph.12045
   Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083
   WHO, 2012, WORLD MALARIA REPORT 2012, P1
   World Health Organization, WHO COVID 19 DASHB
   Xu JY, 2021, RESPIROLOGY, V26, P275, DOI 10.1111/resp.14002
   Yanez JA, 2020, AM J TROP MED HYG, V103, P1614, DOI 10.4269/ajtmh.20-0800
   Zhang SX, 2022, INT J MENT HEALTH AD, V20, P956, DOI 10.1007/s11469-020-00418-6
   Zhang SX, 2020, BRAIN BEHAV IMMUN, V87, P144, DOI 10.1016/j.bbi.2020.05.010
   Zhang XY, 2020, INT J HEALTH PLAN M, V35, P1246, DOI 10.1002/hpm.3005
NR 33
TC 0
Z9 0
U1 18
U2 18
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 4003
EP 4011
DI 10.2147/RMHP.S316509
PG 9
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA WB2ZK
UT WOS:000703445500004
PM 34594139
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Mechanick, JI
   Carbone, S
   Dickerson, RN
   Hernandez, BJD
   Hurt, RT
   Irving, SY
   Li, DY
   McCarthy, MS
   Mogensen, KM
   Gautier, JBO
   Patel, JJ
   Prewitt, TE
   Rosenthal, M
   Warren, M
   Winkler, MF
   McKeever, L
AF Mechanick, Jeffrey I.
   Carbone, Salvatore
   Dickerson, Roland N.
   Hernandez, Beverly J. D.
   Hurt, Ryan T.
   Irving, Sharon Y.
   Li, Ding-You
   McCarthy, Mary S.
   Mogensen, Kris M.
   Gautier, Juan B. Ochoa
   Patel, Jayshil J.
   Prewitt, T. Elaine
   Rosenthal, Martin
   Warren, Malissa
   Winkler, Marion F.
   McKeever, Liam
CA ASPEN COVID-19 Task Force Nutritio
TI Clinical Nutrition Research and the COVID-19 Pandemic: A Scoping Review
   of the ASPEN COVID-19 Task Force on Nutrition Research
SO JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
LA English
DT Review
DE cardiometabolic risk; coronavirus disease 2019; diabetes; enteral
   nutrition; knowledge gap; knowledge translation; metabolic syndrome;
   nutrition; nutrition research; nutrition support therapy; obesity;
   parenteral nutrition; research gap; severe acute respiratory syndrome
   coronavirus&#8208; 2; scoping review; social determinants of health
ID CHRONIC DISEASE; ENTERAL NUTRITION; AMERICAN ASSOCIATION; VITAMIN-D;
   ENDOCRINOLOGISTS; ADIPOSITY; SEVERITY; TERM; CARE
AB The purpose of this scoping review by the American Society for Parenteral and Enteral Nutrition (ASPEN) coronavirus disease 2019 (COVID-19) Nutrition Task Force was to examine nutrition research applicable to the COVID-19 pandemic. The rapid pace of emerging scientific information has prompted this activity to discover research/knowledge gaps. This methodology adhered with recommendations from the Joanna Briggs Institute. There were 2301 citations imported. Of these, there were 439 articles fully abstracted, with 23 main topic areas identified across 24 article types and sourced across 61 countries and 51 specialties in 8 settings and among 14 populations. Epidemiological/mechanistic relationships between nutrition and COVID-19 were reviewed and results mapped to the Population, Intervention, Comparator, Outcome, and Time (PICO-T) questions. The aggregated data were analyzed by clinical stage: pre-COVID-19, acute COVID-19, and chronic/post-COVID-19. Research gaps were discovered for all PICO-T questions. Nutrition topics meriting urgent research included food insecurity/societal infrastructure and transcultural factors (pre-COVID-19); cardiometabolic-based chronic disease, pediatrics, nutrition support, and hospital infrastructure (acute COVID-19); registered dietitian nutritionist counseling (chronic/post-COVID-19); and malnutrition and management (all stages). The paucity of randomized controlled trials (RCTs) was particularly glaring. Knowledge gaps were discovered for PICO-T questions on pediatrics, micronutrients, bariatric surgery, and transcultural factors (pre-COVID-19); enteral nutrition, protein-energy requirements, and glycemic control with nutrition (acute COVID-19); and home enteral and parenteral nutrition support (chronic/post-COVID-19). In conclusion, multiple critical areas for urgent nutrition research were identified, particularly using RCT design, to improve nutrition care for patients before, during, and after COVID-19.
C1 [Mechanick, Jeffrey I.] Icahn Sch Med Mt Sinai, Mt Sinai Heart, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, New York, NY 10029 USA.
   [Mechanick, Jeffrey I.] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, Metab Support, New York, NY 10029 USA.
   [Carbone, Salvatore] Virginia Commonwealth Univ, Coll Humanities & Sci, Dept Kinesiol & Hlth Sci, Richmond, VA USA.
   [Dickerson, Roland N.] Univ Tennessee, Clin Pharm & Translat Sci, Hlth Sci Ctr, Memphis, TN USA.
   [Dickerson, Roland N.] Reg One Hlth, Nutr Support Serv, Memphis, TN USA.
   [Hernandez, Beverly J. D.] Tampa Gen Hosp, Clin Nutr, Tampa, FL 33606 USA.
   [Hurt, Ryan T.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA.
   [Hurt, Ryan T.] Mayo Clin, Div Endocrinol, Rochester, MN USA.
   [Hurt, Ryan T.] Mayo Clin, Div Diabet, Rochester, MN USA.
   [Hurt, Ryan T.] Mayo Clin, Div Metab, Rochester, MN USA.
   [Hurt, Ryan T.] Mayo Clin, Div Nutr, Rochester, MN USA.
   [Irving, Sharon Y.] Univ Penn, Sch Nursing, Dept Family & Community Hlth, Philadelphia, PA 19104 USA.
   [Li, Ding-You] Univ Missouri, Kansas City Sch Med, Gastroenterol & Nutr, Kansas City, MO 64110 USA.
   [McCarthy, Mary S.] Madigan Army Med Hosp, Tacoma, WA USA.
   [Mogensen, Kris M.] Brigham & Womens Hosp, Dept Nutr, 75 Francis St, Boston, MA 02115 USA.
   [Gautier, Juan B. Ochoa] Ochsner Med Ctr, New Orleans, LA USA.
   [Patel, Jayshil J.] Med Coll Wisconsin, Div Pulm & Crit Care Med, Milwaukee, WI 53226 USA.
   [Prewitt, T. Elaine] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Hlth Policy & Management, Little Rock, AR 72205 USA.
   [Rosenthal, Martin] Univ Florida, Coll Med, Acute Care Surg Team, Gainesville, FL USA.
   [Warren, Malissa] Oregon Hlth & Sci Univ, VA Portland HealthCare Syst, Portland, OR 97201 USA.
   [Winkler, Marion F.] Rhode Isl Hosp, Brown Med Sch, Dept Surg & Nutr Support Serv, Providence, RI USA.
   [McKeever, Liam] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA.
RP Mechanick, JI (corresponding author), Mt Sinai Hosp, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.
EM jeffrey.mechanick@mountsinai.org
RI Carbone, Salvatore/J-2830-2019; Mogensen, Kris M./ABI-4502-2020;
   Correia, Maria Isabel Toulson Davisson/I-8617-2012
OI Carbone, Salvatore/0000-0002-8163-0527; Mogensen, Kris
   M./0000-0001-9510-3018; Correia, Maria Isabel Toulson
   Davisson/0000-0002-3503-4302; Rosenthal, Martin/0000-0002-5682-0994;
   mechanick, jeffrey/0000-0002-0657-588X; Dickerson,
   Roland/0000-0002-2086-6317
FU American Heart AssociationAmerican Heart Association [19CDA34660318];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [UL1TR002649]
FX Salvatore Carbone was supported by a Career Development Award
   (19CDA34660318) from the American Heart Association and by the Clinical
   and Translational Science Awards Program (UL1TR002649) from the National
   Institutes of Health to Virginia Commonwealth University. Any
   recommendation in this paper does not constitute medical or other
   professional advice and should not be taken as such. To the extent that
   the information published herein may be used to assist in the care of
   patients, this is the result of the sole professional judgment of the
   attending healthcare professional whose judgment is the primary
   component of quality medical care. The information presented here is not
   a substitute for the exercise of such judgment by the healthcare
   professional. Circumstances in clinical settings and patient indications
   may require actions different from those recommended in this document,
   and in those cases, the judgment of the treating professional should
   prevail. This paper was approved by the ASPEN Board of Directors.
CR Akseer N, 2020, AM J CLIN NUTR, V112, P251, DOI 10.1093/ajcn/nqaa171
   American Society for Parenteral and Enteral Nutrition, RES CLIN CAR PAT COR
   Aromataris E, 2017, JOANNA BRIGGS I REVI
   Barazzoni R, 2020, CLIN NUTR, V39, P1631, DOI 10.1016/j.clnu.2020.03.022
   Batheja S, 2013, J NEUROPSYCH CLIN N, V25, P176, DOI 10.1176/appi.neuropsych.12090223
   Batty GD, 2020, BRAIN BEHAV IMMUN, V89, P569, DOI 10.1016/j.bbi.2020.06.021
   Belanger MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2021264
   Bornstein SR, 2020, LANCET DIABETES ENDO, V8, P546, DOI 10.1016/S2213-8587(20)30152-2
   Butler MJ, 2020, BRAIN BEHAV IMMUN, V87, P53, DOI 10.1016/j.bbi.2020.04.040
   Calder PC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041181
   Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P2464, DOI 10.1001/jama.2020.9252
   Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756
   Dunn CG, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005638
   Fan JL, 2020, METABOLISM, V107, DOI 10.1016/j.metabol.2020.154243
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Food Security Information Network, GLOB REP FOOD CRIS 2
   Gemelli Against COVID-19 Post-Acute Care Study Group, 2020, AGING CLIN EXP RES, V32, P1613, DOI DOI 10.1007/s40520-020-01616-x
   Giuliani C, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108239
   Handu D, 2021, J ACAD NUTR DIET, V121, P979, DOI 10.1016/j.jand.2020.05.012
   Huang JF, 2020, J MED VIROL, V92, P2152, DOI 10.1002/jmv.26003
   Huizar MI, 2021, PROG CARDIOVASC DIS, V64, P105, DOI 10.1016/j.pcad.2020.07.002
   Infusino F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061718
   Jaffri A, 2020, HEART LUNG, DOI 10.1016/j.hrtlng.2020.06.006
   Killerby ME, 2020, MMWR-MORBID MORTAL W, V69, P790, DOI 10.15585/mmwr.mm6925e1
   Klok FA, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01494-2020
   Krznaric Z, 2020, CLIN NUTR, V39, P1983, DOI 10.1016/j.clnu.2020.05.006
   Laurencin CT, 2020, J RACIAL ETHN HEALTH, V7, P398, DOI 10.1007/s40615-020-00756-0
   Levin M, 2020, NEW ENGL J MED, V383, P393, DOI 10.1056/NEJMe2023158
   Li T, 2020, EUR J CLIN NUTR, V74, P871, DOI 10.1038/s41430-020-0642-3
   Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006
   Liu H, 2020, AGING DIS, V11, P668, DOI 10.14336/AD.2020.0502
   Lyons D, 2020, IRISH J PSYCHOL MED, DOI 10.1017/ipm.2020.40
   Parra-Bracamonte GM, 2020, ANN EPIDEMIOL, V52, P93, DOI 10.1016/j.annepidem.2020.08.005
   Marik PE, 2018, PHARMACOL THERAPEUT, V189, P63, DOI 10.1016/j.pharmthera.2018.04.007
   Marik PE, 2017, CHEST, V151, P1229, DOI 10.1016/j.chest.2016.11.036
   Marik PE, 2001, CRIT CARE MED, V29, P2264, DOI 10.1097/00003246-200112000-00005
   Martindale R, 2020, JPEN-PARENTER ENTER, V44, P1174, DOI 10.1002/jpen.1930
   Matras P, 2020, CLIN NUTR ESPEN, V38, P196, DOI 10.1016/j.clnesp.2020.05.002
   McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1177/0148607115621863, 10.1097/CCM.0000000000001525]
   Mechanick JI, 2020, J AM COLL CARDIOL, V76, P2024, DOI 10.1016/j.jacc.2020.07.069
   Mechanick JI, 2020, J AM COLL CARDIOL, V75, P539, DOI 10.1016/j.jacc.2019.11.046
   Mechanick JI, 2020, J AM COLL CARDIOL, V75, P525, DOI 10.1016/j.jacc.2019.11.044
   Mechanick JI, 2017, ENDOCR PRACT, V23, P372, DOI 10.4158/EP161688.PS
   Mechanick JL, 2018, ENDOCR PRACT, V24, P995, DOI 10.4158/PS-2018-0139
   Mehr SE, 2018, CLIN AUTON RES, V28, P411, DOI 10.1007/s10286-018-0519-x
   Minnelli N, 2020, JPEN-PARENTER ENTER, V44, P1439, DOI 10.1002/jpen.1996
   Mulherin DW, 2020, NUTR CLIN PRACT, V35, P783, DOI 10.1002/ncp.10553
   Munn Z, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-017-0468-4
   Muscogiuri G, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154251
   Nikpouraghdam M, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104378
   Paslakis G, 2020, NUTR REV, DOI 10.1093/nutrit/nuaa069
   Patel Aniruddh P, 2020, Int J Equity Health, V19, P114, DOI [10.1101/2020.04.27.20082107, 10.1186/s12939-020-01227-y]
   Pearl RL, 2020, OBESITY, V28, P1180, DOI 10.1002/oby.22850
   Perrin R, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110055
   Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]
   Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686
   Putzu A, 2017, J CRIT CARE, V38, P109, DOI 10.1016/j.jcrc.2016.10.029
   Rayman G, 2020, DIABETIC MED, V37, P1214, DOI 10.1111/dme.14328
   Rollston R, 2020, AM J HEALTH PROMOT, V34, P687, DOI 10.1177/0890117120930536b
   Rosenthal MD, 2020, J PARENTER ENTERAL N, DOI 10.1002/jpen.1794
   Rozga M, 2020, J ACAD NUTR DIETET, DOI 10.1016/j.jand.2020.05.015
   Schorghuber M, 2018, LANCET GASTROENTEROL, V3, P281, DOI 10.1016/S2468-1253(18)30036-0
   Stam HJ, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2677
   Thomas MK, 1998, NEW ENGL J MED, V338, P777, DOI 10.1056/NEJM199803193381201
   Tian JB, 2020, LANCET ONCOL, V21, P893, DOI 10.1016/S1470-2045(20)30309-0
   Wambier CG, 2020, DRUG DEVELOP RES, V81, P771, DOI 10.1002/ddr.21688
   Wolfson JA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030877
   Yan CG, 2021, IEEE T PATTERN ANAL, V43, P1445, DOI 10.1109/TPAMI.2020.2975798
   Yehya A, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3360
   Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427
   Zabetakis I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051466
   Zhang P, 2020, CLIN NUTR, DOI [10.1016/j.clnu.2020.05.05, DOI 10.1016/J.CLNU.2020.05.05]
   Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412
   Zimmer K., 2020, SCIENTIST
NR 76
TC 24
Z9 25
U1 9
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-6071
EI 1941-2444
J9 JPEN-PARENTER ENTER
JI J. Parenter. Enter. Nutr.
PD JAN
PY 2021
VL 45
IS 1
BP 13
EP 31
DI 10.1002/jpen.2036
EA NOV 2020
PG 19
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA PZ4CF
UT WOS:000588792600001
PM 33094848
OA Green Accepted
DA 2022-04-20
ER

PT J
AU Ashiru-Oredope, D
   Chan, AHY
   Olaoye, O
   Rutter, V
   Babar, ZUD
AF Ashiru-Oredope, Diane
   Chan, Amy Hai Yan
   Olaoye, Omotayo
   Rutter, Victoria
   Babar, Zaheer-Ud-Din
CA C P A COVID-19 Action Team
TI Needs assessment and impact of COVID-19 on pharmacy professionals in 31
   commonwealth countries
SO JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
LA English
DT Article
DE Pharmacy; Pharmacists; Commonwealth; COVID-19; Health; Heads of
   Government; Pandemic; CHOGM; CPA; Emergency preparedness; Coronavirus;
   CwPAMS
AB Background The declaration of COVID-19 a pandemic by the World Health Organization on 11 March 2020 marked the beginning of a global health crisis of an unprecedented nature and scale. The approach taken by countries across the world varied widely, however, the delivery of frontline healthcare was consistently recognised as being central to the pandemic response. This study aimed to identify and explore the issues currently facing pharmacy teams across Commonwealth countries during the COVID-19 pandemic. The study also evaluates pharmacy professionals' understanding of key knowledge areas from the COVID-19 webinar hosted by the Commonwealth Pharmacists' Association (CPA). Method A quantitative survey-based approach was adopted, using a 32-item questionnaire developed from the literature on pharmacy and pandemic response. The survey was hosted on Survey Monkey and pilot tested. The final survey was disseminated by CPA member organisations. A 6-item online questionnaire was sent via email to all attendees of CPA's COVID-19 webinar. Descriptive statistics on frequency distributions and percentages were used to analyse the responses. Data were analysed using Microsoft(R) Excel (2010). Results There were 545 responses from pharmacy professionals across 31/54 Commonwealth countries in Africa, Asia, the Americas, Europe and the Pacific. Majority of the respondents reported being at least somewhat worried (90%) and more than 65% were very worried or extremely about the impact of COVID-19 on them personally and professionally. Nearly two-thirds of respondents stated finding it somewhat difficult or very difficult to work effectively during the pandemic. Challenges mostly faced by pharmacy professionals working remotely included; general anxiety about the impact of COVID-19 on their lives (12%), and difficulties in communicating with their co-workers (12%). Most pharmacy professionals had not previously been actively involved in a global health emergency (82%) nor obtained training on global/public health emergency preparedness (62%). Between 45 and 97% of the COVID-19 webinar attendees provided the correct answers to post-webinar questions, suggesting some improvement in knowledge. Conclusion Our study confirms pharmacy professionals' concerns about practice during a pandemic and provides preliminary data on the challenges and learning needs of the profession. The CPA has since acted on these findings, providing ongoing opportunities to develop and refine resources for the profession as the pandemic evolves. Pharmacy professionals have also demonstrated improved knowledge on the management of COVID-19 and resources available for professionals.
C1 [Ashiru-Oredope, Diane; Chan, Amy Hai Yan; Olaoye, Omotayo; Rutter, Victoria] Commonwealth Pharmacists Assoc, London, England.
   [Chan, Amy Hai Yan] Univ Auckland, Fac Med & Hlth Sci, Sch Pharm, Level 3,Bldg 505,85 Pard Rd, Auckland 1023, New Zealand.
   [Babar, Zaheer-Ud-Din] Univ Huddersfield, Dept Pharm, Huddersfield HD1 3DH, W Yorkshire, England.
RP Ashiru-Oredope, D (corresponding author), Commonwealth Pharmacists Assoc, London, England.
EM diane.ashiru-oredope@commonwealthpharmacy.org
RI Olaoye, Omotayo/ABB-8189-2021
OI Olaoye, Omotayo/0000-0001-9886-6109; Ashiru-Oredope,
   Diane/0000-0001-9579-2028; Chan, Amy Hai Yan/0000-0002-1291-3902;
   Anderson, Claire/0000-0002-5406-2296
FU CPA funds
FX The study was approved by the Commonwealth Pharmacists Association
   Trustees and funded within CPA funds. There was no specific grant from
   funding agencies in the public, commercial, or not-for-profit sectors.
CR Ahmad A, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00243-1
   [Anonymous], 2020, PHARM TODAY
   Aruru M, 2020, RES SOC ADMIN PHARM, V20, P30323
   Atif M, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00240-4
   Bukhari N, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00210-w
   Business Services Organisation Northern Ireland, COVID 19 COMM PHARM
   Chan AHY, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00214-6
   Commonwealth Pharmacists Association, 2020, COMM PARTN ANT STEW
   Commonwealth Pharmacists Association, 2020, COVID 19 WEB CPA
   Commonwealth Secretariat, 2020, COMM
   da Costa FA, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00216-4
   Damian M., MEDSCAPE NEWS PERSPE
   Elbeddini A, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00241-3
   EYSENBACH G, 2004, J MED INTERNET RES, V6, P3
   Feroz A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8173-3
   Frias L., 2020, ITALY CLOSING ALL ST
   Goff Debra A, 2020, J Am Coll Clin Pharm, DOI 10.1002/jac5.1329
   Journal TP, 2020, J TP ROYAL PHARM SOC
   McMillan SS, 2013, RES SOC ADMIN PHARM, V9, P863, DOI 10.1016/j.sapharm.2012.11.003
   Pharmaceutical Society of New Zealand (Inc, COVID 19 GUID SOC PH
   Porter KE, 2018, INT J PHARM PRACT, V26, P195, DOI 10.1111/ijpp.12351
   Rubin SE, 2014, BIOSECUR BIOTERROR, V12, P76, DOI 10.1089/bsp.2013.0082
   Scahill S. L., 2018, Journal of Pharmacy Practice and Research, V48, P251, DOI 10.1002/jppr.1410
   Smith AJ, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3120-z
   Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090
   Temsah MH, 2020, J INFECT PUBLIC HEAL, V13, P877, DOI [10.1016/j.jiph.2020.05.021, 10.1016/j.ijph.2020.05.021]
   Watson KE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227132
   WHO, 2020, COVID 19 OP GUID MAI
   World Health Organization, 2020, COMMUNICATION 0311
NR 29
TC 13
Z9 13
U1 0
U2 3
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2052-3211
J9 J PHARM POLICY PRACT
JI J. Pharm. Policy Pract.
PD OCT 21
PY 2020
VL 13
IS 1
AR 72
DI 10.1186/s40545-020-00275-7
PG 11
WC Health Policy & Services; Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services; Pharmacology & Pharmacy
GA ON0AT
UT WOS:000586376200001
PM 33093963
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Huangfu, LW
   Mo, YW
   Zhang, PJ
   Zeng, DD
   He, SK
AF Huangfu, Luwen
   Mo, Yiwen
   Zhang, Peijie
   Zeng, Daniel Dajun
   He, Saike
TI COVID-19 Vaccine Tweets After Vaccine Rollout: Sentiment-Based Topic
   Modeling
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE COVID-19; COVID-19 vaccine; sentiment evolution; topic modeling; social
   media; text mining
AB Background: COVID-19 vaccines are one of the most effective preventive strategies for containing the pandemic. Having a better understanding of the public's conceptions of COVID-19 vaccines may aid in the effort to promptly and thoroughly vaccinate the community. However, because no empirical research has yet fully explored the public's vaccine awareness through sentiment-based topic modeling, little is known about the evolution of public attitude since the rollout of COVID-19 vaccines.
   Objective: In this study, we specifically focused on tweets about COVID-19 vaccines (Pfizer, Moderna, AstraZeneca, and Johnson & Johnson) after vaccines became publicly available. We aimed to explore the overall sentiments and topics of tweets about COVID-19 vaccines, as well as how such sentiments and main concerns evolved.
   Methods: We collected 1, 122, 139 tweets related to COVID-19 vaccines from December 14, 2020, to April 30, 2021, using Twitter's application programming interface. We removed retweets and duplicate tweets to avoid data redundancy, which resulted in 857, 128 tweets. We then applied sentiment-based topic modeling by using the compound score to determine sentiment polarity and the coherence score to determine the optimal topic number for different sentiment polarity categories. Finally, we calculated the topic distribution to illustrate the topic evolution of main concerns.
   Results: Overall, 398, 661 (46.51%) were positive, 204, 084 (23.81%) were negative, 245,976 (28.70%) were neutral, 6899 (0.80%) were highly positive, and 1508 (0.18%) were highly negative sentiments. The main topics of positive and highly positive tweets were planning for getting vaccination (251, 979/405, 560, 62.13%), getting vaccination (76,029/405,560, 18.75%), and vaccine information and knowledge (21,127/405, 560, 5.21%). The main concerns in negative and highly negative tweets were vaccine hesitancy (115, 206/205, 592, 56.04%), extreme side effects of the vaccines (19,690/205,592, 9.58%), and vaccine supply and rollout (17, 154/205, 592, 8.34%). During the study period, negative sentiment trends were stable, while positive sentiments could be easily influenced. Topic heatmap visualization demonstrated how main concerns changed during the current widespread vaccination campaign.
   Conclusions: To the best of our knowledge, this is the first study to evaluate public COVID-19 vaccine awareness and awareness trends on social media with automated sentiment-based topic modeling after vaccine rollout. Our results can help policymakers and research communities track public attitudes toward COVID-19 vaccines and help them make decisions to promote the vaccination campaign.
C1 [Huangfu, Luwen; Mo, Yiwen] San Diego State Univ, Fowler Coll Business, San Diego, CA 92182 USA.
   [Huangfu, Luwen] San Diego State Univ, Ctr Human Dynam Mobile Age, San Diego, CA 92182 USA.
   [Zhang, Peijie; Zeng, Daniel Dajun; He, Saike] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, 95 Zhongguancun East Rd, Beijing 100190, Peoples R China.
   [Zeng, Daniel Dajun; He, Saike] Univ Chinese Acad Sci, Beijing, Peoples R China.
RP He, SK (corresponding author), Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, 95 Zhongguancun East Rd, Beijing 100190, Peoples R China.
EM saike.he@ia.ac.cn
OI Mo, Yiwen/0000-0001-8671-8993; He, Saike/0000-0002-2186-4524; Zeng,
   Daniel Dajun/0000-0002-9046-222X
FU San Diego State University Master Research Scholarship; Fowler College
   of Business
FX This study was supported by a San Diego State University Master Research
   Scholarship and by Research Funds from Fowler College of Business. We
   thank Professor David Banks from Duke University for providing helpful
   and constructive comments and suggestions.
CR Abdulaziz M, 2021, INT J ADV COMPUT SC, V12, P626
   [Anonymous], FORTUNE
   [Anonymous], 2021, COVID 19 VACC AR EFF
   Beyrer C, 2021, LONG HIST MRNA VACCI
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Buntz B., 2021, DRUG DISCOVERY 0301
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   DSouza G, RETHINKING HERD IMMU
   Eysenbach G, 2020, J MED INTERNET RES, V22, DOI 10.2196/21820
   Garcia K, 2021, APPL SOFT COMPUT, V101, DOI 10.1016/j.asoc.2020.107057
   Griffith J, 2021, J MED INTERNET RES, V23, DOI 10.2196/26874
   Hitti FL, 2021, AM J MED, V134, P703, DOI 10.1016/j.amjmed.2021.02.004
   Hou ZY, 2021, J MED INTERNET RES, V23, DOI 10.2196/27632
   Hussain A, 2021, J MED INTERNET RES, V23, DOI 10.2196/26627
   Hutto C., 2014, ICWSM
   Jang HJ, 2021, J MED INTERNET RES, V23, DOI 10.2196/25431
   Jelodar H, 2021, LATENT DIRICHLET ALL
   Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9
   Leischow SJ, 2006, AM J PUBLIC HEALTH, V96, P403, DOI 10.2105/AJPH.2005.082842
   Li LF, 2020, IEEE T COMPUT SOC SY, V7, P556, DOI 10.1109/TCSS.2020.2980007
   Li XM, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02324-w
   Mutanga MB, 2022, AFR J SCI TECHNOL IN, V14, P163, DOI 10.1080/20421338.2020.1817262
   Oyebode O, 2021, JMIR MED INF, V9, DOI 10.2196/22734
   Praveen SV, 2021, INF DISCOV DELIV, V49, P240, DOI 10.1108/IDD-08-2020-0097
   Romer D, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113356
   Serrano P, P 2021 AM C INF SYST, P1723
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Taylor S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.575950
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Wen A, 2021, J BIOMED INFORM, V113, DOI [10.1016/j.jbi.2020.103660, 10.1101/2020.06.08.20124990]
   Yin FL, 2021, J MED INTERNET RES, V23, DOI 10.2196/26089
NR 32
TC 1
Z9 1
U1 3
U2 3
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD FEB 8
PY 2022
VL 24
IS 2
AR e31726
DI 10.2196/31726
PG 14
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Medical Informatics
GA ZQ0BV
UT WOS:000766780400002
PM 34783665
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Knight, J
   Mishra, S
AF Knight, Jesse
   Mishra, Sharmistha
TI Estimating effective reproduction number using generation time versus
   serial interval, with application to COVID-19 in the Greater Toronto
   Area, Canada
SO INFECTIOUS DISEASE MODELLING
LA English
DT Article
DE Reproduction number; Generation time; Serial interval; Incubation
   period; COVID-19
ID TRANSMISSION DYNAMICS; CORONAVIRUS COVID-19; IMPACT; INFECTIVITY;
   INFLUENZA; DISEASE; CHINA
AB BACKGROUND. The effective reproduction number R-e(t) is a critical measure of epidemic potential. R-e(t) can be calculated in near real time using an incidence time series and the generation time distribution: the time between infection events in an infector-infectee pair. In calculating R-e(t), the generation time distribution is often approximated by the serial interval distribution: the time between symptom onset in an infector-infectee pair. However, while generation time must be positive by definition, serial interval can be negative if transmission can occur before symptoms, such as in COVID-19, rendering such an approximation improper in some contexts. METHODS. We developed a method to infer the generation time distribution from parametric definitions of the serial interval and incubation period distributions. We then compared estimates of R-e(t) for COVID-19 in the Greater Toronto Area of Canada using: negative-permitting versus non-negative serial interval distributions, versus the inferred generation time distribution. RESULTS. We estimated the generation time of COVID-19 to be Gamma-distributed with mean 3.99 and standard deviation 2.96 days. Relative to the generation time distribution, non-negative serial interval distribution caused overestimation of R-e(t) due to larger mean, while negative-permitting serial interval distribution caused underestimation of R-e(t) due to larger variance. (C) 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
C1 [Knight, Jesse; Mishra, Sharmistha] Univ Toronto, Inst Med Sci, Toronto, ON, Canada.
   [Knight, Jesse; Mishra, Sharmistha] Unity Hlth Toronto, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada.
   [Mishra, Sharmistha] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada.
   [Mishra, Sharmistha] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
RP Mishra, S (corresponding author), Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Rm 315,3rd Floor,209 Victoria St, Toronto, ON M5B 1T8, Canada.
EM sharmistha.mishra@utoronto.ca
OI Mishra, Sharmistha/0000-0001-8492-5470; Knight,
   Jesse/0000-0002-0455-5455
FU Natural Sciences and Engineering Research Council of Canada (NSERC
   CGS-D); Ontario Early Researcher Award (Canada) [ER17-13-043]; 2020
   COVID-19 Centred Research Award from the St Michael's Hospital
   Foundation Research Innovation Council (Canada)
FX The study was supported by: the Natural Sciences and Engineering
   Research Council of Canada (NSERC CGS-D); Ontario Early Researcher Award
   No. ER17-13-043 (Canada); and the 2020 COVID-19 Centred Research Award
   from the St Michael's Hospital Foundation Research Innovation Council
   (Canada).
CR Ali ST, 2013, EPIDEMICS-NETH, V5, P157, DOI 10.1016/j.epidem.2013.08.001
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Britton T, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2018.0670
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6
   Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.3201/eid2606.200357, 10.1101/2020.02.19.20025452]
   Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257
   Hogg R.V., 2005, INTRO MATH STAT
   Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1
   Klinkenberg D, 2011, J THEOR BIOL, V284, P52, DOI 10.1016/j.jtbi.2011.06.015
   Kuk AYC, 2005, STAT MED, V24, P2525, DOI 10.1002/sim.2123
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538
   Liu Yang, 2020, Wellcome Open Res, V5, P58, DOI 10.12688/wellcomeopenres.15788.1
   Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060
   Osterholm MT, 2015, MBIO, V6, DOI 10.1128/mBio.00137-15
   Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130
   Park M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040967
   Tang B, 2020, LESSONS DRAWN CHINA, DOI [10.2471/BLT.20.257238, DOI 10.2471/BLT.20.257238]
   Tindale LC, 2020, ELIFE, V9, DOI 10.7554/eLife.57149
   You Chong, 2020, Int J Hyg Environ Health, V228, P113555, DOI 10.1016/j.ijheh.2020.113555
   Zeng G, 2009, BIOMED ENVIRON SCI, V22, P502, DOI 10.1016/S0895-3988(10)60008-6
   Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9
   Zhang S, 2020, INT J INFECT DIS, V93, P201, DOI 10.1016/j.ijid.2020.02.033
   Zhao S, 2020, RES SQUARE, DOI [10.21203/rs.3.rs-18805/v1, DOI 10.21203/RS.3.RS-18805/V1]
NR 28
TC 8
Z9 8
U1 1
U2 4
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717,
   PEOPLES R CHINA
EI 2468-0427
J9 INFECT DIS MODEL
JI Infect. Dis. Model.
PY 2020
VL 5
BP 889
EP 896
DI 10.1016/j.idm.2020.10.009
PG 8
WC Mathematical & Computational Biology; Infectious Diseases
WE Emerging Sources Citation Index (ESCI)
SC Mathematical & Computational Biology; Infectious Diseases
GA OO3IF
UT WOS:000587275300001
PM 33163739
OA Green Submitted, Green Published, gold
DA 2022-04-20
ER

PT J
AU An, L
   Bacon, E
   Hawley, S
   Yang, P
   Russell, D
   Huffman, S
   Resnicow, K
AF An, Lawrence
   Bacon, Elizabeth
   Hawley, Sarah
   Yang, Penny
   Russell, Daniel
   Huffman, Scott
   Resnicow, Ken
TI Relationship Between Coronavirus-Related eHealth Literacy and COVID-19
   Knowledge, Attitudes, and Practices among US Adults: Web-Based Survey
   Study
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE internet; digital health; eHealth; eHealth literacy; coronavirus;
   COVID-19; knowledge; conspiracy beliefs; protective behaviors; social
   distancing; survey; health communication; attitude; behavior
ID HEALTH LITERACY; DIGITAL DIVIDE; ASSOCIATION; BEHAVIORS; OUTCOMES
AB Background: During a global pandemic, it is critical that the public is able to rapidly acquire new and accurate health information. The internet is a major source of health information. eHealth literacy is the ability of individuals to find, assess, and use health information available on the internet.
   Objective: The goals of this study were to assess coronavirus-related eHealth literacy and examine the relationship between eHealth literacy and COVID-19-related knowledge, attitudes, and practices (KAPs).
   Methods: We conducted a web-based survey of a representative sample of 1074 US adults. We adapted the 8-item eHealth Literacy Scale to develop the Coronavirus-Related eHealth Literacy Scale (CoV-eHEALS) to measure COVID-19-related knowledge, conspiracy beliefs, and adherence to protective behaviors (eg, wearing facial masks and social distancing). Our analyses identified sociodemographic associations with the participants' CoV-eHEALS scores and an association between the CoV-eHEALS measure and COVID-19 KAPs.
   Results: The internal consistency of the adapted CoV-eHEALS measure was high (Cronbach alpha=.92). The mean score for the CoV-eHEALS was 29.0 (SD 6.1). A total of 29% (306/1074) of the survey participants were classified as having low coronavirus-related eHealth literacy (CoV-eHEALS score <26). Independent associations were found between CoV-eHEALS scores and ethnicity (standardized beta=-.083, P=.016 for Black participants) and education level (standardized beta=-.151, P=.001 for participants with high-school education or lower). Controlling for demographic characteristics, CoV-eHEALS scores demonstrated positive independent associations with knowledge (standardized beta=.168, P<.001) and adherence to protective behaviors (standardized beta=.241, P<.001) and a negative association with conspiracy beliefs (standardized beta=-.082, P=.009).
   Conclusions: This study provides an estimate of coronavirus-related eHealth literacy among US adults. Our findings suggest that a substantial proportion of US adults have low coronavirus-related eHealth literacy and are thus at a greater risk of lower and less-protective COVID-19 KAPs. These findings highlight the need to assess and address eHealth literacy as part of COVID-19 control efforts. Potential strategies include improving the quality of health information about COVID-19 available on the internet, assisting or simplifying web-based search for information about COVID-19, and training to improve general or coronavirus-specific search skills.
C1 [An, Lawrence; Bacon, Elizabeth; Hawley, Sarah; Yang, Penny; Resnicow, Ken] Univ Michigan, Ctr Hlth Commun Res, Rogel Canc Ctr, North Campus Res Complex,Bldg 16,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.
   [An, Lawrence; Hawley, Sarah] Univ Michigan, Div Gen Med, Sch Med, Ann Arbor, MI 48109 USA.
   [Hawley, Sarah] VA Ann Arbor Healthcare Syst, VA Ctr Clin Management Res, Ann Arbor, MI USA.
   [Russell, Daniel; Huffman, Scott] Google, Mountain View, CA 94043 USA.
   [Resnicow, Ken] Univ Michigan, Dept Hlth Behav & Hlth Educ, Sch Publ Hlth, Ann Arbor, MI 48109 USA.
RP An, L (corresponding author), Univ Michigan, Ctr Hlth Commun Res, Rogel Canc Ctr, North Campus Res Complex,Bldg 16,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.
EM lcan@med.umich.edu
OI Yang, Penny/0000-0002-2330-2330; Resnicow, Ken/0000-0003-1416-9627;
   Bacon, Elizabeth/0000-0001-9029-8004; Russell,
   Daniel/0000-0002-7243-9317
FU National Cancer Institute GrantUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [P30CA046592-29-S4]; Google Focus awardGoogle
   Incorporated
FX This work was supported by National Cancer Institute Grant
   P30CA046592-29-S4 and a Google Focus award (to LA).
CR Alobuia WM, 2020, J PUBLIC HEALTH-UK, V42, P470, DOI 10.1093/pubmed/fdaa069
   [Anonymous], CORONAVIRUS DIS 2019
   [Anonymous], Coronavirus Disease (COVID-19) Pandemic
   Bandura A, 1999, COHERENCE OF PERSONALITY, P185
   Bangerter Lauren R, 2019, JMIR Aging, V2, pe11237, DOI 10.2196/11237
   Biddlestone M, 2020, BRIT J SOC PSYCHOL, V59, P663, DOI 10.1111/bjso.12397
   Block Ray Jr, 2020, Health Lit Res Pract, V4, pe166, DOI 10.3928/24748307-20200707-01
   Brors G, 2020, EUR J CARDIOVASC NUR, V19, P458, DOI 10.1177/1474515120941307
   Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37
   Chesser A, 2016, INFORM HEALTH SOC CA, V41, P1, DOI 10.3109/17538157.2014.948171
   Choi NG, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2645
   Chong YY, 2020, INT J NURS STUD, V108, DOI 10.1016/j.ijnurstu.2020.103644
   Chung SY, 2015, CIN-COMPUT INFORM NU, V33, P150, DOI 10.1097/CIN.0000000000000146
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161
   Do BN, 2020, J MED INTERNET RES, V22, DOI 10.2196/22894
   Duplaga M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217818
   Earnshaw VA, 2020, TRANSL BEHAV MED, V10, P850, DOI 10.1093/tbm/ibaa090
   Eysenbach G, 2020, J MED INTERNET RES, V22, DOI 10.2196/21820
   Freeman D, 2022, PSYCHOL MED, V52, P251, DOI 10.1017/S0033291720001890
   Frenkel S, NEW YORK TIMES
   Hernandez-Garcia I, 2020, JMIR PUBLIC HLTH SUR, V6, P110, DOI 10.2196/18717
   Jayasinghe R, 2020, PATIENT EDUC COUNS, V103, P2594, DOI 10.1016/j.pec.2020.08.001
   Kontos Emily, 2014, J Med Internet Res, V16, pe172, DOI 10.2196/jmir.3117
   Lazer L, 2020, COVID STATES PROJECT
   Li SY, 2020, J MED INTERNET RES, V22, DOI 10.2196/19782
   Li XJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/19684
   McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808
   Milne RA, 2015, J CANCER EDUC, V30, P685, DOI 10.1007/s13187-014-0744-5
   Mitsutake S, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5413
   Mitsutake S, 2012, J MED INTERNET RES, V14, P406, DOI 10.2196/jmir.1927
   Moores TT, 2009, INFORM MANAGE-AMSTER, V46, P69, DOI 10.1016/j.im.2008.11.006
   Neter E, 2019, EUR PSYCHOL, V24, P68, DOI 10.1027/1016-9040/a000350
   Neter Efrat, 2017, JMIR Hum Factors, V4, pe2, DOI 10.2196/humanfactors.6523
   Neter E, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1619
   Nguyen Jennifer, 2016, JMIR Public Health Surveill, V2, pe24, DOI 10.2196/publichealth.4967
   Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e27
   Paige SR, 2017, PATIENT EDUC COUNS, V100, P320, DOI 10.1016/j.pec.2016.09.008
   Powell J, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1600
   Rice RE, 2006, INT J MED INFORM, V75, P8, DOI 10.1016/j.ijmedinf.2005.07.032
   Richtering Sarah S, 2017, JMIR Hum Factors, V4, pe4, DOI 10.2196/humanfactors.6217
   Robinson C, 2010, HEALTH INFO LIBR J, V27, P295, DOI 10.1111/j.1471-1842.2010.00898.x
   Romer D, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113356
   Russell D, 2019, SCI AM
   Russell DanielM., 2019, JOY SEARCH GOOGLE IN
   Sentell T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093010
   Sherman LD, 2020, AM J MENS HEALTH, V14, DOI 10.1177/1557988320901377
   Stellefson ML, 2018, HEALTH COMMUN, V33, P1410, DOI 10.1080/10410236.2017.1353868
   Tangcharoensathien V, 2020, J MED INTERNET RES, V22, DOI 10.2196/19659
   Tennant B, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3992
   Toussaint LL, 2020, ANN BEHAV MED, V54, P619, DOI 10.1093/abm/kaaa064
   van der Vaart R, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1840
   van Prooijen JW, 2018, PERSPECT PSYCHOL SCI, V13, P770, DOI 10.1177/1745691618774270
   Weinberg BA, 2009, PAC ECON REV, V14, P502, DOI 10.1111/j.1468-0106.2009.00466.x
NR 54
TC 13
Z9 13
U1 3
U2 20
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD MAR 29
PY 2021
VL 23
IS 3
AR e25042
DI 10.2196/25042
PG 14
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Medical Informatics
GA RH4SF
UT WOS:000636209800003
PM 33626015
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Berlingieri, G
   Alvares, CMA
   Serrano, RV
   Palma, LF
   Campos, L
AF Berlingieri, Giuseppina
   Arvate Alvares, Cristina Maria
   Serrano, Rafael Verardi
   Palma, Luiz Felipe
   Campos, Luana
TI Phototherapies for COVID-19-associated opportunistic oral infections
SO PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
LA English
DT Article
DE COVID-19; SARS-CoV-2; Antimicrobial photodynamic therapy;
   Photobiomodulation therapy; Herpes Labialis; Candidiasis
AB Opportunistic infections are widely described in patients with novel coronavirus disease 2019 (COVID-19); however, very few studies have addressed those affecting the oral cavity. Given the lack of information on the clinical presentations and the available treatment options, the present study aimed to show a case in which a combination of antimicrobial photodynamic therapy (aPDT) and photobiomodulation therapy (PBMT) was used for the management of two concomitant COVID-19-associated opportunistic oral infections (oral pseudomembranous candidiasis and recurrent herpes labialis). Within 7 days and without any systemic drug administration, all the lesions resolved completely, and the patient no longer reported oral pain or discomfort. According to the current case report and taking into consideration the significant gaps in the knowledge and understanding of COVID-19, this combination of phototherapy modalities seems to be a promising tool for managing viral and fungal opportunistic oral infections.
C1 [Berlingieri, Giuseppina; Campos, Luana] Laser & Hlth Inst, Study Grp, Sao Paulo, SP, Brazil.
   [Arvate Alvares, Cristina Maria; Campos, Luana] Univ Santo Amaro, Sch Dent, Grad Program Implantol, Sao Paulo, SP, Brazil.
   [Serrano, Rafael Verardi; Palma, Luiz Felipe] Ibirapuera Univ Sao Paulo, Grad Dent Program, Sao Paulo, SP, Brazil.
RP Campos, L (corresponding author), Univ Santo Amaro, Sch Dent, Rua Prof Eneas de Siqueira Neto 340, BR-04829300 Sao Paulo, SP, Brazil.
EM lucampos@prof.unisa.br
CR Abdoli A, 2021, CLIN EXP MED, DOI 10.1007/s10238-021-00751-7
   Aragoneses J, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.726753
   Ramires MCCH, 2021, PHOTODIAGN PHOTODYN, V33, DOI 10.1016/j.pdpdt.2021.102196
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Teixeira IS, 2021, PHOTODIAGN PHOTODYN, V34, DOI 10.1016/j.pdpdt.2021.102281
   Zhang HC, 2020, EMERG MICROBES INFEC, V9, P1958, DOI 10.1080/22221751.2020.1812437
NR 6
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1572-1000
EI 1873-1597
J9 PHOTODIAGN PHOTODYN
JI Photodiagnosis Photodyn. Ther.
PD MAR
PY 2022
VL 37
AR 102678
DI 10.1016/j.pdpdt.2021.102678
EA DEC 2021
PG 2
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA YW9WX
UT WOS:000753762100001
PM 34890781
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Ekpenyong, BN
   Osuagwu, UL
   Miner, CA
   Ovenseri-Ogbomo, GO
   Abu, EK
   Goson, PC
   Langsi, R
   Nwaeze, O
   Chikasirimobi, TG
   Charwe, DD
   Mashige, KP
   Oloruntoba, R
   Ishaya, T
   Agho, KE
AF Ekpenyong, Bernadine N.
   Osuagwu, Uchechukwu L.
   Miner, Chundung Asabe
   Ovenseri-Ogbomo, Godwin O.
   Abu, Emmanuel Kwasi
   Goson, Piwuna Christopher
   Langsi, Raymond
   Nwaeze, Obinna
   Chikasirimobi, Timothy G.
   Charwe, Deborah Donald
   Mashige, Khathutshelo Percy
   Oloruntoba, Richard
   Ishaya, Tanko
   Agho, Kingsley Emwinyore
TI Knowledge, Attitudes, and Perceptions of COVID-19 among Healthcare and
   Non-Healthcare Workers in Sub-Saharan Africa: A Web-Based Survey
SO HEALTH SECURITY
LA English
DT Article
DE COVID-19; Frontline workers; Public health preparedness; response;
   Lockdown; Risk perception
ID ACUTE RESPIRATORY SYNDROME; SARS; TRANSMISSION; OUTBREAK; IMPACT
AB Due to the current COVID-19 pandemic and associated high mortality in sub-Saharan Africa, there is panic amongst healthcare workers because of the higher risk of being infected. This study compared knowledge, attitudes, and perceptions of COVID-19 among healthcare workers (HCWs) and non-healthcare workers (non-HCWs) and examined common associated factors. A web-based cross-sectional study of 1,871 respondents (430 HCWs and 1,441 non-HCWs) was conducted while lockdown measures were in place in 4 regions of sub-Saharan Africa. Data were obtained using a validated self-administered questionnaire via an online survey platform. Mean scores were calculated and summarized using a t test for both groups. Multivariate linear regression analysis was conducted to assess the unadjusted (B) and adjusted coefficients (beta) with a confidence interval (CI) of 95%. The mean scores were slightly higher among HCWs than non-HCWs, but not statistically significant. Being worried about contracting COVID-19 was the only common factor associated with knowledge, attitudes, and perceptions between the 2 groups. Knowledge of COVID-19 was associated with attitudes and perceptions between the 2 groups. Other significant associated factors were: the sub-Saharan Africa region, ages 29 to 38 years (beta = .32; 95% CI, 0.04 to 0.60 for knowledge among non-HCWs), education (beta = -.43; 95% CI, -0.81 to -0.04; and beta = -.95; 95% CI, -1.69 to -0.22, for knowledge among non-HCWs and HCWs, respectively), practice of self-isolation (beta = .71; 95% CI, 0.41 to 1.02 for attitude among non-HCWs and HCWs (beta = .97; 95% CI, 0.45 to 1.49), and home quarantine due to COVID-19, in both groups. Policymakers and healthcare providers should consider these factors when targeting interventions during COVID-19 and other future pandemics.
C1 [Ekpenyong, Bernadine N.] Univ Calabar, Coll Med Sci, Fac Allied Med Sci, Dept Publ Hlth, Calabar, Cross River Sta, Nigeria.
   [Osuagwu, Uchechukwu L.] Western Sydney Univ, Sch Med, Diabet Obes & Metab Translat Res Unit, Campbelltown, NSW, Australia.
   [Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Hlth Sci, Biostat, Campbelltown, NSW, Australia.
   [Miner, Chundung Asabe] Univ Jos, Coll Hlth Sci, Dept Community Med, Jos, Plateau State, Nigeria.
   [Goson, Piwuna Christopher] Univ Jos, Coll Hlth Sci, Dept Psychiat, Jos, Plateau State, Nigeria.
   [Ishaya, Tanko] Univ Jos, Dept Comp Sci, Jos, Plateau State, Nigeria.
   [Ovenseri-Ogbomo, Godwin O.] Qassim Univ, Coll Appl Med Sci, Dept Optometry, Buraydah, Saudi Arabia.
   [Ovenseri-Ogbomo, Godwin O.] Univ Benin, Fac Life Sci, Dept Optometry, Benin, Nigeria.
   [Abu, Emmanuel Kwasi] Univ Cape Coast, Sch Allied Hlth Sci, Dept Optometry & Vis Sci, Cape Coast, Ghana.
   [Langsi, Raymond] Univ Bamenda, Hlth Div, Bambili, Cameroon.
   [Nwaeze, Obinna] Cty Durham & Darlington Natl Hlth Serv Fdn, Darlington, Durham, England.
   [Chikasirimobi, Timothy G.] Masinde Muliro Univ Sci & Technol, Kakamega, Kenya.
   [Charwe, Deborah Donald] Tanzania Food & Nutr Ctr, Dar Es Salaam, Tanzania.
   [Mashige, Khathutshelo Percy] Univ KwaZulu Natal, African Vis Res Inst, Discipline Optometry, Westville Campus, Durban, South Africa.
   [Oloruntoba, Richard] Curtin Univ, Fac Business & Law, Sch Management & Mkt, Supply Chain Management, Bentley, WA, Australia.
   [Ekpenyong, Bernadine N.; Osuagwu, Uchechukwu L.; Ovenseri-Ogbomo, Godwin O.; Agho, Kingsley Emwinyore] Univ KwaZulu Natal, African Vis Res Inst, Westville Campus, Durban, South Africa.
RP Osuagwu, UL (corresponding author), Western Sydney Univ, Diabet Obes & Metab Translat Res Unit, Level 2,Room 10-08 MacArthur Clin Sch Bldg, Campbelltown, NSW 2560, Australia.
EM l.osuagwu@westernsydney.edu.au
RI osuagwu, Uchechukwu Levi/K-5236-2015; Agho, Kingsley/AAW-5622-2021
OI osuagwu, Uchechukwu Levi/0000-0002-1727-6914; Agho,
   Kingsley/0000-0003-4111-3207; Abu, Emmanuel Kwasi/0000-0003-2354-9170
CR Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0
   Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Abir T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145252
   Abuya T., 2021, COVID 19 RELATED KNO
   Africa Centres for Disease Control and Prevention (Africa CDC), 2021, COR DIS 2019 COVID 1
   Ajisegiri W., 2020, GLOB BIOSECUR, V1
   Alobuia WM, 2020, J PUBLIC HEALTH-UK, V42, P470, DOI 10.1093/pubmed/fdaa069
   [Anonymous], 2020, SURV TOOL GUID BEH I
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Blendon RJ, 2004, CLIN INFECT DIS, V38, P925, DOI 10.1086/382355
   Blustein DL, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103436
   Bwire George M, 2020, SN Compr Clin Med, V2, P874, DOI 10.1007/s42399-020-00341-w
   Chang L, 2020, TRANSFUS MED REV, V34, P75, DOI 10.1016/j.tmrv.2020.02.003
   Deaton AS, 2015, HEALTH AFFAIR, V34, P519, DOI 10.1377/hlthaff.2014.0798
   Di Gennaro F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082690
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Ejeh FE, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05557
   Ekpenyong B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145141
   Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Hamadani JD, 2020, LANCET GLOB HEALTH, V8, pE1380, DOI 10.1016/S2214-109X(20)30366-1
   Hjort J, 2019, AM ECON REV, V109, P1032, DOI 10.1257/aer.20161385
   Hu ZM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00265
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ilesanmi O., 2016, PLOS CURR-TREE LIFE, V8
   Janjua NZ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-81
   Khosravi M, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7856
   Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864
   Law S, 2020, INT J INFECT DIS, V94, P156, DOI 10.1016/j.ijid.2020.03.059
   Lee K, 2009, GLOB INST, P1
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li Y, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0468-6
   Li ZH, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008584
   Lupia T, 2020, J GLOB ANTIMICROB RE, V21, P22, DOI 10.1016/j.jgar.2020.02.021
   Matsuishi K, 2012, PSYCHIAT CLIN NEUROS, V66, P353, DOI 10.1111/j.1440-1819.2012.02336.x
   Maunder RG, 2006, EMERG INFECT DIS, V12, P1924
   Moro Matteo, 2020, Acta Biomed, V91, P29, DOI 10.23750/abm.v91i3-S.9419
   Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633
   Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X
   Nicholas T, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.2020.35.2.22963, 10.11604/pamj.supp.2020.35.2.22963]
   Nkansah C, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.supp.2020.35.2.23644
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Orentlicher D, 2018, AM J PUBLIC HEALTH, V108, P1459, DOI 10.2105/AJPH.2018.304582
   Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925
   Parikh PA, 2020, CUREUS, V12, DOI 10.7759/cureus.8144
   Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z
   Puspitasari IM, 2020, J MULTIDISCIP HEALTH, V13, P727, DOI 10.2147/JMDH.S265527
   Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1
   Serwaa D, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.2020.35.2.22630, 10.11604/pamj.supp.2020.35.2.22630]
   Shaukat N, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00299-5
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Usman IM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00340
   Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002
   World Health Organization Regional Office for Africa, 2020, COVID 19 SIT UPD WHO
   World Health Organization (WHO), 2021, REP WHO CHIN JOINT M
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiao YH, 2020, LANCET INFECT DIS, V20, P523, DOI 10.1016/S1473-3099(20)30152-3
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhong Nan-Shan, 2004, Paediatr Respir Rev, V5, P270, DOI 10.1016/j.prrv.2004.07.011
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 63
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD AUG 1
PY 2021
VL 19
IS 4
BP 393
EP 404
DI 10.1089/hs.2020.0208
EA JUL 2021
PG 12
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA UC8BL
UT WOS:000669976500001
PM 34227870
DA 2022-04-20
ER

PT J
AU Barbaud, A
   Garvey, LH
   Arcolaci, A
   Brockow, K
   Mori, F
   Mayorga, C
   Bonadonna, P
   Atanaskovic-Markovic, M
   Moral, L
   Zanoni, G
   Pagani, M
   Soria, A
   Jost, M
   Caubet, JC
   Carmo, A
   Mona, AA
   Alvarez-Perea, A
   Bavbek, S
   Benedetta, B
   Bilo, MB
   Blanca-Lopez, N
   Bogas, HG
   Buonomo, A
   Calogiuri, G
   Carli, G
   Cernadas, J
   Cortellini, G
   Celik, G
   Demir, S
   Dona, I
   Dursun, AB
   Eberlein, B
   Faria, E
   Fernandes, B
   Garcez, T
   Garcia-Nunez, I
   Gawlik, R
   Gelincik, A
   Gomes, E
   Gooi, JHC
   Grosber, M
   Gulen, T
   Hacard, F
   Hoarau, C
   Janson, C
   Johnston, SL
   Joerg, L
   Ozdemir, SK
   Klimek, L
   Kosnik, M
   Kowalski, ML
   Kuyucu, S
   Kvedariene, V
   Laguna, JJ
   Lombardo, C
   Marinho, S
   Merk, H
   Meucci, E
   Morisset, M
   Munoz-Cano, R
   Murzilli, F
   Nakonechna, A
   Popescu, FD
   Porebski, G
   Radice, A
   Regateiro, FS
   Rockmann, H
   Romano, A
   Sargur, R
   Sastre, J
   Hofmeier, KS
   Sedlackova, L
   Sobotkova, M
   Terreehorst, I
   Treudler, R
   Walusiak-Skorupa, J
   Wedi, B
   Wohrl, S
   Zidarn, M
   Zuberbier, T
   Agache, I
   Torres, MJ
AF Barbaud, Annick
   Garvey, Lene Heise
   Arcolaci, Alessandra
   Brockow, Knut
   Mori, Francesca
   Mayorga, Cristobalina
   Bonadonna, Patrizia
   Atanaskovic-Markovic, Marina
   Moral, Luis
   Zanoni, Giovanna
   Pagani, Mauro
   Soria, Angele
   Jost, Maja
   Caubet, Jean-Christoph
   Carmo, Abreu
   Mona, Al-Ahmad
   Alvarez-Perea, Alberto
   Bavbek, Sevim
   Benedetta, Biagioni
   Bilo, M. Beatrice
   Blanca-Lopez, Natalia
   Bogas, Herrera Gador
   Buonomo, Alessandro
   Calogiuri, Gianfranco
   Carli, Giulia
   Cernadas, Josefina
   Cortellini, Gabriele
   Celik, Gulfem
   Demir, Semra
   Dona, Inmaculada
   Dursun, Adile Berna
   Eberlein, Bernadette
   Faria, Emilia
   Fernandes, Bryan
   Garcez, Tomaz
   Garcia-Nunez, Ignacio
   Gawlik, Radoslaw
   Gelincik, Asli
   Gomes, Eva
   Gooi, Jimmy H. C.
   Grosber, Martine
   Gulen, Theo
   Hacard, Florence
   Hoarau, Cyrille
   Janson, Christer
   Johnston, Sebastian L.
   Joerg, Lukas
   Ozdemir, Secil Kepil
   Klimek, Ludger
   Kosnik, Mitja
   Kowalski, Marek L.
   Kuyucu, Semanur
   Kvedariene, Violeta
   Laguna, Jose Julio
   Lombardo, Carla
   Marinho, Susana
   Merk, Hans
   Meucci, Elisa
   Morisset, Martine
   Munoz-Cano, Rosa
   Murzilli, Francesco
   Nakonechna, Alla
   Popescu, Florin-Dan
   Porebski, Grzegorz
   Radice, Anna
   Regateiro, Frederico S.
   Rockmann, Heike
   Romano, Antonino
   Sargur, Ravishankar
   Sastre, Joaquin
   Hofmeier, Kathrin Scherer
   Sedlackova, Lenka
   Sobotkova, Marta
   Terreehorst, Ingrid
   Treudler, Regina
   Walusiak-Skorupa, Jolanta
   Wedi, Bettina
   Wohrl, Stefan
   Zidarn, Mihael
   Zuberbier, Torsten
   Agache, Ioana
   Torres, Maria J.
TI Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper
SO ALLERGY
LA English
DT Article; Early Access
DE allergy test; anaphylaxis; COVID-19 vaccine; mRNA vaccines; risk
   assessment
ID ANTI-PEG ANTIBODIES; POLYETHYLENE-GLYCOL; HYPERSENSITIVITY REACTIONS;
   MACROGOL HYPERSENSITIVITY; CONTACT SENSITIZATION; ANAPHYLACTIC REACTION;
   SAFETY; MULTICENTER; VACCINATION
AB Background Anaphylaxis, which is rare, has been reported after COVID-19 vaccination, but its management is not standardized. Method Members of the European Network for Drug Allergy and the European Academy of Allergy and Clinical Immunology interested in drug allergy participated in an online questionnaire on pre-vaccination screening and management of allergic reactions to COVID-19 vaccines, and literature was analysed. Results No death due to anaphylaxis to COVID-19 vaccines has been confirmed in scientific literature. Potential allergens, polyethylene glycol (PEG), polysorbate and tromethamine are excipients. The authors propose allergy evaluation of persons with the following histories: 1-anaphylaxis to injectable drug or vaccine containing PEG or derivatives; 2-anaphylaxis to oral/topical PEG containing products; 3-recurrent anaphylaxis of unknown cause; 4-suspected or confirmed allergy to any mRNA vaccine; and 5-confirmed allergy to PEG or derivatives. We recommend a prick-to-prick skin test with the left-over solution in the suspected vaccine vial to avoid waste. Prick test panel should include PEG 4000 or 3500, PEG 2000 and polysorbate 80. The value of in vitro test is arguable. Conclusions These recommendations will lead to a better knowledge of the management and mechanisms involved in anaphylaxis to COVID-19 vaccines and enable more people with history of allergy to be vaccinated.
C1 [Barbaud, Annick] Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, Hop Tenon,AP HP,Dept Dermatol & Allergol, F-75020 Paris, France.
   [Garvey, Lene Heise] Copenhagen Univ Hosp Gentofte, Allergy Clin, Copenhagen, Denmark.
   [Garvey, Lene Heise] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.
   [Arcolaci, Alessandra] Univ Hosp Verona, Immunol Unit, Policlin GB Rossi, Verona, Italy.
   [Brockow, Knut; Eberlein, Bernadette] Tech Univ Munich, Fac Med, Dept Dermatol & Allergy Biederstein, Munich, Germany.
   [Mori, Francesca] Meyer Childrens Univ Hosp, Dept Pediat, Allergy Unit, Florence, Italy.
   [Mayorga, Cristobalina] Hosp Reg Univ Malaga, Allergy Clin Unit, Inst Invest Biomed Malaga IBIMA, ARADyAL, Malaga, Spain.
   [Bonadonna, Patrizia] Verona Univ Hosp, Allergy Unit, Verona, Italy.
   [Atanaskovic-Markovic, Marina] Univ Belgrade, Univ Childrens Hosp, Fac Med, Belgrade, Serbia.
   [Moral, Luis] Alicante Univ Gen Hosp, Alicante Inst Hlth & Biomed Res ISABIAL, Pediat Allergy & Resp Unit, Alicante, Spain.
   [Zanoni, Giovanna] Azienda Osped Univ Integrata Verona, Immunol Unit, Policlin GB Rossi, Verona, Italy.
   [Pagani, Mauro] ASST Mantova, Med Dept, Med Ward Mantova Hosp, Mantua, Italy.
   [Soria, Angele] Sorbonne Univ, INSERM 1135 Cimi Paris, Hop Tenon, Assistance Publ Hop Paris,Dept Dermatol & Allergo, Paris, France.
   [Jost, Maja; Zidarn, Mihael] Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia.
   [Caubet, Jean-Christoph] Univ Hosp Geneva, Dept Women Children Teenagers, Geneva, Switzerland.
   [Carmo, Abreu] Ctr Hosp Tras Os Montes & Alto Douro, Ctr Hosp Baixo Vouga, Allergy & Clin Immunol Unit, Vila Real & Allergy & Clin Immunol Unit, Aveiro, Portugal.
   [Mona, Al-Ahmad] Kuwait Univ, Fac Med, Microbiol Dept, Kuwait, Kuwait.
   [Alvarez-Perea, Alberto] Hosp Gen Univ Gregorio Maranon, Allergy Dept, Madrid, Spain.
   [Bavbek, Sevim] Ankara Univ, Sch Med, Dept Pulm Dis, Div Allergy,FAAAI, Ankara, Turkey.
   [Benedetta, Biagioni] IRCCS Azienda Osped Univ Bologna, Div Internal Med Hepatobiliary & Immunoallerg Dis, Bologna, Italy.
   [Bilo, M. Beatrice] Univ Politecn Marche, Dept Clin & Mol Sci, Ancona, Italy.
   [Bilo, M. Beatrice] Univ Hosp Osped Riuniti Ancona, Allergy Unit, Dept Internal Med, Ancona, Italy.
   [Blanca-Lopez, Natalia] Infanta Leonor Univ Hosp, Madrid, Spain.
   [Bogas, Herrera Gador] Hosp Reg Univ Malaga HRUM, Inst Invest Biomed Malaga IBIMA, Allergy Res Grp, Malaga, Spain.
   [Bogas, Herrera Gador] Hosp Reg Univ Malaga HRUM, Allergy Unit, Malaga, Spain.
   [Buonomo, Alessandro] Fdn Policlin Gemelli IRCCS Largo Gemelli, Allergy Unit, Rome, Italy.
   [Calogiuri, Gianfranco] Hosp Vito Fazzi, Lecce, Italy.
   [Carli, Giulia] Azienda USL Toscana Ctr, Osped S Stefano, SOS Allergol & Immunol, Prato, Italy.
   [Cernadas, Josefina] Ctr Hosp Univ S Joao, Allergy & Clin Immunol Dept, Porto, Portugal.
   [Cernadas, Josefina] Hosp Lusiadas, Allergy Unit, Porto, Portugal.
   [Cortellini, Gabriele] Azienda Sanitaria Romagna, Rimini Hosp, Allergy Unit, Dept Internal Med, Rimini, Italy.
   [Celik, Gulfem] Ankara Univ, Dept Chest Dis, Div Immunol & Allergy, Sch Med,Cebeci Hosp, Ankara, Turkey.
   [Demir, Semra; Gelincik, Asli] Istanbul Univ, Istanbul Fac Med Internal Med Immunol & Allerg Di, Istanbul, Turkey.
   [Dona, Inmaculada] Hosp Reg Univ Malaga, Inst Invest Biomed Malaga IBIMA, Allergy Unit, Allergy Res Grp, Plaza Hosp Civil S-N, Malaga, Spain.
   [Dursun, Adile Berna] Mem Ankara Hosp, Dept Adult Allergy, Ankara, Turkey.
   [Faria, Emilia; Regateiro, Frederico S.] Ctr Hosp & Univ Coimbra, Allergy & Clin Immunol Unit, Coimbra, Portugal.
   [Fernandes, Bryan] Barts Hlth NHS Trust, St Bartholomews Hosp, London, England.
   [Garcez, Tomaz] Manchester Univ NHS Fdn Trust, Immunol Dept, Manchester, Lancs, England.
   [Garcia-Nunez, Ignacio] Hosp Quironsalud Cordoba, Cordoba, Spain.
   [Gawlik, Radoslaw] Med Univ Silesia, Dept Internal Dis Allergol & Clin Immunol, Katowice, Poland.
   [Gomes, Eva] Ctr Hosp Univ Porto, Allergy Dept, Porto, Portugal.
   [Gooi, Jimmy H. C.] Kings Coll Hosp London, Dept Clin Immunol, London, England.
   [Grosber, Martine] Vrije Univ Brussel, Univ Ziekenhuis, Dept Dermatol, Brussels, Belgium.
   [Gulen, Theo] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Resp Med & Allergy, Dept Med, Stockholm, Sweden.
   [Hacard, Florence] Ctr Hosp Lyon Sud, Allergol & Clin Immunol Dept, Pierre Benite, France.
   [Hoarau, Cyrille] CHR Tours, Serv Transversal Allergol & Immunol Clin, Tours, France.
   [Janson, Christer] Uppsala Univ, Dept Med Sci, Uppsala, Sweden.
   [Johnston, Sebastian L.] Imperial Coll London, Natl Heart & Lung Inst, London, England.
   [Joerg, Lukas] Univ Bern, Bern Univ Hosp, Dept Pneumol, Div Allergol & Clin Immunol,Inselspital, Bern, Switzerland.
   [Ozdemir, Secil Kepil] Chest Dis & Surg Training & Res Hosp, Dept Chest Dis, Div Allergy & Immunol, Izmir, Turkey.
   [Klimek, Ludger] Ctr Rhinol & Allergol, Wiesbaden, Germany.
   [Kosnik, Mitja] Univ Clin Golnik, Golnik, Slovenia.
   [Kowalski, Marek L.] Med Univ Lodz, Dept Immunol & Allergy, Lodz, Poland.
   [Kuyucu, Semanur] Mersin Univ, Fac Med, Dept Pediat Allergy & Immunol, Mersin, Turkey.
   [Kvedariene, Violeta] Vilnius Univ, Fac Med, Dept Pathol, Inst Biomed Sci,Clin Chest Dis, Vilnius, Lithuania.
   [Laguna, Jose Julio] Alfonso X El Sabio Univ, Hosp Cent Cruz Roja, Fac Med, Allergy Unit,Allergoanaesthesia Unit, Madrid, Spain.
   [Lombardo, Carla] Allergy Unit, Trento, Italy.
   [Marinho, Susana] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Allergy Ctr, Manchester, Lancs, England.
   [Marinho, Susana] Univ Manchester, Manchester, Lancs, England.
   [Meucci, Elisa; Radice, Anna] Osped San Giovanni di Dio, Azienda USL Toscana Ctr, SOS Allergol & Immunol Clin, Florence, Italy.
   [Morisset, Martine] Angers Univ Hosp, Allergy Unit, Angers, France.
   [Murzilli, Francesco] SS Filippo & Nicola, Allergy Unit, Avezzano, Italy.
   [Nakonechna, Alla] Univ Liverpool, Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Allergy & Clin Immunol Dept, Liverpool, Merseyside, England.
   [Popescu, Florin-Dan] Carol Davila Univ Med & Pharm, Nicolae Malaxa Clin Hosp, Dept Allergol, Bucharest, Romania.
   [Porebski, Grzegorz] Jagiellonian Univ Med Coll, Dept Clin & Environm Allergol, Krakow, Poland.
   [Regateiro, Frederico S.] Univ Coimbra, Fac Med, Inst Immunol, Coimbra, Portugal.
   [Regateiro, Frederico S.] Univ Coimbra, Fac Med, ICBR Coimbra Inst Clin & Biomed Res, CIBB, Coimbra, Portugal.
   [Rockmann, Heike] Univ Med Ctr Utrecht, Dept Dermatol, Heidelberglaan 100, Utrecht, Netherlands.
   [Romano, Antonino] Oasi Res Inst IRCCS, Troina, Italy.
   [Sargur, Ravishankar] Sheffield Teaching Hosp NHS Fdn Trust, Northern Gen Hosp, Clin Immunol & Allergy Unit, Sheffield, S Yorkshire, England.
   [Sastre, Joaquin] Univ Autonoma Madrid, Inst Salud Carlos 3, Allergy Dept, CIBERES,Fdn Jimenez Diaz, Madrid, Spain.
   [Hofmeier, Kathrin Scherer] Cantonal Hosp Aarau, Dept Dermatol & Allergy, Aarau, Switzerland.
   [Sedlackova, Lenka] Gennet Sro, Allergy & Clin Immunol, Prague, Czech Republic.
   [Sobotkova, Marta] Motol Univ Hosp, Dept Immunol, Prague, Czech Republic.
   [Sobotkova, Marta] Charles Univ Prague, Fac Med 2, Prague, Czech Republic.
   [Terreehorst, Ingrid] AUMC, Dept ENT, Amsterdam, Netherlands.
   [Treudler, Regina] Univ Med Leipzig, Dept Dermatol Venerol & Allergol, Leipzig, Germany.
   [Walusiak-Skorupa, Jolanta] Nofer Inst Occupat Med, Dept Occupat Dis & Environm Hlth, Lodz, Poland.
   [Wedi, Bettina] Hannover Med Sch, Comprehens Allergy Ctr, Dept Dermatol & Allergy, OE6600, Hannover, Germany.
   [Wohrl, Stefan] Floridsdorf Allergy Ctr FAZ, Vienna, Austria.
   [Zidarn, Mihael] Univ Ljubljana, Fac Med, Internal Med, Ljubljana, Slovenia.
   [Zuberbier, Torsten] Charite Univ Med Berlin, Klin Dermatol, Berlin, Germany.
   [Agache, Ioana] Transylvania Univ, Fac Med, Brasov, Spain.
   [Torres, Maria J.] Reg Univ Hosp Malaga, Allergy Unit, IBIMA UMA ARADyAL, Malaga, Spain.
RP Barbaud, A (corresponding author), Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, Hop Tenon,AP HP,Dept Dermatol & Allergol, F-75020 Paris, France.
EM annick.barbaud@aphp.fr
RI Wöhrl, Stefan/B-6954-2013; Porebski, Grzegorz/AAS-4969-2021; Regateiro,
   Frederico/F-3914-2011; Sargur, Ravishankar/C-2270-2009
OI Wöhrl, Stefan/0000-0002-6324-0007; Porebski,
   Grzegorz/0000-0002-6146-0188; Brockow, Knut/0000-0002-2775-3681;
   BARBAUD, Annick/0000-0001-8889-1589; Jorg, Lukas/0000-0003-1512-4279;
   Sobotkova, Marta/0000-0003-3864-8008; Regateiro,
   Frederico/0000-0002-6332-3056; Sargur, Ravishankar/0000-0002-8535-630X;
   Walusiak-Skorupa, Jolanta/0000-0003-0836-6800; Scherer,
   Kathrin/0000-0002-5235-2556; Garvey, Lene Heise/0000-0002-7777-4501
CR Amsler E, 2017, CONTACT DERMATITIS, V77, P54, DOI 10.1111/cod.12743
   Antolin-Amerigo D, 2015, OCCUP MED-OXFORD, V65, P502, DOI 10.1093/occmed/kqv072
   Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Badiu I, 2012, BMJ CASE REP, V2012
   Banerji A, 2021, J ALLER CL IMM-PRACT, V9, P1423, DOI 10.1016/j.jaip.2020.12.047
   Barbaud A, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00156
   Barbaud A, 2009, CONTACT DERMATITIS, V60, P279, DOI 10.1111/j.1600-0536.2009.01541.x
   Bommarito L, 2011, ANN ALLERG ASTHMA IM, V107, P542, DOI 10.1016/j.anai.2011.08.008
   Bonadonna P, 2021, J ALLER CL IMM-PRACT, V9, P2139, DOI 10.1016/j.jaip.2021.03.041
   Bordere A, 2012, CONTACT DERMATITIS, V67, P376, DOI 10.1111/j.1600-0536.2012.02104.x
   Bruusgaard-Mouritsen MA, 2021, CLIN EXP ALLERGY, V51, P463, DOI 10.1111/cea.13822
   Bruusgaard-Mouritsen MA, 2022, J ALLERGY CLIN IMMUN, V149, P168, DOI 10.1016/j.jaci.2021.05.020
   Cabanillas B, 2021, ALLERGY, V76, P1617, DOI 10.1111/all.14711
   Calogiuri G., 2017, CLIN IMMUNOL ENDOCR, V4, P9
   Castells MC, 2008, J ALLERGY CLIN IMMUN, V122, P574, DOI 10.1016/j.jaci.2008.02.044
   Castells MC, 2021, NEW ENGL J MED, V384, P643, DOI 10.1056/NEJMra2035343
   Catala A, 2022, BRIT J DERMATOL, V186, P142, DOI 10.1111/bjd.20639
   Co-Minh HB, 2007, ALLERGY, V62, P92, DOI 10.1111/j.1398-9995.2006.01265.x
   Corazza M, 2016, DERMATITIS, V27, P276, DOI 10.1097/DER.0000000000000209
   Dreskin SC, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0120-5
   Gabizon A, 2020, ACS NANO, V14, P7682, DOI 10.1021/acsnano.0c03648
   Garvey LH, 2021, BRIT J ANAESTH, V126, pE106, DOI 10.1016/j.bja.2020.12.020
   Garvey LH, 2019, ALLERGY, V74, P1872, DOI 10.1111/all.13820
   Greenhawt M, 2021, J ALLER CL IMM-PRACT, V9, P3546, DOI 10.1016/j.jaip.2021.06.006
   Johnston MS, 2021, JAMA DERMATOL, V157, P716, DOI 10.1001/jamadermatol.2021.1214
   Cerda VJ, 2019, ALLERGY ASTHMA CL IM, V15, DOI 10.1186/s13223-019-0327-4
   Kelso JM, 2012, J ALLERGY CLIN IMMUN, V130, P25, DOI 10.1016/j.jaci.2012.04.003
   Klimek L, 2021, ALLERGY, V76, P3307, DOI 10.1111/all.14794
   Kounis NG, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030221
   Kozma GT, 2020, ADV DRUG DELIVER REV, V154, P163, DOI 10.1016/j.addr.2020.07.024
   Labella M, 2021, ALLERGY, DOI 10.1111/all.15148
   Limaye S, 2002, J ALLERGY CLIN IMMUN, V110, P530, DOI 10.1067/mai.2002.126460
   Livingston Edward H, 2021, JAMA, V325, P1575, DOI 10.1001/jama.2021.2927
   Logunov DY, 2020, LANCET, V396, P887, DOI 10.1016/S0140-6736(20)31866-3
   Lukawska J, 2019, J ALLER CL IMM-PRACT, V7, P1086, DOI 10.1016/j.jaip.2018.08.035
   Magnusson SE, 2018, IMMUNOL RES, V66, P224, DOI 10.1007/s12026-018-8991-x
   Marcelino J, 2021, J ALLER CL IMM-PRACT, V9, P2476, DOI 10.1016/j.jaip.2021.03.022
   McMahon DE, 2021, J AM ACAD DERMATOL, V85, P46, DOI 10.1016/j.jaad.2021.03.092
   Munavalli Girish Gilly, 2021, JAAD Case Rep, V10, P63, DOI 10.1016/j.jdcr.2021.02.018
   Muraro A, 2014, ALLERGY, V69, P590, DOI 10.1111/all.12398
   Ng Wern Hann, 2020, F1000Res, V9, DOI 10.12688/f1000research.25998.1
   Novembre E, 2006, INT J IMMUNOPATH PH, V19, P449, DOI 10.1177/039463200601900223
   Ozkaya E, 2018, CONTACT DERMATITIS, V78, P211, DOI 10.1111/cod.12931
   Castano MIP, 2016, J INVEST ALLERG CLIN, V26, P394, DOI 10.18176/jiaci.0109
   Perino E, 2018, ANN ALLERG ASTHMA IM, V120, P664, DOI 10.1016/j.anai.2018.02.018
   Pizzimenti S, 2014, J ALLER CL IMM-PRACT, V2, P353, DOI 10.1016/j.jaip.2014.01.017
   Povsic TJ, 2016, J ALLERGY CLIN IMMUN, V138, P1712, DOI 10.1016/j.jaci.2016.04.058
   Rau RE, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26873
   Rojas-Perez-Ezquerra P, 2021, J INVEST ALLERG CLIN, V31, P180, DOI 10.18176/jiaci.0683
   Ruggeberg JU, 2007, VACCINE, V25, P5675, DOI 10.1016/j.vaccine.2007.02.064
   Russo PAJ, 2014, J ALLER CL IMM-PRACT, V2, P225, DOI 10.1016/j.jaip.2013.12.001
   Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201
   Scala E, 2001, J ALLERGY CLIN IMMUN, V107, P557, DOI 10.1067/mai.2001.113241
   Schwartzberg LS, 2018, ADV THER, V35, P754, DOI 10.1007/s12325-018-0707-z
   Shimabukuro T, 2021, JAMA-J AM MED ASSOC, V325, P780, DOI 10.1001/jama.2021.0600
   Shimabukuro T, 2021, MMWR-MORBID MORTAL W, V70, P46, DOI 10.15585/mmwr.mm7002e1
   Sokolowska M, 2021, ALLERGY, V76, P1629, DOI 10.1111/all.14739
   Stone CA, 2019, BRIT J CLIN PHARMACO, V85, P2694, DOI 10.1111/bcp.14112
   Stone CA, 2019, J ALLER CL IMM-PRACT, V7, P1533, DOI 10.1016/j.jaip.2018.12.003
   Su JR, 2019, J ALLERGY CLIN IMMUN, V143, P1465, DOI 10.1016/j.jaci.2018.12.1003
   Troelnikov A, 2021, J ALLERGY CLIN IMMUN, V148, P91, DOI 10.1016/j.jaci.2021.04.032
   Turner PJ, 2021, WORLD ALLERGY ORGAN, V14, DOI 10.1016/j.waojou.2021.100517
   Valois A, 2015, CONTACT DERMATITIS, V72, P90, DOI 10.1111/cod.12307
   Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1
   Weiszhar Z, 2012, EUR J PHARM SCI, V45, P492, DOI 10.1016/j.ejps.2011.09.016
   Wenande E, 2016, CLIN EXP ALLERGY, V46, P907, DOI 10.1111/cea.12760
   Wenande EC, 2013, J ALLERGY CLIN IMMUN, V131, P1425, DOI 10.1016/j.jaci.2012.09.037
   Worm Margitta, 2021, Allergol Select, V5, P72, DOI 10.5414/ALX02225E
   Zhang YJ, 2021, LANCET INFECT DIS, V21, P181, DOI 10.1016/S1473-3099(20)30843-4
   Zhou ZH, 2021, J ALLER CL IMM-PRACT, V9, P1731, DOI 10.1016/j.jaip.2020.11.011
NR 71
TC 1
Z9 1
U1 8
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0105-4538
EI 1398-9995
J9 ALLERGY
JI Allergy
DI 10.1111/all.15241
EA MAR 2022
PG 22
WC Allergy; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Allergy; Immunology
GA ZN4MF
UT WOS:000765009700001
PM 35112371
DA 2022-04-20
ER

PT J
AU Antwi-Boasiako, J
   Nyarkoh, E
AF Antwi-Boasiako, Joseph
   Nyarkoh, Enoch
TI Government Communication during the Covid-19 Pandemic; the Case of Ghana
SO INTERNATIONAL JOURNAL OF PUBLIC ADMINISTRATION
LA English
DT Article
DE Covid-19; Ghana; government communication; policy responses
AB With the novel nature of the Covid-19, different researches are being carried out in various fields of which public administration is no exception. Public administration as an applied field offers more insights on how governments are responding to the pandemic. One key approach to managing the pandemic is through effective government communication. As novel as the Covid-19 situation is, how countries have utilized communication strategies to fight against this Covid-19 pandemic have also not yet been well documented in the literature. Using a qualitative document analysis approach, this paper seeks to answer two questions; what communication strategies have been used by the government of Ghana to fight against the Covid-19 pandemic? How have these communication strategies been effective in fighting against the Covid-19 pandemic in Ghana? The study identified that the government of Ghana has been using frequent Presidential addresses, Minister's Press Briefings, designated Covid-19 Website, and Social and Traditional Media to provide information to the citizens. These communication strategies have been used by the government to "Spread Calm, Not Fear" and to drive the entire population with the government in the fight against Covid-19. Documenting the experiences of Ghana in the literature will greatly contribute to knowledge especially as Ghana has been one of the highlights during the Covid-19 pandemic.
C1 [Antwi-Boasiako, Joseph] Univ Ghana, Sch Business, Dept Publ Adm & Hlth Serv Management, POB LG 78, Legon, Ghana.
   [Nyarkoh, Enoch] Univ Oslo, Fac Educ, Dept Comparat & Int Educ, Oslo, Norway.
RP Antwi-Boasiako, J (corresponding author), Univ Ghana, Sch Business, Dept Publ Adm & Hlth Serv Management, POB LG 78, Legon, Ghana.
EM joelisk1@hotmail.com
CR Akuffo-Addo, 2020, COMMUNICATION COMMUNICATION
   Creswell J.W., 1998, QUAL INQ
   Hood C., 1986, TOOLS GOVT
   Ozili P.K., 2020, 99850 MUN PERS REPEC 99850 MUN PERS REPEC
   Taylor A., 2020, IT COMES CORONAVIRUS
   Torjman, 2005, WHAT IS POLICY
NR 6
TC 1
Z9 1
U1 3
U2 4
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0190-0692
EI 1532-4265
J9 INT J PUBLIC ADMIN
JI Int. J. Public Adm.
PD SEP 10
PY 2021
VL 44
IS 11-12
SI SI
BP 1039
EP 1040
DI 10.1080/01900692.2020.1841792
PG 2
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA TI6XZ
UT WOS:000672946300016
OA Bronze
DA 2022-04-20
ER

PT J
AU Almuzaini, Y
   Mushi, A
   Aburas, A
   Yassin, Y
   Alamri, F
   Alahmari, A
   Yezli, S
   Khan, AA
   Jokhdar, HA
AF Almuzaini, Yasir
   Mushi, Abdulaziz
   Aburas, Alhanouf
   Yassin, Yara
   Alamri, Fahad
   Alahmari, Ahmed
   Yezli, Saber
   Khan, Anas A.
   Jokhdar, Hani A.
TI Risk Communication Effectiveness During COVID-19 Pandemic Among General
   Population in Saudi Arabia
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; risk communication; awareness; Saudi Arabia
ID PERCEPTION; HEALTH
AB Purpose: The novel coronavirus (COVID-19), declared a pandemic by WHO in March 2020, is an unprecedented occurrence in our recent history. Effective risk communication by health authorities, through relaying reliable and authoritative information, is imperative in combating the spread of the outbreak. We aimed to measure the effectiveness of risk communication campaign and overall awareness during COVID-19 pandemic among the general population in Saudi Arabia.
   Patients and Methods: A cross-sectional survey of 5472 individuals in Saudi Arabia was conducted to assess several factors regarding the risk communication messages during the COVID-19 pandemic, including the knowledge and response of the general population toward COVID-19 and MoH efforts. The questionnaire was divided into five main sections: general knowledge of COVID-19, channels and social media platforms used perceived risk and stress or panic toward COVID-19, satisfaction and community perception, most trusted source of information, and type of information received.
   Results: A total of 5472 individuals participated in the study residing in Saudi Arabia. Overall knowledge of COVID-19 was determined to be above average (0.58 + 0.159). Of the general population, 57.1% perceived that the risk of getting sick with COVID-19 is low, while nearly half of the respondents (45.7%) have a high level of stress and panic toward COVID-19. The majority of responders to the questionnaire reinforced that MoH was their most trusted source of information for the COVID-19 pandemic (91.7%).
   Conclusion: This study showed that the risk communication campaign by healthcare authorities during the COVID-19 pandemic has improved the awareness among the general population in Saudi Arabia, where the overwhelming majority placed high trust in the MoH as its main reference for COVID-19 information.
C1 [Almuzaini, Yasir; Mushi, Abdulaziz; Aburas, Alhanouf; Yassin, Yara; Alamri, Fahad; Alahmari, Ahmed; Yezli, Saber; Khan, Anas A.] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 12341, Saudi Arabia.
   [Khan, Anas A.] King Saud Univ, Coll Med, Dept Emergency Med, Riyadh 12372, Saudi Arabia.
   [Jokhdar, Hani A.] Minist Hlth, Deputyship Publ Hlth, Riyadh 11461, Saudi Arabia.
RP Almuzaini, Y (corresponding author), Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 12341, Saudi Arabia.
EM Almuzaini.Yasir1@gmail.com
RI ; Khan, Anas/Q-7349-2017
OI Yassin, Yara/0000-0002-8762-5403; Khan, Anas/0000-0001-5075-7392;
   Almuzaini, Yasir/0000-0001-6483-0028
CR Betsch C, 2020, LANCET, V395, P1255, DOI 10.1016/S0140-6736(20)30729-7
   Boyraz G, 2020, J LOSS TRAUMA, V25, P503, DOI 10.1080/15325024.2020.1763556
   Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   de Paz C., 2020, GENDER DIMENSIONS CO
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765
   Ha TM, 2021, J ASIAN BUS ECON ST, V28, P86, DOI 10.1108/JABES-12-2019-0126
   Han E, 2020, LANCET, V396, P1525, DOI 10.1016/S0140-6736(20)32007-9
   Hassounah M, 2020, J MED INTERNET RES, V22, DOI 10.2196/19338
   Heiervang E, 2011, SOC PSYCH PSYCH EPID, V46, P69, DOI 10.1007/s00127-009-0171-9
   Hiscott J, 2020, CYTOKINE GROWTH F R, V53, P1, DOI 10.1016/j.cytogfr.2020.05.010
   Iorfa SK, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566773
   Karasneh R, 2021, RES SOC ADMIN PHARM, V17, P1897, DOI 10.1016/j.sapharm.2020.04.027
   Kuang JY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197177
   Lanciano T, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.580053
   Tung LT, 2020, DATA BRIEF, V33, DOI 10.1016/j.dib.2020.106348
   Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
   Li MY, 2020, J MED INTERNET RES, V22, DOI 10.2196/20656
   Malhotra C., 2020, ANXIETY PERCEIVED RI, DOI [10.1101/2020.07.24.20161315, DOI 10.1101/2020.07.24.20161315]
   McInroy LB, 2016, SOC WORK RES, V40, P83, DOI 10.1093/swr/svw005
   Nicola M, 2020, INT J SURG, V81, P122, DOI 10.1016/j.ijsu.2020.07.026
   Nicomedes CJC, 2020, J AFFECT DISORDERS, V276, P14, DOI 10.1016/j.jad.2020.06.046
   Otu A, 2020, INT J MENT HEALTH SY, V14, DOI 10.1186/s13033-020-00371-w
   Qian MR, 2022, J PUBLIC HEALTH-HEID, V30, P259, DOI 10.1007/s10389-020-01321-z
   Safarpour H, 2021, DISASTER MED PUBLIC, V15, pE1, DOI 10.1017/dmp.2020.327
   Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w
   Saudi Ministry of Health, COVID 19 DASHB SAUD
   Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2
   Tagliabue Fabio, 2020, SN Compr Clin Med, P1, DOI 10.1007/s42399-020-00439-1
   Tasnim S., 2020, J PREVENTIVE MED PUB, V53, P171, DOI [10.31235/osf.io/uf3zn, DOI 10.3961/JPMPH.20.094, 10.3961/jpmph.20.094]
   Huynh TLD, 2020, REV BEHAV ECON, V7, P145, DOI 10.1561/105.00000121
   Huynh TLD, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104872
   Huynh TLD, 2020, ECON BULL, V40, P758
   Venkatashiva RB, 2020, J FAM MED PRIM CARE, V9, P3793, DOI 10.4103/jfmpc.jfmpc_719_20
   VoPham Trang, 2020, medRxiv, DOI 10.1101/2020.06.10.20127589
   Wang XM, 2020, J INFECTION, V81, P911, DOI 10.1016/j.jinf.2020.10.031
   World Health Organization, RISK COMM COMMM ENG
   World Health Organization (WHO), 2020, 193 WHO, V8
   World Health Organization (WHO), WEEKL EP UPD 19 JAN
   World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053
   Yan Z, 2020, HUM BEHAV EMERG TECH, V2, P110, DOI 10.1002/hbe2.192
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
   Zhang LW, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010064
   Zhong YP, 2021, NURS OUTLOOK, V69, P13, DOI 10.1016/j.outlook.2020.08.005
NR 46
TC 3
Z9 3
U1 7
U2 14
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 779
EP 790
DI 10.2147/RMHP.S294885
PG 12
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA QY9AQ
UT WOS:000630328600001
PM 33658873
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Gencoglu, O
   Gruber, M
AF Gencoglu, Oguzhan
   Gruber, Mathias
TI Causal Modeling of Twitter Activity during COVID-19
SO COMPUTATION
LA English
DT Article
DE Twitter; machine learning; causal inference; COVID-19; sentiment
   analysis; social media
AB Understanding the characteristics of public attention and sentiment is an essential prerequisite for appropriate crisis management during adverse health events. This is even more crucial during a pandemic such as COVID-19, as primary responsibility of risk management is not centralized to a single institution, but distributed across society. While numerous studies utilize Twitter data in descriptive or predictive context during COVID-19 pandemic, causal modeling of public attention has not been investigated. In this study, we propose a causal inference approach to discover and quantify causal relationships between pandemic characteristics (e.g., number of infections and deaths) and Twitter activity as well as public sentiment. Our results show that the proposed method can successfully capture the epidemiological domain knowledge and identify variables that affect public attention and sentiment. We believe our work contributes to the field of infodemiology by distinguishing events that correlate with public attention from events that cause public attention.
C1 [Gencoglu, Oguzhan] Tampere Univ, Fac Med & Hlth Technol, Tampere 33720, Finland.
   [Gruber, Mathias] LEO Pharma, DK-2750 Ballerup, Denmark.
RP Gencoglu, O (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Tampere 33720, Finland.
EM oguzhan.gencoglu@tuni.fi; nano.mathias@gmail.com
CR ABDALRAZAQ A, 2020, J MED INTERNET RES, V22, DOI DOI 10.2196/19016
   Aguilar-Gallegos N, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105684
   Ahmed W, 2020, J MED INTERNET RES, V22, DOI 10.2196/19458
   Alshaabi T., 2020, ARXIV200312614
   Batooli Z., 2020, RES SQUARE, DOI [10.21203/rs.3.rs-21980/v1, DOI 10.21203/RS.3.RS-21980/V1]
   Boberg S., 2020, ARXIV200402566
   Bridgman A, 2020, HARVARD KENNEDY SCH, V1, DOI [10.37016/mr-2020-028, DOI 10.37016/MR-2020-028, 10.37016/mr-2020-38]
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   CHARY M, 2020, CLIN TOXICOL 0902, DOI DOI 10.1101/2020.04.30.20079657
   Chen E., 2020, ARXIV200307372
   Chen Q, 2020, COMPUT HUM BEHAV, V110, DOI 10.1016/j.chb.2020.106380
   Chickering D. M., 1996, LEARNING DATA ARTIFI, P121, DOI DOI 10.1007/978-1-4612-2404-4_12
   Chickering DM, 2004, J MACH LEARN RES, V5, P1287
   Cinelli M., ARXIV200305004
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Cullen W, 2020, QJM-INT J MED, V113, P311, DOI 10.1093/qjmed/hcaa110
   Dewhurst D.R., 2020, ARXIV200403516
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117
   Duong V, 2020, PR I-A I C AD S N A, P126, DOI 10.1109/ASONAM49781.2020.9381379
   Ellis B, 2008, J AM STAT ASSOC, V103, P778, DOI 10.1198/016214508000000193
   Ferrara E., 2020, ARXIV200409531
   GALLOTTI R, 2020, NAT HUM BEHAV 1029, DOI DOI 10.1101/2020.04.08.20057968
   Gao Z., 2020, ARXIV200408145
   Gharavi E., ARXIV200500475
   Golder Su, 2020, medRxiv, DOI 10.1101/2020.05.05.20083436
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hanjia Lyu, 2021, IEEE Transactions on Big Data, V7, P952, DOI 10.1109/TBDATA.2020.2996401
   Hou Z, 2020, RISK PERCEPTION EMOT, DOI [10.2139/ssrn.3551338, DOI 10.2139/SSRN.3551338]
   Jarynowski A., 2020, TRENDS PERCEPTION CO, DOI [10.1101/2020.05.04.20090993, DOI 10.1101/2020.05.04.20090993]
   Jelodar H, 2020, IEEE J BIOMED HEALTH, V24, P2733, DOI 10.1109/JBHI.2020.3001216
   Ji X, 2015, SOC NETW ANAL MIN, V5, DOI 10.1007/s13278-015-0253-5
   Ji X, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI 2013), P335, DOI 10.1109/ICHI.2013.47
   Jordan SE, 2018, DATA, V4, DOI 10.3390/data4010006
   Kayes A., 2020, AUTOMATED MEASUREMEN, DOI 10.20944/preprints202004.0057.v1
   Koller D., 2009, PROBABILISTIC GRAPHI
   Kwon J., 2020, DEFINING FACETS SOCI, DOI [10.1101/2020.04.26.20080937, DOI 10.1101/2020.04.26.20080937]
   Lampos V., 2020, ARXIV200308086
   Lehmann T, 2020, INFODEMIC LEVERAGING, DOI [10.1101/2020.04.03.20052936, DOI 10.1101/2020.04.03.20052936]
   Li CY, 2020, EMERG INFECT DIS, V26, P1626, DOI 10.3201/eid2607.200718
   Li I., 2020, ARXIV200410899
   Li Jiawei, 2020, JMIR Public Health Surveill, V6, pe18700, DOI 10.2196/18700
   Li LF, 2020, IEEE T COMPUT SOC SY, V7, P556, DOI 10.1109/TCSS.2020.2980007
   Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032
   Liu D., 2020, ARXIV200404019
   Lopez C.E., 2020, ARXIV200310359
   Lucas B., 2020, ARXIV200407183
   Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P2011, DOI 10.1001/jama.2020.4469
   Mollema L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3863
   Park HW, 2020, J MED INTERNET RES, V22, DOI 10.2196/18897
   Pearl J., 2009, CAUSALITY CAMBRIDGE
   Pearl Judea, 2010, Int J Biostat, V6, P7, DOI 10.2202/1557-4679.1203
   Pekoz E.A., 2020, COVID 19 SYMPTOM WEB, DOI [10.2139/ssrn.3585532, DOI 10.2139/SSRN.3585532]
   Raff, ARXIV200503082
   Rosenberg H, 2020, CAN J EMERG MED, V22, P418, DOI 10.1017/cem.2020.361
   Rovetta A, 2020, JMIR PUBLIC HLTH SUR, V6, DOI 10.2196/19374
   Rubin DB, 2005, J AM STAT ASSOC, V100, P322, DOI 10.1198/016214504000001880
   Samuel J., 2020, COVID 19 PUBLIC SENT, DOI [10.20944/preprints202005.0015.v1, DOI 10.20944/PREPRINTS202005.0015.V1]
   Sanh V., ARXIV191001108
   Sarker A, 2020, J AM MED INFORM ASSN, V27, P1310, DOI 10.1093/jamia/ocaa116
   Schild L., 2020, ARXIV200404046
   Sha H., 2020, ARXIV200411692
   Shahsavari S., 2020, ARXIV200413783
   Shen C., 2020, ARXIV200406169
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Stokes DC, 2020, J GEN INTERN MED, V35, P2244, DOI 10.1007/s11606-020-05889-w
   THELWALL M, 2020, ASLIB J INFORM 1023, DOI DOI 10.3145/epi.2020.may.01
   Thelwall M, 2020, ASLIB J INFORM MANAG, V72, P945, DOI 10.1108/AJIM-05-2020-0134
   Tripathi, 2020, J INNOVATION MANAGEM, V8, P13, DOI DOI 10.24840/2183-0606_008.001_0003
   Turiel J., 2020, ARXIV200404125
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Velasquez N., 2020, ARXIV200400673
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072459
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   Weeg Christopher, 2015, JMIR Public Health Surveill, V1, pe6, DOI 10.2196/publichealth.3953
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   Wicke P, 2020, COGN PROCESS, V21, P615, DOI 10.1007/s10339-020-00971-x
   Wise T, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200742
   Wongwatkit C, 2020, J COMPUT EDUC, V7, P229, DOI 10.1007/s40692-020-00154-9
   Xu P., 2020, ARXIV200402397
   Yang K.C., 2020, ARXIV200414484
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhao Y., 2020, CHINESE PUBLIC ATTEN, DOI [10.1101/2020.03.18.20038026, DOI 10.1101/2020.03.18.20038026]
   Zheng X, 2018, ADV NEUR IN, V31
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 85
TC 9
Z9 9
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-3197
J9 COMPUTATION
JI Computation
PD DEC
PY 2020
VL 8
IS 4
AR 85
DI 10.3390/computation8040085
PG 14
WC Mathematics, Interdisciplinary Applications
WE Emerging Sources Citation Index (ESCI)
SC Mathematics
GA PJ0WC
UT WOS:000601498600001
OA Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Bardesi, HJ
   Garba, I
AF Bardesi, Hisham Jameel
   Garba, Ibrahim
TI The King Abdulaziz University COVID-19 e-vaccine: An Evaluation of the
   Emergency Training Knowledge Model
SO ARAB WORLD ENGLISH JOURNAL
LA English
DT Article
DE COVID-19; critical reflection; e-learning policy; emergency training
   evaluation; higher education; knowledge-evaluation; process analysis;
   Saudi university context; strategic planning; sustainable development
ID PROGRAM
AB King Abdulaziz University (KAU) took extra measures in response to COVID-19 in March 2020. The current research evaluated an Emergency Training Session (ETS) Knowledge Model during the pandemic with the aim of identifying for the Deanship of e-Learning and Distance Education (DeLDE) to evaluate how the e-learning services support learning and teaching at KAU beyond the pandemic. The Knowledge Model gathered quantitative data regarding the learning management system (LMS) e-service usage from students (n=2359 female and n=1580 male) and teachers (n=414). Also, the model used insights from qualitative data that came from the critical reflections of the trainer-researcher. We offer critical insight from the review of the literature and the results of the evaluation. First, the evaluation outlines the importance of evaluators bringing some assumptions with them when evaluating programmes. In the case of DeLDE, the assumptions promoted the interest of DeLDE in generating knowledge from different perspectives regarding DeLDE's e-learning services contextualised as the ETS Knowledge Model. The assumptions gave importance to behaviourist and constructivist learning theories and a goal and decision-making philosophy of evaluation. Finally, contextualising the participant-researchers as the Dean and trainer at DeLDE, the evaluation gained from the participants' familiarity of the ETS Knowledge Model's context.
C1 [Bardesi, Hisham Jameel] King Abdulaziz Univ, Deanship E Learning & Distance Educ, Jeddah, Saudi Arabia.
   [Garba, Ibrahim] King Abdulaziz Univ, Fac Appl Studies, Jeddah, Saudi Arabia.
RP Garba, I (corresponding author), King Abdulaziz Univ, Fac Appl Studies, Jeddah, Saudi Arabia.
EM igarba90@gmail.com
FU Institutional Fund Projects [IFPAS-075-214-2020]; King Abdulaziz
   University, Jeddah, Saudi Arabia; Ministry of Education
FX This research work was funded by Institutional Fund Projects under Grant
   No (IFPAS-075-214-2020) . Therefore, the authors gratefully acknowledge
   technical and financial support from the Ministry of Education and King
   Abdulaziz University, Jeddah, Saudi Arabia.
CR Ahlstrom H, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020499
   AI-Youbi AO, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114367
   Almaiah MA, 2019, IEEE ACCESS, V7, P171907, DOI 10.1109/ACCESS.2019.2956349
   Alsalamah A, 2021, EDUC SCI, V11, DOI 10.3390/educsci11030116
   Alsowayegh N, 2018, INTED PROC, P8603
   Asgar A., 2021, ASIAN ASS OPEN U J, V16, P98, DOI [10.1108/aaouj-11-2020-0094, DOI 10.1108/AAOUJ-11-2020-0094]
   Ballantine J., 2000, International Journal of Agile Management Systems, V2, P233, DOI 10.1108/14654650010356149
   Barnes SJ, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102175
   Becker H, 1960, HUMAN ORG RES FIELD
   Bonk C. J., 1994, Computers in the Schools, V10, P79
   Bonk C.J., 2016, J OPEN FLEXIBLE DIST, V20, P6
   Brinkerhoff RO, 2005, ADV DEV HUM RESOUR, V7, P86, DOI 10.1177/1523422304272172
   Burke L. A., 2007, HUMAN RESOURCE DEV R, V6, P263, DOI DOI 10.1177/1534484307303035
   Cameron K. S, 1983, ORG EFFECTIVENESS, P261, DOI [10.1016/ b978-0-12-157180- 1.50017-3, DOI 10.1016/B978-0-12-157180-1.50017-3]
   Coffey A., 2014, SAGE HDB QUALITATIVE, P367, DOI [10.4135/9781446282243.n25, DOI 10.4135/9781446282243.N25]
   Cohen DJ, 2006, AM J EVAL, V27, P163, DOI 10.1177/1098214006288448
   Creswell J. W, 2009, RES DESIGN QUALITATI, V3rd, P203
   Durand R, 2014, AM J EVAL, V35, P404, DOI 10.1177/1098214014523824
   E4ENG, 2020, SMASH COVID 19 INN E
   Easterby-Smith M., 1994, EVALUATING MANAGEMEN
   Flanagan J, 1949, INTRO CLASSROOM OBSE
   Galloway D. L., 2005, PERFORMANCE IMPROVEM, V44, P21, DOI [10.1002/pfi.4140440407, DOI 10.1002/PFI.4140440407]
   Guba EG, 1994, HDB QUALITATIVE RES, P105
   Gustafsson J.-E, 2014, EDUC INQ, V5, P461
   Hean S., 2009, LEARNING HLTH SOCIAL, V8, P250, DOI DOI 10.1111/J.1473-6861.2009.00227.X
   Holmes B, 2006, E LEARNING CONCEPTS, DOI [10.4135/9781446212585, DOI 10.4135/9781446212585]
   HOUSE E. R., 1980, EVALUATING VALIDITY
   Ilhan A, 2020, INT J MANAGEMENT IJM, V11, P1086
   Joinson A. N., 2012, OXFORD HDB INTERNET, P405, DOI [10.1093/oxfordhb/9780199561803.013.0026, DOI 10.1093/OXFORDHB/9780199561803.013.0026]
   Judd C. M., 1987, NEW DIRECTIONS PROGR, V1987, P23, DOI [10.1002/ev.1457, DOI 10.1002/EV.1457]
   Kirkpatrick D. L., 2009, EVALUATING TRAINING, P3
   Kirkpatrick D.L., 1998, EVALUATING TRAINING
   Lave J., 1991, SITUATED LEARNING LE, DOI DOI 10.1017/CBO9780511815355
   Lebeau Y, 2021, POLICY REV HIGHER ED, P1, DOI [10.1080/23322969.2021.1904791, DOI 10.1080/23322969.2021.1904791]
   Lee C, 2017, PUBLIC PERS MANAGE, V46, P419, DOI 10.1177/0091026017730382
   Marshall S., 2018, SHAPING U FUTURE USI
   McIntosh T, 2018, SCI ENG ETHICS, V24, P727, DOI 10.1007/s11948-017-9927-x
   Mezirow J, 1990, FOSTERING CRITICAL R, P12
   Mulcahy RS, 2020, ACS CHEM HEALTH SAFE, V27, P362, DOI 10.1021/acs.chas.0c00091
   OKeefe L., 2020, STATE ONLINE LEARNIN
   Osam E. K, 2020, PERFORMANCE IMPROVEM, V59, P17, DOI [10.1002/pfi.21916, DOI 10.1002/PFI.21916]
   Patel SR, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00113
   Reio TG, 2017, NEW HORIZ ADULT EDUC, V29, P35, DOI 10.1002/nha3.20178
   Rosellini A, 2019, J INF KNOWL MANAG, V18, DOI 10.1142/S0219649219500497
   Shannon-Baker P, 2016, J MIX METHOD RES, V10, P319, DOI 10.1177/1558689815575861
   Siengthai S, 2015, HUM RESOUR DEV INT, V18, P317, DOI 10.1080/13678868.2015.1071992
   Sim J., 2008, BIOMEDICAL IMAGING I, V4
   Stake RE., 2005, SAGE HDB QUALITATIVE, V3, P443
   Teddlie C., 2011, SAGE HDB QUALITATIVE, P285
   United Nations Educational Scientific and Cultural Organization (UNESCO), 2020, COVID 19 ED DISR RES
   Valderrama-Hernandez R, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010222
   VENKATRAMAN N, 1986, ACAD MANAGE REV, V11, P801
   Watson WR, 2013, TECHTRENDS, V57, P42, DOI 10.1007/s11528-013-0690-9
   Webb E. J, 2000, J AM STAT ASSOC, V65
   WEICK KE, 1976, ADMIN SCI QUART, V21, P1, DOI 10.2307/2391875
   Yin R. K., 2007, NEW DIRECTIONS EVALU, V2007, P75, DOI [10.1002/ev.216, DOI 10.1002/EV.216]
NR 56
TC 0
Z9 0
U1 0
U2 0
PU ARAB WORLD ENGLISH JOURNAL
PI KUALA LUMPUR
PA JALAN 34-24 WANGSA MAJU, KUALA LUMPUR, 53300, MALAYSIA
SN 2229-9327
J9 ARAB WORLD ENGL J
JI Arab World Engl. J.
PD JAN
PY 2022
SI SI
BP 356
EP 376
DI 10.24093/awej/covid2.24
PG 21
WC Language & Linguistics
WE Emerging Sources Citation Index (ESCI)
SC Linguistics
GA ZS4PE
UT WOS:000768448300024
OA gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Orsini, A
   Corsi, M
   Santangelo, A
   Riva, A
   Peroni, D
   Foiadelli, T
   Savasta, S
   Striano, P
AF Orsini, Alessandro
   Corsi, Martina
   Santangelo, Andrea
   Riva, Antonella
   Peroni, Diego
   Foiadelli, Thomas
   Savasta, Salvatore
   Striano, Pasquale
TI Challenges and management of neurological and psychiatric manifestations
   in SARS-CoV-2 (COVID-19) patients
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE COVID-19; SARS-CoV-2; Coronavirus; Brain; CNS; Neurologic; Psychiatric
ID CYTOKINE STORM; CORONAVIRUS; PATHOGENESIS; INFECTION; MICE
AB COVID-19 is a pandemic caused by human coronavirus (HCoV) SARS-CoV-2, which originated in Wuhan, China, at the end of 2019 and spread globally during 2020. Due to the difficulty of clinical decision-making during this period, our study group reviewed current literature focusing on the neurological and psychiatric aspects of COVID-19. Despite the knowledge on this newly discovered virus which is constantly evolving, different pieces of evidence reported an association between COVID-19 and neurological symptoms like headache, dizziness, taste and smell disorders and complications involving the nervous system eventually triggered by the pathologic processes elicited by SARS-CoV-2. It seems that younger patients are less prone to develop severe forms of COVID-19. However, neurological signs have been reported in paediatric patients as well, and in some cases, the infection presented neurological sequelae. Furthermore, children with particular neurological diseases or treated with specific drugs (e.g. immune-suppressant therapies) must be carefully monitored during this pandemic. Neurologists should be aware of the main drug-drug interactions and the neurological side effects of COVID-19 treatments. Notably, adverse mental health impact has been reported in patients with SARS-CoV-2, which could be related either to the social strain or to the eventual neurotropic effects of the virus, which in other infections have been proven to promote the onset of psychiatric symptoms. Further, psychiatric population may be more vulnerable to the infection and at higher risk for adverse outcomes.
C1 [Orsini, Alessandro; Santangelo, Andrea; Peroni, Diego] Univ Pisa, Dept Clin & Expt Med, Pediat Clin, Via Roma 67, I-56100 Pisa, Italy.
   [Corsi, Martina] Univ Pisa, Dept Clin & Expt Med, Psychiat Clin, Via Roma 67, I-56100 Pisa, Italy.
   [Riva, Antonella; Striano, Pasquale] IRCCS, Pediat Neurol Unit, Ist Giannina Gaslini, Genoa, Italy.
   [Foiadelli, Thomas; Savasta, Salvatore] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Pediat, Pediat Clin, Pavia, Italy.
   [Striano, Pasquale] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy.
RP Corsi, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Psychiat Clin, Via Roma 67, I-56100 Pisa, Italy.
EM aorsini.md@gmail.com; dott.martinacorsi@gmail.com;
   androsantangelo@gmail.com; riva.anto94@gmail.com; perodiego@gmail.com;
   thomas.foiadelli@gmail.com; s.savasta@smatteo.pv.it; strianop@gmail.com
RI Peroni, Diego G/K-4002-2018; Orsini, Alessandro/K-3943-2018; Striano,
   Pasquale/F-9117-2014; Riva, Antonella/ABB-8813-2020; Corsi,
   Martina/J-7227-2018
OI Striano, Pasquale/0000-0002-6065-1476; Riva,
   Antonella/0000-0001-9152-5571; Corsi, Martina/0000-0002-1957-6160
CR AIFA, SPER CLIN COVID 19
   Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Amor S, 2020, ANN NEUROL, V87, P794, DOI 10.1002/ana.25770
   ANDRIES K, 1980, AM J VET RES, V41, P1372
   Asadi-Pooya AA, 2020, J NEUROL SCI, V413, DOI 10.1016/j.jns.2020.116832
   Assini A, 2020, NEUROL SCI, V41, P1657, DOI 10.1007/s10072-020-04484-5
   Avula A, 2020, BRAIN BEHAV IMMUN, V87, P115, DOI 10.1016/j.bbi.2020.04.077
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Bohmwald K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00386
   Bove R, 2019, MULT SCLER J, V25, P1526, DOI 10.1177/1352458518793527
   Brooks J, 1997, AIDS Clin Care, V9, P90
   Brownlee W, 2020, NEUROLOGY, V94, P949, DOI 10.1212/WNL.0000000000009507
   Cai JH, 2020, CLIN INFECT DIS, V71, P1547, DOI 10.1093/cid/ciaa198
   Camdessanche JP, 2020, REV NEUROL-FRANCE, V176, P516, DOI 10.1016/j.neurol.2020.04.003
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   Carlotti APDP, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1894
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Doobay MF, 2007, AM J PHYSIOL-REG I, V292, pR373, DOI 10.1152/ajpregu.00292.2006
   Dube M, 2018, J VIROL, V92, DOI 10.1128/JVI.00404-18
   Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330
   Guidon AC, 2020, NEUROLOGY, V94, P959, DOI 10.1212/WNL.0000000000009566
   Gummi RR, 2019, MUSCLE NERVE, V60, P693, DOI 10.1002/mus.26689
   Gunnell D, 2020, LANCET PSYCHIAT, V7, P468, DOI 10.1016/S2215-0366(20)30171-1
   Henry BM, 2020, CLIN CHEM LAB MED, V58, P1135, DOI 10.1515/cclm-2020-0272
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399
   Jean SS, 2020, J MICROBIOL IMMUNOL, V53, P436, DOI 10.1016/j.jmii.2020.03.034
   Kawohl W, 2020, LANCET PSYCHIAT, V7, P389, DOI 10.1016/S2215-0366(20)30141-3
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Klomek AB, 2020, LANCET PSYCHIAT, V7, P390, DOI 10.1016/S2215-0366(20)30142-5
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Li JW, 2021, CURR NEUROPHARMACOL, V19, P92, DOI 10.2174/1570159X18666200507085335
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   MAY EF, 1990, ANN NEUROL, V28, P577, DOI 10.1002/ana.410280417
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   MULHAUSER P, 1995, ANN INTERN MED, V123, P76, DOI 10.7326/0003-4819-123-1-199507010-00021
   Muller KI, 2017, NEUROLOGY, V89, P153, DOI 10.1212/WNL.0000000000004085
   Multiple Sclerosis International Federation, GLOB COVID 19 ADV PE
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   Oguz-Akarsu E, 2020, MUSCLE NERVE, V62, pE54, DOI 10.1002/mus.26992
   Okusaga O, 2011, J AFFECT DISORDERS, V130, P220, DOI 10.1016/j.jad.2010.09.029
   Oxley TJ, N ENGL J MED, pe60
   Panda PK, 2020, INDIAN J PEDIATR, V87, P556, DOI 10.1007/s12098-020-03326-8
   Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187
   Qubty W, 2018, NEUROLOGY, V90, pE1702, DOI 10.1212/WNL.0000000000005482
   Severance EG, 2011, SCHIZOPHRENIA BULL, V37, P101, DOI 10.1093/schbul/sbp052
   Smith K, 2020, EVID-BASED MENT HEAL, V23, P45, DOI 10.1136/ebmental-2020-300155
   Streng A, 2020, MONATSSCHR KINDERH, V168, P615, DOI 10.1007/s00112-020-00919-7
   Sun D, 2020, WORLD J PEDIATR, V16, P251, DOI 10.1007/s12519-020-00354-4
   Sun JK, 2020, POSTGRAD MED, V132, P604, DOI 10.1080/00325481.2020.1778982
   Szperka CL, 2020, HEADACHE, V60, P833, DOI 10.1111/head.13810
   Tan Xin, 2020, Zhongguo Dang Dai Er Ke Za Zhi, V22, P294
   Tang WJ, 2020, J AFFECT DISORDERS, V274, P1, DOI 10.1016/j.jad.2020.05.009
   To KF, 2004, J PATHOL, V203, P740, DOI 10.1002/path.1597
   Toscano G, 2020, NEW ENGL J MED, V382, P2574, DOI 10.1056/NEJMc2009191
   Wang HL, 2008, AM J EMERG MED, V26, P711, DOI 10.1016/j.ajem.2007.10.031
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   WHO, REP WHO CHI JOINT MI
   Winkelmann A, 2016, NAT REV NEUROL, V12, P217, DOI 10.1038/nrneurol.2016.21
   World Health Organization, 2 M INT HLTH REG 200
   Wu XK, 2015, IEEE T INTELL TRANSP, V16, P2786, DOI [10.1109/TITS.2015.2422778, 10.1109/MWSYM.2015.7166900]
   Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031
   Xiang P, 2020, CHINAXIV20200300015
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Yin R, 2020, J MED VIROL, V92, P1782, DOI 10.1002/jmv.25888
   Zambrelli E, 2020, SLEEP MED, V70, P111, DOI 10.1016/j.sleep.2020.04.006
   Zhao H, 2020, LANCET NEUROL, V19, P383, DOI 10.1016/S1474-4422(20)30109-5
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 83
TC 22
Z9 22
U1 6
U2 14
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD SEP
PY 2020
VL 41
IS 9
BP 2353
EP 2366
DI 10.1007/s10072-020-04544-w
EA AUG 2020
PG 14
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Neurosciences & Neurology
GA MY3NO
UT WOS:000556662300002
PM 32767055
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Nassif, THA
   Daou, KN
   Tannoury, T
   Majdalani, M
AF Nassif, Tania H. Abi
   Daou, Karim N.
   Tannoury, Theresia
   Majdalani, Marianne
TI Cardiac involvement in a child post COVID-19: a case from Lebanon
SO BMJ CASE REPORTS
LA English
DT Article
DE COVID-19; cardiovascular medicine; infectious diseases
ID SHOCK; MANAGEMENT; DIAGNOSIS
AB We report on an 8-year-old boy, who presented to the emergency department at our institution with fever, generalised oedema and hypotension. Investigations revealed anaemia, thrombocytopenia in addition to elevated serum inflammatory markers, a negative COVID-19 PCR test and a positive COVID-19 IgG. His echocardiography was consistent with carditis in otherwise morphologically normal heart with depressed cardiac function, moderate-to-severe mitral valve regurgitation, moderate tricuspid regurgitation with an estimated right ventricular systolic pressure half systemic, trace aortic regurgitation, bilateral small pleural effusions, distended inferior vena cava and normal coronaries. He was started on inotropic support, intravenous immunoglobulin and methylprednisolone, and was transferred to the paediatric intensive care unit. To the best of our knowledge, this was the first case of multisystem inflammatory syndrome in children encountered in Lebanon. The presentation and management were thoroughly described in this article aiming to share our experience and to contribute to the rapidly emerging literature on this syndrome.
C1 [Nassif, Tania H. Abi; Daou, Karim N.; Tannoury, Theresia; Majdalani, Marianne] Amer Univ Beirut, Dept Pediat & Adolescent Med, Med Ctr, Beirut, Lebanon.
   [Tannoury, Theresia] Amer Univ Beirut, Children Heart Ctr, Dept Pediat & Adolescent Med, Med Ctr, Beirut, Lebanon.
   [Majdalani, Marianne] Amer Univ Beirut, Dept Pediat & Adolescent Med, Pediat Intens Care Unit, Med Ctr, Beirut, Lebanon.
RP Majdalani, M (corresponding author), Amer Univ Beirut, Dept Pediat & Adolescent Med, Med Ctr, Beirut, Lebanon.; Majdalani, M (corresponding author), Amer Univ Beirut, Dept Pediat & Adolescent Med, Pediat Intens Care Unit, Med Ctr, Beirut, Lebanon.
EM mn40@aub.edu.lb
CR Ahmed M, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100527
   Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360
   Bertoncelli Deborah, 2020, Acta Biomed, V91, P177, DOI 10.23750/abm.v91i2.9655
   Besler MS, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.100
   Blondiaux E, 2020, RADIOLOGY, V297, pE283, DOI 10.1148/radiol.2020202288
   Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210
   Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467
   Chuang Yu-Yu, 2005, Paediatr Drugs, V7, P11, DOI 10.2165/00148581-200507010-00002
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2
   Hong H, 2020, PEDIATR NEONATOL, V61, P131, DOI 10.1016/j.pedneo.2020.03.001
   Johns Hopkins Coronavirus Resource Center, 2021, COVID 19 MAP
   Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479
   Lee PY, 2020, J CLIN INVEST, V130, P5942, DOI 10.1172/JCI141113
   Li Y, 2004, VIRAL IMMUNOL, V17, P528, DOI 10.1089/vim.2004.17.528
   Lin YJ, 2015, PEDIATR INFECT DIS J, V34, P1163, DOI 10.1097/INF.0000000000000852
   McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
   Molloy EJ, 2020, PEDIATR RES, V88, P340, DOI 10.1038/s41390-020-0881-y
   Parks T, 2018, CLIN INFECT DIS, V67, P1434, DOI 10.1093/cid/ciy401
   Peigh G, 2020, EUR HEART J-CASE REP, V4, DOI 10.1093/ehjcr/ytaa132
   RCPCH, PAED MULT INFL SYNDR
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623
   Sperotto F, 2021, EUR J PEDIATR, V180, P307, DOI 10.1007/s00431-020-03766-6
   Theocharis P, 2021, EUR HEART J-CARD IMG, V22, P896, DOI 10.1093/ehjci/jeaa212
   Valverde I, 2021, CIRCULATION, V143, P21, DOI 10.1161/CIRCULATIONAHA.120.050065
   Wei M, 2020, JAMA-J AM MED ASSOC, V323, P1313, DOI 10.1001/jama.2020.2131
   Weiss SL, 2020, PEDIATR CRIT CARE ME, V21, pE52, DOI [10.1097/PCC.0000000000002198, 10.1007/s00134-019-05878-6]
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   World Health Organization, MULT INFL SYNDR CHIL
   World Health Organization, 2020, MULT INFL SYNDR CHIL
   Yasuhara J, 2020, PEDIATR PULM, V55, P2565, DOI 10.1002/ppul.24991
   Zimmermann P, 2020, PEDIATR INFECT DIS J, V39, P355, DOI 10.1097/INF.0000000000002660
NR 33
TC 0
Z9 0
U1 1
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
EI 1757-790X
J9 BMJ CASE REP
JI BMJ Case Rep.
PD JUN
PY 2021
VL 14
IS 6
AR e242084
DI 10.1136/bcr-2021-242084
PG 6
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA TF2NW
UT WOS:000670549700013
PM 34187796
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Krynytska, I
   Marushchak, M
   Birchenko, I
   Dovgalyuk, A
   Tokarskyy, O
AF Krynytska, Inna
   Marushchak, Mariya
   Birchenko, Inna
   Dovgalyuk, Alina
   Tokarskyy, Oleksandr
TI COVID-19-associated acute respiratory distress syndrome versus classical
   acute respiratory distress syndrome (a narrative review)
SO IRANIAN JOURNAL OF MICROBIOLOGY
LA English
DT Review
DE SARS-CoV-2; COVID-19 pandemic; Respiratory distress syndrome;
   Respiratory mechanics
ID ACUTE LUNG INJURY; DISEASE 2019 COVID-19; VITAMIN-D; CORONAVIRUS;
   MORTALITY
AB Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), led to the ongoing global public health crisis. Existing clinical data suggest that COVID-19 patients with acute respiratory distress syndrome (ARDS) have worse outcomes and increased risk of intensive care unit (ICU) admission. The rapid increase in the numbers of patients requiring ICU care may imply a sudden and major challenge for affected health care systems. In this narrative review, we aim to summarize current knowledge of pathophysiology, clinical and morphological characteristics of COVID-19-associated ARDS and ARDS caused by other factors (classical ARDS) as defined by Berlin criteria, and therefore to elucidate the differences, which can affect clinical management of COVID-19-associated ARDS. Fully understanding the characteristics of COVID-19-associated ARDS will help identify its early progression and tailor the treatment, leading to improved prognosis in severe cases and reduced mortality. The notable mechanisms of COVID-19-associated ARDS include severe pulmonary infiltration/edema and inflammation, leading to impaired alveolar homeostasis, alteration of pulmonary physiology resulting in pulmonary fibrosis, endothelial inflammation and vascular thrombosis. Despite some distinct differences between COVID-19-associated ARDS and classical ARDS as defined by Berlin criteria, general treatment principles, such as lung-protective ventilation and rehabilitation concepts should be applied whenever possible. At the same time, ventilatory settings for COVID-19-associated ARDS require to be adapted in individual cases, depending on respiratory mechanics, recruitability and presentation timing.
C1 [Krynytska, Inna; Marushchak, Mariya] I Horbachevsky Ternopil Natl Med Univ, Dept Funct & Lab Diagnost, Ternopol, Ukraine.
   [Birchenko, Inna; Tokarskyy, Oleksandr] I Horbachevsky Ternopil Natl Med Univ, Dept Med Biochem, Ternopol, Ukraine.
   [Dovgalyuk, Alina] I Horbachevsky Ternopil Natl Med Univ, Dept Histol & Embriol, Ternopol, Ukraine.
RP Krynytska, I (corresponding author), I Horbachevsky Ternopil Natl Med Univ, Dept Funct & Lab Diagnost, Ternopol, Ukraine.
EM krynytska@tdmu.edu.ua
OI Birchenko, Inna/0000-0003-4659-7167
CR Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Arulkumaran N, 2021, J CRIT CARE, V62, P289, DOI 10.1016/j.jcrc.2021.01.001
   Belice T, 2020, IRAN J MICROBIOL, V12, P625, DOI 10.18502/ijm.v12i6.5038
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5
   Bos LDJ, 2020, AM J RESP CRIT CARE, V202, P622, DOI 10.1164/rccm.202004-1423LE
   Burki TK, 2020, LANCET RESP MED, V8, P238, DOI 10.1016/S2213-2600(20)30056-4
   Calabrese F, 2020, VIRCHOWS ARCH, V477, P359, DOI 10.1007/s00428-020-02886-6
   Calfee CS, 2011, AM J RESP CRIT CARE, V183, P1660, DOI 10.1164/rccm.201011-1802OC
   Chakraborty C, 2020, EUR REV MED PHARMACO, V24, P4016, DOI 10.26355/eurrev_202004_20871
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   Confalonieri M, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0116-2016
   Constantin JM, 2019, LANCET RESP MED, V7, P870, DOI 10.1016/S2213-2600(19)30138-9
   Dancer RCA, 2015, THORAX, V70, P617, DOI 10.1136/thoraxjnl-2014-206680
   Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535
   De Michele S, 2020, AM J CLIN PATHOL, V154, P748, DOI 10.1093/ajcp/aqaa156
   Duarte-Neto AN, 2020, HISTOPATHOLOGY, V77, P186, DOI 10.1111/his.14160
   Fan E, 2020, LANCET RESP MED, V8, P816, DOI 10.1016/S2213-2600(20)30304-0
   Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE
   Gibson PG, 2020, MED J AUSTRALIA, V213, P54, DOI 10.5694/mja2.50674
   Gonzalez-Lopez A, 2012, CRIT CARE, V16, DOI 10.1186/cc11224
   Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2
   Hajjar LA, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00820-w
   Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513
   Hashemian SMR, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02165-4
   Haudebourg AF, 2020, AM J RESP CRIT CARE, V202, P287, DOI 10.1164/rccm.202004-1226LE
   Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x
   Hu XS, 2021, WORLD J CLIN CASES, V9, P344, DOI 10.12998/wjcc.v9.i2.344
   Ji HL, 2020, PHYSIOL REV, V100, P1065, DOI 10.1152/physrev.00013.2020
   Jounieaux V, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05805-5
   Kamyshnyi A, 2020, INT J HYPERTENS, V2020, DOI 10.1155/2020/8019360
   Koegelenberg CFN, 2010, QJM-INT J MED, V103, P319, DOI 10.1093/qjmed/hcq022
   Kyrychko YN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76710-1
   Li X, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02911-9
   Lisi M, RADIOL CASE REP, V16, P753
   Mahjoub Y, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02972-w
   Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825
   Marushchak M., 2019, PNEUMOLOGIA, V68, P114, DOI [10.2478/pneum-2019-0019, DOI 10.2478/PNEUM-2019-0019]
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Mauad T, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01628-9
   Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835
   Pfortmueller CA, 2021, BEST PRAC RES-CL ANA, V35, P351, DOI 10.1016/j.bpa.2020.12.011
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Pierrakos Charalampos, 2012, J Clin Med Res, V4, P7, DOI 10.4021/jocmr761w
   Prabhakaran P, 2003, AM J PHYSIOL-LUNG C, V285, pL20, DOI 10.1152/ajplung.00312.2002
   Prescott HC, 2016, AM J RESP CRIT CARE, V194, P147, DOI 10.1164/rccm.201512-2544CP
   Quraishi SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081120
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rawal Gautam, 2018, J Transl Int Med, V6, P74, DOI 10.1515/jtim-2016-0012
   Richards-Belle A, 2020, INTENS CARE MED, V46, P2035, DOI 10.1007/s00134-020-06267-0
   Roshanshad A, 2020, IRAN J MICROBIOL, V12, P376, DOI 10.18502/ijm.v12i5.4597
   Sebag SC, 2011, CURR PHARM BIOTECHNO, V12, P1481
   Sinha P, 2019, CURR OPIN CRIT CARE, V25, P12, DOI 10.1097/MCC.0000000000000571
   Sun HY, 2020, J AM GERIATR SOC, V68, pE19, DOI 10.1111/jgs.16533
   Tang X, 2020, CHEST, V158, P195, DOI 10.1016/j.chest.2020.03.032
   Tsolaki V, 2021, LANCET RESP MED, V9, pE2, DOI 10.1016/S2213-2600(20)30506-3
   Upala S, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0063-3
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Wang DF, 2020, J PLANT PATHOL, V102, P477, DOI 10.1007/s42161-019-00480-7
   Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288
   Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang XB, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.611460
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR
   Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 72
TC 0
Z9 0
U1 4
U2 4
PU UNIV MEDICAL SCIENCES-DANISHGAH-I ULUM-I PIZISHKI-I TIHRAN
PI TEHRAN
PA DEPT MICROBIOLOGY, SCH MEDICINE, POURSINA ST, KESHAVARZ BLVD, TEHRAN,
   00000, IRAN
SN 2008-3289
EI 2008-4447
J9 IRAN J MICROBIOL
JI Iran. J. Microbiol.
PD DEC
PY 2021
VL 13
IS 6
BP 737
EP 747
PG 11
WC Microbiology
WE Emerging Sources Citation Index (ESCI)
SC Microbiology
GA XU7EP
UT WOS:000734423600002
PM 35222850
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Winarti, E
   Wahyuni, CU
   Rias, YA
   Mirasa, YA
   Sidabutar, S
   Wardhani, DL
AF Winarti, Eko
   Wahyuni, Chatarina Umbul
   Rias, Yohanes Andy
   Mirasa, Yudied Agung
   Sidabutar, Sondang
   Wardhani, Desi Lusiana
TI Citizens' health practices during the COVID - 19 pandemic in Indonesia:
   Applying the health belief model
SO BELITUNG NURSING JOURNAL
LA English
DT Article
DE COVID-19; health belief model; health knowledge; Indonesia; nursing;
   practice
AB Background: Understanding the health practice of Indonesian residents and its related factors during the COVID-19 pandemic is crucial, but such association necessitates clarity.
   Objective: To examine the health practices of the Indonesian citizens and their correlations with knowledge and health belief model (perceived susceptibility, barriers, benefits, severity, and self-efficacy) during the COVID-19 pandemic.
   Methods: A community-based online cross-sectional design was employed. The study was conducted from 10 July to 30 August 2020 among 552 citizens selected using convenience sampling. Sociodemographic characteristics, knowledge, health belief model, and health practices, including wearing a mask, social distancing, and washing hands, were measured using validated questionnaires. Adjusted odds ratios (AORs) and logistic regression were employed for data analysis.
   Results: The adjusted AORs (95% CIs) of a good level of health practices-wearing the mask, social distancing, and washing hands-were 3.24 (1.52 similar to 6.89), 2.54 (1.47 similar to 4.39), and 2.11 (1.19 similar to 3.75), respectively, in citizens with the high level of knowledge. Interestingly, respondents with positively perceived susceptibility exhibited significantly good practice in wearing the mask (4.91; 2.34 similar to 10.31), social distancing (1.95; 1.08 similar to 3.52), and washing hands (3.99; 2.26 similar to 7.05) compared to those with negatively perceived susceptibility. In addition, perceived barriers, benefits, severity, and self-efficacy also exhibited a significantly good all variables of health practice regarding COVID-19 pandemic after adjusting for confounding variables.
   Conclusion: Citizens with high levels of knowledge and positive levels of the health belief model had good practice of wearing masks, social distancing, and washing hands. The outcomes of this survey could encourage health professionals, including nurses, through management practices of nursing intervention based on the health belief model during the pandemic.
C1 [Winarti, Eko] Univ Kadiri, Coll Midwifery, Fac Hlth Sci, 1 Selomangleng St, Kediri 64115, Indonesia.
   [Wahyuni, Chatarina Umbul] Univ Airlangga, Coll Epidemiol, Fac Publ Hlth, Surabaya, Indonesia.
   [Rias, Yohanes Andy] Inst Ilmu Kesehatan Bhakti Wiyata Kediri, Fac Hlth & Med, Coll Nursing, Kediri, Indonesia.
   [Mirasa, Yudied Agung] Univ Kadiri, Coll Nursing, Fac Hlth Sci, Kediri, Indonesia.
   [Mirasa, Yudied Agung] Tech Ctr Environm Hlth & Dis Control, Surabaya, Indonesia.
   [Sidabutar, Sondang] Univ Efarina, Coll Publ Hlth, Fac Hlth, Sumatera Utara, Indonesia.
   [Wardhani, Desi Lusiana] Dinas Kesehatan Kabupaten Tulungagung, Tulungagung, Indonesia.
RP Winarti, E (corresponding author), Univ Kadiri, Coll Midwifery, Fac Hlth Sci, 1 Selomangleng St, Kediri 64115, Indonesia.
EM ekowinarti@unik-kediri.ac.id
OI Rias, Yohanes Andy/0000-0001-5403-2161; Sidabutar,
   Sondang/0000-0002-9089-5447
FU Kediri, Indonesia [106/P.1/LP3M/XII/2020]
FX This study was funded by the University of Kadiri, Kediri, Indonesia
   (106/P.1/LP3M/XII/2020).
CR Abdulkareem SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226483
   [Anonymous], 2021, GUGUS TUGAS PERCEPAT
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Barakat A.M., 2020, MIDDLE E CURR PSYCHI, V27, P1, DOI [10.1186/s43045-020-00051-y, DOI 10.1186/S43045-020-00051-Y]
   Bates BR, 2020, J COMMUN HEALTH, V45, P1158, DOI 10.1007/s10900-020-00916-7
   Bechard LE, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.609893
   Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906
   Grech V, 2020, EARLY HUM DEV, V144, DOI 10.1016/j.earlhumdev.2020.105054
   Hsiang S, 2020, NATURE, V585, pE7, DOI [10.1038/s41586-020-2404-8, 10.1038/s41586-020-2691-0]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jose R, 2021, CLIN EPIDEMIOL GLOB, V9, P41, DOI 10.1016/j.cegh.2020.06.009
   Kunle, 2015, INT ORGAN SCI RES J, V20, P11, DOI DOI 10.9790/0837-20951116
   Muslih M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18094473
   Narayana Goruntla, 2020, Curr Med Res Pract, V10, P153, DOI 10.1016/j.cmrp.2020.07.013
   Rias YA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9123798
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Sharma R, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113173
   Tadesse T, 2020, INFECT DRUG RESIST, V13, P3751, DOI 10.2147/IDR.S275933
   World Health Organization, 2020, WHO COR DIS COVID 19
   Yehualashet SS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246006
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 21
TC 0
Z9 0
U1 7
U2 7
PU BELITUNG RAYA FOUNDATION
PI BELITUNG
PA RT 06 RW 02, URISAN JAYA, PADANG, BELITUNG TIMUR, MANGGAR, BANGKA,
   BELITUNG, INDONESIA
SN 2528-181X
EI 2477-4073
J9 BELITUNG NURS J
JI Belitung Nurs. J.
PD JUL-AUG
PY 2021
VL 7
IS 4
BP 277
EP 284
DI 10.33546/bnj.1560
PG 8
WC Nursing
WE Emerging Sources Citation Index (ESCI)
SC Nursing
GA UK5XI
UT WOS:000692042100003
OA gold
DA 2022-04-20
ER

PT J
AU du Plessis, M
   Thomas, EC
AF du Plessis, Marieta
   Thomas, Emma C.
TI Counselling preparedness and responsiveness of industrial psychologists
   in the face of COVID-19
SO SA JOURNAL OF INDUSTRIAL PSYCHOLOGY
LA English
DT Article
DE COVID-19; mental health; counselling; industrial psychology;
   preparedness; responsiveness
ID TRAUMA; MANAGEMENT; BURNOUT
AB Orientation: The coronavirus disease 2019 (COVID-19) pandemic has brought to the forefront the need for industrial-organisational psychologists (IOPs) and organisations to place an emphasis on employees' mental and physical health at all times.
   Research purpose: The purpose of the research was to determine how prepared IOPs are to counsel employees during the pandemic and how responsive they are to provide counselling.
   Motivation for the study: It is not clear to what extent such counselling is being practised by IOPs in the workplace during the COVID-19 pandemic.
   Research approach/design and method: A qualitative approach was used to gain an understanding of registered South African IOPs' experiences of workplace counselling, particularly during the time of the COVID-19 pandemic.
   Main findings: Regarding preparedness, we found that IOPs are ill-prepared to counsel in the workplace. Preparedness was influenced by participants' counselling education, skills and knowledge; experience; convictions about counselling; and psychological and organisational preparedness. Whilst some IOPs did engage in more counselling during the COVID-19 pandemic, most reverted to mitigating actions such as referrals, wellness management, equipping managers and change initiatives.
   Practical/managerial implications: The results of this study indicate that, under pandemic conditions, there is an increased need for counselling practices within the workplace and that IOPs should explore the ways in which they could play a more active role in such counselling.
   Contribution/value-add: Although we found that IOPs generally responded to employees' mental health needs in a positive manner, there was a lack of counselling preparedness and responsiveness during the COVID-19 pandemic.
C1 [du Plessis, Marieta; Thomas, Emma C.] Univ Western Cape, Fac Econ & Management Sci, Dept Ind Psychol, Cape Town, South Africa.
RP du Plessis, M (corresponding author), Univ Western Cape, Fac Econ & Management Sci, Dept Ind Psychol, Cape Town, South Africa.
EM mduplessis@uwc.ac.za
RI Du Plessis, Marieta/N-5705-2017; Du Plessis, Marieta/W-6721-2019
OI Du Plessis, Marieta/0000-0002-3865-6959; Du Plessis,
   Marieta/0000-0002-3865-6959; Thomas, Emmarentia/0000-0002-3301-8819
CR Adalja AA, 2020, JAMA-J AM MED ASSOC, V323, P1343, DOI 10.1001/jama.2020.3413
   Akkermans J, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103434
   American Psychology Association, 2013, PUBL DESCR IND ORG P
   [Anonymous], 2006, REG DEF SCOP PROF PS
   Aquino K, 2009, ANNU REV PSYCHOL, V60, P717, DOI 10.1146/annurev.psych.60.110707.163703
   Arndt C., 2020, IMPACT COVID 19 S AF, V111
   Barkai J., 2020, CONNECTED WORLD
   Barkhuizen H, 2014, SA J IND PSYCHOL, V40, DOI 10.4102/sajip.v40i1.1193
   Barkhuizen Hanri, 2015, Acta Commer., V15, P1, DOI 10.4102/AC.V15I1.253
   Barnard G, 2007, SA J IND PSYCHOL, V33, P45
   Day KW, 2017, J COUNS DEV, V95, P269, DOI 10.1002/jcad.12141
   De Vos AS., 2005, RES GRASS ROOTS SOCI, V4th edn
   Department of Co-operative Governance and Traditional Affairs, 2020, GOVT NOT 608
   Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134
   Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562
   Gautam R, 2020, BRAIN BEHAV IMMUN, V88, P948, DOI 10.1016/j.bbi.2020.04.025
   Georganta K., 2019, CAMBRIDGE HDB PSYCHO, P318
   Gray D.E., 2004, DOING RES REAL WORLD
   Health Professions Council of South Africa (HPCSA), 2006, FORM 223 ETH RUL PSY
   Hite LM, 2020, HUM RESOUR DEV INT, V23, P427, DOI 10.1080/13678868.2020.1779576
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   HPCSA, 2019, REQ RESP INT PROGR I
   Interest Group in Coaching & Consulting Psychology (IGCCP), 2016, FREQUENTLY ASKED QUE
   Ivey A., 2013, INTENTIONAL INTERVIE
   Johnson B.W., 2014, OXFORD HDB ED TRAINI, V1st
   Jonker BE, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00530
   Jorgensen-Graupner L. I., 2019, POSITIVE PSYCHOL INT, P381, DOI [10.1007/978-3-030-20020-6_17, DOI 10.1007/978-3-030-20020-6_17]
   Kapucu N, 2008, DISASTERS, V32, P239, DOI 10.1111/j.1467-7717.2008.01037.x
   Kaushik M., 2020, EUR J BUS MANAGE, V12, P9, DOI [10.7176/EJBM/12-15-02, DOI 10.7176/EJBM/12-15-02]
   Koortzen P, 2010, SA J IND PSYCHOL, V36, DOI 10.4102/sajip.v36i1.837
   Kumar A, 2021, J MENT HEALTH, V30, P1, DOI 10.1080/09638237.2020.1757052
   Lawson G., 2005, PREVENTING COUNSELLO
   Lawson G, 2011, J COUNS DEV, V89, P163, DOI 10.1002/j.1556-6678.2011.tb00074.x
   Lerias D, 2003, STRESS HEALTH, V19, P129, DOI 10.1002/smi.969
   Loiwal M, 2020, INDIA TODAY
   McLeod J, 2003, BRIT J PSYCHIAT, V182, P103, DOI 10.1192/bjp.182.2.103
   McLeod S., 2020, MASLOWS HIERARCHY NE
   Osborn, 2008, QUALITATIVE PSYCHOL, DOI DOI 10.1037/13620-005
   Pienaar Y., 2001, J IND PSYCHOL, V27, P25
   Preece M, 2006, J WORKPLACE BEHAV HE, V21, P67, DOI 10.1300/J490v21n01_06
   Restauri N, 2020, J AM COLL RADIOL, V17, P921, DOI 10.1016/j.jacr.2020.05.021
   Robinson E.H., 2013, J MENTAL HLTH COUNSE, V35, P310, DOI [10.17744/mehc.35.4.7v33258020948502, DOI 10.17744/MEHC.35.4.7V33258020948502]
   Rothmann S, 2007, SA J IND PSYCHOL, V33, P8
   Rudnicka A., 2020, EWORKLIFE DEV EFFECT
   Rudolph CW., 2020, IND ORGAN PSYCHOL-US, DOI [10.31234/osf.io/k8us2, DOI 10.31234/OSF.IO/K8US2]
   Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662
   Skovholt T.M., 2001, RESILIENT PRACTITION
   Society for Industrial Organizational Psychology, 2013, IND ORGAN PSYCHOL-US
   Tan WQ, 2020, BRAIN BEHAV IMMUN, V87, P84, DOI 10.1016/j.bbi.2020.04.055
   Terblanche L, 2014, SOC WORK-MAATSK WERK, V50, P19, DOI [10.15270/50-1-14, 10.15270/50-1-13]
   Trippany RL, 2004, J COUNS DEV, V82, P31, DOI 10.1002/j.1556-6678.2004.tb00283.x
   United Nations, 2020, POL BRIEF COVID 19 N
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   van Vuuren LJ, 2010, SA J IND PSYCHOL, V36, DOI 10.4102/sajip.v36i2.939
   van Zyl LE, 2016, SA J IND PSYCHOL, V42, DOI 10.4102/sajip.v42i1.1379
   Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048
   Waugh WL, 2006, PUBLIC ADMIN REV, V66, P131, DOI 10.1111/j.1540-6210.2006.00673.x
   World Health Organization, 2020, MENT HLTH PSYCH CONS
   World Health Organization, 2020, MENT HLTH COVID 19
   Zacher H, 2021, AM PSYCHOL, V76, P50, DOI 10.1037/amp0000702
   Zhou XY, 2020, TELEMED E-HEALTH, V26, P377, DOI 10.1089/tmj.2020.0068
NR 61
TC 1
Z9 1
U1 0
U2 2
PU AOSIS
PI CAPE TOWN
PA POSTNET SUITE 55, PRIVATE BAG X22, TYGERVALLEY, CAPE TOWN, 00000, SOUTH
   AFRICA
SN 0258-5200
EI 2071-0763
J9 SA J IND PSYCHOL
JI SA J. Ind. Psychol.
PD MAY 17
PY 2021
VL 47
AR a1860
DI 10.4102/sajip.v47i0.1860
PG 13
WC Psychology, Applied
WE Emerging Sources Citation Index (ESCI)
SC Psychology
GA SR5DB
UT WOS:000661060100001
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Elagib, MFA
   Baldo, SMH
   Tawfig, A
   Alqarni, MA
   Ghandour, IA
   Idris, AM
AF Elagib, Mohamed F. A.
   Baldo, Sara M. H.
   Tawfig, Ahmed
   Alqarni, Mohammed A.
   Ghandour, I. A.
   Idris, Abubakr M.
TI Knowledge, attitude, and practice regarding infection control measures
   among dental students during COVID-19 pandemic
SO ARCHIVES OF ENVIRONMENTAL & OCCUPATIONAL HEALTH
LA English
DT Article; Early Access
DE COVID-19; dental; infection control measures; personal protective
   equipment
ID EXPOSURE INCIDENTS; MANAGEMENT; DENTISTRY
AB Among health care professionals, dentists are more prone to infection due to their direct contact with blood and saliva. This study highlights the level of compliance with infection control measures among dental students; and linked this to their knowledge and attitudes regarding infection control measures and proper vaccinations. The study is a multi-centre analytical cross-sectional survey. The sample size was 969 clinical years' students from governmental and private dental colleges in Sudan and Saudi Arabia. A pre-coded, pre-tested, and anonymous questionnaire consisted of seven categories of knowledge, attitude, awareness, and practices, including 40 questions, was answered. The study has linked knowledge, attitude, and practice in dental clinics with possible COVID-19 transmission in dental clinics. The results showed that the use of some Personal Protective Equipment was low in Sudan and moderate in Saudi Arabia (statistically significant, p < 0.001). Moderate percentage of Hepatitis B vaccination status, with low percentage of Post HBV serology, was reported (p < 0.001). The percentages of major causes of percutaneous and/or eye exposure/injury, for examples, were as follows: anesthesia (33.3-62.7%, p 0.006) and suture needle (17.5-39.4%, p 0.037). In conclusion, dental students in the present study had good knowledge and positive attitudes regarding infection control in general, but showed moderate compliance with the recommended infection control guidelines.
C1 [Elagib, Mohamed F. A.; Alqarni, Mohammed A.] King Khalid Univ, Coll Dent, Abha, Saudi Arabia.
   [Elagib, Mohamed F. A.; Ghandour, I. A.] Univ Khartoum, Fac Dent, Khartoum, Sudan.
   [Baldo, Sara M. H.; Ghandour, I. A.] Sudan Med Specializat Board SMSB, Khartoum, Sudan.
   [Tawfig, Ahmed] Riyadh Elm Univ, Coll Dent, Dept Prevent Dent, Riyadh, Saudi Arabia.
   [Idris, Abubakr M.] King Khalid Univ, Coll Sci, Dept Chem, Abha 61321, Saudi Arabia.
   [Idris, Abubakr M.] King Khalid Univ, Res Ctr Adv Mat Sci RCAMS, Abha, Saudi Arabia.
RP Idris, AM (corresponding author), King Khalid Univ, Coll Sci, Dept Chem, Abha 61321, Saudi Arabia.
EM abubakridris@hotmail.com
RI tawfig, ahmed/AAR-9503-2021; alqarni, M/AAR-5874-2021; Idris,
   Abubakr/E-6452-2012
OI alqarni, M/0000-0002-1495-1515; Idris, Abubakr/0000-0003-4038-4769;
   Elagib, Mohamed/0000-0002-6173-3297
FU Re-search Center of Advanced Materials, King Khalid University, Saudi
   Arabia [RCAMS/0020/20]
FX The authors express their gratitude to Re-search Center of Advanced
   Materials, King Khalid University, Saudi Arabia, for support (award
   number RCAMS/0020/20).
CR Al-Essa NA, 2017, SAUDI J DENT RES, V8, P67, DOI [DOI 10.1016/J.SJDR.2016.10.003, 10.1016/j.sjdr.2016.10.003]
   Al-Maweri SA, 2015, GMS HYG INFECT CONTR, V10, DOI 10.3205/dgkh000253
   Alavian SM, 2011, J DENT EDUC, V75, P1627
   Alshiddi IF., 2015, DENT ORAL CRANIOFAC, V1, P116, DOI [10.15761/DOCR.1000128, DOI 10.15761/DOCR.1000128]
   Askarian M, 2009, ARCH IRAN MED, V12, P48
   Assiri K.I., 2018, J INT ORAL HEALTH, V10, P83, DOI 10.4103/jioh. jioh_6_18
   Binalrimal S, 2019, GMS HYG INFECT CONTR, V14, DOI 10.3205/dgkh000326
   Columbus Cristie, 2020, Proc (Bayl Univ Med Cent), V33, P209, DOI 10.1080/08998280.2020.1731272
   Coulthard P, 2020, BRIT DENT J, V228, P503, DOI 10.1038/s41415-020-1482-1
   de Souza RA, 2006, J PUBLIC HEALTH DENT, V66, P282
   Elagib MFA, 2021, TOXIN REV, V40, P1496, DOI 10.1080/15569543.2020.1737824
   Halboub Esam Saleh, 2015, J Int Oral Health, V7, P15
   Hanif M., 2019, PAKISTAN ORAL DENT J, V39, P149
   Jameel T, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4052-3
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kramer A., 2008, Hygiene Medizin, V33, P64
   Lu CW, 2020, LANCET, V395, pE39, DOI 10.1016/S0140-6736(20)30313-5
   Malmberg L, 2019, ACTA ODONTOL SCAND, V77, P434, DOI 10.1080/00016357.2019.1584330
   McCarthy, 2000, J Can Dent Assoc, V66, P561
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Moradi Khanghahi Behnam, 2013, J Dent Res Dent Clin Dent Prospects, V7, P55, DOI 10.5681/joddd.2013.010
   Resende KKM, 2019, J DENT EDUC, V83, P575, DOI 10.21815/JDE.019.060
   Mutters NT, 2014, GMS HYG INFECT CONTR, V9, DOI 10.3205/dgkh000238
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Rahman B, 2013, EUR J DENT, V7, pS15, DOI [DOI 10.4103/1305-7456.119058, 10.4103/1305-7456.119058]
   Sedky NA, 2013, INT J HEALTH SCI-IJH, V7, P174, DOI 10.12816/0006041
   Singh A., 2001, J DENT ED, V75, P422, DOI [10.1002/j.0022-0337.2011.75.3.tb05055.x, DOI 10.1002/J.0022-0337.2011.75.3.TB05055.X]
   Sofola OO, 2007, J DENT EDUC, V71, P832
   Stewardson D A, 2002, Eur J Dent Educ, V6, P104, DOI 10.1034/j.1600-0579.2002.00253.x
   Su J, 2012, INT DENT J, V62, P148, DOI 10.1111/j.1875-595X.2011.00107.x
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   Wei W, 2020, RADIOTHER ONCOL, V148, P203, DOI 10.1016/j.radonc.2020.03.029
   Younai F S, 2001, J Dent Educ, V65, P436
   Yuzbasioglu E, 2009, J APPL ORAL SCI, V17, P565, DOI 10.1590/S1678-77572009000600005
NR 34
TC 0
Z9 0
U1 5
U2 8
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1933-8244
EI 2154-4700
J9 ARCH ENVIRON OCCUP H
JI Arch. Environ. Occup. Health
DI 10.1080/19338244.2021.1931796
EA MAY 2021
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA SJ8ZP
UT WOS:000655816300001
PM 34047677
DA 2022-04-20
ER

PT J
AU Montoya-Torres, JR
   Munoz-Villamizar, A
   Mejia-Argueta, C
AF Montoya-Torres, Jairo R.
   Munoz-Villamizar, Andres
   Mejia-Argueta, Christopher
TI Mapping research in logistics and supply chain management during
   COVID-19 pandemic
SO INTERNATIONAL JOURNAL OF LOGISTICS-RESEARCH AND APPLICATIONS
LA English
DT Article; Early Access
DE Disruption; resilience; SARS-CoV-2; Covid-19; review; sustainability
ID PERFORMANCE-MEASUREMENT; IMPACT; SUSTAINABILITY; DISRUPTIONS; DESIGN;
   INFORMATION; RESILIENCE; COMPLEXITY; NETWORKS; DYNAMICS
AB Supply chains constantly face new problems that go way beyond the traditional issues of supply and demand uncertainty, particularly due to the impact of worldwide disruptive events. This paper aims at mapping academic literature examining so far issues related to the impact on supply chains of the COVID-19 outbreak based on a thorough literature review of peer-reviewed papers published in 2020. Following criteria established by the systematic approach, we build a framework based on the most recent papers of the discipline to address major disruptions that challenge SCM operations. We consider features from individual organisations, characteristics of the whole supply chain, performance metrics for long-term sustainability, and attributes from external disruptions. We derive a list of topics that deserve further investigation such as collaboration, technology adoption and knowledge creation together with their diffusion, strategies to shape and promote awareness along supply chain stakeholders.
C1 [Montoya-Torres, Jairo R.] Univ La Sabana, Sch Engn, Res Grp Logist Syst, Chia, Colombia.
   [Munoz-Villamizar, Andres] Univ La Sabana, Escuela Int Ciencias Econom & Adm, Operat & Supply Chain Management Res Grp, Chia, Colombia.
   [Mejia-Argueta, Christopher] MIT, Food & Retail Operat Lab, Ctr Transportat & Logist, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
RP Montoya-Torres, JR (corresponding author), Univ La Sabana, Sch Engn, Res Grp Logist Syst, Chia, Colombia.
EM jairo.montoya@unisabana.edu.co
OI Montoya-Torres, Jairo R./0000-0002-6251-3667; Mejia Argueta,
   Christopher/0000-0002-4601-2459
FU Universidad de La Sabana [INGPHD-10-2019]
FX This work was supported by Universidad de La Sabana: [grant number
   INGPHD-10-2019].
CR Acikgoz O, 2020, TURK J MED SCI, V50, P520, DOI 10.3906/sag-2004-6
   Akyuz GA, 2010, INT J PROD RES, V48, P5137, DOI 10.1080/00207540903089536
   Amirbagheri K, 2019, CLEAN TECHNOL ENVIR, V21, P3, DOI 10.1007/s10098-018-1624-1
   [Anonymous], ISO260002010
   [Anonymous], 2020, NEWSWIRE
   Badger D., 2000, EVALUATION RES ED, V14, P220, DOI [DOI 10.1080/09500790008666974, 10.1080/09500790008666974]
   Baldwin R, 2020, EC TIME COVID 19
   Barman S, 2001, J OPER MANAG, V19, P367, DOI 10.1016/S0272-6963(00)00060-7
   Baveja A, 2020, ANN OPER RES, V289, P173, DOI 10.1007/s10479-020-03635-3
   Beamon BM, 1999, INT J OPER PROD MAN, V19, P275, DOI 10.1108/01443579910249714
   Bensalem A, 2019, SUPPLY CHAIN FORUM, V20, P15, DOI 10.1080/16258312.2019.1574430
   Bier T, 2020, INT J PROD RES, V58, P1835, DOI 10.1080/00207543.2019.1687954
   Bode C, 2015, J OPER MANAG, V36, P215, DOI 10.1016/j.jom.2014.12.004
   Bozarth CC, 2009, J OPER MANAG, V27, P78, DOI 10.1016/j.jom.2008.07.003
   Chapman K, 2009, J BUS LOGIST, V30, P197, DOI 10.1002/j.2158-1592.2009.tb00119.x
   Choi TY, 2006, J OPER MANAG, V24, P637, DOI 10.1016/j.jom.2005.07.002
   Choi TY, 2002, J OPER MANAG, V20, P469, DOI 10.1016/S0272-6963(02)00025-6
   Columbus L., 2020, FORBES
   Craighead CW, 2007, DECISION SCI, V38, P131, DOI 10.1111/j.1540-5915.2007.00151.x
   Cuthbertson R, 2011, INT J PRODUCT PERFOR, V60, P583, DOI 10.1108/17410401111150760
   Delbufalo E, 2012, SUPPLY CHAIN MANAG, V17, P377, DOI 10.1108/13598541211246549
   Denyer D., 2009, SAGE HDB ORG RES MET
   Dolgui A, 2020, INT J PROD ECON, V229, DOI 10.1016/j.ijpe.2020.107886
   Elleby C, 2020, ENVIRON RESOUR ECON, V76, P1067, DOI 10.1007/s10640-020-00473-6
   Feng YT, 2017, J CLEAN PROD, V158, P296, DOI 10.1016/j.jclepro.2017.05.018
   Fink A., 1998, CONDUCTING RES LIT R
   Gaviria-Marin M, 2019, TECHNOL FORECAST SOC, V140, P194, DOI 10.1016/j.techfore.2018.07.006
   Govindan K, 2020, TRANSPORT RES E-LOG, V138, DOI 10.1016/j.tre.2020.101967
   Gupta V, 2021, OMEGA-INT J MANAGE S, V101, DOI 10.1016/j.omega.2020.102279
   Hakovirta M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093727
   Hendricks KB, 2005, PROD OPER MANAG, V14, P35
   Holguin-Veras J, 2021, TRANSPORT RES E-LOG, V149, DOI 10.1016/j.tre.2021.102301
   Huang GQ, 2003, INT J PROD RES, V41, P1483, DOI 10.1080/0020754031000069625
   Hutchins MJ, 2008, J CLEAN PROD, V16, P1688, DOI 10.1016/j.jclepro.2008.06.001
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922
   Juergensen J, 2020, J IND BUS ECON, V47, P499, DOI 10.1007/s40812-020-00169-4
   Ketchen DJ, 2020, J MANAGE, V46, P1330, DOI 10.1177/0149206320945028
   Kotzab H., 2007, RES METHODOLOGIES SU
   Kouvelis P., 2011, HDB INTEGRATED RISK
   Kun A, 2020, PUBLICATIONS, V8, DOI 10.3390/publications8020030
   Lee HL, 2004, HARVARD BUS REV, V82, P102
   Leone M, 2006, CASE FATTER SUPPLY C
   Li T, 2020, J AIR TRANSP MANAG, V88, DOI 10.1016/j.jairtraman.2020.101875
   Liu YP, 2020, ASIAN BUS MANAG, V19, P277, DOI 10.1057/s41291-020-00119-x
   Maloni M, 2012, INT J PHYS DISTR LOG, V42, P83, DOI 10.1108/09600031211202481
   Manuj I, 2011, INT J PHYS DISTR LOG, V41, P511, DOI 10.1108/09600031111138844
   Meixell MJ, 2005, TRANSPORT RES E-LOG, V41, P531, DOI 10.1016/j.tre.2005.06.003
   Merigo JM, 2017, OMEGA-INT J MANAGE S, V73, P37, DOI 10.1016/j.omega.2016.12.004
   Mishra D, 2018, BENCHMARKING, V25, P932, DOI 10.1108/BIJ-08-2017-0224
   Montoya-Torres J.R., 2022, SERVICE ORIENTED HOL, DOI [10.1007/978-3-030-80906-5_19, DOI 10.1007/978-3-030-80906-5_19]
   Moreno-Camacho CA, 2019, J CLEAN PROD, V231, P600, DOI 10.1016/j.jclepro.2019.05.278
   Munoz-Villamizar A., 2019, UNCERTAIN SUPPLY CHA, V7, P703
   Newbert SL, 2007, STRATEGIC MANAGE J, V28, P121, DOI 10.1002/smj.573
   Noyons ECM, 1999, J AM SOC INFORM SCI, V50, P115, DOI 10.1002/(SICI)1097-4571(1999)50:2<115::AID-ASI3>3.0.CO;2-J
   Patrucco AS, 2022, INT J LOGIST MANAG, V33, P53, DOI 10.1108/IJLM-11-2020-0426
   Pettit TJ, 2019, J BUS LOGIST, V40, P56, DOI 10.1111/jbl.12202
   Pfohl H.C., 2010, LOGIST RES, V2, P33, DOI [10.1007/s12159-010-0023-8, DOI 10.1007/S12159-010-0023-8]
   Pishvaee MS, 2012, FUZZY SET SYST, V206, P1, DOI 10.1016/j.fss.2012.04.010
   PRITCHARD A, 1969, J DOC, V25, P348
   Rao S, 2009, INT J LOGIST MANAG, V20, P97, DOI 10.1108/09574090910954864
   Reynolds D., 2011, DAWN SUPPLY CHAIN IN
   Schmidt W, 2015, DECISION SCI, V46, P465, DOI 10.1111/deci.12133
   Sheffi Y., 2017, POWER RESILIENCE BES, VReprint ed.
   Sheffi Y., 2007, RESILIENT ENTERPRISE
   Sheffi Y., 2020, NEW AB NORMAL RESHAP
   Sheth J, 2020, J BUS RES, V117, P280, DOI 10.1016/j.jbusres.2020.05.059
   Singh S, 2021, INT J PROD RES, V59, P1993, DOI 10.1080/00207543.2020.1792000
   Small H, 1999, J AM SOC INFORM SCI, V50, P799, DOI 10.1002/(SICI)1097-4571(1999)50:9<799::AID-ASI9>3.3.CO;2-7
   Snyder LV, 2016, IIE TRANS, V48, P89, DOI 10.1080/0740817X.2015.1067735
   Sridharan R., 2005, INT J LOGIST MANAG, V16, P257, DOI DOI 10.1108/09574090510634548
   Staszkiewicz P, 2020, IEEE ACCESS, V8, P106009, DOI 10.1109/ACCESS.2020.2999614
   Szekely F., 2005, European Management Journal, V23, P628, DOI 10.1016/j.emj.2005.10.009
   Tang CS, 2006, INT J PROD ECON, V103, P451, DOI 10.1016/j.ijpe.2005.12.006
   Tang O, 2012, INT J PROD ECON, V139, P1, DOI 10.1016/j.ijpe.2012.06.015
   Thome AMT, 2016, PROD PLAN CONTROL, V27, P408, DOI 10.1080/09537287.2015.1129464
   Trautrims A, 2020, J RISK RES, V23, P1067, DOI 10.1080/13669877.2020.1772347
   Trkman P, 2009, INT J PROD ECON, V119, P247, DOI 10.1016/j.ijpe.2009.03.002
   van Barneveld K, 2020, ECON LABOUR RELAT RE, V31, P133, DOI 10.1177/1035304620927107
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Wang YB, 2020, CHINA AGR ECON REV, V12, P427, DOI 10.1108/CAER-04-2020-0053
   Winter M, 2013, INT J PHYS DISTR LOG, V43, P18, DOI 10.1108/09600031311293237
   Won JH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249775
NR 84
TC 2
Z9 2
U1 20
U2 30
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1367-5567
EI 1469-848X
J9 INT J LOGIST-RES APP
JI Int. J. Logist.-Res. Appl.
DI 10.1080/13675567.2021.1958768
EA JUL 2021
PG 21
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA TS8RK
UT WOS:000679914400001
DA 2022-04-20
ER

PT J
AU Mansoorian, M
   Noori, R
   Khosravan, S
   Tabatabaeizadeh, SA
   Khajavian, N
AF Mansoorian, Mozhgan
   Noori, Reza
   Khosravan, Shahla
   Tabatabaeizadeh, Seyed-Amir
   Khajavian, Nasim
TI Nutritional knowledge, attitude and behaviours regarding Coronavirus
   Disease 2019 among residents of Gonabad, Iran
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE COVID-19; Knowledge; Attitude; Behaviour; Nutrition
ID COVID-19
AB Objective:
   Coronavirus Disease 2019 (COVID-19) is a respiratory disease and a major global health-related issue. Knowledge, attitude and behaviours associated with this disease are being developed. Infected animals and consumption of contaminated foods are probably the main sources of this viral infection. Adhering to a healthy diet is effective in preventing patient affliction and recovery. Thus, the present research aims to determine the nutritional knowledge, attitude and behaviours associated with COVID-19 among Residents of Gonabad, Iran.
   Design:
   The present online cross-sectional survey was conducted in March 2020 on 389 people selected through convenient sampling method. The data collection instrument was a questionnaire developed by the present researchers comprising four sections: demographic information, knowledge, attitude and nutritional behaviour. The collected data were analysed statistically in SPSS.
   Setting:
   Gonabad city in Khorasan Razavi in the Northeast of Iran.
   Participants:
   All people at or above 18 years of age.
   Results:
   The present results revealed that the mean age of the participants was 37 center dot 3 +/- 11 center dot 3 years. The mean scores for knowledge, attitude and nutritional behaviour were, respectively, 9 center dot 7 +/- 1 center dot 4, 14 center dot 3 +/- 3 center dot 5 and 29 center dot 6 +/- 4 center dot 2. The mean scores for nutritional knowledge and attitude showed no statistically significant correlation with age, education, occupation, marital status and economic status. However, the mean nutritional behaviour score was significantly higher among women than men (P = 0 center dot 004).
   Conclusions:
   Participants' nutritional attitude and behaviour regarding COVID-19, at its early stage in Iran, were average and above average. The public education provided with this regard can have affected this result.
C1 [Mansoorian, Mozhgan] Mashhad Univ Med Sci, Fac Med, Mashhad, Razavi Khorasan, Iran.
   [Noori, Reza] Gonabad Univ Med Sci, Fac Nursing, Dept Community Hlth Nursing & Management Nursing, Social Dev & Hlth Promot Res Ctr, Gonabad 9693177149, Iran.
   [Khosravan, Shahla] Gonabad Univ Med Sci, Sch Nursing, Dept Community Hlth Nursing & Management Nursing, Social Determinants Hlth Res Ctr, Gonabad, Iran.
   [Tabatabaeizadeh, Seyed-Amir] Gonabad Univ Med Sci, Sch Med, Nutr & Biochem Dept, Social Dev & Hlth Promot Res Ctr, Gonabad, Iran.
   [Khajavian, Nasim] Gonabad Univ Med Sci, Social Dev & Hlth Promot Res Ctr, Gonabad, Iran.
RP Noori, R (corresponding author), Gonabad Univ Med Sci, Fac Nursing, Dept Community Hlth Nursing & Management Nursing, Social Dev & Hlth Promot Res Ctr, Gonabad 9693177149, Iran.
EM rnoori68@gmail.com
OI Tabatabaeizadeh, Seyed-Amir/0000-0002-5205-0697
FU Gonabad University of medical sciences [IR.GMU.REC.1399.003]
FX The authors are grateful to the deputy of research at Gonabad University
   of medical sciences. We are also grateful to all of the participants in
   this study. Financial support: This study was supported by Gonabad
   University of medical sciences (grant number IR.GMU.REC.1399.003).
CR Ahmadiara E., 2020, J FOOD QUAL HAZARDS, V7, P2, DOI [10.18502/jfqhc.7.1.2445, DOI 10.18502/JFQHC.7.1.2445]
   Ali I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138861
   Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04
   [Anonymous], 2020, SITUATION REPORTS
   Butler MJ, 2020, BRAIN BEHAV IMMUN, V87, P53, DOI 10.1016/j.bbi.2020.04.040
   Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161
   Food and Agriculture Organization of the United Nations (FAO), 2020, COR DIS COVID 19 OUT
   Hao Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239960
   Kolawole SO., 2020, SSHOD2000175
   Lim VW., 2020, USE COMMUNITY BASED
   Ross C., 2014, DEFENSES OXIDATIVE S, V11th
   Saul AW, 2020, ORTHOMOL MED NEWS SE
   Srichan P., 2020, WHO S E ASIA J PUBLI, V9, P118, DOI DOI 10.4103/2224-3151.294305
   Taghdir M., 2020, MIL MED, V22, P169
   WHO, 2000, FOODB DIS FOC HLTH E
   WHO, 2020, NUTR ADV AD COVID 19
   Wong SH, 2020, J GASTROEN HEPATOL, V35, P744, DOI 10.1111/jgh.15047
   World Health Organisation W, 2020, COR DIS COVID 19 ADV
   Yu, 2020, PUBLIC EXPOSURE LIVE, DOI [10.1101/2020.02.21.20026146, DOI 10.1101/2020.02.21.20026146]
   Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 21
TC 1
Z9 1
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD APR
PY 2021
VL 24
IS 5
BP 1088
EP 1094
AR PII S1368980021000033
DI 10.1017/S1368980021000033
PG 7
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA RI7RN
UT WOS:000637104900034
PM 33427193
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Zhang, P
   Bu, Y
   Jiang, P
   Shi, XW
   Lun, B
   Chen, CY
   Syafiandini, AF
   Ding, Y
   Song, M
AF Zhang, Peng
   Bu, Yi
   Jiang, Peng
   Shi, Xiaowen
   Lun, Bing
   Chen, Chongyan
   Syafiandini, Arida Ferti
   Ding, Ying
   Song, Min
TI Toward a Coronavirus Knowledge Graph
SO GENES
LA English
DT Article
DE knowledge management applications; knowledge base management; knowledge
   engineering methodologies
ID VIRUS-INFECTION; COVID-19; DRUG
AB This study builds a coronavirus knowledge graph (KG) by merging two information sources. The first source is Analytical Graph (AG), which integrates more than 20 different public datasets related to drug discovery. The second source is CORD-19, a collection of published scientific articles related to COVID-19. We combined both chemo genomic entities in AG with entities extracted from CORD-19 to expand knowledge in the COVID-19 domain. Before populating KG with those entities, we perform entity disambiguation on CORD-19 collections using Wikidata. Our newly built KG contains at least 21,700 genes, 2500 diseases, 94,000 phenotypes, and other biological entities (e.g., compound, species, and cell lines). We define 27 relationship types and use them to label each edge in our KG. This research presents two cases to evaluate the KG's usability: analyzing a subgraph (ego-centered network) from the angiotensin-converting enzyme (ACE) and revealing paths between biological entities (hydroxychloroquine and IL-6 receptor; chloroquine and STAT1). The ego-centered network captured information related to COVID-19. We also found significant COVID-19-related information in top-ranked paths with a depth of three based on our path evaluation.
C1 [Zhang, Peng] Tsinghua Univ, Dept Comp Sci & Technol, Beijing 100084, Peoples R China.
   [Bu, Yi] Peking Univ, Dept Informat Management, Beijing 100871, Peoples R China.
   [Jiang, Peng; Shi, Xiaowen; Lun, Bing] Beijing Knowledge Atlas Technol Co Ltd, Beijing 100043, Peoples R China.
   [Chen, Chongyan; Ding, Ying] Univ Texas Austin, Sch Informat, Austin, TX 78701 USA.
   [Syafiandini, Arida Ferti; Song, Min] Yonsei Univ, Dept Lib & Informat Sci, Seoul 03722, South Korea.
   [Ding, Ying] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA.
RP Song, M (corresponding author), Yonsei Univ, Dept Lib & Informat Sci, Seoul 03722, South Korea.
EM zhangp31@tsinghua.edu.cn; buyi@pku.edu.cn; peng.jiang@aminer.cn;
   shixiaowen_win@163.com; bing.lun@aminer.cn; chongyanchen_hci@utexas.edu;
   afsyafiandini@yonsei.ac.kr; ying.ding@ischool.utexas.edu;
   min.song@yonsei.ac.kr
RI Bu, Yi/B-4964-2018
OI Bu, Yi/0000-0003-2549-4580; Chen, Chongyan/0000-0003-3188-6652
FU National Research Foundation of Korea (NRF) grant by the Korean
   government (MSIT) [NRF-2019R1A2C2002577]; National Science Foundation in
   the United StatesNational Science Foundation (NSF) [NSF Rapid 2028717]
FX This research was funded by the National Research Foundation of Korea
   (NRF) grant by the Korean government (MSIT) with grant number
   NRF-2019R1A2C2002577 and the National Science Foundation in the United
   States with grant number NSF Rapid 2028717.
CR Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Arora S, 2020, GENE, V762, DOI 10.1016/j.gene.2020.145057
   Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x
   Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061
   Bullock J, 2020, J ARTIF INTELL RES, V69, P807
   Campioli CC, 2020, J CLIN VIROL, V130, DOI 10.1016/j.jcv.2020.104577
   Cao Yang, 2020, J Allergy Clin Immunol, V146, P137, DOI 10.1016/j.jaci.2020.05.019
   Chahal M., 2016, INT J COMPUT TRENDS, V36, P140, DOI [10.14445/22312803/IJCTT-V36P124, DOI 10.14445/22312803/IJCTT-V36P124]
   Chahrour M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7357
   Chambers J, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-3
   Church KW, 2017, NAT LANG ENG, V23, P155, DOI 10.1017/S1351324916000334
   Colalto C, 2020, DRUG DEVELOP RES, V81, P950, DOI 10.1002/ddr.21716
   De Spiegeleer, 2019, REFERENCE MODULE BIO
   Di Maria E, 2020, HUM GENOMICS, V14, DOI 10.1186/s40246-020-00280-6
   Domingo-Fernandez D, 2021, BIOINFORMATICS, V37, P1332, DOI 10.1093/bioinformatics/btaa834
   Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]
   Gaudet P, 2017, NUCLEIC ACIDS RES, V45, pD177, DOI 10.1093/nar/gkw1062
   Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777
   Ge Y., 2020, BIORXIV, DOI [10.1101/2020.03.11.986836%, 10.1101/2020.03.11.986836, DOI 10.1101/2020.03.11.986836]
   Haque A, 2015, ANTIMICROB AGENTS CH, V59, P5892, DOI 10.1128/AAC.01105-15
   Hussein MIH, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03541-w
   Joshi AY, 2020, ALLERGY ASTHMA PROC, V41, P296, DOI 10.2500/aap.2020.41.200044
   Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951
   Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795
   Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Liu Y, 2021, CURR OPIN RHEUMATOL, V33, P155, DOI 10.1097/BOR.0000000000000776
   Lu Wang L., 2020, CORD 19 COVID 19 OPE
   McDonald AG, 2009, NUCLEIC ACIDS RES, V37, pD593, DOI 10.1093/nar/gkn582
   Moen S., 2013, P LBM, P39
   Mu JF, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00208-3
   Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5
   Naili M, 2017, PROCEDIA COMPUT SCI, V112, P340, DOI 10.1016/j.procs.2017.08.009
   Pinero J, 2020, NUCLEIC ACIDS RES, V48, pD845, DOI 10.1093/nar/gkz1021
   Pouly, 2019, P 2019 C N AM CHAPT, DOI [10.18653/v1/n19-1181, DOI 10.18653/V1/N19-1181]
   Prasad K, 2020, INT J BIOL MACROMOL, V163, P1, DOI 10.1016/j.ijbiomac.2020.06.228
   Richardson P, 2020, LANCET, V395, pE30, DOI 10.1016/S0140-6736(20)30304-4
   Sallinger, 2004, ARXIV200410119
   Siso-Almirall A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237960
   South AM, 2020, AM J PHYSIOL-HEART C, V318, pH1084, DOI 10.1152/ajpheart.00217.2020
   Sun H, 2018, JOURNAL, DOI DOI 10.18653/V1/D18-1455
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377
   The University of New Mexico, TARG CENTR RES DAT
   Torgerson, 2016, PEDIAT ALLERGY PRINC, P124
   van Eck NJ, 2009, J AM SOC INF SCI TEC, V60, P1635, DOI 10.1002/asi.21075
   Vrandecic D, 2014, COMMUN ACM, V57, P78, DOI 10.1145/2629489
   Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441
   WHO, COR DIS COVID 19
   Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067
   Wu J H, 2020, Zhonghua Bing Li Xue Za Zhi, V49, P568, DOI 10.3760/cma.j.cn112151-20200405-00291
   Xu J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0543-2
   Yi Wei, 2020, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V32, P279, DOI 10.3760/cma.j.cn121430-20200225-00200
   Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098
   Zisman LS, 2005, EUR HEART J, V26, P322, DOI 10.1093/eurheartj/ehi043
NR 55
TC 0
Z9 0
U1 13
U2 18
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD JUL
PY 2021
VL 12
IS 7
AR 998
DI 10.3390/genes12070998
PG 17
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA TO2ZJ
UT WOS:000676786200001
PM 34209818
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ardic, A
   Turan, E
AF Ardic, Aysun
   Turan, Ebru
TI Nursing care management based on the Omaha system for inpatients
   diagnosed with COVID-19: An electronic health record study
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE coronavirus; COVID-19; electronic health record; nursing; pandemic; the
   Omaha System
AB Aims The aim of this study was to identify the clinical characteristics of patients diagnosed with COVID-19 and the existing nursing problems based on the Omaha System, and to establish a comprehensive nursing care management plan by determining the nursing interventions and care outcomes.
   Design This study used a descriptive cross-sectional design.
   Methods This study was conducted in a training and research hospital with 25 non-intubated COVID-19 inpatients between 6 April and 13 May 2020 in Turkey. Data were collected using a Socio-demographic and Clinical Characteristics Form, the COVID-19 Response Separate Guidelines and the Omaha System and Nightingale Notes software. Data were analysed using descriptive statistical tests and the chi-square method.
   Results Using the Omaha System, it was shown that the patients' most common problems were communicable/infectious condition, respiration, circulation, pain, nutrition, personal care and substance use respectively. The most common signs and symptoms were signs of infection, fever, cough, respiratory distress and pain. The interventions that were performed most frequently to the patients included infection precautions, medication action/side effects, signs/symptoms-physical, dietary management and nursing care targets for intervention. These interventions were applied using the category of teaching, guidance and counselling. A significant improvement was observed in the patients' pre- and post-intervention knowledge, behaviour and status scores.
   Conclusions The results showed that the Omaha System provided effective guidelines for diagnosing the problems, planning and implementing appropriate interventions for the COVID-19 patients. Therefore, it is recommended to use the Omaha System in nursing care of COVID-19 patients.
   Impact This is the first study to identify the nursing problems of COVID-19 patients and to evaluate the outcomes of nursing interventions and care using an international taxonomy along with electronic health record software. The findings of this study can provide evidence-based guidelines addressing the nursing problems, interventions and outcomes of COVID-19 patients.
C1 [Ardic, Aysun] Istanbul Univ Cerrahpasa, Florence Nightingale Fac Nursing, Istanbul, Turkey.
   [Turan, Ebru] Istanbul Haydarpasa Numune Training & Res Hosp, Istanbul, Turkey.
RP Ardic, A (corresponding author), Istanbul Univ Cerrahpasa, Florence Nightingale Fac Nursing, Abide I Hurriyet Caddesi, TR-34381 Sisli, Turkey.
EM aysund@istanbul.edu.tr
OI Ardic, Aysun/0000-0003-4146-2562
CR Ardic, 2016, OMAHA SYSTEM KNOWLED
   Aylaz R., 2010, NURS HLTH SCI, V13, P28
   do Nascimento IB, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040941
   CDC, 2020, CORONAVIRUS COVID 19
   Dietz W, 2020, OBESITY, V28, P1005, DOI 10.1002/oby.22818
   Erdogan S, 2006, NURS EDUC TODAY, V26, P396, DOI 10.1016/j.nedt.2005.11.009
   Esin, 2009, J DOKUZ EYLUL U FACU, V2, P39
   Filizc, 2008, J NURS RES DEV, V10, P1
   Kassir R, 2020, OBES REV, V21, DOI 10.1111/obr.13034
   Kato H, 2020, J INFECT CHEMOTHER, V26, P865, DOI 10.1016/j.jiac.2020.05.005
   Martin K.S., 2005, OMAHA SYSTEM KEY PRA
   Ministry of Health of Turkey, 2020, COVID 19 SARS COV 2
   Monsen KA, 2020, CIN-COMPUT INFORM NU, V38, P224, DOI 10.1097/CIN.0000000000000648
   Nuran, 2011, J DOKUZ EYLUL U FACU, V4, P25
   Ornek OK, 2019, CIN-COMPUT INFORM NU, V37, P482, DOI 10.1097/CIN.0000000000000529
   Samuels JD, 2020, OBESITY, V28, P1368, DOI 10.1002/oby.22866
   Savard, 2020, COVID 19 RESPONSE GU
   Turkish Nurses Association (TNA), 2020, COVID 19 NURSE TRAIN
   World Health Organization, 2020, WHO COR DIS COVID 19
NR 19
TC 0
Z9 0
U1 6
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-2402
EI 1365-2648
J9 J ADV NURS
JI J. Adv. Nurs.
PD JUN
PY 2021
VL 77
IS 6
BP 2709
EP 2717
DI 10.1111/jan.14793
EA FEB 2021
PG 9
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA SD0HN
UT WOS:000623044300001
PM 33644905
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Ding, M
   Dong, X
   Sun, YL
   Sokolowska, M
   Akdis, M
   van de Veen, W
   Azkur, AK
   Azkur, D
   Akdis, CA
   Gao, YD
AF Ding, Mei
   Dong, Xiang
   Sun, Yuan-li
   Sokolowska, Milena
   Akdis, Mubeccel
   van de Veen, Willem
   Azkur, Ahmet Kursat
   Azkur, Dilek
   Akdis, Cezmi A.
   Gao, Ya-dong
TI Recent advances and developments in COVID-19 in the context of allergic
   diseases
SO CLINICAL AND TRANSLATIONAL ALLERGY
LA English
DT Review
DE allergy; COVID-19; mechanism; treatment; vaccination
ID SERIOUS HYPERSENSITIVITY REACTIONS; IMMUNE-RESPONSES; INTERFERON;
   EXCIPIENTS; PNEUMONIA; VACCINES; OUTCOMES; CABBAGE; SAFETY; RISK
AB Background Since the first reports of coronavirus disease 2019 (COVID-19) in Wuhan, China, in December 2019, there have been 198 million confirmed cases worldwide as of August 2021. The scientific community has joined efforts to gain knowledge of the newly emerged virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the immunopathological mechanisms leading to COVID-19, and its significance for patients with allergies and asthma. Methods Based on the current literature, recent advances and developments in COVID-19 in the context of allergic diseases were reviewed. Results and Conclusions In this review, we discuss the prevalence of COVID-19 in subjects with asthma, attacks of hereditary angioedema, and other allergic diseases during COVID-19. Underlying mechanisms suggest a protective role of allergy in COVID-19, involving eosinophilia, SARS-CoV-2 receptors expression, interferon responses, and other immunological events, but further studies are needed to fully understand those associations. There has been significant progress in disease evaluation and management of COVID-19, and allergy care should continue during the COVID-19 pandemic. The European Academy of Allergy & Clinical Immunology (EAACI) launched a series of statements and position papers providing recommendations on the organization of the allergy clinic, handling of allergen immunotherapy, asthma, drug hypersensitivity, allergic rhinitis, and other allergic diseases. Treatment of allergies using biologics during the COVID-19 pandemic has also been discussed. Allergic reactions to the COVID-19 vaccines, including severe anaphylaxis, have been reported. Vaccination is a prophylactic strategy that can lead to a significant reduction in the mortality and morbidity associated with SARS-CoV-2 infection, and in this review, we discuss the proposed culprit components causing rare adverse reactions and recommendations to mitigate the risk of anaphylactic events during the administration of the vaccines.
C1 [Ding, Mei; Dong, Xiang; Sun, Yuan-li; Gao, Ya-dong] Wuhan Univ, Zhongnan Hosp, Dept Allergol, Donghu Rd 169, Wuhan 430071, Hubei, Peoples R China.
   [Ding, Mei; Dong, Xiang; Sun, Yuan-li; Gao, Ya-dong] Wuhan Univ, Hubei Prov Key Lab Allergy & Immunol, Wuhan, Peoples R China.
   [Sokolowska, Milena; Akdis, Mubeccel; van de Veen, Willem; Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Herman Burchard Str 9, Davos, Switzerland.
   [Sokolowska, Milena; Akdis, Cezmi A.] Christine Kuhne Ctr Allergy Res & Educ CK CARE, Davos, Switzerland.
   [Azkur, Ahmet Kursat] Kirikkale Univ, Fac Vet Med, Dept Virol, Kirikkale, Turkey.
   [Azkur, Dilek] Kirikkale Univ, Fac Med, Div Pediat Allergy & Immunol, Kirikkale, Turkey.
RP Gao, YD (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Allergol, Donghu Rd 169, Wuhan 430071, Hubei, Peoples R China.; Akdis, CA (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Herman Burchard Str 9, Davos, Switzerland.
EM akdisac@siaf.uzh.ch; gaoyadong@whu.edu.cn
OI AZKUR, DILEK/0000-0002-4396-9087; Yadong, GAO/0000-0003-1251-7608; Dong,
   Xiang/0000-0002-5241-4307; Sokolowska, Milena/0000-0001-9710-6685
CR Alberca RW, 2021, ALLERGY, V76, P963, DOI 10.1111/all.14601
   Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7
   Annesi-Maesano I, 2021, ALLERGY, V76, P2647, DOI 10.1111/all.14818
   [Anonymous], 2021, LANCET, V397, P71, DOI 10.1016/S0140-6736(20)32579-4
   Anto JM, 2021, ALLERGY, V76, P968, DOI 10.1111/all.14653
   Antonicelli L, 2021, ALLERGY, V76, P902, DOI 10.1111/all.14558
   Avdeev S, 2020, ALLERGY, V75, P2703, DOI 10.1111/all.14420
   Badiu I, 2012, ALLERGY, V67, P254, DOI 10.1136/bcr.02.2012.5797
   Bahl Prateek, 2020, J Infect Dis, DOI 10.1093/infdis/jiaa189
   Benenson S, 2021, NEW ENGL J MED, V384, P1775, DOI 10.1056/NEJMc2101951
   Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891
   Bhalla A, 2021, ALLERGY, V76, P957, DOI 10.1111/all.14534
   Bilo MB, 2021, ALLERGY, V76, P949, DOI 10.1111/all.14473
   Borgsteede SD, 2021, ALLERGY, V76, P1941, DOI 10.1111/all.14774
   Bousquet J, 2020, ALLERGY, V75, P2440, DOI 10.1111/all.14302
   Bousquet J, 2021, ALLERGY, V76, P2952, DOI 10.1111/all.14838
   Bousquet J, 2020, CLIN TRANSL ALLERGY, V10, DOI 10.1186/s13601-020-00362-7
   Bousquet J, 2021, ALLERGY, V76, P735, DOI 10.1111/all.14549
   Bousquet J, 2021, ALLERGY, V76, P689, DOI 10.1111/all.14471
   Bousquet J, 2020, CLIN TRANSL ALLERGY, V10, DOI 10.1186/s13601-020-00323-0
   Cabanillas B, 2021, ALLERGY, V76, P1943, DOI 10.1111/all.14761
   Cabanillas B, 2021, ALLERGY, V76, P1938, DOI 10.1111/all.14725
   Cabanillas Beatriz, 2021, Allergy, V76, P1617, DOI 10.1111/all.14711
   Carli G, 2020, ALLERGY, DOI 10.1111/all.14537
   Carli G, 2021, ALLERGY, V76, P866, DOI 10.1111/all.14426
   Centers for Disease Control (CDC), 1984, MMWR Morb Mortal Wkly Rep, V33, P185
   Chang C, 2021, ALLERGY, V76, P586, DOI 10.1111/all.14591
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Chhiba KD, 2020, J ALLERGY CLIN IMMUN, V146, P307, DOI 10.1016/j.jaci.2020.06.010
   Chiricozzi A, 2021, ALLERGY, V76, P1813, DOI 10.1111/all.14767
   Choi HG, 2021, ALLERGY, V76, P921, DOI 10.1111/all.14675
   Combes Alexis J, 2020, bioRxiv, DOI [10.1038/s41586-021-03234-7, 10.1101/2020.10.28.359935]
   Contoli M, 2015, ALLERGY, V70, P910, DOI 10.1111/all.12627
   Crespo-Lessmann A, 2021, ALLERGY, V76, P2407, DOI 10.1111/all.14697
   Damialis A, 2022, ALLERGY, V77, P331, DOI 10.1111/all.14966
   Damialis A, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2019034118, 10.17632/6f8y8d9cgw.1, 10.17632/6f8y8d9cgw.2]
   Dong X, 2020, ALLERGY, V75, P1699, DOI 10.1111/all.14289
   Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC
   Eggert LE, 2022, ALLERGY, V77, P173, DOI 10.1111/all.14972
   Eguiluz-Gracia I, 2021, ALLERGY, V76, P2776, DOI 10.1111/all.14831
   Karabacak DE, 2021, ALLERGY, V76, P2535, DOI 10.1111/all.14796
   Ferastraoaru D, 2021, J ALLER CL IMM-PRACT, V9, P1152, DOI 10.1016/j.jaip.2020.12.045
   Fidel PL, 2020, MBIO, V11, DOI 10.1128/mBio.00907-20
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Gelincik A, 2020, ALLERGY, V75, P2775, DOI 10.1111/all.14439
   Glickman JW, 2021, ALLERGY, V76, P925, DOI 10.1111/all.14708
   Gonzales-van Horn SR, 2015, J LEUKOCYTE BIOL, V98, P185, DOI 10.1189/jlb.3RU0315-099R
   Greening NJ, 2021, ALLERGY, V76, P915, DOI 10.1111/all.14596
   Guttman-Yassky E, 2019, J ALLERGY CLIN IMMUN, V143, P155, DOI 10.1016/j.jaci.2018.08.022
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   Heath PT, 2021, NEW ENGL J MED, V385, P1172, DOI 10.1056/NEJMoa2107659
   Heffler E, 2021, ALLERGY, V76, P961, DOI 10.1111/all.14593
   Heffler E, 2021, ALLERGY, V76, P887, DOI 10.1111/all.14532
   Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Hopkins C, 2020, LANCET, V396, P1630, DOI 10.1016/S0140-6736(20)32317-5
   Huang DB, 2004, J INFECTION, V49, P179, DOI 10.1016/j.jinf.2004.05.018
   Jackson DJ, 2020, J ALLERGY CLIN IMMUN, V146, P203, DOI 10.1016/j.jaci.2020.04.009
   Jacobsen EA, 2011, J IMMUNOL, V187, P6059, DOI 10.4049/jimmunol.1102299
   Jesenak M, 2020, ALLERGY, V75, P1819, DOI 10.1111/all.14353
   Johnston SL, 2020, ALLERGY, V75, P1543, DOI 10.1111/all.14348
   Keesara S, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005835
   Khawaja A., 2020, ASS COVID 19 HOSP AM, DOI [10.1101/2020.05.06.20092957v1., DOI 10.1101/2020.05.06.20092957, 10.1101/2020.05.06.20092957]
   Kim MH, 2021, J INFECT DIS, V224, P777, DOI 10.1093/infdis/jiab288
   Kim S, 2021, ALLERGY, V76, P918, DOI 10.1111/all.14609
   Kimura H, 2020, J ALLERGY CLIN IMMUN, V146, P80, DOI 10.1016/j.jaci.2020.05.004
   Klimek L, 2021, ALLERGY, V76, P3307, DOI 10.1111/all.14794
   Klimek L, 2021, ALLERGY, V76, P1624, DOI [10.1111/all.14726, 10.1007/s40629-021-00165-7]
   Klimek L, 2021, ALLERGY, V76, P677, DOI 10.1111/all.14629
   Klimek L, 2021, ALLERGY, V76, P868, DOI 10.1111/all.14467
   Klimek L, 2020, ALLERGY, V75, P1546, DOI 10.1111/all.14336
   Knoll MD, 2021, LANCET, V397, P72, DOI 10.1016/S0140-6736(20)32623-4
   Kocaturk E, 2021, ALLERGY, V76, P816, DOI 10.1111/all.14687
   Kow CS, 2021, ALLERGY, V76, P959, DOI 10.1111/all.14589
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Krantz MS, 2021, ALLERGY, V76, P1934, DOI 10.1111/all.14722
   Larsson SC, 2021, ALLERGY, V76, P1911, DOI 10.1111/all.14728
   Lebre MC, 2008, J ALLERGY CLIN IMMUN, V122, P969, DOI 10.1016/j.jaci.2008.08.028
   Leonardi A, 2020, ALLERGY, V75, P2399, DOI 10.1111/all.14361
   Leonardi A, 2019, ALLERGY, V74, P1611, DOI 10.1111/all.13786
   Li QL, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100375
   Lindsley AW, 2020, J ALLERGY CLIN IMMUN, V146, P1, DOI 10.1016/j.jaci.2020.04.021
   Lombardi C, 2020, ANN ALLERG ASTHMA IM, V125, P707, DOI 10.1016/j.anai.2020.07.029
   Lommatzsch M, 2020, ALLERGY, V75, P2705, DOI 10.1111/all.14456
   Lovinsky-Desir S, 2020, J ALLERGY CLIN IMMUN, V146, P1027, DOI 10.1016/j.jaci.2020.07.026
   MAGGI E, 1992, J IMMUNOL, V148, P2142
   Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061
   Marin C, 2021, ALLERGY, V76, P2904, DOI 10.1111/all.14904
   Martinez-Lourido E, 2021, ALLERGY, V76, P951, DOI 10.1111/all.14567
   Matito A, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0525-1
   Matucci A, 2021, ALLERGY, V76, P871, DOI 10.1111/all.14516
   McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P2555, DOI 10.1001/jama.2020.21231
   Morais-Almeida M, 2021, ALLERGY, V76, P953, DOI 10.1111/all.14482
   Novak N, 2021, ALLERGY, V76, P698, DOI 10.1111/all.14498
   Papadopoulos NG, 2021, ALLERGY, V76, P1765, DOI 10.1111/all.14787
   Pavel AB, 2021, ALLERGY, V76, P875, DOI 10.1111/all.14522
   Pawankar R, 2021, ALLERGY, V76, P2898, DOI 10.1111/all.14894
   Pfaar O, 2021, ALLERGY, V76, P1621, DOI 10.1111/all.14734
   Pfaar O, 2021, ALLERGY, V76, P3504, DOI 10.1111/all.14793
   Pfaar O, 2021, ALLERGY, V76, P622, DOI 10.1111/all.14472
   Pfaar O, 2021, ALLERGY, V76, P648, DOI 10.1111/all.14453
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Ozyigit LP, 2021, ALLERGY, V76, P2624, DOI 10.1111/all.14873
   Radzikowska U, 2020, ALLERGY, V75, P2829, DOI 10.1111/all.14429
   Rasmussen TH, 2021, CLIN TRANSL ALLERGY, V11, DOI 10.1002/clt2.12044
   Richardson PJ, 2020, LANCET INFECT DIS, V20, P1013, DOI 10.1016/S1473-3099(20)30270-X
   Riggioni C, 2020, ALLERGY, V75, P2503, DOI 10.1111/all.14449
   Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544
   Sajuthi SP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18781-2
   Samarasinghe AE, 2017, J IMMUNOL, V198, P3214, DOI 10.4049/jimmunol.1600787
   Sampath V, 2021, ALLERGY, V76, P1640, DOI 10.1111/all.14840
   Scala E, 2021, ALLERGY, V76, P899, DOI 10.1111/all.14551
   Schaffer DeRoo S, 2020, JAMA-J AM MED ASSOC, V323, P2458, DOI 10.1001/jama.2020.8711
   Shaker MS, 2020, J ALLER CL IMM-PRACT, V8, P1477, DOI 10.1016/j.jaip.2020.03.012
   Shi WD, 2020, ALLERGY, V75, P2405, DOI 10.1111/all.14434
   Shimabukuro T, 2021, JAMA-J AM MED ASSOC, V325, P780, DOI 10.1001/jama.2021.0600
   Shimabukuro TT, 2021, OBSTET GYNECOL SURV, V76, P729, DOI [10.1056/NEJMx210016, 10.1056/NEJMoa2104983, 10.1097/01.ogx.0000802676.57373.17]
   Shinkai K, 2020, JAMA-J AM MED ASSOC, V324, P1133, DOI 10.1001/jama.2020.15276
   Skevaki C, 2021, NAT REV IMMUNOL, V21, P202, DOI 10.1038/s41577-021-00516-z
   Skevaki C, 2020, J ALLERGY CLIN IMMUN, V146, P1295, DOI 10.1016/j.jaci.2020.09.017
   Skowronski DM, 2021, NEW ENGL J MED, V384, P1576, DOI 10.1056/NEJMc2036242
   Sokolowska M, 2021, ALLERGY, V76, P1629, DOI 10.1111/all.14739
   Sokolowska M, 2020, ALLERGY, V75, P2445, DOI 10.1111/all.14462
   Soriano JB, 2021, ALLERGY, V76, P966, DOI 10.1111/all.14654
   Thompson MG, 2021, NEW ENGL J MED, V385, P320, DOI 10.1056/NEJMoa2107058
   Vultaggio A, 2020, ALLERGY, V75, P2764, DOI 10.1111/all.14407
   Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906
   Wang H, 2021, ALLERGY, V76, P906, DOI 10.1111/all.14569
   Webster P, 2020, LANCET, V395, P1180, DOI 10.1016/S0140-6736(20)30818-7
   Weinstein SF, 2018, J ALLERGY CLIN IMMUN, V142, P171, DOI 10.1016/j.jaci.2017.11.051
   Whitcroft KL, 2020, JAMA-J AM MED ASSOC, V323, P2512, DOI 10.1001/jama.2020.8391
   Wu DD, 2020, J MICROBIOL IMMUNOL, V53, P368, DOI 10.1016/j.jmii.2020.03.005
   Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831
   Yang JM, 2020, J ALLERGY CLIN IMMUN, V146, P790, DOI 10.1016/j.jaci.2020.08.008
   Yegit OO, 2022, ALLERGY, V77, P197, DOI 10.1111/all.14876
   Zanoni G, 2017, CLIN EXP ALLERGY, V47, P593, DOI 10.1111/cea.12882
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhao L, 2021, ALLERGY, V76, P562, DOI 10.1111/all.14455
NR 138
TC 1
Z9 1
U1 10
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2045-7022
J9 CLIN TRANSL ALLERGY
JI Clin. Transl. Allergy
PD SEP
PY 2021
VL 11
IS 7
AR e12065
DI 10.1002/clt2.12065
PG 10
WC Allergy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Allergy
GA UX0AV
UT WOS:000700512800005
PM 34582102
OA gold, Green Published, Green Accepted
DA 2022-04-20
ER

PT J
AU Hrivnak, M
   Moritz, P
   Chrenekova, M
AF Hrivnak, Michal
   Moritz, Peter
   Chrenekova, Marcela
TI What Kept the Boat Afloat? Sustainability of Employment in
   Knowledge-Intensive Sectors Due to Government Measures during COVID-19
   Pandemic
SO SUSTAINABILITY
LA English
DT Article
DE SMEs; resilience; sustainable entrepreneurship; governmental support;
   COVID-19
ID BUSINESS; ENTREPRENEURSHIP; CRISIS; IMPACT
AB The COVID-19 pandemic has exposed new aspects of sustainable entrepreneurship and the resilience of SMEs in the conditions of individual countries. This empirical study contributes to entrepreneurship sustainability literature and business resilience literature by estimating the impact of various utilized internal crisis management tools and state compensation measures on retaining the pre-crisis levels of employment after two waves of the pandemic on the conditions of a V4 country. The study adopts an econometric approach towards assessing the influence of key factors of mitigating the problems caused by the pandemic, and the results suggest a crucial role of digitalization, internal policies optimizing variable costs, and utilization of direct governmental supportive measures to compensate for restrictions in force for employment retention in knowledge-intensive SMEs. According to the results, knowledge-intensive SMEs appears to have increased resilience towards economic shocks due to the capability to swiftly change the management of ventures to adapt to a crisis.
C1 [Hrivnak, Michal; Moritz, Peter; Chrenekova, Marcela] Slovak Univ Agr, Dept Reg & Rural Dev, Nitra 94976, Slovakia.
RP Hrivnak, M (corresponding author), Slovak Univ Agr, Dept Reg & Rural Dev, Nitra 94976, Slovakia.
EM michal.hrivnak@hotmail.com; xmoritz@uniag.sk;
   marcela.chrenekova@uniag.sk
RI Moritz, Peter/AAL-9738-2021; Hrivnák, Michal/T-1259-2017
OI Moritz, Peter/0000-0002-6110-4466; Hrivnak, Michal/0000-0003-2816-7825
CR Amankwah-Amoah J, 2021, EUR MANAG J, V39, P179, DOI 10.1016/j.emj.2020.09.002
   Anderton R., 2021, ECB EC B, V8
   Audretsch D.B., 2006, ENTREPRENEURSHIP EC, V1st ed., P227
   Bacq S, 2020, BUS HORIZONS, V63, P705, DOI 10.1016/j.bushor.2020.05.002
   Baker Scott R., 2020, NBER WORKING PAPER S
   Barfi R., 2021, EC FINANCE LETT, V8, P32, DOI [10.18488/journal.29.2021.81.32.43, DOI 10.18488/JOURNAL.29.2021.81.32.43]
   Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117
   Brodeur A, 2021, J ECON SURV, V35, P1007, DOI 10.1111/joes.12423
   Brown R, 2021, INT SMALL BUS J, V39, P319, DOI 10.1177/0266242621989326
   Caraccialo G., 2020, BANCA ITALIA LIT REV, V1, P1
   Cowling M, 2020, INT SMALL BUS J, V38, P593, DOI 10.1177/0266242620945102
   Dar M.S., 2017, PAK BUS REV, V19, P46
   Deliu D., 2020, J EMERG TRENDS MARK, V1, P93
   Dhewanto W., P 15 EUR C INN ENTR, P218, DOI [10.34190/EIE.20.236, DOI 10.34190/EIE.20.236]
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Erlingsson C, 2017, AFR J EMERG MED, V7, P93, DOI 10.1016/j.afjem.2017.08.001
   Fairlie R, 2020, J ECON MANAGE STRAT, V29, P727, DOI 10.1111/jems.12400
   Fischer BB, 2018, ENTREP REGION DEV, V30, P612, DOI 10.1080/08985626.2018.1438523
   Greene FJ, 2020, INT SMALL BUS J, V38, P583, DOI 10.1177/0266242620961912
   Gregurec I, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031098
   Guan DB, 2020, NAT HUM BEHAV, V4, P577, DOI 10.1038/s41562-020-0896-8
   Gupta M, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13329
   Hassan T.A., 2021, 26971 NBER
   Howell S. T., 2020, 27150 NBER
   Jenson HB, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102165
   Korsgaard S, 2020, INT SMALL BUS J, V38, P697, DOI 10.1177/0266242620963942
   Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214
   Kuckertz A., 2020, J BUS VENTURING INSI, DOI 10.1016/j.jbvi.2020.e00169
   Kuckertz A, 2021, INT SMALL BUS J, V39, P191, DOI 10.1177/0266242621997782
   Lamberth D.L., 1950, ASLIB PROC, VVolume 2, P131
   Le H., 2020, MANAGEMENT SCI LETT, V10, P3683
   Lim DSK, 2020, INT SMALL BUS J, V38, P492, DOI 10.1177/0266242620950159
   Linneberg MS, 2019, QUAL RES J, V19, P259, DOI 10.1108/QRJ-12-2018-0012
   Malerba F, 2020, SMALL BUS ECON, V54, P503, DOI 10.1007/s11187-018-0060-2
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Morgan T, 2020, INT SMALL BUS J, V38, P369, DOI 10.1177/0266242620936590
   Mura L., 2020, INT J ENTREP KNOWL, V8, P56, DOI [10.37335/ijek.v8i2.118, DOI 10.37335/IJEK.V8I2.118]
   Mura L., 2021, INSIGHTS REG DEV, V3, P252, DOI [10.9770/IRD.2021.3.2(6), DOI 10.9770/IRD.2021.3.2(6)]
   Mura L, 2021, ENTREP SUSTAIN ISS, V8, P487, DOI 10.9770/jesi.2021.8.3(31)
   Ndiaye N, 2018, BORSA ISTANB REV, V18, P269, DOI 10.1016/j.bir.2018.04.003
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   OECD, 2020, COR COVID 19 SME POL
   Pak A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00241
   Patzelt H, 2011, ENTREP THEORY PRACT, V35, P631, DOI 10.1111/j.1540-6520.2010.00386.x
   Persad, 2020, J ECON BUS, V3, P1165, DOI DOI 10.31014/AIOR.1992.03.03.272
   Pinto H, 2019, REG SCI POLICY PRACT, DOI 10.1111/rsp3.12243
   Ratten V, 2021, STRATEG CHANG, V30, P91, DOI 10.1002/jsc.2392
   Ratten V, 2021, J ENTREP EMERG ECON, V13, P747, DOI 10.1108/JEEE-06-2020-0163
   Razumovskaia E., 2020, J OPEN INNOVAT TECHN, V6, P1, DOI [DOI 10.3390/JOITMC6040160, 10.3390/joitmc6040160]
   Rodrigues M, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13115912
   Runyan R.C., 2006, J CONTING CRISIS MAN, V14, P12, DOI [DOI 10.1111/j.1468-5973.2006.00477.x, 10.1111/jccm.2006.14.issue-1]
   Santoro G, 2021, SMALL BUS ECON, V57, P455, DOI 10.1007/s11187-020-00319-x
   Shang YF, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.632043
   Sharma P, 2020, J BUS RES, V116, P188, DOI 10.1016/j.jbusres.2020.05.026
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Stankovic M., 2018, KNOWL INT J, V28, P1619, DOI [10.35120/kij28051619M, DOI 10.35120/KIJ28051619M]
   Thukral E, 2021, STRATEG CHANG, V30, P153, DOI 10.1002/jsc.2399
   Tsilika T., 2020, J SMALL BUSINESS ENT, P1
   Vasiljeva M., 2020, J OPEN INNOV-TECHNOL, V6, P92, DOI [10.3390/joitmc6030092, DOI 10.3390/JOITMC6030092]
NR 59
TC 0
Z9 0
U1 8
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD AUG
PY 2021
VL 13
IS 15
AR 8441
DI 10.3390/su13158441
PG 21
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA TW3BV
UT WOS:000682281000001
OA gold
DA 2022-04-20
ER

PT J
AU Yuan, T
   Liu, H
   Li, XD
   Liu, HR
AF Yuan, Ting
   Liu, Huan
   Li, Xiang Dong
   Liu, Hai Rong
TI Factors Affecting Infection Control Behaviors to Prevent COVID-19: An
   Online Survey of Nursing Students in Anhui, China in March and April
   2020
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Attitude; COVID-19; Knowledge; Students, Nursing
ID HEALTH
AB Background: The pandemic of coronavirus disease 2019 (COVID-19) has become a major public health challenge all over the world. People's knowledge, attitudes, and preventive behaviors about diseases affect the degree of adherence to control measures. This study aimed to survey the affecting factors of COVID-19 prevention behavior among nursing students in China.
   Material/Methods: Six-hundred thirteen nursing students in Anhui, China participated in an online survey from March 30 to April 5, 2020. The survey collected demographic information, electronic health (eHealth) literacy, COVID-19-related knowledge, attitudes, and prevention behavior data using descriptive analysis and multinomial logistic regression to analyze the data.
   Results: The mean age of study participants was 20.88 years, of which 31.8% were male (n=613). Television (84.9%) and WeChat (79.6%) were the major sources of their information. Nursing students had good knowledge (14.68 +/- 2.83), had positive attitudes (4.03 +/- 0.59), had good practices (3.92 +/- 0.65), and had basic eHealth literacy (30.45 +/- 6.90). Nursing students with higher eHealth literacy (odds ratio [OR]=0.89, P<0.01), good knowledge (OR=0.89, P<0.01), and positive attitudes (OR=0.24, P<0.01) took more preventive behaviors. Students living in the countryside (OR=0.09, P<0.01) and of a young age (OR=1.51, P<0.05) seldom took preventive actions. Men, compared with women, were less likely to take preventive measures. (OR=1.44, P<0.05).
   Conclusions: Good eHealth literacy, good knowledge, and a positive attitude were the most important variables that affected the prevention behavior against COVID-19. Targeted health education should be conducted for male students and students living in the countryside by providing reliable and effective online sources.
C1 [Yuan, Ting] Wannan Med Coll, Sch Nursing, Wuhu, Anhui, Peoples R China.
   [Liu, Huan] Wannan Med Coll, Dept Hemodialysis, Yijishan Hosp, Wuhu, Anhui, Peoples R China.
   [Li, Xiang Dong] Wannan Med Coll, Dept Gerontol, Yijishan Hosp, Wuhu, Anhui, Peoples R China.
   [Liu, Hai Rong] Wannan Med Coll, Sch Humanities & Management, Wuhu, Anhui, Peoples R China.
RP Liu, H (corresponding author), Wannan Med Coll, Dept Hemodialysis, Yijishan Hosp, Wuhu, Anhui, Peoples R China.; Liu, HR (corresponding author), Wannan Med Coll, Sch Humanities & Management, Wuhu, Anhui, Peoples R China.
EM wnyxyliuhuan@foxmail.com; lhr@wnmc.edu.cn
RI Taha, Samy/N-4620-2019
OI Taha, Samy/0000-0003-0284-7806
FU Anhui Provincial Department of Education College Outstanding Talent
   Cultivation Funding Project [gxgwfx2019032]; Humanities and Social
   Sciences Research Project of Colleges and Universities in Anhui Province
   [SK2018A0199]; Wannan Medical College Foundation for Teaching Research
   Project [2019jyxm20]
FX 1. Anhui Provincial Department of Education College Outstanding Talent
   Cultivation Funding Project (gxgwfx2019032); 2. Humanities and Social
   Sciences Research Project of Colleges and Universities in Anhui Province
   (SK2018A0199); 3. This study was supported by Wannan Medical College
   Foundation for Teaching Research Project (2019jyxm20)
CR Alahdal H, 2020, J INFECT PUBLIC HEAL, V13, P1446, DOI 10.1016/j.jiph.2020.06.015
   [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   [Anonymous], 2020, UPDATED GUIDANCE EVA
   Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457
   Cao YK, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-016-0561-x
   Cervera-Gasch A, 2020, NURS EDUC TODAY, V92, DOI 10.1016/j.nedt.2020.104473
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chang D, 2020, LANCET RESP MED, V8, pE13, DOI 10.1016/S2213-2600(20)30066-7
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Christopher DJ, 2020, LUNG INDIA, V37, P238, DOI 10.4103/lungindia.lungindia_189_20
   Guo SJ, 2014, CHIN J HLTH ED, V29, P106
   Gupta M, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13329
   Hamza MS, 2021, J COMMUN HEALTH, V46, P139, DOI 10.1007/s10900-020-00859-z
   Hayat K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103347
   He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   National Health Commission PRC, 2020, GUID DIAGN TREATM NO
   Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e9
   Ojulong J, 2013, Afr Health Sci, V13, P1071, DOI 10.4314/ahs.v13i4.30
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Saefi M, 2020, DATA BRIEF, V31, DOI 10.1016/j.dib.2020.105855
   Salman M, 2020, DRUGS THER PERSPECT, V36, P319, DOI 10.1007/s40267-020-00737-7
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Worldometer, COVID 19 COR PAND
NR 28
TC 11
Z9 11
U1 1
U2 21
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
EI 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD OCT 11
PY 2020
VL 26
AR e925877
DI 10.12659/MSM.925877
PG 10
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA NY8AR
UT WOS:000576605700001
PM 33040074
OA Green Published
DA 2022-04-20
ER

PT J
AU Shah, N
   Kalwar, MS
   Soomro, BA
AF Shah, Naimatullah
   Kalwar, Muhammad Shafique
   Soomro, Bahadur Ali
TI Early COVID-19 outbreak, individuals' mask attitudes and purchase
   intentions: a cohesive care
SO JOURNAL OF SCIENCE AND TECHNOLOGY POLICY MANAGEMENT
LA English
DT Article
DE Health consciousness; Attitudes towards the mask; Fear of complication
   of COVID-19; Knowledge about COVID-19; Mask purchase intention
ID AIDS-RELATED STIGMA; HEALTH CONSCIOUSNESS; CONSUMER ATTITUDES; ORGANIC
   FOODS; SOUTH; FEAR; BEHAVIOR; DETERMINANTS; TRANSMISSION; PERCEPTIONS
AB Purpose
   This study aims to explore individuals' attitudes and intentions towards mask purchase in Pakistan at an initial outbreak of COVID-19.
   Design/methodology/approach
   The study is quantitatively based on the cross-sectional data. The data are collected through a survey questionnaire. Convenience sampling strategy is used to target the individuals of Pakistan. At the first, 650 questionnaires were distributed. In return, the authors received 321 raw samples with the response rate of 53.5%. Finally, 316 useful samples are proceeded to infer the final results.
   Findings
   The structural equation model's results demonstrate a positive and significant effect of fear of complication of COVID-19, knowledge about COVID-19 and health consciousness on attitudes towards the mask. Further, attitudes towards mask are found to be the robust analyst of mask purchase intention.
   Research limitations/implications
   The study used cross-sectional data through a single source of data collection. The findings of the survey are on the sample size of 316.
   Practical implications
   The study would help policymakers to formulate the strategies to make aware individuals regarding their health and COVID-19 issues. The study would provide the guidelines to the government agents of Pakistan to combat with COVID-19 through the purchase of mask. The shopkeepers would be aware to observe the intentions and attitudes of consumers towards mask.
   Originality/value
   The outcomes of this study offer a shred of empirical evidence for attitudes and intentions regarding the purchase of mask, particularly for developing country settings.
C1 [Shah, Naimatullah] Al Yamamah Univ, Coll Business Adm, Riyadh, Saudi Arabia.
   [Shah, Naimatullah] Univ Sindh, Dept Publ Adm, Jamshoro, Pakistan.
   [Kalwar, Muhammad Shafique] Shah Abdul Latif Univ, Dept Publ Adm, Khairpur, Pakistan.
   [Soomro, Bahadur Ali] Fed Urdu Univ Arts Sci & Technol, Dept Econ, Karachi, Pakistan.
RP Soomro, BA (corresponding author), Fed Urdu Univ Arts Sci & Technol, Dept Econ, Karachi, Pakistan.
EM bahadur.ali@scholars.usindh.edu.pk
OI SHAH, NAIMATULLAH/0000-0001-8689-4436; Soomro, Bahadur
   Ali/0000-0001-7120-5423
CR Abdulsahib J.S., 2019, J SOCIAL SCI RES, V5, P1203
   Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Aertsens J, 2009, BRIT FOOD J, V111, P1140, DOI 10.1108/00070700910992961
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   ALBA JW, 1987, J CONSUM RES, V13, P411, DOI 10.1086/209080
   [Anonymous], 2020, ARAB NEWS PK    0226
   [Anonymous], 2020, PAKISTAN TODAY
   [Anonymous], 2020, VOANEWS
   Bartlam M. J., 1993, British Food Journal, V95, P3, DOI 10.1108/00070709310037841
   BECKER MH, 1977, J HEALTH SOC BEHAV, V18, P348, DOI 10.2307/2955344
   Bhatia V, 2018, J INDIAN BUS RES, V10, P193, DOI 10.1108/JIBR-10-2017-0177
   Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826
   Bowen P, 2016, ENG CONSTR ARCHIT MA, V23, P92, DOI 10.1108/ECAM-10-2014-0134
   Bryman A., 2007, BUSINESS RES METHODS, V2nd ed.
   Burns DJ, 2010, INT J RETAIL DISTRIB, V38, P45, DOI 10.1108/09590551011016322
   CDC, 2020, CDC GOV COVID 19
   Chandio J.A., 2013, RES J I BUSINESS ADM, V8, P72
   Chandon P, 2005, J MARKETING, V69, P1, DOI 10.1509/jmkg.69.2.1.60755
   Chen MF, 2007, FOOD QUAL PREFER, V18, P1008, DOI 10.1016/j.foodqual.2007.04.004
   Chen Y, 2019, COMMUN MATH STAT, V7, P1, DOI 10.1007/s40304-018-0132-2
   Chryssochoidis G., 2000, EUR J MARKETING, V34, P705, DOI 10.1108/03090560010321992.
   Cirrincione L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093603
   Dean M, 2008, J APPL SOC PSYCHOL, V38, P2088, DOI 10.1111/j.1559-1816.2008.00382.x
   Dhawan S., 2010, RES METHODOLOGY BUSI
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Fareed R., 2016, AM BASED RES J, V5, P68
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231
   Fung MSK, 2017, YOUNG CONSUM, V18, P1, DOI 10.1108/YC-07-2016-00620
   Gao C, 2017, IEEE T SYST MAN CY-S, V47, P171, DOI 10.1109/TSMC.2016.2608658
   Gefen D., 2000, COMMUN ASSOC INF SYS, V4, P7, DOI [DOI 10.17705/1CAIS.00407, 10.17705/1CAIS.00407]
   George D, 2003, USING SPSS WINDOWS S
   Ghauri P.N., 2005, RES METHODS BUSINESS
   GOULD SJ, 1988, J CONSUM AFF, V22, P96, DOI 10.1111/j.1745-6606.1988.tb00215.x
   Gracia A, 2007, SPAN J AGRIC RES, V5, P439, DOI 10.5424/sjar/2007054-5356
   GROSSMAN GM, 1988, Q J ECON, V103, P79, DOI 10.2307/1882643
   Gurbuz F.G., 2017, RES J MANAGEMENT MAR, V4, P343
   Hair J.F., 2021, PRIMER PARTIAL LEAST
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Hair J.F., 2019, BUS RES, V12, P115, DOI [DOI 10.1007/S40685-018-0072-4, 10.1007/s40685-018-0072-4]
   Hoque MZ, 2018, FOODS, V7, DOI 10.3390/foods7090150
   Huang, 2014, J INT MANAGEMENT STU, V9, P59
   Jayanti RK, 1998, J ACAD MARKET SCI, V26, P6, DOI 10.1177/0092070398261002
   Jensen B.B., 2000, HEALTH EDUC, V100, P146, DOI DOI 10.1108/09654280010330900
   Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x
   Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442
   Kalichman SC, 2004, AIDS CARE, V16, P572, DOI 10.1080/09540120410001716360
   Kline R., 1998, PRINCIPLES PRACTICE
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Magnusson M. K., 2001, British Food Journal, V103, P209, DOI 10.1108/00070700110386755
   Magnusson MK, 2003, APPETITE, V40, P109, DOI 10.1016/S0195-6663(03)00002-3
   Michaelidou N, 2008, INT J CONSUM STUD, V32, P163, DOI 10.1111/j.1470-6431.2007.00619.x
   Nunnally JC., 1994, PSYCHOMETRIC THEORY, P248, DOI DOI 10.1177/014662169501900308
   Overby J, 2004, ASIA PAC J MARKET LO, V16, P69, DOI DOI 10.1108/13555850410765131
   Padel S, 2005, BRIT FOOD J, V107, P606, DOI 10.1108/00070700510611002
   Patra S, 2016, HEALTH EDUC, V116, P395, DOI 10.1108/HE-06-2014-0069
   Phopalia A.K., 2010, MODERN RES METHODOLO
   Phuah K.T., 2011, INT C INNOVATION MAN, V14, P113
   Redmond EC, 2005, BRIT FOOD J, V107, P467, DOI 10.1108/00070700510606882
   Robinson P.B., 1991, ENTREP THEORY PRACT, V15, P13, DOI DOI 10.1177/104225879101500405
   Roddy G., 1996, Journal of International Consumer Marketing, V9, P41, DOI 10.1300/J046v09n02_03
   Royne MB, 2014, J CONSUM AFF, V48, P515, DOI 10.1111/joca.12051
   Shah N, 2017, EDUC TRAIN, V59, P841, DOI 10.1108/ET-11-2016-0168
   Shiu EYC, 2019, CURR OPIN INFECT DIS, V32, P372, DOI 10.1097/QCO.0000000000000563
   Soomro BA, 2015, J ENTERP INF MANAG, V28, P304, DOI 10.1108/JEIM-07-2014-0070
   Stobbelaar D. J., 2007, International Journal of Consumer Studies, V31, P349, DOI 10.1111/j.1470-6431.2006.00560.x
   Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1
   Tannenbaum MB, 2015, PSYCHOL BULL, V141, P1178, DOI 10.1037/a0039729
   Tarkiainen A, 2005, BRIT FOOD J, V107, P808, DOI 10.1108/00070700510629760
   Tavakol M, 2011, INT J MED EDUC, V2, P1, DOI 10.5116/ijme.4d27.32ff
   Taylor EP, 2005, DIABETES-METAB RES, V21, P264, DOI 10.1002/dmrr.524
   ThOgersen J., 2007, TRADITIONAL FOOD PRO
   Verbeke W., 2008, P 12 C EUR ASS AGR E
   WHO, 2020, NOVEL CORONAVIRUS CH
   WMHC, 2020, WUH MUN HLTH HLTH CO
   World Health Organization, 2020, 59 WHO
   World Health Organization, 2020, WHO2019NCOVIPCMASKS2
   Xiao Y, 2019, INT J ENGL LINGUIST, V9, P1, DOI 10.5539/ijel.v9n4p1
   Zanoli R., 2002, British Food Journal, V104, P643, DOI 10.1108/00070700210425930
   Zikmund W.G., 2010, BUSINESS RES METHODS
NR 80
TC 8
Z9 8
U1 3
U2 11
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2053-4620
EI 1758-5538
J9 J SCI TECHNOL POLICY
JI J. Sci. Technol. Policy Manag.
PD SEP 21
PY 2021
VL 12
IS 4
BP 571
EP 586
DI 10.1108/JSTPM-05-2020-0082
EA DEC 2020
PG 16
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA US5IA
UT WOS:000595882400001
OA Bronze
DA 2022-04-20
ER

PT J
AU Wegbom, AI
   Edet, CK
   Raimi, O
   Fagbamigbe, AF
   Kiri, VA
AF Wegbom, Anthony Ike
   Edet, Clement Kevin
   Raimi, Olatunde
   Fagbamigbe, Adeniyi Francis
   Kiri, Victor Alangibi
TI Self-Medication Practices and Associated Factors in the Prevention
   and/or Treatment of COVID-19 Virus: A Population-Based Survey in Nigeria
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE knowledge level; self-medication; COVID-19; determinants; Nigeria
ID ANTIBIOTICS; PREVALENCE; COMMUNITY; WORKERS
AB Background: The anxiety caused by the emergence of the novel coronavirus disease (COVID-19) globally has made many Nigerians resort to self-medication for purported protection against the disease, amid fear of contracting it from health workers and hospital environments. Therefore, this study aimed to estimate the knowledge level, causes, prevalence, and determinants of self-medication practices for the prevention and/or treatment of COVID-19 in Nigeria.
   Methods: A web-based cross-sectional survey was conducted between June and July 2020 among the Nigerian population, using a self-reported questionnaire. Statistical analysis of descriptive, bivariate, and multivariate analyses was done using STATA 15.
   Results: A total of 461 respondents participated in the survey. Almost all the respondents had sufficient knowledge about self-medication (96.7%). The overall prevalence of self-medication for the prevention and treatment of COVID-19 was 41%. The contributing factors were fear of stigmatization or discrimination (79.5%), fear of being quarantine (77.3%), and fear of infection or contact with a suspected person (76.3%). The proximal reasons for self-medication were emergency illness (49.1%), delays in receiving hospital services (28.1%), distance to the health facility (23%), and proximity of the pharmacy (21%). The most commonly used drugs for self-medication were vitamin C and multivitamin (51.8%) and antimalarials (24.9%). These drugs were bought mainly from pharmacies (73.9%). From the multivariable logistic regression model, males (OR: 0.79; 95% CI: 0.07-0.54), and sufficient knowledge on SM (OR: 0.64; 95% CI: 0.19-0.77) were significantly associated with self-medication.
   Conclusion: The key finding of this study was the use of different over-the-counter medications for the prevention (mainly vitamin C and multivitamins) and treatment (antibiotics/antimicrobial) of perceived COVID-19 infection by Nigerians with mainly tertiary education. This is despite their high knowledge and risk associated with self-medication. We suggest that medication outlets, media and community should be engaged to support the rational use of medication.
C1 [Wegbom, Anthony Ike; Edet, Clement Kevin] Rivers State Univ, Coll Med Sci, Dept Community Med, Port Harcourt, Nigeria.
   [Edet, Clement Kevin] Rivers State Primary Hlth Care Management Board, Dept Planning Res & Stat, Port Harcourt, Nigeria.
   [Raimi, Olatunde] Challenge Initiat TCI, Port Harcourt, Nigeria.
   [Fagbamigbe, Adeniyi Francis] Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Epidemiol & Med Stat, Ibadan, Nigeria.
   [Fagbamigbe, Adeniyi Francis] Univ St Andrews, Div Populat & Behav Sci, Sch Med, Hlth Data Sci Grp, St Andrews, Fife, Scotland.
   [Kiri, Victor Alangibi] Northumbria Univ, Dept Math Phys & Elect Engn, Newcastle Upon Tyne, Tyne & Wear, England.
   [Kiri, Victor Alangibi] Univ Port Harcourt, Fac Pharmaceut Sci, Dept Pharm, Port Harcourt, Nigeria.
RP Fagbamigbe, AF (corresponding author), Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Epidemiol & Med Stat, Ibadan, Nigeria.; Fagbamigbe, AF (corresponding author), Univ St Andrews, Div Populat & Behav Sci, Sch Med, Hlth Data Sci Grp, St Andrews, Fife, Scotland.
EM franstel74@yahoo.com
FU Rivers State Primary Health Care Management Board, Nigeria; College of
   Medicine, University of Ibadan, Nigeria; University of St Andrews,
   United Kingdom
FX We thank all those who participated in the study. We also appreciate,
   The Challenge Initiative (TCI), Port Harcourt Nigeria for their
   technical support. The authors acknowledged the support received from
   Rivers State Primary Health Care Management Board, Nigeria; College of
   Medicine, University of Ibadan, Nigeria and the University of St
   Andrews, United Kingdom.
CR Abebe Dilie, 2017, Journal of Public Health and Epidemiology, V9, P106, DOI 10.5897/JPHE2017.0926
   Adibe MO., 2009, INT J DRUG DEV RES, V1, P60
   Afolabi AO, 2008, ANN AFR MED, V7, P120, DOI 10.4103/1596-3519.55666
   Akor O., 2020, DAILY TRUST     0526
   Albawani SM, 2017, TROP J PHARM RES, V16, P1195, DOI 10.4314/tjpr.v16i5.30
   Ateshim Y, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7020-x
   Awad A, 2005, J PHARM PHARM SCI, V8, P326
   Ayanwale M. B., 2017, Journal of Medicine in the Tropics, V19, P65, DOI 10.4103/jomt.jomt_51_16
   Babatunde OA, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.312.8146
   Chu W., 2020, HOSP TURNS HIGH DOSE
   Esan DT, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/5439079
   Ezeoke UE., 2009, J COLL MED, V14, P188
   Quispe-Canari JF, 2021, SAUDI PHARM J, V29, P1, DOI 10.1016/j.jsps.2020.12.001
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gyawali S, 2015, J CLIN DIAGN RES, V9, pFC17, DOI 10.7860/JCDR/2015/16553.6988
   Horumpende PG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206623
   Jember E, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4195-2
   Khan H, 2014, TROP J PHARM RES, V13, P437, DOI 10.4314/tjpr.v13i3.19
   Makeen HA., 2019, SAUDI J HLTH SCI, V8, P54, DOI [10.4103/sjhs.sjhs_9_19, DOI 10.4103/SJHS.SJHS_9_19]
   Omolase C O, 2007, Ann Ib Postgrad Med, V5, P64
   Onchonga D, 2020, SAUDI PHARM J, V28, P1149, DOI 10.1016/j.jsps.2020.08.003
   Oreagba IA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-117
   Osemene KP, 2012, TROP J PHARM RES, V11, P683, DOI 10.4314/tjpr.v11i4.21
   Oshikoya KA, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-9
   Owings L., 2020, AFRICA NOT READY COV
   Sadio AJ, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10145-1
   Sridhar Sathvik B, 2018, Int J Appl Basic Med Res, V8, P3, DOI 10.4103/ijabmr.IJABMR_46_17
   World Health Organisation (WHO), 1998, ROL PHARM SELF CAR S
   World Health Organization, 2020, WHO SUPP SCI PROV TR
   World Health Organization Regional Office for Europe, WHO ANN COVID 19 OUT
   World Health Organization (WHO, 2019, 94 WHO
   Zahan T., 2020, INT J BASIC CLIN PHA, V9, P1325, DOI [DOI 10.18203/2319-2003.IJBCP20203522, 10.18203/2319-2003.ijbcp20203522]
   Zardosht M., 2016, GLOB J HLTH SCI, V8, P150, DOI [10.5539/gjhs.v8n11p150, DOI 10.5539/GJHS.V8N11P150]
NR 33
TC 5
Z9 5
U1 4
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD JUN 4
PY 2021
VL 9
AR 606801
DI 10.3389/fpubh.2021.606801
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA SU1TH
UT WOS:000662923800001
PM 34150693
OA Green Accepted, Green Submitted, Green Published, gold
DA 2022-04-20
ER

PT J
AU Rahman, MS
   Hossain, MA
   Chowdhury, AH
   Hoque, MT
AF Rahman, Muhammad Sabbir
   Hossain, Md Afnan
   Chowdhury, Abdul Hannan
   Hoque, Mohammad Tayeenul
TI Role of enterprise information system management in enhancing firms
   competitive performance towards achieving SDGs during and after COVID-19
   pandemic
SO JOURNAL OF ENTERPRISE INFORMATION MANAGEMENT
LA English
DT Article
DE Information system management capability; Multi-sensory technology
   stimulus capability; Competitive performance; Service and manufacturing
   firms; SDGS; COVID-19 pandemic SEM
ID BIG DATA ANALYTICS; SUSTAINABLE DEVELOPMENT GOALS; DYNAMIC CAPABILITIES;
   SUPPLY CHAIN; BUSINESS-PROCESS; ARTIFICIAL-INTELLIGENCE; VALUE CREATION;
   IMPACT; TECHNOLOGY; RESOURCES
AB Purpose This study aims to investigate the impact of firms' information system management capabilities on competitive performance for achieving sustainable development goals (SDGs). It also examines the moderating effects of multi-sensory stimuli capability on firms' competitive performance. Design/methodology/approach Drawing upon the resource base and dynamic capability view as the overarching theoretical framework, this research conducted an empirical study among manufacturing and services enterprise employees. This study applied multiple cross-sectional surveys for data collection. A total of 241 usable data were obtained and explained through structural equation modelling (SEM). Findings The statistical results explore that variables under their respective direct relationship are positively and significantly influence. Interestingly, firms information system management capability has a relatively large magnitude of positive and direct effects on the competitive performance of firms' that complement on achieving firms SDGs and coping with the COVID-19 pandemic. In addition, the multisensory stimulus capability of service firms positively moderates (amplifies) the relationship between marketing information system management capability and competitive performance. Practical implications The proposed research model provides insights into the utilisation of firms information system management capability to achieve competitive performance in their relevant industry. In addition, it deepens the understanding of the contingency effect of using multisensory stimulus capability of firms on competitive performance. Originality/value To the best of the authors' knowledge, drawing on the resource-based theory and dynamic capability theory, this study is the first to assess and examine the influence of firms information system management capability on the competitive performance of firms by considering the moderating variables (i.e. multisensory stimulus capability) in context to COVID-19 pandemic by considering the scope of SDGs.
C1 [Rahman, Muhammad Sabbir; Hossain, Md Afnan; Hoque, Mohammad Tayeenul] North South Univ, Dept Mkt & Int Business, Dhaka, Bangladesh.
   [Hossain, Md Afnan] Univ Wollongong, Sch Management Operat & Mkt, Wollongong, NSW, Australia.
   [Chowdhury, Abdul Hannan] North South Univ, Dept Management, Dhaka, Bangladesh.
RP Rahman, MS (corresponding author), North South Univ, Dept Mkt & Int Business, Dhaka, Bangladesh.
EM sabbiriiu@gmail.com
RI Hossain, Afnan/M-6626-2017; Rahman, Muhammad/G-3968-2018
OI Hossain, Afnan/0000-0003-2954-1823; Rahman, Muhammad/0000-0003-1613-7944
FU North South University (NSU)
FX The authors acknowledge North South University (NSU) for awarding a
   research grant to conduct this research.
CR Agbozo, 2018, J INFORM SYSTEMS OPE, V12, P70
   Aiken L. S., 1991, MULTIPLE REGRESSION
   Akter S, 2016, INT J PROD ECON, V182, P113, DOI 10.1016/j.ijpe.2016.08.018
   ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411
   Antoni Darius, 2020, International Journal of Agile Systems and Management, V13, P159
   Archimi CS, 2018, J BUS ETHICS, V151, P907, DOI 10.1007/s10551-018-3882-6
   ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783
   AVLONITIS GJ, 1999, EUR J MARKETING, V33, P1003, DOI DOI 10.1108/03090569910285896
   Aydiner AS, 2019, INT J INFORM MANAGE, V47, P168, DOI 10.1016/j.ijinfomgt.2018.12.015
   BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108
   Barreto I, 2010, J MANAGE, V36, P256, DOI 10.1177/0149206309350776
   Bendoly E, 2012, PROD OPER MANAG, V21, P653, DOI 10.1111/j.1937-5956.2011.01299.x
   Bhardwaj RK, 2019, DESIDOC J LIB INF TE, V39, P131, DOI 10.14429/djlit.39.2.13860
   Bienhaus F, 2018, BUS PROCESS MANAG J, V24, P965, DOI 10.1108/BPMJ-06-2017-0139
   Bilgihan A, 2015, INFORM MANAGE-AMSTER, V52, P668, DOI 10.1016/j.im.2015.05.005
   Blunch, 2012, INTRO STRUCTURAL EQU
   Bowman C, 2003, BRIT J MANAGE, V14, P289, DOI 10.1111/j.1467-8551.2003.00380.x
   Brasel SA, 2015, CYBERPSYCH BEH SOC N, V18, P534, DOI 10.1089/cyber.2014.0546
   Browne M.W., 1993, SOCIOL METHOD RES, V154, P136, DOI 10.1177/0049124192021002005
   Brush CG, 1999, J BUS VENTURING, V14, P233, DOI 10.1016/S0883-9026(97)00103-1
   Butt AS, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-11-2020-0455
   Byrne BM, 2001, INT J TEST, V1, P55, DOI [DOI 10.1207/S15327574IJT0101_4, 10.1207/S15327574IJT0101_4]
   CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016
   Chen JS, 2012, J ENG TECHNOL MANAGE, V29, P71, DOI [10.1016/j.jengtecman.2011.09.007, 10.3969/j.issn.1002-0268.2012.08.013]
   Chen YC, 2011, INFORM MANAGE-AMSTER, V48, P145, DOI 10.1016/j.im.2011.04.001
   Chikurova A.A, 2020, RES TECHN PAND COR I, P331
   Citrin AV, 2003, J BUS RES, V56, P915, DOI 10.1016/S0148-2963(01)00278-8
   Claro PBD, 2021, MARK INTELL PLAN, V39, P613, DOI 10.1108/MIP-08-2020-0365
   Constantiou ID, 2015, J INF TECHNOL-UK, V30, P44, DOI 10.1057/jit.2014.17
   COX DF, 1967, HARVARD BUS REV, V45, P145
   Crick JM, 2020, IND MARKET MANAG, V88, P206, DOI 10.1016/j.indmarman.2020.05.016
   Crick JM, 2019, J BUS IND MARK, V34, P518, DOI 10.1108/JBIM-03-2018-0102
   DAVENPORT TH, 1990, SLOAN MANAGE REV, V31, P11
   Di Vaio A, 2020, J BUS RES, V121, P283, DOI 10.1016/j.jbusres.2020.08.019
   Dirgantari P.D., 2020, INDONES J SCI TECHNO, V5, P261, DOI [10.17509/ijost.v5i2.24617, DOI 10.17509/IJOST.V5I2.24617]
   Dubey R, 2021, INT J PROD RES, V59, P110, DOI 10.1080/00207543.2019.1582820
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   Erevelles S, 2016, J BUS RES, V69, P897, DOI 10.1016/j.jbusres.2015.07.001
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fui-Hoon Nah Fiona, 2020, HCI International 2020 - Late Breaking Papers. Interaction, Knowledge and Social Media. 22nd HCI International Conference, HCII 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12427), P585, DOI 10.1007/978-3-030-60152-2_43
   Gallace A., 2012, MULTIPLE SENSORIAL M, P1, DOI DOI 10.4018/978-1-60960-821-7.CH001
   Gallego-Gomez C, 2021, J GLOB INF MANAG, V29, P103, DOI 10.4018/JGIM.2021010106
   Germann F, 2013, INT J RES MARK, V30, P114, DOI 10.1016/j.ijresmar.2012.10.001
   Goh KY, 2013, INFORM SYST RES, V24, P88, DOI 10.1287/isre.1120.0469
   Gounaris SP, 2007, MARK INTELL PLAN, V25, P612, DOI 10.1108/02634500710819978
   Gunasekaran A, 2017, J BUS RES, V70, P308, DOI 10.1016/j.jbusres.2016.08.004
   Guo H, 2020, FRONT BUS RES CHINA, V14, DOI 10.1186/s11782-020-00087-1
   Gupta M, 2016, INFORM MANAGE-AMSTER, V53, P1049, DOI 10.1016/j.im.2016.07.004
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Hair J.F., 2017, INT J MULTIVAR DATA, V1, P107, DOI DOI 10.1504/IJMDA.2017.10008574
   Handfield RB, 2020, INT J OPER PROD MAN, V40, P1649, DOI 10.1108/IJOPM-03-2020-0171
   Haq I.U., 2020, VILAKSHAN XIMB J MAN, V17, P39
   Holzwarth M, 2006, J MARKETING, V70, P19, DOI 10.1509/jmkg.70.4.19
   Hossain MA, 2021, J BUS RES, V131, P287, DOI 10.1016/j.jbusres.2021.03.063
   Ivanov Dmitry, 2020, International Journal of Integrated Supply Management, V13, P90
   Ivanov D, 2020, INT J PROD RES, V58, P3252, DOI 10.1080/00207543.2019.1634850
   Jaim J, 2021, GENDER WORK ORGAN, V28, P209, DOI 10.1111/gwao.12546
   Karimi J, 2001, J MANAGE INFORM SYST, V17, P125, DOI 10.1080/07421222.2001.11045661
   Kim G, 2012, J MANAGE INFORM SYST, V29, P327, DOI 10.2753/MIS0742-1222290310
   Kim RJ, 2021, INT J FOOD SCI NUTR, V72, P537, DOI [10.1109/EMR.2020.2990115, 10.1080/09637486.2020.1840533]
   Kozlenkova IV, 2014, J ACAD MARKET SCI, V42, P1, DOI 10.1007/s11747-013-0336-7
   Krishna A, 2017, J RETAILING, V93, P43, DOI 10.1016/j.jretai.2016.12.002
   Krishna A, 2016, CURR OPIN PSYCHOL, V10, P142, DOI 10.1016/j.copsyc.2016.01.007
   Krishna A, 2014, J CONSUM PSYCHOL, V24, P159, DOI 10.1016/j.jcps.2013.12.006
   Krishna A, 2011, J CONSUM PSYCHOL, V21, P338, DOI 10.1016/j.jcps.2011.02.001
   Krishna A, 2010, J CONSUM RES, V37, P57, DOI 10.1086/649909
   Kristensson P, 2019, J SERV MARK, V33, P502, DOI 10.1108/JSM-01-2019-0031
   Kristinae V., 2020, UNCERTAIN SUPPLY CHA, V8, P675
   Kuznetsova A.M, 2020, INT SCI PRACT C, P288
   Lee S, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010346
   Lemon KN, 2016, J MARKETING, V80, P69, DOI 10.1509/jm.15.0420
   Li L, 2020, IND MANAGE DATA SYST, V120, P1265, DOI 10.1108/IMDS-08-2019-0421
   Li XW, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau6210
   Lima MGB, 2017, INT ENVIRON AGREEM-P, V17, P589, DOI 10.1007/s10784-017-9366-9
   Liou RS, 2021, J INT BUS POLICY, V4, P136, DOI 10.1057/s42214-020-00080-8
   Malhotra NK, 2006, MANAGE SCI, V52, P1865, DOI 10.1287/mnsc.1060.0597
   Manavalan E, 2019, COMPUT IND ENG, V127, P925, DOI 10.1016/j.cie.2018.11.030
   MANSOR NHA, 2016, PROCEDIA EC FINANCE, V35, P2
   Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2
   Mattila AS, 2001, J RETAILING, V77, P273, DOI 10.1016/S0022-4359(01)00042-2
   McDonald H., 2003, MARK INTELL PLAN, V21, P85, DOI [DOI 10.1108/02634500310465399, https://doi.org/10.1108/02634500310465399]
   Mikalef P, 2018, INF SYST E-BUS MANAG, V16, P547, DOI 10.1007/s10257-017-0362-y
   Mikalef P, 2017, J BUS RES, V70, P1, DOI 10.1016/j.jbusres.2016.09.004
   Mithas S, 2011, MIS QUART, V35, P237
   Modgil S, 2020, PROD PLAN CONTROL, V31, P967, DOI 10.1080/09537287.2019.1695916
   Morrison M, 2011, J BUS RES, V64, P558, DOI 10.1016/j.jbusres.2010.06.006
   Nandi S, 2021, IND MANAGE DATA SYST, V121, P333, DOI 10.1108/IMDS-09-2020-0560
   Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1
   Novitasari D., 2020, SOLID STATE TECHNOL, V63, P2927
   Pan SL, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102196
   Papies E.K., 2015, PSYCHOL DESIRE, P36
   Parra CM, 2021, INT J INFORM MANAGE, V57, DOI 10.1016/j.ijinfomgt.2020.102271
   Patel JF., 2014, BRAZILIAN J MARKETIN, V13
   Pateli A., 2016, P 24 EUR C INF SYST, P39
   Peng J, 2016, INT J INFORM MANAGE, V36, P89, DOI 10.1016/j.ijinfomgt.2015.09.006
   Peterson RA, 1997, J ACAD MARKET SCI, V25, P329, DOI 10.1177/0092070397254005
   Petit O, 2019, J INTERACT MARK, V45, P42, DOI 10.1016/j.intmar.2018.07.004
   Petit O, 2016, PSYCHOL MARKET, V33, P608, DOI 10.1002/mar.20903
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Pratono AH, 2016, BUS PROCESS MANAG J, V22, P368, DOI 10.1108/BPMJ-05-2015-0066
   Preacher K.J., 2007, MODELING CONTEXTUAL, P207
   Priyono A., 2020, J OPEN INNOV TECHNOL, V6, P1
   Pullman ME, 2004, DECISION SCI, V35, P551, DOI 10.1111/j.0011-7315.2004.02611.x
   Rahi S., 2017, INT J EC MANAGEMENT, V6, P1, DOI DOI 10.4172/2162-6359.1000403
   Rahman MS, 2022, J ENTERP INF MANAG, V35, P455, DOI 10.1108/JEIM-05-2020-0185
   Rahman MS, 2020, J SERV THEOR PRACT, V30, P681, DOI 10.1108/JSTP-04-2020-0077
   Rahman MS, 2018, MARK INTELL PLAN, V36, P349, DOI 10.1108/MIP-08-2017-0155
   Raman S, 2020, J HUMANITIES SOCIAL, V2, P159
   Ravichandran T, 2005, J MANAGE INFORM SYST, V21, P237, DOI 10.1080/07421222.2005.11045820
   Roberts N, 2012, J MANAGE INFORM SYST, V28, P231, DOI 10.2753/MIS0742-1222280409
   Rodrigues C., 2018, DRIVING CUSTOMER APP, P1
   Rodrigues J, 2021, INFORM MANAGE-AMSTER, V58, DOI 10.1016/j.im.2020.103289
   Rose S, 2012, J RETAILING, V88, P308, DOI 10.1016/j.jretai.2012.03.001
   Ryan SD, 2002, J MANAGE INFORM SYST, V19, P85, DOI 10.1080/07421222.2002.11045725
   Rybnytska O, 2018, J DECIS SYST, V27, P68, DOI 10.1080/12460125.2018.1464312
   Safee S., 2014, ADV NATURAL APPL SCI, V8, P108
   Sanchez-Gutierrez J, 2019, J BUS IND MARK, V34, P618, DOI 10.1108/JBIM-03-2017-0081
   Seetharaman P, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102173
   Sharifi, 2012, IRANIAN BUSINESS MAN, V4, P1
   Sima, 2020, P MAN SYST, V15, P65
   Siomkos, 2008, J TARGETING MEASUREM, V16, P285
   Soto-Acosta P, 2020, INFORM SYST MANAGE, V37, P260, DOI 10.1080/10580530.2020.1814461
   SPECTOR PE, 1994, J ORGAN BEHAV, V15, P385, DOI 10.1002/job.4030150503
   Spence, 2002, ICI REP SECR SENS
   Spence C, 2011, PSYCHOL MARKET, V28, P267, DOI 10.1002/mar.20392
   Spiekermann S, 2015, ELECTRON MARK, V25, P161, DOI 10.1007/s12525-015-0191-0
   Suki NM, 2007, INT J BUS SOC, V8, P81
   Sullivan K, 2018, J CLEAN PROD, V174, P237, DOI 10.1016/j.jclepro.2017.10.201
   Syam N, 2018, IND MARKET MANAG, V69, P135, DOI 10.1016/j.indmarman.2017.12.019
   Tan L, 2017, J SERV THEOR PRACT, V27, P569, DOI 10.1108/JSTP-04-2016-0062
   Tanriverdi H, 2005, MIS QUART, V29, P311
   Teece DJ, 2014, J INT BUS STUD, V45, P8, DOI 10.1057/jibs.2013.54
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Tian J., 2021, TECHNOVATION, P102222, DOI 10.1016/j.technovation.2021.102222
   Tippins MJ, 2003, STRATEGIC MANAGE J, V24, P745, DOI 10.1002/smj.337
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   VanBruggen G., 2001, EUR J MARKETING, V35, P796, DOI [https://doi.org/10.1108/EUM0000000005726, DOI 10.1108/EUM0000000005726]
   Virmani N, 2021, BENCHMARKING, V28, P857, DOI 10.1108/BIJ-08-2020-0413
   Von Krogh G, 2020, MIT SLOAN MANAGE REV, V61, P8
   Vorhies DW, 2011, J ACAD MARKET SCI, V39, P736, DOI 10.1007/s11747-010-0228-z
   Wade M, 2004, MIS QUART, V28, P107
   Wamba SF, 2017, J BUS RES, V70, P356, DOI 10.1016/j.jbusres.2016.08.009
   Wang YG, 2020, J BUS RES, V116, P214, DOI 10.1016/j.jbusres.2020.05.029
   Wedel M, 2016, J MARKETING, V80, P97, DOI 10.1509/jm.15.0413
   Wilden R, 2015, J ACAD MARKET SCI, V43, P181, DOI 10.1007/s11747-014-0380-y
   Wong SI, 2018, J MANAGE, V44, P757, DOI 10.1177/0149206315574597
   Wu LY, 2006, INFORM MANAGE-AMSTER, V43, P447, DOI 10.1016/j.im.2005.11.001
   Wu LY, 2010, J BUS RES, V63, P27, DOI 10.1016/j.jbusres.2009.01.007
   Yasmin M, 2020, J BUS RES, V114, P1, DOI 10.1016/j.jbusres.2020.03.028
   Yeniyurt S, 2019, IND MARKET MANAG, V79, P46, DOI 10.1016/j.indmarman.2019.03.008
   Zahay D, 2004, DECISION SCI, V35, P169, DOI 10.1111/j.00117315.2004.02338.x
NR 151
TC 0
Z9 0
U1 15
U2 15
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1741-0398
EI 1758-7409
J9 J ENTERP INF MANAG
JI J. Enterp. Inf. Manag.
PD FEB 18
PY 2022
VL 35
IS 1
SI SI
BP 214
EP 236
DI 10.1108/JEIM-04-2021-0163
EA OCT 2021
PG 23
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science; Management
WE Social Science Citation Index (SSCI)
SC Computer Science; Information Science & Library Science; Business &
   Economics
GA ZH2CP
UT WOS:000705303900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Sharma, GVSS
   Prasad, CLVRS
   Rambabu, V
AF Sharma, Gummaluri Venkata Surya Subrahmanya
   Prasad, Chilamkurti Lakshmi Venkata Ranga S.
   Rambabu, Velamala
TI Online machine drawing pedagogy-A knowledge management perspective
   through maker education in the COVID-19 pandemic era
SO KNOWLEDGE AND PROCESS MANAGEMENT
LA English
DT Article; Early Access
AB Drawing is a visual mode of communication. Teaching drawing requires one-to-one personal interaction among the tutor and the learner. The technical drawing is no exception, and it requires a considerable amount of imagination skills. On-line mode of pedagogy shall be occupying a substantial portion of the mode of delivery in teaching arid learning during, as well as, after the coronavirus disease 2019 (COVID-19) pandemic era. This work focuses on the training and knowledge sharing of machine drawing skills through online mode, which is the requirement of the present era. A knowledge management perspective for machine drawing pedagogy is involved in this work. Challenges in the online pedagogy of machine drawing are deliberated through Ishikawa diagram and service Failure Modes and Effects Analysis. A maker education perspective of online machine drawing pedagogy is delineated. An approach toward knowledge workforce, knowledge transfer, and tacit knowledge is adopted for online teaching of machine drawing. Finally, conclusions are drawn in context of online pedagogy for a spatial visualization-based course like machine drawing.
C1 [Sharma, Gummaluri Venkata Surya Subrahmanya; Prasad, Chilamkurti Lakshmi Venkata Ranga S.; Rambabu, Velamala] GMR Inst Technol, Mech Engn Dept, Rajam, India.
RP Sharma, GVSS (corresponding author), GMR Inst Technol, Srikakulam 532127, Andhra Pradesh, India.
EM sharma.gvss@gmrit.edu.in
RI SHARMA, GVSS/L-5373-2017
OI SHARMA, GVSS/0000-0002-8263-5522
CR Anderson C., 2012, MAKERS NEW IND REVOL
   Bao W, 2020, HUM BEHAV EMERG TECH, V2, P113, DOI 10.1002/hbe2.191
   Bevan B, 2017, STUD SCI EDUC, V53, P75, DOI 10.1080/03057267.2016.1275380
   Bratianu C., 2014, MANAGEMENT DYNAMICS, V2, P41
   Bratianu C, 2021, KNOWL PROCESS MANAG, V28, P11, DOI 10.1002/kpm.1656
   Bratianu C, 2020, KYBERNETES, V49, P6, DOI 10.1108/K-02-2019-0122
   Bratianu C, 2015, PROC CONF EUR MANAG, P28
   Budge K, 2016, ARTS HUM HIGH EDUC, V15, P432, DOI 10.1177/1474022215592247
   Bullock S.M., 2015, J CANADIAN ASS CURRI, V13, P60
   Cegarra-Navarro J.-G., 2020, INT J EC MANAGE ENG, V14, P1185
   Cegarra-Navarro JG, 2012, J EDUC COMPUT RES, V46, P85, DOI 10.2190/EC.46.1.d
   Cegarra-Sanchez J, 2017, VINE J INF KNOWL MAN, V47, P506, DOI 10.1108/VJIKMS-12-2016-0070
   Chang C.-L., 2020, J PHYS C SERIES, V1547, P1
   Chen KC, 2010, COMPUT HUM BEHAV, V26, P741, DOI 10.1016/j.chb.2010.01.011
   Cipolla C, 2019, WOMEN STUD, V48, P261, DOI 10.1080/00497878.2019.1593842
   Velazquez FD, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072706
   Dhawan Shivangi, 2020, Journal of Educational Technology Systems, V49, P5, DOI 10.1177/0047239520934018
   Drucker PF, 1999, CALIF MANAGE REV, V41, P79, DOI 10.2307/41165987
   Fenwick T, 2007, J ORGAN CHANGE MANAG, V20, P509, DOI 10.1108/09534810710760054
   Gratz E, 2020, INT J ONLINE PEDAGOG, V10, P1, DOI 10.4018/IJOPCD.2020010101
   Halverson ER, 2014, HARVARD EDUC REV, V84, P495, DOI 10.17763/haer.84.4.34j1g68140382063
   Harlow Harold, 2008, Journal of Knowledge Management, V12, P148, DOI 10.1108/13673270810852458
   Ikeda EK, 2021, KNOWL PROCESS MANAG, V28, P181, DOI 10.1002/kpm.1658
   Keebler DW, 2020, INT J ONLINE PEDAGOG, V10, P61, DOI 10.4018/IJOPCD.2020040105
   Kim JY, 2020, EDUC SCI, V10, DOI 10.3390/educsci10050126
   Koole, 2020, POSTDIGITAL SCI EDUC, V2, P923, DOI [10.1007/s42438-020-00155-y, DOI 10.1007/S42438-020-00155-Y]
   Latilla VM, 2018, J KNOWL MANAG, V22, P1310, DOI 10.1108/JKM-08-2017-0367
   Leong P, 2011, DISTANCE EDUC, V32, P5, DOI 10.1080/01587919.2011.565495
   Liao C., 2016, ART EDUC, V69, P44
   Lyon P, 2018, INT J ART DES EDUC, V37, P221, DOI 10.1111/jade.12106
   Mayo N., 2012, J VISUAL ART PRACTIC, V11, P75
   Miller R., 2008, JRC SCI TECHNICAL RE
   Nakash M, 2021, KNOWL PROCESS MANAG, V28, P29, DOI 10.1002/kpm.1655
   Odhiambo C., 2020, COLL TEACH, V68, P138
   Pando Cerra P, 2020, INTERACT LEARN ENVIR, V28, P81, DOI 10.1080/10494820.2018.1517095
   Perez-Nordtvedt L, 2008, J MANAGE STUD, V45, P714, DOI 10.1111/j.1467-6486.2008.00767.x
   Sharma G. V. S. S., 2020, Journal of Engineering Education Transformations, V34, P28, DOI 10.16920/jeet/2020/v34i1/148359
   Stefanini A, 2020, KNOWL PROCESS MANAG, V27, P294, DOI 10.1002/kpm.1649
   Todd C.L., 2021, RES ANTHOLOGY DEV CR, P837
   Van Looy A, 2021, KNOWL PROCESS MANAG, V28, P107, DOI 10.1002/kpm.1659
   Wang VCX, 2017, INT J ONLINE PEDAGOG, V7, P48, DOI 10.4018/IJOPCD.2017040104
   Zhang WN, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13030055
NR 42
TC 0
Z9 0
U1 3
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1092-4604
EI 1099-1441
J9 KNOWL PROCESS MANAG
JI Knowl. Process Manag.
DI 10.1002/kpm.1684
EA AUG 2021
PG 11
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA UE1JE
UT WOS:000687651700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Arcadi, P
   Simonetti, V
   Ambrosca, R
   Cicolini, G
   Simeone, S
   Pucciarelli, G
   Alvaro, R
   Vellone, E
   Durante, A
AF Arcadi, Paola
   Simonetti, Valentina
   Ambrosca, Rossella
   Cicolini, Giancarlo
   Simeone, Silvio
   Pucciarelli, Gianluca
   Alvaro, Rosaria
   Vellone, Ercole
   Durante, Angela
TI Nursing during the COVID-19 outbreak: A phenomenological study
SO JOURNAL OF NURSING MANAGEMENT
LA English
DT Article
DE COVID-19; educational need; experience; nurses; qualitative research
AB Aim: The aim of this study was to explore the experience of Italian nurses engaged in caring for patients with COVID-19.
   Background: COVID-19 found the health care world unprepared to face an emergency of such magnitude. Italy was one of the most affected European countries, with more than 250,000 cases. Understanding the impact of events of this magnitude on nurses provides a framework of knowledge on which educational training could be based to face similar situations in the future to prevent further breakdown.
   Methods: The hermeneutic approach by Cohen was used. Semi-structured interviews were conducted using a voice-over Internet protocol. Interviews were transcribed, read in depth and analysed.
   Results: Twenty nurses were interviewed. Four themes were extracted: uncertainty and fear, alteration of perceptions of time and space, change in the meaning of 'to care' and changes in roles and relationships.
   Conclusions: Psychological support in association with emergency training prevents stress and helps tackle compassion fatigue.
   Implications for nursing management: Policies to improve nursing science should be developed to ensure better quality of care, a higher number of professionals and, consequently, an increase in the safety of patients.
C1 [Arcadi, Paola] Univ Roma Tor Vergata, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy.
   [Simonetti, Valentina] Univ Politecn Marche, Fac Med & Chirurg, Politecn Marche, Ancona, Italy.
   [Simonetti, Valentina] AV5 Ascoli Piceno Hosp, ASUR Marche, Ascoli Piceno, Italy.
   [Ambrosca, Rossella; Simeone, Silvio; Pucciarelli, Gianluca; Vellone, Ercole; Durante, Angela] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.
   [Cicolini, Giancarlo] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Bari, Italy.
   [Alvaro, Rosaria] Univ Roma Tor Vergata, Dept Biomed & Prevent, Fac Med, Rome, Italy.
RP Durante, A (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy.
EM angela.durante@uniroma2.it
RI Cicolini, Giancarlo/Q-5112-2019; Pucciarelli, Gianluca/J-9169-2017
OI Cicolini, Giancarlo/0000-0002-2736-1792; Vellone, PhD, RN, FAAN, FESC,
   Ercole/0000-0003-4673-7473; Simonetti, Valentina/0000-0002-7185-4850;
   DURANTE, ANGELA/0000-0003-1034-5988; simeone,
   silvio/0000-0001-9266-0185; Pucciarelli, Gianluca/0000-0001-6915-6802
CR Arcadi P, 2021, J NURS MANAGE, V29, P1111, DOI 10.1111/jonm.13249
   Bagnasco A, 2020, J ADV NURS, V76, P2212, DOI 10.1111/jan.14407
   Baker SE, 2012, MANY QUALITATIVE INT NATL CTR RES METHODS
   Bu XY, 2007, J ADV NURS, V57, P101, DOI 10.1111/j.1365-2648.2006.04096.x
   Chiang HH, 2007, NURS ETHICS, V14, P18, DOI 10.1177/0969733007071353
   Choi SPP, 2014, J ADV NURS, V70, P1584, DOI 10.1111/jan.12316
   Fernandez R, 2020, INT J NURS STUD, V111, DOI 10.1016/j.ijnurstu.2020.103637
   Gunawan J., 2015, BELITUNS NURSING J, V1, P10, DOI DOI 10.33546/BNJ.4
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Jackson D, 2020, J CLIN NURS, V29, P2041, DOI 10.1111/jocn.15257
   Janghorban R, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.24152
   Johns Hopkins University, 2020, **NON-TRADITIONAL**
   Kang HS, 2018, INT J NURS PRACT, V24, DOI 10.1111/ijn.12664
   Kang LJ, 2020, LANCET PSYCHIAT, V7, pE14, DOI 10.1016/S2215-0366(20)30047-X
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Lee TSH, 2019, J NURS SCHOLARSHIP, V51, P195, DOI 10.1111/jnu.12467
   Legido-Quigley H, 2020, LANCET PUBLIC HEALTH, V5, pE251, DOI 10.1016/S2468-2667(20)30060-8
   Lincoln Y.S., 1986, NEW DIRECTIONS PROGR, V1986, P73, DOI [10.1002/(ISSN)1551-2371, DOI 10.1002/EV.1427, https://doi.org/10.1002/ev.1427]
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   MacLean LM, 2004, QUAL HEALTH RES, V14, P113, DOI 10.1177/1049732303259804
   Nacoti M, 2020, NEJM CATALYST, DOI [10.1056/CAT.20.0080, DOI 10.1056/CAT.20.0080]
   Phillippi J, 2018, QUAL HEALTH RES, V28, P381, DOI 10.1177/1049732317697102
   Polit D. F., 2013, STUDY GUIDE ESSENTIA
   Schantz ML, 2007, NURS FORUM, V42, P48, DOI 10.1111/j.1744-6198.2007.00067.x
   Schmidt BJ, 2018, NURS FORUM, V53, P69, DOI 10.1111/nuf.12211
   Smith GD, 2020, J CLIN NURS, V29, P1425, DOI 10.1111/jocn.15231
   Steeves R., 2000, HERMENEUTIC PHENOMEN, DOI [10.4135/9781452232768, DOI 10.4135/9781452232768]
   Sun NN, 2020, AM J INFECT CONTROL, V48, P592, DOI 10.1016/j.ajic.2020.03.018
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   Usher K, 2020, INT J MENT HEALTH NU, V29, P315, DOI 10.1111/inm.12726
   Vellone E, 2012, J TRANSCULT NURS, V23, P46, DOI 10.1177/1043659611414199
   Watson J, 1988, NLN Publ, P1
   Wong ELY, 2012, J CLIN NURS, V21, P1466, DOI 10.1111/j.1365-2702.2011.03783.x
   World Health Organization, 2020, 62 WHO
   World Health Organization , 2020, PROC TRANSL AD INSTR
   Yin X, 2020, Int J Nurs Sci, V7, P157, DOI 10.1016/j.ijnss.2020.04.002
   Zhang Y, 2020, ISSUES MENT HEALTH N, V41, P525, DOI 10.1080/01612840.2020.1752865
NR 37
TC 12
Z9 12
U1 4
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0966-0429
EI 1365-2834
J9 J NURS MANAGE
JI J. Nurs. Manag.
PD JUL
PY 2021
VL 29
IS 5
BP 1111
EP 1119
DI 10.1111/jonm.13249
EA JAN 2021
PG 9
WC Management; Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Business & Economics; Nursing
GA TN1RZ
UT WOS:000613311400001
PM 33421209
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Giuliani, C
   Li Volsi, P
   Brun, E
   Chiambretti, A
   Giandalia, A
   Tonutti, L
   Di Bartolo, P
   Napoli, A
AF Giuliani, Chiara
   Li Volsi, Patrizia
   Brun, Elisabetta
   Chiambretti, Anna
   Giandalia, Annalisa
   Tonutti, Laura
   Di Bartolo, Paolo
   Napoli, Angela
TI Breastfeeding during the COVID-19 pandemic: Suggestions on behalf of
   woman study group of AMD
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Covid-19; Breastfeeding; Pregnancy; Diabetes
ID WOMEN
AB SARS-Cov2 infection has recently spread to Italy with important consequences on pregnancy management, mother and child health and mother-child contact. Breastfeeding improves the health of mother and child and reduces risk of neonatal infection with other pathogens that are likely to cause serious illness.
   To date no evidence confirmed COVID-19 vertical transmission from infected pregnant mother to their fetus. However it is well known that an infected mother can transmit the COVID-19 virus through respiratory droplets during breastfeeding or intimate contact.
   Thus, the mothers with known or suspected COVID-19 should adhere to standard and contact precautions during breastfeeding.
   Woman Study Group of AMD, after reviewing current knowledge about COVID-19 vertical transmission and the compatibility of breastfeeding in COVID-19 mother, the available recommendations from Health Care Organizations and main experts opinions, issued the following suggestions on breastfeeding during the COVID-19 pandemic, addressed both to mothers with and without diabetes.
   It should be considered that following suggestions may change in the future when more evidence is acquired regarding SARS-Cov2 infection. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Giuliani, Chiara] Sapienza Univ Rome, St Andrea Hosp, Dept Expt Med, Via Grottarossa 1035, I-00189 Rome, Italy.
   [Li Volsi, Patrizia] ASFO Pordenone, SSD Endocrinol & Malattie Ricambio, Pordenone, Italy.
   [Brun, Elisabetta] ULSS 8 Vicenza, Diabetol & Metab Dis Unit, Vicenza, Italy.
   [Chiambretti, Anna] ASL TO4 Chivasso, Metab & Diabet Unit, Chivasso, TO, Italy.
   [Giandalia, Annalisa] Univ Messina, Dept Clin & Expt Med, Messina, Italy.
   [Tonutti, Laura] Azienda Sanit Univ Integrata Udine, Endocrinol Diabet Metab & Clin Nutr, Udine, Italy.
   [Di Bartolo, Paolo] A Usl Romagna, Dipartimento Internist Ravenna, Rete Clin Diabetol Aziendale, Cesena, Italy.
   [Napoli, Angela] Sapienza Univ Rome, St Andrea Hosp, Clin & Mol Med Dept, Rome, Italy.
RP Giuliani, C (corresponding author), Sapienza Univ Rome, St Andrea Hosp, Dept Expt Med, Via Grottarossa 1035, I-00189 Rome, Italy.
EM chiara.giul@gmail.com
RI Di Bartolo, Paolo/AAL-5954-2021
OI Giandalia, Annalisa/0000-0002-0778-4130; Di Bartolo,
   Paolo/0000-0001-5957-1551
CR Academy of Breastfeeding Medicine, 2020, ABM STAT COR 2019 CO
   Achong N, 2016, DIABETIC MED, V33, P947, DOI 10.1111/dme.12993
   [Anonymous], 2020, COVID 19 INDICAZIONI
   Capiglioni AM, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105632
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen S, 2020, Zhonghua Bing Li Xue Za Zhi, V49, P418, DOI 10.3760/cma.j.cn112151-20200225-00138
   Chen Y, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00104
   Colatrella A, 2012, DIABETES TECHNOL THE, V14, P576, DOI 10.1089/dia.2011.0266
   Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021
   Davanzo R, 2015, ITALIAN J PEDIATRICS, V41, P1
   Davanzo R, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.13010
   Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
   Global N. C., 2020, INF YOUNG FEED CONT, P1
   Gunderson EP, 2018, JAMA INTERN MED, V178, P328, DOI 10.1001/jamainternmed.2017.7978
   Istituto superiore di sanita, NUOV COR CONS I SUP
   Karimi-Zarchi M, 2020, FETAL PEDIATR PATHOL, V39, P246, DOI 10.1080/15513815.2020.1747120
   Kimberlin DW, 2020, JAMA-J AM MED ASSOC, V323, P1788, DOI 10.1001/jama.2020.4868
   Mattei L., 2014, J DIAB MELLITUS, V4, P257, DOI DOI 10.4236/JDM.2014.44037
   Panahi L, 2020, ARCH ACAD EMERG MED, V8
   Poon LC, 2020, ULTRASOUND OBST GYN, V55, P700, DOI 10.1002/uog.22013
   Poon LC, 2020, INT J GYNECOL OBSTET, V149, P273, DOI 10.1002/ijgo.13156
   Riviello C, 2009, ENDOCR PRACT, V15, P187, DOI 10.4158/EP.15.3.187
   Roberts A, 2018, DIABETIC MED, V35, P1011, DOI 10.1111/dme.13675
   Robertson CA, 2004, EMERG INFECT DIS, V10, P345, DOI 10.3201/eid1002.030736
   Royal College of Obstetricians and Gynaecologists Royal College of Midwives Royal College of Paediatrics and Child Health Public Health England and Health Protection Scotland, 2020, CORONAVIRUS COVID 19
   Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316
   Wang C, 2020, ULTRASOUND OBST GYN, V55, P724, DOI 10.1002/uog.22045
   Wang Laishuan, 2020, ANN TRANSL MED, V8, P47, DOI [10.21037/atm.2020.02.20, DOI 10.21037/ATM.2020.02.20]
   Wang SS, 2020, CLIN INFECT DIS, V71, P853, DOI 10.1093/cid/ciaa225
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   World Health Organization, 2020, CLIN MANAGEMENT
   Zeng H, 2020, JAMA-J AM MED ASSOC, V323, P1848, DOI 10.1001/jama.2020.4861
NR 32
TC 6
Z9 6
U1 4
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JUL
PY 2020
VL 165
AR 108239
DI 10.1016/j.diabres.2020.108239
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA MT4EL
UT WOS:000554922700019
PM 32479766
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Pahrudin, P
   Liu, LW
   Chang, CY
AF Pahrudin, Pahrudin
   Liu, Li-Wei
   Chang, Chia-Ying
TI The Influencing Factors of ICT Use in Online Learning during Covid-19
   Pandemic in Indonesia
SO ENGINEERING LETTERS
LA English
DT Article
DE UICT; Online Learning; Higher Education; Covid-19
ID PEDAGOGICAL CONTENT KNOWLEDGE; PRESERVICE TEACHERS; TPACK; TECHNOLOGY;
   ACCEPTANCE; IMPACT
AB Most countries in the world are facing new situations due to the corona pandemic or COVID-19. Online learning is a new method of teaching and learning process in education during the COVID-19 period to avoid the spread of virus. The study examines and determines the lecturer's perception of using Information, Communication and Technology (LC.T) based on the Technological Pedagogy and Content Knowledge (TPACK) framework in the teaching and learning process during the COVID-19 pandemic. The study built eleven hypotheses. The study used online questionnaire to collect data with 228 sample respondents who had taught at higher education in Indonesia. Data analysis used Partial Least Squared-Structural Equation Model (PLS-SEM) with Exploratory Factor Analysis (E.F.A). The result showed that all Technological Pedagogy and Content Knowledge (TPACK) variable on Use of Information, Communication, and Technology (UICT) variable had significant effect except for Content Knowledge (CK) Variable on Technological Content Knowledge (TCK) variable and Technological Content Knowledge (TCK) variable on Use of Information, Communication, and Technology (UICT) variable. Overall, the TPACK components are connected and valid model to explain Indonesian lecturers at use of Information, Communication and Technology (UICT) in online learning during the COVID-19 pandemic.
C1 [Pahrudin, Pahrudin] Chaoyang Univ Technol, Business Adm, Taichung, Taiwan.
   [Liu, Li-Wei] Chaoyang Univ Technol, Dept Leisure & Serv Management, Taichung, Taiwan.
   [Chang, Chia-Ying] Natl Taichung Univ Sci & Technol, Prof Phys Educ Dept, Taichung, Taiwan.
RP Liu, LW (corresponding author), Chaoyang Univ Technol, Dept Leisure & Serv Management, Taichung, Taiwan.
EM rudipahru@gmail.com; llouis@cyut.edu.tw; cychang@nutc.edu.tw
CR Abidah A., 2020, STUD PHILOS SCI ED, V1, P38, DOI [10.46627/sipose.v1i1.9, DOI 10.46627/SIPOSE.V1I1.9]
   Agyei DD, 2012, AUSTRALAS J EDUC TEC, V28, P547
   Angeli C, 2009, COMPUT EDUC, V52, P154, DOI 10.1016/j.compedu.2008.07.006
   Archambault LM, 2010, COMPUT EDUC, V55, P1656, DOI 10.1016/j.compedu.2010.07.009
   Aslan A, 2017, BRIT J EDUC TECHNOL, V48, P552, DOI 10.1111/bjet.12437
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   Caraka RE, 2020, GLOB J ENVIRON SCI M, V6, P65, DOI 10.22034/GJESM.2019.06.SI.07
   Caraka RE, 2021, IEEE ACCESS, V9, P1972, DOI 10.1109/ACCESS.2020.3038883
   Chai CS, 2012, AUSTRALAS J EDUC TEC, V28, P1000
   Chin WW, 1998, QUANT METH SER, P295
   Creswell J.W., 2017, RES DESIGN QUALITATI
   Dai H, 2020, ENG LET, V28, P1011
   Dong Y, 2015, EDUC TECHNOL SOC, V18, P158
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Gonzalez T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239490
   Graham CR, 2011, COMPUT EDUC, V57, P1953, DOI 10.1016/j.compedu.2011.04.010
   Hair J.F., 1992, MULTIVARIATE DATA AN
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Hung K, 2011, TOURISM MANAGE, V32, P717, DOI 10.1016/j.tourman.2010.05.027
   Joo YJ, 2018, EDUC TECHNOL SOC, V21, P48
   Koh JHL, 2010, J COMPUT ASSIST LEAR, V26, P563, DOI 10.1111/j.1365-2729.2010.00372.x
   Kumar D.N.S, 2020, IMPACT COVID 19 HIGH
   Luik P, 2018, EDUC INF TECHNOL, V23, P741, DOI 10.1007/s10639-017-9633-y
   Meagher M., 2009, MATH ED, V19, P10
   Mishra P, 2006, TEACH COLL REC, V108, P1017, DOI 10.1111/j.1467-9620.2006.00684.x
   Morano-Fernandez J. A., 2019, LECT NOTES ENG COMPU, P222
   Nunnally J., 1994, PSYCHOL THEORY, V3 rd ed.
   Pamuk S, 2015, EDUC INF TECHNOL, V20, P241, DOI 10.1007/s10639-013-9278-4
   Reyes VC, 2017, COMPUT EDUC, V115, P1, DOI 10.1016/j.compedu.2017.07.009
   Scherer R, 2017, COMPUT EDUC, V112, P1, DOI 10.1016/j.compedu.2017.04.012
   Schmidt DA, 2009, J RES TECHNOL EDUC, V42, P123, DOI 10.1080/15391523.2009.10782544
   Shulman L. S, 1986, EDUC RES-UK, V10, P4
   Strielkowski W., 2020, COVID 19 PANDEMIC DI, DOI [10.20944/preprints202004.0290.v1, DOI 10.20944/PREPRINTS202004.0290.V1]
   Sukamani D, 2020, ENG LET, V28, P783
   Svetsky S., 2019, LECT NOTES ENGGINEER, P226
   Taimalu M, 2019, TEACH TEACH EDUC, V79, P101, DOI 10.1016/j.tate.2018.12.012
   Teo T, 2019, INTERACT LEARN ENVIR, V27, P530, DOI 10.1080/10494820.2018.1489290
   The Task Force of Covid-19, 2020, DISTR DAT COVID 19 I
   Tondeur J, 2017, TECHNOL PEDAGOG EDUC, V26, P157, DOI 10.1080/1475939X.2016.1193556
   Valtonen T, 2019, J COMPUT ASSIST LEAR, V35, P491, DOI 10.1111/jcal.12353
   Venkatesh V, 2012, MIS QUART, V36, P157
   Vinzi V.E., 2010, HDB PARTIAL LEAST SQ, P47, DOI [https://doi.org/10.1007/978-3-540-32827-8_3, DOI 10.1007/978-3-540-32827-8_3, 10.1007/978-3-540-32827-8_3]
   Yudistira N., 2020, IAENG INT J COMPUTER, V47, P829
NR 43
TC 0
Z9 0
U1 4
U2 5
PU NEWSWOOD LTD
PI HONG KONG
PA UNIT 1, 1/F, 37-39 HUNG TO RD, HONG KONG, 00000, HONG KONG
SN 1816-093X
EI 1816-0948
J9 ENG LET
JI Eng. Lett.
PD MAY 17
PY 2021
VL 29
IS 2
BP 382
EP 390
PG 9
WC Engineering, Multidisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Engineering
GA SF0XC
UT WOS:000652486600007
DA 2022-04-20
ER

PT J
AU Mutala, TM
   Onyambu, CK
   Aywak, AA
AF Mutala, Timothy Musila
   Onyambu, Callen Kwamboka
   Aywak, Angeline Anyona
TI Radiology practice in sub-Saharan Africa during the COVID-19 outbreak:
   points to consider
SO PAN AFRICAN MEDICAL JOURNAL
LA English
DT Article
DE COVID-19; radiology practice; sub-Saharan Africa
ID CORONAVIRUS
AB COVID-19 is a rapidly growing pandemic that has grown from a few cases in Wuhan, China to millions of infections and hundreds of thousands of deaths worldwide within a few months. Sub-Saharan Africa is not spared. Radiology has a key role to play in the diagnosis and management of COVID-19 as literature from Wuhan and Italy demonstrates. We therefore share some critical knowledge and practice areas for radiological suspicion and diagnosis. In addition, emphasis on how guarding against healthcare acquired infections (HAIs) by applying "red" and "green" principle is addressed. Given that pandemics such as COVID-19 can worsen the strain on the scantily available radiological resources in this region, we share some practical points that can be applied to manage these precious resources also needed for other essential services. We have noted that radiology does not feature in many main COVID-19 guidelines, regionally and internationally. This paper therefore suggests areas of collaboration for radiology with other clinical and management teams. We note from our local experience that radiology can play a role in COVID-19 surveillance.
C1 [Mutala, Timothy Musila; Onyambu, Callen Kwamboka; Aywak, Angeline Anyona] Univ Nairobi, Coll Hlth Sci, Sch Med, Dept Diagnost Imaging & Radiat Med, Nairobi, Kenya.
RP Mutala, TM (corresponding author), Univ Nairobi, Coll Hlth Sci, Sch Med, Dept Diagnost Imaging & Radiat Med, Nairobi, Kenya.
EM Kenya.mutala@uonbi.ac.ke
OI Mutala, Timothy Musila/0000-0003-2122-3740
CR [Anonymous], 2020, WHO OPERATIONAL CONS
   [Anonymous], 2015, KENYA HLTH WORKFORCE
   Buonsenso D, 2020, EUR REV MED PHARMACO, V24, P2776, DOI 10.26355/eurrev_202003_20549
   Fox TB, 2008, HLTH POLICY NEWSL, V21, P20
   Huang PK, 2020, RADIOLOGY, V295, P22, DOI 10.1148/radiol.2020200330
   Ilyas F, 2019, J MED IMAGING RADIAT, V50, P596, DOI 10.1016/j.jmir.2019.07.011
   Kawooya MG, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.97747
   Korir GK, 2016, RADIAT PROT DOSIM, V168, P242, DOI 10.1093/rpd/ncv020
   Lee K, 2020, ADV THEOR SIMUL, V3, DOI 10.1002/adts.202000012
   Mossa-Basha M, 2020, RADIOLOGY, DOI [10.1148/radiol.2020201326, DOI 10.1148/RADIOL.2020201326]
   Mossa-Basha M, 2020, RADIOLOGY, V296, pE106, DOI 10.1148/radiol.2020200988
   Muchiri S., 2019, KENYA HLTH SYSTEM AS
   Ngoya PS, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.99.9736
   Nyirenda D, 2019, HEALTH SA GESONDHEID, V24, DOI 10.4102/hsag.v24i0.1035
   Qing W., 2020, BEIJING REV
   Rubin GD, 2020, RADIOLOGY, V296, P172, DOI 10.1148/radiol.2020201365
   Simpson Scott, 2020, J Thorac Imaging, V35, P219, DOI [10.1148/ryct.2020200152, 10.1097/RTI.0000000000000524]
   Soroosh G, 2015, NIGERIA COUNTRY REPO
   Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002
   Zhang HW, 2020, ACAD RADIOL, V27, P463, DOI 10.1016/j.acra.2020.02.003
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 21
TC 1
Z9 1
U1 0
U2 0
PU AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET
PI KAMPALA
PA PO BOX 12874, KAMPALA, 00000, UGANDA
EI 1937-8688
J9 PAN AFR MED J
JI Pan Afr. Med. J.
PD SEP 7
PY 2020
VL 37
AR 28
DI 10.11604/pamj.2020.37.28.23081
PG 8
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA OU4UE
UT WOS:000591524300001
PM 33062129
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ismael, OY
   Li, YH
   Sha, ZW
   Wu, QH
   Wei, LF
   Jiao, ML
   Li, Y
   Shan, LH
   Wang, YS
AF Ismael, Omar Yacouba
   Li, Yuanheng
   Sha, Zhuowa
   Wu, Qunhong
   Wei, Lifeng
   Jiao, Mingli
   Li, Ye
   Shan, Linghan
   Wang, Yushu
TI Assessing knowledge and self-report intention from COVID-19 symptoms
   based on the Health Belief Model among international students in
   Heilongjiang, China: a cross-sectional study
SO BMJ OPEN
LA English
DT Article
DE COVID-19; public health; epidemiology; health policy
ID TRANSMISSION DYNAMICS; CANCER; SARS
AB Background A COVID-19 outbreak has been contained in China through effective prevention measures with the collaboration of the citizens. However, there is resistance to self-reported symptoms as required in the international student community. This study explored knowledge level and symptoms reporting behaviours toward COVID-19 among international students. Methods An online cross-sectional investigation was conducted among 119 international students across Heilongjiang province and questionnaires implemented through WeChat between 1 and 25 March 2020. The results were explained using descriptive X-2 test and binary logistic regression analysis using SPSS V.20. Results In total, 119 international students participated, with a response rate of 90.16%. Of the 119 respondents, 96 (80.7%) knew COVID-19 symptoms, 109 (91.6%) took cognisance of questions on the importance of the maintenance of wearing masks and 113 (95%) on questions regarding hand hygiene in the prevention of disease transmission. However, results show that there were still large gaps in knowledge about questions regarding the virus and the treatment methods (many participants incorrectly believed that the virus could be kill by drinking alcohol or smoking). In addition, more than half of the participants declared compliance with positive health behaviours, however 27.7% did not agree with vaccination (if any), and 31.1% did not agree to be quarantined after being diagnosed with COVID-19. Furthermore, 20 participants (16, 80%) expressed an inclination to deliberately withhold symptoms. Variables in the Health Belief Model showed a significant association with behavioural change. Conclusion From our study, we found that there is evident knowledge about COVID-19 among international students, although orientation and sensitisation are still required. Those who were aware of the benefits of reporting, the severity of COVID-19 and the legal consequences of deliberately concealing information showed a greater willingness to report; conversely, those who believed reporting is very inconvenient and feared being quarantined after reporting showed less willingness to report. A study focusing on international students' knowledge and behaviour amid the pandemic will provide information for countries to cut off the chain of disease transmission of all variants of COVID-19.
C1 [Ismael, Omar Yacouba; Li, Yuanheng; Sha, Zhuowa; Jiao, Mingli; Wang, Yushu] Harbin Med Univ, Dept Hlth Policy & Hosp Management, Harbin, Heilongjiang, Peoples R China.
   [Wu, Qunhong; Li, Ye; Shan, Linghan] Harbin Med Univ, Sch Hlth Management, Dept Social Med, Harbin, Heilongjiang, Peoples R China.
   [Wei, Lifeng] Harbin Med Univ, Personnel Dept, Harbin, Heilongjiang, Peoples R China.
RP Jiao, ML (corresponding author), Harbin Med Univ, Dept Hlth Policy & Hosp Management, Harbin, Heilongjiang, Peoples R China.
EM minglijiao@126.com
OI Ismael, Omar Yacouba/0000-0002-7925-0912
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China (NSFC) [71273002, 71473064]; American Chinese Medical Board
   [19--309]; 2020 Heilongjiang Province Applied Technology Research and
   Development Plan [GA20C004]
FX This study was funded by the Natural Science Foundation of China (grant
   nos. 71273002, 71473064), the American Chinese Medical Board (grant no.
   19--309) and 2020 Heilongjiang Province Applied Technology Research and
   Development Plan (grant no. GA20C004).
CR Albashtawy M, 2016, IRAN J PUBLIC HEALTH, V45, P708
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283
   Carico R, 2021, RES SOC ADMIN PHARM, V17, P1984, DOI 10.1016/j.sapharm.2020.03.017
   Champion VL, 2008, HLTH BEHAV HLTH ED T
   Glanz K., 2008, HLTH BEHAV HLTH ED T, V4
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Jones CL, 2015, HEALTH COMMUN, V30, P566, DOI 10.1080/10410236.2013.873363
   Keighley MRB, 2004, EUR J CANCER PREV, V13, P257, DOI 10.1097/01.cej.0000136575.01493.9b
   Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Lu Y, 2020, J INFECTION, V81, pE82, DOI 10.1016/j.jinf.2020.03.050
   McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4
   Powe BD, 2001, J PSYCHOSOC ONCOL, V19, P85, DOI 10.1300/J077v19n03_07
   Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Sun TZ, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109949
   Wei LF, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09282-4
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 20
TC 0
Z9 0
U1 2
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD JAN
PY 2022
VL 12
IS 1
AR e050867
DI 10.1136/bmjopen-2021-050867
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA YF9KC
UT WOS:000742117500007
PM 35017238
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Aljahany, M
   Alassaf, W
   Alibrahim, AA
   Kentab, O
   Alotaibi, A
   Alresseeni, A
   Algarni, A
   Algaeed, HA
   Aljaber, MI
   Alruwaili, B
   Aljohani, K
AF Aljahany, Muna
   Alassaf, Wajdan
   Alibrahim, Ahmed A.
   Kentab, Osama
   Alotaibi, Abdullah
   Alresseeni, Abdulaziz
   Algarni, Abdulaziz
   Algaeed, Hamad A.
   Aljaber, Mohammed I.
   Alruwaili, Badriyah
   Aljohani, Khalid
TI Use of In Situ Simulation to Improve Emergency Department Readiness for
   the COVID-19 Pandemic
SO PREHOSPITAL AND DISASTER MEDICINE
LA English
DT Article
DE COVID-19; emergency department; mock codes; simulation
ID INFLUENZA; LESSONS
AB Introduction:
   During the world-wide coronavirus disease 2019 (COVID-19) outbreak, there is an urgent need to rapidly increase the readiness of hospitals. Emergency departments (EDs) are at high risk of facing unusual situations and need to prepare extensively in order to minimize risks to health care providers (HCPs) and patients. In situ simulation is a well-known method used in training to detect system gaps that could threaten safety.
   Study Objectives:
   One objective is to identify gaps, test hospital systems, and inform necessary modifications to the standard processes required by patients with COVID-19 presenting at the hospital. The other objective is to improve ED staff confidence in managing such patients, and to increase their skills in basic and advanced airway management and proper personal protective equipment (PPE) techniques.
   Methods:
   This is a quasi-experimental study in which 20 unannounced mock codes were carried out in ED resuscitation and isolation rooms. A checklist was designed, validated, and used to evaluate team performances in three areas: donning, basic and advanced airway skills, and doffing. A pre- and post-intervention survey was used to evaluate staff members' perceived knowledge of ED procedures related to COVID-19 and their airway management skills.
   Results:
   A total of 20 mock codes were conducted in the ED. Overall, 16 issues that posed potential harm to staff or patients were identified and prioritized for immediate resolution. Approximately 57.4% of HCPs felt comfortable dealing with suspected/confirmed, unstable COVID-19 cases after mock codes, compared with 33.3% beforehand (P = .033). Of ED HCPs, 44.4% felt comfortable performing airway procedures for suspected/confirmed COVID-19 cases after mock codes compared with 29.6% beforehand. Performance of different skills was observed to be variable following the 20 mock codes. Skills with improved performance included: request of chest x-ray after intubation (88.0%), intubation done by the most experienced ED physician (84.5%), and correct sequence and procedure of PPE (79.0%).
   Conclusion:
   Mock codes identified significant defects, most of which were easily fixed. They included critical equipment availability, transporting beds that were too large to fit through doors, and location of biohazard bins. Repeated mock codes improved ED staff confidence in dealing with patients, in addition to performance of certain skills. In situ simulation proves to be an effective method for increasing the readiness of the ED to address the COVID-19 pandemic and other infection outbreaks.
C1 [Aljahany, Muna; Alassaf, Wajdan] Princess Nourah bint Abdulrahman Univ, Coll Med, POB 84428, Riyadh, Saudi Arabia.
   [Alibrahim, Ahmed A.; Kentab, Osama; Alotaibi, Abdullah; Alresseeni, Abdulaziz; Algarni, Abdulaziz; Algaeed, Hamad A.; Alruwaili, Badriyah; Aljohani, Khalid] King Abdullah bin Abdulaziz Univ Hosp, Emergency Dept, Riyadh, Saudi Arabia.
   [Aljaber, Mohammed I.] Imam Mohammad Ibn Saud Islamic Univ, Coll Med, Riyadh, Saudi Arabia.
RP Alassaf, W (corresponding author), Princess Nourah bint Abdulrahman Univ, Coll Med, POB 84428, Riyadh, Saudi Arabia.
EM wialassaf@pnu.edu.sa
OI Aljahany, Muna/0000-0002-1120-9331; Aljaber,
   Mohammed/0000-0002-7280-1144; alassaf, wajdan/0000-0003-1319-752X
FU KAAUH senior management for simulation training
FX The authors would like to thank ED physicians, nurses, EMT/paramedics,
   and RTs at the King Abdullah bin Abdulaziz University Hospital (KAAUH;
   Riyadh, Saudi Arabia) for their participation and incredible enthusiasm.
   The authors also acknowledge the support of the KAAUH senior management
   for simulation training.
CR Abualenain JT, 2018, J INFECT PUBLIC HEAL, V11, P796, DOI 10.1016/j.jiph.2018.05.002
   Adini B, 2012, EUR J PUBLIC HEALTH, V22, P169, DOI 10.1093/eurpub/ckr030
   Aiello A, 2011, J CONTIN EDUC HEALTH, V31, P15, DOI 10.1002/chp.20096
   [Anonymous], 2020, CHEMCATCHEM, V12, pXXX
   [Anonymous], 2020, ACAD EMERG MED, V27, pS7, DOI 10.1111/acem.13961
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Cardenosa N, 2010, CLIN MICROBIOL INFEC, V16, P1365, DOI [10.1111/j.1469-0691.2010.03144.x, 10.1111/j.1469-0691.2009.03144.x]
   Clarke SO, 2019, BMJ SIMUL TECHNOL EN, V5, P29, DOI 10.1136/bmjstel-2017-000255
   Daugherty EL, 2010, CLIN INFECT DIS, V50, P1145, DOI 10.1086/651272
   Fregene TE, 2020, ANAESTHESIA, V75, P733, DOI 10.1111/anae.15048
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jacobsen KH, 2020, LANCET, V395, P1013, DOI 10.1016/S0140-6736(20)30559-6
   Jones F., 2015, PRINCIPLES PRACTICE, V1, P2
   Lababidi HMS, 2020, BMJ SIMUL TECHNOL EN
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Lateef Fatimah, 2010, J Emerg Trauma Shock, V3, P348, DOI 10.4103/0974-2700.70743
   Leiba A, 2010, ISR MED ASSOC J, V12, P460
   Lopreiato JO, 2016, HLTH CARE SIMULATION
   Maunder RG, 2008, CAN J PUBLIC HEALTH, V99, P486, DOI 10.1007/BF03403782
   Munshi F, 2015, J TAIBAH U MED SCI, P10
   Park SC, 2020, PSYCHIAT INVEST, V17, P85, DOI 10.30773/pi.2020.0058
   Peng PWH, 2020, BRIT J ANAESTH, V124, P497, DOI 10.1016/j.bja.2020.02.008
   Rand VE, 1998, J GEN INTERN MED, V13, P670, DOI 10.1046/j.1525-1497.1998.00202.x
   Richard AN, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20224
   Schuchat A, 2011, CLIN INFECT DIS, V52, pS8, DOI 10.1093/cid/ciq007
   Smith N, 2020, AM J PUBLIC HLTH
   van Dixhoorn Jan, 2015, ERJ Open Res, V1
NR 27
TC 3
Z9 3
U1 2
U2 6
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1049-023X
EI 1945-1938
J9 PREHOSPITAL DISASTER
JI Prehospital Disaster Med.
PD FEB
PY 2021
VL 36
IS 1
BP 6
EP 13
AR PII S1049023X2000134X
DI 10.1017/S1049023X2000134X
PG 8
WC Emergency Medicine
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Emergency Medicine
GA PX2EO
UT WOS:000611174400003
PM 33081859
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Ahmed, N
   Davids, R
AF Ahmed, Nadiya
   Davids, Ryan
TI COVID 19: are South African junior doctors prepared for critical care
   management outside the intensive care unit?
SO PAN AFRICAN MEDICAL JOURNAL
LA English
DT Article
DE COVID-19; junior doctor; critical care; South Africa
ID PATIENT; ETHICS
AB Introduction: the coronavirus disease 2019 (COVID-19) pandemic has negatively impacted countries across the globe. Infected individuals will seek aid at various health care facilities. Many patients will recover without requiring specialised treatment. A significant percentage of infected individuals will need critical care management, which will begin in the emergency department, generally staffed by junior doctors. Junior doctors will need to stabilize, triage and manage these patients prior to referral to specialized units. Above and beyond the usual occupational demands that accompany junior doctors in state facilities, this pandemic will thrust further responsibility on them. The objectives were to describe crisis preparedness of junior doctors in the areas of triage decision-making and critical care management, outside the intensive care unit. Methods: this is a descriptive, cross-sectional study, utilizing a web-based survey. Junior doctors in South Africa, being doctors in year one or year two of internship and community service, were invited to participate anonymously via various social media platforms. Results: a total of 210 junior doctors across South Africa answered the survey. Junior doctors expressed confidence with knowledge of intubation drugs, to perform intubation and cardiopulmonary arrest resuscitation without supervision. Only 13.3% of respondents expressed comfort with setting and adjusting ventilator settings independently. 57% of participants expressed discomfort with making critical care triage decisions. Ninety-three percent (93%) of participants expressed benefit from a telemedicine intervention. Conclusion: junior doctors in South Africa indicate that they are prepared to initiate management of the critically ill patient outside the intensive care unit but remain uncertain in their ability to provide ongoing critical care management. The COVID-19 pandemic has highlighted the need to prepare junior doctors with the ability to manage critical care triage and management in emergency rooms. Leveraging of the workforce in South Africa may be potentiated by telemedicine interventions.
C1 [Ahmed, Nadiya; Davids, Ryan] Stellenbosch Univ, Tygerberg Hosp, Dept Surg Sci, Dept Anaesthesiol & Crit Care, Western Cape, South Africa.
RP Ahmed, N (corresponding author), Stellenbosch Univ, Tygerberg Hosp, Dept Surg Sci, Dept Anaesthesiol & Crit Care, Western Cape, South Africa.
EM nadiya@sun.ac.za
CR Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   [Anonymous], NEWS24
   Caldwell R I, 2016, S Afr Med J, V107, P39, DOI 10.7196/SAMJ.2016.v107.i1.12008
   Callaghan A, 2017, AUST CRIT CARE, V30, P197, DOI 10.1016/j.aucc.2016.09.004
   Clarke DL, 2014, SAMJ S AFR MED J, V104, P57, DOI [10.7196/samj.7252, 10.7196/SAMJ.7252]
   Crawford GB, 2015, ACAD MED, V90, P338, DOI 10.1097/ACM.0000000000000632
   Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235
   Curtis JR, 2010, LANCET, V376, P1347, DOI 10.1016/S0140-6736(10)60143-2
   Donda BM, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0800-4
   Fessler HE, 2012, CRIT CARE MED, V40, P3065, DOI 10.1097/CCM.0b013e31826ab360
   Greenland JR, 2020, ANESTHESIOLOGY, V132, P1346, DOI 10.1097/ALN.0000000000003303
   Hawryluck L, 2006, CRIT CARE, V10, DOI 10.1186/cc5095
   Health Professions Council of South Africa, MED DENT PROF BOARD
   Joynt GM, 2019, SAMJ S AFR MED J, V109, P613, DOI [10.7196/SAJCC.2019.v35i1b.383, 10.7196/2FSAMJ.2019.v109i8b.13947, 10.7196/SAMJ.2019.v109i8b.13947]
   Kerry VB, 2014, GLOB HEART, V9, P275, DOI 10.1016/j.gheart.2014.09.002
   Kyaw BM, 2019, J MED INTERNET RES, V21, DOI 10.2196/12959
   Mash R, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0090-7
   Mathivha LR, 2002, CRIT CARE, V6, P22
   Mayosi BM, 2014, NEW ENGL J MED, V371, P1344, DOI 10.1056/NEJMsr1405012
   Moodley K, 2007, J MED ETHICS, V33, P673, DOI 10.1136/jme.2006.018432
   Murthy S, 2012, CRIT CARE, V16, DOI 10.1186/cc11140
   Naidoo K, 2013, SAMJ S AFR MED J, V103, P751, DOI [10.7196/SAMJ.6415, 10.7196/samj.6415]
   Oyedemi T, 2015, TELEMAT INFORM, V32, P11, DOI 10.1016/j.tele.2014.08.002
   Parker A, 2020, SAMJ S AFR MED J, V110, P463, DOI [10.7196/SAMJ.2020v110i6.14809, 10.7196/SAMJ.2020.v110i6.14809]
   Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002
   Smith CM, 2007, INTENS CARE MED, V33, P901, DOI 10.1007/s00134-007-0564-8
   van Deventer L, 2014, S AFR FAM PRACT, V56, P182, DOI 10.1080/20786204.2014.936667
   Zweli Mkhize hails, ZWEL MKHIZ HAILS BIG
NR 28
TC 0
Z9 0
U1 2
U2 2
PU AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET
PI KAMPALA
PA PO BOX 12874, KAMPALA, 00000, UGANDA
EI 1937-8688
J9 PAN AFR MED J
JI Pan Afr. Med. J.
PD SEP 16
PY 2021
VL 40
AR 41
DI 10.11604/pamj.2021.40.41.30134
PG 13
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA XB4HD
UT WOS:000721290600003
PM 34795822
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ahmadian, E
   Vahed, SZ
   Mammadova, S
   Abediazar, S
AF Ahmadian, Elham
   Vahed, Sepideh Zununi
   Mammadova, Shakar
   Abediazar, Sima
TI Immunosuppressant Management in Renal Transplant Patients with COVID-19
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID SOLID-ORGAN TRANSPLANTATION; ANTIBODY-MEDIATED REJECTION;
   KIDNEY-TRANSPLANTATION; CLINICAL PHARMACOKINETICS; TOCILIZUMAB;
   MORTALITY; PHARMACODYNAMICS; RECIPIENTS; AGENTS
AB The coronavirus disease 2019 (COVID-19) pandemic poses a special risk for both immunosuppressed patients, especially transplant recipients. Although the knowledge about this infection is growing, many uncertainties remain, particularly regarding the kidney. Kidney transplant recipients (KDRs) should be considered immunocompromised hosts since a potential risk for infection, comorbidity, and immunosuppression exposure exists. Additionally, the management of immunosuppressive agents in KDRs remains challenging. Potential drug interactions with immunosuppressive treatment escalated the risk of unwanted side effects. In this review, we aimed to attain an augmented awareness and improved management immunosuppressant for COVID-19 KDRs.
C1 [Ahmadian, Elham; Vahed, Sepideh Zununi; Abediazar, Sima] Tabriz Univ Med Sci, Kidney Res Ctr, Tabriz, Iran.
   [Mammadova, Shakar] Baku State Univ, Dept Phys Geog, Baku, Azerbaijan.
RP Abediazar, S (corresponding author), Tabriz Univ Med Sci, Kidney Res Ctr, Tabriz, Iran.
EM sima_abedi@yahoo.com
RI Ahmadian, Elham/P-8048-2017
OI Ahmadian, Elham/0000-0002-7230-0489
CR Abassi Z, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01312
   Ahmadian E, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2176
   Alberici F, 2020, KIDNEY INT REP, V5, P580, DOI 10.1016/j.ekir.2020.04.001
   AlGhamdi M, 2015, AM J TRANSPLANT, V15, P1101, DOI 10.1111/ajt.13085
   Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC
   Baang JH, 2021, J INFECT DIS, V223, P23, DOI 10.1093/infdis/jiaa666
   Bartiromo M, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13286
   Bergmann TK, 2012, CLIN PHARMACOKINET, V51, P711, DOI 10.1007/s40262-012-0007-8
   Caillard S, 2020, KIDNEY INT, V98, P1549, DOI 10.1016/j.kint.2020.08.005
   Campochiaro C, 2020, EUR J INTERN MED, V76, P43, DOI 10.1016/j.ejim.2020.05.021
   Capra R, 2020, EUR J INTERN MED, V76, P31, DOI 10.1016/j.ejim.2020.05.009
   Cellina M, 2020, DIAGN INTERV IMAG, V101, P323, DOI 10.1016/j.diii.2020.03.010
   Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005
   Chiu MC, 2003, PEDIATR NEPHROL, V18, P1204, DOI 10.1007/s00467-003-1325-8
   Choi J, 2017, AM J TRANSPLANT, V17, P2381, DOI 10.1111/ajt.14228
   Cukuranovic J, 2012, SCI WORLD J, DOI 10.1100/2012/820621
   Ortiz PD, 2020, NEFROLOGIA, V40, P253, DOI 10.1016/j.nefro.2020.03.001
   Della-Torre E, 2020, ANN RHEUM DIS, V79, P1277, DOI [10.1136/annrheumdis-2020-218122, 10.1136/annrheumdis-2020-218724, 10.1136/annrheumdis-2020-218759]
   Eftekhari A, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9020232
   Elias M, 2020, J AM SOC NEPHROL, V31, P2413, DOI 10.1681/ASN.2020050639
   Engelmann C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082352
   Fadel R, 2020, CLIN INFECT DIS, V71, P2114, DOI 10.1093/cid/ciaa601
   Fang XW, 2020, J INFECTION, V81, P147, DOI 10.1016/j.jinf.2020.03.039
   FINIELZ P, 1993, NEPHRON, V65, P333, DOI 10.1159/000187506
   Giacobbe DR, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13319
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hu BY, 2021, J MED VIROL, V93, P250, DOI 10.1002/jmv.26232
   Johnson KM, 2020, PHARMACOTHERAPY, V40, P517, DOI 10.1002/phar.2410
   Kates Olivia S, 2021, Clin Infect Dis, V73, pe4090, DOI 10.1093/cid/ciaa1097
   Kim M. Y., 2020, CURR TRANSPLANT REP, V108, P1
   Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479
   Kow CS, 2021, J INFECTION, V82, pE19, DOI 10.1016/j.jinf.2020.09.017
   Kumar D, 2003, AM J TRANSPLANT, V3, P977, DOI 10.1034/j.1600-6143.2003.00197.x
   Lansbury L., 2019, Cochrane Database of Systematic Reviews, pCD010406
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Lim MA, 2017, TRANSPLANT REV-ORLAN, V31, P10, DOI 10.1016/j.trre.2016.10.006
   Ling Y, 2020, CHINESE MED J-PEKING, V133, P1039, DOI 10.1097/CM9.0000000000000774
   Lopez V, 2020, NEFROLOGIA, V40, P265, DOI 10.1016/j.nefro.2020.03.002
   Lu XF, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02964-w
   Maeda T, 2021, J MED VIROL, V93, P463, DOI 10.1002/jmv.26365
   Mamode N, 2021, TRANSPLANTATION, V105, P212, DOI 10.1097/TP.0000000000003533
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Meziyerh S, 2020, AM J TRANSPLANT, V20, P1896, DOI 10.1111/ajt.15943
   Miarons M, 2021, TRANSPLANTATION, V105, P138, DOI 10.1097/TP.0000000000003460
   Michaels MG, 2020, AM J TRANSPLANT, V20, P1768, DOI 10.1111/ajt.15832
   Mo P., 2020, CLIN INFECT DIS, V71
   Moes DJAR, 2015, DRUG DISCOV TODAY, V20, P1243, DOI 10.1016/j.drudis.2015.05.006
   Nair V, 2020, AM J TRANSPLANT, V20, P1819, DOI 10.1111/ajt.15967
   NAMPOORY MRN, 1992, NEPHRON, V62, P108, DOI 10.1159/000187007
   Nikolich-Zugich J, 2020, GEROSCIENCE, V42, P505, DOI 10.1007/s11357-020-00186-0
   Pascual J, 2018, J AM SOC NEPHROL, V29, P1979, DOI 10.1681/ASN.2018010009
   Ponti G, 2020, CRIT REV CL LAB SCI, V57, P389, DOI 10.1080/10408363.2020.1770685
   Pouton N.G., 2020, TOCILIZUMAB ASS REDU, DOI [10.1101/2020.06.05.20113738, DOI 10.1101/2020.06.05.20113738]
   Rashidzadeh H, 2021, NANOMEDICINE-UK, V16, P497, DOI 10.2217/nnm-2020-0441
   Rilinger J, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04447-3
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Sarkisjan D., 2017, CHEMOTHERAPY LEUKEMI, P311
   Schuurmans M.M, 2020, TRANSPLANTOLOGY, V1, P71, DOI [10.3390/transplantology1020007, DOI 10.3390/TRANSPLANTOLOGY1020007]
   Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8
   Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3
   Snowsill TM, 2017, NEPHROL DIAL TRANSPL, V32, P1251, DOI 10.1093/ndt/gfx074
   Staatz CE, 2007, CLIN PHARMACOKINET, V46, P13, DOI 10.2165/00003088-200746010-00002
   Strehl C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01744
   Terpos E, 2020, AM J HEMATOL, V95, P834, DOI 10.1002/ajh.25829
   Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002
   van Maarseveen EM, 2012, AIDS PATIENT CARE ST, V26, P568, DOI 10.1089/apc.2012.0169
   Wan ER, 2021, KIDNEY BLOOD PRESS R, V46, P137, DOI 10.1159/000515194
   Wan SS, 2018, TRANSPLANTATION, V102, P557, DOI 10.1097/TP.0000000000002049
   Webb GJ, 2020, LANCET GASTROENTEROL, V5, P643, DOI 10.1016/S2468-1253(20)30125-4
   Xing Z, 2020, J LEUKOCYTE BIOL, V108, P825, DOI 10.1002/JLB.4MR0220-446R
   Yalameha B., 2020, J NEPHROPHARMACOLOGY, V9
   Zeng H, 2017, CANCER LETT, V408, P182, DOI 10.1016/j.canlet.2017.08.038
   Zhu L, 2020, AM J TRANSPLANT, V20, P1859, DOI 10.1111/ajt.15869
NR 75
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PD OCT 14
PY 2021
VL 2021
AR 9318725
DI 10.1155/2021/9318725
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA ZV1OH
UT WOS:000770304100010
PM 34692845
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Durst, S
   Acuache, MMGP
   Bruns, G
AF Durst, Susanne
   Acuache, Mariano Martin Genaro Palacios
   Bruns, Guido
TI Peruvian small and medium-sized enterprises and COVID-19: Time for a new
   start!
SO JOURNAL OF ENTREPRENEURSHIP IN EMERGING ECONOMIES
LA English
DT Article
DE Crisis; Latin America; Crisis management; Small and medium-sized
   enterprises; COVID-19; Corona; Peru
AB Purpose - Crises of any type have become an integral part of business activity and responses to them could make the difference between survival and failure. This applies in particular to small and medium-sized enterprises (SMEs). Taking the coronavirus (COVID-19) pandemic as a starting point, this study aims to investigate how Peruvian SMEs have been coping with COVID-19 so far. Based on that a conceptual framework is proposed which highlights the practice of SMEs trying to deal with a new type of crisis.
   Design/methodology/approach - The study is based on an exploratory qualitative research design involving 25 semi-structured interviews conducted in Peruvian SMEs.
   Findings - The findings demonstrate how the Peruvian firms studied to adapt to the new situation and initiate responses to increasing the chance of survival. Furthermore, the role of the companies' decision-makers, as well as the role of crisis management and other related approaches in the companies are shown.
   Research limitations/implications - The paper expands the underdeveloped body of knowledge regarding crisis management in Latin America in general and crisis management in SMEs by providing insight into how Peruvian SMEs perceive and adapt to the COVID-19 pandemic.
   Practical implications - The findings presented in this paper have implications for both managers and managerial staff of SMEs but also for the people in charge of the curricula at universities and other teaching-focused institutes.
   Originality/value - To the authors' knowledge, this is the first empirical study of crisis management on the impacts of COVID-19 with a dedicated focus on SMEs from Latin America. It provides fresh insight into current reactions to the Pandemic.
C1 [Durst, Susanne; Acuache, Mariano Martin Genaro Palacios; Bruns, Guido] Tallinn Univ Technol, Dept Business Adm, Tallinn, Estonia.
RP Durst, S (corresponding author), Tallinn Univ Technol, Dept Business Adm, Tallinn, Estonia.
EM susanne.durst@taltech.ee; mariano.palacios@taltech.ee;
   guido.bruns@taltech.ee
RI Durst, Susanne/J-8919-2017
OI Durst, Susanne/0000-0001-8469-2427
CR Aldairany S, 2018, J ENTREP EMERG ECON, V10, P361, DOI 10.1108/JEEE-06-2017-0042
   Cubillas FA, 2018, J ENTREP EMERG ECON, V10, P489, DOI 10.1108/JEEE-02-2018-0022
   [Anonymous], 2020, WORLD EC FORUM WEF
   ASEP, 2018, SOL 3 PROGR EST EMPR
   Ayres L., 2008, SAGE ENCY QUALITATIV, P867, DOI DOI 10.4135/9781412963909.N451
   Batten JA, 2017, J BANK FINANC, V77, P328, DOI 10.1016/j.jbankfin.2016.07.011
   Boin A, 2016, PUBLIC ADMIN, V94, P289, DOI 10.1111/padm.12264
   Bosma N., 2019, GLOBAL ENTREPRENEURS
   Branicki LJ, 2018, INT J ENTREP BEHAV R, V24, P1244, DOI 10.1108/IJEBR-11-2016-0396
   Brumfield K., 2012, FINANC EXECUTIVE, P45
   Bullough A, 2013, BUS HORIZONS, V56, P343, DOI 10.1016/j.bushor.2013.01.001
   Bundy J, 2017, J MANAGE, V43, P1661, DOI 10.1177/0149206316680030
   Cardona O., 2008, TECNOLOG A HUMANISMO, V3, P1
   Cater JJ, 2014, J FAM BUS MANAG, V4, P62, DOI 10.1108/JFBM-02-2013-0006
   Chin GT, 2010, INT AFF, V86, P693, DOI 10.1111/j.1468-2346.2010.00906.x
   Commission of the European Communities, 2005, OFFICIAL J EUROPEAN, VL124, P36
   Coombs, 2007, CRISIS MANAGEMENT CO
   Curran J., 2001, RES SMALL ENTERPRISE
   Dai L, 2017, STRATEGIC MANAGE J, V38, P1478, DOI 10.1002/smj.2599
   Davidsson P, 2016, ENTREP THEORY PRACT, V40, P915, DOI 10.1111/etap.12152
   Doern R, 2019, ENTREP REGION DEV, V31, P400, DOI 10.1080/08985626.2018.1541590
   Doern R, 2016, ENTREP REGION DEV, V28, P471, DOI 10.1080/08985626.2016.1198091
   Doern R, 2016, INT SMALL BUS J, V34, P276, DOI 10.1177/0266242614553863
   Durst S, 2011, PROMETHEUS, V29, P23, DOI 10.1080/08109028.2011.565693
   Durst S, 2012, J KNOWL MANAG, V16, P879, DOI 10.1108/13673271211276173
   Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   European Centre for Disease Prevention and Control, 2020, COVID 19 SIT UPD WOR
   Faghfouri P, 2015, REV MANAG SCI, V9, P317, DOI 10.1007/s11846-014-0158-0
   Fereday J., 2006, INT J QUAL METH, V5, P1, DOI [10.1177/160940690600500107, DOI 10.1177/160940690600500107]
   FISCHER S, 1987, AM ECON REV, V77, P165
   Galafassi, 2002, DEMOCRACY NATURE, V8, P117
   Gamarra, 2020, INICIATIVAS EMPRESAR
   Gilstrap CA, 2016, VOLUNTAS, V27, P2787, DOI 10.1007/s11266-015-9648-1
   Gray D.E., 2017, DOING RES BUSINESS W
   Herbane B, 2019, ENTREP REGION DEV, V31, P476, DOI 10.1080/08985626.2018.1541594
   Herbane B, 2013, J CONTING CRISIS MAN, V21, P82, DOI 10.1111/1468-5973.12006
   Herbane B, 2010, INT SMALL BUS J, V28, P43, DOI 10.1177/0266242609350804
   Hofstede Insights, 2020, WHAT PER
   Hong Paul, 2012, International Journal of Business Excellence, V5, P535, DOI 10.1504/IJBEX.2012.048802
   Huapaya A., 2007, REV ALTERNATIVA FINA, V4, P15
   Institute for Crisis Management, 2004, ANN ICM CRIS REP NEW
   Institute for Public Relations, 2020, COVID 19 BUS AR HAND
   International Trade Centre, 2020, EX SUMM COVID 19 GRE
   Ito T., 2004, JAPANESE EC REV, V55
   John M., 2019, MIGRATION DEV, V8, P437, DOI [10.1080/21632324.2018.1502003, DOI 10.1080/21632324.2018.1502003]
   Kiss AN, 2012, J BUS VENTURING, V27, P266, DOI 10.1016/j.jbusvent.2011.09.004
   Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214
   Kraus S, 2013, INT J ENTREP VENTUR, V5, P406, DOI 10.1504/IJEV.2013.058169
   Kuan Yew Wong, 2004, Journal of Knowledge Management, V8, P44, DOI 10.1108/13673270410541033
   Kuckertz A., 2020, J BUS VENTURING INSI, DOI 10.1016/j.jbvi.2020.e00169
   Kucher A, 2019, J BUS RES, V98, P503, DOI 10.1016/j.jbusres.2018.05.017
   Kvale S., 2009, INTERVIEWS LEARNING
   Lacerda TC, 2019, BUS HORIZONS, V62, P185, DOI 10.1016/j.bushor.2018.08.005
   Lai YQ, 2016, J BUS VENTURING, V31, P113, DOI 10.1016/j.jbusvent.2015.04.005
   Liodakis G, 2018, INT CRIT THOUGHT, V8, P46, DOI 10.1080/21598282.2017.1357487
   Liu J, 2019, J ENTREP EMERG ECON, V11, P22, DOI 10.1108/JEEE-02-2017-0014
   Liu Y, 2017, J MARKETING, V81, P30, DOI 10.1509/jm.15.0535
   McCarthy B., 2003, Management Decision, V41, P327, DOI 10.1108/00251740310468081
   McNair-Connolly, 2017, EFFECTIVE RESPONSE S
   Melo MA, 2016, J DEMOCR, V27, P50, DOI 10.1353/jod.2016.0019
   Miles M.B., 1994, QUALITATIVE DATA ANA
   Ministerio de Salud del Per?, 2020, COVID 19 PER
   Morehouse, 1994, PHILOS PRACTICAL GUI
   Osiyevskyy O, 2020, J BUS RES, V114, P227, DOI 10.1016/j.jbusres.2020.04.015
   Parnell JA, 2015, J CONTING CRISIS MAN, V23, P221, DOI 10.1111/1468-5973.12060
   Patton M.Q., 2002, QUALITATIVE RES EVAL, V3rd
   Perry C., 1998, EUR J MARKETING, V32, P785, DOI DOI 10.1108/03090569810232237
   Quenan, 2013, IDEAS AUTOMNE, V4, DOI [10.4000/ideas.780, DOI 10.4000/IDEAS.780]
   Rapaccini M, 2020, IND MARKET MANAG, V88, P225, DOI 10.1016/j.indmarman.2020.05.017
   Ratten V., 2020, J SMALL BUSINESS ENT, V32, P503, DOI DOI 10.1080/08276331.2020.1790167
   REMMER KL, 1990, WORLD POLIT, V42, P315, DOI 10.2307/2010414
   Saunders M., 2009, RES METHODS BUSINESS
   Schoenberg R, 2013, EUR BUS REV, V25, P243, DOI 10.1108/09555341311314799
   Scott G.J., 2013, J GLOBAL INITIATIVES, V7
   Shepherd B., 2014, OECD TRADE POLICY PA, V165
   Short JC, 2010, ORGAN RES METHODS, V13, P6, DOI 10.1177/1094428109342448
   Sieger P., 2019, GLOBAL STUDENT ENTRE
   Smallbone D., 1999, ENTREP REGION DEV, V11, P109, DOI DOI 10.1080/089856299283227
   Smith L, 2012, SCH LEADERSH MANAG, V32, P57, DOI 10.1080/13632434.2011.614941
   Stephan U, 2018, ACAD MANAGE PERSPECT, V32, P290, DOI 10.5465/amp.2017.0001
   Trahms CA, 2013, J MANAGE, V39, P1277, DOI 10.1177/0149206312471390
   Wang YJ, 2020, J INT MANAG, V26, DOI 10.1016/j.intman.2019.100708
   WELSH JA, 1981, HARVARD BUS REV, V59, P18
   Wenzel M, 2021, STRATEGIC MANAGE J, V42, pV7, DOI 10.1002/smj.3161
   Williams GA, 2017, COMMUN STUD, V68, P385, DOI 10.1080/10510974.2017.1340901
   Wincent J, 2008, SCAND J MANAG, V24, P232, DOI 10.1016/j.scaman.2008.04.001
NR 87
TC 7
Z9 7
U1 7
U2 22
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2053-4604
EI 2053-4612
J9 J ENTREP EMERG ECON
JI J. Entrep. Emerg. Econ.
PD SEP 9
PY 2021
VL 13
IS 4
SI SI
BP 648
EP 672
DI 10.1108/JEEE-06-2020-0201
EA FEB 2021
PG 25
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA UM8XV
UT WOS:000614560100001
DA 2022-04-20
ER

PT J
AU Pekkola, E
   Siekkinen, T
   Kujala, EN
   Kanniainen, JP
   Laihonen, H
AF Pekkola, Elias
   Siekkinen, Taru
   Kujala, Emmi-Niina
   Kanniainen, Jari-Pekka
   Laihonen, Harri
TI An assessment of COVID-19's impact on Finnish University Leadership
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE Higher education; COVID-19; leadership; coordination; Finland
AB This article maps the management actions that Finnish universities have taken during the COVID-19 pandemic and studies how managers in Finnish higher education coped during the crisis and how they feel about it. The article uses action mapping and a survey that was administered to top- and mid-level managers at Finnish universities, and the findings highlight the importance of collegial coordination and maintenance work abilities among managers.
C1 [Pekkola, Elias; Kujala, Emmi-Niina; Kanniainen, Jari-Pekka] Tampere Univ, Fac Management & Business, Unit Adm Studies, Tampere 33140, Finland.
   [Siekkinen, Taru] Univ Jyvaskyla, Finnish Inst Educ Res, Jyvaskyla, Finland.
   [Laihonen, Harri] Univ Eastern Finland, Fac Social Sci & Business Studies, Dept Hlth & Social Management, Kuopio, Finland.
RP Pekkola, E (corresponding author), Tampere Univ, Fac Management & Business, Unit Adm Studies, Tampere 33140, Finland.
EM elias.pekkola@tuni.fi
RI Laihonen, Harri/AAS-8258-2020
OI Laihonen, Harri/0000-0002-5836-5649; Pekkola, Elias/0000-0002-4805-7423;
   Kanniainen, Jari-Pekka/0000-0002-1984-7290; Siekkinen,
   Taru/0000-0001-7853-9979
FU Finnish Union of University Professors
FX This work was supported by the Finnish Union of University Professors
CR BENDAVID J, 1962, ARCH EUR SOCIOL, V3, P45
   Birnbaum R, 1989, COLL WORK CYBERNETIC
   Bleiklie I, 2017, PALG STUD GLOB HIGHE, P3, DOI 10.1007/978-3-319-53865-5_1
   Bolden R, 2009, EDUC MANAG ADM LEAD, V37, P257, DOI 10.1177/1741143208100301
   Carvalho T, 2010, HIGH EDUC DYNAM, V33, P165, DOI 10.1007/978-90-481-9163-5_9
   Comfort LK, 2007, PUBLIC ADMIN REV, V67, P189, DOI 10.1111/j.1540-6210.2007.00827.x
   Deem R, 2005, OXFORD REV EDUC, V31, P217, DOI 10.1080/03054980500117827
   Enders J., 2001, ACAD STAFF EUROPE CH
   FARAZM A, 2007, PUBLIC ADMIN REV, V67
   Garnett JL, 2007, PUBLIC ADMIN REV, V67, P171, DOI 10.1111/j.1540-6210.2007.00826.x
   Gosling J, 2009, LEADERSHIP-LONDON, V5, P299, DOI 10.1177/1742715009337762
   Gupta AK, 2006, ACAD MANAGE J, V49, P693, DOI 10.2307/20159793
   Hansen MT, 1999, HARVARD BUS REV, V77, P106
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Huther O, 2016, RES SOCIOL ORGAN-RES, V46, P53, DOI 10.1108/S0733-558X20160000046003
   Johanson J.E., 2020, HYBRID GOVERNANCE OR, P59
   Kapyla J, 2011, KNOWL MAN RES PRACT, V9, P315, DOI 10.1057/kmrp.2011.23
   Laihonen H, 2020, KNOWL MAN RES PRACT, DOI 10.1080/14778238.2020.1794993
   March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71
   Massaro M, 2015, J KNOWL MANAG, V19, P530, DOI 10.1108/JKM-11-2014-0466
   Musselin C., 2007, MULTIVERSITY U GLOBA, P63, DOI DOI 10.14361/9783839404683-004
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14
   Pekkola E., 2019, GOVT POLICY ROLE STA
   Quarchioni S, 2020, KNOWL MAN RES PRACT, DOI 10.1080/14778238.2020.1730717
   Schreyogg G, 2010, ORGAN SCI, V21, P1251, DOI 10.1287/orsc.1100.0561
   Siekkinen, 2019, THESIS U JYVASKYLA
   Spender J.-C., 2014, BUSINESS STRATEGY MA
   Stensaker B, 2018, INT J ACAD DEV, V23, P274, DOI 10.1080/1360144X.2017.1366322
   Tiirinki H, 2020, HEALTH POLICY TECHN, V9, P649, DOI 10.1016/j.hlpt.2020.08.005
   Tiplic D., 2006, HIGHER ED GOVERNANCE, V5, P135
   WEICK KE, 1976, ADMIN SCI QUART, V21, P1, DOI 10.2307/2391875
NR 31
TC 0
Z9 0
U1 11
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 510
EP 516
DI 10.1080/14778238.2021.1906773
EA APR 2021
PG 7
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000638454900001
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Sharmin, A
   Rahman, MA
   Ahmed, S
   Ali, SM
AF Sharmin, Aliza
   Rahman, Md Adib
   Ahmed, Sayem
   Ali, Syed Mithun
TI Addressing critical success factors for improving concurrent emergency
   management: lessons learned from the COVID-19 pandemic
SO ANNALS OF OPERATIONS RESEARCH
LA English
DT Article; Early Access
DE Concurrent emergency management; Critical success factors; COVID-19;
   Disaster risk; Floods; Revised rough DEMATEL
ID SUPPLY CHAIN MANAGEMENT; RESOURCE-ALLOCATION; DEMATEL METHOD; BARRIERS;
   DISASTER; SETS
AB The world is witnessing a difficult time trying to circumscribe the spread of COVID-19 pandemic. The situation has become even more challenging as several natural disasters and emergencies coincided with this pandemic and created a situation of concurrent emergency. Effectively managing concurrent emergencies are extremely challenging. Only by utilizing and applying the knowledge gathered while combating a real-life concurrent emergency, one can further be prepared to face such emergencies. Hence, this study intends to identify the critical success factors (CSFs) having a major role in effective management of concurrent emergencies and evaluate the indispensable links among the factors. Twelve CSFs are identified from Pareto analysis, for which feedback from 46 experts involved in the management of emergencies is utilized. In addition, the revised rough-decision making trial and evaluation laboratory (rough-DEMATEL) approach is suggested to analyze the indispensable links among the CSFs and further, these factors are ranked based on the average vector length. The recent case of concurrent emergency in Bangladesh- floods amid a pandemic is considered to establish the applicability of this method. The findings of this research reveal that to handle concurrent emergencies 'Incremental improvement of proactive measures', 'Resilient supply chain and logistics network', and 'Government leadership and military cooperation' are the most critical factors to concurrent emergency management (CEM). These CSFs play a major role in ensuring the effectiveness of CEM. Thus, this study can be a building block in developing an effective CEM plan for the policymakers, managers, and practitioners.
C1 [Sharmin, Aliza; Rahman, Md Adib; Ahmed, Sayem] Ahsanullah Univ Sci & Technol, Dept Mech & Prod Engn, Dhaka 1208, Bangladesh.
   [Ali, Syed Mithun] Bangladesh Univ Engn & Technol, Dept Ind & Prod Engn, Dhaka 1000, Bangladesh.
RP Ali, SM (corresponding author), Bangladesh Univ Engn & Technol, Dept Ind & Prod Engn, Dhaka 1000, Bangladesh.
EM aliza.ipe@aust.edu; adib.ipe@aust.edu; sayem.ipe@aust.edu;
   mithun@ipe.buet.ac.bd
RI Ahmed, Sayem/ABB-3184-2020; Ali, Syed Mithun/AAF-8674-2020
OI Ahmed, Sayem/0000-0001-9360-1160; Ali, Syed Mithun/0000-0002-4302-5991;
   Sharmin, Aliza/0000-0002-2285-845X
CR Ab Talib MS, 2015, EUROMED J BUS, V10, P234, DOI 10.1108/EMJB-09-2014-0028
   Aburas W, 2020, SAUDI PHARM J, V28, P1797, DOI 10.1016/j.jsps.2020.11.006
   Adhikari B, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020367
   Ahmed S., 2021, GLOBAL J FLEXIBLE SY, DOI [10.1007/s40171-021-00267-9, DOI 10.1007/S40171-021-00267-9]
   [Anonymous], 2021, COVID 19 MAP JOHNS H
   Aschemann-Witzel J, 2017, J CLEAN PROD, V155, P33, DOI 10.1016/j.jclepro.2016.11.173
   Bai CG, 2013, INT J PROD ECON, V146, P281, DOI 10.1016/j.ijpe.2013.07.011
   Banik A, 2020, INT J LOGIST-RES APP, DOI 10.1080/13675567.2020.1839029
   Behl A, 2019, IFAC PAPERSONLINE, V52, P159, DOI 10.1016/j.ifacol.2019.11.169
   Behl A, 2019, ANN OPER RES, V283, P1001, DOI 10.1007/s10479-018-2806-2
   Bhatia MS, 2018, RESOUR CONSERV RECY, V136, P79, DOI 10.1016/j.resconrec.2018.03.021
   Borowski Elisa, 2021, Transp Res Interdiscip Perspect, V10, P100352, DOI 10.1016/j.trip.2021.100352
   Cao YB, 2020, ACAD EMERG MED, V27, P309, DOI 10.1111/acem.13951
   Celik E, 2016, COMPUT IND ENG, V101, P21, DOI 10.1016/j.cie.2016.08.020
   Chan DWK, 2020, Int J Nurs Sci, V7, P382, DOI 10.1016/j.ijnss.2020.06.004
   Civljak R, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010349
   Dalalah D, 2011, EXPERT SYST APPL, V38, P8384, DOI 10.1016/j.eswa.2011.01.031
   Davis I., 2014, DISASTER RISK MANAGE, DOI [10.4324/9781315761336, DOI 10.4324/9781315761336]
   Ding XF, 2018, APPL SOFT COMPUT, V71, P386, DOI 10.1016/j.asoc.2018.07.018
   Dinter B, 2013, DECIS SUPPORT SYST, V54, P1207, DOI 10.1016/j.dss.2012.09.001
   Dubey R, 2021, INT J PROD RES, V59, P1586, DOI 10.1080/00207543.2020.1865583
   Dubey R, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03824-0
   Dubey R, 2020, INT J PROD RES, V58, P3381, DOI 10.1080/00207543.2020.1722860
   Dubey R, 2019, ANN OPER RES, V283, P1, DOI 10.1007/s10479-019-03440-7
   Dubey R, 2019, INT J PROD ECON, V210, P120, DOI 10.1016/j.ijpe.2019.01.023
   Ebrahim SH, 2020, LANCET PLANET HEALTH, V4, pE379, DOI 10.1016/S2542-5196(20)30175-3
   Edjossan-Sossou AM, 2020, INT J DISAST RISK RE, V45, DOI 10.1016/j.ijdrr.2020.101474
   Etikan I., 2017, BIOMETRICS BIOSTATIS, V5, P215, DOI [DOI 10.15406/BBIJ.2017.05.00149, 10.15406/bbij.2017.05.00149]
   Fotopoulos C, 2011, BRIT FOOD J, V113, P578, DOI 10.1108/00070701111131700
   Gersons BPR, 2020, EUR J PSYCHOTRAUMATO, V11, DOI 10.1080/20008198.2020.1815283
   Gunessee S, 2018, INT J PROD RES, V56, P6793, DOI 10.1080/00207543.2017.1414330
   Guo FL, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03671-z
   Han YZ, 2018, J AMB INTEL HUM COMP, V9, P1933, DOI 10.1007/s12652-018-0882-4
   Han YZ, 2018, SOFT COMPUT, V22, P5073, DOI 10.1007/s00500-018-3311-x
   Ishiwatari M, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100096
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Kaur J, 2019, INT J MANAG SCI ENG, V14, P113, DOI 10.1080/17509653.2018.1504237
   Khoo LP, 1999, INT J ADV MANUF TECH, V15, P438, DOI 10.1007/s001700050088
   Leake, 2002, MANAGE DECIS, V40, P729, DOI DOI 10.1108/00251740210437699
   Li Y, 2014, APPL SOFT COMPUT, V22, P504, DOI 10.1016/j.asoc.2014.03.042
   Lin KP, 2018, RESOUR CONSERV RECY, V128, P134, DOI 10.1016/j.resconrec.2016.11.017
   Liu XD, 2019, ADAPT BEHAV, V27, P331, DOI 10.1177/1059712319858623
   Liu ZW, 2019, INT J PROD RES, V57, P7104, DOI 10.1080/00207543.2019.1577566
   Mao WX, 2019, NAT HAZARDS, V97, P1025, DOI 10.1007/s11069-019-03684-3
   Meibodi Leili Aghaei, 2010, Business Strategy Series, V11, P124, DOI 10.1108/17515631011026443
   Modgil S, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03695-5
   Moktadir MA, 2018, J CLEAN PROD, V181, P631, DOI 10.1016/j.jclepro.2018.01.245
   Oloruntoba R, 2010, INT J PROD ECON, V126, P85, DOI 10.1016/j.ijpe.2009.10.013
   Pankow KL, 2021, SEISMOL RES LETT, V92, P6, DOI 10.1785/0220200265
   Peters K., 2020, REDUCING RISK PROTRA
   Phillips CA, 2020, NAT CLIM CHANGE, V10, P586, DOI 10.1038/s41558-020-0804-2
   Prager F, 2017, RISK ANAL, V37, P4, DOI 10.1111/risa.12625
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Rajesh R, 2015, COMPUT IND ENG, V87, P126, DOI 10.1016/j.cie.2015.04.028
   Rathnayake DK, 2020, INT J DISASTER RESIL, V11, P275, DOI 10.1108/IJDRBE-07-2019-0050
   Rivera J., 2020, PROGR DISASTER SCI, V6, DOI [10.1016/j.pdisas.2020.100075, DOI 10.1016/J.PDISAS.2020.100075]
   Sakurai M, 2020, EUR J INFORM SYST, V29, P585, DOI 10.1080/0960085X.2020.1814171
   Salim HK, 2019, RESOUR CONSERV RECY, V150, DOI 10.1016/j.resconrec.2019.104444
   Sardjono W, 2020, AIP CONF PROC, V2245, DOI 10.1063/5.0006797
   Sasangohar F, 2020, HUM FACTORS, V62, P1061, DOI 10.1177/0018720820939428
   Simonovic SP, 2021, WIRES WATER, V8, DOI 10.1002/wat2.1509
   Song WY, 2018, J CLEAN PROD, V172, P1592, DOI 10.1016/j.jclepro.2017.10.092
   Song WY, 2017, COMPUT IND ENG, V110, P353, DOI 10.1016/j.cie.2017.06.020
   Su ZP, 2016, INT J DISAST RISK RE, V17, P199, DOI 10.1016/j.ijdrr.2016.05.003
   Venkatesh VG, 2017, TRANSPORT RES D-TR E, V52, P362, DOI 10.1016/j.trd.2017.03.016
   Visuthismajarn, 2018, KASETSART J SOC SCI, V39, P269, DOI [10.1016/j.kjss.2018.01.005, DOI 10.1016/J.KJSS.2018.01.005]
   WHO, 2019, HLTH EM DIS RISK MAN
   Worldometer, 2021, BANGL COR
   Doan XV, 2019, EUR J OPER RES, V274, P687, DOI 10.1016/j.ejor.2018.10.015
   Yadav DK, 2015, INT J DISAST RISK RE, V12, P213, DOI 10.1016/j.ijdrr.2015.01.008
   Zhai LY, 2008, INT J ADV MANUF TECH, V37, P613, DOI 10.1007/s00170-007-0989-9
   Zhai LY, 2009, EXPERT SYST APPL, V36, P7072, DOI 10.1016/j.eswa.2008.08.068
   Zhou Q, 2011, SAFETY SCI, V49, P243, DOI 10.1016/j.ssci.2010.08.005
   Zhou XY, 2017, SAFETY SCI, V91, P93, DOI 10.1016/j.ssci.2016.06.014
NR 74
TC 0
Z9 0
U1 10
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0254-5330
EI 1572-9338
J9 ANN OPER RES
JI Ann. Oper. Res.
DI 10.1007/s10479-021-04447-9
EA DEC 2021
PG 35
WC Operations Research & Management Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Operations Research & Management Science
GA XH4SK
UT WOS:000725426100002
PM 34876767
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Ferrari, D
   Seveso, A
   Sabetta, E
   Ceriotti, D
   Carobene, A
   Banfi, G
   Locatelli, M
   Cabitza, F
AF Ferrari, Davide
   Seveso, Andrea
   Sabetta, Eleonora
   Ceriotti, Daniele
   Carobene, Anna
   Banfi, Giuseppe
   Locatelli, Massimo
   Cabitza, Federico
TI Role of time-normalized laboratory findings in predicting COVID-19
   outcome
SO DIAGNOSIS
LA English
DT Article
DE aminotransferase; COVID-19; laboratory parameters; lactate
   dehydrogenase; longitudinal; lymphocytes; neutrophils; time-dependent;
   white blood cells (WBC)
ID DISEASE 2019 COVID-19
AB Objectives: The pandemic COVID-19 currently reached 213 countries worldwide with nearly 9 million infected people and more than 460,000 deaths. Although several Chinese studies, describing the laboratory findings characteristics of this illness have been reported, European data are still scarce. Furthermore, previous studies often analyzed the averaged laboratory findings collected during the entire hospitalization period, whereas monitoring their time-dependent variations should give more reliable prognostic information.
   Methods: We analyzed the time-dependent variations of 14 laboratory parameters in two groups of COVID-19 patients with, respectively, a positive (40 patients) or a poor (42 patients) outcome, admitted to the San Raffaele Hospital (Milan, Italy). We focused mainly on laboratory parameters that are routinely tested, thus, prognostic information would be readily available even in low-resource settings.
   Results: Statistically significant differences between the two groups were observed for most of the laboratory findings analyzed. We showed that some parameters can be considered as early prognostic indicators whereas others exhibit statistically significant differences only at a later stage of the disease. Among them, earliest indicators were: platelets, lymphocytes, lactate dehydrogenase, creatinine, alanine aminotransferase, C-reactive protein, white blood cells and neutrophils.
   Conclusions: This longitudinal study represents, to the best of our knowledge, the first study describing the laboratory characteristics of Italian COVID-19 patients on a normalized time-scale. The time-dependent prognostic value of the laboratory parameters analyzed in this study can be used by clinicians for the effective treatment of the patients and for the proper management of intensive care beds, which becomes a critical issue during the pandemic peaks.
C1 [Ferrari, Davide] Univ Parma, SCVSA Dept, Parma, Italy.
   [Ferrari, Davide; Sabetta, Eleonora; Ceriotti, Daniele; Carobene, Anna; Locatelli, Massimo] Osped San Raffaele, Lab Med Serv, Milan, Italy.
   [Seveso, Andrea; Cabitza, Federico] Univ Milano Bicocca, Milan, Italy.
   [Sabetta, Eleonora; Ceriotti, Daniele; Banfi, Giuseppe] Univ Vita Salute San Raffaele, Milan, Italy.
   [Banfi, Giuseppe] IRCCS Ist Ortoped Galeazzi, Milan, Italy.
RP Ferrari, D (corresponding author), Univ Parma, SCVSA Dept, Parma, Italy.; Ferrari, D (corresponding author), Osped San Raffaele, Lab Med Serv, Milan, Italy.
EM davide.ferrari@unipr.it
OI ferrari, davide/0000-0001-7084-6800; Ceriotti,
   Daniele/0000-0002-0270-4058
CR Aggarwal S, 2020, DIAGNOSIS, V7, P91, DOI 10.1515/dx-2020-0046
   Bangash MN, 2020, LANCET GASTROENTEROL, V5, P529, DOI 10.1016/S2468-1253(20)30084-4
   Bonetti G, 2020, CLIN CHEM LAB MED, V58, P1100, DOI 10.1515/cclm-2020-0459
   Cheng ZH, 2020, AM J ROENTGENOL, V215, P121, DOI 10.2214/AJR.20.22959
   Ciccocioppo R, 2014, CYTOTHERAPY, V16, P1080, DOI 10.1016/j.jcyt.2014.03.002
   Davide Ferrari, 2020, ACTA BIOMEDICA, V91
   Ferrari D, 2020, CLIN CHEM LAB MED, V58, P1095, DOI 10.1515/cclm-2020-0398
   Ferrari D, 2019, PHOTOCH PHOTOBIO SCI, V18, P2696, DOI 10.1039/c9pp00372j
   Ferrari D, 2019, J PHARMACEUT BIOMED, V169, P11, DOI 10.1016/j.jpba.2019.02.037
   Gao L, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01352-w
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lei F, 2020, HEPATOLOGY, V72, P389, DOI 10.1002/hep.31301
   Lippi G, 2020, J MED VIROL, V92, P1759, DOI 10.1002/jmv.25860
   Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763
   Nap RE, 2008, EMERG INFECT DIS, V14, P1518, DOI 10.3201/eid1410.080440
   Nigam PK, 2007, INDIAN J CLIN BIOCHE, V22, P10, DOI 10.1007/BF02912874
   Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126
   Rismanbaf A, 2020, ARCH ACAD EMERG MED, V8
   Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tosato F, 2020, CLIN CHEM LAB MED, V58, P1149, DOI 10.1515/cclm-2020-0319
   Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108
   Wei S., 2020, ZHONGHUA JIE HE HE H, V43, P203, DOI [10.3760/cmaj.issn.1001-0939.2020.03.013, DOI 10.3760/CMA.J.ISSN.1001-0939.2020.0005]
   Worldometers, COVID 19 STAT
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   ZENG QJ, 2020, ARCH INTERN MED, V29, P400, DOI DOI 10.1080/10670564.2019.1645489
   Zhang Jing, 2020, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V41, P57, DOI 10.16872/j.cnki.1671-4652.2020.02.010
   Zhao DH, 2020, CLIN INFECT DIS, V71, P756, DOI 10.1093/cid/ciaa247
NR 32
TC 2
Z9 2
U1 0
U2 0
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 2194-8011
EI 2194-802X
J9 DIAGNOSIS
JI Diagnosis
PD DEC
PY 2020
VL 7
IS 4
SI SI
BP 387
EP 394
DI 10.1515/dx-2020-0095
PG 8
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA OU2TX
UT WOS:000591387300010
PM 33035183
OA Bronze
DA 2022-04-20
ER

PT J
AU Gul, M
AF Gul, Marcin
TI New challenges in sales management in the context of modern technologies
   development and the COVID-19 pandemic
SO E-MENTOR
LA Polish
DT Article
DE sales management; sales strategy; sales function; sales department;
   COVID-19 pandemic; digitalization of services
ID SOCIAL MEDIA; REVOLUTION
AB The purpose of the article is to systematize the knowledge on sales strategy and answer the question of whether current socio-economic conditions in the form of progressive digitalization and evolution of the sales function induce to update the definition of sales strategy. Furthermore, the study aims to verify whether the COVID-19 pandemic forces companies to reformulate their sales strategy. A non-systematic literature review supplemented by qualitative research was used as the research method. The first part of the paper presents the theoretical backgrounds of the analysis based on the literature review. The second part presents the results of the own research, enriched by the data from existing studies. Then, the results of the conducted discussion are presented. The final part of the paper contains a summary and the author's definition of sales management, focusing on sales strategy and a potential direction for future research. According to the analysis, the greatest challenge in implementing the assumed sales strategy is currently the COVID-19 pandemic, which significantly affects consumer behavior and limits market activities. However, with widespread access to advanced technologies and a flexible approach to strategy, most of the surveyed companies can meet their financial targets despite the economic crisis caused by the pandemic. When defining a sales strategy, it is necessary to consider the aspect of progressing digitalization and the evolution of the sales function, closely integrated with the marketing function.
C1 [Gul, Marcin] Szkola Glowna Handlowa Warszawie, Warsaw, Poland.
RP Gul, M (corresponding author), Szkola Glowna Handlowa Warszawie, Warsaw, Poland.
CR Ambroziak L., 2020, Zeszyty Naukowe Szkoly Glownej Gospodarstwa Wiejskiego w Warszawie - Problemy Rolnictwa Swiatowego, V20, P5, DOI 10.22630/PRS.2020.20.4.18
   Bages-Amat A., 2020, THESE 8 CHARTS SHOW
   Baldwin R., 2020, EC TIME COVID 19, P59
   Bothe J., 2021, 7 BASIQ INT C NEW TR
   Calvin R. J., 2001, SALES MANAGEMENT
   Corbin J.M., 2008, BASICS QUALITATIVE R, V3rd ed., P127, DOI DOI 10.4135/9781452230153
   Cybulski K., 2020, ZARZADZANIE DZIALEM
   Dannenberg H., 2009, EXCELLENCE SALES, P59, DOI [10.1007/978-3- 8349-8782-2_5, DOI 10.1007/978-3-8349-8782-2_5]
   Davenport T, 2020, J ACAD MARKET SCI, V48, P24, DOI 10.1007/s11747-019-00696-0
   Enyinda CI, 2021, J BUS IND MARK, V36, P990, DOI 10.1108/JBIM-01-2019-0053
   EverString, 2018, STAT ART INT B2B MAR
   Geiger S, 2009, EUR J MARKETING, V43, P873, DOI 10.1108/03090560910961434
   Gupta S., 2017, DIGITAL REVOLUTIONS
   Harrison L., 2020, B2B SALES HAVE CHANG
   Hoeft F, 2021, STRATEG CHANG, V30, P117, DOI 10.1002/jsc.2395
   Ingram ThomasN., 2012, SALES MANAGEMENT ANA, V9th ed
   Jobber D., 2019, SELLING SALES MANAGE
   Johnson JS, 2015, J PERS SELL SALES M, V35, P262, DOI 10.1080/08853134.2014.954581
   JOHNSON JS, 2020, J PERS SELL SALES M, V40, P19, DOI 10.1080/08853134.2019.1604143
   Koldyshev M. V., 2020, INT J INNOVATIVE TEC, V4, DOI [10.31435/rsglobal_ ijite/30092020/7149, DOI 10.31435/RSGL0BAL_]
   Lane N, 2009, J STRATEG MARK, V17, P307, DOI 10.1080/09652540903064886
   Lashgari M, 2018, J BUS IND MARK, V33, P730, DOI 10.1108/JBIM-10-2016-0242
   Leigh T. W., 2001, J PERSONAL SELLING S, V21, P83
   Lilien GL, 2016, INT J RES MARK, V33, P543, DOI 10.1016/j.ijresmar.2016.01.003
   Lofland J., 1995, ANAL SOCIAL SETTINGS, V3rd ed.
   Marshall GW, 2012, J PERS SELL SALES M, V32, P349, DOI 10.2753/PSS0885-3134320305
   Mattila M, 2021, J PERS SELL SALES M, V41, P113, DOI 10.1080/08853134.2021.1916396
   MATTIOLI D, 2020, WALL STREET J
   Maxwell J.A., 2008, SAGE HDB APPL SOCIAL, P214
   Murawska M., 2020, NOWOCZESNE SYSTEMY Z, V15, P79, DOI [10.37055/nsz/134106, DOI 10.37055/NSZ/134106]
   Palmer Timothy B., 2016, Journal of Business Strategy, V37, P28, DOI 10.1108/JBS-09-2015-0095
   Panagopoulos NG, 2010, INT J RES MARK, V27, P46, DOI 10.1016/j.ijresmar.2009.11.001
   Paschen J, 2021, AUSTRALAS MARK J, V29, P243, DOI 10.1016/j.ausmj.2020.06.004
   Paschen J, 2020, BUS HORIZONS, V63, P403, DOI 10.1016/j.bushor.2020.01.003
   Pereira DF, 2020, INT J PROD ECON, V228, DOI 10.1016/j.ijpe.2020.107695
   Pindelski M., 2011, STRATEGICZNE OPERACY, P218
   Prieto F., 2021, INT J ADV ENG RES SC, V8, P225, DOI [10.22161/ ijaers.84.27, DOI 10.22161/IJAERS.84.27]
   Radlinska K., 2020, ZESZYTY NAUKOWE WYDZ, V24, P113
   Rangarajan D, 2021, BUS HORIZONS, V64, P647, DOI 10.1016/j.bushor.2021.02.030
   Rangarajan D, 2018, J PERS SELL SALES M, V38, P220, DOI 10.1080/08853134.2018.1450148
   Ray M., 2020, POSTCOVID 19 COMMERC
   Reformat B., 2003, PRACE NAUKOWE, V175
   Rutkowski I. P., 2020, MARKETING RYNEK, V27, P3, DOI [10.33226/1231-7853.2020.6.1, DOI 10.33226/1231-7853.2020.6.1]
   Shankar V, 2021, J RETAILING, V97, P13, DOI 10.1016/j.jretai.2020.10.006
   Shankar V, 2018, J RETAILING, V94, pVI, DOI 10.1016/S0022-4359(18)30076-9
   Slawinska M., 2002, ZARZADZANIE PRZEDSIE
   Spiro R. L., 2008, MANAGEMENT SALES FOR
   Storbacka K, 2009, EUR J MARKETING, V43, P890, DOI 10.1108/03090560910961443
   Syam N, 2018, IND MARKET MANAG, V69, P135, DOI 10.1016/j.indmarman.2017.12.019
   Terho H, 2015, IND MARKET MANAG, V45, P12, DOI 10.1016/j.indmarman.2015.02.017
   Tomczak T., 2014, MARKETING PLANUNG EI
   Urbanowska-Sojkin E., 2001, ZARZADZANIE MARKETIN
   Zdonek D., 2016, ZESZYTY NAUKOWE POLI, V96, P519
   Zhang B. G., 2018, DATA INFORM MANAGEME, V2, P121, DOI [10.2478/dim-2018- 0016, DOI 10.2478/DIM-2018-0016]
   Zoltners A. A., 2005, ZWIEKSZANIE EFEKTYWN
NR 55
TC 0
Z9 0
U1 3
U2 3
PU WARSAW SCH ECONOMICS
PI WARSAW
PA AL NIEPODLEGLOSCI 162, WARSAW, 02554, POLAND
SN 1731-6758
EI 1731-7428
J9 E-MENTOR
JI E-Mentor
PY 2021
IS 4
BP 61
EP 72
DI 10.15219/em91.1536
PG 13
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA XU2FT
UT WOS:000734088400009
OA Bronze
DA 2022-04-20
ER

PT J
AU Romo, ZFG
   Aguirre, SI
AF Gonzalez Romo, Zahaira Fabiola
   Iriarte Aguirre, Sofia
TI Analysis of the communication management of Spanish pharmaceutical
   influencers on Instagram during the COVID-19 pandemic
SO REVISTA ESPANOLA DE COMUNICACION EN SALUD
LA Spanish
DT Article
DE Pharmaceutical influencers; influencer marketing; COVID-19,
   communication management; social media; Instagram iinfluencers
ID SOCIAL MEDIA; INTERNET
AB Introduction: Thanks to the consolidation of the Internet, users have access to many sources of information on health issues, including pharmaceutical influencers who disseminate and create content based on scientific knowledge. Objective: This research focuses on analyzing the communication management of pharmaceutical influencers on Instagram during the Coronavirus crisis in Spain. Methodology: The publications made by 6 pharmaceutical professionals are analyzed. The analysis is based on observing what type of content is published in terms of subject matter, formats and engagement. Results: Some of the most relevant data is that the video format, although present in fewer numbers, is the one that generates the most interaction and, on the other hand, that in no case has it been possible to identify whether the observed influencers work with sponsored content. The informative infographics and the explanatory content that seeks to inform the population about different aspects related to the virus appeared, due to the number of interactions, as very useful in raising public awareness of the seriousness of the situation. Conclusion: Finally, it is concluded that not all the influencers observed, during the period of the current health crisis, have focused mainly on generating content related to COVID-19.
C1 [Gonzalez Romo, Zahaira Fabiola; Iriarte Aguirre, Sofia] Univ Int Catalunya, Fac Ciencias Comunicac, Dept Comunicac, Barcelona, Spain.
RP Romo, ZFG (corresponding author), Univ Int Catalunya, Fac Ciencias Comunicac, Dept Comunicac, Barcelona, Spain.
EM zfgonzalez@uic.es
CR [Anonymous], 2018, DIG FARM OP CREC SIN
   Benetoli A, 2017, INT J CLIN PHARM-NET, V39, P364, DOI 10.1007/s11096-017-0444-4
   Blasco R., 2016, REV ESPANOLA COMU S1, V1, P153
   Brandmaniac, 2018, EST MARK INFL ESP 20
   Crawford Stephanie Y, 2003, J Med Syst, V27, P57, DOI 10.1023/A:1021009212905
   De Veirman M, 2017, INT J ADVERT, V36, P798, DOI 10.1080/02650487.2017.1348035
   Gonzales R., 2019, MARKETING INFLUENCIA
   Grave J.-F., 2018, PAPER PRESENTED 9 IN, V9, P291, DOI DOI 10.1145/3217804.3217931
   IAB Spain, 2019, LIBR BLANC INFL 2019
   Influencer Marketing Hub, 2019, STAT INFL MARK 2019
   Lee JE, 2016, J BUS RES, V69, P5753, DOI 10.1016/j.jbusres.2016.04.171
   Lescure Francois-Xavier, 2020, Lancet Infect Dis, V20, P697, DOI 10.1016/S1473-3099(20)30200-0
   Lyons Barbara, 2005, J CONSUM BEHAV, V4, P319, DOI DOI 10.1002/CB.22
   Monje Alvarez Carlos, 2011, METODOLOGIA INVESTIG
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Morales A., 2018, VOGUE
   Nicolas A., 2019, TELVA
   Paulussen, 2016, FOREIGN FIGHTERS INT, P77, DOI [10.1007/978-94-6265-099-2, DOI 10.1007/978-94-6265-099-2_6]
   Peters K, 2013, J INTERACT MARK, V27, P281, DOI 10.1016/j.intmar.2013.09.007
   Portalfarma, 2020, CAMPANA CONSEJO GEN
   Solomon M.R., 1994, CONSUMER BEHAV BUYIN
   Uzunoglu E, 2014, INT J INFORM MANAGE, V34, P592, DOI 10.1016/j.ijinfomgt.2014.04.007
   Wagner ML, 2001, ANN PHARMACOTHER, V35, P116, DOI 10.1345/1542-6270(2001)035<0116:COIACP>2.0.CO;2
   Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527
   Weimann G, 2007, INT J PUBLIC OPIN R, V19, P173, DOI 10.1093/ijpor/edm005
NR 25
TC 0
Z9 0
U1 3
U2 10
PU UNIV CARLOS III MADRID
PI MADRID
PA DEPT PERIODISMO & COMUNICACION AUDIOVISUAL DESPACHO 18 2 E22 C/MADRID,
   NO 135, GETAFE, MADRID, 28903, SPAIN
EI 1989-9882
J9 REV ESP COMUN SALUD
JI Rev. Esp. Comun. Salud
PY 2020
SU 1
BP S9
EP S30
DI 10.20318/recs.2020.5402
PG 22
WC Communication
WE Emerging Sources Citation Index (ESCI)
SC Communication
GA MO6JL
UT WOS:000551629600002
OA gold
DA 2022-04-20
ER

PT J
AU Kumari, R
   Venaik, A
   Al Hasibuzzaman, M
   Azure, SA
   Ojha, RP
   Sahi, AK
AF Kumari, Rinki
   Venaik, Anita
   Al Hasibuzzaman, Md
   Azure, Simon Agongo
   Ojha, Rudra P.
   Sahi, Ajay Kumar
TI Repurposing of the Herbals as Immune-Boosters in the Prevention and
   Management of COVID-19: A Review
SO JOURNAL OF PURE AND APPLIED MICROBIOLOGY
LA English
DT Review
DE Covid-19; Ayurveda; Immunomodulators; Herbals; Viral infections;
   anti-viral
ID MANGIFERA-INDICA L.; NF-KAPPA-B; MOUSE HEPATITIS-VIRUS;
   TINOSPORA-CORDIFOLIA; ZINGIBER-OFFICINALE; AQUEOUS EXTRACT;
   GENE-EXPRESSION; GOLGI-COMPLEX; SUPPRESSION; GLYCOSIDES
AB Coronavirus disease (COVID) is highly contagious, and negligence of it causes high morbidity and mortality globally. The highly infectious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was abbreviated as COVID-19 (Coronavirus disease 2019) by World Health Organization first time on February 11, 2020, and later on, WHO declared COVID-19 as a global pandemic on 11/3/2020. Epidemiological studies demonstrated that the SARS CoV-2 infects the overall population, irrespective of age, gender, or ethnic variation, but it was observed in clinical studies that older and compromised immunity population is much more prone to COVID-19. SARS-CoV-2 majorly spread through aeration route in droplet form on sneezing and coughing, or by contact when touching eyes, nose or mouth with the infected hands or any other organs, resulting from mild to severe range of SARS-CoV-2 infection. This literature-based review was done by searching the relevant SCI and SCOPUS papers on the pandemic, SARS-CoV-2 and COVID-19, herbal formulation, and Ayurveda from the databases, Academia, Google Scholar, PubMed, and ResearchGate. The present review attempts to recognize the therapeutic strategies to combat Covid-19 because of the current human risk. Indian system of medicine, including herbals, has immense potential in treating and managing various viral infections and provides evidence to utilize Ayurvedic medication to improve immunity. Cumulative research findings suggest that Ayurvedic formulations and herbal immunomodulators (Tino sporacordifolia, Withania somnifera, Crocus sativus, Zafran, Allium sativum, Zingiber officinale, Albizia lebbek, Terminalia chebula, Piper longum, Mangifera indica, Ocimum sanctum, Centella asiatica ) are promising in the treatment of outrageous viral infections without exerting adverse effects. Considering the ancient wisdom of knowledge, the herbal formulations would compel healthcare policymakers to endorse Ayurveda formulations to control the Covid-19 pandemic significantly.
C1 [Kumari, Rinki] Hind Inst Med Sci, Dept Microbiol, Sitapur Rd, Mau Ataria 261303, Uttar Pradesh, India.
   [Venaik, Anita] Amity Univ, Dept Gen Management, Noida 2013132, Uttar Pradesh, India.
   [Al Hasibuzzaman, Md] Ningbo Univ, Med Sch, Ningbo 315211, Zhejiang, Peoples R China.
   [Azure, Simon Agongo] Coll Hlth, Dept Community Hlth, Yamfo, Ghana.
   [Ojha, Rudra P.] Nehru Gram Bharati Deemed Univ, Dept Zool, Prayagraj, Uttar Pradesh, India.
   [Sahi, Ajay Kumar] Banaras Hindu Univ, Indian Inst Technol, Sch Biomed Engn, Varanasi 221005, Uttar Pradesh, India.
RP Kumari, R (corresponding author), Hind Inst Med Sci, Dept Microbiol, Sitapur Rd, Mau Ataria 261303, Uttar Pradesh, India.
EM rinkiv3@gmail.com
RI Hasibuzzaman, Al/AAM-2245-2021; Venaik, Anita/AAD-8398-2022
OI Hasibuzzaman, Al/0000-0003-0548-4836; Seth, Dr Rinki/0000-0003-4720-795X
CR Aher V, 2010, J PHARM SCI RES, V2, P539
   Andujar I, 2010, BRIT J PHARMACOL, V160, P376, DOI 10.1111/j.1476-5381.2010.00696.x
   [Anonymous], CORONAVIRUS DIS 2019
   Azim Kazi Faizul, 2020, Inform Med Unlocked, V20, P100367, DOI 10.1016/j.imu.2020.100367
   BADWIN AS, 2001, J CLIN INVEST, V107, P241, DOI DOI 10.1172/JCI11991
   Bassetti M, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13209
   Baxter D, 2007, OCCUP MED-OXFORD, V57, P552, DOI 10.1093/occmed/kqm110
   Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029
   Chakraborty C, 2020, ASIAN PAC J TROP MED, V13, P242, DOI 10.4103/1995-7645.281613
   Chang JS, 2013, J ETHNOPHARMACOL, V145, P146, DOI 10.1016/j.jep.2012.10.043
   Chen S, 2000, FREE RADICAL BIO MED, V29, P276, DOI 10.1016/S0891-5849(00)00308-7
   Choudhury SS, 2014, J ETHNOPHARMACOL, V154, P148, DOI 10.1016/j.jep.2014.03.049
   Cifci A, 2018, TURK J MED SCI, V48, P892, DOI 10.3906/sag-1803-223
   CYNTHIA Z, 2020, ACS CENTRAL SCI, V6, P315, DOI DOI 10.1021/ACSCENTSCI.0C00272
   DENYER CV, 1994, J NAT PROD, V57, P658, DOI 10.1021/np50107a017
   Dhanasekaran M, 2009, INVEST NEW DRUG, V27, P347, DOI 10.1007/s10637-008-9181-9
   Di Napoli R, 2020, FEATURES EVALUATION
   Du ZC, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190488
   Dubey GP, 2016, REGULATION SEROTONIN, P397
   Elizabeth KM, 2005, INDIAN J CLIN BIOCHE, V20, P150, DOI 10.1007/BF02867416
   Eslami M, 2016, SAUDI J BIOL SCI, V23, P341, DOI 10.1016/j.sjbs.2015.07.004
   Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908
   Gajar, 2014, J PHYTOPHARM, V3, P139
   Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757
   Garcia D, 2003, PHYTOTHER RES, V17, P1182, DOI 10.1002/ptr.1338
   Rivera DG, 2011, J PHARM PHARMACOL, V63, P1336, DOI 10.1111/j.2042-7158.2011.01328.x
   Garrido G, 2004, PHARMACOL RES, V50, P165, DOI 10.1016/j.phrs.2003.12.020
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gohari Ahmad Reza, 2013, Pharmacogn Rev, V7, P61, DOI 10.4103/0973-7847.112850
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Gupta Rekha, 2011, Toxicol Int, V18, P94, DOI 10.4103/0971-6580.84259
   Hofbauer R, 2001, Heart Dis, V3, P14
   Hougee S, 2005, BIOCHEM PHARMACOL, V69, P241, DOI 10.1016/j.bcp.2004.10.002
   Hsieh CC, 2019, AM J CHINESE MED, V47, P1099, DOI 10.1142/S0192415X19500563
   Jagetia GC, 2006, BIOL PHARM BULL, V29, P460, DOI 10.1248/bpb.29.460
   Joycharat N, 2013, ARCH PHARM RES, V36, P723, DOI 10.1007/s12272-013-0085-7
   Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025
   Kapil A, 1997, J ETHNOPHARMACOL, V58, P89, DOI 10.1016/S0378-8741(97)00086-X
   KARPOVA EA, 1991, BIOCHEM INT, V24, P1135
   Khajuria A, 2007, BIOORG MED CHEM LETT, V17, P1608, DOI 10.1016/j.bmcl.2006.12.091
   Khan AM, 2015, PHARM BIOL, V53, P359, DOI 10.3109/13880209.2014.920396
   Kim SK, 2008, ARCH PHARM RES, V31, P424, DOI 10.1007/s12272-001-1174-9
   KLUMPERMAN J, 1994, J VIROL, V68, P6523, DOI 10.1128/JVI.68.10.6523-6534.1994
   Kohno H, 2002, CANCER LETT, V183, P131, DOI 10.1016/S0304-3835(02)00159-3
   KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55
   Krishnamurthy RG, 2009, J NEUROSCI RES, V87, P2541, DOI 10.1002/jnr.22071
   Kumar A, 2013, ANC SCI LIFE, V32, pS85, DOI [10.4103/0257-7941.123913, DOI 10.4103/0257-7941.123913]
   Kumar RA, 2004, J ETHNOPHARMACOL, V92, P291, DOI 10.1016/j.jep.2004.03.004
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lee DY, 2012, J MED FOOD, V15, P992, DOI 10.1089/jmf.2012.2275
   Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0
   Lin WC, 2011, INT IMMUNOPHARMACOL, V11, P1984, DOI 10.1016/j.intimp.2011.08.008
   Lissiman Elizabeth, 2014, Cochrane Database Syst Rev, pCD006206, DOI 10.1002/14651858.CD006206.pub4
   Lv JC, 2012, J AM SOC NEPHROL, V23, P1108, DOI 10.1681/ASN.2011111112
   Ly PTT, 2007, J NEUROSCI RES, V85, P231, DOI 10.1002/jnr.21147
   Makare N, 2001, J ETHNOPHARMACOL, V78, P133, DOI 10.1016/S0378-8741(01)00326-9
   Maraghehpour Bita, 2016, J Indian Soc Periodontol, V20, P603, DOI 10.4103/jisp.jisp_12_17
   Maurya R, 1998, PHYTOCHEMISTRY, V49, P1343, DOI 10.1016/S0031-9422(98)00093-4
   McKeown E, 2012, RHEUMATOLOGY, V51, P1662, DOI 10.1093/rheumatology/kes079
   Mishra L C, 2000, Altern Med Rev, V5, P334
   Moradali MF, 2007, INT IMMUNOPHARMACOL, V7, P701, DOI 10.1016/j.intimp.2007.01.008
   Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238
   Nagarkatti D S, 1994, J Postgrad Med, V40, P65
   Nair PKR, 2004, INT IMMUNOPHARMACOL, V4, P1645, DOI 10.1016/j.intimp.2004.07.024
   Niu XF, 2011, FITOTERAPIA, V82, P620, DOI 10.1016/j.fitote.2011.01.020
   Oberlies NH, 2004, J NAT PROD, V67, P129, DOI 10.1021/np030498t
   OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339
   Pandey DN, 2019, ANN AYURVEDIC MED, V8, P6, DOI [10.5455/AAM.302644286, DOI 10.5455/AAM.302644286]
   Patel SS, 2009, INDIAN J EXP BIOL, V47, P564
   Punturee Khanittha, 2005, Asian Pac J Cancer Prev, V6, P396
   Ramgolam V., 2000, Annals Academy of Medicine Singapore, V29, P11
   Ranjan A., 2020, POTENTIAL PHYTOCHEMI, DOI DOI 10.20944/PREPRINTS202004.0240.V1
   Razavi BM, 2015, DARU, V23, DOI 10.1186/s40199-015-0112-y
   Ren LL, 2020, CHINESE MED J-PEKING, V133, P1015, DOI 10.1097/CM9.0000000000000722
   Rout GR, 2006, Z NATURFORSCH C, V61, P118
   Saastamoinen M, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9010013
   Sachan S, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030106
   Sastry, 2010, DRAVYAGUNA VIGYANA, VII, P33
   Schafer G, 2014, ANTI-CANCER AGENT ME, V14, P233, DOI 10.2174/18715206113136660370
   Sehar I, 2008, CHEM-BIOL INTERACT, V173, P115, DOI 10.1016/j.cbi.2008.01.008
   Shang A, 2019, FOODS, V8, DOI 10.3390/foods8070246
   Sharma RK, 2013, CARAKA SAMHITA, VIII, P8
   Sharma RK, 2013, CARAKA SAMHITA, VIII, P46
   Sharma RK, 2013, CARAKA SAMHITA, VII, P140
   Shashidhara S, 2008, FITOTERAPIA, V79, P301, DOI 10.1016/j.fitote.2008.01.006
   Shen YC, 2002, BRIT J PHARMACOL, V135, P399, DOI 10.1038/sj.bjp.0704493
   Shenoy PA, 2013, J ETHNOPHARMACOL, V147, P373, DOI 10.1016/j.jep.2013.03.022
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   Shin EK, 2009, BIOCHEM BIOPH RES CO, V381, P502, DOI 10.1016/j.bbrc.2009.02.071
   Shivaprasad HN, 2006, PHARM BIOL, V44, P32, DOI 10.1080/13880200500530542
   Singhal GD, 2007, SUSRUTA SAMHITA, VI, P60
   Soleymani S, 2018, CURR DRUG DELIV, V15, P698, DOI 10.2174/1567201814666171129210654
   Son DJ, 2014, NUTRIENTS, V6, P3336, DOI 10.3390/nu6083336
   Sriramaneni RN, 2010, PHARMACOGN RES, V2, P242, DOI 10.4103/0974-8490.69125
   Sundarraj S, 2012, J ETHNOPHARMACOL, V141, P803, DOI 10.1016/j.jep.2012.03.014
   Sunila ES, 2004, J ETHNOPHARMACOL, V90, P339, DOI 10.1016/j.jep.2003.10.016
   Thippeswamy G, 2008, EUR J PHARMACOL, V588, P141, DOI 10.1016/j.ejphar.2008.04.027
   TOOZE J, 1985, EUR J CELL BIOL, V37, P203
   Townsend EA, 2013, AM J RESP CELL MOL, V48, P157, DOI 10.1165/rcmb.2012-0231OC
   TSAI Y, 1985, PLANTA MED, V51, P460, DOI 10.1055/s-2007-969553
   Upadhyay Avnish K, 2010, Int J Ayurveda Res, V1, P112, DOI 10.4103/0974-7788.64405
   Vaibhav K, 2012, MOL CELL BIOCHEM, V367, P73, DOI 10.1007/s11010-012-1321-z
   Vaillancourt F, 2011, J CELL BIOCHEM, V112, P107, DOI 10.1002/jcb.22884
   Verma B, 2012, INT J AYURVEDA ALLIE, V1, P99
   Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324
   World Health Organization, 2020, Q A CORONAVIRUSES
   Yang JH, 2010, PHYTOCHEMISTRY, V71, P641, DOI 10.1016/j.phytochem.2010.01.002
   Yang S, 2010, CLIN CANCER RES, V16, P4755, DOI 10.1158/1078-0432.CCR-10-0883
   Young HY, 2005, J ETHNOPHARMACOL, V96, P207, DOI 10.1016/j.jep.2004.09.009
   Zeinali M, 2019, IRAN J BASIC MED SCI, V22, P334, DOI 10.22038/ijbms.2019.34365.8158
   Zhao F, 2008, J ASIAN NAT PROD RES, V10, P473, DOI 10.1080/10286020801948599
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 112
TC 1
Z9 1
U1 3
U2 4
PU DR M N KHAN
PI BHOPAL
PA 24, NEW MAULANA AZAD COLONY, NEAR ST JOSEPH GIRLS CONVENT SCH, IGDAH
   HILLS, BHOPAL, MADHYA PRADESH 462 001, INDIA
SN 0973-7510
EI 2581-690X
J9 J PURE APPL MICROBIO
JI J. Pure Appl. Microbiol.
PD MAR
PY 2021
VL 15
IS 1
BP 1
EP 19
DI 10.22207/JPAM.15.1.35
PG 19
WC Biotechnology & Applied Microbiology; Microbiology
WE Emerging Sources Citation Index (ESCI)
SC Biotechnology & Applied Microbiology; Microbiology
GA RB3UZ
UT WOS:000632041100001
OA gold
DA 2022-04-20
ER

PT J
AU Miles, L
   Shipway, R
AF Miles, Lee
   Shipway, Richard
TI EXPLORING THE COVID-19 PANDEMIC AS A CATALYST FOR STIMULATING FUTURE
   RESEARCH AGENDAS FOR MANAGING CRISES AND DISASTERS AT INTERNATIONAL
   SPORT EVENTS
SO EVENT MANAGEMENT
LA English
DT Article
DE Resilience; Sports events; Crisis; Disaster management; COVID-19
   coronavirus
ID MANAGEMENT; TOURISM; RISK; RESILIENCE; COUNTRIES; FRAMEWORK; IDENTITY
AB While the interdisciplinary study of crisis, disaster, and emergency management has become increasingly sophisticated, the identification of synergies, useful concepts, and future research agendas in relation to studies within the domain of sport event management to inform these areas, is still at a very early stage of development. The far-reaching global impact of the COVID-19 pandemic further illustrates the timely importance of this research agenda for both sports events and broader studies in festivals and events. The purpose of this article is to critically scope the resilience landscape to help further understand how studies on both international sports events (ISEs) specifically, and both sport and event management studies more generally, could be better informed by disaster management and resilience studies. The article highlights eight key thematic areas that merits further investigation and combines to identify a multidisciplinary research agenda and framework for advancing knowledge on managing crises and disasters in both sport and event management studies.
C1 [Miles, Lee] Bournemouth Univ, Bournemouth Univ Disaster Management Ctr BUDMC, Poole, Dorset, England.
   [Shipway, Richard] Bournemouth Univ, Fac Management, Dept Sport & Event Management, D237,Dorset House,Talbot Campus, Poole BH12 5BB, Dorset, England.
RP Shipway, R (corresponding author), Bournemouth Univ, Fac Management, Dept Sport & Event Management, D237,Dorset House,Talbot Campus, Poole BH12 5BB, Dorset, England.
EM rshipway@bournemouth.ac.uk
CR Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006
   Aldrich D.P., 2012, BUILDING RESILIENCE
   Alexander D, 2016, HOW TO WRITE AN EMERGENCY PLAN
   Alexander D., 2013, NAT HAZARD EARTH SYS, V1, P1257
   Alexander DE, 2014, SCI ENG ETHICS, V20, P717, DOI 10.1007/s11948-013-9502-z
   Aliperti G, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102808
   Ammon R., 2004, SPORT FACILITY MANAG
   Ates A, 2011, INT J PROD RES, V49, P5601, DOI 10.1080/00207543.2011.563825
   Atkinson C. L., 2012, RESILIENT COMMUNITIE
   Auzzir ZA, 2014, PROC ECON FINANC, V18, P807, DOI 10.1016/S2212-5671(14)01006-5
   Bhamra R., 2016, ORG RESILIENCE
   Bosomworth K, 2017, DISASTERS, V41, P306, DOI 10.1111/disa.12196
   Brandstrom A., 2016, CRISIS ACCOUNTABILIT
   Burnard K, 2011, INT J PROD RES, V49, P5581, DOI 10.1080/00207543.2011.563827
   Carey K. M., 2016, Event Management, V20, P119, DOI 10.3727/152599516X14610017108549
   Chandler D, 2017, RETHINK PEACE CONFL, P3, DOI 10.1007/978-3-319-50322-6_1
   Coaffee Jon, 2017, ROUTLEDGE HDB INT RE, P293
   de Milliano C., 2017, ROUTLEDGE HDB INT RE, P260
   Dickson T. J., 2011, Journal of Sport & Tourism, V16, P285, DOI 10.1080/14775085.2011.635014
   Doukas S. G., 2006, SPORT J, V9, P2
   European Commission, 2015, SEC SOC PROT FREED S
   Evans N., 2005, International Journal of Tourism Research, V7, P135, DOI 10.1002/jtr.527
   Ewart J, 2015, DISASTERS, V39, P166, DOI 10.1111/disa.12093
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Filimonau V, 2020, INT J TOUR RES, V22, P202, DOI 10.1002/jtr.2329
   Filo K, 2015, SPORT MANAG REV, V18, P555, DOI 10.1016/j.smr.2015.01.002
   Fyall A., 2012, INT SPORTS EVENTS IM
   Galli N, 2015, INT J SPORT EXERC PS, V13, P243, DOI 10.1080/1612197X.2014.946947
   Getz D, 2008, TOURISM MANAGE, V29, P403, DOI 10.1016/j.tourman.2007.07.017
   Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6
   Haldrup SV, 2013, RESILIENCE, V1, P130, DOI 10.1080/21693293.2013.804659
   Hall S., 2016, CONT ISSUES SPORTS M, P391
   Hall S. A., 2012, SECURITY MANAGEMENT
   Hall S. A., 2008, SPORTS J, V21
   Heath-Kelly C., 2017, ROUTLEDGE HDB INT RE, P307
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Higham J., 2018, SPORT TOURISM DEV
   Higham J., 2005, SPORT TOURISM DESTIN
   Hiller HH, 2000, RES URB SOC, V5, P181
   Horne J., 2007, Leisure Studies, V26, P81, DOI 10.1080/02614360500504628
   Inoue Y, 2015, DISASTER PREV MANAG, V24, P355, DOI 10.1108/DPM-12-2014-0276
   Inoue Y, 2015, GROUP DYN-THEOR RES, V19, P31, DOI 10.1037/gdn0000019
   Jago L., 1998, FESTIVAL MANAGEMENT, V5, P21, DOI [10.3727/106527098792186775, DOI 10.3727/106527098792186775]
   Jiang YW, 2019, CURR ISSUES TOUR, V22, P1925, DOI 10.1080/13683500.2017.1408574
   Jiang YW, 2017, J HOSP TOUR MANAG, V31, P70, DOI 10.1016/j.jhtm.2016.09.004
   Jones I., 2008, Journal of Sport Tourism, V13, P159, DOI 10.1080/14775080802327102
   Kerslake Arena Review, 2018, KERSL REP IND REV PR
   Kozak M., 2007, International Journal of Tourism Research, V9, P233, DOI 10.1002/jtr.607
   Laws E., 2006, TOURISM CRISES MANAG
   Leopkey B, 2009, EUR SPORT MANAG Q, V9, P187, DOI 10.1080/16184740802571443
   Lock D, 2017, EUR SPORT MANAG Q, V17, P413, DOI 10.1080/16184742.2017.1306872
   Mair J, 2016, CURR ISSUES TOUR, V19, P1, DOI 10.1080/13683500.2014.932758
   Masteralexis L., 2012, PRINCIPLES PRACTICE, V4th
   McConnell, 2007, J CONTING CRISIS MAN, V15, P50, DOI DOI 10.1111/J.1468-5973.2007.00504.X
   Miles L., 2016, CRISIS RESPONSE J, V11, P52
   Miles L, 2018, ADV VOLCANOL, P395, DOI 10.1007/11157_2017_2
   Miles L, 2016, PERSPECT PUBLIC HEAL, V136, P323, DOI 10.1177/1757913916672810
   Muller M, 2015, LEISURE STUD, V34, P627, DOI 10.1080/02614367.2014.993333
   O'Brien G, 2010, DISASTER PREV MANAG, V19, P498, DOI 10.1108/09653561011070402
   Orchiston C, 2016, ANN TOURISM RES, V56, P145, DOI 10.1016/j.annals.2015.11.002
   Pescaroli G., 2015, PLANET RISK, V3
   Preuss H., 2007, Journal of Sport Tourism, V12, P207, DOI 10.1080/14775080701736957
   Pyke J., 2018, Journal of Ecotourism, V17, P206, DOI 10.1080/14724049.2018.1505586
   Pyke J, 2016, J HOSP TOUR MANAG, V28, P49, DOI 10.1016/j.jhtm.2016.04.003
   Qi XueQing [Qi X. Q. C.], 2009, Journal of Sport Tourism, V14, P43, DOI 10.1080/14775080902847439
   Reisinger Y., 2005, Journal of Travel Research, V43, P212, DOI 10.1177/0047287504272017
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Ritchie BW, 2017, J TRAVEL TOUR MARK, V34, P274, DOI 10.1080/10548408.2016.1156616
   Ritchie BW, 2004, TOURISM MANAGE, V25, P669, DOI 10.1016/j.tourman.2003.09.004
   Santana G., 2003, Journal of Travel & Tourism Marketing, V15, P299, DOI 10.1300/J073v15n04_05
   Schroeder A, 2015, J TRAVEL RES, V54, P584, DOI 10.1177/0047287514528284
   Shipway R., 2019, REPUTATION IMAGE REC, P148
   Shipway R., 2018, J SPORT TOURISM, V22, P265, DOI https://doi.org/10.1080/14775085.2018.1498152
   Shipway R, 2007, J R SOC PROMO HEALTH, V127, P119, DOI 10.1177/1466424007077344
   Shipway R, 2020, EVENT MANAGE, V24, P185, DOI 10.3727/152599518X15403853721376
   Sonmez S. F., 1999, Journal of Travel Research, V38, P13, DOI 10.1177/004728759903800104
   Stevens A., 2007, SPORTS SECURITY SAFE
   Stott C., 2016, POLIC SOC, P1
   Stott C, 2012, BRIT J CRIMINOL, V52, P381, DOI 10.1093/bjc/azr076
   Tarlow P., 2002, EVENT RISK MANAGEMEN
   Tarlow PE, 2017, SPORTS TRAVEL SECURITY, P1
   Taylor T., 2007, Journal of Sport Tourism, V12, P99, DOI 10.1080/14775080701654754
   Taylor T., 2006, Event Management, V9, P199, DOI 10.3727/152599506776771544
   Toohey K, 2008, J SPORT MANAGE, V22, P451, DOI 10.1123/jsm.22.4.451
   Toohey K, 2012, INT REV SOCIOL SPORT, V47, P324, DOI 10.1177/1012690211433456
   Tsai CH, 2011, TOURISM MANAGE, V32, P158, DOI 10.1016/j.tourman.2010.05.015
   United Nations, 2014, SEND FRAM DIS RISK R
   United Nations Office for Disaster Risk Reduction, 2017, CRIT INFR DIS RES IS
   Walters G, 2017, ANN TOURISM RES, V66, P210, DOI 10.1016/j.annals.2017.07.012
   Wishart M., 2018, BUSINESS RESILIENCE
   Zebrowski C, 2016, INTERVENTIONS, P1
NR 91
TC 27
Z9 27
U1 4
U2 14
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 1525-9951
EI 1943-4308
J9 EVENT MANAGE
JI Event Manage.
PY 2020
VL 24
IS 4
BP 537
EP 552
DI 10.3727/152599519X15506259856688
PG 16
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA QA0EP
UT WOS:000613122100008
OA Green Accepted
DA 2022-04-20
ER

PT J
AU Mathew, RP
   Jose, M
   Jayaram, V
   Joy, P
   George, D
   Joseph, M
   Sleeba, T
   Toms, A
AF Mathew, Rishi Philip
   Jose, Merin
   Jayaram, Vinayak
   Joy, Paul
   George, Danny
   Joseph, Maria
   Sleeba, Teena
   Toms, Ajith
TI Current status quo on COVID-19 including chest imaging
SO WORLD JOURNAL OF RADIOLOGY
LA English
DT Review
DE COVID-19; SARS-CoV-2; Coronavirus disease; Reverse transcriptase
   polymerase chain reaction; Viral pneumonia; Computed tomography
ID CORONAVIRUS; CT; WUHAN
AB With each day the number coronavirus disease 2019 (COVID-19) cases continue to rise rapidly and our imaging knowledge of this disease is expeditiously evolving. The role of chest computed tomography (CT) in the screening or diagnosis of COVID-19 remains the subject of much debate. Despite several months having passed since identifying the disease, and numerous studies related to it, controversy and concern still exists regarding the widespread use of chest CT in the evaluation and management of COVID-19 suspect patients. Several institutes and organizations around the world have released guidelines, recommendations and statements against the use of CT for diagnosing or screening COVID-19 infection and advocating its use only for those cases with a strong clinical suspicion of complication or an alternate diagnosis. However, these guidelines and recommendations are in disagreement with majority of the widely available literature, which strongly favour CT as a pivotal tool in the early diagnosis, management and even follow-up of COVID-19 infection. This article besides comprehensively reviewing the current status quo on COVID-19 disease in general, also writes upon the current consensus statements/recommendations on the use of diagnostic imaging in COVID-19 as well as highlighting the precautions and various disinfection procedures being employed world-wide at the workplace to prevent the spread of infection.
C1 [Mathew, Rishi Philip; Jose, Merin; Jayaram, Vinayak; Joy, Paul; George, Danny; Joseph, Maria; Sleeba, Teena; Toms, Ajith] Rajagiri Hosp, Dept Radiol, Kochi 683112, Kerala, India.
RP Mathew, RP (corresponding author), Rajagiri Hosp, Dept Radiol, Kochi 683112, Kerala, India.
EM dr_rishimathew@yahoo.com
CR Adams HJA, 2020, AM J ROENTGENOL, V215, P1342, DOI 10.2214/AJR.20.23391
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Albano D, 2020, J NUCL MED, V61, P632, DOI 10.2967/jnumed.120.246256
   Alimadadi A, 2020, PHYSIOL GENOMICS, V52, P200, DOI 10.1152/physiolgenomics.00029.2020
   Alvin MD, 2020, RADIOLOGY, V296, P246, DOI 10.1148/radiol.2020201222
   American College of Radiology, 2020, ACR REC US CHEST RAD
   An P, 2020, DIAGN INTERV RADIOL, V26, P200, DOI 10.5152/dir.2020.20167
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823
   Chandy PE, 2020, DIAGN INTERV RADIOL, V26, P236, DOI 10.5152/dir.2020.20166
   Choi Hyewon, 2020, Radiol Cardiothorac Imaging, V2, pe200107, DOI [10.1148/ryct.2020204001, 10.1148/ryct.2020200107]
   Dai WC, 2020, CAN ASSOC RADIOL J, V71, P195, DOI 10.1177/0846537120913033
   Dangis Anthony, 2020, Radiol Cardiothorac Imaging, V2, pe200196, DOI 10.1148/ryct.2020200196
   Deng Y, 2020, EUR J NUCL MED MOL I, V47, P1634, DOI 10.1007/s00259-020-04767-1
   Dennie C, 2020, CAN ASSOC RADIOL J, V71, P470, DOI 10.1177/0846537120924606
   Di Napoli R., 2020, FEATURES EVALUATION
   Fu BJ, 2020, INFECT DRUG RESIST, V13, P2681, DOI 10.2147/IDR.S258677
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Grillet F, 2020, RADIOLOGY, V296, pE186, DOI 10.1148/radiol.2020201544
   Guan CS, 2020, DIAGN INTERV RADIOL, V26, P301, DOI 10.5152/dir.2019.20176
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Hendren NS, 2020, CIRCULATION, V141, P1903, DOI 10.1161/CIRCULATIONAHA.120.047349
   Hope MD, 2020, LANCET, V395, P1189, DOI 10.1016/S0140-6736(20)30728-5
   Hosseiny M, 2020, AM J ROENTGENOL, V214, P1078, DOI 10.2214/AJR.20.22969
   Huang ZX, 2020, J AM COLL RADIOL, V17, P710, DOI 10.1016/j.jacr.2020.03.011
   Jaillon S, 2019, CLIN REV ALLERG IMMU, V56, P308, DOI 10.1007/s12016-017-8648-x
   Joob B, 2020, EUR J NUCL MED MOL I, V47, P1348, DOI 10.1007/s00259-020-04762-6
   Kanne JP, 2020, RADIOLOGY, V296, pE113, DOI 10.1148/radiol.2020200527
   Kim EA, 2002, RADIOGRAPHICS, V22, pS137, DOI 10.1148/radiographics.22.suppl_1.g02oc15s137
   Kim H, 2020, RADIOLOGY, V296, pE145, DOI 10.1148/radiol.2020201343
   Kong Weifang, 2020, Radiol Cardiothorac Imaging, V2, pe200028, DOI 10.1148/ryct.2020200028
   Kwee TC, 2020, RADIOGRAPHICS, V40, P1848, DOI 10.1148/rg.2020200159
   Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012
   Lang Min, 2020, Radiol Cardiothorac Imaging, V2, pe200277, DOI 10.1148/ryct.2020200277
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lei Y, 2020, CAN ASSOC RADIOL J, V71, P251, DOI 10.1177/0846537120914428
   Leonard-Lorant I, 2020, RADIOLOGY, V296, pE189, DOI 10.1148/radiol.2020201561
   Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9
   Li L, 2020, RADIOLOGY, V296, pE65, DOI 10.1148/radiol.2020200905
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Long B, 2020, AM J EMERG MED, V38, P1504, DOI 10.1016/j.ajem.2020.04.048
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Lushina N, 2020, RADIOLOGY, V296, pE181, DOI 10.1148/radiol.2020201623
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   Patel BV, 2020, AM J RESP CRIT CARE, V202, P690, DOI 10.1164/rccm.202004-1412OC
   Patel R, 2020, MBIO, V11, DOI 10.1128/mBio.00722-20
   Qin CX, 2020, EUR J NUCL MED MOL I, V47, P1281, DOI 10.1007/s00259-020-04734-w
   Rubin GD, 2020, CHEST, V158, P106, DOI 10.1016/j.chest.2020.04.003
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Simpson Scott, 2020, J Thorac Imaging, V35, P219, DOI [10.1148/ryct.2020200152, 10.1097/RTI.0000000000000524]
   Song FX, 2020, RADIOLOGY, V297, pE346, DOI 10.1148/radiol.2020209021
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Sverzellati N, 2020, DIAGN INTERV RADIOL, V26, P204, DOI 10.5152/dir.2020.30320
   Tabatabaei SMH, 2020, EMERG RADIOL, V27, P711, DOI 10.1007/s10140-020-01869-z
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wang H, 2020, EUR RADIOL, V30, P4910, DOI 10.1007/s00330-020-06880-z
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wong HYF, 2020, RADIOLOGY, V296, pE72, DOI 10.1148/radiol.2020201160
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yoon SH, 2020, KOREAN J RADIOL, V21, P494, DOI 10.3348/kjr.2020.0132
   Zhang HW, 2020, ACAD RADIOL, V27, P463, DOI 10.1016/j.acra.2020.02.003
   Zhao W, 2020, AM J ROENTGENOL, V214, P1072, DOI 10.2214/AJR.20.22976
   Zhong LS, 2020, CAN RESPIR J, V2020, DOI 10.1155/2020/5328267
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou SJ, 2020, RADIOLOGY, V296, pE118, DOI 10.1148/radiol.2020200770
   Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490
NR 71
TC 0
Z9 1
U1 0
U2 0
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1949-8470
J9 WORLD J RADIOL
JI World J. Radiol.
PD DEC 28
PY 2020
VL 12
IS 12
BP 272
EP 288
DI 10.4329/wjr.v12.i12.272
PG 17
WC Radiology, Nuclear Medicine & Medical Imaging
WE Emerging Sources Citation Index (ESCI)
SC Radiology, Nuclear Medicine & Medical Imaging
GA PR9SU
UT WOS:000607571300001
PM 33510852
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Nas, K
   Eryilmaz, N
   Geyik, MF
   Altas, A
AF Nas, Kemal
   Eryilmaz, Nuran
   Geyik, Mehmet Faruk
   Altas, Ayfer
TI COVID-19 in patients with familial Mediterranean fever treated with
   colchicine: case based review
SO RHEUMATOLOGY INTERNATIONAL
LA English
DT Review
DE Familial Mediterranean fever; COVID-19; Colchicine; Clinical course
AB Coronavirus disease 2019 (COVID-19) refers to the clinical picture of an important and severe infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Considering the current knowledge on the pathophysiology and clinical manifestations of COVID-19, it is safe to state that both COVID-19 and inflammatory rheumatic disorders cause a cytokine storm and merit treatment with anti-rheumatic drugs. Three patients, who were on regular follow-up due to the diagnosis of familial Mediterranean fever (FMF), contracted COVID-19 infection; and their pre-clinical and post-clinical data as well as laboratory, prognosis and treatment data were investigated. Effects of colchicine in FMF patients who contracted COVID-19 infection were presented in this study. All the cases recovered from COVID-19 without complications. The present study suggests that colchicine can positively affect the prognosis of COVID-19 in FMF patients; therefore, experience of rheumatologists in the use of anti-inflammatory drugs can be highly instrumental in management of COVID-19 patients.
C1 [Nas, Kemal; Eryilmaz, Nuran] Sakarya Univ, Div Rheumatol & Immunol, Dept Phys Med & Rehabil, Fac Med, Sakarya, Turkey.
   [Geyik, Mehmet Faruk] Yuzyil Hosp, Dept Clin Microbiol & Infect Dis, Kocaeli, Turkey.
   [Altas, Ayfer] Sakarya Univ, Training & Res Hosp, Dept Internal Med, Sakarya, Turkey.
RP Nas, K (corresponding author), Sakarya Univ, Div Rheumatol & Immunol, Dept Phys Med & Rehabil, Fac Med, Sakarya, Turkey.
EM kemalnas@yahoo.com; nur.yclr@gmail.com; mfgeyik@gmail.com;
   ayfer.erdogan@hotmail.com
CR Aouba A, 2020, ANN RHEUM DIS, V79, P1381, DOI 10.1136/annrheumdis-2020-217706
   Bourguiba R, 2021, ANN RHEUM DIS, V80, P539, DOI 10.1136/annrheumdis-2020-218707
   Cacoub PP, 2014, LANCET, V383, P2193, DOI 10.1016/S0140-6736(14)60113-6
   Caso F, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102524
   Chen IY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00050
   Deftereos SG, 2020, HELL J CARDIOL, V61, P42, DOI 10.1016/j.hjc.2020.03.002
   El Hasbani G, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1201-7
   Filocamo G, 2020, INT J INFECT DIS, V96, P607, DOI 10.1016/j.ijid.2020.05.026
   Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368
   Haslak F, 2020, RHEUMATOL INT, V40, P1423, DOI 10.1007/s00296-020-04645-x
   Hausmann JS, 2019, CLIN IMMUNOL, V206, P23, DOI 10.1016/j.clim.2018.10.016
   Hentgen V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00971
   Kobak S, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-217882
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Mansouri N, 2021, IMMUNOL INVEST, V50, P884, DOI 10.1080/08820139.2020.1789655
   Misra DP, 2020, CLIN RHEUMATOL, V39, P2055, DOI 10.1007/s10067-020-05073-9
   Molad Yair, 2002, Curr Rheumatol Rep, V4, P252, DOI 10.1007/s11926-002-0073-2
   Monti S, 2020, ANN RHEUM DIS, V79, P667, DOI 10.1136/annrheumdis-2020-217424
   Nerlekar N, 2014, MED J AUSTRALIA, V201, P687, DOI 10.5694/mja14.00846
   Nieto-Torres JL, 2015, VIROLOGY, V485, P330, DOI 10.1016/j.virol.2015.08.010
   Pontali E, 2020, J ALLERGY CLIN IMMUN, V146, P213, DOI 10.1016/j.jaci.2020.05.002
   Pope RM, 2007, ARTHRITIS RHEUM-US, V56, P3183, DOI 10.1002/art.22938
   Porta, 2020, ITJM, DOI [10.4081/itjm.2020.1284, DOI 10.4081/ITJM.2020.1284]
   Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393
NR 24
TC 3
Z9 3
U1 2
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0172-8172
EI 1437-160X
J9 RHEUMATOL INT
JI Rheumatol. Int.
PD APR
PY 2021
VL 41
IS 4
BP 811
EP 817
DI 10.1007/s00296-021-04809-3
EA FEB 2021
PG 7
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA QV2JR
UT WOS:000620115100001
PM 33611657
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Orth, D
   Schuldis, PM
AF Orth, Daniel
   Schuldis, Philipa Maria
TI Organizational learning and unlearning capabilities for resilience
   during COVID-19
SO LEARNING ORGANIZATION
LA English
DT Article
DE Capabilities; Crisis management; Organizational resilience;
   Organizational learning; Unlearning; COVID-19; Quantitative research
AB Purpose - The purpose of this paper is to empirically validate the positive effect of learning on organizational resilience and, within this relationship, understand the role of unlearning in the COVID-19 crisis context and progress the current knowledge about these concepts.
   Design/methodology/approach - This paper uses online survey data from German and Austrian organizations' employees to test hypotheses derived from frameworks by Duchek (2019), Stephenson (2010) and Fiol and O'Connor (2017). The used questionnaire is built out of three pre-tested questionnaires to increase reliability. Conceptually, this paper takes a capability approach and a process perspective.
   Findings - The results support the positive effect of organizational learning on resilience, while rejecting the hypothesized moderating effect of unlearning on this relationship. Organizational learning showed to have a particularly strong positive effect on the adaptive capacity of resilience, compared to organizational resilience overall.
   Practical implications - To build a learning capability for organizational resilience, managers should foster an open system culture in their organization, which aims to be generally open to learn and adapt to be able to withstand adversity. During an organizational crisis, managers have the chance to rebuild organizational structures for better information flow, e.g. implementing formal knowledge management structures.
   Originality/value - To the best of the authors' knowledge, this paper is the first to empirically test the causal connection between organizational learning and resilience in the Central European context during the COVID-19 crisis. The inclusion of unlearning enriches the discourse about its conceptualizations and fosters future research.
C1 [Orth, Daniel; Schuldis, Philipa Maria] Malmo Univ, Dept Urban Studies, Malmo, Sweden.
RP Orth, D (corresponding author), Malmo Univ, Dept Urban Studies, Malmo, Sweden.
EM orth.daniel@hotmail.com; p.schuldis@gmail.com
CR AGUINIS H, 1995, J MANAGE, V21, P1141, DOI 10.1177/014920639502100607
   Bantel KA, 1998, J BUS VENTURING, V13, P205, DOI 10.1016/S0883-9026(97)00033-5
   Barasa E, 2018, INT J HEALTH POLICY, V7, P491, DOI 10.15171/ijhpm.2018.06
   Bhamra R, 2011, INT J PROD RES, V49, P5375, DOI 10.1080/00207543.2011.563826
   Blaikie N.W.H., 2003, ANAL QUANTITATIVE DA
   Burnard K, 2011, INT J PROD RES, V49, P5581, DOI 10.1080/00207543.2011.563827
   Burnes B, 2004, J MANAGE STUD, V41, P977, DOI 10.1111/j.1467-6486.2004.00463.x
   Duchek S., 2014, ACAD MANAGEMENT P, P861, DOI [10.5465/ambpp.2014.225, 10.5465/AMBPP.2014.225, DOI 10.5465/AMBPP.2014.225]
   Duchek S., 2020, BUSINESS RES, V13, P215, DOI [DOI 10.1007/S40685-019-0085-7, https://doi.org/10.1007/s40685-019-0085-7]
   European Commission, 2020, SMALL MEDIUM SIZED E
   Fiol M, 2017, LEARN ORGAN, V24, P13, DOI 10.1108/TLO-09-2016-0056
   Grisold T, 2020, MANAGE LEARN, V51, P598, DOI 10.1177/1350507620916042
   Hayes AF., 2017, INTRO MEDIATION MODE
   Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245
   Howells J, 2016, MANAGE LEARN, V47, P443, DOI 10.1177/1350507615624079
   Huang DJ, 2018, MANAGE DECIS, V56, P87, DOI 10.1108/MD-03-2017-0200
   Jerez-Gomez P, 2005, J BUS RES, V58, P715, DOI 10.1016/j.jbusres.2003.11.002
   Klammer A, 2019, J KNOWL MANAG, V23, P860, DOI 10.1108/JKM-05-2018-0277
   Kluge A, 2019, LEARN ORGAN, V26, P518, DOI 10.1108/TLO-09-2018-0146
   Koronis Epaminondas, 2018, Journal of Business Strategy, V39, P32, DOI 10.1108/JBS-10-2016-0124
   Lengnick-Hall CA, 2011, HUM RESOUR MANAGE R, V21, P243, DOI 10.1016/j.hrmr.2010.07.001
   Lyu C, 2020, IND MARKET MANAG, V84, P261, DOI 10.1016/j.indmarman.2019.07.013
   Morais-Storz M, 2017, LEARN ORGAN, V24, P93, DOI 10.1108/TLO-12-2016-0091
   Ponis ST, 2012, KNOWL PROCESS MANAG, V19, P148, DOI 10.1002/kpm.1390
   Starbuck WH, 2017, LEARN ORGAN, V24, P30, DOI 10.1108/TLO-11-2016-0073
   Stephenson, 2010, BENCHMARKING RESILIE
   Stoll J., 2020, COVID19 STOP HURRICA
   Tsang EWK, 2008, HUM RELAT, V61, P1435, DOI 10.1177/0018726708095710
   Tsang EWK, 2017, LEARN ORGAN, V24, P39, DOI 10.1108/TLO-10-2016-0064
   UNDP, 2020, COR DIS COVID 19 PAN
   Vogus T.J., 2003, POSITIVE ORG SCHOLAR
   Wang C.L., 2003, LEARNING ORG, V10, P8, DOI DOI 10.1108/09696470310457469
   Wang J, 2008, ADV DEV HUM RESOUR, V10, P425, DOI 10.1177/1523422308316464
   Wang XY, 2019, BALT J MANAG, V14, P2, DOI 10.1108/BJM-10-2017-0324
   Wang XY, 2013, INT J TECHNOL MANAGE, V61, P132, DOI 10.1504/IJTM.2013.052178
   Whitman ZR, 2013, MEAS BUS EXCELL, V17, P3, DOI 10.1108/MBE-05-2012-0030
   Williams A, 2017, J CLEAN PROD, V148, P866, DOI 10.1016/j.jclepro.2017.02.002
   Witmer H, 2019, GEND MANAG, V34, P510, DOI 10.1108/GM-10-2018-0127
   Witmer H, 2016, WORK, V54, P255, DOI 10.3233/WOR-162303
   Wong PSP, 2021, INT J CONSTR MANAG, V21, P353, DOI 10.1080/15623599.2018.1539160
   Wong PSP, 2012, J CONSTR ENG M ASCE, V138, P1202, DOI 10.1061/(ASCE)CO.1943-7862.0000523
   Zubair T., 2019, J MANAGEMENT RES ANA, V6, P1, DOI [10.18231/j.jmra.2019.001, DOI 10.18231/J.JMRA.2019.001]
   ?zuyar, 2019, ENCY UN SUSTAINABILI, P1
NR 43
TC 7
Z9 7
U1 30
U2 69
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0969-6474
EI 1758-7905
J9 LEARN ORGAN
JI Learn. Organ.
PD NOV 12
PY 2021
VL 28
IS 6
BP 509
EP 522
DI 10.1108/TLO-07-2020-0130
EA FEB 2021
PG 14
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA WZ7AE
UT WOS:000614358900001
DA 2022-04-20
ER

PT J
AU Yong, SS
   Sia, JKM
AF Yong, Siew Siew
   Sia, Joseph Kee-Ming
TI COVID-19 and social wellbeing in Malaysia: A case study
SO CURRENT PSYCHOLOGY
LA English
DT Editorial Material; Early Access
DE COVID-19; Mental health; PEST; Social wellbeing; Malaysia
ID OUTBREAK
AB The world has witnessed the largest single disruption to social wellbeing since the first known case of coronavirus disease 2019 (COVID-19) was reported in China in December 2019. In Malaysia, the government implemented the Movement Control Order (MCO) on 18 March 2020 in response to the COVID-19 pandemic. Thus, this paper highlights how the Malaysian government responded to COVID-19 in comparison with some Asian countries; and what has and has not worked for the MCO imposed by the government. The paper adopts a review approach that is supported by findings from both grey and academic literature. The findings reveal that the COVID-19 pandemic has significant impacts on the society's wellbeing in Malaysia, the most severe of which are negative mental health and job unemployment. On the other hand, COVID-19 has sparked a surge of volunteering in society. This paper presumably and hopefully represents a frontier review with more empirical research to be conducted to investigate the extent of the social impact of COVID-19, the outcomes of which are a call for re-envisioning of social policies in Malaysia. To the best knowledge of the authors, little empirical research has been conducted to explore the social-wellbeing implications of COVID-19 in Malaysia. By reflecting on the various scenarios-both detrimental and beneficial in the context of the COVID-19 pandemic, the paper identifies potential avenues for relevant research in the social wellbeing realm.
C1 [Yong, Siew Siew] Curtin Univ Malaysia, Fac Business, CDT 250, Sarawak, Malaysia.
   [Sia, Joseph Kee-Ming] Curtin Univ Malaysia, Fac Business, Dept Management Mkt & Digital Business, CDT 250, Sarawak, Malaysia.
RP Yong, SS (corresponding author), Curtin Univ Malaysia, Fac Business, CDT 250, Sarawak, Malaysia.
EM yongsiewsiew@postgrad.curtin.edu.my; joseph@curtin.edu.my
RI Sia, Joseph Kee-Ming/ABM-1421-2022; Yong, Siew Siew/AAX-8708-2021
OI Yong, Siew Siew/0000-0002-9138-4737; sia, joseph/0000-0002-7829-2635
CR Abdullah JM, 2020, MALAYS J MED SCI, V27, P1, DOI 10.21315/mjms2020.27.2.1
   Anis M. N., 2020, THE STAR
   [Anonymous], THE STAR
   [Anonymous], BORNEO POST 0123
   [Anonymous], STRAITS TIMES
   Arumugam T., 2020, NEW STRAITS TIMES
   Ashley, 2020, THE STAR
   Aziz NA, 2020, J INFECT PUBLIC HEAL, V13, P1823, DOI 10.1016/j.jiph.2020.08.007
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Azuddin A., 2020, MCO MENTAL WELL BE 1
   Baharin M. F., 2020, BERNAMA
   Baker S., 2020, W COUNTRIES ONLY SEE
   Bedi R. S., 2020, THE STAR 1010
   Beja E. L, 2019, INT J COMMUNITY WELL, V3, P277
   Bernama, NEW STRAITS TIMES
   Bernama, 2020, THE EDGE MARKETS
   Bong K., 2021, DAYAK DAILY
   Cheng SC, 2020, J FORMOS MED ASSOC, V119, P747, DOI 10.1016/j.jfma.2020.02.007
   Chng B., 2020, THE STAR 0415
   Chong SC, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102130
   Chua S., 2020, THE BORNEO POST
   Chung C., 2020, THE STAR
   Dayak Daily, DAYAK DAILY
   Department of Statistics Malaysia, 2020, CURRENT POPULATION E
   Department of Statistics Malaysia, REP SPEC SURV EFF CO
   Department of Statistics Singapore, 2020, SING POP
   Etkind SN, 2020, J PAIN SYMPTOM MANAG, V60, pE31, DOI 10.1016/j.jpainsymman.2020.03.029
   Fevre J. L., 2020, ASEAN NEWS TODA 0429
   Geddies J., 2020, REUTERS
   Geraldine A., 2020, NEW STRAIT TIMES
   Gill BS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155509
   Government of Singapore, 2020, VOT WILL BE SAF COND
   Grubic N, 2020, INT J SOC PSYCHIATR, V66, P517, DOI 10.1177/0020764020925108
   Gunnell D, 2020, LANCET PSYCHIAT, V7, P468, DOI 10.1016/S2215-0366(20)30171-1
   Hassan H., 2020, THE STRAITS TIMES
   Hassan M.R., 2021, J HEALTH RES
   Hassandarvish M., 2020, MALAY MAIL
   Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352
   Hwang TJ, 2020, INT PSYCHOGERIATR, V32, P1217, DOI 10.1017/S1041610220000988
   Jaipragas B., 2020, S CHINA MORNING POST
   Jian SW, 2020, INT J INFECT DIS, V101, P348, DOI 10.1016/j.ijid.2020.09.1483
   Kanyakumari D., 2020, CNA
   Kaos J., 2020, THE STAR
   Kaur S, 2020, PSYCHOL TRAUMA-US, V12, P482, DOI 10.1037/tra0000897
   Khalid N., 2020, BERNAMA
   Khor V, 2020, UROLOGY, V141, P179, DOI 10.1016/j.urology.2020.04.070
   Kim D, 1998, PSYCHOL MARKET, V15, P507, DOI 10.1002/(SICI)1520-6793(199809)15:6<507::AID-MAR2>3.0.CO;2-A
   KPMG, TAIW GOV I MEAS RESP
   KPMG, 2020, SING GOV I MEAS RESP
   Kuo CC, 2021, ASIAN ECON PAP, V20, P98, DOI 10.1162/asep_a_00805
   Lee SJ., 2018, INT J COMMUNITY WELL, V1, P33, DOI 10.1007/s42413-018-0004-2
   Lei MK, 2020, PSYCHOL TRAUMA-US, V12, pS35, DOI 10.1037/tra0000633
   Lim LL, 2020, SOCIOECONOMIC IMPACT
   Lim M. Z., THE STRAITS TIMES
   Malaysia Communications and Multimedia Commission, 2020, COVID 19 MYSEJAHTERA
   Mat NFC, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa059
   Ministry of Health Malaysia, 2020, COV 19 SOC DIST GUID
   Ministry of Health Singapore, 2021, CAS SUMM SING
   Mohtar J, 2020, NEW STRAITS TIMES
   Murad D, 2020, THE STAR
   Murugappan R, 2020, THE STAR
   Murugiah S, 2020, MALAYSIA UNEMPLOYMEN
   Ngui Y, 2020, THE EDGE MARKETS
   Nienhaus A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134881
   Our World in Data, 2021, **NON-TRADITIONAL**
   Palansamy Y., 2020, MALAY MAIL
   Perlman H., 2019, FRANCE UPS MINIMUM W
   Povera A, 2020, THE STAR
   Prime Minister's Office of Malaysia, 2020, PRIM MIN SPEC MESS C
   Profdten D., 2021, THE STAR
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Rahim R., 2020, THE STAR
   Salim S., 2020, THE EDGE MARKETS
   Sandhu S.K., 2020, RES J HUMANIT SOC SC, V2, P131, DOI [10.37534/bp.jhssr.2020.v2.nS.id1038.p131, DOI 10.37534/BP.JHSSR.2020.V2.NS.ID1038.P131]
   Sarawak Disaster Management Committee, 2021, SAR DIS MAN COMM
   Sarkodie SA, 2021, ENVIRON DEV SUSTAIN, V23, P5005, DOI 10.1007/s10668-020-00801-2
   Shah AUM, 2020, INT J INFECT DIS, V97, P108, DOI 10.1016/j.ijid.2020.05.093
   Shankar A.C, 2021, THE EDGE MARKETS
   Shanmugam H., 2020, MALAYSIAN J PSYCHIAT, V29
   Song Q. Y, 2020, J LUMBINI MED COLL, V8
   Sukumaran T, 2020, S CHINA MORNING POST
   Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206
   Surendran S., 2021, THE EDGE MARKETS
   Taiwan Centers for Diesease Control, 2021, TAIW CTR DIES CONTR
   Tan A., THE STRAITS TIMES
   Tan N, THE STAR
   Tan V., 2020, CNA 0512
   Tanzizi N. H, 2020, NEW STRAITS TIMES
   Tay K, 2020, MALAYS ORTHOP J, V14, DOI 10.5704/MOJ.2007.001
   Teoh M, 2020, THE STAR
   The Star, 2020, THE STAR
   Thiessen T.=, 2020, FORBES
   Thoits PA, 2001, J HEALTH SOC BEHAV, V42, P115, DOI 10.2307/3090173
   Tierney S., 2020, VOLUNTEERING COVID 1
   Timbuong J., 2020, THE STAR
   Trading Economics, 2021, UN RAT
   Trautwein S, 2020, NONPROF VOLUNT SEC Q, V49, P1142, DOI 10.1177/0899764020964595
   Ungku F., 2020, THE STAR
   Vanar M., 2020, THE STAR
   Veerasamy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077698
   Wang C., 2020, FORTUNE
   Wang XH, 2021, INT J EQUITY HEALTH, V20, DOI 10.1186/s12939-020-01374-2
   Wilson J, 2012, NONPROF VOLUNT SEC Q, V41, P176, DOI 10.1177/0899764011434558
   Woon LSC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249155
   World Health Organization, 2020, WHO ASS WORLDS HLTH
   Worldometers, TOT COR CAS FRANC
   Yang CJ, 2020, J MICROBIOL IMMUNOL, V53, P381, DOI 10.1016/j.jmii.2020.03.019
   Yong M., 2020, CHANNEL NEWS ASIA
   Zainul E., 2020, THE EDGE MARKETS
   Zolkepli F., 2020, THE STAR
NR 112
TC 1
Z9 1
U1 9
U2 12
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1046-1310
EI 1936-4733
J9 CURR PSYCHOL
JI Curr. Psychol.
DI 10.1007/s12144-021-02290-6
EA SEP 2021
PG 15
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA UP1ND
UT WOS:000695150000002
PM 34539153
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Oleynick, C
AF Oleynick, Christopher
TI Symptoms of Pleurisy as the Initial Presentation of COVID-19
SO AMERICAN JOURNAL OF CASE REPORTS
LA English
DT Article
DE Chest Pain; Coronavirus; COVID-19; Pleural Diseases; Pleurisy
AB Objective: Unusual clinical course
   Background: Severe acute respiratory syndrome coronavirus 2, the virus responsible for Coronavirus Disease 2019 (COVID-19), has infected more than 8 million people worldwide and placed massive strains on healthcare systems around the world. Although classically causing cough, fever, and shortness of breath, increasing evidence suggests that manifestations of COVID-19 can be more subtle or masquerade as other clinical entities.
   Case Report: A 48-year-old man with hypertension and type 2 diabetes mellitus presented to the Emergency Department with acute-onset pleuritic chest pain that had developed 1 day earlier and was found to be hypoxemic, requiring supplemental oxygen. He was admitted under the internal medicine service and underwent an extensive workup for his chest pain and hypoxemia, including a negative computed tomography scan with pulmonary embolism protocol, negative nuclear medicine ventilation/perfusion scan, normal electrocardiogram, and normal echocardiography. In the end, he was diagnosed with viral pleuritis as the diagnosis of exclusion. Our patient subsequently developed a fever and shortness of breath and his nasopharyngeal swab performed on admission to hospital returned positive for COVID-19. The patient's pleuritic pain and oxygen requirements improved with supportive management over the next several days.
   Conclusions: I report a patient who experienced pleuritic chest pain from viral pleurisy that was the initial manifestation of COVID-19 which, to the best of my knowledge, has not yet been reported in the literature. This case report further emphasizes that COVID-19 may present with atypical symptoms. It is crucial to be aware of these atypical presentations of COVID-19 so that patients are appropriately identified, isolated, and treated, while protecting health care workers from exposure.
C1 [Oleynick, Christopher] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.
RP Oleynick, C (corresponding author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.
EM cjoleyni@ucalgary.ca
CR Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hua A, 2020, EUR HEART J, V41, P2130, DOI 10.1093/eurheartj/ehaa253
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787
   Raptis CA, 2020, CARDIOPULM IMAGING
   Wong SH, 2020, J GASTROEN HEPATOL, V35, P744, DOI 10.1111/jgh.15047
   Yan CG, 2021, IEEE T PATTERN ANAL, V43, P1445, DOI 10.1109/TPAMI.2020.2975798
NR 7
TC 2
Z9 2
U1 0
U2 1
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
EI 1941-5923
J9 AM J CASE REP
JI Am. J. Case Rep.
PD JUL 24
PY 2020
VL 21
AR e925775
DI 10.12659/AJCR.925775
PG 4
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA MS7UH
UT WOS:000554480400001
PM 32706769
OA Green Published
DA 2022-04-20
ER

PT J
AU Gutierrez-Flores, R
   Rojas-Baron, L
   Davila-Barrios, L
   Molina-Barreto, M
AF Gutierrez-Flores, Rodolfo
   Rojas-Baron, Lisbeth
   Davila-Barrios, Lorena
   Molina-Barreto, Manuel
TI COVID-19: IMPLICATIONS ON THE ORAL MUCOSA AND PATIENT MANAGEMENT IN
   DENTAL CLINICAL PRACTICE. TOPIC REVIEW
SO ACTA BIOCLINICA
LA Spanish
DT Review
DE oral mucosa; saliva; ACE-2; COVID-19; biosecurity; dental practice
ID CORONAVIRUSES
AB The COVID-19 was first reported in China at late December 2019 and was listed as a pandemic on March 19, 2020 by the WHO. The virus protein S, which mediates the entry and fusion process, has been reported to require ACE-2, the angiotensin converting enzyme-2 as an anchoring receptor. ACE-2 is expressed in oral and gingival tissue, epithelial cells and fibroblast in the oral mucosa, making it a high-risk factor for infectious virus susceptibility. On the other hands, the importance of saliva has been reported for its role as a vehicle for the transmission of viral particles, which allows it to be considered as an instrument of potential diagnostic value in the detection of COVID-19. To know the etiology of SARS-CoV-2 and its impact at the oral level, as well as to recognize and execute biosecurity measures for the management of patients in dental clinical practice is the fundamental object of this review, for this reason, a retrospective cross-sectional study with electronic search was carried out through NCBI, Virtual Health Library, Scielo, LILACS and Redalyc. The reports given by the WHO, CDC and Ministries of Health in Latin America are analyzed. The dissemination of information and the adaptation of knowledge in time of pandemic by COVID-19, will protect the health conditions of both, dentist and patient, which is why it is necessary to put biosafety protocols into practice and constantly update them regarding to health care at the clinical and hospital level.
C1 [Gutierrez-Flores, Rodolfo; Davila-Barrios, Lorena] Univ Los Andes, Fac Odontol, Grp Invest Bioseguridad, Catedra Periodoncia,Dept Med Oral, Merida, Venezuela.
   [Rojas-Baron, Lisbeth] Univ Los Andes, Fac Ciencias, Dept Biol, Biol Mol,Lab Biol & Med Expt LABIOMEX, Merida, Venezuela.
   [Molina-Barreto, Manuel] Univ Los Andes, Fac Odontol, Dept Med Oral, Catedra Anestesiol & Cirugia Estomatol, Merida, Venezuela.
RP Rojas-Baron, L (corresponding author), Univ Los Andes, Lab Biol & Med Expt LABIOMEX, Fac Med, Av Don Tulio Febres Cordero,Edificio Fisiopatol, Merida, Venezuela.
EM liscrb@gmail.com
CR Aquino C, 2020, REV CUB ESTOMAT, V57, pe3242
   Araya-Salas Cristóbal, 2020, Int. J. Odontostomat., V14, P268
   Bermudez J, 2020, REV ADM, V77, P88
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chaux A, 2020, J ORAL MED ORAL SURG, V26
   Grohskopf LA, 2018, MMWR RECOMM REP, V67, DOI 10.15585/mmwr.rr6703a1
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Ministerio de Salud de Argentina, 2020, RECOMENDACIONES ODON
   Morales N, 2020, REV CUB ESTOMAT, V57, pe3245
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Pino LE, 2021, CLIN TRANSL ONCOL, V23, P5, DOI 10.1007/s12094-020-02391-x
   Ramírez-Sagredo Andrea, 2020, Rev Chil Cardiol, V39, P66
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Suaste F, 2020, ODONTOL SANMARQUINA, V23, P101
   Valenzuela M., 2020, J ORAL RES, P14
   Villarroel M, 2020, ACT ODONT VENEZ
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   Xu RS, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0080-z
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 22
TC 0
Z9 0
U1 0
U2 2
PU UNIV LOS ANDES, VENEZUELA
PI MERIDA
PA SCH DENTISTRY, DENTAL RES CTR, BLDG DEPUTY RECTOR, MERIDA, 00000,
   VENEZUELA
SN 2244-8136
J9 ACTA BIOCLINICA
JI ACTA BIOCLINICA
PD JAN-JUN
PY 2021
VL 11
IS 21
BP 288
EP 312
PG 25
WC Dentistry, Oral Surgery & Medicine
WE Emerging Sources Citation Index (ESCI)
SC Dentistry, Oral Surgery & Medicine
GA QQ4FN
UT WOS:000624478800014
DA 2022-04-20
ER

PT J
AU Kapoor, I
   Mahajan, C
   Prabhakar, H
AF Kapoor, Indu
   Mahajan, Charu
   Prabhakar, Hemanshu
TI COVID-19 and the perioperative neuroscience - A narrative review
SO SAUDI JOURNAL OF ANAESTHESIA
LA English
DT Review
DE COVID-19; neuroradiology; neuroanesthesia; neurocritical care
ID CONSENSUS STATEMENT; MANAGEMENT; ANESTHESIOLOGY; SOCIETY
AB Among the several medical specialties, anesthesiologists are probably the most affected ones from the coronavirus disease (COVID-19) pandemic as they are at the frontline. In the present stage of the pandemic, where we are observing community transmission, more people with elective neurologic and neurosurgical problems are likely to be tested positive for this virulent disease. Neuroanesthesiologists play an important role in the perioperative period and in neuroradiology suite. It is imperative to know the best available ways by which health care providers can manage their patients and also necessary steps to prevent the spread of infection, not only amongst themselves but also between patients. A high index of suspicion in such patients may help avoid delay in diagnosis and catastrophic sequelae. An overall knowledge about the disease will help plan the clinical management of neurologic patients, during the perioperative period.
C1 [Kapoor, Indu; Mahajan, Charu; Prabhakar, Hemanshu] All India Inst Med Sci AIIMS, Dept Neuroanaesthesiol & Crit Care, New Delhi, India.
RP Prabhakar, H (corresponding author), AIIMS, Dept Neuroanaesthesiol & Crit Care, Neurosci Ctr, New Delhi 110029, India.
EM prabhakaraiims@yahoo.co.in
CR Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   American Society of Anesthesiologists, 2020, US PERS PROT EQ AN P
   Buonsenso D, 2020, LANCET RESP MED, V8, pE27, DOI 10.1016/S2213-2600(20)30120-X
   Cappuccio FP, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1805
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   D'Silva DF, 2020, BRIT J ANAESTH, V125, pE192, DOI 10.1016/j.bja.2020.03.016
   DeFilippis EM, 2020, CIRCULATION, V141, P1833, DOI 10.1161/CIRCULATIONAHA.120.047260
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Edelson DP, 2020, CIRCULATION, V141, pE933, DOI 10.1161/CIRCULATIONAHA.120.047463
   Flexman AM, 2020, J NEUROSURG ANESTH, V32, P202, DOI 10.1097/ANA.0000000000000691
   Greenland JR, 2020, ANESTHESIOLOGY, V132, P1346, DOI 10.1097/ALN.0000000000003303
   Gujski M, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924725
   Gupta P, 2020, NEUROL INDIA, V68, P246, DOI 10.4103/0028-3886.283130
   He YK, 2020, J NEUROINTERV SURG, V12, P658, DOI 10.1136/neurintsurg-2020-016073
   Hejal, NEUROSURGEONS GUIDE
   Jean WC, 2020, ACTA NEUROCHIR, V162, P1229, DOI 10.1007/s00701-020-04342-5
   Kapoor I, 2020, J CLIN ANESTH, V65, DOI 10.1016/j.jclinane.2020.109931
   Kapoor I, 2020, J CLIN ANESTH, V65, DOI 10.1016/j.jclinane.2020.109879
   Li JY, 2020, MICROBES INFECT, V22, P80, DOI 10.1016/j.micinf.2020.02.002
   Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431
   Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005
   Liu Yangli, 2020, J Infect, DOI 10.1016/j.jinf.2020.02.028
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1282
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Meng LZ, 2020, ANESTHESIOLOGY, V132, P1317, DOI 10.1097/ALN.0000000000003296
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Pandey AS, 2020, J NEUROINTERV SURG, V12, P643, DOI 10.1136/neurintsurg-2020-016161
   Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187
   Prabhakar H, 2020, CLIN NEUROL NEUROSUR, V196, DOI 10.1016/j.clineuro.2020.105991
   Prabhakar H, 2020, ANESTH ANALG, V131, pE91, DOI 10.1213/ANE.0000000000004918
   Sharma D, 2020, J NEUROSURG ANESTH, V32, P193, DOI 10.1097/ANA.0000000000000688
   Spina A, 2020, WORLD NEUROSURG, V139, P715, DOI 10.1016/j.wneu.2020.04.161
   Wang DF, 2020, J PLANT PATHOL, V102, P477, DOI 10.1007/s42161-019-00480-7
   Wong J, 2020, CAN J ANESTH, V67, P732, DOI 10.1007/s12630-020-01620-9
   Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430
   Zhao H, 2020, LANCET NEUROL, V19, P383, DOI 10.1016/S1474-4422(20)30109-5
   Zubair AS, 2020, JAMA NEUROL, V77, P1018, DOI 10.1001/jamaneurol.2020.2065
NR 37
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 1658-354X
EI 0975-3125
J9 SAUDI J ANAESTH
JI Saudi J. Anaesth.
PD JAN-MAR
PY 2021
VL 15
IS 1
BP 19
EP 26
DI 10.4103/sja.SJA_668_20
PG 8
WC Anesthesiology
WE Emerging Sources Citation Index (ESCI)
SC Anesthesiology
GA PU9LU
UT WOS:000609620600004
PM 33824638
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Zhou, JW
   Ghose, B
   Wang, RX
   Wu, RJ
   Li, ZF
   Huang, R
   Feng, D
   Feng, ZC
   Tang, SF
AF Zhou, Jiawei
   Ghose, Bishwajit
   Wang, Ruoxi
   Wu, Ruijun
   Li, Zhifei
   Huang, Rui
   Feng, Da
   Feng, Zhanchun
   Tang, Shangfeng
TI Health Perceptions and Misconceptions Regarding COVID-19 in China:
   Online Survey Study
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE COVID-19; perceptions; knowledge; coronavirus; SARS-CoV-2; pandemic;
   rapid; online; surveys; public health
ID KNOWLEDGE; EPIDEMIC; INSIGHTS
AB Background: Great efforts have been made to prevent the spread of COVID-19, including national initiatives to promote the change of personal behaviors. The lessons learned from the 2003 SARS outbreak indicate that knowledge and attitudes about infectious diseases are related to panic among the population, which may further complicate efforts to prevent the spread of infectious diseases. Misunderstandings may result in behaviors such as underestimation, panic, and taking ineffective measures to avoid infection; these behaviors are likely to cause the epidemic to spread further.
   Objective: The purpose of this study is to assess public health perceptions and misunderstandings about COVID-19 in China, and to propose targeted response measures based on the findings to control the development of the epidemic.
   Methods: The study was conducted in April 2020 through an online survey, with participants in 8 provinces in Eastern, Central, and Western China. We designed a questionnaire with a health knowledge section consisting of 5 questions (4 conventional questions and 1 misleading question) on clinical features of and preventive measures against COVID-19. Descriptive statistics, chi-square analysis, binary logistic regression, and Mantel-Haenszel hierarchical analysis were used for statistical analysis.
   Results: In total, 4788 participants completed the survey and the mean knowledge score was 4.63 (SD 0.67), gained mainly through experts (76.1%), television (60.0%), newspapers (57.9%), and opinions (46.6%) and videos (42.9%) from social media. Compared to those who obtained information from only 1 or 2 channels, people who obtained information from >3 channels had increased health perception and a better ability to identify misleading information. Suggestions from experts were the most positive information source (chi(2)=41.61), while information on social media was the most misleading. Those aged >60 years (OR 1.52, 95% CI 1.10-2.11), those with a lower or middle income (OR 1.36, 95% CI 1.00-1.83), those not working and not able to work (OR 1.83, 95% CI 1.04-3.21), those with a household income <100,000 RMB (<US $14,954; OR 1.34, 95% CI 1.08-1.67), and those with >2 suspected symptoms (OR 2.95, 95% CI 1.50-5.80) were more likely to be misled by videos on social media, but the error correction effect of expert advice was limited in these groups.
   Conclusions: Multiple information channels can improve public health perception and the identification of misleading information during the COVID-19 pandemic. Videos on social media increased the risk of rumor propagation among vulnerable groups. We suggest the government should strengthen social media regulation and increase experts' influence on the targeted vulnerable populations to reduce the risk of rumors spreading.
C1 [Zhou, Jiawei; Wang, Ruoxi; Feng, Zhanchun; Tang, Shangfeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, 13 Hangkong Rd, Wuhan, Peoples R China.
   [Ghose, Bishwajit; Huang, Rui; Feng, Da] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan, Peoples R China.
   [Wu, Ruijun; Li, Zhifei] China Natl Ctr Biotechnol Dev, Beijing, Peoples R China.
RP Tang, SF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, 13 Hangkong Rd, Wuhan, Peoples R China.
EM sftang2018@hust.edu.cn
RI Wang, Ruoxi/U-8016-2017
OI Wang, Ruoxi/0000-0002-9695-0582
FU Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [2020kfyXGYJ071,
   2020kfyXGYJ013]
FX ST received funding from the Fundamental Research Funds for the Central
   Universities (Grant number 2020kfyXGYJ071&2020kfyXGYJ013). The funders
   had no role in the study design; data collection and analysis; decision
   to publish, or preparation of the manuscript.
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Betsch C, 2020, LANCET, V395, P1255, DOI 10.1016/S0140-6736(20)30729-7
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1339, DOI 10.1001/jama.2020.3072
   Fisher D, 2020, LANCET, V395, P1109, DOI 10.1016/S0140-6736(20)30679-6
   Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Hightow-Weidman L, 2020, AIDS BEHAV, V24, P2239, DOI 10.1007/s10461-020-02870-w
   Hung LS, 2003, J ROY SOC MED, V96, P374, DOI 10.1258/jrsm.96.8.374
   Jacobsen KH, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13225
   Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron
   Li JY, 2020, MICROBES INFECT, V22, P80, DOI 10.1016/j.micinf.2020.02.002
   Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125
   Massaad E, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7838
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130
   Tachfouti N, 2012, PAN AFR MED J, V12
   van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X
   Vraga EK, 2017, SCI COMMUN, V39, P621, DOI 10.1177/1075547017731776
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   WHO, 2019, COR DIS COVID SIT RE
   World Health Organization, 2020, WHO DIR GEN POP REM
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3
NR 29
TC 5
Z9 5
U1 13
U2 43
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD NOV 2
PY 2020
VL 22
IS 11
AR e21099
DI 10.2196/21099
PG 15
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; Medical Informatics
GA OL5LR
UT WOS:000585381800014
PM 33027037
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Taber, P
   Staes, CJ
   Phengphoo, S
   Rocha, E
   Lam, A
   Del Fiol, G
   Maviglia, SM
   Rocha, RA
AF Taber, Peter
   Staes, Catherine J.
   Phengphoo, Saifon
   Rocha, Elisa
   Lam, Adria
   Del Fiol, Guilherme
   Maviglia, Saverio M.
   Rocha, Roberto A.
TI Developing a sampling method and preliminary taxonomy for classifying
   COVID-19 public health guidance for healthcare organizations and the
   general public
SO JOURNAL OF BIOMEDICAL INFORMATICS
LA English
DT Article
DE COVID-19; Public health guidance; Taxonomy; Content analysis; Indexing;
   Knowledge management
ID KNOWLEDGE MANAGEMENT; SCIENCE; IMPLEMENTATION; DISSEMINATION;
   INFORMATION; CHALLENGES; SYSTEMS
AB Background: Development and dissemination of public health (PH) guidance to healthcare organizations and the general public (e.g., businesses, schools, individuals) during emergencies like the COVID-19 pandemic is vital for policy, clinical, and public decision-making. Yet, the rapidly evolving nature of these events poses significant challenges for guidance development and dissemination strategies predicated on well-understood concepts and clearly defined access and distribution pathways. Taxonomies are an important but underutilized tool for guidance authoring, dissemination and updating in such dynamic scenarios. Objective: To design a rapid, semi-automated method for sampling and developing a PH guidance taxonomy using widely available Web crawling tools and streamlined manual content analysis. Methods: Iterative samples of guidance documents were taken from four state PH agency websites, the US Center for Disease Control and Prevention, and the World Health Organization. Documents were used to derive and refine a preliminary taxonomy of COVID-19 PH guidance via content analysis. Results: Eight iterations of guidance document sampling and taxonomy revisions were performed, with a final corpus of 226 documents. The preliminary taxonomy contains 110 branches distributed between three major domains: stakeholders (24 branches), settings (25 branches) and topics (61 branches). Thematic saturation measures indicated rapid saturation (<= 5% change) for the domains of "stakeholders" and "settings", and "topic"related branches for clinical decision-making. Branches related to business reopening and economic consequences remained dynamic throughout sampling iterations. Conclusion: The PH guidance taxonomy can support public health agencies by aligning guidance development with curation and indexing strategies; supporting targeted dissemination; increasing the speed of updates; and enhancing public-facing guidance repositories and information retrieval tools. Taxonomies are essential to support knowledge management activities during rapidly evolving scenarios such as disease outbreaks and natural disasters.
C1 [Taber, Peter; Staes, Catherine J.; Phengphoo, Saifon; Del Fiol, Guilherme] Univ Utah, Dept Biomed Informat, 421 Wakara Way, Salt Lake City, UT 84148 USA.
   [Staes, Catherine J.; Phengphoo, Saifon] Univ Utah, Coll Nursing, Salt Lake City, UT 84148 USA.
   [Rocha, Elisa] Univ Massachusetts, Med Sch, Worcester, MA 01605 USA.
   [Lam, Adria] Albany Med Coll, Albany, NY 12208 USA.
   [Maviglia, Saverio M.; Rocha, Roberto A.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.
   [Maviglia, Saverio M.; Rocha, Roberto A.] Semedy Inc, Needham, MA USA.
RP Taber, P (corresponding author), Univ Utah, Dept Biomed Informat, 421 Wakara Way, Salt Lake City, UT 84148 USA.
EM peter.taber@hse.utah.edu
CR Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI [10.1007/s40615-020-00833-4, 10.1101/2020.04.26.20079756]
   Alper B, COVID 19 KNOWLEDGE A
   Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598
   Balas E Andrew, 2004, Stud Health Technol Inform, V100, P149
   Bauer L., 2020, 10 FACTS COVID 19 US
   Bernard H.Russell., 2016, ANAL QUALITATIVE DAT
   Bin Naeem S, 2020, HEALTH INFO LIBR J, V37, P233, DOI 10.1111/hir.12311
   Campbell JL, 2013, SOCIOL METHOD RES, V42, P294, DOI 10.1177/0049124113500475
   Cascio MA, 2019, FIELD METHOD, V31, P116, DOI 10.1177/1525822X19838237
   Chou WYS, 2020, AM J PUBLIC HEALTH, V110, pS270, DOI 10.2105/AJPH.2020.305943
   Cooney MA, 2018, J PUBLIC HEALTH MAN, V24, P185, DOI 10.1097/PHH.0000000000000775
   Creswell J.W., 2017, RES DESIGN QUALITATI
   Del Fiol G, 2012, J BIOMED INFORM, V45, P726, DOI 10.1016/j.jbi.2011.12.006
   Dixon BE, 2009, KNOWL MAN RES PRACT, V7, P249, DOI 10.1057/kmrp.2009.15
   Dobbins Maureen, 2010, BMC Public Health, V10, P496, DOI 10.1186/1471-2458-10-496
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Dorasamy M, 2013, TECHNOL FORECAST SOC, V80, P1834, DOI 10.1016/j.techfore.2012.12.008
   Earl M, 2001, J MANAGE INFORM SYST, V18, P215
   Ely JW, 2000, BRIT MED J, V321, P429, DOI 10.1136/bmj.321.7258.429
   Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157
   Falcone R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17196988
   Friedman C, 2006, BIOINFORMATICS, V22, P2421, DOI 10.1093/bioinformatics/btl405
   Gasser U, 2020, LANCET DIGIT HEALTH, V2, pE425, DOI 10.1016/S2589-7500(20)30137-0
   Genereux M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040587
   Goodman MS, 2017, TRANSL BEHAV MED, V7, P486, DOI 10.1007/s13142-017-0495-z
   Graneheim UH, 2017, NURS EDUC TODAY, V56, P29, DOI 10.1016/j.nedt.2017.06.002
   Green LW, 2009, ANNU REV PUBL HEALTH, V30, P151, DOI 10.1146/annurev.publhealth.031308.100049
   Guest G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232076
   Health UDo, TRAV GUID TRAV GUID
   Health UDo, OV COVID 19 SURV OV COVID 19 SURV
   Jones RM, 2020, AM J INFECT CONTROL, V48, P46, DOI 10.1016/j.ajic.2019.06.023
   Klein D, 2018, STATA J, V18, P871, DOI 10.1177/1536867X1801800408
   Kreimeyer K, 2017, J BIOMED INFORM, V73, P14, DOI 10.1016/j.jbi.2017.07.012
   Li LF, 2020, IEEE T COMPUT SOC SY, V7, P556, DOI 10.1109/TCSS.2020.2980007
   Liu KH, 2011, J BIOMED INFORM, V44, P163, DOI 10.1016/j.jbi.2010.07.006
   Lloria MB, 2008, KNOWL MAN RES PRACT, V6, P77, DOI 10.1057/palgrave.kmrp.8500164
   Lobb R, 2013, ANNU REV PUBL HEALTH, V34, P235, DOI 10.1146/annurev-publhealth-031912-114444
   Lowe A, 2018, FIELD METHOD, V30, P191, DOI 10.1177/1525822X17749386
   Lurie N, 2013, NEW ENGL J MED, V368, P1251, DOI 10.1056/NEJMsb1209510
   McGuire AL, 2020, AM J BIOETHICS, V20, P15, DOI 10.1080/15265161.2020.1764138
   Nelson S.J., J AM MED INFORM ASS, V2021
   O'Cathain A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029954
   Pan SL, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102143
   Quinn E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-443
   Rhodes R, 2020, AM J BIOETHICS, V20, P163, DOI 10.1080/15265161.2020.1777354
   Roberts K, 2020, J AM MED INFORM ASSN, V27, P1431, DOI 10.1093/jamia/ocaa091
   Rollston R, 2020, AM J HEALTH PROMOT, V34, P687, DOI 10.1177/0890117120930536b
   Rovetta A, 2020, J MED INTERNET RES, V22, DOI 10.2196/20673
   Safarnejad L, 2020, AM J PUBLIC HEALTH, V110, pS340, DOI 10.2105/AJPH.2020.305854
   Sittig DF, 2010, INT J MED INFORM, V79, P44, DOI 10.1016/j.ijmedinf.2009.09.003
   Staes C.J., 2011, ONLINE J PUBL HLTH I, V3
   Staes CJ, 2011, J PUBLIC HEALTH MAN, V17, P36, DOI 10.1097/PHH.0b013e3181ee9b29
   Taber P, 2021, DANS, DOI 10.17632/yjcv23t98b.1
   Tangcharoensathien V, 2020, J MED INTERNET RES, V22, DOI 10.2196/19659
   Varpio L, 2017, MED EDUC, V51, P40, DOI 10.1111/medu.13124
   Wensing M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1322-9
NR 56
TC 0
Z9 0
U1 2
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-0464
EI 1532-0480
J9 J BIOMED INFORM
JI J. Biomed. Inform.
PD AUG
PY 2021
VL 120
AR 103852
DI 10.1016/j.jbi.2021.103852
EA JUL 2021
PG 9
WC Computer Science, Interdisciplinary Applications; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Computer Science; Medical Informatics
GA TY1JL
UT WOS:000683539900008
PM 34192573
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Sundnes, KO
   Braut, GS
AF Sundnes, Knut Ole
   Braut, Geir Sverre
TI COVID-19: systematic learning across boundaries requires a conceptual
   agreement
SO SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
DE COVID-19; research; learning; Utstein-template
AB The COVID-19 epidemic has revealed a shortage of basic knowledge and understanding of pandemics, especially regarding their dynamics and how to contain them. The results are a host of governments' decrees and instructions, one replacing the other, often within the same week. It has further, in a truly short time, resulted in an overwhelming number of publications, many of them prioritising early publication over quality. This commentary addresses the concept of structured research related to disasters and how the use of endorsed guidelines will facilitate well-designed evaluation research with improved rigour and external validity, even if applied retrospectively. The outcome should be a solidified knowledge base. Further, the important role of public health efforts is to be highlighted, as their role has proved crucial during the COVID-19 pandemic.
C1 [Sundnes, Knut Ole] Oslo Univ Hosp, Intervent Ctr, Sognsvannsveien 20, N-0372 Oslo, Norway.
   [Sundnes, Knut Ole] Univ Stavanger, Ctr Risk Management & Societal Safety, Stavanger, Norway.
   [Braut, Geir Sverre] Stavanger Univ Hosp, Res Dept, Stavanger, Norway.
RP Sundnes, KO (corresponding author), Oslo Univ Hosp, Intervent Ctr, Sognsvannsveien 20, N-0372 Oslo, Norway.
EM kosundnes@gmail.com
RI Braut, Geir Sverre/ABH-3334-2021
OI Braut, Geir Sverre/0000-0002-3337-4792; Sundnes, Knut
   Ole/0000-0002-0611-5904
CR [Anonymous], 2020, LANCET, V396, P799, DOI [10.1016/S0140-6736(20)31954-1, 10.1016/S0140-6736(20)31958-9]
   [Anonymous], 1625, CHRIST 4 REC PLAG 15
   BjOrnsen G, 2020, ENG ASSETS PUBLIC IN
   Borgenhammar E., 1994, ATT VARDA LIV ORG ET
   Clark H, 2021, COVID 19 MAKE IT LAS
   CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960
   de Goyet CD, 2000, LANCET, V356, P762, DOI 10.1016/S0140-6736(00)02642-8
   Honigsbaum M, 2019, PANDEMIC CENTURY 100, P211
   McNeill, 1976, PLAGUES PEOPLES
   Norwegian Directorate of Health, PRIOR PAT INT CAR UN
   Retraction Watch, RETR COR COVID 19 PA
   Ricci E., 2019, DISASTER EVALUATION
   Soreide E, 2013, RESUSCITATION, V84, P1487, DOI 10.1016/j.resuscitation.2013.07.020
   SUCHMAN E, 1967, EVALUATIVE RES PRINC
   Sundnes K., 2002, PREHOSP DISASTER MED, V17
   Sundnes KO, 2014, SCAND J PUBLIC HEALT, V42, P14
   The Norwegian Coronavirus Commission, 2021, 20216 NOU
   Underwood A, 2021, PREHOSPITAL DISASTER, V36, P4, DOI 10.1017/S1049023X20001417
   Worldometer.info, COR CAS
NR 19
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1403-4948
EI 1651-1905
J9 SCAND J PUBLIC HEALT
JI Scand. J. Public Health
PD NOV
PY 2021
VL 49
IS 7
SI SI
BP 809
EP 814
AR 14034948211027086
DI 10.1177/14034948211027086
EA JUN 2021
PG 6
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA WG6PS
UT WOS:000666618900001
PM 34162297
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Wang, BL
   Li, RB
   Lu, Z
   Huang, Y
AF Wang, Bolin
   Li, Ruobao
   Lu, Zhong
   Huang, Yan
TI Does comorbidity increase the risk of patients with COVID-19: evidence
   from meta-analysis
SO AGING-US
LA English
DT Article
DE COVID-19; comorbidity; meta-analysis; risk
ID WUHAN
AB Currently, the number of patients with coronavirus disease 2019 (COVID-19) has increased rapidly, but relationship between comorbidity and patients with COVID-19 still not clear. The aim was to explore whether the presence of common comorbidities increases COVID-19 patients' risk. A literature search was performed using the electronic platforms (PubMed, Cochrane Library, Embase, and other databases) to obtain relevant research studies published up to March 1, 2020. Relevant data of research endpoints in each study were extracted and merged. All data analysis was performed using Stata12.0 software. A total of 1558 patients with COVID-19 in 6 studies were enrolled in our meta-analysis eventually. Hypertension (OR: 2.29, P<0.001), diabetes (OR: 2.47, P<0.001), chronic obstructive pulmonary disease (COPD) (OR: 5.97, P<0.001), cardiovascular disease (OR: 2.93, P<0.001), and cerebrovascular disease (OR:3.89,P=0.002) were independent risk factors associated with COVID-19 patients. The meta-analysis revealed no correlation between increased risk of COVID-19 and liver disease, malignancy, or renal disease. Hypertension, diabetes, COPD, cardiovascular disease, and cerebrovascular disease are major risk factors for patients with COVID-19. Knowledge of these risk factors can be a resource for clinicians in the early appropriate medical management of patients with COVID-19.
C1 [Wang, Bolin] Weifang Med Univ, Weifang 261031, Peoples R China.
   [Li, Ruobao] Weifang Med Univ, Dept Human Anat, Weifang 261031, Peoples R China.
   [Lu, Zhong; Huang, Yan] Weifang Med Univ, Affiliated Hosp, Dept Oncol, Weifang 261031, Peoples R China.
RP Huang, Y (corresponding author), Weifang Med Univ, Affiliated Hosp, Dept Oncol, Weifang 261031, Peoples R China.
EM Yanhuangdr@163.com
OI wang, bolin/0000-0001-8086-0681
CR Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Guan WJ, 2019, CLIN CHARACTERISTICS, V2020, P2020, DOI [10.1101/2020.02.06.20020974, DOI 10.1101/2020.02.06.20020974]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu W, 2020, CHINESE MED J-PEKING, V133, P1032, DOI 10.1097/CM9.0000000000000775
   McInnes MDF, 2018, JAMA-J AM MED ASSOC, V319, P388, DOI 10.1001/jama.2017.19163
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
NR 13
TC 545
Z9 568
U1 7
U2 57
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD APR 15
PY 2020
VL 12
IS 7
BP 6049
EP 6057
DI 10.18632/aging.103000
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LE7WC
UT WOS:000526933400028
PM 32267833
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Lee, Y
   Tao, WT
   Li, JYQ
   Sun, RY
AF Lee, Yeunjae
   Tao, Weiting
   Li, Jo-Yun Queenie
   Sun, Ruoyu
TI Enhancing employees' knowledge sharing through diversity-oriented
   leadership and strategic internal communication during the COVID-19
   outbreak
SO JOURNAL OF KNOWLEDGE MANAGEMENT
LA English
DT Article
DE Knowledge sharing; Self-determination theory; Job engagement; Internal
   crisis communication; Diversity-oriented leadership; Transparent
   internal communication; Intrinsic needs satisfaction
ID SELF-DETERMINATION THEORY; AFFECTIVE ORGANIZATIONAL COMMITMENT;
   AUTHENTIC LEADERSHIP; JOB CHARACTERISTICS; MEDIATING ROLE; INTRINSIC
   MOTIVATION; INCLUSIVE LEADERSHIP; WORK ORGANIZATIONS; TACIT KNOWLEDGE;
   MODERATING ROLE
AB Purpose
   This study aims to examine the effects of diversity-oriented leadership and strategic internal communication on employees' knowledge-sharing behavior during a crisis situation, coronavirus (COVID-19) outbreak in particular. Integrating knowledge sharing research with internal crisis communication literature as well as self-determination theory, the mediating roles of employees' intrinsic needs satisfaction are also identified.
   Design/methodology/approach
   An online survey was conducted with 490 full-time employees in the USA across industry sectors during the COVID-19 outbreak.
   Findings
   Results suggest that diversity-oriented leadership contributes to transparent internal communication during a crisis and increases employees' satisfaction of autonomy, competence and relatedness needs. Transparent internal communication also increases employees' intrinsic needs satisfaction, which in turn fosters their job engagement and knowledge-sharing behavior during the crisis.
   Originality/value
   This study is one of the earliest studies to demonstrate the effectiveness of diversity-oriented leadership and strategic internal crisis communication in enhancing employees' knowledge-sharing behavior, especially in the context of COVID-19.
C1 [Lee, Yeunjae; Tao, Weiting; Li, Jo-Yun Queenie; Sun, Ruoyu] Univ Miami, Dept Strateg Commun, Coral Gables, FL 33124 USA.
RP Lee, Y (corresponding author), Univ Miami, Dept Strateg Commun, Coral Gables, FL 33124 USA.
EM yxl992@miami.edu; weiting.tao@miami.edu; queenie.li@miami.edu;
   ruoyu.sun@miami.edu
RI von der Wense, Benedikt/ABH-2026-2021
CR Adamu A.A., 2016, INT REV MANAGEMENT M, V6, P33
   Alge BJ, 2006, J APPL PSYCHOL, V91, P221, DOI 10.1037/0021-9010.91.1.221
   Aljuwaiber A, 2016, J KNOWL MANAG, V20, P731, DOI 10.1108/JKM-12-2015-0494
   ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411
   Ardichvili A., 2003, Journal of Knowledge Management, V7, P64, DOI 10.1108/13673270310463626
   Bartol K.M., 2002, J LEADERSHIP ORG STU, V9, P64, DOI DOI 10.1177/107179190200900105
   Bock GW, 2005, MIS QUART, V29, P87, DOI 10.2307/25148669
   Boh WF, 2013, J KNOWL MANAG, V17, P29, DOI 10.1108/13673271311300723
   Bowen D.E., 2006, MANAGING INNOVATION, V33, P155
   Burnett J., 2002, MANAGING BUSINESS CR
   Cabrera A, 2006, INT J HUM RESOUR MAN, V17, P245, DOI 10.1080/09585190500404614
   Cabrera EF, 2005, INT J HUM RESOUR MAN, V16, P720, DOI 10.1080/09585190500083020
   Cao WL, 2012, INFORM TECHNOL MANAG, V13, P333, DOI 10.1007/s10799-012-0129-6
   Carmeli A, 2013, HUM RESOUR MANAGE-US, V52, P95, DOI 10.1002/hrm.21514
   Carmeli A, 2010, CREATIVITY RES J, V22, P250, DOI 10.1080/10400419.2010.504654
   Casimir G, 2012, J KNOWL MANAG, V16, P740, DOI 10.1108/13673271211262781
   Chen CC, 2009, J SOC PSYCHOL, V149, P474, DOI 10.3200/SOCP.149.4.474-494
   Chen CJ, 2010, INT J MANPOWER, V31, P848, DOI 10.1108/01437721011088548
   Chen ZJ, 2011, J APPL SOC PSYCHOL, V41, P1005, DOI 10.1111/j.1559-1816.2011.00745.x
   Choi SB, 2015, SOC BEHAV PERSONAL, V43, P931, DOI 10.2224/sbp.2015.43.6.931
   Connelly C.E., 2003, LEADERSHIP ORG DEV J, V24, P294, DOI DOI 10.1108/01437730310485815
   Coradi A, 2015, J KNOWL MANAG, V19, P236, DOI 10.1108/JKM-06-2014-0234
   Cummings JN, 2004, MANAGE SCI, V50, P352, DOI 10.1287/mnsc.1030.0134
   Damodaran L, 2000, BEHAV INFORM TECHNOL, V19, P405, DOI 10.1080/014492900750052660
   de Vries RE, 2006, COMMUN RES, V33, P115, DOI 10.1177/0093650205285366
   Deci E, 1985, INTRINSIC MOTIVATION
   Deci EL, 2017, ANNU REV ORGAN PSYCH, V4, P19, DOI 10.1146/annurev-orgpsych-032516-113108
   DECI EL, 1989, J APPL PSYCHOL, V74, P580, DOI 10.1037/0021-9010.74.4.580
   Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01
   Deci EL, 2001, PERS SOC PSYCHOL B, V27, P930, DOI 10.1177/0146167201278002
   Devloo T, 2015, EUR J WORK ORGAN PSY, V24, P491, DOI 10.1080/1359432X.2014.931326
   Fernandez S, 2010, LEADERSHIP QUART, V21, P308, DOI 10.1016/j.leaqua.2010.01.009
   Frandsen F, 2011, CORP COMMUN, V16, P347, DOI 10.1108/13563281111186977
   Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512
   Gagne M, 2005, J ORGAN BEHAV, V26, P331, DOI 10.1002/job.322
   Gallup, 2020, COR WILL CHANG NEXT
   Geiger D, 2012, J KNOWL MANAG, V16, P97, DOI 10.1108/13673271211198963
   Gruman JA, 2011, HUM RESOUR MANAGE R, V21, P123, DOI 10.1016/j.hrmr.2010.09.004
   Hair J., 2006, MULTIVARIATE DATA AN
   Hansen MT, 2002, ORGAN SCI, V13, P232, DOI 10.1287/orsc.13.3.232.2771
   Hau YS, 2013, INT J INFORM MANAGE, V33, P356, DOI 10.1016/j.ijinfomgt.2012.10.009
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Institute for Public Relations, 2020, CO AR ENG EMPL COVID
   Jackson SE, 2006, RES PERS H, V25, P27, DOI 10.1016/S0742-7301(06)25002-3
   Javed B, 2019, J MANAGE ORGAN, V25, P554, DOI 10.1017/jmo.2018.50
   Jiang H, 2018, J COMMUN MANAG, V22, P138, DOI 10.1108/JCOM-07-2016-0055
   Jiang H, 2017, COMMUN RES, V44, P225, DOI 10.1177/0093650215613137
   Johansen W, 2012, PUBLIC RELAT REV, V38, P270, DOI 10.1016/j.pubrev.2011.11.008
   KAHN WA, 1990, ACAD MANAGE J, V33, P692, DOI 10.2307/256287
   Kalev A., 2020, HARVARD BUS REV
   Kaltiainen J, 2020, J OCCUP HEALTH PSYCH, V25, P244, DOI 10.1037/ocp0000163
   Kang M, 2019, J PUBLIC RELAT RES, V31, P152, DOI 10.1080/1062726X.2019.1680988
   Kang M, 2017, J COMMUN MANAG, V21, P82, DOI 10.1108/JCOM-04-2016-0026
   Karahanna E, 1999, MIS QUART, V23, P183, DOI 10.2307/249751
   Kim JN, 2011, J PUBLIC RELAT RES, V23, P243, DOI 10.1080/1062726X.2011.582204
   Kim Y, 2020, J PUBLIC RELAT RES, V32, P47, DOI 10.1080/1062726X.2020.1765368
   Kim Y, 2018, J COMMUN MANAG, V22, P451, DOI 10.1108/JCOM-03-2018-0025
   Kock N, 2015, INT J E-COLLAB, V11, P1, DOI 10.4018/ijec.2015040101
   Kock N, 2012, J ASSOC INF SYST, V13, P546, DOI 10.17705/1jais.00302
   Kulik CT, 2014, HUM RESOUR MANAG J, V24, P129, DOI 10.1111/1748-8583.12038
   Lee JN, 2001, INFORM MANAGE, V38, P323, DOI 10.1016/S0378-7206(00)00074-4
   Lin HF, 2007, INT J MANPOWER, V28, P315, DOI 10.1108/01437720710755272
   Lin HF, 2007, J INF SCI, V33, P135, DOI 10.1177/0165551506068174
   Llorens S, 2007, COMPUT HUM BEHAV, V23, P825, DOI 10.1016/j.chb.2004.11.012
   Lu L., 2006, MANAGEMENT ORG REV, V2, P15, DOI [DOI 10.1111/J.1740-8784.2006.00029.X, 10.1111/j.1740-8784.2006.00029.x]
   Tuan LT, 2019, J BUS RES, V95, P303, DOI 10.1016/j.jbusres.2018.08.017
   MacCurtain S, 2010, CREAT INNOV MANAG, V19, P219, DOI 10.1111/j.1467-8691.2010.00564.x
   Men L.R., 2016, EXCELLENCE INTERNAL
   Men LR, 2014, CORP REPUT REV, V17, P254, DOI 10.1057/crr.2014.14
   Men LR, 2014, J PUBLIC RELAT RES, V26, P301, DOI 10.1080/1062726X.2014.908720
   Menguc B, 2013, J BUS RES, V66, P2163, DOI 10.1016/j.jbusres.2012.01.007
   Mesmer-Magnus JR, 2009, J APPL PSYCHOL, V94, P535, DOI 10.1037/a0013773
   Moldogaziev TT, 2015, PUBLIC ADMIN, V93, P557, DOI 10.1111/padm.12139
   Nakano D, 2013, J KNOWL MANAG, V17, P290, DOI 10.1108/13673271311315222
   Nembhard IM, 2006, J ORGAN BEHAV, V27, P941, DOI 10.1002/job.413
   Nishii LH, 2009, J APPL PSYCHOL, V94, P1412, DOI 10.1037/a0017190
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Powley E.H., 2012, OXFORD HDB POSITIVE, P855
   Randel AE, 2018, HUM RESOUR MANAGE R, V28, P190, DOI 10.1016/j.hrmr.2017.07.002
   Rawlins B, 2009, J PUBLIC RELAT RES, V21, P71, DOI 10.1080/10627260802153421
   Reinholt M, 2011, ACAD MANAGE J, V54, P1277, DOI 10.5465/amj.2009.0007
   Rich BL, 2010, ACAD MANAGE J, V53, P617, DOI 10.5465/AMJ.2010.51468988
   Ruck K, 2017, PUBLIC RELAT REV, V43, P904, DOI 10.1016/j.pubrev.2017.04.008
   Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68
   Saks A.M., 2006, J MANAGE PSYCHOL, V21, P600, DOI [DOI 10.1108/02683940610690169, 10.1108/02683940610690169]
   Sawyer K., 2016, CONSULTING PSYCHOL J, V68, P49, DOI DOI 10.1037/CPB0000051
   Schaufeli W., 2002, J HAPPINESS STUD, V3, P71, DOI [DOI 10.1023/A:1015630930326, 10.1023/A:1015630930326]
   Shen HM, 2019, J PUBLIC RELAT RES, V31, P32, DOI 10.1080/1062726X.2019.1585855
   Spreitzer GM, 1996, ACAD MANAGE J, V39, P483, DOI 10.2307/256789
   Stander MW, 2010, SA J IND PSYCHOL, V36, DOI 10.4102/sajip.v36i1.849
   Tao WT, 2018, PUBLIC RELAT REV, V44, P667, DOI 10.1016/j.pubrev.2018.07.002
   Teerikangas S., 2015, ROUTLEDGE COMPANION, P130, DOI DOI 10.4324/9780203761885
   Trepanier SG, 2015, WORK STRESS, V29, P286, DOI 10.1080/02678373.2015.1074957
   Tulshyan R., 2020, HARVARD BUS REV
   University of Pennsylvania, 2020, WHY LEAD DIV MATT HA
   Van den Broeck A, 2008, WORK STRESS, V22, P277, DOI 10.1080/02678370802393672
   Van den Broeck A, 2016, J MANAGE, V42, P1195, DOI 10.1177/0149206316632058
   van den Heuvel M., 2010, CONT OCCUPATIONAL HL, P124
   Wang HJ, 2015, J APPL PSYCHOL, V100, P1249, DOI 10.1037/a0038330
   Wang S, 2010, HUM RESOUR MANAGE R, V20, P115, DOI 10.1016/j.hrmr.2009.10.001
   Welch M, 2007, CORP COMMUN, V12, P177, DOI 10.1108/13563280710744847
   Wooten LP, 2008, ADV DEV HUM RESOUR, V10, P352, DOI 10.1177/1523422308316450
   Yin JL, 2019, J KNOWL MANAG, V24, P150, DOI 10.1108/JKM-12-2018-0776
   Yue CA, 2019, PUBLIC RELAT REV, V45, P114, DOI 10.1016/j.pubrev.2019.04.012
   Zhang Y, 2013, LEADERSHIP QUART, V24, P534, DOI 10.1016/j.leaqua.2013.03.007
NR 105
TC 21
Z9 21
U1 28
U2 78
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1367-3270
EI 1758-7484
J9 J KNOWL MANAG
JI J. Knowl. Manag.
PD JUL 30
PY 2021
VL 25
IS 6
BP 1526
EP 1549
DI 10.1108/JKM-06-2020-0483
EA DEC 2020
PG 24
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA TX3XX
UT WOS:000597968900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Safra, L
   Sijilmassi, A
   Chevallier, C
AF Safra, L.
   Sijilmassi, A.
   Chevallier, C.
TI Disease, perceived infectability and threat reactivity: A COVID-19 study
SO PERSONALITY AND INDIVIDUAL DIFFERENCES
LA English
DT Article
DE Threat reactivity; Disease vulnerability; Pathogen threat; COVID-19;
   Error-management theory
ID VULNERABILITY; PREFERENCES; AVOIDANCE; KNOWLEDGE; BEHAVIOR; PEOPLE; SEX
AB Using a two-wave online experiment, we investigate whether COVID-19 exposure changes participants' threat detection threshold. Threat reactivity was measured in a signal detection task among 277 British adults who also reported how vulnerable they felt to infectious diseases. Participants' data were then matched to the local number of confirmed COVID-19 cases announced by the NHS every day. We found that participants who perceive themselves as more likely to catch infectious diseases displayed higher threat reactivity in response to increased COVID-19 cases.
C1 [Safra, L.] Sci Po, CEVIPOF, CNRS UMR 7048, Paris, France.
   [Sijilmassi, A.] PSL Res Univ, CNRS, Inst Jean Nicod, Dept Etud Cognit,ENS,EHESS, Paris, France.
   [Chevallier, C.] Res Univ, INSERM, PSL, Lab Neurosci Cognit,Dept Etud Cognit,ENS, Paris, France.
RP Safra, L (corresponding author), Sci Po, CEVIPOF, CNRS UMR 7048, Paris, France.
EM lou.safra@sciencespo.fr
RI Gui, Yuliang/AAP-5071-2021
FU  [ANR17EURE0017]
FX This study was supported by the EUR FrontCog grant ANR17EURE0017.
CR Chevallier C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167024
   De Coninck D, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110220
   Duncan LA, 2009, ANAL SOC ISS PUB POL, V9, P97, DOI 10.1111/j.1530-2415.2009.01188.x
   Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001
   Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142
   Haselton MG, 2000, J PERS SOC PSYCHOL, V78, P81, DOI 10.1037/0022-3514.78.1.81
   HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619
   Lieder F, 2018, PSYCHOL REV, V125, P1, DOI 10.1037/rev0000074
   Little AC, 2007, P ROY SOC B-BIOL SCI, V274, P3113, DOI 10.1098/rspb.2007.0895
   Makhanova A, 2020, PERS INDIV DIFFER, V167, DOI 10.1016/j.paid.2020.110221
   McDonald MM, 2015, EVOL HUM BEHAV, V36, P438, DOI 10.1016/j.evolhumbehav.2015.04.002
   Navarrete CD, 2006, EVOL HUM BEHAV, V27, P270, DOI 10.1016/j.evolhumbehav.2005.12.001
   Nettle D, 2012, CURR BIOL, V22, pR712, DOI 10.1016/j.cub.2012.06.020
   Neuhoff JG, 2012, EVOL HUM BEHAV, V33, P318, DOI 10.1016/j.evolhumbehav.2011.11.001
   Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026
   Prokop P, 2010, J ETHOL, V28, P345, DOI 10.1007/s10164-009-0195-3
   Reid SA, 2012, EVOL HUM BEHAV, V33, P471, DOI 10.1016/j.evolhumbehav.2011.12.009
   Safra L., 2021, POVERTY THREAT REACT
   Stahl ST, 2013, GERONTOL GERIATR EDU, V34, P197, DOI 10.1080/02701960.2012.718009
   Stangier U, 2021, CURR PSYCHOL, DOI 10.1007/s12144-021-01456-6
NR 20
TC 1
Z9 1
U1 7
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0191-8869
EI 1873-3549
J9 PERS INDIV DIFFER
JI Pers. Individ. Differ.
PD OCT
PY 2021
VL 180
AR 110945
DI 10.1016/j.paid.2021.110945
EA MAY 2021
PG 6
WC Psychology, Social
WE Social Science Citation Index (SSCI)
SC Psychology
GA SO4ZA
UT WOS:000658981200034
PM 33935341
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Hubsch, C
   Clarenbach, CF
   Petry, H
   Baltes-Wieser, A
   Schmid-Mohler, G
AF Hubsch, Christine
   Clarenbach, Christian F.
   Petry, Heidi
   Baltes-Wieser, Annina
   Schmid-Mohler, Gabriela
TI Health behaviours and needs of people with COPD during COVID-19
   pandemic: a document analysis
SO PFLEGE
LA German
DT Article
DE COPD; COVID-19; nursing; health behaviour; needs
ID SELF-MANAGEMENT
AB Background: The government's guidelines affected people with COPD on different levels during the COVID-19 pandemic. In addition to belonging to a group of particularly vulnerable persons, they had to adapt their health behaviours, in particular physical activity, to recommendations provided in order to prevent negative effects on disease progression. There is tittle knowledge regarding how this group of patients coped with these challenges during the COVID-19 pandemic. Objective: To describe the health behaviours and needs people with COPD convey during nursing phone consultations and which nursing interventions have been carried out. Methods: A document analysis of 50 nursing phone consultations was performed. The data were summarised descriptively and analysed thematically. Results: The main topics were the adaptation of physical activity, the implementation of the recommendations to the individual life situation, the detection of a COVID-19 infection and questions concerning the planning of medical appointments. Conclusion: The COVID-19 pandemic poses additional challenges to the disease management of people with COPD. The increased need for care brought on by the pandemic was able to be met by the knowledge provided in the nursing phone consultations. What remains to be established is what role the consultations play in a sustainable change in behaviour and in dealing with negative emotions.
C1 [Hubsch, Christine; Petry, Heidi; Schmid-Mohler, Gabriela] Univ Spital Zurich, Zentrum Klin Pflegewissensch, Ramistr 100, CH-8091 Zurich, Switzerland.
   [Hubsch, Christine; Baltes-Wieser, Annina; Schmid-Mohler, Gabriela] Univ Spital Zurich, Med Bereich Herz Gefass Thorax, Zurich, Switzerland.
   [Clarenbach, Christian F.; Schmid-Mohler, Gabriela] Univ Spital Zurich, Klin Pneumol, Zurich, Switzerland.
RP Schmid-Mohler, G (corresponding author), Univ Spital Zurich, Zentrum Klin Pflegewissensch, Ramistr 100, CH-8091 Zurich, Switzerland.
EM gabriela.schmid@usz.ch
OI Petry, Heidi/0000-0001-5220-4273
CR Alqahtani JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233147
   Baker E, 2019, INT J NURS STUD, V91, P22, DOI 10.1016/j.ijnurstu.2018.12.004
   Benzo RP, 2016, ANN AM THORAC SOC, V13, P10, DOI 10.1513/AnnalsATS.201508-490OC
   Bhutani M, 2020, CAN J RESP CRIT CARE, V4, P77, DOI 10.1080/24745332.2020.1754712
   Bourbeau J, 2004, PATIENT EDUC COUNS, V52, P271, DOI 10.1016/S0738-3991(03)00102-2
   Bowen GA, 2009, QUAL RES J, V9, P27, DOI 10.3316/QRJ0902027
   Bundesamt fur Gesundheit BAG, 2018, CHRON AT KRANK
   Bundesamt fur Gesundheit BAG, 2020, NEUES COR BES GEF PE
   Bundesamt fur Gesundheit BAG, 2020, NEUES COR
   Der Bundesrat, 2020, COR BUND ERKL AUSS L
   Der Bundesrat, 2020, VER 2 MASSN BEK COR
   Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117
   Global Initiative for Chronic Obstructive Lung Disease, 2020, GOLD COVID 19 GUID V
   Global Initiative for Chronic Obstructive Lung Disease, 2019, GLOB STRAT DIAGN MAN
   Hillas G, 2015, INT J CHRONIC OBSTR, V10, P95, DOI 10.2147/COPD.S54473
   Hurst, 2020, COVID 19 PANDEMIE TR
   IBM, 2017, IBM SPSS STAT WINDOW
   Kanton Zurich, 2020, SIST NICHT DRINGL EN
   Kruis AL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009437.pub2
   Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10
   Neue Zurcher Zeitung, 2020, WIR SIND FITT DEN JE
   Ritchie J., 2003, QUALITATIVE RES PRAC, P219
   Russell R, 2020, INT J CHRONIC OBSTR, V15, P883, DOI 10.2147/COPD.S255101
   Schmid-Mohler G, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00354-2019
   Steurer-Stey C., 2018, BESSER LEBEN COPD ME
   Steurer-Stey C, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01375-2017
   Tal-Singer R, 2020, COPD-J COPD FDN, V7, P73, DOI 10.15326/jcopdf.7.2.2020.0149
   Thorpe O, 2014, INT J CHRONIC OBSTR, V9, P115, DOI 10.2147/COPD.S54457
   Universitatsspital Zurich-Klinik fur Pneumologie, 2020, HEIMTR MENSCH COPD
   World Health Organization, 2017, CHRON OBSTR PULM DIS
NR 30
TC 1
Z9 1
U1 0
U2 3
PU VERLAG HANS HUBER
PI BERN 9
PA LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND
SN 1012-5302
EI 1664-283X
J9 PFLEGE
JI Pflege
PD AUG
PY 2020
VL 33
IS 4
BP 237
EP 245
DI 10.1024/1012-5302/a000754
PG 9
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA NC6ZO
UT WOS:000561365700007
PM 32811328
DA 2022-04-20
ER

PT J
AU Kayaaslan, B
   Kalem, AK
   Asilturk, D
   Kaplan, B
   Donertas, G
   Hasanoglu, I
   Eser, F
   Korkmazer, R
   Oktay, Z
   Turan, IO
   Erdem, D
   Bektas, H
   Guner, R
AF Kayaaslan, Bircan
   Kalem, Ayse Kaya
   Asilturk, Dilek
   Kaplan, Betul
   Donertas, Gulen
   Hasanoglu, Imran
   Eser, Fatma
   Korkmazer, Ruveyda
   Oktay, Zeynep
   Turan, Isil Ozkocak
   Erdem, Deniz
   Bektas, Hesna
   Guner, Rahmet
TI Incidence and risk factors for COVID-19 associated candidemia (CAC) in
   ICU patients
SO MYCOSES
LA English
DT Article; Early Access
DE candida; candidemia; COVID-19; COVID-19 associated candidemia;
   incidence; risk factors
ID CLINICAL-PREDICTION RULE; SEPTIC SHOCK; SEPSIS; MULTICENTER;
   CANDIDIASIS; VALIDATION; MANAGEMENT
AB Background Critically ill COVID-19 patients have a high risk for the development of candidemia due to being exposed to both well-defined classical risk factors and COVID-19-specific risk factors in ICU. Objectives In this study, we investigated the incidence of candidemia in critically COVID-19 patients, and the independent risk factors for candidemia. Patients/methods COVID-19 patients hospitalised in ICU during 1-year period (August 2020 to August 2021) were included. Clinical and laboratory characteristics of all COVID-19 patients, applied treatments, and invasive procedures that may predispose to candidemia were recorded. Results Of 1229 COVID-19 patients, 63 developed candidemia. Candidemia incidence rate was 4.4 episodes per 1000 ICU days. The most common species was Candida albicans (52.3%). Only 37 patients (58.7%) received antifungal therapy. The presence of central venous catheter (OR 4.7, 95% CI 1.8-12.2, p < .005), multifocal candida colonisation (OR 2.7, 95% CI 1.4-5.2, p < .005), a prolonged ICU stay (>= 14 days) (OR 1.9, 95% CI 1.08-3-37, p < .05), the absence of chronic lung disease (OR 0.4, 95% CI 0.1-0.9, p < .05) and the absence of corticosteroid use (OR 0.3, 95% CI 0.14-0.52, p < .0001) were significantly associated with candidemia. Conclusions Our study filled the knowledge gap in the literature about the impact of COVID-19-associated risk factors for the development of candidemia. The classical risk factors for candidemia had a significant effect on candidemia, and contrary to expectations, corticosteroids had a protective effect against the development of candidemia. The results of these studies showing interesting effects of corticosteroids in critically ill COVID-19 patients should be confirmed by further studies.
C1 [Kayaaslan, Bircan; Kalem, Ayse Kaya; Hasanoglu, Imran; Eser, Fatma; Guner, Rahmet] Ankara Yildirim Beyazit Univ, Ankara City Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkey.
   [Asilturk, Dilek; Kaplan, Betul; Donertas, Gulen; Korkmazer, Ruveyda; Oktay, Zeynep] Ankara City Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkey.
   [Turan, Isil Ozkocak; Erdem, Deniz] Univ Hlth Sci Ankara City Hosp, Dept Intens Care Unit, Ankara, Turkey.
   [Bektas, Hesna] Ankara Yildirim Beyazit Univ, Ankara City Hosp, Dept Neurol, Ankara, Turkey.
RP Kayaaslan, B (corresponding author), Ankara Yildirim Beyazit Univ, Ankara City Hosp, Infect Dis & Clin Microbiol, Bilkent St 1, TR-06800 Cankaya, Turkey.
EM drbican@gmail.com
CR Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022
   Arastehfar A, 2020, J FUNGI, V6, DOI 10.3390/jof6040211
   Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z
   Epelbaum O, 2017, CLIN CHEST MED, V38, P493, DOI 10.1016/j.ccm.2017.04.010
   Evans L, 2021, CRIT CARE MED, V49, pE1063, DOI 10.1097/CCM.0000000000005337
   Guillamet CV, 2015, J CRIT CARE, V30, P715, DOI 10.1016/j.jcrc.2015.03.010
   Guner R, 2020, TURK J MED SCI, V50, P1801, DOI 10.3906/sag-2006-164
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Kayaaslan B, 2021, MYCOSES, V64, P1083, DOI 10.1111/myc.13332
   Leon C, 2006, CRIT CARE MED, V34, P730, DOI 10.1097/01.CCM.0000202208.37364.7D
   Lionakis MS, 2003, LANCET, V362, P1828, DOI 10.1016/S0140-6736(03)14904-5
   Macauley P, 2021, MYCOSES, V64, P634, DOI 10.1111/myc.13258
   Mastrangelo A, 2021, CLIN INFECT DIS, V73, pE2838, DOI 10.1093/cid/ciaa1594
   McCarty T, 2022, CLIN INFECT DIS, V74, P812, DOI 10.1093/cid/ciab635
   Nucci M, 2021, MYCOSES, V64, P152, DOI 10.1111/myc.13225
   Omrani AS, 2021, MED MYCOL, V59, P1262, DOI 10.1093/mmy/myab056
   Ostrosky-Zeichner L, 2007, EUR J CLIN MICROBIOL, V26, P271, DOI 10.1007/s10096-007-0270-z
   Pappas PG, 2016, CLIN INFECT DIS, V62, P409, DOI 10.1093/cid/civ1194
   PITTET D, 1994, ANN SURG, V220, P751, DOI 10.1097/00000658-199412000-00008
   Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955
   Riche CVW, 2020, J FUNGI, V6, DOI 10.3390/jof6040286
   Seagle EE, 2022, CLIN INFECT DIS, V74, P802, DOI 10.1093/cid/ciab562
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Stern A, 2017, COCHRANE DB SYST REV, P1, DOI 10.1002/14651858.CD007720.pub3
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Thomas-Ruddel DO, 2022, CHEST, V161, P345, DOI 10.1016/j.chest.2021.08.081
   Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021
   World Health Organization, 2020, CLIN MAN COVID 19 IN
   World Health Organization, 2020, COR DIS COVID 19 TEC
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021
NR 31
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0933-7407
EI 1439-0507
J9 MYCOSES
JI Mycoses
DI 10.1111/myc.13431
EA MAR 2022
PG 9
WC Dermatology; Mycology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology; Mycology
GA ZQ0NI
UT WOS:000766810300001
PM 35156742
OA hybrid
DA 2022-04-20
ER

PT J
AU Werner, P
   AboJabel, H
   Tur-Sinai, A
AF Werner, Perla
   AboJabel, Hanan
   Tur-Sinai, Aviad
TI Ageism towards older and younger people in the wake of the COVID-19
   outbreak
SO MATURITAS
LA English
DT Article
DE COVID-19; Ageism; Stereotypes
ID STEREOTYPES
AB Objectives: The COVID-19 pandemic has provided a rich environment for ageist attitudes towards both older and younger people. However, publications on ageism during the outbreak have been mostly non-empirical and have concentrated on ageist beliefs directed towards older people. To overcome these limitations, we examined empirically the prevalence and the determinants of ageism towards older and younger people in the wake of COVID-19. Study design: A cross-sectional study using an online survey was conducted with 503 Israeli adults (51.9% male, 79.5% Jews, mean age 47 years). Main measures: We used a structured questionnaire that measured the following: COVID-19 ageism towards older people, COVID-19 ageism towards younger people, stereotyping, the experience of discrimination, perceived fears about contracting COVID-19, subjective knowledge about COVID-19, and sociodemographic characteristics. Results: Overall, participants reported a relatively low level of COVID-19 ageism towards older people but a significantly higher level of COVID-19 ageism towards younger people. Hierarchical regressions revealed that negative age stereotypes were the most important determinants of both types of ageism. Sociodemographic variables (including age and majority/minority) were significant determinants only for COVID-19 ageism towards older people. That is, older and Jewish participants reported lower levels of this type of ageism. Conclusions: Our findings demonstrate that negative age-related stereotypes have played a central role in ageist beliefs towards both older and younger people during the COVID-19 crisis. It is recommended that the public and scientific media start disseminating messages aimed at reducing rather than increasing negative stereotypes directed towards younger and older people.
C1 [Werner, Perla; AboJabel, Hanan] Univ Haifa, Dept Community Mental Hlth, Haifa, Israel.
   [Tur-Sinai, Aviad] Max Stern Yezreel Valley Coll, Dept Hlth Syst Management, Yezreel Valley, Israel.
   [Tur-Sinai, Aviad] Univ Rochester, Med Ctr, Sch Nursing, Rochester, NY USA.
RP Werner, P (corresponding author), Univ Haifa, Dept Community Mental Hlth, Haifa, Israel.
EM werner@research.haifa.ac.il; hanan.abojabel.1987@live.com;
   avts2309@netvision.net.il
RI Tur-Sinai, Aviad/AAD-6886-2022
OI Tur-Sinai, Aviad/0000-0002-4802-455X
CR Andrews JL, 2020, TRENDS COGN SCI, V24, P585, DOI 10.1016/j.tics.2020.05.001
   Ayalon L, 2020, INT PSYCHOGERIATR, V32, P1221, DOI 10.1017/S1041610220000575
   Bergman YS, 2020, INT PSYCHOGERIATR, V32, P1371, DOI 10.1017/S1041610220001258
   Bratt C, 2020, DEV PSYCHOL, V56, P1029, DOI 10.1037/dev0000903
   BUTLER RN, 1969, GERONTOLOGIST, V9, P243, DOI 10.1093/geront/9.4_Part_1.243
   Cesari M, 2020, J AM MED DIR ASSOC, V21, P576, DOI 10.1016/j.jamda.2020.03.025
   Chasteen AL, 2021, J GERONTOL B-PSYCHOL, V76, P1323, DOI 10.1093/geronb/gbaa043
   Cohn-Schwartz E, 2021, J GERONTOL B-PSYCHOL, V76, pE313, DOI 10.1093/geronb/gbaa150
   Colenda CC, 2020, GERONTOLOGIST, V60, pE311, DOI 10.1093/geront/gnaa062
   Efuribe C, 2020, J ADOLESCENT HEALTH, V67, P16, DOI 10.1016/j.jadohealth.2020.04.009
   Eylem O, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08964-3
   Field A., 2017, DISCOVERING STAT USI, V5th ed.
   Fraser S, 2020, AGE AGEING, V49, P692, DOI 10.1093/ageing/afaa097
   Garcia-Soler A., 2020, INT LONG TERM CARE P, P1
   Harris J., 2020, GUARDIAN
   Iversen TN, 2009, NORD PSYCHOL, V61, P4, DOI 10.1027/1901-2276.61.3.4
   Jimenez-Sotomayor MR, 2020, J AM GERIATR SOC, V68, P1661, DOI 10.1111/jgs.16508
   Landry MD, 2020, J APPL GERONTOL, V39, P687, DOI 10.1177/0733464820924131
   Marques S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072560
   Ministry of Health, 2020, JOINT COMM NAT BIOET
   North MS, 2013, PSYCHOL ASSESSMENT, V25, P706, DOI 10.1037/a0032367
   Officer A, 2018, B WORLD HEALTH ORGAN, V96, P295, DOI 10.2471/BLT.17.202424
   Previtali F, 2020, J AGING SOC POLICY, V32, P506, DOI 10.1080/08959420.2020.1772002
   Rahman A, 2020, J LOSS TRAUMA, V25, P631, DOI 10.1080/15325024.2020.1757993
   Ramirez L, 2016, J SOC ISSUES, V72, P47, DOI 10.1111/josi.12155
   Raymer M, 2017, PSYCHOL-MANAG J, V20, P148, DOI 10.1037/mgr0000057
   Reicher S, 2020, GUARDIAN
   Shiovitz-Ezra S, 2016, AGEING INT, V41, P298, DOI 10.1007/s12126-016-9251-9
   Sao Jose JM, 2019, GERONTOLOGIST, V59, pE98, DOI 10.1093/geront/gnx020
   Voss P, 2018, INT PERSPECT AGING, V19, P11, DOI 10.1007/978-3-319-73820-8_2
   Werner P., 2020, PREVALENCE COR UNPUB
   Werner P, 2021, ARCH GERONTOL GERIAT, V92, DOI 10.1016/j.archger.2020.104246
   World Health Organization, 2020, WHO WARNS YOUNG PEOP
NR 33
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-5122
EI 1873-4111
J9 MATURITAS
JI Maturitas
PD MAR
PY 2022
VL 157
BP 1
EP 6
DI 10.1016/j.maturitas.2021.11.002
EA NOV 2021
PG 6
WC Geriatrics & Gerontology; Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology; Obstetrics & Gynecology
GA XA0QG
UT WOS:000720362300001
PM 35120667
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Afshan, G
   Shahid, S
   Tunio, MN
AF Afshan, Gul
   Shahid, Subhan
   Tunio, Muhammad Nawaz
TI Learning experiences of women entrepreneurs amidst COVID-19
SO INTERNATIONAL JOURNAL OF GENDER AND ENTREPRENEURSHIP
LA English
DT Article
DE Pakistan; Women entrepreneurs; Entrepreneurial learning; Covid-19
   pandemic; Developing country
ID DEVELOPING-COUNTRIES; CONTEXT; PERSPECTIVE; CONSTRAINTS; GENDER; LINK
AB Purpose COVID-19 pandemic triggered unexpected crises, which were beyond the imaginations of a common man. It changed the order of routine life and the business world. In this challenging condition, the survival of the small business was at high risk. Following experiential learning theory, the purpose of this paper is to explore women's entrepreneurial learning obtained during the COVID-19 pandemic, the challenges experienced by them and strategies undertaken to transform businesses. Design/methodology/approach To explore Pakistani women entrepreneurs' lived experiences and learning during the COVID-19, researchers used a qualitative interview design. The interviewees reported their experiences about the effects of COVID-19 on their business and entrepreneurial learning from such a crisis. Findings The findings of the study indicate new fractions of knowledge from the novel learning of the female entrepreneurs throughout the experience of the COVID-19. The transformation from manual business dealings and financial transactions to virtual dealing and the online transaction was the addition of novel learning. Furthermore, the analysis provides insights into the challenges experienced by women entrepreneurs, strategies undertaken and lessons learned from COVID-19. The life lessons learned showed the importance of technical skills and their business operations during the crisis. Research limitations/implications This study is very specific in its context and limitations of this study offers new avenue for research to extend study in different perspectives. First, interviews were conducted from women entrepreneurs running businesses in sub-urban cities of Pakistan, where study can be extended to include both male and female in a comparative study which can expose new dimensions. Second, this study is conducted in the sub-urban areas of the Sindh province of Pakistan, which can be extended to other areas of the country because Pakistan is multicultural and multilingual, which offer different gender specific factors for entrepreneurial activities in general terms but in case of the Covid-19 situation, there exists great variations and social stratifications. Third, this study can be extended to other developing or developed countries or comparative study can provide a new flavor of knowledge. Practical implications The study's finding offers few implications for the entrepreneurs, societies and government at large. Although the pandemic crisis has had devastating effects on health and lifestyle activities, there is always a ray of coming to innovative approaches to fulfill the entrepreneurial desires and serve the community. Thus, entrepreneurs are encouraged to contribute to the economy as a part of society through their sustainable products and services for the greater good. There is also a need for some social policies to find entrepreneurial ways to deal with the COVID-19 crisis that integrates value co-creation for society (Ratten, 2020b). Government and society should also intervene and play their role to encourage women entrepreneurs to feel a sense of empowerment, contribute to family income, alleviate poverty, create jobs and help in economic growth. Originality/value This study's unique contribution and origin are to explore the COVID-19-related entrepreneurial learning experiences of women entrepreneurs in a developing country (Pakistan). Moreover, this study theoretically contributes to the development of experiential learning theory by expanding its insights during COVID-19.
C1 [Afshan, Gul] Sukkur IBA Univ, Dept Business Adm, Sukkur, Pakistan.
   [Shahid, Subhan] Grenoble Ecole Management, Deparment Management Technol & Strategy, Grenoble, France.
   [Tunio, Muhammad Nawaz] Alpen Adria Univ Klagenfurt, Fac Econ, Doctoral Track Entrepreneurship Innovat & Econ De, Klagenfurt, Austria.
   [Tunio, Muhammad Nawaz] Greenwich Univ, Dept Business Adm, Karachi, Pakistan.
RP Tunio, MN (corresponding author), Alpen Adria Univ Klagenfurt, Fac Econ, Doctoral Track Entrepreneurship Innovat & Econ De, Klagenfurt, Austria.; Tunio, MN (corresponding author), Greenwich Univ, Dept Business Adm, Karachi, Pakistan.
EM gul.afshan@iba-suk.edu.pk; subhan.shahid@grenoble-em.com;
   m1tunio@edu.aau.at
RI Shahid, Subhan/AGG-4889-2022; Afshan, Gul/AAS-4397-2021
OI Shahid, Subhan/0000-0002-5533-2825; Afshan, Gul/0000-0003-0016-5721
CR Ahmad Leila., 1992, WOMEN GENDER ISLAM H
   ALDRICH HE, 1994, ACAD MANAGE REV, V19, P645, DOI 10.2307/258740
   Alhojailan M.I., 2012, W E J SOCIAL SCI, V1, P39
   Alon T., 2020, W27660 NAT BUR EC RE
   Aspers P, 2019, QUAL SOCIOL, V42, P139, DOI 10.1007/s11133-019-9413-7
   Audemard J, 2020, BMS-B SOCIOL METHOD, V145, P30, DOI 10.1177/0759106319888703
   Barnett A, 2021, SCIENTOMETRICS, V126, P6127, DOI 10.1007/s11192-021-04016-8
   Benschop Y, 2009, GENDER WORK ORGAN, V16, P217, DOI 10.1111/j.1468-0432.2009.00438.x
   Birkner S, 2018, FGF ST SM BUS ENTREP, P3, DOI 10.1007/978-3-319-96373-0_1
   Bogenhold D, 2015, INT REV ENTREP, V13, P47
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Brinckmann J., 2020, J BUS VENTUR INSIGHT, V14, DOI [10.1016/j.jbvi.2020.e00186, DOI 10.1016/J.JBVI.2020.E00186]
   Burgelman RA, 2018, STRATEGIC MANAGE J, V39, P531, DOI 10.1002/smj.2741
   Cho Y, 2020, ADV DEV HUM RESOUR, V22, P115, DOI 10.1177/1523422320907042
   Chu, 2010, INT REV BUSINESS RES, V6, P164
   Cope J, 2005, ENTREP THEORY PRACT, V29, P373, DOI 10.1111/j.1540-6520.2005.00090.x
   Cope J., 2000, INT J ENTREPRENEURIA, V6, P104, DOI DOI 10.1108/13552550010346208
   Cope J, 2011, J BUS VENTURING, V26, P604, DOI 10.1016/j.jbusvent.2010.06.002
   Corley KG, 2004, ADMIN SCI QUART, V49, P173
   Crick JM, 2020, IND MARKET MANAG, V88, P206, DOI 10.1016/j.indmarman.2020.05.016
   Ekanem I, 2015, INT J ENTREP BEHAV R, V21, P557, DOI 10.1108/IJEBR-08-2014-0146
   Ettl K, 2010, INT J GEND ENTREP, V2, P108, DOI 10.1108/17566261011050991
   Fabeil N.F., 2020, J ECON BUS, V3, P837
   Fellnhofer K, 2016, INT J ENTREP BEHAV R, V22, P346, DOI 10.1108/IJEBR-12-2015-0286
   Gilal, 2020, ADV SCI TECHNOLOGY E, V5, P645
   Gioia DA, 2013, ORGAN RES METHODS, V16, P15, DOI 10.1177/1094428112452151
   Glasser B. G., 1967, DISCOVERY GROUNDED T
   Handcock MS, 2011, SOCIOL METHODOL, V41, P367, DOI 10.1111/j.1467-9531.2011.01243.x
   Hisrich RD., 1999, J MANAG DEV, V18, P114, DOI 10.1108/02621719910257639
   Holcomb TR, 2009, ENTREP THEORY PRACT, V33, P167, DOI 10.1111/j.1540-6520.2008.00285.x
   Hunter L, 2018, J SMALL BUS ENTERP D, V25, P609, DOI 10.1108/JSBED-02-2017-0075
   Jaim J, 2021, GENDER WORK ORGAN, V28, P209, DOI 10.1111/gwao.12546
   Jamali D, 2009, GEND MANAG, V24, P232, DOI 10.1108/17542410910961532
   Kempster S, 2010, INT J ENTREP BEHAV R, V16, P5, DOI 10.1108/13552551011020054
   Khan MS, 2020, STRATEG CHANG, V29, P375, DOI 10.1002/jsc.2336
   Khurana I, 2021, TECHNOL FORECAST SOC, V167, DOI 10.1016/j.techfore.2021.120694
   Knight P., 1999, INTERVIEWING SOCIAL, P2
   Kolb D. A., 2014, EXPERIENTIAL LEARNIN
   Lattacher W, 2020, INT J ENTREP BEHAV R, V26, P1093, DOI 10.1108/IJEBR-02-2019-0085
   Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941
   Liguori E.W., 2020, J INT COUNC SMALL BU, V1, P106, DOI [10.1080/26437015.2020.1779538, DOI 10.1080/26437015.2020.1779538]
   Lindvert M, 2017, ENTREP REGION DEV, V29, P759, DOI 10.1080/08985626.2017.1349190
   McGrath C, 2019, MED TEACH, V41, P1002, DOI 10.1080/0142159X.2018.1497149
   McGrath KV, 2020, EDUC PSYCHOL MEAS, V80, P617, DOI 10.1177/0013164419885999
   McKeever E, 2015, J BUS VENTURING, V30, P50, DOI 10.1016/j.jbusvent.2014.07.002
   Muehlfeld K, 2012, STRATEGIC MANAGE J, V33, P938, DOI 10.1002/smj.1954
   Narula R, 2020, J INT BUS POLICY, V3, P302, DOI 10.1057/s42214-020-00059-5
   Neumeyer X, 2019, SMALL BUS ECON, V53, P475, DOI 10.1007/s11187-018-9996-5
   Nogueira TF, 2019, LEARN ORGAN, V26, P560, DOI 10.1108/TLO-04-2018-0067
   Noor Shaista, 2020, International Journal of Business and Globalisation, V25, P503
   Nummela N, 2020, INT SMALL BUS J, V38, P711, DOI 10.1177/0266242620954127
   OECD: Organisation for Economic Co-operation and Development, 2020, ECON OUTL, V2020
   Omorede A, 2021, INT ENTREP MANAG J, V17, P1441, DOI 10.1007/s11365-020-00655-0
   Panda S, 2018, GEND MANAG, V33, P315, DOI 10.1108/GM-01-2017-0003
   Papadopoulos T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102192
   Patton M. Q., 2002, QUAL SOC WORK, V1, P261, DOI [DOI 10.1177/1473325002001003636, 10.1177/1473325001003636]
   Pittaway L, 2009, ACTION LEARN, V6, P265, DOI 10.1080/14767330903299480
   Politis D, 2005, ENTREP THEORY PRACT, V29, P399, DOI 10.1111/j.1540-6520.2005.00091.x
   Qureshi, 2011, GLOBAL ENTREPRENEURS
   Rashid S, 2021, WORLD J ENTREP MANAG, V17, P457, DOI 10.1108/WJEMSD-09-2020-0110
   Rashid S, 2020, CONTRIB MANAG SCI, P37, DOI 10.1007/978-3-030-35415-2_4
   Ratten V., 2020, J SMALL BUSINESS ENT, V32, P503, DOI DOI 10.1080/08276331.2020.1790167
   Ratten V, 2022, INT J SOCIOL SOC POL, V42, P222, DOI 10.1108/IJSSP-06-2020-0237
   Roomi MA, 2018, INT J GEND ENTREP, V10, P158, DOI 10.1108/IJGE-03-2018-0019
   Roomi MA, 2008, J ENTREP, V17, P59, DOI 10.1177/097135570701700105
   Ruiz-Rosa I, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176970
   Seale C., 2004, RES SOC CULTURE, V2, P304
   Shah Y, 2020, R-ECONOMY, V3, P222, DOI [10.15826/recon.2020.6.3.019, DOI 10.15826/RECON.2020.6.3.019]
   Shane, 2007, ARE MALE WOMEN ENTRE
   Soomro BA, 2019, WORLD J ENTREP MANAG, V15, P31, DOI 10.1108/WJEMSD-05-2018-0054
   Subramaniam, 2016, INT REV MANAGEMENT M, V6, P224
   Sultan S, 2020, J SMALL BUS ENTERP D, V27, P1069, DOI 10.1108/JSBED-06-2020-0226
   Toutain O, 2017, ENTREP REGION DEV, V29, P869, DOI 10.1080/08985626.2017.1376517
   Tuckett Anthony G, 2004, Nurse Res, V12, P47
   Tunio M. N., 2020, J BUSINESS ECOSYSTEM, V1, P1
   Wahab A, 2020, ASIA PAC MANAG REV, V25, P54, DOI 10.1016/j.apmrv.2019.09.002
   Wang CL, 2014, INT J MANAG REV, V16, P24, DOI 10.1111/ijmr.12007
   Welter F, 2020, INT J GEND ENTREP, V12, P27, DOI 10.1108/IJGE-04-2019-0082
   Welter F, 2011, ENTREP THEORY PRACT, V35, P165, DOI 10.1111/j.1540-6520.2010.00427.x
   Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001
   Yang T., 2020, GENDER MANAGEMENT IN
   Zozimo R, 2017, ENTREP REGION DEV, V29, P889, DOI 10.1080/08985626.2017.1376518
NR 82
TC 6
Z9 6
U1 8
U2 8
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1756-6266
EI 1756-6274
J9 INT J GEND ENTREP
JI Int. J. Gend. Entrep.
PD AUG 17
PY 2021
VL 13
IS 2
SI SI
BP 162
EP 186
DI 10.1108/IJGE-09-2020-0153
EA JUL 2021
PG 25
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA UB1ET
UT WOS:000672784300001
OA Bronze
DA 2022-04-20
ER

PT J
AU Sahu, A
   Naqvi, WM
AF Sahu, Arti
   Naqvi, Waqar M.
TI Quarantine Exercises in the Time of Covid-19- A Review
SO JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS
LA English
DT Review
DE Quarantine Exercises; Physical Activity; Quarantine; Pandemic; Covid-19
AB BACKGROUND
   Coronavirus disease 2019 (Covid-19) originating in Wuhan, China in December 2019 spread worldwide rapidly. It was declared as a global public health emergency, and subsequently as a pandemic by the WHO, owing to its worldwide spread. Currently, Covid-19 is of the gravest concern because of its high transmissibility, high mortality, rapid global spread, lack of knowledge about the disease and lack of management resources. Lockdown and self-quarantine measures have been implemented globally by various nations to mitigate the spread of Covid-19. In several nations, fitness centres and other public places, where people are normally active, had been temporarily closed to prevent further spread of infection. Being quarantined at home for extended periods makes it challenging to stay physically active. Recent studies demonstrated that regular physical activities and exercises lower the incidence of several communicable diseases, including the novel Covid-19 by enhancing the immune system. Regular exercises improve the components of physical fitness, which include muscular strength, cardiorespiratory fitness, coordination, balance and agility, which in turn, enhance the physiological functions of the body. Regular exercises and relaxation techniques are some significant approaches aimed at improving one's overall health during the quarantine. Since organizations and governments worldwide had advised physical activity in quarantine, and also because regular physical activity is beneficial for both the physical and mental health, its role in the quarantine is significant. This review highlights the significance of physical activity and exercise in enhancing the well-being of individuals during the quarantine phase of Covid-19 pandemic.
C1 [Sahu, Arti; Naqvi, Waqar M.] Ravi Nair Physiotherapy Coll, Dept Community Hlth Physiotherapy, Wardha, Maharashtra, India.
RP Naqvi, WM (corresponding author), Ravi Nair Physiotherapy Coll, Dept Community Hlth Physiotherapy, Wardha, Maharashtra, India.
EM waqar.naqvi@dmimsu.edu.in
RI Naqvi, Waqar M/S-5447-2016
OI Naqvi, Waqar M/0000-0003-4484-8225
CR [Anonymous], 2020, BE ACT COV 19
   Berolo S, 2011, APPL ERGON, V42, P371, DOI 10.1016/j.apergo.2010.08.010
   Campbell JP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00648
   Campos MVA., 2020, INTERAM J MED HLTH, V3
   Elias B, 2020, RESP HLTH BETTER COV
   Hall G., 2020, PROG CARDIOVASC DIS, DOI [10.1016%2Fj.pcad.2020.04.005, 10.1016/j.pcad.2020.04.005]
   Jimenez-Pavon D, 2020, PROG CARDIOVASC DIS
   Kim S.W., 2020, BRAIN BEHAV IMMUN
   Klinkhammer J, 2018, ELIFE, V7, DOI 10.7554/eLife.33354
   Lee M, 2015, J PHYS THER SCI, V27, P1743, DOI 10.1589/jpts.27.1743
   Luzi L, 2020, ACTA DIABETOL, V57, P759, DOI 10.1007/s00592-020-01522-8
   Maier HE, 2018, J INFECT DIS, V218, P1378, DOI 10.1093/infdis/jiy370
   Miguel H, 2020, INTERAM J MED HLTH, V3
   Nieman DC, 2019, J SPORT HEALTH SCI, V8, P201, DOI 10.1016/j.jshs.2018.09.009
   Sharan D, 2014, ANN OCCUP ENVIRON ME, V26, DOI 10.1186/s40557-014-0022-3
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Song Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082655
   Suchomel TJ, 2018, SPORTS MED, V48, P765, DOI 10.1007/s40279-018-0862-z
   World Health Organization, STAY PHYS ACT SELF Q
   Yan J, 2018, P NATL ACAD SCI USA, V115, P1081, DOI 10.1073/pnas.1716561115
   Zhu WM, 2020, J SPORT HEALTH SCI, V9, P105, DOI 10.1016/j.jshs.2020.01.005
NR 21
TC 2
Z9 2
U1 4
U2 5
PU JOURNAL EVOLUTION MEDICAL & DENTAL SCIENCES
PI KARNATAKA
PA C/O AKSHANTALA ENTERPRISES, NO 65, 1ST FL, SAHUKAR CHENNIAH RD, MYSORE,
   KARNATAKA, 570 009, INDIA
SN 2278-4748
EI 2278-4802
J9 J EVOL MED DENT SCI-
JI J. Evol. Med. Dent. Sci.-JEMDS
PD JUN 29
PY 2020
VL 9
IS 26
BP 1922
EP 1927
DI 10.14260/jemds/2020/418
PG 6
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA MN3MN
UT WOS:000550748800008
OA gold
DA 2022-04-20
ER

PT J
AU Wollina, U
   Karadag, AS
   Rowland-Payne, C
   Chiriac, A
   Lotti, T
AF Wollina, Uwe
   Karadag, Ayse Serap
   Rowland-Payne, Christopher
   Chiriac, Anca
   Lotti, Torello
TI Cutaneous signs in COVID-19 patients: A review
SO DERMATOLOGIC THERAPY
LA English
DT Review
DE acro-ischemia; androgenetic alopecia; chilblain-like eruptions;
   COVID-19; maculopapular rash; purpuric rash; SARS-CoV-2; urticaria
ID SARS-COV-2
AB Coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the epithelium of the airways. With the increasing involvement of dermatologist in management of this crisis, cutaneous symptoms gained more and more attention. In this review, we will describe cutaneous symptoms of patients of all ages in association with COVID-19. We will focus on such disorders that are caused by direct action of SARS-CoV-2 on tissues, complement, and coagulation system and on nonspecific eruption of the systemic viral infection. Drug-induced reactions are only mentioned in the differential diagnoses. Although more systematic investigations are warranted, it becomes clear that some symptoms are clinical signs of a milder COVID-19 course, while others are a red flag for a more severe course. Knowledge of the cutaneous manifestations of COVID-19 may help in early diagnosis, triage of patients, and risk stratification.
C1 [Wollina, Uwe] Tech Univ Dresden, Acad Teaching Hosp, Stadt Klinikum Dresden, Dept Dermatol & Allergol, Dresden, Germany.
   [Karadag, Ayse Serap] Istanbul Medeniyet Univ, Sch Med, Dept Dermatol, Istanbul, Turkey.
   [Rowland-Payne, Christopher] London Clin, Dept Dermatol, London, England.
   [Chiriac, Anca] Apollonia Univ, Dept Dermatol, Iasi, Romania.
   [Chiriac, Anca] Nicolina Med Ctr, Div Dermatol, Iasi, Romania.
   [Chiriac, Anca] P Poni Inst Macromol Chem, Romanian Acad, Iasi, Romania.
   [Lotti, Torello] Univ Rome G Marconi, Dept Dermatol & Venereol, Rome, Italy.
RP Wollina, U (corresponding author), Acad Teaching Hosp, Stadt Klinikum Dresden, Dept Dermatol & Allergol, Friedrichstr 41, D-01067 Dresden, Germany.
EM uwe.wollina@klinikum-dresden.de
OI Wollina, Uwe/0000-0001-5933-2913
CR Aghdam MK, 2020, INFECT DIS-NOR, V52, P427, DOI 10.1080/23744235.2020.1747634
   Ahouach B, 2020, BRIT J DERMATOL, V183, pE31, DOI 10.1111/bjd.19168
   Alramthan A, 2020, CLIN EXP DERMATOL, V45, P746, DOI 10.1111/ced.14243
   Moreno RA, 2020, J EUR ACAD DERMATOL, V34, pE307, DOI 10.1111/jdv.16531
   Diaz-Guimaraens B, 2020, JAMA DERMATOL, V156, P820, DOI 10.1001/jamadermatol.2020.1741
   Duong TA, 2020, J EUR ACAD DERMATOL, V34, pE348, DOI 10.1111/jdv.16534
   Ehsani AH, 2020, J EUR ACAD DERMATOL, V34, pE436, DOI 10.1111/jdv.16579
   Estebanez A, 2020, J EUR ACAD DERMATOL, V34, pE250, DOI 10.1111/jdv.16474
   Fernandez-Nieto D, 2020, J EUR ACAD DERMATOL, DOI 10.1111/jdv.16470
   Freeman EE, 2020, J AM ACAD DERMATOL, V83, P509, DOI 10.1016/j.jaad.2020.04.045
   Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163
   Garcia-Lara G, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13516
   Gianotti R, 2020, ACTA DERM-VENEREOL, V100, DOI 10.2340/00015555-3490
   Goren A, 2020, J COSMET DERMATOL-US, V19, P1545, DOI 10.1111/jocd.13443
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hedou M, 2020, J EUR ACAD DERMATOL, V34, pE299, DOI 10.1111/jdv.16519
   Henry D, 2020, J EUR ACAD DERMATOL, V34, pE244, DOI 10.1111/jdv.16472
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Joob B, 2020, J AM ACAD DERMATOL, V82, pE177, DOI 10.1016/j.jaad.2020.03.036
   Kruglikov IL, 2020, OBESITY, V28, P1187, DOI 10.1002/oby.22856
   Landa N, 2020, INT J DERMATOL, V59, P739, DOI 10.1111/ijd.14937
   Lei Y, 2020, INFECT DIS POVERTY, DOI [10.21203/rs.3.rs-22978/v1, DOI 10.21203/RS.3.RS-22978/V1]
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757
   Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Mahe A, 2020, J EUR ACAD DERMATOL, V34, pE246, DOI 10.1111/jdv.16471
   Manalo IF, 2020, J AM ACAD DERMATOL, V83, P700, DOI 10.1016/j.jaad.2020.04.018
   Morey-Olive M, 2020, AN PEDIATR, V92, P374, DOI [10.1016/j.anpede.2020.04.002, 10.1016/j.anpedi.2020.04.013]
   Mungmungpuntipantip R, 2020, INT J NEUROSCI, V130, P1182, DOI 10.1080/00207454.2020.1720984
   Najarian David James, 2020, JAAD Case Rep, V6, P493, DOI 10.1016/j.jdcr.2020.04.015
   Piccolo V, 2020, J EUR ACAD DERMATOL, V34, pE291, DOI 10.1111/jdv.16526
   Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE346, DOI 10.1111/jdv.16533
   Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387
   Sabharwal N, 2019, ENDOCRINOLOGY, V160, P2180, DOI 10.1210/en.2019-00366
   Sanchez A, 2020, JAMA DERMATOL, V156, P819, DOI 10.1001/jamadermatol.2020.1704
   van Damme C, 2020, J EUR ACAD DERMATOL, V34, pE300, DOI 10.1111/jdv.16523
   Wang DW, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02895-6
   Wollina U, 2017, Georgian Med News, P41
   Xiao AT, 2020, J MED VIROL, V92, P1755, DOI 10.1002/jmv.25855
   Yao XH, 2020, ZHONGHUA BING LI XUE, V49, P411, DOI DOI 10.3760/CMA.J.CN112151-20200312-00193
   Zengarini C, 2020, J EUR ACAD DERMATOL, V34, pE453, DOI 10.1111/jdv.16569
   Zhang Y, 2020, Zhonghua Xue Ye Xue Za Zhi, V41, P302, DOI [10.3760/cma.j.issn.0253-2727.2020.0006, 10.3760/cma.j.issn.0253-2727.2020.008]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 44
TC 128
Z9 130
U1 3
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1396-0296
EI 1529-8019
J9 DERMATOL THER
JI Dermatol. Ther.
PD SEP
PY 2020
VL 33
IS 5
SI SI
AR e13549
DI 10.1111/dth.13549
EA MAY 2020
PG 6
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA OB4SO
UT WOS:000536053800001
PM 32390279
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Itaya, T
   Torii, M
   Hashimoto, M
   Jindai, K
   Yamamoto, W
   Tanigawa, K
   Urai, Y
   Kinoshita, A
   Nin, K
   Watanabe, R
   Murata, K
   Murakami, K
   Tanaka, M
   Ito, H
   Matsuda, S
   Morinobu, A
AF Itaya, Takahiro
   Torii, Mie
   Hashimoto, Motomu
   Jindai, Kazuaki
   Yamamoto, Wataru
   Tanigawa, Kyosuke
   Urai, Yuki
   Kinoshita, Ayae
   Nin, Kazuko
   Watanabe, Ryu
   Murata, Koichi
   Murakami, Kosaku
   Tanaka, Masao
   Ito, Hiromu
   Matsuda, Shuichi
   Morinobu, Akio
TI Perceptions and behaviours related to COVID-19 in patients with
   rheumatoid arthritis: a cross-sectional study
SO CLINICAL RHEUMATOLOGY
LA English
DT Article
DE COVID-19; Health knowledge; attitudes; practice; Health literacy; KURAMA
   cohort; Rheumatoid arthritis
ID CLASSIFICATION; CRITERIA
AB Objectives To study the perceptions and behavioural changes related to the coronavirus disease 2019 (COVID-19) in patients with rheumatoid arthritis (RA) and determine their associations with patient characteristics, such as health literacy.
   Methods This cross-sectional study was conducted from September to November of 2020 and included 400 outpatients with RA aged 18 and above. We measured self-reported perceptions as outcomes, such as awareness, knowledge and behaviours related to COVID-19. Health literacy and other characteristics as exposures were investigated using self-report questionnaires and electronic health records. To analyse the association between patient factors and the outcomes, multivariable linear and logistic regression models were performed.
   Results In total, 365 patients completed the survey. More than half (51%) of patients reported that they were 'very worried' about possible infection with COVID-19, whereas over 80% believed the possibility of getting COVID-19 was low. In the multivariable analyses, patients with low health literacy had limited knowledge about COVID-19 and did not change daily routines and perform preventive measures.
   Conclusions In this pandemic, healthcare providers may need to be aware of more vulnerable individuals and share COVID-19 related information promptly and effectively with their patients.
C1 [Itaya, Takahiro; Jindai, Kazuaki] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan.
   [Torii, Mie; Tanigawa, Kyosuke; Urai, Yuki; Kinoshita, Ayae; Nin, Kazuko] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan.
   [Hashimoto, Motomu; Yamamoto, Wataru; Watanabe, Ryu; Murata, Koichi; Tanaka, Masao; Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan.
   [Yamamoto, Wataru] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Okayama, Japan.
   [Murata, Koichi; Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan.
   [Murakami, Kosaku; Morinobu, Akio] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.
RP Hashimoto, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan.
EM mohashim@kuhp.kyoto-u.ac.jp
OI Jindai, Kazuaki/0000-0003-4679-3862
FU Daiichi SankyoDaiichi Sankyo Company Limited; JSPS KAKENHIMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [JP19K11165]
FX KURAMA cohort study is supported by a grant from Daiichi Sankyo. Daiichi
   Sankyo had no role in the study design, data collection or analysis,
   manuscript preparation or the decision to submit the manuscript for
   publication. This work was also supported by JSPS KAKENHI (Grant Number
   JP19K11165).
CR ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
   Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0
   Della-Torre E, 2020, ANN RHEUM DIS, V79, P1277, DOI [10.1136/annrheumdis-2020-218122, 10.1136/annrheumdis-2020-218724, 10.1136/annrheumdis-2020-218759]
   Gianfrancesco M, 2020, ANN RHEUM DIS, V79, P859, DOI 10.1136/annrheumdis-2020-217871
   Gupta S, 2020, JAMA INTERN MED, V180, P1436, DOI 10.1001/jamainternmed.2020.3596
   KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096
   Kelly B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2441-7
   Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305
   McCaffery KJ, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp30342012
   Mehta B, 2020, RMD OPEN, V6, DOI 10.1136/rmdopen-2020-001378
   Suka M, 2013, ENVIRON HEALTH PREV, V18, P407, DOI 10.1007/s12199-013-0340-z
   Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   Ye C, 2020, ANN RHEUM DIS, V79, P1007, DOI 10.1136/annrheumdis-2020-217627
   Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021
NR 15
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0770-3198
EI 1434-9949
J9 CLIN RHEUMATOL
JI Clin. Rheumatol.
PD JAN
PY 2022
VL 41
IS 1
BP 45
EP 51
DI 10.1007/s10067-021-05840-2
EA SEP 2021
PG 7
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA XZ9SH
UT WOS:000701592300003
PM 34581890
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Netshakhuma, NS
AF Netshakhuma, Nkholedzeni Sidney
TI Responsibilities of archivist now and in the future as the result of
   COVID-19; Case of ICA-SUV
SO DIGITAL LIBRARY PERSPECTIVES
LA English
DT Article
DE Archives; ICA; Records management; Covid 19; Archives management;
   Universities archives
ID UNIVERSITY ARCHIVES; RECORDS; PIETERMARITZBURG; MANAGEMENT; LIBRARY;
   CAMPUS
AB Purpose The purpose of this study was to examine the strategies for the preservation of archival materials in the International Council on Archives Section on University and Research Institution Archives (ICA SUV) by the members and to make recommendations for the digital archival preservation to continue its accessibility during the national lockdown because of COVID-19. Design/methodology/approach This study is based on the survey conducted on the ICA SUV members during the national lockdown. The study used a survey research methodology through e-mails as data collection instruments. Findings The key findings revealed that most of the sections on university and research institution archives lack digitization preservation strategies and most of their records are not accessible online, as most of their collections are still preserved manually through the paper-based system; furthermore, archivists are not fully trained on digital management. The paper recommends universities to develop preservation strategies to migrate records from the paper-based system to electronic records management system. Research limitations/implications The population of the study comprised ICA SUV members, who responded to the survey. Therefore, the sample size and geographical spread were inadequate for generalization of the findings. In conclusion, the study demonstrated that accessibility of the archives was dependent on the quality of digitized archives. Practical implications This study demonstrates that the development of a preservation strategy enhances access to archival materials during the national lockdown because of COVID-19. Social implications This paper highlights the plight of university archives and reiterates the need for urgent digitization of their archives of universities all over the world. Originality/value To the best of author's knowledge, this paper appears to be the first to review the responsibilities of archivists now and in the future as the result of COVID-19. This study is confirmed to be on the positive side of COVID-19 and change the archive sector by adapting to information communication technology.
C1 [Netshakhuma, Nkholedzeni Sidney] Univ South Africa, Dept Informat Sci, Muckleneuk Campus, Pretoria, South Africa.
RP Netshakhuma, NS (corresponding author), Univ South Africa, Dept Informat Sci, Muckleneuk Campus, Pretoria, South Africa.
EM sidney.netshakhuma@ump.ac.za
RI Netshakhuma, Nkholedzeni Sidney/AAK-2788-2021
OI Netshakhuma, Nkholedzeni Sidney/0000-0003-0673-7137
CR Abankwah RuthM., 2011, J S AFRICAN SOC ARCH, V44, P90
   Asogwa BE, 2013, ELECTRON LIBR, V31, P792, DOI 10.1108/EL-04-2012-0037
   Bunn J, 2019, INFORM CULT, V54, P159, DOI 10.7560/IC54202
   Chaputula AH, 2018, LIBR HI TECH, V36, P270, DOI 10.1108/LHT-10-2017-0204
   Chaterera F, 2015, J S AFRICAN SOC ARCH, V48, P21
   Cheng R., 2013, J DATA INFORM SCI, V6, P65
   Cloonan V.M., 2002, AM ARCHIVIST, V65, P1
   Collins A, 2020, J RISK RES, V23, P1073, DOI 10.1080/13669877.2020.1760332
   Frost I., 2020, COVID 19 S AFRICA NA
   Garaba F, 2007, AFR J LIBR ARCH INFO, V17, P59
   Garaba F, 2018, REC MANAG J, V28, P143, DOI 10.1108/RMJ-11-2016-0043
   Garaba F, 2016, AFR J LIBR ARCH INFO, V26, P73
   Gilliland AJ, 2018, ARCH REC, V39, P117, DOI 10.1080/23257962.2017.1348940
   Harris L.K., 2009, ESARBICA J, V28, P128
   Horton S, 2006, ASLIB PROC, V58, P502, DOI 10.1108/00012530610713588
   ICA SUV, 2009, ICA SUV SOC AM C
   Impellizzeri FM, 2020, SCI MED FOOTBALL, V4, P169, DOI 10.1080/24733938.2020.1775436
   Katuu, 2015, J S AFRICAN SOC ARCH, V48, P1, DOI DOI 10.17234/INFUTURE.2015.16
   Kumar M., 2014, CAPACITY BUILDING DI
   Liebetrau C.P., 2005, INNOVATION, V30, P21
   Lihoma P., 2008, SCOLMA 2008 ANN C BR, V106, P3
   Magama B., 2018, ESARBICA J, V37, P19
   Mkuwira R.M., 2015, J S AFRICAN SOC ARCH, V48, P55
   Moats R., 2018, INT SOC SCI REV, V94, P3
   Molefe N., 2019, INNOVATION J APPROPR, V58, P3
   Muchaonyerwa N, 2014, AFR J LIBR ARCH INFO, V24, P41
   Myburgh S., 2005, INFORM MANAGEMENT J, V39, P24
   Nabutto C.L., 2019, INNOVATION J APPROPR, V58, P35
   Netshakhuma N. S., 2018, RIM Q, V34, P38
   Netshakhuma N.S., 2019, RECORDS MANAGEMENT J, V30
   Netshakhuma N.S., 2019, J ARCH ORG, V16, P178
   Netshakhuma N.S., 2019, P 20 ANN INF SCI C U, P189
   Netshakhuma NS, 2021, IFLA J-INT FED LIBR, V47, P65, DOI 10.1177/0340035220912514
   Netshakhuma NS, 2020, ASLIB J INFORM MANAG, V72, P489, DOI 10.1108/AJIM-02-2020-0043
   Netshakhuma NS, 2019, GLOB KNOWL MEM COMMU, V69, P58, DOI 10.1108/GKMC-02-2019-0026
   Netshakhuma NS, 2020, GLOB KNOWL MEM COMMU, V69, P221, DOI 10.1108/GKMC-03-2019-0043
   Netshakhuma NS, 2021, COLLECT CURATION, V40, P83, DOI 10.1108/CC-09-2019-0029
   Netshakhuma NS, 2019, GLOB KNOWL MEM COMMU, V68, P635, DOI 10.1108/GKMC-02-2019-0015
   Netshakhuma NS, 2019, REC MANAG J, V29, P210, DOI 10.1108/RMJ-09-2018-0024
   Netshakhuma NS, 2016, THESIS
   NETSHAKHUMA NS, 2020, COLLECT MANAG 0321, DOI 10.1080/01462679.2020.1742834
   Netshakhuma NS., 2019, MOUSAION, V37, P1
   Netshakhuma S., 2019, MOUSAION, V36, P1
   Netshakhuma S, 2019, S AFRICA SOC ARCH J, V52, P61
   Netshakhuma S, 2019, INNOVATION, V58, P53
   Nyathi T., 2017, ESARBICA J, V36, P12
   Pereira R., 2018, ESARBICA J, V37, P221
   Prater S., 2019, J ARCH ORG, V14, P90
   Procter M, 2017, ARCH REC, V38, P296, DOI 10.1080/23257962.2017.1285754
   Ramokate K., 2006, ESARBICA J, V25, P84
   Roots SA, 2016, INT J OSTEOPATH MED, V19, P20, DOI 10.1016/j.ijosm.2015.06.003
   Ross S., 2006, INFORM MANAGEMENT PR
   SCHINA B, 2002, ARCHIVAL ISSUES, V27, P35
   Segaetsho T., 2012, J S AFRICAN SOC ARCH, V45, P68
   Senturk B, 2014, TURK LIBRARIANSH, V28, P496
   Shenoy V., 2020, MUKT SHABD J, V9, P698
   Stout L, 1995, AM ARCHIVIST, V58, P124
   Sulej Z., 2009, ESARBICA J J E SO AF, V28, P146
   Vaishya R, 2020, DIABETES METAB SYND, V14, P687, DOI 10.1016/j.dsx.2020.05.027
   Wamukoya JM., 2015, J S AFRICAN SOC ARCH, V48, P14
   Yang GZ, 2020, SCI ROBOT, V5, DOI 10.1126/scirobotics.abb5589
   Young KA, 2012, J LIBR ADM, V52, P341, DOI 10.1080/01930826.2012.684532
   Zalewska M, 2015, SCI J MARIT UNIV SZC, V42, P140
NR 63
TC 0
Z9 0
U1 1
U2 14
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2059-5816
EI 2054-1694
J9 DIGIT LIBR PERSPECT
JI Digit. Libr. Perspect.
PD MAR 22
PY 2021
VL 37
IS 1
SI SI
BP 39
EP 53
DI 10.1108/DLP-06-2020-0050
EA OCT 2020
PG 15
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA RJ7QN
UT WOS:000581624900001
OA Bronze
DA 2022-04-20
ER

PT C
AU Rumbo, H
   Mbaloto, FR
   Mauruh, CV
   Metungku, F
   Sondakh, JR
   Ambabunga, S
AF Rumbo, Helmi
   Mbaloto, Freny Ravika
   Mauruh, Chely Veronica
   Metungku, Fanny
   Sondakh, Julianti Reygina
   Ambabunga, Sriwanti
GP KNOWLEDGE E
TI Evaluating Preceptee's Learning Achievements During the Covid-19
   Pandemic
SO 4TH INTERNATIONAL VIRTUAL CONFERENCE ON NURSING
SE KnE Life Sciences
LA English
DT Proceedings Paper
CT 4th International Virtual Conference on Nursing (IVCN)
CY AUG 30, 2020
CL STIKep PPNI Jawa, Bandung, INDIA
SP National Cheng Kung
HO STIKep PPNI Jawa
DE Learning; Method; Covid-19; Ners; Profession
ID ONLINE; OFFLINE
AB Since the beginning of the Covid-19 pandemic, higher education institutions in Indonesia have had to revise their learning management systems to ensure they can be accessed from anywhere and anytime by students and lecturers. This study aims to evaluate whether there is a difference in learning achievement by Nursing Students in the professional stage (Ners Preceptee) when comparing offline learning programs with online programs. The independent variable is learning method; the dependent variable is learning achievement. A cross-sectional study design was conducted through a secondary data. This study used two different groups, in which preceptees' score' within offline learning programs and online learning programs were compared in June 2020. A total of 52 Ners Preceptee scores were analyzed by using Mann-Whitney U test. The result revealed that significant differences exists in median Learning Achievement scores between the online group and offline group (p = 0.002). It can be concluded that Learning Management Systems including supporting facilities can have an impact on student learning outcomes.
C1 [Rumbo, Helmi; Mbaloto, Freny Ravika; Mauruh, Chely Veronica; Metungku, Fanny; Sondakh, Julianti Reygina; Ambabunga, Sriwanti] STIK Indonesia Jaya, Ners Profess Study Program, Palu, Indonesia.
RP Rumbo, H (corresponding author), STIK Indonesia Jaya, Ners Profess Study Program, Palu, Indonesia.
EM helmi.rumbo@ymail.com
RI Mbaloto, Freny Ravika/ABF-1600-2021; Rumbo, Helmi/AAV-8907-2021
OI Rumbo, Helmi/0000-0003-2000-3244
FU Ners Profession Study Program, STIK Indonesia Jaya Palu
FX This work was supported by Ners Profession Study Program, STIK Indonesia
   Jaya Palu.
CR Abidin Z., 2020, J ILMIAH PROFESI PEN, V5, P64, DOI 10.29303/jipp.v5i1.111
   Ahmed R, 2018, P INT C E LEARN 2018
   Anggrawan A, 2019, JURNAL MATRIK, V18, P339
   Atta IS, 2018, ADV MED EDUC PRACT, V9, P227, DOI 10.2147/AMEP.S158784
   Billings D.M., 2016, TEACHING IN NURSING
   Charles E. B, 2013, IMANAGERS J ED TECHN, V9
   Davis B, 2015, P QSCIENCE ENG LEAD
   Elfaki NK, 2019, INT J MED RES HEALTH, V8, P76
   Fukada M, 2018, YONAGO ACTA MED, V61, P1, DOI 10.33160/yam.2018.03.001
   Hayati A. F, 2020, JURNAL INOVASI PENDI, V10, P79
   Holmes C. M, 2017, J COUNSELOR PREPARAT, V9
   Iskandar S. M, 2020, JURNAL DEDIKASI PEND, V4, P323
   Kusumaningrum Y. R, 2018, EFEKTIVITAS METODE B
   Lee NJ, 2016, CIN COMPUTERS INFORN
   Masters K, 2018, ROLE DEV PROFESSIONA
   Mehrdad N, 2010, ACTA MED IRANICA, V49, P296
   Moran V, 2018, SIMULATION BEST PRAC
   Nguyen T., 2015, MERLOT J ONLINE LEAR, V11, P309
   Ni AY, 2013, J PUBLIC AFF EDUC, V19, P199, DOI 10.1080/15236803.2013.12001730
   Nofitasari D, 2015, P BOOK 1 WID HUS NUR
   Pei LS, 2019, MED EDUC ONLINE, V24, DOI 10.1080/10872981.2019.1666538
   Scott I, 2013, PRACTICE BASED LEARN
   Sukardi, 2019, JIPI JURNAL ILMIAH P, V4, P97
   Tan K, 2011, J MED IMAGING RADIAT, V42, P15, DOI 10.1016/j.jmir.2010.08.004
   Traxler J, 2018, EDUC SCI, V8, DOI 10.3390/educsci8010035
   World Health Organization (WHO), 2016, NURS ED COR COMP
   Yen SC, 2018, EDUC INF TECHNOL, V23, P2141, DOI 10.1007/s10639-018-9707-5
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 28
TC 0
Z9 0
U1 0
U2 0
PU KNOWLEDGE E
PI DUBAI
PA OFFICE 4402, X2 TOWER, JLT, PO BOX 488239, DUBAI, 00000, U ARAB EMIRATES
SN 2413-0877
J9 KNE LIFE SCI
PY 2021
BP 299
EP 309
DI 10.18502/kls.v6i1.8618
PG 11
WC Nursing
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Nursing
GA BR6NL
UT WOS:000662211700025
OA gold
DA 2022-04-20
ER

PT J
AU Jiang, Y
   Ahmad, H
   Butt, AH
   Shafique, MN
   Muhammad, S
AF Jiang, Yun
   Ahmad, Hassan
   Butt, Asad Hassan
   Shafique, Muhammad Nouman
   Muhammad, Sher
TI QR Digital Payment System Adoption by Retailers: The Moderating Role of
   COVID-19 Knowledge
SO INFORMATION RESOURCES MANAGEMENT JOURNAL
LA English
DT Article
DE Business Operations; COVID-19; Innovation; Pandemic; QR Code Payment
   Services
ID TECHNOLOGY ACCEPTANCE MODEL; PERCEIVED USEFULNESS PU; PARTIAL
   LEAST-SQUARES; BEHAVIORAL INTENTIONS; CONSUMER ACCEPTANCE; USER
   ACCEPTANCE; SELF-EFFICACY; USE PEOU; INNOVATION; EASE
AB The acme of this paper was to examine the QR code payment services adoption by retailers in Pakistan. An all-inclusive review of the literature and data analysis has justified the purpose to use this inventive technology. The study established that innovation diffusion theory (IDT) dimensions and convenience impacted the usefulness of QR code payment services which are well-thought-out critical antecedents of accepting future technologies. The inferences of this research work provide valuable acumens for banks, financial institutions, and the government to develop a platform about digital payment for the retailers, wholesalers, and the end consumers. Further, the study approves that QR code payment services will aid to advance the business operations in Pakistan in the COVID-19 pandemic.
C1 [Jiang, Yun] Dongbei Univ Finance & Econ, Strateg Management & Innovat Management & Org The, Dalian, Liaoning, Peoples R China.
   [Ahmad, Hassan; Muhammad, Sher] Dongbei Univ Finance & Econ, Business Management, Dalian, Liaoning, Peoples R China.
   [Butt, Asad Hassan] Dongbei Univ Finance & Econ, Mkt, Dalian, Peoples R China.
   [Shafique, Muhammad Nouman] Gomal Univ, Dera Ismail Khan, Khyber Pakhtoon, Pakistan.
RP Jiang, Y (corresponding author), Dongbei Univ Finance & Econ, Strateg Management & Innovat Management & Org The, Dalian, Liaoning, Peoples R China.
OI Ahmad, Hassan/0000-0003-3925-3956
CR Abdullah F, 2016, COMPUT HUM BEHAV, V63, P75, DOI 10.1016/j.chb.2016.05.014
   Agarwal R, 1997, DECISION SCI, V28, P557, DOI 10.1111/j.1540-5915.1997.tb01322.x
   Agarwal R, 1999, DECISION SCI, V30, P361, DOI 10.1111/j.1540-5915.1999.tb01614.x
   Aktas C., 2017, EVOLUTION EMERGENCE
   Amin M, 2014, NANKAI BUS REV NT, V5, P258, DOI 10.1108/NBRI-01-2014-0005
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   BAGOZZI RP, 1991, ADMIN SCI QUART, V36, P421, DOI 10.2307/2393203
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   Bao W, 2020, HUM BEHAV EMERG TECH, V2, P113, DOI 10.1002/hbe2.191
   Bartik A.W., 2020, ARE SMALL BUSINESSES
   Berry LL, 2002, J MARKETING, V66, P1, DOI 10.1509/jmkg.66.3.1.18505
   Bhattacherjee A, 2000, IEEE T SYST MAN CY A, V30, P411, DOI 10.1109/3468.852435
   Branstad A, 2020, J BUS RES, V116, P561, DOI 10.1016/j.jbusres.2020.01.028
   Brown L. G., 1990, J SERV MARK, V4, P53, DOI DOI 10.1108/EUM0000000002505
   Canadi M, 2010, INFORMATION AND COMMUNICATION TECHNOLOGIES IN TOURISM 2010, P137, DOI 10.1007/978-3-211-99407-8_12
   Carter L, 2005, INFORM SYST J, V15, P5, DOI 10.1111/j.1365-2575.2005.00183.x
   Chang CC, 2012, AUSTRALAS J EDUC TEC, V28, P809
   Chang MC, 2015, BRIT FOOD J, V117, P339, DOI 10.1108/BFJ-09-2013-0247
   Chang SC, 2008, BRIT J EDUC TECHNOL, V39, P71, DOI 10.1111/j.1467-8535.2007.00742.x
   Chau KY, 2019, HEALTH PSYCHOL RES, V7, P33, DOI 10.4081/hpr.2019.8099
   Chin WW, 1998, QUANT METH SER, P295
   Chuah SHW, 2016, COMPUT HUM BEHAV, V65, P276, DOI 10.1016/j.chb.2016.07.047
   DAVIS FD, 1993, INT J MAN MACH STUD, V38, P475, DOI 10.1006/imms.1993.1022
   DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   Eastlick MA, 2012, INT REV RETAIL DISTR, V22, P337, DOI 10.1080/09593969.2012.690775
   Fagan Mary, 2012, Campus-Wide Information Systems, V29, P117, DOI 10.1108/10650741211212368
   Featherman MS, 2010, J SERV MARK, V24, P219, DOI 10.1108/08876041011040622
   Featherman MS, 2003, INT J HUM-COMPUT ST, V59, P451, DOI 10.1016/S1071-5819(03)00111-3
   Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, 10.2139/SSRN.3557504]
   FORNELL C, 1982, J MARKETING RES, V19, P440, DOI 10.2307/3151718
   Gao BW, 2015, INT J HOSP MANAG, V44, P38, DOI 10.1016/j.ijhm.2014.10.004
   Garau C, 2014, REG STUD REG SCI, V1, P286, DOI 10.1080/21681376.2014.973439
   Gretzel U, 2015, ELECTRON MARK, V25, P179, DOI 10.1007/s12525-015-0196-8
   GREWAL D, 1994, J CONSUM RES, V21, P145, DOI 10.1086/209388
   Gupta S, 2007, INT J ELECTRON COMM, V12, P127, DOI 10.2753/JEC1086-4415120105
   Hair J.F., 2017, ADV ISSUES PARTIAL L
   Hair J.F., 2017, INT J MULTIVAR DATA, V1, P107, DOI DOI 10.1504/IJMDA.2017.10008574
   Ham M, 2015, ECON RES-EKON ISTRAZ, V28, P738, DOI 10.1080/1331677X.2015.1083875
   Hardgrave BC, 2003, J MANAGE INFORM SYST, V20, P123
   Hasan B, 2007, INF RESOUR MANAG J, V20, P76, DOI 10.4018/irmj.2007070106
   Hasanat M., 2020, ASIAN J MULTIDISC ST, V3, P85
   Henseler J, 2016, IND MANAGE DATA SYST, V116, P2, DOI 10.1108/IMDS-09-2015-0382
   Hernandez-Garcia A, 2011, J UNIVERS COMPUT SCI, V17, P1314
   Hess TJ, 2014, MIS QUART, V38, P1
   Hodges CB, 2021, ETR&D-EDUC TECH RES, V69, P397, DOI 10.1007/s11423-020-09838-6
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Hongxia P., 2011, DRIVERS BARRIERS ACC
   Hossain MM, 2008, IEEE T ENG MANAGE, V55, P316, DOI 10.1109/TEM.2008.919728
   Hunter William C., 2015, Asia Pacific Journal of Information Systems, V25, P105, DOI 10.14329/apjis.2015.25.1.105
   Hwang RJ, 2007, ELECTRON COMMER R A, V6, P184, DOI 10.1016/j.elerap.2006.07.002
   Inman JJ, 2017, J RETAILING, V93, P7, DOI 10.1016/j.jretai.2016.12.006
   Karahanna E, 1999, MIS QUART, V23, P183, DOI 10.2307/249751
   Kawakami T, 2013, J PROD INNOVAT MANAG, V30, P1112, DOI 10.1111/jpim.12049
   Khan K., 2019, QR code payments-An important move for cashless commerce
   Kim KK, 2011, ELECTRON COMMER R A, V10, P408, DOI 10.1016/j.elerap.2010.11.004
   Kobets V., 2018, ICTERI WORKSH
   Kock N, 2015, INT J E-COLLAB, V11, P1, DOI 10.4018/ijec.2015100101
   Koul Sahil, 2018, Journal of Technology Management & Innovation, V13, P37
   Kourouthanassis P, 2015, PERVASIVE MOB COMPUT, V18, P71, DOI 10.1016/j.pmcj.2014.08.009
   Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron
   Lee J, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8050466
   Lee YH, 2011, EDUC TECHNOL SOC, V14, P124
   Li H, 2016, INT J MED INFORM, V88, P8, DOI 10.1016/j.ijmedinf.2015.12.010
   Liebana Cabanillas F.J., 2012, PAPEL SISTEMAS PAGO
   Liebana-Cabanillas F, 2015, TECHNOL ANAL STRATEG, V27, P1031, DOI 10.1080/09537325.2015.1047757
   Lin HF, 2011, INT J INFORM MANAGE, V31, P252, DOI 10.1016/j.ijinfomgt.2010.07.006
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Lou L, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9071186
   Lu Chen, 2017, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V17, P1, DOI 10.5392/JKCA.2017.17.08.001
   Lunney A, 2016, COMPUT HUM BEHAV, V65, P114, DOI 10.1016/j.chb.2016.08.007
   Mahardika H, 2019, INT REV RETAIL DISTR, V29, P99, DOI 10.1080/09593969.2018.1537192
   Majumder A, 2017, IEEE CONSUM ELECTR M, V6, P78, DOI 10.1109/MCE.2016.2640739
   Mateos-Aparicio G, 2011, COMMUN STAT-THEOR M, V40, P2305, DOI 10.1080/03610921003778225
   Min S, 2019, J TRAVEL TOUR MARK, V36, P770, DOI 10.1080/10548408.2018.1507866
   Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P1, DOI 10.1007/978-3-642-12541-6
   Moore GC, 1991, INFORM SYST RES, V2, P192, DOI 10.1287/isre.2.3.192
   Mustonen-Ollila E, 2003, INFORM SYST J, V13, P275, DOI 10.1046/j.1365-2575.2003.00141.x
   Neuhofer B, 2015, ELECTRON MARK, V25, P243, DOI 10.1007/s12525-015-0182-1
   News I. T., 2019, NEWS IT
   Ng E, 2020, AM J TROP MED HYG, V102, P1158, DOI 10.4269/ajtmh.20-0285
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Ohannessian R, 2020, JMIR PUBLIC HLTH SUR, V6, P121, DOI 10.2196/18810
   Ozturk AB, 2016, INT J INFORM MANAGE, V36, P1350, DOI 10.1016/j.ijinfomgt.2016.04.005
   Park Y, 2007, IND MANAGE DATA SYST, V107, P1349, DOI 10.1108/02635570710834009
   Pease W., 2005, AJIS AUSTRALASIAN J, V13, DOI [10.3127/ajis.v13i1.78, DOI 10.3127/AJIS.V13I1.78]
   Peng DX, 2012, J OPER MANAG, V30, P467, DOI 10.1016/j.jom.2012.06.002
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Premkumar G, 2008, INFORM MANAGE-AMSTER, V45, P451, DOI 10.1016/j.im.2008.06.008
   Pucci T, 2019, BRIT FOOD J, V121, P275, DOI 10.1108/BFJ-06-2018-0400
   Rahman MM, 2017, ACCIDENT ANAL PREV, V108, P361, DOI 10.1016/j.aap.2017.09.011
   Rogers EM., 2010, DIFFUSION INNOVATION, P576
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Ryu J.S., 2013, J DIRECT DATA DIGITA, V15, DOI [10.1057/dddmp.2013.53, DOI 10.1057/DDDMP.2013.53]
   Scherer R, 2019, COMPUT EDUC, V128, P13, DOI 10.1016/j.compedu.2018.09.009
   Schwarz A, 2017, DATA BASE ADV INF SY, V48, P93, DOI 10.1145/3051473.3051479
   Shankar V, 2009, J INTERACT MARK, V23, P118, DOI 10.1016/j.intmar.2009.02.002
   Shen YC, 2010, BEHAV INFORM TECHNOL, V29, P497, DOI 10.1080/01449290903490658
   Suki Norazah Mohd, 2011, Journal of Information Technology Management, V22, P1
   Suki NM, 2016, BRIT FOOD J, V118, P2893, DOI 10.1108/BFJ-06-2016-0295
   Szu Y. -C., 2010, 2010 2 INT C ED TECH
   Tai Y., 2011, JALT CALL J, V7, P3, DOI [10.29140/jaltcall.v7n1.105, DOI 10.29140/JALTCALL.V7N1.105]
   Tinabo R., 2010, INT C NETW DIG TECHN, DOI [10.1007/978-3-642- 14292-5_20, DOI 10.1007/978-3-642-14292-5_20]
   Tung FC, 2009, SOC BEHAV PERSONAL, V37, P621, DOI 10.2224/sbp.2009.37.5.621
   Tuzovic Sven, 2016, Health Mark Q, V33, P127, DOI 10.1080/07359683.2016.1166840
   Ueasangkomsate P, 2016, PROCEDIA ENVIRON SCI, V34, P423, DOI 10.1016/j.proenv.2016.04.037
   Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926
   Venkatesh V, 2012, MIS QUART, V36, P157
   Wang XH, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12051998
   Yang YQ, 2015, IND MANAGE DATA SYST, V115, P253, DOI 10.1108/IMDS-08-2014-0243
   Yoon C, 2007, ELECTRON COMMER R A, V6, P102, DOI 10.1016/j.elerap.2006.06.009
   Yoon H., 2011, INT AR STAND M
   Zafar AU, 2021, COMPUT HUM BEHAV, V115, DOI 10.1016/j.chb.2019.106178
   Zheng W, 2017, TOURISM MANAGE, V59, P267, DOI 10.1016/j.tourman.2016.08.009
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 115
TC 4
Z9 4
U1 6
U2 10
PU IGI GLOBAL
PI HERSHEY
PA 701 E CHOCOLATE AVE, STE 200, HERSHEY, PA 17033-1240 USA
SN 1040-1628
EI 1533-7979
J9 INF RESOUR MANAG J
JI Inf. Resour. Manag. J.
PD JUL-SEP
PY 2021
VL 34
IS 3
BP 41
EP 63
DI 10.4018/IRMJ.2021070103
PG 23
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA SI3OE
UT WOS:000654735800003
DA 2022-04-20
ER

PT J
AU Bedock, D
   Lassen, PB
   Mathian, A
   Moreau, P
   Couffignal, J
   Ciangura, C
   Poitou-Bernert, C
   Jeannin, AC
   Mosbah, H
   Fadlallah, J
   Amoura, Z
   Oppert, JM
   Faucher, P
AF Bedock, Dorothee
   Lassen, Pierre Bel
   Mathian, Alexis
   Moreau, Pauline
   Couffignal, Julie
   Ciangura, Cecile
   Poitou-Bernert, Christine
   Jeannin, Anne-Caroline
   Mosbah, Helena
   Fadlallah, Jehane
   Amoura, Zahir
   Oppert, Jean-Michel
   Faucher, Pauline
TI Prevalence and severity of malnutrition in hospitalized COVID-19
   patients
SO CLINICAL NUTRITION ESPEN
LA English
DT Article
DE COVID-19; Malnutrition; Pneumonia; SARS-Cov2; Albumin
ID NUTRITION; THERAPY
AB Background & aims: Nutritional knowledge in patients with SARS-Cov2 infection (COVID-19) is limited. Our objectives were: i) to assess malnutrition in hospitalized COVID-19 patients, ii) to investigate the links between malnutrition and disease severity at admission, iii) to study the impact of malnutrition on clinical outcomes such as transfer to an intensive care unit (ICU) or death.
   Methods: Consecutive patients hospitalized in a medicine ward at a university hospital were included from March 21st to April 24th 2020 (n = 114, 60.5% males, age: 59.9 +/- 15.9 years). Nutritional status was defined using Global Leadership Initiative on Malnutrition (GLIM) criteria. Clinical, radiological and biological characteristics of COVID-19 patients were compared according to the presence of malnutrition. Logistic regression was used to assess associations between nutritional parameters and unfavourable outcomes such as transfer to intensive care unit (ICU) or death.
   Results: The overall prevalence of malnutrition was 42.1% (moderate: 23.7%, severe: 18.4%). The prevalence of malnutrition reached 66.7% in patients admitted from ICU. No significant association was found between nutritional status and clinical signs of COVID-19. Lower albumin levels were associated with a higher risk of transfer to ICU (for 10 g/l of albumin, OR [95%CI]: 0.31 [0.1; 0.7]; p < 0.01) and this association was independent of age and CRP levels.
   Conclusions: COVID-19 in medical units dedicated to non-intensive care is associated with a high prevalence of malnutrition, especially for patients transferred from ICU. These data emphasize the importance of early nutritional screening in these patients to adapt management accordingly. (C) 2020 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
C1 [Bedock, Dorothee; Lassen, Pierre Bel; Moreau, Pauline; Couffignal, Julie; Ciangura, Cecile; Poitou-Bernert, Christine; Jeannin, Anne-Caroline; Mosbah, Helena; Oppert, Jean-Michel; Faucher, Pauline] Sorbonne Univ, Pitie Salpetriere Univ Hosp, AP HP, Nutr Dept,Inst Cardiometab & Nutr ICAN, 47-83 Blvd Hop, F-75013 Paris, France.
   [Lassen, Pierre Bel; Poitou-Bernert, Christine] Sorbonne Univ, NutriOm Team, INSERM UMRS U1166, Paris, France.
   [Mathian, Alexis; Fadlallah, Jehane; Amoura, Zahir] Sorbonne Univ, Grp Hosp Pitie Salpetriere, AP HP,Serv Med Interne 2 Inst E3M,Inserm UMRS,Ctr, French Natl Referral Ctr Syst Lupus Erythematosus, Paris, France.
RP Oppert, JM (corresponding author), Hop La Pitie Salpetriere, AP HP, Nutr Dept, 47-83 Blvd Hop, F-75013 Paris, France.
EM jean-michel.oppert@aphp.fr
RI FADLALLAH, Jehane/AAJ-3272-2021
CR [Anonymous], 2017, RISK FACTORS COMMUNI
   Arkin N, 2020, CLIN NUTR, V39, P2327, DOI 10.1016/j.clnu.2020.05.007
   Barazzoni R, 2020, CLIN NUTR, V39, P1631, DOI 10.1016/j.clnu.2020.03.022
   Beck MA, 2004, TRENDS MICROBIOL, V12, P417, DOI 10.1016/j.tim.2004.07.007
   Caccialanza R, 2020, NUTRITION, V74, DOI 10.1016/j.nut.2020.110835
   Du, 2020, COMP CLIN IMPLICATIO, DOI [10.1101/2020.04.28.20082644, DOI 10.1101/2020.04.28.20082644]
   Flower L, 2020, BRIT J HOSP MED, V81, DOI 10.12968/hmed.2020.0045
   Jensen GL, 2019, JPEN-PARENTER ENTER, V43, P32, DOI [10.1002/jpen.1440, 10.1016/j.clnu.2018.08.002]
   KAUFFMAN CA, 1986, AM J CLIN NUTR, V44, P449, DOI 10.1093/ajcn/44.4.449
   Keller U, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060775
   Krznaric Z, 2020, CLIN NUTR, V39, P1983, DOI 10.1016/j.clnu.2020.05.006
   Li T, 2020, EUR J CLIN NUTR, V74, P871, DOI 10.1038/s41430-020-0642-3
   Liu W, 2020, CHINESE MED J-PEKING, V133, P1032, DOI 10.1097/CM9.0000000000000775
   Lomax AR, 2009, BRIT J NUTR, V101, P633, DOI 10.1017/S0007114508055608
   Miller R, 2020, CLEV CLIN J MED, V87, P384, DOI 10.3949/ccjm.87a.ccc013
   Russo A, 2020, J INFECT CHEMOTHER, V26, P807, DOI 10.1016/j.jiac.2020.03.011
   Short KR, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00343
   Wischmeyer PE, 2018, CRIT CARE CLIN, V34, P107, DOI 10.1016/j.ccc.2017.08.008
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Yaqoob P, 2017, P NUTR SOC, V76, P347, DOI 10.1017/S0029665116000781
NR 20
TC 46
Z9 46
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2405-4577
J9 CLIN NUTR ESPEN
JI Clin. Nutr. ESPEN
PD DEC
PY 2020
VL 40
BP 214
EP 219
DI 10.1016/j.clnesp.2020.09.018
PG 6
WC Nutrition & Dietetics
WE Emerging Sources Citation Index (ESCI)
SC Nutrition & Dietetics
GA QB3YQ
UT WOS:000614078200031
PM 33183539
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Islahudin, F
   Ariffin, NM
   Aziz, SAA
AF Islahudin, Farida
   Ariffin, Norliza Mat
   Aziz, Siti Azdiah Abdul
TI COVID-19 One Year on Community Response to the New Norms among
   Malaysians
SO ARCHIVES OF PHARMACY PRACTICE
LA English
DT Article
DE Coronavirus; COVID-19; Infection; Pandemic; Prevention; Virus
AB The global community has struggled with COVID-19 for a year. However, the ability to comply with strict preventive measures for many more months to come should be strictly monitored. The study aimed to assess COVID-19 preventive practices and knowledge among the Malaysian public after a year of the COVID-19 pandemic. This was a questionnaire-based study performed on adults in Malaysia, assessing both practices and knowledge of COVID-19 preventive measures. A total of 2558 respondents were included. The average practice score was 7.9 +/- 0.99 (maximum possible score=9). Overall, when leaving the house, the most common type of mask used were medical masks (n=1792, 70.1%). A majority admitted that they always wore masks (n=2284, 89.3%), approximately half (n=1325, 51.8%) only sometimes sanitized their hands, whilst 1456 (56.9%) always complied with the one-meter social distancing rule. The average mask knowledge score was 11.1 +/- 1.9 (maximum possible score=15). The average score for other preventive measures was 5.7 +/- 0.7 (maximum possible score=6). There was a significant positive association between practice and overall total knowledge of prevention measures (rho=0.1, 95% CI=0.02-0.01, p=0.03), in which an increase in prevention practices was observed with an increase in overall knowledge score. This study demonstrates that even after a year of struggling with the new norms of COVID-19, there is still a need to continuously educate the public on COVID-19 preventive measures among Malaysians. In addition, further steps must be taken to improve the current practice of preventive measures, which includes targeting behavioral changes.
C1 [Islahudin, Farida; Aziz, Siti Azdiah Abdul] Univ Kebangsaan Malaysia, Fac Pharm, Qual Management Med, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
   [Ariffin, Norliza Mat] Hosp Selayang, Pharm Dept, Batu Caves 68100, Selangor, Malaysia.
RP Islahudin, F (corresponding author), Univ Kebangsaan Malaysia, Fac Pharm, Qual Management Med, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
EM Faridaislahudin@yahoo.com
CR Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Block Ray Jr, 2020, Health Lit Res Pract, V4, pe166, DOI 10.3928/24748307-20200707-01
   Chiu NC, 2020, J MED INTERNET RES, V22, DOI 10.2196/21257
   Damanhouri Z. A., 2021, Journal of Advanced Pharmacy Education and Research, V11, P128, DOI 10.51847/FE1iOIPTwD
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Filipiak, 2020, DISASTER EMERG MED J, V5, P103, DOI [DOI 10.5603/DEMJ.A2020.0012, 10.5603/DEMJ.a2020.0012]
   Glabska D, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12124930
   Hirotsu Y, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104543
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ijaz MK, 2020, AM J INFECT CONTROL, V48, P972, DOI 10.1016/j.ajic.2020.05.015
   Jones NR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3223
   Kamming D, 2003, BRIT J ANAESTH, V90, P715, DOI 10.1093/bja/aeg173
   Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252
   MacIntyre CR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006577
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m408
   Meconcelli G, 2020, INT J PHARM PHYTOPHA, V10, P1
   National Security Council (NSC), 2020, MOV CONTR STAND OP P
   Papineni RS, 1996, J AEROSOL MED, V10, P105, DOI 10.1089/jam.1997.10.105
   Park SR, 2021, SKIN RES TECHNOL, V27, P554, DOI 10.1111/srt.12983
   Shokrani A, 2020, MATER DESIGN, V192, DOI 10.1016/j.matdes.2020.108749
   Tomar A, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138762
   Weiss Barry D, 2020, Health Lit Res Pract, V4, pe171, DOI 10.3928/24748307-20200723-01
   World Health Organization, 2020, SHORT PERS PROT EQ E
   World Health Organization, 2020, WHO COR DIS COVID 19
   World Health Organization, 2019, NONPH PUBL HLTH MEAS
   World Health Organization, 2020, ADV US MASKS CONT CO, DOI [10.1093/jiaa077, DOI 10.1093/JIAA077]
   World Health Organization (WHO), 2020, WHO GUID HAND HYG HL
   World Health Organization (WHO), 2020, COR DIS 7 COVID 19 A
NR 28
TC 0
Z9 0
U1 0
U2 0
PU ARCHIVES GLOBAL PROFESSIONALS
PI KARACHI
PA ARCHIVES GLOBAL PROFESSIONALS, KARACHI, PAKISTAN
SN 2320-5210
EI 2045-080X
J9 ARCH PHARM PRACT
JI Arch. Pharm. Pract.
PD OCT-DEC
PY 2021
VL 12
IS 4
BP 69
EP 75
DI 10.51847/0C6uf1HYaK
PG 7
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA ZC1ZG
UT WOS:000757326200003
OA gold
DA 2022-04-20
ER

PT J
AU Valk, R
   Planojevic, G
AF Valk, Reimara
   Planojevic, Gabriella
TI Addressing the knowledge divide: digital knowledge sharing and social
   learning of geographically dispersed employees during the COVID-19
   pandemic
SO JOURNAL OF GLOBAL MOBILITY-THE HOME OF EXPATRIATE MANAGEMENT RESEARCH
LA English
DT Article
DE Knowledge sharing; Social learning; Personal factors; Environmental
   factors knowledge sharing platform
ID ORGANIZATIONAL CULTURE; STRATEGY
AB Purpose The purpose of this paper is to investigate digital knowledge sharing (KS) and social learning (SL) of geographically dispersed employees during the COVID-19 pandemic. Design/methodology/approach The method is qualitative case study action research within a leading global provider of comprehensive logistics and transportation solutions; 22 employees from various geographically dispersed entities were selected through purposive sampling. Employees took part in interviews to explore their perspectives on and experiences with digital KS and SL. Findings Findings first show that successful digital KS and SL hinges on the motivation, intentions, attitude and behaviour of employees to share and co-create knowledge embedded in supportive KS culture and climate. Second, findings show that the implementation of knowledge sharing platforms customised to the needs and preferences of employees within the case study organisation facilitated KS and SL, which in turn aided the development of individual and organisational capability, agility and adaptability required in the contemporary, digital knowledge economy, especially during the COVID-19 pandemic. Research limitations/implications This research was a single case study of an organisation within one business sector, namely logistics, encompassing a small sample of 22 employees. Hence, this study does not permit statistical generalisation but only permits internal generalisation. Practical implications Forming and sustaining networks of influencers, i.e. employees who are role models of digital KS and SL, who serve as strong advocates and ambassadors for instilling a KS culture and climate within the organisation have a powerful influence on evoking digital KS and SL organisation-wide. Originality/value The contribution of this paper is that it presents an evidence-based "Digital Knowledge Sharing and Social Learning model" depicting the factors that influence digital KS and SL, the benefits and outcomes. This model aids researchers and practitioners to better understand the dynamics of digital KS and SL between organisational members in a cross-cultural business environment during times of crises.
C1 [Valk, Reimara] Amer Univ Dubai, Dept Management, Dubai, U Arab Emirates.
   [Planojevic, Gabriella] Aramex PJSC, Global Talent Management, Dubai, U Arab Emirates.
RP Valk, R (corresponding author), Amer Univ Dubai, Dept Management, Dubai, U Arab Emirates.
EM rvalk@aud.edu
CR Akbari N, 2017, J KNOWL MANAG, V21, P1120, DOI 10.1108/JKM-10-2016-0435
   Al Saifi SA, 2015, J KNOWL MANAG, V19, P164, DOI 10.1108/JKM-07-2014-0287
   Bandura A., 1977, SOCIAL LEARNING THEO, V1
   Bleijenbergh I, 2021, HUM RESOUR MANAGE R, V31, DOI 10.1016/j.hrmr.2020.100764
   Boullar A., 2018, BASISBOEK KWALITATIE
   Brewster C., 2001, THUNDERBIRD INT BUS, V43, P145
   Bryman A., 2015, BUSINESS RES METHODS
   Burmeister A, 2015, J KNOWL MANAG, V19, P735, DOI 10.1108/JKM-01-2015-0011
   Creswell J.W., 1998, QUAL INQ
   Cross, 2011, HUMAN RESOURCE DEV, P29
   Cross C., 2015, HUMAN RESOURCE DEV, P212
   Dabic, 2021, INT BUS REV, V101868, DOI [10.1016/j.ibusrev.2021.101868, DOI 10.1016/J.IBUSREV.2021.101868]
   Dabic M, 2014, BRQ-BUS RES Q, V17, P129, DOI 10.1016/j.brq.2013.09.001
   Di Vaio A, 2020, IEEE INT TECHNOL MAN, DOI 10.1109/ICTMOD49425.2020.9380581
   Dixon, 2016, 70 20 10 100 EVIDENC
   Feitosa J, 2021, ORGAN DYN, V50, DOI 10.1016/j.orgdyn.2020.100777
   Flick U., 2018, DESIGNING QUALITATIV
   Foss NJ, 2009, HUM RESOUR MANAGE-US, V48, P871, DOI 10.1002/hrm.20320
   Ghahtarani A, 2020, J INNOV KNOWL, V5, P190, DOI 10.1016/j.jik.2019.08.004
   Haak-Saheem W, 2017, INT J HUM RESOUR MAN, V28, P2762, DOI 10.1080/09585192.2016.1138499
   Halisah A, 2021, J KNOWL MANAG, V25, P1708, DOI 10.1108/JKM-08-2020-0631
   Horsburgh J, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1251-x
   Janus, 2016, BECOMING KNOWLEDGE S, DOI [10.1596/978-1-4648-0943-9, DOI 10.1596/978-1-4648-0943-9]
   Kim W, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020205
   Konopaske R., 2019, MANAGEMENT LEADING C
   Kumaraswamy KSN, 2012, J MANAG DEV, V31, P308, DOI 10.1108/02621711211208934
   Lee JC, 2016, COMPUT HUM BEHAV, V54, P462, DOI 10.1016/j.chb.2015.08.030
   Li W, 2010, J KNOWL MANAG, V14, P38, DOI 10.1108/13673271011015552
   Lilleoere AM, 2011, J KNOWL MANAG, V15, P53, DOI 10.1108/13673271111108693
   Lin HF, 2007, J INF SCI, V33, P135, DOI 10.1177/0165551506068174
   Lincoln Y.S., 1985, NATURALISTIC INQUIRY
   Lohman, 2005, HUM RESOUR DEV Q, V16, P501, DOI [10.1002/hrdq.1153, DOI 10.1002/HRDQ.1153]
   Maley JF, 2021, INT J MANPOWER, V42, P131, DOI 10.1108/IJM-10-2019-0483
   Michailova S, 2012, INT BUS REV, V21, P59, DOI 10.1016/j.ibusrev.2010.11.006
   Miles MB., 1994, QUALITATIVE DATA ANA, V2nd ed
   Nathavitharana RR, 2020, J HOSP MED, V15, P299, DOI 10.12788/jhm.3439
   Nesheim T, 2015, PERS REV, V44, P255, DOI 10.1108/PR-11-2013-0203
   Ozlen, 2017, ACAD PUBLISHING HOUS, V6, P115
   Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y
   Park S, 2018, J KNOWL MANAG, V22, P1408, DOI 10.1108/JKM-10-2017-0467
   Park S, 2015, EUR J TRAIN DEV, V39, P769, DOI 10.1108/EJTD-06-2015-0042
   Patton MQ, 2002, QUALITATIVE EVALUATI, V3
   Peltokorpi V., 2006, Knowledge Management Research & Practice, V4, P138, DOI 10.1057/palgrave.kmrp.8500095
   Peltokorpi V, 2017, J WORLD BUS, V52, P404, DOI 10.1016/j.jwb.2017.01.004
   Peralta CF, 2014, J KNOWL MANAG, V18, P538, DOI 10.1108/JKM-12-2013-0494
   Poell R., 2011, HDB HUMAN RESOURCE D, P27
   Poell R., 2011, HDB HUMAN RESOURCE D, P459
   Runhaar, 2011, HDB HUMAN RESOURCE D, P429
   Sakusic A, 2021, BOSNIAN J BASIC MED, V21, P93, DOI 10.17305/bjbms.2020.4934
   Scudellari M, 2020, NATURE, V584, P22, DOI 10.1038/d41586-020-02278-5
   Siemens G., 2005, INT J INSTRUCTIONAL, V2, P3, DOI DOI 10.3109/0142159X.2016.1173661
   Slovenia, 2015, INT J COGNITIVE RES, V3, P66
   Staglian?, 2021, INNOVATION TIMES PAN, DOI [10.1111/radm.12457, DOI 10.1111/RADM.12457]
   Strauss A., 1998, BASIC QUALITATIVE RE
   Tovstiga N, 2021, KNOWL MAN RES PRACT, V19, P427, DOI 10.1080/14778238.2020.1806749
   Vaismoradi M., 2016, J NURSING ED PRACTIC, V6, P100, DOI [DOI 10.5430/JNEP.V6N5P100, 10.5430/jnep.v6n5p100]
   Vlajcic D, 2019, BUS PROCESS MANAG J, V25, P104, DOI 10.1108/BPMJ-05-2017-0129
   Yin R., 2016, QUALITATIVE RES STAR
   Yin R.K., 2013, CASE STUDY RES DESIG
NR 59
TC 0
Z9 0
U1 15
U2 15
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2049-8799
EI 2049-8802
J9 J GLOB MOBIL
JI J. Glob. Mobil.
PD NOV 16
PY 2021
VL 9
IS 4
SI SI
BP 591
EP 621
DI 10.1108/JGM-02-2021-0019
EA OCT 2021
PG 31
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA WZ7JE
UT WOS:000711080700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Chan, HV
   Lan, NTM
   Dung, V
   Thuan, LM
   Trang, VT
   Nga, NTT
   Ai, NN
   Hao, NT
   Linh, DTD
   Long, NX
   Ha, LT
   Nguyet, LM
   Hieu, NX
   Long, DM
   Le, VH
AF Huynh Van Chan
   Nguyen Thi Mai Lan
   Vu Dung
   Le Minh Thuan
   Vu Thu Trang
   Nguyen Thi Thanh Nga
   Nguyen Nhan Ai
   Ngo Thuy Hao
   Dao Thi Dieu Linh
   Nguyen Xuan Long
   Le Thanh Ha
   Le Minh Nguyet
   Ngo Xuan Hieu
   Dau Minh Long
   Vu Ha Le
TI FACTORS PREDICTING INDIVIDUAL HEALTH BEHAVIORS DURING COVID-19 PANDEMIC
SO REVISTA DE INVESTIGACIONES-UNIVERSIDAD DEL QUINDIO
LA English
DT Article
DE Covid - 19; predictors; health behaviors; people in the community
ID ACUTE RESPIRATORY SYNDROME; SICK-ROLE-BEHAVIOR; ILLNESS BEHAVIOR;
   DISEASE; CONSEQUENCES; PERCEPTIONS; RESPONSES; OUTBREAK; RISK
AB Background: Covid - 19 is a global pandemic, affecting all areas of social life in every country. In the current conditions of the Covid-19 pandemic, individual health behaviors are of primary importance. Each citizen consciously implements their health behaviors not only to prevent them from being infected, but also to help the country's prevention of Covid-19 effective. The study of factors predicting people's health behaviors in the community will help managers come up with appropriate measures to improve public health and to quickly repel the pandemic.
   Objectives: The research analyzes factors predicting personal health behaviors during the Covid-19 pandemic in Vietnam, including: pandemic awareness, self-assessment of the possibility of becoming infected, fear of disease, quality of life, and mental health (anxiety).
   Methods: This was a cross-sectional quantitative study. Data were collected from a convenient sample of 572 people in Vietnam (118 males, 451 females; M age =27.0 (sd = 10.0)) by a means of an online questionnaire survey. The questionnaire was constructed based on the YouGov Behavior Change questionnaire; the Fear of Coronavirus-19 Scale (FCV-19), WHOQOL-BREF, the Moral Foundation Questionnaire, and Knowledge of Covid-19. This study performed multivariate regression analysis to explore effects of moral, quality of life, knowledge and fear of Coronavirus-19 on health behaviors of participants.
   Result: The result showed that fear and sex factors explain 4% (R2-adj = 4%) of health behavior change in the Covid-19 pandemic. In addition, there is a significant relationship between health behaviors and fear, age, gender, and occupation.
   Conclusion: People's health behaviors are particularly concerned during the Covid-19 pandemic. Community healthcare activities for the people should be tailored to suit different population groups such as gender, age or emotional experiences. More indepth studies are needed to find out the causes of these differences, thereby proposing practical solutions to help people practice more effective health behaviors, contributing to preventing and combating the outbreak.
C1 [Huynh Van Chan] Vietnam Natl Univ, Univ Social Sci & Humanities, Hanoi, Vietnam.
   [Nguyen Thi Mai Lan; Vu Thu Trang; Nguyen Thi Thanh Nga; Nguyen Nhan Ai] Acad Social Sci, Hanoi, Vietnam.
   [Vu Dung] Vietnam Acad Social Sci, Inst Psychol, Hanoi, Vietnam.
   [Le Minh Thuan] Univ Med & Pharm Ho Chi Minh, Ho Chi Minh City, Vietnam.
   [Ngo Thuy Hao] Xiamen Univ, Xiamen, Peoples R China.
   [Dao Thi Dieu Linh; Nguyen Xuan Long] Vietnam Natl Univ, Univ Languages & Int Studies, Hanoi, Vietnam.
   [Le Thanh Ha] Hanoi Pedag Univ, Hanoi, Vietnam.
   [Le Minh Nguyet] Hanoi Natl Univ Educ, Hanoi, Vietnam.
   [Ngo Xuan Hieu] Hanoi Metropolitan Univ, Fac Social Sci & Humanities, Hanoi, Vietnam.
   [Dau Minh Long] Hue Univ Educ, Hue, Vietnam.
   [Vu Ha Le] Natl Acad Educ Management, Hanoi, Vietnam.
RP Lan, NTM (corresponding author), Acad Social Sci, Hanoi, Vietnam.
EM huynhchan1966@gmail.com; mailantamly@gmail.com; vudungtamly@gmail.com;
   leminhthuannyd@gmail.com; trangvuthu90@gmail.com;
   thanhnga120684@gmail.com; jennynguyengass@gmail.com;
   jennynguyengass@gmail.com; daodieulinh1980@gmail.com;
   xlongt1h@gmail.com; lethanhha78@gmail.com; leminhnguyet@hnue.edu.vn;
   nxhieu@daihocthudo.edu.vn; dauminhlong@gmail.com; halv@niem.edu.vn
OI Le, Thanh Ha/0000-0002-3100-9222; Nguyen, Lan Thi
   Mai/0000-0002-8079-9929
CR Abdelrahman M, 2022, INT J MENT HEALTH AD, V20, P237, DOI 10.1007/s11469-020-00352-7
   Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   An N, 2020, TUOI 3 NEWSPAPER
   Baker S, 2020, BUSINESS INSIDER
   Black Dog Institute Black Dog Institute, 2020, MENT HLTH RAM COVID
   Bouchard TJ, 2001, BEHAV GENET, V31, P243
   Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x
   Bults M, 2015, DISASTER MED PUBLIC, V9, P207, DOI 10.1017/dmp.2014.160
   Charles T, 1980, SANCTIONS SOCIAL DEV
   Craig A. H., 2020, INT J MENT HEALTH AD, P1, DOI [10.1007/s11469-020-00281-5, DOI 10.1007/S11469-020-00281-5]
   Dalia Research Dalia Research, 2020, GLOB STUD COVID 19 D
   Daniel A. K., 2020, FEAR COVID 19 SCALE
   Dong LY, 2020, DRUG DISCOV THER, V14, P58, DOI 10.5582/ddt.2020.01012
   Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001
   Dung T, 2020, WHO SPEAKS HIGHLY VN
   Enternews eMagazine, 2020, ENTERNEWS EMAGAZINE
   Gochman D. S., 1982, HLTH ED Q, V9, P167, DOI [DOI 10.1177/109019818200900213, 10.1177/109019818200900213]
   Gochman DS, 1997, HDB HLTH BEHAV RES
   Haidt J, 2004, DAEDALUS-US, V133, P55, DOI 10.1162/0011526042365555
   Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296
   Jeffrey K, 2020, CORONAVIRUS SEEMS SP
   Jenny A, 2020, SWEDENS VERY DIFFERE
   John S, 2020, WORLD EC FORUM
   KASL SV, 1966, ARCH ENVIRON HEALTH, V12, P531, DOI 10.1080/00039896.1966.10664421
   KASL SV, 1966, ARCH ENVIRON HEALTH, V12, P246, DOI 10.1080/00039896.1966.10664365
   Lau ALD, 2008, AGING MENT HEALTH, V12, P746, DOI 10.1080/13607860802380607
   Leanne L. H., 2020, BRAIN BEHAV IMMUN, V5, DOI [10.1016/j.bbih.2020.100078, DOI 10.1016/J.BBIH.2020.100078]
   Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857
   Liang Z. B., 2020, INT J BIOL SCI, V16, P1745, DOI [10.7150/ijbs.45221, DOI 10.7150/IJBS.45221]
   Luc C. V, 2020, UPDATE REPORT ASSESS
   Luo Y, 2020, PUBLIC HEALTH, V185, P298, DOI 10.1016/j.puhe.2020.06.057
   Michael S. W., 2020, ANN INTERN MED, DOI [10.7326/M20-1239, DOI 10.7326/M20-1239]
   Pappas G, 2009, CLIN MICROBIOL INFEC, V15, P743, DOI 10.1111/j.1469-0691.2009.02947.x
   PARKERSON GR, 1993, MED CARE, V31, P629, DOI 10.1097/00005650-199307000-00005
   Pascal G., 2020, ANN INTERN MED, DOI [10.7326/M20-0912, DOI 10.7326/M20-0912]
   Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750
   Quan H. V, 2020, SUSTAINABILITY-BASEL, V12, P2931, DOI [10.31235/osf.io/cfw8x, DOI 10.31235/OSF.IO/CFW8X]
   Ropeik D, 2004, EMBO REP, V5, pS56, DOI 10.1038/sj.embor.7400228
   Sarah D., 2020, RISK PERCEPTIONS COV
   Seminog OO, 2013, THORAX, V68, P171, DOI 10.1136/thoraxjnl-2012-202480
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   Tao N., 2003, J ANHUI I ED, V21, P78
   Thomas E., 2020, NEW YORK TIMES
   Torgler B, 2007, EDWARD ELGAR, DOI [10.4337/9781847207203, DOI 10.4337/9781847207203]
   Vietnam Television Vietnam Television, 2020, ACT COMM MON SYST GP
   Vietnam's Ministry of Health Vietnam's Ministry of Health, 2020, UPD DAT COV 19
   Vietnamnet Vietnamnet, 2020, COVID 19 COMP E HLTH
   Vincenzo G., 2020, NATL BUREAU EC RES, DOI [10.3386/w27359, DOI 10.3386/W27359]
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   WHO WHO, 2020, COV 19 STRAT
   WHO WHO, 2020, CAMP HLTH HOM
   WHO WHO, 2020, VIRT PRESS C COV 19
   Yao H, 2020, LANCET PSYCHIAT, V7, pE21, DOI 10.1016/S2215-0366(20)30090-0
NR 53
TC 0
Z9 0
U1 3
U2 4
PU UNIV QUINDIO
PI QUINDIO
PA CERRADA 15 C11 12 N, ARMENIA, QUINDIO, 00000, COLOMBIA
SN 1794-631X
J9 REV INVEST-QUINDIO
JI Rev. Investig.
PY 2021
VL 33
IS 1
BP 58
EP 72
DI 10.33975/riuq.vol33n1.461
PG 15
WC Multidisciplinary Sciences
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics
GA SL2DQ
UT WOS:000656730900005
OA gold
DA 2022-04-20
ER

PT J
AU Vieira, BP
AF Vieira, Bianca Pinto
TI Publishing during a pandemic: comparison of scientific knowledge between
   COVID-19 and Swine Flu
SO EM QUESTAO
LA English
DT Article
DE Coronavirus; Viral diseases; Pubmed database; Value of information;
   Scientific knowledge cycle
ID INFLUENZA
AB Scientific knowledge has a well-established cycle of generating hypotheses, testing them in experiments with proper discussion, and submitting it to the scientific community analysis through publications. It takes time to establish sample size for biomedical studies, especially concerning the effect of medicines and vaccines. The World Health Organization's protocol estimates that more than 19 months of experiments are necessary to approve a vaccine, for example. As the world has witnessed, a pandemic with immediate impact on human lives urges scientific methods to speed up finding solutions. Here it was assessed the speed and volume of information generated by the Academia to tackle the COVID-19 compared to the Swine Flu pandemic. Were considered papers published in journals indexed in PubMed, the most comprehensive biomedical scientific database available online. The number of publications about COVID-19 was 11 times higher than the number of publications about Swine Flu in a one-year timeframe. Though the expectation were finding more international collaborations and studies focusing on vaccines for COVID-19, papers were mostly concentrated in China and studying symptoms, managing the pandemic, reviewing knowledge, or establishing clinical trials. For sure, science is working faster every day for solutions in biomedical critical situations. However, the fast volume of information might blurry decisions on public health management. This paper's results show it is mandatory before using papers to take actions, waiting for the scientific community to first progress on its scientific knowledge cycle and mature discussions on the generated knowledge.
C1 [Vieira, Bianca Pinto] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
RP Vieira, BP (corresponding author), Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
CR Akin L, 2020, TURK J MED SCI, V50, P515, DOI 10.3906/sag-2004-133
   Aronson E, 1997, AM J PSYCHOL, V110, P127, DOI 10.2307/1423706
   Baum JR, 2003, STRATEGIC MANAGE J, V24, P1107, DOI 10.1002/smj.343
   Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638
   Costello MJ, 2009, BIOSCIENCE, V59, P418, DOI 10.1525/bio.2009.59.5.9
   DANE Francis., 1990, RES METHODS
   DUTRA Frederico Giffoni de Carvalho., 2020, QUESTAO PORTO ALEGRE, V26, P106
   EISEN Michel, ELIFE, V9
   Feinerer I., 2015, TEXT MINING PACKAGE
   FELLOWS Ian., 2018, WORD CLOUDS
   Ferner RE, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1432
   HACKING Ian., REPRESENTING INTERVE
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Loeffler-Wirth H, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070777
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Lvov D. K., 2010, Voprosy Virusologii, V55, P4
   MAZZUCATO Mariana., 2014, ESTADO EMPREENDEDOR
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   MEHRA Mandeep, 2020, LANCET LONDON, V396, P18
   Norgaard O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010039
   Palayew A, 2020, NAT HUM BEHAV, V4, P666, DOI 10.1038/s41562-020-0911-0
   Rodrigues RS, 2020, EM QUESTAO, V26, P13, DOI 10.19132/1808-5245262.13-31
   Rowley J, 2001, J INFORM SCI, V27, P227, DOI 10.1177/016555101401266674
   Saunders-Hastings PR, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040066
   Singh A, 2020, DIABETES METAB SYND, V14, P277, DOI 10.1016/j.dsx.2020.04.011
   SMITH C. A. P., 1997, MANAGEMENT COMMUNICA, V11, P97
   Smith RD, 2011, SOC SCI MED, V73, P235, DOI 10.1016/j.socscimed.2011.05.025
   Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572
   WHO, 2010, WHO TECH REP SER, V949, P1
   WHO, 2020, NAM COR DIS COVID 19
   WICKHAM Hadley., 2020, XML2 PARSE XML
   WICKHAM Hadley, 2019, HTTR TOOLS WORKING U
   WICKHAM Hadley, 2019, EASILY HARVEST SCRAP
   WORLD ECONOMIC FORUM, 2020, LARG GLOB EC
NR 34
TC 0
Z9 0
U1 0
U2 0
PU UNIV FEDERAL RIO GRANDE SUL, FAC BIBLIOTECONOMIA & COMUNICACAO
PI PORTO ALEGRE
PA RUA RAMIRO BARCELOS, 2705, SALA 519, PORTO ALEGRE, RS 90040-060, BRAZIL
SN 1807-8893
EI 1808-5245
J9 EM QUESTAO
JI Em. Questao
PD APR-JUN
PY 2022
VL 28
IS 2
BP 145
EP 169
AR e-111566
DI 10.19132/1808-5245282.111566
PG 25
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA ZH5ZX
UT WOS:000761017800014
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU De Conto, SM
   Finkler, R
   Steiner, VL
   Bonin, SM
AF De Conto, Suzana Maria
   Finkler, Raquel
   Steiner, Vera Lucia
   Bonin, Sara Massotti
TI The Covid-19 Pandemic and Tourism: Reflections for an Agenda for the
   Area
SO ROSA DOS VENTOS-TURISMO E HOSPITALIDADE
LA Portuguese
DT Article
DE Tourism; Pandemic; Covid-19; Knowledge Production; Post-Graduate Courses
AB One of the sectors most affected by the crisis caused by the Covid-19 pandemic was tourism, which suffered direct impacts, with a strong retraction in its activities. Thus, it is important to understand how themes related to crises and emergency situations have been internalized in the academy. The objectives of this study are to analyze and problematize relationships that can be made between the Covid-19 pandemic and Tourism, prompting the establishment of a research agenda. The research, bibliographic and descriptive, with a predominantly qualitative approach, focuses on the theses, dissertations and disciplines of 11 post-graduate programs in Tourism in Brazil, on topics such as the pandemic, crisis management and management of risk. Gaps were found on these themes in the area of Tourism in the Country. It is considered relevant to reflect on potential issues related to emergencies to be internalized in the Tourism area, which can contribute to different sectors of tourism for facing global crises experienced by humanity.
C1 [De Conto, Suzana Maria; Finkler, Raquel] Univ Caxias do Sul, Programa Posgrad Turismo & Hospitalidade, Caxias Do Sul, RS, Brazil.
   [Steiner, Vera Lucia] Univ Caxias do Sul, Caxias Do Sul, RS, Brazil.
   [Bonin, Sara Massotti] Fac Senac, Porto Alegre, RS, Brazil.
RP De Conto, SM (corresponding author), Univ Caxias do Sul, Programa Posgrad Turismo & Hospitalidade, Caxias Do Sul, RS, Brazil.
EM smcmande@ucs.br; rfinkler1@hotmail.com; vlsteine@ucs.br;
   smbonin@senacrs.com.br
CR [Anonymous], ED ESP COVID 19, V12
   [Anonymous], 2020, REV TURISMO CIDADES
   Associacao Brasileira de Normas Tecnicas-ABNT, 2017, 37120 ABNT NBR ISO
   Associacao Brasileira de Normas Tecnicas-ABNT, 2012, 16001 ABNT NBR
   Botome S. P., 1994, CONT CIENCIA EDUCACA
   Chang CL, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093671
   Chavez E.S., 2020, CENARIO REV INTERDIS, V14, P17
   Clemente A. C. F., 2020, CENARIO REV INTERDIS, V8, P73
   De Conto Suzana Maria, 2011, Estud. perspect. tur., V20, P213
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, 2020, THESIS CAPES
   De Conto S. M., 2020, COVID 19 AMBIENTE TE, P316
   De Negri F., 2020, POLITICAS PUBLICAS P
   De Sa F. Z., 2020, ROSA VENTOS, V12, P1
   Félix Ángel, 2020, Rev. interam. ambient. tur., V16, P66, DOI 10.4067/s0718-235x2020000100066
   Grisotti Marcia, 2020, Physis, V30, pe300202, DOI 10.1590/s0103-73312020300202
   Hakovirta M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093727
   Hamaue S. K., 2008, THESIS U ANHEMBI MOR
   Marinho M. F., 2019, TURISMO ANALISE, V30, P367
   Ministerio da Saude, 2020, COR
   OMS (Organizacao Mundial da Saude), 2020, WHO COR DIS COVID 19
   Organizacao Mundial do Turismo-OMT, 2019, INT TOUR HIGHL
   Panosso Netto A., 2020, CENARIO REV INTERDIS, V14, P17
   Plataforma Sucupira, 2020, CURS AV REC TUR
   Rodrigues V. B., 2019, THESIS U ANHEMBI MOR
   Rogerson CM, 2020, DEV SO AFR, V37, P727, DOI 10.1080/0376835X.2020.1818551
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Tito A. L. de A., 2018, THESIS U FEDERAL RIO
   Universidade de Sao Paulo, 2020, 1 SEM AC TUR IN DEB
   Ventura D. de F. L., 2020, CAD SAUDE PUBLICA, V36, P1
   Zenker S, 2020, TOURISM MANAGE, V81, DOI 10.1016/j.tourman.2020.104164
NR 30
TC 0
Z9 0
U1 0
U2 0
PU UNIV CAXIAS SUL, PROGRAMA POS-GRADUACAO & TURISMO
PI CAXIAS DO SUL
PA RUA FRANCISCO GETULIO VARGAS, 1130, CAXIAS DO SUL, 95070-560, BRAZIL
SN 2178-9061
J9 ROSA VENTOS
JI Rosa Ventos
PD OCT-DEC
PY 2021
VL 13
IS 4
PG 17
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA XZ1ML
UT WOS:000737424400008
DA 2022-04-20
ER

PT J
AU Cernile, G
   Heritage, T
   Sebire, NJ
   Gordon, B
   Schwering, T
   Kazemlou, S
   Borecki, Y
AF Cernile, George
   Heritage, Trevor
   Sebire, Neil J.
   Gordon, Ben
   Schwering, Taralyn
   Kazemlou, Shana
   Borecki, Yulia
TI Network graph representation of COVID-19 scientific publications to aid
   knowledge discovery
SO BMJ HEALTH & CARE INFORMATICS
LA English
DT Article
DE BMJ health informatics; health care; information science; medical
   informatics
AB Introduction
   Numerous scientific journal articles related to COVID-19 have been rapidly published, making navigation and understanding of relationships difficult.
   Methods
   A graph network was constructed from the publicly available COVID-19 Open Research Dataset (CORD-19) of COVID-19-related publications using an engine leveraging medical knowledge bases to identify discrete medical concepts and an open-source tool (Gephi) to visualise the network.
   Results
   The network shows connections between diseases, medications and procedures identified from the title and abstract of 195 958 COVID-19-related publications (CORD-19 Dataset). Connections between terms with few publications, those unconnected to the main network and those irrelevant were not displayed. Nodes were coloured by knowledge base and the size of the node related to the number of publications containing the term. The data set and visualisations were made publicly accessible via a webtool.
   Conclusion
   Knowledge management approaches (text mining and graph networks) can effectively allow rapid navigation and exploration of entity inter-relationships to improve understanding of diseases such as COVID-19.
C1 [Cernile, George; Heritage, Trevor; Schwering, Taralyn; Kazemlou, Shana; Borecki, Yulia] Inspirata, Tampa, FL USA.
   [Sebire, Neil J.; Gordon, Ben] HDRUK, London, England.
RP Sebire, NJ (corresponding author), HDRUK, London, England.
EM neil.sebire@hdruk.ac.uk
OI Sebire, Neil/0000-0001-5348-9063; Gordon, Ben/0000-0002-3105-6774
CR Albahri AS, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01582-x
   [Anonymous], 2019, CORONAVIRUS DIS
   COVIDSurg Collaborative, 2020, BRIT J SURG, V107, P1097, DOI 10.1002/bjs.11646
   Das D, 2020, ACL 2020 WORK NLP CO
   Domingo-Fernandez D, 2021, BIOINFORMATICS, V37, P1332, DOI 10.1093/bioinformatics/btaa834
   Fang Zhou, 2012, Bisociative Knowledge Discovery. An Introduction to Concept, Algorithms, Tools, and Applications: LNCS 7250, P179, DOI 10.1007/978-3-642-31830-6_13
   Kaggle, COVID 19 OP RES DAT
   Kambhampati Srinivas B S, 2020, J Clin Orthop Trauma, V11, pS304, DOI 10.1016/j.jcot.2020.04.030
   Liu N, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01059-y
   Lysenko A, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0102-8
   Sharma S, 2020, EMNLP IJCNLP 2019 20
   Shi LX, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2858423
   Wahler, 2020, KNOWLEDGE GRAPHS
   Wang L.-W., 2020, ARXIV
   Xu J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0543-2
   Zyoud SH, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05293-z
NR 16
TC 4
Z9 4
U1 4
U2 11
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
EI 2632-1009
J9 BMJ HEALTH CARE INFO
JI BMJ Health Care Inform.
PY 2021
VL 28
IS 1
AR e100254
DI 10.1136/bmjhci-2020-100254
PG 4
WC Health Care Sciences & Services; Medical Informatics
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services; Medical Informatics
GA PU7EF
UT WOS:000609462300001
PM 33419870
OA gold, Green Submitted, Green Published
DA 2022-04-20
ER

PT J
AU Bronfman, N
   Repetto, P
   Cordon, P
   Castaneda, J
   Cisternas, P
AF Bronfman, Nicolas
   Repetto, Paula
   Cordon, Paola
   Castaneda, Javiera
   Cisternas, Pamela
TI Gender Differences on Psychosocial Factors Affecting COVID-19 Preventive
   Behaviors
SO SUSTAINABILITY
LA English
DT Article
DE gender; trust; worry; preventive behaviors; COVID-19
ID NATURAL DISASTERS; EARTHQUAKE RISK; PREPAREDNESS; PERCEPTION; HEALTH;
   IMPACT; TRUST; EXPERIENCE
AB Previous studies have reported differences between men and women in the adoption of preventive behaviors against infectious diseases. This study aims to examine gender differences on a set of psychosocial factors shown to influence preventive behaviors against infectious diseases such as COVID-19. We conducted a web survey (N = 1.004) a few weeks after the end of the peak of the first wave of infections in Chile. The survey assessed participants' perception of risk and worry about the COVID-19 pandemic, confidence in the government's competence and integrity in dealing with the crisis, attribution of responsibility to various stakeholders, and adoption of preventive behaviors such as hygiene, distancing, and information-seeking. Our results confirm significant gender-based differences for both the psychosocial factors and the adoption of preventive behaviors. We conclude that women show a higher level of worry and fear of the pandemic and are keener to adopt preventive hygiene and social distancing behaviors. Similarly, participants report a low level of trust in government authorities, with women reporting the lowest trust level. The implications of these findings for the design of future risk communication strategies are discussed.
C1 [Bronfman, Nicolas] Univ Andres Bello, Dept Engn Sci, Santiago 7500973, Chile.
   [Bronfman, Nicolas; Repetto, Paula; Cisternas, Pamela] Res Ctr Integrated Disaster Risk Management ANID, Santiago 7820436, Chile.
   [Repetto, Paula; Cordon, Paola; Castaneda, Javiera] Pontificia Univ Catolica Chile, Dept Psychol, Santiago 7820436, Chile.
   [Cisternas, Pamela] Pontificia Univ Catolica Chile, Ind & Syst Engn Dept, Santiago 7820436, Chile.
RP Bronfman, N (corresponding author), Univ Andres Bello, Dept Engn Sci, Santiago 7500973, Chile.; Bronfman, N (corresponding author), Res Ctr Integrated Disaster Risk Management ANID, Santiago 7820436, Chile.
EM nbronfman@unab.cl; prepetto@uc.cl; pcordon@uc.cl; jvcastaneda@uc.cl;
   pccisternas@uc.cl
RI Repetto, Paula/ABC-5982-2021; repetto, paula/E-5525-2015
OI Repetto, Paula/0000-0002-0331-7375; Castaneda,
   Javiera/0000-0001-9933-039X; Cordon Slowing, Paola/0000-0002-6325-1742;
   Cisternas, Pamela Carmen/0000-0003-3637-7814
FU National Research and Development Agency (ANID) of the Ministry of
   Science, Technology, Knowledge and Innovation of Chile through the
   National Fund for Scientific and Technological Research (Fondecyt)
   [1180996]; Research Center for Integrated Disaster Risk Management
   (CIGIDEN) [ANID/FONDAP/15110017]
FX This research was partially funded by the National Research and
   Development Agency (ANID) of the Ministry of Science, Technology,
   Knowledge and Innovation of Chile through the National Fund for
   Scientific and Technological Research (Fondecyt, Grant 1180996) and by
   the Research Center for Integrated Disaster Risk Management (CIGIDEN),
   ANID/FONDAP/15110017.
CR Ahmad M, 2020, ENVIRON RES, V190, DOI 10.1016/j.envres.2020.109995
   Baker, 2020, INT J MENS SOC COMMU, V3, pE48, DOI [10.22374/ijmsch.v3i1.42, DOI 10.22374/IJMSCH.V3I1.42]
   Baker P, 2020, LANCET, V395, P1886, DOI 10.1016/S0140-6736(20)31303-9
   Barber SJ, 2021, J GERONTOL B-PSYCHOL, V76, pE17, DOI 10.1093/geronb/gbaa068
   Barile JP, 2021, ANN BEHAV MED, V55, P82, DOI 10.1093/abm/kaaa109
   Bateman J.M., 2002, NAT HAZARDS REV, V3, P107, DOI [DOI 10.1061/(ASCE)1527-6988(2002)3:3(107), 10.1061/(ASCE)1527-6988(2002)3:3(107)]
   Bonell C, 2020, J EPIDEMIOL COMMUN H, V74, P617, DOI 10.1136/jech-2020-214290
   Broche-Perez Y, 2022, INT J MENT HEALTH AD, V20, P83, DOI 10.1007/s11469-020-00343-8
   Bronfman NC, 2020, RISK ANAL, V40, P2057, DOI 10.1111/risa.13526
   Bronfman NC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214249
   Bronfman NC, 2016, NAT HAZARDS, V81, P307, DOI 10.1007/s11069-015-2080-4
   Bronfman NC, 2012, ENERG POLICY, V46, P246, DOI 10.1016/j.enpol.2012.03.057
   Brouard S, 2020, CAN J POLIT SCI, V53, P253, DOI 10.1017/S0008423920000335
   Bwire George M, 2020, SN Compr Clin Med, V2, P874, DOI 10.1007/s42399-020-00341-w
   Castaneda JV, 2020, NAT HAZARDS, V103, P1881, DOI 10.1007/s11069-020-04060-2
   Chan HF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240644
   Cheng C, 2006, J APPL SOC PSYCHOL, V36, P222, DOI 10.1111/j.0021-9029.2006.00059.x
   Dehingia N, 2021, LANCET GLOB HEALTH, V9, pE14, DOI 10.1016/S2214-109X(20)30464-2
   Fancourt D, 2020, LANCET, V396, P464, DOI 10.1016/S0140-6736(20)31690-1
   Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117
   Griffith DM, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200247
   Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5
   Howard MC, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110417
   Hung LS, 2018, INT J DISAST RISK SC, V9, P16, DOI 10.1007/s13753-018-0158-9
   Joh E., 2021, FACTORS ASS TIMELY T, DOI [10.1101/2021.02.22.21252219, DOI 10.1101/2021.02.22.21252219]
   Johnson HD, 2003, PERCEPT MOTOR SKILL, V97, P805, DOI 10.2466/PMS.97.7.805-810
   Josa-Laorden C, 2021, J CLIN MED, V10, DOI 10.3390/jcm10050899
   Kohn S, 2012, DISASTER MED PUBLIC, V6, P217, DOI 10.1001/dmp.2012.47
   Kung YW, 2012, RISK ANAL, V32, P1535, DOI 10.1111/j.1539-6924.2011.01760.x
   Lindell MK, 2009, RISK ANAL, V29, P1072, DOI 10.1111/j.1539-6924.2009.01243.x
   McCright AM, 2010, POPUL ENVIRON, V32, P66, DOI 10.1007/s11111-010-0113-1
   Mellstrom U, 2020, NORMA, V15, P94, DOI 10.1080/18902138.2020.1762307
   Mena G, 2021, SCIENCE, V372, P934, DOI 10.1126/science.abg5298
   Neumayer E, 2007, ANN ASSOC AM GEOGR, V97, P551, DOI 10.1111/j.1467-8306.2007.00563.x
   Nino M, 2021, SSM-POPUL HLTH, V13, DOI 10.1016/j.ssmph.2020.100717
   Nivette A, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113370
   Onuma H, 2017, INT J DISAST RISK RE, V21, P148, DOI 10.1016/j.ijdrr.2016.11.004
   Arias JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186455
   Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6
   Pinchoff J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244053
   Rana IA, 2021, INT J DISAST RISK RE, V55, DOI 10.1016/j.ijdrr.2021.102096
   Raude J, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.584500
   Renn O., 1991, COMMUNICATING RISKS, P175, DOI [DOI 10.1007/978-94-009-1952-5_10, 10.1007/978-94-009-1952-5_10]
   Reznik A, 2021, INT J MENT HEALTH AD, V19, P1903, DOI 10.1007/s11469-020-00283-3
   Rickard LN, 2017, RISK ANAL, V37, P2334, DOI 10.1111/risa.12779
   Rieger M.O., 2020, TRUST GOVT ACTIONS C
   Rotarou ES, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5763-4
   Terpstra T, 2011, RISK ANAL, V31, P1658, DOI 10.1111/j.1539-6924.2011.01616.x
   Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0
   Tyler M, 2018, DISASTERS, V42, P697, DOI 10.1111/disa.12285
   Weinstein ND, 2000, BRIT J HEALTH PSYCH, V5, P351, DOI 10.1348/135910700168973
   World Bank, COVID 19 PLUNG GLOB
   World Health Organization, COR DIS COVID 19 DAS
   Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001
NR 54
TC 7
Z9 7
U1 5
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD JUN
PY 2021
VL 13
IS 11
AR 6148
DI 10.3390/su13116148
PG 12
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA SR0GF
UT WOS:000660723300001
OA gold
DA 2022-04-20
ER

PT J
AU Danielak, W
AF Danielak, Wieslaw
TI The impact of the COVID-19 pandemic on the activities of small
   enterprises on the example of business customers of a manufacturing
   company
SO MANAGEMENT-POLAND
LA English
DT Article
DE pandemic crisis; COVID-19; small company
AB The aim of the article is to show the impact of the COVID-19 pandemic on the activities of small enterprises on the example of business customers of a manufacturing company. The article contains current issues and presents problems regarding the global pandemic caused by COVID-19. which started in March 2020. The theoretical part shows the impact of the pandemic crisis on the activities of enterprises. The empirical part presents the results of research showing the decisions of company managers during the COVID-19 pandemic affecting the behavior of employees. suppliers. customers and the paper producer. The results of the research can be a source of knowledge for top and middle management. but also for employees whose safety of life and health is particularly important in the times of the COVID-19 pandemic.
C1 [Danielak, Wieslaw] Univ Zielona Gora, Inst Management & Qual Sci, Zielona Gora, Poland.
RP Danielak, W (corresponding author), Univ Zielona Gora, Inst Management & Qual Sci, Zielona Gora, Poland.
OI Danielak, Wieslaw/0000-0002-7319-6847
CR Arslan A., 2020, INT BUS REV, V29, P21, DOI [10.1108/MBR-07-2020-0153, DOI 10.1108/MBR-07-2020-0153]
   Cortez RM, 2020, IND MARKET MANAG, V88, P125, DOI 10.1016/j.indmarman.2020.05.004
   Duarte, 2021, EUR BUS REV
   Durst S., 2021, COVID 19 ACCELERATOR, DOI [10.1080/26437015.2020.1859935, DOI 10.1080/26437015.2020.1859935]
   Durst S, 2021, J ENTREP EMERG ECON, V13, P648, DOI 10.1108/JEEE-06-2020-0201
   Dvorak J, 2021, J ENTREP EMERG ECON, V13, P628, DOI 10.1108/JEEE-07-2020-0260
   Flieger M, 2020, PRZEGLAD EKONOMICZNY, P41
   Free C, 2021, ACCOUNT AUDIT ACCOUN, V34, P58, DOI 10.1108/AAAJ-06-2020-4634
   Friday D, 2018, INT J PHYS DISTR LOG, V48, P231, DOI 10.1108/IJPDLM-01-2017-0035
   Giousmpasoglou C, 2021, INT J CONTEMP HOSP M, V33, P1297, DOI 10.1108/IJCHM-07-2020-0741
   Homiak-Orsa I., 2020, PRZEGLAD EKONOMICZNY, P45
   Jones P, 2020, INT J CONTEMP HOSP M, V32, P3037, DOI 10.1108/IJCHM-04-2020-0357
   Kang J., 2020, MARK INTELL PLAN
   Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214
   Gomez SM, 2020, MANAG RES, V18, P401, DOI 10.1108/MRJIAM-06-2020-1065
   Portuguez, 2020, J ENTREP EMERG ECON
   Ratten V, 2021, J ENTREP EMERG ECON, V13, P747, DOI 10.1108/JEEE-06-2020-0163
   Ratten V, 2020, INT J ENTREP BEHAV R, V26, P1379, DOI 10.1108/IJEBR-06-2020-0387
   Sharma A, 2020, J BUS RES, V117, P443, DOI 10.1016/j.jbusres.2020.05.035
   Skalik J., 2004, ORGANIZACJA WARUNKAC, P213
   Skalik J., 2006, ZMIANA WARUNKIEM SUK, P42
   Slatter S., 2001, RESTRUKTURYZACJA FIR
   Smallbone D, 2012, INT SMALL BUS J, V30, P754, DOI 10.1177/0266242612448077
   Huynh TLD, 2020, ECON BULL, V40, P758
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Weber C, 2017, J MANAGE STUD, V54, P929, DOI 10.1111/joms.12272
   Zelek A., 2003, ZARZADZANIE KRYZYSEM
NR 27
TC 0
Z9 0
U1 6
U2 6
PU SCIENDO
PI WARSAW
PA BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND
SN 1429-9321
EI 2299-193X
J9 MANAG-POL
JI Manag.-Pol.
PD JAN
PY 2021
VL 25
IS 1
BP 155
EP 171
DI 10.2478/manment-2019-0064
PG 17
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YV4RD
UT WOS:000752716200008
OA gold
DA 2022-04-20
ER

PT J
AU Ouma, OK
   Ephraim, K
   Loyce, N
   Namisango, E
   Nalugoda, F
   Ndagire, R
   Wangi, RN
   Kawala, BA
   Katairo, T
   Okullo, AE
   Apunyo, R
   Semakula, D
   Luwambo, A
   Kinengyere, AA
   Sewankambo, N
   Balinda, SN
   Ocan, M
   Obuku, EA
AF Ouma, Ojiambo Kevin
   Ephraim, Kisangala
   Loyce, Nakalembe
   Namisango, Eve
   Nalugoda, Fred
   Ndagire, Regina
   Wangi, Rachel Nante
   Kawala, Brenda Allen
   Katairo, Thomas
   Okullo, Allen Eva
   Apunyo, Robert
   Semakula, Daniel
   Luwambo, Ash
   Kinengyere, Alison Annet
   Sewankambo, Nelson
   Balinda, Sheila N.
   Ocan, Moses
   Obuku, Ekwaro A.
TI Role and utility of COVID-19 laboratory testing in low-income and
   middle-income countries: protocol for rapid evidence synthesis
SO BMJ OPEN
LA English
DT Article
DE infectious diseases & infestations; protocols & guidelines; infectious
   diseases; microbiology; COVID-19
ID METAANALYSIS; BIAS
AB Introduction Accurate and affordable laboratory testing is key to timely diagnosis and appropriate management of patients with COVID-19. New laboratory test protocols are released into the market under emergency use authorisation with limited evidence on diagnostic test accuracy. As such, robust evidence on the diagnostic accuracy and the costs of available tests is urgently needed to inform policy and practice especially in resource-limited settings. We aim to determine the diagnostic test accuracy, cost-effectiveness and utility of laboratory test strategies for COVID-19 in low-income and middle-income countries.
   Methods and analysis This will be a multistaged, protocol-driven systematic review conducted in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for diagnostic test accuracy studies. We will search for relevant literature in at least six public health databases, including PubMed, Google Scholar, MEDLINE, Scopus, Web of Science and the WHO Global Index Medicus. In addition, we will search Cochrane Library, COVID-END and grey literature databases to identify additional relevant articles before double-screening and abstraction of data. We will conduct a structured narrative and quantitative synthesis of the results guided by the Fryback and Thornbury framework for assessing a diagnostic test. The primary outcome is COVID-19 diagnostic test accuracy. Using the GRADE approach specific to diagnostic accuracy tests, we will appraise the overall quality of evidence and report the results following the original PRISMA statement. The protocol is registered with the International Prospective Register of Systematic Reviews (PROSPERO; ).
   Ethics and dissemination Ethical review was done by the School of Biomedical Sciences Research Ethics Committee and the Uganda National Council for Science and Technology. The published article will be accessible to policy and decision makers. The findings of this review will guide clinical practice and policy decisions and highlight areas for future research. PROSPERO registration number CRD42020209528.
C1 [Ouma, Ojiambo Kevin] Makerere Univ, Coll Hlth Sci, Clin Epidemiol Unit, Dept Med, Kampala, Uganda.
   [Ouma, Ojiambo Kevin; Ephraim, Kisangala; Loyce, Nakalembe; Namisango, Eve; Nalugoda, Fred; Ndagire, Regina; Wangi, Rachel Nante; Kawala, Brenda Allen; Katairo, Thomas; Okullo, Allen Eva; Apunyo, Robert; Semakula, Daniel; Luwambo, Ash; Kinengyere, Alison Annet; Sewankambo, Nelson; Ocan, Moses; Obuku, Ekwaro A.] Makerere Univ, Coll Hlth Sci, Africa Ctr Systemat Reviews & Knowledge Translat, Kampala, Uganda.
   [Ephraim, Kisangala; Ndagire, Regina; Wangi, Rachel Nante] Kairos Hosp, Dept Gen Med, Kampala, Uganda.
   [Loyce, Nakalembe] King Ceasor Univ, Dept Pharmacol, Coll Med & Hlth Sci, Kampala, Uganda.
   [Namisango, Eve] Kings Coll Hosp London, Cicely Saunders Inst Palliat Care Policy & Rehabi, London, England.
   [Nalugoda, Fred] Makerere Univ, Coll Hlth Sci, Rakai Hlth Sci Program, Sch Publ Hlth, Kampala, Uganda.
   [Kawala, Brenda Allen] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth, Gothenburg, Sweden.
   [Katairo, Thomas] Infect Dis Res Collaborat, Kampala, Uganda.
   [Okullo, Allen Eva] Makerere Univ, Dept Med, Kampala, Uganda.
   [Semakula, Daniel] Makerere Univ, Coll Hlth Sci, Reg East African Community Hlth REACH Policy In, Dept Med, Kampala, Uganda.
   [Luwambo, Ash] Makerere Univ, Coll Hlth Sci, Directorate ICT Support, Kampala, Uganda.
   [Kinengyere, Alison Annet] Makerere Univ, Coll Hlth Sci, Albert Cook Lib, Kampala, Uganda.
   [Sewankambo, Nelson] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.
   [Balinda, Sheila N.] Uganda Virus Res Inst, Pathogen Genom Phenotype & Immun, Entebbe, Uganda.
   [Ocan, Moses] Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda.
   [Obuku, Ekwaro A.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
RP Ocan, M (corresponding author), Makerere Univ, Coll Hlth Sci, Africa Ctr Systemat Reviews & Knowledge Translat, Kampala, Uganda.; Ocan, M (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda.
EM ocanmoses@gmail.com
OI Wangi, Rachel/0000-0002-6589-2535; Kinengyere, Alison
   Annet/0000-0002-5341-3218; Katairo, Thomas/0000-0002-2002-8911
FU Makerere University Research and Innovation Fund (MakRIF-COVID-19 fund)
FX This study is funded by the Makerere University Research and Innovation
   Fund (MakRIF-COVID-19 fund). The funder had no role in developing the
   protocol.
CR Bastos ML, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2516
   Bruce EA, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000896
   Dinnes J, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013705
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203
   Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204
   Salameh JP, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2632
   Scells H, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P1646, DOI 10.1145/3308558.3313544
   Schunemann HJ, 2019, J CLIN EPIDEMIOL, V111, P105, DOI 10.1016/j.jclinepi.2018.01.012
   Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008
   Sun F., 2011, ADDRESSING CHALLENGE
   Tahamtan A, 2020, EXPERT REV MOL DIAGN, V20, P453, DOI 10.1080/14737159.2020.1757437
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   World Health Organization, 2020, LAB TEST COR DIS 201
   World Health Organization, 2020, DIAGN TEST SARS COV
   World Health Organization (WHO), 2020, TIM WHO RESP COVID 1
   Yan MT, 2021, J MED VIROL, V93, P441, DOI 10.1002/jmv.26230
   Yeung P, 2020, NEW SCI, V245, P13
NR 19
TC 0
Z9 0
U1 2
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD OCT
PY 2021
VL 11
IS 10
AR e050296
DI 10.1136/bmjopen-2021-050296
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA WJ4IH
UT WOS:000709009700006
PM 34663660
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Milanes, CB
   Montero, OP
   Cabrera, JA
   Cuker, B
AF Milanes, Celene B.
   Montero, Ofelia Perez
   Cabrera, J. Alfredo
   Cuker, Benjamin
TI Recommendations for coastal planning and beach management in Caribbean
   insular states during and after the COVID-19 pandemic
SO OCEAN & COASTAL MANAGEMENT
LA English
DT Article
DE Coastal planning; Beach management; Knowledge networks; Small island
   developing states; Cuba
ID TOOL; PERCEPTION
AB The COVID-19 pandemic has implications for coastal planning and management. Rules for isolation and physical distancing, among other measures for human life protection, have led to the closure of most beaches around the world. The present critical situation has raised the following question: How can some recommendations be designed in sun, sea, and sand tourism-dependent-insular countries to face "the COVID-19 new normality?" We used the content analysis technique to analyze representative publications on a global level to ascertain information on best management practices. A survey of 58 experts provided additional information. We used inferential statistics for sample selection and produced a list of 43 practices and beach planning and management actions to face the COVID-19 pandemic. This led to 27 new recommendations designed for beach planning and management within insular contexts, some of which were tested in the Republic of Cuba. Recommendations aim to guarantee a culture of safety and improvement within the field of beach or coastal planning and management. These recommendations should prove useful for other insular countries, during the COVID-19 period, in the new normality that follows, and in other post-pandemic scenarios.
C1 [Milanes, Celene B.] Univ Costa, Civil & Environm Dept, Barranquilla, Colombia.
   [Milanes, Celene B.; Montero, Ofelia Perez; Cabrera, J. Alfredo] Ibero Amer Network Proplayas, Santa Marta, Colombia.
   [Montero, Ofelia Perez] Univ Oriente, Multidisciplianry Studies Ctr Coastal Zone, Santiago De Cuba, Cuba.
   [Cabrera, J. Alfredo] Univ Matanzas, Observ Ambiental COSTATENAS, Matanzas, Cuba.
   [Cuker, Benjamin] Hampton Univ, Dept Marine & Environm Sci, Hampton, VA 23668 USA.
RP Milanes, CB (corresponding author), Univ Costa, Civil & Environm Dept, Barranquilla, Colombia.
EM cmilanes1@cuc.edu.co
RI Batista, Celene Milanés/B-8690-2019; Montero, Ofelia Pérez/AAE-5892-2021
OI Batista, Celene Milanés/0000-0003-2560-8859; Montero, Ofelia
   Pérez/0000-0002-3423-9744; Cuker, Benjamin/0000-0002-8024-9628
FU Universidad de la Costa [INV.1106-01-002-15]; Universidad de Oriente,
   Cuba [10523, PS223LH001-016]
FX Partial financial support for this research was provided to the first
   authors by Universidad de la Costa [grant numbers INV.1106-01-002-15] by
   the project named "Cultural practices and environmental certification of
   beaches: a contribution for the sustainable development in the insular
   states. Other funding were provided by the Cuban projects named in
   Spanish "Tarea Vida", Code.10523, and "Monitoreo y manejo integrado de
   ecosistemas costeros ante el cambio climatico en la region oriental de
   Cuba. (ECOS)", Code. PS223LH001-016. Both coordinated by Universidad de
   Oriente, Cuba.
CR Amyot J, 2014, OCEAN COAST MANAGE, V102, P317, DOI 10.1016/j.ocecoaman.2014.10.009
   [Anonymous], 2021, DIARIO
   [Anonymous], 2020, REUTERS
   [Anonymous], 2020, CORREO
   [Anonymous], 2020, POC AFL VIS PLAY DEP
   [Anonymous], 2020, HERALDO
   [Anonymous], 2020, REPORTUR
   APA, 2020, REG EXC TEMP PAR OC
   Bates AE, 2020, BIOL CONSERV, V248, DOI 10.1016/j.biocon.2020.108665
   Batista C.M., 2018, ENCY COASTAL SCI, V2nd ed., P471, DOI [10.1007/978-3-319-48657-4_356-1, DOI 10.1007/978-3-319-48657-4_356-1]
   Batista M.C., 2018, ENCY COASTAL SCI, VVolume 1, P524
   Bianchi F, 2020, TURISMO SOL PLAYA CO, P120
   Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554
   Botero C.M., 2017, REV LUNA AZUL, V45, P227, DOI [10.17151/luaz.2017.45.12, DOI 10.17151/LUAZ.2017.45.12]
   Botero C.M., 2020, ESCENARIOS RECOMENDA, P49
   Botero C.M., 2020, ESCENARIOS RECOMENDA, P118
   Botero C.M., 2018, ENCY COASTAL SCI, DOI [10.1007/978-3-319-48657-4_401-1, DOI 10.1007/978-3-319-48657-4_410-1, DOI 10.1007/978-3-319-48657-4_401-1]
   Cabrera H.J.A., 2009, MANEJO INTEGRADO COS
   Cabrera H.J.A., 2019, CIENCIAS MARINO COST
   Cabrera J.A., 2009, REV MEDIO AMBIENTE T
   Cepal, 2020, DIM EF COV 19 PENS R, P21
   Cervantes O, 2008, ENVIRON MANAGE, V42, P249, DOI 10.1007/s00267-008-9104-8
   Chakraborty N, 2020, PROG NEUROL PSYCHIAT, V24, P21, DOI 10.1002/pnp.666
   Collins-Kreiner N, 2021, ANN TOURISM RES, V89, DOI 10.1016/j.annals.2020.103076
   Cubadebate, 2020, IND FARM CUB GAR PRO
   Daza S., 2020, ALGUNOS COMPORTAMIEN
   de Mexico Gobierno, 2020, PROT AT PERS NAC MEX
   Departamento de Salud, 2020, TRANSP NUEB COR COVI
   Diaz-Canel M., 2020, ANALES ACAD CIENCIAS, V10
   Doyle A, 2021, INT J E-PLAN RES, V10, P18, DOI 10.4018/IJEPR.20210401.oa2
   Ehrenberg JP, 2021, INFECT DIS POVERTY, V10, DOI 10.1186/s40249-020-00790-4
   El Cacho Joaquim, 2020, DESCUBREN MILES MASC
   Eyawo O, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00662-y
   Foo LP, 2021, CURR ISSUES TOUR, V24, P2735, DOI 10.1080/13683500.2020.1777951
   Galib B., 2020, J FM BAGHDAD, V61
   Garofano L., 2020, ASI DISENO CHIPIONA
   Gerhartz-Abraham A, 2016, MAR POLICY, V73, P69, DOI 10.1016/j.marpol.2016.07.009
   Gobierno de Mexico, 2020, LIN NAC REAP SECT TU
   Gobierno de Mexico, 2020, LIN GEN MIT PREV COV
   Gobierno Vasco, CRITERIOS SANITARIOS
   Gorrey M., 2020, NEWSPAPER SIDNEY MOR
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Granma, 2020, COVID 19 COM PROT TE
   Graziano T., 2021, INT J PLANN RES, V10, DOI DOI 10.4018/IJEPR.20210401.0A7
   Hernandez Sampieri Roberto, 2014, METODOLOGIA INVESTIG
   Hsiang S, 2020, NATURE, V585, pE7, DOI [10.1038/s41586-020-2404-8, 10.1038/s41586-020-2691-0]
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   IMPLAN, 2020, NORM US PLAYAS COV 1
   Juanes J.L., 2003, DIAGNOSTICO PROCESOS
   Kock F, 2020, ANN TOURISM RES, V85, DOI 10.1016/j.annals.2020.103053
   La Capital, 2020, VER MAR PLAT HABR QU
   Lal R, 2020, SOIL SYST, V4, DOI 10.3390/soilsystems4030046
   Lancet Public Health, 2020, WILL COVID 19 PAND T, V5, pe460, DOI DOI 10.1016/S2468-2667(20)30189-4
   Liu HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082800
   Lozoya J.P.J., 2019, CIENCIAS MARINO COST
   Medio ambiente, 2020, CAS DOB US POD DISF
   Medio ambiente, 2020, APP PLAYAS NIK HOND
   Milanes B.C., 2020, TURISMO SOL PLAYA CO, P49
   Batista CM, 2020, OCEAN COAST MANAGE, V186, DOI 10.1016/j.ocecoaman.2020.105101
   Batista CM, 2019, MAR POLICY, V101, P93, DOI 10.1016/j.marpol.2018.12.030
   Ministerio de Salud, 2020, LSPG013 MIN SAL
   Mintur, 2021, TUR SEG CUB
   Monserrate M.A.Z., 2020, SCI TOTAL ENVIRON, V728, DOI [10.1016/j.scitotenv.2020.138813, DOI 10.1016/J.SCIT0TENV.2020.138813]
   Moret Karla Castillo, 2020, KC MOR BIOM T EMPL P
   Mukherjee M, 2020, PROG DISASTER SCI, V7, DOI 10.1016/j.pdisas.2020.100117
   Munoz R., 2020, PAIS
   Niusdiario.es / Agencias, 2020, NIUSDIARIO
   Noticias, 2020, NOTICIAS
   ONU, 2019, AS GEN REIT CON 187
   ONU, 2019, NEWS UN
   OPS, 2020, CUB PRENT COVID 19 A, V24
   Ostle B., 2012, STAT RES BASIC CONCE, P500
   Pereira CI, 2019, ENVIRON IMPACT ASSES, V79, DOI 10.1016/j.eiar.2019.106284
   Montero OP, 2020, OCEAN COAST MANAGE, V184, DOI 10.1016/j.ocecoaman.2019.105010
   Pirouz B, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12062427
   Prensa Latina, 2020, REFUERZAN MEDIDAS PL
   Ravelo Batista A., 2018, CONTRIBUTION MOBILE, P193
   Rodriguez A., 2020, PLAYAS CUBANAS SE LL
   SEMARNAT, 2020, SUBD GEN TECH MAN OR
   Soto E, 2021, BIOL CONSERV, V255, DOI 10.1016/j.biocon.2021.108972
   Statista, 2021, COVID 19 DEATHS CAP
   UNEP/MAP/PAP, 2015, GUID PREP NAT ICZM S
   Villares M, 2006, J COASTAL RES, P118
   Williams A.T., 2009, BEACH MANAGEMENT PRI, P480
   Xavi F., 2020, DESCONTROL PLAYAS TR
   Yeh SS, 2021, TOUR RECREAT RES, V46, P188, DOI 10.1080/02508281.2020.1805933
   Yepes V., 1999, GESTION TURISTICA PL, V3385, P2534
   Zielinski S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197288
   Zuniga A.G., 2020, HERALDO VIDEO PLAYAS
NR 89
TC 10
Z9 10
U1 2
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0964-5691
EI 1873-524X
J9 OCEAN COAST MANAGE
JI Ocean Coastal Manage.
PD JUL 1
PY 2021
VL 208
AR 105575
DI 10.1016/j.ocecoaman.2021.105575
EA APR 2021
PG 15
WC Oceanography; Water Resources
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Oceanography; Water Resources
GA SG9HA
UT WOS:000653749800005
DA 2022-04-20
ER

PT J
AU Egbi, OG
   Duru, C
   Kasia, B
AF Egbi, Oghenekaro Godwin
   Duru, Chika
   Kasia, Benedicta
TI Knowledge, attitude and practice towards COVID-19 among workers of a
   tertiary hospital in Bayelsa State, Nigeria
SO PAN AFRICAN MEDICAL JOURNAL
LA English
DT Article
DE Attitude; knowledge; coronavirus disease; hospital staff; health
   workers; pandemic; practice
ID HEALTH-CARE; CORONAVIRUS
AB Introduction: coronavirus disease (COVID-19) has since assumed pandemic dimensions with over 14million persons affected in 213 countries and territories worldwide as at mid-July 2020. The level of awareness and knowledge of the disease as well as the related attitude and practice amongst hospital workers could determine its extent of control. The aim of this study was to determine the knowledge, attitude and practices amongst hospital staff regarding COVID-19. Methods: this cross-sectional study was conducted among staff of the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria. A self-administered semistructured questionnaire was adapted in assessing their knowledge, attitude and practice towards COVID-19. Results: one hundred and twenty four respondents completed the study with a mean age of 30.9 +/- 6.5 years. Up to 90% of them demonstrated good knowledge of COVID-19 with regard to preventive and control measures. Approximately 90% of them practiced good hand hygiene though a lesser proportion wore face masks (51.6%) and practiced crowd avoidance (58.1%). Medical doctors had a marginally higher practice score compared with "others" (p = 0,047). Up to 98(79.0%) of respondents were scared of self-infection and 99(79.8%) were not motivated to work due to inadequate facilities, equipment and resources in 50% of cases. Knowledge of COVID-19 was positively correlated with the practices of the participants (p = 0.023). Conclusion: the hospital staff lacked adequate motivation towards management of COVID-19 and were constrained for the fear of self-infection, inadequate equipment, resources and equipment despite possessing a good knowledge of the disease. There is need for concerted efforts by stakeholders in the health care industry to ensure hospital workers are adequately motivated and provided with the needed risk protection devices and resources during this pandemic.
C1 [Egbi, Oghenekaro Godwin] Niger Delta Univ, Coll Hlth Sci, Dept Internal Med, Amassoma, Bayelsa State, Nigeria.
   [Duru, Chika] Niger Delta Univ, Coll Hlth Sci, Dept Pediat, Amassoma, Bayelsa State, Nigeria.
   [Kasia, Benedicta] Niger Delta Univ, Coll Hlth Sci, Dept Chem Pathol, Amassoma, Bayelsa State, Nigeria.
RP Egbi, OG (corresponding author), Niger Delta Univ, Coll Hlth Sci, Dept Internal Med, Amassoma, Bayelsa State, Nigeria.
EM drkoge@yahoo.com
CR Centers for Disease Control and Prevention, PROT YOURS OTH
   Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X
   Habibzadeh P, 2020, INT J OCCUP ENV MED, V11, P65, DOI 10.15171/ijoem.2020.1921
   Nemati M, ARCH CLIN INFECT DIS
   Oluwabamide A. J., 2011, Journal of Sociology and Social Anthropology, V2, P47
   Omrani AS, 2015, J HOSP INFECT, V91, P188, DOI 10.1016/j.jhin.2015.08.002
   Ramadhani HO, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1483-6
   Wang P, 2020, CLIN CHEM, V66, P644, DOI 10.1093/clinchem/hvaa080
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   World Health Organization, 2020, WHO DIR GEN STAT IHR
   World Health Organization, INF PREV CONTR HLTH
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   World Health Organization (WHO), COR DIS COVID 19 ADV
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 15
TC 1
Z9 1
U1 0
U2 1
PU AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET
PI KAMPALA
PA PO BOX 12874, KAMPALA, 00000, UGANDA
EI 1937-8688
J9 PAN AFR MED J
JI Pan Afr. Med. J.
PD SEP
PY 2020
VL 37
SU 1
AR 24
DI 10.11604/pamj.supp.2020.37.24.26259
PG 12
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA QF0PK
UT WOS:000616602900024
PM 33456648
DA 2022-04-20
ER

PT J
AU Ahmad, I
   Wade, S
   Langdon, A
   Chamarette, H
   Walsh, M
   Surda, P
AF Ahmad, I.
   Wade, S.
   Langdon, A.
   Chamarette, H.
   Walsh, M.
   Surda, P.
TI Awake tracheal intubation in a suspected COVID-19 patient with critical
   airway obstruction
SO ANAESTHESIA REPORTS
LA English
DT Article
DE aerosolisation; airway obstruction; awake tracheal intubation; COVID-19
AB We report the airway management of a patient with suspected COVID-19 with impending airway obstruction requiring urgent surgical tracheostomy. To our knowledge, this is the first reported case of an awake tracheal intubation in a suspected COVID-19-positive patient. Various modifications were put in place during the awake tracheal intubation and surgical tracheostomy procedures to minimise aerosol generation from the patient, such as avoiding high-flow nasal oxygen, establishing conscious sedation with remifentanil before commencing airway topicalisation and avoiding transtracheal local anaesthetic infiltration. A multidisciplinary team discussion before performing the case highlighted aspects of both the airway management and the surgical procedure where particular care and modifications are required. There is a lack of national and international guidance for awake tracheal intubation and tracheostomy in COVID-19 cases. This report nevertheless addresses the key procedural modifications required.
C1 [Ahmad, I.; Wade, S.; Langdon, A.; Chamarette, H.] Guys & St Thomas NHS Fdn, Dept Anaesthesia, London, England.
   [Walsh, M.; Surda, P.] Guys & St Thomas NHS Fdn Trust, Dept Ear Nose & Throat Surg, London, England.
RP Ahmad, I (corresponding author), Guys & St Thomas NHS Fdn, Dept Anaesthesia, London, England.
EM drimranahmad1@gmail.com
OI Ahmad, Imran/0000-0003-3675-7040
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   Ahmad I, 2020, ANAESTHESIA, V75, P509, DOI 10.1111/anae.14904
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Department of Health and Social Care (DHSC, 2020, COVID 19 GUID INF PR
   El-Boghdadly K, 2017, ANAESTHESIA, V72, P694, DOI 10.1111/anae.13844
   Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Medical expert group of Tongji hospital, 2020, HERALD MED
   Wax RS, 2020, CAN J ANESTH, V67, P568, DOI 10.1007/s12630-020-01591-x
   Zuo Mingzhang, 2020, Chinese Medical Sciences Journal, V35, P105, DOI 10.24920/003724
NR 10
TC 9
Z9 9
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2637-3726
J9 ANAESTH REP
JI Anaesth. Rep.
PD JAN
PY 2020
VL 8
IS 1
BP 28
EP 31
DI 10.1002/anr3.12041
PG 4
WC Anesthesiology
WE Emerging Sources Citation Index (ESCI)
SC Anesthesiology
GA UW2BT
UT WOS:000699968800010
PM 32373789
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU You, YX
   Yang, XY
   Hung, DN
   Yang, QX
   Wu, T
   Deng, MC
AF You, Yaxian
   Yang, Xinyuan
   Hung, Dongni
   Yang, Qianxi
   Wu, Ting
   Deng, Meichun
TI Asymptomatic COVID-19 infection: diagnosis, transmission, population
   characteristics
SO BMJ SUPPORTIVE & PALLIATIVE CARE
LA English
DT Review; Early Access
DE COVID-19; hospital care; family management; paediatrics; symptoms and
   symptom management
ID CLINICAL CHARACTERISTICS; SPECIMENS; PROVINCE
AB A novel coronavirus first discovered in late December 2019 has spread to many countries around the world. An increasing number of asymptomatic patients have been reported and their ability to spread the virus has been proven. This brings major challenges to the control of the transmission. The discovery and control of asymptomatic patients with COVID-19 are the key issues in future epidemic prevention and recovery. In this narrative review, we summarise the existing knowledge about asymptomatic patients and put forward detection methods that are suitable for finding such patients. Besides, we compared the characteristics and transmissibility of asymptomatic patients in different populations in order to find the best screening, diagnosis and control measures for different populations. Comprehensive preventive advice is also provided to prevent the spread of infection from asymptomatic patients.
C1 [You, Yaxian; Yang, Xinyuan; Hung, Dongni; Yang, Qianxi; Wu, Ting; Deng, Meichun] Cent South Univ, Sch Life Sci, Dept Biochem & Mol Biol, Changsha, Hunan, Peoples R China.
   [You, Yaxian; Yang, Xinyuan; Hung, Dongni; Yang, Qianxi; Wu, Ting; Deng, Meichun] Cent South Univ, Sch Life Sci, Hunan Prov Key Lab Basic & Appl Hematol, Changsha, Hunan, Peoples R China.
   [You, Yaxian; Yang, Xinyuan; Hung, Dongni; Yang, Qianxi; Deng, Meichun] Cent South Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China.
   [Wu, Ting] Cent South Univ, Dept Cardiovasc Med, Xiangya Hosp 3, Changsha, Hunan, Peoples R China.
   [Deng, Meichun] Cent South Univ, Sch Life Sci, Hunan Key Lab Anim Models Human Dis, Hunan Key Lab Med Genet, Changsha, Hunan, Peoples R China.
RP Deng, MC (corresponding author), Cent South Univ, Changsha 410013, Hunan, Peoples R China.
EM dengmch@csu.edu.cn
OI , ting/0000-0003-1708-2869
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [31672290, 31100764]; Natural Science
   Foundation of Hunan Province, ChinaNatural Science Foundation of Hunan
   Province [2016JJ3180]; Open Sharing Fund for the Large--scale
   Instruments and Equipments of Central South University [CSUZC2020043];
   National Undergraduate Innovation Training Program of Central South
   University [S2020105330717]
FX This work was supported by the National Natural Science Foundation of
   China under contract (Nos. 31672290, 31100764), the Natural Science
   Foundation of Hunan Province, China (No. 2016JJ3180), Open Sharing Fund
   for the Large--scale Instruments and Equipments of Central South
   University (No. CSUZC2020043), National Undergraduate Innovation
   Training Program of Central South University (No. S2020105330717).
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346
   Chang TH, 2020, J FORMOS MED ASSOC, V119, P982, DOI 10.1016/j.jfma.2020.04.007
   Chen C, 2021, INT J INFECT DIS, V104, P458, DOI 10.1016/j.ijid.2021.01.017
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Dai JY, 2020, RISK MANAG HEALTHC P, V13, P1111, DOI 10.2147/RMHP.S257907
   Di Mascio D, 2020, J PERINAT MED, V48, P950, DOI 10.1515/jpm-2020-0355
   Dong X, 2020, ALLERGY, V75, P1699, DOI 10.1111/all.14289
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Du WJ, 2020, INFECTION, V48, P445, DOI 10.1007/s15010-020-01427-2
   Fan L, 2020, EUR RADIOL, V30, P5214, DOI 10.1007/s00330-020-06898-3
   He JJ, 2021, J MED VIROL, V93, P820, DOI 10.1002/jmv.26326
   Kang ST, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105950
   Kim Hyungjin, 2020, Radiology, V296, pE145, DOI 10.1148/radiol.2020201343
   Koh WC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240205
   Li BB, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.591132
   Li YQ, 2021, ARCH PATHOL LAB MED, V145, P39, DOI 10.5858/arpa.2020-0310-SA
   Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727
   Madewell ZJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.31756
   Meng H, 2020, J INFECTION, V81, pE33, DOI 10.1016/j.jinf.2020.04.004
   Molina LP, 2020, OBSTET GYNECOL, V136, P838, DOI 10.1097/AOG.0000000000004086
   Nagura-Ikeda M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01438-20
   Ng B H, 2020, Med J Malaysia, V75, P368
   Noor A, 2021, PEDIATR ANN, V50, pE84, DOI 10.3928/19382359-20210112-01
   Pan YF, 2020, J INFECT DIS, V221, P1940, DOI 10.1093/infdis/jiaa205
   Peterson N, 2020, CASE REP PEDIAT, V2020, DOI 10.1155/2020/8880242
   Pettirosso E, 2020, AUST NZ J OBSTET GYN, V60, P640, DOI 10.1111/ajo.13204
   Qiu XT, 2021, CLIN MICROBIOL INFEC, V27, P511, DOI 10.1016/j.cmi.2021.01.011
   Setti L, 2020, EUR J NUCL MED MOL I, V47, P1649, DOI 10.1007/s00259-020-04819-6
   Shah AS, 2020, INFECT CONT HOSP EP, V41, P1375, DOI 10.1017/ice.2020.331
   Taleghani N, 2021, BIOSENS BIOELECTRON, V174, DOI 10.1016/j.bios.2020.112830
   Tanacan A, 2020, EUR J OBSTET GYN R B, V253, P31, DOI 10.1016/j.ejogrb.2020.07.051
   Le TQM, 2020, EMERG INFECT DIS, V26, P1624, DOI 10.3201/eid2607.200591
   Udugama B, 2020, ACS NANO, V14, P3822, DOI 10.1021/acsnano.0c02624
   Verma S, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-005637
   Wang B, 2020, J MED VIROL, V92, P1684, DOI 10.1002/jmv.25946
   Wang M, 2021, BMJ SUPPORT PALLIAT, V11, P45, DOI 10.1136/bmjspcare-2020-002554
   Wang X, 2020, INT J INFECT DIS, V94, P107, DOI 10.1016/j.ijid.2020.04.023
   Wang YX, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010347
   Wellinghausen Nele, 2020, GMS Infect Dis, V8, pDoc22, DOI 10.3205/id000066
   Wu T, 2020, AGING DIS, V11, P874, DOI 10.14336/AD.2020.0520
   Wu XD, 2020, J MED VIROL, V92, P1795, DOI 10.1002/jmv.25904
   Yanes-Lane M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241536
   Yoon S, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56090474
   Yuce M, 2021, BIOSENS BIOELECTRON, V172, DOI 10.1016/j.bios.2020.112752
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zhou MY, 2020, INT J INFECT DIS, V96, P710, DOI 10.1016/j.ijid.2020.04.090
   Zhu X, 2020, BIOSENS BIOELECTRON, V166, DOI 10.1016/j.bios.2020.112437
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 49
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2045-435X
EI 2045-4368
J9 BMJ SUPPORT PALLIAT
JI BMJ Support. Palliat. Care
DI 10.1136/bmjspcare-2020-002813
EA JUL 2021
PG 8
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services
GA XK4ZB
UT WOS:000727474600001
PM 34330791
OA Bronze
DA 2022-04-20
ER

PT J
AU Kim, H
   So, KKF
   Mihalik, JB
   Lopes, AP
AF Kim, Hyunsu
   So, Kevin Kam Fung
   Mihalik, J. Brian
   Lopes, Alexia Pedo
TI Millennials' virtual reality experiences pre- and post-COVID-19
SO JOURNAL OF HOSPITALITY AND TOURISM MANAGEMENT
LA English
DT Article
DE Virtual reality; COVID-19; Possible actions; Self-location;
   Stimuli-organism-response framework; Millennials
ID VISITORS EXPERIENCE; TOURISM; COVID-19; IMPACT; TECHNOLOGIES;
   HOSPITALITY; INVARIANCE; INTENTION; BUSINESS; SERVICES
AB Drawing upon the stimuli-organism-response framework, we investigate the effects of the possible actions and self-location of virtual reality experiences on perceived enjoyment, affecting millennials' attitude changes and visit intentions. The results show a significant influence of possible actions on perceived enjoyment, leading to attitude change and visit intention, while self-location leads to perceived enjoyment and thus attitude change. Through two independent samples (i.e., pre- and post-COVID-19), we examine the moderating effects of a change in circumstances on structural relationships. Our findings suggest that self-location is critical to changing attitudes toward destinations during the pandemic. Thus, we demonstrate that VR plays a critical role in helping tourism destinations recover and building tourism resilience. This study extends current knowledge of spatial presence by examining the respective roles of self-location and possible actions in tourism destinations.
C1 [Kim, Hyunsu; Mihalik, J. Brian] Univ South Carolina, Sch Hotel Restaurant & Tourism Management, Coll Hospitality Retail & Sport Management, Close Hipp Bldg, Columbia, SC 29208 USA.
   [So, Kevin Kam Fung] Oklahoma State Univ, Sch Hospitality & Tourism Management, Spears Sch Business, 365 Nancy Randolph Bldg, Stillwater, OK 74074 USA.
   [Lopes, Alexia Pedo] Univ South Carolina, Coll Hospitality Retail & Sport Management, Dept Sport & Entertainment Management, Close Hipp Bldg, Columbia, SC 29208 USA.
RP Kim, H (corresponding author), Univ South Carolina, Sch Hotel Restaurant & Tourism Management, Coll Hospitality Retail & Sport Management, Close Hipp Bldg, Columbia, SC 29208 USA.
EM hyunsu@email.sc.edu; kevin.so@okstate.edu; bmihalik@hrsm.sc.edu;
   alexiap@email.sc.edu
OI KIM, HYUNSU/0000-0003-0103-9313
CR ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411
   Ayeh JK, 2013, TOURISM MANAGE, V35, P132, DOI 10.1016/j.tourman.2012.06.010
   Balakrishnan B, 2011, HUM-COMPUT INTERACT, V26, P161, DOI 10.1080/07370024.2011.601689
   Bogicevic V, 2019, TOURISM MANAGE, V74, P55, DOI 10.1016/j.tourman.2019.02.009
   Buhalis D, 2019, J SERV MANAGE, V30, P484, DOI 10.1108/JOSM-12-2018-0398
   Byrne B.M., 2001, STRUCTURAL EQUATION
   Byrne BM, 2004, STRUCT EQU MODELING, V11, P272, DOI 10.1207/s15328007sem1102_8
   Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1207/s15328007sem1203_7
   Choi Y, 2018, J TRAVEL TOUR MARK, V35, P320, DOI 10.1080/10548408.2017.1340224
   Chung N, 2018, J TRAVEL RES, V57, P627, DOI 10.1177/0047287517708255
   Connor P, 2020, MORE 9 IN 10 PEOPLE
   Loureiro SMC, 2013, INT J HOSP MANAG, V35, P35, DOI 10.1016/j.ijhm.2013.04.011
   DAVIS FD, 1992, J APPL SOC PSYCHOL, V22, P1111, DOI 10.1111/j.1559-1816.1992.tb00945.x
   Deloitte, 2016, AUGM VIRT REAL GO WO
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Errichiello L, 2019, INT J TOUR RES, V21, P590, DOI 10.1002/jtr.2283
   Flavian C, 2019, J BUS RES, V100, P547, DOI 10.1016/j.jbusres.2018.10.050
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Guttentag DA, 2010, TOURISM MANAGE, V31, P637, DOI 10.1016/j.tourman.2009.07.003
   Hair J.F., 1998, MULTIVARIATE DATA AN, V5th
   Hall CM, 2008, CONTEMP GEOGR LEIS T, P1
   Hao F, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102636
   Harman H.H., 1976, MODERN FACTOR ANAL
   Hartmann T, 2016, J MEDIA PSYCHOL-GER, V28, P1, DOI 10.1027/1864-1105/a000137
   Heinonen K, 2021, J SERV MANAGE, V32, P101, DOI 10.1108/JOSM-05-2020-0161
   Hew JJ, 2018, TOURISM MANAGE, V66, P121, DOI 10.1016/j.tourman.2017.10.005
   Hollebeek L, 2019, INT J CONTEMP HOSP M, V31, P4227, DOI 10.1108/IJCHM-03-2018-0256
   Howe N., 2000, MILLENNIALS RISING N
   Hsieh JK, 2017, J SERV MANAGE, V28, P866, DOI 10.1108/JOSM-03-2016-0062
   HUGHES GD, 1967, J MARKETING RES, V4, P85, DOI 10.2307/3150170
   Itani OS, 2021, TOURISM MANAGE, V84, DOI 10.1016/j.tourman.2021.104290
   Jung T., 2016, INFORM COMMUNICATION, DOI DOI 10.1007/978-3-319-28231-2_45
   Jung T, 2018, PROGR IS, P247, DOI 10.1007/978-3-319-64027-3_17
   Kim M, 2014, INT J CONTEMP HOSP M, V26, P225, DOI 10.1108/IJCHM-09-2012-0165
   Kim MJ, 2020, J TRAVEL RES, V59, P69, DOI 10.1177/0047287518818915
   Kozak M., 2000, Journal of Travel Research, V38, P260, DOI 10.1177/004728750003800308
   Lacina L., 2020, NEARLY 3000000 PEOPL
   Law R, 2014, INT J CONTEMP HOSP M, V26, P727, DOI 10.1108/IJCHM-08-2013-0367
   Lee KM, 2004, COMMUN THEOR, V14, P27, DOI 10.1093/ct/14.1.27
   Lee M, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102595
   Leung XY, 2020, INT J HOSP MANAG, V88, DOI 10.1016/j.ijhm.2019.102391
   Makransky G, 2019, LEARN INSTR, V60, P225, DOI 10.1016/j.learninstruc.2017.12.007
   Marchiori E, 2018, INF TECHNOL TOUR, V18, P133, DOI 10.1007/s40558-018-0104-0
   MARDIA KV, 1974, SANKHYA SER B, V36, P115
   Marketandmarkets, 2019, VIRT REAL MARK WORTH
   Morgan, 2015, NOWNERSHIP NO PROBLE
   Nanni A, 2021, ANN TOURISM RES, V86, DOI 10.1016/j.annals.2020.102942
   Pleyers G, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102175
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Rogers S, 2020, VIRTUAL REALITY COUL
   Russell, 1974, APPROACH ENV PSYCHOL
   Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651
   Schulz M, 2000, 2000 INTERNATIONAL CONFERENCE ON PARALLEL ARCHITECTURES AND COMPILATION TECHNIQUES, PROCEEDINGS, P271, DOI 10.1109/PACT.2000.888351
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Surovaya E, 2020, ANATOLIA, V31, P620, DOI 10.1080/13032917.2020.1808431
   Tung VWS, 2017, INT J CONTEMP HOSP M, V29, P2498, DOI 10.1108/IJCHM-09-2016-0520
   Tussyadiah IP, 2018, TOURISM MANAGE, V66, P140, DOI 10.1016/j.tourman.2017.12.003
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Vorderer P., 2004, REPORT EUROPEAN COMM
   Wei W, 2019, TOURISM MANAGE, V71, P282, DOI 10.1016/j.tourman.2018.10.024
   Weibel D, 2015, PRESENCE-TELEOP VIRT, V24, P44, DOI 10.1162/PRES_a_00214
   Westland JC, 2010, ELECTRON COMMER R A, V9, P476, DOI 10.1016/j.elerap.2010.07.003
   Williams A., 2006, International Journal of Contemporary Hospitality Management, V18, P482, DOI 10.1108/09596110610681520
   Wirth W, 2007, MEDIA PSYCHOL, V9, P493, DOI 10.1080/15213260701283079
   Yim MYC, 2012, J ADVERTISING, V41, P113, DOI 10.2753/JOA0091-3367410208
   Yung R, 2021, CURR ISSUES TOUR, V24, P1505, DOI 10.1080/13683500.2020.1820454
   Yung R, 2019, CURR ISSUES TOUR, V22, P2056, DOI 10.1080/13683500.2017.1417359
NR 67
TC 2
Z9 2
U1 11
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1447-6770
EI 1839-5260
J9 J HOSP TOUR MANAG
JI J. Hosp. Tour. Manag.
PD SEP
PY 2021
VL 48
BP 200
EP 209
DI 10.1016/j.jhtm.2021.06.008
EA JUN 2021
PG 10
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA WC5TP
UT WOS:000704320600021
DA 2022-04-20
ER

PT J
AU Kaur, I
   Sharma, A
   Jakhar, D
   Das, A
   Aradhya, SS
   Sharma, R
   Jindal, V
   Mhatre, M
AF Kaur, Ishmeet
   Sharma, Aseem
   Jakhar, Deepak
   Das, Anupam
   Aradhya, Sujala Sacchidanand
   Sharma, Rashmi
   Jindal, Veenu
   Mhatre, Madhulika
TI Coronavirus disease (COVID-19): An updated review based on current
   knowledge and existing literature for dermatologists
SO DERMATOLOGIC THERAPY
LA English
DT Review
DE coronavirus disease; COVID-19; SARS; SARS-CoV-2; MERS; acute respiratory
   distress syndrome (ARDS); pandemic; pneumonia
ID PNEUMONIA; EFFICACY; WUHAN
AB The world entered the year 2020 with reports of the emergence of a new viral illness in Wuhan city, Hubei province, China. In January 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified to be the causative novel coronavirus for the cluster of patients suffering from pneumonia in China. The disease was later named as coronavirus disease (COVID-19) and was declared a pandemic by the World Health Organization on March 11, 2020. Several studies, since then, have tried to study and explain the origin of SARS-CoV-2, its structure and pathogenicity, epidemiology, modes of transmission, spectrum of illness and causes of mortality and morbidity. The current management strategies focus on supportive care and prevention of complications. With no definite treatment, as of now, encouraging reports of some anti-viral and anti-malarial drugs in the management of COVID-19 generate some hope. This review intends to cover the current known aspects of COVID-19 and SARS-CoV-19, based on the available literature.
C1 [Kaur, Ishmeet; Jakhar, Deepak] North Delhi Municipal Corp Med Coll & Hindu Rao H, Dept Dermatol, New Delhi 110007, India.
   [Sharma, Aseem] LTM Med Coll & Gen Hosp, Dept Dermatol, Mumbai, Maharashtra, India.
   [Das, Anupam] KPC Med Coll & Hosp, Dept Dermatol, Kolkata, W Bengal, India.
   [Aradhya, Sujala Sacchidanand] Sujala Polyclin, Dept Dermatol, Bengaluru, India.
   [Sharma, Rashmi] Fortis Hosp, Dept Dermatol, New Delhi, India.
   [Jindal, Veenu] Clin Dermatech, Dept Dermatol, New Delhi, India.
   [Mhatre, Madhulika] Wockhardt Hosp, Dept Dermatol, Mumbai, Maharashtra, India.
RP Jakhar, D (corresponding author), North Delhi Municipal Corp Med Coll & Hindu Rao H, Dept Dermatol, New Delhi 110007, India.
EM dr.deepakjakhar@yahoo.in
RI Jindal, Veenu/AAL-8104-2021; Sharma, Aseem/AAF-4443-2020
OI Sharma, Aseem/0000-0001-5873-227X; Jakhar, Deepak/0000-0002-5516-8295
FU World Health OrganizationWorld Health Organization
FX World Health Organization
CR Alramthan A, 2020, CLIN EXP DERMATOL, V45, P746, DOI 10.1111/ced.14243
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2020, HAND HYG HEALTHC SET
   [Anonymous], 2020, 2020 AC M CANC REF S
   [Anonymous], 2020, RESP HYG COUGH ET HE
   [Anonymous], 2020, SEARCH COV 19 LIST R
   [Anonymous], 2020, ADVICE USE MASKS COM
   [Anonymous], SAF IMM STUD 2019 NC
   [Anonymous], 2020, PHAS 3 TRIAL EV TOC
   [Anonymous], 2020, NYTIMES
   [Anonymous], 2020, THE GUARDIAN
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Baron Rebecca M, 2016, F1000Res, V5, DOI 10.12688/f1000research.7646.1
   Baud D, 2020, JAMA-J AM MED ASSOC, V323, P2198, DOI 10.1001/jama.2020.7233
   Bellosta R, 2020, J VASC SURG, V72, P1864, DOI 10.1016/j.jvs.2020.04.483
   Bouaziz JD, 2020, J EUR ACAD DERMATOL, V34, pE451, DOI 10.1111/jdv.16544
   Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   CDC, 2020, INT GUID COLL HANDL
   Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 1
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chinese Clinical Trial Register (ChiCTR), 2020, WHO INT CLIN TRIALS
   CHINESE SME, 2004, SCIENCE, V303, P1666, DOI DOI 10.1126/SCIENCE.1092002
   ClinicalTrials.gov, TOC COVID 19 PNEUM T
   COLSON P, 2020, INT J ANTIMICROB AG, V55, DOI [10.1016/j.ijantimicag.2020.105932, DOI 10.1016/J.IJANTIMICAG.2020.105932]
   DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990
   Elston DM, 2020, J AM ACAD DERMATOL, V82, P1085, DOI 10.1016/j.jaad.2020.03.012
   Estebanez A, 2020, J EUR ACAD DERMATOL, V34, pE250, DOI 10.1111/jdv.16474
   EULAR, 2020, EULAR GUID PAT COVID
   FEHR AR, 2015, METHOD MOL BIOL, V1282, DOI [10.1007/978-1-4939-2438-7_1, DOI 10.1007/978-1-4939-2438-7_1]
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198
   Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gianotti R, 2020, J DERMATOL SCI, V98, P141, DOI 10.1016/j.jdermsci.2020.04.007
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   He ZJ, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01551-8
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huaxia, 2020, XINHUANET       0317
   Hulkower RL, 2011, AM J INFECT CONTROL, V39, P401, DOI 10.1016/j.ajic.2010.08.011
   Inui Shohei, 2020, Radiol Cardiothorac Imaging, V2, pe200110, DOI 10.1148/ryct.2020200110
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Joob B, 2020, J AM ACAD DERMATOL, V82, pE177, DOI 10.1016/j.jaad.2020.03.036
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kantor J, 2020, J AM ACAD DERMATOL, V82, P1087, DOI 10.1016/j.jaad.2020.03.013
   Kolivras Athanassios, 2020, JAAD Case Rep, V6, P489, DOI 10.1016/j.jdcr.2020.04.011
   Lan JJ, 2020, J AM ACAD DERMATOL, V82, P1215, DOI 10.1016/j.jaad.2020.03.014
   Mahallawi WH, 2018, CYTOKINE, V104, P8, DOI 10.1016/j.cyto.2018.01.025
   Meyer B, 2014, VIRUS RES, V194, P175, DOI 10.1016/j.virusres.2014.03.018
   Qin C, 2020, DYSREGULATION IMMUNE, DOI [10.2139/ssrn.3541136, DOI 10.2139/SSRN.3541136]
   Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
   SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939
   Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036
   Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010
   Tyrrell DAJ., 1996, MED MICROBIOLOGY
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Watanabe K, 2020, SOC SCI COMPUT REV, DOI 10.1177/0894439320907027
   Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005
   WHO, 2020, UPD WHO ADV INT TRAF
   WHO guidelines, 2020, TECHN GUID
   WHO (World Health Organization), 2020, COR DIS COVID 19 OUT
   Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x
   World Health Organization, 2020, WHO COR DIS COVID 19
   World Health Organization, 2020, COR DIS COVID 19 EV
   World Health Organization, 2020, GLOB SURV HUM INF CO
   World Health Organization, 2020, LAB TEST COR DIS 201
   World Health Organization (WHO), 2020, COR
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia W, 2020, PEDIATR PULM, V55, P1169, DOI 10.1002/ppul.24718
   Xie CJ, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101668
   Xu Z, 2020, EXUBERANT ELEVATION, DOI 10.1101/2020.02.11.20021493
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yan YC, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13310
   Zhang Y, 2020, Zhonghua Xue Ye Xue Za Zhi, V41, P302, DOI [10.3760/cma.j.issn.0253-2727.2020.0006, 10.3760/cma.j.issn.0253-2727.2020.008]
   Zheng Y, 2020, J EUR ACAD DERMATOL, V34, pE210, DOI 10.1111/jdv.16390
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 85
TC 12
Z9 12
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1396-0296
EI 1529-8019
J9 DERMATOL THER
JI Dermatol. Ther.
PD JUL
PY 2020
VL 33
IS 4
AR e13677
DI 10.1111/dth.13677
EA JUN 2020
PG 13
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA NL4WM
UT WOS:000543284500001
PM 32447820
OA Green Published
DA 2022-04-20
ER

PT J
AU Eibensteiner, F
   Ritschl, V
   Ariceta, G
   Jankauskiene, A
   Klaus, G
   Paglialonga, F
   Edefonti, A
   Ranchin, B
   Schmitt, CP
   Shroff, R
   Stefanidis, CJ
   Vande Walle, J
   Verrina, E
   Vondrak, K
   Zurowska, A
   Stamm, T
   Aufricht, C
AF Eibensteiner, Fabian
   Ritschl, Valentin
   Ariceta, Gema
   Jankauskiene, Augustina
   Klaus, Guenter
   Paglialonga, Fabio
   Edefonti, Alberto
   Ranchin, Bruno
   Schmitt, Claus Peter
   Shroff, Rukshana
   Stefanidis, Constantinos J.
   Vande Walle, Johan
   Verrina, Enrico
   Vondrak, Karel
   Zurowska, Aleksandra
   Stamm, Tanja
   Aufricht, Christoph
CA European Pediat Dialysis Working G
TI Rapid response in the COVID-19 pandemic: a Delphi study from the
   European Pediatric Dialysis Working Group
SO PEDIATRIC NEPHROLOGY
LA English
DT Article
DE COVID-19; Pandemic; Delphi; Dialysis; Transplantation
ID PEOPLE
AB Background COVID-19 was declared a global health emergency. Since children are less than 1% of reported cases, there is limited information to develop evidence-based practice recommendations. The objective of this study was to rapidly gather expert knowledge and experience to guide the care of children with chronic kidney disease during the COVID-19 pandemic. Methods A four-round multi-center Delphi exercise was conducted among 13 centers in 11 European countries of the European Pediatric Dialysis Working Group (EPDWG) between March, 16th and 20th 2020. Results were analyzed using a mixed methods qualitative approach and descriptive statistics. Results Thirteen COVID-19 specific topics of particular need for guidance were identified. Main themes encompassed testing strategies and results (n = 4), changes in use of current therapeutics (n = 3), preventive measurements of transmission and management of COVID-19 (n = 3), and changes in standard clinical care (n = 3). Patterns of center-specific responses varied according to regulations and to availability of guidelines. Conclusions As limited quantitative evidence is available in real time during the rapid spread of the COVID-19 pandemic, qualitative expert knowledge and experience represent the best evidence available. This Delphi exercise demonstrates that use of mixed methodologies embedded in an established network of experts allowed prompt analysis of pediatric nephrologists' response to COVID-19 during this fast-emerging public health crisis. Such rapid sharing of knowledge and local practices is essential to timely and optimal guidance for medical management of specific patient groups in multi-country health care systems such as those of Europe and the US.
C1 [Eibensteiner, Fabian; Aufricht, Christoph] Med Univ Vienna, Comprehens Ctr Pediat, Div Pediat Nephrol & Gastroenterol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
   [Ritschl, Valentin; Stamm, Tanja] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Outcomes Res, Vienna, Austria.
   [Ariceta, Gema] Univ Hosp Vall dHebron, Dept Pediat Nephrol, Barcelona, Spain.
   [Jankauskiene, Augustina] Vilnius Univ, Pediat Ctr, Inst Clin Med, Vilnius, Lithuania.
   [Klaus, Guenter] KfH Childrens Kidney Ctr, Dept Pediat Nephrol, Marburg, Germany.
   [Paglialonga, Fabio; Edefonti, Alberto] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Pediat Nephrol Dialysis & Transplant Unit, Milan, Italy.
   [Ranchin, Bruno] Hosp Civils Lyon, Hop Femme Mere Enfant, Dept Pediat Nephrol, Lyon, France.
   [Schmitt, Claus Peter] Ctr Child & Adolescent Med, Pediat Nephrol, Heidelberg, Germany.
   [Shroff, Rukshana] UCL Great Ormond St Hosp Children NHS Fdn Trust, Renal Unit, London, England.
   [Shroff, Rukshana] Inst Child Hlth, London, England.
   [Stefanidis, Constantinos J.] Mitera Childrens Hosp, Dept Pediat Nephrol, Athens, Greece.
   [Vande Walle, Johan] Univ Ziekenhuis Gent, Utoped, Dept Pediat Nephrol, Ghent, Belgium.
   [Verrina, Enrico] IRCCS Giannina Gaslini, Dialysis Unit, Dept Pediat, Genoa, Italy.
   [Vondrak, Karel] Univ Hosp Motol, Dept Pediat Nephrol, Prague, Czech Republic.
   [Zurowska, Aleksandra] Med Univ Gdansk, Dept Pediat Nephrol, Gdansk, Poland.
RP Aufricht, C (corresponding author), Med Univ Vienna, Comprehens Ctr Pediat, Div Pediat Nephrol & Gastroenterol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM christoph.aufricht@meduniwien.ac.at
RI Ritschl, Valentin/ABB-1538-2020; Shroff, Rukshana/AAG-5383-2019; Vande
   Walle, Johan/AAG-3858-2020; Stefanidis, Constantinos J./AEW-8891-2022;
   Paglialonga, Fabio/AAC-6684-2022; Zurowska, Aleksandra/AAA-3131-2021
OI Ritschl, Valentin/0000-0001-8763-8215; Shroff,
   Rukshana/0000-0001-8501-1072; Vande Walle, Johan/0000-0001-9700-5358;
   Stefanidis, Constantinos J./0000-0002-6342-4877; Zurowska,
   Aleksandra/0000-0002-3354-5344; Eibensteiner, Fabian/0000-0001-5012-3082
FU Medical University of Vienna
FX Open access funding provided by Medical University of Vienna.
CR American Society of Transplantation (AST), COR DIS 2019 COVID 1
   [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   [Anonymous], 2019, COVID 19 TRANSPL CLI
   [Anonymous], STAT ADDR CONC RE US
   Bauernfeind B, 2009, ARTHRIT RHEUM-ARTHR, V61, P21, DOI 10.1002/art.24165
   Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   European Centre for Disease Prevention and Control (ECDC), QUEST ANSW COVID 19
   European Centre for Disease Prevention and Control (ECDC), 2020, COVID 19 SIT UPD WOR
   European Renal Association-European Dialysis and Transplant Association (ERA-EDTA), NEWS INF ERA EDTA CO
   European Society of Cardiology (ESC), POS STAT ESC COUNC H
   European Society of Organ Transplantation (ESOT), STAT COVID 19 OUTBR
   Federal Ministry Repbulic of Austria, HLTH CAR CONS PROT C
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   GOODMAN CM, 1987, J ADV NURS, V12, P729, DOI 10.1111/j.1365-2648.1987.tb01376.x
   He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766
   Hoffman JM, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-0496
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ji LN, 2020, WORLD J PEDIATR, V16, P267, DOI 10.1007/s12519-020-00356-2
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Merandi J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0018
   Michaels MG, 2020, AM J TRANSPLANT, V20, P1768, DOI 10.1111/ajt.15832
   Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633
   Naicker S, 2020, KIDNEY INT, V97, P824, DOI 10.1016/j.kint.2020.03.001
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Ritschl V, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1732-7
   Stamm TA, 2011, ANN RHEUM DIS, V70, P1074, DOI 10.1136/ard.2010.148767
   Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018
   Turoff M, 1975, DELPHI METHOD TECHNI
   Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wei M, 2020, JAMA-J AM MED ASSOC, V323, P1313, DOI 10.1001/jama.2020.2131
   Weiss P, 2020, LANCET, V395, P1014, DOI 10.1016/S0140-6736(20)30633-4
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia W, 2020, PEDIATR PULM, V55, P1169, DOI 10.1002/ppul.24718
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 39
TC 7
Z9 8
U1 3
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0931-041X
EI 1432-198X
J9 PEDIATR NEPHROL
JI Pediatr. Nephrol.
PD SEP
PY 2020
VL 35
IS 9
BP 1669
EP 1678
DI 10.1007/s00467-020-04584-6
EA MAY 2020
PG 10
WC Pediatrics; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics; Urology & Nephrology
GA MQ4WD
UT WOS:000533164100001
PM 32418146
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Zielinski, S
   Botero, CM
AF Zielinski, Seweryn
   Botero, Camilo M.
TI Beach Tourism in Times of COVID-19 Pandemic: Critical Issues, Knowledge
   Gaps and Research Opportunities
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE SARS-CoV-2; coronavirus; beach management; tourist beach; crisis
ID QUATERNARY AMMONIUM-COMPOUNDS; HEALTH-RISK; CARRYING-CAPACITY; HUMAN
   ADENOVIRUS; MARINE LITTER; POLYOMAVIRUS; TOXICITY; NITEROI; QUALITY;
   URBAN
AB The strict quarantine measures employed as a response to the COVID-19 pandemic have led the global tourism industry to a complete halt, disrupting the livelihoods of millions. The economic importance of beach tourism for many destinations has led many governments to reopen tourist beaches, as soon as the number of infection cases decreased. The objective of this paper is to provide a scientific basis for understanding the key issues for beach tourism management in these circumstances. These issues include risk perception, environmental considerations directly related to beaches and COVID-19, and management strategies designed to limit the risk of contagion on the beach. The contribution of this paper lies in its interdisciplinary approach to delivering the findings from the latest studies, highly relevant for beach tourism, in psychology, health science, and environmental science (often in preprint and in press format). Particular attention was given to identifying the knowledge gaps evident in the areas of COVID-19 risk perception, with the drivers explaining the risk-taking behavior and the protective strategies employed by beachgoers. Gaps were also found in areas such as the presence of SARS-CoV-2 in bathing waters and the sand, the potential of contaminated sand being a viable route of transmission, and the impact of the use of chemical disinfectants on the marine environment and on bathers. The paper identifies research prospects in these areas, additionally pointing out other questions such as new carrying capacity methods, the opportunity given by COVID-19 in estimation of the impacts of visitation and beach-litter.
C1 [Zielinski, Seweryn] Sejong Univ, Dept Hospitality & Tourism Management, 209 Neungdong Ro, Seoul 05006, South Korea.
   [Botero, Camilo M.] Playas Corp, Grp Invest Sistemas Costeros, Calle 19 8-44, Santa Marta 050022, Colombia.
RP Zielinski, S (corresponding author), Sejong Univ, Dept Hospitality & Tourism Management, 209 Neungdong Ro, Seoul 05006, South Korea.
EM zielinski@sejong.ac.kr; playascol@gmail.com
RI Botero, Camilo/ABC-5309-2021
OI Botero, Camilo/0000-0001-6886-8920; Zielinski,
   Seweryn/0000-0002-8125-6758
FU Sejong University
FX This work was supported by the faculty research fund of Sejong
   University in 2020.
CR Ahmed W, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138764
   Ayittey FK, 2020, J MED VIROL, V92, P473, DOI 10.1002/jmv.25706
   Baker N, 2020, PHARM RES-DORDR, V37, DOI 10.1007/s11095-020-02842-8
   de Araujo MCB, 2007, WASTE MANAGE, V27, P833, DOI 10.1016/j.wasman.2006.04.018
   Benaim R.D, PLEXIGLASS BARRIERS
   Berger M, WORLDS BEACHES ARE R
   Bhowmick GD, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-0079-1
   Biggs D, 2012, J SUSTAIN TOUR, V20, P645, DOI 10.1080/09669582.2011.630080
   BOETHLING RS, 1984, WATER RES, V18, P1061, DOI 10.1016/0043-1354(84)90220-3
   Boevers J, 2008, COAST MANAGE, V36, P524, DOI 10.1080/08920750802398776
   Bonadonna L, 2019, MAR POLLUT BULL, V149, DOI 10.1016/j.marpolbul.2019.110570
   Botero C.M, 2020, ANALISIS GEN RECOMEN, P10
   Botero CM, 2020, TOUR MANAG PERSPECT, V35, DOI 10.1016/j.tmp.2020.100691
   Braga F, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139612
   Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8
   Broom D, BELGIUM EASES LOCKDO
   Brouder P, 2020, TOURISM GEOGR, V22, P484, DOI 10.1080/14616688.2020.1760928
   Buer AL, 2018, MAR POLLUT BULL, V135, P1055, DOI 10.1016/j.marpolbul.2018.08.048
   Chen CL, 2016, MAR POLICY, V74, P213, DOI 10.1016/j.marpol.2016.09.030
   Chen M, 2006, LINKING FORMAL INFOR, P75, DOI DOI 10.1093/0199204764.003.0005
   Clifford C, WATER VENICE ITALYS
   Clifford M, CORONAVIRUS BARCELON
   Cooper M., 2005, Journal of Travel & Tourism Marketing, V19, P117, DOI 10.1300/J073v19n02_10
   Cori L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093114
   Couto G, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187612
   CSIC, 2020, INF TRANSM SARS COV
   da Silva CP, 2002, J COASTAL RES, P190
   da Silva ML, 2015, MAR POLLUT BULL, V92, P233, DOI 10.1016/j.marpolbul.2014.12.036
   Daventry M, CROWDS FLOCK PORTUGA
   de Bruin WB, 2020, AM J PREV MED, V59, P157, DOI 10.1016/j.amepre.2020.05.001
   DeClerq K., ONTARIO PREMIER SHOC
   Dias J, 2018, MAR POLLUT BULL, V133, P240, DOI 10.1016/j.marpolbul.2018.05.031
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Eregno FE, 2016, SCI TOTAL ENVIRON, V548, P270, DOI 10.1016/j.scitotenv.2016.01.034
   Everingham P, 2020, TOURISM GEOGR, V22, P555, DOI 10.1080/14616688.2020.1762119
   Farzan A.N, MASKS GLOVES ARE USE
   Fernandino G, 2020, TURISMO SOL PLAYA CO, P68
   Filimonau V, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102659
   Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7
   Foo LP, 2021, CURR ISSUES TOUR, V24, P2735, DOI 10.1080/13683500.2020.1777951
   France A., 2000, J YOUTH STUD, V3, P317, DOI [10.1080/713684380, DOI 10.1080/713684380]
   Frishberg H, LITTERED MASKS GLOVE
   Gaffney C, 2020, J LAT AM GEOGR, V19, P308, DOI 10.1353/lag.2020.0054
   Galvani A, 2020, TOURISM GEOGR, V22, P567, DOI 10.1080/14616688.2020.1760924
   Gerhold L., 2020, PSYARXIV, DOI [10.31234/osf.io/xmpk4, DOI 10.31234/OSF.IO/XMPK4]
   Giannopoulos D, CORONAVIRUS DISCARDE
   Gispert B, PLAYAS LIBRES CORONA
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Grech V, 2020, INT J RISK SAF MED, V31, P121, DOI 10.3233/JRS-200042
   Guix, 2020, SENTINEL SURVEILLANC, DOI [10.1101/ 2020.06.13.20129627, 10.1101/2020.06.13.20129627, DOI 10.1101/2020.06.13.20129627]
   Gursoy D, 2020, 2 WHEN WASH STAT U C
   Gursoy D, 2020, J HOSP MARKET MANAG, V29, P527, DOI 10.1080/19368623.2020.1788231
   Hall CM, 2020, TOURISM GEOGR, V22, P577, DOI 10.1080/14616688.2020.1759131
   Hall L, GOING ROUND CIRCLES
   Hao F, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102636
   Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5
   Hewitt J, 2013, WATER RES, V47, P6750, DOI 10.1016/j.watres.2013.09.001
   Horobin J, WORLD EC CRASH SPARK
   Hsiang S, 2020, NATURE, V585, pE7, DOI [10.1038/s41586-020-2404-8, 10.1038/s41586-020-2691-0]
   Ioannides D, 2020, TOURISM GEOGR, V22, P624, DOI 10.1080/14616688.2020.1763445
   Jamal T, 2020, J TOUR FUTURES, V6, P181, DOI 10.1108/JTF-02-2020-0014
   Jiang YY, 2020, INT J CONTEMP HOSP M, V32, P2563, DOI 10.1108/IJCHM-03-2020-0237
   Joffe H, 2003, BRIT J SOC PSYCHOL, V42, P55, DOI 10.1348/014466603763276126
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Khosravi M, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7856
   Kim SeongSeop [Kim S. S. S.], 2005, Asia Pacific Journal of Tourism Research, V10, P369, DOI 10.1080/10941660500363694
   Kitajima M, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.139076
   Klemes JJ, 2020, RENEW SUST ENERG REV, V127, DOI 10.1016/j.rser.2020.109883
   Kuper-Smith B.J., 2020, OPTIMISTIC BELIEFS P, DOI [10.31234/osf.io/epcyb, DOI 10.31234/OSF.IO/EPCYB]
   La Rosa G, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139652
   Laglbauer BJL, 2014, MAR POLLUT BULL, V89, P356, DOI 10.1016/j.marpolbul.2014.09.036
   Lodder W, 2020, LANCET GASTROENTEROL, V5, P533, DOI 10.1016/S2468-1253(20)30087-X
   Luscombe R, FLORIDA ENDANGERED S
   Malik MO, 2021, PROD PLAN CONTROL, V32, P1020, DOI 10.1080/09537287.2020.1784481
   Manandhar S, 2020, N AM ACAD RES, V3, P473, DOI DOI 10.5281/ZENODO.3690311
   Maziane F, 2018, MAR POLLUT BULL, V128, P1, DOI 10.1016/j.marpolbul.2017.12.067
   Medema G, 2020, ENVIRON SCI TECH LET, V7, P511, DOI 10.1021/acs.estlett.0c00357
   Meisenzahl M, THESE PLEXIGLASS BOX
   Mestanza-Ramon C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083468
   Ministry of Health, 2020, REC AP PLAYAS ZON BA
   Napierala T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114697
   Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006
   Ormaza-Gonzalez, 2020, COVID 19 IMPACTS BEA, DOI [10.20944/preprints202006.0186.v1., DOI 10.20944/PREPRINTS202006.0186.V1, 10.20944/preprints202006.0186.v1]
   Penza N, DOZENS OVERCROWDED S
   Pound P, 2015, HEALTH SOCIOL REV, V24, P64, DOI 10.1080/14461242.2015.1008537
   Prevenios M, 2018, MAR POLLUT BULL, V129, P448, DOI 10.1016/j.marpolbul.2017.10.013
   Prideaux B, 2020, TOURISM GEOGR, V22, P667, DOI 10.1080/14616688.2020.1762117
   Qiu RTR, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102994
   Quilliam RS, 2020, ENVIRON INT, V140, DOI 10.1016/j.envint.2020.105790
   Rech S, 2014, MAR POLLUT BULL, V82, P66, DOI 10.1016/j.marpolbul.2014.03.019
   Renaud L, 2020, TOURISM GEOGR, V22, P679, DOI 10.1080/14616688.2020.1762116
   Rhodes T, 1997, SOCIOL HEALTH ILL, V19, P208, DOI 10.1111/1467-9566.ep10934410
   Roca E, 2008, OCEAN COAST MANAGE, V51, P314, DOI 10.1016/j.ocecoaman.2007.09.001
   Rosemberg MAS, 2020, OCCUP MED-OXFORD, V70, P382, DOI 10.1093/occmed/kqaa053
   Sah R, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa105
   Gine DS, 2018, PROF GEOGR, V70, P412
   Shin H, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102664
   Simeonova A, 2019, WASTE MANAGE, V84, P182, DOI 10.1016/j.wasman.2018.11.001
   Slovic P., 2010, FEELING RISK NEW PER
   Taylor E, SPANISH BEACHES HAVE
   UNWTO, NEW DAT SHOWS IMP CO
   Valdelamar-Villegas J.C, 2020, TURISMO SOL PLAYA CO, P84
   Valle A.S.D, TOURISM IND IMPACT C
   Van de Voorde A, 2012, ENVIRON POLLUT, V164, P150, DOI 10.1016/j.envpol.2012.01.037
   van der Bles AM, 2020, P NATL ACAD SCI USA, V117, P7672, DOI 10.1073/pnas.1913678117
   Viga Gaier R, BRAZILIANS FLOCK BEA
   Wen J, 2021, TOUR RECREAT RES, V46, P310, DOI 10.1080/02508281.2020.1761120
   WHO-World Health Organization, 2020, OP CONS COVID 19 MAN
   Williams A.T., 2009, BEACH MANAGEMENT PRI
   Wise T., 2020, CHANGES RISK PERCEPT, DOI [10.31234/osf.io/dz428., DOI 10.31234/OSF.IO/DZ428, 10.1098/rsos.200742]
   Roig-Munar FX, 2018, COAST RES LIBR, V24, P545, DOI 10.1007/978-3-319-58304-4_26
   Yeh SS, 2021, TOUR RECREAT RES, V46, P188, DOI 10.1080/02508281.2020.1805933
   Zambrano-Monserrate MA, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138813
   Zhang C, 2015, SCI TOTAL ENVIRON, V518, P352, DOI 10.1016/j.scitotenv.2015.03.007
   Zielinski S, 2020, CURR ISSUES TOUR, V23, P723, DOI 10.1080/13683500.2018.1543254
   Zielinski S, 2019, MAR POLLUT BULL, V139, P390, DOI 10.1016/j.marpolbul.2018.12.027
   Zielinski S, 2015, J SUSTAIN TOUR, V23, P1550, DOI 10.1080/09669582.2015.1047376
NR 117
TC 23
Z9 23
U1 16
U2 34
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD OCT
PY 2020
VL 17
IS 19
AR 7288
DI 10.3390/ijerph17197288
PG 19
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA ON5OC
UT WOS:000586749100001
PM 33036176
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Pounder, P
AF Pounder, Paul
TI Leadership and information dissemination: challenges and opportunities
   in COVID-19
SO INTERNATIONAL JOURNAL OF PUBLIC LEADERSHIP
LA English
DT Article; Early Access
DE Caribbean; Health; Information; Leadership; COVID-19
ID CRISIS MANAGEMENT; PERSONALITY; KNOWLEDGE; COGNITION; TUSKEGEE; IMPACT
AB Purpose The purpose of this paper is to explore leadership and information dissemination during a crisis like COVID-19. The article reviews the information produced and published during the crisis. The author proposes a typology of information and categorizes messages based on their contextualization within the Caribbean environment. Design/methodology/approach The research method is developed around three main stages: a review of literature on leadership and information dissemination; synthesis of information to inform the typology; and discussion of the information reflecting the interplay between leadership and information dissemination. Findings The literature shows a legacy of deceit that dominates the history of healthcare for Blacks and Caribbean people. This heritage has helped to fashion individual attitudes toward the COVID-19 pandemic in the Caribbean. The research also highlights that in addressing the several typologies of information, varying leadership styles came to bare. The democratic leadership style was the most dominant among the Caribbean countries, while some illustrations of autocratic leadership were visible. Other leadership facets and traits fashion responses by the leaders in managing information dissemination during the crisis. The paper also observes a triangular system of information which highlights where influences exist between relationships (governments, media/NGOs and society) and how such relationships lend to shaping the behavior of others. Research limitations/implications Limitations on the research are based on the author's philosophy and interpretation. In addition, much of the information surrounding COVID-19 is novel and hence difficult to fact-check because of the unique nature of COVID-19. Practical implications This paper provides a better understanding of the typology of information during a crisis like COVID-19. The discussion on leveraging leadership strategy and competencies for dissemination of information during a crisis provides an optimistic perspective to guide leaders in managing information dissemination during a crisis. Social implications The typology is helpful in delineating the way society interprets information based on other crisis. It also helps with assessing the leadership styles and understanding potential tailor-made strategies. Originality/value The development of an information typology that provides insight into the influence that historical perspectives give to interpreting information in a health crisis in a Caribbean context. The research also looks at the strategies pursued by Caribbean leaders as they adopt novel and promising techniques to communicate during a crisis.
C1 [Pounder, Paul] St Georges Univ, Dept Business & Management, St Georges, Grenada.
RP Pounder, P (corresponding author), St Georges Univ, Dept Business & Management, St Georges, Grenada.
EM ppounder@sgu.edu
CR Alonso-Galban P, 2020, MEDICC REV, V22, P45, DOI 10.37757/MR2020.V22.N2.12
   Alvesson M., 2014, UNDERSTANDING ORG CU, Vsecond, DOI [10.4135/9781446280072, DOI 10.4135/9781446280072]
   Amabile TM, 2004, LEADERSHIP QUART, V15, P5, DOI 10.1016/j.leaqua.2003.12.003
   Bennett R., 2021, BARBADOS TODAY 0218
   Betancourt JR, 2017, HEALTH AFFAIR, V36, P1095, DOI 10.1377/hlthaff.2017.0022
   Boin A, 2003, PUBLIC ADMIN REV, V63, P544, DOI 10.1111/1540-6210.00318
   Boin A., 2007, HDB DISASTER RES, P42, DOI DOI 10.1007/978-0-387-32353-4
   Boin A, 2010, PUBLIC ADMIN, V88, P706, DOI 10.1111/j.1467-9299.2010.01836.x
   Bono JE, 2004, J APPL PSYCHOL, V89, P901, DOI 10.1037/0021-9010.89.5.901
   Bowen GA, 2009, QUAL RES J, V9, P27, DOI 10.3316/QRJ0902027
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   British High Commission, 2021, ST LUCIA TIMES 0217
   Carrington O., 2020, CNC3 NEWS 0421
   Chabrol D., 2021, NEW COVID 19 VARIANT
   Clarke S., 2020, NATIONNEWS 1220
   Coombs W.T., 2012, HDB CRISIS COMMUNICA, P54, DOI 10.1002/9781444314885.ch2
   Coughlin SS, 1996, AM J PREV MED, V12, P242, DOI 10.1016/S0749-3797(18)30319-2
   DuBrin A., 2010, LEADERSHIP RES FINDI, V6th
   Euwema MC, 2007, J ORGAN BEHAV, V28, P1035, DOI 10.1002/job.496
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387
   Fiaz M., 2017, J DEV AREAS, V51, P143, DOI DOI 10.1353/jda.2017.0093
   Garavaglia C, 2021, EURASIAN GEOGR ECON, V62, P76, DOI 10.1080/15387216.2020.1845222
   Gill R, 2006, THEORY PRACTICE LEAD
   Goodman J, 2020, BBC NEWS
   Hansson S, 2021, J RISK RES, V24, P380, DOI 10.1080/13669877.2020.1871058
   Hartley J, 2018, INT J PUBLIV LEADERS, V14, P202, DOI 10.1108/IJPL-09-2018-0048
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Hittle B, 2011, MANAGE DECIS, V49, P1182, DOI 10.1108/00251741111151208
   Holloway I., 2003, QUALITATIVE RES, V3, P345, DOI DOI 10.1177/1468794103033004
   Hunter D., 2006, BUS REV, V5, P44
   James EH, 2011, ACAD MANAG ANN, V5, P455, DOI 10.1080/19416520.2011.589594
   Kelle U., 2011, SAGE HDB GROUNDED TH, P191
   Kirkpatick S.A., 1991, ACAD MANAGEMENT EXEC, V5, P48, DOI DOI 10.5465/AME.1991.4274679
   Koehn, 2020, HARVARD BUS REV
   Kuczmarski S., 1995, VALUES BASED LEADERS
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Lee KL, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00709-0
   MacNeil W, 2007, J EDUC ENQ, V7, P64
   Mas-Coma S, 2020, ONE HEALTH-AMSTERDAM, V9, DOI 10.1016/j.onehlt.2020.100132
   Moloney A., 2020, NEWSAMERICAS 0729
   Mottley M.A., 2020, PM ANNOUNCES PHASED
   Mumford MD, 2007, LEADERSHIP QUART, V18, P515, DOI 10.1016/j.leaqua.2007.09.002
   Mumford MD, 2015, LEADERSHIP QUART, V26, P301, DOI 10.1016/j.leaqua.2015.03.005
   Muthuswamy V, 2005, INDIAN J MED RES, V121, P601
   Myers M. D., 2007, Information and Organization, V17, P2, DOI 10.1016/j.infoandorg.2006.11.001
   Noftle EE, 2006, J RES PERS, V40, P179, DOI 10.1016/j.jrp.2004.11.003
   Northouse PG., 2016, LEADERSHIP THEORY PR
   O'Leary Z., 2014, ESSENTIAL GUIDE DOIN, V2nd
   OGAWA RT, 1995, EDUC ADMIN QUART, V31, P224, DOI 10.1177/0013161X95031002004
   Porter-O'Grady T, 2003, J NURS ADMIN, V33, P105, DOI 10.1097/00005110-200302000-00007
   Pounder P, 2021, INT J PUBLIV LEADERS, V17, P118, DOI 10.1108/IJPL-08-2020-0085
   Pounder P, 2020, INT J PUBLIV LEADERS, V16, P125, DOI 10.1108/IJPL-01-2019-0001
   Ratzan SC, 2014, J HEALTH COMMUN, V19, P1213, DOI 10.1080/10810730.2014.977680
   Rice R.E., 2001, ACCESSING BROWSING I
   Robson C., 2002, REAL WORLD RES RESOU
   Sayegh L., 2004, HUM RESOUR MANAG REV, V14, P179, DOI [https://doi.org/10.1016/j.hrmr.2004.05.002, DOI 10.1016/J.HRMR.2004.05.002]
   Schwantes M, 2020, 4 SIGNS INSTANTLY ID
   Sellnow T.L., 2013, THEORIZING CRISIS CO
   Semrau M, 2015, EPIDEMIOL PSYCH SCI, V24, P382, DOI 10.1017/S2045796015000359
   Setoya Yutaro, 2018, BJPsych Int, V15, P27, DOI 10.1192/bji.2017.16
   Shaibu S, 2007, NURS ETHICS, V14, P503, DOI 10.1177/0969733007077884
   Shavers VL, 2000, J NATL MED ASSOC, V92, P563
   Thornton J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1401
   Toppin S., 2021, NATION NEWSPAPE 0124
   Ulmer RR, 2012, MANAGE COMMUN Q, V26, P523, DOI 10.1177/0893318912461907
   UNESCO, 2020, SMALL CAR ISL PREP F
   Wanjawa E.W., 2021, THERE ARE MANY REASO
   Warren M. A., 2020, INT J WELLBEING, V10, P1, DOI DOI 10.5502/IJW.V10I3.1357
   Wilson S, 2019, ALTERNATIVE, V15, P3, DOI 10.1177/1177180118803692
   Wooten LP, 2008, ADV DEV HUM RESOUR, V10, P352, DOI 10.1177/1523422308316450
   Yang IJ, 2015, J MANAG DEV, V34, P1246, DOI 10.1108/JMD-02-2015-0016
NR 71
TC 0
Z9 0
U1 3
U2 3
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2056-4929
EI 2042-8642
J9 INT J PUBLIV LEADERS
JI Int. J. Public Leadersh.
DI 10.1108/IJPL-05-2021-0030
EA JAN 2022
PG 22
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA YT1LE
UT WOS:000751128200001
DA 2022-04-20
ER

PT J
AU Han, H
   Lee, S
   Kim, JJ
   Ryu, HB
AF Han, Heesup
   Lee, Soyeun
   Kim, Jinkyung Jenny
   Ryu, Hyungseo Bobby
TI Coronavirus Disease (COVID-19), Traveler Behaviors, and International
   Tourism Businesses: Impact of the Corporate Social Responsibility (CSR),
   Knowledge, Psychological Distress, Attitude, and Ascribed Responsibility
SO SUSTAINABILITY
LA English
DT Article
DE coronavirus disease (COVID-19) pandemic; corporate social responsibility
   of international tourism businesses; traveler behavior; psychological
   distress; attitude; knowledge; ascription of responsibility
ID INTENTIONS; AWARENESS; HOTELS
AB The international tourism industry is among the hardest-hit by the coronavirus disease (COVID-19). Due to this tourism crisis, this research attempted to uncover the possible influence of the corporate social responsibility efforts of the international tourism businesses and of the knowledge of COVID-19 on the US travelers' decision formation for international tourism products. A quantitative approach and survey methodology were used. The findings revealed that corporate social responsibility improves travelers' attitudes and behavioral intentions. In addition, the travelers' knowledge perception of COVID-19 was significantly associated with their psychological distress. Decreasing this psychological distress related to overseas tourism was of importance to boost a positive attitude toward international traveling, which directly leads to increased behavioral intentions. Testing for the metric invariance revealed that an association between the corporate social responsibility and intentions was only significant when the travelers strongly felt an ascription of responsibility for the COVID-19 outbreak and the pandemic. The theoretical uses and the practical values of this research are discussed.
C1 [Han, Heesup; Lee, Soyeun] Sejong Univ, Coll Hospitality & Tourism Management, 98 Gunja Dong, Seoul 05006, South Korea.
   [Kim, Jinkyung Jenny] Youngsan Univ, Sch Hotel & Tourism Management, 142 Bansong Beltway, Busan 48015, South Korea.
   [Ryu, Hyungseo Bobby] Kyungnam Univ, Food Franchise Dept, Coll Hlth Sci, 7 Kyungnamdaehak Ro, Changwon Si 51767, Gyeongsangnam D, South Korea.
RP Ryu, HB (corresponding author), Kyungnam Univ, Food Franchise Dept, Coll Hlth Sci, 7 Kyungnamdaehak Ro, Changwon Si 51767, Gyeongsangnam D, South Korea.
EM heesup.han@gmail.com; lsy2you82@hotmail.com; jennykim1120@gmail.com;
   bobbyryu@kyungnam.ac.kr
OI Han, Heesup/0000-0001-6356-3001; lee, soyeun/0000-0001-7129-6708
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I, 2019, PSYCHOL REV, V126, P774, DOI 10.1037/rev0000155
   Boo S, 2013, J SUSTAIN TOUR, V21, P1129, DOI 10.1080/09669582.2012.750327
   Brody C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2814-6
   Carroll A.B., 1991, BUS HORIZONS, V34, P39, DOI [10.1016/0007-6813(91)90005-G, DOI 10.1016/0007-6813(91)90005-G]
   Chan ESW, 2014, INT J HOSP MANAG, V40, P20, DOI 10.1016/j.ijhm.2014.03.001
   Chiodini J, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101824
   De Groot JIM, 2009, J SOC PSYCHOL, V149, P425, DOI 10.3200/SOCP.149.4.425-449
   De Vos Jonas, 2020, Transp Res Interdiscip Perspect, V5, P100121, DOI 10.1016/j.trip.2020.100121
   Feng LS, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113202
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Grover S, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102147
   Hair J.F., 2010, MULTIVAR DATA ANAL, P600
   Han H, 2020, BUS STRATEG ENVIRON, V29, P2815, DOI 10.1002/bse.2545
   Han H, 2019, J TRAVEL TOUR MARK, V36, P371, DOI 10.1080/10548408.2018.1557580
   Han H, 2018, BUS STRATEG ENVIRON, V27, P1302, DOI 10.1002/bse.2179
   Han H, 2017, J SUSTAIN TOUR, V25, P1240, DOI 10.1080/09669582.2016.1259318
   Han H, 2015, INT J HOSP MANAG, V46, P1, DOI 10.1016/j.ijhm.2015.01.002
   Hong Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103747
   Kim J, 2020, J HOSP TOUR MANAG, V45, P67, DOI 10.1016/j.jhtm.2020.07.008
   Kuhzady S, 2020, J HOSP TOUR MANAG, V44, P131, DOI 10.1016/j.jhtm.2020.05.002
   Lee SY, 2018, J TRAVEL TOUR MARK, V35, P988, DOI 10.1080/10548408.2018.1468852
   Leonard, 1977, ADV EXPT SOCIAL PSYC, P221, DOI [DOI 10.1016/S0065-2601(08)60358-5, 10.1016/s0065-2601(08)60358-5, 10.1016/S0065-2601(08)60358-5]
   Li YQ, 2019, TOURISM MANAGE, V72, P170, DOI 10.1016/j.tourman.2018.10.031
   Lo A, 2020, J TRAVEL TOUR MARK, V37, P185, DOI 10.1080/10548408.2020.1740140
   Losda-Baltar A., 2020, J GERONTOL B-PSYCHOL, DOI 10.1093/geronb/gbaa04832282920
   Maniga P., IMPACT COVID 19 TOUR
   Namikawa Kyoko, 2008, Travel Med Infect Dis, V6, P137, DOI 10.1016/j.tmaid.2008.01.013
   Oliver RichardL, 2010, SATISFACTION BEHAV P, V2nd ed.
   Onwezen MC, 2013, J ECON PSYCHOL, V39, P141, DOI 10.1016/j.joep.2013.07.005
   Park E, 2019, J RETAIL CONSUM SERV, V47, P215, DOI 10.1016/j.jretconser.2018.11.013
   Perugini M, 2001, BRIT J SOC PSYCHOL, V40, P79, DOI 10.1348/014466601164704
   Schultz PW, 1998, J CROSS CULT PSYCHOL, V29, P540, DOI 10.1177/0022022198294003
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Steg L, 2010, BRIT J SOC PSYCHOL, V49, P725, DOI 10.1348/014466609X477745
   Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175
   Su LJ, 2017, J TRAVEL TOUR MARK, V34, P488, DOI 10.1080/10548408.2016.1193101
   Tola HH, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29019
   UNWTO, TOUR NUMB COULD FALL
   VINING J, 1992, J APPL SOC PSYCHOL, V22, P1580, DOI 10.1111/j.1559-1816.1992.tb01758.x
   Williams Y., WHAT IS PSYCHOL DIST
   Wong AKF, 2020, INT J HOSP MANAG, V87, DOI 10.1016/j.ijhm.2020.102507
   World Health Organization, COR DIS COVID 19 DAS
   Zhu S, 2020, BRAIN BEHAV IMMUN, V87, P56, DOI 10.1016/j.bbi.2020.04.045
NR 44
TC 10
Z9 10
U1 14
U2 34
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD OCT
PY 2020
VL 12
IS 20
AR 8639
DI 10.3390/su12208639
PG 18
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA OI2UZ
UT WOS:000583141500001
OA gold
DA 2022-04-20
ER

PT J
AU Brakefield, WS
   Ammar, N
   Olusanya, OA
   Shaban-Nejad, A
AF Brakefield, Whitney S.
   Ammar, Nariman
   Olusanya, Olufunto A.
   Shaban-Nejad, Arash
TI An Urban Population Health Observatory System to Support COVID-19
   Pandemic Preparedness, Response, and Management: Design and Development
   Study
SO JMIR PUBLIC HEALTH AND SURVEILLANCE
LA English
DT Article
DE causal inference; COVID-19 surveillance; COVID-19; digital health;
   health disparities; knowledge integration; SARS-CoV-2; Social
   Determinants of Health; surveillance; urban health
ID INTEGRATION; KNOWLEDGE
AB Background: COVID-19 is impacting people worldwide and is currently a leading cause of death in many countries. Underlying factors, including Social Determinants of Health (SDoH), could contribute to these statistics. Our prior work has explored associations between SDoH and several adverse health outcomes (eg, asthma and obesity). Our findings reinforce the emerging consensus that SDoH factors should be considered when implementing intelligent public health surveillance solutions to inform public health policies and interventions. Objective: This study sought to redefine the Healthy People 2030's SDoH taxonomy to accommodate the COVID-19 pandemic. Furthermore, we aim to provide a blueprint and implement a prototype for the Urban Population Health Observatory (UPHO), a web-based platform that integrates classified group-level SDoH indicators to individual-and aggregate-level population health data. Methods: The process of building the UPHO involves collecting and integrating data from several sources, classifying the collected data into drivers and outcomes, incorporating data science techniques for calculating measurable indicators from the raw variables, and studying the extent to which interventions are identified or developed to mitigate drivers that lead to the undesired outcomes. Results: We generated and classified the indicators of social determinants of health, which are linked to COVID-19. To display the functionalities of the UPHO platform, we presented a prototype design to demonstrate its features. We provided a use case scenario for 4 different users. Conclusions: UPHO serves as an apparatus for implementing effective interventions and can be adopted as a global platform for chronic and infectious diseases. The UPHO surveillance platform provides a novel approach and novel insights into immediate and long-term health policy responses to the COVID-19 pandemic and other future public health crises. The UPHO assists public health organizations and policymakers in their efforts in reducing health disparities, achieving health equity, and improving urban population health.
C1 [Brakefield, Whitney S.] Univ Tennessee, Bredesen Ctr Data Sci & Engn, Knoxville, TN USA.
   [Brakefield, Whitney S.; Ammar, Nariman; Olusanya, Olufunto A.; Shaban-Nejad, Arash] Univ Tennessee, Coll Med, Ctr Biomed Informat, Dept Pediat,Hlth Sci Ctr, 50 N Dunlap St, Memphis, TN 38103 USA.
RP Shaban-Nejad, A (corresponding author), Univ Tennessee, Coll Med, Ctr Biomed Informat, Dept Pediat,Hlth Sci Ctr, 50 N Dunlap St, Memphis, TN 38103 USA.
EM ashabann@uthsc.edu
OI Shaban-Nejad, Arash/0000-0003-2047-4759; Ammar,
   Nariman/0000-0002-5363-2541; Olusanya, Olufunto A./0000-0001-6983-2882
CR Abrams EM, 2020, LANCET RESP MED, V8, P659, DOI 10.1016/S2213-2600(20)30234-4
   [Anonymous], COVID-19 projections: United States of America
   [Anonymous], WHO CORONAVIRUS COVI
   Bai S, 2020, SSRN J, DOI [10.2139/ssrn.3582774, DOI 10.2139/SSRN.3582774]
   Brenas JH, 2020, IEEE ACCESS, V8, P9942, DOI 10.1109/ACCESS.2020.2964802
   Brodersen KH, 2015, ANN APPL STAT, V9, P247, DOI 10.1214/14-AOAS788
   Chen Y, 2020, MODELING SPATIAL FAC
   Cyrus E, 2020, HEALTH EQUITY, V4, P476, DOI [10.1089/heq.2020.0030, 10.1101/2020.05.15.20096552]
   Del Brutto OH, 2021, J COMMUN HEALTH, V46, P292, DOI 10.1007/s10900-020-00887-9
   Fielding-Miller RK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240151
   Jani A, 2020, J ROY SOC MED, V113, P205, DOI 10.1177/0141076820921655
   Jiwani SS, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01199-z
   Laurencin CT, 2020, J RACIAL ETHN HEALTH, V7, P398, DOI 10.1007/s40615-020-00756-0
   McGinnis JM, 2021, J PUBLIC HEALTH MAN, V27, pS213, DOI 10.1097/PHH.0000000000001328
   Meneses-Navarro S, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01178-4
   Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003
   Oehmke JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/21955
   Okhmatovskaia A, 2014, STUD HEALTH TECHNOL, V205, P1125, DOI 10.3233/978-1-61499-432-9-1125
   Ompad DC, 2007, J URBAN HEALTH, V84, pI42, DOI 10.1007/s11524-007-9168-4
   Ryan BJ, 2020, DISASTER MED PUBLIC, V14, P623, DOI 10.1017/dmp.2020.109
   Shaban-Nejad Arash, 2011, Artificial Intelligence in Medicine. Proceedings 13th Conference on Artificial Intelligence in Medicine, AIME 2011, P225, DOI 10.1007/978-3-642-22218-4_28
   Shaban-Nejad A, 2020, ARTIF INTELL MED, V103, DOI 10.1016/j.artmed.2020.101793
   Shaban-Nejad A, 2017, ANN NY ACAD SCI, V1387, P44, DOI 10.1111/nyas.13271
   Shah M, 2020, J AM ACAD DERMATOL, V83, pE35, DOI 10.1016/j.jaad.2020.04.046
   Shin EK, 2019, JAMIA OPEN, V2, P317, DOI 10.1093/jamiaopen/ooz029
   Shin EK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6963
   Shin EK, 2018, IEEE ACCESS, V6, P46281, DOI 10.1109/ACCESS.2018.2866069
   Smith JA, 2020, HEALTH PROMOT J AUST, V31, P158, DOI 10.1002/hpja.333
   Speizer S., 2020, SAN JOSE SOCIAL DIST
   Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000
   Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   Wu X, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd4049
   Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548
   Ye JC, 2020, JMIR MED INF, V8, DOI 10.2196/19866
NR 35
TC 0
Z9 0
U1 0
U2 0
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 2369-2960
J9 JMIR PUBLIC HLTH SUR
JI JMIR Public Health Surveill.
PD JUN
PY 2021
VL 7
IS 6
AR e28269
DI 10.2196/28269
PG 16
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA YA7LO
UT WOS:000738510300025
PM 34081605
OA Green Published, Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Almeida, LDB
   Silveira, RMD
   Silva, BCD
   de Queiroz, JVR
   de Oliveira, PHCD
AF Bento Almeida, Lindijane de Souza
   da Costa Silveira, Raquel Maria
   do Nascimento Silva, Brunno Costa
   Rocha de Queiroz, Joao Victor
   Correia do Nascimento de Oliveira, Pedro Henrique
TI BRAZILIAN PUBLIC UNIVERSITIES IN THE PANDEMIC CONTEXT: INITIATIVES AND
   PARTNERSHIPS AGAINST COVID-19
SO CADERNOS GESTAO PUBLICA E CIDADANIA
LA Portuguese
DT Article
DE Collaborative Governance; Covid-19; Public Universities; UFRN; crisis
   management
AB In the context of a pandemic caused by the new Coronavirus, governments have adopted measures to prevent and combat Covid-19. In this scenario, several social actors made contributions to the fight against the disease. Among these actions, the measures adopted by Brazilian public universities can be highlighted. The various internal and external actions carried out by higher education institutions demonstrate the importance of universities in crisis management, since the scientific knowledge produced has become the main foundation for the coping strategies implemented by state and municipal governments in Brazil. Given the above, the present study aimed to understand the performance of public universities in Brazil in the context of a pandemic caused by Covid-19, with emphasis on the Federal University of Rio Grande do Norte (UFRN), due to its intense performance, support and, mainly, partnerships established with the state government. Methodologically, bibliographic research procedures and the survey and systematization of actions by federal public universities and, specifically, UFRN, were adopted. The results show that, based on the relationship established between the state government of Rio Grande do Norte and UFRN, there are indications of elements that can contribute to the establishment of collaborative governance.
C1 [Bento Almeida, Lindijane de Souza; da Costa Silveira, Raquel Maria; do Nascimento Silva, Brunno Costa; Rocha de Queiroz, Joao Victor; Correia do Nascimento de Oliveira, Pedro Henrique] Univ Fed Rio Grande Norte UFRN, Natal, RN, Brazil.
RP Almeida, LDB (corresponding author), Univ Fed Rio Grande Norte UFRN, Natal, RN, Brazil.
EM almeida.lindijane@gmail.com; raquelmcsilveira@hotmail.com;
   brunno.cns@gmail.com; joaov_12@ufrn.edu.br; pedrohcorreiano@gmail.com
CR Ansell C, 2008, J PUBL ADM RES THEOR, V18, P543, DOI 10.1093/jopart/mum032
   Boothroyd P, 2010, INCLUSAO COLABORACAO
   Castro E., 2010, INCLUSAO COLABORACAO
   Clementino M. L. M., 2020, B SEMANAL OBSERVATOR, P1
   De Negri F., 2020, RADAR TECNOLOGIA PRO, P7
   Kellas H., 2010, GOVERNANCA METROPOLE, P101
   Medeiros S. R. F. Q., 2020, B SEMANAL OBSERVATOR, P1
   Silveira R. M. C., 2020, B SEMANAL OBSERVATOR, P1
   Tonelli D. F., 2018, GESTAO REGIONALIDADE, P34152, DOI [10.13037/gr.vol34n101.3866., DOI 10.13037/GR.VOL34N101.3866]
   Tribuna do Norte, 2020, DECR IS SOC SERA REN
   Universidade Federal do Rio Grande do Nor- te UFRN, 2020, COORD LAIS REPR RN C
   Universidade Federal do Rio Grande do Nor- te UFRN, 2020, PESQ AND DEM PAP U C
NR 12
TC 0
Z9 0
U1 5
U2 10
PU FUNDACAO GETULIO VARGAS ESCOLA ADM EMPRESAS SAO PAULO
PI ASA NORTE
PA S-N-602 MODULO A-B-C, ASA NORTE, DF 70830-05, BRAZIL
SN 1806-2261
EI 2236-5710
J9 CAD GEST PUBLICA CID
JI Cad. Gest. Publica Cid.
PD SEP-DEC
PY 2020
VL 25
IS 82
AR e-82123
DI 10.12660/cgpc.v25n82.82123
PG 20
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA OR8GZ
UT WOS:000589706900007
DA 2022-04-20
ER

PT J
AU Kunnumakkara, AB
   Rana, V
   Parama, D
   Banik, K
   Girisa, S
   Henamayee, S
   Thakur, KK
   Dutta, U
   Garodia, P
   Gupta, SC
   Aggarwal, BB
AF Kunnumakkara, Ajaikumar B.
   Rana, Varsha
   Parama, Dey
   Banik, Kishore
   Girisa, Sosmitha
   Henamayee, Sahu
   Thakur, Krishan Kumar
   Dutta, Uma
   Garodia, Prachi
   Gupta, Subash C.
   Aggarwal, Bharat B.
TI COVID-19, cytokines, inflammation, and spices: How are they related?
SO LIFE SCIENCES
LA English
DT Review
DE SARS-CoV-2; Cytokine storm; COVID-19; Curcumin; Spices; Inflammation
ID NF-KAPPA-B; RESPIRATORY SYNDROME CORONAVIRUS; ACUTE LUNG INJURY; EXHIBIT
   ANTIINFLAMMATORY ACTIVITY; ISCHEMIA-REPERFUSION INJURY; COLLAGEN-INDUCED
   ARTHRITIS; HUMAN COLORECTAL-CANCER; FENUGREEK SEED EXTRACT;
   CORIANDRUM-SATIVUM; OXIDATIVE STRESS
AB Background: Cytokine storm is the exaggerated immune response often observed in viral infections. It is also intimately linked with the progression of COVID-19 disease as well as associated complications and mortality. Therefore, targeting the cytokine storm might help in reducing COVID-19-associated health complications. The number of COVID-19 associated deaths (as of January 15, 2021; https://www.worldometers.info/coronavirus/) in the USA is high (1199/million) as compared to countries like India (110/million). Although the reason behind this is not clear, spices may have some role in explaining this difference. Spices and herbs are used in different traditional medicines, especially in countries such as India to treat various chronic diseases due to their potent antioxidant and anti-inflammatory properties. Aim: To evaluate the literature available on the anti-inflammatory properties of spices which might prove beneficial in the prevention and treatment of COVID-19 associated cytokine storm. Method: A detailed literature search has been conducted on PubMed for collecting information pertaining to the COVID-19; the history, origin, key structural features, and mechanism of infection of SARS-CoV-2; the repurposed drugs in use for the management of COVID-19, and the anti-inflammatory role of spices to combat COVID19 associated cytokine storm. Key findings: The literature search resulted in numerous in vitro, in vivo and clinical trials that have reported the potency of spices to exert anti-inflammatory effects by regulating crucial molecular targets for inflammation. Significance: As spices are derived from Mother Nature and are inexpensive, they are relatively safer to consume. Therefore, their anti-inflammatory property can be exploited to combat the cytokine storm in COVID-19 patients. This review thus focuses on the current knowledge on the role of spices for the treatment of COVID-19 through suppression of inflammation-linked cytokine storm.
C1 [Kunnumakkara, Ajaikumar B.; Rana, Varsha; Parama, Dey; Banik, Kishore; Girisa, Sosmitha; Henamayee, Sahu; Thakur, Krishan Kumar] Indian Inst Technol Guwahati, Canc Biol Lab, Dept Biosci & Bioengn, Gauhati 781039, Assam, India.
   [Kunnumakkara, Ajaikumar B.; Rana, Varsha; Parama, Dey; Banik, Kishore; Girisa, Sosmitha; Henamayee, Sahu; Thakur, Krishan Kumar] Indian Inst Technol Guwahati, Canc Biol Lab, DBT AIST Int Ctr Translat & Environm Res DAICENTE, Gauhati 781039, Assam, India.
   [Dutta, Uma] Cotton Univ, Dept Zool, Cell & Mol Biol Lab, Gauhati 781001, Assam, India.
   [Garodia, Prachi] Integrat Res Ctr, Ashland, OR 97520 USA.
   [Gupta, Subash C.] Banaras Hindu Univ, Inst Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.
   [Aggarwal, Bharat B.] Inflammat Res Ctr, San Diego, CA 92109 USA.
RP Kunnumakkara, AB; Aggarwal, BB (corresponding author), Indian Inst Technol Guwahati, Canc Biol Lab, Dept Biosci & Bioengn, Gauhati 781039, Assam, India.; Kunnumakkara, AB; Aggarwal, BB (corresponding author), Indian Inst Technol Guwahati, Canc Biol Lab, DBT AIST Int Ctr Translat & Environm Res DAICENTE, Gauhati 781039, Assam, India.; Kunnumakkara, AB; Aggarwal, BB (corresponding author), Inflammat Res Ctr, San Diego, CA 92109 USA.
EM kunnumakkara@iitg.ac.in
OI Thakur, Krishan Kumar/0000-0001-5882-6022
FU DBT-AIST International CENter for Translational and Environmental
   Research (DAICENTER); UGC New Delhi, IndiaUniversity Grants Commission,
   India
FX This work was supported by the DBT-AIST International CENter for
   Translational and Environmental Research (DAICENTER) grant awarded to
   Professor Ajaikumar B. Kunnumakkara. The author Kishore Banik
   acknowledges the UGC New Delhi, India for providing him the fellowship.
CR Abbasnezhad A, 2019, J ETHNOPHARMACOL, V228, P142, DOI 10.1016/j.jep.2018.09.021
   Abdolahi M, 2019, ENDOCR METAB IMMUNE, V19, P874, DOI 10.2174/1871530319666190212170140
   Abu Gazia M, 2018, CELLS TISSUES ORGANS, V206, P62, DOI 10.1159/000496109
   Abulfadl YS, 2018, HUM EXP TOXICOL, V37, P1092, DOI 10.1177/0960327118755256
   Acanfora D, 2020, EUR HEART J-CARD PHA, V6, P135, DOI 10.1093/ehjcvp/pvaa028
   Adhikari B, 2021, PHYTOTHER RES, V35, P1298, DOI 10.1002/ptr.6893
   Adibian M, 2019, PHYTOTHER RES, V33, P1374, DOI 10.1002/ptr.6328
   Aggarwal, 2009, MOL TARGETS THERAPEU, P1, DOI DOI 10.1142/9789812837912_0001
   Aggarwal BB, 2008, PLANTA MED, V74, P1560, DOI 10.1055/s-2008-1074578
   Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x
   Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P347, DOI 10.1016/j.coph.2009.06.018
   Aghasi M, 2019, J SCI FOOD AGR, V99, P3933, DOI 10.1002/jsfa.9617
   Ajaikumar KB, 2005, J ETHNOPHARMACOL, V96, P171, DOI 10.1016/j.jep.2004.09.007
   Al-Quraishy S, 2020, ENVIRON SCI POLLUT R, V27, P12395, DOI 10.1007/s11356-020-07686-8
   Algandaby MM, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12895
   Almeida J D, 1967, J Gen Virol, V1, P175, DOI 10.1099/0022-1317-1-2-175
   Almeida JD, 1968, NATURE, V220, P650
   Amalraj A, 2017, J MED FOOD, V20, P1022, DOI 10.1089/jmf.2017.3930
   Amalraj Augustine, 2017, J Tradit Complement Med, V7, P347, DOI 10.1016/j.jtcme.2016.11.004
   Ameeramja J, 2018, INFLAMMATION, V41, P886, DOI 10.1007/s10753-018-0743-5
   Amici C, 2006, ANTIVIR THER, V11, P1021
   Amin B, 2016, PLANTA MED, V82, P8, DOI 10.1055/s-0035-1557838
   Amirian ES, 2020, ONE HEALTH-AMSTERDAM, V9, DOI 10.1016/j.onehlt.2020.100128
   Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008
   Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375
   Anderson DE, 2020, INFECT DIS THER, V9, P669, DOI 10.1007/s40121-020-00316-3
   Andreani J, 2020, MICROB PATHOGENESIS, V145, DOI 10.1016/j.micpath.2020.104228
   Annamalai G, 2018, BIOMED PHARMACOTHER, V98, P484, DOI 10.1016/j.biopha.2017.12.009
   [Anonymous], 2020, LANCET, V395, P1315, DOI 10.1016/S0140-6736(20)30938-7
   [Anonymous], 2018, CISION PR NEWSWIRE
   [Anonymous], 2021, LAT RES COVID 19 TRE
   Arablou T, 2018, BIOMED PHARMACOTHER, V97, P91, DOI 10.1016/j.biopha.2017.10.119
   Arumugam P, 2008, ENVIRON TOXICOL PHAR, V26, P92, DOI 10.1016/j.etap.2008.02.008
   Aryaeian N, 2019, GENE, V698, P179, DOI 10.1016/j.gene.2019.01.048
   Ashokkumar K, 2020, J ETHNOPHARMACOL, V246, DOI 10.1016/j.jep.2019.112244
   Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186
   Astuti I, 2020, DIABETES METAB SYND, V14, P407, DOI 10.1016/j.dsx.2020.04.020
   Babaei F, 2020, FOOD SCI NUTR, V8, P5215, DOI 10.1002/fsn3.1858
   Babu BH, 2003, J EXP CLIN CANC RES, V22, P581
   Bae GS, 2011, BIOCHEM BIOPH RES CO, V410, P382, DOI 10.1016/j.bbrc.2011.05.136
   Baez-Santos YM, 2015, ANTIVIR RES, V115, P21, DOI 10.1016/j.antiviral.2014.12.015
   Bagheri SM, 2017, J AYURVEDA INTEGR ME, V8, P152, DOI 10.1016/j.jaim.2017.02.013
   Bagheri SM, 2016, J EVID-BASED INTEGR, V21, P271, DOI 10.1177/2156587215605903
   Bai XP, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2432416
   Baluchnejadmojarad T, 2019, METAB BRAIN DIS, V34, P1747, DOI 10.1007/s11011-019-00481-6
   Banik K, 2020, PHARMACOL RES, V153, DOI 10.1016/j.phrs.2020.104635
   Banik K, 2019, PHARMACOL RES, V144, P192, DOI 10.1016/j.phrs.2019.04.004
   Banik K, 2018, CANCER LETT, V416, P75, DOI 10.1016/j.canlet.2017.12.014
   Barceloux DG, 2009, DM-DIS MON, V55, P318, DOI [10.1016/j.disamonth.2009.03.011, 10.1016/j.disamonth.2009.03.007, 10.1016/j.disamonth.2009.03.003, 10.1016/j.disamonth.2009.03.006, 10.1016/j.disamonth.2009.03.004, 10.1016/j.disamonth.2009.03.008, 10.1016/j.disamonth.2009.03.002, 10.1016/j.disamonth.2009.03.010, 10.1016/j.disamonth.2009.03.005]
   Barh D, 2020, COMPUT BIOL MED, V126, DOI 10.1016/j.compbiomed.2020.104051
   Basu S, 2020, MICROB PATHOGENESIS, V149, DOI 10.1016/j.micpath.2020.104546
   Beheshti F, 2018, SAUDI J KIDNEY DIS T, V29, P554, DOI 10.4103/1319-2442.235184
   Bernal-Bello D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102565
   Blaising J, 2014, ANTIVIR RES, V107, P84, DOI 10.1016/j.antiviral.2014.04.006
   Boechat N., 2020, VITRO ANTIVIRAL ACTI, DOI [10.1101/2020.06.15.153411, DOI 10.1101/2020.06.15.153411]
   Bordoloi Devivasha, 2019, Asian Pac J Cancer Prev, V20, P3437, DOI 10.31557/APJCP.2019.20.11.3437
   Bordoloi D, 2018, CANC SENSIT AGENTS, V2, P31, DOI 10.1016/B978-0-12-812373-7.00002-4
   Bordoloi D, 2016, RECENT PAT ANTI-CANC, V11, P67, DOI 10.2174/1574892810666151020101706
   Bordoni L, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010020
   Bower A, 2016, CRIT REV FOOD SCI, V56, P2728, DOI 10.1080/10408398.2013.805713
   Bowers KW, 2007, B HIST MED, V81, P335, DOI 10.1353/bhm.2007.0020
   Brahmi F, 2017, PHARM BIOL, V55, P286, DOI 10.1080/13880209.2016.1235208
   Buhrmann C, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8080236
   Bui TT, 2017, CELL IMMUNOL, V322, P64, DOI 10.1016/j.cellimm.2017.10.005
   Butt MS, 2013, CRIT REV FOOD SCI, V53, P875, DOI 10.1080/10408398.2011.571799
   Cai QX, 2020, ENGINEERING-PRC, V6, P1192, DOI 10.1016/j.eng.2020.03.007
   Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787
   Camitz M, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-32
   Cantini F, 2020, J INFECTION, V81, P318, DOI 10.1016/j.jinf.2020.04.017
   Capra R, 2020, EUR J INTERN MED, V76, P31, DOI 10.1016/j.ejim.2020.05.009
   Carbajo-Lozoya J, 2012, VIRUS RES, V165, P112, DOI 10.1016/j.virusres.2012.02.002
   Castillo, 2018, MEDICINES BASEL, V5
   Celik C, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2020.129801
   Chafekar A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020093
   Chang R, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106118
   Che DN, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13198
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen J, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa241
   Chen L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041193
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Chen YC, 2020, DIABETES CARE, V43, P1399, DOI 10.2337/dc20-0660
   Chong L, 2014, INFLAMMATION, V37, P1476, DOI 10.1007/s10753-014-9873-6
   Chong URW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/459017
   Choudhury B, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00003
   Choy KT, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104786
   Cingolani A, 2020, INFECTION, V48, P767, DOI 10.1007/s15010-020-01476-7
   Coleman CM, 2016, J VIROL, V90, P8924, DOI 10.1128/JVI.01429-16
   Conrozier T, 2014, ALTERN THER HEALTH M, V20, P32
   Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003
   Corman VM, 2019, INTERNIST, V60, P1136, DOI 10.1007/s00108-019-00671-5
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Dalamaga M., 2020, METABOL OPEN, V8
   Daneshi-Maskooni M, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2465-0
   Dargad RR, 2018, INDIAN HEART J, V70, pS102, DOI 10.1016/j.ihj.2018.01.002
   Das M, 2018, J ETHNOPHARMACOL, V227, P69, DOI 10.1016/j.jep.2018.08.019
   De M, 2002, PHYTOTHER RES, V16, P94, DOI 10.1002/ptr.989
   De Meyer S, 2020, INT J INFECT DIS, V97, P7, DOI 10.1016/j.ijid.2020.05.085
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   Dehghani S, 2018, PHYTOMEDICINE, V48, P70, DOI 10.1016/j.phymed.2018.04.060
   Devan P, 2007, INT IMMUNOPHARMACOL, V7, P889, DOI 10.1016/j.intimp.2007.02.008
   Devaux CA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105938
   Dey, 2009, WORLD SCI, P373
   Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024
   Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800
   Domiciano TP, 2013, N-S ARCH PHARMACOL, V386, P331, DOI 10.1007/s00210-012-0820-5
   Dong ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15946
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Du Toit A, 2020, NAT REV MICROBIOL, V18, P123, DOI 10.1038/s41579-020-0332-0
   Eftekhar N, 2019, DRUG CHEM TOXICOL, V42, P286, DOI 10.1080/01480545.2018.1459672
   Eftekhar N, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2765-4
   Egilmez OK, 2020, TURK ARCH OTORHINOL, V58, P10, DOI 10.5152/tao.2020.4733
   Eguale T, 2007, J ETHNOPHARMACOL, V110, P428, DOI 10.1016/j.jep.2006.10.003
   Eisenhut M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00872
   El-Ghffar EAA, 2018, FOOD FUNCT, V9, P4457, DOI [10.1039/C8FO00538A, 10.1039/c8fo00538a]
   Elberry AA, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/640746
   Elfiky AA, 2021, J BIOMOL STRUCT DYN, V39, P3204, DOI 10.1080/07391102.2020.1761882
   Elfiky AA, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117592
   Elsayed Y, 2020, ACS CHEM NEUROSCI, V11, P1696, DOI 10.1021/acschemneuro.0c00239
   European Centre for Disease Prevention and Control, COVID 19 SIT UPD WOR
   Fahanik-Babaei J, 2019, METAB BRAIN DIS, V34, P191, DOI 10.1007/s11011-018-0338-8
   Fan CRN, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.920442
   FEHR AR, 2015, METHOD MOL BIOL, V1282, DOI [10.1007/978-1-4939-2438-7_1, DOI 10.1007/978-1-4939-2438-7_1]
   Francis SK, 2019, NAT PROD RES, V33, P1204, DOI 10.1080/14786419.2018.1457670
   Fu Y, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4730878
   Funamoto M, 2016, INT J CHRONIC OBSTR, V11, P2029, DOI 10.2147/COPD.S104490
   Gao Y, 2020, J MED VIROL, V92, P791, DOI 10.1002/jmv.25770
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Ghiasian M, 2019, J BIOCHEM MOL TOXIC, V33, DOI 10.1002/jbt.22410
   Ghosal S, 2020, DIABETES METAB SYND, V14, P707, DOI 10.1016/j.dsx.2020.05.026
   Girisa S, 2019, MOLECULES, V24, DOI 10.3390/molecules24040734
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Gremese E, 2020, ECLINICALMEDICINE, V27, DOI 10.1016/j.eclinm.2020.100553
   Gu SM, 2018, NEUROMOL MED, V20, P312, DOI 10.1007/s12017-018-8495-9
   Guan SB, 2020, AM J TRANSL RES, V12, P493
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Gupta H, 2020, CLIN EXP DERMATOL, V45, P902, DOI 10.1111/ced.14357
   Gupta SC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02160
   Gupta SC, 2017, PHYTOMEDICINE, V34, P14, DOI 10.1016/j.phymed.2017.07.001
   Gupta SK, 2014, MOL CELL BIOCHEM, V388, P1, DOI 10.1007/s11010-013-1893-2
   Gurwitz D, 2020, DRUG DEVELOP RES, V81, P537, DOI 10.1002/ddr.21656
   HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734
   Hamza AA, 2016, ANDROLOGIA, V48, P211, DOI 10.1111/and.12435
   Han JG, 2014, MOL CANCER THER, V13, P2422, DOI 10.1158/1535-7163.MCT-14-0171
   Han SG, 2018, CLIN EXP PHARMACOL P, V45, P84, DOI 10.1111/1440-1681.12848
   Han XS, 2017, PHYTOTHER RES, V31, P1034, DOI 10.1002/ptr.5822
   Han YS, 2012, INFLAMMATION, V35, P1723, DOI 10.1007/s10753-012-9490-1
   Haniadka R, 2013, FOOD FUNCT, V4, P845, DOI 10.1039/c3fo30337c
   Hariri M, 2016, ADV EXP MED BIOL, V929, P1, DOI 10.1007/978-3-319-41342-6_1
   Harsha C, 2017, FOOD CHEM TOXICOL, V108, P104, DOI 10.1016/j.fct.2017.07.023
   Hassaniazad M, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04824-y
   He YQ, 2021, PHARMACOL RES, V163, DOI 10.1016/j.phrs.2020.105224
   Heidari B, 2016, AVICENNA J PHYTOMEDI, V6, P205
   Henamayee S, 2020, MOLECULES, V25, DOI 10.3390/molecules25102278
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hong JW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-237
   Hooper PL, 2020, CELL STRESS CHAPERON, V25, P707, DOI 10.1007/s12192-020-01126-9
   Horowitz RI, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.109851
   Hsieh CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194879
   Hsieh SL, 2015, INT J ONCOL, V47, P2240, DOI 10.3892/ijo.2015.3206
   HSU DZ, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/905670
   Hu BY, 2021, J MED VIROL, V93, P250, DOI 10.1002/jmv.26232
   Hu Jian, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1394
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8
   Hui DSC, 2003, RESPIROLOGY, V8, pS20, DOI 10.1046/j.1440-1843.2003.00520.x
   Ibrahim MAA, 2020, COMPUT BIOL MED, V126, DOI 10.1016/j.compbiomed.2020.104046
   Iman V, 2017, DRUG DES DEV THER, V11, P103, DOI 10.2147/DDDT.S115135
   Iwabuchi K, 2020, J INFECT CHEMOTHER, V26, P625, DOI 10.1016/j.jiac.2020.04.007
   Jagtap S, 2017, BIOFACTORS, V43, P220, DOI 10.1002/biof.1333
   Jain S, 2018, RECENT PATENTS INFLA, V12, P145, DOI [10.2174/1872213x12666180815144803, 10.2174/1872213X12666180815144803]
   Jampilek J, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10112224
   Jang HY, 2011, J MED FOOD, V14, P1144, DOI 10.1089/jmf.2011.1609
   Jin H, 2012, PHYTOTHER RES, V26, P1320, DOI 10.1002/ptr.3707
   Jin L, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106521
   Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60
   Kalaivani P, 2013, CLIN EXP HYPERTENS, V35, P534, DOI 10.3109/10641963.2013.764887
   Kandeel M, 2020, LIFE SCI, V251, DOI 10.1016/j.lfs.2020.117627
   Kandhare AD, 2015, CHEM-BIOL INTERACT, V237, P151, DOI 10.1016/j.cbi.2015.06.019
   Kang P, 2013, LIFE SCI, V93, P955, DOI 10.1016/j.lfs.2013.10.014
   Karampela I, 2020, ARCH MED RES, V51, P741, DOI 10.1016/j.arcmed.2020.06.004
   Kavitha S, 2015, INDIAN J EXP BIOL, V53, P632
   Kawabata K, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/820415
   Kazemi S, 2017, J SCI FOOD AGR, V97, P5296, DOI 10.1002/jsfa.8414
   Keflie TS, 2021, NUTRITION, V84, DOI 10.1016/j.nut.2020.111103
   KENDALL EJC, 1962, BRIT MED J, P82, DOI 10.1136/bmj.2.5297.82
   Kengaiah J, 2020, BIOCHEMISTRY-MOSCOW+, V85, P119, DOI 10.1134/S0006297920010113
   Keyaerts E, 2009, ANTIMICROB AGENTS CH, V53, P3416, DOI 10.1128/AAC.01509-08
   Khadem Haghighian Mahdieh, 2015, Acta Med Iran, V53, P207
   Khajah MA, 2019, J ETHNOPHARMACOL, V241, DOI 10.1016/j.jep.2019.112008
   Khaldi T, 2018, ALLERGOL IMMUNOPATH, V46, P472, DOI 10.1016/j.aller.2018.02.005
   Khanna D, 2007, CURR OPIN PHARMACOL, V7, P344, DOI 10.1016/j.coph.2007.03.002
   Khurana A, 2019, PHYTOTHER RES, V33, P1510, DOI 10.1002/ptr.6344
   Khwairakpam Amrita Devi, 2020, Journal of Basic and Clinical Physiology and Pharmacology, V31
   Khwairakpam AD, 2018, PHARMACOL RES, V133, P53, DOI 10.1016/j.phrs.2018.04.021
   Khwairakpam Amrita Devi, 2018, Journal of Basic and Clinical Physiology and Pharmacology, V29, P107, DOI 10.1515/jbcpp-2016-0132
   Kicska G, 2020, INT J CARDIOVAS IMAG, V36, P1387, DOI 10.1007/s10554-020-01861-1
   Killerby ME, 2020, EMERG INFECT DIS, V26, P191, DOI 10.3201/eid2602.190697
   Kim JH, 2017, J GINSENG RES, V41, P435, DOI 10.1016/j.jgr.2016.08.004
   Kim N, 2018, J PHARMACOL SCI, V137, P195, DOI 10.1016/j.jphs.2018.06.004
   Kindrachuk J, 2015, ANTIMICROB AGENTS CH, V59, P1088, DOI 10.1128/AAC.03659-14
   Koh WS, 1998, INT J IMMUNOPHARMACO, V20, P643, DOI 10.1016/S0192-0561(98)00064-2
   Krishnaswamy K, 2008, ASIA PAC J CLIN NUTR, V17, P265
   Ku SK, 2014, INFLAMM RES, V63, P369, DOI 10.1007/s00011-014-0708-6
   Ku SK, 2014, INFLAMMATION, V37, P435, DOI 10.1007/s10753-013-9756-2
   Kulkarni Rashmi Anant, 2016, J Complement Integr Med, V13, P201, DOI 10.1515/jcim-2015-0032
   KUMAR G, 2020, DRUG RES STUTTG
   Kumar MM, 2020, INT IMMUNOPHARMACOL, V80, DOI 10.1016/j.intimp.2019.106136
   Kumar S, 2019, J PHARM PHARMACOL, V71, P1735, DOI 10.1111/jphp.13173
   Kumar S, 2021, PHYTOMEDICINE, V85, DOI 10.1016/j.phymed.2020.153317
   Kunnumakkara, 2020, CHEM BIOACTIVE COMPO, P150
   Kunnumakkara, 2020, SEMIN CANCER BIOL
   Kunnumakkara A. B., 2015, WORLD SCI, P337
   Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009
   Kunnumakkara AB, 2008, CLIN CANCER RES, V14, P2128, DOI 10.1158/1078-0432.CCR-07-4722
   Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257
   Kunnumakkara AB, 2020, CRIT REV IMMUNOL, V40, P1, DOI 10.1615/CritRevImmunol.2020033210
   Kunnumakkara AB, 2019, CRIT REV IMMUNOL, V39, P439, DOI 10.1615/CritRevImmunol.2020033205
   Kunnumakkara AB, 2019, EXPERT OPIN DRUG MET, V15, P705, DOI 10.1080/17425255.2019.1650914
   Kunnumakkara AB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00686
   Kunnumakkara AB, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1381-2
   Kunnumakkara AB, 2017, CLIN SCI, V131, P1781, DOI 10.1042/CS20160935
   Kunnumakkara AB, 2017, BRIT J PHARMACOL, V174, P1325, DOI 10.1111/bph.13621
   Kunnumakkara AB, 2009, CURR COLORECT CANC R, V5, P5, DOI 10.1007/s11888-009-0002-0
   Kunnumakkara AB, 2009, INT J CANCER, V125, P2187, DOI 10.1002/ijc.24593
   Kunnumakkara AB, 2009, DRUG RESISTANCE IN CANCER CELLS, P177, DOI 10.1007/978-0-387-89445-4_8
   Kunnurnakkara AB, 2007, BLOOD, V109, P5112, DOI 10.1182/blood-2007-01-067256
   Kurzrock R., 2007, J CLIN ONCOL, V25, P4599
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Lee BJ, 2011, IMMUNOPHARM IMMUNOT, V33, P714, DOI 10.3109/08923973.2011.564185
   Lee EH, 2019, J CELL PHYSIOL, V234, P6854, DOI 10.1002/jcp.27434
   Lee HS, 2002, J AGR FOOD CHEM, V50, P7700, DOI 10.1021/jf020751f
   Lee JY, 2011, MOLECULES, V16, P7132, DOI 10.3390/molecules16087132
   Lee W, 2019, AM J CHINESE MED, V47, P1237, DOI 10.1142/S0192415X19500630
   Lertnimitphun P, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01281
   Li CY, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106110
   Li CC, 2019, DRUG DISCOV TODAY, V24, P726, DOI 10.1016/j.drudis.2019.01.018
   Li CD, 2017, SCI REP-UK, V7, DOI 10.1038/srep41331
   Li F, 2013, CANCER PREV RES, V6, P843, DOI 10.1158/1940-6207.CAPR-13-0070
   Li LL, 2015, INT J CLIN EXP MED, V8, P14985
   Li Q, 2016, INFLAMMATION, V39, P467, DOI 10.1007/s10753-015-0270-6
   Li SH, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138070
   Li SP, 2019, MOL MED REP, V20, P4623, DOI 10.3892/mmr.2019.10708
   Li YM, 2020, J GEN VIROL, V101, P1079, DOI 10.1099/jgv.0.001466
   Li YL, 2018, INT IMMUNOPHARMACOL, V64, P319, DOI 10.1016/j.intimp.2018.09.015
   Lian N, 2020, CLIN MICROBIOL INFEC, V26, P917, DOI 10.1016/j.cmi.2020.04.026
   Liang JJ, 2019, INT IMMUNOPHARMACOL, V71, P132, DOI 10.1016/j.intimp.2019.03.024
   Liang JL, 2020, COMPUT BIOL CHEM, V87, DOI 10.1016/j.compbiolchem.2020.107292
   Liang YD, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00390
   Liang ZM, 2016, INT IMMUNOPHARMACOL, V41, P90, DOI 10.1016/j.intimp.2016.10.010
   Liang ZM, 2016, MOLECULES, V21, DOI 10.3390/molecules21060769
   Lin CY, 2020, INFECT DRUG RESIST, V13, P1735, DOI 10.2147/IDR.S256773
   Lin YG, 2007, CLIN CANCER RES, V13, P3423, DOI 10.1158/1078-0432.CCR-06-3072
   Lindeman RJ, 2020, J SURG CASE REP, DOI 10.1093/jscr/rjaa131
   Liou CJ, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040295
   Liu BW, 2020, J AUTOIMMUN, V111, DOI 10.1016/j.jaut.2020.102452
   LIU J, 2020, ANN INTENSIVE CARE, V10, DOI [10.1186/s13613-020-00706-3, DOI 10.1186/S13613-020-00706-3]
   Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763
   Liu J, 2020, J ALLERGY CLIN IMMUN, V146, P325, DOI 10.1016/j.jaci.2020.05.021
   Liu YP, 2020, CLIN INFECT DIS, V71, P2150, DOI 10.1093/cid/ciaa630
   Liu ZT, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00479
   Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395
   Lobo-Galo N, 2021, J BIOMOL STRUCT DYN, V39, P3419, DOI 10.1080/07391102.2020.1764393
   Long JH, 2020, CELL MOL BIOL, V66, P55, DOI 10.14715/cmb/2019.66.1.9
   Lu C, 2019, INT J MOL MED, V44, P1855, DOI 10.3892/ijmm.2019.4322
   Lu QG, 2020, WORLD J GASTROENTERO, V26, P1156, DOI 10.3748/wjg.v26.i11.1156
   Lu XL, 2017, BIOMED PHARMACOTHER, V85, P658, DOI 10.1016/j.biopha.2016.11.077
   Ludwig S, 2020, ANESTH ANALG, V131, P93, DOI 10.1213/ANE.0000000000004845
   Martinez-Rodriguez JL, 2019, ALTERN THER HEALTH M, V25, P54
   Luo P, 2020, AM J TROP MED HYG, V103, P69, DOI 10.4269/ajtmh.20-0375
   Lv J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3942
   Lv Y, 2019, CHIN J NAT MEDICINES, V17, P43, DOI 10.1016/S1875-5364(19)30008-1
   Maggio R, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104837
   Mahendra Poonam, 2012, Pharmacogn Rev, V6, P141, DOI 10.4103/0973-7847.99948
   Majdalawieh AF, 2017, EUR J PHARMACOL, V815, P512, DOI 10.1016/j.ejphar.2017.10.020
   Malek AE, 2020, IDCASES, V21, DOI 10.1016/j.idcr.2020.e00864
   Mallikarjuna GU, 2003, BREAST CANCER RES TR, V81, P1, DOI 10.1023/A:1025448620558
   Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3
   Matsuyama S, 2021, J VIROL, V95, DOI 10.1128/JVI.01648-20
   Maurya Vimal K., 2020, VirusDisease, V31, DOI 10.1007/s13337-020-00598-8
   Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006
   Millan-Onate J, 2020, ANN CLIN MICROB ANTI, V19, DOI 10.1186/s12941-020-00358-y
   Million M, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101738
   Miryan M, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04924-9
   Mitrovic PM, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00299
   Mnif S, 2015, CHEM BIODIVERS, V12, P733, DOI 10.1002/cbdv.201400305
   Mo M, 2020, INT IMMUNOPHARMACOL, V81, DOI 10.1016/j.intimp.2020.106273
   Mohn N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01059
   Moghadamtousi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186864
   Mokhtari-Zaer A, 2020, J ETHNOPHARMACOL, V253, DOI 10.1016/j.jep.2020.112653
   Monisha J, 2017, CURR DRUG TARGETS, V18, P232, DOI 10.2174/1389450117666160201112330
   Monisha J, 2016, CURR PHARM DESIGN, V22, P4173, DOI 10.2174/1381612822666160609110231
   Moreno JC, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-79
   Moshiri M, 2015, DRUG RES, V65, P287, DOI 10.1055/s-0034-1375681
   Mostafavi S, 2019, FOOD CHEM, V276, P700, DOI 10.1016/j.foodchem.2018.10.027
   Mozaffari-Khosravi Hassan, 2016, Journal of Nutrition in Gerontology and Geriatrics, V35, P209, DOI 10.1080/21551197.2016.1206762
   Mrityunjaya M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.570122
   Nair S.A., 2015, WORLD SCI, P131
   Nair Vinod, 2013, J Ayurveda Integr Med, V4, P13, DOI 10.4103/0975-9476.109544
   Naqvi AA, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165878
   Nie YJ, 2019, J PHARMACOL SCI, V139, P377, DOI 10.1016/j.jphs.2019.03.002
   Nilius B, 2013, REV PHYSIOL BIOCH P, V164, P1, DOI 10.1007/112_2013_11
   Opara EI, 2014, INT J MOL SCI, V15, P19183, DOI 10.3390/ijms151019183
   Ouzir M, 2016, FOOD CHEM TOXICOL, V96, P145, DOI 10.1016/j.fct.2016.08.003
   Padmavathi G, 2017, PHYTOMEDICINE, V25, P118, DOI 10.1016/j.phymed.2016.12.002
   Paital B, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138914
   Palanques-Pastor T, 2020, EUR J HOSP PHARM, V27, P297, DOI 10.1136/ejhpharm-2020-002322
   Panahi Y, 2015, DRUG RES, V65, P567, DOI 10.1055/s-0034-1389986
   Panahi Y, 2017, CURR CLIN PHARMACOL, V12, P253, DOI 10.2174/1574884713666180104095641
   Panahi Y, 2015, CLIN NUTR, V34, P1101, DOI 10.1016/j.clnu.2014.12.019
   Pandey A, 2011, J PHARM BIOALLIED SC, V3, P435, DOI 10.4103/0975-7406.84462
   Pandey M.K., 2009, WORLD SCI, P281
   Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.M700890200
   Pandurangan AK, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/605208
   Parama D, 2020, LIFE SCI, V260, DOI 10.1016/j.lfs.2020.118182
   Park G, 2014, J MED FOOD, V17, P862, DOI 10.1089/jmf.2013.2910
   Park SH, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0750-0
   Parra-Lara LG, 2020, J GLOB ANTIMICROB RE, V22, P680, DOI 10.1016/j.jgar.2020.06.016
   Patra JK, 2020, PHYTOTHER RES, V34, P1248, DOI 10.1002/ptr.6614
   Peak CM, 2018, INT J EPIDEMIOL, V47, P1562, DOI 10.1093/ije/dyy095
   Pei HY, 2020, J AGR FOOD CHEM, V68, P2406, DOI 10.1021/acs.jafc.9b07754
   Peng XF, 2018, INT IMMUNOPHARMACOL, V65, P448, DOI 10.1016/j.intimp.2018.10.025
   Periasamy S, 2018, J FUNCT FOODS, V47, P1, DOI 10.1016/j.jff.2018.05.035
   Pietrobelli A, 2020, OBESITY, V28, P1382, DOI 10.1002/oby.22861
   Plos, 2021, VAR 3 NEW COV VACC C
   Pohlmann S., 2020, 237651 BIORXIV
   Prachayasittikul V, 2018, FOOD RES INT, V105, P305, DOI 10.1016/j.foodres.2017.11.019
   Pradeep CR, 2002, CLIN EXP METASTAS, V19, P703, DOI 10.1023/A:1021398601388
   Qiao Z, 2020, COMPUTATION, V8, DOI 10.3390/computation8020053
   Qiblawi S, 2015, J ENVIRON PATHOL TOX, V34, P95, DOI 10.1615/JEnvironPatholToxicolOncol.2015010838
   Quiles JL, 2020, ENVIRON RES, V191, DOI 10.1016/j.envres.2020.110053
   Ngo QT, 2017, PHYTOTHER RES, V31, P663, DOI 10.1002/ptr.5780
   Rabi FA, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030231
   Radhakrishnan, 2020, 297366 BIORXIV
   Ragab D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01446
   Rahban M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9121228
   Rahim VB, 2019, PHARMACOL REP, V71, P1228, DOI 10.1016/j.pharep.2019.07.007
   Rajagopal HM, 2018, INT J BIOL MACROMOL, V118, P864, DOI 10.1016/j.ijbiomac.2018.06.053
   Rajagopal K, 2020, FUTUR J PHARM SCI, V6, DOI 10.1186/s43094-020-00126-x
   Ranaware AM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082362
   Reis RF, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109888
   Reuter J, 2008, J DTSCH DERMATOL GES, V6, P847, DOI [10.1111/j.1610-0387.2008.06704.x, 10.1111/j.1610-0387.2008.06704_supp.x]
   Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006
   Rocha FAC, 2020, PHYTOTHER RES, V34, P2085, DOI 10.1002/ptr.6745
   Rocha J, 2015, BASIC CLIN PHARMACOL, V116, P398, DOI 10.1111/bcpt.12335
   Rodriguez-Nava G, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03154-4
   Romanelli F, 2004, CURR PHARM DESIGN, V10, P2643, DOI 10.2174/1381612043383791
   Roshdy WH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241739
   Rousta AM, 2018, IMMUNOPHARM IMMUNOT, V40, P423, DOI 10.1080/08923973.2018.1523926
   Roy A, 2020, PHYTOTHER RES, V34, P2425, DOI 10.1002/ptr.6766
   Roy NK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174101
   Roy NK, 2016, CANCER LETT, V377, P74, DOI 10.1016/j.canlet.2016.04.017
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Saber-Moghaddam N, 2021, PHYTOTHER RES, V35, P2616, DOI 10.1002/ptr.7004
   Saeedi-Boroujeni A, 2021, BASIC CLIN PHARMACOL, V128, P37, DOI 10.1111/bcpt.13503
   Saha A, 2020, ARCH MED RES, V51, P585, DOI 10.1016/j.arcmed.2020.05.001
   Sailo BL, 2018, PHARMACOL RES, V130, P259, DOI 10.1016/j.phrs.2018.02.017
   Sainz B, 2004, VIROLOGY, V329, P11, DOI 10.1016/j.virol.2004.08.011
   Samadian F, 2017, CLIN NUTR ESPEN, V22, P19, DOI 10.1016/j.clnesp.2017.09.006
   Sandur SK, 2007, FREE RADICAL BIO MED, V43, P568, DOI 10.1016/j.freeradbiomed.2007.05.009
   Sant'Ana M, 2020, PULM PHARMACOL THER, V61, DOI 10.1016/j.pupt.2020.101896
   Scheen AJ, 2020, DIABETES METAB, V46, P423, DOI 10.1016/j.diabet.2020.07.006
   Seifirad S, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110005
   Sekhon-Loodu S, 2015, INFLAMMOPHARMACOLOGY, V23, P173, DOI 10.1007/s10787-015-0237-0
   Selvaraj Vijairam, 2020, R I Med J (2013), V103, P39
   Sestili P, 2018, EXPERT OPIN DRUG MET, V14, P679, DOI 10.1080/17425255.2018.1484450
   Sethi G, 2009, ADV EXP MED BIOL, V647, P37, DOI 10.1007/978-0-387-89520-8_3
   Shakeri F, 2019, ALLERGOL IMMUNOPATH, V47, P16, DOI 10.1016/j.aller.2018.04.004
   Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117
   Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
   Sharma S, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108183
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Shi ZY, 2019, MOLECULES, V24, DOI 10.3390/molecules24132443
   Shim Hyun Ik, 2019, Korean J Gastroenterol, V74, P199, DOI 10.4166/kjg.2019.74.4.199
   Shin K, 2013, LIFE SCI, V92, P1093, DOI 10.1016/j.lfs.2013.04.010
   Shin YH, 2013, J DENT RES, V92, P547, DOI 10.1177/0022034513487376
   Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10
   Si YH, 2015, AM J CHINESE MED, V43, P443, DOI 10.1142/S0192415X15500287
   Siddiqi A, 2022, J INTERPROF CARE, V36, P93, DOI 10.1080/13561820.2020.1825354
   Sindhu G, 2018, PROSTAG OTH LIPID M, V138, P48, DOI 10.1016/j.prostaglandins.2018.08.002
   Singh AK, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108268
   Singh N, 2008, PHYTOMEDICINE, V15, P284, DOI 10.1016/j.phymed.2007.06.007
   Singh YP, 2019, J FUNCT FOODS, V53, P248, DOI 10.1016/j.jff.2018.12.020
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Somers EC, 2021, CLIN INFECT DIS, V73, pE445, DOI [10.1093/cid/ciaa954, 10.1101/2020.05.29.20117358]
   Son DJ, 2012, BIOCHEM BIOPH RES CO, V427, P349, DOI 10.1016/j.bbrc.2012.09.061
   Soni VK, 2020, EUR J PHARMACOL, V886, DOI 10.1016/j.ejphar.2020.173551
   Soni VK, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102378
   Squillace N, 2018, DRUG DES DEV THER, V12, P3635, DOI 10.2147/DDDT.S147493
   Sreedharan, 2020, SN COMPR CLIN MED, P1
   Srivastava S, 2016, INFLAMMOPHARMACOLOGY, V24, P377, DOI 10.1007/s10787-016-0289-9
   Stancioiu F, 2020, INT J MOL MED, V46, P489, DOI 10.3892/ijmm.2020.4636
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Suleria HAR, 2015, CRIT REV FOOD SCI, V55, P50, DOI 10.1080/10408398.2011.646364
   Sun J, 2015, MOL MED REP, V11, P2689, DOI 10.3892/mmr.2014.3001
   Sundaram MS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11117
   Sung BK, 2012, NUTR CANCER, V64, P173, DOI 10.1080/01635581.2012.630551
   Sung YY, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7506808
   Sung YY, 2013, J ETHNOPHARMACOL, V149, P626, DOI 10.1016/j.jep.2013.07.013
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6
   Tahmasebi S, 2020, J CELL PHYSIOL, V235, P9211, DOI 10.1002/jcp.29804
   Tamaddonfard E, 2019, LIFE SCI, V224, P88, DOI 10.1016/j.lfs.2019.03.054
   Tang J, 2015, INT IMMUNOPHARMACOL, V28, P264, DOI 10.1016/j.intimp.2015.06.007
   Tapsell Linda C, 2006, Med J Aust, V185, pS1
   Bui TT, 2020, CELL IMMUNOL, V351, DOI 10.1016/j.cellimm.2019.104035
   Bui TT, 2019, BIOMED PHARMACOTHER, V109, P1915, DOI 10.1016/j.biopha.2018.11.073
   Thomas Deepa, 2015, Journal of Basic and Clinical Physiology and Pharmacology, V26, P485, DOI 10.1515/jbcpp-2014-0093
   Tian W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020355
   Tignanelli, 2020, 20135095 MEDRXIV
   Tsai ML, 2014, MOL NUTR FOOD RES, V58, P1820, DOI 10.1002/mnfr.201400149
   TYRRELL DA, 1966, LANCET, V1, P76
   TYRRELL DAJ, 1965, BMJ-BRIT MED J, V1, P1467, DOI 10.1136/bmj.1.5448.1467
   TYRRELL DAJ, 1975, INTERVIROLOGY, V5, P76, DOI 10.1159/000149883
   Tzeng TF, 2015, NUTRIENTS, V7, P999, DOI 10.3390/nu7020999
   Uchio R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081822
   Umadevi P, 2020, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2020.1866669
   Vador N, 2012, INDIAN J PHARM SCI, V74, P387, DOI 10.4103/0250-474X.108413
   Valizadeh H, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107088
   van der Hoek L, 2007, ANTIVIR THER, V12, P651
   Vankadari N, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105998
   Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383
   Vellingiri B, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138277
   Venkata KCN, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600950
   Verma S., 2019, Experimental Oncology, V41, P90, DOI 10.32471/exp-oncology.2312-8852.vol-41-no-2.12989
   Rosa SGV, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.40
   Wang F, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137799
   Wang J, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13481
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang W., 2020, DEFINITION RISKS CYT, DOI [10.1101/2020.02.26.20026989, DOI 10.1101/2020.02.26.20026989]
   Wang X, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0169-8
   Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Warriar P, 2019, RECENT PATENTS INFLA, V13, P49, DOI 10.2174/1872213X12666181120091528
   Webb L, 2021, J PSYCHIATR MENT HLT, V28, P300, DOI 10.1111/jpm.12644
   Wen CC, 2007, J MED CHEM, V50, P4087, DOI 10.1021/jm070295s
   WHO, 2021, COVID 19 WEEKL EP UP
   WHO, 2020, WHO DISC HYDR IOP RI
   Wilkinson T, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04584-9
   Williamson BN, 2020, NATURE, V585, P273, DOI [10.1038/s41586-020-2423-5, 10.1101/2020.04.15.043166]
   Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Wu Renyi, 2020, Curr Pharmacol Rep, V6, P56, DOI 10.1007/s40495-020-00216-7
   Wu TT, 2010, J SCI FOOD AGR, V90, P1846, DOI 10.1002/jsfa.4023
   Xia TW, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4039472
   Xia ZY, 2005, J THORAC CARDIOV SUR, V130, P258, DOI 10.1016/j.jtcvs.2005.02.046
   Xian YF, 2018, PHYTOMEDICINE, V50, P196, DOI 10.1016/j.phymed.2018.05.010
   Xiao XF, 2012, J SURG RES, V176, pE31, DOI 10.1016/j.jss.2011.11.1032
   Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363
   Xu CJ, 2018, CLIN NUTR ESPEN, V24, P148, DOI 10.1016/j.clnesp.2017.11.010
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   Xu JM, 2020, ACS INFECT DIS, V6, P909, DOI 10.1021/acsinfecdis.0c00052
   Xu T., 2020, BIORXIV, DOI 10.1101/2020.04.01.017624
   Xu XB, 2015, J FOOD SCI TECH MYS, V52, P1724, DOI 10.1007/s13197-013-1138-0
   Yadav N, 2017, IMMUNOBIOLOGY, V223, P49, DOI 10.1016/j.imbio.2017.10.015
   Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428
   Yamamoto M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060629
   Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343
   Yang RP, 2013, J DERMATOL, V40, P543, DOI 10.1111/1346-8138.12119
   Yang XN, 2018, J PROTEOME RES, V17, P1887, DOI 10.1021/acs.jproteome.7b00901
   Yao L, 2014, IMMUNOL LETT, V161, P76, DOI 10.1016/j.imlet.2014.05.001
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   Yeap SK, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0832-z
   Zahedipour F, 2020, PHYTOTHER RES, V34, P2911, DOI 10.1002/ptr.6738
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zarubin A, 2021, GENES-BASEL, V12, DOI 10.3390/genes12010019
   Zhang F, 2015, CLIN EXP PHARMACOL P, V42, P956, DOI 10.1111/1440-1681.12438
   Zhang Jia-hong, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P589
   Zhang X, 2020, NEUROREPORT, V31, P466, DOI 10.1097/WNR.0000000000001426
   Zhang Y, 2020, J AGR FOOD CHEM, V68, P4893, DOI 10.1021/acs.jafc.0c01473
   Zhao YH, 2019, J NUTR BIOCHEM, V64, P61, DOI 10.1016/j.jnutbio.2018.10.006
   Zhao Yu, 2020, American Journal of Respiratory and Critical Care Medicine, V202, P756, DOI 10.1164/rccm.202001-0179LE
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhou YJ, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110139
   Zick SM, 2015, MOL CARCINOGEN, V54, P908, DOI 10.1002/mc.22163
   Zilaee M, 2019, RESP RES, V20, DOI 10.1186/s12931-019-0998-x
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 481
TC 10
Z9 10
U1 11
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD NOV 1
PY 2021
VL 284
AR 119201
DI 10.1016/j.lfs.2021.119201
EA SEP 2021
PG 35
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA WA3MA
UT WOS:000702792000005
PM 33607159
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Vilallonga, R
   Pellino, G
   Almirante, B
   Gonzalez, JMD
   Blanco-Colino, R
   Petrola, C
   Armengol, M
AF Vilallonga, Ramon
   Pellino, Gianluca
   Almirante, Benito
   Dominguez Gonzalez, Jose Manuel
   Blanco-Colino, Ruth
   Petrola, Carlos
   Armengol, Manel
TI A Risk-Based Screening Approach to Patients Needing Surgery During the
   De-Escalation Phase of COVID-19 Pandemic
SO SURGICAL INNOVATION
LA English
DT Article
DE surgery; COVID-19; 2019-nCoV; guidelines; prevention; diagnosis;
   management
AB Since the outbreak of COVID-19 pandemic, many national and international surgical societies have produced guidelines regarding the management of surgical patients. During the mitigation phase of the pandemic, most documents suggested to consider postponing elective procedures, unless this might have impacted the life expectancy of patients. As awareness and knowledge about COVID-19 are gradually increasing, and as we enter a phase when surgical services are resuming their activities, surgical strategies have to adapt to this rapidly evolving scenario. This is particularly relevant when considering screening policies and the associated findings. We herein describe a risk-based approach to the management of patients with surgical diseases, which might be useful in order to limit the risks for healthcare workers and patients, while allowing for resuming elective surgical practice safely.
C1 [Vilallonga, Ramon] Univ Hosp Vall dHebron, Endocrine Bariatr & Metab Unit, Barcelona, Spain.
   [Pellino, Gianluca] Univ Hosp Vall dHebron, Colorectal Surg, Barcelona, Spain.
   [Almirante, Benito] Univ Hosp Vall dHebron, Infect Dis Dept, Barcelona, Spain.
   [Dominguez Gonzalez, Jose Manuel] Univ Hosp Vall dHebron, Vasc Surg Dept, Barcelona, Spain.
   [Blanco-Colino, Ruth; Petrola, Carlos; Armengol, Manel] Univ Hosp Vall dHebron, Gen Surg Dept, Barcelona, Spain.
RP Vilallonga, R (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Ctr Excellence EAC BC, Endocrine Metab & Bariatr Unit, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.
EM vilallongapuy@hotmail.com
RI Blanco-Colino, Ruth/AAC-7612-2019; , VILALLONGA/AAO-5437-2020
OI Blanco-Colino, Ruth/0000-0003-3303-0655; VILALLONGA,
   RAMON/0000-0001-9333-2765; Petrola Chacon, Carlos/0000-0002-0277-8807;
   Armengol, Manuel/0000-0002-3211-3195; Almirante,
   Benito/0000-0002-1189-2361
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Aminian A, 2020, ANN SURG, V272, pE27, DOI 10.1097/SLA.0000000000003925
   [Anonymous], 2020, NEW ENGL J MED, V383, P1479, DOI 10.1056/NEJMe2029812
   Brindle ME, 2020, ANN SURG, V272, pE1, DOI 10.1097/SLA.0000000000003923
   British society of Thoracic Imaging, 2020, COV 19 BSTI BSGAR DE
   Cavaliere D., RACCOMANDAZIONI PRAT
   Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x
   Chen JL, 2020, MICROBES INFECT, V22, P69, DOI 10.1016/j.micinf.2020.01.004
   Dong SJ, 2020, J MED VIROL, V92, P1542, DOI 10.1002/jmv.25768
   Guan WJ, 2020, NEW ENGL J MED, V382, P1708, DOI [DOI 10.1056/NEJMoa2002032, 10.1056/NEJMoa2002032]
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   He JL, 2020, RESP MED, V168, DOI 10.1016/j.rmed.2020.105980
   Jiang SB, 2020, NATURE, V579, P321, DOI 10.1038/d41586-020-00751-9
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   LI Z, 2020, J MED VIROL, DOI DOI 10.1002/JMV.2572710.1002/JMV.25727
   Liu Y, 2020, LANCET, V395, pE47, DOI 10.1016/S0140-6736(20)30462-1
   Lu Z, 2020, YIXUE XINZHI, V30, P7, DOI DOI 10.12173/j.issn.1004-5511.2020.01.04
   Meyer B, 2014, VIRUS RES, V194, P175, DOI 10.1016/j.virusres.2014.03.018
   Ministry of Health from the Spanish Government, 2020, DIAGN TEST TOOLS
   Ng Ming-Yen, 2020, Radiol Cardiothorac Imaging, V2, pe200034, DOI 10.1148/ryct.2020200034
   Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020
   Spanish Association of Surgery, GRUP TRAB COVID 19
   Spinelli A, 2020, BRIT J SURG, V107, P785, DOI 10.1002/bjs.11627
   Tang A, 2020, EMERG INFECT DIS, V26, P1337, DOI 10.3201/eid2606.200301
   Tang G, 2020, PERIOPERATIVE MANAGE
   Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20
   Tuite AR, 2020, ANN INTERN MED, V172, P567, DOI 10.7326/M20-0358
   Whitman Jeffrey D, 2020, medRxiv, DOI 10.1101/2020.04.25.20074856
   WHO, 2004, SUMM PROB SARS CAS O
   WHO, 2020, NOV COR 2019 N COV S
   Wolf RC, 2020, NEUROPSYCHOBIOLOGY, V79, P335, DOI [10.1038/s41586-020-2196-x, 10.1159/000505601, 10.1038/s41586-020-2984-3]
   World Health Organization, LAB TEST STRAT REC C
   World Health Organization, 2020, MIDDLE E RESP SYNDRO
   World Health Organization (WHO), 2020, COVID 19 STRAT UPD
   Xu BY, 2020, EUR RADIOL, V30, P5720, DOI 10.1007/s00330-020-06934-2
   Yang S, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.66
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
NR 39
TC 1
Z9 1
U1 1
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1553-3506
EI 1553-3514
J9 SURG INNOV
JI Surg. Innov.
PD APR
PY 2021
VL 28
IS 2
SI SI
BP 239
EP 244
AR 1553350620975886
DI 10.1177/1553350620975886
EA DEC 2020
PG 6
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA SS7PK
UT WOS:000621899800001
PM 33345708
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Yusuf, L
   Appeaning, M
   Amole, TG
   Musa, BM
   Galadanci, HS
   Quashie, PK
   Aliyu, IA
AF Yusuf, Lukman
   Appeaning, Mark
   Amole, Taiwo Gboluwaga
   Musa, Baba Maiyaki
   Galadanci, Hadiza Shehu
   Quashie, Peter Kojo
   Aliyu, Isah Abubakar
TI Rapid, Cheap, and Effective COVID-19 Diagnostics for Africa
SO DIAGNOSTICS
LA English
DT Review
DE SARS-CoV-2; LAMP; recombinase amplification; COVID-19 diagnostics
ID RECOMBINASE POLYMERASE AMPLIFICATION; SARS-COV-2; LAMP
AB Background: Although comprehensive public health measures such as mass quarantine have been taken internationally, this has generally been ineffective, leading to a high infection and mortality rate. Despite the fact that the COVID-19 pandemic has been downgraded to epidemic status in many countries, the real number of infections is unknown, particularly in low-income countries. However, precision shielding is used in COVID-19 management, and requires estimates of mass infection in key groups. As a result, rapid tests for the virus could be a useful screening tool for asymptomatic virus shedders who are about to come into contact with sensitive groups. In Africa and other low- and middle-income countries there is high rate of COVID-19 under-diagnosis, due to the high cost of molecular assays. Exploring alternate assays to the reverse transcriptase polymerase chain reaction (RT-PCR) for COVID-19 diagnosis is highly warranted. Aim: This review explored the feasibility of using alternate molecular, rapid antigen, and serological diagnostic assays to accurately and precisely diagnose COVID-19 in African populations, and to mitigate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RT-PCR diagnostic challenges in Africa. Method: We reviewed publications from internet sources and searched for appropriate documents available in English. This included Medline, Google Scholar, and Ajol. We included primary literature and some review articles that presented knowledge on the current trends on SARS-CoV-2 diagnostics in Africa and globally. Results: Based on our analysis, we highlight the utility of four different alternatives to RT-PCR. These include two isothermal nucleic acid amplification assays (loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA)), rapid antigen testing, and antibody testing for tackling difficulties posed by SARS-CoV-2 RT-PCR testing in Africa. Conclusion: The economic burden associated COVID-19 mass testing by RT-PCR will be difficult for low-income nations to meet. We provide evidence for the utility and deployment of these alternate testing methods in Africa and other LMICs.
C1 [Yusuf, Lukman; Aliyu, Isah Abubakar] Bayero Univ Kano, Coll Hlth Sci, Dept Med Lab Sci, Kano 700233, Nigeria.
   [Appeaning, Mark; Quashie, Peter Kojo] Univ Ghana, Coll Basic & Appl Sci, West African Ctr Cell Biol Infect Pathogens WACCB, POB LG54, Accra 23321, Ghana.
   [Appeaning, Mark] Koforidua Tech Univ, Fac Hlth & Allied Sci, Dept Med Lab Sci, POB KF981, Koforidua 03420, Ghana.
   [Amole, Taiwo Gboluwaga; Musa, Baba Maiyaki; Galadanci, Hadiza Shehu; Aliyu, Isah Abubakar] Bayero Univ Kano ACEPHAP, Africa Ctr Excellence Populat Hlth & Policy, Kano 700233, Nigeria.
   [Amole, Taiwo Gboluwaga] Bayero Univ Kano, Aminu Kano Teaching Hosp, Dept Community Med, Kano 700233, Nigeria.
   [Musa, Baba Maiyaki] Bayero Univ Kano, Aminu Kano Teaching Hosp, Coll Hlth Sci, Dept Med, Kano 700233, Nigeria.
   [Galadanci, Hadiza Shehu] Bayero Univ Kano, Coll Hlth Sci, Dept Gynecol & Obstet, Kano 700233, Nigeria.
RP Aliyu, IA (corresponding author), Bayero Univ Kano, Coll Hlth Sci, Dept Med Lab Sci, Kano 700233, Nigeria.; Quashie, PK (corresponding author), Univ Ghana, Coll Basic & Appl Sci, West African Ctr Cell Biol Infect Pathogens WACCB, POB LG54, Accra 23321, Ghana.; Aliyu, IA (corresponding author), Bayero Univ Kano ACEPHAP, Africa Ctr Excellence Populat Hlth & Policy, Kano 700233, Nigeria.
EM usuflukman41@yahoo.com; mappeaning@st.ug.edu.gh; tayade10@yahoo.com;
   babamaiyaki2000@yahoo.co.uk; hgaladanci@yahoo.com; pquashie@ug.edu.gh;
   iaaliyu.mls@buk.edu.ng
OI Appeaning, Mark/0000-0001-5633-4024; Quashie, Peter/0000-0003-4114-5460;
   Aliyu, Isah Abubakar/0000-0002-1484-2837
FU West African Network of Infectious Diseases (WANIDA)
FX This work was funded by West African Network of Infectious Diseases
   (WANIDA). The APC was also funded by the same agency.
CR Abd El Wahed A, 2021, ANAL CHEM, V93, P2627, DOI 10.1021/acs.analchem.0c04779
   Abdullahi IN, 2020, J INFECT DEV COUNTR, V14, P691, DOI 10.3855/jidc.12813
   Afzal A, 2020, J ADV RES, V26, P149, DOI 10.1016/j.jare.2020.08.002
   Aliyu IA, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2202
   Aliyu IA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040335
   Bhat A.I., 2020, CHARACTERIZATION PLA, P383
   Chen ZG, 2019, FOOD ANAL METHOD, V12, P190, DOI 10.1007/s12161-018-1351-6
   Cherkaoui D, 2021, BIOSENS BIOELECTRON, V189, DOI 10.1016/j.bios.2021.113328
   Chi YK, 2020, PLANT DIS, V104, P801, DOI 10.1094/PDIS-07-19-1473-RE
   Clark AE, 2020, CURR OPIN INFECT DIS, V33, P304, DOI 10.1097/QCO.0000000000000659
   Colavita F, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11030425
   Dickinson, 2020, WHAT TESTS COULD POT
   Diego JGB, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11030438
   Gededzha MP, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252317
   Inaba M, 2021, INT J INFECT DIS, V107, P195, DOI 10.1016/j.ijid.2021.04.018
   Khamala A.A., 2020, J GEN MOL VIROL, V10, P1
   Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495
   Lalli Matthew A, 2020, medRxiv, DOI 10.1101/2020.05.07.20093542
   Lampos V, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00384-w
   Lei R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60997-1
   Ling L.Y., 2020, KNOWLESI MALARIA
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Margolin E, 2020, NAT REV MICROBIOL, V18, P690, DOI 10.1038/s41579-020-00441-3
   Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631
   Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9
   Nakamura T, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00234
   Nawattanapaiboon K, 2021, ANALYST, V146, P471, DOI [10.1039/D0AN01775B, 10.1039/d0an01775b]
   Ozcurumez MK, 2020, J ALLERGY CLIN IMMUN, V146, P35, DOI 10.1016/j.jaci.2020.05.020
   Oh J, 2020, HEALTH SYST REFORM, V6, DOI 10.1080/23288604.2020.1753464
   Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413
   Quashie P.K., 2021, WELLCOME OPEN RES, V6, P173, DOI [10.12688/wellcomeopenres.16890.1, DOI 10.12688/WELLCOMEOPENRES.16890.1]
   Rostron P, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3755-6
   Tan W., 2020, VIRAL KINETICS ANTIB, DOI [10.1101/2020.03.24.20042382, DOI 10.1101/2020.03.24.20042382]
   The Foundation for Innovative New Diagnostics, 2020, SARS COV 2 DIAGN PIP
   Thommes L, 2021, INT J INFECT DIS, V105, DOI 10.1016/j.ijid.2021.02.052
   US Food and Drug Administration (US FDA), 2020, COR COVID 19 UPD FDA
   Van Honacker E, 2021, J HOSP INFECT, V114, P144, DOI 10.1016/j.jhin.2021.03.021
   Vandenberg O, 2021, NAT REV MICROBIOL, V19, P171, DOI 10.1038/s41579-020-00461-z
   Whitman Jeffrey D, 2020, medRxiv, DOI 10.1101/2020.04.25.20074856
   WHO, 2020, LAB TESTING CORONAVI
   World Health Organisation, 2020, ANT DET DIAGN SARS C
   World Health Organization, 2016, WORLD MALARIA REPORT
   World Health Organization, 2020, SARS COV 2 ANT DET R
NR 45
TC 1
Z9 1
U1 5
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4418
J9 DIAGNOSTICS
JI Diagnostics
PD NOV
PY 2021
VL 11
IS 11
AR 2105
DI 10.3390/diagnostics11112105
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA XF7QS
UT WOS:000724263100001
PM 34829451
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Al Attar, WSA
   Husain, MA
AF Al Attar, Wesam Saleh A.
   Husain, Mohamed A.
TI Physiotherapists' knowledge and the implementation of COVID-19 infection
   prevention and control measures
SO WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION
LA English
DT Article
DE Health risk; viral transmission; disease control; infectious disease;
   SARS-CoV-2
ID ATTITUDES; EDUCATION
AB BACKGROUND: Physiotherapists are required to recognize their role in managing patients with Coronavirus Disease-19 (COVID-19), and to adopt preventive measures to limit transmission of the disease.
   OBJECTIVE: The aim of this study was to assess the perception, knowledge, and application of the preventive measures taken by physiotherapists in managing issues with confirmed or suspected patients suffering from COVID-19.
   METHODS: A self-administered survey comprising 15 questions was divided into four sections related to precautions when interacting with patients with COVID-19: (1) knowledge of the physiotherapy role, (2) knowledge of preventive measures to limit transmission of the virus, (3) practicing these measures, and (4) managing patients with COVID-19.
   RESULTS: A total of 456 physiotherapists from 139 countries participated in the study. Most physiotherapists were knowledgeable regarding their role in the management of COVID-19 patients (M= 94.3%; SD =15.4) and the management of potential COVID-19 patients (M= 84.5%; SD = 20.1). The rating of knowledge and practices of preventive measures to limit transmission of COVID-19 were lower (M=74.3%; SD = 25.7, and M= 62.5%; SD =31.3, respectively). Participants from the European region (M = 83; SD = 15.8) had a higher score than participants from the Asia Western Pacific region (M = 78; SD= 18.49; P=0.01).
   CONCLUSIONS: Physiotherapists are highly knowledgeable about their role in managing COVID-19 patients. Most of them are adopting preventive measures to limit the transmission of the disease. Yet, physiotherapists are required to enroll in medical education, training and infection control workshops and courses to remain updated with the recent advances in such fields.
C1 [Al Attar, Wesam Saleh A.] Umm Al Qura Univ, Coll Appl Med Sci, Dept Physiotherapy, Mecca, Saudi Arabia.
   [Al Attar, Wesam Saleh A.] Univ Sydney, Fac Med & Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW, Australia.
   [Al Attar, Wesam Saleh A.] Univ Basel, Fac Med, Dept Sport Exercise & Hlth, Basel, Switzerland.
   [Husain, Mohamed A.] Univ Bahrain, Coll Hlth & Sport Sci, Dept Physiotherapy, Manama, Bahrain.
RP Al Attar, WSA (corresponding author), Umm Al Qura Univ, Coll Appl Med Sci, Dept Physiotherapy, Physiotherapy, POB 715, Mecca 21955, Saudi Arabia.
EM wsattar@uqu.edu.sa
RI ; Al Attar, Wesam Saleh A/C-2976-2019
OI Husain, Mohamed/0000-0002-2724-828X; Al Attar, Wesam Saleh
   A/0000-0003-1907-4539
CR Alqahtani AS, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.12.21072
   Baker MG, 2020, MED J AUSTRALIA, V213, P198, DOI 10.5694/mja2.50735
   Bandari DK, 2020, NOVEL CORONAVIRUS CO, V6, DOI DOI 10.1101/2020.03.09.20033381
   CDC, 2020, COR DIS 2019 COVID 1
   Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9
   Ding L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2738-5
   Felten-Barentsz KM, 2020, PHYS THER, V100, P1444, DOI 10.1093/ptj/pzaa114
   Holakouie-Naieni K, 2015, IRAN J PUBLIC HEALTH, V44, P1670
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Kim JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e61
   Lazzeri M, 2020, MONALDI ARCH CHEST D, V90, DOI 10.4081/monaldi.2020.1285
   Li L, 2020, LANCET RESP MED, V8, pE23, DOI 10.1016/S2213-2600(20)30125-9
   Maple Tech International LLC, 2020, SAMPL SIZ CALC
   Physiopedia contributors, 2020, ROL PHYS COVID 19
   Sadeghi R, 2019, J EDUC HEALTH PROMOT, V8, DOI 10.4103/jehp.jehp_357_18
   Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6
   Speroni KG, 2015, J NURS ADMIN, V45, P544, DOI 10.1097/NNA.0000000000000261
   Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]
   Thomas P, 2020, J PHYSIOTHER, V66, P73, DOI 10.1016/j.jphys.2020.03.011
   WHO, 2021, STAT 2 M INT HLTH RE
   World Confederation for Physical Therapy, 2020, US
   World Physiotherapy, 2020, COVID 19 INF HUB
   World Physiotherapy, 2020, COVID 19 COVIDPHYSIO
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   2020, J HOSP INFECT, V105, P419, DOI DOI 10.1016/J.JHIN.2020.05.007
NR 25
TC 1
Z9 1
U1 3
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1051-9815
EI 1875-9270
J9 WORK
JI Work
PY 2021
VL 69
IS 2
BP 351
EP 358
DI 10.3233/WOR-210049
PG 8
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA TC1PJ
UT WOS:000668415000004
PM 34092683
OA Bronze
DA 2022-04-20
ER

PT J
AU Veiga, PM
   Fernandes, C
   Ambrosio, F
AF Veiga, Pedro Mota
   Fernandes, Cristina
   Ambrosio, Filipe
TI Knowledge spillover, knowledge management and innovation of the
   Portuguese hotel industry in times of crisis
SO JOURNAL OF HOSPITALITY AND TOURISM INSIGHTS
LA English
DT Article; Early Access
DE Knowledge management capabilities; Knowledge spillovers; Innovation
   capabilities; Tourism; Hotel industry; COVID-19; Portugal
ID DYNAMIC CAPABILITIES; HOSPITALITY INDUSTRY; EMERGING MARKETS;
   PERFORMANCE; TOURISM; COMPETITIVENESS; ORIENTATION; COOPERATION;
   STRATEGY; FIRMS
AB Purpose - The aim of the study is to analyze how knowledge spillovers and knowledge management capabilities affect the innovation capabilities of hospitality sector companies in crisis environments.
   Design/methodology/approach - A survey was completed by 63 hotel directors based in Portugal, gathering data on knowledge spillover, knowledge management capabilities and innovation capabilities. Two multiple linear regression models were used to estimate the impact of knowledge spillovers and knowledge management capabilities on innovative capability.
   Findings - It has been concluded that knowledge spillovers work as external benefits of knowledge creation, increasing the innovation activities of companies in the hospitality sector, which reinforces that knowledge spillovers help to enhance innovation capabilities. The study's results show that it is essential for companies to manage knowledge. It also concludes that effective knowledge management facilitates the exchange of knowledge required in the innovation process. Knowledge spillovers improve the performance of innovation in companies through the development of new insights and innovation capabilities.
   Research limitations/implications - This research was carried out in a period of crisis. As expected in a troubled period, the results are extremely volatile. This study's sample is composed of Portuguese hospitality companies.
   Originality/value - This research provides valuable insights into the overflow of explicit and tacit knowledge in the hotel industry. Moreover, this study offers new insights into the mediating role of knowledge management capability in the relationship between a hotel's knowledge overflow and its innovation performance.
C1 [Veiga, Pedro Mota] Polytech Inst Viseu, Sch Educ, Viseu, Portugal.
   [Veiga, Pedro Mota] Univ Beira Interior, NECE Res Unit Business Sci, Covilha, Portugal.
   [Fernandes, Cristina] Univ Beira Interior, NECE Res Unit Business Sci, Dept Management & Econ, Covilha, Portugal.
   [Fernandes, Cristina] Loughborough Univ, Ctr Corp Entrepreneurship & Innovat, Loughborough, Leics, England.
   [Ambrosio, Filipe] Polytech Inst Viseu, Lamego Sch Technol & Management, Lamego, Portugal.
RP Veiga, PM (corresponding author), Polytech Inst Viseu, Sch Educ, Viseu, Portugal.; Veiga, PM (corresponding author), Univ Beira Interior, NECE Res Unit Business Sci, Covilha, Portugal.
EM motaveiga@curva-de-gauss.pt
RI Fernandes, Cristina/G-6390-2015
OI Fernandes, Cristina/0000-0001-8560-0758; Mota Veiga,
   Pedro/0000-0003-2722-9510
FU FCT-Foundation for Science and Technology, IP [UIDB/04630/2021]
FX This article is financed with national funds through the FCT-Foundation
   for Science and Technology, IP, under the project "UIDB/04630/2021".
CR Alavi M, 2001, MIS QUART, V25, P107, DOI 10.2307/3250961
   Amran A., 2017, GLOBAL BUSINESS MANA, V9, P298
   Andreeva T, 2012, J KNOWL MANAG, V16, P617, DOI 10.1108/13673271211246185
   Audretsch DB, 2005, RES POLICY, V34, P1191, DOI 10.1016/j.respol.2005.03.012
   BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108
   Bouncken R. B., 2002, Journal of Quality Assurance in Hospitality & Tourism, V3, P25, DOI 10.1300/J162v03n03_03
   Brunswicker S, 2018, RES TECHNOL MANAGE, V61, P35, DOI 10.1080/08956308.2018.1399022
   Cerver-Romero E, 2020, J TECHNOL TRANSFER, V45, P780, DOI 10.1007/s10961-018-9698-9
   Chen CJ, 2009, J BUS RES, V62, P104, DOI 10.1016/j.jbusres.2007.11.016
   Choi B, 2008, OMEGA-INT J MANAGE S, V36, P235, DOI 10.1016/j.omega.2006.06.007
   Cristo-Andrade S, 2020, INT ENTREP MANAG J, V16, P263, DOI 10.1007/s11365-018-0541-4
   Cronin B, 2003, J AM SOC INF SCI TEC, V54, P855, DOI 10.1002/asi.10278
   de Lucca T.A., 2020, BRAZILIAN J DEV, V6, P94766
   Dedu E., 2012, RELATIONSHIP TOURISM, P121
   Donate MJ, 2015, J BUS RES, V68, P360, DOI 10.1016/j.jbusres.2014.06.022
   Fainshmidt S, 2017, INT BUS REV, V26, P1088, DOI 10.1016/j.ibusrev.2017.04.002
   Fernandes CI, 2013, R&D MANAGE, V43, P461, DOI 10.1111/radm.12024
   Ferreira R.R., 2020, MULTILEVEL APPROACH, P9
   Filatotchev I, 2009, J INT BUS STUD, V40, P1005, DOI 10.1057/jibs.2008.105
   Fu X., 2021, GLOB STRATEG J, P1
   Gold AH, 2001, J MANAGE INFORM SYST, V18, P185, DOI 10.1080/07421222.2001.11045669
   Grant D.B, 1986, COMPENSATION BENEFIT, V18, P62
   Grant RM, 1996, ORGAN SCI, V7, P375, DOI 10.1287/orsc.7.4.375
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Hallin CA, 2008, TOURISM MANAGE, V29, P366, DOI 10.1016/j.tourman.2007.02.019
   IMF, 2009, WORLD EC OUTL UPD CO
   Kim TT, 2013, INT J HOSP MANAG, V34, P324, DOI 10.1016/j.ijhm.2013.04.009
   Kloosterman RC, 2008, J ECON GEOGR, V8, P545, DOI 10.1093/jeg/lbn010
   Laws E, 2007, CRISIS MANAGEMENT IN TOURISM, P1, DOI 10.1079/9781845930479.0000
   Lee JC, 2016, COMPUT HUM BEHAV, V54, P462, DOI 10.1016/j.chb.2015.08.030
   Liu PL, 2004, TECHNOVATION, V24, P971, DOI 10.1016/S0166-4972(03)00061-0
   Liu XH, 2010, STRATEG ENTREP J, V4, P340, DOI 10.1002/sej.100
   Lock S., 2020, STATISTA 1026
   Mair J, 2016, CURR ISSUES TOUR, V19, P1, DOI 10.1080/13683500.2014.932758
   Marco-Lajara B, 2019, J BUS RES, V101, P767, DOI 10.1016/j.jbusres.2018.12.045
   Martinez-Martinez A, 2015, TOURISM MANAGE, V50, P281, DOI 10.1016/j.tourman.2015.03.006
   Motshegwa N, 2017, TOUR MANAG PERSPECT, V24, P107, DOI 10.1016/j.tmp.2017.07.022
   Nieves J, 2018, INT J CONTEMP HOSP M, V30, P2537, DOI 10.1108/IJCHM-07-2016-0341
   Nonaka I, 1995, KNOWLEDGE CREATING C
   Parker S.C., 2011, ENTREPRENEURSHIP REC
   Peteraf M, 2013, STRATEGIC MANAGE J, V34, P1389, DOI 10.1002/smj.2078
   Racherla P, 2009, CORNELL HOSP Q, V50, P561, DOI 10.1177/1938965509341633
   Salem IEB, 2014, TOUR HOSP RES, V14, P176, DOI 10.1177/1467358414542265
   Shamim S, 2017, INT J HOSP MANAG, V62, P21, DOI 10.1016/j.ijhm.2016.11.013
   Shapoval Valeriya, 2021, Int J Hosp Manag, V94, P102813, DOI 10.1016/j.ijhm.2020.102813
   Shawa G, 2009, TOURISM MANAGE, V30, P325, DOI 10.1016/j.tourman.2008.02.023
   Sigala M, 2015, INT J HOSP MANAG, V45, P44, DOI 10.1016/j.ijhm.2014.11.003
   Spender JC, 1996, STRATEGIC MANAGE J, V17, P45, DOI 10.1002/smj.4250171106
   Teixeira SJ, 2019, KNOWL MAN RES PRACT, V17, P449, DOI 10.1080/14778238.2018.1561166
   Tzortzaki AM, 2012, FORESIGHT, V14, P242, DOI 10.1108/14636681211239773
   Veiga P.M., 2020, ACCELERATING KNOWLED, P172
   Vereb VN, 2018, J KNOWL ECON, V9, P446, DOI 10.1007/s13132-017-0496-7
   Wang CL, 2007, INT J MANAG REV, V9, P31, DOI 10.1111/j.1468-2370.2007.00201.x
   Wang ZN, 2016, MANAGE DECIS, V54, P1861, DOI 10.1108/MD-06-2015-0231
   Wilden R, 2013, LONG RANGE PLANN, V46, P72, DOI 10.1016/j.lrp.2012.12.001
   Wilke EP, 2019, TOURISM MANAGE, V72, P340, DOI 10.1016/j.tourman.2018.12.015
   World Bank, 2008, GLOBAL ECONOMIC PROSPECTS: TECHNOLOGY DIFFUSION IN THE DEVELOPING WORLD, P1, DOI 10.1596/978-0-8213-7365-1
   Yang JT, 2015, TOTAL QUAL MANAG BUS, V26, P76, DOI 10.1080/14783363.2012.661131
   Yi LF, 2021, J BUS RES, V130, P283, DOI 10.1016/j.jbusres.2021.03.024
   Zafari K, 2020, IND MARKET MANAG, V88, P278, DOI 10.1016/j.indmarman.2020.05.026
NR 60
TC 0
Z9 0
U1 6
U2 6
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2514-9792
EI 2514-9806
J9 J HOSP TOUR INSIGHTS
JI J. Hosp. Tour. Insights
DI 10.1108/JHTI-08-2021-0222
EA FEB 2022
PG 14
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA ZD5EG
UT WOS:000758221200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Shadmi, E
   Chen, YY
   Dourado, I
   Faran-Perach, I
   Furler, J
   Hangoma, P
   Hanvoravongchai, P
   Obando, C
   Petrosyan, V
   Rao, KD
   Ruano, AL
   Shi, LY
   de Souza, LE
   Spitzer-Shohat, S
   Sturgiss, E
   Suphanchaimat, R
   Uribe, MV
   Willems, S
AF Shadmi, Efrat
   Chen, Yingyao
   Dourado, Ines
   Faran-Perach, Inbal
   Furler, John
   Hangoma, Peter
   Hanvoravongchai, Piya
   Obando, Claudia
   Petrosyan, Varduhi
   Rao, Krishna D.
   Ruano, Ana Lorena
   Shi, Leiyu
   de Souza, Luis Eugenio
   Spitzer-Shohat, Sivan
   Sturgiss, Elizabeth
   Suphanchaimat, Rapeepong
   Uribe, Manuela Villar
   Willems, Sara
TI Health equity and COVID-19: global perspectives
SO INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH
LA English
DT Article
DE Health equity; Humanitarian crisis; Pandemic; Covid-19
AB The COVID-19 is disproportionally affecting the poor, minorities and a broad range of vulnerable populations, due to its inequitable spread in areas of dense population and limited mitigation capacity due to high prevalence of chronic conditions or poor access to high quality public health and medical care. Moreover, the collateral effects of the pandemic due to the global economic downturn, and social isolation and movement restriction measures, are unequally affecting those in the lowest power strata of societies. To address the challenges to health equity and describe some of the approaches taken by governments and local organizations, we have compiled 13 country case studies from various regions around the world: China, Brazil, Thailand, Sub Saharan Africa, Nicaragua, Armenia, India, Guatemala, United States of America (USA), Israel, Australia, Colombia, and Belgium. This compilation is by no-means representative or all inclusive, and we encourage researchers to continue advancing global knowledge on COVID-19 health equity related issues, through rigorous research and generation of a strong evidence base of new empirical studies in this field.
C1 [Shadmi, Efrat; Faran-Perach, Inbal] Univ Haifa, Fac Social Welf & Hlth Sci, Cheryl Spencer Dept Nursing, IL-31905 Har Hakarmel, Israel.
   [Chen, Yingyao] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.
   [Dourado, Ines; de Souza, Luis Eugenio] Univ Fed Bahia, Hlth Collect Inst, Salvador, BA, Brazil.
   [Faran-Perach, Inbal] Minist Hlth, Mobile Clin Minimizing Prostitut Damages, Haifa, Israel.
   [Faran-Perach, Inbal] Veahavta Clin, Refugees & Noncitizenship People, Nesher, Israel.
   [Furler, John] Univ Melbourne, Dept Gen Practice, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia.
   [Hangoma, Peter] Univ Zambia, Sch Publ Hlth, Dept Hlth Policy & Management, Lusaka, Zambia.
   [Hangoma, Peter] Chr Michelsen Inst, Bergen, Norway.
   [Hangoma, Peter] Univ Bergen, Bergen Ctr Eth Prior Setting BCEP, Bergen, Norway.
   [Hanvoravongchai, Piya] Chulalongkorn Univ, Fac Med, Bangkok, Thailand.
   [Hanvoravongchai, Piya] Natl Hlth Fdn, Bangkok, Thailand.
   [Hanvoravongchai, Piya] CMB Fdn, Equ Initiat, Bangkok, Thailand.
   [Obando, Claudia] Umea Univ, Dept Clin, Umea, Sweden.
   [Petrosyan, Varduhi] Amer Univ Armenia, Gerald & Patricia Turpanjian Sch Publ Hlth, Yerevan, Armenia.
   [Rao, Krishna D.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA.
   [Ruano, Ana Lorena] CEGSS, Ctr Study Equ & Governance Hlth Syst, Guatemala City, Guatemala.
   [Ruano, Ana Lorena] Univ Bergen, Ctr Int Hlth, Bergen, Norway.
   [Shi, Leiyu] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Hlth Policy & Management, Baltimore, MD USA.
   [Spitzer-Shohat, Sivan] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel.
   [Sturgiss, Elizabeth] Monash Univ, Dept Gen Practice, Melbourne, Vic, Australia.
   [Suphanchaimat, Rapeepong] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand.
   [Suphanchaimat, Rapeepong] Minist Publ Hlth, Div Epidemiol, Dept Dis Control, Bangkok, Thailand.
   [Uribe, Manuela Villar] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Willems, Sara] Univ Ghent, Dept Publ Hlth & Primary Care, Fac Med & Hlth Sci, Ghent, Belgium.
RP Shadmi, E (corresponding author), Univ Haifa, Fac Social Welf & Hlth Sci, Cheryl Spencer Dept Nursing, IL-31905 Har Hakarmel, Israel.
EM eshadmi@univ.haifa.ac.il
RI Dourado, Ines/Q-6535-2016; Ruano, Ana Lorena/AAA-1656-2021; Petrosyan,
   Varduhi/ABG-2964-2020; Willems, Sara/AFU-7707-2022; Willems,
   Sara/AAI-4851-2021; Hanvoravongchai, Piya/A-1569-2012
OI Dourado, Ines/0000-0003-1675-2146; Willems, Sara/0000-0002-6349-7785;
   Hanvoravongchai, Piya/0000-0003-4256-1271; Shadmi,
   Efrat/0000-0001-9752-5724; Ruano, Ana Lorena/0000-0003-3913-4228
CR Agostino J, 2020, PANDEMIC CONTROL HOU
   Amnesty International, 2020, COL MUST PROT PRIS P
   Anderson RM, 2001, CHANGING US HLTH CAR, P3
   [Anonymous], 2020, RAPID ASSESSMENT COV
   [Anonymous], 2017, ILO NEWS
   [Anonymous], XINHUA
   [Anonymous], 2020, DALLAS MORNING NEWS
   Armour S., 2020, WALL STREET J
   AssociacAo Brasileira de Saude Coletiva, LET COV 19 POP NEGR
   AssociacAo de Medicina Intensiva Brasileira, CENS AMIB 2016 UT BR
   Attipoe-Dorcoo S, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01175-7
   Australian Government Department of Health, 2020, COR COVID 19 CURR SI
   Behzadifar M, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01181-9
   Benfer EA, 2020, HLTH AFF, DOI [10.1377/hblog20200319.757883, DOI 10.1377/HBLOG20200319.757883]
   Berwick DM, 2020, HLTH AFF, DOI [10.1377/hblog20200428.846534, DOI 10.1377/HBLOG20200428.846534]
   Biggs A, 2004, PARLIAMENT AUSTR
   Cameron Elizabeth, 2019, 2019 GLOBAL HLTH SEC
   Capatides C, 2020, DOCTORS BORDERS DISP
   Carrieri D, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01193-5
   Chen TX, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01190-8
   Department of Disease Control, COR VIR DIS COVID 19
   Funcia FR, 2019, CIENC SAUDE COLETIVA, V24, P4405, DOI 10.1590/1413-812320182412.25892019
   Garcia-Subirats I, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-10
   Gramajo J, 2020, VECINOS INTIMIDAN MA
   Harkins B., 2019, THAILAND MIGRATION R
   Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169
   Hunt GH, 2020, AUSTR GOVT PARTNERSH
   Hussein J, 2020, COVID 19 WHAT IMPLIC, P1
   Institute Brasileiro de Geografia e Estatistica, 2018, PERF MUN BRAS SAN BA
   Instituto de Pesquisa Economica Aplicada (Ipea), PESQ EST QUE BRAS TE
   Johns B, 2019, GLOB HEALTH-SCI PRAC, V7, pS104, DOI 10.9745/GHSP-D-18-00429
   Jongudomsuk P, 2015, KINGDOM THAILAND HLT, P5
   Kanno-Youngs Z, 2020, FEDERAL GOVT MOBILIZ
   Lamprea E, 2016, HEALTH HUM RIGHTS, V18, P49
   Lawin KG., 2019, IMPACT W AFRICAN EBO
   MAHASE E, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1327
   Makoni M, 2020, LANCET RESP MED, V8, P553, DOI 10.1016/S2213-2600(20)30219-8
   Meadows GN, 2015, MED J AUSTRALIA, V202, P298, DOI 10.5694/mjac14.00330
   Meneses-Navarro S, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01178-4
   Ministerio da Saude/Fiocruz. Ministerio do Planejamento Orcamento e GestAo/IBGE, 2014, MIN PLAN ORC GEST IB
   Miroff N, 2020, CORONAVIRUS COULD BE
   Muscatello DJ, 2010, EMERG INFECT DIS, V16, P1396, DOI 10.3201/eid1609.091723
   Nasreen Z, 2019, CONVERSATION
   O'Connor S, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0359-3
   OECD, 2019, POL NOT VEN MIGR SHO
   Poole DN, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01162-y
   Rede CoVida, CIENC INF SOL PAIN C
   Gomez FR, 2013, REV PANAM SALUD PUBL, V33, P107, DOI 10.1590/S1020-49892013000200005
   Sharma V, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01186-4
   Simmons-Duffin S., 2020, SOME INSURERS WAIVE
   Tangcharoensathien V, 2000, SOC SCI MED, V51, P789, DOI 10.1016/S0277-9536(00)00061-7
   Taylor A, 2020, TRUMP SIGNS 484 BILL
   Tsai J, 2020, LANCET PUBLIC HEALTH, V5, pE186, DOI 10.1016/S2468-2667(20)30053-0
   van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X
   Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383
   Vilar-Compte M, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01187-3
   Waitzberg R, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01191-7
   Ward A, 2020, EXCLUSIVE SENATORS U
   Ward J, 2020, CONVERSATION
   Watt G, 2002, LANCET, V360, P252, DOI 10.1016/S0140-6736(02)09466-7
   WHO, ADDR HUM RIGHTS KEY
   Williams B, 2020, HLTH AFF, DOI [10.1377/hblog20200324.784502, DOI 10.1377/HBLOG20200324.784502]
   World Bank, GINI IND WORLD BANK
   Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548
   Zheng Z, 2020, STRONG EFFECT SOCIOE, DOI [10.1101/2020.04.25.20079400, DOI 10.1101/2020.04.25.20079400]
   Zhou L, 2020, HOUSE JUST PASSED 2
   Ziffer D, 2020, ABC NEWS
NR 67
TC 176
Z9 178
U1 26
U2 54
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-9276
J9 INT J EQUITY HEALTH
JI Int. J. Equity Health
PD JUN 26
PY 2020
VL 19
IS 1
AR 104
DI 10.1186/s12939-020-01218-z
PG 16
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA MF8MC
UT WOS:000545592000001
PM 32586388
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Diawara, I
   Benrahma, H
   Meskaouni, N
   Rahoui, J
   Moujid, FZ
   Jaras, K
   Benmessaoud, R
   Arouro, K
   Aadam, Z
   Nahir, S
   Aouzal, Z
   Elguazzar, H
   Jeddan, L
   Rida, H
   Ousti, F
   El Bakkouri, J
   Smyej, I
   Nejjari, C
AF Diawara, Idrissa
   Benrahma, Houda
   Meskaouni, Nida
   Rahoui, Jalila
   Moujid, Fatima-Zahra
   Jaras, Khadija
   Benmessaoud, Rachid
   Arouro, Khadija
   Aadam, Zahra
   Nahir, Salma
   Aouzal, Zineb
   Elguazzar, Hajar
   Jeddan, Leila
   Rida, Hind
   Ousti, Fadoua
   El Bakkouri, Jalila
   Smyej, Imane
   Nejjari, Chakib
TI A laboratory-based study of COVID-19 in Casablanca, Morocco
SO JOURNAL OF PUBLIC HEALTH IN AFRICA
LA English
DT Article
DE COVID-19; SARS-CoV-2; risk factors; laboratory test; RT-PCR
AB Given the spread of coronavirus disease 2019 (COVID-19) and its impact on human health, laboratory confirmation of diagnosis is essential. This study examined the contribution of laboratory diagnosis to the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the diagnosis of COVID-19, taking into account patient risk of exposure to SARS-CoV-2, clinical symptoms and comorbidities. A cross-sectional, laboratory-based study was carried out from 1 April 2020 to 30 April 2020 at the National Reference Laboratory in Morocco using nasopharyngeal samples from patients admitted to the Cheikh Khalifa International University Hospital or other hospitals in Casablanca. A one-step reverse transcription real-time polymerase chain reaction (RT-PCR) was used to detect the presence of the SARS-CoV-2 genome. A national epidemiological investigation form was used to analyze patient exposure risk, clinical symptoms and comorbidities. A total of 793 samples from 375 patients were analyzed and 1150 RT-PCR tests were conducted; 116 patients (30.93%) were COVID-19 positive. Travel to a risk zone, contact with a confirmed COVID-19 case and contact with a person who had been in a risk zone were significantly associated with being positive for COVID-19. Fever and cough were the main symptoms; 7.76 % of positive patients were asymptomatic. This is the first laboratory-based study in Morocco for the diagnosis of COVID-19. Laboratory diagnosis of COVID-19 by RTPCR associated with knowledge of expo- sure risk factors and clinical symptoms and comorbidities remains essential for clinicians for early, appropriate medical management COVID-19 patients.
C1 [Diawara, Idrissa] Mohammed VI Univ Hlth Sci UM6SS, Fac Nursing & Allied Hlth Sci, Dept Hlth Tech, Bld Mohammed Taieb Naciri, Casablanca 82403, Morocco.
   [Diawara, Idrissa; Benrahma, Houda; Meskaouni, Nida; Rahoui, Jalila; Moujid, Fatima-Zahra; Jaras, Khadija; Benmessaoud, Rachid; Arouro, Khadija; Aadam, Zahra; Nahir, Salma; Aouzal, Zineb; Elguazzar, Hajar; Jeddan, Leila; Rida, Hind; Ousti, Fadoua; El Bakkouri, Jalila; Smyej, Imane] Mohammed VI Univ Hlth Sci UM6SS, Natl Reference Lab, Casablanca, Morocco.
   [Benrahma, Houda] Mohammed VI Univ Hlth Sci UM6SS, Fac Med, Casablanca, Morocco.
   [Nejjari, Chakib] Mohammed VI Univ Hlth Sci UM6SS, Int Sch Publ Hlth, Casablanca, Morocco.
RP Diawara, I (corresponding author), Mohammed VI Univ Hlth Sci UM6SS, Fac Nursing & Allied Hlth Sci, Dept Hlth Tech, Bld Mohammed Taieb Naciri, Casablanca 82403, Morocco.
EM idiawara@um6ss.ma
CR Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Emami A, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.600
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Guarner J, 2020, AM J CLIN PATHOL, V153, P420, DOI 10.1093/ajcp/aqaa029
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Konrad R, 2020, EUROSURVEILLANCE, V25, P13, DOI 10.2807/1560-7917.ES.2020.25.9.2000173
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727
   Liu PL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0896-0
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Phan T, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104211
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   WHO, 2020, REC METH LAB DIAGN S
   WHO, 2020, WHO COVID 19 DISEASE
   WHO. World Health Organization, COR DIS 2019 COVID 1
   Wu D, 2020, INT J INFECT DIS, V94, P44, DOI 10.1016/j.ijid.2020.03.004
   Yu XX, 2020, INFLUENZA OTHER RESP, V14, P474, DOI 10.1111/irv.12743
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 21
TC 0
Z9 0
U1 0
U2 0
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 2038-9922
EI 2038-9930
J9 J PUBLIC HEALTH AFR
JI J. Public Health Africa
PY 2021
VL 12
IS 2
AR 1458
DI 10.4081/jphia.2021.1458
PG 5
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA ZB2WW
UT WOS:000756709700005
PM 35126890
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Secco, G
   Delorenzo, M
   Zattera, C
   Moore, BG
   Demitry, L
   Vezzoni, G
   Resta, F
   Barcella, B
   Cappa, G
   Perrone, T
   Salinaro, F
   Perlini, S
AF Secco, Gianmarco
   Delorenzo, Marzia
   Zattera, Caterina
   Moore, Bianca Giacomuzzi
   Demitry, Lorenzo
   Vezzoni, Giulia
   Resta, Flavia
   Barcella, Bruno
   Cappa, Giovanni
   Perrone, Tiziano
   Salinaro, Francesco
   Perlini, Stefano
TI Lung Ultrasound in Covid-19: A useful diagnostic tool
SO EMERGENCY CARE JOURNAL
LA English
DT Review
DE Lung Ultrasound; Covid-19; SARS-CoV-2; B-lines; LUS SCORE
AB Coronavirus disease 2019 (Covid-19), caused by a novel enveloped RNA betacoronavirus, has recently been declared a public health emergency by the World Health Organization (WHO). The lack of knowledge at the beginning of the pandemics, associated with the inherent risk of infective spreading, makes initial recognition and management particularly complex, in terms of defining effective diagnostic and therapeutic protocols. In the Emergency setting, Lung Ultrasound (LUS) can play an important role in the management of patients with SARS-CoV2-related pneumonia, expanding from the initial diagnosis to the subsequent monitoring and follow-up. Among many other potential advantages (such has the absence of ionizing radiation, its inherent cost-effectiveness, and bedside repeatability), LUS provides immediate diagnostic response and might prevent the risk of spreading the infection by moving the patient from the Emergency Room to the Radiology facilities. Aim of this short review is to define the potential role of lung ultrasound in Covid-19 patients, according to the evidence in the medical literature.
C1 [Secco, Gianmarco; Delorenzo, Marzia; Zattera, Caterina; Demitry, Lorenzo; Vezzoni, Giulia; Resta, Flavia; Barcella, Bruno; Cappa, Giovanni; Salinaro, Francesco; Perlini, Stefano] Univ Pavia, IRCCS Policlin San Matteo Fdn, Emergency Med & Emergency Med Postgrad Training P, Dept Internal Med, Viale Liberti 11, Pavia, Italy.
   [Moore, Bianca Giacomuzzi] Hop Morges Ensemble Hop Cote, Internal Med, Morge, Switzerland.
   [Perrone, Tiziano] Univ Pavia, IRCCS Policlin San Matteo Fdn, Internal Med, Dept Internal Med, Pavia, Italy.
RP Secco, G (corresponding author), Univ Pavia, IRCCS Policlin San Matteo Fdn, Emergency Med & Emergency Med Postgrad Training P, Dept Internal Med, Viale Liberti 11, Pavia, Italy.
EM secco.gianmarco@gmail.com
RI secco, gianmarco/ABC-9391-2020; Salinaro, Francesco/AAZ-6603-2020
OI secco, gianmarco/0000-0001-9476-6645; Salinaro,
   Francesco/0000-0002-6117-4392
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Bouhemad B, 2015, ANESTHESIOLOGY, V122, P437, DOI 10.1097/ALN.0000000000000558
   Cortellaro F, 2012, EMERG MED J, V29, P19, DOI 10.1136/emj.2010.101584
   Demi M, 2020, IEEE T ULTRASON FERR, V67, P612, DOI 10.1109/TUFFC.2019.2949597
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Huang Y, 2020, RES SQUARE, DOI [10.21203/rs. 2.24369/v1, DOI 10.21203/RS.2.24369/V1]
   Lichtenstein D, 1997, AM J RESP CRIT CARE, V156, P1640, DOI 10.1164/ajrccm.156.5.96-07096
   Lichtenstein DA, 2007, CRIT CARE MED, V35, pS250, DOI 10.1097/01.CCM.0000260674.60761.85
   Mayo PH, 2019, INTENS CARE MED, V45, P1200, DOI 10.1007/s00134-019-05725-8
   Ministero della Salute, NUOV COR COS CE SAP
   Mojoli F, 2019, AM J RESP CRIT CARE, V199, P701, DOI 10.1164/rccm.201802-0236CI
   Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6
   Perrone T, 2017, EUR J INTERN MED, V46, P61, DOI 10.1016/j.ejim.2017.07.034
   Soldati G, 2007, G ITAL CARDIOL, V8, P139, DOI 10.1714/678.7896
   Soldati G, 2020, J ULTRAS MED, V39, P1459, DOI 10.1002/jum.15284
   Soldati G, 2016, J ULTRAS MED, V35, P2075, DOI 10.7863/ultra.15.08023
   Testa A, 2012, CRIT CARE, V16, DOI 10.1186/cc11201
   Via G, 2012, MINERVA ANESTESIOL, V78, P1282
   Volpicelli G, 2012, INTENS CARE MED, V38, P577, DOI 10.1007/s00134-012-2513-4
   World Health Organization (WHO), 2020, COR
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 21
TC 8
Z9 8
U1 0
U2 0
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 1826-9826
EI 2282-2054
J9 EMER CARE J
JI Emer. Care J.
PY 2020
VL 16
IS 1
BP 35
EP 38
AR 9017
DI 10.4081/ecj.2020.9017
PG 4
WC Emergency Medicine
WE Emerging Sources Citation Index (ESCI)
SC Emergency Medicine
GA NK4UD
UT WOS:000566726100010
OA gold
DA 2022-04-20
ER

PT J
AU Mohammadi, MK
   Mohibbi, AA
   Hedayati, MH
AF Mohammadi, Mustafa Kamel
   Mohibbi, Abdul Aziz
   Hedayati, Mohammad Hadi
TI Investigating the challenges and factors influencing the use of the
   learning management system during the Covid-19 pandemic in Afghanistan
SO EDUCATION AND INFORMATION TECHNOLOGIES
LA English
DT Article
DE E-learning; LMS; Challenges of E-learning; HELMS; Covid-19; Adoption
   factors
AB Successful implementation and use of learning management systems (LMSs) have become a critical challenge for many higher education institutes during the Covid-19 pandemic. Although LMSs with lots of features were developed for universities, the success of those systems is highly related to a detailed understanding of challenges and factors influencing the use of the systems among their users. HELMS (Higher Education Learning Management System) is a countrywide LMS used for teaching and learning during the quarantine period caused by covid-19 in Afghanistan universities. As it was the first experience of Afghan universities in using the learning management systems during the pandemic, challenges were expected to appear. No previous research has been conducted on either studying the challenges of using the HELMS or investigating the factors influencing the use of HELMS during the Covid-19 pandemic in Afghanistan. Hence, there was no unified view of the potential challenges of using HELMS and factors influencing the use of the HELMS among the researchers. This research aims to investigate the challenges that face the use of HELMS and explore the factors influencing the use of HELMS among both lecturers and students. This study employed a qualitative research method by conducting semi-structured interviews with 100 participants including university management, lecturers, and students. Thematic analysis was used as a method for the analysis of qualitative data. The findings of this research will help policymakers, researchers, and practitioners in public and private universities to grasp knowledge on the successful implementation and use of LMSs during covid-19 and afterward.
C1 [Mohammadi, Mustafa Kamel] Bamyan Univ, Educ Fac, Dept Comp Educ, Bamyan, Afghanistan.
   [Mohibbi, Abdul Aziz] Kabul Univ, Agr Fac, Kabul, Afghanistan.
   [Hedayati, Mohammad Hadi] Kabul Univ, Comp Sci Fac, Kabul, Afghanistan.
RP Mohammadi, MK (corresponding author), Bamyan Univ, Educ Fac, Dept Comp Educ, Bamyan, Afghanistan.
EM mustafakamel@bu.edu.af; aziz.mohibbi@bu.edu.af; hdhedayati@gmail.com
OI Mohammadi, Mustafa Kamel/0000-0003-4474-6405
CR Al Musawi AS, 2004, BRIT J EDUC TECHNOL, V35, P363, DOI 10.1111/j.0007-1013.2004.00394.x
   Al-araibi AAM, 2019, EDUC INF TECHNOL, V24, P567, DOI 10.1007/s10639-018-9780-9
   Alaeddini M, 2010, 2010 2nd International Conference on Education Technology and Computer (ICETC 2010), P529, DOI 10.1109/ICETC.2010.5529486
   Alariqi A.A., 2019, ACM INT C P SERIES, P176, DOI [10.1145/3369255.3372275, DOI 10.1145/3369255.3372275]
   Aldowah H, 2019, IEEE ACCESS, V7, P48792, DOI 10.1109/ACCESS.2019.2910148
   Almaiah M.A., 2018, J THEORETICAL APPL I, V96, P5962
   Almaiah MA, 2020, EDUC INF TECHNOL, V25, P5261, DOI 10.1007/s10639-020-10219-y
   Almaiah MA, 2019, IEEE ACCESS, V7, P171907, DOI 10.1109/ACCESS.2019.2956349
   Alqahtani AY, 2020, EDUC SCI, V10, DOI 10.3390/educsci10090216
   Ameen N, 2019, BRIT J EDUC TECHNOL, V50, P1434, DOI 10.1111/bjet.12651
   Aung TN, 2016, ADV INTELL SYST, V388, P405, DOI 10.1007/978-3-319-23207-2_41
   Bamyan University, 2020, E LEARN STAT BAM U
   Beebe M., 2010, E LEARNING AFGHANIST
   Bohlen J.M, 1956, DIFFUSION PROCESS, P111
   Castro R, 2019, EDUC INF TECHNOL, V24, P2523, DOI 10.1007/s10639-019-09886-3
   Chang SC, 2007, LEARN ORGAN, V14, P155, DOI 10.1108/09696470710727014
   De Smet C., 2016, JSSE J SOC SCI ED, V15, P27
   DeLone WH, 1992, INFORM SYST RES, V3, P60, DOI 10.1287/isre.3.1.60
   Dhawan Shivangi, 2020, Journal of Educational Technology Systems, V49, P5, DOI 10.1177/0047239520934018
   El-Masri M, 2017, ETR&D-EDUC TECH RES, V65, P743, DOI 10.1007/s11423-016-9508-8
   Eltahir ME, 2019, IEEE ACCESS, V7, P97784, DOI 10.1109/ACCESS.2019.2930411
   Embi M.A., 2011, E LEARNING MALAYSIAN
   Embi M.A., 2011, E LEARNING MALAYSIAN
   Embi M.A., 2011, E LEARNING MALAYSIAN
   Embi M.A., 2011, E LEARNING MALAYSIAN, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Francis, 2019, INT J HIGH ED, V9, P133, DOI [10.5430/ijhe.v9n1p133, DOI 10.5430/IJHE.V9N1P133]
   Hofstede G., 2010, CULTURES ORG, DOI [10.1007/s11569-007-0005-8, DOI 10.1007/S11569-007-0005-8]
   Hussin S, 2011, E LEARNING MALAYSIAN
   Ibrahim MM, 2019, INT J EDUC TECHNOL H, V16, DOI 10.1186/s41239-019-0145-2
   ITU, 2019, IND US INT POP AFGH
   ITU, 2019, MOB CELL SUBSCR PER
   Kamba MA, 2009, INT J EMERG TECHNOL, V4, P66, DOI 10.3991/ijet.v4i1.653
   Kaplan B., 2005, EVALUATING ORG IMPAC, P30, DOI DOI 10.1007/0-387-30329-4_2
   Lau PYY, 2017, HUM RESOUR DEV INT, V20, P159, DOI 10.1080/13678868.2016.1246306
   Leacock T, 2005, LEARN ORGAN, V12, P355, DOI 10.1108/09696470510599136
   Leavy P., 2017, RES DESIGN QUANTITAT, DOI [10.1177/1558689817751775, DOI 10.1177/1558689817751775]
   Lin CY, 2019, INT J HUM-COMPUT INT, V35, P584, DOI 10.1080/10447318.2018.1480694
   Mailizar M., 2020, EURASIA J MATH SCI T, V16, DOI 10.29333/ejmste/8240
   Malekipour A, 2016, INTERDISCIPLINARY J, V7, P0, DOI [10.5812/ijvlms.12153, DOI 10.5812/IJVLMS.12153]
   Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444
   Marshall S., 2012, J OPEN FLEXIBLE DIST, V16, P141
   Meriem B, 2020, EDUC INF TECHNOL, V25, P2297, DOI 10.1007/s10639-019-10075-5
   Pham L, 2019, INT J EDUC TECHNOL H, V16, DOI 10.1186/s41239-019-0136-3
   Quick J, 2015, J Perioper Pract, V25, P129
   Rosacker KM, 2008, TRANSFORM GOV-PEOPLE, V2, P60, DOI 10.1108/17506160810862955
   Rosenberg M.J., 2002, PERFORM IMPROV, V41, P50, DOI [10.1002/pfi.4140410512, DOI 10.1002/PFI.4140410512]
   Roumell EA, 2016, EDUC POLICY, V30, P365, DOI 10.1177/0895904814550070
   Sabherwal R, 2006, MANAGE SCI, V52, P1849, DOI 10.1287/mnsc.1060.0583
   Sarvestani SM., 2019, INTERDISCIPLINARY J, V10, P1
   Serrano DR, 2019, EUR J EDUC, V54, P273, DOI 10.1111/ejed.12330
   Shanaah A, 2011, ROLE LEARNING MANAGE, V57
   Shraim K, 2010, INFORM TECHNOL DEV, V16, P159, DOI 10.1080/02681102.2010.501782
   Shroff RH, 2007, COMMUN ASSOC INF SYS, V19, P241
   Snoussi, 2019, INT J INNOVATIVE TEC, V8, P664, DOI DOI 10.35940/IJITEE.L1161.10812S19
   Sokout H, 2018, ICEMT 2018: PROCEEDINGS OF THE 2018 2ND INTERNATIONAL CONFERENCE ON EDUCATION AND MULTIMEDIA TECHNOLOGY, P49, DOI 10.1145/3206129.3239428
   Thongsri N, 2020, INNOV EDUC TEACH INT, V57, P577, DOI 10.1080/14703297.2019.1585904
   Tracy S.J., 2013, QUALITATIVE RES METH, DOI [10.5613/rzs.43.1.6, DOI 10.5613/RZS.43.1.6]
   Vaismoradi M., 2016, J NURSING ED PRACTIC, V6, P100, DOI [DOI 10.5430/JNEP.V6N5P100, 10.5430/jnep.v6n5p100]
   Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048
   Vershitskaya ER, 2020, EDUC INF TECHNOL, V25, P611, DOI 10.1007/s10639-019-09978-0
   Weaver D, 2008, AUSTRALAS J EDUC TEC, V24, P30
   Weil P., 2004, IT GOVERNANCE TOP PE
   WHO, 2020, COR COVID 19 EV HAPP
NR 63
TC 2
Z9 2
U1 4
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1360-2357
EI 1573-7608
J9 EDUC INF TECHNOL
JI Educ. Inf. Technol.
PD SEP
PY 2021
VL 26
IS 5
BP 5165
EP 5198
DI 10.1007/s10639-021-10517-z
EA APR 2021
PG 34
WC Education & Educational Research
WE Social Science Citation Index (SSCI)
SC Education & Educational Research
GA UJ0NG
UT WOS:000637695300001
PM 33841030
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Castro, SV
   Perez-Chiques, E
   Meza, O
   Gonzalez, SCA
AF Varela Castro, Samanta
   Perez-Chiques, Elizabeth
   Meza, Oliver
   Campos Gonzalez, Sergio A.
TI Managerial Challenges of Emotional Labor Disruption: The COVID-19 Crisis
   in Mexico
SO REVIEW OF PUBLIC PERSONNEL ADMINISTRATION
LA English
DT Article; Early Access
DE emotional labor; management; Mexico; Covid-19; frontline workers
ID EXHAUSTION
AB The purpose of this article is to contribute to the knowledge of managing emotional labor during a crisis. The COVID-19 pandemic has been a disrupting event, particularly affecting frontline healthcare workers and their supervisors who faced pressures to manage emotions during their interactions with patients. Emotional labor has been studied in emergencies; however, the case of Mexico offers insights into an understudied context and a long and singular crisis. Drawing from multi-level storytelling interviews with medical managers, physicians, and nurses in hospitals in different states of Mexico, this article argues that COVID-19 blurred relationships between performance and outcomes of emotional labor. As the organizational goal focused mainly on saving lives, some workers intensified and performed emotional labor innovatively, but others deviated from feeling rules. Managers' role became crucial for employees to abide by affective requirements facing disruption.
C1 [Varela Castro, Samanta] Ctr Res & Teaching Econ CIDE, Polit Publ, Carretera Mexico Toluca 3655, Alvaro Obregon 01210, Mexico.
   [Perez-Chiques, Elizabeth; Meza, Oliver; Campos Gonzalez, Sergio A.] Ctr Res & Teaching Econ CIDE, Aguascalientes, Aguascalientes, Mexico.
RP Castro, SV (corresponding author), Ctr Res & Teaching Econ CIDE, Polit Publ, Carretera Mexico Toluca 3655, Alvaro Obregon 01210, Mexico.
EM samantavarela.castro@alumnos.cide.edu
OI Perez-Chiques, Elizabeth/0000-0003-4432-718X
CR Agee J, 2009, INT J QUAL STUD EDUC, V22, P431, DOI 10.1080/09518390902736512
   Blau G, 2012, CAREER DEV INT, V17, P626, DOI 10.1108/13620431211283788
   Campos SA, 2020, REV MEX ANAL POLITIC, V9, P4
   Costakis HR, 2021, HUM SERV ORG MANAGE, V45, P29, DOI 10.1080/23303131.2020.1818157
   Davidovitz M, 2021, J COMP POLICY ANAL, V23, P120, DOI 10.1080/13876988.2020.1841561
   Global Health Security Index , 2019, GHS IND COUNTR PROF
   Gonzalez Block Miguel A, 2020, Health Syst Transit, V22, P1
   Grandey A., 2013, EMOTIONAL LABOR 21 C
   Grandey AA, 2003, ACAD MANAGE J, V46, P86, DOI 10.2307/30040678
   Grandey AA, 2004, J ORGAN BEHAV, V25, P397, DOI 10.1002/job.252
   Grandey AA, 2019, CURR DIR PSYCHOL SCI, V28, P131, DOI 10.1177/0963721418812771
   Grandey AA, 2015, ANNU REV ORGAN PSYCH, V2, P323, DOI 10.1146/annurev-orgpsych-032414-111400
   Guy M.E., 2019, PALGRAVE HDB GLOBAL
   Guy ME, 2013, INT J EMERG SERV, V2, P6, DOI 10.1108/IJES-07-2012-0033
   Hendel T, 2000, Int Nurs Rev, V47, P224, DOI 10.1046/j.1466-7657.2000.00046.x
   Henderson AC, 2020, PUBLIC MONEY MANAGE, DOI 10.1080/09540962.2020.1831180
   Hochschild AR, 2012, MANAGED HEART: COMMERCIALIZATION OF HUMAN FEELING, P1
   Kalkman J, 2020, FRONTLINE WORKERS CR, DOI [10.1093/acrefore/9780190228637.001.0001/acrefore-9780190228637-e-1527, DOI 10.1093/ACREFORE/9780190228637.001.0001/ACREFORE-9780190228637-E-1527]
   Kroll A, 2021, GOVERNANCE, V34, P87, DOI 10.1111/gove.12476
   Levy JS, 2008, CONFLICT MANAG PEACE, V25, P1, DOI 10.1080/07388940701860318
   Mann SC, 2015, J HOMEL SECUR EMERG, V12, P145, DOI 10.1515/jhsem-2013-0087
   Mao XR, 2018, INT J DISAST RISK RE, V27, P602, DOI 10.1016/j.ijdrr.2017.10.020
   Mastracci, 2008, EMOTIONAL LABOR PUTT
   Mastracci S., 2019, ANN EMERG DISPATCH R, V7, P5
   Mastracci S.H., 2011, EMOTIONAL LABOR CRIS
   Mastracci S, 2015, J HOMEL SECUR EMERG, V12, P875, DOI 10.1515/jhsem-2014-0060
   Mexico Health Secretariat , 2020, GUID HOSP REC
   Mexico Health Secretariat , 2020, REC GEN STRAT PROT M
   Mexico Health Secretariat , 2002, OP RUL QUAL MAN MON
   Meza O, 2021, J COMP POLICY ANAL, V23, P109, DOI 10.1080/13876988.2020.1846993
   Musheno, 2003, COPS TEACHERS COUNSE
   Pozniak R, 2020, MOVEMENTS J CRITICAL, V5, P2364
   Quarantelli E. L., 2007, HDB DISASTER RES, P16
   RAFAELI A, 1987, ACAD MANAGE REV, V12, P23, DOI 10.2307/257991
   Sanchez-Talanquer M., 2021, MEXICOS RESPONSE COV
   Stark A., 2015, RISK CRISIS MANAGEME
   't Hart Paul., 2021, GOVERNING PANDEMIC P
NR 37
TC 0
Z9 0
U1 4
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0734-371X
EI 1552-759X
J9 REV PUBLIC PERS ADM
JI Rev. Public Pers. Adm.
AR 0734371X211060735
DI 10.1177/0734371X211060735
EA JAN 2022
PG 19
WC Public Administration
WE Social Science Citation Index (SSCI)
SC Public Administration
GA YC0NX
UT WOS:000739398100001
DA 2022-04-20
ER

PT J
AU Poggiali, E
   Bastoni, D
   Ferrari, M
   Moretto, D
   Buttafava, F
   Ramos, PM
   Burzio, V
   Petri, J
   Magnacavallo, A
   Vercelli, A
AF Poggiali, Erika
   Bastoni, Davide
   Ferrari, Mariachiara
   Moretto, Dario
   Buttafava, Federico
   Ramos, Pau Mateo
   Burzio, Valentina
   Petri, Jolanda
   Magnacavallo, Andrea
   Vercelli, Andrea
TI COVID-19 or not COVID-19, that is the question. The role of screening
   criteria and point-of-care lung ultrasound in the triage decision-making
   process in an Emergency Department during the phase 2 of the COVID-19
   Italian epidemic
SO EMERGENCY CARE JOURNAL
LA English
DT Article
DE COVID-19; lung ultrasound; Italian epidemic; triage; Emergency
   Department
AB In the COVID-19 era the real challenge for the Emergency Departments (ED) is to avoid the spread of the viral infection within the so called "clean area" of the emergency room and the hospital. Different protocols have been proposed and adopted in the EDs to quickly identify suspected COVID-19 patients and to correctly manage these patients, all based on clinical and epidemiological criteria. To the best of our knowledge, our pre-triage decisional making-process first integrates the pre-triage interview with point-of-care Lung Ultrasound (LUS) performed in the triage area. The aim of our study is to assess the sensitivity and specificity of our screening clinical and/or epidemiological criteria, and to investigate the role of LUS in the triage decision-making process during the "phase 2" of the COVID-19 Italian epidemic. Our study confirms the pivotal role of the triage in the decision-making process and the management of the entire ED, and it demonstrates that further studies are necessary to validate the role of LUS as tool to promptly identify COVID-19 patients, if combined with a correct pre-triage interview.
C1 [Poggiali, Erika; Bastoni, Davide; Ferrari, Mariachiara; Moretto, Dario; Buttafava, Federico; Ramos, Pau Mateo; Burzio, Valentina; Petri, Jolanda; Magnacavallo, Andrea; Vercelli, Andrea] Guglielmo da Saliceto Hosp, Emergency Dept, Via Giuseppe Taverna 49, Piacenza, Italy.
RP Poggiali, E (corresponding author), Guglielmo da Saliceto Hosp, Emergency Dept, Via Giuseppe Taverna 49, Piacenza, Italy.
EM erikapoggiali2@gmail.com
RI Poggiali, Erika/AAD-6669-2022
CR Buonsenso D, 2020, EUR REV MED PHARMACO, V24, P2776, DOI 10.26355/eurrev_202003_20549
   Carenzo L, 2020, ANAESTHESIA, V75, P928, DOI 10.1111/anae.15072
   Chakraborty C, 2020, EUR REV MED PHARMACO, V24, P4016, DOI 10.26355/eurrev_202004_20871
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Comelli Ivan, 2020, Acta Biomed, V91, P45, DOI 10.23750/abm.v91i2.9565
   Dacrema A, 2021, INTERN EMERG MED, V16, P1297, DOI 10.1007/s11739-020-02596-6
   Erika P, 2020, INTERN EMERG MED, V15, P879, DOI 10.1007/s11739-020-02350-y
   Fiala MJ, 2020, ANN EMERG MED, V75, P784, DOI 10.1016/j.annemergmed.2020.03.033
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Levy Y, 2020, ISR MED ASSOC J, V22, P404
   Maniscalco Pietro, 2020, Acta Biomed, V91, P97, DOI 10.23750/abm.v91i2.9635
   Nakao H, 2017, ACUTE MED SURG, V4, P379, DOI 10.1002/ams2.293
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Poggiali Erika, 2020, Acta Biomed, V91, DOI 10.23750/abm.v91i3.9908
   Poggiali Erika, 2020, Eur J Case Rep Intern Med, V7, P001632, DOI 10.12890/2020_001632
   Poggiali E, 2020, RADIOLOGY, V295, pE6, DOI 10.1148/radiol.2020200847
   Soldati G, 2020, J ULTRAS MED, V39, P1413, DOI 10.1002/jum.15285
   Sorlini C, 2021, INTERN EMERG MED, V16, P749, DOI 10.1007/s11739-020-02524-8
   Turcato G, 2020, INTERN EMERG MED, V15, P1517, DOI 10.1007/s11739-020-02465-2
   Vetrugno L, 2020, ECHOCARDIOGR-J CARD, V37, P625, DOI 10.1111/echo.14664
   Volpicelli G, 2020, ULTRASOUND J, V12, DOI 10.1186/s13089-020-00171-w
   Wee LE, 2020, ACAD EMERG MED, V27, P379, DOI 10.1111/acem.13984
NR 22
TC 1
Z9 1
U1 0
U2 0
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 1826-9826
EI 2282-2054
J9 EMER CARE J
JI Emer. Care J.
PY 2021
VL 17
IS 2
AR 9708
DI 10.4081/ecj.2021.9708
PG 6
WC Emergency Medicine
WE Emerging Sources Citation Index (ESCI)
SC Emergency Medicine
GA TB1GC
UT WOS:000667690000005
OA gold
DA 2022-04-20
ER

PT J
AU Anagiotos, A
   Petrikkos, G
AF Anagiotos, Andreas
   Petrikkos, Georgios
TI Otolaryngology in the COVID-19 pandemic era: the impact on our clinical
   practice
SO EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
LA English
DT Review
DE SARS-CoV-2; COVID-19; Pandemic; Otolaryngology; Clinical practice
   guidelines
AB Purpose To give an overview of the current knowledge about COVID-19 pandemic and its impact on otolaryngology clinical practice. Methods Recent findings about SARS-CoV-2 virus and the COVID-19 infection it causes are reviewed. In addition to international databases and in the absence of hard scientific data, literature search included reports published online from scientific societies and other institutions. Results The role of anosmia as a COVID-19-related symptom is presented. Further, considerations about steroid administration in ENT-related conditions are also discussed. Due to the close work with mucosa surfaces of the upper aerodigestive tract, otolaryngologists and surrounding staff are considered high risk for coronavirus transmission. Hence, staff protection measures for ENT examinations, surgeries and other procedures during COVID-19 pandemic are recommended. Conclusion Knowledge and evidence about the impact of COVID-19 infection on otolaryngology clinical practice are accumulating rapidly. Additionally to patient's management, safety of health care professionals should be a main goal right now by following strict safety guidelines.
C1 [Anagiotos, Andreas] Nicosia Gen Hosp, Dept Otorhinolaryngol, 215 Nicosia Limassol Old Rd, CY-2029 Nicosia, Cyprus.
   [Petrikkos, Georgios] European Univ Cyprus, Sch Med, Nicosia, Cyprus.
   [Petrikkos, Georgios] Natl & Kapodistrian Univ Athens, Sch Med, Univ Gen Hosp Attikon, Infect Dis Res Lab,Dept Internal Med 4, Athens, Greece.
RP Anagiotos, A (corresponding author), Nicosia Gen Hosp, Dept Otorhinolaryngol, 215 Nicosia Limassol Old Rd, CY-2029 Nicosia, Cyprus.
EM andreas.anagiotos@gmail.com
RI Anagiotos, Andreas/ABB-3311-2021
OI Anagiotos, Andreas/0000-0002-2314-0263
CR American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), 2020, OT COVID 19 PAND
   American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), 2020, TRACH REC COVID 19 P
   American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), 2020, AC SUPP CMS OFF SPEC
   American Head and Neck Society (AHNS), 2020, COVID 19 AFF OUR HEA
   [Anonymous], 2020, AN HYP DYSG SYMPT CO
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Bousquet J, 2020, ALLERGY
   CEORL-HNS, 2020, CONF EUR OT HEAD NEC
   Cho RHW, 2020, J OTOLARYNGOL-HEAD N, V49, DOI 10.1186/s40463-020-00427-4
   DGHNO-KHC, 2020, STELL HNO VERB AT HN
   DGHNO-KHC, 2020, STELL ANW GLUK BEI E
   DGHNO-KHC BVHNO, 2020, GEM EMPF DGHNO KHC H
   DGHNO-KHC BVHNO, 2020, AKT INF ZUM THEM PRA
   Eliezer M, 2020, JAMA OTOLARYNGOL HEA
   ENT UK, 2020, COVID 19 EP MAN
   ENT UK, 2020, NAS END LAR EX ENT P
   ENT UK, 2020, GUID UND OT PROC COV
   ENT UK, 2020, COVID 19 TONS QUINS
   ENT UK, 2020, GUID SURG TRACH TRAC
   ENT UK, 2020, LOSS SENS SMELL MARK
   ENT UK-British Association for Paediatric Otolaryngology (BAPO), 2020, BAPO STAT SARS COV2
   ENT-UK, 2020, FRAM OP TRACH COVID
   European Rhinologic Society, 2020, INF RHIN COVID 19
   Givi B, 2020, JAMA OTOLARYNGOL HEA
   Hopkins C, 2020, GUIDELINE MANAGEMENT
   Hopkins C, 2020, J OTOLARYNGOL-HEAD N, V49, DOI 10.1186/s40463-020-00423-8
   Hwang P, 2020, PRECAUTIONS ENDOSCOP
   Jackler R., 2020, COVID 19 EAR SURG
   Kaye R, 2020, COVID 19 ANOSMIA REP
   Kluge S, 2020, AWMF S1 EMPFEHLUNGEN
   Krajewska J, 2020, EUR ARCH OTO-RHINO-L, P1
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Luers JC, 2020, LARYNGO RHINO OTOL, V99, P287, DOI 10.1055/a-1095-2344
   Nunan D, 2020, LOSS SMELL TASTE SYM
   Russell CD, 2020, LANCET, VS0140-6736, P30317
   Sociedad Espanola de Neurologia (SEN), 2020, REC SOC ESP NEUR SEN
   Tay JK, 2020, JAMA OTOLARYNGOL, V146, P517, DOI 10.1001/jamaoto.2020.0764
   The American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), 2020, NEW REC REG URG NON
   The Australian Society of Otolaryngology Head and Neck Surgery (ASOHNS), 2020, AUSTR GUID ENT SURG
   US Centers for Disease Control and Prevention, 2020, INT INF PREV CONTR R
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Van Gerven L, 2020, RHINOLOGY, V58, P289, DOI 10.4193/Rhin20.119
   Vroegop AV, 2020, B-ENT, V16, P81, DOI 10.5152/B-ENT.2020.20127
   WHO, 2020, MOD TRANSM COVID 19
   Workman A.D., 2020, ENDONASAL INSTRUMENT, V00, P1
   World Health Organization, 2020, QUEST ANSW COR COVID
   World Health Organization, 2020, WHO VIRT PRESS C COV
   Zheng MH, 2020, ANN SURG, V272, pE5, DOI 10.1097/SLA.0000000000003924
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 49
TC 17
Z9 17
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0937-4477
EI 1434-4726
J9 EUR ARCH OTO-RHINO-L
JI Eur. Arch. Oto-Rhino-Laryn.
PD MAR
PY 2021
VL 278
IS 3
BP 629
EP 636
DI 10.1007/s00405-020-06161-x
EA JUN 2020
PG 8
WC Otorhinolaryngology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Otorhinolaryngology
GA QJ7IG
UT WOS:000542556800001
PM 32577905
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Lee, JY
   Yahiaoui, D
   Lee, KP
   Cooke, FL
AF Lee, Jeoung Yul
   Yahiaoui, Dorra
   Lee, Khan-Pyo
   Cooke, Fang Lee
TI Global talent management and multinational subsidiaries' resilience in
   the Covid-19 crisis: Moderating roles of regional headquarters' support
   and headquarters-subsidiary friction
SO HUMAN RESOURCE MANAGEMENT
LA English
DT Article; Early Access
DE Covid-19; foreign subsidiary resilience; global talent development;
   global talent management; headquarters-subsidiary friction; regional
   headquarters
ID FOREIGN SUBSIDIARIES; KNOWLEDGE TRANSFER; DISASTER RECOVERY; RESOURCE;
   ENTERPRISES; PERCEPTIONS; PERFORMANCE; FRAMEWORK; SURVIVAL; DISTANCE
AB Resilience is central to developing organizational capability to respond to global crises such as the Covid-19 pandemic. To date, few studies have examined the relationship between global talent management (GTM) and the organizational resilience of multinational enterprise (MNE) subsidiaries during crises. This study contributes to the GTM and crisis management literature by examining the role of GTM in MNE subsidiaries' resilience during the Covid-19 crisis. Based on the sample of 166 Korean MNEs and their 1227 foreign subsidiaries, including 293 regional headquarters, operating in 49 host countries, this study shows a positive and significant impact of GTM on the resilience of Korean MNEs subsidiaries. Drawing on agency problems at the subsidiary level and bounded rationality at the headquarters level as factors that may bring about failure in TM in MNEs, as well as a core competence perspective, we shed light on the importance of the three-layered governance structure of MNEs in the analysis of GTM and MNE subsidiaries' resilience. The study has practical implications for Korean MNEs and the organizational resilience of MNEs' subsidiaries during crises more generally.
C1 [Lee, Jeoung Yul] Chongqing Technol & Business Univ, Natl Res Base Intelligent Mfg Serv, Chongqing, Peoples R China.
   [Lee, Jeoung Yul] Hongik Univ, Sch Business Management, Sejong, South Korea.
   [Yahiaoui, Dorra] Kedge Business Sch, Marseille 9, France.
   [Lee, Khan-Pyo] Sogang Univ, Business Sch, Seoul, South Korea.
   [Cooke, Fang Lee] Monash Univ, Monash Business Sch, Melbourne, Vic, Australia.
RP Cooke, FL (corresponding author), Monash Univ, Monash Business Sch, Melbourne, Vic, Australia.
EM fang.cooke@monash.edu
OI Lee, Jeoung Yul/0000-0002-8751-4594
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [NSFC 71832003]
FX National Natural Science Foundation of China, Grant/Award Number: NSFC
   71832003
CR Adler PS, 2002, ACAD MANAGE REV, V27, P17, DOI 10.2307/4134367
   Allison PD., 2012, LOGISTIC REGRESSION, VSecond
   Avey JB, 2009, HUM RESOUR MANAGE-US, V48, P677, DOI 10.1002/hrm.20294
   Bae J., 2003, ASIA PAC BUS REV, V9, P76
   Bailey K, 2021, INT J MANAG REV, V23, P3, DOI 10.1111/ijmr.12237
   Bardoel EA, 2014, ASIA PAC J HUM RESOU, V52, P279, DOI 10.1111/1744-7941.12033
   Benito R.G., 1997, NATURE INT FIRMS, P309
   Bjorkman I, 2004, J INT BUS STUD, V35, P443, DOI 10.1057/palgrave.jibs.8400094
   Branzei O, 2010, J INT BUS STUD, V41, P804, DOI 10.1057/jibs.2010.6
   Bundy J, 2017, J MANAGE, V43, P1661, DOI 10.1177/0149206316680030
   Caligiuri P, 2020, J INT BUS STUD, V51, P697, DOI 10.1057/s41267-020-00335-9
   Cappelli P., 2008, TALENT DEMAND MANAGI
   Carney M, 2009, ASIA PAC J MANAG, V26, P361, DOI 10.1007/s10490-009-9139-2
   Cerdin JL, 2014, J WORLD BUS, V49, P245, DOI 10.1016/j.jwb.2013.11.008
   Chang SE, 2010, DISASTERS, V34, P303, DOI 10.1111/j.1467-7717.2009.01130.x
   Chung CC, 2015, J INT BUS STUD, V46, P806, DOI 10.1057/jibs.2015.15
   Chung CC, 2010, J INT BUS STUD, V41, P500, DOI 10.1057/jibs.2009.72
   Chung C, 2020, HUM RESOUR MANAGE-US, V59, P537, DOI 10.1002/hrm.22011
   Collings D.G., 2008, INT HUMAN RESOURCE M, V2nd ed., P87
   Collings DG, 2021, J MANAGE STUD, V58, P1378, DOI 10.1111/joms.12695
   Collings DG, 2019, J MANAGE, V45, P540, DOI 10.1177/0149206318757018
   Collings DG, 2018, INT J HUM RESOUR MAN, V29, P165, DOI 10.1080/09585192.2017.1380064
   Collings DG, 2015, HUM RESOUR MANAGE R, V25, P233, DOI 10.1016/j.hrmr.2015.04.005
   Collings DG, 2009, HUM RESOUR MANAGE R, V19, P304, DOI 10.1016/j.hrmr.2009.04.001
   De Cieri H, 2019, J NURS SCHOLARSHIP, V51, P580, DOI 10.1111/jnu.12502
   Debroux P, 2012, ELGAR ORIG REF, P620
   Delios A, 2001, ACAD MANAGE J, V44, P1028, DOI 10.2307/3069446
   Deming W.E, 1990, SAMPLE DESIGN BUSINE, V23
   Dhanaraj C, 2004, STRATEGIC MANAGE J, V25, P295, DOI 10.1002/smj.372
   Dowell GWS, 2011, STRATEGIC MANAGE J, V32, P1025, DOI 10.1002/smj.923
   Farndale E, 2010, J WORLD BUS, V45, P161, DOI 10.1016/j.jwb.2009.09.012
   Fowler F. J., 2009, SURVEY RES METHODS
   Fred Garcia H., 2006, STRATEGY LEADERSHIP, V34, P4, DOI DOI 10.1108/10878570610637849
   Garavan TN, 2012, EUR J TRAIN DEV, V36, P5, DOI 10.1108/03090591211192601
   Gong YP, 2003, ACAD MANAGE J, V46, P728, DOI 10.2307/30040664
   Greene W. H., 2003, ECONOMETRIC ANAL
   Hardin JW, 2002, GEN ESTIMATING EQUAT
   Harney B, 2021, HUM RESOUR MANAGE R, V31, DOI 10.1016/j.hrmr.2021.100824
   Heinen J.S., 2004, EMPLOY REL TOD, V31, P67
   Hennart JF, 1998, ORGAN SCI, V9, P382, DOI 10.1287/orsc.9.3.382
   Hofstede G., 1980, CULTURES CONSEQUENCE
   Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245
   Horak S, 2019, INT J HUM RESOUR MAN, V30, P1419, DOI 10.1080/09585192.2017.1362659
   House R.J., 2004, CULTURE LEADERSHIP O
   Huang SY, 2011, SMALL GR RES, V42, P669, DOI 10.1177/1046496411410073
   Jiang CL, 2019, ASIA PAC BUS REV, V25, P3, DOI 10.1080/13602381.2018.1507283
   Kennedy P., 1992, GUIDE ECONOMETRICS
   Khan Z, 2020, J WORLD BUS, V55, DOI 10.1016/j.jwb.2017.06.009
   Khoreva V, 2017, EMPL RELAT, V39, P19, DOI 10.1108/ER-01-2016-0005
   Kim H, 2010, J INT BUS STUD, V41, P1141, DOI 10.1057/jibs.2010.17
   Konig A, 2020, ACAD MANAGE REV, V45, P130, DOI 10.5465/amr.2017.0387
   KOGUT B, 1988, J INT BUS STUD, V19, P411, DOI 10.1057/palgrave.jibs.8490394
   Lafley AG, 2009, HARVARD BUS REV, V87, P54
   Lee JY, 2014, INT J HUM RESOUR MAN, V25, P588, DOI 10.1080/09585192.2013.792860
   Lee JY, 2010, LONG RANGE PLANN, V43, P585, DOI 10.1016/j.lrp.2010.02.008
   Lengnick-Hall CA, 2011, HUM RESOUR MANAGE R, V21, P243, DOI 10.1016/j.hrmr.2010.07.001
   Linnenluecke MK, 2017, INT J MANAG REV, V19, P4, DOI 10.1111/ijmr.12076
   Long JS., 2006, REGRESSION MODELS CA
   Marshall MI, 2015, NAT HAZARDS, V79, P331, DOI 10.1007/s11069-015-1845-0
   Marshall MI, 2014, NAT HAZARDS, V72, P597, DOI 10.1007/s11069-013-1025-z
   McDonnell A, 2010, J WORLD BUS, V45, P150, DOI 10.1016/j.jwb.2009.09.015
   Mellahi K, 2010, J WORLD BUS, V45, P143, DOI 10.1016/j.jwb.2009.09.018
   Meyer KE, 2018, INT J HUM RESOUR MAN, V29, P1827, DOI 10.1080/09585192.2017.1336362
   Minbaeva D., 2015, ROUTLEDGE COMPANION, P13
   Mithani MA, 2020, ACAD MANAGE PERSPECT, V34, P508, DOI 10.5465/amp.2019.0054
   Moenkemeyer G, 2012, HUM RELAT, V65, P627, DOI 10.1177/0018726711431350
   Morris S, 2016, J INT BUS STUD, V47, P723, DOI 10.1057/jibs.2015.25
   Napathorn C, 2020, REV INT BUS STRATEGY, V30, P537, DOI 10.1108/RIBS-04-2020-0043
   O'Donnell SW, 2000, STRATEGIC MANAGE J, V21, P525, DOI 10.1002/(SICI)1097-0266(200005)21:5<525::AID-SMJ104>3.0.CO;2-Q
   O'Leary MB, 2014, MIS QUART, V38, P1219
   Our World in Data, 2021, COR SOURC DAT
   Piansoongnern O., 2008, EUROPEAN J SOCIAL SC, V6, P70
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Preece D, 2013, INT J HUM RESOUR MAN, V24, P3457, DOI 10.1080/09585192.2013.777676
   Rothwell W.J., 1994, EFFECTIVE SUCCESSION
   Scullion H, 2006, ROUT GLOB HUM RESOUR, P1
   Shenkar O, 2001, J INT BUS STUD, V32, P519, DOI 10.1057/palgrave.jibs.8490982
   SIMON HA, 1979, AM ECON REV, V69, P493
   Sit A, 2017, INT J INTERCULT REL, V57, P1, DOI 10.1016/j.ijintrel.2017.01.001
   Son J, 2020, INT J HUM RESOUR MAN, V31, P2188, DOI 10.1080/09585192.2018.1443955
   Song S, 2017, MANAGE INT REV, V57, P545, DOI 10.1007/s11575-017-0317-z
   Sparrow P., 2013, STRATEGIC TALENT MAN
   Stahl GK, 2010, J INT BUS STUD, V41, P690, DOI 10.1057/jibs.2009.85
   Stiles, 2007, GLOBAL TALENT MANAGE
   Studenmund, 1992, USING ECONOMETRICS P
   Tang CSK, 2006, J PSYCHOSOM RES, V61, P699, DOI 10.1016/j.jpsychores.2006.07.014
   Tarique I., 2021, ROUTLEDGE COMPANION
   Tarique I, 2010, J WORLD BUS, V45, P122, DOI 10.1016/j.jwb.2009.09.019
   Teo WL, 2017, J CONTING CRISIS MAN, V25, P136, DOI 10.1111/1468-5973.12179
   TOOTHMAKER LE, 1994, J OPER RES SOC, V45, P119
   Torres AP, 2019, J CONTING CRISIS MAN, V27, P168, DOI 10.1111/1468-5973.12248
   Tung RL, 2010, J INT BUS STUD, V41, P1259, DOI 10.1057/jibs.2010.41
   Vaiman V., 2019, MACRO TALENT MANAGEM
   Vaiman V, 2013, INT J HUM RESOUR MAN, V24, P1737, DOI 10.1080/09585192.2013.777544
   Vance CM, 2013, INT J HUM RESOUR MAN, V24, P985, DOI 10.1080/09585192.2012.743475
   Wang J, 2014, ASIA PAC J HUM RESOU, V52, P132, DOI 10.1111/1744-7941.12026
   Wildavsky, 1988, SEARCHING SAFETY
   Witt M.A., 2014, OXFORD HDB ASIAN BUS, P216
   Witt MA, 2013, SOCIO-ECON REV, V11, P265, DOI 10.1093/ser/mwt002
   Wooten LP, 2008, ADV DEV HUM RESOUR, V10, P352, DOI 10.1177/1523422308316450
   Yahiaoui D, 2021, HUM RESOUR MANAGE-US, V60, P771, DOI 10.1002/hrm.22063
   Yahiaoui D, 2015, INT J HUM RESOUR MAN, V26, P1665, DOI 10.1080/09585192.2014.958513
   Zaheer S, 2012, J INT BUS STUD, V43, P18, DOI 10.1057/jibs.2011.43
   Zimmermann A, 2011, J VOCAT BEHAV, V78, P351, DOI 10.1016/j.jvb.2011.03.016
   Zou MM, 2009, INT J HUM RESOUR MAN, V20, P2349, DOI 10.1080/09585190903239708
NR 105
TC 1
Z9 1
U1 8
U2 8
PU WILEY PERIODICALS, INC
PI SAN FRANCISCO
PA ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA
SN 0090-4848
EI 1099-050X
J9 HUM RESOUR MANAGE-US
JI Hum. Resour. Manage.
DI 10.1002/hrm.22100
EA FEB 2022
PG 18
WC Psychology, Applied; Management
WE Social Science Citation Index (SSCI)
SC Psychology; Business & Economics
GA YY6DP
UT WOS:000754878500001
DA 2022-04-20
ER

PT J
AU Mansoor, T
   Mansoor, S
   bin Zubair, U
AF Mansoor, Taskeen
   Mansoor, Sawera
   bin Zubair, Usama
TI 'Surviving COVID-19': Illness Narratives of Patients and Family Members
   in Pakistan
SO ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN
LA English
DT Article
DE COVID-19; Illness Narratives; Stigma
ID LESSONS
AB Objective: To explore the emic perspective of survivors and their family members with regards to their lived experience with COVID-19
   Study Design: Cross sectional qualitative research using phenomenological approach with a constructivist paradigm. Telephonic interviews of patients from Punjab and KP for 2 weeks during May 2020, as approved by the ethical review committee of Fauji Foundation Hospital, Rawalpindi
   Methods: Non-probability maximum variation purposive sampling technique was employed to conduct semi structured interviews with 22 individuals; including those who had tested positive for COVID-19 on PCR test and recovered after minimum 2 weeks of isolation, along with their family members. Braun and Clarke's thematic analysis was done concurrently with data collection and management.
   Results: 5 data-driven themes with 21 subthemes were; "Perceived Susceptibility": symptoms, risk factors, causes/origin, modes of transmission, "Knowledge and Experience with Precautionary Behaviors": use of masks, hygiene practices, social distancing, religiosity, "Treatment seeking behavior: Perceived costs and benefits": experience with test, complementary home remedies, medical treatment, mistrust for quarantine facilities, interaction with health care practitioners, less priority to other diseases, "Psycho-social dimensions of COVID-19": guilt and fear, caregiver burden, family quarantined, renewed spiritual connections, "Barriers to Care": health care workers: dichotomy of praise and stigma, media: dramatic and traumatic, stigma-behavior of others.
   Conclusion: This study revealed the lived experiences of COVID-19 survivors and their family members, detailing their conceptualization with regards to disease vulnerability and associated precautionary behaviors. It mainly showed how survivors and family members navigate through biomedical systems, complementary healing practices, resilience and stigma.
C1 [Mansoor, Taskeen] Natl Univ Med Sci, Dept Social & Behav Sci, Rawalpindi, Pakistan.
   [Mansoor, Sawera] Fdn Univ Med Coll, Dept Psychiat, Islamabad, Pakistan.
   [bin Zubair, Usama] Misericordiae Univ Hosp, Psychiat Dept Mater, Dublin, Ireland.
RP Mansoor, S (corresponding author), Fdn Univ Med Coll, Dept Psychiat, Islamabad, Pakistan.
EM sawera85@gmail.com
RI bin zubair, usama/AAK-3927-2020
CR Aliakbari Dehkordi M., 2020, IRANIAN J HLTH PSYCH, V2, P9, DOI [10.30473/ijohp.2020.52395.1074, DOI 10.30473/IJOHP.2020.52395.1074]
   Almutairi AF, 2018, J INFECT PUBLIC HEAL, V11, P187, DOI 10.1016/j.jiph.2017.06.011
   Azhar M., 2020, DATA MODEL PREDICT P
   Bo HX, 2021, PSYCHOL MED, V51, P1052, DOI 10.1017/S0033291720000999
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Claude KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223104
   Dey I., 2012, GROUNDING GROUNDED T
   Dutheil F, 2021, PSYCHOL MED, V51, P1773, DOI 10.1017/S0033291720001336
   Ge HP, 2020, EUR J CLIN MICROBIOL, V39, P1011, DOI 10.1007/s10096-020-03874-z
   HAIDER II, 2020, PAKISTAN J MED SCI, DOI DOI 10.12669/PJMS.36.C0VID19-S4.2756
   Hall RCW, 2008, GEN HOSP PSYCHIAT, V30, P446, DOI 10.1016/j.genhosppsych.2008.05.003
   James PB, 2020, COMPLEMENT THER CLIN, V39, DOI 10.1016/j.ctcp.2020.101127
   Jang WM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122161
   Krystal JH, 2020, NAT MED, V26, P639, DOI 10.1038/s41591-020-0878-4
   Mendoza C, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007970
   Michaud K, 2020, ACR OPEN RHEUMATOL, V2, P335, DOI 10.1002/acr2.11148
   Nuriddin A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000410
   Onyeaka HK, 2020, CUREUS, V12, DOI 10.7759/cureus.7351
   Rabelo I, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00142
   Sun NN, 2020, AM J INFECT CONTROL, V48, P592, DOI 10.1016/j.ajic.2020.03.018
   Taylor S, J ANXIETY
   Tognotti E, 2013, EMERG INFECT DIS, V19, P254, DOI 10.3201/eid1902.120312
   Tufford L, 2012, QUAL SOC WORK, V11, P80, DOI 10.1177/1473325010368316
   Yamanis T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005077
NR 24
TC 6
Z9 6
U1 1
U2 3
PU RESEARCH & MEDICAL EDUCATION CENTRE
PI LAHORE
PA KING EDWARD MEDICAL COLLEGE, NILA GUMBAD, LAHORE, 00000, PAKISTAN
SN 2079-7192
EI 2079-0694
J9 ANN KING EDWARD MED
JI Ann. King Edward Med. Univ. Lahore Pak.
PY 2020
VL 26
SI SI
BP 157
EP 164
PG 8
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA OI7HU
UT WOS:000583445800014
DA 2022-04-20
ER

PT J
AU Snawerdt, J
   Finoli, L
   Bremmer, DN
   Cheema, T
   Bhanot, N
AF Snawerdt, Jessica
   Finoli, Lauren
   Bremmer, Derek N.
   Cheema, Tariq
   Bhanot, Nitin
TI Therapeutic Options for the Treatment of Coronavirus Disease (COVID-19)
SO CRITICAL CARE NURSING QUARTERLY
LA English
DT Article
DE antimalarial agents; antivirals; COVID-19; SARS-CoV-2; treatment
ID ACUTE RESPIRATORY SYNDROME; CRITICALLY-ILL PATIENTS; VITAMIN-C; SARS;
   SEPSIS; IVERMECTIN; GUIDELINES; MANAGEMENT; PNEUMONIA; EFFICACY
AB Coronavirus disease 2019 (COVID-19) has resulted in an unprecedented pandemic, challenging practitioners to identify safe and effective therapeutic options in a limited amount of time. The rapid genomic sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provided a significant number of therapeutic targets. Repurposed and investigational agents are being studied for use in COVID-19. Although knowledge is rapidly expanding in regard to COVID-19 and there is promise with a few agents, there are no definitely proven effective therapies at this time. Supportive care remains the mainstay of therapy while ongoing clinical trials are being conducted.
C1 [Snawerdt, Jessica; Finoli, Lauren; Bremmer, Derek N.] Allegheny Gen Hosp, Allegheny Hlth Network, Dept Pharm, Pittsburgh, PA 15212 USA.
   [Cheema, Tariq] Allegheny Gen Hosp, Allegheny Hlth Network, Div Pulm Crit Care, Pittsburgh, PA 15212 USA.
   [Bhanot, Nitin] Allegheny Gen Hosp, Allegheny Hlth Network, Div Infect Dis, 320 East North Ave, Pittsburgh, PA 15212 USA.
RP Bhanot, N (corresponding author), Allegheny Gen Hosp, Allegheny Hlth Network, Div Infect Dis, 320 East North Ave, Pittsburgh, PA 15212 USA.
EM Nitin.Bhanot@ahn.org
RI Lin, Chen/AFV-2163-2022
OI Reis, AlessanRSS/0000-0001-8486-7469
CR ACC, 2020, VENT ARRH RISK DUE H
   Alhazzani W, 2020, CRIT CARE MED, V48, pE440, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]
   Annane D, 2017, CRIT CARE MED, V45, P2078, DOI 10.1097/CCM.0000000000002737
   [Anonymous], 2020, GIL ANN RES PHAS 3 T
   Arabi Y, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1490-9
   Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC
   Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885
   Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao W, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa102
   Chaccour C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1801-4
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03
   Chen RC, 2006, CHEST, V129, P1441, DOI 10.1378/chest.129.6.1441
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   De Meyer S, 2020, INT J INFECT DIS, V97, P7, DOI 10.1016/j.ijid.2020.05.085
   Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117
   Erol A, 2020, J THORAC DIS S1, V12, pS84, DOI 10.31219/osf.io/p7ex8
   FDA, 2020, INV COV 19 CONV PLAS
   FDA, 2020, EM US AUTH
   FEHR AR, 2015, METHOD MOL BIOL, V1282, DOI [10.1007/978-1-4939-2438-7_1, DOI 10.1007/978-1-4939-2438-7_1]
   Fowler AA, 2019, JAMA-J AM MED ASSOC, V322, P1261, DOI 10.1001/jama.2019.11825
   Fujii T, 2020, JAMA-J AM MED ASSOC, V323, P423, DOI 10.1001/jama.2019.22176
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guzzo CA, 2002, J CLIN PHARMACOL, V42, P1122, DOI 10.1177/009127002401382731
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   IDSA Infectious DIseases Society of America, 2020, INF DIS SOC AM GUID
   Johnson & Johnson, 2020, LACK EV SUPP US DAR
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Lee N, 2004, J CLIN VIROL, V31, P304, DOI 10.1016/j.jcv.2004.07.006
   Luo P., 2020, J MED VIROL
   Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396
   Marik PE, 2020, J THORAC DIS, V12, pS84, DOI 10.21037/jtd.2019.12.64
   Marik PE, 2017, CHEST, V151, P1229, DOI 10.1016/j.chest.2016.11.036
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Morra ME, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1977
   NIH, 2020, COVID 19 TREATM GUID
   Ramos-Casals M, 2014, LANCET, V383, P1503, DOI 10.1016/S0140-6736(13)61048-X
   Regeneron, REG SAN PROV UP US P
   Rossingol JF, 2016, J INFECT PUBLIC HEAL, V9, P227, DOI 10.1016/j.jiph.2016.04.001
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9
   Soo YOY, 2004, CLIN MICROBIOL INFEC, V10, P676, DOI 10.1111/j.1469-0691.2004.00956.x
   Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Tan ELC, 2004, EMERG INFECT DIS, V10, P581, DOI 10.3201/eid1004.030458
   Villar Jesus, 2020, Crit Care Explor, V2, pe0111, DOI 10.1097/CCE.0000000000000111
   Villar J, 2020, LANCET RESP MED, V8, P267, DOI 10.1016/S2213-2600(19)30417-5
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   XU X, 2020, EFFECTIVE TREATMENT, DOI [10.1073/pnas.2005615117, DOI 10.1073/PNAS.2005615117]
   Yan D., 2020, EFFICACY HYDROXYCHLO, DOI 10.1101/2020.03.22.20040758
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 62
TC 2
Z9 2
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0887-9303
EI 1550-5111
J9 CRIT CARE NURS Q
JI Crit. Care Nurs. Q.
PD OCT-DEC
PY 2020
VL 43
IS 4
SI SI
BP 349
EP 368
DI 10.1097/CNQ.0000000000000321
PG 20
WC Critical Care Medicine
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA NQ8VF
UT WOS:000571144900004
PM 32833772
DA 2022-04-20
ER

PT J
AU Tome, E
   Gromova, E
   Hatch, A
AF Tome, Eduardo
   Gromova, Elizaveta
   Hatch, Andrew
TI Did the Bubble Burst? The Portuguese Economy During COVID-19
SO MANAGEMENT & MARKETING-CHALLENGES FOR THE KNOWLEDGE SOCIETY
LA English
DT Article
DE Portuguese Economy; Covid-19; bubble burst
AB In this paper we analyse the situation of the Portuguese Economy referring to the Covid-19. We start by contextualizing in the problematic "Bubble - Miracle" as described by Tome, 2018. We then analyse the current situation in a Macroeconomic way, according to eight specific questions, and then we specify regarding four sectors, namely tourism, education, the public sector, and the industrial sector. We conclude that the Covid-19 is the ultimate and unexpected test to the Portuguese economy, and that it will contribute to solving the "Bubble vs. Miracle" question. Rather curiously, we believe that the Covid-19 will accelerate the change to the "Miracle" society, because solving the crisis will require changes that will direct the society towards the "Miracle" paradigm and will distance Portugal from the old and "Bubble" one.
C1 [Tome, Eduardo; Hatch, Andrew] Univ Europeia Lisbo, Lisbo, Spain.
   [Gromova, Elizaveta] Peter Great St Petersburg Polytech Univ, St Petersburg, Russia.
RP Tome, E (corresponding author), Univ Europeia Lisbo, Lisbo, Spain.
EM eduardo.tome@gmail.com; lizaveta-90@yandex.ru; ahatch@gwcentres.com
RI tome, eduardo/F-2308-2011
OI tome, eduardo/0000-0001-6335-5501
CR Almeida F, 2020, VIAGEM AO FUTURO POS
   Anibal S., 2020, PORTUGAL PERANTE DES
   [Anonymous], 2020, JN
   [Anonymous], 2020, MONDE
   [Anonymous], 2018, THE PORTUGAL NEWS
   [Anonymous], 2020, PESTLE AN
   [Anonymous], 2020, CNN
   [Anonymous], 2020, BBC NEWS
   [Anonymous], 2020, THE PORTUGAL NEWS
   [Anonymous], 2020, EXPRESSO
   [Anonymous], 2020, LUSA
   APOPartner, 2020, MOD PLAN CONT COVID
   Banco de Portugal, 2020, PREV EC
   Blomqvist K., 1997, SCAND J MANAG, V13, P271, DOI DOI 10.1016/S0956-5221(97)84644-1
   Bolisani E., 2018, EMERGENT KNOWLEDGE S
   Bratianu C., 2015, ORG KNOWLEDGE DYNAMI
   Bratianu C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041348
   Bratianu C, 2020, KYBERNETES, V49, P6, DOI 10.1108/K-02-2019-0122
   Bratianu C, 2019, SYSTEMS-BASEL, V7, DOI 10.3390/systems7020020
   Brower T., 2020, WHY AGILE IS MINDSET
   Corpas M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000080
   Dima AM, 2017, P INT CONF BUS EXCEL, V11, P64, DOI 10.1515/picbe-2017-0007
   Dollinger M, 2019, J LEARN ANAL, V6, P10, DOI 10.18608/jla.2019.62.2
   Drahokoupil, 2020, POLITICAL BUSINESS C
   Duncan R, 2020, WHAT WILL POST COVID
   Edwards John, 2011, Electronic Journal of Knowledge Management, V9, P297
   EstamosOn, 2020, QUE FOI DECLARADO ES
   European Commission, 2020, EC FOR PORT
   European Commission, 2020, SUMM EC FOR
   European Parliament, 2020, COV 19 EU PLAN EC RE
   Galha L, 2020, HIST QUEM NAO CONS S
   Germain Marie-Line, 2018, NARCISSISM WORK PERS, VFirst, DOI [10.1007/978-3-319-60330-8, DOI 10.1007/978-3-319-60330-8]
   Goldman S.L., 1995, AGILE COMPETITORS VI
   Goleman D., 1995, EMOTIONAL INTELLIGEN
   Idealista, 2018, THER IS HOUS BUBBL R
   Kahneman D., 2011, THINKING
   Larman C., 2004, AGILE ITERATIVE DEV
   Levy BH, 2020, CE VIRUS QUI REND FO
   Liechfield G, 2020, WERE NOT GOING BACK
   Manifesto, 2020, MANIFESTO AGILE SOFT
   Martins C., 2020, J SOCIAL LEGAL STUDI, VVII
   Milheiro J., 2020, LISBOA VAI TER MONUM
   Ministerio da Saude, 2020, COV 19 ASS AUG 12 20
   Musgrave R., 1957, FINANZARCHIV, V25, P33
   National Institute of Statistics, 2020, EST COM INT
   Neto R., 2020, QUASE 4 CADA 10 REST
   Neto R, 2020, PORTUGAL PERDEU 97 T
   Nunes R, 2020, AEROPORTO LISBOA JA
   Oliveira R. M, 2020, QUEM VIAJA MADEIRA E
   Penela R., 2020, ESTADO CALAMIDADE NA
   Portuguese Repubic, 2020, STATE BUDGET 2020
   Rencher A., 2012, WILEY SERIES PROBABI, V709
   Samuelson P., 2013, ECONOMICS
   Setroikromo R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00318
   Smiljanic J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148528
   Smith S, 2008, EC SOCIAL PROBLEMS
   Sousa J, 2020, PORTUGAL SWEDEN 5 EU
   Sutherland J., 2014, CROWN BUSINESS
   The Editors of Encyclopaedia Britannica, 2020, ENCY BRITTANICA
   Tome E, 2005, B INFORM TRABAJO SOC
   Tome E., 2018, P INT C TOUR RES ICT
   Tome E., 2020, KM POST COVID 19 NEW
   Tome E., 2012, INT HUMAN RESOURCE D, P93
   Trading Economics, 2020, TRADING EC
   Watson K., 2020, ED TRAINING, V62, P31
   World Travel Awards, 2020, WORLD TRAVEL AWARDS
   Zizek S, 2020, POLITY
NR 67
TC 3
Z9 3
U1 5
U2 10
PU SCIENDO
PI WARSAW
PA BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND
SN 1842-0206
EI 2069-8887
J9 MANAG MARK
JI Manag. Mark.
PD OCT
PY 2020
VL 15
SU 1
BP 477
EP 495
DI 10.2478/mmcks-2020-0028
PG 19
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA OH5NR
UT WOS:000582631600005
OA gold
DA 2022-04-20
ER

PT J
AU Mattone, E
   Sofia, M
   Schembari, E
   Palumbo, V
   Bonaccorso, R
   Randazzo, V
   La Greca, G
   Iacobello, C
   Russello, D
   Latteri, S
AF Mattone, E.
   Sofia, M.
   Schembari, E.
   Palumbo, V
   Bonaccorso, R.
   Randazzo, V
   La Greca, G.
   Iacobello, C.
   Russello, D.
   Latteri, S.
TI Acute acalculous cholecystitis on a COVID-19 patient: a case report
SO ANNALS OF MEDICINE AND SURGERY
LA English
DT Article
DE COVID-19 pandemic; Acute acalculous cholecystitis; Cholecystostomy;
   Laparoscopy; Emergency surgery; Case report
ID GALLBLADDER; MANAGEMENT
AB Introduction: We report an extremely rare case of acute acalculous cholecystitis on a COVID-19 patient. In our knowledge, this is the first report of laparoscopic cholecystectomy performed on a COVID-19 patient.
   Presentation of case: A COVID-19 patient was diagnosed with acute acalculous cholecystitis and a multidisciplinary team decided to perform a percutaneous transhepatic biliary drainage (PTBD) as the first treatment. SARS-CoV-2 RNA was not found in the bile fluid. Because of deterioration of the patient's clinical conditions, laparoscopic cholecystectomy had to be performed and since the gallbladder was gangrenous, the severe inflammation made surgery difficult to perform.
   Discussion: Acalculous cholecystitis was related with mechanical ventilation and prolonged total parenteral nutrition, in this case the gangrenous histopathology pattern and the gallbladder wall ischemia was probably caused by vascular insufficiency secondary to severe acute respiratory distress syndrome of COVID-19 pneumonia. The percutaneous transhepatic gallbladder drainage (PTBD) was performed according to Tokyo Guidelines because of high surgical risk. Lapamscopic cholecystectomy was next performed due to no clinical improvement. The absence of viral RNA in the bile highlights that SARS-CoV-2 is not eliminated with the bile while it probably infects small intestinal enterocytes which is responsible of gastrointestinal symptoms such as anorexia, nausea, vomiting, and diarrhoea.
   Conclusions: Although the lack of evidence and guidelines about the management of patient with acute cholecystitis during COVID-19 pandemic, lapamscopic cholecystectomy, at most preceded by PTGBD on high surgical risk patients, remains the gold standard for the treatment of acute cholecystitis on COVID-19 patients.
C1 [Mattone, E.; Sofia, M.; Schembari, E.; Palumbo, V; Bonaccorso, R.; Randazzo, V; La Greca, G.; Russello, D.; Latteri, S.] Univ Catania, Cannizzaro Hosp, Gen Surg Unit, Dept Med Surg Sci & Adv Technol Ingrassia, Via Messina 829, I-95126 Catania, Italy.
   [Iacobello, C.] Cannizzaro Hosp, Infect Dis Unit, Via Messina 829, I-95126 Catania, Italy.
RP Mattone, E (corresponding author), Univ Catania, Cannizzaro Hosp, Gen Surg Unit, Dept Med Surg Sci & Adv Technol Ingrassia, Via Messina 829, I-95126 Catania, Italy.
EM edoardomattone@gmail.com; mariasofia2002@libero.it;
   elenaschembari@gmail.com; valepal90@gmail.com;
   rosario.bonaccorso@tin.it; valentinarandazzo@yahoo.it;
   glagreca@unict.it; carmelo.iacobello@gmail.com; russello@unict.it;
   savlat@tiscali.it
RI Latteri, Saverio/AAC-2434-2022; LA GRECA, GAETANO/G-5489-2012
OI LA GRECA, GAETANO/0000-0003-2930-3905; Sofia, Maria/0000-0002-5680-9939
CR Agarwal A, 2020, J CLIN EXP HEPATOL, V10, P263, DOI 10.1016/j.jceh.2020.03.001
   Agha RA, 2018, INT J SURG, V60, P132, DOI 10.1016/j.ijsu.2018.10.028
   Balmadrid Bryan, 2018, F1000Res, V7, DOI 10.12688/f1000research.14886.1
   BARIE PS, 1995, J AM COLL SURGEONS, V180, P232
   Campanile FC, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00317-0
   Croteau D, 2018, NEUROLOGY, V90, pE1548, DOI 10.1212/WNL.0000000000005422
   Katabathina VS, 2015, TECH VASC INTERV RAD, V18, P256, DOI 10.1053/j.tvir.2015.07.009
   Lei Shaoqing, 2020, EClinicalMedicine, V21, P100331, DOI 10.1016/j.eclinm.2020.100331
   Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095
   Mattone E, 2018, CLIN CASE REP, V6, P522, DOI 10.1002/ccr3.1130
   Monkemuller K, 2020, REV ESP ENFERM DIG, V112, P383, DOI 10.17235/reed.2020.7137/2020
   Mori Y, 2018, J HEPATO-BIL-PAN SCI, V25, P87, DOI 10.1002/jhbp.504
   Penfield CA, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100133
   Pesce A, 2017, MINERVA CHIR, V72, P98, DOI 10.23736/S0026-4733.16.07248-5
   Saxena S.K., 2020, SERIES MED VIROLOGY, DOI [10.1007/978-981-15-4814-7, DOI 10.1007/978-981-15-4814-7]
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhao D., 2020, CLIN INFECT DIS, P1093
NR 17
TC 12
Z9 12
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2049-0801
J9 ANN MED SURG
JI Ann. Med. Surg.
PD OCT
PY 2020
VL 58
BP 73
EP 75
DI 10.1016/j.amsu.2020.08.027
PG 3
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA NU8XF
UT WOS:000573920000014
PM 32895611
OA gold, Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Al-kuraishy, HM
   Al-Gareeb, AI
   Alblihed, M
   Guerreiro, SG
   Cruz-Martins, N
   Batiha, GE
AF Al-kuraishy, Hayder M.
   Al-Gareeb, Ali I.
   Alblihed, M.
   Guerreiro, Susana G.
   Cruz-Martins, Natalia
   Batiha, Gaber El-Saber
TI COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
SO FRONTIERS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
DE COVID-19; SARS-CoV-2; diabetes mellitus; hyperglycemia; cardiometabolic
   disturbances
ID CLINICAL CHARACTERISTICS; SARS-COV-2 INFECTION; INCREASED MORTALITY;
   CORONAVIRUS; METFORMIN; OUTCOMES; DISEASE; PIOGLITAZONE; HYPERTENSION;
   MANAGEMENT
AB Coronavirus disease 2019 (COVID-19), triggered by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), may lead to extrapulmonary manifestations like diabetes mellitus (DM) and hyperglycemia, both predicting a poor prognosis and an increased risk of death. SARS-CoV-2 infects the pancreas through angiotensin-converting enzyme 2 (ACE2), where it is highly expressed compared to other organs, leading to pancreatic damage with subsequent impairment of insulin secretion and development of hyperglycemia even in non-DM patients. Thus, this review aims to provide an overview of the potential link between COVID-19 and hyperglycemia as a risk factor for DM development in relation to DM pharmacotherapy. For that, a systematic search was done in the database of MEDLINE through Scopus, Web of Science, PubMed, Embase, China National Knowledge Infrastructure (CNKI), China Biology Medicine (CBM), and Wanfang Data. Data obtained underline that SARS-CoV-2 infection in DM patients is more severe and associated with poor clinical outcomes due to preexistence of comorbidities and inflammation disorders. SARS-CoV-2 infection impairs glucose homeostasis and metabolism in DM and non-DM patients due to cytokine storm (CS) development, downregulation of ACE2, and direct injury of pancreatic beta-cells. Therefore, the potent anti-inflammatory effect of diabetic pharmacotherapies such as metformin, pioglitazone, sodium-glucose co-transporter-2 inhibitors (SGLT2Is), and dipeptidyl peptidase-4 (DPP4) inhibitors may mitigate COVID-19 severity. In addition, some antidiabetic agents and also insulin may reduce SARS-CoV-2 infectivity and severity through the modulation of the ACE2 receptor expression. The findings presented here illustrate that insulin therapy might seem as more appropriate than other anti-DM pharmacotherapies in the management of COVID-19 patients with DM due to low risk of uncontrolled hyperglycemia and diabetic ketoacidosis (DKA). From these findings, we could not give the final conclusion about the efficacy of diabetic pharmacotherapy in COVID-19; thus, clinical trial and prospective studies are warranted to confirm this finding and concern.
C1 [Al-kuraishy, Hayder M.; Al-Gareeb, Ali I.] ALmustansiriyiah Univ, Coll Med, Dept Clin Pharmacol & Therapeut Med, Baghdad, Iraq.
   [Alblihed, M.] Taif Univ, Coll Med, Dept Microbiol, At Taif, Saudi Arabia.
   [Guerreiro, Susana G.; Cruz-Martins, Natalia] Univ Porto, Fac Med, Porto, Portugal.
   [Guerreiro, Susana G.] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Porto, Portugal.
   [Guerreiro, Susana G.; Cruz-Martins, Natalia] Univ Porto, Inst Res & Innovat Hlth i3S, Porto, Portugal.
   [Cruz-Martins, Natalia] Univ Porto, Fac Psychol & Educ Sci, Lab Neuropsychophysiol, Porto, Portugal.
   [Batiha, Gaber El-Saber] Damanhour Univ, Dept Pharmacol & Therapeut, Fac Vet Med, Damanhour, Egypt.
RP Cruz-Martins, N (corresponding author), Univ Porto, Fac Med, Porto, Portugal.; Cruz-Martins, N (corresponding author), Univ Porto, Inst Res & Innovat Hlth i3S, Porto, Portugal.; Cruz-Martins, N (corresponding author), Univ Porto, Fac Psychol & Educ Sci, Lab Neuropsychophysiol, Porto, Portugal.; Batiha, GE (corresponding author), Damanhour Univ, Dept Pharmacol & Therapeut, Fac Vet Med, Damanhour, Egypt.
EM ncmartins@med.up.pt; gaberbatiha@gmail.com
FU Portuguese Foundation for Science and Technology under the Horizon 2020
   ProgramPortuguese Foundation for Science and Technology
   [PTDC/PSI-GER/28076/2017]; Taif University, Saudi Arabia [TURSP-2020/93]
FX NC-M acknowledges the Portuguese Foundation for Science and Technology
   under the Horizon 2020 Program (PTDC/PSI-GER/28076/2017). HA-k
   acknowledges medical staff members of Al-Shiffa Medical Center, Baghdad,
   Iraq for their participations. This work was supported by Taif
   University Researchers Supporting Program (project number:
   TURSP-2020/93), Taif University, Saudi Arabia.
CR Abdel-Maksoud MS, 2019, MED RES REV, V39, P631, DOI 10.1002/med.21535
   Abdul-Hadi MH, 2020, BIOMED BIOTECH RES J, V4, P166, DOI 10.4103/bbrj.bbrj_7_20
   Al-Hashem F, 2019, J CELL PHYSIOL, V234, P9328, DOI 10.1002/jcp.27616
   Al-Kuraishy H. M., 2020, Asian Pacific Journal of Reproduction, V9, P156, DOI 10.4103/2305-0500.282984
   Al-kuraishy HM, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.644295
   Al-kuraishy HM, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.642181
   Al-Kuraishy Hayder M, 2020, J Microsc Ultrastruct, V8, P141, DOI 10.4103/JMAU.JMAU_63_20
   Al-Kuraishy HM, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102624
   Al-Kuraishy HM, 2020, J ADV PHARM TECHNOL, V11, P142, DOI 10.4103/japtr.JAPTR_18_20
   Al-Kuraishy H, 2020, BIOMED BIOTECH RES J, V4, P189, DOI 10.4103/bbrj.bbrj_103_20
   Al-Nami Marwa S, 2020, Int J Crit Illn Inj Sci, V10, P21, DOI 10.4103/IJCIIS.IJCIIS_62_19
   Al-Nami Marwa S, 2019, Int J Crit Illn Inj Sci, V9, P120, DOI 10.4103/IJCIIS.IJCIIS_40_19
   Albulescu R, 2020, EXP THER MED, V20, DOI 10.3892/etm.2020.9324
   Alon T, 2020, 26947 NBER
   Alves AM, 2020, BRAZ J INFECT DIS, V24, P561, DOI 10.1016/j.bjid.2020.08.011
   Attri B, 2020, DIABETES THER, V11, P2177, DOI 10.1007/s13300-020-00873-3
   Ballak DB, 2018, J BIOL CHEM, V293, P14224, DOI 10.1074/jbc.RA118.003698
   Bassendine MF, 2020, J DIABETES, V12, P649, DOI 10.1111/1753-0407.13052
   Becker CD, 2020, AM J MED, V133, pE568, DOI 10.1016/j.amjmed.2020.03.012
   Bersoff-Matcha SJ, 2019, ANN INTERN MED, V170, P764, DOI 10.7326/M19-0085
   Caballero AE, 2020, J DIABETES COMPLICAT, V34, DOI 10.1016/j.jdiacomp.2020.107671
   Carboni E, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109776
   Caruso I, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3404
   Ceriello A, 2020, DIABETES RES CLIN PR, V167, DOI 10.1016/j.diabres.2020.108383
   Chan KK, 2020, SCIENCE, V369, P1261, DOI 10.1126/science.abc0870
   Chatterjee S, 2020, PRIM CARE DIABETES, V14, P564, DOI 10.1016/j.pcd.2020.05.013
   Cheng X, 2020, CELL METAB, V32, P537, DOI 10.1016/j.cmet.2020.08.013
   Coate KC, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.11.006
   Crouse AB, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.600439
   Vaccari JCD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.583373
   Deacon CF, 2018, DIABETES OBES METAB, V20, P34, DOI 10.1111/dom.13135
   Domingo P, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102887
   Dwi N., 2020, 1 INT C COMM HLTH IC, DOI [10.2991/ahsr.k.200204.014, DOI 10.2991/AHSR.K.200204.014]
   Erener S, 2020, MOL METAB, V39, DOI 10.1016/j.molmet.2020.101044
   Fadini GP, 2020, J ENDOCRINOL INVEST, V43, P867, DOI 10.1007/s40618-020-01236-2
   Fadnavis R., THESIS WRIGHT STATE
   Gallwitz B, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00389
   Gobolos L, 2021, J VASC SURG, V73, P1889, DOI 10.1016/j.jvs.2020.12.056
   Gomes IC, 2020, SARS COV 2 INFECT CE, DOI [10.20944/preprints202009.0297.v1, DOI 10.20944/PREPRINTS202009.0297.V1]
   Gupta R, 2020, EUR J CLIN NUTR, V74, P864, DOI 10.1038/s41430-020-0652-1
   Hanif S, 2020, DIABETIC MED, V37, P1094, DOI 10.1111/dme.14312
   Hariyanto Timotius Ivan, 2020, Obes Med, V19, P100290, DOI 10.1016/j.obmed.2020.100290
   Hasan SS, 2020, EXPERT REV RESP MED, V14, P1149, DOI 10.1080/17476348.2020.1804365
   Heales L, 2020, EXCESS INSULIN REQUI, V24, P525, DOI [10.1101/2020.10.03.20206284, DOI 10.1101/2020.10.03.20206284]
   Hill JR, 2017, CHEMMEDCHEM, V12, P1449, DOI 10.1002/cmdc.201700270
   Hu RH, 2018, CLIN IMMUNOL, V195, P139, DOI 10.1016/j.clim.2018.06.003
   Huang I, 2020, DIABETES METAB SYND, V14, P395, DOI 10.1016/j.dsx.2020.04.018
   Huang W., 2020, REBALANCE RAAS AXES, DOI [10.22541/au.159050479.95287268, DOI 10.22541/AU.159050479.95287268]
   Hussien NR, 2018, J ADV PHARM TECHNOL, V9, P120, DOI 10.4103/japtr.JAPTR_317_18
   Ilahi O, 2002, AM SURGEON, V68, P704
   Ilias I, 2020, IN VIVO, V34, P3029, DOI 10.21873/invivo.12136
   Jagat JM, 2020, DIABETES METAB SYND, V14, P829, DOI 10.1016/j.dsx.2020.06.015
   Jimenez L, 2020, INFLUENCE PH SARS CO, DOI [10.1101/2020.09.10.20179135, DOI 10.1101/2020.09.10.20179135]
   John TJ, 2020, CAN J CARDIOL, V36, DOI 10.1016/j.cjca.2020.03.049
   Kalavalapalli S, 2018, AM J PHYSIOL-ENDOC M, V315, pE163, DOI 10.1152/ajpendo.00023.2018
   Kawabe Y, 2019, AM J PHYSIOL-ENDOC M, V317, pE1140, DOI 10.1152/ajpendo.00311.2019
   Kawaguchi Y, 2019, J DIABETES INVEST, V10, P392, DOI 10.1111/jdi.12877
   Kawahara Y, 2020, J DENT RES, V99, P830, DOI 10.1177/0022034520913250
   Klimstra WB, 2020, J GEN VIROL, V101, P1156, DOI 10.1099/jgv.0.001481
   Kokeny G, 2020, CURR OPIN NEPHROL HY, V29, P171, DOI 10.1097/MNH.0000000000000580
   Koufakis Theocharis, 2020, J Diabetes Sci Technol, V14, P745, DOI 10.1177/1932296820932155
   Kruglikov IL, 2020, OBESITY, V28, P1187, DOI 10.1002/oby.22856
   Kumar A, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110271
   Li C, 2020, AGING-US, V12, P15670, DOI 10.18632/aging.103770
   Li GY, 2019, DIABETES CARE, V42, pE119, DOI 10.2337/dc18-1578
   Li Y, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101160
   Li YM, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108299
   Liu BW, 2020, J AUTOIMMUN, V111, DOI 10.1016/j.jaut.2020.102452
   Liu C, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0771-3
   Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0
   Longo M, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01090-9
   Lugnier C, 2021, BIOCHEM PHARMACOL, V185, DOI 10.1016/j.bcp.2021.114431
   Maddaloni E, 2020, DIABETES CARE, V43, pE86, DOI 10.2337/dc20-0954
   Maddaloni E, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3321
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Meo SA, 2020, EUR REV MED PHARMACO, V24, P2012, DOI 10.26355/eurrev_202002_20379
   Michalakis K, 2020, DIABETES METAB SYND, V14, P469, DOI 10.1016/j.dsx.2020.04.033
   Mirani M, 2020, DIABETES CARE, V43, P3042, DOI 10.2337/dc20-1340
   Muniangi-Muhitu H, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.582936
   Oriot P, 2022, ACTA CLIN BELG, V77, P113, DOI 10.1080/17843286.2020.1780390
   Pal Rimesh, 2020, Diabetes Res Clin Pract, V162, P108132, DOI 10.1016/j.diabres.2020.108132
   Patoulias D, 2020, DIABETES THER, V11, P3003, DOI 10.1007/s13300-020-00942-7
   Pranata R, 2020, J RENIN-ANGIO-ALDO S, V21, DOI 10.1177/1470320320926899
   Rajpal A, 2020, J DIABETES, V12, P895, DOI 10.1111/1753-0407.13085
   Raoult D, 2020, CELL STRESS, V4, P66, DOI 10.15698/cst2020.04.216
   Rasheed HA, 2019, J ADV PHARM TECHNOL, V10, P163, DOI 10.4103/japtr.JAPTR_65_19
   Ren HH, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01035-2
   Roncon L, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104354
   Saad AF, 2020, OBSTET GYNECOL, V136, P823, DOI 10.1097/AOG.0000000000004103
   Sathish T, 2021, PRIM CARE DIABETES, V15, P194, DOI 10.1016/j.pcd.2020.08.014
   Scheen AJ, 2020, DIABETES METAB, V46, P423, DOI 10.1016/j.diabet.2020.07.006
   Sharma RK, 2020, HYPERTENSION, V76, P651, DOI 10.1161/HYPERTENSIONAHA.120.15595
   Sharma S, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108183
   Singh AK, 2020, DIABETES RES CLIN PR, V167, DOI 10.1016/j.diabres.2020.108382
   Singh AK, 2020, DIABETES METAB SYND, V14, P971, DOI 10.1016/j.dsx.2020.06.054
   Singh S, 2020, J IMMUNOL, V204, P1810, DOI 10.4049/jimmunol.1901310
   Sinha S, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209628
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Somasundaram NP, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa082
   Sucheta, 2017, CHEM CENT J, V11, DOI 10.1186/s13065-017-0357-2
   Takeda Y., 2014, JAPAN J HYGIENE, V69, P166, DOI [10.1265/jjh.69.166, DOI 10.1265/JJH.69.166]
   Taneera J, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9080215
   Tawfik MK, 2016, BIOMED PHARMACOTHER, V82, P106, DOI 10.1016/j.biopha.2016.05.005
   Valencia I, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01161
   Vandercam G, 2020, J HOSP INFECT, V106, P713, DOI 10.1016/j.jhin.2020.09.018
   Vankadari N, 2020, EMERG MICROBES INFEC, V9, P601, DOI 10.1080/22221751.2020.1739565
   Velavan TP, 2021, AM J TROP MED HYG, V104, P1041, DOI 10.4269/ajtmh.20-1282
   Wang AH, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108118
   Wang F, 2020, GASTROENTEROLOGY, V159, P367, DOI 10.1053/j.gastro.2020.03.055
   Wang Y, 2020, ACTA DIABETOL, V57, P1227, DOI 10.1007/s00592-020-01532-6
   Wondafrash DZ, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/5214751
   Wu KJ, 2018, CHEM-BIOL INTERACT, V291, P1, DOI 10.1016/j.cbi.2018.05.018
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Yaribeygi H, 2019, J CELL PHYSIOL, V234, P3231, DOI 10.1002/jcp.26760
   Zhang Qing-ling, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P1125
   Zhu LH, 2020, CELL METAB, V31, P1068, DOI 10.1016/j.cmet.2020.04.021
NR 116
TC 14
Z9 14
U1 3
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2297-055X
J9 FRONT CARDIOVASC MED
JI Front. Cardiovasc. Med.
PD MAY 20
PY 2021
VL 8
AR 644095
DI 10.3389/fcvm.2021.644095
PG 13
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA SO8KT
UT WOS:000659224600001
PM 34124187
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Tao, HQ
   Ge, GR
   Li, WM
   Liang, XL
   Wang, HZ
   Li, N
   Sun, HY
   Zhang, W
   Geng, DC
AF Tao, Huaqiang
   Ge, Gaoran
   Li, Wenming
   Liang, Xiaolong
   Wang, Hongzhi
   Li, Ning
   Sun, Houyi
   Zhang, Wei
   Geng, Dechun
TI Dysimmunity and inflammatory storm: Watch out for bone lesions in
   COVID-19 infection
SO MEDICAL HYPOTHESES
LA English
DT Article
DE COVID-19; SARS-CoV-2; Dysimmunity; Inflammatory storm; Bone lesions
AB At the end of 2019, a new kind of pneumonia which was proven to be supported by novel coronaviruses named SARS-CoV-2 emerges and it seems to be more complicate in its clinical course and management. Related researches have demonstrated that SARS-CoV-2 serves roles in respiratory, intestinal and neuronal diseases. Given the growing cases of COVID-19, analyzing the relevance between COVID-19 and fragile patients who suffer from bone destruction is entirely indispensable. Accordingly, the recapitulatory commentary is necessary to advance our knowledge on COVID-19 and orthopedics. In this article, we particularly clarify the possible relationship between the newly COVID-19 infection and bone lesions from the standpoints of dysimmunity and inflammatory storm.
C1 [Tao, Huaqiang; Ge, Gaoran; Li, Wenming; Liang, Xiaolong; Wang, Hongzhi; Li, Ning; Sun, Houyi; Zhang, Wei; Geng, Dechun] Soochow Univ, Dept Orthoped, Affiliated Hosp 1, 188 Shi Zi Rd, Suzhou 215000, Peoples R China.
RP Geng, DC (corresponding author), Soochow Univ, Dept Orthoped, Affiliated Hosp 1, 188 Shi Zi Rd, Suzhou 215000, Peoples R China.
EM szgengdc@suda.edu.cn
RI Liang, Xiaolong/AAH-3876-2021
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81873991, 81771885, 81672238, 81472077,
   81572183, 91849114, 81472105]
FX This study was supported by the National Natural Science Foundation of
   China (81873991, 81771885, 81672238, 81472077, 81572183, 91849114 and
   81472105).
CR Adamopoulos IE, 2018, CURR OPIN RHEUMATOL, V30, P59, DOI 10.1097/BOR.0000000000000449
   Callaway DA, 2015, J BONE MINER METAB, V33, P359, DOI 10.1007/s00774-015-0656-4
   Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3
   Choe JY, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/597512
   de Castro LF, 2019, J BONE MINER RES, V34, P290, DOI 10.1002/jbmr.3602
   Garcia N, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5853238
   Hiraga T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113523
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Khoury M, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00858-2020
   Kubo T, 2016, J ORTHOP SCI, V21, P407, DOI 10.1016/j.jos.2016.03.008
   Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994
   Lin TH, 2017, ADV PROTEIN CHEM STR, V107, P117, DOI 10.1016/bs.apcsb.2016.11.002
   McGarry T, 2018, FREE RADICAL BIO MED, V125, P15, DOI 10.1016/j.freeradbiomed.2018.03.042
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Pang MH, 2019, J CELL BIOCHEM, V120, P12382, DOI 10.1002/jcb.28504
   Pasquier J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16365-7
   Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051
   Rokni M, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2107
   Samarpita S, 2018, CELL IMMUNOL, V332, P39, DOI 10.1016/j.cellimm.2018.07.005
   Thatcher SE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/762094
   Utting JC, 2006, EXP CELL RES, V312, P1693, DOI 10.1016/j.yexcr.2006.02.007
   Wada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035069
   Weitzmann MN, 2017, TOXICOL PATHOL, V45, P911, DOI 10.1177/0192623317735316
   Weitzmann MN, 2016, NAT REV ENDOCRINOL, V12, P518, DOI 10.1038/nrendo.2016.91
   Wu X, 2016, OSTEOPOROSIS INT, V27, P1827, DOI 10.1007/s00198-015-3474-6
   Zhang Q, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01028
NR 26
TC 4
Z9 4
U1 1
U2 4
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD DEC
PY 2020
VL 145
AR 110332
DI 10.1016/j.mehy.2020.110332
PG 3
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA PC8XR
UT WOS:000597282700017
PM 33039950
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Simonovic, SP
   Kundzewicz, ZW
   Wright, N
AF Simonovic, Slobodan P.
   Kundzewicz, Zbigniew W.
   Wright, Nigel
TI Floods and the COVID-19 pandemic-A new double hazard problem
SO WILEY INTERDISCIPLINARY REVIEWS-WATER
LA English
DT Article
DE COVID-19; floods; management; multihazard; natural disasters; resilience
ID RESILIENCE; REDUCTION; CHINA; RISK
AB The coincidence of floods and coronavirus disease 2019 (COVID-19) is a genuine multihazard problem. Since the beginning of 2020, many regions around the World have been experiencing this double hazard of serious flooding and the pandemic. There have been 70 countries with flood events occurring after detection of the country's first COVID-19 case and hundreds of thousands of people have been evacuated. The main objective of this article is to assess challenges that arise from complex intersections between the threat multipliers and to provide guidance on how to address them effectively. We consider the limitations of our knowledge including "unknown unknowns." During emergency evacuation, practicing social distancing can be very difficult. However, people are going to take action to respond to rising waters, even if it means breaking quarantine. This is an emergency manager's nightmare scenario: two potentially serious emergencies happening at once. During this unprecedented year (2020), we are experiencing one of the most challenging flood seasons we have seen in a while. Practical examples of issues and guides for managing floods and COVID-19 are presented. We feel that a new approach is needed in dealing with multiple hazards. Our main messages are: a resilience approach is needed whether in response to floods or a pandemic; preparation is vital, in addition to defense; the responsible actors must be prepared with actions plans and command structure, while the general population must be involved in the discussions so that they are aware of the risk and the reasons for the actions they must take.
C1 [Simonovic, Slobodan P.] Univ Western Ontario, Inst Catastroph Loss Reduct, London, ON N6A 5B9, Canada.
   [Kundzewicz, Zbigniew W.] Polish Acad Sci, Inst Agr & Forest Environm, Poznan, Poland.
   [Wright, Nigel] Nottingham Trent Univ, Sch Architecture Design & Built Environm, Nottingham, England.
RP Simonovic, SP (corresponding author), Univ Western Ontario, Inst Catastroph Loss Reduct, London, ON N6A 5B9, Canada.; Simonovic, SP (corresponding author), Univ Western Ontario, Dept Civil & Environm Engn, London, ON N6A 5B9, Canada.
EM simonovic@uwo.ca
RI Wright, Nigel/B-3846-2009; Simonovic, Slobodan/R-7250-2017
OI Wright, Nigel/0000-0002-1289-2830; Simonovic,
   Slobodan/0000-0001-5072-2915
FU Royal SocietyRoyal Society of LondonEuropean Commission [NAF\R2\180862];
   National Science Centre of PolandNational Science Centre, Poland
   [2017/27/B/ST10/00924]; Institute for Catastrophic Loss Reduction;
   Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada (NSERC)CGIAR;
   EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences
   Research Council (EPSRC) [EP/P004261/2, EP/I030735/1] Funding Source:
   UKRI
FX Royal Society for an Advanced Newton Fellowship, Grant/Award Number: NAF
   \R2\180862; National Science Centre of Poland, Grant/Award Number:
   2017/27/B/ST10/00924; Institute for Catastrophic Loss Reduction; Natural
   Sciences and Engineering Research Council of Canada
CR Agrawal N, 2020, WATER-SUI, V12, DOI 10.3390/w12051254
   Alexander D., 2020, WORKING PAPER
   Ansell C, 2019, ADMIN SOC, V51, P1079, DOI 10.1177/0095399717747655
   Bruneau M, 2003, EARTHQ SPECTRA, V19, P733, DOI 10.1193/1.1623497
   Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013
   Du SQ, 2019, NAT HAZARD EARTH SYS, V19, P715, DOI 10.5194/nhess-19-715-2019
   Guo YM, 2020, LANCET PLANET HEALTH, V4, pE443, DOI 10.1016/S2542-5196(20)30203-5
   Han J, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142491
   HEGGER DLT, 2016, ECOL SOC, V21, DOI DOI 10.5751/ES-08854-210452
   ICHARM, 2020, NEWSLETTER
   Irwin S, 2016, WATER-SUI, V8, DOI 10.3390/w8090377
   Ishiwatari M, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100096
   Keulertz M, 2020, WATER INT, V45, P430, DOI 10.1080/02508060.2020.1779515
   Klemes V., 2002, INT HYDROLOGY SERIES, P22, DOI DOI 10.1017/CBO9780511546006.003
   Kong JJ, 2019, RISK ANAL, V39, P1141, DOI 10.1111/risa.13222
   Kramarz T., 2020, PANDEMICS FLOODS INE
   Kundzewicz ZW, 2019, ADV WATER RESOUR, V130, P37, DOI 10.1016/j.advwatres.2019.05.020
   Kundzewicz ZW, 2018, P NATL ACAD SCI USA, V115, P12321, DOI 10.1073/pnas.1818227115
   Kundzewicz ZW, 2019, WATER-SUI, V11, DOI 10.3390/w11071399
   Latour B, 2000, BRIT J SOCIOL, V51, P107, DOI 10.1111/j.1468-4446.2000.00107.x
   Linstone H. A., 1978, FUTURES RES NEW DIRE, P133
   McDonald T, 2020, ECOL MANAG RESTOR, V21, P73, DOI 10.1111/emr.12415
   Neal MJ, 2020, WATER INT, V45, P435, DOI 10.1080/02508060.2020.1773648
   Peck A., 2013, 083 U W ONT DEP CIV
   Phillips CA, 2020, NAT CLIM CHANGE, V10, P586, DOI 10.1038/s41558-020-0804-2
   Priest SJ, 2016, ECOL SOC, V21, DOI 10.5751/ES-08913-210450
   Reynolds I., 2020, BLOOMBERG
   Schardong A., 2019, INT J SAFETY SECURIT, V9, P13, DOI DOI 10.2495/SAFE-V9-N1-13-25
   Shen XY, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142634
   Simonovic S. P., 2013, British Journal of Environment and Climate Change, V3, P378, DOI 10.9734/BJECC/2013/2504
   Simonovic S. P., 2016, INT J SAF SECUR ENG, V6, P85, DOI 10.2495/SAFE-V6-N2-85-95
   Simonovic S. P., 2011, SYSTEMS APPROACH MAN, P308
   Simonovic SP, 2016, WATER RESOUR RES, V52, P8630, DOI 10.1002/2016WR019551
   SIMONOVIC SP, 2020, WATER-SUI, V12, DOI DOI 10.3390/W12041208
   Staddon C, 2020, WATER INT, V45, P416, DOI 10.1080/02508060.2020.1769345
   Wang F, 2020, WATER RESOUR MANAG, V34, P3199, DOI 10.1007/s11269-020-02608-2
   Wardekker A, 2020, CITIES, V101, DOI 10.1016/j.cities.2020.102691
   Willner SN, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1914
   Xia J., 2020, ICFM WEBINAR 2 FLOOD
NR 39
TC 16
Z9 16
U1 8
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2049-1948
J9 WIRES WATER
JI Wiley Interdiscip. Rev.-Water
PD MAR
PY 2021
VL 8
IS 2
AR e1509
DI 10.1002/wat2.1509
EA JAN 2021
PG 18
WC Environmental Sciences; Water Resources
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Water Resources
GA QG1GA
UT WOS:000606429700001
PM 33786171
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Jones, C
   Arora, Y
   Reddy, R
   Tereja, C
   Faber, C
   Narandran, V
   Mirza, S
   Ghuman, W
   Chait, R
   Chen, K
AF Jones, Can
   Arora, Yingyot
   Reddy, Renuka
   Tereja, Claudia
   Faber, Cristiano
   Narandran, Vijay
   Mirza, Sajid
   Ghuman, Waqas
   Chait, Robert
   Chen, Kai
TI Outcomes of Minority COVID-19 patients managed with ECMO: A
   single-center experience
SO JOURNAL OF CARDIAC SURGERY
LA English
DT Article; Early Access
DE cardiovascular research; COVID-19; ECMO; minority
ID EXTRACORPOREAL MEMBRANE-OXYGENATION; DISPARITIES; SUPPORT
AB Background The coronavirus disease 2019 (COVID-19) pandemic has significantly burdened the global healthcare system since December 2019. Minority populations are found to have a higher incidence of hospitalization and higher mortality when compared to Caucasians. Extracorporeal membrane oxygenation (ECMO) is reserved for COVID-19 patients who develop respiratory failure refractory to conventional management. To our knowledge, no data has been reported on outcome differences between Minority COVID-19 patients and Caucasian COVID-19 patients managed with ECMO. We aimed to investigate the outcome differences between these two groups. Methods Our retrospective cohort study had 23 adults (aged 18 and older) diagnosed with COVID-19 by polymerase chain reaction. All patients developed acute respiratory distress syndrome (ARDS), refractory to conventional treatment, and were managed on ECMO support. The primary outcome of interest was mortality; the secondary outcome was the rate of ECMO-related complications. Results The overall mortality rate of our study was higher (70%) than other reports of the COVID-19 population on ECMO. Caucasians in our study had more severe respiratory acidosis with carbon dioxide retention and appeared to have a higher mortality rate of 85.7% compared to Minorities (62.5%). No differences in complication rates between these two groups were identified. Conclusions Our cohort revealed a high overall mortality rate of COVID-19 patients on ECMO support. The Caucasian group was observed to have higher mortality than the Minority group. The high overall mortality was likely attributed to the Caucasian group, which had more severe respiratory acidosis before ECMO initiation, a known predictor of poor prognosis in ARDS patients. Our cohort's ethnic composition may also partially explain the high mortality rate since COVID-19 Minorities are reported to have worse outcomes than Caucasians. Larger and randomized studies are needed to investigate further the mortality and complication differences between Minority and Caucasian patients diagnosed with COVID-19 and managed by ECMO.
C1 [Jones, Can; Arora, Yingyot; Reddy, Renuka; Tereja, Claudia; Narandran, Vijay; Chait, Robert] Univ Miami, Palm Beach Reg GME Consortium, Internal Med, Atlantis, FL USA.
   [Faber, Cristiano] JFK Med Ctr, Dept Cardiothorac Surg, Atlantis, FL USA.
   [Narandran, Vijay] JFK Med Ctr, Dept Hematol Oncol, Atlantis, FL USA.
   [Mirza, Sajid; Ghuman, Waqas; Chait, Robert] JFK Med Ctr, Dept Cardiol, Atlantis, FL USA.
   [Chen, Kai] Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL 32209 USA.
RP Chen, K (corresponding author), Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL 32209 USA.
EM kaichenmd@gmail.com
OI Arora, Yingyot/0000-0002-8778-3460
CR Barbaro RP, 2020, LANCET, V396, P1071, DOI 10.1016/S0140-6736(20)32008-0
   Bartlett RH, 2020, ASAIO J, V66, P472, DOI 10.1097/MAT.0000000000001173
   Buchner J, 2018, J CARDIOTHOR VASC AN, V32, P1154, DOI 10.1053/j.jvca.2017.09.031
   Gross CP, 2020, J GEN INTERN MED, V35, P3097, DOI 10.1007/s11606-020-06081-w
   Kon ZN, 2021, ANN THORAC SURG, V111, P537, DOI 10.1016/j.athoracsur.2020.07.002
   Mackey K, 2021, ANN INTERN MED, V174, P362, DOI 10.7326/M20-6306
   Mang S, 2021, ARTIF ORGANS, V45, P495, DOI 10.1111/aor.13940
   Mosca Matthew S, 2015, J Extra Corpor Technol, V47, P217
   Posluszny J, 2020, ASAIO J, V66, P825, DOI 10.1097/MAT.0000000000001067
   Raifman MA, 2020, AM J PREV MED, V59, P137, DOI 10.1016/j.amepre.2020.04.003
   Raine S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218115
   Raisi-Estabragh Z, 2020, J PUBLIC HEALTH-UK, V42, P451, DOI 10.1093/pubmed/fdaa095
   Schmidt M, 2020, LANCET RESP MED, V8, P1121, DOI 10.1016/S2213-2600(20)30328-3
   Setti L, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109754
   Tai DBG, 2021, CLIN INFECT DIS, V72, P703, DOI 10.1093/cid/ciaa815
   Tessum CW, 2019, P NATL ACAD SCI USA, V116, P6001, DOI 10.1073/pnas.1818859116
   Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598
   Yang X, 2020, CRIT CARE MED, V48, P1289, DOI 10.1097/CCM.0000000000004447
   Yehia BR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18039
NR 19
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0886-0440
EI 1540-8191
J9 J CARDIAC SURG
JI J. Card. Surg.
DI 10.1111/jocs.16494
EA APR 2022
PG 5
WC Cardiac & Cardiovascular Systems; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Surgery
GA 0K2JM
UT WOS:000780619500001
PM 35411615
DA 2022-04-20
ER

PT J
AU Askari, H
   Sanadgol, N
   Azarnezhad, A
   Tajbakhsh, A
   Ra, H
   Safarpour, AR
   Gheibihayat, SM
   Raeis-Abdollahi, E
   Savardashtaki, A
   Ghanbariasad, A
   Omidifar, N
AF Askari, Hassan
   Sanadgol, Nima
   Azarnezhad, Asaad
   Tajbakhsh, Amir
   Ra, Hossein
   Safarpour, Ali Reza
   Gheibihayat, Seyed Mohammad
   Raeis-Abdollahi, Ehsan
   Savardashtaki, Amir
   Ghanbariasad, Ali
   Omidifar, Navid
TI Kidney diseases and COVID-19 infection: causes and effect, supportive
   therapeutics and nutritional perspectives
SO HELIYON
LA English
DT Review
DE COVID-19; Kidney diseases; Nutritional supplements; Multi-organ failure
ID VITAMIN-D SUPPLEMENTATION; RENIN-ANGIOTENSIN SYSTEM; IMMUNE FUNCTION;
   CROSS-TALK; INFLUENZA VACCINATION; HEPATITIS-B; COMMON COLD; SELENIUM;
   INJURY; COPPER
AB Recently, the novel coronavirus disease 2019 (COVID-19), has attracted the attention of scientists where it has a high mortality rate among older adults and individuals suffering from chronic diseases, such as chronic kidney diseases (CKD). It is important to elucidate molecular mechanisms by which COVID-19 affects the kidneys and accordingly develop proper nutritional and pharmacological strategies. Although numerous studies have recently recommended several approaches for the management of COVID-19 in CKD, its impact on patients with renal diseases remains the biggest challenge worldwide. In this paper, we review the most recent evidence regarding causality, potential nutritional supplements, therapeutic options, and management of COVID-19 infection in vulnerable individuals and patients with CKD. To date, there is no effective treatment for COVID-19-induced kidney dysfunction, and current treatments are yet limited to anti-inflammatory (e.g. ibuprofen) and anti-viral medications (e.g. Remdesivir, and Chloroquine/Hydroxychloroquine) that may increase the chance of treatment. In conclusion, the knowledge about kidney damage in COVID-19 is very limited, and this review improves our ability to introduce novel approaches for future clinical trials for this contiguous disease.
C1 [Askari, Hassan; Safarpour, Ali Reza] Shiraz Univ Med Sci, Gastroenterohepatol Res Ctr, Shiraz, Iran.
   [Sanadgol, Nima] Univ Zabol, Dept Biol, Fac Sci, Zabol, Iran.
   [Sanadgol, Nima] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biomol Sci, Ribeirao Preto, SP, Brazil.
   [Azarnezhad, Asaad] Kurdistan Univ Med Sci, Cellular & Mol Res Ctr, Sanandaj, Iran.
   [Tajbakhsh, Amir; Savardashtaki, Amir] Shiraz Univ Med Sci, Pharmaceut Sci Res Ctr, Shiraz, Iran.
   [Ra, Hossein] BC Canc Res Ctr, Terry Fox Lab, Vancouver, BC, Canada.
   [Gheibihayat, Seyed Mohammad] Shahid Sadoughi Univ Med Sci, Sch Med, Dept Med Biotechnol, Yazd, Iran.
   [Raeis-Abdollahi, Ehsan] Univ Tehran Med Sci, Sch Med, Dept Physiol, Tehran, Iran.
   [Savardashtaki, Amir] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Med Biotechnol, Shiraz, Iran.
   [Ghanbariasad, Ali] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.
   [Ghanbariasad, Ali] Fasa Univ Med Sci, Sch Med, Dept Med Biotechnol, Fasa, Iran.
   [Omidifar, Navid] Shiraz Univ Med Sci, Sch Med, Dept Pathol, Biotechnol Res Ctr, Shiraz, Iran.
RP Ghanbariasad, A (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.; Ghanbariasad, A (corresponding author), Fasa Univ Med Sci, Sch Med, Dept Med Biotechnol, Fasa, Iran.; Omidifar, N (corresponding author), Shiraz Univ Med Sci, Sch Med, Dept Pathol, Biotechnol Res Ctr, Shiraz, Iran.
EM alighanbariasad@gmail.com; omidifar@gmail.com
RI Raeis-Abdollahi, Ehsan/AAT-9173-2021; Gheibihayat, Seyed Mohammad
   ./T-7187-2017; Askari, Hassan/AAO-8945-2021
OI Raeis-Abdollahi, Ehsan/0000-0003-2302-661X; Gheibihayat, Seyed Mohammad
   ./0000-0002-1378-118X; Askari, Hassan/0000-0002-2285-2592; Tajbakhsh,
   Amir/0000-0002-2311-6554
CR Abdelmaksoud A, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13792
   Abed Y, 2006, ANTIVIR RES, V70, P1, DOI 10.1016/j.antiviral.2006.01.006
   Aglipay M, 2017, JAMA-J AM MED ASSOC, V318, P245, DOI 10.1001/jama.2017.8708
   Aguirre L, 2011, OPEN NUTRACEUT J, V4, P189, DOI [10.2174/1876396001104010189, DOI 10.2174/1876396001104010189]
   Ahmadpoor P, 2020, TRANSPL INT, V33, P824, DOI 10.1111/tri.13611
   Akalin E, 2020, NEW ENGL J MED, V382, P2475, DOI 10.1056/NEJMc2011117
   Akatsu H, 2013, JPEN-PARENTER ENTER, V37, P631, DOI 10.1177/0148607112467819
   Akhtar S., 2001, ROLE VITAMIN ENHANCI
   Alasadi L., 2020, AM J NEPHROL, P1
   Alberici F, 2020, KIDNEY INT REP, V5, P580, DOI 10.1016/j.ekir.2020.04.001
   Acevedo-Murillo JA, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00431
   Andreone P, 2001, ANTIVIR RES, V49, P75, DOI 10.1016/S0166-3542(00)00141-8
   Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755
   Arpali E, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13296
   Askari H, 2018, METAB BRAIN DIS, V33, P1945, DOI 10.1007/s11011-018-0301-8
   Assmann N, 2016, J CLIN INVEST, V126, P2031, DOI 10.1172/JCI83005
   Banerjee D, KIDNEY INT
   Batista MN, 2006, BIOL TRACE ELEM RES, V112, P1, DOI 10.1385/BTER:112:1:1
   Berggren A, 2011, EUR J NUTR, V50, P203, DOI 10.1007/s00394-010-0127-6
   Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016
   Boge T, 2009, VACCINE, V27, P5677, DOI 10.1016/j.vaccine.2009.06.094
   Bressendorff I, 2017, KIDNEY INT REP, V2, P380, DOI 10.1016/j.ekir.2016.12.008
   Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7
   Broome CS, 2004, AM J CLIN NUTR, V80, P154
   Calder PC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041181
   Carr AC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111211
   Cavezzi A, 2020, CLINICS PRACT, V10, P24, DOI 10.4081/cp.2020.1271
   Chamsi-Pasha Mohammed A R, 2014, Curr Heart Fail Rep, V11, P58, DOI 10.1007/s11897-013-0178-0
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Cheruiyot Isaac, 2020, Acta Biomed, V91, pe2020029, DOI 10.23750/abm.v91i3.10222
   CHUGH KS, 1977, POSTGRAD MED J, V53, P18, DOI 10.1136/pgmj.53.615.18
   Columbia P, 2020, J AM SOC NEPHROL JAS
   Colunga Biancatelli RML, 2020, ANTIVIRAL PROPERTIES
   Dai J, 2002, J PINEAL RES, V32, P112, DOI 10.1034/j.1600-079x.2002.1844.x
   Dai WL, 2019, INT J MOL MED, V44, P1197, DOI 10.3892/ijmm.2019.4306
   Davis JM, 2009, CURR SPORT MED REP, V8, P206, DOI 10.1249/JSR.0b013e3181ae8959
   de Boer IH, 2007, AM J KIDNEY DIS, V50, P69, DOI 10.1053/j.ajkd.2007.04.015
   de Vrese M, 2006, VACCINE, V24, P6670, DOI 10.1016/j.vaccine.2006.05.048
   Del Vecchio L, 2020, CLIN KIDNEY J, V13, P494, DOI 10.1093/ckj/sfaa149
   Dellepiane S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1219-3
   Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1
   Du, 2020, SARS COV 2 INV HOST
   Ehsani S., 2020, ARXIV PREPRINT ARXIV
   Escobedo-Monge MF, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112671
   Fagundes Raquel Aparecida Bandeira, 2018, Braz. J. Nephrol., V40, P278, DOI [10.1590/2175-8239-jbn-3931, 10.1590/2175-8239-JBN-3931]
   Fanelli V, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02872-z
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Fiorino S, 2017, WORLD J HEPATOL, V9, P333, DOI 10.4254/wjh.v9.i6.333
   Fontana F, 2020, AM J TRANSPLANT, V20, P1902, DOI 10.1111/ajt.15935
   Fortarezza F., 2020, J NEPHROPATHOL, V9, P32
   Foy B.H., 2020, ELEVATED RDW IS ASSO
   FU EL, 2020, YONSEI MED J, V13, P550
   GALLAND L, 1988, MAGNESIUM, V7, P290
   Gandolfini I, 2020, AM J TRANSPLANT, V20, P1941, DOI 10.1111/ajt.15891
   Ginde AA, 2017, J AM GERIATR SOC, V65, P496, DOI 10.1111/jgs.14679
   Goncalves-Mendes N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00065
   Gong J., 2019, SEMIN NEPHROL
   Greiller CL, 2015, NUTRIENTS, V7, P4240, DOI 10.3390/nu7064240
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guillen E, 2020, AM J TRANSPLANT, V20, P1875, DOI 10.1111/ajt.15874
   Gupta R, 2020, DIABETES METAB SYND, V14, P251, DOI 10.1016/j.dsx.2020.03.012
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hasanvand A, 2017, J RENAL INJ PREV, V6, P93, DOI 10.15171/jrip.2017.18
   Hemila H, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-33
   Henry BM, 2020, INT UROL NEPHROL, V52, P1193, DOI 10.1007/s11255-020-02451-9
   Hoffmann PR, 2008, MOL NUTR FOOD RES, V52, P1273, DOI 10.1002/mnfr.200700330
   Hong KS, 2020, YONSEI MED J, V61, P431, DOI 10.3349/ymj.2020.61.5.431
   Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang ZY, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090258
   Husain-Syed F, 2016, AM J RESP CRIT CARE, V194, P402, DOI 10.1164/rccm.201602-0420CP
   Iovino L, 2018, LEUKEMIA RES, V70, P20, DOI 10.1016/j.leukres.2018.04.016
   Ivory K, 2017, CLIN NUTR, V36, P407, DOI 10.1016/j.clnu.2015.12.003
   Izzedine H., 2020, NEPHROL DIAL TRANSPL
   JEFFERSON T, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G2545
   Jing J, 2016, CTS-CLIN TRANSL SCI, V9, P207, DOI 10.1111/cts.12402
   Jolliffe DA, 2013, J STEROID BIOCHEM, V136, P321, DOI 10.1016/j.jsbmb.2012.11.017
   Just A, 2002, J PHYSIOL-LONDON, V538, P167, DOI 10.1113/jphysiol.2001.012593
   Kalantar-Zadeh K, 2020, J RENAL NUTR, V30, P179, DOI 10.1053/j.jrn.2020.03.006
   Kanauchi O, 2018, CURR PHARM DESIGN, V24, P710, DOI 10.2174/1381612824666180116163411
   Kang EJ, 2013, KOREAN J FAM MED, V34, P2, DOI 10.4082/kjfm.2013.34.1.2
   Karami Parisa, 2020, Travel Med Infect Dis, P101665, DOI 10.1016/j.tmaid.2020.101665
   Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658
   Kim Yejin, 2013, Immune Netw, V13, P70, DOI 10.4110/in.2013.13.2.70
   Krawinkel MB, 2012, ANN NUTR METAB, V61, P39, DOI 10.1159/000345162
   Kumar P, 2005, EXP LUNG RES, V31, P449, DOI 10.1080/019021490927088
   Lamarche J, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/146927
   Lambert DW, 2008, FEBS LETT, V582, P385, DOI 10.1016/j.febslet.2007.11.085
   Lee GY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111614
   Li C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010175
   Li J, 2020, EPIDEMIOLOGICAL CLIN, DOI 10.1101/2020.02.11.20022053
   Liakopoulos V, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9109473
   Lin M, 2014, NEPHROL DIAL TRANSPL, V29, P746, DOI 10.1093/ndt/gft446
   Lin R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1375858
   Liu, 2019, NOVEL CORONAVIRUS DI, DOI [10.1101/2020.02.24.20027201(dateofaccessJune17, 10.1101/2020.02.24.20027201, DOI 10.1101/2020.02.24.20027201]
   Liu WB, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00461-20
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Lu, 2019, J REN NUTR
   Malha L, 2020, KIDNEY INT REP, V5, P563, DOI 10.1016/j.ekir.2020.03.024
   Mancio-Silva L, 2017, NATURE, V547, P213, DOI 10.1038/nature23009
   McCarty MF, 2020, PROG CARDIOVASC DIS, V63, P383, DOI 10.1016/j.pcad.2020.02.007
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Meng X, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040367
   Mitchell F, 2020, LANCET DIABETES ENDO, V8, P570, DOI 10.1016/S2213-8587(20)30183-2
   Miyamoto D, 1998, ANTIVIR RES, V39, P89, DOI 10.1016/S0166-3542(98)00034-5
   Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378
   Moriguchi S., 2000, VITAMIN IMMUNITY
   Mousa HAL, 2017, J EVID-BASED INTEGR, V22, P166, DOI 10.1177/2156587216641831
   Mubarak M., 2020, J NEPHROPATHOL, V9, P21, DOI [10.34172/jnp.2020.21, DOI 10.34172/JNP.2020.21]
   Murch SJ, 1997, LANCET, V350, P1598, DOI 10.1016/S0140-6736(05)64014-7
   Murillo-Zamora E, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05408-6
   Murt A., 2020, PLOS ONE, V15
   Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148
   Nicholl DDM, 2014, AM J RESP CRIT CARE, V190, P572, DOI 10.1164/rccm.201403-0526OC
   Oladi E, 2014, SPECTROCHIM ACTA A, V132, P326, DOI 10.1016/j.saa.2014.05.010
   Palmer SC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005633.pub2
   Pan XB, 2020, INT J RADIAT BIOL, V96, P1486, DOI 10.1080/09553002.2020.1807646
   Panitchote A, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0552-5
   Patel N, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100907
   Peng Y D, 2020, Zhonghua Xin Xue Guan Bing Za Zhi, V48, P450, DOI 10.3760/cma.j.cn112148-20200220-00105
   Percival SS, 1998, AM J CLIN NUTR, V67, p1064S, DOI 10.1093/ajcn/67.5.1064S
   Pisano A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091224
   Prasad AS, 2008, MOL MED, V14, P353, DOI 10.2119/2008-00033.Prasad
   Prevention. CfDCa, 2019, CHRON KIDN DIS US
   Provinciali M, 1998, AGE AGEING, V27, P715, DOI 10.1093/ageing/27.6.715
   Raha S, 2020, MED HYPOTHESES, V142, DOI 10.1016/j.mehy.2020.109814
   Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2098, DOI 10.1001/jama.2020.7681
   Robbins-Juarez SY, 2020, KIDNEY INT REP, V5, P1149, DOI 10.1016/j.ekir.2020.06.013
   Rojas A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31777
   Rossi GP, 2020, ELIFE, V9, DOI 10.7554/eLife.57278
   Rupp JC, 2017, VIROL J, V14, DOI 10.1186/s12985-016-0671-7
   Russo E, 2021, J NEPHROL, V34, P173, DOI 10.1007/s40620-020-00875-1
   SanJuan R., 2020, AM J TRANSPL FIC J A
   Shapiro H, 2014, CURR OPIN IMMUNOL, V30, P54, DOI 10.1016/j.coi.2014.07.003
   Sharma P, 2021, TRANSPLANTATION, V105, P128, DOI 10.1097/TP.0000000000003447
   Sharma P, 2020, J AM SOC NEPHROL, V31, P1948, DOI 10.1681/ASN.2020050699
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Shih C-T., 2012, GENOMIC MED BIOMARKE, V4, P128, DOI DOI 10.1016/J.GMBHS.2013.03.001
   Shirazi MK, 2019, J CELL PHYSIOL, V234, P11411, DOI 10.1002/jcp.27797
   Smith A, 1997, J RENAL NUTR, V7, P69
   Smolina K, 2012, BMJ-BRIT MED J, V344, pd8059, DOI DOI 10.1136/BMJ.D8059
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Sommerstein R, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016509
   South AM, 2019, CLIN SCI, V133, P55, DOI 10.1042/CS20171550
   Sparks MA, 2014, COMPR PHYSIOL, V4, P1201, DOI 10.1002/cphy.c130040
   Steinbrenner H, 2015, ADV NUTR, V6, P73, DOI 10.3945/an.114.007575
   Stone CA, 2010, NUTR REV, V68, P671, DOI 10.1111/j.1753-4887.2010.00337.x
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Tajbakhsh A, 2021, EXPERT REV ANTI-INFE, V19, P345, DOI 10.1080/14787210.2020.1822737
   Tam M, 2003, EUR J CLIN NUTR, V57, P1193, DOI 10.1038/sj.ejcn.1601689
   Teijaro JR, 2014, P NATL ACAD SCI USA, V111, P3799, DOI 10.1073/pnas.1400593111
   Toke A, 2001, CONTRIB NEPHROL, V135, P34
   Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8
   Turnlund JR, 2004, AM J CLIN NUTR, V79, P1037
   Valizadeh R, J RENAL INJ PREV
   Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026
   Wang D., 2020, CLIN INFECT DISOFFIC
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Weis S, 2017, CELL, V169, P1263, DOI 10.1016/j.cell.2017.05.031
   Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266
   Wenzhong L., 2020, CHEMRXIV, DOI [10.26434/chemrxiv.11938173.v7, DOI 10.26434/CHEMRXIV.11938173.V8]
   Wintergerst ES, 2006, ANN NUTR METAB, V50, P85, DOI 10.1159/000090495
   Wintergerst ES, 2007, ANN NUTR METAB, V51, P301, DOI 10.1159/000107673
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu J., 2020, TREATMENT STRATEGIES
   Wu WJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010006
   Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d
   Yang H, 2018, MED SCI MONITOR, V24, P4760, DOI 10.12659/MSM.909259
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yeung ML, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.4, 10.1038/NMICROBIOL.2016.4]
   Yu Q., 2020, CLIN J AM SOC NEPHRO
   Zhan WQ, 2020, EUR REV MED PHARMACO, V24, P3385, DOI 10.26355/eurrev_202003_20705
   Zhang H, 2020, EUR UROL, V77, P742, DOI 10.1016/j.eururo.2020.03.030
   Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238
   Zhang JS, 2020, AM J CLIN NUTR, V111, P1297, DOI 10.1093/ajcn/nqaa095
   Zhong JC, 2004, HYPERTENSION, V44, P907, DOI 10.1161/01.HYP.0000146400.57221.74
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou YD, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0153-3
   Zhu L, 2020, EUR UROL, V77, P748, DOI 10.1016/j.eururo.2020.03.039
   Zhu L, 2020, AM J TRANSPLANT, V20, P1859, DOI 10.1111/ajt.15869
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
   1968, J AMER MED ASSOC, V204, P539
NR 185
TC 5
Z9 7
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
EI 2405-8440
J9 HELIYON
JI Heliyon
PD JAN
PY 2021
VL 7
IS 1
AR e06008
DI 10.1016/j.heliyon.2021.e06008
EA JAN 2021
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA QH1NU
UT WOS:000618044000002
PM 33495739
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Mouli, TC
   Davuluri, A
   Vijaya, S
   Priyanka, ADY
   Mishra, SK
AF Mouli, Tatikonda Chandra
   Davuluri, Anjani
   Vijaya, Sana
   Priyanka, Avala Devi Yamini
   Mishra, Sushant Kumar
TI Effectiveness of simulation based teaching of ventilatory management
   among non-anaesthesiology residents to manage COVID 19 pandemic - A
   Quasi experimental cross sectional pilot study
SO INDIAN JOURNAL OF ANAESTHESIA
LA English
DT Article
DE COVID 19; feedback; mechanical ventilation; pandemic; training support
ID POSITION STATEMENT; INDIAN SOCIETY; CARE
AB Background and Aims: Simulation is one of the important learning tools when it comes to skill acquisition and as a supplemental tool for training in high stake situations like COVID-19. The aim of this study is to meet the global requirements of knowledge on ventilatory management, prepare and to evaluate the effectiveness of the teaching module for non-anesthesiology trainees on COVID-19 patients. Methods: Quasi experimental cross sectional pilot study was conducted with a sample of twenty-six trainees. A teaching module was prepared and validated which consisted of lectures, audio-video sessions, demonstrations with hands-on training, debriefing, analytical-phase and reflection. Pre and Post evaluations from student t-test and direct observation of procedural skills (DOPS) were used for knowledge and skill assessment respectively and feedback obtained from Likert's score. Results: Pre- and Post-tests had a mean score of 7.42 +/- 2.12 and 14.92 +/- 2.9 respectively (P value 0.00001). DOPS included 16 point score, in which 23 trainees (88.4%) met the expectations and above expectations as per training objectives. A five-point Likert's score feedback revealed satisfactory and highly satisfactory scores of 100% (ABG), 96.1% (mechanical ventilation), and 84.6% (ventilation in COVID-19 patients). Overall satisfaction for the workshop among respondents was 100 per cent. Confidences of handling scores were 84.5% (interpreting ABG), 65.3% (maneuvering mechanical ventilation), and 96.15% (intubation in COVID-19 patients). Conclusion: A planned teaching module in ventilation management helps to train non-anaesthesiologists more effectively as a part of COVID-19 preparedness. Simulation with debriefing based training to the medical fraternity is the best alternative in the present pandemic and it will also ensure the safety of health care professionals.
C1 [Mouli, Tatikonda Chandra; Davuluri, Anjani; Priyanka, Avala Devi Yamini] GSL Med Coll, Dept Anaesthesiol & Crit Care, Rajahmundry 533296, Andhra Pradesh, India.
   [Vijaya, Sana] GSL Med Coll, Dept Gen Surg, Rajahmundry, Andhra Pradesh, India.
   [Mishra, Sushant Kumar] GSL Med Coll, Dept Community Med, Rajahmundry, Andhra Pradesh, India.
RP Mouli, TC (corresponding author), GSL Med Coll, Dept Anaesthesiol & Crit Care, Rajahmundry 533296, Andhra Pradesh, India.
EM chandradasavatar@gmail.com
CR Agha S, 2015, SAUDI MED J, V36, P730, DOI 10.15537/smj.2015.6.11501
   Bajwa SJS, 2020, INDIAN J ANAESTH, V64, P267, DOI 10.4103/ija.IJA_272_20
   Bhagwat M, 2012, INDIAN J ANAESTH, V56, P14, DOI 10.4103/0019-5049.93338
   Ciullo A, 2019, BMJ SIMUL TECHNOL EN, V5, P22, DOI 10.1136/bmjstel-2017-000254
   Erfani Khanghahi Masoumeh, 2018, Med J Islam Repub Iran, V32, P45, DOI 10.14196/mjiri.32.45
   Fuller BM, 2017, CRIT CARE MED, V45, P645, DOI 10.1097/CCM.0000000000002268
   Green M, 2016, ANESTHESIOL RES PRAC, V2016, DOI 10.1155/2016/4237523
   Higham H, 2017, BRIT J ANAESTH, V119, pI106, DOI 10.1093/bja/aex302
   Janse B, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-140
   Kennedy CC, 2014, CRIT CARE MED, V42, P169, DOI 10.1097/CCM.0b013e31829a721f
   Khanduja PK, 2015, CRIT CARE MED, V43, P186, DOI 10.1097/CCM.0000000000000672
   Krogh Kristian, 2016, Adv Simul (Lond), V1, P12, DOI 10.1186/s41077-016-0011-4
   La Cerra C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025306
   Lorello GR, 2014, BRIT J ANAESTH, V112, P231, DOI 10.1093/bja/aet414
   Malhotra N, 2020, INDIAN J ANAESTH, V64, P355, DOI 10.4103/ija.IJA_454_20
   Malhotra N, 2020, INDIAN J ANAESTH, V64, P259, DOI 10.4103/ija.IJA_288_20
   Peng PWH, 2020, BRIT J ANAESTH, V124, P497, DOI 10.1016/j.bja.2020.02.008
   PURVA M, 2019, BMJ SIMUL TECHNOL EN, DOI DOI 10.1136/BMJSTEL-2019-000496
   Spadaro S, 2017, SIMUL HEALTHC, V12, P349, DOI 10.1097/SIH.0000000000000249
   Stone TE, 2014, NURS EDUC TODAY, V34, P586, DOI 10.1016/j.nedt.2013.07.014
   Sun Q, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00650-2
   Yan GM, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0657-7
   Yee J, 2016, CRIT CARE RES PRACT, V2016, DOI 10.1155/2016/4670672
NR 23
TC 5
Z9 6
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 0019-5049
EI 0976-2817
J9 INDIAN J ANAESTH
JI Indian J. Anaesth.
PD MAY
PY 2020
VL 64
SU 2
BP S136
EP S140
DI 10.4103/ija.IJA_452_20
PG 5
WC Anesthesiology
WE Emerging Sources Citation Index (ESCI)
SC Anesthesiology
GA QE1QI
UT WOS:000615984400010
PM 32773853
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Inoue, M
   Arakida, M
   Paudyal, YR
   Razak, KA
   Tsao, TC
   Ghosh, C
   Ladbrook, W
   Takeuchi, K
   Ishiwatari, M
AF Inoue, Masashi
   Arakida, Masaru
   Paudyal, Youb Raj
   Razak, Khamarrul Azahari
   Tsao, Ting-Chi
   Ghosh, Chandan
   Ladbrook, Warren
   Takeuchi, Kuniyoshi
   Ishiwatari, Mikio
TI Building Disaster Resilience amid the COVID-19 Pandemic: A
   Transdisciplinary Approach for Decision Making
SO JOURNAL OF DISASTER RESEARCH
LA English
DT Article
DE transdisciplinary approach; COVID-19; resilience; disaster risk
   management; information and communication technology (ICT)
AB The fact that COVID-19 caused unprecedented challenges for the first time in the human race and eventually rose against all odds in such a short period is a testament to transdisciplinary capacity building. This study analyzes the approaches to disaster management during the pandemic by examining some cases in the Asian region. Managing disasters during a pandemic requires a transdisciplinary approach (TDA), including multi-sectoral coordination, and an interdisciplinary approach based on sound knowledge sharing. The session, in September 2021, in which nine presenters participated, discussed the role of TDA in managing disasters. Through this special session, it was found that the TDA contributed to managing disasters in complex situations, and three characteristics could be identified. First, as per institutional arrangements, case studies show how disaster risk reduction agencies, which had been responding to the expected scale of disasters, have started to respond to multiple different disasters and infectious diseases because of COVID-19. Second, public trust based on sound knowledge and information sharing is essential for promoting multi-stakeholder coordination. Third, information and communication technology utilization was found not only for information sharing and contact-base registration systems on disaster response to COVID-19 but also for monitoring the reconstruction process after a disaster in a remote manner. Further analysis and review will be conducted to develop these evolving practices to build disaster resilience.
C1 [Inoue, Masashi] Eight Japan Engn Consultants Inc, Nakano Ku, 5-33-11 Honcho, Tokyo 1648601, Japan.
   [Arakida, Masaru] Asian Disaster Reduct Ctr, Kobe, Hyogo, Japan.
   [Paudyal, Youb Raj] Natl Reconstruct Author, Kathmandu, Nepal.
   [Razak, Khamarrul Azahari] Univ Teknol Malaysia UTM, Disaster Preparedness & Prevent Ctr, Malaysia Japan Int Inst Technol, Kuala Lumpur, Malaysia.
   [Tsao, Ting-Chi] Sinotech Engn Consultants Inc, Taipei, Taiwan.
   [Ghosh, Chandan] Natl Inst Disaster Management, Delhi, India.
   [Ladbrook, Warren] Auxilium Ltd, Queenstown, New Zealand.
   [Takeuchi, Kuniyoshi] Univ Yamanashi, Kofu, Yamanashi, Japan.
   [Ishiwatari, Mikio] Univ Tokyo, Chiba, Japan.
RP Inoue, M (corresponding author), Eight Japan Engn Consultants Inc, Nakano Ku, 5-33-11 Honcho, Tokyo 1648601, Japan.
EM inoue-ma@ej-hds.co.jp
FU Japan Society of Civil Engineers (JSCE); Asian Civil Engineering
   Coordinating Council (ACECC)
FX The authors wish to express their appreciation to the Japan Society of
   Civil Engineers (JSCE) and the Asian Civil Engineering Coordinating
   Council (ACECC) for supporting the TC21 Special Session at the Annual
   Meeting of the JSCE. Attendants in spe-cial sessions provided valuable
   information. Their support was sincerely appreciated.
CR Ishiwatari M, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100096
   Kuraoka S, 2020, J DISASTER RES, V15, P868, DOI 10.20965/jdr.2020.p0868
   Potutan G, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18063137
   Takeuchi K., 2019, 21 TECHN COMM TC21 A
   Takeuchi K, 2019, P 8 CIV ENG C AS REG
NR 5
TC 0
Z9 0
U1 2
U2 2
PU FUJI TECHNOLOGY PRESS LTD
PI TOKYO
PA 1-15-7, UCHIKANDA, CHIYODA-KU, UNIZO UCHIKANDA 1-CHOME BLDG 2F, TOKYO,
   101-0047, JAPAN
SN 1881-2473
EI 1883-8030
J9 J DISASTER RES
JI J. Disaster Res.
PD JAN
PY 2022
VL 17
IS 1
SI SI
BP 144
EP 151
DI 10.20965/jdr.2022.p0144
PG 8
WC Geosciences, Multidisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Geology
GA YP5XI
UT WOS:000748695600017
OA gold
DA 2022-04-20
ER

PT J
AU Duvendack, M
   Sonne, L
AF Duvendack, Maren
   Sonne, Lina
TI Responding to the Multifaceted COVID-19 Crisis: The Case of Mumbai,
   India
SO PROGRESS IN DEVELOPMENT STUDIES
LA English
DT Article
DE COVID-19; crisis management; systems thinking; complexity; India
ID POLICY
AB COVID-19 has severely impacted the society not only in terms of health but also in terms of economic survival of individuals. Unless adequate support is provided, the pandemic will have long-lasting effects, especially on the lives of the most vulnerable, often working in the informal sector. In this article, we present a case study drawing on systems thinking and complexity theory, outlining how the city of Mumbai has responded to COVID-19. We find a multifaceted scenario where non-profit organizations, businesses and citizen volunteers operate alongside government bodies to support Mumbai's population to overcome this pandemic. We provide broader policy lessons, as well as more specific lessons in relation to particular actors, from the first wave of the pandemic stressing the importance of becoming 'systems thinkers' and highlighting the importance of forming new partnerships and exploring new modes of knowledge sharing to effectively respond to crises.
C1 [Duvendack, Maren] Univ East Anglia, Norwich, Norfolk, England.
   [Sonne, Lina] OP Jindal Global Univ, Sonipat, India.
RP Duvendack, M (corresponding author), Univ East Anglia, Norwich, Norfolk, England.
EM m.duvendack@uea.ac.uk
OI Duvendack, Maren/0000-0002-8125-9115
CR Alexander D., 2002, DISASTER PREV MANAG, V11, P209
   [Anonymous], 2020, INDIAN EXPRESS
   [Anonymous], 2020, MINT
   [Anonymous], 2021, HINDU
   [Anonymous], 2020, INDIA TODAY
   [Anonymous], 2020, NDTV
   [Anonymous], 2020, SCROLL
   [Anonymous], 2020, BBC NEWS
   [Anonymous], 2020, MIDDAY 0415
   [Anonymous], 2020, BUSINESS STANDARD
   [Anonymous], 2020, HINDU
   [Anonymous], 2020, THE FINANCIAL TIMES
   [Anonymous], 2020, THE GUARDIAN
   [Anonymous], 2020, MIDDAY
   [Anonymous], 2020, MUMBAILIVE
   [Anonymous], 2020, WIRE
   ARNOLD D, 1986, PAST PRESENT, P118
   Barbrook-Johnson P, 2020, EVALUATION-US, V26, P315, DOI 10.1177/1356389020930053
   Birney A., 2017, CULTIVATING SYSTEM C
   Borgatti SP, 1999, SOC NETWORKS, V21, P375
   Cowan R, 1996, ECON J, V106, P521, DOI 10.2307/2235561
   COWAN R, 2000, IND CORP CHANGE, V9, P211, DOI DOI 10.1093/ICC/9.2.211
   Dahlberg H., 2003, HUMANIST PSYCHOL, V31, P34, DOI [https://doi.org/10.1080/08873267.2003.9986933, DOI 10.1080/08873267.2003.9986933]
   Davenport T., 1998, WORKING KNOWLEDGE OR
   David P., 1994, Stochastic Models Optimization Techniques and Computer Applications. Proceedings of the International Conference on Stochastic Models, Optimization Techniques and Computer Applications (ICSOC'94), P205, DOI 10.1016/0954-349X(94)90002-7
   Dowling Maura, 2012, Nurse Res, V20, P21
   Ferrari, 2020, ADAPTIVE LEADERSHIP
   Freeman C., 1988, TECHNICAL CHANGE EC, P330
   Given L.M., 2008, SAGE ENCY QUALITATIV, DOI DOI 10.4135/9781412963909
   Given LM., 2008, SAGE ENCY QUALITATIV, V2, DOI DOI 10.4135/9781412963909.N250
   Hingorani, 2020, SARS COV2 SERO PREVA
   HM Treasury, 2020, MAG BOOK 2020 SUPPL
   Hodgson GM, 2003, J ECON ISSUES, V37, P85, DOI 10.1080/00213624.2003.11506557
   Indian doctors fighting Coronavirus now face social stigma, 2020, QUARTZ INDIA
   KLEIN I, 1988, MOD ASIAN STUD, V22, P723, DOI 10.1017/S0026749X00015729
   Kurtz CF, 2003, IBM SYST J, V42, P462, DOI 10.1147/sj.423.0462
   Lundvall B.A., 1992, NATL SYSTEMS INNOVAT
   Malik K, 2020, OXFORD REV ECON POL, V36, pS138, DOI 10.1093/oxrep/graa014
   MASRI A, 1995, J URBAN PLAN D-ASCE, V121, P19, DOI 10.1061/(ASCE)0733-9488(1995)121:1(19)
   McIntosh I, 2019, J SOC POLICY, V48, P449, DOI 10.1017/S0047279418000570
   Mytelka L.K., 2000, IND INNOV, V7, P15, DOI [10.1080/713670244, DOI 10.1080/713670244]
   Nelson R.R., 2009, EVOL THEOR
   Oxfam, 2020, OXFAM MEDIA BRI 0709
   Pardeshi, 2020, COVID 19 PANDEMIC MA
   Ramalingam B., 2008, EXPLORING SCI COMPLE, V285
   Ramalingam B., 2013, AID EDGE CHAOS RETHI
   Ramanna Mridula., 2012, HLTH CARE BOMBAY PRE
   Sarkar N, 2001, P IND HIST C, V62, P442
   United Nations, 2019, SUST DEV GOALS
   World Bank, 2015, MEAS APPR END POV BO
   Zimmerman, 2002, COMPLICATED COMPLEX, P1
NR 51
TC 0
Z9 0
U1 2
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1464-9934
EI 1477-027X
J9 PROG DEV STUD
JI Prog. Dev. Stud.
PD OCT
PY 2021
VL 21
IS 4
SI SI
BP 361
EP 379
AR 14649934211030449
DI 10.1177/14649934211030449
EA AUG 2021
PG 19
WC Development Studies
WE Social Science Citation Index (SSCI)
SC Development Studies
GA WK0RD
UT WOS:000683965200001
OA Green Accepted, hybrid
DA 2022-04-20
ER

PT J
AU Lin, KC
   Wang, CC
   Huang, WC
   Hwang, JJ
AF Lin, Kun-Chang
   Wang, Chun-Chieh
   Huang, Wei-Chun
   Hwang, Juey-Jen
TI Considerations When Managing Heart Failure during the COVID-19
   Pandemic-Consensus from the Taiwan Society of Cardiology
SO ACTA CARDIOLOGICA SINICA
LA English
DT Review
DE COVID-19; Heart failure; SARS-CoV-2
ID DISEASE
AB Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since December 2019. Acute heart failure has accounted for 23-24% of the initial presentations in patients with COVID-19 infection. Furthermore, COVID-19 might increase metabolic demand and cause acute decompensation of pre-existing stable heart failure. These patients are thus more susceptible to the evolution of more serious clinical symptoms and a higher mortality rate. Given the lack of knowledge about this new disease, this review provides recommendations for the management of heart failure during the COVID-19 pandemic in Taiwan.
C1 [Lin, Kun-Chang; Huang, Wei-Chun] Kaohsiung Vet Gen Hosp, Dept Crit Care Med, 386,Dazhong 1st Rd, Kaohsiung 813, Taiwan.
   [Wang, Chun-Chieh] Linkou Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan.
   [Wang, Chun-Chieh] Chang Gung Univ, Taoyuan, Taiwan.
   [Huang, Wei-Chun] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.
   [Huang, Wei-Chun] Fooyin Univ, Dept Phys Therapy, Kaohsiung, Taiwan.
   [Hwang, Juey-Jen] Natl Taiwan Univ, Dept Internal Med, Div Cardiol, Coll Med & Hosp, Taipei, Taiwan.
   [Hwang, Juey-Jen] Natl Taiwan Univ Hosp, Yulin Branch, Yuanlin, Taiwan.
RP Huang, WC (corresponding author), Kaohsiung Vet Gen Hosp, Dept Crit Care Med, 386,Dazhong 1st Rd, Kaohsiung 813, Taiwan.
EM wchuanglulu@gmail.com
FU Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan [VGHKS
   19-CT10-04]; Ministry of Science and Technology
   [108-2314-B-075B-007-MY2]
FX This study was supported by grants from the Kaohsiung Veterans General
   Hospital, Kaohsiung, Taiwan, i.e., Grant Nos. VGHKS 19-CT10-04 and the
   Ministry of Science and Technology, i.e., Grants
   108-2314-B-075B-007-MY2.
CR Alvi RM, 2018, J AM COLL CARDIOL, V72, P518, DOI 10.1016/j.jacc.2018.04.083
   Ameri P, 2021, CLIN RES CARDIOL, V110, P1020, DOI 10.1007/s00392-020-01766-y
   Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013
   Buckley LF, 2020, J CARDIOVASC PHARM, V75, P526, DOI 10.1097/FJC.0000000000000840
   Buzon J, 2015, INTERNAL MED, V54, P2017, DOI 10.2169/internalmedicine.54.3606
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Chen C, 2020, HERZ, V45, P230, DOI 10.1007/s00059-020-04909-z
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Dixon DL, 2020, J CARDIOVASC PHARM, V75, P359, DOI 10.1097/FJC.0000000000000836
   Dong NG, 2020, JACC-HEART FAIL, V8, P515, DOI 10.1016/j.jchf.2020.04.001
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Foy M, 2014, CURR HIV-AIDS REP, V11, P212, DOI 10.1007/s11904-014-0212-1
   Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hulot JS, 2020, ARCH CARDIOVASC DIS, V113, P225, DOI 10.1016/j.acvd.2020.03.009
   Lippi G, 2020, PROG CARDIOVASC DIS, V63, P390, DOI 10.1016/j.pcad.2020.03.001
   Long B, 2020, AM J EMERG MED, V38, P1504, DOI 10.1016/j.ajem.2020.04.048
   Maisch B, 2020, HERZ, V45, P321, DOI 10.1007/s00059-020-04925-z
   Mehra MR, 2020, JACC-HEART FAIL, V8, P512, DOI 10.1016/j.jchf.2020.03.004
   Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633
   Rico-Mesa JS, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-01291-4
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Sugimoto T, 2020, CIRC J, V84, P1039, DOI 10.1253/circj.CJ-20-0302
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yu CM, 2006, POSTGRAD MED J, V82, P140, DOI 10.1136/pgmj.2005.037515
   Zeng JH, 2020, INFECTION, V48, P773, DOI 10.1007/s15010-020-01424-5
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 33
TC 1
Z9 1
U1 0
U2 0
PU TAIWAN SOC CARDIOLOGY
PI TAIPEI
PA 13F-1, NO. 11, MIN-CHUAN WEST ROAD, TAIPEI, 104, TAIWAN
SN 1011-6842
J9 ACTA CARDIOL SIN
JI Acta Cardiol. Sin.
PD MAR
PY 2021
VL 37
IS 2
BP 125
EP 129
DI 10.6515/ACS.202103_37(2).20200916A
PG 5
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA QX3UU
UT WOS:000629272300001
PM 33716453
DA 2022-04-20
ER

PT J
AU Bastani, P
   Bahmaei, J
   Kharazinejad, E
   Samadbeik, M
   Liang, ZM
   Schneider, CH
AF Bastani, Peivand
   Bahmaei, Jamshid
   Kharazinejad, Ebrahim
   Samadbeik, Mahnaz
   Liang, Zhanming
   Schneider, Carmen Huckel
TI How COVID-19 affects the use of evidence informed policymaking among
   iranian health policymakers and managers
SO ARCHIVES OF PUBLIC HEALTH
LA English
DT Article
DE Evidence informed Policy making; Knowledge Translation Exchange;
   Knowledge Broker; COVID-19; Health policymakers; Health managers; Iran
AB Background The COVID-19 pandemic increased the need for new valid scientific evidence to support urgent clinical and policy decision making; as well as improved processes for the rapid synthesis, uptake and application of that evidence. Evidence informed policymaking (EIPM) can be considered as a way to access and use the results of evidence in practice. This study aimed to determine what effects COVID-19 had on the way Iranian health managers and policymakers use evidence in their decisions. Methods This study was conducted in 2021 applying a qualitative research design. Data was collected through semi-structured interviews. Thirty health care managers, policy makers and medical university faculty members were recruited as the study participants, initially via a purposive sample, followed by snowballing. A conventional content analysis presented by Hsieh and Shannon (2005) was applied for data analysis. Results Ten main themes emerged from the data including: 1) roles and duties of knowledge brokers (KBs); 2-5) the roles, benefits, barriers and necessities of applying Knowledge Translation Exchange (KTE) tools; 6-8) the facilitators, benefits and barriers to the application of evidence during COVID-19; 9) challenges of rapid evidence production evidence during COVID-19 and 10) consequences of not applying evidence during COVID-19. According to the present conceptual framework, KBs act as an intermediator between the large amounts of knowledge produced and decision makers. KTE tools should be applied to enhance EIPM during COVID-19. Attention should be paid to the facilitators, barriers, benefits and necessities of evidence application during COVID-19 to avoid negative consequences for the health system. Conclusions Results of this study show that developing KTE tools and activating KBs can be among the main strategies to produce applied actionable messages for policymakers to move toward EIPM; and that this applies even when rapid decision making is required, such as during the COVID-19 pandemic. It is strongly recommended to reinforce the local capacities through supporting scientific networks and relationships between research centers and local and national policymakers. At the same time, attention to local barriers to and facilitators of the application of evidence while facing a pandemic can pave the way to better identification of health system`s problems and rapid responses.
C1 [Bastani, Peivand] Shiraz Univ Med Sci, Hlth Human Resources Res Ctr, Sch Management & Med Informat, Shiraz, Iran.
   [Bahmaei, Jamshid] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.
   [Kharazinejad, Ebrahim] Abadan Univ Med Sci, Dept Anat Sci, Abadan, Iran.
   [Samadbeik, Mahnaz] Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran.
   [Samadbeik, Mahnaz] Univ Queensland, Fac Med, Ctr Online Hlth, Brisbane, Qld, Australia.
   [Liang, Zhanming] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld 4811, Australia.
   [Schneider, Carmen Huckel] Univ Sydney, Menzies Ctr Hlth Policy & Econ, Sydney Sch Publ Hlth, Sydney, NSW, Australia.
RP Bahmaei, J (corresponding author), Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.
EM jamshid_b1388@yahoo.com
RI Samadbeik, Mahnaz/H-2383-2016; Bastani, Peivand/AAE-1769-2022
OI Samadbeik, Mahnaz/0000-0002-4756-2364; Bastani,
   Peivand/0000-0002-0412-0267
CR Carbone EG, 2018, AM J PUBLIC HEALTH, V108, pS383, DOI [10.2105/ajph.2018.304702, 10.2105/AJPH.2018.304702]
   Dobbins M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-23
   El-Jardali F, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-00576-y
   El-Jardali F, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-15
   Forero R, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2915-2
   Fretheim A, 2020, EUROSURVEILLANCE, V25, P13, DOI 10.2807/1560-7917.ES.2020.25.19.2000687
   Hasanpoor E, 2018, ETHIOP J HEALTH SCI, V28, P665, DOI 10.4314/ejhs.v28i5.18
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]
   Kasonde JM, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-31
   Kuchenmuller T, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005012
   Lancaster K, 2020, EVID POLICY, V16, P477, DOI 10.1332/174426420X15913559981103
   Lavis JN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000141
   Mahendradhata Y, 2021, HEALTH RES POLICY SY, V19, DOI 10.1186/s12961-020-00670-1
   Moat KA, 2014, B WORLD HEALTH ORGAN, V92, P20, DOI 10.2471/BLT.12.116806
   Oliver K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-2
   Oxman AD, 2009, HEALTH RES POLICY SY, V7, DOI [10.1186/1478-4505-7-S1-S15, 10.1186/1478-4505-7-S1-I1, 10.1186/1478-4505-7-S1-S1, 10.1186/1478-4505-7-S1-11]
   Saretzki T, 2019, Z EVIDENZ FORTBILD Q, V144, P78, DOI 10.1016/j.zefq.2019.05.008
   Shafaghat T, 2021, SYST REV-LONDON, V10, DOI 10.1186/s13643-021-01595-8
   Smith K, 2013, EVIDENCE BASED POLIC
   Williams G. A., 2020, Eurohealth, V26, P29
   Wu X., 2017, POLICY CAPACITY GOVE
   Yang KF, 2020, AM REV PUBLIC ADM, V50, P706, DOI 10.1177/0275074020942406
NR 23
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0778-7367
EI 2049-3258
J9 ARCH PUBLIC HEALTH
JI Arch. PUblic Health
PD JAN 5
PY 2022
VL 80
IS 1
AR 16
DI 10.1186/s13690-021-00757-3
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA YA9CP
UT WOS:000738622800001
PM 34983653
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Yao, RL
   Zhu, L
   Wang, J
   Liu, JC
   Xue, RF
   Xue, LY
   Liu, LG
   Li, CY
   Zhao, HY
   Cheng, J
   Huang, SP
   Li, Y
   Zhao, XA
   Zhu, CAW
   Li, M
   Huang, R
   Wu, C
AF Yao, Renling
   Zhu, Li
   Wang, Jian
   Liu, Jiacheng
   Xue, Ruifei
   Xue, Leyang
   Liu, Longgen
   Li, Chunyang
   Zhao, Haiyan
   Cheng, Juan
   Huang, Songping
   Li, Yang
   Zhao, Xiang-an
   Zhu, Chuanwu
   Li, Ming
   Huang, Rui
   Wu, Chao
TI Risk of severe illness of COVID-19 patients with NAFLD and increased
   NAFLD fibrosis scores
SO JOURNAL OF CLINICAL LABORATORY ANALYSIS
LA English
DT Article
DE COVID-19; fibrosis; non-alcoholic fatty liver disease; severe illness
ID FATTY LIVER-DISEASE; MANAGEMENT; PREDICTOR; MORTALITY; INJURY
AB Background There is still little knowledge about the association of liver fibrosis with the clinical outcomes of COVID-19 patients with non-alcoholic fatty liver disease (NAFLD). The aim of the study was to determine the association of NAFLD fibrosis score (NFS)-determined liver fibrosis with clinical outcomes of COVID-19 patients with NAFLD. Methods The NAFLD was diagnosed by the Hepatic Steatosis Index (HSI) in the absence of other causes of chronic liver diseases. NFS was used to evaluate the severity of liver fibrosis. Results A total of 86 COVID-19 patients with NAFLD were included. The median age was 43.5 years, and 58.1% of patients were male. Thirty-eight (44.2%) patients had advanced liver fibrosis according to the NFS. Multivariate analysis indicated that concurrent diabetes (odds ratio [OR] 8.264, 95% confidence interval [CI] 1.202-56.830, p = 0.032) and advanced liver fibrosis (OR 11.057, 95% CI 1.193-102.439, p = 0.034) were independent risk factors of severe illness in COVID-19 patients with NAFLD. Conclusion NAFLD patients with NFS-determined advanced liver fibrosis are at higher risk of severe COVID-19.
C1 [Yao, Renling; Xue, Ruifei; Wu, Chao] Nanjing Med Univ, Dept Infect Dis, Nanjing Drum Tower Hosp, Clin Coll, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.
   [Yao, Renling; Wang, Jian; Huang, Rui; Wu, Chao] Nanjing Univ, Dept Infect Dis, Nanjing Drum Tower Hosp, Affiliated Hosp,Med Sch, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.
   [Zhu, Li; Zhu, Chuanwu] Soochow Univ, Dept Infect Dis, Affiliated Infect Dis Hosp, Suzhou, Peoples R China.
   [Liu, Jiacheng; Wu, Chao] Nanjing Univ Chinese Med, Dept Infect Dis, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Nanjing, Peoples R China.
   [Xue, Leyang] Huaian 4 Peoples Hosp, Dept Crit Med, Huaian, Peoples R China.
   [Liu, Longgen] Third Peoples Hosp Changzhou, Dept Infect Dis, Changzhou, Peoples R China.
   [Li, Chunyang] Xuzhou Med Univ, Dept Infect Dis, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China.
   [Zhao, Haiyan] Peoples Hosp Suqian, Dept Infect Dis, Suqian, Peoples R China.
   [Cheng, Juan] Yancheng Second Peoples Hosp, Dept Infect Dis, Yancheng, Peoples R China.
   [Huang, Songping] Nantong Univ, Dept Infect Dis, Nantong Peoples Hosp 3, Nantong, Peoples R China.
   [Li, Yang] Taizhou Peoples Hosp, Dept Infect Dis, Taizhou, Peoples R China.
   [Zhao, Xiang-an] Yangzhou Univ, Dept Gastroenterol, Northern Jiangsu Peoples Hosp, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China.
   [Li, Ming] Soochow Univ, Dept Hepatol, Affiliated Infect Dis Hosp, 10 Guangqian Rd, Suzhou 215000, Jiangsu, Peoples R China.
RP Wu, C (corresponding author), Nanjing Med Univ, Dept Infect Dis, Nanjing Drum Tower Hosp, Clin Coll, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.; Huang, R (corresponding author), Nanjing Univ, Dept Infect Dis, Nanjing Drum Tower Hosp, Affiliated Hosp,Med Sch, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.; Li, M (corresponding author), Soochow Univ, Dept Hepatol, Affiliated Infect Dis Hosp, 10 Guangqian Rd, Suzhou 215000, Jiangsu, Peoples R China.
EM llttyy97@163.com; doctor_hr@126.com; dr.wu@nju.edu.cn
FU China Postdoctoral Science Foundation for COVID-19China Postdoctoral
   Science Foundation [2020T130049ZX] Funding Source: Medline; Fundamental
   Research Funds for the Central UniversitiesFundamental Research Funds
   for the Central Universities [14380459] Funding Source: Medline; the
   Nanjing Medical Science and Technique Development Foundation [QRX17121]
   Funding Source: Medline; Yangzhou Key R&D Program (Social Development)
   [YZ2020101] Funding Source: Medline
CR Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006
   Balakrishnan M, 2021, DIGEST DIS SCI, V66, P2387, DOI 10.1007/s10620-020-06501-1
   Caussy C, 2019, GUT, V68, P1884, DOI 10.1136/gutjnl-2018-317584
   Durazzo M, 2020, MINERVA GASTROENTERO, V66, P301, DOI 10.23736/S1121-421X.20.02753-1
   EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y
   Fan JG, 2019, J DIGEST DIS, V20, P163, DOI 10.1111/1751-2980.12685
   Forlano R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240400
   Huang R, 2020, HEPATOL COMMUN, V4, P1758, DOI 10.1002/hep4.1592
   Huang R, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008280
   Ji D, 2020, J HEPATOL, V73, P451, DOI 10.1016/j.jhep.2020.03.044
   Kim D, 2019, ALIMENT PHARM THER, V50, P590, DOI 10.1111/apt.15395
   Kim D, 2019, LIVER INT, V39, P1335, DOI 10.1111/liv.14110
   Kim D, 2019, HEPATOL INT, V13, P205, DOI 10.1007/s12072-018-09926-z
   Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002
   Mushtaq K, 2021, J HEPATOL, V74, P482, DOI 10.1016/j.jhep.2020.09.006
   National Health Commission, GUID DIAGN TREATM CO
   Targher G, 2020, DIABETES METAB, V46, P335, DOI 10.1016/j.diabet.2020.05.001
   Targher G, 2020, GUT, V69, P1691, DOI 10.1136/gutjnl-2020-320622
   Treeprasertsuk S, 2013, WORLD J GASTROENTERO, V19, P1219, DOI 10.3748/wjg.v19.i8.1219
   Vilar-Gomez E, 2018, J HEPATOL, V68, P305, DOI 10.1016/j.jhep.2017.11.013
   Wang J, 2020, OBESITY, V28, P2049, DOI 10.1002/oby.22979
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   Wu YK, 2020, HEPATOL INT, V14, P259, DOI 10.1007/s12072-020-10023-3
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 30
TC 0
Z9 0
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-8013
EI 1098-2825
J9 J CLIN LAB ANAL
JI J. Clin. Lab. Anal.
PD AUG
PY 2021
VL 35
IS 8
AR e23880
DI 10.1002/jcla.23880
EA JUL 2021
PG 7
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology
GA UC3YA
UT WOS:000668939600001
PM 34213039
OA Green Published
DA 2022-04-20
ER

PT B
AU Kumar, A
AF Kumar, Anshu
BE Malviya, RK
   Pipleya, S
   Dixit, VK
TI Analysing and Discussing the Role of Industry 4.0 during COVID-19
   Scenario
SO INNOVATIONS IN PRODUCT PROCESS AND SYSTEM DESIGN
LA English
DT Article; Book Chapter
DE COVID-19; Industry 4.0; Assistive Technologies; Coronavirus; Epidemic
AB The COVID 19 (coronavirus) epidemic has increased the need for essential health care tools, medicines, as well as digital information technology advances and applications. A detailed review of the literature is done on the technologies of Industry 4.0 (I4.0) and their applications in the COVID-19 epidemic, utilizing fitting hunt words on the data sets of Science Direct, Google Scholar, and Research Gate. This study discovered several useful I4.0 innovations that aid in the legitimate control and management of the COVID-19 pandemic and these are discussed in this paper. I4.0 can satisfies the prerequisites of modified face masks, gloves, and gather information for medical care frameworks for legitimate controlling and treating of COVID-19 patients. The accessible advancements of I4.0 could likewise help the detection and identification of COVID-19 and distinctive associated symptoms and side effects. It accepts that the appropriate execution of these innovations would assist with improving education, knowledge, and communication in regards to general wellbeing.
C1 [Kumar, Anshu] Shri Vaishnav Vidyapeeth Vishwavidyalaya, Dept Mech Engn, Shri Vaishnav Inst Technol & Sci, Indore, Madhya Pradesh, India.
RP Kumar, A (corresponding author), Shri Vaishnav Vidyapeeth Vishwavidyalaya, Dept Mech Engn, Shri Vaishnav Inst Technol & Sci, Indore, Madhya Pradesh, India.
EM anshukumar@svvv.edu.in
CR Alloghani M, 2018, I C DEV ESYST ENG, P64, DOI 10.1109/DeSE.2018.00016
   [Anonymous], 2020, MED TECH INN NEWS
   Cheng GJ, 2016, 2016 INTERNATIONAL CONFERENCE ON INFORMATION SYSTEM AND ARTIFICIAL INTELLIGENCE (ISAI 2016), P407, DOI [10.1109/ISAI.2016.0092, 10.1109/ISAI.2016.97]
   Dialani P., 2020, VIRTUAL REALITY IS H
   Fisher D, 2020, LANCET, V395, P1109, DOI 10.1016/S0140-6736(20)30679-6
   Georgios Petropoulos, ARTIFICIAL INTELLIGE
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Haleem Abid, 2020, Curr Med Res Pract, V10, P78, DOI 10.1016/j.cmrp.2020.03.011
   Haleem Abid, 2019, J Clin Orthop Trauma, V10, P615, DOI 10.1016/j.jcot.2018.09.015
   He S, USING INTERNET THING
   Ienca M, 2020, NAT MED, V26, P463, DOI 10.1038/s41591-020-0832-5
   Javaid M., 2019, CURRENT MED RES PRAC, V9, P102, DOI DOI 10.1016/J.CMRP.2019.04.001
   Kim P, 2018, AUTOMAT CONSTR, V89, P38, DOI 10.1016/j.autcon.2018.01.009
   Li Q, 2020, J INFECTION, V80, P472, DOI 10.1016/j.jinf.2020.02.014
   No IZADP Naud_e W, 2020, EARLY REV
   Pejcic B, 2006, ANALYST, V131, P1079, DOI 10.1039/b603402k
   Randy Bean, BIG DAT TIM COR COVI
   Sampol C., 2020, MEDICAL EXPO E MAG
NR 18
TC 0
Z9 0
U1 0
U2 0
PU ALLIED PUBLISHERS LTD
PI NEW DELHI
PA 13-14 ASAF ALI ROAD, NEW DELHI 110002, INDIA
BN 978-93-87997-52-3
PY 2021
BP 430
EP 436
PG 7
WC Engineering, Manufacturing; Engineering, Mechanical
WE Book Citation Index – Science (BKCI-S)
SC Engineering
GA BS0OC
UT WOS:000683553400047
DA 2022-04-20
ER

PT J
AU Bastas, A
   Garza-Reyes, JA
AF Bastas, Ali
   Garza-Reyes, Jose Arturo
TI Impact of the COVID-19 pandemic on manufacturing operations and supply
   chain resilience: effects and response strategies
SO JOURNAL OF MANUFACTURING TECHNOLOGY MANAGEMENT
LA English
DT Article; Early Access
DE COVID-19 pandemic; Manufacturing operations; Production management;
   Supply chain resilience; Industrial sustainability
AB Purpose Manufacturing organisations are striving towards adapting and responding to the unprecedented challenges posed by the coronavirus disease 2019 (COVID-19) pandemic, along with the operations research streams endeavouring to support their recovery. With a view to bridging our knowledge gap on the impact of the COVID-19 pandemic on the manufacturing operations, this paper investigates the key challenges and strategies formulated by manufacturing organisations operating in the Northern region of Cyprus. Design/methodology/approach The research was conducted through 10 in-depth interviews that analyzed the effects of the pandemic, the associated causes and the response strategies implemented. Findings The effects of the pandemic on the manufacturing organisations investigated are identified, along with the associated causes, and the response strategies deployed. Learnings and countermeasures implemented to date are established in light of the insights captured from the practitioners. Originality/value Contributions are made to the body of knowledge on manufacturing management and manufacturing supply chain resilience through fostering our understanding of the impacts that the pandemic had on manufacturing organisations, and practical contributions are presented through evidencing and transferring of the operations management knowledge and solutions devised in various sectors to date.
C1 [Bastas, Ali] Eastern Mediterranean Univ, Dept Ind Engn, Via Mersin 10, Famagusta, North Cyprus, Turkey.
   [Garza-Reyes, Jose Arturo] Univ Derby, Ctr Supply Chain Improvement, Derby, England.
RP Bastas, A (corresponding author), Eastern Mediterranean Univ, Dept Ind Engn, Via Mersin 10, Famagusta, North Cyprus, Turkey.
EM ali.bastas@emu.edu.tr
RI Garza-Reyes, Jose Arturo/ABD-5164-2021
OI Garza-Reyes, Jose Arturo/0000-0002-5493-877X
CR Aday S, 2020, FOOD QUAL SAF-OXFORD, V4, P167, DOI 10.1093/fqsafe/fyaa024
   Agrawal A, 2015, 2015 2ND INTERNATIONAL CONFERENCE ON COMPUTING FOR SUSTAINABLE GLOBAL DEVELOPMENT (INDIACOM), P1
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   Bastas A, 2019, SUSTAIN PROD CONSUMP, V20, P207, DOI 10.1016/j.spc.2019.06.005
   Bastas A, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124569
   Bastas A, 2018, J CLEAN PROD, V181, P726, DOI 10.1016/j.jclepro.2018.01.110
   Belhadi A, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120447
   Bogner A, 2009, RES METHODS SER, P1, DOI 10.1057/9780230244276
   Boyce C., 2006, CONDUCTING IN DEPTH, V2
   Castleberry A, 2018, CURR PHARM TEACH LEA, V10, P807, DOI 10.1016/j.cptl.2018.03.019
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Deshmukh S. G., 2020, INT J GLOB BUS COMPE, DOI [10.1007/s42943-020-00009-1, DOI 10.1007/S42943-020-00009-1]
   Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001
   Farthing Trevor S, 2021, medRxiv, DOI 10.1101/2021.04.19.21255737
   Galvin R, 2015, J BUILD ENG, V1, P2, DOI 10.1016/j.jobe.2014.12.001
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   Gigauri Iza., 2020, INT J MANAG SCI BUS, V6, P15, DOI [10.18775/ijmsba.1849-5664-5419.2014.66.1002, DOI 10.18775/IJMSBA.1849-5664-5419.2014.66.1002]
   Haleem A, 2020, AM J EMERG MED, V38, P1524, DOI 10.1016/j.ajem.2020.04.022
   Haraguchi N, 2017, WORLD DEV, V93, P293, DOI 10.1016/j.worlddev.2016.12.013
   Herrmann C, 2014, INT J PR ENG MAN-GT, V1, P283, DOI 10.1007/s40684-014-0034-z
   Ivanov D, 2021, PROD PLAN CONTROL, V32, P775, DOI 10.1080/09537287.2020.1768450
   Juergensen J, 2020, J IND BUS ECON, V47, P499, DOI 10.1007/s40812-020-00169-4
   Li XF, 2020, CHIN J MECH ENG-EN, V33, DOI 10.1186/s10033-019-0428-5
   Loey M, 2021, MEASUREMENT, V167, DOI 10.1016/j.measurement.2020.108288
   Metters R., 1997, Journal of Operations Management, V15, P89, DOI 10.1016/S0272-6963(96)00098-8
   Mogaji E., 2020, SSRN ELECT J, VVol., DOI [10.2139/ssrn.3564702, DOI 10.2139/SSRN.3564702]
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Okorie Okechukwu, 2020, IEEE Engineering Management Review, V48, P167, DOI 10.1109/EMR.2020.3012112
   Paul SK, 2021, INT J PHYS DISTR LOG, V51, P104, DOI 10.1108/IJPDLM-04-2020-0127
   Petrosky-Nadeau N., 2020, FEDERAL RESERVE BANK, P01, DOI [10.24148/wp2020-18, DOI 10.24148/WP2020-18]
   Rapaccini M, 2020, IND MARKET MANAG, V88, P225, DOI 10.1016/j.indmarman.2020.05.017
   Sanders K, 2020, J APPL BEHAV SCI, V56, P289, DOI 10.1177/0021886320937026
   Saunders M., 2015, RES METHODS BUSINESS, V7th ed.
   Shen HY, 2020, EMERG MARK FINANC TR, V56, P2213, DOI 10.1080/1540496X.2020.1785863
   Slack N., 2016, OPERATIONS MANAGEMEN
   Spychalski P, 2020, LANCET INFECT DIS, V20, P774, DOI [10.1016/S1473-3099(20)30245-0, 10.1016/S1473-3099(20)30246-2]
   Statistics US Bureau of Labor, 2019, 3133 NAICS STAT US B
   Tukamuhabwa BR, 2015, INT J PROD RES, V53, P5592, DOI 10.1080/00207543.2015.1037934
   United Nations, 2020, INFR IND UN SUST DEV
   van Kasteren Puck B, 2020, J Clin Virol, V128, P104412, DOI 10.1016/j.jcv.2020.104412
   Yu XX, 2020, INFLUENZA OTHER RESP, V14, P474, DOI 10.1111/irv.12743
   Zimmerling A., 2021, TECHNOL SOC, V65, P101, DOI [10.1016/j.techsoc.2021.101541, DOI 10.1016/j.techsoc.2021.101541]
NR 42
TC 0
Z9 0
U1 2
U2 2
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1741-038X
EI 1758-7786
J9 J MANUF TECHNOL MANA
JI J. Manuf. Technol. Manag.
DI 10.1108/JMTM-09-2021-0357
EA MAR 2022
PG 24
WC Engineering, Industrial; Engineering, Manufacturing; Management
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Engineering; Business & Economics
GA 0A4GF
UT WOS:000773913800001
DA 2022-04-20
ER

PT J
AU Guleryuz, D
   Ozden, E
AF Guleryuz, Didem
   Ozden, Erdemalp
TI Clustering framework to cope with COVID-19 for cities in Turkey
SO INGENIERIA SOLIDARIA
LA English
DT Article
DE COVID-19; Unsupervised Learning; Clustering Algorithm; Decision Support
   System
AB Introduction: This article is the product of the research "Clustering Framework to Cope with COVID-19 for Cities in Turkey", developed at Bayburt University in 2021.
   Problem: Turkey's risk map, presented in January 2021, to take local decisions in tackling the COVID-19 pandemic, was based on confirmed cases only. Health, socio-economic and environmental indicators are also important for management decisions of COVID-19. The risk map to be designed by adding these indicators will support more effective decisions.
   Objective: The research aims to propose a clustering scheme to design a risk map of cities for Turkey.
   Methodology: The unsupervised clustering algorithm suggested dividing the cities of Turkey into clusters, considering health, socio-economic, environmental indicators, and the spread pattern of COVID-19.
   Results: We found that cities are clustered into five groups while megacity Istanbul alone formed a cluster, three of Turkey's largest cities formed another cluster. Other clusters consist of 19, 26, and 32 cities, respectively. The most important determinants which have predictive power are identified.
   Conclusion: The suggested clustering method can be a decision support system for policymakers to determine the differences and similarities of cities in quarantine decisions and normalization phases for the following periods of the pandemic.
   Originality: To the best of our knowledge, this study differs from previous studies because countries were grouped in previous studies by only considering the confirmed cases. In this study, cities were clustered in terms of the health, socio-economic, and environmental indicators to make decisions locally.
   Limitations: The distribution of confirmed cases by age could be added, especially to make decisions about education, but this data is not officially announced.
C1 [Guleryuz, Didem] Bayburt Univ, Dept Management Informat Syst, Bayburt, Turkey.
   [Ozden, Erdemalp] Bayburt Univ, Dept Econ, Bayburt, Turkey.
RP Guleryuz, D (corresponding author), Bayburt Univ, Dept Management Informat Syst, Bayburt, Turkey.
EM dguleryuz@bayburt.edu.tr; eozden@bayburt.edu.tr
CR Azarafza M., 2020, CLUSTERING METHOD SP, DOI [10.1101/2020.05.22.20109942, DOI 10.1101/2020.05.22.20109942]
   Carrillo-Larco Rodrigo M, 2020, Wellcome Open Res, V5, P56, DOI [10.12688/wellcomeopenres.15819.3, 10.12688/wellcomeopenres.15819.1]
   Guleryuz D, 2020, ENVIRON RES TECHNOL, V3, P102
   Guleryuz D, 2021, PROCESS SAF ENVIRON, V149, P927, DOI 10.1016/j.psep.2021.03.032
   ILO, 2020, INT LAB ORG
   JohnsHopkins, 2021, JOHNS HOPK U COVID 1
   Kucukefe B, 2020, EKONOMI POLITIKA VE, V5, P280, DOI DOI 10.30784/EPFAD.811289
   Liu MY, 2021, SCI TOTAL ENVIRON, V777, DOI 10.1016/j.scitotenv.2021.145992
   Mahmoudi MR, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110230
   Melin P, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109917
   MinHealth, 2021, REP TURK MIN HLTH
   Myers J.L., 2003, RES DESIGN STAT ANAL, V2nd
   Nikolopoulos K, 2021, EUR J OPER RES, V290, P99, DOI 10.1016/j.ejor.2020.08.001
   Olivieri A, 2021, INT J INFECT DIS, V102, P363, DOI 10.1016/j.ijid.2020.10.070
   Purnima B., 2014, INT J COMPUT APPL, V105, P17, DOI 10.5120/18405-9674
   Rizvi S. A., 2021, CLUSTERING COUNTRIES, P1, DOI [10.1101/2021.02.15.21251762, DOI 10.1101/2021.02.15.21251762]
   ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7
   TURKSTAT, 2020, TURKISH STAT I
   World Health Organization (WHO), 2020, WHO COR COVID 19 DAS
   Worldbank, 2021, WORLD BANK OPEN DATA
   Wright S, 1920, J AGRIC RES, V20, P0557
   Zarikas V, 2020, DATA BRIEF, V31, DOI 10.1016/j.dib.2020.105787
NR 22
TC 0
Z9 0
U1 0
U2 0
PU UNIV COOPERATIVE COLOMBIA, FAC ENGINEERING
PI BOGOTA
PA AV CARCAS NO 37-15, BOGOTA, 00000, COLOMBIA
SN 1900-3102
EI 2357-6014
J9 ING SOLIDAR
JI Ing. Solidar.
PY 2021
VL 17
IS 3
DI 10.16925/2357-6014.2021.03.06
PG 23
WC Engineering, Multidisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Engineering
GA YO5KE
UT WOS:000747977300004
OA gold
DA 2022-04-20
ER

PT J
AU Niari, MR
   Eshghi, K
   Valilai, OF
AF Niari, Maryam Rezapour
   Eshghi, Kourosh
   Valilai, Omid Fatahi
TI Adaptive capacity management in cloud manufacturing hyper-network
   platform: Case of COVID-19 equipment production
SO INTERNATIONAL JOURNAL OF MANAGEMENT SCIENCE AND ENGINEERING MANAGEMENT
LA English
DT Article; Early Access
DE Cloud Manufacturing network management; SOM system; reliability;
   adaptive capacity; ventilator; Covid-19
ID AWARE SERVICE COMPOSITION; SUPPLY CHAIN; DEMAND; ALGORITHM; SELECTION;
   SYSTEMS; OPTIMIZATION; PRINCIPLES; ALLOCATION; RECOVERY
AB Cloud Manufacturing (CMfg) is a service-oriented manufacturing (SOM) paradigm that provides a dynamic, scalable, and virtualized working ecosystem. The CMfg collaborative structure can be modeled as a hyper-network-based service-demand matching architecture. It is enriched with quality of service (QoS) characteristics to produce customized products in a stable and reliable network. This stability should be considered in the overall manufacturing network mechanism. This paper has provided adaptive strategies utilizing available resources and capacities to enhance the system's stability and reliability against the unexpected events. The capabilities of the enhanced framework are utilized to handle the unexpected situation that has occurred during the COVID-19 disruption treatment in Iran, Tehran. The paper has designed the reliable CMfg network to analyze the virtual ventilator production processes. The proposed framework successfully and efficiently enabled the CMfg architecture to use small and medium enterprises (SMEs) and knowledge-based companies' capabilities in producing common components. These components were transferred among the stakeholders using the adaptive capacities of vehicles. The results of analysis indicated that the adaptive strategies increased collaborations among CMfg members and provided more serving alternatives as possible solutions to decision-makers. An increase in the number of feasible solutions makes the structure more resilient to unexpected events.
C1 [Niari, Maryam Rezapour; Eshghi, Kourosh] Sharif Univ Technol, Ind Engn Dept, Tehran, Iran.
   [Valilai, Omid Fatahi] Jacobs Univ Bremen, Dept Math & Logist, Bremen, Germany.
RP Valilai, OF (corresponding author), Jacobs Univ Bremen, Dept Math & Logist, Bremen, Germany.
EM O.FatahiValilai@jacobs-University.de
RI Valilai, Omid Fatahi/M-4395-2019; Fatahi Valilai, Omid/E-6253-2018
OI Valilai, Omid Fatahi/0000-0001-7087-6946; Fatahi Valilai,
   Omid/0000-0001-7087-6946
CR Aghamohammadzadeh E, 2020, INT J PROD RES, V58, P5280, DOI 10.1080/00207543.2020.1715507
   Aghamohammathadeh E, 2020, INT J PROD RES, V58, P1987, DOI 10.1080/00207543.2019.1640406
   Agi-Journalistic Agency Italia SpA, 2020, EC GUERR COST 100 MI
   [Anonymous], NEWS
   Araz OM, 2020, DECISION SCI, V51, P1316, DOI 10.1111/deci.12443
   Assari M, 2018, PROD MANUF RES, V6, P345, DOI 10.1080/21693277.2018.1517056
   Ayyildiz E, 2021, ENVIRON SCI POLLUT R, DOI 10.1007/s11356-021-16972-y
   Baldwin W, 2020, VENTILATOR MAKER WE
   Basole RC, 2014, DECISION SCI, V45, P753, DOI 10.1111/deci.12099
   Berge C., 1973, GRAPHS HYPERGRAPHS
   Bouzary H, 2020, ROBOT CIM-INT MANUF, V66, DOI 10.1016/j.rcim.2020.101989
   Bouzary H, 2018, PROCEDIA MANUF, V26, P1128, DOI 10.1016/j.promfg.2018.07.149
   Cheng Y, 2018, ENTERP INF SYST-UK, V12, P780, DOI 10.1080/17517575.2016.1183263
   Cheng Y, 2017, ROBOT CIM-INT MANUF, V45, P59, DOI 10.1016/j.rcim.2016.05.007
   Conway M, 2020, TORQUENEWS
   Dahan F, 2021, IEEE ACCESS, V9, P95208, DOI 10.1109/ACCESS.2021.3092288
   Dahan F, 2021, IEEE ACCESS, V9, P17196, DOI 10.1109/ACCESS.2021.3052907
   Delaram J, 2021, J MANUF SYST, V60, P569, DOI 10.1016/j.jmsy.2021.07.012
   Delaram J, 2021, INT J MANAG SCI ENG, V16, P107, DOI 10.1080/17509653.2021.1892549
   Delaram J, 2018, PROCEDIA MANUF, V17, P387, DOI 10.1016/j.promfg.2018.10.061
   Dolgui A, 2020, INT J PROD RES, V58, P4138, DOI 10.1080/00207543.2020.1774679
   Dolgui A, 2018, INT J PROD RES, V56, P414, DOI 10.1080/00207543.2017.1387680
   Ejohwomu OA, 2021, INT J MANAG SCI ENG, V16, P143, DOI 10.1080/17509653.2021.1892548
   Gavvala SK, 2019, FUTURE GENER COMP SY, V90, P273, DOI 10.1016/j.future.2018.07.062
   Gong XR, 2019, J AMB INTEL HUM COMP, V10, P1025, DOI 10.1007/s12652-018-0945-6
   Government, 2020, VIC PRES SCI TECHN
   Hayyolalam V, 2019, INT J ADV MANUF TECH, V105, P471, DOI 10.1007/s00170-019-04213-z
   Hearnshaw EJS, 2013, INT J OPER PROD MAN, V33, P442, DOI 10.1108/01443571311307343
   Helo P, 2021, ROBOT CIM-INT MANUF, V67, DOI 10.1016/j.rcim.2020.102050
   Hessen, 2020, NOVEL CORONAVIRUS IN
   Hosseini S, 2019, INT J PROD ECON, V213, P124, DOI 10.1016/j.ijpe.2019.03.018
   Hosseini S, 2019, TRANSPORT RES E-LOG, V125, P285, DOI 10.1016/j.tre.2019.03.001
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Ivanov D, 2019, INT J PROD RES, V57, P829, DOI 10.1080/00207543.2018.1488086
   Ivanov D, 2017, INT J PROD RES, V55, P6158, DOI 10.1080/00207543.2017.1330572
   Ivanov D, 2016, INT J PROD RES, V54, P7245, DOI 10.1080/00207543.2016.1161253
   Jin H, 2017, J INTELL MANUF, V28, P1947, DOI 10.1007/s10845-015-1080-2
   Kamalahmadi M, 2016, INT J PROD ECON, V171, P116, DOI 10.1016/j.ijpe.2015.10.023
   Koren Y, 2018, FRONT MECH ENG-PRC, V13, P121, DOI 10.1007/s11465-018-0483-0
   Li CY, 2020, IEEE ACCESS, V8, P69579, DOI 10.1109/ACCESS.2020.2987078
   Li YH, 2021, EUR J OPER RES, V291, P1117, DOI 10.1016/j.ejor.2020.09.053
   Liang HG, 2021, ROBOT CIM-INT MANUF, V67, DOI 10.1016/j.rcim.2020.101991
   Lin YK, 2017, INT J PROD RES, V55, P1957, DOI 10.1080/00207543.2016.1247997
   Liu B, 2017, INT J ADV MANUF TECH, V88, P2757, DOI 10.1007/s00170-016-8992-7
   Liu YK, 2017, ROBOT CIM-INT MANUF, V45, P3, DOI 10.1016/j.rcim.2016.09.008
   Mari SI, 2015, INT J IND ENG-THEORY, V22, P102
   MOHME, 2020, IR VIC PRES SCI TECH
   Nasrollahi M., 2019, INT J MANAG SCI ENG, V16, P1
   News, 2020, ISLAMIC REPUBLIC NEW
   Niari MR, 2021, ROBOT CIM-INT MANUF, V72, DOI 10.1016/j.rcim.2021.102205
   Pavlov A, 2019, ANN OPER RES, DOI 10.1007/s10479-019-03454-1
   Pavlov A, 2018, IEEE T ENG MANAGE, V65, P303, DOI 10.1109/TEM.2017.2773574
   Peng H, 2012, PHYSICA A, V391, P2788, DOI 10.1016/j.physa.2011.12.051
   Ponomarov SY, 2009, INT J LOGIST MANAG, V20, P124, DOI 10.1108/09574090910954873
   Tan WJ, 2019, INT J PROD RES, V57, P6385, DOI 10.1080/00207543.2019.1566666
   Valizadeh S, 2021, INT J COMPUT INTEG M, DOI 10.1080/0951192X.2021.1992668
   Wattles J., 2020, AUTOMAKERS ARE RACIN
   Wu YA, 2019, COMPLEXITY, DOI 10.1155/2019/7819523
   Xu NR, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/4346580
   Xu X, 2012, ROBOT CIM-INT MANUF, V28, P75, DOI 10.1016/j.rcim.2011.07.002
   Yang B, 2022, INT J PROD RES, V60, P1134, DOI 10.1080/00207543.2020.1852481
   Yartsev A., 2020, BASIC COMPONENTS MEC
   Yuan MH, 2020, ROBOT CIM-INT MANUF, V61, DOI 10.1016/j.rcim.2019.101840
   Zeynivand M, 2021, INT J COMPUT INTEG M, V34, P1162, DOI 10.1080/0951192X.2021.1972459
   Zhao K, 2011, IEEE SYST J, V5, P28, DOI 10.1109/JSYST.2010.2100192
   Zheng H, 2016, INT J ADV MANUF TECH, V84, P371, DOI 10.1007/s00170-016-8417-7
   Zhou JJ, 2017, APPL SOFT COMPUT, V56, P379, DOI 10.1016/j.asoc.2017.03.017
   Ziaei M, 2021, INT J MANAG SCI ENG, V16, P43, DOI 10.1080/17509653.2020.1852126
NR 68
TC 0
Z9 0
U1 4
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1750-9653
EI 1750-9661
J9 INT J MANAG SCI ENG
JI Int. J. Manag. Sci. Eng. Manag.
DI 10.1080/17509653.2021.2009389
EA JAN 2022
PG 20
WC Operations Research & Management Science
WE Emerging Sources Citation Index (ESCI)
SC Operations Research & Management Science
GA XZ4XN
UT WOS:000737656300001
DA 2022-04-20
ER

PT J
AU Chen, AQ
   Yin, LJ
   Lee, KY
   He, JC
AF Chen, Anqun
   Yin, Lijun
   Lee, Kyung
   He, John Cijiang
TI Similarities and Differences between COVID-19-Associated Nephropathy and
   HIV-Associated Nephropathy
SO KIDNEY DISEASES
LA English
DT Review; Early Access
DE Viral nephropathy; HIV-associated nephropathy; COVID-19 nephropathy;
   Acute kidney injury; Collapsing FSGS
ID ACUTE KIDNEY INJURY; RENAL EPITHELIAL-CELLS; FOCAL SEGMENTAL
   GLOMERULOSCLEROSIS; APOL1 RISK VARIANTS; COLLAPSING GLOMERULOPATHY;
   TRANSGENIC MICE; DISEASE; COVID-19; PODOCYTES; INFECTION
AB Kidney disease is a major complication of viral infection, which can cause both acute and chronic kidney diseases via different mechanisms such as immune-mediated injury, kidney cell injury from a direct viral infection, systemic effects, and antiviral drug-induced nephrotoxicity. HIV-associated nephropathy (HIVAN), characterized by collapsing focal segmental glomerulosclerosis (cFSGS), has been described 2 decades ago as a major complication of acquired-immunodeficiency syndrome. The pathogenesis of HIVAN has been well studied, including viral entry, host response, and genetic factors. The incidence of this disease has been dramatically dropped with current antiretroviral therapy. In the recent severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic, acute kidney injury was also found to be a major complication in patients with (coronavirus disease) COVID-19. These patients also developed glomerular disease such as cFSGS in African Americans with apolipoprotein L1 risk alleles, similar to HIVAN. Whether SARS-CoV-2 can infect kidney cells locally remains controversial, but both local infection and systemic effects are likely involved in the pathogenesis of this disease. In this review, we present a comparison of the clinical presentations, pathological findings, disease mechanisms, and potential treatments between HIVAN and COVID-19. Leveraging the knowledge in HIVAN and experimental approaches used to study HIVAN will facilitate the exploration in the pathogenesis of COVID-19-associated kidney disease and improve our management of COVID-19 patients.
C1 [Chen, Anqun; Yin, Lijun] Cent South Univ, Xiangya Hosp 2, Inst Nephrol, Dept Nephrol,Hunan Key Lab Kidney Dis & Blood Pur, Changsha, Hunan, Peoples R China.
   [Lee, Kyung; He, John Cijiang] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA.
   [He, John Cijiang] James J Peters Vet Affairs Med Ctr, Renal Program, Bronx, NY 10468 USA.
RP Chen, AQ (corresponding author), Cent South Univ, Xiangya Hosp 2, Inst Nephrol, Dept Nephrol,Hunan Key Lab Kidney Dis & Blood Pur, Changsha, Hunan, Peoples R China.; He, JC (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA.; He, JC (corresponding author), James J Peters Vet Affairs Med Ctr, Renal Program, Bronx, NY 10468 USA.
EM anqunchen@csu.edu.cn; cijiang.he@mssm.edu
RI Lee, Kyung/AAD-5009-2021
OI Lee, Kyung/0000-0002-9756-1765
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81800637]; Hunan Natural Science Outstanding
   Youth Fund Projects [2021JJ10075]; VA Merit AwardUS Department of
   Veterans Affairs [IBX000345C]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [1R01DK078897,
   1R01DK088541, P01DK56492, R01DK117913]
FX A. Chen was supported by the grants from the National Natural Science
   Foundation of China (NO.81800637) and Hunan Natural Science Outstanding
   Youth Fund Projects (NO.2021JJ10075); J.C. He was supported by VA Merit
   Award IBX000345C, NIH 1R01DK078897, NIH 1R01DK088541, and NIH
   P01DK56492; and K. Lee is supported by NIH R01DK117913.
CR Abdelhamid Walid Ahmed Ragab, 2021, J Bras Nefrol, DOI 10.1590/2175-8239-JBN-2020-0148
   Abou-Ismail MY, 2020, THROMB RES, V194, P101, DOI 10.1016/j.thromres.2020.06.029
   Akilesh S, 2021, AM J KIDNEY DIS, V77, P82, DOI 10.1053/j.ajkd.2020.10.001
   Batlle D, 2020, J AM SOC NEPHROL, V31, P1380, DOI 10.1681/ASN.2020040419
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Berliner AR, 2008, AM J NEPHROL, V28, P478, DOI 10.1159/000112851
   Binois Y, 2020, KIDNEY INT REP, V5, P1787, DOI 10.1016/j.ekir.2020.07.035
   Birkelo BC, 2021, KIDNEY INT, V100, P894, DOI 10.1016/j.kint.2021.05.029
   Blasi M, 2020, NEW ENGL J MED, V382, P195, DOI 10.1056/NEJMc1910189
   Blasi M, 2014, AIDS, V28, P2345, DOI 10.1097/QAD.0000000000000398
   Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161
   Bowe B, 2021, CLIN J AM SOC NEPHRO, V16, P14, DOI 10.2215/CJN.09610620
   Braun F, 2020, LANCET, V396, P597, DOI 10.1016/S0140-6736(20)31759-1
   Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079
   Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525
   Burns GC, 1997, J AM SOC NEPHROL, V8, P1140
   Caceres PS, 2021, J AM SOC NEPHROL, V32, P2517, DOI 10.1681/ASN.2021010059
   Callaway E, 2020, NATURE, V577, P605, DOI 10.1038/d41586-020-00166-6
   Canaud G, 2014, J AM SOC NEPHROL, V25, P407, DOI 10.1681/ASN.2013050564
   Chan LL, 2021, J AM SOC NEPHROL, V32, P151, DOI [10.1681/ASN.2020050615, 10.33982/clr.2021.11.30.151]
   Chandra P, 2013, CLIN KIDNEY J, V6, P1, DOI 10.1093/ckj/sft002
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   COHEN AH, 1988, MODERN PATHOL, V1, P87
   Cohen SD, 2017, NEW ENGL J MED, V377, P2363, DOI 10.1056/NEJMra1508467
   Daehn IS, 2021, NAT REV DRUG DISCOV, V20, P770, DOI 10.1038/s41573-021-00242-0
   DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5
   Dijkman HBPM, 2006, KIDNEY INT, V70, P338, DOI 10.1038/sj.ki.5001574
   Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8
   Eitner F, 2000, J AM SOC NEPHROL, V11, P856, DOI 10.1681/ASN.V115856
   Feng J, 2021, KIDNEY INT, V99, P914, DOI 10.1016/j.kint.2020.12.012
   Feng XB, 2009, J AM SOC NEPHROL, V20, P2138, DOI 10.1681/ASN.2008080879
   Fine DM, 2012, J AM SOC NEPHROL, V23, P343, DOI 10.1681/ASN.2011060562
   Friedman DJ, 2021, CLIN J AM SOC NEPHRO, V16, P294, DOI 10.2215/CJN.15161219
   Fukao Y, 2021, CLIN EXP NEPHROL, V25, P1240, DOI 10.1007/s10157-021-02101-z
   Gameiro J, 2019, HIV MED, V20, P77, DOI 10.1111/hiv.12685
   Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032
   Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386
   Hassanein M, 2020, CLEV CLIN J MED, V87, P619, DOI 10.3949/ccjm.87a.20072
   He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004
   Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525
   Izzedine H, 2020, INTERN MED J, V50, P1551, DOI 10.1111/imj.15041
   Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719
   Jhaveri KD, 2020, KIDNEY INT, V98, P509, DOI 10.1016/j.kint.2020.05.025
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469
   Kimweri D, 2021, BMC NEPHROL, V22, DOI 10.1186/s12882-021-02451-6
   Kopp Jeffrey B, 2003, Kidney Int Suppl, pS43
   Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388
   Kudose S, 2020, J AM SOC NEPHROL, V31, P1959, DOI 10.1681/ASN.2020060802
   Latus J, 2015, NEPHROL DIAL TRANSPL, V30, P245, DOI 10.1093/ndt/gfu319
   Lazareth H, 2020, AM J KIDNEY DIS, V76, P590, DOI 10.1053/j.ajkd.2020.06.009
   Lescure FX, 2012, NEPHROL DIAL TRANSPL, V27, P2349, DOI 10.1093/ndt/gfr676
   Li JL, 2017, J AM SOC NEPHROL, V28, P862, DOI 10.1681/ASN.2016050564
   Lu TC, 2008, J BIOL CHEM, V283, P8173, DOI 10.1074/jbc.M708920200
   Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617
   Marras D, 2002, NAT MED, V8, P522, DOI 10.1038/nm0502-522
   Martinka S, 2006, AM J PHYSIOL-RENAL, V290, pF657, DOI 10.1152/ajprenal.00208.2005
   Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004
   Nadim MK, 2020, NAT REV NEPHROL, V16, P747, DOI 10.1038/s41581-020-00356-5
   Naicker S, 2007, SEMIN IMMUNOPATHOL, V29, P397, DOI 10.1007/s00281-007-0088-x
   Nasr SH, 2020, KIDNEY INT REP, V5, P759, DOI 10.1016/j.ekir.2020.04.030
   Peleg Y, 2020, KIDNEY INT REP, V5, P940, DOI 10.1016/j.ekir.2020.04.017
   Perazella MA, 2019, CURR OPIN CRIT CARE, V25, P550, DOI 10.1097/MCC.0000000000000653
   Perico L, 2021, NAT REV NEPHROL, V17, P46, DOI 10.1038/s41581-020-00357-4
   Prendecki M, 2020, KIDNEY INT, V98, P780, DOI 10.1016/j.kint.2020.06.009
   Ray PE, 1998, KIDNEY INT, V53, P1217, DOI 10.1046/j.1523-1755.1998.00900.x
   Ricksten SE, 2013, CRIT CARE, V17, DOI 10.1186/cc12530
   Rivero J, 2021, CLIN J AM SOC NEPHRO, V16, P685, DOI 10.2215/CJN.16281020
   Rosenberg AZ, 2015, NAT REV NEPHROL, V11, P150, DOI 10.1038/nrneph.2015.9
   Rosenstiel PE, 2008, KIDNEY INT, V74, P1049, DOI 10.1038/ki.2008.303
   Ross MJ, 2006, JAIDS-J ACQ IMM DEF, V42, P1, DOI 10.1097/01.qai.0000218353.60099.4f
   Sang L, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01305-5
   Sanguedolce F, 2021, CRIT REV CL LAB SCI, V58, P563, DOI 10.1080/10408363.2021.1944047
   Santoriello D, 2020, J AM SOC NEPHROL, V31, P2158, DOI 10.1681/ASN.2020050744
   Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f
   Selby NM, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1963
   Seo JW, 2020, INFECT CHEMOTHER, V52, P381, DOI 10.3947/ic.2020.52.3.381
   Sharma P, 2020, J AM SOC NEPHROL, V31, P1948, DOI 10.1681/ASN.2020050699
   Shetty AA, 2021, J AM SOC NEPHROL, V32, P33, DOI 10.1681/ASN.2020060804
   SMITH MC, 1994, AM J MED, V97, P145, DOI 10.1016/0002-9343(94)90024-8
   Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Suso AS, 2020, KIDNEY INT REP, V5, P2074, DOI 10.1016/j.ekir.2020.08.016
   TAKEKOSHI Y, 1979, NEW ENGL J MED, V300, P814, DOI 10.1056/NEJM197904123001502
   United Nations Programme on HIV and AIDS, GLOB HIV AIDS STAT F
   Velez JCQ, 2020, NAT REV NEPHROL, V16, P565, DOI 10.1038/s41581-020-0332-3
   Werion A, 2020, KIDNEY INT, V98, P1296, DOI 10.1016/j.kint.2020.07.019
   Wu HJ, 2020, J AM SOC NEPHROL, V31, P1688, DOI 10.1681/ASN.2020050558
   Wyatt CM, 2008, SEMIN NEPHROL, V28, P513, DOI 10.1016/j.semnephrol.2008.08.005
   Xia P, 2020, J AM SOC NEPHROL, V31, P2205, DOI 10.1681/ASN.2020040426
   Yan Q, 2021, J GERONTOL A-BIOL, V76, P456, DOI 10.1093/gerona/glaa181
   Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505
   ZHOU P, 2020, NATURE          0203, pNIL1, DOI DOI 10.1038/s41586-020-2012-7
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
   Zuo YQ, 2006, J AM SOC NEPHROL, V17, P2832, DOI 10.1681/ASN.2005080878
NR 100
TC 0
Z9 0
U1 1
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 2296-9381
EI 2296-9357
J9 KIDNEY DIS-BASEL
JI Kidney Dis.
DI 10.1159/000520235
EA NOV 2021
PG 12
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA XI6JK
UT WOS:000726215100001
PM 35127839
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Puxeddu, I
   Ferro, F
   Bartoloni, E
   Elefante, E
   Baldini, C
   Scire, C
   Talarico, R
   Migliorini, P
   Mosca, M
   Bombardieri, S
AF Puxeddu, I
   Ferro, F.
   Bartoloni, E.
   Elefante, E.
   Baldini, C.
   Scire, C.
   Talarico, R.
   Migliorini, P.
   Mosca, M.
   Bombardieri, S.
TI COVID-19: the new challenge for rheumatologists. One year later
SO CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
LA English
DT Review
DE COVID-19; SARS-CoV-2; cytokines; pathogenesis; rheumatic diseases;
   synthetic and targeted therapy
ID TOCILIZUMAB; RECOMMENDATIONS; METHYLPREDNISOLONE; PHARMACOKINETICS;
   PHARMACODYNAMICS; MULTICENTER; MANAGEMENT; PNEUMONIA; ANAKINRA; MODERATE
AB At the beginning of COVID-19, we underlined that this pandemic was a new challenge for rheumatologists. On the one hand, it was necessary to clarify the impact of this new viral disease on the natural history of many rheumatic diseases and, on the other hand, to define the beneficial or harmful effects of the synthetic or targeted therapies used for their treatment.
   In addition, we have postulated that in view of the common pathogenetic mechanisms involved, the therapeutic armamentarium currently employed in the management of viral or idiopathic systemic autoimmune rheumatic diseases could be useful to control the "cytokine storm" induced by SARS-COV-2.
   One year later, in the present review we have analysed the progress of the knowledge on both these aspects and updated the algorithms initially proposed for a rational use of the synthetic and targeted anti-inflammatory and immunomodulatory agents in the management of COVID-19.
C1 [Puxeddu, I; Migliorini, P.] Univ Pisa, Dept Clin & Expt Med, Clin Immunol Unit, Pisa, Italy.
   [Ferro, F.; Elefante, E.; Baldini, C.; Talarico, R.; Mosca, M.] Univ Pisa, Dept Clin & Expt Med, Rheumatol Unit, Pisa, Italy.
   [Bartoloni, E.] Univ Perugia, Dept Med, Rheumatol Unit, Perugia, Italy.
   [Scire, C.] Univ Ferrara, Dept Med Sci, Rheumatol Unit, Ferrara, Italy.
   [Bombardieri, S.] Univ Pisa, Pisa, Italy.
RP Puxeddu, I (corresponding author), Univ Pisa, Dipartimento Med Clin & Sperimentale, Immunol Clin, Via Roma 67, I-56126 Pisa, Italy.
EM ilaria.puxeddu@unipi.it
CR AKIYAMA S, 2020, ANN RHEUM DIS
   Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652
   Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585
   BERNARDO L, 2020, DRUGS THER PERSPECT
   Biran N, 2020, LANCET RHEUMATOL, V2, pE603, DOI 10.1016/S2665-9913(20)30277-0
   Cassione EB, 2020, ANN RHEUM DIS, V79, P1382, DOI 10.1136/annrheumdis-2020-217717
   Bronte V, 2020, J CLIN INVEST, V130, P6409, DOI 10.1172/JCI141772
   Buttgereit F, 2011, ARTHRITIS RHEUM-US, V63, P1, DOI 10.1002/art.30070
   Cantini F, 2020, J INFECTION, V81, P318, DOI 10.1016/j.jinf.2020.04.017
   Cavagna L, 2021, RHEUMATOLOGY, V60, P366, DOI 10.1093/rheumatology/keaa554
   Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014
   Cavalli G, 2020, LANCET RHEUMATOL, V2, pE325, DOI 10.1016/S2665-9913(20)30127-2
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen JJ, 2021, EXP THER MED, V21, DOI 10.3892/etm.2020.9456
   Chiodini P, 2020, CONT CLIN TRIAL COMM, V20, DOI 10.1016/j.conctc.2020.100665
   Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003
   D'Silva KM, 2020, ANN RHEUM DIS, V79, P1156, DOI 10.1136/annrheumdis-2020-217888
   Davoudi-Monfared E, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01061-20
   De Lorenzis E, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102666
   De Rossi N, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100459
   Deftereos SG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13136
   Edalatifard M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02808-2020
   Fatima SA, 2020, ANN MED SURG, V60, P413, DOI 10.1016/j.amsu.2020.11.027
   Felicetti M, 2020, CLIN EXP RHEUMATOL, V38, pS3
   Ferro F, 2020, CLIN EXP RHEUMATOL, V38, P373
   Ferro F, 2020, CLIN EXP RHEUMATOL, V38, P175
   FISHER LE, 1992, CLIN PHARMACOL THER, V51, P677, DOI 10.1038/clpt.1992.80
   Furlow B, 2020, LANCET RHEUMATOL, V2, pE592, DOI 10.1016/S2665-9913(20)30313-1
   Gao ZW, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102557
   Gazzaruso C, 2021, J THROMB THROMBOLYS, V52, P85, DOI 10.1007/s11239-020-02335-w
   Gianfrancesco M, 2020, ANN RHEUM DIS, V79, P859, DOI 10.1136/annrheumdis-2020-217871
   Gupta S, 2021, JAMA INTERN MED, V181, P41, DOI 10.1001/jamainternmed.2020.6252
   Hoes JN, 2007, ANN RHEUM DIS, V66, P1560, DOI 10.1136/ard.2007.072157
   Hooijberg F, 2020, LANCET RHEUMATOL, V2, pE583, DOI 10.1016/S2665-9913(20)30286-1
   Horby P, 2020, N ENGL J MED
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horby PW, 2020, EUR J INTERN MED, V82, P25, DOI 10.1016/j.ejim.2020.11.018
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Iglesias-Julian E, 2020, J AUTOIMMUN, V115, DOI 10.1016/j.jaut.2020.102537
   Kimmig LM, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.583897
   King A, 2020, LANCET RHEUMATOL, V2, pE379, DOI 10.1016/S2665-9913(20)30160-0
   Leung YY, 2015, SEMIN ARTHRITIS RHEU, V45, P341, DOI 10.1016/j.semarthrit.2015.06.013
   Liu DF, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.571597
   Jesus M, 2020, RHEUMATOL INT, V40, P2015, DOI 10.1007/s00296-020-04699-x
   LORENTE L, 2020, MED INTENSIVA
   Mareev VY, 2020, KARDIOLOGIYA, V60, P15, DOI 10.18087/cardio.2020.6.n1226
   Galvan-Roman JM, 2021, J ALLERGY CLIN IMMUN, V147, P72, DOI 10.1016/j.jaci.2020.09.018
   Martinez-Sanz J, 2021, CLIN MICROBIOL INFEC, V27, P238, DOI 10.1016/j.cmi.2020.09.021
   McKechnie JL, 2020, CELL HOST MICROBE, V27, P863, DOI 10.1016/j.chom.2020.05.009
   Saune PM, 2020, RESPIR MED CASE REP, V31, DOI 10.1016/j.rmcr.2020.101221
   Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038
   Morrison AR, 2020, J AUTOIMMUN, V114, DOI 10.1016/j.jaut.2020.102512
   Novelli A, 2020, HLA, V96, P610, DOI 10.1111/tan.14047
   Pablos JL, 2020, ANN RHEUM DIS, V79, P1170, DOI 10.1136/annrheumdis-2020-217763
   Pedersen SF, 2020, J CLIN INVEST, V130, P2202, DOI 10.1172/JCI137647
   PERRICONE C, 2021, ANN RHEUM DIS
   Perrone F, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02573-9
   Pettit NN, 2021, J MED VIROL, V93, P1459, DOI 10.1002/jmv.26429
   Piccirillo MC, 2020, CONTEMP CLIN TRIALS, V98, DOI 10.1016/j.cct.2020.106165
   Pietrogrande M, 2011, AUTOIMMUN REV, V10, P444, DOI 10.1016/j.autrev.2011.01.008
   Potere N, 2020, INT J INFECT DIS, V100, P421, DOI 10.1016/j.ijid.2020.07.078
   Raucci F, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102572
   REYES AZ, 2020, ANN RHEUM DIS
   Romao VC, 2020, RMD OPEN, V6, DOI 10.1136/rmdopen-2020-001314
   Rossotti R, 2020, J INFECTION, V81, pE11, DOI 10.1016/j.jinf.2020.07.008
   Ruiz-Irastorza G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239401
   Salama C, 2021, NEW ENGL J MED, V384, P20, DOI 10.1056/NEJMoa2030340
   Salvarani C, 2021, JAMA INTERN MED, V181, P24, DOI 10.1001/jamainternmed.2020.6615
   Salvarani C, 2020, ANN RHEUM DIS, V79, P986, DOI 10.1136/annrheumdis-2020-217903
   Satarker S, 2021, POSTGRAD MED, V133, P489, DOI 10.1080/00325481.2020.1855921
   Scarsi M, 2020, ANN RHEUM DIS, V79, P1286, DOI 10.1136/annrheumdis-2020-217712
   SCHLESINGER N, 2020, CURR PHARM REP
   Sciascia S, 2020, CLIN EXP RHEUMATOL, V38, P529
   Skipper CP, 2020, ANN INTERN MED, V173, P623, DOI 10.7326/M20-4207
   Stebbing J, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012697
   Sterne JAC, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04641-3
   Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836
   Strehl C, 2016, ANN RHEUM DIS, V75, P952, DOI 10.1136/annrheumdis-2015-208916
   STROHBEHN GW, 2020, CLIN PHARM THER
   Surabotsophon M, 2020, CLIN CASE REP, V8, P3263, DOI 10.1002/ccr3.3407
   Talarico R, 2021, NAT REV RHEUMATOL, V17, P177, DOI 10.1038/s41584-020-00565-z
   Talarico R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228694
   Talotta R, 2020, WORLD J CLIN CASES, V8, P3621, DOI 10.12998/wjcc.v8.i17.3621
   Tamtogl A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14064-7
   Tamura K, 2020, RESPIR MED CASE REP, V31, DOI 10.1016/j.rmcr.2020.101318
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Tomita Y, 2020, IMMUN INFLAMM DIS, V8, P684, DOI 10.1002/iid3.358
   Veiga VC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n84
   VILLARES FERNANDEZ P, 2020, CLIN INFECT DIS, DOI DOI 10.1093/cid/ciaa910
   Wang SJ, 2021, J INFECTION, V82, pE16, DOI 10.1016/j.jinf.2020.09.022
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Xiao M, 2020, ARTHRITIS RHEUMATOL, V72, P1998, DOI 10.1002/art.41425
   Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363
   Younis NK, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.597985
   Zhang XH, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106749
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhou Q, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01061
   Zhou YQ, 2020, CTS-CLIN TRANSL SCI, V13, P1077, DOI 10.1111/cts.12805
   Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017
   Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999
NR 102
TC 3
Z9 3
U1 4
U2 6
PU CLINICAL & EXPER RHEUMATOLOGY
PI PISA
PA VIA SANTA MARIA 31, 56126 PISA, ITALY
SN 0392-856X
EI 1593-098X
J9 CLIN EXP RHEUMATOL
JI Clin. Exp. Rheumatol.
PD JAN-FEB
PY 2021
VL 39
IS 1
BP 203
EP 213
PG 11
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA QL1BV
UT WOS:000620816300028
PM 33555253
DA 2022-04-20
ER

PT J
AU Adem, O
   Cvetkovic, VM
   Baytiyeh, H
   Tedim, FMS
   Zecevic, M
AF Ocal, Adem
   Cvetkovic, Vladimir M.
   Baytiyeh, Hoda
   Tedim, Fantina Maria Santos
   Zecevic, Miodrag
TI Public reactions to the disaster COVID-19: a comparative study in Italy,
   Lebanon, Portugal, and Serbia
SO GEOMATICS NATURAL HAZARDS & RISK
LA English
DT Article
DE Pandemic; stress; anxiety; depression; adult; COVID-19; emotion;
   disaster; disease
ID PSYCHOLOGICAL RESPONSES; TRAIT-ANXIETY; BACK-PAIN; STRESS; DEPRESSION;
   HEALTH; IMPACT; PERCEPTIONS; CHILDREN; STUDENTS
AB A new coronavirus emerged in December 2019 and quickly spread globally, causing unprecedented social, psychological, and economic damage. This study aimed to investigate people's emotional reactions to the COVID-19 pandemic. The dataset for this study consisted of 2,013 adults (962 males and 1,053 females) in four countries (Italy, Lebanon, Portugal, and Serbia). A snowball sampling technique that focused on recruiting the general public living in countries during the COVID-19 epidemic was utilized. An online survey was disseminated at the same time, in March-April 2020, when many countries were exposed to COVID-19. Results indicated that, with regard to gender, females had more psychological reactions to COVID-19 than did males. People who had one child were more stressed than people with no children. Extensive knowledge of COVID-19 was found to trigger more anxiety. Results showed that stress and overall emotional reactions increased with age. The findings can be used to develop psychological interventions to improve mental health and psychological resilience during the COVID-19 epidemic.
C1 [Ocal, Adem] Independent Researcher, Ankara, Turkey.
   [Cvetkovic, Vladimir M.] Univ Belgrade, Fac Secur Studies, Belgrade, Serbia.
   [Baytiyeh, Hoda] Amer Univ, Dept Educ, Beirut, Lebanon.
   [Tedim, Fantina Maria Santos] Univ Porto, Fac Arts & Humanities, Porto, Portugal.
   [Zecevic, Miodrag] European Univ, Fac Int Engn Management, Belgrade, Serbia.
RP Cvetkovic, VM (corresponding author), Univ Belgrade, Fac Secur Studies, Belgrade, Serbia.
EM vmc@fb.bg.ac.rs
RI Cvetković, PhD, Prof. dr Vladimir M./J-3501-2015; Öcal, Adem/X-7314-2018
OI Cvetković, PhD, Prof. dr Vladimir M./0000-0002-3450-0658; Öcal,
   Adem/0000-0003-4067-968X
FU Scientific-Professional Society for Disaster Risk Management, Belgrade,
   Serbia [003/2020]
FX This research was funded by Scientific-Professional Society for Disaster
   Risk Management (http://upravljanje-rizicima.com/), Belgrade, Serbia,
   003/2020.
CR Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339
   ABRAMSON LY, 1989, PSYCHOL REV, V96, P358, DOI 10.1037/0033-295X.96.2.358
   Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114095
   Balmer C., 2020, CORONAVIRUS OUTBREAK
   Baytiyeh H, 2016, INT J DISAST RISK RE, V18, P56, DOI 10.1016/j.ijdrr.2016.06.004
   Baytiyeh H, 2015, INT J DISAST RISK RE, V14, P519, DOI 10.1016/j.ijdrr.2015.10.007
   BECK A T, 1976, P356
   Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4
   CDC, 2020, H1N1 FLU 2009
   [CDC] Centers for Disease Control and Prevention, 2020, COR SPREADS COR DIS
   Chauhan A, 2020, ENVIRON RES, V187, DOI 10.1016/j.envres.2020.109634
   Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391
   CIA, 2020, WORLD FACTBOOK
   Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2
   Cvetkovi V., 2020, DISASTER RISK MANAGE
   Cvetkovic VM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114124
   Cvetkovic VM, 2019, INT J DISAST RISK RE, V35, DOI 10.1016/j.ijdrr.2019.101095
   Cvetkovic VM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122761
   Cvetkovic VM, 2018, IRAN J PUBLIC HEALTH, V47, P1213
   DEMAN A, 1984, PSYCHOL REP, V54, P507, DOI 10.2466/pr0.1984.54.2.507
   DGS, 2020, 055 DGS
   [DGS] DirecAo-Geral da Saude, 2020, 001 DGS
   Francis E., 2020, REUTERS
   Goodwin R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-166
   Graham JE, 2006, J BEHAV MED, V29, P389, DOI 10.1007/s10865-006-9057-4
   Gregory RJ, 2000, PSYCHOL TESTING HIST
   HAMMEN C, 1991, J ABNORM PSYCHOL, V100, P555, DOI 10.1037/0021-843X.100.4.555
   Hankin BL, 2001, PSYCHOL BULL, V127, P773, DOI 10.1037//0033-2909.127.6.773
   Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155
   HOBFOLL SE, 1989, HEALTH PSYCHOL, V8, P61, DOI 10.1037/0278-6133.8.1.61
   Hunter W., 1919, P SECT EP STAT MED K, DOI [10.1177/003591572001301502, DOI 10.1177/003591572001301502]
   Huot A., 2020, BMC INFECT DIS, V10, P296
   [INE] Instituto Nacional de Estatistica, 2020, IND CONT PAND COVID
   Johnson JD., 1997, CANC RELATED INFORM
   Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032
   King MG, 1987, STRESS THEORY PRACTI
   Kumiko F, 2019, INT J DISASTER RISK, V1, P62, DOI DOI 10.18485/IJDRM.2019.1.1.4
   KUSHNIR T, 1982, ENVIRON BEHAV, V14, P84, DOI 10.1177/0013916582141005
   Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500
   LARRAIN P, 1990, PERCEPT MOTOR SKILL, V70, P296, DOI 10.2466/pms.1990.70.1.296
   Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002
   Lazarus R.S., 1999, STRESS EMOTION NEW S
   Lazarus R. S., 1966, PSYCHOL STRESS COPIN
   Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857
   LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U
   McMahon SD, 2003, J CHILD PSYCHOL PSYC, V44, P107, DOI 10.1111/1469-7610.00105
   Miki D., 2010, ZARAZNE BOLESTI SRPS
   Mogg K, 1999, BEHAV RES THER, V37, P595, DOI 10.1016/S0005-7967(98)00158-2
   Nikoli N, 2019, B SERBIAN GEOGR SOC, V100, P51
   Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173
   Paradise TR., 2005, GLOBAL ENV CHANGE PA, V6, P167
   Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033
   Ramzan Musarat, 2015, J Ayub Med Coll Abbottabad, V27, P402
   Rao PK, 2020, IETE J RES, DOI 10.1080/03772063.2020.1819887
   Rico G., 2019, INT J DISASTER RISK, V1, P45
   Ristanovi E., 2015, GAZZETTA SERBIAN MIN, V57, P5, DOI [10.5937/bezbednost1502005R, DOI 10.5937/BEZBEDNOST1502005R]
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99
   Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054
   Sharpley CF, 1997, J INTELLECT DEV DIS, V22, P19, DOI 10.1080/13668259700033261
   SIMPSONHOUSLEY P, 1986, PSYCHOL REP, V58, P509, DOI 10.2466/pr0.1986.58.2.509
   Singh RP, 2020, AIR QUAL ATMOS HLTH, V13, P921, DOI 10.1007/s11869-020-00863-1
   Spielberger CD, 1970, STAI MANUAL STATE TR
   Tan WQ, 2020, BRAIN BEHAV IMMUN, V87, P84, DOI 10.1016/j.bbi.2020.04.055
   Tellegen A., 1985, ANXIETY ANXIETY DISO, P681
   WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072459
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   [WB] The World Bank, 2020, INDICATORS
   WHO, 2020, COR DIS COV 19 SIT D
   [WHO] World Health Organization, 2020, NAM COR DIS COVID 1
   [WPR] World Population Review, 2020, WPR WORLD POP REV
NR 72
TC 18
Z9 18
U1 4
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1947-5705
EI 1947-5713
J9 GEOMAT NAT HAZ RISK
JI Geomat. Nat. Hazards Risk
PY 2020
VL 11
IS 1
BP 1864
EP 1885
DI 10.1080/19475705.2020.1811405
PG 22
WC Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences;
   Water Resources
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geology; Meteorology & Atmospheric Sciences; Water Resources
GA NM7YI
UT WOS:000568310000001
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Singh, MK
   Jain, M
   Shyam, H
   Sahu, DK
   Mishra, A
   Shankar, P
   Kumar, S
   Singh, V
AF Singh, Mukul Kumar
   Jain, Mayank
   Shyam, Hari
   Sahu, Dinesh Kumar
   Mishra, Archana
   Shankar, Pratap
   Kumar, Shailendra
   Singh, Vishwajeet
TI Association of severity and mortality of Covid-19 cases among acute
   kidney injury and sexual dimorphism
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Review; Early Access
DE AKI; Covid-19; Sex-disparity; Immunosuppression; Pathogenesis
ID SUPPRESSOR-CELLS; GENE-EXPRESSION; RECEPTOR; BASIGIN/CD147;
   INTERLEUKIN-6; INFLAMMATION; CORONAVIRUS; ANDROGENS; RESPONSES; IMMUNITY
AB Introduction The outbreak of coronavirus disease 2019 (Covid-19) severely impacted global health and economic status. The native receptor-ligand interaction of Angiotensin-converting enzyme 2 (ACE2) and S protein induces host cell pathogenesis via immunosuppression. Material and Methods The emerging evidence reports the sex disparity in Covid-19 induced mortality rate which affects abundantly men population. Although the biological interaction of Covid-19 with receptor upregulates the viral genome protein interactions and initiates the predictive multiorgan failure followed by acute kidney injury (AKI) in Covid-19 infected male population. Conclusion Besides, the knowledge and lessons learned from the study depict that cellular and molecular links may explain the risk and severity of Covid-19 and AKI in the male population and lead to management of Covid-19 induced AKI. Therefore, this review explored the pathways associated with the pathogenesis of two diseased conditions with sex disparity.
C1 [Singh, Mukul Kumar; Singh, Vishwajeet] King Georges Med Univ, Dept Urol, Lucknow 226003, Uttar Pradesh, India.
   [Jain, Mayank; Shyam, Hari; Mishra, Archana; Kumar, Shailendra] King Georges Med Univ, Dept Thorac Surg, Lucknow 226003, Uttar Pradesh, India.
   [Sahu, Dinesh Kumar] Super Special Paediat Hosp & Post Grad Teaching I, Noida 201301, UP, India.
   [Shankar, Pratap] King Georges Med Univ, Dept Ctr Adv Res, Lucknow 226003, Uttar Pradesh, India.
RP Singh, V (corresponding author), King Georges Med Univ, Dept Urol, Lucknow 226003, Uttar Pradesh, India.
EM drvishwajeet68@gmail.com
OI JAIN, MAYANK/0000-0002-5321-8340
FU University Grant Commission (UGC)University Grants Commission, India
FX The Author's were thankful to the Vice Chancellor, King George's Medical
   University, Lucknow, for their support and guidance. In addition Mr.
   Mayank Jain is grateful to the University Grant Commission (UGC) for
   providing him the Maulana Azad National Fellowship.
CR /50organization. TGH. The Sex gender and COVID-19 project, TGH SEX GEND COVID 1
   Abd El-Lateef SM, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.117082
   Ahmadian E, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2176
   Ahmed S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080836
   Akilesh S, 2021, AM J KIDNEY DIS, V77, P82, DOI 10.1053/j.ajkd.2020.10.001
   Al Kaabi N, 2021, JAMA-J AM MED ASSOC, V326, P35, DOI 10.1001/jama.2021.8565
   Anders HJ, 2014, J AM SOC NEPHROL, V25, P1387, DOI 10.1681/ASN.2014010117
   Arany I, 2011, AM J PHYSIOL-RENAL, V301, pF125, DOI 10.1152/ajprenal.00041.2011
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Baratchian M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90491-1
   Bestle D, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000786
   Bolisetty S, 2009, KIDNEY INT, V75, P674, DOI 10.1038/ki.2008.689
   Bradley AJ, 1999, BBA-BIOMEMBRANES, V1418, P19, DOI 10.1016/S0005-2736(99)00013-9
   Chan LL, 2021, J AM SOC NEPHROL, V32, P151, DOI [10.1681/ASN.2020050615, 10.33982/clr.2021.11.30.151]
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Chen Y, 2020, MOL MED, V26, DOI 10.1186/s10020-020-00230-x
   Chueh TI, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113547
   Dai C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030452
   Danziger J, 2016, CRIT CARE MED, V44, P328, DOI 10.1097/CCM.0000000000001398
   Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001
   Del Valle DM, 2020, NAT MED, V26, P1636, DOI 10.1038/s41591-020-1051-9
   Der E, 2014, J IMMUNOL, V192, P1570, DOI 10.4049/jimmunol.1302479
   Dolzhikova IV, 2021, ONE SHOT IMMUNIZATIO
   Dong MZ, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110678
   Drake CG, 2005, CANCER CELL, V7, P239, DOI 10.1016/j.ccr.2005.01.027
   Dunkle LM, 2022, NEW ENGL J MED, V386, P531, DOI 10.1056/NEJMoa2116185
   Ella R, 2021, LANCET INFECT DIS, V21, P637, DOI [10.1016/S1473-3099(20)30942-7, 10.1016/S1473-3099(21)00070-0]
   Falsey AR, 2021, NEW ENGL J MED, V385, P2348, DOI 10.1056/NEJMoa2105290
   Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111
   Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932
   Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006
   Gonzalez S, 2021, ECLINICALMEDICINE, V40, DOI 10.1016/j.eclinm.2021.101126
   Halperin SA, 2022, LANCET, V399, P237, DOI 10.1016/S0140-6736(21)02753-7
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Huang Y, 2020, METABOLISM, V113, DOI 10.1016/j.metabol.2020.154378
   Kato N, 2011, AM J PATHOL, V178, P572, DOI 10.1016/j.ajpath.2010.10.009
   Kato N, 2009, J AM SOC NEPHROL, V20, P1565, DOI 10.1681/ASN.2008090957
   Khan D, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00635
   Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018
   Kudose S, 2020, J AM SOC NEPHROL, V31, P1959, DOI 10.1681/ASN.2020060802
   Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523
   Lapi F, 2013, JAMA-J AM MED ASSOC, V310, P289, DOI 10.1001/jama.2013.8638
   Larsen CP, 2020, KIDNEY INT REP, V5, P935, DOI 10.1016/j.ekir.2020.04.002
   Li YD, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00695-2
   Liao ZH, 2019, SKELET MUSCLE, V9, DOI 10.1186/s13395-019-0205-2
   Lim S, 2021, NAT REV ENDOCRINOL, V17, P11, DOI 10.1038/s41574-020-00435-4
   Liu H, 2005, CYTOKINE, V31, P251, DOI 10.1016/j.cyto.2004.12.008
   Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630
   Maksimowski N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241534
   Matthay MA, 2020, LANCET RESP MED, V8, P433, DOI 10.1016/S2213-2600(20)30127-2
   Meester I, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-019-0278-y
   Montopoli M, 2020, ANN ONCOL, V31, P1040, DOI 10.1016/j.annonc.2020.04.479
   Muehlenbein MP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-19
   Neugarten J, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0937-y
   Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535
   Nuttall Frank Q, 2015, Nutr Today, V50, P117
   Olsen NJ, 2001, J CLIN INVEST, V108, P1697, DOI 10.1172/JCI13183
   Paharkova-Vatchkova V, 2004, J IMMUNOL, V172, P1426, DOI 10.4049/jimmunol.172.3.1426
   Palacios R, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04775-4
   Pan XW, 2020, INTENS CARE MED, V46, P1114, DOI 10.1007/s00134-020-06026-1
   Patschan D, 2016, INT J NEPHROL, V2016, DOI 10.1155/2016/6232909
   Phiel KL, 2005, IMMUNOL LETT, V97, P107, DOI 10.1016/j.imlet.2004.10.007
   Pittet LF, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-052101
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Poland GA, 2020, LANCET, V396, P1595, DOI 10.1016/S0140-6736(20)32137-1
   Pradhan A, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00330-7
   Pranata R, 2020, J RENIN-ANGIO-ALDO S, V21, DOI 10.1177/1470320320926899
   Qi SH, 2021, BIOL SEX DIFFER, V12, DOI 10.1186/s13293-021-00410-2
   Rabb H, 2016, J AM SOC NEPHROL, V27, P371, DOI 10.1681/ASN.2015030261
   Rodriguez-Romo R, 2015, NEPHROLOGY, V20, P736, DOI 10.1111/nep.12521
   Rupp MRG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00794
   Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   Santoriello D, 2020, J AM SOC NEPHROL, V31, P2158, DOI 10.1681/ASN.2020050744
   Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8
   Sharifi N, 2020, ENDOCR-RELAT CANCER, V27, pE1, DOI 10.1530/ERC-20-0133
   Sharma P, 2020, J AM SOC NEPHROL, V31, P1948, DOI 10.1681/ASN.2020050699
   Yehualashet AS, 2020, INFECT DRUG RESIST, V13, P3217, DOI 10.2147/IDR.S264882
   Singh Mukul Kumar, 2021, VirusDisease, V32, DOI 10.1007/s13337-021-00742-y
   Singh V, 2021, INDIAN J SURG, V83, P398, DOI 10.1007/s12262-020-02697-8
   Szczech LA, 2010, CIRCULATION, V121, P2183, DOI 10.1161/CIRCULATIONAHA.109.896597
   Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700
   Takahashi T, 2020, NATURE, V588, DOI 10.1038/s41586-020-2700-3
   Tamayo E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123928
   Taneja V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01931
   Tanriover MD, 2021, LANCET, V398, P213, DOI 10.1016/S0140-6736(21)01429-X
   Trigunaite A, 2015, CELL IMMUNOL, V294, P87, DOI 10.1016/j.cellimm.2015.02.004
   Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421
   Ulhaq ZS, 2020, MED MALADIES INFECT, V50, P382, DOI 10.1016/j.medmal.2020.04.002
   Wang H, 2020, CELL, V182, P713, DOI 10.1016/j.cell.2020.06.008
   Wang K, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00426-x
   [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1
   Wysocki J, 2020, J AM SOC NEPHROL, V31, P1941, DOI 10.1681/ASN.2020050667
   Xia SL, 2021, LANCET INFECT DIS, V21, P39, DOI 10.1016/S1473-3099(20)30831-8
   Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177
   Zeng FF, 2020, J MED VIROL, V92, P2050, DOI 10.1002/jmv.25989
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang H, 2020, GUT, V69, P1010, DOI 10.1136/gutjnl-2020-320953
   Zhao ST, 2014, CELL MOL IMMUNOL, V11, P428, DOI 10.1038/cmi.2014.38
   Zhao X, 2021, NEUTRALIZATION RECOM
NR 102
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
DI 10.1007/s11033-022-07308-1
EA MAR 2022
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA ZN7DN
UT WOS:000765190200001
PM 35249167
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Herold, DM
   Nowicka, K
   Pluta-Zaremba, A
   Kummer, S
AF Herold, David M.
   Nowicka, Katarzyna
   Pluta-Zaremba, Aneta
   Kummer, Sebastian
TI COVID-19 and the pursuit of supply chain resilience: reactions and
   "lessons learned" from logistics service providers (LSPs)
SO SUPPLY CHAIN MANAGEMENT-AN INTERNATIONAL JOURNAL
LA English
DT Article
DE Resilience; Logistics management; Supply chain vulnerability; Logistics
   service provider; COVID-19; Supply chain resilience; Supply chain
   management
ID BIG DATA ANALYTICS; SEEKING KNOWLEDGE; MANAGEMENT; BLOCKCHAIN;
   FRAMEWORK; FUTURE; PHENOMENOLOGY; CONSUMPTION; SIMULATION; INNOVATION
AB Purpose
   The purpose of this paper is to provide new insights into the reactions and lessons learned with regard to the COVID-19 pandemic in terms of how logistics service providers (LSPs) managed to maintain supply chains resilience and what focus areas have been changed to keep operations functional and uphold financial stability.
   Design/methodology/approach
   Based on data-gathering techniques in interpretive research this study collected primary data via semi-structured interviews, interviewing informants from selected LSPs that operate on a global scale.
   Findings
   The results show that LSPs have built their reactions and actions to the COVID-19 outbreak around five main themes: "create revenue streams," "enhance operational transport flexibility," "enforce digitalization and data management," "optimize logistics infrastructure" and "optimize personnel capacity." These pillars build the foundation to LSP resilience that enables supply chains to stay resilient during an external shock of high impact and low probability.
   Originality/value
   The results of this study provide insights into how LSPs have managed the downsides and found innovative ways to overcome operational and financial challenges during the COVID-19 outbreak. As one of the first studies that specially focuses on the role of LSPs during the COVID-19 pandemic, this study categorizes the LSPs' reactions and provides a "lessons learned" framework from a managerial perspective. From a theoretical perspective, this paper discusses the strategic role of LSPs in supply chain management and thereby extends current supply chain literature with a focus on LSP resilience.
C1 [Herold, David M.] Vienna Univ Econ & Business, Inst Transport & Logist Management, Vienna, Austria.
   [Herold, David M.] Griffith Univ, Dept Business Strategy & Innovat, Brisbane, Qld, Australia.
   [Nowicka, Katarzyna; Pluta-Zaremba, Aneta] Warsaw Sch Econ, Dept Logist, Warsaw, Poland.
   [Kummer, Sebastian] Jilin Univ, Dept Logist, Changchun, Peoples R China.
RP Herold, DM (corresponding author), Vienna Univ Econ & Business, Inst Transport & Logist Management, Vienna, Austria.; Herold, DM (corresponding author), Griffith Univ, Dept Business Strategy & Innovat, Brisbane, Qld, Australia.
EM dherold@wu.ac.at; Katarzyna.Nowicka@sgh.waw.pl; Aneta.Pluta@sgh.waw.pl;
   sebastian.kummer@gmx.at
CR ARNOULD EJ, 1994, J MARKETING RES, V31, P484, DOI 10.2307/3151878
   B?heim P, 2020, OBEROSTERREICHS IND
   BMOE, 2020, AUSW COR KRIS EINK V
   Brenner ME, 2006, HANDBOOK OF COMPLEMENTARY METHODS IN EDUCATION RESEARCH, P357
   Busse C, 2011, INT J PHYS DISTR LOG, V41, P187, DOI 10.1108/09600031111118558
   Cachon GP, 2000, MANAGE SCI, V46, P1032, DOI 10.1287/mnsc.46.8.1032.12029
   Chen YM, 2011, PROD PLAN CONTROL, V22, P308, DOI 10.1080/09537287.2010.498611
   Choi TM, 2020, TRANSPORT RES E-LOG, V140, DOI 10.1016/j.tre.2020.101961
   Christopher M, 2011, LOGISTICS SUPPLY CHA
   Christopher M., 2004, INT J LOGIST MANAG, V15, P1, DOI [10.1108/09574090410700275, DOI 10.1108/09574090410700275]
   Cichosz M, 2020, INT J LOGIST MANAG, V31, P209, DOI 10.1108/IJLM-08-2019-0229
   Coutu DL, 2002, HARVARD BUS REV, V80, P46
   Darby JL, 2019, INT J LOGIST MANAG, V30, P395, DOI 10.1108/IJLM-07-2018-0187
   DB Schenker, 2020, COV 19 PAND HITS DTS
   Deming W, 1990, SAMPLE DESIGN BUSINE
   DENZIN NK, 1984, AM J SOCIOL, V90, P483, DOI 10.1086/228114
   Dobrovnik M, 2018, LOGISTICS-BASEL, V2, DOI 10.3390/logistics2030018
   DVZ, 2020, CHIN SHUTTL DB SCHEN
   Eurofound, 2020, AUSTR WORK TIM FLEX
   Fournier S, 1998, J CONSUM RES, V24, P343, DOI 10.1086/209515
   Fruth M, 2017, COGENT BUS MANAG, V4, DOI 10.1080/23311975.2017.1411066
   Gartner, 2019, GARTN SAYS 85 LOG LE
   Geertz C, 1973, INTERPRETATION CULTU
   Gkanatsas E, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12104323
   Golgeci I, 2015, TECHNOL ANAL STRATEG, V27, P267, DOI 10.1080/09537325.2014.971003
   Grawe SJ, 2009, INT J LOGIST MANAG, V20, P360, DOI 10.1108/09574090911002823
   Grimson J Andrew, 2007, International Journal of Logistics Management, V18, P322, DOI 10.1108/09574090710835093
   Gunasekaran A, 2017, J BUS RES, V70, P308, DOI 10.1016/j.jbusres.2016.08.004
   Hager J., 2020, ARBEITSMARKT 13 MILL
   Herold DM, 2021, J ENTERP INF MANAG, V34, P1917, DOI 10.1108/JEIM-09-2020-0382
   Holmstrom J, 2014, SUPPLY CHAIN MANAG, V19, P421, DOI 10.1108/SCM-10-2013-0387
   Horton W, 2020, FORBES
   Hosseini S, 2019, TRANSPORT RES E-LOG, V125, P285, DOI 10.1016/j.tre.2019.03.001
   Hribernik M., 2020, TRANSPORTATION RES I, V8, P100274, DOI [10.1016/j.trip.2020.100274, DOI 10.1016/J.TRIP.2020.100274]
   HUDSON LA, 1988, J CONSUM RES, V14, P508, DOI 10.1086/209132
   Infosys, 2019, 2019 3 PART LOG STUD
   International Civil Aviation Organization, 2020, EFF NOV COR COVID 19
   Ivanov Dmitry, 2020, International Journal of Integrated Supply Management, V13, P90
   Ivanov D, 2021, PROD PLAN CONTROL, V32, P775, DOI 10.1080/09537287.2020.1768450
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922
   Ivanov D, 2010, EUR J OPER RES, V200, P409, DOI 10.1016/j.ejor.2009.01.002
   Kaipia R, 2017, J OPER MANAG, V52, P15, DOI 10.1016/j.jom.2017.04.001
   Kim Y, 2015, J OPER MANAG, V33-34, P43, DOI 10.1016/j.jom.2014.10.006
   Konig A, 2016, INT J LOGIST MANAG, V27, P122, DOI 10.1108/IJLM-03-2014-0043
   Kramer A, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103442
   Kummer S, 2020, FUTURE INTERNET, V12, DOI 10.3390/fi12030060
   Lam JSL, 2015, INT J PHYS DISTR LOG, V45, P674, DOI 10.1108/IJPDLM-12-2013-0293
   Lee CKH, 2017, INT J PROD RES, V55, P593, DOI 10.1080/00207543.2016.1221162
   Lee HL, 2002, CALIF MANAGE REV, V44, P105, DOI 10.2307/41166135
   Li G, 2010, INT J PROD ECON, V124, P310, DOI 10.1016/j.ijpe.2009.11.027
   Linkov I, 2020, TRENDS APPL RESILIEN
   Liu CL, 2018, INT J LOGIST MANAG, V29, P5, DOI 10.1108/IJLM-11-2016-0283
   Garay-Rondero CL, 2020, J MANUF TECHNOL MANA, V31, P887, DOI 10.1108/JMTM-08-2018-0280
   Lund Susan, 2020, RISK RESILIENCE REBA
   Mikl J, 2020, INT J LOGIST MANAG, DOI 10.1108/IJLM-04-2020-0155
   Mikl J, 2021, REV INT BUS STRATEGY, V31, P62, DOI 10.1108/RIBS-07-2020-0078
   Minichiello V., 1995, IN DEPTH INTERVIEWIN
   Murray JB, 2002, J CONSUM RES, V29, P427, DOI 10.1086/344424
   Oliva R, 2011, J OPER MANAG, V29, P434, DOI 10.1016/j.jom.2010.11.012
   Panayides PA, 2005, TRANSPORT RES E-LOG, V41, P179, DOI 10.1016/j.tre.2004.05.001
   Parikh M.A., 2002, COMMUN ASSOC INF SYS, V8, P25
   Paris C., 2020, WALL STR J
   Pathak SD, 2009, J SUPPLY CHAIN MANAG, V45, P54, DOI 10.1111/j.1745-493X.2009.03171.x
   Paul SK, 2021, INT J PHYS DISTR LOG, V51, P104, DOI 10.1108/IJPDLM-04-2020-0127
   Pereira CR, 2014, SUPPLY CHAIN MANAG, V19, P626, DOI 10.1108/SCM-09-2013-0346
   Pettit TJ, 2019, J BUS LOGIST, V40, P56, DOI 10.1111/jbl.12202
   Pettit TJ, 2010, J BUS LOGIST, V31, P1, DOI 10.1002/j.2158-1592.2010.tb00125.x
   Ponis S.T., 2012, J APPL BUS RES, V28, P921
   Ponomarov SY, 2009, INT J LOGIST MANAG, V20, P124, DOI 10.1108/09574090910954873
   Prasad P., 2017, CRAFTING QUALITATIVE
   Putzger I, 2020, LOADSTAR
   Queiroz MM, 2021, BENCHMARKING, V28, P1761, DOI 10.1108/BIJ-12-2018-0435
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Rabinovich E, 2011, J BUS LOGIST, V32, P303, DOI 10.1111/j.0000-0000.2011.01026.x
   Rangarajan D, 2018, J PERS SELL SALES M, V38, P220, DOI 10.1080/08853134.2018.1450148
   Rossmann B, 2018, TECHNOL FORECAST SOC, V130, P135, DOI 10.1016/j.techfore.2017.10.005
   Rubin H.J., 2011, QUALITATIVE INTERVIE
   Saberi S, 2019, INT J PROD RES, V57, P2117, DOI 10.1080/00207543.2018.1533261
   Scholten K, 2014, SUPPLY CHAIN MANAG, V19, P211, DOI 10.1108/SCM-06-2013-0191
   Sharma M, 2020, INT J LOGIST-RES APP, DOI 10.1080/13675567.2020.1810213
   Singh SK, 2021, INT J HUM RESOUR MAN, V32, P1707, DOI 10.1080/09585192.2018.1547778
   Smaros J., 2003, International Journal of Physical Distribution & Logistics Management, V33, P336, DOI 10.1108/09600030310478801
   Stank T, 2019, INT J PHYS DISTR LOG, V49, P956, DOI 10.1108/IJPDLM-03-2019-0076
   Svensson G., 2001, INT J LOGIST MANAG, V12, P21, DOI DOI 10.1108/09574090110806208
   Swierczek A., 2019, TRANSPORT EC LOGISTI, V78, P7
   The Economist, 2018, ECONOMIST
   Theurl S., 2020, MITIGATING MASS LAYO
   THOMPSON CJ, 1989, J CONSUM RES, V16, P133, DOI 10.1086/209203
   Thompson CJ, 1997, J MARKETING RES, V34, P438, DOI 10.2307/3151963
   Tukamuhabwa BR, 2015, INT J PROD RES, V53, P5592, DOI 10.1080/00207543.2015.1037934
   UPS, 2020, UPS REL 2Q 2020 EARN
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Wackett, 2020, LOADSTAR
   Waller M., 2008, INT J LOGIST MANAG
   Wilson G, 2020, COVID 19 HAS TRANSFO
   Wimpenny P, 2000, J ADV NURS, V31, P1485, DOI 10.1046/j.1365-2648.2000.01431.x
   Yang CS, 2019, TRANSPORT RES E-LOG, V131, P108, DOI 10.1016/j.tre.2019.09.020
   Yin R.K., 2014, CASE STUDY RES APPL, V5th ed.
NR 100
TC 4
Z9 4
U1 44
U2 64
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1359-8546
EI 1758-6852
J9 SUPPLY CHAIN MANAG
JI Supply Chain Manag.
PD SEP 6
PY 2021
VL 26
IS 6
SI SI
BP 702
EP 714
DI 10.1108/SCM-09-2020-0439
EA JUN 2021
PG 13
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA UL6FK
UT WOS:000662319600001
OA Green Submitted
DA 2022-04-20
ER

PT C
AU Guberina, T
   Wang, AM
AF Guberina, Tajana
   Wang, Ai Min
GP IEEE
TI Entrepreneurial Leadership and Fear of COVID-19 Pandemic Impact on Job
   Security and Psychological Well-being: A Conceptual Model
SO 2021 7TH INTERNATIONAL CONFERENCE ON INFORMATION MANAGEMENT (ICIM 2021)
LA English
DT Proceedings Paper
CT 7th International Conference on Information Management (ICIM)
CY MAR 27-29, 2021
CL Imperial Coll London, S Kensington Campus, London, ENGLAND
SP IEEE
HO Imperial Coll London, S Kensington Campus
DE COVID-19 pandemic; entrepreneurial leadership; fear of COVID-19; job
   insecurity; psychological well-being
ID TRANSFORMATIONAL LEADERSHIP; PERFORMANCE; WORK; SATISFACTION; HEALTH
AB In the paper, we posit that leadership and psychological well-being are most conducive to minimizing job insecurity, which is an integral part of enterprise sustainability. Our research explores the relationship between entrepreneurial leadership and mental health. We emphasize the role leaders play in the psychological distress levels of employees. The current conceptual research is based on a leadership theory, explores its internal mechanism from the perspective of entrepreneurial leadership and organizational psychology. The relationships between entrepreneurial leadership, job security, fear of COVID-19, psychological well-being are discussed. We assume that entrepreneurial leadership leads to decreased job insecurity and improved psychological well-being. Moreover, fear of COVID-19 leads to adverse psychological well-being and moderates the relationship between entrepreneurial leadership and job insecurity. The findings suggest that entrepreneurship and innovation are vital components that companies should cultivate to cope with the economic challenges of COVID-19 pandemic. With these new knowledge initiatives to tackle COVID-19 psychological and organizational consequences can be developed.
C1 [Guberina, Tajana; Wang, Ai Min] Wuhan Univ Technol, Sch Management, Wuhan, Peoples R China.
RP Guberina, T (corresponding author), Wuhan Univ Technol, Sch Management, Wuhan, Peoples R China.
EM tajana.guberina@gmail.com; wangam@vip.163.com
CR Adler RW, 2008, ASIA-PAC MANAG ACCOU, V3, P21
   Al-Malki M., 2018, J INT BUSINESS RES M, V3
   Barfi R., 2021, EC FINANCE LETT, V8, P32, DOI [10.18488/journal.29.2021.81.32.43, DOI 10.18488/JOURNAL.29.2021.81.32.43]
   Birkeland IK, 2016, J OCCUP HEALTH PSYCH, V21, P77, DOI 10.1037/a0039389
   Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430
   Braun S, 2013, LEADERSHIP QUART, V24, P270, DOI 10.1016/j.leaqua.2012.11.006
   Burgard SA, 2013, AM BEHAV SCI, V57, P1105, DOI 10.1177/0002764213487347
   Chiu CY, 2021, J OCCUP ORGAN PSYCH, V94, P187, DOI 10.1111/joop.12333
   Cohen WA, 2009, DRUCKER LEADERSHIP N
   Cornell D, 2013, J EDUC PSYCHOL, V105, P138, DOI 10.1037/a0030416
   Courbasson CMA, 2007, FAM COMMUNITY HEALTH, V30, P112, DOI 10.1097/01.FCH.0000264408.36013.03
   Cummins N, 2015, SPEECH COMMUN, V75, P27, DOI 10.1016/j.specom.2015.09.003
   de J Lozoya-Santos Jorge, 2019, 2019 IEEE Global Engineering Education Conference (EDUCON), P622, DOI 10.1109/EDUCON.2019.8725108
   Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01
   Druss BG, 2010, PSYCHIAT SERV, V61, P1087, DOI 10.1176/ps.2010.61.11.1087
   Epitropaki O, 2005, J APPL PSYCHOL, V90, P659, DOI 10.1037/0021-9010.90.4.659
   Fang N., 2017, GLOBAL J ENG ED, V19, P4
   Flum H., 2015, RELATIONSHIPS CAREER
   Ghafoor A, 2011, AFR J BUS MANAGE, V5, P7391
   Gilbreath B, 2004, WORK STRESS, V18, P255, DOI 10.1080/02678370412331317499
   Godinic D., 2020, INT J INNOV EC DEV, V6, P61, DOI DOI 10.18775/IJIED.1849-7551-7020.2015.61.2005
   GRAEN G, 1977, ORGAN BEHAV HUM PERF, V19, P1, DOI 10.1016/0030-5073(77)90051-4
   Hannah ST, 2014, J ORGAN BEHAV, V35, P598, DOI 10.1002/job.1931
   Hutchinson M, 2013, NURS INQ, V20, P11, DOI 10.1111/nin.12006
   Ismail W. K. W., 2011, INT J BUSINESS SOCIA, V2
   Jin Y., 2020, MILITARY MED RES, V7, P24, DOI DOI 10.1186/s40779-020-00254-8
   Lee M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092977
   Lo C. C., 2014, LEADERSHIP MATTERS D
   Miao Q, 2014, PUBLIC ADMIN, V92, P727, DOI 10.1111/padm.12091
   Obrenovic B, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12155981
   Obrenovic B, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00475
   Raab G., 2016, CUSTOMER RELATIONSHI CUSTOMER RELATIONSHI
   Renko M, 2015, J SMALL BUS MANAGE, V53, P54, DOI 10.1111/jsbm.12086
   Sahni J., 2020, INT J OPERAT MANAG, V1, P35, DOI [10.18775//ijom.2757-0509.2020.11.4004, DOI 10.18775//IJOM.2757-0509.2020.11.4004]
   Segal R, 2011, CYBERPSYCH BEH SOC N, V14, P29, DOI 10.1089/cyber.2009.0398
   SELTZER J, 1988, ACAD MANAGE J, V31, P439, DOI 10.2307/256559
   Solomon I. G., 2020, INT J MANAG SCI BUS, V6, P38, DOI DOI 10.18775/IJMSBA.1849-5664-5419.2014.65.1005
   Staufenbiel T, 2010, J OCCUP ORGAN PSYCH, V83, P101, DOI 10.1348/096317908X401912
   Strazovska L., 2019, J INT BUSINESS RES M, V4, P29
   Wang H, 2014, J ORGAN BEHAV, V35, P5, DOI 10.1002/job.1850
   World Bank, 2020, WORLD BANK E AS PAC
   Yanik O., 2018, J BUSINESS RES TURK, V10, P447
NR 42
TC 1
Z9 1
U1 11
U2 18
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-6654-4380-7
PY 2021
BP 144
EP 148
DI 10.1109/ICIM52229.2021.9417130
PG 5
WC Computer Science, Theory & Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BR8WH
UT WOS:000674460200027
DA 2022-04-20
ER

PT J
AU Brandi, ML
AF Brandi, Maria Luisa
TI Are sex hormones promising candidates to explain sex disparities in the
   COVID-19 pandemic?
SO REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
LA English
DT Review
DE COVID-19; Estrogens; Androgens; Progestins; SERMs
ID ACUTE RESPIRATORY SYNDROME; CONVERTING ENZYME TYPE-2;
   GENDER-DIFFERENCES; REPLACEMENT THERAPY; RECEPTOR MAS; ESTROGEN; ACE2;
   ANGIOTENSIN-(1-7); SARS-COV-2; PHYSIOLOGY
AB Emerging evidence suggests that the novel Coronavirus disease-2019 (COVID-19) is deadlier for men than women both in China and in Europe. Male sex is a risk factor for COVID-19 mortality. The meccanisms underlying the reduced morbidity and lethality in women are currently unclear, even though hypotheses have been posed (Brandi and Giustina in Trends Endocrinol Metab. 31:918-27, 2020). This article aims to describe the role of sex hormones in sex- and gender-related fatality of COVID-19. We discuss the possibility that potential sex-specific mechanisms modulating the course of the disease include both the androgen- and the estrogen-response cascade. Sex hormones regulate the respiratory function, the innate and adaptive immune responses, the immunoaging, the cardiovascular system, and the entrance of the virus in the cells. Recommendations for the future government policies and for the management of COVID-19 patients should include a dimorphic approach for males and females. As the estrogen receptor signaling appears critical for protection in women, more studies are needed to translate the basic knowledge into clinical actions. Understanding the etiological bases of sexual dimorphism in COVID-19 could help develop more effective strategies in individual patients in both sexes, including designing a good vaccine.
C1 [Brandi, Maria Luisa] Fdn Italiana Ric Malattie Osso, Florence, Italy.
RP Brandi, ML (corresponding author), Fdn Italiana Ric Malattie Osso, Florence, Italy.
EM marialuisa@marialuisabrandi.it
FU F.I.R.M.O. Foundation
FX This manuscript was supported by F.I.R.M.O. Foundation.
CR Altan N, 1999, P NATL ACAD SCI USA, V96, P4432, DOI 10.1073/pnas.96.8.4432
   Ambhore NS, 2021, ADV EXP MED BIOL, V1303, P243, DOI 10.1007/978-3-030-63046-1_14
   [Anonymous], 2020, MATURITAS, V137, P57
   [Anonymous], 2021, DIAB CARE, V44, pE22
   Archiza B, 2021, EUR J APPL PHYSIOL, V121, P2377, DOI 10.1007/s00421-021-04690-9
   Asselta R., 2020, ACE2 TMPRSS2 VARIANT, DOI [10.1101/2020.03.30.20047878, DOI 10.1101/2020.03.30.20047878]
   Bain CC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc4466
   Bambra C, 2021, SCAND J PUBLIC HEALT, V49, P17, DOI 10.1177/1403494820975604
   Baran-Gale J, 2016, RNA, V22, P1592, DOI 10.1261/rna.056895.116
   Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652
   Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119
   BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086
   Belmonte RL, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03075
   Bienvenue LA, 2020, CARDIOVASC RES, P1
   Blair ML, 2007, ADV PHYSIOL EDUC, V31, P23, DOI 10.1152/advan.00118.2006
   Boese AC, 2017, AM J PHYSIOL-HEART C, V313, pH524, DOI 10.1152/ajpheart.00217.2016
   Brabek J, 2020, SCIENCE, V368, P473, DOI [10.1126/science.abb8925, DOI 10.1126/SCIENCE.ABB8925]
   Brandi ML, 2020, TRENDS ENDOCRIN MET, V31, P918, DOI 10.1016/j.tem.2020.09.003
   Bravaccini S, 2021, CELL TRANSPLANT, V30, DOI 10.1177/0963689721991477
   Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896
   Cheng C, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181117
   Comas C, 2021, J MED VIROL, V93, P22, DOI 10.1002/jmv.26350
   Compston JE, 2019, LANCET, V393, P364, DOI 10.1016/S0140-6736(18)32112-3
   Dale E, 2006, ADV PHYSIOL EDUC, V30, P152, DOI 10.1152/advan.00065.2006
   Darabi P, 2020, GYNECOL ENDOCRINOL, V36, P582, DOI 10.1080/09513590.2019.1706084
   Devaux CA, 2020, J MICROBIOL IMMUNOL, V53, P425, DOI 10.1016/j.jmii.2020.04.015
   di Filippo L, 2021, J CLIN ENDOCR METAB, V106, pE602, DOI 10.1210/clinem/dgaa738
   Douglas GC, 2004, ENDOCRINOLOGY, V145, P4703, DOI 10.1210/en.2004-0443
   Duga S, 2020, MEDRXIV, DOI [10.1101/2020.04.20.20068056, DOI 10.1101/2020.04.20.20068056]
   Elfiky AA, 2021, J BIOMOL STRUCT DYN, V39, P3194, DOI 10.1080/07391102.2020.1761881
   Erfinanda L, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.00921-2020
   Fagan TF, 2004, ADV MOL CEL, V34, P295, DOI 10.1016/S1569-2558(03)34020-2
   Fait Tomas, 2019, Drugs Context, V8, P212551, DOI 10.7573/dic.212551
   Fathi A, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.601170
   FitzGerald LM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-230
   Gal-Oz ST, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12348-6
   Garg R, 2020, J MID-LIFE HEALTH, V11, P250, DOI 10.4103/jmh.jmh_287_20
   Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9
   Gomez J, 2020, GENE, V762, DOI 10.1016/j.gene.2020.145102
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Honorato-Sampaio K, 2012, EXP PHYSIOL, V97, P642, DOI 10.1113/expphysiol.2011.061960
   Horstman AM, 2012, J GERONTOL A-BIOL, V67, P1140, DOI 10.1093/gerona/gls068
   Horwath O, 2021, SCAND J MED SCI SPOR, V31, P303, DOI 10.1111/sms.13848
   Huxley VH, 2007, ADV PHYSIOL EDUC, V31, P17, DOI 10.1152/advan.00099.2006
   Illiano E, 2020, ANDROLOGIA, V52, DOI 10.1111/and.13654
   Jensen-Fangel S, 2004, SCAND J INFECT DIS, V36, P31, DOI 10.1080/00365540310017618
   Jeon S, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00819-20
   Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152
   Karamouzis MV, 2016, TRENDS CANCER, V2, P35, DOI 10.1016/j.trecan.2015.12.001
   Karlberg J, 2004, AM J EPIDEMIOL, V159, P229, DOI 10.1093/aje/kwh056
   Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137
   Kinkead R, 2017, RESP PHYSIOL NEUROBI, V245, P1, DOI 10.1016/j.resp.2017.08.013
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Klein SL, 2012, J LEUKOCYTE BIOL, V92, P67, DOI 10.1189/jlb.0811427
   Langhammer A, 2003, EUR RESPIR J, V21, P1017, DOI 10.1183/09031936.03.00053202
   Leach DA., 2021, NATURE COMM, V12, P4068, DOI 10.1038/S41467-021-24342-Y
   Li HM, 2014, J MED CHEM, V57, P632, DOI 10.1021/jm401144z
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Lim S, 2021, NAT REV ENDOCRINOL, V17, P11, DOI 10.1038/s41574-020-00435-4
   Maeng LY, 2015, HORM BEHAV, V76, P106, DOI 10.1016/j.yhbeh.2015.04.002
   Maggio M, 2005, J Endocrinol Invest, V28, P116
   Marquez EJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14396-9
   Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511
   Matsuyama R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3881-4
   Mauvais-Jarvis F, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa127
   McCoy J, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.668698
   Meng ZJ, 2018, CHIN J NAT MEDICINES, V16, P846, DOI 10.1016/S1875-5364(18)30126-2
   Mikkonen L, 2010, MOL CELL ENDOCRINOL, V317, P14, DOI 10.1016/j.mce.2009.12.022
   Moccia F, 2020, GEROSCIENCE, V42, P1021, DOI 10.1007/s11357-020-00198-w
   Molgat-Seon Y, 2018, CURR OPIN PHYSIOL, V6, P21, DOI 10.1016/j.cophys.2018.03.007
   Mompeon A, 2016, MOL CELL ENDOCRINOL, V422, P1, DOI 10.1016/j.mce.2015.11.004
   Montopoli M, 2021, ANN ONCOL, V32, P676, DOI 10.1016/j.annonc.2021.01.069
   Montopoli M, 2020, ANN ONCOL, V31, P1040, DOI 10.1016/j.annonc.2020.04.479
   Nachman Sharon, ESTR PATCH COVID 19
   Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7
   Okpechi SC, 2021, AGING DIS, V12, P671, DOI 10.14336/AD.2020.1211
   Ortona Elena, 2016, Ann Ist Super Sanita, V52, P205, DOI 10.4415/ANN_16_02_12
   Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y
   Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029
   Pandit P, 2020, AM J MED SCI, V360, P467, DOI 10.1016/j.amjms.2020.04.023
   Park KU, 2021, BREAST CANCER RES TR, V188, P249, DOI 10.1007/s10549-021-06153-3
   Penna C, 2020, BRIT J PHARMACOL, V177, P4375, DOI 10.1111/bph.15207
   Peters SAE, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1005-5
   Pivonello R, 2021, NEUROENDOCRINOLOGY, V111, P1066, DOI 10.1159/000513346
   Porter VR, 2001, EXP GERONTOL, V36, P311, DOI 10.1016/S0531-5565(00)00195-9
   Pozzilli P, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154252
   Ragia G, 2020, PHARMACOGENOMICS, V21, P1311, DOI 10.2217/pgs-2020-0092
   Rahimi G, 2021, INT IMMUNOPHARMACOL, V92, DOI 10.1016/j.intimp.2021.107365
   Reis FM, 2011, FERTIL STERIL, V95, P176, DOI 10.1016/j.fertnstert.2010.06.060
   Lemes RMR, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.14707
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Ruzzo A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47627-1
   Sabharwal N, 2019, ENDOCRINOLOGY, V160, P2180, DOI 10.1210/en.2019-00366
   Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100
   Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659
   Schurz H, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-018-0185-z
   Seeland U, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01851-z
   Selek A, 2021, HORM-INT J ENDOCRINO, V20, P259, DOI 10.1007/s42000-021-00277-3
   Sha J, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.607059
   Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3
   Snell DM, 2018, CURR BIOL, V28, pR1313, DOI 10.1016/j.cub.2018.09.018
   Srivatsan SR, 2020, SCIENCE, V367, P45, DOI 10.1126/science.aax6234
   Stubbs D, 2010, PAIN MED, V11, P232, DOI 10.1111/j.1526-4637.2009.00760.x
   Student S, 2020, EUR J PHARMACOL, V866, DOI 10.1016/j.ejphar.2019.172783
   Suba Z, 2020, J PHARM PHARM SCI, V23, P75, DOI 10.18433/jpps31069
   Takahashi T, 2020, NATURE, V588, DOI 10.1038/s41586-020-2700-3
   Taneja V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01931
   TORDAY JS, 1987, EXP LUNG RES, V12, P1, DOI 10.3109/01902148709068811
   Tower J, 2017, TRENDS ENDOCRIN MET, V28, P735, DOI 10.1016/j.tem.2017.07.002
   Townsend EA, 2012, ENDOCR REV, V33, P1, DOI 10.1210/er.2010-0031
   Tramunt B, 2020, DIABETOLOGIA, V63, P453, DOI 10.1007/s00125-019-05040-3
   van Zyl-Smit RN, 2020, LANCET RESP MED, V8, P664, DOI 10.1016/S2213-2600(20)30239-3
   Vasanthakumar A, 2020, NATURE, V579, P581, DOI 10.1038/s41586-020-2040-3
   Vaz-Silva J, 2009, REPROD SCI, V16, P247, DOI 10.1177/1933719108327593
   Viboud C, 2013, J INFECT DIS, V207, P721, DOI 10.1093/infdis/jis745
   Viswanathan M, 2018, JAMA-J AM MED ASSOC, V319, P2532, DOI 10.1001/jama.2018.6537
   Wambier CG, 2020, J AM ACAD DERMATOL, V83, P308, DOI 10.1016/j.jaad.2020.04.032
   Wang ZP, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040920
   Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101
   Wu Q., 2020, ENVIRON INT, V30, DOI [10.1016/j.ending.2020.106232, DOI 10.1016/J.ENDING.2020.106232]
   Xie XD, 2006, LIFE SCI, V78, P2166, DOI 10.1016/j.lfs.2005.09.038
   Xu H, 2021, ANDROLOGY-US, V9, P107, DOI 10.1111/andr.12942
   Yu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24955
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
NR 125
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-9155
EI 1573-2606
J9 REV ENDOCR METAB DIS
JI Rev. Endocr. Metab. Disord.
PD APR
PY 2022
VL 23
IS 2
SI SI
BP 171
EP 183
DI 10.1007/s11154-021-09692-8
EA NOV 2021
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA ZU6DT
UT WOS:000716864900001
PM 34761329
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Shamsi, A
   Lund, BD
   SeyyedHosseini, S
AF Shamsi, Amrollah
   Lund, Brady Daniel
   SeyyedHosseini, Shohreh
TI Sharing of retracted COVID-19 articles: an altmetric study
SO JOURNAL OF THE MEDICAL LIBRARY ASSOCIATION
LA English
DT Article
DE COVID-19; retractions; altmetrics; articles; social media
AB Objective: This study examines the extent to which retracted articles pertaining to COVID-19 have been shared via social and mass media based on altmetric scores. Methods: Seventy-one retracted articles related to COVID-19 were identified from relevant databases, of which thirty-nine had an Altmetric Attention Score obtained using the Altmetrics Bookmarklet. Data extracted from the articles include overall attention score and demographics of sharers (e.g., geographic location, professional affiliation). Results: Retracted articles related to COVID-19 were shared tens of thousands of times to an audience of potentially hundreds of millions of readers and followers. Twitter was the largest medium for sharing these articles, and the United States was the country with the most sharers. While general members of the public were the largest proportion of sharers, researchers and professionals were not immune to sharing these articles on social media and on websites, blogs, or news media. Conclusions: These findings have potential implications for better understanding the spread of misleading or false information perpetuated in retracted scholarly publications. They emphasize the importance of quality peer review and research ethics among journals and responsibility among individuals who wish to share research findings.
C1 [Lund, Brady Daniel] Emporia State Univ, Sch Lib & Informat Management, Emporia, KS 66801 USA.
   [SeyyedHosseini, Shohreh] Bushehr Univ Med Sci, Knowledge & Informat Sci, Bushehr, Iran.
RP Lund, BD (corresponding author), Emporia State Univ, Sch Lib & Informat Management, Emporia, KS 66801 USA.
EM shamsiamrollah@gmail.com; blund2@g.emporia.edu; tanin64@gmail.com
CR COPE Council, 2019, COPE RETR GUID, DOI [10.24318/cope.2019.1.4>, DOI 10.24318/COPE.2019.1.4, 10.24318/cope.2019.1.4]
   Cortegiani A, 2021, BRIT J ANAESTH, V126, pE155, DOI 10.1016/j.bja.2021.01.008
   Elango B, 2021, SCIENTOMETRICS, V126, P3965, DOI 10.1007/s11192-021-03895-1
   Fagbule O, 2018, ANN IB POSTGRAD MED, V16, P5
   Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]
   Madu AU., 2020, INT J INNOVATION RES, V7, P125
   Mansourzadeh MJ, 2020, ASIA-PAC J PUBLIC HE, V32, P503, DOI 10.1177/1010539520956439
   Ortiz-Núñez Roelvis, 2020, Rev. cuba. inf. cienc. salud, pe1587
   Parabhoi L., 2021, LIB PHILOS PRACTICE
   Perez-Escoda A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145261
   Rao T S Sathyanarayana, 2011, Indian J Psychiatry, V53, P95, DOI 10.4103/0019-5545.82529
   Rosenberg H, 2020, CAN J EMERG MED, V22, P418, DOI 10.1017/cem.2020.361
   Serrano LR, 2021, CORONAVIRUS QUE COMU
   Soltani P, 2020, SCIENTOMETRICS, V125, P819, DOI 10.1007/s11192-020-03661-9
   Steen RG, 2011, J MED ETHICS, V37, P688, DOI 10.1136/jme.2011.043133
   Stern AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02956
   Sutton SW, 2014, KANSAS LIB ASS COLL, V4
   The Office of Research Integrity, DEF RES MISC
   Tornberg HN, 2021, J MED INTERNET RES, V23, DOI 10.2196/21408
   Uysal BB, 2021, IR J MED SCI, P1
   Wang T, 2020, PUBLIC LIBR Q, V39, P283, DOI 10.1080/01616846.2020.1764325
   Xia J, 2021, INT J ENV RES PUBLIC, V18, P1
   Yeo-Teh NSL, 2021, ACCOUNT RES, V28, P47, DOI 10.1080/08989621.2020.1782203
NR 23
TC 0
Z9 0
U1 2
U2 2
PU MEDICAL LIBRARY ASSOC
PI CHICAGO
PA 65 EAST WACKER PLACE, STE 1900, CHICAGO, IL 60601-7298 USA
SN 1536-5050
J9 J MED LIBR ASSOC
JI J. Med. Libr. Assoc.
PD JAN
PY 2022
VL 110
IS 1
BP 97
EP 102
DI 10.5195/jmla.2022.1269
PG 6
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA YY7KQ
UT WOS:000754966000007
PM 35210968
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Orru, B
   Szekeres-Bartho, J
   Bizzarri, M
   Spiga, AM
   Unfer, V
AF Orru, B.
   Szekeres-Bartho, J.
   Bizzarri, M.
   Spiga, A. M.
   Unfer, V
TI Inhibitory effects of Vitamin D on inflammation and IL-6 release. A
   further support for COVID-19 management?
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE COVID-19; Vitamin D; Vitamin D deficiency; Progesterone-induced blocking
   factor; PIBF; IL-6; Interleukin 6
ID IMMUNOMODULATORY PROTEIN; D SUPPLEMENTATION; PROGESTERONE;
   INTERLEUKIN-6; EXPRESSION; CYTOKINES; HORMONE
AB The ongoing worldwide pandemic of Coronavirus disease 2019 (COVID-19), raised the urgency to address knowledge gaps and to establish evidence for improving management and control of this viral infection. Throughout a keen analysis of the World Health Organization (WHO) most updated data, a gender-specific difference in the occurrence of infection was determined, which seems to correlate with patient's vitamin D status. Therefore, our purpose is to provide insights into the nutritional importance of vitamin D for its immunomodulatory effect, in order to help counteracting the COVID-19 pandemic. Novel interesting findings suggest that vitamin D, by inducing progesterone-induced blocking factor (PIBF), might regulate the immune response and also modulate cytokine IL-6, which appears to be increased in COVID-19 infections. Therefore, in addition to the standard recommendations to prevent the infection, supplementation of vitamin D might be considered an approach to help counteracting this global epidemic.
C1 [Orru, B.] LoLi Pharma Srl, R&D Dept, Rome, Italy.
   [Szekeres-Bartho, J.] Pecs Univ, Med Sch, Dept Med Biol, Pecs, Hungary.
   [Bizzarri, M.] Sapienza Univ Roma, Dept Expt Med, Rome, Italy.
   [Spiga, A. M.] ASSL Cagliari, Emergency Dept, ATS Sardegna, Cagliari, Italy.
   [Bizzarri, M.; Unfer, V] Sapienza Univ Roma, Syst Biol Grp Lab, Rome, Italy.
RP Unfer, V (corresponding author), Sapienza Univ Roma, Syst Biol Grp Lab, Rome, Italy.
EM vunfer@gmail.com
OI unfer, vittorio/0000-0002-1805-3181
CR Adegoke SA, 2017, CYTOKINE, V96, P87, DOI 10.1016/j.cyto.2017.03.010
   Albahrani Ali A, 2016, Clin Biochem Rev, V37, P27
   Beilfuss J, 2012, CYTOKINE, V60, P870, DOI 10.1016/j.cyto.2012.07.032
   Berry DJ, 2011, BRIT J NUTR, V106, P1433, DOI 10.1017/S0007114511001991
   Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009
   Carvalho JTG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179540
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chun RF, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00151
   Dalvi Shubhangi M, 2019, Indian J Tuberc, V66, P337, DOI 10.1016/j.ijtb.2018.05.018
   De Rui M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094805
   Del Fiol FD, 2015, J INFECT DEV COUNTR, V9, P355, DOI 10.3855/jidc.5711
   Ding C, 2012, BRIT J NUTR, V108, P1915, DOI 10.1017/S0007114512003285
   Edwards MH, 2014, J AGING RES CLIN PRA, V3, P148, DOI [DOI 10.14283/JARCP.2014.26, 10.14283/jarcp.2014.26]
   HARRISON HE, 1966, YALE J BIOL MED, V38, P393
   Hashemi R, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000278
   IOM (Institute of Medicine), 2011, DIETARY REFERENCE IN
   Karimi S, 2020, CLIN NUTR ESPEN, V36, P76, DOI 10.1016/j.clnesp.2020.02.003
   Krivoy A, 2020, INT CLIN PSYCHOPHARM, V35, P208, DOI 10.1097/YIC.0000000000000303
   Labudzynskyi D, 2016, EUR REV MED PHARMACO, V20, P2916
   Lacroix M, 2019, J ENDOCR SOC, V3, P2165, DOI 10.1210/js.2019-00181
   Liao H, 2018, Zhonghua Yi Xue Za Zhi, V98, P3509, DOI 10.3760/cma.j.issn.0376-2491.2018.43.009
   Lippi Giuseppe, 2015, Acta Biomed, V86, P59
   Manion M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175517
   Marquez EJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14396-9
   Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583
   Miko E, 2020, SOC MATERNAL FETAL M
   Monastra G, 2018, EUR REV MED PHARMACO, V22, P2502, DOI 10.26355/eurrev_201804_14845
   Nair R, 2012, J PHARMACOL PHARMACO, V3, P118, DOI 10.4103/0976-500X.95506
   Paradisi R, 2003, AM J REPROD IMMUNOL, V50, P302, DOI 10.1034/j.1600-0897.2003.00065.x
   Paradisi R, 2003, EUR J OBSTET GYN R B, V111, P43, DOI 10.1016/S0301-2115(03)00119-2
   Pramyothin P, 2012, CURR OPIN GASTROEN, V28, P139, DOI 10.1097/MOG.0b013e32835004dc
   Roth DE, 2008, J INFECT DIS, V197, P676, DOI 10.1086/527488
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Song J, 2019, STEROIDS, V150, DOI 10.1016/j.steroids.2019.108445
   Spiro A, 2014, NUTR BULL, V39, P322, DOI 10.1111/nbu.12108
   Szekeres-Bartho J, 2001, INT IMMUNOPHARMACOL, V1, P1037, DOI 10.1016/S1567-5769(01)00035-2
   Szekeres-Bartho J, 2008, FRONT BIOSCI-LANDMRK, V13, P1981, DOI 10.2741/2817
   Szekeres-Bartho J, 2009, J REPROD IMMUNOL, V83, P60, DOI 10.1016/j.jri.2009.06.262
   SzekeresBartho J, 1996, J REPROD IMMUNOL, V31, P81, DOI 10.1016/0165-0378(96)00964-3
   SZEKERESBARTHO J, 1985, AM J REPROD IM MIC, V9, P19
   SZEKERESBARTHO J, 1995, AM J REPROD IMMUNOL, V34, P342, DOI 10.1111/j.1600-0897.1995.tb00962.x
   Wei R, 2015, NUTRIENTS, V7, P8251, DOI 10.3390/nu7105392
   Xie ZX, 2017, IMMUNOLOGY, V152, P414, DOI 10.1111/imm.12776
   Yu N, 2020, LANCET INFECT DIS, V20, P559, DOI 10.1016/S1473-3099(20)30176-6
   Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707
NR 45
TC 10
Z9 10
U1 1
U2 3
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PY 2020
VL 24
IS 15
BP 8187
EP 8193
DI 10.26355/eurrev_202008_22507
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA MX0BN
UT WOS:000557394400034
PM 32767348
DA 2022-04-20
ER

PT J
AU Yoshioka-Maeda, K
AF Yoshioka-Maeda, Kyoko
TI Developing sustainable public health care systems for responding to
   COVID-19 in Japan
SO PUBLIC HEALTH NURSING
LA English
DT Article
DE change management; COVID-19; health service administration; public
   health nursing
AB Objective: Despite having prevented public health center (PHC) dysfunction in response to COVID-19 during the first wave, public health nurses (PHNs) who play a central role in preventing COVID-19 and supporting community people were unable to share practical knowledge with other PHNs immediately. This report aims to introduce the development of novel sustainable public health care systems with regard to COVID-19 in Japan: task sharing, securing staff, and task shifting.
   Methods: A descriptive study. The Japan Ministry of Health, Labour, and Welfare enlisted good practices regarding resource allocation and developing full readiness for sustainable public health care systems in September 2020.
   Results: Public health center developed systems for office support, infection control, hospital coordination, and outsourced inventory control. To reduce the workload of PHNs, a support team of three to four office workers developed a response manual for residents and a format for telephone consultations regarding COVID-19. Developing an infection control team and web-based system for hospital coordination decreased the workload of PHCs in each community to prepare for the pandemic.
   Conclusion: Public health center should consider managing limited human resources and focus on providing specialized care for COVID-19 patients. Task sharing, securing staff, and task shifting are crucial strategies for developing sustainable public health care systems.
C1 [Yoshioka-Maeda, Kyoko] Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan.
   [Yoshioka-Maeda, Kyoko] Minist Hlth Labour & Welf, Hlth Serv Bur, Tokyo, Japan.
RP Yoshioka-Maeda, K (corresponding author), Natl Inst Publ Hlth, Dept Hlth Promot, 2-3-6 Minami, Wako, Saitama 3510197, Japan.
EM yoshioka.k.aa@niph.go.jp
OI Yoshioka-Maeda, Kyoko/0000-0003-0344-0143
CR Centers for Disease Control and Prevention, 2020, SHAR SHIFT TASKS MAI
   International Council on Archives the International Conference of Information Commissioners, 2020, COVID 19 DUT DOC DOE
   Japanese Association of Public Health Center Directors, 2020, HOK SETT SUU SUII
   Ministry of Health Labour and Welfare, 2019, KEKK GAIYOU SHYUUG H
   Ministry of Health Labour and Welfare, 2020, SECCH SYUT BETS HOK
   Ministry of Health Labour and Welfare and Ministry of Internal Affairs and Communications, 2020, HOK KAK SHING COR VI
   World Health Organization, 2020, PULS SURV CONT ESS H
   World Health Organization World Health Organization, 2020, OP CONS CAS MAN COVI
   Yoshioka-Maeda K, 2020, J ADV NURS, V76, P2215, DOI 10.1111/jan.14409
NR 9
TC 2
Z9 2
U1 4
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0737-1209
EI 1525-1446
J9 PUBLIC HEALTH NURS
JI Public Health Nurs.
PD MAY
PY 2021
VL 38
IS 3
BP 470
EP 472
DI 10.1111/phn.12861
PG 3
WC Public, Environmental & Occupational Health; Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Nursing
GA SJ0LM
UT WOS:000655219100019
PM 33387382
OA Bronze
DA 2022-04-20
ER

PT C
AU Zieba, M
   Durst, S
   Gonsiorowska, M
   Zralov, Z
AF Zieba, Malgorzata
   Durst, Susanne
   Gonsiorowska, Martyna
   Zralov, Zeynaddin
BE GarciaPerez, A
   Simkin, L
TI Knowledge Risks in Organizations - Insights from Companies
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE knowledge risks; knowledge management; risk management; quantitative
   research
ID MANAGEMENT
AB Purpose: Knowledge risks are increasingly becoming a great challenge to a variety of organizations. At the same time, academic research on such types of risks, their consequences, and potential ways of overcoming them is still scarce and fragmented. To fill this gap, the paper aims to find out do companies manage their knowledge risks, what are the possible knowledge risks they face and have they observed an increase of knowledge risks during the COVID-19 pandemic. The paper is aimed to present insights on different types of knowledge risks that organizations face, and the ways organizations handle them. The paper also proposes some potential countermeasures organizations might use to mitigate the consequences of knowledge risks. Methodology: The study presents the results of a quantitative survey performed among 60 professionals dealing with management and knowledge risks in organizations. In the study, the authors also have examined what tools and methods are used to manage these risks. The study also explores the level of readiness organizations have to address potential knowledge risks. Findings: The theoretical study has allowed us to identify a variety of knowledge risks, which can bear severe consequences for organizations, such as knowledge loss, knowledge leaking, knowledge hiding, or risks related to cybercrime. All these risks may potentially reduce the productivity in organizations, thus leading to the degradation of organizational performance. Research limitations: Research results are limited to the convenience sample that was selected for the study and thus may not give a comprehensive overview of the state of the art. Practical implications: The study provides useful insights for managers and owners of organizations in need of dealing with the knowledge risks in their organizations. The paper is enriched with a number of sample solutions that they may apply for the sake of their organization. Originality/value: The paper lays the ground for a better understanding of the knowledge risks that organizations need to face nowadays. As such, the paper offers food for thought for researchers dealing with the topic of knowledge risks, knowledge management, and organizational risk management in general.
C1 [Zieba, Malgorzata; Gonsiorowska, Martyna; Zralov, Zeynaddin] Gdansk Univ Technol, Gdansk, Poland.
   [Durst, Susanne] Tallinn Univ Technol, Tallinn, Estonia.
RP Zieba, M (corresponding author), Gdansk Univ Technol, Gdansk, Poland.
EM mz@zie.pg.gda.pl; susanne.durst@taltech.ee; martynagon@gmail.com;
   zzralov@gmail.com
FU National Science Centre (Poland)National Science Centre, Poland
   [2019/33/B/HS4/02250]
FX Study supported with the research grant from the National Science Centre
   (Poland) in the context of a research project "Knowledge risks in modern
   organizations" (No. 2019/33/B/HS4/02250).
CR Abomhara M, 2015, J CYBER SECURITY, V4, P65, DOI DOI 10.13052/JCSM2245-1439.414
   Agndal H, 2009, BENCHMARKING, V16, P316, DOI 10.1108/14635770910961353
   [Anonymous], 2007, STANFORD ENCY PHILOS
   Bratianu C., 2018, MANAGEMENT DYNAMICS, V6, P593, DOI [10.25019/MDKE/6.4.06, DOI 10.25019/MDKE/6.4.06]
   Connelly CE, 2012, J ORGAN BEHAV, V33, P64, DOI 10.1002/job.737
   Delerue H, 2005, EUR BUS REV, V17, P532, DOI 10.1108/09555340510630563
   Durst S., 2016, COMPETITIVE STRATEGI, P195
   Durst S, 2020, J CLEAN PROD, V251, DOI 10.1016/j.jclepro.2019.119670
   Durst S, 2019, J BUS RES, V105, P1, DOI 10.1016/j.jbusres.2019.08.002
   Durst S, 2019, KNOWL MAN RES PRACT, V17, P1, DOI 10.1080/14778238.2018.1538603
   Durst S, 2017, INT J BUS ENVIRON, V9, P51
   Ferenhof HA, 2016, NAVUS-REV GEST TECNO, V6, P38
   Kim Y, 2014, TECHNOVATION, V34, P454, DOI 10.1016/j.technovation.2014.05.004
   Lambe P., 2013, 4 TYPES KNOWLEDGE RI
   de Holan PM, 2011, J MANAGE INQUIRY, V20, P317, DOI 10.1177/1056492611408265
   Massingham P, 2010, J KNOWL MANAG, V14, P464, DOI 10.1108/13673271011050166
   Nicol DM, 2018, WINT SIMUL C PROC, P2759, DOI 10.1109/WSC.2018.8632318
   Perrott Bruce E., 2007, Business Horizons, V50, P523, DOI 10.1016/j.bushor.2007.08.002
   Saenz J, 2012, J KNOWL MANAG, V16, P919, DOI 10.1108/13673271211276191
   Sallos MP, 2019, J INTELLECT CAP, V20, P581, DOI 10.1108/JIC-03-2019-0041
   Stewart T.A., 1997, INTELLECTUAL CAPITAL
   Temel S, 2021, VINE J INF KNOWL MAN, V51, P655, DOI 10.1108/VJIKMS-10-2019-0155
   Thalmann S., 2020, P 53 HAW INT C SYST, P4940, DOI [10.24251/hicss.2020.607, DOI 10.24251/HICSS.2020.607]
   Tonn G, 2019, TRANSPORT POLICY, V79, P103, DOI 10.1016/j.tranpol.2019.04.019
   Venkatesh VG, 2015, J RETAIL CONSUM SERV, V26, P153, DOI 10.1016/j.jretconser.2015.06.001
   Wang ZN, 2012, EXPERT SYST APPL, V39, P8899, DOI 10.1016/j.eswa.2012.02.017
   Webster J, 2008, RES PERS H, V27, P1, DOI 10.1016/S0742-7301(08)27001-5
   WHO, 2017, WHO INF NOT US DUAL
   Zieba M., 2018, KNOWLEDGE MANAGEMENT, P253, DOI [10.1007/978-3-319-66,890-1_13, DOI 10.1007/978-3-319-66,890-1_13]
NR 29
TC 0
Z9 0
U1 0
U2 0
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 864
EP 873
DI 10.34190/EKM.21.132
PG 10
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900100
DA 2022-04-20
ER

PT J
AU Kaur, S
   Bansal, R
   Kollimuttathuillam, S
   Gowda, AM
   Singh, B
   Mehta, D
   Maroules, M
AF Kaur, Supreet
   Bansal, Rashika
   Kollimuttathuillam, Sudarsan
   Gowda, Anusha Manje
   Singh, Balraj
   Mehta, Dhruv
   Maroules, Michael
TI The looming storm: Blood and cytokines in COVID-19
SO BLOOD REVIEWS
LA English
DT Review
DE COVID-19; Thrombosis; Cytokine release syndrome; Thrombocytopenia;
   Coagulation; Anticoagulation
ID HOSPITALIZED-PATIENTS; RISK-FACTORS; SARS
AB A novel coronavirus termed as COVID-19 by WHO has been the causative agent of an unprecedented pandemic in the history of humanity. The global burden of mortality and morbidity associated with this pandemic continues to increase with each passing day as it is progressively leading to multiorgan dysfunction. In most cases, the cause of death has been attributed to respiratory failure, sepsis, cardiac failure, kidney injury, or coagulopathy. As more knowledge is being unfolded, an in-depth understanding of various systemic manifestations and complications of SARS-CoV2 is vital for optimum management of these patients. This novel virus is known to spread faster than its two ancestors, the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), demonstrating a case fatality ranging from 5 to 8% [1]. Hematological abnormalities such as lymphopenia, thrombocytopenia, elevated D-Dimer, elevated fibrinogen, elevated fibrinogen degradation products as well as cytokines such as IL-6 are emerging as important prognostic marker for worse outcome of COVID-19. Among various systemic manifestations, hematological complications such as venous thrombosis causing pulmonary embolism or deep vein thrombosis, and arterial thrombosis causing myocardial infarction, strokes or limb ischemia are being noted to be directly linked to high mortality from COVID-19. An attempt to understand the pathophysiology of various hematological abnormalities including cytokine storm, hypercoagulable state and some rare presentations of this disease hence becomes imperative. Through this review, we aim to provide an upto-date summary of current evidence-based literature of hematological manifestations, their consequences and management including role of anticoagulation and drugs targeting cytokine storm in patients with SARS-CoV-2.
C1 [Kaur, Supreet; Kollimuttathuillam, Sudarsan; Gowda, Anusha Manje; Singh, Balraj; Maroules, Michael] St Joseph Univ, Med Ctr, Dept Hematol & Oncol, 703 Main St, Paterson, NJ 07503 USA.
   [Bansal, Rashika] NIDDK, Metab Dis Branch, NIH, 6555 Rock Spring Dr, Bethesda, MD 20817 USA.
   [Mehta, Dhruv] New York Med Coll, Westchester Med Ctr, Div Gastroenterol & Hepatobiliary Dis, 100 Woods Rd, Valhalla, NY 10595 USA.
RP Kaur, S (corresponding author), St Joseph Univ, Med Ctr, Dept Hematol & Oncol, 703 Main St, Paterson, NJ 07503 USA.
EM kaurs6@uthscsa.edu; maroulem@sjhmc.org
RI Mehta, Dhruv/AAW-9070-2020
OI Singh, Balraj/0000-0001-7986-6031
CR Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963
   Arachchillage DJ, 2020, BRIT J HAEMATOL, V190, pE286, DOI 10.1111/bjh.16927
   Bangalore S, 2020, NEW ENGL J MED, V382, P2478, DOI 10.1056/NEJMc2009020
   BEERKENS F, 2020, BLOOD, DOI DOI 10.1002/AJH.25809
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   BRUNE K, 2015, MUCOSAL IMMUNOL, V308, pL731
   Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   Choi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160955
   Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604
   COHEN AT, 2013, THROMB RES, V368, P513
   Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830
   Danzi GB, 2020, EUR HEART J, V41, P1858, DOI 10.1093/eurheartj/ehaa254
   DEJONG MD, 2006, INFECT IMMUN, V12, P1203
   Demelo-Rodriguez P, 2020, THROMB RES, V192, P23, DOI 10.1016/j.thromres.2020.05.018
   Fan BE, 2020, AM J HEMATOL, V95, pE131, DOI 10.1002/ajh.25774
   Fardet L, 2014, ARTHRITIS RHEUMATOL, V66, P2613, DOI 10.1002/art.38690
   Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972
   Gao Y, 2020, J MED VIROL, V92, P791, DOI 10.1002/jmv.25770
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   HELMS J, 2020, INTENS CARE MED 0504, DOI DOI 10.1007/S00134-020-06062-X
   HELMS J, 2020, PLOS ONE, DOI DOI 10.1056/NEJMC2008597
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   HORBY P, 2020, NEW ENGL J MED, DOI 10.1101/2020.07.15.20151852
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Lagunas-Rangel FA, 2020, J MED VIROL, V92, P1733, DOI 10.1002/jmv.25819
   LAX SF, 2020, THROMB RES, pM20, DOI DOI 10.7326/M20-2566
   LEIVAJUAREZ MM, 2018, PLOS PATHOG, V11, P21
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Max Roser Hasellx, CORONAVIRUS DIS COVI
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   MIAO M, 2020, AUTOIMMUN REV, V16, P11
   Michot JM, 2020, ANN ONCOL, V31, P961, DOI 10.1016/j.annonc.2020.03.300
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   Mousavi S, 2015, ADV PHARMACOL SCI, V2015, DOI 10.1155/2015/507151
   Mycroft-West C, 2020, BIORXIV, DOI [10.1101/2020.03.28.20046144, DOI 10.1101/2020.03.28.20046144]
   Nur E, 2020, AM J HEMATOL, V95, P725, DOI 10.1002/ajh.25821
   Organization WH, 2020, CORONAVIRUS DIS COVI
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   Poterucha TJ, 2017, THROMB HAEMOSTASIS, V117, P437, DOI 10.1160/TH16-08-0620
   Qu R, 2020, J MED VIROL, V92, P1533, DOI 10.1002/jmv.25767
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415
   Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9
   STROUSE JJ, 2010, SEMIN IMMUNOPATHOL, V116, P3431
   Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4
   Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   TEIJARO JR, 2017, J AM COLL CARDIOL, V39, P501, DOI DOI 10.1007/S00281-017-0640-2
   Terpos E, 2020, AM J HEMATOL, V95, P834, DOI 10.1002/ajh.25829
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Toniati P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102568
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   VARGA Z, 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30937-5
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang T, 2020, LANCET HAEMATOL, V7, pE362, DOI 10.1016/S2352-3026(20)30109-5
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026
   ZENG, 2020, CLIN OBSERVATIONS LO, DOI [10.1101/2020.03.28.20046144., DOI 10.1101/2020.03.28.20046144, 10.1101/2020.03.28.20046144]
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zhang W, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108393
   Zhang XH, 2020, BLOOD ADV, V4, P1307, DOI 10.1182/bloodadvances.2020001907
   Zhang Y, 2020, Zhonghua Xue Ye Xue Za Zhi, V41, P302, DOI [10.3760/cma.j.issn.0253-2727.2020.0006, 10.3760/cma.j.issn.0253-2727.2020.008]
   ZHANG Y, 2020, NEW ENGL J MED, DOI [DOI 10.1056/NEJMC2007575, 10.1056/NEJMc2007575]
   Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
   Zulfiqar AA, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2010472
NR 76
TC 21
Z9 21
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0268-960X
EI 1532-1681
J9 BLOOD REV
JI Blood Rev.
PD MAR
PY 2021
VL 46
AR 100743
DI 10.1016/j.blre.2020.100743
PG 10
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA RD4DC
UT WOS:000633429800012
PM 32829962
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Comfort, LK
AF Comfort, Louise K.
TI Cognition, Collective Action, and COVID-19: Managing Crises in Real Time
SO PUBLIC PERFORMANCE & MANAGEMENT REVIEW
LA English
DT Article; Early Access
DE Complex adaptive systems; complex time; COVID-19; gap between cognition
   and action; global learning process
ID COMMUNICATION; ORGANIZATIONS; COORDINATION; MANAGEMENT
AB Managing crises in real time places a distinctive burden on public managers as they encounter a gap between cognition of risk and action taken to reduce that risk. The uncertainty implicit in risk that has not yet occurred impedes actions that would reduce the risk when it does occur. In practice, actions not taken in time accelerate losses when the hazard does occur. This recurring dilemma in public management is observed acutely in the context of the rapidly escalating threat of COVID-19. This article briefly compares response operations to COVID-19 in four countries-South Korea, Italy, United States, Mexico-and documents different operational responses and different consequences in the number of confirmed cases and deaths from COVID-19 among the countries. The differences in outcomes are linked to the concept of complex time, where the threat of COVID-19 is perceived with different degrees of experience, knowledge, and urgency among the countries. The article concludes that resistance to uncertainty and failure to act is reduced by creating a structured reasoning process for consistent inquiry into unknown conditions, and timely, credible reporting of the changing threat status. Findings are documented with data from Johns Hopkins University Coronavirus Research Center, Baltimore, MD, 2020-2021.
C1 [Comfort, Louise K.] Univ Pittsburgh, Pittsburg, CA 94618 USA.
RP Comfort, LK (corresponding author), Univ Pittsburgh, Grad Sch Publ & Int Affairs, 5248 Golden Gate Ave, Pittsburg, CA 94618 USA.
EM comfort@gspia.pitt.edu
CR [Anonymous], 2020, CBS NEWS
   Ansell CK, 2021, PERSPECT PUBLIC MAN, V4, P24, DOI 10.1093/ppmgov/gvaa025
   Camacho M., 2022, GLOBAL CRISIS MANAGE
   Centers for Disease Control, 2021, HIST 1918 FLU PAND
   Centers for Disease Control, CDC SCI AG COVID 19
   Comfort L.K., 1988, 8822 U CAL I GOV STU
   Comfort L.K., 2022, GLOBAL RISK MANAGEME
   Comfort LK, 2019, PRINC STUD COMPLEX, P1
   Comfort LK, 2007, PUBLIC ADMIN REV, V67, P189, DOI 10.1111/j.1540-6210.2007.00827.x
   Comfort LK, 2020, PUBLIC ADMIN REV, V80, P616, DOI 10.1111/puar.13252
   Comfort LK, 2020, RISK ANAL, V40, P981, DOI 10.1111/risa.13442
   Comfort LK, 2019, AM REV PUBLIC ADM, V49, P159, DOI 10.1177/0275074018783020
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Fligstein N., 2012, THEORY FIELDS
   Gazzola V., 2022, GLOBAL RISK MANAGEME
   Glass R. J., 2011, COMPLEX ADAPTIVE SYS
   Herranz J, 2010, PUBLIC PERFORM MANAG, V33, P311, DOI 10.2753/PMR1530-9576330301
   Holland J.H, 1995, HIDDEN ORDER ADAPTAT
   Holland JH, 2012, SIGNALS AND BOUNDARIES: BUILDING BLOCKS FOR COMPLEX ADAPTIVE SYSTEMS, P1
   Hollnagel E., 2011, RESILIENCE ENG PRACT
   Hutchins E., 1995, COGNITION WILD
   Independent Panel for Preparedness & Response, 2021, COVID 19 MAK IT LAST
   Kamarck E., 2020, GET RID WHITE HOUSE
   Ko K., 2022, GLOBAL RISK MANAGEME
   Krakauer D., 2020, SANTA FE I SEMINAR S
   LAYZER D, 1975, SCI AM, V233, P56, DOI 10.1038/scientificamerican1275-56
   Lee S, 2020, AM REV PUBLIC ADM, V50, P729, DOI 10.1177/0275074020942412
   Mayer RE, 2014, COMPUTER GAMES FOR LEARNING: AN EVIDENCE-BASED APPROACH, P3
   Mileti D., 1999, DISASTERS DESIGN REA
   Moon MJ, 2020, PUBLIC ADMIN REV, V80, P651, DOI 10.1111/puar.13214
   Moynihan D.P., 2009, PUBLIC PERFORM MANAG, V32, P592, DOI [https://doi.org/10.2753/PMR1530-9576320409, DOI 10.2753/PMR1530-9576320409]
   National Research Council, 2001, AM HAZARDSCAPES REGI, DOI [https://doi.org/10.17226/10132, DOI 10.17226/10132]
   OECD (Organization for Economic Cooperation and Development), 2021, FOC RES HLTH CAR
   OECD (Organization of Economic Cooperation and Development), 2020, FLATTENING COVID 19
   Page SB, 2021, PUBLIC PERFORM MANAG, V44, P1161, DOI 10.1080/15309576.2021.1937243
   Rokeach M., 1960, OPEN CLOSED MIND
   Schulman, 2016, RELIABILITY RISK CHA
   Shin Y.A., 2019, THESIS U PITTSBURGH
   Siciliano M.D., 2022, GLOBAL RISK MANAGEME
   Simon H, 1962, P AM PHILOS SOC, V106, P467, DOI [DOI 10.1007/978-1-4899-0718-9_31, DOI 10.1080/14759550302804]
   Sole R., 2019, VIRUSES COMPLEX ADAP
   Sutton J., 2019, NAT HAZARD REV, V20, P04019002, DOI [10.1061/(ASCE)NH.1527-6996.0000324, DOI 10.1061/(ASCE)NH.1527-6996.0000324]
   Vicentini CB, 2020, PARASITOL INT, V75, DOI 10.1016/j.parint.2019.102046
   Weick K.E., 2007, MANAGING UNEXPECTED
   Weick K.E., 1995, SENSEMAKING ORG
   WEICK KE, 1993, ADMIN SCI QUART, V38, P628, DOI 10.2307/2393339
   Wilkie C., 2021, CNBC
   Woodward Bob., 2020, RAGE
   Zhang HB, 2012, J COMP POLICY ANAL, V14, P234, DOI 10.1080/13876988.2012.687621
   Zsambok C.E., 1993, DECISION MAKING ACTI, DOI DOI 10.1002/BDM.3960080307]
NR 50
TC 0
Z9 0
U1 3
U2 3
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1530-9576
EI 1557-9271
J9 PUBLIC PERFORM MANAG
JI Public Perform. Manag. Rev.
DI 10.1080/15309576.2022.2036204
EA MAR 2022
PG 22
WC Public Administration
WE Social Science Citation Index (SSCI)
SC Public Administration
GA ZR8XW
UT WOS:000768061600001
OA Bronze
DA 2022-04-20
ER

PT J
AU Davison, KM
   Thakkar, V
   Lin, S
   Stabler, L
   MacPhee, M
   Carroll, S
   Collins, B
   Rezler, Z
   Colautti, J
   Xu, CQ
   Fuller-Thomson, E
   Hey, B
   Kelly, K
   Mullaly, L
   Remick, R
   Ravindran, A
   Paric, A
   D'Andreamatteo, C
   Smye, V
AF Davison, Karen M.
   Thakkar, Vidhi
   Lin, Shen (Lamson)
   Stabler, Lorna
   MacPhee, Maura
   Carroll, Simon
   Collins, Benjamin
   Rezler, Zachary
   Colautti, Jake
   Xu, Chaoqun (Cherry)
   Fuller-Thomson, Esme
   Hey, Brandon
   Kelly, Krystal
   Mullaly, Laura
   Remick, Ron
   Ravindran, Arun
   Paric, Angela
   D'Andreamatteo, Carla
   Smye, Victoria
TI Interventions to Support Mental Health among Those with Health
   Conditions That Present Risk for Severe Infection from Coronavirus
   Disease 2019 (COVID-19): A Scoping Review of English and
   Chinese-Language Literature
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE COVID-19; mental health; substance use; chronic diseases
ID RANDOMIZED CONTROLLED-TRIAL; INTENSIVE CARE SYNDROME;
   POSTTRAUMATIC-STRESS; PTSD COACH; DEPRESSION; METAANALYSIS; MANAGEMENT;
   ANXIETY; STIGMA; TIME
AB This study aimed to address knowledge gaps related to the prevention and management of mental health responses among those with a condition that presents risk of severe COVID-19 infection. A scoping review that mapped English and Chinese-language studies (2019-2020) located in MEDLINE (Ovid), Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycInfo, Sociological Abstracts, Embase, China National Knowledge Infrastructure (CNKI), Wanfang Data, and Airiti Library was undertaken. Search terms related to COVID-19, mental health, and physical health were used and articles that included all three of these factors were extracted (n = 77). With the exception of one hospital-based pilot study, there were no intervention studies targeting mental health in those at risk of severe COVID-19 infection. Promising practices such as integrated care models that appropriately screen for mental health issues, address health determinants, and include use of digital resources were highlighted. Patient navigator programs, group online medical visits, peer support, and social prescribing may also support those with complex needs. Future policies need to address digital health access inequities and the implementation of multi-integrated health and social care. Furthermore, research is needed to comprehensively assess multi-integrated interventions that are resilient to public health crises.
C1 [Davison, Karen M.; Thakkar, Vidhi] Kwantlen Polytech Univ, Hlth Sci Program, 12666 72 Ave, Surrey, BC V3W 2M8, Canada.
   [Lin, Shen (Lamson); Fuller-Thomson, Esme] Univ Toronto, Factor Inwentash Fac Social Work, 46 Bloor St W, Toronto, ON M5S 1V4, Canada.
   [Stabler, Lorna] Cardiff Univ, CASCADE Childrens Social Care Res & Dev Ctr, Sch Social Sci, 1-3 Museum Pl, Cardiff CF10 3BD, Wales.
   [MacPhee, Maura] Univ British Columbia, Sch Nursing, T201-2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.
   [Carroll, Simon] Univ Victoria, Dept Sociol, Cornett Bldg,A333, Victoria, BC V8W 3P5, Canada.
   [Collins, Benjamin] Univ Manitoba, Dept Anthropol, 432 Fletcher Argue Bldg,15 Chancellor Cirde, Winnipeg, MB R3T 2N2, Canada.
   [Rezler, Zachary; Colautti, Jake; Xu, Chaoqun (Cherry)] McMaster Univ, Hlth Sci Program, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.
   [Hey, Brandon] Mental Hlth Commiss Canada, COVID 19 Policy Programs & Prior, 350 Albert St,Suite 1210, Ottawa, ON K1R 1A4, Canada.
   [Kelly, Krystal; Mullaly, Laura] Mental Hlth Commiss Canada, Mental Hlth Adv, 350 Albert St,Suite 1210, Ottawa, ON K1R 1A4, Canada.
   [Remick, Ron] Lookout Housing & Hlth Soc, 544 Columbia St, New Westminster, BC V3L 1B1, Canada.
   [Ravindran, Arun; Paric, Angela] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, 1001 Queen St W, Toronto, ON M6J 1H4, Canada.
   [D'Andreamatteo, Carla] Univ Manitoba, Dept Food & Human Nutr Sci, 209 Human Ecol Bldg, Winnipeg, MB R3T 2N2, Canada.
   [Smye, Victoria] Western Univ, Arthur Labatt Sch Nursing, 1151 Richmond St, London, ON N6A 3K7, Canada.
RP Davison, KM (corresponding author), Kwantlen Polytech Univ, Hlth Sci Program, 12666 72 Ave, Surrey, BC V3W 2M8, Canada.
EM karen.davison@kpu.ca; vidhi.thakkar@kpu.ca;
   lamsonlin.lin@mail.utoronto.ca; StablerL@Cardiff.ac.uk;
   Maura.MacPhee@ubc.ca; scarroll@uvic.ca; Benjamin.Collins@umanitoba.ca;
   rezlerz@mcmaster.ca; colauttj@mcmaster.ca; xuc73@mcmaster.ca;
   esme.fuller.thomson@utoronto.ca; bhey@mentalhealthcommission.ca;
   kkelly@mentalhealthcommission.ca; lmullaly@mentalhealthcommission.ca;
   ron.remick@lookoutsociety.ca; Arun.Ravindran@camh.ca;
   Angela.Paric@camh.ca; carla@thefoodlady.ca; vsmye@uwo.ca
RI Lin, Shen Lamson/B-4611-2018
OI Lin, Shen Lamson/0000-0002-9792-2372; Rezler,
   Zachary/0000-0003-0481-1217
FU Canadian Institutes of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR) [442712]
FX This research was funded by the Canadian Institutes of Health Research
   (CIHR) Operating Grant: Knowledge Synthesis: COVID-19 in Mental Health &
   Substance Use (#442712).
CR Addiction and Mental Health Collaborative Project Steering Committee, 2014, COLL ADD MENT HLTH C COLL ADD MENT HLTH C
   Ahmed H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2694
   Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092
   Ajilore O, 2020, BRAIN BEHAV IMMUN, V88, P66, DOI 10.1016/j.bbi.2020.06.003
   Algarin AB, 2020, AIDS BEHAV, V24, P2236, DOI 10.1007/s10461-020-02869-3
   Anderson M, 2020, J ROY SOC MED, V113, P176, DOI 10.1177/0141076820925229
   [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1
   Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]
   Armbruster M, 2020, J ADOLESCENT HEALTH, V67, P290, DOI 10.1016/j.jadohealth.2020.05.021
   Baker DW, 1997, AM J PUBLIC HEALTH, V87, P1027, DOI 10.2105/AJPH.87.6.1027
   Barker-Davies RM, 2020, BRIT J SPORT MED, V54, P949, DOI 10.1136/bjsports-2020-102596
   Bloom D.E., 2011, GLOBAL EC BURDEN NON
   Brief DJ, 2013, J CONSULT CLIN PSYCH, V81, P890, DOI 10.1037/a0033697
   Brooks SK, 2018, J OCCUP ENVIRON MED, V60, P248, DOI 10.1097/JOM.0000000000001235
   Brooks SK., 2020, The Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8
   Brown EE, 2020, AM J GERIAT PSYCHIAT, V28, P712, DOI 10.1016/j.jagp.2020.04.010
   Centers for Disease Control and Prevention, 2020, PEOPL WHO AR HIGH RI
   Centre for Addiction and Mental Health, 2014, BEST PRACTICE GUIDEL
   Ceravolo MG, 2020, EUR J PHYS REHAB MED, V56, P347, DOI 10.23736/S1973-9087.20.06329-7
   Chen X., 2020, CHIN J HLTH PSYCHOL
   Cohen A., 2017, BACKGROUND TECHNICAL
   Cornelio-Flores O, 2018, J ALTERN COMPLEM MED, V24, P125, DOI 10.1089/acm.2017.0132
   Corrigan PW, 2009, WORLD PSYCHIATRY, V8, P75
   Cox J, 2017, AIDS BEHAV, V21, P792, DOI 10.1007/s10461-016-1326-9
   Da BL, 2020, HEPATOLOGY, V72, P1102, DOI 10.1002/hep.31307
   Davison K.M., BETTER MENTAL PHYS H
   Davison KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191072
   Dell NA, 2020, J GERONTOL SOC WORK, V63, P659, DOI 10.1080/01634372.2020.1765064
   Doi M, 2018, NURS OPEN, V5, P583, DOI 10.1002/nop2.171
   Eruchalu CN, 2021, J URBAN HEALTH, V98, P183, DOI 10.1007/s11524-020-00508-9
   Farrington C, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-17
   Fiest KM, 2017, JCR-J CLIN RHEUMATOL, V23, P425, DOI 10.1097/RHU.0000000000000489
   Fleury MJ, 2012, CAN FAM PHYSICIAN, V58, pE732
   Fortuna LR, 2020, PSYCHOL TRAUMA-US, V12, P443, DOI 10.1037/tra0000889
   Frank Christine, 2018, BMC Psychol, V6, P61, DOI 10.1186/s40359-018-0273-9
   Frischknecht U, 2011, EUR ADDICT RES, V17, P241, DOI 10.1159/000328637
   Gelfand, 1995, CROSS-CULT RES, V29, P240, DOI [10.1177/106939719502900302, DOI 10.1177/106939719502900302]
   Germani A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103497
   Gillies D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007193.pub2
   Gomez-Salgado J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113947
   Hadlaczky G, 2014, INT REV PSYCHIATR, V26, P467, DOI 10.3109/09540261.2014.924910
   Haines A, 2020, LANCET, V395, P1173, DOI 10.1016/S0140-6736(20)30735-2
   Hamann HA, 2018, J THORAC ONCOL, V13, P1062, DOI 10.1016/j.jtho.2018.05.014
   Hankin B.L., 2005, DEV PSYCHOPATHOLOGY
   Hao XT, 2020, EPILEPSIA, V61, P1166, DOI 10.1111/epi.16544
   Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069
   Helmich RC, 2020, J PARKINSON DIS, V10, P351, DOI 10.3233/JPD-202038
   Hobfoll SE, 2016, J CONSULT CLIN PSYCH, V84, P31, DOI 10.1037/ccp0000041
   Horton R, 2020, LANCET, V396, P874, DOI 10.1016/S0140-6736(20)32000-6
   Huang B.., 2020, GEN NURS, V18, P935
   Huang RR, 2020, J AFFECT DISORDERS, V276, P788, DOI 10.1016/j.jad.2020.06.048
   Huang SW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004016
   Jeffries V., 2013, COLLABORATIVE CARE M
   Kates N, 2011, CAN J PSYCHIAT, V56, pB1
   Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197
   Khan S, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010331
   Kneipp SM, 2011, AM J PUBLIC HEALTH, V101, P1759, DOI 10.2105/AJPH.2011.300210
   Knottnerus A, 2008, J CLIN EPIDEMIOL, V61, P323, DOI 10.1016/j.jclinepi.2007.11.006
   Kosinski S, 2020, AM J RESP CRIT CARE, V201, pP15, DOI 10.1164/rccm.2018P15
   Kuester A, 2016, CLIN PSYCHOL REV, V43, P1, DOI 10.1016/j.cpr.2015.11.004
   Kuhn E, 2014, MIL MED, V179, P12, DOI 10.7205/MILMED-D-13-00271
   Lee M, 2020, AUST CRIT CARE, V33, P287, DOI 10.1016/j.aucc.2019.10.004
   Lichtenstein B, 2021, J GERONTOL B-PSYCHOL, V76, pE206, DOI 10.1093/geronb/gbaa102
   Lili W., 2020, J 2 MIL MED U, V41, P186
   Litz BT, 2007, AM J PSYCHIAT, V164, P1676, DOI 10.1176/appi.ajp.2007.06122057
   Lunn P., 2020, WP656 ESRI WP656 ESRI
   Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137
   Manchikanti L, 2009, PAIN PHYSICIAN, V12, P819
   Mannix R, 2020, ANN INTERN MED, V173, P228, DOI 10.7326/M20-1678
   Goodman-Casanov JM, 2020, J MED INTERNET RES, V22, DOI 10.2196/19434
   Marks IM, 2004, PSYCHOL MED, V34, P9, DOI 10.1017/S003329170300878X
   Mattioli AV, 2020, EUR J CLIN NUTR, V74, P852, DOI 10.1038/s41430-020-0646-z
   McBrien KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191980
   Mediouni Mohamed, 2020, Obes Med, V19, P100255, DOI 10.1016/j.obmed.2020.100255
   Miaomiao Z, 2020, CJIN, V6, P38
   Mickelson KD, 2001, PERS SOC PSYCHOL B, V27, P1046, DOI 10.1177/0146167201278011
   Mikocka-Walus A, 2016, INFLAMM BOWEL DIS, V22, P752, DOI 10.1097/MIB.0000000000000620
   Moghadasi AN, 2020, MULT SCLER RELAT DIS, V41, DOI 10.1016/j.msard.2020.102138
   Nachimuthu S, 2020, DIABETES METAB SYND, V14, P579, DOI 10.1016/j.dsx.2020.04.053
   Neville C, 2015, CLIN NURSE SPEC, V29, P143, DOI 10.1097/NUR.0000000000000127
   Nguyen NP, 2020, CANCERS, V12, DOI 10.3390/cancers12051287
   Norstrom T, 2016, ARCH SUICIDE RES, V20, P489, DOI 10.1080/13811118.2016.1158678
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Ogden J, 2020, PROG NEUROL PSYCHIAT, V24, P4, DOI 10.1002/pnp.670
   Optimus SBR, 2016, ADV INT CONV REP TOR ADV INT CONV REP TOR
   Pace R, 2012, INT J NURS STUD, V49, P47, DOI 10.1016/j.ijnurstu.2011.07.002
   Padala SP, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.113028
   Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282
   Possemato K, 2016, GEN HOSP PSYCHIAT, V38, P94, DOI 10.1016/j.genhosppsych.2015.09.005
   Remick RA, 2014, CAN J PSYCHIAT, V59, P220, DOI 10.1177/070674371405900407
   Rodler S, 2020, EUR UROL FOCUS, V6, P1097, DOI 10.1016/j.euf.2020.05.010
   Rodriguez-Llanes JM, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-115
   Rogers JP, 2020, LANCET PSYCHIAT, V7, P611, DOI 10.1016/S2215-0366(20)30203-0
   Rootman I., 2008, VISION HLTH LITERATE
   Rozanova J, 2020, SUBST USE MISUSE, V55, P1902, DOI 10.1080/10826084.2020.1791183
   Rozental A, 2014, INTERNET INTERV, V1, P12, DOI [10.1016/j.invent.2014.02.001, DOI 10.1016/J.INVENT.2014.02.001]
   Sanchez TH, 2020, AIDS BEHAV, V24, P2024, DOI 10.1007/s10461-020-02894-2
   Sidor A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061657
   Sockalingam S, 2020, OBESITY, V28, P1010, DOI 10.1002/oby.22836
   Soklaridis S, 2020, GEN HOSP PSYCHIAT, V66, P133, DOI 10.1016/j.genhosppsych.2020.08.007
   Spiegel B., 2020, SCI AM SCI AM
   Swerdlow DL, 2020, JAMA-J AM MED ASSOC, V323, P1129, DOI 10.1001/jama.2020.1960
   Taha S, 2014, BRIT J HEALTH PSYCH, V19, P592, DOI 10.1111/bjhp.12058
   Tapper EB, 2019, HEPATOLOGY, V70, P403, DOI 10.1002/hep.30533
   Thompson M, 2012, FRAMEWORK FACILITATE
   Umucu E, 2020, REHABIL PSYCHOL, V65, P193, DOI 10.1037/rep0000328
   Vamos S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041436
   Vanni G, 2020, IN VIVO, V34, P1651, DOI 10.21873/invivo.11957
   Waledziak M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061697
   [王琳 Wang Lin], 2020, [暨南大学学报. 自然科学与医学版, Journal of Jinan University. Natural Science & Medicine Edition], V41, P123
   Wang MY., 2020, CHIN J MULT ORGAN DI, V19, P241
   Wasserman D, 2020, WORLD PSYCHIATRY, V19, P294, DOI 10.1002/wps.20801
   Wei N, 2020, J ZHEJIANG UNIV-SC B, V21, P400, DOI 10.1631/jzus.B2010013
   Wolf MS, 2005, ARCH INTERN MED, V165, P1946, DOI 10.1001/archinte.165.17.1946
   World Health Organization Integrating the Prevention Treatment and Care of MH Conditions and Other Noncommunicable Diseases within Health Systems, 2019, WHO EUR HIGH LEV C N WHO EUR HIGH LEV C N
   Xu Haiyan, 2020, Zhongguo Fei Ai Za Zhi, V23, P247, DOI 10.3779/j.issn.1009-3419.2020.101.18
   Yuan J., 2020, MODERN ONCOL, V28, P1407
   Yuan N, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0570-y
   Zhang C., 2020, GEN NURS, V18, P965
   Zhang JL, 2020, CHINESE J MULTIPLE O, V19, P246
   Zhang Y., 2020, TUMOR PREV TREAT, V33, P106
   Zhang Y.P., 2020, J CANC CONTROL TREAT, V33, P106, DOI DOI 10.3969/J.ISSN.1674-0904.2020.02.005
   Zhao MM, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110230
   Zhao SS, 2020, CLIN RHEUMATOL, V39, P217, DOI 10.1007/s10067-019-04734-8
   Zhou J., 2020, NURS INTEGR TRADIT C, V6, P139
   Zipprich HM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061643
NR 126
TC 3
Z9 3
U1 4
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2021
VL 18
IS 14
AR 7265
DI 10.3390/ijerph18147265
PG 22
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA TO3LH
UT WOS:000676817200001
PM 34299716
OA Green Accepted, gold, Green Published
DA 2022-04-20
ER

PT J
AU Hoque, MS
   Bygvraa, DA
   Pike, K
   Hasan, MM
   Rahman, MA
   Akter, S
   Mitchell, D
   Holliday, E
AF Hoque, Md Sazedul
   Bygvraa, Despena Andrioti
   Pike, Kate
   Hasan, Md Mahmudul
   Rahman, Muhammad Arifur
   Akter, Shaida
   Mitchell, Darren
   Holliday, Eric
TI Knowledge, practice, and economic impacts of COVID-19 on small-scale
   coastal fishing communities in Bangladesh: Policy recommendations for
   improved livelihoods
SO MARINE POLICY
LA English
DT Article
DE COVID-19 Impacts; Artisanal fishers; Coastal Bangladesh; Public health
   risk; Socio-economic impacts
ID CORONAVIRUS
AB COVID-19 has profoundly impacted global livelihoods and disrupted the food supply chain, including the aquaculture and fisheries industries. Little is known about the response to COVID-19 and the impact it has on incomes, livelihoods and knowledge and practice in the coastal artisanal fishers communities of Bangladesh. Therefore, the aim of this study was to determine the socio-demographics of selected coastal fishers, their knowledge about COVID-19 and the preventive practice taken to reduce it. The impact on their fishing habits and income was also examined to determine potential policy areas. Data were collected via a structured questionnaire from 250 respondents from three coastal districts, Cox's Bazar, Patuakhali and Barguna, Bangladesh during April-June 2020. The research shows that the fishers' knowledge about COVID-19 and measures taken to reduce it were significantly higher in Patuakhali and Barguna than in Cox's Bazar. The pandemic caused lower consumer demand, reduced fish prices and created fish transportation issues due to movement restrictions enforced during the lockdown. Irrespective of geographical location, fishing trips were reduced by frequency and duration compared with the pre-COVID-19 period, consequently lowering the income of fishers. Fishers have received little or no support from private, non-governmental or governmental sources. Considering the evidence in this paper of economic hardship, this paper recommends artisanal fishers in Bangladesh should be provided with support to improve their health education, access to professional health facilities and financial services. This will contribute to improved food security and sustainable livelihoods that can better withstand local and/or global crises.
C1 [Hoque, Md Sazedul; Hasan, Md Mahmudul] Patuakhali Sci & Technol Univ, Dept Fisheries Technol, Dumki 8602, Patuakhali, Bangladesh.
   [Bygvraa, Despena Andrioti] Univ Southern Denmark, Ctr Maritime Hlth & Soc, Odense, Denmark.
   [Pike, Kate] Solent Univ, Southampton, Hants, England.
   [Rahman, Muhammad Arifur] WorldFish Bangladesh, ECOFISH Project Coxs Bazar 2, Dhaka 1213, Bangladesh.
   [Akter, Shaida] Bangabandhu Sheikh Mujibur Rahman Agr Univ, Dept Fisheries Management, Gazipur 1706, Bangladesh.
   [Hasan, Md Mahmudul; Mitchell, Darren; Holliday, Eric] FISH Safety Fdn, POB 1695, Paraparaumu Beach, Kapiti Coast, New Zealand.
RP Hoque, MS (corresponding author), Patuakhali Sci & Technol Univ, Dept Fisheries Technol, Dumki 8602, Patuakhali, Bangladesh.
EM sazedul.fst@pstu.ac.bd
OI Andrioti Bygvraa, Despena/0000-0002-9355-3004; Hoque, Md.
   Sazedul/0000-0003-4054-5980
FU Lloyd's Register Foundation, United Kingdom [GA 100307]
FX The authors would like to acknowledge the financial support from the
   fishSAFE20256 project (Phase 1, Bangladesh) primarily funded by Lloyd's
   Register Foundation (grant ID: GA 100307) , United Kingdom and the
   project team members for their combined effort. The authors are also
   thankful to all the respondents from the three different coastal
   districts of Bangladesh for their valuable responses during the data
   collection.
CR Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217
   [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Bennett NJ, 2020, COAST MANAGE, V48, P336, DOI 10.1080/08920753.2020.1766937
   Mahmood SS, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-18
   McCloskey B, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000254
   Rahman A, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8223
   The World Health Organization, 2020, 2019 NCOV OUTBR IS E
   Uddin M. N., 2020, Asian Journal of Medical and Biological Research, V6, P130, DOI 10.3329/ajmbr.v6i2.48043
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   World Health Organization, 2020, 11 WHO
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
NR 12
TC 4
Z9 4
U1 4
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-597X
EI 1872-9460
J9 MAR POLICY
JI Mar. Pol.
PD SEP
PY 2021
VL 131
AR 104647
DI 10.1016/j.marpol.2021.104647
EA JUL 2021
PG 10
WC Environmental Studies; International Relations
WE Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; International Relations
GA TY0GQ
UT WOS:000683462900005
PM 34511705
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Arani, MH
   Kalantary, RR
   Nasiri, M
   Mohammadzadeh, M
   Arani, JS
AF Arani, Mohsen Hesami
   Kalantary, Roshanak Rezaei
   Nasiri, Mehnoosh
   Mohammadzadeh, Mandiyeh
   Arani, Javad Salmani
TI COVID-19 control management in central corona hospitals using SWOT and
   QSPM matrices: A case study in Kashan central hospitals
SO ENVIRONMENTAL HEALTH ENGINEERING AND MANAGEMENT JOURNAL
LA English
DT Article
DE prioritizing strategies COVID-19; Environmental health; Hospitals;
   Research design
ID HEALTH-SERVICES; STRATEGIES; KNOWLEDGE; CHINA
AB Background: During the COVID-19 pandemic, hospitals have been the most important centers for the virus spread. Therefore, this study aimed to evaluate the management of infection control in central corona hospitals in Kashan using the quantitative strategic planning matrix (QSPM) matrix.
   Methods: The existing documents studied the strengths, weaknesses, opportunities, and threats of the organization identified by environmental health experts. The internal and external factors were identified as internal factor evaluation (IFE) and external factor evaluation (EFE) matrices, respectively, then, prioritized and weighted. In the next step, the SWOT matrix was formed and the type of used strategy by the organization was determined, and solutions to improve the current situation were presented by experts. Finally, the attractiveness table was compiled and weighted using the QSPM method to prioritize the proposed strategies.
   Results: After identifying 25 strengths, 28 weaknesses, 15 opportunities, and 13 threats, weighting was performed, the final score for internal and external factors was 2.6475 and 2.3825, respectively. The final strategy for implementing COVID-19 disease control in the studied hospitals was the Conservative Strategy (WO). Based on this, six control strategies were presented. The priority and attractiveness of each strategy were evaluated using the QSPM matrix. Finally, the strategy of "structuring the system and providing and upgrading the equipment and infrastructure facilities" was implemented as a priority.
   Conclusion: According to the results, the combination of SWOT (Strengths, Weaknesses, Opportunities, and Threats) and QSPM methods can play an efficient role in identifying and evaluating the factors affecting the management of the COVID-19 pandemic in hospitals and further developing and prioritizing control strategies for this infectious disease.
C1 [Arani, Mohsen Hesami] Iran Univ Med Sci, Student Res Comm, Tehran, Iran.
   [Arani, Mohsen Hesami] Iran Univ Med Sci, Sch Publ Hlth, Dept Environm Hlth Engn, Tehran, Iran.
   [Kalantary, Roshanak Rezaei] Iran Univ Med Sci, Res Ctr Environm Hlth Technol, Tehran, Iran.
   [Nasiri, Mehnoosh] Shahid Sadoughi Univ Med Sci, Dept Occupat Hlth & Ergon, Yazd, Iran.
   [Mohammadzadeh, Mandiyeh] Kashan Univ Med Sci, Social Determinants Hlth SDH Res Ctr, Kashan, Iran.
   [Mohammadzadeh, Mandiyeh] Kashan Univ Med Sci, Dept Environm Hlth, Kashan, Iran.
   [Arani, Javad Salmani] Kashan Univ Med Sci, Deputy Hlth, Dept Environm Hlth Engn, Kashan, Iran.
RP Mohammadzadeh, M (corresponding author), Kashan Univ Med Sci, Social Determinants Hlth SDH Res Ctr, Kashan, Iran.; Mohammadzadeh, M (corresponding author), Kashan Univ Med Sci, Dept Environm Hlth, Kashan, Iran.
EM m.mohammadzadeh997@gmail.com
RI Hesami Arani, Mohsen/ACM-4896-2022
CR Al-Sayah MH, 2020, J WATER HEALTH, V18, P843, DOI 10.2166/wh.2020.108
   An, 2020, ZHONGHUA JIE HE HE H, V43, P215, DOI DOI 10.3760/CMA.J.ISSN.1001-0939.2020.0013
   [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   [Anonymous], 2020, COR VIR DIS 2019 COV
   Anuradha S, 2019, INT ARCH PUBLIC HLTH, V3, P1, DOI [10.23937/2643-4512/1710024, DOI 10.23937/2643-4512/1710024]
   Aramesh H, 2018, J MANAG RES, V11, P109, DOI [10.22111/JMR.2018.4296, DOI 10.22111/JMR.2018.4296]
   Arshad A, 2017, INT J ADV COMPUT SC, V8, P130
   Babalola MO., 2020, U LOUISVILLE J RESP, V4, P45, DOI [10.18297/jri/vol4/iss1/45, DOI 10.18297/JRI/VOL4/ISS1/45]
   Baggiani A, 2020, INFECT CONT HOSP EP, V41, P1368, DOI 10.1017/ice.2020.177
   Basiji A., 2014, INT J SCI MANAGEMENT, V2, P252
   Brosseau LM, 2020, ANN WORK EXPOS HEAL, V64, P339, DOI 10.1093/annweh/wxaa024
   CDC, 2020, UPD INT GUID OUTBR 2
   Chang D, 2020, LANCET RESP MED, V8, pE13, DOI 10.1016/S2213-2600(20)30066-7
   Choi H, 2021, ENVIRON CHEM LETT, V19, P1945, DOI 10.1007/s10311-021-01180-4
   Cinar F, 2013, PROCD SOC BEHV, V99, P711, DOI 10.1016/j.sbspro.2013.10.542
   David ME, 2017, J STRATEG MARK, V25, P342, DOI 10.1080/0965254X.2016.1148763
   Demirkol Me, 2020, J RES NURS, V6, P341, DOI [10.5222/jaren.2020.90958, DOI 10.5222/JAREN.2020.90958]
   Fini MB, 2020, ORAL ONCOL, V105, DOI 10.1016/j.oraloncology.2020.104741
   Fuertes G, 2020, J ENG-NY, V2020, DOI 10.1155/2020/6253013
   Gomes M, 2014, PLOS CURR-TREE LIFE, DOI [10.1371/currents. outbreaks.cd818f63d40-24aef769dda7df9e0da5, DOI 10.1371/CURRENTS.OUTBREAKS.CD818F63D40-24AEF769DDA7DF9E0DA5]
   Gurel E., 2017, J INT SOC RES, DOI [10.17719/jisr.2017.1832, DOI 10.17719/JISR.2017.1832]
   Harding A, 2020, LIVE SCI
   Her M, 2020, ONE HEALTH-AMSTERDAM, V10, DOI 10.1016/j.onehlt.2020.100137
   Hesami Arani Mohsen, 2021, Toxicol Ind Health, V37, P353, DOI 10.1177/07482337211013319
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Huh S, 2020, J EDUC EVAL HEALTH P, V17, DOI 10.3352/jeehp.2020.17.10
   Ibrahim NK, 2017, J INFECT PUBLIC HEAL, V10, P438, DOI 10.1016/j.jiph.2016.06.002
   Jiang R, 2018, J CLEAN PROD, V173, P225, DOI 10.1016/j.jclepro.2017.06.147
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00254-8
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kawakami N., 2020, FEAR WORRY WORKPLACE, DOI [10.2139/ ssrn.3569887, DOI 10.2139/SSRN.3569887, 10.2139/ssrn.3569887]
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lee K, 2009, GLOB INST, P1
   Liu T., 2020, TRANSMISSION DYNAMIC, DOI 10.1101/2020.01.25.919787
   Mason DJ., 2020, JAMA HLTH FORUM, V1, DOI [10.1001/jamahealthforum.2020.0353, DOI 10.1001/JAMAHEALTHFORUM.2020.0353]
   Mutingi M, 2015, P WORLD C ENG
   Olyaeemanesh Alireza, 2018, Med J Islam Repub Iran, V32, P39, DOI 10.14196/mjiri.32.39
   Qarawi ATA, 2020, AWARENESS PREPAREDNE, DOI [10.2139/ ssrn.3550294, DOI 10.2139/SSRN.3550294]
   Rutala W.A., 2019, GUIDELINE DISINFECTI
   Saravanan A, 2021, ENVIRON CHEM LETT, V19, P189, DOI 10.1007/s10311-020-01072-z
   Setyorini H, 2017, IND JURNAL TEKNOLOGI, V5, P46, DOI [10.21776/ub.industria.2016.005.01.6, DOI 10.21776/UB.INDUSTRIA.2016.005.01.6]
   Shen HC, 2021, ENVIRON SCI TECH LET, V8, P545, DOI 10.1021/acs.estlett.1c00337
   Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y
   Totaro M, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050408
   Van Durme T, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-179
   Wahyuningsih T., 2016, WORLD J AGR RES, V4, P9, DOI [10.12691/wjar-4-1-2, DOI 10.12691/WJAR-4-1-2]
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002
   Wang J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072235
   Wang JC, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0481-y
   Wang RC, 2020, J INFECTION, V80, P354, DOI 10.1016/j.jinf.2020.01.017
   Wati N, 2016, IOSR J BUSINESS MANA, V18, P116
   WHO, 2020, RESP COVID 19 REAL
   WHO, 2020, INF PREV CONTR HLTH
   WHO, 2020, COR DIS COVID 19
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   Wijayanto D, 2016, AQUAT PR, V7, P28, DOI 10.1016/j.aqpro.2016.07.004
   World Health Organization, 2020, COR DIS COVID 19 PAN
   World Health Organization (WHO), 2020, Q A COR COV 19 INT
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu CW, 2020, INDOOR BUILT ENVIRON, V29, P639, DOI 10.1177/1420326X20910408
   Yang M, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00356
   Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1
   Yao MS, 2020, SCI TOTAL ENVIRON, V731, DOI 10.1016/j.scitotenv.2020.139178
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 65
TC 0
Z9 0
U1 0
U2 0
PU KERMAN UNIV MEDICAL SCIENCES
PI KERMAN
PA JAHAD BLVD, KERMAN, 7619813159, IRAN
SN 2423-3765
EI 2423-4311
J9 ENV HEALTH ENG MANAG
JI Environ. Health Eng. Manag.
PY 2022
VL 9
IS 1
BP 41
EP 53
DI 10.34172/EHEM.2022.06
PG 13
WC Environmental Sciences
WE Emerging Sources Citation Index (ESCI)
SC Environmental Sciences & Ecology
GA ZQ0UU
UT WOS:000766830000006
DA 2022-04-20
ER

PT J
AU Boutou, AK
   Asimakos, A
   Kortianou, E
   Vogiatzis, I
   Tzouvelekis, A
AF Boutou, Afroditi K.
   Asimakos, Andreas
   Kortianou, Eleni
   Vogiatzis, Ioannis
   Tzouvelekis, Argyris
TI Long COVID-19 Pulmonary Sequelae and Management Considerations
SO JOURNAL OF PERSONALIZED MEDICINE
LA English
DT Review
DE Post-COVID sequelae; parenchymal abnormalities; functional limitation;
   rehabilitation
ID INTERSTITIAL LUNG-DISEASE; INFECTION
AB The human coronavirus 2019 disease (COVID-19) and the associated acute respiratory distress syndrome (ARDS) are responsible for the worst global health crisis of the last century. Similarly, to previous coronaviruses leading to past pandemics, including severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS), a growing body of evidence support that a substantial minority of patients surviving the acute phase of the disease present with long-term sequelae lasting for up to 6 months following acute infection. The clinical spectrum of these manifestations is widespread across multiple organs and consists of the long-COVID-19 syndrome. The aim of the current review is to summarize the current state of knowledge on the pulmonary manifestations of the long COVID-19 syndrome including clinical symptoms, parenchymal, and functional abnormalities, as well as highlight epidemiology, risk factors, and follow-up strategies for early identification and timely therapeutic interventions. The literature data on management considerations including the role of corticosteroids and antifibrotic treatment, as well as the therapeutic potential of a structured and personalized pulmonary rehabilitation program are detailed and discussed.
C1 [Boutou, Afroditi K.] G Papanikolaou Hosp, Dept Resp Med, Thessaloniki 57010, Greece.
   [Asimakos, Andreas] Natl & Kapodistrian Univ Athens, Med Sch, Evangelismos Hosp, Crit Care Dept, Athens 10676, Greece.
   [Asimakos, Andreas] Natl & Kapodistrian Univ Athens, Med Sch, Evangelismos Hosp, Pulm Unit, Athens 10676, Greece.
   [Kortianou, Eleni] Univ Thessaly, Physiotherapy Dept, Lamia 35100, Greece.
   [Vogiatzis, Ioannis] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.
   [Tzouvelekis, Argyris] Univ Hosp Patras, Dept Resp Med, Patras 26504, Greece.
RP Tzouvelekis, A (corresponding author), Univ Hosp Patras, Dept Resp Med, Patras 26504, Greece.
EM afboutou@yahoo.com; silverakos@gmail.com; ekortianou@uth.gr;
   ioannis.vogiatzis@northumbria.ac.uk; atzouvelekis@upatras.gr
OI VOGIATZIS, IOANNIS/0000-0003-4830-7207
FU Hellenic Thoracic Society
FX This work was funded by the Hellenic Thoracic Society.
CR Ahmed H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2694
   Al Chikhanie Y, 2021, RESP PHYSIOL NEUROBI, V287, DOI 10.1016/j.resp.2021.103639
   [Anonymous], 2021, COR DIS COVID 19
   [Anonymous], INSTR CLEAN DIS ENV
   [Anonymous], 2020, COVID 19 RAP GUID MA
   Baratto C, 2021, J APPL PHYSIOL, V130, P1470, DOI 10.1152/japplphysiol.00710.2020
   Belli S, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02096-2020
   Boutou AK, 2021, INT J CLIN PRACT, DOI 10.1111/ijcp.14301
   Cano EJ, 2021, CHEST, V159, P1019, DOI 10.1016/j.chest.2020.10.054
   Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603
   Carvalho-Schneider C, 2021, CLIN MICROBIOL INFEC, V27, P258, DOI 10.1016/j.cmi.2020.09.052
   Cortes-Telles A, 2021, RESP PHYSIOL NEUROBI, V288, DOI 10.1016/j.resp.2021.103644
   Das Karuna M, 2017, Indian J Radiol Imaging, V27, P342, DOI 10.4103/ijri.IJRI_469_16
   Daynes E, 2021, THORAX, V76, P185, DOI 10.1136/thoraxjnl-2020-215916
   Distler O, 2019, NEW ENGL J MED, V380, P2518, DOI 10.1056/NEJMoa1903076
   Drake TM, 2020, AM J RESP CRIT CARE, V202, P1656, DOI 10.1164/rccm.202007-2794OC
   Evans RA., 2021, LANCET RESP MED, V9, P1275, DOI 10.1101/2021.03.22.21254057
   Flaherty KR, 2019, NEW ENGL J MED, V381, P1718, DOI 10.1056/NEJMoa1908681
   Gandotr S, 2019, ANN AM THORAC SOC, V16, P471, DOI 10.1513/AnnalsATS.201806-375OC
   Gao Y, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.04265-2020
   Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029
   George PM, 2020, THORAX, V75, P1009, DOI 10.1136/thoraxjnl-2020-215314
   George PM, 2020, LANCET RESP MED, V8, P807, DOI 10.1016/S2213-2600(20)30225-3
   Goertz YMJ, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00542-2020
   Guler SA, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03690-2020
   Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368
   Han XY, 2021, RADIOLOGY, V299, pE177, DOI 10.1148/radiol.2021203153
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
   Huang YY, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01429-6
   Hunninghake GM, 2019, THORAX, V74, P506, DOI 10.1136/thoraxjnl-2018-212446
   Karampitsakos T, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01725-9
   Karampitsakos T, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.616292
   Klok FA, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01494-2020
   Lemhofer C, 2021, J REHABIL MED, V53, DOI 10.2340/16501977-2818
   Liu K, 2020, COMPLEMENT THER CLIN, V39, DOI 10.1016/j.ctcp.2020.101166
   Liu XF, 2020, J INFECTION, V81, pE95, DOI 10.1016/j.jinf.2020.04.008
   Logue JK, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0830
   Maher TM, 2020, LANCET RESP MED, V8, P147, DOI 10.1016/S2213-2600(19)30341-8
   Mo XN, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01217-2020
   Myall KJ, 2021, ANN AM THORAC SOC, V18, P799, DOI 10.1513/AnnalsATS.202008-1002OC
   Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z
   Needham DM, 2017, AM J RESP CRIT CARE, V196, P1122, DOI 10.1164/rccm.201702-0372OC
   O'Sullivan O, 2021, CLIN MED, V21, pE68, DOI 10.7861/clinmed.2020-0204
   Prabhakar NR, 2010, RESP PHYSIOL NEUROBI, V174, P156, DOI 10.1016/j.resp.2010.08.021
   Puchner B, 2021, EUR J PHYS REHAB MED, V57, P189, DOI 10.23736/S1973-9087.21.06549-7
   Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354
   Raman B, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100683
   Rinaldo RF, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00870-2021
   Shah AS, 2021, THORAX, V76, P402, DOI 10.1136/thoraxjnl-2020-216308
   Shah W, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n136
   Sonnweber T, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03481-2020
   Spagnolo P, 2020, LANCET RESP MED, V8, P750, DOI 10.1016/S2213-2600(20)30222-8
   Spruit MA, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02197-2020
   Sun TT, 2020, EXPERT REV RESP MED, V14, P1249, DOI 10.1080/17476348.2020.1811687
   Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P841, DOI 10.15585/mmwr.mm6926e3
   Vehar S, 2021, CLEV CLIN J MED, V88, P267, DOI 10.3949/ccjm.88a.21010
   Vitacca M, 2020, MONALDI ARCH CHEST D, V90, P385, DOI 10.4081/monaldi.2020.1444
   Walker P., DELIVERING REHABILIT
   Wells AU, 2021, RADIOLOGY, V299, pE216, DOI 10.1148/radiol.2021204482
   Wong AW, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.03276-2020
   You JJ, 2020, J INFECTION, V81, pE150, DOI 10.1016/j.jinf.2020.06.003
   Zhang PX, 2020, BONE RES, V8, DOI 10.1038/s41413-020-0084-5
NR 63
TC 2
Z9 2
U1 14
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4426
J9 J PERS MED
JI J. Pers. Med.
PD SEP
PY 2021
VL 11
IS 9
AR 838
DI 10.3390/jpm11090838
PG 13
WC Health Care Sciences & Services; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; General & Internal Medicine
GA UV6QK
UT WOS:000699600100001
PM 34575615
OA Green Accepted, Green Published, gold
DA 2022-04-20
ER

PT J
AU Rodrigues, M
   Silva, R
   Franco, M
AF Rodrigues, Margarida
   Silva, Rui
   Franco, Mario
TI COVID-19: Financial Stress and Well-Being in Families
SO JOURNAL OF FAMILY ISSUES
LA English
DT Article; Early Access
DE COVID-19; families; financial stress; well-being
ID MENTAL-HEALTH; DISTRESS; UNEMPLOYMENT; RESPONSES; CRISIS; IMPACT; TIMES
AB In all areas of knowledge, research has shown the devastating effects of COVID-19, and the impact on families' financial stress and well-being is one of them. Crises are predictors of families' financial stress as they produce changes in their income and negative feelings, such as fear and demotivation, which affect well-being. This study analyses the financial and social impact of COVID-19 on families, supported by the ABCE-WB model, with data collection being the result of snowball sampling. The results obtained allow the conclusion that the current pandemic crisis has caused financial stress in families, to a greater or lesser degree, and caused feelings of fear and demotivation as consequences of the general lockdown. The empirical evidence also shows that these effects are positively associated with the perception of their level of well-being. The contribution of the study lies in corroborating the model used. Final considerations are presented together with the limitations and suggestions for future research.
C1 [Rodrigues, Margarida] Univ Beira Interior, CEFAGE UBI Res Ctr, Inst Estudos Super Fafe, Dept Management, Estr Sineiro, Covilha, Portugal.
   [Silva, Rui] Univ Tras Os Montes & Alto Douro UTAD, CETRAD, Vila Real, Portugal.
   [Franco, Mario] Univ Beira Interior, CEFAGE UBI Res Ctr, Dept Management & Econ, Estr Sineiro, P-6200209 Covilha, Portugal.
RP Franco, M (corresponding author), Univ Beira Interior, CEFAGE UBI Res Ctr, Dept Management & Econ, Estr Sineiro, P-6200209 Covilha, Portugal.
EM mfranco@ubi.pt
RI Franco, Mário/ABG-1980-2021; rodrigues, margarida/AAH-7484-2020
OI Franco, Mário/0000-0001-7818-0206; rodrigues,
   margarida/0000-0002-0997-9716
FU National Funds of the FCT - Portuguese Foundation for Science and
   Technology [UIDB/04007/2020]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   authors gratefully acknowledge financial support from National Funds of
   the FCT - Portuguese Foundation for Science and Technology within the
   project UIDB/04007/2020.
CR Alkhiary A., 2011, THESIS
   Aragao, 2013, REV PRAXIS, V3, P59, DOI [10.25119/praxis-3-6-566, DOI 10.25119/PRAXIS-3-6-566]
   Arampatzi E, 2015, APPL ECON LETT, V22, P173, DOI 10.1080/13504851.2014.931916
   Aytac IA, 2008, NEW PERSPECT TURK, P181
   Ayudhya UCN, 2019, EUR MANAG REV, V16, P847, DOI 10.1111/emre.12128
   Babbie E, 2013, PRACTICE SOCIAL RES
   Bacon-Shone, 2015, INTRO QUANTITATIVE R, DOI [10.13140/2.1.4466.3040, DOI 10.13140/2.1.4466.3040]
   Baiano C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165928
   Beland L. P., 2020, IZA DISCUSSION PAPER
   Blustein DL, 2020, J HUMANIST PSYCHOL, V60, P702, DOI 10.1177/0022167820934229
   Blustein DL, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103436
   Boss P., 2002, FAMILY STRESS MANAGE
   Brewer M, 2020, OXFORD REV ECON POL, V36, pS187, DOI 10.1093/oxrep/graa024
   Brodeur A, 2021, J ECON SURV, V35, P1007, DOI 10.1111/joes.12423
   Brown S, 2005, J ECON PSYCHOL, V26, P642, DOI 10.1016/j.joep.2005.01.002
   Burns N, 2005, PRACTICE NURSING RES
   CATALANO R, 1977, J HEALTH SOC BEHAV, V18, P292, DOI 10.2307/2136355
   Conger RD, 2010, J MARRIAGE FAM, V72, P685, DOI 10.1111/j.1741-3737.2010.00725.x
   Daks JS, 2020, J CONTEXT BEHAV SCI, V18, P16, DOI 10.1016/j.jcbs.2020.08.003
   DGS SNE, 2020, REL SIT SIT EP PORT
   ELDER GH, 1992, J FAM ISSUES, V13, P5, DOI 10.1177/019251392013001002
   European Commission, 2009, EC CRIS EUR CAUS CON, DOI [10.1371/journal.pone.0016233, DOI 10.1371/JOURNAL.PONE.0016233]
   Fonseca G, 2016, J FAM PSYCHOL, V30, P687, DOI 10.1037/fam0000230
   Frasquilho D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2720-y
   Friedline T, 2021, J FAM ECON ISS, V42, P34, DOI 10.1007/s10834-020-09694-9
   Furman J, 2020, MITIGATING COVID EC, V191
   Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035
   Giorgi G, 2015, INT J STRESS MANAGE, V22, P137, DOI 10.1037/a0038900
   Godinic D., 2020, INT J INNOV EC DEV, V6, P61, DOI DOI 10.18775/IJIED.1849-7551-7020.2015.61.2005
   Greenglass E, 2014, J BEHAV EXP ECON, V50, P10, DOI 10.1016/j.socec.2014.01.004
   HILL R, 1958, SOC CASEWORK-JCSW, V39, P139, DOI 10.1177/1044389458039002-318
   Hill R., 1949, FAMILIES STRESS ADJU
   Hill S.E., 2016, HLTH INEQUALITIES CR, P164
   ILO, 2020, COVID 19 WORLD WORK, DOI [10.18356/ba5cc386-en, DOI 10.18356/BA5CC386-EN]
   Kluge H., 2013, EUROPEAN OBSERVATORY
   Lau JTF, 2005, EMERG INFECT DIS, V11, P417
   Lee J, 2019, J PEDIATR HEALTH CAR, V33, P107, DOI 10.1016/j.pedhc.2018.09.011
   LOBIONDOWOOD G, 2002, NURSING RES METHODS
   Luechinger S, 2010, J HUM RESOUR, V45, P998, DOI 10.1353/jhr.2010.0024
   Magalhaes P., 2020, IMPACTO SOCIAL PANDE
   Martin-Carrasco M, 2016, EUR ARCH PSY CLIN N, V266, P89, DOI 10.1007/s00406-016-0681-x
   Marvasti A, 2018, CAMBRIDGE HDB SOCIAL, V1, P23, DOI [10.1017/9781108656184.003, DOI 10.1017/9781108656184.003]
   Mastropietro P, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101678
   Olafsson A, 2016, HEALTH ECON, V25, P43, DOI 10.1002/hec.3426
   PATTON MJ, 1991, J COLL STUDENT DEV, V32, P389
   Phan DHB, 2020, EMERG MARK FINANC TR, V56, P2138, DOI 10.1080/1540496X.2020.1784719
   Polit DF, 2014, ESSENTIALS NURSING R
   Qiu Y, 2020, J POPUL ECON, V33, P1127, DOI 10.1007/s00148-020-00778-2
   Rashid Tayyab., 2020, INT J WELLBEING, V10, P113, DOI [10.5502/ijw.v10i4.1441, DOI 10.5502/IJW.V10I4.1441]
   Rath T., 2010, WELLBEING 5 ESSENTIA
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Rosen C.C., 2012, RES OCCUPATIONAL STR, P131, DOI DOI 10.1108/S1479-3555(2012)0000010008
   Salameh P, 2020, PSYCHIAT RES, V294, DOI 10.1016/j.psychres.2020.113520
   Sandford A, 2020, CORONAVIRUS HALF HUM
   Santiago CD, 2011, J ECON PSYCHOL, V32, P218, DOI 10.1016/j.joep.2009.10.008
   Saraceno, 2016, REPORT 1 EPIDEMIOLOG
   Shafi Mohsin., 2020, RES GLOB, V2, DOI [10.1016/j.resglo.2020.100018, DOI 10.1016/J.RESGLO.2020.100018]
   Silva M, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796018000641
   Stein CH, 2011, J FAM PSYCHOL, V25, P449, DOI 10.1037/a0023697
   Stevenson C, 2020, J ECON PSYCHOL, V78, DOI 10.1016/j.joep.2020.102271
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   VanAkin K., 2020, SAFEGUARDING OUR LIV, V372, P11
   Venkatesh V, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102197
   Weber M, 2020, NATL BUR EC RES, DOI [10.3386/w27017, DOI 10.3386/W27017]
   White V., 2007, THESIS
   World Health Organization, 2020, COR DIS 2019 COVID 1
NR 66
TC 0
Z9 0
U1 3
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0192-513X
EI 1552-5481
J9 J FAM ISSUES
JI J. Fam. Issues
AR 0192513X211057009
DI 10.1177/0192513X211057009
EA DEC 2021
PG 22
WC Family Studies
WE Social Science Citation Index (SSCI)
SC Family Studies
GA XL1PO
UT WOS:000727923600001
OA Bronze
DA 2022-04-20
ER

PT J
AU Chigada, J
   Madzinga, R
AF Chigada, Joel
   Madzinga, Rujeko
TI Cyberattacks and threats during COVID-19: A systematic literature review
SO SOUTH AFRICAN JOURNAL OF INFORMATION MANAGEMENT
LA English
DT Review
DE cyberattacks; cyberthreats; COVID-19; information systems
   vulnerabilities; cybersecurity
AB Background: The novel Coronavirus Disease-2019 (COVID-19) pandemic, a deadly contagious disease has left the global village in disarray, driving people and firms, especially healthcare service providers to rely heavily on information communication technologies (ICTs) for administering telemedicine through digital tools. This study contributes to knowledge and information sharing and debates on cybersecurity.
   Objective: The objective was to analyse the impact of cybercrimes on the global economy at a time when the whole world is focused on fighting and minimising the spread of COVID-19. The study also analysed common cybersecurity threats, attacks and information systems security vulnerabilities during the period of the pandemic.
   Method: The study adopted a systematic literature review from December 2019 to June 2020. There are global research studies on cybersecurity issues brought about by the coronavirus pandemic, and therefore, literature survey was not limited to any geographic area. A mixed method research was adopted in this study.
   Results: The study revealed that there is an exponential growth of cyberattacks and threats because the global economy has been paying much attention to the COVID-19 pandemic. During the pandemic, large corporations, healthcare industry and government agencies have been targets for cyberattacks and threats.
   Conclusion: It has been demonstrated that cyberattacks and threats during the COVID-19 pandemic are rising exponentially, creating another wave of challenges for the global economy, which is already reeling under the novel coronavirus. Thus, exerting excessive pressure on financial and human resources that have to contend with the novel coronavirus, with the expectation that resources have to be mobilised to deal with cybercrimes. The study recommends that firms and individuals should devise cybersecurity interventions to protect their data and information systems infrastructure.
C1 [Chigada, Joel; Madzinga, Rujeko] Univ Western Cape, Fac Econ & Management Sci, Dept Informat Syst, Cape Town, South Africa.
RP Chigada, J (corresponding author), Univ Western Cape, Fac Econ & Management Sci, Dept Informat Syst, Cape Town, South Africa.
EM chigadajm@gmail.com
RI ALMEIDA, EVERTON/AAS-8705-2021
OI Madzinga, Rujeko/0000-0002-6758-6697; Chigada, Joel/0000-0002-7633-8345
CR Abukari A.M., 2020, INT J SCIENTIFIE ENG, V11, P1401
   Aldawood H., 2020, INT J SECURITY, V10, P1
   Australian Institute of Criminology, 2020, STAT B, V24
   Babbie ER, 2012, PRACTICE SOCIAL RES
   Balsom W., 2020, COVID 19 SHOWS URGEN
   Bayhack J., 2020, BIZCOMMUNITY
   Binwal P, 2015, CREATING CYBERSECURI
   Centers for Disease Control, 2020, COR DIS 2019 COVID 1
   Checkpoint Risk Intelligence, 2020, 27 APR THREAT INT B
   Chigada J., 2020, THESIS U CAPE TOWN C
   Chigada J., 2018, INT C INF RES MAN CO
   Chigada JM, 2020, S AFR J INFORM MANAG, V22, DOI 10.4102/sajim.v22i1.1194
   Chigada JM, 2017, S AFR J INFORM MANAG, V19, DOI 10.4102/sajim.v19i1.789
   Cook A., 2020, COVID 19 CO VERTICAL
   Council of Europe Cybercrime Convention Committee, 2020, PROT CONV CYB ADD ST
   Crisanto J.C., 2020, FINANCIAL CRIME TIME
   Cybersecurity Ventures, 2020, CYBERCRIME MAGA
   Da Veiga A, 2010, COMPUT SECUR, V29, P196, DOI 10.1016/j.cose.2009.09.002
   Department of Health, 2020, COVID 19 STAT
   Dewey A., 2016, INTRO SYSTEMATIC REV
   Dixon W., 2020, COVID 19 SHOWS URGEN
   Frost & Sullivan, 2016, ARTIF INTELL
   Fuentes M.R., 2020, TREND MICRO
   Ganiyu S.O., 2018, INT J INFORM SECURIT, V7, P49
   Goldberg C, 2020, CYBERSECURITY DATA P
   Gravrock E.V., 2019, HERE ARE BIGGEST CYB
   International Monetary Fund (IMF), 2020, CRIS OTH UNC REC
   International Telecommunications Union [ITU], 2020, REG CYB FOR EUR CIS
   Interpol, 2020, COVID 19 CYB
   Isa M, 2020, SA SUFFERS CYBERCRIM
   Khan N.A., 2020, 10 DEADLY CYBERSECUR
   LEDERER AL, 1986, INFORM MANAGE, V10, P245, DOI 10.1016/0378-7206(86)90027-3
   Magome M., 2020, S AFRICA SEES SHARP
   Munn Z, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0611-x
   NICD, 2020, LAT CONF CAS COVID 1
   Ohki E., 2009, P 1 ACM WORKSH INF S, P1
   Palmer D., 2020, ZDNET
   Payne G., 2004, KEY CONCEPTS SOCIAL
   PwC, 2020, IMP COVID 19 WORLD H
   Quade P, 2020, DEEP DIVE UNIVERSE C
   SABRIC, 2020, IDENTITY THEFT
   Saunders M., 2019, RES METHODS BUSINESS, V8
   Simonovich L., 2020, ARE UTILITIES DOING
   SonicWall, 2020, CYB THREAT REP
   Stein S, 2020, BLOOMBERG
   Stevens T, 2018, POLITICS GOV, V6, P1, DOI 10.17645/pag.v6i2.1569
   Stromquist NP, 2019, INT REV EDUC, V65, P321, DOI 10.1007/s11159-019-09762-9
   SwivelSecure, 2020, 9 REAS WHY HEALTHC I
   Takahashi Y, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1142
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   UNCTAD, 2019, WORLD INVESTMENT REP
   Vlachos Vasileios, 2011, Information Management & Computer Security, V19, P113, DOI 10.1108/09685221111143051
   White K., 2020, LIFE HEALTHCARE REPO
   WHO, 2021, STAT 2 M INT HLTH RE
   World Economic Forum, 2020, COVID 19 RISKS OUTL
   World Economic Forum, 2019, GLOB RISKS REP GLOB
   World Health Organization (WHO), 2020, BEW CRIM PRET BE WHO
   Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430
NR 58
TC 3
Z9 3
U1 0
U2 2
PU AOSIS
PI Durbanville
PA Postnet Suite 110, Private Bag x 19, Durbanville, SOUTH AFRICA
SN 2078-1865
EI 1560-683X
J9 S AFR J INFORM MANAG
JI S. Afr. J. Inform. Manag.
PD FEB 19
PY 2021
VL 23
IS 1
AR a1277
DI 10.4102/sajim.v23i1.1277
PG 11
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA ZH3PC
UT WOS:000760853300001
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Sharma, S
   Choudhary, L
   Kumar, PV
   Yadav, AK
   Taneja, NS
AF Sharma, Seema
   Choudhary, Laxmikant
   Kumar, Pravin, V
   Yadav, Arun Kumar
   Taneja, Nitin S.
TI KAP survey among doctors and nurses regarding methods of disinfection in
   ongoing COVID-19 pandemic
SO JOURNAL OF MARINE MEDICAL SOCIETY
LA English
DT Article
DE COVID-19; disinfection; health-care workers
AB Background: COVID-19 is a viral infectious disease caused by the most recently discovered coronavirus named as SARS-CoV-2. The disease spread from person to person through droplets discharged from the nose or mouth of a person with COVID-19 while coughing or exhaling or through fomites. Hence, disinfection methods play an important role in preventing the COVID-19, which the health-care workers must know for better prevention, control, and the management of COVID-19. Aim: The aim of this study is to assess the knowledge, attitude, and practice (KAP) among health-care workers regarding disinfection measures in an ongoing COVID-19 pandemic. Materials and Methods: The study was a cross-sectional study with a study population as health-care professional (doctors and nurses) directly or indirectly involved in COVID-19. The study conducted partly in Chennai and partly rest over the country between March 2020 and April 2020. A pretested structured questionnaire was used to collect data. Results: A total of 210 participants (87.1% doctors and 21.9% nurses) included the study. Overall, 34 (16.2%) respondents had "adequate" knowledge, "correct" attitude and "proper" practices. Statistically significant association found between occupation and level of attitude (P = 0.003); occupation and level of practice (P = 0.011); qualification and level of knowledge (P = 0.017), attitude (P = 0.002), and practice (P = 0.015); involvement in patient care and level of attitude (P = 0.039) and practice (P = 0.003); involvement in training and level of attitude (P = 0.041) and practice (P = 0.003); ever trained on disinfection and level of attitude (P = 0.036) and practice (P = 0.011). Conclusions: KAPs of health-care workers with respect to methods of disinfection in the present ongoing COVID-19 pandemic are not adequate. These gaps should be addressed through educational initiatives, training, infection control campaigns, and strict implementation of guidelines issued by the WHO, Ministry of Health and Family Welfare India, Indian Council of Medical Research, and other reliable sources.
C1 [Sharma, Seema] Stn Hlth Org, Chennai, Tamil Nadu, India.
   [Taneja, Nitin S.] Mil Hosp, Chennai, Tamil Nadu, India.
   [Choudhary, Laxmikant; Kumar, Pravin, V; Yadav, Arun Kumar] AFMC, Dept Community Med, Pune 411040, Maharashtra, India.
RP Yadav, AK (corresponding author), AFMC, Dept Community Med, Pune 411040, Maharashtra, India.
EM arunyadavpsm@gmail.com
CR Dabhade SA, 2017, J MED SCI CLIN RES, V5, P19267
   Diab SM, 2017, INT J BUS MANAGE, V5
   GOI, 2020, DET QUEST ANSW COVID
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Keita M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5444-3
   Knause BF, 1916, AM J PUBLIC HEALTH, V6, P364, DOI 10.2105/AJPH.6.4.364
   Masaadeh H. A., 2009, American Journal of Applied Sciences, V6, P811
   Memon MS, 2015, PAK J MED SCI, V31, P183, DOI 10.12669/pjms.311.6317
   Rutala WA, 2013, AM J INFECT CONTROL, V41, pS2, DOI 10.1016/j.ajic.2012.11.005
   The Health Foundation, 2012, EV SCAN
NR 10
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0975-3605
EI 2589-1235
J9 J MAR MED SOC
JI J. Mar. Med. Soc.
PD NOV
PY 2020
VL 22
IS 3
SI SI
BP 62
EP 65
DI 10.4103/jmms.jmms_60_20
PG 4
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA PA7EE
UT WOS:000595793200012
OA gold
DA 2022-04-20
ER

PT J
AU Abasimel, NA
   Fufa, HW
AF Abasimel, Nasir Ababulgu
   Fufa, Hika Wana
TI The Horrors of COVID-19 and the Recent Macroeconomy in Ethiopia
SO JOURNAL OF THE KNOWLEDGE ECONOMY
LA English
DT Article
DE COVID-19; Macro-economy; Fiscal and monetary economics; Ethiopia
AB This review paper is emphasized on COVID-19 and macro-economy like GDP, unemployment, inflation and macro-economic policy in Ethiopia. The COVID-19 pandemic represents an unprecedented global crisis. Even if the spread of COVID-19 is suppressed in Africa, its economic damage will be unavoidable. In spite of the fact that COVID-19 was less expanded during the last 3 months, the Ethiopia economy showed a significant shock and drastically reduced in major macroeconomic variables. A 25-30% drop in exports of goods and services during 2020 is possible.COVID-19 will have a two-fold fiscal impact, pulling in opposite directions. Hence, there is a need to re-bounce back the economy while keeping our peoples safe from the pandemic, COVID-19.
C1 [Abasimel, Nasir Ababulgu] Wollega Univ, Dept Agribusiness & Value Chain Management, POB 395, Nekemte, Ethiopia.
   [Fufa, Hika Wana] Wollega Univ, Dept Agr Econ, POB 395, Nekemte, Ethiopia.
RP Abasimel, NA (corresponding author), Wollega Univ, Dept Agribusiness & Value Chain Management, POB 395, Nekemte, Ethiopia.
EM nasirababulgu@gmail.com; wanahika@gmail.com
RI WANA, HIKA/AAL-1652-2021
OI Ababulgu, Nasir/0000-0002-3978-9286
CR Bhagava A, 2001, J HEALTH ECON, V20, P423, DOI 10.1016/S0167-6296(01)00073-X
   Bloom DE, 1998, BROOKINGS PAP ECO AC, P207, DOI 10.2307/2534695
   Burton, 2020, COVID 19 PANDEMIC RE
   CEPHEUS, 2020, RES AN MACR IMP COR
   Data from JCC. World Bank Ethiopia, 2019, PATH EFF STABL FIN S
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   EY,, 2018, FDI ATTR PROGR AFR
   Federal Democratic Republic of Ethiopia,, 2020, COVID 19 EC IMP RESP
   Geda, 2020, COVID 19 DAMAGE ETHI
   Macro research Ethiopia, 2020, MACR  IMP COR VIR PR
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   National Bank of Ethiopia (NBE), 2019, ANN REP 2018 19 2019
   UNCTAD, 2019, WORLD INVESTMENT REP
   United Nations Ethiopia, 2020, ON ASS SOC IMP ETH
   Wit VD, 2005, ERD POLICY BRIEF SER, V42
NR 15
TC 4
Z9 4
U1 7
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1868-7865
EI 1868-7873
J9 J KNOWL ECON
JI J. Knowl. Econ.
PD MAR
PY 2022
VL 13
IS 1
BP 305
EP 320
DI 10.1007/s13132-020-00713-6
EA JAN 2021
PG 16
WC Economics
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA ZS2OB
UT WOS:000608094900002
OA Bronze
DA 2022-04-20
ER

PT J
AU Le, HT
   Nguyen, TTP
   Jacinto, C
   Nguyen, CT
   Vu, LG
   Nguyen, HT
   Le Vu, MN
   Le, XTT
   Nguyen, TT
   Pham, QT
   Ta, NTK
   Nguyen, QT
   Latkin, CA
   Ho, CSH
   Ho, RCM
AF Huong Thi Le
   Thao Thi Phuong Nguyen
   Jacinto, Corey
   Cuong Tat Nguyen
   Linh Gia Vu
   Hien Thu Nguyen
   Minh Ngoc Le Vu
   Xuan Thi Thanh Le
   Thao Thanh Nguyen
   Quan Thi Pham
   Nhung Thi Kim Ta
   Quynh Thi Nguyen
   Latkin, Carl A.
   Ho, Cyrus S. H.
   Ho, Roger C. M.
TI Factors Associated with Community Awareness on COVID-19 in a Developing
   Country: Implications for Optimal Risk Communication
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19 epidemic; risk communication; awareness generation; preventive
   measures; Vietnam
ID CHI MINH CITY; HEALTH; VACCINATION; MANAGEMENT; KNOWLEDGE
AB Purpose: New COVID-19 variants pose great challenges in protecting the success of vaccination programs. Awareness of community becomes an important component to prevent the spread of COVID-19. This study aims to analyze people's awareness of COVID-19 and identify the implications for optimal risk communication in Vietnam. Study Methods and Materials: A total of 341 individuals participated in an online cross-sectional study. Community awareness on COVID-19 was examined by using a structured questionnaire. Multivariable Tobit regression was used to examine associated factors with community awareness. Results: Our results indicated high levels of awareness of local COVID-19 situation, transmission risks, and preventive behavioral practices during the first week of social isolation. Higher awareness of local pandemic situation was associated with female respondents (Coef.: 6.19; 95% CI: 0.51; 11.87) and larger family sizes of above 5 people (Coef.: 9.00; -1.00; 19.00). Respondents between 35-44 years old were shown to be less aware of preventive behavioral practices than other age groups, including the group of participants above 44 years old (Coef.: -0.34; 95% CI: -0.67; -0.02). Lastly, participants who were "fairly satisfied" with information resources had awareness levels of preventive behavioral practices lower than that of "unsatisfied" respondents (Coef.: -0.45; 95% CI: 0.74; -0.16). Conclusion: This study offers crucial insights into the pandemic awareness of citizens and risk communication effectiveness during COVID-19 in Vietnam. The study findings shall serve the development of policies and interventions aimed at empowering individuals in the local and global fight against coronavirus.
C1 [Huong Thi Le; Xuan Thi Thanh Le; Thao Thanh Nguyen; Quan Thi Pham; Nhung Thi Kim Ta; Quynh Thi Nguyen] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.
   [Thao Thi Phuong Nguyen; Cuong Tat Nguyen; Linh Gia Vu; Hien Thu Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam.
   [Thao Thi Phuong Nguyen; Cuong Tat Nguyen; Linh Gia Vu; Hien Thu Nguyen] Duy Tan Univ, Fac Med, Da Nang, Vietnam.
   [Jacinto, Corey] Univ Calif Los Angeles, Dept Hlth Policy & Management, Los Angeles, CA USA.
   [Minh Ngoc Le Vu] Inst Hlth Econ & Technol, Hanoi, Vietnam.
   [Latkin, Carl A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Ho, Cyrus S. H.; Ho, Roger C. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore.
   [Ho, Cyrus S. H.] Natl Univ Hlth Syst, Dept Psychol Med, Singapore, Singapore.
   [Ho, Roger C. M.] Natl Univ Singapore, Inst Hlth Innovat & Technol iHealthtech, Singapore, Singapore.
RP Nguyen, CT (corresponding author), Duy Tan Univ, 254 Nguyen Van Linh St, Da Nang 550000, Vietnam.
EM nguyentatcuong@duytan.edu.vn
FU Vingroup Joint Stock Company (Vingroup JSC); Vingroup; Vingroup
   Innovation Foundation (VINIF) [VINIF. 2020.COVID-19. DA03]; NUS
   Department of Psychological Medicine
   [R-177-000-100-001/R-177-000-003-001/R177000702733]; NUS iHeathtech
   Other Operating Expenses [R-722-000-004-731]
FX This study received funding from Vingroup Joint Stock Company (Vingroup
   JSC) , Vingroup and was supported by Vingroup Innovation Foundation
   (VINIF) under project code VINIF. 2020.COVID-19. DA03. The funder was
   not involved in the study design, collection, analysis, interpretation
   of data, the writing of this article or the decision to submit it for
   publication. All authors declare no other competing interests.
   Publication fee for the manuscript was funded by the NUS Department of
   Psychological Medicine
   (R-177-000-100-001/R-177-000-003-001/R177000702733) ; and NUS iHeathtech
   Other Operating Expenses (R-722-000-004-731).
CR Abbas J, 2021, FRONT PSYCHIATRY, V12, P1732
   Abbas J, 2021, RISK MANAG HEALTHC P, V14, P1917, DOI 10.2147/RMHP.S284313
   Akhtar N, 2021, SAGE OPEN, V11, DOI 10.1177/21582440211057127
   Alahdal H, 2020, J INFECT PUBLIC HEAL, V13, P1446, DOI 10.1016/j.jiph.2020.06.015
   Albarrak AI, 2021, J INFECT PUBLIC HEAL, V14, P89, DOI 10.1016/j.jiph.2019.06.029
   Amodan BO, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238810
   [Anonymous], 2021, TUOI TRE NEWS 0519
   [Anonymous], 2021, VN EXPRESS INT 0305
   Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.571689
   Aqeel M, 2022, INT J HUM RIGHTS HEA, V15, P17, DOI 10.1108/IJHRH-10-2020-0095
   Azizi MR, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e07233
   Centers for Disease Control and Prevention, 2021, VAR VIR CAUS COVID 1
   Ek S, 2015, HEALTH PROMOT INT, V30, P736, DOI 10.1093/heapro/dat063
   Francis AI, 2021, POSTGRAD MED J, DOI 10.1136/postgradmedj-2021-140654
   Gebretsadik D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246154
   Huynh G, 2021, RISK MANAG HEALTHC P, V14, P2517, DOI 10.2147/RMHP.S301645
   Huynh G, 2021, INFECT DRUG RESIST, V14, P1773, DOI 10.2147/IDR.S308446
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Hooker C, 2020, J BIOETHIC INQ, V17, P581, DOI 10.1007/s11673-020-10057-0
   Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396
   Ivic S, 2020, ASIAN BIOETHICS REV, V12, P341, DOI 10.1007/s41649-020-00134-2
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Li J, 2021, FRONT PSYCHOL, V13, P5280
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Mahase E., 2021, COVID 19 ARE WE VACC
   Maqsood A., 2021, CURR RES BEHAV SCI, V2, P100011, DOI [10.1016/j.crbeha.2020.100011, DOI 10.1016/J.CRBEHA.2020.100011]
   NeJhaddadgar N, 2022, J PUBLIC HEALTH-HEID, V30, P1301, DOI 10.1007/s10389-020-01407-8
   Nguyen TTP, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.589872
   Nguyen THD, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101651
   Rice RE, 2009, COMMUN SER, P436
   Rimal RN, 2009, B WORLD HEALTH ORGAN, V87, P247, DOI 10.2471/BLT.08.056713
   Rossmann C., 2017, INT ENCY MEDIA EFFEC, P1
   Shuja KH, 2020, INT J GERIATR PSYCH, V35, P1477, DOI 10.1002/gps.5423
   Su ZH, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9091024
   Symonds E, 2011, LIBR HI TECH, V29, P436, DOI 10.1108/07378831111174404
   Tam LT, 2021, GLOB J FLEX SYST MAN, V22, P45, DOI 10.1007/s40171-021-00269-7
   Trevisan M, 2020, COVID 19 PANDEMIC VI
   Umakanthan S, 2021, AIMS PUBLIC HEALTH, V8, P665, DOI 10.3934/publichealth.2021053
   Umakanthan S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101064
   Umakanthan S, 2021, AIMS PUBLIC HEALTH, V8, P137, DOI 10.3934/publichealth.2021011
   Umakanthan S, 2020, POSTGRAD MED J, V96, P753, DOI 10.1136/postgradmedj-2020-138234
   University JH, CORONAVIRUS COVID 19
   Nguyen HV, 2021, J EVAL CLIN PRACT, V27, P325, DOI 10.1111/jep.13416
   La VP, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072931
   Vietnam Ministry of Health, 2020, INF COVID 19 EP
   Vietnam Ministry of Health, 2020, WAR COVID 19 START N
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   WHO (World Health Organization), 2020, COR DIS COVID 19 OUT
   World Health Organization, 2021, 31 WHO
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Lebni JY, 2021, INT J SOC PSYCHIATR, V67, P298, DOI 10.1177/0020764020939984
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 53
TC 0
Z9 0
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2022
VL 15
BP 415
EP 426
DI 10.2147/RMHP.S356690
PG 12
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA ZV0OP
UT WOS:000770235600002
PM 35300278
OA Green Published
DA 2022-04-20
ER

PT J
AU Clunie, GM
   Bolton, L
   Lovell, L
   Bradley, E
   Bond, C
   Bennington, S
   Roe, J
AF Clunie, Gemma M.
   Bolton, Lee
   Lovell, Lindsay
   Bradley, Elizabeth
   Bond, Cara
   Bennington, Sarah
   Roe, Justin
TI Considerations for speech and language therapy management of dysphagia
   in patients who are critically ill with COVID-19: a single centre case
   series
SO INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION
LA English
DT Article
DE COVID-19; Deglutition; Deglutition disorders; Dysphagia; Tracheostomy
ID INTENSIVE-CARE-UNIT; FIBEROPTIC ENDOSCOPIC EVALUATION; ENDOTRACHEAL
   INTUBATION; CHIN TUCK; ASPIRATION; SCALE; TRACHEOSTOMY; EXERCISE;
   DIAGNOSIS; STROKE
AB Background/Aims Patients treated with intubation and tracheostomy for COVID-19 infection are at risk of increased incidence of laryngeal injury, dysphagia and dysphonia. Because of the novelty of the SARS-CoV-2 virus, little is known about the type of dysphagia patients experience as a result of infection and critical illness. The aim of this case series report was to progress understanding of COVID-19 and dysphagia following admission to an intensive care unit and to guide speech and language therapy clinical practice in the ongoing pandemic.
   Methods A retrospective case review was conducted of all patients at Imperial College Healthcare NHS Trust, London who underwent a tracheostomy because of COVID-19 and received an instrumental assessment of swallowing in the early stages of the pandemic.
   Results A total of 11 patients were identified, and descriptive statistics were used to present demographic data, with a narrative account of their dysphagia profile used to describe presentation. Causes and presentation of dysphagia were heterogenous, with each patient requiring individualised clinical management to maximise outcome. A positive trend was seen in terms of recovery trajectory and progressing to oral intake.
   Conclusions This study reports on early experience of the presentation of dysphagia in patients with COVID-19 and demonstrates the value of instrumental assessment. It indicates the need for further research to consolidate knowledge and guide clinical practice.
C1 [Clunie, Gemma M.; Bolton, Lee; Lovell, Lindsay; Bradley, Elizabeth; Bond, Cara; Bennington, Sarah; Roe, Justin] Imperial Coll Healthcare NHS Trust, Speech & Language Therapy Dept, London, England.
   [Clunie, Gemma M.; Roe, Justin] Imperial Coll London, Dept Surg & Canc, London, England.
RP Clunie, GM (corresponding author), Imperial Coll Healthcare NHS Trust, Speech & Language Therapy Dept, London, England.; Clunie, GM (corresponding author), Imperial Coll London, Dept Surg & Canc, London, England.
EM gemmaclunie@nhs.net
OI Clunie, Gemma/0000-0002-1796-731X
FU NIHR Imperial Biomedical Research Centre
FX The authors acknowledge the support and infrastructure provided by the
   NIHR Imperial Biomedical Research Centre.
CR Adly A, 2018, EUR ARCH OTO-RHINO-L, V275, P679, DOI 10.1007/s00405-017-4838-7
   Aoyagi Y, 2020, DYSPHAGIA, V35, P545, DOI 10.1007/s00455-020-10140-z
   Atkinson K, 2018, BR J NEUROSCI NURS, V14, pS13, DOI [10.12968/bjnn. 2018.14.Sup2.S13, DOI 10.12968/BJNN.2018.14.SUP2.S13]
   Bergstresser SM, 2015, INT J FEM APPROACHES, V8, P204
   Bolton L, 2020, INT J LANG COMM DIS, V55, P629, DOI 10.1111/1460-6984.12544
   Brodsky MB, 2020, INTENS CARE MED, V46, P93, DOI 10.1007/s00134-019-05865-x
   Brodsky MB, 2018, CRIT CARE MED, V46, P2010, DOI 10.1097/CCM.0000000000003368
   Byeon Haewon, 2016, J Phys Ther Sci, V28, P2069, DOI 10.1589/jpts.28.2069
   Carda S, 2020, ANN PHYS REHABIL MED, V63, P554, DOI 10.1016/j.rehab.2020.04.001
   Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603
   Cariati Paolo, 2016, J Med Case Rep, V10, P23, DOI 10.1186/s13256-016-0802-1
   Cavalagli A, 2020, EUR J PHYS REHAB MED, V56, P853, DOI 10.23736/S1973-9087.20.06452-7
   Clark HM, 2014, DYSPHAGIA, V29, P553, DOI 10.1007/s00455-014-9544-7
   Coninckx M, 2015, ACTA NEUROL BELG, V115, P533, DOI 10.1007/s13760-015-0500-6
   Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049
   Dawson C, 2020, J LARYNGOL OTOL, V134, P981, DOI 10.1017/S0022215120002443
   Decavel P, 2020, NEUROLOGY, V95, P312, DOI 10.1212/WNL.0000000000010011
   Doeltgen SH, 2011, AM J SPEECH-LANG PAT, V20, P124, DOI 10.1044/1058-0360(2011/10-0067)
   Dziewas R, 2020, EUR J NEUROL, V27, pE46, DOI 10.1111/ene.14367
   Dziewas Rainer, 2021, Neurol Res Pract, V3, P23, DOI 10.1186/s42466-021-00122-3
   Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0
   Ghannouchi I, 2016, RESP MED, V117, P54, DOI 10.1016/j.rmed.2016.05.024
   Ghelichkhani P, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.674
   Gillman A, 2017, DYSPHAGIA, V32, P345, DOI 10.1007/s00455-016-9761-3
   Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0
   Hafner G, 2008, EUR ARCH OTO-RHINO-L, V265, P441, DOI 10.1007/s00405-007-0507-6
   Hiss SG, 2003, LARYNGOSCOPE, V113, P1386, DOI 10.1097/00005537-200308000-00023
   Hutcheson KA, 2017, CANCER-AM CANCER SOC, V123, P62, DOI 10.1002/cncr.30283
   Intensive Care National Audit and Research Centre, 2021, ICNARC REP COVID 19
   Langmore SE, 2015, INT J SPEECH-LANG PA, V17, P222, DOI 10.3109/17549507.2015.1024171
   Lazenby-Paterson T, 2020, CURR OPIN OTOLARYNGO, V28, P145, DOI 10.1097/MOO.0000000000000622
   Maas Matthew B, 2020, Continuum (Minneap Minn), V26, P675, DOI 10.1212/CON.0000000000000869
   McCullough GH, 2012, TOP STROKE REHABIL, V19, P234, DOI 10.1310/tsr1903-234
   McGrath BA, 2020, ANAESTHESIA, V75, P972, DOI 10.1111/anae.15092
   McGrath BA, 2020, LANCET RESP MED, V8, P717, DOI 10.1016/S2213-2600(20)30230-7
   McGrath BA, 2014, CURR OPIN OTOLARYNGO, V22, P181, DOI 10.1097/MOO.0000000000000046
   McRae Jackie, 2020, J Intensive Care Soc, V21, P344, DOI 10.1177/1751143719875687
   Miles A, 2019, INT J SPEECH-LANG PA, V21, P377, DOI 10.1080/17549507.2018.1458901
   Miles A, 2018, INT J LANG COMM DIS, V53, P909, DOI 10.1111/1460-6984.12401
   Montalvan V, 2020, CLIN NEUROL NEUROSUR, V194, DOI 10.1016/j.clineuro.2020.105921
   Nativ-Zeltzer N, 2018, LARYNGOSCOPE, V128, P327, DOI 10.1002/lary.26698
   Neubauer PD, 2015, DYSPHAGIA, V30, P521, DOI 10.1007/s00455-015-9631-4
   O'Horo JC, 2015, J HOSP MED, V10, P256, DOI 10.1002/jhm.2313
   O'Kane Lisa, 2009, Rev. CEFAC, V11, P449
   Park HS, 2019, INT J LANG COMM DIS, V54, P479, DOI 10.1111/1460-6984.12453
   Park JS, 2021, J ORAL REHABIL, V48, P968, DOI 10.1111/joor.13181
   Park JS, 2018, NEUROREHABILITATION, V42, P191, DOI 10.3233/NRE-172250
   Piazza C, 2021, EUR ARCH OTO-RHINO-L, V278, P1, DOI 10.1007/s00405-020-06112-6
   Roberts CM, 2020, BRIT J ANAESTH, V125, P238, DOI 10.1016/j.bja.2020.06.013
   Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897
   Royal College of Speech and Language Therapists, 2020, SPEECH LANG THER LED
   Samudrala PK, 2020, EUR J PHARMACOL, V883, DOI 10.1016/j.ejphar.2020.173375
   Shaker R, 2002, GASTROENTEROLOGY, V122, P1314, DOI 10.1053/gast.2002.32999
   Skoretz SA, 2020, DYSPHAGIA, V35, P935, DOI 10.1007/s00455-020-10115-0
   Skoretz SA, 2010, CHEST, V137, P665, DOI 10.1378/chest.09-1823
   Steele CM, 2018, ARCH PHYS MED REHAB, V99, P934, DOI 10.1016/j.apmr.2018.01.012
   Steele CM, 2017, DYSPHAGIA, V32, P601, DOI 10.1007/s00455-017-9809-z
   Steele CM, 2014, DYSPHAGIA, V29, P295, DOI 10.1007/s00455-014-9516-y
   Tolep K, 1996, CHEST, V109, P167, DOI 10.1378/chest.109.1.167
   Vergara J, 2020, AM J SPEECH-LANG PAT, V29, P2242, DOI 10.1044/2020_AJSLP-20-00163
   Wirth R, 2016, CLIN INTERV AGING, V11, P189, DOI 10.2147/CIA.S97481
   Yatim N, 2021, CLIN NEUROPHYSIOL, V132, P505, DOI 10.1016/j.clinph.2020.12.007
   Yoon WL, 2014, DYSPHAGIA, V29, P243, DOI 10.1007/s00455-013-9502-9
   Zuercher P, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2400-2
NR 64
TC 0
Z9 0
U1 0
U2 0
PU MARK ALLEN GROUP
PI LONDON
PA ST JUDES CHURCH, DULWICH RD, LONDON, SE24 0PB, ENGLAND
SN 1741-1645
EI 1759-779X
J9 INT J THER REHABIL
JI Int. J. Ther. Rehabil.
PD FEB 2
PY 2022
VL 29
IS 2
DI 10.12968/ijtr.2021.0078
PG 13
WC Rehabilitation
WE Emerging Sources Citation Index (ESCI)
SC Rehabilitation
GA ZK9KE
UT WOS:000763300100004
DA 2022-04-20
ER

PT J
AU Kanno, M
AF Kanno, Masayasu
TI Risk contagion of COVID-19 in Japanese firms: A network approach
SO RESEARCH IN INTERNATIONAL BUSINESS AND FINANCE
LA English
DT Article
DE COVID-19; Risk contagion; Susceptible-infected-recovered-dead (SIRD)
   model; Correlation-based network; Stock market; Net cash
ID SYSTEMIC RISK
AB The novel coronavirus disease (COVID-19) is one of the worst pandemics in human history. Our research objective is to assess the contagion effect on Japanese firms and to evaluate the Japanese government's COVID-19 measures during the period from April 7, 2020, to May 25, 2020. We propose a susceptible-infected-recovered-dead model for COVID-19 and derive COVID-19 parameters for Japan. Subsequently, we analyze the effect of COVID-19 on Japanese firms through correlation-based network and credit risk analyses. The main findings are that the Tokyo Stock Price Index moved in the opposite direction of COVID-19 parameters and COVID-19 parameters are almost the only risk factors that impact a firm's credit risk during the period. Finally, we find that the interconnection analysis between the COVID-19 infection network and the financial networks contribute to the existing pandemic risk management knowledge.
C1 [Kanno, Masayasu] Nihon Univ, Coll Commerce, 5-2-1 Setagaya, Tokyo 1578570, Japan.
RP Kanno, M (corresponding author), Nihon Univ, Coll Commerce, 5-2-1 Setagaya, Tokyo 1578570, Japan.
EM kanno.masayasu@nihon-u.ac.jp
RI Kanno, Masayasu/AAW-6079-2021
OI Kanno, Masayasu/0000-0002-5904-0424
FU Japan Society for the Promotion of Science (JSPS)KAKENHIMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [JP17K03813, JP20K01754]; KAMPO Foundation
FX This study was supported by the Japan Society for the Promotion of
   Science (JSPS)KAKENHI Grant-in-Aid for Scientific Research [grant
   numbers JP17K03813, JP20K01754] and the FY2020 Research Grant from KAMPO
   Foundation. These assistances are sincerely appreciated.
CR Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405
   Andersen R., 2008, MODERN METHODS ROBUS
   ANDERSON R M, 1991
   [Anonymous], 2013, SCALE FREE NETWORKS
   Ashraf BN, 2020, RES INT BUS FINANC, V54, DOI 10.1016/j.ribaf.2020.101249
   Brauer F., 2019, MATH MODELS EPIDEMIO
   Caccavo D, 2020, SIRD MODEL COVID 19
   Conlon T, 2020, RES INT BUS FINANC, V54, DOI 10.1016/j.ribaf.2020.101248
   Contreras S, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110087
   Goodell JW, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101512
   Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1
   Kanno M, 2021, RES INT BUS FINANC, V58, DOI 10.1016/j.ribaf.2021.101488
   Kanno M, 2015, J RISK FINANC, V16, P554, DOI 10.1108/JRF-11-2014-0170
   Kanno M, 2015, JPN WORLD ECON, V36, P102, DOI 10.1016/j.japwor.2015.10.001
   Kanno M, 2015, J FINANC STABIL, V20, P105, DOI 10.1016/j.jfs.2015.08.006
   Kleinbaum DG, 2010, LOGISTIC REGRESSION
   Lagoarde-Segot T, 2013, J BANK FINANC, V37, P4574, DOI 10.1016/j.jbankfin.2013.04.004
   Narayan PK, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101732
   National Institute of Infectious Diseases Japan (NIID), 2020, REPORT SUMMARY DIAMO
   Posch P.N, 2011, CREDIT RISK MODELING
   Simon P.L, 2018, MATH EPIDEMICS NETWO
   Trueck S, 2009, ACAD PR ADV FINANC S, P1
   Vynnycky E, 2010, INTRO INFECT DIS MOD
   World Health Organization, 2020, WHO COR DIS COVID 19
   Zhang DY, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101528
NR 25
TC 1
Z9 1
U1 12
U2 17
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0275-5319
EI 1878-3384
J9 RES INT BUS FINANC
JI Res. Int. Bus. Financ.
PD DEC
PY 2021
VL 58
AR 101491
DI 10.1016/j.ribaf.2021.101491
EA JUL 2021
PG 18
WC Business, Finance
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA UX1AU
UT WOS:000700580700007
PM 34248246
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Sezer, R
   Esendagli, D
   Erol, C
   Hekimoglu, K
AF Sezer, Rahime
   Esendagli, Dorina
   Erol, Cigdem
   Hekimoglu, Koray
TI New challenges for management of COVID-19 patients: Analysis of MDCT
   based "Automated pneumonia analysis program"
SO EUROPEAN JOURNAL OF RADIOLOGY OPEN
LA English
DT Article
DE COVID-19 pneumonia; Automated pneumonia analysis; Pneumonic scoring
ID CT
AB Purpose: The aim of this study is to define the role of an "Automated Multi Detector Computed Tomography (MDCT) Pneumonia Analysis Program" as an early outcome predictor for COVID-19 pneumonia in hospitalized patients.
   Materials and Methods: A total of 96 patients who had RT-PCR proven COVID-19 pneumonia diagnosed by non contrast enhanced chest MDCT and hospitalized were enrolled in this retrospective study. An automated CT pneumonia analysis program was used for each patient to see the extent of disease. Patients were divided into two clinical subgroups upon their clinical status as good and bad clinical course. Total opacity scores (TOS), intensive care unit (ICU) entry, and mortality rates were measured for each clinical subgroups and also laboratory values were used to compare each subgroup.
   Results: Left lower lobe was the mostly effected side with a percentage of 78.12 % and followed up by right lower lobe with 73.95 %. TOS, ICU entry, and mortality rates were higher in bad clinical course subgroup. TOS values were also higher in patients older than 60 years and in patients with comorbidities including, Hypertension (HT), Diabetes Mellitus (DM), Chronic Obstructive Pulmonary Disease (COPD), Chronic Heart Failure (CHF) and malignancy.
   Conclusion: Automated MDCT analysis programs for pneumonia are fast and an objective way to define the disease extent in COVID-19 pneumonia and it is highly correlated with the disease severity and clinical outcome thus providing physicians with valuable knowledge from the time of diagnosis.
C1 [Sezer, Rahime; Hekimoglu, Koray] Baskent Univ, Fac Med, Dept Radiol, Maresal Fevzi Cakmak Cd 45, TR-06490 Ankara, Turkey.
   [Esendagli, Dorina] Baskent Univ, Fac Med, Dept Chest Dis, Ankara, Turkey.
   [Erol, Cigdem] Baskent Univ, Fac Med, Dept Infect Dis, Ankara, Turkey.
RP Sezer, R (corresponding author), Baskent Univ, Fac Med, Dept Radiol, Maresal Fevzi Cakmak Cd 45, TR-06490 Ankara, Turkey.
EM rahime.sezer@gmail.com
RI ESENDAĞLI, Dorina/ABF-9398-2020; Erol, Çiğdem/AAJ-1219-2021
OI ESENDAĞLI, Dorina/0000-0002-6619-2952; Erol, Çiğdem/0000-0002-2535-2534
CR Adams HJA, 2020, CHEST, V158, P1885, DOI 10.1016/j.chest.2020.06.025
   Chaganti S, QUANTIFICATION TOMOG
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   Dawoud MM, 2020, EGYPT J RADIOL NUC M, V51, DOI 10.1186/s43055-020-00359-z
   Francone M, 2020, EUR RADIOL, V30, P6808, DOI 10.1007/s00330-020-07033-y
   Franquet T, 2011, RADIOLOGY, V260, P18, DOI 10.1148/radiol.11092149
   Guan W-J, 2020, NEW ENGL J MED
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Kanne JP, 2020, RADIOLOGY, V295, P16, DOI 10.1148/radiol.2020200241
   Kim Hyungjin, 2020, Radiology, V296, pE145, DOI 10.1148/radiol.2020201343
   Koo HJ, 2018, RADIOGRAPHICS, V38, P719, DOI 10.1148/rg.2018170048
   Larici AR, 2021, EUR J RADIOL, V144, DOI 10.1016/j.ejrad.2021.109983
   Lei JQ, 2020, RADIOLOGY, V295, P18, DOI 10.1148/radiol.2020200236
   Malpani Dhoot N., 2020, BJR OPEN, V2, P20200024, DOI 10.1259/bjro.20200024
   Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7
   Mohamed IAI, 2021, EGYPT J RADIOL NUC M, V52, DOI 10.1186/s43055-020-00385-x
   Ng Ming-Yen, 2020, Radiol Cardiothorac Imaging, V2, pe200034, DOI 10.1148/ryct.2020200034
   Pan YY, 2020, EUR RADIOL, V30, P3306, DOI 10.1007/s00330-020-06731-x
   Sabri YY, 2020, EGYPT J RADIOL NUC M, V51, DOI 10.1186/s43055-020-00351-7
   Song Y, 2021, NEURORADIOLOGY, V63, P267, DOI 10.1007/s00234-020-02537-2
   Sultan OM, 2020, EGYPT J RADIOL NUC M, V51, DOI 10.1186/s43055-020-00223-0
   Ufuk F, 2021, DIAGN INTERV RADIOL, V27, P164, DOI 10.5152/dir.2020.20281
   Xia Xintian, 2020, Nan Fang Yi Ke Da Xue Xue Bao, V40, P333, DOI 10.12122/j.issn.1673-4254.2020.03.06
   Yang Q, 2020, EUR J RADIOL, V127, DOI 10.1016/j.ejrad.2020.109008
   Yang Ran, 2020, Radiol Cardiothorac Imaging, V2, pe200047, DOI 10.1148/ryct.2020200047
   Zhu JY, 2020, J MED VIROL, V92, P891, DOI 10.1002/jmv.25910
   Zitek T, 2020, WEST J EMERG MED, V21, P470, DOI 10.5811/westjem.2020.4.47370
NR 27
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2352-0477
J9 EUR J RADIOL OPEN
JI Eur. J. Radiol. Open
PY 2021
VL 8
AR 100370
DI 10.1016/j.ejro.2021.100370
EA JUL 2021
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
WE Emerging Sources Citation Index (ESCI)
SC Radiology, Nuclear Medicine & Medical Imaging
GA WB5KT
UT WOS:000703611300013
PM 34307790
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ramya, SM
   Baral, R
AF Ramya, S. M.
   Baral, Rupashree
TI CSR during COVID-19: exploring select organizations' intents and
   activities
SO CORPORATE GOVERNANCE-THE INTERNATIONAL JOURNAL OF BUSINESS IN SOCIETY
LA English
DT Article
DE Corporate social responsibility; COVID-19; Pandemic; India;
   Organizational practices; Paradox
ID CORPORATE SOCIAL-RESPONSIBILITY; SHORT-TERMISM; SUSTAINABILITY;
   MANAGEMENT; COMMITMENT; MODEL
AB Purpose
   This paper aims to explore the immediate proactive corporate social responsibility (CSR) efforts undertaken by select organizations in India in response to the coronavirus (COVID-19) pandemic and the approach they have adopted toward it.
   Design/methodology/approach
   Semi-structured interviews were conducted with 27 senior managers across top Bombay Stock Exchange indexed organizations from the manufacturing and services sector in India during the national COVID-19 pandemic lockdown between March and June 2020. Manual content analysis and the Gioia method were used to arrive at the insights.
   Findings
   Results of the analysis showcase the spirited immediate CSR measures undertaken by the select organizations in the broader interests of the community at large. The study also highlights the need for a paradox approach toward CSR strategy.
   Research limitations/implications
   Given that the present study adopts an exploratory qualitative research design, the scope for generalization is rather limited.
   Practical implications
   This paper classifies COVID-19 related initiatives undertaken by selected few top organizations in India and attempts to justify the need to opt for a paradox approach toward CSR strategy.
   Originality/value
   To the best of the author's knowledge, this is one of the first few studies to have attempted to put forth a dialog at the intersection of COVID-19 and CSR with rich insights gained from qualitative data collected during India's intense lockdown period and offering a different perspective with the inclusion of paradox theory into the discussion.
C1 [Ramya, S. M.; Baral, Rupashree] Indian Inst Technol Madras, Dept Management Studies, Chennai, Tamil Nadu, India.
RP Ramya, SM (corresponding author), Indian Inst Technol Madras, Dept Management Studies, Chennai, Tamil Nadu, India.
EM sm.ramya12@gmail.com
OI Ramya, S.M./0000-0002-1588-6970
FU Exploratory Research Proposal (ERP) grant from Indian Institute of
   Technology, Madras
FX The authors gratefully acknowledge the financial support from
   Exploratory Research Proposal (ERP) grant from Indian Institute of
   Technology, Madras.
CR Adegbite E, 2020, CORP GOV-INT J BUS S, V20, P797, DOI 10.1108/CG-12-2019-0389
   Agnihotri A, 2015, CORP GOV-INT J BUS S, V15, P678, DOI 10.1108/CG-05-2014-0057
   Aguinis H, 2020, MANAG RES, V18, P421, DOI 10.1108/MRJIAM-06-2020-1053
   Aguinis H, 2012, J MANAGE, V38, P932, DOI 10.1177/0149206311436079
   Ahmad R, 2020, EMPL RELAT, V42, P232, DOI 10.1108/ER-04-2018-0105
   Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2
   Amankwah-Amoah J, 2020, J CLEAN PROD, V271, DOI 10.1016/j.jclepro.2020.123000
   Antwi H.A., 2020, COVID 19 PANDEMIC SY, P1, DOI [10.21203/rs.3.rs-40212/v1, DOI 10.21203/RS.3.RS-40212/V1]
   Bae KH, 2021, J CORP FINANC, V67, DOI 10.1016/j.jcorpfin.2020.101876
   Bansal P, 2018, ACAD MANAGE REV, V43, P217, DOI 10.5465/amr.2014.0238
   Bansal P, 2014, STRATEG ORGAN, V12, P70, DOI 10.1177/1476127013520265
   Bapuji H, 2020, J MANAGE, V46, P1205, DOI 10.1177/0149206320925881
   Baral R., 2020, SUSTAINABILITY BUSIN, V4, P99, DOI [10.1108/S2514-175920200000004006, DOI 10.1108/S2514-175920200000004006]
   Barbier EB, 2020, WORLD DEV, V135, DOI 10.1016/j.worlddev.2020.105082
   Beattie V., 2004, ACCOUNT FORUM, V28, P205, DOI [10.1016/j.accfor.2004.07.001, DOI 10.1016/J.ACCFOR.2004.07.001]
   Bhattacharyya SS, 2020, INT J SOCIOL SOC POL, V40, P1551, DOI 10.1108/IJSSP-12-2019-0263
   Business Standard News, 2020, BUSINESS STANDARD NE
   Christensen LT, 2020, J BUS RES, V114, P327, DOI 10.1016/j.jbusres.2019.07.020
   Crane A, 2021, J MANAGE STUD, V58, P278, DOI 10.1111/joms.12642
   Economic Times, 2020, EC TIMES
   Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x
   Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633
   Fahad P, 2021, CORP GOV-INT J BUS S, V21, P553, DOI 10.1108/CG-05-2020-0201
   Fatma M, 2020, INT J ORGAN ANAL, V28, P941, DOI 10.1108/IJOA-10-2019-1895
   Filimonau V, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102659
   Francis NN, 2020, EXTRACT IND SOC, V7, P576, DOI 10.1016/j.exis.2020.04.007
   Gaudencio P, 2017, J MANAG DEV, V36, P478, DOI 10.1108/JMD-02-2016-0026
   Gioia DA, 2013, ORGAN RES METHODS, V16, P15, DOI 10.1177/1094428112452151
   Government of India, 2020, PM CARES FUND EM DIS
   Ham CD, 2019, J BUS ETHICS, V158, P353, DOI 10.1007/s10551-017-3706-0
   Hamid S, 2020, CORP GOV-INT J BUS S, V20, P365, DOI 10.1108/CG-10-2018-0317
   He HW, 2020, J BUS RES, V116, P176, DOI 10.1016/j.jbusres.2020.05.030
   HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513
   Hosoda M, 2021, CORP GOV-INT J BUS S, V21, P397, DOI 10.1108/CG-06-2020-0238
   Hoy C., 2020, PRECARITY PANDEMIC C, DOI DOI 10.35188/UNU-WIDER/2020/834-4
   Hur WM, 2020, CORP SOC RESP ENV MA, V27, P1878, DOI 10.1002/csr.1933
   Ike M, 2019, J CLEAN PROD, V216, P139, DOI 10.1016/j.jclepro.2019.01.151
   Im J, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102701
   Ivory SB, 2018, J BUS ETHICS, V148, P347, DOI 10.1007/s10551-017-3583-6
   Iyengar KP, 2021, POSTGRAD MED J, V97, P471, DOI 10.1136/postgradmedj-2020-138454
   Jose A, 2007, J BUS ETHICS, V72, P307, DOI 10.1007/s10551-006-9172-8
   Joseph J, 2020, J BUS ETHICS, V164, P349, DOI 10.1007/s10551-018-4065-1
   Kim H.K, 2009, PUBLIC RELAT J, V3, P1
   Kowszyk Y, 2021, CORP GOV-INT J BUS S, V21, P279, DOI 10.1108/CG-01-2020-0038
   Laverty KJ, 1996, ACAD MANAGE REV, V21, P825, DOI 10.2307/259003
   Levine, 2020, CORPORATE IMMUNITY C
   Lodh S, 2014, CORP GOV-OXFORD, V22, P4, DOI 10.1111/corg.12034
   Lopez-Carril S, 2020, INT J SPORT COMMUN, V13, P447, DOI 10.1123/ijsc.2020-0230
   Luo BN, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.579272
   Manogna RL, 2021, J ASIA BUS STUD, V15, P345, DOI 10.1108/JABS-12-2019-0361
   Manral, 2021, INDIAS COVID 19 TALL
   Mao Y, 2021, CURR ISSUES TOUR, V24, P2716, DOI 10.1080/13683500.2020.1770706
   Gonzalez-Gonzalez JM, 2019, J ORGAN CHANGE MANAG, V32, P2, DOI 10.1108/JOCM-01-2018-0018
   Mattera M, 2021, CORP GOV-INT J BUS S, V21, P1100, DOI 10.1108/CG-07-2020-0309
   Miller SR, 2020, J BUS ETHICS, V163, P619, DOI 10.1007/s10551-018-4057-1
   Miron-Spektor E, 2018, ACAD MANAGE J, V61, P26, DOI 10.5465/amj.2016.0594
   Nag T, 2016, GLOB BUS REV, V17, P1427, DOI 10.1177/0972150916653032
   Podgorodnichenko N, 2020, HUM RESOUR MANAGE R, V30, DOI 10.1016/j.hrmr.2019.04.001
   Ramya SM, 2021, MANAGE DECIS, V59, P719, DOI 10.1108/MD-01-2019-0061
   Ramya SM, 2020, SOC RESPONSIB J, V16, P843, DOI 10.1108/SRJ-11-2019-0376
   Rim H, 2020, INT J BUS COMMUN, V57, P545, DOI 10.1177/2329488417719835
   Sardana D, 2020, J CLEAN PROD, V258, DOI 10.1016/j.jclepro.2020.120766
   Scheepers, 2020, 10 EMERALD EMERGING, P1, DOI [10.1108/EEMCS-05-2020-0167, DOI 10.1108/EEMCS-05-2020-0167]
   Siltaloppi J, 2021, J BUS ETHICS, V174, P507, DOI 10.1007/s10551-020-04569-3
   Sinha, 2020, CONTRIBUTIONS PM CAR
   Slawinski N, 2017, BUS SOC, V56, P253, DOI 10.1177/0007650315576136
   Slawinski N, 2015, ORGAN SCI, V26, P531, DOI 10.1287/orsc.2014.0960
   Slawinski N, 2012, ORGAN STUD, V33, P1537, DOI 10.1177/0170840612463319
   Smith WK, 2011, ACAD MANAGE REV, V36, P381, DOI 10.5465/AMR.2011.59330958
   Stacchezzini R, 2016, J CLEAN PROD, V136, P102, DOI 10.1016/j.jclepro.2016.01.109
   STARIK M, 1995, J BUS ETHICS, V14, P207, DOI 10.1007/BF00881435
   Susi V, 2020, CORP GOV-INT J BUS S, V20, P703, DOI 10.1108/CG-11-2019-0348
   Tao WT, 2020, PUBLIC RELAT REV, V46, DOI 10.1016/j.pubrev.2020.101883
   Vishwanathan P, 2020, J MANAGE STUD, V57, P314, DOI 10.1111/joms.12514
   WHO, 2020, NOV COR 2019 NCOV SI
NR 75
TC 3
Z9 3
U1 5
U2 12
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1472-0701
EI 1758-6054
J9 CORP GOV-INT J BUS S
JI Corp. Gov.-Int. J. Bus. Soc.
PD SEP 22
PY 2021
VL 21
IS 6
SI SI
BP 1028
EP 1042
DI 10.1108/CG-09-2020-0426
EA JUN 2021
PG 15
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA US4PQ
UT WOS:000658640200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Adekoya, CO
   Fasae, JK
AF Adekoya, Clement Ola
   Fasae, Joseph Kehinde
TI Social media and the spread of COVID-19 infodemic
SO GLOBAL KNOWLEDGE MEMORY AND COMMUNICATION
LA English
DT Article
DE Nigeria; Social media; Social media platform; Misinformation;
   Misleading; Pandemic; COVID-19; Infodemic; Rumours; Verified information
AB Purpose - The purpose of this paper is to investigate the social media application and the spread of COVID-19 infodemic in Nigeria.
   Design/methodology/approach - A descriptive survey research design was used for this study. A total of 1,200 social media users, regardless of their professions, were randomly selected for the study betweenmid-June and July 2020. Stratified and purposive sampling techniques were used for this study. The questionnaire was designed using Google form and administered using WhatsApp and Telegram to social media users above 18 years old in Nigeria. The data generated was analyzed using descriptive (frequency count) and inferential (mean) statistics, and was presented in tables.
   Findings - It was found that people make use of social media during COVID-19 pandemic for diverse reasons such as listening to announcement to be informed, knowing the necessary measures to take by those infected and spreading up-to-date information on the pandemic. Social media tools were highly used during the COVID-19 pandemic, especially WhatsApp and Zoom. Findings reflected that misinformation was spread on social media. This study also showed that the infodemic associated with COVID-19 is managed by confirming the source of the information before sharing it and trusting information from reliable sources.
   Research limitations/implications - The result of this research will contribute to the body of knowledge on social media application, fake news and the spread of COVID-19 infodemic in Nigeria and beyond.
   Practical implications - Infodemic is a disaster in the health sector. The spread of infodemic is capable of misleading people, losing trust in government, health providers and health regulatory authorities. This study will help social media users to know how to properly manage social media infodemic during a pandemic or any health-related situations.
   Originality/value - This study is novel as it approaches fake news from a COVID-19 perspective. Very few articles emanate from the developing countries in this area. This was because most of the narrative around fake news previously centered around the Western occurrences such as the Iraqi invasion by the USA, the US presidential elections and BREXIT. COVID-19 has demonstrated that the developing world is not immune from fake news as well. This study, therefore, assessed the management of infodemic associated with COVID-19 in Nigeria.
C1 [Adekoya, Clement Ola] Fed Univ Technol Akure, Albert Ilemobade Lib, Akure, Nigeria.
   [Fasae, Joseph Kehinde] Afe Babalola Univ, Univ Lib, Ado Ekiti, Nigeria.
RP Fasae, JK (corresponding author), Afe Babalola Univ, Univ Lib, Ado Ekiti, Nigeria.
EM kennyfash2000@gmail.com
RI Fasae, Joseph Kehinde/C-8056-2014
OI Fasae, Joseph Kehinde/0000-0003-4383-8594
CR Ahmad AR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19556
   [Anonymous], 2020, UNNEWS
   Baines R., 2020, LONDON SCH EC POLITI
   Brennen J. S., 2020, TYPES SOURCES CLAIMS
   Cinelli Matteo, 2020, Sci Rep, V10, P16598, DOI 10.1038/s41598-020-73510-5
   Clement J., 2020, SOCIAL MEDIA USED US, DOI [1112995/social-media-platforms-usa-coronavirus/, DOI 1112995/SOCIAL-MEDIA-PLATFORMS-USA-CORONAVIRUS]
   Eke H.N., 2014, USE SOCIAL NETWORKIN
   Ezeah G.H., 2013, IOSR J HUMANITIES SO, V16, P23, DOI DOI 10.9790/0837-1632332
   Federal Ministry of Budget and National Planning, 2020, MINISTERIAL PRESS ST
   Ferri C., 2020, ASS PROGRESSIVE COMM
   Gregory J., 2020, STAT-US
   Griffin D., 2020, CONVERSATION
   Hua JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072309
   Jin K.X., 2020, FACEBOOK NEWSROOM WE
   Lima DL, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1953
   Lipfert K., 2020, FAKE NEWS CORONAVIRU
   Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P2011, DOI 10.1001/jama.2020.4469
   Mickle D., 2020, DIFFERENT THREAT INF
   NCDC, 2020, 1 CASE CORONA VIRUS
   Ndoro T., 2020, IHARARENEWS BLOG
   Okoro N., 2013, GLOBAL J ARTS HUMANI, V1, P29
   Olan R., 2020, INFECT DIS POVERTY, V9, DOI [10.1186/s40249-020-006501-1, DOI 10.1186/S40249-020-006501-1]
   Pan American Health Organization, 2020, UNDERSTANDING INFODE
   Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054
   Pulido CM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072430
   Reid A., 2020, 1 DRAFT ONLINE
   Swale Y., 2020, PANDEMIC INFODEMIC C
   Tan, 2020, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.20.255695, DOI 10.2471/BLT.20.255695]
   UNESCO Abuja Office, 2020, CREDIBLE SOURCES VAC
   United Nations Africa Renewal, 2020, EC DEV MAUR SEN S AF
   Vanguard, 2020, VANGUARD NEWS NIGERI
   Victor D, 2020, PANIC CRITICISM SPRE
   World Health Organisation, 2020, NOV COR 2019 NCOV SI
   World Health Organization Regional Office for Africa [WHO-AFRO], 2020, PREVENTIONWEB NEWS
   Zarocostas J, 2020, LANCET, V395, P259, DOI 10.1016/S0140-6736(20)30153-7
   Zurayk R, 2020, J AGRIC FOOD SYST CO, V9, P17, DOI 10.5304/jafscd.2020.093.014
NR 36
TC 0
Z9 0
U1 33
U2 55
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2514-9342
EI 2514-9350
J9 GLOB KNOWL MEM COMMU
JI Glob. Knowl. Mem. Commun.
PD MAR 3
PY 2022
VL 71
IS 3
BP 105
EP 120
DI 10.1108/GKMC-11-2020-0165
EA APR 2021
PG 16
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA ZO6DG
UT WOS:000638804200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Favilli, A
   Gentili, MM
   Raspa, F
   Giardina, I
   Parazzini, F
   Vitagliano, A
   Borisova, AV
   Gerli, S
AF Favilli, Alessandro
   Mattei Gentili, Marta
   Raspa, Francesca
   Giardina, Irene
   Parazzini, Fabio
   Vitagliano, Amerigo
   Borisova, Anna V.
   Gerli, Sandro
TI Effectiveness and safety of available treatments for COVID-19 during
   pregnancy: a critical review
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Review; Early Access
DE COVID-19; SARS-CoV-2; pregnancy; therapy
ID RESPIRATORY SYNDROME CORONAVIRUS; CONVALESCENT PLASMA; INFLAMMATORY
   CYTOKINES; INTERFERON-BETA; ILL PATIENTS; LUNG INJURY;
   LOPINAVIR/RITONAVIR; PIOGLITAZONE; EXPOSURE; OUTCOMES
AB Background: COVID-19 is a pandemic disease caused by the SARS-CoV-2 and it spread globally in the last few months. The complete lack of specific treatment forced clinicians to use old drugs, chosen for their efficacy against similar viruses or theirin vitroactivity. Trials on patients are ongoing but the majority of information comes from small case series and single center reports. We aimed to provide a literature review on the putative effectiveness and safety of available treatments for COVID-19 in pregnant women. Methods: We reviewed all the available literature concerning the drugs that have been used in the treatment of COVID-19 during pregnancy and whose safe assumption during pregnancy had been demonstrated by clinical studies (i.e. including studies on other infectious diseases). Drugs contra-indicated during pregnancy or with unknown adverse effects were not included in our review. Results and conclusions: Clinical trials are not often conducted among pregnant patients for safety reasons and this means that drugs that may be effective in general population cannot be used for pregnant women due to the lack of knowledge of side effects in this category of people .The choice to use a specific drug for COVID-19 in pregnancy should take into account benefits and possible adverse events in each single case. In the current situation of uncertainty and poor knowledge about the management of COVID-19 during pregnancy, this present overview may provide useful information for physicians with practical implications.
C1 [Favilli, Alessandro] AOUI Verona, Dept Obstet & Gynecol, Verona, Italy.
   [Mattei Gentili, Marta; Raspa, Francesca; Giardina, Irene; Gerli, Sandro] Univ Perugia, Ctr Perinatal & Reprod Med, Dept Surg & Biochem Sci, I-06156 Perugia, Italy.
   [Parazzini, Fabio] Univ Milan, Dipartimento Sci Clin & Comunita, Osped Maggiore Policlin, Fdn IRCCS Ca Granda,Dipartimento Maternoinfantil, Milan, Italy.
   [Vitagliano, Amerigo] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy.
   [Borisova, Anna V.] RUDN Univ, Peoples Friendship Univ Russia, Dept Obstet & Gynecol Course Perinatol, Moscow, Russia.
RP Gerli, S (corresponding author), Univ Perugia, Ctr Perinatal & Reprod Med, Dept Surg & Biochem Sci, I-06156 Perugia, Italy.
EM sandro.gerli@unipg.it
RI Borisova, Anna/AAD-1904-2019; Favilli, Alessandro/B-5269-2011
OI Favilli, Alessandro/0000-0002-1556-0962; Borisova,
   Anna/0000-0003-4716-2886; parazzini, fabio/0000-0001-5624-4854; GERLI,
   Sandro Francesco/0000-0003-1082-3062
FU Peoples' Friendship University of Russia University Program 5-100
FX This publication was prepared with the support of the Peoples'
   Friendship University of Russia University Program 5-100.
CR Alfaraj SH, 2019, J MICROBIOL IMMUNOL, V52, P501, DOI 10.1016/j.jmii.2018.04.005
   Anesi G L, CORONAVIRUS DIS 2019
   Martinez MA, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00399-20
   [Anonymous], 2020, CHINESE MED J-PEKING, V133, P1087, DOI 10.1097/CM9.0000000000000819
   [Anonymous], 2005, CEFTR DRUG APPR PACK
   [Anonymous], 2010, ACT DRUG APPR PACK
   [Anonymous], 2000, AM DRUG APPR PACK
   [Anonymous], 2020, COR COVID 19 UPD CHL
   [Anonymous], 2006, AZ DRUG APPR PACK
   Aoki Y, 2009, RESPIRATION, V77, P311, DOI 10.1159/000168676
   Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC
   Assiri A, 2016, CLIN INFECT DIS, V63, P951, DOI 10.1093/cid/ciw412
   Barbarin V, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-112
   Beigel JH, 2019, ANTIVIR RES, V167, P45, DOI 10.1016/j.antiviral.2019.04.006
   Brojeni PY, 2012, REPROD TOXICOL, V33, P265, DOI 10.1016/j.reprotox.2011.11.003
   Burnouf T, 2016, NEW ENGL J MED, V374, P2499, DOI 10.1056/NEJMc1602284
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   CAO B, 2020, SEVERE 2019 NCOV REM
   CAO B, 2020, MILD MODERATE 2019 N
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chen L, 2020, LANCET INFECT DIS, V20, P398, DOI 10.1016/S1473-3099(20)30141-9
   Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9
   Colbers A, 2013, CURR OPIN INFECT DIS, V26, P575, DOI 10.1097/QCO.0000000000000017
   COLSON P, 2020, INT J ANTIMICROB AG, V55, DOI [10.1016/j.ijantimicag.2020.105932, DOI 10.1016/J.IJANTIMICAG.2020.105932]
   Costantine MM, 2020, OBSTET GYNECOL, V136, P26, DOI [10.1097/A0G.0000000000003924, 10.1097/AOG.0000000000003924]
   da Silva JC, 2013, CLINICS, V68, P766, DOI 10.6061/clinics/2013(06)07
   Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Di Renzo GC, 2020, AM J OBSTET GYNECOL, V20, P30465
   Dong LY, 2020, DRUG DISCOV THER, V14, P58, DOI 10.5582/ddt.2020.01012
   Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117
   FDA, COR COVID 19 UPD FDA
   Fedson DS, 2013, ANTIVIR RES, V99, P417, DOI 10.1016/j.antiviral.2013.06.018
   Gilbert C, 2006, FERTIL STERIL, V86, P658, DOI 10.1016/j.fertnstert.2006.02.098
   Gisanddata, GIS
   Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056
   Hanada S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02640
   Hart BJ, 2014, J GEN VIROL, V95, P571, DOI 10.1099/vir.0.061911-0
   Hellwig K, 2020, J NEUROL, V267, P1715, DOI 10.1007/s00415-020-09762-y
   Hiratsuka M, 2000, J PERINAT MED, V28, P372, DOI 10.1515/JPM.2000.047
   Hoeltzenbein M, 2016, SEMIN ARTHRITIS RHEU, V46, P238, DOI 10.1016/j.semarthrit.2016.05.004
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Kakoulidis I, 2020, DIABETES METAB SYND, V14, P519, DOI 10.1016/j.dsx.2020.04.045
   Kalil AC, 2020, JAMA-J AM MED ASSOC, V323, P1897, DOI 10.1001/jama.2020.4742
   Karalis DG, 2016, J CLIN LIPIDOL, V10, P1081, DOI 10.1016/j.jacl.2016.07.002
   Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085
   Keyaerts E, 2009, ANTIMICROB AGENTS CH, V53, P3416, DOI 10.1128/AAC.01509-08
   KLUMPP TG, 1965, J AMER MED ASSOC, V191, P765, DOI 10.1001/jama.1965.03080090079027
   Koss CA, 2014, JAIDS-J ACQ IMM DEF, V67, P128, DOI 10.1097/QAI.0000000000000281
   Kutsukake M, 2014, J SURG RES, V189, P295, DOI 10.1016/j.jss.2014.03.007
   LaCourse SM, 2020, CLIN INFECT DIS, V71, P879, DOI 10.1093/cid/ciaa444
   Lazzaroni MG, 2016, J AUTOIMMUN, V74, P106, DOI 10.1016/j.jaut.2016.06.016
   Lexicomp Inc, 2016, HYDR
   Li CC, 2019, DRUG DISCOV TODAY, V24, P726, DOI 10.1016/j.drudis.2019.01.018
   Li GX, 2015, ARCH GYNECOL OBSTET, V292, P111, DOI 10.1007/s00404-014-3566-0
   Li L, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00661-z
   Li N, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa352, 10.1101/2020.03.10.20033605, DOI 10.1093/CID/CIAA352]
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liang H, 2020, ACTA OBSTET GYN SCAN, V99, P439, DOI 10.1111/aogs.13836
   Loutfy MR, 2003, JAMA-J AM MED ASSOC, V290, P3222, DOI 10.1001/jama.290.24.3222
   Mantlo E, 2020, ANTIVIR RES, V179, DOI 10.1016/j.antiviral.2020.104811
   Many A, 2005, CAN FAM PHYSICIAN, V51, P199
   Moriguchi H, 2003, LANCET, V362, P1159, DOI 10.1016/S0140-6736(03)14484-4
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   Nakajima K, 2016, MOD RHEUMATOL, V26, P667, DOI 10.3109/14397595.2016.1147405
   Ota H, 2008, FERTIL STERIL, V90, P709, DOI 10.1016/j.fertnstert.2007.01.117
   Parazzini F, 2020, INT J GYNECOL OBSTET, V150, P41, DOI 10.1002/ijgo.13166
   Plantone D, 2018, CLIN DRUG INVEST, V38, P653, DOI 10.1007/s40261-018-0656-y
   Pollack PS, 2005, BIRTH DEFECTS RES A, V73, P888, DOI 10.1002/bdra.20181
   Poon LC, 2020, INT J GYNECOL OBSTET, V149, P273, DOI 10.1002/ijgo.13156
   Qiu D, 2015, INT J CLIN PHARM TH, V53, P746, DOI 10.5414/CP202339
   Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017
   RCOG, 2020, COR COVID 19 INF PRE
   Roberts SS, 2009, JAIDS-J ACQ IMM DEF, V51, P456, DOI 10.1097/QAI.0b013e3181a2813f
   Romero RS, 2015, J NEUROL NEUROSUR PS, V86, P587, DOI 10.1136/jnnp-2014-308113
   Sakamoto A, 2012, EUR J PHARMACOL, V682, P131, DOI 10.1016/j.ejphar.2012.02.027
   Sallard E, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104791
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Shalhoub S, 2015, J ANTIMICROB CHEMOTH, V70, P2129, DOI 10.1093/jac/dkv085
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   Soo YOY, 2004, CLIN MICROBIOL INFEC, V10, P676, DOI 10.1111/j.1469-0691.2004.00956.x
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Thiel S, 2016, MULT SCLER J, V22, P801, DOI 10.1177/1352458516634872
   van der Lee M, 2007, ANTIVIR THER, V12, P1127
   van Griensven J, 2016, NEW ENGL J MED, V375, P2307, DOI 10.1056/NEJMc1609116
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Weber-Schoendorfer C, 2016, REPROD TOXICOL, V60, P29, DOI 10.1016/j.reprotox.2016.01.002
   Wong SF, 2004, AM J OBSTET GYNECOL, V191, P292, DOI 10.1016/j.ajog.2003.11.019
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xie X, 2018, INT J OBESITY, V42, P213, DOI 10.1038/ijo.2017.192
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Yao TT, 2020, J MED VIROL, V92, P556, DOI 10.1002/jmv.25729
   Yaris F, 2004, REPROD TOXICOL, V18, P619, DOI 10.1016/j.reprotox.2004.02.014
   Zhang WY, 2008, ARTERIOSCL THROM VAS, V28, P2312, DOI 10.1161/ATVBAHA.108.175687
   Zhao XX, 2020, EUR J CLIN MICROBIOL, V39, P1209, DOI 10.1007/s10096-020-03897-6
   Zhou CG, 2020, J MATERN-FETAL NEO M, V19, P1, DOI DOI 10.1080/14767058.2020.1763951
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
   Zumla A, 2015, INT J INFECT DIS, V40, P71, DOI 10.1016/j.ijid.2015.09.005
NR 105
TC 15
Z9 18
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
DI 10.1080/14767058.2020.1774875
EA JUN 2020
PG 14
WC Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology
GA MC8ZG
UT WOS:000543567000001
PM 32508168
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Bisceglia, I
   Gabrielli, D
   Canale, ML
   Gallucci, G
   Parrini, I
   Turazza, FM
   Russo, G
   Maurea, N
   Quagliariello, V
   Lestuzzi, C
   Oliva, S
   Di Fusco, SA
   Luca, F
   Tarantini, L
   Trambaiolo, P
   Gulizia, MM
   Colivicchi, F
AF Bisceglia, Irma
   Gabrielli, Domenico
   Canale, Maria Laura
   Gallucci, Giuseppina
   Parrini, Iris
   Turazza, Fabio Maria
   Russo, Giulia
   Maurea, Nicola
   Quagliariello, Vincenzo
   Lestuzzi, Chiara
   Oliva, Stefano
   Di Fusco, Stefania Angela
   Luca, Fabiana
   Tarantini, Luigi
   Trambaiolo, Paolo
   Gulizia, Michele Massimo
   Colivicchi, Furio
TI Position paper ANMCO: Cardio-oncologia in era COVID-19
SO GIORNALE ITALIANO DI CARDIOLOGIA
LA English
DT Article
DE Biomarkers; Cancer; Cardio-oncology; Cardiovascular disease;
   Cardiovascular imaging; COVID-19; SARS-CoV-2; Telehealth
ID ATRIAL-FIBRILLATION; CANCER-PATIENTS; INDUCED CARDIOTOXICITY;
   DRUG-INTERACTIONS; AMERICAN SOCIETY; RISK-FACTORS; DISEASE; MANAGEMENT;
   OUTCOMES; CORONAVIRUS
AB The COVID-19 pandemic and its impact on patients with cancer and cardiovascular disease have confirmed the particular vulnerability of this population. Indeed, not only a higher risk of contracting the infection has been reported, but also an increased occurrence of a more severe course and unfavorable outcome. Beyond the direct consequences of COVID-19, the pandemic has an enormous impact on global health systems. Screening programs and non-urgent tests have been postponed; clinical trials have suffered a setback. Similarly, in the area of cardiology care, a significant decline in ST-elevation myocardial infarction accesses and an increase in cases of late presenting heart attacks with increased mortality and complication rates have been reported. Health care systems must therefore get ready to tackle the "rebound effect" that will likely show a relative increase in the short and medium term incidence of diseases such as heart failure, myocardial infarction, arrhythmias and cardio- and cerebrovascular complications. Scientific societies are taking action to provide general guidance and recommendations aimed at mitigating the unfavorable outcomes of this pandemic emergency. Cardio-oncology, as an emerging discipline, is more flexible in modulating care pathways and represents a beacon of innovation in the development of multi-specialty patient management. In the era of the COVID-19 pandemic, cardio-oncology has rapidly modified its clinical care pathways and implemented flexible monitoring protocols that include targeted use of cardiac imaging, increased use of biomarkers, and telemedicine systems. The goal of these strategic adjustments is to minimize the risk of infection for providers and patients while maintaining standards of care for the treatment of oncologic and cardiovascular diseases. The aim of this position paper is to evaluate the impact of the COVID-19 pandemic on the management of cardio-oncologic patients with the-state-of-the-art knowledge about SARS-CoV-2 and COVID-19 in order to optimize medical strategies during and after the pandemic.
C1 [Bisceglia, Irma] Azienda Osped San Camillo Forlanini, Dipartimento Cardiotoracovasc, Servizi Cardiol Integrati, Circonvallaz Gianicolense 87, I-00152 Rome, Italy.
   [Gabrielli, Domenico] Azienda Osped San Camillo Forlanini, Dipartimento Cardiotoracovasc, UOC Cardiol, Rome, Italy.
   [Canale, Maria Laura] Osped Versilia, UOC Cardiol, Lido Di Camaiore, LU, Italy.
   [Gallucci, Giuseppina] Ctr Riferimento Oncol Basilicata CROB IRCCS, Cardiol, Rionero In Vulture, PZ, Italy.
   [Parrini, Iris] Osped Mauriziano Umberto 1, SC Cardiol, Turin, Italy.
   [Turazza, Fabio Maria] Fdn IRCCS, Ist Nazl Tumori, SC Cardiol, Milan, Italy.
   [Russo, Giulia] Azienda Sanit Univ Giuliano Isontina ASUGI, SC Cardiovasc & Med Sport, Trieste, Italy.
   [Maurea, Nicola; Quagliariello, Vincenzo] Fdn G Pascale, IRCCS, Ist Nazl Tumori, SC Cardiol, Naples, Italy.
   [Lestuzzi, Chiara] Azienda Sanit Friuli Occidentale ASFO, Ctr Riferimento Oncol CRO Aviano, Riabilitaz Cardiol & Cardiooncol, Pordenone, Italy.
   [Oliva, Stefano] Ist Tumori Giovanni Paolo II, IRCCS, UOSD Cardiol, Bari, Italy.
   [Di Fusco, Stefania Angela; Colivicchi, Furio] Presidio Osped San Filippo Neri ASL Roma 1, UOC Cardiol Clin & Riabilitat, Rome, Italy.
   [Luca, Fabiana] Grande Osped Metropolitano Bianchi Melacrino More, Presidio Osped Riuniti, Cardiol UTIC, Reggio Di Calabria, Italy.
   [Tarantini, Luigi] Presidio Osped Santa Maria Nuova AUSL RE, IRCCS, SOC Cardiol Osped, Reggio Emilia, Italy.
   [Trambaiolo, Paolo] Presidio Osped Sandro Pertini, UOS Terapia Intens Cardiol, Rome, Italy.
   [Gulizia, Michele Massimo] Azienda Rilievo Nazl & Alta Specializzaz Garibald, Osped Garibaldi Nesima, UOC Cardiol, Catania, Italy.
   [Gulizia, Michele Massimo] Fdn Tuo Cuore, Heart Care Fdn, Florence, Italy.
RP Bisceglia, I (corresponding author), Azienda Osped San Camillo Forlanini, Dipartimento Cardiotoracovasc, Servizi Cardiol Integrati, Circonvallaz Gianicolense 87, I-00152 Rome, Italy.
EM irmabisceglia@gmail.com
RI Lestuzzi, Chiara/AAX-2361-2021; Maurea, Nicola/AAC-2341-2022; Gabrielli,
   Domenico/AAC-1130-2022
OI Lestuzzi, Chiara/0000-0002-9709-4909; 
CR Addison D, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017787
   Ahmed Mukhtar H, 2020, SN Compr Clin Med, P1, DOI 10.1007/s42399-020-00610-8
   American Society of Echocardiography, 2020, ASE STAT COVID 19
   Amigues I, 2020, EXPERT REV CLIN IMMU, V16, P1185, DOI 10.1080/1744666X.2021.1847084
   Amraei R, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071652
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2019, Eur Heart J, V40, P475, DOI 10.1093/eurheartj/ehy686
   Armenian SH, 2017, J CLIN ONCOL, V35, P893, DOI 10.1200/JCO.2016.70.5400
   Asokan I, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-00945-4
   Bakouny Z, 2020, CANCER CELL, V38, P629, DOI 10.1016/j.ccell.2020.09.018
   Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Berghoff AS, 2020, J CLIN ONCOL, V38, P3547, DOI 10.1200/JCO.20.01442
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Bozkurt B, 2020, J CARD FAIL, V26, P370, DOI 10.1016/j.cardfail.2020.04.013
   Brar G, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.01580
   Brown SA, 2021, CARDIO-ONCOLOGY, V7, DOI 10.1186/s40959-020-00088-2
   Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010
   Calvillo-Arguelles O, 2020, JACC-CARDIOONCOL, V2, P345, DOI 10.1016/j.jaccao.2020.04.001
   Cammann VL, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010881
   Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243
   Cavallari I, 2020, THROMB HAEMOSTASIS, V120, P314, DOI 10.1055/s-0039-3400300
   Chen C, 2020, HERZ, V45, P230, DOI 10.1007/s00059-020-04909-z
   Chen ST, 2019, EUR HEART J-QUAL CAR, V5, P145, DOI 10.1093/ehjqcco/qcy040
   Chew MS, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/139537
   Chinese Society of Cardiology of Chi- nese Medical Association, 2020, ZHONGHUA XIN XUE GUA, V48, P565
   Choi AD, 2020, J CARDIOVASC COMPUT, V14, P101, DOI 10.1016/j.jcct.2020.03.002
   Clarivet B, 2016, EUR J CLIN PHARMACOL, V72, P1413, DOI 10.1007/s00228-016-2107-0
   Copetti R, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-16
   COVIDSurg Collaborative, 2020, BRIT J SURG, V107, P1097, DOI 10.1002/bjs.11646
   Curigliano G, 2020, ANN ONCOL, V31, P171, DOI 10.1016/j.annonc.2019.10.023
   Dai MY, 2020, CANCER DISCOV, V10, P783, DOI 10.1158/2159-8290.CD-20-0422
   Dal'bo Natalie, 2020, Curr Treat Options Cardiovasc Med, V22, P62, DOI 10.1007/s11936-020-00867-1
   de Simone G., 2020, EUROPEAN SOC CARDIOL
   Delluc A, 2019, J THROMB HAEMOST, V17, P1247, DOI 10.1111/jth.14478
   Deng YQ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012540
   Di Liso E, 2019, J PALLIAT MED, V22, P691, DOI 10.1089/jpm.2018.0491
   Di Pasquale G, 2021, G ITAL CARDIOL, V22, P188, DOI 10.1714/3557.35336
   Di Pasquale G, 2020, G ITAL CARDIOL, V21, P243, DOI 10.1714/3328.32981
   Dirix LY, 2002, BRIT J CANCER, V86, P389, DOI 10.1038/sj.bjc.6600069
   Domercant J, 2016, OCHSNER J, V16, P250
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Duceppe E, 2017, CAN J CARDIOL, V33, P17, DOI 10.1016/j.cjca.2016.09.008
   Egan G, 2014, ANN PHARMACOTHER, V48, P734, DOI 10.1177/1060028014523115
   European Society of Cardiology, 2020, ROUT CARD ECH CHEM P
   Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131
   Fanola CL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008987
   Farmakis D, 2020, EUR J HEART FAIL, V22, P929, DOI 10.1002/ejhf.1898
   Feher A, 2017, ONCOLOGIST, V22, P213, DOI 10.1634/theoncologist.2016-0110
   Fix Oren K, 2020, Clin Liver Dis (Hoboken), V15, P187, DOI 10.1002/cld.971
   Gambichler T, 2020, J IMMUNOTHER CANCER, V8
   Ganatra S, 2020, JACC-CARDIOONCOL, V2, P350, DOI 10.1016/j.jaccao.2020.03.001
   Garassino MC, 2020, LANCET ONCOL, V21, P914, DOI 10.1016/S1470-2045(20)30314-4
   Garcia S, 2020, J AM COLL CARDIOL, V75, P2871, DOI 10.1016/j.jacc.2020.04.011
   Gargani L, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-6
   Gatti Milo, 2020, Curr Heart Fail Rep, V17, P365, DOI 10.1007/s11897-020-00485-9
   Gensini Gian Franco, 2017, Card Fail Rev, V3, P116, DOI 10.15420/cfr.2017:6:2
   Ghosh AK, 2020, JACC-CARDIOONCOL, V2, P97, DOI 10.1016/j.jaccao.2020.02.011
   Giustino G, 2020, J AM COLL CARDIOL, V76, P2043, DOI 10.1016/j.jacc.2020.08.069
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Guha A, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014248
   Guha A, 2019, EUR HEART J, V40, P3007, DOI 10.1093/eurheartj/ehz649
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Hanna TP, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4087
   Hanna TP, 2020, NAT REV CLIN ONCOL, V17, P268, DOI 10.1038/s41571-020-0362-6
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Hendren NS, 2020, CIRCULATION, V141, P1903, DOI 10.1161/CIRCULATIONAHA.120.047349
   Ho JSY, 2020, HEART LUNG, V49, P681, DOI 10.1016/j.hrtlng.2020.08.013
   Hodge C, 2020, J ANTIMICROB CHEMOTH, V75, P3417, DOI 10.1093/jac/dkaa340
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horowitz NA, 2020, SEMIN THROMB HEMOST, V46, P785, DOI 10.1055/s-0040-1714275
   Hosoba S, 2018, INTERACT CARDIOV TH, V26, P420, DOI 10.1093/icvts/ivx355
   Hu BY, 2021, J MED VIROL, V93, P250, DOI 10.1002/jmv.26232
   Hu HD, 2021, EUR HEART J, V42, P206, DOI 10.1093/eurheartj/ehaa190
   Huang TT, 2011, CHEST, V140, P881, DOI 10.1378/chest.10-2133
   Huang X, 2019, INT HEART J, V60, P359, DOI 10.1536/ihj.18-299
   Hull MC, 2003, JAMA-J AM MED ASSOC, V290, P2831, DOI 10.1001/jama.290.21.2831
   Hussain A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03369-5
   Imazio M, 2020, HEART, V106, P1127, DOI [10.1136/heartjnl-2020-317186, 10.1136/heartjnl-2020-317108]
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Jabri A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14780
   Jimenez D, 2021, CHEST, V159, P1182, DOI 10.1016/j.chest.2020.11.005
   Jover R, 2002, FASEB J, V16, P1799, DOI 10.1096/fj.02-0195fje
   Kampf G, 2020, J HOSP INFECT, V106, P678, DOI 10.1016/j.jhin.2020.09.022
   Kapoor Aditya, 2020, Indian Pacing Electrophysiol J, V20, P117, DOI 10.1016/j.ipej.2020.04.003
   Kattan J, 2020, IMMUNOTHERAPY-UK, V12, P351, DOI 10.2217/imt-2020-0077
   Keramida K, 2020, ECHOCARDIOGR-J CARD, V37, P1149, DOI 10.1111/echo.14800
   Key NS, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.01461
   Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479
   Kow CS, 2020, INFECTION, V48, P805, DOI 10.1007/s15010-020-01441-4
   Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9
   LAKKIREDDY DR, 2020, HEART RHYTHM, V141, pE82, DOI DOI 10.1161/CIRCULATIONAHA.120.047063
   Lazzerini PE, 2020, CIRCULATION, V142, P7, DOI 10.1161/CIRCULATIONAHA.120.047293
   Lazzerini PE, 2019, NAT REV IMMUNOL, V19, P63, DOI 10.1038/s41577-018-0098-z
   Lazzerini PE, 2017, HEART, V103, P1821, DOI 10.1136/heartjnl-2016-311079
   Lee EB, 2017, CLIN PHARMACOKINET, V56, P607, DOI 10.1007/s40262-016-0462-8
   Lee LYW, 2020, LANCET, V395, P1919, DOI 10.1016/S0140-6736(20)31173-9
   Lemaitre F, 2020, FUND CLIN PHARMACOL, V34, P530, DOI 10.1111/fcp.12586
   Lenihan D, 2020, CA-CANCER J CLIN, V70, P480, DOI 10.3322/caac.21635
   Lestuzzi C, 2010, WORLD J CARDIOL, V2, P270, DOI 10.4330/wjc.v2.i9.270
   Leung JM, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00688-2020
   Levy BI, 2019, CARDIOVASC RES, V115, P1460, DOI 10.1093/cvr/cvz160
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li L, 2018, EXPERT REV ANTICANC, V18, P1041, DOI 10.1080/14737140.2018.1500180
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Lim Michael Anthonius, 2020, Can J Kidney Health Dis, V7, p2054358120938573, DOI 10.1177/2054358120938573
   Lindner D, 2020, JAMA CARDIOL, V5, P1281, DOI 10.1001/jamacardio.2020.3551
   Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125
   Lo AC, 2021, J CANCER SURVIV, V15, P837, DOI 10.1007/s11764-020-00976-7
   Lombardy Section Italian Society Infectious And Tropical Diseases -, 2020, Infez Med, V28, P143
   Lopez-Sendon J, 2020, EUR HEART J, V41, P1720, DOI 10.1093/eurheartj/ehaa006
   Lyman GH, 2021, BLOOD ADV, V5, P927, DOI 10.1182/bloodadvances.2020003442
   Ma IWY, 2017, J GEN INTERN MED, V32, P1052, DOI 10.1007/s11606-017-4071-5
   Madan R, 2015, J EGYPT NATL CANCER, V27, P187, DOI 10.1016/j.jnci.2015.07.005
   Mahmood S, 2018, J AM COLL CARDIOL, V71, P699, DOI 10.1016/S0735-1097(18)31240-3
   Mahmud E, 2020, CATHETER CARDIO INTE, V96, P336, DOI 10.1002/ccd.28946
   Maringe C, 2020, LANCET ONCOL, V21, P1023, DOI 10.1016/S1470-2045(20)30388-0
   Mason S, 2021, CLIN INFECT DIS, V73, pE1870, DOI DOI 10.1093/CID/CIAA905
   McBane RD, 2020, MAYO CLIN PROC, V95, P2467, DOI 10.1016/j.mayocp.2020.08.030
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mehta V, 2020, CANCER DISCOV, V10, P935, DOI 10.1158/2159-8290.CD-20-0516
   Melloni C, 2017, AM J MED, V130, P1440, DOI 10.1016/j.amjmed.2017.06.026
   Moores LK, 2020, CHEST, V158, P1143, DOI 10.1016/j.chest.2020.05.559
   Mosarla RC, 2019, J AM COLL CARDIOL, V73, P1336, DOI 10.1016/j.jacc.2019.01.017
   Mrotzek SM, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00041
   Napolitano M, 2019, BLOOD TRANSFUS-ITALY, V17, P171, DOI 10.2450/2018.0143-18
   National Institutes of Health, 2019, COVID 19 TREATM GUID
   Neskovic AN, 2013, EUR HEART J-CARD IMG, V14, P1, DOI 10.1093/ehjci/jes193
   Nguyen JL, 2016, JAMA CARDIOL, V1, P274, DOI 10.1001/jamacardio.2016.0433
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Pasin L, 2020, J CARDIOTHOR VASC AN, V34, P2341, DOI 10.1053/j.jvca.2020.05.005
   Patell R, 2020, J THROMB HAEMOST, V18, P2349, DOI 10.1111/jth.15018
   Perrone AM, 2021, GYNECOL ONCOL, V161, P89, DOI 10.1016/j.ygyno.2020.09.030
   Piazza G, 2020, JAMA-J AM MED ASSOC, V324, P2548, DOI 10.1001/jama.2020.23422
   PLANA JC, 2014, EUR HEART J-CARD IMG, V27, P911, DOI DOI 10.1016/J.ECHO.2014.07.012
   Posteraro A, 2017, MANUALE ECOCARDIOGRA
   Pranata Raymond, 2020, Indian Pacing Electrophysiol J, V20, P193, DOI 10.1016/j.ipej.2020.08.001
   Pranata R, 2020, POSTGRAD MED J, V96, P387, DOI 10.1136/postgradmedj-2020-137884
   Public Health England, 2020, EXC WEIGHT COVID 19
   Quagliariello V, 2020, CANCERS, V12, DOI 10.3390/cancers12113316
   Radmilovic J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9123926
   Raschi E, 2018, INTERN EMERG MED, V13, P1, DOI 10.1007/s11739-017-1755-0
   RICHARDSON S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]
   Robilotti Elizabeth V, 2020, medRxiv, DOI 10.1101/2020.05.04.20086322
   Rocco B, 2020, UROLOGIA J, V87, P175, DOI 10.1177/0391560320938579
   Roden DM, 2020, CIRCULATION, V141, pE906, DOI 10.1161/CIRCULATIONAHA.120.047521
   Rodriguez-Leor O, 2020, REC INTERV CARDIOL, V2, P82, DOI 10.24875/RECIC.M20000120
   Rosovsky R, 2020, RES PRACT THROMB S1, V4
   Sadler D, 2020, CARDIO-ONCOLOGY, V6, DOI 10.1186/s40959-020-00085-5
   Sapp JL, 2020, CAN J CARDIOL, V36, P948, DOI 10.1016/j.cjca.2020.04.003
   Shah PB, 2020, CATHETER CARDIO INTE, V96, P659, DOI 10.1002/ccd.28910
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Siddiqi HK, 2021, TRENDS CARDIOVAS MED, V31, P1, DOI 10.1016/j.tcm.2020.10.005
   Siripanthong B, 2020, HEART RHYTHM, V17, P1463, DOI 10.1016/j.hrthm.2020.05.001
   Skulstad H, 2020, EUR HEART J-CARD IMG, V21, P592, DOI 10.1093/ehjci/jeaa072
   Smith AC, 2020, J TELEMED TELECARE, V26, P309, DOI 10.1177/1357633X20916567
   Smith CB, 2020, J CLIN ONCOL, V38
   Society for Cardiovascular Magnetic Resonance, 2020, SCMRS COVID 19 PREP
   Sorouri M, 2020, INFECT AGENTS CANCER, V15, DOI 10.1186/s13027-020-00339-y
   Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929
   Stefanini GG, 2020, CIRCULATION, V141, P2113, DOI 10.1161/CIRCULATIONAHA.120.047525
   Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136
   Stern A, 2017, COCHRANE DB SYST REV, V12
   Tashiro M, 2008, TOHOKU J EXP MED, V216, P77, DOI 10.1620/tjem.216.77
   Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828
   Testa S, 2020, J THROMB HAEMOST, V18, P1320, DOI 10.1111/jth.14871
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Tisdale JE, 2013, CIRC-CARDIOVASC QUAL, V6, P479, DOI 10.1161/CIRCOUTCOMES.113.000152
   Tsamakis K, 2020, ONCOL LETT, V20, P441, DOI 10.3892/ol.2020.11599
   Tuech JJ, 2020, J VISC SURG, V157, pS7, DOI 10.1016/j.jviscsurg.2020.03.008
   Uri K, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316668435
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Vecchio S, 2020, G ITAL CARDIOL, V21, P502, DOI 10.1714/3386.33635
   Viganego F, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0730-0
   Walley PE, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0681-z
   Wang BL, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1824646
   Wang BL, 2020, CRIT REV ONCOL HEMAT, V153, DOI 10.1016/j.critrevonc.2020.103032
   Wang DY, 2018, JAMA ONCOL, V4, P1721, DOI 10.1001/jamaoncol.2018.3923
   Wang T, 2020, LANCET HAEMATOL, V7, pE362, DOI 10.1016/S2352-3026(20)30109-5
   Wang TF, 2014, THROMB HAEMOSTASIS, V111, P88, DOI 10.1160/TH13-01-0042
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   Wang YX, 2021, J MED VIROL, V93, P1370, DOI 10.1002/jmv.26625
   Whitten P, 2008, TELEMED J E-HEALTH, V14, P952, DOI 10.1089/tmj.2008.0129
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wood DA, 2020, EUROINTERVENTION, V16, pE451, DOI 10.4244/EIJV16I6A82
   World Health Organization, 2020, TRANSM SARS COV 2 IM
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiong TY, 2020, EUR HEART J, V41, P1798, DOI 10.1093/eurheartj/ehaa231
   Yang KY, 2020, LANCET ONCOL, V21, P904, DOI 10.1016/S1470-2045(20)30310-7
   Yu J, 2020, JAMA ONCOL, V6, P1108, DOI 10.1001/jamaoncol.2020.0980
   Zaid Y, 2020, CIRC RES, V127, P1404, DOI 10.1161/CIRCRESAHA.120.317703
   Zhang NN, 2021, INT J MED SCI, V18, P921, DOI 10.7150/ijms.51205
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhang XD, 2020, NEW ENGL J MED, V382, P1869, DOI 10.1056/NEJMc2005157
   Zheng J, 2020, INT J BIOL SCI, V16, P1678, DOI 10.7150/ijbs.45053
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou HX, 2018, J ATHEROSCLER THROMB, V25, P1091, DOI 10.5551/jat.43653
NR 202
TC 0
Z9 0
U1 0
U2 0
PU PENSIERO SCIENTIFICO EDITORE
PI ROME
PA VIA SAN GIOVANNI VALDARNO 8, ROME, ITALY
SN 1827-6806
EI 1972-6481
J9 G ITAL CARDIOL
JI G. Ital. Cardiol.
PD OCT
PY 2021
VL 22
IS 10
BP 800
EP 825
PG 26
WC Cardiac & Cardiovascular Systems
WE Emerging Sources Citation Index (ESCI)
SC Cardiovascular System & Cardiology
GA XN8ZU
UT WOS:000729787800001
PM 34570114
DA 2022-04-20
ER

PT J
AU Habiyaremye, A
AF Habiyaremye, Alexis
TI Co-Operative Learning and Resilience to COVID-19 in a Small-Sized South
   African Enterprise
SO SUSTAINABILITY
LA English
DT Article
DE co-operative learning; sustainable innovation; crisis resilience;
   knowledge management strategies
ID ORGANIZATIONAL RESILIENCE; CRISIS MANAGEMENT; KNOWLEDGE; ANTECEDENTS;
   RESOURCES; DISASTER
AB Constraints imposed by the shrinking resources and the climate change dynamics necessitate a behavioral change to increase knowledge exchange and optimize resource utilization. Existing entrepreneurship and innovation practices are therefore undergoing transformation to adapt production systems to the post-COVID-19 reality of increased risks of calamities within a context of shrinking resources. This paper uses a knowledge-centered crisis management framework to examine how enhanced knowledge sharing through co-operative learning can be applied to induce higher innovation performance and more efficient resource utilization structures during crises comparable to the current pandemic. Using the collaborative learning experiences of a small enterprise producing ecological fertilizers, this study was able to link crisis resilience enhancement to increased knowledge exchange between business entities connected through the agro-ecological value chain. New insights generated through the co-learning process were found to constitute a key input for strengthening the required capability endowments that enable the organization and its partners to weather the COVID-19 crisis and lay the foundation for the sustainability of post-COVID-19 operations.
C1 [Habiyaremye, Alexis] Univ Johannesburg, Coll Business & Econ, ZA-2006 Johannesburg, South Africa.
RP Habiyaremye, A (corresponding author), Univ Johannesburg, Coll Business & Econ, ZA-2006 Johannesburg, South Africa.
EM habiyaremye@merit.unu.edu
OI Habiyaremye, Alexis/0000-0002-8614-2485
CR Amabile TM, 2005, ADMIN SCI QUART, V50, P367, DOI 10.2189/asqu.2005.50.3.367
   Auf der Heide E., 1989, DISASTER RESPONSE PR
   Baron RA, 2016, J MANAGE, V42, P742, DOI 10.1177/0149206313495411
   Barsade SG, 2015, ANNU REV ORGAN PSYCH, V2, P21, DOI 10.1146/annurev-orgpsych-032414-111316
   Benneworth P, 2018, SCI PUBL POLICY, V45, P764, DOI 10.1093/scipol/scy021
   Boardman C, 2010, J TECHNOL TRANSFER, V35, P445, DOI 10.1007/s10961-010-9162-y
   Bonanno George A, 2010, Psychol Sci Public Interest, V11, P1, DOI 10.1177/1529100610387086
   Brueck H., 15 METRE SOCIAL DIST
   Chesbrough H, 2006, OPEN INNOVATION RES
   Connell C.M., 2004, OR MANAG, V42, P1178, DOI [10.1108/00251740410565190, DOI 10.1108/00251740410565190]
   Cummings JN, 2005, SOC STUD SCI, V35, P703, DOI 10.1177/0306312705055535
   Deutsch M, 1949, HUM RELAT, V2, P129, DOI 10.1177/001872674900200204
   Drabek T.E., 2005, INT J MASS EMERGENCI, V23, P49
   du Plessis Marina, 2007, Journal of Knowledge Management, V11, P20, DOI 10.1108/13673270710762684
   Dynes R.R., 1990, INT J MASS EMERGENCI, V12, P141
   Earl S., 2001, OUTCOME MAPPING BUIL
   Elsubbaugh S., 2004, J CONTING CRISIS MAN, V12, P112
   Gittell JH, 2006, J APPL BEHAV SCI, V42, P300, DOI 10.1177/0021886306286466
   Gundel S., 2005, J CONTING CRISIS MAN, V13, P106, DOI [10.1111/j.1468-5973.2005.00465.x, DOI 10.1111/JCCM.2005.13.ISSUE-3]
   HERMANN CF, 1963, ADMIN SCI QUART, V8, P61, DOI 10.2307/2390887
   HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513
   Jacobs PT, 2019, EUR J DEV RES, V31, P881, DOI 10.1057/s41287-019-0192-5
   James EH, 2011, ACAD MANAG ANN, V5, P455, DOI 10.1080/19416520.2011.589594
   Johnson D. W., 1991, ACTIVE LEARNING COOP
   Johnson DW, 2007, EDUC PSYCHOL REV, V19, P15, DOI 10.1007/s10648-006-9038-8
   Kahn WA, 2013, ACAD MANAGE REV, V38, P377, DOI 10.5465/amr.2011.0363
   Kaplan S, 2013, J ORGAN BEHAV, V34, P473, DOI 10.1002/job.1817
   KREPS GA, 1993, AM J SOCIOL, V99, P428, DOI 10.1086/230270
   Lawson C, 1999, REG STUD, V33, P305, DOI 10.1080/713693555
   Lengnick-Hall CA, 2005, J MANAGE, V31, P738, DOI 10.1177/0149206305279367
   Lengnick-Hall CA, 2011, HUM RESOUR MANAGE R, V21, P243, DOI 10.1016/j.hrmr.2010.07.001
   Lin Z, 2000, J MATH SOCIOL, V24, P129, DOI 10.1080/0022250X.2000.9990232
   Linnenluecke MK, 2017, INT J MANAG REV, V19, P4, DOI 10.1111/ijmr.12076
   Lundvall B.A, SOCIAL DIMENSION LEA
   MEYER AD, 1982, ADMIN SCI QUART, V27, P515, DOI 10.2307/2392528
   MILBURN TW, 1983, HUM RELAT, V36, P1141, DOI 10.1177/001872678303601205
   Nahapiet J, 1998, ACAD MANAGE REV, V23, P242, DOI 10.2307/259373
   NEAL DM, 1995, DISASTERS, V19, P327, DOI 10.1111/j.1467-7717.1995.tb00353.x
   Nishiguchi T, 1998, SLOAN MANAGE REV, V40, P49
   OECD, 2020, COVID 19 FOOD AGR SE
   Parrilli MD, 2010, EUR PLAN STUD, V18, P351, DOI 10.1080/09654310903497660
   Pauchant I.I., 1992, TRANSFORMING CRISIS
   Pearson CM, 2011, ORGAN DYN, V40, P27, DOI 10.1016/j.orgdyn.2010.10.008
   Pearson CM, 1998, ACAD MANAGE REV, V23, P59, DOI 10.2307/259099
   Pearson CM., 1993, ACAD MANAGEMENT EXEC, V7, P48, DOI DOI 10.5465/AME.1993.9409142058
   Petersen IH, 2018, J INT DEV, V30, P865, DOI 10.1002/jid.3232
   Pohl C, 2010, SCI PUBL POLICY, V37, P267, DOI 10.3152/030234210X496628
   Quarantelli E., 2005, WHAT IS DISASTER, P325
   Rebucci A., 2020, W27855 NAT BUR EC RE
   Rentsch JR, 2001, J ORGAN BEHAV, V22, P107, DOI 10.1002/job.81
   Rice M., 2003, IPC03003
   Roux-Dufort C., 2009, J CONTING CRISIS MAN, V17, P4, DOI DOI 10.1111/J.1468-5973.2009.00563.X
   Salter J., 1997, J CONTING CRISIS MAN, V5, P60, DOI [10.1111/1468-5973.00037, DOI 10.1111/1468-5973.00037]
   SCHNEIDER SK, 1992, PUBLIC ADMIN REV, V52, P135, DOI 10.2307/976467
   Shepherd DA, 2014, J MANAGE STUD, V51, P952, DOI 10.1111/joms.12084
   Shin J, 2012, ACAD MANAGE J, V55, P727, DOI 10.5465/amj.2010.0325
   Smith-Jentsch KA, 2001, J ORGAN BEHAV, V22, P179, DOI 10.1002/job.88
   Sommer A, 2007, TECHNOL FORECAST SOC, V74, P1234, DOI 10.1016/j.techfore.2006.10.006
   STALLINGS RA, 1985, PUBLIC ADMIN REV, V45, P93, DOI 10.2307/3135003
   Turok I, 2020, REG STUD, V54, P1776, DOI 10.1080/00343404.2020.1807490
   Vogus T.J., 2003, POSITIVE ORG SCHOLAR
   Wang WT, 2009, IND MANAGE DATA SYST, V109, P445, DOI 10.1108/02635570910948605
   Wenger D.E., 1992, EMERGENT VOLUNTEER B
   Wildavsky, 1988, SEARCHING SAFETY
   Williams TA, 2017, ACAD MANAG ANN, V11, P733, DOI 10.5465/annals.2015.0134
   Woolthuis RK, 2005, TECHNOVATION, V25, P609, DOI 10.1016/j.technovation.2003.11.002
NR 66
TC 2
Z9 2
U1 4
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD FEB
PY 2021
VL 13
IS 4
AR 1976
DI 10.3390/su13041976
PG 17
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA QQ9HI
UT WOS:000624827900001
OA gold
DA 2022-04-20
ER

PT J
AU Gracia-Ramos, AE
   Martin-Nares, E
   Hernandez-Molina, G
AF Gracia-Ramos, Abraham Edgar
   Martin-Nares, Eduardo
   Hernandez-Molina, Gabriela
TI New Onset of Autoimmune Diseases Following COVID-19 Diagnosis
SO CELLS
LA English
DT Article
DE COVID-19; SARS-CoV-2; autoimmunity; rheumatic diseases
ID MULTISYSTEM INFLAMMATORY SYNDROME; CONSENSUS CONFERENCE NOMENCLATURE;
   SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOLOGY 1990 CRITERIA;
   KAWASAKI-DISEASE; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; CUTANEOUS
   VASCULITIS; REACTIVE ARTHRITIS; ADULT
AB There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a dysregulation of the immune system with the development of autoimmune phenomena. The consequence of this immune dysregulation ranges from the production of autoantibodies to the onset of rheumatic autoimmune disease. In this context, we conducted a systematic review to analyze the current data regarding the new-onset systemic and rheumatic autoimmune diseases in COVID-19 patients. A literature search in PubMed and Scopus databases from December 2019 to September 2021 identified 99 patients that fulfilled the specific diagnostic/classification criteria and/or nomenclature for each rheumatic autoimmune disease. The main diseases reported were vasculitis and arthritis. Idiopathic inflammatory myopathies, systemic lupus erythematosus, and sarcoidosis were also reported in a limited number of patients, as well as isolated cases of systemic sclerosis and adult-onset Still's disease. These findings highlight the potential spectrum of systemic and rheumatic autoimmune diseases that could be precipitated by SARS-CoV-2 infection. Complementary studies are needed to discern the link between the SARS-CoV-2 and new onset-rheumatic diseases so that this knowledge can be used in early diagnosis and the most suitable management.
C1 [Gracia-Ramos, Abraham Edgar] Inst Mexicano Seguro Social, Hosp Gen, Dept Med Interna, Ctr Med Nacl La Raza, Mexico City 02990, DF, Mexico.
   [Gracia-Ramos, Abraham Edgar] Escuela Super Med, Inst Politecn Nacl, Secc Estudios Posgrad & Invest, Mexico City 11340, DF, Mexico.
   [Martin-Nares, Eduardo; Hernandez-Molina, Gabriela] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City 14080, DF, Mexico.
RP Gracia-Ramos, AE (corresponding author), Inst Mexicano Seguro Social, Hosp Gen, Dept Med Interna, Ctr Med Nacl La Raza, Mexico City 02990, DF, Mexico.; Gracia-Ramos, AE (corresponding author), Escuela Super Med, Inst Politecn Nacl, Secc Estudios Posgrad & Invest, Mexico City 11340, DF, Mexico.
EM dr.gracia.dmm@gmail.com; eduardomartinnares@gmail.com; gabyhm@yahoo.com
OI Gracia-Ramos, Abraham Edgar/0000-0003-1842-2554; Hernandez-Molina,
   Gabriela/0000-0001-7958-0391
CR Adler BL, 2018, DISCOV MED, V25, P75
   Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584
   Alivernini S, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-218315
   Allez M, 2020, ARTHRITIS RHEUMATOL, V72, P1952, DOI 10.1002/art.41428
   [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736
   Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1002/art.40930, 10.1136/annrheumdis-2018-214819]
   Baimukhamedov C, 2020, LANCET RHEUMATOL, V3, pE324, DOI 10.1016/S2665-9913(21)00067-9
   Bamidis AD, 2021, LANCET RHEUMATOL, V3, pE319, DOI 10.1016/S2665-9913(21)00072-2
   Barbetta Laura, 2021, Clin Exp Rheumatol, V39 Suppl 129, P191, DOI 10.55563/clinexprheumatol/5epvob
   Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585
   Behbahani Sara, 2020, JAAD Case Rep, V6, P915, DOI 10.1016/j.jdcr.2020.07.026
   Berth SH, 2020, CURR TREAT OPTION NE, V22, DOI 10.1007/s11940-020-00646-0
   Beydon M, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-217573
   BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807
   BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
   Bonometti R, 2020, EUR REV MED PHARMACO, V24, P9695, DOI 10.26355/eurrev_202009_23060
   Caputo V, 2020, J EUR ACAD DERMATOL, V34, pE579, DOI 10.1111/jdv.16737
   Chang LY, 2014, J FORMOS MED ASSOC, V113, P148, DOI 10.1016/j.jfma.2013.12.008
   Cherif Mohammad Yassine, 2020, JAAD Case Rep, V6, P780, DOI 10.1016/j.jdcr.2020.06.023
   Cincinelli G, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000026089
   Cogan E, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00428
   Colmenero I, 2020, BRIT J DERMATOL, V183, P729, DOI 10.1111/bjd.19327
   Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016
   Danssaert Z, 2020, CUREUS, V12, DOI 10.7759/cureus.9698
   de Perosanz-Lobo D, 2020, J EUR ACAD DERMATOL, V34, pE566, DOI 10.1111/jdv.16713
   De Stefano Ludovico, 2020, Ann Rheum Dis, DOI 10.1136/annrheumdis-2020-218520
   Derksen VFAM, 2021, ANN RHEUM DIS, V80, P1096, DOI 10.1136/annrheumdis-2021-219859
   Dhakal P, 2021, IDCASES, V24, DOI 10.1016/j.idcr.2021.e01063
   Di Carlo M, 2021, CLIN EXP RHEUMATOL, V39, pS25
   Dixon L, 2021, J NEUROL NEUROSUR PS, V92, P103, DOI 10.1136/jnnp-2020-324291
   Dominguez-Santas M, 2020, J EUR ACAD DERMATOL, V34, pE536, DOI 10.1111/jdv.16663
   Dotan A, 2021, AUTOIMMUN REV, V20, DOI 10.1016/j.autrev.2021.102792
   Dudouet P, 2021, CLIN MICROBIOL INFEC, V27, P1873, DOI 10.1016/j.cmi.2021.09.020
   Duran TI, 2021, RHEUMATOL INT, V41, P1523, DOI 10.1007/s00296-021-04914-3
   Gracia-Ramos AE, 2021, RHEUMATOL INT, V41, P799, DOI 10.1007/s00296-021-04794-7
   Gracia-Ramos AE, 2020, ARCH MED RES, V51, P345, DOI 10.1016/j.arcmed.2020.03.011
   El Hasbani G, 2021, REUMATISMO, V73, P59, DOI 10.4081/reumatismo.2021.1374
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Fineschi S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.686699
   Fragata I, 2020, ACTA REUMATOL PORT, V45, P278
   Fraison JB, 2016, AUTOIMMUN REV, V15, P242, DOI 10.1016/j.autrev.2015.11.010
   Fujii H, 2020, CLIN RHEUMATOL, V39, P3171, DOI 10.1007/s10067-020-05359-y
   Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006
   Gasparotto M, 2021, CLIN RHEUMATOL, V40, P3357, DOI 10.1007/s10067-020-05550-1
   Gazzaruso C, 2020, CLIN RHEUMATOL, V39, P2095, DOI 10.1007/s10067-020-05180-7
   Gelzo M, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13091718
   Getts DR, 2013, IMMUNOL REV, V255, P197, DOI 10.1111/imr.12091
   Gibson M., 2020, RHEUMATOL ADV PRACT, V4, DOI 10.1093/rap/rkaa052.014
   Gokhale Yojana, 2020, J Assoc Physicians India, V68, P20
   Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765
   Guleria S, 2018, JCR-J CLIN RHEUMATOL, V24, P401, DOI 10.1097/RHU.0000000000000704
   Hali F, 2021, INT J DERMATOL, V60, P1030, DOI 10.1111/ijd.15592
   Henderson LA, 2021, ARTHRITIS RHEUMATOL, V73, pE13, DOI 10.1002/art.41616
   Honge BL, 2021, BMJ CASE REP, V14, DOI 10.1136/bcr-2020-241375
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122
   Hussein A, 2020, CUREUS, V12, DOI 10.7759/cureus.9643
   Hussein HM, 2019, CRIT REV MICROBIOL, V45, P394, DOI 10.1080/1040841X.2019.1614904
   Iraji F, 2021, CLIN CASE REP, V9, P830, DOI 10.1002/ccr3.3596
   Jali I, 2020, CUREUS, V12, DOI 10.7759/cureus.11761
   Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715
   Jones I, 2020, LANCET RHEUMATOL, V2, pE520, DOI 10.1016/S2665-9913(20)30234-4
   Joob B, 2020, RHEUMATOL INT, V40, P823, DOI 10.1007/s00296-020-04561-0
   Kanegaye JT, 2009, PEDIATRICS, V123, pE783, DOI 10.1542/peds.2008-1871
   KAWASAKI T, 1995, ACTA PAEDIATR, V84, P713, DOI 10.1111/j.1651-2227.1995.tb13742.x
   Kocyigit BF, 2021, RHEUMATOL INT, V41, P2031, DOI 10.1007/s00296-021-04998-x
   Kosters K, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa474
   Kofman AD, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05439-z
   Kudose S, 2020, J AM SOC NEPHROL, V31, P1959, DOI 10.1681/ASN.2020060802
   Kuriyama Y, 2021, J DERMATOL, V48, P1588, DOI 10.1111/1346-8138.16071
   Kuschner Z, 2021, JACEP OPEN, V2, DOI 10.1002/emp2.12452
   Lechien JR, 2021, ENT-EAR NOSE THROAT, DOI 10.1177/01455613211006011
   Li NL, 2021, CAN J KIDNEY HEALTH, V8, DOI 10.1177/2054358121991684
   Lidder Alcina K, 2020, Am J Ophthalmol Case Rep, V20, P100875, DOI 10.1016/j.ajoc.2020.100875
   Liew IY, 2020, JCR-J CLIN RHEUMATOL, V26, P233, DOI 10.1097/RHU.0000000000001560
   LIGHTFOOT RW, 1990, ARTHRITIS RHEUM, V33, P1088
   Lind E, 2021, BMJ CASE REP, V14, DOI 10.1136/bcr-2021-242628
   Loffler C, 2020, CHEST, V158, pE215, DOI 10.1016/j.chest.2020.06.051
   Lokineni Sravani, 2021, Eur J Case Rep Intern Med, V8, P002461, DOI 10.12890/2021_002461
   Loricera J, 2015, RHEUMATOLOGY, V54, P77, DOI 10.1093/rheumatology/keu295
   Lundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468
   Malangu B, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.11750
   Cardoso EM, 2020, CLIN RHEUMATOL, V39, P2811, DOI 10.1007/s10067-020-05310-1
   Mayor-Ibarguren A, 2020, J EUR ACAD DERMATOL, V34, pE541, DOI 10.1111/jdv.16670
   McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
   McGonagle D, 2021, LANCET RHEUMATOL, V3, pE224, DOI 10.1016/S2665-9913(20)30420-3
   Mertz P, 2021, AUTOIMMUN REV, V20, DOI 10.1016/j.autrev.2021.102824
   Mir A, 2021, CASE REP DERMATOL ME, V2021, P77292, DOI [10.1155/2021/8877292, DOI 10.1155/2021/8877292]
   Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x
   Moeinzadeh F, 2020, IRAN J KIDNEY DIS, V14, P239
   Mohkhedkar M, 2021, MOL IMMUNOL, V137, P105, DOI 10.1016/j.molimm.2021.06.021
   Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527
   Mukarram M.S., 2020, CLIN STUD MED CASE R, V7, P1, DOI 10.24966/CSMC-8801/100101
   Nadim MK, 2020, NAT REV NEPHROL, V16, P747, DOI 10.1038/s41581-020-00356-5
   Nagra D., 2021, RHEUMATOL ADV PRACT, V5, DOI [10.1093/rap/rkab035, DOI 10.1093/RAP/RKAB035]
   Nasiri S, 2020, INT J DERMATOL, V59, P1285, DOI 10.1111/ijd.15112
   Negrini S, 2020, J EUR ACAD DERMATOL, V34, pE675, DOI 10.1111/jdv.16760
   Novelli L, 2021, RHEUMATOLOGY, V60, pE21, DOI 10.1093/rheumatology/keaa691
   Oda Ryohei, 2020, Ann Rheum Dis, DOI 10.1136/annrheumdis-2020-218440
   Ono K, 2020, RMD OPEN, V6, DOI 10.1136/rmdopen-2020-001350
   Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n71
   Paliwal VK, 2020, NEUROL SCI, V41, P3039, DOI 10.1007/s10072-020-04708-8
   Parisi S, 2020, LANCET RHEUMATOL, V2, pE655, DOI 10.1016/S2665-9913(20)30348-9
   Parker A, 2020, SAMJ S AFR MED J, V110, P957, DOI [10.7196/SAMJ.2020.v110i10.15244, 10.7196/samj.2020.v110i10.15244]
   Pastuszczak M, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006376
   Patel P, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.26456
   Patel R, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.14403
   Perrot L, 2021, LANCET RHEUMATOL, V3, pE6, DOI 10.1016/S2665-9913(20)30396-9
   Ekinci AP, 2021, J EUR ACAD DERMATOL, V35, pE477, DOI 10.1111/jdv.17286
   Pouletty M, 2020, ANN RHEUM DIS, V79, P999, DOI 10.1136/annrheumdis-2020-217960
   Ramos-Casals M, 2021, NAT REV RHEUMATOL, V17, P315, DOI 10.1038/s41584-021-00608-z
   Riebeling-Navarro C, 2009, REUMATOL CLIN, V5, P6, DOI 10.1016/j.reuma.2009.07.006
   Riera-Marti N, 2021, MED CLIN-BARCELONA, V156, P253, DOI 10.1016/j.medcli.2020.11.005
   Rigante D, 2014, AUTOIMMUN REV, V13, P96, DOI 10.1016/j.autrev.2013.09.004
   Rodriguez-Smith JJ, 2021, LANCET RHEUMATOL, V3, pE574, DOI 10.1016/S2665-9913(21)00139-9
   Roncati L, 2020, CLIN IMMUNOL, V217, DOI 10.1016/j.clim.2020.108487
   Roongta R, 2021, ANN RHEUM DIS, DOI 10.1136/annrheumdis-2021-220479
   Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233
   Sacchi MC, 2020, EUR REV MED PHARMACO, V24, P11960, DOI 10.26355/eurrev_202011_23857
   Saikali W, 2021, IMMUN INFLAMM DIS, V9, P628, DOI 10.1002/iid3.448
   Salvatierra J, 2020, JOINT BONE SPINE, V87, P660, DOI 10.1016/j.jbspin.2020.06.009
   Sandhu S, 2021, DERMATOL THER, V34, DOI 10.1111/dth.14551
   Santoriello D, 2020, J AM SOC NEPHROL, V31, P2158, DOI 10.1681/ASN.2020050744
   Saud A, 2021, CURR RHEUMATOL REP, V23, DOI 10.1007/s11926-021-01023-9
   Schenker HM, 2021, RHEUMATOLOGY, V60, P479, DOI 10.1093/rheumatology/keaa689
   Selvaraj V, 2021, BMJ CASE REP, V14, DOI 10.1136/bcr-2021-242142
   Shabbir A, 2020, EUR HEART J-CASE REP, V4, DOI 10.1093/ehjcr/ytaa370
   Shah SK, 2020, RHEUMATOL INT, V40, P1539, DOI 10.1007/s00296-020-04639-9
   Shaigany S, 2020, LANCET, V396, pE8, DOI 10.1016/S0140-6736(20)31526-9
   Shergill S, 2020, EUR HEART J, V41, P4286, DOI 10.1093/eurheartj/ehaa635
   Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1136/annrheumdis-2016-210571, 10.1002/art.39859]
   Sieper J, 2000, ARTHRITIS RHEUM, V43, P720, DOI 10.1002/1529-0131(200004)43:4<720::AID-ANR2>3.0.CO;2-8
   Slimani Y, 2021, J MED VIROL, V93, P1184, DOI 10.1002/jmv.26513
   Smatti MK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11080762
   Sokolovsky S, 2021, AM J EMERG MED, V39, DOI 10.1016/j.ajem.2020.06.053
   Sollini M, 2021, EUR J NUCL MED MOL I, V48, P1460, DOI 10.1007/s00259-020-05084-3
   Stavropoulos PG, 2015, J EUR ACAD DERMATOL, V29, P415, DOI 10.1111/jdv.12741
   Sun ZH, 2020, QUANT IMAG MED SURG, V10, P1058, DOI 10.21037/qims-20-564
   Sureja NP, 2021, RHEUMATOL ADV PRACT, V5, DOI 10.1093/rap/rkab001
   Suso AS, 2020, KIDNEY INT REP, V5, P2074, DOI 10.1016/j.ekir.2020.08.016
   Talarico RR, 2020, LANCET RHEUMATOL, V2, pE518, DOI 10.1016/S2665-9913(20)30216-2
   Timmons GM, 2021, NEUROL-NEUROIMMUNOL, V8, DOI 10.1212/NXI.0000000000001048
   Toubiana J, 2021, J CLIN IMMUNOL, V41, P526, DOI 10.1007/s10875-020-00941-0
   Tsivgoulis G, 2020, THER ADV NEUROL DISO, V13, DOI 10.1177/1756286420932036
   Turnier JL, 2015, PEDIATRICS, V136, pE609, DOI 10.1542/peds.2015-0950
   Uppal NN, 2020, KIDNEY INT REP, V5, P2079, DOI 10.1016/j.ekir.2020.08.012
   Uslu S, 2021, POSTGRAD MED J, V97, P399, DOI 10.1136/postgradmedj-2021-139725
   Vacchi C, 2020, RHEUMATOLOGY, V59, pE147, DOI 10.1093/rheumatology/keaa581
   Vassilopoulos D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2480
   Ventura Meredith J, 2020, Ann Rheum Dis, DOI 10.1136/annrheumdis-2020-218959
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Vergnano S, 2020, LANCET RHEUMATOL, V2, pE520, DOI 10.1016/S2665-9913(20)30231-9
   Veyseh M, 2021, BMJ CASE REP, V14, DOI 10.1136/bcr-2020-239457
   Vlachoyiannopoulos PG, 2020, ANN RHEUM DIS, V79, P1661, DOI 10.1136/annrheumdis-2020-218009
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593
   Winchester N, 2021, Pathog Immun, V6, P31, DOI 10.20411/pai.v6i1.417
   Woodruff M, 2021, ARTHRITIS RHEUMATOL, V73, P13, DOI 10.1101/2020.10.21.20216192
   YAMAGUCHI M, 1992, J RHEUMATOL, V19, P424
   Yener GO, 2021, RHEUMATOL INT, DOI 10.1007/s00296-021-04980-7
   Yokogawa N, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-218281
   Zacharias H, 2021, AUTOIMMUN REV, V20, DOI 10.1016/j.autrev.2021.102883
   Zamani B, 2021, J MED CASE REP, V15, DOI 10.1186/s13256-020-02582-8
   Zhang H, 2020, MUSCLE NERVE, V62, pE57, DOI 10.1002/mus.27003
   Zhou YQ, 2020, CTS-CLIN TRANSL SCI, V13, P1077, DOI 10.1111/cts.12805
NR 165
TC 1
Z9 1
U1 9
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD DEC
PY 2021
VL 10
IS 12
AR 3592
DI 10.3390/cells10123592
PG 19
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA XW9YJ
UT WOS:000735964700001
PM 34944099
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Aftab, R
   Naveed, M
   Hanif, S
AF Aftab, Rehan
   Naveed, Muhammad
   Hanif, Sajjad
TI An analysis of Covid-19 implications for SMEs in Pakistan
SO JOURNAL OF CHINESE ECONOMIC AND FOREIGN TRADE STUDIES
LA English
DT Article
DE SMEs; Covid-19; Government of Pakistan; SMEDA
AB Purpose
   The purpose of this paper is to ascertain the impact of coronavirus (Covid-19) on small and medium enterprises in Pakistan, which are vulnerable to crisis situations. This study also aims to provide policy recommendations to the stakeholders by reviewing the situation of small and medium scale enterprises (SMEs) after the Covid-19 sudden surge.
   Design/methodology/approach
   The descriptive study is based on quantitative data technique and primary data collection is undertaken. The survey instrument is adapted from the US Bureau of Labor Statistics public documents. Collected responses from SME owners are descriptively analyzed using appropriate graphs.
   Findings
   The analysis infers that SMEs in Pakistan have encountered unfavorable implications of Covid-19 in the form of shortage of goods, blockage in transportation, decrease in demand of products and services, decline in profits and sales, limited operations, lockdown and employee's layoff.
   Research limitations/implications
   The limited sample and precise use of instruments are few limitations along with valuable implications of this research. The analysis of Covid-19 impact on SMEs is an ongoing phenomenon and aids in proactive planning for the second wave of this outbreak. Financing schemes, youth entrepreneurship loans, retention of skilled staff and proactive planning for adverse future are few recommended measures for revival of the SMEs sector.
   Originality/value
   The use of a unique sample and quality data set collected using the Bureau of Labor Statistics instrument adds value to the findings of the study and their consistency. The existing body of knowledge in the context of the SMEs sector of Pakistan is strengthened with an analysis of crisis implications for this sector, which remained unaddressed in the past.
C1 [Aftab, Rehan] SZABIST, Dept Management Sci, Islamabad, Pakistan.
   [Naveed, Muhammad] SZABIST, Fac Management Sci, Islamabad, Pakistan.
   [Hanif, Sajjad] Natl Univ Comp & Emerging Sci, Islamabad, Pakistan.
RP Aftab, R (corresponding author), SZABIST, Dept Management Sci, Islamabad, Pakistan.
EM rehanaftab64@gmail.com; dr.naveed@szabist-isb.edu.pk;
   sajjad.hanif@nu.edu.pk
RI Aftab, Rehan/AAY-5288-2021; Hanif, Sajjad/ADV-8722-2022
OI Aftab, Rehan/0000-0003-3900-0879; 
CR ADB, 2020, PAK EC
   Aftab R, 2021, MANAG FINANC, V47, P856, DOI 10.1108/MF-04-2020-0214
   [Anonymous], 2020, THE EXPRESS TRIBUNE
   [Anonymous], 2020, COVID 19 HLTH ADV PL
   Auzzir Z, 2018, PROCEDIA ENGINEER, V212, P1131, DOI 10.1016/j.proeng.2018.01.146
   Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117
   Basuno E, 2010, TRANSBOUND EMERG DIS, V57, P7, DOI 10.1111/j.1865-1682.2010.01121.x
   Burhan M, 2020, EMPL RELAT, V42, P1513, DOI 10.1108/ER-11-2019-0440
   Chen Ming-Hsiang, 2007, Int J Hosp Manag, V26, P200, DOI 10.1016/j.ijhm.2005.11.004
   Cuervo-Cazurra A, 2019, GLOB STRATEG J, V9, P491, DOI 10.1002/gsj.1362
   Fairlie R.W., 2020, W27462 NAT BUR EC RE
   Hai W., 2004, ASIAN ECON PAP, V3, P57, DOI 10.1162/1535351041747905
   IMF International Monetery Fund, 2020, POL RESP COV 19
   Javed S.A., 2020, PROJECTED IMPACT LOC
   Juergensen J, 2020, J IND BUS ECON, V47, P499, DOI 10.1007/s40812-020-00169-4
   Lu Y, 2020, ENVIRON HAZARDS-UK, V19, P323, DOI 10.1080/17477891.2020.1763902
   Naqvi, 2020, SMEDAS SURVEY IMPACT
   Peng H, 2020, J CLEAN PROD, V254, DOI 10.1016/j.jclepro.2020.120032
   Pfeffer J., 2003, EXTERNAL CONTROL ORG
   Ratnasingam J, 2020, BIORESOURCES, V15, P5951, DOI 10.15376/biores.15.3.5951-5964
   Robinson J, 2020, J APPL ECON BUS RES, V10, P115
   Sareen S, 2020, COVID 19 PAKISTAN EC
   Saunders-Hastings PR, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040066
   Seetharaman P, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102173
   Sekaran U., 2016, RES METHODS BUSINESS, V7th Edition
   Shafi M., 2020, RES GLOBALIZATION, V2
   SMEDA, 2020, STAT SMES
   State Bank of Pakistan, 2020, REF SCHEM
   Stefania O., 2018, CITY CULT SOC, V15, P53, DOI [10.1016/j.ccs.2018.05.005, DOI 10.1016/J.CCS.2018.05.005]
   Tan WJ, 2006, THUNDERBIRD INT BUS, V48, P515, DOI 10.1002/tie.20107
   The World Bank, 2020, GLOB EC OUTL COVID 1
   UNDP, 2020, COVID 19 PAK SOC IMP
   Watkins RE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-157
   World Bank, 2020, COVID 19 PLUNG GLOB
NR 34
TC 2
Z9 2
U1 6
U2 23
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1754-4408
EI 1754-4416
J9 J CHIN ECON FOREIGN
JI J. Chin. Econ. Foreign Trade Stud.
PD MAR 16
PY 2021
VL 14
IS 1
SI SI
BP 74
EP 88
DI 10.1108/JCEFTS-08-2020-0054
EA FEB 2021
PG 15
WC Economics
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA QX9GB
UT WOS:000616266100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Villaescusa, L
   Zaragoza, F
   Gayo-Abeleira, I
   Zaragoza, C
AF Villaescusa, Lucinda
   Zaragoza, Francisco
   Gayo-Abeleira, Irene
   Zaragoza, Cristina
TI A New Approach to the Management of COVID-19. Antagonists of IL-6:
   Siltuximab
SO ADVANCES IN THERAPY
LA English
DT Review
DE COVID-19; Cytokine release syndrome; Interleukin-6; Monoclonal
   antibodies; Siltuximab
ID SOLUBLE INTERLEUKIN-6 RECEPTOR; CYTOKINE RELEASE SYNDROME;
   MONOCLONAL-ANTIBODY; MULTIPLE-MYELOMA; OPEN-LABEL; PHASE-I; BLOCKADE;
   STRATEGIES; MORTALITY; DISEASE
AB Since the beginning of the pandemic, numerous national and international clinical trials have been conducted with a large number of drugs. Many of them are intended for the treatment of other pathologies; however, despite the great effort made, no specific drug is available for the treatment of the symptoms of respiratory disease caused by SARS-CoV-2 infection. The aim of this article is to provide data to justify the use of drugs to tackle the effects produced by IL-6 as the main inflammatory mediator in patients with COVID-19 with severe respiratory complications, considering all clinical evidence linking the poor prognosis of these patients with increased IL-6 levels in the context of cytokine release syndrome. Furthermore, data are provided to justify the proposal of a rational dosing of siltuximab, a monoclonal antibody specifically targeting IL-6, based on RCP levels, considering the limited results published so far on the use of this drug in COVID-19. A literature search was conducted on the clinical trials of siltuximab published to date as well as on the different IL-6 signalling pathways and the effects of its overexpression. Knowledge of the mechanisms of action on these pathways may provide important information for the design of drugs useful in the treatment of these patients. This article describes the characteristics, properties, mechanism of action, therapeutic uses and clinical studies conducted with siltuximab so far. The results confirm that administration of siltuximab downregulates IL-6 levels, thereby reducing the inflammatory process in COVID-19 patients with severe respiratory disease, suggesting that it can be successfully used to prevent cytokine release syndrome and death from this cause.
C1 [Villaescusa, Lucinda; Zaragoza, Francisco; Gayo-Abeleira, Irene; Zaragoza, Cristina] Univ Alcala, Pharmacol Unit, Biomed Sci Dept, Alcala De Henares 28805, Spain.
RP Villaescusa, L (corresponding author), Univ Alcala, Pharmacol Unit, Biomed Sci Dept, Alcala De Henares 28805, Spain.
EM lucinda.villaescusa@uah.es
CR Abramson JS, 2019, J NATL COMPR CANC NE, V17, P1417, DOI 10.6004/jnccn.2019.5037
   Agencia Espanola de Medicamentos y Productos Sanitarios, 2020, TRAT DISP MAN INF RE
   Alborghetti L., 2020, IL 6 SIGNALLING PATH, DOI 10.1101/2020.04.01.20048561
   [Anonymous], 2018, SYLVANT INTERNET
   Avci AB, 2018, BIODRUGS, V32, P531, DOI 10.1007/s40259-018-0320-3
   Bower M, 2014, LANCET ONCOL, V15, P910, DOI 10.1016/S1470-2045(14)70333-X
   Brunetta E, 2021, NAT IMMUNOL, V22, P19, DOI 10.1038/s41590-020-00832-x
   Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761
   Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E
   Del Valle Diane Marie, 2020, medRxiv, DOI 10.1101/2020.05.28.20115758
   Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202
   Gritti G, 2021, LEUKEMIA, V35, P2710, DOI 10.1038/s41375-021-01299-x
   Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632
   HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7
   HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0
   Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153
   Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158
   Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x
   Kang SJ, 2019, IMMUNITY, V50, P1007, DOI 10.1016/j.immuni.2019.03.026
   Kurzrock R, 2013, CLIN CANCER RES, V19, P3659, DOI 10.1158/1078-0432.CCR-12-3349
   Lamb YN, 2018, DRUGS, V78, P929, DOI 10.1007/s40265-018-0929-z
   Ledford H, 2021, NATURE, V591, P513, DOI 10.1038/d41586-021-00650-7
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Liu BW, 2020, J AUTOIMMUN, V111, DOI 10.1016/j.jaut.2020.102452
   LU ZY, 1995, BLOOD, V86, P3123
   Maes B, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04453-5
   Marshall JL, 2012, J CLIN ONCOL, V30, P2815, DOI 10.1200/JCO.2012.43.4233
   Mayer CL, 2015, CANCER CHEMOTH PHARM, V75, P1037, DOI 10.1007/s00280-015-2720-0
   Meira F, 2021, REV ESP QUIM, V34, P337, DOI 10.37201/req/045.2021
   Meizlish ML, 2021, BLOOD ADV, V5, P1164, DOI 10.1182/bloodadvances.2020003568
   Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340
   MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226
   Nowell MA, 2003, J IMMUNOL, V171, P3202, DOI 10.4049/jimmunol.171.6.3202
   Puchalski T, 2010, CLIN CANCER RES, V16, P1652, DOI 10.1158/1078-0432.CCR-09-2581
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Riegler LL, 2019, THER CLIN RISK MANAG, V15, P323, DOI 10.2147/TCRM.S150524
   Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989
   ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004
   Scheller J, 2012, LANCET, V380, P338, DOI 10.1016/S0140-6736(12)61246-X
   Schirinzi A, 2021, J INFECTION, V82, P121, DOI 10.1016/j.jinf.2020.10.027
   Shankar-Hari M, 2021, JAMA-J AM MED ASSOC, V326, P499, DOI 10.1001/jama.2021.11330
   Sheppard M, 2017, HUM VACC IMMUNOTHER, V13, P1972, DOI 10.1080/21645515.2017.1316909
   Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9
   Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501
   van Rhee F, 2015, ONCOTARGET, V6, P30408, DOI 10.18632/oncotarget.4655
   van Rhee F, 2014, LANCET ONCOL, V15, P966, DOI 10.1016/S1470-2045(14)70319-5
   van Zaanen HCT, 1998, BRIT J HAEMATOL, V102, P783
   WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333
   Walkey Allan J, 2020, Crit Care Explor, V2, pe0113, DOI 10.1097/CCE.0000000000000113
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041
   Zumla A, 2020, LANCET, V395, pE35, DOI 10.1016/S0140-6736(20)30305-6
NR 54
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0741-238X
EI 1865-8652
J9 ADV THER
JI Adv. Ther.
PD MAR
PY 2022
VL 39
IS 3
BP 1126
EP 1148
DI 10.1007/s12325-022-02042-3
EA JAN 2022
PG 23
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 0D1TB
UT WOS:000746346500001
PM 35072887
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Anand, P
   Yadav, A
   Debata, P
   Bachani, S
   Gupta, N
   Gera, R
AF Anand, Pratima
   Yadav, Anita
   Debata, Pradeep
   Bachani, Sumitra
   Gupta, Nitesh
   Gera, Rani
TI Clinical profile, viral load, management and outcome of neonates born to
   COVID 19 positive mothers: a tertiary care centre experience from India
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE Neonates; COVID 19; Viral load; Clinical profile
ID SARS-COV-2 INFECTION
AB Despite rapidly evolving knowledge about COVID 19 infection, routes of perinatal COVID 19 transmission and viral load in mother neonate dyad remain uncertain. Data were analysed to describe the clinicodemographic profile and viral load in neonates born to COVID 19 positive mothers. Of 2947 deliveries, 69 mothers were COVID 19 positive (2.3%), with 1 abortion, 2 macerated stillbirths and 2 fresh stillbirths as pregnancy outcomes. Of 65 tested neonates, 10.7% (7) were confirmed COVID 19 positive by RTPCR (reverse transcriptase-polymerase chain reaction). Viral load (cycle threshold, Ct of E, RDRp) in neonates was comparable with the Ct reported from adults; however, neonates had milder clinical manifestations. All 7 neonates who tested positive for COVID 19 were subsequently discharged. Six of the 7 neonates were asymptomatic and 1 neonate needed respiratory support (indication being prematurity) which resolved after 48 h. Maternal and neonatal comparison of Ct of E and RdRp gene was statistically non-significant (25.97 vs 19.68,p= 0.34 and 26.5 vs 25.0,p= 0.84). Viral loads of mothers with COVID 19 positive neonates compared with mothers with COVID 19 negative neonates for E and RdRp gene were also statistically non-significant (25 vs 27.19,p= 0.63 and 19.6 vs 27.6,p= 0.08). The majority (93%) of neonates tested later than 48 h (roomed in with mother and breastfed) tested negative.
   Conclusion: The study supports milder manifestation in COVID 19 positive neonates. Risk of transmission from COVID 19 positive mother to neonate by rooming-in and breastfeeding is low. In this study on a limited number of neonates, maternal viral load was not found to be associated with the positivity status or severity of the illness of neonate.
   What is Known:
   .Neonates born to COVID 19 positive mothers are at risk of COVID 19 infection.
   What is New:
   . Risk of transmission of COVID 19 from mother to neonate, with rooming-in and breastfeeding, appears low.
   . In this study on a limited number of neonates, maternal viral load of COVID 19 (E and RdRp cycle thresholds) was not associated with severity of illness or COVID 19 positivity in neonates.
C1 [Anand, Pratima; Yadav, Anita; Debata, Pradeep; Gera, Rani] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Paediat, New Delhi 110023, India.
   [Bachani, Sumitra] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Obstet & Gynaecol, New Delhi, India.
   [Gupta, Nitesh] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Resp Med, New Delhi, India.
RP Debata, P (corresponding author), Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Paediat, New Delhi 110023, India.
EM anandpratima@gmail.com; ann_y26@yahoo.com; drpkdebata@gmail.com;
   sumitrabachani@gmail.com; niteshgupta2107@gmail.com;
   drranigera@gmail.com
OI Reis, AlessanRSS/0000-0001-8486-7469
CR Abbas AR, 2020, INT J SURG, V79, P6, DOI 10.1016/j.ijsu.2020.04.083
   Alagarasu K, 2020, INDIAN J MED RES, V151, P483, DOI 10.4103/ijmr.IJMR_1256_20
   [Anonymous], 2019, BREASTF COVID 19 SCI
   Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480
   Badr DA, 2020, AM J OBSTET GYNECOL, V223, P764, DOI 10.1016/j.ajog.2020.07.045
   Blitz MJ, 2020, AM J OBSTET GYNECOL
   Buonsenso D, 2020, AM J PERINAT, V37, P869, DOI 10.1055/s-0040-1710541
   Centeno-Tablante E, 2020, TRANSMISSION NOVEL C
   Chambers C, 2020, JAMA-J AM MED ASSOC, V324, P1347, DOI 10.1001/jama.2020.15580
   Chawla D, 2020, INDIAN PEDIATR, V57, P536, DOI 10.1007/s13312-020-1852-4
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen S, 2020, Zhonghua Bing Li Xue Za Zhi, V49, P418, DOI 10.3760/cma.j.cn112151-20200225-00138
   Chen Y, 2020, FRONT PEDIAT, P2020
   Costa S, 2020, CLIN MICROBIOL INFEC
   De Luca D, 2020, EUR J PEDIATR, V179, P1271, DOI 10.1007/s00431-020-03690-9
   de Winter JP, 2020, EUR J PEDIATR, V179, P1945, DOI 10.1007/s00431-020-03773-7
   Dercle L, 2020, J CLIN ONCOL, V38
   Dong L, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.46211, DOI 10.1001/JAMA.2020.46211]
   Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
   Dong YB, 2022, ENVIRON TECHNOL, V43, P83, DOI 10.1080/09593330.2020.1777589
   Ellington S, 2020, MMWR-MORBID MORTAL W, V69, P769, DOI 10.15585/mmwr.mm6925a1externalicon
   Fan CF, 2021, CLIN INFECT DIS, V72, P862, DOI 10.1093/cid/ciaa226
   Fox A, 2020, EVIDENCE SIGNIFICANT, DOI [10.1101/2020.05.04.20089995, DOI 10.1101/2020.05.04.20089995]
   Gregorio-Hernandez R, 2020, EUR J PEDIATR, V179, P1279, DOI 10.1007/s00431-020-03706-4
   Hantoushzadeh S, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.030
   Kimberlin DW, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.4868.6, DOI 10.1001/JAMA.2020.4868.6]
   La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9
   Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1
   Li Y, 2020, EMERG INFECT DIS, V26, P1335, DOI 10.3201/eid2606.200287
   Liguoro I, 2020, EUR J PEDIATR, V179, P1029, DOI 10.1007/s00431-020-03684-7
   Liu FL, 2020, PREPRINT
   Martinez-Perez O, 2020, JAMA-J AM MED ASSOC, V324, P296, DOI 10.1001/jama.2020.10125
   Mimouni F, 2020, J PERINATOL, V40, P820, DOI 10.1038/s41372-020-0665-6
   Munoz AC, 2020, NEW ENGL J MED, V382, pE49, DOI 10.1056/NEJMc2010614
   Murphy S., NEWBORN BABY TESTS P
   Oncel MY, 2021, EUR J PEDIATR, V180, P733, DOI 10.1007/s00431-020-03767-5
   Ritz N, 2020, EUR J PEDIATR, V179, P1179, DOI 10.1007/s00431-020-03708-2
   Shah PKS, 2020, ACTA OBSTET GYN SCAN, V99, P565, DOI 10.1111/aogs.13870
   Sisman J, 2020, PEDIATR INFECT DIS J, V39, pE265, DOI 10.1097/INF.0000000000002815
   Smith V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234187
   Stuebe A, 2020, BREASTFEED MED, V15, P351, DOI 10.1089/bfm.2020.29153.ams
   Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316
   Vivanti AJ, 2020, EMERG INFECT DIS
   Vivanti AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17436-6
   Wang LS, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.20
   Watson J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1808
   World Health Organization, 46 WHO
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu QC, 2020, INT J INFECT DIS, V95, P376, DOI 10.1016/j.ijid.2020.04.065
   Xu TM, 2020, INT J INFECT DIS, V94, P68, DOI 10.1016/j.ijid.2020.03.022
   Yoon SH, 2020, EUR REV MED PHARMACO, V24, P7804, DOI 10.26355/eurrev_202007_22285
   Zamaniyan M, 2020, PRENATAL DIAG, V40, P1759, DOI 10.1002/pd.5713
   Zeng H, 2020, JAMA-J AM MED ASSOC, V323, P1848, DOI 10.1001/jama.2020.4861
   Zeng LK, 2020, JAMA PEDIATR, V174, P722, DOI 10.1001/jamapediatrics.2020.0878
   Zhang L, 2020, ZHONGHUA FU CHAN KE, V55, pE009
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zhang ZJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00697-2020
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 58
TC 17
Z9 17
U1 4
U2 10
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0340-6199
EI 1432-1076
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD FEB
PY 2021
VL 180
IS 2
BP 547
EP 559
DI 10.1007/s00431-020-03800-7
EA SEP 2020
PG 13
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA PT7YY
UT WOS:000568135000001
PM 32910210
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Chen, DC
   Chen, TW
AF Chen, Dyi-Cheng
   Chen, Tzu-Wen
TI Research on Sustainable Management Strategies for the Machine Tool
   Industry during the COVID-19 Pandemic in Taiwan
SO SUSTAINABILITY
LA English
DT Article
DE analytic network process; COVID-19 pandemic; dynamic capability theory;
   fuzzy Delphi method; machine tool industry; sustainable management
ID FUZZY DELPHI METHOD
AB The machine tool industry is an economically important industry in Taiwan. However, due to the limited natural resources in Taiwan, many of the raw materials required for production must be imported. In 2020, COVID-19, the most serious infectious disease in modern times, broke out across the globe. This has had a great impact on the economic and industrial development of various countries and indirectly affected the development of the machine tool industry. The machine tool industry generally is facing shocks and crises. Therefore, this research article mainly discusses a sustainable operation strategy for the machine tool industry during the COVID-19 epidemic period in Taiwan. Firstly, through the literature on dynamic capability theory (DCT) and expert interviews, the relevant dimensions and criteria are summarized. Then, the fuzzy Delphi method (FDM) and the analytic network process (ANP) are integrated to confirm the relevant dimensions and criteria and to sort the criteria. The five dimensions, in order, are integration ability, learning ability, quality improvement, environmental adaptation, and marketing ability. The ten criteria are diversified learning and innovation ability, integration of multiple sources of knowledge, the ability to learn across departments, the ability to adapt to the external environment, marketing strategy ability, organizational learning ability, integration of resources, improved management efficiency, market research ability, and backward integration. Finally, we put forward business strategies for the ranking results and provide relevant research and industry references.
C1 [Chen, Dyi-Cheng; Chen, Tzu-Wen] Natl Changhua Univ Educ, Dept Ind Educ & Technol, 1 Jin De Rd, Changhua 500, Taiwan.
RP Chen, TW (corresponding author), Natl Changhua Univ Educ, Dept Ind Educ & Technol, 1 Jin De Rd, Changhua 500, Taiwan.
EM twchen@tcivs.tc.edu.tw
OI CHEN, TZUWEN/0000-0002-6490-7993
CR Ali M. R., 2020, Agricultural Engineering International: CIGR Journal, V22, P65
   Bengtsson L., 2016, OPEN INNOVATION MANA, DOI [10.1093/acprof:oso/9780198785972.003.0006, DOI 10.1093/ACPROF:OSO/9780198785972.003.0006]
   Bologa O, 2016, PROCEDIA COMPUT SCI, V91, P683, DOI 10.1016/j.procs.2016.07.171
   Borland H, 2016, J BUS ETHICS, V135, P293, DOI 10.1007/s10551-014-2471-6
   Chang PL, 2011, INT J HYDROGEN ENERG, V36, P14172, DOI 10.1016/j.ijhydene.2011.05.045
   Chung SH, 2020, NETW SPAT ECON, V20, P703, DOI 10.1007/s11067-020-09493-7
   DALKEY N, 1969, FUTURES, V1, P408, DOI 10.1016/S0016-3287(69)80025-X
   Damke Luana Ines, 2021, Environmental Quality Management, V30, P5, DOI 10.1002/tqem.21724
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Helfat CE, 2015, STRATEGIC MANAGE J, V36, P831, DOI 10.1002/smj.2247
   Homan AC, 2020, J APPL PSYCHOL, V105, P1101, DOI 10.1037/apl0000482
   ISHIKAWA A, 1993, FUZZY SET SYST, V55, P241, DOI 10.1016/0165-0114(93)90251-C
   Jou G.T., 2014, I MANAG TECHNOL NATL, V22, P543
   Kaur J, 2020, AUSTRALAS ACCOUNT BU, V15, DOI 10.14453/aabfj.v15i5.6
   Kota HB, 2020, AUSTRALAS ACCOUNT BU, V15, DOI 10.14453/aabfj.v15i5.1
   Krithiga P, 2021, ASIA-PAC J HEALTH MA, V16, P154
   Lee H, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su132212671
   Li JT, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su132313050
   Lifshitz-Assaf H, 2021, ACAD MANAGE J, V64, P684, DOI 10.5465/amj.2017.0712
   MEDDOUR H., 2016, INT J EC PERSPECT, V10, P47
   Munro MM, 2017, SOC ENTERP J, V13, P38, DOI 10.1108/SEJ-06-2016-0021
   MURRAY TJ, 1985, HUM SYST MANAGE, V5, P76
   Nikolic VM, 2021, THERM SCI, V25, P1921, DOI 10.2298/TSCI200726304N
   Noori A, 2020, EXPERT SYST, V37, DOI 10.1111/exsy.12568
   Oum TH, 2020, TRANSPORT POLICY, V96, P94, DOI 10.1016/j.tranpol.2020.07.003
   Polychronopoulos D., 2021, P 2021 IEEE INT C EN, P1, DOI [10.1109/ICE/ITMC52061.2021.9570254, DOI 10.1109/ICE/ITMC52061.2021.9570254]
   Prada-Rios J, 2020, CALDASIA, V42, P313, DOI 10.15446/caldasia.v42n2.76390
   Rogers ML, 2019, J CONSULT CLIN PSYCH, V87, P56, DOI 10.1037/ccp0000373
   Ruolin L, 2021, FRONT EC MANAG, P109
   Saaty T. L., 2004, Journal of Systems Science and Systems Engineering, V13, P1, DOI 10.1007/s11518-006-0151-5
   Saha R, 2021, J MANAG PRACT, V6, P1
   Samiee S, 2019, J INT MARKETING, V27, P20, DOI 10.1177/1069031X1881231
   Sarkar B, 2022, ENVIRON RES, V207, DOI 10.1016/j.envres.2021.112179
   Schmandt J., 2000, SUSTAINABLE DEV CHAL
   Sehnem Simone, 2019, Rev. adm. contemp., V23, P182, DOI 10.1590/1982-7849rac2019170294
   Sensuse D. I., 2018, TURK ONLINE J EDUC T, V17, P25
   SOUZA ELNIVAN M., 2019, RAM, Rev. Adm. Mackenzie, V20, peRAMR190171, DOI 10.1590/1678-6971/eramr190171
   Teece DJ, 2016, EUR ECON REV, V86, P202, DOI 10.1016/j.euroecorev.2015.11.006
   Tseng ML, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su131810150
   Wang P, 2021, MIS QUART, V45, P397, DOI 10.25300/MISQ/2021/15864
   Wang Q, 2021, ENVIRON RES, V202, DOI 10.1016/j.envres.2021.111637
NR 41
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD DEC
PY 2021
VL 13
IS 23
AR 13449
DI 10.3390/su132313449
PG 15
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA XU9NA
UT WOS:000734581100001
OA gold
DA 2022-04-20
ER

PT C
AU Ahmad, A
   Bandara, M
   Fahmideh, M
   Proper, HA
   Guizzardi, G
   Soar, J
AF Ahmad, Aakash
   Bandara, Madhushi
   Fahmideh, Mahdi
   Proper, Henderik A.
   Guizzardi, Giancarlo
   Soar, Jeffrey
GP IEEE Comp Soc
TI An Overview of Ontologies and Tool Support for COVID-19 Analytics
SO 2021 IEEE 25TH INTERNATIONAL ENTERPRISE DISTRIBUTED OBJECT COMPUTING
   CONFERENCE WORKSHOPS (EDOCW 2021)
SE IEEE International Enterprise Distributed Object Computing Conference
   Workshops-EDOCW
LA English
DT Proceedings Paper
CT 25th IEEE International Enterprise Distributed Object Computing
   Conference (IEEE EDOC)
CY OCT 25-29, 2021
CL ELECTR NETWORK
SP IEEE, IEEE Comp Soc, Griffith Univ, Destinat Gold Coast
DE COVID-19; Ontology; Analytics; Semantic Web; Reference Architecture;
   Tool Support
AB Context: The outbreak of the SARS-CoV-2 pandemic of the new COVID-19 disease (COVID-19 for short) demands empowering existing medical, economic, and social emergency backend systems with data analytics capabilities. An impediment in taking advantages of data analytics in these systems is the lack of a unified framework or reference model. Ontologies are highlighted as a promising solution to bridge this gap by providing a formal representation of COVID-19 concepts such as symptoms, infections rate, contact tracing, and drug modelling. Ontology-based solutions enable the integration of diverse data sources that leads to a better understanding of pandemic data, management of smart lockdowns by identifying pandemic hotspots, and knowledge-driven inference, reasoning, and recommendations to tackle surrounding issues.
   Objective: This study aims to investigate COVID-19 related challenges that can benefit from ontology-based solutions, analyse available tool support, and identify emerging challenges that impact research and development of ontologies for COVID-19. Moreover, reference architecture models are presented to facilitate the design and development of innovative solutions that rely on ontology-based solutions and relevant tool support to address a multitude of challenges related to COVID-19.
   Method: We followed the formal guidelines of systematic mapping studies and systematic reviews to identify a total of 56 solutions - published research on ontology models for COVID-19 - and qualitatively selected 10 of them for the review.
   Results: Thematic analysis of the investigated solutions pinpoints five research themes including telehealth, health monitoring, disease modelling, data intelligence, and drug modelling. Each theme is supported by tool(s) enabling automation and user-decision support. Furthermore, we present four reference architectures that can address recurring challenges towards the development of the next generation of ontology-based solutions for COVID-19 analytics.
C1 [Ahmad, Aakash] Univ Hail, Coll Comp Sci & Engn, Hail, Saudi Arabia.
   [Bandara, Madhushi] Univ Technol Sydney, Sch Comp Sci, Sydney, NSW, Australia.
   [Fahmideh, Mahdi; Soar, Jeffrey] Univ Southern Queensland, Brisbane, Qld, Australia.
   [Proper, Henderik A.] Luxembourg Inst Sci & Technol, Luxembourg, Luxembourg.
   [Proper, Henderik A.] Univ Luxembourg, Luxembourg, Luxembourg.
   [Guizzardi, Giancarlo] Free Univ Bozen Bolzano, Fac Comp Sci, Bolzano, Italy.
RP Ahmad, A (corresponding author), Univ Hail, Coll Comp Sci & Engn, Hail, Saudi Arabia.
EM a.abbasi@uoh.edu.sa; Madhushi.bandara@uts.edu.au;
   Mahdi.Fahmideh@usq.edu.au; e.proper@acm.org;
   giancarlo.guizzardi@unibz.it; Jeffrey.Soar@usq.edu.au
CR Ahmed N, 2020, IEEE ACCESS, V8, P134577, DOI 10.1109/ACCESS.2020.3010226
   Anjum N., 2021, INTELLIGENT COVID 19
   Antes G., 2011, SYSTEMATIC REV SUPPO
   Aviv-Sharon E, 2020, INFECT DIS MODEL, V5, P502, DOI 10.1016/j.idm.2020.07.003
   Babcock S, 2021, J BIOMED SEMANT, V12, DOI 10.1186/s13326-021-00245-1
   Bandara M, 2020, SEMANT WEB, V11, P525, DOI 10.3233/SW-190352
   Bastos S. B., 2020, MODELING FORECASTING
   Bernasconi A, 2020, LECT NOTES COMPUT SC, V12400, P388, DOI 10.1007/978-3-030-62522-1_29
   Boldrini C., PERVASIVE MOB COMPUT
   Bragazzi NL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093176
   Costa Daniel G., 2020, IET Smart Cities, V2, P64, DOI 10.1049/iet-smc.2020.0044
   Dutta B., 2020, ARXIV PREPRINT ARXIV
   Fernandes J. A., 2009, NUMEROS ESTATISTICA, P1
   Garba SM, 2020, MATH BIOSCI, V328, DOI 10.1016/j.mbs.2020.108441
   Kachaoui J., 2020, ONTOLOGY PROPOSAL MO
   Kaxiras E, 2020, J MED INTERNET RES, V22, DOI 10.2196/20912
   Keele S., 2007, GUIDELINES PERFORMIN
   Kim J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186691
   Kocic D., 2020, P ICETRAN
   Lecue F, 2020, SEMANT WEB, V11, P41, DOI 10.3233/SW-190374
   Mahalle PN, 2020, DATA ANAL COVID 19 P, DOI DOI 10.20944/PREPRINTS202004.0257.V2
   Mattsson M, 2008, P 12 INT C EV ASS SO, V12, P1
   Pietz J, 2020, EUR J INFORM SYST, V29, P388, DOI 10.1080/0960085X.2020.1793698
   Seeliger A., 2019, JOINT P 6 INT WORKSH, V2465, P30
   Singhal A, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.110023
   Vespignani A., 2018, CHARTING NEXT PANDEM
   Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151
   Wohlin C., 2014, P 18 INT C EVALUATIO, P1, DOI DOI 10.1145/2601248.2601268
   Yan JH, 2018, FRONT COMPUT SCI-CHI, V12, P55, DOI 10.1007/s11704-016-5228-9
   Zeng M.L., 2020, DATA INFORM MANAGEME, V4, P148
   Zuo F., 2020, ARXIV200614882
NR 31
TC 2
Z9 2
U1 0
U2 1
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
SN 2325-6583
BN 978-1-6654-4488-0
J9 IEEE INT ENTERP
PY 2021
BP 1
EP 8
DI 10.1109/EDOCW52865.2021.00026
PG 8
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Computer Science, Theory & Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS5YZ
UT WOS:000744466000001
OA Green Submitted, Bronze
DA 2022-04-20
ER

PT C
AU Tsabalira, M
   Patient, R
AF Tsabalira, Mampho
   Patient, Rambe
BE GarciaPerez, A
   Simkin, L
TI Appropriating Smartphone Applications and Wearables Data for Knowledge
   Management and Effective Health Management
SO PROCEEDINGS OF THE 21ST EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2020)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 21st European Conference on Knowledge Management (ECKM)
CY DEC 02-04, 2020
CL Conventry Univ, ELECTR NETWORK
HO Conventry Univ
DE Smartphone applications; Wearables; Knowledge management; effective
   health management; Unified theory of acceptance and use of technology
   (UTAUT)
ID TECHNOLOGY; ACCEPTANCE; CARE
AB With more smartphones and wearables being unveiled annually, there is a greater potential for them to facilitate data analysis and aggregation for data-intensive sectors such as healthcare. In spite of the smartphones applications and wearables being predicted to be technologically innovative in providing advanced and basic health care monitoring features, South African public sector healthcare use of these monitoring tools is poorly theorized and demonstrates limited empirical application due to the lack of opportunities for sharing, collaborating and accessing new information dealing with patients with chronic diseases. This theoretical study explored relationships between usage of smartphone applications and wearables data (predictor variables) on knowledge management (mediating variable) and desired health management (outcome variable). This paper is a work in progress developed on theory and literature review to unpack the contribution of these digital technologies to enhance the efficiency of healthcare. The results of this preliminary review of literature demonstrated that smartphone and applications-supported medical care rendered personalized health management system that facilitated early detection and monitoring for chronic sickness. Knowledge management partly mediated the relationship between wearables and health management too. Future directions for research could examine the potential impact of the wider rollout of technology-facilitated management of patient data on the prevention and monitoring mechanisms of diseases and their implications for desired health management outcomes. This is particularly critical in view of the prevalence of pandemic such as 2019 novel Coronavirus (Covid-19) which has disastrous effects for on economies with fragile and fragmented healthcare systems.
C1 [Tsabalira, Mampho; Patient, Rambe] Cent Univ Technol, Bloemfontein, South Africa.
RP Tsabalira, M (corresponding author), Cent Univ Technol, Bloemfontein, South Africa.
EM mamphot@fsl.gov.za; prambe@cut.ac.za
CR Ahmad P., 2015, NTERNATIONAL J COMPU, V15, P38
   Al Thomairy N, 2015, HEALTH CARE MANAG, V34, P297, DOI 10.1097/HCM.0000000000000080
   Bhansali R, 2012, PEDIATR ANESTH, V22, P400, DOI 10.1111/j.1460-9592.2012.03805.x
   DePasse JW, 2016, BMJ INNOV, V2, P4, DOI [10. 1136/bmjinnov-2015-000069, DOI 10.1136/BMJINNOV-2015-000069]
   Dwivedi YK, 2019, INFORM SYST FRONT, V21, P719, DOI 10.1007/s10796-017-9774-y
   Ekambaram A, 2018, PROCEDIA COMPUT SCI, V138, P851, DOI 10.1016/j.procs.2018.10.111
   Fuka K., 2014, P IRIS, V23, P1
   Gavali MY, 2017, J CLIN DIAGN RES, V11, DOI 10.7860/JCDR/2017/20948.9826
   Karamitri I, 2017, INT J HEALTH PLAN M, V32, P4, DOI 10.1002/hpm.2303
   Kaye R, 2012, GUIDANCE IND FDA PRE
   Kennedy M.M., 2007, EDUC RESEARCHER, V36, P139
   Lionarons H, 2018, J MHEALTH SIMEDICS L, V1, P1
   Mohammadzadeh Niloofar, 2014, Med Arch, V68, P57
   Murfin Melissa, 2013, J Physician Assist Educ, V24, P38
   Shahmoradi L, 2017, ETHIOP J HEALTH SCI, V27, P541, DOI 10.4314/ejhs.v27i5.13
   Silwattananusarn T., 2012, INT J DATA MINING KN, V2, DOI [10.5121/ijdkp.2012.2502, DOI 10.5121/IJDKP.2012.2502]
   The Department of Health (DoH), 2017, NATL HLTH STRATEGY
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Williams MD, 2015, J ENTERP INF MANAG, V28, P443, DOI 10.1108/JEIM-09-2014-0088
NR 19
TC 1
Z9 1
U1 1
U2 1
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-912764-82-2
J9 PROC EUR CONF KNOWL
PY 2020
BP 1007
EP 1012
DI 10.34190/EKM.20.051
PG 6
WC Business; Information Science & Library Science; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics; Information Science & Library Science
GA BS0SF
UT WOS:000684204300117
DA 2022-04-20
ER

PT J
AU Ricci, L
   Maesa, DD
   Favenza, A
   Ferro, E
AF Ricci, Laura
   Maesa, Damiano Di Francesco
   Favenza, Alfredo
   Ferro, Enrico
TI Blockchains for COVID-19 Contact Tracing and Vaccine Support: A
   Systematic Review
SO IEEE ACCESS
LA English
DT Review
DE Blockchain; COVID-19; Cryptography; Protocols; Vaccines; Public key;
   Privacy; Blockchain; distributed ledgers; cryptography; smart contracts;
   COVID-19; contact tracing; vaccine
AB Several blockchain projects to help against COVID-19 are emerging at a fast pace, showing the potential of this disruptive technology to mitigate the multi-systemic threats the pandemic is posing on all phases of the emergency management and generate value for the economy and society as a whole. This survey investigates how blockchain technology can be useful in the scope of supporting health actions that can reduce the spread of COVID-19 infections and allow a return to normality. Since the prominent use of blockchains to mitigate COVID-19 consequences are in the area of contact tracing and vaccine/immunity passport support, the survey mainly focuses on these two classes of applications. The aim of the survey is to show that only a proper combination of blockchain technology with advanced cryptographic techniques can guarantee a secure and privacy preserving support to fight COVID-19. In particular, this article first presents these techniques, i.e. zero-knowledge, Diffie Hellman, blind signatures, and proxy re-encryption, then describes how they are used in combination with blockchains to define robust and privacy-preserving solutions. Finally, a brief description of blockchain applications beyond contact tracing and vaccine certification is presented.
C1 [Ricci, Laura] Univ Pisa, Dept Comp Sci, I-56126 Pisa, Italy.
   [Maesa, Damiano Di Francesco] Univ Cambridge, Dept Engn, Cambridge CB3 0FS, England.
   [Favenza, Alfredo] LINKS Fdn, I-10131 Turin, Italy.
   [Ferro, Enrico] LINKS Fdn, Dept Business Model Innovat, I-10131 Turin, Italy.
RP Ricci, L (corresponding author), Univ Pisa, Dept Comp Sci, I-56126 Pisa, Italy.
EM laura.ricci@unipi.it
RI ; ricci, laura/Q-7651-2016
OI Favenza, Alfredo/0000-0002-1393-0798; ricci, laura/0000-0002-8179-8215
CR Abd-alrazaq A. A., 2021, COMPUT METHODS PROGR, V1
   Ahmed N, 2020, IEEE ACCESS, V8, P134577, DOI 10.1109/ACCESS.2020.3010226
   Amoretti M, 2018, 2018 IEEE 18TH INTERNATIONAL CONFERENCE ON SOFTWARE QUALITY, RELIABILITY AND SECURITY COMPANION (QRS-C), P146, DOI 10.1109/QRS-C.2018.00038
   Androulaki E, 2018, EUROSYS '18: PROCEEDINGS OF THE THIRTEENTH EUROSYS CONFERENCE, DOI 10.1145/3190508.3190538
   Angelopoulos C. M., 2020, ARXIV200508922
   [Anonymous], 2020, COR PAND EU FUND RIG
   [Anonymous], 2020, P IEEE INT S SYST EN, DOI DOI 10.1007/978-981-13-9097-5
   [Anonymous], 2020, CORONAVIRUS COMM LAU
   [Anonymous], 2020, IMMUNITY PASSPORTS C
   Arifeen M. M., 2020, TECH REP
   Avitabile G., 2020, IACR CRYPTOL, V2020, P493
   Bansal A, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01616-4
   Baumgartner L., 2020, ARXIV200605914
   Bay J., 2020, TECH REP
   Ben-Sasson E, 2014, P IEEE S SECUR PRIV, P459, DOI 10.1109/SP.2014.36
   Benet J., 2014, ARXIV14073561, DOI DOI 10.1109/ICPADS.2007.4447808
   Blaze M, 1998, LECT NOTES COMPUT SC, V1403, P127
   Blum M., 2019, PROVIDING SOUND FDN, P329, DOI DOI 10.1145/3335741.3335757
   Buterin V, 2013, GITHUB REPOSITORY, V1, P22
   Castelo-Branco C, 2021, CLIMACTERIC, V24, P109, DOI 10.1080/13697137.2020.1820477
   Castro M, 1999, USENIX ASSOCIATION PROCEEDINGS OF THE THIRD SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDI '99), P173
   Chamola V, 2020, IEEE ACCESS, V8, P90225, DOI 10.1109/ACCESS.2020.2992341
   Chaudhari S., 2020, ARXIV200801120
   Chaum D., 1983, Advances in Cryptology, Proceedings of Crypto 82, P199
   Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177
   Dar AB, 2020, COMPUT SCI REV, V38, DOI 10.1016/j.cosrev.2020.100307
   De Aguiar EJ, 2020, ACM COMPUT SURV, V53, DOI 10.1145/3376915
   DIFFIE W, 1976, IEEE T INFORM THEORY, V22, P644, DOI 10.1109/TIT.1976.1055638
   Eberhardt J, 2018, IEEE 2018 INTERNATIONAL CONGRESS ON CYBERMATICS / 2018 IEEE CONFERENCES ON INTERNET OF THINGS, GREEN COMPUTING AND COMMUNICATIONS, CYBER, PHYSICAL AND SOCIAL COMPUTING, SMART DATA, BLOCKCHAIN, COMPUTER AND INFORMATION TECHNOLOGY, P1084, DOI 10.1109/Cybermatics_2018.2018.00199
   Eisenstadt M, 2020, IEEE OPEN J ENG MED, V1, P148, DOI 10.1109/OJEMB.2020.2999214
   Esteves-Verissimo P., 2020, ARXIV200504519
   Feige U., 1988, Journal of Cryptology, V1, P77, DOI 10.1007/BF02351717
   Fromknecht C., 2014, IACR CRYPTOL EPRINT, V2014
   Garg C, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01628-0
   Gensini GF, 2004, J INFECTION, V49, P257, DOI 10.1016/j.jinf.2004.03.002
   Gilad Y, 2017, PROCEEDINGS OF THE TWENTY-SIXTH ACM SYMPOSIUM ON OPERATING SYSTEMS PRINCIPLES (SOSP '17), P51, DOI 10.1145/3132747.3132757
   Gueta GG, 2019, I C DEPEND SYS NETWO, P568, DOI 10.1109/DSN.2019.00063
   Hall MA, 2020, JAMA-J AM MED ASSOC, V323, P2243, DOI 10.1001/jama.2020.7712
   Hasan HR, 2020, IEEE ACCESS, V8, P222093, DOI 10.1109/ACCESS.2020.3043350
   Hicks C., 2020, ARXIV200511833
   Huang HW, 2020, IEEE ACCESS, V8, P50574, DOI 10.1109/ACCESS.2020.2979881
   Kalla Anshuman, 2020, IEEE Engineering Management Review, V48, P85, DOI 10.1109/EMR.2020.3014052
   Kapitza R., 2012, P 7 ACM EUR C COMP S, P295, DOI DOI 10.1145/2168836.2168866
   Kritikos, 2020, 10 TECHNOLOGIES FIGH
   Kumar R., 2020, ARXIV200706537
   Legendre F., 2020, ARXIV200702806
   Lv WZ, 2022, IEEE T NETW SCI ENG, V9, P282, DOI 10.1109/TNSE.2020.3030925
   Maesa DD, 2020, J PARALLEL DISTR COM, V138, P99, DOI 10.1016/j.jpdc.2019.12.019
   Micali S., 2020, TECH REP
   Nakamoto S., 2008, BITCOIN TECH REP, V4
   Parno B, 2013, P IEEE S SECUR PRIV, P238, DOI 10.1109/SP.2013.47
   Phelan AL, 2020, LANCET, V395, P1595, DOI 10.1016/S0140-6736(20)31034-5
   Sharma A, 2020, REPROD MED BIOL, V19, P243, DOI 10.1002/rmb2.12326
   Sompolinsky Y., 2013, FAST MONEY GROWS TRE
   Song J., 2020, ARXIV200710529
   Tobin A., 2016, SOVRIN FDN, V29, P1
   Vaudenay S., 2020, IACR CRYPTOL EPRINT
   Vaudenay S., 2020, CENTRALIZED DECENTRA, V2020, P531
   Veronese GS, 2013, IEEE T COMPUT, V62, P16, DOI 10.1109/TC.2011.221
   Warnat-Herresthal S., 2020, BIORXIV
   Wood G, 2014, ETHEREUM PROJECT YEL
   Xu H., 2020, ARXIV200510103
NR 62
TC 12
Z9 12
U1 21
U2 32
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 2169-3536
J9 IEEE ACCESS
JI IEEE Access
PY 2021
VL 9
BP 37936
EP 37950
DI 10.1109/ACCESS.2021.3063152
PG 15
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Engineering; Telecommunications
GA QW8NX
UT WOS:000628906000001
PM 34812382
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Al-Dossary, R
   Alamri, M
   Albaqawi, H
   Al Hosis, K
   Aljeldah, M
   Aljohan, M
   Aljohani, K
   Almadani, N
   Alrasheadi, B
   Falatah, R
   Almazan, J
AF Al-Dossary, Reem
   Alamri, Majed
   Albaqawi, Hamdan
   Al Hosis, Khaled
   Aljeldah, Mohammed
   Aljohan, Mohammed
   Aljohani, Khalid
   Almadani, Noura
   Alrasheadi, Bader
   Falatah, Rawaih
   Almazan, Joseph
TI Awareness, Attitudes, Prevention, and Perceptions of COVID-19 Outbreak
   among Nurses in Saudi Arabia
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; nurses; outbreak; pandemic; Saudi Arabia
ID CHALLENGES; BEHAVIORS; CARE
AB The newly discovered coronavirus (COVID-19) has become a pandemic, infecting thousands of people around the world. This study examines nurses' demographic information (age, gender, marital status, area of practice, total years of experience in the current hospital, work region, monthly salary, educational level, workplace, nationality, working hours per day, total nursing experience, and the respondents' main source of information on COVID-19), awareness, attitudes, prevention, and perceptions of COVID-19 during the outbreak in Saudi Arabia. A cross-sectional descriptive design of 500 nurses working at government and non-governmental hospitals in five regions in Saudi Arabia were selected using convenience sampling. The Kruskal-Wallis test was applied and the Mann-Whitney test was utilized as a post hoc test. The majority of nurses in this study, 96.85%, had excellent knowledge of COVID-19. Some (83.2%) of nurses reported significant prevention knowledge and treatment skills about COVID-19, while 7.6% had little knowledge about prevention. More than half of the nurses (60.4%) had high positive attitudes toward caring for COVID-19 patients. In conclusion, female nurses, married nurses, and bachelor's degree nurses had greater awareness, better attitude, and prevention clinical experience towards COVID-19. Meanwhile, non-Saudi nurses had higher self-reported awareness, positive attitudes, optimal prevention, and positive perceptions compared to Saudi nurses. This study provides baseline information immediately needed to enable health authorities to prioritize training programs that support nurses during the COVID-19 pandemic.
C1 [Al-Dossary, Reem] Imam Abdulrahman Bin Faisal Univ, Nursing Educ Dept, Nursing Coll, Dammam 34221, Saudi Arabia.
   [Alamri, Majed] Univ Hafr Al Batin, Coll Appl Med Sci, Nursing Dept, Hafar al Batin 39911, Saudi Arabia.
   [Albaqawi, Hamdan] Univ Hail, Coll Nursing, Saudi Arabia Asudehou Iwaqablah, Hail 81491, Saudi Arabia.
   [Al Hosis, Khaled] Qassim Univ, Nursing Coll, Dept Nursing Educ, Buraydah 51452, Saudi Arabia.
   [Aljeldah, Mohammed] Univ Hafr Al Batin, Coll Appl Med Sci, Clin Lab Sci Dept, Hafar al Batin 39911, Saudi Arabia.
   [Aljohan, Mohammed] Taibah Univ, Nursing Coll, Al Madinah 42362, Saudi Arabia.
   [Aljohani, Khalid] Taibah Univ, Nursing Coll, Community Hlth Nursing Dept, Al Madinah 42356, Saudi Arabia.
   [Almadani, Noura] Princess Nourah Bint Abdulrahman Univ, Nursing Coll, Nursing Management & Educ Dept, Riyadh 84428, Saudi Arabia.
   [Alrasheadi, Bader] Majmaah Univ, Coll Appl Med Sci, Nursing Dept, Majmaah 11952, Saudi Arabia.
   [Falatah, Rawaih] King Saud Univ, Coll Nursing, Nursing Adm & Educ Dept, Riyadh 13253, Saudi Arabia.
   [Almazan, Joseph] Nazarbayev Univ, Sch Med, Nursultan 010000, Kazakhstan.
RP Almazan, J (corresponding author), Nazarbayev Univ, Sch Med, Nursultan 010000, Kazakhstan.
EM rnaldosari@iau.edu.sa; m.alamri@uhb.edu.sa; h.albaqawi@uoh.edu.sa;
   3747@qu.edu.sa; mmaljeldah@uhb.edu.sa; msejohani@taibahu.edu.sa;
   kajohani@taibahu.edu.sa; naalmadani@pnu.edu.sa; b.alrasheadi@mu.edu.sa;
   rfalatah@ksu.edu.sa; joalmazan030@gmail.com
RI Falatah, Rawaih S/G-9772-2017; Alamri, Majed/AAG-3555-2021; Almadani,
   Noura/AAQ-2066-2021; Falatah, Rawaih/AAB-2891-2021; AL-Dossary,
   Reem/G-2119-2017
OI Falatah, Rawaih S/0000-0003-0673-8105; Almadani,
   Noura/0000-0003-1404-6854; Falatah, Rawaih/0000-0003-0673-8105; Alamri,
   Majed/0000-0002-4463-3534; AL-Dossary, Reem/0000-0002-4272-7609;
   Albaqawi, Hamdan/0000-0001-9749-9669
CR Adams JG, 2020, JAMA-J AM MED ASSOC, V323, P1439, DOI 10.1001/jama.2020.3972
   AL-Dossary RN, 2018, INT NURS REV, V65, P484, DOI 10.1111/inr.12458
   Aldohyan M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3898-2
   Algaissi AA, 2020, J INFECT PUBLIC HEAL, V13, P834, DOI 10.1016/j.jiph.2020.04.016
   Almazan JU, 2019, J TAIBAH UNIV MED SC, V14, P376, DOI 10.1016/j.jtumed.2019.04.006
   Alosaimi DN, 2016, RES THEOR NURS PRACT, V30, P302, DOI 10.1891/1541-6577.30.4.302
   Alsahafi AJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121214
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], **NON-TRADITIONAL**
   [Anonymous], **NON-TRADITIONAL**
   Asaad A, 2020, E MEDITERR HEALTH J, V26, P435, DOI 10.26719/emhj.19.079
   ASIF M, 2019, INT J ENV RES PUB HE, V0016
   Banakhar M., 2017, J NURS ED PRACT, V7, DOI [10.5430/jnep.v7n11p69, DOI 10.5430/JNEP.V7N11P69]
   Buerhaus PI, 2020, JAMA-J AM MED ASSOC, V323, P1777, DOI 10.1001/jama.2020.4978
   Cai ZX, 2020, J PSYCHIATR RES, V131, P132, DOI 10.1016/j.jpsychires.2020.09.007
   Centers for Disease Control and Prevention, 2020, CENT DIS CONTROL PRE
   Condliffe S, 2020, CONTEMP ECON POLICY, V38, P127, DOI 10.1111/coep.12433
   Diomidous Marianna, 2020, Med Arch, V74, P210, DOI 10.5455/medarh.2020.74.210-215
   Drennan J, 2010, J ADV NURS, V66, P422, DOI 10.1111/j.1365-2648.2009.05170.x
   Fang L, 2014, WORKPLACE HEALTH SAF, V62, P447, DOI 10.3928/21650799-20140804-06
   Galedar N, 2021, NURS OPEN, V8, P171, DOI 10.1002/nop2.616
   Garcia-Martin M, 2021, J NURS MANAGE, V29, P258, DOI 10.1111/jonm.13148
   Hessels AJ, 2019, AM J INFECT CONTROL, V47, P623, DOI 10.1016/j.ajic.2019.02.007
   Huynh G, 2020, J TROPICAL MED, V13, P260, DOI DOI 10.4103/1995-7645.280396
   Khattak SR, 2021, J LOSS TRAUMA, V26, P421, DOI 10.1080/15325024.2020.1814580
   Khitam Al, 2020, COVID 19 SAUDI ARABI
   Kieft RAMM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-249
   Kim Y, 2018, AM J INFECT CONTROL, V46, P781, DOI 10.1016/j.ajic.2018.01.012
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Loibner M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210775
   McCloskey B, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000254
   Modi PD, 2020, CUREUS, V12, DOI 10.7759/cureus.7514
   Patiraki E, 2014, CLIN NURS RES, V23, P132, DOI 10.1177/1054773812468447
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P702, DOI 10.1016/j.jiph.2017.05.005
   Sagherian K, 2018, APPL ERGON, V73, P42, DOI 10.1016/j.apergo.2018.05.012
   Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893
   Smith MW, 2017, HEALTH SECUR, V15, P104, DOI 10.1089/hs.2016.0068
   Sun NN, 2020, AM J INFECT CONTROL, V48, P592, DOI 10.1016/j.ajic.2020.03.018
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Thompson BJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211715
   United Nations, UN SECR GEN POL BRIE
   Wankowicz P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165849
   Wong J, 2020, CAN J ANESTH, V67, P732, DOI 10.1007/s12630-020-01620-9
   World Health Organization, 2020, WHO GUID 2014
   World Health Organization, 2020, NOV COR 2019 NCOV TE
NR 47
TC 11
Z9 11
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD NOV
PY 2020
VL 17
IS 21
AR 8269
DI 10.3390/ijerph17218269
PG 16
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA OR0IA
UT WOS:000589157700001
PM 33182352
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Rashed, EA
   Kodera, S
   Shirakami, H
   Kawaguchi, R
   Watanabe, K
   Hirata, A
AF Rashed, Essam A.
   Kodera, Sachiko
   Shirakami, Hidenobu
   Kawaguchi, Ryotetsu
   Watanabe, Kazuhiro
   Hirata, Akimasa
TI Knowledge discovery from emergency ambulance dispatch during COVID-19: A
   case study of Nagoya City, Japan
SO JOURNAL OF BIOMEDICAL INFORMATICS
LA English
DT Article
DE Deep learning; Long short-term memory (LSTM); COVID-19; Emergency
   ambulance dispatch (EAD)
ID TEMPERATURE
AB Accurate forecasting of medical service requirements is an important big data problem that is crucial for resource management in critical times such as natural disasters and pandemics. With the global spread of coronavirus disease 2019 (COVID-19), several concerns have been raised regarding the ability of medical systems to handle sudden changes in the daily routines of healthcare providers. One significant problem is the management of ambulance dispatch and control during a pandemic. To help address this problem, we first analyze ambulance dispatch data records from April 2014 to August 2020 for Nagoya City, Japan. Significant changes were observed in the data during the pandemic, including the state of emergency (SoE) declared across Japan. In this study, we propose a deep learning framework based on recurrent neural networks to estimate the number of emergency ambulance dispatches (EADs) during a SoE. The fusion of data includes environmental factors, the localization data of mobile phone users, and the past history of EADs, thereby providing a general framework for knowledge discovery and better resource management. The results indicate that the proposed blend of training data can be used efficiently in a real-world estimation of EAD requirements during periods of high uncertainties such as pandemics.
C1 [Rashed, Essam A.; Kodera, Sachiko; Hirata, Akimasa] Nagoya Inst Technol, Dept Elect & Mech Engn, Nagoya, Aichi 4668555, Japan.
   [Rashed, Essam A.] Suez Canal Univ, Fac Sci, Dept Math, Ismailia 41522, Egypt.
   [Shirakami, Hidenobu; Kawaguchi, Ryotetsu; Watanabe, Kazuhiro] Nagoya City Fire Dept, Nagoya, Aichi, Japan.
   [Hirata, Akimasa] Nagoya Inst Technol, Ctr Biomed Phys & Informat Technol, Nagoya, Aichi 4668555, Japan.
   [Hirata, Akimasa] Nagoya Inst Technol, Frontier Res Inst Informat Sci, Nagoya, Aichi 4668555, Japan.
RP Rashed, EA (corresponding author), Nagoya Inst Technol, Dept Elect & Mech Engn, Nagoya, Aichi 4668555, Japan.; Rashed, EA (corresponding author), Suez Canal Univ, Fac Sci, Dept Math, Ismailia 41522, Egypt.
EM essam.rashed@nitech.ac.jp
RI Kodera, Sachiko/ABC-5776-2020; Hirata, Akimasa/I-8245-2012; Rashed,
   Essam/F-4320-2012
OI Kodera, Sachiko/0000-0001-6595-0742; Hirata,
   Akimasa/0000-0001-8336-1140; Rashed, Essam/0000-0001-6571-9807
FU JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP20H05753]
FX This work was supported by JSPS KAKENHI Grant NumberJP20H05753.
CR Alessandrini E, 2011, ENVIRON RES, V111, P1192, DOI 10.1016/j.envres.2011.07.005
   Armocida B, 2020, LANCET PUBLIC HEALTH, V5, pE253, DOI 10.1016/S2468-2667(20)30074-8
   Bassil KL, 2011, J EPIDEMIOL COMMUN H, V65, P829, DOI 10.1136/jech.2009.101485
   Bielajs I, 2008, PREHOSPITAL DISASTER, V23, P420, DOI 10.1017/S1049023X00006154
   Buick JE, 2020, CAN J EMERG MED, V22, P426, DOI 10.1017/cem.2020.367
   Cheng J, 2016, INT J BIOMETEOROL, V60, P1863, DOI 10.1007/s00484-016-1173-4
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Glauser W, 2020, CAN MED ASSOC J, V192, pE264, DOI 10.1503/cmaj.1095852
   Graves A, 2009, IEEE T PATTERN ANAL, V31, P855, DOI 10.1109/TPAMI.2008.137
   Higginson R., 2020, J PARAMEDIC PRACT, V12, P179, DOI 10.12968/jpar.2020.12.5.179
   Hu J, 2020, ENVIRON POLLUT, V261, DOI 10.1016/j.envpol.2020.114156
   Irelli EC, 2020, J NEUROL SCI, V418, DOI 10.1016/j.jns.2020.117111
   Kingma D.P., 2014, ARXIV PREPRINT ARXIV, P1
   Kotani K, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1437882
   Lange S.J., 2020, POTENTIAL INDIRECT E, DOI [10.15585/ mmwr.mm6925, DOI 10.15585/MMWR.MM6925]
   Patel D, 2019, ENVIRON POLLUT, V252, P532, DOI 10.1016/j.envpol.2019.05.125
   Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141
   Raoofi A, 2020, ARCH IRAN MED, V23, P220, DOI 10.34172/aim.2020.02
   Sangkharat K, 2020, ENVIRON RES, V182, DOI 10.1016/j.envres.2019.109100
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Terada M., 2013, NTT DOCOMO TECHNICAL, V14, P10
   Whitfield S., 2020, AUSTR J PARAMED, V17, DOI [10.33151/ajp.17.809, DOI 10.33151/AJP.17.809]
   World Health Organization, 2020, PREV ID MAN HLTH WOR
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 24
TC 3
Z9 3
U1 2
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-0464
EI 1532-0480
J9 J BIOMED INFORM
JI J. Biomed. Inform.
PD MAY
PY 2021
VL 117
AR 103743
DI 10.1016/j.jbi.2021.103743
EA MAR 2021
PG 9
WC Computer Science, Interdisciplinary Applications; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Medical Informatics
GA SU3YI
UT WOS:000663077000004
PM 33753268
OA Green Submitted, Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Nagy, DK
   Hall, JJ
   Charrois, TL
AF Nagy, Danielle K.
   Hall, Jill J.
   Charrois, Theresa L.
TI The impact of the COVID-19 pandemic on pharmacy students' personal and
   professional learning
SO CURRENTS IN PHARMACY TEACHING AND LEARNING
LA English
DT Article
DE Pharmacy student; Pharmacy school; Learning; COVID-19; Pandemic;
   Thematic analysis
AB Introduction: The COVID-19 pandemic impacted both healthcare delivery and the education of healthcare students, with a shift to remote delivery of coursework and assessment alongside the expansion of the scope of practice of Alberta pharmacists. The objective of this research was to understand how the learning of pharmacy students at the University of Alberta was impacted by the COVID-19 pandemic.
   Methods: A cross-sectional survey was distributed to 397 pharmacy students in years one through three. Students responded to three short-answer reflection questions: (1) how has the COVID-19 pandemic situation affected your learning; (2) from a pharmacy and pharmacy school perspective, what have you learned since the COVID-19 pandemic began; and (3) from a personal perspective, what have you learned about yourself since the COVID-19 pandemic began? A thematic analysis was undertaken of students' responses to these reflection questions.
   Results: A total of 53 students responded to the survey (response rate 13%). Two major themes were identified across all three reflection questions, with several subthemes: remote learning (learning environment, knowledge transfer, knowledge retention, assessment) and mental health (appreciation, stress, extroversion, motivation). Adaptability, routine, professional identity, and the role of the pharmacist were also identified as less prevalent themes.
   Conclusions: Pharmacy students' responses led to the identification of several themes related to their learning given the changes brought about by the COVID-19 pandemic. This increased understanding of student perceptions has the potential to improve the remote delivery of education, support increased university-wide mental health resourcing, and shape pharmacy curriculum development. (C) 2021 Elsevier Inc. All rights reserved.
C1 [Nagy, Danielle K.] Univ Alberta, Fac Pharm & Pharmaceut Sci, 2-35 Med Sci Bldg,8613-114 St, Edmonton, AB T6G1C9, Canada.
   [Hall, Jill J.] Univ Alberta, Fac Pharm & Pharmaceut Sci, 3-236 Edmonton Clin Hlth Acad,11405-87 Ave, Edmonton, AB T6G1C9, Canada.
   [Charrois, Theresa L.] Univ Alberta, Fac Pharm & Pharmaceut Sci, 3-227 Edmonton Clin Hlth Acad,11405-87 Ave, Edmonton, AB T6G1C9, Canada.
RP Charrois, TL (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, 3-227 Edmonton Clin Hlth Acad,11405-87 Ave, Edmonton, AB T6G1C9, Canada.
EM dwowk@ualberta.ca; jhall@ualberta.ca; tcharroi@ualberta.ca
FU Endowed Chair in Patient Health Management
FX Danielle Nagy received funding in part by the Endowed Chair in Patient
   Health Management, jointly held by the Faculty of Pharmacy and
   Pharmaceutical Sciences and the Faculty of Medicine and Dentistry,
   University of Alberta.
CR [Anonymous], 2020, SUBSECTION 56 1 CLAS
   [Anonymous], 2020, WHAT IMPACT IS PANDE
   [Anonymous], 2021, PHARMACISTS EXPANDE
   [Anonymous], 2020, SURV POST SECONDARY
   [Anonymous], 2020, PHARM BEN NUMB
   Berinato S., 2020, HARVARD BUS REV
   Castleberry A, 2018, CURR PHARM TEACH LEA, V10, P807, DOI 10.1016/j.cptl.2018.03.019
   McCourt E, 2021, INT J PHARM PRACT, V29, P12, DOI 10.1111/ijpp.12669
   Persky AM, 2020, AM J PHARM EDUC, V84, P993, DOI 10.5688/ajpe7782
   Rajab MH, 2020, CUREUS, V12, DOI 10.7759/cureus.8966
   Soland J, 2020, BROWN CTR CHALKBOARD
   Usher K, 2020, INT J MENT HEALTH NU, V29, P1015, DOI 10.1111/inm.12791
   Ward A, 2019, J AM PHARM ASSOC, V59, P23, DOI 10.1016/j.japh.2018.09.001
   Yin RobertK., 2011, QUALITATIVE RES STAR
NR 14
TC 3
Z9 3
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1877-1297
EI 1877-1300
J9 CURR PHARM TEACH LEA
JI Curr. Pharm. Teach. Learn.
PD OCT
PY 2021
VL 13
IS 10
BP 1312
EP 1318
DI 10.1016/j.cptl.2021.07.014
EA SEP 2021
PG 7
WC Education, Scientific Disciplines
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA WW3WQ
UT WOS:000717851500010
PM 34521525
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Colas, K
AF Colas, Kelly
TI Unexpected Intimacies An Exploration of the Physician-Patient
   Relationship during the COVID-19 Pandemic
SO ANTHROPOLOGY IN ACTION-JOURNAL FOR APPLIED ANTHROPOLOGY IN POLICY AND
   PRACTICE
LA English
DT Article
DE biomedicine; COVID-19; intimacy; medical training; moral economy;
   physician-patient relationship
ID HEALTH
AB Anthropologists examining the relationship between physician and patient in Western biomedicine have observed an inherent power discrepancy between the physician, assumed to hold scientific knowledge, and the patient, the recipient of this knowledge. COVID-19 presents a unique challenge to that dynamic, as physicians, scientists and medical experts possess limited understanding of the pathophysiology, interventions and treatment of the disease. Drawing on my experience as a resident physician on the frontlines of the COVID-19 pandemic, I contend that the absence of knowledge surrounding COVID-19 fosters a new form of intimacy between physician and patient through greater emphasis on subjective patient experience, increased transparency between physician and patient, and an expanding physician role beyond management of the physical disease state.
C1 [Colas, Kelly] Internal Med, Washington, DC 20007 USA.
RP Colas, K (corresponding author), Internal Med, Washington, DC 20007 USA.
EM Kelly.colas@medstar.net
CR Adams Vincanne, 2016, METRICS WHAT COUNTS
   Baer H.A., 2003, MED ANTHR WORLD SYST
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bates DG, 2000, PERSPECT BIOL MED, V43, P502
   Berlant L, 1998, CRIT INQUIRY, V24, P281, DOI 10.1086/448875
   Biruk C, 2012, MED ANTHROPOL, V31, P347, DOI 10.1080/01459740.2011.631960
   Burri R. V., 2007, BIOMEDICINE CULTURE
   Centers for Disease Control (CDC), 2020, CDC OV TEST SARS COV
   Clarke AE, 2003, AM SOCIOL REV, V68, P161, DOI 10.2307/1519765
   DiGiacomo S. M., 1987, ENCOUNTERS BIOMEDICI, P315
   Foucault M., 2012, BIRTH CLIN
   Gaines A. D., 2004, ENCY MED ANTHR, P95
   Good, 1993, MED RATIONALITY EXPE
   Good MJD, 2007, ETHNOG STUD SUBJ, V7, P362
   Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054
   Higashi RT, 2013, ANTHROPOL MED, V20, P13, DOI 10.1080/13648470.2012.747595
   Hunt LM, 2017, MED ANTHROPOL Q, V31, P403, DOI 10.1111/maq.12375
   Jordan B, 1993, BIRTH 4 CULTURES CRO
   Jordan J, 1997, NEW TECHNOLOGY-BASED FIRMS IN THE 1990S, VOL III, P55
   Kleinman A, 2006, PLOS MED, V3, P1673, DOI 10.1371/journal.pmed.0030294
   Landa N, 2020, INT J DERMATOL, V59, P739, DOI 10.1111/ijd.14937
   Lock M., 2010, ANTHR BIOMEDICINE
   Oldani Michael J, 2010, Anthropol Med, V17, P215, DOI 10.1080/13648470.2010.493649
   Prince R, 2012, MED ANTHROPOL Q, V26, P534, DOI 10.1111/maq.12006
   Sargent Carolyn, 1996, MED ANTHR CONT THEOR
   Sehlikoglu S, 2015, CAMB J ANTHROPOL, V33, P20, DOI 10.3167/ca.2015.330203
   Singer Merrill, 1986, MED ANTHROPOL Q, V17, P128
   Taylor JS, 2003, ACAD MED, V78, P555, DOI 10.1097/00001888-200306000-00003
   Vaira LA, 2020, LARYNGOSCOPE, V130, P1787, DOI 10.1002/lary.28692
   Wendland CL, 2012, AM ANTHROPOL, V114, P108, DOI 10.1111/j.1548-1433.2011.01400.x
   West CP, 2020, MAYO CLIN PROC, V95, P1127, DOI 10.1016/j.mayocp.2020.04.004
   WHO, 2020, WHO TIM COVID 19
   Wilson A, 2012, PERSPECT INSTR TECHN, P311
   Winichakoon P, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00297-20
NR 34
TC 0
Z9 1
U1 2
U2 2
PU BERGHAHN JOURNALS
PI BROOKLYN
PA 20 JAY ST, SUITE 512, BROOKLYN, NY 11201 USA
SN 0967-201X
EI 1752-2285
J9 ANTHROPOL ACTION
JI Anthropol. Action
PD JUN
PY 2020
VL 27
IS 2
BP 20
EP 27
DI 10.3167/aia.2020.270203
PG 8
WC Anthropology
WE Emerging Sources Citation Index (ESCI)
SC Anthropology
GA OT5OU
UT WOS:000590896300003
OA gold
DA 2022-04-20
ER

PT J
AU Noruzi, A
   Gholampour, B
   Gholampour, S
   Jafari, S
   Farshid, R
   Stanek, A
   Saboury, AA
AF Noruzi, Alireza
   Gholampour, Behzad
   Gholampour, Sajad
   Jafari, Somayeh
   Farshid, Razieh
   Stanek, Agata
   Saboury, Ali Akbar
TI Current and Future Perspectives on the COVID-19 Vaccine: A Scientometric
   Review
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE COVID-19 vaccine; COVID-19 vaccination; bibliometric analysis; research
   trends; research topics; scientific collaboration
AB This study attempted to draw the present and future perspective of the COVID-19 vaccine by identifying the most important scientists and their scientific contexts, trends of research topics, and relationships between different entities. Methods: To achieve this purpose, bibliometric and scientometric techniques were used to analyze 6288 scientific documents contributing to COVID-19 vaccines from the beginning of 2019 to 13 December 2021, indexed in the Web of Science. Results: The United States (US) had the greatest impact by publishing 2104 documents and receiving 32,958 citations. The US and the UK countries had the highest level of scientific collaborations with 192 collaborative studies. The University of Oxford and the Harvard Medical School were the most active institutions, and the University of Oxford and Emory University were the most influential institutions. Pollard AJ and Lambe T had the most publications and the highest citations and h-index. T Lambe, SC Gilbert, M Voysey, and AJ Pollard from the University of Oxford had the highest number of co-authorships. More than 19% of the research was conducted in the field of immunology. The Vaccines journal had the most publications, with 425 articles. The US Department of Health & Human Services granted the most research. In 2019, studies were focused on the topics of COVID-19 virus identification and ways to deal with it; in 2020, studies focused on the topics of COVID-19 and vaccines, whereas in 2021, they focused on the topics of COVID-19 vaccines and their effects, vaccines hesitancy, the role of healthcare workers in COVID-19, as well as discussions about these vaccines in the social media. Conclusions: Recognition of the most important actors (countries, institutes, researchers, and channels for the release of COVID-19 vaccine studies), research trends, and fields of study on the COVID-19 vaccine can be useful for researchers, countries, and policy makers in the field of science and health to make decisions and better understand these vaccines.
C1 [Noruzi, Alireza; Gholampour, Behzad; Jafari, Somayeh] Univ Tehran, Dept Knowledge & Informat Sci, Fac Management, Tehran 1417935840, Iran.
   [Gholampour, Sajad] Kharazmi Univ, Fac Phys Educ & Sports Sci, Dept Sport Management, Tehran 3197937551, Iran.
   [Farshid, Razieh] Kharazmi Univ, Fac Psychol & Educ, Dept Knowledge & Informat Sci, Tehran 3197937551, Iran.
   [Stanek, Agata] Med Univ Silesia, Fac Med Sci Zabrze, Dept Internal Med Angiol & Phys Med, Batorego 15 St, PL-41902 Bytom, Poland.
   [Saboury, Ali Akbar] Univ Tehran, Inst Biochem & Biophys, Tehran 1417614335, Iran.
RP Stanek, A (corresponding author), Med Univ Silesia, Fac Med Sci Zabrze, Dept Internal Med Angiol & Phys Med, Batorego 15 St, PL-41902 Bytom, Poland.; Saboury, AA (corresponding author), Univ Tehran, Inst Biochem & Biophys, Tehran 1417614335, Iran.
EM noruzi@ut.ac.ir; behzad903727@yahoo.com; sajad908919@yahoo.com;
   jafari.somayyeh@gmail.com; razieh.farshid@gmail.com; astanek@tlen.pl;
   Saboury@ut.ac.ir
RI Nouruzi, Alireza/AGJ-8718-2022; Stanek, Agata/N-8179-2017; Gholampour,
   Behzad/AFP-5375-2022; Gholampour, Sajad/AFP-5350-2022; Noruzi,
   Alireza/D-1868-2010
OI Stanek, Agata/0000-0001-6939-9898; Gholampour,
   Behzad/0000-0003-4418-1117; Gholampour, Sajad/0000-0002-1687-770X;
   Noruzi, Alireza/0000-0003-0877-1566; Saboury, Ali
   Akbar/0000-0003-0604-9465
CR Ay M.O., 2021, WORLD J ADV RES REV, V9, P138, DOI [10.30574/WJARR.2021.9.3.0093, DOI 10.30574/WJARR.2021.9.3.0093]
   Chen YM, 2021, BIOSCI TRENDS, V15, P64, DOI 10.5582/bst.2021.01061
   Gholampour B., 2022, INT J INF SCI MANAG
   Gholampour B., 2022, SCIENTOMETRICS
   Gholampour B., 2020, IRAN J INF PROCESS M, V35, P1119
   Gholampour S., 2019, WEBOLOGY, V16, P223, DOI [10.14704/WEB/V16I2/a200, DOI 10.14704/WEB/V16I2/A200]
   Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Haber P, 2018, HUM VACC IMMUNOTHER, V14, P2755, DOI 10.1080/21645515.2018.1491509
   Hasan A, 2021, J BIOMOL STRUCT DYN, V39, P3025, DOI 10.1080/07391102.2020.1754293
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jafari S.B., 2021, IRAN J MED MICROBIOL, V15, P414
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Moradian N, 2021, ADV EXP MED BIOL, V1318, P923, DOI 10.1007/978-3-030-63761-3_52
   Moradian N, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02364-2
   Rahban M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10214802
   Shin MD, 2020, NAT NANOTECHNOL, V15, P646, DOI 10.1038/s41565-020-0737-y
   Surulinathi M., 2020, LIB PHILOS PRACT, P4781
   US Food & Drug Administration, COM PFIZ BIONTECH CO
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhang YG, 2019, HUM VACC IMMUNOTHER, V15, P3024, DOI 10.1080/21645515.2019.1614398
   Zimmer C., COVID 19 VACCINE TRA
NR 23
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD FEB
PY 2022
VL 11
IS 3
AR 750
DI 10.3390/jcm11030750
PG 20
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA ZA4OB
UT WOS:000756143800001
PM 35160202
OA gold, Green Accepted, Green Published
DA 2022-04-20
ER

PT J
AU Pulk, RA
   Leber, M
   Tran, L
   Ammar, M
   Amin, N
   Miller, L
   Yazdi, M
AF Pulk, Rebecca Ann
   Leber, Molly
   Tran, Lydia
   Ammar, Mahmoud
   Amin, Nilesh
   Miller, LeeAnn
   Yazdi, Marina
TI Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing
   patient care through formulary and drug shortage management
SO AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
LA English
DT Article
DE COVID-19; learning health system; organizational innovation; medication
   supply and distribution; pharmacy; policy
AB Purpose. The coronavirus disease 2019 (COVID-19) pandemic has created unprecedented challenges for health systems around the world. We describe our approach to adapting the pharmacy leadership structure to address critical medication shortages through innovative data analysis, procurement strategies, and rapid implementation of medication policy.
   Summary. Yale New Haven Health deployed a system incident management command structure to effectively respond to the COVID-19 crisis. System pharmacy services adopted a similar framework to enable efficient communication and quick decision-making in key domains, including drug procurement and policy. By refining a model to project health-system medication needs, we were able to anticipate challenges and devise alternative treatment algorithms. By leveraging big data and creating a system knowledge base, we were able to consolidate reporting and coordinate efforts to ensure system success. Various procurement strategies were employed to ensure adequate supply, including frequent communication with our wholesaler, sourcing direct from suppliers, outsourcing of sterile products compounding to registered 503B outsourcing facilities, and acquisition of active pharmaceutical ingredients for compounding of essential medications. Strategic positioning of pharmacists within the health system's incident command response teams and rapid adaption of drug use policy governance fueled accelerated response and nimble implementation. Communication was streamlined and executed via multiple outlets to reach a broad audience across the health system.
   Conclusion. With medication shortages posing a threat to patient care, dynamic pharmacy leadership proved essential to providing patient care at the height of the COVID-19 pandemic. System alignment and the rapid adaption of the existing framework for drug shortage management and medication use policy were crucial to success in crisis response.
C1 [Pulk, Rebecca Ann; Leber, Molly; Miller, LeeAnn; Yazdi, Marina] Yale New Haven Hlth, Corp Pharm Serv, New Haven, CT 06519 USA.
   [Tran, Lydia; Ammar, Mahmoud; Amin, Nilesh] Yale New Haven Med Ctr, Dept Pharm Serv, 20 York St, New Haven, CT 06504 USA.
RP Yazdi, M (corresponding author), Yale New Haven Hlth, Corp Pharm Serv, New Haven, CT 06519 USA.
EM marina.yazdi@ynhh.org
OI Pulk, Rebecca/0000-0003-0949-9699; /0000-0002-6315-5435; Miller,
   LeeAnn/0000-0001-7611-0781; Ammar, Mahmoud/0000-0002-3401-9960
FU NCATS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1 TR001863] Funding Source: Medline
CR American Society of Health-System Pharmacists, ASHP COVID 19 PAND A
   Centers for Disease Control and Prevention, COVIDVIEW WEEKL SURV
   Institute for Health Metrics Evaluation, COVID 19 PROJ CONN
   Murray CJL, 2020, IHME COVID 19 HLTH S, DOI [10.1101/2020.04.21.20074732v1, DOI 10.1101/2020.04.21.20074732V1]
NR 4
TC 8
Z9 8
U1 2
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-2082
EI 1535-2900
J9 AM J HEALTH-SYST PH
JI Am. J. Health-Syst. Pharm.
PD NOV 15
PY 2020
VL 77
IS 22
BP 1874
EP 1884
DI 10.1093/ajhp/zxaa219
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA QC2FO
UT WOS:000614650600013
PM 32710774
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU McCulloch, H
   Campbell-Yeo, M
   Richardson, B
   Dol, J
   Hundert, A
   Dorling, J
   Whitehead, L
   MacRae, G
   Bishop, T
   Afifi, J
   Earle, R
   Rose, AE
   Foye, S
   Inglis, D
   Kim, T
   Leighton, C
   Melanson, A
   Simpson, DC
   Smit, M
AF McCulloch, Holly
   Campbell-Yeo, Marsha
   Richardson, Brianna
   Dol, Justine
   Hundert, Amos
   Dorling, Jon
   Whitehead, Leah
   MacRae, Gail
   Bishop, Tanya
   Afifi, Jehier
   Earle, Rebecca
   Rose, Annette Elliott
   Foye, Sarah
   Inglis, Darlene
   Kim, Theresa
   Leighton, Carye
   Melanson, Andrea
   Simpson, David C.
   Smit, Mike
TI The Impact of Restrictive Family Presence Policies in Response to
   COVID-19 on Family Integrated Care in the NICU: A Qualitative Study
SO HERD-HEALTH ENVIRONMENTS RESEARCH & DESIGN JOURNAL
LA English
DT Article; Early Access
DE neonatal intensive care; COVID-19; qualitative; family-integrated care;
   presence
ID SOCIAL SUPPORT; NEWBORN CARE; SYMPTOMS; STRESS; NEEDS
AB Objectives: To conduct a needs assessment with families and their healthcare team to understand the impact of restrictive family presence policies in the neonatal intensive care unit (NICU) in response to COVID-19. Background: In response to the COVID-19 pandemic, significant restrictive family presence policies were instituted in most NICUs globally intended to protect infants, families, and HCPs. However, knowledge on the impact of the stress of the pandemic and policies restricting family presence in the NICU on vulnerable neonates and their families remains limited. Methods: Individuals were eligible to participate if they were a caregiver of an infant requiring NICU care or a healthcare provider (HCP) in the NICU after March 1, 2020. Semi-structured interviews were conducted using a virtual communication platform, and transcripts were analyzed using inductive thematic qualitative content analysis. Results: Twenty-three participants were interviewed (12 families and 11 HCPs). Three themes emerged: (1) successes (family-integrated care, use of technology), (2) challenges (lack of standardized messaging and family engagement, impact on parental wellbeing, institutional barriers, and virtual care), and (3) moving forward (responsive and supportive leadership). Conclusions: Our findings highlight the significant impact of family restrictions on the mental well-being of families, physical closeness with parents, and empathetic stress to HCPs. Further study of potential long-term impact is warranted.
C1 [McCulloch, Holly; Campbell-Yeo, Marsha; Dol, Justine; Hundert, Amos; Dorling, Jon; Whitehead, Leah; MacRae, Gail; Bishop, Tanya; Afifi, Jehier; Earle, Rebecca; Rose, Annette Elliott; Foye, Sarah; Inglis, Darlene; Kim, Theresa; Leighton, Carye; Melanson, Andrea; Simpson, David C.] IWK Hlth, Halifax, NS, Canada.
   [Campbell-Yeo, Marsha; Richardson, Brianna; Dol, Justine] Dalhousie Univ, Fac Hlth, Sch Nursing, Halifax, NS, Canada.
   [Smit, Mike] Dalhousie Univ, Sch Informat Management, Halifax, NS, Canada.
RP Campbell-Yeo, M (corresponding author), 5850-5869 Univ Ave,POB 15000, Halifax, NS B3H 4R2, Canada.
EM marsha.campbell-yeo@dal.ca
RI Dorling, Jon/B-7409-2015; Dol, Justine/AAC-3973-2022
OI Dorling, Jon/0000-0002-1691-3221; Dol, Justine/0000-0002-8928-7647
FU Nova Scotia Health Research COVID-19 Coalition
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by the Nova Scotia Health Research COVID-19 Coalition.
CR Baley J, 2015, PEDIATRICS, V136, P596, DOI 10.1542/peds.2015-2335
   Bembich S, 2021, ACTA PAEDIATR, V110, P940, DOI 10.1111/apa.15620
   Bouchoucha SL, 2021, NURS HEALTH SCI, V23, P4, DOI 10.1111/nhs.12748
   Bryanton J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004068.pub4
   Carter JD, 2007, PERSONAL MENT HEALTH, V1, P40, DOI 10.1002/pmh.4
   Cheng C, 2021, J REPROD INFANT PSYC, V39, P166, DOI 10.1080/02646838.2019.1659940
   Darcy Mahoney Ashley, 2020, J Perinatol, V40, P36, DOI 10.1038/s41372-020-0753-7
   Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x
   Erdei C, 2020, J PERINATOL, V40, P1283, DOI 10.1038/s41372-020-0745-7
   Franck LS, 2020, CRIT CARE NURS CLIN, V32, P149, DOI 10.1016/j.cnc.2020.01.001
   Franck LS, 2019, BIRTH DEFECTS RES, V111, P1044, DOI 10.1002/bdr2.1521
   Gaulton J., 2020, NEJM CATAL INNOV CAR, DOI [10.1056/CAT.20.0169, DOI 10.1056/CAT.20.0169]
   Gehl MB, 2020, ADV NEONAT CARE, V20, P59, DOI 10.1097/ANC.0000000000000644
   Guttmann K, 2020, J PATIENT EXPERIENCE, V7, P1378, DOI 10.1177/2374373520950927
   Hall SL, 2015, J PERINATOL, V35, pS9, DOI 10.1038/jp.2015.143
   Hart JL, 2020, J PAIN SYMPTOM MANAG, V60, pE93, DOI 10.1016/j.jpainsymman.2020.04.017
   Hynan MT, 2020, J PERINATOL, V40, P985, DOI 10.1038/s41372-020-0696-z
   Jiang SY, 2014, EARLY HUM DEV, V90, P781, DOI 10.1016/j.earlhumdev.2014.08.019
   Kim THM, 2020, JOGNN-J OBST GYN NEO, V49, P452, DOI 10.1016/j.jogn.2020.05.007
   Lebel C, 2020, J AFFECT DISORDERS, V277, P5, DOI 10.1016/j.jad.2020.07.126
   Mayopoulos Gus, 2020, medRxiv, DOI 10.1101/2020.11.30.20241026
   MCHAFFIE HE, 1992, J ADV NURS, V17, P279, DOI 10.1111/j.1365-2648.1992.tb01905.x
   Monaghan J., 2020, J NEONATAL NURSING, V26, P101, DOI [10.1016/j.jnn.2019.09.001, DOI 10.1016/J.JNN.2019.09.001]
   Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375091, 10.1080/13814788.2017.1375092]
   Munshi L, 2021, CAN MED ASSOC J, V193, pE135, DOI 10.1503/cmaj.202636
   Murray PD, 2020, J PERINATOL, V40, P1576, DOI 10.1038/s41372-020-00781-1
   Negron R, 2013, MATERN CHILD HLTH J, V17, P616, DOI 10.1007/s10995-012-1037-4
   Nottage SL, 2005, COMPR CHILD ADOLES N, V28, P257, DOI 10.1080/01460860500396922
   O'Brien K, 2018, LANCET CHILD ADOLESC, V2, pE5, DOI 10.1016/S2352-4642(18)30072-5
   O'Brien K, 2018, LANCET CHILD ADOLESC, V2, P245, DOI 10.1016/S2352-4642(18)30039-7
   Pang Emily M, 2021, Neoreviews, V22, pe1, DOI 10.1542/neo.22-1-e1
   Patterson ES, 2019, HERD-HEALTH ENV RES, V12, P124, DOI 10.1177/1937586718792885
   Pinelli J, 2000, Neonatal Netw, V19, P27
   Shorey S, 2014, J CLIN NURS, V23, P2272, DOI 10.1111/jocn.12507
   Tandberg BS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224488
   Tscherning C, 2020, ACTA PAEDIATR, V109, P1937, DOI 10.1111/apa.15455
   van Veenendaal NR, 2021, ACTA PAEDIATR, V110, P2008, DOI 10.1111/apa.15857
   Wong A, 2021, J MED INTERNET RES, V23, DOI 10.2196/20621
NR 38
TC 0
Z9 0
U1 2
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1937-5867
EI 2167-5112
J9 HERD-HEALTH ENV RES
JI Herd-Health Env. Res. Des. J.
AR 19375867211065178
DI 10.1177/19375867211065178
EA DEC 2021
PG 14
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA XX6MA
UT WOS:000736405900001
PM 34931565
OA hybrid
DA 2022-04-20
ER

PT C
AU Qatanani, D
   Al-Tawara, F
   Qusef, A
AF Qatanani, Diala
   Al-Tawara, Feda'a
   Qusef, Abdallah
GP IEEE
TI SUCCESS FACTORS OF AGILE PROJECTS: CASE STUDY FOR PROJECTS IN JORDAN
   DURING COVID-19 PANDEMIC
SO 2021 IEEE JORDAN INTERNATIONAL JOINT CONFERENCE ON ELECTRICAL
   ENGINEERING AND INFORMATION TECHNOLOGY (JEEIT)
LA English
DT Proceedings Paper
CT IEEE Jordan International Joint Conference on Electrical Engineering and
   Information Technology (JEEIT)
CY NOV 16-17, 2021
CL JORDAN
SP IEEE, IEEE Jordan Sect, IEEE Reg 8, Jordan Engineers Assoc, Atypon
DE Agile software development; Projeet management; Productivity in
   COVID-19; Response
ID SOFTWARE PROJECTS
AB The world has responded to the COVID-19 pandemic by obtaining minimal knowledge and using it to confront several nncertainties. Their capacity to be agile and innovative has been stressed, especially with the timing of policy measures, the degree of decentralization, the balance between flexibility and stability. The agile project management approach was commonly used to resolve the risks, where it illustrates individuals and collaboration ability that simplifies the production phase. This paper presents the results of a study that mainly focused on investigating the success factors of agile projects in Jordan during the COVID-19 pandemic. This was achieved by conducting a questionnaire distributed to employees and managers in several Jordanian companies. The results show that team capability and motivation are the most important success factors for many firms. However, most of the firms agreed that activate a reward system is not an important factor during extraordinary times for agile projects.
C1 [Qatanani, Diala; Al-Tawara, Feda'a; Qusef, Abdallah] Princess Sumaya Univ Technol, Dept Software Engn, Amman, Jordan.
RP Qatanani, D (corresponding author), Princess Sumaya Univ Technol, Dept Software Engn, Amman, Jordan.
EM dia20188100@std.psut.edu.jo; fed20208093@std.psut.edu.jo;
   a.qusef@psut.edu.jo
CR Anderson D. J., AGILE MANAGEMENT SOF
   Batra D, 2020, INFORM SYST MANAGE, V37, P361, DOI 10.1080/10580530.2020.1821843
   Bhavsar K., 2020, INT J INNOV TECHNOL, V9, P840
   Boghossian Z. J., 2002, INVESTIGATION CRITIC
   Bullen C. V., 1981, PRIMER CRITICAL SUCC
   Bytheway AJ, 1999, IEEE SOFTWARE, V16, P15, DOI 10.1109/MS.1999.765781
   Chiyangwa TB, 2017, S AFR J INFORM MANAG, V19, DOI 10.4102/sajim.v19i1.838
   Chow T, 2008, J SYST SOFTWARE, V81, P961, DOI 10.1016/j.jss.2007.08.020
   Cockburn A., 2001, MANIF ESTO AGILE SOF
   da Camara R., 2020, ARXIV200613715, p137I5
   Darwish N. R., 2015, INT J COMPUTER APPL, V118
   Dev CAG, 2016, CHIN J MECH ENG-EN, V29, P880, DOI 10.3901/CJME.2016.0608.071
   Dhahri A. A., 2020, CUREUS J MED SCIENCE, V12
   Ghayyur SAK, 2018, INT J ADV COMPUT SC, V9, P278
   Highsmith A, 2002, AGILE SOFTWARE DEV E
   Karlstrom D, 2005, IEEE SOFTWARE, V22, P43, DOI 10.1109/MS.2005.59
   Koch A. S., 2005, AGILE SOFTWARE DEV E
   Lindvall M, COMPUTER, V37
   Mancl D, 2020, LECT NOTES BUS INF P, V396, P309, DOI 10.1007/978-3-030-58858-8_32
   Nerur S, 2005, COMMUN ACM, V48, P72, DOI 10.1145/1060710.1060712
   Ozienulska A., 2016, J EC MANAGEMENT, V25, P79
   PINTO JK, 1988, J MANAGE, V14, P5, DOI 10.1177/014920638801400102
   Reel JS, 1999, IEEE SOFTWARE, V16, P18, DOI 10.1109/52.765782
   Reifer DJ, 2003, IEEE SOFTWARE, V20, P12, DOI 10.1109/MS.2003.1207448
   ROCKART JF, 1984, SLOAN MANAGE REV, V25, P3
   Schatz B, 2005, IEEE SOFTWARE, V22, P36, DOI 10.1109/MS.2005.74
   Serrador P, 2015, INT J PROJ MANAG, V33, P1040, DOI 10.1016/j.ijproman.2015.01.006
   Shakya P., 2020, J INFORM TECHNOLOGY, V2, P3
   Srivastava A, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON COMPUTING, COMMUNICATION AND AUTOMATION (ICCCA), P864, DOI 10.1109/CCAA.2017.8229928
   Stankovic D, 2013, J SYST SOFTWARE, V86, P1663, DOI 10.1016/j.jss.2013.02.027
   Wahbi A., 2020, 2020 INT COT ADV COM
NR 31
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-6654-4293-0
PY 2021
BP 95
EP 102
DI 10.1109/JEEIT53412.2021.9634094
PG 8
WC Computer Science, Theory & Methods; Engineering, Electrical & Electronic
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science; Engineering
GA BS7NW
UT WOS:000765316500017
DA 2022-04-20
ER

PT J
AU Bohlken, J
   Schomig, F
   Seehagen, T
   Kohler, S
   Gehring, K
   Roth-Sackenheim, C
   Matschinger, H
   Riedel-Heller, SG
AF Bohlken, Jens
   Schoemig, Friederike
   Seehagen, Thorsten
   Koehler, Sabine
   Gehring, Klaus
   Roth-Sackenheim, Christa
   Matschinger, Herbert
   Riedel-Heller, Steffi G.
TI Experience of Practice-Based Psychiatrists and Neurologists During the
   COVID-19 Pandemic
SO PSYCHIATRISCHE PRAXIS
LA German
DT Article
DE survey; burden; outpatient care; psychiatrists; COVID-19
AB Aim To date, to our knowledge there are no studies regarding attitudes and experiences of outpatient medical personnel during a pandemic. This study's aim was to evaluate the impact of the COVID-19 pandemic in March 2020 on German psychiatrists and neurologists.
   Methods An e-mail and fax-based short survey of 2,072 practice-based psychiatrists and neurologists was performed including Likert-type questions on personal burden and concerns, anticipated risk of infection, practice management as well as anxiety and sleep problems.
   Results 396 physicians returned the questionnaire (19 %). More than 60% of the participants felt restricted strongly or very strongly, more than 30% were strongly and very strongly concerned. They anticipated a high own risk of infection. However, 91% did not report any contact with patients positively screened for COVID-19, which they were aware of. One third felt financially threatened and loss of business volume was anticipated. 18% reported, that the pandemic triggers substantial anxiety. Sleep problems, which occur at least almost every night, were rarely reported (9 %).
   Conclusion Practice-based psychiatrists and neurologists are negatively affected by the COVID-19 pandemic.
C1 [Bohlken, Jens; Matschinger, Herbert; Riedel-Heller, Steffi G.] Univ Leipzig, Med Fak, Inst Sozialmed Arbeitsmed & Publ Hlth ISAP, Philipp Rosenthal Str 55, Leipzig, Germany.
   [Schoemig, Friederike] Univ Med Berlin, Charite Campus Berlin Mitte, Klin Unfall & Wiederherstellungschirurg, Ctr Muskuloskeletale Chirurg CMSC,Klin Orthopad, Berlin, Germany.
   [Bohlken, Jens; Seehagen, Thorsten; Koehler, Sabine; Gehring, Klaus; Roth-Sackenheim, Christa] Berufsverband Deutsch Nervenarzte BVDN, Berlin, Germany.
RP Bohlken, J (corresponding author), Univ Leipzig, Med Fak, Inst Sozialmed Arbeitsmed & Publ Hlth ISAP, Philipp Rosenthal Str 55, Leipzig, Germany.
EM dr.j.bohlken@gmx.net
RI Riedel-Heller, Steffi/ABG-1537-2021
CR Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X
   Li ZY, 2020, BRAIN BEHAV IMMUN, V88, P916, DOI 10.1016/j.bbi.2020.03.007
   Luo TD., 2020, ZHONGHUA LAO DONG WE, V38, P192, DOI [DOI 10.3760/CMA.J.CN121094-20200219-00063, 10.3760/cma.j.cn121094-20200219-00063]
   Petzold MB, 2020, NERVENARZT, V91, P417, DOI 10.1007/s00115-020-00905-0
   Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Xu J, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112955
NR 8
TC 14
Z9 15
U1 0
U2 7
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0303-4259
EI 1439-0876
J9 PSYCHIAT PRAX
JI Psychiatr. Prax.
PD MAY
PY 2020
VL 47
IS 4
BP 214
EP 217
DI 10.1055/a-1159-5575
PG 4
WC Psychiatry
WE Social Science Citation Index (SSCI)
SC Psychiatry
GA LJ7US
UT WOS:000530367300009
PM 32340050
DA 2022-04-20
ER

PT J
AU Sharathkumar, AA
   Faustino, EVS
   Takemoto, CM
AF Sharathkumar, Anjali A.
   Faustino, E. Vincent S.
   Takemoto, Clifford M.
TI How we approach thrombosis risk in children with COVID-19 infection and
   MIS-C
SO PEDIATRIC BLOOD & CANCER
LA English
DT Article
DE anticoagulation; COVID-19; MIS-C; thrombosis
ID DISEASE; COAGULOPATHY; MANAGEMENT
AB Thrombosis within the microvasculature and medium to large vessels is a serious and common complication among critically ill individuals with coronavirus disease 2019 (COVID-19). While children are markedly less likely to develop severe disease than adults, they remain at risk for thrombosis during acute infection and with the post-acute inflammatory illness termed multisystem inflammatory syndrome in children. Significant knowledge deficits in understanding COVID-19-associated coagulopathy and thrombotic risk pose clinical challenges for pediatric providers who must incorporate expert opinion and personal experience to manage individual patients. We discuss clinical scenarios to provide framework for characterizing thrombosis risk and thromboprophylaxis in children with COVID-19.
C1 [Sharathkumar, Anjali A.] Univ Iowa, Carver Coll Med, Stead Family Dept Pediat, 200 Hawkins Dr, Iowa City, IA 52246 USA.
   [Faustino, E. Vincent S.] Yale Sch Med, Dept Pediat, Sect Pediat Crit Care Med, New Haven, CT USA.
   [Takemoto, Clifford M.] St Jude Childrens Res Hosp, Div Clin Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA.
RP Sharathkumar, AA (corresponding author), Univ Iowa, Carver Coll Med, Stead Family Dept Pediat, 200 Hawkins Dr, Iowa City, IA 52246 USA.
EM anjali-sharathkumar@uiowa.edu
OI Faustino, Edward Vincent S./0000-0001-6155-2691
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Al-Ani F, 2020, THROMB RES, V192, P152, DOI 10.1016/j.thromres.2020.05.039
   Al-Ghafry M, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28737
   Arachchillage DRJ, 2020, BRIT J HAEMATOL, V189, P216, DOI 10.1111/bjh.16431
   Arlet JB, 2020, LANCET HAEMATOL, V7, pE632, DOI 10.1016/S2352-3026(20)30204-0
   Aydillo T, 2020, NEW ENGL J MED, V383, P2586, DOI 10.1056/NEJMc2031670
   Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Barton LM, 2020, AM J CLIN PATHOL, V153, P725, DOI [10.1093/ajcp/aqaa062, 10.1093/AJCP/AQAA062]
   Lemos ACB, 2020, THROMB RES, V196, P359, DOI 10.1016/j.thromres.2020.09.026
   Beun R, 2020, INT J LAB HEMATOL, V42, P19, DOI 10.1111/ijlh.13230
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Bianconi V, 2020, DRUGS, V80, P1383, DOI 10.1007/s40265-020-01365-1
   Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016
   D'Alessandro A, 2020, J PROTEOME RES, V19, P4417, DOI 10.1021/acs.jproteome.0c00365
   Datta SD, 2020, JAMA-J AM MED ASSOC, V324, P2251, DOI 10.1001/jama.2020.22717
   Del Borrello G, 2021, J THROMB HAEMOST, V19, P522, DOI 10.1111/jth.15216
   Duarte-Salles Talita, 2020, medRxiv, DOI 10.1101/2020.10.29.20222083
   Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756
   Dujardin RWG, 2020, THROMB RES, V196, P308, DOI 10.1016/j.thromres.2020.09.017
   Fan Q, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00404
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Fernandes DM, 2021, J PEDIATR-US, V230, P23, DOI 10.1016/j.jpeds.2020.11.016
   Goldenberg NA, 2020, J THROMB HAEMOST, V18, P3099, DOI 10.1111/jth.15073
   Goshua G, 2020, LANCET HAEMATOL, V7, pE575, DOI 10.1016/S2352-3026(20)30216-7
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Halton J, 2021, LANCET HAEMATOL, V8, pE22, DOI 10.1016/S2352-3026(20)30368-9
   Hasan SS, 2020, J THROMB THROMBOLYS, V50, P814, DOI 10.1007/s11239-020-02235-z
   Henderson LA, 2021, ARTHRITIS RHEUMATOL, V73, pE13, DOI 10.1002/art.41616
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Iba T, 2020, INFLAMM RES, V69, P1181, DOI 10.1007/s00011-020-01401-6
   Iba T, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03077-0
   Kappelman MD, 2011, GUT, V60, P937, DOI 10.1136/gut.2010.228585
   Key NS, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.01461
   Kim SY, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104873
   Klaassen ILM, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0877-x
   Ko RH, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00012
   Kumar R, 2018, BLOOD ADV, V2, P285, DOI 10.1182/bloodadvances.2017012336
   Li A, 2019, THROMB RES, V173, P158, DOI 10.1016/j.thromres.2018.02.144
   Lisman T, 2020, J THROMB THROMBOLYS, V50, P1015, DOI 10.1007/s11239-020-02259-5
   Liu WY, 2020, NEW ENGL J MED, V382, P1370, DOI 10.1056/NEJMc2003717
   Ma HJ, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01596-9
   Male C, 2020, LANCET HAEMATOL, V7, pE18, DOI 10.1016/S2352-3026(19)30219-4
   Mazzeffi M, 2020, ANESTH ANALG, V131, P690, DOI 10.1213/ANE.0000000000005059
   McCloskey KA, 2020, BRIT J HAEMATOL, V190, pE57, DOI 10.1111/bjh.16779
   McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   Mitchell WB, 2021, PEDIATR BLOOD CANCER, V68, DOI 10.1002/pbc.28975
   Monagle P, 2018, BLOOD ADV, V2, P3292, DOI 10.1182/bloodadvances.2018024786
   Naik RP, 2014, J THROMB HAEMOST, V12, P2010, DOI 10.1111/jth.12744
   National Institutes of Health, 2014, EVIDENCE BASED MANAG
   Nicolai L, 2020, CIRCULATION, V142, P1176, DOI 10.1161/CIRCULATIONAHA.120.048488
   Nopp S, 2020, RES PRACT THROMB HAE, V4, P1178, DOI 10.1002/rth2.12439
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Overstad S, 2020, THROMB RES, V194, P116, DOI 10.1016/j.thromres.2020.06.032
   Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850
   Piovesan D, 2014, THROMB HAEMOSTASIS, V111, P1015, DOI 10.1160/TH13-10-0827
   Quinn CT, 2011, BRIT J HAEMATOL, V155, P263, DOI 10.1111/j.1365-2141.2011.08827.x
   Ranucci M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113487
   Rowley AH, 2020, NAT REV IMMUNOL, V20, P453, DOI 10.1038/s41577-020-0367-5
   Shekerdemian LS, 2020, JAMA PEDIATR, V174, P868, DOI 10.1001/jamapediatrics.2020.1948
   Shet AS, 2020, HAEMATOLOGICA, V105, P2368, DOI 10.3324/haematol.2019.239350
   Strouse JJ, 2008, PEDIATR BLOOD CANCER, V50, P1006, DOI 10.1002/pbc.21336
   Sullivan M, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28409
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Telfer P, 2020, HAEMATOLOGICA, V105, P2651, DOI 10.3324/haematol.2020.259440
   Thachil J, 2020, J THROMB HAEMOST, V18, P1023, DOI 10.1111/jth.14810
   Thachil J, 2020, J THROMB HAEMOST, V18, P2424, DOI 10.1111/jth.14933
   Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021
   van Haren FMP, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03148-2
   Wang J, 2020, J THROMB HAEMOST, V18, P1752, DOI 10.1111/jth.14828
   Warkentin TE, 2020, THROMB RES, V196, P38, DOI 10.1016/j.thromres.2020.08.017
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   Whitworth H, 2021, BLOOD, V138, P190, DOI 10.1182/blood.2020010218
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   World Health Organization, 2020, MULT INFL SYNDR CHIL
   Yin SY, 2021, J THROMB THROMBOLYS, V51, P1107, DOI 10.1007/s11239-020-02105-8
   Yu HH, 2020, THROMB RES, V195, P219, DOI 10.1016/j.thromres.2020.07.047
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 80
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD JUL
PY 2021
VL 68
IS 7
AR e29049
DI 10.1002/pbc.29049
EA MAY 2021
PG 9
WC Oncology; Hematology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Hematology; Pediatrics
GA SJ9DL
UT WOS:000647537200001
PM 33955167
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Lee, CC
   Lee, CC
   Wu, YZ
AF Lee, Chi-Chuan
   Lee, Chien-Chiang
   Wu, Yizhong
TI The impact of COVID-19 pandemic on hospitality stock returns in China
SO INTERNATIONAL JOURNAL OF FINANCE & ECONOMICS
LA English
DT Article; Early Access
DE China; COVID-19; stock returns; structural VAR
AB Coronavirus disease (COVID-19) has already devastated the world, and the economy becomes the most critical challenge for any country worldwide. The increasing uncertainty of the COVID-19 outbreak has made stock markets in China more turbulent and less predictable. Under the current exceptional circumstances, the hospitality industry suffered the most due to the travel restrictions. This research thus assesses the dynamic relationship among the COVID-19 outbreak, macroeconomic fluctuations and hospitality stock returns based on a structural VAR framework from 13 January to 11 May 2020, in China. Evidence reveals that macroeconomic fluctuations and hospitality stock returns are significantly affected by shocks from the COVID-19 outbreak. An unanticipated positive change of the COVID-19 explosion triggers an addition in exchange rates and causes a reduction in the stock market and hospitality industry returns. For the impacts of the exchange rate, findings reveal that a surprise increase in exchange rates (currency depreciation) exerts a significant negative influence on stock market returns. Additionally, a positive change of stock market returns is linked to a decline in exchange rates and a rise in hospitality industry returns. Therefore, knowledge of these relationships can enable policymakers to evaluate and implement effective policies to stabilize the stock markets and help investors to make appropriate investment strategies.
C1 [Lee, Chi-Chuan] Southwestern Univ Finance & Econ, Inst Dev Studies, Chengdu, Peoples R China.
   [Lee, Chien-Chiang] Nanchang Univ, Cent China Econ & Social Dev, Res Ctr, Nanchang, Jiangxi, Peoples R China.
   [Lee, Chien-Chiang; Wu, Yizhong] Nanchang Univ, Sch Econ & Management, Nanchang, Jiangxi, Peoples R China.
RP Lee, CC (corresponding author), Nanchang Univ, Sch Econ & Management, Nanchang, Jiangxi, Peoples R China.
EM cclee6101@gmail.com
RI Lee, Chien-Chiang/AAZ-9983-2020
OI Lee, Chien-Chiang/0000-0003-0037-4347; Lee,
   Chi-Chuan/0000-0003-0644-1168
FU Fundamental Research Funds for the Central Universities of
   ChinaFundamental Research Funds for the Central Universities
   [JBK2102019]; Jiangxi Humanities and Social Sciences Project of
   University [JJ20125]; Natural Science Foundation of Jiangxi Province of
   ChinaNatural Science Foundation of Jiangxi Province [20202BAB201006]
FX Fundamental Research Funds for the Central Universities of China,
   Grant/Award Number: JBK2102019; Jiangxi Humanities and Social Sciences
   Project of University, Grant/Award Number: JJ20125; Natural Science
   Foundation of Jiangxi Province of China, Grant/Award Number:
   20202BAB201006
CR Al-Awadhi AM, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100326
   Al-Thaqeb SA, 2020, INT J FINANC ECON, DOI 10.1002/ijfe.2298
   [Anonymous], 2020, NATL BUREAU STAT CHI
   Apergis E., 2020, ENERGY RES LETT, V1, P1, DOI DOI 10.46557/001C.13144
   Assaf AG, 2012, J TRAVEL RES, V51, P388, DOI 10.1177/0047287511426337
   Bai, 2014, APPL FINANCIAL EC, V24, P259, DOI [10.1080/09603107.2013.864035, DOI 10.1080/09603107.2013.864035]
   Baker M, 2007, J ECON PERSPECT, V21, P129, DOI 10.1257/jep.21.2.129
   Baker M, 2012, J FINANC ECON, V104, P272, DOI 10.1016/j.jfineco.2011.11.002
   Baker SR, 2020, REV ASSET PRICING ST, V10, P742, DOI 10.1093/rapstu/raaa008
   Baldwin R., 2020, MITIGATING COVID EC
   Barrows C. W., 1994, International Journal of Hospitality Management, V13, P119, DOI 10.1016/0278-4319(94)90033-7
   BULMASH SB, 1991, J PORTFOLIO MANAGE, V17, P61, DOI 10.3905/jpm.1991.409351
   Cen L, 2013, MANAGE SCI, V59, P1076, DOI 10.1287/mnsc.1120.1633
   Chen Ming-Hsiang, 2007, Int J Hosp Manag, V26, P200, DOI 10.1016/j.ijhm.2005.11.004
   Chen Ming-Hsiang, 2005, Int J Hosp Manag, V24, P243, DOI 10.1016/j.ijhm.2004.06.008
   Chen MH, 2018, INT J HOSP MANAG, V71, P141, DOI 10.1016/j.ijhm.2017.09.011
   Chen Ming-Hsiang, 2007, Int J Hosp Manag, V26, P991, DOI 10.1016/j.ijhm.2006.04.002
   CHEN NF, 1986, J BUS, V59, P383, DOI 10.1086/296344
   Chen PF, 2011, J HOUS ECON, V20, P315, DOI 10.1016/j.jhe.2011.09.002
   Chen Y-PP., 2021, INT J FIN EC, P1
   DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348
   Dwyer L, 2000, TOURISM MANAGE, V21, P9, DOI 10.1016/S0261-5177(99)00081-3
   FAMA EF, 1988, J FINANC ECON, V22, P3, DOI 10.1016/0304-405X(88)90020-7
   Gokmenoglu KK, 2019, ASIA PAC J TOUR RES, V24, P584, DOI 10.1080/10941665.2019.1610003
   Goodell JW, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101512
   He PL, 2020, EMERG MARK FINANC TR, V56, P2198, DOI 10.1080/1540496X.2020.1785865
   Ichev R, 2018, INT REV FINANC ANAL, V56, P153, DOI 10.1016/j.irfa.2017.12.004
   Kim J., 2021, INT J HOSP MANAG, V92, P102752
   KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y
   Lee CC, 2017, ENERG ECON, V66, P571, DOI 10.1016/j.eneco.2017.01.028
   Lee CC, 2022, TOURISM ECON, V28, P451, DOI 10.1177/1354816620971981
   Lee CC, 2021, J TRAVEL RES, V60, P1445, DOI 10.1177/0047287520954539
   Lee CC, 2021, INT J TOUR RES, V23, P26, DOI 10.1002/jtr.2389
   Lee CC, 2019, J FUTURES MARKETS, V39, P366, DOI 10.1002/fut.21976
   Lee CC, 2014, ECON MODEL, V42, P29, DOI 10.1016/j.econmod.2014.05.042
   Lin YX, 2021, TOURISM ECON, V27, P795, DOI 10.1177/1354816620904886
   LINTNER J, 1965, REV ECON STAT, V47, P13, DOI 10.2307/1924119
   Liu L., 2020, ENERGY RES LETT, V1, DOI [10.46557/001c.13154, DOI 10.1002/ESSOAR.10504696.1]
   Liu M, 2020, EMERG MARK FINANC TR, V56, P3562, DOI 10.1080/1540496X.2020.1850441
   Liu TY, 2018, ENERGY, V150, P276, DOI 10.1016/j.energy.2018.02.075
   Liu XG, 2020, ECON POLIT STUD-EPS, V8, P395, DOI 10.1080/20954816.2020.1844609
   Loria E, 2010, J INT MONEY FINANC, V29, P540, DOI 10.1016/j.jimonfin.2009.07.007
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.2307/2336182
   Rapach DE, 2005, INT J FORECASTING, V21, P137, DOI 10.1016/j.ijforecast.2004.05.004
   ROSS SA, 1976, J ECON THEORY, V13, P341, DOI 10.1016/0022-0531(76)90046-6
   Ahmar AS, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138883
   Salisu AA, 2020, INT J FINANC ECON, DOI 10.1002/ijfe.2390
   SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928
   SIMS CA, 1980, ECONOMETRICA, V48, P1, DOI 10.2307/1912017
   Skare M, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120469
   Sobieralski Joseph B, 2020, Transp Res Interdiscip Perspect, V5, P100123, DOI 10.1016/j.trip.2020.100123
   Sonmez S. F., 1999, Journal of Travel Research, V38, P13, DOI 10.1177/004728759903800104
   Stafford G., 2002, Cornell Hotel and Restaurant Administration Quarterly, V43, P27, DOI 10.1016/S0010-8804(02)80054-4
   Tse Alan C B, 2006, Int J Hosp Manag, V25, P3, DOI 10.1016/j.ijhm.2004.12.001
   Wang YS, 2009, TOURISM MANAGE, V30, P75, DOI 10.1016/j.tourman.2008.04.010
   Zhang DY, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101528
   Zhao B, 2020, CHINA ECON REV, V64, DOI 10.1016/j.chieco.2020.101561
   ZIVOT E, 1992, J BUS ECON STAT, V10, P251, DOI 10.2307/1391541
NR 59
TC 11
Z9 11
U1 16
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1076-9307
EI 1099-1158
J9 INT J FINANC ECON
JI Int. J. Financ. Econ.
DI 10.1002/ijfe.2508
EA FEB 2021
PG 14
WC Business, Finance
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA QA6MZ
UT WOS:000613559000001
OA Bronze
DA 2022-04-20
ER

PT J
AU Simpeh, F
   Bamfo-Agyei, E
   Amoah, C
AF Simpeh, Fredrick
   Bamfo-Agyei, Emmanuel
   Amoah, Christopher
TI Barriers to the implementation of COVID-19 safety regulations: insight
   from Ghanaian construction sites
SO JOURNAL OF ENGINEERING DESIGN AND TECHNOLOGY
LA English
DT Article
DE Challenges; Safety measures; COVID-19; Site workers; Site
ID RISK
AB Purpose
   The new normal introduced by COVID-19 has ushered in new safety regulations that are required to be implemented by all organisations, including the construction industry. The implementation of the COVID-19 regulations, like any health and safety regulation, is not without hindrances. Consequently, this study aims to explore factors hindering the implementation of COVID-19 safety regulations at construction sites in Ghana.
   Design/methodology/approach
   The study adopted a qualitative research method using an open-ended questionnaire as a data collection instrument. The set of questionnaires were distributed by means of purposive and snowball sampling methods. The collected data were analysed by means of the thematic analysis technique.
   Findings
   It became evident that several factors militate against implementing COVID-19 safety regulations at construction sites. Cost of implementing COVID-19 safety measures, lack of compliance and ignorance were identified as the most hindering factors, whereas superstition, lack of personal protective equipment supply and theft of COVID-19 materials were reported by fewer respondents.
   Research limitations/implications
   The set of questionnaires were limited to small construction firms who were operating on site within the Central, Western and Greater Accra regions of Ghana during the second wave of the COVID-19 pandemic. However, the findings may be applicable to firms outside these regions because most of the small construction firms in the country share similar characteristics.
   Practical implications
   The recommendations proffered could help construction organisations devise strategies to overcome the barriers that hamper the implementation of COVID-19 safety regulations on site. Moreover, the findings could inform policymakers on what is required to enforce compliance on site.
   Originality/value
   COVID 19 is still new, and as a result, the body of knowledge is at the infancy stage. This article contributes to advancing the body of knowledge in the area of COVID-19 implementation challenges on construction sites.
C1 [Simpeh, Fredrick; Amoah, Christopher] Univ Free State, Dept Quant Surveying & Construct Management, Bloemfontein Campus, Bloemfontein, South Africa.
   [Bamfo-Agyei, Emmanuel] Cape Coast Tech Univ, Dept Bldg Technol, Cape Coast, Ghana.
RP Simpeh, F (corresponding author), Univ Free State, Dept Quant Surveying & Construct Management, Bloemfontein Campus, Bloemfontein, South Africa.
EM simfredy24@yahoo.com; emmanuel.bamfo-agyei@cctu.edu; amoahc@ufs.ac.za
CR Achaw O.W., 2012, INT J DEV SUSTAINABI, V1, P456
   Agyekum K, 2022, J ENG DES TECHNOL, V20, P222, DOI 10.1108/JEDT-11-2020-0476
   Akintayo O., 2018, P 12 BUILT ENV C 6 7, P62
   Amoah C, 2021, J FACIL MANAG, V19, P111, DOI 10.1108/JFM-08-2020-0061
   Amponsah R., 2020, OPEN J BUSINESS MANA, V8, P1404, DOI [https://doi.org/10.4236/ojbm.2020.84089, DOI 10.4236/OJBM.2020.84089]
   Amponsah-Tawiah K., 2011, INT J BUS SOC SCI, V14, P120
   Andolfo C, 2015, PROCEDIA ENGINEER, V123, P15, DOI 10.1016/j.proeng.2015.10.052
   Antwi-Afari MF, 2017, AUTOMAT CONSTR, V83, P41, DOI 10.1016/j.autcon.2017.07.007
   Avice T, 2020, J PEDIATR REHAB MED, V13, P433, DOI 10.3233/PRM-200808
   Beck C.T., 2017, NURSING RES GENERATI
   Blumberg B.C., 2008, BUSINESS RES METHODS
   Bondinuba, 2012, CIVIL ENV RES, V2, P25
   Bsisu K. A. D., 2020, INT J ENG RES TECH, V13, P828
   CDC, 2020, SYMPT COR
   Centers for Disease Control and Prevention (CDC), 2020, How COVID-19 Spreads
   Clarke V., 2012, THEMATIC ANAL HDB RE
   Construction Industry Development Board (cidb), 2009, CONSTR HLTH SAF S AF
   Creswell J.W., 1998, QUAL INQ
   Creswell J.W, 2014, RES DESIGN QUALITATI, V4th
   Damon C., 2014, YOU CANT BEAT THEM J, V1
   Dutta A, 2020, ERGONOMICS, V63, P1182, DOI 10.1080/00140139.2020.1772378
   Emuze F., 2016, J CONSTRUCTION ASS S, V9, P14
   Gamil Y., 2020, MEDITERRANEAN J SOCI, V11, P122, DOI 10.36941/mjss-2020-0047
   Geller, 2001, WORKING SAFE HELP PE
   Hansson, 2007, CIB WORLD BUILD C CO, P1208
   Harinarain N., 2020, J CONSTRUCTION, V13, P52
   Hartmann B, 2005, SCAND J WORK ENV HEA, V31, P88
   Haslam RA, 2005, APPL ERGON, V36, P401, DOI 10.1016/j.apergo.2004.12.002
   Health and Safety Executive (HSE), 2002, REV HLTH SAF CONSTR
   International Labour Organization, 2017, GLOB EST MOD SLAV FO
   Jallow H, 2021, SMART SUSTAIN BUILT, V10, P581, DOI 10.1108/SASBE-05-2020-0068
   Koh D, 2020, OCCUP MED-OXFORD, V70, P3, DOI 10.1093/occmed/kqaa036
   Lemke MK, 2020, AM J IND MED, V63, P659, DOI 10.1002/ajim.23138
   Ogunnusi M, 2020, INT J REAL ESTATE ST, V14
   PERL TM, 2020, CLIN INFECT DIS, DOI DOI 10.1093/CID/CIAA229/5800048
   Pollitt, 2006, HUMAN RESOURCE MANAG, V14, P23
   Safman RM, 2004, HEALTH EDUC BEHAV, V31, P9, DOI 10.1177/1090198103259185
   Sauni R, 2001, OCCUP MED-OXFORD, V51, P163, DOI 10.1093/occmed/51.3.163
   Sawacha E., 1999, INT J PROJ MANAG, V17, P309, DOI DOI 10.1016/S0263-7863(98)00042-8
   Simpeh F, 2021, INT J CONSTR MANAG, DOI 10.1080/15623599.2021.1874678
   Smallwood JJ, 2007, J ENG DES TECHNOL, V5, P23, DOI 10.1108/17260530710746588
   Stiles S, 2021, HUM FACTOR ERGON MAN, V31, P425, DOI 10.1002/hfm.20882
   Thanh N.C., 2015, AM J ED SCI, V1, P24
   Vasconcelos B, 2015, PROCEDIA MANUF, V3, P4392, DOI 10.1016/j.promfg.2015.07.437
   VERTIC, 2020, MAY 2020 FACT SHEET
   Vitharana VHP, 2015, ENG-J INST ENG SRI L, V48, P35, DOI 10.4038/engineer.v48i3.6840
   Wang Z., 2020, ADV MATER SCI ENG, V2020, P1, DOI [10.21203/rs.3.rs-23885/v1, DOI 10.21203/RS.3.RS-23885/V1, 10.1155/2020/6563520, DOI 10.1155/2020/6563520]
   WHO, 2020, Q A COR COVID 19
NR 48
TC 3
Z9 3
U1 2
U2 6
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1726-0531
J9 J ENG DES TECHNOL
JI J. Eng. Des. Technol.
PD JAN 3
PY 2022
VL 20
IS 1
SI SI
BP 47
EP 65
DI 10.1108/JEDT-03-2021-0153
EA JUN 2021
PG 19
WC Engineering, Multidisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Engineering
GA XZ8UW
UT WOS:000660777200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Yesilkaya, UH
   Balcioglu, YH
   Sen, M
AF Yesilkaya, Umit Haluk
   Balcioglu, Yasin Hasan
   Sen, Meltem
TI Psychotic Agitation in a Patient with COVID-19: Pathogenesis or
   latrogenesis?
SO PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
LA English
DT Article
DE Coronavirus pandemic; COVID-19; neuropsychiatric symptoms; psychosis;
   SARS-CoV-2; side effects; viral encephalitis
AB The pathophysiological underpinnings of central nervous system (CNS) involvement in SARS-CoV-2 infection, as well as the profile of adverse neuropsychiatric effects of pharmacological agents employed in the management of COVID-19, are yet to be elucidated. Here, we report a 43-year-old female patient who suffered from COVID-19 and who developed new-onset psychotic agitated behavior which may be related to either the COVID-19 infection itself or to the drugs that were used in the treatment. On her third day of treatment with oseltamivir, hydroxychloroquine, and azithromycin, the patient, who had no previous background of neurological or psychiatric diagnosis, presented with a new-onset psychomotor agitation with auditory hallucinations and insomnia. Her psychiatric symptoms have improved with oral olanzapine 5 mg/d. This report underscores the importance of neuropsychiatric monitoring in patients with COVID-19. Clinicians should be aware of the limited knowledge on the neuropsychiatric safety profile of the medication used for COVID-19 treatment, while they have focused on the neuropsychiatric outcomes of COVID-19 itself.
C1 [Yesilkaya, Umit Haluk; Balcioglu, Yasin Hasan; Sen, Meltem] Bakirkoy Prof Mazhar Osman Training & Res Hosp Ps, Dept Psychiat, Istanbul, Turkey.
RP Balcioglu, YH (corresponding author), Bakirkoy Prof Mazhar Osman Training & Res Hosp Ps, Dept Psychiat, Istanbul, Turkey.
EM yhasanbalcioglu@gmail.com
RI Balcioglu, Yasin Hasan/T-6914-2019; sen, meltem/ABD-9350-2021;
   yesilkaya, umit haluk/ABD-1346-2021
OI Balcioglu, Yasin Hasan/0000-0002-1336-1724; 
CR Balcioglu YH, 2020, J NEUROIMMUNE PHARM, V15, P343, DOI 10.1007/s11481-020-09932-9
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Desforges M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010014
   Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1
   Hiasa M, 2013, BRIT J PHARMACOL, V169, P115, DOI 10.1111/bph.12102
   Mascolo A, 2018, INFLAMMOPHARMACOLOGY, V26, P1141, DOI 10.1007/s10787-018-0498-5
   McKernan DP, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.37
   O'Shaughnessy TJ, 2003, BRAIN RES, V959, P280, DOI 10.1016/S0006-8993(02)03763-0
   Severance EG, 2011, SCHIZOPHRENIA BULL, V37, P101, DOI 10.1093/schbul/sbp052
   Troyer EA, 2020, BRAIN BEHAV IMMUN, V87, P34, DOI 10.1016/j.bbi.2020.04.027
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Yesilkaya UH, 2020, J CLIN NEUROSCI, V80, P72, DOI 10.1016/j.jocn.2020.08.014
   Yesilkaya UH, 2020, J CLIN NEUROSCI, V78, P449, DOI 10.1016/j.jocn.2020.05.056
NR 13
TC 0
Z9 0
U1 4
U2 4
PU AVES
PI SISLI
PA BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY
SN 2475-0573
EI 2475-0581
J9 PSYCHIAT CLIN PSYCH
JI Psychiatry Clin. Psychopharmacol.
PD JUN
PY 2021
VL 31
IS 2
BP 238
EP 240
DI 10.5152/pcp.2021.21101
PG 3
WC Pharmacology & Pharmacy; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Psychiatry
GA TF5KN
UT WOS:000670758400014
OA gold
DA 2022-04-20
ER

PT J
AU Leong, YC
   Cheskes, S
   Drennan, IR
   Buick, JE
   Latchmansingh, RG
   Verbeek, PR
AF Leong, Yuen Chin
   Cheskes, Sheldon
   Drennan, Ian R.
   Buick, Jason E.
   Latchmansingh, Ron G.
   Verbeek, P. Richard
TI Clinical considerations for out-of-hospital cardiac arrest management
   during COVID-19
SO RESUSCITATION PLUS
LA English
DT Editorial Material
DE Out-of-hospital cardiac arrest (OHCA); Paramedic; COVID-19; Aerosol
   generating medical procedures (AGMPs); Termination of resuscitation
   (TOR)
ID RESUSCITATION; RECOMMENDATIONS; OUTCOMES
AB Managing out-of-hospital cardiac arrest requires paramedics to perform multiple aerosol generating medical procedures in an uncontrolled setting. This increases the risk of cross infection during the COVID-19 pandemic. Modifications to conventional protocols are required to balance paramedic safety with optimal patient care and potential stresses on the capacity of critical care resources. Despite this, little specific advice has been published to guide paramedic practice. In this commentary, we highlight challenges and controversies regarding critical decision making around initiation of resuscitation, airway management, mechanical chest compression, and termination of resuscitation. We also discuss suggested triggers for implementation and revocation of recommended protocol changes and present an accompanying paramedic-specific algorithm.
C1 [Leong, Yuen Chin; Cheskes, Sheldon; Buick, Jason E.; Latchmansingh, Ron G.; Verbeek, P. Richard] Sunnybrook Ctr Prehosp Med, 77 Browns Line,Suite 100, Toronto, ON M8W 3S2, Canada.
   [Leong, Yuen Chin; Cheskes, Sheldon; Verbeek, P. Richard] Univ Toronto, Fac Med, Toronto, ON, Canada.
   [Cheskes, Sheldon] Univ Toronto, Div Emergency Med, Dept Family & Community Med, Toronto, ON, Canada.
   [Cheskes, Sheldon] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Drennan, Ian R.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada.
   [Drennan, Ian R.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada.
   [Buick, Jason E.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Verbeek, P. Richard] Univ Toronto, Div Emergency Med, Dept Med, Toronto, ON, Canada.
RP Verbeek, PR (corresponding author), Sunnybrook Ctr Prehosp Med, 77 Browns Line,Suite 100, Toronto, ON M8W 3S2, Canada.
EM richard.verbeek@sunnybrook.ca
RI Cheskes, Sheldon/I-4456-2015
OI Cheskes, Sheldon/0000-0001-7835-3074; Leong, Yuen
   Chin/0000-0001-7334-9826
CR Baldi E, 2020, NEW ENGL J MED, V383, P496, DOI 10.1056/NEJMc2010418
   Bergstrom M, 2018, RESUSCITATION, V133, P147, DOI 10.1016/j.resuscitation.2018.10.018
   Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011
   Bonnes JL, 2016, ANN EMERG MED, V67, P349, DOI 10.1016/j.annemergmed.2015.09.023
   Bottiger BW, EUROPEAN RESUSCITATI
   Buick JE, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.003561
   Cheskes S, 2014, RESUSCITATION, V85, P336, DOI 10.1016/j.resuscitation.2013.10.014
   Couper K, 2020, RESUSCITATION, V151, P59, DOI 10.1016/j.resuscitation.2020.04.022
   Drennan IR, 2017, RESUSCITATION, V111, P96, DOI 10.1016/j.resuscitation.2016.11.021
   Edelson Dana P, 2020, CIRCULATION, V0
   Hassager C, 2020, EUR HEART J-ACUTE CA, V9, P239, DOI 10.1177/2048872620922789
   Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797
   Marijon E, 2020, LANCET PUBLIC HEALTH, V5, pE437, DOI 10.1016/S2468-2667(20)30117-1
   Nolan B, 2020, CAN J EMERG MED, V22, P571, DOI 10.1017/cem.2020.389
   Nolan JP, 2020, RESUSCITATION, V153, P45, DOI 10.1016/j.resuscitation.2020.06.001
   Perkins GD, 2020, RESUSCITATION, V151, P145, DOI 10.1016/j.resuscitation.2020.04.035
   Poole K, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2059-0
   Shao F, 2020, RESUSCITATION, V151, P18, DOI 10.1016/j.resuscitation.2020.04.005
   Van de Voorde P, EUROPEAN RESUSCITATI
NR 19
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2666-5204
J9 RESUSC PLUS
JI Resusc. Plus
PD DEC
PY 2020
VL 4
AR 100027
DI 10.1016/j.resplu.2020.100027
PG 5
WC Critical Care Medicine; Emergency Medicine
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine; Emergency Medicine
GA TM4HC
UT WOS:000675511000004
PM 33403363
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Wang, YN
   Ahmed, A
   Azam, A
   Bing, D
   Shan, Z
   Zhang, ZT
   Tariq, MK
   Sultana, J
   Mushtaq, RT
   Mehboob, A
   Chen, XH
   Rehman, M
AF Wang, Yanen
   Ahmed, Ammar
   Azam, Ali
   Bing, Du
   Shan, Zhang
   Zhang, Zutao
   Tariq, Muhammad Kashif
   Sultana, Jakiya
   Mushtaq, Ray Tahir
   Mehboob, Asad
   Chen Xiaohu
   Rehman, Mudassar
TI Applications of additive manufacturing (AM) in sustainable energy
   generation and battle against COVID-19 pandemic: The knowledge evolution
   of 3D printing
SO JOURNAL OF MANUFACTURING SYSTEMS
LA English
DT Review
DE 3D printing; Sustainability; COVID-19; Pandemic; Research frontiers
ID CONSTRUCTION; SYSTEM; IMPACT; FUTURE
AB Sustainable and cleaner manufacturing systems have found broad applications in industrial processes, especially aerospace, automotive and power generation. Conventional manufacturing methods are highly unsustainable regarding carbon emissions, energy consumption, material wastage, costly shipment and complex supply management. Besides, during global COVID-19 pandemic, advanced fabrication and management strategies were extremely required to fulfill the shortfall of basic and medical emergency supplies. Three-dimensional printing (3DP) reduces global energy consumption and CO2 emissions related to industrial manufacturing. Various renewable energy harvesting mechanisms utilizing solar, wind, tidal and human potential have been fabricated through additive manufacturing. 3D printing aided the manufacturing companies in combating the deficiencies of medical healthcare devices for patients and professionals globally. In this regard, 3D printed medical face shields, respiratory masks, personal protective equipment, PLA-based recyclable air filtration masks, additively manufactured ideal tissue models and new information technology (IT) based rapid manufacturing are some significant contributions of 3DP. Furthermore, a bibliometric study of 3D printing research was conducted in CiteSpace. The most influential keywords and latest research frontiers were found and the 3DP knowledge was categorized into 10 diverse research themes. The potential challenges incurred by AM industry during the pandemic were categorized in terms of design, safety, manufacturing, certification and legal issues. Significantly, this study highlights the versatile role of 3DP in battle against COVID-19 pandemic and provides up-to-date research frontiers, leading the readers to focus on the current hurdles encountered by AM industry, henceforth conduct further investigations to enhance 3DP technology.
C1 [Wang, Yanen; Ahmed, Ammar; Shan, Zhang; Sultana, Jakiya; Mushtaq, Ray Tahir; Chen Xiaohu; Rehman, Mudassar] Northwestern Polytech Univ, Dept Ind Engn, Xian 710072, Peoples R China.
   [Azam, Ali; Zhang, Zutao] Southwest Jiaotong Univ, Sch Mech Engn, Chengdu 610031, Peoples R China.
   [Bing, Du] Second Peoples Hosp Foshan, Ctr Stomatol, Foshan 528000, Peoples R China.
   [Tariq, Muhammad Kashif] Univ Engn & Technol, Dept Mech Engn, Lahore 54890, Pakistan.
   [Mehboob, Asad] Northwestern Polytech Univ, Dept Mat Sci & Engn, Xian 710072, Peoples R China.
RP Wang, YN (corresponding author), Northwestern Polytech Univ, Dept Ind Engn, Xian 710072, Peoples R China.
EM wangyanen@126.com; ammartahir@uet.edu.pk; aliazam@uet.edu.pk;
   93881976@qq.com; zzt@swjtu.edu.cn
RI Mushtaq, Ray Tahir/ABA-5716-2020; Azam, Ali/ABA-3756-2020; Ahmed,
   Ammar/ABA-3630-2020; Rehman, Mudassar/AAC-1242-2021
OI Mushtaq, Ray Tahir/0000-0002-1233-4986; Azam, Ali/0000-0002-0175-3966;
   Ahmed, Ammar/0000-0002-8978-5638; Rehman, Mudassar/0000-0001-6145-9315
FU National Key Research and Development Program of China [2019QY (Y)
   0502]; Key Research and Development Program of Shaanxi Province
   [2020ZDLSF04-07]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China (NSFC) [51905438]; Fundamental
   Research Funds for the Central UniversitiesFundamental Research Funds
   for the Central Universities [31020190502009]; China postdoctoral
   Science FoundationChina Postdoctoral Science Foundation [2020M673471];
   Innovation Platform of Bio fabrication [17SF0002]
FX The current study was funded by; The National Key Research and
   Development Program of China [Grant No. 2019QY (Y) 0502] ; The Key
   Research and Development Program of Shaanxi Province [Grant No.
   2020ZDLSF04-07] ; The National Natural Science Foundation of China
   [Grant No. 51905438] ; The Fundamental Research Funds for the Central
   Universities [Grant No. 31020190502009] ; The Innovation Platform of Bio
   fabrication [Grant No. 17SF0002] ; and China postdoctoral Science
   Foundation [Grant No. 2020M673471] . We are highly grateful to Sir
   Muhammad Kashif Tariq from Mechanical Engineering Department, University
   of Engineering and Technology Lahore for his special contribution,
   supervision and guidance in the current study. Ammar Ahmed is the
   co-first author of this manuscript.
CR Ahmed A, 2020, ENERG CONVERS MANAGE, V211, DOI 10.1016/j.enconman.2020.112748
   Ahmed MH, 2011, MANUFACTURING TECHNO
   Akbari M, 2020, ASIAN J SHIPPING LOG, V36, P78, DOI 10.1016/j.ajsl.2019.11.001
   Anderson C., 2012, MAKERS NEW IND REVOL
   [Anonymous], PRUSA FACE SHIELD PR
   Attaran M., 2020, AM J IND BUS MANAG, V10, P988, DOI 10.4236/ajibm.2020.105066
   Attaran M, 2017, BUS HORIZONS, V60, P677, DOI 10.1016/j.bushor.2017.05.011
   Barker T, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P25
   BEG S, 2020, DRUG DISCOV TODAY
   Beltagui A, 2020, INT J PROD ECON, V221, DOI 10.1016/j.ijpe.2019.07.035
   Bishop EG, 2020, INT J BIOPRINTING, V6, DOI 10.18063/ijb.v6i4.281
   Bito J, 2017, IEEE T MICROW THEORY, V65, P1831, DOI 10.1109/TMTT.2017.2660487
   Blair N, 2020, FATIGUE ANAL 3D PRIN
   Brundtland G., 1987, REPORT WORLD COMMISS
   Buchanan C, 2019, ENG STRUCT, V180, P332, DOI 10.1016/j.engstruct.2018.11.045
   Callaway E, 2020, NATURE, V580, P576, DOI 10.1038/d41586-020-01221-y
   Celik HK, 2020, INT J BIOPRINTING, V6, P30, DOI 10.18063/ijb.v6i4.286
   Chan SSL, 2020, ADDIT MANUF, V35, DOI 10.1016/j.addma.2020.101335
   Chen C., 2014, COLL COMPUT INF, V1, P1
   Chen MX, 2020, COMPOS PART B-ENG, V186, DOI 10.1016/j.compositesb.2020.107821
   Cheng M, 2020, BATTERIES SUPERCAPS, V3, P130, DOI 10.1002/batt.201900130
   Choong YYC, 2020, NAT REV MATER, V5, P637, DOI 10.1038/s41578-020-00234-3
   Cox JL, 2020, LAB MED, V51, pE45, DOI 10.1093/labmed/lmaa031
   CROES M, 2020, ACTA BIOMATER
   Dass A, 2019, COATINGS, V9, DOI 10.3390/coatings9070418
   Dermeik B, 2020, ADV ENG MATER, V22, DOI 10.1002/adem.202000256
   Dilag J, 2019, ADDIT MANUF, V27, P167, DOI 10.1016/j.addma.2019.01.009
   Dimogianopoulos DG, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10031029
   Ding SY, 2016, NAT REV MATER, V1, DOI [10.1038/natrevmats.2016.21, 10.1038/natrevmats.2016.71]
   Dogan E, 2020, APPL MATER TODAY, V20, DOI 10.1016/j.apmt.2020.100752
   Dorrington MS, J MANUF SYST, V2021
   Dutta B, 2016, ADDITIVE MANUFACTURING OF TITANIUM ALLOYS: STATE OF THE ART, CHALLENGES AND OPPORTUNITIES, P1, DOI 10.1016/B978-0-12-804782-8.00001-X
   Erickson MM, 2020, J ARTHROPLASTY, V35, pS23, DOI 10.1016/j.arth.2020.04.035
   Euchi J., 2020, CHINESE J AERONAUT
   Farizhandi AAK, 2020, J MECH BEHAV BIOMED, V110, DOI 10.1016/j.jmbbm.2020.103960
   Ford J, 2020, 3D PRINT MED, V6, DOI 10.1186/s41205-020-00076-3
   Francois PM, 2021, J STOMATOL ORAL MAXI, V122, P381, DOI 10.1016/j.jormas.2020.06.010
   Fudos I, 2019, 3D PRINTING TECHNOLO
   Garcia-Granada AA, ENG FRACT MECH
   Garrett B, 2011, COULD 3D PRINTING CH, P3
   Garrett B, 2014, GLOB POLICY, V5, P70, DOI 10.1111/1758-5899.12119
   Gebler M, 2014, ENERG POLICY, V74, P158, DOI 10.1016/j.enpol.2014.08.033
   Gohil, 2020, J MANUF SYST
   Guo R, EUR POLYM J, V2020
   Haleem Abid, 2020, J Clin Orthop Trauma, V11, pS118, DOI 10.1016/j.jcot.2019.12.002
   Hamidi A, 2020, MATER DESIGN, V187, DOI 10.1016/j.matdes.2019.108324
   Han NM, 2016, APPL ENERG, V178, P672, DOI 10.1016/j.apenergy.2016.06.103
   Haq, 2020, RES BIOMED ENG, P1, DOI [DOI 10.1007/S42600-020-00098-0, 10.1007/s42600-020-00098-0]
   He HJ, 2020, INT J BIOPRINTING, V6, P1, DOI 10.18063/ijb.v6i4.278
   Hernandez-Quintanar L, 2019, INT J BIOPRINTING, V5, DOI 10.18063/IJB.v5i1.178
   Hossain M, 2020, ADDIT MANUF, V35, DOI 10.1016/j.addma.2020.101395
   Ibrahim Y, 2020, ADV MANUF-POLYM COMP, V6, P17, DOI 10.1080/20550340.2019.1710023
   IEA IEA, 2013, KEY WORLD EN STAT
   Ingarao, 2020, MANAGING 3D PRINTING, P97
   Ionita CN, 2020, COVID 19 ROLE 3D PRI
   Iqbal A, 2019, J KING SAUD U ENG SC, DOI [10.1016/j.jksues.2019.10.002, DOI 10.1016/J.JKSUES.2019.10.002]
   IYENGAR K, 2020, DIABET METAB SYND OB
   Ji Shen, 2017, Front Bioeng Biotechnol, V5, P23, DOI 10.3389/fbioe.2017.00023
   Joshi SC, 2015, VIRTUAL PHYS PROTOTY, V10, P175, DOI 10.1080/17452759.2015.1111519
   Kanik M, 2015, ADV MATER, V27, P2367, DOI 10.1002/adma.201405944
   Kawa B, 2020, ENERGIES, V13, DOI 10.3390/en13112800
   Kayacan MY, 2019, MATER MANUF PROCESS, V34, P1467, DOI 10.1080/10426914.2019.1655151
   Khajavi SH, 2014, COMPUT IND, V65, P50, DOI 10.1016/j.compind.2013.07.008
   Kimmig R, 2020, J GYNECOL ONCOL, V31, DOI 10.3802/jgo.2020.31.e59
   Knaus J, 2020, MACROMOL BIOSCI, V20, DOI 10.1002/mabi.201900239
   Koch C, 2012, 23TH ANN INT SOL FRE
   Korkees F, 2020, RAPID PROTOTYPING J, V26, P699, DOI 10.1108/RPJ-07-2019-0188
   Kubalak LB, J MANUF SYST, V2021
   Kumar A, 2021, FUTURE GENER COMP SY, V115, P1, DOI 10.1016/j.future.2020.08.046
   Kumar LJ, 2017, ADV 3D PRINTING ADDI, P39, DOI [10.1007/978-981-10-0812-2_4, DOI 10.1007/978-981-10-0812-2_4]
   Lange D, 2020, RILEM INT C CONCR DI, P353
   Larraneta E, 2020, 3D PRINT ADDIT MANUF, V7, P100, DOI 10.1089/3dp.2020.0106
   Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434
   Lewis JA, 2015, NATURE, V518, P42, DOI 10.1038/518042a
   Li GJ, 2020, J APPL PHYS, V127, DOI 10.1063/1.5120056
   Liu Y, 2020, SCRIPTA MATER, V183, P6, DOI 10.1016/j.scriptamat.2020.03.009
   Loy, 2020, EMERALD OPEN RES, P2
   Loy J., 2020, EMERALD OPEN RES, V2, P1, DOI [10.35241/emeraldopenres.13697.1, DOI 10.35241/EMERALDOPENRES.13697.1]
   Malik AA, 2021, J MANUF SYST, V60, P864, DOI 10.1016/j.jmsy.2020.09.008
   Mandal S, 2020, P NATL ACAD SCI USA, V117, P8366, DOI 10.1073/pnas.1921778117
   Mangal U, 2020, J MECH BEHAV BIOMED, V110, DOI 10.1016/j.jmbbm.2020.103992
   Manigandan S, 2020, PROCESS BIOCHEM, V98, P233, DOI 10.1016/j.procbio.2020.08.016
   Marrs, 2013, DISRUPTIVE TECHNOLOG, V180
   Mitsche S, MAT BASEL, V13, P139
   Mostafaei A, 2021, PROG MATER SCI, V119, DOI 10.1016/j.pmatsci.2020.100707
   Nazir A, 2021, J MANUF SYST, V60, P774, DOI 10.1016/j.jmsy.2020.10.009
   Nazir A, 2020, P I MECH ENG C-J MEC, V234, P2741, DOI 10.1177/0954406219861664
   Nee Q, J MANUF SYST, V2021
   Nejat P, 2015, RENEW SUST ENERG REV, V43, P843, DOI 10.1016/j.rser.2014.11.066
   Neumuller Moritz, 2014, 3D Research Challenges in Cultural Heritage. A Roadmap in Digital Heritage Preservation: LNCS 8355, P119, DOI 10.1007/978-3-662-44630-0_9
   Ngo TD, 2018, COMPOS PART B-ENG, V143, P172, DOI 10.1016/j.compositesb.2018.02.012
   Niklaus F., 2020, HDB SILICON BASED ME, P531
   Nomani J, 2020, MATER TODAY COMMUN, V22, DOI 10.1016/j.mtcomm.2019.100626
   Oh WJ, 2019, OPT LASER TECHNOL, V117, P6, DOI 10.1016/j.optlastec.2019.04.012
   Oladapo BI, 2021, MATER CHEM PHYS, V258, DOI 10.1016/j.matchemphys.2020.123943
   Organization W.H. Organization W.H. Health, COR DIS COVID 2019 S
   Peeters T, J MANUF SYST
   Petch, 2020, 3D PRINTING COMMUNIT
   Petrovic V, 2011, INT J PROD RES, V49, P1061, DOI 10.1080/00207540903479786
   Potoczek E, 2020, J EUR CERAM SOC
   Potschke P, ADDIT MANUF
   Prashanth KG, 2020, SELECTIVE LASER MELT
   Previtera J, 2020, MEDRXIV
   Quanjin M, 2020, PROCEDIA COMPUT SCI, V167, P1210, DOI 10.1016/j.procs.2020.03.434
   Rahim TNAT, 2019, POLYM REV, V59, P589, DOI 10.1080/15583724.2019.1597883
   Rahimi A, 2020, MODARES MECH ENG, V20, P689
   Rahman MT, 2019, 2019 20TH INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS, ACTUATORS AND MICROSYSTEMS & EUROSENSORS XXXIII (TRANSDUCERS & EUROSENSORS XXXIII), P1443, DOI 10.1109/TRANSDUCERS.2019.8808321
   Rayna T, 2016, TECHNOL FORECAST SOC, V102, P214, DOI 10.1016/j.techfore.2015.07.023
   Reeves P., 2012, EXAMPLE ECONOLYST RE
   Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x
   Robinson, J MECH BEHAV BIOMED, P114
   Rodriguez-Salvador M, 2021, INT J BIOPRINTING, V7, P135, DOI 10.18063/ijb.v7i1.331
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Sanjayan J, 2019, NOVEL METHODOLOGY PO
   Schelly C, 2015, J VISUAL LANG COMPUT, V28, P226, DOI 10.1016/j.jvlc.2015.01.004
   Sehgal T, 2020, MATER TODAY-PROC
   Selvan CP, 2017, EUROPEAN J ADV ENG T, V4, P497
   Serdeczny MP, 2020, ADDIT MANUF, V32, DOI 10.1016/j.addma.2019.100997
   Shahrubudin N, 2019, PROCEDIA MANUF, V35, P1286, DOI 10.1016/j.promfg.2019.06.089
   Shaqour B, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12060517
   Sharma P, 2020, MATER TODAY-PROC
   Sherborne C, 2021, INT J BIOPRINTING, V7, P47, DOI 10.18063/ijb.v7i1.316
   Shpichka A, 2020, INT J BIOPRINTING, V6, P10, DOI 10.18063/ijb.v6i4.302
   Shree MV, 2020, MATER TODAY-PROC, V21, P958, DOI 10.1016/j.matpr.2019.09.060
   Simon M., 2013, SPORTS ENTERTAINMENT, V3, P60
   Stern D.I., 2010, ROLE ENERGY EC GROWT, P10
   Tahir MM, 2021, CLEAN ENV SYST, V2021, DOI 10.1016/j.cesys.2021.100042
   Tijing LD, 2020, APPL MATER TODAY, V18, DOI 10.1016/j.apmt.2019.100486
   Tol S, 2019, ADDIT MANUF, V29, DOI 10.1016/j.addma.2019.100780
   Tong YX, 2020, NANO ENERGY, V75, DOI 10.1016/j.nanoen.2020.104973
   Tung DT, 2020, J ELECTRON MATER, V49, P4671, DOI 10.1007/s11664-020-08165-z
   Tyagi M, 2021, SOFT ROBOT, V8, P19, DOI 10.1089/soro.2019.0129
   Vafea MT, 2020, CELL MOL BIOENG, V13, P249, DOI 10.1007/s12195-020-00629-w
   Valvez S, 2020, PROCEDIA STRUCT INTE, V25, P394, DOI 10.1016/j.prostr.2020.04.056
   Vaut L, 2020, ACS BIOMATER SCI ENG, V6, P2478, DOI 10.1021/acsbiomaterials.9b01760
   Wang G, 2019, CHEM ENG SCI, V195, P250, DOI 10.1016/j.ces.2018.07.021
   Wang L, INT J IND MANUF SYST
   Wang ZZ, 2021, RAPID PROTOTYPING J, V27, P145, DOI 10.1108/RPJ-04-2020-0072
   Wee A, 2020, BIORXIV
   Wei JX, 2020, CARBOHYD POLYM, V238, DOI 10.1016/j.carbpol.2020.116207
   Wilts EM, 2019, POLYM CHEM-UK, V10, P1442, DOI 10.1039/c8py01792a
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Yap YL, 2014, VIRTUAL PHYS PROTOTY, V9, P195, DOI 10.1080/17452759.2014.938993
   Zelenika-Zovko I, 2010, 3 D PRINTING OPEN SO
   Zeng RC, 2017, ENERG BUILDINGS, V155, P172, DOI 10.1016/j.enbuild.2017.09.025
   Zhai YW, 2014, JOM-US, V66, P808, DOI 10.1007/s11837-014-0886-2
   Zhang A, J CLEAN PROD
   Zhong BT, 2019, AUTOMAT CONSTR, V101, P17, DOI 10.1016/j.autcon.2018.12.013
   Zhu H, 2020, J BIOMED MATER RES A
   Zhu J, 2020, RENEW ENERG, V150, P523, DOI 10.1016/j.renene.2020.01.013
   Ziaee M, 2019, ADDIT MANUF, V28, P781, DOI 10.1016/j.addma.2019.05.031
NR 151
TC 3
Z9 3
U1 20
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0278-6125
EI 1878-6642
J9 J MANUF SYST
JI J. Manuf. Syst.
PD JUL
PY 2021
VL 60
BP 709
EP 733
DI 10.1016/j.jmsy.2021.07.023
EA AUG 2021
PG 25
WC Engineering, Industrial; Engineering, Manufacturing; Operations Research
   & Management Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Operations Research & Management Science
GA UI6UM
UT WOS:000690739400004
PM 35068653
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Akande, OW
   Elimian, KO
   Igumbor, E
   Dunkwu, L
   Kaduru, C
   Olopha, OO
   Ohanu, DO
   Nwozor, L
   Agogo, E
   Aruna, O
   Balogun, MS
   Aderinola, O
   Ahumibe, A
   Arinze, C
   Badaru, SO
   Nwachukwu, W
   Dada, AO
   Erameh, C
   Hamza, K
   Mohammed, TB
   Ndodo, N
   Obiekea, C
   Ofoegbunam, C
   Ogunbode, O
   Ohonsi, C
   Tobin, EA
   Yashe, R
   Adekaiyaoja, A
   Asuzu, MC
   Audu, RA
   Bello, MB
   Bello, SO
   Deeni, YY
   Disu, Y
   Joseph, G
   Ezeokafor, C
   Habib, ZG
   Ibeh, C
   Ike, IF
   Iwara, E
   Luka-Lawal, RK
   Namara, G
   Okwor, T
   Olajide, L
   Ilesanmi, OO
   Omonigho, S
   Oyiri, F
   Takpa, K
   Ugbogulu, NU
   Ibekwe, P
   Oladejo, J
   Ilori, E
   Ochu, CL
   Ihekweazu, C
AF Akande, Oluwatosin Wuraola
   Elimian, Kelly Osezele
   Igumbor, Ehimario
   Dunkwu, Lauryn
   Kaduru, Chijioke
   Olopha, Olubunmi Omowunmi
   Ohanu, Dabri Olohije
   Nwozor, Lilian
   Agogo, Emmanuel
   Aruna, Olusola
   Balogun, Muhammad Shakir
   Aderinola, Olaolu
   Ahumibe, Anthony
   Arinze, Chinedu
   Badaru, Sikiru Olanrewaju
   Nwachukwu, William
   Dada, Augustine Olajide
   Erameh, Cyril
   Hamza, Khadeejah
   Mohammed, Tarik Benjamin
   Ndodo, Nnaemeka
   Obiekea, Celestina
   Ofoegbunam, Chinenye
   Ogunbode, Oladipo
   Ohonsi, Cornelius
   Tobin, Ekaete Alice
   Yashe, Rimamdeyati
   Adekaiyaoja, Afolabi
   Asuzu, Michael C.
   Audu, Rosemary Ajuma
   Bello, Muhammad Bashir
   Bello, Shaibu Oricha
   Deeni, Yusuf Yahaya
   Disu, Yahya
   Joseph, Gbenga
   Ezeokafor, Chidiebere
   Habib, Zaiyad Garba
   Ibeh, Christian
   Ike, Ifeanyi Franklin
   Iwara, Emem
   Luka-Lawal, Rejoice Kudirat
   Namara, Geoffrey
   Okwor, Tochi
   Olajide, Lois
   Ilesanmi, Oluwafunke Olufemi
   Omonigho, Solomon
   Oyiri, Ferdinand
   Takpa, Koubagnine
   Ugbogulu, Nkem Usha
   Ibekwe, Priscilla
   Oladejo, John
   Ilori, Elsie
   Ochu, Chinwe Lucia
   Ihekweazu, Chikwe
TI Epidemiological comparison of the first and second waves of the COVID-19
   pandemic in Nigeria, February 2020-April 2021
SO BMJ GLOBAL HEALTH
LA English
DT Article
DE COVID-19; epidemiology; descriptive study
AB Background With reports of surges in COVID-19 case numbers across over 50 countries, country-level epidemiological analysis is required to inform context-appropriate response strategies for containment and mitigation of the outbreak. We aimed to compare the epidemiological features of the first and second waves of COVID-19 in Nigeria. Methods We conducted a retrospective analysis of the Surveillance Outbreak Response Management and Analysis System data of the first and second epidemiological waves, which were between 27 February and 24 October 2020, and 25 October 2020 to 3 April 2021, respectively. Descriptive statistical measures including frequencies and percentages, test positivity rate (TPR), cumulative incidence (CI) and case fatality rates (CFRs) were compared. A p value of Results There were 802 143 tests recorded during the study period (362 550 and 439 593 in the first and second waves, respectively). Of these, 66 121 (18.2%) and 91 644 (20.8%) tested positive in the first and second waves, respectively. There was a 21.3% increase in the number of tests conducted in the second wave with TPR increasing by 14.3%. CI during the first and second waves were 30.3/100 000 and 42.0/100 000 respectively. During the second wave, confirmed COVID-19 cases increased among females and people 30 years old or younger and decreased among urban residents and individuals with travel history within 14 days of sample collection (p value <0.001). Most confirmed cases were asymptomatic at diagnosis during both waves: 74.9% in the first wave; 79.7% in the second wave. CFR decreased during the second wave (0.7%) compared with the first wave (1.8%). Conclusion Nigeria experienced a larger but less severe second wave of COVID-19. Continued implementation of public health and social measures is needed to mitigate the resurgence of another wave.
C1 [Akande, Oluwatosin Wuraola; Elimian, Kelly Osezele; Olopha, Olubunmi Omowunmi; Nwozor, Lilian; Badaru, Sikiru Olanrewaju; Ogunbode, Oladipo; Ohonsi, Cornelius; Disu, Yahya; Okwor, Tochi; Ochu, Chinwe Lucia] Nigeria Ctr Dis Control, Prevent Programmes & Knowledge Management, Abuja, Federal Capital, Nigeria.
   [Akande, Oluwatosin Wuraola; Elimian, Kelly Osezele; Igumbor, Ehimario; Kaduru, Chijioke; Olopha, Olubunmi Omowunmi; Ohanu, Dabri Olohije; Nwozor, Lilian; Agogo, Emmanuel; Ohonsi, Cornelius; Asuzu, Michael C.; Audu, Rosemary Ajuma; Bello, Muhammad Bashir; Bello, Shaibu Oricha; Deeni, Yusuf Yahaya; Ezeokafor, Chidiebere; Habib, Zaiyad Garba; Ibeh, Christian; Iwara, Emem; Okwor, Tochi; Ilesanmi, Oluwafunke Olufemi; Takpa, Koubagnine; Ochu, Chinwe Lucia; Ihekweazu, Chikwe] Nigeria COVID 19 Res Coalit, Abuja, Federal Capital, Nigeria.
   [Elimian, Kelly Osezele] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.
   [Igumbor, Ehimario; Ohanu, Dabri Olohije; Mohammed, Tarik Benjamin; Ibekwe, Priscilla; Ihekweazu, Chikwe] Nigeria Ctr Dis Control, Off Director Gen, Abuja, Federal Capital, Nigeria.
   [Igumbor, Ehimario] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa.
   [Dunkwu, Lauryn; Adekaiyaoja, Afolabi] Tony Blair Inst Global Change, Abuja, Federal Capital, Nigeria.
   [Kaduru, Chijioke] IQVIA, Abuja, Nigeria.
   [Agogo, Emmanuel] Resolve Save Lives, Abuja, Federal Capital, Nigeria.
   [Aruna, Olusola] UK Hlth Secur Agcy, Global Operat, Int Hlth Regulat IHR Strengthening Project, London, England.
   [Balogun, Muhammad Shakir; Dada, Augustine Olajide] African Field Epidemiol Network, Abuja, Federal Capital, Nigeria.
   [Aderinola, Olaolu; Joseph, Gbenga; Luka-Lawal, Rejoice Kudirat; Oladejo, John] Nigeria Ctr Dis Control, Hlth Emergency Preparedness & Response, Abuja, Federal Capital, Nigeria.
   [Ahumibe, Anthony; Ndodo, Nnaemeka; Obiekea, Celestina] Nigeria Ctr Dis Control, Publ Hlth Lab Serv, Abuja, Federal Capital, Nigeria.
   [Arinze, Chinedu; Nwachukwu, William; Ofoegbunam, Chinenye; Yashe, Rimamdeyati; Olajide, Lois; Oyiri, Ferdinand; Ugbogulu, Nkem Usha; Ilori, Elsie] Nigeria Ctr Dis Control, Surveillance & Epidemiol, Abuja, Federal Capital, Nigeria.
   [Erameh, Cyril; Tobin, Ekaete Alice] Irrua Specialist Teaching Hosp, Irrua, Edo State, Nigeria.
   [Hamza, Khadeejah] Ahmadu Bello Univ, Dept Community Med, Zaria, Nigeria.
   [Asuzu, Michael C.] Univ Coll Hosp, Dept Community Med, Ibadan, Oyo State, Nigeria.
   [Audu, Rosemary Ajuma] Nigerian Inst Med Res, Dept Microbiol, Yaba, Lagos State, Nigeria.
   [Bello, Muhammad Bashir] Usmanu Danfodiyo Univ, Ctr Adv Med Res & Training, Sokoto, Sokoto State, Nigeria.
   [Bello, Shaibu Oricha] Usmanu Danfodiyo Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Sokoto, Sokoto State, Nigeria.
   [Deeni, Yusuf Yahaya] Fed Univ Dutse, Dept Microbiol & Biotechnol, Dutse, Jigawa State, Nigeria.
   [Deeni, Yusuf Yahaya] Ctr Environm & Publ Hlth Res & Dev, Kano, Kano State, Nigeria.
   [Ezeokafor, Chidiebere] Natl Agcy Control AIDS, Abuja, Federal Capital, Nigeria.
   [Habib, Zaiyad Garba] Univ Abuja Teaching Hosp, Abuja, Federal Capital, Nigeria.
   [Ibeh, Christian] Nnamdi Azikiwe Univ Teaching Hosp, Dept Community Med, Nnewi, Anambra State, Nigeria.
   [Ike, Ifeanyi Franklin] eHlth Africa, Abuja, Federal Capital, Nigeria.
   [Iwara, Emem] Maryland Global Initiat Corp, Abuja, Federal Capital, Nigeria.
   [Namara, Geoffrey; Ilesanmi, Oluwafunke Olufemi] WHO, Abuja, Federal Capital, Nigeria.
   [Omonigho, Solomon] Univ Benin, Dept Microbiol, Benin, Edo State, Nigeria.
   [Takpa, Koubagnine] Joint United Nations Programme AIDS UNAIDS, Abuja, Federal Capital, Nigeria.
RP Akande, OW (corresponding author), Nigeria Ctr Dis Control, Prevent Programmes & Knowledge Management, Abuja, Federal Capital, Nigeria.; Akande, OW (corresponding author), Nigeria COVID 19 Res Coalit, Abuja, Federal Capital, Nigeria.
EM akande.wuraola@gmail.com
RI Erameh, Cyril/ABF-3824-2020; Agogo, Emmanuel/AAD-1459-2022; Igumbor,
   Ehimario U/B-2652-2012; Okwor, Tochi/T-9223-2018
OI Erameh, Cyril/0000-0001-7783-2495; Agogo, Emmanuel/0000-0002-3570-3254;
   Igumbor, Ehimario U/0000-0002-6313-6031; Akande,
   Oluwatosin/0000-0001-6906-895X; Kaduru, Chijioke/0000-0002-6861-9876;
   OHONSI, CORNELIUS EHIZOKHAI/0000-0002-4727-6835; Ofoegbunam,
   Chinenye/0000-0002-3330-7178; OMONIGHO, Solomon
   Esharegoma/0000-0001-7557-1789; Okwor, Tochi/0000-0003-2391-7770
FU African Field Epidemiology Network (AFENET)
FX We appreciate all the Nigerian frontline health workers for their
   contribution to the collection of the data used for this study. We
   acknowledge the leadership and coordination provided by all state
   commissioners for health, epidemiologists and disease notification and
   surveillance officers. We are also grateful to colleagues, including
   members of the Epidemiological Working Group of the Nigeria COVID--19
   Research Coalition (NCRC) who provided technical and administrative
   support for this manuscript. In addition, we acknowledge the African
   Field Epidemiology Network (AFENET) for providing financial support
   towards the publication of this manuscript.
CR Abubakar I, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004793
   Adebowale N., 2020, COVID 19 NIGERIA APP
   Adedigba A., 2020, CORONAVIRUS NIGERIAN
   [Anonymous], 2020, REUTERS
   [Anonymous], 2020, PUNCH NEWSPAPERS
   [Anonymous], 2021, PARTNERSHIP EVIDENCE
   Burki T, 2021, LANCET INFECT DIS, V21, P922, DOI 10.1016/S1473-3099(21)00344-3
   Center for Disease Control and Prevention, 2021, MMWR WEEKS
   Centers for Disease Control and Prevention, 2020, SARS COV 2 VAR CLASS
   Centre for Communication and Social Impact, 2020, COVID 19 AUD PERC SU
   Centre for the the Study of the Economies of Africa, 2020, REOP SCH LEARN AM CO
   Chibnik L., 2016, SUBS AFR CFAR M
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Dan-Nwafor C, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020399
   Elimian KO, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S095026882000206X
   Elimian KO, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-044079
   Equator Network, 2015, STROBE STAT CHECKL I
   Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117
   Gallagher J., 2020, BBC NEWS
   Groenwold RHH, 2012, CAN MED ASSOC J, V184, P1265, DOI 10.1503/cmaj.110977
   Ibrahim OR, 2020, AM J TROP MED HYG, V103, P2376, DOI 10.4269/ajtmh.20-0759
   James N, 2021, CHAOS, V31, DOI 10.1063/5.0041569
   National Primary Health Care Development Agency, 2021, COVID 19 VACC PLAN
   National Primary Health Care Development Agency, 2021, PERC TOT TARG REACH
   Nigeria Centre for Disease Control, 2020, NCDC NIMR LAUNCH COV
   Nigeria Centre for Disease Control, 2020, NAT INT GUID CLIN MA
   Nigeria Centre for Disease Control, 2021, RISK COMM COMM ENG S
   Nigeria Centre for Disease Control, 2020, SPEC COLL PACK TRANS
   Nigeria Centre for Disease Control, 2021, ON YEAR NIG COVID 19
   Nigeria Centre for Disease Control, 2018, DIG SURV NIG SURV OU
   Nigeria Centre for Disease Control, 2021, NCDC APPR COVID 19 L
   Nigeria Centre for Disease Control, 2021, COVID 19 NIG
   Nigeria Centre for Disease Control, 2020, GUID 2020 NAT YOUTH
   Nigeria Centre for Disease Control, 2020, 130 NIG CTR DIS CONT
   Ochu CL, 2021, HEALTH SECUR, V19, P223, DOI 10.1089/hs.2020.0151
   Ochu CL., 2021, BMJ INNOV, V7, P347, DOI [10.1136/bmjinnov-2020-000637, DOI 10.1136/BMJINNOV-2020-000637]
   Ogboghodo EO, 2021, AM J TROP MED HYG, V104, P1034, DOI 10.4269/ajtmh.20-1402
   Ohia C, 2020, PAN AFR MED J, V37, DOI 10.11604/pamj.supp.2020.37.47.26956
   Osibogun A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248281
   Our World in Data, 2021, COR COVID 19 TEST ST
   Premium Times, 2020, PREMIUM TIMES
   Saito S, 2021, J INFECTION, V82, P116, DOI 10.1016/j.jinf.2020.10.033
   Salyer SJ, 2021, LANCET, V397, P1265, DOI 10.1016/S0140-6736(21)00632-2
   Seong H, 2021, INT J INFECT DIS, V104, P742, DOI 10.1016/j.ijid.2021.02.004
   Smith P, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3350
   Soriano V, 2021, INT J INFECT DIS, V105, P374, DOI 10.1016/j.ijid.2021.02.115
   Taboada M, 2021, J INFECTION, V82, pE14, DOI 10.1016/j.jinf.2021.03.027
   Wagner A., 2020, WHAT MAKES WAVE DIS
   Wibawa T., 2020, IS THERE EVEN SUCH T
   World Health Organisation Regional Office for Africa, 2021, AFR FAC STEEP COVID
   World Health Organization, 2021, COVID 19 VACC SHIPP
   World health organization (WHO), 2020, CORONAVIRUS
   Yanez ND, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09826-8
NR 53
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD NOV
PY 2021
VL 6
IS 11
AR e007076
DI 10.1136/bmjgh-2021-007076
PG 14
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA XA9TD
UT WOS:000720980400001
PM 34794956
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Owhonda, G
   Maduka, O
   Nwadiuto, I
   Tobin-West, C
   Azi, E
   Ojimah, C
   Alasia, D
   Olofinuka, AM
   Agala, V
   Paul, JN
   Nria, D
   Okafor, C
   Ndekwu, I
   Opara, C
   Newsom, C
AF Owhonda, Golden
   Maduka, Omosivie
   Nwadiuto, Ifeoma
   Tobin-West, Charles
   Azi, Esther
   Ojimah, Chibianotu
   Alasia, Datonye
   Olofinuka, Ayo-Maria
   Agala, Vetty
   Paul, John Nwolim
   Nria, Doris
   Okafor, Chinenye
   Ndekwu, Ifeoma
   Opara, Chikezie
   Newsom, Chris
TI Awareness, perception and the practice of COVID-19 prevention among
   residents of a state in the South-South region of Nigeria: implications
   for public health control efforts
SO INTERNATIONAL HEALTH
LA English
DT Article; Early Access
DE attitude; COVID-19 prevention; knowledge; practice; public health
   control
ID RISK COMMUNICATION
AB Background As with any epidemic, coronavirus disease 2019 (COVID-19) has evoked panic, fear and misconceptions. The risk communication pillar of the Public Health Emergency Operations Centre is responding to the pandemic by facilitating correct and consistent information to enable the adoption of behaviours to prevent and control COVID-19. This study explored awareness, perception and practice of COVID-19 prevention among residents in Rivers State, Nigeria, during the early stages of the COVID-19 pandemic response. Methods This was a descriptive cross-sectional survey among 1294 adult residents across all districts of the state. It employed an interviewer-administered questionnaire. Knowledge was graded as excellent for scores of >= 80%, good for scores of 50-79% and poor for scores of Results The respondents were aged 18-80 y with an average age of 39.6 (SD=11.9) y. A total of 710 (54.9%) were male, 476 (36.8%) were unemployed with 685 (52.9%) having secondary education. The most common sources of information about COVID-19 were radio jingles (1102; 86.7%) and television adverts (940; 74.0%). Overall, 608 (47.0%) of the respondents had a poor knowledge of COVID-19. About 443 (34.9%) respondents believed they were unlikely to contract the virus. Only 505 (39.0%) of respondents washed all the critical parts of their hands correctly. Occupation (adjusted OR [AOR]=1.39, 95% CI 1.07 to 1.82, p=0.01), level of education (AOR=4.71, 95% CI 1.90 to 11.68, p<0.001) and location (AOR=1.75, 95% CI 1.29 to 2.38; p<0.001) significantly predicted respondents' knowledge about COVID-19. The significant predictors of practice of COVID-19 were age (AOR=0.60, 95% CI 0.42 to 0.84, p=0.003), occupation (AOR=1.93, 95% CI 1.41 to 2.63, p<0.001), location (AOR=2.35, 95% CI 1.65 to 3.34, p<0.001) and knowledge about COVID-19 (AOR=7.75, 95% CI 5.94 to 10.11, p<0.001). Conclusions Broadcast media has a pivotal role to play in risk communication for behavioural change for the control of current and future epidemics in this population.
C1 [Owhonda, Golden; Nwadiuto, Ifeoma; Paul, John Nwolim; Nria, Doris] Rivers State Minist Hlth, Dept Publ Hlth & Dis Control, Port Harcourt 50001, Nigeria.
   [Owhonda, Golden; Maduka, Omosivie; Nwadiuto, Ifeoma; Tobin-West, Charles; Azi, Esther; Ojimah, Chibianotu; Alasia, Datonye; Olofinuka, Ayo-Maria; Agala, Vetty; Paul, John Nwolim; Nria, Doris; Okafor, Chinenye; Ndekwu, Ifeoma; Opara, Chikezie; Newsom, Chris] Rivers State Publ Hlth Emergency Operat Ctr, Port Harcourt 50001, Nigeria.
   [Maduka, Omosivie; Tobin-West, Charles] Univ Port Harcourt, Dept Prevent & Social Med, Port Harcourt 50001, Nigeria.
   [Azi, Esther] Rivers State Univ, Dept Community Med, Port Harcourt 50001, Nigeria.
   [Ojimah, Chibianotu; Olofinuka, Ayo-Maria; Okafor, Chinenye] Rivers State Field Off, WHO, Port Harcourt 50001, Nigeria.
   [Alasia, Datonye] Univ Port Harcourt, Dept Internal Med, Port Harcourt 50001, Nigeria.
   [Agala, Vetty] Rivers State Hosp Management Board, Port Harcourt 50001, Nigeria.
   [Ndekwu, Ifeoma; Opara, Chikezie; Newsom, Chris] Stakeholder Democracy Network, Port Harcourt 50001, Nigeria.
RP Maduka, O (corresponding author), Rivers State Publ Hlth Emergency Operat Ctr, Port Harcourt 50001, Nigeria.; Maduka, O (corresponding author), Univ Port Harcourt, Dept Prevent & Social Med, Port Harcourt 50001, Nigeria.
EM omosivie.maduka@uniport.edu.ng
RI Maduka, Omosivie/E-8345-2013
OI Maduka, Omosivie/0000-0002-8243-8131
FU Stakeholder Democracy Network
FX 1. DSNOs of Rivers State Primary Health Care Management Board for their
   role in data collection. 2. The Stakeholder Democracy Network for
   funding the survey. 3. Technical and administrative staff of Rivers
   State PHEO C for the key roles they perform in the pandemic response.
CR Bedrosian SR, 2016, MMWR-MORBID MORTAL W, V65, P68, DOI 10.15585/mmwr.su6503a10
   Bruns DP, 2020, J TRANSCULT NURS, V31, P326, DOI 10.1177/1043659620917724
   Buli BG, 2015, PAN AFR MED J, V22, DOI 10.11694/pamj.supp.2015.22.1.6269
   Edet CK., 2020, INT J TROP DIS HEAL, V19, P66
   Green LA, 2005, J AM BOARD FAM PRACT, V18, P541, DOI 10.3122/jabfm.18.6.541
   Iliyasu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135955
   Maduka O, 2016, PUBLIC HEALTH, V135, P140, DOI 10.1016/j.puhe.2015.10.037
   Maduka O, 2015, PERSPECT PUBLIC HEAL, V135, P282, DOI 10.1177/1757913915606662
   Nigeria Centre for Disease Control, 2020, DAIL COV 19 SIT REP
   Nigeria Centre for Disease Control, 2020, WEEKL SIT REP
   Ramaci T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093834
   Rivers Public Health Emergency Operations Centre, 2020, SIT REP
   Tadesse T, 2020, INFECT DRUG RESIST, V13, P3751, DOI 10.2147/IDR.S275933
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   World Health Organization. Coronavirus, 2020, HLTH TOPICS
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 16
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1876-3413
EI 1876-3405
J9 INT HEALTH
JI Int. Health
DI 10.1093/inthealth/ihab046
EA AUG 2021
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZA8UZ
UT WOS:000756433600001
PM 34383047
OA hybrid, Green Submitted
DA 2022-04-20
ER

PT J
AU Bajaj, S
   Bhatia, U
   Barrett, S
   LeGout, J
   Bi, Y
AF Bajaj, Suryansh
   Bhatia, Unnati
   Barrett, Stevi
   LeGout, Jordan
   Bi, Yan
TI Necrotizing pancreatitis in a COVID-19 patient managed with endoscopic
   AXIOS stent placement
SO INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION
LA English
DT Article
DE Coronavirus; COVID-19; Endoscopy; Pancreatitis; acute necrotizing;
   Stents
ID INFECTION
AB As coronavirus disease 2019 (COVID-19) is a relatively novel infectious process, atypical presentations like acute pancreatitis (AP) are still being studied and a clear association between pancreatic injury and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has yet to be estab-lished. This makes the diagnosis and management of such conditions exceedingly difficult. Although several cases of severe AP with concurrent SARS-CoV-2 infection have been reported, to the best of our knowledge, ours is the first COVID-19 case to present with necrotizing pancreatitis and the first reported case requiring intervention for associated local complications. Copyright (C) 2022, Society of Gastrointestinal Intervention.
C1 [Bajaj, Suryansh] Yale Sch Med, Dept Radiol, 333 Cedar St, New Haven, CT 06510 USA.
   [Bhatia, Unnati] Maulana Azad Med Coll, Dept Internal Med, New Delhi, India.
   [Barrett, Stevi; Bi, Yan] Mayo Clin, Div Gastroenterol & Hepatol, Jacksonville, FL 32224 USA.
   [LeGout, Jordan] Mayo Clin, Dept Radiol, Jacksonville, FL 32224 USA.
RP Bajaj, S (corresponding author), Yale Sch Med, Dept Radiol, 333 Cedar St, New Haven, CT 06510 USA.
EM suryanshbajaj26@gmail.com
OI LeGout, Jordan/0000-0003-3608-726X; Bajaj, Suryansh/0000-0002-1642-4620
CR Ahmad FB, 2021, MMWR-MORBID MORTAL W, V70, P519, DOI [10.15585/mmwr.mm7014e1, 10.15585/mmwr.mm7014e1externalicon]
   Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779
   de-Madaria E, 2021, NAT REV GASTRO HEPAT, V18, P3, DOI 10.1038/s41575-020-00389-y
   Dholakia K, 2004, J CLIN GASTROENTEROL, V38, P81, DOI 10.1097/00004836-200401000-00017
   Gadiparthi C, 2020, PANCREAS, V49, pE62, DOI 10.1097/MPA.0000000000001595
   George J, 2019, PANCREATOLOGY, V19, P587, DOI 10.1016/j.pan.2019.04.015
   Gupta V, 2020, INDIAN J SURG, V82, P301, DOI 10.1007/s12262-020-02447-w
   Jones MR, 2015, OCHSNER J, V15, P45
   Kumar V, 2021, EUR J GASTROEN HEPAT, V33, P695, DOI 10.1097/MEG.0000000000002160
   Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566
   Liu FR, 2020, CLIN GASTROENTEROL H, V18, P2128, DOI 10.1016/j.cgh.2020.04.040
   Miro O, 2021, J HEPATO-BIL-PAN SCI, V28, P953, DOI 10.1002/jhbp.873
   Pandanaboyana S, 2021, GUT, V70, P1061, DOI 10.1136/gutjnl-2020-323364
   Wang F, 2020, GASTROENTEROLOGY, V159, P367, DOI 10.1053/j.gastro.2020.03.055
   Wolfe D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231883
NR 15
TC 0
Z9 0
U1 0
U2 0
PU SOC GASTROINTESTINAL INTERVENTION
PI SEOUL
PA 12, HAKDONG-RO 31, GANGNAM-GU, SEOUL, 00000, SOUTH KOREA
SN 2636-0004
EI 2636-0012
J9 INT J GASTROINT INT
JI Int. J. Gastrointest. Interv.
PD JAN
PY 2022
VL 11
IS 1
BP 42
EP 45
DI 10.18528/ijgii210052
PG 4
WC Gastroenterology & Hepatology
WE Emerging Sources Citation Index (ESCI)
SC Gastroenterology & Hepatology
GA YP5KP
UT WOS:000748661900009
OA gold
DA 2022-04-20
ER

PT J
AU Kim, YK
   Poncelet, JL
   Min, G
   Lee, J
   Yang, YJ
AF Kim, Yong-kyun
   Poncelet, Jean-Luc
   Min, Geumyoung
   Lee, Jaekyung
   Yang, Yunjung
TI COVID-19: Systemic risk and response management in the Republic of Korea
SO PROGRESS IN DISASTER SCIENCE
LA English
DT Article
DE COVID-19; Systemic risk; Response management; Republic of Korea; Risk
   management flow
AB This study aimed to investigate the different kinds of risks associated with the novel coronavirus infection in the Republic of Korea and how those risks have been changed by the countermeasures taken by the Korean authorities and citizens. To this end, the authors explored the official database of the Korea Centers for Disease Control and Prevention (KCDC) in order to extract risk-related data from January 2020 to April 2021, and then identified the disaster risks and countermeasures from the government press briefings and news media in the same period. Consequently, this study identified three important approaches to enhance the infectious disease response management. First, the government has to respond immediately, even when they lack information and knowledge about the new type of risk. Second, a multi-sectoral response must be prepared to cope with systemic risks. Third, the government should prioritize transparency, inclusive risk governance, and innovative technologies during the initial response stage against risks with high uncertainty and novelty. Aside from these approaches, the types of risks were divided into four categories based on the response measures: anticipated risk against which countermeasures can be planned in advance, lingering risk against which adaptive response should be taken promptly, amplified risk, and emerging risk; the last two risks require the established plan to be modified drastically in order to secure higher-level engagement and additional resources. Finally, the authors proposed a risk management flow that can be applied to an in-depth analysis of the intersection between risk and response.
C1 [Kim, Yong-kyun] Minist Interior & Safety, Seoul, South Korea.
   [Poncelet, Jean-Luc] Independent Disaster Management Consultant, Paris, France.
   [Min, Geumyoung] Dongguk Univ, Seoul, South Korea.
   [Lee, Jaekyung] SMG SNU Boramae Med Ctr, Seoul, South Korea.
   [Yang, Yunjung] Sungshin Womens Univ, Seoul, South Korea.
RP Kim, YK (corresponding author), Haemil 3 Ro,90 217-1604, Sejong City 30092, South Korea.
EM unkim68@gmail.com
CR Cheongwadae, 2020, OP REM M JAE IN 7 CA
   Government of the Repulic of Korea, 2020, KOR RESP COVID 19 FU
   HO LEE YOON, 2020, Korean Journal of Clinical Psychology, V39, P368
   Howitt AM, 2017, PUBLIC HLTH PREPARED
   Jeong IS, 2014, DEV DIRECTION KOREAS, V19, P15
   Johns Hopkins University & Medicine, COVID 19 DASHB CTR S
   KIET, 2021, INTERIM EVALUATION, V109, P2021
   Kim YK, 2018, DISAST RISK REDUCT, P1, DOI 10.1007/978-981-10-4789-3
   Lee David, 2020, Transp Res Interdiscip Perspect, V5, P100111, DOI 10.1016/j.trip.2020.100111
   Nebehay S., 2020, WHO OFFICIALS RETHIN
   Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031
   Renn O, 2009, ENVIRON POLICY GOV, V19, P174, DOI [10.1002/eet.507, DOI 10.1002/EET.507]
   United Nations, SHARED RESPONSIBILIT
   United Nations Office for Disaster Risk Reduction, ONL GLOSS DIS RISK
   WHO, 2019, HLTH EM DIS RISK MAN
   Yang Y, 2020, TRACING DIGITAL CONT, DOI [10.2139/ssrn.3743491, DOI 10.2139/SSRN.3743491]
NR 16
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2590-0617
J9 PROG DISASTER SCI
JI Prog. Disaster Sci.
PD DEC
PY 2021
VL 12
AR 100200
DI 10.1016/j.pdisas.2021.100200
EA SEP 2021
PG 9
WC Environmental Sciences; Environmental Studies; Geosciences,
   Multidisciplinary; Public, Environmental & Occupational Health;
   Meteorology & Atmospheric Sciences
WE Emerging Sources Citation Index (ESCI)
SC Environmental Sciences & Ecology; Geology; Public, Environmental &
   Occupational Health; Meteorology & Atmospheric Sciences
GA YP9TA
UT WOS:000748961200008
PM 34493999
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Dorji, T
   Tamang, ST
   Tilak, TVSVGK
AF Dorji, Thinley
   Tamang, Saran Tenzin
   Tilak, T. V. S. V. G. K.
TI Self-learning on COVID-19 among medical students in Bhutan: A
   cross-sectional study
SO HELIYON
LA English
DT Article
DE COVID-19; Medical education; Medical school; Online learning; Social
   media; Pandemic
AB Background: Bhutan lacks a medical school and all medical students are trained in Sri Lanka, Bangladesh and India. When the COVID-19 pandemic led to the closure of medical schools in these countries in March-April 2020, the medical students were repatriated to Bhutan. Upon return, they were kept in government-sponsored facility quarantine for 21 days. This study assessed their knowledge on COVID-19 as a part of self-learning and their attitude towards participation in government's health response to COVID-19.
   Methods: This was a cross-sectional study among medical students who had returned to the country. The survey was conducted through an online questionnaire while the students were in facility quarantine. The sample size calculated was 129 and convenient sampling was used. Knowledge was assessed using 20 questions, each scored 1/20. Knowledge was considered "good" if the cumulative score was >= 80%, "satisfactory" if >= 60-79% and "poor" if <60%. Correlation between knowledge score and duration of clinical clerkship was tested using Pearson's correlation coefficient. Attitude of students towards their willingness to participate in the national COVID-19 response was tested using rating scales. Data were analysed using Stata 13.1.
   Results: 120 medical students responded to the survey (response rate = 93%). Eighty-eight (74%) had good knowledge, 28 (23%) had satisfactory knowledge and only four (3%) had poor knowledge on COVID-19. The students scored high on the symptomatology, mode of transmission, prevention and treatment options and on local epidemiology; and scored low on the forms of mechanical ventilation and on home-management of non-critical cases. The knowledge score correlated with the duration of clinical clerkship they had undertaken (r = 0.326, p = 0.001). The primary source of information were social media sites (102, 85%), television (94, 78%) and newspapers (76, 63%). The majority (78, 65%) were willing to participate in the government's COVID-19 response but could not identify what roles they could play. The fear of contracting COVID-19 was reported by eight students (7%).
   Conclusions: Medical students had good knowledge on COVID-19 and had self-learned through social media, television and newspapers. The students held positive attitude towards participation in the government's COVID-19 response.
C1 [Dorji, Thinley; Tilak, T. V. S. V. G. K.] Maharashtra Univ Hlth Sci, Armed Forces Med Coll, Dept Internal Med, Pune, Maharashtra, India.
   [Dorji, Thinley] His Majestys Peoples Project, Kidu Mobile Med Unit, Thimphu, Bhutan.
   [Tamang, Saran Tenzin] Khesar Gyalpo Univ Med Sci Bhutan, Fac Postgrad Med, Thimphu, Bhutan.
RP Dorji, T (corresponding author), Maharashtra Univ Hlth Sci, Armed Forces Med Coll, Dept Internal Med, Pune, Maharashtra, India.; Dorji, T (corresponding author), His Majestys Peoples Project, Kidu Mobile Med Unit, Thimphu, Bhutan.
EM dorji.thinleydr@gmail.com
RI Dorji, Thinley/K-7906-2019; Tamang, Saran Tenzin/AAV-7665-2020
OI Dorji, Thinley/0000-0003-4932-8704; Tamang, Saran
   Tenzin/0000-0003-2619-7043; TVSVGK, Tilak/0000-0002-1380-8346
CR Akers A, 2020, CUREUS, V12, DOI 10.7759/cureus.7800
   Caliskan F, 2020, POSTGRAD MED, V132, P764, DOI 10.1080/00325481.2020.1795486
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Chan TM, 2020, PERSPECT MED EDUC, V9, P20, DOI 10.1007/s40037-019-00542-7
   Choi B, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02117-1
   Compton S, 2020, MED EDUC, V54, P943, DOI 10.1111/medu.14268
   Dem P., 2020, MED STUDENTS SHARE V
   Di Donato V., FRESH OUT MED SCH YO
   Dorji T., 2020, POPULATION MED, P2
   Dorji T., 2020, AM J TROPICAL MED HY
   Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34
   Harvey A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1197
   Iacobucci G, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1064
   Karunathilake I.M., 2020, S E ASIAN J MED ED, V14, P1
   Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253
   Miller DG, 2020, ANN INTERN MED, V173, P145, DOI 10.7326/M20-1281
   Ministry of Education, 2019, ANN ED STAT 2019, V31st
   Ministry of Health, 2019, ANN HLTH B
   Rasmussen S, 2020, LANCET, V395, pE79, DOI 10.1016/S0140-6736(20)30923-5
   Sandhu P, 2020, MED EDUC ONLINE, V25, DOI 10.1080/10872981.2020.1764740
   Stokes DC, 2020, ACAD EMERG MED, V27, P343, DOI 10.1111/acem.13972
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
NR 22
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
EI 2405-8440
J9 HELIYON
JI Heliyon
PD JUL
PY 2021
VL 7
IS 7
AR e07533
DI 10.1016/j.heliyon.2021.e07533
EA JUL 2021
PG 5
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA UD5SS
UT WOS:000687266900024
PM 34307948
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Cho, S
   Shin, N
   Kwak, DH
   Kim, ACH
   Jang, WS
   Lee, JS
   Ko, YJ
AF Cho, Sungho
   Shin, Nari
   Kwak, Dae Hee
   Kim, Amy Chan Hyung
   Jang, Won Seok
   Lee, Joon Sung
   Ko, Yong Jae
TI The Impact of COVID-19 Crisis on Major Spectator Sport Industry in the
   US and South Korea: Challenges and Outlook
SO JOURNAL OF GLOBAL SPORT MANAGEMENT
LA English
DT Article; Early Access
DE Sport industry; sport leagues; COVID-19; risk management; focus-group
ID RISK-MANAGEMENT; LEAGUE; TYPOLOGY; QUALITY; DEMAND; FAN
AB This study explored the challenges facing sport leagues in the U.S. and Korea due to the COVID-19 pandemic, their strategies in dealing with the crisis, and what post-pandemic spectator sport industry in the two countries might look like. We recruited three industry practitioners from the U.S. and South Korea for a focus group interview conducted during a panel discussion organized by an academic organization. An inductive-open coding extracted several themes from the qualitative data. Main challenges included uncertainty, increased competition, and weakened fan experience. Strategies included contingency planning, flexible venue management, and revitalizing the fan experience. While the panel agreed that the pandemic constrained the industry's traditional business practices, countervailing effects were also noted such as the facilitation of technological diffusion. This study presents implications for the industry and the relevant body of knowledge including: Technology-based media consumption, advanced risk management protocols and product characterizations, and approaches to incorporate sociocultural connotations of spectating sport.
C1 [Cho, Sungho] Green State Univ, Sch Human Movement Sport & Leisure Studies, Bowling Green, OH USA.
   [Shin, Nari] Texas Tech Univ, Dept Kinesiol & Sport Management, Box 43011, Lubbock, TX 79409 USA.
   [Kwak, Dae Hee] Univ Michigan, Dept Sport Management, Ann Arbor, MI 48109 USA.
   [Kim, Amy Chan Hyung] Florida State Univ, Dept Sport Management, Tallahassee, FL 32306 USA.
   [Jang, Won Seok] Sungkyunkwan Univ, Coll Sport Sci, Suwon, Gyeonggi Do, South Korea.
   [Lee, Joon Sung] Yonsei Univ, Dept Sport Ind Studies, Seoul, South Korea.
   [Ko, Yong Jae] Univ Florida, Dept Sport Management, Gainesville, FL USA.
RP Shin, N (corresponding author), Texas Tech Univ, Dept Kinesiol & Sport Management, Box 43011, Lubbock, TX 79409 USA.
EM NaRi.Shin@ttu.edu
OI Lee, Joon Sung/0000-0001-7104-5183; Cho, Sungho/0000-0002-0462-0798
CR Ahn SC, 2014, J SPORT ECON, V15, P451, DOI 10.1177/1527002514535171
   [Anonymous], 2020, WASH POST
   Arnegger J, 2010, J SUSTAIN TOUR, V18, P915, DOI 10.1080/09669582.2010.485680
   Ashraf BN, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100371
   Becker Friedman Institute, KEY EC FACTS COVID 1
   Bernthal M. J., 2003, Journal of Sport Behavior, V26, P223
   Bird H, 2020, BOSTON 0814
   Bizzozero P, 2016, J ECON BEHAV ORGAN, V130, P47, DOI 10.1016/j.jebo.2016.07.006
   Blasi W, 2020, NBA GAMES RETURN TOD
   Bonesteel, 2020, WASH POST
   BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301
   Byon KK, 2013, EUR SPORT MANAG Q, V13, P232, DOI 10.1080/16184742.2013.767278
   Caruso R, 2019, J SPORT ECON, V20, P25, DOI 10.1177/1527002517717298
   Chelladurai P., 2014, MANAGING ORG SPORT P, V4th
   Ciocchetti CA, 2008, J LEG STUD EDUC, V25, P127, DOI 10.1111/j.1744-1722.2008.00049.x
   Claussen C.L., 2014, SPORT LAW MANAGERIAL
   Cleland J, 2019, SOCIOL SPORT J, V36, P144, DOI 10.1123/ssj.2018-0039
   Cooper JN, 2019, INT REV SOCIOL SPORT, V54, P151, DOI 10.1177/1012690217718170
   Cox A, 2018, J SPORT ECON, V19, P3, DOI 10.1177/1527002515619655
   Creswell J.W., 1998, QUAL INQ
   Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2
   Czarnecki M, 2014, MANAG-POL, V18, P169, DOI 10.2478/manment-2014-0013
   Davies M., 2019, J SPORT BEHAV, V42, P177
   Depken CA, 1999, REV IND ORGAN, V14, P205
   Dhurup M, 2010, AFRICAN J PHYS HLTH, V16, P204, DOI [https://doi.org/10.4314/ajpherd.v16i2.55959, DOI 10.4314/AJPHERD.V16I2.55959]
   Di Stefano M, 2020, FINANCIAL TIMES 0320
   Duan N, 2015, ADM POLICY MENT HLTH, V42, P524, DOI 10.1007/s10488-014-0596-7
   Dugalic S., 2011, SPORT SCI PRACTISE, V2, P67
   EASTMAN ST, 1994, SOCIOL SPORT J, V11, P249, DOI 10.1123/SSJ.11.3.249
   Erhardt N, 2019, INT J CONTEMP HOSP M, V31, P4192, DOI 10.1108/IJCHM-03-2018-0244
   ESPN, 2020, ESPN
   Foldesi GS, 2014, PHYS CULT SPORT STUD, V63, P22, DOI 10.2478/pcssr-2013-0029
   Fort R., 2011, SPORT EC
   Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001
   Fuller CW, 2012, BRIT J SPORT MED, V46, P11, DOI 10.1136/bjsports-2011-090634
   Gooding C, 2017, J SPORT ECON, V18, P867, DOI 10.1177/1527002516637649
   Goolsbee A, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104311
   Gough C, 2020, COVID 19 POTENTIAL T
   Gropper CC, 2018, J SPORT ECON, V19, P522, DOI 10.1177/1527002516661600
   Haber L.J, 2006, J COLLECTIVE NEGOTIA, V31, P21, DOI [https://doi.org/10.2190/3451-2NJM-VGE6-EN7C, DOI 10.2190/3451-2NJM-VGE6-EN7C]
   Holden, 2020, WISCONSIN LAW REV FO
   Humphreys BR, 2020, ECON INQ, V58, P462, DOI 10.1111/ecin.12844
   Humphreys BR, 2019, J SPORT ECON, V20, P782, DOI 10.1177/1527002518817590
   INSIDESPORT, 2020, SPORTS BUS GLOB SPOR
   Kruger M, 2012, S AFR J RES SPORT PH, V34, P63
   LaGree D, 2019, INT J SPORT MARK SPO, V20, P407, DOI 10.1108/IJSMS-05-2018-0045
   Lee Hyun-Woo, 2013, IJASS(International Journal of Applied Sports Sciences), V25, P127
   Majumdara B, 2020, SPORT SOC, V23, P1091, DOI 10.1080/17430437.2020.1776972
   Maloney J., 2020, CBS SPORTS 0730
   Mandavilli, 2021, NEW YORK TIMES
   Manzini P, 2006, INT J GAME THEORY, V34, P67, DOI 10.1007/s00182-005-0006-1
   McCullagh K, 2020, SPORT BUSINESS 0416
   Merriam S.B., 2002, QUALITATIVE RES PRAC
   Miles MB., 2014, QUALITATIVE DATA ANA, V3
   Mitroff I.I., 2001, MANAGING CRISIS THEY
   Moreno M, 2020, DODGERS SELLING FAN
   Morgan J.P, 2020, MEDIA CONSUMPTION AG
   MOSLEH A, 1988, RELIAB ENG SYST SAFE, V20, P63, DOI 10.1016/0951-8320(88)90006-3
   Mueller TS, 2010, J APPL SPORT MANAG, V2, P20
   NBA, 2020, NBA PLAYOFFS 2020 YO
   Niven D, 2019, SOC SCI QUART, V100, P997, DOI 10.1111/ssqu.12630
   Ouchi, 2004, WORLD BANK POLICY RE
   Park B, 2020, COMMUN SPORT, V8, P629, DOI 10.1177/2167479519894691
   Parlow M.J., 2010, TEXAS REV ENTERTAIN, V11, P179
   Parnell D, 2022, MANAG SPORT LEIS, V27, P72, DOI 10.1080/23750472.2020.1750100
   Peeters T, 2012, INT J IND ORGAN, V30, P153, DOI 10.1016/j.ijindorg.2011.07.004
   Price S, 2020, FORBES
   Richelieu A., 2005, INT J SPORT MARK SPO, V7, P23
   ROSS S, 2004, MARQUETTE SPORTS LAW, V15, P49
   Ross SD, 2006, J SPORT MANAGE, V20, P22, DOI 10.1123/jsm.20.1.22
   Rottenberg S., 2000, Journal of Sports Economics, V1, P11, DOI 10.1177/152700250000100102
   SANDELOWSKI M, 1994, RES NURS HEALTH, V17, P479, DOI 10.1002/nur.4770170611
   Sanderson AR, 2018, REV IND ORGAN, V52, P305, DOI 10.1007/s11151-017-9593-9
   Sanderson J, 2016, MASS COMMUN SOC, V19, P301, DOI 10.1080/15205436.2015.1128549
   Scelles N, 2017, APPL ECON LETT, V24, P1399, DOI 10.1080/13504851.2017.1282125
   Schick S, 2020, MARKETING DIVE 0326
   Schmidt SH, 2018, SPORT MARKET Q, V27, P31
   Schwandt, 2015, SAGE DICT QUALITATIV
   Seifried C, 2011, J SPORT MANAGE, V25, P515, DOI 10.1123/jsm.25.6.515
   Sierra JJ, 2019, J BRAND MANAG, V26, P209, DOI 10.1057/s41262-018-0121-5
   Slavich MA, 2018, SPORT MARKET Q, V27, P167
   Surdam D.G, 2010, BALL GAME BIZ
   Tainsky S, 2016, REV IND ORGAN, V48, P29, DOI 10.1007/s11151-015-9479-7
   Thomas K., 2021, NEW YORK TIMES
   Wenz MG, 2012, J SPORT MANAGE, V26, P479, DOI 10.1123/jsm.26.6.479
   Yildiz AE, 2014, PROCD SOC BEHV, V119, P519, DOI 10.1016/j.sbspro.2014.03.058
   Yim BH, 2020, INT J SPORT MARK SPO, V21, P427, DOI 10.1108/IJSMS-03-2019-0031
   Zorzou A., 2014, Journal of Physical Education and Sport, V14, P507
NR 88
TC 1
Z9 1
U1 6
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2470-4067
EI 2470-4075
J9 J GLOB SPORT MANAGE
JI J. Glob. Sport Manage.
DI 10.1080/24704067.2021.1936591
EA JUN 2021
PG 25
WC Hospitality, Leisure, Sport & Tourism; Management
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics; Business & Economics
GA SV8NA
UT WOS:000664073200001
DA 2022-04-20
ER

PT J
AU Kukoyi, PO
   Simpeh, F
   Adebowale, OJ
   Agumba, JN
AF Kukoyi, Patricia Omega
   Simpeh, Fredrick
   Adebowale, Oluseyi Julius
   Agumba, Justus Ngala
TI Managing the risk and challenges of COVID-19 on construction sites in
   Lagos, Nigeria
SO JOURNAL OF ENGINEERING DESIGN AND TECHNOLOGY
LA English
DT Article
DE Challenges; Construction site; COVID-19; Health and safety; Risk;
   Nigeria; COVID-19 measures
ID HEALTH
AB Purpose The novel COVID-19 pandemic has increased the risk in construction operations. New systems are, thus, required on construction sites to mitigate the risk and challenges associated with the pandemic. This paper aims to determine construction organisations risk control systems and the challenges of implementing safety measures on construction sites. Design/methodology/approach The study adopted a qualitative research method. A purposive sampling method was used to select study participants, who were administered open-ended questionnaires designed to gather qualitative data. The contents of the data were analysed, presented and reported based on the objectives of the study. Findings Some of the construction organisations conducted COVID-19 related risk assessments, whilst a few organisations did not conduct a risk assessment. Inspections to ensure COVID-19 compliance was done by government officials, health organisations and client's health and safety officers. The construction organisations demonstrated considerable competence in record keeping and some organisations further evolved a follow-up plan for sick workers. The study found that some construction practitioners had misconceptions about the disease, used COVID-19 personal protective equipment incorrectly and lack adequate information about the virus. It is required that construction stakeholders evolve policies and strategies that would promote risk control and foster compliance to COVID-19 safety measures. Originality/value COVID-19 is still new, therefore, the body of knowledge is still at the infancy stage. This paper provided insight into the COVID-19 related risk and challenges that may increase the rate of virus infection amongst construction practitioners.
C1 [Kukoyi, Patricia Omega] Univ Lagos, Dept Bldg, Lagos, Nigeria.
   [Simpeh, Fredrick] Univ Free State, Dept Quant Surveying & Construct Management, Bloemfontein, South Africa.
   [Adebowale, Oluseyi Julius; Agumba, Justus Ngala] Tshwane Univ Technol, Dept Bldg Sci, Pretoria, South Africa.
RP Kukoyi, PO (corresponding author), Univ Lagos, Dept Bldg, Lagos, Nigeria.
EM patsimonomega@yahoo.co.uk; SimpehF@ufs.ac.za; agumbajn@tut.ac.za
CR Adeyemo O, 2017, PROCEDIA ENGINEER, V196, P785, DOI 10.1016/j.proeng.2017.08.008
   Alsharef A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041559
   Amoah C, 2021, J FACIL MANAG, V19, P111, DOI 10.1108/JFM-08-2020-0061
   Amoah C, 2019, J ENG DES TECHNOL, V18, P611, DOI 10.1108/JEDT-06-2018-0098
   Basri F.M., 2016, INT REV MANAG MARK, V6, P280
   Beck C.T., 2017, NURSING RES GENERATI
   Centre for Diseases Control and Prevention, 2020, COR IS PAND WHAT MEA
   Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2
   CHUDLEY R, 2006, BUILDING CONSTRUCTIO
   Creswell J.W., 1998, QUAL INQ
   Creswell J.W, 2014, RES DESIGN QUALITATI, V4th
   Creswell J.W., 2017, RES DESIGN QUALITATI, P20
   Elsebaei MA, 2021, J ENG DES TECHNOL, V19, P1158, DOI 10.1108/JEDT-05-2020-0194
   Famakin IO, 2020, INT J CONSTR MANAG, DOI 10.1080/15623599.2020.1850201
   Hardy T.L., 2013, ELEMENTS PROCESS SAF, P1
   Harinarain N., 2020, J CONSTRUCTION, V13, P52
   Hinze J, 2008, SAFETY SCI, V46, P634, DOI 10.1016/j.ssci.2007.06.015
   Hofstede G., 2011, ONLINE READ PSYCHOL, V2, P1, DOI [10.9707/2307-0919.1014, DOI 10.9707/2307-0919.1014]
   Hughes C., 2012, QUAL QUANT, P1
   Hwang S, 2008, SOC SCI COMPUT REV, V26, P519, DOI 10.1177/0894439307312485
   Ifelunini I., 2020, EC CONSEQUENCES STRA
   Jordan V, 2020, J PRIM HEALTH CARE, V12, P96, DOI 10.1071/HC15950
   Karakhan AA, 2020, J CONSTR ENG M, V146, DOI 10.1061/(ASCE)CO.1943-7862.0001794
   Karakhan AA, 2017, J CONSTR ENG M, V143, DOI 10.1061/(ASCE)CO.1943-7862.0001379
   Lan FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233588
   Leedy P.D., 2015, PRACTICAL RES PLANNI
   Li X, 2018, AUTOMAT CONSTR, V86, P150, DOI 10.1016/j.autcon.2017.11.003
   Malecka M, 2020, CLIN CHEM LAB MED, V58, pE205, DOI 10.1515/cclm-2020-0764
   Mishra A.K., 2019, J ADV RES CONSTRUCTI, V4, P17
   Mohajan H.K., 2018, J EC DEV ENV PEOPLE, V7, P23, DOI [10.26458/jedep.v7i1.571, DOI 10.26458/JEDEP.V7I1.571]
   Nairametric, 2021, PRES MUH BUH FULL SP
   Nigeria Centre for Disease Control, 2021, 1 CAS COR DIS CONF N
   Ogundipe K. E., 2018, INT J APPL ENG RES, V13, P4314
   Ogunnusi M, 2020, INT J REAL ESTATE ST, V14
   Okoye P. U., 2016, J SAFETY ENG, V5, P17
   Olutuase S.O., 2014, IOSR J BUSINESS MANA, V16, P1, DOI DOI 10.9790/487X-16350110
   Omorodion F., 2020, INT J HEALTHCARE MED, V6, P27
   Osunsanmi TO, 2020, INT J CONSTR MANAG, DOI 10.1080/15623599.2020.1842960
   Pasco RF, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.26373
   Raoufi M, 2021, PUBLIC WORKS MANAG P, V26, P47, DOI 10.1177/1087724X20969164
   Renault, 2018, CREAT CONSTR C 2018
   Renault BY, 2020, CONSTR ECON BUILD, V20, P1, DOI 10.5130/AJCEB.v20i1.6721
   Safman RM, 2004, HEALTH EDUC BEHAV, V31, P9, DOI 10.1177/1090198103259185
   Samantra C, 2017, ENG APPL ARTIF INTEL, V65, P449, DOI 10.1016/j.engappai.2017.04.019
   Saunders M., 2012, RES METHODS BUSINESS
   Simpeh F, 2021, INT J CONSTR MANAG, DOI 10.1080/15623599.2021.1874678
   Simpson KB, 2019, J ENG DES TECHNOL, V18, P431, DOI 10.1108/JEDT-07-2019-0189
   Smallwood, 2017, J CONSTRUCTION BUSIN, V1, P1
   Squires A, 2018, J NURS REGUL, V9, P15, DOI 10.1016/S2155-8256(18)30150-9
   Suresh, 2018, RISK MANAGEMENT TREA
   Taofeeq D. M., 2019, J CONSTRUCTION BUSIN, V3, P59
   The Cable, 2020, EG REC 1 CAS COR FIN
   Umeokafor N, 2020, INT J CONSTR MANAG, DOI 10.1080/15623599.2019.1707853
   White MD, 2006, LIBR TRENDS, V55, P22, DOI 10.1353/lib.2006.0053
   World Health Organisation, 2020, NAM COR DIS COVID 20
   World Health Organization, 2020, WHO COR DIS COVID 19
   World Health Organization (WHO), 2020, Q A COR COV 19 INT
   Yap JBH, 2020, PROD PLAN CONTROL, V31, P1061, DOI 10.1080/09537287.2019.1695292
   Yezli S, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101692
   Yin R., 2016, QUALITATIVE RES STAR
   Yiu NSN, 2018, J SAFETY RES, V64, P1, DOI 10.1016/j.jsr.2017.12.011
   Zhang H, 2017, J MANAGE ENG, V33, DOI 10.1061/(ASCE)ME.1943-5479.0000495
NR 62
TC 1
Z9 1
U1 6
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1726-0531
J9 J ENG DES TECHNOL
JI J. Eng. Des. Technol.
PD JAN 3
PY 2022
VL 20
IS 1
SI SI
BP 99
EP 114
DI 10.1108/JEDT-01-2021-0058
EA AUG 2021
PG 16
WC Engineering, Multidisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Engineering
GA XZ8UW
UT WOS:000691730700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Lopez, V
   Vazquez, T
   Alonso-Titos, J
   Cabello, M
   Alonso, A
   Beneyto, I
   Crespo, M
   Diaz-Corte, C
   Franco, A
   Gonzalez-Roncero, F
   Gutierrez, E
   Guirado, L
   Jimenez, C
   Jironda, C
   Lauzurica, R
   Llorente, S
   Mazuecos, A
   Paul, J
   Rodriguez-Benot, A
   Ruiz, JC
   Sanchez-Fructuoso, A
   Sola, E
   Torregrosa, V
   Zarraga, S
   Hernandez, D
AF Lopez, Veronica
   Vazquez, Teresa
   Alonso-Titos, Juana
   Cabello, Mercedes
   Alonso, Angel
   Beneyto, Isabel
   Crespo, Marta
   Diaz-Corte, Carmen
   Franco, Antonio
   Gonzalez-Roncero, Francisco
   Gutierrez, Elena
   Guirado, Luis
   Jimenez, Carlos
   Jironda, Cristina
   Lauzurica, Ricardo
   Llorente, Santiago
   Mazuecos, Auxiliadora
   Paul, Javier
   Rodriguez-Benot, Alberto
   Carlos Ruiz, Juan
   Sanchez-Fructuoso, Ana
   Sola, Eugenia
   Torregrosa, Vicente
   Zarraga, Sofia
   Hernandez, Domingo
CA Grp Estudio GREAT Grp Espanol Actu
TI Recommendations on management of the SARS-CoV-2 coronavirus pandemic
   (Covid-19) in kidney transplant patients
SO NEFROLOGIA
LA Spanish
DT Article
DE Covid-19; Kidney transplantation; Immunosuppressed; SARS-CoV-2
AB The SARS-CoV-2 (Covid-19) coronavirus pandemic is evolving very quickly and means a special risk for both immunosuppressed and comorbid patients. Knowledge about this growing infection is also increasing although many uncertainties remain, especially in the kidney transplant population. This manuscript presents a proposal for action with general and specific recommendations to protect and prevent infection in this vulnerable population such as kidney transplant recipients. (C) 2020 Sociedad Espanola de Nefrologia. Published by Elsevier Espana, S.L.U.
C1 [Lopez, Veronica; Vazquez, Teresa; Alonso-Titos, Juana; Cabello, Mercedes; Gutierrez, Elena; Jironda, Cristina; Sola, Eugenia; Hernandez, Domingo] Univ Malaga, Hosp Reg Univ Malaga, Inst Biomed Invest Malaga IBIMA, Unidad Gest Clin Nefrol,REDinREN RD16 0009 0006, Malaga, Spain.
   [Alonso, Angel] Complejo Hosp A Coruna, Serv Nefrol, La Coruna, Spain.
   [Beneyto, Isabel] Hosp Univ Politecn La Fe, Serv Nefrol, Valencia, Spain.
   [Crespo, Marta; Diaz-Corte, Carmen] Hosp del Mar, Serv Nefrol, Barcelona, Spain.
   [Crespo, Marta; Diaz-Corte, Carmen] Hosp Cent Asturias, Serv Nefrol, REDinREN RD16 0009 0006, Asturias, Spain.
   [Franco, Antonio] Hosp Alicante, Serv Nefrol, Alicante, Spain.
   [Gonzalez-Roncero, Francisco] Hosp Virgen del Rocio, Serv Nefrol, Seville, Spain.
   [Guirado, Luis] Fdn Puigvert, Serv Nefrol, REDinREN RD16 0009 0019, Barcelona, Spain.
   [Jimenez, Carlos] Hosp La Paz, Serv Nefrol, Madrid, Spain.
   [Lauzurica, Ricardo] Hosp Trias & Pujol, Serv Nefrol, REDinREN RD16 0009 0032, Barcelona, Spain.
   [Llorente, Santiago] Hosp Virgen Arrixaca, Serv Nefrol, Murcia, Spain.
   [Mazuecos, Auxiliadora] Hosp Univ Puerta del Mar, Serv Nefrol, Cadiz, Spain.
   [Paul, Javier] Hosp Miguel Servet, Serv Nefrol, Zaragoza, Spain.
   [Rodriguez-Benot, Alberto] Hosp Reina Sofia, Inst Maimonides Invest Biomed Cordoba, Serv Nefrol, Cordoba, Spain.
   [Carlos Ruiz, Juan] Hosp Marques Valdecilla, Serv Nefrol, IDIVAL, REDinREN RD16 0009 0027, Santander, Spain.
   [Sanchez-Fructuoso, Ana] Univ Complutense Madrid, Hosp Clin San Carlos, Serv Nefrol, Madrid, Spain.
   [Torregrosa, Vicente] Hosp Clin Barcelona, Serv Nefrol, Barcelona, Spain.
   [Zarraga, Sofia] Hosp Cruces, Serv Nefrol, Bilbao, Spain.
RP Hernandez, D (corresponding author), Univ Malaga, Hosp Reg Univ Malaga, Inst Biomed Invest Malaga IBIMA, Unidad Gest Clin Nefrol,REDinREN RD16 0009 0006, Malaga, Spain.
EM domingohernandez@gmail.com
RI ; Sanchez Fructuoso, Ana Isabel/U-5623-2017
OI Hernandez Marrero, Domingo Jeronimo/0000-0001-5469-2119; Rodriguez
   Benot, Alberto/0000-0003-1385-4526; Sanchez Fructuoso, Ana
   Isabel/0000-0001-7017-9729
CR AlGhamdi M, 2015, AM J TRANSPLANT, V15, P1101, DOI 10.1111/ajt.13085
   [Anonymous], HFSA ACC AHA STATEME
   [Anonymous], 2020, CORONAVIRUS DIS 2019
   Baden LR, 2020, NEW ENGL J MED, V382, P1851, DOI 10.1056/NEJMe2005477
   Cao B, 2020, NEW ENGL J MED, V382
   Documento tecnico, 2020, DOCUMENTO TECNICO MA
   Fowler AA, 2019, JAMA-J AM MED ASSOC, V322, P1261, DOI 10.1001/jama.2019.11825
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   KO WC, 2020, INT J ANTIMICROB AG, V55, DOI [10.1016/j.ijantimicag.2020.105933, DOI 10.1016/J.IJANTIMICAG.2020.105933]
   Kumar D, 2003, AM J TRANSPLANT, V3, P977, DOI 10.1034/j.1600-6143.2003.00197.x
   Lansbury L, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010406.pub3
   Liu, 2019, NOVEL CORONAVIRUS DI, DOI [10.1101/2020.02.24.20027201(dateofaccessJune17, 10.1101/2020.02.24.20027201, DOI 10.1101/2020.02.24.20027201]
   Lopez-Oliva MO, MANAGEMENT KIDNEY TR
   Michaels MG, 2020, AM J TRANSPLANT, V20, P1768, DOI 10.1111/ajt.15832
   Naicker S, 2020, KIDNEY INT, V97, P824, DOI 10.1016/j.kint.2020.03.001
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Schonder KS, 2003, ANN PHARMACOTHER, V37, P1793, DOI 10.1345/aph.1D076
   UYEKI TM, 2020, NEW ENGL J MED, V382
   Wu J, 2020, J INTERN MED, V288, P128, DOI 10.1111/joim.13063
   Xu X., EFFECTIVE TREATMENT
   Zhu L, 2020, AM J TRANSPLANT, V20, P1859, DOI 10.1111/ajt.15869
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 22
TC 34
Z9 38
U1 0
U2 0
PU SOC ESPANOLA NEFROLOGIA DR RAFAEL MATESANZ
PI SANTANDER
PA C/PASAJE DE PENA 2, 3-C, SANTANDER, SPAIN
SN 0211-6995
EI 1989-2284
J9 NEFROLOGIA
JI Nefrologia
PD MAY-JUN
PY 2020
VL 40
IS 3
BP 265
EP 271
DI 10.1016/j.nefro.2020.03.002
PG 7
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA MA4JQ
UT WOS:000541881900007
PM 32278616
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Anser, MK
   Yousaf, Z
   Khan, MA
   Voo, XH
   Nassani, AA
   Alotaibi, SM
   Abro, MMQ
   Zaman, K
AF Anser, Muhammad Khalid
   Yousaf, Zahid
   Khan, Muhammad Azhar
   Xuan Hinh Voo
   Nassani, Abdelmohsen A.
   Alotaibi, Saad M.
   Abro, Muhammad Moinuddin Qazi
   Zaman, Khalid
TI The impacts of COVID-19 measures on global environment and fertility
   rate: double coincidence
SO AIR QUALITY ATMOSPHERE AND HEALTH
LA English
DT Article
DE COVID-19; Carbon emissions; Fertility rate; Knowledge spillover; Energy
   demand; World aggregated data
ID CORONAVIRUS
AB The study aims to examine the effects of coronavirus disease-2019 (COVID-19) measures on global environment and fertility rate by using the data of 1980 to 2019. The results show that communicable diseases including COVID-19 measures decrease carbon emissions and increase the chances of fertility rates in an account of city-wide lockdown. The knowledge spillover substantially decreases carbon emissions, while high energy demand increases carbon emissions. Poverty incidence increases fertility rate in the short-run; however, in the long-run, the result only supported with vulnerable employment and food prices that lead to increase fertility rates worldwide. The study concludes that besides some high negative externalities associated with COVID-19 pandemic in the form of increasing death tolls and rising healthcare costs, the global world should have to know how to direct high mass carbon emissions and population growth through acceptance of preventive measures, which would be helpful to contain coronavirus pandemic at a global scale.
C1 [Anser, Muhammad Khalid] Xian Univ Architecture & Technol, Dept Publ Adm, Xian 710000, Peoples R China.
   [Yousaf, Zahid] Govt Coll Management Sci, Higher Educ Dept Khyber Pakhtunkhwa, Abbottabad 22060, Pakistan.
   [Khan, Muhammad Azhar] Univ Haripur, Dept Econ, Haripur, Khyber Pakhtunk, Pakistan.
   [Xuan Hinh Voo] VASS Acad, Business Dept, Helsinki, Finland.
   [Nassani, Abdelmohsen A.; Alotaibi, Saad M.; Abro, Muhammad Moinuddin Qazi] King Saud Univ, Coll Business Adm, Dept Management, POB 71115, Riyadh 11587, Saudi Arabia.
   [Zaman, Khalid] Univ Wah, Dept Econ, Quaid Ave, Wah Cantt, Pakistan.
RP Zaman, K (corresponding author), Univ Wah, Dept Econ, Quaid Ave, Wah Cantt, Pakistan.
EM khalid_zaman786@yahoo.com
RI Nassani, Abdelmohsen A./AAG-9442-2021; Anser, Muhammad
   Khalid/AAS-1284-2020
OI Nassani, Abdelmohsen A./0000-0001-9658-8299; Anser, Muhammad
   Khalid/0000-0003-1882-0907
FU King Saud University, Riyadh, Saudi ArabiaKing Saud University
   [RSP-2020/87]
FX Researchers Supporting Project number (RSP-2020/87), King Saud
   University, Riyadh, Saudi Arabia.
CR Adsera A, 2011, POP STUD-J DEMOG, V65, P37, DOI 10.1080/00324728.2010.530291
   Almutairi KM, 2015, FAM COMMUNITY HEALTH, V38, P332, DOI 10.1097/FCH.0000000000000082
   Anser MK, 2020, ENVIRON RES, V187, DOI 10.1016/j.envres.2020.109668
   Awan U., 2020, U SUSTAINABLE COMMUN, P89, DOI [DOI 10.1007/978-3-030-30306-8_5, 10.1007/978-3-030-30306-8_5]
   Awan U., 2020, HDB ENV MAT MANAGEME
   Bahamondes L, 2020, EUR J CONTRACEP REPR, V25, P319, DOI 10.1080/13625187.2020.1768368
   Baker S. R., 2020, 26945 NBER
   Bherwani H, 2020, AIR QUAL ATMOS HLTH, V13, P683, DOI 10.1007/s11869-020-00845-3
   Breslin N, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100111
   Burke SF, 2020, POLICY BRIEF PRICING
   Chakraborty I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138882
   Chan AKM, 2020, ANAESTHESIA, V75, P1579, DOI 10.1111/anae.15057
   Contini D, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11040377
   Fareed Z, 2020, AIR QUAL ATMOS HLTH, V13, P673, DOI 10.1007/s11869-020-00847-1
   Gautam S, 2020, AIR QUAL ATMOS HLTH, V13, P853, DOI 10.1007/s11869-020-00842-6
   Geldsetzer P., 2020, KNOWLEDGE PERCEPTION, DOI [10.1101/2020.03.13.20035568, DOI 10.1101/2020.03.13.20035568]
   He QC, 2018, INT REV ECON FINANC, V58, P113, DOI 10.1016/j.iref.2018.03.003
   Hiscott J, 2020, CYTOKINE GROWTH F R, V53, P1, DOI 10.1016/j.cytogfr.2020.05.010
   Hosseini SE, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101633
   Iwasaki I, 2020, POST-COMMUNIST ECON, V32, P176, DOI 10.1080/14631377.2019.1678333
   Jones M, 2020, AUST J RURAL HEALTH, V28, P107, DOI 10.1111/ajr.12623
   Klemes JJ, 2020, RENEW SUST ENERG REV, V127, DOI 10.1016/j.rser.2020.109883
   LIPPI G, 2020, ASS ENV POLLUTION PR, DOI DOI 10.1101/2020.04.22.20075986
   Liu Q, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12101576
   Lu JY, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138777
   Mohanty SK, 2011, POPUL REV, V50
   Odwe G.O., 2015, AFR POPUL STUD, V29, P1785, DOI [DOI 10.11564/29-2-751, 10.11564/29-2-751]
   Osborn D., 2020, UCL OPEN ENV, V1, P5, DOI 10.14324/111.444/ucloe.000008
   Pesaran MH, 2001, J APPL ECONOMET, V16, P289, DOI 10.1002/jae.616
   Ranjan MR., 2020, ASIAN J ENV ECOLOGY, V13, P10, DOI DOI 10.9734/AJEE/2020/V13I130171
   Reshadat S, 2018, SOC INDIC RES, V140, P619, DOI 10.1007/s11205-017-1790-2
   Riley T, 2020, INT PERSPECT SEX R H, V46, P73, DOI 10.1363/46e9020
   Sanita di Toppi L, 2020, CHALLENGES, V11, P6, DOI [10.3390/challe11010006, DOI 10.3390/CHALLE11010006]
   Sarkis J, 2020, RESOUR CONSERV RECY, V159, DOI 10.1016/j.resconrec.2020.104894
   Schoumaker B., 2004, POP ASS AM M BOST
   Schwartz DA, 2020, ARCH PATHOL LAB MED, V144, P799, DOI 10.5858/arpa.2020-0901-SA
   Selby D, 2020, POLICY PRACT, P104
   Sharma VK, 2020, ENVIRON CHEM LETT, V18, P993, DOI 10.1007/s10311-020-01017-6
   Sheykhi M.T., 2020, SIASAT J, V4, P1
   Steinberg, 2020, BOSTON HOSP REV
   Wietzke FB, 2020, POPUL DEV REV, V46, P65, DOI 10.1111/padr.12317
   World Bank, 2020, WORLD DEV IND
   Yi JJ, 2010, ECON INQ, V48, P635, DOI 10.1111/j.1465-7295.2009.00213.x
   Zaman, 2020, SCI ED, V6, P84, DOI DOI 10.5281/ZENODO.3779156
   Zambrano-Monserrate MA, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138813
   Zhang L, 2020, Zhonghua Fu Chan Ke Za Zhi, V55, P166, DOI 10.3760/cma.j.cn112141-20200218-00111
   Zhou XY, 2020, TELEMED E-HEALTH, V26, P377, DOI 10.1089/tmj.2020.0068
NR 47
TC 15
Z9 15
U1 8
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1873-9318
EI 1873-9326
J9 AIR QUAL ATMOS HLTH
JI Air Qual. Atmos. Health
PD SEP
PY 2020
VL 13
IS 9
BP 1083
EP 1092
DI 10.1007/s11869-020-00865-z
EA JUL 2020
PG 10
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology
GA MT1WC
UT WOS:000547363000001
PM 32837614
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Alsaif, B
   Elhassan, NEE
   Itumalla, R
   Ali, KE
   Alzain, MA
AF Alsaif, Bandar
   Elhassan, Najm Eldinn Elsser
   Itumalla, Ramaiah
   Ali, Kamal Elbassir
   Alzain, Mohamed Ali
TI Assessing the Level of Awareness of COVID-19 and Prevalence of General
   Anxiety Disorder among the Hail Community, Kingdom of Saudi Arabia
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE attitude; COVID-19; general anxiety disorder; Hail; knowledge; practice
ID IMPACT
AB Background: The COVID-19 pandemic has caused a major public health problem around the world. Therefore, the aim of the study was to assess the awareness and prevalence of General Anxiety Disorder (GAD) with regard to COVID-19 among the Hail community, in the Kingdom of Saudi Arabia, in order to help health authorities to effectively control the pandemic. Methods: A cross-sectional online survey was completed by 412 participants living in Hail, Saudi Arabia. The questionnaire assessed demographic characteristics, knowledge, attitudes, and practices for the prevention of COVID-19, as well as psychological feelings in terms of GAD as an impact of the COVID-19 pandemic. Results: The study found that most of the respondents demonstrated good knowledge, attitudes, and practice for COVID-19 prevention. The elderly and employed demonstrated significant positive attitudes and practices (p < 0.05). Participants with a positive attitude were almost two and a half times (OR = 2.4; 95% CI: 1.54-3.99) more likely to have good practices. Additionally, the rural respondents were less likely (OR = 0.45; 95% CI: 0.21-0.96) to have a positive attitude. Married participants were more than one and a half (OR = 1.60; 95% CI: 1.04-2.44) times more likely to have a positive attitude. The prevalence of GAD was 21.8% and was significantly increased among participants with inadequate knowledge (OR = 2.01; 95% CI: 1.25-3.22), females (OR = 1.92; 95% CI: 1.19-3.09), individuals with chronic diseases (OR = 1.71; 95% CI: 1.02-2.86), and non-Saudi participants (OR = 2.44; 95% CI: 1.02-5.85). Conclusions: Ensuring a sufficient combination of relatively good levels of knowledge, positive attitudes, and desired practices serves as a good approach to preventing the spread of COVID-19. However, the increased prevalence of GAD requires the attention of policymakers. Therefore, a great emphasis should be placed on health awareness campaigns, with a focus on misconceptions and the provision of counseling.
C1 [Alsaif, Bandar; Elhassan, Najm Eldinn Elsser; Ali, Kamal Elbassir; Alzain, Mohamed Ali] Univ Hail, Dept Publ Hlth, Coll Publ Hlth & Hlth Informat, Hail 55476, Saudi Arabia.
   [Itumalla, Ramaiah] Univ Hail, Dept Hlth Management, Coll Publ Hlth & Hlth Informat, Hail 55476, Saudi Arabia.
RP Alzain, MA (corresponding author), Univ Hail, Dept Publ Hlth, Coll Publ Hlth & Hlth Informat, Hail 55476, Saudi Arabia.
EM b.alsaif@uoh.edu.sa; n.hamedelneel@uoh.edu.sa; r.itumalla@uoh.edu.sa;
   K.ali@uoh.edu.sa; m.alzain@uoh.edu.sa
RI Alsaif, Bandar/AAP-6225-2021; Alzain, Mohamed Ali/AAF-5957-2019
OI Alsaif, Bandar/0000-0002-1501-7396; Alzain, Mohamed
   Ali/0000-0002-0085-5805
FU Deanship of scientific research, University of Hail [COVID-1933]
FX This research was funded by Deanship of scientific research, University
   of Hail, grant number COVID-1933.
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Alahdal H, 2020, J INFECT PUBLIC HEAL, V13, P1446, DOI 10.1016/j.jiph.2020.06.015
   Algahtani FD, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030847
   Alsaif B., 2020, SYST REV PHARM, V11, P649, DOI [10.31838/srp.2020.12.103, DOI 10.31838/SRP.2020.12.103]
   Alshammari TM, 2020, SAUDI PHARM J, V28, P898, DOI 10.1016/j.jsps.2020.05.005
   Alyami H.S., 2020, KNOWLEDGE COVID 19 P, DOI [10.1101/2020.06.23.20138107v1, DOI 10.1101/2020.06.23.20138107V1]
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103577
   Bauerle A, 2020, J PUBLIC HEALTH-UK, V42, P672, DOI 10.1093/pubmed/fdaa106
   BioSpace, WHAT WE NOW KNOW COR
   CDC, 2020, US PERS PROT EQ PPE
   Chudasama YV, 2020, DIABETES METAB SYND, V14, P965, DOI 10.1016/j.dsx.2020.06.042
   Hassounah M, 2020, J MED INTERNET RES, V22, DOI 10.2196/19338
   Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Kassahun CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170040
   Kutsuna S, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa243
   MERS-COV, GUID HEALTHC PROF MA
   Sallam M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144915
   Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282
   Saudi Geological Survey, KSA FACTS
   Semo BW, 2020, PSYCHOL RES BEHAV MA, V13, P713, DOI 10.2147/PRBM.S264286
   She J, 2020, CLIN TRANSL MED, V9, DOI 10.1186/s40169-020-00271-z
   Sherman AC, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113476
   Sun ZG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165889
   Syrovatkova A, 2020, EUR J CASE REP INTER, V7, DOI [DOI 10.12890/2020_001641, 10.12890/2020_001641]
   Wadood MA, 2020, KNOWLEDGE ATTITUDE P, DOI DOI 10.1101/2020.04.21.20074757
   Wang CY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246824
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   World Health Organization, REP WHO CHIN JOINT M
   World Health Organization (WHO), 2020, COVID 19 STRAT UPD
NR 32
TC 2
Z9 2
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2021
VL 18
IS 13
AR 7035
DI 10.3390/ijerph18137035
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA TF9YV
UT WOS:000671071300001
PM 34209469
OA Green Published, gold
DA 2022-04-20
ER

PT C
AU Velazquez-Diaz, JE
   Gosain, P
   Ganapati, NE
   Zhang, L
AF Velazquez-Diaz, Jose E.
   Gosain, Parasar
   Ganapati, N. Emel
   Zhang, Lu
BE Jazizadeh, F
   Shealy, T
   Garvin, MJ
TI Understanding COVID-19's Impacts on Multisector Stakeholder Values on
   Housing Resilience
SO CONSTRUCTION RESEARCH CONGRESS 2022: INFRASTRUCTURE, SUSTAINABILITY, AND
   RESILIENCE
LA English
DT Proceedings Paper
CT Construction Research Congress (CRC) on Project Management and Delivery,
   Contracts, and Design and Materials
CY MAR 09-12, 2022
CL Via Dept Civil & Environm Engn, Vecellio Construct Engn & Management
   Progr, Arlington, VA
SP Amer Soc Civil Engineers, Construct Inst, Virginia Polytechn Inst & State Univ, Construct Res Council
HO Via Dept Civil & Environm Engn, Vecellio Construct Engn & Management Progr
DE Stakeholder values; Housing resilience; Multisector stakeholders;
   COVID-19
ID PUBLIC VALUES
AB Multisector stakeholders (e.g., public, private, and the nonprofit sector) have different values on housing resilience, which may shift with extreme events. Despite emerging research on changing stakeholder values after hurricane events, there is limited knowledge on how stakeholders may modify their values on housing resilience after public health crises. An example of such crises is the COVID-19 pandemic, which has altered the home and work environment of many. To address this gap in the literature, this paper analyzes how COVID-19 has impacted multisector stakeholder values on housing resilience. It is mainly based on semi-structured interviews with 50 multisector stakeholders. The results indicate that COVID-19 has impacted stakeholder values on different aspects of housing resilience, such as comfort and health, recreation, design and use of open space, and connectivity. The study's findings may inform multisector stakeholders (e.g., planners, architects, contractors, engineers, and NGO representatives) on how to better plan, design, and develop value-centered resilient housing systems that take into account the challenges faced in a public health crisis.
C1 [Velazquez-Diaz, Jose E.; Ganapati, N. Emel] Florida Int Univ, Dept Publ Adm, Miami, FL 33199 USA.
   [Gosain, Parasar] Florida Int Univ, Dept Civil & Environm Engn, Miami, FL 33199 USA.
   [Zhang, Lu] Florida Int Univ, Moss Dept Construct Management, Miami, FL 33199 USA.
RP Zhang, L (corresponding author), Florida Int Univ, Moss Dept Construct Management, Miami, FL 33199 USA.
EM jvela165@fiu.edu; pgosa002@fiu.edu; ganapat@fiu.edu; luzhang@fiu.edu
FU National Science Foundation (NSF)National Science Foundation
   (NSF)National Research Foundation of Korea [1933345]
FX This material is based upon work supported by the National Science
   Foundation (NSF) under Grant No. 1933345. Any opinions, findings, and
   conclusions or recommendations expressed in this material are those of
   the author(s) and do not necessarily reflect the views of the NSF.
CR Afrin S, 2021, FRONT SUSTAIN CITIES, V3, DOI 10.3389/frsc.2021.668263
   Boon H. J., 2012, RESILIENCE ADAPTABIL, P467
   Bostick TP, 2017, RISK ANAL, V37, P1181, DOI 10.1111/risa.12737
   Burnside-Lawry J, 2016, INT J DISASTER RESIL, V7, P4, DOI 10.1108/IJDRBE-07-2013-0028
   Cashman AC, 2011, J FLOOD RISK MANAG, V4, P33, DOI 10.1111/j.1753-318X.2010.01087.x
   Cohen A, 2011, ADMIN SOC, V43, P446, DOI 10.1177/0095399711413080
   Coolen H., 2002, J HOUS BUILT ENVIRON, V17, P215
   Nabatchi T, 2018, PERSPECT PUBLIC MAN, V1, P59, DOI 10.1093/ppmgov/gvx009
   NAS (National Academy of Sciences), 2012, DIRENAT IMP
   Pathak A, 2020, NAT HAZARDS REV, V21, DOI 10.1061/(ASCE)NH.1527-6996.0000400
   Pelling M, 2011, ECOL SOC, V16
   Purc E, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00865
   Rawluk A, 2017, J ENVIRON MANAGE, V185, P11, DOI 10.1016/j.jenvman.2016.10.052
   RICE. Kinder Institute for Urban Research, 2018, BUILD MOR RES HOUS S
   Sanyal B, 2001, WORLD DEV, V29, P2043, DOI 10.1016/S0305-750X(01)00082-1
   Schwartz S.H., 2012, ONLINE READ PSYCHOL, V2, P1, DOI [DOI 10.9707/2307-0919.1116, 10.9707/2307-0919.1116]
   Taeby M, 2019, NAT HAZARDS REV, V20, DOI 10.1061/(ASCE)NH.1527-6996.0000319
   USEPA, 2021, IND AIR COR COVID 19
   Wells KB, 2013, AM J PUBLIC HEALTH, V103, P1172, DOI 10.2105/AJPH.2013.301407
   Zavei SJAP, 2012, PROCD SOC BEHV, V42, P311, DOI 10.1016/j.sbspro.2012.04.195
   Zhang L, 2016, J CONSTR ENG M, V142, DOI 10.1061/(ASCE)CO.1943-7862.0001004
NR 21
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CIVIL ENGINEERS
PI NEW YORK
PA UNITED ENGINEERING CENTER, 345 E 47TH ST, NEW YORK, NY 10017-2398 USA
BN 978-0-7844-8395-4
PY 2022
BP 396
EP 405
PG 10
WC Engineering, Civil
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Engineering
GA BS8TF
UT WOS:000776637300041
DA 2022-04-20
ER

PT J
AU Gronkjaer, AB
   Froyen, AF
AF Gronkjaer, Allan Bennich
   Froyen, Anne Fylling
TI Leading and managing during COVID-19: empirical insights from the
   Norwegian women's national handball team in a time of crisis
SO SPORT IN SOCIETY
LA English
DT Article; Early Access
DE COVID-19; elite sport; management; leadership; national team;
   high-performance; values
ID ELITE SPORT; MANAGEMENT
AB From March 2020, the COVID-19 pandemic influenced elite sport as uncertainty and restrictions came with the crisis. National teams had to implement crisis management. This qualitative case study examines how the leader group led and managed the Norwegian national women's handball team through three phases of the crisis, trying to uphold performance. We found that collective leadership efforts led to new ways to use digital communication tools and flexible management. From a framework of concepts from organisational culture, leadership, and management during a crisis, we argue that the leader group used the pandemic to take advantage of the opportunities. They implemented a focus on improving the players' physical and tactical conditions and their restitution. Furthermore, the leader group draw on robust institutional factors such as trust to handle the crisis. This study contributes to knowledge on leadership and management in a time of crisis and, in particular, on COVID-19.
C1 [Gronkjaer, Allan Bennich; Froyen, Anne Fylling] Norwegian Sch Sport Sci, Inst Sport & Social Sci, Oslo, Norway.
RP Gronkjaer, AB (corresponding author), Norwegian Sch Sport Sci, Inst Sport & Social Sci, Oslo, Norway.
EM allanbg@nih.no
CR Andel S., 2021, EUROPEAN J WORK ORG, P1
   Andersen, 2021, EMBEDDED MULTILEVEL, P142
   Andersen SS, 2013, INT J MANAG PROJ BUS, V6, P236, DOI 10.1108/17538371311319007
   Andersen SveinS., 2014, SPORTS COACHING REV, V3, P17, DOI [10.1080/21640629.2014.901712, DOI 10.1080/21640629.2014.901712]
   Arnold R, 2015, SPORT BUS MANAG, V5, P386, DOI 10.1108/SBM-01-2014-0003
   Berger R, 2015, QUAL RES, V15, P219, DOI 10.1177/1468794112468475
   Bohlke N, 2009, MANAGE DECIS, V47, P67, DOI 10.1108/00251740910929704
   Bowes A, 2020, MANAG SPORT LEIS, DOI 10.1080/23750472.2020.1825988
   Brannick T, 2007, ORGAN RES METHODS, V10, P59, DOI 10.1177/1094428106289253
   Braun V., 2013, SUCCESSFUL QUALITATI
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806
   Brockner J, 2008, J APPL BEHAV SCI, V44, P94, DOI 10.1177/0021886307313824
   Christensen T, 2020, PUBLIC ADMIN REV, V80, P774, DOI 10.1111/puar.13241
   Chroni Stiliani"Ani"., 2020, SCANDINAVIAN SPORT S, V11, P93
   Cole J, 2018, SPORT SOC, V21, P1204, DOI 10.1080/17430437.2018.1442197
   Combe IA, 2015, LEADERSHIP QUART, V26, P307, DOI 10.1016/j.leaqua.2015.02.002
   Corbin J.M., 2008, BASICS QUALITATIVE R, V3rd ed., P127, DOI DOI 10.4135/9781452230153
   Cullen-Lester KL, 2016, LEADERSHIP QUART, V27, P173, DOI 10.1016/j.leaqua.2016.02.001
   di Fronso S, 2022, INT J SPORT EXERC PS, V20, P79, DOI 10.1080/1612197X.2020.1802612
   EHF, 2020, DENM HOST ALL GROUPS
   Eubank Martin., 2020, ADVICE ATHLETES COVI
   Evans AB, 2021, EUR J SPORT SOC, V18, P1, DOI 10.1080/16138171.2021.1899969
   Ferkins L, 2018, J SPORT MANAGE, V32, P77, DOI 10.1123/jsm.2018-0054
   Fletcher D, 2009, PSYCHOL SPORT EXERC, V10, P427, DOI 10.1016/j.psychsport.2009.03.009
   Garcia-Garcia B, 2020, INT SPORTS LAW J, V20, P115, DOI 10.1007/s40318-020-00174-8
   Gardner, 2020, LEADERSHIP ORG GLOBA
   Gerring J, 2004, AM POLIT SCI REV, V98, P341
   Government Norwegian, 2020, OMF TILT BEKJ KOR
   Hansen PO, 2021, SPORTS COACH REV, V10, P274, DOI 10.1080/21640629.2021.1896213
   Hemmestad LB, 2019, SPORT SOC, V22, P671, DOI 10.1080/17430437.2017.1389062
   Clemente-Suarez VJ, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01985
   Jones G., 2009, ANN REV HIGH PERFORM, V1, P139, DOI DOI 10.1260/IJSSC.4.SUPPL-2.671Q532J757771RL
   Kaiser RB, 2020, CONSULT PSYCH J, V72, P135, DOI 10.1037/cpb0000186
   Kirchner K, 2021, KNOWL MAN RES PRACT, V19, P493, DOI 10.1080/14778238.2021.1877579
   Kvale S., 2009, INTERVIEWS LEARNING
   Mallett CJ, 2010, SPORTS COACHING PROF, P119
   McMahon J.T., 2001, CLASSICS ORG BEHAV, P335
   Molan C, 2019, J APPL SPORT PSYCHOL, V31, P87, DOI 10.1080/10413200.2018.1440659
   Nakstad, 2018, BEREDSKAP KRISELEDEL
   NIF, 2019, NOKK RAPP 2019
   Northouse PG., 2019, LEADERSHIP THEORY PR, V8
   Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y
   Parnell D, 2022, MANAG SPORT LEIS, V27, P72, DOI 10.1080/23750472.2020.1750100
   Peachey JW, 2015, J SPORT MANAGE, V29, P570, DOI 10.1123/jsm.2014-0126
   Pensgaard AM, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2020-001025
   Purdy LG, 2011, SOCIOL SPORT J, V28, P329, DOI 10.1123/ssj.28.3.329
   Ramsey Phil., 2012, ASIA PACIFIC MANAGEM, V1, P53, DOI [10.21776/ub.apmba.2012.001.01.4, DOI 10.21776/UB.APMBA.2012.001.01.4]
   Ronglan LarsTore., 2012, NORDIC ELITE SPORT S, P27
   Ronglan LarsTore., 2012, NORDIC ELITE SPORT S, P11
   Saldaa, 2020, QUALITATIVE DATA ANA
   Schinke R, 2020, INT J SPORT EXERC PS, V18, P269, DOI 10.1080/1612197X.2020.1754616
   Skille EA, 2018, INT J SPORT POLICY P, V10, P321, DOI 10.1080/19406940.2018.1425733
   Smith B, 2016, ROUT INT HANDB, P103
   Smith J., 2016, The Sport Journal, V19, punpaginated
   Sotiriadou P., 2013, MANAGING HIGH PERFOR, P1
   Sotiriadou P, 2018, EUR SPORT MANAG Q, V18, P1, DOI 10.1080/16184742.2017.1400225
   Stambulova NB, 2021, INT J SPORT EXERC PS, V19, P524, DOI 10.1080/1612197X.2020.1737836
   Tjonndal A, 2020, FRONT SPORTS ACT LIV, V2, DOI 10.3389/fspor.2020.589483
   Washington M., 2008, SAGE HDB ORG I, P721
   Weick KE, 2015, MANAGING THE UNEXPECTED: SUSTAINED PERFORMANCE IN A COMPLEX WORLD, 3RD EDITION, P1, DOI 10.1002/9781119175834
   WHO, 2020, WHO DIR GEN OP REM M
   Wooten LP, 2008, ADV DEV HUM RESOUR, V10, P352, DOI 10.1177/1523422308316450
   World Health Organization, 2012, World Health Organ Tech Rep Ser, P1
   Yammarino F, 2013, J LEADERSH ORG STUD, V20, P149, DOI 10.1177/1548051812471559
   Yin R.K., 2018, CASE STUDY RES APPL
NR 66
TC 0
Z9 0
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1743-0437
EI 1743-0445
J9 SPORT SOC
JI Sport Soc.
DI 10.1080/17430437.2021.2016704
EA DEC 2021
PG 16
WC Hospitality, Leisure, Sport & Tourism; Sociology
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Sociology
GA XU4UA
UT WOS:000734260700001
DA 2022-04-20
ER

PT J
AU Verma, S
   Kumar, K
   Meena, R
AF Verma, S.
   Kumar, K.
   Meena, R.
TI Belief of Indian population on traditional yoga system during COVID-19
   crisis
SO INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE
LA English
DT Article
DE COVID-19 Crisis; Immunity; Stress; Yoga
AB Today, the world is suffering with various psychological diseases due to the ongoing COVID-19 pandemic. According to Arogya Setu statisticstill date, the overall death caused by COVID pandemic is approx. 5.9 lakhs with approximately 2.01 Crore affected people globally1. In the meantime, we the Yoga therapists are also gathering knowledge about this virus. Though we are neither medical professionals nor we have much understanding about the viruses, but still we have an idea that none of the bacteria, virus or fungus can affect a person with higher immunity. On the other hands, due to the uncertainty created by the COVID-19 pandemic, the world is suffering with stress and anxiety. Therefore, in order to know the perception of common population of Gautam Buddha Nagar towards the Yogic practices, we had conducted a study during this pandemic in which total 350 participants of both genders (165 professionals and 185 students) took part and collected the data regarding their perception about Yogic Practices. Under the umbrella of evidences, it can be stated that younger people have more belief and interest in Yogic Practices than elderly people. The result has a significant difference at 0.05 level of confidence. Thus, the hypothesis is accepted that Yoga has a potential to buffer the overall management of health and immunity.
C1 [Verma, S.] Sharda Univ, Dept Yog Sci, Gautam Buddha Nagar 201310, Uttar Pradesh, India.
   [Kumar, K.] Uttarakhand Sanskrit Univ, Dept Yoga Sci, Haridwar 249411, Uttrakhand, India.
   [Meena, R.] Indian Assoc Yoga, Haridwar 249502, Uttrakhand, India.
RP Verma, S (corresponding author), Sharda Univ, Dept Yog Sci, Gautam Buddha Nagar 201310, Uttar Pradesh, India.
EM Sudhanshu.verma@sharda.ac.in
CR [Anonymous], 2020, WORLD STAT AR SET AP
   Baride J P, 1994, World Health Forum, V15, P61
   Benson H, 1975, RELAXATION RESPONSE, P27
   Bera T K, 1988, INDIA J PHYSIO PHARM, V42, P473
   Bhavanani A B, 2008, YOGIC APPROACH STRES, P29
   BhavananiA B., 2010, PROCIN NATL YOGAWEEK, P210
   Curtis J D, 1985, TEACHING STRESS MANA, P87
   JENKINS CD, 1974, NEW ENGL J MED, V290, P1271, DOI 10.1056/NEJM197406062902301
   Joyner MJ, 2015, PHYSIOL REV, V95, P549, DOI 10.1152/physrev.00035.2013
   Kumari C, 2005, IMPACT YOGA STRESS P, P247
   Selye H, 1956, STRESS LIFE, P57
   Sinha P, 1994, ORIENT PAPER BOOKS
   Verma J P, 2005, RES BIANNUAL MOVEMEN, V22
   Verma S, 2017, INT J SCI CONSCIOUSN, V3, P78
   Verma S, 2020, YOGAMIMANSA, V52, P34
   Verma S, 2018, INNOV INFRASTRUCT SO, V3, DOI 10.1007/s41062-018-0169-9
NR 16
TC 0
Z9 0
U1 0
U2 3
PU NATL INST SCIENCE COMMUNICATION-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
SN 0972-5938
EI 0975-1068
J9 INDIAN J TRADIT KNOW
JI Indian J. Tradit. Knowl.
PD DEC
PY 2020
VL 19
IS 4
SI SI
BP S133
EP S138
PG 6
WC Plant Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences
GA QJ6AA
UT WOS:000619769800016
DA 2022-04-20
ER

PT J
AU Tan, CX
   Goh, SD
   Tan, SS
   Tan, ST
AF Tan, Chin Xuan
   Goh, Shuen Dee
   Tan, Seok Shin
   Tan, Seok Tyug
TI Eating behavior among remote working adults during the COVID-19 pandemic
SO NUTRITION & FOOD SCIENCE
LA English
DT Article; Early Access
DE COVID-19; Eating behavior; Remote working
AB Purpose The Malaysian movement control order is a series of national lockdowns implemented by the Malaysian federal government to contain the spread of Coronavirus disease-2019 (COVID-19). The government has made it mandatory for all non-essential sectors to work remotely to mitigate the spread of COVID-19. The eating behavior of working adults may have altered following the changes in working norms. This study aimed to assess the eating behavior of remote working adults during the COVID-19 pandemic. Design/methodology/approach A total of 159 remote working adults were recruited through a convenience sampling approach. Bodyweight and body height were self-reported by the respondents. Body mass index was calculated according to the cut-off of World Health Organization standards. The eating behavior was evaluated using the eating behavior questionnaire. Findings Results revealed more than half of the remote working respondents did not practice meal skipping. Irrespective of the gender, more than 70% of the respondents consumed either breakfast, lunch or dinner every day. Most of the respondents consumed vegetables, bread/rice/noodles and meat/chicken at least two times per day. Regression analysis revealed meal skipping was associated with younger people, overweight status and median monthly household income. Originality/value Many sectors adopted remote working systems during the COVID-19 pandemic. It is postulated that working remotely will be a new normal even after this pandemic. Until now, to the best of the authors' knowledge, little or no data are available on assessing the eating behavior of remote working adults during the COVID-19 pandemic. This study could provide an insight into the eating behavior of adults during remote working.
C1 [Tan, Chin Xuan; Goh, Shuen Dee] Univ Tunku Abdul Rahman, Fac Sci, Dept Allied Hlth Sci, Kampar, Malaysia.
   [Tan, Seok Shin] Int Med Univ, Sch Hlth Sci, Dept Nutr & Dietet, Bukit Jalil, Malaysia.
   [Tan, Seok Tyug] Management & Sci Univ, Fac Hlth & Life Sci, Dept Healthcare Profess, Shah Alam, Malaysia.
RP Tan, CX (corresponding author), Univ Tunku Abdul Rahman, Fac Sci, Dept Allied Hlth Sci, Kampar, Malaysia.
EM tanchinxuan@ymail.com
CR Abdalla M.I., 2020, US ENDOCRINOLOGY, V16, P69
   Ammar A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061583
   Chin E.S.M, 2021, MCO COMPULSORY WORK
   Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005
   Coelho-Ravagnani CD, 2021, NUTR REV, V79, P382, DOI 10.1093/nutrit/nuaa067
   Daim N, 2021, NEW STRAITS TIMES
   Davies A, 2020, NUTRITION, V71, DOI 10.1016/j.nut.2019.110622
   Escoto KH, 2012, AM J HEALTH BEHAV, V36, P786, DOI 10.5993/AJHB.36.6.6
   Gan W Y, 2011, Malays J Nutr, V17, P213
   Hall G, 2021, PROG CARDIOVASC DIS, V64, P108, DOI 10.1016/j.pcad.2020.04.005
   Hayashi F, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113864
   Hodge JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231229
   Hunter P, 2019, EMBO REP, V20, DOI 10.15252/embr.201847435
   Karbownik MS, 2021, RES SOC ADMIN PHARM, V17, P1501, DOI 10.1016/j.sapharm.2020.11.015
   LaCaille L., 2013, ENCY BEHAV MED, P641, DOI [10.1007/978-1-4419-1005-9_1613., DOI 10.1007/978-1-4419-1005-9_1613]
   Lee K, 2009, GLOB INST, P1
   Livingstone KM, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-01059-7
   Ma XM, 2020, OBES RES CLIN PRACT, V14, P1, DOI 10.1016/j.orcp.2019.12.002
   McCurley JL, 2022, J ACAD NUTR DIET, V122, P110, DOI 10.1016/j.jand.2021.08.109
   Mohd Zaki N.A., 2018, GLOBAL J HLTH SCI, V10, P127
   Moy M.F., 2021, LETT OBESITY MALAYSI
   Pendergast FJ, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0451-5
   Pendergast FJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0451-1
   Pinho MGM, 2018, EUR J NUTR, V57, P1761, DOI 10.1007/s00394-017-1458-3
   Poulain J.P., 2020, MALAYSIAN J NUTR, V26, P1
   Pung CYY, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182312820
   Shin WY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243160
   Tan S.T., 2022, HUMAN NUTR METABOLIS, V27
   Tan ST, 2022, NUTR FOOD SCI, V52, P281, DOI 10.1108/NFS-05-2021-0156
   Toosty Nishat Tasnim, 2022, Sustain Prod Consum, V30, P608, DOI 10.1016/j.spc.2022.01.001
   U.S. Food and Drug Administration, 2017, WHAT YOU NEED KNOW D
   Vyas L, 2022, POLICY SOC, V41, P155, DOI 10.1093/polsoc/puab011
   World Health Organization, 2020, DIR GEN REM MED BRIE
   World Health Organization (WHO), 2018, CUT OFF BMI ACC WHO
   Yamamoto R, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010271
NR 35
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0034-6659
EI 1758-6917
J9 NUTR FOOD SCI
JI Nutr. Food Sci.
DI 10.1108/NFS-11-2021-0331
EA MAR 2022
PG 12
WC Food Science & Technology
WE Emerging Sources Citation Index (ESCI)
SC Food Science & Technology
GA ZZ9XF
UT WOS:000773615700001
DA 2022-04-20
ER

PT J
AU Tsatsakis, A
   Calina, D
   Falzone, L
   Petrakis, D
   Mitrut, R
   Siokas, V
   Pennisi, M
   Lanza, G
   Libra, M
   Doukas, SG
   Doukas, PG
   Kavali, L
   Bukhari, A
   Gadiparthi, C
   Vageli, DP
   Kofteridis, DP
   Spandidos, DA
   Paoliello, MMB
   Aschner, M
   Docea, AO
AF Tsatsakis, Aristides
   Calina, Daniela
   Falzone, Luca
   Petrakis, Dimitrios
   Mitrut, Radu
   Siokas, Vasileios
   Pennisi, Manuela
   Lanza, Giuseppe
   Libra, Massimo
   Doukas, Sotirios G.
   Doukas, Panagiotis G.
   Kavali, Leena
   Bukhari, Amar
   Gadiparthi, Chiranjeevi
   Vageli, Dimitra P.
   Kofteridis, Diamantis P.
   Spandidos, Demetrios A.
   Paoliello, Monica M. B.
   Aschner, Michael
   Docea, Anca Oana
TI SARS-CoV-2 pathophysiology and its clinical implications: An integrative
   overview of the pharmacotherapeutic management of COVID-19
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE SARS-COV-2; Clinical signs; COVID-19 pandemic; Cancer; Cardiovascular
   system; Pulmonary system; Gastrointestinal system; Neurological system
ID NF-KAPPA-B; IMMUNE CHECKPOINT BLOCKADE; CORONAVIRUS DISEASE 2019;
   SARS-CORONAVIRUS; CANCER-PATIENTS; FUNCTIONAL RECEPTOR; ENTERIC
   INVOLVEMENT; CEREBROSPINAL-FLUID; CONVERTING ENZYME; ACE2
AB Common manifestations of COVID-19 are respiratory and can extend from mild symptoms to severe acute respiratory distress. The severity of the illness can also extend from mild disease to life-threatening acute respiratory distress syndrome (ARDS). SARS CoV-2 infection can also affect the gastrointestinal tract, liver and pancreatic functions, leading to gastrointestinal symptoms. Moreover, SARS-CoV-2 can cause central and peripheral neurological manifestations, affect the cardiovascular system and promote renal dysfunction. Epidemiological data have indicated that cancer patients are at a higher risk of contracting the SARS CoV-2 virus. Considering the multitude of clinical symptoms of COVID-19, the objective of the present review was to summarize their pathophysiology in previously healthy patients, as well as in those with comorbidities. The present review summarizes the current, though admittedly fluid knowledge on the pathophysiology and symptoms of COVID-19 infection. Although unclear issues still remain, the present study contributes to a more complete understanding of the disease, and may drive the direction of new research. The recognition of the severity of the clinical symptoms of COVID-19 is crucial for the specific therapeutic management of affected patients.
C1 [Tsatsakis, Aristides; Petrakis, Dimitrios; Doukas, Sotirios G.] Univ Crete, Fac Med, Dept Forens Sci & Toxicol, Iraklion 71003, Greece.
   [Tsatsakis, Aristides; Aschner, Michael] IM Sechenov First Moscow State Med Univ, Sechenov Univ, Moscow 119146, Russia.
   [Calina, Daniela] Univ Med & Pharm Craiova, Dept Clin Pharm, Craiova 200349, Romania.
   [Falzone, Luca] IRCCS Ist Nazl Tumori Fdn G Pascale, Epidemiol Unit, I-80131 Naples, Italy.
   [Mitrut, Radu] Univ & Emergency Hosp, Dept Cardiol, Bucharest 050098, Romania.
   [Siokas, Vasileios] Univ Thessaly, Univ Hosp Larissa, Dept Neurol, Larisa 41221, Greece.
   [Pennisi, Manuela; Libra, Massimo] Univ Catania, Dept Biomed & Biotechnol Sci, I-95123 Catania, Italy.
   [Lanza, Giuseppe] Univ Catania, Dept Surg & Med Surg Specialties, I-95123 Catania, Italy.
   [Lanza, Giuseppe] Oasi Res Inst IRCCS, Dept Neurol IC, I-94018 Troina, Italy.
   [Libra, Massimo] Univ Catania, Res Ctr Prevent Diag & Treatment Canc, I-95123 Catania, Italy.
   [Doukas, Sotirios G.; Kavali, Leena] St Peters Univ Hosp, Dept Internal Med, 254 Easton Ave, New Brunswick, NJ 08901 USA.
   [Doukas, Panagiotis G.] Univ Pavol Josef Safarik Univ, Fac Med, Kosice, Slovakia.
   [Bukhari, Amar] Dept Med, Div Pulm & Crit Care, 240 Easton Ave, New Brunswick, NJ 08901 USA.
   [Gadiparthi, Chiranjeevi] St Peters Univ Hosp, Div Gastroenterol Hepatol & Clin Nutr, New Brunswick, NJ USA.
   [Vageli, Dimitra P.] Yale Larynx Lab, Dept Surg, New Haven, CT 06510 USA.
   [Kofteridis, Diamantis P.] Univ Hosp Heraklion, Dept Internal Med, Iraklion 71110, Crete, Greece.
   [Spandidos, Demetrios A.] Univ Crete, Med Sch, Lab Clin Virol, Iraklion 71003, Greece.
   [Paoliello, Monica M. B.; Aschner, Michael] Albert Eisntein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
   [Docea, Anca Oana] Univ Med & Pharm Craiova, Dept Toxicol, 2-4 Petru Rares St, Craiova 200349, Romania.
RP Tsatsakis, A (corresponding author), Univ Crete, Fac Med, Dept Forens Sci & Toxicol, Iraklion 71003, Greece.; Docea, AO (corresponding author), Univ Med & Pharm Craiova, Dept Toxicol, 2-4 Petru Rares St, Craiova 200349, Romania.
EM tsatsaka@uoc.gr; calinadaniela@gmail.com;
   l.falzone@istitutotumori.na.it; dimitriospetrakis@hotmail.com;
   radumitrut@yahoo.co.uk; bill_s1983@hotmail.com;
   manuela.pennisi@unict.it; giuseppe.lanza1@unict.it; m.libra@unict.it;
   sotirios.doukas.mail@gmail.com; panagiotis.doukas.mail@gmail.com;
   leena.kavali@gmail.com; ABukhari@saintpetersuh.com;
   cgadiparthi@saintpetersuh.com; dimitra.vangeli@yale.edu;
   kofteridisd@hotmail.com; spandidos@spandidos.gr; monibas2@gmail.com;
   michael.aschner@einsteinmed.org; daoana00@gmail.com
RI Lanza, Giuseppe/R-3065-2017; Calina, Daniela/I-5509-2017; Libra,
   Massimo/L-8241-2018; Mitrut, Radu/AAR-3344-2021; Docea, Anca
   Oana/P-5807-2019; Falzone, Luca/AAC-2085-2019; Tsatsakis, Aristidis
   M./H-2890-2013
OI Lanza, Giuseppe/0000-0002-5659-662X; Calina,
   Daniela/0000-0002-1523-9116; Libra, Massimo/0000-0002-7232-7737; Docea,
   Anca Oana/0000-0002-8162-5955; Falzone, Luca/0000-0001-7349-6826;
   Tsatsakis, Aristidis M./0000-0003-3824-2462; Mitrut,
   Radu/0000-0003-2207-6519
FU national Institute of Environmental Health Sciences (NIEHS)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS)
   [R01ES10563, R01ES07331]
FX The present study was supported in part by grants from the national
   Institute of Environmental Health Sciences (NIEHS) R01ES10563 and
   R01ES07331 (to MA).
CR Abedi F, 2020, PHARMACOL RES, V156, DOI 10.1016/j.phrs.2020.104808
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Aiello F, 2020, EYE, V34, P1206, DOI 10.1038/s41433-020-0926-9
   Allegra A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134782
   Azwar MK, 2020, ACTA MED INDONES, V52, P63
   Babapoor-Farrokhran S, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117723
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013
   Benny R, 2020, ANN INDIAN ACAD NEUR, V23, pS40, DOI 10.4103/aian.AIAN_309_20
   Bersanelli M, 2020, IMMUNOTHERAPY-UK, V12, P269, DOI 10.2217/imt-2020-0067
   Bersanelli M, 2020, IMMUNOTHERAPY-UK, V12, P105, DOI 10.2217/imt-2019-0200
   Boettler T, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100113
   Bohmwald K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00386
   Boriani G, 2018, EP EUR, V21, P7, DOI 10.1093/europace/euy110
   Brown E, 2020, SCHIZOPHR RES, V222, P79, DOI 10.1016/j.schres.2020.05.005
   Buga AM, 2019, ONCOL LETT, V17, P4170, DOI 10.3892/ol.2019.9933
   Cai G., 2020, BULK SINGLE CELL TRA, DOI [10.1101/2020.02.05.20020107v3, 10.1101/2020.02.05.20020107, DOI 10.1101/2020.02.05.20020107]
   Cai QX, 2020, ALLERGY, V75, P1742, DOI 10.1111/all.14309
   Calina D, 2020, INT J MOL MED, V46, P3, DOI 10.3892/ijmm.2020.4596
   Camdessanche J.P., 2020, REV NEUROL, V176, P595
   Cannizzaro R, 2020, DIGEST LIVER DIS, V52, P595, DOI 10.1016/j.dld.2020.03.030
   Carod-Artal FJ, 2020, REV NEUROLOGIA, V70, P311, DOI 10.33588/rn.7009.2020179
   Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z
   Chau TN, 2004, HEPATOLOGY, V39, P302, DOI 10.1002/hep.20111
   Chen C, 2020, Zhonghua Shao Shang Za Zhi, V36, P471, DOI 10.3760/cma.j.cn501120-20200224-00088
   Chen XF, 2020, EUR RADIOL, V30, P4893, DOI 10.1007/s00330-020-06829-2
   Christofi T, 2019, CANCERS, V11, DOI 10.3390/cancers11101472
   Chu KH, 2005, KIDNEY INT, V67, P698, DOI 10.1111/j.1523-1755.2005.67130.x
   Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230
   Contentti EC, 2020, MULT SCLER RELAT DIS, V41, DOI 10.1016/j.msard.2020.102097
   Cordonnier DJ, 2001, DRUGS, V61, P1883, DOI 10.2165/00003495-200161130-00001
   Costa S, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00587
   Cristelo C, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108228
   Cunningham AC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2818-6
   Curigliano G, 2020, BREAST, V52, P8, DOI 10.1016/j.breast.2020.04.006
   Dallan C, 2020, LANCET CHILD ADOLESC, V4, pE21, DOI 10.1016/S2352-4642(20)30164-4
   De Simone V, 2015, ONCOGENE, V34, P3493, DOI 10.1038/onc.2014.286
   DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13
   Dehelean CA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072084
   Deng SQ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020575
   Desforges M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010014
   Dessau RB, 1999, ACTA NEUROL SCAND, V100, P88
   Di Giambenedetto S, 2020, J MED VIROL, V92, P1787, DOI 10.1002/jmv.25897
   Dinkin M, 2020, NEUROLOGY, V95, P221, DOI 10.1212/WNL.0000000000009700
   Docea AO, 2020, INT J MOL MED, V45, P1631, DOI 10.3892/ijmm.2020.4555
   Dockery DM, 2020, J EMERG MED, V59, P137, DOI 10.1016/j.jemermed.2020.04.060
   Doukas SG, 2018, J CELL MOL MED, V22, P2922, DOI 10.1111/jcmm.13591
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Falzone L, 2020, INT J MOL MED, V46, P957, DOI 10.3892/ijmm.2020.4673
   Falzone L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01300
   Fan ZY, 2020, CLIN GASTROENTEROL H, V18, P1561, DOI 10.1016/j.cgh.2020.04.002
   Fang M, 2012, P NATL ACAD SCI USA, V109, P9983, DOI 10.1073/pnas.1202143109
   Farsalinos K, 2020, TOXICOL REP, V7, P658, DOI 10.1016/j.toxrep.2020.04.012
   FAZZINI E, 1992, MOVEMENT DISORD, V7, P153, DOI 10.1002/mds.870070210
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Filatov A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7352
   Filetti V, 2020, ECOTOX ENVIRON SAFE, V198, DOI 10.1016/j.ecoenv.2020.110640
   FLEMING JO, 1982, ARCH NEUROL-CHICAGO, V39, P455, DOI 10.1001/archneur.1982.00510190073030
   Fried JA, 2020, CIRCULATION, V141, P1930, DOI 10.1161/CIRCULATIONAHA.120.047164
   Gambhir S, 2015, WORLD J GASTROENTERO, V21, P3174, DOI 10.3748/wjg.v21.i11.3174
   Gao QX, 2019, EXP DERMATOL, V28, P413, DOI 10.1111/exd.13846
   Gattinoni L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02880-z
   Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330
   Gong J., 2020, CORRELATION ANAL DIS, DOI [10.1186/s12879-020-05681-5, 10.1101/2020.02.25.20025643, DOI 10.1101/2020.02.25.20025643]
   Goumenou M, 2020, MOL MED REP, V21, P2293, DOI 10.3892/mmr.2020.11037
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054
   Guan W-J, 2020, CLIN CHARACTERISTICS
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Gupta MD, 2020, INDIAN HEART J, V72, P1, DOI 10.1016/j.ihj.2020.03.006
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hanna TP, 2020, NAT REV CLIN ONCOL, V17, P268, DOI 10.1038/s41571-020-0362-6
   He WJ, 2020, LEUKEMIA, V34, P1637, DOI 10.1038/s41375-020-0836-7
   Hindson J, 2020, NAT REV GASTRO HEPAT, V17, P259, DOI 10.1038/s41575-020-0295-7
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang I, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00453-4
   Huang PK, 2020, RADIOLOGY, V295, P22, DOI 10.1148/radiol.2020200330
   Hung ECW, 2003, CLIN CHEM, V49, P2108, DOI 10.1373/clinchem.2003.025437
   Ibrahim IM, 2020, J INFECTION, V80, P554, DOI 10.1016/j.jinf.2020.02.026
   Ibrahim Umma A, 2016, Gulf J Oncolog, V1, P80
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Jacobi A, 2020, CLIN IMAG, V64, P35, DOI 10.1016/j.clinimag.2020.04.001
   Jarred G, 2010, THER ADV ENDOCRINOL, V1, P23, DOI 10.1177/2042018810369437
   Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005
   Jin M, 2020, EMERG INFECT DIS, V26, P1618, DOI 10.3201/eid2607.200445
   Jin X, 2020, GUT, V69, P1002, DOI 10.1136/gutjnl-2020-320926
   Caamano DSJ, 2020, J CLIN NEUROSCI, V77, P230, DOI 10.1016/j.jocn.2020.05.016
   Kattan J, 2020, IMMUNOTHERAPY-UK, V12, P351, DOI 10.2217/imt-2020-0077
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Kostoff RN, 2020, FOOD CHEM TOXICOL, V145, DOI 10.1016/j.fct.2020.111687
   Kostoff RN, 2020, INT J MOL MED, V46, P463, DOI 10.3892/ijmm.2020.4640
   Kwenandar F, 2020, IJC HEART VASC, V29, DOI 10.1016/j.ijcha.2020.100557
   Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090
   Lagana SM, 2020, MODERN PATHOL, V33, P2147, DOI 10.1038/s41379-020-00649-x
   Lau KK, 2004, EMERG INFECT DIS, V10, P342, DOI 10.3201/eid1002.030638
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lechien JR, 2020, J INTERN MED, V288, P335, DOI 10.1111/joim.13089
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1053/S0016-5085(03)01215-0, 10.1016/j.gastro.2003.08.001]
   Li L, 2020, RISK FACTORS RELATED, DOI [10.1101/2020.02.28.20028514, DOI 10.1101/2020.02.28.20028514]
   Li RH., 2020, 1 CASE 2019 NOVEL CO, P00015
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431
   Li YY, 2020, J MED VIROL, V92, P1491, DOI 10.1002/jmv.25973
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Lin L, 2020, GUT, V69, P997, DOI 10.1136/gutjnl-2020-321013
   Liu BW, 2020, J AUTOIMMUN, V111, DOI 10.1016/j.jaut.2020.102452
   Liu CC, 2019, IMMUNOLOGY, V158, P70, DOI 10.1111/imm.13101
   Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Lomoro P, 2020, EUR J RADIOL OPEN, V7, DOI 10.1016/j.ejro.2020.100231
   Maiolo G, 2018, AM J RESP CRIT CARE, V197, P1586, DOI 10.1164/rccm.201709-1804OC
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825
   Mariotto S, 2020, NEUROLOGY, V94
   Maschmeyer G, 2008, INT J ANTIMICROB AG, V31, P193, DOI 10.1016/j.ijantimicag.2007.06.014
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mititelu RR, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8050125
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Moujaess E, 2020, CRIT REV ONCOL HEMAT, V150, DOI 10.1016/j.critrevonc.2020.102972
   Musa S, 2020, ARAB J GASTROENTEROL, V21, P3, DOI 10.1016/j.ajg.2020.03.002
   Nasi A, 2020, TOXICOL REP, V7, P768, DOI 10.1016/j.toxrep.2020.06.003
   Ng SC, 2020, GUT, V69, P973, DOI 10.1136/gutjnl-2020-321195
   Nicin L, 2020, EUR HEART J, V41, P1804, DOI 10.1093/eurheartj/ehaa311
   Nile SH, 2020, CYTOKINE GROWTH F R, V53, P66, DOI 10.1016/j.cytogfr.2020.05.002
   Nitulescu GM, 2020, INT J MOL MED, V46, P467, DOI 10.3892/ijmm.2020.4608
   Nussbaum L, 2017, FARMACIA, V65, P75
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   Onofrio L, 2020, FUTUR SCI OA, V6, DOI 10.2144/fsoa-2020-0091
   Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
   Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787
   Padureanu R, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111815
   Paramasivam A, 2020, HYPERTENS RES, V43, P729, DOI 10.1038/s41440-020-0461-x
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   Peng FJ, 2020, CAN J CARDIOL, V36, P915, DOI 10.1016/j.cjca.2020.04.010
   Pennisi M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155475
   Petrakis D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101282
   Porcheddu R, 2020, J INFECT DEV COUNTR, V14, P125, DOI 10.3855/jidc.12600
   Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   RASMUSSEN L, 1982, ENVIRON HEALTH PERSP, V43, P21, DOI 10.2307/3429163
   Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775
   Rivera A, 2020, ADV RADIAT ONCOL, V5, P538, DOI 10.1016/j.adro.2020.03.006
   Rizzo P, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0791-5
   Rogoveanu OC, 2018, EXP THER MED, V16, P2659, DOI 10.3892/etm.2018.6477
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Salehi B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020430
   Salehi B, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010130
   Salemi R, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00856
   SALMI A, 1982, NEUROLOGY, V32, P292, DOI 10.1212/WNL.32.3.292
   Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]
   Sani TA, 2017, FARMACIA, V65, P189
   Sarkar C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.572870
   Schonrich G, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00207
   Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486
   Sedaghat Z, 2020, J CLIN NEUROSCI, V76, P233, DOI 10.1016/j.jocn.2020.04.062
   Seirafianpour F, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13986
   Sharifi-Rad J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072326
   Sharifi-Rad M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00694
   Sharifi-Rad M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041061
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Sidaway P, 2020, NAT REV CLIN ONCOL, V17, P336, DOI 10.1038/s41571-020-0366-2
   Singh AK, 2020, DIABETES METAB SYND, V14, P303, DOI 10.1016/j.dsx.2020.04.004
   Skalny AV, 2020, INT J MOL MED, V46, P17, DOI 10.3892/ijmm.2020.4575
   Small BA, 2001, J EXP MED, V194, P1835, DOI 10.1084/jem.194.12.1835
   Stancioiu F, 2020, INT J MOL MED, V46, P489, DOI 10.3892/ijmm.2020.4636
   Tahamtan A, 2020, EXPERT REV MOL DIAGN, V20, P453, DOI 10.1080/14737159.2020.1757437
   Tanase A, 2016, EXP THER MED, V12, P2078, DOI 10.3892/etm.2016.3562
   The Lancet Oncology, 2020, Lancet Oncol, V21, P467, DOI 10.1016/S1470-2045(20)30175-3
   Tian SF, 2020, MODERN PATHOL, V33, P1007, DOI 10.1038/s41379-020-0536-x
   Islam MT, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00281
   Toscano G, 2020, NEW ENGL J MED, V382, P2574, DOI 10.1056/NEJMc2009191
   Trejo-Gabriel-Galan JM, 2020, NEUROLOGIA, V35, P318, DOI 10.1016/j.nrl.2020.04.015
   Tsai Li-Kai, 2005, Acta Neurol Taiwan, V14, P113
   Tsatsakis A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091295
   Tsatsakis A, 2020, FOOD CHEM TOXICOL, V141, DOI 10.1016/j.fct.2020.111418
   Turtle L, 2020, J MED VIROL, V92, P705, DOI 10.1002/jmv.25828
   Ulhaq ZS, 2020, MED MALADIES INFECT, V50, P382, DOI 10.1016/j.medmal.2020.04.002
   Ulrich H, 2020, STEM CELL REV REP, V16, P434, DOI 10.1007/s12015-020-09976-7
   Vageli DP, 2018, J CELL MOL MED, V22, P4209, DOI 10.1111/jcmm.13701
   Vaira LA, 2020, LARYNGOSCOPE, V130, P1787, DOI 10.1002/lary.28692
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Virani A, 2020, IDCASES, V20, DOI 10.1016/j.idcr.2020.e00771
   Vivarelli S, 2020, CANCERS, V12, DOI 10.3390/cancers12082237
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang F, 2020, GASTROENTEROLOGY, V159, P367, DOI 10.1053/j.gastro.2020.03.055
   Wang Y, 2006, CURR CANCER THER REV, V2, P271, DOI 10.2174/157339406777934717
   Wang YY, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00245-9
   Wargo JA, 2015, SEMIN ONCOL, V42, P601, DOI 10.1053/j.seminoncol.2015.05.007
   Wei XS, 2020, CLIN GASTROENTEROL H, V18, P1753, DOI 10.1016/j.cgh.2020.04.030
   Wojciechowski VV, 2017, DARU, V25, DOI 10.1186/s40199-017-0175-z
   WONG HYF, 2019, RADIOLOGY, DOI [10.1148/radiol.2020201160, DOI 10.1148/RADIOL.2020201160]
   Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031
   Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112
   Xia JH, 2020, J MED VIROL, V92, P589, DOI 10.1002/jmv.25725
   Xia Y, 2020, LANCET ONCOL, V21, pE180, DOI 10.1016/S1470-2045(20)30150-9
   Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112
   Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343
   Xu L, 2020, LIVER INT, V40, P998, DOI 10.1111/liv.14435
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762
   Yang H, 2014, INT J INFLAMM, V2014, DOI 10.1155/2014/130981
   Yeo C, 2020, LANCET GASTROENTEROL, V5, P335, DOI 10.1016/S2468-1253(20)30048-0
   Yeoh CB, 2020, ANESTH ANALG, V131, P16, DOI 10.1213/ANE.0000000000004884
   Yu J, 2020, JAMA ONCOL, V6, P1108, DOI 10.1001/jamaoncol.2020.0980
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang ZQ, 2006, INT J ONCOL, V29, P185
   Zhao H, 2020, LANCET NEUROL, V19, P383, DOI 10.1016/S1474-4422(20)30109-5
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou Y, 2021, MACROMOL REACT ENG, V15, DOI 10.1002/mren.202000041
   Zlatian O, 2018, EXP THER MED, V16, P4499, DOI 10.3892/etm.2018.6737
   Zlatian OM, 2015, ROM J MORPHOL EMBRYO, V56, P175
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
NR 228
TC 67
Z9 67
U1 8
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD DEC
PY 2020
VL 146
AR 111769
DI 10.1016/j.fct.2020.111769
PG 18
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA PM9VU
UT WOS:000604138100002
PM 32979398
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Borman, P
   Yaman, A
   Umaroglu, M
   Cakit, BD
AF Borman, Pinar
   Yaman, Ayseguel
   Umaroglu, Mutlu
   Cakit, Burcu Duyur
TI The Impact of COVID-19 Lockdown on Patients with Lymphedema
SO LYMPHATIC RESEARCH AND BIOLOGY
LA English
DT Article; Early Access
DE lymphedema; COVID-19; impact; lock down; access to care
AB Background: The coronavirus disease 2019 (COVID-19) pandemic poses a challenge to management of lymphedema. The aim of this study was to assess general health conditions and evaluate the problems and concerns of lymphedema patients with regard to access to care and provision of management and control follow-ups during the lockdown period between March and June 2020.Methods: A web-based online survey, which included questions about demographic and clinical properties, compliance with restrictions and self-management, complications, needs, and difficulties in accessing health care, as well as the presence of psychological symptoms, was applied.Results: Two hundred three patients (190 female and 13 male) replied. Majority of them (73.4%) were between 30 and 60 years old and had high school/university education (67%). The duration of lymphedema was more than 3 years and sites were commonly extremities with mild to moderate intensity in 70.5% patients. Majority of them adhered to stay home warnings (88.7%). Weight gain was a common problem and self-care methods were generally skipped (81.8%). Seventeen percent of them had wounds and/or cellulitis. Forty percent of patients needed to apply to health centers to renew the pressure garment, but could not reach it. More than 70% of patients had sleep disorders and anxiety/stress. Majority of patients used television and social media to get information related to COVID-19 and the exposure time was commonly 2 to 6 hours.Conclusions: The COVID-19 lockdown had a great impact on lymphedema patients' health care not only from medical but also from psychosocial aspects. All these implications have to be identified and dealt with properly to avoid concerns and consequences of future pandemic lockdowns. Lymphedema services should be well prepared to be delivered virtually, enable effective care, and share knowledge to meet the needs of patients suffering from lymphedema.
C1 [Borman, Pinar] Univ Hlth Sci, Ankara City Hosp, Dept Phys Med & Rehabil, Niversiteler Mahallesi 1604,Cadde 9 Cxankaya, TR-06800 Ankara, Turkey.
   [Yaman, Ayseguel] Gulhane Training & Res Hosp, Dept Phys Med & Rehabil, Ankara, Turkey.
   [Umaroglu, Mutlu] Univ Sakarya, Fac Med, Dept Biostat, Sakarya, Turkey.
   [Cakit, Burcu Duyur] Univ Hlth Sci, Ankara Training & Res Hosp, Dept Phys Med & Rehabil, Ankara, Turkey.
RP Borman, P (corresponding author), Univ Hlth Sci, Ankara City Hosp, Dept Phys Med & Rehabil, Niversiteler Mahallesi 1604,Cadde 9 Cxankaya, TR-06800 Ankara, Turkey.
EM pinarborman@gmail.com
RI UMAROGLU, Mutlu/J-1556-2013
OI UMAROGLU, Mutlu/0000-0002-4122-6431
CR [Anonymous], 2020, LYMPHOLOGY, V53, P3
   Borman P, 2018, TURK J PH MED REHAB, V64, P179, DOI 10.5606/tftrd.2018.3539
   Cakit BD, 2019, LYMPHAT RES BIOL, V17, P45, DOI 10.1089/lrb.2017.0086
   Carter J, 2021, GYNECOL ONCOL, V160, P244, DOI 10.1016/j.ygyno.2020.10.023
   Chevallard M, 2021, RHEUMATOL INT, V41, P1253, DOI 10.1007/s00296-021-04863-x
   Gabe-Walters Marie, 2021, Br J Nurs, V30, P210, DOI 10.12968/bjon.2021.30.4.210
   Leray H, 2020, LYMPHAT RES BIOL, V18, P510, DOI 10.1089/lrb.2019.0009
   Lopez CJ, 2021, ARCH PHYS MED REHAB, V102, P1283, DOI 10.1016/j.apmr.2021.02.002
   Narici M, 2021, EUR J SPORT SCI, V21, P614, DOI 10.1080/17461391.2020.1761076
   Noble-Jones Rhian, 2021, Br J Nurs, V30, P218, DOI 10.12968/bjon.2021.30.4.218
   Seyahi E, 2020, RHEUMATOL INT, V40, P1229, DOI 10.1007/s00296-020-04626-0
   Woods Jeffrey A, 2020, Sports Med Health Sci, V2, P55, DOI 10.1016/j.smhs.2020.05.006
   Zuther JE, 2018, LYMPHEDEMA MANAGEMEN, P246
NR 13
TC 0
Z9 0
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1539-6851
EI 1557-8585
J9 LYMPHAT RES BIOL
JI Lymphat. Res. Biol.
DI 10.1089/lrb.2021.0070
EA JAN 2022
PG 6
WC Medicine, Research & Experimental; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Physiology
GA YI7RB
UT WOS:000744040900001
PM 35021887
DA 2022-04-20
ER

PT J
AU Hartley, K
   Bales, S
   Bali, AS
AF Hartley, Kris
   Bales, Sarah
   Bali, Azad Singh
TI COVID-19 response in a unitary state: emerging lessons from Vietnam
SO POLICY DESIGN AND PRACTICE
LA English
DT Article
DE COVID-19; pandemic response; policy success; policy effectiveness;
   Vietnam
AB The global reach of COVID-19 presents opportunities to compare policy responses to the pandemic and the role of knowledge across political contexts. This article examines the case of Vietnam's COVID-19 response. Recognized for its early effectiveness, Vietnam exhibits the standard characteristics of unitary states but has also engaged communities, strengthening the legitimacy of and buy-in to response efforts. This article identifies six factors that shaped Vietnam's response to the pandemic: (i) command-and-control governance, (ii) extensive preparation, (iii) fostering cooperative sentiment and solidarity, (iv) political readiness and communication, (v) policy coordination, and (vi) adaptation. The article contributes to practical discussions about country-specific responses to the pandemic, and to scholarship on policy effectiveness and success within the policy sciences and public management.
C1 [Hartley, Kris] Educ Univ Hong Kong, Dept Asian & Policy Studies, Hong Kong, Peoples R China.
   [Bales, Sarah] Hanoi Univ Publ Hlth, Hanoi, Vietnam.
   [Bali, Azad Singh] Australian Natl Univ, Sch Polit & Int Relat, Canberra, ACT, Australia.
   [Bali, Azad Singh] Australian Natl Univ, Crawford Sch Publ Policy, Canberra, ACT, Australia.
RP Hartley, K (corresponding author), Educ Univ Hong Kong, Dept Asian & Policy Studies, Tai Po, 10 Lo Ping Rd, Hong Kong, Peoples R China.
EM hartley@eduhk.hk
OI Bales, Sarah/0000-0002-9480-1751
CR Acosta M., 2020, SOCARXIV, V2020, P1
   Tran BX, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011006
   Tran BX, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104811
   Baekkeskov E, 2017, J EUR PUBLIC POLICY, V24, P1006, DOI 10.1080/13501763.2016.1170192
   Bali AS, 2019, POLICY SOC, V38, P1, DOI 10.1080/14494035.2019.1579502
   Black G, 2020, NATION
   Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104
   Ha BTT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093125
   Capano G, 2020, POLICY SOC, V39, P326, DOI 10.1080/14494035.2020.1783790
   Capano G, 2020, POLICY SOC, V39, P285, DOI 10.1080/14494035.2020.1787628
   CDC, 2019, CDC VIETN
   Compton M., 2019, GREAT POLICY SUCCESS
   Cotillon H., 2017, J CURR SE ASIAN AFF, V36, P51, DOI DOI 10.1177/186810341703600103
   Duong DM, 2020, ASIA-PAC J PUBLIC HE, V32, P161, DOI 10.1177/1010539520927290
   El Zowalaty ME, 2020, ONE HEALTH-AMSTERDAM, V9, DOI 10.1016/j.onehlt.2020.100124
   Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795
   Fforde A., 2020, MELBOURNE ASIA 1029
   FitzGerald C, 2019, ADMINSTRATION, V67, P1, DOI 10.2478/admin-2019-0011
   Fritzen S., 2005, GOVERNANCE I ANTICOR
   Gonzalez Block Miguel A, 2003, Health Res Policy Syst, V1, P1, DOI 10.1186/1478-4505-1-1
   Quach HL, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104379
   Thanh HN, 2020, LANCET INFECT DIS, V20, P535, DOI 10.1016/S1473-3099(20)30159-6
   Hartley K, 2020, POLICY SOC, V39, P403, DOI 10.1080/14494035.2020.1783791
   Hoang VM, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1776526
   Nguyen HV, 2020, INT J HEALTH PLAN M, V35, P988, DOI 10.1002/hpm.3004
   IMF, 2020, VIETN SUCC CONT COVI
   Kelly TR, 2017, PREV VET MED, V137, P112, DOI 10.1016/j.prevetmed.2016.11.023
   Le L., 2020, NATL HEROISM MEDIA V
   Le T.V., 2020, DIPLOMAT 0317
   Luetjens J, 2019, SUCCESSFUL PUBLIC POLICY: LESSONS FROM AUSTRALIA AND NEW ZEALAND, P1
   Luong T, 2020, ANTHR NOW, V12, P45, DOI [10.1080/19428200.2020.1761209, DOI 10.1080/19428200.2020.1761209]
   Marsh D, 2010, PUBLIC ADMIN, V88, P564, DOI 10.1111/j.1467-9299.2009.01803.x
   Moghadas SM, 2011, INFLUENZA OTHER RESP, V5, P83, DOI 10.1111/j.1750-2659.2010.00184.x
   Morisset J., 2020, VIETNAM POTENTIAL PO, DOI [10.1596/33779, DOI 10.1596/33779]
   Moynihan D, 2019, POSITIVE PUBLIC ADM
   Nguyen T.M., 2020, REOPENING VIETNAM CO
   Nguyen THD, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101651
   Nicklin G., 2019, INT REV PUBLIC POLIC, V1
   Pham T.D., 2020, EPIDEMIOLOGICAL CHAR
   Hoang P, 2019, J ASIAN SECUR INT AF, V6, P1, DOI 10.1177/2347797019826747
   Rani M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-877
   Rocco P, 2020, POLICY SOC, V39, P458, DOI 10.1080/14494035.2020.1783793
   Taneja P., 2021, ROUND TABLE, DOI [10.1080/00358533.2021.1875685, DOI 10.1080/00358533.2021.1875685]
   Thayer C.A., 2011, CONTEMP SE ASIA, V33, P348
   Thu H.L., 2020, VIETNAM SUCCESSFUL B
   Huynh TLD, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010338
   Trevisan M, 2020, AM J PUBLIC HEALTH, V110, P1152, DOI 10.2105/AJPH.2020.305751
   Tung LT, 2020, J GERONTOL SOC WORK, V63, P682, DOI 10.1080/01634372.2020.1773596
   Minh HV, 2021, J RURAL HEALTH, V37, P148, DOI 10.1111/jrh.12430
   La VP, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072931
   Vu M., 2020, DIPLOMAT 0418
   Vu T., 2009, 19 STEPS
   Vu T., 2014, J VIETNAM STUD, V9, P33, DOI 10.1525/vs.2014.9.4.33
   Wolman H, 1981, J PUBLIC POLICY, V1, P433, DOI DOI 10.1017/S0143814X00002336
   Woo JJ, 2020, POLICY SOC, V39, P345, DOI 10.1080/14494035.2020.1783789
   World Bank, 2020, WORLD BANK GROUP AUS
   World Bank, 2020, COVID 19 POL RESP NO
   World Health Organization, 2003, WHO ISS GLOB AL CAS
NR 58
TC 2
Z9 2
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2574-1292
J9 POLICY DES PRACT
JI Policy Des. Pract.
PD JAN 2
PY 2021
VL 4
IS 1
SI SI
BP 152
EP 168
DI 10.1080/25741292.2021.1877923
PG 17
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA TA5HU
UT WOS:000667280800010
OA gold
DA 2022-04-20
ER

PT J
AU Almosawey, NAS
   AL-Khikani, FHO
   Hameed, RM
   Abdullah, YJ
   Al-lbraheemi, MKM
   Al-Asadi, AA
AF Almosawey, Nude Ali Salman
   AL-Khikani, Falah Hasan Obayes
   Hameed, Raghdah Maytham
   Abdullah, Younus Jasim
   Al-lbraheemi, Mohanad Kadhim Mirdan
   Al-Asadi, Atyaf Ali
TI Tamoxifen from chemotherapy to antiviral drug: Possible activity against
   COVID-19
SO BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL
LA English
DT Article
DE Antimicrobial agents; antiviral drugs; chemotherapy; coronavirus;
   COVID-19; tamoxifen
ID KILLER CELL-ACTIVITY; PROTEIN-KINASE-C; ESTROGEN-RECEPTOR; PROSTAGLANDIN
   E-2; BREAST-CANCER; NK ACTIVITY; VIRUS; INHIBITION; BINDING; INFECTION
AB Tamoxifen (TAM) is the oldest and the most-prescribed selective estrogen receptor modulator (SERM). It is a member of the triphenylethylene group. TAM has been used to treat breast cancer that spreads to other parts of the human body; it is also utilized to decreasing the chances of breast cancer developing in high-risk patients. Recently, some studies focused on the potential antimicrobial action of TAM. Coronaviruses are enveloped positive-sense RNA nucleic acid viruses that have club-like spikes, characterized by a distinctive replication strategy; they are round and sometimes pleomorphic in shape. Coronavirus disease 2019 (COVID-19) is regarding the new genera of coronaviredia that appeared for the first time in Wuhan, China, in early December 2019. Due to the continuous spread of the novel COVID-19 with the exponential rise in death numbers, new therapeutic development is urgent; in general, there are no specific antiviral drugs or vaccines for 2019-nCoV. Hence, this review will discuss the most recent information about the antiviral action of TAM against COVID-19 infection by trying to give a deep understanding of major properties, mechanisms of action, immune system responses, and antimicrobial efficiency of TAM that is regarding the promising way to treat COVID-19 novel infection. The current review may serve as an impetus for researchers working in the field of medical microbiology, vaccination, and antiviral drug design. The review also rationally reports and critically analyzes the available knowledge by focusing and mentioning future steps and strategies trying to find appropriate solutions regarding challenges in COVID-19 management by TAM utilization.
C1 [Almosawey, Nude Ali Salman] Ahlulbait Univ, Dept Med Labs, Kerbala, Iraq.
   [AL-Khikani, Falah Hasan Obayes] Al Shomali Gen Hosp, Dept Microbiol, Babil, Iraq.
   [Hameed, Raghdah Maytham; Al-lbraheemi, Mohanad Kadhim Mirdan] Alsader Hosp, Dept Immunol, Najaf, Iraq.
   [Abdullah, Younus Jasim] Southern Tech Univ, Dept Med Labs, Amara Tech Inst, Amara, Iraq.
   [Al-Asadi, Atyaf Ali] Al Haboby Educ Hosp, Thi Qar Hlth Directorate, Thi Qar, Iraq.
RP AL-Khikani, FHO (corresponding author), Al Shomali Gen Hosp, Dept Microbiol, Babil, Iraq.
EM falahgh38@gmail.com
RI Abdullah, Younus/AAV-4307-2020; AL-Khikani, Falah Hasan
   Obayes/AAH-5501-2021; Abdullah, Younus Jasim/D-4010-2019
OI Abdullah, Younus/0000-0001-6929-4914; AL-Khikani, Falah Hasan
   Obayes/0000-0002-8890-7090; Maytham, Raghdah/0000-0001-5038-2367
CR Adav SS, 2016, J PHARM CHEM, V3, P10, DOI DOI 10.14805/JPHCHEM.2016.ART47
   Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Ahmed MI, 2009, INT J SURG, V7, P416, DOI 10.1016/j.ijsu.2009.06.001
   Al-Janabi AAHS, 2019, INT J MED REV, V6, P88, DOI [10.29252/IJMR-060304, DOI 10.29252/IJMR-060304]
   AL-Khikani, 2020, J NAT SCI MED, V3, P225
   AL-Khikani FHO, 2020, BIOMED BIOTECH RES J, V4, P81, DOI 10.4103/bbrj.bbrj_16_20
   AL-Khikani FHO, 2020, BIOMED BIOTECH RES J, V4, P123, DOI 10.4103/bbrj.bbrj_12_20
   AL-Khikani FH, 2019, INT J MED SCI CURREN, V2, P187
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   [Anonymous], 55 WHO
   BANKHURST AD, 1982, J CLIN LAB IMMUNOL, V7, P85
   Baral E, 1996, INT J CANCER, V67, P580
   Baral E, 2000, ANTICANCER RES, V20, P2027
   Barnard Dale L., 2007, Antiviral Chemistry & Chemotherapy, V18, P125
   Bartz H, 2002, CLIN EXP IMMUNOL, V129, P438, DOI 10.1046/j.1365-2249.2002.01927.x
   Bekele RT, 2016, SCI REP-UK, V6, DOI 10.1038/srep21164
   Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123
   Benten WPM, 1998, FEBS LETT, V422, P349, DOI 10.1016/S0014-5793(98)00039-8
   BERRY J, 1987, EUR J CANCER CLIN ON, V23, P517, DOI 10.1016/0277-5379(87)90313-0
   Bishop BM, 2015, ANN PHARMACOTHER, V49, P196, DOI 10.1177/1060028014561227
   Bond JA, 1996, INT J CANCER, V67, P563, DOI 10.1002/(SICI)1097-0215(19960807)67:4<563::AID-IJC16>3.0.CO;2-8
   Bourassa P, 2014, J PHARMACEUT BIOMED, V95, P193, DOI 10.1016/j.jpba.2014.02.028
   Butts A, 2014, MBIO, V5, DOI 10.1128/mBio.00765-13
   Cham LB, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12040142
   Colson P, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105923
   Cong JJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01416
   Crothers KA, 1997, EFFECTS TAMOXIFEN PR
   Daurio NA, 2016, CANCER RES, V76, P3295, DOI 10.1158/0008-5472.CAN-15-2197
   De Clercq E, 2015, BIOCHEM PHARMACOL, V93, P1, DOI 10.1016/j.bcp.2014.11.008
   Doan TL, 2011, ANNU REP MED CHEM, V46, P385, DOI 10.1016/B978-0-12-386009-5.00004-7
   Dolan K, 2009, ANTIMICROB AGENTS CH, V53, P3337, DOI 10.1128/AAC.01564-08
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Eissa MM, 2011, EXP PARASITOL, V128, P382, DOI 10.1016/j.exppara.2011.05.009
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   GULINO A, 1985, J LEUKOCYTE BIOL, V38, P159
   Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001
   Hariri RJ, 2020, INCLUDE NATURAL KILL
   HORGAN K, 1986, BIOCHEM PHARMACOL, V35, P4463, DOI 10.1016/0006-2952(86)90764-1
   Ingvarsson S, 2001, SEMIN CANCER BIOL, V11, P323, DOI 10.1006/scbi.2001.0381
   Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471
   JORDAN VC, 1993, BRIT J PHARMACOL, V110, P507, DOI 10.1111/j.1476-5381.1993.tb13840.x
   Joshi PC, 2001, J IMMUNOL, V166, P885, DOI 10.4049/jimmunol.166.2.885
   Kalinski P, 1997, J IMMUNOL, V159, P28
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   LAURENCE J, 1990, BLOOD, V75, P696
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Maciazek-Jurczyk M, 2013, J MOL STRUCT, V1044, P194, DOI 10.1016/j.molstruc.2012.11.024
   Madrid PB, 2015, ACS INFECT DIS, V1, P317, DOI 10.1021/acsinfecdis.5b00030
   Mailliard RB, 2005, J EXP MED, V202, P941, DOI 10.1084/hem.20050128
   MANDEVILLE R, 1984, EUR J CANCER CLIN ON, V20, P983, DOI 10.1016/0277-5379(84)90174-3
   Manna S, 2016, SIGNAL T INSIG, V5, P65
   Maximov P.Y., 2013, TAMOXIFEN PIONEERING
   Mesange F, 1996, MOL PHARMACOL, V50, P75
   Montoya MC, 2018, MBIO, V9, DOI 10.1128/mBio.02272-18
   Morello KC, 2003, CLIN PHARMACOKINET, V42, P361, DOI 10.2165/00003088-200342040-00004
   Murakami Y, 2013, MICROBES INFECT, V15, P45, DOI 10.1016/j.micinf.2012.10.003
   National Center for Biotechnology Information, PUBCHEM DAT TAM
   National Health Commission of the People's Republic of China, NOT PRINT DISTR DIAG
   Nokta MA, 1996, J CLIN INVEST, V97, P2635, DOI 10.1172/JCI118713
   OBRIAN CA, 1985, CANCER RES, V45, P2462
   Pillaiyar T, 2020, DRUG DISCOV TODAY
   Quirke VM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00620
   Ramani KV, 2017, BREAST CANC MED TREA
   Rana Ritika, 2019, Infectious Disorders - Drug Targets, V19, P224, DOI 10.2174/1871526518666180806123230
   Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004
   Sander WJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00089
   SEAMAN WE, 1978, J IMMUNOL, V121, P2193
   SEAMAN WE, 1979, ARTHRITIS RHEUM, V22, P1234, DOI 10.1002/art.1780221110
   Shagufta, 2018, EUR J MED CHEM, V143, P515, DOI 10.1016/j.ejmech.2017.11.056
   SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321
   Somily AM, 2020, J NAT SCI MED, V32, P65, DOI [10.4103/JNSM.JNSM_22_20, DOI 10.4103/JNSM.JNSM_22_20]
   Steer SA, 2003, J IMMUNOL, V170, P1070, DOI 10.4049/jimmunol.170.2.1070
   Ulitzky L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145212
   Walker JD, 2011, J VIROL, V85, P7363, DOI 10.1128/JVI.00098-11
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   WARD HWC, 1973, BMJ-BRIT MED J, V1, P13, DOI 10.1136/bmj.1.5844.13
   Watashi K, 2007, J BIOL CHEM, V282, P32765, DOI 10.1074/jbc.M704418200
   Whalen K, 2015, PHARMACOLOGY, V26, P351
   WHO, 2019, MODEL LIST ESSENTIAL
   Yasri S, 2020, ASIAN PAC J TROP MED, V13, P137, DOI 10.4103/1995-7645.277815
   Yu F, 2020, MICROBES INFECT, V22, P74, DOI 10.1016/j.micinf.2020.01.003
   Zheng K, 2014, BIOCHEM BIOPH RES CO, V446, P990, DOI 10.1016/j.bbrc.2014.03.050
   Zumla A, 2015, INT J INFECT DIS, V40, P71, DOI 10.1016/j.ijid.2015.09.005
NR 83
TC 5
Z9 5
U1 1
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 2588-9834
EI 2588-9842
J9 BIOMED BIOTECH RES J
JI Biomed. Biotech. Res. J.
PD APR-JUN
PY 2020
VL 4
IS 2
BP 108
EP 116
DI 10.4103/bbrj.bbrj_53_20
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA RQ2QJ
UT WOS:000642264500004
DA 2022-04-20
ER

PT J
AU Jones, L
   Walsh, K
   Willcox, M
   Morgan, P
   Nichols, J
AF Jones, Lyndon
   Walsh, Karen
   Willcox, Mark
   Morgan, Philip
   Nichols, Jason
TI The COVID-19 pandemic: Important considerations for contact lens
   practitioners
SO CONTACT LENS & ANTERIOR EYE
LA English
DT Article
DE COVID-19; contact lens; lens care; lens wear
ID RISK-FACTORS; MICROBIAL KERATITIS; BACTERIAL ADHESION; DAILY-WEAR;
   CORONAVIRUS; HYDROGEL; VIRUS; DISINFECTION; ACANTHAMOEBA; EFFICACY
AB A novel coronavirus (CoV), the Severe Acute Respiratory Syndrome Coronavirus - 2 (SARS-CoV-2), results in the coronavirus disease 2019 (COVID-19). As information concerning the COVID-19 disease continues to evolve, patients look to their eye care practitioners for accurate eye health guidance. There is currently no evidence to suggest an increased risk of contracting COVID-19 through contact lens (CL) wear compared to spectacle lens wear and no scientific evidence that wearing standard prescription spectacles provides protection against COVID-19 or other viral transmissions.
   During the pandemic there will potentially be significant changes in access to local eyecare. Thus, it is imperative CL wearers are reminded of the steps they should follow to minimise their risk of complications, to reduce their need to leave isolation and seek care. Management of adverse events should be retained within optometric systems if possible, to minimise the impact on the wider healthcare service, which will be stretched. Optimal CL care behaviours should be the same as those under normal circumstances, which include appropriate hand washing (thoroughly with soap and water) and drying (with paper towels) before both CL application and removal. Daily CL cleaning and correct case care for reusable CL should be followed according to appropriate guidelines, and CL exposure to water must be avoided. Where the availability of local clinical care is restricted, practitioners could consider advising patients to reduce or eliminate sleeping in their CL (where patients have the appropriate knowledge about correct daily care and access to suitable lens-care products) or consider the option of moving patients to daily disposable lenses (where patients have appropriate lens supplies available). Patients should also avoid touching their face, including their eyes, nose and mouth, with unwashed hands and avoid CL wear altogether if unwell (particularly with any cold or flu-like symptoms).
C1 [Jones, Lyndon] Univ Waterloo, Ctr Ocular Res & Educ CORE, Sch Optometry & Vis Sci, Waterloo, ON, Canada.
   [Walsh, Karen] Univ Waterloo, Ctr Ocular Res & Educ CORE, Waterloo, ON, Canada.
   [Willcox, Mark] UNSW, Sch Optometry & Vis Sci, Sydney, NSW, Australia.
   [Morgan, Philip] Univ Manchester, Manchester, Lancs, England.
   [Nichols, Jason] Univ Alabama Birmingham, Birmingham, AL USA.
RP Jones, L (corresponding author), Univ Waterloo, Ctr Ocular Res & Educ CORE, Sch Optometry & Vis Sci, Waterloo, ON, Canada.
EM lwjones@uwaterloo.ca; karen.walsh@uwaterloo.ca; m.willcox@unsw.edu.au;
   philip.morgan@manchester.ac.uk; jjn@uab.edu
RI Jones, Lyndon/AAH-9472-2021; Nichols, Jason J/AAK-9373-2021
OI Jones, Lyndon/0000-0002-7409-7349; Nichols, Jason J/0000-0003-1519-7734
CR Abbey AM, 2014, CORNEA, V33, P610, DOI 10.1097/ICO.0000000000000117
   ABLASHI D V, 1987, Journal of Experimental Pathology (New York), V3, P693
   Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   America Academy of Ophthalmology, 2020, AL IMP COR UPD OPHTH
   AMIN RM, 1991, AIDS RES HUM RETROV, V7, P403, DOI 10.1089/aid.1991.7.403
   [Anonymous], 2020, EXPERTS NOT RECOMMEN
   Armanious A, 2016, ENVIRON SCI TECHNOL, V50, P732, DOI 10.1021/acs.est.5b04644
   Arshad M, 2019, CORNEA, V38, P791, DOI 10.1097/ICO.0000000000001898
   Azari AA, 2013, JAMA-J AM MED ASSOC, V310, P1721, DOI 10.1001/jama.2013.280318
   Bonn D, 2004, LANCET INFECT DIS, V4, P480, DOI 10.1016/S1473-3099(04)01093-X
   BRANDT BM, 1994, ANN OPHTHALMOL, V26, P12
   Carnt N, 2018, BRIT J OPHTHALMOL, V102, P1621, DOI 10.1136/bjophthalmol-2018-312544
   Centers for Disease Control and prevention, 2020, INT INF PREV CONTR R
   Centers for Disease Control and Prevention, 2019, HIV SURVEILLANCE SUP
   Centers for Disease Control and Prevention, 2020, HIV TRANSM
   Centers for Disease Control and Prevention, 2020, INF CDCS DIV HIV AID
   Chalmers RL, 2015, INVEST OPHTH VIS SCI, V56, P654, DOI 10.1167/iovs.14-15582
   Chalmers RL, 2012, OPTOMETRY VISION SCI, V89, P316, DOI 10.1097/OPX.0b013e318240c7ff
   Chalmers RL, 2011, INVEST OPHTH VIS SCI, V52, P6690, DOI 10.1167/iovs.10-7018
   Chalmers RL, 2010, OPTOMETRY VISION SCI, V87, P725, DOI 10.1097/OPX.0b013e3181f31f68
   Chan K, 2011, ADV OPTOELECTRON, V2011, DOI [10.1155/2011/734690, 10.1155/2011/196707]
   Chan WM, 2004, BRIT J OPHTHALMOL, V88, P968, DOI 10.1136/bjo.2003.039461
   Chen Y, 2020, BIOCHEM BIOPH RES CO, V525, P135, DOI 10.1016/j.bbrc.2020.02.071
   Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4
   Cohen F, 2000, ARCH OPHTHALMOL-CHIC, V118, P1617
   Creager HM, 2018, J VIROL, V92, DOI 10.1128/JVI.02192-17
   Dantam J, 2020, BIOFOULING, V36, P32, DOI 10.1080/08927014.2019.1710832
   Dart JKG, 2008, OPHTHALMOLOGY, V115, P1647, DOI 10.1016/j.ophtha.2008.05.003
   Devroey D, 2002, SCAND J PRIM HEALTH, V20, P242, DOI 10.1080/028134302321004917
   Diaz JH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa041
   Doyle TJ, 2010, INFECT DIS REP, V2, P52, DOI 10.4081/idr.2010.e17
   Dutta D, 2012, MOL VIS, V18, P14
   Feldman J., 2020, DITCHING CONTACTS GL
   Flanagan JL, 2009, BIOCHIMIE, V91, P35, DOI 10.1016/j.biochi.2008.07.007
   Fonn D, 2019, CONTACT LENS ANTERIO, V42, P132, DOI 10.1016/j.clae.2018.10.022
   Garcia-Zalisnak D, 2018, EYE CONTACT LENS, V44, pS1, DOI 10.1097/ICL.0000000000000226
   General Optical Council, 2020, JOINT STAT ADV EYE C
   Gielen AC, 2015, ANNU REV PUBL HEALTH, V36, P231, DOI 10.1146/annurev-publhealth-031914-122722
   Gottsch J D, 1999, Ophthalmic Epidemiol, V6, P29
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Habibzadeh P, 2020, INT J OCCUP ENV MED, V11, P65, DOI 10.15171/ijoem.2020.1921
   Hamroush A, 2014, CONTACT LENS ANTERIO, V37, P228, DOI 10.1016/j.clae.2013.11.007
   Heaselgrave W, 2010, EYE CONTACT LENS, V36, P90, DOI 10.1097/ICL.0b013e3181d13c2d
   Holappa M, 2017, OPEN OPHTHALMOL J, V11, P122, DOI 10.2174/1874364101711010122
   Ikonen N, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3150-5
   Jhanji V, 2015, SURV OPHTHALMOL, V60, P435, DOI 10.1016/j.survophthal.2015.04.001
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Khatri U., 2020, ITS PANDEMIC
   Kowalski RP, 2001, AM J OPHTHALMOL, V132, P777, DOI 10.1016/S0002-9394(01)01128-X
   Kuc CJ, 2018, EYE CONTACT LENS, V44, P355, DOI 10.1097/ICL.0000000000000458
   Kwok YLA, 2015, AM J INFECT CONTROL, V43, P112, DOI 10.1016/j.ajic.2014.10.015
   Lam DSC, 2002, EYE, V16, P608, DOI 10.1038/sj.eye.6700151
   Lazzaro DR, 2009, EYE CONTACT LENS, V35, P329, DOI 10.1097/ICL.0b013e3181c1060a
   Lee GH, 2016, CORNEA, V35, P663, DOI 10.1097/ICO.0000000000000788
   Lee R, 2016, OPHTHAL EPIDEMIOL, V23, P257, DOI 10.3109/09286586.2016.1172648
   Loon SC, 2004, BRIT J OPHTHALMOL, V88, P861, DOI 10.1136/bjo.2003.035931
   Lu J., 2020, NATL SCI REV
   Macias AE, 2009, J HOSP INFECT, V73, P280, DOI 10.1016/j.jhin.2009.06.017
   Malaczewska J, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2067-6
   Mann A, 2013, EXP EYE RES, V117, P88, DOI 10.1016/j.exer.2013.07.013
   Marinos E, 2019, CONTACT LENS ANTERIO, V42, P679, DOI 10.1016/j.clae.2019.07.001
   Miller G., 2020, RES ARE TRACKING PAN
   Morgan PB, 2005, INVEST OPHTH VIS SCI, V46, P3136, DOI 10.1167/iovs.05-0133
   Morgan PB, 2005, BRIT J OPHTHALMOL, V89, P430, DOI 10.1136/bjo.2004.052688
   Mucci JJ, 2009, EYE CONTACT LENS, V35, P185, DOI 10.1097/ICL.0b013e3181a9d788
   Mueller A J, 1993, Ger J Ophthalmol, V2, P224
   Muller MP, 2018, AM J INFECT CONTROL, V46, P581, DOI 10.1016/j.ajic.2017.11.011
   NORDBO SA, 1986, EUR J CLIN MICROBIOL, V5, P678, DOI 10.1007/BF02013302
   Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227
   OYong K, 2018, MMWR-MORBID MORTAL W, V67, P1347, DOI 10.15585/mmwr.mm6748a4
   Peng L, 2020, J MED VIROL, V92, P1676, DOI 10.1002/jmv.25936
   PEPOSE J S, 1988, CLAO Journal, V14, P165
   Perico L, 2021, NAT REV NEPHROL, V17, P46, DOI 10.1038/s41581-020-00357-4
   Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4
   Radford CF, 2009, OPHTHALMOLOGY, V116, P385, DOI 10.1016/j.ophtha.2008.09.053
   Ramchandani M, 2016, SEX TRANSM DIS, V43, P756, DOI 10.1097/OLQ.0000000000000522
   Randag AC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222092
   ROHRER MD, 1986, AM J OPHTHALMOL, V101, P49, DOI 10.1016/0002-9394(86)90464-2
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Sammons JS, 2019, OPHTHALMOLOGY, V126, P137, DOI 10.1016/j.ophtha.2018.07.008
   Sankaridurg P., 2004, SILICONE HYDROGELS C, P217
   SCHEIN OD, 1989, NEW ENGL J MED, V321, P773, DOI 10.1056/NEJM198909213211201
   Schein OD, 2005, OPHTHALMOLOGY, V112, P2172, DOI 10.1016/j.ophtha.2005.09.014
   Seah I, 2020, OCUL IMMUNOL INFLAMM, V28, P391, DOI 10.1080/09273948.2020.1738501
   Seah I, 2020, EYE, V34, P1155, DOI 10.1038/s41433-020-0790-7
   Seah IYJ, 2020, OPHTHALMOLOGY, V127, P977, DOI 10.1016/j.ophtha.2020.03.026
   Sharma A, 2010, MOL VIS, V16, P720
   Simmons PA, 1998, OPTOMETRY VISION SCI, V75, P860, DOI 10.1097/00006324-199812000-00007
   Smith VJ, 2015, MOL IMMUNOL, V68, P383, DOI 10.1016/j.molimm.2015.08.009
   Stapleton F, 2008, OPHTHALMOLOGY, V115, P1655, DOI 10.1016/j.ophtha.2008.04.002
   Stapleton F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181343
   Stapleton F, 2013, EYE CONTACT LENS, V39, P79, DOI 10.1097/ICL.0b013e3182713919
   Stapleton F, 2012, OPHTHALMOLOGY, V119, P1516, DOI 10.1016/j.ophtha.2012.01.052
   Steele KR, 2017, CLIN EXP OPTOM, V100, P473, DOI 10.1111/cxo.12598
   Subbaraman LN, 2011, OPTOMETRY VISION SCI, V88, P959, DOI 10.1097/OPX.0b013e31821ffccb
   Sun CB, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00155
   Sweeney D, 2004, SILICONE HYDROGELS C, P164
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Teichroeb JH, 2008, OPTOMETRY VISION SCI, V85, P1151, DOI 10.1097/OPX.0b013e31818e8ad6
   TERVO T, 1986, LANCET, V1, P379
   Tighe BJ, 2013, EYE CONTACT LENS, V39, P4, DOI 10.1097/ICL.0b013e318275452b
   Ucakhan O, 2016, EYE CONTACT LENS, V42, P388, DOI 10.1097/ICL.0000000000000206
   van Doremalen N, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.38.20590
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Warnes SL, 2015, MBIO, V6, DOI 10.1128/mBio.01697-15
   Weiss S., 2020, DOES WEARING GLASSES
   White AJR, 2015, J RENIN-ANGIO-ALDO S, V16, P59, DOI 10.1177/1470320314549791
   WHO, 2021, STAT 2 M INT HLTH RE
   Willcox M., 2004, SILICONE HYDROGELS C, P90
   Willcox MDP, 2013, EYE CONTACT LENS, V39, P61, DOI 10.1097/ICL.0b013e318275e284
   World Health Organization, 2020, RAT US PERS PROT EQ
   Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008
   Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]
   Xia Y, 2020, J MED VIROL, V92, P3736, DOI 10.1002/jmv.25667
   Zeri F., 2020, CONT LENS ANTERIOR E
NR 115
TC 39
Z9 39
U1 5
U2 16
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1367-0484
EI 1476-5411
J9 CONTACT LENS ANTERIO
JI Contact Lens Anterior Eye
PD JUN
PY 2020
VL 43
IS 3
BP 196
EP 203
DI 10.1016/j.clae.2020.03.012
PG 8
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA LS7RB
UT WOS:000536577600002
PM 32273245
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Emrani, J
   Hefner, EN
AF Emrani, Jahangir
   Hefner, Elia Nichelle
TI Socio-demographic Heterogeneity in Prevalence of SARS-COV-2 Infection
   and Death Rate: Relevance to Black College Student Knowledge of COVID-19
   and SARS-COV-2
SO JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES
LA English
DT Article; Early Access
DE BIPOC (Black, Indigenous, People of Color); African Americans;
   Education; Socioeconomic status; Infection, transmission; College
   student knowledge; COVID-19; STEM; Racial/ethnic; Health disparities;
   Pandemic; Disproportionate infectivity and mortality
ID STATES
AB Black and Brown communities are affected disproportionately by COVID-19. In an attempt to learn if young Black college students unknowingly contribute to the spread of the COVID-19 in their communities, using surveys, this pilot study gauges the general safety knowledge and basic scientific knowledge of Black college students about SARS-COV-2 virus and COVID-19 at an HBCU. We also investigated whether students enrolled in chemistry courses designed for STEM (Science, Technology, and Engineering Majors) majors displayed increased knowledge of SARS-COV-2 and COVID-19 in comparison to their non-STEM major peers. Two sets of surveys with multiple choice questions, one with 25 and the other with 34 questions, were designed to assess general safety knowledge and basic scientific knowledge of the students about COVID-19 and the SARS-COV-2 virus. Survey questions were administered through Blackboard learning management system to one hundred eighty-seven (187) students in the summer of 2020 to two freshman non-science majors and in the fall of 2020 to one freshman non-science-major class, two freshmen STEM-major classes, and one senior STEM-major class. All students self-registered in the 6 chemistry classes at North Carolina A&T State University at random with no predetermined criteria. Results of the study show that regardless of their year of study, majority (> 90%) of the students possess basic scientific knowledge and are aware of the safety precautions concerning SARS-COV-2 virus and COVID-19. Majority of non-science major freshmen answered the basic safety questions correctly but were not able to choose the correct answers for the more specific scientific questions concerning SARS-COV-2 and COVID-19. Surprisingly, there was no significant difference in basic scientific knowledge regarding SARS-COV-2 and COVID-19 between STEM and non-STEM student populations, and first year STEM students were just as knowledgeable as senior STEM students. Based on these data, we speculate that students surveyed here have an acceptable basic understanding of how SARS-CoV-2 is transmitted, and therefore, they may not be a source of COVID-19 transmission to Black and Brown communities as this study confirms they are receiving accurate information about SARS-COV-2 and COVID-19. Possession of crucial timely and accurate knowledge about the health and safety is important in fighting racism and to gain equity within the society at large. By sharing the acquired knowledge, students can serve as positive role models for others in the community thus encouraging them to pursue science. Education brings equity, sharing the acquired knowledge encourages others to continue their education and succeed in obtaining higher degrees and better jobs as remedies for social inequality. Spread of accurate knowledge on various aspects of COVID-19 will also help remove fears of vaccination and hesitation towards visits to health clinics to resolve health issues. Relying on the results of this pilot study, we plan to explore these important factors further in our next study.
C1 [Emrani, Jahangir; Hefner, Elia Nichelle] North Carolina A&T State Univ, Dept Chem, Greensboro, NC 27410 USA.
RP Emrani, J (corresponding author), North Carolina A&T State Univ, Dept Chem, Greensboro, NC 27410 USA.
EM emrani@ncat.edu; enhefner@ncat.edu
CR Acemoglu D., 2020, 27102 NBER, P27102, DOI 10.3386/w27102
   Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Alcendor DJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082442
   Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007
   AminJafari A, 2020, INT IMMUNOPHARMACOL, V83, DOI 10.1016/j.intimp.2020.106455
   Attia ZI, 2019, NAT MED, V25, P70, DOI 10.1038/s41591-018-0240-2
   Bhattacharyya U, 2020, J GENET, V99, DOI 10.1007/s12041-020-01233-7
   Boehmer TK, 2020, MMWR-MORBID MORTAL W, V69, P1404, DOI 10.15585/mmwr.mm6939e1
   Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5
   Chaouch M, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2215
   Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849
   Cheng KJG, 2020, J RURAL HEALTH, V36, P602, DOI 10.1111/jrh.12511
   Chowdhury R, 2020, COMPUT STRUCT BIOTEC, V18, P2573, DOI 10.1016/j.csbj.2020.09.019
   Manchanda ECC, 2021, J RACIAL ETHN HEALTH, V8, P824, DOI 10.1007/s40615-020-00840-5
   Cohen AK, 2020, J ADOLESCENT HEALTH, V67, P369, DOI 10.1016/j.jadohealth.2020.06.009
   Cowger TL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16933
   Cross R., 2021, C EN GLOB ENTERP, V99, P38, DOI [10.1021/cen-09903-feature3, DOI 10.1021/CEN-09903-FEATURE3]
   Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489
   Ding YN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237626
   Dong YT, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00352-y
   Eastman RT, 2020, ACS CENTRAL SCI, V6, P672, DOI 10.1021/acscentsci.0c00489
   Emrani J, 2020, J CHEM EDUC, V97, P1931, DOI 10.1021/acs.jchemed.9b01154
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Garcia MA, 2021, J GERONTOL B-PSYCHOL, V76, pE75, DOI 10.1093/geronb/gbaa114
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Gunther S, 2021, SCIENCE, V372, P642, DOI 10.1126/science.abf7945
   Halford B., 2020, C EN GLOB ENTERP, V98, P11, DOI [10.1021/cen-09814-buscon3, DOI 10.1021/CEN-09814-BUSCON3]
   Holmes L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124322
   Howes L, 2021, CHEM ENG NEWS, V99, P18
   Jarvis LM, 2020, CHEM ENG NEWS, V98, P23
   Jiang SB, 2020, CELL MOL IMMUNOL, V17, P554, DOI 10.1038/s41423-020-0372-4
   Kolilekas L, 2020, J MED VIROL, V92, P2866, DOI 10.1002/jmv.26165
   Kullar R, 2020, J INFECT DIS, V222, P890, DOI 10.1093/infdis/jiaa372
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lam Cabanillas E, 2021, REV FM HUMANA, V21, P22
   Laurini E, 2020, ACS NANO, V14, P11821, DOI 10.1021/acsnano.0c04674
   Li YF, 2020, J MED VIROL, V92, P903, DOI 10.1002/jmv.25786
   Liu T, 2020, INT J INFECT DIS, V99, P374, DOI 10.1016/j.ijid.2020.07.073
   Livingston Edward H, 2021, JAMA, V325, P1575, DOI 10.1001/jama.2021.2927
   Lu RF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082826
   McCoy M., 2020, C EN GLOB ENTERP, V98, P13, DOI [10.1021/cen-09815-buscon17, DOI 10.1021/CEN-09815-BUSCON17]
   Muhammed Y., 2020, INT J SCI GLOBAL SUS, V6, P9
   Muus, 2020, INTEGRATED ANAL SING, DOI [10.1101/2020.04.19.049254, DOI 10.1101/2020.04.19.049254]
   O'Dowd K, 2020, MATERIALS, V13, DOI 10.3390/ma13153363
   Ortuso F, 2021, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2021.1886175
   Romano M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051267
   Stockard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020508118
   To Kelvin Kai-Wang, 2021, Clin Infect Dis, V73, pe2946, DOI 10.1093/cid/ciaa1275
   Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728
   Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]
   Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560
   Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954
   Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037
   Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035
NR 56
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER INT PUBL AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2197-3792
EI 2196-8837
J9 J RACIAL ETHN HEALTH
JI J. Racial Ethn. Health Disparities
DI 10.1007/s40615-021-01193-3
EA FEB 2022
PG 18
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA YT2ZL
UT WOS:000751233600001
PM 35119679
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Richter, I
   Avillanosa, A
   Cheung, V
   Goh, HC
   Johari, S
   Kay, S
   Maharja, C
   Nguyen, TH
   Pahl, S
   Sugardjito, J
   Sumeldan, J
   Nguyen, QV
   Vu, HT
   Ariffin, WNSWM
   Austen, MC
AF Richter, Isabell
   Avillanosa, Arlene
   Cheung, Victoria
   Goh, Hong Ching
   Johari, Sofia
   Kay, Susan
   Maharja, Carya
   Thu Ha Nguyen
   Pahl, Sabine
   Sugardjito, Jito
   Sumeldan, Joel
   Quyen van Nguyen
   Hien Thuc Vu
   Ariffin, Wan Nur Syazana Wan Mohamad
   Austen, Melanie C.
TI Looking Through the COVID-19 Window of Opportunity: Future Scenarios
   Arising From the COVID-19 Pandemic Across Five Case Study Sites
SO FRONTIERS IN PSYCHOLOGY
LA English
DT Article
DE scenarios; window of opportunity; COVID-19; sustainable development;
   Southeast Asia; coastal communities
ID HABIT DISCONTINUITY; PERSPECTIVE; POLICY; TIME; TOOL
AB The COVID-19 pandemic has caused (and continues to cause) severe disruption in global and local economies and has forced countries, societies, and individuals to adapt quickly to the unprecedented and unpredictable situations. Despite the obvious negative consequences of the pandemic, many have called for efforts to identify transformative opportunities for sustainable development throughout this disorderly time. In the present paper, we explore such potential opportunities in the context of an interdisciplinary, international research project, which is focusing on sustainable marine management in biosphere reserves and marine parks in Southeast Asia. During a virtual workshop conducted as part of the GCRF (Government's Global Challenges Research Fund) Blue Communities Project, future scenarios were developed depicting the potential effects of the COVID-19 pandemic on five case study sites. All of these sites are in areas of internationally recognized outstanding ecological value (Taka Bonerate Kepulauan-Selayar Biosphere Reserve, Indonesia; Tun Mustapha Park, Sabah, Malaysia; Palawan Biosphere Reserve, Philippines; North Devon Biosphere Reserve, United Kingdom; Cu Lao Cham-Hoi An Biosphere Reserve, Vietnam). At the macro-level, economies, governance structures, and societal norms are undergoing big changes. At the micro-level, the livelihoods, lifestyles, and backyards of local residents have to adapt. Collaboratively, we explored how COVID-19 posed challenges in our five case study sites, but we also focused on the potential COVID-19-related windows of opportunity for future sustainable development. Opportunities could be identified in all three pillars of sustainable development: the environment, the society, and the economy. Although remarkable similarities can be found across all five sites, we conclude that there cannot be a "one-size-fits-all" solution to turn the tide toward achieving sustainable development. Just as before the pandemic, sustainable development starts with engaging with and understanding local environments, challenges, and situations; building on local knowledge; and developing tailor-made solutions for the communities in situ.
C1 [Richter, Isabell] Univ Plymouth, Sch Psychol, Plymouth, Devon, England.
   [Richter, Isabell] Norwegian Univ Sci & Technol, Psykol Inst, Trondheim, Norway.
   [Avillanosa, Arlene; Sumeldan, Joel] Western Philippines Univ, Coll Fisheries & Aquat Sci, Puerto Princesa Campus, Puerto Princesa, Philippines.
   [Cheung, Victoria; Austen, Melanie C.] Univ Plymouth, Sch Biol & Marine Sci, Plymouth, Devon, England.
   [Goh, Hong Ching; Johari, Sofia; Ariffin, Wan Nur Syazana Wan Mohamad] Univ Malaya, Fac Built Environm, Dept Urban & Reg Planning, Kuala Lumpur, Malaysia.
   [Kay, Susan] Plymouth Marine Lab, Plymouth, Devon, England.
   [Maharja, Carya; Sugardjito, Jito] Univ Nasional, Ctr Sustainable Energy & Resources Management, Jakarta, Indonesia.
   [Thu Ha Nguyen] Hanoi Natl Univ Educ, Fac Social Work, Hanoi, Vietnam.
   [Pahl, Sabine] Univ Vienna, Urban & Environm Psychol Grp, Vienna, Austria.
   [Quyen van Nguyen] Hanoi Natl Univ Educ, Fac Biol, Hanoi, Vietnam.
   [Hien Thuc Vu] Vietnam Natl Commiss UNESCO, Vietnam Man & Biosphere Program Natl Comm, Hanoi, Vietnam.
RP Richter, I (corresponding author), Univ Plymouth, Sch Psychol, Plymouth, Devon, England.; Richter, I (corresponding author), Norwegian Univ Sci & Technol, Psykol Inst, Trondheim, Norway.
EM isabel.richter@ntnu.no
RI GOH, HONG CHING/B-8546-2010; Pahl, Sabine/AAT-1829-2021; Nguyen Van,
   Quyen/J-7130-2015
OI GOH, HONG CHING/0000-0002-9250-2205; Maharja, Carya/0000-0001-9581-8283;
   Richter, Isabel/0000-0003-1196-2769; Nguyen Van,
   Quyen/0000-0003-4843-9402; Kay, Susan/0000-0003-1510-8578; Pahl,
   Sabine/0000-0002-3799-6716
FU GCRF via the United Kingdom Research and Innovation (UKRI)
   [NE/P021107/1]
FX This work has received funding in part from the GCRF via the United
   Kingdom Research and Innovation (UKRI) under grant agreement reference
   NE/P021107/1 to the Blue Communities Project.
CR Arnocky S, 2014, ENVIRON BEHAV, V46, P556, DOI 10.1177/0013916512474987
   Basu B, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102597
   Birkmann J, 2010, NAT HAZARDS, V55, P637, DOI 10.1007/s11069-008-9319-2
   Blundell R, 2020, FISC STUD, V41, P291, DOI 10.1111/1475-5890.12232
   Boyko CT, 2012, GLOBAL ENVIRON CHANG, V22, P245, DOI 10.1016/j.gloenvcha.2011.10.004
   Bratman GN, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0903
   Brem A, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120451
   Burch S, 2010, ENERG POLICY, V38, P7575, DOI 10.1016/j.enpol.2009.06.070
   Chaudhury M, 2013, REG ENVIRON CHANGE, V13, P389, DOI 10.1007/s10113-012-0350-1
   Conway D, 2010, TOUR HOSP RES, V10, P329, DOI 10.1057/thr.2010.12
   de Haas Mathijs, 2020, Transp Res Interdiscip Perspect, V6, P100150, DOI 10.1016/j.trip.2020.100150
   De R, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102171
   Dong HX, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00751
   Dwivedi YK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102211
   Eckstein D, 2019, GLOBAL CLIMATE RISK
   Edward JKP, 2021, MAR POLLUT BULL, V165, DOI 10.1016/j.marpolbul.2021.112124
   Enfors EI, 2008, ECOL SOC, V13
   Erokhin V, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165775
   Evans S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.588667
   Fan SG, 2021, GLOB FOOD SECUR-AGR, V28, DOI 10.1016/j.gfs.2021.100501
   Fotiadis A, 2021, ANN TOURISM RES, V87, DOI 10.1016/j.annals.2020.103117
   Gabbiadini A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.554678
   Gardner G. T., 1996, ENV PROBLEMS HUMAN B
   Groarke JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239698
   Guan DB, 2020, NAT HUM BEHAV, V4, P577, DOI 10.1038/s41562-020-0896-8
   Haines-Young R., 2014, UK NATL ECOSYSTEM AS
   Hulse DW, 2004, ECOL APPL, V14, P325, DOI 10.1890/02-5260
   Ibn-Mohammed T, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105169
   Imtyaz Ayman, 2020, J Oral Biol Craniofac Res, V10, P504, DOI 10.1016/j.jobcr.2020.08.005
   Johnson KA, 2012, ECOL SOC, V17, DOI 10.5751/ES-04780-170209
   Kok K, 2007, ECOL SOC, V12
   Kok K, 2011, TECHNOL FORECAST SOC, V78, P835, DOI 10.1016/j.techfore.2011.01.004
   Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI DOI 10.1080/13504620220145401
   Kuss DJ, 2014, CURR PHARM DESIGN, V20, P4026, DOI 10.2174/13816128113199990617
   Lambert H, 2020, LANCET PLANET HEALTH, V4, pE312, DOI 10.1016/S2542-5196(20)30168-6
   Lead C., 2010, UK NEA SCENARIOS DEV
   Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299
   Martin L, 2020, J ENVIRON PSYCHOL, V68, DOI 10.1016/j.jenvp.2020.101389
   Moser SC, 2011, OXFORD HDB CLIMATE C, P161, DOI DOI 10.1093/OXFORDHB/9780199566600.003.0011
   Muhammad S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138820
   Nicholson-Cole S. A., 2005, Computers, Environment and Urban Systems, V29, P255, DOI 10.1016/j.compenvurbsys.2004.05.002
   Nygren NA, 2019, FUTURES, V107, P29, DOI 10.1016/j.futures.2018.10.004
   OECD, 2021, EC OUTL SO AS CHIN I EC OUTL SO AS CHIN I
   OECD, 2020, BUILDING BACK BETTER
   Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS)
   Pahl S, 2014, WIRES CLIM CHANGE, V5, P375, DOI 10.1002/wcc.272
   Pahl S, 2013, ENVIRON BEHAV, V45, P155, DOI 10.1177/0013916511417618
   Pan KY, 2021, LANCET PSYCHIAT, V8, P121, DOI 10.1016/S2215-0366(20)30491-0
   Pomeroy RS, 2008, MAR POLICY, V32, P55, DOI 10.1016/j.marpol.2007.04.006
   Pouso S, 2021, SCI TOTAL ENVIRON, V756, DOI 10.1016/j.scitotenv.2020.143984
   Reed MS, 2013, J ENVIRON MANAGE, V128, P345, DOI 10.1016/j.jenvman.2013.05.016
   Richter I., 2021, FRONT COMMUN, V5, DOI [10.3389/fcomm.2020.562828, DOI 10.3389/FCOMM.2020.562828]
   Schafer M, 2012, J CONSUM POLICY, V35, P65, DOI 10.1007/s10603-011-9181-6
   Schmidt K., 2021, TRANSP RES INTERDISC, V10, DOI [10.1016/j.trip.2021.100374, DOI 10.1016/J.TRIP.2021.100374]
   Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201
   Sharma N., 2020, TORN SAFETY NETS COV
   Sheppard S.R., 2008, PLAN CANADA, V48, P36
   Sheppard SRJ, 2011, FUTURES, V43, P400, DOI 10.1016/j.futures.2011.01.009
   Shih WC, 2020, HARVARD BUS REV, V98, P82
   Silva ALP, 2021, CHEM ENG J, V405, DOI 10.1016/j.cej.2020.126683
   Terry C, 2021, BIOL CONSERV, V256, DOI 10.1016/j.biocon.2021.109039
   Thogersen J, 2012, HABITS CONSUMPTION, P130
   Thomas GO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153490
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   United Nations Development Programme [UNDP], 2020, WOM FAC INCR WORKL S WOM FAC INCR WORKL S
   van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X
   Verplanken B, 2008, J ENVIRON PSYCHOL, V28, P121, DOI 10.1016/j.jenvp.2007.10.005
   Verplanken B, 2016, J ENVIRON PSYCHOL, V45, P127, DOI 10.1016/j.jenvp.2015.11.008
   Wassler P, 2021, TOUR MANAG PERSPECT, V38, DOI 10.1016/j.tmp.2021.100818
   White MP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44097-3
   Wong, 2021, PARKS, V27, P135, DOI DOI 10.2305/IUCN.CH.2021.PARKS-27-SIRGK.EN
   Wood W, 2005, J PERS SOC PSYCHOL, V88, P918, DOI 10.1037/0022-3514.88.6.918
   World Health Organization (WHO), 2020, COVID 19 STRAT UPD
NR 73
TC 2
Z9 2
U1 5
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-1078
J9 FRONT PSYCHOL
JI Front. Psychol.
PD JUL 7
PY 2021
VL 12
AR 635686
DI 10.3389/fpsyg.2021.635686
PG 12
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA TL6EE
UT WOS:000674951500001
PM 34305710
OA Green Accepted, Green Submitted, gold, Green Published
DA 2022-04-20
ER

PT J
AU Muhsen, WS
   Marshall-Roberts, R
AF Muhsen, Wisam S.
   Marshall-Roberts, Rachel
TI Simulation-guided preparations for the management of suspected or
   confirmed COVID-19 cases in the obstetric emergency theater
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Clinical simulation; suspected or confirmed COVID-19 cases; neonatal
   resuscitation; obstetric emergency
AB Aims: The coronavirus 2019 infection (COVID-19) global outbreak has resulted in unprecedented pressures on health services, the need to prepare for the worst-case scenario, and the need for health experts to utilize their knowledge and expertise to fight this virus. The simulation training objective of this study was to enhance the neonatal, maternity, and anesthetics teams' preparedness for the management of the emergency delivery of pregnant women with suspected or confirmed COVID-19 infection. Methods: Three clinical simulation training sessions were conducted in March 2020 at the University Hospital Plymouth, Plymouth, UK. The neonatal, maternity, and anesthetics clinical teams participated in these joint training sessions in the obstetric emergency theater. Results: Each session lasted for around an hour. Suggestions were discussed and recommendations made. The key changes were: first, floor plan adjustment, increase of the clinical area by converting some offices to clinical spaces, and standard operating procedures for transporting patients; second, enhancement of the efficiency of the communication and coordination between the clinical teams; third, availability of extra support for the staff in the Central Delivery Suite (CDS); and fourth, introduction of a neonatal care pathway to manage neonatal resuscitation in such an emergency. Conclusions: Collaboration and joint training between the different clinical teams involved in the care of suspected or confirmed COVID-19 patients was proven to be one of the most effective ways of improving performance.
C1 [Muhsen, Wisam S.] Univ Hosp Plymouth NHS Trust, Dept Neonatal Med, Neonatal Intens Care Unit, Plymouth, Devon, England.
   [Muhsen, Wisam S.] Univ Plymouth, Fac Med & Dent, Plymouth, Devon, England.
   [Marshall-Roberts, Rachel] Univ Hosp Plymouth NHS Trust, Dept Obstet & Gynaecol, Plymouth, Devon, England.
RP Muhsen, WS (corresponding author), Univ Hosp Plymouth NHS Trust, Dept Neonatal Med, Neonatal Intens Care Unit, Plymouth, Devon, England.
EM wsalih2001@gmail.com
CR Capalbo F, 2021, J MANAG GOV, V25, P707, DOI 10.1007/s10997-020-09523-z
   Davis M, 2017, TEACH USING SIMULATI
   Krishnan DG, 2017, EDUCATION, V5, P7
   Lame G, 2020, BMJ SIMUL TECHNOL EN, V6, P87, DOI 10.1136/bmjstel-2018-000370
   Mirzaei M, 2021, J BIOMOL STRUCT DYN, V39, P6424, DOI 10.1080/07391102.2020.1800513
   Public Health England, GUID COVID 19 PERS P
   Rubin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080671
   Sturgeon BA, 2015, JOGNN-J OBST GYN NEO, V44, pS7, DOI 10.1111/1552-6909.12667
   Wong JPH, 2021, CULT HEALTH SEX, V23, P723, DOI 10.1080/13691058.2020.1725643
NR 9
TC 1
Z9 1
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD MAY 3
PY 2022
VL 35
IS 9
BP 1801
EP 1804
DI 10.1080/14767058.2020.1765333
EA MAY 2020
PG 4
WC Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Obstetrics & Gynecology
GA 0A1KO
UT WOS:000536345800001
PM 32429714
OA Bronze
DA 2022-04-20
ER

PT J
AU Smyrnakis, E
   Symintiridou, D
   Andreou, M
   Dandoulakis, M
   Theodoropoulos, E
   Kokkali, S
   Manolaki, C
   Papageorgiou, DI
   Birtsou, C
   Paganas, A
   Stachteas, P
   Vlachopoulos, N
   Pagkozidis, I
   Zeimbekis, A
   Roka, V
   Giakoumis, A
   Kotsani, M
   Avakian, I
   Makridou, E
   Gavana, M
   Haidich, AB
   Avgerinou, C
AF Smyrnakis, Emmanouil
   Symintiridou, Despoina
   Andreou, Martha
   Dandoulakis, Michael
   Theodoropoulos, Elias
   Kokkali, Stamatia
   Manolaki, Chrysanthi
   Papageorgiou, Dimitra Iosifina
   Birtsou, Charis
   Paganas, Aristofanis
   Stachteas, Panagiotis
   Vlachopoulos, Nikolaos
   Pagkozidis, Ilias
   Zeimbekis, Akis
   Roka, Violeta
   Giakoumis, Anastasios
   Kotsani, Marina
   Avakian, Ioanna
   Makridou, Efthymia
   Gavana, Magda
   Haidich, Anna-Bettina
   Avgerinou, Christina
TI Primary care professionals' experiences during the first wave of the
   COVID-19 pandemic in Greece: a qualitative study
SO BMC FAMILY PRACTICE
LA English
DT Article
DE Primary health care; Covid-19; Pandemic; Management; Greece
ID HEALTH-CARE; TELEMEDICINE
AB Background The coronavirus outbreak (COVID-19) tested health care systems worldwide. This qualitative study aimed to explore and understand the experiences, beliefs and concerns of Primary Care Professionals (PCPs) regarding the preparedness and response of primary care to the first wave of the pandemic in Greece, a country where a public structured primary care system has been developing. Methods We conducted semi-structured telephone interviews with 33 PCPs (General Practitioners, community General Internal Medicine Specialists, community Paediatricians and nurses) recruited from all regions of Greece after the first wave of the pandemic (June 2020). Interviews were transcribed verbatim, data were anonymised and analysed. Thematic analysis was applied developing a conceptual framework. Results Four main themes were identified: a) Primary care unit adaptation and issues faced during the pandemic; b) Management of suspected COVID-19 cases; c) Management of non-suspected cases; d) Consequences of the pandemic. In the first phase of the pandemic, remote management of suspected cases and their referral to the hospital were preferred as a result of a shortage of personal protective equipment and inaccessibility to coronavirus testing in primary care. Due to the discontinuation of regular medical services and the limited in-person contact between doctors and patients, chronic disease management and prevention programmes were left behind. Social and emotional consequences of the pandemic, such as workplace stigma, isolation and social seclusion, deriving from fear of viral transmission, as well as burnout symptoms and exhaustion were commonly experienced among PCPs. Positive consequences of the pandemic were considered to be the recognition of the importance of an empowered public healthcare system by citizens and the valuable insight, knowledge and experience professionals gained in times of crisis. Conclusions Primary care has a key role to play during and after the pandemic by using its information infrastructure to identify at-risk groups, detect new cases of COVID-19, provide care according to needs, and carry out vaccination programmes. Central coordination and empowerment of primary care will increase its effectiveness, via public awareness, holistic patient management, and unburdening of hospitals.
C1 [Smyrnakis, Emmanouil; Stachteas, Panagiotis; Makridou, Efthymia; Gavana, Magda] Aristotle Univ Thessaloniki, Gen Practice & Hlth Serv Res, Lab Primary Hlth Care, Thessaloniki, Greece.
   [Symintiridou, Despoina] 1st TOMY Serron, Serres, Prefecture Of S, Greece.
   [Andreou, Martha] Avdira Hlth Ctr, Abdera, Prefecture Of X, Greece.
   [Dandoulakis, Michael] Vari Hlth Ctr, Vari, Prefecture Of A, Greece.
   [Theodoropoulos, Elias] Pirgi Hlth Ctr, Pirgi, Prefecture Of C, Greece.
   [Kokkali, Stamatia] Nea Kallikratia Hlth Ctr, Nea Kallikratia, Prefecture Of H, Greece.
   [Manolaki, Chrysanthi] Rodolivos Hlth Ctr, Rodolivos, Prefecture Of S, Greece.
   [Papageorgiou, Dimitra Iosifina; Pagkozidis, Ilias] Aristotle Univ Thessaloniki Primary Hlth Care Res, Thessaloniki, Greece.
   [Birtsou, Charis] Zagliveri Hlth Ctr, Reg Practice Lagadikia, Zagkliveri, Prefecture Of T, Greece.
   [Paganas, Aristofanis] Litochoro Hlth Ctr, Litochoro, Prefecture Of P, Greece.
   [Vlachopoulos, Nikolaos] 251 Hellen Air Force Gen Hosp, Athens, Greece.
   [Zeimbekis, Akis] Kalloni Hlth Ctr, Kalloni, Prefecture Of L, Greece.
   [Roka, Violeta] Farkadona Hlth Ctr, Farkadona, Prefecture Of T, Greece.
   [Giakoumis, Anastasios] Kato Achaea Hlth Ctr, Kato Achaia, Prefecture Of A, Greece.
   [Kotsani, Marina] Univ Lorraine, Pole Malad Vieillissement Gerontol & Soins Pallia, CHRU Nancy, F-54000 Nancy, France.
   [Avakian, Ioanna] Farsala Hlth Ctr, Reg Practice Zappeio, Farsala, Prefecture Of L, Greece.
   [Haidich, Anna-Bettina] Aristotle Univ Thessaloniki, Lab Hyg Social & Prevent Med & Med Stat, Thessaloniki, Greece.
   [Avgerinou, Christina] UCL, Dept Primary Care & Populat Hlth, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.
RP Avgerinou, C (corresponding author), UCL, Dept Primary Care & Populat Hlth, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.
EM c.avgerinou@ucl.ac.uk
RI Stachteas, Panagiotis/AAQ-3468-2021; Avgerinou, Christina/X-7342-2019
OI Stachteas, Panagiotis/0000-0002-1657-4696; Avgerinou,
   Christina/0000-0002-1445-1676; Vlachopoulos,
   Nikolaos/0000-0002-7876-9990; Pagkozidis, Ilias/0000-0003-4500-4892
CR Aguilar-Guerra TL, 2020, MEDICC REV, V22, P53, DOI 10.37757/MR2020.V22.N2.15
   Allen Luke N, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101130
   [Anonymous], 2020, TIME
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Danhieux K, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-020-01326-3
   Desborough J, 2020, MED J AUSTRALIA, V213, P104, DOI 10.5694/mja2.50693
   Dunlop Catherine, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101041
   Ekeland AG, 2010, INT J MED INFORM, V79, P736, DOI 10.1016/j.ijmedinf.2010.08.006
   European Commission, 2020, JOINT EUR ROADM LIFT, P1
   Galbraith N, 2021, BJPSYCH BULL, V45, P93, DOI 10.1192/bjb.2020.44
   Garattini L, 2021, EUR J HEALTH ECON, V22, P183, DOI 10.1007/s10198-020-01248-y
   Gray R, 2020, J INTERPROF CARE, V34, P672, DOI 10.1080/13561820.2020.1823948
   Halcomb E, 2020, J NURS SCHOLARSHIP, V52, P553, DOI 10.1111/jnu.12589
   Hong Z, 2020, J MED INTERNET RES, V22, DOI 10.2196/19577
   Huston Patricia, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101128
   Kidd MR, 2020, BRIT J GEN PRACT, V70, P316, DOI 10.3399/bjgp20X710765
   Klaassen B, 2016, INT J MED INFORM, V93, P57, DOI 10.1016/j.ijmedinf.2016.06.004
   Kringos D, 2013, BRIT J GEN PRACT, V63, pE742, DOI 10.3399/bjgp13X674422
   Krist AH, 2020, ANN FAM MED, V18, P349, DOI 10.1370/afm.2557
   Levene LS, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3793
   Lin S, 2020, MAYO CLIN PROC, V95, P1831, DOI 10.1016/j.mayocp.2020.06.050
   Majeed A, 2020, J ROY SOC MED, V113, P208, DOI 10.1177/0141076820931452
   Masotti P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-687
   Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2
   Mughal F, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1064
   OECD, 2020, REAL POT PRIM HLTH C, DOI [10.1787/a92adee4-en, DOI 10.1787/A92ADEE4-EN]
   Park S, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3691
   Primary Care Development Corporation (PCDC), 2020, PCDC REP MAN NYC AR
   Rawaf S, 2020, EUR J GEN PRACT, V26, P129, DOI 10.1080/13814788.2020.1820479
   Roehr B, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2333
   Tomos I, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00468-2020
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   Verhoeven V, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039674
   Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048
   Walton M, 2020, EUR HEART J-ACUTE CA, V9, P241, DOI 10.1177/2048872620922795
   Wang SW, 2020, PSYCHOSOMATICS, V61, P616, DOI 10.1016/j.psym.2020.05.005
   Weinstein E, 2020, DISASTER MED PUBLIC, V14, pE19, DOI 10.1017/dmp.2020.148
   World Health Organisation, 2020, COVID 19 STRAT PREP
   World Health Organization, REG OFF W PAC 2020 R
   Xu ZJ, 2020, J GEN INTERN MED, V35, P3278, DOI 10.1007/s11606-020-06107-3
NR 40
TC 0
Z9 0
U1 3
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2296
J9 BMC FAM PRACT
JI BMC Fam. Pract.
PD SEP 3
PY 2021
VL 22
IS 1
AR 174
DI 10.1186/s12875-021-01522-9
PG 10
WC Primary Health Care; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA UN8EN
UT WOS:000694242700001
PM 34474684
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Bahlol, M
   Dewey, RS
AF Bahlol, Mohamed
   Dewey, Rebecca Susan
TI Pandemic preparedness of community pharmacies for COVID-19
SO RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY
LA English
DT Article
DE COVID-19; Cross-sectional survey; Egypt; Pandemic; Community pharmacy
ID CHLOROQUINE
AB Background: Community pharmacies provide an important healthcare service, which is broadly established, and constitutes the preferred and initial contact for members of the community. The significant value of community pharmacies was further highlighted during the COVID-19 pandemic crisis.
   Objective: The assessment of community pharmacies preparedness for the COVID-19 pandemic.
   Methods: A cross-sectional interview survey of 1018 community pharmacies working in four regions of Egypt (South, East, Centre, and North). Data collection was conducted from 8-19 April 2020.
   Results: Availability of personal protective equipment (PPE) and medication was better than alcohol (70% conc.). Home delivery services were available in 49.1% of pharmacies. Infection control measures covering interactions between staff were in place in up to 99.5% of pharmacies. Conversely, there was less frequent availability of contactless payment (29.1%), hand sanitizers (62.1%) or masks (86.5%) for customer use, or a separate area for patients with suspected COVID-19 (64%). Verbal customer education (90.4%) was used preferably to written (81.3%). Despite high clinical knowledge and awareness (97.6%-99.2%), only 8.8% of pharmacists had reported suspected COVID-19 cases, however this varied significantly with pharmacist demographics (geographic region P < 0.001; pandemic training p < 0.001; position p = 0.019; age p = 0.046).
   Conclusions: Government and policymakers strive to mitigate the shortage of PPE and medication. More attention should be given to infection control measures around interactions between staff and customers to ensure community pharmacists are fit and able to provide continuity in their important role. Educating customers using regularly-updated posters, banners or signs will contribute to decreasing contact with patients, and reducing the number and duration of visits to the pharmacy. Pandemic preparedness of community pharmacists must also extend to reporting procedures. By avoiding under-reporting or over-reporting, community pharmacists will contribute to accurate monitoring of the national spread of infection.
C1 [Bahlol, Mohamed] Egyptian Russian Univ, Pharmaceut Management & Econ, Fac Pharm, Cairo, Egypt.
   [Bahlol, Mohamed] Jazan Univ, Pharmaceut Management & Econ, Fac Pharm, Jazan, Saudi Arabia.
   [Dewey, Rebecca Susan] Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Imaging Ctr, Nottingham, England.
RP Bahlol, M (corresponding author), Egyptian Russian Univ, Cairo Suez Rd, Badr City 11829, Cairo Governora, Egypt.
EM ph_hossni@yahoo.com; rebecca.dewey@nottingham.ac.uk
RI Bahlol, Mohamed/AAP-7457-2020
OI Bahlol, Mohamed/0000-0002-2990-2708
CR Alderman L., 2020, NEW YORK TIMES
   Andalo D, 2020, OUTBREAK SPREADS, DOI [10.1211/PJ.2020.20207830, DOI 10.1211/PJ.2020.20207830]
   [Anonymous], 2019, PAT CAR STRAT SCARC
   [Anonymous], 2020, NHS DIG COR COVID 19
   Balmer, 2020, IT LOMB ASKS RET HLT
   BBC, 2020, BBC
   Betsch C, 2020, NAT HUM BEHAV, V4, P438, DOI 10.1038/s41562-020-0866-1
   Bialek S., 2020, GEOGRAPHIC DIFFERENC
   Bigdeli MP, 2014, MED HLTH SYSTEMS ADV, V2014
   BLOCK BL, 2020, JAMA INTERN MED, V2020, DOI DOI 10.1001/JAMAINTERNMED.2019.7535HTTPS://JAMANETWORK.COM/JOURNALS
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI [10.1056/NEJMp0900702, 10.1056/NEJMp0904012]
   Christian MD, 2014, CHEST, V146, pE61S, DOI 10.1378/chest.14-0736
   *COVID C, 2020, MMWR-MORBID MORTAL W, V2020, P343
   Creative Research Systems, 1982, SAMPL SIZ CALC
   GAO J, 2020, BIOSCI TRENDS, DOI DOI 10.5582/BST.2020.01047HTTPS://WWW.10.5582/BST.2020.01047
   Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663
   General Pharmaceutical Council, 2020, Q A COR, P2020
   Govuk, 2020, PM STAT COR 16 MARCH
   Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4
   Hughes ML, 2019, PHARMACOEPIDEM DR S, V28, P1552, DOI 10.1002/pds.4800
   Jacobs A., 2020, NEW YORK TIMES
   Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117
   Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085
   La Maestra S, 2020, J MED VIROL, V92, P1956, DOI 10.1002/jmv.25908
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007
   Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936
   MORRIS C, 2008, QUANTITATIVE APPROAC
   multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE019, DOI [10.3760/cma.j.issn.1001-0939.2020.03.009, 10.3760/cma.j.issn.1001-0939.2020.0019]
   National Pharmacy Association, 2020, REP PAR COR COVID 19, P2020
   Nepal A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032422
   NHS England, 2020, JOINT LETT S STEV AM
   NHS England and NHS Improvement, 2020, LETT COMM PHARM
   Payne C, 2020, NAT HUM BEHAV, V4, P436, DOI 10.1038/s41562-020-0870-5
   Public Health England, 2020, GUID SOC DIST EV UK
   Qualls N, 2017, MMWR RECOMM REP, V66, P1, DOI 10.15585/mmwr.rr6601a1
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Said R, VETOGATES
   Smith F, 2009, PHARM WORLD SCI, V31, P351, DOI 10.1007/s11096-009-9294-z
   Stenson B, 2001, SOC SCI MED, V52, P393, DOI 10.1016/S0277-9536(00)00142-8
   The Presidency of the Council of Egyptian Ministers, 2020, COR DIS
   The UK Government, 2020, COR COVID 19 WHAT YO
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105
   Trostle J, 1996, SOC SCI MED, V42, P1117, DOI 10.1016/0277-9536(95)00384-3
   UK Government, 2020, GUID SOC DIST EV UK
   United States Embasy in Egypt, 2020, COVID 19 INF
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Walker P. G. T, 2020, 12 IMP COLL LOND
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang YR, 2020, J INFECT DIS, V221, P1770, DOI 10.1093/infdis/jiaa119
   Wickware C., PHARM J, V2020, P2020
   Wu WZ, 2020, J MED VIROL, V92, P1962, DOI 10.1002/jmv.25914
   Xu B, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0448-0
   Xu B, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30119-5
NR 54
TC 20
Z9 22
U1 7
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1551-7411
EI 1934-8150
J9 RES SOC ADMIN PHARM
JI Res. Soc. Adm. Pharm.
PD JAN
PY 2021
VL 17
IS 1
BP 1888
EP 1896
DI 10.1016/j.sapharm.2020.05.009
PG 9
WC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
GA QD2JC
UT WOS:000615350400014
PM 32417070
OA Green Accepted, Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Osuagwu, UL
   Miner, CA
   Bhattarai, D
   Mashige, KP
   Oloruntoba, R
   Abu, EK
   Ekpenyong, B
   Chikasirimobi, TG
   Goson, PC
   Ovenseri-Ogbomo, GO
   Langsi, R
   Charwe, DD
   Ishaya, T
   Nwaeze, O
   Agho, KE
AF Osuagwu, Uchechukwu L.
   Miner, Chundung A.
   Bhattarai, Dipesh
   Mashige, Khathutshelo Percy
   Oloruntoba, Richard
   Abu, Emmanuel Kwasi
   Ekpenyong, Bernadine
   Chikasirimobi, Timothy G.
   Goson, Piwuna Christopher
   Ovenseri-Ogbomo, Godwin O.
   Langsi, Raymond
   Charwe, Deborah Donald
   Ishaya, Tanko
   Nwaeze, Obinna
   Agho, Kingsley Emwinyore
TI Misinformation About COVID-19 in Sub-Saharan Africa: Evidence from a
   Cross-Sectional Survey
SO HEALTH SECURITY
LA English
DT Article
DE COVID-19; Infodemic; Misinformation; Public health preparedness;
   response; Epidemic management; response
AB Misinformation about coronavirus disease 2019 (COVID-19) is a significant threat to global public health because it can inadvertently exacerbate public health challenges by promoting spread of the disease. This study used a convenience sampling technique to examine factors associated with misinformation about COVID-19 in sub-Saharan Africa using an online cross-sectional survey. A link to the online self-administered questionnaire was distributed to 1,969 participants through social media platforms and the authors' email networks. Four false statements-informed by results from a pilot study-were included in the survey. The participants' responses were classified as "Agree," "Neutral," and "Disagree." A multinomial logistic regression was used to examine associated factors. Among those who responded to the survey, 19.3% believed that COVID-19 was designed to reduce world population, 22.2% thought the ability to hold your breath for 10 seconds meant that you do not have COVID-19, 27.8% believed drinking hot water flushes down the virus, and 13.9% thought that COVID-19 had little effect on Blacks compared with Whites. An average of 33.7% were unsure whether the 4 false statements were true. Multivariate analysis revealed that those who thought COVID-19 was unlikely to continue in their countries reported higher odds of believing in these 4 false statements. Other significant factors associated with belief in misinformation were age (older adults), employment status (unemployed), gender (female), education (bachelor's degree), and knowledge about the main clinical symptoms of COVID-19. Strategies to reduce the spread of false information about COVID-19 and other future pandemics should target these subpopulations, especially those with limited education. This will also enhance compliance with public health measures to reduce spread of further outbreaks.
C1 [Osuagwu, Uchechukwu L.] Western Sydney Univ, Diabet Obes & Metab Translat Res Unit, Sch Med, Campbelltown, NSW, Australia.
   [Agho, Kingsley Emwinyore] Western Sydney Univ, Biostat, Sch Hlth Sci, Campbelltown, NSW, Australia.
   [Miner, Chundung A.] Univ Jos, Dept Community Med, Coll Hlth Sci, Jos, Plateau State, Nigeria.
   [Goson, Piwuna Christopher] Univ Jos, Dept Psychiat, Coll Hlth Sci, Jos, Plateau State, Nigeria.
   [Ishaya, Tanko] Univ Jos, Dept Comp Sci, Jos, Plateau State, Nigeria.
   [Bhattarai, Dipesh] Deakin Univ, Fac Hlth, Sch Med, Geelong, Vic, Australia.
   [Osuagwu, Uchechukwu L.; Mashige, Khathutshelo Percy; Ekpenyong, Bernadine; Ovenseri-Ogbomo, Godwin O.; Agho, Kingsley Emwinyore] Univ KwaZulu Natal, African Vis Res Inst, Discipline Optometry, Westville Campus, Durban, South Africa.
   [Oloruntoba, Richard] Curtin Univ, Fac Business & Law, Sch Management & Mkt, Bentley, WA, Australia.
   [Abu, Emmanuel Kwasi] Univ Cape Coast, Sch Allied Hlth Sci, Dept Optometry & Vis Sci, Cape Coast, Ghana.
   [Ekpenyong, Bernadine] Univ Calabar, Dept Publ Hlth, Fac Allied Med Sci, Coll Med Sci, Calabar, Cross River Sta, Nigeria.
   [Chikasirimobi, Timothy G.] Masinde Muliro Univ Sci & Technol, Kakamega, Kenya.
   [Ovenseri-Ogbomo, Godwin O.] Qassim Univ, Coll Appl Med Sci, Dept Optometry, Buraydah, Saudi Arabia.
   [Ovenseri-Ogbomo, Godwin O.] Univ Benin, Fac Life Sci, Dept Optometry, Benin, Nigeria.
   [Langsi, Raymond] Univ Bamenda, Hlth Div, Bambili, Cameroon.
   [Charwe, Deborah Donald] Tanzania Food & Nutr Ctr, Dar Es Salaam, Tanzania.
   [Nwaeze, Obinna] Natl Hlth Serv Fdn, Cty Durham & Darlington, London, England.
RP Osuagwu, UL (corresponding author), Western Sydney Univ, Diabet Obes & Metab Translat Res Unit, Level 2,Room 10-8,MacArthur Clinical Sch Bldg, Campbelltown, NSW 2560, Australia.
EM l.osuagwu@westernsydney.edu.au
RI Timothy, Chikasirimobi/ABG-3240-2021; Agho, Kingsley/AAW-5622-2021;
   osuagwu, Uchechukwu Levi/K-5236-2015
OI Timothy, Chikasirimobi/0000-0001-5832-484X; Agho,
   Kingsley/0000-0003-4111-3207; osuagwu, Uchechukwu
   Levi/0000-0002-1727-6914
CR Amgain K., 2020, J KARNALI ACAD HLTH, V3, P7
   [Anonymous], 2020, J RACIAL ETHN HEALTH, DOI DOI 10.1007/s40615-020-00833-4
   Bastani Peivand, 2020, J Med Internet Res, DOI 10.2196/18932
   Brashier NM, 2020, CURR DIR PSYCHOL SCI, V29, P316, DOI 10.1177/0963721420915872
   Cameron KA, 2013, PATIENT EDUC COUNS, V92, P381, DOI 10.1016/j.pec.2013.06.017
   Carbone M, 2020, J THORAC ONCOL, V15, P675, DOI 10.1016/j.jtho.2020.02.024
   Cram P, 2003, ARCH INTERN MED, V163, P1601, DOI 10.1001/archinte.163.13.1601
   Effenberger M, 2020, INT J INFECT DIS, V95, P192, DOI 10.1016/j.ijid.2020.04.033
   Eysenbach G, 2002, AM J MED, V113, P763, DOI 10.1016/S0002-9343(02)01473-0
   Freeman D, 2022, PSYCHOL MED, V52, P251, DOI 10.1017/S0033291720001890
   Fricker RD., 2017, SAGE HDB ONLINE RES, P184
   Gupta L, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e256
   Gyasi RM, 2020, INT PSYCHOGERIATR, V32, P1187, DOI 10.1017/S1041610220003312
   Health System Strengthening in Sub-Saharan Africa (ASSET), COVID 19 SUBS AFR
   Higgs P, 2011, HEPAT MON, V11, P513
   Hjort J, 2019, AM ECON REV, V109, P1032, DOI 10.1257/aer.20161385
   Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812
   Jakubu MG., 2020, NOW IS TIME GLOBAL L
   Jelnov P, 2020, CONFRONTING COVID 19
   Kim Sue, 2004, J Cardiovasc Nurs, V19, P192
   Kishore Jugal, 2011, Indian J Psychiatry, V53, P324, DOI 10.4103/0019-5545.91906
   Kraemer Moritz U G, 2020, medRxiv, DOI 10.1101/2020.03.02.20026708
   Loembe MM, 2020, NAT MED, V26, P999, DOI 10.1038/s41591-020-0961-x
   Mennechet FJD, 2020, VIROL SIN, V35, P875, DOI 10.1007/s12250-020-00279-2
   Moehler DC, 2011, POLIT RES QUART, V64, P276, DOI 10.1177/1065912909349624
   Nadler JT, 2015, J GEN PSYCHOL, V142, P71, DOI 10.1080/00221309.2014.994590
   Nakkazi E, 2020, LANCET INFECT DIS, V20, P660, DOI 10.1016/S1473-3099(20)30382-0
   Ovenseri-Ogbomo G, 2020, J GLOB HEALTH REP, V4, DOI DOI 10.29392/001C.17606
   Palmieri L, 2020, J GERONTOL A-BIOL, V75, P1796, DOI 10.1093/gerona/glaa146
   Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054
   Pickles K., 2020, COVID 19 BELIEFS MIS, DOI [10.1101/2020.08.04.20168583, DOI 10.1101/2020.08.04.20168583]
   Porat T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.573397
   Roberts Michelle, 2017, Information Services & Use, V37, P177, DOI 10.3233/ISU-170836
   Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199
   Russonello G., 2020, NEW YORK TIMES
   Sahoo S, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102244
   Shamshina JL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176002
   Singh L., 2020, ARXIV200313907
   Stanley M., 2020, ANAL THINKING PREDIC, DOI [10.31234/osf.io/m3vth, DOI 10.31234/OSF.IO/M3VTH]
   The World Bank, 2020, DAT PHYS PER 1 000 P
   United Nations Economic Commission for Africa (UNECA), 2020, COVID 19 LOCKD EX ST
   Uscinski J., 2020, HARVARD KENNEDY SCH, DOI 10.37016/mr-2020-015
   World Health Organisation (WHO), 2021, COR COR
   World Health Organization, NOV COR 2016 NCOV SI
   World Health Organization, 2020, COR DIS COVID 19 SIT
   Zhong R., 2020, NEW YORK TIMES
NR 46
TC 6
Z9 6
U1 9
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD FEB 1
PY 2021
VL 19
IS 1
BP 44
EP 56
DI 10.1089/HS.2020.0202
PG 13
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA QJ3WW
UT WOS:000619623600006
PM 33606572
OA hybrid, Green Submitted
DA 2022-04-20
ER

PT J
AU Kumar, A
   Prasoon, P
   Kumari, C
   Pareek, V
   Faiq, MA
   Narayan, RK
   Kulandhasamy, M
   Kant, K
AF Kumar, Ashutosh
   Prasoon, Pranav
   Kumari, Chiman
   Pareek, Vikas
   Faiq, Muneeb A.
   Narayan, Ravi K.
   Kulandhasamy, Maheswari
   Kant, Kamla
TI SARS-CoV-2-specific virulence factors in COVID-19
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Review
DE COVID-19; host immune response; interferon; SARS-CoV-2; virulence
   factors
ID IMMUNE-RESPONSE; CYTOKINE STORM; PROTEASE
AB The paucity of knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific virulence factors has greatly hampered the therapeutic management of patients with coronavirus disease 2019 (COVID-19). Recently, a cluster of studies appeared, which presented empirical evidence for SARS-CoV-2-specific virulence factors that can explain key elements of COVID-19 pathology. These studies unravel multiple structural and nonstructural specifics of SARS-CoV-2, such as a unique FURIN cleavage site, papain-like protease (SCoV2-PLpro), ORF3b and nonstructural proteins, and dynamic conformational changes in the structure of spike protein during host cell fusion, which give it an edge in infectivity and virulence over previous coronaviruses causing pandemics. Investigators provided robust evidence that SARS-CoV-2-specific virulence factors may have an impact on viral infectivity and transmissibility and disease severity as well as the development of immunity against the infection, including response to the vaccines. In this article, we are presenting a summarized account of the newly reported studies.
C1 [Kumar, Ashutosh; Prasoon, Pranav; Kumari, Chiman; Pareek, Vikas; Faiq, Muneeb A.; Narayan, Ravi K.; Kulandhasamy, Maheswari; Kant, Kamla] Etiol Elus Disorders Res Network EEDRN, New Delhi, India.
   [Kumar, Ashutosh; Narayan, Ravi K.] All India Inst Med Sci AIIMS, Dept Anat, Patna 801505, Bihar, India.
   [Prasoon, Pranav] Univ Pittsburgh, Sch Med, Pittsburgh Ctr Pain Res, Pittsburgh, PA USA.
   [Kumari, Chiman] Postgrad Inst Med Educ & Res PGIMER, Dept Anat, Chandigarh, India.
   [Pareek, Vikas] Natl Brain Res Ctr, Manesar, Haryana, India.
   [Faiq, Muneeb A.] NYU, Langone Hlth Ctr, Robert I Grossman Sch Med, New York, NY USA.
   [Kulandhasamy, Maheswari] Maulana Azad Med Coll MAMC, Dept Biochem, New Delhi, India.
   [Kant, Kamla] All India Inst Med Sci AIIMS, Dept Microbiol, Bathinda, India.
RP Kumar, A (corresponding author), All India Inst Med Sci AIIMS, Dept Anat, Patna 801505, Bihar, India.
EM drashutoshkumar@aiimspatna.org
RI Prasoon, Pranav/AAE-4642-2022; Kumar, Ashutosh/AAA-1035-2021; NARAYAN,
   RAVI KANT/Y-7912-2019
OI Prasoon, Pranav/0000-0002-5035-3619; Kumar,
   Ashutosh/0000-0003-1589-9568; NARAYAN, RAVI KANT/0000-0003-2510-6744;
   Kumari, Chiman/0000-0002-9116-8380; Faiq, Muneeb/0000-0002-1430-3139;
   Pareek, Dr. Vikas/0000-0001-8985-4982; kant, kamla/0000-0002-8966-6268;
   kulandhasamy, maheswari/0000-0002-6769-2596
CR Abobaker A, 2021, WORLD J UROL, V39, P975, DOI 10.1007/s00345-020-03208-w
   Alqahtani JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233147
   Anand P, 2020, ELIFE, V9, DOI 10.7554/eLife.58603
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Bouhaddou M, 2020, CELL, V182, P685, DOI 10.1016/j.cell.2020.06.034
   Cai Yongfei, 2020, bioRxiv, DOI 10.1101/2020.05.16.099317
   Channappanavar R, 2019, J CLIN INVEST, V129, P3625, DOI 10.1172/JCI126363
   Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z
   Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003
   Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742
   Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827
   Frieman M, 2008, MICROBIOL MOL BIOL R, V72, P672, DOI 10.1128/MMBR.00015-08
   Goetz L, 2020, J APPL LAB MED, V5, P1401, DOI 10.1093/jalm/jfaa137
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179
   Jaimes JA, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101212
   Johnson Bryan A, 2020, bioRxiv, DOI 10.1101/2020.08.26.268854
   Kaneko Naoki, 2020, Cell, V183, P143, DOI [10.2139/ssrn.3652322, 10.1016/j.cell.2020.08.025]
   Klann K, 2020, MOL CELL, V80, P164, DOI 10.1016/j.molcel.2020.08.006
   Konno Y, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108185
   Li Y, 2017, ONCOTARGET, V8, P83509, DOI 10.18632/oncotarget.17840
   Liu AD, 2020, CLIN MICROBIOL INFEC, V26, P1703, DOI 10.1016/j.cmi.2020.07.009
   Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6
   Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y
   Mutchler SM, 2019, CURR OPIN NEPHROL HY, V28, P113, DOI 10.1097/MNH.0000000000000479
   Naqvi AA, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165878
   Newton AH, 2016, SEMIN IMMUNOPATHOL, V38, P471, DOI 10.1007/s00281-016-0558-0
   Rubino F, 2020, NEW ENGL J MED, V383, P789, DOI [10.1056/NEJMc2021832, 10.1056/NEJMc2018688]
   Rut Wioletta, 2020, bioRxiv, DOI 10.1101/2020.04.29.068890
   Shanker AKK, 2020, NEW J CHEM, V44, P9202, DOI 10.1039/d0nj00974a
   Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5
   Sun XJ, 2020, CYTOKINE GROWTH F R, V53, P38, DOI 10.1016/j.cytogfr.2020.04.002
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6
   Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665
   van der Heide V, 2020, NAT REV IMMUNOL, DOI 10.1038/s41577-020-0325-2
   Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
   Viswanathan T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17496-8
   Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008
   Wu F, 2020, JAMA INTERN MED, V180, P1356, DOI 10.1001/jamainternmed.2020.4616
   Wu Y, 2020, NOVEL SEVERE ACUTE R, DOI [10.1101/2020.03.27.20045427, DOI 10.1101/2020.03.27.20045427]
   Wynne BM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00766
   Xia S, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0184-0
   Xu H, 2007, EUR RESPIR J, V30, P633, DOI 10.1183/09031936.00014107
   Xu JB, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020244
   Yelin D, 2020, LANCET INFECT DIS, V20, P1115, DOI 10.1016/S1473-3099(20)30701-5
   Zhang XN, 2020, NATURE, V583, P437, DOI 10.1038/s41586-020-2355-0
   Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004
NR 50
TC 17
Z9 17
U1 8
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAR
PY 2021
VL 93
IS 3
BP 1343
EP 1350
DI 10.1002/jmv.26615
EA NOV 2020
PG 8
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Virology
GA PZ1QN
UT WOS:000583193100001
PM 33085084
DA 2022-04-20
ER

PT J
AU Imran, E
   Khurshid, Z
   Adanir, N
   Ashi, H
   Almarzouki, N
   Baeshen, HA
AF Imran, Eisha
   Khurshid, Zohaib
   Adanir, Necdet
   Ashi, Heba
   Almarzouki, Nawaf
   Baeshen, Hosam Ali
TI Dental Practitioners' Knowledge, Attitude and Practices for Mouthwash
   Use Amidst the COVID-19 Pandemic
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE mouthwash; povidone-iodine; PVP-I; SARS-CoV-2; COVID-19; dental
   procedures
ID ORAL HYGIENE; AWARENESS; CORONAVIRUS
AB Introduction: COVID-19 created a peculiar situation worldwide, thus altering the fundamental dynamics of clinical dentistry. This KAP survey was carried out to evaluate the knowledge, attitude and practices among dental practitioners regarding the use of mouthwashes and emphasize on pre-procedural utilization of mouthwashes.
   Methodology: A descriptive, cross-sectional study was conducted during 1st to 15th July 2020, among working dental practitioners across the globe. A questionnaire was formed on Kwiksurveys.com , it comprised of demographic details, it further investigated the level of knowledge and new precautionary measures adopted. A total number of 707 dental practitioners from eighteen different countries responded.
   Results: Data were analyzed using SPSS version 23. A "fisher exact test" was applied to assess the difference between the mouthwashes prescribed by various countries. Knowledge section revealed a requisite understanding regarding the disease and its transmission. Only 38.9% of the participants knew that Povidone-iodine (PVP-I) mouthwashes are more efficient in reducing coronaviruses in contrast to mouthwashes made of chlorhexidine (CHX). Whereas 33.9% knew that 0.23% of PVP-I had substantial virucidal activity against SARS-COV, MERS-CoV, influenza virus and rotavirus while 31.1% recognized that oral rinses of Cetylpyridinium chloride (CPC) remained successful in the oral cavity for up to 180-300 minutes.
   Conclusion: There is an immense need to raise awareness among practitioners, regarding the viricidal activity of commercially available mouthwashes as demonstrated by numerous in-vitro studies and urge health workers to carry out more clinical trials and to get a translational step towards clinical practice.
C1 [Imran, Eisha] Riphah Int Univ, Islamic Int Dent Coll, Dept Dent Mat, Islamabad 44000, Pakistan.
   [Khurshid, Zohaib] King Faisal Univ, Coll Dent, Dept Prosthodont & Dent Implantol, Al Hasa 31982, Saudi Arabia.
   [Adanir, Necdet] King Faisal Univ, Coll Dent, Dept Restorat Dent, Al Hasa 31982, Saudi Arabia.
   [Ashi, Heba] King Abdulaziz Univ, Coll Dent, Dept Dent Publ Hlth, Jeddah, Saudi Arabia.
   [Almarzouki, Nawaf] King Abdulaziz Univ, Coll Med, Dept Ophthalmol, Jeddah, Saudi Arabia.
   [Baeshen, Hosam Ali] King Abdulaziz Univ, Coll Dent, Dept Orthodont, Jeddah, Saudi Arabia.
RP Khurshid, Z (corresponding author), King Faisal Univ, Coll Dent, Dept Prosthodont & Dent Implantol, Al Hasa 31982, Saudi Arabia.
EM drzohaibkhurshid@gmail.com
RI Khurshid, Zohaib/K-9314-2015; Adanir, Nejdet/I-3183-2019
OI Khurshid, Zohaib/0000-0001-7998-7335; Adanir, Nejdet/0000-0002-6235-3448
CR Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Anderson EL, 2020, RISK ANAL, V40, P902, DOI 10.1111/risa.13500
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Bidra AS, 2020, J PROSTHODONT, V29, P529, DOI 10.1111/jopr.13209
   Carrouel F, 2021, J DENT RES, V100, P124, DOI 10.1177/0022034520967933
   Carrouel F, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04846-6
   Carrouel F, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041126
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Combes J, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3563092, DOI 10.2139/SSRN.3563092]
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1039, DOI 10.1001/jama.2020.1490
   Elworthy A, 1996, J PERIODONTOL, V67, P572, DOI 10.1902/jop.1996.67.6.572
   Farzan A., 2020, J REGENERATION RECON, V5, pe2, DOI [10.22037/rrr.v5i1.29543., DOI 10.22037/RRR.V5I1.29543]
   Frank S, 2020, ENT-EAR NOSE THROAT, V99, P586, DOI 10.1177/0145561320932318
   Hamid H, 2020, J ORAL RES, V2020, DOI [10.34133/2020/9426453, DOI 10.34133/2020/9426453]
   Harrel SK, 2004, J AM DENT ASSOC, V135, P429, DOI 10.14219/jada.archive.2004.0207
   Haydari M, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0400-7
   Herrera D, 2020, CLIN ORAL INVEST, V24, P2925, DOI 10.1007/s00784-020-03413-2
   Heymann DL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1499
   Imran E, 2020, EUR J DENT
   Kariwa H, 2004, JPN J VET RES, V52, P105
   Kelly Niamh, 2020, Evid Based Dent, V21, P42, DOI 10.1038/s41432-020-0099-1
   Khan FR, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04634-2
   Khan MM, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102618
   Khurshid Z, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072225
   Lodhi SK, 2020, BIOMEDICA, V36, P275
   Lu SH, 2009, INT J TUBERC LUNG D, V13, P1493
   Mady LJ, 2020, ORAL ONCOL, V105, DOI 10.1016/j.oraloncology.2020.104724
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Mohan M, 2016, DENT MED PROBL, V53, P78, DOI 10.17219/dmp/60694
   Mubeen SM, 2020, J PAK MED ASSOC, V70, pS169, DOI 10.5455/JPMA.40
   O'Donnell VB, 2020, FUNCTION, V1, DOI 10.1093/function/zqaa002
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Quadri MFA, 2020, J INFECT PUBLIC HEAL, V13, P856, DOI 10.1016/j.jiph.2020.05.010
   ROBERTS WR, 1981, J CLIN PERIODONTOL, V8, P295, DOI 10.1111/j.1600-051X.1981.tb02040.x
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Saini R, 2015, DENT HYPOTHESES, V6, P65
   Sampson V, 2020, BRIT DENT J, V228, P971, DOI 10.1038/s41415-020-1747-8
   Sarfaraz S, 2020, HEALTHC
   Seneviratne CJ, 2021, INFECTION, V49, P305, DOI 10.1007/s15010-020-01563-9
   Sriwilaijaroen N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-124
   Stangvaltaite-Mouhat L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165843
   Willman M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11121119
   World Health Organization (WHO), 2020, ROLLING UPDATES CORO
   Zupin L, 2021, J CLIN PATHOL, V74, P209, DOI 10.1136/jclinpath-2020-206788
NR 45
TC 6
Z9 6
U1 2
U2 6
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 605
EP 618
DI 10.2147/RMHP.S287547
PG 14
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA QK8AT
UT WOS:000620603500001
PM 33623451
OA Green Published
DA 2022-04-20
ER

PT J
AU Trichilli, Y
   Abbes, MB
AF Trichilli, Yousra
   Abbes, Mouna Boujelbene
TI The impact of COVID-19 on the portfolio optimization
SO EUROMED JOURNAL OF BUSINESS
LA English
DT Article; Early Access
DE COVID-19 pandemic; Commodities; Bitcoin; Portfolio optimization; Thermal
   optimal path; Bayesian approach
ID TIME LAG STRUCTURE; NONPARAMETRIC DETERMINATION; SAFE HAVEN; BITCOIN;
   SERIES; HEDGE
AB Purpose - This article unveils first the lead-lag structure between the confirmed cases of COVID-19 and financial markets, including the stock (DJI), cryptocurrency (Bitcoin) and commodities (crude oil, gold, copper and brent oil) compared to the financial stress index. Second, this paper assesses the role of Bitcoin as a hedge or diversifier by determining the efficient frontier with and without including Bitcoin before and during the COVID-19 pandemic.
   Design/methodology/approach - The authors examine the lead-lag relationship between COVID-19 and financial market returns compared to the financial stress index and between all markets returns using the thermal optimal path model. Moreover, the authors estimate the efficient frontier of the portfolio with and without Bitcoin using the Bayesian approach.
   Findings - Employing thermal optimal path model, the authors find that COVID-19 confirmed cases are leading returns prices of DJI, Bitcoin and crude oil, gold, copper and brent oil. Moreover, the authors find a strong lead-lag relationship between all financial market returns. By relying on the Bayesian approach, findings show when Bitcoin was included in the portfolio optimization before or during COVID-19 period; the Bayesian efficient frontier shifts to the left giving the investor a better risk return trade-off. Consequently, Bitcoin serves as a safe haven asset for the two sub-periods: pre-COVID-19 period and COVID-19 period.
   Practical implications - Based on the above research conclusions, investors can use the number of COVID-19 confirmed cases to predict financial market dynamics. Similarly, the work is helpful for decision-makers who search for portfolio diversification opportunities, especially during health crisis. In addition, the results support the fact that Bitcoin is a safe haven asset that should be combined with commodities and stocks for better performance in portfolio optimization and hedging before and during COVID-19 periods.
   Originality/value - This research thus adds value to the existing literature along four directions. First, the novelty of this study lies in the analysis of several financial markets (stock, cryptocurrencies and commodities)' response to different pandemics and epidemics events, financial crises and natural disasters (Correia et al., 2020; Ma et al., 2020). Second, to the best of the authors' knowledge, this is the first study that examine the lead-lag relationship between COVID-19 and financial markets compared to financial stress index by employing the Thermal Optimal Path method. Third, it is a first endeavor to analyze the lead-lag interplay between the financial markets within a thermal optimal path method that can provide useful insights for the spillover effect studies in all countries and regions around the world. To check the robustness of our findings, the authors have employed financial stress index compared to COVID-19 confirmed cases. Fourth, this study tests whether Bitcoin is a hedge or diversifier given this current pandemic situation using the Bayesian approach.
C1 [Trichilli, Yousra; Abbes, Mouna Boujelbene] Univ Sfax, Fac Econ & Management Sfax, Sfax, Tunisia.
RP Trichilli, Y (corresponding author), Univ Sfax, Fac Econ & Management Sfax, Sfax, Tunisia.
EM yousratrichilli@yahoo.fr
CR Abbes MB, 2015, BORSA ISTANB REV, V15, P93, DOI 10.1016/j.bir.2015.03.001
   Alam GM, 2021, TECHNOL FORECAST SOC, V172, DOI 10.1016/j.techfore.2021.121008
   Alam GM, 2021, TECHNOL FORECAST SOC, V172, DOI 10.1016/j.techfore.2021.121034
   Alam GM, 2021, TECHNOL SOC, V66, DOI 10.1016/j.techsoc.2021.101677
   Arner D.W., 2020, U HONG KONG FACULTY, DOI [10.2139/ssrn.3558889, DOI 10.2139/SSRN.3558889]
   Baker SR, 2020, REV ASSET PRICING ST, V10, P742, DOI 10.1093/rapstu/raaa008
   Bansal Y., 2014, GLOBAL BUSINESS MANA, V6, P112
   Ben Ameur H., 2019, COMPUT ECON, V5, P1
   Botman D., 2013, IMF WORKING PAPER
   Bouoiyour J., 2017, BITCOIN PRICE FORMAT
   Bouri E, 2020, ENERGIES, V13, DOI 10.3390/en13164090
   Bouri E, 2017, FINANC RES LETT, V20, P192, DOI 10.1016/j.fri.2016.09.025
   Campra M., 2021, INT J BUSINESS MANAG, V16, P1
   Cheema M.A., 2020, COVID 19 PANDEMIC IT
   CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133
   Conlon T, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101607
   Corbet S, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101554
   Correia S., 2020, TECH REP 2020 PANDEM
   Demirer R, 2020, RESOUR POLICY, V69, DOI 10.1016/j.resourpol.2020.101856
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Eisl A., 2015, SSRN ELECT J, V21, DOI [10.2139/ssrn.2408997, DOI 10.2139/SSRN.2408997]
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   Golubeva O, 2021, CORP GOV-INT J BUS S, V21, P1011, DOI 10.1108/CG-09-2020-0405
   Goodell JW, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101625
   Grisse C., 2013, SWISS NATL BANK WORK
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guesmi K, 2019, INT REV FINANC ANAL, V63, P431, DOI 10.1016/j.irfa.2018.03.004
   Iqbal S, 2022, CHINA FINANC REV INT, V12, P219, DOI 10.1108/CFRI-02-2021-0046
   Kajtazi A, 2019, INT REV FINANC ANAL, V61, P143, DOI 10.1016/j.irfa.2018.10.003
   Kristoufek L, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.00296
   Ma C., 2020, GLOBAL EC FINANCIAL
   Mezghani T, 2021, INT J EMERG MARK, DOI 10.1108/IJOEM-06-2020-0619
   Mokni K, 2022, RES INT BUS FINANC, V60, DOI 10.1016/j.ribaf.2021.101573
   Morema K, 2020, RESOUR POLICY, V68, DOI 10.1016/j.resourpol.2020.101740
   Narayan P.K., 2020, ENERGY RES LETT, V1, P13176, DOI [10.46557/001c.13176, 10.46557/ 001c.13176, DOI 10.46557/001C.13176]
   Nogueira R.P.M., 2021, PANDEMICS TRAVEL, P121, DOI [10.1108/978-1-80071-070-220211008, DOI 10.1108/978-1-80071-070-220211008]
   Nur-Al-Ahad Md., 2018, INT J EC BUSINESS RE, V6
   Parveen S, 2021, J ECONOM ADM SCI, DOI 10.1108/JEAS-08-2020-0153
   Pinudom B., 2018, J PHYS C SERIES, V1053
   Ngo QT, 2022, CHINA FINANC REV INT, V12, P261, DOI 10.1108/CFRI-05-2021-0087
   Ramelli F., 2020, VOXEU ORG, V4, P439
   Salisu AA, 2021, RESOUR POLICY, V70, DOI 10.1016/j.resourpol.2020.101897
   Salisu AA, 2020, INT REV FINANC ANAL, V71, DOI 10.1016/j.irfa.2020.101546
   Shaikh I, 2021, J ECON STUD, DOI 10.1108/JES-10-2020-0503
   Sharif A, 2020, INT REV FINANC ANAL, V70, DOI 10.1016/j.irfa.2020.101496
   Smales LA, 2019, FINANC RES LETT, V30, P385, DOI 10.1016/j.frl.2018.11.002
   Sornette D, 2005, QUANT FINANC, V5, P577, DOI 10.1080/14697680500383763
   Takada HH, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20010042
   Trichilli Y., 2018, INT ECON J, V32, P1, DOI [10.1080/10168737.2018.15220, DOI 10.1080/10168737.2018.15220]
   Trichilli Y, 2021, J ASSET MANAG, V22, P163, DOI 10.1057/s41260-021-00222-4
   Trichilli Y, 2020, J ASSET MANAG, V21, P261, DOI 10.1057/s41260-020-00159-0
   Trichilli Y, 2020, RES INT BUS FINANC, V51, DOI 10.1016/j.ribaf.2019.101071
   Urquhart A, 2019, INT REV FINANC ANAL, V63, P49, DOI 10.1016/j.irfa.2019.02.009
   Wang Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256879
   Wu C., 2014, J FINANCIAL PLANNING, V27, P44
   Yang MH, 2022, J ENTERP INF MANAG, V35, P125, DOI 10.1108/JEIM-02-2021-0077
   Yang YH, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.00132
   Yao CZ, 2018, KYBERNETES, V47, P1242, DOI 10.1108/K-04-2017-0139
   Yarovaya L, 2021, J INT FINANC MARK I, V75, DOI 10.1016/j.intfin.2021.101321
   Zhang DY, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101528
   Zhou WX, 2007, PHYSICA A, V380, P287, DOI 10.1016/j.physa.2007.02.114
   Zhou WX, 2006, J MACROECON, V28, P195, DOI 10.1016/j.jmacro.2005.10.015
NR 62
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1450-2194
EI 1758-888X
J9 EUROMED J BUS
JI EuroMed J. Bus.
DI 10.1108/EMJB-11-2021-0179
EA APR 2022
PG 22
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA 0J1EW
UT WOS:000779851700001
OA Bronze
DA 2022-04-20
ER

PT J
AU De Kock, JH
   Latham, HA
   Leslie, SJ
   Grindle, M
   Munoz, SA
   Ellis, L
   Polson, R
   O'Malley, CM
AF De Kock, Johannes H.
   Latham, Helen Ann
   Leslie, Stephen J.
   Grindle, Mark
   Munoz, Sarah-Anne
   Ellis, Liz
   Polson, Rob
   O'Malley, Christopher M.
TI A rapid review of the impact of COVID-19 on the mental health of
   healthcare workers: implications for supporting psychological well-being
SO BMC PUBLIC HEALTH
LA English
DT Review
DE COVID-19; Mental health; Psychology; Intervention; Review; Frontline;
   Staff; Workers; Healthcare; Social care
ID DISEASE; OUTCOMES; SARS
AB BackgroundHealth and social care workers (HSCWs) have carried a heavy burden during the COVID-19 crisis and, in the challenge to control the virus, have directly faced its consequences. Supporting their psychological wellbeing continues, therefore, to be a priority. This rapid review was carried out to establish whether there are any identifiable risk factors for adverse mental health outcomes amongst HSCWs during the COVID-19 crisis.MethodsWe undertook a rapid review of the literature following guidelines by the WHO and the Cochrane Collaboration's recommendations. We searched across 14 databases, executing the search at two different time points. We included published, observational and experimental studies that reported the psychological effects on HSCWs during the COVID-19 pandemic.ResultsThe 24 studies included in this review reported data predominantly from China (18 out of 24 included studies) and most sampled urban hospital staff. Our study indicates that COVID-19 has a considerable impact on the psychological wellbeing of front-line hospital staff. Results suggest that nurses may be at higher risk of adverse mental health outcomes during this pandemic, but no studies compare this group with the primary care workforce. Furthermore, no studies investigated the psychological impact of the COVID-19 pandemic on social care staff. Other risk factors identified were underlying organic illness, gender (female), concern about family, fear of infection, lack of personal protective equipment (PPE) and close contact with COVID-19. Systemic support, adequate knowledge and resilience were identified as factors protecting against adverse mental health outcomes.ConclusionsThe evidence to date suggests that female nurses with close contact with COVID-19 patients may have the most to gain from efforts aimed at supporting psychological well-being. However, inconsistencies in findings and a lack of data collected outside of hospital settings, suggest that we should not exclude any groups when addressing psychological well-being in health and social care workers. Whilst psychological interventions aimed at enhancing resilience in the individual may be of benefit, it is evident that to build a resilient workforce, occupational and environmental factors must be addressed. Further research including social care workers and analysis of wider societal structural factors is recommended.
C1 [De Kock, Johannes H.; Grindle, Mark; Munoz, Sarah-Anne; Ellis, Liz; Polson, Rob; O'Malley, Christopher M.] Univ Highlands & Isl, Inst Hlth Res & Innovat, Old Perth Rd, Inverness IV2 3JH, Scotland.
   [De Kock, Johannes H.] New Craigs Hosp, Dept Clin Psychol, NHS Highland, Inverness IV3 8NP, Scotland.
   [Latham, Helen Ann] Nairn Healthcare Grp, NHS Highland, Cawdor Rd, Nairn IV12 5EE, Scotland.
   [Leslie, Stephen J.] NHS Highland Cardiac Unit Raigmore Hosp, NHS Highland, Inverness IV2 3UJ, Scotland.
RP De Kock, JH (corresponding author), Univ Highlands & Isl, Inst Hlth Res & Innovat, Old Perth Rd, Inverness IV2 3JH, Scotland.; De Kock, JH (corresponding author), New Craigs Hosp, Dept Clin Psychol, NHS Highland, Inverness IV3 8NP, Scotland.
EM hannes.dekock@uhi.ac.uk
RI De Kock, Hannes/B-7245-2019
OI De Kock, Hannes/0000-0002-2468-5572
FU Chief Science Office of the Scottish Government: RAPID RESEARCH IN
   COVID-19 PROGRAMME
FX This project is funded by the Chief Science Office of the Scottish
   Government: RAPID RESEARCH IN COVID-19 PROGRAMME REF: COV/UHI/Portfolio.
   The funding sources had no role in the design or conduct of the study
   nor in the collection, management, analysis, and interpretation of the
   data; preparation, review, or approval of the manuscript; or decision to
   submit the manuscript for publication.
CR Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Al Knawy BA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2017-017476
   Aldridge Robert W, 2020, Wellcome Open Res, V5, P88, DOI [10.12688/wellcomeopenres.15922.2, 10.12688/wellcomeopenres.15922.1]
   APM Research Lab, 2020, COL COR COVID 19 DEA
   Balakumar C, 2020, BRIT J SURG, V107, pE195, DOI 10.1002/bjs.11663
   Boniol M, 2019, GENDER EQUITY HLTH W
   British Medical Association, 2020, MENTAL HLTH WELLBEIN
   Brooks SK, 2011, J MENT HEALTH, V20, P146, DOI 10.3109/09638237.2010.541300
   Brooks SK, 2018, J OCCUP ENVIRON MED, V60, P248, DOI 10.1097/JOM.0000000000001235
   Burchell B., 2020, CUT HOURS NOT PEOPLE
   Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171
   Cai WP, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102111
   Campbell M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020064
   Cao JY, 2020, PSYCHOTHER PSYCHOSOM, V89, P252, DOI 10.1159/000507453
   CASP, 2020, COH STUD CHECKL
   Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049
   Chung J P Y, 2020, East Asian Arch Psychiatry, V30, P34, DOI 10.12809/eaap2014
   Critical Appraisal Skills Programme, COH STUD CHECKL CRIT
   Evidence Partners, TOOL ASSESS RISK BIA
   Evidence Partners CLARITY Group at McMaster University, 2020, METH RES TOOLS ASS R
   Gentilini U., 2020, SOCIAL PROTECTION JO
   Gold JA, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1815
   Grace SL, 2005, PSYCHOSOMATICS, V46, P385, DOI 10.1176/appi.psy.46.5.385
   Higgins J., 2019, COCHRANE HDB SYSTEMA, P403, DOI DOI 10.1002/9781119536604.CH15
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Hong QN, 2018, EDUC INFORM, V34, P285, DOI 10.3233/EFI-180221
   Hsu AT., 2020, MORTALITY ASS COVID
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Juni P., 2016, RISK BIAS NONRANDOMI
   Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028
   Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10
   Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Li ZY, 2020, BRAIN BEHAV IMMUN, V88, P916, DOI 10.1016/j.bbi.2020.03.007
   Liang YJ, 2020, J PSYCHOSOM RES, V133, DOI 10.1016/j.jpsychores.2020.110102
   Lockwood C, 2015, INT J EVID-BASED HEA, V13, P179, DOI 10.1097/XEB.0000000000000062
   Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936
   Markwell A, 2020, EMERG MED AUSTRALAS, V32, P520, DOI 10.1111/1742-6723.13514
   Maunder RG, 2006, EMERG INFECT DIS, V12, P1924
   Melnyk BM, 2020, AM J HEALTH PROMOT, V34, P929, DOI 10.1177/0890117120920451
   Mo YY, 2020, J NURS MANAGE, V28, P1002, DOI 10.1111/jonm.13014
   Montgomery A, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4774
   Moola S., 2020, JBI REVIEWERS MANUAL, DOI [DOI 10.46658/JBIMES-20-08, 10.46658/JBIMES-20-01]
   Munn, 2020, JBI MANUAL EVIDENCE, DOI [10.46658/JBIRM-17-06, DOI 10.46658/JBIMES-20-08]
   Nguyen Long H, 2020, medRxiv, DOI [10.1016/S2468-2667(20)30164-X, 10.1101/2020.04.29.20084111]
   Ortolan A, 2020, INT J INFECT DIS, V99, P496, DOI 10.1016/j.ijid.2020.07.076
   Perez-Lopez FR, 2020, MATURITAS, V141, P59, DOI 10.1016/j.maturitas.2020.06.017
   Petrie K, 2019, LANCET PSYCHIAT, V6, P225, DOI 10.1016/S2215-0366(18)30509-1
   Popay J, 2006, GUIDANCE CONDUCT NAR, DOI DOI 10.13140/2.1.1018.4643
   Reger MA, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.20com13381
   Neto MLR, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112972
   Shacham M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082900
   Spoorthy MS, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102119
   Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919
   Stevens, 2020, COCHRANE RAPID REV
   Sun NN, 2020, AM J INFECT CONTROL, V48, P592, DOI 10.1016/j.ajic.2020.03.018
   Tai DBG, 2021, CLIN INFECT DIS, V72, P703, DOI 10.1093/cid/ciaa815
   Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083
   Tawfik DS, 2019, ANN INTERN MED, V171, P555, DOI 10.7326/M19-1152
   Tricco A.C., 2017, RAPID REV STRENGTHEN
   UN, 2020, POL BRIEF COVID 19 N
   Urooj U, 2020, PAK J MED SCI, V36, pS37, DOI 10.12669/pjms.36.COVID19-S4.2643
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wang S, 2020, OCCUP MED-OXFORD, V70, P364, DOI 10.1093/occmed/kqaa074
   Wu Y, 2020, J PAIN SYMPTOM MANAG, V60, pE60, DOI 10.1016/j.jpainsymman.2020.04.008
   Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923921
   Xu J, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112955
   Yin X, 2020, Int J Nurs Sci, V7, P157, DOI 10.1016/j.ijnss.2020.04.002
   Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639
   Zhang XB, 2020, DEMENTIA-LONDON, V19, P2821, DOI 10.1177/1471301219861466
NR 70
TC 117
Z9 117
U1 41
U2 60
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 9
PY 2021
VL 21
IS 1
AR 104
DI 10.1186/s12889-020-10070-3
PG 18
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA PU6UQ
UT WOS:000609437100001
PM 33422039
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Iqbal, S
   Baleanu, D
   Ali, J
   Younas, HM
   Riaz, MB
AF Iqbal, S.
   Baleanu, D.
   Ali, Javaid
   Younas, H. M.
   Riaz, M. B.
TI Fractional Analysis of Dynamical Novel COVID-19 by Semi-Analytical
   Technique
SO CMES-COMPUTER MODELING IN ENGINEERING & SCIENCES
LA English
DT Article
DE Novel COVID-19; semi-analytical scheme; fractional analysis
AB This study employs a semi-analytical approach, called Optimal Homotopy Asymptotic Method (OHAM), to analyze a coronavirus (COVID-19) transmission model of fractional order. The proposed method employs Caputo's fractional derivatives and Reimann-Liouville fractional integral sense to solve the underlying model. To the best of our knowledge, this work presents the first application of an optimal homotopy asymptotic scheme for better estimation of the future dynamics of the COVID-19 pandemic. Our proposed fractional-order scheme for the parameterized model is based on the available number of infected cases from January 21 to January 28, 2020, in Wuhan City of China. For the considered real-time data, the basic reproduction number is R0 approximate to 2.48293 that is quite high. The proposed fractional-order scheme for solving the COVID-19 fractional-order model possesses some salient features like producing closed-form semi-analytical solutions, fast convergence and non-dependence on the discretization of the domain. Several graphical presentations have demonstrated the dynamical behaviors of subpopulations involved in the underlying fractional COVID-19 model. The successful application of the scheme presented in this work reveals new horizons of its application to several other fractional-order epidemiological models.
C1 [Iqbal, S.] Univ Management & Technol, Sch Syst & Technol, Lahore 54770, Pakistan.
   [Baleanu, D.] Cankaya Univ, Dept Math, TR-06530 Ankara, Turkey.
   [Baleanu, D.] Inst Space Sci, Bucharest 077125, Romania.
   [Ali, Javaid] Govt Coll Township, Punjab Higher Educ Dept, Dept Math, Lahore 54770, Pakistan.
   [Younas, H. M.] Islamia Univ Bahawalpur, Dept Math, Bahawalpur 63100, Pakistan.
   [Riaz, M. B.] Univ Management & Technol, Dept Math, Lahore 54770, Pakistan.
   [Riaz, M. B.] Univ Free State, Inst Groundwater Studies, ZA-9300 Bloemfontein, South Africa.
RP Riaz, MB (corresponding author), Univ Management & Technol, Dept Math, Lahore 54770, Pakistan.; Riaz, MB (corresponding author), Univ Free State, Inst Groundwater Studies, ZA-9300 Bloemfontein, South Africa.
EM bilalsehole@gmail.com
CR Ali Z, 2021, FRACTALS, V29, DOI 10.1142/S0218348X21500201
   Ali Z, 2021, ALEX ENG J, V60, P477, DOI 10.1016/j.aej.2020.09.020
   [Anonymous], 2020, NEW YORK TIMES
   Batista M., 2020, ESTIMATION FINAL SIZ
   Blake T.D., 1997, LIQUID FILM COATING
   Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243
   Cao JL, 2020, INTENS CARE MED, V46, P851, DOI 10.1007/s00134-020-05987-7
   CNBC, 2020, CHIN VIR DEATH TOLL
   Freihet A, 2019, ADV DIFFER EQU-NY, DOI 10.1186/s13662-019-2042-3
   Gaskell P. H., 1995, P 1 EUR COAT S, P19
   Iqbal S, 2019, AIP CONF PROC, V2116, DOI 10.1063/1.5114307
   Iqbal S, 2011, APPL MATH COMPUT, V217, P7753, DOI 10.1016/j.amc.2011.02.083
   Iqbal S, 2010, APPL MATH COMPUT, V216, P2898, DOI 10.1016/j.amc.2010.04.001
   Kumar S, 2022, NUMER METH PART D E, V38, P490, DOI 10.1002/num.22650
   Kumar S, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110048
   Kumar S, 2020, SPEC TOP REV POROUS, V11, P33
   Kumar S, 2020, MATH METHOD APPL SCI, V43, P8595, DOI 10.1002/mma.6517
   Kumar S, 2020, INT J BIOMATH, V13, DOI 10.1142/S1793524520500217
   Kumar S, 2020, CHAOS SOLITON FRACT, V130, DOI 10.1016/j.chaos.2019.109456
   Macrotrends, 2020, WUH CHIN POP 1950 20
   Miller K. S., 1993, INTRO FRACTIONAL CAL
   Ming WK, 2020, BREAKING HEALTHCARE, DOI 10.1101/2020.01.27.922443
   Mustahsan M, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.00131
   Nesteruk I., 2020, INNOV BIOSYST BIOENG, DOI [10.20535/ibb.2020.4.1.195074, DOI 10.20535/IBB.2020.4.1.195074]
   Oldham K.B., 1974, FRACTIONAL CALCULUS
   Pandey P, 2019, THERM SCI, V23, pS2045, DOI 10.2298/TSCI190725369P
   Pandey P, 2019, EUR PHYS J PLUS, V134, DOI 10.1140/epjp/i2019-12727-6
   Podlubny I., 1998, FRACTIONAL DIFFERENT
   RUSCHAK KJ, 1985, ANNU REV FLUID MECH, V17, P65, DOI 10.1146/annurev.fl.17.010185.000433
   Sarwar S, 2018, CHINESE J PHYS, V56, P374, DOI 10.1016/j.cjph.2017.11.009
   Sarwar S, 2016, INT J BIOMATH, V9, DOI 10.1142/S1793524516500819
   Sarwar S, 2015, COMPUT MATH APPL, V70, P942, DOI 10.1016/j.camwa.2015.06.017
   Sarwar S., 2017, NONLINEAR SCI LETT A, V8, P340
   Victor A., 2020, MATH PREDICTIONS FOR, DOI [10.2139/ssrn.3555879, DOI 10.2139/SSRN.3555879]
   Younas HM, 2019, MATHEMATICS-BASEL, V7, DOI 10.3390/math7030264
   Zeb A, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/3452402
NR 36
TC 0
Z9 0
U1 2
U2 2
PU TECH SCIENCE PRESS
PI HENDERSON
PA 871 CORONADO CENTER DR, SUTE 200, HENDERSON, NV 89052 USA
SN 1526-1492
EI 1526-1506
J9 CMES-COMP MODEL ENG
JI CMES-Comp. Model. Eng. Sci.
PY 2021
VL 129
IS 2
BP 705
EP 727
DI 10.32604/cmes.2021.015375
PG 23
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Mathematics
GA WG0OJ
UT WOS:000706698100006
OA gold
DA 2022-04-20
ER

PT J
AU Ferri, M
   Lloyd-Evans, M
AF Ferri, Maurizio
   Lloyd-Evans, Meredith
TI The contribution of veterinary public health to the management of the
   COVID-19 pandemic from a One Health perspective
SO ONE HEALTH
LA English
DT Article
DE Covid-19; SARS-CoV-2; Public health veterinarians; Epidemiological
   surveillance; One Health
ID CORONAVIRUS; SARS-COV-2
AB The human coronavirus disease 2019 (COVID-19) pandemic represents one of the greatest public health crises in recent history, which has caused unprecedented and massive disruptions of social and economic life globally, and the biggest communication challenges for public information-sharing. While there is strong evidence that bats are the animal source of SARS-CoV-2, the causative agent of COVID-19, there are many uncertainties around the epidemiology, the intermediate animal species, and potential animal routes of SARS-Cov-2 transmission to humans. While it has also long been known that coronaviruses circulate among different animal species, including SARS-CoV and MERS-CoV, responsible for the pandemics of severe acute respiratory syndrome and Middle East respiratory syndrome endemic in Middle Eastern countries in 2002-2003 and 2012 respectively, the way this pandemic is being managed tends to downplay or neglect the veterinary contribution, which is not in line with the One Health approach, if we consider that the genesis of the COVID-19 pandemic, likewise SARS and MERS lies on a close and interdependent links of humans, animals and the environment. To overcome this flaw, and to better operationalize the One Health approach, there are several lines of contributions the veterinary profession might provide to manage the COVID-19 pandemic in the framework of interventions jointly concerted in the veterinary and medical domains, notably: the experience in dealing with past animal epidemics, the skills in conducting wildlife surveillance targeting emerging pathogens at risky hot spots, and with the aim to predict and prevent future pandemics, the laboratory support for the diagnosis and molecular characterization of SARSCoV-2 and human samples testing, and animal import risk assessment to define COVID-19 risk strategy for international air travel. The veterinary profession presents itself ontologically with a strong One Health accent and all the related valuable knowledge can be properly integrated within centralised multidisciplinary task-forces set up at the national and international level, with a renewed role in the management and monitoring structures required for managing the COVID-19 pandemic.
C1 [Ferri, Maurizio] Italian Soc Prevent Vet Med SIMeVeP, Rome, Italy.
   [Lloyd-Evans, Meredith] European Food Safety Agcy, Assoc Vet Consultants, Stakeholder Advisory Grp Emerging Risks, Cambridge, England.
   [Lloyd-Evans, Meredith] BioBridge Ltd, Cambridge, England.
RP Ferri, M (corresponding author), Via Nizza 11, I-00198 Rome, Italy.
EM ferrim282@gmail.com
CR Ahn M, 2019, NAT MICROBIOL, V4, P789, DOI 10.1038/s41564-019-0371-3
   Alemanno A, 2020, EUR J RISK REGUL, V11, P307, DOI 10.1017/err.2020.44
   American Society for Microbiology (ASM), 2020, COVID 19 TRANSM DYN
   Amuasi JH, 2020, LANCET, V395, P1543, DOI 10.1016/S0140-6736(20)31028-X
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   [Anonymous], 2021, ERAVSCORONAS ACTION
   Bivins A, 2020, ENVIRON SCI TECHNOL, V54, P7754, DOI 10.1021/acs.est.0c02388
   Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4
   Brackney DE, 2020, SARS COV 2 RNA CONCE, DOI [10.1101/2020.05.19.20105999, DOI 10.1101/2020.05.19.20105999]
   Chen Q, 2020, PATIENT DERIVED MUTA, DOI [10.1101/2020.04.14.20060160., DOI 10.1101/2020.04.14.20060160]
   Cohen J., 2020, SCIENCE, V10, DOI [10.1126/science.abb0611, DOI 10.1126/SCIENCE.ABB0611]
   Conceicao C, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3001016
   Conrad M.F., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.08.19.256800, DOI 10.1101/2020.08.19.256800]
   Corman VM, 2018, ADV VIRUS RES, V100, P163, DOI 10.1016/bs.aivir.2018.01.001
   Daszak P., 2020, PBES WORKSH REP BIOD, DOI [10.5281/zenodo.4147318, DOI 10.5281/ZENODO.4147318]
   Di Teodoro G, 2021, VET MICROBIOL, V252, DOI 10.1016/j.vetmic.2020.108933
   ECDC, 2020, COVID 19 SIT UPD EU
   ECDC (European Centre for Disease Prevention and Control), 2020, DET NEW SARS COV 2 V
   Edwards CE, 2020, P NATL ACAD SCI USA, V117, P26915, DOI [10.1073/pnas.2001046117, 10.1073/pnas.2001046117/-/DCSupplemental]
   EU Commission, 2021, COR 117 MILL GRANT T
   EU Commission DG for Health and Food Safety, 2020, EU HLTH PREP REC COM
   European Centre for Disease Prevention and Control (ECDC), 2020, COVID 19 TEST STRAT
   European Union, 2020, JOINT EUR ROADM LIFT
   FAO, 2021, FAO ANIMAL PRODUCTIO
   Foddai A, 2020, ONE HEALTH-AMSTERDAM, V9, DOI 10.1016/j.onehlt.2020.100129
   Foddai A, 2020, ONE HEALTH-AMSTERDAM, V9, DOI 10.1016/j.onehlt.2020.100130
   Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4
   Franklin AB, 2020, SCI TOTAL ENVIRON, V733, DOI 10.1016/j.scitotenv.2020.139358
   Ge X., 2020, POTENT HUMAN NEUTRAL, DOI [10.1101/ 2020.03.21.990770v2, DOI 10.1101/2020.03.21.990770V2]
   Geller C, 2012, VIRUSES-BASEL, V4, P3044, DOI 10.3390/v4113044
   Genzel L, 2020, CURR BIOL, V30, pR1014, DOI 10.1016/j.cub.2020.08.030
   Gerdts V, 2007, FUTURE MICROBIOL, V2, P667, DOI 10.2217/17460913.2.6.667
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Gorse GJ, 2009, J INFECT DIS, V199, P847, DOI 10.1086/597122
   Gruetzmacher K, 2021, SCI TOTAL ENVIRON, V764, DOI 10.1016/j.scitotenv.2020.142919
   Harrison S, 2019, ENVIRON INT, V132, DOI 10.1016/j.envint.2019.105058
   Hoinville LJ, 2013, PREV VET MED, V112, P1, DOI 10.1016/j.prevetmed.2013.06.006
   Hu B, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0422-1
   Jo WK, 2021, TRANSBOUND EMERG DIS, V68, P1824, DOI 10.1111/tbed.13872
   Jordana J, 2020, LANCET, V395, P1611, DOI 10.1016/S0140-6736(20)31132-6
   Koopmans M, 2021, LANCET INFECT DIS, V21, P18, DOI [10.1016/1473-3099(20)30912-9, 10.1016/S1473-3099(20)30912-9]
   La Bella G, 2017, FOOD ENVIRON VIROL, V9, P179, DOI 10.1007/s12560-016-9273-1
   Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0
   Latinne A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17687-3
   Lecis R, 2019, VIRUS GENES, V55, P60, DOI 10.1007/s11262-018-1614-8
   Lee J, 2020, ECOHEALTH, V17, P406, DOI 10.1007/s10393-020-01503-x
   Leroy EM, 2020, ONE HEALTH-AMSTERDAM, V10, DOI 10.1016/j.onehlt.2020.100133
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li Xiaojun, 2020, bioRxiv, DOI 10.1101/2020.03.20.000885
   Lopez-Camacho C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040322
   Lorusso A, 2020, VET ITAL, V56, P5, DOI 10.12834/VetIt.2173.11599.1
   Medema G, 2020, ENVIRON SCI TECH LET, V7, P511, DOI 10.1021/acs.estlett.0c00357
   Messenger AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089055
   Ministry of Environment and Food of Denmark, 2021, UPD 6 COVD 19 SIT DE
   Munir K, 2020, EMERG MICROBES INFEC, V9, P2222, DOI 10.1080/22221751.2020.1827984
   Munnink BBO, 2021, SCIENCE, V371, P172, DOI 10.1126/science.abe5901
   OIE, 2021, GUID WORK FARM AN SP
   Olival KJ, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008758
   Oreshkova N, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.23.2001005
   Pene F, 2003, CLIN INFECT DIS, V37, P929, DOI 10.1086/377612
   Petrovan S.O., POSTCOVID 19 SOLUTIO
   PROMED International Society for Infectious Diseases, 2020, COVID 19 UPD 536 AN
   Rasmussen, 2020, WORKING PAPER SARS C
   Rausch JW, 2020, P NATL ACAD SCI USA, V117, P24614, DOI 10.1073/pnas.2017726117
   Report T., 2020, COVID 19 VACC PRIOR, P1
   Riccardo F, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.32.1800427
   Rizzo F, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1307-x
   Robson F, 2020, MOL CELL, V79, P710, DOI 10.1016/j.molcel.2020.07.027
   Samaddar A., 2020, OPEN FORUM INFECT DI, DOI [10.1093/ofid.ofaa599, DOI 10.1093/OFID.OFAA599]
   Santini JM, 2020, LANCET MICROBE, V1, pE141, DOI 10.1016/S2666-5247(20)30069-0
   Schlottau K, 2020, LANCET MICROBE, V1, pE218, DOI 10.1016/S2666-5247(20)30089-6
   Schulz C., SARS COV 2 INFECT CA
   Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y
   Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015
   Sit THC, 2020, NATURE, V586, P776, DOI 10.1038/s41586-020-2334-5
   Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702
   Stedman A, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0138-0
   Taylor R., 2020, RISK INTRO SARS COV, DOI [10.1101/2020.09.09.20190454, DOI 10.1101/2020.09.09.20190454]
   Tobaiqy M, 2020, THERAPEUTIC MANAGEME, DOI DOI 10.1016/J.INFPIP.2020.100061
   United Nations Industrial Developments Organizations (UNIDO), 2020, COR EC IMP 10
   van Doremalen N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba8399
   van Doremalen N, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007462
   von Borries R, 2020, LANCET PLANET HEALTH, V4, pE501, DOI 10.1016/S2542-5196(20)30241-2
   Wabnitz KJ, 2020, LANCET PLANET HEALTH, V4, pE257, DOI 10.1016/S2542-5196(20)30142-X
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wigginton KR, 2015, ENVIRON SCI-WAT RES, V1, P735, DOI [10.1039/c5ew00125k, 10.1039/C5EW00125K]
   World Health Organization, 2020, SARS COV 2 VAR
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Xiao KP, 2020, NATURE, V583, P286, DOI 10.1038/s41586-020-2313-x
   Zhang Q, 2020, EMERG MICROBES INFEC, V9, P2013, DOI 10.1080/22221751.2020.1817796
   Zhang T, 2020, PROBABLE PANGOLIN OR, DOI [10.2139/ssrn.3542586, DOI 10.2139/SSRN.3542586]
   Zhang YZ, 2020, CELL, V181, P223, DOI 10.1016/j.cell.2020.03.035
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 97
TC 3
Z9 3
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2352-7714
J9 ONE HEALTH-AMSTERDAM
JI One Health
PD JUN
PY 2021
VL 12
AR 100230
DI 10.1016/j.onehlt.2021.100230
EA MAR 2021
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA XW7YI
UT WOS:000735829200015
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Jnr, BA
   Noel, S
AF Anthony Jnr, Bokolo
   Noel, Selwyn
TI Examining the adoption of emergency remote teaching and virtual learning
   during and after COVID-19 pandemic
SO INTERNATIONAL JOURNAL OF EDUCATIONAL MANAGEMENT
LA English
DT Review
DE Education management; Online leaning theories; Emergency remote
   teaching; Learning crisis and school closures; Virtual learning tools;
   COVID-19 pandemic
ID EDUCATION
AB Purpose The Coronavirus 2019 (COVID-19) pandemic has already had a significant disruptive impact on the society, posing challenges to the provision of education across the world. Due to this crises governments over the world have temporarily closed educational institutions to help reduce the spread of COVID-19. Accordingly, educational institutions are deploying innovative emergency remote teaching (ERT) and virtual learning (VL) approaches for students to study at home. Digital technologies are being employed as a positive response to COVID-19 pandemic. Therefore, this study draws on existing literature and theories of online learning and change management to provide evidence on the state of art of ERT and VL. Design/methodology/approach This current study employs a systemic review of 53 sources to provide descriptive analysis leveraging on secondary sources from the literature and document reports on theories of online learning and change management, COVID-19, pandemic, emergency remote teaching and virtual learning. Findings Findings from this study present the theories of online learning and change management and significance and challenges of adopting ERT and VL during the COVID-19 pandemic. Also, our findings present application platforms that are being deployed for the adoption of ERT and VL during and after COVID-19 pandemic. Lastly, the findings explore potential strategies as recommendations to be employed to improve current and future adoption of ERT and VL in educational institutions. Originality/value This study draws on existing literature and adds to existing body of knowledge by exploring the adoption of emergency remote teaching and virtual learning during and after COVID-19 pandemic. This study provides a timely guide on the potential of emergency remote teaching and virtual learning in higher education as a response to COVID-19 crises now and into the future. This study discusses the theories of online learning and change management and also offers recommendations to educationalists and policymakers in educational institutions on addressing the crisis.
C1 [Anthony Jnr, Bokolo] Norwegian Univ Sci & Technol NTNU, Dept Comp Sci, Trondheim, Norway.
   [Noel, Selwyn] Walden Univ, Sch Educ Educ Technol & Design, Minneapolis, MN USA.
RP Jnr, BA (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Comp Sci, Trondheim, Norway.
EM anthony.j.bokolo@ntnu.no; snoel@lesystems.org
RI Anthony, Bokolo/K-9280-2016
OI Anthony, Bokolo/0000-0002-7276-0258; Noel, Selwyn/0000-0002-7381-1483
CR Abdulrahim H., 2020, ASIAN J DIS ED, V15, P291
   Abusalim N, 2020, INT J EDUC MANAG, V34, P1203, DOI 10.1108/IJEM-08-2019-0326
   Aguliera E, 2020, INFORM LEARN SCI, V121, P471, DOI 10.1108/ILS-04-2020-0100
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   Anderson ML, 2020, J HOSP MED, V15, P287, DOI 10.12788/jhm.3431
   [Anonymous], 2020, BLOOMS TAX ULT GUID
   Anthony BJ, 2020, INT J INF LEARN TECH, V37, P179, DOI 10.1108/IJILT-02-2020-0013
   Anthony B, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01596-5
   Anthony B, 2019, EDUC INF TECHNOL, V24, P3433, DOI 10.1007/s10639-019-09941-z
   Basilaia G., 2020, PEDAGOGICAL RES, V5, DOI [DOI 10.29333/PR/7937, 10.29333/pr/7937]
   Bokolo AJ, 2021, IRISH J MED SCI, V190, P1, DOI 10.1007/s11845-020-02299-z
   Bokolo A, 2020, J RES TECHNOL EDUC, V52, P37, DOI 10.1080/15391523.2019.1675203
   Bozkurt A., 2020, ASIAN J DISTANCE ED, V15, pi, DOI [10.5281/zenodo.3778083, DOI 10.5281/ZENODO.3778083, https://doi.org/10.5281/zenodo.3778083]
   Ceylan R F, 2020, RES J ADV HUMANITIES, V1, P21
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Crawford J., 2020, J APPL LEARN TEACH, V3, P1, DOI DOI 10.37074/JALT.2020.3.1.7
   d'Orville Hans, 2020, Prospects (Paris), V49, P11, DOI 10.1007/s11125-020-09475-0
   Daniel Sir John, 2020, Prospects (Paris), P1, DOI 10.1007/s11125-020-09464-3
   Espino-Diaz L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145646
   Hayes S., 2020, POSTDIGITAL SCI ED, V2, P968, DOI [10.1007/s42438-020-00128-1, DOI 10.1007/S42438-020-00128-1]
   Inchausti F, 2020, J CONTEMP PSYCHOTHER, V50, P243, DOI 10.1007/s10879-020-09460-w
   Jones K., 2020, REIMAGINING FUTURE O, DOI [10.2139/ssrn.3578310, DOI 10.2139/SSRN.3578310]
   Karalis T., 2020, INT J ACAD RES BUS S, V10, P479, DOI [10.6007/IJARBSS/v10-i5/7219, DOI 10.6007/IJARBSS/V10-I5/7219]
   Karalis T., 2020, EUROPEAN J ED STUDIE, V7, P125, DOI [10.46827/ejes.v0i0.3047, DOI 10.5281/ZENODO.3789022]
   Keefe T., 2020, RESEARCHGATE
   Kerres M., 2020, POSTDIGITAL SCI EDUC, V2, P690, DOI [10.1007/s42438-020-00130-7, DOI 10.1007/S42438-020-00130-7]
   Khlaif ZN, 2020, MED SCI, V11, P135, DOI DOI 10.30476/IJVLMS.2020.86120.1033
   Koumpouras F, 2020, ARTHRITIS RHEUMATOL, V72, P1064, DOI 10.1002/art.41278
   Krishnamurthy S, 2020, J BUS RES, V117, P1, DOI 10.1016/j.jbusres.2020.05.034
   Leung CC, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30520-1
   Mehall S, 2020, ONLINE LEARN, V24, P182, DOI 10.24059/olj.v24i1.2002
   Mian A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01556-3
   Mulenga E. M., 2020, CONT ED TECHNOLOGY, V12, P1, DOI [10.30935/cedtech/7949, DOI 10.30935/CEDTECH/7949]
   Olo D. P., 2020, EXAMINING ROLE ENTRE, P1
   Onofrei G, 2020, INT J EDUC MANAG, V34, P1559, DOI 10.1108/IJEM-12-2019-0418
   Pillai R, 2020, INT J EDUC MANAG, V34, P586, DOI 10.1108/IJEM-01-2019-0025
   Rahim AFA., 2020, ED MED J, V12, P59, DOI [10.21315/eimj2020.12.2.6, DOI 10.21315/EIMJ2020.12.2.6]
   Reimers F. M., 2020, FRAMEWORK GUIDE ED R
   Rose S, 2020, JAMA-J AM MED ASSOC, V323, P2131, DOI 10.1001/jama.2020.5227
   Salha S., 2020, INTERDISCIPLINARY J, V11, P130, DOI [10.30476/ijvlms.2020.86119.1034, DOI 10.30476/IJVLMS.2020.86119.1034]
   schrockguide, 2020, RES SUPP SAMR MOD
   Schwartz Andrew M, 2020, JB JS Open Access, V5, pe0045, DOI 10.2106/JBJS.OA.20.00045
   techedges, 2020, RAT MOD
   thetechedvocate, 2020, DIG LEARN THEOR MOD
   Toquero CM, 2020, ASIAN J DISTANCE ED, V15, P185, DOI [10.5281/zenodo. 3881748, DOI 10.5281/ZENODO.3881748]
   tpack, 2020, TPACK EXPLAINED
   Trust T., 2020, J TECHNOLOGY TEACHER, V28, P189
   UNESCO, 2020, COVID 19 ED RESP
   Valko N, 2020, UKRAINIAN J ED STUDI, V8, P1
   Van Lancker W, 2020, LANCET PUBLIC HEALTH, V5, pE243, DOI 10.1016/S2468-2667(20)30084-0
   Yousfi N, 2020, BIOL SPORT, V37, P211, DOI 10.5114/biolsport.2020.95125
   Zayapragassarazan Z, 2020, F1000 RES, DOI [10.7490/f1000research.1117835.1, DOI 10.7490/F1000RESEARCH.1117835.1]
   Zhu X., 2020, POSTDIGITAL SCI EDUC, V2, P695, DOI 10.1007/s42438-020-00126-3
NR 53
TC 3
Z9 3
U1 18
U2 30
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0951-354X
EI 1758-6518
J9 INT J EDUC MANAG
JI Int. J. Educ. Manag.
PD OCT 21
PY 2021
VL 35
IS 6
BP 1136
EP 1150
DI 10.1108/IJEM-08-2020-0370
EA MAY 2021
PG 15
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA WM1NK
UT WOS:000653196300001
OA Bronze
DA 2022-04-20
ER

PT J
AU Ferreira-da-Silva, R
   Ribeiro-Vaz, I
   Morato, M
   Polonia, JJ
AF Ferreira-da-Silva, Renato
   Ribeiro-Vaz, Ines
   Morato, Manuela
   Polonia, Jorge Junqueira
TI Guiding axes for drug safety management of pharmacovigilance centres
   during the COVID-19 era
SO INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
LA English
DT Editorial Material
DE Adverse Drug Event; Adverse Drug Reaction; Drug Monitoring; Incident
   Reporting System; Pharmacovigilance
ID SIGNAL-DETECTION
AB The COVID-19 pandemic presents several challenges to the organisation and workflow of pharmacovigilance centres as a result of the massive increase in reports, the need for quick detection, processing and reporting of safety issues and the management of these within the context of lack of complete information on the disease. Pharmacovigilance centres permanently monitor the safety profile of medicines, ensuring risk management to evaluate the benefit-risk relationship. However, traditional pharmacovigilance approaches of spontaneous reporting, are not suitable in the context of a pandemic; the scientific community and regulators need information on a near real-time point. The aim of this commentary is to suggest six interrelated multidimensional guiding axes for drug safety management by pharmacovigilance centres during the COVID-19 pandemic. This working plan can increase knowledge on COVID-19 and associated therapeutic approaches, support decisions by the regulatory authorities, oppose fake news and promote more efficient public health protection.
C1 [Ferreira-da-Silva, Renato; Ribeiro-Vaz, Ines; Polonia, Jorge Junqueira] Porto Pharmacovigilance Ctr, Rua Doutor Placido da Costa, P-4200450 Porto, Portugal.
   [Ferreira-da-Silva, Renato; Ribeiro-Vaz, Ines] Dept Community Med Hlth Informat & Decis, Porto, Portugal.
   [Ferreira-da-Silva, Renato; Ribeiro-Vaz, Ines; Polonia, Jorge Junqueira] CINTESIS Ctr Hlth Technol & Serv Res, Porto, Portugal.
   [Morato, Manuela] LAQV REQUIMTE, Dept Drug Sci, Lab Pharmacol, Porto, Portugal.
   [Polonia, Jorge Junqueira] Univ Porto, Dept Med, Porto, Portugal.
RP Ferreira-da-Silva, R (corresponding author), Porto Pharmacovigilance Ctr, Rua Doutor Placido da Costa, P-4200450 Porto, Portugal.; Ferreira-da-Silva, R (corresponding author), Dept Community Med Hlth Informat & Decis, Porto, Portugal.; Ferreira-da-Silva, R (corresponding author), CINTESIS Ctr Hlth Technol & Serv Res, Porto, Portugal.
EM renato.ivos@gmail.com
RI Ribeiro-Vaz, Inês/AAZ-7511-2021; da Silva, Renato Ferreira/AAC-7360-2021
OI Ribeiro-Vaz, Inês/0000-0002-3442-8158; da Silva, Renato
   Ferreira/0000-0001-6517-6021; Polonia, Jorge/0000-0002-0133-7217;
   Morato, Manuela/0000-0002-9509-0613; Vaz, Ines Regio/0000-0003-2410-7307
FU Portuguese national fundsPortuguese Foundation for Science and
   Technology [2020.10231.BD]; European Social Fund (ESF) through FCT -
   Fundacao para a Ciencia e a Tecnologia (Portugal)
FX This commentary was supported by the PhD scholarship 2020.10231.BD
   (DOCTORATES 4 COVID-19), funded by Portuguese national funds and
   Community funds from the European Social Fund (ESF) through FCT -
   Fundacao para a Ciencia e a Tecnologia (Portugal).
CR Agency EM, 2021, EMA ECDC JOIN FORC E
   Agency EM, 2021, LIST MED ADD MON
   Agoro OO, 2018, J AM MED INFORM ASSN, V25, P627, DOI 10.1093/jamia/ocx102
   Alhazzani W, 2020, CRIT CARE MED
   [Anonymous], 2020, LOW COST DEXAMETHASO
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Chinchilla K, 2021, DRUG SAFETY, V44, P181, DOI 10.1007/s40264-020-00999-0
   Ferreira-Da-Silva R, 2021, ACTA MEDICA PORT, V34, P173, DOI 10.20344/amp.15375
   Food and Drug Administration US, 2021, COVID 19 VACC SAF SU
   Gatti M, 2021, BRIT J CLIN PHARMACO, V87, P1533, DOI 10.1111/bcp.14459
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Inacio P, 2018, INT J CLIN PHARM-NET, V40, P754, DOI 10.1007/s11096-018-0689-6
   Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208
   Meyboom RHB, 1997, DRUG SAFETY, V16, P355, DOI 10.2165/00002018-199716060-00002
   Pontes H, 2014, DRUG SAFETY, V37, P471, DOI 10.1007/s40264-014-0180-9
   Rodrigues PP, 2018, ARTIF INTELL MED, V91, P12, DOI 10.1016/j.artmed.2018.07.005
   Sato K, 2020, BIOSCI TRENDS, V14, P139, DOI 10.5582/bst.2020.03082
   Senanayake S.L., 2020, FUTURE DRUG DISCOV, V2, DOI DOI 10.4155/FDD-2020-0010
   Sun J, 2020, CLIN PHARMACOL THER, V108, P791, DOI 10.1002/cpt.1866
   Tuccori M, 2020, DRUG SAFETY, V43, P699, DOI 10.1007/s40264-020-00965-w
   VAC4EU) VmCfE, 2021, COH EV MON SAF COVID
NR 21
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2210-7703
EI 2210-7711
J9 INT J CLIN PHARM-NET
JI Int. J. Clin. Phar,.
PD AUG
PY 2021
VL 43
IS 4
BP 1133
EP 1138
DI 10.1007/s11096-021-01289-0
EA JUN 2021
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA TX8RO
UT WOS:000657333900003
PM 34076805
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Martinez-Beneyto, Y
   Ausina-Marquez, V
   Exposito-Delgado, AJ
   Ortiz-Ruiz, AJ
   Ibanez-Lopez, FJ
   Llodra-Calvo, JC
   Bravo, M
AF Martinez-Beneyto, Yolanda
   Ausina-Marquez, Veronica
   Exposito-Delgado, Antonio J.
   Ortiz-Ruiz, Antonio J.
   Ibanez-Lopez, Francisco J.
   Llodra-Calvo, Juan C.
   Bravo, Manuel
TI Spanish Dentists' Awareness, Knowledge, and Practice Regarding COVID-19:
   A Multiple Regression Analysis
SO INTERNATIONAL DENTAL JOURNAL
LA English
DT Article
DE COVID-19; Infection control; Dentist; Dental hygienist; Dental practice
   management
AB Introduction: During the first months of the coronavirus disease 2019 (COVID-19) pandemic, Spain had the highest mortality rate and the second-highest infection rate in the world. Objective: To analyze the occupational situation of dentists, hygienists, and dental auxiliary staff during the peak of the pandemic, after the state of alarm was declared in Spain, and when the state of alarm was declared. In addition, a possible relationship between the geo-graphical distribution of infected people and the availability of individual protection sys-tems was investigated. Material and Methods: A cross-sectional questionnaire was answered by 6470 dentists and dental staff via WhatsApp and social media. Results: A total of 1 in 4 dental professionals ceased working completely. Of those that kept working, 25.28% of dentists and 19.61% of hygienist-auxiliary were equipped with filtering face piece (FFP) 2 masks (P < .05), and 61.8% complied with the official protection recommen-dations set by the General Council of Dentists of Spain. Nearly 59.4% of respondents had symptoms, but only 1.5% of dentists were tested, with 14% of dentists in isolation at the time of response. Overall, it is suggested that 10% of dental professionals may have been in direct contact with the coronavirus. Conclusions: Direct contact of Spanish dental health professionals with severe acute respira-tory syndrome coronavirus disease 2 (SARS CoV-2) has been high during the most active phase of the pandemic. Dental professionals did not have personal protective equipment (PPE) nec-essary to care for patients, a situation that justified the reduction in scheduled dental care and only emergencies being treated. The Spanish geographical regions with the highest number of contagions had the least amount of individual protective resources (FFP2 and FFP3 masks). (c) 2021 The Authors. Published by Elsevier Inc. on behalf of FDI World Dental Federation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
C1 [Martinez-Beneyto, Yolanda] Univ Murcia, Fac Med Dent, Dept Stomatol, Unit Prevent & Community Dent, Murcia, Spain.
   [Ausina-Marquez, Veronica] European Univ Valencia, Fac Dent, Dept Pediat & Prevent Dent, Valencia, Spain.
   [Exposito-Delgado, Antonio J.] Serv Andaluz Salud, Area Gest Sanitaria Jaen Norte, Jaen, Spain.
   [Ortiz-Ruiz, Antonio J.] Univ Murcia, Fac Med Dent, Dept Stomatol, Unit Integrated Pediat Dent, Murcia, Spain.
   [Ibanez-Lopez, Francisco J.] Univ Murcia, Stat Serv, Sci & Tech Res Area, Murcia, Spain.
   [Llodra-Calvo, Juan C.; Bravo, Manuel] Univ Granada, Fac Dent, Dept Prevent & Community Dent, Granada, Spain.
RP Martinez-Beneyto, Y (corresponding author), Univ Murcia, Fac Med Dent, Dept Stomatol, Clin Odontol Univ Morales Meseguer, Avda Marques de los Velez S-N,2a Planta, Murcia, Spain.
RI ; ORTIZ RUIZ, ANTONIO JOSE/M-2458-2018
OI EXPOSITO DELGADO, Antonio Javier/0000-0002-7978-2804; Ibanez-Lopez,
   Francisco Javier/0000-0003-2367-7260; ORTIZ RUIZ, ANTONIO
   JOSE/0000-0001-9113-8416
CR [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Centers for Disease Control and Prevention, DEV GUID REG RESP CO
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen L, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009226
   Cohen J., 1988, STAT POWER ANAL BEHA, V2, DOI [10.1111/1467-9507.00183, DOI 10.4324/9780203771587]
   Consejo General de Dentistas, PLAN ESTR ACC PAR PE
   Consejo General de Dentistas, REC BUEN PRACT AT UR
   Guan W, 2020, N Engl J Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Instituto Nacional de Estad ~istica, VIS DENT EST HIGH DE
   Izzetti R, 2020, J DENT RES, V99, P1030, DOI 10.1177/0022034520920580
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Khader Y, 2020, JMIR PUBLIC HLTH SUR, V6, P185, DOI 10.2196/18798
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   LlodraCalvo, 2016, RCOE S1, V21, P8
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Ministerio de Sanidad consumo y bienestar social, EST ENE COVID 19 PRI
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Razai MS, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m800
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Shacham M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082900
   The American Dental Association, COR FREQ ASK QUEST
   To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149
   (WHO) WHO, ROLL UPD COR DIS COV
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   Xu J, 2020, J DENT RES, V99, P989, DOI 10.1177/0022034520918518
NR 26
TC 3
Z9 3
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0020-6539
EI 1875-595X
J9 INT DENT J
JI Int. Dent. J.
PD DEC
PY 2021
VL 71
IS 6
BP 530
EP 539
DI 10.1016/j.identj.2021.01.012
EA NOV 2021
PG 10
WC Dentistry, Oral Surgery & Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dentistry, Oral Surgery & Medicine
GA XD7LS
UT WOS:000722886500013
PM 33795144
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Malik, UR
   Atif, N
   Hashmi, FK
   Saleem, F
   Saeed, H
   Islam, M
   Jiang, MH
   Zhao, MY
   Yang, CJ
   Fang, Y
AF Malik, Usman Rashid
   Atif, Naveel
   Hashmi, Furqan Khurshid
   Saleem, Fahad
   Saeed, Hamid
   Islam, Muhammad
   Jiang, Minghuan
   Zhao, Mingyue
   Yang, Caijun
   Fang, Yu
TI Knowledge, Attitude, and Practices of Healthcare Professionals on
   COVID-19 and Risk Assessment to Prevent the Epidemic Spread: A
   Multicenter Cross-Sectional Study from Punjab, Pakistan
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE KAP; COVID-19; healthcare professionals; risk assessment; Pakistan
AB In the current outbreak of novel coronavirus (COVID-19), healthcare professionals (HCPs) have a primary role in combating the epidemic threat. HCPs are at high risk of not only contracting the infection but also spreading it unknowingly. It is of utmost importance to evaluate their knowledge, attitudes, and practices (KAP) and the ability to assess the risks associated with the outbreak. A cross-sectional online survey involving physicians, pharmacists, and nurses was conducted. A 39-itemed questionnaire based on the World Health Organization (WHO)COVID-19 risk assessment tool was shared with healthcare professionals in three purposively selected key divisions of Punjab province. Out of 500 healthcare professionals, 385 responded to the survey. The majority (70%) were aged 22-29 years; 144 (37.4%) physicians, 113 (29.4%) nurses, and 128 (33.2%) pharmacists completed the survey. Overall, 94.8% of healthcare professionals scored adequately (>14) for COVID-19-related knowledge; 97.9% displayed an optimistic attitude (>42) and 94.5% had an adequate practice score (>28). Kruskal-Wallis and Jonckheere-Terpstra tests showed significant differences (p< 0.05) in KAP and risk assessment scores among groups; physicians and nurses scored higher as compared to pharmacists. Further research and follow-up investigations on disaster management and risk assessment can help policy-makers better tackle future epidemics.
C1 [Malik, Usman Rashid; Atif, Naveel; Jiang, Minghuan; Zhao, Mingyue; Yang, Caijun; Fang, Yu] Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian 710061, Peoples R China.
   [Hashmi, Furqan Khurshid; Saeed, Hamid; Islam, Muhammad] Univ Punjab, Univ Coll Pharm, Lahore 54000, Punjab, Pakistan.
   [Saleem, Fahad] Univ Balochistan, Dept Pharm, Quetta 87900, Balochistan, Pakistan.
RP Fang, Y (corresponding author), Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian 710061, Peoples R China.
EM usmanmalik_ucp@hotmail.com; atifnaveel@stu.xjtu.edu.cn;
   furcian.pharmacy@pu.edu.pk; fahaduob@gmail.com;
   hamid.pharmacy@pu.edu.pk; islam.pharmacy@pu.edu.pk;
   jiangmh2017@xjtu.edu.cn; mingyue0204@xjtu.edu.cn;
   yangcj@mail.xjtu.edu.cn; yufang@mail.xjtu.edu.cn
RI Atif, Naveel/P-9084-2015; Hashmi, Furqan/ABG-5594-2020; Malik,
   Usman/ABF-9270-2020; Saleem, Fahad/D-8321-2014
OI Atif, Naveel/0000-0001-6810-6133; Hashmi, Furqan/0000-0003-4921-3739;
   Saleem, Fahad/0000-0001-8100-8992; Saeed, HAMID/0000-0002-1400-4825;
   Malik, Usman Rashid/0000-0002-8872-9749
FU "Young Talent Support Program" of Health Science Center, Xi'an Jiaotong
   University
FX This research was funded by "Young Talent Support Program" of Health
   Science Center, Xi'an Jiaotong University.
CR Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0
   Al-Hazmi A., 2016, J BOIL SCI, V25, P572, DOI [10.1016/j.sjbs.2016.01.032, DOI 10.1016/J.SJBS.2016.01.032]
   Anelli F, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1254
   Asaad A, 2020, E MEDITERR HEALTH J, V26, P435, DOI 10.26719/emhj.19.079
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1339, DOI 10.1001/jama.2020.3072
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1039, DOI 10.1001/jama.2020.1490
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Khan S, 2020, J MED VIROL, V92, P824, DOI 10.1002/jmv.25814
   Million M, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101738
   Ministry of National Health Services, GOP COVID 19 PAK
   Mitja O, 2020, LANCET GLOB HEALTH, V8, pE639, DOI 10.1016/S2214-109X(20)30114-5
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   USA Food and Drug Administration, 2019, FOOD SAF COR DIS
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   WHO, MED BRIEF 11 MARCH 2
   World Health Organization, REP WHO CHIN JOINT M
   World Health Organization, 2020, 181 WHO
   World Health Organization, 2020, RISK ASS MAN EXP HLT
   World Health Organization (WHO), NAM COR DIS
   World Health Organization (WHO), COR DIS 2019 ADV PUB
   World Health Organization (WHO), 2020, COVID 19 FOOD SAF GU
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zhan MK, 2020, NEW ENGL J MED, V382, P2267, DOI 10.1056/NEJMc2005696
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
NR 31
TC 18
Z9 18
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD SEP
PY 2020
VL 17
IS 17
AR 6395
DI 10.3390/ijerph17176395
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA NO9SU
UT WOS:000569826600001
PM 32887410
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Cai, WQ
   Gao, RG
   Jing, Q
   Wang, CP
   Hou, NN
   Liu, WD
   Gao, QQ
   Sun, XD
AF Cai, Weiqin
   Gao, Runguo
   Jing, Qi
   Wang, Chunping
   Hou, Ningning
   Liu, Weide
   Gao, Qianqian
   Sun, Xiaodong
TI Doctor of Public Health-Crisis Management and COVID-19 Prevention and
   Control: A Case Study in China
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE COVID-19; public health crisis; doctor education; curriculum; scientific
   research
ID WORKFORCE DEVELOPMENT; EDUCATION; INSTITUTIONS
AB In the fields of public health policy and public health care, advanced educational programs are an important strategy in dealing with public health crises. The COVID-19 pandemic has exposed the global need for skilled public health leaders and managers to address complex public health challenges, which requires the strengthening of public health education at the highest levels. This paper is a qualitative case study of a special educational program for doctors of public health in China. The program's educational objectives are in line with epidemic prevention and control. With the goal of developing the world's leading national public health management system, the Chinese government established an advanced academic program for public health crisis management. The program offers doctoral students a multidisciplinary degree based upon the theoretical knowledge of crisis management, supported by advanced training in the foundational concepts, theories, and practices of public health, and the study of basic medicine which provides the theoretical support for developing essential clinical skills. Program graduates develop the theoretical, practical, and leadership-related capabilities required for the management of national emergencies. The program introduced in this paper meets current epidemic prevention and control needs and should be considered by public health policy makers, leaders, and scholars in the discussion of advanced public health policy and health care education in China, including the development of an internationally recognized Doctor of Public Health program.
C1 [Cai, Weiqin; Jing, Qi; Gao, Qianqian] Weifang Med Univ, Sch Management, Weifang, Peoples R China.
   [Cai, Weiqin] Weifang Med Univ, Sch Grad, Weifang, Peoples R China.
   [Gao, Runguo; Wang, Chunping] Weifang Med Univ, Sch Publ Hlth, Weifang, Peoples R China.
   [Hou, Ningning; Sun, Xiaodong] Weifang Med Univ, Affiliated Hosp, Dept Endocrinol & Metab, Weifang, Peoples R China.
   [Hou, Ningning; Sun, Xiaodong] Weifang Med Univ, Affiliated Hosp, Clin Res Ctr, Weifang, Peoples R China.
   [Liu, Weide] Weifang Med Univ, Affiliated Hosp, Dept Teaching & Res, Weifang, Peoples R China.
RP Gao, QQ (corresponding author), Weifang Med Univ, Sch Management, Weifang, Peoples R China.; Sun, XD (corresponding author), Weifang Med Univ, Affiliated Hosp, Dept Endocrinol & Metab, Weifang, Peoples R China.; Sun, XD (corresponding author), Weifang Med Univ, Affiliated Hosp, Clin Res Ctr, Weifang, Peoples R China.
EM gaoqq@wfmc.edu.cn; xiaodong.sun@wfmc.edu.cn
RI Sun, Xiaodong/Q-8284-2018
OI Sun, Xiaodong/0000-0001-7775-2823
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [72104186, 81870593]; Humanities and Social
   Science Research Youth Fund program of Ministry of Education
   [20YJCZH002]; Natural Science Foundation program of Shandong Province
   [ZR202102180607, ZR2020MH106]; Quality Improvement of Postgraduate
   Education in Shandong Province [SDYAL19156]; Research Project of China
   Academic Degree and Graduate Education Society [B3-YX20180305-04]
FX This study was funded by the National Natural Science Foundation of
   China (grants 72104186, 81870593), Humanities and Social Science
   Research Youth Fund program of Ministry of Education (grants
   20YJCZH002), Natural Science Foundation program of Shandong Province
   (grants ZR202102180607, ZR2020MH106), the Quality Improvement of
   Postgraduate Education in Shandong Province (grants SDYAL19156), and
   Research Project of China Academic Degree and Graduate Education Society
   (B3-YX20180305-04).
CR Berman P, 2018, PUBLIC HEALTH REP, V133, P759, DOI 10.1177/0033354918804523
   Calhoun JG, 2012, AM J PUBLIC HEALTH, V102, P22, DOI 10.2105/AJPH.2011.300469
   Carlin M, 2021, J PUBLIC HEALTH MAN, V27, P92, DOI 10.1097/PHH.0000000000001294
   Czabanowska K, 2021, INT J HEALTH PLAN M, V36, P14, DOI 10.1002/hpm.3131
   DeBate RD, 2015, AM J PUBLIC HEALTH, V105, pS27, DOI 10.2105/AJPH.2014.302304
   Freudenberg N, 2021, AM J PUBLIC HEALTH, V111, P1757, DOI [10.2105/AJPH.2021.306481, 10.2105/AJPH.2021.306327]
   Galea S, 2021, AM J PUBLIC HEALTH, V111, P350, DOI 10.2105/AJPH.2020.306110
   Gebbie KM, 2008, PUBLIC HEALTH REP, V123, P18, DOI 10.1177/00333549081230S204
   Hou JL, 2018, BMC PUBLIC HEALTH, V18, DOI [10.1186/S12889-018-5605-4, 10.1186/s12889-018-5605-4]
   Kentucky Uo., GRADUATE PROGRAMS
   Kilmarx PH, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab304
   Kuhlmann E, 2021, INT J HEALTH PLAN M, V36, P5, DOI 10.1002/hpm.3160
   Northridge ME, 2012, AM J PUBLIC HEALTH, V102, P17, DOI 10.2105/AJPH.2011.300395
   Park C, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11086-z
   Qiushi, 2021, GIV STRAT PRIOR SAF
   Ren Tao, 2020, Zhonghua Yufang Yixue Zazhi, V54, P457, DOI 10.3760/cma.j.cn112150-20200330-00473
   Said D, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18179325
   Schober DJ, 2022, J PREV INTERV COMMUN, V50, P1, DOI 10.1080/10852352.2021.1915736
   Tocco-Tussardi I, 2021, ANN IG MED PREV COMU, V33, P410, DOI 10.7416/ai.2021.2438
   Wong BL, 2021, HUM RESOUR HEALTH, V19, DOI 10.1186/s12960-021-00627-7
   Yan H., 2020, CHIN J MED ED, V40, P248, DOI [10.3760/CMA.J.CN115259-20200302-00235, DOI 10.3760/CMA.J.CN115259-20200302-00235]
NR 21
TC 0
Z9 0
U1 4
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD FEB 4
PY 2022
VL 10
AR 814632
DI 10.3389/fpubh.2022.814632
PG 8
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZF9QU
UT WOS:000759903200001
PM 35186846
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Haider, M
   Anwar, AI
AF Haider, Murtaza
   Anwar, Amar Iqbal
TI The prevalence of telework under Covid-19 in Canada
SO INFORMATION TECHNOLOGY & PEOPLE
LA English
DT Article; Early Access
DE COVID-19; Teleworking; Telecommuting; Working from home; Knowledge
   economy; Information and communication technologies (ICT);
   Videoconferencing
ID WORKING; HOME; RESOURCES; ADOPTION; SUPPORT; ICT
AB Purpose This study investigates the determinants of teleworking before and during COVID-19 in Canada. It explores the extent of telework adoption across industrial sectors, as well as the long-term impacts of large-scale adoption of teleworking on urban travel demand and the dwindling demand for commercial real estate in downtowns. Design/methodology/approach Using data from a survey of business establishments, this study employs data visualization techniques to illustrate how telework adoption evolved during the early stages of the COVID-19 lockdown. The study also estimates Logit models to explore the determinants of telework before and during the pandemic using a subsample from the Canadian labor force survey. Findings The study found that telework adoption reached a peak in March and April of 2020 when almost 40% of the workers in Canada were teleworking. Only 12% of employees reported teleworking before the pandemic. The adoption of teleworking was far more pronounced amongst firms that use information and communication technologies (ICTs) extensively. Teleworking appears to be far more frequent among university-educated (knowledge economy) workers. Practical implications Knowledge economy and highly educated workers, who switched to teleworking during the pandemic at higher rates than workers with less education, are more frequently employed in offices located in the urban core or downtowns. The drastic decline in commuting to the urban core via public transit and record low occupancy levels in downtown office towers suggests that, even if telework prevailed at levels much lower than those observed during March and April of 2020, landlords holding large portfolios of commercial real estate must prepare to cope with the lower demand for commercial real estate. This is especially significant when commercial leases come up for renewal in the next few years. In addition, governments struggling to address traffic congestion by spending hundreds of billions of dollars on transport and transit infrastructure might want to promote teleworking as a means of reducing travel demands and costly infrastructure expenditures. Social implications Teleworking has partially eroded the boundaries between work and home by enabling millions to continue being productive while working from home. However, teleworking would require new norms and rules to maintain a work-life balance. This change requires workers and employers to cooperate. Originality/value To the best of the authors' knowledge, this is the first study that explores the extent of telework adoption during COVID-19 in Canada and the determinants of telework adoption, presenting both employee and firm-level perspectives using Canada-wide representative data.
C1 [Haider, Murtaza] Ryerson Univ, Ted Rogers Sch Management, Toronto, ON, Canada.
   [Anwar, Amar Iqbal] Cape Breton Univ, Shannon Sch Business, Sydney, PQ, Canada.
   [Anwar, Amar Iqbal] Univ Leipzig, Int SEPT Competence Ctr, Leipzig, Germany.
RP Anwar, AI (corresponding author), Cape Breton Univ, Shannon Sch Business, Sydney, PQ, Canada.; Anwar, AI (corresponding author), Univ Leipzig, Int SEPT Competence Ctr, Leipzig, Germany.
EM amar_anwar@cbu.ca
FU Cape Breton University [8824]
FX This research was financially supported by Cape Breton University grant
   number 8824.
CR Aggarwal G., 2021, FORBES
   Beck MJ, 2020, J TRANSP GEOGR, V88, DOI 10.1016/j.jtrangeo.2020.102846
   Belanger F, 1999, INFORM MANAGE, V35, P139, DOI 10.1016/S0378-7206(98)00091-3
   Bentley K, 2000, INTERNET RES, V10, P346, DOI 10.1108/10662240010342658
   Bentley TA, 2016, APPL ERGON, V52, P207, DOI 10.1016/j.apergo.2015.07.019
   Berniell L, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105247
   Bhuiyan MA, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145781
   Bloom N, 2021, AEA PAP P, V111, P263, DOI 10.1257/pandp.20211057
   Boswell WR, 2014, PERS PSYCHOL, V67, P887, DOI 10.1111/peps.12061
   Collins M, 2005, NEW TECH WORK EMPLOY, V20, P115, DOI 10.1111/j.1468-005X.2005.00148.x
   Cuerdo-Vilches T, 2021, SUSTAIN CITIES SOC, V75, DOI 10.1016/j.scs.2021.103262
   Dalton M, 2021, J ECON INEQUAL, V19, P527, DOI 10.1007/s10888-021-09506-6
   Daniels K, 2001, J MANAGE STUD, V38, P1151, DOI 10.1111/1467-6486.00276
   de Graaff T, 2007, TRANSPORT RES A-POL, V41, P142, DOI 10.1016/j.tra.2006.02.005
   de Haas Mathijs, 2020, Transp Res Interdiscip Perspect, V6, P100150, DOI 10.1016/j.trip.2020.100150
   Eurofound and ILO, 2017, WORK AN AN EFF WORLD
   Feldmann A., 2021, BROADBAND COVERAGE G, P1
   Fraja G.D., 2020, DISCUSSION PAPERS
   Georgescu GC, 2021, AMFITEATRU ECON, V23, P669, DOI 10.24818/EA/2021/58/669
   Golden TD, 2008, J APPL PSYCHOL, V93, P1412, DOI 10.1037/a0012722
   Gray M., 1993, TELEWORKING EXPLAINE
   Haddad H, 2009, J TRANSP GEOGR, V17, P124, DOI 10.1016/j.jtrangeo.2008.11.008
   Hetschko C, 2020, J ECON PSYCHOL, V79, DOI 10.1016/j.joep.2019.05.005
   Horn C.V., 2000, TELEWORK COMING AGE
   Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387
   Jiao J., 2021, SOCIOECONOMIC FACTOR, DOI [10.32866/001c.23573, DOI 10.32866/001C.23573]
   KRUGMAN Paul., 2020, NEW YORK TIMES
   Liu ST, 2021, ECON LETT, V207, DOI 10.1016/j.econlet.2021.110010
   Loo BPY, 2018, TRANSPORTATION, V45, P365, DOI 10.1007/s11116-017-9792-0
   Lopez-Igual P, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12218797
   Moller-Jensen L., 2003, P TRIP RES C EC ENV, P395
   Mouratidis K, 2021, SUSTAIN CITIES SOC, V74, DOI 10.1016/j.scs.2021.103182
   Nguyen MH, 2020, SOC MEDIA SOC, V6, DOI 10.1177/2056305120948255
   Nguyen MH, 2021, TRANSPORTATION, V48, P3207, DOI 10.1007/s11116-021-10169-5
   NILLES JM, 1988, TRANSPORT RES A-POL, V22, P301, DOI 10.1016/0191-2607(88)90008-8
   Niu Q, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256530
   Perez MP, 2005, TECHNOVATION, V25, P1476, DOI 10.1016/j.technovation.2005.04.002
   Perez MP, 2007, INT J SERV TECHNOL M, V8, P188, DOI 10.1504/IJSTM.2007.012868
   Pigini C, 2019, INT J MANPOWER, V40, P265, DOI 10.1108/IJM-07-2017-0154
   Richtel, 2020, NEW YORK TIMES
   Schifano S, 2021, INFORM TECHNOL PEOPL, DOI 10.1108/ITP-01-2021-0033
   Schur LA, 2020, J OCCUP REHABIL, V30, P521, DOI 10.1007/s10926-020-09936-5
   Sener IN, 2012, ENVIRON PLANN A, V44, P1459, DOI 10.1068/a44436
   Statistics Canada a G. of C., 2020, DAIL CAN SURV BUS CO
   Statistics Canada b G. of C., 2020, CAN PERSP SURV SER C
   Straus SG, 2000, RES MANAG GRP TEAM, V3, P257, DOI 10.1016/S1534-0856(00)03013-9
   Tokarchuk O, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042147
   Vilhelmson B, 2016, NEW TECH WORK EMPLOY, V31, P77, DOI 10.1111/ntwe.12060
NR 48
TC 0
Z9 0
U1 3
U2 3
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0959-3845
EI 1758-5813
J9 INFORM TECHNOL PEOPL
JI Inf. Technol. People
DI 10.1108/ITP-08-2021-0585
EA MAR 2022
PG 28
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA ZT8IE
UT WOS:000769392900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Luo, L
   Jiang, JW
   Wang, C
   Fitzgerald, M
   Hu, WF
   Zhou, YM
   Zhang, H
   Chen, SL
AF Luo, Lu
   Jiang, Jingwen
   Wang, Cheng
   Fitzgerald, Martin
   Hu, Weifeng
   Zhou, Yumei
   Zhang, Hui
   Chen, Shilin
TI Analysis on herbal medicines utilized for treatment of COVID-19
SO ACTA PHARMACEUTICA SINICA B
LA English
DT Article
DE COVID-19; Traditional Chinese medicine (TCM); Herbal medicines;
   Clustering analysis; Scaffold analysis
ID GLYCYRRHIZIC ACID; 18-BETA-GLYCYRRHETINIC ACID; INFLAMMATORY RESPONSE;
   SCUTELLARIAE RADIX; CELLS; EXPRESSION; BAICALIN; BINDING;
   CYCLOOXYGENASE-2; INHIBITION
AB As coronavirus disease 2019 (COVID-19) pandemic poses a substantial global public health threat, traditional Chinese medicine (TCM) was used in 91.50% of the COVID-19 cases in China, showing encouraging results in improving symptom management and reducing the deterioration, mortality, and recurrence rates. A total of 166 modified herbal formulae consisting of 179 single herbal medicines were collected for treating COVID-19 in China. Glycyrrhizae Radix et Rhizome, Scutellariae Radix, and Armeniacae Semen Amarum are the most frequently utilized in clinics, most of which are antipyretic (47, 26.26%), expectorant and cough- suppressing (22, 12.29%), and dampness-resolving (21, 11.73%) from traditional descriptions. A total of 1212 chemical components containing beta-sitosterol, stigmasterol, and quercetin were primarily selected. Additionally, using complex system entropy and unsupervised hierarchical clustering, 8 core herbal combinations and 10 newformulae emerged as potentially useful candidates for COVID-19. Finally, following scaffold analysis, self-organizing mapping (SOM) and cluster analysis, 12 clusters of molecules yielded 8 pharmacophore families of structures that were further screened as pharmacological targets in human metabolic pathways for inhibiting coronavirus. This article aims to make more easily accessible and share historical herbal knowledge used in contemporary treatments in a modern manner to assist researchers contain the global spread of COVID-19. (C) 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
C1 [Luo, Lu; Chen, Shilin] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China.
   [Jiang, Jingwen] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu 610041, Peoples R China.
   [Wang, Cheng] Chinese Acad Med Sci & Peking Union Med Coll, Inst Basic Med Sci, Beijing 100006, Peoples R China.
   [Fitzgerald, Martin] Ashdale Clin, Cork T12 T2VK, Ireland.
   [Hu, Weifeng] Zhejiang Chinese Med Univ, Clin Med Coll 3, Hangzhou 310000, Peoples R China.
   [Zhou, Yumei] Guangzhou Univ Chinese Med, Clin Med Coll 4, Guangzhou 518033, Peoples R China.
   [Zhang, Hui] Akupunktur Akademiet, DK-8230 Aabyhoej, Denmark.
RP Chen, SL (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China.
EM slchen@icmm.ac.cn
OI wang, cheng/0000-0001-9738-8918; Zhang, Hui/0000-0002-4442-2788; Chen,
   Shilin/0000-0002-0449-236X
CR Abourashed EA, 2003, PHYTOTHER RES, V17, P703, DOI 10.1002/ptr.1337
   Aghagolzadeh M, 2007, IEEE IMAGE PROC, P277
   Ahn HC, 2001, MOL CELLS, V12, P127
   Fontes LBA, 2014, J PHARM PHARMACOL, V66, P886, DOI 10.1111/jphp.12212
   [Anonymous], 2020, CNR NEWS
   Bhattacharjee S, 2012, J ANTIMICROB CHEMOTH, V67, P1905, DOI 10.1093/jac/dks159
   Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885
   Briggs JP, 2014, SCIENCE, V346, pS7
   Cai Y, 1956, FUJIAN J TRADIT CHIN, V2, P13
   Chen CS, 2006, J ETHNOPHARMACOL, V105, P346, DOI 10.1016/j.jep.2005.11.012
   Choi JG, 2002, BBA-GEN SUBJECTS, V1571, P201, DOI 10.1016/S0304-4165(02)00217-9
   Chu Ming, 2007, Zhong Yao Cai, V30, P63
   Deng H, 2020, SH J TCM, V54, P14
   Evers DL, 2005, ANTIVIR RES, V68, P124, DOI 10.1016/j.antiviral.2005.08.002
   Fu YH, 2014, FEBS J, V281, P2543, DOI 10.1111/febs.12801
   Gaulton A, 2017, NUCLEIC ACIDS RES, V45, pD945, DOI 10.1093/nar/gkw1074
   Gong S., 2003, ACTA GEOGRAPH SIN, V58, P878
   Han D, 1958, SHANGHAI J TRADIT CH, V8, P8
   He W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-538
   He Y.A., 2020, CHIN TRADIT HERB DRU, V2, P1
   Hendricks JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049491
   Imai K., 2013, Free Radicals and Antioxidants, V3, P40, DOI 10.1016/j.fra.2013.04.003
   Ishida T, 2013, EUR J PHARMACOL, V714, P125, DOI 10.1016/j.ejphar.2013.06.007
   Jung HJ, 2008, EXP NEUROBIO, V17, P71
   Kang KL, 2005, MOL BRAIN RES, V142, P139, DOI 10.1016/j.molbrainres.2005.09.006
   Kaptchuk TJ, 2000, WEB HAS NO WEAVER UN
   Kim ME, 2013, IMMUNOPHARM IMMUNOT, V35, P329, DOI 10.3109/08923973.2013.768636
   Kitamura K, 1998, ANTIVIR RES, V37, P131, DOI 10.1016/S0166-3542(97)00069-7
   Kunimoto R, 2018, ACS OMEGA, V3, P3768, DOI 10.1021/acsomega.8b00344
   Kwon HJ, 2010, BIOORGAN MED CHEM, V18, P7668, DOI 10.1016/j.bmc.2010.07.073
   Lab of Systems Pharmacology, 2013, TRAD CHIN MED SYST P
   Lee JY, 2009, INT IMMUNOPHARMACOL, V9, P632, DOI 10.1016/j.intimp.2009.02.007
   Lee YY, 2011, J NEUROIMMUNE PHARM, V2, P294
   Leung ELH, 2014, SCIENCE, V346, pS16
   Li BQ, 2000, IMMUNOPHARMACOLOGY, V49, P295, DOI 10.1016/S0162-3109(00)00244-7
   Li CR, 2011, BIOPHARM DRUG DISPOS, V32, P427, DOI 10.1002/bdd.771
   Li JY, 2010, PHARM BIOL, V48, P1177, DOI 10.3109/13880200903573169
   Li S, 2017, BIOORG MED CHEM LETT, V18, P5177
   Li S.Z., 2007, COMPENDIUM MAT MED
   Liang F., 2008, STAT HOUSEHOLD REGIS
   Liang Z, 1985, CHIN J LEPROSY SKIN, V6, P79
   Liu JP, 2004, J ALTERN COMPLEM MED, V10, P1041, DOI 10.1089/acm.2004.10.1041
   Liu RH, 2015, SCIENCE, V347, pS40
   Luo H, 2020, CHINESE J INTERN MED, V1, P8
   Luo Lidan, 2013, Exp Neurobiol, V22, P107, DOI 10.5607/en.2013.22.2.107
   Lv RB, 2020, J CHIN MED, V2, p1e5
   Ma CH, 2013, J ETHNOPHARMACOL, V148, P755, DOI 10.1016/j.jep.2013.04.021
   McGhee JJ, 2020, PEERJ, V8, DOI 10.7717/peerj.8783
   Michaelis M, 2010, MED MICROBIOL IMMUN, V199, P291, DOI 10.1007/s00430-010-0155-0
   Moisy D, 2012, J VIROL, V86, P9122, DOI 10.1128/JVI.00789-12
   Mrvar A, 2018, PAJEK, V5, P3
   National Health andHealth Commission, 2020, NOT COVID 19 DIAGN T
   National Pharmacopoeia Commission, 2015, CHIN PHARM 4
   Ni YF, 2011, J SURG RES, V165, pE29, DOI 10.1016/j.jss.2010.10.004
   Nirmala P, 2011, J AGR TECHNOL, V7, P815
   Oztanir MN, 2014, NEUROL SCI, V35, P1221, DOI 10.1007/s10072-014-1685-9
   R Core Team, 2020, R LANG ENV STAT COMP
   Ryan, 2020, WHO DECLARES CORONAV
   Sasaki H, 2002, PATHOBIOLOGY, V70, P229, DOI 10.1159/000069334
   Schinella GR, 2002, LIFE SCI, V70, P1023, DOI 10.1016/S0024-3205(01)01482-5
   Shao ZH, 1999, J MOL CELL CARDIOL, V31, P1885, DOI 10.1006/jmcc.1999.1021
   Shebl Rania I, 2012, Chang Gung Med J, V35, P231
   Shimazu, 2014, J BEHAV SOC SCI, V1, P6
   Smirnov V. S., 2012, Voprosy Virusologii, V57, P23
   Soufy H, 2012, AFR J TRADIT COMPLEM, V9, P389, DOI 10.4314/ajtcam.v9i3.14
   State Administration of Traditional Chinese Medicine (SATCM), 1999, CHINESE MAT MED
   Sun S., 1999, INVALUABLE PRESCRIPT
   Tang SH, 2010, J TRADIT CHIN MED, V30, P288, DOI 10.1016/S0254-6272(10)60058-1
   Unnited TCM hospital of Quanzhou Fujian provice, 1957, FUJIAN J TRADIT CHIN, V2, P8
   Wang C, 2011, ANN INTERN MED, V155, P217, DOI 10.7326/0003-4819-155-4-201108160-00005
   Wang CY, 2011, J AGR FOOD CHEM, V59, P7726, DOI 10.1021/jf2013265
   Wang H, 1958, J ZHENGZHOU U MED SC, V1, P1
   Wang JJ, 2013, J ETHNOPHARMACOL, V147, P114, DOI 10.1016/j.jep.2013.02.017
   Wang ML, 2016, MOL INFORM, V35, P109, DOI 10.1002/minf.201500115
   Wang Y, 2003, J TIANJIN U TRADIT C, V4, P33
   Wang Y, 2003, J TIANJIN U TRADIT C, V3, p84e8
   Wang YH, 2014, SCIENCE, V346, pS13
   WHO, 2020, COR DIS COVID 2019 S
   WHO, 2003, SARS CLIN TRIALS TRE
   Witt CM, 2015, SCIENCE, V347, pS50
   Woo KJ, 2006, IMMUNOBIOLOGY, V211, P359, DOI 10.1016/j.imbio.2006.02.002
   Wu TY, 2011, AAPS J, V13, P1, DOI 10.1208/s12248-010-9239-4
   Xia W, 2020, J CHIN MED, V2, P1
   Xie Y, 2020, J CHIN MED, V3, P1
   Yang R, 2015, PLANTA MED, V81, P1654, DOI 10.1055/s-0035-1557893
   Yongye AB, 2012, CHEM BIOL DRUG DES, V80, P717, DOI 10.1111/cbdd.12011
   Yoon SB, 2009, J ETHNOPHARMACOL, V125, P286, DOI 10.1016/j.jep.2009.06.027
   Yu T., 1876, SOLUTION POX FAMILY
   Yu X, 2018, J ETHNOPHARMACOL, V220, P265, DOI 10.1016/j.jep.2018.03.031
   Zhang L., 1995, ZHANGS MED TREATMENT
   [张依倩 Zhang Yiqian], 2020, [中草药, Chinese Traditional and Herbal Drugs], V51, P1435
   Zhang Z., 2007, EPIDEMIC CHRONOLOGY
   Zhangsun W., 2013, COMMENT LAW TANG DYN
   Zhao X, 2015, SCIENCE, V347, pS38
NR 94
TC 38
Z9 41
U1 18
U2 28
PU INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
PI BEIJING
PA C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST,
   BEIJING, 100050, PEOPLES R CHINA
SN 2211-3835
EI 2211-3843
J9 ACTA PHARMACOL SIN B
JI Acta Pharm. Sin. B
PD JUL
PY 2020
VL 10
IS 7
BP 1192
EP 1204
DI 10.1016/j.apsb.2020.05.007
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA NC5VE
UT WOS:000561284200005
PM 32834949
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Coutinho, JG
   Padilla, M
AF Coutinho, Janine Giuberti
   Padilla, Monica
TI Adequate, reliable and timely information in times of the COVID-19
   pandemic
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA Portuguese
DT Article
DE Coronavirus infections; knowledge management; pandemics
AB In times of the COVID-19 pandemic, adequate, reliable and timely information becomes even more relevant. The Pan American Health Organization/World Health Organization office in Brazil and key partners have developed initiatives to improve access, sharing and dissemination of the information and knowledge produced, translated and systematized about COVID-19 as a technical contribution to the fight against the pandemic. This article presents some of these resources. The production and synthesis of knowledge made available in a timely manner to professionals on the frontline of response to COVID-19 is essential and a basic requirement for improving response capacity. It is also important to strengthen and increase investment in the production of scientific evidence, and to recognize and build upon the tireless work of a large group of scientists and institutions that continue to respond to the COVID-19 pandemic.
C1 [Coutinho, Janine Giuberti; Padilla, Monica] Org Pan Amer Saude, Brasilia, DF, Brazil.
RP Coutinho, JG (corresponding author), Org Pan Amer Saude, Brasilia, DF, Brazil.
EM giubertjan@paho.org
CR [Anonymous], 2020, LANCET DIGIT HEALTH, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8
   Organizacao Pan-Americana da Saude, PLAN ESTR OPAS 2020
   Organizacao Pan-Americana da Saude, ESTR GEST CONH
   Organizacao Pan-Americana da Saude, INF COVID 19 PROF SA
   Organizacao Pan-Americana da Saude, BIR
   Organizacao Pan-Americana da Saude, 2018, PORTF COOP TECN OPAS
   Organizacao Pan-Americana da Saude, OPAS OMS BRAS
   Organizacao Pan -Americana de Saude, 2020, ENT INF DES LUT COVI
   World Health Organization, OP WHO
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
NR 10
TC 0
Z9 0
U1 2
U2 5
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2020
VL 44
AR e118
DI 10.26633/RPSP.2020.118
PG 4
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA NY8FE
UT WOS:000576618100001
PM 32994790
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Nazir, M
   Hussain, I
   Tian, J
   Akram, S
   Tshiaba, SM
   Mushtaq, S
   Shad, MA
AF Nazir, Mehrab
   Hussain, Iftikhar
   Tian, Jian
   Akram, Sabahat
   Tshiaba, Sidney Mangenda
   Mushtaq, Shahrukh
   Shad, Muhammad Afzal
TI A Multidimensional Model of Public Health Approaches Against COVID-19
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; social media; preventive behavior; social actors; pandemic
ID SOCIAL MEDIA; AVIAN INFLUENZA; SARS EPIDEMIC; HONG-KONG; DISEASE;
   INFORMATION; RESPONSES; OUTBREAK; SURVEILLANCE; AWARENESS
AB COVID-19 is appearing as one of the most fetal disease of the world's history and has caused a global health emergency. Therefore, this study was designed with the aim to address the issue of public response against COVID-19. The literature lacks studies on social aspects of COVID-19. Therefore, the current study is an attempt to investigate its social aspects and suggest a theoretical structural equation model to examine the associations between social media exposure, awareness, and information exchange and preventive behavior and to determine the indirect as well as direct impact of social media exposure on preventive behavior from the viewpoints of awareness and information exchange. The current empirical investigation was held in Pakistan, and the collected survey data from 500 respondents through social media tools were utilized to examine the associations between studied variables as stated in the anticipated study model. The findings of the study indicate that social media exposure has no significant and direct effect on preventive behavior. Social media exposure influences preventive behavior indirectly through awareness and information exchange. In addition, awareness and information exchange have significant and direct effects on preventive behavior. Findings are valuable for health administrators, governments, policymakers, and social scientists, specifically for individuals whose situations are like those in Pakistan. This research validates how social media exposure indirectly effects preventive behavior concerning COVID-19 and explains the paths of effect through awareness or information exchange. To the best of our knowledge, there is no work at present that covers this gap, for this reason the authors propose a new model. The conceptual model offers valuable information for policymakers and practitioners to enhance preventive behavior through the adoption of appropriate awareness strategies and information exchange and social media strategies.
C1 [Nazir, Mehrab; Tian, Jian; Tshiaba, Sidney Mangenda] Jiangsu Univ Sci & Technol, Sch Econ & Management, Zhenjiang 212003, Jiangsu, Peoples R China.
   [Hussain, Iftikhar] Univ Kotli Azad Jammu & Kashmir, Fac Comp & Engn, Kotli 11100, Pakistan.
   [Akram, Sabahat] Univ Kotli Azad Jammu & Kashmir, Dept Econm, Kotli 11100, Pakistan.
   [Mushtaq, Shahrukh] Univ Kotli Azad Jammu & Kashmir, Dept Business Adm, Kotli 11100, Pakistan.
   [Shad, Muhammad Afzal] Univ Kotli Azad Jammu & Kashmir, Dept Commerce, Kotli 11100, Pakistan.
RP Tian, J (corresponding author), Jiangsu Univ Sci & Technol, Sch Econ & Management, Zhenjiang 212003, Jiangsu, Peoples R China.; Hussain, I (corresponding author), Univ Kotli Azad Jammu & Kashmir, Fac Comp & Engn, Kotli 11100, Pakistan.
EM mehrabnazir9@gmail.com; iftikhar_raja@live.com; tianjian@just.edu.cn;
   sabahat_abrar@hotmail.com; christhackman@outlook.com;
   shahrukh.dbms@must.edu.pk; afzaalshaad@gmail.com
RI Hussain, Iftikhar/Q-8413-2019; nazir, mehrab/ABF-5794-2020; Akram,
   sabahat/AAK-3929-2021
OI Hussain, Iftikhar/0000-0001-5063-6267; nazir,
   mehrab/0000-0003-0645-8445; Akram, sabahat/0000-0002-9550-6658; Shad,
   Muhammad Afzal/0000-0001-5361-0994; Tian, Jian/0000-0003-3826-8072
FU National Social Sciences Fund for China [17BGL028]; Jiangsu University
   of Science and Technology, Zhenjiang Jiangsu, China
FX This research was funded by National Social Sciences Fund for China,
   under the grant number 17BGL028 to School of Economics and Management,
   Jiangsu University of Science and Technology, Zhenjiang Jiangsu, China.
CR Al-Surimi K, 2017, ADV EXP MED BIOL, V972, P131, DOI 10.1007/5584_2016_132
   BALLROKEACH SJ, 1976, COMMUN RES, V3, P3, DOI 10.1177/009365027600300101
   Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI [10.1056/NEJMp0900702, 10.1056/NEJMp0904012]
   Chang CC, 2012, HEALTH COMMUN, V27, P111, DOI 10.1080/10410236.2011.569004
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Davies M., 2009, SWINE FLU SOCIAL MED
   Dudo AD, 2007, SCI COMMUN, V28, P429, DOI 10.1177/1075547007302211
   Eke PI, 2011, J DENT RES, V90, P1045, DOI 10.1177/0022034511415277
   Fox S., 2011, SOCIAL LIFE HLTH INF
   Funk S, 2010, J THEOR BIOL, V264, P501, DOI 10.1016/j.jtbi.2010.02.032
   Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713
   Hobbs J, 2004, J HEALTH COMMUN, V9, P67, DOI 10.1080/10810730490271638
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Iafusco D, 2000, DIABETES CARE, V23, P1853, DOI 10.2337/diacare.23.12.1853b
   Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032
   Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003
   Kass-Hout TA, 2013, BRIT MED BULL, V108, P5, DOI 10.1093/bmb/ldt028
   Kumar A, 2017, J THEOR BIOL, V414, P103, DOI 10.1016/j.jtbi.2016.11.016
   Lau JTF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-18
   Lau JTF, 2007, AM J INFECT CONTROL, V35, P38, DOI 10.1016/j.ajic.2006.07.010
   Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864
   Lemon SM, 2007, GLOBAL INFECT DIS SU
   Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857
   Liao QY, 2011, INT J BEHAV MED, V18, P93, DOI 10.1007/s12529-010-9123-8
   Lin WY, 2016, COMPUT HUM BEHAV, V56, P289, DOI 10.1016/j.chb.2015.11.055
   Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5
   Misra AK, 2015, BIOSYSTEMS, V138, P53, DOI 10.1016/j.biosystems.2015.11.002
   Pawelek KA, 2014, MATH BIOSCI ENG, V11, P1337, DOI 10.3934/mbe.2014.11.1337
   Prem K., 2020, LANCET PUBLIC HEALTH, V90, P210
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Tai ZX, 2007, NEW MEDIA SOC, V9, P987, DOI 10.1177/1461444807082691
   Velasco E, 2014, MILBANK Q, V92, P7, DOI 10.1111/1468-0009.12038
   Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]
   Xiao YN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07838
   You M, 2015, J MASS COMMUN Q, V92, P959, DOI 10.1177/1077699015596339
   Zhu N., 2020, N ENGL J MED, V7, P1
NR 37
TC 15
Z9 15
U1 3
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUN
PY 2020
VL 17
IS 11
AR 3780
DI 10.3390/ijerph17113780
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA MB5FY
UT WOS:000542629600033
PM 32466581
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Rahman, MM
   Rahaman, MS
   Salamzadeh, A
   Jantan, AH
AF Rahman Md Mizanur
   Rahaman Md Saidur
   Salamzadeh Aidin
   Jantan Amer Hamzah
TI POSITIVE CONSEQUENCES OF COVID-19 PANDEMIC: REFLECTIONS BASED ON
   UNIVERSITY STUDENTS' COMMUNITY IN BANGLADESH
SO INTERNATIONAL REVIEW
LA English
DT Article
DE COVID-19; Bangladesh; pandemic; positive; students
ID CORONAVIRUS OUTBREAK; CARE
AB The fundamental aim of this study is to demonstrate the positive consequences of the COVID-19 pandemic while everyone else is talking about COVID-19's adverse effects. Researchers collected data through FGD (Focus Group Discussion) via an internet platform from April 2021 to June 2021. FGD was conducted with final-year undergraduate students from Bangladesh's Sylhet division. We purposively selected 20 students who have good knowledge about the consequences of COVID-19 and who were voluntarily involved at the university's different social clubs. According to this study, COVID-19 has positive impacts on people's life. People spent crucial time with their families, explored their interests, developed a range of new skills, and appreciated the need for sanitation, hygiene, and social separation.
   Nature recovers energy, and greenhouse gas emissions are significantly reduced to protect the ecosystem. Among other notable positive effects, people build religious learning's in conjunction with crime reduction notions. Researchers study a particular division (Sylhet) of a country, which may differ from that of other cultures and countries. As a result, generalizing the research findings is complex; more research in different divisions of Bangladesh, countries, and cultures is required. The study outcomes are intended to assist the community in building positive psychology to confront the COVID-19 and establish a new normal and a guideline for dealing with any impending pandemic. To the best of our knowledge, this is one of the most comprehensive studies on the positive effects of COVID-19, as well as a guideline for dealing with any pandemic that may occur in the near future.
C1 [Rahman Md Mizanur] BRAC Univ, BRAC Business Sch, Dhaka, Bangladesh.
   [Rahaman Md Saidur] Metropolitan Univ, Sylhet, Bangladesh.
   [Salamzadeh Aidin] Univ Tehran, Fac Management, Tehran, Iran.
   [Jantan Amer Hamzah] City Univ, City Grad Sch, Petaling Jaya, Malaysia.
RP Rahman, MM (corresponding author), BRAC Univ, BRAC Business Sch, Dhaka, Bangladesh.
EM mizanmgt@gmail.com; saidurmgt@gmail.com; salamzadeh@ut.ac.ir;
   mizanmgt@gmail.com
RI Rahaman, Saidur/T-8473-2018; Salamzadeh, Aidin/O-1675-2016
OI Rahaman, Saidur/0000-0002-3319-7853; Salamzadeh,
   Aidin/0000-0001-6808-1327
CR Balmford B, 2020, ENVIRON RESOUR ECON, V76, P525, DOI 10.1007/s10640-020-00466-5
   Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003
   bdnews24.com, 2020, BANGL BANK ANN INC B
   Bhuiyan Tareq Rafi, 2020, POSTCOVID ERA MEGATR
   Brani O., 2014, INT BODY PSYCHOTHERA, V13, P95
   Burke M., 2020, COVID 19 REDUCES EC
   Cardenas M., 2020, LOOKING BRIGHT SIDE
   Cathy Li, 2020, COVID19 PANDEMIC HAS
   Dana L.P., 2015, INT J ENTREPRENEURSH, V26, P154, DOI DOI 10.1504/IJESB.2015.071822
   Fadiyah Syifa., 2020, 5 BENEFITS ERP HOME
   Frare AB, 2021, REGE-REV GEST, V28, P263, DOI 10.1108/REGE-01-2021-0005
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903
   Hameed N. S. S., 2021, IMPACT BUSINESS PROC
   Harvath TA, 2020, GERONTOLOGIST, V60, pS5, DOI 10.1093/geront/gnz138
   Henriques SF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18049-9
   Institute of Epidemiology Disease Control (IEDCR), 2020, RES COR GOV BD
   Kawamorita H., 2020, J ENTREPRENEURSHIP B, V8, P77
   Khan I, 2021, INT J ENVIRON SCI TE, V18, P521, DOI 10.1007/s13762-020-03021-3
   Kroll T, 2007, QUAL HEALTH RES, V17, P690, DOI 10.1177/1049732307301488
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Li C., 2020, WORLD EC FOR
   Lomas T, 2020, J POSIT PSYCHOL, V15, P716, DOI 10.1080/17439760.2019.1651892
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Magomedov I. A., 2020, J PHYS C SERIES, V1691, DOI [10.1088/1742-6596/1691/1/012134, DOI 10.1088/1742-6596/1691/1/012134]
   Marotti de Mello A., 2021, REV GESTAO, V28, P100
   Ming W, 2020, EMERG MARK FINANC TR, V56, P2422, DOI 10.1080/1540496X.2020.1790353
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020330
   Pereira J, 2021, J ENTREP PUBLIC POLI, V10, P424, DOI 10.1108/JEPP-06-2021-0070
   Rahaman M.S., 2020, INT J TECHNOLOGY TRA, V17, P354
   Rahaman MS, 2021, J ENTERP COMMUNITIES, V15, P548, DOI 10.1108/JEC-10-2020-0176
   Rahman M., J ED MANAGEMENT DEV, V1, P1
   Rahman M. M, 2021, J BUSINESS STRATEGY, V2
   Salami AT, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13501
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   Susanta Nanda IFS, 2020, TWITTER IS AMAZED
   Thomas Vipin, 2020, 8 POSITIVE IMPACTS L
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8
NR 39
TC 0
Z9 0
U1 2
U2 2
PU FAC BUSINESS ECONOMICS & ENTREPRENEURSHIP
PI BELGRADE
PA VOJVDE VLAHOVICA STR NO 35B, BELGRADE, 00000, SERBIA
SN 2217-9739
J9 INT REV
JI Int. Rev.
PY 2021
IS 3-4
BP 77
EP 86
DI 10.5937/intrev2103083R
PG 10
WC Economics
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YK2HM
UT WOS:000745040700010
OA gold
DA 2022-04-20
ER

PT J
AU Danaeefard, H
   Sedaghat, A
   Kazemi, SH
   Elahi, AK
AF Danaeefard, Hassan
   Sedaghat, Atiye
   Kazemi, Seyed Hosein
   Elahi, Ahmadali Khaef
TI Investment Areas to Enhance Public Employee Resilience during the
   Coronavirus Disease 2019 (COVID-19): Evidence from Iran
SO PUBLIC ORGANIZATION REVIEW
LA English
DT Article; Early Access
DE Employee resilience; Public organization; Human resource management;
   Investment areas; COVID-19
ID PSYCHOLOGICAL RESILIENCE; ORGANIZATIONS; PERFORMANCE; RESOURCES;
   PERSPECTIVE; LEADERSHIP; WORKPLACE; BEHAVIORS; ATTITUDES; SYSTEMS
AB This study aims to investigate the areas of investment that the human resources management of the Iranian public sector has invested in for improving employees' resilience in the COVID-19 pandemic period. This study is qualitative and the qualitative content analysis is used to analyze the data. The qualitative content analysis is used to analyze the data. According to findings, essential areas for investment to improve employee resilience are hardware investments, software investments, and wetware investments.While increasing the knowledge of employee resilience, this qualitative study provides valuable and practical implications for policymakers and managers in the public sector.
C1 [Danaeefard, Hassan; Sedaghat, Atiye; Kazemi, Seyed Hosein; Elahi, Ahmadali Khaef] Tarbiat Modares Univ, Fac Management & Econ, Tehran, Iran.
RP Danaeefard, H (corresponding author), Tarbiat Modares Univ, Fac Management & Econ, Tehran, Iran.
EM hdanaee@modares.ac.ir; Atiyesedaghat@modares.ac.ir;
   H.kazemi@modares.ac.ir; khaefelahi@modares.ac.ir
CR Agrawal P., 2014, EC BUSINESS J, V5, P11
   Jnr BA, 2021, ENTERP INF SYST-UK, V15, P617, DOI 10.1080/17517575.2020.1829075
   Appolloni A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031388
   Athota VS, 2020, APPL PSYCHOL-INT REV, V69, P653, DOI 10.1111/apps.12198
   Avey JB, 2009, HUM RESOUR MANAGE-US, V48, P677, DOI 10.1002/hrm.20294
   Bardoel EA, 2014, ASIA PAC J HUM RESOU, V52, P279, DOI 10.1111/1744-7941.12033
   Boxall P, 2007, ASIA PAC J HUM RESOU, V45, P261, DOI 10.1177/1038411107082273
   Britt TW, 2016, IND ORGAN PSYCHOL-US, V9, P378, DOI 10.1017/iop.2015.107
   Caniels MCJ, 2022, INT J HUM RESOUR MAN, V33, P297, DOI 10.1080/09585192.2019.1695648
   Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113
   Cooke FL, 2019, INT J HUM RESOUR MAN, V30, P1239, DOI 10.1080/09585192.2015.1137618
   Cooper CL., 2014, INT J HUM RESOUR MAN, V25, P2466, DOI [10.1080/09585192.2014.926688, DOI 10.1080/09585192.2014.926688]
   Daum DL, 2021, IND ORGAN PSYCHOL-US, V14, P160, DOI 10.1017/iop.2021.40
   Su DN, 2021, CURR ISSUES TOUR, V24, P3189, DOI 10.1080/13683500.2020.1863930
   Edeh F. O., 2018, AM J EC BUSINESS MAN, V2, P147, DOI [10.31150/ajebm.v2i4.99, DOI 10.31150/AJEBM.V2I4.99]
   Farazmand A., 2009, PUBLIC ORGAN REV, V9, P399, DOI [10.1007/s11115-009-0099-2, DOI 10.1007/S11115-009-0099-2]
   Farazmand A, 2021, INT J PUBLIC ADMIN, V44, P1149, DOI 10.1080/01900692.2021.1931315
   Farazmand A, 2021, INT J PUBLIC ADMIN, V44, P931, DOI 10.1080/01900692.2021.1903926
   Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124
   Flick U., 1998, INTRO QUALITATIVE RE
   Franken E, 2020, AUST J PUBL ADMIN, V79, P93, DOI 10.1111/1467-8500.12396
   Gillispie SK, 2016, J WORKPLACE BEHAV HE, V31, P1, DOI 10.1080/15555240.2015.1100519
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Gupta N, 2018, J INDIAN BUS RES, V10, P126, DOI 10.1108/JIBR-09-2017-0147
   Hamalainen T, 2012, INSEAD WORKING PAPER
   Harmand K, 2021, ERA FORUM, V22, P39, DOI [10.1007/s12027-021-00656-8, DOI 10.1007/S12027-021-00656-8]
   Hartmann S, 2020, APPL PSYCHOL-INT REV, V69, P913, DOI 10.1111/apps.12191
   Holzer M, 2020, AM REV PUBLIC ADM, V50, P450, DOI 10.1177/0275074020941666
   Hoopes L, 2004, MANAGING CHANGE PERS
   Huang QH, 2019, INT J HUM RESOUR MAN, V30, P1323, DOI 10.1080/09585192.2016.1226191
   Iacoviello BM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23970
   Iacovino N, 2017, PUBLIC ORGAN REV, V17, P61, DOI [10.1007/s11115-015-0327-x, DOI 10.1007/S11115-015-0327-X]
   Jorgensen TB, 1998, PUBLIC ADMIN, V76, P499, DOI 10.1111/1467-9299.00114
   Kabat-Zinn J., 2013, FULL CATASTROPHE LIV
   Kaplan S, 2014, J BUS PSYCHOL, V29, P367, DOI 10.1007/s10869-013-9319-4
   Katz R, 2020, CAN DIGITALIZATION M
   Khan Z, 2019, INT J HUM RESOUR MAN, V30, P1342, DOI 10.1080/09585192.2017.1316759
   Koliba C., 2011, GOVERNANCE NETWORKS
   Kossek EE, 2016, ACAD MANAG ANN, V10, P729, DOI 10.1080/19416520.2016.1159878
   Kovoor-Misra S, 2020, CRISIS MANAGEMENT RE, DOI [10.4135/9781506328676, DOI 10.4135/9781506328676]
   Krishnamara S, 2020, SHOULD BUSINESS LEAD
   Kuntz J, 2017, CAREER DEV INT, V22, P419, DOI 10.1108/CDI-11-2016-0208
   Kuntz JRC, 2016, IND ORGAN PSYCHOL-US, V9, P456, DOI 10.1017/iop.2016.39
   Kuye J. O., 2007, J PUBLIC ADM, V42, P597
   Lai AY, 2012, ASIA-PAC J PUBLIC HE, V24, P7, DOI 10.1177/1010539511429592
   Lemonakis C., 2020, PUBLIC SECTOR CRISIS, P85
   Lincoln Y.S., 1985, NATURALISTIC INQUIRY
   Liu YP, 2019, INT J HUM RESOUR MAN, V30, P1227, DOI 10.1080/09585192.2019.1565370
   Macky K, 2007, INT J HUM RESOUR MAN, V18, P537, DOI 10.1080/09585190601178745
   Malik P, 2017, J ORGAN CHANGE MANAG, V30, P610, DOI 10.1108/JOCM-09-2016-0176
   Ojo AO, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13052902
   Olowu D., 2002, BETTER GOVERNANCE PU
   Prayag G, 2018, ANN TOURISM RES, V73, P193, DOI 10.1016/j.annals.2018.06.006
   Nguyen Q, 2016, NEW ZEAL J PSYCHOL, V45, P13
   Richard EM, 2020, ADV DEV HUM RESOUR, V22, P387, DOI 10.1177/1523422320949143
   Rodrigo B, 2020, U MINDANAO, V1, P121
   Roman AV, 2017, AM REV PUBLIC ADM, V47, P102, DOI 10.1177/0275074015577799
   Seville E., 2018, DEV LEARNING ORG, V32, P15, DOI [10.1108/DLO-09-2017-0076, DOI 10.1108/DLO-09-2017-0076]
   Shaw J, 2016, PSYCHOL VIOLENCE, V6, P34, DOI 10.1037/vio0000020
   Shin J, 2012, ACAD MANAGE J, V55, P727, DOI 10.5465/amj.2010.0325
   Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338
   Teng-Calleja M, 2020, J BEHAV SCI, V15, P34
   Teng-Calleja M, 2020, INT J WORKPLACE HEAL, V13, P393, DOI 10.1108/IJWHM-09-2019-0122
   Tonkin K, 2018, HUM RESOUR DEV Q, V29, P107, DOI 10.1002/hrdq.21306
   van der Wal Z, 2020, PUBLIC ADMIN REV, V80, P759, DOI 10.1111/puar.13245
   Waite Phillip J, 2004, J Allied Health, V33, P178
   Youssef CM, 2007, J MANAGE, V33, P774, DOI 10.1177/0149206307305562
   Zarnadze N, 2020, EUROPEAN J LANGUAGE, V6, P55
   Zhu YH, 2021, SOC BEHAV PERSONAL, V49, DOI 10.2224/sbp.9632
NR 69
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1566-7170
EI 1573-7098
J9 PUBLIC ORGAN REV
JI Public Organ. Rev.
DI 10.1007/s11115-022-00617-w
EA APR 2022
PG 19
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA 0H7NA
UT WOS:000778917200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Honarmand, K
   Penn, J
   Agarwal, A
   Siemieniuk, R
   Brignardello-Petersen, R
   Bartoszko, JJ
   Zeraatkar, D
   Agoritsas, T
   Burns, K
   Fernando, SM
   Foroutan, F
   Ge, L
   Lamontagne, F
   Jimenez-Mora, MA
   Murthy, S
   Yepes-Nunez, JJ
   Vandvik, PO
   Ye, ZK
   Rochwerg, B
AF Honarmand, Kimia
   Penn, Jeremy
   Agarwal, Arnav
   Siemieniuk, Reed
   Brignardello-Petersen, Romina
   Bartoszko, Jessica J.
   Zeraatkar, Dena
   Agoritsas, Thomas
   Burns, Karen
   Fernando, Shannon M.
   Foroutan, Farid
   Ge, Long
   Lamontagne, Francois
   Jimenez-Mora, Mario A.
   Murthy, Srinivas
   Yepes-Nunez, Juan Jose
   Vandvik, Per O.
   Ye, Zhikang
   Rochwerg, Bram
TI Clinical trials in COVID-19 management & prevention: A
   meta-epidemiological study examining methodological quality
SO JOURNAL OF CLINICAL EPIDEMIOLOGY
LA English
DT Article
DE Covid-19; Systematic review; Risk of bias; Meta-epidemiology;
   Methodological quality; Clinical trials; Randomized controlled trials
ID EMPIRICAL-EVIDENCE; OPEN-LABEL; MULTICENTER; OUTCOMES; BIAS
AB Objective: To describe the characteristics of Covid-19 randomized clinical trials (RCTs) and examine the association between trial characteristics and the likelihood of finding a significant effect.
   Study design: We conducted a systematic review to identify RCTs (up to October 21, 2020) evaluating drugs or blood products to treat or prevent Covid-19. We extracted trial characteristics (number of centers, funding sources, and sample size) and assessed risk of bias (RoB) using the Cochrane RoB 2.0 tool. We performed logistic regressions to evaluate the association between RoB due to randomization, single vs. multicentre, funding source, and sample size, and finding a statistically significant effect.
   Results: We included 91 RCTs (n = 46,802); 40 (44%) were single-center, 23 (25.3%) enrolled < 50 patients, 28 (30.8%) received industry funding, and 75 (82.4%) had high or probably high RoB. Thirty-eight trials (41.8%) reported a statistically significant effect. RoB due to randomization and being a single-center trial were associated with increased odds of finding a statistically significant effect.
   Conclusions: There is high variability in RoB among Covid-19 trials. Researchers, funders, and knowledge-users should be cognizant of the impact of RoB due to randomization and single-center trial status in designing, evaluating, and interpreting the results of RCTs. (C) 2021 Elsevier Inc. All rights reserved.
C1 [Honarmand, Kimia] Western Univ, Dept Med, Div Crit Care, 1151 Richmond St, London, ON N6A 3K7, Canada.
   [Penn, Jeremy] McMaster Univ, Fac Hlth Sci, 1280 Main St West, Hamilton, ON L8S 4L8, Canada.
   [Agarwal, Arnav; Siemieniuk, Reed; Brignardello-Petersen, Romina; Bartoszko, Jessica J.; Zeraatkar, Dena; Agoritsas, Thomas; Burns, Karen; Ye, Zhikang; Rochwerg, Bram] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, 1280 Main St West, Hamilton, ON L8S 4L8, Canada.
   [Agarwal, Arnav] Univ Toronto, Dept Med, 27 Kings Coll Circle, Toronto, ON M5S 1A1, Canada.
   [Zeraatkar, Dena] Harvard Med Sch, Dept Biomed Informat, 25 Shattuck St, Boston, MA 02115 USA.
   [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Rue Gabrielle Perrat Gentil 4, CH-1205 Geneva, Switzerland.
   [Burns, Karen] St Michaels Hosp, Unity Hlth Toronto, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Fernando, Shannon M.] Univ Ottawa, Dept Med, Div Crit Care, 75 Laurier Ave E, Ottawa, ON K1N 6N5, Canada.
   [Foroutan, Farid] Toronto Gen Hosp, Univ Hlth Network, Ted Rogers Ctr Heart Res, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.
   [Ge, Long] Lanzhou Univ, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, 222 Tianshui S Rd, Lanzhou, Gansu, Peoples R China.
   [Lamontagne, Francois] CHU Sherbrooke, Dept Med, 12e Ave N Porte 6, Sherbrooke, PQ J1H 5N4, Canada.
   [Lamontagne, Francois] CHU Sherbrooke, Ctr Rech, 12e Ave N Porte 6, Sherbrooke, PQ J1H 5N4, Canada.
   [Jimenez-Mora, Mario A.; Yepes-Nunez, Juan Jose] Univ los Andes, Sch Med, Cra 1 18a-12, Bogota, DC, Colombia.
   [Murthy, Srinivas] Univ British Columbia, Fac Med, Dept Pediat, Vancouver, BC V6T 1Z4, Canada.
   [Yepes-Nunez, Juan Jose] Fdn Santa Fe Bogota Univ Hosp, Internal Med Sect, Pulmonol Serv, Cra 7b 12390, Bogota, DC, Colombia.
   [Vandvik, Per O.] Univ Oslo, Fac Med, Dept Hlth & Soc, Problemveien 7, N-0315 Oslo, Norway.
   [Rochwerg, Bram] McMaster Univ, Dept Med, 1280 Main St West, Hamilton, ON L8S 4L8, Canada.
RP Honarmand, K (corresponding author), Western Univ, Dept Med, Div Crit Care, 1151 Richmond St, London, ON N6A 3K7, Canada.
EM kimia.honarmand@medportal.ca
RI Yepes-Nuñez, Juan Jose/M-3796-2017
OI Yepes-Nuñez, Juan Jose/0000-0002-9912-0031; Murthy,
   Srinivas/0000-0002-9476-839X
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [CIHR-IRSC: 0579001321]; Hamilton Health Sciences Early
   Career Re-search Award
FX This is a substudy of the living network meta-analysis, supported by the
   Canadian Institutes of Health Research (grant CIHR-IRSC: 0579001321) .
   Dr. Rochwerg is sup-ported by a Hamilton Health Sciences Early Career
   Re-search Award. The funders had no role in the conduct of this study.
CR Abd-Elsalam S, 2020, AM J TROP MED HYG, V103, P1635, DOI 10.4269/ajtmh.20-0873
   Abella BS, 2021, JAMA INTERN MED, V181, P195, DOI 10.1001/jamainternmed.2020.6319
   Alexander PE, 2020, J CLIN EPIDEMIOL, V123, P120, DOI 10.1016/j.jclinepi.2020.04.016
   Altay O., 2020, COMBINED METABOLIC C, DOI [10.1101/2020.10.02.20202614, DOI 10.1101/2020.10.02.20202614]
   Amat-Santos IJ, 2020, J AM COLL CARDIOL, V76, P268, DOI 10.1016/j.jacc.2020.05.040
   Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022
   Ansarin K, 2020, BIOIMPACTS, V10, P209, DOI 10.34172/bi.2020.27
   Araujo E.P., 2020, LA PHARMACOLOGICAL I, DOI [10.1101/2020.08.11.20167353, DOI 10.1101/2020.08.11.20167353]
   Avendano-Sola C, 2020, CONVALESCENT PLASMA, DOI [DOI 10.1101/2020.08.26.20182444, 10.1101/2020.08.26.20182444]
   Baladron I, 2020, TREATMENT ANTI CK2 S, DOI [10.1101/2020.09.03.20187112, DOI 10.1101/2020.09.03.20187112]
   Barajas-Saucedo CE, 2020, RES SQUARE, DOI [10.21203/rs, DOI 10.21203/RS]
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Lemos ACB, 2020, THROMB RES, V196, P359, DOI 10.1016/j.thromres.2020.09.026
   Bialy Liza, 2014, Evid Based Child Health, V9, P1052, DOI 10.1002/ebch.1985
   Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857
   Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638
   Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao Yang, 2020, J Allergy Clin Immunol, V146, P137, DOI 10.1016/j.jaci.2020.05.019
   Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014
   CHEN CP, 2020, MEDRXIV, DOI DOI 10.1101/2020.07.08.20148841
   Chen L., 2020, EFFICACY SAFETY CHLO, DOI [10.1101/2020.06.19.20136093, DOI 10.1101/2020.06.19.20136093]
   Cheng LL, 2021, JAMA INTERN MED, V181, P71, DOI 10.1001/jamainternmed.2020.5503
   Corre N., 2020, EARLY ANTI SARS COV, DOI [10.1101/2020.09.17.20196212, DOI 10.1101/2020.09.17.20196212]
   Dabbous H, 2020, RES SQUARE, DOI [10.21203/rs.3.rs-83677/v1, DOI 10.21203/RS.3.RS-83677/V1]
   Dal-Re R, 2020, EUR J INTERN MED, V81, P91, DOI 10.1016/j.ejim.2020.07.002
   Davoodi L, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13600
   Davoudi-Monfared E, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01061-20
   Deftereos SG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13136
   Delgado AF, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1872-0
   Dequin PF, 2020, JAMA-J AM MED ASSOC, V324, P1298, DOI 10.1001/jama.2020.16761
   Doi Y, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01897-20
   Duarte M., 2020, PRELIMINARY REPORT
   Edalatifard M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02808-2020
   Entrenas Castillo Marta, 2020, J Steroid Biochem Mol Biol, V203, P105751, DOI 10.1016/j.jsbmb.2020.105751
   Fu WH, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100478
   Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6
   de Alencar JCG, 2021, CLIN INFECT DIS, V72, pE736, DOI 10.1093/cid/ciaa1443
   Geurtsvankessel C, 2020, CONVALESCENT PLASMA, DOI [10.1101/2020.07.01.20139857, DOI 10.1101/2020.07.01.20139857]
   Gharebaghi N, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05507-4
   Giannini MC., 2020, BENEFICIAL EFFECTS C, DOI [10.1101/2020.08.06.20169573, DOI 10.1101/2020.08.06.20169573]
   Glasziou PP, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1847
   Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301
   Gomez-Barquero, 2020, GLUCOCOVID CONTROLLE
   Grau-Pujol B., 2020, BMC INFECT DIS, DOI [10.21203/rs.3.rs-72132/v1, DOI 10.21203/RS.3.RS-72132/V1]
   Guvenmez O, 2020, J POPUL THER CLIN PH, V27, pE5, DOI 10.15586/jptcp.v27iSP1.684
   Horby P, 2020, NEW ENGL J MED, V383, P2030, DOI 10.1056/NEJMoa2022926
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4
   Hsiehchen D, 2020, MED-CAMBRIDGE, V1, P103, DOI 10.1016/j.medj.2020.06.007
   Hu K, 2020, VIROL SIN, V35, P725, DOI 10.1007/s12250-020-00258-7
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Huang MX, 2020, J MOL CELL BIOL, V12, P322, DOI 10.1093/jmcb/mjaa014
   Huang YQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01071
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Idelsis E-M, 2020, EFFECT SAFETY COMBIN, DOI [10.1101/2020.07.29.20164251, DOI 10.1101/2020.07.29.20164251]
   Ivashchenko AA, 2021, CLIN INFECT DIS, V73, P531, DOI 10.1093/cid/ciaa1176
   Janiaud Perrine, 2020, F1000Res, V9, P1193, DOI [10.12688/f1000research.26707.1, 10.12688/f1000research.26707.2]
   Janiaud P, 2018, INTENS CARE MED, V44, P1613, DOI 10.1007/s00134-018-5325-3
   Jeronimo C.M.P., 2021, CLIN INFECT DIS, V72, pe373, DOI [DOI 10.1093/CID/CIAA1177, 10.1093/CID/CIAA1177., DOI 10.1093/cid/ciaa1177]
   Kasgari HA, 2020, J ANTIMICROB CHEMOTH, V75, P3373, DOI 10.1093/jac/dkaa332
   Keyvani, 2020, RES SQ, DOI [10. 21203/rs.3.rs-78316/v1, DOI 10.21203/RS.3.RS-78316/V1]
   Khan NA, 2012, ARTHRITIS RHEUM-US, V64, P2059, DOI 10.1002/art.34393
   Kimura KS, 2020, INT FORUM ALLERGY RH, V10, P1325, DOI 10.1002/alr.22703
   Kumar G, 2020, CONVALESCENT PLASMA, DOI [10.1101/ 2020.09.03, DOI 10.1101/2020.09.03]
   Lahiri, 2020, NATURE DIMENSIONS CY, DOI [10.1101/ 2020.09. 21.20199109, 10.1101/2020.09.21.20199109, DOI 10.1101/2020.09.21.20199109]
   Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379
   Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044
   Li T, 2020, CTS-CLIN TRANSL SCI, V13, P1096, DOI 10.1111/cts.12881
   Li Y., 2020, RES SQUARE, DOI [10.21203/rs.3.rs-52778/v1, DOI 10.21203/RS.3.RS-52778/V1]
   Li YP, 2020, MED-CAMBRIDGE, V1, P105, DOI 10.1016/j.medj.2020.04.001
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Lou Y, 2021, EUR J PHARM SCI, V157, DOI 10.1016/j.ejps.2020.105631
   Lyngbakken MN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19056-6
   Marshall IJ, 2018, RES SYNTH METHODS, V9, P602, DOI 10.1002/jrsm.1287
   Mehta HB, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039978
   Meneses-Echavez JF, 2020, RES SQ, DOI [10.21203/rs.3.rs- 107409/v1, DOI 10.21203/RS.3.RS-107409/V1]
   Miller J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03220-x
   Mitja O., 2020, CLUSTER RANDOMIZED T, DOI [10.1101/2020.07.20.20157651, DOI 10.1101/2020.07.20.20157651]
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Montgomery JH, 2004, CONTROL CLIN TRIALS, V25, P598, DOI 10.1016/j.cct.2004.09.002
   Peng Z., 2020, TOCILIZUMAB AMELIORA, DOI [10.2139/ssrn.3667681, DOI 10.2139/SSRN.3667681]
   Rahmani H, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106903
   Rajasingham R, 2021, CLIN INFECT DIS, V72, pE835, DOI 10.1093/cid/ciaa1571
   Ramanan M, 2020, MED J AUSTRALIA, V213, P380, DOI 10.5694/mja2.50790
   Ren ZG, 2020, ADV SCI, V7, DOI 10.1002/advs.202001435
   Rochwerg Bram, 2020, Crit Care Explor, V2, pe0098, DOI 10.1097/CCE.0000000000000098
   Sadeghi A, 2020, J ANTIMICROB CHEMOTH, V75, P3379, DOI 10.1093/jac/dkaa334
   Sakoulas G, 2020, INTRAVENOUS IMMUNOGL, DOI [10.1101/2020.07.20.20157891, DOI 10.1101/2020.07.20.20157891]
   Salehzadeh F., 2020, RES SQUARE, DOI [10.21203/rs.3.rs-69374/v1, DOI 10.21203/RS.3.RS-69374/V1]
   Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   Sekhavati E, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106143
   Shu L, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01875-5
   Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980
   Skipper CP, 2020, ANN INTERN MED, V173, P623, DOI 10.7326/M20-4207
   Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349
   Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849
   Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021
   Ulrich RJ, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa446
   Uulu, 2020, INT J PHARM SCI RES, V11, P506, DOI [10.26452/ ijrps. v11iSPL1.2839, DOI 10.26452/IJRPS.V11ISPL1.2839]
   Vlaar APJ, 2020, LANCET RHEUMATOL, V2, pE764, DOI 10.1016/S2665-9913(20)30341-6
   Wang M., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1417, DOI 10.1093/CID/CIAA1417]
   Waters, 2020, TOCILIZUMAB HOSPITAL, DOI [10.1101/ 2020.08.27.20183442, 10.1101/2020.08.27.20183442]
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD
   WU X, 2020, IN PRESS
   Xu Z, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3622363, DOI 10.2139/SSRN.3622363]
   Yan D., 2020, EFFICACY HYDROXYCHLO, DOI 10.1101/2020.03.22.20040758
   Yuan X, 2020, PULMONARY RADIOLOGIC, DOI [10.1101/2020.04.07.20054767, DOI 10.1101/2020.04.07.20054767]
   Zhang ZH, 2013, CRIT CARE, V17, DOI 10.1186/cc11919
   Zhao H, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.110825
   Zheng F, 2020, INT J INFECT DIS, V99, P84, DOI 10.1016/j.ijid.2020.07.053
   Zhong M, 2020, MEDRXIV2020041520066, DOI [10.1101/2020.04.15.20066266, DOI 10.1101/2020.04.15.20066266]
   Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6
   Zhu RF, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02442-5
NR 116
TC 2
Z9 2
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0895-4356
EI 1878-5921
J9 J CLIN EPIDEMIOL
JI J. Clin. Epidemiol.
PD NOV
PY 2021
VL 139
BP 68
EP 79
DI 10.1016/j.jclinepi.2021.07.002
EA AUG 2021
PG 12
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA WA9JZ
UT WOS:000703200600008
PM 34274489
OA Green Published, Bronze, Green Submitted
DA 2022-04-20
ER

PT C
AU Haave, H
   Vold, T
AF Haave, Hanne
   Vold, Tone
BE GarciaPerez, A
   Simkin, L
TI Knowledge Management During a long-term Crisis: Challenges with
   Distributed Employees
SO PROCEEDINGS OF THE 22ND EUROPEAN CONFERENCE ON KNOWLEDGE MANAGEMENT
   (ECKM 2021)
SE Proceedings of the European Conference on Knowledge Management
LA English
DT Proceedings Paper
CT 22nd European Conference on Knowledge Management (ECKM)
CY SEP 02-03, 2021
CL Coventry Univ, ELECTR NETWORK
HO Coventry Univ
DE Knowledge Management processes; Crisis Management; Distributed
   employees; Communities of Practice
AB The pandemic caused by the Covid-19 virus led to an extensive, and rather immediate, situation of a substantial number of employees being "forced" to work from home. Even if the technology was developed for enabling this "new" type of telework, not all employees or managers were prepared for this abrupt introduction. The pandemic represented a crisis that needed the resolving of Knowledge Management issues, while maintaining a reasonable level of production. This posed managerial issues, such as maintaining communication with the employees, as well as maintaining the focus on the production, customers and other stakeholders. Our paper shows how the management in two different organizations, one public and one private, perceived the crisis and its challenges, and how they handled the various stages of the crisis. The managers have experienced the issues described in the literature of telework, Work From Home (WFH), remote work and flexible work, such as resolving to empowering leadership (EL), installing the employees with trust and autonomy and recognizing the loss of informal communication. They struggle to acquire an overview of the employees' well-being, at the same time as they experience a decrease in sick leaves and an increase in production.
C1 [Haave, Hanne; Vold, Tone] Inland Norway Univ Appl Sci, Rena, Norway.
RP Haave, H (corresponding author), Inland Norway Univ Appl Sci, Rena, Norway.
EM Hanne.haave@inn.no; Tone.vold@inn.no
CR Alvesson M., 2002, MANAGE COMMUN Q, V16, P282, DOI [10.1177/089331802237242, DOI 10.1177/089331802237242]
   Amundsen S, 2014, LEADERSHIP QUART, V25, P487, DOI 10.1016/j.leaqua.2013.11.009
   Argyris C., 1996, ADDISON WESLEY SERIE
   Bergum S, 2001, MANAGERIAL COMMUNICA
   Bergum S., 2014, MANAGEMENT TELEWORKE
   Bolisani E, 2020, MANAG MARK, V15, P458, DOI 10.2478/mmcks-2020-0027
   Coombs W.T., 2019, ONGOING CRISIS COMMU, V5th
   Darling J. R., 1996, LIIKETALOUDELLINEN A, P407
   Davenport T., 1998, WORKING KNOWLEDGE OR
   Dewey J, 1938, EXPERIENCE ED
   Duncan A, 2020, LEADERS LOCKDOWN INS
   Fink S., 1986, CRISIS MANAGEMENT PL
   Gangdal J., 2014, KRISE FOREBYGGING BE
   Grant C.A., 2013, EMPL RELAT
   Hackman J.R., 1980, WORK REDESIGN
   Hertel G., 2005, Human Resources Management Review, V15, P69, DOI 10.1016/j.hrmr.2005.01.002
   Hesketh I., 2019, WELLBEING WORK DESIG
   Hislop D., 2018, KNOWLEDGE MANAGEMENT
   Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245
   Ivan Siang-Meng SIN, 2017, Global Business and Finance Review, V22, P38, DOI 10.17549/gbfr.2017.22.1.38
   Jung H.- S., 2021, FUTURE REMOTE WORK T
   Kash T. J., 1998, LEADERSHIP ORG DEV J
   Kirchner K, 2021, KNOWL MAN RES PRACT, V19, P493, DOI 10.1080/14778238.2021.1877579
   Koenig M. E. D, 2012, KM WORLD, V4
   Kolb D. A., 2014, EXPERIENTIAL LEARNIN
   Lampel J, 2009, ORGAN SCI, V20, P835, DOI 10.1287/orsc.1090.0479
   Lave J., 1991, SITUATED LEARNING LE
   McAlpine K.L, 2018, AC MAN P AC MAN BRIA, V1, DOI 10.5465/AMBPP.2018.205
   Nilles J. M., 1998, MANAGING TELEWORK ST
   Penrose JM, 2000, PUBLIC RELAT REV, V26, P155, DOI 10.1016/S0363-8111(00)00038-2
   Peters P, 2014, HUM RESOUR MANAGE-US, V53, P271, DOI 10.1002/hrm.21588
   Vargas Llave O., 2020, COVID 19 UNLEASHED T
   Vogus T.J., 2003, POSITIVE ORG SCHOLAR
   Weick K.E., 1995, SENSEMAKING ORG
   Weick KE, 2015, MANAGING THE UNEXPECTED: SUSTAINED PERFORMANCE IN A COMPLEX WORLD, 3RD EDITION, P1, DOI 10.1002/9781119175834
   WEICK KE, 1988, J MANAGE STUD, V25, P305, DOI 10.1111/j.1467-6486.1988.tb00039.x
   Wenger E., 2011, COMMUNITIES PRACTICE
   Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y
NR 38
TC 0
Z9 0
U1 1
U2 1
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-8963
BN 978-1-914587-07-8
J9 PROC EUR CONF KNOWL
PY 2021
BP 813
EP 820
DI 10.34190/EKM.21.120
PG 8
WC Business; Management
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BS7BB
UT WOS:000758201900094
DA 2022-04-20
ER

PT J
AU Costa-Santos, C
   Neves, AL
   Correia, R
   Santos, P
   Monteiro-Soares, M
   Freitas, A
   Ribeiro-Vaz, I
   Henriques, TS
   Rodrigues, PP
   Costa-Pereira, A
   Pereira, AM
   Fonseca, JA
AF Costa-Santos, Cristina
   Neves, Ana Luisa
   Correia, Ricardo
   Santos, Paulo
   Monteiro-Soares, Matilde
   Freitas, Alberto
   Ribeiro-Vaz, Ines
   Henriques, Teresa S.
   Rodrigues, Pedro Pereira
   Costa-Pereira, Altamiro
   Pereira, Ana Margarida
   Fonseca, Joao A.
TI COVID-19 surveillance data quality issues: a national consecutive case
   series
SO BMJ OPEN
LA English
DT Article
DE COVID-19; information management; health informatics; epidemiology;
   public health; statistics & research methods
ID TIMELINESS; SYSTEM
AB Objectives High-quality data are crucial for guiding decision-making and practising evidence-based healthcare, especially if previous knowledge is lacking. Nevertheless, data quality frailties have been exposed worldwide during the current COVID-19 pandemic. Focusing on a major Portuguese epidemiological surveillance dataset, our study aims to assess COVID-19 data quality issues and suggest possible solutions. Settings On 27 April 2020, the Portuguese Directorate-General of Health (DGS) made available a dataset (DGSApril) for researchers, upon request. On 4 August, an updated dataset (DGSAugust) was also obtained. Participants All COVID-19-confirmed cases notified through the medical component of National System for Epidemiological Surveillance until end of June. Primary and secondary outcome measures Data completeness and consistency. Results DGSAugust has not followed the data format and variables as DGSApril and a significant number of missing data and inconsistencies were found (eg, 4075 cases from the DGSApril were apparently not included in DGSAugust). Several variables also showed a low degree of completeness and/or changed their values from one dataset to another (eg, the variable 'underlying conditions' had more than half of cases showing different information between datasets). There were also significant inconsistencies between the number of cases and deaths due to COVID-19 shown in DGSAugust and by the DGS reports publicly provided daily. Conclusions Important quality issues of the Portuguese COVID-19 surveillance datasets were described. These issues can limit surveillance data usability to inform good decisions and perform useful research. Major improvements in surveillance datasets are therefore urgently needed-for example, simplification of data entry processes, constant monitoring of data, and increased training and awareness of healthcare providers-as low data quality may lead to a deficient pandemic control.
C1 [Costa-Santos, Cristina; Neves, Ana Luisa; Correia, Ricardo; Santos, Paulo; Monteiro-Soares, Matilde; Freitas, Alberto; Ribeiro-Vaz, Ines; Henriques, Teresa S.; Rodrigues, Pedro Pereira; Costa-Pereira, Altamiro; Pereira, Ana Margarida; Fonseca, Joao A.] Univ Porto, Fac Med, Dept Community Med Informat & Hlth Decis Sci MEDC, Porto, Portugal.
   [Costa-Santos, Cristina; Neves, Ana Luisa; Correia, Ricardo; Santos, Paulo; Monteiro-Soares, Matilde; Freitas, Alberto; Ribeiro-Vaz, Ines; Henriques, Teresa S.; Rodrigues, Pedro Pereira; Costa-Pereira, Altamiro; Pereira, Ana Margarida; Fonseca, Joao A.] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, Porto, Portugal.
   [Neves, Ana Luisa] Imperial Coll London, Patient Safety Translat Res Ctr, Inst Global Hlth Innovat, London, England.
   [Monteiro-Soares, Matilde] Escola Super Saude Cruz Vermelha Portuguesa, Lisbon, Portugal.
   [Ribeiro-Vaz, Ines] Univ Porto, Fac Med, Porto Pharmacovigilance Ctr, P-4200450 Porto, Portugal.
RP Costa-Santos, C (corresponding author), Univ Porto, Fac Med, Dept Community Med Informat & Hlth Decis Sci MEDC, Porto, Portugal.; Costa-Santos, C (corresponding author), Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, Porto, Portugal.
EM csantos.cristina@gmail.com
RI Fonseca, Joao Almeida/B-7562-2008; Santos, Paulo AAP/C-5923-2013; ,
   Cristina/S-7443-2019; Rodrigues, Pedro Pereira/H-5789-2012; Freitas,
   Alberto/C-1972-2012; Pereira, Ana Margarida/K-3343-2014; Santos,
   Cristina/J-3255-2013; Costa-Pereira, Altamiro/I-5987-2012; Cruz-Correia,
   Ricardo/A-2756-2009; Henriques, Teresa/B-3919-2016
OI Fonseca, Joao Almeida/0000-0002-0887-8796; Santos, Paulo
   AAP/0000-0002-2362-5527; , Cristina/0000-0002-7109-1101; Rodrigues,
   Pedro Pereira/0000-0001-7867-6682; Freitas, Alberto/0000-0003-2113-9653;
   Pereira, Ana Margarida/0000-0002-5468-0932; Santos,
   Cristina/0000-0002-7109-1101; Costa-Pereira,
   Altamiro/0000-0001-8467-6398; Cruz-Correia, Ricardo/0000-0002-3764-5158;
   Henriques, Teresa/0000-0002-4032-9594
FU FCT -Fundacao para a Ciencia e a Tecnologia,I.P., within CINTESIS, RD
   Unit [UIDB/4255/2020]
FX This work was supported by National Funds through FCT -Fundacao para a
   Ciencia e a Tecnologia,I.P., within CINTESIS, R&D Unit (reference
   UIDB/4255/2020).
CR Alonso V, 2020, HEALTH INF MANAG J, V49, P28, DOI 10.1177/1833358319826351
   Tuberculosis Along the US-Mexico Border Work Group Centers for Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1
   Ashofteh Afshin, 2020, Statistical Journal of the IAOS, V36, P291, DOI 10.3233/SJI-200674
   Boes L, 2020, PUBLIC HEALTH, V180, P141, DOI 10.1016/j.puhe.2019.11.012
   Carta aberta AO Conselho Nacional de Saude Publica, 2020, CONTR PESS AC EP COV
   Chen H, 2014, INT J ENV RES PUB HE, V11, P5170, DOI 10.3390/ijerph110505170
   D'Amore John, 2018, AMIA Annu Symp Proc, V2018, P358
   Direcao Geral da Saude, 2020, COVID MET
   Direcao Geral da Saude, 2020, COM CAS INF POR NOV
   Direcao Geral da Saude, 2020, COVID 19 DISP DAD
   Direcao Geral da Saude, 2020, REL SIT INF PUBL DIA
   Institute of Medicine, 2015, CONTINUOUSLY LEARNIN
   Martins, 2020, BMJ-BRIT MED J, DOI [10.1101/2020.07.02.20144378, DOI 10.1101/2020.07.02.20144378]
   Morgan O, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0365
   Nogueira PJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082368
   Peixoto V.R., 2020, COVID 19 DETERMINANT, DOI [10.1101/2020.05.29.20115824, DOI 10.1101/2020.05.29.20115824]
   Quinaz Romana G, 2019, ACTA MEDICA PORT, V32, P30, DOI 10.20344/amp.11227
   Sa-Sousa Ana, 2012, Clin Transl Allergy, V2, P15, DOI 10.1186/2045-7022-2-15
   Tosti ME, 2015, PUBLIC HEALTH, V129, P561, DOI 10.1016/j.puhe.2015.02.015
   Visa TI, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-0629-2
   Wolkewitz M, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-00972-6
   Xu B, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30119-5
   Yazidi R, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7035-3
   Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
NR 24
TC 1
Z9 1
U1 2
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD DEC
PY 2021
VL 11
IS 12
AR e047623
DI 10.1136/bmjopen-2020-047623
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA XM2EL
UT WOS:000728646900015
PM 34872992
DA 2022-04-20
ER

PT J
AU Kou, Y
   Chen, P
   Pan, JX
AF Kou, Yin
   Chen, Ping
   Pan, Jie-Xing
TI The Service Experiences of Public Libraries during the COVID-19
   Emergency in Wuhan: Three Case Studies
SO JOURNAL OF THE AUSTRALIAN LIBRARY AND INFORMATION ASSOCIATION
LA English
DT Article
DE COVID-19; public library; Wuhan; disaster; emergency management;
   community resilience
AB As the first libraries encountering COVID-19, public libraries in Wuhan developed innovative practices to deal with the emergency, which can provide great reference points for other libraries dealing with the crisis. Three of the major libraries in Wuhan, namely Hubei provincial library, Wuhan library, and Jianghan district library, were selected as cases to study how the first closed public libraries in China responded to the COVID-19 pandemic. Through an analysis of library portal news, WeChat public account tweets, social media information, and voice call discussions with librarians etc., the responses of the three libraries during the closure and reopening period can be summarised as follows: establishing an emergency management system to ensure internal team stability; disseminating authoritative information and knowledge to curb social anxiety and rumours; developing online cultural activities to dissipate the boredom of isolation at home; setting up book corners in special spaces to support government's innovative practices and to ease patients' panic; and, encouraging staff to improve resilience in the community.
C1 [Kou, Yin; Chen, Ping; Pan, Jie-Xing] Wuhan Univ, Natl Inst Cultural Dev, Wuhan, Peoples R China.
RP Kou, Y (corresponding author), Wuhan Univ, Villa 20,299 Bayi Rd, Wuhan 430072, Hubei, Peoples R China.
EM kouyin@whu.edu.cn
CR Alajmi BM, 2021, PUBLIC LIBR Q, V40, P540, DOI 10.1080/01616846.2020.1827618
   American Public Library Association, 2020, PUBL LIB RESP COVID
   [Anonymous], 2020, HUBEI DAILY 0427
   Featherstone RM, 2008, J MED LIBR ASSOC, V96, P343, DOI 10.3163/1536-5050.96.4.009
   Fraser-Arnott, 2020, REFER LIBR, V61, P165, DOI [10.1080/02763877.2020.1862021, DOI 10.1080/02763877.2020.1862021]
   Garner J, 2021, J AUST LIB INF ASSOC, V70, P102, DOI 10.1080/24750158.2021.1901329
   Hubei COVID-19 Prevention and Control Command, 2020, NOT HUB PROV HEADQ P
   Hubei Provincial Library, OV LIB
   Hubei Provincial Library, 2020, ACT SEE ROL EARL PRE
   Hubei Provincial Library, 2020, IMP NOT CLOS NOT
   Hubei Provincial Library, 2020, RECH HLTH START ME H
   Hubei Provincial Library, 2020, ANN REOP HUB PROV LI
   Hubei Provincial Library, HUB PROV LIB REG
   Hubei Provincial Library, 2020, SECR PART COMM DIR H
   IFLA, 2020, COVID 19 GLOB LIB FE
   Jiang, 2020, JIANGHAN CULTURAL TR
   Jianghan District Library, 2020, NEW COR PREV SAF PUB
   Jianghan District Library, 2020, GUESS LANT RIDDL SPE
   Jianghan District Library, 2020, CIT FULL BOOKS CLASS
   Jianghan District Library, 2020, ANN SAF ORD OP JIANG
   Jianghan District Library, WUH JIANGH DISTR LIB
   Jianghan District Library, 2020, FAM AUTH EXPL CLASS
   Jianghan District Library, 2020, FIGHT EP ALL PEOPL L
   Jianghan District Library, 2020, CLOS ANN
   Li J.X., 2020, J LIB SCI CHINA, V46, P38, DOI [10.13530/j.cnki.jlis.2020022, DOI 10.13530/J.CNKI.JLIS.2020022]
   Lu W.W, 2021, NEI MONGO SCI TECHNO, V25, P98
   Smith J, 2020, J AUST LIB INF ASSOC, V69, P422, DOI 10.1080/24750158.2020.1840719
   The Voice of Culture and Tourism in Hubei, 2020, THEPAPER 0225
   Tu L., 2020, HEBEI LIB J SCI TECH, V33, P33, DOI [10.13897/j.cnki.hbkjty.2020.0081, DOI 10.13897/J.CNKI.HBKJTY.2020.0081]
   Wang T, 2020, PUBLIC LIBR Q, V39, P283, DOI 10.1080/01616846.2020.1764325
   WHO, 2020, NOV COR 2019 NCOV SI
   Wuhan COVID-19 Prevention and Control Command, 2020, WUH MUN PEOPL GOV
   Wuhan Library, 2020, CLOS NOT
   Wuhan Library, 2020, WUH LIB ACT PROM COH
   Wuhan Library, 2020, CLOS LIB DO NOT CLOS
   Wuhan Library, WHL
   Wuhan Library, 2020, GO COMM WUH LIB STAF
   Wuhan Library, 2020, WUH VIC MAYOR CHEN X
   Wuhan Library, 2020, YI BU RONG CI YI XIA
   Wuhan Library, 2020, CIT CAN STEP WUH LIB
   Wuhan Municipal Statistics Bureau, 2019, 70 ANN FOUND NEW CHI
   Wuhan Municipal Statistics Bureau et al, 2020, WUHAN STAT YB, P285
   Xin Hua Net, 2020, CLOS WUH FANG CHANG
   Xinhua News Agency, 2020, XINHUA NEWS AGE 0219
   Xu X.F, 2021, GANSU SCI TECHNOLOGY, V37
   Yin R.K, 2018, CASE STUDY RES DESIG, P9
   Zhang N, 2020, LIB WORK RES LIB WOR, V32, P58, DOI [10.16384/j.cnki.lwas.2020.09.009, DOI 10.16384/J.CNKI.LWAS.2020.09.009]
NR 47
TC 1
Z9 1
U1 20
U2 27
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2475-0158
EI 2475-0166
J9 J AUST LIB INF ASSOC
JI J. Aust. Libr. Inf. Assoc.
PD JUL 3
PY 2021
VL 70
IS 3
BP 287
EP 300
DI 10.1080/24750158.2021.1960251
EA AUG 2021
PG 14
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA UO1GF
UT WOS:000687117700001
DA 2022-04-20
ER

PT J
AU Clampit, J
   Hasija, D
   Dugan, M
   Gamble, J
AF Clampit, Jack
   Hasija, Dinesh
   Dugan, Michael
   Gamble, John
TI The Effect of Risk, R&D Intensity, Liquidity, and Inventory on Firm
   Performance during COVID-19: Evidence from US Manufacturing Industry
SO JOURNAL OF RISK AND FINANCIAL MANAGEMENT
LA English
DT Article
DE COVID-19; pandemic; crisis; firm risk; R&D; inventory; cash; firm
   performance
ID NATURAL DISASTERS; STRATEGY RESEARCH; CRISIS; IMPACT; EXPLORATION;
   ENTREPRENEURSHIP; HETEROGENEITY; EXPLOITATION; CAPABILITIES; MANAGEMENT
AB Because prior knowledge may not generalize to the COVID-19 setting, scholars are racing to test the efficacy of existing theoretical frameworks during COVID-19. Most business studies are conceptual or surveys of damage. The main purpose of the paper is to extend the forthcoming stream that tests firm performance by examining it during COVID-19. We examine the sales growth of 1298 US manufacturers during COVID-19 compared to their pre-COVID-19 baselines. Riskier firms with higher R & D intensities performed better during COVID-19, especially when cash-to-inventory levels were low. This study is among the first to empirically identify actionable predictors of firm performance during COVID-19 via a quantitative analysis of strategies and performance outcomes. Understanding what type of firms perform at higher levels during COVID-19 will help decision makers make more informed decisions moving forward. Employing ordinary least squares (OLS) regression to test our hypotheses, our findings suggest that R & D intensive firms should pivot tactically regarding current asset management, if needed, but not strategically, while prioritizing inventory versus cash retention. The positive effect of inventory versus cash extends theory by suggesting a new boundary condition related to pandemics that reverses the positive link between cash and performance found during crises with more conventional levels of turbulence. Our most important contribution, however, is practical, via the testing of predictors that can help firms during COVID-19. For example, we found that firms with higher levels of operating risk experienced 60 percent more sales growth than risk-averse firms. This knowledge that risk-taking predicted performance during COVID-19 (especially when coupled with a focus on R & D intensity and inventory level) may encourage those that can adopt less risk-averse strategies, while others focus on tactical adjustments or mitigative measures during COVID-19 and future black swan events.</p>
C1 [Clampit, Jack; Gamble, John] Texas A&M Univ, Dept Management & Mkt, Corpus Christi, TX 78412 USA.
   [Hasija, Dinesh; Dugan, Michael] Augusta Univ, Dept Management & Mkt, Augusta, GA 30912 USA.
RP Dugan, M (corresponding author), Augusta Univ, Dept Management & Mkt, Augusta, GA 30912 USA.
EM Jack.Clampit@tamucc.edu; dhasija@augusta.edu; mdugan@augusta.edu;
   John.Gamble@tamucc.edu
CR Adams Donald., 2021, EC MANAGEMENT FINANC, V16, P81, DOI [10.22381/emfm16320215, DOI 10.22381/EMFM16320215]
   Ahn JM, 2018, IND CORP CHANGE, V27, P49, DOI 10.1093/icc/dtx048
   Aldrich H. E., 1986, RES ORGAN BEHAV, V8, P165, DOI DOI 10.2139/SSRN.1497769
   Archibugi D, 2013, RES POLICY, V42, P303, DOI 10.1016/j.respol.2012.07.002
   Atan Z, 2012, SUPPLY CHAIN DISRUPTIONS: THEORY AND PRACTICE OF MANAGING RISK, P115, DOI 10.1007/978-0-85729-778-5_5
   Bai CU, 2021, DECISION SCI, V52, P920, DOI 10.1111/deci.12467
   Batrancea L, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9060630
   Batrancea L, 2015, TRANSYLV REV ADM SCI, P5
   BOWMAN EH, 1980, SLOAN MANAGE REV, V21, P17
   Cainelli G, 2018, ADV SPAT SCI, P223, DOI 10.1007/978-3-319-90575-4_13
   Carvalho VM, 2021, Q J ECON, V136, P1255, DOI 10.1093/qje/qjaa044
   Chiu CH, 2016, ANN OPER RES, V240, P489, DOI 10.1007/s10479-013-1386-4
   Clampit JA, 2022, INT SMALL BUS J, V40, P403, DOI 10.1177/02662426211033270
   Cohen S., 2021, EC MANAG FINANC MARK, V16, P55
   Cole MA, 2019, J ECON GEOGR, V19, P373, DOI 10.1093/jeg/lbx037
   Cole MA, 2017, INT J DISAST RISK RE, V21, P291, DOI 10.1016/j.ijdrr.2016.12.015
   Cowling M, 2020, INT SMALL BUS J, V38, P593, DOI 10.1177/0266242620945102
   Cowling M, 2018, J EVOL ECON, V28, P77, DOI 10.1007/s00191-017-0502-z
   De Mel S, 2012, ECON J, V122, P64, DOI 10.1111/j.1468-0297.2011.02475.x
   Alonso-Almeida MD, 2015, INT J CONTEMP HOSP M, V27, P1641, DOI 10.1108/IJCHM-03-2014-0117
   Doern R, 2019, ENTREP REGION DEV, V31, P400, DOI 10.1080/08985626.2018.1541590
   Eggers F, 2020, J BUS RES, V116, P199, DOI 10.1016/j.jbusres.2020.05.025
   Evans Simon., 2021, FINANCIAL REV 0411
   Fabling R, 2019, NEW HORIZ REG SCI, P30
   Fainshmidt S, 2019, J MANAGE STUD, V56, P758, DOI 10.1111/joms.12415
   Fairlie RW., 2020, IMPACT COVID 19 SMAL
   FISHER IN, 1969, Q J ECON, V83, P79, DOI 10.2307/1883994
   Fletcher J., 2000, INT REV FINANC ANAL, V9, P235
   George G, 2005, ACAD MANAGE J, V48, P661
   Gibson Peter., 2021, J SELF GOVERNANCE MA, V9, P22, DOI [10.22381/jsme9320212, DOI 10.22381/JSME9320212]
   Gomes J, 2001, J MONETARY ECON, V48, P109, DOI 10.1016/S0304-3932(01)00071-X
   HALL RE, 1995, BROOKINGS PAP ECO AC, P221
   Hayakawa K, 2015, J JPN INT ECON, V38, P244, DOI 10.1016/j.jjie.2015.10.001
   Imhof MJ, 2014, ADV ACCOUNT, V30, P328, DOI 10.1016/j.adiac.2014.09.004
   Irdina Irdina., 2020, INT J TOURISM HOSPIT, V3, P22, DOI [10.32535/ijthap.v3i3.941, DOI 10.32535/IJTHAP.V3I3.941]
   JACQUEMIN AP, 1979, J IND ECON, V27, P359, DOI 10.2307/2097958
   Jansen JJP, 2006, MANAGE SCI, V52, P1661, DOI 10.1287/mnsc.1060.0576
   JOVANOVIC B, 1982, ECONOMETRICA, V50, P649, DOI 10.2307/1912606
   Kanini Ndung'u., 2020, INT ACAD J EC FINANC, V3, P238
   Kantor A, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14040181
   Kee DaisyMuiHung., 2021, J COMMUNITY DEV ASIA, V4, P44, DOI [10.32535/jcda.v4i2.1072, DOI 10.32535/JCDA.V4I2.1072]
   Kotabe M, 2002, J INT BUS STUD, V33, P79, DOI 10.1057/palgrave.jibs.8491006
   Kovacova M., 2021, J SELF GOVERN MANAG, V9, P9, DOI [10.22381/jsme9320211, DOI 10.22381/JSME9320211]
   Kovacova M., 2021, ECO MANAGE FINANC MA, V16, P41, DOI [10.22381/emfm16320212, DOI 10.22381/EMFM16320212]
   Kristjansdottir H, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14010023
   Kumar Navaneetha., 2021, INT J TOURISM HOSPIT, V4, P28, DOI [10.32535/ijthap.v4i2.1055, DOI 10.32535/IJTHAP.V4I2.1055]
   Lee J, 2021, DISASTERS, V45, P296, DOI 10.1111/disa.12417
   Lee KJ, 2018, J RISK FINANC MANAG, V11, DOI 10.3390/jrfm11020016
   LONG WF, 1993, STRATEGIC MANAGE J, V14, P119, DOI 10.1002/smj.4250140910
   March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71
   Melitz MJ, 2003, ECONOMETRICA, V71, P1695, DOI 10.1111/1468-0262.00467
   MERTON RC, 1974, J FINANC, V29, P449, DOI 10.2307/2978814
   MILLER KD, 1990, ACAD MANAGE J, V33, P756, DOI 10.2307/256289
   Modigliani Franco., 1974, FINANC ANAL J, V30, P69, DOI [10.2469/faj.v30.n3.69, DOI 10.2469/FAJ.V30.N3.69]
   Musk Elon., 2021, TWITTER
   Nair A, 2014, MANAG DECIS ECON, V35, P555, DOI 10.1002/mde.2641
   Neter J., 1996, APPL LINEAR STAT MOD
   Nickel MN, 2002, OMEGA-INT J MANAGE S, V30, P1, DOI 10.1016/S0305-0483(01)00055-X
   O'Kane Sean., 2019, VERGE 0411
   Olson, 2002, J BUSINESS STRATEGIE, V19, P95
   Oravsky R, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13080179
   Osiyevskyy O, 2020, J BUS RES, V114, P227, DOI 10.1016/j.jbusres.2020.04.015
   Ozili P., 2020, SPILLOVER COVID 19 I, DOI [DOI 10.2139/SSRN.3562570, 10.2139/ssrn.3562570]
   Park Y, 2013, BUS HORIZONS, V56, P75, DOI 10.1016/j.bushor.2012.09.008
   Polukhina A, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14010038
   Pratono AH, 2018, J RISK FINANC, V19, P361, DOI 10.1108/JRF-10-2017-0170
   Robinson J, 2020, J APPL ECON BUS RES, V10, P115
   Rodrigues R, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13080162
   Semadeni M, 2014, STRATEGIC MANAGE J, V35, P1070, DOI 10.1002/smj.2136
   Shin H, 2019, ASIA PAC J MANAG, V36, P661, DOI 10.1007/s10490-018-9564-1
   Shirokova G, 2019, FORESIGHT STI GOV, V13, P62, DOI 10.17323/2500-2597.2019.3.62.76
   Singhal P., 2011, INT J BUS SCI APPL M, V6, P15
   Stromberg D., 2007, Journal of Economic Perspectives, V21, P199, DOI 10.1257/jep.21.3.199
   Syukriyah Syukriyah., 2020, INT J ACCOUNTING FIN, V3, P91
   Tang CF, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14050207
   Taylor Paul., 2021, POLITICO 0101
   Todo Y, 2015, J REGIONAL SCI, V55, P209, DOI 10.1111/jors.12119
   Tokui J, 2017, JPN WORLD ECON, V41, P59, DOI 10.1016/j.japwor.2016.12.005
   Tse Alan C B, 2006, Int J Hosp Manag, V25, P3, DOI 10.1016/j.ijhm.2004.12.001
   US Bureau of Labor Statistics, 2020, BUS RESP SURV COR PA
   Vaaler PA, 2004, ORGAN SCI, V15, P687, DOI 10.1287/orsc.1040.0089
   VENKATRAMAN N, 1986, ACAD MANAGE REV, V11, P801
   Wade K., 2021, J SELF GOVT MANAGE E, V9, P48, DOI [10.22381/jsme9320214, DOI 10.22381/JSME9320214]
   Wang HK, 2012, TOTAL QUAL MANAG BUS, V23, P1035, DOI 10.1080/14783363.2012.670917
   Wanke P, 2004, INT J PHYS DISTRIBUT, V34, P466
   Wogwu V.E., 2018, MANAGEMENT, V8, P47
   Wooldridge JM, 2003, AM ECON REV, V93, P133, DOI 10.1257/000282803321946930
   Wright P, 1996, ACAD MANAGE J, V39, P441, DOI 10.2307/256787
   Yousef I, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13120307
   Yue W, 2021, INT SMALL BUS J, V39, P93, DOI 10.1177/0266242620986763
   Yuzbasi B, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13060131
   Zimon G, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14040169
NR 92
TC 2
Z9 2
U1 13
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1911-8066
EI 1911-8074
J9 J RISK FINANC MANAG
JI J. Risk Financ. Manag.
PD OCT
PY 2021
VL 14
IS 10
AR 499
DI 10.3390/jrfm14100499
PG 16
WC Business, Finance
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA WS9GF
UT WOS:000715483600001
OA gold
DA 2022-04-20
ER

PT J
AU Mrozla, TJ
AF Mrozla, Thomas J.
TI Policing in the COVID-19 pandemic: are rural police organizations
   immune?
SO POLICING-AN INTERNATIONAL JOURNAL OF POLICE STRATEGIES & MANAGEMENT
LA English
DT Article
DE Contingency theory; Rural policing; COVID-19; Coronavirus pandemic
ID RAPID POPULATION-GROWTH; SMALL-TOWN; CRIME; DIFFERENTIATION; FEAR
AB Purpose This study examined how rural police agencies have responded to the COVID-19 pandemic. Design/methodology/approach Using data from various sources, this study first analyzed what factors influenced agency preparedness to respond to pandemics. Second, it examined how the pandemic influenced specific organizational practices. Findings Findings revealed that as coronavirus infections increased in counties, supervisors were more likely be tasked with inspecting personal protective equipment (PPE), agencies were more likely to offer pandemic related training, health tracking of officers was more likely to occur and agencies were more likely to encounter a shortage of officers. In addition, as rurality increased, agencies were more likely to offer training but less likely to experience officers contracting COVID-19 and an officer shortage. Lastly, as the rurality of the county in which the agency resides increased, the ability to supply PPE decreased. Practical implications Based on these findings, it is imperative that rural police agencies give attention to risk management and the formulation of policy to prepare for public health emergencies. Originality/value While knowledge about how large police agencies in the United States have responded during the coronavirus pandemic is building, little is known about rural policing during pandemics.
C1 [Mrozla, Thomas J.] Univ South Dakota, Vermillion, SD 57069 USA.
RP Mrozla, TJ (corresponding author), Univ South Dakota, Vermillion, SD 57069 USA.
EM thomas.mrozla@usd.edu
OI Mrozla, Thomas/0000-0002-8455-2528
CR Archbold CA, 2005, POLICING, V28, P30, DOI 10.1108/13639510510580968
   Archbold CA, 2014, POLICE Q, V17, P386, DOI 10.1177/1098611114549629
   Associated Press, 2020, ASS PRESS
   Barndollar H, 2020, MAINE 1 RESPONDERS A
   Bittner Egon., 1970, FUNCTIONS POLICE MOD
   Blau PM., 1972, SOC SCI RES, V1, P1, DOI [10.1016/0049-089X(72)90055-5, DOI 10.1016/0049-089X(72)90055-5]
   Brauer, 2020, LACKING PROTECTIVE G
   Burns T., 1961, CLASSICS ORG THEORY, P209
   CNN, 2020, CNN
   CORDNER GW, 1978, J POLICE SCI ADMIN, V6, P22
   CRANK J, 1991, JUSTICE Q, V8, P169
   Dahle TO, 2015, POLICING, V38, P805, DOI 10.1108/PIJPSM-03-2015-0037
   DEWAR R, 1978, ADMIN SCI QUART, V23, P111, DOI 10.2307/2392436
   Donaldson, 1995, AM ANTIMANAGEMENT TH, V25
   DONALDSON L, 1987, J MANAGE STUD, V24, P1, DOI 10.1111/j.1467-6486.1987.tb00444.x
   Falcone DN, 2002, POLICING, V25, P371, DOI 10.1108/13639510210429419
   Field A., 2017, DISCOVERING STAT USI, V5th ed.
   Galbadage T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00163
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020
   Hyland S.S., 2019, LOCAL POLICE DEP 201
   King WR, 2014, CRIME DELINQUENCY, V60, P667, DOI 10.1177/0011128709344675
   KRALEWSKI JE, 1985, ADMIN SCI QUART, V30, P34, DOI 10.2307/2392810
   LANGWORTHY RH, 1985, JUSTICE Q, V0002
   LAWRENCE PR, 1967, ADMIN SCI QUART, V12, P1, DOI 10.2307/2391211
   Little J, 2005, J RURAL STUD, V21, P151, DOI 10.1016/j.jrurstud.2005.02.001
   Lopez, 2020, COVID 19 RAPID RESPO
   Lum C., 2020, IMPACT COVID 19 LAW
   Madden, 2005, STAT CRIMINOLOGY CRI
   Maguire E.R., 2003, ORG STRUCTURE AM POL
   MAGUIRE ER, 1997, JUSTICE Q, V0014
   Maskaly J, 2021, INT CRIM JUSTICE REV, V31, P266, DOI 10.1177/10575677211012807
   Menard S. W., 1995, APPL LOGISTIC REGRES
   Mrozla TJ, 2020, POLICING, V43, P625, DOI 10.1108/PIJPSM-02-2020-0024
   MURDOCH J, 1994, J RURAL STUD, V10, P83, DOI 10.1016/0743-0167(94)90008-6
   Nix J, 2021, POLICE PRACT RES, V22, P1443, DOI 10.1080/15614263.2021.1883018
   Pickett J., 2020, CRIMINOL PUBLIC POL
   Pleggenkuhle B, 2018, J CRIME JUSTICE, V41, P382, DOI 10.1080/0735648X.2017.1391109
   Pro, 2020, IS LOW MASK WEARING
   Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115
   Ritti, 1996, JUSTICE Q, V13, P291, DOI DOI 10.1080/07418829600092951
   Schuppe J., 2020, NBC NEWS
   Somerville P, 2015, J RURAL STUD, V39, P219, DOI 10.1016/j.jrurstud.2014.12.001
   Stickle B, 2020, AM J CRIM JUSTICE, V45, P525, DOI 10.1007/s12103-020-09546-0
   Stogner J, 2020, AM J CRIM JUSTICE, V45, P718, DOI 10.1007/s12103-020-09548-y
   Thompson, 1967, CLASSICS ORG MANAGEM
   Ullrich F., 2020, CONFIRMED COVID 19 C
   Villegas, 2020, S DAKOTA NURSE SAYS
   Weisheit RA, 1996, CRIME DELINQUENCY, V42, P379, DOI 10.1177/0011128796042003003
   WEISHEIT RA, 1994, CRIME DELINQUENCY, V40, P549, DOI 10.1177/0011128794040004005
   Weisheit RalphA., 1994, RURAL CRIME RURAL PO, V2
   Wells L.E., 2005, CRIME POLICING RURAL
   Zhao JH, 2010, POLICE Q, V13, P209, DOI 10.1177/1098611110365691
NR 52
TC 1
Z9 1
U1 6
U2 10
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1363-951X
EI 1758-695X
J9 POLICING
JI Policing-An Int J Police Strategies & Manag.
PD FEB 8
PY 2022
VL 45
IS 1
SI SI
BP 23
EP 41
DI 10.1108/PIJPSM-02-2021-0021
EA JUL 2021
PG 19
WC Criminology & Penology
WE Social Science Citation Index (SSCI)
SC Criminology & Penology
GA ZF4SD
UT WOS:000674684700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Veeranna, CH
   Rani, S
AF Veeranna, Chandrakanth Hungund
   Rani, Smitha
TI Cause of Death Certification in COVID-19 Deaths
SO INDIAN JOURNAL OF CRITICAL CARE MEDICINE
LA English
DT Review
DE Cause of death; COVID-19; Medical certification of cause of death;
   Mortality statistics
AB Introduction: Appropriate cause of death reporting is vital in the pandemic circumstance for effective planning of the control measures. Accurate reporting and registration of the reason for death are crucial in planning of health programs in turn contributing for the national development.
   Background: All births and deaths occurring across India should be mandatorily registered per the Registration of Births and Deaths Act passed in the year 1969. The act also requires the issuance of cause of death certificate by the doctor attending the departed during his last illness. Data obtained from the cause of death certificate provides cause-specific mortality profile, which is required to analyze the health trends of the population.
   Review results: This article discusses the available guidelines on the appropriate documentation of cause of death in the confirmed or suspected coronavirus disease-2019 (COVID-19) infection resulting into death.
   Conclusion: Proper certification of the cause of death leads to better epidemic surveillance. Scrutiny of the clinical sequences from the cause of death certificate is useful to prioritize the allocation of resources for critical care management and to augment our knowledge about underlying causes resulting in mortality from COVID-19.
   Clinical significance: Dissemination of available guidelines on proper documentation of the cause of death in confirmed/suspected COVID-19 cases will reduce the errors in cause of death reporting.
C1 [Veeranna, Chandrakanth Hungund; Rani, Smitha] JSS Acad Higher Educ & Res, JSS Med Coll, Dept Forens Med & Toxicol, Mysuru, Karnataka, India.
RP Rani, S (corresponding author), JSS Acad Higher Educ & Res, JSS Med Coll, Dept Forens Med & Toxicol, Mysuru, Karnataka, India.
EM smitha_2444@yahoo.co.in
RI Rani, Smitha/AAE-2031-2022
CR [Anonymous], 1993, INT STAT CLASS DIS H, V2
   [Anonymous], 2012, PHYS MAN MED CERT CA
   Gill JR, 2020, JAMA-J AM MED ASSOC, V324, P27, DOI 10.1001/jama.2020.9536
   Kotabagi R B, 2004, Med J Armed Forces India, V60, P261, DOI 10.1016/S0377-1237(04)80060-1
   National Center for Health Statistics, 2020, GUID CERT DEATHS DUE
   National Center for Health Statistics, 2003, PHYS HDB MED CERT CA
   National Centre for Disease Informatics and Research, GUID REC COVID 19 RE
   Office of the Registrar General Ministry of Home Affairs Government of India, EXT SCHEM MED CERT C
   Office of the Registrar General of India, 2000, PHYS MAN MED CERT CA
   Rao C, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001810
   WHO, INT CLASS DIS ICD IN
   World Health Organization, WHO TIM COVID 19
   World Health Organization, COVID 19 COD ICD 10
   World Health organization, INT GUID CERT CLASS
NR 14
TC 0
Z9 0
U1 5
U2 8
PU JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD
PI NEW DEHLI
PA 4838-24, ANSARI RD, DARYAGANJ, NEW DEHLI, 110 002, INDIA
SN 0972-5229
EI 1998-359X
J9 INDIAN J CRIT CARE M
JI Indian J. Crit. Care Med.
PD SEP
PY 2020
VL 24
IS 9
BP 863
EP 867
DI 10.5005/jp-journals-10071-23561
PG 5
WC Critical Care Medicine
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA OG9ID
UT WOS:000582187600025
PM 33132574
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Simpeh, F
   Amoah, C
AF Simpeh, Fredrick
   Amoah, Christopher
TI Assessment of measures instituted to curb the spread of COVID-19 on
   construction site
SO INTERNATIONAL JOURNAL OF CONSTRUCTION MANAGEMENT
LA English
DT Article; Early Access
DE Construction site; COVID-19; health; measures; safety; workers
AB COVID-19 pandemic has become a global health issue that is ravaging every aspect of human life. Various countries, thus, institute many measures to prevent the spread of the disease among the citizenry. This article investigates measures that are put in place at construction project sites to curb the spread of COVID-19 among construction site workers. An open-ended questionnaire was used as an instrument to collect qualitative data from construction companies. A purposive sampling method was used to distribute the interview questions. The collected data were analyzed with content analysis. The findings show that most construction companies have instituted prescribed and appropriate measures to curb the spread of COVID-19 on-site. Moreover, some construction companies had implemented extra measures and developed new protocols to help mitigate the spread of COVID-19 on-site. However, few construction companies were lacking in the provision of some of the recommended measures. The study identified three categories of measures (i.e. screening, site access and handling of material and equipment deliveries on-site) where improvement is required. Construction companies could use the recommendations provided to improve upon the approach adopted to curb the spread of COVID-19 on-site. The study could also inform policymakers on COVID-19 measures that are unsatisfactorily implemented on site for which more attention and oversight is required. Research on construction site health and safety measures during this COVID-19 season are still being developed. Thus, this article contributes to advancing the body of knowledge in this area of study. Data were collected from grades 6 to 9 construction firms; therefore, the research findings may not be applied to smaller construction firms. A study that focuses on lower grades is recommended.
C1 [Simpeh, Fredrick; Amoah, Christopher] Univ Free State, Dept Quant Surveying & Construct Management, Bloemfontein, South Africa.
RP Amoah, C (corresponding author), Univ Free State, Dept Quant Surveying & Construct Management, Bloemfontein, South Africa.
EM amoahc@ufs.ac.za
RI Amoah, Christopher/AAJ-3578-2021; Simpeh, Fredrick/AAI-8832-2021
OI Amoah, Christopher/0000-0001-7657-3874; Simpeh,
   Fredrick/0000-0002-9986-3417
CR Abrey M, 2014, PROCEDIA ENGINEER, V85, P3, DOI 10.1016/j.proeng.2014.10.522
   Akintayo O., 2018, P 12 BUILT ENV C 6 7, P62
   [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Beck C.T., 2017, NURSING RES GENERATI
   Blumberg B.C., 2008, BUSINESS RES METHODS
   CDC, 2020, COR DIS 2019 COVID 1
   Centres for Disease Control and Prevention (CDC), 2019, 2019 NOV COR 2019 NC
   CIDB, 2015, APPL CONTR REG GRAD
   Creswell J.W., 1998, QUAL INQ
   Creswell J.W., 2009, RES DESIGN QUALITATI, DOI [10.2307/1523157., DOI 10.2307/1523157]
   Harinarain N., 2020, J CONSTRUCTION, V13, P52
   Hinze J, 2008, SAFETY SCI, V46, P634, DOI 10.1016/j.ssci.2007.06.015
   Leedy P.D., 2015, PRACTICAL RES PLANNI
   Legg SJ, 2015, SAFETY SCI, V71, P189, DOI 10.1016/j.ssci.2014.11.007
   Lemke MK, 2020, AM J IND MED, V63, P659, DOI 10.1002/ajim.23138
   Maiti S, 2021, INT J CONSTR MANAG, V21, P997, DOI 10.1080/15623599.2019.1602580
   Malecka M, 2020, CLIN CHEM LAB MED, V58, pE205, DOI 10.1515/cclm-2020-0764
   Mohajan H.K., 2018, J EC DEV ENV PEOPLE, V7, P23, DOI [10.26458/jedep.v7i1.571, DOI 10.26458/JEDEP.V7I1.571]
   Ohia C, 2020, INT J INFECT DIS, V95, P279, DOI 10.1016/j.ijid.2020.04.062
   Okorie VN, 2020, INT J CONSTR MANAG, V20, P357, DOI 10.1080/15623599.2018.1531808
   Okoro C.S., 2016, J CONSTRUCTION, V9, P1
   Pinto A, 2011, SAFETY SCI, V49, P616, DOI 10.1016/j.ssci.2011.01.003
   Rosemberg MAS, 2020, OCCUP MED-OXFORD, V70, P382, DOI 10.1093/occmed/kqaa053
   Schutt R.K., 2012, INVESTIGATING SOCIAL
   Umeokafor N, 2020, INT J CONSTR MANAG, DOI 10.1080/15623599.2019.1707853
   WHO, 2020, Q A COR COVID 19
   World Health Organization (WHO), 2020, WHO REF READ RESP AC
   World Health Organization (WHO), 2019, ADV PUBL
NR 28
TC 17
Z9 17
U1 4
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1562-3599
EI 2331-2327
J9 INT J CONSTR MANAG
JI Int. J. Constr. Manag.
DI 10.1080/15623599.2021.1874678
EA JAN 2021
PG 9
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA PT8WD
UT WOS:000608891100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Fosse, A
   Svensson, A
   Konradsen, I
   Abelsen, B
AF Fosse, Anette
   Svensson, Anders
   Konradsen, Ingvill
   Abelsen, Birgit
TI Tension between local, regional and national levels in Norway's handling
   of COVID-19
SO SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article; Early Access
DE COVID-19; rural; chief medical officer; communicable disease control;
   crisis management; qualitative
AB Aims: This study aimed to explore the tension between local, regional, and national authorities evoked by some rural municipalities' decisions to impose local infection-control measures during the first weeks of the COVID-19 pandemic in Norway. Methods: Eight municipal Chief Medical Officers of Health (CMOs) participated in semi-structured interviews, and six crisis management teams participated in focus-group interviews. Data were analysed with systematic text condensation. Boin and Bynander's interpretation of crisis management and coordination and Nesheim et al.'s framework for non-hierarchical coordination in the state sector inspired the analysis. Results: Uncertainty in the face of a pandemic with unknown damage potential, lack of infection-control equipment, patient transport challenges, vulnerable staff situation and planning of local COVID-19 beds were some of the reasons for rural municipalities imposing local infection-control measures the first weeks of the pandemic. Local CMOs' engagement, visibility and knowledge contributed to trust and safety. Differences in perspectives between local, regional and national actors created tension. Existing roles and structures were adjusted, and new informal networks arose. Conclusions: Strong municipal responsibility in Norway and the quite unique arrangement with local CMOs in every municipality with the legal right to decide temporary local infection-control measures seemed to facilitate a balance between top-down and bottom-up decision making. Tension between rural, regional and national actors that arose due to local infection-control measures, and the following dialogue and mutual adjustment of perspectives, led to a fruitful balance between national and local measures in Norway's handling of the COVID-19 pandemic.
C1 [Fosse, Anette; Svensson, Anders; Konradsen, Ingvill; Abelsen, Birgit] UiT Arctic Univ Norway, Dept Community Med, Norwegian Ctr Rural Med, N-9037 Tromso, Norway.
RP Fosse, A (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Norwegian Ctr Rural Med, N-9037 Tromso, Norway.
EM anette.fosse@uit.no
OI Fosse, Anette/0000-0003-4572-3723
FU Institute of Public Health, UiT The Arctic University of Norway
FX The authors disclosed receipt of the following financial support for the
   research, authorship and/or publication of this article: The authors
   disclosed internal funding from Institute of Public Health, UiT The
   Arctic University of Norway covering the expenses incurred to transcribe
   audiotaped interviews.
CR Boin A, 2015, GEOGR ANN A, V97, P123, DOI 10.1111/geoa.12072
   Christensen T, 2020, PUBLIC ADMIN REV, V80, P774, DOI 10.1111/puar.13241
   Christensen T, 2016, PUBLIC ADMIN REV, V76, P887, DOI 10.1111/puar.12558
   Commission C, 2021, 20216 NORW GOV
   Crabtree B. F., 1999, DOING QUALITATIVE RE, V2, P163
   Folkehelseinstituttet, 2020, FOLK ANB LOK KAR INN
   Fors M, 2018, PSYCHOANAL PSYCHOL, V35, P446, DOI 10.1037/pap0000179
   Fosse A., 2021, LOKALT SMITTEVERN NO
   Grunnloven, 1814, LOV18140517 GRUNNL
   Helsedirektoratet, 2020, RAPP NASJ KARTL KOMM
   Helseog omsorgsdepartementet, 2020, VEIL KOMM LOK KAR IN
   Koronaloven (midlertidig lov), 2020, MIDL LOV FORSKR AVH
   Lagreid P, 2015, INT J PUBLIC SECT MA, V28, P475, DOI 10.1108/IJPSM-01-2015-0009
   Malterud K, 2012, SCAND J PUBLIC HEALT, V40, P795, DOI 10.1177/1403494812465030
   Ministry of Justice and Public Security, 2019, STEER PRINC CRIS MAN
   Morgan D.L., 1997, FOCUS GROUPS QUALITA, DOI [10.4135/9781412984287, DOI 10.4135/9781412984287]
   Neby, 2019, NORSK STATSVITENSKAP, V35, P28, DOI [10.18261/.1504-2936-2019-01-02, DOI 10.18261/.1504-2936-2019-01-02]
   OECD, 2021, TRUST GOVT IND
   omsorgsdepartementet H-o., 2020, COVID 19 REG FORSKR
   Rajan D, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002655
   Ross S., 2021, DIRECTORS PUBLIC HLT
   Siegrist M, 2014, EUR PSYCHOL, V19, P23, DOI 10.1027/1016-9040/a000169
   Statistics Norway, 2021, POPULATION
   Statistics Norway, 2017, SENTR
NR 24
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1403-4948
EI 1651-1905
J9 SCAND J PUBLIC HEALT
JI Scand. J. Public Health
AR 14034948221075408
DI 10.1177/14034948221075408
EA FEB 2022
PG 8
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA YV8GT
UT WOS:000752963800001
PM 35114861
OA hybrid
DA 2022-04-20
ER

PT J
AU Bala, A
   Sengupta, A
   Matsabisa, MG
   Chabalala, HP
AF Bala, Asis
   Sengupta, Abhijit
   Matsabisa, Motlalepula G.
   Chabalala, Hlupheka P.
TI Covid-19: Pathophysiology; Mechanism of Transmission and Possible
   Molecular Drug Target for Management
SO CURRENT MOLECULAR PHARMACOLOGY
LA English
DT Review
DE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);
   coronavirus disease 2019 (COVID-19); patho-physiology; mechanism of
   transmission; molecular drug targets
ID ANGIOTENSIN-CONVERTING ENZYME-2; ACUTE RESPIRATORY SYNDROME;
   RNA-POLYMERASE; CORONAVIRUS; VIRUS; CHLOROQUINE; EXPRESSION; EFFICACY;
   CELL; HYDROXYCHLOROQUINE
AB Coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2). At present, it is a potentially fatal disease and is of great global public health concern. The pathophysiological understanding of the mode of transmission of COVID-9 and the possible molecular targets are exploring successively to fight against this contagious disease. In this pandemic situation, a large number of countries have been forced to do social distancing and lockdown. The two main pathways of SARS-CoV-2 transmission include (1) droplet infection via the respiratory secretions or by close person to person contact, whereas (2) faecal to oral route transmission is also possible. Thus, the route of entry of SARS-CoV-2 is through the nasal and or oral cavity. Here, we briefly reviewed the current knowledge about COVID-19, considering the potential explanation of the mode of transmission and the different possible molecular drug targets. We highlighted potential approaches to address the antiviral therapy inhibiting the replication of SARS-CoV-2 in the host targeting (a.) RNA-dependent RNA polymerase (b.) serine protease and (c.) proteolytic activation pathways or the cell membrane receptor called the angiotensin-converting enzyme-2 (ACE2). The recently exercised immuno-enhancement therapy to fight against SARS-CoV-2 and treatment strategy using drug combination are also explored here in this review.
C1 [Bala, Asis; Sengupta, Abhijit] Guru Nanak Inst Pharmaceut Sci & Technol, Div Pharmacol, 157-F Nilgunj Rd, Kolkata 700114, W Bengal, India.
   [Matsabisa, Motlalepula G.] Univ Free State, Fac Hlth Sci, Sch Clin Med, Dept Pharmacol, ZA-9300 Bloemfontein, Free State, South Africa.
   [Chabalala, Hlupheka P.] Indigenous Knowledge Based Technol Innovat, Dept Sci & Innovat, ZA-0001 Brummeria Pretoria, South Africa.
RP Bala, A (corresponding author), Guru Nanak Inst Pharmaceut Sci & Technol, Div Pharmacol, 157-F Nilgunj Rd, Kolkata 700114, W Bengal, India.
EM asisbala_ju@yahoo.co.in
RI Bala, Asis/D-6931-2016
OI Bala, Asis/0000-0002-2148-2331; Matsabisa, Motlalepula
   Gilbert/0000-0003-2921-8882
FU Principal (I/C) of Guru Nanak Institute of Pharmaceutical Science and
   Technology, Kolkata, India; University of the Free State and Department
   of Pharmacology
FX The Principal (I/C) of Guru Nanak Institute of Pharmaceutical Science
   and Technology, Kolkata, India and the management of JIS Group, Kolkata
   India are highly acknowledged for encouragement and support. University
   of the Free State and Department of Pharmacology is also acknowledged
   for giving all the support to write and review this report.
CR AminJafari A, 2020, INT IMMUNOPHARMACOL, V83, DOI 10.1016/j.intimp.2020.106455
   [Anonymous], 2020, THE MAGAZINE
   Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1
   Babapoor-Farrokhran S, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117723
   Bala A, 2019, CURR PHARM DESIGN, V25, P1643, DOI 10.2174/1381612825666190705205155
   Bala A, 2017, INFLAMMOPHARMACOLOGY, V25, P595, DOI 10.1007/s10787-017-0397-1
   Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013
   Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130
   Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011
   Caly L, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104787
   CASTRANOVA V, 1988, TOXICOL APPL PHARM, V93, P472, DOI 10.1016/0041-008X(88)90051-8
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Chinchar VG, 1999, ENCY VIROL, P1471
   Cinatl J, 2005, INT J MOL MED, V15, P323
   Colson P, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105923
   Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003
   Darnel J., 2000, MOL CELL BIOL, V4th 4th
   De Ceukelaire W, 2020, INT J HEALTH SERV, V50, P276, DOI 10.1177/0020731420916725
   de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7
   Di Napoli, 2021, STATPEARLS
   Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560
   Drexler M., 2010, WHAT YOU NEED KNOW I
   Elfiky AA, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117592
   Elfiky AA, 2020, LIFE SCI, V248, DOI 10.1016/j.lfs.2020.117477
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Fernstrom A, 2013, J PATHOG, V2013, DOI [10.1155/013/493960, 10.1155/2013/493960]
   Ferreira AC, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01389-18
   Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147
   Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gordan R, 2015, WORLD J CARDIOL, V7, P204, DOI 10.4330/wjc.v7.i4.204
   Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679
   Gordon D. E., 2020, BIORXIV2020202003220
   Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hofmann H, 2004, BIOCHEM BIOPH RES CO, V319, P1216, DOI 10.1016/j.bbrc.2004.05.114
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Kelleni MT, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104874
   Khalid M, 2015, ANTIVIR THER, V20, P87, DOI 10.3851/IMP2792
   Khalili JS, 2020, J MED VIROL, V92, P740, DOI 10.1002/jmv.25798
   Khedkar PH, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13470
   Khomich OA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080392
   Kumar S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092159
   Kumar V, 2013, EXPERT OPIN THER PAT, V23, P1337, DOI 10.1517/13543776.2013.823159
   Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/JVI.79.13.7951-7958.2005
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Loutfy MR, 2003, JAMA-J AM MED ASSOC, V290, P3222, DOI 10.1001/jama.290.24.3222
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Magrone T, 2020, ENDOCR METAB IMMUNE, V20, P807, DOI 10.2174/1871530320666200427112902
   McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991
   McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537
   Mehta DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031688
   Meo SA, 2020, EUR REV MED PHARMACO, V24, P4539, DOI 10.26355/eurrev_202004_21038
   Moldoveanu B, 2009, J INFLAMM RES, V2, P1
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x
   Mousavizadeh L, 2021, J MICROBIOL IMMUNOL, V54, P159, DOI 10.1016/j.jmii.2020.03.022
   Muscogiuri G, 2020, EUR J CLIN NUTR, V74, P850, DOI 10.1038/s41430-020-0635-2
   Nakagawa K, 2016, ADV VIRUS RES, V96, P165, DOI 10.1016/bs.aivir.2016.08.001
   Pan XW, 2020, INTENS CARE MED, V46, P1114, DOI 10.1007/s00134-020-06026-1
   Prajapat M, 2020, INDIAN J PHARMACOL, V52, P56, DOI 10.4103/ijp.IJP_115_20
   Regidor PA, 2020, MED HYPOTHESES, V142, DOI 10.1016/j.mehy.2020.109813
   Rizzo E, 2020, N-S ARCH PHARMACOL, V393, P1153, DOI 10.1007/s00210-020-01902-5
   Rosales C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00113
   Rossi G, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0009-2017
   Rossi G, 2015, AM J CLIN PATHOL, V144, P174, DOI 10.1309/AJCPCWHLWZ8JN0OE
   Sarma P, 2020, INDIAN J PHARMACOL, V52, P1, DOI 10.4103/ijp.IJP_119_20
   Sayad B, 2020, ARCH MED RES, V51, P577, DOI 10.1016/j.arcmed.2020.04.018
   Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041
   Shanmugaraj B, 2020, ASIAN PAC J ALLERGY, V38, P10, DOI 10.12932/AP-200220-0773
   Shetty R, 2020, INDIAN J OPHTHALMOL, V68, P693, DOI 10.4103/ijo.IJO_639_20
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   Singh AK, 2020, DIABETES METAB SYND, V14, P241, DOI 10.1016/j.dsx.2020.03.011
   Skums P, 2020, MEDRXIV2020032220041, DOI 10.1101/2020.03.22.20041145.2020.03.22.20041145
   Slobbe L, 2012, SIDE EFFECT, V34, P609, DOI 10.1016/B978-0-444-59499-0.00038-6
   Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236
   Soy M, 2020, CLIN RHEUMATOL, V39, P2085, DOI 10.1007/s10067-020-05190-5
   Stobart CC, 2013, J VIROL, V87, P12611, DOI 10.1128/JVI.02050-13
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069
   Tripathy S, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106028
   University of Texas Health Science Center at Houston, 2020, COVID 19 LINK CARD I
   van der Schaar H.M., 2020, CORONAVIRUS HEMAGGLU, P1
   Velthuis AJWT, 2012, NUCLEIC ACIDS RES, V40, P1737, DOI 10.1093/nar/gkr893
   Vukkadala N, 2020, LARYNGOSCOPE, V130, P2537, DOI 10.1002/lary.28672
   Wang LS, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105948
   Wang TB, 2020, LANCET, V395, pE52, DOI 10.1016/S0140-6736(20)30558-4
   WHO, 2019, NOV COR
   World Health Organization, 2020, TRANSM SARS COV 2 IM
   Wu D, 2020, INT J INFECT DIS, V94, P44, DOI 10.1016/j.ijid.2020.03.004
   Xie Y, 2020, J INFECTION, V81, P340, DOI 10.1016/j.jinf.2020.03.044
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yamamoto M, 2016, ANTIMICROB AGENTS CH, V60, P6532, DOI 10.1128/AAC.01043-16
   Yazdany J, 2020, ANN INTERN MED, V172, P754, DOI 10.7326/M20-1334
   Yu K., THYMOSIN ALPHA 1 PRO
   Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105
   Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954
   Zhang YH, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110195
   Zhou F
NR 105
TC 1
Z9 1
U1 2
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1874-4672
EI 1874-4702
J9 CURR MOL PHARMACOL
JI Curr. Molec. Pharmacol.
PY 2021
VL 14
IS 4
BP 509
EP 519
DI 10.2174/1874467213999200831104324
PG 11
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA UY8VX
UT WOS:000701796100004
PM 32867666
DA 2022-04-20
ER

PT J
AU Alrashedi, MG
   Alrashedi, AG
   Ali, AS
   Ibrahim, IM
AF Alrashedi, Mohsen Geza
   Alrashedi, Ahmed Geza.
   Ali, Ahmed Shaker.
   Ibrahim, Ibrahim M.
TI Lung Delivery Systems to Optimize Pharmacotherapy of COVID-19: A Concise
   Review
SO JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL
LA English
DT Review
DE COVID-19; antiviral drugs; pulmonary drug delivery; aerosol;
   niclosamide; remdesivir; hydroxychloroquine; azithromycin
ID AZITHROMYCIN; HYDROXYCHLOROQUINE; CHLOROQUINE; MICROPARTICLES;
   RESVERATROL; FORMULATION; MANAGEMENT; SAFETY
AB Background: COVID-19 is an ongoing viral pandemic caused by the SARS-COV-2 virus. Several drugs were repurposed for its management; however, most of these drugs were not ideal treatments by traditional methods of administration, whether given by injection or orally. This is due to many reasons including pharmacokinetic limitations or drug-induced adverse effects. There is an urgent need to develop these drugs to target the virus in the lung tissue through inhalation.
   Objective: To address the gap in knowledge regarding efficacy and safety of pulmonary drug delivery of repurposed antiviral against COVID-19.
   Findings: Ongoing trials for inhalable formulations of several drugs such as Niclosamide; Remdesivir, Hydroxychloroquine, and Azithromycin among others showed promising results.
   Conclusion: The development of pharmaceutical forms for inhaled administration of antiviral and anti-inflammatory drugs is an important direction that needs more attention to achieve the optimal management of respiratory infectious diseases.
C1 [Alrashedi, Mohsen Geza] Minist Hlth, Jeddah, Saudi Arabia.
   [Alrashedi, Mohsen Geza; Ali, Ahmed Shaker.; Ibrahim, Ibrahim M.] King Abdulaziz Univ, Dept Pharmacol, Fac Med, Jeddah, Saudi Arabia.
   [Alrashedi, Ahmed Geza.] Qassim Univ, Jeddah, Saudi Arabia.
RP Alrashedi, MG (corresponding author), Minist Hlth, Jeddah, Saudi Arabia.; Alrashedi, MG (corresponding author), King Abdulaziz Univ, Dept Pharmacol, Fac Med, Jeddah, Saudi Arabia.
EM abu_geza@hotmail.com
OI IBRAHIM, IBRAHIM/0000-0001-5280-9555
CR Akkerman O.W., 2020, TOLERABILITY PHARMAC, DOI [10.1101/2020.12.03.20243162, DOI 10.1101/2020.12.03.20243162]
   Albariqi AH, 2021, J AEROSOL MED PULM D, V34, P20, DOI 10.1089/jamp.2020.1648
   Aleem A., 2021, STATPEARLS
   Alhumaid S, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5040180
   Ali AS, 2020, J PHARM RES INT, V32, P29, DOI 10.9734/JPRI/2020/v32i830468
   Ali M, 2010, HANDBOOK OF NON-INVASIVE DRUG DELIVERY SYSTEMS: NON-INVASIVE AND MINIMALLY-INVASIVE DRUG DELIVERY SYSTEMS FOR PHARMACEUTICAL AND PERSONAL CARE PRODUCTS, P209, DOI 10.1016/B978-0-8155-2025-2.10009-5
   Alkotaji M, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106192
   Amirian ES, 2020, ONE HEALTH-AMSTERDAM, V9, DOI 10.1016/j.onehlt.2020.100128
   [Anonymous], 2021, TLC ENR 1 SUBJ PHAS
   Arab-Zozani, 2020, HLTH TECHNOLOGY ASSE, V4
   Arshad U, 2020, CLIN PHARMACOL THER, V108, P775, DOI 10.1002/cpt.1909
   Backer V, 2021, LANCET REG HEALTH-EU, V4, DOI 10.1016/j.lanepe.2021.100084
   Bentur O, 2021, J ALLERGY CLIN IMMUN, V147, pAB237
   Bistrovic P, 2021, J MED VIROL, V93, P5724, DOI 10.1002/jmv.27177
   Brunaugh, BROAD SPECTRUM PATIE
   Brunaugh AD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246803
   Cai QX, 2020, ENGINEERING-PRC, V6, P1192, DOI 10.1016/j.eng.2020.03.007
   Caracciolo M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.613070
   Cattaneo D, 2021, EUR J CLIN PHARMACOL, V77, P791, DOI 10.1007/s00228-020-03053-1
   Cavalcanti IDL, CURR DRUG DELIV, V2021
   Chaccour C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74084-y
   Chakraborty I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138882
   Chen PJ, 2021, J INFECTION, V82, P199, DOI 10.1016/j.jinf.2020.12.005
   Ciotti M, 2020, CHEMOTHERAPY, V64, P215, DOI 10.1159/000507423
   Conzelmann C, 2020, CLIN MED, V20, DOI 10.7861/clinmed.2020-0351
   de Almeida JR, 2018, FUTURE MED CHEM, V10, P1037, DOI 10.4155/fmc-2017-0201
   Dorward J, 2020, LOPINAVIR RITONAVIR
   Drozdzal S, 2020, DRUG RESIST UPDATE, V53, DOI 10.1016/j.drup.2020.100719
   Drug-Bank, 2021, HYROXYCHLOROQUINE
   DRug-Bank(b), LOP 2021
   Eastman RT, 2020, ACS CENTRAL SCI, V6, P672, DOI 10.1021/acscentsci.0c00489
   Echeverria-Esnal D, 2021, EXPERT REV ANTI-INFE, V19, P147, DOI 10.1080/14787210.2020.1813024
   Errecalde J, 2021, J PHARM SCI-US, V110, P2501, DOI 10.1016/j.xphs.2021.01.017
   Fan JH, 2020, CLIN INFECT DIS, V71, P3232, DOI 10.1093/cid/ciaa623
   Food and Drug Administration (FDA), 2020, FACT SHEET HLTH CAR
   Fu WH, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100478
   Furst DE, 1996, LUPUS, V5, pS11, DOI 10.1177/096120339600500104
   Hayden FG, 2019, CURR OPIN INFECT DIS, V32, P176, DOI 10.1097/QCO.0000000000000532
   Hickey AJ, 2006, J AEROSOL MED, V19, P54, DOI 10.1089/jam.2006.19.54
   Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4
   Hughes JH, 2020, CPT-PHARMACOMET SYST, V9, P435, DOI 10.1002/psp4.12537
   Indari O, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.632677
   Irie K, 2020, CTS-CLIN TRANSL SCI, V13, P880, DOI 10.1111/cts.12827
   Jara MO, 2021, INT J PHARMACEUT, V603, DOI 10.1016/j.ijpharm.2021.120701
   Javelot H, 2020, BRIT J CLIN PHARMACO, V86, P1176, DOI 10.1111/bcp.14335
   Jelliffe R, 2017, INDIVIDUALIZED DRUG THERAPY FOR PATIENTS: BASIC FOUNDATIONS, RELEVANT SOFTWARE AND CLINICAL APPLICATIONS, P91, DOI 10.1016/B978-0-12-803348-7.00008-3
   Jomah S, 2020, J INFECT PUBLIC HEAL, V13, P1187, DOI 10.1016/j.jiph.2020.07.013
   Jorgensen SCJ, 2020, PHARMACOTHERAPY, V40, P659, DOI 10.1002/phar.2429
   Altube MJ, 2020, MOL PHARMACEUT, V17, P70, DOI 10.1021/acs.molpharmaceut.9b00721
   Juurlink DN, 2020, CAN MED ASSOC J, V192, pE450, DOI 10.1503/cmaj.200528
   Kang JE, 2020, J CLIN PHARM THER, V45, P1199, DOI 10.1111/jcpt.13199
   Kasten G, 2016, DRUG DEV IND PHARM, V42, P776, DOI 10.3109/03639045.2015.1075032
   Kaur RJ, 2020, INFECT DRUG RESIST, V13, P4427, DOI 10.2147/IDR.S287934
   Kavanagh O, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.110110
   Labiris NR, 2003, BRIT J CLIN PHARMACO, V56, P588, DOI 10.1046/j.1365-2125.2003.01892.x
   MacIntyre N, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA812
   Madelain V, 2016, CLIN PHARMACOKINET, V55, P907, DOI 10.1007/s40262-015-0364-1
   Maneshi A, 2019, IRAN J PEDIATR, V29, DOI 10.5812/ijp.96977
   Mansour SM, 2021, INT IMMUNOPHARMACOL, V99, DOI 10.1016/j.intimp.2021.108004
   Mittal N, 2021, MED HYPOTHESES, V146, DOI 10.1016/j.mehy.2020.110364
   Ortiz-Ospina, 2021, CORONAVIRUS PANDEMIC
   Parvathaneni V, 2021, THER DELIV, V12, P105, DOI 10.4155/tde-2020-0092
   Pfeifer ND, CTS-CLIN TRANSL SCI, V2021
   Pindiprolu SKSS, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109765
   Rother N, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100146
   Saghir SAM, 2021, THER CLIN RISK MANAG, V17, P371, DOI 10.2147/TCRM.S301817
   Sahakijpijarn S, 2021, INT J PHARM-X, V3, DOI 10.1016/j.ijpx.2021.100073
   Sahakijpijarn S, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12111002
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Shetty N, 2020, PHARM RES-DORDR, V37, DOI 10.1007/s11095-020-02937-2
   Singh D, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00673-2021
   Siordia Juan A Jr, 2020, SN Compr Clin Med, V2, P1120, DOI 10.1007/s42399-020-00399-6
   Sun DX, 2020, AAPS J, V22, DOI 10.1208/s12248-020-00459-8
   Susanti D, 2021, J PHARM, V1, P34
   Tai TT, 2021, CTS-CLIN TRANSL SCI, V14, P132, DOI 10.1111/cts.12923
   Nguyen THT, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005389
   Touafchia A, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.02.013
   Touret F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70143-6
   Trotta V, 2016, EUR J PHARM SCI, V86, P20, DOI 10.1016/j.ejps.2016.02.018
   Trotta V, 2015, INT J PHARMACEUT, V491, P190, DOI 10.1016/j.ijpharm.2015.06.033
   UPTODATE, 2021, REMD DRUG INF
   Vartak R, 2021, NANOMEDICINE-UK, V16, P1187, DOI 10.2217/nnm-2020-0475
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang QY, 2018, BIOMATERIALS, V160, P107, DOI 10.1016/j.biomaterials.2018.01.022
   Warnken Z, 2020, BROAD SPECTRUM PATIE
   Weston S, 2020, J VIROL, V94, DOI 10.1128/JVI.01218-20
   Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004
   Xu JM, 2020, ACS INFECT DIS, V6, P909, DOI 10.1021/acsinfecdis.0c00052
   Yu J, BRIT J CLIN PHARMACO, V2021
   Yu SJ, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13071044
NR 90
TC 0
Z9 0
U1 2
U2 2
PU SCIENCEDOMAIN INT
PI GURGAON
PA SCIENCEDOMAIN INT, GURGAON, 00000, INDIA
SN 2456-9119
J9 J PHARM RES INT
JI J. Pharm. Res. Int.
PY 2021
VL 33
IS 43B
BP 268
EP 277
AR 72703
DI 10.9734/JPRI/2021/v33i43B32552
PG 10
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA XO4HB
UT WOS:000730146700026
OA gold
DA 2022-04-20
ER

PT J
AU Zhao, B
   Kong, FL
   Nam, EW
AF Zhao, Bo
   Kong, Fanlei
   Nam, Eun Woo
TI Assessing Knowledge, Preventive Practices, and Depression among Chinese
   University Students in Korea and China during the COVID-19 Pandemic: An
   Online Cross-Sectional Study
SO HEALTHCARE
LA English
DT Article
DE COVID-19; Chinese university students; China; Korea; preventive
   practices; depression
ID MENTAL-HEALTH; COLLEGE-STUDENTS; PHYSICAL-ACTIVITY; ANXIETY; PREVALENCE;
   SYMPTOMS; STRESS; VALIDATION; DISORDERS; ATTITUDES
AB To investigate the knowledge, preventive practices, and depression of Chinese university students living in South Korea and Mainland China during the COVID-19 outbreak and explore the determinants of depression among these students, an online cross-sectional questionnaire survey was conducted from 23 March to 12 April 2020. The online questionnaire included questions on knowledge and preventive practices related to COVID-19, and the Patient Health Questionnaire-9 was used to diagnose depressive symptoms. A total of 420 Chinese university students were finally included in the study (171 students from South Korea and 249 students from Mainland China). The majority of these students had a good level of knowledge of COVID-19. Students living in South Korea displayed better preventive practices than those living in Mainland China; however, the proportion of students (28.7%) with moderate-to-severe depression in this group was relatively higher than that (18.9%) of the Mainland Group (chi(2) = 5.50, p < 0.05). More severe depression was related to high levels of concern about family members and contracting COVID-19 as well as suspecting themselves of having come into contact with patients. Displaying more preventive behaviors decreased the depressive symptoms in both groups. These data could be used as a reference for further studies in different regions to take measures (e.g., psychological counseling and encouragement for physical activities) to reduce depressive symptoms in university students.
C1 [Zhao, Bo; Nam, Eun Woo] Yonsei Univ, Grad Sch, Dept Hlth Adm, 1 Yonseidae Gil, Wonju 26493, South Korea.
   [Kong, Fanlei] Shandong Univ, Sch Publ Hlth, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Jinan 250012, Peoples R China.
   [Kong, Fanlei] Shandong Univ, NHC Key Lab Hlth Econ & Policy Res, Jinan 250012, Peoples R China.
   [Nam, Eun Woo] Yonsei Univ, Inst Hlth & Welf, Hlth City Res Ctr, 1 Yonseidae Gil, Wonju 26493, South Korea.
RP Nam, EW (corresponding author), Yonsei Univ, Grad Sch, Dept Hlth Adm, 1 Yonseidae Gil, Wonju 26493, South Korea.; Kong, FL (corresponding author), Shandong Univ, Sch Publ Hlth, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Jinan 250012, Peoples R China.; Kong, FL (corresponding author), Shandong Univ, NHC Key Lab Hlth Econ & Policy Res, Jinan 250012, Peoples R China.; Nam, EW (corresponding author), Yonsei Univ, Inst Hlth & Welf, Hlth City Res Ctr, 1 Yonseidae Gil, Wonju 26493, South Korea.
EM zhaobo@yonsei.ac.kr; kongfanlei@sdu.edu.cn; ewnam@yonsei.ac.kr
RI ‍ZHAO, BO/AAP-1850-2021
OI ‍ZHAO, BO/0000-0002-6780-1633; Nam, Eun Woo/0000-0002-3517-6247
CR Agarwal V, 2020, DISASTER MED PUBLIC, V14, P387, DOI 10.1017/dmp.2020.219
   [Anonymous], COVID-19 Dashboard by the Centre for Systems Science and Engineering at John Hopkins University
   [Anonymous], 2020, MINISTRY FOREIGN AFF
   Apatoff B., 2007, INT J MS CARE, V9, P99, DOI [10.7224/1537-2073-9.3.99, DOI 10.7224/1537-2073-9.3.99]
   Auerbach RP, 2016, PSYCHOL MED, V46, P2955, DOI 10.1017/S0033291716001665
   Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3
   Beiter R, 2015, J AFFECT DISORDERS, V173, P90, DOI 10.1016/j.jad.2014.10.054
   Blanco C, 2008, ARCH GEN PSYCHIAT, V65, P1429, DOI 10.1001/archpsyc.65.12.1429
   Callow DD, 2020, AM J GERIAT PSYCHIAT, V28, P1046, DOI 10.1016/j.jagp.2020.06.024
   Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934
   Chang G. -C., 2020, ARE COUNTRIES ADDRES
   Chen D., 2011, RES PREDICTIVE MODEL
   Chen ZL, 2020, CHINESE MED J-PEKING, V133, P1044, DOI 10.1097/CM9.0000000000000782
   Choi Byoungsook, 2012, [Korean Journal of Human Ecology, 한국생활과학회지], V21, P1235
   Choi S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020011
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   Coughlin SS, 2012, PUBLIC HEALTH REV, V34, DOI 10.1007/BF03391675
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Ding YN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237626
   Faulkner J, 2021, J SCI MED SPORT, V24, P320, DOI 10.1016/j.jsams.2020.11.016
   Fisher M., 2020, NEW YORK TIMES
   Galle F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103481
   Godbout JP, 2006, J NEUROIMMUNE PHARM, V1, P421, DOI 10.1007/s11481-006-9036-0
   Hasan H, 2021, AM J TROP MED HYG, V104, P75, DOI 10.4269/ajtmh.20-0857
   Hua L., 2001, CHIN GEN PRACT, V4, P757, DOI [10.3969/j.issn.1007-9572.2001.10.001, DOI 10.3969/J.ISSN.1007-9572.2001.10.001]
   Huang YQ, 2019, LANCET PSYCHIAT, V6, P211, DOI 10.1016/S2215-0366(18)30511-X
   Hunley HA, 2010, INT J INTERCULT REL, V34, P386, DOI 10.1016/j.ijintrel.2009.08.005
   Husky MM, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152191
   Jacob L, 2020, MENT HEALTH PHYS ACT, V19, DOI 10.1016/j.mhpa.2020.100345
   Jang IC, 2020, MULTILINGUA, V39, P541, DOI 10.1515/multi-2020-0097
   Jekielek S., 2005, TRANSITION ADULTHOOD
   Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Laddu R, 2021, PROG CARDIOVASC DIS, V64, P102, DOI 10.1016/j.pcad.2020.04.006
   Lee SW, 2017, J STUD INT EDUC, V21, P170, DOI 10.1177/1028315317697540
   Liu X., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3552814, DOI 10.2139/SSRN.3552814]
   Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829
   McCabe L., 2005, INT ED, V14, P52
   Meng H., 2004, CHIN J SCH HLTH, V25, P160, DOI [10.3969/j.issn.1000-9817.2004.02.010, DOI 10.3969/J.ISSN.1000-9817.2004.02.010]
   Mohammed A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2167-6
   Nicomedes CJC, 2020, J AFFECT DISORDERS, V276, P14, DOI 10.1016/j.jad.2020.06.046
   Nurunnabi Mohammad, 2020, F1000Res, V9, P1115, DOI 10.12688/f1000research.25557.1
   Olaimat AN, 2020, AM J TROP MED HYG, V103, P1177, DOI 10.4269/ajtmh.20-0418
   Pedrelli P, 2015, ACAD PSYCHIATR, V39, P503, DOI 10.1007/s40596-014-0205-9
   Qun L, 2003, CHIN MENT HLTH J, V17, P534, DOI [10.3321/j.issn:1000-6729.2003.08.007, DOI 10.3321/J.ISSN:1000-6729.2003.08.007]
   Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066
   Rakhmanov O, 2020, J RES MED DENT SCI, V8, P53
   Reperant LA, 2017, VACCINE, V35, P4470, DOI 10.1016/j.vaccine.2017.04.082
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Ruthig J, 2009, SOC PSYCHOL EDUC, V12, P233, DOI DOI 10.1007/S11218-008-9079-6
   Sahu P, 2020, CUREUS, V12, DOI 10.7759/cureus.7541
   Scharl, 2020, ACAD QUEST, V33, P71, DOI [10.1007/s12129-019-09858-6, DOI 10.1007/S12129-019-09858-6]
   Schlipkoter U, 2010, PUBLIC HEALTH REV, V32, P90, DOI [10.1007/BF03391594, 10.1093/pubmed/fdp087]
   Sherry M, 2010, HIGH EDUC, V60, P33, DOI 10.1007/s10734-009-9284-z
   Smith L, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113138
   Solomou I, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144924
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   Twenge JM, 2019, J ABNORM PSYCHOL, V128, P185, DOI 10.1037/abn0000410
   Usher K, 2020, INT J MENT HEALTH NU, V29, P315, DOI 10.1111/inm.12726
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   WHO, 2020, MENT HLTH PSYCH CONS, P1
   World Health Organization, 2012, SEC REG HLTH APSED B
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiong NN, 2015, J AFFECT DISORDERS, V174, P636, DOI 10.1016/j.jad.2014.12.042
   Yoo JH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e62
   Zhao B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186671
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   Zhong R, 2020, PSYCHOLOGY, V11, P1757, DOI [10.4236/psych.2020.1111111, DOI 10.4236/PSYCH.2020.1111111]
NR 70
TC 2
Z9 2
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9032
J9 HEALTHCARE-BASEL
JI Healthcare
PD APR
PY 2021
VL 9
IS 4
AR 433
DI 10.3390/healthcare9040433
PG 14
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA RR4IF
UT WOS:000643063300001
PM 33917674
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Kraus, S
   Clauss, T
   Breier, M
   Gast, J
   Zardini, A
   Tiberius, V
AF Kraus, Sascha
   Clauss, Thomas
   Breier, Matthias
   Gast, Johanna
   Zardini, Alessandro
   Tiberius, Victor
TI The economics of COVID-19: initial empirical evidence on how family
   firms in five European countries cope with the corona crisis
SO INTERNATIONAL JOURNAL OF ENTREPRENEURIAL BEHAVIOR & RESEARCH
LA English
DT Article; Early Access
DE Corona; COVID-19; Crisis management; Family firms; Strategic management;
   Business model adaptation
ID BUSINESS MODEL INNOVATION; QUALITATIVE RESEARCH; SOCIOEMOTIONAL WEALTH;
   STRATEGIC CHANGE; MANAGEMENT; PERFORMANCE; DYNAMICS; CAPABILITIES;
   TECHNOLOGY; LEADERSHIP
AB Purpose Within a very short period of time, the worldwide pandemic triggered by the novel coronavirus has not only claimed numerous lives but also caused severe limitations to daily private as well as business life. Just about every company has been affected in one way or another. This first empirical study on the effects of the COVID-19 crisis on family firms allows initial conclusions to be drawn about family firm crisis management. Design/methodology/approach Exploratory qualitative research design based on 27 semi-structured interviews with key informants of family firms of all sizes in five Western European countries that are in different stages of the crisis. Findings The COVID-19 crisis represents a new type and quality of challenge for companies. These companies are applying measures that can be assigned to three different strategies to adapt to the crisis in the short term and emerge from it stronger in the long run. Our findings show how companies in all industries and of all sizes adapt their business models to changing environmental conditions within a short period of time. Finally, the findings also show that the crisis is bringing about a significant yet unintended cultural change. On the one hand, a stronger solidarity and cohesion within the company was observed, while on the other hand, the crisis has led to a tentative digitalization. Originality/value To the knowledge of the authors, this is the first empirical study in the management realm on the impacts of COVID-19 on (family) firms. It provides cross-national evidence of family firms' current reactions to the crisis.
C1 [Kraus, Sascha] Univ Durham, Durham, England.
   [Clauss, Thomas] Univ Witten Herdecke, Witten, Germany.
   [Breier, Matthias] Lappeenranta Lahti Univ Technol, Lappeenranta, Finland.
   [Gast, Johanna] Montpellier Business Sch, Montpellier, France.
   [Zardini, Alessandro] Univ Verona, Verona, Italy.
   [Tiberius, Victor] Univ Potsdam, Potsdam, Germany.
RP Kraus, S (corresponding author), Univ Durham, Durham, England.
EM sascha.kraus@zfke.de
RI Clauß, Thomas/O-7380-2019; Tiberius, Victor/E-9133-2010; Zardini,
   Alessandro/J-8400-2014
OI Clauß, Thomas/0000-0001-7799-6369; Tiberius, Victor/0000-0002-6492-0872;
   Kraus, Sascha/0000-0003-4886-7482; Zardini,
   Alessandro/0000-0002-2598-9877
FU French government (Labex Entreprendre) [ANR-10-Labex-11-01]
FX Montpellier Business School (MBS) is a founding member of the public
   research center Montpellier Research in Management, MRM (EA 4557, Univ.
   Montpellier). Johanna Gast is a member of the LabEx Entrepreneurship
   (University of Montpellier, France), funded by the French government
   (Labex Entreprendre, ANR-10-Labex-11-01).
CR Amann B, 2012, ASIA PAC BUS REV, V18, P203, DOI 10.1080/13602381.2010.537057
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   Archibugi D, 2013, RES POLICY, V42, P303, DOI 10.1016/j.respol.2012.07.002
   Aronoff C. E., 1995, FAM BUS REV, V8, P121, DOI [10.1111/j.1741-6248.1995.00121.x, DOI 10.1111/J.1741-6248.1995.00121.X]
   Arrondo-Garcia R, 2016, J FAM BUS STRATEG, V7, P227, DOI 10.1016/j.jfbs.2016.11.003
   Baekkeskov E, 2014, DISASTER PREV MANAG, V23, P81, DOI 10.1108/DPM-05-2012-0060
   Baker S, 2020, RADIAT ONCOL, V15, DOI 10.1186/s13014-020-01537-z
   Baldwin R., 2020, EC TIME COVID 19, P59
   Bansal P., 2012, PUBLISHING AMJ PART
   Barker VL, 1997, STRATEGIC MANAGE J, V18, P13, DOI 10.1002/(SICI)1097-0266(199701)18:1<13::AID-SMJ843>3.3.CO;2-O
   Bauweraerts J., 2013, INT BUSINESS RES, V6, P91, DOI [10.5539/ibr.v6n8p91, DOI 10.5539/IBR.V6N8P91]
   Benner MJ, 2016, STRATEG SCI, V1, P71, DOI 10.1287/stsc.2015.0010
   Berrone P, 2012, FAM BUS REV, V25, P258, DOI 10.1177/0894486511435355
   Betts P., 2001, FINANC TIMES, V30, P18
   Bluhm DJ, 2011, J MANAGE STUD, V48, P1866, DOI 10.1111/j.1467-6486.2010.00972.x
   Boddy CR, 2016, QUAL MARK RES, V19, P426, DOI 10.1108/QMR-06-2016-0053
   Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104
   Brand M, 2021, REV MANAG SCI, V15, P157, DOI 10.1007/s11846-019-00373-0
   Brockner J, 2008, J APPL BEHAV SCI, V44, P94, DOI 10.1177/0021886307313824
   Bundy J, 2017, J MANAGE, V43, P1661, DOI 10.1177/0149206316680030
   Cahyanto I, 2016, TOUR MANAG PERSPECT, V20, P195, DOI 10.1016/j.tmp.2016.09.004
   Carnahan S, 2017, STRATEGIC MANAGE J, V38, P2189, DOI 10.1002/smj.2653
   Carney M, 2005, ENTREP THEORY PRACT, V29, P249, DOI 10.1111/j.1540-6520.2005.00081.x
   Casadesus-Masanell R, 2010, LONG RANGE PLANN, V43, P195, DOI 10.1016/j.lrp.2010.01.004
   Cater J, 2008, FAM BUS REV, V21, P31, DOI 10.1111/j.1741-6248.2007.00113.x
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chesbrough H, 2020, IND MARKET MANAG, V88, P410, DOI 10.1016/j.indmarman.2020.04.010
   Chrisman JJ, 2005, ENTREP THEORY PRACT, V29, P555, DOI 10.1111/j.1540-6520.2005.00098.x
   Clauss T, 2021, IEEE T ENG MANAGE, V68, P767, DOI 10.1109/TEM.2019.2910381
   Clauss T, 2017, R&D MANAGE, V47, P385, DOI 10.1111/radm.12186
   Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206
   Coombs WT, 2007, CORP REPUT REV, V10, P163, DOI 10.1057/palgrave.crr.1550049
   Corbin J., 2008, BASICS QUALITATIVE R, P65, DOI [10.4135/9781452230153., DOI 10.4135/9781452230153]
   Dane E, 2007, ACAD MANAGE REV, V32, P33, DOI 10.5465/AMR.2007.23463682
   DAVENI RA, 1990, ADMIN SCI QUART, V35, P634, DOI 10.2307/2393512
   David G., 2003, ENTREP THEORY PRACT, V27, P339, DOI [10.1111/1540-8520.t01-1-00013, DOI 10.1111/1540-8520.T01-1-00013]
   De Massis A, 2013, J FAM BUS STRATEG, V4, P166, DOI 10.1016/j.jfbs.2013.05.001
   Denis JL, 2001, ACAD MANAGE J, V44, P809, DOI 10.2307/3069417
   Denzin NK, 2008, QUALITATIVE INQUIRY AND THE POLITICS OF EVIDENCE, P9
   DEVRIES MFRK, 1993, ORGAN DYN, V21, P59
   Dobrzynski J., 1993, BUS WEEK, V3309, P68
   Dominic E., 2005, J SERV MARK, V19, P336
   Doz Y, 2011, J INT BUS STUD, V42, P582, DOI 10.1057/jibs.2011.18
   Dyer WG, 2006, ENTREP THEORY PRACT, V30, P785, DOI 10.1111/j.1540-6520.2006.00151.x
   Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   Elliot D., 2002, J CONTING CRISIS MAN, V10, P14, DOI [10.1111/1468-5973.00177, DOI 10.1111/1468-5973.00177]
   ELSBACH KD, 1994, ADMIN SCI QUART, V39, P57, DOI 10.2307/2393494
   Faghfouri P, 2015, REV MANAG SCI, V9, P317, DOI 10.1007/s11846-014-0158-0
   Farmer D.., 2020, COVID EC, V6, DOI DOI 10.1093/OXREP/GRAA033
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Fenichel EP, 2013, J HEALTH ECON, V32, P440, DOI 10.1016/j.jhealeco.2013.01.002
   FERGUSON NM, 2020, IMPACT NONPHARMACEUT, DOI DOI 10.25561/77482
   Ferlie E, 2005, ACAD MANAGE J, V48, P117, DOI 10.5465/amj.2005.15993150
   Filser M, 2016, INT J INNOV MANAG, V20, DOI 10.1142/S1363919616500547
   Foss NJ, 2017, J MANAGE, V43, P200, DOI 10.1177/0149206316675927
   Gaskell G, 2000, QUALITATIVE RES TEXT, P38, DOI DOI 10.4135/9781849209731
   Gioia DA, 2013, ORGAN RES METHODS, V16, P15, DOI 10.1177/1094428112452151
   Gomez-Mejia LR, 2007, ADMIN SCI QUART, V52, P106, DOI 10.2189/asqu.52.1.106
   Gomez-Mejia LR, 2011, ACAD MANAG ANN, V5, P653, DOI 10.1080/19416520.2011.593320
   Graebner ME, 2012, STRATEG ORGAN, V10, P276, DOI 10.1177/1476127012452821
   Greiner L.E., 1989, EVOLUTION REVOLUTION
   Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903
   Hale J. E., 2005, Journal of Business Communication, V42, P113, DOI 10.1177/0021943605274751
   Harvey S, 2005, J BUS PSYCHOL, V20, P53, DOI 10.1007/s10869-005-6983-z
   Heath R., 1995, DISASTER PREV MANAG, V4, P11, DOI DOI 10.1108/09653569510100965
   Herbane B, 2013, J CONTING CRISIS MAN, V21, P82, DOI 10.1111/1468-5973.12006
   Hills A., 1998, J CONTING CRISIS MAN, V6, P162, DOI [10.1111/1468-5973.00085, DOI 10.1111/1468-5973.00085]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jacobides MG, 2005, ACAD MANAGE J, V48, P465
   James EH, 2005, ORGAN DYN, V34, P141, DOI 10.1016/j.orgdyn.2005.03.005
   Kim Y, 2014, EUR MANAG J, V32, P795, DOI 10.1016/j.emj.2014.02.003
   Kirk J., 1986, RELIABILITY VALIDITY
   Kraus S, 2013, INT J ENTREP VENTUR, V5, P406, DOI 10.1504/IJEV.2013.058169
   KVALE S, 1983, J PHENOMENOL PSYCHOL, V14, P171, DOI 10.1163/156916283X00090
   Lampel J, 2009, ORGAN SCI, V20, P835, DOI 10.1287/orsc.1090.0479
   Last J.M., 2001, DICT EPIDEMIOLOGY
   Lau K, 2019, HEALTH ECON, V28, P175, DOI 10.1002/hec.3834
   Lechner C, 2006, J BUS VENTURING, V21, P514, DOI 10.1016/j.jbusvent.2005.02.004
   Lee CK, 2012, TOURISM MANAGE, V33, P89, DOI 10.1016/j.tourman.2011.02.006
   Lee J, 2006, FAM BUS REV, V19, P103, DOI 10.1111/j.1741-6248.2006.00060.x
   Lee TW, 1999, J VOCAT BEHAV, V55, P161, DOI 10.1006/jvbe.1999.1707
   Lins KV, 2013, REV FINANC STUD, V26, P2583, DOI 10.1093/rfs/hht044
   Maitlis S, 2005, ACAD MANAGE J, V48, P21
   McKercher B, 2004, ANN TOURISM RES, V31, P716, DOI 10.1016/j.annals.2003.11.002
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Miles MB., 1994, QUALITATIVE DATA ANA, V2nd ed
   Miller D., 2005, MANAGING LONG RUN LE
   Minichilli A, 2016, CORP GOV-OXFORD, V24, P552, DOI 10.1111/corg.12125
   Muellbauer J, 2020, VOX CERP POLICY PORT
   Nambisan S, 2017, MIS QUART, V41, P223, DOI 10.25300/MISQ/2017/41:1.03
   Ndofor HA, 2013, STRATEGIC MANAGE J, V34, P1123, DOI 10.1002/smj.2050
   Neergaard H, 2007, ELGAR ORIG REF, P1
   Nigmatulina KR, 2009, EUR J OPER RES, V195, P613, DOI 10.1016/j.ejor.2008.02.016
   Outhwaite, 1975, UNDERSTANDING SOCIAL
   Pajunen K, 2006, J MANAGE STUD, V43, P1261, DOI 10.1111/j.1467-6486.2006.00624.x
   Park Y, 2013, BUS HORIZONS, V56, P75, DOI 10.1016/j.bushor.2012.09.008
   Pasquini-Descomps H, 2017, VALUE HEALTH, V20, P819, DOI 10.1016/j.jval.2016.05.005
   Pateli AG, 2005, J ORGAN CHANGE MANAG, V18, P167, DOI 10.1108/09534810510589589
   PEARCE JA, 1994, STRATEGIC MANAGE J, V15, P407, DOI 10.1002/smj.4250150507
   PEARCE JA, 1993, J MANAGE, V19, P613, DOI 10.1177/014920639301900306
   Pearson CM, 1998, ACAD MANAGE REV, V23, P59, DOI 10.2307/259099
   Pfarrer MD, 2008, ACAD MANAGE REV, V33, P730, DOI 10.5465/amr.2008.32465757
   Ren CR, 2019, STRATEGIC MANAGE J, V40, P253, DOI 10.1002/smj.2970
   Ritchie BW, 2004, TOURISM MANAGE, V25, P669, DOI 10.1016/j.tourman.2003.09.004
   Roy R, 2018, STRATEG ENTREP J, V12, P261, DOI 10.1002/sej.1278
   Runyan R.C., 2006, J CONTING CRISIS MAN, V14, P12, DOI [DOI 10.1111/j.1468-5973.2006.00477.x, 10.1111/jccm.2006.14.issue-1]
   Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372
   Schmitt A, 2010, MANAGEMENT, V13, P128, DOI 10.3917/mana.133.0128
   Seawright J, 2008, POLIT RES QUART, V61, P294, DOI 10.1177/1065912907313077
   Seeger MW, 2005, J ORGAN CHANGE MANAG, V18, P78, DOI 10.1108/09534810510579869
   Simchi-Levi D, 2014, HARVARD BUS REV, V92, P96
   Sousa D, 2014, QUAL RES PSYCHOL, V11, P211, DOI 10.1080/14780887.2013.853855
   Spiers J., 2002, INT J QUAL METH, V1, P13, DOI [10.1177/160940690200100202, DOI 10.1177/160940690200100202]
   Stieglitz N, 2016, STRATEGIC MANAGE J, V37, P1854, DOI 10.1002/smj.2433
   Tagiuri R., 1996, FAM BUS REV, V9, P199
   Tilson D, 2010, INFORM SYST RES, V21, P748, DOI 10.1287/isre.1100.0318
   Ucakturk A, 2011, PROCD SOC BEHV, V24, DOI 10.1016/j.sbspro.2011.09.095
   van Essen M, 2015, CORP GOV-OXFORD, V23, P3, DOI 10.1111/corg.12080
   Veil ShariR., 2011, J BUS COMMUN, V48, P116, DOI [10.1177/0021943610382294, DOI 10.1177/0021943610382294]
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Villalonga B, 2010, FINANC MANAGE, V39, P863, DOI 10.1111/j.1755-053X.2010.01098.x
   Wang J, 2008, ADV DEV HUM RESOUR, V10, P425, DOI 10.1177/1523422308316464
   Ward J.L., 1997, FAM BUS REV, V10, P323, DOI [10.1111/j.1741-6248.1997.00323.x, DOI 10.1111/J.1741-6248.1997.00323.X]
   Warner KSR, 2019, LONG RANGE PLANN, V52, P326, DOI 10.1016/j.lrp.2018.12.001
   Wenzel M, 2021, STRATEGIC MANAGE J, V42, pV7, DOI 10.1002/smj.3161
   WHO, 2020, NOV COR WORLD HLTH O
   WITTE B, 1981, TEXT KRITIK, P7
   Xi J, 2015, INT ENTREP MANAG J, V11, P113, DOI 10.1007/s11365-013-0286-z
   Yin RK, 2017, CASE STUDY RES APPL
   Yin RK, 2013, EVALUATION-US, V19, P321, DOI 10.1177/1356389013497081
   Zahra S. A., 2002, FAMILY BUSINESS REV, V15, P205, DOI DOI 10.1111/J.1741-6248.2002.00205.X
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 133
TC 149
Z9 150
U1 36
U2 202
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1355-2554
EI 1758-6534
J9 INT J ENTREP BEHAV R
JI Int. J. Entrep. Behav. Res.
DI 10.1108/IJEBR-04-2020-0214
EA MAY 2020
PG 26
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA LQ8HA
UT WOS:000535238000001
OA Bronze, Green Accepted
DA 2022-04-20
ER

PT J
AU Ignatowski, G
   Sulkowski, L
   Stopczynski, B
AF Ignatowski, Grzegorz
   Sulkowski, Lukasz
   Stopczynski, Bartlomiej
TI Risk of Increased Acceptance for Organizational Nepotism and Cronyism
   during the COVID-19 Pandemic
SO RISKS
LA English
DT Article
DE nepotism; cronyism; nepotism acceptance; pandemic; COVID-19
ID FAMILY BUSINESS; MANAGEMENT; DEPRESSION; STRESS; IMPACT; SUSTAINABILITY;
   FAVOURITISM; PERCEPTIONS; INVOLVEMENT; PREVALENCE
AB Nepotism and cronyism are forms of favoritism towards certain people in the workplace. For this reason, they constitute a problem for organization managers, ethicists and psychologists. Identifying the impact of COVID-19 pandemic on the increase of nepotism and cronyism may provide a basis for organizations to assess their extent and to take possible measures to prevent their negative effects. At the same time, the research presented in the article may provide a basis for further research work related to nepotism and cronyism at the times of other threats, different from the pandemic. The aim of the article is to examine the impact of the COVID-19 pandemic on growing acceptance for nepotism and cronyism in Polish enterprises. Qualitative and quantitative methods have been included in the conducted research. Qualitative study aimed at improving knowledge of nepotism and cronyism and the impact of the COVID-19 pandemic on these phenomena, followed by a quantitative study conducted in order to verify the information obtained in the qualitative study. This research has demonstrated that Nepotism and cronyism in the workplace, are phenomenon that are basically evaluated negatively. They adversely influences social and economic development, but the impact of COVID-19 pandemic on nepotism and cronyism is not significant.
C1 [Ignatowski, Grzegorz; Stopczynski, Bartlomiej] Univ Social Sci, Dept Management, PL-90113 Lodz, Poland.
   [Sulkowski, Lukasz] Jagiellonian Univ, Inst Publ Affairs, Dept Management & Social Commun, PL-31007 Krakow, Poland.
RP Ignatowski, G (corresponding author), Univ Social Sci, Dept Management, PL-90113 Lodz, Poland.
EM gignatowski@san.edu.pl; lsulkowski@san.edu.pl; bstopczynski@san.edu.pl
OI Ignatowski, Grzegorz/0000-0002-4432-8476; Stopczynski,
   Bartlomiej/0000-0001-8941-7424; Sulkowski, Lukasz/0000-0002-1248-2743
CR Abdalla HF, 1998, INT J MANPOWER, V19, P554, DOI 10.1108/01437729810242235
   AL-shawawreh T.B., 2016, RES APPL EC, V1, P58, DOI [10.5296/rae.v8i1.9227, DOI 10.5296/RAE.V8I1.9227]
   Al-Youbi AO, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12177090
   Aldraehim M., 2012, INT J INFONOMICS IJI, V5, P655, DOI DOI 10.20533/IJI.1742.4712.2012.0075
   Allchin Douglas., 2015, BASICS HUMAN EVOLUTI, P505, DOI [10.1016/B978-0-12-802652-6, DOI 10.1016/B978-0-12-802652-6]
   Arasli H, 2006, INT J SOCIOL SOC POL, V26, P295, DOI 10.1108/01443330610680399
   Arasli H, 2008, SOC BEHAV PERSONAL, V36, P1237, DOI 10.2224/sbp.2008.36.9.1237
   Arici HE, 2020, LEADERSHIP ORG DEV J, V41, P597, DOI 10.1108/LODJ-06-2019-0250
   Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X
   Arrunada Benito., 2004, EC EFECTS CHRISTIAN
   Arrunada Benito., 2019, ADV EC RELIG, P295
   Austin MonicaL., 2019, THESIS
   Bauerle A, 2020, J PUBLIC HEALTH-UK, V42, P672, DOI 10.1093/pubmed/fdaa106
   Basu Sayan., 2009, SSRN ELECT J, DOI [10.2139/ssrn.1409089, DOI 10.2139/SSRN.1409089]
   Basu Sayan., 2020, INT J SCI RES ENG DE, V3, P860
   Bekesiene S, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031536
   Belzunegui-Eraso A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093662
   Biroli Pietro., 2020, IZA RES PAPER SERIES
   Blasco-Belled A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12156243
   Bourion-Bedes S, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113559
   Bozer G, 2017, J SMALL BUS ENTERP D, V24, P753, DOI 10.1108/JSBED-10-2016-0163
   Camara, 2007, QUALITAT RES REP COM, V8, P21, DOI [10.1080/17459430701617879, DOI 10.1080/17459430701617879]
   Carikici Dlker., 2009, INT S SUST DEV SAR B
   Castellanos-Redondo S, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12219268
   Cenat JM, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113599
   Cherchem N, 2017, J FAM BUS STRATEG, V8, P87, DOI 10.1016/j.jfbs.2017.04.001
   Demaj Esmir., 2012, THESIS EPOKA U TIRAN, DOI [10.13140/RG.2.2.20503.93608, DOI 10.13140/RG.2.2.20503.93608]
   Derkacz AJ, 2020, RISKS, V8, DOI 10.3390/risks8040122
   Dickson M. W., 2012, NEPOTISM ORG, P93
   Efferin S, 2015, J ACCOUNT ORGAN CHAN, V11, P130, DOI 10.1108/JAOC-08-2012-0074
   Escola-Gascon A, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113628
   Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686
   Every-Palmer S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241658
   Fendt J, 2008, ORGAN RES METHODS, V11, P430, DOI 10.1177/1094428106297812
   Fershtman C, 2005, J LEGAL STUD, V34, P371, DOI 10.1086/429846
   Fetahu D., 2017, EUROPEAN J MULTIDISC, V2, P133, DOI [10.26417/ejms.v6i2.p133-143, DOI 10.26417/EJMS.V6I2.P133-143]
   Filipova Lenka., 2012, 804 NUPI
   Fisher CynthiaD., 2005, BLACKWELL ENCY MANAG, Vvol. 5
   Fu I-Pang, 2015, J VALUES BASED LEADE, V8, P56
   Gjinovci Arsim., 2016, EC ENV STUDIES, V16, P421
   Goatly A, 2006, SOC ANIM, V14, P15, DOI 10.1163/156853006776137131
   Gustafsson Carina., 2014, THESIS UMEA SCH BUSI
   Hiebl MRW, 2015, MANAGE DECIS, V53, P1061, DOI 10.1108/MD-04-2014-0191
   Humphreys KL, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-0982
   Ibrahim Mahdani., 2020, AFEBI MANAGEMENT BUS, V5, P31, DOI [10.47312/ambr.v5i2.316, DOI 10.47312/AMBR.V5I2.316]
   Ignatowski G, 2020, RELIGIONS, V11, DOI 10.3390/rel11010047
   Ignatowski G, 2019, MARK MANAG INNOV, P295, DOI 10.21272/mmi.2019.2-25
   Ikram M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208747
   Islam MM, 2020, WORLD, V1, P283, DOI [10.3390/world1030020, DOI 10.3390/WORLD1030020]
   Jaskiewicz P, 2013, FAM BUS REV, V26, P121, DOI 10.1177/0894486512470841
   Joffe AH, 2004, SOCIETY, V41, P74, DOI 10.1007/BF02688236
   Jones RG, 2015, IND ORGAN PSYCHOL-US, V8, P2, DOI 10.1017/iop.2014.3
   Kar N, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113598
   Katsabian Tammy., 2020, TELEWORK VIRUS COVID, DOI [10.2139/ssrn.3684702, DOI 10.2139/SSRN.3684702]
   Keles H.N., 2011, INT BUSINESS EC RES, V10, P9, DOI DOI 10.19030/IBER.V10I9.5622
   Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214
   Krizanova A, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11247016
   Kumar V Dinesh, 2018, J Adv Med Educ Prof, V6, P186
   Lebow JL, 2020, FAM PROCESS, V59, P309, DOI 10.1111/famp.12543
   Li TW, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238888
   Lin SH, 2007, CORP GOV, V15, P1348, DOI 10.1111/j.1467-8683.2007.00650.x
   Liu CW, 2015, LEADERSHIP QUART, V26, P419, DOI 10.1016/j.leaqua.2015.02.007
   Luttik MLA, 2020, J FAM NURS, V26, P87, DOI 10.1177/1074840720920883
   Ma YF, 2020, J AFFECT DISORDERS, V275, P145, DOI 10.1016/j.jad.2020.06.033
   Mazza MG, 2020, BRAIN BEHAV IMMUN, V89, P594, DOI 10.1016/j.bbi.2020.07.037
   Mechili EA, 2021, J PSYCHIATR MENT HLT, V28, P317, DOI 10.1111/jpm.12672
   Moasa Horia, 2020, B TRANSILVANIA U BRA, V13, P59, DOI [10.31926/but.ssl.2020.13.62.1.6, DOI 10.31926/BUT.SSL.2020.13.62.1.6]
   Oducado RMF, 2021, IJERI-INT J EDUC RES, P305, DOI 10.46661/ijeri.5284
   Okubo T., 2020, COVID EC, V32, P1
   Okyere-Kwakye E, 2010, AFR J BUS MANAGE, V4, P3508
   Onoshchenko O, 2014, EMPL RELAT, V36, P254, DOI 10.1108/ER-06-2013-0070
   Padgett M. Y., 2005, J LEADERSH ORG STUD, V11, P34, DOI DOI 10.1177/107179190501100205
   Padgett MY, 2015, J BUS PSYCHOL, V30, P283, DOI 10.1007/s10869-014-9354-9
   Pearce JL, 2015, IND ORGAN PSYCHOL-US, V8, P41, DOI 10.1017/iop.2014.10
   Pelletier KL, 2008, J BUS ETHICS, V80, P823, DOI 10.1007/s10551-007-9471-8
   Pereda N, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00347-1
   Pfeffer Jeffrey., 2005, STANFORD GRADUATE SC, V1906, DOI [10.2139/ssrn.804544, DOI 10.2139/SSRN.804544]
   Popczyk Wojciech., 2017, RESP INT C SOC ISS E, DOI [10.19275/RSEPCONFERENCES107, DOI 10.19275/RSEPCONFERENCES107]
   Prime H, 2020, AM PSYCHOL, V75, P631, DOI 10.1037/amp0000660
   Qaisar I., 2016, INT J MANAGEMENT ACC, V3, P490
   Raisiene AG, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135332
   Rehman U, 2021, COMMUNITY MENT HLT J, V57, P42, DOI 10.1007/s10597-020-00664-x
   Riggio RE, 2015, IND ORGAN PSYCHOL-US, V8, P19, DOI 10.1017/iop.2014.5
   Safina D, 2015, PROC ECON FINANC, V23, P630, DOI 10.1016/S2212-5671(15)00416-5
   Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w
   Salter F, 2013, PERS INDIV DIFFER, V55, P256, DOI 10.1016/j.paid.2012.11.014
   Samankova Dita., 2018, CONTEXTUAL CHARACTER, DOI [10.1007/978-3-319-89536-9, DOI 10.1007/978-3-319-89536-9]
   Serafini RA, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113595
   Sidani YM, 2013, BUS ETHICS Q, V23, P69, DOI 10.5840/beq20132313
   Soava G, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su122310141
   Sostero M., 2020, JRC WORKING PAPERS S
   Sroka W., 2018, FORUM SCI OECONOMIA, V6, P31, DOI 10.23762/FSO_VOL6NO1_18_
   Stake RobertE, 2010, QUAL RES
   Stawicka Anna., 2020, OPRACOWANIA TEMATYCZ
   Steingruber S., 2020, CORRUPTION TIME COVI
   Sulkowski L, 2017, CONTRIB MANAG SCI, P155, DOI 10.1007/978-3-319-39771-9_11
   Sulkowski L, 2009, ARGUM OECON, V23, P127
   Sunny AR, 2021, MAR POLICY, V126, DOI 10.1016/j.marpol.2021.104422
   Teremetskyi Vladyslav, 2021, Med Leg J, V89, P25, DOI 10.1177/0025817220971925
   Treisman D, 2000, J PUBLIC ECON, V76, P399, DOI 10.1016/S0047-2727(99)00092-4
   Tubiana M., 2020, JRC WORKING PAPERS L
   Usher K, 2020, INT J MENT HEALTH NU, V29, P549, DOI 10.1111/inm.12735
   Vatavali F, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12229410
   Vveinhardt J., 2013, MANAGEMENT ORG SYSTE, V66, P129, DOI [https://doi.org/10.7220/MOSR.1392.1142.2013.66.9, DOI 10.7220/MOSR.1392.1142.2013.66.9]
   Vveinhardt J., 2020, FORUM SCI OECONOMIA, V8, P79, DOI DOI 10.23762/FSO_VOL8_NO2_5
   Vveinhardt J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041425
   Wated G, 2015, J BUS ETHICS, V130, P45, DOI 10.1007/s10551-014-2195-7
   Weytjens, 2020, COVID 19 CRISIS TELE
   Williams CC, 2014, INT J SOC ECON, V41, P747, DOI 10.1108/IJSE-06-2013-0147
   Williams M., 2010, NABET NE ASS BUSINES, P230
   World Health Organization, 2020, WHO DIR GEN OP REM M
   Wu JY, 2022, J ENTERP COMMUNITIES, V16, P218, DOI 10.1108/JEC-10-2019-0111
   Xue J, 2020, J MED INTERNET RES, V22, DOI 10.2196/24361
   Zhang HW, 2020, J FAM VIOLENCE, DOI 10.1007/s10896-020-00196-8
NR 114
TC 2
Z9 2
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9091
J9 RISKS
JI Risks
PD APR
PY 2021
VL 9
IS 4
AR 59
DI 10.3390/risks9040059
PG 35
WC Business, Finance
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA RS2JP
UT WOS:000643608600001
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Hrishikesh, S
   Aladeojebi, A
   Murcott, D
   Nnaji, M
   Tsiamis, A
   Cheruvu, CVN
AF Hrishikesh, Salgaonkar
   Aladeojebi, Adebimpe
   Murcott, David
   Nnaji, Martin
   Tsiamis, Achilleas
   Cheruvu, Chandra V. N.
TI Emergency appendicectomy during COVID-19 pandemic-a single UK centre
   experience
SO POLISH JOURNAL OF SURGERY
LA English
DT Article
DE appendicectomy; COVID-19; coronavirus; emergency surgery; laparoscopy
AB Introduction: In December 2019 following an outbreak of Novel coronavirus infection (COVID-19) in Wuhan, China, it spread rapidly overwhelming the healthcare systems globally. With little knowledge of COVID-19 virus, very few published reports on surgical outcomes; hospitals stopped elective surgery, whilst emergency surgery was offered only after exhausting all conservative treatment modalities.
   Aim: This study presents our experience of outcomes of emergency appendectomies performed during the pandemic.
   Methods: Prospectively we collected data on 132 patients in peak pandemic period from 1st March to 5th June 2020 and data compared with 206 patients operated in similar period in 2019. Patient demographics, presenting symptoms, preoperative events, investigations, surgical management, postoperative outcomes and complications were analysed.
   Results: Demographics and ASA grades of both cohorts were comparable. In study cohort 84.4% and 96.7% in control cohort had laparoscopic appendicectomy. Whilst the study cohort had 13.6% primary open operations, control cohort had 5.3%. Mean length of stay and early post-operative complications (<30 days) were similar in both cohorts apart from surgical site infections (p= 0.02) and one mortality in study cohort.
   Conclusion: In these overwhelming pandemic times, although conservative treatment of acute appendicitis is an option, a proportion of patients will need surgery. Our study shows that with careful planning and strict theatre protocols, emergency appendicectomy can be safely offered with minimal risk of spreading COVID-19 infection. These observations warrant further prospective randomised studies.
C1 [Hrishikesh, Salgaonkar; Aladeojebi, Adebimpe; Murcott, David; Nnaji, Martin; Tsiamis, Achilleas; Cheruvu, Chandra V. N.] Univ Hosp North Midlands, Dept Surg, Newcastle Rd, Stoke On Trent ST4 6QG, Staffs, England.
RP Hrishikesh, S (corresponding author), Univ Hosp North Midlands, Dept Surg, Newcastle Rd, Stoke On Trent ST4 6QG, Staffs, England.
EM hrishikesh.salgaonkar@gmail.com
CR [Anonymous], 2020, SCENARIO MANAGING SU
   Chew MH, 2020, SINGAP MED J, V61, P509, DOI 10.11622/smedj.2020070
   Coccolini F, 2020, ANN SURG, V272, P240, DOI DOI 10.1097/SLA.0000000000004030
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Dreifuss NH, 2020, BRIT J SURG, V107, pE368, DOI 10.1002/bjs.11806
   Flemming S, 2020, BRIT J SURG, V107, pE259, DOI 10.1002/bjs.11713
   Gangakhedkar GR, 2020, WORLD J SURG, V44, P3192, DOI 10.1007/s00268-020-05659-z
   Golub R, 1998, J AM COLL SURGEONS, V186, P545, DOI 10.1016/S1072-7515(98)00080-5
   Kelly ME, 2020, COLORECTAL DIS, V22, P648, DOI 10.1111/codi.15141
   Khan Muhammad Najm, 2007, JSLS, V11, P363
   Kim C, 2020, WORLD J CLIN CASES, V8, P1944, DOI 10.12998/wjcc.v8.i10.1944
   Lei SQ, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100331
   Lewis SRR, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5976
   Li YK, 2020, CURR MED SCI, V40, P295, DOI 10.1007/s11596-020-2176-2
   Ngaserin SHN, 2020, LANGENBECK ARCH SURG, V405, P353, DOI 10.1007/s00423-020-01891-2
   Pryor A., 2020, SAGES EAES RECOMMEND
   SEMM K, 1983, ENDOSCOPY, V15, P59, DOI 10.1055/s-2007-1021466
   Shabbir A, 2020, SURG ENDOSC, V34, P3292, DOI 10.1007/s00464-020-07618-0
   Shrikhande SV, 2020, ANN SURG, V272, pE249, DOI 10.1097/SLA.0000000000004116
   Towfigh S, 2006, SURG ENDOSC, V20, P495, DOI 10.1007/s00464-005-0249-8
   Tschuor C, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-154
NR 21
TC 0
Z9 0
U1 0
U2 1
PU INDEX COPERNICUS INT
PI WARSAW
PA Kasprzaka 31A/184 STR, WARSAW, 01-234, POLAND
SN 0032-373X
EI 2299-2847
J9 POL J SURG
JI Pol. J. Surg.
PY 2021
VL 93
IS 2
BP 32
EP 38
DI 10.5604/01.3001.0014.8090
PG 7
WC Surgery
WE Emerging Sources Citation Index (ESCI)
SC Surgery
GA SO6SV
UT WOS:000659103700006
PM 33949323
DA 2022-04-20
ER

PT J
AU Cifuentes-Faura, J
AF Cifuentes-Faura, Javier
TI Transparency in Spanish Government in Times of Covid-19
SO PUBLIC INTEGRITY
LA English
DT Article; Early Access
DE Transparency; COVID-19; Spain; government
ID CORRUPTION; CONFIDENCE; GOVERNANCE; KNOWLEDGE; HEALTH; TRUST
AB Transparency is fundamental for the development of good governance, and even more so in times of crisis. The current crisis caused by the coronavirus has raised questions worldwide as to whether the government is acting transparently. In the case of Spain, the state of alarm decreed has suspended the terms and interrupted the deadlines for processing the procedures of public sector entities, including those affecting the Law on Transparency. This paper analyses how this suspension is affecting the actions carried out in Spain. It shows those practices that we consider to violate citizens' right to public information, and which are therefore not transparent. In Spain, there has been a setback in terms of access to public information and transparency, which has not only been visible in the management of COVID-19 data, but has also affected other areas such as public procurement.
C1 [Cifuentes-Faura, Javier] Univ Murcia, Murcia, Spain.
RP Cifuentes-Faura, J (corresponding author), Univ Murcia, Fac Econ & Business, Dept Financial Econ & Accounting, Campus Espinardo, Murcia 30100, Spain.
EM javier.cifuentes@um.es
CR Armstrong E., 2005, INTEGRITY TRANSPAREN, P1
   Bauhr M, 2014, GOVERNANCE, V27, P291, DOI 10.1111/gove.12033
   Bertot JC, 2010, GOV INFORM Q, V27, P264, DOI 10.1016/j.giq.2010.03.001
   Blanes Climent M.A., 2020, REV ESPANOLA TRANSPA, V11, P13, DOI [https://doi.org/10.51915/ret.118, DOI 10.51915/RET.118]
   Cifuentes-Faura J, 2021, ONLINE INFORM REV, V45, P830, DOI 10.1108/OIR-08-2020-0352
   Cook FL, 2010, J POLIT, V72, P397, DOI 10.1017/S0022381610000034
   Cucciniello M, 2017, PUBLIC ADMIN REV, V77, P32, DOI 10.1111/puar.12685
   Ellis CJ, 2006, INT TAX PUBLIC FINAN, V13, P115, DOI 10.1007/s10797-006-1664-z
   Faura-Martinez U, 2020, INT J ELECTRON GOV R, V16, P42, DOI 10.4018/IJEGR.2020100103
   Fung A, 2013, POLIT SOC, V41, P183, DOI 10.1177/0032329213483107
   Gamero Casado E., 2020, TRANSPARENCIA CONTRA
   Grimmelikhuijsen S, 2012, INT REV ADM SCI, V78, P50, DOI 10.1177/0020852311429667
   Grimmelikhuijsen SG, 2014, J PUBL ADM RES THEOR, V24, P137, DOI 10.1093/jopart/mus048
   Hambleton R, 2007, GOVERNING CITIES IN A GLOBAL ERA: URBAN INNOVATION, COMPETITION, AND DEMOCRATIC REFORM, P1, DOI 10.1057/9780230608795
   Heald D., 2005, TRANSPARENCY KEY BET, P25
   Hernandez-Aguado I, 2012, GAC SANIT, V26, P295, DOI 10.1016/j.gaceta.2012.05.004
   Hood C., 2006, P BRIT ACAD
   Hyland-Wood B, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-020-00701-w
   Islam R., 2003, WPS3077 WORLD BANK
   Jimenez Asensio R., 2020, ANUARIO DERECHO MUNI, V13, P85
   Kaufmann D., 2002, 2928 WORLD BANK
   Kim PS, 2005, PUBLIC ADMIN REV, V65, P646, DOI 10.1111/j.1540-6210.2005.00494.x
   Kim S., 2009, MANAGEMENT STRATEGY
   Kim S, 2012, PUBLIC ADMIN REV, V72, P819, DOI 10.1111/j.1540-6210.2012.02593.x
   Kjaer A.M., 2004, GOVERNANCE KEY CONCE
   Meijer A, 2013, PUBLIC ADMIN REV, V73, P429, DOI 10.1111/puar.12032
   Meneu R, 2011, GAC SANIT, V25, P333, DOI 10.1016/j.gaceta.2011.02.010
   Mestre Delgado J.F., 2020, REV ELECT INAP
   Miranzo Diaz J., 2020, REFLEXIONES TRANSPAR
   OECD, 2020, TRANSP COMM TRUST RO
   Piotrowski S. J, 2007, GOVT TRANSPARENCY PA
   Piotrowski SJ, 2007, AM REV PUBLIC ADM, V37, P306, DOI 10.1177/0275074006296777
   Rahimi F, 2020, INFECT CONT HOSP EP, V41, P1366, DOI 10.1017/ice.2020.174
   Rajan D, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002655
   Tolbert CJ, 2006, PUBLIC ADMIN REV, V66, P354, DOI 10.1111/j.1540-6210.2006.00594.x
   Transparency International, 2020, CORR COR
   Valero Torrijos J., 2020, EUNOMIA REV CULTURA, P103, DOI [https://doi.org/10.20318/eunomia.2020.5705, DOI 10.20318/EUNOMIA.2020.5705]
   Villoria M., 2014, EUNOMIA REV CULTURA, V7, P85
   Welch EW, 2012, INT REV ADM SCI, V78, P93, DOI 10.1177/0020852312437982
   World Bank, 2017, WORLD DEV REP 2016 G
   World Bank, 2020, ENH GOV EFF TRANSP F
NR 41
TC 0
Z9 0
U1 4
U2 5
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1099-9922
EI 1558-0989
J9 PUBLIC INTEGR
JI Public Integr.
DI 10.1080/10999922.2021.1958562
EA AUG 2021
PG 10
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA UC5XD
UT WOS:000686597700001
DA 2022-04-20
ER

PT J
AU Bellissimo, N
   Gabay, G
   Gere, A
   Kucab, M
   Moskowitz, H
AF Bellissimo, Nick
   Gabay, Gillie
   Gere, Attila
   Kucab, Michaela
   Moskowitz, Howard
TI Containing COVID-19 by Matching Messages on Social Distancing to
   Emergent Mindsets-The Case of North America
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE communication; messages; compliance; COVID-19; health policy; social
   distancing
ID CONJOINT-ANALYSIS; HEALTH; COMMUNICATION; BEHAVIOR; DETERMINANTS;
   NARRATIVES; CAMPAIGNS; GENOMICS; SCIENCE
AB Public compliance with social distancing is key to containing COVID-19, yet there is a lack of knowledge on which communication 'messages' drive compliance. Respondents (224 Canadians and Americans) rated combinations of messages about compliance, systematically varied by an experimental design. Independent variables were perceived risk; the agent communicating the policy; specific social distancing practices; and methods to enforce compliance. Response patterns to each message suggest three mindset segments in each country reflecting how a person thinks. Two mindsets, the same in Canada and the US, were 'tell me exactly what to do,' and 'pandemic onlookers.' The third was 'bow to authority' in Canada, and 'tell me how' in the US. Each mindset showed different messages strongly driving compliance. To effectively use messaging about compliance, policy makers may assign any person or group in the population to the appropriate mindset segment by using a Personal Viewpoint Identifier that we developed.
C1 [Bellissimo, Nick; Kucab, Michaela] Ryerson Univ, Sch Nutr, Toronto, ON M5B 2K3, Canada.
   [Gabay, Gillie] Coll Management Acad Studies, Sch Behav Sci & Psychol, IL-91750 Rishon Leziyyon, Israel.
   [Gere, Attila; Moskowitz, Howard] Szent Istvan Univ, Fac Food Sci, Inst Food Technol, Dept Postharvest & Sensory Evaluat, H-1118 Budapest, Hungary.
   [Moskowitz, Howard] MindCart Inc, White Plains, NY 10605 USA.
RP Bellissimo, N (corresponding author), Ryerson Univ, Sch Nutr, Toronto, ON M5B 2K3, Canada.
EM nick.bellissimo@ryerson.ca; gillie.gabay@gmail.com;
   gereattilaphd@gmail.com; michaela.kucab@ryerson.ca; mjihrm@gmail.com
OI Gere, Attila/0000-0003-3075-1561
FU Ryerson University, Faculty of Community Services COVID-19 Rapid
   Response Research Grant; Premium Postdoctoral Researcher Program of the
   Hungarian Academy of Sciences
FX This study was funded by a Ryerson University, Faculty of Community
   Services COVID-19 Rapid Response Research Grant. A.G. thanks the support
   of the Premium Postdoctoral Researcher Program of the Hungarian Academy
   of Sciences.
CR Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208
   Allcott H, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104254
   Asmundson GJG, 2020, J ANXIETY DISORD, V71, DOI 10.1016/j.janxdis.2020.102211
   Austin E. W, 2014, INT J COMMUNICATION, V1-3, P831
   Bodas M, 2020, HEALTH AFFAIR, V39, P936, DOI 10.1377/hlthaff.2020.00382
   Bonell C, 2020, J EPIDEMIOL COMMUN H, V74, P617, DOI 10.1136/jech-2020-214290
   Boring E., 2008, HIST EXPT PSYCHOL
   CATTIN P, 1982, J MARKETING, V46, P44, DOI 10.2307/1251701
   Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9
   Clarke CE, 2012, INT J ENV RES PUB HE, V9, P4254, DOI 10.3390/ijerph9124254
   Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608
   Cronin CJ, 2020, PRIVATE PRECAUTION P
   Cruz-Correa M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134839
   Dubes Richard, 1980, ADV COMPUT, V19, P113
   Elcheroth G, 2020, BRIT J SOC PSYCHOL, V59, P703, DOI 10.1111/bjso.12403
   Frank LB, 2015, HEALTH COMMUN, V30, P154, DOI 10.1080/10410236.2014.974126
   Gabay G., 2020, P EUR 2020 C VIRT C
   Gofman A, 2010, INT J INNOV MANAG, V14, P435, DOI 10.1142/S1363919610002726
   Gollust SE, 2009, AM J PUBLIC HEALTH, V99, P2160, DOI 10.2105/AJPH.2009.161414
   Green P.E., 1988, DATA EXPERT KNOWLEDG, DOI [10.1007/978-3-642-73489-2_21, DOI 10.1007/978-3-642-73489-2_21]
   GREEN PE, 1990, J MARKETING, V54, P3, DOI 10.2307/1251756
   Gualano MR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134779
   Hagger MS, 2020, ANN BEHAV MED, V54, P713, DOI 10.1093/abm/kaaa073
   Hastie T., 2001, PROTOTYPES NEAREST N, P460, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]
   Heydari B., 2020, IMMEDIATE EFFECT COV, DOI [10.2139/ssrn.3571421, DOI 10.2139/SSRN.3571421]
   Hinyard LJ, 2007, HEALTH EDUC BEHAV, V34, P777, DOI 10.1177/1090198106291963
   Hopkins DJ, 2020, J BEHAV PUBLIC ADM, V3, DOI [10.30636/jbpa.32.178, DOI 10.30636/JBPA.32.178]
   Kahneman D., 2011, THINKING
   Leiras G., 2020, EUR J PUBLIC HEALTH, V30, DOI 10.1093/eurpub/ckaa165.566
   Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
   Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7
   MILLIGAN GW, 1981, MULTIVAR BEHAV RES, V16, P379, DOI 10.1207/s15327906mbr1603_7
   Morrison LG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-258
   Moskowitz HR, 2012, PHYSIOL BEHAV, V107, P606, DOI 10.1016/j.physbeh.2012.04.009
   Oosterhoff B, 2020, J ADOLESCENT HEALTH, V67, P179, DOI 10.1016/j.jadohealth.2020.05.004
   Painter M, 2020, POLITICAL BELIEFS AF, DOI DOI 10.2139/SSRN.3569098
   Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006
   Porretta S, 2019, TRENDS FOOD SCI TECH, V84, P29, DOI 10.1016/j.tifs.2018.01.004
   Schank RC, 2002, NARRATIVE IMPACT: SOCIAL AND COGNITIVE FOUNDATIONS, P287
   Shen FY, 2015, J ADVERTISING, V44, P105, DOI 10.1080/00913367.2015.1018467
   Stern S., 2011 BAR IL U FAC LA
   Stewart W.E., 1979, J MARKETING RES, V25, P383, DOI [10.1002/aic.690250233, DOI 10.1002/AIC.690250233]
   Torbay R, 2020, HEALTH AFFAIR, V39, P1104, DOI 10.1377/hlthaff.2020.00467
NR 43
TC 3
Z9 3
U1 3
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD NOV
PY 2020
VL 17
IS 21
AR 8096
DI 10.3390/ijerph17218096
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA OQ6HB
UT WOS:000588880900001
PM 33153071
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Harland, CM
   Knight, L
   Patrucco, AS
   Lynch, J
   Telgen, J
   Peters, E
   Tatrai, T
   Ferk, P
AF Harland, Christine Mary
   Knight, Louise
   Patrucco, Andrea S.
   Lynch, Jane
   Telgen, Jan
   Peters, Esmee
   Tatrai, Tunde
   Ferk, Petra
TI Practitioners' learning about healthcare supply chain management in the
   COVID-19 pandemic: a public procurement perspective
SO INTERNATIONAL JOURNAL OF OPERATIONS & PRODUCTION MANAGEMENT
LA English
DT Article
DE COVID-19; Procurement; Awareness; Motivation; Capability; Supply markets
AB Purpose The procurement and supply of crucial healthcare products in the early stages of the COVID-19 emergency were chaotic. To prepare for future crises, we must be able to describe what went wrong, and why, and map out ways to build agility and resilience. How can this be done effectively, given the highly complex and diverse network of actors across governments, care providers and supply chains, and the extreme uncertainty and dynamism in the procurement system and supplier markets? The purpose of this study was to capture learning from practitioners in "real time" in a way that could frame and inform capacity building across healthcare systems with varying procurement and supply management maturity. Design/methodology/approach This exploratory study involved interviews with 58 senior public procurement practitioners in central and regional governments, NGOs and leaders of professional organizations from 23 countries, very early in the COVID crisis. Following the first, inductive phase of analysis leading to five descriptive dimensions, the awareness-motivation-capability (A-M-C) framework was applied in a further round of coding, to understand immediate challenges faced by procurement practitioners, how the complex, multi-level procurement system that shaped their motivations to respond and critical capabilities required to face these challenges. Findings Developments across 23 countries and practitioners' learning about procurement and supply in the pandemic crisis can be captured in five overarching themes: governance and organization, knowledge and skills, information systems, regulation and supply base issues. Together these themes cover the strengths and gaps in procurement and supply capability encountered by procurement leaders and front-line personnel. They highlight the various facets of structure, resource and process which constitute organizational capability. However, to account better for the highly dynamic situation characterized by both unprecedented rivalry and cooperation, analysts must also pay attention to actors' emerging awareness of the situation and their rapidly changing motivations. Originality/value The application of the A-M-C framework is unique in the healthcare supply chain and disaster management literature. It enables a comprehensive overview of healthcare procurement from a system perspective. This study shows how increasing system preparedness for future emergencies depends both on developing critical capabilities and understanding how awareness and motivation influence the effective deployment of those capabilities.
C1 [Harland, Christine Mary] Politecn Milan, Dept Management Econ & Ind Engn, Milan, Italy.
   [Knight, Louise] Univ Twente, Fac Behav Management & Social Sci, Enschede, Netherlands.
   [Patrucco, Andrea S.] Florida Int Univ, Coll Business, Dept Mkt & Logist, Miami, FL 33199 USA.
   [Lynch, Jane] Cardiff Univ, Logist & Operat Management, Cardiff, Wales.
   [Telgen, Jan; Peters, Esmee] Publ Procurement Res Ctr, Barneveld, Netherlands.
   [Telgen, Jan; Peters, Esmee] Univ Twente, Enschede, Netherlands.
   [Tatrai, Tunde] Corvinus Univ Budapest, Budapest, Hungary.
   [Ferk, Petra] New Univ, Nova Gorica, Slovenia.
RP Patrucco, AS (corresponding author), Florida Int Univ, Coll Business, Dept Mkt & Logist, Miami, FL 33199 USA.
EM andreastefano.patrucco@gmail.com
RI Tatrai, Tunde/B-6697-2013; Patrucco, Andrea/L-2359-2019
OI Tatrai, Tunde/0000-0001-6008-526X; Patrucco, Andrea/0000-0002-9367-1561;
   Lynch, Jane/0000-0003-2863-8594
CR Atkinson CL, 2020, AM REV PUBLIC ADM, V50, P628, DOI 10.1177/0275074020942055
   Calnan M, 2018, INT J HEALTH POLICY, V7, P402, DOI 10.15171/ijhpm.2017.104
   Checkland P, 1999, SYSTEMS THINKING RET
   Chen MJ, 2014, ACAD MANAGE REV, V39, P119, DOI 10.5465/amr.2013.0493
   Chen MJ, 2012, ACAD MANAG ANN, V6, P135, DOI 10.1080/19416520.2012.660762
   Chen MJ, 1996, ACAD MANAGE REV, V21, P100
   Choi TY, 2001, J OPER MANAG, V19, P351, DOI 10.1016/S0272-6963(00)00068-1
   CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593
   Craighead CW, 2020, DECISION SCI, V51, P838, DOI 10.1111/deci.12468
   Dai TL, 2021, J CLIN NURS, V30, pE1, DOI 10.1111/jocn.15400
   Dasaklis TK, 2012, INT J PROD ECON, V139, P393, DOI 10.1016/j.ijpe.2012.05.023
   Doringer S, 2021, INT J SOC RES METHOD, V24, P265, DOI 10.1080/13645579.2020.1766777
   European Commission, 2021, EXP PAN EFF WAYS INV
   Finkenstadt DJ, 2021, J PURCH SUPPLY MANAG, V27, DOI 10.1016/j.pursup.2021.100689
   Handfield R, 2020, MILBANK Q, V98, P1058, DOI 10.1111/1468-0009.12485
   Harland C, 2021, J SUPPLY CHAIN MANAG, V57, P27, DOI 10.1111/jscm.12249
   Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922
   Kamerow D, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1367
   Leite H., 2020, TQM J, V33, P247, DOI DOI 10.1108/TQM-05-2020-0111
   McGuire M, 2010, PUBLIC ADMIN REV, V70, pS201, DOI 10.1111/j.1540-6210.2010.02273.x
   Patrucco AS, 2021, J PURCH SUPPLY MANAG, V27, DOI 10.1016/j.pursup.2021.100719
   Scala B, 2021, SUPPLY CHAIN MANAG, V26, P672, DOI 10.1108/SCM-09-2020-0434
   Stratieva S.V., 2018, SUPPLY CHAIN FORUM I, V19, P4, DOI [10.1080/16258312.2017.1395276, DOI 10.1080/16258312.2017.1395276]
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
NR 24
TC 2
Z9 2
U1 15
U2 15
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0144-3577
EI 1758-6593
J9 INT J OPER PROD MAN
JI Int. J. Oper. Prod. Manage.
PD DEC 17
PY 2021
VL 41
IS 13
BP 178
EP 189
DI 10.1108/IJOPM-05-2021-0348
PG 12
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA XO2FQ
UT WOS:000730007200001
OA Green Accepted, Green Submitted, hybrid
DA 2022-04-20
ER

PT J
AU Kazemian, S
   Grant, SB
AF Kazemian, Shakiba
   Grant, Susan Barbara
TI The impact of the COVID-19 pandemic on knowledge sharing in UK higher
   education
SO VINE JOURNAL OF INFORMATION AND KNOWLEDGE MANAGEMENT SYSTEMS
LA English
DT Article; Early Access
DE Knowledge sharing; Grounded theory; Enterprise social network (ESN);
   Consumptive use; Contributive use; Higher education staff; User content
ID SOCIAL MEDIA; INFORMATION-TECHNOLOGY; MANAGEMENT; NETWORKS; ANTECEDENTS;
   INTENTION; FACEBOOK; ADOPTION; USAGE; ORGANIZATIONS
AB Purpose The paper aims to explore "content" factors influencing consumptive and contributive use of enterprise social networking within UK higher education during the COVID-19 pandemic. Design/methodology/approach The methodology uses genre analysis and grounded theory to analyse empirical data from posts obtained through Microsoft Yammer and a focus group. Findings The findings reveal the motivators-outcomes-strategies and the barriers-outcomes-strategies of users. Motivators (M) include feature value, Information value, organizational requirement and adequate organizational and technical support. Barriers (B) include six factors, including resisting engagement on the online platform, emotional anxiety, loss of knowledge, the lack of organizational pressure, lack of content quality and lack of time. An Outcomes (O) framework reveals benefits and dis-benefits and strategies (S) relating to improving user engagement. Practical implications The research method and resultant model may serve as guidelines to higher educational establishments interested in motivating their staff and scholars around the use of enterprise social network (ESN) systems, especially during face-to-face restrictions. Originality/value This research study was conducted during the COVID-19 pandemic which provides a unique setting to examine consumptive and contributive user behaviour of ESN's. Furthermore, the study develops a greater understanding of "content" factors leading to the benefits or dis-benefits of ESN use, drawing on user motivators, barriers and strategies during the COVID-19 pandemic in UK education.
C1 [Kazemian, Shakiba] Brunel Univ London, Dept Mech & Aerosp Engn, Uxbridge, Middx, England.
   [Grant, Susan Barbara] Brunel Univ London, London, England.
RP Kazemian, S (corresponding author), Brunel Univ London, Dept Mech & Aerosp Engn, Uxbridge, Middx, England.
EM shakibak22@gmail.com
CR Adu P., 2019, STEP BY STEP GUIDE Q, V1st ed
   Al-Daihani SM, 2018, J ACAD LIBR, V44, P216, DOI 10.1016/j.acalib.2018.02.004
   Al-Kurdi O, 2018, J ENTERP INF MANAG, V31, P226, DOI 10.1108/JEIM-09-2017-0129
   Aladwani AM, 2017, INT J INFORM MANAGE, V37, P576, DOI 10.1016/j.ijinfomgt.2017.05.014
   Ali I, 2020, MED ANTHROPOL, V39, P376, DOI 10.1080/01459740.2020.1745481
   [Anonymous], 2012, P 33 INT C INF SYST
   Aral S, 2013, INFORM SYST RES, V24, P3, DOI 10.1287/isre.1120.0470
   Ardichvili A., 2003, Journal of Knowledge Management, V7, P64, DOI 10.1108/13673270310463626
   Arshad M, 2018, INT REV RES OPEN DIS, V19, P243
   Beck R, 2014, MIS QUART, V38, P1245, DOI 10.25300/MISQ/2014/38.4.14
   BENBASAT I, 1987, MIS QUART, V11, P369, DOI 10.2307/248684
   Bock GW, 2008, IEEE T ENG MANAGE, V55, P292, DOI 10.1109/TEM.2008.919679
   Bonetta L, 2007, CELL, V129, P443, DOI 10.1016/j.cell.2007.04.032
   Bright R., 2015, SIDE SIDE
   Brown K.S, 2012, COHOMOLOGY GROUPS, V87
   Bukvova H, 2010, STUDYING RES COLLABO
   Cabrera EF, 2005, INT J HUM RESOUR MAN, V16, P720, DOI 10.1080/09585190500083020
   Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd ed.
   Cheung CMK, 2013, J AM SOC INF SCI TEC, V64, P1357, DOI 10.1002/asi.22854
   Chin CPY, 2015, J ORG COMP ELECT COM, V25, P289, DOI 10.1080/10919392.2015.1058118
   Chin PY, 2020, INFORM SYST FRONT, V22, P1357, DOI 10.1007/s10796-019-09939-5
   Cleveland S, 2016, INFORMATICS-BASEL, V3, DOI 10.3390/informatics3030011
   Collins E., 2010, INT C EL PUBL HELS F, P271
   Corcoran N., 2018, AUSTRALAS J INF SYST, V22, DOI [10.3127/ajis.v22i0.1647, DOI 10.3127/AJIS.V22I0.1647]
   Cramer AOJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167490
   Crawford C. B., 2003, J LEADERSHIP ED, V2, P1, DOI DOI 10.12806/V2/I1/C3
   Del Giudice M, 2016, J KNOWL MANAG, V20, P484, DOI 10.1108/JKM-07-2015-0257
   Del Giudice M, 2014, J KNOWL MANAG, V18, P841, DOI 10.1108/JKM-06-2014-0264
   DeLone WH, 1992, INFORM SYST RES, V3, P60, DOI 10.1287/isre.3.1.60
   Dermentzi E, 2016, COMPUT HUM BEHAV, V61, P321, DOI 10.1016/j.chb.2016.03.019
   Dhir A, 2019, INT J INFORM MANAGE, V48, P193, DOI 10.1016/j.ijinfomgt.2019.05.021
   Dholakia UM, 2004, INT J RES MARK, V21, P241, DOI 10.1016/j.ijresmar.2003.12.004
   Donelan H, 2016, J FURTH HIGH EDUC, V40, P706, DOI 10.1080/0309877X.2015.1014321
   Du Chatenier E., 2009, HUM RESOUR DEV REV, V8, P350
   Dumpit DZ, 2017, INT J EDUC TECHNOL H, V14, DOI 10.1186/s41239-017-0045-2
   EISENHARDT KM, 1989, ACAD MANAGE J, V32, P543, DOI 10.2307/256434
   Elkaseh Ali Mohamed, 2016, International Journal of Information and Education Technology, V6, P192, DOI 10.7763/IJIET.2016.V6.683
   Ellram L.M., 1996, J BUSINESS LOGISTICS, V17, P93
   Fullwood R, 2013, J KNOWL MANAG, V17, P123, DOI 10.1108/13673271311300831
   Gable GG, 1994, EUR J INFORM SYST, V3, P112, DOI 10.1057/ejis.1994.12
   Gilstrap CM, 2019, COMMUN Q, V67, P506, DOI 10.1080/01463373.2019.1668441
   Glaser B.G., 1978, THEORETICAL SENSITIV
   Gloor P.A., 2006, SWARM CREATIVITY COM
   Grant SB, 2019, INFORM MANAGE-AMSTER, V56, P625, DOI 10.1016/j.im.2018.10.004
   Grant SB, 2016, J KNOWL MANAG, V20, P898, DOI 10.1108/JKM-11-2015-0432
   Gruzd A, 2012, COMPUT HUM BEHAV, V28, P2340, DOI 10.1016/j.chb.2012.07.004
   Gu F, 2011, ELECTRON LIBR, V29, P762, DOI 10.1108/02640471111187999
   Haeussler C, 2014, RES POLICY, V43, P465, DOI 10.1016/j.respol.2013.08.017
   Nguyen HN, 2011, J MANAG DEV, V30, P206, DOI 10.1108/02621711111105786
   Heisig P, 2009, J KNOWL MANAG, V13, P4, DOI 10.1108/13673270910971798
   Hennink M.M., 2013, FOCUS GROUP DISCUSSI
   Hoyla T, 2016, SCIENTOMETRICS, V108, P263, DOI 10.1007/s11192-016-1940-3
   Hung HT, 2010, TEACH HIGH EDUC, V15, P703, DOI 10.1080/13562517.2010.507307
   Ivaskiv Roman, 2019, 2019 IEEE 14th International Conference on Computer Sciences and Information Technologies (CSIT), P39, DOI 10.1109/STC-CSIT.2019.8929880
   Jolaee A, 2014, INT J EDUC MANAG, V28, P413, DOI 10.1108/IJEM-03-2013-0041
   Luzon MJ, 2009, J AM SOC INF SCI TEC, V60, P75, DOI 10.1002/asi.20937
   Kane GC, 2014, MIS QUART, V38, P275, DOI 10.25300/MISQ/2014/38.1.13
   Kang KP, 2014, MOL MED REP, V9, P2061, DOI 10.3892/mmr.2014.2089
   Kazemian S, 2020, EXPLORING NATURE ENT
   Kazemian S, 2021, VINE J INF KNOWL MAN, DOI 10.1108/VJIKMS-12-2020-0222
   Koch H, 2013, INFORM SYST J, V23, P501, DOI 10.1111/isj.12020
   Kugler M, 2015, BUS INFORM SYST ENG+, V57, P181, DOI 10.1007/s12599-015-0379-z
   Kuettner T, 2013, ELECTRON MARK, V23, P329, DOI 10.1007/s12525-013-0141-7
   Lee TW, 1999, J VOCAT BEHAV, V55, P161, DOI 10.1006/jvbe.1999.1707
   Leonardi PM, 2013, J COMPUT-MEDIAT COMM, V19, P1, DOI 10.1111/jcc4.12029
   Liamputtong P., 2011, FOCUS GROUP METHODOL, DOI [10.4135/9781473957657, DOI 10.4135/9781473957657]
   Lim JS, 2015, COMPUT HUM BEHAV, V46, P158, DOI 10.1016/j.chb.2015.01.013
   Luqman A, 2017, COMPUT HUM BEHAV, V70, P544, DOI 10.1016/j.chb.2017.01.020
   Maican CI, 2019, COMPUT EDUC, V128, P113, DOI 10.1016/j.compedu.2018.09.010
   Manca S, 2016, COMPUT EDUC, V95, P216, DOI 10.1016/j.compedu.2016.01.012
   Mantymaki M, 2016, INT J INFORM MANAGE, V36, P1042, DOI 10.1016/j.ijinfomgt.2016.06.009
   Matikiti R, 2018, S AFR J INFORM MANAG, V20, DOI 10.4102/sajim.v20i1.790
   Matschke C, 2014, COMPUT HUM BEHAV, V36, P549, DOI 10.1016/j.chb.2014.04.044
   Miles MB., 1994, QUALITATIVE DATA ANA, V2nd ed
   Morris M. R., 2012, P ACM 2012 C COMP SU, P441, DOI [DOI 10.1145/2145204.2145274, 10.1145/]
   Morris MG, 2000, PERS PSYCHOL, V53, P375, DOI 10.1111/j.1744-6570.2000.tb00206.x
   Morse Janice M., 1996, NURSING RES APPL QUA
   Mukkamala AM, 2014, J GLOB INF TECH MAN, V17, P188, DOI 10.1080/1097198X.2014.951296
   Mumford E., 1985, RES METHODS INFORM S
   Nandez G, 2013, ELECTRON LIBR, V31, P781, DOI 10.1108/EL-03-2012-0031
   Nguyen TM, 2020, J KNOWL MANAG, V24, P1241, DOI 10.1108/JKM-12-2019-0742
   Nguyen TM, 2021, VINE J INF KNOWL MAN, V51, P109, DOI 10.1108/VJIKMS-05-2019-0077
   Nonaka I, 2000, LONG RANGE PLANN, V33, P5, DOI 10.1016/S0024-6301(99)00115-6
   Nonaka I, 2007, HARVARD BUS REV, V85, P162
   Ortbach K., 2014, P 35 INT C INF SYST, P1
   Panahi S, 2016, J INF SCI, V42, P539, DOI 10.1177/0165551515598883
   Panahi S, 2013, J KNOWL MANAG, V17, P379, DOI 10.1108/JKM-11-2012-0364
   Park JG, 2014, INT J PROJ MANAG, V32, P153, DOI 10.1016/j.ijproman.2013.02.004
   Paroutis S, 2009, J KNOWL MANAG, V13, P52, DOI 10.1108/13673270910971824
   Politis J. D., 2002, LEADERSHIP ORG DEV J, V23, P4, DOI DOI 10.1108/01437730210429052
   POLLITT C, 1990, PUBLIC ADMIN, V68, P435, DOI 10.1111/j.1467-9299.1990.tb00771.x
   Polster C, 2007, HIGH EDUC, V53, P599, DOI 10.1007/s10734-005-1118-z
   Razmerita L, 2016, J KNOWL MANAG, V20, P1225, DOI 10.1108/JKM-03-2016-0112
   Razmerita L, 2014, J ORG COMP ELECT COM, V24, P74, DOI 10.1080/10919392.2014.866504
   Razmerita L, 2009, ONLINE INFORM REV, V33, P1021, DOI 10.1108/14684520911010981
   Reid R.P., 1988, TIMES HIGHER ED SUPP
   Rice C., 2012, GUARDIAN, V24
   Rowlands I, 2011, LEARN PUBL, V24, P183, DOI 10.1087/20110306
   Sajeva S., 2007, EC MANAGEMENT, V12, P643
   Sarwar B, 2019, J EDUC COMPUT RES, V57, P246, DOI 10.1177/0735633117748415
   Sayed Y., 2002, COMP ED, V32, P35
   SHELLEY M, 1984, J AM STAT ASSOC, V79, P240, DOI 10.2307/2288384
   Singh SK, 2021, J BUS RES, V128, P788, DOI 10.1016/j.jbusres.2019.04.040
   Smith N. C., 1990, Journal of Information Technology, V5, P123
   Sohail M Sadiq, 2009, VINE, V39, P125, DOI 10.1108/03055720910988841
   Star S. L., 2007, SAGE HDB GROUNDED TH, P75
   Swar B, 2017, COMPUT HUM BEHAV, V70, P416, DOI 10.1016/j.chb.2016.12.068
   Tajudeen FP, 2018, INFORM MANAGE-AMSTER, V55, P308, DOI 10.1016/j.im.2017.08.004
   Taylor, 2008, J KNOWLEDGE MANAGEME, V6, DOI DOI 10.1016/J.JADOHEALTH.2011.08.010
   Tohidinia Z, 2010, IND MANAGE DATA SYST, V110, P611, DOI 10.1108/02635571011039052
   Tsai Y, 2007, INT J EDUC MANAG, V21, P6, DOI 10.1108/09513540710716786
   Nguyen TM, 2019, J KNOWL MANAG, V23, P998, DOI 10.1108/JKM-01-2019-0029
   United Nations Educational Scientific and Cultural Organization (UNESCO), 2020, COVID 19 ED DISR RES
   Vaast E, 2013, J COMPUT-MEDIAT COMM, V19, P78, DOI 10.1111/jcc4.12032
   Vandenberghe V, 1999, COMP EDUC, V35, P271, DOI 10.1080/03050069927829
   Veletsianos G, 2012, J COMPUT ASSIST LEAR, V28, P336, DOI 10.1111/j.1365-2729.2011.00449.x
   Veletsianos G, 2012, COMPUT EDUC, V58, P766, DOI 10.1016/j.compedu.2011.10.001
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417
   Wamba SF, 2014, PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL CONFERENCE ON ELECTRONIC COMMERCE (ICEC 2014), P20, DOI 10.1145/2617848.2617852
   Wang T, 2014, BEHAV INFORM TECHNOL, V33, P1048, DOI 10.1080/0144929X.2013.781221
   Westman S., 2010, P 3 S INF INT CONT, P323
   Xiao L, 2019, COMPUT HUM BEHAV, V101, P297, DOI 10.1016/j.chb.2019.08.001
   Yin, 2004, CASE STUDY RES
   Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x
   Zhang X, 2019, INFORM MANAGE-AMSTER, V56, DOI 10.1016/j.im.2018.12.004
   Zhang X, 2017, COMPUT HUM BEHAV, V75, P797, DOI 10.1016/j.chb.2017.06.028
   Zhang YC, 2022, STRATEGIC MANAGE J, V43, P599, DOI 10.1002/smj.3191
   Zhao DJ, 2009, GROUP 2009 PROCEEDINGS, P243
NR 129
TC 0
Z9 0
U1 4
U2 4
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2059-5891
EI 1474-1032
J9 VINE J INF KNOWL MAN
JI VINE J. INF. KNOWL. MANAG. SYST.
DI 10.1108/VJIKMS-06-2021-0096
EA JAN 2022
PG 34
WC Information Science & Library Science; Management
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science; Business & Economics
GA YC7JW
UT WOS:000739865100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Shi, XR
   Liu, WH
   Zhang, JH
AF Shi, Xiaoran
   Liu, Weihua
   Zhang, Jiahui
TI Present and future trends of supply chain management in the presence of
   COVID-19: a structured literature review
SO INTERNATIONAL JOURNAL OF LOGISTICS-RESEARCH AND APPLICATIONS
LA English
DT Review; Early Access
DE COVID-19; supply chain disruptions; 3Rs; structured literature review
ID IMPACT; DECISIONS; KNOWLEDGE; BEHAVIOR; CREATION; CRISES
AB The COVID-19 inflicted worldwide heavy losses and exposed the vulnerability of the global supply chain. Since then, the number of research works exploring the supply chain-related issues raised by this terrible pandemic steadily increases, making a structured review a necessity. To this end, this paper figured out three major tasks: (1) 166 relevant articles are identified, along with a macro-level analysis in terms of general information of the literature; (2) through mapping the relevant research works from the problem-oriented and methodology-driven perspective, the present research hotspots and methodologies/theories used in these studies are revealed; and (3) a research agenda with the consideration of supply chain disruptions and 3Rs in the supply chain is proposed. Research findings may shed more light on the discussion of the COVID-19's impacts on supply chains, and providing academical guides for researchers and managerial insights for decision-makers to develop appropriate responses to the pandemic.
C1 [Shi, Xiaoran; Zhang, Jiahui] Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China.
   [Liu, Weihua] Tianjin Univ, Coll Management & Econ, Dept Logist & Supply Chain Management, Tianjin, Peoples R China.
   [Shi, Xiaoran] Tianjin Univ Technol, Sch Management, Tianjin, Peoples R China.
RP Liu, WH (corresponding author), Tianjin Univ, Coll Management & Econ, Dept Logist & Supply Chain Management, Tianjin, Peoples R China.
EM xiaoran_eileen@163.com; lwhliu@tju.edu.cn; tju_jiahuizhang@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71701151, 71702130]; Research Program of
   Tianjin Municipal Science and Technology Development Strategy
   [18ZLZXZF00140]; Major Project of National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China (NSFC) [91646117];
   Major Project of National Social Science Foundation of China [18ZDA060]
FX This work was supported by National Natural Science Foundation of China
   [Grant Number 71701151, 71702130]; Research Program of Tianjin Municipal
   Science and Technology Development Strategy [Grant Number
   18ZLZXZF00140]; Major Project of National Natural Science Foundation of
   China [Grant Number 91646117]; Major Project of National Social Science
   Foundation of China [Grant Number 18ZDA060].
CR Al-Omoush KS, 2020, J INNOV KNOWL, V5, P279, DOI 10.1016/j.jik.2020.10.002
   Anastasiadou E, 2020, INT J SOCIOL SOC POL, V40, P893, DOI 10.1108/IJSSP-07-2020-0275
   Azadegan A, 2021, J SUPPLY CHAIN MANAG, V57, P17, DOI 10.1111/jscm.12256
   Bassett HR, 2021, WORLD DEV, V143, DOI 10.1016/j.worlddev.2021.105473
   Baveja A, 2020, ANN OPER RES, V289, P173, DOI 10.1007/s10479-020-03635-3
   BELHADI A, 2021, ANN OPERATIONS RES E
   Bharti K, 2015, INT J MARKET RES, V57, P571, DOI 10.2501/IJMR-2015-012
   Brakman Steven, 2020, Soc Sci Humanit Open, V2, P100034, DOI 10.1016/j.ssaho.2020.100034
   Brodie RJ, 2021, J SERV THEOR PRACT, V31, P225, DOI 10.1108/JSTP-07-2020-0178
   Burgos D, 2021, TRANSPORT RES E-LOG, V152, DOI 10.1016/j.tre.2021.102412
   Butt AS, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-11-2020-0455
   Cakir M, 2021, APPL ECON PERSPECT P, V43, P341, DOI 10.1002/aepp.13136
   Chen C, 2021, TRANSPORT RES E-LOG, V146, DOI 10.1016/j.tre.2020.102214
   Chen Dawei, 2020, Transp Res Interdiscip Perspect, V8, P100233, DOI 10.1016/j.trip.2020.100233
   Choi TM, 2020, TRANSPORT RES E-LOG, V140, DOI 10.1016/j.tre.2020.101961
   Chopra S, 2021, DECISION SCI, V52, P817, DOI 10.1111/deci.12526
   Chowdhury MT, 2020, OPER MANAGE RES, DOI 10.1007/s12063-020-00166-9
   Christopher M., 2000, SUPPLY CHAIN MANAG, V5, P206, DOI DOI 10.1108/13598540010347334
   Christopher M., 2004, INT J LOGIST MANAG, V15, P1, DOI [10.1108/09574090410700275, DOI 10.1108/09574090410700275]
   Craighead C.W., 2020, J SUPPLY CHAIN MANAG, V57, P1
   Crick JM, 2020, IND MARKET MANAG, V88, P206, DOI 10.1016/j.indmarman.2020.05.016
   de Sousa Jabbour A.B.L., 2020, MODERN SUPPLY CHAIN, DOI DOI 10.1108/MSCRA-05-2020-0011
   Dirk, 2020, J MANAGE STUD
   Doetzer M, 2021, INT J PHYS DISTR LOG, V51, P181, DOI 10.1108/IJPDLM-01-2020-0030
   Dohale V, 2022, INT J PHYS DISTR LOG, V52, P109, DOI 10.1108/IJPDLM-12-2020-0450
   Du HB, 2014, RENEW ENERG, V66, P696, DOI 10.1016/j.renene.2014.01.018
   Duan W, 2021, ADV PROD ENG MANAG, V16, P5, DOI 10.14743/apem2021.1.381
   Dubey R, 2021, IND MARKET MANAG, V96, P135, DOI 10.1016/j.indmarman.2021.05.003
   El Baz J, 2021, INT J PROD ECON, V233, DOI 10.1016/j.ijpe.2020.107972
   Eren E, 2021, COMPUT IND ENG, V157, DOI 10.1016/j.cie.2021.107328
   Esmat A., 2020, AGRIBUSINESS EARLY A
   Fasan M, 2021, BUS STRATEG ENVIRON, V30, P2702, DOI 10.1002/bse.2772
   Feng XJ, 2020, DECISION SCI, DOI 10.1111/deci.12494
   Fonseca LM, 2020, MANAG MARK, V15, P424, DOI 10.2478/mmcks-2020-0025
   Free C, 2021, ACCOUNT AUDIT ACCOUN, V34, P58, DOI 10.1108/AAAJ-06-2020-4634
   Friday D, 2021, J HUMANIT LOGIST SUP, V11, P248, DOI 10.1108/JHLSCM-07-2020-0061
   Ghadge A, 2021, INT J RETAIL DISTRIB, V49, P165, DOI 10.1108/IJRDM-04-2020-0127
   Goldsby T., 2006, J BUS LOGIST, V27, P57
   Govindan K, 2020, TRANSPORT RES E-LOG, V138, DOI 10.1016/j.tre.2020.101967
   Gray RS, 2020, CAN J AGR ECON, V68, P239, DOI 10.1111/cjag.12235
   Gulmez S, 2021, MARIT POLICY MANAG, DOI 10.1080/03088839.2021.1962557
   Gunessee S, 2020, INT J OPER PROD MAN, V40, P1201, DOI 10.1108/IJOPM-07-2019-0530
   Guo HD, 2021, CHINA AGR ECON REV, V13, P436, DOI 10.1108/CAER-06-2020-0146
   GUPTA V, 2021, OMEGA-J DEATH DYING, V101, P10279
   Habel J, 2020, IND MARKET MANAG, V88, P195, DOI 10.1016/j.indmarman.2020.05.015
   Haghani M, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104806
   Hajiagha SHR, 2021, OPER MANAGE RES, DOI 10.1007/s12063-021-00195-y
   Hall MC, 2021, J SERV MANAGE, V32, P113, DOI 10.1108/JOSM-05-2020-0151
   Handfield RB, 2020, INT J OPER PROD MAN, V40, P1649, DOI 10.1108/IJOPM-03-2020-0171
   Hao N, 2020, CHINA AGR ECON REV, V12, P459, DOI 10.1108/CAER-04-2020-0064
   Harland, 2020, J SUPPLY CHAIN MANAG, V57, P1
   Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664
   Hayes DJ, 2021, AGRIBUSINESS, V37, P122, DOI 10.1002/agr.21674
   He HW, 2020, J BUS RES, V116, P176, DOI 10.1016/j.jbusres.2020.05.030
   Hobbs JE, 2020, CAN J AGR ECON, V68, P171, DOI 10.1111/cjag.12237
   Hong JD, 2020, J HUMANIT LOGIST SUP, V10, P485, DOI 10.1108/JHLSCM-03-2020-0019
   Hossain MK, 2021, J BUS IND MARK, DOI 10.1108/JBIM-07-2020-0315
   Hosseini S, 2019, TRANSPORT RES E-LOG, V125, P285, DOI 10.1016/j.tre.2019.03.001
   Huang A, 2021, SERV IND J, V41, P138, DOI 10.1080/02642069.2020.1862092
   International Monetary Fund, 2020, GREAT LOCKD WORST EC
   IVANOV D, 2021, ANN OPER RES
   Ivanov D, 2021, OPER MANAGE RES, DOI 10.1007/s12063-021-00194-z
   Ivanov D, 2021, INT J PROD RES, V59, P3535, DOI 10.1080/00207543.2021.1890852
   Ivanov D, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-11-2020-0448
   Ivanov D, 2021, PROD PLAN CONTROL, V32, P775, DOI 10.1080/09537287.2020.1768450
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Ivanov D, 2020, INT J PROD RES, V58, P3252, DOI 10.1080/00207543.2019.1634850
   John J, 2021, EUR J MARKETING, V55, P1679, DOI 10.1108/EJM-08-2020-0607
   Ju YJ, 2021, IND MANAGE DATA SYST, V121, P364, DOI 10.1108/IMDS-08-2020-0445
   Kantar, 2020, CORONAVIRUS OUTBREAK
   Kapser S, 2021, TRANSPORT RES A-POL, V148, P183, DOI 10.1016/j.tra.2021.02.020
   KARWASRA K, 2021, INT J LOGIST-RES APP, P1
   Kerr WA, 2020, CAN J AGR ECON, V68, P225, DOI 10.1111/cjag.12230
   Koppenberg M, 2021, AGRIBUSINESS, V37, P25, DOI 10.1002/agr.21684
   Kovacs G, 2021, J SUPPLY CHAIN MANAG, V57, P41, DOI 10.1111/jscm.12253
   Kumar A, 2021, J HUMANIT LOGIST SUP, V11, P1, DOI 10.1108/JHLSCM-06-2020-0050
   Kumar P, 2021, INT J LOGIST-RES APP, DOI 10.1080/13675567.2021.1908524
   Laato S, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102224
   Lang LD, 2021, INT J LOGIST MANAG, DOI 10.1108/IJLM-01-2021-0039
   Larue B, 2020, CAN J AGR ECON, V68, P231, DOI 10.1111/cjag.12233
   Li T, 2020, J AIR TRANSP MANAG, V88, DOI 10.1016/j.jairtraman.2020.101875
   Li YH, 2021, EUR J OPER RES, V291, P1117, DOI 10.1016/j.ejor.2020.09.053
   Lin JB, 2020, DECIS SUPPORT SYST, V135, DOI 10.1016/j.dss.2020.113342
   Liu WJ, 2021, IMMUNOL INVEST, V50, P869, DOI 10.1080/08820139.2020.1787438
   Loske Dominic, 2020, Transp Res Interdiscip Perspect, V6, P100165, DOI 10.1016/j.trip.2020.100165
   Lowe N, 2020, ECON GEOGR, V96, P315, DOI 10.1080/00130095.2020.1812381
   Luckstead J, 2021, J AGR RESOUR ECON, V46, P189, DOI 10.22004/ag.econ.310519
   Magableh GM, 2021, EUR MANAG REV, V18, P363, DOI 10.1111/emre.12449
   Mao ZZ, 2021, COMPUT IND ENG, V158, DOI 10.1016/j.cie.2021.107386
   Marathe, 2021, TRANSP RES INTERDISC, V10
   Mashud AM, 2021, COMPUT IND ENG, V157, DOI 10.1016/j.cie.2021.107249
   Medel K, 2020, J HUMANIT LOGIST SUP, V10, P509, DOI 10.1108/JHLSCM-09-2019-0066
   Mehrolia S, 2021, INT J CONSUM STUD, V45, P396, DOI 10.1111/ijcs.12630
   Mehrotra S, 2020, NAV RES LOG, V67, P303, DOI 10.1002/nav.21905
   Mele C, 2021, J SERV THEOR PRACT, V31, P184, DOI 10.1108/JSTP-07-2020-0180
   Messina D, 2020, INT J LOGIST MANAG, V31, P489, DOI 10.1108/IJLM-11-2018-0294
   Milioti C, 2021, INT J RETAIL DISTRIB, V49, P281, DOI 10.1108/IJRDM-08-2019-0260
   Modgil S, 2022, INT J PHYS DISTR LOG, V52, P130, DOI 10.1108/IJPDLM-12-2020-0434
   Mollenkopf DA, 2021, J SERV MANAGE, V32, P190, DOI 10.1108/JOSM-05-2020-0143
   MONCH T, 2020, INT J PRODUCTION RES
   Mondal A, 2021, COMPUT IND ENG, V159, DOI 10.1016/j.cie.2021.107453
   Mor R.S., 2021, J ENTERPRISE INFORM
   MORETTO A, 2021, J PURCH SUPPLY MANAG
   Nagurney A, 2021, INT J PROD ECON, V235, DOI 10.1016/j.ijpe.2021.108080
   Nagurney A, 2021, EUR J OPER RES, V293, P880, DOI 10.1016/j.ejor.2020.12.054
   Nandi S, 2021, IND MANAGE DATA SYST, V121, P333, DOI 10.1108/IMDS-09-2020-0560
   NAYAL K, 2021, INT J LOGISTICS MANA
   Nikolopoulos K, 2021, EUR J OPER RES, V290, P99, DOI 10.1016/j.ejor.2020.08.001
   Nordhagen S, 2021, WORLD DEV, V141, DOI 10.1016/j.worlddev.2021.105405
   Norwood FB, 2021, APPL ECON PERSPECT P, V43, P412, DOI 10.1002/aepp.13125
   Nurunnabi M, 2020, J ACCOUNT ORGAN CHAN, V16, P643, DOI 10.1108/JAOC-07-2020-0095
   Oeser G, 2021, OPER MANAGE RES, V14, P78, DOI 10.1007/s12063-020-00171-y
   Omar NA, 2021, J RETAIL CONSUM SERV, V62, DOI 10.1016/j.jretconser.2021.102600
   Pantano E, 2020, J BUS RES, V116, P209, DOI 10.1016/j.jbusres.2020.05.036
   Parast MM, 2021, SUPPLY CHAIN MANAG, V26, P548, DOI 10.1108/SCM-07-2020-0313
   Paul SK, 2021, INT J PHYS DISTR LOG, V51, P104, DOI 10.1108/IJPDLM-04-2020-0127
   Praharsi Y, 2021, INT J LEAN SIX SIG, V12, P800, DOI 10.1108/IJLSS-11-2020-0196
   Prentice C, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102203
   Previero, 2021, NAV RES LOG
   Qin R, 2021, J OPER RES SOC, DOI 10.1080/01605682.2021.1897485
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Rahman T, 2021, COMPUT IND ENG, V158, DOI 10.1016/j.cie.2021.107401
   RANA RS, 2021, INT J LOGISTICS RES
   Rapaccini M, 2020, IND MARKET MANAG, V88, P225, DOI 10.1016/j.indmarman.2020.05.017
   Richards TJ, 2020, CAN J AGR ECON, V68, P189, DOI 10.1111/cjag.12231
   Rude J, 2020, CAN J AGR ECON, V68, P207, DOI 10.1111/cjag.12228
   Ruel S, 2021, ANN OPER RES, DOI 10.1007/s10479-021-03974-9
   Safara F, 2020, COMPUT ECON, DOI 10.1007/s10614-020-10069-3
   Sarkis J, 2021, INT J OPER PROD MAN, V41, P63, DOI 10.1108/IJOPM-08-2020-0568
   Sato Y, 2020, IND MANAGE DATA SYST, V120, P1617, DOI 10.1108/IMDS-01-2020-0049
   Sazvar Z, 2021, COMPUT IND ENG, V159, DOI 10.1016/j.cie.2021.107406
   Scala B, 2021, SUPPLY CHAIN MANAG, V26, P672, DOI 10.1108/SCM-09-2020-0434
   Schaltegger S, 2021, SUSTAIN ACCOUNT MANA, V12, P889, DOI 10.1108/SAMPJ-08-2020-0296
   Schaltegger S, 2014, SUPPLY CHAIN MANAG, V19, P232, DOI [10.1108/SCM-02-2014-0061, 10.1108/SCM-02-2014-0083]
   Schleper MC, 2021, INT J OPER PROD MAN, V41, P193, DOI 10.1108/IJOPM-12-2020-0837
   Shanker S, 2021, INT J LOGIST-RES APP, DOI 10.1080/13675567.2021.1893671
   Sharma A, 2020, J BUS RES, V117, P443, DOI 10.1016/j.jbusres.2020.05.035
   SHARMA M, 2021, J ENTERP INF MANAG
   Sharma M, 2020, INT J LOGIST-RES APP, DOI 10.1080/13675567.2020.1810213
   Sharma R, 2020, INT J LOGIST-RES APP, DOI 10.1080/13675567.2020.1830049
   SHARMA SK, 2021, ANN OPER RES, V247
   Sheng J, 2021, BRIT J MANAGE, V32, P1164, DOI 10.1111/1467-8551.12441
   Sherman E.., 2020, 94 FORTUNE 1000 ARE
   Sheth J, 2021, J BUS RES, V125, P780, DOI 10.1016/j.jbusres.2020.04.050
   Singh S, 2021, INT J PROD RES, V59, P1993, DOI 10.1080/00207543.2020.1792000
   Sodhi MS, 2021, INT J PROD RES, DOI 10.1080/00207543.2021.1884310
   Spina G, 2013, IND MARKET MANAG, V42, P1202, DOI 10.1016/j.indmarman.2013.04.001
   Sundarakani B, 2021, INT J LOGIST MANAG, V32, P357, DOI 10.1108/IJLM-12-2019-0333
   Swanson D, 2020, TRANSPORT J, V59, P325, DOI 10.5325/transportationj.59.4.0325
   THILMANY D, 2020, APPL EC PERSPECTIVES
   Tingey-Holyoak JL, 2021, SUSTAIN ACCOUNT MANA, V12, P898, DOI 10.1108/SAMPJ-07-2020-0258
   Tortorella G, 2021, J SERV THEOR PRACT, V31, P203, DOI 10.1108/JSTP-07-2020-0182
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   Vakil, 2020, HARVARD BUS REV
   van Hoek R, 2021, SUPPLY CHAIN MANAG, V26, P689, DOI 10.1108/SCM-09-2020-0498
   van Hoek R, 2020, J BUS LOGIST, V41, P334, DOI 10.1111/jbl.12266
   van Hoek R, 2020, INT J OPER PROD MAN, V40, P341, DOI 10.1108/IJOPM-03-2020-0165
   Wang D., 2020, 3608302 GEORG TECH S
   Wang YG, 2020, J BUS RES, V116, P214, DOI 10.1016/j.jbusres.2020.05.029
   Wang YB, 2020, CHINA AGR ECON REV, V12, P427, DOI 10.1108/CAER-04-2020-0053
   World Health Organisation, 2021, WHO COR DIS COVID 19
   Xiao H, 2020, ECON SYST RES, V32, P540, DOI 10.1080/09535314.2020.1783643
   Xu W, 2020, OPER RES-GER, DOI 10.1007/s12351-020-00609-y
   Yadav S, 2020, OPER MANAGE RES, DOI 10.1007/s12063-020-00164-x
   Yang J, 2021, INT J PROD RES, V59, P1573, DOI 10.1080/00207543.2020.1856958
   Yaprak U, 2021, TECHNOL FORECAST SOC, V169, DOI 10.1016/j.techfore.2021.120829
   Yaroson EV, 2021, SUPPLY CHAIN MANAG, V26, P323, DOI 10.1108/SCM-05-2019-0184
   Yi XJ, 2020, INT J LOGIST-RES APP, DOI 10.1080/13675567.2020.1856800
   Yin S, 2020, J IND INF INTEGR, V19, DOI 10.1016/j.jii.2020.100157
   YU Z, 2021, INT J LOGISTICS RES
   Yu Z, 2021, OPER MANAGE RES, DOI 10.1007/s12063-021-00179-y
   Zhang SR, 2020, CHINA AGR ECON REV, V12, P409, DOI 10.1108/CAER-04-2020-0055
   Zhang YC, 2021, INT J LOGIST-RES APP, DOI 10.1080/13675567.2021.1914566
NR 174
TC 1
Z9 1
U1 60
U2 60
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1367-5567
EI 1469-848X
J9 INT J LOGIST-RES APP
JI Int. J. Logist.-Res. Appl.
DI 10.1080/13675567.2021.1988909
EA OCT 2021
PG 30
WC Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA WH4AU
UT WOS:000707623600001
DA 2022-04-20
ER

PT J
AU Wahezi, DM
   Peskin, M
   Tanner, T
AF Wahezi, Dawn M.
   Peskin, Malki
   Tanner, Tamara
TI The impact of the COVID-19 pandemic on the field of pediatric
   rheumatology
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE COVID-19; multisystem inflammatory syndrome in children (MIS-C);
   pediatric rheumatic disease
ID JUVENILE IDIOPATHIC ARTHRITIS; CHILDREN; PREVALENCE; ANXIETY
AB Purpose of review The purpose of this review is to discuss the clinical management of children with pediatric rheumatic disease (PRD) during the Coronavirus disease of 2019 (COVID-19) pandemic, as well as the unique role of the pediatric rheumatologist during a time of emerging post-COVID inflammatory sequelae including, multisystem inflammatory syndrome in children (MIS-C). Recent findings To date, there has been little evidence to suggest that children with PRD, including those on immunomodulatory therapies, are at increased risk for severe COVID-19. Clinical guidance statements have been created to support clinical providers in providing care to children with PRD during the COVID-19 pandemic. Pediatric rheumatologists have also been called upon to assist in the identification and management of post-COVID sequelae, including the rapidly emerging inflammatory illness, MIS-C. The COVID-19 era has been defined by a rapid expansion in scientific knowledge and a time of extraordinary local and worldwide collaboration, both within the pediatric rheumatology community, as well as across multiple disciplines. Through collective efforts, we have learned that children with PRD, including those on immunomodulatory therapies, are not at increased risk for severe COVID-19. Pediatric rheumatologists have also worked alongside other disciplines to develop guidance for the management of MIS-C, with the majority of patients experiencing excellent clinical outcomes.
C1 [Wahezi, Dawn M.; Peskin, Malki; Tanner, Tamara] Childrens Hosp Montefiore, Albert Einstein Coll Med, Univ Hosp, Div Pediat Rheumatol, 3415 Bainbridge Ave, Bronx, NY 10467 USA.
RP Wahezi, DM (corresponding author), Childrens Hosp Montefiore, Albert Einstein Coll Med, Univ Hosp, Div Pediat Rheumatol, 3415 Bainbridge Ave, Bronx, NY 10467 USA.
EM dwahezi@montefiore.org
CR Akintayo RO, 2021, RHEUMATOLOGY, V60, P392, DOI 10.1093/rheumatology/keaa600
   Andina D, 2021, CLIN EXP DERMATOL, V46, P462, DOI 10.1111/ced.14483
   Balmuri N, 2020, PEDIATR RHEUMATOL, V18, DOI 10.1186/s12969-020-00477-y
   Batu ED, 2020, SEMIN ARTHRITIS RHEU, V50, P1262, DOI 10.1016/j.semarthrit.2020.09.008
   Bos WH, 2021, RHEUMATOL INT, V41, P565, DOI 10.1007/s00296-020-04771-6
   Bossa F, 2021, DIGEST LIVER DIS, V53, P277, DOI 10.1016/j.dld.2020.12.120
   Bower H, 2021, ANN RHEUM DIS, V80, P1086, DOI 10.1136/annrheumdis-2021-219845
   Brenner EJ, 2021, CLIN GASTROENTEROL H, V19, P394, DOI 10.1016/j.cgh.2020.10.010
   Calvo C, 2021, J RHEUMATOL, V48, P1190, DOI [10.3899/jrheum.201548.C1, 10.3899/jrheum.201548]
   Colmenero I, 2020, BRIT J DERMATOL, V183, P729, DOI 10.1111/bjd.19327
   Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]
   D'Arcangelo G, 2021, J PEDIATR GASTR NUTR, V72, P736, DOI 10.1097/MPG.0000000000003044
   Diorio C, 2020, J CLIN INVEST, V130, P5967, DOI 10.1172/JCI140970
   Elias Matthew D, 2020, CJC Open, V2, P632, DOI 10.1016/j.cjco.2020.09.004
   Fair DC, 2019, OPEN ACCESS RHEUMATO, V11, P237, DOI 10.2147/OARRR.S174408
   Feldstein LR, 2021, JAMA-J AM MED ASSOC, V325, P1074, DOI 10.1001/jama.2021.2091
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Gheita TA, 2020, RHEUMATOL INT, V40, P1599, DOI 10.1007/s00296-020-04655-9
   Gianfrancesco M, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-218328
   Gianfrancesco MA, 2021, ARTHRITIS RHEUMATOL, V73, P374, DOI 10.1002/art.41567
   Haslak F, 2020, RHEUMATOL INT, V40, P1423, DOI 10.1007/s00296-020-04645-x
   Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1791, DOI 10.1002/art.41454
   Hoste L, 2021, EUR J PEDIATR, V180, P2019, DOI 10.1007/s00431-021-03993-5
   Huang Yong, 2021, medRxiv, DOI 10.1101/2021.03.03.21252086
   Cuceoglu MK, 2021, ANN RHEUM DIS, V80, DOI [10.1136/annrheumdis-2020-218364, 10.1136/annrheumdis-2020-218341]
   Koschitzky M, 2021, CLIN DERMATOL, V39, P84, DOI 10.1016/j.clindermatol.2020.12.016
   Lee PY, 2020, J CLIN INVEST, V130, P5942, DOI 10.1172/JCI141113
   Li X, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.021101
   Lopez-Leon S., 2021, MEDRXIV, DOI [DOI 10.1101/2021.01.27.21250617, 10.1101/2021.01.27.21250617]
   Ludvigsson JF, 2021, ACTA PAEDIATR, V110, P914, DOI 10.1111/apa.15673
   Maguire S, 2021, IRISH J MED SCI, V190, P33, DOI 10.1007/s11845-020-02307-2
   Maldonado D, 2021, ARTHRIT CARE RES, V73, P1162, DOI 10.1002/acr.24531
   Marino A, 2020, SEMIN ARTHRITIS RHEU, V50, P1214, DOI 10.1016/j.semarthrit.2020.09.012
   Marlais M, 2021, ARCH DIS CHILD, V106, P798, DOI 10.1136/archdischild-2020-320616
   Naveen R, 2021, RHEUMATOL INT, V41, P67, DOI 10.1007/s00296-020-04737-8
   Ouldali N, 2021, JAMA-J AM MED ASSOC, V325, P855, DOI 10.1001/jama.2021.0694
   Penner J, 2021, LANCET CHILD ADOLESC, V5, P473, DOI 10.1016/S2352-4642(21)00138-3
   Quilter MC, 2019, LUPUS, V28, P878, DOI 10.1177/0961203319853621
   Rahimi H, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1236520
   Ramani SL, 2021, SKELETAL RADIOL, V50, P1763, DOI 10.1007/s00256-021-03734-7
   Schafer M, 2021, ANN RHEUM DIS, DOI 10.1136/annrheumdis-2021-220134
   Seyahi E, 2020, RHEUMATOL INT, V40, P1229, DOI 10.1007/s00296-020-04626-0
   Shakoory B, 2016, CRIT CARE MED, V44, P275, DOI 10.1097/CCM.0000000000001402
   Shenoi S, 2020, PEDIATR RHEUMATOL, V18, DOI 10.1186/s12969-020-00476-z
   Strangfeld A, 2021, ANN RHEUM DIS, V80, P930, DOI 10.1136/annrheumdis-2020-219498
   Turner D, 2020, J PEDIATR GASTR NUTR, V70, P727, DOI 10.1097/MPG.0000000000002729
   Wahezi DM, 2020, ARTHRITIS RHEUMATOL, V72, P1809, DOI 10.1002/art.41455
   Yildiz M, 2020, CLIN EXP RHEUMATOL, V38, P1271
NR 48
TC 0
Z9 0
U1 2
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8711
EI 1531-6963
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD SEP
PY 2021
VL 33
IS 5
BP 446
EP 452
DI 10.1097/BOR.0000000000000814
PG 7
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA TP7GK
UT WOS:000677763900010
PM 34175864
OA Green Published
DA 2022-04-20
ER

PT J
AU Nasr, S
AF Nasr, Shrief
TI Impact of COVID-19 on obstetric anesthesia: a systematic review
SO AIN SHAMS JOURNAL OF ANESTHESIOLOGY
LA English
DT Review
DE COVID-19; SARS-CoV-II; Obstetric anesthesia; Pregnancy; Practice
   recommendations
ID RECOMMENDATIONS; CARE
AB With an increase in Coronavirus Disease 2019 (Covid-19) incidents around the world, it has become more important than ever to be prepared for the uncertain context of labor and delivery in obstetrics. As medical staff did not encounter such a situation previously, no prior knowledge and guidelines were present to assist them. During the care of obstetric women infected with COVID-19 as well as those who are suspected of COVID-19 infection, there are two objectives, the care of asymptomatic to severely sick pregnant and postpartum women and preventing exposure of medical professionals and others during childbirth hospitalization. The focus of this review is to provide anesthesiologists who are dealing with infected pregnant mothers with some facts or, as data is insufficient, expert opinion, with an emphasis on awareness and optimal medical obstetric anesthesia training. This review will provide possible recommendations for the obstetric anesthesiologists when treating infected obstetric women and these recommendations also help anesthesia providers to prepare themselves for future pandemics.
C1 [Nasr, Shrief] Queen Elizabeth Hosp Kings Lynn, Dept Anesthesia, Kings Lynn, Norfolk, England.
   [Nasr, Shrief] Ain Shams Univ, Dept Anesthesia Intens Care & Pain Management, Fac Med, Cairo, Egypt.
RP Nasr, S (corresponding author), Queen Elizabeth Hosp Kings Lynn, Dept Anesthesia, Kings Lynn, Norfolk, England.; Nasr, S (corresponding author), Ain Shams Univ, Dept Anesthesia Intens Care & Pain Management, Fac Med, Cairo, Egypt.
EM Shrief2006@gmail.com
CR Alyamani O, 2020, SAUDI J ANAESTH, V14, P359, DOI 10.4103/sja.SJA_310_20
   [Anonymous], 2020, CRITICAL CARE ANAEST
   [Anonymous], 2020, CORONAVIRUS COVID 19
   Bampoe S, 2020, INT J OBSTET ANESTH, V43, P1, DOI 10.1016/j.ijoa.2020.04.006
   BAUER M, 2020, ANESTHESIA ANALGESIA, V40, P172, DOI DOI 10.1097/01.AOA.0000719436.64984.F6
   Bauer ME, 2020, ANESTH ANALG, V131, pE22, DOI 10.1213/ANE.0000000000004831
   Breslin N, 2020, AM J OBSTET GYNECOL, V2, P100118, DOI [DOI 10.1016/J.AJOGMF.2020.100118, 10.1016/j.ajogmf.2020.100118]
   Chan ANT, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2016259
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen R, 2020, CAN J ANESTH, V67, P655, DOI 10.1007/s12630-020-01630-7
   Cook TM, 2020, ANAESTHESIA, V75, P920, DOI 10.1111/anae.15071
   Hani DAB, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.925512
   Herman JA, 2020, J CLIN ANESTH, V65, DOI 10.1016/j.jclinane.2020.109860
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ismail S, 2020, J OBSTET ANAESTH CRI, V10, P65, DOI 10.4103/joacc.JOACC_50_20
   Kjaer, 2021, ANESTHESIA ANALGESIA
   Lee JSE, 2020, INT J OBSTET ANESTH, V43, P114, DOI 10.1016/j.ijoa.2020.04.003
   Melnick ER, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1924
   Mhyre JM, 2011, ANESTHESIOLOGY, V115, P963, DOI 10.1097/ALN.0b013e318233042d
   Moore, 2020, ANAESTHETIC MANAGEME
   Oxford-Horrey C, 2020, AM J PERINAT, V37, P1044, DOI [10.1055/s-0040-1713121, 10.1055/s-0040-1713121.]
   Perinatology SfOaAa, 2020, INT CONS OBST AN CAR
   Ring LE, 2020, SEMIN PERINATOL, V44, DOI 10.1016/j.semperi.2020.151277
   Shirodkar, 2019, ASS COMORBIDITIES OB, DOI [10.18203/2320-1770.ijrcog20193043, DOI 10.18203/2320-1770.IJRCOG20193043]
   Siddik-Sayyid S, 2020, MIDDLE EAST J ANESTH, V27, P145
   Song L, 2020, TRANSL PERIOPER PAIN, V7, P234, DOI DOI 10.31480/2330-4871/118
   Uppal V, 2020, PRACTICE RECOMMENDAT
   Wastnedge EAN, 2021, PHYSIOL REV, V101, P303, DOI 10.1152/physrev.00024.2020
   Yamakage M, 2021, J ANESTH, V35, P325, DOI 10.1007/s00540-020-02798-4
   Yerger P, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002974
   Zhao S, 2020, J CARDIOTHOR VASC AN, V34, P1125, DOI 10.1053/j.jvca.2020.02.039
   Zhong Q, 2020, BRIT J ANAESTH, V124, P670, DOI 10.1016/j.bja.2020.03.007
NR 32
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1687-7934
EI 2090-925X
J9 AIN SHAMS J ANESTHES
JI Ain Shams J. Anesthesiol.
PD NOV 2
PY 2021
VL 13
IS 1
AR 70
DI 10.1186/s42077-021-00188-w
PG 7
WC Anesthesiology
WE Emerging Sources Citation Index (ESCI)
SC Anesthesiology
GA WQ7ZJ
UT WOS:000714030400001
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Osman, DM
   Khalaf, FR
   Ahmed, GK
   Abdelbadee, AY
   Abbas, AM
   Mohammed, HM
AF Osman, Doaa Mohamed
   Khalaf, Fatma R.
   Ahmed, Gellan K.
   Abdelbadee, Ahmed Y.
   Abbas, Ahmed M.
   Mohammed, Heba M.
TI Worry from contracting COVID-19 infection and its stigma among Egyptian
   health care providers
SO JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION
LA English
DT Article
DE Health care providers; Egypt; Worry; Stigma; COVID-19
ID WORKERS; SARS; HIV/AIDS; STRESS
AB Backgrounds: Healthcare providers (HCPs) in COVID-19 epidemic face stressful workload of disease management, shortage of protective equipment and high risk of infection and mortality. These stressors affect greatly their mental health. The aim is to identify working conditions among Egyptian HCPs during COVID-19 epidemic as well as stigma and worry perceptions from contracting COVID-19 infection and their predictors.
   Methods: A cross-sectional study was conducted among 565 HCPs. Data was collected through Google online self-administered questionnaire comprised seven parts: demographics characteristics, knowledge and attitude of COVID-19, working condition, worry of contracting COVID-19 at work, discrimination intention at work for COVID-19 patients, stigma assessment using impact stigma, and internalized shame scales.
   Results: The vast majority of HCPs (94.7%) were worried from contracting COVID-19 at work. Risk factors for perceiving severe worry from contracting COVID-19 were expecting infection as a severe illness, believing that infection will not be successfully controlled, improbability to continue working during the pandemic even if in a well/fit health, high discrimination intention and impact stigma scales. Significantly high impact stigma scores were detected among those aged < 30 years, females, workers primarily in sites susceptible for contracting COVID-19 infection, those had severe worry from contracting infection at work, and high internalized shame scale. The risk factors for perceiving higher internalized shame scores were not having a previous experience in working during a pandemic, high discrimination intention towards COVID-19 patients and high impact stigma scale.
   Conclusions: Considerable levels of worry and stigma were detected among Egyptian HCPs during COVID-19 outbreak The psychological aspect of health care providers should not be overlooked during epidemic; appropriate institutional mental health support should be provided especially for young HCPs, those without previous work experience in epidemic and those who work in high-risk units. Raising the community awareness about contribution of HCPs in fighting the epidemic might decrease stigmatization action toward HCPs.
C1 [Osman, Doaa Mohamed; Mohammed, Heba M.] Assiut Univ, Fac Med, Dept Publ Hlth & Community Med, Assiut, Egypt.
   [Khalaf, Fatma R.] Assiut Univ, Fac Nursing, Family & Community Hlth Nursing, Assiut, Egypt.
   [Ahmed, Gellan K.] Assiut Univ, Fac Med, Dept Neurol & Psychiat, Assiut, Egypt.
   [Ahmed, Gellan K.] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London, England.
   [Abdelbadee, Ahmed Y.; Abbas, Ahmed M.] Assiut Univ, Fac Med, Dept Obstet & Gynecol, Assiut, Egypt.
RP Osman, DM (corresponding author), Assiut Univ, Fac Med, Dept Publ Hlth & Community Med, Assiut, Egypt.
EM doaamouhammed@aun.edu.eg
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Ahmad Junaid, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.438
   Ahmed J, 2020, CUREUS, V12, DOI 10.7759/cureus.8550
   Albahri AH, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.617679
   ALdowyan N., 2017, INT ARCHIV MED, V10, P1, DOI [10.3823/2524sph.2016.15012016330, DOI 10.3823/2524SPH.2016.15012016330, DOI 10.3823/2524]
   Ataro Z, 2020, PSYCHOL RES BEHAV MA, V13, P1191, DOI 10.2147/PRBM.S283969
   Badrfam R, 2020, ARCH MED RES, V51, P593, DOI 10.1016/j.arcmed.2020.05.006
   Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055
   Barbisch D, 2015, DISASTER MED PUBLIC, V9, P547, DOI 10.1017/dmp.2015.38
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Bruns DP, 2020, J TRANSCULT NURS, V31, P326, DOI 10.1177/1043659620917724
   Cook TM, 2020, ANAESTHESIA, V75, P920, DOI 10.1111/anae.15071
   Deressa W, 2021, ARCH PUBLIC HEALTH, V79, DOI 10.1186/s13690-021-00668-3
   Deressa W, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0242471
   Engelbrecht M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4115-z
   Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028
   Kapata N, 2020, INT J INFECT DIS, V93, P233, DOI 10.1016/j.ijid.2020.02.049
   Kwaghe AV, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06835-0
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Li L, 2007, AIDS CARE, V19, P258, DOI 10.1080/09540120600828473
   Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032
   Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125
   Livingston E, 2020, JAMA-J AM MED ASSOC, V323, P1912, DOI 10.1001/jama.2020.5317
   Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936
   Lu YC, 2006, PSYCHOTHER PSYCHOSOM, V75, P370, DOI 10.1159/000095443
   Martin-Delgado J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242185
   Mohsin SF, 2021, INQUIRY-J HEALTH CAR, V58, DOI 10.1177/00469580211025225
   Mostafa A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244172
   Occupational Safety and Health Administration (OSHA), COVID 19 CONTR PREV
   Pellecchia U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143036
   ProMED, 2020, PRO AH EDR COVID 19
   REDcap, COVID 19 QUEST AR VE
   Sahashi Y, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-021-00716-x
   Sim MR, 2020, OCCUP ENVIRON MED, V77, P281, DOI 10.1136/oemed-2020-106567
   Stein JA, 2008, AIDS BEHAV, V12, P789, DOI 10.1007/s10461-007-9339-z
   Tam CWC, 2004, PSYCHOL MED, V34, P1197, DOI 10.1017/S0033291704002247
   Lima CKT, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112915
   Taylor S, 2020, J ANXIETY DISORD, V75, DOI 10.1016/j.janxdis.2020.102289
   Tegegne GT, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.606666
   WHO, 2020, NOV COR 2019 NCOV SI
   WHO, 2020, MENT HLTH PSYCH CONS, P1
   WHO, 2020, KEEP HLTH WORK SAF
   World Health Organization, 2020, RAT US PERS PROT EQ
   World Health Organization, 2020, MENT HLTH COVID 19
   Yufika A, 2021, DISASTER MED PUBLIC, DOI 10.1017/dmp.2021.93
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 47
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
EI 2090-262X
J9 J EGYPT PUBLIC HEAL
JI J. Egypt Public Health Assoc.
PD JAN 10
PY 2022
VL 97
IS 1
AR 2
DI 10.1186/s42506-021-00099-6
PG 10
WC Public, Environmental & Occupational Health
WE Emerging Sources Citation Index (ESCI)
SC Public, Environmental & Occupational Health
GA YE2SF
UT WOS:000740979400001
PM 35006408
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Fontanari, M
   Traskevich, A
AF Fontanari, Martin
   Traskevich, Anastasia
TI Smart-Solutions for Handling Overtourism and Developing Destination
   Resilience for the Post-Covid-19 Era
SO TOURISM PLANNING & DEVELOPMENT
LA English
DT Article; Early Access
DE Destination resilience; sustainable development; overtourism;
   digitalisation; post-Covid-19
ID TOURISM DESTINATIONS; COMMUNITY RESILIENCE; OVER-TOURISM; CO-CREATION;
   ANALYTICS; LESSONS; VULNERABILITY; FOUNDATIONS; PERSPECTIVE; SERVICES
AB The article addresses perspectives to mitigate overtourism through introduction of the integrative concept of destination resilience and its innovative implementation with the help of smart-solutions applied to management of Covid-19-related risks, as well as to overall destination governance, regionally-based networking, destination infrastructure and entrepreneurial resilience for tourism businesses. This solution is justified through empirical study based on 104 expert-discussions (research sample is in Europe) which were implemented under the methodology of Delphi-analysis. The results of the study appeal to the idea of integrative application of intelligent solutions within tourism cooperative networks and destination governance. The research contributes to resilience knowledge in tourism with the model of application of smart-technologies to prevent overtourism and to develop destination resilience in the post-Covid-19 era. The research argues that the technology-driven application of multidimensional resilience knowledge represents a way of overcoming the impacts of mass-tourism for meaningful life of local communities and tourists.
C1 [Fontanari, Martin] Int Sch Management ISM, Cologne, Germany.
   [Traskevich, Anastasia] Belarusian State Econ Univ, Minsk, BELARUS.
RP Fontanari, M (corresponding author), Int Sch Management ISM, Cologne, Germany.
EM anastasia.traskevich@akalem.de
CR Aliperti G, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102803
   Arbulu I, 2021, J DESTIN MARK MANAGE, V20, DOI 10.1016/j.jdmm.2021.100568
   Bain & Company, 2018, LAB 2030 COLL DEM AU
   Bec A, 2016, CURR ISSUES TOUR, V19, P431, DOI 10.1080/13683500.2015.1083538
   Bethune E, 2022, J DESTIN MARK MANAGE, V23, DOI 10.1016/j.jdmm.2021.100687
   Boes K, 2016, INT J TOUR CITIES, V2, P108, DOI 10.1108/IJTC-12-2015-0032
   Buhalis D, 2020, TOUR REV, V75, P267, DOI 10.1108/TR-06-2019-0258
   Buhalis D, 2019, J SERV MANAGE, V30, P484, DOI 10.1108/JOSM-12-2018-0398
   Buhalis D, 2019, J TRAVEL TOUR MARK, V36, P563, DOI 10.1080/10548408.2019.1592059
   Buhalis D, 2015, J DESTIN MARK MANAGE, V4, P151, DOI 10.1016/j.jdmm.2015.04.001
   Bulchand-Gidumal J, 2022, J DESTIN MARK MANAGE, V23, DOI 10.1016/j.jdmm.2022.100689
   Bustard JRT, 2019, TOUR REV, V74, P116, DOI 10.1108/TR-10-2017-0156
   Butler RW, 2022, TOUR REV, V77, P35, DOI 10.1108/TR-04-2021-0215
   Butler RW, 2017, TOURISM AND RESILIENCE, P1, DOI 10.1079/9781780648330.0000
   Calgaro E, 2014, J SUSTAIN TOUR, V22, P341, DOI 10.1080/09669582.2013.826229
   Carvache-Franco O, 2022, TOUR HOSP RES, V22, P32, DOI 10.1177/1467358421993882
   Cheer JM, 2019, J SUSTAIN TOUR, V27, P554, DOI 10.1080/09669582.2019.1578363
   Coca-Stefaniak JA, 2019, INT J TOUR CITIES, V5, P513, DOI 10.1108/IJTC-12-2019-163
   Contu G., 2019, International Journal of Tourism Policy, V9, P99, DOI 10.1504/IJTP.2019.102627
   Cornelisse M, 2020, TOUR PLAN DEV, V17, P404, DOI 10.1080/21568316.2019.1622591
   Del Chiappa G, 2015, J DESTIN MARK MANAGE, V4, P145, DOI 10.1016/j.jdmm.2015.02.001
   Dieck MCT, 2017, J DESTIN MARK MANAGE, V6, P110, DOI 10.1016/j.jdmm.2017.03.002
   Dodds R., 2019, OVERTOURISM ISSUES R
   Elshaer AM, 2022, TOUR RECREAT RES, DOI 10.1080/02508281.2022.2027203
   Espiner S, 2017, J SUSTAIN TOUR, V25, P1385, DOI 10.1080/09669582.2017.1281929
   Femenia-Serra F, 2019, TOUR REV, V74, P63, DOI 10.1108/TR-02-2018-0018
   Filimonau V, 2020, INT J TOUR RES, V22, P202, DOI 10.1002/jtr.2329
   Fontanari M., 2021, International Journal of Tourism Policy, V11, P161, DOI 10.1504/IJTP.2021.117375
   Fontanari M., 2021, Issues and cases of degrowth in tourism, P22, DOI 10.1079/9781789245073.0022
   Fontanari M., 2022, Mendeley Data, VV1, DOI 10.17632/6v6ht5mcvg.1
   Fontanari M., 2021, RESILIENCE SUSTAINAB, P77
   Fyall A, 2012, J DESTIN MARK MANAGE, V1, P10, DOI 10.1016/j.jdmm.2012.10.002
   Gajdosik T, 2021, TOUR REV, V76, P47, DOI 10.1108/TR-07-2019-0285
   Garcia A, 2019, TOUR REV, V74, P30, DOI 10.1108/TR-08-2017-0131
   Glaesser D., 2003, CRISIS MANAGEMENT TO
   Goodwin H, 2021, INT J TOUR CITIES, V7, P916, DOI 10.1108/IJTC-02-2021-0024
   Goodwin H, 2019, DE GRU STUD TOURISM, V1, P125, DOI 10.1515/9783110607369-009
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Grant M., 2004, TOURISM HOSPITALITY, V1, P219, DOI [https://doi.org/10.1080/1479053042000306493, DOI 10.1080/1479053042000306493]
   Gretzel U, 2022, EUR J TOUR RES, V30
   Gretzel U, 2020, INF TECHNOL TOUR, V22, P187, DOI 10.1007/s40558-020-00181-3
   Gretzel U, 2019, DE GRU STUD TOURISM, V1, P62, DOI 10.1515/9783110607369-005
   Gretzel U, 2018, TOUR REV INT, V22, P263, DOI 10.3727/154427218X15369305779065
   Gretzel U, 2018, INVESTIG REG, P171
   Gretzel U, 2015, ELECTRON MARK, V25, P179, DOI 10.1007/s12525-015-0196-8
   Guiver J, 2014, J DESTIN MARK MANAGE, V3, P140, DOI 10.1016/j.jdmm.2013.11.005
   Gurtner Y, 2016, J HOSP TOUR MANAG, V28, P11, DOI 10.1016/j.jhtm.2016.04.007
   Hall C.M., 2018, TOURISM RESILIENCE I
   Hall CM, 2020, TOURISM GEOGR, V22, P577, DOI 10.1080/14616688.2020.1759131
   Hammond M., 2013, RES METHODS KEY CONC
   Higgins-Desbiolles F, 2020, TOURISM GEOGR, V22, P610, DOI 10.1080/14616688.2020.1757748
   Holladay PJ, 2018, TOUR REV INT, V22, P251, DOI 10.3727/154427218X15369305779029
   Ioannides D, 2020, TOURISM GEOGR, V22, P624, DOI 10.1080/14616688.2020.1763445
   Jiang S, 2022, CURR ISSUES TOUR, DOI 10.1080/13683500.2022.2026303
   Jiang YW, 2019, INT J TOUR RES, V21, P882, DOI 10.1002/jtr.2312
   Jiang YaWei, 2018, Strategic management in tourism, P264, DOI 10.1079/9781786390240.0264
   Joppe M, 2019, DE GRU STUD TOURISM, V1, P250, DOI 10.1515/9783110607369-017
   Kirilenko AP, 2021, J TRAVEL RES, DOI 10.1177/00472875211064635
   Koens K, 2021, J DESTIN MARK MANAGE, V19, DOI 10.1016/j.jdmm.2019.100376
   Koens K, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124384
   Kuo HI, 2008, TOURISM MANAGE, V29, P917, DOI 10.1016/j.tourman.2007.10.006
   Lai H.K., 2020, HDB RES IMPACTS CHAL, P75
   Leung R, 2019, TOUR REV, V74, P50, DOI 10.1108/TR-09-2017-0149
   Lew AA, 2020, TOURISM GEOGR, V22, P455, DOI 10.1080/14616688.2020.1770326
   Li SCH, 2017, J DESTIN MARK MANAGE, V6, P95, DOI 10.1016/j.jdmm.2017.04.008
   Lindberg F., 2021, OVERTOURISM DESTINAT, P129
   Lu PW, 2013, CITIES, V35, P200, DOI 10.1016/j.cities.2013.06.001
   Marine-Roig E, 2015, J DESTIN MARK MANAGE, V4, P162, DOI 10.1016/j.jdmm.2015.06.004
   Milano C., 2019, OVERTOURISM EXCESSES
   Milano C, 2022, CURR ISSUES TOUR, V25, P219, DOI 10.1080/13683500.2021.1908967
   Milano C, 2019, TOUR PLAN DEV, V16, P353, DOI 10.1080/21568316.2019.1599604
   Mizrachi I, 2020, INF TECHNOL TOUR, V22, P489, DOI 10.1007/s40558-020-00192-0
   Mo Koo， Chul, 2016, Asia Pacific Journal of Information Systems, V26, P561, DOI 10.14329/apjis.2016.26.4.561
   Gonzalez VM, 2018, TOUR REV, V73, P277, DOI [10.1108/tr-08-2017-0138, 10.1108/TR-08-2017-0138]
   Nadeau J, 2022, TOUR HOSP RES, V22, P60, DOI 10.1177/14673584211038317
   Nagai H, 2018, J DESTIN MARK MANAGE, V9, P377, DOI 10.1016/j.jdmm.2018.02.001
   Namberger P, 2019, TOUR PLAN DEV, V16, P452, DOI 10.1080/21568316.2019.1595706
   Niederberger M., 2018, GRUPPENDELPHI VERFAH
   Niewiadomski P, 2020, TOURISM GEOGR, V22, P651, DOI 10.1080/14616688.2020.1757749
   Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006
   O' Regan M, 2022, TOUR REV, V77, P54, DOI 10.1108/TR-12-2020-0594
   Oggionni T, 2018, J DESTIN MARK MANAGE, V9, P85, DOI 10.1016/j.jdmm.2017.11.003
   Oklevik O, 2019, J SUSTAIN TOUR, V27, P1804, DOI 10.1080/09669582.2018.1533020
   Orden-Mejia M, 2021, CURR ISSUES TOUR, DOI 10.1080/13683500.2021.1997942
   Panayiotopoulos A, 2019, TOUR PLAN DEV, V16, P393, DOI 10.1080/21568316.2019.1569123
   Paskova M, 2021, J DESTIN MARK MANAGE, V21, DOI 10.1016/j.jdmm.2021.100638
   Pechlaner H, 2020, CONTEMP GEOGR LEIS T, P1
   Pechlaner H, 2019, INT J TOUR CITIES, V5, P146, DOI 10.1108/IJTC-12-2017-0093
   Pechlaner H, 2018, CONTEMP GEOGR LEIS T, P3
   Pillmayer M., 2021, INFORM COMMUNICATION, P517
   Pocinho M., 2021, Bulletin of the Transilvania University of Brasov, Series V - Economic Sciences, V14, P51, DOI 10.31926/but.es.2021.14.63.1.5
   Powell RB, 2018, TOUR PLAN DEV, V15, P436, DOI 10.1080/21568316.2017.1338202
   Preedy V. R., 2010, HDB DIS BURDENS QUAL
   Reif J, 2020, J DESTIN MARK MANAGE, V18, DOI 10.1016/j.jdmm.2020.100481
   Rickly JM, 2019, DE GRU STUD TOURISM, V1, P46, DOI 10.1515/9783110607369-004
   Ritchie BW, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102812
   Rodrigues P., 2022, BUSINESS CRISIS, V3, P157
   Romao J, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102995
   Santana-Jimenez Y, 2011, TOURISM MANAGE, V32, P415, DOI 10.1016/j.tourman.2010.03.013
   Sausmarez N., 2004, TOURISM HOSPITALITY, V1, P157, DOI [https://doi.org/10.1080/1479053042000251070, DOI 10.1080/1479053042000251070]
   Seraphin H, 2019, J HOSP TOUR MANAG, V38, P1, DOI 10.1016/j.jhtm.2018.11.003
   Seraphin H, 2018, J DESTIN MARK MANAGE, V9, P374, DOI 10.1016/j.jdmm.2018.01.011
   Shafiee S, 2021, TOUR REV, V76, P505, DOI 10.1108/TR-06-2019-0235
   Shafiee S, 2019, TOUR MANAG PERSPECT, V31, P287, DOI 10.1016/j.tmp.2019.06.002
   Sharma GD, 2021, TOUR MANAG PERSPECT, V37, DOI 10.1016/j.tmp.2020.100786
   Sharpley R., 2022, HDB TOURIST EXPERIEN
   Sharpley R, 2012, TOUR RECREAT RES, V37, P257, DOI 10.1080/02508281.2012.11081714
   Sheller M, 2021, J SUSTAIN TOUR, V29, P1436, DOI 10.1080/09669582.2020.1791141
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Singh T, 2018, TOUR RECREAT RES, V43, P415, DOI 10.1080/02508281.2018.1513890
   Smith MK, 2019, TOUR PLAN DEV, V16, P376, DOI 10.1080/21568316.2019.1595705
   Suhartanto D, 2021, TOUR RECREAT RES, DOI 10.1080/02508281.2021.1974274
   Supak S, 2015, J DESTIN MARK MANAGE, V4, P173, DOI 10.1016/j.jdmm.2015.05.002
   Traskevich A., 2018, International Journal of Spa and Wellness, V1, P193, DOI 10.1080/24721735.2019.1596656
   Traskevich A, 2021, TOUR PLAN DEV, DOI 10.1080/21568316.2021.1894599
   Tung VWS, 2020, TOUR REV, V75, P283, DOI 10.1108/TR-05-2019-0180
   Vieira ACL, 2020, OMEGA-INT J MANAGE S, V94, DOI 10.1016/j.omega.2019.03.005
   Vorgrimler D., 2003, WIRTSCHAFT STATISTIK, V8, P763
   Wall G, 2020, TOUR REV, V75, P212, DOI 10.1108/TR-08-2019-0356
   Wall G, 2019, DE GRU STUD TOURISM, V1, P27, DOI 10.1515/9783110607369-003
   Wall G, 2018, TOUR RECREAT RES, V43, P390, DOI 10.1080/02508281.2018.1475880
   Wang J, 2020, J DESTIN MARK MANAGE, V15, DOI 10.1016/j.jdmm.2019.100383
   Wen J, 2021, TOUR RECREAT RES, V46, P310, DOI 10.1080/02508281.2020.1761120
   Wut TM, 2021, TOURISM MANAGE, V85, DOI 10.1016/j.tourman.2021.104307
   Xiang Z, 2015, J DESTIN MARK MANAGE, V4, P143, DOI 10.1016/j.jdmm.2015.07.001
   Yen MY, 2014, J HOSP INFECT, V87, P185, DOI 10.1016/j.jhin.2014.05.005
   Ying TY, 2021, TOUR RECREAT RES, V46, P304, DOI 10.1080/02508281.2020.1743048
   Yung R, 2021, CURR ISSUES TOUR, V24, P1505, DOI 10.1080/13683500.2020.1820454
   Zhang HY, 2021, ANN TOURISM RES, V87, DOI 10.1016/j.annals.2021.103149
NR 129
TC 0
Z9 0
U1 2
U2 2
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2156-8316
EI 2156-8324
J9 TOUR PLAN DEV
JI Tour. Plan. Dev.
DI 10.1080/21568316.2022.2056234
EA MAR 2022
PG 22
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA 0A2BX
UT WOS:000773766200001
DA 2022-04-20
ER

PT J
AU Fares, N
   Lloret, J
AF Fares, Naila
   Lloret, Jaime
TI An integrated SWOT-AHP-fuzzy TOPSIS approach for maturity management
   following the COVID-19 outbreak: lessons learned from fast fashion
SO JOURNAL OF GLOBAL OPERATIONS AND STRATEGIC SOURCING
LA English
DT Article; Early Access
DE SWOT-AHP; Fuzzy-TOPSIS; Maturity; Agility factors; COVID-19; Resilience
   management; Fast fashion
ID SUPPLY CHAIN AGILITY; RESILIENCE; PERFORMANCE; RISK; CAPABILITIES;
   STRATEGIES; FRAMEWORK; BARRIERS; ENABLERS; SMES
AB Purpose Focussing on issues that have impacted textiles, clothing and fast fashion following the COVID-19 outbreak, this study aims to identify agility factors pertinent to retail maturity management, mainly on resilience. These factors were then assessed based on priority.
   Design/methodology/approach The authors conducted a strengths, weaknesses, opportunities and threats (SWOT) analysis to identify the main factors. This analysis was integrated with the analytic hierarchy process to rank the internal and external factors. Then, the authors used fuzzy technique for order of preference by similarity to the ideal solution to evaluate the significant strategies from the SWOT analysis based on adaptability and flexibility. Thus, the authors produced a prioritised list of relevant factors and guidelines useful in practical settings.
   Findings The authors identified and ranked 14 agility and resilience SWOT factors for maturity management and proposed and prioritised six relevant strategies. These highlighted changes and adaptations must be undertaken by various actors, ranging from the supply/manufacturing side to global retail locations.
   Research limitations/implications The sampling study of experts is limited, and the application is focussed on one area. Future research might investigate other fields, for retail and industry.
   Practical implications The output of this study enables a better understanding of the internal and external factors of maturity management for fast-fashion retailers. Hence, it will further help them go through resilience and agility challenges following the pandemic.
   Originality/value This study significantly contributes to the literature because the results can guide retailers in developing effective decision-making systems for mature business operations following the pandemic outbreak. Here, the authors incorporate internal, external, agility and resilience aspects into one decision-making support system while enhancing existing knowledge on fuzzy multi-criteria decision-making applications. Further, this study discusses critical issues that have affected several aspects of the fashion and textile industry and will likely persist for some time.
C1 [Fares, Naila; Lloret, Jaime] Univ Politecn Valencia, Integrated Management Costal Res Inst, Campus Gandia, Gandia, Spain.
RP Fares, N (corresponding author), Univ Politecn Valencia, Integrated Management Costal Res Inst, Campus Gandia, Gandia, Spain.
EM naila.fares@gmail.com
RI Lloret, Jaime/H-3994-2013
OI Lloret, Jaime/0000-0002-0862-0533
CR Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974
   Al Humdan E, 2020, INT J PHYS DISTR LOG, V50, P287, DOI 10.1108/IJPDLM-06-2019-0192
   Ali A, 2017, SUPPLY CHAIN MANAG, V22, P16, DOI 10.1108/SCM-06-2016-0197
   Ali B., 2020, EC STUDIES J, V18, P267
   Ali I, 2019, INT J PHYS DISTR LOG, V49, P793, DOI 10.1108/IJPDLM-02-2019-0038
   Ali I, 2017, PROD PLAN CONTROL, V28, P1236, DOI 10.1080/09537287.2017.1362487
   Ali MH, 2021, TRENDS FOOD SCI TECH, V109, P94, DOI 10.1016/j.tifs.2021.01.021
   Ambros M, 2021, APPL ECON LETT, V28, P1686, DOI 10.1080/13504851.2020.1851643
   Artusi E, 2021, PROMOTING FRONTEND B
   Atayah OF, 2021, J GLOB OPER STRATEG, DOI 10.1108/JGOSS-03-2021-0028
   Baba IA, 2021, RESULTS PHYS, V20, DOI 10.1016/j.rinp.2020.103716
   Badulescu Y., 2021, J GLOB OPER STRATEG, DOI [10.1108/JGOSS-11-2020-0069, DOI 10.1108/JGOSS-11-2020-0069]
   Barton MA, 2020, BMJ LEAD, V4, P117, DOI 10.1136/leader-2020-000260
   Belhadi A, 2021, TECHNOL FORECAST SOC, V163, DOI 10.1016/j.techfore.2020.120447
   Belhadi A, 2019, INT J LEAN SIX SIG, V10, P803, DOI 10.1108/IJLSS-12-2016-0078
   Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891
   Blome C, 2013, INT J PROD RES, V51, P1295, DOI 10.1080/00207543.2012.728011
   Burgos D, 2021, TRANSPORT RES E-LOG, V152, DOI 10.1016/j.tre.2021.102412
   Chakraborty Samit, 2020, J SUPPLY CHAIN MANAG, V3, P181
   Chang TS, 2021, J RETAIL CONSUM SERV, V62, DOI 10.1016/j.jretconser.2021.102613
   Chen T, 2020, INT J ADV MANUF TECH, V111, P3545, DOI 10.1007/s00170-020-06097-w
   Choi Yeong-Hyeon, 2020, [The Research Journal of the Costume Culture, 복식문화연구], V28, P285, DOI 10.29049/rjcc.2020.28.3.285
   Christopher M, 2000, IND MARKET MANAG, V29, P37, DOI 10.1016/S0019-8501(99)00110-8
   Christopher M., 2000, SUPPLY CHAIN MANAG, V5, P206, DOI [10.1108/13598540010347334, DOI 10.1108/13598540010347334]
   Dawes J, 2019, DEV AGILITY QUICKNES
   Dinesh S., 2021, INT J RES GRANTHAALA, V9, P123, DOI [10.29121/granthaalayah.v9.i1.2021.3032, DOI 10.29121/GRANTHAALAYAH.V9.I1.2021.3032]
   Ding D, 2020, BRIT J SPORT MED, V54, P1183, DOI 10.1136/bjsports-2020-102575
   Elavarasan RM, 2020, ENERGY REP, V6, P1838, DOI 10.1016/j.egyr.2020.07.007
   Faisal M N, 2007, International Journal of Agile Systems and Management, V2, P76
   Forbes S, 2020, MANAGING EMPLOYEES C
   Fuzeki E, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13147677
   Galanakis CM, 2021, TRENDS FOOD SCI TECH, V110, P193, DOI 10.1016/j.tifs.2021.02.002
   Gligor D, 2019, INT J LOGIST MANAG, V30, P467, DOI 10.1108/IJLM-10-2017-0259
   Godinic D., 2020, INT J INNOV EC DEV, V6, P61, DOI DOI 10.18775/IJIED.1849-7551-7020.2015.61.2005
   Gogoi N, 2021, INFLUENCE COVID 19 P
   Goh Y, 2020, J AM COLL RADIOL, V17, P717, DOI 10.1016/j.jacr.2020.03.027
   Golan Maureen S., 2020, Environment Systems & Decisions, V40, DOI 10.1007/s10669-020-09777-w
   Golgeci I, 2020, PERS REV, V49, P733, DOI 10.1108/PR-12-2018-0507
   Grela G, 2021, J GLOB OPER STRATEG, DOI 10.1108/JGOSS-06-2020-0029
   Hajli N, 2020, IND MARKET MANAG, V86, DOI 10.1016/j.indmarman.2019.09.010
   Hasan S.A, 2011, NEW ARTICLE CLOTHING
   He LN, 2021, INT J PROD RES, V59, P1714, DOI 10.1080/00207543.2020.1724343
   Hernandez DF, 2018, J GLOB OPER STRATEG, V11, P250, DOI 10.1108/JGOSS-09-2017-0037
   Huang M, 2020, ELECTRON COMMER R A, V41, DOI 10.1016/j.elerap.2020.100977
   Ilmiah D., 2021, EKBIS JURNAL EKONOMI, V5, P515
   Iriani SS, 2021, J ASIAN FINANC ECON, V8, P939, DOI 10.13106/jafeb.2021.vol8.no4.0939
   Ivanov Dmitry, 2020, International Journal of Integrated Supply Management, V13, P90
   Ivanov Dmitry, 2021, Int J Prod Econ, V232, P107921, DOI 10.1016/j.ijpe.2020.107921
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Jalkanen P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24285-4
   Jia P, 2021, APPETITE, V158, DOI 10.1016/j.appet.2020.105015
   Johnson JE, 2021, J GLOB OPER STRATEG, V14, P701, DOI 10.1108/JGOSS-12-2020-0074
   Jordan RE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1198
   Kamalahmadi M, 2016, INT J PROD ECON, V171, P116, DOI 10.1016/j.ijpe.2015.10.023
   Kaur K., 2021, MANAGEMENT LABOUR ST, V46, DOI 10.1177%2F0258042X21991018
   Khemiri R, 2017, INT J PROD RES, V55, P5305, DOI 10.1080/00207543.2017.1308575
   Kumar P, 2021, INT J LOGIST-RES APP, DOI 10.1080/13675567.2021.1908524
   Li T, 2021, TRANSPORT POLICY, V106, P226, DOI 10.1016/j.tranpol.2021.04.009
   Lin CT, 2006, INT J PROD ECON, V100, P285, DOI 10.1016/j.ijpe.2004.11.013
   Liu J., 2021, INFOR, V59, P232
   Majercakova M., 2021, SHS WEB C, V92, DOI [10.1051/shsconf/20219201029, DOI 10.1051/SHSCONF/20219201029]
   Mandal P, 2021, EUR J OPER RES, V292, P633, DOI 10.1016/j.ejor.2020.10.042
   Mason A., 2020, J CUSTOMER BEHAV, V19, P299
   McMaster M, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13080173
   Meredith S., 2000, THE TQM MAGAZINE, V12, P137, DOI [10.1108/09544780010318398, DOI 10.1108/09544780010318398]
   Milakovic IK, 2021, INT J CONSUM STUD, V45, P1425, DOI 10.1111/ijcs.12672
   Nieman DC, 2021, CURR SPORT MED REP, V20, P395, DOI 10.1249/JSR.0000000000000867
   O'Donnell A., 1999, QUAL MARK RES, V2, P82, DOI 10.1108/13522759910269991
   Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130
   Pandey VC, 2009, J ADV MANAG RES, V6, P99, DOI 10.1108/09727980910972190
   Pantano E, 2020, J BUS RES, V116, P209, DOI 10.1016/j.jbusres.2020.05.036
   Pathak G., 2020, ZEICHEN, V6, P282
   Paul SK, 2021, J BUS RES, V136, P316, DOI 10.1016/j.jbusres.2021.07.056
   Ponomarov SY, 2009, INT J LOGIST MANAG, V20, P124, DOI 10.1108/09574090910954873
   Power D.J., 2001, INT J PHYS DISTRIB L, V31, P247, DOI DOI 10.1108/09600030110394923
   Putnik GD, 2007, DIGITAL ENTERPRISE TECHNOLOGY: PERSPECTIVES AND FUTURE CHALLENGES, P91, DOI 10.1007/978-0-387-49864-5_10
   Qu SQ, 2011, QUAL RES ACCOUNT MAN, V8, P238, DOI 10.1108/11766091111162070
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Rajesh R, 2019, SUSTAIN PROD CONSUMP, V18, P224, DOI 10.1016/j.spc.2019.02.005
   Rajesh R, 2018, MEASUREMENT, V126, P259, DOI 10.1016/j.measurement.2018.05.043
   Rizou M, 2020, TRENDS FOOD SCI TECH, V102, P293, DOI 10.1016/j.tifs.2020.06.008
   Robertson M, 2021, APPETITE, V159, DOI 10.1016/j.appet.2020.105062
   Saaty T.L., 1980, ANAL HIERARCHY PROCE
   Samvedi A, 2013, INT J PROD RES, V51, P2433, DOI 10.1080/00207543.2012.741330
   Sangari M.S., 2019, INT J BUS EXCELL, V18, P242, DOI [10.1504/IJBEX.2019.099558, DOI 10.1504/IJBEX.2019.099558]
   Schmid B, 2021, PROG DISASTER SCI, V11, DOI 10.1016/j.pdisas.2021.100181
   Sen S, 2020, SUPPLY CHAIN MANAGEM, DOI [10.2139/ssrn.3598542, DOI 10.2139/SSRN.3598542]
   Sequeira M, 2021, J GLOB OPER STRATEG, DOI 10.1108/JGOSS-07-2020-0037
   Sharma A, 2000, J BUS RES, V49, P183, DOI 10.1016/S0148-2963(99)00004-1
   Shashi, 2020, BUS STRATEG ENVIRON, V29, P1215, DOI 10.1002/bse.2428
   Shumsky RA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019225118
   Siagian H, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13094669
   Sobaih AE, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102824
   Sofaer S, 1999, HEALTH SERV RES, V34, P1101
   Solangi YA, 2019, J CLEAN PROD, V236, DOI 10.1016/j.jclepro.2019.117655
   Sreenivasan A, 2021, J GLOB OPER STRATEG, DOI 10.1108/JGOSS-12-2020-0070
   Sulaiman M.A.B.A., 2020, UTOPIA PRAXIS LATINO, V25, P81
   Tarigan ZJH, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13105460
   Tregoning JS, 2021, NAT REV IMMUNOL, V21, P626, DOI 10.1038/s41577-021-00592-1
   van Oosterhout C, 2021, VIRULENCE, V12, P507, DOI 10.1080/21505594.2021.1877066
   Viswanathan M, 2021, J CONSUM AFF, V55, P151, DOI 10.1111/joca.12351
   Wallo A, 2018, PERS REV, V47, P1008, DOI 10.1108/PR-03-2017-0066
   Wang TY, 2000, INT J PROD RES, V38, P2079, DOI 10.1080/002075400188519
   Worley CG, 2010, ORGAN DYN, V39, P194, DOI 10.1016/j.orgdyn.2010.01.006
   Wu KJ, 2017, INT J PROD ECON, V190, P96, DOI 10.1016/j.ijpe.2016.08.027
   Youn SY, 2021, CLOTH TEXT RES J, V39, P139, DOI 10.1177/0887302X20986521
   Yusuf YY, 2004, EUR J OPER RES, V159, P379, DOI 10.1016/j.ejor.2003.08.022
   ZAHEDI F, 1986, INTERFACES, V16, P96, DOI 10.1287/inte.16.4.96
   Zhao L, 2021, CLOTH TEXT RES J, V39, P157, DOI 10.1177/0887302X21994207
   Zhitao Xu, 2020, IEEE Engineering Management Review, V48, P153, DOI 10.1109/EMR.2020.3018420
NR 111
TC 0
Z9 0
U1 3
U2 3
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2398-5364
J9 J GLOB OPER STRATEG
JI J. Glob. Oper. Strateg. Sourc.
DI 10.1108/JGOSS-09-2021-0072
EA JAN 2022
PG 24
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YC7LO
UT WOS:000739869500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Mehta, N
   Sales, RM
   Babagbemi, K
   Levy, AD
   McGrath, AL
   Drotman, M
   Dodelzon, K
AF Mehta, Nishi
   Sales, Rachel Marcus
   Babagbemi, Kemi
   Levy, Allison D.
   McGrath, Anika L.
   Drotman, Michele
   Dodelzon, Katerina
TI Unilateral axillary adenopathy in the setting of COVID-19 vaccine:
   Follow-up
SO CLINICAL IMAGING
LA English
DT Article
DE COVID-19; Vaccine; Unilateral axillary Adenopathy; Breast imaging;
   Screening
AB With the Pfizer-BioNTech, Moderna, and now Johnson and Johnson COVID-19 vaccines readily available to the general population, the appearance of vaccine-induced axillary adenopathy on imaging has become more prevalent. We are presenting follow up to the first reported four cases of vaccine induced unilateral axillary adenopathy on imaging to our knowledge, which demonstrate expected self-resolving adenopathy. Our hope is that by providing this follow-up and reviewing current management guidelines, clinicians as well as patients will appreciate that this is an expected, benign, and self-resolving finding. In addition, we hope to quell any vaccine hesitancy brought about by recent mainstream media attention to this topic and ultimately empower patients to receive both the COVID-19 vaccine and undergo routine screening mammography, as both are vital to their health.
C1 [Mehta, Nishi; Sales, Rachel Marcus; Babagbemi, Kemi; Levy, Allison D.; McGrath, Anika L.; Drotman, Michele; Dodelzon, Katerina] Weill Cornell NewYork Presbyterian, Dept Radiol, 525 East 68th St, New York, NY 10065 USA.
RP Mehta, N (corresponding author), Weill Cornell NewYork Presbyterian, Dept Radiol, 525 East 68th St, New York, NY 10065 USA.
EM kad9090@med.cornell.edu
CR Kern J., 2021, VACCINATION PROVOQUE
   Lee BY, FORBES 0303, V2021
   Lee Karen A, 2018, Curr Radiol Rep, V6, P5, DOI 10.1007/s40134-018-0266-8
   Lehman CD, 2021, AM J ROENTGENOL, V217, P584, DOI 10.2214/AJR.21.25688
   Means SP, 2021, WOMEN WHO GET COVID
   Mehta N, 2021, CLIN IMAG, V75, P12, DOI 10.1016/j.clinimag.2021.01.016
   Nelson R., MEDSCAPE 0225
   Pablos T., 2021, ULTRASOUND SHOWS LYM
   Palmer WJ, 2021, COVID 19 VACCINE LIN
   Scherer L, 2021, MAMMOGRAMS SHOULD BE
   Shapiro N., FORBES 0218
   Stamatia DoganBasak, SBI RECOMMENDATIONS, V2021, P3
   Thompson D., 2021, US NEWS WORLD REPORT
   Watson S., 2021, WARNING WOMEN MAMMOG
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-7071
EI 1873-4499
J9 CLIN IMAG
JI Clin. Imaging
PD DEC
PY 2021
VL 80
BP 83
EP 87
DI 10.1016/j.clinimag.2021.06.037
EA JUL 2021
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA WD4YL
UT WOS:000704948000014
PM 34298342
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Ullah, S
AF Ullah, Sabeeh
TI Impact of COVID-19 Pandemic on Financial Markets: a Global Perspective
SO JOURNAL OF THE KNOWLEDGE ECONOMY
LA English
DT Article; Early Access
DE COVID-19 pandemic; Market returns; Global markets; Panel quantile
   regression
ID UNIT-ROOT TESTS; QUANTILE REGRESSION; PANEL-DATA; VOLATILITY
AB This study aims to examine the influence of the COVID-19 outbreak on daily market returns in most affected developed and emerging markets. For this purpose, panel data of 30 most affected developed and emerging markets over the period January 1, 2020, to December 12, 2020, were analyzed by using panel estimated generalized least square (panel-EGLS) and panel quantile regression approaches. The results confirm that the new COVID-19 daily cases and deaths adversely impact daily market returns around the globe. Also, the positive rate of new COVID-19 cases has also negatively influenced market returns. Further, the number of new COVID-19 daily tests conducted has a positive impact on market returns. Interestingly, the study also found similar impacts for both developed and emerging markets except the news announcement of new COVID-19 daily deaths, which have a positive impact on emerging market returns. The findings of this study present some policy implications for governments to adopt early proactive and control measures to protect financial markets from an adverse decline in future pandemics and to increase investors' confidence.
C1 [Ullah, Sabeeh] Univ Agr Peshawar, Fac Management & Comp Sci FM&CS, Inst Business & Management Sci IBMS, Peshawar, Pakistan.
RP Ullah, S (corresponding author), Univ Agr Peshawar, Fac Management & Comp Sci FM&CS, Inst Business & Management Sci IBMS, Peshawar, Pakistan.
EM Sabeeh@aup.edu.pk
CR Al-Awadhi AM, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100326
   Albulescu C., 2020, CORONAVIRUS OIL PRIC, DOI 10.2139/ssrn.3553452
   Albulescu CT, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101699
   Aldieri L., 2017, 76405 MPRA
   Alexakis C, 2021, J BEHAV EXP FINANC, V29, DOI 10.1016/j.jbef.2020.100428
   Alfaro L., 2020, AGGREGATE FIRM LEVEL
   Anser MK, 2021, ENVIRON SCI POLLUT R, V28, P61554, DOI 10.1007/s11356-021-15067-y
   Ashraf BN, 2020, RES INT BUS FINANC, V54, DOI 10.1016/j.ribaf.2020.101249
   Azimli A, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101648
   Baker, 2016, STAT SOFTWARE COMPON
   Barnes M.L., 2002, QUANTILE REGRESSION
   Basuony MAK, 2021, J PUBLIC AFF, DOI 10.1002/pa.2761
   Bell C., 2004, EC GROWTH HUMAN CAPI
   BELL C, 2005, EC IMPLICATIONS EPID
   Belsley DA., 1980, REGRESSION DIAGNOSTI
   Boot A., 2020, CORONAVIRUS FINANCIA
   Bouoiyour J., 2020, IDHAL02514428 HAL
   Brainerd E, 2003, EC EFFECTS 1918 INFL
   Burdekin RCK, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14040177
   Cepoi CO, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101658
   Chatjuthamard P, 2021, ACCOUNT FINANC, V61, P4923, DOI 10.1111/acfi.12838
   Ciner C, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101705
   Cirakli U, 2021, J KNOWL ECON, DOI 10.1007/s13132-021-00792-z
   Coleman T. S., 2020, THOUGHTS FINANCIAL C
   Colvin C., 2020, CONVERSATION, V11
   Cuesta J, 2020, EUR J DEV RES, V32, P1558, DOI 10.1057/s41287-020-00328-2
   Czech K, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12156282
   Anh DLT, 2021, J ECON STUD, V48, P836, DOI 10.1108/JES-06-2020-0312
   Hung DV, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14090441
   Diaz F, 2022, RES INT BUS FINANC, V59, DOI 10.1016/j.ribaf.2021.101517
   du Plooy S, 2019, INVEST ANAL J, V48, P188, DOI 10.1080/10293523.2019.1643126
   Forti Cristiano Augusto Borges, 2011, BAR, Braz. Adm. Rev., V8, P351, DOI 10.1590/s1807-76922011000400002
   Galvao AF, 2020, J ECONOMETRICS, V218, P178, DOI 10.1016/j.jeconom.2019.12.017
   Gormsen N. J., 2020, 202022 U CHIC B FRIE
   Harjoto MA, 2021, APPL ECON LETT, V28, P795, DOI 10.1080/13504851.2020.1781767
   Haroon O, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100343
   Hartwell CA, 2018, J COMP ECON, V46, P598, DOI 10.1016/j.jce.2017.11.002
   He PL, 2020, EMERG MARK FINANC TR, V56, P2198, DOI 10.1080/1540496X.2020.1785865
   Hevia C., 2020, UNDP LAC C19 PDS NO, V1, P29
   Hong H, 2021, FINANC INNOV, V7, DOI 10.1186/s40854-021-00229-1
   Hua X., 2020, CHINA DAILY HON 0322
   Im KS, 2003, J ECONOMETRICS, V115, P53, DOI 10.1016/S0304-4076(03)00092-7
   Ismahene Y, 2021, J KNOWL ECON, DOI 10.1007/s13132-021-00811-z
   Just M, 2020, FINANC RES LETT, V37, DOI 10.1016/j.frl.2020.101775
   Kalyvas A, 2020, ECON LETT, V191, DOI 10.1016/j.econlet.2019.108777
   Kickbusch I., 2020, COVID 19 VIRUS IS TU, V369
   Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254
   Kuan TH, 2012, INT REV ECON FINANC, V24, P303, DOI 10.1016/j.iref.2012.04.006
   Levin A, 2002, J ECONOMETRICS, V108, P1, DOI 10.1016/S0304-4076(01)00098-7
   Li ZH, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2019.101303
   Liu HY, 2020, APPL ECON, V52, P5859, DOI 10.1080/00036846.2020.1776837
   Liu HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082800
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Lloyd C., 2020, SEEKING ALPHA
   Machmuddah Z., 2020, J OPEN INNOV TECHNOL, V6, P99, DOI [10.3390/joitmc6040099, DOI 10.3390/JOITMC6040099]
   Maddala GS, 1999, OXFORD B ECON STAT, V61, P631, DOI 10.1111/1468-0084.61.s1.13
   Mance D, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187243
   Mei DX, 2018, PHYSICA A, V512, P215, DOI 10.1016/j.physa.2018.08.019
   Mirza N, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101657
   Najam A., 2020, HARVARD BUS REV
   Narayan PK, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101732
   Nikiforos M, 2020, 2 MINSKYAN PROCESSES
   Oliveira J, 2021, SOC SCI-BASEL, V10, DOI 10.3390/socsci10060218
   Onan M, 2014, FINANC RES LETT, V11, P454, DOI 10.1016/j.frl.2014.07.006
   Organisation for Economic Co-operation and Development (OECD), 2020, POL RESP COR COVID 1
   Phillipou A, 2020, INT J EAT DISORDER, V53, P1158, DOI 10.1002/eat.23317
   Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x
   Raifu IA, 2021, FUTUR BUS J, V7, DOI 10.1186/s43093-021-00080-x
   Rakshit B, 2021, STUD ECON FINANC, DOI 10.1108/SEF-09-2020-0389
   Ramelli S, 2020, REV CORP FINANC STUD, V9, P622, DOI 10.1093/rcfs/cfaa012
   Ranis G, 2000, WORLD DEV, V28, P197, DOI 10.1016/S0305-750X(99)00131-X
   Roeger W., 2006, MACROECONOMIC EFFECT
   Sansa N., 2020, ELECT RES J SOC SCI, V2, P28, DOI [10.2139/ssrn.3567901, DOI 10.2139/SSRN.3567901]
   Spreeuwenberg P, 2018, AM J EPIDEMIOL, V187, P2561, DOI 10.1093/aje/kwy191
   Tahat Y., 2020, STOCK MARKET RETURNS
   Tiwari AK, 2019, FINANC RES LETT, V31, P278, DOI 10.1016/j.frl.2018.11.016
   Umar B., 2018, PAKISTAN J HUMANIT S, V6, P338, DOI [10.52131/pjhss.2018.0603.0051, DOI 10.52131/PJHSS.2018.0603.0051]
   Waheed R, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2290
   Xu LB, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101872
   Young A, 2005, Q J ECON, V120, P423, DOI 10.1162/0033553053970223
   Zhang DY, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101528
NR 81
TC 0
Z9 0
U1 7
U2 7
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1868-7865
EI 1868-7873
J9 J KNOWL ECON
JI J. Knowl. Econ.
DI 10.1007/s13132-022-00970-7
EA FEB 2022
PG 22
WC Economics
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA YT9LT
UT WOS:000751675900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Dong, XL
   Wei, XQ
   Shu, F
   Su, Q
   Wang, JT
   Liu, N
   Qiu, JP
AF Dong, Xilu
   Wei, Xuqiu
   Shu, Fei
   Su, Qiang
   Wang, Juntao
   Liu, Ning
   Qiu, Junping
TI A Bibliometric Analysis on Global Psychological and Behavioral Research
   Landscape on COVID-19 Pandemic
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; psychological; behavioral; bibliometric; VOSviewer
ID IMPACT; EXPOSURE; SARS
AB The COVID-19 pandemic outbreak in December 2019 has spread globally. The ongoing psychological and behavioral effects of the COVID-19 pandemic, which poses a major challenge to humanity, are of concern to researchers. To understand the academic community's attention, focus and research collaboration on psychological and behavioral research during the COVID-19 pandemic, we conducted a macro analysis using a bibliometric approach. Using the topic selection strategy of TS = ("COVID-19" OR "coronavirus disease 2019" OR "SARS-CoV-2" OR "2019-nCoV") AND TS = ("behavio*") AND TS = ("psycholog*"), 2096 high-quality research articles and reviews were downloaded as data from the Web of Science core collection on 16 November 2021. Through analysis and visualization, the following conclusions are drawn in this study: (1) The popularity and importance of psychological and behavioral research under COVID-19 has increased significantly and needs further attention; (2). Related research focuses on eight hotspots, with quarantine, health care workers, the elderly, students, pregnant women, family, consumers, social media and emergency preparedness knowledge as the focus of the research object; and (3) Research collaboration is relatively high at the author, organizational and national levels. However, low-income countries need to get more attention. Furthermore, this article would help researchers make decisions for the research of psychological and behavioral issues under COVID-19 and planning for future prospects to contribute to academic development and applied methodology.
C1 [Dong, Xilu; Shu, Fei; Liu, Ning; Qiu, Junping] Hangzhou Dianzi Univ, Chinese Acad Sci & Educ Evaluat, 1158,Block 2,Baiyang St, Hangzhou 310018, Peoples R China.
   [Wei, Xuqiu] Shandong Univ Technol, Inst Informat Management, 266 Xincun West Rd, Zhangdian 255000, Zibo, Peoples R China.
   [Su, Qiang] Hangzhou Dianzi Univ, Zhejiang Acad Higher Educ, 1158,Block 2,Baiyang St, Hangzhou 310018, Peoples R China.
   [Wang, Juntao] Univ Queensland, Fac Engn Architecture & Informat Technol, St Lucia, Qld 4072, Australia.
RP Dong, XL (corresponding author), Hangzhou Dianzi Univ, Chinese Acad Sci & Educ Evaluat, 1158,Block 2,Baiyang St, Hangzhou 310018, Peoples R China.; Wei, XQ (corresponding author), Shandong Univ Technol, Inst Informat Management, 266 Xincun West Rd, Zhangdian 255000, Zibo, Peoples R China.
EM xl.dong@hdu.edu.cn; weixuqiu@sdut.edu.cn; fei.shu@mail.mcgill.ca;
   sq@hdu.edu.cn; juntao.wang@uqconnect.edu.au; liuning@hdu.edu.cn;
   jpqiu@hdu.edu.cn
RI Shu, Fei/A-4056-2017
OI Shu, Fei/0000-0002-1946-5065
CR Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092
   Al-Jabi SW, 2021, WORLD J PSYCHIATR, V11, DOI 10.5498/wjp.v11.i6.253
   Ale Ebrahim N., 2013, INT ED STUDIES, V6, P93, DOI DOI 10.5539/IES.V6N11P93
   Alva-Manchego F, 2020, COMPUT LINGUIST, V46, P135, DOI [10.1162/COLI_a_00370, 10.1162/coli_a_00370]
   Aristovnik A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12219132
   Atkeson, 2020, WHAT WILL BE EC IMPA
   Berger D., 2020, WORKING PAPERS B FRI
   Blake H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092997
   Bueno-Notivol J, 2021, INT J CLIN HLTH PSYC, V21, DOI 10.1016/j.ijchp.2020.07.007
   Cenat JM, 2021, PSYCHIAT RES, V297, DOI 10.1016/j.psychres.2021.113714
   Chen CM, 2017, J DATA INFO SCI, V2, P1, DOI 10.1515/jdis-2017-0006
   Chen HQ, 2021, AEA PAP P, V111, P307, DOI 10.1257/pandp.20211003
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   Correia S, 2020, PUBLIC HLTH INTERVEN, P1, DOI [10.2139/ssrn.3561560, DOI 10.2139/SSRN.3561560]
   Cruz-Cardenas J, 2021, TECHNOL FORECAST SOC, V173, DOI 10.1016/j.techfore.2021.121179
   Ding XS, 2020, PSYCHIAT DANUB, V32, P527, DOI 10.24869/psyd.2020.527
   Dubey S, 2020, DIABETES METAB SYND, V14, P779, DOI 10.1016/j.dsx.2020.05.035
   Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686
   Gauntlett L, 2019, LANCET PSYCHIAT, V6, P72, DOI 10.1016/S2215-0366(18)30173-1
   Greenstone M., 2020, WORKING PAPERS B FRI
   Groarke JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239698
   Guo F., 2021, REV IND EC, V1, P34
   Haghani M, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104806
   Hoffman D. L., 2000, Journal of Agricultural Genomics, V5, P1
   Hong YX, 2019, J ENVIRON PSYCHOL, V63, P82, DOI 10.1016/j.jenvp.2019.04.005
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jiang Y., 2020, PHILOS ANAL, V11, P160
   Jiao WY, 2020, J PEDIATR-US, V221, P264, DOI 10.1016/j.jpeds.2020.03.013
   Jones C, 2021, REV FINANC STUD, V34, P5188, DOI 10.1093/rfs/hhab076
   Kambhampati Srinivas B S, 2020, J Clin Orthop Trauma, V11, pS304, DOI 10.1016/j.jcot.2020.04.030
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Leydesdorff L, 2013, SCIENTOMETRICS, V94, P589, DOI 10.1007/s11192-012-0784-8
   Liang LL, 2020, PSYCHIAT QUART, V91, P841, DOI 10.1007/s11126-020-09744-3
   Liu N, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01059-y
   Liu Y., 2020, CHIN J SPEC ED, V12, P89
   Lou J, 2020, EUR REV MED PHARMACO, V24, P3411, DOI 10.26355/eurrev_202003_20712
   Maunder R, 2003, CAN MED ASSOC J, V168, P1245
   Neece C, 2020, J INTELL DISABIL RES, V64, P739, DOI 10.1111/jir.12769
   Newby JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236562
   Nieminen Pentti, 2006, BMC Med Res Methodol, V6, P42, DOI 10.1186/1471-2288-6-42
   Oh J, 2020, SCI ED, V7, P118, DOI 10.6087/kcse.205
   Robertson E, 2004, CAN J PSYCHIAT, V49, P403
   Sahin MK, 2020, J COMMUN HEALTH, V45, P1168, DOI 10.1007/s10900-020-00921-w
   Shechter A, 2020, GEN HOSP PSYCHIAT, V66, P1, DOI 10.1016/j.genhosppsych.2020.06.007
   Soytas RB, 2021, ANN GERIATR MED RES, V25, P197, DOI 10.4235/agmr.21.0060
   Stanton R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114065
   Tao ZB, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.04.26
   Tian FY, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112992
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   van Eck NJ, 2017, SCIENTOMETRICS, V111, P1053, DOI 10.1007/s11192-017-2300-7
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   Verhoeven V, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039674
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Wang X., 2021, CHIN J APPL PSYCHOL, V27, P178
   Yuan S, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923767
NR 55
TC 0
Z9 0
U1 14
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JAN
PY 2022
VL 19
IS 2
AR 879
DI 10.3390/ijerph19020879
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA YN3SI
UT WOS:000747180600001
PM 35055700
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Dashash, M
   Almasri, B
   Takaleh, E
   Abou Halawah, A
   Sahyouni, A
AF Dashash, Mayssoon
   Almasri, Bashar
   Takaleh, Eman
   Abou Halawah, Alaa
   Sahyouni, Amal
TI Educational perspective for the identification of essential competencies
   required for approaching patients with COVID-19
SO EASTERN MEDITERRANEAN HEALTH JOURNAL
LA English
DT Article
DE COVID-19; competencies; health professional; education; Syria
ID MEDICINE
AB Background: Health professionals are at the frontline of the COVID-19 pandemic and are directly exposed to infection hazards. Therefore, they should have the essential competencies for approaching patients.
   Aims: The study aimed to identify essential competencies required for approaching patients with COVID-19.
   Methods: All postgraduate health professionals at the Syrian Virtual University SVU (n=28) were invited to participate in the study during the Covid-19 lockdown in 2020, resulting in 20 postgraduates accepting. The Delphi technique was adopted for identifying competencies in medical education and a virtual meeting was undertaken through the University Management System in order to provide instruction and create a list of competencies. Competency domains were divided into 'knowledge', 'skills', and 'attitudes' and were classified into four categories: etiology, assessment and diagnosis, management, and prognosis.
   Results: Fifty-two essential competencies were identified; 7 competencies on etiology, 7 related to assessment and diagnosis, 34 related to management, and 4 related to prognosis
   Conclusion: It is hoped that the identified competencies would help health professionals to deliver the best health care for COVI-19 patients, as well as help policy-makers to support comprehensive training programmes that can equip health professionals with the required competencies to fight the pandemic.
C1 [Dashash, Mayssoon] Damascus Univ, Damascus, Syria.
   [Dashash, Mayssoon; Almasri, Bashar; Takaleh, Eman; Abou Halawah, Alaa; Sahyouni, Amal] Syrian Virtual Univ, Damascus, Syria.
RP Dashash, M (corresponding author), Damascus Univ, Damascus, Syria.; Dashash, M (corresponding author), Syrian Virtual Univ, Damascus, Syria.
EM mdashash@yahoo.com
RI Dashash, Mayssoon/AFQ-7952-2022
OI Dashash, Mayssoon/0000-0002-9877-3217
CR Almoallim H., 2011, Eastern Mediterranean Health Journal, V17, P656
   Bajammal S, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-53
   Centers for Disease Control and Prevention (CDC), 2020, INF HEALTHC PROF COR
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cochrane, COR COVID 19 COCHR R
   Dashash M, IJCMPR, V2, P708
   De Villiers MR, 2005, MED TEACH, V27, P639, DOI 10.1080/13611260500069947
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   DUNN WR, 1985, MED TEACH, V7, P15, DOI 10.3109/01421598509036787
   Frank JR, 2010, MED TEACH, V32, P631, DOI 10.3109/0142159X.2010.500898
   Hand JS, J DENT ED, V70, P937
   Harden RM, 1999, MED TEACH, V21, P7, DOI 10.1080/01421599979969
   Hoffmann, COVID REFERENCE
   Huynh G, 2020, J TROPICAL MED, V13, P260, DOI DOI 10.4103/1995-7645.280396
   Jamil Shazia, 2020, Am J Respir Crit Care Med, V201, pP19, DOI 10.1164/rccm.2020C1
   Mantovani C., 2020, REUTERS
   MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045
   Penciner R, 2013, CAN J EMERG MED, V15, P24, DOI 10.2310/8000.2012.120686
   Shah S, 2020, CAN J DIABETES, V44, P30, DOI 10.1016/j.jcjd.2019.04.019
   The Royal College of Emergency Medicine (RCEM), 2015, CURR ASS SYST TRAIN
   Tonni I, 2012, EUR J DENT EDUC, P1
   WHO (World Health Organization), 2020, COR DIS COVID 19 OUT
   World Health Organization, 2020, COR DIS COVID 19 PAN
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 27
TC 1
Z9 1
U1 1
U2 2
PU WHO EASTERN MEDITERRANEAN REGIONAL OFFICE
PI NASR CITY, CAIRO
PA P. O. BOX 7608, NASR CITY, CAIRO, EGYPT
SN 1020-3397
EI 1687-1634
J9 E MEDITERR HEALTH J
JI East Mediterr. Health J.
PD SEP
PY 2020
VL 26
IS 9
BP 1011
EP 1017
DI 10.26719/emhj.20.111
PG 7
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA NY8XS
UT WOS:000576668100005
PM 33047791
OA gold
DA 2022-04-20
ER

PT J
AU Ipsen, C
   van Veldhoven, M
   Kirchner, K
   Hansen, JP
AF Ipsen, Christine
   van Veldhoven, Marc
   Kirchner, Kathrin
   Hansen, John Paulin
TI Six Key Advantages and Disadvantages of Working from Home in Europe
   during COVID-19
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; experiences; working from home; survey; advantages;
   disadvantages; knowledge work
AB The number of people working from home (WFH) increased radically during the coronavirus (COVID-19) pandemic. The purpose of this study was therefore to investigate people's experiences of WFH during the pandemic and to identify the main factors of advantages and disadvantages of WFH. Data from 29 European countries on the experiences of knowledge workers (N = 5748) WFH during the early stages of lockdown (11 March to 8 May 2020) were collected. A factor analysis showed the overall distribution of people's experiences and how the advantages and disadvantages of WFH during the early weeks of the pandemic can be grouped into six key factors. The results indicated that most people had a more positive rather than negative experience of WFH during lockdown. Three factors represent the main advantages of WFH: (i) work-life balance, (ii) improved work efficiency and (iii) greater work control. The main disadvantages were (iv) home office constraints, (v) work uncertainties and (vi) inadequate tools. Comparing gender, number of children at home, age and managers versus employees in relation to these factors provided insights into the differential impact of WFH on people's lives. The factors help organisations understand where action is most needed to safeguard both performance and well-being. As the data were collected amidst the COVID-19 pandemic, we recommend further studies to validate the six factors and investigate their importance for well-being and performance in knowledge work.
C1 [Ipsen, Christine; Kirchner, Kathrin; Hansen, John Paulin] Tech Univ Denmark, DTU Management Dept, DK-2800 Lyngby, Denmark.
   [van Veldhoven, Marc] Tilburg Univ, Dept Human Resource Studies, NL-5037 AB Tilburg, Netherlands.
RP Kirchner, K (corresponding author), Tech Univ Denmark, DTU Management Dept, DK-2800 Lyngby, Denmark.
EM chip@dtu.dk; M.J.P.M.vanVeldhoven@tilburguniversity.edu; kakir@dtu.dk;
   jpha@dtu.dk
RI Ipsen, Christine/A-8583-2017; Kirchner, Kathrin/C-4984-2016
OI Ipsen, Christine/0000-0002-2394-5571; Kirchner,
   Kathrin/0000-0002-4638-0403; van veldhoven, marc/0000-0001-5762-7945;
   Hansen, John Paulin/0000-0001-5594-3645
CR Alvesson M, 2004, KNOWLEDGE WORK KNOWL, P1
   Alvesson M, 1995, MANAGEMENT KNOWLEDGE, P1
   Anderson AJ, 2015, EUR J WORK ORGAN PSY, V24, P882, DOI 10.1080/1359432X.2014.966086
   [Anonymous], 2020, THE ECONOMIST    SEP, P1
   [Anonymous], THERES NO PLACE HOME
   Bailey DE, 2002, J ORGAN BEHAV, V23, P383, DOI 10.1002/job.144
   Bell BS, 2002, GROUP ORGAN MANAGE, V27, P14, DOI 10.1177/1059601102027001003
   Biron M, 2016, J ORGAN BEHAV, V37, P1317, DOI 10.1002/job.2106
   Center for Sustainable Systems University of Michigan, 2020, WIND EN FACTSH 2019, P1
   Charalampous M, 2019, EUR J WORK ORGAN PSY, V28, P51, DOI 10.1080/1359432X.2018.1541886
   Cooper CD, 2002, J ORGAN BEHAV, V23, P511, DOI 10.1002/job.145
   COVID-19 Disrupting Mental Health Services in Most Countries, 2020, WHO SURV
   Cropper S., 2008, OXFORD HDB INTERORGA, P1
   DeFilippis E., NATL BUREAU EC RES W, DOI [10.3386 /w27612, DOI 10.3386/W27612, 10.2139/ssrn.3654470, DOI 10.2139/SSRN.3654470]
   European Comission, 2020, STRAT PLAN 2020 2024, P1
   Fabrigar L.R., 2011, EXPLORATORY FACTOR A, P1
   Fisher K., 2001, DISTANCE MANAGERA HA, V1st, P1
   Fonner KL, 2010, J APPL COMMUN RES, V38, P336, DOI 10.1080/00909882.2010.513998
   Guest D, 2021, HUM RELAT, V74, P153, DOI 10.1177/0018726720973156
   Gurstein P., 2001, WIRED WORLD CHAINED, P1
   Hertel G., 2005, Human Resources Management Review, V15, P69, DOI 10.1016/j.hrmr.2005.01.002
   Hesketh I., 2019, WELLBEING WORK DESIG, P1
   International Ski Federation, 2020, TIM BOOKL ALP SKIING, P1
   Ipsen C., 2020, EXPERIENCES WORKING, DOI [10.11581/dtu:00000085, DOI 10.11581/DTU:00000085]
   Ipsen C, 2012, INT J IND ERGONOM, V42, P325, DOI 10.1016/j.ergon.2012.02.006
   Jackson P.J, 1999, VIRTUAL WORKING SOCI, P1
   Kirchner K, 2021, KNOWL MAN RES PRACT, V19, P493, DOI 10.1080/14778238.2021.1877579
   Kurland NB, 1999, ORGAN DYN, V28, P53
   Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346
   Messenger J., 2017, WORKING ANYTIME ANYW, P1
   Mitchell D, 2017, 50 TOP TOOLS EMPLOYE, P1
   Moretti A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176284
   OCHA, 2020, IASC REF GROUP MENT, P1
   Parent-Thirion A., 2017, EUROFOUND 6 EUROPEAN, P1
   Passos L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186794
   Pierce M, 2020, LANCET PSYCHIAT, V7, P883, DOI 10.1016/S2215-0366(20)30308-4
   Poulsen S, 2017, SAFETY SCI, V100, P37, DOI 10.1016/j.ssci.2017.05.002
   Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w
   Stich JF, 2020, INTELL BUILD INT, V12, P208, DOI 10.1080/17508975.2020.1759023
   Verburg RM, 2013, INT J PROJ MANAG, V31, P68, DOI 10.1016/j.ijproman.2012.04.005
NR 40
TC 34
Z9 34
U1 66
U2 106
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB
PY 2021
VL 18
IS 4
AR 1826
DI 10.3390/ijerph18041826
PG 17
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA QP1RB
UT WOS:000623612600001
PM 33668505
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Kobat, MA
   Kivrak, T
   Barua, PD
   Tuncer, T
   Dogan, S
   Tan, RS
   Ciaccio, EJ
   Acharya, UR
AF Kobat, Mehmet Ali
   Kivrak, Tarik
   Barua, Prabal Datta
   Tuncer, Turker
   Dogan, Sengul
   Tan, Ru-San
   Ciaccio, Edward J.
   Acharya, U. Rajendra
TI Automated COVID-19 and Heart Failure Detection Using DNA Pattern
   Technique with Cough Sounds
SO DIAGNOSTICS
LA English
DT Article
DE COVID-19; heart failure; cough sounds; DNA pattern; advanced sound
   processing
ID NEURAL-NETWORK; CLASSIFIER
AB COVID-19 and heart failure (HF) are common disorders and although they share some similar symptoms, they require different treatments. Accurate diagnosis of these disorders is crucial for disease management, including patient isolation to curb infection spread of COVID-19. In this work, we aim to develop a computer-aided diagnostic system that can accurately differentiate these three classes (normal, COVID-19 and HF) using cough sounds. A novel handcrafted model was used to classify COVID-19 vs. healthy (Case 1), HF vs. healthy (Case 2) and COVID-19 vs. HF vs. healthy (Case 3) automatically using deoxyribonucleic acid (DNA) patterns. The model was developed using the cough sounds collected from 241 COVID-19 patients, 244 HF patients, and 247 healthy subjects using a hand phone. To the best our knowledge, this is the first work to automatically classify healthy subjects, HF and COVID-19 patients using cough sounds signals. Our proposed model comprises a graph-based local feature generator (DNA pattern), an iterative maximum relevance minimum redundancy (ImRMR) iterative feature selector, with classification using the k-nearest neighbor classifier. Our proposed model attained an accuracy of 100.0%, 99.38%, and 99.49% for Case 1, Case 2, and Case 3, respectively. The developed system is completely automated and economical, and can be utilized to accurately detect COVID-19 versus HF using cough sounds.
C1 [Kobat, Mehmet Ali; Kivrak, Tarik] Firat Univ, Firat Univ Hosp, Dept Cardiol, TR-23119 Elazig, Turkey.
   [Barua, Prabal Datta] Univ Southern Queensland, Sch Management Enterprise, Toowoomba, Qld 4350, Australia.
   [Barua, Prabal Datta] Univ Technol Sydney, Fac Engn & Informat Technol, Sydney, NSW 2007, Australia.
   [Barua, Prabal Datta] Cogninet Australia, Cogninet Brain Team, Sydney, NSW 2010, Australia.
   [Tuncer, Turker; Dogan, Sengul] Firat Univ, Dept Digital Forens Engn, Coll Technol, TR-23119 Elazig, Turkey.
   [Tan, Ru-San] Natl Heart Ctr Singapore, Dept Cardiol, Singapore 169609, Singapore.
   [Tan, Ru-San] Duke NUS Grad Med Sch, Dept Cardiol, Singapore 169857, Singapore.
   [Ciaccio, Edward J.] Columbia Univ, Dept Med, Celiac Dis Ctr, Irving Med Ctr, New York, NY 10032 USA.
   [Acharya, U. Rajendra] Ngee Ann Polytech, Dept Elect & Comp Engn, Singapore 599489, Singapore.
   [Acharya, U. Rajendra] SUSS Univ, Sch Sci & Technol, Dept Biomed Engn, Clementi 599494, Singapore.
   [Acharya, U. Rajendra] Asia Univ, Dept Biomed Informat & Med Engn, Taichung 41354, Taiwan.
RP Acharya, UR (corresponding author), Ngee Ann Polytech, Dept Elect & Comp Engn, Singapore 599489, Singapore.; Acharya, UR (corresponding author), SUSS Univ, Sch Sci & Technol, Dept Biomed Engn, Clementi 599494, Singapore.; Acharya, UR (corresponding author), Asia Univ, Dept Biomed Informat & Med Engn, Taichung 41354, Taiwan.
EM mkobat@firat.edu.tr; tarikkivrak@firat.edu.tr; Prabal.Barua@usq.edu.au;
   turkertuncer@firat.edu.tr; sdogan@firat.edu.tr;
   tan.ru.san@singhealth.com.sg; ciaccio@columbia.edu; aru@np.edu.sg
RI TUNCER, Türker/W-4846-2018; DOGAN, Sengul/W-4854-2018
OI DOGAN, Sengul/0000-0001-9677-5684; TUNCER, Turker/0000-0002-5126-6445;
   Acharya, U Rajendra/0000-0003-2689-8552; Tan, Ru
   San/0000-0003-2086-6517; Barua, Prabal Datta/0000-0001-5117-8333
CR Abbas A, 2021, APPL INTELL, V51, P854, DOI 10.1007/s10489-020-01829-7
   Andreu-Perez J, 2021, IEEE T SERV COMPUT, DOI [10.1109/TSC.2021.3061402, 1-1, DOI 10.1109/TSC.2021.3061402, 10.1109/TSC.2021.3061402]
   Ashour AS, 2018, HEALTH INF SCI SYST, V6, DOI 10.1007/s13755-018-0059-8
   Aslan MF, 2021, APPL SOFT COMPUT, V98, DOI 10.1016/j.asoc.2020.106912
   BAIM DS, 1986, J AM COLL CARDIOL, V7, P661, DOI 10.1016/S0735-1097(86)80478-8
   Born J., 2020, ARXIV PREPRINT ARXIV
   Brown C, 2020, KDD '20: PROCEEDINGS OF THE 26TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P3474, DOI 10.1145/3394486.3412865
   Candemir S, 2014, IEEE T MED IMAGING, V33, P577, DOI 10.1109/TMI.2013.2290491
   Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195
   Chowdhury M.E., 2021, ARXIV2021210312063
   Cohen J. P., 2020, J MACH LEARN BIOMED
   Cohen-McFarlane M, 2020, IEEE ACCESS, V8, P154087, DOI 10.1109/ACCESS.2020.3018028
   Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215
   Gupta A, 2021, J INTERDISCIP MATH, V24, P285, DOI 10.1080/09720502.2020.1838060
   Gupta A, 2021, MATER TODAY-PROC, V46, P10927, DOI 10.1016/j.matpr.2021.01.950
   Hall G, 2021, PROG CARDIOVASC DIS, V64, P108, DOI 10.1016/j.pcad.2020.04.005
   Han J, 2021, 2021 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP 2021), P8328, DOI 10.1109/ICASSP39728.2021.9414576
   Hassan A., 2020, 2020 INT C COMM COMP, P1
   He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90
   Horry MJ, 2020, IEEE ACCESS, V8, P149808, DOI 10.1109/ACCESS.2020.3016780
   Huang GL, 2017, IEEE ICC
   Huang Q, 2018, BUILDINGS-BASEL, V8, DOI 10.3390/buildings8060078
   Hussain E, 2021, CHAOS SOLITON FRACT, V142, DOI 10.1016/j.chaos.2020.110495
   Jaeger S, 2014, IEEE T MED IMAGING, V33, P233, DOI 10.1109/TMI.2013.2284099
   Jaiswal A, 2021, J BIOMOL STRUCT DYN, V39, P5682, DOI 10.1080/07391102.2020.1788642
   Kanne JP, 2021, RADIOLOGY, V299, pE262, DOI 10.1148/radiol.2021204522
   Krithika LB, 2021, J AMB INTEL HUM COMP, V12, P2131, DOI 10.1007/s12652-020-02311-5
   Maghdid HS, 2021, PROC SPIE, V11734, DOI 10.1117/12.2588672
   Maillo J, 2017, KNOWL-BASED SYST, V117, P3, DOI 10.1016/j.knosys.2016.06.012
   Maleki M., 2021, ARXIV2021210204880
   Masetic Z, 2016, COMPUT METH PROG BIO, V130, P54, DOI 10.1016/j.cmpb.2016.03.020
   Megahed NA, 2020, SUSTAIN CITIES SOC, V61, DOI 10.1016/j.scs.2020.102350
   Miah Y., 2021, P ICACIN, V2021, P79, DOI [10.1007/978-981-15-6048-4_8, DOI 10.1007/978-981-15-6048-4_8]
   Mishra PK, 2018, IEEE ACCESS, V6, P27373, DOI 10.1109/ACCESS.2018.2836401
   Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724
   Mouawad Pauline, 2021, SN Comput Sci, V2, P34, DOI 10.1007/s42979-020-00422-6
   Nazari S, 2018, EXPERT SYST APPL, V95, P261, DOI 10.1016/j.eswa.2017.11.001
   Niesler T., 2020, ARXIV201201926
   Okoshi H., 2020, J OCCUP HEALTH, DOI [10.1002/1348-9585.12225, DOI 10.1002/1348-9585.12225]
   Orlandic L., 2020, ARXIV2020200911644
   Pahuja G, 2021, IETE J RES, V67, P4, DOI 10.1080/03772063.2018.1531730
   Porumb M, 2020, BIOMED SIGNAL PROCES, V55, DOI 10.1016/j.bspc.2019.101597
   Ralf-Dieter B., PTB DIAGNOSTIC ECG D
   Rish I., 2001, IJCAI 2001 WORKSH EM, P41, DOI DOI 10.1039/B104835J
   SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458
   Schuller B.W., P 22 ANN C INT SPEEC, P431, DOI [10.21437/Interspeech.2021-19, DOI 10.21437/INTERSPEECH.2021-19]
   Sharma N., 2020, ARXIV2020200510548
   Shchedrygina A, 2021, EXPERT REV CARDIOVAS, V19, P5, DOI 10.1080/14779072.2021.1844005
   Sheffi Y., 2020, NEW AB NORMAL RESHAP
   Shen S., 2020, ARXIV PREPRINT ARXIV
   Simonyan K., 2014, ARXIV14091556
   Singh D, 2020, EUR J CLIN MICROBIOL, V39, P1379, DOI 10.1007/s10096-020-03901-z
   Sinn R., 2020, ARTIF INTELL REV
   Szegedy C, 2017, THIRTY-FIRST AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4278
   Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308
   Tao HC, 2021, NAT REV MATER, V6, P701, DOI 10.1038/s41578-021-00337-5
   Tripathy RK, 2019, COMPUT METH PROG BIO, V173, P53, DOI 10.1016/j.cmpb.2019.03.008
   Tuncer T, 2021, INFORM SCIENCES, V565, P91, DOI 10.1016/j.ins.2021.01.088
   Tuncer T, 2019, KNOWL-BASED SYST, V186, DOI 10.1016/j.knosys.2019.104923
   Unler A, 2011, INFORM SCIENCES, V181, P4625, DOI 10.1016/j.ins.2010.05.037
   Vapnik V.N., 2000, NATURE STAT LEARNING, V2nd
   Wang YB, 2017, PROC CVPR IEEE, P2097, DOI 10.1109/CVPR.2017.226
   Wardhani NWS, 2019, 2019 INTERNATIONAL CONFERENCE ON COMPUTER, CONTROL, INFORMATICS AND ITS APPLICATIONS (IC3INA), P14, DOI 10.1109/IC3INA48034.2019.8949568
   Wei W., 2020, ARXIV2020200807695
   Xia T., 2021, ARXIV2021210402005
   Yang X., 2020, ARXIV200313865
   Yu Xiang, 2021, Inf Process Manag, V58, P102411, DOI 10.1016/j.ipm.2020.102411
   Zebin T, 2021, APPL INTELL, V51, P1010, DOI 10.1007/s10489-020-01867-1
   Zhao W, 1998, PROC CVPR IEEE, P164, DOI 10.1109/CVPR.1998.698604
   Zheng JW, 2021, IEEE T COGN DEV SYST, V13, P607, DOI 10.1109/TCDS.2020.2965166
   Zoph B, 2018, PROC CVPR IEEE, P8697, DOI 10.1109/CVPR.2018.00907
NR 71
TC 1
Z9 1
U1 4
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4418
J9 DIAGNOSTICS
JI Diagnostics
PD NOV
PY 2021
VL 11
IS 11
AR 1962
DI 10.3390/diagnostics11111962
PG 15
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA XF6KG
UT WOS:000724177600001
PM 34829308
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Baigent, C
   Windecker, S
   Andreini, D
   Arbelo, E
   Barbato, E
   Bartorelli, AL
   Baumbach, A
   Behr, ER
   Berti, S
   Bueno, H
   Capodanno, D
   Cappato, R
   Chieffo, A
   Collet, JP
   Cuisset, T
   de Simone, G
   Delgado, V
   Dendale, P
   Dudek, D
   Edvardsen, T
   Elvan, A
   Gonzalez-Juanatey, JR
   Gori, M
   Grobbee, D
   Guzik, TJ
   Halvorsen, S
   Haude, M
   Heidbuchel, H
   Hindricks, G
   Ibanez, B
   Karam, N
   Katus, H
   Klok, FA
   Konstantinides, SV
   Landmesser, U
   Leclercq, C
   Leonardi, S
   Lettino, M
   Marenzi, G
   Mauri, J
   Metra, M
   Morici, N
   Mueller, C
   Petronio, AS
   Polovina, MM
   Potpara, T
   Praz, F
   Prendergast, B
   Prescott, E
   Price, S
   Pruszczyk, P
   Rodriguez-Leor, O
   Roffi, M
   Romaguera, R
   Rosenkranz, S
   Sarkozy, A
   Scherrenberg, M
   Seferovic, P
   Senni, M
   Spera, FR
   Stefanini, G
   Thiele, H
   Tomasoni, D
   Torracca, L
   Touyz, RM
   Wilde, AA
   Williams, B
AF Baigent, Colin
   Windecker, Stephan
   Andreini, Daniele
   Arbelo, Elena
   Barbato, Emanuele
   Bartorelli, Antonio L.
   Baumbach, Andreas
   Behr, Elijah R.
   Berti, Sergio
   Bueno, Hector
   Capodanno, Davide
   Cappato, Riccardo
   Chieffo, Alaide
   Collet, Jean-Philippe
   Cuisset, Thomas
   de Simone, Giovanni
   Delgado, Victoria
   Dendale, Paul
   Dudek, Dariusz
   Edvardsen, Thor
   Elvan, Arif
   Gonzalez-Juanatey, Jose R.
   Gori, Mauro
   Grobbee, Diederick
   Guzik, Tomasz J.
   Halvorsen, Sigrun
   Haude, Michael
   Heidbuchel, Hein
   Hindricks, Gerhard
   Ibanez, Borja
   Karam, Nicole
   Katus, Hugo
   Klok, Fredrikus A.
   Konstantinides, Stavros, V
   Landmesser, Ulf
   Leclercq, Christophe
   Leonardi, Sergio
   Lettino, Maddalena
   Marenzi, Giancarlo
   Mauri, Josepa
   Metra, Marco
   Morici, Nuccia
   Mueller, Christian
   Petronio, Anna Sonia
   Polovina, Marija M.
   Potpara, Tatjana
   Praz, Fabien
   Prendergast, Bernard
   Prescott, Eva
   Price, Susanna
   Pruszczyk, Piotr
   Rodriguez-Leor, Oriol
   Roffi, Marco
   Romaguera, Rafael
   Rosenkranz, Stephan
   Sarkozy, Andrea
   Scherrenberg, Martijn
   Seferovic, Petar
   Senni, Michele
   Spera, Francesco R.
   Stefanini, Giulio
   Thiele, Holger
   Tomasoni, Daniela
   Torracca, Lucia
   Touyz, Rhian M.
   Wilde, Arthur A.
   Williams, Bryan
CA European Soc Cardiology
TI ESC guidance for the diagnosis and management of cardiovascular disease
   during the COVID-19 pandemic: part 2-care pathways, treatment, and
   follow-up
SO EUROPEAN HEART JOURNAL
LA English
DT Article
DE ACE2; Acute coronary syndromes; Arrhythmias; Biomarkers; Cardiogenic
   shock; COVID-19; Heart failure; Myocarditis; Venous thromboembolism;
   Pulmonary embolism; Thrombosis
ID ONSET ATRIAL-FIBRILLATION; RESUSCITATION COUNCIL GUIDELINES;
   ANGIOTENSIN-CONVERTING ENZYME-2; ACUTE RESPIRATORY SYNDROME;
   AORTIC-VALVE-REPLACEMENT; HEART-RATE-VARIABILITY; II RECEPTOR BLOCKERS;
   ST-SEGMENT ELEVATION; MERS-COV INFECTION; MYOCARDIAL-INFARCTION
AB Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular (CV) disease in association with COVID-19.
   Methods and results A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, which was reported previously, focused on the epidemiology, pathophysiology, and diagnosis of CV conditions that may be manifest in patients with COVID-19. This second part addresses the topics of: care pathways and triage systems and management and treatment pathways, both of the most commonly encountered CV conditions and of COVID-19; and information that may be considered useful to help patients with CV disease (CVD) to avoid exposure to COVID-19.
   Conclusion This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.
   [GRAPHICS]
   .
C1 [Baigent, Colin] Nuffield Dept Populat Hlth, MRC Populat Hlth Res Unit, Oxford, England.
   [Windecker, Stephan] Bern Univ Hosp, Dept Cardiol, Inselspital, Bern, Switzerland.
   [Andreini, Daniele; Bartorelli, Antonio L.; Marenzi, Giancarlo] IRCCS, Ctr Cardiol Monzino, Milan, Italy.
   [Andreini, Daniele] Univ Milan, Cardiovasc Sect, Dept Clin Sci & Community Hlth, Milan, Italy.
   [Arbelo, Elena] Univ Barcelona, Hosp Clin, Cardiol Dept, Arrhythmia Sect, Barcelona, Spain.
   [Arbelo, Elena] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.
   [Arbelo, Elena; Bueno, Hector; Ibanez, Borja; Rodriguez-Leor, Oriol] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.
   [Arbelo, Elena] EHRA, Cardiogenet Focus Grp, ECGen, Sophia Antipolis, France.
   [Barbato, Emanuele; de Simone, Giovanni] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy.
   [Barbato, Emanuele] Onze Lieve Vrouw Hosp, Cardiovasc Ctr Aalst, Aalst, Belgium.
   [Bartorelli, Antonio L.] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.
   [Bartorelli, Antonio L.] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Milan, Italy.
   [Baumbach, Andreas] Queen Mary Univ London, William Harvey Res Inst, Ctr Cardiovasc Med & Devices, London, England.
   [Baumbach, Andreas] Barts Heart Ctr, London, England.
   [Baumbach, Andreas] Yale Univ, Sch Med, New Haven, CT USA.
   [Behr, Elijah R.] St Georges Univ London, ECGen, Cardiogenet Focus Grp, Cardiol Clin Acad Grp,Inst Mol & Clin Sci,EHRA, London, England.
   [Behr, Elijah R.; Wilde, Arthur A.] European Reference Network Rare & Low Prevalence, London, England.
   [Berti, Sergio] Osped Cuore G Pasquinucci, Fdn Toscana G Monasterio, Dipartimento Cardiotorac, UOC Cardiol Diagnost & Interventist, Massa, Italy.
   [Bueno, Hector; Ibanez, Borja] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain.
   [Bueno, Hector] Hosp Univ 12 Octubre, Cardiol Dept, Madrid, Spain.
   [Bueno, Hector] Hosp 12 Octubre Imasl2, Inst Invest Sanitaria, Madrid, Spain.
   [Capodanno, Davide] Univ Catania, AOU Policlin G Rodolico San Marco, Div Cardiol, Catania, Italy.
   [Cappato, Riccardo] IRCCS Grp MultiMed, Arrhythmia & Electrophysiol Ctr, Milan, Italy.
   [Chieffo, Alaide] Ist Sci San Raffaele, Milan, Italy.
   [Collet, Jean-Philippe] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, ACTION Study Grp,Inst Cardiol, Paris, France.
   [Cuisset, Thomas] CHU Timone, Dept Cardiol, Marseille, France.
   [Cuisset, Thomas] INSERM, UMR1062, Nutr Obes & Risk Thrombosis, Marseille, France.
   [Cuisset, Thomas] Aix Marseille Univ, Fac Med, Marseille, France.
   [de Simone, Giovanni] Federico II Univ Hosp, Hypertens Res Ctr, Naples, Italy.
   [Delgado, Victoria] Leiden Univ Med Ctr, Heart Lung Ctr, Leiden, Netherlands.
   [Dendale, Paul] Jessa Hosp, Heart Ctr Hasselt, Hasseit, Belgium.
   [Dendale, Paul; Scherrenberg, Martijn] Uhasselt, Fac Med & Life Sci, Diepenbeek, Belgium.
   [Dudek, Dariusz] Jagiellonian Univ Med Coll, Inst Cardiol, Krakow, Poland.
   [Dudek, Dariusz] Maria Cecilia Hosp, GVM Care & Res, Ravenna, RA, Italy.
   [Edvardsen, Thor] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway.
   [Elvan, Arif] Isala Heart Ctr, Zwolle, Netherlands.
   [Gonzalez-Juanatey, Jose R.] Univ Santiago de Compostela, Cardiol Dept, Univ Hosp, IDIS,CIBERCV, Santiago De Compostela, Spain.
   [Gori, Mauro; Senni, Michele] Papa Giovanni XXIII Hosp Bergamo, Cardiovasc Dept, Bergamo, Italy.
   [Gori, Mauro; Senni, Michele] Papa Giovanni XXIII Hosp Bergamo, Cardiol Unit, Bergamo, Italy.
   [Grobbee, Diederick] Univ Med Ctr Utrecht, Julius Global Hlth, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Guzik, Tomasz J.; Touyz, Rhian M.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.
   [Guzik, Tomasz J.] Jagiellonian Univ Coll Med, Dept Med, Krakow, Poland.
   [Halvorsen, Sigrun] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway.
   [Halvorsen, Sigrun] Univ Oslo, Oslo, Norway.
   [Haude, Michael] Lukaskrankenhaus GmbH, Stadt Kliniken Neuss, Med Clin 1, Neuss, Germany.
   [Heidbuchel, Hein; Sarkozy, Andrea; Spera, Francesco R.] Univ Hosp Antwerp, Dept Cardiol, Antwerp, Belgium.
   [Heidbuchel, Hein; Sarkozy, Andrea; Spera, Francesco R.] Univ Antwerp, Antwerp, Belgium.
   [Hindricks, Gerhard] Univ Hosp Leipzig, Heart Ctr Leipzig, Dept Internal Med Cardiol Electrophysiol, Leipzig, Germany.
   [Hindricks, Gerhard] Leipzig Heart Inst LHI, Leipzig, Germany.
   [Ibanez, Borja] Ctr Invest Biomed Red Enfermedades Cardiovasc CNI, Madrid, Spain.
   [Karam, Nicole] Univ Paris, PARCC, INSERM, Paris, France.
   [Katus, Hugo] Hop Europeen Georges Pompidou, Paris, France.
   [Katus, Hugo] Univ Hosp Heidelberg, Dept Internal Med, Heidelberg, Germany.
   [Klok, Fredrikus A.] Leiden Univ Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands.
   [Konstantinides, Stavros, V] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany.
   [Konstantinides, Stavros, V] Democritus Univ Thrace, Dept Cardiol, Alexandroupolis, Greece.
   [Landmesser, Ulf] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany.
   [Landmesser, Ulf] German Ctr Cardiovasc Res DZHK, Berlin Inst Hlth BIH, Partner Site Berlin, Berlin, Germany.
   [Leclercq, Christophe] Univ Rennes, CHU Rennes, INSERM, LTSI UMR 1099, Rennes, France.
   [Leonardi, Sergio] Univ Pavia, Pavia, Italy.
   [Leonardi, Sergio] Fdn IRCCS Policlin S Matteo, Pavia, Italy.
   [Lettino, Maddalena] ASST Monza, San Gerardo Hosp, Cardiothorac & Vasc Dept, Monza, Italy.
   [Mauri, Josepa; Rodriguez-Leor, Oriol] Hosp Badalona Germans Trias & Pujol, Inst Cor, Badalona, Spain.
   [Mauri, Josepa] Govt Catalonia, Hlth Dept, Barcelona, Spain.
   [Metra, Marco; Tomasoni, Daniela] ASST Spedali Civili Brescia, Inst Cardiol, Brescia, Italy.
   [Metra, Marco] Univ Brescia, Dept Med & Surg Special, Radiol Sci & Publ Hlth, Brescia, Italy.
   [Morici, Nuccia] ASST Grande Osped Metropolitano Niguarda, Cardio Ctr, Unita Cure Intens Cardiol & Gasperis, Milan, Italy.
   [Morici, Nuccia] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy.
   [Mueller, Christian] Univ Hosp Basel, Cardiovasc Res Inst Basel CRIB, Basel, Switzerland.
   [Mueller, Christian] Univ Basel, Basel, Switzerland.
   [Petronio, Anna Sonia] Univ Pisa, Cardiothorac & Vasc Dept, Osped Cisanello, Pisa, Italy.
   [Polovina, Marija M.; Seferovic, Petar] Univ Belgrade, Fac Med, Belgrade, Serbia.
   [Polovina, Marija M.] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia.
   [Potpara, Tatjana] Univ Belgrade, Sch Med, Belgrade, Serbia.
   [Potpara, Tatjana] Clin Ctr Serbia, Cardiol Clin, Dept Intens Arrhythmia Care, Belgrade, Serbia.
   [Praz, Fabien] Univ Hosp Bern, Dept Cardiol, Bern, Switzerland.
   [Prendergast, Bernard] St Thomas Hosp, London, England.
   [Prendergast, Bernard] Cleveland Clin London, London, England.
   [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark.
   [Price, Susanna] Royal Brompton Hosp, London, England.
   [Price, Susanna] Imperial Coll, Natl Heart & Lung Inst, London, England.
   [Pruszczyk, Piotr] Med Univ Warsaw, Dept Internal Med & Cardiol, Warsaw, Poland.
   [Roffi, Marco] Geneva Univ Hosp, Dept Cardiol, Geneva, Switzerland.
   [Romaguera, Rafael] Hosp Univ Bellvitge IDIBELL, Serv Cardiol, Barcelona, Spain.
   [Rosenkranz, Stephan] Univ Cologne, Heart Ctr, Clin Internal Med Cardiol 3, Cologne, Germany.
   [Rosenkranz, Stephan] Univ Cologne, CCRC Heart Ctr, Cologne Cardiovasc Res Ctr CCRC, Cologne, Germany.
   [Rosenkranz, Stephan] Univ Cologne, Ctr Mol Med Cologne CMMC, Cologne, Germany.
   [Scherrenberg, Martijn] Jessa Hosp, Heart Ctr Hasselt, Hasselt, Belgium.
   [Seferovic, Petar] Serbian Acad Arts & Sci, Belgrade, Serbia.
   [Stefanini, Giulio; Torracca, Lucia] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele Milan, Italy.
   [Stefanini, Giulio; Torracca, Lucia] Humanitas Res Hosp IRCCS, Rozzano Milan, Germany.
   [Thiele, Holger] Univ Leipzig, Heart Ctr Leipzig, Dept Internal Med Cardiol, Leipzig, Germany.
   [Tomasoni, Daniela] Univ Brescia, Dept Med & Surg Special Radiol Sci & Publ Hlth, Brescia, Italy.
   [Wilde, Arthur A.] EHRA, ECGen, Cardiogenet Focus Grp, London, England.
   [Wilde, Arthur A.] Univ Amsterdam, Amsterdam UMC, Heart Ctr, Amsterdam, Netherlands.
   [Wilde, Arthur A.] Amsterdam Cardiovasc Sci, Dept Clin Cardiol, Amsterdam, Netherlands.
   [Williams, Bryan] UCL, Inst Cardiovasc Sci, London, England.
RP Baigent, C (corresponding author), Nuffield Dept Populat Hlth, MRC Populat Hlth Res Unit, Oxford, England.; Windecker, S (corresponding author), Bern Univ Hosp, Dept Cardiol, Inselspital, Bern, Switzerland.
EM colin.baigent@ndph.ox.ac.uk; stephan.windecker@insel.ch
RI Bueno, Hector/I-3910-2015; delgado, victoria/AAL-4731-2021
OI Bueno, Hector/0000-0003-0277-7596; delgado,
   victoria/0000-0002-9841-2737; Karam, Nicole/0000-0002-3861-6914;
   Rodriguez-Leor, Oriol/0000-0003-2657-5657; Williams,
   Bryan/0000-0002-8094-1841; Behr, Elijah/0000-0002-8731-2853
CR Abrams MP, 2020, J CARDIOVASC ELECTR, V31, P3086, DOI 10.1111/jce.14772
   Abrams Mark P, 2020, HeartRhythm Case Rep, V6, P858, DOI 10.1016/j.hrcr.2020.08.017
   ACTIV-3 TICO LY-CoV555 Study Grp, 2021, NEW ENGL J MED, V384, P905, DOI 10.1056/NEJMoa2033130
   Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Akbulak RO, 2018, MULT SCLER RELAT DIS, V19, P44, DOI 10.1016/j.msard.2017.10.020
   Al Shibli Amar, 2012, Arab J Nephrol Transplant, V5, P47
   Al-Assaf Omar, 2020, HeartRhythm Case Rep, V6, P884, DOI 10.1016/j.hrcr.2020.09.003
   Albert CL, 2020, CIRCULATION, V142, P1865, DOI 10.1161/CIRCULATIONAHA.120.050097
   AlGhamdi M, 2015, AM J TRANSPLANT, V15, P1101, DOI 10.1111/ajt.13085
   Alvarez-Garcia J, 2020, J AM COLL CARDIOL, V76, P2334, DOI 10.1016/j.jacc.2020.09.549
   Ambrus DB, 2015, J CRIT CARE, V30, P994, DOI 10.1016/j.jcrc.2015.06.003
   Andersson C, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007274
   Andhika R, 2021, THER APHER DIAL, V25, P706, DOI 10.1111/1744-9987.13597
   Annane D, 2008, AM J RESP CRIT CARE, V178, P20, DOI 10.1164/rccm.200701-031OC
   Arabi YM, 2020, TRIALS, V21, DOI 10.1186/s13063-019-3846-x
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Argulian E, 2020, JACC-CARDIOVASC IMAG, V13, P2459, DOI 10.1016/j.jcmg.2020.05.010
   Arora S, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.006929
   Asgar AW, 2015, J AM COLL CARDIOL, V65, P1231, DOI 10.1016/j.jacc.2015.02.009
   Attisano T, 2019, ESC HEART FAIL
   Azarkish M, 2020, EUR HEART J, V41, P2131, DOI 10.1093/eurheartj/ehaa307
   Aziz H, 2020, TRANSPL P, V52, P2642, DOI 10.1016/j.transproceed.2020.09.006
   Badri Marwan, 2015, JACC Clin Electrophysiol, V1, P315, DOI 10.1016/j.jacep.2015.05.008
   Basille D, 2017, LUNG, V195, P201, DOI 10.1007/s00408-016-9973-1
   Basso C, 2020, EUR HEART J, V41, P3827, DOI 10.1093/eurheartj/ehaa664
   Bauernschmitt R, 2020, EUR J CARDIO-THORAC, V58, P188, DOI 10.1093/ejcts/ezaa193
   Bean DM, 2020, EUR J HEART FAIL, V22, P967, DOI 10.1002/ejhf.1924
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Belanger MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2021264
   Bergler-Klein J, 2004, CIRCULATION, V109, P2302, DOI 10.1161/01.CIR.0000126825.50903.18
   Bessiere F, 2020, JAMA CARDIOL, V5, P1067, DOI 10.1001/jamacardio.2020.1787
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857
   Boriani G, 2019, EUROPACE, V21, P7, DOI 10.1093/europace/euy110
   Borsini F, 2012, ANTIMICROB AGENTS CH, V56, P3261, DOI 10.1128/AAC.05688-11
   Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638
   Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150
   Bromage DI, 2020, EUR J HEART FAIL, V22, P978, DOI 10.1002/ejhf.1925
   Brown B, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1506-0
   Brugada J, 2020, EUR HEART J, V41, P655, DOI 10.1093/eurheartj/ehz467
   Budak JZ, ANTIRETROVIRAL THERA
   Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114
   Cannata A, 2020, EUR J HEART FAIL, V22, P2219, DOI 10.1002/ejhf.1986
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Capel RA, 2015, HEART RHYTHM, V12, P2186, DOI 10.1016/j.hrthm.2015.05.027
   Cardiac Society of Australia and New Zealand, COVID 19 RES
   Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014
   Cave DM, 2010, CIRCULATION, V122, pS720, DOI 10.1161/CIRCULATIONAHA.110.970970
   Celutkiene J, 2020, EUR J HEART FAIL, V22, P181, DOI 10.1002/ejhf.1678
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Chang David, 2020, HeartRhythm Case Rep, V6, P237, DOI 10.1016/j.hrcr.2020.03.012
   Chen D, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11122
   Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849
   Chen XH, 2020, CLIN INFECT DIS, V71, P1937, DOI 10.1093/cid/ciaa449
   Chen Y, 2020, BIOCHEM BIOPH RES CO, V525, P135, DOI 10.1016/j.bbrc.2020.02.071
   Cheng YJ, 2015, J AM COLL CARDIOL, V66, P2173, DOI 10.1016/j.jacc.2015.09.029
   Chin CWL, 2014, EUR HEART J, V35, P2312, DOI 10.1093/eurheartj/ehu189
   Chioncel O, 2020, EUR J HEART FAIL, V22, P1315, DOI 10.1002/ejhf.1922
   Chorin E, 2020, HEART RHYTHM, V17, P1425, DOI 10.1016/j.hrthm.2020.05.014
   Choudry FA, 2020, J AM COLL CARDIOL, V76, P1168, DOI 10.1016/j.jacc.2020.07.022
   Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911
   Clavel MA, 2014, J AM COLL CARDIOL, V63, P2016, DOI 10.1016/j.jacc.2014.02.581
   Collet JP, 2021, EUR HEART J, V42, P1289, DOI [10.1093/eurheartj/ehaa575, 10.15829/1560-4071-2021-4418]
   Colon CM, 2020, JACC-CLIN ELECTROPHY, V6, P1189, DOI 10.1016/j.jacep.2020.05.015
   Costedoat-Chalumeau N, 2007, RHEUMATOLOGY, V46, P808, DOI 10.1093/rheumatology/kel402
   Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082
   de Abajo FJ, 2020, LANCET, V395, P1705, DOI 10.1016/S0140-6736(20)31030-8
   De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409
   de Simone G, POS STAT ESC COUNC H
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Deftereos SG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13136
   Deng SQ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020575
   Devreese KMJ, 2020, J THROMB HAEMOST, V18, P2191, DOI 10.1111/jth.14994
   Douglas I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1642
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Duchin K, 2018, CLIN PHARMACOKINET, V57, P221, DOI 10.1007/s40262-017-0554-0
   Dvir D., SEVERE VALVULAR HEAR
   Egede LE, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2023616
   El-Assaad Iqbal, 2020, JACC Case Rep, V2, P1351, DOI 10.1016/j.jaccas.2020.05.023
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Eneizat Mahdawi Tala, 2020, HeartRhythm Case Rep, V6, P652, DOI 10.1016/j.hrcr.2020.06.014
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Fauvel C, 2020, EUR HEART J, V41, P3058, DOI 10.1093/eurheartj/ehaa500
   Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461
   Fleming DM, 2010, EPIDEMIOL INFECT, V138, P1281, DOI 10.1017/S0950268810000105
   Frankfurter C, 2020, CAN J CARDIOL, V36, P1680, DOI 10.1016/j.cjca.2020.07.006
   Fresse A, 2021, INT J CARDIOL, V324, P255, DOI 10.1016/j.ijcard.2020.10.028
   Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6
   Furuhashi M, 2015, AM J HYPERTENS, V28, P15, DOI 10.1093/ajh/hpu086
   Garabelli P, 2016, J CARDIOVASC ELECTR, V27, P827, DOI 10.1111/jce.12976
   Gasperetti A, 2020, EUROPACE, V22, P1855, DOI 10.1093/europace/euaa216
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gil MR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17539
   Giudicessi JR, 2020, MAYO CLIN PROC, V95, P1213, DOI 10.1016/j.mayocp.2020.03.024
   Gold R, 2014, J NEUROL, V261, P267, DOI 10.1007/s00415-013-7115-8
   Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Grange S, 2011, INT J CLIN PHARM TH, V49, P648, DOI 10.5414/CP201549
   Guan WJ, 2020, NEW ENGL J MED, V382, P1708
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Gupta S, 2021, JAMA INTERN MED, V181, P41, DOI 10.1001/jamainternmed.2020.6252
   Gurwitz D, 2020, DRUG DEVELOP RES, V81, P537, DOI 10.1002/ddr.21656
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hasan Ali O, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1496, DOI 10.1093/CID/CIAA1496]
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Holzhauser L, 2020, AM J TRANSPLANT, V20, P2916, DOI 10.1111/ajt.15982
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7
   Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0
   Hsia BC, 2020, J INTERV CARD ELECTR, V59, P337, DOI 10.1007/s10840-020-00822-x
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huisman MV, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.28
   Humeniuk R, 2020, CTS-CLIN TRANSL SCI, V13, P896, DOI 10.1111/cts.12840
   Iacopino S, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.009040
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Imazio M, 2020, HEART, V106, P1127, DOI [10.1136/heartjnl-2020-317186, 10.1136/heartjnl-2020-317108]
   Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096
   Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a
   Jiang X, 2020, EUR HEART J, V41, P4580, DOI 10.1093/eurheartj/ehaa794
   Joyner MJ, 2020, J CLIN INVEST, V130, P4791, DOI [10.1172/JCI140200, 10.1101/2020.05.12.20099879]
   Kang DH, 2019, CIRCULATION, V139, P1354, DOI 10.1161/CIRCULATIONAHA.118.037077
   Kearon C, 2019, NEW ENGL J MED, V381, P2125, DOI 10.1056/NEJMoa1909159
   Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026
   Kerr B, 2020, IJC HEART VASC, V31, DOI 10.1016/j.ijcha.2020.100665
   Kim DW, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e243
   Kim J, 2020, J AM COLL CARDIOL, V76, P1965, DOI 10.1016/j.jacc.2020.08.066
   Kir Devika, 2020, JACC Case Rep, V2, P1252, DOI 10.1016/j.jaccas.2020.04.026
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Klok FA, 2020, THROMB RES, V191, P148, DOI 10.1016/j.thromres.2020.04.041
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Klouwenberg PMCK, 2017, AM J RESP CRIT CARE, V195, P205, DOI [10.1164/rccm.201603-06180C, 10.1164/rccm.201603-0618OC]
   Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]
   Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425
   Konig S, 2020, EUR J HEART FAIL, V22, P2190, DOI 10.1002/ejhf.2044
   Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4
   Kumar D, 2003, AM J TRANSPLANT, V3, P977, DOI 10.1034/j.1600-6143.2003.00197.x
   Lafaurie M, 2021, FUND CLIN PHARMACOL, V35, P194, DOI 10.1111/fcp.12613
   Lakkireddy DR, 2020, CIRCULATION, V141, pE823, DOI 10.1161/CIRCULATIONAHA.120.047063
   Latif F, 2019, JAMA CARDIOL
   Laurencin CT, 2020, J RACIAL ETHN HEALTH, V7, P398, DOI 10.1007/s40615-020-00756-0
   Lee Jae Hak, 2010, Korean Circ J, V40, P604, DOI 10.4070/kcj.2010.40.11.604
   Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li F, 2020, J HEART LUNG TRANSPL, V39, P496, DOI 10.1016/j.healun.2020.03.006
   Li JY, 2020, JAMA CARDIOL, V5, P825, DOI 10.1001/jamacardio.2020.1624
   Li Y, 2020, ANN NONINVAS ELECTRO, V25, DOI 10.1111/anec.12805
   Li YM, 2020, JACC-CARDIOVASC IMAG, V13, P2287, DOI 10.1016/j.jcmg.2020.04.014
   Limmroth V, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-016-0789-7
   Lip GYH, 2017, EUROPACE, V19, P891, DOI 10.1093/europace/eux091
   Lippi G, 2020, PROG CARDIOVASC DIS, V63, P390, DOI 10.1016/j.pcad.2020.03.001
   Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125
   Liu STH, 2021, LANCET, V397, P2024, DOI 10.1016/S0140-6736(21)01064-3
   Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Lopes RD, 2021, JAMA-J AM MED ASSOC, V325, P254, DOI 10.1001/jama.2020.25864
   Lopez-Otero D, 2021, REV ESP CARDIOL, V74, P105, DOI [10.1016/j.recesp.2020.08.003, 10.1016/j.rec.2020.08.005]
   Lowe DA, 2020, JAMA INTERN MED, V180, P1491, DOI 10.1001/jamainternmed.2020.4153
   Lu ZK, 2015, EXPERT OPIN DRUG SAF, V14, P295, DOI 10.1517/14740338.2015.989210
   Mack MJ, 2019, NEW ENGL J MED, V380, P1695, DOI 10.1056/NEJMoa1814052
   Madjid M, 2019, AM J CARDIOL, V124, P44, DOI 10.1016/j.amjcard.2019.04.011
   Maglione Theodore J, 2020, HeartRhythm Case Rep, V6, P676, DOI 10.1016/j.hrcr.2020.07.008
   Makkar RR, 2020, NEW ENGL J MED, V382, P799, DOI 10.1056/NEJMoa1910555
   Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923
   Maron DJ, 2020, NEW ENGL J MED, V382, P1395, DOI 10.1056/NEJMoa1915922
   Mazer SP, 2003, RESUSCITATION, V57, P279, DOI 10.1016/S0300-9572(03)00037-6
   McGhie TK, 2018, CLIN EXP RHEUMATOL, V36, P545
   Mebazaa A, 2018, INTENS CARE MED, V44, P760, DOI 10.1007/s00134-018-5214-9
   Medscape, DRUG INT CHECK
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mercuro NJ, 2020, JAMA CARDIOL, V5, P1036, DOI 10.1001/jamacardio.2020.1834
   Middleton EA, 2020, BLOOD, V136, P1169, DOI 10.1182/blood.2020007008
   Mitja O, 2021, CLIN INFECT DIS, V73, pE4073, DOI 10.1093/cid/ciaa1009
   Mitra Raman L, 2020, HeartRhythm Case Rep, V6, P244, DOI 10.1016/j.hrcr.2020.03.016
   Moey MYY, 2020, CIRC-ARRHYTHMIA ELEC, V13, P1223, DOI 10.1161/CIRCEP.120.009023
   Mohamed MO, 2021, EUR HEART J-QUAL CAR, V7, P247, DOI 10.1093/ehjqcco/qcaa079
   Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038
   Moore KT, 2014, CLIN PHARM DRUG DEV, V3, P321, DOI 10.1002/cpdd.123
   Moschini L, 2021, HEART VESSELS, V36, P115, DOI 10.1007/s00380-020-01671-4
   Mzayek Fawaz, 2007, PLoS Clin Trials, V2, pe6, DOI 10.1371/journal.pctr.0020006
   Nadkarni GN, 2020, J AM COLL CARDIOL, V76, P1815, DOI 10.1016/j.jacc.2020.08.041
   National Health Society, NHS CLIN GUID MAN CA
   National Institutes of Health, NIH SPONS ACTIV 3 CL
   Neumann FJ, 2019, EUROINTERVENTION, V14, P1435, DOI 10.4244/EIJY19M01_01
   Nguyen LS, 2020, CIRCULATION, V142, P303, DOI 10.1161/CIRCULATIONAHA.120.048238
   Nicolai L, 2020, CIRCULATION, V142, P1176, DOI 10.1161/CIRCULATIONAHA.120.048488
   Nopp S, 2020, RES PRACT THROMB HAE, V4, P1178, DOI 10.1002/rth2.12439
   Offerhaus JA, 2020, HEART RHYTHM, V17, P1480, DOI 10.1016/j.hrthm.2020.07.001
   Oikonomou E, 2020, PUBLIC HEALTH, V187, P115, DOI 10.1016/j.puhe.2020.08.007
   Oliveira JS, 2020, BRIT J SPORT MED, V54, P1188, DOI 10.1136/bjsports-2018-100324
   Otto CM, 2014, NEW ENGL J MED, V371, P744, DOI 10.1056/NEJMra1313875
   Ozieranski K, 2021, J CARD FAIL, V27, P92, DOI 10.1016/j.cardfail.2020.11.002
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   Peigh G, 2020, EUR HEART J-CASE REP, V4, DOI 10.1093/ehjcr/ytaa132
   Peltzer B, 2020, CIRC-ARRHYTHMIA ELEC, V13, P1229, DOI 10.1161/CIRCEP.120.009121
   Peltzer B, 2020, J CARDIOVASC ELECTR, V31, P3077, DOI 10.1111/jce.14770
   Perkins GD, 2018, RESUSCITATION, V123, P43, DOI 10.1016/j.resuscitation.2017.12.007
   Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106
   Piro A, 2020, J CARDIOVASC ELECTR, V31, P2814, DOI 10.1111/jce.14755
   Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Pontone G, 2020, JACC-CARDIOVASC IMAG, V13, P1854, DOI 10.1016/j.jcmg.2020.04.012
   Popma JJ, 2019, NEW ENGL J MED, V380, P1706, DOI 10.1056/NEJMoa1816885
   Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686
   Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316
   Priori SG, 2013, EUROPACE, V15, P1389, DOI 10.1093/europace/eut272
   Ramireddy A, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017144
   Ramiro S, 2020, ANN RHEUM DIS, V79, P1143, DOI 10.1136/annrheumdis-2020-218479
   Rao GA, 2014, ANN FAM MED, V12, P121, DOI 10.1370/afm.1601
   Rathbun RC, 2009, HIV CLIN TRIALS, V10, P328, DOI 10.1310/hct1005-328
   Ren ZL, 2020, J HEART LUNG TRANSPL, V39, P412, DOI 10.1016/j.healun.2020.03.008
   Rey JR, 2020, EUR J HEART FAIL, V22, P2205, DOI 10.1002/ejhf.1990
   Ro R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19801
   Prestes TRR, 2017, CURR DRUG TARGETS, V18, P1301, DOI 10.2174/1389450117666160727142401
   Rodriguez-Leor O, 2021, EUROINTERVENTION, V16, P1426, DOI 10.4244/EIJ-D-20-00935
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630
   Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903
   Rosenhek R, 2010, CIRCULATION, V121, P151, DOI 10.1161/CIRCULATIONAHA.109.894170
   Rossi PG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238281
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Rubio-Rivas M, 2020, INT J INFECT DIS, V101, P290, DOI 10.1016/j.ijid.2020.09.1486
   Russell MR, 2020, J HEART LUNG TRANSPL, V39, P732, DOI 10.1016/j.healun.2020.04.021
   Russo V, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13387
   Ryffel C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20402
   Sala S, 2020, PACE, V43, P891, DOI 10.1111/pace.13987
   Saleh M, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008937
   Saleh M, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008662
   Salvarani C, 2021, JAMA INTERN MED, V181, P24, DOI 10.1001/jamainternmed.2020.6615
   Salzano A, 2020, EUR J HEART FAIL, V22, P1048, DOI 10.1002/ejhf.1911
   Sanchis-Gomar F, 2020, AM J CARDIOVASC DRUG, V20, P413, DOI 10.1007/s40256-020-00429-7
   Seferovic PM, 2019, EUR J HEART FAIL, V21, P1169, DOI 10.1002/ejhf.1531
   Shankar-Hari M, 2021, JAMA-J AM MED ASSOC, V326, P499, DOI 10.1001/jama.2021.11330
   Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Sinan U, 2018, INT J CARDIOVASC ACA, V4, P82
   Sinkeler FS, 2020, NETH HEART J, V28, P418, DOI 10.1007/s12471-020-01462-6
   Skipper CP, 2020, ANN INTERN MED, V173, P623, DOI 10.7326/M20-4207
   Sodero A, 2019, CLIN MED INSIGHT-CAS, V12, DOI 10.1177/1179547619831026
   Song Y, 2016, CLIN THER, V38, P1674, DOI 10.1016/j.clinthera.2016.05.004
   Song Y, 2015, CLIN THER, V37, P1703, DOI 10.1016/j.clinthera.2015.05.497
   Sorajja P, 2017, J AM COLL CARDIOL, V70, P2315, DOI 10.1016/j.jacc.2017.09.015
   Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349
   Sridhar Arun R, 2020, Heart Rhythm O2, V1, P167, DOI 10.1016/j.hroo.2020.06.002
   Stefanini GG, 2020, HEART, V106, P1512, DOI 10.1136/heartjnl-2020-317322
   Stefanini GG, 2020, CIRCULATION, V141, P1597, DOI 10.1161/CIRCULATIONAHA.120.047070
   Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Szekely Y, 2020, HEART RHYTHM, V17, P1452, DOI 10.1016/j.hrthm.2020.04.046
   Tardif JC, 2021, LANCET RESP MED, V9, P924, DOI 10.1016/S2213-2600(21)00222-8
   Teixeira Ricardo Alkmim, 2002, Arq. Bras. Cardiol., V79, P85, DOI 10.1590/S0066-782X2002001000009
   Teixeira RA, 2014, EUROPACE, V16, P887, DOI 10.1093/europace/eut290
   Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841
   Thiele H, 2019, EUR HEART J, V40, P2671, DOI 10.1093/eurheartj/ehz363
   Tomasoni D, 2020, EUR J HEART FAIL, V22, P2238, DOI 10.1002/ejhf.2052
   Tomasoni D, 2020, EUR J HEART FAIL, V22, P957, DOI 10.1002/ejhf.1871
   Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021
   Touret F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70143-6
   Turagam MK, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008920
   University of Liverpool, COVID 19 DRUG INT PR
   Vakili K, 2020, REV CARDIOVASC MED, V21, P433, DOI 10.31083/j.rcm.2020.03.129
   van Dam LF, 2020, THROMB RES, V193, P86, DOI 10.1016/j.thromres.2020.06.010
   van de Poll SWE, 2020, NETH HEART J, V28, P431, DOI 10.1007/s12471-020-01459-1
   van den Broek MPH, 2020, NETH HEART J, V28, P406, DOI 10.1007/s12471-020-01429-7
   van der Hulle T, 2017, LANCET, V390, P289, DOI 10.1016/S0140-6736(17)30885-1
   van der Pol LM, 2019, NEW ENGL J MED, V380, P1139, DOI 10.1056/NEJMoa1813865
   Varma N, 2020, J AM COLL CARDIOL, V76, P1363, DOI [10.1016/j.jacc.2020.06.019, 10.1016/j.hrthm.2020.06.010, 10.1002/joa3.12389, 10.1093/europace/euaa187, 10.1161/CIRCEP.120.009007]
   Vicente J, 2019, CLIN PHARMACOL THER, V105, P943, DOI 10.1002/cpt.1303
   Vidovich Mladen I, 2020, JACC Case Rep, V2, P1245, DOI 10.1016/j.jaccas.2020.04.007
   Walkey AJ, 2014, CHEST, V146, P1187, DOI 10.1378/chest.14-0003
   Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wang YN, 2020, ANN NONINVAS ELECTRO, V25, DOI 10.1111/anec.12806
   Watkins J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m810
   Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002
   Wenzel P, 2020, CARDIOVASC RES, V116, P1661, DOI 10.1093/cvr/cvaa160
   White NJ, 2007, LANCET INFECT DIS, V7, P549, DOI 10.1016/S1473-3099(07)70187-1
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Williams B, 2021, LANCET RESP MED, V9, P221, DOI 10.1016/S2213-2600(21)00003-5
   Williams B, 2020, LANCET, V395, P1671, DOI 10.1016/S0140-6736(20)31131-4
   Williams B, 2018, J HYPERTENS, V36, P1953, DOI [10.1097/HJH.0000000000001940, 10.1714/3026.30245]
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   World Health Organization, THER COVID 19 LIV GU
   Wozniacka A, 2006, LUPUS, V15, P521, DOI 10.1191/0961203306lu2345oa
   Wu CI, 2020, HEART RHYTHM, V17, P1456, DOI 10.1016/j.hrthm.2020.03.024
   Wu JH, 2021, HEART, V107, P113, DOI 10.1136/heartjnl-2020-317912
   Xu L, 2020, LIVER INT, V40, P998, DOI 10.1111/liv.14435
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Yang T, 1996, CIRCULATION, V93, P407, DOI 10.1161/01.CIR.93.3.407
   Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Yogasundaram H, 2014, CAN J CARDIOL, V30, P1706, DOI 10.1016/j.cjca.2014.08.016
   Zhang JS, 2020, AM J CLIN NUTR, V111, P1297, DOI 10.1093/ajcn/nqaa095
   Zhang MD, 2017, CARDIOVASC TOXICOL, V17, P434, DOI 10.1007/s12012-017-9401-7
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhang YH, 2020, EUR J HEART FAIL, V22, P941, DOI 10.1002/ejhf.1915
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zilberszac R, 2018, JACC-CARDIOVASC IMAG, V11, P1213, DOI 10.1016/j.jcmg.2018.05.014
   Zlotnick DM, 2013, AM J CARDIOL, V112, P1635, DOI 10.1016/j.amjcard.2013.07.025
NR 308
TC 8
Z9 8
U1 3
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
EI 1522-9645
J9 EUR HEART J
JI Eur. Heart J.
PD MAR 14
PY 2022
VL 43
IS 11
SI SI
BP 1059
EP 1103
DI 10.1093/eurheartj/ehab697
PG 45
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA ZS4OV
UT WOS:000768447300008
PM 34791154
OA Bronze, Green Submitted, Green Published
DA 2022-04-20
ER

PT J
AU Sideris, GA
   Nikolakea, M
   Karanikola, AE
   Konstantinopoulou, S
   Giannis, D
   Modahl, L
AF Sideris, Georgios Antonios
   Nikolakea, Melina
   Karanikola, Aikaterini-Eleftheria
   Konstantinopoulou, Sofia
   Giannis, Dimitrios
   Modahl, Lucy
TI Imaging in the COVID-19 era: Lessons learned during a pandemic
SO WORLD JOURNAL OF RADIOLOGY
LA English
DT Review
DE COVID-19; Infectious diseases; Diagnostic imaging; Radiography; Computed
   tomography; Artificial intelligence
ID CORONAVIRUS DISEASE 2019; ACUTE RESPIRATORY SYNDROME; CHEST
   COMPUTED-TOMOGRAPHY; POLYMERASE CHAIN-REACTION; ACUTE KIDNEY INJURY; CT
   FEATURES; CUTANEOUS MANIFESTATIONS; RADIOLOGY; INFECTION; DIAGNOSIS
AB The first year of the coronavirus disease 2019 (COVID-19) pandemic has been a year of unprecedented changes, scientific breakthroughs, and controversies. The radiology community has not been spared from the challenges imposed on global healthcare systems. Radiology has played a crucial part in tackling this pandemic, either by demonstrating the manifestations of the virus and guiding patient management, or by safely handling the patients and mitigating transmission within the hospital. Major modifications involving all aspects of daily radiology practice have occurred as a result of the pandemic, including workflow alterations, volume reductions, and strict infection control strategies. Despite the ongoing challenges, considerable knowledge has been gained that will guide future innovations. The aim of this review is to provide the latest evidence on the role of imaging in the diagnosis of the multifaceted manifestations of COVID-19, and to discuss the implications of the pandemic on radiology departments globally, including infection control strategies and delays in cancer screening. Lastly, the promising contribution of artificial intelligence in the COVID-19 pandemic is explored.
C1 [Sideris, Georgios Antonios; Modahl, Lucy] Univ Massachusetts, Dept Radiol, Baystate Med Ctr, Med Sch, 759 Chestnut St, Springfield, MA 01199 USA.
   [Sideris, Georgios Antonios; Nikolakea, Melina; Karanikola, Aikaterini-Eleftheria] Soc Jr Doctors, Radiol Working Grp, Athens 11527, Greece.
   [Konstantinopoulou, Sofia] Sheikh Khalifa Med City, Div Pulm Med, Dept Pediat, Abu Dhabi W1301, U Arab Emirates.
   [Giannis, Dimitrios] Northwell Hlth, Inst Hlth Innovat & Outcomes Res, Feinstein Inst Med Res, Manhasset, NY 11030 USA.
RP Sideris, GA (corresponding author), Univ Massachusetts, Dept Radiol, Baystate Med Ctr, Med Sch, 759 Chestnut St, Springfield, MA 01199 USA.
EM siderismd@gmail.com
OI Giannis, Dimitrios/0000-0001-9246-976X
CR Adams HJA, 2020, AM J ROENTGENOL, V215, P1342, DOI 10.2214/AJR.20.23391
   Adams HJA, 2020, RADIOLOGY, V297, pE236, DOI 10.1148/radiol.2020201709
   Aghagoli G, 2021, NEUROCRIT CARE, V34, P1062, DOI 10.1007/s12028-020-01049-4
   Agostini A, 2020, RADIOL MED, V125, P365, DOI 10.1007/s11547-020-01179-x
   Ahmed M, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100527
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Akl EA, 2021, RADIOLOGY, V298, pE63, DOI 10.1148/radiol.2020203173
   Aljondi R, 2020, J MED INTERNET RES, V22, DOI 10.2196/19673
   Allinovi M, 2020, ULTRASOUND MED BIOL, V46, P2908, DOI 10.1016/j.ultrasmedbio.2020.07.018
   Altundag A, 2021, OTOLARYNG HEAD NECK, V164, P1337, DOI 10.1177/0194599820965920
   American Cancer Society, CANC SCREEN COVID 19
   American College of Radiology, ACR REC US CHEST RAD
   Andalib S, 2021, CURR NEUROL NEUROSCI, V21, DOI 10.1007/s11910-021-01102-5
   Eskandar Emad Nader, 2021, Neurology, V96, pe1527, DOI [10.1212/WNL.0000000000011607, 10.1212/WNL.0000000000011356]
   [Anonymous], COVID 19 ACR STAT NU
   Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4
   Awulachew E, 2020, RADIOL RES PRACT, V2020, DOI 10.1155/2020/1023506
   Aycock RD, 2018, ANN EMERG MED, V71, P44, DOI 10.1016/j.annemergmed.2017.06.041
   Bai HX, 2020, RADIOLOGY, V296, pE156, DOI 10.1148/radiol.2020201491
   Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823
   Bar S, 2020, ANAESTHESIA, V75, P1620, DOI 10.1111/anae.15175
   Barkmeier DT, 2021, ABDOM RADIOL, V46, P1256, DOI 10.1007/s00261-020-02747-5
   Bayramoglu Z, 2021, ACAD RADIOL, V28, P18, DOI 10.1016/j.acra.2020.10.002
   Becker AS, 2021, RADIOLOGY, V300, pE323, DOI 10.1148/radiol.2021210436
   Beitzke D, 2020, INT J CARDIOVAS IMAG, V36, P1801, DOI 10.1007/s10554-020-01892-8
   Bennett D, 2021, ULTRASOUND MED BIOL, V47, P19, DOI 10.1016/j.ultrasmedbio.2020.09.014
   Bhayana R, 2020, RADIOLOGY, V297, pE207, DOI 10.1148/radiol.2020201908
   Bin Naeem S, 2020, HEALTH INFO LIBR J, V37, P233, DOI 10.1111/hir.12311
   Byrne D, 2021, CAN ASSOC RADIOL J, V72, P159, DOI 10.1177/0846537120938328
   Cabanes-Martinez L, 2020, CLIN NEUROPHYSIOL, V131, P2809, DOI 10.1016/j.clinph.2020.09.017
   Capaccione KM, 2021, ACAD RADIOL, V28, P595, DOI 10.1016/j.acra.2021.01.022
   Carlon T, 2021, ACAD RADIOL, V28, P447, DOI 10.1016/j.acra.2021.01.015
   Carotti M, 2020, RADIOL MED, V125, P636, DOI 10.1007/s11547-020-01237-4
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Cau R, 2021, INT J CARDIOVAS IMAG, V37, P1349, DOI 10.1007/s10554-020-02089-9
   Chassagnon G, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101860
   Chen JY, 2020, J MED INTERNET RES, V22, DOI 10.2196/21476
   Cheung KS, 2020, GASTROENTEROLOGY, V159, P81, DOI 10.1053/j.gastro.2020.03.065
   Ciccarese Federica, 2020, Radiol Cardiothorac Imaging, V2, pe200312, DOI 10.1148/ryct.2020200312
   Cornejo R, 2010, BMJ CASE REP
   Coronavirus (COVID-19) vaccinations, 2021, CORONAVIRUS COVID 19, P2021
   Das JP, 2021, EUR J NUCL MED MOL I, V48, P794, DOI 10.1007/s00259-020-05043-y
   De Giorgi V, 2020, J AM ACAD DERMATOL, V83, P674, DOI 10.1016/j.jaad.2020.05.073
   De Sanctis P, 2020, EUR J NEUROL, V27, P2361, DOI 10.1111/ene.14462
   De Smet K, 2021, RADIOLOGY, V298, pE30, DOI 10.1148/radiol.2020202708
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Eifer M, 2021, RADIOLOGY, V299, pE248, DOI 10.1148/radiol.2020210030
   El Homsi M, 2020, EUR J RADIOL OPEN, V7, DOI 10.1016/j.ejro.2020.100239
   Fan ZY, 2020, CLIN GASTROENTEROL H, V18, P1561, DOI 10.1016/j.cgh.2020.04.002
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Fang Y, 2020, AM J EMERG MED, V38, P2134, DOI 10.1016/j.ajem.2020.05.120
   Fenlon EP, 2021, PEDIATR RADIOL, V51, P831, DOI 10.1007/s00247-020-04929-1
   Fields BKK, 2021, SEMIN NUCL MED, V51, P312, DOI 10.1053/j.semnuclmed.2020.11.003
   Gandhi D, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3043
   Gandhi D, 2020, WORLD J RADIOL, V12, P195, DOI 10.4329/wjr.v12.i9.195
   Gazendam A, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.20.00610
   Gogia B, 2020, INT J NEUROSCI, DOI 10.1080/00207454.2020.1869001
   Goh Y, 2020, J AM COLL RADIOL, V17, P717, DOI 10.1016/j.jacr.2020.03.027
   Greenspan H, 2020, MED IMAGE ANAL, V66, DOI 10.1016/j.media.2020.101800
   Grimm L, SBI RECOMMENDATIONS
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Haak SL, 2021, EMERG MED J, V38, P94, DOI 10.1136/emermed-2020-210125
   Hameed S, 2021, RADIOLOGY, V298, pE1, DOI 10.1148/radiol.2020202543
   Han XY, 2021, RADIOLOGY, V299, pE177, DOI 10.1148/radiol.2021203153
   Hani C, 2020, DIAGN INTERV IMAG, V101, P263, DOI 10.1016/j.diii.2020.03.014
   Hare SS, 2020, CLIN RADIOL, V75, P399, DOI 10.1016/j.crad.2020.04.002
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Henry BM, 2020, CLIN CHIM ACTA, V507, P167, DOI 10.1016/j.cca.2020.04.027
   Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
   Hizal M, 2021, PEDIATR PULM, V56, P1018, DOI 10.1002/ppul.25127
   Homayounieh F, 2021, RADIOLOGY, V298, pE141, DOI 10.1148/radiol.2020203453
   Homayounieh F, 2020, J COMPUT ASSIST TOMO, V44, P640, DOI 10.1097/RCT.0000000000001094
   Hope MD, 2020, LANCET, V395, P1189, DOI 10.1016/S0140-6736(20)30728-5
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hosseiny M, 2020, AM J ROENTGENOL, V214, P1078, DOI 10.2214/AJR.20.22969
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Husain Rola, 2020, Radiol Case Rep, V15, P1633, DOI 10.1016/j.radcr.2020.07.003
   Hwang DM, 2005, MODERN PATHOL, V18, P1, DOI 10.1038/modpathol.3800247
   Jacobi A, 2020, CLIN IMAG, V64, P35, DOI 10.1016/j.clinimag.2020.04.001
   Jaiswal A, 2021, J BIOMOL STRUCT DYN, V39, P5682, DOI 10.1080/07391102.2020.1788642
   Jajodia A, 2020, EUR J RADIOL OPEN, V7, DOI 10.1016/j.ejro.2020.100237
   Jaremko JL, 2019, CAN ASSOC RADIOL J, V70, P107, DOI 10.1016/j.carj.2019.03.001
   Johns Hopkins University & Medicine, COVID 19 DASHB CTR S
   Joseph NP, 2020, RADIOLOGY, V297, pE303, DOI 10.1148/radiol.2020202602
   Joudi N, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100146
   Kalra MK, 2020, EUR RADIOL, V30, P6554, DOI 10.1007/s00330-020-07034-x
   Kang Z, 2020, EUR RADIOL, V30, P4356, DOI 10.1007/s00330-020-06809-6
   Katal S, 2020, ACAD RADIOL, V27, P1608, DOI 10.1016/j.acra.2020.07.031
   Kaufman HW, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17267
   Kerpel A, 2020, WEST J EMERG MED, V21, P1067, DOI 10.5811/westjem.2020.7.48842
   Kim Hyungjin, 2020, Radiology, V296, pE145, DOI 10.1148/radiol.2020201343
   Koo HJ, 2018, RADIOGRAPHICS, V38, P719, DOI 10.1148/rg.2018170048
   Kory P, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000724
   Kremer S, 2020, RADIOLOGY, V297, pE242, DOI [10.1148/radiol.202020222, 10.1148/radiol.2020202222]
   Kunutsor SK, 2020, ANN MED, V52, P345, DOI 10.1080/07853890.2020.1790643
   Kwee TC, 2020, RADIOGRAPHICS, V40, P1848, DOI 10.1148/rg.2020200159
   Landecho MF, 2021, J INTERN MED, V289, P116, DOI 10.1111/joim.13156
   Lang M, 2021, CHEST, V159, P1288, DOI 10.1016/j.chest.2020.10.045
   Lang M, 2020, LANCET INFECT DIS, V20, P1365, DOI 10.1016/S1473-3099(20)30367-4
   Larici AR, 2020, EUR J RADIOL, V131, DOI 10.1016/j.ejrad.2020.109217
   Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363
   Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1
   Lecler A, 2021, RADIOLOGY, V299, pE226, DOI 10.1148/radiol.2021204394
   Lee C, 2021, RADIOLOGY, V298, pE158, DOI 10.1148/radiol.2020204129
   Lehman CD, 2021, J AM COLL RADIOL, V18, P843, DOI 10.1016/j.jacr.2021.03.001
   Lehman CD, 2021, AM J ROENTGENOL, V217, P584, DOI 10.2214/AJR.21.25688
   Leonard-Lorant I, 2020, RADIOLOGY, V296, pE189, DOI 10.1148/radiol.2020201561
   Li JW, 2021, DIAGN INTERV IMAG, V102, P69, DOI 10.1016/j.diii.2020.11.008
   Li KH, 2020, INVEST RADIOL, V55, P327, DOI 10.1097/RLI.0000000000000672
   Li L, 2020, RADIOLOGY, V296, pE65, DOI 10.1148/radiol.2020200905
   Li X, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02911-9
   Li YF, 2020, J MED VIROL, V92, P903, DOI 10.1002/jmv.25786
   Li Y, 2020, AM J ROENTGENOL, V214, P1280, DOI 10.2214/AJR.20.22954
   Li ZQ, 2020, FRONT MED-PRC, V14, P533, DOI 10.1007/s11684-020-0786-5
   Lima M, 2020, CURR TREAT OPTION NE, V22, DOI 10.1007/s11940-020-00647-z
   Ling XC, 2020, TAIWAN J OPHTHALMOL, V10, P153, DOI 10.4103/tjo.tjo_53_20
   Lippi G, 2020, THROMB HAEMOSTASIS, V120, P876, DOI 10.1055/s-0040-1709650
   Lu WZ, 2020, ULTRASCHALL MED, V41, P300, DOI 10.1055/a-1154-8795
   Lu Y, 2014, CHEST, V145, P1079, DOI 10.1378/chest.13-2090
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Lui K, 2021, ABDOM RADIOL, V46, P1249, DOI 10.1007/s00261-020-02739-5
   Luker Gary D, 2021, Radiol Imaging Cancer, V3, pe210003, DOI 10.1148/rycan.2021210003
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5
   Maringe C, 2020, LANCET ONCOL, V21, P1023, DOI 10.1016/S1470-2045(20)30388-0
   Marzano AV, 2021, J AM ACAD DERMATOL, V84, P1356, DOI 10.1016/j.jaad.2021.01.023
   Mast C, DELAYED CANC SCREENI
   Mazzone PJ, 2020, CHEST, V158, P406, DOI 10.1016/j.chest.2020.04.020
   McGuinness G, 2020, RADIOLOGY, V297, pE252, DOI 10.1148/radiol.2020202352
   Mehraeen E, 2020, EUR J INTEGR MED, V40, DOI 10.1016/j.eujim.2020.101226
   Mehta NA, 2021, CLIN GASTROENTEROL H, V19, P760, DOI 10.1016/j.cgh.2020.05.054
   Mollura DJ, 2010, J AM COLL RADIOL, V7, P690, DOI 10.1016/j.jacr.2010.01.007
   Moreno CC, 2021, ABDOM RADIOL, V46, P486, DOI 10.1007/s00261-020-02674-5
   Mossa-Basha M, 2020, RADIOLOGY, V296, pE106, DOI 10.1148/radiol.2020200988
   Moy L, 2020, RADIOLOGY, V296, DOI 10.1148/radiol.2020204005
   Musolino AM, 2021, PEDIATR PULM, V56, P1045, DOI 10.1002/ppul.25255
   Naude W, 2020, AI SOC, V35, P761, DOI 10.1007/s00146-020-00978-0
   Ojha V, 2020, EUR RADIOL, V30, P6129, DOI 10.1007/s00330-020-06975-7
   Oudkerk M, 2020, RADIOLOGY, V297, pE216, DOI 10.1148/radiol.2020201629
   ozutemiz C, 2021, RADIOLOGY, V2021
   Palaiodimos L, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154262
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Parry AH, 2020, ACAD RADIOL, V27, P1190, DOI 10.1016/j.acra.2020.05.016
   Patt D, 2020, JCO CLIN CANCER INFO, V4, P1059, DOI 10.1200/CCI.20.00134
   Peng SM, 2020, CANCER-AM CANCER SOC, V126, P5202, DOI 10.1002/cncr.33180
   Peng XH, 2021, PEDIATR RADIOL, V51, P222, DOI 10.1007/s00247-020-04826-7
   Pesapane F, 2018, INSIGHTS IMAGING, V9, P745, DOI 10.1007/s13244-018-0645-y
   Planquette B, 2021, THROMB RES, V197, P94, DOI 10.1016/j.thromres.2020.11.001
   Politi LS, 2020, JAMA NEUROL, V77, P1028, DOI 10.1001/jamaneurol.2020.2125
   Poyiadji N, 2020, RADIOLOGY, V297, pE335, DOI 10.1148/radiol.2020201955
   Prokop M, 2020, RADIOLOGY, V296, pE97, DOI 10.1148/radiol.2020201473
   Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]
   Radmanesh A, 2020, RADIOLOGY, V297, pE223, DOI 10.1148/radiol.2020202040
   Rafiee F, 2020, SEMIN NUCL MED, V51, P178, DOI 10.1053/j.semnuclmed.2020.10.002
   Raissaki M, 2020, PEDIATR RADIOL, V50, P1313, DOI 10.1007/s00247-020-04749-3
   Ramani SL, 2021, SKELETAL RADIOL, V50, P1763, DOI 10.1007/s00256-021-03734-7
   Raptis CA, 2020, AM J ROENTGENOL, V215, P839, DOI 10.2214/AJR.20.23202
   Restivo DA, 2020, ANN INTERN MED, V173, P1027, DOI 10.7326/L20-0845
   Revzin MV, 2020, RADIOGRAPHICS, V40, P1866, DOI 10.1148/rg.2020200195
   Revzin MV, 2020, RADIOGRAPHICS, V40, P1574, DOI 10.1148/rg.2020200149
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Rubin GD, 2020, RADIOLOGY, V296, P172, DOI 10.1148/radiol.2020201365
   Salaffi F, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022433
   Salameh JP, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013639.pub2
   Salehi S, 2020, AM J ROENTGENOL, V215, P87, DOI [10.2214/AJR.20.23034, 10.2214/AJR.20.23034S.]
   Sanghi P, 2021, J INTENSIVE CARE MED, V36, P361, DOI 10.1177/0885066620959031
   Sansone P, 2021, LIFE-BASEL, V11, DOI 10.3390/life11020167
   Saritas Tuba Berra, 2013, ScientificWorldJournal, V2013, P182038, DOI 10.1155/2013/182038
   Sawlani V, 2021, CLIN RADIOL, V76, P108, DOI 10.1016/j.crad.2020.09.002
   Schalekamp S, 2021, RADIOLOGY, V298, pE98, DOI 10.1148/radiol.2020203465
   Sekhawat Vivek, 2021, Diagn Histopathol (Oxf), V27, P103, DOI 10.1016/j.mpdhp.2020.11.008
   Selway WG, 2020, BRIT J SURG, V107, pE646, DOI 10.1002/bjs.12059
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Simoni P, 2020, J MED IMAG RADIAT ON, V64, P649, DOI 10.1111/1754-9485.13098
   Simpson Scott, 2020, J Thorac Imaging, V35, P219, DOI [10.1148/ryct.2020200152, 10.1097/RTI.0000000000000524]
   Siripanthong B, 2020, HEART RHYTHM, V17, P1463, DOI 10.1016/j.hrthm.2020.05.001
   Skulstad H, 2020, EUR HEART J-CARD IMG, V21, P592, DOI 10.1093/ehjci/jeaa072
   Soldati G, 2020, J ULTRAS MED, V39, P1413, DOI 10.1002/jum.15285
   Tan KK, 2020, EJSO-EUR J SURG ONC, V46, P2154, DOI 10.1016/j.ejso.2020.05.004
   The American Society of Breast Surgeons, ASBRS ACR JOINT STAT
   Torkian P, 2021, CLIN IMAG, V69, P261, DOI 10.1016/j.clinimag.2020.09.002
   Torrealba JR, 2018, HUM PATHOL, V71, P30, DOI 10.1016/j.humpath.2017.10.028
   Toyoda H, 2020, HEPATOL COMMUN, V4, P1751, DOI 10.1002/hep4.1579
   Tsai HY, 2020, BREAST, V54, P52, DOI 10.1016/j.breast.2020.08.014
   Tsou IYY, 2020, CLIN RADIOL, V75, P415, DOI 10.1016/j.crad.2020.03.028
   Tu Wendy, 2021, Radiol Imaging Cancer, V3, pe210038, DOI 10.1148/rycan.2021210038
   TUNGCHEN Y, 2020, ULTRASOUND MED BIOL, V46, P2918, DOI DOI 10.1016/J.ULTRASMEDBIO.2020.07.003
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Vrettou AR, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00129
   Waller JV, 2020, INVEST RADIOL, V55, P754, DOI 10.1097/RLI.0000000000000700
   Wang F, 2020, GASTROENTEROLOGY, V159, P367, DOI 10.1053/j.gastro.2020.03.055
   Wang Y, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3554
   Wang Yuhui, 2020, Radiology, V296, pE55, DOI 10.1148/radiol.2020200843
   Warren MA, 2018, THORAX, V73, P840, DOI 10.1136/thoraxjnl-2017-211280
   Wehbe RM, 2021, RADIOLOGY, V299, pE167, DOI 10.1148/radiol.2020203511
   Wei JF, 2020, HEART, V106, P1154, DOI 10.1136/heartjnl-2020-317007
   WHO, LAB TEST 2019 NOV CO
   Wong HYF, 2020, RADIOLOGY, V296, pE72, DOI 10.1148/radiol.2020201160
   World Health Organization, MULT INFL SYNDR CHIL
   Wu X, 2021, LANCET RESP MED, P2021
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia W, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.579512
   Yang SY, 2020, J MAGN RESON IMAGING, V52, P397, DOI 10.1002/jmri.27208
   Yates A, 2021, EUR J RADIOL, V134, DOI 10.1016/j.ejrad.2020.109414
   Yin ZL, 2020, AM J ROENTGENOL, V215, P1065, DOI 10.2214/AJR.20.23214
   Yu J, 2020, ACAD RADIOL, V27, P614, DOI 10.1016/j.acra.2020.03.025
   Zhang B, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022747
   Zhang R, 2021, RADIOLOGY, V298, pE88, DOI 10.1148/radiol.2020202944
   Zhou CK, 2014, NEURAL REGEN RES, V9, P101, DOI 10.4103/1673-5374.125337
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu FX, 2021, ENGINEERING-PRC, V7, P95, DOI 10.1016/j.eng.2020.09.007
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
   Zuo HD, 2020, CAN RESPIR J, V2020, DOI 10.1155/2020/1237418
NR 215
TC 3
Z9 3
U1 6
U2 9
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1949-8470
J9 WORLD J RADIOL
JI World J. Radiol.
PD JUN 28
PY 2021
VL 13
IS 6
BP 192
EP 222
DI 10.4329/wjr.v13.i6.192
PG 31
WC Radiology, Nuclear Medicine & Medical Imaging
WE Emerging Sources Citation Index (ESCI)
SC Radiology, Nuclear Medicine & Medical Imaging
GA TG8UN
UT WOS:000671672700004
PM 34249239
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Kumari, P
   Singh, A
   Ngasainao, MR
   Shakeel, I
   Kumar, S
   Lal, S
   Singhal, A
   Sohal, SS
   Singh, IK
   Hassan, MI
AF Kumari, Pratibha
   Singh, Archana
   Ngasainao, Moses Rinchui
   Shakeel, Ilma
   Kumar, Sanjay
   Lal, Seema
   Singhal, Anchal
   Sohal, S. S.
   Singh, Indrakant Kumar
   Hassan, M., I
TI Potential diagnostics and therapeutic approaches in COVID-19
SO CLINICA CHIMICA ACTA
LA English
DT Review
DE COVID-19; SARS-CoV-2; Antiviral drugs; Molecular diagnosis; RT-P CR;
   Immunochromatographic assay and Drug discovery
ID CORONAVIRUS; PNEUMONIA; WUHAN; SARS; CT
AB The most important aspect of controlling COVID-19 is its timely diagnosis. Molecular diagnostic tests target the detection of any of the following markers such as the specific region of the viral genome, certain enzyme, RNA-dependent RNA polymerase, the structural proteins such as surface spike glycoprotein, nucleocapsid protein, envelope protein, or membrane protein of SARS-CoV-2. This review highlights the underlying mechanisms, advancements, and clinical limitations for each of the diagnostic techniques authorized by the Food and Drug Administration (USA). Significance of diagnosis triaging, information on specimen collection, safety considerations while handling, transport, and storage of samples have been highlighted to make medical and research community more informed so that better clinical strategies are developed. We have discussed here the clinical manifestations and hospital outcomes along with the underlying mechanisms for several drugs administered to COVID-19 prophylaxis. In addition to favourable clinical outcomes, the challenges, and the future directions of management of COVOD-19 are highlighted. Having a comprehensive knowledge of the diagnostic approaches of SARS-CoV-2, and its pathogenesis will be of great value in designing a long-term strategy to tackle COVID-19.
C1 [Kumari, Pratibha; Kumar, Sanjay; Lal, Seema] Univ Delhi, Deshbandhu Coll, Dept Chem, New Delhi 110019, India.
   [Kumari, Pratibha] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA.
   [Singh, Archana] Univ Delhi, Hansraj Coll, Dept Bot, Delhi 110007, India.
   [Ngasainao, Moses Rinchui; Singh, Indrakant Kumar] Univ Delhi, Deshbandhu Coll, Dept Zool, New Delhi 110019, India.
   [Shakeel, Ilma] Aligarh Muslim Univ, Dept Zool, Aligarh 202002, Uttar Pradesh, India.
   [Singhal, Anchal] St Josephs Coll, Dept Chem, Bengaluru 560027, Karnataka, India.
   [Sohal, S. S.] Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Resp Translat Res Grp,Dept Lab Med, Launceston, Tas, Australia.
   [Hassan, M., I] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
RP Singh, IK (corresponding author), Univ Delhi, Deshbandhu Coll, Dept Zool, New Delhi 110019, India.; Hassan, MI (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
EM iksingh@db.du.ac.in; mihassan@jmi.ac.in
RI Singh, Indrakant K/AAC-7080-2022; Kumar, Sanjay/AAH-2457-2021; HASSAN,
   Imtaiyaz/G-7072-2017
OI Singh, Indrakant K/0000-0002-3211-8471; Kumar,
   Sanjay/0000-0003-4127-2160; HASSAN, Imtaiyaz/0000-0002-3663-4940; Singh,
   Archana/0000-0003-3916-7513; SHAKEEL, ILMA/0000-0003-0919-5556
FU Department of Health Reseach [12013/11/2019-HR/E]; Indian Council of
   Medical ResearchIndian Council of Medical Research (ICMR)
   [BIC/12(01)/2015]
FX SSS thanks to the Clifford Craig Foundation Launceston General Hospital,
   Tasmania, Australia. IKS is thankful to Department of Health Reseach for
   financial support (Grant no. No.12013/11/2019-HR/E). MIH thanks to the
   Indian Council of Medical Research for financial support (Grant No.
   BIC/12(01)/2015). Authors are also thankful to Dr. Amit Kumar (Hansraj
   College) for the help in drawing of figures.
CR Ahmed SR, 2016, BIOSENS BIOELECTRON, V85, P503, DOI 10.1016/j.bios.2016.05.050
   Amirian ES, 2020, ONE HEALTH-AMSTERDAM, V9, DOI 10.1016/j.onehlt.2020.100128
   Arab-Zozani M, 2020, INT J PREVENTIVE MED, V11, DOI 10.4103/ijpvm.IJPVM_400_19
   Boccaletti S, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109794
   Borrell B, 2020, SCI MAGAZINE, DOI [10.1126/science.abc4739, DOI 10.1126/SCIENCE.ABC4739]
   Bourouiba L, 2020, JAMA-J AM MED ASSOC, V323, P1837, DOI 10.1001/jama.2020.4756
   Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787
   Cantini F, 2020, J INFECTION, V81, P318, DOI 10.1016/j.jinf.2020.04.017
   Cao Y-c, 2018, MBIO, V9, pe00221
   Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chatre C, 2018, DRUG SAFETY, V41, P919, DOI 10.1007/s40264-018-0689-4
   Chen J, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa241
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   ClinicalTrials.gov, 2020, COVID MED TRIAL COMP
   ClinicalTrials.gov, 2020, TREATM COVID 19 CAN
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   Dong LY, 2020, DRUG DISCOV THER, V14, P58, DOI 10.5582/ddt.2020.01012
   Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117
   Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120
   FDA, 2020, COMMUNICATION   0410
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Hoffmann M, 2020, P NATL ACAD SCI USA, V117, P11727
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jin ZM, 2020, NAT STRUCT MOL BIOL, V27, P529, DOI 10.1038/s41594-020-0440-6
   Khalili JS, 2020, J MED VIROL, V92, P740, DOI 10.1002/jmv.25798
   La Rosee F, 2020, LEUKEMIA, V34, P1805, DOI 10.1038/s41375-020-0891-0
   Lee KS, 2020, KOREAN J RADIOL, V21, P257, DOI 10.3348/kjr.2020.0096
   Lee Y, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e174
   Li Y, 2020, AM J ROENTGENOL, V214, P1280, DOI 10.2214/AJR.20.22954
   Lillie PJ, 2020, J INFECTION, V80, P600, DOI 10.1016/j.jinf.2020.02.020
   Liu YJ, 2015, ANALYST, V140, P3989, DOI 10.1039/c5an00407a
   Mohammad T, 2020, VIRUS RES, V288, DOI 10.1016/j.virusres.2020.198102
   Moriyama M, 2020, ANNU REV VIROL, V7, P83, DOI 10.1146/annurev-virology-012420-022445
   Naqvi AAT, 2020, BIOCH BIOPHYS ACTA M
   Nikolaev EN, 2020, J PROTEOME RES, V19, P4393, DOI 10.1021/acs.jproteome.0c00412
   Pan YY, 2020, EUR RADIOL, V30, P3306, DOI 10.1007/s00330-020-06731-x
   Rothan HA, 2020, VIROLOGY, V547, P7, DOI 10.1016/j.virol.2020.05.002
   Roussel Y., 2020, NEW MICROBES NEW INF
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   Seo G, 2020, ACS NANO, V14, P12257, DOI [10.1021/acsnano.0c06726, 10.1021/acsnano.0c02823]
   Sepunaru L, 2016, CHEM SCI, V7, P3892, DOI 10.1039/c6sc00412a
   Shamsi A, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201256
   Shereen MA, 2020, J MED VIROL, V92, P719
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Singhal C, 2017, INT J BIOL MACROMOL, V98, P84, DOI 10.1016/j.ijbiomac.2017.01.093
   To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149
   Rosa SGV, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.40
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wang XD, 2013, BIOSENS BIOELECTRON, V47, P171, DOI 10.1016/j.bios.2013.03.021
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wolf RC, 2020, NEUROPSYCHOBIOLOGY, V79, P335, DOI [10.1038/s41586-020-2196-x, 10.1159/000505601, 10.1038/s41586-020-2984-3]
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Wu HS, 2004, EMERG INFECT DIS, V10, P304
   Xia X., 2020, MOL BIOL EVOL
   Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430
   Xu Kaijin, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P147, DOI 10.3785/j.issn.1008-9292.2020.02.02
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Yan C, 2020, CLIN MICROBIOL INFEC, V26, P773, DOI 10.1016/j.cmi.2020.04.001
   Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
   Zhao W, 2012, ANAL CHEM, V84, P2358, DOI 10.1021/ac203102u
   Zheng F., 2020, INT J INFECT DIS
   Zhu Y, 2020, J INFECTION, V81, P154, DOI [10.1016/j.jinf.2020.03.033, 10.1016/j.jinf.2020.02.022]
   Zhu Z, 2020, J INFECTION, V81, pE21, DOI 10.1016/j.jinf.2020.03.060
NR 69
TC 23
Z9 23
U1 1
U2 21
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0009-8981
EI 1873-3492
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD NOV
PY 2020
VL 510
BP 488
EP 497
DI 10.1016/j.caa.2020.08.013
PG 10
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology
GA OH3XC
UT WOS:000582504300077
PM 32795547
DA 2022-04-20
ER

PT J
AU Allocca, CM
   Snapes, E
   Albert, M
   Bledsoe, MJ
   Castelhano, MG
   De Wilde, M
   Furuta, K
   Kozlakidis, Z
   Martin, D
   Martins, A
   McCall, SJ
   Schacter, B
AF Allocca, Clare M.
   Snapes, Emma
   Albert, Monique
   Bledsoe, Marianna J.
   Castelhano, Marta G.
   De Wilde, Mieke
   Furuta, Koh
   Kozlakidis, Zisis
   Martin, Dunja
   Martins, Anabela
   McCall, Shannon J.
   Schacter, Brent
TI Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool
   Implementation Case Studies
SO BIOPRESERVATION AND BIOBANKING
LA English
DT Article
DE COVID-19; conformity assessment; standards; biobanking; tools; quality
   management system
ID MANAGEMENT
AB The COVID-19 era has brought about a number of novel challenges for the global biobanking community. An array of diverse tools (e.g., standards, best practices, and plans) exists to support quality and fitness-for-purpose in biobank operations. The International Society for Biological and Environmental Repositories (ISBER) COVID-19 Response Task Force has set out to identify needs and gaps in these tools and make recommendations for the next generation of available tools, having closely examined the COVID-19-related challenges. While conducting this work to examine the relationships between tools and biobank adaptability, a subgroup of the task force conducted a parallel effort to develop and describe individual COVID-19 era case studies based on a number of operating biobanks. Each case study presents a different combination of implemented tools. Observations and lessons learned from these case studies are provided, and experiences with tool implementation are discussed. This information is supplemented by data relating to tool usefulness that was obtained through an ISBER survey discussed in a companion article. The knowledge gained from this study will be combined with other task force efforts to make recommendations to better position the biobanking community in their response to future emergencies.
C1 [Allocca, Clare M.] NIST, Stand Coordinat Off, Gaithersburg, MD 20899 USA.
   [Snapes, Emma] BioConsulting, Cork, Ireland.
   [Albert, Monique] Ontario Inst Canc Res, Ontario Tumour Bank, Toronto, ON, Canada.
   [Bledsoe, Marianna J.] Biopreservat & Biobanking, Colorado Springs, CO USA.
   [Castelhano, Marta G.] Cornell Univ, Coll Vet Med, Cornell Vet Biobank, Ithaca, NY 14853 USA.
   [De Wilde, Mieke] UZA UAntwerpen, Biobank Antwerp, Antwerp, Belgium.
   [Furuta, Koh] Urayasu Warakuen Clin, Urayasu, Japan.
   [Furuta, Koh; Kozlakidis, Zisis] WHO, Int Agcy Res Canc, Lyon, France.
   [Martin, Dunja] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany.
   [Martins, Anabela] Micoteca Univ Minho, Ctr Engn Biol, Braga, Portugal.
   [McCall, Shannon J.] Duke Univ, Durham, NC USA.
   [Schacter, Brent] Univ Manitoba, CancerCare Manitoba, Winnipeg, MB, Canada.
RP Allocca, CM (corresponding author), NIST, Stand Coordinat Off, Gaithersburg, MD 20899 USA.
EM clare.allocca@nist.gov
RI Kozlakidis, Zisis/AAX-8081-2020
OI Kozlakidis, Zisis/0000-0002-3836-7209; McCall,
   Shannon/0000-0003-3957-061X; Castelhano, Marta/0000-0003-2497-1939;
   Allocca, Clare M/0000-0003-4132-0396; Snapes, Emma/0000-0001-5429-6925
FU United States National Institutes of Health, National Cancer
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [UM1CA239755, P30CA014236]
FX Shannon McCall and the Duke University BioRepository & Precision
   Pathology Center receive funding from the United States National
   Institutes of Health, National Cancer Institute under UM1CA239755 (The
   Cooperative Human Tissue Network) and P30CA014236 (Duke University's
   Cancer Center Support Grant).
CR Allocca CM, 2020, BIOPRESERV BIOBANK, DOI 10.1089/bio.2020.0082.
   Betsou F., 2017, BIOBANKING HUMAN BIO, P23
   Betsou F, 2018, BIOPRESERV BIOBANK, V16, P9, DOI 10.1089/bio.2017.0109
   Betsou F, 2018, BIOPRESERV BIOBANK, V16, P7, DOI 10.1089/bio.2017.0121
   Canadian Tissue Repository Network (CTRNet), 2020, CAN TISS REP NETW ED
   Centers for Disease Control and Prevention (CDC), 2020, COR RES REF
   Church TD, 2019, BIOPRESERV BIOBANK, V17, P410, DOI 10.1089/bio.2018.0142
   Ciaburri M, 2017, BIOPRESERV BIOBANK, V15, P46, DOI 10.1089/bio.2016.0045
   College of American Pathologists, 2020, CAP GUID
   Fernandez IC, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-019-02187-w
   Fantus B, 1937, J AMER MED ASSOC, V109, P128
   Gaignaux A, 2016, BIOPRESERV BIOBANK, V14, P429, DOI 10.1089/bio.2015.0108
   Hannigan L, 2019, BIOPRESERV BIOBANK, V17, P506, DOI 10.1089/bio.2019.0076
   Hartman V, 2019, BIOPRESERV BIOBANK, V17, P530, DOI 10.1089/bio.2019.0015
   Henderson MK, 2017, BIOPRESERV BIOBANK, V15, P1, DOI 10.1089/bio.2016.0083
   Henderson Marianne Krall, 2018, Biopreserv Biobank, V16, P393, DOI 10.1089/bio.2018.29043.mkh
   International Organizations for Standardization (ISO), 2020, 151892012 ISO
   International Organizations for Standardization (ISO), 2020, 90012015 ISO
   International Organizations for Standardization (ISO), 2020, 203872018 ISO
   International Organizations for Standardization (ISO), 2020, 170342016 ISO
   International Organizations for Standardization (ISO), 2020, 170252017 ISO
   International Society for Biological and Environmental Repositories (ISBER), 2020, ISBER BEST PRACT
   International Society for Biological and Environmental Repositories (ISBER), 2020, ESS BIOB COURS
   ISBER Standards Committee, 2020, WEB BIOB COVID 19 ER
   ISBER Townhall Meeting, 2020, COVID 19 IMP 2
   ISBER Townhall Meeting, 2020, COVID 19 IMP 1
   Lehmann S, 2012, BIOPRESERV BIOBANK, V10, P366, DOI 10.1089/bio.2012.0012
   Littrell OM, 2019, NONCLINICAL PHARM BI, P399
   Molinero-Demilly V., 2018, INT J METROLOGY QUAL, V9, P2, DOI [10.1051/ijmqe/2017025, DOI 10.1051/IJMQE/2017025]
   Mouttham L, 2020, BIOPRESERV BIOBANK, DOI 10.1089/bio.2020.0068
   National Cancer Institute (NCI), 2020, NCI BEST PRACT BIOSP
   OECD, 2007, BEST PRACT GUID BIOL
   Parry-Jones A, 2017, BIOPRESERV BIOBANK, V15, P253, DOI 10.1089/bio.2016.0048
   Schacter Brent, 2020, Biopreserv Biobank, V18, P43, DOI 10.1089/bio.2020.29063.bjs
   Tarling T, 2020, BIOPRESERV BIOBANK, V18, P82, DOI 10.1089/bio.2019.0126
   Vaught J., 2017, BIOBANKING HUMAN BIO, P207
   Wenger E, 2015, INTRO COMMUNITIES PR
   World Federation for Culture Collections (WFCC), 1994, WFCC GUID EST OP COL
   Yadav BK, 2020, BIOPRESERV BIOBANK, DOI 10.1089/bio.2020.0078
NR 39
TC 4
Z9 4
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1947-5535
EI 1947-5543
J9 BIOPRESERV BIOBANK
JI Biopreserv. Biobank.
PD DEC 1
PY 2020
VL 18
IS 6
BP 547
EP 560
DI 10.1089/bio.2020.0083
EA NOV 2020
PG 14
WC Cell Biology; Chemistry, Applied; Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Chemistry; Medical Laboratory Technology
GA PF0CN
UT WOS:000592477600001
PM 33226280
OA Green Published
DA 2022-04-20
ER

PT J
AU Telukdarie, A
   Munsamy, M
   Mohlala, P
AF Telukdarie, Arnesh
   Munsamy, Megashnee
   Mohlala, Popopo
TI Analysis of the Impact of COVID-19 on the Food and Beverages
   Manufacturing Sector
SO SUSTAINABILITY
LA English
DT Article
DE COVID-19; food and beverage; manufacturing; sustainability
AB The globe has been subjected to an unprecedented health challenge in the form of COVID-19, indiscriminately impacting the global economy, global supply chains, and nations. The resolution of this unprecedented challenge does not seem to be in the short-term horizon but rather something the globe has to live with. Initial data provides for some insights on responses, precautions, and sustainability protocols and processes. The Food and Beverages Manufacturing sector in South Africa (SA) and globally is an expeditious respondent to the COVID-19 challenge. Food is essential for human existence, but the food value chain is subjected to significant COVID-19 risks. The Food and Beverage Sector Education and Training Authority is responsible for skills development in the Food and Beverages (FoodBev) Manufacturing Sector in South Africa and seeks to quantify Foodbev sustainability. This research paper reviews global literature, performs a high-level knowledge classification, with the aim of expedited awareness, knowledge sharing, and most importantly, quantification of an expedited response, within the FoodBev Manufacturing sector in SA. The research is contextualized via a SA sector-based instrument deployment and data analysis. The paper provides insights into COVID-19 impact, adaptations, and responses in the SA Food and Beverages Manufacturing sector.
C1 [Telukdarie, Arnesh; Munsamy, Megashnee] Univ Johannesburg, Postgrad Sch Engn Management, ZA-2006 Johannesburg, Gauteng, South Africa.
   [Mohlala, Popopo] Food & Beverage Mfg Sect Educ & Training Author, ZA-2006 Johannesburg, Gauteng, South Africa.
RP Telukdarie, A (corresponding author), Univ Johannesburg, Postgrad Sch Engn Management, ZA-2006 Johannesburg, Gauteng, South Africa.
EM arnesht@uj.ac.za; mmunsamy@uj.ac.za; PopopoM@FoodBev.co.za
FU FoodBev manufacturing SETA in South Africa
FX This research was funded by the FoodBev manufacturing SETA in South
   Africa.
CR Accenture, COR BUS EC IMP
   Accenture, PROD UNC EL DIG WORK
   Aldaco R, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140524
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   Brenner M, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-1979-4
   Choudhury N.R., FOOD SECTOR FACES MU
   Citizan T., TIGER BRANDS SAYS SA
   Daniel Sir John, 2020, Prospects (Paris), P1, DOI 10.1007/s11125-020-09464-3
   Dyal JW, 2020, MMWR-MORBID MORTAL W, V69, P557, DOI 10.15585/mmwr.mm6918e3
   Falconer T., SHIFTING FOCUS COVID
   Fan S., PREVENTING GLOBAL FO
   FAO, 2020, IS COVID 19 AFF FISH
   FAO, 2020, SUMM IMP COVID 19 PA
   FAO, 2020, COVID 19 SMALLH PROD
   FAO, 2020, COVID 19 RISK FOOD S
   Fitch Solutions, EC SUPPL CHAIN DIV A
   Food And Agriculture Organization (FAO), 2020, FAO ROLLS OUT TOOLK
   Galanakis CM, 2020, FOODS, V9, DOI 10.3390/foods9040523
   Gemmill-Herren B, 2020, AGR HUM VALUES, V37, P613, DOI 10.1007/s10460-020-10097-7
   Helm D, 2020, ENVIRON RESOUR ECON, V76, P21, DOI 10.1007/s10640-020-00426-z
   Hobbs JE, 2020, CAN J AGR ECON, V68, P171, DOI 10.1111/cjag.12237
   Hossain ST, 2020, J AGR SCI-SRI LANKA, V15, P116, DOI 10.4038/jas.v15i2.8794
   Hyslop G., JUMPING BAKING BOOM
   Kalpana S, 2019, TRENDS FOOD SCI TECH, V93, P145, DOI 10.1016/j.tifs.2019.09.008
   Latchem C, 2017, USING ICTS BLENDED L
   Norje C., EC IMPACT COVID 19 M
   Preiss PV, 2020, AGR HUM VALUES, V37, P571, DOI 10.1007/s10460-020-10062-4
   Rasool H., LABOUR MARKET SERI 2
   Rizou M, 2020, TRENDS FOOD SCI TECH, V102, P293, DOI 10.1016/j.tifs.2020.06.008
   Rosenbloom D, 2020, SCIENCE, V368, P447, DOI 10.1126/science.abc4887
   Rugani B, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.139806
   Sriwahyuni, 2020, J TALENT DEV EXCELL, V12, P385
   Weersink A, 2020, CAN J AGR ECON, V68, P195, DOI 10.1111/cjag.12240
   World Bank Group, 2020, ASS EC IMP COVID 19
   World Economic Forum, 2018, FUT JOBS REP 2018
NR 35
TC 16
Z9 16
U1 10
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD NOV
PY 2020
VL 12
IS 22
AR 9331
DI 10.3390/su12229331
PG 22
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA OY9KE
UT WOS:000594556800001
OA gold
DA 2022-04-20
ER

PT J
AU Rafiq, M
   Naz, S
   Martins, JM
   Mata, MN
   Mata, PN
   Maqbool, S
AF Rafiq, Muhammad
   Naz, Shumaila
   Martins, Jose Moleiro
   Mata, Mario Nuno
   Mata, Pedro Neves
   Maqbool, Saif
TI A Study on Emerging Management Practices of Renewable Energy Companies
   after the Outbreak of Covid-19: Using an Interpretive Structural
   Modeling (ISM) Approach
SO SUSTAINABILITY
LA English
DT Article
DE renewable energy; emerging management practices; knowledge management;
   decentralization; sustainable organizational performance
ID RESOURCE-BASED VIEW; ORGANIZATIONAL PERFORMANCE; KNOWLEDGE MANAGEMENT;
   DECENTRALIZATION; INNOVATION; SYSTEMS; IMPACT
AB The role of management practices in the success of renewable energy organizations is not negligible because management practices are the backbone of any organization. Energy organizations are facing drastic environmental issues; therefore, the sector inevitably requires environment- friendly production, which is only possible through the deployment of concurrent management practices because sluggish management practices lead to dormancy and inadequate performance. This study investigates the emerging management practices that will enable the renewable energy sector to fulfill the current demands of the market, especially after the outbreak of the Covid-19 pandemic. This research deployed a qualitative research methodology that is grounded in the interpretivism research paradigm. Interpretive structural modeling (ISM) was applied due to the extent of its logical thinking, and its ability to address complex issues and disseminate results precisely. Data were collected through primary (structured and unstructured interviews) and secondary sources (literature reviews published in the last 10 years). Interviews of top- and middle-level managers working in the renewable energy sector of developing countries were conducted. The findings of the study postulate that the implementation of knowledge management practices and policy changes are the key influencing factors to achieve sustainable organizational performance. Decentralization also has the potential to influence and navigate the organizational performance of energy companies. The findings of the research advocate innovative practices for the energy sector that influence organizational performance. The qualitative findings of the study suggest that emerging practices, including knowledge management practices and decentralization, may proliferate organizational growth and development. The novel framework of the study implies that organizations should work progressively in deploying emerging management practices such as establishing a central response hub to avoid delays under the umbrella of resilience leadership.
C1 [Rafiq, Muhammad] Super Univ, Fac Management Sci, Lahore 54000, Pakistan.
   [Naz, Shumaila] Iqra Univ, Fac Business Adm, Karachi 75500, Pakistan.
   [Martins, Jose Moleiro] Polytech Inst Lisbon, Lisbon Accounting & Business Sch ISCAL, Dept Management, P-1069035 Lisbon, Portugal.
   [Martins, Jose Moleiro] Lisbon Univ Inst ISCTE IUL, Business Res Unit BRU IUL, P-1649026 Lisbon, Portugal.
   [Mata, Mario Nuno] Polytech Inst Lisbon, Lisbon Accounting & Business Sch ISCAL, Dept Finance, P-1069035 Lisbon, Portugal.
   [Mata, Mario Nuno] Polytech Inst Santarem, Santarem Management Sch ESGTS IPS, Dept Management & Technol, P-2001904 Santarem, Portugal.
   [Mata, Pedro Neves] Lisbon Univ Inst ISCTE IUL, Dept Informat Sci & Technol, Informat Sci & Technol & Architecture Res Ctr ISC, P-1649026 Lisbon, Portugal.
   [Maqbool, Saif] Natl Univ Comp & Emerging Sci, Dept Management, Chiniot Faisalabad Campus, Islamabad 44000, Pakistan.
RP Naz, S (corresponding author), Iqra Univ, Fac Business Adm, Karachi 75500, Pakistan.
EM m.rafiq@ncepu.edu.cn; shumaila.superior@gmail.com; zdmmartins@gmail.com;
   mnmata@iscal.ipl.pt; pmata@escs.ipl.pt; saif.maqbool@nu.edu.pk
RI Rafiq, Dr. Muhammad/AAY-8401-2021; Maqbool, Saif/AAJ-9669-2021; Rafiq,
   Muhammad/E-6924-2014
OI Maqbool, Saif/0000-0003-0387-7943; Mata, Pedro/0000-0001-8465-9539;
   naz12, shumaila/0000-0002-0030-0981; Moleiro Martins,
   Jose/0000-0001-6853-2917; Rafiq, Muhammad/0000-0002-3263-5161
CR Adhikari DR, 2010, INT J EDUC MANAG, V24, P94, DOI 10.1108/09513541011020918
   Agyemang-Duah W, 2018, COGENT ECON FINANC, V6, DOI 10.1080/23322039.2018.1476035
   [Anonymous], 2020, EC TIMES
   BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108
   Bernardoni P, 2021, ENERGIES, V14, DOI 10.3390/en14040816
   Bossert T, 1998, SOC SCI MED, V47, P1513, DOI 10.1016/S0277-9536(98)00234-2
   Brecht J.K., 2020, EDIS, V2020, DOI [10.32473/edis-hs1185-2020, DOI 10.32473/EDIS-HS1185-2020]
   Cakin B., 2017, DECENTRALIZATION CON
   Ceryova D, 2020, RESOURCES-BASEL, V9, DOI 10.3390/resources9090102
   Chai DS, 2020, PERFORM IMPROV Q, V33, P305, DOI 10.1002/piq.21326
   Cheema A., 2005, DECENTRALIZATION LOC
   CONNER KR, 1991, J MANAGE, V17, P121, DOI 10.1177/014920639101700109
   Creswell J.W., 2011, SAGE HDB QUALITATIVE, V4th ed., P269
   Goulding C, 2005, EUR J MARKETING, V39, P294, DOI 10.1108/03090560510581782
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Hamel, 1993, EUROPEAN MANAGEMENT, V11, P150, DOI [10.1016/0263-2373(93)90038-J, DOI 10.1016/0263-2373(93)90038-J]
   Hustedt JW, 2016, J HAND SURG-AM, V41, P593, DOI 10.1016/j.jhsa.2016.02.011
   Ilyas M., 2012, INT J BUS SOC SCI, V3, P178
   John MS, 2003, PUBLIC ADMIN DEVELOP, V23, P347, DOI 10.1002/pad.277
   Karmaker CL, 2021, SUSTAIN PROD CONSUMP, V26, P411, DOI 10.1016/j.spc.2020.09.019
   Lee H, 2003, J MANAGE INFORM SYST, V20, P179
   Lopez-Nicolas C, 2011, INT J INFORM MANAGE, V31, P502, DOI 10.1016/j.ijinfomgt.2011.02.003
   MAHONEY JT, 1992, STRATEGIC MANAGE J, V13, P363, DOI 10.1002/smj.4250130505
   Michael A., 2019, HDB HUMAN RESOURCE M
   Naz S, 2019, MIDDLE EAST J MANAG, V6, P318, DOI 10.1504/MEJM.2019.098598
   Nonaka I, 2016, GLOB STRATEG J, V6, P168, DOI 10.1002/gsj.1125
   Paauwe J, 2009, J MANAGE STUD, V46, P129, DOI 10.1111/j.1467-6486.2008.00809.x
   Penrose R., 1959, MATH PROC CAMBRIDGE
   Rafiq M., 2017, ARCH BUS RES, V5, DOI [10.14738/abr.53.2819, DOI 10.14738/ABR.53.2819]
   Rafiq M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041365
   Richard PJ, 2009, J MANAGE, V35, P718, DOI 10.1177/0149206308330560
   Rondinelli D., 1983, DECENTRALIZATION DEV, DOI [10.1201/noe1420052756.ch96, DOI 10.1201/NOE1420052756.CH96]
   Rubenstein-Montano B, 2001, DECIS SUPPORT SYST, V31, P5, DOI 10.1016/S0167-9236(00)00116-0
   Sadler GR, 2010, NURS HEALTH SCI, V12, P369, DOI 10.1111/j.1442-2018.2010.00541.x
   Sadun R., 2017, TURBULENCE FIRM DECE
   Sage AP, 1977, METHODOLOGY LARGE SC, P165
   Santoro G, 2018, TECHNOL FORECAST SOC, V136, P347, DOI 10.1016/j.techfore.2017.02.034
   Schroeder W., 1999, GER POLITICS SOC, V17, P52, DOI [10.3167/104503099782486770, DOI 10.3167/104503099782486770]
   Shakeel SR, 2018, J RENEW SUSTAIN ENER, V10, DOI 10.1063/1.5033454
   Skarvada P, 2014, APPL SURF SCI, V312, P50, DOI 10.1016/j.apsusc.2014.05.064
   Spender JC, 1996, STRATEGIC MANAGE J, V17, P5, DOI 10.1002/smj.4250171103
   UNDP U., 2014, BEING LGBT ASIA THAI
   VENGROFF R, 1992, PUBLIC ADMIN DEVELOP, V12, P473, DOI 10.1002/pad.4230120505
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   WARFIELD JN, 1974, IEEE T SYST MAN CYB, VSMC4, P81, DOI 10.1109/TSMC.1974.5408524
   WERNERFELT B, 1984, STRATEGIC MANAGE J, V5, P171, DOI 10.1002/smj.4250050207
   Wu H, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9040484
   Zou X, 2019, J ENVIRON DEV, V28, P412, DOI 10.1177/1070496519870276
   Zwilling M, 2016, JOINT INT C 2016 TEC, P1123
NR 49
TC 2
Z9 2
U1 6
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD MAR
PY 2021
VL 13
IS 6
AR 3420
DI 10.3390/su13063420
PG 15
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA RV4JX
UT WOS:000645802200001
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Thierry, AR
AF Thierry, Alain R.
TI Host/genetic factors associated with COVID-19 call for precision
   medicine
SO PRECISION CLINICAL MEDICINE
LA English
DT Article
DE COVID-19; neutrophil extracellular traps; sequelae; genetic factors;
   host factors; circulating DNA
ID NEUTROPHIL EXTRACELLULAR TRAPS; POLYMORPHISM
AB If the current rate of infection are to be better managed, and future waves of infection kept at bay, it is absolutely necessary that the conditions and mechanisms of exposure to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) be better understood, as well as the downstream severe or lethal clinical complications. While the identification of notable comorbidities has now helped to define broad risk groups, the idiosyncratic responses of individual patients can generate unexpected clinical deterioration that is difficult to predict from initial clinical features. Thus, physicians caring for patients with COVID-19 face clinical dilemmas on a daily basis. The ability to decipher individual predispositions to SARS-CoV-2 infection or severe illness, in light of variations in host immunological and inflammatory responses, in particular as a result of genetic variations, would be of great benefit in infection management. To this end, this work associates the description of COVID-19 clinical complications, comorbidities, sequelae, and environmental and genetic factors. We also give examples of underlying genomic susceptibility to COVID-19, especially with regard to the newly reported link between the disease and the unbalanced formation of neutrophil extracellular traps. As a consequence, we propose that the host/genetic factors associated with COVID-19 call for precision medicine in its treatment. This is to our knowledge the first article describing elements towards precision medicine for patients with COVID-19.
C1 [Thierry, Alain R.] Montpellier Univ, ICM, IRCM, Res Inst Cancerol Montpellier,INSERM U1194, F-34298 Montpellier, France.
RP Thierry, AR (corresponding author), Montpellier Univ, ICM, IRCM, Res Inst Cancerol Montpellier,INSERM U1194, F-34298 Montpellier, France.
EM alain.thierry@inserm.fr
FU INSERMInstitut National de la Sante et de la Recherche Medicale
   (Inserm)European Commission; SIRIC Montpellier Cancer Grant [INCa Inserm
   DGOS 12553]
FX The author thanks S. Dejasse, C. McCarthy, M. Ychou, and RC Gallo. A.R.
   Thierry is supported by INSERM. This work was funded by the SIRIC
   Montpellier Cancer Grant (No. INCa Inserm DGOS 12553).
CR Arun AK, 2018, J CLIN PATHOL, V71, P1046, DOI 10.1136/jclinpath-2018-205235
   Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652
   Campos-Rodriguez R, 2016, PARASITE, V23, DOI 10.1051/parasite/2016006
   Chang HH, 2015, ARTHRITIS RHEUMATOL, V67, P2323, DOI 10.1002/art.39215
   Danese S, 2020, NAT REV GASTRO HEPAT, V17, P1, DOI 10.1038/s41575-019-0211-1
   Daniel C, 2019, NAT REV NEPHROL, V15, P559, DOI 10.1038/s41581-019-0163-2
   Delanghe JR, 2020, CLIN CHIM ACTA, V505, P192, DOI 10.1016/j.cca.2020.03.031
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Favalli EG, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102523
   Pollitt KJG, 2020, HUM GENOMICS, V14, DOI 10.1186/s40246-020-00267-3
   Gu, 2020, RELATIONSHIP ABO BLO, DOI [10.1101/2020.03.11.20031096, DOI 10.1101/2020.03.11.20031096]
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gupta N, 2019, THROMB RES, V181, P77, DOI 10.1016/j.thromres.2019.07.013
   Hussain FA, 2020, BRIT J HAEMATOL, V189, P851, DOI 10.1111/bjh.16734
   Ikitimur H, 2021, J MED VIROL, V93, P357, DOI 10.1002/jmv.26106
   Sagkan RI, 2020, J MED VIROL, V92, P2637, DOI 10.1002/jmv.26107
   Johns Hopkins University. Coronavirus Ressource Center, 2020, COVID 19 DASHB CTR S, DOI [10.1038/s41525-018-0069-0, DOI 10.1038/S41525-018-0069-0]
   Kim J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170977
   Laffranchi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206955
   Li TH, 2020, EMERG MICROBES INFEC, V9, P687, DOI 10.1080/22221751.2020.1741327
   Liu S, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.60
   Lo MS, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108385
   McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412
   Nguyen A, 2020, J VIROL, V94, DOI 10.1128/JVI.00510-20
   Onouchi Y, 2018, INT J RHEUM DIS, V21, P26, DOI 10.1111/1756-185X.13218
   Poli CL, 2017, J IMMUNOL, V198, P3650, DOI 10.4049/jimmunol.1600594
   Premraj A, 2015, MOL IMMUNOL, V67, P357, DOI 10.1016/j.molimm.2015.06.022
   Roch, J CELL IMMUNOL
   Roch B., 2020, MED PHARM, DOI [10.20944/preprints202004.0238.v1, DOI 10.20944/PREPRINTS202004.0238.V1]
   Schonrich G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00366
   Skopelja-Gardner S, 2018, J AUTOIMMUN, V88, P1, DOI 10.1016/j.jaut.2017.10.008
   Soderberg D, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00256
   Thierry AR, 2020, PHYSIOL REV, V100, P1597, DOI 10.1152/physrev.00019.2020
   Thierry AR, 2020, CLIN SCI, V134, P1295, DOI 10.1042/CS20200531
   Thierry AR, 2021, PEDIATR RES, V89, P716, DOI 10.1038/s41390-020-0996-1
   Ueki M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49935-y
   Ulrich H, 2020, STEM CELL REV REP, V16, P434, DOI 10.1007/s12015-020-09976-7
   Wang MJ, 2020, PRECIS CLIN MED, V3, P14, DOI 10.1093/pcmedi/pbaa002
   Weber Andrew G, 2020, Mol Med, V26, P91, DOI [10.1101/2020.05.13.20087734, 10.1186/s10020-020-00215-w]
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Yoshida Y, 2020, PEDIATR RES, V87, P998, DOI 10.1038/s41390-019-0710-3
   Yousefi S, 2019, EUR J IMMUNOL, V49, P221, DOI 10.1002/eji.201747053
   Zhang BC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235458
   Zhang W, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108393
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zuo Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138999
NR 46
TC 12
Z9 12
U1 1
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2096-5303
EI 2516-1571
J9 PRECIS CLIN MED
JI Precis. Clin. Med.
PD SEP
PY 2020
VL 3
IS 3
BP 228
EP 234
DI 10.1093/pcmedi/pbaa026
PG 7
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA SS7EG
UT WOS:000661916800008
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Turner, J
   Hodgson, LE
   Leckie, T
   Eade, L
   Ford-Dunn, S
AF Turner, Jennifer
   Hodgson, Luke Eliot
   Leckie, Todd
   Eade, Lisa
   Ford-Dunn, Suzanne
TI A Dual-Center Observational Review of Hospital-Based Palliative Care in
   Patients Dying With COVID-19
SO JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
LA English
DT Review
DE Palliative care; COVID-19; frailty; symptom management; end-of-life care
AB The current coronavirus disease 2019 (COVID-19) pandemic has put significant strain on all aspects of health care delivery, including palliative care services. Given the high mortality from this disease, particularly in the more vulnerable members of society, it is important to examine how best to deliver a high standard of end-of-life care during this crisis. This case series collected data from two acute hospitals examining the management of patients diagnosed with COVID-19 who subsequently flied (n = 36) and compared this with national and local end-of-life audit data for all other deaths. Our results demonstrated a shorter dying phase (38.25 hours vs. 74 hours) and higher rates of syringe driver use (72% vs. 33% in local audits), although with similar average mediation doses. Of note was the significant heterogeneity in the phenotype of deterioration in the dying phase, two distinct patterns emerged, with one group demonstrating severe illness with a short interval between symptom onset and death and another group presenting with a nwre protracted deterioration. This brief report suggests a spectrum of mode of dying. Overall, the cohort reflects previously described experiences, with increased frailty (median Clinical Frailty Scale score of 5) and extensive comorbidity burden. This brief report provides clinicians with a contemporaneous overview of our experience, knowledge, and pattern recognition when caring for people with COVID-19 and highlights the value of proactive identification of patients and risk of deterioration and palliation. (C) 2020 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
C1 [Turner, Jennifer] Western Sussex Hosp NHS Fdn Trust, Worthing Hosp, ST5 Geriatr Med, Worthing, England.
   [Hodgson, Luke Eliot] Worthing Hosp Western Sussex Hosp NHS Fdn Trust, Intens Care Dept, Worthing, England.
   [Hodgson, Luke Eliot] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England.
   [Leckie, Todd] Western Sussex Hosp NHS Fdn Trust, Worthing Hosp, Intens Care Dept, ST3 Anaesthet, Worthing, England.
   [Eade, Lisa] Western Sussex Hosp NHS Fdn Trust, St Richards Hosp, Palliat Care, Chichester, England.
   [Ford-Dunn, Suzanne] Western Sussex Hosp NHS Fdn Trust, Worthing Hosp, Palliat Med, Worthing, England.
   [Ford-Dunn, Suzanne] St Barnabas House Hosp, Worthing, England.
RP Ford-Dunn, S (corresponding author), Western Sussex Hosp NHS Fdn Trust, Worthing Hosp, Lyndhurst Rd, Worthing BN11 2DH, England.
EM suzanne.ford-dunn@nhs.net
RI hodgson, luke/AAG-1477-2019
OI hodgson, luke/0000-0002-8278-9513; Leckie, Todd/0000-0003-4309-5225
CR [Anonymous], 2014, 67 WORLD HLTH ASS, P24
   Arya A, 2020, CAN MED ASSOC J, V192, pE400, DOI 10.1503/cmaj.200465
   Bajwah S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00815-2020
   Fusi-Schmidhauser T, 2020, J PAIN SYMPTOM MANAG, V60, pE27, DOI 10.1016/j.jpainsymman.2020.03.030
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   HQIP, 2019, NHS BENCHM NETW NAT
   Knaul FM, 2015, LANCET, V386, P722, DOI 10.1016/S0140-6736(15)60289-6
   Lovell N, 2020, J PAIN SYMPTOM MANAG, V60, pE77, DOI 10.1016/j.jpainsymman.2020.04.015
   Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 11
TC 18
Z9 18
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0885-3924
EI 1873-6513
J9 J PAIN SYMPTOM MANAG
JI J. Pain Symptom Manage.
PD AUG
PY 2020
VL 60
IS 2
BP E75
EP E78
DI 10.1016/j.jpainsymman.2020.04.031
PG 4
WC Health Care Sciences & Services; Medicine, General & Internal; Clinical
   Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; General & Internal Medicine;
   Neurosciences & Neurology
GA NI0RK
UT WOS:000565066200015
PM 32387139
OA Green Published, Bronze
DA 2022-04-20
ER

PT C
AU Kinnunen, R
   Jaaskelainen, A
   Sillanpaa, V
   Helander, N
   Venkitachalam, K
AF Kinnunen, Reetta
   Jaaskelainen, Aki
   Sillanpaa, Virpi
   Helander, Nina
   Venkitachalam, Krishna
BE Schiuma, G
TI Evaluating the Status of Information and Knowledge Management in a Large
   Municipality
SO 15TH INTERNATIONAL FORUM ON KNOWLEDGE ASSET DYNAMICS (IFKAD 2020):
   KNOWLEDGE IN DIGITAL AGE
SE Proceedings IFKAD
LA English
DT Proceedings Paper
CT 15th International Forum on Knowledge Asset Dynamics (IFKAD) - Knowledge
   in Digital Age
CY SEP 09-11, 2020
CL ELECTR NETWORK
DE Digital-era governance; Knowledge management; Information management;
   Maturity analysis; Public sector
ID MATURITY; MODEL; PERFORMANCE
AB In modem society, municipalities and cities are accountable for various societal service missions. In addition, cities and municipalities are expected to take a responsible role in solving the wicked problems such as climate change and ageing of population, coupled with sudden challenges, like the COVID-19 virus, together with the government. This kind of development has increased the role of municipalities and cities as decision-makers in global and social challenges and their ability to use information has become a critical success factor in modem society. By systematically exploiting information use possibilities in the public sector, it is possible not only to make more informed decisions, but also to serve the citizens better and use resources more effectively.
   The purpose of information and knowledge management is to collect, process, organize, store, share and utilize information in a way that enhances individual and organizational decision making and operations. The current trend of digitalization in the cities and municipalities is changing the way these activities can be carried out. At present, public organization's ability to manage its information and knowledge resources is critical and there are still many lessons to be learnt in taking the best out of digitalization. In this study, a maturity evaluation instrument (Jaaskelainen et al., 2019) based on Choo's knowledge management model (2002) is used to evaluate the status of information and knowledge management in a large municipality organization. The aim of the study is to increase our understanding on the status of information and knowledge management practices used in the digital era governance of public sector. Theoretical part of the paper analyses and combines research literature related to digital era governance and knowledge management in order to find out connections between these research areas for the empirical analysis of this study. The empirical context of the study is a large Finnish municipality that has gone through a large scale administrative and managerial system reform a few years ago. A survey will be used to gather the empirical data for this study. Around 300 responses representing all the branches of the municipality were received. The results show that organizational information and knowledge management requires improvement especially in relation to organizing and storing knowledge, knowledge acquisition and information products and services. However, performance benefits of information and knowledge management can be obtained only through successful knowledge usage.
C1 [Kinnunen, Reetta; Jaaskelainen, Aki; Sillanpaa, Virpi; Helander, Nina] Tampere Univ, Fac Management & Business, Korkeakoulunkatu 7, Tampere 33720, Finland.
   [Venkitachalam, Krishna] Stockholm Univ, Stockholm Business Sch, Stockholm, Sweden.
RP Kinnunen, R (corresponding author), Tampere Univ, Fac Management & Business, Korkeakoulunkatu 7, Tampere 33720, Finland.
OI Sillanpaa, Virpi Susanna/0000-0003-4949-5203; Jaaskelainen,
   Aki/0000-0002-6427-8437
CR Aho M., 2012, PMA 2012 C CAMBR UK
   Argento D, 2019, ACCOUNT AUDIT ACCOUN, V33, P204, DOI 10.1108/AAAJ-04-2017-2922
   Bardzki B, 2004, LECT NOTES COMPUT SC, V3025, P278
   Becker J, 2009, BUS INFORM SYST ENG+, V1, P213, DOI 10.1007/s12599-009-0044-5
   Bititci US, 2015, INT J PROD RES, V53, P3062, DOI 10.1080/00207543.2014.970709
   Bolivar R., 2015, INFORM POLITY, V20
   CHOO C. W., 1995, DIGITAL LIB C P
   Choo CA/V., 2002, INFORM TODAY
   Choo CW, 1996, INT J INFORM MANAGE, V16, P329, DOI 10.1016/0268-4012(96)00020-5
   Daddieco RJ, 2004, LECT NOTES COMPUT SC, V3025, P95
   DUNLEAVY P, 1994, PUBLIC MONEY MANAGE, V14, P9, DOI 10.1080/09540969409387823
   Dunleavy P., 2006, DIGITAL ERA GOVERNAN
   Hansen H., 2005, EVALUATION-US, V11, P447, DOI [10.1177/1356389005060265, DOI 10.1177/1356389005060265]
   Helsingin kaupunki, 2016, UUD PER SYKS 2016
   Hsieh PJ, 2009, EXPERT SYST APPL, V36, P4087, DOI 10.1016/j.eswa.2008.03.005
   Jaaskelainen A., 2019, P 14 IFKAD 2019 C MA
   Jaaskelainen A, 2015, INT J PRODUCT PERFOR, V64, P5, DOI 10.1108/IJPPM-01-2014-0001
   Kim S., 2004, ELECT GOVT
   Kruger CJ, 2010, INT J INFORM MANAGE, V30, P57, DOI 10.1016/j.ijinfomgt.2009.06.007
   Laihonen H., 2013, TIETOJOHTAMINEN TAMP
   Lappi T., 2019, ACTA U OUL C, V709
   Margetts H., 2014, GOVT CITIZENS GETTIN
   Margetts H, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0382
   Metsamuuronen J., 2001, MONIMUUTTUJAMENETELM
   Nummenmaa L., 2010, KAYTTAYTYMISTIETEIDE
   Pee LG, 2009, J INF KNOWL MANAG, V8, P79, DOI 10.1142/S0219649209002270
   Poeppelbuss J., 2011, COMMUN ASSOC INF SYS, V29, P505
   Pollitt C., 2011, CONTINUITY CHANGE PU
   Reinartz W, 2009, INT J RES MARK, V26, P332, DOI 10.1016/j.ijresmar.2009.08.001
   Riege A., 2006, Journal of Knowledge Management, V10, P24, DOI 10.1108/13673270610670830
   Teah HY, 2006, PACIFIC ASIA CONFERENCE ON INFORMATION SYSTEMS 2006, SECTIONS 1-8, P401
   Tuomi J., 2009, LAADULLINEN TUTKIMUS, V5th
   Van Aken EM, 2005, INT J PRODUCT PERFOR, V54, P400, DOI 10.1108/17410400510604557
   Wettstein T, 2002, MANAG INFORMAT SYST, V4, P113
   Zaharova S, 2004, LECT NOTES COMPUT SC, V3025, P37
NR 35
TC 0
Z9 0
U1 0
U2 0
PU IKAM-INST KNOWLEDGE ASSET MANAGEMENT
PI MATERA
PA VIA D SCHIAVONE 1, MATERA, MT 75100, ITALY
SN 2280-787X
BN 978-88-96687-13-0
J9 PR IFKAD
PY 2020
BP 1442
EP 1459
PG 18
WC Business; Computer Science, Interdisciplinary Applications; Information
   Science & Library Science; Management; Operations Research & Management
   Science
WE Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics; Computer Science; Information Science & Library
   Science; Operations Research & Management Science
GA BS4CI
UT WOS:000717224200106
DA 2022-04-20
ER

PT J
AU Li, B
   Zhong, YY
   Zhang, TT
   Hua, N
AF Li, Bin
   Zhong, YunYing
   Zhang, Tingting
   Hua, Nan
TI Transcending the COVID-19 crisis: Business resilience and innovation of
   the restaurant industry in China
SO JOURNAL OF HOSPITALITY AND TOURISM MANAGEMENT
LA English
DT Article
DE Business resilience; Innovation; Restaurants; COVID-19
ID CORPORATE SOCIAL-RESPONSIBILITY; TOURISM; HOSPITALITY; PERFORMANCE;
   MANAGEMENT; KNOWLEDGE; CHAOS
AB Utilizing the content analysis approach, this study analyzed 153 textual information sources to explore Chinese restaurant enterprises' innovative activities during and after COVID-19. An innovative crisis management model was synthesized from a micro-level perspective by adopting the life cycle model to dynamically measure the innovative strategies applied by Chinese restaurant enterprises in their emergency responses and recovery efforts. Two types of innovative activities that led to internal and external performances were identified based on the push and pull theory of business motivation. Findings further indicated five dimensions of innovative strategies at two different stages: pandemic prevention and control, government and community, corporate social responsibility, marketing response, and management response at the stage of emergency responses; and pandemic prevention and control, cooperation with third parties, customer service innovation, product innovation, and innovative marketing strategy at the stage of recovery efforts. Theoretical and empirical implications are also carefully discussed.
C1 [Li, Bin] Minnan Normal Univ, Sch Business, Tourism Management Dept, Zhangzhou, Fujian, Peoples R China.
   [Zhong, YunYing; Zhang, Tingting; Hua, Nan] Univ Cent Florida, Rosen Coll Hospitality Management, Orlando, FL 32816 USA.
RP Li, B (corresponding author), Minnan Normal Univ, Sch Business, Tourism Management Dept, Zhangzhou, Fujian, Peoples R China.
EM 654435996@qq.com; YunYing.zhong@ucf.edu; tingting.zhang@ucf.edu;
   Nan.Hua@ucf.edu
CR Adams R, 2006, INT J MANAG REV, V8, P21, DOI 10.1111/j.1468-2370.2006.00119.x
   Aguilera RV, 2007, ACAD MANAGE REV, V32, P836, DOI 10.5465/AMR.2007.25275678
   [Anonymous], 2020, CHINA DAILY 0418
   [Anonymous], 2020, RESTAURANT NEWS
   [Anonymous], 2020, GLOBAL TIMES JUN
   Barasa E, 2018, INT J HEALTH POLICY, V7, P491, DOI 10.15171/ijhpm.2018.06
   Bhaskara GI, 2021, J HOSP TOUR MANAG, V46, P364, DOI 10.1016/j.jhtm.2021.01.011
   Brewer P, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102777
   Bufquin D, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102764
   Burnett M, 2020, TOUR REV, V75, P595, DOI 10.1108/TR-04-2019-0118
   Byrd K, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102821
   Chen H, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102850
   Cheng E, 2020, CNBC
   Choe JY, 2021, INT J CONTEMP HOSP M, V33, P1276, DOI 10.1108/IJCHM-08-2020-0839
   Corpuz JCG, 2021, J PUBLIC HEALTH-UK, V43, pE344, DOI 10.1093/pubmed/fdab057
   Dahles H, 2015, ANN TOURISM RES, V51, P34, DOI 10.1016/j.annals.2015.01.002
   Dedeoglu BB, 2021, INT J HOSP MANAG, V95, DOI 10.1016/j.ijhm.2021.102905
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Foroudi P, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102717
   Henderson J. C., 2007, International Journal of Hospitality Management, V26, P228, DOI 10.1016/j.ijhm.2006.02.001
   Hong Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103747
   Hu XW, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102662
   Hua N, 2016, INT J CONTEMP HOSP M, V28, P2052, DOI 10.1108/IJCHM-05-2015-0247
   Huang Y. C., 2008, J TRAVEL TOUR MARK, V23, P203, DOI [10.1300/J073v23n02_16, DOI 10.1300/J073v23n02_16, DOI 10.1300/J073V23N02_16]
   Jackson MS, 1996, ANN TOURISM RES, V23, P798, DOI 10.1016/0160-7383(96)00003-5
   Jiang C., 2021, INT HOSPITALITY REV, P1
   Kim J, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102752
   Kwok AOJ, 2021, CURR ISSUES TOUR, V24, P1935, DOI 10.1080/13683500.2020.1798896
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Li B, 2021, TOUR REV, V76, P764, DOI 10.1108/TR-09-2020-0413
   Liu CY, 2020, J RURAL STUD, V79, P177, DOI 10.1016/j.jrurstud.2020.08.046
   Lock S, 2021, STATISTA
   Luo Y, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102849
   Magrizos S, 2020, EUR MANAG J
   Mair J, 2016, CURR ISSUES TOUR, V19, P1, DOI 10.1080/13683500.2014.932758
   Marasco A, 2018, INT J CONTEMP HOSP M, V30, P2364, DOI [10.1108/IJCHM-01-2018-0043, 10.1108/ijchm-01-2018-0043]
   McKenzie-Mohr D, 2000, AM PSYCHOL, V55, P531, DOI 10.1037/0003-066X.55.5.531
   Newswire P. R, 2020, YUM CHINA STANDS COM
   Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006
   Orchiston C, 2016, ANN TOURISM RES, V56, P145, DOI 10.1016/j.annals.2015.11.002
   Paraskevas A, 2013, ANN TOURISM RES, V41, P130, DOI 10.1016/j.annals.2012.12.005
   Prideaux B, 2003, TOURISM MANAGE, V24, P475, DOI 10.1016/S0261-5177(02)00115-2
   Qi X. X., 2020, NEXT GENERATION INFO
   Reddy MV, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102940
   Ribeiro Gutemberg, 2017, RAI Revista de Administracao e Inovacao, V14, P30, DOI 10.1016/j.rai.2016.10.002
   Ritchie BW, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102812
   Ritchie BW, 2004, TOURISM MANAGE, V25, P669, DOI 10.1016/j.tourman.2003.09.004
   Ritter T, 2020, IND MARKET MANAG, V88, P214, DOI 10.1016/j.indmarman.2020.05.014
   Rogers E.M., 2010, DIFFUSION INNOVATION
   Russell R, 2004, ANN TOURISM RES, V31, P556, DOI 10.1016/j.annals.2004.01.008
   Sausmarez N. de, 2003, Journal of Travel & Tourism Marketing, V15, P217, DOI 10.1300/J073v15n04_01
   Stafford G, 2002, CRONELL HOTEL RESTAU, P27
   Sung YK, 2021, INT J HOSP MANAG, V95, DOI 10.1016/j.ijhm.2021.102906
   Theodoulidis B, 2017, TOURISM MANAGE, V62, P173, DOI 10.1016/j.tourman.2017.03.018
   Tse Alan C B, 2006, Int J Hosp Manag, V25, P3, DOI 10.1016/j.ijhm.2004.12.001
   Wang WK, 2019, COMPUT HUM BEHAV, V95, P284, DOI 10.1016/j.chb.2018.06.029
   Wei CH, 2021, INT J HOSP MANAG, V95, DOI 10.1016/j.ijhm.2021.102894
   Wen J, 2020, ANATOLIA, V31, P666, DOI 10.1080/13032917.2020.1742750
   Wilks J., 2004, TOURISM RISK MANAGEM
   Yang FX, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102855
   York QY, 2010, TOURISM MANAGE, V31, P881, DOI 10.1016/j.tourman.2009.10.003
   Yost E, 2021, J HOSP TOUR MANAG, V47, P408, DOI 10.1016/j.jhtm.2021.04.012
   Yost E, 2021, INT J HOSP MANAG, V95, DOI 10.1016/j.ijhm.2021.102889
   Yu N., 2021, EASTSPRING INVESTMEN
   Zeng ZJ, 2020, TOURISM GEOGR, V22, P724, DOI 10.1080/14616688.2020.1762118
   Zhang A, 2020, IS CHINAS CATERING I
   Zhang CX, 2019, INT J HOSP MANAG, V81, P193, DOI 10.1016/j.ijhm.2019.04.013
   Zhang TT, 2019, INT J HOSP MANAG, V79, P148, DOI 10.1016/j.ijhm.2019.01.010
   ZMUD RW, 1984, MANAGE SCI, V30, P727, DOI 10.1287/mnsc.30.6.727
NR 69
TC 4
Z9 4
U1 22
U2 22
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1447-6770
EI 1839-5260
J9 J HOSP TOUR MANAG
JI J. Hosp. Tour. Manag.
PD DEC
PY 2021
VL 49
BP 44
EP 53
DI 10.1016/j.jhtm.2021.08.024
EA SEP 2021
PG 10
WC Hospitality, Leisure, Sport & Tourism; Management
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics; Business & Economics
GA XG2IY
UT WOS:000724583000005
OA Bronze
DA 2022-04-20
ER

PT J
AU Manolescu, LSC
   Zaharia, CN
   Dumitrescu, AI
   Prasacu, I
   Radu, MC
   Boeru, AC
   Boidache, L
   Nita, I
   Necsulescu, A
   Chivu, RD
AF Manolescu, Loredana Sabina Cornelia
   Zaharia, Corneliu Nicolae
   Dumitrescu, Anca Irina
   Prasacu, Irina
   Radu, Mihaela Corina
   Boeru, Adrian Calin
   Boidache, Liliana
   Nita, Irina
   Necsulescu, Andrei
   Chivu, Razvan Daniel
TI Early COVID-19 Vaccination of Romanian Medical and Social Personnel
SO VACCINES
LA English
DT Article
DE COVID-19 vaccines; medical and social staff vaccination; mRNA vaccine
ID INFLUENZA VACCINATION; INFECTION; INTENTION; STUDENTS
AB Background: In December 2020, the first doses of COVID-19 vaccines arrived in Romania and were made available to medical and social staff. Vaccine hesitancy appeared as a barrier to effectively ending the pandemic. The opinions of medical and social staff influence the opinion of the general population. This study assesess the attitudes, knowledge, and opinion of medical and social personnel toward COVID-19 vaccines and vaccination and the influencing factors.
   Methods: 1025 persons participated in an online cross-sectional study from March until July 2021.
   Results: Out of 1021 eligible responders, 719 (70.42%) had been vaccinated: 227 with one dose (22.23%) and 492 with two doses (48.18%). There were 302 responders who were not vaccinated at all. Out of them, 188 refused vaccinations. The participants showed a good understanding and knowledge of SARScoV-2 transmission and treatment. Geographic area, medical profession, and medical experience influenced COVID-19 vaccination (p < 0.001). There were no associations between willingness to vaccinate and vaccine/virus knowledge. Most of the responders who were vaccinated or wanted to be vaccinated indicated an mRNA vaccine as their first choice. The variables that were significantly associated with reporting COVID-19 vaccine acceptance after logistic regression were: living in an urban area (Ora = 1.58, 95% CI: 0.98-2.56), being female (Ora = 1.59; 95% CI:1.03-2.44), and being a medical doctor (Ora = 3.40; 95% CI: 1.84-6.26).
   Conclusions: These findings show that vaccine hesitancy persists in medical and social personnel in Romania, and, hence, it may be reflected in the hesitancy of the general population toward vaccination.
C1 [Manolescu, Loredana Sabina Cornelia; Radu, Mihaela Corina; Boidache, Liliana; Nita, Irina] Carol Davila Univ Med & Pharm, Fac Midw & Nursing, Dept Microbiol Parasitol & Virol, Bucharest 050474, Romania.
   [Manolescu, Loredana Sabina Cornelia; Zaharia, Corneliu Nicolae] Inst Virol Stefan S Nicolau, Dept Virol, Bucharest 030304, Romania.
   [Dumitrescu, Anca Irina; Prasacu, Irina] Carol Davila Univ Med & Pharm, Fac Pharm, Dept Fundamental Sci, Bucharest 050474, Romania.
   [Radu, Mihaela Corina; Boeru, Adrian Calin] Obstet & Gynecol Hosp, Dept Birth, Ploiesti 100409, Romania.
   [Nita, Irina] Elias Univ Emergency Hosp, Dept Med Oncol, Bucharest 011461, Romania.
   [Necsulescu, Andrei] Cent Mil Emergency Univ Hosp Dr Carol Davila, Dept Emergency, Bucharest 010825, Romania.
   [Chivu, Razvan Daniel] Carol Davila Univ Med & Pharm, Fac Midwives & Nursing, Dept Publ Hlth & Hlth Management, Bucharest 050474, Romania.
RP Manolescu, LSC; Radu, MC (corresponding author), Carol Davila Univ Med & Pharm, Fac Midw & Nursing, Dept Microbiol Parasitol & Virol, Bucharest 050474, Romania.; Manolescu, LSC (corresponding author), Inst Virol Stefan S Nicolau, Dept Virol, Bucharest 030304, Romania.; Radu, MC (corresponding author), Obstet & Gynecol Hosp, Dept Birth, Ploiesti 100409, Romania.
EM loredana.manolescu@umfcd.ro; corneliu.zaharia@gmail.com;
   ancairinadumitrescu@yahoo.com; irinaprasacu@yahoo.com;
   radu_mihaela72@yahoo.com; calinboeru@yahoo.com;
   liliana.boidache@yahoo.com; irina.nita0910@gmail.com;
   andrei.neck@gmail.com; razvan.chivu@umfcd.ro
RI Radu, Mihaela Corina/ABD-7359-2021; Radu, Mihaela Corina/AAA-7991-2022;
   Manolescu, Loredana/AAC-5584-2020
OI Manolescu, Loredana/0000-0001-8694-6195
FU European UnionEuropean Commission [883441]
FX This paper was supported by the STAMINA project, which received funding
   from the European Unions Horizon 2020 research and innovation program
   under grant agreement No. 883441. All authors have equally contributed
   to the writing and editing of the manuscript.
CR Al-Jayyousi GF, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060548
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Balan A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080854
   Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891
   Dragomirescu CC, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9010031
   Fabricius D, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080918
   Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5
   Gagneux-Brunon A, 2021, J HOSP INFECT, V108, P168, DOI [10.1016/j.jhin.2020.11.0200195-6701, 10.1016/j.jhin.2020.11.020]
   Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056
   Kerneis S, 2017, AM J PREV MED, V53, pE97, DOI 10.1016/j.amepre.2017.01.014
   Keske S, 2020, VACCINE, V38, P8357, DOI 10.1016/j.vaccine.2020.11.003
   Kowalska JD, 2021, INT J INFECT DIS, V104, P293, DOI 10.1016/j.ijid.2020.12.026
   Marinescu P, 2012, ROM BIOTECH LETT, V17, P7817
   Nita I, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56110600
   Olashore AA, 2021, ASIAN J SOCIAL HLTH, V4, P85, DOI [10.4103/shb.shb_32_21, DOI 10.4103/SHB.SHB_32_21]
   Papagiannis D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144925
   Pless A, 2017, BMC NURS, V16, DOI 10.1186/s12912-017-0215-5
   Popa GL, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040774
   Radu MC, 2021, CUREUS, V13, DOI 10.7759/cureus.12811
   Raude J, 2016, EXPERT REV VACCINES, V15, P937, DOI 10.1080/14760584.2016.1184092
   Ricco M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080889
   Rieger MO., 2021, ASIAN J SOCIAL HLTH, V4, P81, DOI [10.4103/shb.shb_7_21, DOI 10.4103/SHB.SHB_7_21]
   Sharma R., 2021, ASIAN J SOC HLTH BEH, V4, P98, DOI [10.4103/shb.shb_9_21, DOI 10.4103/SHB.SHB_9_21]
   Wang KL, 2020, VACCINE, V38, P7049, DOI 10.1016/j.vaccine.2020.09.021
NR 24
TC 3
Z9 3
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD OCT
PY 2021
VL 9
IS 10
AR 1127
DI 10.3390/vaccines9101127
PG 9
WC Immunology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Research & Experimental Medicine
GA WN6TL
UT WOS:000711899900001
PM 34696235
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Mahmud, MR
   Bin Reza, R
   Ahmed, SMZ
AF Mahmud, Md Rifat
   Bin Reza, Raiyan
   Ahmed, S. M. Zabed
TI The effects of misinformation on COVID-19 vaccine hesitancy in
   Bangladesh
SO GLOBAL KNOWLEDGE MEMORY AND COMMUNICATION
LA English
DT Article; Early Access
DE Bangladesh; Misinformation; Vaccine; COVID-19; Counter-misinformation
   strategies; Vaccine hesitancy
ID REFUSAL
AB Purpose - The main purpose of this study is to assess the prevalence of COVID-19 vaccine hesitancy among the general population in Bangladesh and the role of misinformation in this process.
   Design/methodology/approach - An online survey was conducted to assess COVID-19 vaccine hesitancy among ordinary citizens. In addition to demographic and vaccine-related information, a five-point Likert scale was used to measure vaccine-related misinformation beliefs and how to counter them. Chi-square tests were used to examine the relationship between demographic variables and vaccine acceptance. A binary logistic regression analysis was conducted to identify vaccine hesitancy by different demographic groups. Nonparametric Mann-Whitney and Kruskal-Wallis tests were performed to determine the significance of difference between demographic groups in terms of their vaccine-related misinformation beliefs. Finally, the total misinformation score was computed to examine the correlation between vaccine hesitancy and the total score.
   Findings - This study found that nearly half of the respondents were willing to receive COVID-19 vaccine, whereas more than one third of the participants were unsure about taking the vaccine. Demographic variables (e.g., gender, age and education) were found to be significantly related to COVID-19 vaccine acceptance. The results of binary logistic regression analysis showed that respondents who were below 40 years of age, females and those who had lower education attainments had significantly higher odds of vaccine hesitancy. There were significant differences in participants' vaccine-related misinformation beliefs based on their demographic characteristics, particularly in the case of educational accomplishments. A highly significant negative correlation was found between total misinformation score and vaccine acceptance.
   Research limitations/implications - The survey was conducted online, and therefore, it automatically precluded non-internet users from completing the survey. Further, the number of participants from villages was relatively low. Overall, the results may not be representative of the entire population in Bangladesh.
   Practical implications - The findings of this paper could guide government agencies and policymakers in devising appropriate strategies to counter COVID-related misinformation to reduce the level of vaccine hesitancy in Bangladesh.
   Originality/value - To the authors' best knowledge, this study is the first to measure the level of COVID-19 vaccine hesitancy and the influence of misinformation in this process among the general public in Bangladesh.
C1 [Mahmud, Md Rifat; Bin Reza, Raiyan; Ahmed, S. M. Zabed] Univ Dhaka, Dept Informat Sci & Lib Management, Dhaka, Bangladesh.
RP Ahmed, SMZ (corresponding author), Univ Dhaka, Dept Informat Sci & Lib Management, Dhaka, Bangladesh.
EM smzahmed@du.ac.bd
RI Ahmed, S.M. Zabed/AAE-4936-2020
OI Ahmed, S.M. Zabed/0000-0003-3939-6367; Mahmud, Md.
   Rifat/0000-0002-2137-2917
CR abc NEWS, 2021, ABC NEWS
   Ali M, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-050303
   Allington, 2020, MODE FREQUENCY COVID
   Badur S, 2020, HUM VACC IMMUNOTHER, V16, P1007, DOI 10.1080/21645515.2020.1740559
   Basch CH, 2017, CHILD CARE HLTH DEV, V43, P499, DOI 10.1111/cch.12442
   BBC News, 2020, BBC NEWS 0626
   Brennen J. S., 2020, TYPES SOURCES CLAIMS
   Carrieri V, 2019, HEALTH ECON, V28, P1377, DOI 10.1002/hec.3937
   CNBC, 2021, CNBC 0127
   Cook J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175799
   Daily Star, 2021, DAILY STAR 0619
   de Bruin YB, 2020, SAFETY SCI, V128, DOI 10.1016/j.ssci.2020.104773
   Dhaka Tribune, 2021, DHAKA TRIBUNE 0208
   Dhaka Tribune, 2021, DHAKA TRIBUNE 0429
   Dhaka Tribune, 2021, DHAKA TRIBUNE 0719
   Dhaka Tribune, 2021, DHAKA TRIBUNE 0801
   Dhaka Tribune, 2020, DHAKA TRIBUNE 0308
   Dhaka Tribune, 2021, DHAKA TRIBUNE 0425
   Dib F, 2022, HUM VACC IMMUNOTHER, V18, DOI 10.1080/21645515.2021.1874218
   Dinleyici EC, 2021, HUM VACC IMMUNOTHER, V17, P400, DOI 10.1080/21645515.2020.1804776
   Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212
   DW.COM, 2021, COVID BANGL FAC VACC
   Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5
   Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912
   Gu C, 2021, SCI EDUC-NETHERLANDS, DOI 10.1007/s11191-021-00261-8
   Harvey Chelsea and EE News, 2020, SCI AM
   Hornik R, 2021, HEALTH COMMUN, V36, P6, DOI 10.1080/10410236.2020.1847437
   Hotez PJ, 2020, CURR OPIN VIROL, V41, P1, DOI 10.1016/j.coviro.2020.01.001
   Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177
   Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081
   Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9
   Lewandowsky S, 2017, J APPL RES MEM COGN, V6, P418, DOI 10.1016/j.jarmac.2017.11.002
   Li HOY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002604
   Lin YL, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008961
   Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1
   Mahmud S., 2021, ACCEPTANCE COVID 19
   NPR.Org, 2021, VIR WHO TEAM FOUND N
   Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd
   Nuzhath T., 2020, COVID 19 VACCINATION
   Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054
   Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6
   Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353
   Ruiz JB, 2021, VACCINE, V39, P1080, DOI 10.1016/j.vaccine.2021.01.010
   Salali Gul Deniz, 2020, Psychol Med, P1, DOI 10.1017/S0033291720004067
   Salathe M, 2013, EPJ DATA SCI, V2, DOI 10.1140/epjds16
   Sarkar P.K., 2015, BANGLADESH J CHILD H, V39, P93, DOI [10.3329/bjch.v39i2.31540, DOI 10.3329/BJCH.V39I2.31540]
   Sarma H, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7176-4
   Tasnim Samia, 2020, J Prev Med Public Health, V53, P171, DOI 10.3961/jpmph.20.094
   The Business Standard, 2021, BUSINESS STANDA 0210
   Tomeny TS, 2017, SOC SCI MED, V191, P168, DOI 10.1016/j.socscimed.2017.08.041
   Wang JL, 2020, AAPS PHARMSCITECH, V21, DOI 10.1208/s12249-020-01744-7
   WHO, 2020, REP MIS ONL
   WHO EMRO, 2021, ALC DOES NOT PROT CO
   Wilson SL, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-004206
   World Economic Forum, 2020, HER GLOB COVID 19 VA
   World Health Organization, 2014, REP SAG WORK GROUP V, P64
   Worldometer, 2021, COR CAS
   Yesmin S, 2022, DIGIT LIBR PERSPECT, V38, P3, DOI 10.1108/DLP-03-2021-0020
NR 58
TC 0
Z9 0
U1 9
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2514-9342
EI 2514-9350
J9 GLOB KNOWL MEM COMMU
JI Glob. Knowl. Mem. Commun.
DI 10.1108/GKMC-05-2021-0080
EA OCT 2021
PG 16
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA WM5LT
UT WOS:000711127500001
DA 2022-04-20
ER

PT J
AU Schlabitz, F
   Teich, N
   Riesner-Wehner, A
   Bohm, S
   Greinert, R
   Eisenmann, S
   Michl, P
   Walldorf, J
AF Schlabitz, Franziska
   Teich, Niels
   Riesner-Wehner, Anica
   Bohm, Sebastian
   Greinert, Robin
   Eisenmann, Stephan
   Michl, Patrick
   Walldorf, Jens
TI Inflammatory Bowel Disease and COVID-19 How Have Patients Coped So Far?
SO JOURNAL OF CLINICAL GASTROENTEROLOGY
LA English
DT Article
DE IBD; SARS-CoV2; COVID-19; patients' perspective; telemedicine
ID MANAGEMENT; CROHNS
AB Objective: Knowledge about SARS-CoV2 and coronavirus disease 2019 (COVID-19) is growing fast. Massive changes in the health care system imposed by the COVID-19 pandemic clearly impact the overall quality of medical care. In this survey, we aim to explore experiences and concerns of patients with inflammatory bowel disease (IBD) regarding the current pandemic. Methods: A 40-item web-based questionnaire on disease-related experiences and concerns during the COVID-19 pandemic was made available to patients with IBD from 28 April 2020 to 31 July 2020. Results: An increased risk of SARS-CoV2 infection was a concern for 56.7% of the 1199 patients (aged 41.3 +/- 12.8, women 77%, Crohn's disease 58.8%, ulcerative colitis 38.5%); 61.7% feared an increased risk of severe disease course of COVID-19. Effective preventive measures in either outpatient practices or hospitals were observed by 84.7% of the patients. Appointments with an IBD specialist were canceled in 38.7%, frequently on the patients' initiative. Telecommunication visits were considered an acceptable alternative to personal visits by 71.0%. Medication was reduced or paused in 6.9% because of the pandemic. A swab (SARS-CoV2-PCR) was done in 13.2% of the patients; only 3 patients (0.25%) were tested positive. Conclusion: The COVID-19 pandemic is a major concern of patients with IBD. However, the cumulative prevalence in our cohort is low. Patients at risk should be identified and counseled individually. When required because of the local COVID-19 situation, telecommunication visits and liberal prescription policies are advisable to reduce in-person contacts, while ensuring continuous therapy and maintaining communication with patients.
C1 [Schlabitz, Franziska; Riesner-Wehner, Anica; Bohm, Sebastian; Greinert, Robin; Eisenmann, Stephan; Michl, Patrick; Walldorf, Jens] Martin Luther Univ Halle Wittenberg, Dept Internal Med 1, Ernst Grube Str 40, D-06120 Halle, Germany.
   [Teich, Niels] IBD Outpatient Practice, Leipzig, Germany.
   [Teich, Niels] IBD Outpatient Practice, Schkeuditz, Germany.
RP Walldorf, J (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Internal Med 1, Ernst Grube Str 40, D-06120 Halle, Germany.
EM jens.walldorf@uk-halle.de
OI Eisenmann, Stephan/0000-0002-0387-0760
CR Allocca M, 2020, CLIN GASTROENTEROL H, V18, P1882, DOI 10.1016/j.cgh.2020.04.028
   Bai XY, 2020, J CROHNS COLITIS, V14, P1494, DOI 10.1093/ecco-jcc/jjaa064
   Bezzio C, 2020, GUT, V69, P1213, DOI 10.1136/gutjnl-2020-321411
   Brenner EJ, SECURE IBD DATABASE
   Brenner EJ, 2020, GASTROENTEROLOGY, V159, P481, DOI 10.1053/j.gastro.2020.05.032
   D'Amico F, 2020, CLIN GASTROENTEROL H, V18, P2689, DOI 10.1016/j.cgh.2020.08.003
   D'Amico F, 2020, GASTROENTEROLOGY, V159, P14, DOI 10.1053/j.gastro.2020.04.059
   D'Amico F, 2020, LANCET GASTROENTEROL, V5, P631, DOI 10.1016/S2468-1253(20)30151-5
   Garbr J, 2020, GASTROENTEROLOGY, V159, P778, DOI 10.1053/j.gastro.2020.04.061
   Grunert PC, 2020, J CROHNS COLITIS, V14, P1702, DOI 10.1093/ecco-jcc/jjaa126
   Gubatan J, 2020, GASTROENTEROLOGY, V159, P1141, DOI 10.1053/j.gastro.2020.05.009
   Magro F, 2020, UNITED EUR GASTROENT, V8, P520, DOI 10.1177/2050640620920157
   Monteleone G, 2020, J CROHNS COLITIS, V14, P1334, DOI 10.1093/ecco-jcc/jjaa061
   Stallmach A, 2020, Z GASTROENTEROL, V58, P672, DOI 10.1055/a-1193-5475
NR 14
TC 3
Z9 3
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0192-0790
EI 1539-2031
J9 J CLIN GASTROENTEROL
JI J. Clin. Gastroenterol.
PD FEB
PY 2022
VL 56
IS 2
BP E126
EP E130
DI 10.1097/MCG.0000000000001504
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA YQ3YB
UT WOS:000749246500011
PM 33538442
DA 2022-04-20
ER

PT J
AU Mazinani, M
   Rude, BJ
AF Mazinani, M.
   Rude, B. J.
TI The novel zoonotic Coronavirus disease 2019 (COVID-19) pandemic: Health
   perspective on the outbreak
SO JOURNAL OF HEALTHCARE QUALITY RESEARCH
LA English
DT Review
DE Coronavirus; COVID-19; Zoonotic disease; Pandemic; MERS-CoV; SARS-CoV
AB During late 2019, the first cases of the Coronavirus disease-2019 (COVID-19) were observed in a Seafood Market in Wuhan. As the first cases took place in a seafood market that consumed live animals, it has been identified as a zoonotic disease. Some reports sug-gested snakes were the animal host, while others reported bat and pangolin were the sources of infection because coronavirus-origin of these two animals had similar genomic sequences to COVID-19. The common diagnosis method for detection COVID-19 was according to clinical man-ifestation, epidemiological histories, and ancillary tests, like CT scan, nucleic acid detection, immune identification technology, blood culture, Radiology, and enzyme-linked immunosorbent assay (ELISA). This review presented a perspective about current knowledge about COVID-19 in different aspects including probable zoonotic origins, and Coronaviruses classification was discussed in this context. In addition, epidemiology, clinical signs, treatment, and management strategies for controlling COVID-19 were also highlighted. (c) 2020 FECA. Published by Elsevier Espana, S.L.U. All rights reserved.
C1 [Mazinani, M.; Rude, B. J.] Mississippi State Univ, Fac Agr, Dept Anim & Dairy Sci, Starkville, MS 39759 USA.
RP Mazinani, M (corresponding author), Mississippi State Univ, Fac Agr, Dept Anim & Dairy Sci, Starkville, MS 39759 USA.
EM mm5001@msstate.edu
RI Lin, Chen/AFV-2163-2022
CR Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Culp WC, 2020, A A PRACT, V14, DOI 10.1213/XAA.0000000000001218
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   General Office of National Health Committee, 2020, NOT ISS PROGR DIAGN
   Goldstein E, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.17.2000596
   Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056
   Guan W-J, 2020, CLIN CHARACTERISTICS
   Hernandez M, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9060480
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kam KQ, 2020, CLIN INFECT DIS, V71, P847, DOI 10.1093/cid/ciaa201
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Li XW, 2020, J PHARM ANAL, V10, P102, DOI 10.1016/j.jpha.2020.03.001
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Mallapaty Smriti, 2020, Nature, DOI 10.1038/d41586-020-00984-8
   Ng Ming-Yen, 2020, Radiol Cardiothorac Imaging, V2, pe200034, DOI 10.1148/ryct.2020200034
   Nguyen NPT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238830
   Pan F, 2020, RADIOLOGY
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   See KC, 2020, INT J INFECT DIS, V94, P125, DOI 10.1016/j.ijid.2020.03.049
   Sit THC, 2020, NATURE, V586, P776, DOI 10.1038/s41586-020-2334-5
   Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018
   Tilocca B, 2020, MICROBES INFECT, V22, P182, DOI 10.1016/j.micinf.2020.05.013
   Tilocca B, 2020, MICROBES INFECT, V22, P218, DOI 10.1016/j.micinf.2020.03.002
   Tncpere T., 2020, CHINA CDC WEEKLY, V2019, P113
   Wang P, EPIDEMIOLOGICAL CHAR, V202
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Zhang Q., 2020, SARS COV 2 NEUTRALIZ, DOI [10.1101/2020.04.01.021196, DOI 10.1101/2020.04.01.021196]
   Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490
NR 31
TC 5
Z9 5
U1 4
U2 5
PU ELSEVIER ESPANA SLU
PI BARCELONA
PA AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN
EI 2603-6479
J9 J HEALTHC QUAL RES
JI J. Healthc. Qual. Res.
PD JAN-FEB
PY 2021
VL 36
IS 1
BP 47
EP 51
DI 10.1016/j.jhqr.2020.09.004
PG 5
WC Health Care Sciences & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA YY6MJ
UT WOS:000754902000008
PM 33162382
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Yi, ZM
   Hu, Y
   Wang, GR
   Zhao, RS
AF Yi, Zhan-Miao
   Hu, Yang
   Wang, Guan-Ru
   Zhao, Rong-Sheng
TI Mapping Evidence of Pharmacy Services for COVID-19 in China
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE COVID-19; pharmacy service; guideline development; emergency supply;
   service model innovation; treatment regimens
ID PHARMACEUTICAL CARE; RATIONAL USE; CONTROL STRATEGIES; ANTIVIRAL DRUGS;
   PREVENTION; MANAGEMENT; MODEL; COUNTERMEASURES; RECOMMENDATIONS;
   OUTPATIENT
AB Objective To explore the role of pharmacists and innovation of pharmacy interventions for COVID-19 patients in China. Methods We comprehensively searched PubMed and Chinese databases Sinomed, China National Knowledge Infrastructure to identify articles reporting pharmacist interventions and pharmacy services for COVID-19 patients using a predefined search strategy. The search period was from inception to April 7(th)2020. We also manually searched the reference list of included articles and websites of important journals with special issues for COVID-19. Results A total of 156 articles were identified by applying the search criteria. After screening, 91 articles, with the majority are literature reviews (n = 77, 84.62%) published in Chinese (n = 83, 91.2%), were included. Pharmacist interventions for COVID-19 patients most commonly related to guidelines or consensus development for the treatment of disease and practice procedure to prevent the spread of COVID-19 (n = 10, 10.98%), the supply of medicines to treat patients with severe respiratory or systematic symptoms related to COVID-19 (n = 10, 10.98%), formulating infections prevention and control strategies related to COVID-19 for pharmaceutical personnel/pharmacy staff (n = 14, 15.39%), new way of delivery pharmacy services and the implementation of new pharmacy services for COVID-19 outbreak (n = 14, 15.39%), routine pharmacy services under the restrict limit of COVID-19 outbreak (n = 39, 42.86%), and case series analysis of treatment regimens using existing, routinely collected data (n = 4, 4.40%). Conclusion Pharmacy services have a role in the COVID-19 pandemic control, and there were many rapid changes in response to the pandemic.
C1 [Yi, Zhan-Miao; Hu, Yang; Wang, Guan-Ru; Zhao, Rong-Sheng] Peking Univ Third Hosp, Dept Pharm, Beijing, Peoples R China.
   [Yi, Zhan-Miao; Hu, Yang; Wang, Guan-Ru; Zhao, Rong-Sheng] Peking Univ, Inst Drug Evaluat, Hlth Sci Ctr, Beijing, Peoples R China.
   [Yi, Zhan-Miao; Hu, Yang; Wang, Guan-Ru; Zhao, Rong-Sheng] Peking Univ, Therapeut Drug Monitoring & Clin Toxicol Ctr, Beijing, Peoples R China.
   [Hu, Yang; Wang, Guan-Ru] Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing, Peoples R China.
RP Zhao, RS (corresponding author), Peking Univ Third Hosp, Dept Pharm, Beijing, Peoples R China.; Zhao, RS (corresponding author), Peking Univ, Inst Drug Evaluat, Hlth Sci Ctr, Beijing, Peoples R China.; Zhao, RS (corresponding author), Peking Univ, Therapeut Drug Monitoring & Clin Toxicol Ctr, Beijing, Peoples R China.
EM zhaorongsheng@bjmu.edu.cn
OI , ZhanMiao/0000-0001-8575-3770
CR Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x
   AGREE Next Steps Consortium, 2017, AGREE 2 INSTR EL VER
   ALQUTEIMAT O, 2020, J ONCOL PHARM P 0611, DOI DOI 10.1016/j.sapharm.2020.03.018
   Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]
   BIAN Y, 2020, HER MED, V39, P338, DOI DOI 10.3870/j.issn.1004-0781.2020.03.016
   [边原 Bian Yuan], 2020, [中国新药与临床杂志, Chinese Journal of New Drugs and Clinical Remedies], V39, P212
   Cao J., 2020, J JIANGSU U MED, V30, P109, DOI [10.13312/j.issn.1671-7783.y200080, DOI 10.13312/J.ISSN.1671-7783.Y200080]
   Carico R, 2021, RES SOC ADMIN PHARM, V17, P1984, DOI 10.1016/j.sapharm.2020.03.017
   [车坷科 Che Keke], 2020, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V42, P1
   Chen J. Z., 2020, CHINA PHARMACY, V31, P536, DOI [10.6039/j.issn.1001-0408.2020.05.06, DOI 10.6039/j.issn.1001-0408.2020.05.06]
   Chen L., 2020, CHIN J CHIN MAT MED, V45, P2232, DOI [10.19540/j.cnki.cjcmm.20200322.505, DOI 10.19540/J.CNKI.CJCMM.20200322.505]
   Chen L. F., 2020, CHINA PHARM, V29, P18, DOI [10.3969/j.issn.1006-4931.2020.05.004, DOI 10.3969/J.ISSN.1006-4931.2020.05.004]
   [陈灵 Chen Ling], 2020, [中国实验方剂学杂志, Chinese Journal of Experimental Traditional Medical Formulae], V26, P35
   [陈丽坪 Chen Liping], 2020, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V37, P549
   CHEN M, 2020, HER MED, V39, P483, DOI DOI 10.3870/j.issn.1004-0781.2020.04.010
   Chen ND, 2020, CURR TOP NUTRACEUT R, V18, P21
   CHEN YW, 2020, CHIN J HOSP PHARM, V40, P632, DOI DOI 10.13286/j.1001-5213.2020.06.07
   CHENG F, 2020, CHIN J HOSP PHARM, V40, P1189, DOI DOI 10.13286/j.1001-5213.2020.11.03
   Dong S. J., 2020, CHINA PHARMACY, V31, P513, DOI [10.6039/j.issn.1001-0408.2020.05.01, DOI 10.6039/j.issn.1001-0408.2020.05.01]
   Duan H. F., 2020, MODERN TRADIT CHIN M, V3, P597, DOI [10.11842/wst.20200224009, DOI 10.11842/WST.20200224009]
   GAO YY, 2020, CHIN J HOSP PHARM, V40, P606, DOI DOI 10.13286/j.1001-5213.2020.06.02
   GONG WJ, 2020, CHIN J HOSP PHARM, V40, P876, DOI DOI 10.13286/j.1001-5213.2020.08.08
   GONG WJ, 2020, HER MED, V39, P650, DOI DOI 10.3870/j.issn.1004-0781.2020.05.014
   Gu M., 2020, CHINA PHARMACIST, V23, P702
   Guo W., 2020, ADVERSE DRUG REACT J, V3, P176, DOI [10.3760/cma.j.cn114015-20200222-00146, DOI 10.3760/CMA.J.CN114015-20200222-00146]
   Han L. Z., 2020, CENT S PHARM, V18, P591
   [何璐璐 He Lulu], 2020, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V35, P225
   He S. Z., 2020, PHARM TODAY, V335, P313
   Hu C. J., 2020, W CHIN J PHARM SCI, V33, P100, DOI [10.3969/j.issn.1674-0904.2020.02.004, DOI 10.3969/J.ISSN.1674-0904.2020.02.004]
   Hu Z. Q., 2020, J CANC CONT TREAT, V33, P100
   Huang L. J., 2020, CENTRAL S PHARM, V18, P739, DOI DOI 10.7539/J.ISSN.1672-2981.2020.05.005
   Huang L. J., 2020, CHINESE PHARMACOL B, V36, P30
   [黄凌斐 Huang Lingfei], 2020, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V37, P555
   International Pharmaceutical Federation, 2020, CHIN PHARM J, V55, P249, DOI [10.11669/cpj.2020.04.001, DOI 10.11669/CPJ.2020.04.001]
   Jin Y., 2020, CHIN J HOSP PHARM
   Leading Group of the Central Committee on Response to COVID-19, 2020, GUID OP CENTR LEAD G
   Li G. H., 2020, ADVERSE DRUG REACT J, V22, P139, DOI [10.3760/cma.j.issn.1008-5734.2020.0004, DOI 10.3760/CMA.J.ISSN.1008-5734.2020.0004]
   Li HB, 2021, RES SOC ADMIN PHARM, V17, P1813, DOI 10.1016/j.sapharm.2020.04.003
   Lin Zhi-Jian, 2020, Zhongguo Zhong Yao Za Zhi, V45, P1259, DOI 10.19540/j.cnki.cjcmm.20200211.501
   Liu Q. Y., 2020, ADVERSE DRUG REACT J, DOI [10.3760/cma.j.cn114015-20200224-00158, DOI 10.3760/CMA.J.CN114015-20200224-00158]
   LIU S, 2020, CHIN J HOSP PHARM, V40, P243, DOI DOI 10.13286/j.1001-5213.2020.03.01
   Liu S, 2020, INT J CLIN PHARM-NET, V42, P299, DOI 10.1007/s11096-020-01017-0
   Liu X. L., 2020, CHIN J HOSP ADM, V4, P324, DOI [10.3760/cma.j.cn112225-20200302-00440, DOI 10.3760/CMA.J.CN112225-20200302-00440]
   LIU XX, 2020, HER MED, V39, P451, DOI DOI 10.3870/j.issn.1004-0781.2020.04.006
   LIU Y, 2020, HER MED, V39, P522, DOI DOI 10.3870/j.issn.1004-0781.2020.04.017
   Liu Y, 2021, FUND CLIN PHARMACOL, V35, P156, DOI 10.1111/fcp.12574
   Martin P, 2018, JAMA-J AM MED ASSOC, V320, P1889, DOI 10.1001/jama.2018.16131
   Medical Research Council, 2019, DEV EV COMPL INT FOL
   Meng L, 2020, INT J CLIN PHARM-NET, V42, P305, DOI 10.1007/s11096-020-01020-5
   Munn, 2020, JBI MANUAL EVIDENCE, DOI [10.46658/JBIRM-17-06, DOI 10.46658/JBIMES-20-08]
   National Health Commission of People's Republic of China, 2020, PRESS C JOINT DEF JO
   National Institute for Health and Care Excellence, 2020, COVID 19 RAP GUID CR
   Omer SB, 2020, JAMA-J AM MED ASSOC, V323, P1767, DOI 10.1001/jama.2020.5788
   [彭玲玲 Peng Lingling], 2020, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V36, P926
   RAO YF, 2020, CHIN J HOSP PHARM, V40, P726, DOI DOI 10.13286/j.1001-5213.2020.07.02
   Shao M. M., 2020, CHIN J HOSP PHARM, V40, P753, DOI [10.13286/j.1001-5213.2020.07.08, DOI 10.13286/j.1001-5213.2020.07.08]
   SHEN AZ, 2020, CHIN J HOSP PHARM, V40, P1603, DOI DOI 10.13286/j.1001-5213.2020.15.01
   SONG B, 2020, CHIN J HOSP PHARM, V40, P748, DOI DOI 10.13286/j.1001-5213.2020.07.07
   Song ZW, 2021, RES SOC ADMIN PHARM, V17, P2027, DOI 10.1016/j.sapharm.2020.03.027
   Tan S. L., 2020, CENT S PHARM, V18, P335, DOI [10.7539/j.issn.1672-2981.2020.02.038, DOI 10.7539/J.ISSN.1672-2981.2020.02.038]
   The State Council of the People's Republic of China, 2020, NOT ISS GUID PREV CO
   Therapeutic Drug Monitoring Pharmacists Branch of Chinese Pharmacists Association Hospital Pharmacy Branch of China Association of Chinese Medicine Emergency Medicine Branch of Chinese Geriatrics Society Cardiovascular Medicine Branch of Chinese Society of Cardiothoracic and Vascular Anesthesiology Clinical Toxicology Professional Committee of Chinese Society of Toxicology Drug induced Diseases Professional Committee of Chinese Pharmacological Society, 2020, ADVERSE DRUG REACT J, V3, P121, DOI [10.3760/cma.j.cn114015-20200304-00211, DOI 10.3760/CMA.J.CN114015-20200304-00211]
   Ung COL, 2020, RES SOC ADMIN PHARM, V16, P583, DOI 10.1016/j.sapharm.2020.02.003
   Wang N. N., 2020, CHINA PHARM, V29, P15, DOI [10.3969/j.issn.1006-4931.2020.05.003, DOI 10.3969/J.ISSN.1006-4931.2020.05.003]
   WANG RR, 2020, CHIN J HOSP PHARM, V40, P612, DOI DOI 10.13286/j.1001-5213.2020.06.03
   WANG XY, 2020, CHIN J HOSP PHARM, V40, P847, DOI DOI 10.13286/j.1001-5213.2020.08.02
   Wang Y., 2020, CHIN J HOSP PHARM, V40, P593, DOI [10.13286/j.1001-5213.2020.06.01, DOI 10.13286/J.1001-5213.2020.06.01]
   Wei L., 2020, PHARM TODAY
   WHO, 2021, STAT 2 M INT HLTH RE
   World Health Organization, 2020, ROLL UPD COR DIS COV
   Xie Y. L., 2020, EMERGENCY PLAN HOSP, V18, P1
   Xiong Y., 2020, W CHINA J PHARM SCI
   XIONG Y, 2020, CHIN J HOSP PHARM, V40, P857, DOI DOI 10.13286/j.1001-5213.2020.08.04
   [徐晓涵 Xu Xiaohan], 2020, [中国药学杂志, Chinese Pharmaceutical Journal], V55, P700
   Xu Y. X., 2020, CHIN J CLIN PHARM, V36, P922, DOI [10.13699/j.cnki.1001-6821.2020.07.054, DOI 10.13699/J.CNKI.1001-6821.2020.07.054]
   Xu Y, 2020, J CLIN PHARM THER, V45, P1363, DOI 10.1111/jcpt.13228
   Yan J. L., 2020, CHINA PHARM, V29, P16, DOI [10.3969/j.issn.1006-4931.2020.06.004, DOI 10.3969/J.ISSN.1006-4931.2020.06.004]
   Yan Y. Y., 2020, CHINA PHARMACY, V31, P523, DOI [10.6039/j.issn.1001-0408.2020.05.03, DOI 10.6039/j.issn.1001-0408.2020.05.03]
   [闫盈盈 Yan Yingying], 2012, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V12, P92
   Yang C. X., 2020, HERALD MED
   [杨晨 Yang Chen], 2020, [暨南大学学报. 自然科学与医学版, Journal of Jinan University. Natural Science & Medicine Edition], V41, P137
   YANG CX, 2020, CHIN J HOSP PHARM, V40, P1071, DOI DOI 10.13286/j.1001-5213.2020.10.01
   Yang L., 2020, CHINA PHARM, V29, P46, DOI [10.3969/j.issn.1006-4931.2020.05.010, DOI 10.3969/J.ISSN.1006-4931.2020.05.010]
   Yang L., 2020, CHINA PHARMACY, V31, P517, DOI [10.6039/j.issn.1001-0408.2020.05.02, DOI 10.6039/j.issn.1001-0408.2020.05.02]
   YANG MY, 2020, CHIN J HOSP PHARM, V40, P617, DOI DOI 10.13286/j.1001-5213.2020.06.04
   YANG Y, 2020, HER MED, V39, P518, DOI DOI 10.3870/j.issn.1004-0781.2020.04.016
   Yang Y. H., 2020, CLIN MED J, V18, P1, DOI [10.3969/j.issn.1672-3384.2020.02.001, DOI 10.3969/J.ISSN.1672-3384.2020.02.001]
   YANG YY, 2020, CHIN J HOSP PHARM, V40, P864, DOI DOI 10.13286/j.1001-5213.2020.08.05
   Yi Z. M., 2020, CHINA PHARMACY, V31, P527, DOI [10.6039/j.issn.1001-0408.2020.05.04, DOI 10.6039/j.issn.1001-0408.2020.05.04]
   Yin Y. Q., 2020, CHINA PHARMACY, V31, P532, DOI [10.6039/j.issn.1001-0408.2020.05.05, DOI 10.6039/j.issn.1001-0408.2020.05.05]
   Ying W, 2021, RES SOC ADMIN PHARM, V17, P1978, DOI 10.1016/j.sapharm.2020.04.001
   YUAN DD, 2020, CHIN J HOSP PHARM, V40, P869, DOI DOI 10.13286/j.1001-5213.2020.08.06
   Zeng D. Y., 2020, ADVERSE DRUG REACT J, DOI [10.3760/cma.j.issn.1008-5734.2020.0010, DOI 10.3760/CMA.J.ISSN.1008-5734.2020.0010]
   Zhang Dan, 2020, Zhongguo Zhong Yao Za Zhi, V45, P2275, DOI 10.19540/j.cnki.cjcmm.20200322.503
   [章晓茜 Zhang Xiaoqian], 2020, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V37, P536
   Zhang Y. L., 2020, CHINA PHARM, V29, P27, DOI [10.3969/j.issn.1006-4931.2020.05.006, DOI 10.3969/J.ISSN.1006-4931.2020.05.006]
   Zhang Z. H., 2020, CHIN J HOSP PHARM
   ZHANG ZH, 2020, CHIN J HOSP PHARM, V40, P721, DOI DOI 10.13286/j.1001-5213.2020.07.01
   Zhao R. S., 2020, CHINA PHARMACY, V31, P385, DOI [10.6039/j.issn.1001-0408.2020.04.01, DOI 10.6039/j.issn.1001-0408.2020.04.01]
   Zhao RS, 2020, ZHONGGUO YAO XUE ZA, V55, P268, DOI DOI 10.11669/cpj.2020.04.002
   Zheng SQ, 2021, RES SOC ADMIN PHARM, V17, P1819, DOI 10.1016/j.sapharm.2020.03.012
   ZHOU H, 2020, HER MED, V39, P330, DOI DOI 10.3870/j.issn.1004-0781.2020.03.014
   Zhou P. X., 2020, CLIN MED J, V18, P34, DOI [10.3969/j.issn.1672-3384.2020.02.007, DOI 10.3969/J.ISSN.1672-3384.2020.02.007]
   Zhou W, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0127-9
   [朱素燕 Zhu Suyan], 2020, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V37, P560
   Zhu Y. G., 2020, DRUG INFORM COMPILAT
   杜姗, 2020, [药物不良反应杂志, Adverse Drug Reactions Journal], V22, P147
   王婧雯, 2020, [中国药学杂志, Chinese Pharmaceutical Journal], V55, P278
NR 108
TC 4
Z9 4
U1 1
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD OCT 2
PY 2020
VL 11
AR 555753
DI 10.3389/fphar.2020.555753
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA OA3IW
UT WOS:000577684500001
PM 33117160
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Barile, L
   Cerrano, M
   Locatelli, A
   Puppo, A
   Signorile, AF
   Barzaghi, N
AF Barile, Luigi
   Cerrano, Martina
   Locatelli, Alessandro
   Puppo, Andrea
   Signorile, Anna F.
   Barzaghi, Nicoletta
TI Prone Ventilation in a 27 Week Pregnant Woman with COVID-19 Severe ARDS
SO SIGNA VITAE
LA English
DT Article
DE COVID-19; Respiratory distress syndrome; Adult; Pronation; Pregnancy;
   Respiration; Artificial
ID POSITION
AB Pregnant women arc more sensitive to respiratory pathogens due to the physiological changes related to pregnancy with an increase in morbidity and mortality. Pregnancy and childbirth do not seem to aggravate the course of symptoms of COVID-19 pneumonia. However, reports on optimal management of severe COVID-19-related ARDS during pregnancy are still lacking. To our knowledge only two case reports describe prone ventilation in pregnant women with severe ARDS, no one related to COVID-19. We report the case of a COVID-19 related severe ARDS in a 48-year-old woman in the last trimester of pregnancy. The patient required intensive care hospitalization for 20 days and invasive mechanical ventilation for 15 days. Pronation maneuver during mechanical ventilation relieved hypoxia and prevented mother and fetus damages, thus avoiding an urgent cesarean section and a premature birth. The patient was successfully discharged from the hospital without maternal and fetal sequelae. In our experience prone ventilation can be safely used to improve respiratory gas exchanges in the last trimester of pregnancy in case of severe ARDS.
C1 [Barile, Luigi; Cerrano, Martina; Locatelli, Alessandro; Barzaghi, Nicoletta] Azienda Osped Santa Croce & Carle, Dept Anesthesia & Intens Care, Via Michele Coppino 26, I-12100 Cuneo, Italy.
   [Puppo, Andrea; Signorile, Anna F.] Azienda Osped Santa Croce & Carle, Dept Obstet & Gynecol, Via Michele Coppino 26, I-12100 Cuneo, Italy.
RP Barile, L (corresponding author), Azienda Osped Santa Croce & Carle, Dept Anesthesia & Intens Care, Via Michele Coppino 26, I-12100 Cuneo, Italy.
EM luigi.barile85@hotmail.it
RI Locatelli, Alessandro/ABC-1446-2021
CR Bhatia Pradeep Kumar, 2016, J Anaesthesiol Clin Pharmacol, V32, P431, DOI 10.4103/0970-9185.194779
   Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107
   Kenn S, 2009, INT J OBSTET ANESTH, V18, P268, DOI 10.1016/j.ijoa.2009.02.003
   Liu DH, 2020, AM J ROENTGENOL, V215, P127, DOI 10.2214/AJR.20.23072
   Liu H, 2020, J REPROD IMMUNOL, V139, DOI 10.1016/j.jri.2020.103122
   Mehta N, 2015, BEST PRACT RES CL OB, V29, P598, DOI 10.1016/j.bpobgyn.2015.04.005
   Oliveira C, 2017, CLINICS, V72, P325, DOI 10.6061/clinics/2017(06)01
   Pelosi P, 1996, ANESTH ANALG, V83, P578, DOI 10.1097/00000539-199609000-00025
   Pelosi P, 2002, EUR RESPIR J, V20, P1017, DOI 10.1183/09031936.02.00401702
   Samanta S, 2014, AM J EMERG MED, V32
NR 10
TC 4
Z9 4
U1 0
U2 3
PU MRE PRESS
PI SINGAPORE
PA 14 ROBINSON RD #08-01A FAR EAST FINANCE, SINGAPORE, SINGAPORE
SN 1334-5605
EI 1845-206X
J9 SIGNA VITAE
JI Signa Vitae
PD JUN
PY 2020
VL 16
IS 1
BP 199
EP 202
DI 10.22514/sv.2020.16.0028
PG 4
WC Emergency Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Emergency Medicine
GA MO4SY
UT WOS:000551519100028
OA gold
DA 2022-04-20
ER

PT J
AU Liu, H
   Zhou, ZQ
   Tao, XB
   Huang, L
   Zhu, EG
   Yu, L
   Zhang, M
AF Liu, Huan
   Zhou, Zhiqing
   Tao, Xiubin
   Huang, Long
   Zhu, Ergang
   Yu, Liang
   Zhang, Ming
TI COVID-19 vaccine hesitancy among Chinese residents under the free
   vaccination policy
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Article
DE COVID-19; Vaccine; China; Government
AB OBJECTIVE: This study aimed to assess the attitudes of Chinese residents toward COVID-19 vaccines and explore the potential drivers for Chinese residents' vaccine hesitancy.
   METHODS: A cross-sectional survey was conducted from February 16 to March 16, 2021, by administering an online questionnaire to the Chinese residents.
   RESULTS: Of 5240 residents who completed the survey, 464 (8.9%) participants reported to have had one shot, and 348 (6.6%) reported to have had 2 shots. At the time the questionnaire was administered, 2298 (43.9%) participants reported they wanted to get vaccinated, while 2255 (43.0%) declared that they still did not know, and 687 (13.1%) respondents declared vaccine refusal. Overall, 2255 (43%) participants were categorized as vaccine hesitancy. Female participants (p=0.000), <20 years old (p=0.000), have low risk of COVID-19 (p=0.000) infection and strong associations of vaccine hesitancy. eHealth literacy was a protective factor.
   CONCLUSIONS: The results of this study show high rates of vaccine hesitancy in China. This could pose a serious threat to the preventive measures that aimed at controlling COVID-19 spread in the country. The government and different media platforms should encourage the dissemination of correct information about vaccines, the communities and medical staff to improve residents' knowledge about vaccines, and strive to improve residents' electronic health literacy.
C1 [Liu, Huan] Wannan Med Coll, Yijishan Hosp, Dept Hemodialysis, Wuhu, Anhui, Peoples R China.
   [Zhou, Zhiqing; Tao, Xiubin] Wannan Med Coll, Yijishan Hosp, Dept Nursing, Wuhu, Anhui, Peoples R China.
   [Huang, Long] Wannan Med Coll, Sch Humanities & Management, Wuhu, Anhui, Peoples R China.
   [Zhu, Ergang] Wannan Med Coll, Sch Comprehens Fdn, Wuhu, Anhui, Peoples R China.
   [Yu, Liang] Warman Med Coll, Sch Humanities & Management, Wuhu, Anhui, Peoples R China.
   [Zhang, Ming] Wannan Med Coll, Sch Innovat & Entrepreneurship, Wuhu, Anhui, Peoples R China.
RP Zhang, M (corresponding author), Wannan Med Coll, Sch Innovat & Entrepreneurship, Wuhu, Anhui, Peoples R China.
EM wnyxyzhangming@foxmail.com
OI Liu, Huan/0000-0003-1598-5335; Huang, Long/0000-0002-0548-7757
CR Batty GD, 2021, BRAIN BEHAV IMMUN, V96, P100, DOI 10.1016/j.bbi.2021.05.016
   Ding YB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165728
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   Fan KS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040487
   Fisher D, 2020, LANCET, V396, P653, DOI 10.1016/S0140-6736(20)31601-9
   Guo SJ, 2013, CHIN J HLTH ED, V29, P106, DOI DOI 10.16168/J.CNKI.ISSN.1002
   Larson HJ, 2016, EBIOMEDICINE, V12, P295, DOI 10.1016/j.ebiom.2016.08.042
   Male V, 2021, NAT REV IMMUNOL, V21, P268, DOI 10.1038/s41577-021-00533-y
   McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003
   Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e27
   Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e9
   Schwarze J, 2018, ALLERGY, V73, P1151, DOI 10.1111/all.13333
   Verelst F, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0820
   Zhang Ke Chun, 2020, JMIR Pediatr Parent, V3, pe24827, DOI 10.2196/24827
NR 14
TC 0
Z9 0
U1 4
U2 4
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PY 2021
VL 67
IS 9
BP 1317
EP 1321
DI 10.1590/1806-9282.20210633
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA XA8ZM
UT WOS:000720928800022
PM 34816927
OA gold
DA 2022-04-20
ER

PT J
AU Kameda, T
   Mizuma, Y
   Taniguchi, H
   Fujita, M
   Taniguchi, N
AF Kameda, Toru
   Mizuma, Yoshihiro
   Taniguchi, Hayato
   Fujita, Masato
   Taniguchi, Nobuyuki
TI Point-of-care lung ultrasound for the assessment of pneumonia: a
   narrative review in the COVID-19 era
SO JOURNAL OF MEDICAL ULTRASONICS
LA English
DT Review
DE Lung ultrasound; Pneumonia; COVID-19
ID VENTILATOR-ASSOCIATED PNEUMONIA; ACUTE RESPIRATORY-FAILURE; CHEST-X-RAY;
   EMERGENCY-DEPARTMENT; DIAGNOSING PNEUMONIA; THORACIC ULTRASOUND;
   ULTRASONOGRAPHY; ACCURACY; CONSOLIDATION; PERFORMANCE
AB In the coronavirus disease-2019 (COVID-19) era, point-of-care lung ultrasound (LUS) has attracted increased attention. Prospective studies on LUS for the assessment of pneumonia in adult patients were extensively carried out for more than 10 years before this era. None of these prospective studies attempted to differentiate bacterial and viral pneumonia in adult patients using LUS. The majority of studies considered the LUS examination to be positive if sonographic consolidations or multiple B-lines were observed. Significant differences existed in the accuracy of these studies. Some studies revealed that LUS showed superior sensitivity to chest X-ray. These results indicate that point-of-care LUS has the potential to be an initial imaging modality for the diagnosis of pneumonia. The LUS diagnosis of ventilator-associated pneumonia in intensive care units is more challenging in comparison with the diagnosis of community-acquired pneumonia in emergency departments due to the limited access to the mechanically ventilated patients and the high prevalence of atelectasis. However, several studies have demonstrated that the combination of LUS findings with other clinical markers improved the diagnostic accuracy. In the COVID-19 era, many case reports and small observational studies on COVID-19 pneumonia have been published in a short period. Multiple B-lines were the most common and consistent finding in COVID-19 pneumonia. Serial LUS showed the deterioration of the disease. The knowledge and ideas on the application of LUS in the management of pneumonia that are expected to accumulate in the COVID-19 era may provide us with clues regarding more appropriate management.
C1 [Kameda, Toru; Taniguchi, Nobuyuki] Jichi Med Univ, Dept Clin Lab Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
   [Kameda, Toru; Fujita, Masato] Red Cross Soc Azumino Hosp, Dept Emergency Med, 5685 Toyoshina, Azumino, Nagano 3998293, Japan.
   [Mizuma, Yoshihiro] Higashi Kobe Hosp, Dept Internal Med, Higashinada Ku, 1-24-13 Sumiyoshihonmachi, Kobe, Hyogo 6580051, Japan.
   [Taniguchi, Hayato] Yokohama City Univ, Adv Crit Care & Emergency Ctr, Med Ctr, Minami Ku, 4-57 Urafunecho, Yokohama, Kanagawa 2320044, Japan.
RP Kameda, T (corresponding author), Jichi Med Univ, Dept Clin Lab Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.; Kameda, T (corresponding author), Red Cross Soc Azumino Hosp, Dept Emergency Med, 5685 Toyoshina, Azumino, Nagano 3998293, Japan.
EM kamekame@pb3.so-net.ne.jp
CR Abramowicz JS, 2020, ULTRASOUND MED BIOL, V46, P1821, DOI 10.1016/j.ultrasmedbio.2020.03.033
   Amatya Y, 2018, INT J EMERG MED, V11, DOI 10.1186/s12245-018-0170-2
   [Anonymous], 2017, Ann Emerg Med, V69, pe27, DOI 10.1016/j.annemergmed.2016.08.457
   Bao CP, 2020, J AM COLL RADIOL, V17, P701, DOI 10.1016/j.jacr.2020.03.006
   Berlet T, 2015, J CRIT CARE, V30, P327, DOI 10.1016/j.jcrc.2014.11.021
   Bluthgen C, 2017, J ULTRAS MED, V36, P2133, DOI 10.1002/jum.14266
   Bonadia N, 2020, ULTRASOUND MED BIOL, V46, P2927, DOI 10.1016/j.ultrasmedbio.2020.07.005
   Bouhemad B, 2010, CRIT CARE MED, V38, P84, DOI 10.1097/CCM.0b013e3181b08cdb
   Bourcier JE, 2014, AM J EMERG MED, V32, P115, DOI 10.1016/j.ajem.2013.10.003
   Buonsenso D, 2020, ULTRASOUND OBST GYN, V56, P106, DOI 10.1002/uog.22055
   Buonsenso D, 2020, EUR REV MED PHARMACO, V24, P2776, DOI 10.26355/eurrev_202003_20549
   Buonsenso D, 2020, LANCET RESP MED, V8, pE27, DOI 10.1016/S2213-2600(20)30120-X
   Busti C, 2014, INTERN EMERG MED, V9, P173, DOI 10.1007/s11739-012-0832-7
   Castelao J, 2021, J ULTRAS MED, V40, P1315, DOI 10.1002/jum.15508
   Copetti R, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-16
   CORRADI F, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/868707
   Cortellaro F, 2012, EMERG MED J, V29, P19, DOI 10.1136/emj.2010.101584
   D'Amato M, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-017-0225-5
   Daabis R, 2014, EGYPT J CHEST DIS TU, V63, P979, DOI 10.1016/j.ejcdt.2014.05.005
   Neto FLD, 2015, J BRAS PNEUMOL, V41, P58, DOI [10.1590/S1806-37132015000100008, 10.1590/s1806-37132015000100008]
   Dietrich CF, 2016, J THORAC DIS, V8, DOI 10.21037/jtd.2016.04.55
   Dimitrios P, 2017, W J EMERG MED, V18, P382, DOI DOI 10.5811/westjem.2017.1.31223
   Fartoukh M, 2003, AM J RESP CRIT CARE, V168, P173, DOI 10.1164/rccm.200212-1449OC
   Fiala MJ, 2020, CLIN RADIOL, V75, P553, DOI 10.1016/j.crad.2020.04.003
   Frankel HL, 2015, CRIT CARE MED, V43, P2479, DOI 10.1097/CCM.0000000000001216
   Gallard E, 2015, AM J EMERG MED, V33, P352, DOI 10.1016/j.ajem.2014.12.003
   Gargani L, 2020, EUR HEART J-CARD IMG, V21, P941, DOI 10.1093/ehjci/jeaa163
   Giannini A, 2020, MINERVA ANESTESIOL, V86, P1248, DOI 10.23736/S0375-9393.20.14726-6
   Hagaman JT, 2009, AM J MED SCI, V337, P236, DOI 10.1097/MAJ.0b013e31818ad805
   Hamasaki N, 2016, JPN J MED ULTRASON, V43, P15, DOI [10.3179/jjmu.JJMU.R.66, DOI 10.3179/JJMU.JJMU.R.66]
   Interrigi MC, 2017, THER CLIN RISK MANAG, V13, P151, DOI 10.2147/TCRM.S126770
   Kameda T, 2019, ULTRASOUND MED BIOL, V45, P1617, DOI 10.1016/j.ultrasmedbio.2019.03.003
   Kameda T, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0175-y
   Kim DJ, 2020, CAN J EMERG MED, V22, P445, DOI 10.1017/cem.2020.364
   Kim MJ, 2011, RADIOGRAPHICS, V31, P663, DOI 10.1148/rg.313105038
   Kulkarni S, 2020, CLIN RADIOL, V75, DOI 10.1016/j.crad.2020.05.001
   Laursen CB, 2014, LANCET RESP MED, V2, P638, DOI 10.1016/S2213-2600(14)70135-3
   Li H, 2017, J ULTRAS MED, V36, P707, DOI 10.7863/ultra.16.04030
   Lichtenstein D, 1997, AM J RESP CRIT CARE, V156, P1640, DOI 10.1164/ajrccm.156.5.96-07096
   Lichtenstein D, 2009, CHEST, V135, P1421, DOI 10.1378/chest.08-2281
   Lichtenstein DA, 2008, CHEST, V134, P117, DOI 10.1378/chest.07-2800
   Lichter Y, 2020, INTENS CARE MED, V46, P1873, DOI 10.1007/s00134-020-06212-1
   Liu XL, 2015, EMERG MED J, V32, P433, DOI 10.1136/emermed-2013-203039
   Lopes AJ, 2021, J ULTRAS MED, V40, P1391, DOI 10.1002/jum.15521
   Lu WZ, 2020, ULTRASCHALL MED, V41, P300, DOI 10.1055/a-1154-8795
   Mantuani D, 2016, WEST J EMERG MED, V17, P46, DOI 10.5811/westjem.2015.11.28525
   Marin JR, 2016, CRIT ULTRASOUND J, V8, DOI 10.1186/s13089-016-0049-5
   Mathis G, 2005, CHEST, V128, P1531, DOI 10.1378/chest.128.3.1531
   Mathis G., 2017, CHEST SONOGRAPHY
   Mayo PH, 2019, INTENS CARE MED, V45, P1200, DOI 10.1007/s00134-019-05725-8
   Mohamed MFH, 2020, AM J TROP MED HYG, V103, P815, DOI 10.4269/ajtmh.20-0371
   Mongodi S, 2020, ULTRASOUND MED BIOL, V46, P2090, DOI 10.1016/j.ultrasmedbio.2020.04.033
   Mongodi S, 2016, CHEST, V149, P969, DOI 10.1016/j.chest.2015.12.012
   Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487
   Nafae R, 2013, EGYPT J CHEST DIS TU, V62, P281, DOI 10.1016/j.ejcdt.2013.04.007
   Nazerian P, 2015, AM J EMERG MED, V33, P620, DOI 10.1016/j.ajem.2015.01.035
   Nouvenne A, 2020, J AM MED DIR ASSOC, V21, P919, DOI 10.1016/j.jamda.2020.05.050
   Orso D, 2018, EUR J EMERG MED, V25, P312, DOI 10.1097/MEJ.0000000000000517
   Pagano A, 2015, INTERN EMERG MED, V10, P851, DOI 10.1007/s11739-015-1297-2
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Parlamento S, 2009, AM J EMERG MED, V27, P379, DOI 10.1016/j.ajem.2008.03.009
   Peng QY, 2020, INTENS CARE MED, V46, P849, DOI 10.1007/s00134-020-05996-6
   Peyrony O, 2020, ANN EMERG MED, V76, P405, DOI 10.1016/j.annemergmed.2020.05.022
   Picano E, 2016, EUR HEART J, V37, P2097, DOI 10.1093/eurheartj/ehw164
   Pivetta E, 2015, CHEST, V148, P202, DOI 10.1378/chest.14-2608
   Pradhan S, 2020, J CRIT CARE, V58, P65, DOI 10.1016/j.jcrc.2020.03.012
   PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121
   Raptis CA, 2020, AM J ROENTGENOL, V215, P839, DOI 10.2214/AJR.20.23202
   Reissig A, 2012, CHEST, V142, P965, DOI 10.1378/chest.12-0364
   Rouby JJ, 2018, AM J RESP CRIT CARE, V198, P398, DOI 10.1164/rccm.201802-0227LE
   Sezgin C, 2020, ULTRASOUND MED BIOL, V46, P1189, DOI 10.1016/j.ultrasmedbio.2020.01.014
   Shokoohi H, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.079
   Singh Y, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2787-9
   Soldati G, 2020, J ULTRAS MED, V39, P1413, DOI 10.1002/jum.15285
   Soldati G, 2020, J ULTRAS MED, V39, P1459, DOI 10.1002/jum.15284
   Soldati G, 2012, ULTRASOUND MED BIOL, V38, P1169, DOI 10.1016/j.ultrasmedbio.2012.03.001
   Soni Nilam J, 2019, J Hosp Med, V14, pE1, DOI 10.12788/jhm.3079
   Staub LJ, 2021, J INTENSIVE CARE MED, V36, P304, DOI 10.1177/0885066619894279
   Staub LJ, 2019, J EMERG MED, V56, P53, DOI 10.1016/j.jemermed.2018.09.009
   Staub LJ, 2018, INJURY, V49, P457, DOI 10.1016/j.injury.2018.01.033
   Taghizadieh A, 2015, EMERGENCY, V3, P114
   Tan GL, 2020, ULTRASOUND MED BIOL, V46, P2651, DOI 10.1016/j.ultrasmedbio.2020.05.006
   Testa A, 2012, CRIT CARE, V16, DOI 10.1186/cc11201
   Ticinesi A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004153
   Tsou PY, 2019, ACAD EMERG MED, V26, P1074, DOI 10.1111/acem.13818
   Unluer EE, 2013, HONG KONG J EMERG ME, V20, P98, DOI 10.1177/102490791302000205
   Via G, 2014, J AM SOC ECHOCARDIOG, V27, DOI 10.1016/j.echo.2014.05.001
   Volpicelli G, 2008, MED SCI MONITOR, V14, pCR122
   Volpicelli G, 2020, INTENS CARE MED, V46, P1445, DOI 10.1007/s00134-020-06048-9
   Volpicelli G, 2012, INTENS CARE MED, V38, P577, DOI 10.1007/s00134-012-2513-4
   Volpicelli G, 2009, AM J EMERG MED, V27, DOI 10.1016/j.ajem.2008.03.052
   Wang YK, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1409-7
   Yang Y, 2020, INTENS CARE MED, V46, P1761, DOI 10.1007/s00134-020-06096-1
   Yassa M, 2021, J ULTRAS MED, V40, P191, DOI 10.1002/jum.15367
   Zagli G, 2014, CHEST, V146, P1578, DOI 10.1378/chest.13-2922
   Zanobetti M, 2017, CHEST, V151, P1295, DOI 10.1016/j.chest.2017.02.003
   Zhang YK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0406-1
   Zhou JD, 2019, RESP CARE, V64, P519, DOI 10.4187/respcare.06377
   Zieleskiewicz L, 2020, INTENS CARE MED, V46, P1707, DOI 10.1007/s00134-020-06186-0
NR 99
TC 7
Z9 7
U1 0
U2 2
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 1346-4523
EI 1613-2254
J9 J MED ULTRASON
JI J. Med. Ultrason.
PD JAN
PY 2021
VL 48
IS 1
BP 31
EP 43
DI 10.1007/s10396-020-01074-y
EA JAN 2021
PG 13
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA QG8XS
UT WOS:000607354000001
PM 33438132
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Singh, S
   Thomas, N
   Numbudiri, R
AF Singh, Surabhi
   Thomas, Nobin
   Numbudiri, Ranjeet
TI Knowledge sharing in times of a pandemic: An intergenerational learning
   approach
SO KNOWLEDGE AND PROCESS MANAGEMENT
LA English
DT Article
DE COVID-19; intergenerational learning; knowledge sharing; new ways of
   working; PRISMA; reverse mentoring
ID UNLEARNING CONTEXT; COUNTER-KNOWLEDGE; REVERSE; MANAGEMENT; MENTORS
AB Knowledge sharing is a key challenge for modern organizations, especially in periods of uncertainty such as that of the current pandemic. This conceptual paper argues that intergenerational learning (IGL) is a useful intervention to address the challenge of knowledge sharing in the New Ways of Working. We conducted an integrated literature review based on the PRISMA methodology. Our findings reveal the limited adoption of reverse mentoring in practice, indicating the need to have a more curated intervention to promote knowledge sharing in modern organizations. We advance the discourse about reverse mentoring with the aim of overcoming its challenges and presenting a self-driven approach to sharing the tacit knowledge inherent in an organization. The study contributes by presenting a conceptual model of IGL that promotes knowledge sharing during the COVID-19 pandemic through the leveraging of the multi-generational workforce's diversity. Further, the study has implications for practice that can aid effective knowledge management in the current times.
C1 [Singh, Surabhi; Thomas, Nobin; Numbudiri, Ranjeet] Indian Inst Management Indore, Org Behav & Human Resource Management, Indore, India.
RP Singh, S (corresponding author), Indian Inst Management Indore, Org Behav & Human Resource Management, Indore, India.
EM fi19surabhis@iimidr.ac.in
OI Singh, Surabhi/0000-0001-6520-8978
CR Andreeva T, 2011, KNOWL PROCESS MANAG, V18, P56, DOI 10.1002/kpm.351
   Arnett JJ, 2013, EMERG ADULTHOOD, V1, P5, DOI 10.1177/2167696812466842
   Aryee S, 2016, J MANAGE, V42, P480, DOI 10.1177/0149206312471394
   Ayalon L, 2021, J GERONTOL B-PSYCHOL, V76, pE49, DOI 10.1093/geronb/gbaa051
   Baily C, 2009, AI SOC, V23, P111, DOI 10.1007/s00146-007-0169-3
   Baumeister RF, 2004, REV GEN PSYCHOL, V8, P111, DOI 10.1037/1089-2680.8.2.111
   Becker KL, 2020, J INTERGENER RELATSH, DOI 10.1080/15350770.2020.1837708
   Bontis N, 2002, J MANAGE STUD, V39, P437, DOI 10.1111/1467-6486.t01-1-00299
   Bratianu C, 2019, SYSTEMS-BASEL, V7, DOI 10.3390/systems7020020
   Bratianu C, 2015, PROC EUR CONF KNOWL, P169
   Breck BM, 2018, J GERONTOL SOC WORK, V61, P513, DOI 10.1080/01634372.2018.1448030
   Burdett Jane, 2014, Development & Learning in Organizations, V28, P13, DOI 10.1108/DLO-01-2014-0001
   Busch P, 2008, KNOWL PROCESS MANAG, V15, P45, DOI 10.1002/kpm.298
   Calo TJ, 2008, PUBLIC PERS MANAGE, V37, P403, DOI 10.1177/009102600803700403
   Cathcart A, 2014, ASSESS EVAL HIGH EDU, V39, P790, DOI 10.1080/02602938.2013.870969
   Cegarra-Navarro JG, 2016, LEARN INDIVID DIFFER, V45, P260, DOI 10.1016/j.lindif.2015.11.005
   Cegarra-Navarro JG, 2012, J MANAGE ORGAN, V18, P231
   Chaudhuri S, 2019, NEW HORIZ ADULT EDUC, V31, P65, DOI 10.1002/nha3.20256
   Chaudhuri S, 2012, HUM RESOUR DEV REV, V11, P55, DOI 10.1177/1534484311417562
   Chen Y.C., 2013, LEADERSHIP MANAGEMEN, V13, P199
   Clarke AJ, 2019, ADV MED EDUC PRACT, V10, P693, DOI 10.2147/AMEP.S179303
   Cox CB, 2018, J APPL SOC PSYCHOL, V48, P71, DOI 10.1111/jasp.12491
   Crossan MM, 1999, ACAD MANAGE REV, V24, P522, DOI 10.2307/259140
   Gabriel AG, 2020, SAGE OPEN, V10, DOI 10.1177/2158244020914651
   Gadomska-Lila K, 2020, J ORGAN CHANGE MANAG, V33, P1313, DOI 10.1108/JOCM-10-2019-0326
   Gerards R, 2021, PERS REV, V50, P1200, DOI 10.1108/PR-10-2019-0549
   Gerpott FH, 2017, ACAD MANAG LEARN EDU, V16, P193, DOI 10.5465/amle.2015.0185
   Hall E. T., 1989, CULTURE
   Harrison A.E., 2017, CASE STUDIES BUSINES, V4, P25
   Harvey JF, 2012, J KNOWL MANAG, V16, P400, DOI 10.1108/13673271211238733
   Harvey M, 2009, INT J HUM RESOUR MAN, V20, P1344, DOI 10.1080/09585190902909863
   Hernandez J.S., 2018, PHYS LEADERSHIP J, V5, P41
   Hofstede G., 2011, ONLINE READINGS PSYC, V2, DOI [10.9707/2307-0919.1014, DOI 10.9707/2307-0919.1014]
   Joshi A, 2011, RES ORGAN BEHAV, V31, P177, DOI 10.1016/j.riob.2011.10.002
   Kase R, 2019, HUM RESOUR MANAGE-US, V58, P57, DOI 10.1002/hrm.21932
   Keller J.M., 1983, INSTRUCTIONAL DESIGN, V1, P383
   KRAM KE, 1985, ACAD MANAGE J, V28, P110, DOI 10.2307/256064
   Leedahl SN, 2019, GERONTOL GERIATR EDU, V40, P71, DOI 10.1080/02701960.2018.1428574
   Malhotra Y., 2005, Journal of Knowledge Management, V9, P7, DOI 10.1108/13673270510582938
   Martelo-Landroguez S, 2019, KNOWL MAN RES PRACT, V17, P203, DOI 10.1080/14778238.2019.1599497
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Mullen EJ, 1999, J ORGAN BEHAV, V20, P233, DOI 10.1002/(SICI)1099-1379(199903)20:2<233::AID-JOB925>3.0.CO;2-F
   Murphy WM, 2012, HUM RESOUR MANAGE-US, V51, P549, DOI 10.1002/hrm.21489
   Nagi M., 2018, INT J BUSINESS MARKE, V3, P2456
   Nishimura S., 2008, RENEWING EVOLVING SU, V8, P783
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14
   Peet M.R., 2010, INT J ED ADV, V10, P71
   Pruett C.C., 2020, THESIS U MARYLAND U
   Ramaswami A, 2010, HUM RESOUR MANAGE-US, V49, P501, DOI 10.1002/hrm.20363
   Raza Ali, 2020, Future Healthc J, V7, P94, DOI 10.7861/fhj.2019-0028
   Richard O.C., 2013, OXFORD HDB DIVERSITY, P239
   Ropes D, 2013, EUR J TRAIN DEV, V37, P713, DOI 10.1108/EJTD-11-2012-0081
   Sulopuisto O, 2020, REVERSE MENTORING CO
   Suomaki A, 2019, KNOWL PROCESS MANAG, V26, P140, DOI 10.1002/kpm.1604
   Tempest S, 2003, MANAGE LEARN, V34, P181, DOI 10.1177/1350507603034002002
   TUCKMAN BW, 1965, PSYCHOL BULL, V63, P384, DOI 10.1037/h0022100
   Twenge JM, 2010, J MANAGE, V36, P1117, DOI 10.1177/0149206309352246
   von Preu&beta;en P.W, 2019, TURNING MENTORING AR
   WAGNER RK, 1985, J PERS SOC PSYCHOL, V49, P436
   White Teresa, 2019, Strategic HR Review, V18, P250, DOI 10.1108/SHR-07-2019-0066
   Yin-Che Chen, 2016, International Journal of Human Resources Development and Management, V16, P161
   Yin-Che Chen, 2014, International Journal of Technology, Policy and Management, V14, P205, DOI 10.1504/IJTPM.2014.062931
   Zucchero RA, 2011, EDUC GERONTOL, V37, P687, DOI 10.1080/03601271003723487
NR 63
TC 2
Z9 2
U1 10
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1092-4604
EI 1099-1441
J9 KNOWL PROCESS MANAG
JI Knowl. Process Manag.
PD APR
PY 2021
VL 28
IS 2
BP 153
EP 164
DI 10.1002/kpm.1669
EA MAY 2021
PG 12
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA SB9TZ
UT WOS:000647236600001
OA Bronze
DA 2022-04-20
ER

PT J
AU Ho, CLT
   Oligbu, P
   Ojubolamo, O
   Pervaiz, M
   Oligbu, G
AF Ho, Carmen Lok Tung
   Oligbu, Peter
   Ojubolamo, Olakunle
   Pervaiz, Muhammad
   Oligbu, Godwin
TI Clinical Characteristics of Children with COVID-19
SO AIMS PUBLIC HEALTH
LA English
DT Review
DE COVID-19; coronavirus; infectious disease; pandemic; 2019-nCoV; severe
   acute respiratory syndrome coronavirus 2; paediatric; children;
   SARS-CoV-2; virus
ID 2019-NCOV
AB Background: In December 2019, the infection caused by 2019 novel coronavirus (COVID-19) led to an outbreak in Wuhan, situated in the Hubei Province of China. Following this, there has been a rapid increase in the number of cases. On 12th March 2020, there were over 100,000 confirmed cases and almost 4,300 deaths worldwide. The clinical profile of children with COVID-19 is unknown due to the few number of cases reported. Currently, available data suggest they may have a milder form of illness. Methods: A review of the literature published from June 2019 to March 2020 was undertaken to evaluate the clinical presentation, management and outcomes of COVID-19 in in children. Data sources included EMBASE, MEDLINE, Cochrane library, ISI Web of Knowledge and references within identified articles. Results: We identified 303 potential studies, and 295 were excluded for reasons including duplicates, experimental studies and case reports. Eight studies were eligible for inclusion, including a total of 820 paediatric cases of COVID-19. Asymptomatic cases represented 14.3% (n = 117) of the total number of cases identified, and thus the remaining 85.7% (n = 703) experienced symptoms. Fever was the commonest symptom in 53.9% (n = 48) of cases, followed by cough in 39.3% (n = 35) of cases, and rhinorrhoea or pharyngeal congestion in 13.5% (n = 12) of cases. Diarrhoea and sore throats were less common symptoms, 7.9% (n = 7) and 9.0% (n = 8) respectively. Other symptoms, including fatigue, headache and dizziness were rare. Conclusion: Children are disproportionately affected by COVID-19 and are more likely to run a milder cause of illness following this infection compared to adults. This outbreak only started 3 months ago, therefore, further population wide studies are needed to validate these findings.
C1 [Ho, Carmen Lok Tung] Imperial Coll London, Imperial Coll, Sch Med, London SW7 2AZ, England.
   [Oligbu, Peter] Univ Benin Teaching Hosp UBTH, Benin, Nigeria.
   [Ojubolamo, Olakunle] Queens Hosp, Dept Med, London, England.
   [Pervaiz, Muhammad] NHS Dumfries & Galloway, Dept Paediat Dumfries & Galloway, Moffat, Scotland.
   [Oligbu, Godwin] Dr Grays Hosp, NHS Grampian, Dept Paediat, Elgin, Scotland.
   [Oligbu, Godwin] St Georges Univ London, Inst Infect & Immun, Paediat Infect Dis Res Grp, London, England.
RP Oligbu, G (corresponding author), Dr Grays Hosp, NHS Grampian, Dept Paediat, Elgin, Scotland.; Oligbu, G (corresponding author), St Georges Univ London, Inst Infect & Immun, Paediat Infect Dis Res Grp, London, England.
EM godwin.oligbu@nhs.net
CR Cai J, 2020, CLIN INF DIS
   Calfee CS, 2015, CRIT CARE MED, V43, P1790, DOI 10.1097/CCM.0000000000001089
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   European Centre for Disease Prevention and Control, 2020, COR DIS 2019 COR DIS
   Feng K, 2020, CHIN J CONT PEDIAT, V58, pE007
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ji LN, 2020, WORLD J PEDIATR, V16, P267, DOI 10.1007/s12519-020-00356-2
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Li QQ, 2021, NUTR CANCER, V73, P502, DOI 10.1080/01635581.2020.1756355
   Li Y, 2020, AM J ROENTGENOL, V214, P1, DOI [DOI 10.2214/AJR.20.22954, 10.2214/AJR.20.22954]
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Liu H, 2020, SOL RRL, V4, DOI 10.1002/solr.202000011
   Moreton E, 2020, CLIN MANAGEMENT SEVE
   Oligbu G, 2019, PHARMACY BASEL SWITZ, V7, pe9
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Public Health England, STAY HOM GUID HOUS P
   Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058
   Statista, NUMB NOV COR COVID 1
   Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1
   Virlogeux V, 2015, EPIDEMIOLOGY, V26, P666, DOI 10.1097/EDE.0000000000000339
   Wang D, 2020, Zhonghua Er Ke Za Zhi, V58, P269, DOI 10.3760/cma.j.cn112140-20200225-00138
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Xia W, 2020, PEDIATR PULM, V55, P1169, DOI 10.1002/ppul.24718
   Xu Z, 2020, EXUBERANT ELEVATION, DOI 10.1101/2020.02.11.20021493
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 30
TC 10
Z9 10
U1 2
U2 3
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 2327-8994
J9 AIMS PUBLIC HEALTH
JI AIMS Public Health
PY 2020
VL 7
IS 2
BP 258
EP 273
DI 10.3934/publichealth.2020022
PG 16
WC Health Care Sciences & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA MB7VW
UT WOS:000542808000005
PM 32617354
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Liu, Y
   Lv, XY
   Tang, ZY
AF Liu, Yue
   Lv, Xingyang
   Tang, Ziyan
TI The impact of mortality salience on quantified self behavior during the
   COVID-19 pandemic
SO PERSONALITY AND INDIVIDUAL DIFFERENCES
LA English
DT Article
DE COVID-19; Quantified self; Mortality salience; Perceived control; Social
   distance; Terror management theory
ID TERROR MANAGEMENT; CLOSE RELATIONSHIPS; SOCIAL DISTANCE; DEATH; ESTEEM;
   CONSUMPTION; MATERIALISM; ANXIETY; WORLDVIEWS; THOUGHTS
AB Quantified self refers to the process consumers collect, analyze to reflect, control, and optimize their behaviors, thus obtaining self-knowledge. Since the COVID-19 pandemic has changed our lives dramatically, this research aims to explore how mortality salience caused by COVID-19 affects people's quantified self behavior. The current study used an online survey and the experimental method to test multiple research hypotheses. The results indicated that mortality salience has a positive impact on quantified self; perceived control mediates the relationship between mortality salience and the quantified self, and social distance plays a moderating role between mortality salience and perceived control. The conclusions provide a new way to help people deal with anxiety and fear brought by the COVID-19, and enhance public health and well-being.
C1 [Liu, Yue] Southwestern Univ Finance & Econ, Sch Sports Sci & Phys Educ, Chengdu, Sichuan, Peoples R China.
   [Lv, Xingyang] Southwestern Univ Finance & Econ, Fac Business Adm, Sch Business Adm, Chengdu, Sichuan, Peoples R China.
   [Tang, Ziyan] Sichuan Univ, Business Sch, Chengdu, Peoples R China.
   [Tang, Ziyan] Sichuan Univ, Interdisciplinary Ctr Culture Sci & Technol, Chengdu, Peoples R China.
RP Tang, ZY (corresponding author), Sichuan Univ, Business Sch, Chengdu, Peoples R China.
EM tangziyan@foxmail.com
CR Andrew, 2020, FORENSIC SCI INT REP, V2, P100089, DOI [10.1016/j.fsir.2020.100089, DOI 10.1016/J.FSIR.2020.100089]
   [Anonymous], CHIN STAT YB
   Appelboom G, 2014, CURR MED RES OPIN, V30, P2585, DOI 10.1185/03007995.2014.954032
   Arndt J, 2004, J CONSUM PSYCHOL, V14, P198, DOI 10.1207/s15327663jcp1403_2
   Bashir MF, 2020, ENVIRON RES, V187, DOI 10.1016/j.envres.2020.109652
   Beck, 2004, DENIAL DEATH
   Belk R, 2014, J BUS RES, V67, P1595, DOI 10.1016/j.jbusres.2013.10.001
   Bogardus ES, 1933, SOCIOL SOC RES, V17, P265
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Brophy-Warren J, 2008, WALL STREET J
   BURGER J M, 1979, Motivation and Emotion, V3, P381, DOI 10.1007/BF00994052
   Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005
   Chen CY, 2017, J CONSUM RES, V43, P1031, DOI 10.1093/jcr/ucw068
   Choe E.K., 2014, P 32 ANN ACM C HUM F, P1143, DOI [10.1145/2556288.2557372, DOI 10.1145/2556288.2557372]
   COLLEEN P, 2015, J MARKET THEORY PRAC, V23, P166, DOI DOI 10.1080/10696679.2015.1002335
   Cox CR, 2012, J PERS SOC PSYCHOL, V102, P616, DOI 10.1037/a0025947
   Dammeyer J, 2020, PERS INDIV DIFFER, V167, DOI 10.1016/j.paid.2020.110263
   Ferraro R, 2005, J CONSUM RES, V32, P65, DOI 10.1086/429601
   Florian V, 2002, J PERS SOC PSYCHOL, V82, P527, DOI 10.1037//0022-3514.82.4.527
   Fofana NK, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113230
   Fransen ML, 2008, J BUS RES, V61, P1053, DOI 10.1016/j.jbusres.2007.09.020
   Friese M, 2008, J EXP SOC PSYCHOL, V44, P1388, DOI 10.1016/j.jesp.2008.06.003
   Fritsche I, 2008, J PERS SOC PSYCHOL, V95, P524, DOI 10.1037/a0012666
   Gotz FM, 2021, AM PSYCHOL, V76, P39, DOI 10.1037/amp0000740
   Greenberg J, 1997, ADV EXP SOC PSYCHOL, V29, P61, DOI 10.1016/S0065-2601(08)60016-7
   GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627
   Griffin JM, 2002, SOC SCI MED, V54, P783, DOI 10.1016/S0277-9536(01)00109-5
   Guan LL, 2015, PERS INDIV DIFFER, V85, P77, DOI 10.1016/j.paid.2015.04.032
   Harkin B, 2016, PSYCHOL BULL, V142, P198, DOI 10.1037/bul0000025
   Hart J, 2005, J PERS SOC PSYCHOL, V88, P999, DOI 10.1037/0022-3514.88.6.999
   Hayes A.F., 2013, INTRO MEDIATION MODE
   Higgins S. T, 1996, HDB MOTIVATION COGNI, V3, P322
   Hunter, FOOD STUD SPEC REP A
   Joo D, 2018, TOURISM MANAGE, V64, P245, DOI 10.1016/j.tourman.2017.08.012
   Kasser T, 2000, PSYCHOL SCI, V11, P348, DOI 10.1111/1467-9280.00269
   Khan AH, 2020, J AFFECT DISORDERS, V277, P121, DOI 10.1016/j.jad.2020.07.135
   Kirk CP, 2020, J BUS RES, V117, P124, DOI 10.1016/j.jbusres.2020.05.028
   Klein R.A., 2019, MANY LABS, DOI [10.31234/osf.io/vef2c, DOI 10.31234/OSF.IO/VEF2C, 10.31234/ osf.io/vef2c]
   Kwon S, 2020, COMPUT HUM BEHAV, V105, DOI 10.1016/j.chb.2019.106207
   Leung S., 2002, WALL STREET J
   Lev-On A, 2015, COMPUT HUM BEHAV, V48, P448, DOI 10.1016/j.chb.2015.02.009
   Liu J, 2010, J MARKETING RES, V47, P251, DOI 10.1509/jmkr.47.2.251
   [柳武妹 Liu Wumei], 2016, [心理学报, Acta Psychologica Sinica], V48, P410
   Lupton D, 2014, SSRN ELECT J, DOI https://doi.org/10.2139/ssrn.2483549
   Lupton D, 2013, CRIT PUBLIC HEALTH, V23, P393, DOI 10.1080/09581596.2013.794931
   Lv XY, 2020, INTERNET RES, V30, P1783, DOI 10.1108/INTR-11-2019-0464
   Lv XY, 2020, TOURISM MANAGE, V77, DOI 10.1016/j.tourman.2019.104025
   Lv XY, 2020, TOURISM MANAGE, V77, DOI 10.1016/j.tourman.2019.104026
   Mandel N, 1999, ADV CONSUM RES, V26, P527
   Mandel N, 2008, J CONSUM RES, V35, P309, DOI 10.1086/587626
   Martens A, 2011, EUR J SOC PSYCHOL, V41, P6, DOI 10.1002/ejsp.767
   Martin LL, 1999, PSYCHOL INQ, V10, P195, DOI 10.1207/S15327965PLI1003_1
   Mikulincer M, 2003, PERS SOC PSYCHOL REV, V7, P20, DOI 10.1207/S15327957PSPR0701_2
   Mochon D, 2012, INT J RES MARK, V29, P363, DOI 10.1016/j.ijresmar.2012.05.001
   Montinari N, 2018, J RISK UNCERTAINTY, V57, P81, DOI 10.1007/s11166-018-9286-2
   Moore P, 2016, NEW MEDIA SOC, V18, P2774, DOI 10.1177/1461444815604328
   Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247
   Nicomedes CJC, 2020, J AFFECT DISORDERS, V276, P14, DOI 10.1016/j.jad.2020.06.046
   Oosterhoff B, 2020, J ADOLESCENT HEALTH, V67, P179, DOI 10.1016/j.jadohealth.2020.05.004
   Paredes MR, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110455
   Park RE, 1924, J APPL SOCIOL, V8, P339
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Rafique H, 2020, COMPUT EDUC, V145, DOI 10.1016/j.compedu.2019.103732
   Raines AM, 2014, PERS INDIV DIFFER, V56, P175, DOI 10.1016/j.paid.2013.09.005
   Rindfleisch A, 2009, J CONSUM RES, V36, P1, DOI 10.1086/595718
   RODIN J, 1986, SCIENCE, V233, P1271, DOI 10.1126/science.3749877
   Ruckenstein M, 2014, SOCIETIES, V4, P68, DOI 10.3390/soc4010068
   Ruderman MN, 2020, IND ORGAN PSYCHOL-US, V13, P103, DOI 10.1017/iop.2020.18
   Saw AE, 2015, J SPORT SCI MED, V14, P137
   Sensor Tower, 2021, MOB WELLN APPS FOR E
   Shawn H., 2001, LOS ANGELES TIM 1002, pE1
   Snyder CR, 1997, PSYCHOL INQ, V8, P48, DOI 10.1207/s15327965pli0801_10
   SOLOMON S, 1991, ADV EXP SOC PSYCHOL, V24, P93
   Solomon S., 2004, HDB EXPT EXISTENTIAL, P13
   Swami V, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110426
   Taparia H, 2020, NEW YORK TIMES
   TEMPLER DI, 1970, J GEN PSYCHOL, V82, P165, DOI 10.1080/00221309.1970.9920634
   Thomson M, 2005, J CONSUM PSYCHOL, V15, P77, DOI 10.1207/s15327663jcp1501_10
   Trope Y, 2007, J CONSUM PSYCHOL, V17, P83, DOI 10.1016/S1057-7408(07)70013-X
   Vaes J, 2010, J PERS SOC PSYCHOL, V98, P750, DOI 10.1037/a0017658
   Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912
   WHO, COVID 19 ALR AFF PEO
   Wisman A, 2003, J PERS SOC PSYCHOL, V84, P511, DOI 10.1037/0022-3514.84.3.511
   Xu Q, 2020, J CONSUM PSYCHOL, V30, P486, DOI 10.1002/jcpy.1163
NR 84
TC 22
Z9 22
U1 28
U2 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0191-8869
EI 1873-3549
J9 PERS INDIV DIFFER
JI Pers. Individ. Differ.
PD OCT
PY 2021
VL 180
AR 110972
DI 10.1016/j.paid.2021.110972
EA MAY 2021
PG 10
WC Psychology, Social
WE Social Science Citation Index (SSCI)
SC Psychology
GA SO4ZA
UT WOS:000658981200024
OA Bronze
DA 2022-04-20
ER

PT J
AU Pittman, J
   Severino, L
   DeCarlo-Tecce, MJ
   Kiosoglous, C
AF Pittman, Joyce
   Severino, Lori
   DeCarlo-Tecce, Mary Jean
   Kiosoglous, Cameron
TI An action research case study: digital equity and educational inclusion
   during an emergent COVID-19 divide
SO JOURNAL FOR MULTICULTURAL EDUCATION
LA English
DT Article
DE Online learning; Assessment; New technologies; Diversity; Transformative
   knowledge; COVID-19
AB Purpose
   This paper aims to share responses from current literature, a small case study about perceptions and practices of the school of education faculty toward multicultural and educational issues concerning the rapid rise in online environments during coronavirus (COVID-19) experiences and just-in-time strategies for addressing digital equity and educational inclusion in K-16 online educational settings.
   Design/methodology/approach
   This is a conceptual paper that emerged from an action research case study. The study included four faculty in an urban school of education. The faculty participants were asked to provide examples of educational inclusion strategies used during transitioning their courses and advising to online environments in a Research I university. Faculty included one educational leadership, one sports management, one special education and one teacher education professor. Central issues explored practices related to language, technology access, curriculum design and technological competencies and assessment. A driving question was: How do institutions, schools or educators provide learning opportunities to support digital equity and inclusive education practice to maintain and strengthen relationships and core practices of multicultural education during a time of physical distancing during COVID-19? And what are the experiences, barriers, successes?
   Findings
   Research-based transformative knowledge, real situations and practical resources for considering inclusive education curriculum concepts were found that are connecting educators, teachers, learners and communities during this time of crisis.
   Research limitations/implications
   Methodological limitations that influenced the research design include conducting research in a totally virtual environment, small sample size, lack of diversity in curriculum content and one research site. The data collection was limited to written responses from the faculty participants. This action research study took place in a time frame limited by COVID-19 conditions during a four-month period.
   Practical implications
   In theory and practice, this new online movement suggests learners, teachers, educators and leaders are gaining experience and knowledge about resources and strategies for using new technologies, assessments and flexible curriculum as powerful tools for building language, curriculum and social-cultural communication bonds across generations and including special needs populations. Such new and emerging strategies could be used to bridge gaps in a time of distancing to support inclusive and equitable learning environments in education to minimize the effects of an emergent COVID-19 digital divide. Social learning culture as constructed, performed and captured in patterns of cooperation among faculties shows the world becoming more open and less restricted by borders. In conclusion, an emerging new conceptual framework is presented in Figure 2 to support action planning to bridge the digital equity access and learning gaps created by COVID-19.
   Social implications
   It is in times of strife and difficulty that problems and issues become exacerbated. While some educators easily adapted and took on the challenges of online learning, others needed time for learning and mourning (literally and figuratively). The issues of equity and access have become even more apparent as this paper takes inventory of intersections between multicultural education, special education, sports education and K-16 education overall.
   This is an excellent time to reflect on how education can address the cultural, economic and social barriers that impact student learning globally for all learners.
   Originality/value
   The brief collective case study reports educational experiences during a time of crisis that stimulates creative and innovative approaches to creating inclusive and equitable online learning environments to address diverse learning needs. The various and often contrasting educator responses from faculty facing digital and educational challenges present ideas that might be applicable in the global learning environment beyond the COVID-19 pandemic.
C1 [Pittman, Joyce; Severino, Lori; DeCarlo-Tecce, Mary Jean] Drexel Univ, Sch Educ, Philadelphia, PA 19104 USA.
   [Kiosoglous, Cameron] Drexel Univ, Philadelphia, PA 19104 USA.
RP Pittman, J (corresponding author), Drexel Univ, Sch Educ, Philadelphia, PA 19104 USA.
EM jap386@drexel.edu; las492@drexel.edu; mt623@drexel.edu;
   cmk385@drexel.edu
CR [Anonymous], 2020, UN NEWS
   [Anonymous], 2020, UNESCO GLOBAL ED COV
   Bell, 2016, HDB RES TEACHING, P717, DOI DOI 10.3102/978-0-935302-48-6
   Burdette P., 2013, J ASYNCHRONOUS LEARN, V17, P65, DOI DOI 10.24059/olj.v17i3.327
   Coalition for Responsible Home Schooling, 2020, HOM COVID 19
   EdWeekResearch Center, 2020, SURV STUD WANT MOR O
   Elfil M, 2017, EMERGENCY, V5
   Goodwin A.L., 2020, ACTION TEACHER ED, V42, P6, DOI [10.1080/01626620.2019.1700848, DOI 10.1080/01626620.2019.1700848]
   Goodwin AL, 2017, EDUC STUD-AESA, V53, P433, DOI 10.1080/00131946.2016.1261028
   Grant, 2019, LEARNING INFORM RICH, P93
   Gzel P, 2020, INT J PSYCHOL ED STU, V7, P122, DOI [10.17220/ijpes.2020.02.011, DOI 10.17220/IJPES.2020.02.011]
   Hohlfeld TN, 2017, COMPUT EDUC, V113, P135, DOI 10.1016/j.compedu.2017.05.017
   Knezek, 2008, INT HDB INFORM TECHN, P803
   Marston H, 2020, COVID 19 VS SOCIAL I
   Maxwell L., 2014, ED WEEK
   Neeley T, 2012, HARVARD BUS REV, V90, P116
   OECD, 2019, TALIS 2018 RES TEACH, DOI [10.1787/1d0bc92a-en, DOI 10.1787/1D0BC92A-EN]
   Patricios J, 2020, BRIT J SPORT MED, V54, P561, DOI 10.1136/bjsports-2020-102305
   Pew Research, 2020, GLOBAL ATTITUDES TRE
   Rauf, 2020, DISTRICTS ARE HELPIN
   Reich J., 2020, REMOTE LEARNING GUID, DOI DOI 10.35542/OSF.IO/437E2
   Resta P., 2008, INT HDB INFORM TECHN, P765, DOI DOI 10.1007/978-0-387-73315-9_44
   STANOVICH KE, 1986, READ RES QUART, V21, P360, DOI 10.1598/RRQ.21.4.1
   Sugarman, 2017, TEACHING ENGLISH SUP
   Swee-Hin, 2020, EDITORIAL WORLD COUN
   The Herald Dispatch Media, 2020, NCAA ALL MOR TIM VIR
   The National Association for Multicultural Education, 2020, MULTICULTURAL LEARNI
   U.S. Department of Education, 2014, PREP INF DIS DEP ED
   UNESCO, 2020, GLOB ED COVID 19 COA
NR 29
TC 5
Z9 5
U1 17
U2 55
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2053-535X
J9 J MULTICULT EDUC
JI J. Multicult. Educ.
PD JUN 4
PY 2021
VL 15
IS 1
BP 68
EP 84
DI 10.1108/JME-09-2020-0099
EA JAN 2021
PG 17
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA SO6UN
UT WOS:000610953900001
DA 2022-04-20
ER

PT J
AU Nguyen, V
   Nguyen, BN
   Nguyen, TQ
   Chu, AT
   Dinh, HT
AF Van Tam Nguyen
   Bao Ngoc Nguyen
   Toan Quoc Nguyen
   Anh Tung Chu
   Hai Tuan Dinh
TI The Impact of the COVID-19 on the Construction Industry in Vietnam
SO INTERNATIONAL JOURNAL OF BUILT ENVIRONMENT AND SUSTAINABILITY
LA English
DT Article
DE Covid-19; construction industry; performance; impact; developing
   countries; Vietnam
ID LABOR PRODUCTIVITY; PERFORMANCE; RECESSION; HIV/AIDS; HEALTH; AIDS; HIV
AB The COVID-19 pandemic has generated a wide range of socio-economic disruption, which causes devastating in numerous aspects. Our knowledge of the true health of the construction industry under the ravage of COVID-19 outbreak is largely based on very limited data. This study aims to assess the impact of pandemic on the construction industry through an investigation in Vietnam. Data were collected through 129 respondents whose online questionnaire survey completed according to their recent direct or indirect participation in delivering construction projects during the spread. The implications of COVID-19 on the construction industry were examined based on simple percentage analysis and Relative Importance Index approaches. Three principal facets of the construction industry were considered: firms' business activities, project performance, and workforce demand. The findings highlighted the multilevel, multidimensional nature of the epidemic consequences on the construction sector. Notably, the revenue and profitability, in a general sense, have decreased during the COVID-19 period, while most of the production and business costs had remained unchanged. Further, the pandemic was argued to impair construction practitioners' incomes and mental health and sabotage projects' schedule and cost. (C) 2021 Penerbit UTM Press. All rights reserved
C1 [Van Tam Nguyen; Bao Ngoc Nguyen; Toan Quoc Nguyen; Anh Tung Chu] Natl Univ Civil Engn, Fac Construct Econ & Management, Hanoi, Vietnam.
   [Hai Tuan Dinh] Hanoi Architectural Univ, Fac Urban Management, Hanoi, Vietnam.
RP Nguyen, BN (corresponding author), Natl Univ Civil Engn, Fac Construct Econ & Management, Hanoi, Vietnam.
EM ngocnb@nuce.edu.vn
RI Van Tam, Nguyen/AAD-1858-2021
OI Van Tam, Nguyen/0000-0001-6238-6082; Nguyen, Bao
   Ngoc/0000-0003-0978-1678; QUOC TOAN, NGUYEN/0000-0001-7086-2974
CR Afkhamiaghd A Mahdi, 2020, J Emerg Manag, V18, P9, DOI 10.5055/jem.2020.0481
   Alaghbari W, 2019, INT J CONSTR MANAG, V19, P79, DOI 10.1080/15623599.2017.1382091
   Alenezi T., 2020, INT J ENG RES GEN SC, V8, P6
   Alon T, 2020, 26947 NBER
   Alon T. M., 2020, THIS TIME ITS DIFFER
   Alshenqeeti H., 2014, ENGLISH LINGUISTICS, V3, P39, DOI DOI 10.5430/elr.v3n1p39
   Andersen E, 2006, BALT J MANAG, V1, P127, DOI DOI 10.1108/17465260610663854
   [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Araya F, 2021, SAFETY SCI, V133, DOI 10.1016/j.ssci.2020.105022
   Ataguba OA, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1788263
   Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117
   Belout A., 2004, International Journal of Project Management, V22, P1, DOI 10.1016/S0263-7863(03)00003-6
   Bery L, 2012, P SPE APPEA INT C HL, P1
   Bowen P, 2008, CONSTR MANAG ECON, V26, P827, DOI 10.1080/01446190802061225
   Brainerd E., 2002, EC EFFECTS 1918 INFL
   Bsisu K. A. D., 2020, INT J ENG RES TECH, V13, P828
   Burkle FM, 2020, PREHOSP DISASTER MED, V35, P237, DOI 10.1017/S1049023X20000424
   Can L. V., 2020, VIETNAM FINANCIAL MO
   Daniel Sir John, 2020, Prospects (Paris), P1, DOI 10.1007/s11125-020-09464-3
   Dinh HH, 2021, ASIAN EDUC DEV STUD, V10, P239, DOI 10.1108/AEDS-07-2020-0165
   Dinh PL, 2020, INTER-ASIA CULT STUD, V21, P506, DOI 10.1080/14649373.2020.1831811
   Dixon S, 2002, BRIT MED J, V324, P232, DOI 10.1136/bmj.324.7331.232
   Durdyev S, 2017, CONSTR ECON BUILD, V17, P48, DOI 10.5130/AJCEB.v17i4.5596
   El-Gohary KM, 2014, J MANAGE ENG, V30, P1, DOI 10.1061/(ASCE)ME.1943-5479.0000168
   Gallant J., 2020, TEMPORARY UNEMPLOYME
   Gamil Y., 2020, MEDITERRANEAN J SOCI, V11, P122, DOI 10.36941/mjss-2020-0047
   Gerard F, 2020, OXFORD REV ECON POL, V36, pS281, DOI 10.1093/oxrep/graa026
   Gill P, 2008, BRIT DENT J, V204, P291, DOI 10.1038/bdj.2008.192
   Gruber J, 2021, AM PSYCHOL, V76, P409, DOI 10.1037/amp0000707
   Guerrieri V., 2020, MACROECONOMIC IMPLIC
   Gunduz M, 2020, J MANAGE ENG, V36, DOI 10.1061/(ASCE)ME.1943-5479.0000773
   Hadi A, 2011, MON LABOR REV, V134, P24
   Hai D.T., 2020, OPEN CONSTRUCTION BU, V13, P353, DOI 10.2174/1874836801913010353
   Hansen S, 2020, J CIVIL ENG FORUM, V6, P201
   Harinarain N, 2014, AJAR-AFR J AIDS RES, V13, P291, DOI 10.2989/16085906.2014.952653
   Hiyassat MA, 2016, INT J CONSTR MANAG, V16, P138, DOI 10.1080/15623599.2016.1142266
   Hogg RV., 2010, PROBABILITY STAT INF
   Jarkas AM, 2012, INT J CONSTR MANAG, V12, P1, DOI 10.1080/15623599.2012.10773192
   Jarkas AM, 2015, INT J CONSTR MANAG, V15, P94, DOI 10.1080/15623599.2015.1012143
   Jim Toole F., 2010, POTENTIAL IMPACT PAN
   Karlsson M, 2014, J HEALTH ECON, V36, P1, DOI 10.1016/j.jhealeco.2014.03.005
   Kissi E, 2020, INT J PRODUCT PERFOR, DOI 10.1108/IJPPM-11-2019-0546
   Kurmann A., 2020, IMPACT COVID 19 US E
   Le H. T., 2020, FRONT PUBLIC HEALTH, V8, P648
   Loayza N.V., 2020, MACROECONOMIC POLICY, V28, DOI DOI 10.1596/33540
   Lum LHW, 2020, SINGAP MED J, V61, P55, DOI 10.11622/smedj.2020018
   Luo HB, 2020, AUTOMAT CONSTR, V119, DOI 10.1016/j.autcon.2020.103345
   MacLean LM, 2004, QUAL HEALTH RES, V14, P113, DOI 10.1177/1049732303259804
   Maldin B, 2005, BIOSECUR BIOTERROR, V3, P363, DOI 10.1089/bsp.2005.3.363
   Marey-Perez M., 2020, TECHNIUM SOC SCI J, V9, P661, DOI [10.47577/tssj.v9i1.1021, DOI 10.47577/TSSJ.V9I1.1021]
   Matangi C. N., 2006, J INT DEV, V18, P599, DOI DOI 10.1002/JID.1249
   McGrail M. R., 2006, HIGHER ED RES DEV, V25.1, P19, DOI DOI 10.1080/07294360500453053
   McTague B., 2002, PRODUCTIVITY IMPROVE
   Megahed NA, 2020, SUSTAIN CITIES SOC, V61, DOI 10.1016/j.scs.2020.102350
   Meintjes I, 2007, CONSTR MANAG ECON, V25, P255, DOI 10.1080/01446190601071813
   Toan NQ, 2020, ENTREP SUSTAIN ISS, V8, P751, DOI 10.9770/jesi.2020.8.2(45)
   Obayelu A. E., 2007, Livestock Research for Rural Development, V19, P4
   Ofori G., 2018, 7 ETH CONSTR TECHN M
   Ogunnusi M, 2020, INT J REAL ESTATE ST, V14
   Otu A, 2020, INT J MENT HEALTH SY, V14, DOI 10.1186/s13033-020-00371-w
   Page S, 2006, TOURISM MANAGE, V27, P361, DOI 10.1016/j.tourman.2006.01.001
   Page S. J., 2007, J BUSINESS CONTINUIT, V1, P167
   Patterson B., 1993, PUBLIC RELAT J, V49, P48
   Phimister I R, 1973, Cent Afr J Med, V19, P143
   PricewaterhouseCoopers, 2020, COVID 19 IMP ASS
   Raithel S, 2010, J PROD BRAND MANAG, V19, P389, DOI 10.1108/10610421011085703
   Rassy D, 2013, HEALTH ECON, V22, P824, DOI 10.1002/hec.2862
   Sfakianaki E., 2015, INT J MANAGEMENT DEC, V14, P373, DOI DOI 10.1504/IJMDM.2015.074015
   Sontaite-Petkeviciene M, 2014, PROCD SOC BEHV, V156, P452, DOI 10.1016/j.sbspro.2014.11.220
   Tansey P., 2014, GOVT INFLUENCE CONST
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   Truelove S, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003144
   Valikangas L, 2020, MANAGE ORGAN REV, V16, P467, DOI 10.1017/mor.2020.32
   Van TN., 2018, J SCI TECH CIV ENG, V12, P127
   Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035
   World Bank, 2008, GLOBAL ECONOMIC PROSPECTS: TECHNOLOGY DIFFUSION IN THE DEVELOPING WORLD, P1, DOI 10.1596/978-0-8213-7365-1
   Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001
   Yoo S, 2015, SUSTAINABILITY-BASEL, V7, P15982, DOI 10.3390/su71215796
   Zengeni D. M., 2012, INT J DEV SUSTAINABI, V1
NR 79
TC 1
Z9 1
U1 14
U2 24
PU PENERBIT UTM PRESS
PI JOHOR
PA PENERBIT UTM PRESS, SKUDAI, JOHOR, 81310, MALAYSIA
SN 1511-1369
EI 2289-8948
J9 INT J BUILT ENV SUST
JI Int. J. Built Environ. Sustain.
PY 2021
VL 8
IS 3
BP 47
EP 61
DI 10.11113/ijbes.v8.n3.745
PG 15
WC Urban Studies
WE Emerging Sources Citation Index (ESCI)
SC Urban Studies
GA UK5FL
UT WOS:000691995300005
OA gold
DA 2022-04-20
ER

PT J
AU Mohanty, P
   Hassan, A
   Ekis, E
AF Mohanty, Priyakrushna
   Hassan, Azizul
   Ekis, Erdogan
TI Augmented reality for relaunching tourism post-COVID-19: socially
   distant, virtually connected
SO WORLDWIDE HOSPITALITY AND TOURISM THEMES
LA English
DT Article
DE Augmented reality; Tourist satisfaction; COVID-19; Tourism 5; 0; Tourist
   safety
AB Purpose
   This paper aims to understand the various facets of augmented reality (AR) and to explore its prospects for supporting the relaunch of the tourism sector post-COVID-19 in accordance with the guidelines set out by WHO and UNWTO.
   Design/methodology/approach
   This study falls into the category of exploratory research. It is based on a systematic review of secondary data. Thematic content analysis has been adopted to trace out the various ways in which AR can be an aid in overcoming challenges in the relaunch of tourism after the pandemic.
   Findings
   It was found that norms such as social distancing and lower mobility are going to be followed even after the COVID-19. Therefore, there will be a great demand for mobile and Web-based AR to not only ensure tourist safety but also to create unique, accessible, personalized, context-specific, deep and memorable experiences.
   Practical implications
   Apart from its academic contribution to the existing body of knowledge, this work can assist various tourism DMOs and policymakers to devise futuristic policies for AR-driven tourism management and development.
   Originality/value
   The COVID-19 pandemic is unprecedented and never seen before. In this context, this study establishes its novelty by exclusively focusing on the aspects of AR that can support the relaunch of tourism post-pandemic.
C1 [Mohanty, Priyakrushna] Pondicherry Univ, Sch Management, Dept Tourism Studies, Pondicherry, India.
   [Hassan, Azizul] Tourism Soc, London, England.
   [Ekis, Erdogan] Mohammed VI Polytech Univ, Sch Hospitality Business & Management, Ben Guerir, Morocco.
RP Mohanty, P (corresponding author), Pondicherry Univ, Sch Management, Dept Tourism Studies, Pondicherry, India.
EM p.mohanty@ipdt.pt; a.hassan@ipdt.pt; e.ekis@ipdt.pt
RI Mohanty, Priyakrushna/AAJ-5970-2021
OI Mohanty, Priyakrushna/0000-0001-6933-2757
CR Brouder P, 2020, TOURISM GEOGR, V22, P484, DOI 10.1080/14616688.2020.1760928
   Buhalis D., 2013, TRENDS EUROPEAN TOUR
   Carbone F., 2020, TURISMO MUNDIAL CRIS, V43, P56
   Celtek E., 2016, MOBILE COMPUTING WIR, P876
   Chang YL, 2015, EDUC TECHNOL SOC, V18, P166
   Chung N, 2018, J TRAVEL RES, V57, P627, DOI 10.1177/0047287517708255
   Loureiro SMC, 2020, TOURISM MANAGE, V77, DOI 10.1016/j.tourman.2019.104028
   Cranmer EE, 2020, TOUR MANAG PERSPECT, V35, DOI 10.1016/j.tmp.2020.100672
   Cranmer EE, 2018, PROGR IS, P21, DOI 10.1007/978-3-319-64027-3_2
   Dadwal S.S., 2016, MOBILE COMPUTING WIR, P63
   Dieck MCT, 2018, COMPUT HUM BEHAV, V82, P44, DOI 10.1016/j.chb.2017.12.043
   Fernandes N., 2020, EC EFFECTS CORONAVIR
   Georgakopoulos V., 2008, TOURISMOS INT MULTID, V5, P55
   Goodwin H., 2020, LATEST DEV RESPONSIB
   Gustafson P, 2012, TOURISM MANAGE, V33, P276, DOI 10.1016/j.tourman.2011.03.006
   Haleem A, 2020, AM J EMERG MED, V38, P1524, DOI 10.1016/j.ajem.2020.04.022
   Han D.-I., 2013, INFORM COMMUNICATION
   Han DI, 2018, J HERIT TOUR, V13, P46, DOI [10.1080/1743873X.2016.1251931, 10.1080/1743873x.2016.1251931]
   Hassan A, 2018, PROGR IS, P47, DOI 10.1007/978-3-319-64027-3_4
   Hassan A, 2016, ADV HOSP TOUR SERV, P130, DOI 10.4018/978-1-5225-0201-2.ch008
   He ZY, 2018, TOURISM MANAGE, V68, P127, DOI 10.1016/j.tourman.2018.03.003
   Hemachandran Rajamanicam, 2018, Journal of Hospitality Application & Research, V13, P1
   Higgins-Desbiolles F, 2020, TOURISM GEOGR, V22, P610, DOI 10.1080/14616688.2020.1757748
   Ioannides D, 2020, TOURISM GEOGR, V22, P624, DOI 10.1080/14616688.2020.1763445
   Keckes AL, 2017, INTERDISCIP DESCR CO, V15, P157, DOI 10.7906/indecs.15.2.5
   Kipper G., 2012, AUGMENTED REALITY EM
   Kounavis CD, 2012, INT J ENG BUS MANAG, V4, DOI 10.5772/51644
   Maital S, 2020, GLOBAL EC IMPACT COV
   McKibbin W., 2020, GLOBAL MACROECONOMIC, DOI DOI 10.2139/SSRN.3547729
   Michele G., 2013, 18 INT C DIG SIGN PR, P1, DOI DOI 10.1145/2543651.2543665
   Mora C., 2020, TURISMO MUNDIAL CRIS, P33
   Nicolas E.S., 2020, EU PLEDGES HELP TOUR
   Niewiadomski P, 2020, TOURISM GEOGR, V22, P651, DOI 10.1080/14616688.2020.1757749
   RAHIMI R, 2020, DESTINATION MANAGEME, P1066
   Schott C, 2017, J HOSP LEIS SPORT TO, V21, P13, DOI 10.1016/j.jhlste.2017.05.002
   SHABANI N, 2018, VIRTUAL AUGMENTED RE, P1808
   Singhal T., 2020, INDIAN PRACT, V73, P38
   Tom Dieck M.C., 2016, J HOSPITALITY TOURIS, V7
   United Nations World Tourism Organization (UNWTO), 2020, IMP ASS COV 19 OUTBR
   UNWTO, 2020, GLOB GUID REST TOUR
   UNWTO, 2020, INT TOUR NUMB COULD
   UNWTO, 2020, NEW DAT SHOWS IMP CO
   UNWTO, 2020, UNWTO LAUNCH GLOB GU
   Van Kleef N., 2010, STUDY TOUR PIXEL, V1, P1
   Voitik N.V., 2019, A A, V5, P3, DOI [10.18413/2408-9346-2019-5-3-0-1, DOI 10.18413/2408-9346-2019-5-3-0-1]
   WHO, 2020, GUID AIR TRAV COVID
   Ye GQ, 2003, IEEE SYS MAN CYBERN, P3425
   Yovcheva Z., 2013, ENG AUGMENTED TOURIS, P24
   Yung R, 2019, CURR ISSUES TOUR, V22, P2056, DOI 10.1080/13683500.2017.1417359
NR 49
TC 16
Z9 16
U1 6
U2 28
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1755-4217
EI 1755-4225
J9 WORLDW HOSP TOUR THE
JI Worldw. Hosp. Tour. Themes
PD DEC 17
PY 2020
VL 12
IS 6
SI SI
BP 753
EP 760
DI 10.1108/WHATT-07-2020-0073
EA DEC 2020
PG 8
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA PG6HP
UT WOS:000595501200001
OA Bronze
DA 2022-04-20
ER

PT J
AU Sriharan, A
   Ratnapalan, S
   Tricco, AC
   Lupea, D
AF Sriharan, Abi
   Ratnapalan, Savithiri
   Tricco, Andrea C.
   Lupea, Doina
TI Women in healthcare experiencing occupational stress and burnout during
   COVID-19: a rapid review
SO BMJ OPEN
LA English
DT Review
DE health services administration &amp; management; health &amp; safety;
   organisation of health services
ID PSYCHOLOGICAL IMPACT; MENTAL-HEALTH; PHYSICIANS
AB Context COVID-19 has had an unprecedent impact on physicians, nurses and other health professionals around the world, and a serious healthcare burnout crisis is emerging as a result of this pandemic. Objectives We aim to identify the causes of occupational stress and burnout in women in medicine, nursing and other health professions during the COVID-19 pandemic and interventions that can support female health professionals deal with this crisis through a rapid review. Methods We searched MEDLINE, Embase, CINAHL, PsycINFO and ERIC from December 2019 to 30 September 2020. The review protocol was registered in PROSPERO and is available online. We selected all empirical studies that discussed stress and burnout in women healthcare workers during the COVID-19 pandemic. Results The literature search identified 6148 citations. A review of abstracts led to the retrieval of 721 full-text articles for assessment, of which 47 articles were included for review. Our findings show that concerns of safety (65%), staff and resource adequacy (43%), workload and compensation (37%) and job roles and security (41%) appeared as common triggers of stress in the literature. Conclusions and relevance The current literature primarily focuses on self-focused initiatives such as wellness activities, coping strategies, reliance of family, friends and work colleagues to organisational-led initiatives such as access to psychological support and training. Very limited evidence exists about the organisational interventions such as work modification, financial security and systems improvement.
C1 [Sriharan, Abi; Tricco, Andrea C.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Ratnapalan, Savithiri] Hosp Sick Children, Div Emergency Med, Toronto, ON, Canada.
   [Ratnapalan, Savithiri] Temerty Fac Med, Dept Paediat, Toronto, ON, Canada.
   [Tricco, Andrea C.] Unity Hlth, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Lupea, Doina] Ontario Med Assoc, Toronto, ON, Canada.
RP Sriharan, A (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
EM abi.sriharan@utoronto.ca
RI Sriharan, Abi/AAR-6978-2020; Tricco, Andrea/B-9920-2011; Sriharan,
   Abi/AAQ-3369-2021
OI Sriharan, Abi/0000-0002-8191-7050; Tricco, Andrea/0000-0002-4114-8971;
   Sriharan, Abi/0000-0002-8191-7050
FU Canadian Institute for Health Research Operating Grant: Knowledge
   Synthesis: COVID-19 in Mental Health Substance UseCanadian Institutes of
   Health Research (CIHR); Tier 2 Canada Research Chair in Knowledge
   Synthesis
FX This research was supported through a grant from the Canadian Institute
   for Health Research Operating Grant: Knowledge Synthesis: COVID-19 in
   Mental Health & Substance Use. ACT is funded by a Tier 2 Canada Research
   Chair in Knowledge Synthesis.
CR Al Sulais E, 2020, SAUDI J GASTROENTERO, V26, P249, DOI 10.4103/sjg.SJG_174_20
   Algunmeeyn A, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00262-y
   Amnesty International, 2020, GLOBAL AMNESTY ANAL
   Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9
   Bolman LG, 2017, REFRAMING ORGANIZATIONS : ARTISTRY, CHOICE, AND LEADERSHIP, 6TH EDITION
   Brubaker L, 2020, JAMA-J AM MED ASSOC, V324, P835, DOI 10.1001/jama.2020.14797
   Busis N., 2019, GENDER BASED DIFFERE, DOI DOI 10.31478/201905A
   Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171
   CDC, CASES DEATHS HEALTHC
   Clarke V., 2017, QUALITATIVE PSYCHOL, P232, DOI 10.1080/17439760.2016.1262613
   De Stefani A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113867
   Elbay RY, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113130
   Fargen KM, 2020, J NEUROINTERV SURG, V12, P927, DOI 10.1136/neurintsurg-2020-016513
   Gao XY, 2020, J CLIN NURS, V29, P4270, DOI 10.1111/jocn.15464
   Ghebreyesus TA, 2019, FEMALE HLTH WORKERS
   Gold KJ, 2016, GEN HOSP PSYCHIAT, V43, P51, DOI 10.1016/j.genhosppsych.2016.09.004
   Guille C, 2017, JAMA INTERN MED, V177, P1766, DOI 10.1001/jamainternmed.2017.5138
   Hoffman KE, 2020, INT J RADIAT ONCOL, V108, P370, DOI 10.1016/j.ijrobp.2020.06.062
   JAMA, QUALITY RATING SCHEM
   Kackin O, 2021, INT J SOC PSYCHIATR, V67, P158, DOI 10.1177/0020764020942788
   Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028
   Karimii Z, 2020, RISK MANAG HEALTHC P, V13, P1271, DOI 10.2147/RMHP.S258785
   Khalafallah AM, 2020, CLIN NEUROL NEUROSUR, V198, DOI 10.1016/j.clineuro.2020.106193
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Li G, 2020, J NEUROL NEUROSUR PS, V91, P895, DOI 10.1136/jnnp-2020-323134
   Liu CY, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001107
   Martinez-Lopez JA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9093029
   McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021
   Mock J, 2020, SCI AM
   Moorthy A, 2020, J PUBLIC HEALTH-UK, V42, P486, DOI 10.1093/pubmed/fdaa096
   Mosheva M, 2020, DEPRESS ANXIETY, V37, P965, DOI 10.1002/da.23085
   Ng B H, 2020, Med J Malaysia, V75, P485
   Nowicki GJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186491
   Nyashanu M, 2020, J INTERPROF CARE, V34, P655, DOI 10.1080/13561820.2020.1792425
   Orr C., 2020, CANADAS NATL OBSERVE
   Osama M, 2020, INT J SURG, V79, P252, DOI 10.1016/j.ijsu.2020.06.004
   Prasad Aman, 2020, OTO Open, V4, p2473974X20948835, DOI 10.1177/2473974X20948835
   Rabbani U, 2021, J EPIDEMIOL GLOB HEA, V11, P60, DOI 10.2991/jegh.k.200819.002
   Rodriguez RM, 2020, ACAD EMERG MED, V27, P700, DOI 10.1111/acem.14065
   Roycroft M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1702
   Ruiz-Fernandez MD, 2020, J CLIN NURS, V29, P4321, DOI 10.1111/jocn.15469
   Rymarowicz J, 2021, EUR SURG, V53, P5, DOI 10.1007/s10353-020-00649-w
   Sandesh R, 2020, CUREUS, V12, DOI 10.7759/cureus.8974
   Shah N, 2020, EUR J OBSTET GYN R B, V253, P90, DOI 10.1016/j.ejogrb.2020.07.060
   Shalhub S., 2020, J VASC SURG, V15
   Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893
   Sharma M, 2021, CLIN INFECT DIS, V72, pE566, DOI 10.1093/cid/ciaa1311
   Shechter A., 2020, GEN HOSP PSYCHIAT, V9
   Shoichet, 2020, COVID 19 IS TAKING D
   Si MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00724-0
   Sil A., 2020, DERMATOL THER, V2020
   Silczuk A, 2020, J PUBLIC HEALTH-UK, V42, P461, DOI 10.1093/pubmed/fdaa110
   Smith PM, 2021, CAN J PSYCHIAT, V66, P17, DOI 10.1177/0706743720961729
   Spiller Tobias R, 2020, Psychol Med, P1, DOI 10.1017/S0033291720003128
   Stojanov J, 2021, INT J SOC PSYCHIATR, V67, P175, DOI 10.1177/0020764020942800
   Suryavanshi N, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1837
   Tan R, 2020, J NURS MANAGE, V28, P1381, DOI 10.1111/jonm.13095
   Temsah MH, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001958
   Thomaier L., 2020, MEDRXIV
   Tricco A.C., 2017, RAPID REV STRENGTHEN
   Tsan SEH, 2021, ANAESTHESIA, V76, P8, DOI 10.1111/anae.15231
   UN Women, REDISTRIBUTE UNPAID
   Uvais N A, 2020, Prim Care Companion CNS Disord, V22, DOI 10.4088/PCC.20br02724
   World Health Organization, 2020, INT STAT CLASS DIS R, V11th ed
   World Health Organization, 2008, GENDER HLTH WORKFORC
   Xiao X, 2020, J AFFECT DISORDERS, V274, P405, DOI 10.1016/j.jad.2020.05.081
   Zhang SX, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113174
   Zhang SX, 2020, BRAIN BEHAV IMMUN, V87, P144, DOI 10.1016/j.bbi.2020.05.010
NR 68
TC 5
Z9 5
U1 6
U2 13
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PY 2021
VL 11
IS 4
AR e048861
DI 10.1136/bmjopen-2021-048861
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA RM0XO
UT WOS:000639385400014
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Belitski, M
   Guenther, C
   Kritikos, AS
   Thurik, R
AF Belitski, Maksim
   Guenther, Christina
   Kritikos, Alexander S.
   Thurik, Roy
TI Economic effects of the COVID-19 pandemic on entrepreneurship and small
   businesses
SO SMALL BUSINESS ECONOMICS
LA English
DT Article
DE Small businesses; Entrepreneurs; COVID-19 pandemic; Economic effects
ID DYNAMIC CAPABILITIES; MANAGEMENT; KNOWLEDGE; ENTERPRISES; RESILIENCE
AB Plain English Summary Responding to COVID-19 involves not just shielding small business jobs, supporting entrepreneurship, and raising government debt but also creating productive entrepreneurship and resilient location-specific entrepreneurial ecosystems. The COVID-19 pandemic is an unprecedented challenge for small businesses that also brings new market opportunities. The papers in this special issue of Small Business Economics Journal aim to shed light on the economic effects of the COVID-19 pandemic by looking at the macro- and microeconomic effects on entrepreneurship and small businesses as well as the role of financial support policies and well-being in both developed and developing countries. Future research should focus on the role of digitization and financial mechanisms supporting small businesses during crises.
   The existential threat to small businesses, based on their crucial role in the economy, is behind the plethora of scholarly studies in 2020, the first year of the COVID-19 pandemic. Examining the 15 contributions of the special issue on the "Economic effects of the COVID-19 pandemic on entrepreneurship and small businesses," the paper comprises four parts: a systematic review of the literature on the effect on entrepreneurship and small businesses; a discussion of four literature strands based on this review; an overview of the contributions in this special issue; and some ideas for post-pandemic economic research.
C1 [Belitski, Maksim] Univ Reading, Henley Business Sch, Reading, Berks, England.
   [Belitski, Maksim] ICD Business Sch, IGS Grp, Paris, France.
   [Guenther, Christina] WHU, Otto Beisheim Sch Management, Vallendar, Germany.
   [Kritikos, Alexander S.] German Inst Econ Res DIW Berlin, Berlin, Germany.
   [Kritikos, Alexander S.] Univ Potsdam, Potsdam, Germany.
   [Kritikos, Alexander S.] IZA, Bonn, Germany.
   [Kritikos, Alexander S.] IAB, Nurnberg, Germany.
   [Thurik, Roy] Montpellier Business Sch, Montpellier, France.
   [Thurik, Roy] Erasmus Sch Econ, Rotterdam, Netherlands.
RP Belitski, M (corresponding author), Univ Reading, Henley Business Sch, Reading, Berks, England.; Belitski, M (corresponding author), ICD Business Sch, IGS Grp, Paris, France.
EM m.belitski@reading.ac.uk; christina.guenther@whu.edu; akritikos@diw.de;
   thurik@ese.eur.nl
RI Thurik, Roy/A-9386-2012
OI Thurik, Roy/0000-0002-0242-6908
CR Arend RJ, 2013, SMALL BUS ECON, V41, P1, DOI 10.1007/s11187-012-9415-2
   Asemokha A, 2019, J INT ENTREP, V17, P425, DOI 10.1007/s10843-019-00254-3
   Audretsch DB, 2021, SMALL BUS ECON, V56, P593, DOI 10.1007/s11187-019-00191-4
   Audretsch DB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247609
   Audretsch DB, 2021, J KNOWL MANAG, V25, P693, DOI 10.1108/JKM-03-2020-0178
   Banerjee D, 2020, INT J SOC PSYCHIATR, V66, P525, DOI 10.1177/0020764020922269
   Barrero JM, 2020, BROOKINGS PAP ECO AC, P329, DOI 10.1353/eca.2020.0012
   Bartik, 2020, ARE SMALL BUSINESSES, DOI [10.3386/w26989, DOI 10.3386/W26989]
   Battisti M, 2017, INT SMALL BUS J, V35, P78, DOI 10.1177/0266242615611471
   Beach B., 2020, NATL BUREAU EC RES W
   Belghitar Y, 2022, SMALL BUS ECON, V58, P943, DOI 10.1007/s11187-021-00510-8
   Bhutta N, 2020, NATL TAX J, V73, P645, DOI 10.17310/ntj.2020.3.02
   Bin O., 2009, J SOCIO-ECON, V38, P601, DOI [10.1016/j.socec.2009.02.010, DOI 10.1016/J.SOCEC.2009.02.010]
   Block J., 2020, 1924 DIW BERL GERM I
   Block JH, 2022, SMALL BUS ECON, V58, P867, DOI 10.1007/s11187-020-00445-6
   Block JH, 2015, SMALL BUS ECON, V44, P37, DOI 10.1007/s11187-014-9589-x
   Blundell R, 2020, FISC STUD, V41, P291, DOI 10.1111/1475-5890.12232
   Braunerhjelm P, 2022, SMALL BUS ECON, V58, P963, DOI 10.1007/s11187-021-00520-6
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Buheji M. etal, 2020, AM J EC, V10, P213, DOI [10.5923/j.economics.20201004.02, DOI 10.5923/J.ECONOMICS.20201004.02]
   Bullough A, 2014, ENTREP THEORY PRACT, V38, P473, DOI 10.1111/etap.12006
   Bullough A, 2013, BUS HORIZONS, V56, P343, DOI 10.1016/j.bushor.2013.01.001
   Caballero R. J., 1991, CLEANSING EFFECT REC
   Caliendo M., 2019, IND ORG ENTREPRENEUR, P247, DOI [10.1007/978-3-030-25237-3_23, DOI 10.1007/978-3-030-25237-3_23]
   Campbell D. T., 1965, SOCIAL CHANGE DEV AR, P19
   Child J, 2017, J WORLD BUS, V52, P664, DOI 10.1016/j.jwb.2017.05.004
   Clauss T, 2021, IEEE T ENG MANAGE, V68, P767, DOI 10.1109/TEM.2019.2910381
   de Vries N, 2020, SMALL BUS ECON, V55, P447, DOI 10.1007/s11187-019-00244-8
   Digitally Driven, 2020, US SMALL BUS DIG SAF
   Digitally Driven, 2021, EUR SMALL BUS FIND D
   Dorr JO, 2022, SMALL BUS ECON, V58, P887, DOI 10.1007/s11187-021-00514-4
   Dua A, 2020, WHICH SMALL BUSINESS
   Duchek S., 2020, BUSINESS RES, V13, P215, DOI [DOI 10.1007/S40685-019-0085-7, https://doi.org/10.1007/s40685-019-0085-7]
   Economist, 2021, ECONOMIST
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   Fainshmidt S, 2017, LONG RANGE PLANN, V50, P550, DOI 10.1016/j.lrp.2016.05.005
   Fairlie R, 2022, SMALL BUS ECON, V58, P829, DOI 10.1007/s11187-021-00501-9
   Fairlie R, 2020, J ECON MANAGE STRAT, V29, P727, DOI 10.1111/jems.12400
   Flammer C, 2021, STRATEGIC MANAGE J, V42, P1275, DOI 10.1002/smj.3265
   GEM, 2020, DIAGN COVID 19 IMP E
   Giuri P., 2021, BEING RESILIENT SOC
   Graeber, 2021, 152021 DIW WOCH
   Graeber D, 2021, J POPUL ECON, V34, P1141, DOI 10.1007/s00148-021-00849-y
   Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110
   Grozinger AC, 2022, SMALL BUS ECON, V58, P689, DOI 10.1007/s11187-021-00506-4
   Hennart JF, 2014, ENTREP THEORY PRACT, V38, P117, DOI 10.1111/etap.12076
   History.com, 2020, SPAN FLU
   Kalenkoski CM, 2022, SMALL BUS ECON, V58, P741, DOI 10.1007/s11187-021-00522-4
   Karlsson M, 2014, J HEALTH ECON, V36, P1, DOI 10.1016/j.jhealeco.2014.03.005
   Kenney M, 2020, MANAGE ORGAN REV, V16, P747, DOI 10.1017/mor.2020.48
   Komlosi E, 2021, EVOLUTION GLOBAL DIG
   KPMG, 2020, GOV I MEAS RESP COVI
   Kritikos, 2020, DIW AKTUELL, V47
   Kuckertz A., 2020, J BUS VENTURING INSI, DOI 10.1016/j.jbvi.2020.e00169
   Kuratko DF, 2020, BUS HORIZONS, V63, P109, DOI 10.1016/j.bushor.2019.10.002
   Lastauskas P, 2022, SMALL BUS ECON, V58, P919, DOI 10.1007/s11187-021-00496-3
   Li WZ, 2016, J INF TECHNOL-UK, V31, P185, DOI 10.1057/jit.2016.10
   Linnenluecke MK, 2012, BUS STRATEG ENVIRON, V21, P17, DOI 10.1002/bse.708
   Liu Y, 2022, SMALL BUS ECON, V58, P807, DOI 10.1007/s11187-021-00474-9
   Maalaoui, 2021, REV INT PETITES MOYE
   Makkonen H, 2014, J BUS RES, V67, P2707, DOI 10.1016/j.jbusres.2013.03.020
   Malik MO, 2021, PROD PLAN CONTROL, V32, P1020, DOI 10.1080/09537287.2020.1784481
   Markman GD, 2019, ACAD MANAGE PERSPECT, V33, P371, DOI 10.5465/amp.2019.0130
   Marques F., 2020, BLOOMBERG 0528
   Marshall MI, 2014, NAT HAZARDS, V72, P597, DOI 10.1007/s11069-013-1025-z
   Meurer M., 2021, DIGITAL AFFORDANCES
   MEYER AD, 1982, ADMIN SCI QUART, V27, P515, DOI 10.2307/2392528
   Michael Ryan J., 2020, COVID 19 GLOBAL PAND, V1st, P109
   Nassauer S., 2020, WALL STREET J 0417
   Nunez-Castillo C, 2020, 8 INT C INN MAN ENTR
   Obal M, 2020, IND MARKET MANAG, V88, P247, DOI 10.1016/j.indmarman.2020.05.025
   OSullivan F, 2021, PANDEMIC LESSONS ERA
   Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006
   Pedauga L, 2022, SMALL BUS ECON, V58, P665, DOI 10.1007/s11187-021-00476-7
   Pereira I, 2022, SMALL BUS ECON, V58, P769, DOI 10.1007/s11187-021-00529-x
   Pollack, 2017, J BUSINESS VENTURING, V8, P1, DOI [10.1016/j.jbvi.2017.04.002, DOI 10.1016/J.JBVI.2017.04.002]
   Priyono A., 2020, J OPEN INNOV TECHNOL, V6, P1
   PWC, 2020, FIN UNT COV 19 KRIS
   Robinson J, 2020, J APPL ECON BUS RES, V10, P115
   Rousseau DM, 2008, ACAD MANAG ANN, V2, P475, DOI 10.1080/19416520802211651
   Seamans, 2021, DISCRIMINATION LENDI
   Seetharaman P, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102173
   Shepherd DA, 2020, J MANAGE STUD, V57, P1750, DOI 10.1111/joms.12633
   STAW BM, 1981, ADMIN SCI QUART, V26, P501, DOI 10.2307/2392337
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Thomas, 2020, BBC NEWS
   Thurik R., 2021, IN PRESS
   Torres AP, 2019, J CONTING CRISIS MAN, V27, P168, DOI 10.1111/1468-5973.12248
   Torres O., 2021, REV INT PETITES MOYE, V34, P63
   Torres O, 2022, SMALL BUS ECON, V58, P717, DOI 10.1007/s11187-021-00516-2
   Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375
   Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320
   Vadana II, 2020, INT MARKET REV, V37, P471, DOI 10.1108/IMR-04-2018-0129
   van der Zwan P, 2016, EURASIAN BUS REV, V6, P273, DOI 10.1007/s40821-016-0065-1
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Welter F, 2019, SMALL BUS ECON, V52, P319, DOI 10.1007/s11187-018-0094-5
   Welter F, 2011, ENTREP THEORY PRACT, V35, P165, DOI 10.1111/j.1540-6520.2010.00427.x
   Worldometers, 2021, COVID 19 COR PAND
   Yue W, 2021, INT SMALL BUS J, V39, P93, DOI 10.1177/0266242620986763
   Zahra SA, 2021, J WORLD BUS, V56, DOI 10.1016/j.jwb.2020.101143
   Zhange T, 2022, SMALL BUS ECON, V58, P611, DOI 10.1007/s11187-021-00493-6
NR 101
TC 11
Z9 11
U1 80
U2 100
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0921-898X
EI 1573-0913
J9 SMALL BUS ECON
JI Small Bus. Econ. Group
PD FEB
PY 2022
VL 58
IS 2
SI SI
BP 593
EP 609
DI 10.1007/s11187-021-00544-y
EA SEP 2021
PG 17
WC Business; Economics; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA YQ3EW
UT WOS:000695131700002
OA Green Published, Green Submitted, hybrid, Green Accepted
DA 2022-04-20
ER

PT J
AU Keshta, AS
   Mallah, SI
   Al Zubaidi, K
   Ghorab, OK
   Keshta, MS
   Alarabi, D
   Abousaleh, MA
   Salman, MT
   Taha, OE
   Zeidan, AA
   Elsaid, MF
   Tang, P
AF Keshta, Ahmed S.
   Mallah, Saad, I
   Al Zubaidi, Khaled
   Ghorab, Omar K.
   Keshta, Mohamed S.
   Alarabi, Dalal
   Abousaleh, Mohammad A.
   Salman, Mustafa Thaer
   Taha, Omer E.
   Zeidan, Anas A.
   Elsaid, Mahmoud F.
   Tang, Patrick
TI COVID-19 versus SARS: A comparative review
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Review
DE COVID-19; SARS; Public health; Coronavirus; Infectious disease
ID ACUTE RESPIRATORY SYNDROME; CORONAVIRUS DISEASE 2019; NEUTRALIZING
   ANTIBODIES; VIRAL LOAD; TRANSMISSION; SARS-COV-2; VACCINE; INFECTIONS;
   PNEUMONIA; DIAGNOSIS
AB The two genetically similar severe acute respiratory syndrome coronaviruses, SARS-CoV-1 and SARS-CoV-2, have each been responsible for global epidemics of vastly different scales. Although both viruses arose from similar origins, they quickly diverged due to differences in their transmission dynamics and spectrum of clinical presentations. The potential involvement of multiple organs systems, including the respiratory, cardiac, gastrointestinal and neurological, during infection necessitates a comprehensive understanding of the clinical pathogenesis of each virus. The management of COVID-19, initially modelled after SARS and other respiratory illnesses, has continued to evolve as we accumulate more knowledge and experience during the pandemic, as well as develop new therapeutics and vaccines. The impact of these two coronaviruses has been profound for our health care and public health systems, and we hope that the lessons learned will not only bring the current pandemic under control, but also prevent and reduce the impact of future pandemics. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
C1 [Keshta, Ahmed S.; Mallah, Saad, I; Ghorab, Omar K.; Keshta, Mohamed S.; Alarabi, Dalal; Abousaleh, Mohammad A.; Salman, Mustafa Thaer; Taha, Omer E.; Zeidan, Anas A.] Royal Coll Surg Ireland Bahrain, Sch Med, Busaiteen, Bahrain.
   [Al Zubaidi, Khaled] Hamad Med Corp, Div Paediat Infect Dis, Doha, Qatar.
   [Elsaid, Mahmoud F.] Hamad Med Corp, Div Pediat Neurol, Doha, Qatar.
   [Elsaid, Mahmoud F.] Sidra Med, Div Neurol, Doha, Qatar.
   [Elsaid, Mahmoud F.] Weill Cornell Med Qatar, Dept Pediat, Doha, Qatar.
   [Tang, Patrick] Sidra Med, Dept Pathol, POB 26999, Doha, Qatar.
   [Tang, Patrick] Weill Cornell Med Qatar, Dept Pathol & Lab Med, Doha, Qatar.
RP Tang, P (corresponding author), Sidra Med, Dept Pathol, POB 26999, Doha, Qatar.
EM ptang@sidra.org
OI Ghorab, Omar/0000-0002-9045-2929; Mallah, Saad/0000-0002-2234-1530;
   Zeidan, Anas/0000-0002-9560-8187
CR Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Amirian ES, 2020, INT J INFECT DIS, V95, P363, DOI 10.1016/j.ijid.2020.04.057
   [Anonymous], COVID 19 SER SURV ST
   Atallah B, 2020, EUR HEART J-CARD PHA, V6, P260, DOI 10.1093/ehjcvp/pvaa036
   Atallah B, 2020, EUR HEART J-QUAL CAR, V6, P204, DOI 10.1093/ehjqcco/qcaa033
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bannister R, 2015, OPEN FORUM INFECT DI, V2, DOI [10.1093/ofid/ofv130.02.LB-2, DOI 10.1093/OFID/OFV130.02.LB-2]
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Biot C, 2006, J MED CHEM, V49, P2845, DOI 10.1021/jm0601856
   Borras-Bermejo B, 2020, EMERG INFECT DIS, V26, P2281, DOI 10.3201/eid2609.202603
   Callaway E, 2020, NATURE, V580, P576, DOI 10.1038/d41586-020-01221-y
   Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014
   Carter LJ, 2020, ACS CENTRAL SCI, V6, P591, DOI 10.1021/acscentsci.0c00501
   Center for Disease Control and Prevention, SYMPT COR
   Centers for Disease Control and Prevention, HUM COR TYP
   Centers for Disease Control and Prevention, SARS GUID INF CONTR
   Centers for Disease Control and Prevention, CONS WEAR CLOTH FAC
   Centers for Disease Control and Prevention Centers for Disease Control and Prevention, CDC SARS RESP TIM
   Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686
   Chan PKS, 2004, EMERG INFECT DIS, V10, P825, DOI 10.3201/eid1005.030682
   Chan PKS, 2004, EMERG INFECT DIS, V10, P530, DOI 10.3201/eid1003.030493
   Chen Cheng-Yu, 2005, J Chin Med Assoc, V68, P4, DOI 10.1016/S1726-4901(09)70124-8
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Cheung TMT, 2004, CHEST, V126, P845, DOI 10.1378/chest.126.3.845
   Chowdhury R, 2020, EUR J EPIDEMIOL, V35, P389, DOI 10.1007/s10654-020-00649-w
   Chu KH, 2005, KIDNEY INT, V67, P698, DOI 10.1111/j.1523-1755.2005.67130.x
   Clancy CJ, 2020, CLIN INFECT DIS, V71, P2736, DOI 10.1093/cid/ciaa524
   Alzamora MC, 2020, AM J PERINAT, V37, P861, DOI 10.1055/s-0040-1710050
   Cox, 2020, OXFORD TXB MED
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Cuker A, 2021, BLOOD ADV, V5, P872, DOI 10.1182/bloodadvances.2020003763
   Deshmukh V, 2021, J CLIN PATHOL, V74, P76, DOI 10.1136/jclinpath-2020-206995
   Di Carlo DT, 2021, J NEUROL, V268, P1561, DOI 10.1007/s00415-020-09978-y
   Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366
   European Centre for Disease Prevention and Control, GUID DISCH END IS CO
   European Society of Cardiology, ESOCJ
   Fahmi M, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104272
   Fang DP, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002815
   Fisicaro F, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041415
   FORD N, 2020, J INT AIDS SOC, V23, DOI DOI 10.1002/JIA2.25489
   Fujii Takeshi, 2004, Journal of Infection and Chemotherapy, V10, P1, DOI 10.1007/s10156-003-0296-9
   Glasziou P., 2020, J ASS MED MICROBIOL, V5, P223, DOI [DOI 10.3138/JAMMI-2020-0030, 10.1101/2020.05.10.20097543]
   Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017
   Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P2137, DOI 10.1001/jama.2020.5460
   Gu J, 2007, AM J PATHOL, V170, P1136, DOI 10.2353/ajpath.2007.061088
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Hajifathalian K, 2020, WORLD J GASTROENTERO, V26, P1546, DOI 10.3748/wjg.v26.i14.1546
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hase R, 2020, INFECT DIS-NOR, V52, P423, DOI 10.1080/23744235.2020.1744711
   He YX, 2004, BIOCHEM BIOPH RES CO, V325, P445, DOI 10.1016/j.bbrc.2004.10.052
   Heymann DL, 2013, LANCET, V381, P779, DOI 10.1016/S0140-6736(13)60185-3
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X
   Infectious Diseases Society of America, IDSA COVID 19 ANT TE
   Island, 2021, FEATURES EVALUATION
   Jung SM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030637
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Karimi-Zarchi M, 2020, FETAL PEDIATR PATHOL, V39, P246, DOI 10.1080/15513815.2020.1747120
   Kim Jeong-Min, 2020, Osong Public Health Res Perspect, V11, P3, DOI 10.24171/j.phrp.2020.11.1.02
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6
   Kwok KO, 2020, J HOSP INFECT, V105, P682, DOI 10.1016/j.jhin.2020.05.027
   Lau JTF, 2004, EMERG INFECT DIS, V10, P280, DOI 10.3201/eid1002.030534
   Lee HKK, 2003, EMERG INFECT DIS, V9, P1491, DOI 10.3201/eid0911.030401
   Lee Nelson, 2003, Curr Infect Dis Rep, V5, P473, DOI 10.1007/s11908-003-0089-4
   Lemon S, 2004, I MED US FORUM MICRO
   Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6
   Leung C W, 2004, Paediatr Respir Rev, V5, P275, DOI 10.1016/j.prrv.2004.07.010
   Leung C, 2020, INFECT CONT HOSP EP, V41, P594, DOI 10.1017/ice.2020.81
   Leung GM, 2004, ANN INTERN MED, V141, P662, DOI 10.7326/0003-4819-141-9-200411020-00006
   Li AM, 2005, ARCH DIS CHILD-FETAL, V90, pF461, DOI 10.1136/adc.2005.075309
   Liu P, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008421
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1089
   Mansueto G, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.153195
   Marshall E, 2004, SCIENCE, V303, P944, DOI 10.1126/science.303.5660.944
   Martin-Delgado J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242185
   Mayr V, 2020, GESUNDHEITSWESEN, V82, P501, DOI 10.1055/a-1164-6611
   Medscape, SEV AC RESP SYNDR SA
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Meng LZ, 2020, ANESTHESIOLOGY, V132, P1317, DOI 10.1097/ALN.0000000000003296
   Morse JS, 2020, CHEMBIOCHEM, V21, P730, DOI 10.1002/cbic.202000047
   National Institutes of Health, ANT THER PAT COVID 1
   National Institutes of Health, COVID 19 TREATM GUID
   Nie YC, 2004, J INFECT DIS, V190, P1119, DOI 10.1086/423286
   NIH, THER MAN AD COVID 19
   O'Neill LAJ, 2020, NAT REV IMMUNOL, V20, P335, DOI 10.1038/s41577-020-0337-y
   Ooi GC, 2003, RESPIROLOGY, V8, pS15, DOI 10.1046/j.1440-1843.2003.00519.x
   Pan F, 2020, FERTIL STERIL, V113, P1135, DOI 10.1016/j.fertnstert.2020.04.024
   Patri A, 2020, J AM ACAD DERMATOL, V82, pE227, DOI 10.1016/j.jaad.2020.03.098
   Payus AO, 2020, BOSNIAN J BASIC MED, V20, P283, DOI 10.17305/bjbms.2020.4860
   Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Popescu S, 2020, DISASTER MED PUBLIC, V14, P538, DOI 10.1017/dmp.2020.55
   Remmelink M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03218-5
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
   Rodriguez P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20817-6
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Salehi S, 2020, AM J ROENTGENOL, V215, P87, DOI [10.2214/AJR.20.23034, 10.2214/AJR.20.23034S.]
   Santoriello D, 2020, J AM SOC NEPHROL, V31, P2158, DOI 10.1681/ASN.2020050744
   Stainsby Brynne, 2011, J Can Chiropr Assoc, V55, P32
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Sun PF, 2020, J MED VIROL, V92, P612, DOI 10.1002/jmv.25735
   Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4
   Takasuka N, 2004, INT IMMUNOL, V16, P1423, DOI 10.1093/intimm/dxh143
   Tang L, 2004, DNA CELL BIOL, V23, P391, DOI 10.1089/104454904323145272
   Tian Y, 2020, ALIMENT PHARM THER, V51, P843, DOI 10.1111/apt.15731
   Tsai LK, 2004, ARCH NEUROL-CHICAGO, V61, P1669, DOI 10.1001/archneur.61.11.1669
   TYRRELL DA, 1966, LANCET, V1, P76
   U.S. Food and Drug Administration, REC INV COVID 19 CON
   Umapathi T, 2004, J NEUROL, V251, P1227, DOI 10.1007/s00415-004-0519-8
   Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang DN, 2004, PHYSIOL GENOMICS, V18, P245, DOI 10.1152/physiolgenomics.00102.2004
   Wang TB, 2020, LANCET, V395, pE52, DOI 10.1016/S0140-6736(20)30558-4
   Wang YY, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00245-9
   WHO, COR DIS COVID 2019 S
   WHO, SARS SEV AC RESP SYN
   WHO, 2020, 2 WHO
   WHO, UPD WHO REC INT TRAF
   WHO, UPD 49 SARS CAS FAT
   WHO, SEV AC RESP SYNDR SA
   WHO, PNEUM UNKN CAUS CHIN
   Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8
   Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013
   Wong HYF, 2020, RADIOLOGY, V296, pE72, DOI 10.1148/radiol.2020201160
   Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803
   World Health Organization, REP WHO CHIN JOINT M
   World Health Organization, HOSP INFECT CONTROL
   World Health Organization, CONS DOC EP SEV AC R
   World Health Organization, DRAFT LANDSC COVID 1
   World Health Organization, 2021, WEEKLY EPIDEMIOLOGIC
   World Health Organization, INF PREV CONTR HLTH
   World Health Organization, SUMM PROB SARS CAS O
   World Health Organization (WHO), CONS QUAR IND CONT C
   World Health Organization (WHO), 84 WHO
   World Health Organization (WHO), LIST CAND VACC DEV S
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430
   Xiong S, 2004, IMMUNOL LETT, V95, P139, DOI 10.1016/j.imlet.2004.06.014
   Xu J, 2006, BIOL REPROD, V74, P410, DOI 10.1095/biolreprod.105.044776
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yam LYC, 2003, RESPIROLOGY, V8, pS31, DOI 10.1046/j.1440-1843.2003.00521.x
   Yang Y, 2020, INFECT CONT HOSP EP, V41, P872, DOI 10.1017/ice.2020.97
   Yang YS, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102434
   Yi XH, 2010, AM J RESP CRIT CARE, V182, P436, DOI 10.1164/ajrccm.182.3.436
   Yu CM, 2006, POSTGRAD MED J, V82, P140, DOI 10.1136/pgmj.2005.037515
   Zainol Rashid Z, 2020, MALAYS J PATHOL, V42, P13
   Zhai Pan, 2020, Int J Antimicrob Agents, V55, P105955, DOI 10.1016/j.ijantimicag.2020.105955
   Zhang, 2020, LAB DIAGNOSIS MONITO
   Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405
   Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022
   Zhao Q, 2020, J EUR ACAD DERMATOL, V34, P2505, DOI 10.1111/jdv.16778
   Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu JY, 2020, J MED VIROL, V92, P1902, DOI 10.1002/jmv.25884
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
   Zubair AS, 2020, JAMA NEUROL, V77, P1018, DOI 10.1001/jamaneurol.2020.2065
NR 169
TC 1
Z9 1
U1 2
U2 3
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JUL
PY 2021
VL 14
IS 7
BP 967
EP 977
DI 10.1016/j.jiph.2021.04.007
EA JUN 2021
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA TE2VJ
UT WOS:000669873300024
PM 34130121
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Asghari, E
   Archibald, M
   Roshangar, F
AF Asghari, Elnaz
   Archibald, Mandy
   Roshangar, Fariborz
TI Nursing interventions for patients with COVID-19: A medical record
   review and nursing interventions classification study
SO INTERNATIONAL JOURNAL OF NURSING KNOWLEDGE
LA English
DT Review
DE Clinical protocols; COVID-19 virus; nurses; standardized nursing
   terminologies
AB Purpose To describe the nursing interventions provided to patients with COVID-19 using the Nursing Interventions Classification.
   Method This is a retrospective study involving the review of 1,344 patient records of adults admitted to a specialty hospital for COVID-19 in Tabriz, Iran. The nursing intervention was used to classify documented nursing care and interventions provided to COVID-19-positive patients from February 20 to August 20, 2020. Data were analyzed descriptively using SPSS16.
   Findings The 10 most frequently documented nursing interventions across in-patient (ward) and intensive care unit (ICU) contexts included Admission Care (7310), Environmental Management (6486), Health Education (5510), Infection Protection (6550), Medication Administration (2300), Positioning (0840), Respiratory Monitoring (3350), Vital Signs Monitoring (6680), Nausea Management (1450), and Diarrhea Management (0460). No records of distraction, relaxation techniques, or massage for anxiety reduction were documented.
   Conclusion This study used a common language to describe nursing interventions for patients with COVID-19 admitted to a tertiary hospital.
   Implications for nursing practice The most commonly identified nursing interventions for COVID-19 identified in this study provide evidence-based insight into nurses' scope of practice in the COVID-19 in-patient context.
C1 [Asghari, Elnaz; Roshangar, Fariborz] Tabriz Univ Med Sci, Fac Nursing & Midwifery, Nursing, Tabriz, Iran.
   [Archibald, Mandy] Univ Manitoba, Coll Nursing, Rady Fac Hlth Sci, Childrens Hosp Res Inst Manitoba CHRIM, Winnipeg, MB R3T 2N2, Canada.
RP Roshangar, F (corresponding author), Tabriz Univ Med Sci, Fac Nursing & Midwifery, Nursing, Tabriz, Iran.
EM froshangar@tbzmed.ac.ir
FU Research Deputy of Tabriz University of Medical Science
   [IR.TBZMED.REC.1398.1317]
FX Research Deputy of Tabriz University of Medical Science, Grant/Award
   Number: IR.TBZMED.REC.1398.1317
CR Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   AllahBakhshian M, 2017, NURS OUTLOOK, V65, P392, DOI 10.1016/j.outlook.2016.12.004
   Fernandez R, 2020, INT J NURS STUD, V111, DOI 10.1016/j.ijnurstu.2020.103637
   Gaede, 2017, INT J AFR NURS SCI, V7, P75, DOI DOI 10.1016/J.IJANS.2017.09.002
   Herron JBT, 2020, BRIT J ORAL MAX SURG, V58, P500, DOI [10.1016/j.bjoms.2020.01.015, 10.1016/j.bjoms.2020.04.015]
   Johny S.A., 2017, INT J NURSING ED, V9, P120
   Khajehgoodari M, 2020, NURS OPEN, V7, P980, DOI 10.1002/nop2.470
   KUNZ R, 2020, SWISS MED WEEKLY, V150, DOI [DOI 10.4414/SMW.2020.20235, 10.4414/smw.2020.20235.eCollection2020Mar23]
   Liu K, 2020, COMPLEMENT THER CLIN, V39, DOI 10.1016/j.ctcp.2020.101132
   Lotfi M, 2020, NURS OPEN, V7, P42, DOI 10.1002/nop2.410
   Lucchini A, 2020, INTENS CRIT CARE NUR, V59, DOI 10.1016/j.iccn.2020.102876
   Moorhead S., 2018, EFFECTIVENESS NURSIN
   Othman EH, 2020, INT J NURS KNOWL, V31, P19, DOI 10.1111/2047-3095.12265
   Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]
   Rivas FJP, 2016, INT J NURS KNOWL, V27, P43, DOI 10.1111/2047-3095.12073
   Pickler RH, 2020, NURS OUTLOOK, V68, P685, DOI 10.1016/j.outlook.2020.08.012
   Possari JF, 2015, REV LAT-AM ENFERM, V23, P781, DOI 10.1590/0104-1169.0419.2615
   Rosa WE, 2020, J NURS SCHOLARSHIP, V52, P341, DOI 10.1111/jnu.12570
   Sekse RJT, 2018, J CLIN NURS, V27, pE21, DOI 10.1111/jocn.13912
   Swanson E, 2020, INT J NURS KNOWL, DOI 10.1111/2047-3095.12307
   Tang JY, 2020, INT WOUND J, V17, P1523, DOI 10.1111/iwj.13399
   Vafaei Seyed Majid, 2018, Open Access Maced J Med Sci, V6, P1527, DOI 10.3889/oamjms.2018.303
   Wagner C.M., 2018, NURSING INTERVENTION
   Wagner C.M., 2019, NURSING INTERVENTION
   WHO, 2021, STAT 2 M INT HLTH RE
   WHO, 2020, IRAN ISLAMIC REPUBLI
NR 26
TC 0
Z9 0
U1 8
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-3087
EI 2047-3095
J9 INT J NURS KNOWL
JI Int. J. Nurs. Knowl.
PD JAN
PY 2022
VL 33
IS 1
BP 57
EP 63
DI 10.1111/2047-3095.12332
EA JUN 2021
PG 7
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA YF4QF
UT WOS:000658015900001
PM 34089240
OA Green Published
DA 2022-04-20
ER

PT J
AU Milojevic, I
AF Milojevic, Ivana
TI COVID-19 and Pandemic Preparedness: Foresight Narratives and Public
   Sector Responses
SO JOURNAL OF FUTURES STUDIES
LA English
DT Article
DE Pandemic; COVID-19; Preparedness; Foresight; Public Sector
ID FUTURE; IMPACT
AB The management of the COVID-19 pandemic is a novel global challenge being addressed in real time. While some countries and regions of the world have had more recent experience managing similar viruses (such as SARS), all have had to deal with the new corona virus and the novel challenges that it presents. Public policy responses are rapidly changing, sometimes daily. This article focuses on how foresight narratives have impacted policymaking as related to the COVID-19 pandemic. More specifically, it provides an overview of the use of foresight within the public sector prior to the pandemic. It also investigates the key narratives in circulation during the implementation of governments' strategic objectives and the realization of visions of a 'pandemic-free' society. The approach used here is that of narrative foresight which predominantly focuses on the stories that individuals, organizations, states and civilizations tell themselves about the future. In addition to the overarching narratives, the article also investigates more specifically the most commonly used metaphors prior to and during the COVID-19 pandemic. The goal of the article is to ascertain which lessons we can learn in terms of successes and failures of narrative foresight in action', so as to be able to utilise this knowledge for future global problems. Finally, the article argues that many current metaphors and narratives are linked to 'futures fallacies' - detrimental thinking patterns about the future. It then concludes by briefly investigating alternative narratives and metaphors which are more likely to facilitate the desired future of adequate pandemic preparedness.
C1 [Milojevic, Ivana] Metafuture & Metafuture Sch, Brisbane, Qld, Australia.
RP Milojevic, I (corresponding author), Metafuture & Metafuture Sch, Brisbane, Qld, Australia.
EM ivana@metafuture.org
FU First Futures Research Grant - Prince Mohammad Bin Fahd Center for
   Futuristic Studies (PMFCFS); World Futures Studies Federation (WFSF)
FX Research reported in this article was supported by the First Futures
   Research Grant, awarded by the Prince Mohammad Bin Fahd Center for
   Futuristic Studies (PMFCFS) and World Futures Studies Federation (WFSF).
   The article was finalised in October 2020. Its content is solely the
   responsibility of the author.
CR AHMPPI, 2014, AUSTR HLTH MAN PLAN
   [Anonymous], 2017, LANCET, V389, P881, DOI 10.1016/S0140-6736(17)30640-2
   Baumgaertner E, 2020, LOS ANGELES TIMES
   BFI, 2017, BRUN FUT DECK BRUN F
   Bin Larif S., 2015, CLA 2 0 TRANSFORMATI
   Black P., 2015, CLA 2 0 TRANSFORMATI
   Board GPM., 2019, WORLD RISK ANN REPOR
   Brownlie J., 2006, FORESIGHT INFECT DIS
   Brundtland GH, 2003, NEW GLOBAL CHALLENGE
   Calof J, 2012, FORESIGHT, V14, P5, DOI 10.1108/14636681211214879
   Cameron E, 2019, GLOBAL HLTH SECURITY
   Cameron H., 2006, EVALUATION UK FORESI
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   CISET, 1994, GLOB MICR THREATS 19
   Coates JF, 2010, TECHNOL FORECAST SOC, V77, P1428, DOI 10.1016/j.techfore.2010.07.009
   Cohn SK, 2012, HIST RES, V85, P535, DOI 10.1111/j.1468-2281.2012.00603.x
   Conway M., 2004, CREATING SUSTAINING
   Cook CN, 2014, TRENDS ECOL EVOL, V29, P531, DOI 10.1016/j.tree.2014.07.005
   Cuhls K, 2004, RES EVALUAT, V13, P143, DOI 10.3152/147154404781776437
   Da Costa O, 2008, TECHNOL ANAL STRATEG, V20, P369, DOI 10.1080/09537320802000146
   Dalglish SL, 2020, LANCET, V395, P1189, DOI 10.1016/S0140-6736(20)30739-X
   Dator J., 2011, LEADERSHIP SCI TECHN
   Dator J, 2007, J FUTURES STUD, V11, P1
   Davies K., 2020, GEN GENETIC ENG BIOT
   Department of Health and Ageing, 2003, RET INV PUBL HLTH EP
   Dorr A, 2017, TECHNOL FORECAST SOC, V116, P322, DOI 10.1016/j.techfore.2016.06.018
   Dreyer I., 2013, EUISS YB EUROPEAN SE
   ECDC, 2015, PREP PLANN RESP VIR
   ForesightNZ, 2016, FORESIGHTNZ PLAYING
   Garrett L., 1996, MICROBES VS MANKIND
   GHSI, 2020, GLOBAL HLTH SECURITY
   Gilbert D., 2007, STUMBLING HAPPINESS
   GILMAN SL, 1987, OCTOBER, P87
   Greenblott Joseph M, 2018, World Futures Rev, V25, P1, DOI 10.1177/1946756718814908
   Grey S., 2020, REUTERS 0408
   Guterres A., 2020, UN COVID 19 COUNTERS
   Hart L, 2017, LANCET, V389, P888, DOI 10.1016/S0140-6736(17)30599-8
   Havas A, 2010, RES EVALUAT, V19, P91, DOI 10.3152/095820210X510133
   Henig, 2020, NATL GEOGR
   Horton R., 2020, GUARDIAN
   Horton R, 2020, LANCET, V396, P874, DOI 10.1016/S0140-6736(20)32000-6
   HSC, 2005, NAT STRAT PAND INFL
   Ibrahim H, 2020, CONTEMP CLIN TRIALS, V96, DOI 10.1016/j.cct.2020.106106
   Inayatullah S, 2018, J FUTURES STUD, V22, P15, DOI 10.6531/JFS.201806.22(4).0002
   Jennings L, 2017, FORESIGHT PUBLIC SEC
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kahneman D., 2011, THINKING
   Kinsman J, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3326-0
   Krause R. M., 1993, EMERGING VIRUSES 17
   Kuosa T, 2012, EVOLUTION OF STRATEGIC FORESIGHT: NAVIGATING PUBLIC POLICY MAKING
   Lederberg Joshua, 1993, P3
   Merrill S, 2009, INTRO SYNDEMICS CRIT
   Milojevic I, MIRROR MIRROR WALL W
   Milojevic I., IN PRESS
   Milojevic I., J FUTURES STUDIES PE
   Milojevic I, 2015, FUTURES, V73, P151, DOI 10.1016/j.futures.2015.08.007
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Morse Stephen S., 1993, P10
   Mosk M., 2020, IN PRESS
   Murphy FA, 1998, EMERG INFECT DIS, V4, P429, DOI 10.3201/eid0403.980324
   Next Strain, 2020, REAL TIME TRACKING P
   *NIC, 2000, GLOB INF DIS THREAT
   Ortu G, 2008, HEALTH POLICY PLANN, V23, P161, DOI 10.1093/heapol/czn004
   Ross AGP, 2015, INT J INFECT DIS, V38, P89, DOI 10.1016/j.ijid.2015.07.016
   Rubin H., 2011, FUTURE GLOBAL SHOCKS
   Savio ND, 2009, FORESIGHT, V11, P86, DOI 10.1108/14636680911004984
   Schartinger D, 2012, FORESIGHT, V14, P41, DOI 10.1108/14636681211210350
   Shapiro R., 2008, SUCKERS ALTERNATIVE
   Silver N., 2012, SIGNAL NOISE WHY MOS
   Solem KE, 2011, FORESIGHT, V13, P18, DOI 10.1108/14636681111126229
   Terranova D., 2015, CLA 2 0 TRANSFORMATI
   The Takshashila Future Deck, 2014, FUT DECK
   The World Bank, 2014, WORLD BANK GROUP PRE
   The World Bank, 2018, MAK PAND PREP FIN SU
   UNDP, 2014, FORES MAN
   UNEP, 2016, UNEP FRONT 2016 REP
   United Nations, 2016, PROT HUM FUT HLTH CR PROT HUM FUT HLTH CR
   Van Asselt M.B.A., 2010, FORESIGHT ACTION DEV
   Webster Robert G., 1997, Journal of Infectious Diseases, V176, pS14, DOI 10.1086/514168
   WHO, 2015, ANT EM INF DIS EP
   WHO, EM PREP RESP DIS OUT
   WHO, 2018, MEM UND UN FOOD AGR
   WHO, COVID 19 PAND NUMB G
   WHO, 1999, INFL PAND PLAN ROL W
   Who, 2009, WHOL OF SOC PAND REA
   WHO (World Health Organization), 2019, WHO LAUNCH NEW GLOB
   Wilson M., 1994, DIS EVOLUTION
   World Bank, 2017, PAN NEGL INV HLTH SE
   World Economic Forum. (WEF), 2020, GLOBAL RISKS
   Yamey G, 2017, LANCET GLOB HEALTH, V5, pE742, DOI 10.1016/S2214-109X(17)30203-6
NR 90
TC 0
Z9 0
U1 2
U2 2
PU TAMKANG UNIV
PI TAMSUI
PA GRAD SCHOOL LANG LIT, TAMSUI, TAIPEI, TAIWAN
SN 1027-6084
J9 J FUTURES STUD
JI J. Futures Stud.
PD SEP
PY 2021
VL 26
IS 1
BP 1
EP 17
DI 10.6531/JFS.202109_26(1).0001
PG 17
WC Regional & Urban Planning
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA WC5FV
UT WOS:000704283400001
DA 2022-04-20
ER

PT J
AU Kho, ME
   Rewa, OG
   Boyd, JG
   Choong, K
   Stewart, GCH
   Herridge, MS
AF Kho, Michelle E.
   Rewa, Oleksa G.
   Boyd, J. Gordon
   Choong, Karen
   Stewart, Graeme C. H.
   Herridge, Margaret S.
TI Outcomes of critically ill COVID-19 survivors and caregivers: a case
   study-centred narrative review
SO CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE
LA English
DT Review; Early Access
DE mechanical ventilation; acute respiratory distress syndrome; outcome;
   COVID-19; post-intensive care syndrome
ID INTENSIVE-CARE-UNIT; RESPIRATORY-DISTRESS-SYNDROME; TERM COGNITIVE
   IMPAIRMENT; CRITICAL ILLNESS; FUNCTIONAL DISABILITY; RISK-FACTORS;
   REHABILITATION; DELIRIUM; ICU; INTERVENTIONS
AB Purpose Critical illness is a transformative experience for both patients and their family members. For COVID-19 patients admitted to the intensive care unit (ICU), survival may be the start of a long road to recovery. Our knowledge of the post-ICU long-term sequelae of acute respiratory distress syndrome (ARDS) and severe acute respiratory syndrome (SARS) may inform our understanding and management of the long-term effects of COVID-19. Source We identified international and Canadian epidemiologic data on ICU admissions for COVID-19, COVID-19 pathophysiology, emerging ICU practice patterns, early reports of long-term outcomes, and federal support programs for survivors and their families. Centred around an illustrating case study, we applied relevant literature from ARDS and SARS to contextualize knowledge within emerging COVID-19 research and extrapolate findings to future long-term outcomes. Principal findings COVID-19 is a multisystem disease with unknown long-term morbidity and mortality. Its pathophysiology is distinct and unique from ARDS, SARS, and critical illness. Nevertheless, based on initial reports of critical care management for COVID-19 and the varied injurious supportive practices employed in the ICU, patients and families are at risk for post-intensive care syndrome. The distinct incremental risk of COVID-19 multiple organ dysfunction is unknown. The risk of mood disorders in family members may be further exacerbated by imposed isolation and stigma. Conclusion Emerging literature on COVID-19 outcomes suggests some similarities with those of ARDS/SARS and prolonged mechanical ventilation. The pathophysiology of COVID-19 is presented here in the context of early outcome data and to inform an agenda for longitudinal research for patients and families.
C1 [Kho, Michelle E.] McMaster Univ, Fac Hlth Sci, Sch Rehabil Sci, Hamilton, ON, Canada.
   [Kho, Michelle E.] McMaster Univ, Sch Rehabil Sci, Inst Appl Hlth Sci, Room 403,1400 Main St West, Hamilton, ON L8S 1C7, Canada.
   [Rewa, Oleksa G.] Univ Alberta, Fac Med & Dent, Dept Crit Care Med, Edmonton, AB, Canada.
   [Boyd, J. Gordon] Queens Univ, Fac Hlth Sci, Ctr Neurosci Studies, Kingston Hlth Sci Ctr, Kingston, ON, Canada.
   [Boyd, J. Gordon] Queens Univ, Fac Hlth Sci, Dept Crit Care, Kingston, ON, Canada.
   [Choong, Karen] McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
   [Choong, Karen] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.
   [Stewart, Graeme C. H.] Carleton Univ, Fac Publ Affairs, Ottawa, ON, Canada.
   [Herridge, Margaret S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada.
   [Herridge, Margaret S.] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada.
RP Kho, ME (corresponding author), McMaster Univ, Fac Hlth Sci, Sch Rehabil Sci, Hamilton, ON, Canada.
EM khome@mcmaster.ca
RI Choong, Karen/ABB-7867-2021
OI Choong, Karen/0000-0002-4608-4508; Kho, Michelle/0000-0003-3170-031X;
   Herridge, Margaret/0000-0002-2903-1631
FU Canada Research ChairNatural Resources CanadaCanadian Forest
   ServiceCanada Research Chairs; CIHR grantsCanadian Institutes of Health
   Research (CIHR)
FX Michelle Kho is funded by a Canada Research Chair. Michelle Kho, J
   Gordon Boyd, and Margaret Herridge hold CIHR grants related to the
   submitted work.
CR Aoyama H, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8116
   Armstrong RA, 2021, ANAESTHESIA, V76, P537, DOI 10.1111/anae.15425
   Armstrong RA, 2020, ANAESTHESIA, V75, P1340, DOI 10.1111/anae.15201
   Brummel NE, 2020, CRIT CARE MED, V48, P1419, DOI 10.1097/CCM.0000000000004444
   Brummel NE, 2014, CRIT CARE MED, V42, P369, DOI 10.1097/CCM.0b013e3182a645bd
   Cameron JI, 2016, NEW ENGL J MED, V374, P1831, DOI 10.1056/NEJMoa1511160
   Cavayas YA, 2021, CAN J ANESTH, V68, P204, DOI 10.1007/s12630-020-01816-z
   Centre for Addiction and Mental Health, 2020, COVID 19 PAND ADV AF
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC
   Chopra V, 2021, ANN INTERN MED, V174, P576, DOI 10.7326/M20-5661
   Clavet H, 2008, CAN MED ASSOC J, V178, P691, DOI 10.1503/cmaj.071056
   Courcelle R, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03164-2
   Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006
   Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd
   Davydow DS, 2009, INTENS CARE MED, V35, P796, DOI 10.1007/s00134-009-1396-5
   De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859
   Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI 10.1097/CCM.0000000000003259
   DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U
   dos Santos C, 2016, AM J RESP CRIT CARE, V194, P821, DOI 10.1164/rccm.201512-2344OC
   Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8
   Gardner PJ, 2015, CAN PSYCHOL, V56, P123, DOI 10.1037/a0037973
   Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043
   Girard TD, 2008, CRIT CARE, V12, DOI 10.1186/cc6149
   Goldberg TE, 2020, JAMA NEUROL, V77, P1373, DOI 10.1001/jamaneurol.2020.2273
   Goldfarb MJ, 2017, CRIT CARE MED, V45, P1751, DOI 10.1097/CCM.0000000000002624
   Government of Canada, CONS FED LAWS CAN QU
   Government of Canada; Department of Finance Canada, CAN COVID 19 EC RESP
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Helms J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03200-1
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Herridge MS, 2016, AM J RESP CRIT CARE, V194, P831, DOI 10.1164/rccm.201512-2343OC
   Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8
   Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802
   Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450
   Hill AD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1248-y
   Hodgson CL, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0658-y
   Hopkins RO, 2012, AM J RESP CRIT CARE, V186, P1220, DOI 10.1164/rccm.201206-1022CP
   Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
   Huang LX, 2021, LANCET, V398, P747, DOI 10.1016/S0140-6736(21)01755-4
   Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553
   Kamdar BB, 2020, THORAX, V75, P17, DOI 10.1136/thoraxjnl-2019-213803
   KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111
   Koo Karen K Y, 2016, CMAJ Open, V4, pE448
   Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390
   Labeau SO, 2021, INTENS CARE MED, V47, P160, DOI 10.1007/s00134-020-06234-9
   Lad H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21217840
   Latronico N, 1996, LANCET, V347, P1579, DOI 10.1016/S0140-6736(96)91074-0
   Lim ZJ, 2020, PRONE POSITIONING NO, DOI [10.1101/2020.10.12.20211748, DOI 10.1101/2020.10.12.20211748, 10.12.20211748]
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   McWilliams D, 2021, ANN AM THORAC SOC, V18, P122, DOI 10.1513/AnnalsATS.202005-560OC
   Mehta S, 2012, JAMA-J AM MED ASSOC, V308, P1985, DOI 10.1001/jama.2012.13872
   Miller C, 2021, PHYS THER, V101, DOI 10.1093/ptj/pzaa191
   Mitra AR, 2020, CAN MED ASSOC J, V192, pE694, DOI 10.1503/cmaj.200794
   Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022
   Munshi L, 2021, CAN MED ASSOC J, V193, pE135, DOI 10.1503/cmaj.202636
   Munshi L, 2017, ANN AM THORAC SOC, V14, pS280, DOI 10.1513/AnnalsATS.201704-343OT
   Murthy Srinivas, 2021, CMAJ Open, V9, pE181, DOI 10.9778/cmajo.20200250
   Nauen DW, 2021, JAMA NEUROL, V78, P760, DOI 10.1001/jamaneurol.2021.0225
   Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75
   Nydahl P, 2017, ANN AM THORAC SOC, V14, P766, DOI 10.1513/AnnalsATS.201611-843SR
   Osbeck Sandblom H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252347
   Osuchowski MF, 2021, LANCET RESP MED, V9, P622, DOI 10.1016/S2213-2600(21)00218-6
   Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7
   Pandharipande PP, 2014, NEW ENGL J MED, V370, P185, DOI 10.1056/NEJMc1313886
   Pansarasa O, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100935
   Patel Urvish, 2020, SN Compr Clin Med, V2, P1740, DOI 10.1007/s42399-020-00476-w
   Peritogiannis V, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/416792
   Pun BT, 2021, LANCET RESP MED, V9, P239, DOI 10.1016/S2213-2600(20)30552-X
   Rees EM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01726-3
   Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.7681, 10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775]
   Rochwerg B, 2018, CRIT CARE MED, V46, P1411, DOI 10.1097/CCM.0000000000003262
   Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0
   Rousseau AF, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03535-3
   Sakusic A, 2018, MAYO CLIN PROC, V93, P68, DOI 10.1016/j.mayocp.2017.11.005
   Stevens Robert D, 2009, Crit Care Med, V37, pS299, DOI 10.1097/CCM.0b013e3181b6ef67
   Stilma W, 2021, J CLIN MED, V10, DOI 10.3390/jcm10204783
   Takaoka A, 2020, ANN AM THORAC SOC, V17, P1289, DOI 10.1513/AnnalsATS.202001-059OC
   Tansey CM, 2007, ARCH INTERN MED, V167, P1312, DOI 10.1001/archinte.167.12.1312
   Tarazan N, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00348-6
   Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007
   Valley TS, 2020, AM J RESP CRIT CARE, V202, P883, DOI 10.1164/rccm.202005-1706LE
   Venus K, 2020, CAN MED ASSOC J, V192, pE1532, DOI 10.1503/cmaj.201201
   Verma AA, 2021, CAN MED ASSOC J, V193, pE410, DOI 10.1503/cmaj.202795
   Waldauf P, 2020, CRIT CARE MED, V48, P1055, DOI 10.1097/CCM.0000000000004382
   Yang T, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2111-0
   Yang T, 2018, ACTA NEUROL SCAND, V138, P104, DOI 10.1111/ane.12964
   Zaal IJ, 2015, CRIT CARE MED, V43, P40, DOI 10.1097/CCM.0000000000000625
   Zanni JM, 2010, J CRIT CARE, V25, P254, DOI 10.1016/j.jcrc.2009.10.010
   Zubair AS, 2020, JAMA NEUROL, V77, P1018, DOI 10.1001/jamaneurol.2020.2065
NR 92
TC 0
Z9 0
U1 7
U2 7
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0832-610X
EI 1496-8975
J9 CAN J ANESTH
JI Can. J. Anesth.
DI 10.1007/s12630-022-02194-4
EA JAN 2022
PG 14
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA YR9GZ
UT WOS:000750298100001
PM 35102495
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Liu, YY
   Li, PF
   Lv, YL
   Hou, XR
   Rao, QM
   Tan, JT
   Gong, J
   Tan, C
   Liao, LF
   Cui, WL
AF Liu, Yunyu
   Li, Pengfei
   Lv, Yalan
   Hou, Xiaorong
   Rao, Qingmao
   Tan, Juntao
   Gong, Jun
   Tan, Chao
   Liao, Lifan
   Cui, Weilu
TI Public awareness and anxiety during COVID-19 epidemic in China: A
   cross-sectional study
SO COMPREHENSIVE PSYCHIATRY
LA English
DT Article
DE COVID-19; Outbreak; Public; Awareness; Anxiety
ID SARS OUTBREAK; BEHAVIOR; IMPACT; CORONAVIRUS
AB Objective: The study aims to investigate public awareness of coronavirus disease 2019 (COVID-19) and measure levels of anxiety during the outbreak.
   Method: A total of 2115 subjects from 34 provinces in China were evaluated. A questionnaire was designed, which covers demographic characteristics, knowledge of COVID-19, and factors that influenced anxiety during the outbreak to test public awareness and determine the impact of the outbreak on people's lives. In addition, a generalized anxiety disorder (GAD) scale was utilized to assess anxiety levels during the outbreak. Lastly, the chi-square test and multiple logistic regression analysis were used to identify factors associated with levels of public anxiety.
   Results: A majority of respondents reported high levels of awareness of COVID-19. A total of 1107 (52.3%), 707 (33.4%), 154 (7.3%), and 147 (7%) respondents exhibited no, mild, moderate, and severe levels of anxiety, respectively. Results of the chi-square test and multiple logistic regression analysis demonstrated that respondents (a) with no college education, (b) are unaware of neighbors who may have been infected, (c) who spent considerable time collecting information and browsing negative information related to the virus, (d) are unhealthy, and (e) displayed low levels of awareness of the transmission routes were highly likely to be anxious.
   Conclusion: During the outbreak, the majority of people exhibited high levels of awareness and knowledge regarding preventive measures from COVID-19. The absence of psychological anxiety was observed in more than half of the respondents. Adaptive responses to anxiety and high levels of awareness about COVID-19 may have protected the public during the outbreak. (C) 2021 The Author(s). Published by Elsevier Inc.
C1 [Liu, Yunyu; Li, Pengfei; Lv, Yalan; Hou, Xiaorong; Rao, Qingmao; Tan, Juntao; Gong, Jun; Tan, Chao] ChongQing Med Univ, Inst Med Informat, 1 Yixueyuanlu, Chongqing 400016, Peoples R China.
   [Liao, Lifan] Guangxi Med Univ, Inst Informat & Management, Nanning, Peoples R China.
   [Cui, Weilu] Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China.
RP Li, PF (corresponding author), ChongQing Med Univ, Inst Med Informat, 1 Yixueyuanlu, Chongqing 400016, Peoples R China.
EM 1043742861@qq.com
CR [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0
   Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103577
   Bilevicius E, 2020, CAN J PSYCHIAT, V65, P418, DOI 10.1177/0706743719895340
   Biscayart C, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2020.101567
   Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049
   Chinese Center for Disease Control and Prevention, 2020, DISTRIBUTION NEW COR
   Choi JS, 2016, NURS EDUC TODAY, V40, P168, DOI 10.1016/j.nedt.2016.03.006
   Hao FY, 2020, BRAIN BEHAV IMMUN, V87, P100, DOI 10.1016/j.bbi.2020.04.069
   Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kendall C, 2008, AIDS BEHAV, V12, pS97, DOI 10.1007/s10461-008-9390-4
   Le HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124377
   Lun KWC, 2018, HONG KONG MED J, V24, P466, DOI 10.12809/hkmj176915
   Maunder R, 2003, CAN MED ASSOC J, V168, P1245
   Ministry of Industry and Information Technology, 2020, STAT B COMMUNICATION, DOI 1146312/n1146904/n1648372/c7696411/content.html
   Seng SL, 2004, ANN ACAD MED SINGAP, V33, P623
   She J, 2020, CLIN TRANSL MED, V9, DOI 10.1186/s40169-020-00271-z
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Tam CWC, 2004, PSYCHOL MED, V34, P1197, DOI 10.1017/S0033291704002247
   Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083
   Tan WQ, 2020, BRAIN BEHAV IMMUN, V87, P84, DOI 10.1016/j.bbi.2020.04.055
   van Wijngaarden B, 2000, BRIT J PSYCHIAT, V177, pS21, DOI 10.1192/bjp.177.39.s21
   Vijaya K, 2005, INT J HEALTH PROMOT, V43, P17, DOI 10.1080/14635240.2005.10708030
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wang H, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2128-1
   World Health Organization, 2020, WHO COR DIS COVID 19
   Wuhan China, 2020, NEW ENGL J MED, P1, DOI [10.1056/nejmoa2001316, DOI 10.1056/NEJMOA2001316]
   Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y
   Yuan H, 2020, BASIC CLIN PHARMACOL, V126, P498, DOI 10.1111/bcpt.13412
   Yunus A, 2013, Malays Fam Physician, V8, P5
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
NR 33
TC 4
Z9 4
U1 8
U2 10
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0010-440X
EI 1532-8384
J9 COMPR PSYCHIAT
JI Compr. Psychiat.
PD MAY
PY 2021
VL 107
AR 152235
DI 10.1016/j.comppsych.2021.152235
EA MAR 2021
PG 7
WC Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry
GA RP2SE
UT WOS:000641583000003
PM 33765493
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Jaju, S
   Rawat, S
   Raipurkar, AR
AF Jaju, Sanay
   Rawat, Sunita
   Raipurkar, Abhijeet R.
TI Role of Ethics in Information Technology During COVID-19 Pandemic: A
   Review
SO BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS
LA English
DT Review
DE ETHICS; INFORMATION TECHNOLOGY; CHALLENGES POSED BY COVID-19
AB Ethical principle consists of ethics. Ethics plays an important role and have impact on individual and their lives. Whistle blowing is an important situation which has direct impact on ethics in IT. The problem raises moral queries and has social and economic implications. Organizations implement codes of ethics within their policies that highlight the moral responsibilities of users in the use of knowledge technology. Company's name can be shielded and increase worker engagement by making a work wherever moral conduct is that the norm. COVID-19 has incontestable the impotency of current technologies. The COVID-19 pandemic has raised a bunch of moral challenges; however key among these has been the chance that health care systems may have to be compelled to ration scarce essential care resources. World Health Organization (WHO) has established a global unit on Ethics and COVID-19 so as to develop recommendation on key moral queries that Member States have to be compelled to address.
C1 [Jaju, Sanay; Raipurkar, Abhijeet R.] Shri Ramdeobaba Coll Engn & Management, Dept Comp Sci & Engn, Nagpur, Maharashtra, India.
   [Rawat, Sunita] GH Raisoni Coll Engn, Nagpur, Maharashtra, India.
RP Jaju, S (corresponding author), Shri Ramdeobaba Coll Engn & Management, Dept Comp Sci & Engn, Nagpur, Maharashtra, India.
EM jajuss@rknec.edu
RI rawat, sunita/AAB-8316-2021; Raipurkar, Abhijeet/AAW-1561-2021;
   Raipurkar, Abhijeet Ramesh/AAC-2485-2021
OI rawat, sunita/0000-0001-6927-6070; 
CR Abusaada H., 2020, INT J COMMUNITY WELL, V3, P417
   Dubov A, 2020, AM J BIOETHICS, V20, pW7, DOI 10.1080/15265161.2020.1764136
   Elgesem D., 2008, CAMBRIDGE STUDIES PH, P354
   Ienca M, 2020, NAT MED, V26, P463, DOI 10.1038/s41591-020-0832-5
   Martin R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-532
   McGuire AL, 2020, AM J BIOETHICS, V20, P15, DOI 10.1080/15265161.2020.1764138
   Van Kolfschooten H, 2019, EUR J RISK REGUL, V10, P635, DOI 10.1017/err.2019.70
   Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151
   Yan SJ, 2017, INT J INFECT DIS, V63, P77, DOI 10.1016/j.ijid.2017.07.020
NR 9
TC 0
Z9 0
U1 4
U2 4
PU SOC SCIENCE & NATURE
PI BHOPAL
PA C-52 HOUSING BOARD COLONY, KOHE FIZA, BHOPAL, MADHYA PRADESH 462 001,
   INDIA
SN 0974-6455
J9 BIOSCI BIOTECH RES C
JI Biosci. Biotechnol. Res. Commun.
PY 2020
VL 13
IS 14
SI SI
BP 217
EP 220
DI 10.21786/bbrc/13.14/51
PG 4
WC Biotechnology & Applied Microbiology
WE Emerging Sources Citation Index (ESCI)
SC Biotechnology & Applied Microbiology
GA RN0YF
UT WOS:000640081000051
OA Bronze
DA 2022-04-20
ER

PT J
AU Kumar, R
AF Kumar, Rajiv
TI Impact of Societal Culture on Covid-19 Morbidity and Mortality across
   Countries
SO JOURNAL OF CROSS-CULTURAL PSYCHOLOGY
LA English
DT Article
DE Covid-19; culture; GLOBE; power distance; collectivism; institutional
   collectivism; performance orientation
ID CORPORATE SOCIAL-RESPONSIBILITY; INDIVIDUALISM-COLLECTIVISM; NATIONAL
   CULTURE; GLOBE; HOFSTEDE; PREVALENCE; HEALTH; PREDICTORS; CONFORMITY;
   BEHAVIORS
AB Researchers have begun exploring the impact of societal culture on Covid-19 outcomes (morbidity and mortality). However, emerging findings need integration with prior literature on societal culture and infectious diseases. Moreover, accumulation of knowledge warrants an update while overcoming certain limitations of samples as well as construct validity concerns. Accordingly, hypotheses are derived based on extant evidence proposing the impact of certain cultural practices on Covid-19 outcomes across countries. These hypotheses are tested using the cultural practice scores from GLOBE studies after controlling for certain covariates identified in literature. Multiple regression results reveal that societal culture significantly explains Covid-19 outcomes beyond the explanation due to control variables. Specifically, power distance and institutional collectivism show negative association with both Covid-19 morbidity and mortality. Additionally, performance orientation shows negative association with Covid-19 morbidity. It appears that power distance may ensure conformity to prescribed behaviors and features of performance orientation may facilitate swift and effective containment of Covid-19 cases. The significance of institutional collectivism-but not in-group collectivism-emerging as the form of collectivism showing negative association with Covid-19 outcomes is also discussed.
C1 [Kumar, Rajiv] Indian Inst Management Calcutta, Kolkata, W Bengal, India.
RP Kumar, R (corresponding author), IIM Calcutta, Org Behav Grp, K-405,New Acad Block,Diamond Harbor Rd, Kolkata 700104, W Bengal, India.
EM rajiv@iimcal.ac.in
OI KUMAR, RAJIV/0000-0003-2366-2747
CR Applegate WB, 2020, J AM GERIATR SOC, V68, P681, DOI 10.1111/jgs.16426
   Ashkanasy N.M., 2004, CULTURE LEADERSHIP O, P282
   Bank W., 2021, DATA
   Bazzi S, 2021, J PUBLIC ECON, V195, DOI 10.1016/j.jpubeco.2020.104357
   Betsch C, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0056
   Bond R, 1996, PSYCHOL BULL, V119, P111, DOI 10.1037/0033-2909.119.1.111
   Borg MA, 2012, J HOSP INFECT, V81, P251, DOI 10.1016/j.jhin.2012.05.001
   Brewer P, 2011, J INT BUS STUD, V42, P436, DOI 10.1057/jibs.2010.62
   Cao C, 2020, INT J SOCIOL SOC POL, V40, P939, DOI 10.1108/IJSSP-07-2020-0334
   Cho HC, 2015, ASIAN J SOC PSYCHOL, V18, P311, DOI 10.1111/ajsp.12104
   Christensen T, 2020, PUBLIC ADMIN REV, V80, P774, DOI 10.1111/puar.13241
   Den Hartog D.N., 2004, CULTURE LEADERSHIP O, P395
   Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P1279, DOI 10.1098/rspb.2008.0094
   Fincher CL, 2012, BEHAV BRAIN SCI, V35, P61, DOI 10.1017/S0140525X11000021
   Fischer R, 2009, J CROSS CULT PSYCHOL, V40, P187, DOI 10.1177/0022022109332738
   Gaye B, 2020, EUR HEART J, V41, P3500, DOI 10.1093/eurheartj/ehaa282
   Gelfand MJ, 2021, LANCET PLANET HEALTH, V5, pe135, DOI 10.1016/S2542-5196(20)30301-6
   Gelfand MJ., 2004, CULTURE LEADERSHIP O, P437
   Gokmen Y, 2021, INT J INTERCULT REL, V81, P1, DOI 10.1016/j.ijintrel.2020.12.006
   Hair J., 1998, MULTIVARIATE DATA AN
   Hale T., 2020, VARIATION GEV RESPON, V31
   Hennekam S, 2020, J APPL PSYCHOL, V105, P1088, DOI 10.1037/apl0000832
   Hofstede G.H., 2010, CULTURES ORG SOFTWAR
   Hofstede G.H., 2001, CULTURES ORG SOFTWAR
   Hofstede G, 2006, J INT BUS STUD, V37, P882, DOI 10.1057/palgrave.jibs.8400233
   Hofstede G, 2010, J INT BUS STUD, V41, P1339, DOI 10.1057/jibs.2010.31
   House R.J., 2004, CULTURE LEADERSHIP
   Huang F, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09674-6
   Hussein NH, 2022, INT J SOCIOL SOC POL, V42, P276, DOI 10.1108/IJSSP-07-2020-0297
   Ibanez A, 2022, GEOJOURNAL, V87, P1175, DOI 10.1007/s10708-020-10306-0
   Inglehart R., 2005, MODERNIZATION
   Javidan M., 2004, CULTURE LEADERSHIP O, P602
   Javidan M, 2006, J INT BUS STUD, V37, P897, DOI 10.1057/palgrave.jibs.8400234
   Ji LJ, 2004, ASIAN J SOC PSYCHOL, V7, P25, DOI 10.1111/j.1467-839X.2004.00132.x
   Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5
   Liang LL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68862-x
   Maaravi Y, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.627559
   Mackenbach JP, 2014, HEALTH PLACE, V28, P116, DOI 10.1016/j.healthplace.2014.04.004
   MARMOT MG, 1976, AM J EPIDEMIOL, V104, P225, DOI 10.1093/oxfordjournals.aje.a112296
   Marziali ME, 2021, INT J INFECT DIS, V104, P370, DOI 10.1016/j.ijid.2020.12.083
   Matsumoto D., 1996, J GENDER CULTURE HLT, V1, P71
   Mayer JD, 2020, WORLD MED HEALTH POL, V12, P498, DOI 10.1002/wmh3.377
   McCrae RR, 2008, J CROSS CULT PSYCHOL, V39, P805, DOI 10.1177/0022022108323806
   Minkov M, 2021, CROSS CULT STRATEG M, V28, P384, DOI 10.1108/CCSM-05-2020-0120
   Morand S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22014-4
   Mueller K, 2012, J APPL PSYCHOL, V97, P1186, DOI 10.1037/a0030204
   Murray DR, 2011, PERS SOC PSYCHOL B, V37, P318, DOI 10.1177/0146167210394451
   Murray DR, 2010, J CROSS CULT PSYCHOL, V41, P99, DOI 10.1177/0022022109349510
   Ng Jing-Han, 2021, Psychol Med, P1, DOI 10.1017/S0033291721001823
   Oishi S, 2017, J CROSS CULT PSYCHOL, V48, P1263, DOI 10.1177/0022022117719496
   Parboteeah KP, 2005, INT J CROSS CULT MAN, V5, P123, DOI 10.1177/1470595805054489
   Realo A, 2008, J CROSS CULT PSYCHOL, V39, P447, DOI 10.1177/0022022108318096
   Romano A, 2021, J CROSS CULT PSYCHOL, V52, P622, DOI 10.1177/0022022120988913
   Salami AT, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13501
   Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596
   Smith PB, 2006, J INT BUS STUD, V37, P915, DOI 10.1057/palgrave.jibs.8400235
   Taras V, 2010, J INT BUS STUD, V41, P1330, DOI 10.1057/jibs.2010.30
   Thielsch MT, 2021, APPL PSYCHOL-INT REV, V70, P150, DOI 10.1111/apps.12303
   Thornhill R., 2014, PARASITE STRESS THEO
   Huynh TLD, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104872
   TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323
   Trougakos JP, 2020, J APPL PSYCHOL, V105, P1234, DOI 10.1037/apl0000739
   Upadhyaya A, 2022, J HEALTH RES, V36, P166, DOI 10.1108/JHR-09-2020-0448
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Venaik S, 2013, CROSS CULT MANAG, V20, P361, DOI 10.1108/CCM-02-2012-0014
   Venaik S, 2010, J INT BUS STUD, V41, P1294, DOI 10.1057/jibs.2009.96
   Waldman DA, 2006, J INT BUS STUD, V37, P823, DOI 10.1057/palgrave.jibs.8400230
   Wanberg CR, 2020, J APPL PSYCHOL, V105, P1382, DOI 10.1037/apl0000831
   Webster GD, 2021, PERS INDIV DIFFER, V178, DOI 10.1016/j.paid.2021.110853
   Yan B, 2020, AM REV PUBLIC ADM, V50, P762, DOI 10.1177/0275074020942445
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu N, 2021, J CROSS CULT PSYCHOL, V52, P606, DOI 10.1177/0022022121995971
NR 72
TC 2
Z9 2
U1 13
U2 21
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0221
EI 1552-5422
J9 J CROSS CULT PSYCHOL
JI J. Cross-Cult. Psychol.
PD AUG
PY 2021
VL 52
IS 7
BP 643
EP 662
AR 00220221211025100
DI 10.1177/00220221211025100
EA JUN 2021
PG 20
WC Psychology, Social
WE Social Science Citation Index (SSCI)
SC Psychology
GA UF4EO
UT WOS:000665240000001
DA 2022-04-20
ER

PT J
AU Marin-Garcia, JA
   Garcia-Sabater, JP
   Ruiz, A
   Maheut, J
   Garcia-Sabater, JJ
AF Marin-Garcia, Juan A.
   Garcia-Sabater, Jose P.
   Ruiz, Angel
   Maheut, Julien
   Garcia-Sabater, Julio J.
TI Operations Management at the Service of Health Care Management: Example
   of a Proposal for Action Research to Plan and Schedule Health Resources
   in Scenarios Derived from the COVID-19 Outbreak
SO JOURNAL OF INDUSTRIAL ENGINEERING AND MANAGEMENT-JIEM
LA English
DT Article
DE Action research; COVID-19; discrete event simulation; theory of
   constraints; operations management; healthcare
ID LOGISTICS RESPONSE; CHAIN; SIMULATION; SYSTEMS; JIT; TOC; MRP
AB Purpose: With this work, we intend to promote research on the application of Operations Management tools in order to assist with decision-making in health crisis situations. During the first six weeks of the COVID-19 crisis in Spain, we have contacted a large number of hospital and health department managers in the Valencian Community and other regions of Spain. The result is that very few, at least when contact was made and at the time of writing this article, had consulted staff members in the Operations Management area for advice on this situation, and they are quite reluctant to do so. This is in spite of the fact that some medical sources also consider this crisis to be one of resources, not merely a medical crisis. Our opinion is that Operations Management can make a useful and valuable contribution to anticipate and improve the management of scarce resources, even in times of crisis. If those responsible for public health or heads of hospitals do not see this usefulness, then there is a huge gap between research and practice in Operations Management and what is transmitted to the healthcare sector. Our aim is to help reduce this gap.
   Design/methodology/approach: In the first part of the article, we will justify that this crisis, besides being a medical crisis, is also a crisis in terms of resources. We will briefly review some of the Operations Management tools that we believe are appropriate for managing this crisis. We will focus on those that we will illustrate in the second part of the article as a practical example of the action research protocol (only the action planning phase), in which we are currently involved.
   Findings: Due to the peculiarities of the COVID-19 epidemic, it is reasonable to think that the evolution and duration of each outbreak, and the way it is dealt with, will be different in each hospital and/or each health department. Anticipating the number of patients who will require care and forecasting the consumption of resources over time is complex, due to the long and variable incubation times and the uncontrolled evolution of the treatments needed by each patient. Furthermore, since the evolution of new patient admissions is not homogeneous, the forecasting of requirements is difficult. Providing real-time support and detecting with a certain degree of anticipation the potential levels of demand for health care will enable hospitals to define what stages of the contingency plan to apply and how to (re)assign the available resources in the most efficient way possible.
   Research limitations/implications: Hardly any current data are available, not only publicly, but also through public health ministries and managers; those that are available are not very reliable and come from studies with non-representative samples. For this reason, all forecasts must be taken with a note of caution, and in particular, designing review mechanisms every time a new set of updated reliable data becomes available (something that occurs on a weekly basis).
   Originality/value: In this work, we will show an example of a proposal for the practical application of Operations Management tools. Our proposal may be useful to hospital managers and public administrators in the healthcare sector (regional ministries or their equivalents). Each health department, hospital or hospital group will generate the aggregate data that facilitate the calculation of needs as input parameters for the model (available and occupied beds, daily admissions, mean lengths of stay in each healing phase and the percent of patients who evolve from one stage to another in the progression of the disease/healing process) and will be able to analyze how the system responds and evaluate different strategies or mitigating actions. These tools have been shown to be useful and reliable in manufacturing and service contexts that show a strong seasonal demand (both occasional and recurring) requiring a great deal of resources. We believe these situations are analogous to those faced by hospitals and the healthcare system in an epidemic like COVID-19. With them, we could facilitate the aggregate planning of resources for hospital administrators in order to provide them operational support during the COVID-19 contingency plan. However, the array of useful tools for this crisis is not limited to those that we will illustrate. Our intent is to encourage the Operations Management academic community to demonstrate how they contribute to the service of society in this COVID-19 epidemic, providing knowledge that can be extrapolated to other similar situations in the future that we may be unfortunate enough to experience.
C1 [Marin-Garcia, Juan A.; Garcia-Sabater, Jose P.; Maheut, Julien; Garcia-Sabater, Julio J.] Univ Politecn Valencia, Dept Org Empresas, ROGLE, Valencia, Spain.
   [Ruiz, Angel] FSA ULaval, Dept Operat & Syst Decis, Laval, PQ, Canada.
RP Marin-Garcia, JA (corresponding author), Univ Politecn Valencia, Dept Org Empresas, ROGLE, Valencia, Spain.
EM jamarin@omp.upv.es; jpgarcia@omp.upv.es; Angel.Ruiz@osd.ulaval.ca;
   juma2@upvnet.upv.es; jugarsa@omp.upv.es
RI Marin-Garcia, Juan A./A-4069-2011; ruiz, angel/P-6960-2015; Maheut,
   Julien/H-6800-2012
OI Marin-Garcia, Juan A./0000-0001-5416-3938; ruiz,
   angel/0000-0002-3151-283X; Maheut, Julien/0000-0002-5796-9053
CR Ahlstrom P., 1998, EUR MANAG J, V16, P327
   Aijing L, 2015, W INDIAN MED J, V64, P521, DOI 10.7727/wimj.2016.057
   Alzubi E, 2019, PROCESSES, V7, DOI 10.3390/pr7110816
   Arias Aranda D., 2018, DIRECCION PRODUCCION
   Avella L, 2014, ACTION RES-LONDON, V12, P194, DOI 10.1177/1476750314528010
   Aylward B., 2020, REPORT WHO CHINA JOI, P16
   Aytug H, 2005, EUR J OPER RES, V161, P86, DOI 10.1016/j.ejor.2003.08.027
   Bae KH, 2019, HEALTH SYST, V8, P1, DOI 10.1080/20476965.2017.1405873
   Bayou ME, 2008, J ENG TECHNOL MANAGE, V25, P287, DOI 10.1016/j.jengtecman.2008.10.003
   Bean DM, 2019, BMJ SIMUL TECHNOL EN, V5, P49, DOI 10.1136/bmjstel-2017-000251
   Bedoya-Valencia L, 2016, SIMUL-T SOC MOD SIM, V92, P1041, DOI 10.1177/0037549716673150
   Belanger V, 2020, EUR J OPER RES, V286, P713, DOI 10.1016/j.ejor.2020.03.041
   Benton WC, 1998, EUR J OPER RES, V110, P411, DOI 10.1016/S0377-2217(98)00080-0
   Berger G., 1987, APICS C P
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Brailsford S, 2011, EUR J OPER RES, V212, P223, DOI 10.1016/j.ejor.2010.10.026
   Chase R.B., 2004, OPERATIONS MANAGEMEN, V10th
   Chen W, 2015, IFAC PAPERSONLINE, V48, P180, DOI 10.1016/j.ifacol.2015.06.078
   Chen WY, 2016, EUR J OPER RES, V254, P458, DOI 10.1016/j.ejor.2016.03.052
   Cho M, 2019, IEEE ACCESS, V7, P15239, DOI 10.1109/ACCESS.2019.2894116
   Choi TY, 2001, J OPER MANAG, V19, P351, DOI 10.1016/S0272-6963(00)00068-1
   Cooney R, 2002, INT J OPER PROD MAN, V22, P1130, DOI 10.1108/01443570210446342
   Dasaklis TK, 2012, INT J PROD ECON, V139, P393, DOI 10.1016/j.ijpe.2012.05.023
   Demir E, 2017, HEALTH SYST, V6, P33, DOI 10.1057/hs.2016.1
   Doolen TL, 2005, J MANUF SYST, V24, P55, DOI 10.1016/S0278-6125(05)80007-X
   Eroglu C, 2011, J OPER MANAG, V29, P356, DOI 10.1016/j.jom.2010.05.002
   Erro-Garces A, 2020, INT J QUAL METH, V19, DOI 10.1177/1609406920917489
   European Centre for Disease Prevention and Control, 2020, COR DIS 2019 COVID 1
   European Centre for Disease Prevention and Control, 2020, DIS BACKGR COVID 19
   Ferguson NM, 2020, IMPACT NONPHARMACEUT, DOI DOI 10.25561/77482
   Fernandes EG, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002461
   Forrester J. W., 1997, J OPER RES SOC, DOI [DOI 10.1057/palgrave.jors.2600946, 10.1057/palgrave.jors.2600946, DOI 10.1057/PALGRAVE.JORS.2600946]
   Frazee T, 2016, J IND ENG MANAG-JIEM, V9, P432, DOI 10.3926/jiem.1248
   Geary S, 2006, INT J PROD ECON, V101, P2, DOI 10.1016/j.ijpe.2005.05.009
   Generalitat Valenciana, 2018, MEM GEST CONS SAN U
   GODDARD W, 1982, MODERN MAT HANDLING, V0037, P00025
   Gonzalez-R PL, 2010, INT J COMPUT INTEG M, V23, P155, DOI 10.1080/09511920903440362
   Gupta M, 2009, INT J PROD RES, V47, P3705, DOI 10.1080/00207540701636322
   Gupta M, 2018, INT J PROD RES, V56, P4659, DOI 10.1080/00207543.2018.1444805
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Hu X, 2018, INT T OPER RES, V25, P7, DOI 10.1111/itor.12400
   Ileri YY, 2016, J INF KNOWL MANAG, V15, DOI 10.1142/S0219649216500313
   Jina J., 1997, LOGISTICS INFORM MAN, V10, P5, DOI DOI 10.1108/09576059710159655
   Kiourtis A, 2019, INT J MED INFORM, V132, DOI 10.1016/j.ijmedinf.2019.104002
   Kiourtis A, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1183-y
   Lin JT, 2004, INT J PROD RES, V42, P79, DOI 10.1080/0020754032000123588
   Maheut J, 2012, IND ENG INN NETW 5 I, P309
   Manninen K., 2020, TYPICAL PROGR COVID
   Marin-Garcia JA, 2019, WPOM-WORKING PAP OPE, V10, P36, DOI 10.4995/wpom.v10i2.12297
   Marin-Garcia JA, 2018, WPOM-WORKING PAP OPE, V9, P1, DOI 10.4995/wpom.v9i1.8990
   Martin-barroso D., 2020, ENCAJANDO PUZLE ESTI
   Mejia-Villa A, 2017, WPOM-WORKING PAP OPE, V8, P191, DOI 10.4995/wpom.v8i0.7660
   Miclo R, 2019, INT J PROD RES, V57, P166, DOI 10.1080/00207543.2018.1464230
   Moktadir MA, 2018, IND MANAGE DATA SYST, V118, P1388, DOI 10.1108/IMDS-10-2017-0465
   Molina-Pariente JM, 2015, COMPUT IND ENG, V82, P8, DOI 10.1016/j.cie.2015.01.006
   Monden Y., 2011, TOYOTA PRODUCTION SY
   Mula J, 2007, FUZZY SET SYST, V158, P783, DOI 10.1016/j.fss.2006.11.003
   National Vital Statistics System, 2020, PROV DEATH COR DIS C
   Ohno T., 1988, TOYOTA PRODUCTION SY
   Paavola A., 2020, BECKERS HEALTHCARE H
   Packowski J., 2013, LEAN SUPPLY CHAIN PL
   Paul SA, 2010, SIMUL-T SOC MOD SIM, V86, P559, DOI 10.1177/0037549710360912
   Perez-Campdesuner R, 2017, J IND ENG MANAG-JIEM, V10, P7, DOI 10.3926/jiem.2089
   Pilar VC, 2015, 2015 INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND SYSTEMS MANAGEMENT (IESM), P272, DOI 10.1109/IESM.2015.7380170
   Pitt M, 2016, BMJ QUAL SAF, V25, P38, DOI 10.1136/bmjqs-2015-004430
   Postacchini L, 2016, J IND ENG MANAG-JIEM, V9, P207, DOI 10.3926/jiem.1262
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Saez-Mas A, 2018, INT J SIMUL MODEL, V17, P30, DOI 10.2507/IJSIMM17(1)408
   Saez-Mas A, 2020, COMPUT IND ENG, V143, DOI 10.1016/j.cie.2020.106422
   Safdar KA, 2016, J MED SYST, V40, DOI 10.1007/s10916-015-0393-1
   Salje H, 2020, ESTIMATING BURDEN SA
   Sanchis J., 2020, LAS PROVINCIAS
   Shingo S., 1989, STUDY TOYOTA PRODUCT
   Sholihah SA, 2018, J IND ENG MANAG-JIEM, V11, P776, DOI 10.3926/jiem.2538
   Sodhi MS, 2011, EUR J OPER RES, V215, P374, DOI 10.1016/j.ejor.2011.06.019
   Squires H, 2016, INT J PUBLIC HEALTH, V61, P289, DOI 10.1007/s00038-015-0775-7
   Thurer M, 2015, PROD OPER MANAG, V24, P1179, DOI 10.1111/poms.12304
   Vall d'Hebron Barcelona Hospital Campus, 2020, PLA CONT VALL HEBR F, P1
   van Donk D. P., 2010, LEAN PROCESS IND DEA
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   Wee HM, 2016, INT J LOGIST-RES APP, V19, P380, DOI 10.1080/13675567.2015.1090964
   Zhang T, 2020, MODEL ESTIMATE BED D, DOI [10.1101/2020.03.24.20042762, DOI 10.1101/2020.03.24.20042762]
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 83
TC 7
Z9 7
U1 6
U2 16
PU OMNIASCIENCE
PI BARCELONA
PA TERRASSA, BARCELONA, 00000, SPAIN
SN 2013-8423
EI 2013-0953
J9 J IND ENG MANAG-JIEM
JI J. Ind. Eng. Manag.-JIEM
PY 2020
VL 13
IS 2
BP 213
EP 227
DI 10.3926/jiem.3190
PG 15
WC Engineering, Industrial
WE Emerging Sources Citation Index (ESCI)
SC Engineering
GA NS2EM
UT WOS:000572078200001
OA Green Submitted, gold, Green Published
DA 2022-04-20
ER

PT J
AU Owida, A
   Galal, NM
   Elrafie, A
AF Owida, Aly
   Galal, Noha M.
   Elrafie, Ayman
TI Decision-making framework for a resilient sustainable production system
   during COVID-19: An evidence-based research
SO COMPUTERS & INDUSTRIAL ENGINEERING
LA English
DT Article
DE Decision-making; Sustainability; Resilience; COVID-19; Food supply
   chain; Case study
ID SUPPLY CHAIN SUSTAINABILITY; PERFORMANCE; MANAGEMENT; SAFETY; RISK
AB This work presents a decision-making framework for integrating resilience and sustainability in managing production systems during COVID-19. An operationalization scheme manifested via a case study at a manufacturer in the food production sector supports the proposed framework. The focus is laid on the tactical and operational decisions within the production system. Through the discussion of the introduced changes to mitigate risks emanating from COVID-19, a set of findings related to the deployment of digital solutions, new dimensions of sustainability and resilience, the introduction of new workforce scheduling rules, the importance of alignment and coordination across supply chain members, and the approach of risk management are identified. This work contributes to a better understanding of the decision-making process during the pandemic and to building up knowledge for the management of resilient and sustainable production systems.
C1 [Owida, Aly; Galal, Noha M.] Arab Acad Sci Technol & Maritime Transport, Dept Ind & Management Engn, Alexandria, Egypt.
   [Elrafie, Ayman] Unilever Arabia, Dubai, U Arab Emirates.
RP Owida, A (corresponding author), POB 1029 Abu Kir Campus, Alexandria, Egypt.
EM alyowida@aast.edu
RI Owida, Aly/B-5860-2016
OI Owida, Aly/0000-0002-4163-7257
CR Ahi P, 2015, APPL MATH MODEL, V39, P2882, DOI 10.1016/j.apm.2014.10.055
   Akkerman R, 2010, OR SPECTRUM, V32, P863, DOI 10.1007/s00291-010-0223-2
   Ardebili AA, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072602
   Baghersad M, 2021, INT J PROD ECON, V231, DOI 10.1016/j.ijpe.2020.107862
   Balugani E, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12051742
   Behzadi G, 2018, OMEGA-INT J MANAGE S, V79, P21, DOI 10.1016/j.omega.2017.07.005
   BENBASAT I, 1987, MIS QUART, V11, P369, DOI 10.2307/248684
   Cai Min, 2020, J Shanghai Jiaotong Univ Sci, V25, P409, DOI 10.1007/s12204-020-2206-z
   Camuffo A, 2017, J BUS ETHICS, V143, P245, DOI 10.1007/s10551-015-2590-8
   Cardoso SR, 2015, OMEGA-INT J MANAGE S, V56, P53, DOI 10.1016/j.omega.2015.03.008
   Carvalho H., 2014, INT J SUPPLY CHAIN O, V1, P3
   Christopher M., 2004, INT J LOGIST MANAG, V15, P1, DOI [10.1108/09574090410700275, DOI 10.1108/09574090410700275]
   Currie CSM, 2020, J SIMUL, V14, P83, DOI 10.1080/17477778.2020.1751570
   Das K, 2019, INT J MATH ENG MANAG, V4, P259, DOI 10.33889/IJMEMS.2019.4.2-022
   Dolgui A, 2018, INT J PROD RES, V56, P414, DOI 10.1080/00207543.2017.1387680
   Duminy L., 2018, UNDERSTING COMPLE, P223
   Erol I, 2011, ECOL ECON, V70, P1088, DOI 10.1016/j.ecolecon.2011.01.001
   Fahimnia B, 2016, TRANSPORT RES E-LOG, V91, P306, DOI 10.1016/j.tre.2016.02.007
   Giannakis Mihalis, 2016, International Journal of Production Economics, V171, P455, DOI 10.1016/j.ijpe.2015.06.032
   Gimenez-Escalante P, 2020, J CLEAN PROD, V266, DOI 10.1016/j.jclepro.2020.121934
   Haghani M, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104806
   Hakovirta M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093727
   Han YS, 2020, IEEE T MED IMAGING, V39, P3571, DOI 10.1109/TMI.2020.3000341
   Hassani L, 2019, J CLEAN PROD, V228, P1062, DOI 10.1016/j.jclepro.2019.04.324
   Heinicke M, 2016, PROC CIRP, V41, P117, DOI 10.1016/j.procir.2015.12.067
   Heinicke M, 2014, IFIP ADV INF COMM TE, V440, P200
   Heinicke M, 2014, PROC CIRP, V19, P105, DOI 10.1016/j.procir.2014.05.001
   Ivanov D., 2018, NEW DRIVERS SUPPLY C, P293
   Ivanov D, 2021, PROD PLAN CONTROL, V32, P775, DOI 10.1080/09537287.2020.1768450
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922
   Ivanov D, 2018, INT J PROD RES, V56, P3507, DOI 10.1080/00207543.2017.1343507
   Ivanov D, 2019, INT J PROD RES, V57, P5119, DOI 10.1080/00207543.2018.1521025
   Ivanov D, 2017, INT J PROD RES, V55, P6158, DOI 10.1080/00207543.2017.1330572
   Ivanov D, 2014, INT J PROD RES, V52, P2154, DOI 10.1080/00207543.2013.858836
   Jabbarzadeh A, 2018, INT J PROD RES, V56, P5945, DOI 10.1080/00207543.2018.1461950
   Jermsittiparsert K, 2019, INT J SUPPLY CHAIN M, V8, P622
   Jilcha K, 2017, ENG SCI TECHNOL, V20, P372, DOI 10.1016/j.jestch.2016.10.011
   Kim TY, 2020, COMPUT IND ENG, V139, DOI 10.1016/j.cie.2018.12.011
   Li RY, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9010144
   Malak-Rawlikowska A, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11154004
   Marchese D, 2018, SCI TOTAL ENVIRON, V613, P1275, DOI 10.1016/j.scitotenv.2017.09.086
   McQuaid J, 2000, PROCESS SAF ENVIRON, V78, P262, DOI 10.1205/095758200530772
   Meredith J, 1998, J OPER MANAG, V16, P441, DOI 10.1016/S0272-6963(98)00023-0
   Mohammed A, 2020, RESOUR CONSERV RECY, V155, DOI 10.1016/j.resconrec.2019.104641
   Nawaz W, 2019, J CLEAN PROD, V216, P74, DOI 10.1016/j.jclepro.2019.01.167
   Pecillo M, 2016, INT J OCCUP SAF ERGO, V22, P291, DOI 10.1080/10803548.2015.1126142
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Rajesh R, 2019, INT J PROD RES, V57, P3748, DOI 10.1080/00207543.2019.1566656
   Ramezankhani MJ, 2018, COMPUT IND ENG, V126, P531, DOI 10.1016/j.cie.2018.09.054
   ranco D., 2020, COMPUT IND ENG, V148
   Renn O, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12166466
   Roostaie S, 2019, J CLEAN PROD, V232, P1158, DOI 10.1016/j.jclepro.2019.05.382
   Roostaie S, 2019, BUILD ENVIRON, V154, P132, DOI 10.1016/j.buildenv.2019.02.042
   Schaltegger S, 2014, SUPPLY CHAIN MANAG, V19, P232, DOI [10.1108/SCM-02-2014-0061, 10.1108/SCM-02-2014-0083]
   Shin N, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020484
   Singh Chandra Shekhar, 2019, Journal of Industrial Engineering International, V15, P105, DOI 10.1007/s40092-019-00322-2
   Singh S, 2021, INT J PROD RES, V59, P1993, DOI 10.1080/00207543.2020.1792000
   Soni U, 2014, COMPUT IND ENG, V74, P11, DOI 10.1016/j.cie.2014.04.019
   Staniskiene E, 2018, J CLEAN PROD, V188, P708, DOI 10.1016/j.jclepro.2018.03.269
   Stone J, 2018, SUPPLY CHAIN MANAG, V23, P207, DOI 10.1108/SCM-06-2017-0201
   Thomas A, 2016, J MANUF TECHNOL MANA, V27, P82, DOI 10.1108/JMTM-06-2014-0086
   Thomas A, 2015, INT J PROD RES, V53, P3934, DOI 10.1080/00207543.2014.975850
   Vishnu C, 2020, J ADV MANAG RES, V17, P173, DOI 10.1108/JAMR-04-2019-0061
   Voss C, 2002, INT J OPER PROD MAN, V22, P195, DOI 10.1108/01443570210414329
   Wang B, 2020, J CLEAN PROD, V252, DOI 10.1016/j.jclepro.2019.119852
   Xu M, 2019, J CLEAN PROD, V225, P857, DOI 10.1016/j.jclepro.2019.03.307
   Zavala-Alcivar A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12166300
   Zhang FQ, 2020, PROD OPER MANAG, V29, P2219, DOI 10.1111/poms.13231
   Zhao GQ, 2017, IFIP ADV INF COMM TE, V506, P739, DOI 10.1007/978-3-319-65151-4_66
   Zhu Q, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12125004
   Zhu ZG, 2018, INT J PROD RES, V56, P5700, DOI 10.1080/00207543.2018.1425014
NR 72
TC 0
Z9 0
U1 12
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-8352
EI 1879-0550
J9 COMPUT IND ENG
JI Comput. Ind. Eng.
PD FEB
PY 2022
VL 164
AR 107905
DI 10.1016/j.cie.2021.107905
PG 14
WC Computer Science, Interdisciplinary Applications; Engineering,
   Industrial
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Computer Science; Engineering
GA YN0IC
UT WOS:000746950400001
PM 34975207
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Riahinia, N
   Danesh, F
   GhaviDel, S
AF Riahinia, Nosrat
   Danesh, Farshid
   GhaviDel, Somayeh
TI Synergistic networks of COVID-19's top papers
SO LIBRARY HI TECH
LA English
DT Article; Early Access
DE COVID-19; Social network analysis (SNA); Synergy indicator; Redundancy;
   Essential science indicator (ESI); Web of science core collection
   (WOSCC)
ID CO-AUTHORSHIP NETWORKS; COLLABORATION NETWORKS; BIBLIOMETRIC ANALYSIS;
   TRIPLE-HELIX; SCIENCE; PERFORMANCE; PATTERNS; TRENDS; IMPACT; FIELD
AB Purpose - Synergy indicators and social network analysis (SNA), as practical tools, provide the possibility of explaining the pattern of scientific collaboration and visualization of network relations. Recognition of scientific capacities is the basis of synergy. The present study aims to measure and discover the synergistic networks of COVID-19's top papers at the level of co-authorship, countries, journals, bibliographic couples and titles.
   Design/methodology/approach - The synergy indicator, co-authorship co-citation network analysis methods were applied. The research population comprises COVID-19's top papers indexed in Essential Science Indicator and Web of Science Core Collection 2020 and 2021. Excel 2016, UCINET 6.528.0.0 2017, NetDraw, Ravar Matrix, VOSviewer version 1.6.14 and Python 3.9.5 were applied to analyze the data and visualize the networks.
   Findings - The findings indicate that considering the three possible possibilities for authors, countries and journals, more redundancy and information are created and potential for further cooperation is observed. The synergy of scientific collaboration has revealed that "Wang, Y," "USA" and "Science of the Total Environment" have the most effective capabilities and results. "Guan (2020b)" and "Zhou (2020)" are bibliographic couplings that have received the most citations. The keywords "CORONAVIRUS DISEASE 2019 (COVID-19)" were the most frequent in article titles.
   Originality/value - Ina circumstance that the world is suffering from a COVID-19 pandemic and all scientists are conducting various researches to discover vaccines, medicines and new treatment methods, scientometric studies, and analysis of social networks of COVID-19 publications to be able to specify the synergy rate and the scientific collaboration networks, are not only innovative and original but also of great importance and priority; SNA tools along with the synergy indicator is capable of visualizing the complicated and multifaceted pattern of scientific collaboration in COVID-19. As a result, analyses can help identify existing capacities and define a new space for using COVID-19 researchers' capabilities.
C1 [Riahinia, Nosrat] Kharazmi Univ, Dept Knowledge & Informat Sci, Tehran, Iran.
   [Danesh, Farshid] Reg Informat Ctr Sci & Technol, Informat Management Dept, Shiraz, Iran.
   [GhaviDel, Somayeh] Kharazmi Univ, Dept Knowledge & Informat Sci, Tehran, Iran.
RP Riahinia, N (corresponding author), Kharazmi Univ, Dept Knowledge & Informat Sci, Tehran, Iran.
EM riahinia@khu.ac.ir; farshiddanesh@ricest.ac.ir
RI danesh, farshid/D-3829-2011
OI danesh, farshid/0000-0001-5481-3988
FU Vice-Chancellor for Research and Technology of Kharazmi University
FX Researchers appreciate the Vice-Chancellor for Research and Technology
   of Kharazmi University for its support.
CR Abideen AZ, 2020, J HEALTH RES, V34, P547, DOI 10.1108/JHR-04-2020-0109
   Ahmed W, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218235
   Amjad T, 2018, LIBR HI TECH, V36, P97, DOI 10.1108/LHT-05-2017-0090
   Biglu, 2008, THESIS HUMBOLDT U BE
   Birkle C, 2020, QUANT SCI STUD, V1, P363, DOI 10.1162/qss_a_00018
   Callon M., 1986, MAPPING DYNAMICS SCI, DOI DOI 10.1007/978-1-349-07408-2_2
   Chahrour M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7357
   Chen PY, 2020, LIBR HI TECH, V38, P293, DOI 10.1108/LHT-01-2019-0026
   Cheng B, 2006, THESIS BRIGHAM YOUNG
   Chiu WT, 2004, SCIENTOMETRICS, V61, P69, DOI 10.1023/B:SCIE.0000037363.49623.28
   Chopra R.K., 1989, NASSP BULL, V73, P44
   Clarivate, 2021, CLAR ESS SCI IND ESI
   Colavizza G, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244839
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   Danesh F., 2020, IRANIAN J MED MICROB, V14, P1, DOI [DOI 10.30699/IJMM.14.1.1, 10.30699/ijmm.14.1.1]
   Dehghanbanadaki Hojat, 2020, Med J Islam Repub Iran, V34, P51, DOI 10.34171/mjiri.34.51
   Ekundayo TC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207655
   Espinosa Isabel, 2021, rev.fac.med., V69, pe210, DOI 10.15446/revfacmed.v69n3.94520
   Etzkowitz H, 2000, RES POLICY, V29, P109, DOI 10.1016/S0048-7333(99)00055-4
   Etzkowitz H, 1998, MINERVA, V36, P203
   Etzkowitz H., 1995, EASST REV, V14, P14, DOI DOI 10.1177/095042229801200402
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Gupta B. M., 2021, International Journal of Medicine and Public Health, V11, P139, DOI 10.5530/ijmedph.2021.3.25
   Hossain MM, 2020, CURRENT STATUS GLOBA, V9, P374, DOI DOI 10.2139/SSRN.3547824
   Hudson J, 1996, J ECON PERSPECT, V10, P153, DOI 10.1257/jep.10.3.153
   Inkpen AC, 2005, ACAD MANAGE REV, V30, P146, DOI 10.5465/AMR.2005.15281445
   Ivancheva L, 2008, COLLNET J SCIENTOMET, V2, P47, DOI 10.1080/09737766.2008.10700853
   Ivanova, 2016, J OPEN INNOVATION TE, V2, P1, DOI 10.1186/s40852-016-0039-7
   Jafari S, 2020, SCIENTOMETRICS RES J, V6, P277
   Jayasuriya, 2020, J INFORM COMPUTATION, V10, P568
   Kambhampati Srinivas B S, 2020, J Clin Orthop Trauma, V11, pS304, DOI 10.1016/j.jcot.2020.04.030
   KESSLER MM, 1963, AM DOC, V14, P10, DOI 10.1002/asi.5090140103
   Khalili, 2015, IRANIAN J EPIDEMIOLO, V10, P78
   Kumar S, 2015, ASLIB J INFORM MANAG, V67, P55, DOI 10.1108/AJIM-09-2014-0116
   Kuzhabekova A, 2018, EUR EDUC, V50, P266, DOI 10.1080/10564934.2018.1444942
   Leydesdorff L., 2017, SSRN ELECT J, DOI [10.2139/ssrn.2937647, DOI 10.2139/SSRN.2937647]
   Leydesdorff L, 2021, J ASSOC INF SCI TECH, V72, P387, DOI 10.1002/asi.24416
   Leydesdorff L, 2020, SCIENTOMETRICS, V123, P1247, DOI 10.1007/s11192-020-03451-3
   Leydesdorff L, 2019, J INFORMETR, V13, P255, DOI 10.1016/j.joi.2018.12.006
   Leydesdorff L, 2013, PROF INFORM, V22, P87, DOI 10.3145/epi.2013.ene.12
   Lu XX, 2020, PEDIAT ALLERG IMM-UK, V31, P449, DOI 10.1111/pai.13267
   Marin A., 2011, SAGE HDB SOCIAL NETW, V11, P25
   Medicine J. H. U., 2020, CORONAVIRUS COVID 19
   Melin G, 1996, SCIENTOMETRICS, V36, P363, DOI 10.1007/BF02129600
   Muthuraj S, 2020, LIBR PHILOS PRACT E, P4196
   Nagai K, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01814-2
   Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100
   Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016131
   Oh J, 2020, SCI ED, V7, P118, DOI 10.6087/kcse.205
   Okhovati Maryam, 2021, Med J Islam Repub Iran, V35, P20, DOI 10.47176/mjiri.35.20
   Ozdagoglu G., 2020, DIGITAL BUSINESS STR, P569
   Pal JK, 2021, SCIENTOMETRICS, V126, P4173, DOI 10.1007/s11192-021-03912-3
   Paraskevis D, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104212
   Piranfar V., 2020, J ADV MED BIOMEDICAL, V28, P253, DOI DOI 10.30699/JAMBS.28.130.253
   Riahi A., 2010, J SCI TECHNOLOGY POL, V3, P81
   Rotolo D, 2017, J ASSOC INF SCI TECH, V68, P214, DOI 10.1002/asi.23631
   Sa'ed H.Z, 2021, GLOBALIZATION HEALTH, V17, P1, DOI DOI 10.1186/S12992-020-00651-7
   Sabah F, 2019, LIBR HI TECH, V37, P19, DOI 10.1108/LHT-03-2018-0036
   Sachini E, 2021, SCIENTOMETRICS, V126, P5225, DOI 10.1007/s11192-021-03952-9
   Sadatmoosavi A, 2018, MALAYS J LIBR INF SC, V23, P51, DOI 10.22452/mjlis.vol23no1.4
   Sadatmoosavi O, 2019, IRANIAN J INFORM PRO, V34, P1423
   Sahoo S, 2020, ONLINE INFORM REV, V44, P1443, DOI 10.1108/OIR-06-2020-0252
   Sajana C., 2020, SCIENTOMETRICS ANAL
   Scott J., 2000, SOCIAL NETWORK ANAL, V2nd
   Scott J., 2012
   Shamsi A, 2020, J DIABETES METAB DIS, V19, P1845, DOI 10.1007/s40200-020-00606-0
   Soheili F, 2014, IRANIAN J INFORM PRO, V29, P351
   Soheili M, 2014, LIB INFORM SCI, V17, P99
   Synnestvedt Marie B, 2005, AMIA Annu Symp Proc, P724
   Phan T, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104211
   Van Noorden R, 2014, NATURE, V514, P550, DOI 10.1038/514550a
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Wang JH, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022849
   Wang M., 2020, CELL RES, V30, P269, DOI [10.1038/s41422-020-0282-0, DOI 10.1038/s41422-020-0282-0]
   Wang MJ, 2020, PRECIS CLIN MED, V3, P14, DOI 10.1093/pcmedi/pbaa002
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Wen J, 2020, ANATOLIA, V31, P331, DOI 10.1080/13032917.2020.1730621
   World Health Organization (WHO), 2021, NOV COR 2019 NCOV
   Yan EJ, 2009, J AM SOC INF SCI TEC, V60, P2107, DOI 10.1002/asi.21128
   Yum S, 2020, SOC SCI QUART, V101, P1642, DOI 10.1111/ssqu.12808
   Zhai F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113766
   Zhao S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020388
   Zhao YH, 2016, SCIENTOMETRICS, V107, P759, DOI 10.1007/s11192-016-1857-x
   Zhu ZZ, 2018, INFECT GENET EVOL, V61, P183, DOI 10.1016/j.meegid.2018.03.028
   Zyoud SH, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1600-5
NR 87
TC 0
Z9 0
U1 7
U2 7
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0737-8831
J9 LIBR HI TECH
JI Libr. Hi Tech
DI 10.1108/LHT-08-2021-0286
EA OCT 2021
PG 41
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA XT6JP
UT WOS:000733691700001
OA Bronze
DA 2022-04-20
ER

PT J
AU Dhillon, P
   Breuer, M
   Hirst, N
AF Dhillon, Paraminder
   Breuer, Manuel
   Hirst, Natasha
TI COVID-19 breakthroughs: separating fact from fiction
SO FEBS JOURNAL
LA English
DT Review
DE ACE2; coronavirus; COVID-19; ethnic minorities; fomites; ibuprofen;
   nicotine; SARS-CoV-2; viral transmission; vitamin D
ID ANGIOTENSIN-CONVERTING ENZYME-2; VITAMIN-D DEFICIENCY; SARS CORONAVIRUS;
   SARS-COV-2; ACE2; HEALTH; DISPARITIES; MANAGEMENT; INFLUENZA; INFECTION
AB The newly recognised coronavirus SARS-CoV-2, causative agent of coronavirus disease (COVID-19), has caused a pandemic with huge ramifications for human interactions around the globe. As expected, research efforts to understand the virus and curtail the disease are moving at a frantic pace alongside the spread of rumours, speculations and falsehoods. In this article, we aim to clarify the current scientific view behind several claims or controversies related to COVID-19. Starting with the origin of the virus, we then discuss the effect of ibuprofen and nicotine on the severity of the disease. We highlight the knowledge on fomites and SARS-CoV-2 and discuss the evidence and explications for a disproportionately stronger impact of COVID-19 on ethnic minorities, including a potential protective role for vitamin D. We further review what is known about the effects of SARS-CoV-2 infection in children, including their role in transmission of the disease, and conclude with the science on different mortality rates between different countries and whether this hints at the existence of more pathogenic cohorts of SARS-CoV-2.
C1 [Dhillon, Paraminder; Breuer, Manuel; Hirst, Natasha] FEBS Journal Editorial Off, Suite B1,Third Floor,St Andrews House, Cambridge, England.
RP Dhillon, P (corresponding author), FEBS Journal Editorial Off, Suite B1,Third Floor,St Andrews House, Cambridge, England.
EM dhillon@febs.org
RI Breuer, Manuel/ABD-5440-2021
OI Breuer, Manuel/0000-0003-1982-2517; Dhillon,
   Paraminder/0000-0001-5115-6361
CR Abrahao JS, 2020, DETECTION SARS COV 2
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   [Anonymous], 2020, FDA ADV PAT US NONST
   [Anonymous], 2020, ECONOMIST
   [Anonymous], 2020, SCIENTIST
   [Anonymous], 2020, SKY NEWS
   [Anonymous], 2020, BBC NEWS
   [Anonymous], 2020, NY TIMES, P1
   [Anonymous], 2020, FORBES
   [Anonymous], 2020, SCI NEWS
   [Anonymous], 2020, THE GUARDIAN
   [Anonymous], 2020, RACE MATTERS COVID 1
   Atzrodt CL, 2020, FEBS J, V287, P3633, DOI 10.1111/febs.15375
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bast F, 2020, NOBEL LAUREATE SAID
   Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5
   Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
   Blocken B, 2020, AERODYNAMICALLY EQUI
   Bloise I, 2020, J HOSP INFECT, V105, P784, DOI 10.1016/j.jhin.2020.05.017
   Bourouiba L, 2020, JAMA-J AM MED ASSOC, V323, P1837, DOI 10.1001/jama.2020.4756
   Brake SJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030841
   Buitrago-Garcia D, 2020, ROLE ASYMPTOMATIC SA, DOI [10.1101/2020.04.25.20079103, DOI 10.1101/2020.04.25.20079103]
   Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707
   Cai G., 2020, TOBACCO USE DISPARIT
   Callaway Ewen, 2020, Nature, DOI 10.1038/d41586-020-00180-8
   Capuano A, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104849
   Carsetti R, 2020, LANCET CHILD ADOLESC, V4, P414, DOI 10.1016/S2352-4642(20)30135-8
   CDC, 2014, SURG GEN REP SMOK HL
   Changeux JP, 2020, CR BIOL, V343, P33, DOI 10.5802/crbiol.8
   Chen JW, 2020, AGING CELL, V19, DOI 10.1111/acel.13168
   Chen Q, 2020, PATIENT DERIVED MUTA, DOI [10.1101/2020.04.14.20060160., DOI 10.1101/2020.04.14.20060160]
   Chen YC, 2004, EMERG INFECT DIS, V10, P782, DOI 10.3201/eid1005.030579
   Chen ZP, 2020, J GLOBAL OPTIM, V77, P825, DOI 10.1007/s10898-020-00901-3
   Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI 10.1016/S2666-5247(20)30003-3
   Ciaglia E, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00206
   Couzin-Frankel, 2020, SCIENCE
   COVID-19 National Emergency Response Center Epidemiology and Case Management Team Korea Centers for Disease Control and Prevention, 2020, Osong Public Health Res Perspect, V11, P85, DOI 10.24171/j.phrp.2020.11.2.05
   Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786
   Cristiani L, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00749-2020
   DailyMail, 2020, DAILYMAIL
   Dallan C, 2020, LANCET CHILD ADOLESC, V4, pE21, DOI 10.1016/S2352-4642(20)30164-4
   Danis K, 2020, CLIN INFECT DIS, V71, P825, DOI 10.1093/cid/ciaa424
   Darling A. L., 2020, VITAMIN D STATUS BOD, DOI [10.1101/2020.04.29.20084277, DOI 10.1101/2020.04.29.20084277]
   Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9
   Day Michael, 2020, BMJ, V368, pm1086, DOI 10.1136/bmj.m1086
   De Rose DU, 2020, ITAL J PEDIATR, V46, DOI 10.1186/s13052-020-0820-x
   De Smet D., 2020, VITAMIN D DEFICIENCY
   Deslandes A, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.106006
   Dhama K, 2020, HUM VACC IMMUNOTHER, V16, P2913, DOI 10.1080/21645515.2020.1842034
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Don't Forget the Bubbles, 2020, DONT FORGET BUBBLES
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   DW, 2020, DW
   El-Kebir, 2020, CHARACTERIZATION SAR, DOI [https://doi.org/10.1101/2020.05.07.083410, DOI 10.1101/2020.05.07.083410]
   European Medicines Agency, 2020, EMA END US DEX COVID
   Eurostat, 2020, POP STRUCT AG
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Farsalinos K, 2020, INTERN EMERG MED, V15, P845, DOI 10.1007/s11739-020-02355-7
   Farsalinos K, 2020, TOXICOL REP, V7, P658, DOI 10.1016/j.toxrep.2020.04.012
   Feldmann M, 2020, LANCET, V395, P1407, DOI 10.1016/S0140-6736(20)30858-8
   Ferrari MFR, 2008, J MOL NEUROSCI, V35, P151, DOI 10.1007/s12031-007-9025-7
   Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117
   Glebov OO, 2020, FEBS J, V287, P3664, DOI 10.1111/febs.15369
   Golden SH, 2012, J CLIN ENDOCR METAB, V97, pE1579, DOI 10.1210/jc.2012-2043
   Green, 2020, FEATURES 16749 HOSP, DOI [10.1136/bmj.m1985, DOI 10.1101/2020.04.23.20076042]
   Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100
   Gupta R, 2020, DIABETES METAB SYND, V14, P251, DOI 10.1016/j.dsx.2020.03.012
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hastie CE, 2020, DIABETES METAB SYND, V14, P561, DOI 10.1016/j.dsx.2020.04.050
   Herrick KA, 2019, AM J CLIN NUTR, V110, P150, DOI 10.1093/ajcn/nqz037
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   HSJ, 2020, HSJ
   Huang Angkana T, 2020, medRxiv, DOI [10.1038/s41467-020-18450-4, 10.1101/2020.04.14.20065771]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   ICNARC, ICNARC COVID 19 STUD
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Jia Y., 2020, ANAL MUTATION DYNAMI, DOI [10.1101/2020.04.09.034942, 10. 1101/2020.04.09.034942, DOI 10.1101/2020.04.09.034942]
   Jiang FC, 2020, EMERG INFECT DIS, V26, P2162, DOI 10.3201/eid2609.201435
   John Hopkins University Coronavirus Resource Center, 2020, STAT COVID 19 DAT RA
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kaner J, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0194-4
   Kim DS, 2006, YONSEI MED J, V47, P759, DOI 10.3349/ymj.2006.47.6.759
   Kolin David A, 2020, medRxiv, DOI 10.1101/2020.05.05.20075507
   Korber, 2020, SPIKE MUTATION PIPEL, DOI [10.1101/2020.04.29.069054, DOI 10.1101/2020.04.29.069054]
   Kox M, 2009, BIOCHEM PHARMACOL, V78, P863, DOI 10.1016/j.bcp.2009.06.096
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0
   Lanham-New Susan A, 2020, BMJ Nutr Prev Health, V3, P106, DOI 10.1136/bmjnph-2020-000089
   Lau FH., 2020, VITAMIN INSUFFICIENC, DOI [10.1101/2020.04.24.20075838, DOI 10.1101/2020.04.24.20075838]
   Lavezzo E., 2020, SUPPRESSION COVID 19, DOI [10.1101/2020.04. 17.20053157v1, 10.1038/s41586-020-2488-1, DOI 10.1101/2020.04.17.20053157]
   Leung JM, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00688-2020
   Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2
   Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x
   Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]
   Li W, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa450, DOI 10.1093/CID/CIAA450]
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Lippi G, 2020, EUR J INTERN MED, V75, P107, DOI 10.1016/j.ejim.2020.03.014
   Little P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1185
   Liu P, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008421
   Liu Y, 2020, STABILITY SARS COV 2, DOI [10.1101/2020.05.07.20094805, DOI 10.1101/2020.05.07.20094805]
   Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3
   Liu ZX, 2020, J MED VIROL, V92, P595, DOI 10.1002/jmv.25726
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   MacLean O.A., 2020, RESPONSE ORIGIN CONT
   MacLean OA, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa034
   Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583
   May M, 2020, PREPRINT
   McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537
   MEDPAGETODAY, 2020, MEDPAGETODAY
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04
   Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004
   Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730
   Munro APS, 2020, ARCH DIS CHILD, V105, P618, DOI 10.1136/archdischild-2020-319474
   National Centre for Immunisation Research and Surveillance (NCIRS), 2020, COVID 19 SCH EXP NSW
   National Institute for Health and Care Excellence, 2020, COVID 19 RAP EV SUMM
   Nextstrain, 2020, GEN EP NOV COR GLOB
   Nextstrain, 2020, REAL TIM TRACK INFL
   Nitulescu GM, 2020, INT J MOL MED, V46, P467, DOI 10.3892/ijmm.2020.4608
   Oakes JM, 2018, AM J PHYSIOL-REG I, V315, pR895, DOI 10.1152/ajpregu.00099.2018
   Office for National Statistics, 2020, 2011 CENS AN ETHN RE
   Office for National Statistics, 2020, COUNTS RAT COR REL D
   Office for National Statistics, 2020, COR KEY WORK UK
   Olds JL, 2020, FEBS J, V287, P3651, DOI 10.1111/febs.15303
   Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6
   Pareek M, 2020, LANCET, V395, P1421, DOI 10.1016/S0140-6736(20)30922-3
   Patel AB, 2020, JAMA-J AM MED ASSOC, V323, P2386, DOI 10.1001/jama.2020.8946
   Patel JV, 2013, INT J CARDIOL, V167, P2172, DOI 10.1016/j.ijcard.2012.05.081
   Phelan J., 2020, CONTROLLING SARS COV, DOI [10.1101/2020.04.28.066977, DOI 10.1101/2020.04.28.066977]
   Pradhan P, 2020, UNCANNY SIMILARITY U, DOI [10.1101/2020.01.30.927871, DOI 10.1101/2020.01.30.927871]
   PUBPEER, 2020, PROX OR SARS COV2
   RECOVERY, 2020, NO CLIN BENEFIT USE
   Reuters, 2020, REUTERS
   Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]
   Royal College of Paediatrics and Child Health, 2020, GUID PAED MULT INFL
   Royal College of Paediatrics and Child Health, 2020, COVID 19 RES EV SUMM
   Ruf BR, 2014, EUR J PEDIATR, V173, P265, DOI 10.1007/s00431-013-2023-6
   Russo P, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01116-2020
   Sajuthi Satria P, 2020, bioRxiv, DOI 10.1101/2020.04.09.034454
   SANTARPIA JL, 2020, TRANSMISSION POTENTI, DOI [10.1101/2020.03.23.20039446, DOI 10.1038/S41598-020-69286-3]
   Schuler Bryce A, 2020, bioRxiv, DOI 10.1101/2020.05.22.111187
   Setti L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082932
   Shah M, 2020, J AM ACAD DERMATOL, V83, pE35, DOI 10.1016/j.jaad.2020.04.046
   Sharpe HR, 2020, IMMUNOLOGY, V160, P223, DOI 10.1111/imm.13222
   Sinha IP, 2020, LANCET RESP MED, V8, P446, DOI 10.1016/S2213-2600(20)30152-1
   Sodhi M, 2020, PHARMACOTHERAPY, V40, P487, DOI 10.1002/phar.2395
   STOP, 2020, STUD SUGG SMOK NIC P
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6
   Tagarro A, 2021, JAMA PEDIATR, V175, P316, DOI 10.1001/jamapediatrics.2020.1346
   Taksler GB, 2015, PUBLIC HEALTH NUTR, V18, P379, DOI 10.1017/S1368980014000457
   Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036
   The Local, 2020, THE LOCAL
   Tindle HA, 2020, NICOTINE TOB RES, V22, P1669, DOI 10.1093/ntr/ntaa077
   Tobias A, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138539
   Toubiana J., 2020, OUTBREAK KAWASAKI DI, DOI [10.1101/2020.05.10.20097394, 10.1101/2020.05.10.20097394., DOI 10.1101/2020.05.10.20097394]
   Tullie L, 2020, LANCET CHILD ADOLESC, V4, pE19, DOI 10.1016/S2352-4642(20)30165-6
   Twitter, 2020, COMM SPIK MUT PIP RE
   UK Government, 2020, ETHN GROUP DIFF DEAT
   UK Government, 2020, NHS WORKF ETHN
   Urrego F, 2009, PEDIATR PULM, V44, P1075, DOI 10.1002/ppul.21099
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X
   Virological, 2020, VIROLOGICAL
   Voiriot G, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060786
   Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000
   Wang W, 2020, ENV CONTAMINATION SA, DOI [10.1101/2020.03.11.2 0034546, DOI 10.1101/2020.03.11.20034546]
   Web24 News, 2020, WEB24 NEWS
   Wikipedia, 2020, 2010 US CENS
   Worby CJ, 2015, EPIDEMICS-NETH, V13, P10, DOI 10.1016/j.epidem.2015.04.003
   World Health Organization, 2020, MULT INFL SYNDR CHIL
   World Health Organization, 2020, US NONST ANT DRUGS N
   Worldometers, 2021, COVID 19 COR PAND
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu Renyi, 2020, Curr Pharmacol Rep, V6, P56, DOI 10.1007/s40495-020-00216-7
   Wu SJ, 2020, AM J INFECT CONTROL, V48, P910, DOI 10.1016/j.ajic.2020.05.003
   Xiao C, 2020, EMERG MICROBES INFEC, V9, P378, DOI 10.1080/22221751.2020.1727299
   Xiao KP, 2020, NATURE, V583, P286, DOI 10.1038/s41586-020-2313-x
   Xing YH, 2020, J MICROBIOL IMMUNOL, V53, P473, DOI 10.1016/j.jmii.2020.03.021
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548
   Yue XP, 2018, ANN AM THORAC SOC, V15, pS126, DOI 10.1513/AnnalsATS.201706-464MG
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang JC, 2020, BRAIN BEHAV IMMUN, V87, P59, DOI 10.1016/j.bbi.2020.04.046
   Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022
   Zhang YZ, 2020, CELL, V181, P223, DOI 10.1016/j.cell.2020.03.035
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou H, 2020, CURR BIOL, V30, P2196, DOI 10.1016/j.cub.2020.05.023
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zhu Y., 2020, CHILDREN ARE UNLIKEL, DOI [10.2139/ssrn.3564428, DOI 10.1101/2020.03.26.20044826]
   Zuchowski J, 2020, ANAL SARS COV 2 VIRA, DOI [10.1101/2020.06.08.20125484, DOI 10.1101/2020.06.08.20125484]
NR 198
TC 25
Z9 26
U1 10
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD SEP
PY 2020
VL 287
IS 17
BP 3612
EP 3632
DI 10.1111/febs.15442
EA JUL 2020
PG 21
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Biochemistry & Molecular Biology
GA NK6MS
UT WOS:000545238600001
PM 32500928
OA Green Published
DA 2022-04-20
ER

PT J
AU Mahmud, I
   Garrett, TJ
AF Mahmud, Iqbal
   Garrett, Timothy J.
TI Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19
   Perspectives
SO JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
LA English
DT Article
DE mass spectrometry; emerging pathogen; COVID-19; proteomics; glycomics;
   metabolomics and lipidomics
ID HEPATITIS-C VIRUS; LIPID RAFT MICRODOMAINS; NMR-BASED METABOLOMICS;
   POSTTRANSLATIONAL MODIFICATIONS; EBOLA; IDENTIFICATION; METABOLITES;
   RECEPTORS; TISSUE; ROLES
AB As corona virus disease 2019 (COVID-19) is a rapidly growing public health crisis across the world, our knowledge of meaningful diagnostic tests and treatment for severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is still evolving. This novel coronavirus disease COVID-19 can be diagnosed using RT-PCR, but inadequate access to reagents, equipment, and a nonspecific target has slowed disease detection and management. Precision medicine, individualized patient care, requires suitable diagnostics approaches to tackle the challenging aspects of viral outbreaks where many tests are needed in a rapid and deployable approach. Mass spectrometry (MS)-based technologies such as proteomics, glycomics, lipidomics, and metabolomics have been applied in disease outbreaks for identification of infectious disease agents such as virus and bacteria and the molecular phenomena associated with pathogenesis. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF/MS) is widely used in clinical diagnostics in the United States and Europe for bacterial pathogen identification. Paper spray ionization mass spectrometry (PSI-MS), a rapid ambient MS technique, has recently open a new opportunity for future clinical investigation to diagnose pathogens. Ultra-high-pressure liquid chromatography coupled high-resolution mass spectrometry (UHPLC-HRMS)based metabolomics and lipidomics have been employed in large-scale biomedical research to discriminate infectious pathogens and uncover biomarkers associated with pathogenesis. PCR-MS has emerged as a new technology with the capability to directly identify known pathogens from the clinical specimens and the potential to identify genetic evidence of undiscovered pathogens. Moreover, miniaturized MS offers possible applications with relatively fast, highly sensitive, and potentially portable ways to analyze for viral compounds. However, beneficial aspects of these rapidly growing MS technologies in pandemics like COVID-19 outbreaks has been limited. Hence, this perspective gives a brief of the existing knowledge, current challenges, and opportunities for MS-based techniques as a promising avenue in studying emerging pathogen outbreaks such as COVID-19.
C1 [Mahmud, Iqbal; Garrett, Timothy J.] Univ Florida, Clin & Translat Sci Inst, Dept Pathol Immunol & Lab Med, Southeast Ctr Integrated Metabol SECIM, Gainesville, FL 32610 USA.
   [Mahmud, Iqbal; Garrett, Timothy J.] Univ Florida, Univ Florida Hlth, Gainesville, FL 32610 USA.
RP Garrett, TJ (corresponding author), Univ Florida, Clin & Translat Sci Inst, Dept Pathol Immunol & Lab Med, Southeast Ctr Integrated Metabol SECIM, Gainesville, FL 32610 USA.; Garrett, TJ (corresponding author), Univ Florida, Univ Florida Hlth, Gainesville, FL 32610 USA.
EM tgarrett@ufl.edu
OI Mahmud, Iqbal/0000-0001-7729-8122
CR Adamo R, 2020, GLYCOCONJUGATE J, V37, P511, DOI 10.1007/s10719-020-09929-9
   Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15
   Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766
   [Anonymous], 2020, METABOLOMIC PROFILIN, DOI [10.1016/j.freeradbiomed.2012.05.001, DOI 10.1016/J.FREERADBIOMED.2012.05.001]
   Baluya DL, 2007, ANAL CHEM, V79, P6862, DOI 10.1021/ac070958d
   Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500
   Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106
   Bezstarosti K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259165
   Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443
   Bojkova D, 2020, NATURE, V583, P469, DOI 10.1038/s41586-020-2332-7
   Buchan BW, 2014, CLIN MICROBIOL REV, V27, P783, DOI 10.1128/CMR.00003-14
   Byers NM, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030225
   Chamberlain CA, 2019, ANAL CHEM, V91, P4964, DOI 10.1021/acs.analchem.9b00330
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003
   Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Ciazynska M, 2020, PSYCHO-ONCOLOGY, V29, P1377, DOI 10.1002/pon.5434
   Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3
   Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10
   Darnell MER, 2004, J VIROL METHODS, V121, P85, DOI 10.1016/j.jviromet.2004.06.006
   Das UN, 2020, ARCH MED RES, V51, P282, DOI 10.1016/j.arcmed.2020.03.004
   Dietz W, 2020, OBESITY, V28, P1005, DOI 10.1002/oby.22818
   Drexler Dieter M., 2007, Journal of Pharmacological and Toxicological Methods, V55, P279, DOI 10.1016/j.vascn.2006.11.004
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h
   Fu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep29680
   Fung TS, 2018, FUTURE VIROL, V13, P405, DOI 10.2217/fvl-2018-0008
   Garcia-Dorival I, 2016, J PROTEOME RES, V15, P4290, DOI 10.1021/acs.jproteome.6b00337
   Garrett TJ, 2011, ANAL BIOANAL CHEM, V401, P103, DOI 10.1007/s00216-011-5044-x
   GARRETT TJ, 2009, METHODS MOL BIOL 1, V579, P247, DOI DOI 10.1007/978-1-60761-322-0_12
   Ghaffari S, 2020, ARCH MED RES, V51, P464, DOI 10.1016/j.arcmed.2020.04.006
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386
   Gori T, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0792-4
   Hao J, 2014, NAT PROTOC, V9, P1416, DOI 10.1038/nprot.2014.090
   Hatzakis E, 2019, COMPR REV FOOD SCI F, V18, P189, DOI 10.1111/1541-4337.12408
   Hayden RT, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00888-19
   Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007
   Heer CD, 2020, J BIOL CHEM, V295, P17986, DOI [10.1074/jbc.RA120.015138, 10.1101/2020.04.17.047480]
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4
   Ihling C, 2020, J PROTEOME RES, V19, P4389, DOI 10.1021/acs.jproteome.0c00280
   Ison MG, 2020, JAMA-J AM MED ASSOC, V323, P2365, DOI 10.1001/jama.2020.8863
   Kelly DL, 2020, BIOL BLOOD MARROW TR, V26, P1803, DOI 10.1016/j.bbmt.2020.06.014
   Khoubnasabjafari M, 2020, BIOANALYSIS, V12, P1195, DOI 10.4155/bio-2020-0083
   Kwong KCNK, 2020, J CLIN NEUROSCI, V77, P13, DOI 10.1016/j.jocn.2020.04.124
   Kyle JE, 2019, P NATL ACAD SCI USA, V116, P3919, DOI 10.1073/pnas.1815356116
   Lahiri D, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7889
   Landgraf RR, 2009, ANAL CHEM, V81, P8488, DOI 10.1021/ac901387u
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lee BY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60616-z
   Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]
   Li Yanchang, 2020, Urine (Amst), V2, P1, DOI 10.1016/j.urine.2021.02.001
   Liang Q, 2020, BIORXIV, DOI [10.1101/2020.03.31.019216, DOI 10.1101/2020.03.31.019216, 10.1016/j.medj.2020.07.002]
   Liu W-C., 2020, SARS COV 2 LAUNCHES, DOI [10.1101/2020.03.24.004655, DOI 10.1101/2020.03.24.004655]
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Mahmud I., 2020, LIPIDOMICS HUMAN CAN, DOI [10.1201/ 9780429461385-2, DOI 10.1201/9780429461385-2]
   Mahmud I, 2019, ANAL CHEM, V91, P14784, DOI 10.1021/acs.analchem.9b03338
   Mahmud I, 2019, NUCLEIC ACIDS RES, V47, P7734, DOI 10.1093/nar/gkz634
   Mahmud I, 2017, ANAL BIOANAL CHEM, V409, P6173, DOI 10.1007/s00216-017-0557-6
   Mahmud I, 2015, J AGR FOOD CHEM, V63, P8083, DOI 10.1021/acs.jafc.5b02108
   Mahmud I, 2015, IN VITRO CELL DEV-PL, V51, P340, DOI 10.1007/s11627-015-9687-8
   Mahmud I, 2014, ANAL BIOANAL CHEM, V406, P5997, DOI 10.1007/s00216-014-8002-6
   Mahmud Iqbal, 2014, Plant Tissue Culture & Biotechnology, V24, P77
   Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129
   Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686
   Menzies V, 2021, BIOL RES NURS, V23, P119, DOI 10.1177/1099800420941109
   Messner C. B., 2020, J AM SOC MASS SPECTR, V31, P2013, DOI [10.1101/ 2020.04.27.20081810, DOI 10.1101/2020.04.27.20081810]
   Migaud M, 2020, AM J RESP CELL MOL, V63, P396, DOI 10.1165/rcmb.2020-0206LE
   Miller ME, 2012, J VIROL, V86, P7473, DOI 10.1128/JVI.00136-12
   Nanbo A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006848
   Nehme Z, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0654-9
   Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908
   Nicora CD, 2020, METHODS MOL BIOL, V2099, P173, DOI 10.1007/978-1-0716-0211-9_14
   Ong J, 2020, GUT, V69, P1144, DOI [10.1136/gutjnl-2020-321051, 10.1136/gutjnl-2020-321154]
   Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Pinto FG, 2020, J PROTEOME RES, V19, P2080, DOI 10.1021/acs.jproteome.0c00006
   Puttamallesh Vinuth N, 2013, Clin Proteomics, V10, P14, DOI 10.1186/1559-0275-10-14
   Raj VS, 2015, METHODS MOL BIOL, V1282, P165, DOI 10.1007/978-1-4939-2438-7_15
   Ribet D, 2010, CELL, V143, P694, DOI 10.1016/j.cell.2010.11.019
   Rocca MF, 2020, J VIROL METHODS, V286, DOI 10.1016/j.jviromet.2020.113991
   Rodrigues M, 2018, THERANOSTICS, V8, P2709, DOI 10.7150/thno.20576
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Sahu S, 1978, Inflammation, V3, P27, DOI 10.1007/BF00917319
   Scaturro P, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090878
   Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259
   Shajahan A., 2020, Glycobiology, V31, P410, DOI 10.1093/glycob/cwaa101
   Shen Bingzheng, 2020, SN Compr Clin Med, V2, P1029, DOI 10.1007/s42399-020-00382-1
   Singh N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00606
   Snyder DT, 2016, ANAL CHEM, V88, P2, DOI 10.1021/acs.analchem.5b03070
   Soni SP, 2014, J BIOL CHEM, V289, P33590, DOI 10.1074/jbc.M114.586396
   Soudani N, 2019, J VIROL, V93, DOI 10.1128/JVI.00053-19
   Srzentic K, 2020, J AM SOC MASS SPECTR, V31, P1783, DOI 10.1021/jasms.0c00036
   Stefan N, 2020, NAT REV ENDOCRINOL, V16, P341, DOI 10.1038/s41574-020-0364-6
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6
   Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001
   Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100
   Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052
   Taube S, 2010, VIRUSES-BASEL, V2, P1011, DOI 10.3390/v2041011
   Taube S, 2009, J VIROL, V83, P4092, DOI 10.1128/JVI.02245-08
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Thomas JJ, 2001, P NATL ACAD SCI USA, V98, P4932, DOI 10.1073/pnas.081069298
   Thomas T., 2020, COVID 19 INFECT RESU, DOI [10.1172/jci.insight.140327, DOI 10.1172/JCI.INSIGHT.140327]
   Tian XD, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111007
   Udugama B, 2020, ACS NANO, V14, P3822, DOI 10.1021/acsnano.0c02624
   Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y
   Watanabe Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16567-0
   Wei XQ, 2020, J CLIN LIPIDOL, V14, P297, DOI 10.1016/j.jacl.2020.04.008
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wenk MR, 2006, FEBS LETT, V580, P5541, DOI 10.1016/j.febslet.2006.07.007
   WHO, OUTBR COMM GUID
   Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32
   Wolk DM, 2012, J MOL DIAGN, V14, P295, DOI 10.1016/j.jmoldx.2012.02.005
   Wu D., 2020, J AM SOC MASS SPECTR, V31, P2013, DOI [10.1021/jasms.0c00238, DOI 10.1021/JASMS.0C00238]
   Wu Di, 2020, Natl Sci Rev, V7, P1157, DOI 10.1093/nsr/nwaa086
   Yalameha B., 2020, PERSPECTIVES RELATIO, V9, P5
   Yan BP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010073
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhao P, 2020, CELL HOST MICROBE, V28, P586, DOI [10.1101/2020.06.25.172403, 10.1016/j.chom.2020.08.004]
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhou ST, 2011, SCI CHINA LIFE SCI, V54, P502, DOI 10.1007/s11427-011-4177-7
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 126
TC 25
Z9 28
U1 14
U2 41
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1044-0305
EI 1879-1123
J9 J AM SOC MASS SPECTR
JI J. Am. Soc. Mass Spectrom.
PD OCT 7
PY 2020
VL 31
IS 10
BP 2013
EP 2024
DI 10.1021/jasms.0c00238
PG 12
WC Biochemical Research Methods; Chemistry, Analytical; Chemistry,
   Physical; Spectroscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Spectroscopy
GA OE4PM
UT WOS:000580514400002
PM 32880453
OA Green Published
DA 2022-04-20
ER

PT J
AU Wallace, H
   Angus, R
AF Wallace, Helen
   Angus, Robert
TI Supplemental Learning in Respiratory Physiology for Healthcare
   Professionals Towards Successful Treatment of COVID-19
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE education; respiratory; physiology; clinical; COVID-19; pathophysiology;
   treatment
ID HEART-RATE RESPONSES; HYPOXIA; ANGIOTENSIN; HYPERCAPNIA
AB The immunological and pathophysiological response to COVID-19 can cause severe respiratory impairment affecting gas exchange and lung mechanics. Such was the scale of the respiratory support needed during the first wave of the pandemic, that recruitment of non-respiratory clinical staff was essential to help deal with the growing number of cases. It quickly became apparent that it was vital to rapidly equip these healthcare professionals with appropriate physiological knowledge and practical skills if therapies were to be applied effectively. Furthermore, the unravelling of unusual clinical features of COVID-19, further highlighted a need for knowledge of long-established principles of respiratory physiology. An online digital educational resource, or "respiratory learning tool kit" was developed with interactive material including visualisations, animations, and pathophysiological examples to facilitate understanding. The learning outcomes were centred on physiological principles, essential for understanding the pathophysiology relating to COVID-19, and management and treatment. Topics included principles of gas exchange, gas transport, homeostasis and central control of respiration. These basic physiological principles were linked to pathophysiology and clinical skills around oxygen administration and non-invasive supports such as Continuous Positive Airway Pressure (CPAP). From the degree of engagement and evaluation comments, it was clear that the resource successfully achieved its aim-to increase physiological knowledge and its practical understanding, enabling healthcare professionals to practice with confidence in such an uncertain environment.
C1 [Wallace, Helen] Univ Liverpool, Inst Life Course & Med Sci, Dept Women & Childrens Hlth, Liverpool, Merseyside, England.
   [Angus, Robert] Univ Liverpool, Inst Life Course & Med Sci, Sch Med, Liverpool, Merseyside, England.
RP Wallace, H (corresponding author), Univ Liverpool, Inst Life Course & Med Sci, Dept Women & Childrens Hlth, Liverpool, Merseyside, England.
EM hwaliace@liverpool.ac.uk
FU Centre for Educational Development and Support (CEDS), University Of
   Liverpool
FX We would also like to thank Andrew Evans Think Philanthropy,
   https://www.thinkphilanthropy.com, Karen Ward, Consultant
   Physiotherapist Liverpool University Hospitals NHS Foundation Trust,
   Verity Ford, Principal Physiotherapist Liverpool University Hospitals
   NHS Foundation Trust and Han Duijvendak, Producer/Director, HANDSTAND
   Films, http: //www.handstand- uk.eu. Moreover, the design and
   development of the physiology animations was supported by Dr. Rebecca
   Hamm and the Centre for Educational Development and Support (CEDS),
   University Of Liverpool.
CR Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chandra A, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-237207
   Fraser E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3001
   Fung ML, 2015, RESP PHYSIOL NEUROBI, V209, P6, DOI 10.1016/j.resp.2014.09.014
   George PP, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010406
   Hwang I, 2012, ELECTRON J E-LEARN, V10, P368
   KRONENBERG RS, 1973, J CLIN INVEST, V52, P1812, DOI 10.1172/JCI107363
   Laurillard D, 2012, TEACHING AS A DESIGN SCIENCE, P1
   Levitan R, 2020, NEW YORK TIMES
   Nicoll P, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9085
   NISHIMURA M, 1989, THORAX, V44, P251, DOI 10.1136/thx.44.4.251
   ODONNELL CR, 1988, NEW ENGL J MED, V319, P1369, DOI 10.1056/NEJM198811243192102
   PETERSON DD, 1981, AM REV RESPIR DIS, V124, P387
   Sun KY, 2021, SCIENCE, V371, P254, DOI 10.1126/science.abe2424
   Tobin MJ, 2020, AM J RESP CRIT CARE, V202, P356, DOI 10.1164/rccm.202006-2157CP
   Vaona Alberto, 2018, Cochrane Database Syst Rev, V1, pCD011736, DOI 10.1002/14651858.CD011736.pub2
   Weisbrod CJ, 2005, DIABETIC MED, V22, P563, DOI 10.1111/j.1464-5491.2005.01458.x
   World Health Organization, 2020, CLIN MAN COVID 19 IN
   Xia HJ, 2008, J NEUROCHEM, V107, P1482, DOI 10.1111/j.1471-4159.2008.05723.x
NR 19
TC 0
Z9 0
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD APR 20
PY 2021
VL 12
AR 624528
DI 10.3389/fphys.2021.624528
PG 6
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA RW2TA
UT WOS:000646379300001
PM 33959035
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Abu, EK
   Oloruntoba, R
   Osuagwu, UL
   Bhattarai, D
   Miner, CA
   Goson, PC
   Langsi, R
   Nwaeze, O
   Chikasirimobi, TG
   Ovenseri-Ogbomo, GO
   Ekpenyong, BN
   Charwe, DD
   Mashige, KP
   Ishaya, T
   Agho, KE
AF Abu, Emmanuel Kwasi
   Oloruntoba, Richard
   Osuagwu, Uchechukwu Levi
   Bhattarai, Dipesh
   Miner, Chundung Asabe
   Goson, Piwuna Christopher
   Langsi, Raymond
   Nwaeze, Obinna
   Chikasirimobi, Timothy G.
   Ovenseri-Ogbomo, Godwin O.
   Ekpenyong, Bernadine N.
   Charwe, Deborah Donald
   Mashige, Khathutshelo Percy
   Ishaya, Tanko
   Agho, Kingsley Emwinyore
TI Risk perception of COVID-19 among sub-Sahara Africans: a web-based
   comparative survey of local and diaspora residents
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Africa; Pandemic; Diaspora; Lockdown; Risk perception; Sub-Sahara
   Africa; Knowledge; COVID-19
ID RESPIRATORY-SYNDROME SARS; IMPACT; TRANSMISSION; QUARANTINE
AB Background Perceived risk towards the coronavirus pandemic is key to improved compliance with public health measures to reduce the infection rates. This study investigated how Sub-Saharan Africans (SSA) living in their respective countries and those in the diaspora perceive their risk of getting infected by the COVID-19 virus as well as the associated factors. Methods A web-based cross-sectional survey on 1969 participants aged 18 years and above (55.1% male) was conducted between April 27th and May 17th 2020, corresponding to the mandatory lockdown in most SSA countries. The dependent variable was the perception of risk for contracting COVID-19 scores. Independent variables included demographic characteristics, and COVID-19 related knowledge and attitude scores. Univariate and multiple linear regression analyses identified the factors associated with risk perception towards COVID-19. Results Among the respondents, majority were living in SSA (n = 1855, 92.8%) and 143 (7.2%) in the diaspora. There was no significant difference in the mean risk perception scores between the two groups (p = 0.117), however, those aged 18-28 years had lower risk perception scores (p = 0.003) than the older respondents, while those who were employed (p = 0.040) and had higher levels of education (p < 0.001) had significantly higher risk perception scores than other respondents. After adjusting for covariates, multivariable analyses revealed that SSA residents aged 39-48 years (adjusted coefficient, beta = 0.06, 95% CI [0.01, 1.19]) and health care sector workers (beta = 0.61, 95% CI [0.09, 1.14]) reported a higher perceived risk of COVID-19. Knowledge and attitude scores increased as perceived risk for COVID-19 increased for both SSAs in Africa (beta = 1.19, 95% CI [1.05, 1.34] for knowledge; beta = 0.63, 95% CI [0.58, 0.69] for attitude) and in Diaspora (beta = 1.97, 95% CI [1.16, 2.41] for knowledge; beta = 0.30, 95% CI [0.02, 0.58] for attitude). Conclusions There is a need to promote preventive measures focusing on increasing people's knowledge about COVID-19 and encouraging positive attitudes towards the mitigation measures such as vaccines and education. Such interventions should target the younger population, less educated and non-healthcare workers.
C1 [Abu, Emmanuel Kwasi] Univ Cape Coast, Sch Allied Hlth Sci, Dept Optometry & Vis Sci, Cape Coast 00233, Ghana.
   [Oloruntoba, Richard] Curtin Univ, Sch Management & Mkt, Fac Business & Law, Bentley, WA 6151, Australia.
   [Osuagwu, Uchechukwu Levi] Western Sydney Univ, Translat Hlth Res Inst THRI, Sch Med, Campbelltown, NSW 2560, Australia.
   [Osuagwu, Uchechukwu Levi; Ovenseri-Ogbomo, Godwin O.; Ekpenyong, Bernadine N.; Mashige, Khathutshelo Percy; Agho, Kingsley Emwinyore] Univ KwaZulu Natal, African Vis Res Inst AVRI, Sch Hlth Sci, Discipline Optometry, Westville Campus, ZA-3629 Durban, South Africa.
   [Bhattarai, Dipesh] Deakin Univ, Sch Med, Fac Hlth, Geelong, Vic, Australia.
   [Miner, Chundung Asabe] Univ Jos, Dept Community Med, Coll Hlth Sci, Jos, Nigeria.
   [Goson, Piwuna Christopher] Univ Jos, Dept Psychiat, Coll Hlth Sci, Jos, Nigeria.
   [Langsi, Raymond] Univ Bamenda Bambili, Hlth Div, Bamenda, Cameroon.
   [Nwaeze, Obinna] Cty Durham & Darlington Natl Hlth Serv NHS Fdn, Darlington DL3 0PD, Durham, England.
   [Chikasirimobi, Timothy G.] Masinde Muliro Univ Sci & Technol, Sch Publ Hlth Biomed Sci & Technol, Dept Optometry & Vis Sci, Kakamega 50100, Kenya.
   [Ovenseri-Ogbomo, Godwin O.] Univ Highlands & Isl, Ctr Hlth Sci, Dept Optometry, Old Perth Rd, Inverness IV2 3JH, Scotland.
   [Ovenseri-Ogbomo, Godwin O.] Univ Benin, Fac Life Sci, Dept Optometry, Benin, Nigeria.
   [Ekpenyong, Bernadine N.] Univ Calabar, Fac Allied Med Sci, Coll Med Sci, Dept Publ Hlth, Calabar, Cross River Sta, Nigeria.
   [Charwe, Deborah Donald] Tanzania Food & Nutr Ctr, POB 977, Dar Es Salaam, Tanzania.
   [Ishaya, Tanko] Univ Jos, Dept Comp Sci, Jos, Nigeria.
   [Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Hlth Sci, Campbelltown, NSW 2560, Australia.
RP Osuagwu, UL (corresponding author), Western Sydney Univ, Translat Hlth Res Inst THRI, Sch Med, Campbelltown, NSW 2560, Australia.; Osuagwu, UL (corresponding author), Univ KwaZulu Natal, African Vis Res Inst AVRI, Sch Hlth Sci, Discipline Optometry, Westville Campus, ZA-3629 Durban, South Africa.
EM l.osuagwu@westernsydney.edu.au
RI Agho, Kingsley/AAW-5622-2021
OI Agho, Kingsley/0000-0003-4111-3207; Abu, Emmanuel
   Kwasi/0000-0003-2354-9170
CR Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0
   Abir T., 2020, FACTORS ASS PERCEPTI
   Abir T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145252
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   Appleby-Arnold S, 2018, INT J DISAST RISK RE, V31, P37, DOI 10.1016/j.ijdrr.2018.04.015
   Asefa A, 2020, RISK MANAG HEALTHC P, V13, P2601, DOI 10.2147/RMHP.S276257
   Barnes SJ, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102175
   Brown P, 2020, HEALTH RISK SOC, V22, P1, DOI 10.1080/13698575.2020.1745508
   Cousins S, 2020, LANCET, V396, P1322, DOI 10.1016/S0140-6736(20)32206-6
   DDG/P Office and OECD, 2020, IMP COVID 19 PAND JO, P1
   De Juan A, 2020, WORLD DEV, V126, DOI 10.1016/j.worlddev.2019.104715
   Di Gennaro F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082690
   Dillard AJ, 2018, PSYCHOL HEALTH, V33, P573, DOI 10.1080/08870446.2017.1380811
   Drefahl S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18926-3
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Ekpenyong B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145141
   Farrell TW, 2020, J AM GERIATR SOC, V68, P1143, DOI 10.1111/jgs.16539
   Ferioli M, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0068-2020
   Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012
   Girma S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241101
   Golden I, 2020, HLTH SCI J, DOI 10.36648/1791-809X.S1.002
   Haeffele S, 2020, GOVT RESPONSES CRISI, P1
   Hasmuk K., 2020, LONG TERM CARE COVID
   Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703
   Henley J, 2020, THE GUARDIAN 1204
   Herrera-Diestra JL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225576
   Hjort J, 2019, AM ECON REV, V109, P1032, DOI 10.1257/aer.20161385
   Hsu A.T., 2020, INT LONG TERM CARE P, V17, P1
   Huang L, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.006
   Jahangiry L, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09681-7
   Karim W., 2020, INT TOURISM HOSPITAL, V3, P1, DOI DOI 10.37227/ITHJ-2020-02-09
   Koh D, 2005, MED CARE, V43, P676, DOI 10.1097/01.mlr.0000167181.36730.cc
   Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628
   Law S, 2020, INT J INFECT DIS, V94, P156, DOI 10.1016/j.ijid.2020.03.059
   Li ZH, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008584
   Marron JM, 2020, J CLIN ONCOL, V38, P2201, DOI 10.1200/JCO.20.00960
   McMaster M, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13080173
   Morgado AM, 2020, COMMUNITY DEV, V51, P3, DOI 10.1080/15575330.2020.1714685
   Mustaffa N, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020370
   Organization WH, 2020, COR DIS 2019 COVID 1
   Organization WH, 2020, COVID 19 GLOB RISK C
   Ovenseri-Ogbomo G, 2020, J GLOB HEALTH REP, V4, DOI DOI 10.29392/001C.17606
   Paek HJ, 2017, RISK PERCEPTIONS RIS, P1, DOI [DOI 10.1093/ACREFORE/9780190228613.013.283, 10.1093/acrefore/9780190228613.013.283]
   Pereira M, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01439-4
   Quinn T, 2018, ECOL SOC, V23, DOI 10.5751/ES-10004-230239
   Rathod S., 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1556, DOI 10.1136/BMJ.M1556]
   Reynolds DL, 2008, EPIDEMIOL INFECT, V136, P997, DOI 10.1017/S0950268807009156
   Roser M., 2020, CORONAVIRUS PANDEMIC
   Serwaa D, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.2020.35.2.22630, 10.11604/pamj.supp.2020.35.2.22630]
   Tang RM, 2019, INT J DISAST RISK SC, V10, P371, DOI 10.1007/s13753-019-00234-0
   Vatcheva Kristina P, 2016, Epidemiology (Sunnyvale), V6
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   World Health Organization, 2020, COR DIS 2019 COV 19
   Xiao YH, 2020, LANCET INFECT DIS, V20, P523, DOI 10.1016/S1473-3099(20)30152-3
   Zhong YP, 2021, NURS OUTLOOK, V69, P13, DOI 10.1016/j.outlook.2020.08.005
   Zito RR, 2020, MATH FDN SYSTEM SAFE, P51, DOI [10.1007/978-3-030-26241-9_3, DOI 10.1007/978-3-030-26241-9_3]
NR 56
TC 3
Z9 3
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD AUG 18
PY 2021
VL 21
IS 1
AR 1562
DI 10.1186/s12889-021-11600-3
PG 13
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA UC6GH
UT WOS:000686621900001
PM 34404377
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Abbas-Hanif, A
   Rezai, H
   Ahmed, SF
   Ahmed, A
AF Abbas-Hanif, Allyah
   Rezai, Homira
   Ahmed, Syed Faraz
   Ahmed, Asif
TI The impact of COVID-19 on pregnancy and therapeutic drug development
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Review
DE cardiovascular diseases; clinical trials; COVID-19; drug development;
   pre-eclampsia; pregnancy; vaccines
ID ENDOTHELIAL GROWTH-FACTOR; CONCISE GUIDE; PREECLAMPSIA; RISK;
   PATHOPHYSIOLOGY; HYPERTENSION; EXPRESSION; SARS-COV-2; MORBIDITY;
   RELEASE
AB Emerging data show that pregnant women with COVID-19 are at significantly higher risk of severe outcomes compared with non-pregnant women of similar age. This review discusses the invaluable insight revealed from vaccine clinical trials in women who were vaccinated and inadvertently became pregnant during the trial period. It further explores a number of clinical avenues in their management and proposes a drug development strategy in line with clinical trials for vaccines and drug treatments for the drug development community. Little is known of the long-term effects of COVID-19 on the mother and the baby. Our hypothesis that COVID-19 predisposes pregnant women to pre-eclampsia or hypertensive disorders during pregnancy is supported by a clinical study, and this may also adversely impact a woman's cardiovascular disease risk later in life. It may also increase a woman's risk of pre-eclampsia in subsequent pregnancy. This is an ever-evolving landscape, and early knowledge for healthcare providers and drug innovators is offered to ensure benefits outweigh the risks. COVID-19 mRNA vaccines appear to generate robust humoral immunity in pregnant and lactating women. This novel approach to vaccination also offers new ways to therapeutically tackle disorders of many unmet medical needs.
C1 [Abbas-Hanif, Allyah; Rezai, Homira; Ahmed, Syed Faraz; Ahmed, Asif] MirZyme Therapeut, Div Drug Dev, Birmingham, W Midlands, England.
   [Abbas-Hanif, Allyah] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Cardiol, London, England.
   [Ahmed, Asif] Univ Southampton, Sch Hlth Sci, Southampton, England.
RP Abbas-Hanif, A; Ahmed, A (corresponding author), MirZyme Therapeut, Div Drug Dev, Innovation Birmingham Campus,Holt St, Birmingham B7 4BB, England.
EM allyah.abbas@doctors.org.uk; asif.ahmed@mirzyme.com
RI Ahmed, Asif/ABE-9544-2020
OI Ahmed, Asif/0000-0002-8755-8546
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5
   Ahmed A, 1997, LAB INVEST, V76, P779
   Ahmed A, 2017, ADV EXP MED BIOL, V956, P355, DOI 10.1007/5584_2016_168
   Ahmed A, 2015, BRIT J PHARMACOL, V172, P1574, DOI 10.1111/bph.12977
   Al-Lami RA, 2021, AM J OBSTET GYNECOL, V224, P550, DOI 10.1016/j.ajog.2021.01.007
   Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS247, DOI 10.1111/bph.14751
   Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS297, DOI 10.1111/bph.14752
   Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS21, DOI 10.1111/bph.14748
   Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320
   Bandyopadhyay D, 2020, AM J CARDIOVASC DRUG, V20, P311, DOI 10.1007/s40256-020-00420-2
   Basit S, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4109
   Behrens I, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3078
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE
   Bennett WA, 1998, AM J REPROD IMMUNOL, V40, P309
   Bermejo-Martin JF, 2020, CARDIOVASC RES, V116, pE132, DOI 10.1093/cvr/cvaa140
   Bharadwaj MS, 2011, HYPERTENSION, V58, P852, DOI 10.1161/HYPERTENSIONAHA.111.179358
   Bokslag A, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.02.015
   Brouwers L, 2018, BJOG-INT J OBSTET GY, V125, P1642, DOI 10.1111/1471-0528.15394
   Carosso A, 2020, EUR J OBSTET GYN R B, V250, P246, DOI 10.1016/j.ejogrb.2020.04.065
   Centers for Disease Control and Prevention, 2021, SARS COV 2 VAR CLASS
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Clark P, 1998, SEMIN REPROD ENDOCR, V16, P57
   Clark RL, 2009, REPROD TOXICOL, V28, P285, DOI 10.1016/j.reprotox.2009.05.002
   ClinicalTrials.gov, 2021, PK SAF REMD TREATM C
   ClinicalTrials.gov, 2021, STUD EV SAF TOL IMM
   Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134
   D.o.H.a.S.C. (DHSC), 2020, PUBL ASS REP AUTH TE
   Dhaundiyal A, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118676
   Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107
   Duley Lelia, 2008, BMJ Clin Evid, V2008
   Ellington S, 2020, MMWR-MORBID MORTAL W, V69, P769, DOI 10.15585/mmwr.mm6925a1externalicon
   European Medicines Agency, 2021, EMA STARTS 1 ROLL RE
   European Medicines Agency, 1996, NOT GUID GOOD CLIN P
   Fenizia C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18933-4
   Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336
   Flannery DD, 2021, JAMA PEDIATR, V175, P594, DOI 10.1001/jamapediatrics.2021.0038
   Food and Drug Administration, 2020, VACC REL BIOL PROD A
   Food and Drug Administration, 2006, GUID CLIN TRIAL SPON
   Gilbert P., 2021, NEWBORN ANTIBODIES S
   Gordon A.C., 2021, INTERLEUKIN 6 RECEPT, DOI [10.1101/2021.01.07.21249390, DOI 10.1101/2021.01.07.21249390]
   Graham JM, 2020, BIRTH DEFECTS RES, V112, P943, DOI 10.1002/bdr2.1696
   Gray Kathryn J, 2021, medRxiv, DOI 10.1101/2021.03.07.21253094
   GREENE R, 1981, AM REV RESPIR DIS, V124, P593
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   GRIMES DA, 1994, AM J OBSTET GYNECOL, V170, P1489
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Hellwig K, 2020, J NEUROL, V267, P1715, DOI 10.1007/s00415-020-09762-y
   Horby P.W., 2021, TOCILIZUMIAB PATIENT
   Horby P.W., 2021, CONVALESCENT PLASMA
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Intensive Care National Audit Research Centre, 2021, INT CAR NAT AUD RES
   International Conference on Harmonisation, 2021, ICH GUID M3 R2 GUID
   Jering KS, 2021, JAMA INTERN MED, V181, P714, DOI 10.1001/jamainternmed.2020.9241
   Jin YF, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00454-7
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Joyner MJ, 2021, NEW ENGL J MED, V384, P1015, DOI 10.1056/NEJMoa2031893
   Juusela A, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100113
   Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884
   Li CZ, 2020, J MOL CELL CARDIOL, V147, P74, DOI 10.1016/j.yjmcc.2020.08.008
   Li MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230295
   Lokken EM, 2021, AM J OBSTET GYNECOL, V225, DOI 10.1016/j.ajog.2020.12.1221
   Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n597
   Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189
   Mccoy JA, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100164
   Metz TD, 2021, OBSTET GYNECOL, V137, P571, DOI 10.1097/AOG.0000000000004339
   Mitrani RD, 2020, HEART RHYTHM, V17, P1984, DOI 10.1016/j.hrthm.2020.06.026
   Monk PD, 2021, LANCET RESP MED, V9, P196, DOI 10.1016/S2213-2600(20)30511-7
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   Mullins E, 2021, ULTRASOUND OBST GYN, V57, P573, DOI 10.1002/uog.23619
   Naqvi M, 2020, OBSTET GYNECOL, V136, P1025, DOI 10.1097/AOG.0000000000004050
   Park KS, 2021, ADV DRUG DELIVER REV, V169, P137, DOI 10.1016/j.addr.2020.12.008
   Patone M., 2021, ANAL SEVERE OUTCOMES
   Pringle KG, 2011, PLACENTA, V32, P956, DOI 10.1016/j.placenta.2011.09.020
   Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557
   Rana S, 2019, CIRC RES, V124, P1094, DOI 10.1161/CIRCRESAHA.118.313276
   Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068
   RECOVERY Trial, 2020, RAND EV COVID 19 THE
   Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5
   Rezai H, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101768
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rosenbloom JI, 2021, AM J OBSTET GYNECOL, V224, P623, DOI 10.1016/j.ajog.2021.03.001
   Royal College of Obstetricians and Gynaecologists, 2020, UPD ADV COVID 19 VAC
   Royal College of Obstetricians and Gynaecologists, 2020, COR COVID 19 INF PRE
   Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201
   Saif J, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101814
   Samavati L, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00317
   Sanchez-Aranguren LC, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9070598
   Sentilhes L, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.06.022
   Shakib JH, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2360
   Ssentongo P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238215
   Taylor MM, 2021, LANCET GLOB HEALTH, V9, pE366, DOI 10.1016/S2214-109X(20)30484-8
   Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0
   Vousden N., 2021, PLoS ONE, V16, DOI 10.1371/journal.pone.0251123
   Wang KQ, 2013, CIRCULATION, V127, P2514, DOI 10.1161/CIRCULATIONAHA.113.001631
   WHO, 2021, DRAFT LANDSC TRACK C
   Zambrano LD, 2020, MMWR-MORBID MORTAL W, V69, P1641, DOI 10.15585/mmwr.mm6944e3
   Zeng LK, 2020, JAMA PEDIATR, V174, P722, DOI 10.1001/jamapediatrics.2020.0878
NR 102
TC 2
Z9 2
U1 2
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD MAY
PY 2022
VL 179
IS 10
BP 2108
EP 2120
DI 10.1111/bph.15582
EA JUL 2021
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 0G5VD
UT WOS:000670115200001
PM 34085281
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Albagli, S
   Rocha, L
AF Albagli, Sarita
   Rocha, Luana
TI CITIZEN SCIENCE DURING EMERGENCIES: BRAZILIAN INITIATIVES TO FACE THE
   COVID-19 PANDEMIC
SO ARBOR-CIENCIA PENSAMIENTO Y CULTURA
LA Portuguese
DT Article
DE Citizen science; COVID-19; reduction of risk from disasters
ID TOOL
AB The COVID-19 pandemic highlights the possibilities, limits, and new challenges for Open Science. This article presents the results of research that sought to contribute to the understanding of the role of citizen science, one of the axes of Open Science, to deal with issues posed by the pandemic. In addition to a literature review, the study involved identification and categorization of these citizen initiatives in Brazil during the COVID-19 outbreak. Mutual learning can be seen between citizen science approaches and participatory actions to reduce risks from disasters. On the one hand, this learning strengthens the role of citizens' production of data, information, and knowledge relevant for the prevention, resilience to, and management of these risks; and, on the other hand, it broadens the scope of citizen science to confront emergency and disaster situations while reinforcing the situated character of this approach.
C1 [Albagli, Sarita; Rocha, Luana] Inst Brasileiro Informacao Ciencia & Tecnol IBICT, Brasilia, DF, Brazil.
RP Albagli, S (corresponding author), Inst Brasileiro Informacao Ciencia & Tecnol IBICT, Brasilia, DF, Brazil.
EM sarita.albagli@gmail.com; luaroc@gmail.com
CR Albagli Sarita, 2015, CIENCIA ABERTA QUEST, P9
   Albagli Sarita, HUMANITIES SOCIAL SC
   Albagli Sarita, 2021, SOB LENTE CIENCIA AB, P489
   Bezerra Arthur Coelho, 2019, INFORM SOC, V29
   Black PF, 2014, REV SCI TECH OIE, V33, P465, DOI 10.20506/rst.33.2.2293
   Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9
   Bowser Anne, CTRL FORWARD BLOG SC
   Calyx C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114522
   Chan L, 2019, CONTEXTUALIZING OPEN
   Clinio Anne, 2020, LIINC EM REV, V16, DOI [10.18617/LIINC.V16I2.5386, DOI 10.18617/LIINC.V16I2.5386]
   Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5
   Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236
   Flores R, 2020, JCOM-J SCI COMMUN, V19, DOI 10.22323/2.19070209
   Hacklay Muki, 2015, CITIZEN SCI POLICY E
   Hicks A, 2019, FRONT EARTH SC-SWITZ, V7, DOI 10.3389/feart.2019.00226
   Horton R, 2020, LANCET, V396, P874, DOI 10.1016/S0140-6736(20)32000-6
   Hussain A, 2018, CUREUS, V10, DOI 10.7759/cureus.2919
   Irwin, 1995, CITIZEN SCI STUDY PE
   Lafuente Antonio, 2015, CIENCIA ABERTA QUEST, P27
   Lafuente Antonio, 2018, AGENDA CULTURAL ALMA, P19
   Lasser J, 2020, JCOM-J SCI COMMUN, V19, DOI 10.22323/2.19050801
   Marchezini V, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00184
   MARÍA ÁNGELES ABELLÁN LÓPEZ, 2021, Tabula Rasa, P283, DOI 10.25058/20112742.n37.13
   Martins BC, 2020, EM QUESTAO, V26, P161, DOI 10.19132/1808-5245261.161-185
   Martins Beatriz Cintra, 2017, LIINC EM REV, V13, P59, DOI [10.18617/LIINC.V13I1.3752, DOI 10.18617/LIINC.V13I1.3752]
   METCALFE J, 2020, JCOM J SCI COMMUN 2, V19, DOI DOI 10.22323/2.19070205
   Oliveira T. M. de., 2020, LIINC EM REV, V16, pe5374, DOI [10.18617/liinc.v16i2.5374, DOI 10.18617/LIINC.V16I2.5374]
   Rios RS, 2020, EXPERT REV GASTROENT, V14, P1125, DOI 10.1080/17474124.2020.1815533
   Rodrigues KF, 2020, REV ADM PUBL-RIO JAN, V54, P614, DOI [10.1590/0034-761220200291x, 10.1590/0034-761220200291]
   Smith A, 2017, PATHWAYS SUSTAIN, P1
   Stevens M, 2014, IEEE PERVAS COMPUT, V13, P20, DOI 10.1109/MPRV.2014.37
   Tse Edwin G, 2020, F1000Res, V9, P1043, DOI 10.12688/f1000research.26084.1
   Velho Léa, 2011, Sociologias, V13, P128
NR 33
TC 0
Z9 0
U1 1
U2 2
PU CONSEJO SUPERIOR INVESTIGACIONES CIENTIFICAS-CSIC
PI MADRID
PA VITRUVIO 8, 28006 MADRID, SPAIN
SN 0210-1963
EI 1988-303X
J9 ARBOR
JI Arbor-Cienc. Pensam. Cult.
PD JAN-MAR
PY 2021
VL 197
IS 799
AR a589
DI 10.3989/arbor.2021.799004
PG 14
WC Humanities, Multidisciplinary
WE Arts &amp; Humanities Citation Index (A&amp;HCI)
SC Arts & Humanities - Other Topics
GA RN1CB
UT WOS:000640091100005
OA gold
DA 2022-04-20
ER

PT J
AU Roziqin, A
   Mas'udi, SYF
   Sihidi, IT
AF Roziqin, Ali
   Mas'udi, Syasya Y. F.
   Sihidi, Iradhad T.
TI An analysis of Indonesian government policies against COVID-19
SO PUBLIC ADMINISTRATION AND POLICY-AN ASIA-PACIFIC JOURNAL
LA English
DT Article
DE Policy analysis; COVID-19; Large-scale social restriction; Physical
   distancing; Social safety net; Systematic literature review
ID PUBLIC-POLICY
AB Purpose - COVID-19 cases in Indonesia continue to increase and spread. This article aims to analyse the Indonesian government policies as a response in dealing with COVID-19.
   Design/methodology/approach - This article is a narrative analysis with the approach of a systematic literature review.
   Findings - This article found that the Indonesian government responded slowly to the COVID-19 pandemic at the beginning of its spread in March 2020. The government then issued some policies such as physical distancing, large-scale social restriction (PSBB - Pombalasan Sosial Berskala Besar) and social safety net. These policies will only work if the society follows them. The society could be the key to success of those policies, either as the support or the obstacles.
   Practical implications - This policy analysis with literature review, conducted from March to July 2020 in Indonesia, provides experiences and knowledge in how to respond to the dynamic problems of public policy in dealing with the COVID-19 outbreak, especially in the context of a developing country.
   Originality/value - The novelty of the article lies in the unique policy response in a diverse society. It suggests that the policymakers should pay more attention to the society's characteristics as well as the mitigation system as a preventive measure and risk management to make clear policy in the society.
C1 [Roziqin, Ali; Sihidi, Iradhad T.] Univ Muhammadiyah Malang, Dept Govt Studies, Malang, Indonesia.
   [Mas'udi, Syasya Y. F.] Univ Muhammadiyah Malang, Dept Int Relat, Malang, Indonesia.
RP Roziqin, A (corresponding author), Univ Muhammadiyah Malang, Dept Govt Studies, Malang, Indonesia.
EM ali.roziqin@ymail.com
RI Roziqin, Ali/AAA-1462-2021
OI Roziqin, Ali/0000-0001-8336-3103
FU Universitas Muhammadiyah Malang
FX Thanks to the editorial board as well as the anonymous reviewers for the
   suggestions to improve this manuscript's quality. Also, thanks to the
   Universitas Muhammadiyah Malang for supporting us in writing this
   article.
CR [Anonymous], 2020, JAKARTA POST
   Atkinson P, 2020, SOC SCI MED, V266, DOI 10.1016/j.socscimed.2020.113423
   Australia-Indonesia Disability Research Network (AIDRAN), 2020, PROGR BANT SOS DAR I
   Balmford B, 2020, ENVIRON RESOUR ECON, V76, P525, DOI 10.1007/s10640-020-00466-5
   Bernauer T, 2016, GLOBAL ENVIRON CHANG, V40, P1, DOI 10.1016/j.gloenvcha.2016.06.001
   BPS Indonesia (Statistics Indonesia), 2020, KATADATA DATABOKS
   Buick F, 2016, PUBLIC ADMIN REV, V76, P35, DOI 10.1111/puar.12481
   Carter D., 2020, ADM THEORY PRAXIS, V42, DOI [10.1080/10841806.2020.1758991, DOI 10.1080/10841806.2020.1758991]
   CNN Indonesia, 2020, CNN INDONESIA
   COVID-19 Task Force, 2020, SATUAN TUGAS PENANGA
   Creswell JW, 2007, COUNS PSYCHOL, V35, P236, DOI 10.1177/0011000006287390
   DELEON P, 1992, PUBLIC ADMIN REV, V52, P125, DOI 10.2307/976465
   Detik, 2020, PAND COR ANGG PKH DI
   Djalante R., 2020, SCIENCE, V6, P1
   Doern BruceG., 1993, GOVERNANCE INT J POL, V6, P172
   Eddyono S., 2020, TATA KELOLA PENANGAN, P214
   El Zowalaty Mohamed E., 2020, Infection Ecology & Epidemiology, V10, P1768023, DOI 10.1080/20008686.2020.1768023
   Fawcett P, 2018, AUST J POLIT SCI, V53, P480, DOI 10.1080/10361146.2018.1519776
   Gong FH, 2020, FRONT MED-PRC, V14, P220, DOI 10.1007/s11684-020-0755-z
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Gusman H., 2020, BAGAIMANA PANDEMI CO
   Hale K., 2011, INFORM MATTERS NETWO
   Hartley K, 2020, POLICY SCI, V53, P735, DOI 10.1007/s11077-020-09405-z
   Kettl DF, 2003, AM REV PUBLIC ADM, V33, P253, DOI 10.1177/0275074003254472
   Kiraly G, 2019, SYST RES BEHAV SCI, V36, P199, DOI 10.1002/sres.2580
   Knowledge Sector Initiative (KSI), 2020, MIT IMP COV 19 SOC S
   Kompas, 2020, SOC DIST HAMB DAL SO
   Kompas, 2020, PAK EP PRED PEN COV
   Kompas, 2020, TEK PEN COR SEB EF P
   Kompas, 2020, FAKT LENGK KAS PERT
   Lee D, 2020, WORLD DEV, V135, DOI 10.1016/j.worlddev.2020.105057
   Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]
   Liu P, 2020, J CHIN GOV, V5, P198, DOI 10.1080/23812346.2020.1745412
   LSI Indonesia (Indonesian Survey Institute), 2020, LOCKD 5 JUN IND MUL
   Madhav N., 2018, DIS CONTROL PRIORITI, V9, P315
   Malloy J, 1999, GOVERNANCE, V12, P267, DOI 10.1111/0952-1895.00103
   Masudi W., 2020, TATA KELOLA PENANGAN, P214
   Ministry of Health of the Republic of Indonesia, 2020, SIT TERK PERK COR DI
   Moon MJ, 2020, PUBLIC ADMIN REV, V80, P651, DOI 10.1111/puar.13214
   Mueller B., 2019, WHY PUBLIC POLICIES
   Nicholls A.D, 2020, ROUND TABLE, V109, P1
   Oh J, 2020, HEALTH SYST REFORM, V6, DOI 10.1080/23288604.2020.1753464
   Olivia S, 2020, B INDONES ECON STUD, V56, P143, DOI 10.1080/00074918.2020.1798581
   Roziqin A, 2018, E3S WEB C, V31, P1
   Shammi M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04063
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Spalding T, 2020, KNEE SURG SPORT TR A, V28, P1677, DOI 10.1007/s00167-020-06034-0
   Stewart J, 2013, PROMETHEUS, V31, P3, DOI 10.1080/08109028.2013.763630
   Strassheim H, 2021, PUBLIC POLICY ADMIN, V36, P187, DOI 10.1177/0952076719827062
   Suryahadi A., 2020, IMPACT COVID 19 POVE
   Suryahadi A, 2020, B INDONES ECON STUD, V56, P175, DOI 10.1080/00074918.2020.1779390
   Susilo A, 2020, J PENYAKIT DALAM IND, V7, P45, DOI DOI 10.7454/jpdi.v7i1.415
   Tempo, 2020, DAMP COR 3 05 JUT OR
   Tosepu R, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138436
   van Barneveld K, 2020, ECON LABOUR RELAT RE, V31, P133, DOI 10.1177/1035304620927107
   Wang JS, 2009, TRANSNATL CORP REV, V1, P67, DOI 10.1080/19186444.2009.11658214
   Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4
   Winanti P.S., 2020, PROBLEM INFODEMIC DA
   World Health Organization, 2020, WHO COR DIS COVID 19
   Yang QW, 2020, CLIN TRANSL MED, V10, P13, DOI 10.1002/ctm2.7
   Yu M, 2021, CURR ISSUES TOUR, V24, P2699, DOI 10.1080/13683500.2020.1752632
NR 61
TC 0
Z9 0
U1 1
U2 1
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1727-2645
EI 2517-679X
J9 PUBLIC ADMIN POLICY
JI Public Admin. Policy
PY 2021
VL 24
IS 1
SI SI
BP 92
EP 107
DI 10.1108/PAP-08-2020-0039
PG 16
WC Political Science; Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Government & Law; Public Administration
GA YT8ZF
UT WOS:000751642200009
OA gold
DA 2022-04-20
ER

PT J
AU Clements, C
AF Clements, Charlotte
TI Supporting Frontline Staff During the COVID-19 Pandemic
SO AMERICAN JOURNAL OF NURSING
LA English
DT Article
DE communication; COVID-19; emotional support; nursing leadership;
   pandemic; staff feedback; staff support
AB The coronavirus disease 2019 (COVID-19) pandemic that emerged in early 2020 put unprecedented physical, mental, and emotional strain on the staff of health care organizations, who have been caring for a critically ill patient population for more than a year and a half. Amid the ongoing pandemic, health care workers have struggled to keep up with new information about the disease, while also coping with the anxiety associated with caring for affected patients. It has also been a continual challenge for nurse leaders to provide adequate support for staff members and keep them informed about frequently changing practices and protocols. In this article, nursing leaders at an academic medical center in Boston reflect on the initial COVID-19 patient surge, which occurred from March to June 2020, and identify key actions taken to provide clinical and emotional support to frontline staff who cared for these patients. Lessons learned in this period provide insight into the management of redeployed staff, use of emotional support and debriefing, and relationship between access to information and staff morale. The knowledge gained through these initial experiences has been a vital resource as health care workers continue to face challenges associated with the ongoing pandemic.
C1 [Clements, Charlotte] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
RP Clements, C (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
CR AJMC, 2021, TIM COVID 19 DEV 202
   American Medical Association, 2020, CRIS STAND CAR GUID
   American Psychiatric Nurses Association, 2020, MAN STRESS SELFCARE
   Centers for Medicare Medicaid Services, 2020, COVID 19 EM DECL BLA
   City of Boston Public Health Commission, 2020, PUBL HLTH EM DEC BOS
   City of Boston Public Health Commission, 2020, 1 CAS 2019 NOV COR C
   Kelly L, 2020, CRIT CARE NURS Q, V43, P73, DOI 10.1097/CNQ.0000000000000293
   Kessler G., 2021, WASH POST
   Lemieux JE, 2021, SCIENCE, V371, P588, DOI 10.1126/science.abe3261
   National Academy of Medicine, 2020, RES SUPP HLTH WELLBE
   Shelhamer MC, 2021, J INTENSIVE CARE MED, V36, P241, DOI 10.1177/0885066620980399
   U.S. Food and Drug Administration, 2020, INSTR DUK DEC FAC DE
   WHO, 2020, LIST WHOS RESP COVID
NR 13
TC 0
Z9 0
U1 3
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0002-936X
EI 1538-7488
J9 AM J NURS
JI Am. J. Nurs.
PD SEP
PY 2021
VL 121
IS 9
BP 46
EP 55
PG 10
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA WK1FN
UT WOS:000709479000024
PM 34438429
DA 2022-04-20
ER

PT J
AU Li, ZD
   Zhao, SX
   Chen, Y
   Luo, FY
   Kang, ZQ
   Cai, SP
   Zhao, W
   Liu, J
   Zhao, D
   Li, YJ
AF Li, Zhidan
   Zhao, Shixuan
   Chen, Yang
   Luo, Fuya
   Kang, Zhiqing
   Cai, Shengping
   Zhao, Wei
   Liu, Jun
   Zhao, Di
   Li, Yongjie
TI A deep-learning-based framework for severity assessment of COVID-19 with
   CT images
SO EXPERT SYSTEMS WITH APPLICATIONS
LA English
DT Article
DE COVID-19; Deep learning; Severity assessment; Multi-view lesion;
   Dual-Siamese channels; Clinical metadata
ID LUNG INFECTION SEGMENTATION; ACCURATE
AB Millions of positive COVID-19 patients are suffering from the pandemic around the world, a critical step in the management and treatment is severity assessment, which is quite challenging with the limited medical resources. Currently, several artificial intelligence systems have been developed for the severity assessment. However, imprecise severity assessment and insufficient data are still obstacles. To address these issues, we proposed a novel deep-learning-based framework for the fine-grained severity assessment using 3D CT scans, by jointly performing lung segmentation and lesion segmentation. The main innovations in the proposed framework include: 1) decomposing 3D CT scan into multi-view slices for reducing the complexity of 3D model, 2) integrating prior knowledge (dual-Siamese channels and clinical metadata) into our model for improving the model performance. We evaluated the proposed method on 1301 CT scans of 449 COVID-19 cases collected by us, our method achieved an accuracy of 86.7% for four-way classification, with the sensitivities of 92%, 78%, 95%, 89% for four stages. Moreover, ablation study demonstrated the effectiveness of the major components in our model. This indicates that our method may contribute a potential solution to severity assessment of COVID-19 patients using CT images and clinical metadata.
C1 [Li, Zhidan; Zhao, Shixuan; Luo, Fuya; Kang, Zhiqing; Li, Yongjie] Univ Elect Sci & Technol China, MOE Key Lab Neuroinformat, Chengdu, Peoples R China.
   [Chen, Yang] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Peoples R China.
   [Cai, Shengping] Wuhan Red Cross Hosp, Dept Radiol, Wuhan, Peoples R China.
   [Zhao, Wei; Liu, Jun] Cent South Univ, Second Xiangya Hosp, Dept Radiol, Changsha, Peoples R China.
   [Zhao, Di] Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China.
RP Li, YJ (corresponding author), Univ Elect Sci & Technol China, MOE Key Lab Neuroinformat, Chengdu, Peoples R China.; Chen, Y (corresponding author), Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Peoples R China.
EM 627296145@qq.com; 975086188@qq.com; Sophie-0627@163.com;
   luofuya@std.uestc.edu.cn; 351942136@qq.com; 110063279@qq.com;
   wei.zhao@csu.edu.cn; junliu123@csu.edu.cn; zhaodi@ict.ac.cn;
   liyj@uestc.edu.cn
RI Zhao, Wei/K-3724-2019
OI Zhao, Wei/0000-0002-8520-2087; Liu, Jun/0000-0002-7851-6782
FU Key Area R&D Program of Guangdong Province [2018B030338001]
FX This work is supported by the Key Area R&D Program of Guangdong Province
   (NO. 2018B030338001) . We thank Jun Ma et al. and Kang Zhang et al. for
   providing the public COVID-19 dataset, and Jiao Xu for helping with data
   pre-processing.
CR Aboutalebi H., 2021, ARXIV210501284
   Ali AR, 2021, IEEE IJCNN, DOI 10.1109/IJCNN52387.2021.9533786
   Altan A, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110071
   [Anonymous], 2021, CORONAVIRUS DIS COVI
   Chassagnon G., 2020, AI DRIVEN CT BASED Q, DOI [10.1101/2020.04.17.20069187, DOI 10.1101/2020.04.17.20069187]
   Fan DP, 2020, IEEE T MED IMAGING, V39, P2626, DOI 10.1109/TMI.2020.2996645
   Gao K, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101836
   Gotmare A., 2018, ARXIV181013243
   He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90
   He KL, 2021, PATTERN RECOGN, V113, DOI 10.1016/j.patcog.2021.107828
   Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/TPAMI.2019.2913372, 10.1109/CVPR.2018.00745]
   Jin QG, 2021, EXPERT SYST APPL, V176, DOI 10.1016/j.eswa.2021.114848
   Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010
   Lessmann N, 2021, RADIOLOGY, V298, pE18, DOI 10.1148/radiol.2020202439
   Li ZK, 2021, MED IMAGE ANAL, V69, DOI 10.1016/j.media.2021.101978
   Lizzi F., 2021, ARXIV210502566
   Ma J, 2020, ARXIV PREPRINT ARXIV
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Roberts M, 2021, NAT MACH INTELL, V3, P199, DOI 10.1038/s42256-021-00307-0
   Rodriguez-Nava G, 2021, INT J INFECT DIS, V102, P571, DOI 10.1016/j.ijid.2020.11.003
   Shahzad Arfan, 2020, Qual Quant, P1, DOI 10.1007/s11135-020-01028-z
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Taylor L, 2018, 2018 IEEE SYMPOSIUM SERIES ON COMPUTATIONAL INTELLIGENCE (IEEE SSCI), P1542, DOI 10.1109/SSCI.2018.8628742
   van der Maaten L, 2008, J MACH LEARN RES, V9, P2579
   Xie SN, 2017, PROC CVPR IEEE, P5987, DOI 10.1109/CVPR.2017.634
   Xie YT, 2019, IEEE T MED IMAGING, V38, P991, DOI 10.1109/TMI.2018.2876510
   Yang Ran, 2020, Radiol Cardiothorac Imaging, V2, pe200047, DOI 10.1148/ryct.2020200047
   Zhang K, 2020, CELL, V181, P1423, DOI 10.1016/j.cell.2020.04.045
   Zhao A, 2019, PROC CVPR IEEE, P8535, DOI 10.1109/CVPR.2019.00874
   Zhao S., 2020, SCOAT NET NOVEL NETW
   Zheng BB, 2020, IEEE ACCESS, V8, P185786, DOI 10.1109/ACCESS.2020.3027738
   Zhou LX, 2020, IEEE T MED IMAGING, V39, P2638, DOI 10.1109/TMI.2020.3001810
   Zhou ZW, 2018, LECT NOTES COMPUT SC, V11045, P3, DOI 10.1007/978-3-030-00889-5_1
NR 33
TC 1
Z9 1
U1 13
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0957-4174
EI 1873-6793
J9 EXPERT SYST APPL
JI Expert Syst. Appl.
PD DEC 15
PY 2021
VL 185
AR 115616
DI 10.1016/j.eswa.2021.115616
EA JUL 2021
PG 11
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic; Operations Research & Management Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Engineering; Operations Research & Management Science
GA WE2FA
UT WOS:000705440000003
PM 34334965
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Matyjaszek-Matuszek, B
   Wozniak, M
   Ochmanska, A
   Sawicka-Gutaj, N
   Ruchala, M
   Czarnywojtek, A
AF Matyjaszek-Matuszek, Beata
   Wozniak, Magdalena
   Ochmanska, Alicja
   Sawicka-Gutaj, Nadia
   Ruchala, Marek
   Czarnywojtek, Agata
TI Selected thyreology problems during the COVID-19 pandemic.
   Hypothyroidism and hyperthyroidism - did anything change?
SO ENDOKRYNOLOGIA POLSKA
LA English
DT Review
DE COVID-19 pandemic; COVID-19; SARS-CoV-2; TSH; hypothyroidism;
   hyperthyroidism; orbitopathy; levothyroxine; antithyroid therapy; ATD
ID L-THYROXINE; LIQUID; TABLET; REPLACEMENT; POPULATION; TSH; FORMULATION;
   MANAGEMENT; DISORDERS; THERAPY
AB On March 11, 2020, the World Health Organisation (WHO) observed the scale of epidemic risk and declared the state of the COVID-19 pandemic. Most countries, including Poland, implemented national and local emergency management plans to deal with the imminent threat of SARS-CoV-2 infection, one of the most serious in this century, according to many experts. In the era of pandemic, during which an epidemiological regime and social distancing are constantly recommended, and routine medical care and planned surgical procedures have been postponed or significantly reduced, patients and their physicians have to struggle on a daily basis with difficult access to diagnostic and therapeutic procedures. This is a great challenge for both groups. The aim of this study is to assess the current state of knowledge about thyreological diseases during the COVID-19 pandemic and to provide indications for the introduced therapeutic changes on the basis of recent scientific literature published up to December 2020 and searches of the PubMed, Google Scholar, EMBASE, and Web of Science databases, which searched for keywords related to SARS-CoV-2 and its influence on thyreology problems. The main focus was on diagnostic and therapeutic differences in the era of the COVID-19 pandemic, bearing in mind the most common endocrinopathies, i.e. hypothyroidism and hyperthyroidism, as well as advantages and disadvantages and possibilities of using telemedicine in the common practice of a specialist physician.
C1 [Matyjaszek-Matuszek, Beata; Wozniak, Magdalena] Med Univ, Chair & Dept Endocrinol, Jaczewskiego 8, PL-20934 Lublin, Poland.
   [Ochmanska, Alicja; Sawicka-Gutaj, Nadia; Ruchala, Marek; Czarnywojtek, Agata] Univ Med Sci, Chair & Dept Endocrinol Metab & Internal Med, Poznan, Poland.
   [Czarnywojtek, Agata] Poznan Univ Med Sci, Dept Pharmacol, Poznan, Poland.
RP Matyjaszek-Matuszek, B (corresponding author), Med Univ, Chair & Dept Endocrinol, Jaczewskiego 8, PL-20934 Lublin, Poland.
EM bmm@2com.pl
OI Wozniak, Magdalena Maria/0000-0001-7436-2432; Matyjaszek-Matuszek,
   Beata/0000-0001-7386-8087
CR Abraham P, 2003, COCHRANE DB SYST REV, DOI [10.1002/ 14651858.CD003420, DOI 10.1002/14651858.CD003420]
   Anawalt B, 2000, ENDOTEXT
   Andersen SL, 2020, THYROID RES, V13, DOI 10.1186/s13044-020-00085-8
   Andersen SL, 2016, J CLIN ENDOCR METAB, V101, P1606, DOI 10.1210/jc.2015-4274
   Bartalena L, 2016, EUR THYROID J, V5, P9, DOI 10.1159/000443828
   Benvenga S, 2019, ADV THER, V36, P59, DOI 10.1007/s12325-019-01079-1
   Biondi B, 2014, ENDOCR REV, V35, P433, DOI 10.1210/er.2013-1083
   Biondi B, 2012, J CLIN ENDOCR METAB, V97, P2256, DOI 10.1210/jc.2011-3399
   Boelaert K, 2010, J CLIN ENDOCR METAB, V95, P2715, DOI 10.1210/jc.2009-2495
   Boelaert K, 2020, EUR J ENDOCRINOL, V183, pG33, DOI 10.1530/EJE-20-0445
   Burch HB, 2015, JAMA-J AM MED ASSOC, V314, P2544, DOI 10.1001/jama.2015.16535
   Cappelli C, 2016, GYNECOL ENDOCRINOL, V32, P290, DOI 10.3109/09513590.2015.1113518
   Chaker L, 2017, LANCET, V390, P1550, DOI 10.1016/S0140-6736(17)30703-1
   Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1
   Fallahi P, 2017, OBES SURG, V27, P78, DOI 10.1007/s11695-016-2247-4
   Madariaga AG, 2014, J CLIN ENDOCR METAB, V99, P923, DOI 10.1210/jc.2013-2409
   Gietka-Czernel M, 2020, ENDOKRYNOL POL, V71, P441, DOI [10.5603/EP.a2020.0065, 10.5603/EPa2020.0065]
   Hannemann Anke, 2010, BMC Res Notes, V3, P227, DOI 10.1186/1756-0500-3-227
   Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489
   Idrees T, 2020, THYROID, V30, P1399, DOI 10.1089/thy.2020.0153
   Kahaly GJ, 2018, EUR THYROID J, V7, P167, DOI 10.1159/000490384
   Leese GP, 2016, CLIN ENDOCRINOL, V85, P918, DOI 10.1111/cen.13052
   Nair Rakesh, 2014, Indian J Endocrinol Metab, V18, P705, DOI 10.4103/2230-8210.139237
   National Guideline Centre (UK), 2019, THYR DIS ASS MAN
   Novel Coronavirus (COVID-19) and the Thyroid, FREQ ASK QUEST
   Pal R, 2020, DIABETES METAB SYND, V14, P767, DOI 10.1016/j.dsx.2020.05.050
   PARLE JV, 1993, BRIT J GEN PRACT, V43, P107
   Peeters RP, 2017, NEW ENGL J MED, V376, P2556, DOI 10.1056/NEJMcp1611144
   Peroni E, 2014, HORM RES PAEDIAT, V81, P50, DOI 10.1159/000356047
   Pirola I, 2018, J ENDOCRINOL INVEST, V41, P1301, DOI 10.1007/s40618-018-0867-3
   Ross DS, 2016, THYROID, V26, P1343, DOI 10.1089/thy.2016.0229
   ROSS DS, 1990, J CLIN ENDOCR METAB, V71, P764, DOI 10.1210/jcem-71-3-764
   Samuels MH, 2018, J CLIN ENDOCR METAB, V103, P1997, DOI 10.1210/jc.2017-02668
   Sheehan MT, 2016, CLIN MED RES, V14, P83, DOI 10.3121/cmr.2016.1309
   Somwaru LL, 2009, J CLIN ENDOCR METAB, V94, P1342, DOI 10.1210/jc.2008-1696
   Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087
   Stangierski A, 2016, ENDOKRYNOL POL, V67, P359, DOI 10.5603/EP.a2016.0025
   Tariq A, 2018, SOUTH MED J, V111, P363, DOI 10.14423/SMJ.0000000000000823
   Taylor PN, 2020, NAT REV ENDOCRINOL, V16, P104, DOI 10.1038/s41574-019-0305-4
   Taylor PN, 2018, NAT REV ENDOCRINOL, V14, P301, DOI 10.1038/nrendo.2018.18
   Trimboli P, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00118
   Vita R, 2017, EXPERT OPIN DRUG DEL, V14, P467, DOI 10.1080/17425247.2017.1290604
   Wiersinga WM, 2012, EUR THYROID J, V1, P55, DOI [10.1159/000337020, 10.1159/000339444]
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Xia JH, 2020, J MED VIROL, V92, P589, DOI 10.1002/jmv.25725
   Yan YM, 2020, ENDOKRYNOL POL, V71, P367, DOI 10.5603/EP.a2020.0055
   Yue CS, 2012, ARZNEIMITTELFORSCH, V62, P631, DOI 10.1055/s-0032-1329951
NR 47
TC 0
Z9 0
U1 2
U2 5
PU VIA MEDICA
PI GDANSK
PA UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND
SN 0423-104X
J9 ENDOKRYNOL POL
JI Endokrynol. Pol.
PY 2021
VL 72
IS 2
BP 171
EP 178
DI 10.5603/EP.a2021.0013
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA SD0FA
UT WOS:000651036300013
PM 33970482
OA gold
DA 2022-04-20
ER

PT J
AU Santoriello, D
   Khairallah, P
   Bomback, AS
   Xu, KE
   Kudose, S
   Batal, I
   Barasch, J
   Radhakrishnan, J
   D'Agati, V
   Markowitz, G
AF Santoriello, Dominick
   Khairallah, Pascale
   Bomback, Andrew S.
   Xu, Katherine
   Kudose, Satoru
   Batal, Ibrahim
   Barasch, Jonathan
   Radhakrishnan, Jai
   D'Agati, Vivette
   Markowitz, Glen
TI Postmortem Kidney Pathology Findings in Patients with COVID-19
SO JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
LA English
DT Article
DE acute renal failure; pathology; acute tubular injury; COVID-19;
   SARS-CoV-2; acute kidney injury
ID CRITICALLY-ILL PATIENTS; INJURY; ENZYME
AB Background AKI is common among hospitalized patients with coronavirus disease 2019 (COVID-19) and is an independent risk factor for mortality. Although there are numerous potential mechanisms underlying COVID-19-associated AKI, our current knowledge of kidney pathologic findings in COVID-19 is limited.
   Methods We examined the postmortem kidneys from 42 patients who died of COVID-19. We reviewed light microscopy findings in all autopsies and performed immunofluorescence, electron microscopy, and in situ hybridization studies for SARS-CoV-2 on a subset of samples.
   Results The cohort had a median age of 71.5 years (range, 38-97 years); 69% were men, 57% were Hispanic, and 73% had a history of hypertension. Among patients with available data, AKI developed in 31 of 33 patients (94%), including 6 with AKI stage 1, 9 with stage 2, and 16 with stage 3. The predominant finding correlating with AKI was acute tubular injury. However, the degree of acute tubular injury was often less severe than predicted for the degree of AKI, suggesting a role for hemodynamic factors, such as aggressive fluid management. Background changes of hypertensive arterionephrosclerosis and diabetic glomerulosclerosis were frequent but typically mild. We identified focal kidney fibrin thrombi in 6 of 42 (14%) autopsies. A single Black patient had collapsing FSGS. Immunofluorescence and electron microscopy were largely unrevealing, and in situ hybridization for SARS-CoV-2 showed no definitive positivity.
   Conclusions Among a cohort of 42 patients dying with COVID-19, autopsy histologic evaluation revealed acute tubular injury, which was typically mild relative to the degree of creatinine elevation. These findings suggest potential for reversibility upon resolution of SARS-CoV-2 infection.
C1 [Santoriello, Dominick; Kudose, Satoru; Batal, Ibrahim; D'Agati, Vivette; Markowitz, Glen] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, New York, NY USA.
   [Khairallah, Pascale; Bomback, Andrew S.; Xu, Katherine; Barasch, Jonathan; Radhakrishnan, Jai] Columbia Univ, Dept Med, Irving Med Ctr, Div Nephrol, New York, NY USA.
RP Markowitz, G (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, 630 West 168th St,VC14-240D, New York, NY 10032 USA.
OI Khairallah, Pascale/0000-0003-2105-0130; Kudose,
   Satoru/0000-0001-8396-9877
CR Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Aslan A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2287-3
   Centers for Disease Control and Prevention, 2020, CAS DAT SURV
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Cruickshank J, 1911, J PATHOL BACTERIOL, VXVI, P167
   Darmon M, 2014, CLIN J AM SOC NEPHRO, V9, P1347, DOI 10.2215/CJN.08300813
   Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8
   Fanelli V, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02872-z
   Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Joannidis M, 2020, INTENS CARE MED, V46, P654, DOI 10.1007/s00134-019-05869-7
   Kosaka J, 2016, CRIT CARE MED, V44, pE897, DOI 10.1097/CCM.0000000000001735
   Langenberg C, 2008, CRIT CARE, V12, DOI 10.1186/cc6863
   Larsen CP, 2020, KIDNEY INT REP, V5, P935, DOI 10.1016/j.ekir.2020.04.002
   Moeckel GW, 2018, SEMIN NEPHROL, V38, P21, DOI 10.1016/j.semnephrol.2017.09.003
   Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925
   New York State Department of Health, 2020, NYSDOH COVID 19 TRAC
   Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276
   Peleg Y, 2020, KIDNEY INT REP, V5, P940, DOI 10.1016/j.ekir.2020.04.017
   Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]
   Serfozo P, 2020, HYPERTENSION, V75, P173, DOI 10.1161/HYPERTENSIONAHA.119.14071
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   WHO, 2020, COR DIS COVID 2019 S
   Wilson JG, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2778-x
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 34
TC 124
Z9 128
U1 6
U2 8
PU AMER SOC NEPHROLOGY
PI WASHINGTON
PA 1401 H Street NW, Suite 900, WASHINGTON, DC 20005, UNITED STATES
SN 1046-6673
EI 1533-3450
J9 J AM SOC NEPHROL
JI J. Am. Soc. Nephrol.
PD SEP
PY 2020
VL 31
IS 9
BP 2158
EP 2167
DI 10.1681/ASN.2020050744
PG 10
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA NR8KY
UT WOS:000571810200018
PM 32727719
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Di Pasquale, G
   De Palma, R
   Fortuna, D
   Berti, E
   Campo, G
   Casella, G
AF Di Pasquale, Giuseppe
   De Palma, Rossana
   Fortuna, Daniela
   Berti, Elena
   Campo, Gianluca
   Casella, Gianni
TI Indirect effects of the COVID-19 pandemic on cardiovascular mortality
SO GIORNALE ITALIANO DI CARDIOLOGIA
LA Italian
DT Article
DE Acute coronary syndrome; COVID-19 pandemic; Excess cardiac mortality;
   Out-of-hospital cardiac arrest
ID ACUTE CORONARY SYNDROME; ACUTE MYOCARDIAL-INFARCTION; CARDIAC-ARREST;
   IMPACT; ADMISSIONS; HOSPITALIZATIONS; MANAGEMENT; CARDIOLOGY; DEATHS;
   RISK
AB The dramatic impact of the COVID-19 pandemic extends beyond the risk of deaths related to virus infection. Excess deaths from other causes, particularly cardiovascular deaths, have been reported worldwide. Our study based on administrative databases of the Emilia-Romagna region demonstrates a 17% excess of out-of-hospital cardiac deaths in the first 2020 semester with a peak of +62% on April. The excess of cardiac deaths may be explained by the indirect consequences of the response to the COVID-19 pandemic. These include a dramatic reduction of hospital admissions during the pandemic, particularly for acute coronary syndromes; an increase of out-of-hospital cardiac arrests; a reduction of outpatient clinic activities and cardiac procedures; long-term cardiovascular effects of COVID-19; and unfavorable cardiac effects of the lockdown imposed by the spread of COVID-19 infection. The knowledge of the indirect consequences of COVID-19 pandemic is important for planning cardiologic strategies.
C1 [Di Pasquale, Giuseppe] Azienda USL Bologna, Direz Sanitaria, Bologna, Italy.
   [De Palma, Rossana] Reg Emilia Romagna, Serv Assistenza Osped, Direz Gen Cura Persona Salute & Welf, Bologna, Italy.
   [Fortuna, Daniela; Berti, Elena] Agenzia Sanitaria & Sociale Reg, Emilia Romagna, Italy.
   [Campo, Gianluca] Azienda Osped Univ Ferarra, Ist Cardiol, Ferrara, Italy.
   [Casella, Gianni] Osped Maggiore Bologna, UO Cardiol, Bologna, Italy.
RP Di Pasquale, G (corresponding author), Via San Ruffillo 10-A, I-40068 San Lazzaro, BO, Italy.
EM g.dipa@libero.it
RI ; Berti, Elena/J-9405-2016
OI fortuna, daniela/0000-0003-0927-7199; Berti, Elena/0000-0001-6164-3550
CR Bakouny Z, 2021, JAMA ONCOL, V7, P458, DOI 10.1001/jamaoncol.2020.7600
   Baldi E, 2020, NEW ENGL J MED, V383, P496, DOI 10.1056/NEJMc2010418
   Beaney T, 2020, J ROY SOC MED, V113, P329, DOI 10.1177/0141076820956802
   Becker RC, 2020, J THROMB THROMBOLYS, V50, P512, DOI 10.1007/s11239-020-02266-6
   Bhatt AS, 2020, J AM COLL CARDIOL, V76, P280, DOI 10.1016/j.jacc.2020.05.038
   Bonalumi G, 2020, EUR J CARDIO-THORAC, V57, P1025, DOI 10.1093/ejcts/ezaa151
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Coutsoumbas GV, 2018, G ITAL CARDIOL, V19, P620, DOI 10.1714/3012.30109
   De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166
   De Luca G, 2020, J AM COLL CARDIOL, V76, P2321, DOI 10.1016/j.jacc.2020.09.546
   De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409
   Di Pasquale G, 2020, G ITAL CARDIOL, V21, P243, DOI 10.1714/3328.32981
   Einstein AJ, 2021, J AM COLL CARDIOL, V77, P173, DOI 10.1016/j.jacc.2020.10.054
   Garcia S, 2020, J AM COLL CARDIOL, V75, P2871, DOI 10.1016/j.jacc.2020.04.011
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Holland M, 2020, JACC-CARDIOVASC INTE, V13, P1968, DOI 10.1016/j.jcin.2020.06.022
   Katsoulis M, 2021, CIRC-CARDIOVASC QUAL, V14, P82, DOI 10.1161/CIRCOUTCOMES.120.007085
   Kishore N, 2018, NEW ENGL J MED, V379, P162, DOI [10.1056/NEJMsa1803972, 10.1056/nejmsa1803972]
   Lai PH, 2020, JAMA CARDIOL, V5, P1154, DOI 10.1001/jamacardio.2020.2488
   Lee K, 2009, GLOB INST, P1
   Leong DP, 2021, J AM COLL CARDIOL, V77, P186, DOI 10.1016/j.jacc.2020.11.028
   Lippi G, 2020, EUR J PREV CARDIOL, V27, P906, DOI 10.1177/2047487320916823
   Mafham MM, 2020, LANCET, V396, P381, DOI 10.1016/S0140-6736(20)31356-8
   Marijon E, 2020, LANCET PUBLIC HEALTH, V5, pE437, DOI 10.1016/S2468-2667(20)30117-1
   McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740
   Mesnier J, 2020, LANCET PUBLIC HEALTH, V5, pE536, DOI 10.1016/S2468-2667(20)30188-2
   Metzler B, 2020, EUR HEART J, V41, P1852, DOI 10.1093/eurheartj/ehaa314
   Migliore F, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008722
   Mureddu GF, 2020, G ITAL CARDIOL, V21, P527, DOI 10.1714/3386.33640
   Nafilyan, 2021, EPIDEMIOLOGY POSTCOV, V27, P601, DOI [DOI 10.1101/2021.01.15.21249885, 10.1101/2021.01.15.21249885]
   Niccoli G, 2020, CARDIOVASC RES, V116, pE126, DOI 10.1093/cvr/cvaa146
   Pessoa-Amorim G, 2020, EUR HEART J-QUAL CAR, V6, P210, DOI 10.1093/ehjqcco/qcaa046
   Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557
   Quadri G, 2021, INT J CARDIOL, V323, P288, DOI 10.1016/j.ijcard.2020.08.072
   Rafanelli C, 2005, PSYCHOTHER PSYCHOSOM, V74, P179, DOI 10.1159/000084003
   Rodriguez-Leor O, 2020, REC INTERV CARDIOL, V2, P82, DOI 10.24875/RECIC.M20000120
   Romeo F, 2020, J CARDIOVASC MED, V21, P403, DOI 10.2459/JCM.0000000000000980
   Semeraro F, 2020, RESUSCITATION, V157, P1, DOI 10.1016/j.resuscitation.2020.09.032
   Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558
   Solomon MD, 2020, NEW ENGL J MED, V383, P691, DOI 10.1056/NEJMc2015630
   Valente S, 2020, G ITAL CARDIOL, V21, P341, DOI 10.1714/3343.33131
   Vecchio S, 2020, G ITAL CARDIOL, V21, P502, DOI 10.1714/3386.33635
   Wadhera RK, 2021, J AM COLL CARDIOL, V77, P159, DOI 10.1016/j.jacc.2020.10.055
   Weinberger DM, 2020, JAMA INTERN MED, V180, P1336, DOI 10.1001/jamainternmed.2020.3391
   WHO, COVID 19 SIGN IMP HL
   Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P1562, DOI 10.1001/jama.2020.19545
   Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P510, DOI 10.1001/jama.2020.11787
   Wu JH, 2021, HEART, V107, P113, DOI 10.1136/heartjnl-2020-317912
   Xiang DC, 2020, J AM COLL CARDIOL, V76, P1318, DOI 10.1016/j.jacc.2020.06.039
   Zylke JW, 2020, JAMA-J AM MED ASSOC, V324, P458, DOI 10.1001/jama.2020.11761
NR 50
TC 4
Z9 4
U1 2
U2 6
PU PENSIERO SCIENTIFICO EDITORE
PI ROME
PA VIA SAN GIOVANNI VALDARNO 8, ROME, ITALY
SN 1827-6806
EI 1972-6481
J9 G ITAL CARDIOL
JI G. Ital. Cardiol.
PD MAR
PY 2021
VL 22
IS 3
BP 188
EP 192
DI 10.1714/3557.35336
PG 5
WC Cardiac & Cardiovascular Systems
WE Emerging Sources Citation Index (ESCI)
SC Cardiovascular System & Cardiology
GA SG2GB
UT WOS:000653260000003
PM 33687369
DA 2022-04-20
ER

PT J
AU Wanberg, CR
   Csillag, B
   Douglass, RP
   Zhou, L
   Pollard, MS
AF Wanberg, Connie R.
   Csillag, Borbala
   Douglass, Richard P.
   Zhou, Le
   Pollard, Michael S.
TI Socioeconomic Status and Well-Being During COVID-19: A Resource-Based
   Examination
SO JOURNAL OF APPLIED PSYCHOLOGY
LA English
DT Article
DE socioeconomic status; conservation of resources; well-being; COVID-19
ID SOCIAL-CLASS; NATURAL DISASTER; FUNDAMENTAL CAUSES; HEALTH; DEPRESSION;
   LIFE; SYMPTOMS; INEQUALITIES; DISTRESS; OUTCOMES
AB The authors assess levels and within-person changes in psychological well-being (i.e., depressive symptoms and life satisfaction) from before to during the COVID-19 pandemic for individuals in the United States, in general and by socioeconomic status (SES). The data is from 2 surveys of 1,143 adults from RAND Corporation's nationally representative American Life Panel. the first administered between April-June, 2019 and the second during the initial peak of the pandemic in the United States in April, 2020. Depressive symptoms during the pandemic were higher than population norms before the pandemic. Depressive symptoms increased from before to during COVID-19 and life satisfaction decreased. Individuals with higher education experienced a greater increase in depressive symptoms and a greater decrease in life satisfaction from before to during COVID-19 in comparison to those with lower education. Supplemental analysis illustrates that income had a curvilinear relationship with changes in well-being, such that individuals at the highest levels of income experienced a greater decrease in life satisfaction from before to during COVID-19 than individuals with lower levels of income. We draw on conservation of resources theory and the theory of fundamental social causes to examine four key mechanisms (perceived financial resources, perceived control, interpersonal resources, and COVID-19-related knowledge/news consumption) underlying the relationship between SES and well-being during COVID-19. These resources explained changes in well-being for the sample as a whole but did not provide insight into why individuals of higher education experienced a greater decline in well-being from before to during COVID-19.
C1 [Wanberg, Connie R.; Csillag, Borbala; Zhou, Le] Univ Minnesota, Dept Work & Org, 3-300 Carlson Sch Management,321 19th Ave South, Minneapolis, MN 55455 USA.
   [Douglass, Richard P.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.
   [Pollard, Michael S.] RAND Corp, Santa Monica, CA USA.
RP Wanberg, CR (corresponding author), Univ Minnesota, Dept Work & Org, 3-300 Carlson Sch Management,321 19th Ave South, Minneapolis, MN 55455 USA.
EM wanbe001@umn.edu
RI Pollard, Michael/AAX-3052-2020
OI Pollard, Michael/0000-0002-8434-688X; Wanberg,
   Connie/0000-0003-3536-9740
FU National Institute on Alcohol Abuse and AlcoholismUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)
   [R01AA025956]
FX The study questions and relationships examined in the present article
   have not been examined in previous manuscripts. A portion of the data
   reported in this article was obtained from the RAND American Life Panel
   Adult Social Networks and Well Being study
   [https://grantome.com/grant/NIH/R01-AA025956-01A1] funded by Grant
   R01AA025956 from the National Institute on Alcohol Abuse and Alcoholism
   (PI: Michael S. Pollard).
CR Afridi L., 2020, FRONTLINE COMMUNITIE
   Algren MH, 2020, SSM-POPUL HLTH, V10, DOI 10.1016/j.ssmph.2020.100546
   Anderson C, 2012, PSYCHOL SCI, V23, P764, DOI 10.1177/0956797611434537
   Asparouhov T, 2005, STRUCT EQU MODELING, V12, P411, DOI 10.1207/s15328007sem1203_4
   Bapuji H, 2020, J MANAGE, V46, P1205, DOI 10.1177/0149206320925881
   Bapuji H, 2020, ACAD MANAG ANN, V14, P60, DOI 10.5465/annals.2018.0029
   Bhargava A, 2020, CLIN INFECT DIS, V71, P1962, DOI 10.1093/cid/ciaa674
   Boyd M., 2015, SO DEM ASS ANN M SAN
   Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218
   Cheng C, 2013, PSYCHOL BULL, V139, P152, DOI 10.1037/a0028596
   Christie AM, 2009, J APPL PSYCHOL, V94, P1466, DOI 10.1037/a0016847
   Cooper R, 2016, REV ECON DYNAM, V20, P63, DOI 10.1016/j.red.2015.12.001
   Cote S, 2011, RES ORGAN BEHAV, V31, P43, DOI 10.1016/j.riob.2011.09.004
   Cutler D., 2020, DISPARITIES COVID 19, DOI [10.1101/2020.05.15.20095927, DOI 10.1101/2020.05.15.20095927]
   DeGarmo DS, 1999, CHILD DEV, V70, P1231, DOI 10.1111/1467-8624.00089
   Diemer MA, 2013, ANAL SOC ISS PUB POL, V13, P77, DOI 10.1111/asap.12001
   Diener E, 2002, SOC INDIC RES, V57, P119, DOI 10.1023/A:1014411319119
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Emeruwa UN, 2020, JAMA-J AM MED ASSOC, V324, P390, DOI 10.1001/jama.2020.11370
   Ennis NE, 2000, AM J COMMUN PSYCHOL, V28, P149, DOI 10.1023/A:1005183100610
   Fiske ST, 2012, FACING SOCIAL CLASS: HOW SOCIETAL RANK INFLUENCES INTERACTION, P1
   Folkman S., 2011, OXFORD HDB STRESS HL, P127, DOI DOI 10.1093/OXFORDHB/9780195375343.013.0007
   Galama TJ, 2019, ECON J, V129, P338, DOI 10.1111/ecoj.12577
   Ginexi EM, 2000, AM J COMMUN PSYCHOL, V28, P495, DOI 10.1023/A:1005188515149
   HINKIN TR, 1989, J APPL PSYCHOL, V74, P561, DOI 10.1037//0021-9010.74.4.561
   Hobfoll S.E., 2016, STRESS CONCEPTS COGN, P65, DOI [10.1016/B978-0-12-800951-2.00007-8, DOI 10.1016/B978-0-12-800951-2.00007-8]
   HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513
   Hobfoll SE, 2003, J PERS SOC PSYCHOL, V84, P632, DOI 10.1037/0022-3514.84.3.632
   House J.S., 2000, PROMOTING HLTH INTER, P81
   HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293, DOI 10.1146/annurev.so.14.080188.001453
   Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574
   IHME, 2020, COVID 19 PROJ US
   Kiviruusu O, 2013, HEALTH PSYCHOL, V32, P627, DOI 10.1037/a0029291
   Knight R., 2020, HARVARD BUSINESS REV
   Kobau R, 2010, APPL PSYCHOL-HLTH WE, V2, P272, DOI 10.1111/j.1758-0854.2010.01035.x
   Kraus MW, 2012, PSYCHOL REV, V119, P546, DOI 10.1037/a0028756
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Lachman ME, 1998, J PERS SOC PSYCHOL, V74, P763, DOI 10.1037/0022-3514.74.3.763
   Leana CR, 2015, ACAD MANAG ANN, V9, P55, DOI 10.1080/19416520.2015.1007654
   Lei L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924609
   LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958
   Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182
   MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4
   Mayo Clinic, 2020, COVID 19 WHOS HIGH R
   McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612
   Meuris J, 2018, ORGAN SCI, V29, P398, DOI 10.1287/orsc.2017.1187
   Muthen L. K., 2012, MPLUS USERS GUIDE, V7th
   Newman DA, 2014, ORGAN RES METHODS, V17, P372, DOI 10.1177/1094428114548590
   Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173
   Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4
   Oppel R., 2020, NY TIMES
   Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008
   Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498
   PHIFER JF, 1990, PSYCHOL AGING, V5, P412, DOI 10.1037/0882-7974.5.3.412
   Pinquart M, 2000, PSYCHOL AGING, V15, P187, DOI 10.1037//0882-7974.15.2.187
   Pollard M., 2017, RAND AM LIFE PANEL T, DOI [10.7249/RR1651, DOI 10.7249/RR1651]
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   RAVEN BH, 1993, J SOC ISSUES, V49, P227, DOI 10.1111/j.1540-4560.1993.tb01191.x
   Reeves R. V., 2020, CLASS COVID LESS AFF
   S&P Dow Jones Indices, 2020, DOW JON IND AV
   Salk RH, 2017, PSYCHOL BULL, V143, P783, DOI 10.1037/bul0000102
   Talev M., 2020, AXIOS IPSOS CORONAVI
   Teo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062396
   Tomitaka S, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1696-9
   TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956
   Venables WN, 2002, MODERN APPL STAT S, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Wang JL, 2010, J EPIDEMIOL COMMUN H, V64, P447, DOI 10.1136/jech.2009.090910
   Warr P, 2019, WORLD DEV, V122, P446, DOI 10.1016/j.worlddev.2019.05.016
   World Health Organization, 2020, MEN HLTH PSYCH CONS
NR 71
TC 46
Z9 46
U1 45
U2 90
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0021-9010
EI 1939-1854
J9 J APPL PSYCHOL
JI J. Appl. Psychol.
PD DEC
PY 2020
VL 105
IS 12
BP 1382
EP 1396
DI 10.1037/apl0000831
PG 15
WC Psychology, Applied; Management
WE Social Science Citation Index (SSCI)
SC Psychology; Business & Economics
GA PC0XU
UT WOS:000596734200002
PM 33090858
OA Green Accepted
DA 2022-04-20
ER

PT J
AU Mizrachi, I
   Gretzel, U
AF Mizrachi, Isaac
   Gretzel, Ulrike
TI Collaborating against COVID-19: bridging travel and travel tech
SO INFORMATION TECHNOLOGY & TOURISM
LA English
DT Article
DE Travel tech; Travel startups; Travel safety perceptions; Destination
   marketing; COVID-19
ID PERCEPTION
AB The distinction between "traditional" travel businesses and travel tech companies has remained steady for years due to knowledge, resource and financial reasons, leading them to operate in separate bubbles. The massive damages caused by COVID-19 for both sides of the industry pose a unique opportunity for them to ditch the old transactional working model, and to seek for more strategic collaborations in order to weather the storm. This viewpoint article discusses the business potential behind such collaborations in the short and long runs-from improving immediate safety perceptions to building technological foundations for the travel industry of tomorrow. It argues that local government mediation is needed for it to succeed, in formats such as funded hackathons or incubation programs that are targeted at addressing COVID-19 and its unique challenges.
C1 [Mizrachi, Isaac; Gretzel, Ulrike] Ben Gurion Univ Negev, Dept Hotel & Tourism Management, Beer Sheva, Israel.
   [Mizrachi, Isaac; Gretzel, Ulrike] Univ Southern Calif, Annenberg Sch Commun & Journalism, USC Ctr Publ Relat, Los Angeles, CA 90007 USA.
RP Mizrachi, I (corresponding author), Ben Gurion Univ Negev, Dept Hotel & Tourism Management, Beer Sheva, Israel.; Mizrachi, I (corresponding author), Univ Southern Calif, Annenberg Sch Commun & Journalism, USC Ctr Publ Relat, Los Angeles, CA 90007 USA.
EM ismizrachi@gmail.com; gretzel@usc.edu
RI Gretzel, Ulrike/H-3848-2019
OI Gretzel, Ulrike/0000-0001-8416-1829; Mizrachi, Isaac/0000-0002-3089-9147
CR Anuar Faiz, 2011, ENTER 2011 C INNSBR
   Arana JE, 2008, ANN TOURISM RES, V35, P299, DOI 10.1016/j.annals.2007.08.003
   Bastakis C, 2004, TOURISM MANAGE, V25, P151, DOI 10.1016/S0261-5177(03)00098-0
   Chew EYT, 2014, TOURISM MANAGE, V40, P382, DOI 10.1016/j.tourman.2013.07.008
   DeTienne DR, 2010, J BUS VENTURING, V25, P203, DOI 10.1016/j.jbusvent.2008.05.004
   Dodds R., 2019, OVERTOURISM ISSUES R
   Fuchs G., 2006, Journal of Hospitality & Leisure Marketing, V14, P83, DOI 10.1300/J150v14n02_06
   Fuchs G, 2011, TOURISM MANAGE, V32, P266, DOI 10.1016/j.tourman.2010.01.012
   Fuchs M, 2020, HDB E TOURISM, P1
   Gretzel U, 2018, MANAGING ASIAN DESTI
   Gretzel U, 2020, INF TECHNOL TOUR, V22, P187, DOI 10.1007/s40558-020-00181-3
   Jonas A, 2011, J TRAVEL RES, V50, P87, DOI 10.1177/0047287509355323
   Komppula R., 2004, Small firms in tourism: international perspectives, P115, DOI 10.1016/B978-0-08-044132-0.50011-3
   Lenzen M, 2018, NAT CLIM CHANGE, V8, P522, DOI 10.1038/s41558-018-0141-x
   Milano C., 2019, OVERTOURISM EXCESSES
   Mistilis N., 2013, TOURISM OPERATORS DI
   Peters M, 2018, CURR ISSUES TOUR, V21, P21, DOI 10.1080/13683500.2015.1053849
   Roehl W. S., 1992, Journal of Travel Research, V30, P17, DOI 10.1177/004728759203000403
   Tussyadiah I, 2019, INFORMATION AND COMMUNICATION TECHNOLOGIES IN TOURISM 2019, P278, DOI 10.1007/978-3-030-05940-8_22
   Wang Y., 2007, J TRAVEL RES, V46, P75, DOI DOI 10.1177/0047287507302384
NR 20
TC 5
Z9 5
U1 10
U2 19
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1098-3058
EI 1943-4294
J9 INF TECHNOL TOUR
JI Inf. Technol. Tour.
PD DEC
PY 2020
VL 22
IS 4
BP 489
EP 496
DI 10.1007/s40558-020-00192-0
EA NOV 2020
PG 8
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA PA1EO
UT WOS:000589984300001
OA Bronze
DA 2022-04-20
ER

PT J
AU Presanis, AM
   Kunzmann, K
   Grosso, FM
   Jackson, CH
   Corbella, A
   Grasselli, G
   Salmoiraghi, M
   Gramegna, M
   De Angelis, D
   Cereda, D
AF Presanis, Anne M.
   Kunzmann, Kevin
   Grosso, Francesca M.
   Jackson, Christopher H.
   Corbella, Alice
   Grasselli, Giacomo
   Salmoiraghi, Marco
   Gramegna, Maria
   De Angelis, Daniela
   Cereda, Danilo
TI Risk factors associated with severe hospital burden of COVID-19 disease
   in Regione Lombardia: a cohort study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE COVID-19; Hospital-fatality risk; Critical care; Multi-state model;
   Mixture model
ID COMPETING RISKS; MULTICENTER
AB Background Understanding the risk factors associated with hospital burden of COVID-19 is crucial for healthcare planning for any future waves of infection. Methods An observational cohort study is performed, using data on all PCR-confirmed cases of COVID-19 in Regione Lombardia, Italy, during the first wave of infection from February-June 2020. A multi-state modelling approach is used to simultaneously estimate risks of progression through hospital to final outcomes of either death or discharge, by pathway (via critical care or not) and the times to final events (lengths of stay). Logistic and time-to-event regressions are used to quantify the association of patient and population characteristics with the risks of hospital outcomes and lengths of stay respectively. Results Risks of severe outcomes such as ICU admission and mortality have decreased with month of admission (for example, the odds ratio of ICU admission in June vs March is 0.247 [0.120-0.508]) and increased with age (odds ratio of ICU admission in 45-65 vs 65 + age group is 0.286 [0.201-0.406]). Care home residents aged 65 + are associated with increased risk of hospital mortality and decreased risk of ICU admission. Being a healthcare worker appears to have a protective association with mortality risk (odds ratio of ICU mortality is 0.254 [0.143-0.453] relative to non-healthcare workers) and length of stay. Lengths of stay decrease with month of admission for survivors, but do not appear to vary with month for non-survivors. Conclusions Improvements in clinical knowledge, treatment, patient and hospital management and public health surveillance, together with the waning of the first wave after the first lockdown, are hypothesised to have contributed to the reduced risks and lengths of stay over time.
C1 [Presanis, Anne M.; Kunzmann, Kevin; Jackson, Christopher H.; Corbella, Alice; De Angelis, Daniela] Univ Cambridge, Sch Clin Med, Med Res Council Biostat Unit, Cambridge, England.
   [Grosso, Francesca M.] Univ Milan, Postgrad Sch Publ Hlth, Dept Biomed Sci Hlth, Milan, Italy.
   [Corbella, Alice] Univ Warwick, Coventry, W Midlands, England.
   [Grasselli, Giacomo] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy.
   [Salmoiraghi, Marco; Gramegna, Maria; Cereda, Danilo] Welf Gen Directorate, Milan, Regione Lombard, Italy.
RP Presanis, AM (corresponding author), Univ Cambridge, Sch Clin Med, Med Res Council Biostat Unit, Cambridge, England.
EM anne.presanis@mrc-bsu.cam.ac.uk
OI Presanis, Anne/0000-0003-3078-4427; De Angelis,
   Daniela/0000-0001-6619-6112
FU Medical Research CouncilUK Research & Innovation (UKRI)Medical Research
   Council UK (MRC)European Commission [MC_UU_00002/11, MC_UU_00002/10];
   UKRI-MRC/NIHR/DHSC COVID-19 rapid response call [MC_PC_19074]
FX This work has been funded by the Medical Research Council (De Angelis,
   Jackson, Presanis: Unit programme number MC_UU_00002/11; Kunzmann: Unit
   programme number MC_UU_00002/10); and the UKRI-MRC/NIHR/DHSC COVID-19
   rapid response call (Presanis, De Angelis, Corbella, grant no
   MC_PC_19074).
CR Ahmed AE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2712-2
   Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213
   [Anonymous], 2020, LANCET INFECT DIS, V20, P1101, DOI 10.1016/S1473-3099(20)30706-4
   Burton JK, 2020, LANCET HEALTH LONGEV, V1, pE21, DOI 10.1016/S2666-7568(20)30012-X
   Docherty AB, 2021, LANCET RESP MED, V9, P773, DOI 10.1016/S2213-2600(21)00175-2
   Elkholy AA, 2020, J INFECT PUBLIC HEAL, V13, P418, DOI 10.1016/j.jiph.2019.04.011
   European Centre for Disease Prevention and Control, 2020, INCR FAT CAS COVID 1
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Guzzetta G, 2021, EMERG INFECT DIS, V27, P267, DOI 10.3201/eid2701.202114
   Hagg S, 2020, J AM MED DIR ASSOC, V21, P1555, DOI 10.1016/j.jamda.2020.08.014
   Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9
   Italian National Institute of Health, 2020, NAT SURVCOVID 19 OUT
   Jackson C., 2021, STAT METHODS MED RES
   Kirwan PD, 2021, ARXIV210304867
   Lahner E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124417
   LARSON MG, 1985, J R STAT SOC C-APPL, V34, P201
   Lombardy Section Italian Society Infectious And Tropical Diseases -, 2020, Infez Med, V28, P143
   Maria GF, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11669-w
   Ministero della Salute, 2020, COVID 19 BOLL PROT C
   Nandy K, 2020, DIABETES METAB SYND, V14, P1017, DOI 10.1016/j.dsx.2020.06.064
   Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X
   Pecoraro F, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030848
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   Welfare Directorate of Regione Lombardia, 2020, REG LOMB COVID 19 DA
   Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 26
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD OCT 7
PY 2021
VL 21
IS 1
AR 1041
DI 10.1186/s12879-021-06750-z
PG 16
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA WD5JN
UT WOS:000704976800001
PM 34620121
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Zain, NM
   Mut, NAIC
AF Zain, Norhayati Mohd
   Mut, Nur Anis Izzati Che
TI The perceptions on the recent COVID-19 pandemic: a study on health-care
   students in Malaysia
SO ASIAN EDUCATION AND DEVELOPMENT STUDIES
LA English
DT Article
DE Health-care students; Perceptions; COVID-19; Pandemics
ID INFLUENZA
AB Purpose The purpose of this paper is to study the perception of health-care students on the recent COVID-19 pandemic in Malaysia. There was one study by Caliskhan et al. (2020) conducted among Turkish final-year medical students showed that the students were knowledgeable about and aware of the COVID-19 pandemic. To the authors' knowledge, there are limited number of studies conducted among health-care students in Malaysia. Design/methodology/approach The online questionnaire was randomly distributed to the health-care students in Malaysia. The questionnaire consists of socio-demographic data and perceptions on COVID-19. Descriptive analysis was used to analyse the perceptions of the health-care students on COVID-19. Findings Health-care students in Malaysia have positive perceptions on COVID-19, and it did not give huge impact of their interest in this health-care field. Thus, it is important that this issue is investigated, and the perceptions of health-care students on COVID-19 can be highlighted. Research limitations/implications The strength of this study was the participation from the health-care students from various institutions, which have different experience and backgrounds. The study was limited on the items of question utilised. Due to the limited time and urgency of the survey, the authors were unable to study their knowledge, attitudes and way they are going to cope with this kind of pandemic as the students and as future health-care workers. Originality/value The paper points out the effect on the recent COVID-19 pandemic on health-care students in Malaysia. It also points out the perceptions of health-care students in Malaysia on the current pandemic. It is expected that the results of this research would serve as baseline data for health-care institutions in Malaysia to continue equip the future front liners that can adapt future challenges.
C1 [Zain, Norhayati Mohd; Mut, Nur Anis Izzati Che] KPJ Healthcare Univ Coll, Res Management Ctr, Nilai, Negeri Sembilan, Malaysia.
RP Zain, NM (corresponding author), KPJ Healthcare Univ Coll, Res Management Ctr, Nilai, Negeri Sembilan, Malaysia.
EM norhayati@kpjuc.edu.my
OI Mohd Zain, Norhayati/0000-0001-7216-087X
CR AFP, 2020, NEW STRAITS TIMES
   [Anonymous], 2020, NEW STRAITS TIMES
   Babiker Amir, 2014, Sudan J Paediatr, V14, P9
   Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160
   Caliskan F, 2020, POSTGRAD MED, V132, P764, DOI 10.1080/00325481.2020.1795486
   Chandra Y, 2021, ASIAN EDUC DEV STUD, V10, P229, DOI 10.1108/AEDS-05-2020-0097
   Damery S, 2010, J MED ETHICS, V36, P12, DOI 10.1136/jme.2009.032821
   Gaede, 2017, INT J AFR NURS SCI, V7, P75, DOI DOI 10.1016/J.IJANS.2017.09.002
   Honigsbaum M, 2009, LANCET, V373, P1939, DOI 10.1016/S0140-6736(09)61053-9
   Hope M, 2009, J GEOGR HIGHER EDUC, V33, P169, DOI 10.1080/03098260802276698
   Hornby A. S., 2006, OXFORD ADV LEARNERS, V7th
   Iqbal MZ, 2016, VALUE HEALTH, V19, pA913, DOI 10.1016/j.jval.2016.08.118
   Kementerian Kesihatan Malaysia, 2020, SIT TERK 22 MEI 2020
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   Malave Adriel, 2010, Virtual Mentor, V12, P719, DOI 10.1001/virtualmentor.2010.12.9.cprl1-1009
   Mertens G, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102258
   Mya K.M., 2015, MED J, V57, P8
   Nation, 2020, STAR 0207
   Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X
   Njiti, 2017, IOSR J DENT MED SCI, V16, P94
   Pareek A., 2018, CANC THERAPY ONCOLOG, V10, P001
   Prime Minister's Office of Malaysia, 2020, PRIM MIN SPEC MESS C
   Rewar S, 2015, ANN GLOB HEALTH, V81, P645, DOI 10.1016/j.aogh.2015.08.014
   Rossow CC, 2015, J HOMEL SECUR EMERG, V12, P823, DOI 10.1515/jhsem-2014-0115
   Saim L., 2020, BERITA HARIAN
   Saim L., 2020, BERITA HARIAN, V27, P11
   Sim MR, 2020, OCCUP ENVIRON MED, V77, P281, DOI 10.1136/oemed-2020-106567
   Smith, 2019, ROLES NURSE NEWS MED
   Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979
   Bui TH, 2020, DATA BRIEF, V32, DOI 10.1016/j.dib.2020.106142
   Turtle L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120013
   World Health Organization, 2020, PNEUM UNKN CAUS CHIN
   Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504
   Zadra JR, 2011, WIRES COGN SCI, V2, P676, DOI 10.1002/wcs.147
NR 34
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2046-3162
EI 2046-3170
J9 ASIAN EDUC DEV STUD
JI Asian Educ. Dev. Stud.
PD JAN 3
PY 2022
VL 11
IS 1
BP 188
EP 195
DI 10.1108/AEDS-05-2020-0109
PG 8
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA XV4II
UT WOS:000734907100015
OA Bronze
DA 2022-04-20
ER

PT J
AU Krishnan, A
   Hamilton, JP
   Alqahtani, SA
   Woreta, TA
AF Krishnan, Arunkumar
   Hamilton, James P.
   Alqahtani, Saleh A.
   Woreta, Tinsay A.
TI COVID-19: An overview and a clinical update
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Review
DE Coronaviruses; COVID-19; SARS-CoV-2; Epidemiology; Symptoms; Laboratory;
   Imaging; Treatment; Vaccines; Prevention
ID SARS CORONAVIRUS; GUT MICROBIOME; OBESITY; WUHAN; DRUG; ACE2;
   EPIDEMIOLOGY; INFECTIONS; NUTRITION; RESPONSES
AB The outbreak of coronavirus disease-2019 (COVID-19, previously known as 2019 nCoV) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan City, China, has spread rapidly around the world. Most patients from the first cluster had an epidemiological connection to the Wuhan's Huanan Seafood Wholesale Market. Available evidence has shown that SARS-CoV-2 can be easily transmitted from person to person through close contact and respiratory droplets, posing a substantial challenge to public health. At present, the research on SARS-CoV-2 is still in the primary stages. However, dexa-methasone and remdesivir are appeared to be promising medical therapies. Still, there is no definite specific treatment, and the mainstay of treatment is still focused on supportive therapies. Currently, over 150 vaccines are under investigation. It is necessary to understand the nature of the virus and its clinical characteristics in order to find effectively manage the disease. The knowledge about this virus is rapidly evolving, and clinicians must update themselves regularly. The present review comprehensively summarizes the epidemiology, pathogenesis, clinical characteristics, and management of COVID-19 based on the current evidence.
C1 [Krishnan, Arunkumar; Hamilton, James P.; Alqahtani, Saleh A.; Woreta, Tinsay A.] Johns Hopkins Sch Med, Div Gastroenterol & Hepatol, 600 Wolfe St,Hal 407, Baltimore, MD 21287 USA.
   [Alqahtani, Saleh A.] King Faisal Specialist Hosp & Res Ctr, Liver Transplant Ctr, Riyadh 12713, Saudi Arabia.
RP Krishnan, A (corresponding author), Johns Hopkins Sch Med, Div Gastroenterol & Hepatol, 600 Wolfe St,Hal 407, Baltimore, MD 21287 USA.
EM dr.arunkumar.krishnan@gmail.com
OI Alqahtani, Saleh/0000-0003-2017-3526
CR [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2020, Nature, DOI 10.1038/d41586-020-00154-w
   [Anonymous], 2020, COV 19 RAP EV SUMM V
   [Anonymous], 2020, NOV COR
   [Anonymous], 2020, BBC NEWS
   Arabi YM, 2020, TRIALS, V21, DOI 10.1186/s13063-019-3846-x
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bartley JM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01164
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bimonte S, 2020, IN VIVO, V34, P1597, DOI 10.21873/invivo.11949
   BioSpace, 2020, COD SER I IND IN COD
   BONDARENKO NA, 1985, FARMAKOL TOKSIKOL, V48, P31
   Bradley KC, 2019, CELL REP, V28, P245, DOI 10.1016/j.celrep.2019.05.105
   Burton DR, 2020, CELL HOST MICROBE, V27, P695, DOI 10.1016/j.chom.2020.04.022
   Cai QX, 2020, DIABETES CARE, V43, P1392, DOI 10.2337/dc20-0576
   Calder PC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041181
   Caussy C, 2020, LANCET DIABETES ENDO, V8, P562, DOI [10.1016/S2213-8587(20)30160-1, 10.1016/S2213-8587(20)30160-0]
   Centers for Disease Control and Prevention, 2020, US MASKS HELP SLOW S
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x
   Chatterjee SK, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00196
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen WH, 2020, CURR TROP MED REP, V7, P61, DOI 10.1007/s40475-020-00201-6
   Childs CE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081933
   Ciabattini A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01305
   Cowling BJ, 2020, EUROSURVEILLANCE, V25, DOI 10.2807/1560-7917.ES.2020.25.49.2001998
   Deriu E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005572
   Dhar D, 2020, VIRUS RES, V285, DOI 10.1016/j.virusres.2020.198018
   Emami A, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.600
   Emoto T, 2016, J ATHEROSCLER THROMB, V23, P908, DOI 10.5551/jat.32672
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Farsalinos K, 2020, INTERN EMERG MED, V15, P845, DOI 10.1007/s11739-020-02355-7
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4
   Glantz Stanton A, 2020, REDUCE YOUR RISK SER
   Gombart AF, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010236
   GRANT WB, 2020, NUTRIENTS, V12, DOI [DOI 10.3390/NU12040988, 10.3390/nu12040988]
   Green WD, 2017, ANN AM THORAC SOC, V14, pS406, DOI 10.1513/AnnalsATS.201706-447AW
   Groves HT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00182
   Gu SL, 2020, CLIN INFECT DIS, V71, P2669, DOI 10.1093/cid/ciaa709
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Han LF, 2019, EPIDEMIOLOGY, V30, P405, DOI 10.1097/EDE.0000000000000984
   Harvard Medical School, 2014, BOOST YOUR IMM
   He Y, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01302
   Hennessy J, 2020, SCI ALERT
   Hirsch HH, 2013, CLIN INFECT DIS, V56, P258, DOI 10.1093/cid/cis844
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hufnagl K, 2020, SEMIN IMMUNOPATHOL, V42, P75, DOI 10.1007/s00281-019-00775-y
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483
   Kalantar-Zadeh K, 2020, J RENAL NUTR, V30, P179, DOI 10.1053/j.jrn.2020.03.006
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1053/S0016-5085(03)01215-0, 10.1016/j.gastro.2003.08.001]
   Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044
   Li YW, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104833
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Memish ZA, 2014, J INFECT DIS, V210, P1590, DOI 10.1093/infdis/jiu292
   Molina PE, 2010, ALCOHOL RES HEALTH, V33, P97
   Morrish GA, 2011, EXPERT OPIN DRUG MET, V7, P697, DOI 10.1517/17425255.2011.570331
   Mukherjee S, 2020, FORTUNE
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   NASRAWI CW, 1990, PHYSIOL BEHAV, V47, P611, DOI 10.1016/0031-9384(90)90066-D
   National Geographic, 2020, NATL GEOGRAPHIC
   National Institutes of Health, COVID 19 TREATM GUID
   Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471
   Park A., 2020, TIME
   Pereira-Santos M, 2015, OBES REV, V16, P341, DOI 10.1111/obr.12239
   Pharmaceutical Technology, 2020, COR VIR BIOT NOV ANN
   Polverino F, 2020, AM J RESP CRIT CARE, V202, P471, DOI 10.1164/rccm.202005-1646LE
   Richman DD, 2016, CLIN VIROLOGY, V4th
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Scientific Advisory Committee on Nutrition, 2016, SACN VIT D HLTH REP
   Simou E, 2018, CHEST, V154, P58, DOI 10.1016/j.chest.2017.11.041
   Smith J, 2020, CUREVAC BIDS DEV 1 M
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Sundararaman A, 2020, APPL MICROBIOL BIOT, V104, P8089, DOI 10.1007/s00253-020-10832-4
   van der Lelie D, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00453-20
   Vaxart, 2020, PIPELINEREVIEW VAX A
   Villar J, 2020, LANCET RESP MED, V8, P267, DOI 10.1016/S2213-2600(19)30417-5
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Vlasova AN, 2019, CURR OPIN VIROL, V37, P16, DOI 10.1016/j.coviro.2019.05.001
   Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2
   WHO, 2020, NOVEL CORONAVIRUS CH
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013
   World Health Organization, 41 WHO
   World Health Organization, ALC COVID 19 WHAT YO
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Yu G, 2020, CNN
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
   Zuo TT, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104987
NR 106
TC 9
Z9 10
U1 1
U2 5
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD JAN 6
PY 2021
VL 9
IS 1
BP 8
EP 23
DI 10.12998/wjcc.v9.i1.8
PG 16
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PV2FY
UT WOS:000609809300002
PM 33511168
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Cieszanowski, A
   Czekajska, E
   Gizycka, B
   Gruszczynska, K
   Podgorska, J
   Oronowicz-Jaskowiak, A
   Serafin, Z
   Szurowska, E
   Walecki, JM
AF Cieszanowski, Andrzej
   Czekajska, Elzbieta
   Gizycka, Barbara
   Gruszczynska, Katarzyna
   Podgorska, Joanna
   Oronowicz-Jaskowiak, Agnieszka
   Serafin, Zbigniew
   Szurowska, Edyta
   Walecki, Jerzy M.
TI Management of patients with COVID-19 in radiology departments, and
   indications regarding imaging studies - recommendations of the Polish
   Medical Society of Radiology
SO POLISH JOURNAL OF RADIOLOGY
LA English
DT Article
DE COVID-19; SARS-CoV-2; PMSR; PLTR
AB The pandemic involving COVID-19 caused by the SARS-CoV-2 coronavirus, due to its severe symptoms and high transmission rate, has gone on to pose a control challenge for healthcare systems all around the world. We present the second version of the Recommendations of the Polish Medical Society of Radiology, presuming that our knowledge on COVID-19 will advance further rapidly, to the extent that further supplementation and modification will prove necessary. These Recommendations involve rules of conduct, procedures, and safety measures that should be introduced in radiology departments, as well as indications for imaging studies.
C1 [Cieszanowski, Andrzej; Podgorska, Joanna; Oronowicz-Jaskowiak, Agnieszka] Maria Sklodowska Curie Natl Res Inst Oncol, Radiol Dept 1, 5 Roentgena St, Warsaw 02781, Poland.
   [Czekajska, Elzbieta] Med Univ Lublin, Dept Radiol, Lublin, Poland.
   [Gizycka, Barbara] Multispecial Hosp Megrez Sp Zoo, Dept Diagnost Imaging, Tychy, Poland.
   [Gruszczynska, Katarzyna] Med Univ Silesia, Fac Med Sci Katowice, Dept Radiol & Nucl Med, Katowice, Poland.
   [Serafin, Zbigniew] Nicolaus Copernicus Univ, Coll Med, Dept Radiol & Diagnost Imaging, Bydgoszcz, Poland.
   [Szurowska, Edyta] Med Univ Gdansk, Dept Radiol 2, Gdansk, Poland.
   [Walecki, Jerzy M.] Ctr Postgrad Med Educ, Dept Diagnost Imaging, Warsaw, Poland.
RP Podgorska, J (corresponding author), Maria Sklodowska Curie Natl Res Inst Oncol, Radiol Dept 1, 5 Roentgena St, Warsaw 02781, Poland.
EM jpodgo@gmail.com
OI Szurowska, Edyta/0000-0002-7042-4381; WALECKI,
   JERZY/0000-0001-7494-7764; Podgorska, Joanna/0000-0002-8649-4165;
   Gruszczynska, Katarzyna/0000-0002-0863-4492; Czekajska-Chehab,
   Elzbieta/0000-0002-4053-7713
CR [Anonymous], [No title captured]
   [Anonymous], 2020, RADIOLOGY, DOI [DOI 10.1148/RADIOL.2020200490, DOI 10.1148/radiol.2020200490]
   [Anonymous], [No title captured]
   [Anonymous], 2020, AM J ROENTGENOL, DOI DOI 10.2214/AJR.20.23034
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   Buonsenso D, 2020, LANCET RESP MED, V8, pE27, DOI 10.1016/S2213-2600(20)30120-X
   Cheung JCH, 2020, LANCET RESP MED, V8, pE19, DOI 10.1016/S2213-2600(20)30084-9
   Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432
   Huang C, 2020, Lancet, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang ZX, 2020, J AM COLL RADIOL, V17, P710, DOI 10.1016/j.jacr.2020.03.011
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kanne Jeffrey P, 2020, Radiology, V296, pE113, DOI 10.1148/radiol.2020200527
   Kooraki S, 2020, J AM COLL RADIOL, V17, P447, DOI 10.1016/j.jacr.2020.02.008
   Lee SA, 2008, ANN OCCUP HYG, V52, P177, DOI 10.1093/annhyg/men005
   Mitchell R, 2013, AM J INFECT CONTROL, V41, P240, DOI 10.1016/j.ajic.2012.04.332
   Mossa-Basha M, 2020, RADIOLOGY, V296, pE106, DOI 10.1148/radiol.2020200988
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Song FX, 2020, RADIOLOGY, V295, P210, DOI [10.1148/radiol.2020200274, 10.1148/radiol.2020209021]
   Sun PF, 2020, J MED VIROL, V92, P548, DOI 10.1002/jmv.25722
   WHO, 2020, INF PREV CONTR HLTH
NR 22
TC 9
Z9 9
U1 0
U2 2
PU INT SCIENTIFIC INFORMATION INC
PI SMITHTOWN
PA 361 FOREST LN, SMITHTOWN, NY 11787 USA
SN 0137-7183
EI 1899-0967
J9 POL J RADIOL
JI Pol. J. Radiol.
PD APR 29
PY 2020
VL 85
BP E209
EP E214
DI 10.5114/pjr.2020.95022
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
WE Emerging Sources Citation Index (ESCI)
SC Radiology, Nuclear Medicine & Medical Imaging
GA LL6CY
UT WOS:000531646600001
PM 32419887
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Ferrari, SG
   De Narvaez, SC
   Mera, WEC
   Velasquez, C
   Bain, AA
AF Ferrari, Soledad Garcia
   De Narvaez, Stephanie Crane
   Mera, Wilmar Edgardo Castro
   Velasquez, Carlos
   Bain, Amelia A.
TI Collective Action Towards Risk Management in Informal Urban Areas in
   Medellin: COVID-19 Lessons for Reducing Vulnerability and Inequality
SO FRONTIERS IN ENVIRONMENTAL SCIENCE
LA English
DT Article
DE collective action; disaster risk management; social production of
   habitat; co-production; vulnerability; inequality; COVID-19
ID RESILIENCE
AB Recent experiences of socio-environmental disasters in Latin America have demonstrated the ineffectiveness of the state as a social actor in the organisation, coordination and implementation of adequate public policies to face these emergencies. This affects the most vulnerable urban areas, leading to unequal levels of impact from crises and disasters within cities. As a response, local collective actions, led by citizens, have emerged to manage risks. In Medellin, Colombia, in the context of the current COVID-19 crisis, our research identified a diverse repertoire of collective actions within informal, vulnerable communities, including collaboration towards improving food security, sanitation, pedagogy for self-care and prevention, and financial aid. Although these actions have had limited scope within the context of the ongoing COVID-19 pandemic, they demonstrate the need to promote a more proactive interaction between society and the state, based on a series of agreed interventions, promoting the exchange of knowledge and articulation of actions in the production and improvement of informal urban areas. This research explores how these collective actions have developed through a set of semi-structured interviews with community leaders and key actors in Medellin, with a view to identifying lessons for state-community dynamics in relation to disaster risk management and achieving a more integrated approach to improving habitat conditions within vulnerable urban areas. This work demonstrates that vulnerable communities in informal urban settlements can actively address their exposure to risk through locally-oriented, bottom-up collective actions. However, key linkages with institutional frameworks are needed to strengthen state-community dynamics and facilitate sustainable, inclusive and equitable development in cities.
C1 [Ferrari, Soledad Garcia; De Narvaez, Stephanie Crane; Bain, Amelia A.] Univ Edinburgh, Sch Architecture & Landscape Architecture, Edinburgh, Midlothian, Scotland.
   [Mera, Wilmar Edgardo Castro] Univ Nacl Colombia, Escuela Habitat, Medellin, Colombia.
   [Velasquez, Carlos] Univ Antioquia, Dept Sociol, Medellin, Colombia.
RP Ferrari, SG (corresponding author), Univ Edinburgh, Sch Architecture & Landscape Architecture, Edinburgh, Midlothian, Scotland.
EM s.garcia@ed.ac.uk
FU British Academy Infrastructures of Wellbeing [UWB190128]; Scottish
   Funding Council-GCRF (University of EdinburghInternal ) [278000 GCRF12];
   ESRC ImpactAcceleration grant (University of Edinburgh Internal)
   [EDI-20/21-P0034]
FX This work was supported by a British Academy Infrastructures of
   Wellbeing grant (UWB190128), as well as funding from the Scottish
   Funding Council-GCRF (University of EdinburghInternal grant 278000
   GCRF12), and an ESRC ImpactAcceleration grant (University of Edinburgh
   Internal grant EDI-20/21-P0034)
CR Agrawal N, 2018, INT PERSPECTIVES NAT, V21, DOI [10.1007/978-1-4020-2851-910.1007/978-94-024-1283-3, DOI 10.1007/978-1-4020-2851-910.1007/978-94-024-1283-3]
   Agudelo O, 2010, PROCESO RIESGO HACIA
   Alcaldia de Medellin, 2014, PLAN ORDENAMIENTO TE
   d'Alercon PA, 2018, HABITAT INT, V75, P59, DOI 10.1016/j.habitatint.2018.04.007
   Althor G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20281
   Anderson MG, 2013, COMMUNITY-BASED LANDSLIDE RISK REDUCTION: MANAGING DISASTERS IN SMALL STEPS, P1, DOI 10.1596/978-0-8213-9456-4
   Borquez R, 2017, SUSTAIN SCI, V12, P163, DOI 10.1007/s11625-016-0400-6
   Brassiolo P., 2017, CRECIMIENTO URBANO A
   Brugnach M, 2017, CLIMATIC CHANGE, V140, P19, DOI 10.1007/s10584-014-1280-3
   Cardona O., 2003, NOCION RIESGO PERSPE
   CARE, 2014, REFLECTION LEARNING
   Charania NA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-268
   Corburn J, 2020, J URBAN HEALTH, V97, P348, DOI 10.1007/s11524-020-00438-6
   Corburn J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040342
   Corporacion OSSO and Universidad EAFIT, 2011, BAS DAT PERD HIST CO
   DANE, 2020, GRUP NIV VULN
   DANE, 2019, CENS NAC POBL VIV 20
   DANE, 2020, MERC LAB INF JUN 202
   Davila J.D., 2013, URBAN MOBILITY POVER
   Duran Vargas L.R., 2011, REDUCCION RIESGO DES, V17
   Echeverri Restrepo A., 2010, MEDELLIN MEDIO AMBIE, P130
   Echeverria Ramirez M.C., 2009, QUE HABITAT PREGUNTA
   EKANAYAKE SB, 1990, PROSPECTS, V20, P115, DOI 10.1007/BF02195434
   Ferrari SG, 2018, CITIES, V74, P354, DOI 10.1016/j.cities.2017.12.011
   Franco Gomez L., 2013, HABITAT POLITICAS HA
   Gellert-de Pinto G. -I., 2012, B CIENTIFICO SAPIENS, V2, P13
   Hallegatte S., 2018, BUILDING BACK BETTER
   Harkins C., 2020, SUPPORTING COMMUNITY
   Lampis A., 2012, DESASTRES SOC MARCO
   Lavell A., 2020, COVID 19 RELACIONES
   Lavell A., 2020, CONSTRUCCION SOCIAL
   Lavell A., 2004, RED ESTUDIOS SOCIALE
   Manzanedo RD, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140563
   Marulanda M., 2006, ANALISIS IMPACTO DES
   Maskrey A., 1989, DISASTER MITIGATION, P1
   Maskrey A, 2011, ENVIRON HAZARDS-UK, V10, P42, DOI 10.3763/ehaz.2011.0005
   Meerow S, 2016, LANDSCAPE URBAN PLAN, V147, P38, DOI 10.1016/j.landurbplan.2015.11.011
   Narvaez L., 2009, GESTION RIESGO DESAS, V1st
   Ortiz C, 2012, THESIS U ILLINOIS CH
   Oviedo D., 2020, EFECTOS MEDIDAS MITI
   Pandey B., 2005, TSUK INT WORKSH 2005
   Romero G, 1995, HABITAT INT COALITIO, V1, P9
   Roth A., 2004, POLITICAS PUBLICAS F
   Singer M., 2018, CLIM CHANGE SOC INEQ, DOI [10.4324/9781315103358, DOI 10.4324/9781315103358]
   Smith H, 2020, ECOL SOC, V25, DOI 10.5751/ES-11337-250119
   Sperling F., 2005, WORLD C DIST RED KOB
   Torres Carrillo Alfonso, 2009, Folios, P51
   UN-Habitat, 2012, EST CIUD AM LAT CAR
   UNISDR, 2015, MARC SEND RED RIESG
   UNISDR, 2015, INF EV GLOB RED RIES
   UNISDR, 2005, MARC ACC HYOG PAR 20
   UNISDR, 2009, ISDR GLOB ASS REP DI
   Vallejo A., 2010, GESTION RIESGO COLOM
   Velasquez C., 2019, REV KAVILANDO, V11, P17
   Velasquez C.A., 2015, THESIS U NACL COLOMB
   Weston M., 2020, TACKLE CORONAVIRUS S
   Wijkman A., 1985, DESASTRES NATURALES
NR 57
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-665X
J9 FRONT ENV SCI-SWITZ
JI Front. Environ. Sci.
PD FEB 25
PY 2022
VL 9
AR 726867
DI 10.3389/fenvs.2021.726867
PG 17
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology
GA ZV8ME
UT WOS:000770777100001
OA gold
DA 2022-04-20
ER

PT J
AU Emmerichs, L
   Welter, VDE
   Schluetr, K
AF Emmerichs, Lars
   Welter, Virginia Deborah Elaine
   Schluetr, Kirsten
TI University Teacher Students' Learning in Times of COVID-19
SO EDUCATION SCIENCES
LA English
DT Article
DE teacher students; COVID-19; distance learning; professional knowledge;
   self-concept of abilities
ID ACADEMIC SELF-CONCEPT; PEDAGOGICAL CONTENT KNOWLEDGE; CLASSROOM
   MANAGEMENT; LIFE SATISFACTION; 5-FACTOR MODEL; PERSONALITY; EDUCATION;
   ACHIEVEMENT; VALIDATION; JOB
AB At the beginning of the COVID-19 pandemic in spring 2020, school and university learning were abruptly switched to distance learning, coming along with psychological strains and various learning lags on the part of the students. These problems come to a head when focusing on university teacher students, since an expectable competence lag on their part, similarly arising from pandemic-caused distance learning in university teacher training, could affect their future teaching in schools, possibly then disadvantaging school students a second time. To determine changes of teacher students' self-concept of professional knowledge, we used data of a repeated cross-sectional survey carried out in a period from 2018 to 2021, including several comparable cohorts of overall N = 395 teacher students. This design allowed for splitting the participants in two groups relating to times before and after switching to distance learning. Our results show that the switch to distance learning goes hand in hand with lower scores on almost every dimension of teacher students' self-concept of professional knowledge, although, in parallel, their scores on variables such as openness to experiences, agreeableness, and conscientiousness increased significantly, indicating a certain degree of compliance with the new situation. Beyond that, we report on an evaluative survey among N = 84 teacher students carried out in July 2020, offering further insights into their situation during the first semester of distance learning. Its results primarily show which specific aspects of distance learning the students consider in need of improvement. On the other hand, it becomes clear that they experienced handicaps in various areas, accompanied by a significant decrease of their core self-evaluations when comparing them to a reference sample. Practical implications and recommendations that can be derived from these results are discussed.
C1 [Emmerichs, Lars; Welter, Virginia Deborah Elaine; Schluetr, Kirsten] Univ Cologne, Inst Biol Educ, D-50931 Cologne, Germany.
RP Schluetr, K (corresponding author), Univ Cologne, Inst Biol Educ, D-50931 Cologne, Germany.
EM lars.emmerichs@uni-koeln.de; virginia.welter@uni-koeln.de;
   kirsten.schlueter@uni-koeln.de
OI Welter, Virginia Deborah Elaine/0000-0002-1968-5551; Schluter,
   Kirsten/0000-0001-9614-8824
CR Agasisti T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su122410312
   Ahmed Akif, 2020, 7th NSysS 2020: 7th International Conference on Networking, Systems and Security, P12, DOI 10.1145/3428363.3428370
   Algermissen P., 2020, QFI QUALIF INKL, V2, P1, DOI [10.21248/QfI.23, DOI 10.21248/QFI.23]
   Andresen S., 2021, LEBEN JUNGEN MENSCHE, V1st
   Angeli C, 2009, COMPUT EDUC, V52, P154, DOI 10.1016/j.compedu.2008.07.006
   Anger C., 2021, SCHULISCHE BILDUNG Z
   Arndt A.-K., 2017, LEHRER SCHULER INTER, V3rd, P607
   Bailey DH, 2021, EDUC RESEARCHER, V50, P266, DOI 10.3102/0013189X211011237
   Baumert J., 2013, COGNITIVE ACTIVATION, P25
   Blasko Z., 2021, LEARNING LOSS ED INE
   Borgwardt A., 2021, ZOOM GEMACHT STUDIER
   Borkenau P., 2008, NEO 5 FACTOR INVENTO, V2nd
   BOSSE E., 2020, CORONA HOCHSCHULE BE
   Breitenbach Andrea, 2021, DIGITALE LEHRE ZEITE
   Bujard M, 2021, BIB BEVOLKERUNGS STU, V2, P1, DOI [10.12765/bro-2020-02, DOI 10.12765/BRO-2020-02]
   Bundesministerium fur Bildung und Forschung, 2016, BILD DIG WISS STRAT
   Bundesministerium fur Bildung und Forschung, 2016, NEUE WEG LEHR QUAL L
   Caena F, 2019, EUR J EDUC, V54, P356, DOI 10.1111/ejed.12345
   CALSYN RJ, 1977, J EDUC PSYCHOL, V69, P136, DOI 10.1037/0022-0663.69.2.136
   Choate K, 2021, PHI DELTA KAPPAN, V102, P52, DOI 10.1177/00317217211007340
   Cook C.T., 2016, THESIS U MANCHESTER
   COSTA PT, 1992, J PERS DISORD, V6, P343, DOI 10.1521/pedi.1992.6.4.343
   De Raad B., 2000, BIG 5 PERSONALITY FA
   DeRaad B, 1996, EUR J PERSONALITY, V10, P303, DOI 10.1002/(SICI)1099-0984(199612)10:5<303::AID-PER262>3.0.CO;2-2
   Di Fabio A., 2020, WILEY ENCY PERSONALI, VIII, P83
   Donitsa-Schmidt S, 2020, J EDUC TEACHING, V46, P586, DOI 10.1080/02607476.2020.1799708
   Dorn E., 2020, COVID 19 STUDENT LEA
   Edelstein, 2020, LANGSAM VERMISSE ICH, P117, DOI [10.31244/9783830992318.07, DOI 10.31244/9783830992318.07]
   Egger D., 2019, J PSYCHOL, V27, P50, DOI [10.30820/0942-2285-2019-2-50, DOI 10.30820/0942-2285-2019-2-50]
   Elsholz M., 2019, AKAD SELBSTKONZEPT A, V1st
   Engzell P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022376118
   Falkenstern A., 2020, DIGITALE PRAENZ RUND, V1st, P41
   Ferrel B., IS COVID 19 CHANGING
   Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202
   Fickermann D., 2020, DTSCH SCHULE S16, V16, P9
   Fischer C., 2020, DSCHE SCHULE S, V16, P136
   Friedrich-Ebert-Stiftung, 2021, LEHR PAND GLEICH CHA
   Gatzka T, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110422
   Geis-Thone W., 2021, AUSWIRKUNGEN CORONA
   Geven K., 2020, SIMULATING POTENTIAL, DOI [10.1596/1813-9450-9284, DOI 10.1596/1813-9450-9284]
   Godoy LD, 2021, EDUC SCI, V11, DOI 10.3390/educsci11090473
   Goertz L., 2021, 56 HOCHSCH DIG BERL
   Grewenig E, 2021, EUR ECON REV, V140, DOI 10.1016/j.euroecorev.2021.103920
   Grossschedl J, 2019, J RES SCI TEACH, V56, P402, DOI 10.1002/tea.21482
   Hammerstein S, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.746289
   Han H, 2021, PERS INDIV DIFFER, V176, DOI 10.1016/j.paid.2021.110787
   Harvey MW, 2010, REM SPEC EDUC, V31, P24, DOI 10.1177/0741932508324397
   Hattie JAC, 2009, VISIBLE LEARNING: A SYNTHESIS OF OVER 800 META-ANALYSES RELATING TO ACHIEVEMENT, P1
   Helm C, 2021, Z ERZIEHWISS, V24, P237, DOI 10.1007/s11618-021-01000-z
   Helmke A., 2015, HDB UNTERRICHTSENTWI, V1st ed., P242
   Hogan J., 1997, HDB PERSONALITY PSYC, P849, DOI [DOI 10.1016/B978-012134645-4/50033-0, 10.1016/b978-012134645-4/50033-0]
   Horn S.P., 1997, J PERSONNEL EVALUATI, V11, P57, DOI [DOI 10.1023/A:1007999204543, 10.1023/A:1007999204543]
   John O. P., 2008, HDB PERSONALITY THEO, V3, P114, DOI DOI 10.1016/S0191-8869(97)81000-8
   John R., 2020, J LAW SOCIAL STUDIES, V1, P10
   Judge TA, 2005, J APPL PSYCHOL, V90, P257, DOI 10.1037/0021-9010.90.2.257
   Judge TA, 1998, HUM PERFORM, V11, P167, DOI 10.1207/s15327043hup1102&3_4
   Judge TA, 1998, J APPL PSYCHOL, V83, P17, DOI 10.1037/0021-9010.83.1.17
   Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x
   Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693
   Karakose T, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13179631
   Kerres M., 2020, POSTDIGITAL SCI EDUC, V2, P690, DOI [10.1007/s42438-020-00130-7, DOI 10.1007/S42438-020-00130-7]
   Koehler Matthew J, 2009, Contemporary Issues in Technology and Teacher Education, V9, P60
   Koehler MJ, 2007, COMPUT EDUC, V49, P740, DOI 10.1016/j.compedu.2005.11.012
   Konig J, 2020, EUR J TEACH EDUC, V43, P608, DOI 10.1080/02619768.2020.1809650
   Korner A, 2002, DIAGNOSTICA, V48, P19, DOI 10.1026//0012-1924.48.1.19
   Kosar G., 2021, IAFOR J ED, V9, P111, DOI [10.22492/ije.9.2.07, DOI 10.22492/IJE.9.2.07]
   Lauret D, 2021, EDUC SCI, V11, DOI 10.3390/educsci11050221
   Lederman N.G., 1999, EXAMINING PEDAGOGICA
   Limniou M, 2021, EDUC SCI, V11, DOI 10.3390/educsci11070361
   Lorz M, 2021, PSYCHOL ERZ UNTERR, V68, P312, DOI 10.2378/peu2021.art28d
   M?ller J., 2015, PADAGOGISCHE PSYCHOL, P177
   Mammadov S, 2022, J PERS, V90, P222, DOI 10.1111/jopy.12663
   Marsh HW, 2006, PERSPECT PSYCHOL SCI, V1, P133, DOI 10.1111/j.1745-6916.2006.00010.x
   Marsh HW, 2014, CONTEMP EDUC PSYCHOL, V39, P326, DOI 10.1016/j.cedpsych.2014.08.003
   MARSH HW, 1988, J EDUC PSYCHOL, V80, P366, DOI 10.1037/0022-0663.80.3.366
   Marsh HW, 2005, CHILD DEV, V76, P397, DOI 10.1111/j.1467-8624.2005.00853.x
   Marsh HW, 1997, J EDUC PSYCHOL, V89, P41, DOI 10.1037/0022-0663.89.1.41
   MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x
   MEYER WU, 1984, PSYCHOL RUNDSCH, V35, P136
   Mishra P, 2006, TEACH COLL REC, V108, P1017, DOI 10.1111/j.1467-9620.2006.00684.x
   Mitchell BS, 2017, TEACH EDUC SPEC EDUC, V40, P140, DOI 10.1177/0888406417700961
   Neumann S., 2020, NICHT SYSTEMRELEVANT
   Neyer F.J., 2018, PSYCHOL PERSONALITY, V6th
   O'Connor MC, 2007, PERS INDIV DIFFER, V43, P971, DOI 10.1016/j.paid.2007.03.017
   Onyeaka Helen, 2021, Sci Prog, V104, p368504211019854, DOI 10.1177/00368504211019854
   Patrinos H.A, 2021, RES SQ, DOI [10.21203/rs.3.rs-518655/v1, DOI 10.21203/RS.3.RS-518655/V1]
   Paulus D., 2021, BILDUNGSSYSTEM ZEITE, V1st, P205
   Petousi V., 2020, INT J SUSTAIN DEV, V23, P149, DOI [10.1504/IJSD.2020.115206, DOI 10.1504/IJSD.2020.115206]
   Porsch R., 2021, BILDUNGSSYSTEM ZEITE, V1st, P187
   Postholm MB, 2013, EUR EDUC RES J, V12, P389, DOI 10.2304/eerj.2013.12.3.389
   Rauthmann J.F., 2017, PERSONALITY PSYCHOL, V1st
   Redecker C., 2017, TECH REP JRC107466, DOI [10.2760/159770, DOI 10.2760/159770]
   Reinhold F., 2021, BILDUNG CORONA, P104
   Rheinberg F., 2014, PERFORMANCE ASSESSME, V3rd, P59
   Richter-Kornweitz, 2020, CORONA CHRONIK GRUPP
   Ritchie L, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.559114
   Roccas S, 2002, PERS SOC PSYCHOL B, V28, P789, DOI 10.1177/0146167202289008
   Rudert SC, 2021, EUR PSYCHOL, V26, P259, DOI 10.1027/1016-9040/a000457
   Schaumburg H., 2015, CHANCEN RISIKEN DIGI
   Schmidt DA, 2009, J RES TECHNOL EDUC, V42, P123, DOI 10.1080/15391523.2009.10782544
   Schmitt, 2017, STAT FORSCHUNGSMETHO
   Schult J., 2021, PSYARXIV, DOI [10.31234/osf.io/pqtgf, DOI 10.31234/OSF.IO/PQTGF]
   Seaton M, 2014, EDUC PSYCHOL-UK, V34, P49, DOI 10.1080/01443410.2013.825232
   Shulman L.S., 1986, ED RES, V15, P4, DOI [10.3102/0013189X015002004, DOI 10.3102/0013189X015002004, 10.2307/1175860]
   SHULMAN LS, 1987, HARVARD EDUC REV, V57, P1, DOI 10.17763/haer.57.1.j463w79r56455411
   Sikali K, 2020, J COMMUNITY PSYCHOL, V48, P2435, DOI 10.1002/jcop.22430
   Sliwka A, 2020, DTSCH SCHULE S16, V16, P216
   Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279
   Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950
   Stringer E., 2020, J TECHNOLOGY TEACHER, V28, P223
   Stumpp T, 2010, APPL PSYCHOL-INT REV, V59, P674, DOI 10.1111/j.1464-0597.2010.00422.x
   Sturm T, 2018, DEALING DIVERSITY IN, V6, P15
   Sutin AR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237056
   Tesser A., 1988, ADV EXP SOC PSYCHOL, V21, P181, DOI [10.1016/S0065-2601(08)60227-0, DOI 10.1016/S0065-2601(08)60227-0]
   Trapmann S, 2007, Z PSYCHOL, V215, P132, DOI 10.1027/0044-3409.215.2.132
   Traus A., 2020, STUDICO STUDIEREN DI
   UNESCO, 2020, INKL BILD ALL HEISST
   UNESCO UNICEF WORLD BANK & OECD, 2021, WHATS NEXT LESS ED R
   Valentine JC, 2004, EDUC PSYCHOL-US, V39, P111, DOI 10.1207/s15326985ep3902_3
   van Ackeren I, 2020, DDS-DEUT SCH, V112, P245, DOI 10.31244/dds.2020.02.10
   van Ackeren I, 2019, DDS-DEUT SCH, V111, P103, DOI 10.31244/dds.2019.01.10
   Welter VDE, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030933
   World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053
   Zancajo A., 2020, IMPACT COVID 19 PAND
   Zuchner I, 2021, Z ERZIEHWISS, V24, P479, DOI 10.1007/s11618-021-01006-7
NR 125
TC 0
Z9 0
U1 5
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-7102
J9 EDUC SCI
JI Educ. Sci.
PD DEC
PY 2021
VL 11
IS 12
AR 776
DI 10.3390/educsci11120776
PG 24
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA XW3YP
UT WOS:000735559200001
OA gold
DA 2022-04-20
ER

PT J
AU Noor, S
   Guo, Y
   Shah, SHH
   Fournier-Viger, P
   Nawaz, MS
AF Noor, Saleha
   Guo, Yi
   Shah, Syed Hamad Hassan
   Fournier-Viger, Philippe
   Nawaz, M. Saqib
TI Analysis of public reactions to the novel Coronavirus (COVID-19)
   outbreak on Twitter
SO KYBERNETES
LA English
DT Article
DE Clusters; VOSviewer; COVID-19; Sequential pattern mining; Tweets
ID SOCIAL MEDIA
AB Purpose
   The novel Coronavirus (COVID-19) pandemic, which started in late December 2019, has spread to more than 200 countries. As no vaccine is yet available for this pandemic, government and health agencies are taking draconian steps to contain it. This pandemic is also trending on social media, particularly on Twitter. The purpose of this study is to explore and analyze the general public reactions to the COVID-19 outbreak on Twitter.
   Design/methodology/approach
   This study conducts a thematic analysis of COVID-19 tweets through VOSviewer to examine people's reactions related to the COVID-19 outbreak in the world. Moreover, sequential pattern mining (SPM) techniques are used to find frequent words/patterns and their relationship in tweets.
   Findings
   Seven clusters (themes) were found through VOSviewer: Cluster 1 (green): public sentiments about COVID-19 in the USA. Cluster 2 (red): public sentiments about COVID-19 in Italy and Iran and a vaccine, Cluster 3 (purple): public sentiments about doomsday and science credibility. Cluster 4 (blue): public sentiments about COVID-19 in India. Cluster 5 (yellow): public sentiments about COVID-19's emergence. Cluster 6 (light blue): public sentiments about COVID-19 in the Philippines. Cluster 7 (orange): Public sentiments about COVID-19 US Intelligence Report. The most frequent words/patterns discovered with SPM were "COVID-19," "Coronavirus," "Chinese virus" and the most frequent and high confidence sequential rules were related to "Coronavirus, testing, lockdown, China and Wuhan."
   Research limitations/implications
   The methodology can be used to analyze the opinions/thoughts of the general public on Twitter and to categorize them accordingly. Moreover, the categories (generated by VOSviewer) can be correlated with the results obtained with pattern mining techniques.
   Social implications
   This study has a significant socio-economic impact as Twitter offers content posting and sharing to billions of users worldwide.
   Originality/value
   According to the authors' best knowledge, this may be the first study to carry out a thematic analysis of COVID-19 tweets at a glance and mining the tweets with SPM to investigate how people reacted to the COVID-19 outbreak on Twitter.
C1 [Noor, Saleha; Guo, Yi] East China Univ Sci & Technol, Sch Informat Sci & Engn, Shanghai, Peoples R China.
   [Shah, Syed Hamad Hassan] Donghua Univ, Glorious Sun Sch Business & Management, Shanghai, Peoples R China.
   [Fournier-Viger, Philippe; Nawaz, M. Saqib] Harbin Inst Technol Shenzhen, Sch Humanities & Social Sci, Shenzhen, Peoples R China.
RP Guo, Y (corresponding author), East China Univ Sci & Technol, Sch Informat Sci & Engn, Shanghai, Peoples R China.
EM salehanoorse@gmail.com; guoyi@ecust.edu.cn; hamad74shah@gmail.com;
   philfv8@yahoo.com; msaqibnawaz@hit.edu.cn
RI Lin, Chen/AFV-2163-2022; shah, syed hamad hassan/AAL-9077-2021; Nawaz,
   M. Saqib/AAV-3633-2020
OI shah, syed hamad hassan/0000-0001-9043-4811; Nawaz, M.
   Saqib/0000-0001-9856-2885
CR Agrawal R., 1994, P 20 INT C VER LARG, P487
   Al-Barakati A, 2018, INT J SEMANT WEB INF, V14, P184, DOI 10.4018/IJSWIS.2018070109
   Aladwani AM, 2015, INT J INFORM MANAGE, V35, P15, DOI 10.1016/j.ijinfomgt.2014.09.003
   Anjum, 2020, INT J INFORM MANAGE, V31, P79, DOI [10.6186/IJIMS.202003, DOI 10.6186/IJIMS.20200331(1).0005, 10.1108/K-03-2019-0198]
   Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4
   Barstugan M., 2020, ARXIV PREPRINT ARXIV
   Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263
   Breland JY, 2017, AM J PUBLIC HEALTH, V107, P1890, DOI 10.2105/AJPH.2017.304098
   Butt C, 2020, APPL INTELL, DOI 10.1007/s10489-020-01714-3
   Chan MPS, 2018, SOC SCI MED, V212, P50, DOI 10.1016/j.socscimed.2018.07.007
   Dabbagh Mohammad, 2020, Blockchain and Applications. International Congress. Advances in Intelligent Systems and Computing (1010), P27, DOI 10.1007/978-3-030-23813-1_4
   Fournier-Viger Philippe, 2014, Advances in Knowledge Discovery and Data Mining. 18th Pacific-Asia Conference (PAKDD 2014). Proceedings: LNCS 8443, P40, DOI 10.1007/978-3-319-06608-0_4
   Fournier-Viger Philippe, 2013, Advanced Data Mining and Applications. 9th International Conference, ADMA 2013. Proceedings: LNCS 8346, P109, DOI 10.1007/978-3-642-53914-5_10
   Fournier-Viger P., 2017, DATA SCI PATTERN REC, V1, P54
   Fournier-Viger P, 2019, STUD BIG DATA, V51, P1, DOI 10.1007/978-3-030-04921-8_1
   Fournier-Viger P, 2016, LECT NOTES ARTIF INT, V9853, P36, DOI 10.1007/978-3-319-46131-1_8
   Fournier-Viger P, 2014, LECT NOTES COMPUT SC, V8819, P108, DOI 10.1007/978-3-319-12571-8_10
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Fung ICH, 2016, AM J INFECT CONTROL, V44, P1660, DOI 10.1016/j.ajic.2016.05.011
   Henning K. J., 2004, MORB MORTAL WKLY R S, V53, P5
   Khan AS, 2010, AM J PUBLIC HEALTH, V100, P1237, DOI 10.2105/AJPH.2009.180489
   Kim EHJ, 2016, J INF SCI, V42, P763, DOI 10.1177/0165551515608733
   Kraemer MUG, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0144-x
   Kumar A, 2018, KYBERNETES, V47, P1053, DOI 10.1108/K-06-2017-0210
   Lehnert JD, 2017, J PUBLIC HEALTH MAN, V23, P608, DOI 10.1097/PHH.0000000000000537
   Li KH, 2020, INVEST RADIOL, V55, P327, DOI 10.1097/RLI.0000000000000672
   Mishra Prerna, 2016, 2016 International Conference on Information Technology (InCITe): Next-Generation IT Summit on the Theme "Internet of Things: Connect Your Worlds", P148, DOI 10.1109/INCITE.2016.7857607
   Mohamadou Y, 2020, APPL INTELL, V50, P3913, DOI 10.1007/s10489-020-01770-9
   Nawaz MS, 2017, J MED IMAG HEALTH IN, V7, P1365, DOI 10.1166/jmihi.2017.2148
   Noor Saleha, 2020, Knowledge Science, Engineering and Management. 13th International Conference, KSEM 2020. Proceedings. Lecture Notes in Artificial Intelligence. Subseries of Lecture Notes in Computer Science (LNAI 12274), P341, DOI 10.1007/978-3-030-55130-8_30
   Noor S, 2020, INT J KNOWL MANAG, V16, P33, DOI 10.4018/IJKM.2020070103
   Noor S, 2020, INT J SEMANT WEB INF, V16, P88, DOI 10.4018/IJSWIS.2020070106
   Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023
   Ozturk T, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103792
   Shah SHH, 2020, KYBERNETES, V49, P1020, DOI 10.1108/K-12-2018-0696
   Shahzad B, 2017, INF DISCOV DELIV, V45, P130, DOI 10.1108/IDD-03-2017-0023
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Sinha A.K., 2018, SENTIMENT ANAL TWITT, P170, DOI [10.4018/978-1-5225-3787-8.ch011, DOI 10.4018/978-1-5225-3787-8.CH011]
   Sinnenberg L, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2016.303512
   Ueda M, 2017, SOC SCI MED, V189, P158, DOI 10.1016/j.socscimed.2017.06.032
   van Eck NJ, 2009, J AM SOC INF SCI TEC, V60, P1635, DOI 10.1002/asi.21075
   VanEck N.J., 2013, VOSVIEWER MANUAL, V1, P1, DOI DOI 10.3402/JAC.V8.30072
   Vosner HB, 2017, KYBERNETES, V46, P750, DOI 10.1108/K-10-2016-0292
   Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002
   Wang YM, 2015, KNOWL-BASED SYST, V88, P12, DOI 10.1016/j.knosys.2015.08.013
   Wang ZJ, 2019, LECT NOTES ARTIF INT, V11888, P658, DOI 10.1007/978-3-030-35231-8_48
   Wood MJ, 2018, CYBERPSYCH BEH SOC N, V21, P485, DOI 10.1089/cyber.2017.0669
   World Health Organization, 2020, CONT TRAC CONT COVID
   Yoon YS, 2018, I C INF COMM TECH CO, P1194, DOI 10.1109/ICTC.2018.8539363
   Zarrad A., 2014, P 2014 IEEE ACM 7 IN, DOI [10.1109/UCC.2014.107, DOI 10.1109/UCC.2014.107]
   Zupic I, 2015, ORGAN RES METHODS, V18, P429, DOI 10.1177/1094428114562629
NR 52
TC 12
Z9 12
U1 12
U2 47
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0368-492X
EI 1758-7883
J9 KYBERNETES
JI Kybernetes
PD MAY 3
PY 2021
VL 50
IS 5
BP 1633
EP 1653
DI 10.1108/K-05-2020-0258
EA NOV 2020
PG 21
WC Computer Science, Cybernetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Computer Science
GA WB2FM
UT WOS:000592085400001
DA 2022-04-20
ER

PT J
AU Kim, JI
   Im, Y
   Song, JE
   Jang, SJ
AF Kim, Jeung-Im
   Im, YeoJin
   Song, Ju-Eun
   Jang, Sun Joo
TI Healthcare Considerations for Special Populations during the COVID-19
   Pandemic: A Review
SO JOURNAL OF KOREAN ACADEMY OF NURSING
LA English
DT Review
DE Child; Pregnant Women; Aged; COVID-19; SARS-CoV-2
ID MANAGEMENT; SYMPTOMS
AB The coronavirus disease 2019 (COVID-19) has emerged as a threat to human health and public safety. People of all ages are susceptible to severe acute respiratory syndrome coronavirus 2 infection. However, the clinical manifestations of this infection differ by age. This study purposes to describe healthcare considerations for special populations, such as children, pregnant and lactating women, and older adults, who may have unique healthcare needs, in the pandemic situation. To realize the research purpose, we conducted a review of the practice guidelines of public documents and qualified studies that were published online/offline during a specific period. The review identified current knowledge on care for newborns, children in schools, pregnant women (from antenatal to postpartum care), and older adults suffering from high-risk conditions. Subsequently, we summarize vaccination guidance for special populations and, finally, discuss the issues currently affecting special populations. Therefore, this current knowledge on care for special populations helps nurses to provide accurate information on vaccinations aimed at preventing COVID-19 and protecting the masses from infection. Currently, the scarcity of information on COVID-19 variants necessitates further research on measures to reduce pandemic spread.
C1 [Kim, Jeung-Im] Soonchunhyang Univ, Sch Nursing, Cheonan, South Korea.
   [Im, YeoJin] Kyung Hee Univ, Coll Nursing Sci, East West Nursing Res Inst, Seoul, South Korea.
   [Song, Ju-Eun] Ajou Univ, Coll Nursing, Res Inst Nursing Sci, 164 Worldcup Ro, Suwon 16499, South Korea.
   [Jang, Sun Joo] Chung Ang Univ, Red Cross Coll Nursing, 221 Heukseok Dong, Seoul 06974, South Korea.
RP Song, JE (corresponding author), Ajou Univ, Coll Nursing, Res Inst Nursing Sci, 164 Worldcup Ro, Suwon 16499, South Korea.; Jang, SJ (corresponding author), Chung Ang Univ, Red Cross Coll Nursing, 221 Heukseok Dong, Seoul 06974, South Korea.
EM songje@ajou.ac.kr; icedcoffee@cau.ac.kr
OI Im, Yeo Jin/0000-0001-7054-0713; Kim, Jeung-Im/0000-0001-5499-8281;
   Jang, Sun Joo/0000-0002-7655-1744
FU Soonchuhyang University
FX This study was supported by Soonchuhyang University.
CR ACOG, 2020, COVID 19 FAQS OBST G
   Assaker R, 2020, BRIT J ANAESTH, V125, pE330, DOI 10.1016/j.bja.2020.05.026
   Bignardi G, 2021, ARCH DIS CHILD, V106, P791, DOI 10.1136/archdischild-2020-320372
   CDC, 2021, COR DIS 2019 COVID 1
   CDC, 2021, COVID 19 VACC PREGN
   Center for Disease Control, 2020, CONS INP OBST HEALTH
   Centers for Disease Control and Prevention (CDC), 2021, DIFF GROUPS PEOPL
   Centers for Disease Control and Prevention (CDC), 2021, COR DIS COVID 19 BRE
   Centers for Disease Control and Prevention (CDC), 2021, DAT COVID 19 PREGN B
   Centers for Disease Control and Prevention (CDC), 2021, PREGN REC PREGN PEOP
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Christie A, 2021, MMWR-MORBID MORTAL W, V70, P858, DOI 10.15585/mmwr.mm7023e2externalicon
   Collier ARY, 2021, JAMA-J AM MED ASSOC, V325, P2370, DOI 10.1001/jama.2021.7563
   Department of Health & Social Care (DHSC), 2021, JOINT COMM VACC IMM
   Division of Population Health National Center for Chronic Disease Prevention and Health Promotion, 2021, COVID 19 REC OLD AD
   Donovan NJ, 2020, AM J GERIAT PSYCHIAT, V28, P1233, DOI 10.1016/j.jagp.2020.08.005
   Engzell P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022376118
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Hippisley-Cox J, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4208
   Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7
   Kim JI, 2021, J KOREAN ACAD NURS, V51, P395, DOI 10.4040/jkan.21137
   Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112
   Lee Sooyeon, 2018, [Journal of Critical Social Welfare, 비판사회정책], V58, P53, DOI 10.47042/ACSW.2018.02.58.53
   Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009
   Lopez M, 2020, SUPPLEMENTARY MAT CO
   Lopez M, 2020, FETAL DIAGN THER, V47, P519, DOI 10.1159/000508487
   Minckas N, 2021, ECLINICALMEDICINE, V33, DOI 10.1016/j.eclinm.2021.100733
   Ministry of Education ( MOE), 2021, KOR DIS CONTR PREV A
   Ministry of Health, 2021, COVID 19 VACC REC SP
   Ministry of Health and Welfare (MOHW), 2021, CAS AG
   National Health Service (NHS), 2021, PREGN COR COVID 19
   National Health Service (NHS), 2021, OTH COND COR COVID 1
   National Institute on Aging (NIA), 2021, GOV COVID 19 RES OLD
   Norman M, 2021, JAMA-J AM MED ASSOC, V325, P2076, DOI 10.1001/jama.2021.5775
   Public Health England (PHE), 2021, COVID 19 VACC SURV R
   Public Health England (PHE), 2021, COVID 19 VACC GUID A
   Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017
   RCOG, 2021, COR COVID 19 INF PRE
   Salvatore CM, 2020, LANCET CHILD ADOLESC, V4, P721, DOI 10.1016/S2352-4642(20)30235-2
   Santini ZI, 2020, LANCET PUBLIC HEALTH, V5, pE62, DOI 10.1016/S2468-2667(19)30230-0
   Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8
   Shimabukuro TT, 2021, OBSTET GYNECOL SURV, V76, P729, DOI [10.1056/NEJMx210016, 10.1056/NEJMoa2104983, 10.1097/01.ogx.0000802676.57373.17]
   Singh AP, 2021, PEDIATRIC REP, V13, P289, DOI 10.3390/pediatric13020037
   Vernon MJ, 2020, IDENTIFYING OLDER PE
   Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X
   Wang YY, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-021-00234-z
   Wastnedge EAN, 2021, PHYSIOL REV, V101, P303, DOI 10.1152/physrev.00024.2020
   WHO, 2020, COR DIS COVID 19 PRE
   WHO Regional Office for the Western Pacific, 2020, GUID COVID 19 CAR OL
   World Health Organization, 2020, RAT US PERS PROT EQ
   World Health Organization, 2018, AG HLTH
   Yasuhara J, 2020, PEDIATR PULM, V55, P2565, DOI 10.1002/ppul.24991
   Yildirim H, 2021, SOC WORK PUBLIC HLTH, V36, P194, DOI 10.1080/19371918.2020.1868372
NR 53
TC 0
Z9 0
U1 2
U2 2
PU KOREAN SOC NURSING SCIENCE
PI SEOUL
PA KOREA SCIENCE & TECHNOL CTR, 635-4 YEOKSAM-DONG, KANGNAM-GU,, SEOUL,
   135-703, SOUTH KOREA
SN 2005-3673
EI 2093-758X
J9 J KOREAN ACAD NURS
JI J. Korean Acad. Nurs.
PD OCT
PY 2021
VL 51
IS 5
BP 511
EP 524
DI 10.4040/jkan.21156
PG 14
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA WS7JI
UT WOS:000715352800002
PM 34737245
DA 2022-04-20
ER

PT J
AU Simckes, M
   Shah, A
   Guthrie, BL
   Ross, JM
   Wasserheit, J
   Wickersham, K
   Wasserman, C
AF Simckes, Maayan
   Shah, Anar
   Guthrie, Brandon L.
   Ross, Jennifer M.
   Wasserheit, Judith
   Wickersham, Kevin
   Wasserman, Cathy
TI Navigating the Storm of COVID-19 Literature Through Academic-Practice
   Partnership in Washington State: The COVID-19 Literature Situation
   Report
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Article
DE academic-practice partnerships; COVID-19; National Incident Management
   System; public health practice
AB Context: Shortly after the first COVID-19 case in the United States was identified in Washington, the Washington State Department of Health (WA DOH) determined that real-time knowledge of scientific findings related to SARS-CoV-2 was critical for an effective response. Epidemiologists at the WA DOH established the Daily Literature Situation Report (Lit Rep), within the agency's incident management team, to support public health and state leaders in evidence-based decision making. However, from January to May, the scale of the pandemic response and daily volume of emerging information grew beyond the capacity of the WA DOH epidemiology team tasked with gathering, reviewing, summarizing, and disseminating it daily. Objective: To ensure public health leaders maintained awareness of the rapidly evolving scientific literature during the pandemic to support evidence-based practice. Design: The WA DOH contracted the University of Washington (UW) Alliance for Pandemic Preparedness to assemble a team of faculty and students to continue producing the Lit Rep. Main Outcome: In addition to the daily Lit Rep, the UW team developed in-depth reports addressing questions from public health leadership and further evolved the methodology for the daily reports to support long-term sustainability and broader accessibility. Results: Throughout its existence, the Lit Rep had summarized more than 4300 articles from more than 150 000 citations and had more than 5600 subscribers from public health practice, academia, and the general public, both domestic and international. Conclusions: The flexible Lit Rep model sets a standard for responding to emerging public health threats and communicating complex scientific information to government leaders, public health staff, and other interested parties. The WA DOH and the UW have exemplified how a mutually beneficial partnership can be established to support more effective public health practice based on real-time evidence both during a crisis and potentially for future public health challenges.
C1 [Simckes, Maayan; Shah, Anar; Wickersham, Kevin; Wasserman, Cathy] Washington State Dept Hlth, 101 Israel Rd SE, Tumwater, WA 98501, Australia.
   [Guthrie, Brandon L.; Wasserheit, Judith; Wasserman, Cathy] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Guthrie, Brandon L.; Ross, Jennifer M.; Wasserheit, Judith] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Ross, Jennifer M.; Wasserheit, Judith] Univ Washington, Dept Med, Seattle, WA 98195 USA.
   [Guthrie, Brandon L.; Ross, Jennifer M.; Wasserheit, Judith] Univ Washington, Alliance Pandem Preparedness, Seattle, WA USA.
RP Simckes, M (corresponding author), Washington State Dept Hlth, 101 Israel Rd SE, Tumwater, WA 98501, Australia.
EM maayan.simckes@doh.wa.gov
FU Washington State Department of Health
FX Funding for this work was provided by the Washington State Department of
   Health.
CR Alliance for Pandemic Preparedness, 2021, COVID 19 LIT SIT REP
   Belluck, 2020, NEW YORK TIMES
   Chakrabarti M., 2020, WBUR 0722
   Emergency Management Services International Inc, 2020, HIST ICS
   Federal Emergency Management Agency, 2017, NAT INC MAN SYST
   Folmer K., 2020, GOOD MORNING AM
   Guthrie B., 2020, SUMMARY EVIDENCE REL
   Guthrie B., 2021, SUMMARY EVIDENCE REL
   Guthrie B.L., 2020, SUMMARY SCH REOPENIN
   Herr C., 2020, PSYCHOSOCIAL CORRELA
   Ross J., 2020, SUMMARY COVID 19 LON
   Ross J., 2020, COVID 19 TREATMENT S
   Simckes M., 2020, PANDEMIC PREPAREDNES
   Simckes M, 2018, PUBLIC HEALTH REP, V133, P749, DOI 10.1177/0033354918798805
   Tolentino L., 2020, SUMMARY EVIDENCE REL
   Tseng A., 2021, SUMMARY EVIDENCE REL
   Tseng A., 2021, SUMMARY SARS COV 2 N
NR 17
TC 0
Z9 0
U1 3
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD JAN-FEB
PY 2022
VL 28
IS 1
SI SI
BP E9
EP E15
DI 10.1097/PHH.0000000000001447
PG 7
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA XA2BG
UT WOS:000720458700005
PM 34797248
DA 2022-04-20
ER

PT J
AU Serbezova, A
   Mangelov, M
   Zaykova, K
   Nikolova, S
   Zhelyazkova, D
   Balgarinova, N
AF Serbezova, Asena
   Mangelov, Martin
   Zaykova, Krassimira
   Nikolova, Silviya
   Zhelyazkova, Desislava
   Balgarinova, Niya
TI Knowledge and attitude toward COVID-19 vaccines amongst medical, dental
   and pharmacy students. A cross-sectional study from Bulgaria
SO BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
LA English
DT Article
DE COVID-19 vaccines; medical universities; medical; dental; pharmacy;
   students
ID HESITANCY; HEALTH
AB SARS-CoV-2 has disseminated rapidly, resulting in one of the most severe pandemic outbreaks in decades. Countries around the world have been working hard to acquire legislative authorization for vaccination and its subsequent distribution. However, some members of the European Union registered very low uptake of vaccines. Students in the healthcare field could act as contributors to the conflict resolution of vaccine hesitancy. This study investigated the awareness, knowledge and attitudes of Bulgarian medical, dental and pharmacy undergraduate students toward vaccines against COVID-19. In the period 24(th) Apr - 10(th) May 2021, a cross-sectional survey was conducted online. A total of 480 students answered the questionnaire form. Only 27% of the responders were negative regarding the vaccination against COVID-19. About 73% of the responders were either already vaccinated or were on the waiting list. Both groups of students believed that the type of vaccine is important, regardless of their vaccination status. Our findings demonstrate a general positive attitude of Bulgarian medical university students toward coronavirus vaccination. The barriers to vaccinations were mainly related to concerns related to the effectiveness of the vaccines consistent with studies in other countries. Government authorities must oppose barriers to vaccination by introducing pro-vaccination campaigns with the help of a multidisciplinary approach in higher education. Thereby, the positive attitudes of medical students can be successfully formed and further increased. This could be utilized to increase the public trust in the immunization process, which would help to oppose the spread of disinformation.
C1 [Serbezova, Asena] Med Univ Sofia, Fac Publ Hlth, Dept Hlth Policy & Management, Sofia, Bulgaria.
   [Mangelov, Martin; Zaykova, Krassimira; Zhelyazkova, Desislava; Balgarinova, Niya] Med Univ Varna, Fac Med, Varna, Bulgaria.
   [Nikolova, Silviya] Med Univ Varna, Fac Publ Hlth, Dept Social Med & Org Healthcare, Varna, Bulgaria.
RP Serbezova, A (corresponding author), Med Univ Sofia, Fac Publ Hlth, Dept Hlth Policy & Management, Sofia, Bulgaria.
EM assena.stoimenova@foz.mu-sofia.bg
CR [Anonymous], 2021, MU SOFIA VAKSINIRA 5
   [Anonymous], 2021, SAF COVID 19 VACC EU
   [Anonymous], 2021, GUID MED DEV OTH STA
   [Anonymous], 2020, SU COVID 19 SOFIYSKI
   [Anonymous], 2021, MU SOFIA PREDOSTAVI
   [Anonymous], [Merki pri COVID-19, COVID-19 Measures]
   [Anonymous], 2021, PRIZIV VAKSINATSIYA
   [Anonymous], 2021, MED U VARNA MU VARNA
   Balan A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080854
   Barello S, 2020, EUR J EPIDEMIOL, V35, P781, DOI 10.1007/s10654-020-00670-z
   Black S, 2020, SEMIN IMMUNOL, V50, DOI 10.1016/j.smim.2020.101413
   European Commission, QUEST ANSW COVID 19
   Frank E, 2004, JAMA-J AM MED ASSOC, V291, P637, DOI 10.1001/jama.291.5.637
   Hafizh M., 2021, J HUMAN BEHAV SOC EN, V32, P1
   Jain J, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268821001205
   Kasabov B., 2021, MED U VARNA
   Kaya MO., 2021, EUR RES J, V7, P417
   Kerneis S, 2017, AM J PREV MED, V53, pE97, DOI 10.1016/j.amepre.2017.01.014
   Kose S, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13917
   Lee K, 2009, GLOB INST, P1
   MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
   Mustapha Toheeb, 2021, Brain Behav Immun Health, V16, P100289, DOI 10.1016/j.bbih.2021.100289
   Petousis-Harris H, 2020, DRUG SAFETY, V43, P1205, DOI 10.1007/s40264-020-01002-6
   Pullan S, 2021, VACCINE, V39, P1877, DOI 10.1016/j.vaccine.2021.03.019
   Qayum I., 2019, J REHMAN MED I, V5, P1
   Riad A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9090948
   Riad A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060566
   Sadaqat W, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.17283
   Saied SM, 2021, J MED VIROL, V93, P4280, DOI 10.1002/jmv.26910
   Sallam M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052407
   Schaffer DeRoo S, 2020, JAMA-J AM MED ASSOC, V323, P2458, DOI 10.1001/jama.2020.8711
   Strizova Z, 2021, INT ARCH ALLERGY IMM, V182, P339, DOI 10.1159/000514225
   Szmyd B, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020128
   Usman J., 2021, JRMC, V25, P61
   Vaksina S., BULGARIAN NATL 0822
   Wagner R, 2022, ALLERGY, V77, P72, DOI 10.1111/all.14868
NR 36
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1310-2818
EI 1314-3530
J9 BIOTECHNOL BIOTEC EQ
JI Biotechnol. Biotechnol. Equip.
PD JAN 1
PY 2021
VL 35
IS 1
BP 2046
EP 2054
DI 10.1080/13102818.2022.2041097
PG 9
WC Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology
GA ZS6OR
UT WOS:000768583900001
OA gold
DA 2022-04-20
ER

PT J
AU Chi, NTK
AF Nguyen Thi Khanh Chi
TI Innovation capability: The impact of e-CRM and COVID-19 risk perception
SO TECHNOLOGY IN SOCIETY
LA English
DT Article
DE Customer orientation; Knowledge management; Risk perception; Innovation
   capability; Technology-based CRM; Hotel sector
ID CUSTOMER RELATIONSHIP MANAGEMENT; KNOWLEDGE MANAGEMENT;
   INFORMATION-TECHNOLOGY; SERVICE INNOVATION; PERFORMANCE; ANTECEDENTS;
   ORIENTATION; LEADERSHIP; ADOPTION; SCALE
AB The e-CRM application has currently offered benefits for companies in different business sectors, especially in hospitality industry. The objective of this paper is to investigate the impact of e-CRM components (i.e. technology-based CRM, knowledge management and customer orientation) on firms' innovation capabilities. Data was collected through a structured questionnaire survey conducted in Vietnam. The dataset consists of 213 valid responses by managers. Correlation analysis and structural equation modeling (SEM) were employed to examine the causal relationships among technology-based CRM, knowledge management, customer orientation, long-term relationships and innovation capability. The results show that knowledge management, customer orientation and technology-based CRM have positively influence on long-term relationships and innovation capability. Covid-19 risk perception has the role in enhancing the link between long-term relationships and innovation capability. From these findings, this study provides an improved understanding of how knowledge management, customer orientation and technology affect on innovating activities. This study also provides several implications for practice.
C1 [Nguyen Thi Khanh Chi] Foreign Trade Univ, 91 Chua Lang, Hanoi, Vietnam.
RP Chi, NTK (corresponding author), Foreign Trade Univ, 91 Chua Lang, Hanoi, Vietnam.
EM chintk@ftu.edu.vn
CR Ab Hamid N.R., 2005, J AM ACAD BUSINESS, V6, P51
   Agrawal S.R., 2020, J RELATIONSHIP MARKE, P1, DOI DOI 10.1080/15332667.2020.1802643
   Aldaihani F.M.F., 2020, INT J SUP CHAIN MGT, V9, P330
   Alshawi S, 2011, IND MARKET MANAG, V40, P376, DOI 10.1016/j.indmarman.2010.08.006
   Aminullah E, 2021, TECHNOL SOC, V66, DOI 10.1016/j.techsoc.2021.101682
   Armstrong CP, 1999, INFORM SYST RES, V10, P304, DOI 10.1287/isre.10.4.304
   Babakus E, 2009, J RETAILING, V85, P480, DOI 10.1016/j.jretai.2009.07.001
   Bae SY, 2021, CURR ISSUES TOUR, V24, P1017, DOI 10.1080/13683500.2020.1798895
   Bhatia R, 2021, TECHNOL SOC, V64, DOI 10.1016/j.techsoc.2020.101465
   Chan S.S., 2004, E COMMERCE M COMMERC, P1
   Chatterjee S., 2020, J RELATIONSHIP MARKE, V19, P75
   Chege SM, 2020, TECHNOL SOC, V60, DOI 10.1016/j.techsoc.2019.101210
   Dabic M, 2021, TECHNOVATION, V106, DOI 10.1016/j.technovation.2021.102303
   Dabic M, 2021, J BUS RES, V123, P683, DOI 10.1016/j.jbusres.2020.10.013
   Dabic M, 2019, J SMALL BUS ENTERP D, V26, P522, DOI 10.1108/JSBED-04-2018-0117
   Domi S, 2020, J VACAT MARK, V26, P130, DOI 10.1177/1356766719867374
   Donate MJ, 2015, J BUS RES, V68, P360, DOI 10.1016/j.jbusres.2014.06.022
   Donavan DT, 2004, J MARKETING, V68, P128, DOI 10.1509/jmkg.68.1.128.24034
   Dost M, 2020, TECHNOL SOC, V62, DOI 10.1016/j.techsoc.2020.101309
   Ferreira J, 2020, TECHNOVATION, V92-93, DOI 10.1016/j.technovation.2018.11.004
   Frambach RT, 2016, J BUS RES, V69, P1428, DOI 10.1016/j.jbusres.2015.10.120
   Garrido-Moreno A, 2015, BALT J MANAG, V10, P393, DOI 10.1108/BJM-10-2014-0166
   Garrido-Moreno A, 2011, INT J INFORM MANAGE, V31, P437, DOI 10.1016/j.ijinfomgt.2011.01.002
   Gronroos C., 2000, SERVICE MARKETING MA
   Henneberg S.C., 2006, J RELATIONSHIP MARKE, V4, P85
   Hermans L, 2020, JOURNALISM, DOI 10.1177/1464884920944741
   Ortega BH, 2008, INT J E-BUS RES, V4, P40
   Huang JW, 2009, INT J MANPOWER, V30, P285, DOI 10.1108/01437720910956772
   Ja-Shen Chen, 2004, Journal of Global Information Management, V12, P1
   Jarideh N., 2016, INT J SCI RES, V5, P1837
   Kim H, 2020, INT J HOSP MANAG, V89, DOI 10.1016/j.ijhm.2020.102577
   Knox, 2001, EUROPEAN MANAGEMENT, V19, P534, DOI DOI 10.1016/S0263-2373(01)00067-6
   Krishen AS, 2021, J BUS RES, V131, P183, DOI 10.1016/j.jbusres.2021.03.061
   Lee VH, 2013, J KNOWL MANAG, V17, P848, DOI 10.1108/JKM-08-2013-0315
   Lew SS, 2020, TECHNOL SOC, V63, DOI 10.1016/j.techsoc.2020.101430
   Lin YC, 2003, TOTAL QUAL MANAG BUS, V14, P715, DOI 10.1080/1478336032000053843
   Liu FH, 2018, J BUS IND MARK, V33, P466, DOI 10.1108/JBIM-12-2016-0294
   Love P, 2009, ENG CONSTR ARCHIT MA, V16, P459, DOI 10.1108/09699980910988366
   Lucchetti R, 2004, SMALL BUS ECON, V23, P151, DOI 10.1023/B:SBEJ.0000027667.55821.53
   Mahawrah Fadi, 2016, International Journal of Electronic Customer Relationship Management, V10, P138
   Mata FJ, 1995, MIS QUART, V19, P487, DOI 10.2307/249630
   Melovic B, 2020, TECHNOL SOC, V63, DOI 10.1016/j.techsoc.2020.101425
   Melovic M, 2020, IEEE T ENG MANAGE, DOI [doi:10.1109/tem.2020.2972532, DOI 10.1109/TEM.2020.2972532]
   Migdadi MM, 2021, J BUS IND MARK, V36, P111, DOI 10.1108/JBIM-12-2019-0504
   Mohammad AA, 2013, J HOSP TOUR TECHNOL, V4, P228, DOI 10.1108/JHTT-01-2013-0002
   MOORMAN C, 1992, J MARKETING RES, V29, P314, DOI 10.1177/002224379202900303
   Mousavizadeh M, 2015, J COMPUT INFORM SYST, V55, P35, DOI 10.1080/08874417.2015.11645785
   Mukhopadhyay S., 2016, J RELATIONSHIP MARKE, V15, P299, DOI DOI 10.1080/15332667.2016.1209053
   Mulyana M., 2020, J RELATIONSHIP MARKE, V19, P52
   Nahapiet J, 1998, ACAD MANAGE REV, V23, P242, DOI 10.2307/259373
   Nazari-Shirkouhi S, 2015, TEH VJESN, V22, P191, DOI 10.17559/TV-20140623130536
   Nguyen T.K.C., 2021, VINE J INF KNOWL MAN
   Nurhayati T., 2017, J RELATIONSHIP MARKE, V16, P1
   Ode E, 2020, J INNOV KNOWL, V5, P209, DOI 10.1016/j.jik.2019.08.002
   Pascual-Fernandez P, 2021, INT J HOSP MANAG, V94, DOI 10.1016/j.ijhm.2020.102825
   Payne, 2009, J BUSINESS MARKET MA, V3, P7, DOI DOI 10.1007/S12087-008-0035-8
   Rajapathirana RPJ, 2018, J INNOV KNOWL, V3, P44, DOI 10.1016/j.jik.2017.06.002
   Raman P, 2006, J PERS SELL SALES M, V26, P39, DOI 10.2753/PSS0885-3134260104
   Ranganathan C, 2011, INT J INFORM MANAGE, V31, P533, DOI 10.1016/j.ijinfomgt.2011.02.004
   Sa MLL, 2020, ASIA PAC MANAG REV, V25, P65, DOI 10.1016/j.apmrv.2019.07.002
   SAXE R, 1982, J MARKETING RES, V19, P343, DOI 10.2307/3151568
   Sen A, 2011, DECIS SUPPORT SYST, V51, P609, DOI 10.1016/j.dss.2010.12.014
   Severo EA, 2021, J CLEAN PROD, V286, DOI 10.1016/j.jclepro.2020.124947
   Sin LYM, 2005, EUR J MARKETING, V39, P1264, DOI 10.1108/03090560510623253
   Singh S, 2020, TECHNOL SOC, V62, DOI 10.1016/j.techsoc.2020.101305
   Tajeddini K, 2012, INT J HOSP MANAG, V31, P1119, DOI 10.1016/j.ijhm.2012.01.009
   Tajeddini K, 2010, TOURISM MANAGE, V31, P221, DOI 10.1016/j.tourman.2009.02.013
   Tang TW, 2015, SERV BUS, V9, P97, DOI 10.1007/s11628-013-0220-z
   Tang TW, 2014, INT J HOSP MANAG, V39, P1, DOI 10.1016/j.ijhm.2014.01.008
   Teece DJ, 2007, STRATEGIC MANAGE J, V28, P1319, DOI 10.1002/smj.640
   Udunuwara M, 2019, J VACAT MARK, V25, P444, DOI 10.1177/1356766718817793
   Valmohammadi C, 2017, INT J INOV SCI, V9, P374, DOI 10.1108/IJIS-02-2017-0011
   Velasquez RMA, 2021, TECHNOL SOC, V64, DOI 10.1016/j.techsoc.2020.101479
   Wei J, 2009, J COMPUT INFORM SYST, V49, P11
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   Wong WP, 2011, BUS PROCESS MANAG J, V17, P940, DOI 10.1108/14637151111182701
   Zhao WH, 2021, INT ENTREP MANAG J, V17, P839, DOI 10.1007/s11365-020-00637-2
   Zimmerling A., 2021, TECHNOL SOC, V65, P101, DOI [10.1016/j.techsoc.2021.101541, DOI 10.1016/j.techsoc.2021.101541]
   Zineldin M, 1996, INT J BANK MARK, V14, P12, DOI DOI 10.1108/02652329610130136
NR 79
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0160-791X
EI 1879-3274
J9 TECHNOL SOC
JI Technol. Soc.
PD NOV
PY 2021
VL 67
AR 101725
DI 10.1016/j.techsoc.2021.101725
EA SEP 2021
PG 9
WC Social Issues; Social Sciences, Interdisciplinary
WE Social Science Citation Index (SSCI)
SC Social Issues; Social Sciences - Other Topics
GA WC8OG
UT WOS:000704511300007
OA Bronze
DA 2022-04-20
ER

PT J
AU Khader, Y
   Al Nsour, M
   Al-Batayneh, OB
   Saadeh, R
   Bashier, H
   Alfaqih, M
   Al-Azzam, S
   AlShurman, BA
AF Khader, Yousef
   Al Nsour, Mohannad
   Al-Batayneh, Ola Barakat
   Saadeh, Rami
   Bashier, Haitham
   Alfaqih, Mahmoud
   Al-Azzam, Sayer
   AlShurman, Bara' Abdallah
TI Dentists' Awareness, Perception, and Attitude Regarding COVID-19 and
   Infection Control: Cross-Sectional Study Among Jordanian Dentists
SO JMIR PUBLIC HEALTH AND SURVEILLANCE
LA English
DT Article
DE COVID-19; infection; dentist; infection control
ID KNOWLEDGE
AB Background: Despite the availability of prevention guidelines and recommendations on infection control, many dental practices lack the minimum requirements for infection control.
   Objective: This study aimed to assess the level of awareness, perception, and attitude regarding the coronavirus disease (COVID-19) and infection control among Jordanian dentists.
   Methods: The study population consisted of dentists who worked in private clinics, hospitals, and health centers in Jordan. An online questionnaire was sent to a sample of Jordanian dentists in March 2020. The questionnaire was comprised of a series of questions about dentists' demographic characteristics; their awareness of the incubation period, the symptoms of the disease, mode of transmission of COVID-19 and infection control measures for preventing COVID-19; and their attitude toward treating patients with COVID-19.
   Results: This study included a total of 368 dentists aged 22-73 years (mean 32.9 years, SD 10.6 years). A total of 112 (30.4%) dentists had completed a master or residency program in dentistry, 195 (53.0%) had received training in infection control in dentistry, and 28 (7.6%) had attended training or lectures regarding COVID-19. A total of 133 (36.1%) dentists reported that the incubation period is 1-14 days. The majority of dentists were aware of COVID-19 symptoms and ways of identifying patients at risk of having COVID-19, were able to correctly report known modes of transmission, and were aware of measures for preventing COVID-19 transmission in dental clinics. A total of 275 (74.7%) believed that it was necessary to ask patients to sit far from each other, wear masks while in the waiting room, and wash hands before getting in the dental chair to decrease disease transmission.
   Conclusions: Jordanian dentists were aware of COVID-19 symptoms, mode of transmission, and infection controls and measures in dental clinics. However, dentists had limited comprehension of the extra precautionary measures that protect the dental staff and other patients from COVID-19. National and international guidelines should be sent by the regional and national dental associations to all registered dentists during a crisis, including the COVID-19 pandemic, to make sure that dentists are well informed and aware of best practices and recommended disease management approaches.
C1 [Khader, Yousef; Al-Batayneh, Ola Barakat; Saadeh, Rami; Alfaqih, Mahmoud; Al-Azzam, Sayer; AlShurman, Bara' Abdallah] Jordan Univ Sci & Technol, Alramtha Amman St, Irbid 22110, Jordan.
   [Al Nsour, Mohannad; Bashier, Haitham] Global Hlth Dev Eastern Mediterranean Publ Hlth N, Amman, Jordan.
RP Khader, Y (corresponding author), Jordan Univ Sci & Technol, Alramtha Amman St, Irbid 22110, Jordan.
EM yskhader@just.edu.jo
RI Nsour, Mohannad Al/ABE-8741-2020; Khader, Yousef/AAE-9620-2019;
   Al-Batayneh, Ola B./AAF-2338-2019
OI Nsour, Mohannad Al/0000-0003-1212-1611; Khader,
   Yousef/0000-0002-7830-6857; Al-Batayneh, Ola B./0000-0003-1670-497X;
   Bashier, Haitham/0000-0002-9648-5473
CR Abolfotouh MA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2096-8
   American Dental Association, 2020, ADA REC DENT POSTP E
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Baseer Mohammad-Abdul, 2016, J Clin Exp Dent, V8, pe379
   Centers for Disease Control & Prevention, 2020, CDC REC POSTP NON DE
   Gaffar BO, 2019, SAUDI MED J, V40, P714, DOI 10.15537/smj.2019.7.24304
   Ibrahim NK, 2017, J INFECT PUBLIC HEAL, V10, P438, DOI 10.1016/j.jiph.2016.06.002
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Matsuda JK, 2011, BRAZ J INFECT DIS, V15, P45, DOI 10.1590/S1413-86702011000100009
   Mehtar S, 2007, J HOSP INFECT, V66, P65, DOI 10.1016/j.jhin.2007.02.008
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Secon H., 2020, BUSINESS INSIDER
   The American Dental Association, 2020, COR FREQ ASK QUEST
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   Zemouri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178007
NR 17
TC 163
Z9 168
U1 4
U2 24
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 2369-2960
J9 JMIR PUBLIC HLTH SUR
JI JMIR Public Health Surveill.
PD APR-JUN
PY 2020
VL 6
IS 2
BP 185
EP 191
AR e18798
DI 10.2196/18798
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA LE6ES
UT WOS:000526817200018
PM 32250959
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Chan, EYY
   Huang, Z
   Lo, ESK
   Hung, KKC
   Wong, ELY
   Wong, SYS
AF Chan, Emily Ying Yang
   Huang, Zhe
   Lo, Eugene Siu Kai
   Hung, Kevin Kei Ching
   Wong, Eliza Lai Yi
   Wong, Samuel Yeung Shan
TI Sociodemographic Predictors of Health Risk Perception, Attitude and
   Behavior Practices Associated with Health-Emergency Disaster Risk
   Management for Biological Hazards: The Case of COVID-19 Pandemic in Hong
   Kong, SAR China
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; urban; health risks; Health-Emergency and Disaster Risk
   Management; biological hazard; pandemic; PHEIC; Hong Kong
ID INFLUENZA; TRANSMISSION; PREVENTION; IMPACT
AB In addition to top-down Health-Emergency and Disaster Risk Management (Health-EDRM) efforts, bottom-up individual and household measures are crucial for prevention and emergency response of the COVID-19 pandemic, a Public Health Emergency of International Concern (PHEIC). There is limited scientific evidence of the knowledge, perception, attitude and behavior patterns of the urban population. A computerized randomized digital dialing, cross-sectional, population landline-based telephone survey was conducted from 22 March to 1 April 2020 in Hong Kong Special Administrative Region, China. Data were collected for socio-demographic characteristics, knowledge, attitude and risk perception, and various self-reported Health-EDRM behavior patterns associated with COVID-19. The final study sample was 765. Although the respondents thought that individuals (68.6%) had similar responsibilities as government (67.5%) in infection control, less than 50% had sufficient health risk management knowledge to safeguard health and well-being. Among the examined Health-EDRM measures, significant differences were found between attitude and practice in regards to washing hands with soap, ordering takeaways, wearing masks, avoidance of visiting public places or using public transport, and travel avoidance to COVID-19-confirmed regions. Logistic regression indicated that the elderly were less likely to worry about infection with COVID-19. Compared to personal and household hygiene practices, lower compliance was found for public social distancing.
C1 [Chan, Emily Ying Yang; Huang, Zhe; Lo, Eugene Siu Kai; Hung, Kevin Kei Ching] Chinese Univ Hong Kong, Collaborating Ctr, Oxford Univ, Hong Kong, Peoples R China.
   [Chan, Emily Ying Yang; Huang, Zhe; Lo, Eugene Siu Kai; Hung, Kevin Kei Ching] Chinese Univ Hong Kong, CUHK Disaster & Med Humanitarian Response CCOUC, Hong Kong, Peoples R China.
   [Chan, Emily Ying Yang] Univ Oxford, Nuffield Dept Med, Oxford OX3 7BN, England.
   [Chan, Emily Ying Yang; Wong, Eliza Lai Yi; Wong, Samuel Yeung Shan] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.
   [Hung, Kevin Kei Ching] Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Med Acad Unit, Hong Kong, Peoples R China.
RP Chan, EYY (corresponding author), Chinese Univ Hong Kong, Collaborating Ctr, Oxford Univ, Hong Kong, Peoples R China.; Chan, EYY (corresponding author), Chinese Univ Hong Kong, CUHK Disaster & Med Humanitarian Response CCOUC, Hong Kong, Peoples R China.; Chan, EYY (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford OX3 7BN, England.; Chan, EYY (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.
EM emily.chan@cuhk.edu.hk; huangzhe@cuhk.edu.hk; euglsk@cuhk.edu.hk;
   kevin.hung@cuhk.edu.hk; lywong@cuhk.edu.hk; yeungshanwong@cuhk.edu.hk
RI Wong, Eliza Lai-Yi/ABI-2092-2020; Hung, Kevin KC/H-8327-2016
OI Hung, Kevin KC/0000-0001-8706-7758; Chan, Emily Ying
   Yang/0000-0002-8854-5093
CR Abdel-Aty AH, 2020, J INTELL FUZZY SYST, V38, P2809, DOI 10.3233/JIFS-179566
   Chan, 2018, BUILDING BOTTOM UP H
   Chan E.Y.Y., 2020, NONPHARMACEUTI UNPUB
   Chan EYY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2245-9
   Chan EYY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020228
   Chan EYY, 2017, INT J DISAST RISK SC, V8, P134, DOI 10.1007/s13753-017-0127-8
   Chan EYY, 2015, VACCINE, V33, P4737, DOI 10.1016/j.vaccine.2015.07.046
   Chan YYE, 2020, PUBLIC HLTH DISASTER, P7
   Cheng VCC, 2015, J HOSP INFECT, V90, P355, DOI 10.1016/j.jhin.2015.04.016
   Collinson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141423
   Cook TM, 2020, ANAESTHESIA, V75, P976, DOI 10.1111/anae.15103
   Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6
   Day M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1165
   Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954
   Hussain A, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108142
   Kalligeros M, 2020, OBESITY, V28, P1200, DOI 10.1002/oby.22859
   Kim DD, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30234-6
   Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1
   Kung NY, 2007, EMERG INFECT DIS, V13, P412, DOI 10.3201/eid1303.060365
   Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500
   Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628
   Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857
   Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m641
   MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Petrovcic A, 2016, TECHNOL SOC, V45, P91, DOI 10.1016/j.techsoc.2016.02.007
   Rajgor DD, 2020, LANCET INFECT DIS, V20, P776, DOI 10.1016/S1473-3099(20)30244-9
   Shahid Z, 2020, J AM GERIATR SOC, V68, P926, DOI 10.1111/jgs.16472
   Tam G, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081598
   Wan YKP, 2013, TOURISM MANAGE, V36, P164, DOI 10.1016/j.tourman.2012.12.005
   Wells CR, 2020, P NATL ACAD SCI USA, V117, P7504, DOI 10.1073/pnas.2002616117
   West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9
   Wong ATY, 2017, CLIN INFECT DIS, V64, pS98, DOI 10.1093/cid/cix123
   World Health Organization, WHO2019NCOVSCIBRIEFT
   Ye ZW, 2020, INT J BIOL SCI, V16, P1686, DOI 10.7150/ijbs.45472
NR 36
TC 56
Z9 56
U1 32
U2 58
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUN
PY 2020
VL 17
IS 11
AR 3869
DI 10.3390/ijerph17113869
PG 18
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA MB5FY
UT WOS:000542629600122
PM 32485979
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Alonso, AD
   Kok, SK
   Bressan, A
   O'Shea, M
   Sakellarios, N
   Koresis, A
   Solis, MAB
   Santoni, LJ
AF Alonso, Abel Duarte
   Kok, Seng Kiat
   Bressan, Alessandro
   O'Shea, Michelle
   Sakellarios, Nikolaos
   Koresis, Alex
   Solis, Maria Alejandra Buitrago
   Santoni, Leonardo J.
TI COVID-19, aftermath, impacts, and hospitality firms: An international
   perspective
SO INTERNATIONAL JOURNAL OF HOSPITALITY MANAGEMENT
LA English
DT Article
DE COVID-19; Resilience; Concerns; Coping; Changes; Adjustments;
   Hospitality businesses; Extreme context
ID CREATIVE SELF-EFFICACY; ORGANIZATIONAL RESILIENCE; DISASTER RESILIENCE;
   PREPAREDNESS; ANTECEDENTS; SECTOR; SMES
AB Drawing on the theory of resilience, and on an international sample of 45 predominantly small hospitality businesses, this exploratory study extends knowledge about the key concerns, ways of coping, and the changes and adjustments undertaken by these firms' owners and managers during the COVID-19 outbreak. The various emergent relationships between the findings and the considered conceptual underpinnings of the literature on resilience, revealed nine theoretical dimensions. These dimensions critically illuminate and extend understanding concerning the actions and alternatives owners-managers resorted to when confronted with an extreme context. For instance, with financial impacts and uncertainty being predominant issues among participants, over one-third indicated actioning alternative measures to create much-needed revenue streams, and preparing for a new post-COVID-19 operational regime, respectively. Furthermore, 60 percent recognised making changes to the day-to-day running of the business to respond to initial impacts, or biding time in anticipation of a changing business and legal environment.
C1 [Alonso, Abel Duarte] Curtin Univ, Sch Management, Curtin Business Sch, BL 402,Kent St, Bentley, WA 6102, Australia.
   [Kok, Seng Kiat] RMIT Univ Vietnam, Sch Business & Management, 702 Nguyen Linh Blvd,Dist 7, Hcmc, Saigon, Vietnam.
   [Bressan, Alessandro] Univ Notre Dame Australia, Sch Business, 128-140 Broadway, Chippendale, NSW 2007, Australia.
   [O'Shea, Michelle] Western Sydney Univ, Sch Business, Locked Bag 1797, Penrith, NSW 2571, Australia.
   [Sakellarios, Nikolaos] Liverpool John Moores Univ, Liverpool L3 5UG, Merseyside, England.
   [Koresis, Alex] Curtin Univ, Sch Management, BL 402,Kent St, Bentley, WA 6102, Australia.
   [Solis, Maria Alejandra Buitrago] Bolivian Catholic Univ, Zona Tupuraya, Cochabamba, Bolivia.
   [Santoni, Leonardo J.] UNCUYO, Fac Agr Sci, Sch Econ, Almirante Brown 500, Mendoza, Argentina.
RP Alonso, AD (corresponding author), Curtin Univ, Sch Management, Curtin Business Sch, BL 402,Kent St, Bentley, WA 6102, Australia.
EM a.alonso@curtin.edu.au; seng.kok@rmit.edu.vn;
   alessandro.bressan@nd.edu.au; m.oshea@westernsydney.edu.au;
   N.Sakellarios@2016.ljmu.ac.uk; alex.koresis@postgrad.curtin.edu.au;
   mabs@ucbcba.edu.bo; leojsantoni@gmail.com
RI Kok, Seng/AAM-2329-2020
OI Kok, Seng/0000-0002-3356-6567; Duarte Alonso, Abel/0000-0001-6742-7373
CR Argentinian Government, 2018, NUEV CAT SER PYME
   Ates A, 2011, INT J PROD RES, V49, P5601, DOI 10.1080/00207543.2011.563825
   Australian Bureau of Statistics, 2002, SMALL BUS AUSTR
   BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L
   Bandura A., 2000, HDB PRINCIPLES ORG B, P120, DOI DOI 10.1002/9781119206422.CH10
   Bandura A, 1977, COGNITIVE THERAPY RE, V1, P287, DOI [10.1007/bf01663995, DOI 10.1007/BF01663995, 10.1007/BF01663995]
   Barczak G, 2015, J PROD INNOVAT MANAG, V32, P658, DOI 10.1111/jpim.12277
   Bartik A.W., 2020, 26989 NAT BUR EC RES
   Baum T, 2020, INT J CONTEMP HOSP M, V32, P2397, DOI 10.1108/IJCHM-03-2020-0242
   Bazeley P., 2013, QUALITATIVE DATA ANA
   Branicki LJ, 2018, INT J ENTREP BEHAV R, V24, P1244, DOI 10.1108/IJEBR-11-2016-0396
   Brown NA, 2019, INT J DISAST RISK RE, V33, P108, DOI 10.1016/j.ijdrr.2018.09.014
   Brown NA, 2018, J HOSP TOUR MANAG, V36, P67, DOI 10.1016/j.jhtm.2018.07.004
   Brown NA, 2017, INT J DISAST RISK RE, V22, P362, DOI 10.1016/j.ijdrr.2017.02.005
   Conz E, 2017, J ENTERP COMMUNITIES, V11, P186, DOI 10.1108/JEC-02-2015-0015
   Davis S.J., 2020, WORKING PAPER
   Dobie S, 2018, INFRASTRUCTURES-BASE, V3, DOI 10.3390/infrastructures3040046
   Duran M.A, 2009, MANUAL MICRO PEQUENA
   Eggers F, 2020, J BUS RES, V116, P199, DOI 10.1016/j.jbusres.2020.05.025
   European Commission, 2003, WHAT IS AN SME
   European Parliament, 2020, COV 19 TOUR SECT
   GATTO F, 1999, REV CEPAL, V68, P61
   Gioia DA, 2013, ORGAN RES METHODS, V16, P15, DOI 10.1177/1094428112452151
   GIST ME, 1987, ACAD MANAGE REV, V12, P472, DOI 10.2307/258514
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Gruman JA, 2011, INT J HOSP TOUR ADM, V12, P43, DOI 10.1080/15256480.2011.540980
   Hall CM, 2020, TOURISM GEOGR, V22, P577, DOI 10.1080/14616688.2020.1759131
   Hallak R, 2018, J RETAIL CONSUM SERV, V40, P229, DOI 10.1016/j.jretconser.2017.10.014
   Hannah ST, 2009, LEADERSHIP QUART, V20, P897, DOI 10.1016/j.leaqua.2009.09.006
   Herbane B, 2019, ENTREP REGION DEV, V31, P476, DOI 10.1080/08985626.2018.1541594
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Kuckertz A., 2020, J BUS VENTUR INSIGHT, V13, DOI [10.1016/j.jbvi.2020.e00169, DOI 10.1016/J.JBVI.2020.E00169]
   Lamanna Z., 2012, Journal of Human Resources in Hospitality & Tourism, V11, P210, DOI 10.1080/15332845.2012.668653
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6
   OECD, 2020, OECD INT EC ASS COR
   Orchiston C, 2013, CURR ISSUES TOUR, V16, P477, DOI 10.1080/13683500.2012.741115
   Pal R, 2014, INT J PROD ECON, V147, P410, DOI 10.1016/j.ijpe.2013.02.031
   Patton M.Q., 2015, QUALITATIVE RES EVAL
   Rivera MA, 2020, INT J HOSP MANAG, V87, DOI 10.1016/j.ijhm.2020.102528
   Sainaghi R, 2019, J HOSP TOUR RES, V43, P517, DOI 10.1177/1096348018810388
   Sharma A, 2020, J BUS RES, V117, P443, DOI 10.1016/j.jbusres.2020.05.035
   Sydnor-Bousso S., 2011, Journal of Human Resources in Hospitality & Tourism, V10, P195, DOI 10.1080/15332845.2011.536942
   Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748
   Tibay V, 2018, PROCEDIA ENGINEER, V212, P1217, DOI 10.1016/j.proeng.2018.01.157
   Tierney P, 2002, ACAD MANAGE J, V45, P1137, DOI 10.2307/3069429
   Wen J., 2020, TOUR RECREAT RES
NR 47
TC 94
Z9 94
U1 22
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0278-4319
EI 1873-4693
J9 INT J HOSP MANAG
JI Int. J. Hosp. Manag.
PD OCT
PY 2020
VL 91
AR 102654
DI 10.1016/j.ijhm.2020.102654
PG 11
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA OM0UA
UT WOS:000585744300023
PM 32863526
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Adane, D
   Yeshaneh, A
   Wassihun, B
   Gasheneit, A
AF Adane, Daniel
   Yeshaneh, Alex
   Wassihun, Biresaw
   Gasheneit, Addisu
TI Level of Community Readiness for the Prevention of COVID-19 Pandemic and
   Associated Factors Among Residents of Awi Zone, Ethiopia: A
   Community-Based Cross-Sectional Study
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; knowledge; attitude; readiness; practice; perception; Ethiopia
ID KNOWLEDGE; ATTITUDE
AB Background: Novel coronavirus 19 is a contagious disease that affects all most all countries of the world and puts the world in great challenge. Even though, there is a limited testing capacity in Africa the number of cases and deaths is progressively increased. This catastrophic case has a great impact in Africa unless preventive measures are effectively undertaken. In Ethiopia, the number of COVID-19 cases and death are increasing over time. Therefore, this study was aimed to assess the level of community readiness for COVID-19 pandemic prevention and its associated factors in residents of Awi Zone, Northwest Ethiopia.
   Methods: A community-based cross-sectional study design was conducted among 1524 study participants from July 28 to August 27, 2020. Data were collected using structured and pre-tested interviewer-administered questionnaires. The collected data were entered into EPI data 4.6 versions and analyzed using Statistical Package for Social Science (SPSS) version 24.0. Those variables with P-value<0.25 were entered into multivariable analyses and those variables with P-value < 0.05 were considered statistically significant. Finally, the findings of the result were explained using texts, figures, and tables.
   Results: A total of 1423 participants have participated in the study. The finding revealed that the prevalence of knowledge, attitude, perception, and practice towards COVID-19 were found to be 76.6%, 68.4%, 68.5%, and 29% respectively. In final model, being a female [AOR=1.388 (95% CI: 1.050-1.834) P=0.021], married respondents [AOR=3.116 (95% CI: 1.592-6.099) P=0.001], Muslim religion followers [AOR=2.392 (95% CI:1.503-3.806) P=0.002], and able to read and write [AOR=1.986 (95% CI:1.311-3.006) P=0.002] were some of the variables significantly associated with the level of community readiness towards COVID-19 preventive measures.
   Conclusion: The study findings indicate that respondent's level of community readiness for COVID-19 prevention was mainly affected by sex, marital status, religion, and educational status. The Health education programs aimed at mobilizing and improving COVID-19 related level of community readiness especially practice are urgently needed. Awareness creation programs on more targeted groups such as men, unmarried and those with low educational level and religious leaders should be teaching the believers by interacting with faith and science on the means of preventing the pandemic.
C1 [Adane, Daniel; Yeshaneh, Alex] Wolkite Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolkite, Ethiopia.
   [Wassihun, Biresaw] Arbaminch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arbaminch, Ethiopia.
   [Gasheneit, Addisu] Amhara Reg State Hlth Bur, Awi Zone Hlth Off, Bahir Dar, Ethiopia.
RP Yeshaneh, A (corresponding author), Wolkite Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolkite, Ethiopia.
EM alexyeshaneh7@gmail.com
RI Yeshaneh, Alex/AAD-1562-2021
OI Yeshaneh, Alex/0000-0001-5876-7325
FU Awi Zone Health Office
FX This study was funded by Awi Zone Health Office, but the funder has no
   role in the design of the study, collection, analysis, and
   interpretation of the data and in writing the manuscript.
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Abrams EM, 2020, J ALLER CL IMM-PRACT, V8, P1791, DOI 10.1016/j.jaip.2020.04.012
   Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2
   Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092
   Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Al Ahdab S, 2020, KNOWLEDGE ATTITUDES
   Alrubaiee GG, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09644-y
   AMBAW G, 2020, GSJ, V8, DOI DOI 10.3390/CLI8110124
   [Anonymous], 2020, NAT MED, V26, P151, DOI 10.1038/s41591-020-0775-x
   Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485
   Aynalem YA, 2020, ASSESSMENT UNDERGRAD
   Balachandar V, 2020, EUR REV MED PHARMACO, V24, P3422, DOI 10.26355/eurrev_202003_20713
   Banerjee D, 2020, ASIAN J PSYCHIATR, V50, DOI 10.1016/j.ajp.2020.102014
   Berger ZD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1141
   Bhutta ZA, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1190
   Biadgilign S, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.supp.2020.35.2.23906
   Bong CL, 2020, ANESTH ANALG, V131, P86, DOI 10.1213/ANE.0000000000004846
   Chen Yan, 2020, Zhonghua Yufang Yixue Zazhi, V54, P367, DOI [10.3760/cma.j.cn112150-20200205-00069, 10.3760/cma.j.cn112150.20200205.00069]
   Chiang CY, 2020, INT J TUBERC LUNG D, V24, P541, DOI 10.5588/ijtld.20.0192
   Chowdhury S.H., 2020, KNOWLEDGE ATTITUDE P
   CSA, 2020, 2007 POP HOUS CENS E, P1
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Erfani A, 2020, B WHO
   Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6
   Islam S, 2020, KNOWLEDGE ATTITUDES, DOI [10.1101/2020.09.15.20195255, DOI 10.1101/2020.09.15.20195255]
   Kangwana, 2020, COVID 19 RELATED KNO
   Kassie BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238415
   Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744
   Lihua M, 2020, KNOWLEDGE BELIEFS AT
   Mechessa DF, 2020, INT J GEN MED, V13, P507, DOI 10.2147/IJGM.S263665
   Nadeem, 2020, J ORGAN WORLD J ONGO, V5, P7, DOI DOI 10.5281/ZENODO.3722904
   Olapegba PO, 2020, COVID 19 KNOWLEDGE P
   Rapid Risk Assessment, 2020, COR DIS 2019 COVID 1
   Rios-Gonzalez CM, 2020, KNOWLEDGE ATTITUDES
   Shigute Z, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010369
   Srichan P, 2020, KNOWLEDGE ATTITUDE P
   Wondimu W, 2020, PRACTICE CORONAVIRUS
   World Health Organization, 2020, CRITICAL PREPAREDNES
   World Health Organization (WHO), 2020, RISK COMM COMM ENG R
   Zegarra-Valdivia J, 2020, KNOWLEDGE PERCEPTION
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 41
TC 2
Z9 2
U1 1
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2021
VL 14
BP 1509
EP 1524
DI 10.2147/RMHP.S302974
PG 16
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA RN4KG
UT WOS:000640319800001
PM 33883957
OA Green Published
DA 2022-04-20
ER

PT C
AU Chen, YX
   Wang, KR
   Xu, WK
   Huang, Y
AF Chen, Yixin
   Wang, Ke-Rou
   Xu, Weikai
   Huang, Yun
GP ACM
TI Exploring Commenting Behavior in the COVID-19 Super-Topic on Weibo
SO EXTENDED ABSTRACTS OF THE 2021 CHI CONFERENCE ON HUMAN FACTORS IN
   COMPUTING SYSTEMS (CHI'21)
LA English
DT Proceedings Paper
CT CHI Conference on Human Factors in Computing Systems
CY MAY 08-13, 2021
CL ELECTR NETWORK
SP ACM SIGCHI, Assoc Comp Machinery, Bloomberg, Facebook, Google, Kyocera, Microsoft, Monash Univ, Verizon Media
DE Help-Providing; Crisis Informatics; COVID-19; Weibo; Super-Topic
ID SOCIAL MEDIA; SUPPORT; ANTECEDENTS; COMMUNITIES; MANAGEMENT
AB During the COVID-19 pandemic, Chinese social media platform Weibo created a special super-topic for online users to seek help through posts or provide help through comments. Prior work has analyzed online help-seeking and help-providing messages during crisis situations, however, it is not clear why and how people commented on help-seeking posts to provide support, especially in such a crisis support community. In this study, we interviewed 23 commenters in the COVID-19 super-topic to examine their motivations and strategies for commenting. Our findings showed that geographical proximity and expertise level affected users' commenting behaviors. For example, non-locals or people lacking professional knowledge applied a "copy-and-paste" strategy and acted as a bridge between help-seekers and influencers on social media, while locals and experts focused on detailed information and provided targeted help. Some commenters also exhibited avoidance behaviors due to their sense of powerlessness and frustration in such a long-lasting pandemic. We discuss the implications of our findings for designing social media platforms to better support people in need during crisis situations.
C1 [Chen, Yixin] Peking Univ, Dept Informat Management, Beijing, Peoples R China.
   [Wang, Ke-Rou; Huang, Yun] Univ Illinois, Sch Informat Sci, Champaign, IL USA.
   [Xu, Weikai] Univ Illinois, Dept Comp Sci, Champaign, IL USA.
RP Chen, YX (corresponding author), Peking Univ, Dept Informat Management, Beijing, Peoples R China.
EM chenyix@pku.edu.cn; kerourw2@illinois.edu; weikaix2@illinois.edu;
   yunhuang@illinois.edu
CR Andrews C, 2016, ACM CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW 2016), P452, DOI 10.1145/2818048.2819986
   Brashers DE, 2000, COMMUN MONOGR, V67, P63, DOI 10.1080/03637750009376495
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Bruns  Axel, 2012, P 2012 AUSTR NZ DIS, V2012, P86
   Castillo C, 2016, BIG CRISIS DATA: SOCIAL MEDIA IN DISASTERS AND TIME-CRITICAL SITUATIONS
   Charmaz K., 2006, CONSTRUCTING GROUNDE
   Denis L A, 2012, ISCRAM 2012 C P 9 IN, P1
   Dovgopol Roman, 2015, ARXIV150200094CSIR
   Ellison Nicole, 2013, P 7 ANN INT C WEBL S, P155
   Fischer HW., 1998, RESPONSE DISASTER FA
   Folkestad Lars, 2011, Ugeskr Laeger, V173, P3174
   Fritz Charles E, 1957, CONVERGENCE BEHAV DI
   Fung ICH, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-31
   Halford E, 2002, ROGUE VOLUNTEERS RES
   Hiltz Starr Roxanne, 2014, 11 INT C INF SYST CR, P602, DOI DOI 10.13140/2.1.3122.4005
   Huang YLL, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P969, DOI 10.1145/2675133.2675202
   Kaufhold M.-A., 2014, I COM, V13, P20, DOI DOI 10.1515/ICOM-2014-0004
   Kendra JM, 2003, RES SOC PROBL PUBLIC, V11, P97, DOI 10.1016/S0196-1152(03)11007-1
   Lachlan KA, 2016, COMPUT HUM BEHAV, V54, P647, DOI 10.1016/j.chb.2015.05.027
   Lampe Clif, 2014, P 17 ACM C COMP SUPP, P3, DOI DOI 10.1145/2531602.2531720
   Maity SK, 2017, CSCW'17: COMPANION OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P243, DOI 10.1145/3022198.3026360
   Malecki CK, 2003, SCHOOL PSYCHOL QUART, V18, P231, DOI 10.1521/scpq.18.3.231.22576
   Meier Patrick, 2015, DIGITAL HUMANITARIAN
   Mills RA, 2018, AI SOC, V33, P39, DOI 10.1007/s00146-017-0712-9
   Munoz-Laboy M, 2014, AM J MENS HEALTH, V8, P226, DOI 10.1177/1557988313508303
   Park CH, 2017, NEW MEDIA SOC, V19, DOI 10.1177/1461444817706877
   Peterson Steve, 2019, ISCRAM, P867
   Purohit H, 2014, COMPUT SUPP COOP W J, V23, P513, DOI 10.1007/s10606-014-9209-y
   Qu Y., 2011, CSCW 2011 MARCH 19 2, P25, DOI [DOI 10.1145/1958824.1958830, 10.1145/1958824.1958830]
   Ravindran T, 2014, J ASSOC INF SCI TECH, V65, P2306, DOI 10.1002/asi.23122
   Rodriguez H, 2006, ANN AM ACAD POLIT SS, V604, P82, DOI 10.1177/0002716205284677
   Sarcevic Aleksandra, 2012, P ACM 2012 C COMP SU, P47, DOI DOI 10.1145/2145204.2145217
   Semaan B., 2012, P CSCW 2012, P27, DOI [https://doi.org/10.1145/2145204.2145214, DOI 10.1145/2145204.2145214]
   Shibuya Yuya, 2019, P 16 INT C INF SYST, P706
   SLATER DH, 2012, ASIA PAC J JPN FOCU, V10
   Starbird K, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1071
   Starbird K, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P241
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963
   Xiao L, 2019, COMPUT HUM BEHAV, V101, P297, DOI 10.1016/j.chb.2019.08.001
   Yao XX, 2020, TELEMED E-HEALTH, V26, P734, DOI 10.1089/tmj.2019.0108
   Zhang J, 2020, J ASSOC INF SCI TECH, V71, P282, DOI 10.1002/asi.24245
   Zhao L, 2016, COMPUT COMMUN, V76, P1, DOI 10.1016/j.comcom.2015.08.001
   Zubiaga A, 2014, SOC NETW ANAL MIN, V4, DOI 10.1007/s13278-014-0163-y
NR 44
TC 0
Z9 0
U1 0
U2 0
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1601 Broadway, 10th Floor, NEW YORK, NY, UNITED STATES
BN 978-1-4503-8095-9
PY 2021
DI 10.1145/3411763.3451717
PG 7
WC Computer Science, Cybernetics; Computer Science, Interdisciplinary
   Applications; Computer Science, Theory & Methods
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS7DM
UT WOS:000759178502027
DA 2022-04-20
ER

PT J
AU Szelenberger, R
   Saluk-Bijak, J
   Bijak, M
AF Szelenberger, Rafal
   Saluk-Bijak, Joanna
   Bijak, Michal
TI Ischemic Stroke among the Symptoms Caused by the COVID-19 Infection
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE COVID-19; SARS-CoV-2; coagulopathy; thrombosis; stroke
ID RESPIRATORY SYNDROME CORONAVIRUS; RISK-FACTORS; PATHOGENESIS; BRAIN;
   ENDOTHELIUM; RECRUITMENT; CYTOKINES; PATHOPHYSIOLOGY; COAGULATION;
   MANAGEMENT
AB The 2019 global pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been declared a public health emergency of international concern by the World Health Organization (WHO). The WHO recognized the spread of COVID-19 as a pandemic on 11 March 2020. Based on statistics from 10 August 2020, more than 20.2 million cases of COVID-19 have been reported resulting in more than 738,000 deaths. This completely new coronavirus has spread worldwide in a short period, causing economic crises and healthcare system failures worldwide. Initially, it was thought that the main health threat was associated with respiratory system failures, but since then, SARS-CoV-2 has been linked to a broad spectrum of symptoms indicating neurological manifestations, including ischemic stroke. Current knowledge about SARS-CoV-2 and its complications is very limited because of its rapidly evolving character. However, further research is undoubtedly necessary to understand the causes of neurological abnormalities, including acute cerebrovascular disease. The viral infection is inextricably associated with the activation of the immune system and the release of pro-inflammatory factors, that can stimulate the host organism to defend itself. However, the body's immune response is a double-edged sword that on one hand, destroys the virus but also disrupts the homeostasis leading to serious complications, including thrombosis. Numerous studies have linked coagulopathies with COVID-19, however, there is great uncertainty regarding it functions on the molecular level. In this review, a detailed insight into the biological processes associated with ischemic stroke in COVID-19 patients and suggest a possible explanation for this phenomenon is provided.
C1 [Szelenberger, Rafal; Saluk-Bijak, Joanna] Univ Lodz, Dept Gen Biochem, Fac Biol & Environm Protect, Pomorska 141-143, PL-90236 Lodz, Poland.
   [Bijak, Michal] Univ Lodz, Biohazard Prevent Ctr, Fac Biol & Environm Protect, Pomorska 141-143, PL-90236 Lodz, Poland.
RP Bijak, M (corresponding author), Univ Lodz, Biohazard Prevent Ctr, Fac Biol & Environm Protect, Pomorska 141-143, PL-90236 Lodz, Poland.
EM rafal.szelenberger@unilodz.eu; joanna.saluk@biol.uni.lodz.pl;
   michal.bijak@biol.uni.lodz.pl
OI Szelenberger, Rafal/0000-0002-6646-2203; Saluk-Bijak,
   Joanna/0000-0002-1197-1713; Bijak, Michal/0000-0002-7838-4097
FU University of Lodz [506/1136]
FX This work was supported by Grant 506/1136 from the University of Lodz
CR [Anonymous], COVID 19 TREATM GUID
   Beyrouti R, 2020, J NEUROL NEUROSUR PS, V91, P889, DOI 10.1136/jnnp-2020-323586
   Bharosay A, 2012, INDIAN J CLIN BIOCHE, V27, P186, DOI 10.1007/s12291-011-0172-9
   Bobryshev YV, 2006, MICRON, V37, P208, DOI 10.1016/j.micron.2005.10.007
   Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398
   Carsana L., 2020, PULMONARY POSTMORTEM, DOI [10.2139/ssrn.3572890, DOI 10.2139/SSRN.3572890]
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Corman VM, 2019, INTERNIST, V60, P1136, DOI 10.1007/s00108-019-00671-5
   COTRAN RS, 1989, KIDNEY INT, V35, P969, DOI 10.1038/ki.1989.80
   Dalrymple NA, 2014, CURR OPIN VIROL, V7, P134, DOI 10.1016/j.coviro.2014.06.006
   De Meyer SF, 2016, STROKE, V47, P1165, DOI 10.1161/STROKEAHA.115.011238
   Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027
   Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560
   Doll DN, 2014, AGING DIS, V5, P294, DOI 10.14336/AD.2014.0500294
   Donkel SJ, 2019, ARTERIOSCL THROM VAS, V39, P360, DOI 10.1161/ATVBAHA.118.312102
   Donkor ES, 2018, STROKE RES TREAT, V2018, DOI 10.1155/2018/3238165
   Frizzell JP, 2005, AACN ADV CRIT CARE, V16, P421, DOI 10.1097/00044067-200510000-00002
   Gale AJ, 2011, TOXICOL PATHOL, V39, P273, DOI 10.1177/0192623310389474
   Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758
   Rojas-Zuleta WG, 2017, METHODS MOL BIOL, V1585, P21, DOI 10.1007/978-1-4939-6877-0_2
   Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828
   Hamilos M, 2018, CARDIOVASC DIAGN THE, V8, P568, DOI 10.21037/cdt.2018.07.01
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X
   Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Javanmard Shaghayegh Haghjooy, 2012, Adv Biomed Res, V1, P69, DOI 10.4103/2277-9175.102973
   Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766
   Kanyal N., 2015, INT J PHARM RES REV, V4, P65, DOI DOI 10.1017/9781316161609.006
   Kawabori M, 2015, CURR MED CHEM, V22, P1258, DOI 10.2174/0929867322666150209154036
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951
   Li RY, 2012, EUR HEART J, V33, P3114, DOI 10.1093/eurheartj/ehr245
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Lindsberg PJ, 2003, STROKE, V34, P2518, DOI 10.1161/01.STR.0000089015.51603.CC
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Martins A, 2010, IUBMB LIFE, V62, P611, DOI 10.1002/iub.361
   McFadyen JD, 2020, CIRC RES, V127, P571, DOI 10.1161/CIRCRESAHA.120.317447
   Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X
   Merkler AE, 2020, JAMA NEUROL, V77, P1366, DOI 10.1001/jamaneurol.2020.2730
   Mousavizadeh L, 2021, J MICROBIOL IMMUNOL, V54, P159, DOI 10.1016/j.jmii.2020.03.022
   Mtairag E, 2001, CARDIOVASC RES, V49, P882
   Musuka TD, 2015, CAN MED ASSOC J, V187, P887, DOI 10.1503/cmaj.140355
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   Oklu R, 2017, CARDIOVASC DIAGN THE, V7, pS131, DOI 10.21037/cdt.2017.11.08
   Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787
   Pawluk H, 2020, CLIN INTERV AGING, V15, P469, DOI 10.2147/CIA.S233909
   Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158
   Qin C, 2020, STROKE, V51, P2219, DOI 10.1161/STROKEAHA.120.030365
   Rainger GE, 2015, PLATELETS, V26, P507, DOI 10.3109/09537104.2015.1064881
   Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854
   Rezaei O, 2017, IRAN J NEUROL, V16, P83
   Strecker JK, 2017, NEUROCHEM INT, V107, P117, DOI 10.1016/j.neuint.2016.11.006
   Szelenberger R, 2020, CURR NEUROPHARMACOL, V18, P51, DOI 10.2174/1570159X17666190726104139
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tu YF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072657
   van Gorp ECM, 1999, J INFECT DIS, V180, P176, DOI 10.1086/314829
   van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5
   Venugopal A, 2014, INDIAN J ANAESTH, V58, P603, DOI 10.4103/0019-5049.144666
   Verdecchia P, 2020, EUR J INTERN MED, V76, P14, DOI 10.1016/j.ejim.2020.04.037
   World Health Organization, Q A COR COVID 19
   Wright FL, 2020, J AM COLL SURGEONS, V231, P193, DOI 10.1016/j.jamcollsurg.2020.05.007
   Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031
   Xia HJ, 2010, CURR HYPERTENS REP, V12, P170, DOI 10.1007/s11906-010-0105-7
   Xing DQ, 2012, CIRCULATION, V125, P1533, DOI 10.1161/CIRCULATIONAHA.111.078436
   Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461
   Yaghi S, 2020, STROKE, V51, P2002, DOI 10.1161/STROKEAHA.120.030335
   Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427
   Zheng J, 2020, INT J BIOL SCI, V16, P1678, DOI 10.7150/ijbs.45053
NR 74
TC 3
Z9 3
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD SEP
PY 2020
VL 9
IS 9
AR 2688
DI 10.3390/jcm9092688
PG 16
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA OE0SZ
UT WOS:000580252900001
PM 32825182
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Mainar, LB
   Mendez, SS
   Perez, PD
   Aragon, MH
   de Guevara, NML
AF Baquedano Mainar, Laura
   Sanchez Mendez, Sonia
   Dieste Perez, Pena
   Hernandez Aragon, Monica
   Ladron de Guevara, Nicolas Mendoza
CA COMEM Study Spanish Investigators
TI Women's knowledge about the genitourinary syndrome of menopause:
   adherence to its treatments in the COVID-19 era in a sample of them:
   COMEM-GSM study
SO BMC WOMENS HEALTH
LA English
DT Article
DE Genitourinary syndrome of menopause; Knowledge; Menopause; COVID-19;
   Confinement; Adherence
ID VAGINAL HEALTH INSIGHTS; POSTMENOPAUSAL WOMEN; TREATMENT OPTIONS;
   ATROPHY; ATTITUDES; VULVAR; VIEWS; MANAGEMENT
AB Objective To study knowledge regarding genitourinary syndrome of menopause (GSM) and the treatments for it and to analyze treatment adherence during the COVID-19 confinement. Methods Multi-center observational study including women between 35 and 75 years. An extension study of treatment adherence was conducted during the coronavirus pandemic between March and April 2020. Results A sample of 2355 women were included. Vaginal dryness was the most frequently identified symptom (74.3%). Lubricants were the best-known treatments (69.6%), followed by local estrogens (25.7%); 66% of the women did not speak to their gynecologist about sexuality. Comparative analyses were conducted according to age, menopausal status, type of menopause, place of residence, type of health care received and level of education. During the coronavirus confinement period, adherence to treatments for vulvovaginal atrophy was poor in 72.5% asked (n = 204). Reduced sexual activity (p > 0.001) and coronavirus diagnosis (p = 0.003) were significantly associated with poorer treatment compliance. Conclusions There is great lack of knowledge of the treatments used for GSM. Most women do not talk to their gynecologist about sexuality. Adherence to treatments during the coronavirus confinement has been worryingly low.
C1 [Baquedano Mainar, Laura; Dieste Perez, Pena; Hernandez Aragon, Monica] Miguel Servet Univ Hosp, Gynecol Dept, Paseo Isabel La Catolica 1-3, Zaragoza 50009, Spain.
   [Sanchez Mendez, Sonia] Hosp Univ Gen Catalunya, Serv Obstet & Gynecol, Barcelona, Spain.
   [Ladron de Guevara, Nicolas Mendoza] Univ Granada, Dept Obstet & Gynecol, Granada, Spain.
RP Mainar, LB (corresponding author), Miguel Servet Univ Hosp, Gynecol Dept, Paseo Isabel La Catolica 1-3, Zaragoza 50009, Spain.
EM lbaquedanome@hotmail.com
RI Sánchez-Borrego, Rafael/AAT-4437-2021
OI Sánchez-Borrego, Rafael/0000-0001-6583-7440; Coronado,
   Pluvio/0000-0003-0357-2015
CR Baquedano L, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-01151-x
   Cain VS, 2003, J SEX RES, V40, P266, DOI 10.1080/00224490309552191
   Cuerva MJ, 2018, MATURITAS, V108, P31, DOI 10.1016/j.maturitas.2017.11.009
   Damsted Petersen C., 2013, EFS ESSM SYLLABUS CL, V1, P1173
   Escribano JJ, 2020, SINDROME GENITOURINA, VPrimera
   Harun MGD, 2020, MENOPAUSE, V27, P648, DOI 10.1097/GME.0000000000001525
   Kingsberg SA, 2013, J SEX MED, V10, P1790, DOI 10.1111/jsm.12190
   Krychman M, 2017, J SEX MED, V14, P425, DOI 10.1016/j.jsxm.2017.01.011
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Nappi RE, 2016, CLIMACTERIC, V19, P188, DOI 10.3109/13697137.2015.1107039
   Nappi RE, 2012, CLIMACTERIC, V15, P36, DOI 10.3109/13697137.2011.647840
   Nappi RE, 2013, MATURITAS, V75, P373, DOI 10.1016/j.maturitas.2013.05.003
   Palacios S, 2018, CLIMACTERIC, V21, P286, DOI 10.1080/13697137.2018.1446930
   Palacios S, 2017, CLIMACTERIC, V20, P55, DOI 10.1080/13697137.2016.1262840
   Palacios S, 2019, MENOPAUSE, V26, P919, DOI 10.1097/GME.0000000000001368
   Palacios S, 2015, MATURITAS, V82, P308, DOI 10.1016/j.maturitas.2015.07.020
   Palma F, 2016, CLIMACTERIC, V19, P553, DOI 10.1080/13697137.2016.1240770
   Sabate E, 2003, WHO ADHERENCE LONG T
   Simon JA, 2013, MENOPAUSE, V20, P1043, DOI [10.1097/gme.0b013e318287342d, 10.1097/GME.0b013e318287342d]
   Utian WH, 2014, CLIMACTERIC, V17, P29, DOI 10.3109/13697137.2013.850480
NR 20
TC 0
Z9 0
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6874
J9 BMC WOMENS HEALTH
JI BMC Womens Health
PD NOV 30
PY 2021
VL 21
IS 1
AR 398
DI 10.1186/s12905-021-01548-2
PG 6
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology
GA XF3UD
UT WOS:000723998400001
PM 34847892
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Niknam, F
   Samadbeik, M
   Fatehi, F
   Shirdel, M
   Rezazadeh, M
   Bastani, P
AF Niknam, Fatemeh
   Samadbeik, Mahnaz
   Fatehi, Farhad
   Shirdel, Mohammad
   Rezazadeh, Mahboobeh
   Bastani, Peivand
TI COVID-19 on Instagram: A content analysis of selected accounts
SO HEALTH POLICY AND TECHNOLOGY
LA English
DT Article
DE COVID-19; Coronavirus; Instagram; Social networking; Social media;
   Content analysis
ID SOCIAL MEDIA
AB Objective: This study aimed to characterize the representation of public health information related to COVID-19 posted on Instagram in 2020.
   Methods: This qualitative content analysis study was conducted in Iran as one of the countries with the highest number of confirmed cases of COVID-19. Data were collected from the contents published from February 19 to April 3, 2020, on Instagram. The search feature of the Instagram app was used to find the posts related to Coronavirus or COVID-19. Overall, 1612 posts from 92 accounts were retrieved and analyzed using thematic analysis.
   Results: A total of 23 themes emerged from the analysis of the retrieved posts. These themes include epidemiology and statistics, training and caring, general prevention guidelines, hygiene, healthy diet and lifestyle, patients, diagnosis and treatment, personal protective equipment, traditional medicine, psychol-ogy, children, cultural aspects, socio-cultural impacts, religious, misinformation, and wrong behaviors, an-imals, satire, condition of the healthcare system, politics, quarantine, operations of the Iranian National Disaster Management Organization (NDMO), economic impacts, and world news.
   Conclusion: The contents analysis of Instagram posts during a public health crisis can provide new and realistic insights into the crisis and identify the topics of interest or concern of the public. Furthermore, the information collected in this way can help policymakers identify the most critical issues from the public perspective and utilize the gained knowledge to manage the ongoing and future pandemics.
   (c) 2020 Fellowship of Postgraduate Medicine. Published by Elsevier Ltd. All rights reserved.
C1 [Niknam, Fatemeh; Shirdel, Mohammad; Rezazadeh, Mahboobeh] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.
   [Samadbeik, Mahnaz] Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran.
   [Samadbeik, Mahnaz; Fatehi, Farhad] Univ Queensland, Fac Med, Ctr Online Hlth, Brisbane, Qld, Australia.
   [Fatehi, Farhad] Univ Tehran Med Sci, Sch Adv Technol Med, Tehran, Iran.
   [Bastani, Peivand] Shiraz Univ Med Sci, Hlth Human Resources Res Ctr, Shiraz, Iran.
RP Samadbeik, M (corresponding author), Lorestan Univ Med Sci, Sch Allied Med, East Goldasht 6819789741, Khorramabad, Iran.
EM mahbeik@gmail.com
RI Samadbeik, Mahnaz/H-2383-2016; Bastani, Peivand/AAE-1769-2022
OI Samadbeik, Mahnaz/0000-0002-4756-2364; Bastani,
   Peivand/0000-0002-0412-0267; niknam, fatemeh/0000-0002-9062-6837
CR Aakko Eric, 2004, WMJ, V103, P25
   Abd-Alrazaq A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19016
   Al-Garadi MA, 2016, J BIOMED INFORM, V62, P1, DOI 10.1016/j.jbi.2016.05.005
   Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117
   CDC, 2020, COR DIS 2019 COVID 1
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   Denecke K, 2016, PARTICIPATORY HLTH S, P42, DOI DOI 10.1016/8978-0-12-809269-9.00004-9
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Habersaat KB, 2020, NAT HUM BEHAV, V4, P677, DOI 10.1038/s41562-020-0906-x
   Han XH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082788
   Han XH, 2019, ISPRS INT J GEO-INF, V8, DOI 10.3390/ijgi8040185
   Hayajneh Y., 2007, MANAGEMENT HLTH CARE, P1
   Irna, 2018, SOC MED IR INST TEL
   Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255
   Laranjo L, 2015, J AM MED INFORM ASSN, V22, P243, DOI 10.1136/amiajnl-2014-002841
   Loh J, 2013, QUAL REP, V18
   Lu Y, 2020, J INFECTION, V81, pE82, DOI 10.1016/j.jinf.2020.03.050
   Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P2011, DOI 10.1001/jama.2020.4469
   Ngai EWT, 2015, INT J INFORM MANAGE, V35, P33, DOI 10.1016/j.ijinfomgt.2014.09.004
   Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847
   Omnicore, INSTAGRAM NUMBERS ST
   Savoia E, 2013, BIOSECUR BIOTERROR, V11, P170, DOI 10.1089/bsp.2013.0038
   Schild L, 2020, ARXIV PREPRINT ARXIV
   Seltzer EK, 2015, PUBLIC HEALTH, V129, P1273, DOI 10.1016/j.puhe.2015.07.025
   Stechemesser A, 2020, ECLINICAL MED
   World Health Organization, COR DIS COVID 19 PAN
   Zarei K., 2020, ARXIV PREPRINT ARXIV
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
NR 28
TC 6
Z9 6
U1 14
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2211-8837
J9 HEALTH POLICY TECHN
JI Health Policy Technol.
PD MAR
PY 2021
VL 10
IS 1
BP 165
EP 173
DI 10.1016/j.hlpt.2020.10.016
EA MAR 2021
PG 9
WC Health Policy & Services
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA RB3AC
UT WOS:000631985400028
PM 33723502
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Crain, DE
   Hollings, S
   Kayode, HM
   Ogunniran, MO
   Worapot, Y
   Guanuna, P
   Yasmeen, T
   Riaz, A
   Samilo, A
   Jiang, YH
   Bolanle, OF
   Jackson, L
   Sturm, S
AF Crain, Daniel E.
   Hollings, Stephanie
   Kayode, Hazzan Moses
   Ogunniran, Moses Oladele
   Worapot, Yodpet
   Guanuna, Paola
   Yasmeen, Tahira
   Riaz, Anum
   Samilo, Artem
   Jiang, Yuhan
   Bolanle, Ogunyemi Folasade
   Jackson, Liz
   Sturm, Sean
TI Knowledge socialism in the COVID-19 era: a collective exploration of
   needs, forms, and possibilities
SO EDUCATIONAL PHILOSOPHY AND THEORY
LA English
DT Article; Early Access
DE Collective intelligence; gamification; indigenous knowledge; knowledge
   socialism; knowledge socialist pedagogy; MOOCs; peer production; virtual
   education
ID HIGHER-EDUCATION; MOOCS; ENGAGEMENT
AB The inspiration for this collective writing project began with a digital conference entitled 'Knowledge Socialism, COVID-19 and the New Reality of Education' held at Beijing Normal University. In this conference and through this article, multiple researchers spread across six continents have engaged in the collaborative task of outlining emerging innovations and alternative contingencies towards education, international collaboration, and digital reform in this time of global crisis. Trends associated with digital education, knowledge openness, peer production, and collective intelligence as articulated by Michael A. Peters' conception of Knowledge Socialism are given careful analysis and exploration. Some of the members of this collective endeavor to identify problems, others, begin to draw boxes around potential solutions. Overall, this article engages with real world challenges and innovations that look beyond dominant neoliberal trends in the knowledge economy to build bridges toward novel possibilities in this era of rapid digital change.
C1 [Crain, Daniel E.] Peking Univ, Sch Int Studies, Beijing, Peoples R China.
   [Hollings, Stephanie; Worapot, Yodpet; Guanuna, Paola; Yasmeen, Tahira; Riaz, Anum; Samilo, Artem; Jiang, Yuhan; Bolanle, Ogunyemi Folasade] Beijing Normal Univ, Fac Educ, Beijing, Peoples R China.
   [Kayode, Hazzan Moses] Univ Ibadan, Fac Educ, Dept Educ Management, Ibadan, Nigeria.
   [Ogunniran, Moses Oladele] UNESCO Mahatma Gandhi Inst Educ Peace & Sustainab, New Delhi, India.
   [Jackson, Liz] Educ Univ Hong Kong, Hong Kong, Peoples R China.
   [Sturm, Sean] Univ Auckland, Auckland, New Zealand.
RP Crain, DE (corresponding author), Peking Univ, Sch Int Studies, Beijing, Peoples R China.
EM danielcrain1@gmail.com
OI MOSES KAYODE, HAZZAN/0000-0003-2933-5798; OLADELE, OGUNNIRAN
   MOSES/0000-0002-9615-2775; Yodpet, Worapot/0000-0003-3888-748X; JIANG,
   Yuhan/0000-0001-8738-5297; Samilo, Artem/0000-0002-6787-7910
CR Adams J., 1765, ADAMS PAPERS DIGITAL
   Agamben G., 1995, IDEA PROSE, P63
   Akram W., 2020, SCENARIO ANAL PROPOS, DOI [10.33774/coe-2020-ql1w6, DOI 10.33774/COE-2020-QL1W6]
   Al-Azawi R., 2016, INT J INNOV MANAG TE, V7, P132
   Alhazzani Noura, 2020, Soc Sci Humanit Open, V2, P100030, DOI 10.1016/j.ssaho.2020.100030
   Almutairi F, 2018, INTERACT TECHNOL SMA, V15, P262, DOI 10.1108/ITSE-07-2018-0046
   Anderson J., 2010, GAMIFICATION HUMAN F, P199
   Annabi CA, 2016, INT J EDUC MANAG, V30, P959, DOI 10.1108/IJEM-05-2015-0057
   [Anonymous], 2020, VIET NAM 1112
   [Anonymous], 1789, COMMUNICATION
   Assie-Lumumba NT, 2017, COMP EDUC REV, V61, P1
   Bauwens M., 2017, EMERGENCE PEER PRODU
   Benkler Y., 2018, NETWORK PROPAGANDA M
   Benkler Y., 2005, HLS SCHOLARLY ARTICL
   Benkler Yochai, 2016, HDB EC INTERNET
   Blum-Smith S, 2021, COMPUT EDUC, V160, DOI 10.1016/j.compedu.2020.104042
   Bordoloi R., 2018, ASIAN ASS OPEN U J, V13, P24, DOI DOI 10.1108/AAOUJ-11-2017-0037
   Buddharaksa W, 2016, MANUSYA, V19, P112, DOI [https://doi.org/10.1163/26659077-01902007, DOI 10.1163/26659077-01902007]
   Cammaerts B, 2020, INT J COMMUN-US, V14, P135
   Chee YS, 2013, ELECTRON J E-LEARN, V11, P16
   Chen TG, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187329
   Cheng Y, 2014, CURRICULUM TEACHING, V11, P153
   Cherkaoui M., 2020, SHIFTING GEOPOLITI 2
   de Freitas SI, 2015, BRIT J EDUC TECHNOL, V46, P455, DOI 10.1111/bjet.12268
   De Santos B, 2016, POSTCOLONIAL ITALIA, V1
   Dewey J, 1983, MIDDLE WORKS J DEWEY, V13, P1921
   Elliott KC, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4808
   Fan L, 2020, JIBEN JIAOYU YANJIU, V544, P76
   Galvao J, 2021, LANCET INFECT DIS, V21, pE114, DOI 10.1016/S1473-3099(20)30721-0
   Giang V., 2013, BUSINESS INSIDER
   Graber D.A, 2018, MASS MEDIA AM POLITI, V10th ed.
   Guattari F., 2000, 3 ECOLOGIES
   Hajdukiewicz A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208542
   Hannah M, 2021, 1 MONDAY, V26, DOI [10.5210/fm.v26i2.10868, DOI 10.5210/FM.V26I2.10868]
   Hardt M., 2009, COMMONWEALTH
   Higgs P, 2010, PROCD SOC BEHV, V2, P2414, DOI 10.1016/j.sbspro.2010.03.347
   Hitkul J, 2021, ARXIV210106914CS, V111, P1
   Hodgkinson-Williams C., 2009, INT J ED DEV USING I, V5, P101
   Huang Wendy Hsin-Yuan, 2013, PRACTITIONERS GUIDE
   Hyvonen M., 2018, POSTTRUTH FAKE NEWS, DOI [https://doi.org/10.1007/978-981-10-8013-5, DOI 10.1007/978-981-10-8013-5]
   Islam M.F, 2019, P W BALK INF MED LIT, P20
   Jackson L, 2021, MARXISM NEOLIBERALIS, VXI
   Jacobs GM, 2019, SPRINGERBRIEFS EDUC, P1, DOI 10.1007/978-981-13-7213-1
   Kapp K., 2012, GAMIFICATION LEARNIN
   Lan T., 2018, J DALIAN ED U, V34, P28
   Lee C., P 2021 CHI C HUM FAC, P1, DOI [10.1145/3411764.3445211, DOI 10.1145/3411764.3445211]
   Lee JJ, 2021, J HIGH EDUC-UK, V92, P303, DOI 10.1080/00221546.2020.1827924
   Lenin V, 1916, LENIN IMPERIALISM HI
   Letseka M., 2013, MEDITERRANEAN J SOCI, V4, P351
   Levy P, 2020, KNOWLEDGE SOCIALISM, P33, DOI [10.1007/978-981-13-8126-3, DOI 10.1007/978-981-13-8126-3]
   Luke T, 2020, KNOWLEDGE SOCIALISM, P61, DOI [https://doi.org/10.1007/978-981-13-8126-3, DOI 10.1007/978-981-13-8126-3]
   Lunacharsky A, 1918, SELF ED WORKERS A LU
   Ma S, 2020, J HUNAN RADIO TELEVI, V81, P138
   Marino MT, 2012, CULT STUD SCI EDUCAT, V7, P945, DOI 10.1007/s11422-012-9429-8
   Mbiti, 1969, AFRICAN RELIG PHILOS
   McGonigal J., 2011, REALITY IS BROKEN WH
   Menkiti I., 2004, COMPANION AFRICAN PH, P324
   Milligan C, 2014, INT REV RES OPEN DIS, V15, P197
   Ministy of Foreign Affairs (MFA), 2020, MFAS NEWS CHINA
   Mohamed MH, 2018, INT J INF LEARN TECH, V35, P2, DOI 10.1108/IJILT-07-2017-0062
   MOOC.org, 2020, MOOCS
   Morford ZH, 2014, BEHAV ANALYST, V37, P25, DOI 10.1007/s40614-014-0006-1
   Nacke L., 2011, P 15 INT AC MINDTREK
   Ndlovu-Gatsheni SJ, 2020, J DEV SOC, V36, P366, DOI 10.1177/0169796X20963252
   Neilson D., 2020, KNOWLEDGE SOCIALISM, DOI [10.1007/978-981-13-8126-3, DOI 10.1007/978-981-13-8126-3]
   Odgers CL, 2020, J CHILD PSYCHOL PSYC, V61, P336, DOI 10.1111/jcpp.13190
   Ong David, 2016, Development & Learning in Organizations, V30, P18, DOI 10.1108/DLO-08-2015-0066
   Peters M., 2006, BUILDING KNOWLEDGE C
   Peters M., 2018, BUILDING KNOWLEDGE C
   Peters M.A, 2021, RADICAL MARXISM KNOW, VXI
   Peters M.A, 2020, KNOWLEDGE SOCIALISM, P1, DOI [10.1007/978-981-13-8126-3_1, DOI 10.1007/978-981-13-8126-3_1]
   Peters MA, 2020, EDUC PHILOS THEORY, V52, P1016, DOI 10.1080/00131857.2019.1699992
   Peters MA, 2021, EDUC PHILOS THEORY, V53, P1, DOI 10.1080/00131857.2019.1654375
   Peters MA, 2019, OPEN REV EDUC RES, V6, P25, DOI 10.1080/23265507.2018.1557072
   Peters MA, 2020, EDUC PHILOS THEORY, V52, P1, DOI 10.1080/00131857.2019.1593033
   Petersen A.H, 2019, AMASS SOC POPULAR DE, V23, P16
   Purkayastha N, 2021, LIB PHILOS PRACTICE, P4791
   Ramose M. B., 2002, PHILOS AFRICA TEXT R
   Ranjan P, 2021, CASE WAIVING INTELLE
   Ren Y, 2020, CHENGZHANG ZHILU, V31, P82
   Richter G., 2015, GAMIFICATION ED BUSI, P21, DOI [DOI 10.1007/978-3-319-10208-5_2, 10.1007/978-3-319-10208-5_2]
   Rigby CS, 2014, GAMEFUL WORLD: APPROACHES, ISSUES, APPLICATIONS, P113
   Rogers C., 1983, FREEDOM LEARN 80, V2
   Sanchez-Gordon S, 2014, INTED PROC, P1449
   Shah D., 2020, NUMBERS MOOCS 2020
   Snyder T., 2021, NEW YORK TIMES
   Sunstein C.R., 2017, REPUBLIC DIVIDED DEM
   Tambini D, 2017, MEDIA POLICY BRIEF, P28
   Tanabe J, 2020, SOCIAL ETHICS SOC J, P31
   Topol E., 2020, COVID19 PANDEMIC COU
   Trajkovic S, 2016, VIRTUAL LEARNING, P137, DOI 10.5772/65930
   Unger R.M, 2020, AM AFFAIRS, V5, P29
   Vanolo A, 2018, CITIES, V74, P320, DOI 10.1016/j.cities.2017.12.021
   Virno, 1996, RADICAL THOUGHT ITAL, P133
   Virno P, 2004, GRAMMAR MULTITUDE AN
   Virno Paolo, 1996, RADICAL THOUGHT ITAL, P189
   Xu B, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30119-5
   Yuan L., 2013, MOOCS OPEN ED IMPLIC
   Zhu Y, 2020, ED MODERNIZATION, V29, P193
   Zuboff S., 2019, AGE SURVEILLANCE CAP
NR 100
TC 1
Z9 1
U1 6
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0013-1857
EI 1469-5812
J9 EDUC PHILOS THEORY
JI Educ. Philos. Theory
DI 10.1080/00131857.2021.1952864
EA JUL 2021
PG 22
WC Education & Educational Research
WE Social Science Citation Index (SSCI)
SC Education & Educational Research
GA TM1CN
UT WOS:000675291600001
DA 2022-04-20
ER

PT J
AU Stawicki, SP
AF Stawicki, Stanislaw P.
TI Could tracheo-bronchial ultraviolet C irradiation be a valuable adjunct
   in the management of severe COVID-19 pulmonary infections?
SO INTERNATIONAL JOURNAL OF ACADEMIC MEDICINE
LA English
DT Article
DE Acute respiratory distress syndrome; COVID-19; endobronchial therapy;
   respiratory failure; SARS-CoV-2 pandemic; tracheo-bronchial therapy;
   ultraviolet C; ultraviolet light therapy
ID PHOTODYNAMIC THERAPY; RESPIRATORY SYNDROME; CORONAVIRUS; INACTIVATION;
   LIGHT
AB The coronavirus pandemic is wreaking havoc as it mercilessly devastates communities around the world, disproportionately affecting the most vulnerable populations. Thus far, other than high-acuity mechanical ventilatory support and traditional critical care management strategies, there are no proven or effective ways of lessening the impact of COVID-19 pulmonary infection and the associated acute respiratory distress syndrome. This article outlines a proposal for repeated short-term tracheo-bronchial application of ultraviolet C irradiation as a potential adjunctive treatment option for tracheally intubated patients suffering from severe COVID-19 infections. The following core competencies are addressed in this article: Medical knowledge, Patient care.
C1 [Stawicki, Stanislaw P.] St Lukes Univ Hlth Network, Dept Res & Innovat, 801 Ostrum St, Bethlehem, PA 18015 USA.
RP Stawicki, SP (corresponding author), St Lukes Univ Hlth Network, Dept Res & Innovat, 801 Ostrum St, Bethlehem, PA 18015 USA.
EM stawicki.ace@gmail.com
CR Ansaldi F, 2004, J PREV MED HYG, V45, P5
   BAEUMLER W, 2001, COMPREHENSIVE SERIES, V2, P83, DOI DOI 10.1016/S1568-461X(01)80110-1
   CCOHS, 2020, OSH ANSW FACT SHEETS
   Chen ZM, 2020, WORLD J PEDIATR, V16, P240, DOI 10.1007/s12519-020-00345-5
   Dai TH, 2012, EXPERT REV ANTI-INFE, V10, P185, DOI [10.1586/eri.11.166, 10.1586/ERI.11.166]
   Darnell MER, 2004, J VIROL METHODS, V121, P85, DOI 10.1016/j.jviromet.2004.06.006
   Eickmann M, 2018, TRANSFUSION, V58, P2202, DOI 10.1111/trf.14652
   Hagemeijer MC, 2010, J VIROL, V84, P2134, DOI 10.1128/JVI.01716-09
   Hashem AM, 2019, TRANSFUSION MED, DOI 10.1111/tme.12638
   HASSELGREN L, 1990, APPL OPTICS, V29, P4481, DOI 10.1364/AO.29.004481
   HEIER SK, 1995, GASTROENTEROLOGY, V109, P63, DOI 10.1016/0016-5085(95)90269-4
   Hindawi SI, 2018, TRANSFUSION, V58, P52, DOI 10.1111/trf.14422
   HPS, 2020, ANSW QUEST 9450 CAT
   Mitchell D, 2010, J CELL MOL MED, V14, P313, DOI 10.1111/j.1582-4934.2008.00442.x
   Momattin H, 2019, TRAVEL MED INFECT DI, V30, P9, DOI 10.1016/j.tmaid.2019.06.012
   Oxidation_Technologies_LLC, 2020, OZ PROD UV DOES UV L
NR 16
TC 1
Z9 1
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
EI 2455-5568
J9 INT J ACAD MED
JI Int. J. Acad. Med.
PD APR-JUN
PY 2020
VL 6
IS 2
BP 156
EP 158
DI 10.4103/IJAM.IJAM_19_20
PG 3
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA RN9FS
UT WOS:000640658900024
DA 2022-04-20
ER

PT J
AU Khan, MA
   Khan, ZA
   Charles, M
   Pratap, P
   Naeem, A
   Siddiqui, Z
   Naqvi, N
   Srivastava, S
AF Khan, Mohsin Ali
   Khan, Zaw Ali
   Charles, Mark
   Pratap, Pushpendra
   Naeem, Abdul
   Siddiqui, Zainab
   Naqvi, Nigar
   Srivastava, Shikha
TI Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of
   Mechanisms
SO JOURNAL OF INFLAMMATION RESEARCH
LA English
DT Review
DE COVID-19; cytokine storm; mucus; coronavirus; viral infection
ID OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; GENE-EXPRESSION; IN-VITRO;
   AIRWAY HYPERRESPONSIVENESS; MONOCLONAL-ANTIBODY; TH2 CELLS; MUCIN;
   RECEPTOR; MUC5AC
AB Mucus is an integral part of the respiratory physiology. It protects the respiratory tract by acting as a physical barrier against inhaled particles and microbes. Excessive inflammation in conditions such as COVID-19 can result in over-production of mucus which obstructs the airway. Build-up of mucus can also contribute to recurrent airway infection, causing further obstruction. This article summarizes the current understanding and knowledge of respiratory mucus production and proposes the role of cytokine storm in inducing sudden mucus hypersecretion in COVID-19. Based on these cascades, the active constituents that inhibit or activate several potential targets are outlined for further research. These may be explored for the discovery and design of drugs to combat cytokine storm and its ensuing complications.
C1 [Khan, Mohsin Ali; Khan, Zaw Ali] Eras Lucknow Med Coll & Hosp, Res & Dev Dept, Lucknow, Uttar Pradesh, India.
   [Charles, Mark; Pratap, Pushpendra; Naeem, Abdul] Eras Lucknow Med Coll & Hosp, Metab Res Unit, Lucknow, Uttar Pradesh, India.
   [Siddiqui, Zainab] Eras Lucknow Med Coll & Hosp, Dept Pathol, Lucknow, Uttar Pradesh, India.
   [Naqvi, Nigar; Srivastava, Shikha] Eras Lucknow Med Coll & Hosp, Dept Nutr, Lucknow, Uttar Pradesh, India.
RP Khan, MA (corresponding author), Era Univ, Eras Lucknow Med Coll & Hosp, Hardoi Rd, Lucknow 226001, Uttar Pradesh, India.
EM zawali@erauniversity.in
RI Siddiqui, Zainab/AAK-2891-2021; Khan, Zaw Ali/AAH-9115-2021
OI Siddiqui, Zainab/0000-0003-4384-197X; Khan, Zaw Ali/0000-0002-8418-8068;
   srivastava, shikha/0000-0001-8224-3038; Naeem, Abdul/0000-0001-5041-5675
FU Era's Lucknow Medical College Hospital
FX The authors are grateful to Dr Shadab Raza and Dr Mohd. Faheem Khan for
   their advice in selection of journal for publication. We are also
   thankful to Dr. M.M.A. Faridi for the encouragement provided by him for
   the analytical approach of this review. Lastly, we thank the entire
   management of Era's Lucknow Medical College & Hospital for supporting
   this work.
CR Abdalla AE, 2015, INT J BIOL SCI, V11, P168, DOI 10.7150/ijbs.10464
   Adler Kenneth B, 2013, Front Endocrinol (Lausanne), V4, P129, DOI 10.3389/fendo.2013.00129
   Allinson JP, 2016, AM J RESP CRIT CARE, V193, P662, DOI 10.1164/rccm.201511-2210OC
   Almughem FA, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12070616
   [Anonymous], 2020, VEGF LEVELS COVID 19
   Arora S, 2019, LIFE SCI, V233, DOI 10.1016/j.lfs.2019.116671
   Atal S, 2020, PHARM MED, V34, P223, DOI 10.1007/s40290-020-00342-z
   Banos-Lara MD, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/347292
   Bao Lei, 2013, JAKSTAT, V2, pe24137, DOI 10.4161/jkst.24137
   Bassoy EY, 2018, IMMUNOL REV, V281, P169, DOI 10.1111/imr.12610
   Bosmann M, 2013, J LEUKOCYTE BIOL, V94, P1159, DOI 10.1189/jlb.0213107
   Boutet MA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061257
   Brightling CE, 2014, LANCET RESP MED, V2, P891, DOI 10.1016/S2213-2600(14)70187-0
   Burgos-Blasco B, 2020, EXP EYE RES, V200, DOI 10.1016/j.exer.2020.108253
   Busse PJ, 2005, J ALLERGY CLIN IMMUN, V116, P1256, DOI 10.1016/j.jaci.2005.08.059
   Bustamante-Marin XM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028241
   Cabrita I, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128414
   Cerveri I, 2010, EUR RESPIR REV, V19, P109, DOI 10.1183/09059180.00002710
   Chen CH, 2014, ONCOGENE, V33, P3696, DOI 10.1038/onc.2013.336
   Chen Y, 2014, AM J PHYSIOL-LUNG C, V306, pL797, DOI 10.1152/ajplung.00347.2013
   Choy EH, 2020, NAT REV RHEUMATOL, V16, P335, DOI 10.1038/s41584-020-0419-z
   Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737
   Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003
   Costela-Ruiz VJ, 2020, CYTOKINE GROWTH F R, V54, P62, DOI 10.1016/j.cytogfr.2020.06.001
   Dabbagh K, 1999, J IMMUNOL, V162, P6233
   Deeks ED, 2017, DRUGS, V77, P777, DOI 10.1007/s40265-017-0740-2
   Demoulin JB, 1996, MOL CELL BIOL, V16, P4710
   Earhart AP, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100689
   Farooqi FI, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.926596
   Fenini G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00278
   Fung MM, 2005, ONCOGENE, V24, P4624, DOI 10.1038/sj.onc.1208507
   Ghandadi M, 2017, CURR PHARM DESIGN, V23, P921, DOI 10.2174/1381612822666161006151605
   Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200
   Girija ASS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01206
   Goldbach-Mansky R, 2009, ANN NY ACAD SCI, V1182, P111, DOI 10.1111/j.1749-6632.2009.05159.x
   Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049
   Goyal, 2020, STATPEARLS
   Griffin DO, 2020, EMERG INFECT DIS, V26, P1941, DOI 10.3201/eid2608.201477
   Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261
   Grunstein MM, 2000, AM J PHYSIOL, V6, P1146
   Hedi H, 2004, J BIOMED BIOTECHNOL, P99, DOI 10.1155/S1110724304310041
   Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297
   Hodges R. R., 2010, ENCY EYE, P369
   Holtzman MJ, 2006, AM J RESP CELL MOL, V35, P29, DOI 10.1165/rcmb.2006-0092SF
   Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319
   Huang A, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0164-5
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huber M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-7
   Hynes GM, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00364-2019
   Ito T, 2020, J GASTROENTEROL, V55, P789, DOI 10.1007/s00535-020-01689-5
   Jarosz-Griffiths HH, 2020, ELIFE, V9, DOI 10.7554/eLife.54556
   Jartti T, 2020, SEMIN IMMUNOPATHOL, V42, P61, DOI 10.1007/s00281-020-00781-5
   Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC
   Kankaanranta H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090298
   Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458
   Khashkhosha HK, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.110066
   Kim JH, 2012, MOL NUTR FOOD RES, V56, P454, DOI 10.1002/mnfr.201100270
   Knoop KA, 2018, MUCOSAL IMMUNOL, V11, P1551, DOI 10.1038/s41385-018-0039-y
   Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589
   Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012
   Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6
   Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143
   Li L, 2016, ONCOL LETT, V12, P3045, DOI 10.3892/ol.2016.5110
   Li X, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02911-9
   Lillehoj EP, 2013, INT REV CEL MOL BIO, V303, P139, DOI 10.1016/B978-0-12-407697-6.00004-0
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Madonna S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133318
   Mao QQ, 2019, FOODS, V8, DOI 10.3390/foods8060185
   Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088
   Nagata DED, 2014, AM J PATHOL, V184, P1807, DOI 10.1016/j.ajpath.2014.02.004
   Nakanishi K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00763
   Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944
   Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103
   Ohar JA, 2019, COPD-J COPD FDN, V6, P341, DOI 10.15326/jcopdf.6.4.2019.0139
   Ohishi Tomokazu, 2016, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V15, P74, DOI 10.2174/1871523015666160915154443
   Paunovic V, 2013, DRUGS, V73, P101, DOI 10.1007/s40265-013-0014-6
   Pavord ID, 2017, NEW ENGL J MED, V377, P1613, DOI 10.1056/NEJMoa1708208
   Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014
   Prompetchara E, ASIAN PAC J ALLERGY
   Queen D, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00317
   Radmark O, 2009, J LIPID RES, V50, pS40, DOI 10.1194/jlr.R800062-JLR200
   Ranaker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102002
   Russell B, 2020, ECANCERMEDICALSCIENC, V14, DOI 10.3332/ecancer.2020.1023
   Saint-Criq V, 2017, CELL MOL LIFE SCI, V74, P93, DOI 10.1007/s00018-016-2391-y
   Sciascia S, 2020, CLIN EXP RHEUMATOL, V38, P529
   Seelaender M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/169852
   Seibold MA, 2018, ANN AM THORAC SOC, V15, pS98, DOI 10.1513/AnnalsATS.201711-868MG
   Shishikura Y, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0438-0
   Shukla SD, 2017, RESP RES, V18, DOI 10.1186/s12931-016-0483-8
   Stokes KL, 2013, J VIROL, V87, P10070, DOI 10.1128/JVI.01347-13
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6
   Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x
   Thai P, 2005, AM J RESP CELL MOL, V33, P523, DOI 10.1165/rcmb.2004-0220RC
   Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441
   Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010
   Upadhyay J, 2020, EXP BIOL MED, V245, P1368, DOI 10.1177/1535370220939477
   van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109
   Vetrugno L, 2020, ULTRASOUND J, V12, DOI 10.1186/s13089-020-00185-4
   Wang IJ, 2007, CLIN OPHTHALMOL, V1, P71
   Wang LJ, 2018, ONCOL LETT, V15, P4711, DOI 10.3892/ol.2018.7982
   Wang WJ, 2020, J INFECT DIS, V222, P1444, DOI 10.1093/infdis/jiaa387
   Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x
   Wen Fu-qiang, 2011, Zhonghua Jie He He Hu Xi Za Zhi, V34, P243
   Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685
   Wilson MS, 2008, J IMMUNOL, V181, P6942, DOI 10.4049/jimmunol.181.10.6942
   Wu KK, 2020, J DERMATOL TREAT, V9, P1
   Xia Y, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0657-z
   Xiang LL, 2008, AM J RESP CELL MOL, V38, P310, DOI 10.1165/rcmb.2007-0078OC
   Xue LZ, 2012, J IMMUNOL, V188, P694, DOI 10.4049/jimmunol.1102474
   Ye Z, 2020, EUR RADIOL, V30, P4381, DOI 10.1007/s00330-020-06801-0
   Yu HM, 2010, CELL COMMUN ADHES, V17, P83, DOI 10.3109/15419061.2010.551682
   Zanin M, 2016, CELL HOST MICROBE, V19, P159, DOI 10.1016/j.chom.2016.01.001
   Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913
   Zhang LN, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0675-x
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 116
TC 15
Z9 15
U1 1
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1178-7031
J9 J INFLAMM RES
JI J. Inflamm. Res.
PY 2021
VL 14
BP 175
EP 189
DI 10.2147/JIR.S271292
PG 15
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA QB4GW
UT WOS:000614099900001
PM 33519225
OA Green Published
DA 2022-04-20
ER

PT J
AU Durugbo, CM
   Almahamid, SM
   Budalamah, LH
   Al-Jayyousi, OR
   BendiMerad, B
AF Durugbo, Christopher M.
   Almahamid, Soud M.
   Budalamah, Lulwa H.
   Al-Jayyousi, Odeh R.
   BendiMerad, Batoul
TI Managing regional logistics in times of crisis: a COVID-19 case study
SO JOURNAL OF HUMANITARIAN LOGISTICS AND SUPPLY CHAIN MANAGEMENT
LA English
DT Article
DE Regional logistics; Crisis-driven logistics; Coronavirus; Pandemics;
   Case study; Bahrain
ID SUPPLY CHAIN; HUMANITARIAN LOGISTICS; COMPETITIVE PRIORITIES; SMALL
   MANUFACTURERS; COORDINATION; COLLABORATION; PREPAREDNESS; PERFORMANCE;
   MANAGEMENT; FRAMEWORK
AB Purpose Coronavirus Disease 2019 (COVID-19) is a pandemic with unique regional logistics management (RLM) challenges to respond to the chaos created by the crisis and to restore normality for operations and supply chains in home nations. The purpose of this article is to explore RLM in times of crisis from the perspective of public authorities responsible for combating the COVID-19 pandemic. The article also discusses the significance of crisis-driven RLM for humanitarian logistics and supply chain (HLSC) management. Design/methodology/approach Grounded on an inductive case study logic and guided by a constructivist perspective, this research involves semi-structured interviews with 15 managers and strategists responsible for the RLM of COVID-19 to capture lessons learnt so far from mitigating the transmission and spread of COVID-19. Underpinning the research is a conceptual RLM model premised on coordination, communication, and containment mechanisms (the 3Cs of crisis-driven logistics), as crisis response. Findings The study finds that the triggering of regional logistics in times of crisis for the COVID-19 case involves taskforce teams with centralisation for crisis readiness, information infrastructure with digitalisation for crisis protocols, and capacity calculations with orchestration for crisis scenarios. The study also finds that navigating the challenges for the 3Cs of crisis-driven logistics entails forward-thinking leadership for culture-based commitments, first-hand clarity for compliance-based campaigns, and far-reaching solidarity for compassion-based contributions. Originality/value This article addresses the gap in knowledge on RLM and potential priorities that underpin crisis-driven RLM strategies for HLSCs. The research is original in its argument for regional perspectives on logistics strategies that contribute to the "viability" and "integrity" of HLSCs. The research also uniquely focuses on RLM in times of crisis and proposes a conceptual RLM model of strategies for enhancing HLSCs.
C1 [Durugbo, Christopher M.; Almahamid, Soud M.; Al-Jayyousi, Odeh R.] Arabian Gulf Univ, Manama, Bahrain.
   [Budalamah, Lulwa H.] Minist Informat Affairs, Isa Town, Bahrain.
   [BendiMerad, Batoul] Bahrain Inst Publ Adm, Manama, Bahrain.
RP Durugbo, CM (corresponding author), Arabian Gulf Univ, Manama, Bahrain.
EM mcmillanod@agu.edu.bh; soudmm@agu.edu.bh; lulwa777@gmail.com;
   odehaj@agu.edu.bh; B.Murad@bipa.gov.bh
RI Almahamid, Soud/AGN-2970-2022
OI Almahamid, Soud/0000-0002-2678-4435; Durugbo, C.M./0000-0002-6315-8345
FU Ministry of Health; Supreme Council of Health; National Health
   Regulatory Authority; Bahrain Institute for Public Administration;
   Arabian Gulf University; National Taskforce to Combat Covid-19
FX The authors acknowledge the support of the Ministry of Health, the
   Supreme Council of Health, the National Health Regulatory Authority, the
   National Taskforce to Combat Covid-19, the Bahrain Institute for Public
   Administration and the Arabian Gulf University for this research. The
   authors also thank the interviewees for giving their insights on
   Bahrain's COVID-19 response and the contributions of Mohamed Sabba,
   Rabab Habib, Lulwa Fareed, Deema Meshaal, Sara Bahmen, Aysha Alansari
   and Afnan Alkoheji for arranging interviews and conducting this study.
CR Abidi H, 2014, SUPPLY CHAIN MANAG, V19, P592, DOI 10.1108/SCM-09-2013-0349
   Akhtar P, 2012, J HUMANIT LOGIST SUP, V2, P85, DOI 10.1108/20426741211226019
   Al Adem S, 2018, J HUMANIT LOGIST SUP, V8, P295, DOI 10.1108/JHLSCM-05-2017-0020
   Al-Balushi Z, 2020, INT J PHYS DISTR LOG, V50, P457, DOI 10.1108/IJPDLM-06-2019-0201
   Allal-Cherif O, 2011, INT J PHYS DISTR LOG, V41, P860, DOI 10.1108/09600031111175825
   B?ck E., 2017, INT J STRATEG COMMUN, V11, P324, DOI [DOI 10.1080/1553118X.2017.1341889, 10.1080/1553118X.2017.1341889]
   Balcik B, 2010, INT J PROD ECON, V126, P22, DOI 10.1016/j.ijpe.2009.09.008
   Baldini G, 2012, DISASTER PREV MANAG, V21, P51, DOI 10.1108/09653561211202700
   Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115
   Barnes P., 2005, J INT MANAGEMENT, V11, P519, DOI DOI 10.1016/J.INTMAN.2005.09.008
   Baveja A, 2020, ANN OPER RES, V289, P173, DOI 10.1007/s10479-020-03635-3
   Blackmon L, 2021, PROD OPER MANAG, V30, P3391, DOI 10.1111/poms.13365
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Burgess T.F., 1998, BENCHMARKING QUALITY, V5, P304
   Chanaron Jean-Jacques, 2013, International Journal of Automotive Technology and Management, V13, P320
   Comes T, 2020, PROD OPER MANAG, V29, P2484, DOI 10.1111/poms.13236
   Craighead CW, 2020, DECISION SCI, V51, P838, DOI 10.1111/deci.12468
   Poberschnigg TFD, 2020, SUPPLY CHAIN MANAG, V25, P789, DOI 10.1108/SCM-10-2019-0390
   Davis Mark, 2020, PANDEMICS PUBLICS NA
   de Leeuw S, 2015, PROD PLAN CONTROL, V26, P328, DOI 10.1080/09537287.2014.904531
   Demirbag M, 2020, J WORLD BUS, V55, DOI 10.1016/j.jwb.2019.101026
   Denzin, 2007, BLACKWELL ENCY SOCIO, DOI [10.1002/9781405165518.wbeosa048, DOI 10.1002/9781405165518.WBEOSA048]
   Dubey R, 2019, ANN OPER RES, V283, P159, DOI 10.1007/s10479-017-2676-z
   Dubina IN, 2012, J KNOWL ECON, V3, P1, DOI 10.1007/s13132-011-0042-y
   Dufour E, 2018, OMEGA-INT J MANAGE S, V74, P1, DOI 10.1016/j.omega.2017.01.002
   Durugbo CM, 2021, PROD PLAN CONTROL, V32, P1295, DOI 10.1080/09537287.2020.1805809
   Durugbo CM, 2021, PROD PLAN CONTROL, V32, P1265, DOI 10.1080/09537287.2020.1796144
   Durugbo CM, 2020, SUPPLY CHAIN MANAG, V25, P549, DOI 10.1108/SCM-10-2019-0373
   Eftekhar M, 2017, PROD OPER MANAG, V26, P802, DOI 10.1111/poms.12669
   Enria L, 2019, DEV CHANGE, V50, P1602, DOI 10.1111/dech.12538
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387
   Gereffi G, 2012, J SUPPLY CHAIN MANAG, V48, P24, DOI 10.1111/j.1745-493X.2012.03271.x
   Giles D., 2009, MANAGING CRISIS RESP
   Gillet D., 2017, P 9 INT C INF COMM T, P1
   Gilpin D., 2008, CRISIS MANAGEMENT CO
   Glasersfeld E., 2005, CONSTRUCTIVISM THEOR, V2nd, P2
   Groome D., 2014, INTRO COGNITIVE PSYC
   Guest G., 2012, APPL THEMATIC ANAL, DOI [10.4135/9781483384436, DOI 10.4135/9781483384436]
   Hagen, 2013, ENCY CRISIS MANAGEME, DOI [10.5860/choice.50-6528, DOI 10.5860/CHOICE.50-6528]
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Ivanov D, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03640-6
   Ivanov D, 2020, INT J PROD RES, V58, P2904, DOI 10.1080/00207543.2020.1750727
   Jahre M, 2010, INT J PHYS DISTR LOG, V40, P657, DOI 10.1108/09600031011079319
   Kahn L.H., 2009, WHOS CHARGE LEADERSH
   Ketchen DJ, 2020, J MANAGE, V46, P1330, DOI 10.1177/0149206320945028
   Kovacs G, 2021, J SUPPLY CHAIN MANAG, V57, P41, DOI 10.1111/jscm.12253
   Kovacs G, 2010, INT J LOGIST-RES APP, V13, P411, DOI 10.1080/13675567.2010.511609
   Krause M., 2017, CARING CRISIS HUMANI, P111
   Kumar S, 2013, INT J PROD ECON, V145, P613, DOI 10.1016/j.ijpe.2013.05.016
   Kuokkanen A, 2017, J CLEAN PROD, V140, P933, DOI 10.1016/j.jclepro.2016.06.171
   Labib A, 2019, PROD OPER MANAG, V28, P2323, DOI 10.1111/poms.13054
   Lacroix V., 2012, ALL PANDEMICS
   Lavissi?re A, 2018, SUPPLY CHAIN FORUM I, V19, P219
   Leidner DE, 2009, J STRATEGIC INF SYST, V18, P80, DOI 10.1016/j.jsis.2009.05.001
   Levine DK, 2012, REV ECON DYNAM, V15, P271, DOI 10.1016/j.red.2012.01.003
   Li HHJK, 2011, INT J PROD RES, V49, P5415, DOI 10.1080/00207543.2011.563897
   Lu Q, 2018, J HUMANIT LOGIST SUP, V8, P70, DOI 10.1108/JHLSCM-07-2017-0033
   Luft H.S., 2008, TOTAL CURE ANTIDOTE
   Manenti F, 2013, AICHE J, V59, P1588, DOI 10.1002/aic.13951
   Maresh-Fuehrer MM, 2016, COMPUT HUM BEHAV, V54, P620, DOI 10.1016/j.chb.2015.08.041
   Mceachern, 2002, MANAGERIAL AUDITING, V17, P79
   McLachlin R, 2011, J HUMANIT LOGIST SUP, V1, P32, DOI 10.1108/20426741111122402
   Meehan J, 2017, J PURCH SUPPLY MANAG, V23, P229, DOI 10.1016/j.pursup.2017.05.003
   Minear L., 2002, HUMANITARIAN ENTERPR
   Mohanty A, 2013, J HUMANIT LOGIST SUP, V3, P52, DOI 10.1108/20426741311328510
   Mutebi H, 2020, J HUMANIT LOGIST SUP, V10, P447, DOI 10.1108/JHLSCM-10-2019-0074
   Natarajarathinam M, 2009, INT J PHYS DISTR LOG, V39, P535, DOI 10.1108/09600030910996251
   Oloruntoba R, 2006, SUPPLY CHAIN MANAG, V11, P115, DOI 10.1108/13598540610652492
   Oloruntoba R, 2019, ANN OPER RES, V283, P543, DOI 10.1007/s10479-016-2378-y
   Onuf N, 2013, MAKING SENSE MAKING, DOI [10.4324/9780203096710, DOI 10.4324/9780203096710]
   Orgad S., 2017, CARING CRISIS HUMANI, P83
   Pach? G., 2010, PROBLEMS PERSPECTIVE, V8, P99
   Patton MQ., 2014, QUALITATIVE RES EVAL
   Prakash C, 2020, J HUMANIT LOGIST SUP, V10, P261, DOI 10.1108/JHLSCM-08-2019-0051
   Reindorp N, 2001, HUMANITARIAN COORDIN
   Richey RG, 2009, INT J PHYS DISTR LOG, V39, P619, DOI 10.1108/09600030910996288
   Rodriguez-Espindola O, 2018, EUR J OPER RES, V264, P978, DOI 10.1016/j.ejor.2017.01.021
   Roehrich J., 2013, J ENTERPRISE TRANSFO, V3, P33, DOI DOI 10.1080/19488289.2013.784223
   Rosenthal U., 2001, MANAGING CRISES THRE
   Rugman A.M., 2005, REGIONAL MULTINATION
   Rugman AM, 2009, INT MARKET REV, V26, P384, DOI 10.1108/02651330910971940
   Salehi F, 2019, ANN OPER RES, V283, P679, DOI 10.1007/s10479-017-2533-0
   Sawyerr E, 2020, SUPPLY CHAIN MANAG, V25, P77, DOI 10.1108/SCM-09-2018-0329
   Shaheen I, 2020, PROD OPER MANAG, V29, P2828, DOI 10.1111/poms.13254
   Sheppard A, 2013, J HUMANIT LOGIST SUP, V3, P22, DOI 10.1108/20426741311328493
   Stephenson M, 2005, DISASTERS, V29, P337, DOI 10.1111/j.0361-3666.2005.00296.x
   Tan WJ, 2006, THUNDERBIRD INT BUS, V48, P515, DOI 10.1002/tie.20107
   Thurer M, 2014, INT J ADV MANUF TECH, V74, P1175, DOI 10.1007/s00170-014-6042-x
   Thurer M, 2013, IND MANAGE DATA SYST, V113, P856, DOI 10.1108/IMDS-01-2013-0049
   van Baalen PJ, 2009, DECIS SUPPORT SYST, V47, P277, DOI 10.1016/j.dss.2009.05.005
   Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383
   Villa S, 2017, J HUMANIT LOGIST SUP, V7, P126, DOI 10.1108/JHLSCM-05-2016-0021
   Wang JW, 2018, COMPUT IND ENG, V125, P668, DOI 10.1016/j.cie.2017.12.021
   Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013
   Yin RK, 2017, CASE STUDY RES APPL
   Yoo E, 2016, J OPER MANAG, V45, P123, DOI 10.1016/j.jom.2016.05.007
   Zhang JH, 2019, ANN OPER RES, V283, P1551, DOI 10.1007/s10479-018-03127-5
NR 97
TC 0
Z9 0
U1 16
U2 21
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2042-6747
EI 2042-6755
J9 J HUMANIT LOGIST SUP
JI J. Humanist. Logist. Supply Chain Manag.
PD JAN 11
PY 2022
VL 12
IS 1
BP 54
EP 77
DI 10.1108/JHLSCM-01-2021-0001
EA JUN 2021
PG 24
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YM3QV
UT WOS:000660340500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Vinciguerra, C
   Federico, A
AF Vinciguerra, Claudia
   Federico, Antonio
TI Neurological music therapy during the COVID-19 outbreak: updates and
   future challenges
SO NEUROLOGICAL SCIENCES
LA English
DT Article; Early Access
DE Music therapy; Music-based interventions; Telemedicine; Rehabilitation;
   COVID-19 outbreak
ID INTERVENTIONS; PEOPLE
AB Background In the last few years, several studies confirmed the effectiveness of music therapy (MT) for the rehabilitative management of patients with neurological disorders.
   Aim Here we discuss the feasibility and disadvantages of tele-neurological MT (tele-NMT) compared to the traditional MT programmes
   Methods We selected all the articles registered in the Web of Knowledge, PubMed, Google Scholar and ScienceDirect from March 2020 to November 2021 concerning tele-NMT during the COVID-19 outbreak, collecting same examples and experiences.
   Results With the advent of the COVID-19, several music-based interventions (MBIs) have been adapted from "in person" to a "remote and virtual" mode (through the telemedicine).
   Discussion Tele-NMT could represent a promising option to provide constant care and support to people with neurological diseases during the pandemic.
C1 [Vinciguerra, Claudia] Univ Hosp San Giovanni Di Dio E Ruggi dAragona, Neurol Unit, EMG Lab, I-84100 Salerno, Italy.
   [Federico, Antonio] Univ Siena, Med Sch, Dept Med Surg & Neurosci, Viale Bracci 2, I-53100 Siena, Italy.
RP Vinciguerra, C (corresponding author), Univ Hosp San Giovanni Di Dio E Ruggi dAragona, Neurol Unit, EMG Lab, I-84100 Salerno, Italy.
EM claudiavinci@hotmail.it
CR Agres KR, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.647790
   Ahessy B., 2021, BR J VIS IMPAIR, V2021
   Ashoori A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00234
   Baker FA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031332
   Bompard S, 2021, J TELEMED TELECARE, DOI 10.1177/1357633X20981213
   Brooke J, 2020, J CLIN NURS, V29, P2044, DOI 10.1111/jocn.15274
   Cole LP, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.648489
   Dowson B, 2021, PUBLIC HEALTH, V194, P196, DOI 10.1016/j.puhe.2021.03.002
   Dowson B, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.625258
   Eze ND, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237585
   Gaddy S, 2020, MUSIC THER PERSPECT, V38, P157, DOI 10.1093/mtp/miaa018
   Garza-Villarreal EA, 2017, PAIN PHYSICIAN, V20, P597
   Gilson A, 2019, J MED INTERNET RES, V21, P1
   Glover KK., 2020, PHENOMENOLOGICAL STU
   Gonzalez-Hoelling S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18042032
   Isernia S, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00846
   Kantorova L, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18105138
   Kim SJ, 2020, ANN NY ACAD SCI, V1473, P11, DOI 10.1111/nyas.14306
   Koenig J, 2013, J PAIN, V14, P1196, DOI 10.1016/j.jpain.2013.05.006
   Laver KE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010255.pub2
   Leubner D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01109
   Leuk JSP, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00243
   Mainka S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00755
   Moumdjian L, 2017, EUR J PHYS REHAB MED, V53, P466, DOI 10.23736/S1973-9087.16.04429-4
   Murgia M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00348
   Nardone V, 2020, COMPLEMENT THER CLIN, V39, DOI 10.1016/j.ctcp.2020.101124
   Ohannessian R, 2020, JMIR PUBLIC HLTH SUR, V6, P121, DOI 10.2196/18810
   Raglio A, 2015, WORLD J PSYCHIATR, V5, P68, DOI 10.5498/wjp.v5.i1.68
   Seebacher BA, 2019, MULT SCLER J, V25, P1593, DOI 10.1177/1352458518795332
   Sihvonen AJ, 2017, LANCET NEUROL, V16, P648, DOI 10.1016/S1474-4422(17)30168-0
   Tamplin J, 2020, J TELEMED TELECARE, V26, P365, DOI 10.1177/1357633X19828463
   Thaut MH, 2019, CLIN REHABIL, V33, P34, DOI 10.1177/0269215518788615
   Vinciguerra C, 2019, NEUROL SCI, V40, P2277, DOI 10.1007/s10072-019-04007-x
   Wang ST, 2018, PSYCHIAT DANUB, V30, P595
NR 34
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
DI 10.1007/s10072-022-05957-5
EA MAR 2022
PG 6
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA ZK3CH
UT WOS:000762869500002
PM 35230597
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Witkowski, K
   Yeo, J
   Belligoni, S
   Ganapati, NE
   Corbin, T
   Rivera, F
AF Witkowski, Kaila
   Yeo, Jungwon
   Belligoni, Sara
   Ganapati, N. Emel
   Corbin, Tanya
   Rivera, Fernando
TI Florida as a COVID-19 Epicenter: Exploring the Role of Institutions in
   the State's Response
SO INTERNATIONAL JOURNAL OF PUBLIC ADMINISTRATION
LA English
DT Article; Early Access
DE Emergency management; pandemic response; Institutional Analysis and
   Development (IAD) framework; COVID-19
ID TRANSBOUNDARY CRISIS; EMERGENCY MANAGEMENT; CHALLENGE; DISASTER; WORLD
AB This case study explores Florida's emergency management response during the COVID-19 pandemic. Utilizing the Institutional Analysis and Development Framework and transboundary crisis literature, this article identifies how state attributes, institutions, multi-sector stakeholders, and their interactions may have influenced the state's response to the pandemic. Findings from the content analyses of government policies, documents, and news reports indicate that some aspects of Florida's response were politically motivated, inflexible, and driven by a small circle of advisors, often ignoring expert opinions and the needs of uniquely vulnerable populations. Furthermore, the findings indicate that public health departments had sidelined locally-controlled emergency management departments. This research offers insight into effective decision-making practices during the response phase of a pandemic and contributes knowledge to the literature in emergency management and public administration focusing on transboundary crises.
C1 [Witkowski, Kaila; Ganapati, N. Emel] Florida Int Univ, Dept Publ Policy & Adm, Miami, FL 33199 USA.
   [Yeo, Jungwon] Univ Cent Florida, Sch Publ Adm, Orlando, FL 32816 USA.
   [Belligoni, Sara] Univ Cent Florida, Dept Polit Secur & Int Affairs, Orlando, FL 32816 USA.
   [Corbin, Tanya] Embry Riddle Aeronaut Univ Worldwide, Dept Secur & Emergency Serv, Daytona Beach, FL USA.
   [Rivera, Fernando] Univ Cent Florida, Dept Sociol, Orlando, FL 32816 USA.
RP Witkowski, K (corresponding author), Florida Int Univ, Modesto A Maidique PCA 257,11200 SW 8th St, Miami, FL 33199 USA.
EM kwill147@FIU.edu
CR Agrawal A, 2001, COMMUNITIES ENV ETHN
   [Anonymous], 2020, ORLANDO SENTINEL 041
   Ansell C., 2010, J CONTING CRISIS MAN, V18, P195, DOI [10.1111/j.1468-5973.2010.00620, DOI 10.1111/J.1468-5973.2010.00620.X]
   Ansell C, 2021, PUBLIC MANAG REV, V23, P949, DOI 10.1080/14719037.2020.1820272
   Askew S., 2020, FLORIDA ENTERS PHASE
   Associated Press, 2020, ASS PRESS
   Atterburry, 2020, POLITICO
   Baker MG, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2025203
   Barry J., 2004, GREAT INFLUENZA EPIC
   Blondin D, 2020, PERSPECT PUBLIC MAN, V3, P197, DOI 10.1093/ppmgov/gvz031
   Boin A, 2019, J CONTING CRISIS MAN, V27, P94, DOI 10.1111/1468-5973.12241
   Boin A, 2016, PUBLIC ADMIN, V94, P289, DOI 10.1111/padm.12264
   Boin A, 2009, REV POLICY RES, V26, P367, DOI 10.1111/j.1541-1338.2009.00389.x
   Boin A, 2008, INT STUD REV, V10, P1, DOI 10.1111/j.1468-2486.2008.00745.x
   Briffaule R, 2018, STANFORD LAW REV, V70, P1995
   Brownstein R., 2020, THE CNN
   Bryce C, 2020, J RISK RES, V23, P880, DOI 10.1080/13669877.2020.1756379
   Calvan, 2020, US NEWS
   Carter D., 2020, ADM THEORY PRAXIS, V42, DOI [10.1080/10841806.2020.1758991, DOI 10.1080/10841806.2020.1758991]
   Ceballos A., 2020, TAMPA BAY TIMES 0930
   Charles J., 2020, THE MIAMI HERALD
   Chavez J.C., 2020, TAMPA BAY TIMES 0417
   Choi, 2004, STATE LOCAL GOVT REV, V36, P216, DOI [https://doi.org/10.1177/0160323X0403600305, DOI 10.1177/0160323X0403600305]
   Christensen T, 2020, PUBLIC ADMIN REV, V80, P774, DOI 10.1111/puar.13241
   Christensen T, 2016, PUBLIC ADMIN REV, V76, P887, DOI 10.1111/puar.12558
   Congleton RD, 2007, PUBLIC CHOICE, V132, P509, DOI 10.1007/s11127-007-9157-x
   Contorno S., 2020, TAMPA BAY TIMES 0402
   Contorno S., 2020, TAMPA BAY TIMES 0404
   Corbin T., 2015, J PUBLIC MANAGEMENT, V22
   Cottle Michelle., 2020, NEW YORK TIMES
   COVID-Local, 2021, COVID LOCAL 0729
   CtU, 2020, CONVERSATION 0716
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Faiola A., 2020, WASH POST
   Fineout, 2020, POLITICO
   Flamini D., 2020, NBC MIAMI 1004
   Flocks J, 2020, J AGROMEDICINE, V25, P367, DOI 10.1080/1059924X.2020.1814922
   Florida Department of Health, 2017, STAT AG ORG OP FLOR
   Florida Department of Health, 2012, 2012 2017 FLOR DEP H
   Florida Statutes, 2018, TITLE 29
   Florida Statutes, 2020, EMERGENCY MANAGEMENT
   Gadarian SK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249596
   Ganapati NE, 2014, NAT HAZARDS REV, V15, P58, DOI 10.1061/(ASCE)NH.1527-6996.0000120
   Gelfert A, 2018, INFORMAL LOG, V38, P84, DOI 10.22329/il.v38i1.5068
   Gillespie R., 2020, ORLANDO SENTINEL
   Girdhar R., 2020, J GERIATR CARE RES, V7, P32
   Grossman G, 2020, P NATL ACAD SCI USA, V117, P24144, DOI 10.1073/pnas.2007835117
   Hatcher W, 2020, AM REV PUBLIC ADM, V50, P614, DOI 10.1177/0275074020941734
   Hu Q, 2016, PUBLIC MANAG REV, V18, P323, DOI 10.1080/14719037.2014.969762
   Johns Hopkins University, 2021, COVID 19 DASHB
   Jordana J, 2020, PUBLIC ADMIN, V98, P515, DOI 10.1111/padm.12652
   Kiser LL, 2000, INST ANALYSIS, P56
   Lagadec P., 2000, J CONTING CRISIS MAN, V8, P185
   Lee S, 2020, POLICY SOC, V39, P363, DOI 10.1080/14494035.2020.1785195
   Lee Seulki, 2020, International Review of Public Administration, V25, P19, DOI 10.1080/12294659.2020.1852715
   Lee S, 2020, AM REV PUBLIC ADM, V50, P729, DOI 10.1177/0275074020942412
   Ling GHT, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041704
   Marra A., 2020, PALM BEACH POST 0807
   Martin MK, 2013, SOC NETW ANAL MIN, V3, P1165, DOI 10.1007/s13278-013-0129-5
   Mazzei P., 2020, NEW YORK TIMES
   McGinnis MD, 2011, POLICY STUD J, V39, P169, DOI 10.1111/j.1541-0072.2010.00401.x
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mergel I, 2021, PUBLIC ADMIN REV, V81, P161, DOI 10.1111/puar.13202
   Moloney K, 2020, PUBLIC ADMIN REV, V80, P671, DOI 10.1111/puar.13224
   Moon MJ, 2020, PUBLIC ADMIN REV, V80, P651, DOI 10.1111/puar.13214
   MUSHKATEL AH, 1985, PUBLIC ADMIN REV, V45, P49, DOI 10.2307/3134997
   Musser E. D., 2021, CHILD ABUSE NEGLECT, DOI [10.1016/j.chiabu.2021.104945, DOI 10.1016/J.CHIABU.2021.104945]
   Mzezewa T., 2020, NEW YORK TIMES
   Na Chongmin, 2020, The Korean Journal of Policy Studies, V35, P95
   Nazaryan, 2020, RON DESANTIS SIDELIN
   Nehamas, 2020, THE MIAMI HERALD
   NPR, 2020, EXT FAM LIV TOG RAIS
   Ostrom E, 2003, RUSSELL SAGE TRUST, V6, P19
   PETAK WJ, 1985, PUBLIC ADMIN REV, V45, P3, DOI 10.2307/3134992
   Recht H, 2020, AP NEWS 0823
   Reiley Laura, 2020, WASH POST
   Reyes MV, 2020, HEALTH HUM RIGHTS, V22, P299
   Rivera FI, 2015, ENVIR HAZARD, P1, DOI 10.1007/978-3-319-16453-3
   Roberts, 2020, WASH POST
   Rocco P, 2020, POLICY SOC, V39, P458, DOI 10.1080/14494035.2020.1783793
   Sauer MA, 2021, HEALTH SECUR, V19, P65, DOI 10.1089/hs.2020.0190
   Selznick P., 1957, LEADERSHIP ADM SOCIO
   Siemaszko C., 2020, NBC NEWS
   Slobodin O, 2020, PSYCHOL TRAUMA-US, V12, P470, DOI 10.1037/tra0000790
   Summers J, 2020, LANCET REG HEALTH-W, V4, DOI 10.1016/j.lanwpc.2020.100044
   Tai DBG, 2021, CLIN INFECT DIS, V72, P703, DOI 10.1093/cid/ciaa815
   Tatar M, 2021, AM J PUBLIC HEALTH, V111, P704, DOI 10.2105/AJPH.2020.306130
   The New York Times, 2020, NEW YORK TIMES
   Trainor, 2018, HDB DISASTER RES
   Treisman R., 2020, FLORIDA SMASHES US S
   U.S. Census Bureau, 2020, QUICK FACTS FLORIDA
   U.S. Census Bureau, AM COMMUNITY SURVEY
   U.S. Census Bureau, 2019, AM COMMUNITY SURVEY
   Wamsley L., 2020, FIRED FLORIDA DATA S
   Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4
   WHO, 2020, COR DIS COVID 19 WEE
   Wootson Jr Cleve R., 2020, WASH POST
   Xiuhtecutli N, 2021, J PEASANT STUD, V48, P73, DOI 10.1080/03066150.2020.1856089
   Yang L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082731
   Yeo J, 2021, NAT HAZARDS REV, V22, DOI 10.1061/(ASCE)NH.1527-6996.0000427
   Yeo J, 2021, TRANSFORM GOV-PEOPLE, V15, P248, DOI 10.1108/TG-05-2020-0088
   Yeo J, 2018, ONLINE INFORM REV, V42, P1010, DOI 10.1108/OIR-09-2016-0280
   Yin R.K., 2011, APPL CASE STUDY RES
NR 103
TC 0
Z9 0
U1 6
U2 6
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0190-0692
EI 1532-4265
J9 INT J PUBLIC ADMIN
JI Int. J. Public Adm.
DI 10.1080/01900692.2021.2001013
EA DEC 2021
PG 15
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA XP6NR
UT WOS:000730980600001
DA 2022-04-20
ER

PT J
AU Xi, HX
   Zhang, CZ
   Zhao, Y
   He, S
AF Xi, Haixu
   Zhang, Chengzhi
   Zhao, Yi
   He, Sheng
TI Public Emotional Diffusion over COVID-19 Related Tweets Posted by Major
   Public Health Agencies in the United States
SO DATA INTELLIGENCE
LA English
DT Article
DE Emotional diffusion; Tweets; COVID-19; Pandemic management; US Public
   Health Agency
ID SOCIAL NETWORKS; PROPAGATION; CONTAGION
AB Since the end of 2019, the COVID-19 outbreak worldwide has not only presented challenges for government agencies in addressing public health emergency, but also tested their capacity in dealing with public opinion on social media and responding to social emergencies. To understand the impact of COVID-19 related tweets posted by the major public health agencies in the United States on public emotion, this paper studied public emotional diffusion in the tweets network, including its process and characteristics, by taking Twitter users of four official public health systems in the United States as an example. We extracted the interactions between tweets in the COVID-19-TweetIds data set and drew the tweets diffusion network. We proposed a method to measure the characteristics of the emotional diffusion network, with which we analyzed the changes of the public emotional intensity and the proportion of emotional polarity, investigated the emotional influence of key nodes and users, and the emotional diffusion of tweets at different tweeting time, tweet topics and the tweet posting agencies. The results show that the emotional polarity of tweets has changed from negative to positive with the improvement of pandemic management measures. The public's emotional polarity on pandemic related topics tends to be negative, and the emotional intensity of management measures such as pandemic medical services turn from positive to negative to the greatest extent, while the emotional intensity of pandemic related knowledge changes the most. The tweets posted by the Centers for Disease Control and Prevention and the Food and Drug Administration of the United States have a broad impact on public emotions, and the emotional spread of tweets' polarity eventually forms a very close proportion of opposite emotions.
C1 [Xi, Haixu; Zhang, Chengzhi; Zhao, Yi] Nanjing Univ Sci & Technol, Sch Econ & Management, Nanjing 210094, Peoples R China.
   [Xi, Haixu; He, Sheng] Jiangsu Univ Technol, Sch Comp Engn, Changzhou 213001, Jiangsu, Peoples R China.
RP Zhang, CZ (corresponding author), Nanjing Univ Sci & Technol, Sch Econ & Management, Nanjing 210094, Peoples R China.
EM zhangcz@njust.edu.cn
FU Humanities and Social Science Research Fund of the Ministry of Education
   in China [18YJC840045]; Jiangsu Social Science Fund [20TQA001]
FX This work is supported by Humanities and Social Science Research Fund of
   the Ministry of Education in China (Grant No. 18YJC840045) and Jiangsu
   Social Science Fund (No. 20TQA001). The authors are grateful to all the
   anonymous reviewers for their precious comments and suggestions.
CR Ahmed W, 2020, J MED INTERNET RES, V22, DOI 10.2196/19458
   Chen Emily, 2020, JMIR Public Health Surveill, V6, pe19273, DOI 10.2196/19273
   Trung DN, 2013, INT CONF COGN INFO, P331, DOI 10.1109/CogInfoCom.2013.6719266
   Everett MG, 1999, J MATH SOCIOL, V23, P181, DOI 10.1080/0022250X.1999.9990219
   Fabiano N., 2020, ANAL COVID 19 ARTICL
   Hutto C., 2014, ICWSM
   Institute of Medicine (US) Committee for the Study of the Future of Public Health, 1988, FUT PUBL HLTH
   Kramer ADI, 2014, P NATL ACAD SCI USA, V111, P8788, DOI 10.1073/pnas.1320040111
   Li LF, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2020.102313
   Miller M., 2011, P 5 INT C WEBL SOC M, P550
   Park HW, 2020, J MED INTERNET RES, V22, DOI 10.2196/18897
   Peters K, 2015, PSYCHOL BULL, V141, P966, DOI 10.1037/bul0000020
   Prastyo P. H., 2020, J INF SYST ENG BUS I, V6, P112, DOI [10.20473/jisebi.6.2.112- 122, DOI 10.20473/JISEBI.6.2.112-122]
   Rao HR, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102187
   Xiong H, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9020113
   Xiong X, 2018, PHYSICA A, V490, P185, DOI 10.1016/j.physa.2017.08.025
   Xu X., 2017, CHINESE J JOURNALISM, V39, P76
   Zafarani R, 2010, LECT NOTES COMPUT SC, V6007, P413, DOI 10.1007/978-3-642-12079-4_52
NR 18
TC 0
Z9 0
U1 2
U2 2
PU MIT PRESS
PI CAMBRIDGE
PA ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA
EI 2641-435X
J9 DATA INTELLIGENCE
JI Data Intell.
PD FEB 3
PY 2022
VL 4
IS 1
BP 66
EP 87
DI 10.1162/dint_a_00101
PG 22
WC Computer Science, Information Systems
WE Emerging Sources Citation Index (ESCI)
SC Computer Science
GA YS3VQ
UT WOS:000750608300004
OA gold
DA 2022-04-20
ER

PT J
AU Ghali-Zinoubi, Z
AF Ghali-Zinoubi, Zohra
TI Local food consumption during the covid-19 pandemic
SO ITALIAN JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE consumer behavior; COVID-19 pandemic; local food; purchase intention;
   Tunisia
ID CONSUMERS; PREFERENCES; ATTITUDES; IMPACT; MATTER
AB The influence of intrinsic quality, health consciousness, environmental awareness, local support, and proximity of process on consumers' intention to consume local food during the COVID-19 pandemic was tested, with food availability as a moderator. Online survey results were analyzed using a two-step structural equation modelling (SEM). Health consciousness was the major reason for consuming local food. Intrinsic quality and proximity of process were also significant drivers. Local support and environmental awareness have little impact on the intention to purchase local food. This study contributes to knowledge regarding the main factors driving local food consumption during a health crisis, providing directions.
C1 [Ghali-Zinoubi, Zohra] Saudi Elect Univ, Coll Adm & Financial Sci, Riyadh, Saudi Arabia.
   [Ghali-Zinoubi, Zohra] Univ Tunis, Higher Inst Management Tunis, Le Bardo, Tunisia.
RP Ghali-Zinoubi, Z (corresponding author), Saudi Elect Univ, Coll Adm & Financial Sci, Riyadh, Saudi Arabia.; Ghali-Zinoubi, Z (corresponding author), Univ Tunis, Higher Inst Management Tunis, Le Bardo, Tunisia.
EM zohragh@yahoo.fr
OI Ghali-Zinoubi, Zohra/0000-0002-7926-9445
CR Aday S, 2020, FOOD QUAL SAF-OXFORD, V4, P167, DOI 10.1093/fqsafe/fyaa024
   Almayed A., 2019, FOOD SECURITY TUNISI
   ANDERSON JC, 1990, J MARKETING, V54, P42, DOI 10.2307/1252172
   Aprile MC, 2016, J FOOD PROD MARK, V22, P19, DOI 10.1080/10454446.2014.949990
   Arsil P., 2018, J BUS RETAIL MANAG R, V13, P184, DOI [10.24052/JBRMR/V13IS02/ART-16, DOI 10.24052/JBRMR/V13IS02/ART-16]
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   Bagozzi RP, 1999, J ECONOMETRICS, V89, P393
   Bazzani C, 2017, ITAL J FOOD SCI, V29, P505, DOI 10.14674/IJFS-733
   Ben Hassen T, 2022, J AGRIBUS DEV EMERG, V12, P281, DOI 10.1108/JADEE-01-2021-0022
   Ben Hassen T, 2021, APPETITE, V165, DOI 10.1016/j.appet.2021.105309
   Ben Hassen T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176973
   Bentsen K, 2021, BRIT FOOD J, V123, P1083, DOI 10.1108/BFJ-03-2020-0173
   Bergadaa M., 2009, REV MANAGEMENT AVENI, V121, P121, DOI [10.3917/mav.021.0121, DOI 10.3917/MAV.021.0121]
   Birch D, 2018, J RETAIL CONSUM SERV, V40, P221, DOI 10.1016/j.jretconser.2017.10.013
   Celimli S, 2021, ITAL J FOOD SCI, V33, P54, DOI 10.15586/ijfs.v33i2.2031
   Chin WW, 1997, INFORM SYST RES, V8, P342, DOI 10.1287/isre.8.4.342
   Cranfield JAL, 2020, CAN J AGR ECON, V68, P151, DOI 10.1111/cjag.12246
   Duda-Chodak A, 2020, TRENDS FOOD SCI TECH, V105, P145, DOI 10.1016/j.tifs.2020.08.020
   Dutta-Bergman MJ, 2004, HEALTH COMMUN, V16, P273, DOI 10.1207/S15327027HC1603_1
   Eger L, 2021, J RETAIL CONSUM SERV, V61, DOI 10.1016/j.jretconser.2021.102542
   Fandos C, 2006, BRIT FOOD J, V108, P646, DOI 10.1108/00070700610682337
   Galanakis CM, 2020, FOODS, V9, DOI 10.3390/foods9040523
   Ghali ZZ, 2020, BRIT FOOD J, V122, P1013, DOI 10.1108/BFJ-06-2019-0414
   Ghali-Zinoubi Z, 2021, PAK J AGR SCI, V58, P779
   Hair JF, 2013, LONG RANGE PLANN, V46, P1, DOI 10.1016/j.lrp.2013.01.001
   Hobbs JE, 2020, CAN J AGR ECON, V68, P171, DOI 10.1111/cjag.12237
   IGD, 2005, LOC REG FOOD OPP, P1
   Janetius S.T., 2020, INT J HLTH SCI RES, V5
   Jribi S, 2020, ENVIRON DEV SUSTAIN, V22, P3939, DOI 10.1007/s10668-020-00740-y
   Kirk CP, 2020, J BUS RES, V117, P124, DOI 10.1016/j.jbusres.2020.05.028
   Kumar A, 2018, INT J RETAIL DISTRIB, V46, P247, DOI 10.1108/IJRDM-08-2017-0161
   Loiseau E, 2020, J CLEAN PROD, V276, DOI 10.1016/j.jclepro.2020.124166
   Lovell A., 2005, INT J LOGIST MANAG, V16, P142, DOI [10.1108/09574090510617394, DOI 10.1108/09574090510617394]
   Mazieres B., 2015, ACT C 18 THILL 2015, P14
   Megicks P, 2012, J MARKET MANAG-UK, V28, P264, DOI 10.1080/0267257X.2012.658838
   Memery J, 2015, EUR J MARKETING, V49, P1207, DOI 10.1108/EJM-02-2014-0075
   Merle A., 2012, DECISIONS MARKETING, P37
   Mesic Z, 2021, ECON RES-EKON ISTRAZ, V34, P221, DOI 10.1080/1331677X.2020.1782243
   Meyerding SGH, 2019, J CLEAN PROD, V207, P30, DOI 10.1016/j.jclepro.2018.09.224
   Moderator Intelligence, 2020, TUNISIA FRUIT VEGETA
   Naja F, 2020, EUR J CLIN NUTR, V74, P1117, DOI 10.1038/s41430-020-0634-3
   Ozturk SB, 2020, INT J GASTRON FOOD S, V20, DOI 10.1016/j.ijgfs.2020.100194
   Pantano E, 2020, J BUS RES, V116, P209, DOI 10.1016/j.jbusres.2020.05.036
   Peterson GR, 2013, J AGR ENVIRON ETHIC, V26, P421, DOI 10.1007/s10806-012-9397-8
   Picha K, 2018, J FOOD PROD MARK, V24, P125, DOI 10.1080/10454446.2016.1266549
   Pressman P., 2020, NUTR TODAY, V55, P125, DOI 10.1097/NT.0000000000000415
   Pu B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165693
   Qi X, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197106
   Rizou M, 2020, TRENDS FOOD SCI TECH, V102, P293, DOI 10.1016/j.tifs.2020.06.008
   Rousseau S, 2020, ENVIRON RESOUR ECON, V76, P1149, DOI 10.1007/s10640-020-00445-w
   Roy H., 2019, Journal of Foodservice Business Research, V22, P261, DOI 10.1080/15378020.2019.1600891
   Salah M., 2021, VALUE IMPORTS EXPORT
   Severo EA, 2021, J CLEAN PROD, V286, DOI 10.1016/j.jclepro.2020.124947
   Sheth J, 2020, J BUS RES, V117, P280, DOI 10.1016/j.jbusres.2020.05.059
   Shveda K, 2020, How Coronavirus Is Changing Grocery Shopping
   Skallerud K, 2019, J RURAL STUD, V67, P79, DOI 10.1016/j.jrurstud.2019.02.020
   Smith MD, 2020, J NUTR, V150, P2855, DOI 10.1093/jn/nxaa270
   Steinhart Y, 2013, MARKET LETT, V24, P217, DOI 10.1007/s11002-013-9227-4
   Todorovic V, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10103481
   Toukabri M, 2020, INT J ECOL DEV, V35, P63
   Verma P., 2020, J FOODSERVICE BUSINE, V23, P285, DOI [10.1080/15378020.2020.1761586, DOI 10.1080/15378020.2020.1761586]
   Xie XR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093148
   Yadav R, 2016, J RETAIL CONSUM SERV, V33, P92, DOI 10.1016/j.jretconser.2016.08.008
   Yuen KF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103513
NR 64
TC 0
Z9 0
U1 5
U2 5
PU CODON PUBLICATIONS
PI BRISBANE
PA LEVEL 9, 167 EAGLE ST, BRISBANE, QLD 4000, AUSTRALIA
SN 1120-1770
EI 2239-5687
J9 ITAL J FOOD SCI
JI Ital. J. Food Sci.
PY 2021
VL 33
IS 4
BP 21
EP 32
DI 10.15586/ijfs.v33i4.2079
PG 12
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA YL0TQ
UT WOS:000745614200003
OA gold
DA 2022-04-20
ER

PT J
AU Das, DBC
   Bhuiyan, SI
   Ullah, ASMW
   Alam, MZ
   Mostofa, GG
   Hasan, KZ
   Sarwar, S
   Chowdhury, RU
   Paul, J
   Haque, AM
   Islam, MS
   Alauddin, M
AF Das, Dr Bimal Chandra
   Bhuiyan, Sahedul Islam
   Ullah, A. S. M. Wali
   Alam, Muhammad Zahangir
   Mostofa, Gazi Golam
   Hasan, Khondaker Zahirul
   Sarwar, Sohel
   Chowdhury, Reaz Uddin
   Paul, Joya
   Haque, Akm Mahbubul
   Islam, Mohammad Shamsal
   Alauddin, Mohammed
TI COMMUNITY PEOPLE PREPAREDNESS AND RESPONSE ON PREVENTION AND CONTROL OF
   COVID-19 BEST PRACTICE IN BANGLADESH
SO ASIA PACIFIC JOURNAL OF HEALTH MANAGEMENT
LA English
DT Article
DE COVID-19; KAP; community mitigation; preparedness; response; Bangladesh
AB PURPOSE:
   The major objectives of the study were to assess the knowledge, attitude & practice (KAP) towards community preparedness and response on prevention of COVID-19 among the community.
   METHOD:
   A sample survey was conducted to collect data from people admitted in a district level tertiary hospital for treatment of various health complications during COVID-19 pandemic. A total of 300 randomly selected patients and their attendants were interviewed in the hospital setting.
   RESULTS:
   The mean knowledge score was 18.73 out of 24 and the main sources of information were TV (86.5%), radio (13%), newspaper (13%), social media (13.5%), friends/relatives (14%), formal healthcare providers (6%) and religious leaders (3%). Knowledge was significantly poor among aged people, women, less educated and those on low incomes. The Majority of participants (79%) suggested wearing facemasks as effective tools to prevent COVID-19 from spreading, 56% mentioned maintaining of physical or social distance as crucial to prevent the infection. We found strong relationship between monthly total family expenses and wearing of facemasks by gender to prevent the COVID-19 (x2= 18.405; Cramer's V= .17, df = 8; sig; P= < .018). Similarly maintaining physical/social distance to prevent COVID-19 is also related to respondents' economic strata (x2= 43.741; Cramer's V= .14, df = 20; Sig; P= < .002).
   CONCLUSIONS:
   An awareness program on COVID-19 is very important to prevent the spread of the virus. Effective communication intervention with increasing treatment facilities is essential for prevention and control of COVID-19. Government and development agencies should prioritize the COVID-19 response program with regular health care services.
C1 [Das, Dr Bimal Chandra; Ullah, A. S. M. Wali; Alam, Muhammad Zahangir; Mostofa, Gazi Golam; Hasan, Khondaker Zahirul; Sarwar, Sohel; Chowdhury, Reaz Uddin] Abdul Malek Ukil Med Coll & Hosp, Chowmuhani, Bangladesh.
   [Bhuiyan, Sahedul Islam] Brahmanbaria Med Coll & Hosp, Brahmanbaria, Bangladesh.
   [Paul, Joya] Upasham Gen Hosp Feni, Mohipal, Bangladesh.
   [Haque, Akm Mahbubul] Konika Consulting Serv Pvt Ltd, Dhaka, Bangladesh.
   [Islam, Mohammad Shamsal] Orbis Int, Dhaka, Bangladesh.
   [Alauddin, Mohammed] Bangladesh Univ Professionals BUP, Dhaka, Bangladesh.
RP Das, DBC (corresponding author), Abdul Malek Ukil Med Coll & Hosp, Chowmuhani, Bangladesh.
EM drbimalcmc28@gmail.com
RI Chowdhury, Reaz Uddin/AAV-7569-2020
OI Chowdhury, Reaz Uddin/0000-0003-2735-627X
CR Abir Tanvir, 2020, FACTORS ASS PERCEPTI, DOI [10.13140/RG.2.2.15130.67526, DOI 10.13140/RG.2.2.15130.67526]
   [Anonymous], 2020, NAT PREP RESP PLAN C
   [Anonymous], 2020, CHIN JOINT MISS COR
   Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154
   Centre for Evidence-Based Medicine, 2020, GLOB COV 19 CAS FAT
   Day M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1165
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Rezvi Minhazur Rahman, 2019, S ASIA J
   Srichan Peeradone, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3546046, DOI 10.2139/SSRN.3546046]
   WHO, 2020, COR DIS COVID 19 WEE
   World Health Organization, 2020, CONT TRAC CONT COVID
   World Health Organization, 2020, SIT REP BANGL 18
   World Health Organization, 2020, NAT PREP RESP PLAN C
   World Health Organization (WHO), MOD TRANSM VIR CAUS
   Zhu HB, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00135-6
NR 15
TC 0
Z9 0
U1 0
U2 1
PU AUSTRALIAN COLL HEALTH SERVICE MANAGEMENT
PI NORTH RYDE
PA PO BOX 341, NORTH RYDE, NSW 1670, AUSTRALIA
SN 1833-3818
J9 ASIA-PAC J HEALTH MA
JI Asia Pac. J. Health Manag.
PY 2021
VL 15
IS 4
BP 98
EP 105
AR 499
DI 10.24083/apjhm.v15i4.499
PG 8
WC Health Policy & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA QR4XQ
UT WOS:000625221300012
OA gold
DA 2022-04-20
ER

PT J
AU Do, B
   Nguyen, N
   D'Souza, C
   Bui, HD
   Nguyen, TNH
AF Do, Binh
   Nguyen, Ninh
   D'Souza, Clare
   Bui, Huu Duc
   Nguyen, Thi Nguyen Hong
TI Strategic responses to COVID-19: The case of tour operators in Vietnam
SO TOURISM AND HOSPITALITY RESEARCH
LA English
DT Article
DE COVID-19; crisis; strategic response; tour operators; tourism; emerging
   market; Vietnam
ID ECONOMIC-CRISIS; IMPACTS; MANAGEMENT; RECOVERY; EXIT; INNOVATION;
   DEMAND; FIRMS; SARS; FLU
AB The COVID-19 outbreak has challenged the global tourism economy. It has particularly threatened the survival of tourism firms in developing countries especially those with the greatest growth of international visitors, such as Vietnam. This study aims to highlight the impact of COVID-19 on tour operators in Vietnam and explore their strategic responses to the crisis. Data were obtained from a recent survey initiated by the National Tourism Advisory Board and 32 in-depth interviews with managers of selected firms. The survey results demonstrate that the key influences of COVID-19 include plummeting revenue, increased costs, and employee redundancy. Furthermore, the majority of tour operators are aware of the need for restructuring and expect financial support from the government to overcome the crisis. The findings from the interviews reveal that tour operators focus more on short and medium-term strategies (i.e., retrenchment, persevering, and exiting) rather than long-term planning (i.e., innovating) in response to COVID-19. This study advances the knowledge and application of response-to-crisis strategies in tourism research, and its findings have practical implications for managers and policymakers in times of exceptional crisis like the COVID-19 pandemic.
C1 [Do, Binh] Thuongmai Univ, Dept Strateg Management, Fac Business Adm, Hanoi, Vietnam.
   [Nguyen, Ninh] Thuongmai Univ, Business Sustainabil Res Grp, Hanoi, Vietnam.
   [Nguyen, Ninh] Charles Darwin Univ, Asia Pacific Coll Business & Law, Casuarina, NT, Australia.
   [D'Souza, Clare] La Trobe Business Sch, Dept Econ Finance & Mkt, Bundoora, Vic, Australia.
   [Bui, Huu Duc] Thuongmai Univ, Fac Business Adm, Hanoi, Vietnam.
   [Nguyen, Thi Nguyen Hong] Thuongmai Univ, Fac Hospitality & Tourism, Hanoi, Vietnam.
RP Nguyen, N (corresponding author), Charles Darwin Univ, Asia Pacific Coll Business & Law, Casuarina, NT, Australia.
EM ninh.nguyen@cdu.edu.au
RI Nguyen, Ninh/R-2900-2019
OI Nguyen, Ninh/0000-0001-6050-2633; Binh, Do/0000-0003-0361-2558
CR Adongo R., 2017, International Journal of Tourism Sciences, V17, P86, DOI 10.1080/15980634.2017.1294344
   Archibugi D, 2013, RES POLICY, V42, P303, DOI 10.1016/j.respol.2012.07.002
   Barker VL, 1997, STRATEGIC MANAGE J, V18, P13, DOI 10.1002/(SICI)1097-0266(199701)18:1<13::AID-SMJ843>3.3.CO;2-O
   Benner MJ., 2015, ACAD MANAGEMENT P, V2015, P12448
   Blake A., 2003, Tourism Economics, V9, P449
   Blake A, 2003, ANN TOURISM RES, V30, P813, DOI 10.1016/S0160-7383(03)00056-2
   Braun V., 2013, SUCCESSFUL QUALITATI
   Bruton GD, 2003, STRATEGIC MANAGE J, V24, P519, DOI 10.1002/smj.312
   Bundy J, 2015, ACAD MANAGE REV, V40, P345, DOI 10.5465/amr.2013.0027
   Burgelman RA, 1996, STRATEGIC MANAGE J, V17, P193
   Campiranon K, 2014, J TRAVEL TOUR MARK, V31, P313, DOI 10.1080/10548408.2013.877414
   Carnahan S, 2017, STRATEGIC MANAGE J, V38, P2189, DOI 10.1002/smj.2653
   Castrogiovanni GJ, 2000, J BUS RES, V48, P25, DOI 10.1016/S0148-2963(98)00072-1
   Chakrabarti A, 2015, STRATEGIC MANAGE J, V36, P1717, DOI 10.1002/smj.2309
   Dai L, 2017, STRATEGIC MANAGE J, V38, P1478, DOI 10.1002/smj.2599
   Danneels E, 2011, STRATEGIC MANAGE J, V32, P1, DOI 10.1002/smj.863
   Truong VD, 2013, J POLICY RES TOUR LE, V5, P28, DOI 10.1080/19407963.2012.760224
   DeDee JK, 1998, J SMALL BUS MANAGE, V36, P46
   Dolnicar S, 2020, ANN TOURISM RES, V83, DOI 10.1016/j.annals.2020.102961
   Gartenberg C, 2017, STRATEGIC MANAGE J, V38, P300, DOI 10.1002/smj.2481
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   GSO, 2020, STAT YB VIETNAM 2019
   GSO, 2020, TRADE PRICE TOURIST
   Gu HM, 2006, TOUR ANAL, V11, P367, DOI 10.3727/108354206781040731
   Hall CM, 2020, TOURISM GEOGR, V22, P577, DOI 10.1080/14616688.2020.1759131
   Huang JH, 2002, TOURISM MANAGE, V23, P145, DOI 10.1016/S0261-5177(01)00051-6
   Hystad PW, 2008, TOURISM MANAGE, V29, P151, DOI 10.1016/j.tourman.2007.02.017
   Ioannides D, 2020, TOURISM GEOGR, V22, P624, DOI 10.1080/14616688.2020.1763445
   Jarratt D, 2021, TOUR HOSP RES, V21, P156, DOI 10.1177/1467358420963370
   Kuo HI, 2008, TOURISM MANAGE, V29, P917, DOI 10.1016/j.tourman.2007.10.006
   Li SL, 2011, STRATEGIC MANAGE J, V32, P1119, DOI 10.1002/smj.918
   Liu-Lastres B, 2020, TOUR HOSP RES, V20, P372, DOI 10.1177/1467358419857779
   Mansfeld Y., 1999, Journal of Travel Research, V38, P30, DOI 10.1177/004728759903800107
   Marcell M.H., 2008, J TRAVEL TOUR MARK, V23, P223, DOI DOI 10.1300/J073V23N02_17
   Martin-Rios C, 2016, J BUS RES, V69, P2890, DOI 10.1016/j.jbusres.2015.12.058
   Mason P, 2010, INT J TOUR RES, V12, P432, DOI 10.1002/jtr.763
   Nhandan, 2020, L CH N I A GHI NH N
   OECD, 2020, TOURISM POLICY RESPO
   Okumus F, 2005, ANN TOURISM RES, V32, P942, DOI 10.1016/j.annals.2005.04.001
   Page S, 2012, J TRAVEL RES, V51, P142, DOI 10.1177/0047287511400754
   PEARCE JA, 1994, STRATEGIC MANAGE J, V15, P407, DOI 10.1002/smj.4250150507
   Ren CR, 2019, STRATEGIC MANAGE J, V40, P253, DOI 10.1002/smj.2970
   Ritchie BW, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102812
   Saldaa, 2020, QUALITATIVE DATA ANA
   Schmitt A, 2016, LONG RANGE PLANN, V49, P361, DOI 10.1016/j.lrp.2015.08.004
   Schoenberg R, 2013, EUR BUS REV, V25, P243, DOI 10.1108/09555341311314799
   Sharpley R., 2001, Current Issues in Tourism, V4, P527, DOI 10.1080/13683500108667901
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Stieglitz N, 2016, STRATEGIC MANAGE J, V37, P1854, DOI 10.1002/smj.2433
   TAB PSD Commitee Grant Thomton VietnamExpress, 2020, IMPACT COVID 19 VIET
   UNCTAD, 2020, COVID 19 TOURISM ASS
   Unrau, 2010, SOCIAL WORK RES EVAL
   UNWTO, 2019, INT TOURISM HIGHLIGH
   Vasileiou K, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0594-7
   Wenzel M, 2021, STRATEGIC MANAGE J, V42, pV7, DOI 10.1002/smj.3161
   World Health Organization, 2020, WHO COR DIS COVID 19
   Yang Y, 2020, ANN TOURISM RES, V83, DOI 10.1016/j.annals.2020.102913
NR 57
TC 5
Z9 5
U1 5
U2 11
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1467-3584
EI 1742-9692
J9 TOUR HOSP RES
JI Tour. Hosp. Res.
PD JAN
PY 2022
VL 22
IS 1
SI SI
BP 5
EP 17
AR 1467358421993902
DI 10.1177/1467358421993902
EA FEB 2021
PG 13
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA YK0UP
UT WOS:000619997100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Asnakew, Z
   Asrese, K
   Andualem, M
AF Asnakew, Zeleke
   Asrese, Kerebih
   Andualem, Mulusew
TI Community Risk Perception and Compliance with Preventive Measures for
   COVID-19 Pandemic in Ethiopia
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; risk perception; media exposure; compliance with prevention
AB Purpose: This study assessed the community's level of risk perception of COVID-19, their compliance with recommended precautionary measures, and factors that influence compliance behavior.
   Methods: This study is a cross-sectional online survey administered using google forms. Data were collected from 521 respondents using various social media channels, including e-mail, Facebook, messenger, telegram, and IMO.
   Results: About 9 in 10 respondents (90.4%) perceived that they are susceptible to COVID-19. Nearly 9 in 10 participants (87.5%) perceived that COVID-19 is a serious disease. The majority of respondents (81%) got information about COVID-19 from television and social networking sites. The regression analyses revealed that compliance with preventive behaviors is differed by respondents' socio-demographic characteristics. Being female (beta: 0.094, P<0.05), higher perceived effectiveness of recommended preventive measures (beta: 0.367, P<0.001), and higher perceived reliability of media (beta: 0.189, P<0.001) facilitated compliance with preventive measures. On the other hand, increasing age (beta: -0.096, P<0.05), being single (beta: -0.127, P<0.01), lower education level (beta: -0.168, P<0.01), and living at a lower administrative level were barriers to be compliant with preventive measures.
   Conclusion: The majority of the respondents exercised one or more of the recommended preventive measures to avoid COVID-19 infection. Most of the respondents got information about COVID-19 from television and social networking sites. Given that about 80% of the Ethiopian population is living in rural areas without television and higher illiteracy rate to use social networking sites, concerned bodies should introduce tailored interventions to impart knowledge about COVID-19 infection and mitigating measures.
   Limitations: Although the sampling procedure was random through the online system, it might not be representative to study the perception and compliance of people towards COVID-19 prevention practices at a country level due to its small size. Thus, the interpretation of the study findings needs to consider this limitation.
C1 [Asnakew, Zeleke] Bahir Dar Univ, Dept Management, Bahir Dar, Ethiopia.
   [Asrese, Kerebih] Bahir Dar Univ, Dept Social Work, Bahir Dar, Ethiopia.
   [Andualem, Mulusew] Bahir Dar Univ, Sch Publ Hlth, Bahir Dar, Ethiopia.
RP Asnakew, Z (corresponding author), Bahir Dar Univ, Dept Management, Bahir Dar, Ethiopia.
EM Sirayez2013@gmail.com
RI Asnakew, Zeleke Siraye/ABG-5904-2020
OI Asnakew, Zeleke Siraye/0000-0002-1868-1145
CR Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3
   Atchison CJ, 2020, PERCEPTIONS BEHAV RE
   Austrian K, 2020, LANCET, DOI [10.2139/ssrn.35767854., DOI 10.2139/SSRN.35767854]
   Baye K, 2020, INT FOOD POLICY RES, V141
   Cvetkovic VM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114124
   de bruin Wandi bruine, 2020, J GERONTOLOGY B
   He SK, 2022, J INVEST SURG, V35, P157, DOI 10.1080/08941939.2020.1824247
   Hernandez-Garcia I, 2020, JMIR PUBLIC HLTH SUR, V6, P110, DOI 10.2196/18717
   Honarvar B, 2020, INT J PUBLIC HEALTH, P1
   Honarvar B, 2020, INT J PUBLIC HEALTH, V65, P731, DOI 10.1007/s00038-020-01406-2
   Jayasinghe R, 2020, PATIENT EDUC COUNS, V103, P2594, DOI 10.1016/j.pec.2020.08.001
   Karasneh R, 2020, RES SOC ADMIN PHARM, DOI [10.1016/j.sapharm.2020.04.02713, DOI 10.1016/J.SAPHARM.2020.04.02713]
   Karijo E, 2020, BMC PUBLIC HLTH
   Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744
   Kwok KO, 2020, COMMUNITY RESPONSES
   Li SY, 2020, J MED INTERNET RES, V22, DOI 10.2196/19782
   Mya Kyaw S, 2020, AWARENESS PERCEIVED
   Rogers R. W., 1997, PROTECTION MOTIVATIO
   (WHO) WHO, ROLL UPD COR DIS COV
NR 19
TC 11
Z9 11
U1 8
U2 11
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2020
VL 13
BP 2887
EP 2897
DI 10.2147/RMHP.S279907
PG 11
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA PC9MV
UT WOS:000597322400001
PM 33335434
OA Green Published
DA 2022-04-20
ER

PT J
AU Khaled, A
   Siddiqua, A
   Makki, S
AF Khaled, Arwa
   Siddiqua, Ayesha
   Makki, Soha
TI The Knowledge and Attitude of the Community from the Aseer Region, Saudi
   Arabia, Toward COVID-19 and Their Precautionary Measures Against the
   Disease
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE knowledge; attitude; precautionary measures; coronavirus
AB Background: Community adherence to current control measures is one of the vital factors that determines the success of controlling the spread of COVID-19. This adherence depends on the knowledge and attitude of a community toward COVID-19 and their precautionary measures against the disease.
   Objective: This study aims to evaluate the knowledge and attitude of the community from the Aseer Region, Saudi Arabia, toward COVID-19 and their precautionary measures against the disease.
   Methods: The descriptive cross-sectional study involved an online sample of participants from the Aseer Region, Saudi Arabia, who were recruited based on a nonprobability convenience sampling method from April to May 2020. The self-administered online questionnaire comprised four parts: the first included the demographic details of the participants; the second consisted of 11 closed-ended questions that assessed the participants' knowledge of COVID-19; the third contained six closed-ended questions that assessed the participants' overall attitude toward COVID-19; and the fourth comprised six closed-ended questions on the participants' precautionary measures against COVID-19. The data were analyzed using Statistisoftware SPSS 21.0.
   Results: Altogether, 740 participants completed the online questionnaire. The mean knowledge score concerning COVID-19 was 8.08 +/- 1.765. Graduate participants scored significantly higher for all knowledge items than those from other educational levels. Furthermore, the main source of COVID-19 information was the Ministry of Health website 661 (89.3%). The mean attitude score regarding COVID-19 was 9.74 +/- 1.935, whereas the mean precautionary measures score was 10.09 +/- 1.91. University-educated participants scored significantly higher for all knowledge items than those from other educational levels. Female participants had significantly higher precautionary measures scores than male participants.
   Conclusion: This study confirms that residents of the Aseer Region have high knowledge of, demonstrate a positive attitude toward, and use appropriate precautionary measures against COVID-19, which is associated with obtaining information about the virus from the Ministry of Health website.
C1 [Khaled, Arwa; Siddiqua, Ayesha; Makki, Soha] King Khalid Univ, Coll Pharm, Dept Clin Pharm, Abha, Saudi Arabia.
   [Khaled, Arwa] Beni Suef Univ, Beni Suef Univ Hosp, Dept Clin Pharm, Bani Suwayf 62515, Egypt.
RP Khaled, A (corresponding author), Beni Suef Univ, Beni Suef Univ Hosp, Dept Clin Pharm, Bani Suwayf 62515, Egypt.
EM dr_arwakhaled@yahoo.com
OI Khaled, Arwa/0000-0002-0064-7870; Makki, Soha/0000-0002-0097-6404;
   siddiqua, Ayesha/0000-0001-9882-7695
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736
   Althobaity HM, 2017, INT J HEALTH SCI-IJH, V11, P20
   [Anonymous], 2020, RECOMMENDATION REGAR
   [Anonymous], 2020, CORONAVIRUS DIS COVI
   Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485
   Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003
   Bener A, 2004, J R SOC PROMO HEALTH, V124, P167, DOI 10.1177/146642400412400408
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chirwa GC, 2019, MALAWI MED J, V31, P104, DOI 10.4314/mmj.v31i2.1
   Ebrahim SH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa029
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Huynh G, 2020, J TROPICAL MED, V13, P260, DOI DOI 10.4103/1995-7645.280396
   Ministry of Health, 2018, STAT YB 1439H
   Nahida A., 2007, THESIS
   Rahman A, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8223
   The World Health Organization, 2020, 2019 NCOV OUTBR IS E
   WHO, 2020, COR DIS COVID 2019 S
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   World Health Organization, 2020, COR DIS COVID 2019 S
   Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012
   Zheng Z, 2020, KNOWLEDGE ATTITUDE P
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
   ZHOU P, 2020, DISCOVERY NOVEL CORO
NR 25
TC 5
Z9 5
U1 1
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2020
VL 13
BP 1825
EP 1834
DI 10.2147/RMHP.S271899
PG 10
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA NW2LU
UT WOS:000574842200001
PM 33061715
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Alam, S
   Kamal, TB
   Sarker, MMR
   Zhou, JR
   Rahman, SMA
   Mohamed, IN
AF Alam, Safaet
   Kamal, Taslima Binte
   Sarker, Md. Moklesur Rahman
   Zhou, Jin-Rong
   Rahman, S. M. Abdur
   Mohamed, Isa Naina
TI Therapeutic Effectiveness and Safety of Repurposing Drugs for the
   Treatment of COVID-19: Position Standing in 2021
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Review
DE COVID-19; repurposing drugs; favipiravir; remdesivir; doxycycline;
   hydroxychloroquine; ivermectin; rivaroxaban
ID RNA-POLYMERASE INHIBITOR; TO-MODERATE COVID-19; FACTOR XA INHIBITOR;
   SARS CORONAVIRUS; SPIKE PROTEIN; OPEN-LABEL; OLD DRUG; CHLOROQUINE;
   HYDROXYCHLOROQUINE; FAVIPIRAVIR
AB COVID-19, transmitted by SARS-CoV-2, is one of the most serious pandemic situations in the history of mankind, and has already infected a huge population across the globe. This horrendously contagious viral outbreak was first identified in China and within a very short time it affected the world's health, transport, economic, and academic sectors. Despite the recent approval of a few anti-COVID-19 vaccines, their unavailability and insufficiency along with the lack of other potential therapeutic options are continuing to worsen the situation, with valuable lives continuing to be lost. In this situation, researchers across the globe are focusing on repurposing prospective drugs and prophylaxis such as favipiravir, remdesivir, chloroquine, hydroxychloroquine, ivermectin, lopinavir-ritonavir, azithromycin, doxycycline, ACEIs/ARBs, rivaroxaban, and protease inhibitors, which were preliminarily based on in vitro and in vivo pharmacological and toxicological study reports followed by clinical applications. Based on available preliminary data derived from limited clinical trials, the US National Institute of Health (NIH) and USFDA also recommended a few drugs to be repurposed i.e., hydroxychloroquine, remdesivir, and favipiravir. However, World Health Organization later recommended against the use of chloroquine, hydroxychloroquine, remdesivir, and lopinavir/ritonavir in the treatment of COVID-19 infections. Combining basic knowledge of viral pathogenesis and pharmacodynamics of drug molecules as well as in silico approaches, many drug candidates have been investigated in clinical trials, some of which have been proven to be partially effective against COVID-19, and many of the other drugs are currently under extensive screening. The repurposing of prospective drug candidates from different stages of evaluation can be a handy wellspring in COVID-19 management and treatment along with approved anti-COVID-19 vaccines. This review article combined the information from completed clinical trials, case series, cohort studies, meta-analyses, and retrospective studies to focus on the current status of repurposing drugs in 2021.
C1 [Alam, Safaet; Kamal, Taslima Binte; Sarker, Md. Moklesur Rahman] State Univ Bangladesh, Dept Pharm, Dhaka, Bangladesh.
   [Sarker, Md. Moklesur Rahman] Hlth Med Sci Res Ltd, Pharmacol & Toxicol Res Div, Dhaka, Bangladesh.
   [Zhou, Jin-Rong] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Nutr Metab Lab, Boston, MA 02115 USA.
   [Rahman, S. M. Abdur] Univ Dhaka, Fac Pharm, Dept Clin Pharm & Pharmacol, Dhaka, Bangladesh.
   [Mohamed, Isa Naina] Univ Kebangsaan Malaysia, Fac Med, Pharmacol Dept, Kuala Lumpur, Malaysia.
RP Sarker, MMR (corresponding author), Hlth Med Sci Res Ltd, Pharmacol & Toxicol Res Div, Dhaka, Bangladesh.; Mohamed, IN (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Pharmacol Dept, Kuala Lumpur, Malaysia.
EM moklesur2002@yahoo.com; isanaina@ppukm.ukm.edu.my
RI Sarker, Moklesur Rahman/G-2396-2014; Alam, Safaet/AAV-1816-2020; Sarker,
   Prof. Dr. Md. Moklesur Rahman/G-2396-2014
OI Sarker, Moklesur Rahman/0000-0002-0787-0944; Alam,
   Safaet/0000-0002-1831-2278; Sarker, Prof. Dr. Md. Moklesur
   Rahman/0000-0001-9795-0608
CR Abdalla Z.A., 2021, EUR J BIOMED, V8, P13, DOI [10.17605/OSF.IO/SVPHJ, DOI 10.17605/OSF.IO/SVPHJ]
   Abdullah M, 2021, CUREUS, V13, DOI 10.7759/cureus.12757
   Ahmed S, 2021, INT J INFECT DIS, V103, P214, DOI 10.1016/j.ijid.2020.11.191
   Al-Abdouh A, 2021, CONTEMP CLIN TRIALS, V101, DOI 10.1016/j.cct.2021.106272
   Al-Horani RA, 2020, AM J CARDIOVASC DRUG, V20, P525, DOI 10.1007/s40256-020-00438-6
   Al-Monitor news, 2020, ALMONITOR NEWS
   Alam MM, 2020, CUREUS, V12, DOI 10.7759/cureus.9658
   Alborghetti L., 2020, IL 6 SIGNALLING PATH, DOI 10.1101/2020.04.01.20048561
   [Anonymous], 2020, RIVAROXABAN
   [Anonymous], 2020, DOXYCYCLINE CLINICAL
   [Anonymous], 2020, CHLOROQUINE
   [Anonymous], 2020, REMDESIVIR CLINICALT
   [Anonymous], 2020, WHO CORONAVIRUS DIS
   [Anonymous], 2020, ACEIS ARB
   [Anonymous], 2020, LOPINAVIR RITONAVIR
   [Anonymous], 2020, FAVIPIRAVIR CLIN TRI
   Arshad S, 2020, INT J INFECT DIS, V97, P396, DOI 10.1016/j.ijid.2020.06.099
   Asif, 2020, INT J SCI, V9, P31, DOI [DOI 10.18483/IJSCI.2378, 10.18483/ijSci.2378]
   Babalola OE, 2021, QJM-INT J MED, V114, P780, DOI 10.1093/qjmed/hcab035
   BALLOW CH, 1992, ANN PHARMACOTHER, V26, P1253, DOI 10.1177/106002809202601014
   Banerjee I., 2020, J BIOMED SCI, V7, P40, DOI [DOI 10.3126/JBS.V7I1.29852, 10.3126/jbs.v7i1.29852]
   Batista P.B., 2020, EMPIRICAL TREATMENT, P25
   Batlle, 2020, KIDNEY LUNG ACE2 EXP, DOI [10.1101/2020.05.20.106658, DOI 10.1101/2020.05.20.106658]
   Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106
   Boras Britton, 2021, bioRxiv, DOI 10.1101/2020.09.12.293498
   Borba MG, 2020, CHLOROQUINE DIPHOSPH, DOI [10.1101/2020.04.07.20056424, DOI 10.1101/2020.04.07.20056424]
   Bounameaux H, 2014, DRUGS, V74, P1209, DOI 10.1007/s40265-014-0261-1
   Brojakowska A, 2020, J AM COLL CARDIOL, V75, P3085, DOI 10.1016/j.jacc.2020.04.028
   Bull-Otterson L, 2020, MMWR-MORBID MORTAL W, V69, P1210, DOI 10.15585/mmwr.mm6935a4
   Butler CC, 2021, LANCET, V397, P1063, DOI 10.1016/S0140-6736(21)00461-X
   Byon W, 2019, CLIN PHARMACOKINET, V58, P1265, DOI 10.1007/s40262-019-00775-z
   Cai QX, 2020, ENGINEERING-PRC, V6, P1192, DOI 10.1016/j.eng.2020.03.007
   Caly L, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104787
   Caly L, 2012, ANTIVIR RES, V95, P202, DOI 10.1016/j.antiviral.2012.06.008
   Campbell WC, 2012, CURR PHARM BIOTECHNO, V13, P853
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Capell WH, 2021, AM HEART J, V235, P12, DOI 10.1016/j.ahj.2021.02.001
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chandwani Ashish, 2008, Ther Clin Risk Manag, V4, P1023
   COLSON P, 2020, INT J ANTIMICROB AG, V55, DOI [10.1016/j.ijantimicag.2020.105932, DOI 10.1016/J.IJANTIMICAG.2020.105932]
   Cordova A, 2003, BIOPHYS J, V85, P70, DOI 10.1016/S0006-3495(03)74455-5
   CUBERO GI, 1993, BRIT HEART J, V69, P451
   Dabbous HM, 2021, ARCH VIROL, V166, P949, DOI 10.1007/s00705-021-04956-9
   Damle B, 2020, CLIN PHARMACOL THER, V108, P201, DOI 10.1002/cpt.1857
   Davies M, 2020, DRUG SAFETY, V43, P645, DOI 10.1007/s40264-020-00952-1
   Delang L, 2018, ANTIVIR RES, V153, P85, DOI 10.1016/j.antiviral.2018.03.003
   Du LY, 2007, BIOCHEM BIOPH RES CO, V359, P174, DOI 10.1016/j.bbrc.2007.05.092
   Eastman RT, 2020, ACS CENTRAL SCI, V6, P672, DOI 10.1021/acscentsci.0c00489
   Echeverria-Esnal D, 2021, EXPERT REV ANTI-INFE, V19, P147, DOI 10.1080/14787210.2020.1813024
   Elgazzar A., 2020, RES SQUARE, DOI [10.21203/rs.3.rs-100956/v3, DOI 10.21203/RS.3.RS-100956/V2, 10.21203/ rs.3.rs-100956/v2]
   Farouk A, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109768
   Ferner RE, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1432
   Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4
   FRISKHOLMBERG M, 1983, BRIT J CLIN PHARMACO, V15, P502, DOI 10.1111/j.1365-2125.1983.tb01540.x
   Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Garcuia-LleduE A., 2021, HOSPITAL CONTINUATIO, DOI [10.1101/2021.02.01.21250853, DOI 10.1101/2021.02.01.21250853]
   Garland SG, 2018, ANN PHARMACOTHER, V52, P554, DOI 10.1177/1060028018754383
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Gendrot M, 2020, MOLECULES, V25, DOI 10.3390/molecules25215064
   Giudicessi JR, 2020, MAYO CLIN PROC, V95, P1213, DOI 10.1016/j.mayocp.2020.03.024
   Goldberg E, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.02.029
   Good SS, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.02479-20
   Guo JY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016219
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Harrison C, 2020, NAT BIOTECHNOL, V38, P379, DOI 10.1038/d41587-020-00003-1
   Hashim HA., 2020, MEDRXIV, DOI [10.1101/2020.10.26.20219345, DOI 10.1101/2020.10.26.20219345]
   Heidary F, 2020, J ANTIBIOT, V73, P593, DOI 10.1038/s41429-020-0336-z
   Hippisley-Cox J, 2020, HEART, V106, P1503, DOI [10.1136/heartjnl-2020-317393, 10.1136/heartjnl-2020-318312]
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hossain MJ, 2021, EXPERT REV ANTI-INFE, V19, P1009, DOI 10.1080/14787210.2021.1864327
   Hossen Md Shafiul, 2020, SN Compr Clin Med, V2, P1777, DOI 10.1007/s42399-020-00485-9
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Ishaqui AA, 2020, EXPERT REV RESP MED, V14, P533, DOI 10.1080/17476348.2020.1730180
   Ison MG, 2021, EBIOMEDICINE, V63, DOI 10.1016/j.ebiom.2020.103204
   Jans DA, 2019, CURR OPIN CELL BIOL, V58, P50, DOI 10.1016/j.ceb.2019.01.001
   Javadi, 2020, IVERMECTIN ADJUNCT T, DOI [10.21203/rs.3.rs-109670/v1, DOI 10.21203/RS.3.RS-109670/V1]
   Joo EJ, 2021, J KOREAN MED SCI, V36, DOI 10.3346/jkms.2021.36.e83
   Joshi N, 1997, ARCH INTERN MED, V157, P1421, DOI 10.1001/archinte.157.13.1421
   Juurlink DN, 2020, CAN MED ASSOC J, V192, pE450, DOI 10.1503/cmaj.200528
   Kaka AS, 2021, ANN INTERN MED, V174, P663, DOI 10.7326/M20-8148
   Kashour Z, 2021, J ANTIMICROB CHEMOTH, V76, P30, DOI 10.1093/jac/dkaa403
   Keyaerts E, 2009, ANTIMICROB AGENTS CH, V53, P3416, DOI 10.1128/AAC.01509-08
   Khambholja K, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101710
   Khan, 2021, MORTALITY SEVERITY C
   Khan Z., 2021, Le Pharmacien Hospitalier & Clinicien, V56, P3, DOI 10.1016/j.phclin.2020.06.003
   Kim Jason, 2020, J Transl Med, V18, P257, DOI 10.1186/s12967-020-02430-9
   Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379
   Lepage MA, 2021, CLIN TOXICOL, V59, P644, DOI 10.1080/15563650.2020.1842882
   Li XC, 2017, PHARMACOL RES, V125, P21, DOI 10.1016/j.phrs.2017.06.005
   Lim J, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e79
   Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0
   Liu XL, 2021, J MED VIROL, V93, P854, DOI 10.1002/jmv.26315
   Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8
   Lora-Tamayo J, 2021, J INFECTION, V82, P293, DOI 10.1016/j.jinf.2021.02.011
   Luo P, 2021, CLIN MED, V21, pE80, DOI 10.7861/clinmed.2020-0348
   Machiels JD, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106056
   Maione A, 2011, NEPHROL DIAL TRANSPL, V26, P2827, DOI 10.1093/ndt/gfq792
   Malabade, 2021, EFFICACY SAFETY REMD, DOI [10.21203/rs.3.rs-366384/v1, DOI 10.21203/RS.3.RS-366384/V1]
   Malek AE, 2020, IDCASES, V21, DOI 10.1016/j.idcr.2020.e00864
   McCurry J., 2020, GUARDIAN
   McLaughlin E.C., FEARING CORONAVIRUS
   Medisetty MK, 2021, INT J INFECT DIS, V105, P722, DOI 10.1016/j.ijid.2021.02.035
   Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621
   Meini S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072050
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Mothay Dipti, 2020, VirusDisease, V31, DOI 10.1007/s13337-020-00585-z
   Mueck W, 2008, CLIN PHARMACOKINET, V47, P203, DOI 10.2165/00003088-200847030-00006
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE019, DOI [10.3760/cma.j.issn.1001-0939.2020.03.009, 10.3760/cma.j.issn.1001-0939.2020.0019]
   Narendrakumar L, 2021, EXPERT REV ANTI-INFE, V19, P1001, DOI 10.1080/14787210.2021.1865803
   Ohtsu, 2021, EFFICACY REMDESIVIR, DOI [10.1101/2021.03.09.21253183, DOI 10.1101/2021.03.09.21253183]
   Onweni CL, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03195-9
   Owlia, 2021, EFFICACY DOXYCYCLINE, DOI [10.21203/rs.3.rs-141875/v3, DOI 10.21203/RS.3.RS-141875/V3]
   Paton NI, 2011, LANCET INFECT DIS, V11, P677, DOI 10.1016/S1473-3099(11)70065-2
   Perico L, 2020, NEPHRON, V144, P213, DOI 10.1159/000507305
   Perzborn E, 2011, NAT REV DRUG DISCOV, V10, P61, DOI 10.1038/nrd3185
   Podder CS., 2020, IMC J MED SCI, V14, P002, DOI DOI 10.3329/IMCJMS.V14I2.52826
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Prosser T., 2020, COVID 19 DRUG THERAP
   Reilly J, 2020, HOSP PRACT, V48, P119, DOI 10.1080/21548331.2020.1754618
   Ridwan R., 2020, REMDESIVIR COVID 19, DOI [10.22541/au.158999392.29347277, DOI 10.22541/AU.158999392.29347277]
   Rizzo E, 2020, N-S ARCH PHARMACOL, V393, P1153, DOI 10.1007/s00210-020-01902-5
   Rodruiguez O.I.S., 2021, JACCOA, V13, P12, DOI [10.15406/jaccoa.2021.13.00463, DOI 10.15406/JACCOA.2021.13.00463]
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Rynes RI, 1997, BRIT J RHEUMATOL, V36, P799
   Saha A, 2020, ARCH MED RES, V51, P585, DOI 10.1016/j.arcmed.2020.05.001
   Saqrane S, 2021, J INFECT PUBLIC HEAL, V14, P655, DOI 10.1016/j.jiph.2021.02.006
   Sargiacomo C, 2020, AGING-US, V12, P6511, DOI 10.18632/aging.103001
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117
   Yehualashet AS, 2020, INFECT DRUG RESIST, V13, P3217, DOI 10.2147/IDR.S264882
   Shippey EA, 2018, CLEV CLIN J MED, V85, P459, DOI 10.3949/ccjm.85a.17034
   Sigrist CJA, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104759
   Singh TU, 2020, PHARMACOL REP, V72, P1479, DOI 10.1007/s43440-020-00155-6
   Sodhi Mohit, 2020, Pharmacotherapy, V40, P487, DOI 10.1002/phar.2395
   Spyropoulos AC, 2020, LANCET, V395, pE75, DOI 10.1016/S0140-6736(20)30926-0
   Szolnoky G, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13810
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849
   Tian C, 2021, WORLD J CLIN CASES, V9, P47, DOI 10.12998/wjcc.v9.i1.47
   Touret F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70143-6
   Touret F, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104762
   Udwadia ZF, 2021, INT J INFECT DIS, V103, P62, DOI 10.1016/j.ijid.2020.11.142
   Vijayvargiya P, 2020, MAYO CLIN PROC, V95, P1454, DOI 10.1016/j.mayocp.2020.04.027
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Wahl A, 2021, NATURE, V591, P451, DOI 10.1038/s41586-021-03312-w
   Wang FH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22677
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   World Health Organization (WHO), 2020, WHO REC US REMD COVI
   Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8
   Wu PE, 2021, CAN MED ASSOC J, V193, pE125, DOI 10.1503/cmaj.202505
   Wu Renyi, 2020, Curr Pharmacol Rep, V6, P56, DOI 10.1007/s40495-020-00216-7
   Yagmuroglu, 2021, BENEFITS TREATMENT F, DOI [10.21203/rs.3.rs-175340/v1, DOI 10.21203/RS.3.RS-175340/V1]
   Yan D., 2020, EFFICACY HYDROXYCHLO, DOI 10.1101/2020.03.22.20040758
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhang GY, 2021, J MED VIROL, V93, P2287, DOI 10.1002/jmv.26695
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   ZHOU P, 2020, NATURE          0203, pNIL1, DOI DOI 10.1038/s41586-020-2012-7
   Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011
   Zhou YC, 2011, ANTIVIR RES, V92, P187, DOI 10.1016/j.antiviral.2011.07.016
NR 164
TC 8
Z9 8
U1 8
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JUN 14
PY 2021
VL 12
AR 659577
DI 10.3389/fphar.2021.659577
PG 19
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA TB9BQ
UT WOS:000668240000001
PM 34220503
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Marinaki, S
   Tsiakas, S
   Skalioti, C
   Lourida, P
   Argyraki, A
   Grigorakos, K
   Boletis, I
AF Marinaki, Smaragdi
   Tsiakas, Stathis
   Skalioti, Chrysanthi
   Lourida, Panayiota
   Argyraki, Aikaterini
   Grigorakos, Konstantinos
   Boletis, Ioannis
TI A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who
   Survived COVID-19 Disease: Case Presentation and Current Data of
   COVID-19 Infection in Dialysis and Transplanted Patients in Greece
SO MEDICINA-LITHUANIA
LA English
DT Article
DE COVID-19; pneumonia; glomerulonephritis; immunosuppression;
   transplantation; Renal Replacement Therapy (RRT)
AB The evolving pandemic of Coronavirus Disease 2019 has posed a substantial health risk worldwide. However, there is a paucity of data regarding the clinical course and the therapeutic management of patients with chronic kidney disease and COVID-19 infection. To date, most evidence has come from renal transplantation, with about 45 patients reported thus far, and the current data from the ERA-EDTA (ERACODA) registry for transplanted patients and patients on Renal Replacement Therapy (RRT); as for those with glomerular diseases, data are lacking. Herein, we report the case of a 62-year-old patient with severe membranoproliferative glomerulonephritis who had been receiving a high burden of immunosuppression until four months before the COVID-19 infection. He developed severe disease with acute respiratory failure requiring mechanical ventilation. After treatment with hydroxychloroquine and azithromycin, despite his low chances, he gradually recovered and survived. To the best of our knowledge, this is one of the few reported patients with glomerulonephritis who had COVID-19 Besides our single case with glomerulonephritis early during the disease outbreak, the very low prevalence of COVID-19 infection in the country's transplant recipients (0.038%) and dialysis patients (0.24%) reflects the impact of the rapid implementation of social distancing rules as well as of preventive measures for disease control in the hospitals and dialysis units in our country.
C1 [Marinaki, Smaragdi; Tsiakas, Stathis; Skalioti, Chrysanthi; Boletis, Ioannis] Natl & Kapodistrian Univ Athens, Laiko Hosp, Med Sch, Clin Nephrol & Renal Transplantat, Athens 11527, Greece.
   [Lourida, Panayiota; Argyraki, Aikaterini] Sotiria Chest Dis Hosp, Infect Dis Clin A, Athens 11527, Greece.
   [Grigorakos, Konstantinos] 12 Protopappa Ave, Athens 16345, Greece.
RP Skalioti, C (corresponding author), Natl & Kapodistrian Univ Athens, Laiko Hosp, Med Sch, Clin Nephrol & Renal Transplantat, Athens 11527, Greece.
EM smaragdimarinaki@yahoo.com; stathis.tsiakas@gmail.com;
   c_skalioti@yahoo.com; giotalourida@gmail.com; katrin.argyraki@gmail.com;
   gk_pediatr@yahoo.gr; laikneph@laiko.gr
CR Alberici F, 2020, KIDNEY INT REP, V5, P580, DOI 10.1016/j.ekir.2020.04.001
   Banerjee D, 2020, KIDNEY INT, V97, P1076, DOI 10.1016/j.kint.2020.03.018
   Bomback AS, 2020, CLIN J AM SOC NEPHRO, V15, P876, DOI 10.2215/CJN.04530420
   Greek Ministry of Health, 2020, NAT REG PAT ENG STAG
   Guillen E, 2020, AM J TRANSPLANT, V20, P1875, DOI 10.1111/ajt.15874
   Johnson KM, 2020, PHARMACOTHERAPY, V40, P517, DOI 10.1002/phar.2410
   Juni P, 2020, CAN MED ASSOC J, V192, pE566, DOI 10.1503/cmaj.200920
   Nacif LS, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1983
   NPHO, CURR STAT COVID 19 O
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   Sun PF, 2020, J MED VIROL, V92, P548, DOI 10.1002/jmv.25722
   Thiel J, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1306-0
   Xu JB, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020244
   Zhu L, 2020, EUR UROL, V77, P748, DOI 10.1016/j.eururo.2020.03.039
NR 14
TC 3
Z9 3
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1010-660X
EI 1648-9144
J9 MEDICINA-LITHUANIA
JI Med. Lith.
PD JUL
PY 2020
VL 56
IS 7
AR 355
DI 10.3390/medicina56070355
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA MS2UL
UT WOS:000554137800001
PM 32708858
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Battisti, NML
   Mislang, AR
   Cooper, L
   O'Donovan, A
   Audisio, RA
   Cheung, KL
   Sarrio, RG
   Stauder, R
   Soto-Perez-de-Celis, E
   Jaklitsch, M
   Williams, GR
   O'Hanlon, S
   Alam, M
   Cairo, C
   Colloca, G
   Gil, LA
   Sattar, S
   Kantilal, K
   Russo, C
   Lichtman, SM
   Brain, E
   Kanesvaran, R
   Wildiers, H
AF Luca Battisti, Nicolo Matteo
   Mislang, Anna Rachelle
   Cooper, Lisa
   O'Donovan, Anita
   Audisio, Riccardo A.
   Cheung, Kwok-Leung
   Girones Sarrio, Regina
   Stauder, Reinhard
   Soto-Perez-de-Celis, Enrique
   Jaklitsch, Michael
   Williams, Grant R.
   O'Hanlon, Shane
   Alam, Mahmood
   Cairo, Clarito
   Colloca, Giuseppe
   Gil Jr, Luiz Antonio
   Sattar, Schroder
   Kantilal, Kumud
   Russo, Chiara
   Lichtman, Stuart M.
   Brain, Etienne
   Kanesvaran, Ravindran
   Wildiers, Hans
TI Adapting care for older cancer patients during the COVID-19 pandemic:
   Recommendations from the International Society of Geriatric Oncology
   (SIOG) COVID-19 Working Group
SO JOURNAL OF GERIATRIC ONCOLOGY
LA English
DT Review
DE Geriatric oncology; Older patients; COVID-19; SARS-CoV-2; Competing
   risks; Recommendations
ID CELL LUNG-CANCER; BREAST-CANCER; ADJUVANT CHEMOTHERAPY;
   ELDERLY-PATIENTS; NON-INFERIORITY; RADICAL PROSTATECTOMY; ANDROGEN
   DEPRIVATION; RADIATION-THERAPY; RANDOMIZED-TRIAL; FOLLOW-UP
AB The COVID-19 pandemic poses a barrier to equal and evidence-based management of cancer in older adults. The International Society of Geriatric Oncology (SIOG) formed a panel of experts to develop consensus recommendations on the implications of the pandemic on several aspects of cancer care in this age group including geriatric assessment (GA), surgery, radiotherapy, systemic treatment, palliative care and research.
   Age and cancer diagnosis are significant predictors of adverse outcomes of the COVID-19 infection. In this setting, GA is particularly valuable to drive decision-making. GA may aid estimating physiologic reserve and adaptive capability, assessing risk-benefits of either providing or temporarily withholding treatments, and determining patient preferences to help inform treatment decisions. In a resource-constrained setting, geriatric screening tools may be administered remotely to identify patients requiring comprehensive GA. Tele-health is also crucial to ensure adequate continuity of care and minimize the risk of infection exposure.
   In general, therapeutic decisions should favor the most effective and least invasive approach with the lowest risk of adverse outcomes. In selected cases, this might require deferring or omitting surgery, radiotherapy or systemic treatments especially where benefits are marginal and alternative safe therapeutic options are available. Ongoing research is necessary to expand knowledge of the management of cancer in older adults. However, the pandemic presents a significant barrier and efforts should be made to ensure equitable access to clinical trials and prospective data collection to elucidate the outcomes of COVID-19 in this population. (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Luca Battisti, Nicolo Matteo] Royal Marsden NHS Fdn Trust, Inst Canc Res, Dept Med Dept, Breast Canc Res Div,Breast Unit, London, England.
   [Mislang, Anna Rachelle] Flinders Ctr Innovat Canc, Dept Med Oncol, Bedford Pk, SA, Australia.
   [Cooper, Lisa] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02115 USA.
   [O'Donovan, Anita] Trinity Coll Dublin, Discipline Radiat Therapy, Dublin, Ireland.
   [Audisio, Riccardo A.] Univ Gothenburg, Sahlgrenska Acad, Dept Surg, Gothenburg, Sweden.
   [Cheung, Kwok-Leung] Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Derby, England.
   [Girones Sarrio, Regina] Hosp Univ & Politecn La FE, Dept Med Oncol, Valencia, Spain.
   [Stauder, Reinhard] Innsbruck Med Univ, Dept Internal Med 5, Haematol & Oncol, Innsbruck, Austria.
   [Soto-Perez-de-Celis, Enrique] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Geriatr, Mexico City, DF, Mexico.
   [Jaklitsch, Michael] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Williams, Grant R.] Univ Alabama Birmingham, Sch Med, Inst Canc Outcomes & Survivorship, Birmingham, AL USA.
   [O'Hanlon, Shane] Univ Coll Dublin, St Vincents Univ Hosp, Dublin, Ireland.
   [Alam, Mahmood] Pfizer Oncol, Sydney, NSW, Australia.
   [Cairo, Clarito] Dept Hlth, Natl Integrated Canc Control Program, Manila, Philippines.
   [Colloca, Giuseppe] Policlin A Gemelli, Rome, Italy.
   [Gil Jr, Luiz Antonio] Univ Sao Paulo, Geriatr Div, Sao Paulo, Brazil.
   [Sattar, Schroder] Univ Saskatchewan, Coll Nursing, Regina, SK, Canada.
   [Kantilal, Kumud] Univ East Anglia, Sch Pharm, Norwich, Norfolk, England.
   [Russo, Chiara] Claude Bernard Lyon 1 Univ, Ctr Leon Berard, Reg Comprehens Canc Ctr, Dept Med Oncol, Lyon, France.
   [Lichtman, Stuart M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.
   [Brain, Etienne] Inst Curie St Cloud, Dept Med Oncol, Paris, France.
   [Kanesvaran, Ravindran] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore.
   [Wildiers, Hans] Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium.
RP Battisti, NML (corresponding author), Royal Marsden NHS Fdn Trust, Inst Canc Res, Dept Med Dept, Breast Canc Res Div,Breast Unit, London, England.
EM nicolo.battisti@rmh.nhs.uk; Anna.Mislang@sa.gov.au;
   lcooper5@bwh.harvard.edu; Anita.ODonovan@tcd.ie;
   raudisio@doctors.org.uk; kl.cheung@nottingham.ac.uk;
   reinhard.stauder@i-med.ac.at; enrique.sotop@incmnsz.mx;
   mjaklitsch@bwh.harvard.edu; grwilliams@uabmc.edu; shaneohanlon@svhg.ie;
   Mahmood.Alam2@pfizer.com; schroder.sattar@usask.ca;
   k.kantilal@uea.ac.uk; Chiara.RUSSO@lyon.unicancer.fr;
   LichtmaS@mskcc.org; Etienne.brain@curie.fr;
   ravindran.kanesvaran@singhealth.com.sg; hans.wildiers@uzleuven.be
RI wildiers, hans/AAV-8158-2021; LICHTMAN, STUART/AAM-8106-2021; O'Hanlon,
   Shane/I-5990-2019; colloca, giuseppe/B-7908-2019; Williams, Grant
   R./N-2168-2019
OI LICHTMAN, STUART/0000-0003-4146-6192; O'Hanlon,
   Shane/0000-0002-9270-2768; colloca, giuseppe/0000-0001-6763-0793;
   Williams, Grant R./0000-0003-4294-5232; Kantilal,
   Kumud/0000-0002-8517-4637; Kanesvaran, Ravindran/0000-0002-2351-881X;
   Gil Junior, Luiz Antonio/0000-0002-2027-5170; Cheung,
   Kwok-Leung/0000-0003-2973-0755; Sattar, Schroder/0000-0001-8700-1804;
   Audisio, Riccardo A./0000-0002-7538-4809
FU Cridlan Ross Smith Charitable Trust; NIHR Biomedical Research Centre at
   The Royal Marsden NHS Foundation Trust; Institute of Cancer Research,
   London, UK; NCI Cancer Center Support GrantUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) [P30CA008748]
FX Dr. Battisti would like to acknowledge the support of the Cridlan Ross
   Smith Charitable Trust and the NIHR Biomedical Research Centre at The
   Royal Marsden NHS Foundation Trust and the Institute of Cancer Research,
   London, UK. Dr. Lichtman is supported by the NCI Cancer Center Support
   Grant (P30CA008748).
CR [Anonymous], 2020, GUID MAN CLIN TRIALS
   [Anonymous], 2020, POLICY BRIEF IMPACT
   [Anonymous], 2008, 2 MILLION REASONS CA
   [Anonymous], 2020, CDC GUIDANCE HLTH CA
   [Anonymous], 2020, COVID 19 RAP GUID CR
   Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X
   Balducci L, 2020, J GERIATR ONCOL, V11, P750, DOI 10.1016/j.jgo.2020.03.016
   Bellelli G, 2020, INTENS CARE MED, V46, P1634, DOI 10.1007/s00134-020-06087-2
   Bluethmann SM, 2016, CANCER EPIDEM BIOMAR, V25, P1029, DOI 10.1158/1055-9965.EPI-16-0133
   Bos ACRK, 2015, EUR J CANCER, V51, P2553, DOI 10.1016/j.ejca.2015.08.016
   Brunt AM, 2020, LANCET, V395, P1613, DOI 10.1016/S0140-6736(20)30932-6
   Burdett S, 2020, COCHRANE DB SYST REV, V2015
   Calton B, 2020, J PAIN SYMPTOM MANAG, V60, pE12, DOI 10.1016/j.jpainsymman.2020.03.019
   Chakrabarti J, 2011, CRIT REV ONCOL HEMAT, V78, P260, DOI 10.1016/j.critrevonc.2010.04.006
   Chang JY, 2015, LANCET ONCOL, V16, P630, DOI 10.1016/S1470-2045(15)70168-3
   Chong EW, 2020, J AM GERIATR SOC, V68, pE30, DOI 10.1111/jgs.16528
   Chow R, 2019, RADIOTHER ONCOL, V141, P56, DOI 10.1016/j.radonc.2019.06.037
   Cohen HJ, 2016, CANCER-AM CANCER SOC, V122, P3865, DOI 10.1002/cncr.30269
   Corre R, 2016, J CLIN ONCOL, V34, P1476, DOI 10.1200/JCO.2015.63.5839
   COVID19 Subcomm O R Executive Comm, 2020, ANN SURG ONCOL, V27, P1713, DOI 10.1245/s10434-020-08462-1
   COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X
   Crivellari D, 2000, J CLIN ONCOL, V18, P1412, DOI 10.1200/JCO.2000.18.7.1412
   Crook J, 2009, INT J RADIAT ONCOL, V73, P327, DOI 10.1016/j.ijrobp.2008.04.075
   Davis JN, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0417-5
   de Paula BHR, 2020, LANCET ONCOL, V21, P624, DOI 10.1016/S1470-2045(20)30226-6
   Dearnaley D, 2016, LANCET ONCOL, V17, P1047, DOI 10.1016/S1470-2045(16)30102-4
   Decoster L, 2015, ANN ONCOL, V26, P288, DOI 10.1093/annonc/mdu210
   Dees EC, 2000, CANCER INVEST, V18, P521, DOI 10.3109/07357900009012191
   DiGiovanni G, 2020, J GERIATR ONCOL, V11, P761, DOI 10.1016/j.jgo.2020.04.007
   DuMontier C, 2020, J CLIN ONCOL, V38, P2558, DOI 10.1200/JCO.19.02809
   Esposito E, 2018, ECANCERMEDICALSCIENC, V12, DOI 10.3332/ecancer.2018.793
   Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646
   FDA, 2020, GUID COND CLIN TRIAL
   Fleming TR, 2020, JAMA-J AM MED ASSOC, V324, P33, DOI 10.1001/jama.2020.9286
   Fratino L, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00648
   Garassino MC, 2020, LANCET ONCOL, V21, P914, DOI 10.1016/S1470-2045(20)30314-4
   Ghadjar P, 2018, STRAHLENTHER ONKOL, V194, P619, DOI 10.1007/s00066-018-1269-3
   Giordano SH, 2006, J CLIN ONCOL, V24, P2750, DOI 10.1200/JCO.2005.02.3028
   Goede V, 2019, J GERIATR ONCOL, V10, P497, DOI 10.1016/j.jgo.2018.09.003
   Gomez H, 1998, J CLIN ONCOL, V16, P2352, DOI 10.1200/JCO.1998.16.7.2352
   Grimmer M, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-018-0458-8
   Grothey A, 2018, NEW ENGL J MED, V378, P1177, DOI 10.1056/NEJMoa1713709
   Guerard EJ, 2017, J NATL COMPR CANC NE, V15, P894, DOI 10.6004/jnccn.2017.0122
   Hall PS, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.4006
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Hind D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004272.pub2
   Hofheinz RD, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70116-X
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Hoskin PJ, 2019, JAMA-J AM MED ASSOC, V322, P2084, DOI 10.1001/jama.2019.17913
   Hughes KS, 2013, J CLIN ONCOL, V31, P2382, DOI 10.1200/JCO.2012.45.2615
   Hurria A, 2016, J CLIN ONCOL, V34, P2366, DOI 10.1200/JCO.2015.65.4327
   Hurria A, 2011, J CLIN ONCOL, V29, P3457, DOI 10.1200/JCO.2011.34.7625
   Johnston SJ, 2012, ANN ONCOL, V23, P2296, DOI 10.1093/annonc/mdr630
   Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9
   Kupstas AR, 2019, ANN SURG ONCOL, V26, P3240, DOI 10.1245/s10434-019-07566-7
   Lee LYW, 2020, LANCET, V395, P1919, DOI 10.1016/S0140-6736(20)31173-9
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
   Mansfield SA, 2017, BREAST J, V23, P444, DOI 10.1111/tbj.12758
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Marijnen CAM, 2020, RADIOTHER ONCOL, V148, P213, DOI 10.1016/j.radonc.2020.03.039
   Matuschek C, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0796-x
   Mohile S, 2020, J GERIATR ONCOL, V11, P753, DOI 10.1016/j.jgo.2020.04.010
   Mohile SG, 2018, J CLIN ONCOL, V36, P2326, DOI 10.1200/JCO.2018.78.8687
   Moug S, 2020, GERIATRICS-BASEL, V5, DOI 10.3390/geriatrics5020030
   Mulvenna P, 2016, LANCET, V388, P2004, DOI 10.1016/S0140-6736(16)30825-X
   Nagar H, 2020, NAT REV CLIN ONCOL, V17, P332, DOI 10.1038/s41571-020-0375-1
   Neal DE, 2020, EUR UROL, V77, P320, DOI 10.1016/j.eururo.2019.10.030
   Nekhlyudov L, 2020, J CANCER SURVIV, V14, P601, DOI 10.1007/s11764-020-00884-w
   Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, ZHONGHUA LIU XING BI, V41, P145, DOI DOI 10.3760/CMA.J.ISSN.0254-6450.2020.02.003
   O'Hanlon S, 2020, AGE AGEING, V49, P497, DOI 10.1093/ageing/afaa094
   Olivotto IA, 2009, J CLIN ONCOL, V27, P16, DOI 10.1200/JCO.2008.18.1891
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38
   Petretto DR, 2020, GERIATRICS-BASEL, V5, DOI 10.3390/geriatrics5020025
   Powell IJ, 2002, J UROLOGY, V168, P2016, DOI 10.1016/S0022-5347(05)64285-1
   Richardson Safiya, 2020, JAMA, V323, P2052, DOI 10.1001/jama.2020.6775
   Russell B, 2020, ECANCERMEDICALSCIENC, V14, DOI 10.3332/ecancer.2020.1023
   Sanita ISD, 2020, CHARACTERISTICS SARS
   Scher KS, 2012, J CLIN ONCOL, V30, P2036, DOI 10.1200/JCO.2012.41.6727
   Schild SE, 2003, J CLIN ONCOL, V21, P3201, DOI 10.1200/JCO.2003.12.019
   Schneider BJ, 2018, J CLIN ONCOL, V36, P710, DOI 10.1200/JCO.2017.74.9671
   Scolieri MJ, 2000, J UROLOGY, V164, P1465, DOI 10.1016/S0022-5347(05)67008-5
   Silver JK, 2020, AM J PHYS MED REHAB, V99, P459, DOI 10.1097/PHM.0000000000001452
   Simcock R, 2020, CLIN TRANSL RAD ONCO, V22, P55, DOI 10.1016/j.ctro.2020.03.009
   Spring LM, 2016, JAMA ONCOL, V2, P1477, DOI 10.1001/jamaoncol.2016.1897
   Sud A, 2020, Ann Oncol, V31, P1065, DOI 10.1016/j.annonc.2020.05.009
   Toolkit, 2020, TOOLKIT PROVIDING ON
   Tsang Yat, 2020, Tech Innov Patient Support Radiat Oncol, V15, P6, DOI 10.1016/j.tipsro.2020.05.003
   Ueda M, 2020, J NATL COMPR CANC NE, V18, P366, DOI 10.6004/jnccn.2020.7560
   Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Von Lilienfeld-Toal M, 2020, LEUKEMIA, V34, P1487, DOI 10.1038/s41375-020-0832-y
   Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000
   Waterhouse DM, 2008, JCO ONCOL PRACT
   Williams CP, 2020, CANCER-AM CANCER SOC, V126, P3534, DOI 10.1002/cncr.32961
   Yahalom J, 2020, BLOOD, V135, P1829, DOI 10.1182/blood.2020006028
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 98
TC 28
Z9 28
U1 8
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1879-4068
EI 1879-4076
J9 J GERIATR ONCOL
JI J. Geriatr. Oncol.
PD NOV
PY 2020
VL 11
IS 8
BP 1190
EP 1198
DI 10.1016/j.jgo.2020.07.008
PG 9
WC Oncology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Geriatrics & Gerontology
GA OI5WI
UT WOS:000583348000002
PM 32709495
OA Green Published, Bronze, Green Accepted
DA 2022-04-20
ER

PT J
AU Harapan, H
   Itoh, N
   Yufika, A
   Winardi, W
   Keam, S
   Te, H
   Megawati, D
   Hayati, Z
   Wagner, AL
   Mudatsir, M
AF Harapan, Harapan
   Itoh, Naoya
   Yufika, Amanda
   Winardi, Wira
   Keam, Synat
   Te, Haypheng
   Megawati, Dewi
   Hayati, Zinatul
   Wagner, Abram L.
   Mudatsir, Mudatsir
TI Coronavirus disease 2019 (COVID-19): A literature review
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Review
DE 2019-nCoV; COVID-19; Outbreak; SARS-CoV-2; Novel coronavirus
ID RESPIRATORY SYNDROME CORONAVIRUS; TRANSMISSION DYNAMICS; FUNCTIONAL
   RECEPTOR; SARS CORONAVIRUS; HEALTH; WUHAN; PNEUMONIA; OUTBREAK
AB In early December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan City, Hubei Province, China. On January 30, 2020 the World Health Organization declared the outbreak as a Public Health Emergency of International Concern. As of February 14, 2020, 49,053 laboratory-confirmed and 1,381 deaths have been reported globally. Perceived risk of acquiring disease has led many governments to institute a variety of control measures. We conducted a literature review of publicly available information to summarize knowledge about the pathogen and the current epidemic. In this literature review, the causative agent, pathogenesis and immune responses, epidemiology, diagnosis, treatment and management of the disease, control and preventions strategies are all reviewed. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
C1 [Harapan, Harapan; Hayati, Zinatul; Mudatsir, Mudatsir] Univ Syiah Kuala, Sch Med, Med Res Unit, Darussalam 23111, Banda Aceh, Indonesia.
   [Harapan, Harapan; Hayati, Zinatul; Mudatsir, Mudatsir] Univ Syiah Kuala, Sch Med, Trop Dis Ctr, Banda Aceh, Indonesia.
   [Harapan, Harapan; Hayati, Zinatul; Mudatsir, Mudatsir] Univ Syiah Kuala, Sch Med, Dept Microbiol, Banda Aceh, Indonesia.
   [Itoh, Naoya] AichiCanc Ctr Hosp, Div Infect Dis, Chikusa Ku, Nagoya, Aichi, Japan.
   [Yufika, Amanda] Univ Syiah Kuala, Sch Med, Dept Family Med, Banda Aceh, Indonesia.
   [Winardi, Wira] Univ Syiah Kuala, Sch Med, Dept Pulmonol & Resp Med, Banda Aceh, Indonesia.
   [Keam, Synat] Univ Western Australia, Sch Med, Perth, WA, Australia.
   [Te, Haypheng] Minist Hlth, Siem Reap Prov Hlth Dept, Siem Reap, Cambodia.
   [Megawati, Dewi] Warmadewa Univ, Fac Med & Hlth Sci, Dept Microbiol & Parasitol, Denpasar, Indonesia.
   [Megawati, Dewi] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.
   [Hayati, Zinatul] Univ Syiah Kuala, Sch Med, Dept Clin Microbiol, Banda Aceh, Indonesia.
   [Wagner, Abram L.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.
RP Harapan, H (corresponding author), Univ Syiah Kuala, Sch Med, Med Res Unit, Darussalam 23111, Banda Aceh, Indonesia.
EM harapan@unsyiah.ac.id; itohnaoya0925@ybb.ne.jp; amandayufika@gmail.com;
   wira.winardi@unsyiah.ac.id; synat.keam@research.uwa.edu.au;
   hayphengte@gmail.com; amegawati@ucdavis.edu; hayatikarmil@unsyiah.ac.id;
   awag@umich.edu; mudatsir@unsyiah.ac.id
RI Harapan, Harapan/I-8741-2016; Itoh, Naoya/AAQ-3286-2020; Wagner,
   Abram/X-6379-2019; Mudatsir, Mudatsir/Q-4999-2017; Mudatsir,
   Mudatsir/AAC-1633-2021
OI Harapan, Harapan/0000-0001-7630-8413; Itoh, Naoya/0000-0001-6269-7884;
   Wagner, Abram/0000-0003-4691-7802; Mudatsir,
   Mudatsir/0000-0002-5643-9384; Mudatsir, Mudatsir/0000-0002-5643-9384;
   Yufika, Amanda/0000-0001-8408-9396; Winardi, Wira/0000-0002-0880-7445
CR Alagaili Abdulaziz N, 2014, mBio, V5, pe00884, DOI 10.1128/mBio.00884-14
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2020, NHS PRESS C
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bauch CT, 2013, LANCET, V382, P662, DOI 10.1016/S0140-6736(13)61504-4
   Brennan G, PLOS PATHOG
   Burki TK, 2020, LANCET RESP MED, V8, P238, DOI 10.1016/S2213-2600(20)30056-4
   Centers for Disease Control and Prevention. National Notifiable Disease Surveillance System, 2020, COR DIS 2019 COVID 1
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chang D, 2020, JAMA-J AM MED ASSOC, V323, P1092, DOI 10.1001/jama.2020.1623
   Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Chen N, 2020, LANCET
   China CDC, 2020, EP UPD RISK ASS 2019
   Chu DKW, 2020, CLIN CHEM, V66, P549, DOI 10.1093/clinchem/hvaa029
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   de Wit E, 2020, P NATL ACAD SCI USA, V3
   DeBolt C, 2020, NEW ENGL J MED, V382, P929, DOI DOI 10.1056/NEJM0A2001191
   Gidengil CA, 2012, AM J PUBLIC HEALTH, V102, P672, DOI 10.2105/AJPH.2011.300407
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Habibzadeh P, 2020, INT J OCCUP ENV MED, V11, P65, DOI 10.15171/ijoem.2020.1921
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130
   Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167
   Kupferschmidt K, 2020, SCIENCE
   Lei J, 2020, RADIOLOGY, DOI [10.1148/radiol.2020200236, DOI 10.1148/RADIOL.2020200236]
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liu WY, 2020, NEW ENGL J MED, V382, P1370, DOI 10.1056/NEJMc2003717
   Liu X, 2020, POTENTIAL INHIBITORS
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951
   Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m641
   Murphy, 2016, FENNER WHITES MED VI
   Paraskevis D, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104212
   Patel A, 2020, MMWR-MORBID MORTAL W, V69, P140, DOI 10.15585/mmwr.mm6905e1
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Randhawa GS, 2020, BIORXIV
   Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Shen KL, 2020, WORLD J PEDIATR, V16, P219, DOI 10.1007/s12519-020-00344-6
   Smits SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000756
   Sookaromdee P, 2020, ASIAN PAC J TROP MED, V13, P139, DOI 10.4103/1995-7645.277516
   Tang JJ, 2020, SURG INFECT, V21, P895, DOI 10.1089/sur.2020.042
   Totura AL, 2012, CURR OPIN VIROL
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang M, 2020, CELL RES
   Wang ZW, 2020, BIOSCI TRENDS, V14, P64, DOI 10.5582/bst.2020.01030
   WHO, 2020, WHO COR DIS 2019 COV
   Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x
   World Health Organization, 2020, GLOB SURV HUM INF NO
   Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373
   Yu WB, DECODING EVOLUTION T
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   ZHOU P, 2020, DISCOVERY NOVEL CORO
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 70
TC 494
Z9 514
U1 20
U2 59
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD MAY
PY 2020
VL 13
IS 5
BP 667
EP 673
DI 10.1016/j.jiph.2020.03.019
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA LK5GQ
UT WOS:000530894700001
PM 32340833
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Mi, BB
   Xiong, Y
   Lin, Z
   Panayi, AC
   Chen, L
   Liu, GH
AF Mi, Bobin
   Xiong, Yuan
   Lin, Ze
   Panayi, Adriana C.
   Chen, Lang
   Liu, Guohui
TI COVID-19 Orthopaedic Safe Care Toolset Guidelines for the Diagnosis and
   Management of Patients with Fracture and COVID-19
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Editorial Material
ID CORONAVIRUS; WUHAN; PNEUMONIA
AB The SARS-CoV-2 (severe acute respiratory syndrome-coronavirus 2) was reported in Wuhan, Hubei Province, People's Republic of China, and, subsequently, in other provinces and regions across the People's Republic of China and >212 countries. COVID-19, the disease caused by this coronavirus, was declared a worldwide pandemic by the World Health Organization (WHO). The incidence of patients with fracture who are also positive for COVID-19 is on the rise. The diagnosis and management of such patients can be complicated as their clinical characteristics are heterogeneous. Furthermore, a surgical procedure can be particularly challenging given that the use of high-speed devices results in aerosol generation. In this study, we develop and propose globally applicable guidelines to fill this knowledge gap and we identify and propose the necessary protective strategies for medical personnel in an orthopaedic emergency department and in the inpatient wards. We also introduce diagnostic criteria, surgical complication management, and follow-up strategies for infected patients. These guidelines may be helpful to decrease the infection rate of orthopaedic trauma personnel and to provide diagnosis and treatment therapy for patients with fracture and COVID-19.
C1 [Mi, Bobin; Xiong, Yuan; Lin, Ze; Panayi, Adriana C.; Chen, Lang; Liu, Guohui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China.
   [Mi, Bobin; Xiong, Yuan; Lin, Ze; Chen, Lang; Liu, Guohui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan, Peoples R China.
   [Panayi, Adriana C.] Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02115 USA.
RP Chen, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China.; Chen, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan, Peoples R China.
EM langchen199508@163.com; liuguohui@hust.edu.cn
RI Xiong, Yuan/AAQ-3642-2021; Panayi, Adriana C./AAF-1817-2020
OI Panayi, Adriana C./0000-0003-4053-9855; Xiong, Yuan/0000-0003-1090-9288
FU National Science Foundation of ChinaNational Natural Science Foundation
   of China (NSFC) [81772345]; National Key Research & Development Program
   of China [2018YFC2001502, 2018YFB1105705]; National Health Commission of
   the People's Republic of China [ZX-01-018, ZX-01C2016153]; Health
   Commission of Hubei Province [WJ2019Z009]
FX This work was supported by the National Science Foundation of China (no.
   81772345), National Key Research & Development Program of China (no.
   2018YFC2001502 and 2018YFB1105705), National Health Commission of the
   People's Republic of China (no. ZX-01-018 and ZX-01C2016153), and the
   Health Commission of Hubei Province (no. WJ2019Z009).
CR Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Chen LJ, 2020, EMERG MICROBES INFEC, V9, P313, DOI 10.1080/22221751.2020.1725399
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chow A, 2012, AM J INFECT CONTROL, V40, P800, DOI 10.1016/j.ajic.2011.10.005
   Harrod M, 2019, CLIN INFECT DIS, V69, pS185, DOI 10.1093/cid/ciz527
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Punia Sangini, 2014, Int Sch Res Notices, V2014, P685072, DOI 10.1155/2014/685072
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   West K H, 1997, J INTRAVEN NURS, V20, P7
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
NR 13
TC 2
Z9 2
U1 1
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0021-9355
EI 1535-1386
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PD JUL 1
PY 2020
VL 102
IS 13
BP 1116
EP 1122
DI 10.2106/JBJS.20.00532
PG 7
WC Orthopedics; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Orthopedics; Surgery
GA MU1EI
UT WOS:000555412100014
PM 32618909
OA Green Published, Bronze
DA 2022-04-20
ER

PT C
AU Guo, YH
   Li, P
   Meng, H
AF Guo, Yanhong
   Li, Ping
   Meng, Hui
BE Sun, Y
   Thomas, P
   Bie, R
   Cheng, X
TI The Impact of COVID-19 on Chinese Systemic Risk Based on Dynamic
   Tail-risk Network Model
SO 2020 INTERNATIONAL CONFERENCE ON IDENTIFICATION, INFORMATION AND
   KNOWLEDGE IN THE INTERNET OF THINGS (IIKI2020)
SE Procedia Computer Science
LA English
DT Proceedings Paper
CT International Conference on Identification, Information and Knowledge in
   the Internet of Things (IIKI)
CY NOV 27-29, 2020
CL Zhuhai, PEOPLES R CHINA
DE COVID-19; Syetemic risk; FARM-Selection; Dynamic tail-risk network
AB This paper investigates the impact of COVID-19 pandemic on Chinese systemic risk using a dynamic network model. We select 104 listed financial institutions to construct a dynamic tail-risk network during the epidemic. The tail-risk network is estimated by the Factor-Adjusted Regularized Model (FARM) selection approach. To analyze the impact of COVID-19 pandemic on systemic risk, we identify the role of financial institutions in the dynamic tail-risk network. Results show that COVID-19 pandemic increases the number of risk-drivers and decreases the number of risk-takers, meaning that it enhances systemic financial risk in China. Our evidence provides an effective method to regulate systemic risk in the financial market and is helpful to offer rescue policies once systemic risk events occur. (c) 2021 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0) Peer-review under responsibility of the scientific committee of the International Conference on Identification, Information and Knowledge in the internet of Things, 2020.
C1 [Guo, Yanhong; Li, Ping] Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China.
   [Li, Ping] Beihang Univ, Minist Educ, Key Lab Complex Syst Anal Management & Decis, Beijing 100191, Peoples R China.
   [Meng, Hui] China Export & Credit Insurance Corp, Beijing 100033, Peoples R China.
RP Li, P (corresponding author), Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China.; Li, P (corresponding author), Beihang Univ, Minist Educ, Key Lab Complex Syst Anal Management & Decis, Beijing 100191, Peoples R China.
EM liping124@buaa.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [71571008, 72033001]; Open Fund of Hubei
   Cultural Industry Economy Research Center [HBCIR2018Z001]
FX This research is supported by the National Natural Science Foundation of
   China (No. 71571008 and No.72033001) and Open Fund of Hubei Cultural
   Industry Economy Research Center (HBCIR2018Z001).
CR Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109
   Betz F, 2016, J FINANC STABIL, V25, P206, DOI 10.1016/j.jfs.2015.10.006
   Cifuentes R, 2005, J EUR ECON ASSOC, V3, P556, DOI 10.1162/jeea.2005.3.2-3.556
   Detering N., 2017, MANAGING DEFAULT CON
   Diebold FX, 2014, J ECONOMETRICS, V182, P119, DOI 10.1016/j.jeconom.2014.04.012
   Fan JQ, 2020, J ECONOMETRICS, V216, P71, DOI 10.1016/j.jeconom.2020.01.006
   Glasserman P, 2015, J BANK FINANC, V50, P383, DOI 10.1016/j.jbankfin.2014.02.006
   Greenwood R, 2015, J FINANC ECON, V115, P471, DOI 10.1016/j.jfineco.2014.11.006
   Guerrieri V., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts)
   Li P., 2020, INT REV FINANC ANAL
   Staum J. C., 2016, SYSTEMIC RISK COMPON
   Sun Y., 2020, FINANC RES LETT
   Zhang DY, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101528
NR 13
TC 0
Z9 0
U1 4
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-0509
J9 PROCEDIA COMPUT SCI
PY 2021
VL 187
BP 164
EP 169
DI 10.1016/j.procs.2021.04.107
PG 6
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Theory & Methods; Engineering, Electrical &
   Electronic; Telecommunications
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science; Engineering; Telecommunications
GA BS0DU
UT WOS:000681301200026
OA gold
DA 2022-04-20
ER

PT J
AU Burel, G
   Farrell, T
   Alani, H
AF Burel, Gregoire
   Farrell, Tracie
   Alani, Harith
TI Demographics and topics impact on the co-spread of COVID-19
   misinformation and fact-checks on Twitter
SO INFORMATION PROCESSING & MANAGEMENT
LA English
DT Article
DE COVID-19; Misinformation; Fact-checking; Social media; Demographics
AB Correcting misconceptions and false beliefs are important for injecting reliable information about COVID-19 into public discourse, but what impact does this have on the continued proliferation of misinforming claims? Fact-checking organisations produce content with the aim of reducing misinformation spread, but our knowledge of its impact on misinformation for particular topics and demographics is limited. In this article, we explore the relation between misinformation and fact-checking spread during the COVID-19 pandemic for different topics, user demographics and attributes. We specifically follow misinformation and fact checks emerging from December 2019 until the 4th of January 2021 on Twitter. Using a combination of spread variance analysis, impulse response modelling and causal analysis, we highlight the bidirectional, weak causation spread behaviour between misinformation and fact checks. Although we observe that fact-checks about COVID-19 are appearing fairly quickly after misinformation is circulated, its ability to reduce overall misinformation spread appears to be limited. This is especially visible for misinformation about conspiracy theories and the causes of the virus.
C1 [Burel, Gregoire; Farrell, Tracie; Alani, Harith] Open Univ, Knowledge Media Inst, Milton Keynes, Bucks, England.
RP Burel, G (corresponding author), Open Univ, Knowledge Media Inst, Milton Keynes, Bucks, England.
EM gregoire.burel@open.ac.uk; tracie.farrell@open.ac.uk;
   harith.alani@open.ac.uk
OI Farrell, Tracie/0000-0002-2386-4333; Burel,
   Gregoire/0000-0003-0029-5219; Alani, Harith/0000-0003-2784-349X
FU European Union's Horizon 2020 research and innovation programme [770302,
   101003606]
FX This work has received support from the European Union's Horizon 2020
   research and innovation programme under grants agreement No. 770302
   (Co-Inform) and No. 101003606 (HERoS).
CR Agley J, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10103-x
   Aird MJ, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180593
   Allgaier J, 2015, CROAT MED J, V56, P496, DOI 10.3325/cmj.2015.56.496
   Almaliki M, 2019, PROCEEDINGS OF 3RD INTERNATIONAL CONFERENCE ON INFORMATION SYSTEM AND DATA MINING (ICISDM 2019), P171, DOI 10.1145/3325917.3325938
   Amazeen MA, 2019, COMMUN MONOGR, V86, P112, DOI 10.1080/03637751.2018.1521984
   Barrera O, 2020, J PUBLIC ECON, V182, DOI 10.1016/j.jpubeco.2019.104123
   Bedard M, 2018, COMPANION PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE 2018 (WWW 2018), P613, DOI 10.1145/3184558.3188732
   Berger J, 2012, J MARKETING RES, V49, P192, DOI 10.1509/jmr.10.0353
   Beskow DM, 2018, 2018 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P825, DOI 10.1109/ASONAM.2018.8508322
   Bode L., 2020, HARVARD KENNEDY SCH
   Brandt J., 2020, J COMPUT SOC SCI, P1
   Brennen J. S., 2020, TYPES SOURCES CLAIMS
   Brennen JS, 2021, INT J PRESS/POLIT, V26, P277, DOI 10.1177/1940161220964780
   Burel Gregoire, 2020, Social Informatics. 12th International Conference, SocInfo 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12467), P28, DOI 10.1007/978-3-030-60975-7_3
   Cha M., 2020, JMIR HUMAN FACTORS
   Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5
   Culotta A, 2016, MARKET SCI, V35, P343, DOI 10.1287/mksc.2015.0968
   Douglas KM, 2019, POLIT PSYCHOL, V40, P3, DOI 10.1111/pops.12568
   Evanega S., 2020, CORONAVIRUS MISINFOR
   Farrell T, 2019, C TRUTH TRUST ONL
   Giorgi S., 2019, ARXIV PREPRINT ARXIV
   Guess A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4586
   Gurlek M, 2021, THESIS MIDDLE E TU
   Harman S, 2020, LANCET, V395, P776, DOI 10.1016/S0140-6736(20)30427-X
   Jin F, 2014, COMPUTER, V47, P90, DOI 10.1109/MC.2014.361
   Jin Fang, 2013, P 7 WORKSH SOC NETW, P8
   Kendall L, 1998, SYMB INTERACT, V21, P129, DOI 10.1525/si.1998.21.2.129
   Kim J, 2018, WSDM'18: PROCEEDINGS OF THE ELEVENTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P324, DOI 10.1145/3159652.3159734
   Koetke J, 2022, SOC PSYCHOL PERS SCI, V13, P277, DOI 10.1177/1948550620988242
   Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255
   Krause NM, 2020, J RISK RES, V23, P1052, DOI 10.1080/13669877.2020.1756385
   Kuklinski JH, 2000, J POLIT, V62, P790, DOI 10.1111/0022-3816.00033
   Laato S, 2020, EUR J INFORM SYST, V29, P288, DOI 10.1080/0960085X.2020.1770632
   Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9
   Lee JJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/22205
   Lewandowsky S, 2013, AM PSYCHOL, V68, P487, DOI 10.1037/a0034515
   Masuda N., 2017, TEMPORAL NETWORK EPI
   Mensio M, 2019, TRUTH TRUST C
   Micallef N, 2020, IEEE INT CONF BIG DA, P748, DOI 10.1109/BigData50022.2020.9377956
   Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545
   Nieminen S, 2019, POLIT STUD REV, V17, P296, DOI 10.1177/1478929918786852
   Pyszczynski T, 2021, J HUMANIST PSYCHOL, V61, P173, DOI 10.1177/0022167820959488
   Rampersad G, 2020, J INF TECHNOL POLITI, V17, P1, DOI 10.1080/19331681.2019.1686676
   Reifler, 2015, ESTIMATING FACT CHEC
   Rich T. S., 2020, HARVARD KENNEDY SCH
   Robertson CT, 2020, INT J PRESS/POLIT, V25, P217, DOI 10.1177/1940161219898055
   Rodriguez-Ruiz J, 2020, COMPUT SECUR, V91, DOI 10.1016/j.cose.2020.101715
   Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199
   Ruberg B, 2020, BIG DATA SOC, V7, DOI 10.1177/2053951720933286
   Salali Gul Deniz, 2020, Psychol Med, P1, DOI 10.1017/S0033291720004067
   Sarkar S, 2019, SOC NETW ANAL MIN, V9, DOI 10.1007/s13278-019-0556-z
   Saxena A, 2020, WWW'20: COMPANION PROCEEDINGS OF THE WEB CONFERENCE 2020, P363, DOI 10.1145/3366424.3383297
   Shan Jiang, 2018, Proceedings of the ACM on Human-Computer Interaction, V2, DOI 10.1145/3274351
   Sloan L, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.3001
   Starbird K, 2018, PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2018), DOI 10.1145/3173574.3173679
   Swire B, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160802
   Tambuscio M, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P977, DOI 10.1145/2740908.2742572
   Tong GM, 2019, IEEE INFOCOM SER, P1711, DOI 10.1109/INFOCOM.2019.8737485
   Vaezi A, 2020, ADV BIOMED RES-INDIA, V9, DOI 10.4103/abr.abr_47_20
   van Der Linden S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566790
   Vlachos A., 2014, P ACL 2014 WORKSH LA, P18, DOI DOI 10.3115/V1/W14-2508
   Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559
   Wang ZJ, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P2056, DOI 10.1145/3308558.3313684
   Xian JJ, 2019, CHAOS, V29, DOI 10.1063/1.5121394
   Xie B, 2020, J ASSOC INF SCI TECH, V71, P1419, DOI 10.1002/asi.24357
   Yang YC, 2021, JAMIA OPEN, V4, DOI 10.1093/jamiaopen/ooab042
   Cuan-Baltazar JY, 2020, JMIR PUBLIC HLTH SUR, V6, P176, DOI 10.2196/18444
NR 67
TC 3
Z9 3
U1 47
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0306-4573
EI 1873-5371
J9 INFORM PROCESS MANAG
JI Inf. Process. Manage.
PD NOV
PY 2021
VL 58
IS 6
AR 102732
DI 10.1016/j.ipm.2021.102732
EA SEP 2021
PG 23
WC Computer Science, Information Systems; Information Science & Library
   Science
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Computer Science; Information Science & Library Science
GA US8TR
UT WOS:000697699500001
PM 34511703
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Loutradis, C
   Pitoulias, AG
   Pagkopoulou, E
   Pitoulias, GA
AF Loutradis, Charalampos
   Pitoulias, Apostolos G.
   Pagkopoulou, Eleni
   Pitoulias, Georgios A.
TI Cardiovascular complications after COVID-19 in chronic kidney disease,
   dialysis and kidney transplant patients
SO INTERNATIONAL UROLOGY AND NEPHROLOGY
LA English
DT Review; Early Access
DE COVID-19; Hemodialysis; Chronic Kidney Disease; Renal Transplantation;
   Cardiovascular Disease
ID ANGIOTENSIN-CONVERTING ENZYME-2; HEMODIALYSIS-PATIENTS; CLINICAL
   CHARACTERISTICS; INTERNATIONAL REGISTRY; SARS-CORONAVIRUS; MORTALITY;
   ACE2; INFECTION; INFLAMMATION; DYSFUNCTION
AB The coronavirus disease 2019 (COVID-19) is associated with increased mortality in patients with chronic kidney disease (CKD), dialysis patients and kidney transplant recipients (KTR). Cardiovascular complications, such as sudden arrhythmias, thromboembolic events, coronary events, cardiomyopathies and heart failure, may present in about 10-20% of patients with COVID-19. Patients with CKD, dialysis patients and KTR are all at increased cardiovascular risk and present with more cardiovascular complications after COVID-19 compared to the general population. During the pandemic, health care giving has rapidly changed by reducing elective outpatient reviews, which may refrain these high-risk patients from the appropriate management of their medical conditions, further increasing cardiovascular risk. Importantly, acute kidney injury (AKI) is another common complication of severe COVID-19 and associates with increased mortality. A large proportion of the AKI patients need renal replacement treatment, while 30% of them may not present renal function recovery and remain dialysis-dependent after discharge, thereby having potentially increased future cardiovascular risk. This review summarizes current knowledge regarding the cardiovascular events and mortality in patients with CKD or undergoing hemodialysis and in KTR.
C1 [Loutradis, Charalampos] Evangelismos Private Hosp, Veroia 59132, Greece.
   [Loutradis, Charalampos] Hemodialysis Unit, Veroia 59132, Greece.
   [Loutradis, Charalampos; Pitoulias, Apostolos G.; Pitoulias, Georgios A.] Aristotle Univ Thessaloniki, Dept Surg 2, Div Vasc Surg, G Gennimatas Hosp, Thessaloniki, Greece.
   [Pagkopoulou, Eleni] Aristotle Univ Thessaloniki, Dept Internal Med 4, Hippokrat Hosp, Thessaloniki, Greece.
RP Loutradis, C (corresponding author), Evangelismos Private Hosp, Veroia 59132, Greece.; Loutradis, C (corresponding author), Hemodialysis Unit, Veroia 59132, Greece.; Loutradis, C (corresponding author), Aristotle Univ Thessaloniki, Dept Surg 2, Div Vasc Surg, G Gennimatas Hosp, Thessaloniki, Greece.
EM loutradis_haris@hotmail.com
OI Loutradis, Charalampos/0000-0001-6387-4176
CR Akalin E, 2020, NEW ENGL J MED, V382, P2475, DOI 10.1056/NEJMc2011117
   Al-Wahaibi Kamla, 2020, SN Compr Clin Med, P1, DOI 10.1007/s42399-020-00569-6
   Alberici F, 2020, KIDNEY INT, V98, P20, DOI 10.1016/j.kint.2020.04.030
   Ameri P, 2021, CLIN RES CARDIOL, V110, P1020, DOI 10.1007/s00392-020-01766-y
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Awan AA, 2018, AM J NEPHROL, V48, P472, DOI 10.1159/000495081
   Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389
   Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013
   Becker RC, 2020, J THROMB THROMBOLYS, V50, P512, DOI 10.1007/s11239-020-02266-6
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Bhatla A, 2020, HEART RHYTHM, V17, P1439, DOI 10.1016/j.hrthm.2020.06.016
   Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3
   Blumenthal D, 2020, NEW ENGL J MED, V383, P1483, DOI 10.1056/NEJMsb2021088
   Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2
   Bruchfeld A, 2021, NAT REV NEPHROL, V17, P81, DOI 10.1038/s41581-020-00381-4
   Carriazo S, 2020, CLIN KIDNEY J, V13, P274, DOI 10.1093/ckj/sfaa112
   Chan LL, 2021, J AM SOC NEPHROL, V32, P151, DOI [10.1681/ASN.2020050615, 10.33982/clr.2021.11.30.151]
   Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
   Clarke C, 2020, J AM SOC NEPHROL, V31, P1969, DOI 10.1681/ASN.2020060827
   Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379
   Corbett RW, 2020, J AM SOC NEPHROL, V31, P1815, DOI 10.1681/ASN.2020040534
   Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786
   Cravedi P, 2020, AM J TRANSPLANT, V20, P3140, DOI 10.1111/ajt.16185
   D'Marco L, 2020, CLIN KIDNEY J, V13, P297, DOI 10.1093/ckj/sfaa104
   De Meester J, 2021, J AM SOC NEPHROL, V32, P385, DOI 10.1681/ASN.2020060875
   Dirim AB, 2021, INT UROL NEPHROL, V53, P2117, DOI 10.1007/s11255-021-02783-0
   Emami A, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.600
   Fathi M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246190
   Ferlicot S, 2021, NEPHROL DIAL TRANSPL, V36, P1253, DOI 10.1093/ndt/gfab042
   Fisher Molly, 2020, Kidney360, V1, P755, DOI 10.34067/KID.0003672020
   Fishman JA., 2008, KIDNEY TRANSPLANT, DOI [10.1016/B978-1-4160-3343-1.50033-5, DOI 10.1016/B978-1-4160-3343-1.50033-5]
   Flythe JE, 2021, AM J KIDNEY DIS, V77, P190, DOI 10.1053/j.ajkd.2020.09.003
   Fontana F, 2020, CLIN KIDNEY J, V13, P334, DOI 10.1093/ckj/sfaa084
   Giannis D, 2021, BLOOD, V137, P2838, DOI 10.1182/blood.2020010529
   Goicoechea M, 2020, KIDNEY INT, V98, P27, DOI 10.1016/j.kint.2020.04.031
   Gok M, 2021, INT UROL NEPHROL, V53, P1891, DOI 10.1007/s11255-020-02758-7
   Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Gupta S, 2021, J AM SOC NEPHROL, V32, P161, DOI 10.1681/ASN.2020060897
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hilbrands LB, 2020, NEPHROL DIAL TRANSPL, V35, P1973, DOI 10.1093/ndt/gfaa261
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hong DQ, 2020, CLIN KIDNEY J, V13, P340, DOI 10.1093/ckj/sfaa083
   Hsu CM, 2021, AM J KIDNEY DIS, V77, P748, DOI [10.1053/j.ajkd.2021.01.003, 10.1053/.ajkd.2021.01.003]
   Huart J, 2021, J NEPHROL, V34, P355, DOI 10.1007/s40620-020-00931-w
   Jager KJ, 2020, KIDNEY INT, V98, P1540, DOI 10.1016/j.kint.2020.09.006
   Soler MJ, 2013, NEPHROL DIAL TRANSPL, V28, P2687, DOI 10.1093/ndt/gft320
   Kalil AC, 2021, NEW ENGL J MED, V384, P795, DOI 10.1056/NEJMoa2031994
   Kang SH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e434
   Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208
   Krittanawong C, 2020, AM J CARDIOVASC DIS, V10, P479
   La Milia V, 2020, KIDNEY INT REP, V5, P1095, DOI 10.1016/j.ekir.2020.05.019
   Lambert H, 2020, LANCET PLANET HEALTH, V4, pE312, DOI 10.1016/S2542-5196(20)30168-6
   Lano G, 2020, CLIN KIDNEY J, V13, P878, DOI 10.1093/ckj/sfaa199
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Major R, 2020, J AM SOC NEPHROL, V31, P2250, DOI 10.1681/ASN.2020060877
   Min YL, 2021, INT UROL NEPHROL, V53, P797, DOI 10.1007/s11255-020-02700-x
   Ng JH, 2021, AM J KIDNEY DIS, V77, P204, DOI 10.1053/j.ajkd.2020.09.002
   Ng JH, 2020, KIDNEY INT, V98, P1530, DOI 10.1016/j.kint.2020.07.030
   Ogutmen B, 2006, TRANSPLANT P, V38, P419, DOI 10.1016/j.transproceed.2006.01.016
   Ortiz A, 2021, NEPHROL DIAL TRANSPL, V36, P87, DOI 10.1093/ndt/gfaa314
   Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
   Ozturk S, 2020, NEPHROL DIAL TRANSPL, V35, P2083, DOI 10.1093/ndt/gfaa271
   Papageorgiou N, 2022, ACTA CARDIOL, V77, P81, DOI 10.1080/00015385.2021.1887586
   Patel VB, 2012, CIRC RES, V110, P1322, DOI 10.1161/CIRCRESAHA.112.268029
   Pereira MR, 2020, AM J TRANSPLANT, V20, P1800, DOI 10.1111/ajt.15941
   Petrovic V, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.575600
   Pilmore H, 2010, TRANSPLANTATION, V89, P851, DOI 10.1097/TP.0b013e3181caeead
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Portoles J, 2020, NEPHROL DIAL TRANSPL, V35, P1353, DOI 10.1093/ndt/gfaa189
   Rao A, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.121.020910
   Roberts MA, 2013, NEPHROL DIAL TRANSPL, V28, P2287, DOI 10.1093/ndt/gft038
   Rombola G, 2020, J NEPHROL, V33, P193, DOI 10.1007/s40620-020-00727-y
   Rose C, 2017, CLIN J AM SOC NEPHRO, V12, P2024, DOI 10.2215/CJN.06100617
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Russo E, 2021, J NEPHROL, V34, P173, DOI 10.1007/s40620-020-00875-1
   Saran R, 2019, AM J KIDNEY DIS, V73, pSVII
   Sinsky C, 2020, HEALTH AFFAIR, V39, P1405, DOI 10.1377/hlthaff.2020.00612
   South AM, 2020, AM J PHYSIOL-HEART C, V318, pH1084, DOI 10.1152/ajpheart.00217.2020
   Stefan G, 2021, RENAL FAILURE, V43, P49, DOI 10.1080/0886022X.2020.1853571
   Sun PF, 2020, J MED VIROL, V92, P548, DOI 10.1002/jmv.25722
   Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4
   Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x
   Tsai S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88111-z
   Valeri AM, 2020, J AM SOC NEPHROL, V31, P1409, DOI 10.1681/ASN.2020040470
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1
   Waldman M, 2021, KIDNEY INT, V99, P227, DOI 10.1016/j.kint.2020.10.032
   Walsh Mary Norine, 2020, JACC Case Rep, V2, P1235, DOI 10.1016/j.jaccas.2020.06.017
   Wen CP, 2014, KIDNEY INT, V86, P819, DOI 10.1038/ki.2013.553
   WHO, 2020, NOV COR 2019 NCOV SI
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   Wu J, 2020, CLIN J AM SOC NEPHRO, V15, P1139, DOI 10.2215/CJN.04160320
   Xie Yuanliang, 2020, Radiol Cardiothorac Imaging, V2, pe200067, DOI 10.1148/ryct.2020200067
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   Ying T, 2020, J AM SOC NEPHROL, V31, P2887, DOI 10.1681/ASN.2020050566
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   ZHOU P, 2020, NATURE, V579, P270, DOI DOI 10.1038/S41586-020-2012-7
   Zoccali C, 2003, BLOOD PURIFICAT, V21, P29, DOI 10.1159/000067852
   Zoccali C, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.52
   Zou R, 2020, RENAL FAILURE, V42, P950, DOI 10.1080/0886022X.2020.1816179
NR 104
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-1623
EI 1573-2584
J9 INT UROL NEPHROL
JI Int. Urol. Nephrol.
DI 10.1007/s11255-021-03059-3
EA NOV 2021
PG 13
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA XB7EO
UT WOS:000721488600003
PM 34811606
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Rovers, JJE
   van de Linde, LS
   Kenters, N
   Bisseling, EM
   Nieuwenhuijse, DF
   Munnink, BBO
   Voss, A
   Nabuurs-Franssen, M
AF Rovers, J. J. E.
   van de Linde, L. S.
   Kenters, N.
   Bisseling, E. M.
   Nieuwenhuijse, D. F.
   Oude Munnink, B. B.
   Voss, A.
   Nabuurs-Franssen, M.
TI Why psychiatry is different-challenges and difficulties in managing a
   nosocomial outbreak of coronavirus disease (COVID-19) in hospital care
SO ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL
LA English
DT Article
DE COVID-19; Hospital psychiatry; Nosocomial outbreak; Hospital outbreak
   management
ID TRANSMISSION; MANAGEMENT; PNEUMONIA; ILLNESS; HEALTH; WUHAN; RISK
AB Objective Coronavirus disease (COVID-19) was officially declared a pandemic in March 2020. Many cases of COVID-19 are nosocomial, but to the best of our knowledge, no nosocomial outbreaks on psychiatric departments of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported in Europe. The different nature of psychiatry makes outbreak management more difficult. This study determines which psychiatry specific factors contributed to a nosocomial outbreak taking place in a psychiatric department. This will provide possible interventions in future outbreak management. Method A case series describing a nosocomial outbreak in a psychiatric department of an acute care hospital in the Netherlands between March 13, 2020 and April, 14 2020. The outbreak was analyzed by combining data from standardized interviews, polymerase chain reaction (PCR) tests and whole genome sequencing (WGS). Results The nosocomial outbreak in which 43% of staff of the psychiatric department and 19% of admitted patients were involved, was caused by healthcare worker (HCW)-to-HCW transmissions, as well as patient-to-HCW-to-patient transmission. We identified four aspects associated with the mental health care system which might have made our department more susceptible to an outbreak. Conclusions Infection control measures designed for hospitals are not directly applicable to psychiatric departments. Psychiatric patients should be considered a high-risk group for infectious diseases and customized measures should be designed and implemented. Extra attention for psychiatric departments is necessary during a pandemic as psychiatric HCWs are less familiar with outbreak management. Clear communication and governance is crucial in correctly implementing these measures.
C1 [Rovers, J. J. E.; van de Linde, L. S.; Bisseling, E. M.; Oude Munnink, B. B.] Canisius Wilhelmina Hosp, Dept Psychiat, Weg Door Jonkerbos 100, NL-6534 SZ Nijmegen, Netherlands.
   [Kenters, N.; Voss, A.; Nabuurs-Franssen, M.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands.
   [Kenters, N.; Voss, A.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands.
   [Nieuwenhuijse, D. F.; Oude Munnink, B. B.] Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands.
RP Rovers, JJE (corresponding author), Canisius Wilhelmina Hosp, Dept Psychiat, Weg Door Jonkerbos 100, NL-6534 SZ Nijmegen, Netherlands.
EM j.rovers@cwz.nl
OI Rovers, Jordy/0000-0003-4636-9412
CR Andersson NW, 2016, INT J EPIDEMIOL, V45, P131, DOI 10.1093/ije/dyv333
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Chow EJ, 2020, JAMA-J AM MED ASSOC, V323, P2087, DOI 10.1001/jama.2020.6637
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   De Hert M, 2011, WORLD PSYCHIATRY, V10, P138
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Gaspard P, 2014, GEN HOSP PSYCHIAT, V36, P46, DOI 10.1016/j.genhosppsych.2013.01.009
   Health N, 2020, NOVEL CORONA CASE QU
   Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Luming Li M.D, PSYCHIAT SERVICES
   Millar H, 2008, EUR NEUROPSYCHOPHARM, V18, pS121, DOI 10.1016/j.euroneuro.2008.02.002
   Nepusz, 2006, INT J COMPLEX SYST, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191
   Munnink BOB, 2020, NAT MED, V26, P1802, DOI 10.1038/s41591-020-1128-5
   Paradis Emmanuel, 2019, Bioinformatics, V35, P526, DOI 10.1093/bioinformatics/bty633
   Ran L, 2020, CLIN INFECT DIS, V71, P2218, DOI 10.1093/cid/ciaa287
   Seminog OO, 2013, THORAX, V68, P171, DOI 10.1136/thoraxjnl-2012-202480
   Shefer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111682
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   Sikkema RS, 2020, LANCET INFECT DIS, V20, P1273, DOI 10.1016/S1473-3099(20)30527-2
   Tartari E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232168
   Thompson JW, 2020, PSYCHIAT SERV, V71, P1285, DOI 10.1176/appi.ps.202000270
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002
   Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiang YT, 2020, JAMA PSYCHIAT, V77, P989, DOI 10.1001/jamapsychiatry.2020.1057
   Xie MX, 2020, INT J INFECT DIS, V94, P119, DOI 10.1016/j.ijid.2020.03.071
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhou PC, 2020, INFECT CONT HOSP EP, V41, P745, DOI 10.1017/ice.2020.60
NR 31
TC 3
Z9 3
U1 3
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2047-2994
J9 ANTIMICROB RESIST IN
JI Antimicrob. Resist. Infect. Control
PD DEC 1
PY 2020
VL 9
IS 1
AR 190
DI 10.1186/s13756-020-00853-z
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Microbiology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Microbiology; Pharmacology & Pharmacy
GA PD9NI
UT WOS:000598002000002
PM 33261660
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Taxbro, K
   Granath, A
   Sunnergren, O
   Seifert, S
   Jakubczyk, MN
   Persson, M
   Hammarskjold, A
   Alkemark, C
   Hammarskjold, F
AF Taxbro, Knut
   Granath, Andreas
   Sunnergren, Ola
   Seifert, Stefanie
   Jakubczyk, Milena N.
   Persson, Magnus
   Hammarskjold, Anneli
   Alkemark, Catarina
   Hammarskjold, Fredrik
CA RJL COVID-19 Res Grp
TI Low mortality rates among critically ill adults with COVID-19 at three
   non-academic intensive care units in south Sweden
SO ACTA ANAESTHESIOLOGICA SCANDINAVICA
LA English
DT Article
DE acute respiratory distress syndrome; COVID-19; intensive care;
   ventilation
ID RESPIRATORY-DISTRESS-SYNDROME; COHORT; VOLUME
AB Background The COVID-19 pandemic has put an exceptional strain on intensive care units worldwide. During the first year, the survival of patients with acute hypoxaemic respiratory failure appears to have improved. We aimed to describe the mortality rates, management characteristics and two pandemic waves during the first year at three non-academic rural intensive care units in Sweden. Methods We retrospectively analysed all cases of COVID-19 admitted to intensive care units in Region Jonkoping County during 1 year. The primary endpoint was 30-day mortality. Results Between 14th March 2020 and 13th March 2021, 264 patients were admitted to undergo intensive care with confirmed SARS-CoV-2 infection. The 30-day mortality rate after the initial intensive care admission was 12.9%, and this rate remained unchanged during both pandemic waves. However, we found several distinct differences between the two pandemic waves, including an increase in the use of high-flow nasal oxygen but a decrease in invasive mechanical ventilation use, biochemical markers of inflammation, continuous renal replacement therapy and length of stay in the intensive care unit. Conclusion Our study showed that critically ill patients with COVID-19 in Sweden have a low 30-day mortality rate which compares well with results published from academic centres and national cohorts throughout Scandinavia. During the second pandemic wave, the proportion of patients receiving invasive mechanical ventilation and continuous renal replacement therapy was lower than that in the first wave. This could be the result of increased knowledge and improved therapeutic options.
C1 [Taxbro, Knut; Granath, Andreas; Seifert, Stefanie; Hammarskjold, Anneli; Alkemark, Catarina; Hammarskjold, Fredrik] Ryhov Cty Hosp, Dept Anaesthesia & Intens Care Med, S-55185 Jonkoping, Sweden.
   [Taxbro, Knut; Sunnergren, Ola; Hammarskjold, Fredrik] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden.
   [Sunnergren, Ola] Reg Jonkoping Cty, Dept Otorhinolaryngol, Jonkoping, Sweden.
   [Jakubczyk, Milena N.] Eksjo Nassjo Hosp, Dept Anaesthesia & Intens Care Med, Eksjo, Sweden.
   [Persson, Magnus] Varnamo Hosp, Dept Anaesthesia & Intens Care Med, Varnamo, Sweden.
RP Taxbro, K (corresponding author), Ryhov Cty Hosp, Dept Anaesthesia & Intens Care Med, S-55185 Jonkoping, Sweden.
EM knut.taxbro@rjl.se
RI Taxbro, Knut/P-1358-2019
OI Taxbro, Knut/0000-0001-8711-9044
FU Futurum, the Academy for Healthcare, Jonkoping County Council,
   Jonkoping, Sweden
FX This trial was supported by Futurum, the Academy for Healthcare,
   Jonkoping County Council, Jonkoping, Sweden.
CR Ahlstrom B, 2021, ACTA ANAESTH SCAND, V65, P525, DOI 10.1111/aas.13781
   Al-Samkari H, 2021, ANN INTERN MED, V174, P622, DOI 10.7326/M20-6739
   Attaway AH, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n436
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Berkowitz SA, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2021209
   Chew MS, 2021, EUR J ANAESTH, V38, P335, DOI 10.1097/EJA.0000000000001459
   Covid-Icu Group on Behalf of the REVA Network the Covid- I. C. U. Investigators, 2021, INTENSIVE CARE MED, V47, P60, DOI 10.1007/s00134-020-06294-x
   Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8
   ESICM LIVES 2019: Berlin Germany, 2019, INTENSIVE CARE MED E, V7, P55
   Givi B, 2020, JAMA OTOLARYNGOL, V146, P579, DOI 10.1001/jamaoto.2020.0780
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394
   Guillon A, 2021, INTENS CARE MED, V47, P798, DOI 10.1007/s00134-021-06412-3
   Haase N, 2021, ACTA ANAESTH SCAND, V65, P68, DOI 10.1111/aas.13701
   Ike JD, 2018, CRIT CARE MED, V46, P764, DOI 10.1097/CCM.0000000000003015
   Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993
   Kwak PE, 2021, JAMA OTOLARYNGOL, V147, P239, DOI 10.1001/jamaoto.2020.4837
   Laake JH., 2020, ACTA ANAESTH SCAND, V2021, P618
   Larsson E, 2021, ACTA ANAESTH SCAND, V65, P76, DOI 10.1111/aas.13694
   LEWANDOWSKI K, 1995, AM J RESP CRIT CARE, V151, P1121
   Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639
   Mathur R, 2021, LANCET, V397, P1711, DOI 10.1016/S0140-6736(21)00634-6
   McGahan M, 2012, AUST CRIT CARE, V25, P64, DOI 10.1016/j.aucc.2012.03.003
   Painvin B, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00841-5
   Rentsch CT, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n311
   Sommer DD, 2020, J OTOLARYNGOL-HEAD N, V49, DOI 10.1186/s40463-020-00414-9
   Sovik S, 2021, ACTA ANAESTH SCAND, V65, P351, DOI 10.1111/aas.13726
   Statistics Sweden, 2019, POP DAT
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Swedish Association for Anesthesia and Intensive Care and the Swedish Intensive Care Society-SFAI, 2015, GUID SWED INT CAR
   Swedish Intensive Care Registry, 2021, SIR DIAGN CRIT
   Swedish Intensive Care Registry, 2021, DAT PORT SWED INT CA
   The REMAP-CAP ACTIV-4a and ATTACC Investigators, 2021, THER ANT CRIT 3 PAT
   The SAPS 3 Research Group, 2021, PUBLICATIONS
   The Swedish Public Health Agency, 2021, COVID 19 CAS SWED
   Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]
   West E, 2014, INT J NURS STUD, V51, P781, DOI 10.1016/j.ijnurstu.2014.02.007
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
NR 37
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-5172
EI 1399-6576
J9 ACTA ANAESTH SCAND
JI Acta Anaesthesiol. Scand.
PD NOV
PY 2021
VL 65
IS 10
BP 1457
EP 1465
DI 10.1111/aas.13972
EA SEP 2021
PG 9
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA WI1IG
UT WOS:000692608900001
PM 34386972
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Obayelu, AE
   Edewor, SE
   Ogbe, AO
AF Obayelu, Abiodun Elijah
   Edewor, Sarah Edore
   Ogbe, Agatha Osivweneta
TI Trade effects, policy responses and opportunities of COVID-19 outbreak
   in Africa
SO JOURNAL OF CHINESE ECONOMIC AND FOREIGN TRADE STUDIES
LA English
DT Article
DE Intra-regional trade; International trade; COVID-19 lockdown; COVID-19
   border closure; Global economic recession; COVID trade policies; Market
   opportunities
AB Purpose
   The paper is a preliminary assessment of coronavirus disease's (COVID-19) effects on African trade, policy responses and opportunities within the limitations imposed by data and the information currently available and in the lights of other international organizations' growth forecasts. The study was undertaken to get deeper understanding of the threats and opportunities of COVID-19 on African trade because of the existing interconnected trade networks making African countries to be more vulnerable and increasing number of restrictions and distortions among major traders. This study aims to present strong information required in underpinning sound national, regional and inter-regional policy responses to keep trade flowing.
   Design/methodology/approach
   To assess COVID-19's effects on African trade, policy responses and opportunities, this study relied on data and information currently available from organizations such as World Trade Organization (WTO), World Bank (WB), Organisation for Economic Co-operation and Development, International Monetary Fund, European Union, International Trade Statistics and various African countries' trade and national statistics publications. The analysis contains two main scenarios. The first, an observed effects scenario (first quarter of year 2020), looks at the observed effect of COVID-19 outbreak on trade in Africa. The second, a potential effects scenario, analyses the potential trade effects if the COVID-19 outbreak lingers and spreads more intensively than is assumed in the baseline scenario.
   Findings
   The COVID-19 outbreak affects several aspects of international trade even though the full effects of the outbreak are not yet visible in most trade data. Some leading indicators had shown that keeping trade flow can support the fight against COVID-19 as well as having damaging effect on Africa's trade. COVID-19 had led to a deep fall in transaction, both at the international level and within-regions. Tariffs and other restrictions to imports harm the flow of critical products to African countries. Uncooperative trade policies lead to higher prices of goods in fragile and vulnerable African countries.
   Research limitations/implications
   Long term in-depth analysis of the effects of COVID-19 on trade using quantitative data is still very difficult because of paucity of data and the great level of the improbability of the trajectory of the spread of the virus. Informed assessment of the full trade impact of the pandemic on African countries is therefore still difficult. Notwithstanding, this study assesses the immediate effects and conveys the likely extent of impending African trade pains and the potential needs for assistance.
   Practical implications
   Trade in both goods and services plays a key role in overcoming the pandemic and limit its effects by providing access to essential medical goods to treat those affected, ensuring access to food, providing farmers with needed inputs, support jobs and sustain economic activity during global recession. However, temporary COVID-19 trade measures such as borders closure, export prohibition and import ban are a threat to globalization and free trade agreements engaged by some African countries.
   Social implications
   The continuous rise in COVID-19 cases is expected to trigger economic recession in Africa despite a rapid expansion and creation of new social protection programmes.
   The unavoidable decline in trade caused by COVID-19 is already having painful consequences on the economy, social anxiety among families, households, businesses and trade across countries in the continent. COVID-19 trade restrictions aimed at reducing the transmission of the virus have led to loss of income and jobs as well as closure of small and vulnerable businesses. Policymakers should enforce social policies that unite countries within the continents in bad times to reduce social anxiety and hardship.
   Originality/value
   Although the effects of COVID-19 outbreak on global and regional trade have received enormous attention recently, facts in the form of data have been thin particularly on African trade. This paper, to the best of the authors' knowledge, is one of the first set of studies that provides preliminary assessment of COVID-19's effects on trade in Africa using scenarios-building approach based on the available data and information on regional trade, complemented by those from the WTO, WB and departments of trade and statistics from various African countries such as the Nigeria Nation Bureau of Statistic and Kenyan National Bureau of Statistics.
C1 [Obayelu, Abiodun Elijah; Edewor, Sarah Edore; Ogbe, Agatha Osivweneta] Fed Univ Agr, Abeokuta FUNAAB, Dept Agr Econ & Farm Management, Abeokuta, Nigeria.
RP Obayelu, AE (corresponding author), Fed Univ Agr, Abeokuta FUNAAB, Dept Agr Econ & Farm Management, Abeokuta, Nigeria.
EM obayelu@yahoo.com; saradowe@yahoo.co.uk; ag05ogbe@gmail.com
RI Edewor, Sarah E/C-4412-2017
CR Ademola A., 2020, COVID 19 LAGOS INFOR
   African Union, 2020, COMMUNIQUE BUREAU AS
   [Anonymous], 2020, COVID 19 SHOCK DEV C
   AUC/OECD, 2019, AFRICA S DEV DYNAMIC
   Baldwin R., 2020, EC TIME COVID 19, P59
   Baldwin R., 2020, EC TIME COVID 19 NEW
   Baschuk B., 2020, BLOOMBERG
   Bouet A, 2012, REV WORLD ECON, V148, P209, DOI 10.1007/s10290-011-0108-8
   Bown, 2020, PIIE TRADE INVESTMEN
   Brooks D.J., 2020, COVID 19 WORLD WORK
   Buehler K., 2020, LEADERSHIP TIME CORO
   Caliendo L, 2015, REV ECON STUD, V82, P1, DOI 10.1093/restud/rdu035
   Centre for Economic Policy Research (CEPR), 2020, COVID EC VETTED REAL
   Chandrasekhar C., 2020, CORONAVIRUS INFORMAL
   Committee for European Construction Equipment (CECE), 2020, COVID 19 IMPACT TRAD
   Curran E., 2020, BLOOMBERG
   di Mauro, 2020, MITIGATING COVID EC
   Ec, 2020, COVID 19 FOOD SAFETY
   EIU, 2020, EIU UPDATE COVID 19
   Elleby C, 2020, ENVIRON RESOUR ECON, V76, P1067, DOI 10.1007/s10640-020-00473-6
   Evenett Simon J, 2020, GLOBAL TRADE ALERT
   Gonzalez, 2020, MEMO TRADE MINISTERS
   ILO, 2020, ILO MONITOR COVID 19
   IMF, 2020, WORLD EC OUTLOOK GRE
   Jackson J. K., 2020, GLOBAL EC EFFECTS CO
   Krader K., 2020, BLOOMBERG BUSINESSWE
   Laborde D, 2020, SCIENCE, V369, P500, DOI 10.1126/science.abc4765
   Macapagal J., 2020, APPL MED INFORM, V42, P133
   Maliszewska M., 2020, POLICY RES WORKING P
   Market Access Map, 2020, TEMPORARY TRADE MEAS
   McKibbin W., 2004, ASIAN ECON PAP, V3, P112
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Moitra M., 2020, EC TIMES
   O'Dea S., 2020, CORONAVIRUS COVID 19
   OECD, 2020, COVID 19 AFRICA SOCI
   Ruta, 2020, FINANCIAL TIMES
   Sforza A., 2020, 8184 CESIFO
   Sherman E., 2020, OIL SECTOR SEARCHES
   Sidorenko A., 2006, MODELING MACROECONOM
   Sikder Mukut, 2020, AM J EC, V10, P325, DOI [10.5923 / j.economics.20201006.02, DOI 10.5923/J.ECONOMICS.20201006.02]
   Suneson, 2020, 24 7 WALL STREET
   Terry, 2020, NBER WORKING PAPER 2
   The Economist, 2020, ECONOMIST
   UNCTAD, 2020, CORONAVIRUS SHOCK ST
   UNCTAD, 2020, UNCTAD DIAE IA INF 2
   Vaitinligam R., 2020, LIVELIHOOD CORONAVIR
   Van Seters, 2016, EUROPEAN CTR DEV POL
   Verikios G., 2011, GLOBAL EC EFFECTS PA
   Vos R., 2020, MUCH WILL GLOBAL POV
   World Tourism Organisation, 2020, TOURISM COVID 19
   WorldAware, 2020, COVID 19 ALERT COUNT
   WTO, 2020, METHODOLOGY WTO TRAD
   WTO, 2020, EXPORT PROHIBITIONS
   WTO World Trade Organization, 2020, TRADE SET PLUNGE COV
   Wu, 2020, DATA BLOG BLOG
NR 55
TC 3
Z9 3
U1 6
U2 26
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1754-4408
EI 1754-4416
J9 J CHIN ECON FOREIGN
JI J. Chin. Econ. Foreign Trade Stud.
PD MAR 16
PY 2021
VL 14
IS 1
SI SI
BP 44
EP 59
DI 10.1108/JCEFTS-08-2020-0050
EA DEC 2020
PG 16
WC Economics
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA QX9GB
UT WOS:000600848700001
OA hybrid
DA 2022-04-20
ER

PT J
AU Dunlop, CA
   Ongaro, E
   Baker, K
AF Dunlop, Claire A.
   Ongaro, Edoardo
   Baker, Keith
TI Researching COVID-19: A research agenda for public policy and
   administration scholars
SO PUBLIC POLICY AND ADMINISTRATION
LA English
DT Article
DE Coronavirus; COVID-19; pandemic; public administration; public policy;
   relevance
ID MANAGEMENT; GOVERNANCE; COPRODUCTION; LEADERSHIP; INNOVATION; LESSONS;
   SECTOR; EU
AB Coronavirus (COVID-19) is one of the defining policy challenges of an era. In this article, we sketch some possible ways in which the public policy and administration community can make an enduring contribution about how to cope with this terrible crisis. We do so by offering some elements that delineate a tentative research agenda for public policy and administration scholars, to be pursued with epistemic humility. We outline the contours of seven analytical themes that are central to the challenges presented by COVID-19: policy design and instruments, policy learning, public service and its publics, organisational capacity, public governance, administrative traditions and public sector reforms in multi-level governance (MLG). The list is neither exhaustive nor exclusive to COVID-19. The knowledge we can generate must speak not only to the daunting challenge of COVID-19 itself but also to policymakers, and indeed humankind, trying to cope with future unexpected but high impact threats, by leveraging better public policies and building administrative capacities to enable more resilient, equitable and effective public services.
C1 [Dunlop, Claire A.] Univ Exeter, Amory Bldg,Rennes Dr, Exeter EX4 4RJ, Devon, England.
   [Ongaro, Edoardo] Open Univ, Milton Keynes, Bucks, England.
   [Baker, Keith] SUNY Coll Brockport, Brockport Downtown, Rochester, NY USA.
RP Dunlop, CA (corresponding author), Univ Exeter, Amory Bldg,Rennes Dr, Exeter EX4 4RJ, Devon, England.
EM c.a.dunlop@exeter.ac.uk
OI Baker, Keith/0000-0003-4154-3987; Dunlop, Claire/0000-0003-2122-1075
CR Ansell C, 2021, PUBLIC MANAG REV, V23, P949, DOI 10.1080/14719037.2020.1820272
   Argyris C., 1978, ORG LEARNING THEORY
   Baker K, 2017, PUBLIC POLICY ADMIN, V32, P261, DOI 10.1177/0952076717720321
   Barberis P, 2012, TEACH PUBLIC ADMIN, V30, P76, DOI 10.1177/0144739412462232
   BENNETT CJ, 1992, POLICY SCI, V25, P275, DOI 10.1007/BF00138786
   Borras S, 2011, SCI PUBL POLICY, V38, P725, DOI 10.3152/030234211X13070021633323
   Bovaird T, 2018, PALGRAVE HDB PUBLIC, P403
   Bovaird T, 2012, VOLUNTAS, V23, P1119, DOI 10.1007/s11266-012-9309-6
   Capano G, 2020, SAGE OPEN, V10, DOI 10.1177/2158244019900568
   Capano G, 2021, PUBLIC POLICY ADMIN, V36, P141, DOI 10.1177/0952076719827068
   Crespy A, 2015, SOCIAL POLICY EUROCR
   Crosby B., 2005, LEADERSHIP COMMON GO
   Dewey J, 1938, EXPERIENCE ED
   Dixon R, 2020, POLITICAL STUDI 0609
   Drechsler W, 2019, ELGAR RES AGENDAS, P220
   Drechsler Wolfgang., 2013, SOC EC, V35, P319
   Dunlop CA, 2021, FUTURE POLICY SCI
   Dunlop CA, 2022, J COMP POLICY ANAL, V24, P51, DOI 10.1080/13876988.2020.1762077
   Dunlop CA, 2019, MAKING POLICIES WORK: FIRST- AND SECOND-ORDER MECHANISMS IN POLICY DESIGN, P115
   Dunlop CA, 2017, POLICY POLIT, V45, P3, DOI 10.1332/030557316X14824871742750
   Dunlop CA, 2015, POLICY SOC, V34, P259, DOI 10.1016/j.polsoc.2015.09.007
   Dunlop CA, 2013, POLIT STUD-LONDON, V61, P599, DOI 10.1111/j.1467-9248.2012.00982.x
   Dunlop CA, 2009, POLICY STUD-UK, V30, P289, DOI 10.1080/01442870902863869
   DUNSIRE A, 1973, ADM WORD SCI
   Fredrickson G, 2007, OXFORD HDB PUBLIC MA, P284
   Game C, 2020, POLITICAL STUDI 0605
   GORMLEY WT, 1986, POLITY, V18, P595, DOI 10.2307/3234884
   Government Accountability Office, 2006, GAO06844T
   Graham J.D., 1995, RISK VERSUS RISK TRA
   Hartley J, 2019, PUBLIC ADMIN, V97, P239, DOI 10.1111/padm.12597
   Heclo H., 1974, MODERN SOCIAL POLITI
   Henning C. R., 2017, TANGLED GOVERNANCE I
   Hirschman AO, 1981, ESSAYS TRESPASSING E, P294
   Hood C, 2011, BLAME GAME: SPIN, BUREAUCRACY, AND SELF-PRESERVATION IN GOVERNMENT, P1
   Hood C, 2002, GOV OPPOS, V37, P15, DOI 10.1111/1477-7053.00085
   Hood Christopher., 1983, TOOLS GOVT
   Howlett M, 2015, POLICY POLIT, V43, P291, DOI 10.1332/147084414X13992869118596
   Howlett Michael, 2005, DESIGNING GOVT INSTR, P31
   Huxham C., 2013, MANAGING COLLABORATE
   Johnson N., 1989, LIMITS POLITICAL SCI
   Kickert W. J. M., 1997, MANAGING COMPLEX NET
   Kickert W, 2019, PUBLIC MANAG REV, V21, P1348, DOI 10.1080/14719037.2019.1618383
   Kickert WJM, 2015, EUROPE MANAGING THE CRISIS: THE POLITICS OF FISCAL CONSOLIDATION, P1
   Kickert WJM, 1997, PUBLIC ADMIN, V75, P731, DOI 10.1111/1467-9299.00084
   Kolb D, 1984, EXPERIENTIAL LEARNIN
   Koppell JGS, 2010, PUBLIC ADMIN REV, V70, pS46, DOI 10.1111/j.1540-6210.2010.02245.x
   Lascoumes P, 2007, GOVERNANCE, V20, P1, DOI 10.1111/j.1468-0491.2007.00342.x
   Lipsky M, 2010, STREET-LEVEL BUREAUCRACY: DILEMMAS OF THE INDIVIDUAL IN PUBLIC SERVICES, 30TH EDITION, P1
   Lipsky Michael, 1980, STREET LEVEL BUREAUC
   Madrigal Alexis C., 2020, ATLANTIC
   Massey A., 2011, POLICY PERFORMANCE M
   May Peter, 1992, J PUBLIC POLICY, V12, P331, DOI [10.1017/S0143814X00005602, DOI 10.1017/S0143814X00005602]
   McTavish D., 2019, THEMES FLUX BRIT POL
   McTavish D, 2009, EDUC MANAG ADM LEAD, V37, P350, DOI 10.1177/1741143209102784
   Milward B, 2016, GOVERNANCE, V29, P311, DOI 10.1111/gove.12201
   Musheno, 2003, COPS TEACHERS COUNSE
   Needham C, 2008, SOC POLICY SOC, V7, P221, DOI 10.1017/S1474746407004174
   O'Leary, 2020, ETHICS DISSENT MANAG
   Ongaro E., 2018, PALGRAVE HDB PUBLIC
   Ongaro E, 2009, PUBLIC MANAGEMENT RE
   Ongaro E, 2018, PALGRAVE MACMILLAN, P61, DOI DOI 10.1057/978-1-137-55269-3_4
   Ongaro E., 2018, PALGRAVE HDB PUBLIC, P11
   Ongaro E, 2020, PUBLIC POLICY ADMIN, V35, P117, DOI 10.1177/0952076719827624
   Ongaro E, 2010, GOVERNANCE AND INTERGOVERNMENTAL RELATIONS IN THE EUROPEAN UNION AND THE UNITED STATES: THEORETICAL PERSPECTIVES, P1
   Ongaro Edoardo, 2017, PHILOS PUBLIC ADM IN
   Osborne S., 2010, NEW PUBLIC GOVERNANC
   Painter M, 2010, TRADITION ADM
   Peters BG, 2008, INT J PUBLIC SECT MA, V21, P118, DOI 10.1108/09513550810855627
   PIATTONI S., 2009, J EUROPEAN INTEGRATI, V31, P163, DOI [DOI 10.1080/07036330802642755, 10.1080/07036330802642755]
   Pierre J, 2006, HDB PUBLIC POLICY, P1
   Pierre J, 2012, SAGE HDB PUBLIC ADM, P1
   Pollitt C., 2009, CONTINUITY CHANGE PU
   POLLITT C., 2008, TIME POLICY MANAGEME
   Pollitt C, 2017, INT J PUBLIC SECT MA, V30, P555, DOI 10.1108/IJPSM-04-2017-0113
   Pollitt C, 2016, PUBLIC POLICY ADMIN, V31, P3, DOI 10.1177/0952076715590696
   Pollitt C, 2013, PUBLIC MANAG REV, V15, P899, DOI 10.1080/14719037.2012.725761
   Porter SJ., 2020, COVID 19 IS CHANGING
   Potter M, 2012, ADMIN SOC, V44, P367, DOI 10.1177/0095399712451521
   Randma-Liiv T., 2018, PALGRAVE HDB PUBLIC, Vvol. 2, P899
   Rhodes RA, 1997, UNDERSTANDING GOVERN
   Richardson J, 2018, BRIT POLIT, V13, P215, DOI 10.1057/s41293-017-0051-y
   Richardson Jeremy., 1982, POLICY STYLES EUROPE, P1
   Rietig K., 2018, LEARNING PUBLIC POLI, P51
   Roberts A, 2020, ASIA PAC J PUBLIC AM, V42, P12, DOI 10.1080/23276665.2020.1733285
   ROMZEK BS, 1987, PUBLIC ADMIN REV, V47, P227, DOI 10.2307/975901
   Simons A, 2018, POLICY SOC, V37, P14, DOI 10.1080/14494035.2017.1375248
   Smith D., 2020, GUARDIAN
   Sorensen Eva., 2012, INTERACTIVE GOVERNAN
   Spanou C, 2020, PUBLIC POLICY ADMIN, V35, P135, DOI 10.1177/0952076718772008
   Stark A., 2019, PUBLIC INQUIRIES POL
   Talbot C, 2020, GOVT VERSUS VIRUS
   Talbot C, 2018, PALGRAVE HDB PUBLIC, P1213
   Torfing Jacob., 2016, COLLABORATIVE INNOVA
   Tosun J., 2021, ROUTLEDGE HDB POLICY
   Turnpenny J, 2009, J EUR PUBLIC POLICY, V16, P640, DOI 10.1080/13501760902872783
   Vagionaki T, 2020, POLIT STUD REV, V18, P304, DOI 10.1177/1478929919834863
   van Thiel S, 2018, PALGRAVE HDB PUBLIC, P1235
   Verdun A, 2018, J EUR PUBLIC POLICY, V25, P137, DOI 10.1080/13501763.2017.1363807
   Voss JP, 2014, ENVIRON POLIT, V23, P735, DOI 10.1080/09644016.2014.923625
   White C, 2020, J ENERGY STORAGE, V28, DOI 10.1016/j.est.2020.101278
   Wildavsky A., 1979, SPEAKING TRUTH POWER
   Wu X, 2015, POLICY SOC, V34, P165, DOI 10.1016/j.polsoc.2015.09.001
   Zacka Bernardo., 2017, STATE MEETS STREET P
   Zavattaro S., 2020, ADM THEORY PRAXIS, V42, P233, DOI [10.1080/10841806.2020.1752593, DOI 10.1080/10841806.2020.1752593]
NR 104
TC 18
Z9 19
U1 27
U2 87
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0952-0767
EI 1749-4192
J9 PUBLIC POLICY ADMIN
JI Public. Policy Adm.
PD OCT
PY 2020
VL 35
IS 4
BP 365
EP 383
DI 10.1177/0952076720939631
PG 19
WC Public Administration
WE Social Science Citation Index (SSCI)
SC Public Administration
GA MS8LN
UT WOS:000554525300002
OA Green Accepted, hybrid
DA 2022-04-20
ER

PT J
AU Acciarini, C
   Boccardelli, P
   Vitale, M
AF Acciarini, Chiara
   Boccardelli, Paolo
   Vitale, Mario
TI Resilient companies in the time of Covid-19 pandemic: a case study
   approach
SO JOURNAL OF ENTREPRENEURSHIP AND PUBLIC POLICY
LA English
DT Article
DE Covid-19; Organisational resilience; Digital; Technology; Strategy
ID ORGANIZATIONS; TECHNOLOGIES
AB Purpose The Covid-19 pandemic represents an extraordinary and unpredictable event influencing the whole economy and society. Using a case study approach, the authors explored how big companies operating in Italy were able to respond to the crisis to ensure business continuity. Therefore, the authors discussed different business disruptions caused by Covid-19; in addition, they developed an integrated policy framework in which they proposed specific strategic responses for increasing the level of organizational resilience. The aim of the paper is to discuss and reflect on the ability of specific companies to increase their level of organizational resilience when unexpected events happen. Design/methodology/approach The authors conducted semi-structured interviews with target CEOs of four major companies operating in Italy in different industries. Especially, the authors focused on multiutilities, media and communications, investment banking and mobile telecommunications. The interviews were based on questions dealing with Covid-19 implications and strategic responses to navigate this complex scenario. Findings Based on the CEOs' contributions, the authors presented short-term actions and long-term strategies planned and implemented by each Italian company. In particular, the authors emphasized similarities and dissimilarities in terms of strategic responses and future business development. Originality/value The analysis of practical cases was helpful for increasing their knowledge on organizational resilience and for providing the managerial community with a policy framework to navigate unexpected events like the Covid-19 pandemic.
C1 [Acciarini, Chiara; Boccardelli, Paolo] Luiss Univ, Business & Management, Rome, Italy.
   [Vitale, Mario] Luiss Business Sch, Rome, Italy.
RP Acciarini, C (corresponding author), Luiss Univ, Business & Management, Rome, Italy.
EM cacciarini@luiss.it; pboccard@luiss.it; mvitale@luiss.it
OI Boccardelli, Paolo/0000-0003-0760-9719; ACCIARINI,
   Chiara/0000-0001-5287-0890
CR Acciarini C, 2021, MANAGE DECIS, V59, P638, DOI 10.1108/MD-07-2019-1006
   Africa Union, 2021, AFR CDC DASHB
   Bacq S, 2021, J MANAGE STUD, V58, P283, DOI 10.1111/joms.12641
   Baek S, 2020, FINANC RES LETT, V37, DOI 10.1016/j.frl.2020.101748
   Bloomberg.com, 2020, BLOOMBERG
   Boisot M, 1999, ORGAN SCI, V10, P237, DOI 10.1287/orsc.10.3.237
   Buliga O., 2016, J BUS EC, V86, P647, DOI [10.1007/s11573-015-0796-y, DOI 10.1007/S11573-015-0796-Y]
   Chen CF, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101688
   Choi TM, 2020, TRANSPORT RES E-LOG, V140, DOI 10.1016/j.tre.2020.101961
   Continetti M, 2020, NATL REV
   Di Vaio A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12124851
   Eurostat, 2020, IND PROD 9 1 BOTH EU
   Fintech, 2020, IMP COVID 19 CRIS IN
   Frank AG, 2019, INT J PROD ECON, V210, P15, DOI 10.1016/j.ijpe.2019.01.004
   Gregorioa GB, 2020, ASIAN J AGRIC DEV, V17, P1, DOI 10.37801/ajad2020.17.1.1
   Haren P., 2020, HARVARD BUS REV
   Herrera-Echeverri H, 2014, J BUS RES, V67, P1921, DOI 10.1016/j.jbusres.2013.11.020
   Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245
   Iborra M, 2020, LONG RANGE PLANN, V53, DOI 10.1016/j.lrp.2019.101947
   International Finance Corporation, 2020, COVID 19 S IMP GLOB
   International Labor Organization, 2020, COVID 19 WORLD WORK
   International Monetary Fund, 2021, POL SUPP VACC EXP LI
   Ishack S, 2020, AM J MED, V133, pE385, DOI 10.1016/j.amjmed.2020.04.002
   Jani, 2020, ME WE COVID 19 HER N
   Kumar A, 2020, DIABETES METAB SYND, V14, P569, DOI 10.1016/j.dsx.2020.05.008
   Kumar S, 2020, DIABETES METAB SYND, V14, P1283, DOI 10.1016/j.dsx.2020.07.010
   Landry S, 2016, TECHNOL FORECAST SOC, V113, P429, DOI 10.1016/j.techfore.2016.09.006
   Lengnick-Hall CA, 2005, J MANAGE, V31, P738, DOI 10.1177/0149206305279367
   Levius Seon, 2018, International Journal of Business and Globalisation, V20, P128
   Li JG, 2018, ENGINEERING-PRC, V4, P381, DOI 10.1016/j.eng.2018.05.013
   Lindquist E., 2017, IMPORTANT ARE MOBILE, P1744
   Linnenluecke MK, 2017, INT J MANAG REV, V19, P4, DOI 10.1111/ijmr.12076
   Luthans F, 2002, J ORGAN BEHAV, V23, P695, DOI 10.1002/job.165
   Maritz A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114612
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   OECD, 2020, COR COVID 19 SME POL
   OECD, 2019, ENH ACC CONN HARN DI
   Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033
   Peng MW, 2009, ACAD MANAGE PERSPECT, V23, P63, DOI 10.5465/AMP.2009.43479264
   Ratten V., 2020, J SMALL BUSINESS ENT, V32, P503, DOI DOI 10.1080/08276331.2020.1790167
   Sarkis J, 2020, RESOUR CONSERV RECY, V159, DOI 10.1016/j.resconrec.2020.104894
   Schwab, 2020, FIGHTING COVID 19 CO
   Sepasgozar SME, 2019, BUILDINGS-BASEL, V9, DOI 10.3390/buildings9070158
   Sergi E., 2020, ARTIF INTELL, V1100, DOI [10.1007/978-3-030-39319-9_11, DOI 10.1007/978-3-030-39319-9_11]
   Shepherd DA, 2020, J MANAGE STUD, V57, P1750, DOI 10.1111/joms.12633
   Sounderajah V., 2020, DETERMINANTS BURNOUT
   Statista, 2020, YEAR ON YEAR CHANG W
   Sullivan-Taylor B, 2011, INT J PROD RES, V49, P5565, DOI 10.1080/00207543.2011.563837
   Tayur, 2020, IMPACT COVID 19 MANU, DOI [10.2139/ssrn.3593540, DOI 10.2139/SSRN.3593540]
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   UNCTAD, 2019, DIG EC REP VAL CREAT
   United Nations, 2020, POL BRIEF DIS INCL R
   Vogus TJ, 2007, IEEE SYS MAN CYBERN, P3476
   Wang YT, 2020, EMERG MARK FINANC TR, V56, P2350, DOI 10.1080/1540496X.2020.1791074
   We Are Social, 2020, DIG 2020
   Weber FD, 2019, DIGIT POLICY REGUL G, V21, P264, DOI 10.1108/DPRG-09-2018-0050
   Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4
   Weick KE, 2015, MANAGING THE UNEXPECTED: SUSTAINED PERFORMANCE IN A COMPLEX WORLD, 3RD EDITION, P1, DOI 10.1002/9781119175834
   Weinberg, 2020, HERES US CAN GET BES
   WHO, 2020, NOV COR 2019 NCOV SI
   Yang KF, 2020, PUBLIC ADMIN REV, V80, P657, DOI 10.1111/puar.13248
   Yin R.K., 2014, CASE STUDY RES APPL, V5th ed.
NR 62
TC 1
Z9 1
U1 14
U2 26
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2045-2101
EI 2045-211X
J9 J ENTREP PUBLIC POLI
JI J. Engrep. Public Policy
PD OCT 28
PY 2021
VL 10
IS 3
SI SI
BP 336
EP 351
DI 10.1108/JEPP-03-2021-0021
EA JUN 2021
PG 16
WC Economics
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA WN7WC
UT WOS:000669558100001
OA Green Submitted, hybrid
DA 2022-04-20
ER

PT J
AU Alshawwa, SZ
   Almass, SA
   Alotaibi, SA
   Almutairi, IM
   Otain, AY
   Al-Najjar, AH
   Benajiba, N
AF Alshawwa, Samar Zuhair
   Almass, Sarah Abdulaziz
   Alotaibi, Sara Abdullah
   Almutairi, Injood Mnwer
   Otain, Amjad Yhaya
   Al-Najjar, Amal Hassan
   Benajiba, Nada
TI Assessment of knowledge and challenges toward the use of subcutaneous
   self-injecting insulin among diabetes patients during COVID-19 pandemic
   in Saudi Arabia
SO SAUDI PHARMACEUTICAL JOURNAL
LA English
DT Article
DE Assessment; Self-Injecting; Insulin; COVID-19 Pandemic; Diabetes; Saudi
   Arabia
ID PREVALENCE; MANAGEMENT; QUALITY; RATES; CARE
AB Background: The COVID-19 pandemic has revolutionized the delivery of chronic health care. For diabetic patients, maintaining regular contact with healthcare providers and visiting healthcare centers are crucial to patients' overall ability to control their glycemic status. Objective: To assess patients' knowledge regarding the use of insulin injection devices and the challenges these patients face in obtaining medical advice, as well as to suggest alternative solutions for addressing these challenges among diabetic patients self-administering their injections during the COVID-19 pandemic. Methodology: An observational cross-sectional study was conducted among a sample population (N = 178) of diabetic patients attending Security Forces Hospital-Riyadh, Saudi Arabia, from which the Institutional Review Board (IRB) was granted. Data was collected using a self-administered questionnaire, which was distributed from August to September 2020. Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) program (version 21). Significant P-value = < 0.05. Results: The majority of patients had good knowledge and practice explained with values 73.6% of total papulation. Sixty-four percent of patients with type 1 diabetes and 59% of patients with type 2 diabetes reported experiencing moderately severe challenges obtaining counseling. There was no correlation between severity of disease and knowledge levels (p-value = 0.36). The most appropriate means of obtaining counseling was determined to be conversations with healthcare providers; this strategy received an overall average score of 4.9 +/- 0.4 (p-value < 0.0001). Conclusion: Regardless of whether knowledge is high among patients with diabetes, continuous support and counseling from healthcare providers is critical. The creation of innovative approaches to facilitate communication between diabetes patients and healthcare providers is recommended for continued patient care during the COVID-19 pandemic. (c) 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Alshawwa, Samar Zuhair] Princess Nourah Bint Abdulrahman Univ, Coll Pharm, Dept Pharmaceut Sci, POB 84428, Riyadh 11671, Saudi Arabia.
   [Almass, Sarah Abdulaziz; Alotaibi, Sara Abdullah; Almutairi, Injood Mnwer; Otain, Amjad Yhaya] Princess Nourah Bint Abdulrahman Univ, Coll Pharm, Pharm Grad, Riyadh, Saudi Arabia.
   [Al-Najjar, Amal Hassan] Secur Forces Hosp Program, Riyadh, Saudi Arabia.
   [Benajiba, Nada] Princess Nourah Bint Abdulrahman Univ, Dept Basic Hlth Sci, POB 84428, Riyadh 11671, Saudi Arabia.
RP Alshawwa, SZ (corresponding author), Princess Nourah Bint Abdulrahman Univ, Coll Pharm, Dept Pharmaceut Sci, POB 84428, Riyadh 11671, Saudi Arabia.; Benajiba, N (corresponding author), Princess Nourah Bint Abdulrahman Univ, Dept Basic Hlth Sci, POB 84428, Riyadh 11671, Saudi Arabia.
EM szalshawwa@pnu.edu.sa; nabenajiba@pnu.edu.sa
RI Alshawwa, Samar/AGO-8238-2022
FU Princess Nourah bint Abdulrahman Univer-sity, Riyadh, Saudi
   ArabiaPrincess Nourah bint Abdulrahman University [PNURSP2022R165]
FX This research was funded by the Princess Nourah bint Abdul-rahman
   University Researchers Supporting Project number (PNURSP2022R165) ,
   Princess Nourah bint Abdulrahman Univer-sity, Riyadh, Saudi Arabia.
CR Almutairi KM, 2015, ARCH IRAN MED, V18, P816, DOI 0151812/AIM.005
   Alotaibi A, 2017, J EPIDEMIOL GLOB HEA, V7, P211, DOI 10.1016/j.jegh.2017.10.001
   AlShareef Saad M., 2021, GLOBAL J HLTH SCI, V9, P25
   Alsmadi Ismail Nasir, COVID19 DIAB MAN RIS, P1
   Baldoni S, 2020, PHARM PRACT-GRANADA, V18, DOI [10.18549/pharmpract.2020.3.1926, 10.18549/PharmPract.2020.3.1926]
   Banerjee M, 2020, DIABETES METAB SYND, V14, P351, DOI 10.1016/j.dsx.2020.04.013
   Battineni G, 2021, J TAIBAH UNIV MED SC, V16, P300, DOI 10.1016/j.jtumed.2020.12.010
   Boeru G, 2013, MED DEVICES-EVID RES, V6, P175, DOI 10.2147/MDER.S52590
   Davidson Mayer B, 2015, Clin Diabetes, V33, P123, DOI 10.2337/diaclin.33.3.123
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Koster ES, 2021, RES SOC ADMIN PHARM, V17, P2002, DOI 10.1016/j.sapharm.2020.07.001
   Mohamed I. E., 2013, Food and Public Health, V3, P341
   Patil M, 2017, DIABETES METAB SYND, V11, pS53, DOI 10.1016/j.dsx.2016.09.010
   Petrelli F, 2021, PRIM HEALTH CARE RES, V22, DOI 10.1017/S1463423621000268
   Petrelli F, 2020, DIABETES RES CLIN PR, V169, DOI 10.1016/j.diabres.2020.108481
   Robert AA, 2018, INT J PEDIAT, V2018, DOI 10.1155/2018/9408370
   Sadera R, 2020, J ENDOCRINOL METAB, V10, P155, DOI 10.14740/jem699
   Sanii Y, 2016, J RES PHARM PRACT, V5, P132, DOI 10.4103/2279-042X.179580
   Tosun B, 2019, AFR HEALTH SCI, V19, P1628, DOI 10.4314/ahs.v19i1.38
   Trief Paula M., 2021, CLIN DIABETOL, V34, P25
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Zhang XP, 2012, DIABETES CARE, V35, P1566, DOI 10.2337/dc12-0081
NR 23
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-0164
EI 2213-7475
J9 SAUDI PHARM J
JI Saudi Pharm. J.
PD DEC
PY 2021
VL 29
IS 12
BP 1506
EP 1512
DI 10.1016/j.jsps.2021.11.010
EA DEC 2021
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA XY7BF
UT WOS:000737122200018
PM 34899013
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Sachdeva, K
   Daga, MK
   Mawari, G
   Karra, VK
   Kumar, N
   Garg, S
AF Sachdeva, Karan
   Daga, Mradul Kumar
   Mawari, Govind
   Karra, Vijay Kumar
   Kumar, Naresh
   Garg, Sandeep
TI Management and Therapeutic Options for COVID-19: A Review
SO JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
LA English
DT Review
DE Acute respiratory distress syndrome; Coronavirus disease 2019;
   Hydroxychloroquine; Severe acute respiratory syndrome coronavirus 2;
   World health organisation
ID ACUTE RESPIRATORY SYNDROME; CONVALESCENT PLASMA; SYNDROME CORONAVIRUS;
   TRIPLE COMBINATION; INHIBITION; INFECTION; EFFICACY; VIRUS; CHINA; TIME
AB Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative organism for Coronavirus Disease 2019 (COVID-19), originated in Wuhan, China and has now spread to most parts of the world. A pandemic of this magnitude has not been witnessed in more than 100 years since the Spanish flu in 1918. The major challenge for scientists and doctors worldwide has been to find a therapeutic intervention to prevent the spread and development of this disease. As more research is being done, the pathophysiology of COVID-19 has been explained, although no effective therapy has been found. Multiple drugs and therapies are under trials and a few have shown inconclusive results. The attempts have ranged from repurposing drugs to trying to develop new vaccines. Formulation of guidelines pose another challenge to the government and international agencies owing to the lack of data. These agencies have constantly released and updated guidelines based on new research and growing knowledge. In this review, we aim to compare and bring out the different international guidelines for management of COVID-19, along with a review of tried therapeutic interventions and their primitive results. The COVID-19 has been a major global health crisis that is overpowering most heath care systems and multiple agencies and research teams are trying to limit and manage this spread. Currently no effective treatment is available and guidelines differ regarding the drugs that can be used, which are mostly off-label.
C1 [Sachdeva, Karan] Maulana Azad Med Coll, New Delhi, India.
   [Daga, Mradul Kumar; Mawari, Govind; Kumar, Naresh; Garg, Sandeep] Maulana Azad Med Coll, Dept Med, New Delhi, India.
   [Daga, Mradul Kumar; Mawari, Govind] Maulana Azad Med Coll, Ctr Occupat & Environm Hlth, New Delhi, India.
   [Karra, Vijay Kumar] Indian Council Med Res, Dept Hlth Res, Div Epidemiol & Communicable Dis, New Delhi, India.
RP Daga, MK (corresponding author), Maulana Azad Med Coll, Dept Med, New Delhi, India.
EM drmraduldaga@gmail.com
CR Abstract, 2012, KIDNEY INT S
   Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2020, PRIVATE HOSP DELHI T
   [Anonymous], 2020, INT PULMONOLOGISTS C
   [Anonymous], 2020, STUDY EVALUATE SAFET
   [Anonymous], 2020, CORTICOSTEROIDS COVI
   [Anonymous], 2020, GIL ANN RES PHAS 3 T
   [Anonymous], 2020, NY TIMES, P1
   [Anonymous], 2020, EM ACC REMD OUTS CLI
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bean DM, 2020, EUR J HEART FAIL, V22, P967, DOI 10.1002/ejhf.1924
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Biran N, 2020, LANCET RHEUMATOL, V2, pE603, DOI 10.1016/S2665-9913(20)30277-0
   Bloch EM, 2020, J CLIN INVEST, V130, P2757, DOI 10.1172/JCI138745
   Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638
   Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Cao W, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa102
   Casadevall A, 2020, J CLIN INVEST, V130, P1545, DOI 10.1172/JCI138003
   cdc, CLIN CAR GUID
   Ceccarelli G, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106029
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chatterjee P, 2020, INDIAN J MED RES, V151, P459, DOI 10.4103/ijmr.IJMR_2234_20
   Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03
   Chen L, 2020, LANCET INFECT DIS, V20, P398, DOI 10.1016/S1473-3099(20)30141-9
   Chen Z, 2020, EFFICACY HYDROXYCHLO, V3
   Choy KT, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104786
   Clinicaltrialsgov, 2020, LOS PAT COVID 19 NOT
   Clinicaltrialsgov, 2020, LOS PAT COVID 19 REQ, P2020
   CTRI, NTR
   Daga M. K., 2019, J ADV RES MED, V6, P1, DOI [10.24321/2349.7181.201917, DOI 10.24321/2349.7181.201917]
   Davoudi-Monfared E, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01061-20
   Devasenapathy N, 2020, CAN MED ASSOC J, V192, pE745, DOI 10.1503/cmaj.200642
   Duan K Bc, 2020, P NATL ACAD SCI USA, P1, DOI DOI 10.1073/PNAS.2004168117
   Elharrar X, 2020, JAMA-J AM MED ASSOC, V323, P2336, DOI 10.1001/jama.2020.8255
   Fadel R, 2020, CLIN INFECT DIS, V71, P2114, DOI 10.1093/cid/ciaa601
   FDA, 2020, REC INV COVID 19 CON
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301
   Government of India. Ministry of health & family Welfare Services DG of HD (EMR), 2020, REV GUID CLIN MAN CO
   Guaraldi G, 2020, LANCET RHEUMATOL, V2, pE474, DOI 10.1016/S2665-9913(20)30173-9
   Gurwitz D, 2020, DRUG DEVELOP RES, V81, P537, DOI 10.1002/ddr.21656
   Hernandez AV, 2020, ANN INTERN MED, V173, P287, DOI 10.7326/M20-2496
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang D, 2021, J MED VIROL, V93, P481, DOI 10.1002/jmv.26256
   Huang MX, 2020, J MOL CELL BIOL, V12, P322, DOI 10.1093/jmcb/mjaa014
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   ICMR, 2020, THER PLASM EXCH COVI
   Institute M, NTR
   Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085
   Khamitov R. A., 2008, Voprosy Virusologii, V53, P9
   LENZER J, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1335
   LI L, 2020, JAMA-J AM MED ASSOC, DOI [DOI 10.1001/JAMA.2020.10044, 10.1001/jama.2020.10044]
   Li Y, 2020, ELACOI MEDRXIV, V2020
   Liu JY, 2020, EMERG INFECT DIS, V26, P1320, DOI 10.3201/eid2606.200239
   Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395
   Mao R, 2020, LANCET GASTROENTEROL, V5, P426, DOI 10.1016/S2468-1253(20)30076-5
   Ministry of health and family welfare, NTR
   Ministry of Health & Family Welfare Government of India, 2020, REV GUID HOM IS VER
   MoHaF W., 2020, GUIDANCE DOCUMENT AP
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   NIH, NTR
   NIH, 2020, CAR CRIT ILL PAT COV
   NIH, INT ALF BET
   Organisation WH, 2020, CLIN MANAGEMENT COVI
   Prescott HC, 2020, JAMA-J AM MED ASSOC, V324, P1292, DOI 10.1001/jama.2020.16747
   Ranard Lauren S, 2020, CIRC-HEART FAIL, V13
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roback JD, 2020, JAMA-J AM MED ASSOC, V323, P1561, DOI 10.1001/jama.2020.4940
   Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Schultz MJ, 2017, INTENS CARE MED, V43, P612, DOI 10.1007/s00134-017-4750-z
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Singh AK, 2020, DIABETES METAB SYND, V14, P589, DOI 10.1016/j.dsx.2020.05.017
   Spanakis N, 2014, INT J ANTIMICROB AG, V44, P528, DOI 10.1016/j.ijantimicag.2014.07.026
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Toth K, 2008, P NATL ACAD SCI USA, V105, P7293, DOI 10.1073/pnas.0800200105
   Totura AL, 2019, EXPERT OPIN DRUG DIS, V14, P397, DOI 10.1080/17460441.2019.1581171
   USNLo M, 2020, MILD MODERATE 2019 N
   USNLo M, 2020, INFECTION
   USNLo M, NTR
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   WHO, 2020, DRAFT LANDSC COVID 1
   World Health Organization, 2020, HOM CAR PAT SUSP CON
   World Health Organization, 2020, WEEKL OP UPD COVID 1
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Yousefifard M, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13557
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zhang J, 2020, BIORXIV
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 104
TC 0
Z9 0
U1 0
U2 0
PU PREMCHAND SHANTIDEVI RESEARCH FOUNDATION
PI DELHI
PA 71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA
SN 2249-782X
EI 0973-709X
J9 J CLIN DIAGN RES
JI J. Clin. Diagn. Res.
PD NOV
PY 2020
VL 14
IS 11
BP OE1
EP OE8
DI 10.7860/JCDR/2020/46071.14233
PG 8
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA OU6ZX
UT WOS:000591676200082
OA gold
DA 2022-04-20
ER

PT J
AU Alah, MA
   Abdeen, S
   Selim, N
   Hamdani, D
   Radwan, E
   Sharaf, N
   Al-katheeri, H
   Bougmiza, I
AF Abed Alah, Muna
   Abdeen, Sami
   Selim, Nagah
   Hamdani, Dhouha
   Radwan, Eman
   Sharaf, Nahla
   Al-katheeri, Huda
   Bougmiza, Iheb
TI Knowledge and Perceived Effectiveness of Infection Prevention and
   Control Measures Among Health Care Workers During the COVID-19 Pandemic
   A National Survey
SO JOURNAL OF NURSING CARE QUALITY
LA English
DT Article
DE COVID-19; hand hygiene; health care worker; infection prevention and
   control; personal protective equipment; Qatar
ID PERSONAL PROTECTIVE EQUIPMENT; STANDARD PRECAUTIONS; ATTITUDE
AB Background: Being the first line of defense against COVID-19 infection, health care workers (HCWs) are at an increased risk of getting infected. Infection prevention and control (IPC) measures were deemed to be instrumental in protecting them and their patients against infection. Purpose: To assess HCWs' knowledge of IPC measures and their perceived effectiveness in protecting against COVID-19. Methods: A national web-based survey was conducted in different health care sectors in Qatar. Results: A total of 1757 HCWs completed the survey. HCWs believed in applying stricter IPC precautions while dealing with confirmed COVID-19 cases than with suspected cases. Males and physicians were more likely to have high perceived effectiveness of IPC measures than females, nurses, and pharmacists. Higher proportions of HCWs believed in the effectiveness of hand hygiene than most types of personal protective equipment. Conclusion: Further research is recommended to assess the impact of HCWs' knowledge and perceived effectiveness of IPC measures on their compliance.
C1 [Abed Alah, Muna; Abdeen, Sami] Hamad Med Corp HMC, Dept Community Med, POB 3050, Doha, Qatar.
   [Selim, Nagah] Cairo Univ, Publ Hlth & Prevent Med, Cairo, Egypt.
   [Selim, Nagah] Primary Hlth Care Corp PHCC, Dept Family & Community Med, Doha, Qatar.
   [Bougmiza, Iheb] Primary Hlth Care Corp PHCC, Dept Community Med, Doha, Qatar.
   [Hamdani, Dhouha; Radwan, Eman; Sharaf, Nahla] Minist Publ Hlth MOPH, Hlth Care Qual Management & Patient Safety Dept, Doha, Qatar.
   [Al-katheeri, Huda] Minist Publ Hlth MOPH, Strateg Planning & Performance Dept, Doha, Qatar.
   [Bougmiza, Iheb] Sousse Univ, Coll Med, Dept Community Med, Sousse, Tunisia.
RP Alah, MA (corresponding author), Hamad Med Corp HMC, Dept Community Med, POB 3050, Doha, Qatar.
EM MAbedAlah@hamad.qa; SAbdeen@hamad.qa; nselim@phcc.gov.qa;
   dhamdani@moph.gov.qa; eradwan@moph.gov.qa; Nahlasharaf61@gmail.com;
   halkatheeri@moph.gov.qa; mbougmiza@phcc.gov.qa
CR Ahmed J, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7036
   Alajmi J, 2020, INT J INFECT DIS, V100, P386, DOI 10.1016/j.ijid.2020.09.027
   Askarian M, 2004, J HOSP INFECT, V58, P292, DOI 10.1016/j.jhin.2004.07.004
   Brooks SK, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-049857
   Centers for Disease Control and Prevention (CDC), US PERS PROT EQ PPE
   Chia SE, 2005, OCCUP ENVIRON MED, V62, P473, DOI 10.1136/oem.2004.015024
   Gholami M, 2021, INT J INFECT DIS, V104, P335, DOI 10.1016/j.ijid.2021.01.013
   Jemal Suoud, 2018, Adv Prev Med, V2018, P5290797, DOI 10.1155/2018/5290797
   Jeong I, 2008, AM J INFECT CONTROL, V36, P739, DOI 10.1016/j.ajic.2008.04.253
   Majeed P., 2018, POLYTECH J, V8, P190
   Oliveira AC, 2009, REV ESC ENFERM USP, V43, P313, DOI 10.1590/S0080-62342009000200009
   Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181
   Parker MJ, 2006, EMERG MED J, V23, P349, DOI 10.1136/emj.2005.026146
   Schwartz D, 2014, DISASTER MED PUBLIC, V8, P150, DOI 10.1017/dmp.2014.25
   Shimokura G, 2006, AM J INFECT CONTROL, V34, P100, DOI 10.1016/j.ajic.2005.08.012
   Smith LE, 2022, EMERG MED J, V39, P100, DOI 10.1136/emermed-2021-211454
   Wong TW, 2005, AM J INFECT CONTROL, V33, P580, DOI 10.1016/j.ajic.2005.05.025
   World Health Organization, 2019, INFECT PREVENTION CO
   World Health Organization (WHO), BURD HLTH CAR ASS IN
NR 19
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1057-3631
EI 1550-5065
J9 J NURS CARE QUAL
JI J. Nurs. Care Qual.
PD APR-JUN
PY 2022
VL 37
IS 2
BP E23
EP E30
DI 10.1097/NCQ.0000000000000615
PG 8
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA ZF7SP
UT WOS:000759769600001
PM 34935733
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Tilocca, B
   Britti, D
   Urbani, A
   Roncada, P
AF Tilocca, Bruno
   Britti, Domenico
   Urbani, Andrea
   Roncada, Paola
TI Computational Immune Proteomics Approach to Target COVID-19
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Review
DE SARS-CoV-2; COVID-19; computational immune proteomics; bioinformatics;
   personalized medicine; diagnostics; vaccines
ID B-CELL EPITOPES; PEPTIDE PHAGE DISPLAY; PREDICTION; IMMUNOINFORMATICS;
   PROTEIN; BIOINFORMATICS; ANTIGENICITY; BENCHMARKING; DISCOVERY
AB Progress of the omics platforms widens their application to diverse fields, including immunology. This enables a deeper level of knowledge and the provision of a huge amount of data for which management and fruitful integration with the past evidence requires a steadily growing computational effort. In light of this, immunoinformatics emerges as a new discipline placed in between the traditional labbased investigations and the computational analysis of the biological data. Immunoinformatics make use of tailored bioinformatics tools and data repositories to facilitate the analysis of data from a plurality of disciplines and help drive novel research hypotheses and in silico screening investigations in a fast, reliable, and cost-effective manner. Such computational immunoproteomics studies may as well prepare and guide lab-based investigations, representing valuable technology for the investigation of novel pathogens, to tentatively evaluate specificity of diagnostic products, to forecast on potential adverse effects of vaccines and to reduce the use of animal models. The present manuscript provides an overview of the COVID-19 pandemic and reviews the state of the art of the omics technologies employed in fighting SARS-CoV-2 infections. A comprehensive description of the immunoinformatics approaches and its potential role in contrasting COVID-19 pandemics is provided.
C1 [Tilocca, Bruno; Britti, Domenico; Roncada, Paola] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy.
   [Urbani, Andrea] Univ Cattolica Sacro Cuore, Intensivol & Perioperat Clin, Dept Basic Biotechnol Sci, I-00168 Rome, Italy.
   [Urbani, Andrea] Fdn Policlin Univ Agostino Gemelli, Dipartimento Sci Lab & Infettivol, I-00168 Rome, Italy.
RP Roncada, P (corresponding author), Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy.
EM roncada@unicz.it
RI Urbani, Andrea/AAD-1675-2022; Urbani, Andrea/B-2953-2012; Roncada,
   Paola/C-5263-2013
OI Reis, AlessanRSS/0000-0001-8486-7469; TILOCCA,
   Bruno/0000-0001-6196-9358; Roncada, Paola/0000-0002-0114-5872
CR Abdelmageed MI, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/2683286
   Adhikari UK, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/6718083
   Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254
   Amin N, 2009, MALAYS J MED SCI, V16, P4
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   Backert L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0245-0
   Bahrami AA, 2019, INT REV IMMUNOL, V38, P307, DOI 10.1080/08830185.2019.1657426
   Bansal AK, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-19
   Baruah V, 2020, J MED VIROL, V92, P495, DOI 10.1002/jmv.25698
   Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005
   Bianchi M., 2020, PREPRINTS, DOI [10.20944/preprints202004.0089.v1, DOI 10.20944/PREPRINTS202004.0089.V1]
   Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505
   Bojkova D, 2020, NATURE, V583, P469, DOI 10.1038/s41586-020-2332-7
   Brusic V, 2008, IMMUNOINFORMATICS, DOI [10.1007/978-0-387-72968-8, DOI 10.1007/978-0-387-72968-8]
   Buonavoglia C, 2006, EMERG INFECT DIS, V12, P492, DOI 10.3201/eid1203.050839
   Cardozo K. H. M., 2020, RES SQUARE, P1
   Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Davey Hazel M., 2002, Methods in Cell Science, V24, P91, DOI 10.1023/A:1024106317540
   Davies MN, 2007, DRUG DISCOV TODAY, V12, P389, DOI 10.1016/j.drudis.2007.03.010
   De Maio F., 2020, PREPRINT, DOI [10.21203/rs.3.rs-30903/v1, DOI 10.21203/RS.3RS-30903/V1]
   Decaro N, 2020, VET MICROBIOL, V244, DOI 10.1016/j.vetmic.2020.108693
   Desai Dattatraya V, 2014, Methods Mol Biol, V1184, P333, DOI 10.1007/978-1-4939-1115-8_19
   DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033
   Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117
   Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009
   Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015
   Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002
   Gyles C. L., 2010, PATHOGENESIS BACTERI, DOI [10.1002/9780470958209, DOI 10.1002/9780470958209]
   Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7
   Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006
   Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071
   Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0
   Liu JH, 2019, MATH BIOSCI, V315, DOI 10.1016/j.mbs.2019.108217
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Ma H., 2006, NAT SCI, V4, P36
   Manavalan B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01695
   Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3
   Messner CB, 2020, CELL SYST, V11, P11, DOI 10.1016/j.cels.2020.05.012
   Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857
   Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9
   Mukherjee S, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020290
   Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403
   ORESHKOVA N, 2020, SARS COV2 INFECT FAR, V25, P2, DOI DOI 10.2807/1560-7917.ES.2020.25.23.2001005
   Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   Paul S, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007757
   Pedersen SF, 2020, J CLIN INVEST, V130, P2202, DOI 10.1172/JCI137647
   RAMAKRISHNAN S, 2019, RECENT ADV ANIMAL VI, V6, P301
   Ramanathan B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155900
   Rosa DS, 2010, ARCH IMMUNOL THER EX, V58, P121, DOI 10.1007/s00005-010-0067-0
   Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009
   Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Sanchez-Trincado JL, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2680160
   Shapshak P., 2019, GLOBAL VIROLOGY 3 VI, VIII, DOI [10.1007/978-3-030- 29022-1, DOI 10.1007/978-3-030-29022-1]
   Shen B, 2020, CELL, V182, P59, DOI 10.1016/j.cell.2020.05.032
   Martins LMS, 2013, FUTURE MICROBIOL, V8, P549, DOI [10.2217/FMB.13.22, 10.2217/fmb.13.22]
   Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771
   Soria-Guerra RE, 2015, J BIOMED INFORM, V53, P405, DOI 10.1016/j.jbi.2014.11.003
   Tan J., 2020, HOST INFECTIVITY PRE, DOI [10.1101/2020.01.21.914044, DOI 10.1101/2020.01.21.914044]
   Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036
   Tetro JA, 2020, MICROBES INFECT, V22, P72, DOI 10.1016/j.micinf.2020.02.006
   Tilocca B, 2020, MICROBES INFECT, V22, P188, DOI 10.1016/j.micinf.2020.04.002
   Tilocca B, 2020, MICROBES INFECT, V22, P182, DOI 10.1016/j.micinf.2020.05.013
   Tilocca B, 2020, MICROBES INFECT, V22, P218, DOI 10.1016/j.micinf.2020.03.002
   Tomar Namrata, 2014, Methods Mol Biol, V1184, P23, DOI 10.1007/978-1-4939-1115-8_3
   Tomar N, 2010, IMMUNOLOGY, V131, P153, DOI 10.1111/j.1365-2567.2010.03330.x
   Tong JC, 2009, DRUG DISCOV TODAY, V14, P684, DOI 10.1016/j.drudis.2009.04.001
   Trolle T, 2015, BIOINFORMATICS, V31, P2174, DOI 10.1093/bioinformatics/btv123
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Van Regenmortel MHV, 2009, METHODS MOL BIOL, V524, P3, DOI 10.1007/978-1-59745-450-6_1
   Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522
   Wang HY, 2020, ACS CENTRAL SCI, V6, P2238, DOI 10.1021/acscentsci.0c00742
   Wu CH, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0223-x
   Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]
   Yang YS, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102434
   Yates A, 2001, Brief Bioinform, V2, P245, DOI 10.1093/bib/2.3.245
   Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022
   Zhao YD, 2003, BIOINFORMATICS, V19, P1978, DOI 10.1093/bioinformatics/btg255
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 83
TC 8
Z9 8
U1 3
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD NOV 6
PY 2020
VL 19
IS 11
BP 4233
EP 4241
DI 10.1021/acs.jproteome.0c00553
PG 9
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA OS1RZ
UT WOS:000589944200004
PM 32914632
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Tome, E
   Gromova, E
AF Tome, Eduardo
   Gromova, Elizaveta
TI Development of Emergent Knowledge Strategies and New Dynamic
   Capabilities for Business Education in a Time of Crisis
SO SUSTAINABILITY
LA English
DT Article
DE knowledge strategies; dynamic capabilities; COVID-19; knowledge
   education
ID MANAGEMENT
AB The current pandemic is, above all, a crisis of knowledge-Humanity had to find a vaccine, and now we are not sure how to behave socially to minimize the pandemic bad effects. For organizations, this situation requires an update in the reflection regarding both the strategy and the actions that should be performed. Therefore, the current crisis requires new ways of applying knowledge strategies and dealing with dynamic capabilities. We first analyze the two questions (knowledge strategies and dynamic capabilities) in abstract and general terms, and then we specifically focus on business education during the COVID-19 crisis. We conclude that COVID-19 creates a need for all knowledge strategies in terms of business education. Data, information, knowledge, and wisdom will be needed; above all, it requires the Unknown-Knowns, which is the basis for Knowledge Sharing, and the Unknown-Unknowns that base Knowledge Exploration because both Knowledge Exploitation and Knowledge Acquisition are strategies business schools use to perform in times of crisis. They are more difficult to implement because both the Known-Knowns and the Known-Unknowns are less valuable to solve a crisis like this one: all this will result in "agile universities", which will be (and already are) those that will use the right strategies and the right dynamic capabilities and will have better results. The paper is original because we link Knowledge Management and Human Resources Development Concepts to generate a broader and more comprehensive understanding of the organizational behavior about a very specific problem-business education-in a very specific time of the COVID-19 crisis. The limits of the paper relate to the evolution of society itself; we do not know when the crisis will end, and we are not sure how much of the "new normal" will remain in the "post-COVID-19" situation. The topic and analysis are of interest for practitioners because daily, they experience how their reality changed and their need to adapt, yet they do not know how. This topic and analysis are also of interest to scholars because science is based on questions, explaining and providing ways to improve one's reality. COVID-19 has shown us, dramatically and uniquely, the need for new solutions in times of peace.
C1 [Tome, Eduardo] Univ Lusofona Humanidades & Tecnol, Econ Dept, P-1749024 Lisbon, Portugal.
   [Gromova, Elizaveta] Peter Great St Petersburg Polytech Univ, Grad Sch Ind Econ, St Petersburg 195251, Russia.
RP Tome, E (corresponding author), Univ Lusofona Humanidades & Tecnol, Econ Dept, P-1749024 Lisbon, Portugal.
EM eduardo.tome@gmail.com; lizaveta-90@yandex.ru
CR Amundsen B., CORONAVIRUS SPREADS
   Augier M, 2009, ORGAN SCI, V20, P410, DOI 10.1287/orsc.1090.0424
   Bejinaru R., 2017, MANAG DYN KNOWL EC, V5, P577, DOI [10.25019/MDKE/5.4.07, DOI 10.25019/MDKE/5.4.07]
   Bolisani E., 2018, EMERGENT KNOWLEDGE S
   Bratianu C., ECKM 2020 KEYNOTE SP
   Bratianu C, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042313
   COLLIS DJ, 1994, STRATEGIC MANAGE J, V15, P143, DOI 10.1002/smj.4250150910
   Curtiss P.R., 1973, LIFE SKILLS SERIES
   Denrell J., 2016, DYNAMIC CAPABILITY T
   Descartes D., 2001, DISCOURSE METHOD OPT
   Dickerson M., SOCIAL DISTANCING ME
   Duncan R. B., 1976, AMBIDEXTROUS ORG DES
   Edwards John, 2011, Electronic Journal of Knowledge Management, V9, P297
   Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E
   European Commission, INNOVATION NETWORKS
   Hamidi S, 2020, J AM PLANN ASSOC, V86, P495, DOI 10.1080/01944363.2020.1777891
   Horgan Denis, 2020, Biomed Hub, V5, P1341, DOI 10.1159/000511232
   Javidan M, 1998, LONG RANGE PLANN, V31, P60, DOI 10.1016/S0024-6301(97)00091-5
   Kavis M., 4 STAGE CLOUD COMPET
   Kianto Aino, 2007, International Journal of Learning and Intellectual Capital, V4, P342, DOI 10.1504/IJLIC.2007.016332
   Kianto A, 2008, J INNOV REG DEV, V1, DOI [10.1504/IJIRD.2008.020843, DOI 10.1504/IJIRD.2008.020843]
   Lee D., 2003, MODERATING EFFECTS E
   Liedtka Jeanne M., 1998, STRATEGY LEADERSHIP, V26, P30, DOI DOI 10.1016/S0024-6301(97)00098-8
   Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818
   Mallapaty S, 2020, NATURE, V585, P16, DOI 10.1038/d41586-020-02483-2
   Morton D., RUMSFELDIAN PERSONAL
   Nijssen M, 2012, INT J HUM RESOUR MAN, V23, P3315, DOI 10.1080/09585192.2012.689160
   Nonaka I., 1995, KNOWLEDGE CREATING C
   Oxtoby B., 2002, EUROPEAN MANAGEMENT, V20, P310
   Popper K, 1934, LOGIK FORSCHUNG
   Probst G.J.B., PRACTICAL KNOWLEDGE
   Reinhardt R., 2003, P I KNOW03 3 INT C K, P389
   Rumsfeld D., 2002, NEWS BRIEFING 12 FEB
   Sambamurthy V, 2003, MIS QUART, V27, P237
   Silva C., PARTIES NOT PROTESTS
   Spender J.-C., 2014, BUSINESS STRATEGY MA
   Swayne L., 2006, STRATEG MANAG
   Teece D, 2016, CALIF MANAGE REV, V58, P13, DOI 10.1525/cmr.2016.58.4.13
   Teece DJ, 2018, J MANAGE ORGAN, V24, P359, DOI 10.1017/jmo.2017.75
   Teece DJ, 2018, LONG RANGE PLANN, V51, P40, DOI 10.1016/j.lrp.2017.06.007
   Teece DJ, 2016, EUR ECON REV, V86, P202, DOI 10.1016/j.euroecorev.2015.11.006
   Teece DJ, 2012, J MANAGE STUD, V49, P1395, DOI 10.1111/j.1467-6486.2012.01080.x
   Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
   Tome Eduardo, 2011, Journal of European Industrial Training, V35, P524, DOI 10.1108/03090591111150077
   Tome E., 2021, CUBE INTANGIBLES MAK
   Tome E., 2020, KM POST COVID 19 NEW
   TRIANDIS HC, 1993, ADMIN SCI QUART, V38, P132, DOI 10.2307/2393257
   University of Bath, EXP MATH COV 19 ITS
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   Yoshikuni AC, 2021, VINE J INF KNOWL MAN, DOI 10.1108/VJIKMS-07-2020-0128
   Zack MH, 1999, CALIF MANAGE REV, V41, P125, DOI 10.2307/41166000
   Zhang X, 2019, CHIN MANAG STUD, V13, P171, DOI 10.1108/CMS-12-2016-0239
NR 52
TC 5
Z9 5
U1 4
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD APR
PY 2021
VL 13
IS 8
AR 4518
DI 10.3390/su13084518
PG 16
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA RU7VB
UT WOS:000645350100001
OA gold
DA 2022-04-20
ER

PT J
AU Gali, N
AF Gali, Nuria
TI Impacts of COVID-19 on local tour guides
SO JOURNAL OF TOURISM AND CULTURAL CHANGE
LA English
DT Article; Early Access
DE Tour guide; COVID-19; face-to-face tour; virtual tour; resilient
ID SATISFACTION; PERFORMANCE; MANAGEMENT; BEHAVIOR
AB The COVID-19 health crisis has severely affected the tourism industry worldwide. Some subsectors of the industry have suffered much more than others, particularly the tour guiding profession, which has been damaged considerably. The primary role of the tour guide, which is to interact with visitors' face-to-face, has changed significantly. The purpose of this article is to outline how COVID-19 has affected local tour guides and the guiding profession; and assess the future outlook for the profession. Qualitative data were analyzed using an inductive approach involving 10 in-depth interviews with local tour guides and several virtual guided tours. Results reveal that the current situation in local guiding has highlighted issues such as the fragility of the profession, the lack of legal protection, and guides' vulnerability when faced with the threat of unfair competition from free tours. The study also highlights the passivity of many professionals, whereas other, more resilient tour guides have reactivated their profession in new ways. The findings contribute to knowledge on how the pandemic has impacted the tour guiding profession, and sheds light on how local tour guides can cope with the future.
C1 [Gali, Nuria] Univ Girona, Fac Tourism, Girona, Spain.
RP Gali, N (corresponding author), Placa Ferrater Mora 1, Girona 17004, Spain.
EM nuria.gali@udg.edu
CR Abdullah Muhammad, 2020, Transp Res Interdiscip Perspect, V8, P100255, DOI 10.1016/j.trip.2020.100255
   Alrawadieh D. D., 2021, Journal of Tourismology, V7, P55, DOI 10.26650/jot.2021.7.1.0003
   Alrawadieh Z, 2020, SERV IND J, V40, P50, DOI 10.1080/02642069.2019.1590554
   [Anonymous], 2020, UNWTO WORLD TOUR BAR, V18, P1, DOI [10.18111/wtobarometereng.2020.18.1.1, DOI 10.18111/WTOBAROMETERENG]
   Bae SY, 2021, CURR ISSUES TOUR, V24, P1017, DOI 10.1080/13683500.2020.1798895
   Cetin G, 2017, SCAND J HOSP TOUR, V17, P345, DOI 10.1080/15022250.2017.1330844
   Chan A, 2015, J TRAVEL TOUR MARK, V32, P18, DOI 10.1080/10548408.2014.986010
   COHEN E, 1985, ANN TOURISM RES, V12, P5, DOI 10.1016/0160-7383(85)90037-4
   Dahles H, 2002, ANN TOURISM RES, V29, P783, DOI 10.1016/S0160-7383(01)00083-4
   Donaire JA, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13084356
   Gali N, 2019, INT J TOUR RES, V21, P388, DOI 10.1002/jtr.2270
   Generalitat de Catalunya-Departament d'Empresa i Coneixament, 2021, DIR GUIES HAB
   Gustavsson TK, 2013, SCAND J HOSP TOUR, V13, P127, DOI 10.1080/15022250.2013.796226
   Hansen AH, 2017, SCAND J HOSP TOUR, V17, P259, DOI 10.1080/15022250.2016.1162347
   Harpe M. de la, 2020, Journal of Tourismology, V6, P13, DOI 10.26650/jot.2020.6.1.0009
   Higgins-Desbiolles F, 2020, TOURISM GEOGR, V22, P610, DOI 10.1080/14616688.2020.1757748
   Hoguane AM, 2021, HEALTH CARE WOMEN IN, V42, P288, DOI 10.1080/07399332.2021.1876066
   HUGHES K, 1991, AUST PSYCHOL, V26, P166, DOI 10.1080/00050069108257243
   Instituto Nacional de EstadisticaINE, 2020, MOV TUR FRONT NUM TU
   Io MU, 2011, J TOUR CULT CHANGE, V9, P140, DOI 10.1080/14766825.2011.568621
   Li ZY, 2020, J DESTIN MARK MANAGE, V18, DOI 10.1016/j.jdmm.2020.100502
   Mak AHN, 2011, TOURISM MANAGE, V32, P1442, DOI 10.1016/j.tourman.2011.01.003
   Mak AHN, 2010, INT J TOUR RES, V12, P205, DOI 10.1002/jtr.746
   Matteucci X, 2017, ANN TOURISM RES, V65, P49, DOI 10.1016/j.annals.2017.05.003
   Navalon-Garcia R, 2021, TOURIST STUD, V21, P486, DOI 10.1177/14687976211016073
   Nilsson JH, 2020, SCAND J HOSP TOUR, V20, P286, DOI 10.1080/15022250.2020.1772866
   Ong CE, 2014, ANN TOURISM RES, V48, P221, DOI 10.1016/j.annals.2014.06.010
   Pauner M.M, 2020, BARCELONA
   Poudel S, 2013, J TRAVEL RES, V52, P659, DOI 10.1177/0047287513478496
   Qiu RTR, 2020, ANN TOURISM RES, V84, DOI 10.1016/j.annals.2020.102994
   Quinn B, 2016, CURR ISSUES TOUR, V19, P322, DOI 10.1080/13683500.2014.1001727
   Song HY, 2010, ASIA PAC J TOUR RES, V15, P223, DOI 10.1080/10941661003687431
   Weiler B, 2015, TOUR RECREAT RES, V40, P364, DOI 10.1080/02508281.2015.1083742
   Weiler B, 2014, J HOSP TOUR MANAG, V21, P90, DOI 10.1016/j.jhtm.2014.08.001
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   Williams P, 2013, SCAND J HOSP TOUR, V13, P115, DOI 10.1080/15022250.2013.796228
   Wise N, 2018, HBK RES METH MANAG, P115
   Wong CUI, 2013, J SUSTAIN TOUR, V21, P915, DOI 10.1080/09669582.2013.790390
   World Federation of Tourist Guide Associations, 2021, WHAT IS TOURIST GUID
   Yarcan S., 2021, TOUR OPERATING BUSIN
   Zhang HQ, 2004, TOURISM MANAGE, V25, P81, DOI 10.1016/S0261-5177(03)00064-5
   Zillinger M, 2012, SCAND J HOSP TOUR, V12, P1, DOI 10.1080/15022250.2012.660314
NR 42
TC 0
Z9 0
U1 7
U2 7
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1476-6825
EI 1747-7654
J9 J TOUR CULT CHANGE
JI J. Tour. Cult. Chang.
DI 10.1080/14766825.2022.2046016
EA MAR 2022
PG 18
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA ZN3QZ
UT WOS:000764954300001
DA 2022-04-20
ER

PT J
AU Diab, AM
   Carleton, BC
   Goralski, KB
AF Diab, Antonios M.
   Carleton, Bruce C.
   Goralski, Kerry B.
TI COVID-19 pathophysiology and pharmacology: what do we know and how did
   Canadians respond? A review of Health Canada authorized clinical vaccine
   and drug trials
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Review
DE COVID-19; COVID-19 pharmacology; COVID-19 pathophysiology; Health Canada
   authorized clinical trials; COVID-19 drugs and vaccines
ID RECEPTOR; MANIFESTATIONS; CORONAVIRUS; MANAGEMENT; INJURY; CELLS; ACE2
AB Coronavirus disease 2019 (COVID-19) has resulted in the death of over 18 000 Canadians and has impacted the lives of all Canadians. Many Canadian research groups have expanded their research programs to include COVID-19. Over the past year, our knowledge of this novel disease has grown and has led to the initiation of a number of clinical vaccine and drug trials for the prevention and treatment of COVID-19. Here, we review SARS-CoV-2 (the coronavirus that causes COVID-19) and the natural history of COVID-19, including a timeline of disease progression after SARS-CoV-2 exposure. We also review the pathophysiological effects of COVID-19 on the organ systems that have been implicated in the disease, including the lungs, upper respiratory tract, immune system, central nervous system, cardiovascular system, gastrointestinal organs, the liver, and the kidneys. Then we review general therapeutics strategies that are being applied and investigated for the prevention or treatment of COVID-19, including vaccines, antivirals, immune system enhancers, pulmonary supportive agents, immunosuppressants and (or) anti-inflammatories, and cardiovascular system regulators. Finally, we provide an overview of all current Health Canada authorized clinical drug and vaccine trials for the prevention or treatment of COVID-19.
C1 [Diab, Antonios M.; Goralski, Kerry B.] Dalhousie Univ, Coll Pharm, Fac Hlth, Halifax, NS, Canada.
   [Carleton, Bruce C.] Univ British Columbia, Fac Med, Dept Pediat, Div Translat Therapeut, Vancouver, BC, Canada.
   [Carleton, Bruce C.] BC Childrens Hosp Res Inst, Vancouver, BC, Canada.
   [Carleton, Bruce C.] BC Childrens Hosp, Pharmaceut Outcomes Programme, Vancouver, BC, Canada.
   [Goralski, Kerry B.] Dalhousie Univ, Fac Med, Dept Pharmacol, Halifax, NS, Canada.
   [Goralski, Kerry B.] Dalhousie Univ, Fac Med, Dept Pediat, Halifax, NS, Canada.
   [Goralski, Kerry B.] IWK Hlth Ctr, Div Hematol Oncol, Halifax, NS, Canada.
RP Diab, AM (corresponding author), Dalhousie Univ, Coll Pharm, Fac Hlth, Halifax, NS, Canada.
EM Antonios.Diab@dal.ca
FU Mitacs Accelerate program; Canadian Society of Pharmacology and
   Therapeutics
FX This research was supported by the Mitacs Accelerate program and the
   Canadian Society of Pharmacology and Therapeutics.
CR Agyeman AA, 2020, MAYO CLIN PROC, V95, P1621, DOI 10.1016/j.mayocp.2020.05.030
   Al-Tubaikh J.A., 2010, INTERNAL MED, P113, DOI [10.1007/978- 3-642-03709-2_19, DOI 10.1007/978-3-642-03709-2_19]
   Alqahtani SA, 2020, UNITED EUR GASTROENT, V8, P509, DOI 10.1177/2050640620924157
   Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022
   [Anonymous], 2021, JAMA-J AM MED ASSOC, V325, P880, DOI 10.1001/jama.2020.24415
   Arashiro T, 2020, EMERG INFECT DIS, V26, P1346, DOI 10.3201/eid2606.200452
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Bos R, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-00243-x
   Brann DH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5801
   Byrne, 2020, PRESYMPTOMATIC TRANS, DOI [10.1101/2020.05.08.20094870, DOI 10.1101/2020.05.08.20094870]
   Cardinal-Fernandez P, 2017, ANN AM THORAC SOC, V14, P844, DOI 10.1513/AnnalsATS.201609-728PS
   Cavanagh D., 2005, Coronaviruses with special emphasis on first insights concerning SARS, P1, DOI 10.1007/3-7643-7339-3_1
   CDC, 2020, COVID 19 YOUR HLTH
   Centers for Disease Control and Prevention (CDC), 2021, SARS COV 2 VAR CLASS
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen JY, 2020, CELL RES, V30, P708, DOI 10.1038/s41422-020-0369-7
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Czumbel LM, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00465
   dos Santos WG, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110493
   Du ML, 2020, GASTROENTEROLOGY, V158, P2298, DOI 10.1053/j.gastro.2020.03.045
   Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST
   Feld JJ, 2021, LANCET RESP MED, V9, P498, DOI 10.1016/S2213-2600(20)30566-X
   Fisman DN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.15957
   Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2, 10.15585/mmwr.mm7003e2externalicon]
   Gengler I, 2020, LARYNGOSCOPE INVEST, V5, P354, DOI 10.1002/lio2.384
   Giles AJ, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0371-5
   Godoy LC, 2020, CAN MED ASSOC J, V192, pE1156, DOI 10.1503/cmaj.201240
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Government of Canada, 2020, COVID 19 DEATH COM C
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2
   Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guggemos, 2020, NATURE          0401, V581, DOI [10.1038/s41586-020-2196-x, DOI 10.1038/s41586-020-2196-x]
   Gupta, 2021, RECURRENT EMERGENCE, DOI 10.1101/2020.12.14.422555
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hamming I, 2007, J PATHOL, V212, P1, DOI 10.1002/path.2162
   Hay KA, 2017, BLOOD, V130, P2295, DOI 10.1182/blood-2017-06-793141
   HE X, 2020, NAT MED, V26, P672, DOI [10.1038/s41591-020-0869-5, DOI 10.1038/S41591-020-0869-5]
   Health Canada, 2021, DRUGS VACC COVID 19
   Health Canada, 2020, DRUG VACC AUTH COVID
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Henze, TRANSFORMATIONS COMP, DOI DOI 10.1101/2021.02.09.430519
   Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483
   Jayaweera M, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109819
   Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729
   Li YW, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104833
   [李仲平 Li Zhongping], 2020, [中国软科学, China Soft Science], P1
   Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021
   Mao L, 2020, JAMA NEUROL, P1, DOI [10.1001/jamaneurol.2020.1127, 10.2139/ssrn.3544840, 10.1101/ 2020.02.22.20026500, DOI 10.1101/2020.02.22.20026500]
   Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222
   Moein ST, 2020, INT FORUM ALLERGY RH, V10, P1127, DOI 10.1002/alr.22680
   Mohammadi Abbas, 2020, medRxiv, DOI 10.1101/2020.05.14.20102038
   Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4
   Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148
   Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9
   Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4
   Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276
   Perl DP, 2021, NEW ENGL J MED, V384, P481, DOI 10.1056/NEJMc2033369
   Public Health Agency of Canada, 2020, STAT DEX COVID 19 CL
   Public Health Agency of Canada, 2020, EP SUMM COVID 19 CAS
   Ragab D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01446
   Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1
   Sahin U, 2020, NATURE, V586, P594, DOI 10.1038/s41586-020-2814-7
   Sankowski R, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00028
   Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117
   Shi SB, 2020, EUR HEART J, V41, P2070, DOI 10.1093/eurheartj/ehaa408
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Sinha P, 2020, JAMA INTERN MED, V180, P1152, DOI 10.1001/jamainternmed.2020.3313
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326
   V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6
   van Riel D, 2020, NAT MATER, V19, P810, DOI 10.1038/s41563-020-0746-0
   Vardhana SA, 2020, J EXP MED, V217, DOI 10.1084/jem.20200678
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Volz Erik, 2021, Cell, V184, P64, DOI 10.1016/j.cell.2020.11.020
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   WHO, 2020, DRAFT LANDSC COVID 1
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031
   Xia HJ, 2010, CURR HYPERTENS REP, V12, P170, DOI 10.1007/s11906-010-0105-7
   Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   Yang CN, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001127.pub4
   Yang LJ, 2020, LANCET GASTROENTEROL, V5, P629, DOI 10.1016/S2468-1253(20)30132-1
   Yao XH, 2020, CELL RES, V30, P541, DOI 10.1038/s41422-020-0318-5
   Yao ZX, 2020, AGING-US, V12, P7639, DOI 10.18632/aging.103101
   Zhang H, 2020, GUT, V69, P1010, DOI 10.1136/gutjnl-2020-320953
   Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117
   Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zou HL, 2021, ASIA PAC BUS REV, V27, P749, DOI 10.1080/13602381.2020.1843243
   Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0
   Zuo YY, 2007, LANGMUIR, V23, P1339, DOI 10.1021/la061608+
NR 111
TC 0
Z9 0
U1 0
U2 2
PU CANADIAN SCIENCE PUBLISHING
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD JUN
PY 2021
VL 99
IS 6
BP 577
EP 588
DI 10.1139/cjpp-2021-0038
PG 12
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA SW4HR
UT WOS:000664477100002
PM 33852809
OA hybrid
DA 2022-04-20
ER

PT J
AU Alzahrani, AAH
AF Alzahrani, Abdullah Ali H.
TI Practices and Attitudes of Dental Practitioners toward Patient
   Management during the COVID-19 Pandemic in Saudi Arabia
SO JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE
LA English
DT Article
DE Coronavirus; COVID-19; SARS-CoV-2; Dentist; Dental Service
ID DENTISTRY; GUIDELINES; KNOWLEDGE; RISK
AB Background: Exploring practices and attitudes of dental staff toward the COVID-19 pandemic is critically important; however, little is known about this territory of research.
   Aim: The aim of this study is, first, to evaluate practices and attitudes of dental practitioners during the COVID-19 outbreak and, second, to examine associations between several demographic characteristics in relation to dental workers' practices and attitudes in Saudi Arabia.
   Materials and Methods: A national dental survey using a pre-designed and validated practices and attitudes electronic questionnaire (PADPs-EQ) was conducted in Saudi Arabia between April and May 2020. Mean PADPs-EQ scores, descriptive analysis, Chi-square test, Fisher's exact test and correlations between participants' demographic characteristics and responses were used as appropriate. Data were analyzed using the Statistical Package for the Social Sciences (R) software (version 20.0).
   Results: A total of 567 participants were included. The overall mean and standard deviation of the PADPs-EQ scores was 74.5 +/- 15.2, which indicates a moderate level of participants' practices and attitudes. All demographic items significantly influenced participants' practices and attitudes (p<0.0001). Most participants had some critical practices that were not always implemented as suggested by the Saudi Dental Emergency Protocol (SDEP) during the COVID-19 pandemic.
   Conclusions: An obvious deficit in implementing the SDEP was observed. Developing effective strategies for improving dentists' practices and attitudes may be recommended. Emphasis on updating current courses related to preventive dentistry in dental schools and an increasing number of required continuing education hours and workshops related to infection control may also be advocated.
C1 [Alzahrani, Abdullah Ali H.] Albaha Univ, Fac Appl Med Sci, Dept Dent Hlth, Albaha, Saudi Arabia.
RP Alzahrani, AAH (corresponding author), Albaha Univ, Fac Appl Med Sci, Dept Dent Hlth, Albaha, Saudi Arabia.
EM aahalzahrani@bu.edu.sa
CR Ahmed MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082821
   Alharbi A, 2020, SAUDI DENT J, V32, P181, DOI 10.1016/j.sdentj.2020.04.001
   Ali A, 2016, PAK ORAL DENT J, V36, P468
   Althomairy SA, 2018, J INT SOC PREV COMMU, V8, P137, DOI [10.4103/jispcd.JISPCD_9_18, 10.4103/jispcd.jispcd_9_18]
   Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Cleveland JL, 2012, J AM DENT ASSOC, V143, P1127, DOI 10.14219/jada.archive.2012.0044
   Coulthard P, 2020, BRIT DENT J, V228, P503, DOI 10.1038/s41415-020-1482-1
   Dar-Odeh N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093151
   Domejean S, 2017, CLIN ORAL INVEST, V21, P653, DOI 10.1007/s00784-016-1932-y
   Ghai S, 2020, J DENT EDUC, V84, P24
   Gilbert GH, 2010, OPER DENT, V35, P491, DOI 10.2341/09-287C
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Hu T, 2007, INFECT CONT HOSP EP, V28, P80, DOI 10.1086/510808
   Iyer P, 2020, J DENT EDUC, V84, P16
   Javed MQ, 2020, RES SQUARE, V1
   Kakudate N, 2017, J EVAL CLIN PRACT, V23, P96, DOI 10.1111/jep.12611
   Khurshid Z, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072225
   Li Y, 2020, MOL ORAL MICROBIOL, V35, P1
   Moodley R, 2018, J OCCUP HEALTH, V60, P111, DOI 10.1539/joh.17-0188-RA
   Park M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040967
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   RODRIGUEZMORALE.AJ, 2020, TRAVEL MED INFECT DI, V35, DOI DOI 10.1016/J.TMAID.2020.101613
   Sharma S, 2020, INT ENDOD J, V53, P1017, DOI 10.1111/iej.13317
   Tiwari RVC, 2020, J ADV MED DENT SCI R, V8, P100
   To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149
   Turkistani KA, 2020, AM J ORTHOD DENTOFAC, V157, P591
   Umer F, 2020, INT ENDOD J, V53, P1
   Volgenant CMC, 2020, ORAL DIS, V26, P1
   Zou H, 2016, INT J DENT, V2016, P1
NR 29
TC 0
Z9 0
U1 0
U2 4
PU AMBER PUBLICATION
PI GUJARAT
PA 402, PARIJAT APT, WALKESHWARI NAGAR, JAMNAGAR, GUJARAT, 361 008, INDIA
SN 2347-2545
EI 2347-2367
J9 J RES MED DENT SCI
JI J. Res. Med. Dent. Sci.
PY 2020
VL 8
IS 3
BP 214
EP 223
PG 10
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA MJ5HK
UT WOS:000548121100039
DA 2022-04-20
ER

PT J
AU Rubbaniy, G
   Khalid, AA
   Rizwan, MF
   Ali, S
AF Rubbaniy, Ghulame
   Khalid, Ali Awais
   Rizwan, Muhammad Faisal
   Ali, Shoaib
TI Are ESG stocks safe-haven during COVID-19?
SO STUDIES IN ECONOMICS AND FINANCE
LA English
DT Article
DE VIX; Wavelet coherence; Safe-haven; COVID-19; ESG stocks; Global fear
   index; Infectious disease equity market volatility index; G01; G11; G15;
   M14
ID SOCIALLY RESPONSIBLE FUNDS; QUANTILE DEPENDENCE; WAVELET COHERENCE;
   MARKET; CRYPTOCURRENCIES; PERFORMANCE; BITCOIN; HEDGE; RISK; GOLD
AB Purpose The purpose of this study is to investigate safe-haven properties of environmental, social and governance (ESG) stocks in global and emerging ESG stock markets during the times of COVID-19 so that portfolio managers and equity market investors could decide to use ESG stocks in their portfolio hedging strategies during times of health and market crisis similar to COVID-19 pandemic. Design/methodology/approach The study uses a wavelet coherence framework on four major ESG stock indices from global and emerging stock markets, and two proxies of COVID-19 fear over the period from 5 February 2020 to 18 March 2021. Findings The results of the study show a positive co-movement of the global COVID-19 fear index (GFI) with ESG stock indices on the frequency band of 32 to 64 days, which confirms hedging and safe-haven properties of ESG stocks using the health fear proxy of COVID-19. However, the relationship between all indices and GFI is mixed and inconclusive on a frequency of 0-8 days. Further, the findings do not support the safe-haven characteristics of ESG indices using the market fear proxy (IDEMV index) of COVID-19. The robustness analysis using the CBOE VIX as a proxy of market fear supports that ESG indices do not possess safe-haven properties. The results of the study conclude that the safe-haven properties of ESG indices during the ongoing COVID-19 pandemic is contingent upon the proxy of COVID-19 fear. Practical implications The findings have important implications for the equity investors and assetty managers to improve their portfolio performance by including ESG stocks in their portfolio choice during the COVID-19 pandemic and similar health crisis. However, their investment decisions could be affected by the choice of COVID-19 proxy. Originality/value The authors believe in the originality of the paper due to following reasons. First, to the best of the knowledge, this is the first study investigating the safe-haven properties of ESG stocks. Second, the authors use both health fear (GFI) and market fear (IDEMV index) proxies of COVID-19 to compare whether safe-haven properties are characterized by health fear or market fear due to COVID-19. Finally, the authors use the wavelet coherency framework, which not only takes both time and frequency dimensions of the data into account but also remains unaffected by data stationarity and size issues.
C1 [Rubbaniy, Ghulame] Zayed Univ, Coll Business, Abu Dhabi, U Arab Emirates.
   [Khalid, Ali Awais] Univ Lahore, Lahore Business Sch, Lahore, Pakistan.
   [Rizwan, Muhammad Faisal] Int Islamic Univ, Fac Management Sci, Islamabad, Pakistan.
   [Ali, Shoaib] Air Univ, Sch Management, Islamabad, Pakistan.
RP Rubbaniy, G (corresponding author), Zayed Univ, Coll Business, Abu Dhabi, U Arab Emirates.
EM ghulame.rubbaniy@zu.ac.ae; aliawaischeema@gmail.com;
   faisal.rizwan@iiu.edu.pk; Shoaib0819@yahoo.com
RI Khalid, Ali Awais/K-1360-2013
OI Khalid, Ali Awais/0000-0002-8777-2171
CR Ahmad, 2020, ISLAMIC EQUITY INVES
   Akhtaruzzaman M, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101604
   Albuquerque R, 2020, REV CORP FINANC STUD, V9, P593, DOI 10.1093/rcfs/cfaa011
   Alessandrini F, 2020, J PORTFOLIO MANAGE, V46, P75, DOI 10.3905/jpm.2020.46.3.075
   Andersson E, 2020, INT J FINANC ECON, DOI 10.1002/ijfe.2341
   Auer BR, 2016, J BUS ETHICS, V135, P381, DOI 10.1007/s10551-014-2454-7
   Bai L, 2021, FINANC RES LETT, V40, DOI 10.1016/j.frl.2020.101709
   Baker S. R., 2019, POLICY NEWS STOCK MA, DOI [10.3386/w25720, DOI 10.2139/SSRN.3363862]
   Baker SR, 2020, REV ASSET PRICING ST, V10, P742, DOI 10.1093/rapstu/raaa008
   Barunik J, 2019, ECONOMET J, V22, P131, DOI 10.1093/ectj/utz002
   Bashir MF, 2020, AIR QUAL ATMOS HLTH, V13, P1403, DOI 10.1007/s11869-020-00894-8
   Baumohl E, 2019, FINANC RES LETT, V29, P363, DOI 10.1016/j.frl.2018.09.002
   Baur DG, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101431
   Baur DG, 2010, FINAN REV, V45, P217, DOI 10.1111/j.1540-6288.2010.00244.x
   Baur DG, 2010, J BANK FINANC, V34, P1886, DOI 10.1016/j.jbankfin.2009.12.008
   Bouri E, 2020, Q REV ECON FINANC, V77, P156, DOI 10.1016/j.qref.2020.03.004
   Broadstock DC, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101716
   Chowdhury EK, 2021, BUS SOC REV, DOI 10.1111/basr.12219
   Conlon T., 2021, ENDURING RELIEF FLEE
   Corbet S, 2020, INT REV FINANC ANAL, V71, DOI 10.1016/j.irfa.2020.101571
   De I, 2015, J INVEST, V24, P49, DOI 10.3905/joi.2015.24.4.049
   Diaz V, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101870
   Dutta A, 2020, RESOUR POLICY, V69, DOI 10.1016/j.resourpol.2020.101816
   Elliott RJR, 2020, ENVIRON RESOUR ECON, V76, P1187, DOI 10.1007/s10640-020-00478-1
   Ferrero F, 2021, ARCH DIS CHILD, V106, DOI 10.1136/archdischild-2020-319833
   Fetzer T, 2021, REV ECON STAT, V103, P968, DOI 10.1162/rest_a_00946
   Cunha FAFD, 2020, BUS STRATEG ENVIRON, V29, P682, DOI 10.1002/bse.2397
   Goodell JW, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101625
   Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004
   Grisse C, 2015, J EMPIR FINANC, V32, P153, DOI 10.1016/j.jempfin.2015.03.006
   Gupta R, 2021, INT REV ECON FINANC, V71, P289, DOI 10.1016/j.iref.2020.09.019
   Hasan MB, 2021, N AM J ECON FINANC, V58, DOI 10.1016/j.najef.2021.101504
   HSBC, 2020, HSBC SUST FIN INV SU
   Ji Q, 2020, INT REV FINANC ANAL, V71, DOI 10.1016/j.irfa.2020.101526
   Jiang YH, 2021, J INT FINANC MARK I, V72, DOI 10.1016/j.intfin.2021.101324
   Kamran M., 2021, GLOB FINANC J, DOI 10.1016/j.gfj.2021.100643
   Kinateder H, 2021, FINANC RES LETT, V43, DOI 10.1016/j.frl.2021.101951
   Leite P, 2015, INT REV FINANC ANAL, V40, P132, DOI 10.1016/j.irfa.2015.05.012
   Liu M, 2020, EMERG MARK FINANC TR, V56, P3562, DOI 10.1080/1540496X.2020.1850441
   Maghyereh A, 2021, N AM J ECON FINANC, V56
   Mariana CD, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101798
   Mirza N., 2020, EUROPEAN STOCK MARKE
   Munoz F, 2014, J BUS ETHICS, V124, P551, DOI 10.1007/s10551-013-1893-x
   Nakai M., 2020, FINANC RES LETT
   Nofsinger J, 2014, J BANK FINANC, V48, P180, DOI 10.1016/j.jbankfin.2013.12.016
   Phan DHB, 2020, EMERG MARK FINANC TR, V56, P2138, DOI 10.1080/1540496X.2020.1784719
   Rehman MU, 2020, RESOUR POLICY, V66, DOI 10.1016/j.resourpol.2020.101652
   Ritchie, 2020, CORONAVIRUS PANDEMIC
   Rizvi S.K.A., 2021, COVID 19 STOCK MARKE
   Rizvi SKA, 2020, J ASSET MANAG, V21, P281, DOI 10.1057/s41260-020-00172-3
   Rua A, 2009, J EMPIR FINANC, V16, P632, DOI 10.1016/j.jempfin.2009.02.002
   Rubbaniy G, 2021, EMERG MARK FINANC TR, V57, P1741, DOI 10.1080/1540496X.2021.1897004
   Salisu AA, 2020, BORSA ISTANB REV, V20, pS40, DOI 10.1016/j.bir.2020.11.004
   Salisu AA, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100383
   Salisu AA, 2020, EMERG MARK FINANC TR, V56, P2310, DOI 10.1080/1540496X.2020.1785424
   Samitas, 2021, J COMMOD MARK
   Shahzad SJH, 2020, ECON MODEL, V87, P212, DOI 10.1016/j.econmod.2019.07.023
   Sharma GD, 2021, J SUSTAIN FINANC INV, DOI 10.1080/20430795.2021.1874215
   Sherif M, 2020, J BEHAV EXP FINANC, V28, DOI 10.1016/j.jbef.2020.100403
   Silva F, 2016, J CLEAN PROD, V135, P558, DOI 10.1016/j.jclepro.2016.06.112
   Singh A, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101729
   Syed QasimRaza., 2021, ASIAN EC LETT, P1, DOI [10.46557/001c.18642, DOI 10.46557/001C.18642]
   Tessema A., 2021, STOCK MARKET FEAR EC
   Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2
   Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2
   Umar Z, 2021, J BEHAV EXP FINANC, V30, DOI 10.1016/j.jbef.2021.100501
   Urquhart A, 2019, INT REV FINANC ANAL, V63, P49, DOI 10.1016/j.irfa.2019.02.009
   Verheyden T, 2016, J APPL CORP FINANC, V28, P47
   Xiong H, 2020, EMERG MARK FINANC TR, V56, P2231, DOI 10.1080/1540496X.2020.1787151
   Yarovaya L., 2020, SEARCHING SAFE HAVEN
   Yarovaya L, 2021, FINANC RES LETT, V43, DOI 10.1016/j.frl.2021.101979
   Yarovaya L, 2021, INT REV ECON FINANC, V71, P584, DOI 10.1016/j.iref.2020.09.017
   Yousaf I, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14040186
   Yousaf I, 2021, SINGAP ECON REV, DOI 10.1142/S0217590821470019
   Yousaf I, 2020, BORSA ISTANB REV, V20, pS1, DOI 10.1016/j.bir.2020.10.003
   Zhu WZ, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.661482
NR 76
TC 2
Z9 2
U1 9
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1086-7376
EI 1755-6791
J9 STUD ECON FINANC
JI Stud. Econ. Financ.
PD FEB 28
PY 2022
VL 39
IS 2
BP 239
EP 255
DI 10.1108/SEF-08-2021-0320
EA DEC 2021
PG 17
WC Business, Finance
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA ZL3OK
UT WOS:000730644900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Saggam, A
   Limgaokar, K
   Borse, S
   Chavan-Gautam, P
   Dixit, S
   Tillu, G
   Patwardhan, B
AF Saggam, Akash
   Limgaokar, Kirti
   Borse, Swapnil
   Chavan-Gautam, Preeti
   Dixit, Santosh
   Tillu, Girish
   Patwardhan, Bhushan
TI Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in
   COVID-19 Management
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Review
DE Ashwagandha; Ayurveda; Rasayana; Immunomodulation; Inflammation;
   Cytokine; Adjuvant
ID NF-KAPPA-B; MEDIATED IMMUNE-RESPONSES; IMMUNOMODULATORY ACTIVITY;
   AQUEOUS EXTRACT; WITHAFERIN-A; ROOT POWDER; IN-VIVO; INFLAMMATORY
   RESPONSES; MOLECULAR DOCKING; OXIDATIVE STRESS
AB As the COVID-19 pandemic is progressing, the therapeutic gaps in conventional management have highlighted the need for the integration of traditional knowledge systems with modern medicine. Ayurvedic medicines, especially Ashwagandha (Withania somnifera (L.) Dunal, WS), may be beneficial in the management of COVID-19. WS is a widely prescribed Ayurvedic botanical known as an immunomodulatory, antiviral, anti-inflammatory, and adaptogenic agent. The chemical profile and pharmacological activities of WS have been extensively reported. Several clinical studies have reported its safety for use in humans. This review presents a research synthesis of in silico, in vitro, in vivo, and clinical studies on Withania somnifera (L.) Dunal (WS) and discusses its potential for prophylaxis and management of COVID-19. We have collated the data from studies on WS that focused on viral infections (HIV, HSV, H1N1 influenza, etc.) and noncommunicable diseases (hypertension, diabetes, cancer, etc.). The experimental literature indicates that WS has the potential for 1) maintaining immune homeostasis, 2) regulating inflammation, 3) suppressing pro-inflammatory cytokines, 4) organ protection (nervous system, heart, lung, liver, and kidney), and 5) anti-stress, antihypertensive, and antidiabetic activities. Using these trends, the review presents a triangulation of Ayurveda wisdom, pharmacological properties, and COVID-19 pathophysiology ranging from viral entry to end-stage acute respiratory distress syndrome (ARDS). The review proposes WS as a potential therapeutic adjuvant for various stages of COVID-19 management. WS may also have beneficial effects on comorbidities associated with the COVID-19. However, systematic studies are needed to realize the potential of WS for improving clinical outcome of patients with COVID-19.
C1 [Saggam, Akash; Borse, Swapnil; Chavan-Gautam, Preeti; Tillu, Girish; Patwardhan, Bhushan] Savitribai Phule Pune Univ, Interdisciplinary Sch Hlth Sci, AYUSH Ctr Excellence, Ctr Complementary & Integrat Hlth, Pune, Maharashtra, India.
   [Limgaokar, Kirti] Fergusson Coll Autonomous, Div Biochem, Dept Chem, Pune, Maharashtra, India.
   [Dixit, Santosh] Prashanti Canc Care Mission, Pune, Maharashtra, India.
RP Patwardhan, B (corresponding author), Savitribai Phule Pune Univ, Interdisciplinary Sch Hlth Sci, AYUSH Ctr Excellence, Ctr Complementary & Integrat Hlth, Pune, Maharashtra, India.
EM bpatwardhan@gmail.com
RI Patwardhan, Bhushan/F-1583-2011; Saggam, Akash/R-3604-2017
OI Patwardhan, Bhushan/0000-0003-3918-2609; Saggam,
   Akash/0000-0003-1845-9226; Chavan-Gautam, Preeti/0000-0001-8514-3171
FU Ministry of AYUSHMinistry of AYUSH [No.-Z-15015/07/2017-COE]; Savitribai
   Phule Pune University
FX This study was supported by the Ministry of AYUSH, Govt. of India
   (Sanction No.-Z-15015/07/2017-COE, dated 27.11.2017), and Savitribai
   Phule Pune University.
CR Adao R, 2020, CARDIOVASC RES, V116, pE59, DOI 10.1093/cvr/cvaa086
   Agarwal R, 1999, J ETHNOPHARMACOL, V67, P27, DOI 10.1016/S0378-8741(99)00065-3
   Ahmad M, 2017, SUSTAINED ENERGY FOR ENHANCED HUMAN FUNCTIONS AND ACTIVITY, P137, DOI 10.1016/B978-0-12-805413-0.00008-9
   Akbarsha MA, 2000, PHYTOMEDICINE, V7, P499, DOI 10.1016/S0944-7113(00)80036-7
   Al-Awthan Yahya S, 2014, Pak J Biol Sci, V17, P504, DOI 10.3923/pjbs.2014.504.510
   Alam N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-65
   Alanagreh L, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050331
   An JH, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-5602
   Annunziata G, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00240
   [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2020, REVISED ADVISORY USE
   [Anonymous], 2020, ASHWAGANDHA TAKES LE
   [Anonymous], 2020, BEVACIZUMAB SEVERE C
   [Anonymous], 2020, WHO ANNOUNCES COVID
   [Anonymous], 2020, J BIOMOL STRUCT DYN, DOI DOI 10.1080/07391102.2020.1775704
   [Anonymous], 2020, WHO CORONAVIRUS DIS
   [Anonymous], 2020, CLIN MANAGEMENT PROT
   [Anonymous], 2020, WHO R BLUEPRINT COVI
   Anwer T, 2012, ACTA POL PHARM, V69, P1095
   Azgomi RND, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4076430
   Aziz M, 2020, J MED VIROL, V92, P2283, DOI 10.1002/jmv.25948
   Baitharu I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105311
   Balasubramani SP, 2011, CHIN J INTEGR MED, V17, P88, DOI 10.1007/s11655-011-0659-5
   Bale S, 2018, BIOFACTORS, V44, P507, DOI 10.1002/biof.1446
   Bale S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00248
   Baliga MS, 2015, FOODS AND DIETARY SUPPLEMENTS IN THE PREVENTION AND TREATMENT OF DISEASE IN OLDER ADULTS, P151, DOI 10.1016/B978-0-12-418680-4.00016-6
   Balkrishna A, 2021, DRUG DES DEV THER, V15, P1111, DOI 10.2147/DDDT.S292805
   Balkrishna A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020185
   Bangash MN, 2020, LANCET GASTROENTEROL, V5, P529, DOI 10.1016/S2468-1253(20)30084-4
   Bani S, 2006, J ETHNOPHARMACOL, V107, P107, DOI 10.1016/j.jep.2006.02.016
   Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058
   Bhattarai JP, 2010, PHYTOTHER RES, V24, P1147, DOI 10.1002/ptr.3088
   Bisht Punum, 2014, Ayu, V35, P330, DOI 10.4103/0974-8520.153757
   Biswal BM, 2013, INTEGR CANCER THER, V12, P312, DOI 10.1177/1534735412464551
   Blignaut M, 2019, CARDIOVASC DRUG THER, V33, P1, DOI 10.1007/s10557-018-06847-9
   Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857
   Borse S., 2020, AYURVEDA BOT COVID 1, DOI [10.21203/rs.3.rs-30361/v1, DOI 10.21203/RS.3.RS-30361/V1]
   Cai Z, 2015, CELL BIOCHEM BIOPHYS, V72, P727, DOI 10.1007/s12013-015-0524-9
   Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3
   Carod-Artal FJ, 2020, REV NEUROLOGIA, V70, P311, DOI 10.33588/rn.7009.2020179
   Chandran U, 2017, J ETHNOPHARMACOL, V197, P250, DOI 10.1016/j.jep.2016.07.080
   Chikhale RV, 2021, J BIOMOL STRUCT DYN, V39, P4510, DOI 10.1080/07391102.2020.1778539
   Chinthakunta N, 2018, NETW MODEL ANAL HLTH, V7, DOI 10.1007/s13721-018-0166-0
   Chorin E, 2020, NAT MED, V26, P808, DOI 10.1038/s41591-020-0888-2
   Cortinovis M, 2021, LANCET, V397, P173, DOI 10.1016/S0140-6736(21)00039-8
   Davis L, 2002, J EXP CLIN CANC RES, V21, P585
   Davis L, 1999, IMMUNOPHARM IMMUNOT, V21, P695, DOI 10.3109/08923979909007135
   Davis L, 2000, J ETHNOPHARMACOL, V71, P193, DOI 10.1016/S0378-8741(99)00206-8
   De Giorgio Maria Rita, 2020, Acta Myol, V39, P307, DOI 10.36185/2532-1900-034
   de-Madaria E, 2021, NAT REV GASTRO HEPAT, V18, P3, DOI 10.1038/s41575-020-00389-y
   de-Madaria E, 2021, GASTROENTEROLOGY, V160, P1871, DOI 10.1053/j.gastro.2020.04.044
   Devkar ST, 2016, PHARM BIOL, V54, P2394, DOI 10.3109/13880209.2016.1157193
   Di Vito A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8417183
   Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   Dubey S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00195
   Durg S, 2020, PHYTOTHER RES, V34, P1041, DOI 10.1002/ptr.6589
   El-Boshy M. S., 2013, ISRN VET SCI, V2013, DOI 10.1155/2013/153427
   Ferner RE, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1432
   Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041
   Gambhir L, 2015, TOXICOL APPL PHARM, V289, P297, DOI 10.1016/j.taap.2015.09.014
   Ganguly B, 2020, TROP ANIM HEALTH PRO, V52, P1195, DOI 10.1007/s11250-019-02104-9
   Ganguly B, 2018, J ANIM SCI TECHNOL, V60, DOI 10.1186/s40781-017-0156-2
   Gautam M, 2004, INT IMMUNOPHARMACOL, V4, P841, DOI 10.1016/j.intimp.2004.03.005
   Gautam M, 2008, VACCINE, V26, P5239, DOI 10.1016/j.vaccine.2008.07.045
   Gengler I, 2020, LARYNGOSCOPE INVEST, V5, P354, DOI 10.1002/lio2.384
   George PM, 2020, LANCET RESP MED, V8, P807, DOI 10.1016/S2213-2600(20)30225-3
   Grover A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S22
   Gu MC, 2014, INVEST NEW DRUG, V32, P68, DOI 10.1007/s10637-013-9987-y
   Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893
   Gupta A, 2014, PHARM BIOL, V52, P308, DOI 10.3109/13880209.2013.835325
   Gupta M, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2635-0
   Gupta M, 2018, NEUROMOL MED, V20, P343, DOI 10.1007/s12017-018-8497-7
   Gustine JN, 2021, AM J PATHOL, V191, P4, DOI 10.1016/j.ajpath.2020.08.009
   Heyninck K, 2014, BIOCHEM PHARMACOL, V91, P501, DOI 10.1016/j.bcp.2014.08.004
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06
   Jacobi A, 2020, CLIN IMAG, V64, P35, DOI 10.1016/j.clinimag.2020.04.001
   Jadhav S., 2010, ADJUVANT COMPOSITION
   Jeyanthi Thangavel, 2010, Journal of Basic and Clinical Physiology and Pharmacology, V21, P61
   JORIS I, 1972, VIRCHOWS ARCH B, V12, P73
   Kalra R, 2017, PHYTOCHEM REV, V16, P953, DOI 10.1007/s11101-017-9504-6
   Kasperkiewicz M, 2021, CELL STRESS CHAPERON, V26, P1, DOI 10.1007/s12192-020-01180-3
   Kaur G, 2015, PHARM BIOL, V53, P147, DOI 10.3109/13880209.2014.912240
   Kaur SP, 2020, VIRUS RES, V288, DOI 10.1016/j.virusres.2020.198114
   Khalil MI, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/624159
   Khan B, 2006, INT IMMUNOPHARMACOL, V6, P1394, DOI 10.1016/j.intimp.2006.04.001
   Khan Mahmood Ahmad, 2019, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V18, P55, DOI 10.2174/1871523017666181116092934
   Khan S, 2009, VACCINE, V27, P6080, DOI 10.1016/j.vaccine.2009.07.011
   Khanal P, 2020, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2020.1869588
   Kim JE, 2015, IMMUNE NETW, V15, P269, DOI 10.4110/in.2015.15.6.269
   Kinnula VL, 2002, THORAX, V57, P157, DOI 10.1136/thorax.57.2.157
   Kita Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133663
   Knoops B, 2016, MOL CELLS, V39, P60, DOI 10.14348/molcells.2016.2341
   Kour K, 2009, INT IMMUNOPHARMACOL, V9, P1137, DOI 10.1016/j.intimp.2009.05.011
   Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122
   Kumar PKP, 2016, PAK J PHARM SCI, V29, P1279
   Kushwaha S, 2012, PARASITE IMMUNOL, V34, P199, DOI 10.1111/j.1365-3024.2012.01352.x
   Kushwaha S, 2012, STUD ETHNO-MED, V6, P111, DOI 10.1080/09735070.2012.11886427
   Kushwaha S, 2012, VACCINE, V30, P1083, DOI 10.1016/j.vaccine.2011.12.031
   Lane JCE, 2020, LANCET RHEUMATOL, V2, pE698, DOI 10.1016/S2665-9913(20)30276-9
   Latheef Shyma K., 2017, VirusDisease, V28, P115, DOI 10.1007/s13337-016-0355-3
   Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651
   Lee W, 2012, TOXICOL APPL PHARM, V262, P91, DOI 10.1016/j.taap.2012.04.025
   Li C, 2020, EMERG MICROBES INFEC, V9, P2663, DOI 10.1080/22221751.2020.1850183
   Li R, 2020, REPROD BIOMED ONLINE, V41, P89, DOI 10.1016/j.rbmo.2020.04.018
   Li S, 2001, BRAIN RES, V910, P163, DOI 10.1016/S0006-8993(01)02707-X
   Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23
   Luo XH, 2021, SCAND J IMMUNOL, V93, DOI 10.1111/sji.12989
   Lurie N, 2021, LANCET, V397, P1229, DOI 10.1016/S0140-6736(21)00503-1
   Madhusudan M, 2016, PHARM BIOL, V54, P1936, DOI 10.3109/13880209.2015.1123729
   MAKIN AJ, 1994, GUT, V35, P569, DOI 10.1136/gut.35.4.569
   Malik F, 2007, LIFE SCI, V80, P1525, DOI 10.1016/j.lfs.2007.01.029
   Mandlik DS, 2021, J DIET SUPPL, V18, P183, DOI 10.1080/19390211.2020.1741484
   Maurya SP, 2019, CLIN IMMUNOL, V203, P122, DOI 10.1016/j.clim.2019.04.003
   Mazzio EA, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1429-x
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Michot JM, 2020, ANN ONCOL, V31, P961, DOI 10.1016/j.annonc.2020.03.300
   Mikolai J, 2009, J ALTERN COMPLEM MED, V15, P423, DOI 10.1089/acm.2008.0215
   Min KJ, 2011, INT IMMUNOPHARMACOL, V11, P1137, DOI 10.1016/j.intimp.2011.02.029
   Minhas Ujla, 2012, Inflammopharmacology, V20, P195, DOI 10.1007/s10787-011-0102-8
   Minhas U, 2011, DRUG DISCOV THER, V5, P195, DOI 10.5582/ddt.2011.v5.4.195
   Mishra L C, 2000, Altern Med Rev, V5, P334
   Mohanty I, 2004, BASIC CLIN PHARMACOL, V94, P184, DOI 10.1111/j.1742-7843.2004.pto940405.x
   Mohanty IR, 2008, CLIN NUTR, V27, P635, DOI 10.1016/j.clnu.2008.05.006
   Mooney JP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00135
   Morsy MA, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/3041438
   Mortaz E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02037
   Mukherjee S, 2020, XENOBIOTICA, V50, P957, DOI 10.1080/00498254.2019.1709228
   Neog MK, 2018, INT IMMUNOPHARMACOL, V61, P64, DOI 10.1016/j.intimp.2018.05.019
   Ngoungoure FP, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.111564
   Noh EJ, 2016, MOL MED REP, V14, P983, DOI 10.3892/mmr.2016.5326
   Nosalova G, 2015, ADV EXP MED BIOL, V838, P19, DOI 10.1007/5584_2014_79
   Ojha SK, 2009, WORLD J MED SCI, V4, P156
   Owais M, 2005, PHYTOMEDICINE, V12, P229, DOI 10.1016/j.phymed.2003.07.012
   Paramadhas S., 2016, LEAFY MED HERBS BOT, P19, DOI [10.1079/9781780645599.0019, DOI 10.1079/9781780645599.0019]
   Parida PK, 2020, PHYTOTHER RES, V34, P3420, DOI 10.1002/ptr.6868
   Parisi L, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/8917804
   Patwardhan B, 2004, CURR SCI INDIA, V86, P789
   Patwardhan B, 2020, CURR SCI INDIA, V118, P1158
   Pawar P, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-34
   Payyappallimana U, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00057
   Peng SL, 2010, INT J BIOCHEM CELL B, V42, P482, DOI 10.1016/j.biocel.2009.10.013
   Prabhakaran Y, 2012, PAK J PHARM SCI, V25, P595
   Radmark O, 2009, J LIPID RES, V50, pS40, DOI 10.1194/jlr.R800062-JLR200
   Raghavan A, 2015, NEURAL REGEN RES, V10, P183, DOI 10.4103/1673-5374.152362
   Rajendran K, 2020, J MED VIROL, V92, P1475, DOI 10.1002/jmv.25961
   Rasool M, 2006, VASC PHARMACOL, V44, P406, DOI 10.1016/j.vph.2006.01.015
   Raut Ashwinikumar A, 2012, J Ayurveda Integr Med, V3, P111, DOI 10.4103/0975-9476.100168
   Rege NN, 1999, PHYTOTHER RES, V13, P275, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;275::AID-PTR510&gt;3.0.CO;2-S
   Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945
   Ritchie AI, 2020, LANCET, V395, P1111, DOI 10.1016/S0140-6736(20)30691-7
   Roh C, 2012, INT J NANOMED, V7, P2173, DOI 10.2147/IJN.S31379
   Ruchi Tiwari, 2014, Journal of Biological Sciences, V14, P77
   Sabirli R, 2021, LIFE SCI, V265, DOI 10.1016/j.lfs.2020.118781
   Sadanandam A, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00376-x
   Saggam A, 2020, J ETHNOPHARMACOL, V255, DOI 10.1016/j.jep.2020.112759
   Saha Sanjib, 2013, In Silico Pharmacology, V1, P11, DOI 10.1186/2193-9616-1-11
   Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4
   SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960
   Shah A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01021
   Sharma A., 2020, ANTIGM CSF ANTIBODIE
   Sharma A, 2010, FISH SHELLFISH IMMUN, V29, P508, DOI 10.1016/j.fsi.2010.05.005
   Sharma S, 2022, J BIOMOL STRUCT DYN, V40, P3003, DOI 10.1080/07391102.2020.1844058
   Shenoy Shweta, 2012, J Ayurveda Integr Med, V3, P209, DOI 10.4103/0975-9476.104444
   Shimmi S. C., 1970, J BANGLADESH SOC PHY, V6, P84, DOI [10.3329/jbsp.v6i2.9756, DOI 10.3329/JBSP.V6I2.9756]
   Shin HS, 2020, INFECT CHEMOTHER, V52, P142, DOI 10.3947/ic.2020.52.2.142
   Shree P, 2022, J BIOMOL STRUCT DYN, V40, P190, DOI 10.1080/07391102.2020.1810778
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   Sikandan A, 2018, INT J MOL MED, V42, P425, DOI 10.3892/ijmm.2018.3608
   Singh D, 2007, PHYTOTHER RES, V21, P905, DOI 10.1002/ptr.2180
   SINGH N, 1982, International Journal of Crude Drug Research, V20, P29
   Singh N, 2011, AFR J TRADIT COMPLEM, V8, P208, DOI 10.4314/ajtcam.v8i5S.9
   Srivastava A, 2022, J BIOMOL STRUCT DYN, V40, P1858, DOI 10.1080/07391102.2020.1835725
   Srivastava DN., 1993, J APPL ANIM RES, V3, P129, DOI [10.1080/09712119.1993.9705964, DOI 10.1080/09712119.1993.9705964]
   Sudeep HV, 2020, BIOINFORMATION, V16, P411, DOI 10.6026/97320630016411
   Sultana F, 2017, COLLOID SURFACE B, V155, P349, DOI 10.1016/j.colsurfb.2017.04.046
   Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200
   Tandon N, 2020, J ETHNOPHARMACOL, V255, DOI 10.1016/j.jep.2020.112768
   Tang YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01708
   Teixeira ST, 2006, INT IMMUNOPHARMACOL, V6, P1535, DOI 10.1016/j.intimp.2006.03.016
   Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0
   Tian Y, 2020, ALIMENT PHARM THER, V51, P843, DOI 10.1111/apt.15731
   Tiruveedi VL, 2018, PHYTOTHER RES, V32, P2586, DOI 10.1002/ptr.6200
   Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036
   Tripathi A K, 1998, Anc Sci Life, V17, P169
   Tripathi MK, 2021, J BIOMOL STRUCT DYN, V39, P5668, DOI 10.1080/07391102.2020.1790425
   Tufan A, 2020, TURK J MED SCI, V50, P620, DOI 10.3906/sag-2004-168
   Vaidya B., 2000, NIGHANTU ADARSH, V2nd
   Valizadeh R, 2020, J RENAL INJ PREV, V9, DOI 10.34172/jrip.2020.18
   van den Berg DF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01580
   Vareed SK, 2014, PHYTOTHER RES, V28, P1260, DOI 10.1002/ptr.5118
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Vasavan SS, 2020, PHARMACOGN MAG, V16, P218, DOI 10.4103/pm.pm_349_19
   Vedi M, 2016, CELL BIOL TOXICOL, V32, P373, DOI 10.1007/s10565-016-9340-2
   Vedi M, 2014, RENAL FAILURE, V36, P1095, DOI 10.3109/0886022X.2014.918812
   Walid M S, 2008, Indian J Nephrol, V18, P173, DOI 10.4103/0971-4065.45295
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wang Z, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4063562
   Wankhede S, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0104-9
   White PT, 2016, ADV EXP MED BIOL, V928, P329, DOI 10.1007/978-3-319-41334-1_14
   Whittaker A, 2020, ACTA NEUROL SCAND, V142, P14, DOI 10.1111/ane.13266
   Wijeratne EMK, 2014, J MED CHEM, V57, P2851, DOI 10.1021/jm401279n
   Yamada K, 2011, J ETHNOPHARMACOL, V137, P231, DOI 10.1016/j.jep.2011.05.017
   Yang LJ, 2020, LANCET GASTROENTEROL, V5, P629, DOI 10.1016/S2468-1253(20)30132-1
   Yu SM, 2013, EXP CELL RES, V319, P2822, DOI 10.1016/j.yexcr.2013.08.026
   Zaim S, 2020, CURR PROB CARDIOLOGY, V45, DOI 10.1016/j.cpcardiol.2020.100618
   Zhao HM, 2019, FRONT BIOSCI-LANDMRK, V24, P576, DOI 10.2741/4737
   Zhao Q, 2015, CHEM SCI, V6, P4124, DOI 10.1039/c5sc00633c
   Zhao YM, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100463
   Zheng J, 2018, CURR OPIN VIROL, V28, P43, DOI 10.1016/j.coviro.2017.11.002
   Zheng KI, 2021, J MED VIROL, V93, P323, DOI 10.1002/jmv.26294
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041
   Zhou ZX, 2020, EUR J PHARMACOL, V874, DOI 10.1016/j.ejphar.2020.172988
   Ziegenfuss TN, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111807
NR 218
TC 8
Z9 8
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD MAY 3
PY 2021
VL 12
AR 623795
DI 10.3389/fphar.2021.623795
PG 18
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA SD0LK
UT WOS:000651054000001
PM 34012390
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Rahmafitria, F
   Suryadi, K
   Oktadiana, H
   Putro, HPH
   Rosyidie, A
AF Rahmafitria, Fitri
   Suryadi, Karim
   Oktadiana, Hera
   Putro, Heru Purboyo H.
   Rosyidie, Arief
TI Applying knowledge, social concern and perceived risk in planned
   behavior theory for tourism in the Covid-19 pandemic
SO TOURISM REVIEW
LA English
DT Article
DE Physical distancing; Tourism in pandemic; Covid-19 pandemic; Theory of
   planned behavior; Perceived risk; Social concern; ????; ???????; ??????;
   ??????; ????; ????; Distancia fisica; Turismo en pandemia; Pandemia del
   Covid-19; Teoria del comportamiento planificado; Riesgo percibido;
   Preocupacion social
ID SWINE FLU; INTENTION; UNCERTAINTY; DESTINATION; MODEL; CONSUMPTION;
   ATTITUDES; ADOPTION; MEDIA; NORMS
AB Purpose
   The paper aims to examine the effect of physical distancing control on the intention to travel during the pandemic and to assess the influence of knowledge, social concern and perceived risk on the theory of planned behavior (TPB).
   Design/methodology/approach
   A total of 1,068 Indonesian respondents through a purposive sampling approach, filled out online questionnaires during the pandemic. The collected data were analyzed using partial least squares-structural equation modeling.
   Findings
   The results indicated that subjective norm as the external factor of the TPB has a stronger effect than the internal factors; attitude and behavioral control. It appears that in a collectivist society, prohibition enforced by family and friends, as well as the government's sanctions have a stronger influence on one's decision to travel. The findings also suggested that knowledge, perceived risks and social concern effect tourists' behavior. Uncertainty and inadequate knowledge will decrease the level of perceived risk, which leads to lower control in practicing physical distancing and increasing intention to travel during the pandemic.
   Research limitations/implications
   The research has limitations in its use of a convenient sampling method. This method may not represent the whole population, causing the results to be difficult for generalization. There is also the need for extending the TPB model with different variables in the context of tourism and pandemic. This study enriches the existing tourism literature by applying TPB to examine tourists' behavior during the Covid-19 pandemic, focusing on knowledge, social concern and perceived risk theory.
   Practical implications
   This paper offers useful insights for tourism planners in the government and private destination management levels. It is crucial for a destination management organization to understand the relationship between knowledge, perception and social concern with tourists' behavior while traveling during pandemics. The understanding of tourist's behavior when traveling during the pandemic will assist in developing and creating activities and designing health protocols at tourist attractions.
   Originality/value
   This study extended the TPB to analyze tourists behavior during the pandemic by applying knowledge, social concern and perceived risk elements.
C1 [Rahmafitria, Fitri] Bandung Inst Technol, Dept Urban & Reg Planning, Bandung, Indonesia.
   [Rahmafitria, Fitri] Univ Pendidikan Indonesia, Dept Resort & Leisure Management, Bandung, Indonesia.
   [Suryadi, Karim] Univ Pendidikan Indonesia, Dept Commun Sci, Bandung, Indonesia.
   [Oktadiana, Hera] James Cook Univ, Coll Business Law & Governance, Townsville, Qld, Australia.
   [Oktadiana, Hera] Trisakti Sch Tourism, Jakarta, Indonesia.
   [Putro, Heru Purboyo H.; Rosyidie, Arief] Bandung Inst Technol, Dept Urban & Reg Planning, Bandung, Indonesia.
RP Rahmafitria, F (corresponding author), Bandung Inst Technol, Dept Urban & Reg Planning, Bandung, Indonesia.
EM rahmafitria@upi.edu; karimsuryadi@upi.edu; hera.oktadiana@jcu.edu.au;
   purboyohp@gmail.com; ariefrosyidie@yahoo.com
FU Indonesia Endowment Fund for Education (LPDP); Indonesian Ministry of
   FinanceMinistry of Research and Technology of the Republic of Indonesia
   (RISTEK)
FX The first author would like to thank the Indonesia Endowment Fund for
   Education (LPDP), as the full-ride scholarship from the Indonesian
   Ministry of Finance, for supporting the first author as a doctoral
   candidate at Bandung Institute of Technology.
CR Agarwal V, 2014, J AM COLL HEALTH, V62, P416, DOI 10.1080/07448481.2014.917650
   Agnew R., 2011, UNIFIED CRIMINOLOGY
   Agnew R, 2014, CRIMINOLOGY, V52, P1, DOI 10.1111/1745-9125.12031
   Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I, 2011, BASIC APPL SOC PSYCH, V33, P101, DOI 10.1080/01973533.2011.568834
   Bagozzi RP, 2000, J CONSUM PSYCHOL, V9, P97, DOI 10.1207/S15327663JCP0902_4
   Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42
   Beirman D., 2006, TOURISM TURBULENT TI, P309
   Birkmann J, 2010, NAT HAZARD EARTH SYS, V10, P2659, DOI 10.5194/nhess-10-2659-2010
   Briggs CL, 2009, MED ANTHROPOL, V28, P189, DOI 10.1080/01459740903070410
   Bujang MA, 2012, 2012 INT C STAT SCI, P1
   Cavlek N, 2002, ANN TOURISM RES, V29, P478, DOI 10.1016/S0160-7383(01)00067-6
   Chew EYT, 2014, TOURISM MANAGE, V40, P382, DOI 10.1016/j.tourman.2013.07.008
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Daugherty EL, 2009, INFECT CONT HOSP EP, V30, P1143, DOI 10.1086/648085
   Esterman, 2020, ABC
   Fabrigar L.R., 2005, STRUCTURE ATTITUDES
   Finstad K, 2010, J USABILITY STUD, V5, P104
   Fishbein M, 2011, PREDICTING AND CHANGING BEHAVIOR: THE REASONED ACTION APPROACH, P1
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Hair J.F., 2014, PRIMER PARTIAL LEAST
   Hall, 2006, TOURISM GLOBAL ENV C
   Han H, 2015, TOURISM MANAGE, V47, P164, DOI 10.1016/j.tourman.2014.09.014
   Hansen JM, 2018, COMPUT HUM BEHAV, V80, P197, DOI 10.1016/j.chb.2017.11.010
   Ho SS, 2013, J HEALTH COMMUN, V18, P773, DOI 10.1080/10810730.2012.743624
   Ho SM, 2017, COMPUT SECUR, V70, P581, DOI 10.1016/j.cose.2017.08.004
   Holland K, 2012, J RISK RES, V15, P657, DOI 10.1080/13669877.2011.652651
   Hunter, 2021, THE CNN
   Kamate Shivlingesh Krishnappa, 2009, J Infect Dev Ctries, V4, P7
   Klerck D, 2007, PSYCHOL MARKET, V24, P171, DOI 10.1002/mar.20157
   Kock N, 2018, INFORM SYST J, V28, P227, DOI 10.1111/isj.12131
   Mansfeld Y., 2006, ROLE SECURITY INFORM
   Mizumoto K, 2020, INFECT DIS MODEL, V5, P264, DOI 10.1016/j.idm.2020.02.003
   MOUTINHO L, 1987, EUR J MARKETING, V21, P1, DOI 10.1108/EUM0000000004718
   Muluk H., 2018, ASIA PACIFIC PERSPEC, P140
   Myers LB, 2012, PUBLIC HEALTH, V126, pS53, DOI 10.1016/j.puhe.2012.05.024
   Neuman W.L., 2011, SOCIAL RES METHODS Q
   Oh S, 2003, J INFORM TECHNOL, V18, P267, DOI 10.1080/0268396032000150807
   Olsen S. O., 2004, Journal of Aquatic Food Product Technology, V13, P79, DOI 10.1300/J030v13n03_08
   Park HS, 2009, J BUS ETHICS, V85, P545, DOI 10.1007/s10551-008-9788-y
   Paul J, 2016, J RETAIL CONSUM SERV, V29, P123, DOI 10.1016/j.jretconser.2015.11.006
   Prati G, 2011, RISK ANAL, V31, P645, DOI 10.1111/j.1539-6924.2010.01529.x
   Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
   Quintal VA, 2010, TOURISM MANAGE, V31, P797, DOI 10.1016/j.tourman.2009.08.006
   Rahmafitria F, 2018, IOP C SER EARTH ENV, V179, DOI 10.1088/1755-1315/179/1/012006
   Rahmafitria F, 2020, TOUR MANAG PERSPECT, V35, DOI 10.1016/j.tmp.2020.100703
   Rittichainuwat B, 2018, TOURISM MANAGE, V66, P221, DOI 10.1016/j.tourman.2017.09.013
   Rittichainuwat BN, 2009, TOURISM MANAGE, V30, P410, DOI 10.1016/j.tourman.2008.08.001
   Roosa K, 2020, INFECT DIS MODEL, V5, P256, DOI 10.1016/j.idm.2020.02.002
   Shaver, 2010, PROSOCIAL MOTIVES EM, P15, DOI [10.1037/12061-001, DOI 10.1037/12061-001]
   Sparks B, 2009, TOURISM MANAGE, V30, P483, DOI 10.1016/j.tourman.2008.10.014
   Spector, 2020, TOUR RECREAT RES, V45, P1
   Tasci ADA, 2019, J DESTIN MARK MANAGE, V13, P24, DOI 10.1016/j.jdmm.2019.03.007
   Tooher R, 2013, INFLUENZA OTHER RESP, V7, P1316, DOI 10.1111/irv.12103
   Tuu HH, 2008, APPETITE, V51, P546, DOI 10.1016/j.appet.2008.04.007
   Ulker-Demirel E, 2020, J HOSP TOUR MANAG, V43, P209, DOI 10.1016/j.jhtm.2020.04.003
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   WHO, 2020, NOV COR 2019 NCOV SI
   Wu JY, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12218758
   Yadav R, 2016, J CLEAN PROD, V135, P732, DOI 10.1016/j.jclepro.2016.06.120
   Yeh SS, 2021, TOUR RECREAT RES, V46, P188, DOI 10.1080/02508281.2020.1805933
   Yuzhanin S, 2016, TOUR REV, V71, P135, DOI 10.1108/TR-11-2015-0055
   Zhang HM, 2018, J DESTIN MARK MANAGE, V8, P326, DOI 10.1016/j.jdmm.2017.06.004
   Zheng Y, 2020, ANATOLIA, V31, P337, DOI 10.1080/13032917.2020.1747208
NR 65
TC 5
Z9 5
U1 14
U2 32
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1660-5373
EI 1759-8451
J9 TOUR REV
JI Tour. Rev.
PD JUL 27
PY 2021
VL 76
IS 4
BP 809
EP 828
DI 10.1108/TR-11-2020-0542
EA JUN 2021
PG 20
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA TQ8NS
UT WOS:000661136900001
OA Bronze
DA 2022-04-20
ER

PT J
AU He, DH
   Zhao, S
   Lin, QY
   Zhuang, Z
   Cao, PH
   Wang, MH
   Yang, L
AF He, Daihai
   Zhao, Shi
   Lin, Qianying
   Zhuang, Zian
   Cao, Peihua
   Wang, Maggie H.
   Yang, Lin
TI The relative transmissibility of asymptomatic COVID-19 infections among
   close contacts
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE COVID-19; Asymptomatic infection; Relative transmissibility
AB Asymptomatic transmission of the coronavirus disease 2019 is an important topic. A recent study in China showed that transmissibility of the asymptomatic cases is comparable to that of symptomatic cases. Here, we discuss that the conclusion may depend on how we interpret the data. To the best of our knowledge, this is the first time the relative transmissibility of asymptomatic COVID-19 infections is quantified. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [He, Daihai; Zhuang, Zian] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
   [Zhao, Shi; Wang, Maggie H.] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.
   [Zhao, Shi; Wang, Maggie H.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.
   [Lin, Qianying] Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA.
   [Cao, Peihua] Southern Med Univ, Zhujiang Hosp, Clin Res Ctr, Guangzhou, Peoples R China.
   [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China.
RP He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
EM daihai.he@polyu.edu.hk
RI He, Daihai/AAT-8735-2021; Lin, Qianying/ABD-8415-2021; Zhao,
   Shi/AAW-6992-2021
OI Zhao, Shi/0000-0001-8722-6149; He, Daihai/0000-0003-3253-654X
FU Research Grants Council of Hong KongHong Kong Research Grants Council
   [15205119]; Alibaba (China) - Hong Kong Polytechnic University
   Collaborative Research project [P0031768]
FX DH was supported by General Research Fund (15205119) of Research Grants
   Council of Hong Kong and an Alibaba (China) - Hong Kong Polytechnic
   University Collaborative Research project (P0031768). The funding
   agencies had no role in the design and conduct of the study; collection,
   management, analysis, and interpretation of the data; preparation,
   review, or approval of the manuscript; or decision to submit the
   manuscript for publication.
CR Chen Y, 2020, ZHONGHUA LIU XING BI, P41, DOI [10.3760/cma.j.cn112338-20200304-00251, DOI 10.3760/CMA.J.CN112338-20200304-00251]
   Du ZQ, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4855-9
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guggemos, 2020, NATURE          0401, V581, DOI [10.1038/s41586-020-2196-x, DOI 10.1038/s41586-020-2196-x]
   Mao ZQ, 2020, INT J INFECT DIS, V2020
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Nishiura H, 2020, INT J INFECT DIS, V2020
   Qiu Jane, 2020, Nature, DOI 10.1038/d41586-020-00822-x
   Zhao S, 2020, MODELLING CORONAVIRU, DOI [10.1101/2020.02.26.20028449medRxiv, DOI 10.1101/2020.02.26.20028449]
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 10
TC 62
Z9 66
U1 4
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAY
PY 2020
VL 94
BP 145
EP 147
DI 10.1016/j.ijid.2020.04.034
PG 3
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA LO5BT
UT WOS:000533643700033
PM 32315808
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ch'ang, JH
   Ford, J
   Cifrese, L
   Woodward, E
   Mears, J
   Lowrie, R
   Holland, C
   Kaplan, A
   Zhang, CA
   Guterman, EL
AF Ch'ang, Judy H.
   Ford, Jenna
   Cifrese, Laura
   Woodward, Elliott
   Mears, Jennifer
   Lowrie, Rachel
   Holland, Chloe
   Kaplan, Aaron
   Zhang, Cenai
   Guterman, Elan L.
TI Preparing Neurology Residents and Advanced Practice Providers for the
   COVID-19 ICU-A Neurocritical Care Led Intervention
SO NEUROHOSPITALIST
LA English
DT Article
DE COVID-19; neurology; critical care; severe acute respiratory syndrome
   coronavirus 2; curriculum
ID IMPACT
AB Background and Purpose: With the surge of critically ill COVID-19 patients, neurology and neurosurgery residents and advanced practice providers (APPs) were deployed to intensive care units (ICU). These providers lacked relevant critical care training. We investigated whether a focused video-based learning curriculum could effectively teach high priority intensive care topics in this unprecedented setting to these neurology providers. Methods: Neurocritical care clinicians led a multidisciplinary team in developing a 2.5-hour lecture series covering the critical care management of COVID-19 patients. We examined whether provider confidence, stress, and knowledge base improved after viewing the lectures. Results: A total of 88 residents and APPs participated across 2 academic institutions. 64 participants (73%) had not spent time as an ICU provider. After viewing the lecture series, the proportion of providers who felt moderately, quite, or extremely confident increased from 11% to 72% (60% difference, 95% CI 49-72%) and the proportion of providers who felt nervous/stressed, very nervous/stressed, or extremely nervous/stressed decreased from 78% to 48% (38% difference, 95% CI 26-49%). Scores on knowledge base questions increased an average of 2.5 out of 12 points (SD 2.1; p < 0.001). Conclusion: A targeted, asynchronous curriculum on critical care COVID-19 management led to significantly increased confidence, decreased stress, and improved knowledge among resident trainees and APPs. This curriculum could serve as an effective didactic resource for neurology providers preparing for the COVID-19 ICU.
C1 [Ch'ang, Judy H.; Ford, Jenna; Cifrese, Laura] Weill Cornell Med Coll, Dept Neurol, 525 East 68th St,F610, New York, NY 10065 USA.
   [Woodward, Elliott] Univ Calif San Francisco, Dept Anesthesiol, San Francisco, CA USA.
   [Mears, Jennifer; Kaplan, Aaron] New York Presbyterian Hosp Weill Cornell, Dept Neurol, New York, NY USA.
   [Lowrie, Rachel; Holland, Chloe] New York Presbyterian Hosp Weill Cornell, Dept Neurosurg, New York, NY USA.
   [Zhang, Cenai] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA.
   [Guterman, Elan L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.
RP Ch'ang, JH (corresponding author), Weill Cornell Med Coll, Dept Neurol, 525 East 68th St,F610, New York, NY 10065 USA.
EM jhc9010@med.cornell.edu
OI Ch'ang, Judy/0000-0001-9017-9830; Zhang, Cenai/0000-0001-8137-1644
FU National Institute of Neurological Disorders and StrokeUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [1K23NS116128-01]; National Institute on AgingUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute on Aging (NIA) [5R01AG056715]; American Academy of
   Neurology
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: Dr.
   Guterman receives funding from the National Institute of Neurological
   Disorders and Stroke (1K23NS116128-01), the National Institute on Aging
   (5R01AG056715), and the American Academy of Neurology as well as
   consulting fees from Marinus Pharmaceuticals, Inc. and honoraria from
   Knowledge to Practice that are unrelated to the submitted work.
CR Campbell JK, 1999, BRIT MED J, V318, P1272
   Cook DA, 2006, ACAD MED, V81, P231, DOI 10.1097/00001888-200603000-00005
   Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181
   Cook DA, 2008, J GEN INTERN MED, V23, P985, DOI 10.1007/s11606-008-0541-0
   Grundman JA, 2000, ACAD MED, V75, pS47, DOI 10.1097/00001888-200010001-00015
   Kumta S., 2003, J ED MULTIMEDIA HYPE, V78, P295
   Leong SL, 2003, ACAD MED, V78, P295, DOI 10.1097/00001888-200303000-00012
   MacKenzie J D, 1997, JAMA, V278, P1785, DOI 10.1001/jama.278.21.1785
   Masic Izet, 2008, Acta Inform Med, V16, P102, DOI 10.5455/aim.2008.16.102-117
   Pajares F, 1996, REV EDUC RES, V66, P543, DOI 10.2307/1170653
   Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002
   Sawatsky AP, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-129
   Sawatsky Adam P, 2014, J Grad Med Educ, V6, P32, DOI 10.4300/JGME-06-01-37.1
   Shoji K, 2016, ANXIETY STRESS COPIN, V29, P367, DOI 10.1080/10615806.2015.1058369
   Xanthopoulou D., 2007, J MANAGE PSYCHOL, V22, P766, DOI [10.1108/02683940710837714, DOI 10.1108/02683940710837714]
   Zucker S, 1998, ACAD MED, V73, P1072
NR 16
TC 1
Z9 1
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1941-8744
EI 1941-8752
J9 NEUROHOSPITALIST
JI Neurohospitalist
PD OCT
PY 2021
VL 11
IS 4
BP 342
EP 347
AR 19418744211016220
DI 10.1177/19418744211016220
EA MAY 2021
PG 6
WC Clinical Neurology
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA UP8IV
UT WOS:000654188200001
PM 34567395
OA Bronze
DA 2022-04-20
ER

PT J
AU Ma, L
   Zou, SY
   Liu, YY
   Lai, J
   Yang, JH
AF Ma, Li
   Zou, Shiyue
   Liu, Yanyi
   Lai, Jing
   Yang, Junhua
TI The Application of Hazard Vulnerability Analysis in the Prevention and
   Control of COVID-19 in Medical Institutions
SO IRANIAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Hazard vulnerability analysis; COVID-19; Prevention and control
AB Background: Coronavirus disease 2019 (COVID-19) has caused massive casualties, severe economic losses, and poses a threat to the world. This study's primary objective was to analyze the hospital's potential hazards of COVID-19 prevention and control. The second objective was to review the disaster plan and make recommendations to minimize the spread of COVID-19 in hospitals.
   Methods: An expert group for the prevention and control of COVID-19 in the First People's Hospital of Longquanyi Dis-trict, Chengdu, China was established. We adopted the hazard vulnerability analysis (HVA) to risk-stratify potential hazards and calculated relative risk values. We used the Delphi expert consultation method to propose and implement targeted improvement measures for the top five potential hazards. Then, the effects before and after the intervention were compared.
   Results: The top five hazards were: insufficient Personal Protective Equipment (PPE) (25.68%), inadequate diagnosis ability of clinicians (22.55%), and inadequate management strategies of patients and caregivers (22.38%), lack of professional ability of pre-checking and triage staff (16.96%), lack of knowledge of COVID-19 of medical staff (15.59%). After taking targeted improvement measures, the average score of the hospital staffs COVID-19 knowledge test increased from 73.26 points to 90.44 points, the average test score of the outsourcing company employees increased from 68.55 to 89.75 points. The differences were statistically significant (P<0.05).
   Conclusion: HVA can be used to systematically risk-stratify potential threats, measure the probability of those potential hazards, and develop various hospital prevention and control measures for COVID-19 epidemics.
C1 [Ma, Li] Sichuan Univ, Inst Urol, Dept Urol, West China Hosp, Chengdu, Peoples R China.
   [Zou, Shiyue; Liu, Yanyi; Lai, Jing; Yang, Junhua] Peoples Hosp Longquanyi Dist 1, Chengdu, Peoples R China.
RP Zou, SY (corresponding author), Peoples Hosp Longquanyi Dist 1, Chengdu, Peoples R China.
EM 522092862@qq.com
FU fund of Chengdu Science and Technology Bureau [2020-YF05-00031-SN]
FX Support for this study came from the fund of Chengdu Science and
   Technology Bureau (Project number: 2020-YF05-00031-SN)
CR BU W, 2020, WORLD LATEST MED INF, V19, P1
   Chen B, 2020, CHINESE NURSING RES, V34, P371
   Fu Kai, 2020, Journal of Jiangsu University - Medicine Edition, V30, P101, DOI 10.13312/j.issn.1671-7783.y200088
   Jiang Q, 2020, HUA XI YAO XUE ZA ZH, V35, P113
   Li X, 2019, CHINESE HLTH QUALITY, V26, P70
   Luan Rong-Sheng, 2020, Sichuan Da Xue Xue Bao Yi Xue Ban, V51, P131, DOI 10.12182/20200360505
   McLaughlin SB, 2001, HAZARD VULNERABILITY
   Rossignol N, 2015, RISK ANAL, V35, P129, DOI 10.1111/risa.12233
   Siyan L, 2019, JIANGSU HEALTHCARE A, V30, P1543
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   Yao Y, 2013, CHINESE HOSP MANAGEM, V33, P36
   Zhiwei X, 2018, J CHINESE RES HOSP, V5, P1
NR 12
TC 0
Z9 0
U1 6
U2 8
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 2251-6085
EI 2251-6093
J9 IRAN J PUBLIC HEALTH
JI Iran J. Public Health
PD FEB
PY 2021
VL 50
IS 2
BP 271
EP 279
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA QJ6FW
UT WOS:000619785300006
PM 33747990
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ungureanu, P
   Bertolotti, F
AF Ungureanu, Paula
   Bertolotti, Fabiola
TI Backing up emergency teams in healthcare and law enforcement
   organizations: strategies to socialize newcomers in the time of COVID-19
SO JOURNAL OF RISK RESEARCH
LA English
DT Article
DE COVID-19; organizational socialization; emergency teams; newcomers;
   healthcare organizations; law enforcement teams; role crafting;
   knowledge management; swift trust; emotions; risk management
ID COORDINATION; TACTICS; ADJUSTMENT; RISK; ANTECEDENTS; KNOWLEDGE; STRESS;
   WORK
AB The COVID-19 pandemic is putting significant pressure on emergency teams in healthcare and law enforcement organizations. In order to provide rapid backup, new workers must be socialized rapidly and effectively. In addition to considering the pros and cons of various newcomer socialization strategies and tools, healthcare and law enforcement organizations may need to design hybrid socialization strategies at the light of four essential processes of emergency teams: roles, knowledge, interpersonal relations and emotion management. We suggest that emergency teams based on the combined resources of old-timers and newcomers where the more experienced team members contribute actively to the socialization of new members can have unexpected positive effects on the team.
C1 [Ungureanu, Paula; Bertolotti, Fabiola] Univ Modena & Reggio Emilia, Dept Sci & Methods Engn, Via Amendola 2 Pad Morselli, I-42122 Reggio Emilia, Italy.
RP Ungureanu, P (corresponding author), Univ Modena & Reggio Emilia, Dept Sci & Methods Engn, Via Amendola 2 Pad Morselli, I-42122 Reggio Emilia, Italy.
EM paula.ungureanu@unimore.it
CR AlArshani S., 2020, BUSINESS INSIDER
   ARGOTE L, 1982, ADMIN SCI QUART, V27, P420, DOI 10.2307/2392320
   Ashforth BE, 2007, J VOCAT BEHAV, V70, P447, DOI 10.1016/j.jvb.2007.02.001
   Aven T, 2020, J RISK RES, V23, P849, DOI 10.1080/13669877.2020.1756383
   Balog-Way DHP, 2020, J RISK RES, V23, P838, DOI 10.1080/13669877.2020.1758192
   Bao GM, 2019, J RISK RES, V22, P1490, DOI 10.1080/13669877.2018.1485171
   BARLEY SR, 1986, ADMIN SCI QUART, V31, P78, DOI 10.2307/2392767
   Bauer TN, 2007, J APPL PSYCHOL, V92, P707, DOI 10.1037/0021-9010.92.3.707
   Bauer Talya Niehaus, 1996, APA HDB I O PSYCHOL, V3, P51
   Bechky BA, 2003, ORGAN SCI, V14, P312, DOI 10.1287/orsc.14.3.312.15162
   Blomqvist K, 2018, ROUTL COMPANION BUS, P29
   Bouder F, 2007, TOLERABILITY RISK NE
   Bravo MJ, 2003, WORK STRESS, V17, P195, DOI 10.1080/02678370310001625658
   CHAO GT, 1994, J APPL PSYCHOL, V79, P730, DOI 10.1037/0021-9010.79.5.730
   Collins D.L., 2003, J HUMAN PERFORMANCE, V7, P43, DOI [10.7771/2327-2937.1021, DOI 10.7771/2327-2937.1021]
   Colquitt JA, 2007, J APPL PSYCHOL, V92, P909, DOI 10.1037/0021-9010.92.4.909
   Constantinides P, 2012, INFORM ORGAN-UK, V22, P273, DOI 10.1016/j.infoandorg.2012.07.001
   Cooke NJ, 2003, GROUP DYN-THEOR RES, V7, P179, DOI 10.1037/1089-2699.7.3.179
   Cooper-Thomas H, 2002, J OCCUP ORGAN PSYCH, V75, P423, DOI 10.1348/096317902321119583
   Cooper-Thomas H. D., 2006, J MANAGERIAL PSYCHOL, V21, P492, DOI [DOI 10.1108/02683940610673997, 10.1108/02683940610673997]
   Dietz AS., 2017, WILEY BLACKWELL HDB, P297
   Driskell J.E., 2008, PERFORMANCE STRESS, P271
   Driskell T, 2018, HUM RESOUR MANAGE R, V28, P434, DOI 10.1016/j.hrmr.2017.01.002
   Ellis APJ, 2006, ACAD MANAGE J, V49, P576
   Feldman D. C., 1981, ACAD MANAGE REV, V6, DOI [10.5465/amr.1981.4287859, DOI 10.2307/257888]
   Fernandez R, 2008, ACAD EMERG MED, V15, P1104, DOI 10.1111/j.1553-2712.2008.00250.x
   Florentino Flavia., 2020, GEMELLI SUPPORTO PSI
   Fu KW, 2020, J RISK RES, V23, P1047, DOI 10.1080/13669877.2020.1756380
   Nygren KG, 2020, J RISK RES, V23, P1031, DOI 10.1080/13669877.2020.1756382
   Haueter JA, 2003, J VOCAT BEHAV, V63, P20, DOI 10.1016/S0001-8791(02)00017-9
   Hong SY, 2020, J RISK RES, V23, P398, DOI 10.1080/13669877.2019.1569100
   JONES GR, 1986, ACAD MANAGE J, V29, P262, DOI 10.2307/256188
   KATZ P, 1990, ETHOS, V18, P457, DOI 10.1525/eth.1990.18.4.02a00060
   Krause NM, 2020, J RISK RES, V23, P1052, DOI 10.1080/13669877.2020.1756385
   Langan-Fox J, 2004, HUM FACTORS ERGONOM, V14, P333, DOI 10.1002/hfm.20004
   Langley A, 2019, ACAD MANAG ANN, V13, P704, DOI 10.5465/annals.2017.0089
   Levina N, 2005, MIS QUART, V29, P335
   Lofstedt R, 2011, J RISK RES, V14, P409, DOI 10.1080/13669877.2011.557479
   MEARNS K, 2001, J RISK RES, V0004, P00377, DOI DOI 10.1080/13669870110063225
   Meyerson D., 1996, TRUST ORG FRONTIERS, VVolume 166
   MILBURN TW, 1976, AM BEHAV SCI, V20, P111, DOI 10.1177/000276427602000107
   Moreland R. L., 2002, GROUP PROCESS INTERG, V5, P185, DOI [DOI 10.1177/1368430202005003001, 10.1177/1368430202005003001]
   Perrot S, 2014, GROUP ORGAN MANAGE, V39, P247, DOI 10.1177/1059601114535469
   Pramanik R, 2015, J RISK RES, V18, P989, DOI 10.1080/13669877.2015.1043566
   Pratt MG, 1997, MANAGE LEARN, V28, P65, DOI 10.1177/1350507697281005
   Rico R, 2008, ACAD MANAGE REV, V33, P163
   Saks AM, 2018, CAREER DEV INT, V23, P12, DOI 10.1108/CDI-12-2016-0214
   Saks AM, 1997, J VOCAT BEHAV, V51, P234, DOI 10.1006/jvbe.1997.1614
   Scott C, 2005, J APPL COMMUN RES, V33, P67, DOI 10.1080/0090988042000318521
   Smith-Jentsch Kimberly A, 2015, NASATM2015218589
   STAR SL, 1989, SOC STUD SCI, V19, P387, DOI 10.1177/030631289019003001
   Stryker S, 1985, HDB SOCIAL PSYCHOL, P311, DOI DOI 10.14966/JSSP.KJ00003724954
   Tasic J, 2020, J RISK RES, V23, P713, DOI 10.1080/13669877.2019.1617340
   Turkington K, 2008, PROCEEDINGS OF THE 2008 INTERNATIONAL CONFERENCE ON FIELD-PROGRAMMABLE TECHNOLOGY, P1, DOI 10.1109/FPT.2008.4762359
   Ungureanu P., 2018, CERN IDEASQUARE J EX, V2, P38
   Ungureanu P, 2019, EUR MANAG J, V37, P742, DOI 10.1016/j.emj.2019.03.005
   Ungureanu P, 2018, ACAD MANAG LEARN EDU, V17, P425, DOI 10.5465/amle.2016.0095
   Ungureanu P, 2018, EUR J INNOV MANAG, V21, P636, DOI 10.1108/EJIM-01-2018-0015
   Ungureanu Paula, 2016, ACAD MANAGEMENT P, V2016, P15623, DOI [10.5465/ambpp.2016.110, DOI 10.5465/AMBPP.2016.110]
   Van Maanen John, 1977, THEORY ORG SOCIALIZA
   Wright AL, 2017, ACAD MANAGE J, V60, P200, DOI 10.5465/amj.2013.0870
   Wynne B., 1992, RISK SOC NEW MODERNI
   Zinn JO, 2020, J RISK RES, V23, P1083, DOI 10.1080/13669877.2020.1758194
NR 63
TC 1
Z9 1
U1 4
U2 15
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1366-9877
EI 1466-4461
J9 J RISK RES
JI J. Risk Res.
PD AUG 2
PY 2020
VL 23
IS 7-8
BP 888
EP 901
DI 10.1080/13669877.2020.1765002
EA MAY 2020
PG 14
WC Social Sciences, Interdisciplinary
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA PB6YF
UT WOS:000533733300001
OA Bronze
DA 2022-04-20
ER

PT J
AU Vergoulis, T
   Kanellos, I
   Chatzopoulos, S
   Karidi, DP
   Dalamagas, T
AF Vergoulis, Thanasis
   Kanellos, Ilias
   Chatzopoulos, Serafeim
   Karidi, Danae Pla
   Dalamagas, Theodore
TI BIP4COVID19: Releasing impact measures for articles relevant to COVID-19
SO QUANTITATIVE SCIENCE STUDIES
LA English
DT Article
DE scientometrics; impact measures; covid-19; open scholarly data
AB Since the beginning of the coronavirus pandemic, a large number of relevant articles have been published or become available in preprint servers. These articles, along with earlier related literature, compose a valuable knowledge base affecting contemporary research studies or even government actions to limit the spread of the disease, and directing treatment decisions taken by physicians. However, the number of such articles is increasing at an intense rate, making the exploration of the relevant literature and the identification of useful knowledge challenging. In this work, we describe BIP4COVID19, an open data set that offers a variety of impact measures for coronavirus-related scientific articles. These measures can be exploited for the creation or extension of added-value services aiming to facilitate the exploration of the respective literature, alleviating the aforementioned issue. In the same context, as a use case, we provide a publicly accessible keyword-based search interface for COVID-19-related articles, which leverages our data to rank search results according to the calculated impact indicators.
C1 [Vergoulis, Thanasis; Kanellos, Ilias; Chatzopoulos, Serafeim; Karidi, Danae Pla; Dalamagas, Theodore] IMSI, Athena RC, Athens, Greece.
   [Chatzopoulos, Serafeim] Univ Peloponnese, Dept Informat & Tele Tions, Tripolis, Greece.
   [Karidi, Danae Pla] NTU Athens, Athens, Greece.
RP Vergoulis, T (corresponding author), IMSI, Athena RC, Athens, Greece.
EM vergoulis@athenarc.gr
OI Vergoulis, Thanasis/0000-0003-0555-4128; Dalamagas,
   Theodore/0000-0002-5002-7901; Chatzopoulos, Serafeim/0000-0003-1714-5225
FU project "Moving from Big Data Management to Data Science" - Operational
   Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF
   2014-2020) [MIS 5002437/3]; European Union (European Regional
   Development Fund)European Commission
FX We acknowledge support of this work by the project "Moving from Big Data
   Management to Data Science" (MIS 5002437/3) which is implemented under
   the Action "Reinforcement of the Research and Innovation
   Infrastructure," funded by the Operational Programme "Competitiveness,
   Entrepreneurship and Innovation" (NSRF 2014-2020) and cofinanced by
   Greece and the European Union (European Regional Development Fund).
CR Banda Juan M, 2020, ArXiv
   Bhatia P., 2020, ARXIV200709186
   Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022
   Chen E., 2020, ARXIV200307372
   Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001
   Chen QY, 2021, NUCLEIC ACIDS RES, V49, pD1534, DOI 10.1093/nar/gkaa952
   Chen QY, 2020, NATURE, V579, P193, DOI 10.1038/d41586-020-00694-1
   Colavizza G, 2020, QUANT SCI STUD, V1, P1349, DOI 10.1162/qss_a_00080
   Farber M, 2019, LECT NOTES COMPUT SC, V11779, P113, DOI 10.1007/978-3-030-30796-7_8
   Fox E. A., 1994, Second Text REtrieval Conference (TREC-2) (NIST-SP 500-215), P243
   Ghosh R., 2011, 2011 IEEE International Conference on Data Mining Workshops, P373, DOI 10.1109/ICDMW.2011.183
   Hope T., 2020, P 2020 C EMP METH NA, P135, DOI [10.18653/v1/2020.emnlp-demos.18, DOI 10.18653/V1/2020.EMNLP-DEMOS.18]
   Horbach SPJM, 2021, RES EVALUAT, V30, P231, DOI 10.1093/reseval/rvaa037
   Horbach SPJM, 2020, QUANT SCI STUD, V1, P1056, DOI 10.1162/qss_a_00076
   Jaradeh MY, 2019, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON KNOWLEDGE CAPTURE (K-CAP '19), P243, DOI 10.1145/3360901.3364435
   Kanellos I, 2021, PROC INT CONF DATA, P1997, DOI 10.1109/ICDE51399.2021.00190
   Kanellos I, 2021, IEEE T KNOWL DATA EN, V33, P1567, DOI 10.1109/TKDE.2019.2941206
   Kousha K, 2020, QUANT SCI STUD, V1, P1068, DOI 10.1162/qss_a_00066
   Lu Wang L., 2020, CORD 19 COVID 19 OPE
   Lucas-Dominguez R, 2021, SCIENTOMETRICS, V126, P4975, DOI 10.1007/s11192-021-03971-6
   Page L., 1999, PAGERANK CITATION RA
   Panja S., 2020, 63 IEEE INT MIDW S C, P500, DOI [10.1109/MWSCAS48704.2020.9184598, DOI 10.1109/MWSCAS48704.2020.9184598]
   Piwowar H, 2013, B AM SOC INF SCI TEC, V39, P8, DOI DOI 10.1002/BULT.2013.1720390404
   Rohatgi S., 2020, ACM S DOC ENG 2020, DOI [10.1145/3395027.3419597, DOI 10.1145/3395027.3419597]
   Thelwall M, 2020, QUANT SCI STUD, V1, P1381, DOI 10.1162/qss_a_00083
   Trewartha, 2020, ARXIV201203891
   Vergoulis T., 2021, DOI 10.5281/zenodo.4555117
   Vergoulis T, 2021, WEB CONFERENCE 2021: COMPANION OF THE WORLD WIDE WEB CONFERENCE (WWW 2021), P456, DOI [10.6084/m9.figshare.16733170.v1, 10.1145/3442442.3451369]
   Vergoulis T, 2019, PROCEEDINGS OF THE 28TH ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM '19), P2937, DOI 10.1145/3357384.3357850
   Wang, 2020, ARXIV200700576, DOI DOI 10.18653/V1/2021.NAACL-DEMOS.8
   Wise C, 2020, ARXIV200712731
   Xu Y, 2020, P 1STWORKSHOP NLP CO, DOI [10.18653/v1/2020.nlpcovid19-2.14, DOI 10.18653/V1/2020.NLPCOVID19-2.14]
NR 32
TC 2
Z9 2
U1 2
U2 2
PU MIT PRESS
PI CAMBRIDGE
PA ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA
EI 2641-3337
J9 QUANT SCI STUD
JI Quant. Sci. Stud.
PD FEB 4
PY 2022
VL 2
IS 4
BP 1447
EP 1465
DI 10.1162/qss_a_00169
PG 19
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA YU4AT
UT WOS:000751988600013
OA gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Durst, S
AF Durst, Susanne
TI A plea for responsible and inclusive knowledge management at the world
   level
SO VINE JOURNAL OF INFORMATION AND KNOWLEDGE MANAGEMENT SYSTEMS
LA English
DT Article; Early Access
DE Knowledge management; Inclusive knowledge management; New research
   direction; Responsible knowledge; Responsible knowledge management
ID CRISIS MANAGEMENT; COVID-19; BUSINESS
AB Purpose This essay aims to draw attention to the idea of a new research approach to knowledge management (KM) labelled responsible KM (rKM) as a possible answer to not only address the consequences of the pandemic but also other present and upcoming societal challenges. Design/methodology/approach This essay has been prepared by a KM researcher who shares their own personal views and opinion regarding past and current societal developments and based on that offers a potentially new KM direction. Findings Switching the focus to rKM may help address current and upcoming social challenges that can only be addressed jointly by the global community and which would also involve a new consideration of the "knowledge" resource. Originality/value The essay proposes a new alternative approach to KM called rKM that is based on ideas that to the author's knowledge have not been discussed in this way in the contemporary literature on KM.
C1 [Durst, Susanne] Tallinn Univ Technol, Dept Business Adm, Tallinn, Estonia.
   [Durst, Susanne] Hogskolan Skovde, Sch Business, Skovde, Sweden.
RP Durst, S (corresponding author), Tallinn Univ Technol, Dept Business Adm, Tallinn, Estonia.; Durst, S (corresponding author), Hogskolan Skovde, Sch Business, Skovde, Sweden.
EM susanne.durst@taltech.ee
RI Durst, Susanne/J-8919-2017
OI Durst, Susanne/0000-0001-8469-2427
CR [Anonymous], 2021, WIRED BUSINESS
   Boin A, 2016, PUBLIC ADMIN, V94, P289, DOI 10.1111/padm.12264
   Clauss T, 2022, R&D MANAGE, V52, P294, DOI 10.1111/radm.12498
   Davidsson P, 2016, ENTREP THEORY PRACT, V40, P915, DOI 10.1111/etap.12152
   Di Mascio F, 2020, AM REV PUBLIC ADM, V50, P621, DOI 10.1177/0275074020941735
   Doern R, 2019, ENTREP REGION DEV, V31, P400, DOI 10.1080/08985626.2018.1541590
   Dunlop CA, 2020, PUBLIC POLICY ADMIN, V35, P365, DOI 10.1177/0952076720939631
   Durst S., 2021, J INT COUNCIL SMALL, V2, P1
   Durst S, 2019, KNOWL MAN RES PRACT, V17, P1, DOI 10.1080/14778238.2018.1538603
   Durst S, 2016, INT J KNOWL SYST SCI, V7, P19, DOI 10.4018/IJKSS.2016070102
   Durst S, 2012, J KNOWL MANAG, V16, P879, DOI 10.1108/13673271211276173
   Dyllick T, 2016, ORGAN ENVIRON, V29, P156, DOI 10.1177/1086026615575176
   Herbane B, 2019, ENTREP REGION DEV, V31, P476, DOI 10.1080/08985626.2018.1541594
   Herbane B, 2013, J CONTING CRISIS MAN, V21, P82, DOI 10.1111/1468-5973.12006
   Institute for Public Relations, 2020, COVID 19 BUS HANDL C
   Massaro M, 2016, J KNOWL MANAG, V20, P258, DOI 10.1108/JKM-08-2015-0320
   Mayr S., 2019, J SMALL BUS STRATEGY, V29, P85
   Paul SK, 2021, J BUS RES, V136, P316, DOI 10.1016/j.jbusres.2021.07.056
   Ritter T, 2020, IND MARKET MANAG, V88, P214, DOI 10.1016/j.indmarman.2020.05.014
NR 19
TC 1
Z9 1
U1 3
U2 3
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2059-5891
EI 1474-1032
J9 VINE J INF KNOWL MAN
JI VINE J. INF. KNOWL. MANAG. SYST.
DI 10.1108/VJIKMS-09-2021-0204
EA DEC 2021
PG 9
WC Information Science & Library Science; Management
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science; Business & Economics
GA XZ7UV
UT WOS:000737854900001
OA hybrid, Green Submitted
DA 2022-04-20
ER

PT C
AU Jiang, RH
   Wang, ZN
   Cai, ZK
   Yang, C
   Fan, ZP
   Xia, TQ
   Matsubara, G
   Mizuseki, H
   Song, X
   Shibasaki, R
AF Jiang, Renhe
   Wang, Zhaonan
   Cai, Zekun
   Yang, Chuang
   Fan, Zipei
   Xia, Tianqi
   Matsubara, Go
   Mizuseki, Hiroto
   Song, Xuan
   Shibasaki, Ryosuke
BE Dong, Y
   Kourtellis, N
   Hammer, B
   Lozano, JA
TI Countrywide Origin-Destination Matrix Prediction and Its Application for
   COVID-19
SO MACHINE LEARNING AND KNOWLEDGE DISCOVERY IN DATABASES, ECML PKDD 2021:
   APPLIED DATA SCIENCE TRACK, PT IV
SE Lecture Notes in Artificial Intelligence
LA English
DT Proceedings Paper
CT European Conference on Machine Learning and Principles and Practice of
   Knowledge Discovery in Databases (ECML PKDD)
CY SEP 13-17, 2021
CL ELECTR NETWORK
SP Google, ASML, Amazon, Ikerlan, KNIME, EurAi, Springer
DE Human mobility; Origin-destination; OD matrix; Graph convolutional
   network; Deep learning; COVID-19
AB Modeling and predicting human mobility are of great significance to various application scenarios such as intelligent transportation system, crowd management, and disaster response. In particular, in a severe pandemic situation like COVID-19, human movements among different regions are taken as the most important point for understanding and forecasting the epidemic spread in a country. Thus, in this study, we collect big human GPS trajectory data covering the total 47 prefectures of Japan and model the daily human movements between each pair of prefectures with time-series Origin-Destination (OD) matrix. Then, given the historical observations from past days, we predict the country-wide OD matrices for the future one or more weeks by proposing a novel deep learning model called Origin-Destination Convolutional Recurrent Network (ODCRN). It integrates the recurrent and 2-dimensional graph convolutional components to deal with the highly complex spatiotemporal dependencies in sequential OD matrices. Experiment results over the entire COVID-19 period demonstrate the superiority of our proposed methodology over existing OD prediction models. Last, we apply the predicted countrywide OD matrices to the SEIR model, one of the most classic and widely used epidemic simulation model, to forecast the COVID-19 infection numbers for the entire Japan. The simulation results also demonstrate the high reliability and applicability of our countrywide OD prediction model for a pandemic scenario like COVID-19.
C1 [Jiang, Renhe; Wang, Zhaonan; Cai, Zekun; Yang, Chuang; Fan, Zipei; Song, Xuan; Shibasaki, Ryosuke] Univ Tokyo, Tokyo, Japan.
   [Xia, Tianqi; Matsubara, Go] LocationMind Inc, Tokyo, Japan.
   [Mizuseki, Hiroto] BlogWatcher Inc, Tokyo, Japan.
   [Jiang, Renhe; Fan, Zipei; Song, Xuan] Southern Univ Sci & Technol, Shenzhen, Peoples R China.
RP Song, X (corresponding author), Univ Tokyo, Tokyo, Japan.; Song, X (corresponding author), Southern Univ Sci & Technol, Shenzhen, Peoples R China.
EM jiangrh@csis.u-tokyo.ac.jp; znwang@csis.u-tokyo.ac.jp;
   songxuan@csis.u-tokyo.ac.jp
OI YANG, Chuang/0000-0002-8504-0057
CR Bai L, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1981
   Bertuzzo E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18050-2
   Bruna J., 2014, ICLR
   Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Cong G, 2018, P 27 INT JOINT C ART, P3732
   Della Rossa F, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-16343-0, 10.1038/s41467-020-18827-5]
   Diao ZL, 2019, THIRTY-THIRD AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTY-FIRST INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / NINTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P890
   Feng J, 2018, WEB CONFERENCE 2018: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW2018), P1459, DOI 10.1145/3178876.3186058
   Gao Q, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P2750, DOI 10.1145/3308558.3313610
   Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117
   Geng X, 2019, THIRTY-THIRD AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTY-FIRST INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / NINTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P3656
   Guo SN, 2019, THIRTY-THIRD AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTY-FIRST INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / NINTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P922
   Hamilton William L., 2017, ADV NEURAL INFORM PR
   Hoang MX, 2016, 24TH ACM SIGSPATIAL INTERNATIONAL CONFERENCE ON ADVANCES IN GEOGRAPHIC INFORMATION SYSTEMS (ACM SIGSPATIAL GIS 2016), DOI 10.1145/2996913.2996934
   Hu JL, 2020, PROC INT CONF DATA, P1417, DOI 10.1109/ICDE48307.2020.00126
   Jiang RH, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P2114, DOI 10.1145/3292500.3330654
   Jiang RH, 2018, THIRTY-SECOND AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTIETH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / EIGHTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P784
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791
   Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]
   Li Y., 2018, ICLR
   Lin ZQ, 2019, THIRTY-THIRD AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTY-FIRST INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / NINTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P1020
   Liu LB, 2019, IEEE T INTELL TRANSP, V20, P3875, DOI 10.1109/TITS.2019.2915525
   Liu Q, 2016, THIRTIETH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P194
   Monti F, 2017, ADV NEURAL INFORM PR, P3700, DOI 10.5555/3294996.3295127
   Renhe Jiang, 2018, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, V2, DOI 10.1145/3191746
   Shi HZ, 2020, PROC INT CONF DATA, P1818, DOI 10.1109/ICDE48307.2020.00178
   Shi XJ, 2015, ADV NEUR IN, V28
   Sun JK, 2022, IEEE T KNOWL DATA EN, V34, P2348, DOI 10.1109/TKDE.2020.3008774
   Wang D, 2017, PROC INT CONF DATA, P243, DOI 10.1109/ICDE.2017.83
   Wang YD, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1227, DOI 10.1145/3292500.3330877
   Wu ZL, 2020, PREP BIOCHEM BIOTECH, V50, P37, DOI 10.1080/10826068.2019.1658119
   Yao HX, 2018, THIRTY-SECOND AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTIETH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / EIGHTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P2588
   Ye JC, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P305, DOI 10.1145/3292500.3330887
   Yu B, 2018, PROCEEDINGS OF THE TWENTY-SEVENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P3634
   Yuan ZN, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P984, DOI 10.1145/3219819.3219922
   Zhang JP, 2019, IEEE T MED IMAGING, V38, P2092, DOI [10.1109/TMI.2019.2893944, 10.1109/TKDE.2019.2891537]
   Zhang JB, 2017, THIRTY-FIRST AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1655
   Zhang Q, 2020, AAAI CONF ARTIF INTE, V34, P1177
NR 40
TC 0
Z9 0
U1 9
U2 9
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0302-9743
EI 1611-3349
BN 978-3-030-86514-6; 978-3-030-86513-9
J9 LECT NOTES ARTIF INT
PY 2021
VL 12978
BP 319
EP 334
DI 10.1007/978-3-030-86514-6_20
PG 16
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Interdisciplinary Applications
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Computer Science
GA BS3MD
UT WOS:000713055600020
DA 2022-04-20
ER

PT J
AU Dong, YH
   Li, ZJ
   Ding, S
   Liu, SL
   Tang, ZY
   Jia, LN
   Liu, JH
   Liu, Y
AF Dong, Yonghai
   Li, Zhongjian
   Ding, Sheng
   Liu, Shulong
   Tang, Zhiyuan
   Jia, Lina
   Liu, Jiahong
   Liu, Yun
TI HIV infection and risk of COVID-19 mortality A meta-analysis
SO MEDICINE
LA English
DT Review
DE COVID-19; HIV; meta-analysis; mortality; SARS-CoV-2
ID BURDEN; OUTCOMES; DISPARITIES; PEOPLE
AB Background: This meta-analysis aimed to estimate the association of human immunodeficiency virus (HIV) infection and risk of coronavirus disease 2019 (COVID-19) mortality. Methods: We systematically retrieved articles published on HIV infection and risk of COVID-19 mortality through PubMed, EMBase, China National Knowledge Infrastructure, WanFang, and Chongqing VIP databases using a predefined search strategy from December 1, 2019 to January 31, 2021. Newcastle-Ottawa Scale (NOS) was used to assess the quality of the included studies. Cochran Q test and I-2 statistics were quantified to measure heterogeneity. Odds ratio (OR) and 95% confidence intervals (CI) were computed and displayed in the form of forest plots. Subgroup analysis was performed to explore the source of heterogeneity. Funnel plot, Begg test, and Egger test were used to assess potential publication bias. Stata software version 11.0 was used to analyze all the statistical data. Results: We included 10 studies with 18,122,370 COVID-19 patients, of whom 41,113 were with HIV infection and 18,081,257 were without HIV infection. The pooled overall results suggested that people living with HIV infection had a higher risk of mortality from COVID-19 than those without HIV infection (OR = 1.252, 95% CI 1.027-1.524). Subgroup analysis showed that people living with HIV infection had a higher risk of COVID-19 mortality than those without HIV infection in the United States (OR = 1.520, 95% CI 1.252-1.845) and in South Africa (OR = 1.122, 95% CI 1.032-1.220); however, no significant association was found in the United Kingdom (OR = 0.878, 95% CI 0.657-1.174). Conclusion: Patients with HIV infection should be the emphasis population to prevent the risk of mortality during the clinical treatment of COVID-19 patients.
C1 [Dong, Yonghai; Li, Zhongjian; Ding, Sheng; Liu, Jiahong] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang 330029, Jiangxi, Peoples R China.
   [Liu, Shulong] Jiangxi Prov Chest Hosp, Dept Hosp Infect Management, Nanchang, Jiangxi, Peoples R China.
   [Tang, Zhiyuan] Jiangxi Prov Ctr Hlth Monitoring & Evaluat, Dept Data Collect, Nanchang, Jiangxi, Peoples R China.
   [Jia, Lina] Jiangxi Prov Ctr Hlth Dev, Dept Hosp Accreditat, Nanchang, Jiangxi, Peoples R China.
   [Liu, Yun] Nanchang Univ, Jiangxi Prov Peoples Hosp, Dept Imaging, Nanchang, Jiangxi, Peoples R China.
RP Liu, JH (corresponding author), Jiangxi Prov Ctr Dis Control & Prevent, Nanchang 330029, Jiangxi, Peoples R China.
EM wydx01_2021@163.com
CR Amimo F, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00666-8
   Arif TB, 2022, INFECT CONT HOSP EP, V43, P415, DOI 10.1017/ice.2020.1434
   Ayinbuomwan S A, 2021, West Afr J Med, V38, P109
   Bell N, 2021, CLIN INFECT DIS, pciab128
   Bhaskaran K, 2021, LANCET HIV, V8, pe24, DOI 10.1016/S2352-3018(20)30305-2
   Boulle, 2020, CLIN INFECT DIS
   Braunstein SL, 2020, CLIN INFECT DIS
   Cabello A, 2021, INT J INFECT DIS, V102, P310, DOI 10.1016/j.ijid.2020.10.060
   del Amo J, 2020, ANN INTERN MED, V173, P536, DOI 10.7326/M20-3689
   El-Jawahri A, 2021, J GEN INTERN MED, V36, P1285, DOI 10.1007/s11606-021-06622-x
   Eleni M, 2021, PATHOG GLOB HEALTH, V115, P243, DOI 10.1080/20477724.2021.1893485
   Elezkurtaj S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82862-5
   Gacche RN, 2021, EUR REV MED PHARMACO, V25, P1684, DOI 10.26355/eurrev_202102_24880
   Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2, 10.15585/mmwr.mm7003e2externalicon]
   Geretti AM, 2021, CLIN INFECT DIS, V73, pE2095, DOI 10.1093/cid/ciaa1605
   Gudipati S, 2020, JAIDS-J ACQ IMM DEF, V85, P123, DOI 10.1097/QAI.0000000000002450
   Hadi YB, 2020, AIDS, V34, pF3, DOI 10.1097/QAD.0000000000002666
   Harrison SL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003321
   Hoffmann C, 2021, HIV MED, V22, P372, DOI 10.1111/hiv.13037
   Jardine R, 2020, E MEDITERR HEALTH J, V26, P1173, DOI 10.26719/emhj.20.120
   Jassat W., 2020, COVID 19 HOSP MORTAL, DOI [10.2139/ssrn.3783089, DOI 10.2139/SSRN.3783089]
   Jones DL, 2021, AIDS RES HUM RETROV, V37, P314, DOI [10.1089/aid.2020.0289, 10.1089/AID.2020.0289]
   Kogut SJ, 2020, J MANAG CARE SPEC PH, V26, P1468, DOI 10.18553/jmcp.2020.26.11.1468
   Kostaki EG, 2021, LIFE-BASEL, P11
   Kowalska JD, 2021, INT J INFECT DIS, V104, P293, DOI 10.1016/j.ijid.2020.12.026
   Kumar N, 2021, ECLINICALMEDICINE, V32, DOI 10.1016/j.eclinm.2020.100717
   Labgold K, 2021, EPIDEMIOLOGY, V32, P157, DOI 10.1097/EDE.0000000000001314
   Laracy J, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab029
   Mehta SA, 2021, TRANSPLANTATION, V105, P216, DOI 10.1097/TP.0000000000003527
   Miyashita H, 2021, HIV MED, V22, pE1, DOI 10.1111/hiv.12920
   Morani Zoya, 2020, SN Compr Clin Med, V2, P2647, DOI 10.1007/s42399-020-00593-6
   Nagarakanti SR, 2021, J MED VIROL, V93, P1687, DOI 10.1002/jmv.26533
   Patel RH, 2021, AIDS RES HUM RETROV, V37, P266, DOI [10.1089/aid.2020.0284, 10.1089/AID.2020.0284]
   Sarkar S, 2021, J MED VIROL, V93, P2385, DOI 10.1002/jmv.26740
   Schneider M, 2021, EUR J INTERN MED, V83, P96, DOI 10.1016/j.ejim.2020.11.011
   Singh DR, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06176-y
   Ssentongo P., 2020, PLOS ONE, V15
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Tesoriero James M, 2020, medRxiv, DOI 10.1101/2020.11.04.20226118
   Thiabaud A., 2021, SWISS MED WKLY, V151
   Tian C, 2020, ANN PALLIAT MED, V9, P03
   Waters LJ, 2021, LANCET HIV, V8, pe2, DOI 10.1016/S2352-3018(20)30332-5
   World Health Organization, WHO COR DIS COVID 19
   Zhang JC, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05480-y
NR 44
TC 3
Z9 3
U1 3
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JUL 2
PY 2021
VL 100
IS 26
DI 10.1097/MD.0000000000026573
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA TB9YL
UT WOS:000668300100060
PM 34190201
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Farmakis, D
   Giakoumis, A
   Cannon, L
   Angastiniotis, M
   Eleftheriou, A
AF Farmakis, Dimitrios
   Giakoumis, Anastasios
   Cannon, Lily
   Angastiniotis, Michael
   Eleftheriou, Androulla
TI COVID-19 and thalassaemia: A position statement of the Thalassaemia
   International Federation
SO EUROPEAN JOURNAL OF HAEMATOLOGY
LA English
DT Review
DE coronavirus; COVID-19; haemoglobinopathies; pandemic; SARS-CoV-2;
   thalassaemia
AB Objectives Many patients with haemoglobinopathies, including thalassaemia and sickle cell disease, are at increased risk of developing severe complications from the coronavirus disease 2019 (COVID-19). Although epidemiologic evidence concerning the novel coronavirus (SARS-CoV-2) infection in these patients is currently lacking, the COVID-19 pandemic represents a significant challenge for haemoglobinopathy patients, their families and their attending physicians. Methods The present statement summarizes the key challenges concerning the management of haemoglobinopathies, with particular focus on patients with either transfusion-dependent or non-transfusion-dependent thalassaemia, identifies the gaps in knowledge and suggests measures and strategies to deal with the pandemic, based on available evidence and expert opinions. Key areas covered include patients' risk level, adaptation of haemoglobinopathy care, safety of blood transfusions, blood supply challenges, and lifestyle and nutritional considerations. Conclusions The proposed measures and strategies may be useful as a blueprint for other disorders which require regular hospital visits, as well as for the timely adaptation of patient care during similar future pandemics.
C1 [Farmakis, Dimitrios] Univ Cyprus, Sch Med, Nicosia, Cyprus.
   [Giakoumis, Anastasios] G Gennimatas Hosp, Thalassaemia Unit, Leof Mesoge 154, Athens 11527, Greece.
   [Cannon, Lily; Angastiniotis, Michael; Eleftheriou, Androulla] Thalassaemia Int Federat, Nicosia, Cyprus.
RP Giakoumis, A (corresponding author), G Gennimatas Hosp, Thalassaemia Unit, Leof Mesoge 154, Athens 11527, Greece.
EM giakanas@otenet.gr
OI Giakoumis, Anastasios/0000-0001-7892-0315
CR Algiraigri Ali H, 2017, Hematol Oncol Stem Cell Ther, V10, P116, DOI 10.1016/j.hemonc.2017.02.002
   Alschuler L, 2020, EXPLORE-NY, V16, P354, DOI 10.1016/j.explore.2020.03.007
   American Association of Blood Banks, AABBS RES FDAS UPD I
   American Red Cross, COR OUTBR HELP US CO
   [Anonymous], UPD INF BLOOD EST RE
   Beerkens F, 2020, AM J HEMATOL, V95, pE154, DOI 10.1002/ajh.25809
   Buhner Stephen Harrod, 2013, HERBAL ANTIVIRALS NA, P54
   Bundy DG, 2010, PEDIATRICS, V125, P234, DOI 10.1542/peds.2009-1465
   Cappellini MD, 2020, NEW ENGL J MED, V382, P1219, DOI 10.1056/NEJMoa1910182
   Centers for Disease Control and Prevention, COR COVID 19
   Chang L, 2020, EMERG INFECT DIS, V26, P1631, DOI 10.3201/eid2607.200839
   De Clercq Erik, 2006, Expert Rev Anti Infect Ther, V4, P291, DOI 10.1586/14787210.4.2.291
   European Centre for Disease Prevention and Control, COR COVID 19
   European Centre for Disease Prevention and Control, COR DIS 2019 COVID 1
   Farmakis D, 2020, EUR J HAEMATOL, V105, P16, DOI 10.1111/ejh.13410
   Farmakis D, 2003, MED SCI MONITOR, V9, pRA19
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Heart Failure Society of America / American College of Cardiology / American Heart Association, STAT ADDR RE US RAAS
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Institute of Medicine (US) Forum on Microbial Threats, DOM INT IMP 2009 H1N
   International Society of Blood Transfusion, WEB UPD COVID 19 COR
   Kreutz R, 2020, CARDIOVASC RES, V116, P1688, DOI 10.1093/cvr/cvaa097
   Kwon SY, 2020, VOX SANG, V115, P601, DOI 10.1111/vox.12925
   Motta I, 2020, AM J HEMATOL, V95, pE198, DOI 10.1002/ajh.25840
   Musallam KM, 2013, BLOOD, V121, P2199, DOI 10.1182/blood-2012-10-408021
   Nur E, 2020, AM J HEMATOL, V95, P725, DOI 10.1002/ajh.25821
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Shander A, 2020, ANESTH ANALG, V131, P74, DOI 10.1213/ANE.0000000000004844
   Thalassaemia International Federation, 2017, GUID MAN NONTR DEP T
   Thalassaemia International Federation, 2014, GUID MAN TRANSF DEP
   Thalassaemia International Federation, US HLTH NUTR SHOR GU
   U.S. Food & Drug Administration, ALT PROC BLOOD BLOOD
   World Health Organization, COR DIS COVID 19 PAN
   World Health Organization, PROT BLOOD SUPPL INF
   World Health Organization, WHO COVID 19 DASHB
   World Health Organization, RAT US PERS PROT EQ
   World Health Organization (WHO), MAINT SAF AD BLOOD S
NR 37
TC 11
Z9 11
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0902-4441
EI 1600-0609
J9 EUR J HAEMATOL
JI Eur. J. Haematol.
PD OCT
PY 2020
VL 105
IS 4
BP 378
EP 386
DI 10.1111/ejh.13476
EA JUL 2020
PG 9
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA NT3BM
UT WOS:000547817000001
PM 32573838
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Modgil, S
   Singh, RK
   Gupta, S
   Dennehy, D
AF Modgil, Sachin
   Singh, Rohit Kumar
   Gupta, Shivam
   Dennehy, Denis
TI A Confirmation Bias View on Social Media Induced Polarisation During
   Covid-19
SO INFORMATION SYSTEMS FRONTIERS
LA English
DT Article; Early Access
DE Echo Chambers; Social Media Induced Polarisation; Confirmation Bias;
   Covid-19
ID SUPPLY CHAIN MANAGEMENT; INFORMATION-SYSTEMS RESEARCH; ECHO CHAMBERS;
   SELECTIVE EXPOSURE; POLITICAL POLARIZATION; GRAND CHALLENGES; CUSTOMER
   VALUE; NEWS; KNOWLEDGE; INTERNET
AB Social media has played a pivotal role in polarising views on politics, climate change, and more recently, the Covid-19 pandemic. Social media induced polarisation (SMIP) poses serious challenges to society as it could enable 'digital wildfires' that can wreak havoc worldwide. While the effects of SMIP have been extensively studied, there is limited understanding of the interplay between two key components of this phenomenon: confirmation bias (reinforcing one's attitudes and beliefs) and echo chambers (i.e., hear their own voice). This paper addresses this knowledge deficit by exploring how manifestations of confirmation bias contributed to the development of 'echo chambers' at the height of the Covid-19 pandemic. Thematic analysis of data collected from 35 participants involved in supply chain information processing forms the basis of a conceptual model of SMIP and four key cross-cutting propositions emerging from the data that have implications for research and practice.
C1 [Modgil, Sachin; Singh, Rohit Kumar] Int Management Inst IMI Kolkata, Kolkata, India.
   [Gupta, Shivam] NEOMA Business Sch, Mont St Aignan, France.
   [Dennehy, Denis] Natl Univ Ireland Galway, Galway, Ireland.
RP Dennehy, D (corresponding author), Natl Univ Ireland Galway, Galway, Ireland.
EM denis.dennehy@nuigalway.ie
RI Dennehy, Denis/AAA-7119-2022; Gupta, Shivam/R-2996-2016; Dennehy,
   Denis/AAA-6716-2022
OI Gupta, Shivam/0000-0002-2714-4958; Dennehy, Denis/0000-0001-9931-762X
CR Agerfalk PJ, 2014, EUR J INFORM SYST, V23, P593, DOI 10.1057/ejis.2014.35
   Anand N, 2007, ACAD MANAGE J, V50, P406
   [Anonymous], 2019, LATIMES
   [Anonymous], 2021, REUTERS
   Arnott D, 2006, INFORM SYST J, V16, P55, DOI 10.1111/j.1365-2575.2006.00208.x
   Atlantic Council, 2019, BOL REFL DEEP POL CR
   Barbera P, 2015, PSYCHOL SCI, V26, P1531, DOI 10.1177/0956797615594620
   Barnett ML, 2007, ACAD MANAGE REV, V32, P794, DOI 10.5465/AMR.2007.25275520
   Batrinca B, 2015, AI SOC, V30, P89, DOI 10.1007/s00146-014-0549-4
   Becker J, 2015, BUS INFORM SYST ENG+, V57, P377, DOI 10.1007/s12599-015-0394-0
   BENBASAT I, 1987, MIS QUART, V11, P369, DOI 10.2307/248684
   Bessi A, 2016, COMPUT HUM BEHAV, V65, P319, DOI 10.1016/j.chb.2016.08.016
   Bhagwat R, 2007, COMPUT IND ENG, V53, P43, DOI 10.1016/j.cie.2007.04.001
   Bhardwaj A, 2016, GROUP ORGAN MANAGE, V41, P526, DOI 10.1177/1059601115608027
   Birks DF, 2013, EUR J INFORM SYST, V22, P1, DOI 10.1057/ejis.2012.48
   Boulianne S, 2020, NEW MEDIA SOC, V22, P683, DOI 10.1177/1461444819893983
   Boutyline A, 2017, POLIT PSYCHOL, V38, P551, DOI 10.1111/pops.12337
   Brugnoli E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56191-7
   Brummette J, 2018, J MASS COMMUN Q, V95, P497, DOI 10.1177/1077699018769906
   Brusset X, 2017, INT J PROD ECON, V184, P59, DOI 10.1016/j.ijpe.2016.09.008
   Butler BS, 2006, MIS QUART, V30, P211
   Carr CT, 2015, ATL J COMMUN, V23, P46, DOI 10.1080/15456870.2015.972282
   Choi TM, 2020, TRANSPORT RES E-LOG, V135, DOI 10.1016/j.tre.2020.101860
   Chou WYS, 2018, JAMA-J AM MED ASSOC, V320, P2417, DOI 10.1001/jama.2018.16865
   Clapham B, 2021, INFORM SYST FRONT, V23, P477, DOI 10.1007/s10796-019-09950-w
   Corbin, 1997, GROUNDED THEORY PRAC
   Corley KG, 2011, ACAD MANAGE REV, V36, P12, DOI 10.5465/amr.2009.0486
   Cui X., 2019, INT J OPER PROD MAN, V40, P1749
   Culnan MJ, 2010, MIS Q EXEC, V9, P243
   Culp S, 2020, COMPREHENSIVE APPROA
   Del Vicario M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40391
   Dernbecher S, 2017, EUR J INFORM SYST, V26, P121, DOI 10.1057/s41303-016-0032-z
   Dezdar S, 2009, IND MANAGE DATA SYST, V109, P1037, DOI 10.1108/02635570910991283
   Dubois E, 2018, INFORM COMMUN SOC, V21, P729, DOI 10.1080/1369118X.2018.1428656
   Dwivedi YK, 2018, INFORM SYST FRONT, V20, P419, DOI 10.1007/s10796-018-9848-5
   EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557
   Endsley MR, 2018, HUM FACTORS, V60, P1081, DOI 10.1177/0018720818807357
   Erkan I, 2016, COMPUT HUM BEHAV, V61, P47, DOI 10.1016/j.chb.2016.03.003
   Fan Y, 2016, INT J OPER PROD MAN, V36, P1014, DOI 10.1108/IJOPM-10-2013-0461
   Felix R, 2017, J BUS RES, V70, P118, DOI 10.1016/j.jbusres.2016.05.001
   Fidel R, 2004, INFORM PROCESS MANAG, V40, P563, DOI 10.1016/S0306-4573(03)00003-7
   Fisher DR, 2013, AM BEHAV SCI, V57, P70, DOI 10.1177/0002764212463360
   Flaxman S, 2016, PUBLIC OPIN QUART, V80, P298, DOI 10.1093/poq/nfw006
   Fletcher R, 2018, NEW MEDIA SOC, V20, P2450, DOI 10.1177/1461444817724170
   Fu XJ, 2013, IN C IND ENG ENG MAN, P206, DOI 10.1109/IEEM.2013.6962404
   Gallaugher J, 2010, MIS Q EXEC, V9, P197
   Garimella K, 2018, WEB CONFERENCE 2018: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW2018), P913, DOI 10.1145/3178876.3186139
   Garrett RK, 2009, J COMPUT-MEDIAT COMM, V14, P265, DOI 10.1111/j.1083-6101.2009.01440.x
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   Geschke D, 2019, BRIT J SOC PSYCHOL, V58, P129, DOI 10.1111/bjso.12286
   Giannakis M, 2022, ANN OPER RES, V308, P145, DOI 10.1007/s10479-020-03775-6
   Giannoccaro I, 2018, IND MARKET MANAG, V73, P59, DOI 10.1016/j.indmarman.2018.01.034
   Gillespie T, 2014, INSIDE TECHNOL, P1
   Go E, 2016, TELEMAT INFORM, V33, P176, DOI 10.1016/j.tele.2015.06.016
   Goli, 2017, STRIDES DEV MED ED, V14, DOI [10.5812/sdme. 67670, DOI 10.5812/SDME.67670]
   Gomber P, 2018, J MANAGE INFORM SYST, V35, P220, DOI 10.1080/07421222.2018.1440766
   Gorwa R, 2020, POLICY INTERNET, V12, P225, DOI 10.1002/poi3.184
   Grant SB, 2016, J KNOWL MANAG, V20, P898, DOI 10.1108/JKM-11-2015-0432
   Gupta M, 2021, INFORM SYST FRONT, DOI 10.1007/s10796-021-10156-2
   Gupta M, 2019, J BUS RES, V97, P20, DOI 10.1016/j.jbusres.2018.12.018
   Gupta M, 2018, J BUS RES, V85, P10, DOI 10.1016/j.jbusres.2017.12.006
   Han J, 2018, J COMMUN, V68, P685, DOI 10.1093/joc/jqy025
   Havakhor T, 2018, INFORM SYST J, V28, P104, DOI 10.1111/isj.12127
   He W, 2017, J KNOWL MANAG, V21, P275, DOI 10.1108/JKM-07-2015-0296
   Huang HH, 2012, DECIS SUPPORT SYST, V53, P438, DOI 10.1016/j.dss.2012.03.009
   Huang SP, 2020, INT J PROD RES, V58, P1893, DOI 10.1080/00207543.2019.1702228
   Hutchens MJ, 2021, MASS COMMUN SOC, V24, P701, DOI 10.1080/15205436.2021.1904262
   Hyun KD, 2016, J MASS COMMUN Q, V93, P509, DOI 10.1177/1077699016628820
   India Today, INDIA TODAY
   Islam AKMN, 2020, TECHNOL FORECAST SOC, V159, DOI 10.1016/j.techfore.2020.120201
   Itzchakov G, 2018, J EXP SOC PSYCHOL, V75, P19, DOI 10.1016/j.jesp.2017.11.003
   Jacobson S, 2016, INFORM COMMUN SOC, V19, P875, DOI 10.1080/1369118X.2015.1064461
   Jamieson Kathleen H., 2020, CYBERWAR RUSSIAN HAC
   Jaramillo-Dent D, 2021, NEW MEDIA SOC, V23, P121, DOI 10.1177/1461444819894241
   Juris JS, 2012, AM ETHNOL, V39, P259, DOI 10.1111/j.1548-1425.2012.01362.x
   Kanagarajoo MV, 2020, INT J PRODUCT PERFOR, V69, P834, DOI 10.1108/IJPPM-09-2018-0316
   Kapoor KK, 2018, INFORM SYST FRONT, V20, P531, DOI 10.1007/s10796-017-9810-y
   Kelman HC, 2006, ANNU REV PSYCHOL, V57, P1, DOI 10.1146/annurev.psych.57.102904.190156
   Kietzmann JH, 2011, BUS HORIZONS, V54, P241, DOI 10.1016/j.bushor.2011.01.005
   Kim Y, 2019, COMPUT HUM BEHAV, V99, P219, DOI 10.1016/j.chb.2019.05.022
   Knobloch-Westerwick S, 2012, COMMUN RES, V39, P170, DOI 10.1177/0093650211400597
   KPMG, 2021, COMB FRAUD TIM COV 1
   Laato S, 2020, EUR J INFORM SYST, V29, P288, DOI 10.1080/0960085X.2020.1770632
   Langley D., 2021, LNCS, P656
   Layman GC, 2006, ANNU REV POLIT SCI, V9, P83, DOI 10.1146/annurev.polisci.9.070204.105138
   Lee F.L., 2016, COMMUN PUBLIC, V1, P56, DOI [10.1177/2057047315617763, DOI 10.1177/2057047315617763]
   Lee JK, 2014, J COMMUN, V64, P702, DOI 10.1111/jcom.12077
   Lee J, 2015, INFORM SYST FRONT, V17, P997, DOI 10.1007/s10796-015-9568-z
   Legner C, 2017, BUS INFORM SYST ENG+, V59, P301, DOI 10.1007/s12599-017-0484-2
   Leviston Z, 2013, NAT CLIM CHANGE, V3, P334, DOI [10.1038/nclimate1743, 10.1038/NCLIMATE1743]
   Liang Wu, 2019, ACM SIGKDD Explorations Newsletter, V21, P80, DOI 10.1145/3373464.3373475
   Linvill DL, 2020, POLIT COMMUN, V37, P447, DOI 10.1080/10584609.2020.1718257
   Manavalan E, 2019, COMPUT IND ENG, V127, P925, DOI 10.1016/j.cie.2018.11.030
   Matavire R, 2013, EUR J INFORM SYST, V22, P119, DOI 10.1057/ejis.2011.35
   McKinsey & Company, 2015, GETT SHARP PICT SOC
   Mheidly N, 2020, J PUBLIC HEALTH POL, V41, P410, DOI 10.1057/s41271-020-00247-w
   Min H, 2002, COMPUT IND ENG, V43, P231, DOI 10.1016/S0360-8352(02)00066-9
   Miroudot S, 2020, J INT BUS POLICY, V3, P430, DOI 10.1057/s42214-020-00074-6
   Mondal T, 2018, INFORM SYST FRONT, V20, P961, DOI 10.1007/s10796-018-9837-8
   Montalvo JG, 2005, AM ECON REV, V95, P796, DOI 10.1257/0002828054201468
   Muckstadt JA, 2001, INFORM SYST FRONT, V3, P427, DOI 10.1023/A:1012824820895
   Nabity-Grover T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102188
   Neiman JL, 2016, POLIT COMMUN, V33, P212, DOI 10.1080/10584609.2014.969465
   Nelson J, 2017, QUAL RES, V17, P554, DOI 10.1177/1468794116679873
   Neves ARD, 2014, EXPERT SYST APPL, V41, P563, DOI 10.1016/j.eswa.2013.07.081
   Newman N., 2017, REUTERS I DIGITAL NE
   Nikolov D, 2019, J ASSOC INF SCI TECH, V70, P218, DOI 10.1002/asi.24121
   Noy C, 2008, INT J SOC RES METHOD, V11, P327, DOI 10.1080/13645570701401305
   O'Hara K, 2015, POLICY INTERNET, V7, P401, DOI 10.1002/poi3.88
   O'Leary DE, 2011, INTELL SYST ACCOUNT, V18, P121, DOI 10.1002/isaf.327
   Obar JA, 2012, J INFORM POLICY, V2, P1, DOI 10.5325/jinfopoli.2.2012.0001
   Orji IJ, 2020, INT J PROD RES, V58, P1522, DOI 10.1080/00207543.2019.1660829
   Osatuyi B, 2013, COMPUT HUM BEHAV, V29, P2622, DOI 10.1016/j.chb.2013.07.001
   Pagell M, 2009, J SUPPLY CHAIN MANAG, V45, P37, DOI 10.1111/j.1745-493X.2009.03162.x
   Pariser E., 2011, PENGUIN
   Parra C., 2021, IEEE T TECHNOLOGY SO, DOI [10.1109/TTS.2021.3120303, DOI 10.1109/TTS.2021.3120303]
   PETTY RE, 1987, COMMUN MONOGR, V54, P233, DOI 10.1080/03637758709390229
   Petty RE, 2009, COMMUN SER, P125
   PwC, 2021, FAK NEWS HAS EXPL CO
   Rauniar R, 2014, J ENTERP INF MANAG, V27, P6, DOI 10.1108/JEIM-04-2012-0011
   Reifler, 2018, SELECTIVE EXPOSURE M
   Ribarsky W, 2014, COMPUT GRAPH-UK, V38, P328, DOI 10.1016/j.cag.2013.11.003
   Rim H, 2020, PUBLIC RELAT REV, V46, DOI 10.1016/j.pubrev.2019.101869
   Roozenbeek J, 2019, J RISK RES, V22, P570, DOI 10.1080/13669877.2018.1443491
   Rousidis D, 2020, MULTIMED TOOLS APPL, V79, P6279, DOI 10.1007/s11042-019-08291-9
   Said EW, 2008, COVERING ISLAM MEDIA
   Sarimveis H, 2008, COMPUT OPER RES, V35, P3530, DOI 10.1016/j.cor.2007.01.017
   Sarkis J, 2021, INT J OPER PROD MAN, V41, P63, DOI 10.1108/IJOPM-08-2020-0568
   Sasahara K., 2020, J COMPUT SOC SCI, P1
   Sasahara K, 2021, J COMPUT SOC SCI, V4, P381, DOI 10.1007/s42001-020-00084-7
   Schafer F, 2017, BIG DATA-US, V5, P294, DOI 10.1089/big.2017.0049
   Schilling MA, 2014, STRATEGIC MANAGE J, V35, P974, DOI 10.1002/smj.2142
   Sestino A, 2020, TECHNOVATION, V98, DOI 10.1016/j.technovation.2020.102173
   Sharif AM, 2002, INFORM SYST MANAGE, V19, P19, DOI 10.1201/1078/43200.19.2.20020228/35138.4
   Sharma A, 2020, J BUS RES, V117, P443, DOI 10.1016/j.jbusres.2020.05.035
   Shearer E., 2019, AM ARE WARY ROLE SOC
   Shin JE, 2017, J COMMUN, V67, P233, DOI 10.1111/jcom.12284
   Sikder O, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62085-w
   Singh A, 2018, TRANSPORT RES E-LOG, V114, P398, DOI 10.1016/j.tre.2017.05.008
   Singh JP, 2020, INFORM SYST FRONT, DOI 10.1007/s10796-020-10040-5
   Sodhi MS, 2019, PROD OPER MANAG, V28, P2946, DOI 10.1111/poms.13115
   Spanaki K, 2019, INFORM TECHNOL PEOPL, V32, P516, DOI 10.1108/ITP-04-2017-0131
   Spohr Dominic., 2017, BUSINESS INFORM REV, V34, P150, DOI [10.1177/0266382117722446, DOI 10.1177/0266382117722446]
   Stake R., 2000, ART CASE STUDY RES
   Stepan T, 2016, IEEE TRANS COMPUT SO, V3, P164, DOI 10.1109/TCSS.2016.2631473
   Stieglitz S, 2013, SOC NETW ANAL MIN, V3, P1277, DOI 10.1007/s13278-012-0079-3
   Stroud NJ, 2008, POLIT BEHAV, V30, P341, DOI 10.1007/s11109-007-9050-9
   Stuart I, 2002, J OPER MANAG, V20, P419, DOI 10.1016/S0272-6963(02)00022-0
   Susarla A, 2012, INFORM SYST RES, V23, P23, DOI 10.1287/isre.1100.0339
   Teo TSH, 2008, J MANAGE INFORM SYST, V25, P99, DOI 10.2753/MIS0742-1222250303
   Thatcher JB, 2018, MIS QUART, V42, P831, DOI 10.25300/MISQ/2018/11881
   Tim YN, 2021, INFORM SYST J, V31, P323, DOI 10.1111/isj.12312
   Tim Y, 2018, INFORM SYST J, V28, P48, DOI 10.1111/isj.12140
   Toubiana M, 2017, ACAD MANAGE J, V60, P922, DOI 10.5465/amj.2014.0208
   Tran T, 2021, INFORM SYST FRONT, V23, P931, DOI 10.1007/s10796-020-10088-3
   van Strien JLH, 2016, COMPUT HUM BEHAV, V60, P245, DOI 10.1016/j.chb.2016.02.057
   Verma S, 2020, J BUS RES, V118, P253, DOI 10.1016/j.jbusres.2020.06.057
   Vishwanath A, 2015, INFORM SYST FRONT, V17, P1353, DOI 10.1007/s10796-014-9509-2
   Walsham G., 1993, SIGOIS Bulletin, V14, P13
   Wang XH, 2015, J ORGAN BEHAV, V36, P403, DOI 10.1002/job.1994
   Weckler A, 2021, APPLES TIM COOK ACCU
   Westerwick A, 2017, COMMUN MONOGR, V84, P343, DOI 10.1080/03637751.2016.1272761
   Winter SJ, 2011, J INF TECHNOL, V26, P99, DOI 10.1057/jit.2011.6
   World Economic Forum, 2018, DIG WILDF REP
   Wu YL, 2018, INTERNET RES, V28, P74, DOI 10.1108/IntR-08-2016-0250
   Wuebben Daniel, 2016, Computers and Composition, V42, P66, DOI 10.1016/j.compcom.2016.08.004
   Xie K, 2015, J MANAGE INFORM SYST, V32, P204, DOI 10.1080/07421222.2015.1063297
   Yarchi M, 2021, POLIT COMMUN, V38, P98, DOI 10.1080/10584609.2020.1785067
   Yin R.K., 2014, CASE STUDY RES APPL, V5th ed.
   Zadeh AH, 2014, DECIS SUPPORT SYST, V65, P59, DOI 10.1016/j.dss.2014.05.003
   Zamani ED, 2022, INFORM TECHNOL PEOPL, V35, P723, DOI 10.1108/ITP-02-2020-0072
   Zamani ED, 2022, INFORM SYST FRONT, V24, P97, DOI 10.1007/s10796-020-10067-8
   Zhang ML, 2017, INT J INFORM MANAGE, V37, P229, DOI 10.1016/j.ijinfomgt.2016.04.010
   Zhao HP, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2020.102354
NR 174
TC 3
Z9 3
U1 22
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-3326
EI 1572-9419
J9 INFORM SYST FRONT
JI Inf. Syst. Front.
DI 10.1007/s10796-021-10222-9
EA NOV 2021
PG 25
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA XA5KX
UT WOS:000720686600001
PM 34840520
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Tanriverdi, G
   Bakir, M
   Merkert, R
AF Tanriverdi, Gokhan
   Bakir, Mahmut
   Merkert, Rico
TI What can we learn from the JATM literature for the future of aviation
   post Covid-19? - A bibliometric and visualization analysis
SO JOURNAL OF AIR TRANSPORT MANAGEMENT
LA English
DT Article
DE Bibliometric analysis; COVID-19; Pandemics; Airlines; JATM; Recovery;
   Crisis
ID HOSPITALITY MANAGEMENT; TOURISM RESEARCH; BUSINESS MODEL; TRANSPORT;
   AIRLINES; EFFICIENCY; CITATION; IMPACT; AUTHOR; STRATEGIES
AB This paper aims to draw lessons from retrospectively evaluating the evolution of the air transport discipline right up to the COVID-19 outbreak through the Journal of Air Transport Management (JATM), the main scholarly air transportation journal globally. As such, this study deploys a comprehensive bibliometric analysis and graphical mapping of the JATM knowledge body through CiteSpace visualization of 1483 JATM papers from 2001 to 2019. Our results suggest that while the industry has experienced pandemics and economic crises in the past, both were not dominant in influencing JATM literature neither in frequency nor in impact. That said, recovery, crisis and disruption are important key words in JATM papers not just in regard to safety and economic crisis management but increasingly also related to health concerns with recent key papers published in the pandemic and recovery management context which may have helped the industry dealing with the current crisis as well as current JATM papers on this topic assisting with preparing for a transitioning out of COVID-19 world.
C1 [Tanriverdi, Gokhan] Erzincan Binali Yildirim Univ, Dept Aviat Management, Erzincan, Turkey.
   [Bakir, Mahmut] Anadolu Univ, Dept Civil Aviat Management, Eskisehir, Turkey.
   [Merkert, Rico] Univ Sydney, Inst Transport & Logist Studies, Sch Business, Sydney, NSW, Australia.
RP Bakir, M (corresponding author), Anadolu Univ, Eskisehir, Australia.
EM mahmutbakir@anadolu.edu.tr
RI BAKIR, Mahmut/O-8875-2019
OI BAKIR, Mahmut/0000-0002-3898-4987; Merkert, Rico/0000-0001-9939-7199
CR ACI and IATA, 2020, ACI IATA CALL URG FI
   Albers S, 2020, J AIR TRANSP MANAG, V87, DOI 10.1016/j.jairtraman.2020.101863
   Aldemir H.O., 2017, INT J AVIATION SYSTE, V4, P15, DOI [10.4018/IJASOT.2017010102, DOI 10.4018/IJASOT.2017010102]
   Barrios M, 2008, SCIENTOMETRICS, V77, P453, DOI 10.1007/s11192-007-1952-0
   Barros CP, 2008, J AIR TRANSP MANAG, V14, P315, DOI 10.1016/j.jairtraman.2008.08.005
   Bergiante NCR, 2015, SCIENTOMETRICS, V105, P941, DOI 10.1007/s11192-015-1711-6
   Black AJ, 2017, EPIDEMICS-NETH, V19, P61, DOI 10.1016/j.epidem.2017.01.004
   Cancino CA, 2017, COMPUT IND ENG, V113, P614, DOI 10.1016/j.cie.2017.08.033
   Cavaignac L, 2017, SOCIO-ECON PLAN SCI, V57, P84, DOI 10.1016/j.seps.2016.11.003
   Chang YH, 2018, J AIR TRANSP MANAG, V70, P62, DOI 10.1016/j.jairtraman.2018.04.017
   Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317
   Chen XY, 2020, TRANSPORT POLICY, V85, P1, DOI 10.1016/j.tranpol.2019.10.004
   Chou PF, 2011, J AIR TRANSP MANAG, V17, P228, DOI 10.1016/j.jairtraman.2010.09.003
   Chung KH, 2001, FINANC MANAGE, V30, P99, DOI 10.2307/3666378
   Chung LH, 2015, J AIR TRANSP MANAG, V44-45, P42, DOI 10.1016/j.jairtraman.2015.02.003
   de Wit JG, 2012, J AIR TRANSP MANAG, V21, P17, DOI 10.1016/j.jairtraman.2011.12.013
   Delgado F, 2020, J AIR TRANSP MANAG, V85, DOI 10.1016/j.jairtraman.2020.101799
   Derudder B, 2019, J TRANSP GEOGR, V81, DOI 10.1016/j.jtrangeo.2019.102538
   Donthu N, 2020, J BUS RES, V109, P1, DOI 10.1016/j.jbusres.2019.10.039
   EUROCONTROL, 2020, COVID19 IMP EUR TRAF
   Fabregat-Aibar L, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11092526
   Garcia-Lillo F, 2016, INT J HOSP MANAG, V52, P121, DOI 10.1016/j.ijhm.2015.10.007
   Ginieis M, 2012, J AIR TRANSP MANAG, V19, P31, DOI 10.1016/j.jairtraman.2011.12.005
   Gold L, 2019, J AIR TRANSP MANAG, V75, P27, DOI 10.1016/j.jairtraman.2018.11.006
   Graham A, 2020, J AIR TRANSP MANAG, V87, DOI 10.1016/j.jairtraman.2020.101865
   Guzeller CO, 2019, ASIA PAC J TOUR RES, V24, P108, DOI 10.1080/10941665.2018.1541182
   Haghani M, 2020, SAFETY SCI, V129, DOI 10.1016/j.ssci.2020.104806
   HECK JL, 1986, ACCOUNT REV, V61, P735
   Hopkins University Johns, 2020, COVID 19 DASHB CTR S
   IATA, 2020, AIRL FIN MON
   IATA, 2020, DEEP REV HIT COVID 1
   Industry High Level Group, 2019, AV BEN REP 2019
   International Civil Aviation Organization, 2020, EFF NOV COR COVID 19
   Jogaratnam G, 2005, TOURISM MANAGE, V26, P641, DOI 10.1016/j.tourman.2004.04.002
   Ko YD, 2016, J AIR TRANSP MANAG, V50, P53, DOI 10.1016/j.jairtraman.2015.10.005
   Koc E, 2014, TOUR MANAG PERSPECT, V12, P9, DOI 10.1016/j.tmp.2014.06.003
   Koseoglu MA, 2015, INT J HOSP MANAG, V45, P130, DOI 10.1016/j.ijhm.2014.12.004
   Kuhn T., 1970, STRUCTURE SCI REVOLU
   Li XJ, 2017, INT J HOSP MANAG, V60, P77, DOI 10.1016/j.ijhm.2016.10.006
   Liang F, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3286-3
   Liou JJH, 2008, J AIR TRANSP MANAG, V14, P20, DOI 10.1016/j.jairtraman.2007.10.002
   Liou JJH, 2007, J AIR TRANSP MANAG, V13, P243, DOI 10.1016/j.jairtraman.2007.04.008
   Loos M.J., 2016, ESPACIOS, V37
   Macilree J, 2020, J AIR TRANSP MANAG, V88, DOI 10.1016/j.jairtraman.2020.101864
   Valenzuela L, 2017, J BUS IND MARK, V32, P1, DOI 10.1108/JBIM-04-2016-0079
   McKercher B, 2008, TOURISM MANAGE, V29, P1226, DOI 10.1016/j.tourman.2008.03.003
   Merigo JM, 2019, TOURISM GEOGR, V21, P881, DOI 10.1080/14616688.2019.1666913
   Merigo JM, 2017, INT J INTELL SYST, V32, P526, DOI 10.1002/int.21859
   Merigo JM, 2015, J BUS RES, V68, P2645, DOI 10.1016/j.jbusres.2015.04.006
   Merigo JM, 2015, APPL SOFT COMPUT, V27, P420, DOI 10.1016/j.asoc.2014.10.035
   Merkert R, 2019, TRANSPORT RES E-LOG, V127, P206, DOI 10.1016/j.tre.2019.05.012
   Merkert R, 2017, J AIR TRANSP MANAG, V61, P1, DOI 10.1016/j.jairtraman.2017.02.001
   Merkert R, 2015, J TRANSP ECON POLICY, V49, P261
   Merkert R, 2011, TRANSPORT RES A-POL, V45, P686, DOI 10.1016/j.tra.2011.04.015
   Modak NM, 2019, TRANSPORT RES A-POL, V120, P188, DOI 10.1016/j.tra.2018.11.015
   Mulet-Forteza C, 2019, J BUS RES, V101, P819, DOI 10.1016/j.jbusres.2018.12.002
   Mulet-Forteza C, 2018, J TRAVEL TOUR MARK, V35, P1201, DOI 10.1080/10548408.2018.1487368
   Nikolaou P, 2020, J AIR TRANSP MANAG, V85, DOI 10.1016/j.jairtraman.2020.101819
   O'Connell JF, 2005, J AIR TRANSP MANAG, V11, P259, DOI 10.1016/j.jairtraman.2005.01.007
   Olawumi TO, 2018, J CLEAN PROD, V183, P231, DOI 10.1016/j.jclepro.2018.02.162
   Park JW, 2004, J AIR TRANSP MANAG, V10, P435, DOI 10.1016/j.jairtraman.2004.06.001
   Park K, 2011, J HOSP TOUR RES, V35, P381, DOI 10.1177/1096348011400743
   Pearson J, 2014, J AIR TRANSP MANAG, V38, P21, DOI 10.1016/j.jairtraman.2013.12.014
   Podsakoff PM, 2008, J MANAGE, V34, P641, DOI 10.1177/0149206308319533
   Samiee S, 2012, J ACAD MARKET SCI, V40, P364, DOI 10.1007/s11747-011-0296-8
   Spasojevic B., 2016, CAUTHE 2016 CHANGING, P293
   Suau-Sanchez P, 2020, J TRANSP GEOGR, V86, DOI 10.1016/j.jtrangeo.2020.102749
   Sun LJ, 2017, TRANSPORT RES A-POL, V100, P135, DOI 10.1016/j.tra.2017.04.011
   Tian X, 2018, TRANSPORT RES D-TR E, V59, P1, DOI 10.1016/j.trd.2017.12.009
   Tomaszewska E.J., 2018, ENG MANAG PROD SERV, V10, P41, DOI [10.2478/emj-2018-0010, DOI 10.2478/EMJ-2018-0010]
   Wang C, 2020, OMEGA-INT J MANAGE S, V93, DOI 10.1016/j.omega.2019.08.005
   Yang Y, 2020, ANN TOURISM RES, V83, DOI 10.1016/j.annals.2020.102913
   Ye Q, 2012, TOUR MANAG PERSPECT, V2-3, P55, DOI 10.1016/j.tmp.2012.03.002
   Zhao XB, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2020.120404
   Zheng X., 2017, CHIN NURS RES, V4, P133, DOI DOI 10.1016/J.CNRE.2017.07.004
   Zhou W, 2019, TRANSPORT-VILNIUS, V34, P741, DOI 10.3846/transport.2019.11774
NR 76
TC 19
Z9 19
U1 11
U2 68
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0969-6997
EI 1873-2089
J9 J AIR TRANSP MANAG
JI J. Air Transp. Manag.
PD OCT
PY 2020
VL 89
AR 101916
DI 10.1016/j.jairtraman.2020.101916
PG 15
WC Transportation
WE Social Science Citation Index (SSCI)
SC Transportation
GA OE4RE
UT WOS:000580518800024
PM 32901183
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Erok, B
   Kibici, K
AF Erok, Berrin
   Kibici, Kenan
TI COVID-19 Infection Manifesting with Lumbar Spondylodiscitis Complicating
   With Psoas Abscess without Pneumonia
SO INDIAN JOURNAL OF NEUROSURGERY
LA English
DT Article; Early Access
DE Covid-19; Sars-CoV-2; spondylodiscitis; psoas abscess; endotheliitis
AB Extrapulmonary manifestations of COVID-19 (Coronavirus disease 2019) are increasingly recognized. Secondary spinal infections are dangerous complications reported in a few cases in the literature. However, to our knowledge, there is no reported case of a severe spondylodiscitis (SD) complicated with a large psoas abscess in a COVID-19 patient. We would like to report a 43-year-old male patient living in central Anatolia and dealing with farming who presented to the hospital with a complaint of severe back pain. The patient who was given oral treatment with analgesic, anti-inflammatory, and myorelaxant agents was readmitted with increased complaints. His nasopharyngeal swab was positive for COVID-19 without pneumonia on chest computed tomography (CT). He spent the quarantine and treatment period at home but was admitted to our outpatient clinic with a wheelchair with increased complaints and right leg pain preventing daily activities. The control nasopharyngeal swab was negative for COVID-19 but further increase in C-reactive protein (CRP) (152,8 mg/L) and creatine kinase (CK) level (549 IU/L) were revealed. Lumbar magnetic resonance imaging (MRI) showed SD in the L3-L4 level along with right-sided prevertebral inflammatory soft tissue and a large right psoas muscle abscess. Pyogenic lumbar SD complicated with the right psoas abscess in the setting of COVID-19 was considered and antibacterial treatment was started following hospitalization. On the same day, percutaneous aspiration from the psoas abscess under CT guidance was performed and revealed no growth in the culture. After 3 weeks, follow-up MRI showed worsening of all the bone, soft tissue and disc findings. Myalgia is a common manifestation in viral infections, which was also demonstrated in COVID-19 patients, with possible increase in muscle enzymes. Secondary spinal infections and its soft-tissue complications should be considered in the management of COVID-19 patients with neuromuscular symptoms, and detailed neurological and neurosurgical evaluation should be performed in order to avoid progression and permanent damage.
C1 [Erok, Berrin] Univ Hlth Sci, Prof Dr Cemil Tascioglu City Hosp, Dept Radiol, Istanbul, Turkey.
   [Kibici, Kenan] Altinbas Univ, Dept Neurosurg, Sch Med, Bahcelievler Med Pk Hosp, Istanbul, Turkey.
RP Erok, B (corresponding author), Univ Hlth Sci, Prof Dr Cemil Tascioglu City Hosp, Dept Radiol, Istanbul, Turkey.
EM drberrinerok@hotmail.com
RI Erok, Berrin/AAE-3149-2022
OI Erok, Berrin/0000-0001-8036-547X
CR Li T, 2016, EXP THER MED, V12, P2069, DOI 10.3892/etm.2016.3602
   Meegada S, 2020, CUREUS, V12, DOI 10.7759/cureus.10123
   Naderi S., 2020, IRAN J NEUROSURG, V6, P151
   Talamonti G., 2020, SPINAL EPIDURAL ABSC, DOI [10.1007/s00415-020-10211-z, DOI 10.1007/S00415-020-10211-Z]
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
NR 5
TC 0
Z9 0
U1 1
U2 1
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 2277-954X
EI 2277-9167
J9 INDIAN J NEUROSURG
JI Indian J. Neurosurg.
DI 10.1055/s-0041-1741405
EA DEC 2021
PG 3
WC Surgery
WE Emerging Sources Citation Index (ESCI)
SC Surgery
GA XU0KT
UT WOS:000733966000001
OA gold
DA 2022-04-20
ER

PT J
AU Rello, J
   Belliato, M
   Dimopoulos, MA
   Giamarellos-Bourboulis, EJ
   Jaksic, V
   Martin-Loeches, I
   Mporas, I
   Pelosi, P
   Poulakou, G
   Pournaras, S
   Tamae-Kakazu, M
   Timsit, JF
   Waterer, G
   Tejada, S
   Dimopoulos, G
AF Rello, Jordi
   Belliato, Mirko
   Dimopoulos, Meletios-Athanasios
   Giamarellos-Bourboulis, Evangelos J.
   Jaksic, Vladimir
   Martin-Loeches, Ignacio
   Mporas, Iosif
   Pelosi, Paolo
   Poulakou, Garyphallia
   Pournaras, Spyridon
   Tamae-Kakazu, Maximiliano
   Timsit, Jean-Francois
   Waterer, Grant
   Tejada, Sofia
   Dimopoulos, George
TI Update in COVID-19 in the intensive care unit from the 2020 HELLENIC
   Athens International symposium
SO ANAESTHESIA CRITICAL CARE & PAIN MEDICINE
LA English
DT Review
DE COVID-19; SARS-CoV-2; Pneumonia; Acute respiratory failure; ARDS;
   Intensive care
ID CORONAVIRUS; INFECTIONS; 1ST
AB The 2020 International Web Scientific Event in COVID-19 pandemic in critically ill patients aimed at updating the information and knowledge on the COVID-19 pandemic in the intensive care unit. Experts reviewed the latest literature relating to the COVID-19 pandemic in critically ill patients, such as epidemiology, pathophysiology, phenotypes of infection, COVID-19 as a systematic infection, molecular diagnosis, mechanical ventilation, thromboprophylaxis, COVID-19 associated co-infections, immunotherapy, plasma treatment, catheter-related bloodstream infections, artificial intelligence for COVID-19, and vaccination. Antiviral therapy and co-infections are out of the scope of this review. In this review, each of these issues is discussed with key messages regarding management and further research being presented after a brief review of available evidence. (C) 2020 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.
C1 [Rello, Jordi; Tejada, Sofia] Vall dHebron Inst Res VHIR, Clin Res Epidemiol Pneumonia & Sepsis CRIPS, Barcelona, Spain.
   [Rello, Jordi; Martin-Loeches, Ignacio; Tejada, Sofia] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain.
   [Rello, Jordi] Univ Nimes Montpellier, CHU Nimes, Clin Res ICU, Anaesthesia Dept, Montpellier, France.
   [Belliato, Mirko] Fdn IRCCS Policlin San Matteo, Anestesia & Rianimaz Cardiopolmonare 2, Pavia, Italy.
   [Dimopoulos, Meletios-Athanasios] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece.
   [Giamarellos-Bourboulis, Evangelos J.] Natl & Kapodistrian Univ Athens, Med Sch, Dept Internal Med 4, Athens, Greece.
   [Jaksic, Vladimir] 3M Co, 3M Hlth Care, St Paul, MN USA.
   [Martin-Loeches, Ignacio] St James Univ Hosp, Multidisciplinary Intens Care Res Org MICRO, Dept Intens Care Med, Dublin, Ireland.
   [Martin-Loeches, Ignacio] Trinity Ctr Hlth Sci, Dublin, Ireland.
   [Martin-Loeches, Ignacio] Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona, Spain.
   [Mporas, Iosif] Univ Hertfordshire, Sch Phys Engn & Comp Sci, Hatfield, Herts, England.
   [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost DISC, Genoa, Italy.
   [Pelosi, Paolo] San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anaesthesia & Intens Care, Genoa, Italy.
   [Poulakou, Garyphallia] Natl & Kapodistrian Univ Athens, Sotiria Gen Hosp Athens, Med Sch, Dept Internal Med 3, Athens, Greece.
   [Pournaras, Spyridon] Natl & Kapodistrian Univ Athens, ATTIKON Univ Hosp, Sch Med, Lab Clin Microbiol, Athens, Greece.
   [Tamae-Kakazu, Maximiliano] Michigan State Univ, Spectrum Hlth, Div Pulm Crit Care & Sleep Med, Grand Rapids, MI USA.
   [Timsit, Jean-Francois] Hop Xavier Bichat, AP HP, Med & Infect Dis ICU MI2, F-75018 Paris, France.
   [Timsit, Jean-Francois] Univ Paris, INSERM, IAME, F-75018 Paris, France.
   [Waterer, Grant] Univ Western Australia, Sch Med, Perth, WA, Australia.
   [Dimopoulos, George] Natl & Kapodistrian Univ Athens, Med Sch, Dept Crit Care Med, Athens, Greece.
RP Tejada, S (corresponding author), Vall Hebron Inst Recerca, Ps Vall dHebron 119 AMI-14th Floor, Barcelona 08035, Spain.
EM stmagraner@gmail.com
RI Kakazu, Maximiliano Tamae/I-8304-2019; Waterer, Grant/AAG-2385-2021;
   martin-loeches, Prof. Ignacio/Q-6645-2018
OI Kakazu, Maximiliano Tamae/0000-0003-4943-1656; Tejada,
   Sofia/0000-0002-2000-6587; martin-loeches, Prof.
   Ignacio/0000-0002-5834-4063; Poulakou, Garyphallia/0000-0003-0778-0006;
   Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911
FU Centro de investigacion Biomedica en Red en Enfermedades Respiratorias
   (CIBERES), Instituto de Salud Carlos III, Madrid, Spain [CB06-06-036]
FX Supported in part (CB06-06-036) by Centro de investigacion Biomedica en
   Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos
   III, Madrid, Spain
CR Al-Ani F, 2020, THROMB RES, V192, P152, DOI 10.1016/j.thromres.2020.05.039
   Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520
   Bai CX, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0287-2020
   Barisione E, 2021, VIRCHOWS ARCH, V478, P471, DOI 10.1007/s00428-020-02934-1
   Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z
   Barrasa H, 2020, ANAESTH CRIT CARE PA, V39, P553, DOI 10.1016/j.accpm.2020.04.001
   Battaglini D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00845
   Brown C, 2020, 200605919CSEESS ARXI
   Buetti N, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1315, DOI 10.1093/CID/CIAA1315]
   Caruana G, 2020, CLIN MICROBIOL INFEC, V26, P1178, DOI 10.1016/j.cmi.2020.06.019
   Chen ZY, 2020, NAT REV IMMUNOL, V20, P529, DOI 10.1038/s41577-020-0402-6
   Eggimann P, 2019, INTENS CARE MED, V45, P823, DOI 10.1007/s00134-019-05617-x
   Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4
   Ge HP, 2020, EUR J CLIN MICROBIOL, V39, P1011, DOI 10.1007/s10096-020-03874-z
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hanley B, 2020, LANCET MICROBE, V1, pE245, DOI 10.1016/S2666-5247(20)30115-4
   Hendren NS, 2020, CIRCULATION, V141, P1903, DOI 10.1161/CIRCULATIONAHA.120.047349
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8
   Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179
   Idilman IS, 2021, EUR RADIOL, V31, P1090, DOI 10.1007/s00330-020-07155-3
   Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483
   Jansson M, 2020, INTENS CRIT CARE NUR, V57, DOI 10.1016/j.iccn.2020.102812
   Jin C, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.567672
   Kaminski MA, 2020, INT J INFECT DIS, V101, P59, DOI 10.1016/j.ijid.2020.09.1447
   Kim YG, 2017, J CLIN MICROBIOL, V55, P226, DOI [10.1128/jcm.01704-16, 10.1128/JCM.01704-16]
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044
   Liang WH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17280-8
   Liao DY, 2020, LANCET HAEMATOL, V7, pE671, DOI 10.1016/S2352-3026(20)30217-9
   Logunov DY, 2020, LANCET, V396, P887, DOI 10.1016/S0140-6736(20)31866-3
   Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825
   McElvaney OJ, 2020, AM J RESP CRIT CARE, V202, P812, DOI 10.1164/rccm.202005-1583OC
   McMullen KM, 2020, AM J INFECT CONTROL, V48, P1409, DOI 10.1016/j.ajic.2020.06.209
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Moores LK, 2020, CHEST, V158, P1143, DOI 10.1016/j.chest.2020.05.559
   Naronglerdrit P, 2021, DATA SCI COVID 19
   Pau AK, 2021, ANN INTERN MED, V174, P93, DOI 10.7326/M20-6448
   Pelosi P, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1991-3
   Pham Quoc-Viet, 2020, IEEE Access, V8, P130820, DOI 10.1109/ACCESS.2020.3009328
   Psaltopoulou T, 2020, HEMASPHERE, V4, DOI 10.1097/HS9.0000000000000409
   Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557
   Rawson TM, 2020, CLIN INFECT DIS, V71, P2459, DOI 10.1093/cid/ciaa530
   Rello J, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01028-2020
   Rello J, 2020, ANAESTH CRIT CARE PA, V39, P167, DOI 10.1016/j.accpm.2020.03.001
   Robba C, 2020, EXPERT REV RESP MED, V14, P865, DOI 10.1080/17476348.2020.1778470
   Robba C, 2020, RESP PHYSIOL NEUROBI, V279, DOI 10.1016/j.resp.2020.103455
   Rovina N, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02897-4
   Rubio-Rivas M, 2020, BENEFICIAL HARMFUL O, V2020, DOI [10.1101/2020.09.05.20188912, DOI 10.1101/2020.09.05.20188912]
   Sprung CL, 2020, CRIT CARE MED, V48, P1196, DOI 10.1097/CCM.0000000000004410
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Sturdy A, 2020, J HOSP INFECT, V105, P593, DOI 10.1016/j.jhin.2020.06.027
   Terpos E, 2020, NEW ENGL J MED, V383, P1695, DOI 10.1056/NEJMc2027051
   Vailati D, 2020, SIAARTI VASCOVID APP
   van Berkel M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03291-w
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Vena A, 2020, CLIN MICROBIOL INFEC, V26, P1537, DOI 10.1016/j.cmi.2020.07.049
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7
   Waterer GW, 2020, INFECT DIS THER, V9, P701, DOI 10.1007/s40121-020-00338-x
   Waterer GW, 2020, AM J RESP CRIT CARE, V201, P1324, DOI 10.1164/rccm.202004-1153ED
   Weinberger DM, 2020, JAMA INTERN MED, V180, P1336, DOI 10.1001/jamainternmed.2020.3391
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yan, 2020, MACHINE LEARNING BAS
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3
   Zubieta-Calleja G, 2020, OPEN SCI FRAMEWORK, DOI [10.31219/osf.io/qde8w, DOI 10.31219/OSF.IO/QDE8W]
NR 69
TC 5
Z9 5
U1 2
U2 6
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 2352-5568
J9 ANAESTH CRIT CARE PA
JI Anaesth. Crit. Care Pain Med.
PD DEC
PY 2020
VL 39
IS 6
BP 723
EP 730
DI 10.1016/j.accpm.2020.10.008
PG 8
WC Anesthesiology; Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology; General & Internal Medicine
GA PF2TT
UT WOS:000598914100009
PM 33172592
OA Green Published
DA 2022-04-20
ER

PT J
AU Wu, J
   Li, QM
   Tarimo, CS
   Wang, MY
   Gu, JQ
   Wei, W
   Ma, MZ
   Zhao, LP
   Mu, ZH
   Miao, YD
AF Wu, Jian
   Li, Quanman
   Silver Tarimo, Clifford
   Wang, Meiyun
   Gu, Jianqin
   Wei, Wei
   Ma, Mingze
   Zhao, Lipei
   Mu, Zihan
   Miao, Yudong
TI COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale
   National Study
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE COVID-19 vaccine hesitancy; China; primary vaccination; booster
   vaccination; factors (individual factors; contextual factors)
ID HEALTH; RISK
AB Globally, vaccine hesitancy is a growing public health problem. It is detrimental to the consolidation of immunization program achievements and elimination of vaccine-targeted diseases. The objective of this study was to estimate the prevalence of COVID-19 vaccine hesitancy in China and explore its contributing factors. A national cross-sectional online survey among Chinese adults (>= 18 years old) was conducted between August 6, 2021 and August 9 via a market research company. We collected sociodemographic information; lifestyle behavior; quality of life; the knowledge, awareness, and behavior of COVID-19; the knowledge, awareness, and behavior of COVID-19 vaccine; willingness of COVID-19 vaccination; accessibility of COVID-19 vaccination services; skepticism about COVID-19 and COVID-19 vaccine; doctor and vaccine developer scale; and so on. Odds ratios (OR) with 95% confidence intervals (CI) were used to estimate the associations by using logistic regression models. A total of 29,925 residents (48.64% men) were enrolled in our study with mean age of 30.99 years. We found an overall prevalence of COVID-19 vaccine hesitancy at 8.40% (95% CI, 8.09-8.72) in primary vaccination and 8.39% (95% CI, 8.07-8.70) in booster vaccination. In addition, after adjusting for potential confounders, we found that women, higher educational level, married residents, higher score of health condition, never smoked, increased washing hands, increased wearing mask, increased social distance, lower level of vaccine conspiracy beliefs, disease risks outweigh vaccine risk, higher level of convenient vaccination, and higher level of trust in doctor and developer were more willing to vaccinate than all others (all p < 0.05). Age, sex, educational level, marital status, chronic disease condition, smoking, healthy behaviors, the curability of COVID-19, the channel of accessing information of COVID-19 vaccine, endorsement of vaccine conspiracy beliefs, weigh risks of vaccination against risks of the disease, making a positive influence on the health of others around you, and lower trust in healthcare system may affect the variation of willingness to take a COVID-19 vaccine (all p < 0.05). The prevalence of COVID-19 vaccine hesitancy was modest in China, even with the slight resulting cascade of changing vaccination rates between the primary and booster vaccination. Urgent action to address vaccine hesitancy is needed in building trust in medical personnel and vaccine producers, promoting the convenience of vaccination services, and spreading reliable information of COVID-19 vaccination via the Internet and other media.
C1 [Wu, Jian; Li, Quanman; Silver Tarimo, Clifford; Ma, Mingze; Zhao, Lipei; Mu, Zihan; Miao, Yudong] Zhengzhou Univ, Dept Hlth Management Publ Hlth, Zhengzhou, Peoples R China.
   [Wang, Meiyun; Wei, Wei] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Zhengzhou, Peoples R China.
   [Gu, Jianqin] Southern Univ Sci & Technol, Sch Med, Shenzhen, Peoples R China.
RP Miao, YD (corresponding author), Zhengzhou Univ, Dept Hlth Management Publ Hlth, Zhengzhou, Peoples R China.
EM meldon@zzu.edu.cn
FU National Social Science Fund of China [21BGL222]; Collaborative
   Innovation Key Project of Zhengzhou [20XTZX05015]; Joint Project of
   National Health Commission [SB201901072]; Postgraduate Education Reform
   and Quality Improvement Project of Henan Province [YJS2021KC07];
   Performance Evaluation of New Basic Public Health Service Projects in
   Henan Province [2020130B]
FX This study is supported by the National Social Science Fund of China
   (number 21BGL222); the Collaborative Innovation Key Project of Zhengzhou
   (number 20XTZX05015); Joint Project of National Health Commission and
   Henan Province (number SB201901072); 2021 Postgraduate Education Reform
   and Quality Improvement Project of Henan Province (number YJS2021KC07);
   Performance Evaluation of New Basic Public Health Service Projects in
   Henan Province (number 2020130B).
CR Abbas K, 2020, LANCET GLOB HEALTH, V8, pE1264, DOI [10.1016/52214-109X(20)30308-9, 10.1016/S2214-109X(20)30308-9]
   Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007
   Arce JSS, 2021, NAT MED, V27, P1385, DOI 10.1038/s41591-021-01454-y
   Broadbent JJ, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4457
   Debellut F, 2021, LANCET GLOB HEALTH, V9, pE942, DOI 10.1016/S2214-109X(21)00167-4
   Du FX, 2020, VACCINE, V38, P7464, DOI 10.1016/j.vaccine.2020.09.075
   Dube E, 2021, ANNU REV PUBL HEALTH, V42, P175, DOI 10.1146/annurev-publhealth-090419-102240
   Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569
   Freeman D, 2021, LANCET PUBLIC HEALTH, V6, pE416, DOI 10.1016/S2468-2667(21)00096-7
   Freeman Daniel, 2020, Psychol Med, P1, DOI [10.1017/S0033291721002609, 10.1017/S0033291720005188]
   Gardner L, 2020, LANCET INFECT DIS, V20, P1114, DOI 10.1016/S1473-3099(20)30522-3
   Hofer Ursula, 2021, Nat Rev Microbiol, V19, P406, DOI 10.1038/s41579-021-00579-8
   Jentsch PC, 2021, LANCET INFECT DIS, V21, P1097, DOI 10.1016/S1473-3099(21)00057-8
   Kumar D, 2016, ISR J HEALTH POLICY, V5, DOI 10.1186/s13584-016-0062-y
   MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
   Phelan AL, 2020, LANCET, V396, P800, DOI 10.1016/S0140-6736(20)31873-0
   Quinn SC, 2021, NEW ENGL J MED, V385, P97, DOI 10.1056/NEJMp2103104
   Ratzan S, 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMp2106137
   Razai MS, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1138
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160
   Sandmann FG, 2021, LANCET INFECT DIS, V21, P962, DOI 10.1016/S1473-3099(21)00079-7
   Schaffer DeRoo S, 2020, JAMA-J AM MED ASSOC, V323, P2458, DOI 10.1001/jama.2020.8711
   Simas C, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00279-w
   Su S, 2021, NAT REV MICROBIOL, V19, P211, DOI 10.1038/s41579-020-00462-y
   Tanne JH, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1640
   Wang KL, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010062
   Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8
NR 27
TC 2
Z9 2
U1 14
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD NOV 29
PY 2021
VL 12
AR 781161
DI 10.3389/fimmu.2021.781161
PG 15
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA XS2HF
UT WOS:000732735600001
PM 34912346
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Endriyas, M
   Kawza, A
   Alano, A
   Hussen, M
   Shibru, E
AF Endriyas, Misganu
   Kawza, Aknaw
   Alano, Abraham
   Hussen, Mamush
   Shibru, Endashaw
TI COVID-19 prevention practices in urban setting during early introduction
   of the disease: results from community survey in SNNP Region, Ethiopia
SO BMJ OPEN
LA English
DT Article
DE public health; COVID-19; health services administration & management
ID ATTITUDES; KNOWLEDGE
AB ObjectiveTo assess community practices related to COVID-19 prevention and its associated factors during the early introduction of the disease to the study area.Setting and participantsA community-based cross-sectional study was conducted in Southern Nations, Nationalities and People's Region, Ethiopia. Ten zonal towns with high population density and mobility and 1239 participants were included in the study.Outcome measureA semistructured questionnaire was uploaded to SurveyCTO data collection system with security patterns. Mask usage was assessed by observation, while social distancing and handwashing were assessed by interview. Data were collected by health professionals who have Bachelor of Science degree and above and analysed using SPSS V.25. Descriptive statistics and binary logistic regression were performed.ResultsFrom 1239 individuals, about half, 657 (53%), of respondents were women and about two-thirds, 795 (64.2%), were married. Nearly 9 out of 10 (90.3%) and about 8 out of 10 (82.0%) respondents reported that they frequently wash hands with soap and/or use sanitiser and keep social distancing as means to prevent COVID-19, respectively. Less than three-fifths (57.8%) of respondents wore masks during the interview. In summary, about half (48.9%) of respondents were practising the three recommended methods (social distancing, handwashing and wearing masks). Sex, educational status, family size and overall knowledge about COVID-19 were associated with practising COVID-19 prevention measures.ConclusionCOVID-19 prevention practice was low as only about half of participants were practising social distancing, handwashing and wearing masks. Although awareness creation has been implemented through different forms of media, it should be strengthened in different local languages. Concerned government bodies should strictly follow using masks in public gatherings.
C1 [Endriyas, Misganu] Southern Nations Nationalities & Peoples Reg Hlth, Hlth Res & Technol Transfer, Hawassa, Ethiopia.
   [Kawza, Aknaw] Southern Nations Nationalities & Peoples Reg Hlth, Head Off, Hawassa, Ethiopia.
   [Alano, Abraham] SNNPR Policy Study & Res Inst, SNNPR President Off, Hawassa, Ethiopia.
   [Hussen, Mamush; Shibru, Endashaw] Southern Nations Nationalities & Peoples Reg Hlth, Publ Hlth Inst, Hawassa, Ethiopia.
RP Endriyas, M (corresponding author), Southern Nations Nationalities & Peoples Reg Hlth, Hlth Res & Technol Transfer, Hawassa, Ethiopia.
EM misganuendrias@yahoo.com
OI Endriyas, Misganu/0000-0002-0026-9611
FU SNNPR Health Bureau and Public Health Institute
FX This study was supported by the SNNPR Health Bureau and Public Health
   Institute (award number not available). Manuscript writing was not
   supported financially.
CR Abuya T., 2020, POPULATION COUNCIL
   ALdowyan N., 2017, INT ARCHIV MED, V10, P1, DOI [10.3823/2524sph.2016.15012016330, DOI 10.3823/2524SPH.2016.15012016330, DOI 10.3823/2524]
   Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04
   Federal ministry of health [Ethiopia], 2020, NAT COMPR COVID 19 M
   Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Haftom M, 2020, INFECT DRUG RESIST, V13, P3727, DOI 10.2147/IDR.S275744
   Qutob N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244925
   SNNPR Regional Health Bureau, 2020, ANN PLAN 2019 2020
   Wondimu W, 2020, INT J GEN MED, V13, P1603, DOI 10.2147/IJGM.S288067
   World Health Organization, 2020, SEV AC RESP INF TREA
   World Health Organization, 2020, MENT HLTH PSYCH CONS
   World Health Organization, 2018, INV CAS HUM INF MIDD
   Yoseph A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246283
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 14
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PY 2021
VL 11
IS 5
AR e047373
DI 10.1136/bmjopen-2020-047373
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA UK5PZ
UT WOS:000692022900024
PM 34049921
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU dos Santos, WG
AF dos Santos, Wagner Gouvea
TI Natural history of COVID-19 and current knowledge on treatment
   therapeutic options
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Review
DE SARS-CoV-2; Hydroxychloroquine; Convalescent plasma; Anakinra;
   Corticosteroids; Vaccine
ID RESPIRATORY SYNDROME CORONAVIRUS; CONVERTING ENZYME-INHIBITORS; II
   RECEPTOR BLOCKERS; MERS-COV INFECTION; SARS-CORONAVIRUS; IN-VITRO;
   INFLAMMATORY CYTOKINES; POTENTIAL TREATMENT; RNA-POLYMERASE;
   DOUBLE-BLIND
AB Despite intense research there is currently no effective vaccine available against the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 and responsible for the COVID-19 pandemic. This infectious and communicable disease has become one of the major public health challenges in the world. The clinical management of COVID-19 has been limited to infection prevention and control measures associated with supportive care such as supplemental oxygen and mechanical ventilation. Meanwhile efforts to find an effective treatment to inhibit virus replication, mitigate the symptoms, increase survival and decrease mortality rate are ongoing. Several classes of drugs, many of them already in use for other diseases, are being evaluated based on the body of clinical knowledge obtained from infected patients regarding to the natural history and evolution of the infection. Herein we will provide an updated overview of the natural history and current knowledge on drugs and therapeutic agents being tested for the prevention and treatment of COVID-19. These include different classes of drugs such as antiviral agents (chloroquine, ivermectin, nitazoxanide, hydroxychloroquine, lopinavir, remdesivir, tocilizumab), supporting agents (Vitamin C, Vitamin D, azithromycin, corticosteroids) and promising investigational vaccines. Considering the controversies and excessive number of compounds being tested and reported in the literature we hope that this review can provide useful and updated consolidated information on potential drugs used to prevent, control and treat COVID-19 patients worldwide.
C1 [dos Santos, Wagner Gouvea] Fed Univ Jatai UFJ, Special Acad Unit Hlth Sci, Dept Biomed, Lab Genet & Mol Biol,Grad Program Appl Hlth Sci, BR 364,Km 195,3800, BR-75801615 Jatai, Go, Brazil.
RP dos Santos, WG (corresponding author), Fed Univ Jatai UFJ, Special Acad Unit Hlth Sci, Dept Biomed, Lab Genet & Mol Biol,Grad Program Appl Hlth Sci, BR 364,Km 195,3800, BR-75801615 Jatai, Go, Brazil.
EM wagner_santos@ufg.br
RI Dos Santos, Wagner Gouvea/N-2052-2016
CR Agencia Espanola de Medicamentos y Productos Sanitarios, TRAT DISP MAN INF RE
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9
   Andreakos E, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012465
   Andreakos E, 2019, CURR OPIN IMMUNOL, V56, P67, DOI 10.1016/j.coi.2018.10.007
   [Anonymous], 2020, GLOBAL INITIATIVE SH
   Baez-Santos YM, 2015, ANTIVIR RES, V115, P21, DOI 10.1016/j.antiviral.2014.12.015
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Bao SY, 2006, AM J PHYSIOL-LUNG C, V291, pL1132, DOI 10.1152/ajplung.00207.2006
   Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010
   Bean DM, 2020, EUR J HEART FAIL, V22, P967, DOI 10.1002/ejhf.1924
   Bechman K, 2019, RHEUMATOLOGY, V58, P1755, DOI 10.1093/rheumatology/kez087
   Ben-Zvi I, 2012, CLIN REV ALLERG IMMU, V42, P145, DOI 10.1007/s12016-010-8243-x
   Bhardwaj K, 2006, J MOL BIOL, V361, P243, DOI 10.1016/j.jmb.2006.06.021
   Biaggio VS, 2010, EXP LUNG RES, V36, P31, DOI 10.3109/01902140903061787
   Bloch EM, 2020, J CLIN INVEST, V130, P2757, DOI 10.1172/JCI138745
   Boretti A, 2020, PHARMANUTRITION, V12, DOI 10.1016/j.phanu.2020.100190
   Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658
   Bouros Demosthenes, 2004, BMC Pulm Med, V4, P6, DOI 10.1186/1471-2466-4-6
   Brighenti S, 2018, J INTERN MED, V284, P145, DOI 10.1111/joim.12777
   Browning DJ, 2002, AM J OPHTHALMOL, V133, P649, DOI 10.1016/S0002-9394(02)01392-2
   Cai Q., 2020, ENGINEERING-LONDON, pS2095, DOI [10.1016/j.eng.2020.03.007, DOI 10.1016/J.ENG.2020.03.007S2095-8099(20)30063-1]
   Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040
   Calligari P, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040445
   Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787
   Cantini F, 2020, J INFECTION, V81, P318, DOI 10.1016/j.jinf.2020.04.017
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Carr AC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02851-4
   Carr AC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111211
   CASADEVALL A, 1994, ANTIMICROB AGENTS CH, V38, P1695, DOI 10.1128/AAC.38.8.1695
   Casadevall A, 2020, J CLIN INVEST, V130, P1545, DOI 10.1172/JCI138003
   Case JB, 2016, J VIROL, V90, P7248, DOI 10.1128/JVI.00542-16
   Casillo GM, 2020, PHARMACOL RES, V156, DOI 10.1016/j.phrs.2020.104791
   Cavalli G, 2020, LANCET RHEUMATOL, V2, pE325, DOI 10.1016/S2665-9913(20)30127-2
   Cavalli G, 2015, RHEUMATOLOGY, V54, P2134, DOI 10.1093/rheumatology/kev269
   Ceccarelli G, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104933
   Center for Disease Control, 2020, PROT YOUS
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z
   Chattopadhyay S, 2014, CYTOKINE GROWTH F R, V25, P533, DOI 10.1016/j.cytogfr.2014.06.002
   Chen F, 2004, J CLIN VIROL, V31, P69, DOI 10.1016/j.jcv.2004.03.003
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Chen Yu Wai, 2020, F1000Res, V9, P129, DOI 10.12688/f1000research.22457.2
   Chen Y, 2020, BIOCHEM BIOPH RES CO, V525, P135, DOI 10.1016/j.bbrc.2020.02.071
   Cheng Richard Z, 2020, Med Drug Discov, V5, P100028, DOI 10.1016/j.medidd.2020.100028
   Choy KT, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104786
   Biancatelli RMLC, 2020, EXPERT REV ANTI-INFE, V18, P99, DOI 10.1080/14787210.2020.1706483
   Cornillez-Ty CT, 2009, J VIROL, V83, P10314, DOI 10.1128/JVI.00842-09
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   Costedoat-Chalumeau N, 2007, RHEUMATOLOGY, V46, P808, DOI 10.1093/rheumatology/kel402
   Cottam EM, 2014, AUTOPHAGY, V10, P1426, DOI 10.4161/auto.29309
   CUBERO GI, 1993, BRIT HEART J, V69, P451
   D'Acquisto F, 2010, BIOCHEM PHARMACOL, V79, P525, DOI 10.1016/j.bcp.2009.09.015
   D'Elia RV, 2013, CLIN VACCINE IMMUNOL, V20, P319, DOI 10.1128/CVI.00636-12
   Damle B, 2020, CLIN PHARMACOL THER, V108, P201, DOI 10.1002/cpt.1857
   de Abajo FJ, 2020, LANCET, V395, P1705, DOI 10.1016/S0140-6736(20)31030-8
   De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010
   de Godoy CMG, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00067
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Decroly Etienne, 2011, PLoS Pathog, V7, pe1002059, DOI 10.1371/journal.ppat.1002059
   Delang L, 2018, ANTIVIR RES, V153, P85, DOI 10.1016/j.antiviral.2018.03.003
   Deng LS, 2020, J INFECTION, V81, pE1, DOI 10.1016/j.jinf.2020.03.002
   Devaux CA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105938
   Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621
   Dong LY, 2020, DRUG DISCOV THER, V14, P58, DOI 10.5582/ddt.2020.01012
   Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117
   Duarte NA, 2020, CAN PEOPLE ASYMPTONA, DOI [10.1101/2020.04.08.20054023, DOI 10.1101/2020.04.08.20054023]
   Durham LE, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0529-9
   EASTERBROOK M, 1993, SEMIN ARTHRITIS RHEU, V23, P62, DOI 10.1016/S0049-0172(10)80009-5
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Fantini J, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106020
   Fender AC, 2019, PHARMACOL RES, V145, DOI 10.1016/j.phrs.2019.104257
   Fensterl V, 2015, ANNU REV VIROL, V2, P549, DOI 10.1146/annurev-virology-100114-055249
   Finzi E, 2020, INT J INFECT DIS, V99, P307, DOI 10.1016/j.ijid.2020.06.006
   Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027
   Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025
   Gao C, 2020, EUR HEART J, V41, P2058, DOI 10.1093/eurheartj/ehaa433
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gao Y, 2020, J MED VIROL, V92, P791, DOI 10.1002/jmv.25770
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gendrot M, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105980
   Gibson PG, 2017, LANCET, V390, P659, DOI 10.1016/S0140-6736(17)31281-3
   Gnavi R., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa634, DOI 10.1093/CID/CIAA634MAY22]
   Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gurwitz D, 2020, DRUG DEVELOP RES, V81, P537, DOI 10.1002/ddr.21656
   Hackbart M, 2020, P NATL ACAD SCI USA, V117, P8094, DOI 10.1073/pnas.1921485117
   Haffizulla J, 2014, LANCET INFECT DIS, V14, P609, DOI 10.1016/S1473-3099(14)70717-0
   Hastie CE, 2020, DIABETES METAB SYND, V14, P561, DOI 10.1016/j.dsx.2020.04.050
   Hemila H, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040708
   Hindson J, 2020, NAT REV GASTRO HEPAT, V17, P259, DOI 10.1038/s41575-020-0295-7
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4
   Huang C., 2020, FAVIPIRAVIR VERSUS A, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433
   Huet T, 2020, LANCET RHEUMATOL, V2, pE393, DOI 10.1016/S2665-9913(20)30164-8
   Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4
   Ingraham NE, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00912-2020
   Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004
   Iversen MB, 2010, J INTERF CYTOK RES, V30, P573, DOI 10.1089/jir.2010.0063
   Jaffe A, 2001, PEDIATR PULM, V31, P464, DOI 10.1002/ppul.1076
   Jarcho JA, 2020, NEW ENGL J MED, V382, P2462, DOI 10.1056/NEJMe2012924
   Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Kalil AC, 2020, JAMA-J AM MED ASSOC, V323, P1897, DOI 10.1001/jama.2020.4742
   Kaly L, 2012, BEST PRACT RES CL RH, V26, P157, DOI 10.1016/j.berh.2012.01.001
   Kanne JP, 2020, RADIOLOGY, V295, P16, DOI 10.1148/radiol.2020200241
   Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09
   Kelleni MT, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104874
   Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085
   Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479
   Kong WH, 2020, NAT MICROBIOL, V5, P675, DOI 10.1038/s41564-020-0713-1
   Lai CC, 2018, INT J CHRONIC OBSTR, V13, P867, DOI 10.2147/COPD.S158634
   Ledford H, 2020, NATURE, V582, P160, DOI 10.1038/d41586-020-01695-w
   Lei J, 2018, ANTIVIR RES, V149, P58, DOI 10.1016/j.antiviral.2017.11.001
   Lespine A, 2005, VET PARASITOL, V128, P251, DOI 10.1016/j.vetpar.2004.11.028
   Letko Michael, 2020, bioRxiv, DOI 10.1101/2020.01.22.915660
   Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001
   Li WB, 2020, APPL PHYS EXPRESS, V13, DOI 10.35848/1882-0786/ab998e
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Lim JK, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e92
   Liu BW, 2020, J AUTOIMMUN, V111, DOI 10.1016/j.jaut.2020.102452
   Liu K, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-019-0132-8
   Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139
   Ma YY, 2015, P NATL ACAD SCI USA, V112, P9436, DOI 10.1073/pnas.1508686112
   Mahallawi WH, 2018, CYTOKINE, V104, P8, DOI 10.1016/j.cyto.2018.01.025
   Mantlo Emily, 2020, bioRxiv, DOI 10.1101/2020.04.02.022764
   Marik PE, 2017, CHEST, V151, P1229, DOI 10.1016/j.chest.2016.11.036
   Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583
   Mavrikakis M, 1996, ANN RHEUM DIS, V55, P187, DOI 10.1136/ard.55.3.187
   MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Menezes-Rodrigues FS, 2020, J THROMB HAEMOST, V18, P2073, DOI 10.1111/jth.14902
   Menzel M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28698
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Misra DP, 2020, CLIN RHEUMATOL, V39, P2055, DOI 10.1007/s10067-020-05073-9
   Moderna, 2020, MOD ANN POS INT PHAS
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Mortensen EM, 2012, CLIN INFECT DIS, V55, P1466, DOI 10.1093/cid/cis733
   Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novelcoronavirus pneumonia, 2020, ZHONGHUA JIE HE HE H, V43, pE019, DOI [10.3760/cma.j.issn.1001-0939., DOI 10.3760/CMA.J.ISSN.1001-0939]
   Negri EM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.573044
   Nelemans T, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100961
   Okour M, 2020, J PHARMACOKINET PHAR, V47, P187, DOI 10.1007/s10928-020-09689-x
   Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9
   Oxford, 2020, DEX RED DEATH HOSP P
   Oxford, 2020, OXF COVID 19 VACC BE
   Pacha O, 2020, NAT REV IMMUNOL, V20, P345, DOI 10.1038/s41577-020-0328-z
   Paderno A, 2020, INT FORUM ALLERGY RH, V10, P955, DOI 10.1002/alr.22610
   Paraskevis D, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104212
   Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013
   Pepperrell T, 2020, J VIRUS ERAD, V6, P52
   Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Raucci F, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102572
   Raychaudhuri SP, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1249-5
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richardson P, 2020, LANCET, V395, pE30, DOI 10.1016/S0140-6736(20)30304-4
   Rossingol JF, 2016, J INFECT PUBLIC HEAL, V9, P227, DOI 10.1016/j.jiph.2016.04.001
   Rynes RI, 1997, BRIT J RHEUMATOL, V36, P799
   Sakai Y, 2017, VIROLOGY, V510, P165, DOI 10.1016/j.virol.2017.07.019
   Saleh M, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008662
   Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   SCHMITH VD, 2020, CLIN PHARMACOL 0607, DOI DOI 10.1002/CPT.1889
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0
   Sedaghat AR, 2020, OTOLARYNG HEAD NECK, V163, P12, DOI 10.1177/0194599820926464
   Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Shirato K, 2018, VIROLOGY, V517, P9, DOI 10.1016/j.virol.2017.11.012
   Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594
   Smyth LJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026777
   Srinivasa Amar, 2017, J Rheumatol, V44, P398, DOI 10.3899/jrheum.161063
   Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111
   Syedbasha M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00119
   Tang N., 2020, J THROMB HAEMOST, P1, DOI DOI 10.1111/JTH.14817
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   te Velthuis Aartjan J W, 2010, PLoS Pathog, V6, pe1001176, DOI 10.1371/journal.ppat.1001176
   Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018
   Tomar S, 2015, J BIOL CHEM, V290, P19403, DOI 10.1074/jbc.M115.651463
   Toth K, 2008, P NATL ACAD SCI USA, V105, P7293, DOI 10.1073/pnas.0800200105
   Touret F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70143-6
   U.S. Food and Drug Administration, 2020, EUA HYDR SULF HLTH C
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   van Doremalen Neeltje, 2020, bioRxiv, DOI 10.1101/2020.05.13.093195
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]
   Vankadari N, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105998
   Velthuis AJWT, 2012, NUCLEIC ACIDS RES, V40, P1737, DOI 10.1093/nar/gkr893
   Verity R., LANCET INFECT DIS, DOI [10.1016/S1473-3099(20)30243-7, DOI 10.1038/S41586-020-2012-7]
   Villalain J, 2010, J PHYS CHEM B, V114, P8544, DOI 10.1021/jp102619w
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Wang Y, 2015, J VIROL, V89, P8416, DOI 10.1128/JVI.00948-15
   Wang Y, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0158-2
   WHO, 2020, NAM COR DIS COVID 19
   Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x
   World Health Organization, 2020, MIS SUMM WHO FIELD V
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101
   Wu DD, 2020, J MICROBIOL IMMUNOL, V53, P368, DOI 10.1016/j.jmii.2020.03.005
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Xu Y, 2020, NAT MED, V26, P502, DOI 10.1038/s41591-020-0817-4
   Xue J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109180
   Yan CG, 2021, IEEE T PATTERN ANAL, V43, P1445, DOI 10.1109/TPAMI.2020.2975798
   Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Yang SNY, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104760
   Yang X, 2020, LANCET RESP MED, V8, pE26
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Yao ZX, 2020, AGING-US, V12, P7639, DOI 10.18632/aging.103101
   Yoshimoto FK, 2020, PROTEIN J, V39, P198, DOI 10.1007/s10930-020-09901-4
   Zhan MK, 2020, NEW ENGL J MED, V382, P2267, DOI 10.1056/NEJMc2005696
   Zhang JJ, 2020, ALLERGY, V75, P1809, DOI 10.1111/all.14316
   Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117
   Zhang T., 2020, PANGOLIN HOMOLOGY AS, DOI [10.1101/2020.02.19.950253, DOI 10.1101/2020.02.19.950253]
   Zhang W., 2020, CHIN J INFECT DIS, V38, DOI 10.3760/cma.j.issn.1000-6680.2020.0016
   ZHAO J, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa344, DOI 10.1093/CID/CIAA344]
   Zhao S, 2015, VIRUS RES, V195, P217, DOI 10.1016/j.virusres.2014.10.021
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhou SC, 2020, AM J ROENTGENOL, V214, P1287, DOI 10.2214/AJR.20.22975
   Zhou W, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0127-9
   Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zhu Z, 2020, J INFECTION, V81, pE21, DOI 10.1016/j.jinf.2020.03.060
NR 240
TC 51
Z9 52
U1 5
U2 17
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD SEP
PY 2020
VL 129
AR 110493
DI 10.1016/j.biopha.2020.110493
PG 18
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA NJ9PM
UT WOS:000566375700003
PM 32768971
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Santos, E
   Ratten, V
   Diogo, A
   Tavares, F
AF Santos, Eulalia
   Ratten, Vanessa
   Diogo, Ana
   Tavares, Fernando
TI Positive and negative affect during the COVID-19 pandemic quarantine in
   Portugal
SO JOURNAL OF SCIENCE AND TECHNOLOGY POLICY MANAGEMENT
LA English
DT Article; Early Access
DE Affects; COVID-19; Pandemic; Positive affect; Negative affect
ID AFFECT SCHEDULE PANAS; HAPPINESS; HEALTH; PERSONALITY; VALIDATION;
   VALIDITY
AB Purpose The COVID-19 pandemic has spread rapidly around the world and Portugal is no exception. Positive and negative effects are extremely important in individual's life experiences and in particular in the context of the quarantine, in which it is important to maintain the balance between favorable and unfavorable situations. The purpose of this paper is to study in depth the intensity of the affect during the COVID-19 pandemic in Portugal and to validate a scale of positive and negative affect in the context of quarantine and confinement. Design/methodology/approach The methodology used is of a quantitative nature, based on a questionnaire survey to measure the intensity of the affects and to analyze some sociodemographic variables. The sample consists of 726 individuals of age 18 years or older, who were in Portugal during the quarantine of the COVID-19 pandemic. Findings The results show that respondents were concerned, anxious, well-disposed and impatient. Exploratory and confirmatory factor analysis applied to affects produced a latent structure with two factors: negative affect and positive affect. The affect scale has adequate convergent and discriminant validity and good internal consistency, with negative affect being experienced by individuals with greater intensity compared to positive affect. Originality/value It is hoped that this study contributes to an increase in the scientific knowledge in the field of the affects in the context of delicate situations such as the pandemic COVID-19 so that health professionals can intervene to improve individual's well-being. This is an important way to provide better health policy that considers in more depth individual wellbeing and emotions during times of crisis. Limitations and suggestions for future research are also stated that highlight the importance of understanding emotional states of individuals during crisis events.
C1 [Santos, Eulalia; Diogo, Ana] Leiria Higher Inst Management & Adm, Leiria, Portugal.
   [Ratten, Vanessa] La Trobe Univ, Melbourne, Vic, Australia.
   [Tavares, Fernando] ISCET Higher Inst Business & Tourism, Porto, Portugal.
RP Ratten, V (corresponding author), La Trobe Univ, Melbourne, Vic, Australia.
EM v.ratten@latrobe.edu.au
RI santos, Eulália/AAO-4024-2020; Tavares, Fernando Oliveira/AAE-6873-2021;
   Diogo, Ana Paula Louro/E-2758-2010
OI santos, Eulália/0000-0001-8069-2657; Diogo, Ana Paula
   Louro/0000-0003-4939-9158
CR Akhter N, 2017, J PAK MED ASSOC, V67, P1517
   Allen J. J. B, 2007, HDB EMOTION ELICITAT, P171
   Andrade L., 2020, HLTH RESIDENCIES J H, V1, P44
   [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   Arbuckle, 2014, IBM AMOS TM 23 USERS
   Atlas da Saude (AS), 2020, FUND PORT CARD AP AO
   Brooks SK., 2020, The Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8
   Cohen J. B., 2008, HDB CONSUMER PSYCHOL
   Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934
   Cruz-Saez S, 2020, J HEALTH PSYCHOL, V25, P1098, DOI 10.1177/1359105317748734
   Desclaux A, 2017, SOC SCI MED, V178, P38, DOI 10.1016/j.socscimed.2017.02.009
   Diaz-Garcia A, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-2472-1
   DIENER E, 1984, J PERS SOC PSYCHOL, V47, P871, DOI 10.1037/0022-3514.47.4.871
   Diener E, 2010, SOC INDIC RES, V97, P143, DOI 10.1007/s11205-009-9493-y
   Diener E, 2017, APPL PSYCHOL-HLTH WE, V9, P133, DOI 10.1111/aphw.12090
   Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x
   Ferreira M.C., 2008, AVALIACAO PSICOLOGIC, V7, P143
   Gadermann AM, 2007, SOC INDIC RES, V81, P1, DOI 10.1007/s11205-006-0015-x
   Galinha Iolanda Costa, 2014, Psicologia, V28, P50
   Gouveia VV, 2008, PSICOL-REFLEX CRIT, V21, P464, DOI 10.1590/S0102-79722008000300015
   Gross JJ, 1998, PERS SOC PSYCHOL B, V24, P279, DOI 10.1177/0146167298243005
   Gyollai Agoston, 2011, Neuropsychopharmacol Hung, V13, P73
   Hair J.F.Jr., 2010, MULTIVARIATE DATA AN, V7th ed.
   Kline R., 1998, PRINCIPLES PRACTICE
   Liu JR, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.607548
   Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803
   Maroco J., 2014, ANAL EQUACOES ESTRUT, V2nd
   Maroco J., 2018, ANAL ESTATISTICA COM, V7
   Naragon K., 2009, ENCY POSITIVE PSYCHO, P707
   Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003
   Oliveira E., 2020, NAVUS REV GESTAO TEC, V10, P01, DOI [10.22279/navus.2020.v10.p01-19.1038, DOI 10.22279/NAVUS.2020.V10.P01-19.1038]
   Orita R, 2019, JPN PSYCHOL RES, V61, P94, DOI 10.1111/jpr.12237
   PASCHOAL T., 2008, AVALIACAO PSICOLOGIC, V7, P11
   Pelechano V, 2013, INT J CLIN HLTH PSYC, V13, P18, DOI 10.1016/S1697-2600(13)70003-6
   Perez-Fuentes MD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235305
   Pestana M.H., 2014, ANAL DADOS CIENCIAS, V6
   Pires P, 2013, SPAN J PSYCHOL, V16, DOI 10.1017/sjp.2013.60
   Ratten V., 2020, J SMALL BUSINESS ENT, V32, P503, DOI DOI 10.1080/08276331.2020.1790167
   Sandin B., 2020, REV PSICOPATOLOGIA P, V25, P1, DOI [10.5944/rppc.27569, DOI 10.5944/RPPC.27569]
   Santos I.L.S., 2020, PSICOLOGIA PANDEMIA
   Sartorio C.L., 2020, CADERNOS PROSPECCAO, V13, P425, DOI [10.9771/cp.v13i2.COVID-19.36157, DOI 10.9771/CP.V13I2.COVID-19.36157]
   Satuf C, 2018, INT J OCCUP SAF ERGO, V24, P181, DOI 10.1080/10803548.2016.1216365
   Sheldon KM, 2021, J POSIT PSYCHOL, V16, P145, DOI 10.1080/17439760.2019.1689421
   Spagnoli P, 2020, BEHAV SCI-BASEL, V10, DOI 10.3390/bs10120192
   Stroe S, 2020, J BUS VENTURING, V35, DOI 10.1016/j.jbusvent.2019.105948
   Tuccitto DE, 2010, EDUC PSYCHOL MEAS, V70, P125, DOI 10.1177/0013164409344522
   Van den Bulck J, 2009, EUR J PUBLIC HEALTH, V19, P370, DOI 10.1093/eurpub/ckp061
   van Horn JE, 2004, J OCCUP ORGAN PSYCH, V77, P365
   Vera-Villarroel P, 2019, EVAL HEALTH PROF, V42, P473, DOI 10.1177/0163278717745344
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   Wong SS, 2009, PERS INDIV DIFFER, V46, P648, DOI 10.1016/j.paid.2009.01.009
   Zanon Cristian, 2013, Psico-USF, V18, P193
   Zhai QG, 2009, INT C MANAGE SCI ENG, P1184, DOI 10.1109/ICMSE.2009.5318066
NR 53
TC 0
Z9 0
U1 8
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2053-4620
EI 1758-5538
J9 J SCI TECHNOL POLICY
JI J. Sci. Technol. Policy Manag.
DI 10.1108/JSTPM-07-2020-0111
EA JUL 2021
PG 18
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA TQ2CV
UT WOS:000678094400001
OA Bronze
DA 2022-04-20
ER

PT J
AU Guo, MN
   Joanpere, M
   Pulido, C
   Cuxart, MP
AF Guo, Mengna
   Joanpere, Mar
   Pulido, Cristina
   Padros Cuxart, Maria
TI Coping of Chinese Citizens Living in Spain during the COVID-19 Pandemic:
   Lessons for Personal Well-Being and Social Cohesion
SO SUSTAINABILITY
LA English
DT Article
DE COVID-19; coping strategies; well-being; cultural knowledge
ID RISK PERCEPTION; CULTURAL-VALUES; RESPONSES; SARS; STRATEGIES; EPIDEMIC;
   STRESS; THREAT
AB Chinese citizens in China were the first affected by the COVID-19 outbreak. Nevertheless, the disease rapidly spread around the world, leading to the worst pandemic experienced in modern societies. Spain has become one of the countries more severely affected by it, while having a large Chinese community. This study aims to explore the perception of Chinese citizens living in Spain regarding the outbreak in their host country. Communicative interviews were conducted with ten Chinese men and women who had been living in Spain for at least five years. Results show cultural differences in the coping strategies of the Chinese as a response to the pandemic, which differ from those observed by the participants in their fellow Spanish citizens. These findings unveil the potential of integrating the cultural knowledge and coping strategies of migrant groups in the host communities in managing a pandemic, as well as the negative outcomes for social cohesion and well-being from new racism emerging in the context of COVID-19.
C1 [Guo, Mengna] Univ Barcelona, Dept Sociol, Barcelona 08007, Spain.
   [Joanpere, Mar] Univ Rovira & Virgili, Dept Business Management, Reus 43002, Spain.
   [Pulido, Cristina] Autonomous Univ Barcelona, Dept Journalism & Commun Studies, Barcelona 08193, Spain.
   [Padros Cuxart, Maria] Univ Barcelona, Dept Didact & Educ Org, Barcelona 08035, Spain.
RP Cuxart, MP (corresponding author), Univ Barcelona, Dept Didact & Educ Org, Barcelona 08035, Spain.
EM mguoguog14@alumnes.ub.edu; mar.joanpere@urv.cat;
   Cristina.pulido@uab.cat; mariapadros@ub.edu
RI Padrós, Maria/F-9932-2014; Pulido, Cristina/Q-3479-2017
OI Padrós, Maria/0000-0002-4949-4545; Pulido, Cristina/0000-0001-8630-7529;
   Guo, Mengna/0000-0003-4770-3638; Joanpere, Mar/0000-0002-6006-0190
CR Bailey FJ, 1999, AUST PSYCHOL, V34, P177, DOI 10.1080/00050069908257451
   Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7
   Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x
   Chetty R., 2020, J BLACK STUD, V17, P684, DOI [10.3386/w27431, DOI 10.3386/W27431]
   Chew Qian Hui, 2020, Singapore Med J, V61, P350, DOI 10.11622/smedj.2020046
   COPE, COR COM VAL CONF PRI
   de Zwart O, 2009, INT J BEHAV MED, V16, P30, DOI 10.1007/s12529-008-9008-2
   Devakumar D, 2020, LANCET, V395, P1194, DOI 10.1016/S0140-6736(20)30792-3
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Gairal-Casado R, 2019, CHILD YOUTH SERV REV, V103, P116, DOI 10.1016/j.childyouth.2019.05.037
   Gerhold L., 2020, PSYARXIV, DOI [10.31234/osf.io/xmpk4, DOI 10.31234/OSF.IO/XMPK4]
   Gomez A, 2019, FRONT EDUC, V4, DOI 10.3389/feduc.2019.00009
   Gt Walker P., 2020, 12 IMP COLL LOND
   Habermas J., 1984, THEORY COMMUNICATIVE
   Hove T., 2017, OXFORD RES ENCY COMM, DOI [10.1093/acrefore/9780190228613.001.0001/acrefore-9780190228613-e-283?print=pdf, DOI 10.1093/ACREFORE/9780190228613.013.283]
   Hsiang S, 2020, NATURE, V585, pE7, DOI [10.1038/s41586-020-2404-8, 10.1038/s41586-020-2691-0]
   Huang F, 2019, COMPUT EDUC, V133, P69, DOI 10.1016/j.compedu.2019.01.012
   Kiss IZ, 2010, MATH BIOSCI, V225, P1, DOI 10.1016/j.mbs.2009.11.009
   Kupferschmidt K, 2020, SCIENCE, V367, P1061, DOI 10.1126/science.367.6482.1061
   La Moncloa, GOB DECR EST AL HAC
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Lazarus RS, 1984, STRESS APPRAISAL COP
   Lee-Baggley D, 2004, ASIAN J SOC PSYCHOL, V7, P9, DOI 10.1111/j.1467-839X.2004.00131.x
   Li ML, 2020, J THEOR BIOL, V486, DOI 10.1016/j.jtbi.2019.110090
   Liu Q, 2020, J INFECT PUBLIC HEAL, V13, P1611, DOI 10.1016/j.jiph.2020.08.001
   Marjanovic Z, 2007, INT J NURS STUD, V44, P991, DOI 10.1016/j.ijnurstu.2006.02.012
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Paek HJ, 2008, HEALTH PROMOT PRACT, V9, p60S, DOI 10.1177/1524839908322114
   Pascual AM, 2020, AFFILIA J WOM SOC WO, V35, P516, DOI 10.1177/0886109920906780
   Poletti Piero, 2011, PLoS One, V6, pe16460, DOI 10.1371/journal.pone.0016460
   Poletti P, 2012, MATH BIOSCI, V238, P80, DOI 10.1016/j.mbs.2012.04.003
   Prentice C, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101789
   Prior MT, 2018, APPL LINGUIST REV, V9, P487, DOI 10.1515/applirev-2017-0029
   Pulido CM, 2020, INT SOCIOL, V35, P377, DOI 10.1177/0268580920914755
   Rodriguez CP, 2020, INT MULTIDISCIP J SO, V9, P107, DOI 10.17583/rimcis.2020.5386
   Puterman E, 2009, GLOB PUBLIC HEALTH, V4, P69, DOI 10.1080/17441690802063304
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Redondo-Sama G, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00286
   Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662
   Sorokowski P, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12124912
   SteelFisher Gillian K, 2010, N Engl J Med, V362, pe65, DOI 10.1056/NEJMp1005102
   Syed Q, 2003, J EPIDEMIOL COMMUN H, V57, P855, DOI 10.1136/jech.57.11.855
   Tweed RG, 2004, J CROSS CULT PSYCHOL, V35, P652, DOI 10.1177/0022022104270109
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   WEINSTEIN ND, 1987, J BEHAV MED, V10, P481, DOI 10.1007/BF00846146
   Whitworth J, 2020, T ROY SOC TROP MED H, V114, P227, DOI 10.1093/trstmh/traa025
   WHO, 2020, NOV COR 2019 NCOV SI
   Wise T., 2020, CHANGES RISK PERCEPT, DOI [10.31234/osf.io/dz428., DOI 10.31234/OSF.IO/DZ428, 10.1098/rsos.200742]
   World Health Organization, 2020, ROLL UPD COR DIS COV
   World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]
   Zotzmann Y, 2019, SAFETY SCI, V120, P185, DOI 10.1016/j.ssci.2019.06.013
NR 53
TC 2
Z9 2
U1 1
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD OCT
PY 2020
VL 12
IS 19
AR 7949
DI 10.3390/su12197949
PG 15
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA ON4BQ
UT WOS:000586648900001
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Kerawala, AA
   Das, B
   Solangi, A
AF Kerawala, Asad Ali
   Das, Bhagwan
   Solangi, Ahda
TI Mesenteric ischemia in COVID-19 patients: A review of current literature
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Review
DE Mesenteric ischemia; COVID-19; SARS-CoV-2; Influenza; Severe acute
   respiratory syndrome; Acute abdomen
ID THROMBOTIC COMPLICATIONS
AB BACKGROUND Coronavirus disease 2019 (COVID-19) virus has affected all the systems of the body, defying all impressions of it being a respiratory virus only. AIM To see the association of mesenteric ischemia with COVID-19. METHODS After initial screening and filtering of the titles on PubMed and Google Scholar, 124 articles were selected. Articles were read in full, and the references were skimmed for relevance. Twenty-six articles (case reports and case series) were found to eligible for inclusion. References of these 26 articles were checked for any additional cases. Two more publications were found, and a total of 28 articles (22 case reports and 6 case series) have been included for review in this manuscript. RESULTS A total of 41 cases of acute mesenteric ischemia in COVID-19 patients have been reported in the literature since the outbreak of this pandemic. Most of them include patients with comorbidities. CONCLUSION In conclusion, based on this literature review and precise published knowledge regarding acute mesenteric ischemia in patients with COVID-19, it is essential to understand its relevance in all patients with gastrointestinal symptoms. The threshold for the diagnostic investigations should also be kept low for the timely diagnosis and management of this disorder.
C1 [Kerawala, Asad Ali] Canc Fdn Hosp, Dept Surg, C-130,Block 09, Karachi 75300, Pakistan.
   [Das, Bhagwan] Canc Fdn Hosp, Dept Med, Karachi 75300, Pakistan.
   [Solangi, Ahda] New York Med Coll, Valhalla, NY 10595 USA.
RP Kerawala, AA (corresponding author), Canc Fdn Hosp, Dept Surg, C-130,Block 09, Karachi 75300, Pakistan.
EM asadali4@yahoo.com
CR A Beccara Lia, 2020, Eur J Case Rep Intern Med, V7, P001690, DOI 10.12890/2020_001690
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461
   Azouz E, 2020, INTENS CARE MED, V46, P1464, DOI 10.1007/s00134-020-06079-2
   Barilla F, 2020, J CARDIOVASC MED, V21, P630, DOI 10.2459/JCM.0000000000001071
   Besutti G, 2020, EMERG INFECT DIS, V26, P1926, DOI 10.3201/eid2608.201161
   Bhayana R, 2020, RADIOLOGY, V297, pE207, DOI 10.1148/radiol.2020201908
   Bianco F, 2020, TECH COLOPROCTOL, V24, P1217, DOI 10.1007/s10151-020-02255-0
   Celebi F., 2020, SURG INNOV
   Cheung S, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.925753
   da, 2020, CASE REPORT INFERIOR
   de Barry Olivier, 2020, Radiol Case Rep, V15, P1054, DOI 10.1016/j.radcr.2020.04.055
   de Roquetaillade C, 2021, INT J CARDIOL, V323, P281, DOI 10.1016/j.ijcard.2020.08.103
   English W, 2020, ANZ J SURG, V90, P1826, DOI 10.1111/ans.16151
   Espuin-Basany E, 2020, SURG-J R COLL SURG E
   Farina D, 2021, J GASTROEN HEPATOL, V36, P41, DOI 10.1111/jgh.15094
   Fraisse M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03025-y
   Gopal, 2020, CLIN GASTROENTEROLOG, V3565, P30835
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Henry BM, 2020, CLIN CHIM ACTA, V507, P167, DOI 10.1016/j.cca.2020.04.027
   HEYS SD, 1993, POSTGRAD MED J, V69, P48, DOI 10.1136/pgmj.69.807.48
   Ignat M, 2020, SURGERY, V168, P14, DOI 10.1016/j.surg.2020.04.035
   Karna ST, 2020, INDIAN J SURG, V82, P1235, DOI 10.1007/s12262-020-02638-5
   Khesrani LS, 2020, J PEDIAT SURG CASE R, V61, DOI 10.1016/j.epsc.2020.101604
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Lari E, 2020, INT J SURG CASE REP, V75, P131, DOI 10.1016/j.ijscr.2020.09.009
   Levolger S, 2020, J VASC SURG CASES IN, V6, P454, DOI 10.1016/j.jvscit.2020.06.012
   Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024
   Maier CL, 2020, LANCET, V395, P1758, DOI 10.1016/S0140-6736(20)31209-5
   Norsa L, 2020, DIGEST LIVER DIS, V52, P1090, DOI 10.1016/j.dld.2020.05.030
   Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850
   Parry AH, 2020, ACAD RADIOL, V27, P1190, DOI 10.1016/j.acra.2020.05.016
   Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854
   Rodriguez-Nakamura RM, 2020, INT J SURG CASE REP, V76, P409, DOI 10.1016/j.ijscr.2020.10.040
   Roncati L, 2020, CLIN IMMUNOL, V217, DOI 10.1016/j.clim.2020.108487
   Sehhat S, 2020, ARCH IRAN MED, V23, P639, DOI 10.34172/aim.2020.77
   Singh Balraj, 2020, Korean J Gastroenterol, V76, P164, DOI 10.4166/kjg.2020.76.3.164
   Spiezia L, 2020, THROMB HAEMOSTASIS, V120, P998, DOI 10.1055/s-0040-1710018
   Thomas W, 2020, THROMB RES, V191, P76, DOI 10.1016/j.thromres.2020.04.028
   Thuluva SK, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.926785
   Ucpinar BA, 2020, JCPSP-J COLL PHYSICI, V30, pS112, DOI [10.29271/jcpsp.2020.Supp1.S112, 10.29271/jcpsp.2020.Supp2.S112, 10.29271/jcpsp.2020.supp2.112]
   Vulliamy P, 2020, BRIT J HAEMATOL, V189, P1053, DOI 10.1111/bjh.16760
   World Health Organization, STAT 2 M INT HLTH RE
   World Health Organization, COR DIS COVID 19 WHO
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
NR 45
TC 2
Z9 2
U1 0
U2 0
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD JUN 26
PY 2021
VL 9
IS 18
BP 4700
EP 4708
DI 10.12998/wjcc.v9.i18.4700
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA TC7GC
UT WOS:000668807100023
PM 34222436
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Umakanthan, S
   Sahu, P
   Ranade, AV
   Bukelo, MM
   Rao, JS
   Abrahao-Machado, LF
   Dahal, S
   Kumar, H
   Dhananjaya, KV
AF Umakanthan, Srikanth
   Sahu, Pradeep
   Ranade, Anu, V
   Bukelo, Maryann M.
   Rao, Joseph Sushil
   Abrahao-Machado, Lucas Faria
   Dahal, Samarika
   Kumar, Hari
   Dhananjaya, K., V
TI Origin, transmission, diagnosis and management of coronavirus disease
   2019 (COVID-19)
SO POSTGRADUATE MEDICAL JOURNAL
LA English
DT Review
ID RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; MEMBRANE-PROTEIN;
   SPIKE PROTEIN; PNEUMONIA; WUHAN; COV; IDENTIFICATION; SEQUENCE; RECEPTOR
AB Coronavirus has emerged as a global health threat due to its accelerated geographic spread over the last two decades. This article reviews the current state of knowledge concerning the origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Historically, it has caused two pandemics: severe acute respiratory syndrome and Middle East respiratory syndrome followed by the present COVID-19 that emerged from China. The virus is believed to be acquired from zoonotic source and spreads through direct and contact transmission. The symptomatic phase manifests with fever, cough and myalgia to severe respiratory failure. The diagnosis is confirmed using reverse transcriptase PCR. Management of COVID-19 is mainly by supportive therapy along with mechanical ventilation in severe cases. Preventive strategies form the major role in reducing the public spread of virus along with successful disease isolation and community containment. Development of a vaccine to eliminate the virus from the host still remains an ongoing challenge.
C1 [Umakanthan, Srikanth] Univ West Indies St Augustine, Fac Med Sci, Paraclin Sci, St Augustine, Trinidad Tobago.
   [Sahu, Pradeep] Univ West Indies St Augustine, Ctr Med Sci Educ, St Augustine, Trinidad Tobago.
   [Ranade, Anu, V] Univ Sharjah, Basic Med Sci, Sharjah, U Arab Emirates.
   [Bukelo, Maryann M.] North Cent Reg Hlth Author, Dept Anat Pathol, Eric Williams Med Sci Complex, Mt Hope, Trinidad Tobago.
   [Rao, Joseph Sushil] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.
   [Abrahao-Machado, Lucas Faria] Dept Pathol, Bacchi Lab, Sao Paulo, Brazil.
   [Dahal, Samarika] Inst Med, Dept Oral Pathol, Kathmandu, Nepal.
   [Kumar, Hari] Dept Int Publ Hlth & Dis Surveillance, Midwest, Australia.
   [Dhananjaya, K., V] Indiragandhi Inst Child Hlth, Dept Radiol, Bangalore, Karnataka, India.
RP Umakanthan, S (corresponding author), Univ West Indies, EWMSC, Fac Med Sci, Pathol Unit,Dept Paraclin Sci, Bldg 5,Room 30, Mt Hope, Trinidad Tobago.
EM Srikanth.Umakanthan@sta.uwi.edu
RI Umakanthan, Srikanth/AAD-7903-2022; Lin, Chen/AFV-2163-2022; Umakanthan,
   Srikanth/ABE-4754-2021
OI Umakanthan, Srikanth/0000-0002-6713-2265; Sahu,
   Pradeep/0000-0001-7910-9399
CR Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254
   [Anonymous], 2020, CORONAVIRUS COVID 19
   Aquino-Jarquin G, 2019, NANOMED-NANOTECHNOL, V18, P428, DOI 10.1016/j.nano.2019.03.006
   Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC
   ARMSTRONG J, 1984, NATURE, V308, P751, DOI 10.1038/308751a0
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Barcena M, 2009, P NATL ACAD SCI USA, V106, P582, DOI 10.1073/pnas.0805270106
   Beniac DR, 2006, NAT STRUCT MOL BIOL, V13, P751, DOI 10.1038/nsmb1123
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380
   Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]
   Cong YY, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070182
   Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090
   El Zowalaty ME, 2020, ONE HEALTH-AMSTERDAM, V9, DOI 10.1016/j.onehlt.2020.100124
   Fisher D, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01533-w
   Fowler AA, 2019, JAMA-J AM MED ASSOC, V322, P1261, DOI 10.1001/jama.2019.11825
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   GODET M, 1992, VIROLOGY, V188, P666, DOI 10.1016/0042-6822(92)90521-P
   Goh KJ, 2020, ANN ACAD MED SINGAP, V49, P108
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Haines A, 2020, LANCET, V395, P1173, DOI 10.1016/S0140-6736(20)30735-2
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Hoek L. van der, 2004, Nature Medicine, V10, P368, DOI 10.1038/nm1024
   Jia L, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1100-x
   Karakike E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00055
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Lin C, 2020, CLIN IMAG, V63, P7, DOI 10.1016/j.clinimag.2020.02.008
   Lin Y, 2003, CELL RES, V13, P141, DOI 10.1038/sj.cr.7290158
   Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Mahevas M, 2020, NO EVIDENCE CLIN EFF, P369, DOI [10.1101/2020.04.10.20060699, DOI 10.1101/2020.04.10.20060699]
   Malik YS, 2020, VET QUART, V40, P68, DOI 10.1080/01652176.2020.1727993
   Malta M, 2020, ECLINICALMEDICINE, V20, DOI 10.1016/j.eclinm.2020.100289
   Matthay MA, 2020, LANCET RESP MED, V8, P433, DOI 10.1016/S2213-2600(20)30127-2
   MCINTOSH K, 1967, P NATL ACAD SCI USA, V58, P2268, DOI 10.1073/pnas.58.6.2268
   McNicholl JM, 1997, EMERG INFECT DIS, V3, P261, DOI 10.3201/eid0303.970302
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Meo SA, 2020, EUR REV MED PHARMACO, V24, P2012, DOI 10.26355/eurrev_202002_20379
   Mitja O, 2020, LANCET GLOB HEALTH, V8, pE639, DOI 10.1016/S2214-109X(20)30114-5
   Peckham R, 2020, LANCET, V395, P850, DOI 10.1016/S0140-6736(20)30468-2
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Porcheddu R, 2020, J INFECT DEV COUNTR, V14, P125, DOI 10.3855/jidc.12600
   Raoult D, 2020, CELL STRESS, V4, P66, DOI 10.15698/cst2020.04.216
   Rodriguez-Morales Alfonso J, 2020, Travel Med Infect Dis, V34, P101623, DOI 10.1016/j.tmaid.2020.101623
   Sahu P, 2020, CUREUS, V12, DOI 10.7759/cureus.7541
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6
   Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P139, DOI 10.3760/cma.j.issn.0254-6450.2020.02.002
   Tang B, 2020, INFECT DIS MODEL, V5, P248, DOI 10.1016/j.idm.2020.02.001
   van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wang TB, 2020, LANCET, V395, pE52, DOI 10.1016/S0140-6736(20)30558-4
   Wang YXJ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.71
   Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005
   Wilson N, 2020, EMERG INFECT DIS, V26, P1339, DOI 10.3201/eid2606.200320
   Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Wujtewicz MA, 2020, ANAESTH INTENSIVE TH, V52, P34, DOI 10.5114/ait.2020.93756
   Xia W, 2020, PEDIATR PULM, V55, P1169, DOI 10.1002/ppul.24718
   Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]
   Xu JB, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020244
   Xu Kaijin, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P147, DOI 10.3785/j.issn.1008-9292.2020.02.02
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang JC, 2020, J MED VIROL, V92, P680, DOI 10.1002/jmv.25742
   Zhang M, 2020, CLIN INFECT DIS
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737
NR 79
TC 57
Z9 59
U1 5
U2 10
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0032-5473
EI 1469-0756
J9 POSTGRAD MED J
JI Postgrad. Med. J.
PD DEC
PY 2020
VL 96
IS 1142
BP 753
EP 758
DI 10.1136/postgradmedj-2020-138234
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PR5IB
UT WOS:000607269100007
PM 32563999
DA 2022-04-20
ER

PT J
AU Jordan, E
   Shin, DE
   Leekha, S
   Azarm, S
AF Jordan, Elizabeth
   Shin, Delia E.
   Leekha, Surbhi
   Azarm, Shapour
TI Optimization in the Context of COVID-19 Prediction and Control: A
   Literature Review
SO IEEE ACCESS
LA English
DT Review
DE COVID-19; Optimization; Pandemics; Vaccines; Coronaviruses; Predictive
   models; Hospitals; Optimization; COVID-19; decision support; screening
   testing; prediction; prevention; control; resource allocation;
   vaccination; literature review
ID PARTICLE SWARM OPTIMIZATION; MODEL; ALGORITHM; DISEASE; TRANSMISSION;
   ALLOCATION; POLICIES; DYNAMICS; OUTBREAK; VACCINE
AB This paper presents an overview of some key results from a body of optimization studies that are specifically related to COVID-19, as reported in the literature during 2020-2021. As shown in this paper, optimization studies in the context of COVID-19 have been used for many aspects of the pandemic. From these studies, it is observed that since COVID-19 is a multifaceted problem, it cannot be studied from a single perspective or framework, and neither can the related optimization models. Four new and different frameworks are proposed that capture the essence of analyzing COVID-19 (or any pandemic for that matter) and the relevant optimization models. These are: (i) microscale vs. macroscale perspective; (ii) early stages vs. later stages perspective; (iii) aspects with direct vs. indirect relationship to COVID-19; and (iv) compartmentalized perspective. To limit the scope of the review, only optimization studies related to the prediction and control of COVID-19 are considered (public health focused), and which utilize formal optimization techniques or machine learning approaches. In this context and to the best of our knowledge, this survey paper is the first in the literature with a focus on the prediction and control related optimization studies. These studies include optimization of screening testing strategies, prediction, prevention and control, resource management, vaccination prioritization, and decision support tools. Upon reviewing the literature, this paper identifies current gaps and major challenges that hinder the closure of these gaps and provides some insights into future research directions.
C1 [Jordan, Elizabeth; Shin, Delia E.; Azarm, Shapour] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.
   [Leekha, Surbhi] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.
RP Jordan, E (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.
EM ejordan3@umd.edu
OI Azarm, Shapour/0000-0001-5248-6266; Jordan,
   Elizabeth/0000-0002-8773-0203
CR Abbasimehr H, 2021, CHAOS SOLITON FRACT, V142, DOI 10.1016/j.chaos.2020.110511
   Abdel-Basset M, 2020, IEEE ACCESS, V8, P79521, DOI 10.1109/ACCESS.2020.2990893
   AbdelAziz AM, 2021, ALGORITHMS, V14, DOI 10.3390/a14020038
   Abou-Ismail Anas, 2020, SN Compr Clin Med, V2, P852, DOI 10.1007/s42399-020-00330-z
   Abry P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237901
   Ahmed HM, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9060659
   Ahmed I, 2021, RESULTS PHYS, V21, DOI 10.1016/j.rinp.2020.103776
   Al-Betar MA, 2021, NEURAL COMPUT APPL, V33, P5011, DOI 10.1007/s00521-020-05296-6
   Al-qaness MAA, 2021, PROCESS SAF ENVIRON, V149, P399, DOI 10.1016/j.psep.2020.11.007
   Al-qaness MAA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030674
   Albahri OS, 2020, J INFECT PUBLIC HEAL, V13, P1381, DOI 10.1016/j.jiph.2020.06.028
   Firmino PRA, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110211
   Anam S, 2021, APPL COMPUT INTELL S, V2021, DOI 10.1155/2021/6658552
   Andelic N, 2021, HEALTH INFORM J, V27, DOI 10.1177/1460458220976728
   Ankamah JDG, 2021, COMMUN MATH BIOL NEU, DOI 10.28919/cmbn/5095
   Aragon-Caqueo D, 2020, J MED VIROL, V92, P1988, DOI 10.1002/jmv.25929
   Arango M., ARXIV200904647
   Arora J., 2004, INTRO OPTIMUM DESIGN, VSecond
   Arora R, 2021, J INTERDISCIP MATH, V24, P227, DOI 10.1080/09720502.2020.1840075
   Asgary A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010268
   Asgary A, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8040469
   Bairagi AK, 2020, IEEE ACCESS, V8, P215570, DOI 10.1109/ACCESS.2020.3040821
   Bazaraa M.S., 1993, NONLINEAR PROGRAMMIN
   Behnood A, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110051
   Belciug S, 2020, ADV ELECTR COMPUT EN, V20, P23, DOI 10.4316/AECE.2020.03003
   Benneyan James C, 2020, medRxiv, DOI 10.1101/2020.08.29.20184366
   Bertozzi AL, 2020, P NATL ACAD SCI USA, V117, P16732, DOI 10.1073/pnas.2006520117
   Bertsimas D, 2022, NAV RES LOG, V69, P179, DOI 10.1002/nav.22007
   Blank F, 2021, J HUMANIT LOGIST SUP, V11, P296, DOI 10.1108/JHLSCM-07-2020-0058
   Bliman PA, 2021, J THEOR BIOL, V511, DOI 10.1016/j.jtbi.2020.110557
   Bokharaie VS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247439
   Brandao MP, 2021, NONLINEAR DYNAM, V104, P2961, DOI 10.1007/s11071-021-06361-y
   Brodeur A, 2021, J ECON SURV, V35, P1007, DOI 10.1111/joes.12423
   Burgess LH, 2020, J PHARM PRACT, DOI 10.1177/0897190020961655
   Calafiore GC, 2020, ANNU REV CONTROL, V50, P361, DOI 10.1016/j.arcontrol.2020.10.005
   Cetin E, 2020, EUR J PURE APPL MATH, V13, P369, DOI 10.29020/nybg.ejpam.v13i2.3700
   Ceylan Z, 2021, APPL SOFT COMPUT, V109, DOI 10.1016/j.asoc.2021.107592
   Chander S, 2020, BIO-ALGORITHMS MED-S, V16, DOI 10.1515/bams-2020-0030
   Chen V. C. P., 2020, OPTIMIZATION FRAMEWO, DOI [10.1101/2020.07.16.20152033, DOI 10.1101/2020.07.16.20152033]
   Cheng CH, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01281-0
   Choi W, 2021, J THEOR BIOL, V512, DOI 10.1016/j.jtbi.2020.110568
   Comunian A, 2020, PHYSICA D, V413, DOI 10.1016/j.physd.2020.132674
   Costa ML, 2021, SYST REV-LONDON, V10, DOI 10.1186/s13643-021-01603-x
   Cristian L, 2020, INT C INTELL COMP CO, P123, DOI 10.1109/ICCP51029.2020.9266155
   Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
   Cuevas-Maraver J, 2021, MATH BIOSCI, V336, DOI 10.1016/j.mbs.2021.108590
   Currie CSM, 2020, J SIMUL, V14, P83, DOI 10.1080/17477778.2020.1751570
   Demertzis K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134693
   Devaraj J, 2021, RESULTS PHYS, V21, DOI 10.1016/j.rinp.2021.103817
   Dhamodharavadhani S, 2021, J CASES INF TECHNOL, V23, P1, DOI 10.4018/JCIT.20211001.oa1
   Dhiman G, 2021, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2021.1875049
   Dua A, 2021, J VASC SURG-VENOUS L, V9, P299, DOI 10.1016/j.jvsv.2020.08.005
   Duan JL, 2021, RISK MANAG HEALTHC P, V14, P541, DOI 10.2147/RMHP.S291441
   Duque D, 2020, P NATL ACAD SCI USA, V117, P19873, DOI 10.1073/pnas.2009033117
   El Hajj H, 2022, NAV RES LOG, V69, P3, DOI 10.1002/nav.21985
   El-kenawy ESM, 2020, IEEE ACCESS, V8, P179317, DOI 10.1109/ACCESS.2020.3028012
   Elaziz MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235187
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Fang YQ, 2020, J MED VIROL, V92, P645, DOI 10.1002/jmv.25750
   Farkas C, 2021, PEERJ, V9, DOI 10.7717/peerj.10790
   Fenga L, 2021, J PROBAB STAT, V2021, DOI 10.1155/2021/1235973
   Ferchiou A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.606371
   Fleming N, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14509
   Fokas AS, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110244
   Fokas AS, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2020.0494
   Frej EA, 2021, COMPUT MATH METHOD M, V2021, DOI 10.1155/2021/8853787
   Friji H, 2021, IEEE ACCESS, V9, P13266, DOI 10.1109/ACCESS.2021.3051929
   Ghamizi S., ARXIV200607087
   Ghosh S, 2021, IEEE OPEN J SIGNAL P, V2, P248, DOI 10.1109/OJSP.2021.3075913
   Giraldo JH, 2020, IEEE INT WORKS MACH
   Godio A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103535
   Golan Maureen S., 2020, Environment Systems & Decisions, V40, DOI 10.1007/s10669-020-09777-w
   Goodarzian F, 2021, ENG APPL ARTIF INTEL, V100, DOI 10.1016/j.engappai.2021.104188
   Gopal K, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11031138
   Grushka-Cohen H., ARXIV200714805
   Guan LN, 2020, ANNU REV CONTROL, V50, P394, DOI 10.1016/j.arcontrol.2020.09.009
   Guevara C, 2020, IEEE ACCESS, V8, P201925, DOI 10.1109/ACCESS.2020.3036347
   Guler MG, 2020, COMPUT IND ENG, V150, DOI 10.1016/j.cie.2020.106874
   Gupta H, 2021, ELECTRONICS-SWITZ, V10, DOI 10.3390/electronics10020127
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   Zolfani SH, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12060886
   Hassan SA, 2021, CMC-COMPUT MATER CON, V68, P1183, DOI 10.32604/cmc.2021.015514
   He SB, 2020, NONLINEAR DYNAM, V101, P1667, DOI 10.1007/s11071-020-05743-y
   Hernandez-Perez LG, 2021, PROC INTEGR OPTIM, V5, P429, DOI 10.1007/s41660-020-00154-3
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Hezam IM, 2021, CMC-COMPUT MATER CON, V67, P1153, DOI 10.32604/cmc.2021.014710
   Higazy M, 2020, ALEX ENG J, V59, P4719, DOI 10.1016/j.aej.2020.08.034
   Hogan AB, 2021, VACCINE, V39, P2995, DOI 10.1016/j.vaccine.2021.04.002
   Hosseini E, 2020, IEEE J BIOMED HEALTH, V24, P2765, DOI 10.1109/JBHI.2020.3012487
   Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922
   Jadidi M, 2021, SUSTAIN CITIES SOC, V70, DOI 10.1016/j.scs.2021.102886
   James G, 2013, SPRINGER TEXTS STAT, V103, P303, DOI 10.1007/978-1-4614-7138-7_8
   Janes, 2021, OPTIMIZING VACCINE A, DOI [10. 1101/2020.12.31.20249099, DOI 10.1101/2020.12.31.20249099]
   Javaheri T, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00399-3
   Jeong H, 2021, INFECT CHEMOTHER, V53, P118, DOI 10.3947/ic.2021.0005
   Jiloha RC, 2020, EPIDEMIOLOGY INTERNA, V5, P7, DOI DOI 10.24321/2455.7048.202002
   Kakodkar P, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7560
   Karaarslan E., DATA SCI COVID 19, V2021, P25
   Karatza E., 2021, XENOBIOTICA, V51, P127, DOI [10.1080/00498254.2020.1824301, DOI 10.1080/00498254.2020.1746981]
   Khalilpourazari S, 2021, EXPERT SYST APPL, V177, DOI 10.1016/j.eswa.2021.114920
   Khalilpourazari S, 2021, ANN OPER RES, DOI 10.1007/s10479-020-03871-7
   Khan YA, 2020, COMPUT METH PROG BIO, V197, DOI 10.1016/j.cmpb.2020.105704
   Kompella V., ARXIV201010560
   Kouznetsov VV, 2020, EUR J MED CHEM, V203, DOI 10.1016/j.ejmech.2020.112647
   Lacasa L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241027
   Lampariello L, 2021, OPER RES HEALTH CARE, V28, DOI 10.1016/j.orhc.2021.100287
   Li KQ, 2020, IEEE OPEN J COMP SOC, V1, P276, DOI 10.1109/OJCS.2020.3036581
   Li LL, 2021, AM J OTOLARYNG, V42, DOI 10.1016/j.amjoto.2020.102777
   Libotte GB, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105664
   Ling HF, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9020126
   Liu Chenzhengyi, 2020, J Shanghai Jiaotong Univ Sci, V25, P165, DOI 10.1007/s12204-020-2170-7
   LOBATO F. S., 2021, Trends Comput. Appl. Math., V22, P91, DOI 10.5540/tcam.2021.022.01.00091
   Lobato FS, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/9214159
   Lu HF, 2021, ENERGY, V219, DOI 10.1016/j.energy.2020.119568
   Lu X, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02914-6
   Makade RG, 2020, INFECT DIS MODEL, V5, P772, DOI 10.1016/j.idm.2020.09.003
   Malik Arti, 2022, Mater Today Proc, V49, P3265, DOI 10.1016/j.matpr.2020.12.918
   Martinez-Alvarez F, 2020, BIG DATA-US, V8, P308, DOI 10.1089/big.2020.0051
   Martonosi SE, 2021, OMEGA-INT J MANAGE S, V103, DOI 10.1016/j.omega.2021.102451
   Matrajt L, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf1374
   Mehrotra S, 2020, NAV RES LOG, V67, P303, DOI 10.1002/nav.21905
   Melin P, 2021, SOFT COMPUT, DOI 10.1007/s00500-020-05549-5
   Melin P, 2020, SOFT COMPUT, DOI 10.1007/s00500-020-05452-z
   Miikkulainen R, 2021, IEEE T EVOLUT COMPUT, V25, P386, DOI 10.1109/TEVC.2021.3063217
   Minoza J. M. A., ARXIV210111400
   Mokhtari A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92000-w
   Morato Marcelo M, 2020, ISA Trans, DOI 10.1016/j.isatra.2020.12.012
   Morato MM, 2020, ANNU REV CONTROL, V50, P417, DOI 10.1016/j.arcontrol.2020.07.001
   Munguia-Lopez AD, 2021, PROC INTEGR OPTIM, V5, P3, DOI 10.1007/s41660-020-00141-8
   Nabi KN, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110046
   Nagurney A, 2021, INT J PROD ECON, V235, DOI 10.1016/j.ijpe.2021.108080
   Nah K, 2020, EUR J PURE APPL MATH, V13, P710, DOI 10.29020/nybg.ejpam.v13i3.3792
   Naraigh LO, 2020, MATH BIOSCI, V330, DOI 10.1016/j.mbs.2020.108496
   Nayak SR, 2021, BIOMED SIGNAL PROCES, V64, DOI 10.1016/j.bspc.2020.102365
   Nenchev V, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.110139
   Neto OP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20687-y
   Ng Ming-Yen, 2020, Radiol Cardiothorac Imaging, V2, pe200034, DOI 10.1148/ryct.2020200034
   Niu YT, 2021, QUANT IMAG MED SURG, V11, P380, DOI 10.21037/qims-20-603
   Onari MA, 2021, COMPLEX INTELL SYST, V7, P2037, DOI 10.1007/s40747-021-00312-1
   Ortiz-Prado E, 2020, DIAGN MICR INFEC DIS, V98, DOI 10.1016/j.diagmicrobio.2020.115094
   Pacheco J, 2020, J HEURISTICS, V26, P619, DOI 10.1007/s10732-020-09456-8
   Paggi M, 2020, PHYSICS-BASEL, V2, P368, DOI 10.3390/physics2030020
   Paiva HM, 2021, APPL SOFT COMPUT, V105, DOI 10.1016/j.asoc.2021.107289
   Papalambros P.Y., 2000, PRINCIPLES OPTIMAL D
   Patricio A, 2021, J MED INTERNET RES, V23, DOI 10.2196/26075
   Pekpe KM, 2022, APPL INTELL, V52, P71, DOI 10.1007/s10489-021-02379-2
   Petrovic N, 2020, 2020 55TH INTERNATIONAL SCIENTIFIC CONFERENCE ON INFORMATION, COMMUNICATION AND ENERGY SYSTEMS AND TECHNOLOGIES (IEEE ICEST 2020), P23, DOI 10.1109/ICEST49890.2020.9232908
   Pinzon R. T., 2020, TROP MED HEALTH, V48, DOI [10.1186/ s41182- 020- 00277-w, DOI 10.1186/s41182-020-00277-w]
   Pirouz B, 2020, INFORMATION, V11, DOI 10.3390/info11090454
   Prinzi A., SCREENING VERSUS DIA
   Quaranta G, 2020, NONLINEAR DYNAM, V101, P1583, DOI 10.1007/s11071-020-05902-1
   Queiroz MM, 2020, ANN OPER RES, DOI 10.1007/s10479-020-03685-7
   Rahimi I, 2021, INFORMATION, V12, DOI 10.3390/info12030109
   Rastegar M, 2021, VACCINE, V39, P495, DOI 10.1016/j.vaccine.2020.12.022
   Raval A., P 8 ACM IKDD CODS 26, P432
   Rawson T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00262
   Risanger S, 2021, HEALTH CARE MANAG SC, V24, P330, DOI 10.1007/s10729-020-09538-w
   Roy S, 2021, IEEE ACCESS, V9, P15110, DOI 10.1109/ACCESS.2021.3053268
   Ruf M., HLTH KNOWLEDGE
   Runvik H, 2020, IFAC PAPERSONLINE, V53, P839, DOI [10.1016/j.ifaco1.2021.04.178, 10.1016/j.ifacol.2021.04.178]
   Russell D, 2022, MARIT ECON LOGIST, V24, P92, DOI 10.1057/s41278-020-00168-1
   Russo L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240649
   Salarpour M, 2021, INT J PROD ECON, V236, DOI 10.1016/j.ijpe.2021.108074
   Santini A, 2021, OMEGA-INT J MANAGE S, V102, DOI 10.1016/j.omega.2020.102341
   Sarma U., 2020, COUNTRY SPECIFIC OPT, DOI [10.1101/2020.05.20.20107169, DOI 10.1101/2020.05.20.20107169]
   Schwab P, 2020, J MED INTERNET RES, V22, DOI 10.2196/21439
   Sharma GD, 2020, MATH PROBL ENG, V2020, DOI 10.1155/2020/1479507
   Sharma RR, 2021, IEEE T INSTRUM MEAS, V70, DOI 10.1109/TIM.2020.3041833
   Shim E, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040591
   Sra S, 2012, OPTIMIZATION FOR MACHINE LEARNING, P1
   Srivastava A., ARXIV200709780
   Sun F., 2021, J PHYS C SER, V1815, DOI [10.1088/1742- 6596/1815/1/012033, DOI 10.1088/1742-6596/1815/1/012033]
   Sun JC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78084-w
   Sun SL, 2020, IEEE T CYBERNETICS, V50, P3668, DOI 10.1109/TCYB.2019.2950779
   Tayarani M.-H., 2021, CHAOS SOLITON FRACT, V142, DOI [10.1016/j.chaos.2020.110338, DOI 10.1016/j.chaos.2020.110338]
   Themans P, 2020, EUR J DRUG METAB PH, V45, P703, DOI 10.1007/s13318-020-00648-y
   Theodoridis S., 2020, MACHINE LEARNING BAY, V2
   Do TD, 2021, PEERJ, V9, DOI 10.7717/peerj.10806
   Tsiotas D, 2020, PHYSICS-BASEL, V2, P325, DOI 10.3390/physics2020017
   Tsuchida N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77468-2
   Tutsoy O, 2020, IEEE ACCESS, V8, P225272, DOI 10.1109/ACCESS.2020.3044929
   Umar M, 2021, ALEX ENG J, V60, P2811, DOI 10.1016/j.aej.2021.01.043
   Van Pelt A, 2021, J ADOLESCENT HEALTH, V68, P28, DOI 10.1016/j.jadohealth.2020.09.038
   Wang CY, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.00383
   Wang Q, 2020, EMERG MICROBES INFEC, V9, P2358, DOI 10.1080/22221751.2020.1837016
   Wang Z, 2020, COMPUT MECH, V66, P1153, DOI 10.1007/s00466-020-01894-2
   WHO Checklist for In, 2005, INFL PAND PREP PLANN
   Wulkow H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249676
   Xue L, 2020, MATH BIOSCI, V326, DOI 10.1016/j.mbs.2020.108391
   Yaesoubi R, 2021, MED DECIS MAKING, V41, P386, DOI 10.1177/0272989X21990371
   Yan Y, 2021, COMPLEX INTELL SYST, DOI 10.1007/s40747-021-00290-4
   Yu H., RES SQUARE, DOI [10.21203/rs.3.rs-257573/v1, DOI 10.21203/RS.3.RS-257573/V1]
   Zaliskyi M, 2020, CEUR WORKSHOP PROCEE, V2753
   Zebrowski AM, 2020, ANN EMERG MED, V76, pS1
   Zhan CJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241171
   Zhan CJ, 2021, NEURAL COMPUT APPL, V33, P4915, DOI 10.1007/s00521-020-05285-9
   Zheng YJ, 2020, IEEE COMPUT INTELL M, V15, P62, DOI 10.1109/MCI.2020.3019899
   Zhu HJ, 2021, APPL MATH MODEL, V89, P1983, DOI 10.1016/j.apm.2020.08.056
   Zork NM, 2020, SEMIN PERINATOL, V44, DOI 10.1016/j.semperi.2020.151300
   Zreiq R, 2020, AIMS PUBLIC HEALTH, V7, P828, DOI 10.3934/publichealth.2020064
NR 200
TC 3
Z9 3
U1 17
U2 21
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 2169-3536
J9 IEEE ACCESS
JI IEEE Access
PY 2021
VL 9
BP 130072
EP 130093
DI 10.1109/ACCESS.2021.3113812
PG 22
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Engineering; Telecommunications
GA UY0TF
UT WOS:000701245200001
OA gold
DA 2022-04-20
ER

PT J
AU Nayak, J
   Naik, B
   Dinesh, P
   Vakula, K
   Rao, BK
   Ding, WP
   Pelusi, D
AF Nayak, Janmenjoy
   Naik, Bighnaraj
   Dinesh, Paidi
   Vakula, Kanithi
   Rao, B. Kameswara
   Ding, Weiping
   Pelusi, Danilo
TI Intelligent system for COVID-19 prognosis: a state-of-the-art survey
SO APPLIED INTELLIGENCE
LA English
DT Article
DE COVID-19; Machine learning; Deep learning; Mathematical model;
   Intelligent system
ID ARTIFICIAL-INTELLIGENCE; CORONAVIRUS; SEGMENTATION; DIAGNOSIS; ACCURATE;
   DISEASES
AB This 21st century is notable for experiencing so many disturbances at economic, social, cultural, and political levels in the entire world. The outbreak of novel corona virus 2019 (COVID-19) has been treated as a Public Health crisis of global Concern by the World Health Organization (WHO). Various outbreak models for COVID-19 are being utilized by researchers throughout the world to get well-versed decisions and impose significant control measures. Amid the standard methods for COVID-19 worldwide epidemic prediction, easy statistical, as well as epidemiological methods have got more consideration by researchers and authorities. One main difficulty in controlling the spreading of COVID-19 is the inadequacy and lack of medical tests for detecting as well as identifying a solution. To solve this problem, a few statistical-based advances are being enhanced and turn into a partial resolution up-to some level. To deal with the challenges of the medical field, a broad range of intelligent based methods, frameworks, and equipment have been recommended by Machine Learning (ML) and Deep Learning. As ML and DL have the ability of identifying and predicting patterns in complex large datasets, they are recognized as a suitable procedure for producing effective solutions for the diagnosis of COVID-19. In this paper, a perspective research has been conducted in the applicability of intelligent systems such as ML, DL and others in solving COVID-19 related outbreak issues. The main intention behind this study is (i) to understand the importance of intelligent approaches such as ML and DL for COVID-19 pandemic, (ii) discussing the efficiency and impact of these methods in the prognosis of COVID-19, (iii) the growth in the development of type of ML and advanced ML methods for COVID-19 prognosis,(iv) analyzing the impact of data types and the nature of data along with challenges in processing the data for COVID-19,(v) to focus on some future challenges in COVID-19 prognosis to inspire the researchers for innovating and enhancing their knowledge and research on other impacted sectors due to COVID-19.
C1 [Nayak, Janmenjoy; Rao, B. Kameswara] Aditya Inst Technol & Management AITAM, Dept Comp Sci & Engn, Tekkali 532201, AP, India.
   [Naik, Bighnaraj] Veer Surendra Sai Univ Technol, Dept Comp Applicat, Burla 768018, Odisha, India.
   [Dinesh, Paidi; Vakula, Kanithi] Sri Sivani Coll Engn, Dept Comp Sci & Engn, Srikakulam 532402, AP, India.
   [Ding, Weiping] Nantong Univ, Sch Informat Sci & Technol, Nantong, Peoples R China.
   [Pelusi, Danilo] Univ Teramo, Fac Commun Sci, Coste St 39,Agostino Campus, Teramo, Italy.
RP Naik, B (corresponding author), Veer Surendra Sai Univ Technol, Dept Comp Applicat, Burla 768018, Odisha, India.
EM jnayak.cse@adityatekkali.edu.in; bnaik_mca@vssut.ac.in;
   dinesh.pydi98@gmail.com; vakku.bi@gmail.com; kamesh3410@gmail.com;
   dwp9988@163.com; dpelusi@unite.it
RI Naik, Bighnaraj/A-1212-2016; Rao, Kameswara/ABB-9217-2021
OI Naik, Bighnaraj/0000-0002-9761-8389; p, dinesh/0000-0003-4195-9536; Rao,
   Dr B.Kameswara/0000-0002-2792-2385
CR Ahamad MM, 2020, EXPERT SYST APPL, V160, DOI 10.1016/j.eswa.2020.113661
   Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   Alaa, 2020, ARTIFICIAL INTELLIGE
   Alakus TB, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110120
   Albahri AS, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01582-x
   Alimadadi A, 2020, PHYSIOL GENOMICS, V52, P200, DOI 10.1152/physiolgenomics.00029.2020
   Altan A, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110071
   [Anonymous], 2020, IEEE T MED IMAGING, DOI DOI 10.1109/TMI.2020.2995965
   Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4
   Apostolopoulos ID, 2020, J MED BIOL ENG, V40, P462, DOI 10.1007/s40846-020-00529-4
   Ardabili S.F., 2020, COVID 19 OUTBREAK PR, V13, DOI [10.1101/2020.04.17.20070094, DOI 10.1101/2020.04.17.20070094]
   Ardakani AA, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103795
   Arora P, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110017
   Assaf D, 2020, INTERN EMERG MED, V15, P1435, DOI 10.1007/s11739-020-02475-0
   Ayyoubzadeh SM, 2020, JMIR PUBLIC HLTH SUR, V6, P192, DOI 10.2196/18828
   Banerjee A, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106705
   Behera S. K., 2020, DETECTION CORONAVIRU, DOI 10.20944/preprints202003.0300.v1
   Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50
   Bentez-Pena S, 2020, SHORT TERM PREDICTIO
   Brinati D, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01597-4
   Brunese L, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105608
   Burdick H, 2020, COMPUT BIOL MED, V124, DOI 10.1016/j.compbiomed.2020.103949
   Butt C, 2020, APPL INTELL, DOI 10.1007/s10489-020-01714-3
   Cao Yukun, 2020, Radiol Cardiothorac Imaging, V2, pe200082, DOI 10.1148/ryct.2020200082
   Carrillo-Larco Rodrigo M, 2020, Wellcome Open Res, V5, P56, DOI [10.12688/wellcomeopenres.15819.3, 10.12688/wellcomeopenres.15819.1]
   Catelli R, 2020, APPL SOFT COMPUT, V97, DOI 10.1016/j.asoc.2020.106779
   Chaurasia R, 2020, INT J SCI RES ENG 1, P1
   Cheng FY, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061668
   Chimmula VKR, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109864
   Civit-Masot J, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10134640
   Cohen JP, 2020, COVID 19 IMAGE DATA
   CSSEGISandData, 2020, CSSEGISANDDATA COVID
   De Felice F, 2020, IN VIVO, V34, P1613, DOI 10.21873/invivo.11951
   Debnath Shubham, 2020, Bioelectron Med, V6, P14, DOI 10.1186/s42234-020-00050-8
   Ekins Sean, 2015, F1000Res, V4, P1091, DOI 10.12688/f1000research.7217.3
   El Asnaoui K, 2021, J BIOMOL STRUCT DYN, V39, P3615, DOI 10.1080/07391102.2020.1767212
   Elaziz MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235187
   ESTOLA T, 1970, AVIAN DIS, V14, P330, DOI 10.2307/1588476
   Fan DP, 2020, IEEE T MED IMAGING, V39, P2626, DOI 10.1109/TMI.2020.2996645
   Farid A.A., 2020, INT J SCI ENG RES, V11, P1, DOI [10.14299/ijser.2020.03.02, DOI 10.14299/IJSER.2020.03.02]
   Farooq J, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.110148
   Frazer John Scott, 2020, Journal of Medical Engineering & Technology, V44, DOI 10.1080/03091902.2020.1757772
   Han ZY, 2020, IEEE T MED IMAGING, V39, P2584, DOI 10.1109/TMI.2020.2996256
   Hasan N, 2020, INTERNET THINGS-NETH, V11, DOI 10.1016/j.iot.2020.100228
   Hernandez-Matamoros A, 2020, APPL SOFT COMPUT, V96, DOI 10.1016/j.asoc.2020.106610
   Hu SP, 2020, IEEE ACCESS, V8, P118869, DOI 10.1109/ACCESS.2020.3005510
   Huang Lu, 2020, Radiol Cardiothorac Imaging, V2, pe200075, DOI 10.1148/ryct.2020200075
   Jain G, 2020, BIOCYBERN BIOMED ENG, V40, P1391, DOI 10.1016/j.bbe.2020.08.008
   Jamshidi MB, 2020, IEEE ACCESS, V8, P109581, DOI 10.1109/ACCESS.2020.3001973
   Jayendiran R, 2020, J FLUID STRUCT, V97, DOI 10.1016/j.jfluidstructs.2020.103108
   Kang HY, 2020, IEEE T MED IMAGING, V39, P2606, DOI 10.1109/TMI.2020.2992546
   Kavadi DP, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110056
   KayvanJoo Amir Hossein, 2014, BMC Res Notes, V7, P565, DOI 10.1186/1756-0500-7-565
   Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010
   Khan AI, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105581
   Khanday Akib Mohi Ud Din, 2020, Int J Inf Technol, P1, DOI 10.1007/s41870-020-00495-9
   Klon AE, 2004, J CHEM INF COMP SCI, V44, P2216, DOI 10.1021/ci0497861
   Kwok KO, 2019, COMPUT STRUCT BIOTEC, V17, P186, DOI 10.1016/j.csbj.2019.01.003
   Lalmuanawma S, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110059
   Loey M, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12040651
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Lundervold AS, 2019, Z MED PHYS, V29, P102, DOI 10.1016/j.zemedi.2018.11.002
   Marques G, 2020, APPL SOFT COMPUT, V96, DOI 10.1016/j.asoc.2020.106691
   McCall B, 2020, LANCET DIGIT HEALTH, V2, pE166, DOI 10.1016/S2589-7500(20)30054-6
   McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480
   Minaee S, 2020, MED IMAGE ANAL, V65, DOI 10.1016/j.media.2020.101794
   Narayan Das N, 2022, Ing Rech Biomed, V43, P114, DOI 10.1016/j.irbm.2020.07.001
   Ni QQ, 2020, EUR RADIOL, V30, P6517, DOI 10.1007/s00330-020-07044-9
   Oh Y, 2020, IEEE T MED IMAGING, V39, P2688, DOI 10.1109/TMI.2020.2993291
   Ou SQ, 2020, NAT ENERGY, V5, P666, DOI 10.1038/s41560-020-0662-1
   Ouchicha C, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110245
   Ozturk T, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103792
   Panwar H, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109944
   Pathak Y, 2022, Ing Rech Biomed, V43, P87, DOI 10.1016/j.irbm.2020.05.003
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Peng YH, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110055
   Pereira RM, 2020, COMPUT METH PROG BIO, V194, DOI 10.1016/j.cmpb.2020.105532
   Pinter G, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8060890
   Qjidaa M., 2020, 2020 INT C INT SYST, P1, DOI DOI 10.1109/ISCV49265.2020.9204282
   Rahimzadeh Mohammad, 2020, Inform Med Unlocked, V19, P100360, DOI 10.1016/j.imu.2020.100360
   Rajaraman S, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10060358
   Randhawa GS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232391
   Razzak MI, 2018, L N COMPUT VIS BIOME, V26, P323, DOI 10.1007/978-3-319-65981-7_12
   Roy S, 2020, IEEE T MED IMAGING, V39, P2676, DOI 10.1109/TMI.2020.2994459
   Rustam F, 2020, IEEE ACCESS, V8, P101489, DOI 10.1109/ACCESS.2020.2997311
   Samuel J, 2020, INFORMATION, V11, DOI 10.3390/info11060314
   Santosh K, 2020, TRUNCATED INCEPTION, DOI [10.1007/s13246-020-00888-x, DOI 10.1007/S13246-020-00888-X]
   Schwabe K, 2020, WATER-SUI, V12, DOI 10.3390/w12010233
   Sedik A, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070769
   Sethi R, 2020, P 2020 2 INT C INV R, P1
   Shaban WM, 2020, KNOWL-BASED SYST, V205, DOI 10.1016/j.knosys.2020.106270
   Sharma S, 2020, ENVIRON SCI POLLUT R, V27, P37155, DOI 10.1007/s11356-020-10133-3
   Shi F, 2021, IEEE REV BIOMED ENG, V14, P4, DOI 10.1109/RBME.2020.2987975
   Shi W, 2020, DEEP LEARNING BASED, DOI [10.2139/ssrn.3546089, DOI 10.2139/SSRN.3546089]
   Singh D, 2020, EUR J CLIN MICROBIOL, V39, P1379, DOI 10.1007/s10096-020-03901-z
   Sujath R, 2020, STOCH ENV RES RISK A, V34, P959, DOI [10.1007/s00477-020-01827-8, 10.1007/s00477-020-01843-8]
   Sun CLF, 2020, J AM MED DIR ASSOC, V21, P1533, DOI 10.1016/j.jamda.2020.08.030
   Togacar M, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103805
   Tuli S, 2020, INTERNET THINGS-NETH, V11, DOI 10.1016/j.iot.2020.100222
   Ucar F, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109761
   Uddin MI, 2020, J SENSORS, V2020, DOI 10.1155/2020/8856801
   Vaid S, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.20.00715
   Vaid S, 2020, INT ORTHOP, V44, P1539, DOI 10.1007/s00264-020-04609-7
   Waheed A, 2020, IEEE ACCESS, V8, P91916, DOI 10.1109/ACCESS.2020.2994762
   Wang NW, 2020, IEEE INT CONF ELECTR, P281
   Wang PP, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110058
   World Health Organization, 2020, WHO NOV COR VIR THAI
   Wu XJ, 2020, EUR J RADIOL, V128, DOI 10.1016/j.ejrad.2020.109041
   Xu B, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30119-5
   Yadav M, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110050
   Yadav Ramjeet Singh, 2020, Int J Inf Technol, V12, P1321, DOI 10.1007/s41870-020-00484-y
   Yang WJ, 2020, RADIOLOGY, V295, pE3, DOI 10.1148/radiol.2020200702
   Yoo SH, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00427
   Zame WR, 2020, STAT BIOPHARM RES, V12, P506, DOI 10.1080/19466315.2020.1797867
   Zeng XX, 2020, J PROTEOME RES, V19, P4624, DOI 10.1021/acs.jproteome.0c00316
   Zeroual A, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110121
   Zhang HT, 2020, EUR J NUCL MED MOL I, V47, P2525, DOI 10.1007/s00259-020-04953-1
   Zhang HP, 2020, INTERDISCIP SCI, V12, P368, DOI 10.1007/s12539-020-00376-6
   Zhavoronkov A, 2020, POTENTIAL COVID 2019, DOI 10.26434/chemrxiv.11829102.v2
   Zhong LH, 2020, IEEE ACCESS, V8, P51761, DOI 10.1109/ACCESS.2020.2979599
   Zhou LX, 2020, IEEE T MED IMAGING, V39, P2638, DOI 10.1109/TMI.2020.3001810
NR 121
TC 8
Z9 8
U1 1
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0924-669X
EI 1573-7497
J9 APPL INTELL
JI Appl. Intell.
PD MAY
PY 2021
VL 51
IS 5
SI SI
BP 2908
EP 2938
DI 10.1007/s10489-020-02102-7
EA JAN 2021
PG 31
WC Computer Science, Artificial Intelligence
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA RW6ZK
UT WOS:000605561600008
PM 34764577
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Herrera, MRG
   Hernandez, JAA
   Herrera, LDA
   Legarreta, JML
AF Gonzalez Herrera, Manuel Ramon
   Alvarez Hernandez, Julian Alberto
   Azpeitia Herrera, Luis Daniel
   Lerma Legarreta, Jose Manuel
TI RESPONSE TO THE CRISIS GENERATED BY THE COVID-19 PANDEMIC IN TOURISM.
   FROM THE GLOBAL TO THE LOCAL: CIUDAD JUAREZ (MEXICO)
SO TURISMO-ESTUDOS E PRATICAS
LA Spanish
DT Article
DE COVID-19; coronavirus; crisis; tourism; management
AB Changes as a consequence of the crisis generated by the COVID-19 are causing a critical problem at the global level. Therefore, the aim of this research is to promote knowledge about the current crisis in tourism and provide tools and strategies that facilitate the search for answers and recovery-oriented options. This is a qualitative, exploratory and propositional research study based on which, empirical and theoretical methods were used; the main source for obtaining primary data was interviews, and secondary data was obtained through documentary research. As a result of this study, a conceptual theoretical framework for understanding crisis in tourism is recommended, and a conceptual model for the management of this crisis in tourism is proposed, based on a process that integrates risks and crises. Finally, a methodological management scheme to implement in Juarez City is suggested. It concludes by highlighting the value of research, education and the culture of preparedness to face these pandemics.
C1 [Gonzalez Herrera, Manuel Ramon; Alvarez Hernandez, Julian Alberto; Azpeitia Herrera, Luis Daniel; Lerma Legarreta, Jose Manuel] Univ Autonoma Ciudad Juarez, Inst Ciencias Sociales & Adm, Dept Ciencias Adm, Escuela Turismo, Ciudad Juarez, Chihuahua, Mexico.
RP Herrera, MRG (corresponding author), Univ Autonoma Ciudad Juarez, Inst Ciencias Sociales & Adm, Dept Ciencias Adm, Escuela Turismo, Ciudad Juarez, Chihuahua, Mexico.
EM manuel.gonzalez@uacj.mx; jualvare@uacj.mx; daniel.azpeitia@uacj.mx;
   lic_mlerma@hotmail.com
CR Aguilar Karina, 2020, MSN NOTICIAS
   AKTAS G, 2005, GLOBAL TOURISM, P00440
   [Anonymous], 2020, BBC NEWS MUNDO
   Banco Interamericano de Desarrollo (BID), 2020, GRUP BID RESP COVID
   Cardenas Yuriana, 2020, PERIODICO OMNIA
   CDC, 2020, ENFERMEDAD CORONAVIR
   Cutter SL, 2015, NATURE, V522, P277, DOI 10.1038/522277a
   IDB, 2020, COVID 19 SIT UPD
   Lopez-Gatell Hugo, 2020, MSN NOTICIAS
   Mancinas Ibeth, 2020, PERIODICO UNIVERSAL
   Ministerio de Industria Comercio y Turismo Gobierno de Espana, 2020, COVID 19 GUIA BUEN P
   Ministerio de Sanidad Consumo y Bienestar Social de Espana, 2020, INF COR
   Ministerio de Sanidad Gobierno de Espana, 2020, ENF NUEV COR COVID 1
   Mitroff Ian, 2002, COMO GESTIONAR CRISI
   MSN Noticias, 2020, MSN NOTICIAS PROVIST
   Muñiz Diego Rodríguez-Toubes, 2010, Encontros Científicos, P49
   Nuguer Victoria, 2020, BANCO INTERAMERICANO
   Organizacion Mundial de la Salud -OMS, 2020, PREG RESP SOBR ENF C
   Organizacion Mundial del Turismo-OMT, 2020, TOUR COVID 19
   Pennington-Gray L., 2011, International Journal of Safety and Security in Tourism/Hospitality, V1, P64
   Pennington-Gray L, 2013, NAT HAZARDS, V66, P77, DOI 10.1007/s11069-012-0101-0
   Redaccion El Pulso Laboral, 2020, PULSO LABORAL
   Redaccion Gestion, 2020, REDACCION GESTION
   Responsible Tourism Institute -RTI, 2020, BIOSPHERECORONAVIRUS
   Rodriguez-Toubes Muniz D., 2010, REV ENCONTROS CIENTI, V6
   Muniz DRT, 2011, PASOS, V9, P279, DOI 10.25145/j.pasos.2011.09.025
   Secretaria de Salud Gobierno de Mexico, 2020, COVID 19 FASE 2
   Sharpley R., 2005, The management of tourism, P275
   Sosa Luz del Carmen, 2020, EL DIARIO
   Strielkowski W., 2020, INT TOURISM COVID 19, DOI [10.20944/PREPRINTS202003.0445.V1, DOI 10.20944/PREPRINTS202003.0445.V1]
   TRINET, 2020, IN TRIN RESP COVID 1
   UNWTO, 2020, IMP ASS COVID 19 OUT
   Villegas J, 2013, NAT HAZARDS, V66, P97, DOI 10.1007/s11069-012-0119-3
   WILKS J, 2003, TOURISM RISK MANAGEM
NR 34
TC 0
Z9 0
U1 0
U2 4
PU UNIV ESTADO RIO GRANDE NORTE
PI MOSSORO
PA RUA ANTONIO VICTOR 116, BAIRRO RINCAO, MOSSORO, RN CEP59626-310, BRAZIL
SN 2316-1493
J9 TURISMO
JI Turismo
PD JUL-DEC
PY 2020
VL 9
IS 2
PG 23
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA NE5ZS
UT WOS:000562679900016
DA 2022-04-20
ER

PT J
AU van der Schaar, M
   Alaa, AM
   Floto, A
   Gimson, A
   Scholtes, S
   Wood, A
   McKinney, E
   Jarrett, D
   Lio, P
   Ercole, A
AF van der Schaar, Mihaela
   Alaa, Ahmed M.
   Floto, Andres
   Gimson, Alexander
   Scholtes, Stefan
   Wood, Angela
   McKinney, Eoin
   Jarrett, Daniel
   Lio, Pietro
   Ercole, Ari
TI How artificial intelligence and machine learning can help healthcare
   systems respond to COVID-19
SO MACHINE LEARNING
LA English
DT Article
DE Clinical decision support; Healthcare; COVID-19
AB The COVID-19 global pandemic is a threat not only to the health of millions of individuals, but also to the stability of infrastructure and economies around the world. The disease will inevitably place an overwhelming burden on healthcare systems that cannot be effectively dealt with by existing facilities or responses based on conventional approaches. We believe that a rigorous clinical and societal response can only be mounted by using intelligence derived from a variety of data sources to better utilize scarce healthcare resources, provide personalized patient management plans, inform policy, and expedite clinical trials. In this paper, we introduce five of the most important challenges in responding to COVID-19 and show how each of them can be addressed by recent developments in machine learning (ML) and artificial intelligence (AI). We argue that the integration of these techniques into local, national, and international healthcare systems will save lives, and propose specific methods by which implementation can happen swiftly and efficiently. We offer to extend these resources and knowledge to assist policymakers seeking to implement these techniques.
C1 [van der Schaar, Mihaela; Floto, Andres; Scholtes, Stefan; Wood, Angela; McKinney, Eoin; Jarrett, Daniel; Lio, Pietro; Ercole, Ari] Univ Cambridge, Cambridge, England.
   [van der Schaar, Mihaela; Alaa, Ahmed M.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA.
   [Gimson, Alexander; Ercole, Ari] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England.
RP van der Schaar, M (corresponding author), Univ Cambridge, Cambridge, England.; van der Schaar, M (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.
EM mv472@cam.ac.uk
RI Ercole, Ari/B-6288-2009; P. Lió, Pietro Lio/AAV-3358-2021
OI Ercole, Ari/0000-0001-8350-8093; P. Lió, Pietro Lio/0000-0002-0540-5053
FU British Heart FoundationBritish Heart Foundation [SP/18/3/33801] Funding
   Source: Medline
CR Alaa AM, 2018, IEEE T NETW SCI ENG, V5, P14, DOI 10.1109/TNSE.2017.2729782
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5
   Dave C., 2020, BUILDING KNOWLEDGE G
   Ercole, 2020, INTENSIVE CARE MED I, V2020
   Ferguson NM, 2020, REPORT 9 IMPACT NONP, DOI DOI 10.25561/77482
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c
   Hwang S. J, 2018, INT C LEARN REPR ICL
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   van der Schaar, 2018, AUTOPROGNOSIS AUTOMA
   van der Schaar, 2017, NEURIPS 2017
   van der Schaar, 2019, LIFELONG BAYESIAN OP
   van der Schaar, 2017, IEEE T BIO-MED ENG, V2017
   van der Schaar, 2020, INVERSE ACTIVE SENSI
   van der Schaar, 2020, DISCRIMINATIVE JACKK
   van der Schaar, 2020, INT C ART INT STAT A
   van der Schaar, 2020, ESTIMATING COUNTERFA
   van der Schaar, 2019, MACHINE LEARNING HEA
   van der Schaar, 2018, INT C LEARN REPR ICL
   van der Schaar, 2020, UNLABELLED DATA IMPR
   van der Schaar, 2020, FREQUENTIST UNCERTAI
   van der Schaar, 2020, INT C ART INT STAT A
   van der Schaar, 2020, ACM T COMPUTING HEAL, V2020
   van der Schaar, 2019, IEEE T BIOMEDICAL EN, V2019
   van der Schaar, 2020, BATCH INVERSE REINFO
   van der Schaar, 2020, EXPLAINING IMITATING
   van der Schaar M., 2018, 32 AAAI C ART INT AA
   van der Schaar M., 2019, ADV NEURAL INFORM PR, V2019
   van der Schaar M., 2019, INT C ART INT STAT A
   van der Schaar M., 2019, INT C ART INT STAT A
   Xu J, 2015, IEEE J-STSP, V9, P330, DOI 10.1109/JSTSP.2014.2370942
   Yoon J., 2018, GAIN MISSING DATA IM
   Yoon J, 2016, P ICML, P1680
   Yoon J, 2019, IEEE T BIO-MED ENG, V66, P1477, DOI 10.1109/TBME.2018.2874712
   Zame WR, 2020, STAT BIOPHARM RES, V12, P506, DOI 10.1080/19466315.2020.1797867
   Zhang Y., 2020, INT C ART INT STAT A
   Zhengyuan, 2020, J GEN INTERN MED, V2020, P1
   Zhou F., 2020, LANCET
NR 38
TC 20
Z9 20
U1 5
U2 30
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0885-6125
EI 1573-0565
J9 MACH LEARN
JI Mach. Learn.
PD JAN
PY 2021
VL 110
IS 1
BP 1
EP 14
DI 10.1007/s10994-020-05928-x
EA DEC 2020
PG 14
WC Computer Science, Artificial Intelligence
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science
GA PX7PG
UT WOS:000597727000001
PM 33318723
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Basar, EZ
   Sonmez, HE
   Oncel, S
   Yetimakman, AF
   Babaoglu, K
AF Basar, Evic Zeynep
   Sonmez, Hafize Emine
   Oncel, Selim
   Yetimakman, Ayse Filiz
   Babaoglu, Kadir
TI Multisystemic inflammatory syndrome in children associated with
   COVID-19: a single center experience in Turkey
SO TURKISH ARCHIVES OF PEDIATRICS
LA English
DT Article
DE COVID-19; Kawasaki disease; MIS-C; MIS-C associated with COVID-19
ID SARS-COV-2
AB Objective: Multisystem inflammatory syndrome in children (MIS-C) associated with the coronavirus disease 2019 (COVID-19) is a new concern emerging as a severe presentation of COVID-19 in children. We aimed to describe the characteristics and short-term outcomes of children diagnosed with MIS-C.
   Material and Methods: A retrospective study was conducted on 24 patients who were diagnosed with MIS-C between June 1, 2020 and December 1, 2020. A total of 24 (14 male and 10 female) patients were included in the study.
   Results: The median age at the diagnosis was 111 (10-180) months. A total of 17 patients had a history of contact with a patient with COVID-19. Among the 24 patients, the most common findings were gastrointestinal involvement (n=20), followed by conjunctivitis (n=12), erythematous rash (n=11), and oral changes (n=10). Cardiovascular involvement was detected in 12 patients, of whom six had systolic dysfunction, four had mild coronary artery involvement, four had pericardial effusion, and three had mitral insufficiency. All patients received intravenous immunoglobulin, and 14 patients were treated with methylprednisolone in addition. Anti-interleukin-1 was given to two patients. The median duration of hospitalization was 8 (5-15) days. A total of 23 patients were discharged and evaluated on the median of 68.5 (52-140) days after discharge. The remaining one patient with dilated cardiomyopathy died after 2 months in the intensive care unit.
   Conclusion: Increasing the knowledge on MIS-C will provide clinicians with information on early recognition, evaluation, and management of these patients.
C1 [Basar, Evic Zeynep; Babaoglu, Kadir] Kocaeli Univ, Div Cardiol, Dept Pediat, Kocaeli, Turkey.
   [Sonmez, Hafize Emine] Kocaeli Univ, Dept Pediat, Div Rheumatol, Kocaeli, Turkey.
   [Oncel, Selim] Kocaeli Univ, Dept Pediat, Div Infect Dis, Kocaeli, Turkey.
   [Yetimakman, Ayse Filiz] Kocaeli Univ, Dept Pediat, Div Pediat Intens Care Unit, Kocaeli, Turkey.
RP Basar, EZ (corresponding author), Kocaeli Univ, Div Cardiol, Dept Pediat, Kocaeli, Turkey.
EM evicbasar@gmail.com
RI ÖNCEL, Selim/A-7286-2013
OI ÖNCEL, Selim/0000-0002-5493-1818
CR Amirfakhryan H, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.110117
   Belhadjer Z, 2020, CIRCULATION, V142, P2282, DOI 10.1161/CIRCULATIONAHA.120.050147
   Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707
   Cheung EW, 2020, JAMA-J AM MED ASSOC, V324, P294, DOI 10.1001/jama.2020.10374
   Clouser KN, 2021, J PEDIAT INF DIS SOC, V10, P52, DOI 10.1093/jpids/piaa151
   Davies P, 2020, LANCET CHILD ADOLESC, V4, P669, DOI 10.1016/S2352-4642(20)30215-7
   Dolhnikoff M, 2020, LANCET CHILD ADOLESC, V4, P790, DOI 10.1016/S2352-4642(20)30257-1
   Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756
   Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
   Godfred-Cato S, 2020, MMWR-MORBID MORTAL W, V69, P1074, DOI 10.15585/mmwr.mm6932e2
   Haslak F, 2021, TURK ARCH PEDIATR, V56, P3, DOI 10.5152/TurkArchPediatr.2020.20245
   Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1791, DOI 10.1002/art.41454
   Jonat B, 2021, PEDIATR CRIT CARE ME, V22, pe178, DOI 10.1097/PCC.0000000000002598
   Lin JE, 2021, NEUROSCI LETT, V743, DOI 10.1016/j.neulet.2020.135567
   Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
   Matsubara D, 2020, J AM COLL CARDIOL, V76, P1947, DOI 10.1016/j.jacc.2020.08.056
   McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
   Ramcharan T, 2020, PEDIATR CARDIOL, V41, P1391, DOI 10.1007/s00246-020-02391-2
   Ravelli A, 2016, ANN RHEUM DIS, V75, P481, DOI 10.1136/annrheumdis-2015-208982
   Sperotto F, 2021, EUR J PEDIATR, V180, P307, DOI 10.1007/s00431-020-03766-6
   Theocharis P, 2020, EUR HEART J CARDIOVA
   Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002
   Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
NR 24
TC 7
Z9 7
U1 3
U2 3
PU AVES
PI SISLI
PA BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY
EI 2757-6256
J9 TURK ARCH PEDIATR
JI Turk. Arch. Pediatr.
PD MAY
PY 2021
VL 56
IS 3
BP 192
EP +
DI 10.5152/TurkArchPediatr.2021.21018
PG 9
WC Pediatrics
WE Emerging Sources Citation Index (ESCI)
SC Pediatrics
GA SD0HM
UT WOS:000651042900004
PM 34104908
OA Green Published
DA 2022-04-20
ER

PT J
AU Romano-Keeler, J
   Zhang, JL
   Sun, J
AF Romano-Keeler, Joann
   Zhang, Jilei
   Sun, Jun
TI COVID-19 and the neonatal microbiome: will the pandemic cost infants
   their microbes?
SO GUT MICROBES
LA English
DT Editorial Material
DE COVID-19; mother-infant dyad; gut microbiome; newborn health; perinatal
   practice policies
ID CESAREAN-SECTION; HEALTH; IMPACT; DELIVERY
AB Mortality and morbidity from SARS-CoV2 (COVID-19) infections in children remains low, including an exceedingly low rate of horizontal and vertical transmission. However, unforeseen complications to childhood health have emerged secondary to the pandemic. Few studies to date have examined unintended complications of the pandemic in newborns and infants. In this Commentary, we discuss the impact that COVID-19 may have on inheritance of the newborn microbiome and its assembly throughout the first years of life. In the early stages of the pandemic when vertical transmission of COVID-19 was poorly understood, several studies reported increased rates of C-sections in COVID-19 positive women. Initial recommendations discouraged COVID-19 positive mothers from breastfeeding and participating in skin-to-skin care, advising them to isolate during their window of infectivity. These shifts in perinatal care can adversely impact microbial colonization during the first 1000 days of life. While obstetrical and neonatal management have evolved to reflect our current knowledge of perinatal transmission, we are observing other changes in early life exposures of infants, including increased attention to hygiene, fewer social interactions, and decreased global travel, all of which are major drivers of early-life gut colonization. Composition of the gut microbiota in adults directly impacts severity of infection, suggesting a role of microbial communities in modulating immune responses to COVID-19. Conversely, the role of the intestinal microbiome in susceptibility and severity of COVID-19 in newborns and children remains unknown. The onset of adulthood diseases is related to the establishment of a healthy gut microbiome during childhood. As we continue to define COVID-19 biology, further research is necessary to understand how acquisition of the neonatal microbiome is affected by the pandemic. Furthermore, infection control measures must be balanced with strategies that promote microbial diversity to impart optimal health outcomes and potentially modulate susceptibility of children to COVID-19.
C1 [Romano-Keeler, Joann] Univ Illinois, Dept Pediat, Div Neonatol, Chicago, IL USA.
   [Zhang, Jilei; Sun, Jun] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA.
   [Sun, Jun] Univ Illinois, Canc Ctr, Chicago, IL USA.
   [Sun, Jun] Jesse Brown VA Med Ctr, Chicago, IL USA.
RP Romano-Keeler, J (corresponding author), Univ Illinois, 840 S Wood St,Room 704,Clin Sci Bldg,MC716, Chicago, IL 60612 USA.
EM junsun7@uic.edu
FU U.S. National Institutes of Health [NIDDK]United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R01 DK105118, R01DK114126]; U.S. National Institutes of Health [DOD]
   [BC160450P1]; UIC Cancer Center support
FX This work was supported by the U.S. National Institutes of Health grant
   [NIDDK R01 DK105118, R01DK114126, DOD BC160450P1], and the UIC Cancer
   Center support (JS).
CR Almgren M, 2018, GENES DIS, V5, P24, DOI 10.1016/j.gendis.2018.01.004
   Bauer KW, 2021, AM J PUBLIC HEALTH, V111, P116, DOI 10.2105/AJPH.2020.305980
   Bielecki M, 2021, TRAVEL MED INFECT DI, V39, DOI 10.1016/j.tmaid.2020.101915
   Brito IL, 2019, NAT MICROBIOL, V4, P964, DOI 10.1038/s41564-019-0409-6
   Brooks AW, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006842
   Budding A., AGE DEPENDENT PHARYN
   Cai JH, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.634949
   Chen L, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009226
   Children NAftEoY, 2020, STATE BY STATE LOOK
   Debrabandere ML, 2021, AM J PERINAT, V38, P332, DOI 10.1055/s-0040-1721658
   Della Gatta AN, 2020, AM J OBSTET GYNECOL, V223, P36, DOI 10.1016/j.ajog.2020.04.013
   Di Toro F, 2021, CLIN MICROBIOL INFEC, V27, P36, DOI 10.1016/j.cmi.2020.10.007
   Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107
   Durack J, 2019, J EXP MED, V216, P20, DOI 10.1084/jem.20180448
   Finlay BB, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2010217118
   Hendricks-Munoz KD, 2015, AM J PERINAT, V32, P1205, DOI 10.1055/s-0035-1552941
   Hermes GDA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66404-z
   Islam MM, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.573468
   Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107
   Lamouroux A, 2020, AM J OBSTET GYNECOL, V223, P91, DOI 10.1016/j.ajog.2020.04.039
   Liu JJ, 2020, LANCET CHILD ADOLESC, V4, P347, DOI 10.1016/S2352-4642(20)30096-1
   Motrico E, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10330-w
   Pediatrics AAP., 2021, FAQS MANAGEMENT INFA
   Prideaux L, 2013, INFLAMM BOWEL DIS, V19, P2906, DOI 10.1097/01.MIB.0000435759.05577.12
   Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x
   Robertson RC, 2019, TRENDS MICROBIOL, V27, P131, DOI 10.1016/j.tim.2018.09.008
   Rundle AG, 2020, OBESITY, V28, P1008, DOI 10.1002/oby.22813
   Sheh A, 2013, GUT MICROBES, V4, P505, DOI 10.4161/gmic.26205
   Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458
   Spatz DL, 2012, JOGNN-J OBST GYN NEO, V41, P138, DOI 10.1111/j.1552-6909.2011.01315.x
   Wang JX, 2021, JAMA OPHTHALMOL, V139, P293, DOI 10.1001/jamaophthalmol.2020.6239
   Wiklund I, 2018, LANCET, V392, P1288, DOI 10.1016/S0140-6736(18)32325-0
   Zhang JL, 2021, GENES DIS, V8, P385, DOI 10.1016/j.gendis.2020.08.013
   Zhang MN, 2021, EUR J GASTROEN HEPAT, V33, P610, DOI 10.1097/MEG.0000000000001984
   Zijlmans MAC, 2015, PSYCHONEUROENDOCRINO, V53, P233, DOI 10.1016/j.psyneuen.2015.01.006
NR 35
TC 4
Z9 4
U1 3
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1949-0976
EI 1949-0984
J9 GUT MICROBES
JI Gut Microbes
PD JAN 1
PY 2021
VL 13
IS 1
BP 1
EP 7
DI 10.1080/19490976.2021.1912562
PG 7
WC Gastroenterology & Hepatology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Microbiology
GA RY7ZF
UT WOS:000648124900001
PM 33960272
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ahmadi, S
   Irandoost, SF
   Ahmadi, A
   Lebni, JY
   Gharehghani, MAM
   Safari, NB
AF Ahmadi, Sina
   Irandoost, Seyed Fahim
   Ahmadi, Ahmad
   Yoosefi Lebni, Javad
   Mohammadi Gharehghani, Mohammad Ali
   Baba Safari, Nafe
TI Explaining Experiences, Challenges and Adaptation Strategies in COVID-19
   Patients: A Qualitative Study in Iran
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE COVID-19; patients; experiences; adaptation strategies; qualitative
   study; Iran
ID COPING STRATEGIES; SOCIAL MEDIA; HEALTH; CORONAVIRUS; QUARANTINE;
   IMPACT; SARS
AB ObjectiveGetting COVID-19 makes a person confront numerous individual, physical, psychological, family and social challenges. Therefore, the present study was conducted to explain the experiences, challenges and adaptation strategies in patients with COVID-19 in Tehran, Iran. MethodsThe present study was performed with a qualitative approach and phenomenological method among 33 patients with COVID-19. From July 20 to September 21, access to participants and data collection were done in person (15 people) and by phone (18 people) through targeted sampling and snowball and semi-structured interviews. Data management was carried out using MAXQDA-2018 software and its analysis was done by the Colaizzi analysis method. Guba and Lincoln's criteria were also observed to improve the quality of results. ResultsAfter analyzing the data, two main categories and 17 subcategories were obtained, including (1) experiences and challenges (ignoring the disease, blaming, physical health disorders, mental problems, guilt, and remorse, being blamed, living a life of disappointment and ambiguity, emotional challenges, frustrating reactions from others, helplessness and limitation) and (2) disease adaptation strategies (spirituality, learning about COVID-19, doing valuable and fun activities, participating in treatment, strengthening one's spirit and hope, trying to make up for past mistakes and virtual communication). ConclusionsBased on the results, interventions and policies such as increasing people's health knowledge and literacy to get acquainted with the symptoms of the disease and prompt referral for diagnosis and treatment, teaching stress and psychological pressure management techniques, instructing families to continue emotional and social support for patients and strengthening and reproducing the strategies patients use, along with teaching disease coping skills, harnessing the potential of cyberspace and the media can make it easier to tolerate illness and get back to life.
C1 [Ahmadi, Sina] Univ Social Welf & Rehabil Sci, Dept Social Welf Management, Tehran, Iran.
   [Ahmadi, Sina; Mohammadi Gharehghani, Mohammad Ali] Univ Social Welf & Rehabil Sci, Social Welf Management Res Ctr, Tehran, Iran.
   [Irandoost, Seyed Fahim] Urmia Univ Med Sci, Clin Res Inst, Social Determinants Hlth Res Ctr, Orumiyeh, Iran.
   [Ahmadi, Ahmad] Allameh Tabatabai Univ, Fac Psychol & Educ Sci, Educ Technol, Tehran, Iran.
   [Yoosefi Lebni, Javad] Iran Univ Med Sci, Hlth Promot Res Ctr, Tehran, Iran.
   [Baba Safari, Nafe] Univ Tehran, Fac Social Sci, Anthropol, Tehran, Iran.
RP Gharehghani, MAM (corresponding author), Univ Social Welf & Rehabil Sci, Social Welf Management Res Ctr, Tehran, Iran.; Lebni, JY (corresponding author), Iran Univ Med Sci, Hlth Promot Res Ctr, Tehran, Iran.
EM j.yousefi28@yahoo.com; ali_gh75@yahoo.com
CR Ahmad AR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19556
   Alase A., 2017, INT J ED LITERACY ST, V5, P9, DOI [DOI 10.7575/AIAC.IJELS.V.5N.2P.9, 10.7575/aiac.ijels.v.5n.2p.9]
   Aliakbari Dehkordi M., 2020, IRANIAN J HLTH PSYCH, V2, P9, DOI [10.30473/ijohp.2020.52395.1074, DOI 10.30473/IJOHP.2020.52395.1074]
   Arkin N, 2020, CLIN NUTR, V39, P2327, DOI 10.1016/j.clnu.2020.05.007
   Bajema KL, 2020, MMWR-MORBID MORTAL W, V69, P166, DOI 10.15585/mmwr.mm6906e1
   Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3
   Barreneche, 2020, SOC REGISTER, V4, P19, DOI [10.14746/sr.2020.4.2.02, DOI 10.14746/SR.2020.4.2.02]
   Cava MA, 2005, PUBLIC HEALTH NURS, V22, P398, DOI 10.1111/j.0737-1209.2005.220504.x
   Cuello-Garcia C, 2020, J CLIN EPIDEMIOL, V127, P198, DOI 10.1016/j.jclinepi.2020.06.028
   Danhauer SC, 2009, J BEHAV MED, V32, P371, DOI 10.1007/s10865-009-9211-x
   Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001
   Filgueiras A., 2020, SSRN, DOI [10.2139/ssrn.3566245, DOI 10.2139/SSRN.3566245]
   Finlay JM, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.643807
   Flick U, 2018, MANAGING QUALITY QUA, V2nd, DOI [10.4135/9781529716641, DOI 10.4135/9781529716641]
   Glass K, 2009, J SOC CLIN PSYCHOL, V28, P779, DOI 10.1521/jscp.2009.28.6.779
   Grey I, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113452
   Grover S, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102381
   Henderson TL, 2010, J APPL GERONTOL, V29, P48, DOI 10.1177/0733464809334287
   Howard MC, 2020, BRIT J HEALTH PSYCH, V25, P912, DOI 10.1111/bjhp.12453
   Idoiaga N, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01952
   Iheduru-Anderson K, 2021, NURS INQ, V28, DOI 10.1111/nin.12382
   Jakovljevic M, 2020, PSYCHIAT DANUB, V32, P221, DOI 10.24869/psyd.2020.221
   Kahambing JGS, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102292
   Karmakar M, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.36462
   Lebni JY, 2021, WOMENS HEALTH, V17, DOI 10.1177/17455065211063291
   Lebni JY, 2021, J RELIG HEALTH, V60, P2387, DOI 10.1007/s10943-021-01295-6
   Lebni JY, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08752-z
   Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032
   Lin ECL, 2010, AM J INFECT CONTROL, V38, P302, DOI 10.1016/j.ajic.2009.09.008
   Lincoln YS., 2011, SAGE HDB QUALITATIVE, V4, P97
   Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8
   Mantovani A, 2020, INT J PUBLIC HEALTH, V65, P235, DOI 10.1007/s00038-020-01369-4
   Mohammadzadeh A., 2020, J MILITARY MED, V22, P139
   Mousavi-Almaleky Z., 2021, Q CLIN PSYCHOL STUD, V10, P1, DOI [10.22054/JCPS.2021.55243.2434, DOI 10.22054/JCPS.2021.55243.2434]
   Parkinson D, 2019, J INTERPERS VIOLENCE, V34, P2333, DOI 10.1177/0886260517696876
   Pellegrini V, 2021, PERS INDIV DIFFER, V181, DOI 10.1016/j.paid.2021.111011
   Rahmatinejad P, 2020, J RES PSYCHOL HLTH, V14, P71
   Rehman U, 2021, COMMUNITY MENT HLT J, V57, P42, DOI 10.1007/s10597-020-00664-x
   Robert R, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00702-7
   Rong XM, 2020, MATH BIOSCI ENG, V17, P2725, DOI 10.3934/mbe.2020149
   Rudan I, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.03035
   Sallam M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243264
   Savovic, 2020, POTENTIAL IMPACT COV
   Shahyad S., 2020, Journal of Military Medicine, V22, pFa184, DOI 10.30491/JMM.22.2.184
   Sharif N, 2021, DIABETES METAB SYND, V15, DOI 10.1016/j.dsx.2021.102206
   Shosha G.A., 2012, EUR SCI J, V8, P31, DOI DOI 10.19044/esj.2012.v8n27p%25p
   SoleimanvandiAzar N, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10889-4
   Sotgiu G, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02461-2020
   Struyf T, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013665
   To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
   Venegas-Vera AV, 2020, REV CARDIOVASC MED, V21, P561, DOI 10.31083/j.rcm.2020.04.195
   Wallace CL, 2020, J PAIN SYMPTOM MANAG, V60, pE70, DOI 10.1016/j.jpainsymman.2020.04.012
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Willgoss TG, 2012, HEART LUNG, V41, P562, DOI 10.1016/j.hrtlng.2012.07.003
   Williams SN, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039334
   Wu Y., 2020, AM J OBSTET GYNECOL, DOI [10.2139/ssrn.3539359, DOI 10.2139/SSRN.3539359]
   Xu C., 2021, J BEHAV PUBLIC ADMIN, V4, P1, DOI [10.30636/jbpa.42.225, DOI 10.30636/JBPA.42.225]
   Yang L., 2020, ANAL PSYCHOL STATE C, DOI [10.1101/2020.03.22.20040899, DOI 10.1101/2020.03.22.20040899]
   Yang Y, 2020, J MED VIROL, V92, P536, DOI 10.1002/jmv.25720
   Yao H, 2020, LANCET PSYCHIAT, V7, pE21, DOI 10.1016/S2215-0366(20)30090-0
   Yoosefi Lebni Javad, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.498
   Lebni JY, 2021, INT J SOC PSYCHIATR, V67, P298, DOI 10.1177/0020764020939984
   Zahran S., 2009, INT J MASS EMERGENCI, V27, P26
NR 64
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD FEB 3
PY 2022
VL 9
AR 778026
DI 10.3389/fpubh.2021.778026
PG 13
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZG7OD
UT WOS:000760443700001
PM 35186867
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ahmed, T
   Khan, MS
   Thitivesa, D
   Siraphatthada, Y
   Phumdara, T
AF Ahmed, Tanveer
   Khan, Muhammad Shahid
   Thitivesa, Duangkamol
   Siraphatthada, Yananda
   Phumdara, Tawat
TI Impact of employees engagement and knowledge sharing on organizational
   performance: Study of HR challenges in COVID-19 pandemic
SO HUMAN SYSTEMS MANAGEMENT
LA English
DT Article
DE Employee engagement; knowledge sharing; organizational performance
ID JOB-SATISFACTION
AB PURPOSE: When the economy's in terrible shape, any of us is lucky to have a job, human resources managers worrying about whether or not employees are contributing to the organizational goals and objectives, and how to pursue the recruitment and selection process, employee's engagement, and, training and development activities, these are the current human resource management challenges which are created due to COVID-19 pandemic. Organizations around the world are facing a tough situation, first time in history, the worth of one-barrel oil fell to less than nothing on 20th April 2020, the only reason is behind this is the current lockdown around the world. The physical workplace is converted into a virtual workplace, now the HR managers are planning how to engage the employees efficiently. This study pursued to examine the effect of employee's engagement on organizational performance through the mediating effect of knowledge sharing for employees of higher educational institutions.
   METHOD: A quantitative research method is used in this study, non-probability sampling design with a focus on convenient sampling frame is deployed in this study. The questionnaire is adapted from the past studies, Initially Google forms were used to collect the data, due to lower response rate questionnaire were distributed in hard copies and sent to the targeted respondents. Structured Equation Modeling (SEM) is used to test the conceptual framework.
   RESULTS: The results showed that employee engagement has a significant and positive impact on organizational performance. Further, it was found that knowledge sharing has a significant and positive impact on organizational performance. Moreover, knowledge sharing only partially mediated the association between employee engagement and organizational performance. Covid-19 pandemic is destroying global economies, but at the same time its bringing different opportunities for organizations also. Now organizations have to think about how to avail this opportunity, organizations are going virtually, and in this situation, it is the biggest challenge for the Human Resource (HR) managers to manage the employee effectively.
C1 [Ahmed, Tanveer] DHA Suffa Univ, Karachi, Pakistan.
   [Khan, Muhammad Shahid; Siraphatthada, Yananda; Phumdara, Tawat] Suan Sunandha Rajabhat Univ, Coll Innovat & Management, Bangkok, Thailand.
   [Thitivesa, Duangkamol] Suan Sunandha Rajabhat Univ, Fac Educaiton, Bangkok, Thailand.
RP Khan, MS (corresponding author), Suan Sunandha Rajabhat Univ, Bangkok, Thailand.
EM shahid.kh@ssru.ac.th
RI von der Wense, Benedikt/ABH-2026-2021; Khan, Muhammad
   Shahid/AAK-6222-2020
OI Khan, Muhammad Shahid/0000-0001-8969-4763
CR Abrahma S., 2012, J EC DEV MANAGEMENT, V4, P27
   Abukhait RM, 2019, INT J INNOV MANAG, V23, DOI 10.1142/S1363919619500063
   Ahmadi A, 2018, HUM SYST MANAGE, V37, P271, DOI 10.3233/HSM-17169
   Aktar A., 2017, IOSR J BUSINESS MANA, V19, P54, DOI DOI 10.9790/487X-1906065467
   Akter K, 2011, P INT C BUS MAN, V8, P245
   Al-Ababneh M., 2014, SSRN ELECT J, DOI [10.2139/ssrn.3633078., DOI 10.2139/SSRN.3633078]
   Albrecht SL, 2012, INT J MANPOWER, V33, P840, DOI 10.1108/01437721211268357
   Andrew O., 2011, AM J EC BUSINESS ADM, V3, P569
   [Anonymous], 2016, SCMS J INDIAN MANAGE, P120
   Asadullah M.A., 2014, MIDDLE E J SCI RES, V19, P593
   Aslam M.H., 2013, J BEHAV APPL MANAGEM, V15, P25
   Bailey AA, 2016, INT J BANK MARK, V34, P821, DOI 10.1108/IJBM-06-2015-0097
   Bakker AB, 2011, EUR J WORK ORGAN PSY, V20, P4, DOI 10.1080/1359432X.2010.485352
   Becerra-Fernandez I, 2010, P 5 INT ISCRAM C WAS, P88
   Bhuvanaiah T., 2014, SCMS J INDIAN MANAG, V11, P61
   Blanchard PN, 2012, EFFECTIVE TRAINING S
   Chauhan R., 2018, INT J ENG RES MANAGE, V5
   Chen Y, 2010, J AM ACAD BUSINESS, V11, P71
   Chin WW, 2008, J MARKET THEORY PRAC, V16, P287, DOI 10.2753/MTP1069-6679160402
   Cohen J., 1988, STAT POWER ANAL BEHA, V2, DOI [10.1111/1467-9507.00183, DOI 10.4324/9780203771587]
   Dastgir, 2015, EFFECTIVENESS USE MU
   DeFranzo S., 2011, WHATS DIFFERENCE QUA
   Djikhy S, 2019, HUM SYST MANAGE, V38, P423, DOI 10.3233/HSM-190614
   Hair J. F., 2013, PRIMER PARTIAL LEAST
   Hanaysha J, 2016, PROCD SOC BEHV, V229, P289, DOI 10.1016/j.sbspro.2016.07.139
   Harter JK, 2002, J APPL PSYCHOL, V87, P268, DOI 10.1037/0021-9010.87.2.268
   Hromei A., 2014, EC MANAGEMENT, P504
   Ilyasa M, 2018, INT J SCI RES MANAGE, V6, P57
   Juan S, 2017, FGIC 1 C GOV INT 201, P224
   Kazimoto P., 2016, AM J IND BUSINESMA, V6, P516, DOI [10.4236/ajibm.2016.64047, DOI 10.4236/AJIBM.2016.64047]
   Khan A, 2017, INT J ADV APPL SCI, V4, P17, DOI 10.21833/ijaas.2017.02.003
   Khan M., 2020, INT J SCI TECHNOLOGY, V9, P929
   Khan MS, 2019, MEDIATING EFFECT EMP, P66
   Khan MS, 2018, WORLD J ENTREP MANAG, V14, P191, DOI 10.1108/WJEMSD-10-2017-0075
   Kline P., 2000, HDB PSYCHOL TESTING, P13
   Lin CH, 2012, INFORM MANAGE-AMSTER, V49, P10, DOI 10.1016/j.im.2011.11.001
   Maldonado-Guzman G, MANAGEMENT RES REV, V39, P830
   Mansoor A, 2021, HUM SYST MANAGE, V40, P93, DOI 10.3233/HSM-200972
   Markos S., 2010, INT J BUSINESS MANA, V5, P89
   Nassazi A., 2013, THESIS
   Pinho JC, 2016, MANAG RES REV, V39, P425, DOI 10.1108/MRR-08-2014-0189
   Questica, 2015, IMP MEAS NONF FACT
   Rayton BA, 2014, INT J HUM RESOUR MAN, V25, P2382, DOI 10.1080/09585192.2013.876440
   Risley C, 2020, J LIBR ADM, V60, P653, DOI 10.1080/01930826.2020.1773716
   Schaufeli WB, 2009, J HAPPINESS STUD, V3, P71
   Shamila VJ, 2013, INT J SOCIAL SCI INT, V2, P111
   Shekari H., 2015, J ED MANAGEMENT STUD, V5, P168
   Shuck B., 2010, HUM RESOUR DEV REV, V9, P89, DOI DOI 10.1177/1534484309353560
   Son TT, 2020, SAGE OPEN, V10, DOI 10.1177/2158244020927426
   Sundaray B., 2011, EUR J BUS MANAGE, V3, P53
   Tak I., 2014, CCI3 EC MANAGEMENT, P547
   TALAL A, 2020, SUSTAIN DEV, P1, DOI DOI 10.1002/SD.2066
   Vance RJ, 2006, CUSTOMER SERVICE DEL, P22
   Wang S, 2010, HUM RESOUR MANAGE R, V20, P115, DOI 10.1016/j.hrmr.2009.10.001
   Welch M, 2011, CORP COMMUN, V16, P328, DOI 10.1108/13563281111186968
   Witherspoon CL, 2013, J KNOWL MANAG, V17, P250, DOI 10.1108/13673271311315204
   Yalabik ZY, 2017, EVID-BASED HRM, V5, P248, DOI 10.1108/EBHRM-08-2015-0036
   Zannahjuan UN, 2013, KNOWLEDGE SHARING IM
NR 58
TC 5
Z9 5
U1 17
U2 32
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0167-2533
EI 1875-8703
J9 HUM SYST MANAGE
JI Hum. Syst. Manag.
PY 2020
VL 39
IS 4
BP 589
EP 601
DI 10.3233/HSM-201052
PG 13
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA OW3PO
UT WOS:000592803300010
OA Bronze
DA 2022-04-20
ER

PT J
AU Duan, YL
   Liu, Y
   Chen, YL
   Guo, WQ
   Yang, LS
AF Duan, Yunlong
   Liu, Yan
   Chen, Yilin
   Guo, Weiqi
   Yang, Lisheng
TI Research on the impact of knowledge sharing on risk control of inclusive
   finance in rural areas during the post-COVID-19 era
SO JOURNAL OF KNOWLEDGE MANAGEMENT
LA English
DT Article; Early Access
DE Knowledge sharing; Risk control; Inclusive finance
ID MANAGEMENT; INNOVATION; PERFORMANCE; ACCESS
AB Purpose This study aims to focus on the impact of multi-level knowledge sharing between and within organizations on the risk control of rural inclusive finance. The paper presents a synergistic risk control system integrating external and internal factors for rural inclusive finance by constructing different knowledge-sharing platforms in an environment, which is full of many uncertainties. Design/methodology/approach This study is based on survey methods. To achieve the research objectives, the authors adopt a single case study approach. For data collection, the authors apply a wide variety of methods such as semi-structured interviews, field visits, second-hand databases and official websites. Findings The results emphasize that using multi-level knowledge sharing such as the inter- and intra-organizational level, can facilitate the risk control of rural inclusive finance during the post-COVID-19 era. Furthermore, it is also noted that achieving knowledge sharing at different levels by building diverse knowledge-sharing platforms can promote the risk control of rural inclusive finance from the individual-organization level to the chain level of multi-organization collaboration, which contributes to the formation of symbiotic risk control ecology. Research limitations/implications The authors have formed the "Chinese wisdom" to deal with inclusive financial risks and to promote in-depth development in relation to the "last mile" practice of inclusive finance, which means the final and the most important phase of a project. The conclusions contribute to enriching the outcomes regarding the risk control of rural inclusive finance, provide experiences to its sustainable development and offer a reference to other countries with their risk control of rural inclusive finance. Originality/value Drawing on the knowledge-sharing approach, this study creatively resolves the persistent problems in the risk control of rural inclusive finance, which forms a powerful supplement to the extant literature. Meanwhile, the paper combines the two contextual factors of the post-COVID-19 era and emerging economies, which can be deemed as a novel attempt.
C1 [Duan, Yunlong; Chen, Yilin] Yunnan Univ Finance & Econ, Int Business Sch, Kunming, Yunnan, Peoples R China.
   [Liu, Yan] Yunnan Univ Finance & Econ, Business Sch, Kunming, Yunnan, Peoples R China.
   [Liu, Yan] Honghe Univ, Business Sch, Mengzi, Peoples R China.
   [Guo, Weiqi] Bank HangZhou, Shenzhen Branch, Shenzhen, Peoples R China.
   [Yang, Lisheng] Yunnan Minzu Univ, Sch Management, Kunming, Yunnan, Peoples R China.
RP Yang, LS (corresponding author), Yunnan Minzu Univ, Sch Management, Kunming, Yunnan, Peoples R China.
EM yanglisheng66@126.com
FU National Natural Science Foundation Project of ChinaNational Natural
   Science Foundation of China (NSFC) [71663058, 71663062]; Applied Basic
   Research Key Project of Yunnan Province [2018FA037]
FX The paper was supported by the National Natural Science Foundation
   Project of China (Grant NO. 71663058, 71663062) and the Applied Basic
   Research Key Project of Yunnan Province (grant NO.2018FA037). The
   authors thank them wholeheartedly for funding our research.
CR Ajefu JB, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100630
   Akhtaruzzaman M., 2021, FINANC RES LETT
   Ali I, 2020, KNOWL PROCESS MANAG, V27, P322, DOI 10.1002/kpm.1645
   Beck T, 2007, J FINANC ECON, V85, P234, DOI 10.1016/j.jfineco.2006.07.002
   Bruhn M, 2014, J FINANC, V69, P1347, DOI 10.1111/jofi.12091
   Burgess R, 2005, AM ECON REV, V95, P780, DOI 10.1257/0002828054201242
   Caimo A, 2015, J MANAGE, V41, P665, DOI 10.1177/0149206314552192
   Chatterjee S, 2020, J KNOWL MANAG, V24, P2531, DOI 10.1108/JKM-04-2020-0252
   Chin T, 2021, J KNOWL MANAG, V25, P1, DOI 10.1108/JKM-04-2020-0244
   Clarkson G, 2007, GOV INFORM Q, V24, P827, DOI 10.1016/j.giq.2007.08.001
   Corrado G, 2017, CURR OPIN ENV SUST, V24, P19, DOI 10.1016/j.cosust.2017.01.013
   Cricelli L, 2010, J KNOWL MANAG, V14, P348, DOI 10.1108/13673271011050094
   Del Giudice M, 2017, J TECHNOL TRANSFER, V42, P229, DOI 10.1007/s10961-016-9496-1
   Del Giudice M, 2014, J KNOWL MANAG, V18, P841, DOI 10.1108/JKM-06-2014-0264
   Derrien F., 2016, J CORP FINANC, V39295
   Dexu H., 2016, CHINA EC, V11, P64
   Dierkes M, 2013, J BANK FINANC, V37, P2867, DOI 10.1016/j.jbankfin.2013.03.018
   Dost M, 2019, J KNOWL MANAG, V23, P1245, DOI 10.1108/JKM-01-2019-0035
   Duan YL, 2021, INT J PROD ECON, V233, DOI 10.1016/j.ijpe.2020.108019
   Dupas P, 2013, AM ECON J-APPL ECON, V5, P163, DOI 10.1257/app.5.1.163
   Dyer JH, 2000, STRATEGIC MANAGE J, V21, P345, DOI 10.1002/(SICI)1097-0266(200003)21:3<345::AID-SMJ96>3.3.CO;2-E
   Houston JF, 2010, J FINANC ECON, V96, P485, DOI 10.1016/j.jfineco.2010.02.008
   Jimenez-Jimenez D, 2014, J KNOWL MANAG, V18, P905, DOI 10.1108/JKM-06-2014-0242
   Liao HH, 2009, J BANK FINANC, V33, P1520, DOI 10.1016/j.jbankfin.2009.02.016
   Muhammed S, 2020, J KNOWL MANAG, V24, P2455, DOI 10.1108/JKM-03-2020-0227
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Oliva FL, 2019, J KNOWL MANAG, V23, P1838, DOI 10.1108/JKM-06-2018-0361
   Oliva FL, 2019, MANAGE DECIS, V57, P1960, DOI 10.1108/MD-06-2018-0670
   Oliva FL, 2014, J KNOWL MANAG, V18, P1053, DOI 10.1108/JKM-03-2014-0080
   Orr A., 2006, G24
   Papa A, 2020, J KNOWL MANAG, V24, P589, DOI 10.1108/JKM-09-2017-0391
   Pellegrino R, 2019, BUILT ENVIRON PROJ A, V9, P248, DOI 10.1108/BEPAM-01-2018-0012
   Reinhart CM, 2011, AM ECON REV, V101, P1676, DOI 10.1257/aer.101.5.1676
   Rice RE, 2019, J KNOWL MANAG, V23, P1, DOI 10.1108/JKM-06-2018-0360
   Saenz J, 2012, J KNOWL MANAG, V16, P919, DOI 10.1108/13673271211276191
   Santomero AM, 1997, J FINANC SERV RES, V12, P83, DOI 10.1023/A:1007971801810
   Wang S, 2014, J MANAGE, V40, P978, DOI 10.1177/0149206311412192
   Wang SY, 2020, J INT MANAG, V26, DOI 10.1016/j.intman.2020.100780
   Xu XH, 2018, INT J PROD ECON, V204, P160, DOI 10.1016/j.ijpe.2018.08.003
   Zack M, 2009, J KNOWL MANAG, V13, P392, DOI 10.1108/13673270910997088
   Zhang J., 2020, ADV EC BUSINESS, V8, P95
   Zhu J., 2020, FINANCIAL ENG RISK M, V3, P147
NR 42
TC 1
Z9 1
U1 23
U2 34
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1367-3270
EI 1758-7484
J9 J KNOWL MANAG
JI J. Knowl. Manag.
DI 10.1108/JKM-11-2020-0854
EA AUG 2021
PG 18
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA UB0VR
UT WOS:000685571500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Tuan, J
   Spichler-Moffarah, A
   Ogbuagu, O
AF Tuan, Jessica
   Spichler-Moffarah, Anne
   Ogbuagu, Onyema
TI A new positive SARS-CoV-2 test months after severe COVID-19 illness:
   reinfection or intermittent viral shedding?
SO BMJ CASE REPORTS
LA English
DT Article
DE COVID-19; immunology; pneumonia (infectious disease)
AB We present a case of a patient who had a history of severe coronavirus disease (COVID-19) 4 months prior to this current presentation and, after a long asymptomatic period, subsequently tested positive for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by a RNA PCR assay, after several interval negative SARS-CoV-2 RNA tests. We present this potential case of SARS-CoV-2 reinfection in order to incite discussion around differentiating persistent infection with intermittent viral shedding and reinfection, as well as to discuss evolving knowledge and approaches to the clinical management, follow-up molecular testing and treatment of COVID-19 reinfection.
C1 [Tuan, Jessica; Spichler-Moffarah, Anne; Ogbuagu, Onyema] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.
RP Tuan, J (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.
EM Jessica.Tuan@Yale.Edu
CR An JH, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-5602
   Centers for Disease Control and Prevention, 2020, DUR IS PREC AD COVID
   European Centre for Disease Prevention and Control, 2020, REINF SARS COV 2 CON
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Huang AT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18450-4
   Kellam P, 2020, J GEN VIROL, V101, P791, DOI 10.1099/jgv.0.001439
   Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1
   Lu J, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102960
   Thach PN, 2020, ARCH CLIN MED CASE R, V4, P766
   To Kelvin Kai-Wang, 2021, Clin Infect Dis, V73, pe2946, DOI 10.1093/cid/ciaa1275
   Widders A, 2020, INFECT DIS HEALTH, V25, P210, DOI 10.1016/j.idh.2020.05.002
   Wolf RC, 2020, NEUROPSYCHOBIOLOGY, V79, P335, DOI [10.1038/s41586-020-2196-x, 10.1159/000505601, 10.1038/s41586-020-2984-3]
   Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344
NR 13
TC 7
Z9 7
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
EI 1757-790X
J9 BMJ CASE REP
JI BMJ Case Rep.
PD FEB
PY 2021
VL 14
IS 2
AR e240531
DI 10.1136/bcr-2020-240531
PG 5
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA SF8RJ
UT WOS:000653015600001
PM 33542020
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Khire, RU
   Bell, AE
   Wiebke, S
   Wang, C
AF Khire, Rushikesh Ulhas
   Bell, Adam Edward
   Wiebke, Schreiber
   Wang, Chun
TI EXPATRIATES' INTENTION TO SEND SURGICAL MASKS TO THEIR NATIVE COUNTRIES
   DURING THE COVID-19 PANDEMIC
SO INDEPENDENT JOURNAL OF MANAGEMENT & PRODUCTION
LA English
DT Article
DE Covid-19; Perceived scarcity; Risk perception; Surgical masks; Theory of
   Reasoned Action (TRA)
ID RISK PERCEPTION; AVIAN INFLUENZA; SUPPLY CHAINS; KNOWLEDGE; FOOD;
   INFORMATION; IMPACT; TRUST; FEAR
AB The main purpose of this study is to gain a better understanding of the factors that determine behavioral intention of expatiates living in Taiwan to send surgical masks to their native country following the Covid-19 outbreak. To achieve this, the study builds a research model by extending Theory of Reasoned Action (TRA) with Knowledge-Attitude-Behavior (KAB) and Risk perception conceptions, incorporating Covid-19 related factors such as knowledge, fear, and risk perception and situational factors such as perceived mask scarcity. An online questionnaire was administered with 83 respondents participating. A partial least squares structural equation modeling (PLS-SEM) analysis was used to evaluate the collected data. We found that no significant relationship between both Covid-19 risk perception, and fear and expatiates' attitudes to send surgical masks back home. Results further reveal that Covid-19 knowledge is the only factor that significantly influence expatriates' attitudes, which in turn impact their on the intention to send surgical masks to their native countries.
   Perceived mask scarcity found to positively moderate relationship between attitude and intention. This study contributes to the growing body of literature and research focused on the Covid-19 pandemic, and offers some implications for future research on the correlations between knowledge and scarcity in the context of the theory of reasoned action. Although the current study examines a contemporary critical issue, it presents a key example of personal protective equipment (PPE).
C1 [Khire, Rushikesh Ulhas] Providence Univ, Int Business Adm Program, Taichung, Taiwan.
   [Bell, Adam Edward; Wiebke, Schreiber; Wang, Chun] Providence Univ, Int Coll, Taichung, Taiwan.
RP Khire, RU (corresponding author), Providence Univ, Int Business Adm Program, Taichung, Taiwan.
EM rukhire@pu.edu.tw; abell1018@yahoo.com; wiebke_schreiber@gmx.de;
   Vicentewang1009@gmail.com
CR Addo PC, 2020, SERV IND J, V40, P471, DOI 10.1080/02642069.2020.1751823
   Ajzen I., 1980, UNDERSTANDING ATTITU
   Al -Monitor, 2020, QAT DOL 55000 FIN JA
   BETTINGHAUS EP, 1986, PREV MED, V15, P475, DOI 10.1016/0091-7435(86)90025-3
   Boccia F, 2018, FOOD RES INT, V111, P682, DOI 10.1016/j.foodres.2018.06.013
   Capone V, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12177039
   CDC, 2020, CONS WEAR CLOTH FAC
   Chen CC, 2018, TELEMAT INFORM, V35, P1249, DOI 10.1016/j.tele.2018.02.007
   Chin WW, 1998, QUANT METH SER, P295
   Cori L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093114
   Costarelli S, 2007, EUR J SOC PSYCHOL, V37, P923, DOI 10.1002/ejsp.403
   Cyr D, 2006, INFORM MANAGE-AMSTER, V43, P950, DOI 10.1016/j.im.2006.08.009
   Dillard J.P., 2002, PERSUASION HDB
   Ducharme, 2020, WHO DECLARES COVID 1
   Fenton I, 2020, CORONAVIRUS AVIATION
   Fischbein M., 1975, BELIEF ATTITUDE INTE
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Friedman Uri, 2020, ATLANTIC
   Gerhold L., 2020, PSYARXIV, DOI [10.31234/osf.io/xmpk4, DOI 10.31234/OSF.IO/XMPK4]
   Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6
   Heiland I., 2020, UNINTENDED CRISIS CO
   Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014
   Hutjens M., 2014, INFLUENCE FEAR BUYIN
   Iorfa S. K., 2020, COVID 19 KNOWLEDGE R
   Lei X, 2019, PREV VET MED, V162, P151, DOI 10.1016/j.prevetmed.2018.12.004
   Lobb AE, 2007, FOOD QUAL PREFER, V18, P384, DOI 10.1016/j.foodqual.2006.04.004
   Maghsoudi A, 2018, INT J LOGIST-RES APP, V21, P407, DOI 10.1080/13675567.2018.1437894
   McKenna B, 2013, INFORM MANAGE-AMSTER, V50, P248, DOI 10.1016/j.im.2013.04.004
   Organisation WH, 2020, NAMING CORONAVIRUS D
   Peel M., 2020, TAIWAN DONATE 10M MA
   Sakka O, 2013, INFORM MANAGE-AMSTER, V50, P265, DOI 10.1016/j.im.2013.02.008
   Scerri A, 2017, EDUC GERONTOL, V43, P117, DOI 10.1080/03601277.2016.1266445
   Shan S, 2020, VIRUS OUTBREAK POSTO
   Strong M, 2020, TAIWAN DONATE 1 MILL
   Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]
   Taplin N, 2020, WHY RICHEST COUNTRY
   Timsit A, 2020, PSYCHOL CORONAVIRUS
   Huynh TLD, 2020, ECON BULL, V40, P758
   Wang C. Y, 2020, TEAM TECHNICIANS IS
   Wang JH, 2017, FOOD CONTROL, V80, P143, DOI 10.1016/j.foodcont.2017.05.003
   Wang YC, 2013, INT J PHYS DISTR LOG, V43, P866, DOI 10.1108/IJPDLM-01-2013-0011
   World Health Organization 1, 2020, WHO DIR GEN OP REM M
   Wu P. W, 2020, NEW ONLINE SYSTEM SE
   Yang J, 2014, QUICK HIST WHY ASIAN
   Zhang L, 2020, TAIWAN GOVT LIFTS MA
   Zhang YH, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110195
   Zhou L, 2016, CHINA ECON REV, V40, P91, DOI 10.1016/j.chieco.2016.06.003
   Zhu H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103514
NR 48
TC 0
Z9 0
U1 1
U2 1
PU INST FEDERAL EDUCACAO, CIENCIA & TECNOLOGIA SAO PAULO
PI SAO PAULO
PA RUA PEDRO VICENTE 625, CANINDE, SAO PAULO, 01109-010, BRAZIL
SN 2236-269X
J9 INDEP J MANAG PROD
JI Indep. J. Manag. Prod.
PD NOV-DEC
PY 2021
VL 12
IS 8
BP 2061
EP 2078
DI 10.14807/ijmp.v12i8.1453
PG 18
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA XJ8UY
UT WOS:000727056700011
OA Green Published, gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Nami, M
   Gadad, BS
   Chong, L
   Ghumman, U
   Misra, A
   Gadad, SS
   Kumar, D
   Perry, G
   Abraham, SJK
   Rao, KS
AF Nami, Mohammad
   Gadad, Bharathi S.
   Chong, Li
   Ghumman, Usman
   Misra, Amogh
   Gadad, Shrikanth S.
   Kumar, Dharmendra
   Perry, George
   Abraham, Samuel J. K.
   Rao, K. S.
TI The Interrelation of Neurological and Psychological Symptoms of
   COVID-19: Risks and Remedies
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE mental health; COVID-19; neurological; psychological; inflammation
ID MENTAL-HEALTH-SERVICES; CHINA; OUTBREAK; CARE
AB COVID-19 has catastrophically affected the world's panoramic view of human well-being in terms of healthcare and management. With the increase in the number of cases worldwide, neurological symptoms and psychological illnesses from COVID-19 have increasingly upsurged. Mental health illness and affective disorders, including depression, obsessive-compulsive disorder, anxiety, phobia, and panic disorders, are highly impacted due to social distress. The COVID-19 pandemic not only affected people with pre-existing mental and affective illnesses, but also healthy individuals with anxiety, worrying, and panic symptoms, and fear conditioning. In addditon, the novel coronavirus is known to impact the central nervous system in the brain, resulting in severe and certain long-lasting neurological issues. Owing to the significance of neurological and psychological events, the present perspective has been an attempt to disseminate the impact of COVID-19 on neural injury through inflammation, and its interrelation with psychological symptoms. In this current review, we synthesize the literature to highlight the critical associations between SARS-CoV-2 infection and the nervous system, and mental health illness, and discuss potential mechanisms of neural injury through psycho-neuroimmunity.
C1 [Nami, Mohammad; Rao, K. S.] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Neurosci Ctr, City Of Knowledge 084301103, Panama.
   [Nami, Mohammad] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Shiraz 7134814336, Iran.
   [Nami, Mohammad] Iranian Neurosci Soc Fars Chapter, Dana Brain Hlth Inst, Shiraz 7136476172, Iran.
   [Nami, Mohammad] Senses Cultural Fdn, Acad Hlth, Sacramento, CA 66006 USA.
   [Nami, Mohammad] Inst Cognit Sci Studies ICSS, Dept Cognit Neurosci, Tehran 1658344575, Iran.
   [Gadad, Bharathi S.; Ghumman, Usman] Texas Tech Univ, Paul L Foster Sch Med, Dept Psychiat, Hlth Sci Ctr El Paso, El Paso, TX 79905 USA.
   [Chong, Li] Beijing Zhongke Jianlan Biotechnol Co Ltd, Beijing 100101, Peoples R China.
   [Chong, Li] Zhongke Jianlan Int Med Res Inst, Melbourne, Vic 3000, Australia.
   [Chong, Li] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.
   [Misra, Amogh] Univ Texas Austin, Dept Biochem, Austin, TX 78712 USA.
   [Gadad, Shrikanth S.] Texas Tech Univ, Ctr Emphasis Canc, Paul L Foster Sch Med, Hlth Sci Ctr El Paso,Dept Mol & Translat Med, El Paso, TX 79905 USA.
   [Gadad, Shrikanth S.] Texas Tech Univ, Paul L Foster Sch Med, Dept Mol & Translat Med, Hlth Sci Ctr El Paso, El Paso, TX 79905 USA.
   [Gadad, Shrikanth S.] Texas Tech Univ, Grad Sch Biomed Sci, Hlth Sci Ctr El Paso, El Paso, TX 79905 USA.
   [Kumar, Dharmendra] Greater Hts Holist Psychiat, Houston, TX 77008 USA.
   [Perry, George] Univ Texas San Antonio, Semmes Fdn Distinguished Univ Chair Neurobiol, San Antonio, TX 78249 USA.
   [Abraham, Samuel J. K.] Yamanashi Univ, Sch Med, Chuo 4093898, Japan.
RP Nami, M; Rao, KS (corresponding author), Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Neurosci Ctr, City Of Knowledge 084301103, Panama.; Nami, M (corresponding author), Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Shiraz 7134814336, Iran.; Nami, M (corresponding author), Iranian Neurosci Soc Fars Chapter, Dana Brain Hlth Inst, Shiraz 7136476172, Iran.; Nami, M (corresponding author), Senses Cultural Fdn, Acad Hlth, Sacramento, CA 66006 USA.; Nami, M (corresponding author), Inst Cognit Sci Studies ICSS, Dept Cognit Neurosci, Tehran 1658344575, Iran.; Gadad, BS (corresponding author), Texas Tech Univ, Paul L Foster Sch Med, Dept Psychiat, Hlth Sci Ctr El Paso, El Paso, TX 79905 USA.
EM torabnami@sums.ac.ir; bharathi.gadad@ttuhsc.edu; chongli@moon.ibp.ac.cn;
   kjr5n2009@gmail.com; shrikanth.gadad@ttuhsc.edu;
   Drkumar.dharmendra@gmail.com; george.perry@utsa.edu; drsam@nichimail.jp;
   jrao@indicasat.org.pa
RI Gadad, Shrikanth/AAF-4030-2020; Perry, George/A-8611-2009
OI Gadad, Shrikanth/0000-0003-0030-5472; Gadad,
   Bharathi/0000-0002-8841-8174; Perry, George/0000-0002-6547-0172
FU National Science system (S.N.I.) of SENACYT; COVID19 Rapid Grant of
   SENACYT, the Republic of Panama [077]
FX KS Rao is thankful to the National Science system (S.N.I.) of SENACYT,
   and COVID19 Rapid Grant number 077 of SENACYT, the Republic of Panama
   for the support.
CR Aghagoli G, 2021, NEUROCRIT CARE, V34, P1062, DOI 10.1007/s12028-020-01049-4
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Blake H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092997
   Bohmwald K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00386
   Brietzke Elisa, 2020, Brain Behav Immun Health, V5, P100076, DOI 10.1016/j.bbih.2020.100076
   Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8
   Canady V.A., 2020, MENT HLTH WKLY, V20, P1, DOI [10.1002/mhw.32272, DOI 10.1002/MHW.32272]
   Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3
   Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X
   Conti P, 2020, J BIOL REG HOMEOS AG, V34, P333, DOI 10.23812/Editorial-Conti-2
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1339, DOI 10.1001/jama.2020.3072
   Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827
   Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0
   Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0
   Fatke B, 2020, DEUT MED WOCHENSCHR, V145, P675, DOI 10.1055/a-1147-2889
   Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330
   Greenberg N, 2020, LANCET PSYCHIAT, V7, P733, DOI 10.1016/S2215-0366(20)30224-8
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155
   Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Karadas O, 2020, NEUROL SCI, V41, P1991, DOI 10.1007/s10072-020-04547-7
   Kim SW, 2020, BRAIN BEHAV IMMUN, V87, P4, DOI 10.1016/j.bbi.2020.03.025
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Li W, 2020, INT J BIOL SCI, V16, P1732, DOI 10.7150/ijbs.45120
   Machado A, 2014, REV NEUROSCIENCE, V25, P785, DOI 10.1515/revneuro-2014-0035
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Nazaraghaei F., 2020, J CLIN MED, V1, P1
   Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]
   Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201
   Shao Y, 2020, BRAIN BEHAV IMMUN, V88, P947, DOI 10.1016/j.bbi.2020.04.018
   Shi Yudong, 2020, Brain Behav Immun Health, V4, P100064, DOI 10.1016/j.bbih.2020.100064
   Swanson PA, 2015, CURR OPIN VIROL, V11, P44, DOI 10.1016/j.coviro.2014.12.009
   Unni SK, 2011, MICROBES INFECT, V13, P312, DOI 10.1016/j.micinf.2011.01.002
   Vachon H, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0673-1
   Varatharaj Aravinthan, 2020, Lancet Psychiatry, V7, P875, DOI 10.1016/S2215-0366(20)30287-X
   Wan SX, 2020, BRIT J HAEMATOL, V189, P428, DOI 10.1111/bjh.16659
   Wong AHK, 2020, BEHAV RES THER, V129, DOI 10.1016/j.brat.2020.103606
   Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031
   Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8
   Yang JZ, 2020, BRAIN BEHAV IMMUN, V87, P113, DOI 10.1016/j.bbi.2020.04.075
   Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1
   Zautra A. J., 2006, EMOTIONS STRESS HLTH
NR 45
TC 7
Z9 7
U1 3
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD AUG
PY 2020
VL 9
IS 8
AR 2624
DI 10.3390/jcm9082624
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA NH3VI
UT WOS:000564600800001
PM 32823540
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Awwad, I
   Greuel, S
   Tacke, F
   Fischer, C
AF Awwad, Ibrahim
   Greuel, Selina
   Tacke, Frank
   Fischer, Christian
TI Haemorrhagic ulcerative duodenitis in a patient with COVID-19 infection:
   clinical improvement following treatment with budesonide
SO BMJ OPEN GASTROENTEROLOGY
LA English
DT Article
DE bleeding; COVID-19; duodenal mucosa; duodenal ulcer; intestinal tract
AB We present a case of a male patient in his mid-30s with COVID-19-induced lung failure requiring extracorporeal membrane oxygenation, who needed an emergency oesophagogastroduodenoscopy due to major upper gastrointestinal bleeding. Endoscopy exposed severe ulcerative duodenitis with diffuse mucosal bleeding. While CT angiography did not show any signs of ischaemia, histopathology revealed duodenitis with substantial inflammatory cell infiltrates consisting of neutrophils and CD3(+) T lymphocytes with equal CD4(+)/CD8(+) distribution. Since the composition of cell infiltrates coincides with changes in inflammatory patterns of the respiratory mucosa from patients with COVID-19 and in COVID-19-associated enterocolitis, and systemic dexamethasone treatment became standard of care in ventilated intensive care unit patients with COVID-19 infection, we initiated an individualised therapeutic attempt to treat the duodenitis with topical enteral budesonide. Follow-up oesophagogastroduodenoscopies within 4 weeks of enteral budesonide administration revealed a full clinical and histological healing of the duodenal mucosa with marked reduction of neutrophilic and lymphocytic infiltrates. To our knowledge, the current report is the first description of enteral budesonide treatment of duodenitis in a patient with COVID-19 infection and warrants further investigation, whether budesonide might constitute a novel therapeutic strategy for the management of COVID-19-related intestinal mucosal damage.
C1 [Awwad, Ibrahim; Tacke, Frank; Fischer, Christian] Charite Unive Med Berlin, Dept Gastroenterol & Hepatol, Berlin, Germany.
   [Greuel, Selina] Charite Univ Med Berlin, Dept Pathol, Berlin, Germany.
RP Awwad, I (corresponding author), Charite Unive Med Berlin, Dept Gastroenterol & Hepatol, Berlin, Germany.
EM ibrahim.awwad@charite.de
OI Tacke, Frank/0000-0001-6206-0226
CR Cavalcante-Silva LHA, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107233
   Amarapurkar AD, 2020, J CLIN PATHOL, V73, P686, DOI 10.1136/jclinpath-2020-206743
   Daval M, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04585-8
   Deshmukh V, 2021, J CLIN PATHOL, V74, P76, DOI 10.1136/jclinpath-2020-206995
   Hemmat N, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00641
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Korswagen L, 2007, ENDOSCOPY, V39, pE271, DOI 10.1055/s-2007-966610
   Lin L, 2020, GUT, V69, P997, DOI 10.1136/gutjnl-2020-321013
   Martin TA, 2020, AM J GASTROENTEROL, V115, P1609, DOI 10.14309/ajg.0000000000000805
   Stahl K, 2021, INTENS CARE MED, V47, P359, DOI 10.1007/s00134-020-06326-6
   Trindade AJ, 2021, J INTERN MED, V289, P887, DOI 10.1111/joim.13232
   Uberti G, 2014, SEMIN DIAGN PATHOL, V31, P152, DOI 10.1053/j.semdp.2014.02.001
   Veras FP, 2020, J EXP MED, V217, DOI 10.1084/jem.20201129
   Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055
   Zhang ML, 2021, HISTOPATHOLOGY, V79, P1004, DOI 10.1111/his.14457
   Ziai SA, 2021, J CELL PHYSIOL, V236, P2430, DOI 10.1002/jcp.30041
NR 16
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2054-4774
J9 BMJ OPEN GASTROENTER
JI BMJ Open Gastroenterol.
PD OCT
PY 2021
VL 8
IS 1
AR e000757
DI 10.1136/bmjgast-2021-000757
PG 3
WC Gastroenterology & Hepatology
WE Emerging Sources Citation Index (ESCI)
SC Gastroenterology & Hepatology
GA WL6VN
UT WOS:000710541000001
PM 34663581
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Mastan, A
   Tripathi, A
   Rai, SK
   Pai, V
   Venkatachalam, L
AF Mastan, A.
   Tripathi, A.
   Rai, S. K.
   Pai, V
   Venkatachalam, L.
TI Emergence of Severe Acute Respiratory Syndrome (SARS) COVID-19 and
   approach of AYUSH systems of medicine towards its prevention and
   management
SO INDIAN JOURNAL OF TRADITIONAL KNOWLEDGE
LA English
DT Article
DE AYUSH systems of medicine; Coronavirus; COVID-19; SARS-CoV-2; Unani
   Medicine
ID PSYCHOLOGICAL STRESS; ANTIVIRAL ACTIVITIES; ACTIVE CONSTITUENTS;
   EXTRACT; EFFICACY; HEALTH; CASSIA; INDIA
AB SARS-CoV-2/novel coronavirus is a fresh virus strain that was first detected in the city of Wuhan located at Hubei province of China in December, 2019. Within a couple of months the virus has spread rapidly to different geographical regions through human transmission leading to serious disease burden worldwide. Although research is under progress to develop effective vaccine and drugs for the disease, a unified approach between conventional and traditional medicine system may prove to be beneficial in early prevention and management of the disease. Joint efforts are being put up at global scientific community level to enhance the research on advancement of meticulous diagnostics, antiviral measures and finally leading to development of an effective vaccine against the novel coronavirus. Some basic and safe measures from AYUSH systems of medicine have also been advocated for prophylaxis and treatment of COVID-19 which can be used independently or with integrated approach. The rationale of this review paper is to provide the details regarding disease spectrum, modes of transmission, social & economic consequences, and role of AYUSH systems of medicine in prevention and management of COVID-19. Based on the signs and symptoms of COVID-19, list of herbs and drugs of AYUSH systems of medicine were also searched and are being reported here.
C1 [Mastan, A.] All India Inst Med Sci, Dept Unani, Raipur, Chhattisgarh, India.
   [Tripathi, A.] All India Inst Med Sci, Dept Homoeopathy, Raipur, Chhattisgarh, India.
   [Rai, S. K.] All India Inst Med Sci, Dept Ayurveda, Raipur, Chhattisgarh, India.
   [Pai, V] All India Inst Med Sci, Dept Yoga & Naturopathy, Raipur, Chhattisgarh, India.
   [Venkatachalam, L.] All India Inst Med Sci, Dept Siddha, Raipur, Chhattisgarh, India.
RP Mastan, A (corresponding author), All India Inst Med Sci, Dept Unani, Raipur, Chhattisgarh, India.
EM dradnanmastan@aiimsraipur.edu.in
CR Ali I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138861
   Bano N, 2017, J BIOEQUIV BIOAVAILA, V9, P387, DOI DOI 10.4172/jbb.1000330
   Bassiri-Jahromi S, 2018, ONCOL REV, V12, P1, DOI 10.4081/oncol.2018.345
   Bayan L, 2014, AVICENNA J PHYTOMEDI, V4, P1
   Bernheim A, 2020, RADIOLOGY, V295, P685, DOI 10.1148/radiol.2020200463
   Chaleshtori FS, 2018, J EVID-BASED INTEGR, V23, DOI 10.1177/2515690X17751314
   Chan JFW, 2020, J CLIN MICROBIOL, V58, DOI [10.1128/JCM.00310-20, 10.1128/JCM.00310-20.]
   Chen L, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009226
   Cohen S, 1996, CURR DIR PSYCHOL SCI, V5, P86, DOI 10.1111/1467-8721.ep10772808
   Durairajan, 1993, NOIILLANERI
   Fatima M, 2016, J MICROBIOL BIOTECHN, V26, P151, DOI 10.4014/jmb.1508.08024
   Fleming SA, 2010, PRIMARY CARE, V37, P119, DOI 10.1016/j.pop.2009.09.002
   Gard T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00770
   Ghoke SS, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2238-1
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guarner J, 2020, AM J CLIN PATHOL, V153, P420, DOI 10.1093/ajcp/aqaa029
   Hashemipour MA, 2014, WOUNDS, V26, P47
   Hayes D, 2016, CRIT REV FOOD SCI, V56, P1231, DOI 10.1080/10408398.2012.760516
   Ho CW, 2017, FOOD CHEM, V221, P1621, DOI 10.1016/j.foodchem.2016.10.128
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Husain A., 2010, MED J ISLAMIC WORLD, V18, P27
   Imani G, 2020, J HERBMED PHARM, V9, px
   Jiang SB, 2020, LANCET, V395, P949, DOI 10.1016/S0140-6736(20)30419-0
   Jiang ZY, 2013, BIOORG MED CHEM LETT, V23, P2123, DOI 10.1016/j.bmcl.2013.01.118
   John KMM, 2015, SAUDI J BIOL SCI, V22, P191, DOI 10.1016/j.sjbs.2014.09.009
   Joshi VK, 2017, J ETHNOPHARMACOL, V197, P32, DOI 10.1016/j.jep.2016.07.030
   KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5
   Kim HY, 2010, ANTIVIR THER, V15, P697, DOI 10.3851/IMP1615
   Komakech R, 2019, INTEGR MED RES, V8, P181, DOI 10.1016/j.imr.2019.07.002
   KONOWALCHUK J, 1978, APPL ENVIRON MICROB, V35, P1219, DOI 10.1128/AEM.35.6.1219-1220.1978
   Kuppusamy K N, 1998, SIDDHA VAIDYATHIRATT, V1st
   Lee JB, 2012, FOOD CHEM, V134, P2164, DOI 10.1016/j.foodchem.2012.04.016
   Li SY, 2005, ANTIVIR RES, V67, P18, DOI 10.1016/j.antiviral.2005.02.007
   Lim SH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020437
   Lin Liang-Tzung, 2014, J Tradit Complement Med, V4, P24, DOI 10.4103/2225-4110.124335
   Mathie RT, 2013, HOMEOPATHY, V102, P187, DOI 10.1016/j.homp.2013.04.001
   Miladi S, 2012, NAT PROD RES, V26, P1027, DOI 10.1080/14786419.2010.550263
   Nagarathna R, 2020, INT J YOGA, V13, P89, DOI 10.4103/ijoy.IJOY_22_20
   Omer MO, 2014, PHARMACOGN RES, V6, P6, DOI 10.4103/0974-8490.122911
   Panda A.K., 2020, J AYURVEDA INTEGRATE, V5, P98, DOI [10.21760/jaims.5.1.16, DOI 10.21760/JAIMS.5.1.16]
   Pandith SA, 2018, PHYTOCHEM REV, V17, P573, DOI 10.1007/s11101-018-9551-7
   Parsley NC, 2018, PHYTOCHEMISTRY, V152, P61, DOI 10.1016/j.phytochem.2018.04.014
   Pedersen A, 2010, PSYCHOSOM MED, V72, P823, DOI 10.1097/PSY.0b013e3181f1d003
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Praditya D, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00912
   Rahmani AH, 2015, PHARMACOGN RES, V7, P217, DOI 10.4103/0974-8490.157956
   Rajkumar RP, 2020, BRAIN BEHAV IMMUN, V87, P8, DOI 10.1016/j.bbi.2020.04.056
   Razi Z, 1991, KITAB UL MUNSOORI, P48
   Rushd I, 1987, KITABUL KULLIYAT, V2nd
   Samarqandi N, 2010, SHARAH ASBAB
   Saxena S, 2017, J CLIN DIAGN RES, V11, pZC47, DOI 10.7860/JCDR/2017/23558.9355
   Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0
   Sharma S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138878
   Vahid-Dastjerdi E, 2014, IRAN J MICROBIOL, V6, P269
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20
   WEBER ND, 1992, PLANTA MED, V58, P417, DOI 10.1055/s-2006-961504
   World Health Organization, COR
   Zambrano-Monserrate MA, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138813
   Zeinali M, 2019, IRAN J BASIC MED SCI, V22, P334, DOI 10.22038/ijbms.2019.34365.8158
NR 59
TC 0
Z9 0
U1 0
U2 0
PU NATL INST SCIENCE COMMUNICATION-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
SN 0972-5938
EI 0975-1068
J9 INDIAN J TRADIT KNOW
JI Indian J. Tradit. Knowl.
PD DEC
PY 2020
VL 19
IS 4
SI SI
BP S95
EP S102
PG 8
WC Plant Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences
GA QJ6AA
UT WOS:000619769800012
DA 2022-04-20
ER

PT J
AU Semaan, A
   Banke-Thomas, A
   Amongin, D
   Babah, O
   Dioubate, N
   Kikula, A
   Nakubulwa, S
   Ogein, O
   Adroma, M
   Adiga, WA
   Diallo, A
   Diallo, L
   Diallo, MC
   Maomou, C
   Mtinangi, N
   Sy, T
   Delvaux, T
   Afolabi, BB
   Delamou, A
   Nakimuli, A
   Pembe, AB
   Benova, L
AF Semaan, Aline
   Banke-Thomas, Aduragbemi
   Amongin, Dinah
   Babah, Ochuwa
   Dioubate, Nafissatou
   Kikula, Amani
   Nakubulwa, Sarah
   Ogein, Olubunmi
   Adroma, Moses
   Adiga, William Anzo
   Diallo, Abdourahmane
   Diallo, Lamine
   Diallo, Mamadou Cellou
   Maomou, Cece
   Mtinangi, Nathanael
   Sy, Telly
   Delvaux, Therese
   Afolabi, Bosede Bukola
   Delamou, Alexandre
   Nakimuli, Annettee
   Pembe, Andrea B.
   Benova, Lenka
TI 'We are not going to shut down, because we cannot postpone pregnancy': a
   mixed-methods study of the provision of maternal healthcare in six
   referral maternity wards in four sub-Saharan African countries during
   the COVID-19 pandemic
SO BMJ GLOBAL HEALTH
LA English
DT Article
DE maternal health; COVID-19; health services research
AB Introduction Referral hospitals in sub-Saharan Africa are located in crowded urban areas, which were often epicentres of the COVID-19 pandemic. This paper prospectively assesses how maternal healthcare was provided in six referral hospitals in Guinea, Nigeria, Tanzania and Uganda during the first year of the COVID-19 pandemic. Methods Mixed-methods design using three data sources: (1) qualitative data from repeated rounds of semi-structured interviews conducted between July 2020 and February 2021 with 22 maternity skilled heath personnel (SHP) on perceptions of care provision; (2) quantitative monthly routine data on caesarean section and labour induction from March 2019 to February 2021; and (3) timeline data of COVID-19 epidemiology, national and hospital-level events. Qualitative and quantitative data were analysed separately, framed based on timeline analysis, and triangulated during reporting. Results We identified three periods: first wave, slow period and second wave. The first wave was challenging for SHP given little knowledge about COVID-19, lack of infection prevention and control training, and difficulties reaching workplace. Challenges that persisted beyond the first wave were shortage of personal protective equipment and no rapid testing for women suspected with COVID-19. We noted no change in the proportion of caesarean sections during the pandemic, and a small increase in the proportion of labour inductions. All hospitals arranged isolation areas for women suspected/confirmed with COVID-19 and three hospitals provided care to women with suspected/confirmed COVID-19. Breastfeeding was not discouraged and newborns were not separated from mothers confirmed with COVID-19. Care provision was maintained through dedication of SHP, support from hospital management and remote communication between SHP. Conclusion Routine maternal care provision was maintained in referral hospitals, despite first wave challenges. Referral hospitals and SHP contributed to guideline development for pregnant women suspected/confirmed with COVID-19. Maternity SHP, women and pregnancy must always be included in priority setting when responding to health system shocks, including outbreaks.
C1 [Semaan, Aline; Delvaux, Therese; Benova, Lenka] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium.
   [Banke-Thomas, Aduragbemi] London Sch Econ & Polit Sci, LSE Hlth, London, England.
   [Banke-Thomas, Aduragbemi] Univ Greenwich, Sch Human Sci, London, England.
   [Amongin, Dinah; Nakubulwa, Sarah; Adroma, Moses; Nakimuli, Annettee] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Obstet & Gynaecol, Kampala, Uganda.
   [Amongin, Dinah] Makerere Univ, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda.
   [Babah, Ochuwa; Ogein, Olubunmi] Univ Lagos, Coll Med, Lagos, Nigeria.
   [Dioubate, Nafissatou; Delamou, Alexandre] Ctr Natl Format & Rech Sante Rurale Maferinyah, Dept Sante Publ, Maferinyah, Forecariah, Guinea.
   [Kikula, Amani] Muhimbili Univ Hlth & Allied Sci, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania.
   [Nakubulwa, Sarah] Kawempe Natl Referral Hosp, Dept Obstet & Gynaecol, Kampala, Uganda.
   [Adiga, William Anzo] Mulago Specialized Women & Neonatal Hosp, Dept Obstet & Gynaecol, Kampala, Uganda.
   [Diallo, Abdourahmane; Diallo, Mamadou Cellou; Sy, Telly] Hop Natl Ignace Deen Conakry, Maternite Ignace Deen, Conakry, Guinea.
   [Diallo, Lamine; Maomou, Cece] Hop Reg Mamou, Maternite, Mamou, Guinea.
   [Mtinangi, Nathanael; Pembe, Andrea B.] Muhimbili Natl Hosp, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania.
   [Afolabi, Bosede Bukola] Univ Lagos, Dept Obstet & Gynaecol, Lagos, Nigeria.
   [Delamou, Alexandre] Univ Gamal Abdel Nasser Conakry, Dept Publ Hlth, Conakry, Guinea.
RP Semaan, A (corresponding author), Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium.
EM asemaan@itg.be; lbenova@itg.be
OI Kikula, Amani/0000-0002-1130-9279; Amongin, Dinah/0000-0002-1420-005X
FU Institute of Tropical Medicine s COVID-19 Pump Priming fund - Flemish
   Government-Department of Economy, Science Innovation; Embassy of the UK
   in Belgium; Research Foundation-Flanders (FWO)FWO; Institute of Tropical
   Medicine; Maferinya Research Centre - Belgian Development Cooperation
FX This study was funded by the Institute of Tropical Medicine's COVID--19
   Pump Priming fund supported by the Flemish Government-Department of
   Economy, Science & Innovation and by the Embassy of the UK in Belgium.
   LB is funded in part by the Research Foundation-Flanders (FWO) as part
   of her Senior Postdoctoral Fellowship. Research in Guinea was funded by
   the 4th framework agreement between the Institute of Tropical Medicine
   and Maferinya Research Centre funded by the Belgian Development
   Cooperation.
CR Africa CDC, 2020, COR DIS 2019 COVID 1
   Afulani PA., 2021, PLOS GLOB PUBLIC HLT, V1
   Ameh C, 2021, AM J TROP MED HYG, V104, P1495, DOI 10.4269/ajtmh.20-1324
   Ashish KC, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.05010
   Ashish KC, 2020, LANCET GLOB HEALTH, V8, pE1273, DOI [10.1016/S2214-109X(20)30345-4, 10.10161/52214-109X(20)30345-4]
   Banke-Thomas A, 2021, BMJ GLOB HEALTH
   Bonnet E, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11529-7
   Bradfield Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248488
   Chigwedere OC, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18136695
   Chmielewska B, 2021, LANCET GLOB HEALTH, V9, pE759, DOI 10.1016/S2214-109X(21)00079-6
   Creswell J.W, 2011, DESIGNING CONDUCTING
   Drevin G, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001361
   Ezenwa BN, 2022, J MATERN-FETAL NEO M, V35, P1789, DOI 10.1080/14767058.2020.1763948
   Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117
   Hale T, 2021, NAT HUM BEHAV, V5, P529, DOI 10.1038/s41562-021-01079-8
   Harkness M, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03781-x
   Huysmans E., 2021, COVID 19 CHALLENGED
   Ishola O., 2020, GIVING HOPE PREGNANT
   Khalil A, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100446
   Khan MMA, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020503
   Kotlar B, 2021, REPROD HEALTH, V18, DOI 10.1186/s12978-021-01070-6
   Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417
   Kumari V, 2020, LANCET GLOB HEALTH, V8, pE1116, DOI 10.1016/S2214-109X(20)30319-3
   Lee K, 2009, GLOB INST, P1
   Maaloe N, 2021, LANCET GLOB HEALTH, V9, pE875, DOI 10.1016/S2214-109X(21)00059-0
   McClure EM, 2020, LANCET GLOB HEALTH, V8, pE1258, DOI 10.1016/S2214-109X(20)30326-0
   Nair M, 2021, ECLINICALMEDICINE, V39, DOI 10.1016/j.eclinm.2021.101063
   Okunade KS, 2020, INT J GYNECOL OBSTET, V150, P278, DOI 10.1002/ijgo.13278
   Pattinson R., 2020, OBSTET GYNAECOLOGY F, V30, P38
   Rao SPN, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004347
   Rimmer MP, 2020, BJOG-INT J OBSTET GY, V127, P1123, DOI 10.1111/1471-0528.16313
   Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1
   Salyer SJ, 2021, LANCET, V397, P1265, DOI 10.1016/S0140-6736(21)00632-2
   Semaan A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002967
   Shapira G, 2021, HEALTH POLICY PLANN, V36, P1140, DOI 10.1093/heapol/czab064
   Stein DT, 2021, HEALTH POLICY PLANN, V36, P84, DOI 10.1093/heapol/czaa092
   Szabo RA, 2021, AUST NZ J OBSTET GYN, V61, P408, DOI 10.1111/ajo.13307
   Townsend R, 2021, ECLINICALMEDICINE, V37, DOI 10.1016/j.eclinm.2021.100947
   University of Oxford, OUR WORLD DAT STAT R
   Villar J, 2021, JAMA PEDIATR, V175, P817, DOI 10.1001/jamapediatrics.2021.1050
   Wagner M, 2021, BIRTH-ISS PERINAT C, DOI 10.1111/birt.12594
   Wilson AN, 2021, WOMEN BIRTH, V34, P206, DOI 10.1016/j.wombi.2020.03.011
   World Health Organization, 2020, CONT ESS SEX REPR MA
   World Health Organization, 2021, 2 ROUND NAT PULS SUR
   World Health Organization, 2020, CONT TRAC CONT COVID
   World Health Organization, 2020, BREASTF COVID 19 SCI
   World Health Organization, 2018, WHO REC INTR CAR POS
   Yerger P, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002974
NR 48
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD FEB
PY 2022
VL 7
IS 2
AR e008063
DI 10.1136/bmjgh-2021-008063
PG 17
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZA9JB
UT WOS:000756470500004
PM 35144921
OA Green Accepted, Green Published, gold
DA 2022-04-20
ER

PT J
AU Al-Omran, K
   Khan, E
   Ali, N
   Bilal, M
AF Al-Omran, Khadija
   Khan, Ezzat
   Ali, Nisar
   Bilal, Muhammad
TI Estimation of COVID-19 generated medical waste in the Kingdom of Bahrain
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article
DE Environmental pollution; COVID-19; Solid medical waste; Personal
   protective equipment; Sustainable management
ID CORONAVIRUS
AB Coronavirus disease 2019 (COVID-19) is not only a great matter of concern from a medical and health perspec-tive, but it is a serious threat to the environment in terms of waste generated during the prevention and cure of COVID-19. The world has so far compromised more than 3 million human lives, and millions are being infected. Environmental threat is most serious because it can cause secondary complications. As per our knowledge, the amount of waste generated during the pandemic and its estimated quantity has not been assessed, thereby keeping the scientific community, Government authorities and public ignorant of its adverse effects. In this con-text, we have evaluated the waste generated by the Kingdom of Bahrain, estimated to be 35.480 kg/day (face masks), 1894 kg/day (PPEs) by the selected health facilities, 16,633.505 kg (vaccination-related) and 53,551.240 kg (related to tests conducted so far) in the Kingdom of Bahrain. (c) 2021 Elsevier B.V. All rights reserved.
C1 [Al-Omran, Khadija] Univ Bahrain, Coll Sci, Environm & Sustainable Dev Program, Sakhir 32038, Bahrain.
   [Al-Omran, Khadija] Bahrain Training Inst, Math & Sci Div, Isa Town 33090, Bahrain.
   [Khan, Ezzat] Univ Bahrain, Coll Sci, Dept Chem, Sakhir 32038, Bahrain.
   [Khan, Ezzat] Univ Malakand, Dept Chem, Chakdara 18800, Khyber Pakhtunk, Pakistan.
   [Ali, Nisar] Huaiyin Inst Technol, Natl & Local Joint Engn Res Ctr Deep Utilizat Tec, Fac Chem Engn, Key Lab Palygorskite Sci & Appl Technol Jiangsu P, Huaian 223003, Peoples R China.
   [Bilal, Muhammad] Huaiyin Inst Technol, Sch Life Sci & Food Engn, Huaian 223003, Peoples R China.
RP Khan, E (corresponding author), Univ Bahrain, Coll Sci, Dept Chem, Sakhir 32038, Bahrain.; Bilal, M (corresponding author), Huaiyin Inst Technol, Sch Life Sci & Food Engn, Huaian 223003, Peoples R China.
EM ezkhan@uob.edu.bh; bilaluaf@hyit.edu.cn
RI Ali, Nisar/AAE-3314-2020; Khan, Ezzat/E-7312-2012; Bilal,
   Muhammad/AAH-6461-2020
OI Ali, Nisar/0000-0002-4794-8929; Khan, Ezzat/0000-0001-7849-6083; Bilal,
   Muhammad/0000-0001-5388-3183; Al Omran, Khadija/0000-0003-3658-1938
CR Adams JG, 2020, JAMA-J AM MED ASSOC, V323, P1439, DOI 10.1001/jama.2020.3972
   ADB, 2020, MAN INF MED WAST COV, V2
   [Anonymous], 2021, TRACKERS
   Celis JE, 2021, SCI TOTAL ENVIRON, V760, DOI 10.1016/j.scitotenv.2020.144167
   Chen FY, 2021, SCI TOTAL ENVIRON, V787, DOI 10.1016/j.scitotenv.2021.147522
   Czigany T, 2020, EXPRESS POLYM LETT, V14, P510, DOI 10.3144/expresspolymlett.2020.41
   Data O.W., 2021, COVID 19 VACCINE DOS
   Data O.W., 2021, TOTAL COVID 19 TESTS
   Dharmaraj S, 2021, CHEMOSPHERE, V275, DOI 10.1016/j.chemosphere.2021.130092
   Dzekashu L.G., 2017, INT J MED MED SCI, V9, P1
   Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001
   Elachola H, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101637
   Hantoko D, 2021, J ENVIRON MANAGE, V286, DOI 10.1016/j.jenvman.2021.112140
   Ilyas S, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141652
   Investopedia, 2020, COEFFICIENT DETERMIN
   Kampf G, 2020, J HOSP INFECT, V105, P424, DOI 10.1016/j.jhin.2020.04.041
   Kumar H, 2021, ENVIRON DEV SUSTAIN, V23, P9418, DOI 10.1007/s10668-020-01033-0
   MOH, 2021, APPR MEAS AIM MIT SP
   MOH, 2021, HLTH MIN CALLS PEOPL
   MOH, 2021, DAIL COVID 19 REP
   Nzediegwu C, 2020, RESOUR CONSERV RECY, V161, DOI 10.1016/j.resconrec.2020.104947
   OECD, 2007, DAT MET REP PRES HDB
   OWID, 2021, DAT COVID 19 COR OUR
   Phadke Rachana, 2021, J Clim Chang Health, V1, P100005, DOI 10.1016/j.joclim.2021.100005
   POLITICO, 2021, ENV IMP MASS COR VAC
   Purnomo CW, 2021, RESOUR CONSERV RECY, V167, DOI 10.1016/j.resconrec.2021.105429
   Research M, 2020, GLOBAL RESP MASKS MA
   Rowan NJ, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138532
   Siddique A, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110443
   Singh N, 2022, CRIT REV ENV SCI TEC, V52, P2000, DOI 10.1080/10643389.2021.1885325
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Study.com, 2021, STUDY
   Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20
   Times K, 2021, ADDITIONAL PCR TESTS
   UCLA, 2014, ADDR VACC WAST
   UNICEF, 2020, COVID 19 EM RESP WAS
   Vahabi N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82384-0
   Vanapalli KR, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.141514
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wei YJ, 2021, J CLEAN PROD, V291, DOI 10.1016/j.jclepro.2020.125246
   WHO, 2021, SHORT PERS PROT EQ E
   Windfeld ES, 2015, J ENVIRON MANAGE, V163, P98, DOI 10.1016/j.jenvman.2015.08.013
   Worldometer, 2021, POP AS
   Worldometers, 2021, COVID 19 COR PAND
   Wu HL, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100329
   Xinhuanet, 2020, CHIN FOC MASK MARK G
   Zand AD, 2021, ENVIRON TECHNOL, V42, P329, DOI 10.1080/09593330.2020.1866082
NR 47
TC 3
Z9 3
U1 6
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-9697
EI 1879-1026
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD DEC 20
PY 2021
VL 801
AR 149642
DI 10.1016/j.scitotenv.2021.149642
EA AUG 2021
PG 8
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology
GA UY9CJ
UT WOS:000701812900001
PM 34425445
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Camporesi, S
   Angeli, F
   Dal Fabbro, G
AF Camporesi, Silvia
   Angeli, Federica
   Dal Fabbro, Giorgia
TI Mobilization of expert knowledge and advice for the management of the
   Covid-19 emergency in Italy in 2020
SO HUMANITIES & SOCIAL SCIENCES COMMUNICATIONS
LA English
DT Article
AB This qualitative case study is part of the international research project ESCaPE (Evaluating Scientific Advice in a Pandemic Emergency) and aims at understanding how expert advice has been sought, produced and utilized in the management of the Covid-19 emergency in Italy in 2020. Italy was the first country after China having to face the devastating effects of the Covid-19 soon to be pandemic. The state of national emergency was declared on January 31st, 2020, and the Italian Government sought expert advice as an important resource in the management of the pandemic. The Covid-19 crisis in Italy witnessed the emergence of different expert advisory groups: some envisaged by the law; some instituted ad hoc and tasked to deal with specific aspects of the emergency; and others that were already in place before the pandemic but that came to play a crucial role during the unfolding of the outbreak. This case study relies on a mix of both primary (stakeholder interviews) and secondary data collection (official documents and communications by expert advisory bodies, ministerial decrees, and policy documents). Our research shows three main findings: (a) the nearcomplete overlap of technical advice and political response in the first phase of the pandemic in Spring 2020, with a key policy role played by the advice provided by the Technical and Scientific Committee (CTS); (b) a predominance of epidemiologists and infectious disease specialists over social scientists in the mobilisation of experts for the management of the crisis in Italy; (c) a shift in containment policies from an emergency-based, very strict, national lockdown in the spring of 2020, to proactive risk-informed colour-coded regional restrictions in the fall and winter of 2020. Our case study ends at the end of 2020 and provides an overview and encompassing representation of the mobilization of experts, and of selected types of evidence, to manage the unprecedented health emergency, in year 1 of the Covid-19 pandemic in Italy. Our findings suggest that expert politics can lead to the confirmation of knowledge hierarchies that privilege hard sciences, and corroborate prior literature indicating that economic and social expertize has not been well integrated into public health expert advice, constituting a major challenge for policymaking during a health emergency.
C1 [Camporesi, Silvia] Kings Coll London, London, England.
   [Angeli, Federica] Univ York, York, N Yorkshire, England.
   [Dal Fabbro, Giorgia] Univ Trento, Trento, Italy.
RP Camporesi, S (corresponding author), Kings Coll London, London, England.
EM silvia.camporesi@kcl.ac.uk
OI Angeli, Federica/0000-0003-4010-3103
CR ADN Kronos, 2020, CTS MIN CONF NOT CLA
   Agenzia Italia, 2020, SON PIU SCI TANT ALT
   Angeli F, 2020, RES SOCIOLOGY ORG, V67, P153
   Angeli F, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-021-00839-1
   [Anonymous], 2020, DECREE HLTH MINISTRY
   [Anonymous], 2021, REUTERS 0301
   [Anonymous], 2020, DECR PRES CONS MIN
   [Anonymous], 2020, PROT CIV OCDPC 663 1
   [Anonymous], 2020, ITALIAN COUNCIL MINI
   [Anonymous], 2021, ULT INT URG PROT CIV
   [Anonymous], 2021, LIST ORDINANCES SPEC
   [Anonymous], 2006, ITALYS NATL PLAN PRE
   ANSA, 2020, COR CONT LOMB COR 1
   ANSA (2020bis), 2020, COVID ABR ZON ROSS G
   Bjorkdahl K., 2019, PANDEMICS PUBLICS PO, DOI [10.1007/978-981-13-2802-2, DOI 10.1007/978-981-13-2802-2]
   Boin A, 2020, CAN PUBLIC ADMIN, V63, P339, DOI 10.1111/capa.12386
   Brown MB, 2008, MINERVA, V46, P485, DOI 10.1007/s11024-008-9106-y
   Civil Protection Department, 2020, ORD 630 DIP PROT CIV
   De Lorenzo G., 2020, IL GIORNALE
   Decree of Ministry of Interior, 2020, DECR MIN INT
   Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888
   European Centre for Disease Prevention and Control, 2021, LIST INFL PAND PREP
   Eyal G, 2013, AM J SOCIOL, V118, P863, DOI 10.1086/668448
   Feuer Will, 2020, CNBC
   Fregonara G, 2020, SCUOLA MIOZZO CTS GO
   Giuffrida A, 2021, GUARDIAN 0813
   Guerzoni M, 2020, COVID ITALY SECRET P
   Guerzoni M, 2020, CORRIERE 1220
   Horowitz J, 2020, NEW YORK TIMES
   Horton R, 2020, LANCET, V396, P1319, DOI 10.1016/S0140-6736(20)32221-2
   Iles A, 2020, AGR HUM VALUES, V37, P659, DOI 10.1007/s10460-020-10118-5
   Intemann, 2018, FIGHT DOUBT BRIDGE G
   Italian Committee for Bioethics, 2020, OP VACC COVID 19 ETH
   Italian National Institute of Health, 2021, OUR MISSION
   La Repubblica, 2020, LA REPUBBLICA
   Lavazza A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00356
   Luna R., 2020, REPUBBLICA 0905
   Moore K., 2006, NEW POLITICAL SOCIOL
   Norwood A., 2004, BIOTERRORISM PSYCHOL, P200, DOI DOI 10.1037//1089-2680.6.4.307
   Observa, OBSERVA
   Ordinance n. 11/2020 of Special Covid Commissioner, 2020, ORD 11 2020 SPEC COV
   Pastorella G, 2016, POLIT STUD-LONDON, V64, P948, DOI 10.1111/1467-9248.12217
   Report of the experts on economics and social matters for the President of the Council of the Ministries, 2020, REPORT EXPERTS EC SO
   Sarzanini F, 2020, CORRIERE 1020
   Severgnini C, 2020, CORONAVIRUS 1 2 CASE
   Sole 24 Ore, 2020, THINGS HUM COULD NEV
   Timmermans S, 2012, SOCIOL THEOR, V30, P167, DOI 10.1177/0735275112457914
   Urbani A, 2020, PREVENT ION RESPONSE, DOI [10.1057/s41599-022-01042, DOI 10.1057/S41599-022-01042]
   WHO, 2020, NAM COR DIS COVID 19
   World Health Organization, 2005, WHO GLOB INFL PREP P
NR 50
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2662-9992
J9 HUM SOC SCI COMMUN
JI Hum. Soc. Sci. Commun.
PD FEB 14
PY 2022
VL 9
IS 1
AR 54
DI 10.1057/s41599-022-01042-6
PG 14
WC Humanities, Multidisciplinary; Social Sciences, Interdisciplinary
WE Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)
SC Arts & Humanities - Other Topics; Social Sciences - Other Topics
GA YY9TH
UT WOS:000755127200001
OA gold
DA 2022-04-20
ER

PT J
AU Tsheten, T
   Clements, ACA
   Gray, DJ
   Adhikary, RK
   Wangdi, K
AF Tsheten, Tsheten
   Clements, Archie C. A.
   Gray, Darren J.
   Adhikary, Ripon K.
   Wangdi, Kinley
TI Clinical features and outcomes of COVID-19 and dengue co-infection: a
   systematic review
SO BMC INFECTIOUS DISEASES
LA English
DT Review
DE Dengue; COVID-19; Co-infection; Clinical features; Symptoms; Outcomes
ID UNITED-STATES; THROMBOCYTOPENIA; EPIDEMIOLOGY; DIAGNOSIS; VACCINES;
   INCREASE; ANXIETY; VIRUS
AB BackgroundDengue is the most common arboviral disease in the tropical and sub-tropical regions of the world. Like other regions, dengue-endemic areas have faced the additional public health and socio-economic impact of the ongoing coronavirus disease 2019 (COVID-19) pandemic. COVID-19 and dengue co-infections have been reported, with complicated patient management and care requirements. This review aimed to collate and synthesise current knowledge on the clinical features and outcomes of COVID-19 and dengue virus co-infection, a potentially important new dimension to be considered in public health management of the COVID-19 pandemic.MethodsA systematic literature review was conducted using PubMed, Web of Science and Scopus databases from 1st January to 21st November 2020. The key search terms used were "dengue" and "coronavirus". Descriptive analysis with graphical illustrations were used to present the clinical and laboratory parameters of the co-infection.ResultsThirteen published papers and four news articles were included in the review. Most studies were case reports with a detailed description of the clinical and laboratory characteristics of the co-infection. All cases were in adults with the exception of a six-year old child. The common symptoms of co-infection were fever, dyspnea, headache, and cough. Common laboratory results included thrombocytopenia, lymphocytopenia, elevated transaminases, and leukopenia. Serious outcomes of co-infection included septic shock, acute respiratory disease syndrome and multi-organ failure, leading to death in some patients.ConclusionsCOVID-19 and dengue co-infection was associated with severe disease and fatal outcomes. The correct diagnosis and treatment of co-infection poses a substantial challenge due to the overlapping clinical and laboratory parameters. Therefore, confirmative diagnostic tests are necessary for accurate and timely diagnosis and patient management.
C1 [Tsheten, Tsheten; Gray, Darren J.; Adhikary, Ripon K.; Wangdi, Kinley] Australian Natl Univ, Res Sch Populat Hlth, Coll Hlth & Med, Canberra, ACT, Australia.
   [Tsheten, Tsheten] Minist Hlth, Royal Ctr Dis Control, Thimphu, Bhutan.
   [Clements, Archie C. A.] Telethon Kids Inst, Nedlands, WA, Australia.
   [Clements, Archie C. A.] Curtin Univ, Perth, WA, Australia.
RP Tsheten, T (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Coll Hlth & Med, Canberra, ACT, Australia.; Tsheten, T (corresponding author), Minist Hlth, Royal Ctr Dis Control, Thimphu, Bhutan.
EM tsheten.tsheten@anu.edu.au
OI Wangdi, Dr Kinley/0000-0002-8857-2665
CR Ahn DG, 2020, J MICROBIOL BIOTECHN, V30, P313, DOI 10.4014/jmb.2003.03011
   [Anonymous], 2020, FATAL COURSE MULTIPL FATAL COURSE MULTIPL, V22
   [Anonymous], 2020, SEROLOGICAL CROSS RE
   Bhatia Rajesh, 2013, WHO South East Asia J Public Health, V2, P23, DOI 10.4103/2224-3151.115830
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bicudo N, 2020, BRAZ J INFECT DIS, V24, P452, DOI 10.1016/j.bjid.2020.07.008
   Chen N., 2020, Lancet, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Epelboin L, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa114
   Estofolete CF, 2021, J MED VIROL, V93, P1770, DOI 10.1002/jmv.26476
   Fisher KA, 2020, MMWR-MORBID MORTAL W, V69, P1258, DOI 10.15585/mmwr.mm6936a5
   Ganeshkumar P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006618
   Goodwin R, 2021, J PSYCHIATR RES, V135, P212, DOI 10.1016/j.jpsychires.2021.01.025
   Guan Wei-Jie, 2020, N Engl J Med, V382, P1861, DOI 10.1056/NEJMc2005203
   Nunes PCG, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6641-4
   Harjana NPA, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.630295
   Htun YM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252189
   Huang KJ, 2000, J GEN VIROL, V81, P2177, DOI 10.1099/0022-1317-81-9-2177
   India TTo, 2020, INDIA TTO INDIA TTO
   Kembuan GJ, 2020, IDCases, V22, DOI 10.1016/j.idcr.2020.e00927
   Khan E, 2012, CURRENT TOPICS IN TROPICAL MEDICINE, P91
   Lee IK, 2020, J MICROBIOL IMMUNOL, V53, P69, DOI 10.1016/j.jmii.2017.12.005
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Lodha R, 2021, INDIAN J PEDIATR, V88, P225, DOI 10.1007/s12098-020-03596-2
   Lokida D, 2020, AM J TROP MED HYG, V103, P1220, DOI 10.4269/ajtmh.20-0676
   Lorenz C, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101659
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Mahajan NN, 2020, INT J GYNECOL OBSTET, V151, P459, DOI 10.1002/ijgo.13415
   Maula AW, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1504398
   Navarro JC, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101656
   News Desk, 2020, OUTBREAK NEWS TODAY
   Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011
   Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
   Nguyen PH, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-048738
   Pontes RL, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101862
   Radisic Marcelo Victor, 2020, Infez Med, V28, P416
   Ratnarathon AC, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04175
   Rayamajhee B, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.597808
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623
   Saddique A, 2020, J INF SECUR
   Salvatore PP, 2020, MMWR-MORBID MORTAL W, V69, P1419, DOI 10.15585/mmwr.mm6939e4
   Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]
   Sirisena PDNN, 2014, INT J INFECT DIS, V19, P6, DOI 10.1016/j.ijid.2013.10.012
   Srichan Peeradone, 2020, WHO South East Asia J Public Health, V9, P118, DOI 10.4103/2224-3151.294305
   Star TD, 2020, STAR TD STAR TD
   Star TD, 2020, STAR TD STAR TD
   Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x
   Thevarajan I, 2020, MED J AUSTRALIA, V213, P134, DOI 10.5694/mja2.50698
   Thomas SJ, 2011, HUM VACCINES, V7, P674, DOI 10.4161/hv.7.6.14985
   Tsheten T, 2021, J MED ENTOMOL, V58, P502, DOI 10.1093/jme/tjaa225
   Tsheten T, 2020, EMERG MICROBES INFEC, V9, P1360, DOI 10.1080/22221751.2020.1775497
   Vasishtha G, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06026-6
   Verduyn M, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008476
   Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000
   WHO, 2009, WHO TECH REP SER, V958, P1
   World Health Organization,, 2012, GLOB STRAT DENG PREV
   World Health Organization, 2020, CLIN MANAGEMENT COVI
   World Health Organization, 2021, COR DIS 2019 COVID 1 COR DIS 2019 COVID 1, V45
   Xu PY, 2020, ANN HEMATOL, V99, P1205, DOI 10.1007/s00277-020-04019-0
NR 59
TC 7
Z9 8
U1 4
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD AUG 2
PY 2021
VL 21
IS 1
AR 729
DI 10.1186/s12879-021-06409-9
PG 9
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA TX8HS
UT WOS:000683328300002
PM 34340682
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Chen, YJ
   Hsu, RLW
AF Chen, Yen-Jung
   Hsu, Robert Li-Wei
TI Understanding the Difference of Teachers' TLPACK before and during the
   COVID-19 Pandemic: Evidence from Two Groups of Teachers
SO SUSTAINABILITY
LA English
DT Article
DE Bayes factor; COVID-19; frequentist statistics; online education; TLPACK
ID PEDAGOGICAL CONTENT KNOWLEDGE; TECHNOLOGY; TPACK; ONLINE; INTEGRATION;
   FRAMEWORK
AB The COVID-19 outbreak has suddenly changed the landscape of education worldwide. Many governments have moved education completely online, with the idea that although schools are shut, classes can continue; however, the question regarding whether teachers are prepared for this massive shift in educational practice remains unanswered. This study addresses this issue through the lens of teachers' technology, learners, pedagogy, academic discipline content, and content knowledge (TLPACK). Two groups of 250 teachers (n = 500) who teach various levels of students participated in a two-phase survey. The phases of the survey took place in 2017 and 2020 (i.e., before and during the COVID-19 pandemic). Participants answered 38 reliable and valid questions about TLPACK to address three research questions, and the collected data were subjected to frequentist and Bayesian statistical analysis. The analysis indicated that teachers' TLPACKs were significantly different before and during the COVID-19 pandemic. This study revealed significant correlations among teachers' TLPACK constructs and found that, among these constructs, the strongest relationship was that between learner knowledge (i.e., knowledge about the learners) and pedagogy knowledge. The study ends by reflecting on our findings' implications, especially since the COVID-19 pandemic continues to have significant altering effects on both education and society at large.
C1 [Chen, Yen-Jung] Natl Sun Yat Sen Univ, Inst Educ, Kaohsiung 80424, Taiwan.
   [Hsu, Robert Li-Wei] Natl Kaohsiung Univ Hosp & Tourism, Grad Inst Hospitality Management, Kaohsiung 81271, Taiwan.
RP Hsu, RLW (corresponding author), Natl Kaohsiung Univ Hosp & Tourism, Grad Inst Hospitality Management, Kaohsiung 81271, Taiwan.
EM jungjunger@gmail.com; liweihsu@mail.nkuht.edu.tw
RI Chen, Yen-Jung/AAJ-8442-2021
OI Chen, Yen-Jung/0000-0002-3597-7546; Hsu, Liwei/0000-0002-4901-744X
FU Ministry of Science and Technology, TaiwanMinistry of Science and
   Technology, Taiwan
FX The APC was funded by Ministry of Science and Technology, Taiwan.
CR Abourjeili, 2012, TURKISH J TEACHER ED, V1, P41
   Adiastuty, 2020, INT C AGR SOCIAL SCI, P257
   Allen RJ, 2020, MEM COGNITION, V48, P400, DOI 10.3758/s13421-019-00978-6
   Almarzooq ZI, 2020, J AM COLL CARDIOL, V75, P2635, DOI 10.1016/j.jacc.2020.04.015
   Amornpipat I, 2019, PSYCHOLOGY, V7, P278
   Andrews T., 2015, EUROPEAN J OPEN DIST, V18, P85
   Angeli C, 2009, COMPUT EDUC, V52, P154, DOI 10.1016/j.compedu.2008.07.006
   Azim A.M.M., 2012, AM J APPL SCI, V9, P740
   Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   Bai Y, 2016, COMPUT EDUC, V96, P1, DOI 10.1016/j.compedu.2016.02.005
   Bao W, 2020, HUM BEHAV EMERG TECH, V2, P113, DOI 10.1002/hbe2.191
   Basilaia G., 2020, PEDAGOGICAL RES, V5, DOI [DOI 10.29333/PR/7937, 10.29333/pr/7937]
   Beard E, 2016, ADDICTION, V111, P2230, DOI 10.1111/add.13501
   Bell RL, 2013, J RES SCI TEACH, V50, P348, DOI 10.1002/tea.21075
   Benedetti C, 2015, J COLL TEACH LEARN, V12, P171, DOI [10.19030/tlc.v12i3.9308, DOI 10.19030/TLC.V12I3.9308]
   Benson S.K., 2010, MERLOT J ONLINE LEAR, V6, P482
   Benson SNK, 2013, J EDUC COMPUT RES, V48, P153, DOI 10.2190/EC.48.2.c
   BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238
   BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588
   Berger J.O., 2006, ENCY STAT SCI, V1, P378, DOI DOI 10.1002/0471667196.ESS0985.PUB2
   Brinkley-Etzkorn KE, 2018, INTERNET HIGH EDUC, V38, P28, DOI 10.1016/j.iheduc.2018.04.004
   Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]
   Chai C. S., 2020, INT J MOBILE LEARNIN, V11, P203
   Cheng X., 2020, SCI INSIGHTS ED FRON, V5, P501, DOI [10.15354/sief.20.ar043, DOI 10.15354/SIEF.20.AR043]
   Cohen J., 1988, STAT POWER ANAL BEHA, V2, DOI [DOI 10.4324/9780203771587, 10.4324/9780203771587]
   De Guzman M.J.J, 2020, ASIAN J MULTIDISCIP, V3, P28
   Delgado AJ, 2015, J INF TECHNOL EDUC-R, V14, P397
   DOLL WJ, 1994, MIS QUART, V18, P453, DOI 10.2307/249524
   Ebren E., 2016, SHS WEB C
   Ettinger K, 2020, EDUC INF TECHNOL, V25, P623, DOI 10.1007/s10639-019-09982-4
   Etz A, 2018, PSYCHON B REV, V25, P5, DOI 10.3758/s13423-017-1262-3
   Goretzko D, 2021, CURR PSYCHOL, V40, P3510, DOI 10.1007/s12144-019-00300-2
   Gronau QF, 2020, AM STAT, V74, P137, DOI 10.1080/00031305.2018.1562983
   Hair J.F., 1998, MULTIVARIATE DATA AN, V5th
   Held L, 2018, ANNU REV STAT APPL, V5, P393, DOI 10.1146/annurev-statistics-031017-100307
   Henriksen D., 2020, J TECHNOL TEACH ED, V28, P201
   Hodges CB, 2021, ETR&D-EDUC TECH RES, V69, P397, DOI 10.1007/s11423-020-09838-6
   Hsu L., 2017, J ED TRAINING, V4, P88, DOI [10.5296/jet.v4i1.10933, DOI 10.5296/JET.V4I1.10933]
   Hsu LW, 2019, S AFR J EDUC, V39, DOI 10.15700/saje.v39ns2a1572
   Hsu PS, 2012, TURK ONLINE J EDUC T, V11, P210
   Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167
   Jeffreys H., 1961, THEORY PROBABILITY
   KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116
   Kirschner PA, 2017, COMPUT EDUC, V106, P166, DOI 10.1016/j.compedu.2016.12.006
   Klenner M, 2015, PROCD SOC BEHV, V176, P312, DOI 10.1016/j.sbspro.2015.01.477
   Koehler Matthew J, 2009, Contemporary Issues in Technology and Teacher Education, V9, P60
   Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146
   Lam L.T., 2010, PSYCHOL HLTH RELATE, P34
   Lam LW, 2012, J BUS RES, V65, P1328, DOI 10.1016/j.jbusres.2011.10.026
   Langford M., ONLINE TEACHING TIME
   Lederman D, INSIDER HIGHERED
   Li P., 2021, J CONT ED RES, V5, P1, DOI [10.26689/jcer.v5i2.1826, DOI 10.26689/JCER.V5I2.1826]
   Lindsay DS, 2015, PSYCHOL SCI, V26, P1827, DOI 10.1177/0956797615616374
   Longhurst GJ, 2020, ANAT SCI EDUC, V13, P298, DOI 10.1002/ase.1967
   Lowenthal P., 2020, J TECHNOLOGY TEACHER, V28, P383
   Lu H.L, 2019, ASIA PAC SCI ED, V5, P1, DOI [10.1186/s41029-019-0044-9, DOI 10.1186/S41029-019-0044-9]
   Makowski D., 2019, J OPEN SOURCE SOFTW, V4, P1541, DOI [10.21105/joss.01541, DOI 10.21105/JOSS.01541]
   Maniraho, 2020, J DIGITAL LEARNING T, V36, P1, DOI [10.1080/21532974.2020.1724840, DOI 10.1080/21532974.2020.1724840]
   Marshall AL, 2020, MAYO CLIN PROC, V95, P1135, DOI 10.1016/j.mayocp.2020.04.015
   Martin S, 2011, COMPUT EDUC, V57, P1893, DOI 10.1016/j.compedu.2011.04.003
   Miguel-Revilla D, 2020, AUSTRALAS J EDUC TEC, V36, DOI 10.14742/ajet.5281
   Mishra Punya, 2011, Educational Technology, V51, P22
   Mishra P, 2006, TEACH COLL REC, V108, P1017, DOI 10.1111/j.1467-9620.2006.00684.x
   Niess ML, 2011, J EDUC COMPUT RES, V44, P299, DOI [10.2190/EC.44.3.C, 10.2190/EC.44.3.c]
   Peimani N, 2021, EDUC SCI, V11, DOI 10.3390/educsci11020072
   Phillips M., P SOC INF TECHN TEAC
   Quezada RL, 2020, J EDUC TEACHING, V46, P472, DOI 10.1080/02607476.2020.1801330
   Rapp E.E., 2016, J LEARNING TEACHING, V1, P32
   Saleh A., 2017, J MULTIDISCIPLINARY, V13, P63
   Sandars J., 2020, MEDEDPUBLISH, V9, P49, DOI [10.15694/mep.2020.000049.1, DOI 10.15694/MEP.2020.000049.1]
   Saubern R, 2020, COMPUT EDUC, V147, DOI 10.1016/j.compedu.2019.103784
   Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100
   Schafer E, 2019, P UND RES SCHOL C BO, P123
   Seufert S, 2021, COMPUT HUM BEHAV, V115, DOI 10.1016/j.chb.2020.106552
   SHULMAN LS, 1987, HARVARD EDUC REV, V57, P1, DOI 10.17763/haer.57.1.j463w79r56455411
   Sudman, 1976, APPL SAMPLING
   Tomte C, 2015, COMPUT EDUC, V84, P26, DOI 10.1016/j.compedu.2015.01.005
   Valtonen T, 2020, EDUC INF TECHNOL, V25, P2823, DOI 10.1007/s10639-019-10092-4
   Vlachopoulos D., 2020, HIGH LEARN RES COMMU, V10, P2, DOI [10.18870/hlrc.v10i1.1179, DOI 10.18870/HLRC.V10I1.1179]
   Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105
   Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1343-3, 10.3758/s13423-017-1323-7]
   Wang CY, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13020036
   Wang M, 2016, AM STAT, V70, P195, DOI 10.1080/00031305.2015.1093027
   Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370
   Wong AYL, 2010, PHYS THER REV, V15, P372, DOI 10.1179/174328810X12786297204756
   World Health Organization, 2020, CURR NOV COR 2019 NC
   Xu AX, 2016, EURASIA J MATH SCI T, V12, P335
   Yan L.N., 2014, ADV SCI TECHNOLOGY L, V47, P227, DOI [10.14257/astl.2014.47.52, DOI 10.14257/ASTL.2014.47.52]
   Zhou Y, 2021, ACM SIGMOD REC, V49, P28, DOI [10.1145/3456859.3456866, DOI 10.1145/3456859.3456866]
NR 89
TC 0
Z9 0
U1 3
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD AUG
PY 2021
VL 13
IS 16
AR 8827
DI 10.3390/su13168827
PG 17
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA UH5KY
UT WOS:000689970800001
OA gold
DA 2022-04-20
ER

PT J
AU Deligiorgi, MV
   Siasos, G
   Vakkas, L
   Trafalis, DT
AF Deligiorgi, Maria, V
   Siasos, Gerasimos
   Vakkas, Lampros
   Trafalis, Dimitrios T.
TI Charting the Unknown Association of COVID-19 with Thyroid Cancer,
   Focusing on Differentiated Thyroid Cancer: A Call for Caution
SO CANCERS
LA English
DT Review
DE COVID-19; SARS-CoV-2; thyroid cancer; differentiated thyroid cancer;
   COVID-19 severity; inflammation; immunity; oxidative stress; obesity
ID OXIDATIVE STRESS; OBESITY; IMPACT; RISK; GUIDELINES; CARE; METAANALYSIS;
   ADIPONECTIN; STATISTICS; OVERWEIGHT
AB Leveraging lessons learned from the coronavirus disease 2019 (COVID-19) pandemic, resilient health systems focus on the preservation of the continuum of care of chronic diseases, especially of cancer, beyond addressing emergency health requirements. Obesity has a detrimental impact on COVID-19 and affects the epidemic of thyroid cancer (TC). TC, especially differentiated TC (DTC), is a notable paradigm of obesity-related cancers. Thus, obesity-COVID-19-(D)TC interplay can be a constant threat to public health. The present review dissects the COVID-19-(D)TC association in the setting of obesity and beyond, highlighting: (i) the interrelationship between immunity, inflammation, obesity, oxidative stress, and cancer underlying this association; (ii) the challenging management of (D)TC in the COVID-19 era; (iii) the impact of COVID-19 on (D)TC and vice versa; and (iv) the oncogenic potential of SARS-CoV-2. Future perspectives for understanding and harnessing the COVID-19-(D)TC association to inform decision-making are underlined.
   Background: Conceived of as the "silver lining" of the dark cloud of the coronavirus disease 2019 (COVID-19) pandemic, lessons taught by this catastrophe should be leveraged by medical authorities and policy makers to optimize health care globally. A major lesson is that resilient health systems should absorb sudden shocks incited by overwhelming health emergencies without compromising the continuum of care of chronic diseases, especially of cancer. Methods: The present review dissects the association between COVID-19 and thyroid cancer (TC), especially with differentiated TC (DTC), focusing on available data, knowledge gaps, current challenges, and future perspectives. Results: Obesity has been incriminated in terms of both COVID-19 severity and a rising incidence of TC, especially of DTC. The current conceptualization of the pathophysiological landscape of COVID-19-(D)TC association implicates an interplay between obesity, inflammation, immunity, and oxidative stress. Whether COVID-19 could aggravate the health burden posed by (D)TC or vice versa has yet to be clarified. Improved understanding and harnessing of the pathophysiological landscape of the COVID-19-(D)TC association will empower a mechanism-guided, safe, evidence-based, and risk-stratified management of (D)TC in the COVID-19 era and beyond. Conclusion: A multidisciplinary patient-centered decision-making will ensure high-quality (D)TC care for patients, with or without COVID-19.
C1 [Deligiorgi, Maria, V; Vakkas, Lampros; Trafalis, Dimitrios T.] Natl & Kapodistrian Univ Athens, Fac Med, Clin Pharmacol Unit, Dept Pharmacol, 75 Mikras Asias St, Athens 11527, Greece.
   [Siasos, Gerasimos] Natl & Kapodistrian Univ Athens, Hippokrat Gen Hosp Athens, Fac Mediine, Dept Cardiol 1, Athens 11527, Greece.
RP Deligiorgi, MV (corresponding author), Natl & Kapodistrian Univ Athens, Fac Med, Clin Pharmacol Unit, Dept Pharmacol, 75 Mikras Asias St, Athens 11527, Greece.
EM mdeligiorgi@yahoo.com; gsiasos@med.uoa.gr; smd1700343@uoa.gr;
   dtrafal@med.uoa.gr
RI Siasos, Gerasimos/AAD-7218-2019
OI Siasos, Gerasimos/0000-0001-7601-8870; Trafalis,
   Dimitrios/0000-0003-4066-9780
FU ATHENA Institute of Biomedical Sciences and EnergonBio Technologies
   S.A., Greece
FX This manuscript was funded by the ATHENA Institute of Biomedical
   Sciences and EnergonBio Technologies S.A., Greece that cover the
   publication costs.
CR Addeo A, 2020, CANCER TREAT REV, V88, DOI 10.1016/j.ctrv.2020.102041
   Agcaoglu O, 2022, UPDATES SURG, V74, P325, DOI 10.1007/s13304-021-00979-8
   Albiges L, 2020, NAT CANCER, V1, P965, DOI 10.1038/s43018-020-00120-5
   Alhusseini LB, 2021, ANN IG MED PREV COMU, V33, P426, DOI 10.7416/ai.2021.2414
   Alpalhao M, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.109882
   Alraouji NN, 2020, MOL CARCINOGEN, V59, P1041, DOI 10.1002/mc.23234
   El Hassani RA, 2019, ENDOCR-RELAT CANCER, V26, pR131, DOI 10.1530/ERC-18-0476
   Anwar F, 2000, MODERN PATHOL, V13, P562, DOI 10.1038/modpathol.3880097
   Arfin S, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10050642
   Assi M, 2017, AM J PHYSIOL-REG I, V313, pR646, DOI 10.1152/ajpregu.00247.2017
   Avgerinos KI, 2019, METABOLISM, V92, P121, DOI 10.1016/j.metabol.2018.11.001
   Aygun N, 2020, MED B SISLI ETFAL HO, V54, P117, DOI 10.14744/SEMB.2020.65902
   Azer P, 2013, ENDOCRINOL NUTR, V60, P158, DOI 10.1016/j.endonu.2012.03.004
   Bakkar S, 2020, UPDATES SURG, V72, P867, DOI 10.1007/s13304-020-00833-3
   Barasa E, 2018, INT J HEALTH POLICY, V7, P491, DOI 10.15171/ijhpm.2018.06
   Baud G, 2020, J VISC SURG, V157, pS43, DOI 10.1016/j.jviscsurg.2020.04.018
   Bellou Vanesa, 2022, Eur Respir J, V59, DOI 10.1183/13993003.02964-2020
   Beltran-Garcia J, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100936
   Bhattacharya I, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.556962
   Bible KC, 2021, THYROID, V31, P337, DOI 10.1089/thy.2020.0944
   Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Brancatella A, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa537
   Bruno DS, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2019.09.26
   Caballero B, 2019, ADV NUTR, V10, pS4, DOI 10.1093/advances/nmy055
   Cava E, 2021, CLIN NUTR, V40, P1637, DOI 10.1016/j.clnu.2021.02.038
   Chablani SV, 2021, J ENDOCR SOC, V5, DOI 10.1210/jendso/bvab059
   Chatzitomaris A, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00163
   Chippa V, 2021, STATPEARLS
   Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005
   CIUFFO G, 1907, GIORN ITAL MAL VENER, V48, P12
   Colditz GA, 2018, CLIN CHEM, V64, P154, DOI 10.1373/clinchem.2017.277376
   COVIDSurg Collaborative, 2021, CANCER-AM CANCER SOC, V127, P2476, DOI 10.1002/cncr.33320
   Croce L, 2021, J ENDOCRINOL INVEST, V44, P891, DOI 10.1007/s40618-021-01506-7
   Dai MY, 2020, CANCER DISCOV, V10, P783, DOI 10.1158/2159-8290.CD-20-0422
   Dalamaga M, 2020, METABOLISM, V109, DOI 10.1016/j.metabol.2020.154282
   Davis PJ, 2020, ENDOCR RES, V45, P210, DOI 10.1080/07435800.2020.1767127
   Delgado-Roche L, 2020, ARCH MED RES, V51, P384, DOI 10.1016/j.arcmed.2020.04.019
   Deligiorgi M.V., PAPILLARY THYROID CA
   Deligiorgi MV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239175
   Derosa L, 2020, NAT CANCER, V1, P946, DOI 10.1038/s43018-020-00122-3
   Dietrich JW, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00287
   Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Du WH, 2017, EXP THER MED, V13, P1155, DOI 10.3892/etm.2017.4047
   Dyson NJ, 2016, GENE DEV, V30, P1492, DOI 10.1101/gad.282145.116
   Evans Alfred S., 1990, Annals of Epidemiology, V1, P71
   Farfel A, 2014, THYROID, V24, P987, DOI 10.1089/thy.2013.0173
   Feng GH, 2019, PSYCHONEUROENDOCRINO, V107, P119, DOI 10.1016/j.psyneuen.2019.05.013
   Fischer S, 2019, PSYCHONEUROENDOCRINO, V110, DOI 10.1016/j.psyneuen.2019.104438
   Fussey JM, 2020, J CLIN ENDOCR METAB, V105, pE2398, DOI 10.1210/clinem/dgaa250
   Galimberti S, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01428
   Graves C.E., 2021, J ENDOCR SOC, V5, DOI [10.1210/jendso/bvab048.1706, DOI 10.1210/JENDSO/BVAB048.1706]
   Greenwood E, 2021, NAT REV CLIN ONCOL, V18, P3, DOI 10.1038/s41571-020-00446-0
   Gul N, 2018, RADIOL ONCOL, V52, P257, DOI 10.2478/raon-2018-0027
   Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020
   Haugen BR, 2009, BEST PRACT RES CL EN, V23, P793, DOI 10.1016/j.beem.2009.08.003
   Hayes JD, 2020, CANCER CELL, V38, P167, DOI 10.1016/j.ccell.2020.06.001
   Hojaij FC, 2020, INT ARCH OTORHINOLAR, V24, pE518, DOI 10.1055/s-0040-1715506
   Jazieh AR, 2020, JCO GLOB ONCOL, V6, P1428, DOI 10.1200/GO.20.00351
   Joseph-Bravo P, 2015, J ENDOCRINOL, V226, pT85, DOI 10.1530/JOE-15-0124
   Kathuria-Prakash N, 2021, ENDOCR PRACT, V27, P90, DOI 10.1016/j.eprac.2020.12.013
   Kitahara CM, 2020, JNCI-J NATL CANCER I, V112, P810, DOI 10.1093/jnci/djz202
   Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008
   Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9
   Kumar A, 2020, DIABETES METAB SYND, V14, P535, DOI 10.1016/j.dsx.2020.04.044
   Kwon H, 2019, THYROID, V29, P349, DOI 10.1089/thy.2018.0327
   Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602
   Liao ZH, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0961-y
   London JW, 2020, JCO CLIN CANCER INFO, V4, P657, DOI 10.1200/CCI.20.00068
   Ma J, 2015, MED SCI MONITOR, V21, P283, DOI 10.12659/MSM.892035
   Magreni A, 2015, JAMA OTOLARYNGOL, V141, P319, DOI 10.1001/jamaoto.2014.3740
   Marcello MA, 2014, ENDOCR-RELAT CANCER, V21, pT255, DOI 10.1530/ERC-14-0070
   Knaul FM, 2021, LANCET, V398, P1114, DOI 10.1016/S0140-6736(21)01895-X
   Martins JRM, 2021, ARCH ENDOCRIN METAB, V65, P368, DOI 10.20945/2359-3997000000352
   Masone S, 2021, J CLIN MED, V10, DOI 10.3390/jcm10091894
   McFadyen JD, 2020, CIRC RES, V127, P571, DOI 10.1161/CIRCRESAHA.120.317447
   Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621
   Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011
   Mohammad S, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-020-00212-x
   Morris LGT, 2010, AM J SURG, V200, P454, DOI 10.1016/j.amjsurg.2009.11.008
   Nagai H, 2017, J THORAC DIS, V9, P448, DOI 10.21037/jtd.2017.02.75
   Nepogodiev D, 2020, BRIT J SURG, V107, P1440, DOI 10.1002/bjs.11746
   Ni WT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03120-0
   Ntyonga-Pono MP, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.2020.35.2.22877
   Obeid Stephanie, 2012, Cancer Biology Medicine, V9, P213, DOI 10.7497/j.issn.2095-3941.2012.04.001
   Olff M, 2006, PSYCHONEUROENDOCRINO, V31, P1220, DOI 10.1016/j.psyneuen.2006.09.003
   Orosco RK, 2019, ENDOCR-RELAT CANCER, V26, P795, DOI 10.1530/ERC-19-0292
   Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026
   Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009
   Palladino R, 2021, ENDOCRINE, V71, P20, DOI 10.1007/s12020-020-02559-z
   Park R, 2021, CANCERS, V13, DOI 10.3390/cancers13143619
   Park R, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.2021.39.15_suppl.e18578
   Park R, 2021, FUTURE ONCOL, V17, P3541, DOI 10.2217/fon-2021-0676
   Patt D, 2020, JCO CLIN CANCER INFO, V4, P1059, DOI 10.1200/CCI.20.00134
   Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212
   Peng T, 2018, EUR J MED CHEM, V150, P742, DOI 10.1016/j.ejmech.2018.03.046
   Mayoral LPC, 2020, INDIAN J MED RES, V151, P11, DOI 10.4103/ijmr.IJMR_1768_17
   Pillaiyar T, 2022, J MED CHEM, V65, P955, DOI 10.1021/acs.jmedchem.1c00335
   Poly TN, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.620044
   Proal AD, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.698169
   Riera R, 2021, JCO GLOB ONCOL, V7, P311, DOI 10.1200/GO.20.00639
   Riley AS, 2019, INT J RADIAT BIOL, V95, P1718, DOI 10.1080/09553002.2019.1665206
   Rotondi M, 2016, EUR THYROID J, V5, P125, DOI 10.1159/000445054
   Rous P, 1910, J EXP MED, V12, P696, DOI 10.1084/jem.12.5.696
   Ruggeri RM, 2021, EXPERT REV CLIN IMMU, V17, P737, DOI 10.1080/1744666X.2021.1932467
   Sahin M, 2021, CLIN ENDOCRINOL, V95, P628, DOI 10.1111/cen.14486
   Santos AL, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1941285
   Scappaticcio L, 2022, J ENDOCRINOL INVEST, V45, P181, DOI 10.1007/s40618-021-01641-1
   Scappaticcio L, 2021, REV ENDOCR METAB DIS, V22, P803, DOI 10.1007/s11154-020-09615-z
   Schmid D, 2015, OBES REV, V16, P1042, DOI 10.1111/obr.12321
   Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201
   Shen YM, 2019, J AFFECT DISORDERS, V259, P180, DOI 10.1016/j.jad.2019.08.067
   Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654
   Siegmann EM, 2018, JAMA PSYCHIAT, V75, P577, DOI 10.1001/jamapsychiatry.2018.0190
   Skoric L, 2020, CROAT MED J, V61, P79, DOI 10.3325/cmj.2020.61.79
   Sohrabpour S, 2021, EUR THYROID J, V9, P321, DOI 10.1159/000511707
   Sponziello M, 2015, ENDOCRINE, V50, P434, DOI 10.1007/s12020-015-0586-x
   Stefan N, 2020, NAT REV ENDOCRINOL, V16, P341, DOI 10.1038/s41574-020-0364-6
   Stingi A, 2021, BIOESSAYS, V43, DOI 10.1002/bies.202000289
   Stipcevic T, 2008, COLLEGIUM ANTROPOL, V32, P973
   Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943
   Sung H, 2019, CA-CANCER J CLIN, V69, P88, DOI 10.3322/caac.21499
   Tagliamento M, 2021, CRIT REV ONCOL HEMAT, V163, DOI 10.1016/j.critrevonc.2021.103365
   Taylor Erin B, 2021, Clin Sci (Lond), V135, P731, DOI 10.1042/CS20200895
   Tleyjeh IM, 2021, CLIN MICROBIOL INFEC, V27, P215, DOI 10.1016/j.cmi.2020.10.036
   Trimboli P, 2021, REV ENDOCR METAB DIS, V22, P485, DOI 10.1007/s11154-021-09653-1
   Ucan B, 2014, ARQ BRAS ENDOCRINOL, V58, P851, DOI 10.1590/0004-2730000003222
   van Dam PA, 2020, CANCER TREAT REV, V89, DOI 10.1016/j.ctrv.2020.102068
   Vasileva LV, 2018, FOOD CHEM TOXICOL, V121, P173, DOI 10.1016/j.fct.2018.08.071
   Vigliar E, 2020, CANCER CYTOPATHOL, V128, P885, DOI 10.1002/cncy.22373
   Vuorio A, 2020, J INTERN MED, V287, P746, DOI 10.1111/joim.13070
   Walitt B, 2021, PAIN REP, V6, DOI 10.1097/PR9.0000000000000887
   Wang QQ, 2021, JAMA ONCOL, V7, P220, DOI 10.1001/jamaoncol.2020.6178
   Weng YS, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0988-0
   Wichmann IA, 2021, INT J GYNECOL OBSTET, V155, P123, DOI 10.1002/ijgo.13870
   Yang J, 2021, J MED VIROL, V93, P257, DOI 10.1002/jmv.26237
   Zane M, 2017, BIOMED PHARMACOTHER, V85, P399, DOI 10.1016/j.biopha.2016.11.043
   Zhai MM, 2021, CANCER MED-US, V10, P4542, DOI 10.1002/cam4.3970
   Zhang D, 2021, J ENDOCRINOL INVEST, V44, P1065, DOI 10.1007/s40618-020-01407-1
   Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296
   Zhao ZG, 2012, J INT MED RES, V40, P2041, DOI 10.1177/030006051204000601
   Zhao Z, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70439-7
NR 142
TC 1
Z9 1
U1 8
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6694
J9 CANCERS
JI Cancers
PD NOV
PY 2021
VL 13
IS 22
AR 5785
DI 10.3390/cancers13225785
PG 28
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA XI0NB
UT WOS:000725818800001
PM 34830939
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Masmas, BA
   Mohamed, A
AF Masmas, Bahaa Ahmad
   Mohamed, Azlinah
TI Knowledge-Based Decision Support System for Emergency Management: The
   Pandemic Framework
SO JOURNAL OF INFORMATION AND COMMUNICATION TECHNOLOGY-MALAYSIA
LA English
DT Article
DE Decision support system; emergency management; knowledge-based system;
   pandemic
ID DESIGN; MODELS
AB Emergency management systems (EMS) assist emergency managers to resolve emergencies on hand, through analyzing the emergency characteristics and consolidating data from different departments that are involved in resolving the emergency. Many countries have adopted various forms of EMS that are specialized in resolving one type of emergency, and studies demonstrate their effectiveness in producing better decisions. However, the COVID-19 pandemic uncovered the lack of a comprehensive framework that could deal with different emergencies. It also revealed the inability of the current systems to communicate with each other to retrieve the needed data. The aim of this study is to show the current state of EMS in emergency departments by constructing a framework for a knowledge-based decision support system for emergency management focusing on resolving pandemics. Qualitative approach was adopted in this research, where the authors reviewed emergency management in general and pandemics in specific. Existing EMS systems were investigated, and knowledge-based decision support systems were explored. Approaches for integration, communication, and collaboration were also studied. As a result of this study, a comprehensive framework, i.e., a knowledge-based decision support system for emergency departments, focusing on resolving pandemics was introduced. The framework was validated by a domain expert who provided insights and suggestions for future research. While the primary research focus is to assist emergency managers in resolving the COVID-19 pandemic, the proposed framework is unique by adopting different approaches and techniques that enable the system to deal with various emergencies not limited to the current pandemic.
C1 [Masmas, Bahaa Ahmad] Univ Teknol MARA, Fac Comp & Math Sci, Shah Alam, Selangor, Malaysia.
   [Mohamed, Azlinah] Univ Teknol MARA, Inst Big Data Analyt & Artificial Intelligence, Shah Alam, Selangor, Malaysia.
RP Masmas, BA (corresponding author), Univ Teknol MARA, Fac Comp & Math Sci, Shah Alam, Selangor, Malaysia.
EM bahaa.ahmad.m@hotmail.com; azlinah@uitm.edu.my
FU Fundamental Research Grant Scheme [600-IRMI/FRGS 5/3 (370/2019) .];
   Ministry of Higher EducationScience and Technology Development Fund
   (STDF)Ministry of Higher Education & Scientific Research (MHESR); IRMI
   (Institute of Research, Management and Innovation), UiTM
FX This work is supported under the Fundamental Research Grant Scheme
   (600-IRMI/FRGS 5/3 (370/2019) . We thank the Ministry of Higher
   Education and IRMI (Institute of Research, Management and Innovation) ,
   UiTM for their continuous support and to anonymous reviewers for their
   useful suggestion.
CR Abu-Elkheir M, 2016, INT WIREL COMMUN, P188, DOI 10.1109/IWCMC.2016.7577055
   Alwidyan MT, 2020, INT J DISAST RISK RE, V44, DOI 10.1016/j.ijdrr.2019.101440
   Arain F, 2015, PROCEDIA ENGINEER, V118, P232, DOI 10.1016/j.proeng.2015.08.422
   Astarita V, 2018, PROCEDIA COMPUT SCI, V134, P433, DOI 10.1016/j.procs.2018.07.187
   Avvenuti Marco, 2020, Pervasive and Mobile Computing, V67, P132, DOI 10.1016/j.pmcj.2020.101225
   Axelsson J, 2019, SYSTEMS ENG, V22, P455, DOI 10.1002/sys.21516
   Benali H, 2012, IEEE ENABL TECHNOL, P397, DOI 10.1109/WETICE.2012.80
   Bhavanishankar R., 2009, P 2009 INT C WIR COM, P1350, DOI 10.1145/1582379.1582675
   Chansanam W., 2020, INT J MANAGEMENT, V11, P47, DOI [10.34218/IJM.11.8.2020.005, DOI 10.34218/IJM.11.8.2020.005]
   Chen N, 2019, INT J DISAST RISK RE, V39, DOI 10.1016/j.ijdrr.2019.101243
   Chen XL, 2015, 2015 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY (WI-IAT), VOL 3, P152, DOI 10.1109/WI-IAT.2015.15
   de Lusignan S, 2020, JMIR PUBLIC HLTH SUR, V6, P288, DOI 10.2196/21434
   De Nicola A, 2019, INFORM SYST, V81, P21, DOI 10.1016/j.is.2018.10.005
   Desmet A, 2013, FUTURE INTERNET, V5, P46, DOI 10.3390/fi5010046
   Dhakal S, 2020, INT J CONSTR MANAG, DOI 10.1080/15623599.2020.1765097
   Fathi R, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2019.102174
   Feng MY, 2016, PROCEDIA COMPUT SCI, V91, P268, DOI 10.1016/j.procs.2016.07.073
   Foddai A, 2020, MICROB RISK ANAL, V16, DOI 10.1016/j.mran.2020.100130
   Fogli D, 2013, DECIS SUPPORT SYST, V55, P336, DOI 10.1016/j.dss.2013.01.022
   Gampfer F, 2018, COMPUT IND, V100, P70, DOI 10.1016/j.compind.2018.03.006
   Gang Kou, 2010, 2010 3rd International Conference on Information Sciences and Interaction Sciences (ICIS), P672, DOI 10.1109/ICICIS.2010.5534684
   Han Y., 2015, PHARM DEV TECHNOL, P1, DOI 10.1145/2835596.2835602
   Hartama D, 2017, J PHYS CONF SER, V890, DOI 10.1088/1742-6596/890/1/012076
   He YQ, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0523-6
   Hernandez JZ, 2001, EXPERT SYST APPL, V20, P173, DOI 10.1016/S0957-4174(00)00057-9
   Jacobsen KH, 2020, LANCET, V395, P1013, DOI 10.1016/S0140-6736(20)30559-6
   Jiang Y, 2013, 2013 INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY AND APPLICATIONS (ITA), P185, DOI 10.1109/ITA.2013.49
   Khovrichev M, 2019, PROCEDIA COMPUT SCI, V156, P134, DOI 10.1016/j.procs.2019.08.188
   Lauras M., 2013, INFORM SYSTEMS FRONT, V17, P857
   Laurini R, 2017, GEOGRAPHIC KNOWLEDGE INFRASTRUCTURE: APPLICATIONS TO TERRITORIAL INTELLIGENCE AND SMART CITIES, P19
   LI X, 2010, P 2010 IEEE INT C EM, V6292, P295, DOI DOI 10.1109/ICEMMS.2010.5563442
   Liu C. K., 2018, IEEE BIOM CIRC SYST, P1, DOI [10.1109/BIOCAS.2017.8325127, DOI 10.1109/BIOCAS.2017.8325127]
   Liu Y, 2020, Int J Nurs Sci, V7, P135, DOI 10.1016/j.ijnss.2020.03.011
   Matta Shanker, 2020, Indian J Tuberc, V67, pS132, DOI 10.1016/j.ijtb.2020.09.032
   Mp J. M., 2020, COVID 19 PANDEMIC PL
   Murota Tomoki, 2010, 2010 8th IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops), P394, DOI 10.1109/PERCOMW.2010.5470637
   Neville K, 2016, J DECIS SYST, V25, P381, DOI 10.1080/12460125.2016.1187393
   Nunes-Vaz R, 2019, INT J DISAST RISK RE, V38, DOI 10.1016/j.ijdrr.2019.101234
   Penkova T. G., 2012, 2012 35th International Convention on Information and Communication Technology, Electronics and Microelectronics, P1595
   Rautela P., 2006, DISASTER PREVENTION, V15, P799
   REPTA D, 2014, IFAC PAPERSONLINE, V47, P827
   Riehle D, 1998, ACM SIGPLAN NOTICES, V33, P117, DOI 10.1145/286942.286951
   Sahoh B, 2017, PROCEEDINGS OF THE 2017 INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY (ICIT 2017), P1, DOI 10.1145/3176653.3176657
   Schreyer KE, 2020, J EMERG MED, V59, P946, DOI 10.1016/j.jemermed.2020.07.022
   Shan SQ, 2012, INFORM TECHNOL MANAG, V13, P411, DOI 10.1007/s10799-012-0130-0
   Sienkiewicz M, 2020, SCI POLICY HDB, P182, DOI [10.1016/B978-0-12-822596-7.00016-4, DOI 10.1016/B978-0-12-822596-7.00016-4]
   Smith AC, 2020, J TELEMED TELECARE, V26, P309, DOI 10.1177/1357633X20916567
   Son C, 2020, APPL ERGON, V87, DOI 10.1016/j.apergo.2020.103114
   Sriramulu R. K., 2017, ITENDER 2017 P 2017, P37, DOI [10.1145/3152896.3152904, DOI 10.1145/3152896.3152904]
   Stephan D.F., 2014, EVEN YOU CAN LEARN S, V3rd ed.
   Tang M., 2016, P 24 ACM INT C MULT, P938
   Utunen H, 2018, IEEE CONF WIREL MOB, P20
   Vargas IG, 2016, 2016 IEEE/ACM 4TH INTERNATIONAL WORKSHOP ON SOFTWARE ENGINEERING FOR SYSTEMS-OF-SYSTEMS (SESOS), P32, DOI [10.1145/2897829.2897835, 10.1109/SESoS.2016.014]
   Vernadat F.B., 2006, IFAC P, V39, P13, DOI [10.3182/20060517-3-FR-2903.00010, DOI 10.3182/20060517-3-FR-2903.00010]
   Xue-Long Chen, 2011, 2011 IEEE/WIC/ACM International Joint Conferences on Web Intelligence (WI) and Intelligent Agent Technologies, P74, DOI 10.1109/WI-IAT.2011.153
   Zhang XH, 2012, PROCEEDING OF 2012 INTERNATIONAL SYMPOSIUM ON MANAGEMENT OF TECHNOLOGY (ISMOT'2012), P683, DOI 10.1109/ISMOT.2012.6679560
NR 56
TC 0
Z9 0
U1 5
U2 5
PU UNIV UTARA MALAYSIA PRESS
PI SINTOK
PA UNIV UTARA MALAYSIA PRESS, SINTOK, KEDAH 06010, MALAYSIA
SN 1675-414X
EI 2180-3862
J9 J INF COMMUN TECHNOL
JI J. Inf. Commun. Technol.-Malays.
PD OCT
PY 2021
VL 20
IS 4
BP 599
EP 628
DI 10.32890/jict2021.20.4.6
PG 30
WC Computer Science, Information Systems
WE Emerging Sources Citation Index (ESCI)
SC Computer Science
GA WY2LE
UT WOS:000719113500006
OA gold
DA 2022-04-20
ER

PT J
AU Marjanski, A
   Sulkowski, L
AF Marjanski, Andrzej
   Sulkowski, Lukasz
TI Consolidation strategies of small family firms in Poland during the
   Covid-19 crisis
SO ENTREPRENEURIAL BUSINESS AND ECONOMICS REVIEW
LA English
DT Article
DE Covid-19; pandemic; small firms; family business; entrepreneurship;
   crisis
ID EUROPEAN CAPITAL-MARKETS; BUSINESS; ENTREPRENEURSHIP; IMPACT;
   EXPLOITATION; EXPLORATION; ENTERPRISES; CONTEXT; CHINA
AB Objective: The objective of the article is to contribute to research into family businesses by understanding how small family businesses are responding and adapting to the Covid-19 crisis.
   Research Design & Methods: The research method is based on a comparative analysis of case studies. To investigate the impact of Covid-19 on small family businesses in Poland, we conducted exploratory studies in 12 entities, based on 29 partially structured interviews with managers of these companies.
   Findings: The sudden spread of the Covid-19 pandemic around the world took many lives and caused severe restrictions in social and private life, including the business sector. While almost every firm has been affected by the pandemic crisis, small businesses, dominated by family businesses, are particularly vulnerable to it. Our findings show that the Covid-19 crisis affects all companies and presents a completely new challenge that has so far had no precedent. Small family businesses are not prepared for the prolonged state of uncertainty and tension threatening the continuity of their operations, which particularly endangers financial stability and employee maintenance. In responding to the crisis, small family firms cannot refer to previous experience or developed methods and patterns of operation.
   Implications & Recommendations: Small family businesses must quickly adapt their operations to changing conditions, regardless of their size and industry in which they operate. Covid-19 in small family businesses causes changes in their approach to running the business and family life.
   Contribution & Value Added: According to our knowledge, this is the first empirical study in Poland on the impact of Covid-19 on small family businesses.
C1 [Marjanski, Andrzej] Univ Social Sci Lodz, Fac Management, Lodz, Poland.
   [Marjanski, Andrzej] Univ Social Sci Lodz, Dept Entrepreneurship & Family Businesses, Ul Sienkiewicza 9, PL-90113 Lodz, Poland.
   [Sulkowski, Lukasz] Jagiellonian Univ, Fac Management & Social Commun, Krakow, Poland.
   [Sulkowski, Lukasz] Clark Univ, Worcester, MA 01610 USA.
   [Sulkowski, Lukasz] Univ Social Sci Lodz, Management Dept, Lodz, Poland.
RP Marjanski, A (corresponding author), Univ Social Sci Lodz, Dept Entrepreneurship & Family Businesses, Ul Sienkiewicza 9, PL-90113 Lodz, Poland.; Sulkowski, L (corresponding author), Jagiellonian Univ, Inst Publ Affairs, Ul Loja Siewicza 4, PL-30348 Krakow, Poland.
EM amarjanski@san.edu.pl; lukasz.sulkowski@uj.edu.pl
OI Marjanski, Andrzej/0000-0001-6534-2632
FU University of Social Sciences research funds
FX The research was funded by the University of Social Sciences research
   funds. The authors declare no potential conflicts of interest with
   regard to the research, authorship, and publication of this article.
CR Akpan I.J., 2020, J SMALL BUS ENTERPRE, P1
   Albulescu Claudiu, 2020, ARXIV PREPRINT ARXIV, DOI 10.2139/ssrn.3550630
   Aldrich H.E., 2006, ORG EVOLVING
   Amorelli MF, 2021, CORP SOC RESP ENV MA, V28, P537, DOI 10.1002/csr.2079
   Androniceanu A., 2020, ADM MANAGEMENT PUBLI, V34, P137, DOI 10.24818/amp/2020.34-08(
   Androniceanu A., 2019, ADM SI MANAGEMENT PU, V33, P103, DOI [10.24818/amp/2019.33-06, DOI 10.24818/AMP/2019.33-06]
   Astrachan JH, 2003, J BUS VENTURING, V18, P567, DOI 10.1016/S0883-9026(03)00010-7
   Ayittey FK, 2020, J MED VIROL, V92, P473, DOI 10.1002/jmv.25706
   Balsa-Barreiro J, 2020, PALGR COMMUN, V6, DOI 10.1057/s41599-020-0403-x
   Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117
   Bednarz J, 2017, ENTREPR BUS ECON REV, V5, P123, DOI 10.15678/EBER.2017.050207
   Bertschi-Michel A, 2021, SMALL BUS ECON, V56, P1531, DOI 10.1007/s11187-019-00266-2
   Bilan Y, 2020, ENTREPR BUS ECON REV, V8, P189, DOI 10.15678/EBER.2020.080311
   Binz-Astrachan C., 2018, J FAM BUS STRATEG, V9, P1
   Carletti E., 2020, CEPR DISCUSSION PAPE, P1
   Cera G, 2020, ECON SOCIOL, V13, P86, DOI 10.14254/2071-789X.2020/13-2/6
   Cristiano E, 2017, EURAS STUD BUS ECON, V4, P577, DOI 10.1007/978-3-319-39919-5_42
   Cuervo-Cazurra A, 2008, J INT MANAG, V14, P12, DOI 10.1016/j.intman.2007.02.003
   Dias R, 2020, OECON COPERNIC, V11, P585, DOI 10.24136/oc.2020.024
   Ertel S., 2020, COMPENSATION BENEFIT, P1
   Fairlie R, 2020, J ECON MANAGE STRAT, V29, P727, DOI 10.1111/jems.12400
   Fetzer T., 2020, ARXIV200303848, P1
   Filser M, 2016, INT J INNOV MANAG, V20, DOI 10.1142/S1363919616500547
   Foghani S, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017697152
   Fornaro L., 2000, CEPR DISCUSSION PAPE, P1
   GASSON R, 1988, J AGR ECON, V39, P1, DOI 10.1111/j.1477-9552.1988.tb00560.x
   Glodowska A, 2019, CENT EUR MANAG J, V27, P55, DOI 10.7206/cemj.2658-0845.3
   Gomez-Mejia LR, 2007, ADMIN SCI QUART, V52, P106, DOI 10.2189/asqu.52.1.106
   Hallova M., 2019, AGRIS ON LINE PAPERS, V11, P27, DOI 10.7160/aol.2019.110103
   Handler, 1989, FAMILY BUSINESS REV, V2, P257, DOI [10.1111/j.1741-6248.1989.00257.x, DOI 10.1111/J.1741-6248.1989.00257.X]
   He LY, 2020, J POLICY MODEL, V42, P628, DOI 10.1016/j.jpolmod.2020.02.001
   Hradecka M., 2019, AGRIS On-line Papers in Economics and Informatics, V11, P31, DOI 10.7160/aol.2019.110204
   Ibrahim N. A., 2008, INT J MANAGEMENT, V25, P95
   IFERA, 2003, FAMILY BUSINESS REV, V16, P235, DOI DOI 10.1177/08944865030160040201
   Khan NS, 2020, COGN COMPUT, V12, P748, DOI 10.1007/s12559-020-09731-7
   Kickbusch I, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m406
   Klonowski D, 2008, CORNELL HOSP Q, V49, P436, DOI 10.1177/1938965508324294
   Ko A., 2020, OH MY WHATS THIS STU
   Konczos-Szombathelyi M., 2020, J INT STUDIES, V13, P143, DOI 10.14254/2071-8330.2020/13-3/10
   Korzeb Z, 2020, EQUILIBRIUM, V15, P205, DOI 10.24136/eq.2020.010
   Kozlov N., 2020, NORWEGIAN J DEV INT, V38, P20
   KRAUS S, 2020, INT J ENTREP BEHAV R, V2, P1067
   Kuc-Czarnecka M, 2020, OECON COPERNIC, V11, P415, DOI 10.24136/oc.2020.017
   Kufel T, 2020, EQUILIBRIUM, V15, P181, DOI 10.24136/eq.2020.009
   Loan L, 2021, ENTREPR BUS ECON REV, V9, P7, DOI 10.15678/EBER.2021.090301
   Leiva-Leon D., 2020, 2381 ECB, P1
   Leonardi P, 2020, MIT SLOAN MANAGE REV, V61, P28
   Lumpkin GT, 2011, ENTREP THEORY PRACT, V35, P1149, DOI 10.1111/j.1540-6520.2011.00495.x
   Lusnakova Z, 2019, EQUILIBRIUM, V14, P503, DOI 10.24136/eq.2019.024
   Maciejewski M, 2019, J MAN BUS ADM-CEN EU, V27, P60, DOI 10.7206/jmba.ce.2450-7814.247
   Marjanski A., 2018, ORG REV, V11, P36, DOI [10.33141/po.2018.11.05, DOI 10.33141/PO.2018.11.05]
   Marjanski A., 2018, RES PAPERS WROCLAW U, V538, P216
   Marjanski A, 2019, GER J HUM RESOUR MAN, V33, P280, DOI 10.1177/2397002219847668
   Marjanski A, 2019, ENTREPR BUS ECON REV, V7, P95, DOI 10.15678/EBER.2019.070106
   Marona B, 2020, ENTREPR BUS ECON REV, V8, P221, DOI 10.15678/EBER.2020.080412
   Meyer N., 2021, FORUM SCI OECONOMIA, V9, P75, DOI [10.23762/FSO_VOL9_NO1_5, DOI 10.23762/FSO_VOL9_NO1_5]
   Miller D, 2006, ADV STRATEG MANAGE, V23, P215, DOI 10.1016/S0742-3322(06)23007-9
   Moss TW, 2014, FAM BUS REV, V27, P51, DOI 10.1177/0894486513504434
   Nordqvist, 2014, SAGE HDB FAMILY BUSI, P620
   Novak J. S., 2019, AGRIS On-line Papers in Economics and Informatics, V11, P75, DOI 10.7160/aol.2019.110407
   Nowinski W, 2020, J VOCAT BEHAV, V121, DOI 10.1016/j.jvb.2020.103474
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Obloj K, 2019, ECON BUS REV-POL, V5, P35, DOI 10.18559/ebr.2019.3.3
   Pardal P, 2020, EQUILIBRIUM, V15, P627, DOI 10.24136/eq.2020.027
   PARP, 2020, REP COND SMALL MED S
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Pieper TM, 2020, J FAM BUS STRATEG, V11, DOI 10.1016/j.jfbs.2020.100362
   Ragheb M., 2020, PROBABILISTIC POSSIB
   Ramelli S, 2020, REV CORP FINANC STUD, V9, P622, DOI 10.1093/rcfs/cfaa012
   Ratten V., 2020, J SMALL BUSINESS ENT, V32, P503, DOI DOI 10.1080/08276331.2020.1790167
   Ratten V, 2020, INT J ENTREP BEHAV R, V26, P1379, DOI 10.1108/IJEBR-06-2020-0387
   Sapovadia V.K., 2020, TERRESTRIAL CELESTIA, P1, DOI [10.2139/ssrn.3547745, DOI 10.2139/SSRN.3547745]
   Sharma, 2014, SAGE HDB FAMILY BUSI, P1, DOI 10.4135/9781473915282
   Sieja M, 2019, ENTREPR BUS ECON REV, V7, P117, DOI 10.15678/EBER.2019.070407
   Solesvik M.Z., 2019, FORUM SCI OECONOMIA, V7, P9, DOI 10.23762/FSO_VOL7_NO1_1
   Sulkowski L., 2015, MANAGEMENT GOUVERNAN, V13, P75
   Sulkowski L., 2009, FAMILY BUSINESSES PO
   Sulkowski L, 2018, CONTRIB MANAG SCI, P255, DOI 10.1007/978-3-319-72239-9_12
   Tian F, 2020, SERV ORIENTED COMPUT, V14, P1, DOI 10.1007/s11761-020-00288-9
   Wach K., 2021, ADM SI MANAGEMENT PU, V36
   Wach K, 2017, ENTREPR BUS ECON REV, V5, P205, DOI 10.15678/EBER.2017.050410
   Wilson SR, 2014, J FAM BUS STRATEG, V5, P4, DOI 10.1016/j.jfbs.2014.01.011
   Zahra SA, 2021, J WORLD BUS, V56, DOI 10.1016/j.jwb.2020.101143
   Zajkowski R, 2019, OECON COPERNIC, V10, P359, DOI 10.24136/oc.2019.018
   Zak M., 2020, INT ENTREPRENEURSHIP, V6, P21, DOI DOI 10.15678/IER.2020.0604.02
NR 85
TC 8
Z9 8
U1 18
U2 23
PU CRACOW UNIV ECONOMICS
PI KRACOW
PA UL RAKOWICKA 27, KRACOW, 31510, POLAND
SN 2353-883X
EI 2353-8821
J9 ENTREPR BUS ECON REV
JI Entrepr. Bus. Econ. Rev.
PD JUN
PY 2021
VL 9
IS 2
BP 167
EP 182
DI 10.15678/EBER.2021.090211
PG 16
WC Economics
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA RW5IJ
UT WOS:000646555600011
OA gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Pounder, P
AF Pounder, Paul
TI Responsible leadership and COVID-19: small Island making big waves in
   cruise tourism
SO INTERNATIONAL JOURNAL OF PUBLIC LEADERSHIP
LA English
DT Article
DE Barbados; Crisis management; Responsible leadership; Coronavirus;
   COVID-19; Cruise tourism
AB Purpose - The purpose of this paper is to explore responsible leadership and crisis management. Many sectors and economies have faced the stark effect of coronavirus; however, the damage done was felt more in some areas than others. Cruise tourism is one such sector dramatically affected, as it ground to a screeching halt in March 2020. This has led to crisis management, as passengers, cruise-line crew, large cruise companies and governments were now faced with a new reality as countries around the world closed their borders. This article aims at discussing in detail how responsible leadership, in the small island of Barbados, championed a response to support the cruise tourism sector and assist in managing the crisis.
   Design/methodology/approach - The author conducted a literature review on the current knowledge relating leadership and crisis management. Thus building a better understanding in the field and identifying gaps for making new arguments for best practices of leadership development in crisis management established in the cruise tourism sector. The author gave viewpoints based on the leadership style of the Prime Minister of Barbados.
   Findings - Responsible leadership is a style that has been best observed as one that emphasizes a commitment to the common good and provides a constructive societal impact. With this approach, the leaders navigated the uncertainty surrounding the crisis and provided fresh hope to future plans. Thus, the coronavirus was perceived in a positive way, producing opportunities for progress and change.
   Research limitations/implications - By developing an understanding of traditional leadership theories, it provides a framework for the adaptation of responsible leadership approach in crisis management. Moreover, the practice of responsible leadership in this COVID-19 era is shown to be crucial to crisis management and enhancing performance. Limitations on viewpoint are based on the author's philosophies.
   Practical implications - This paper provides a better understanding of the principles surrounding leadership and fashions a framework for discussing responsible leadership from a crisis management standpoint. The viewpoint provides an optimistic difference in managing a crisis. Social implications The paper provides a better understanding of responsible leadership as an integrated approach to governance, ethics and social responsibility. The paper provides a basis to assess the intersection of the literature on leadership and crisis management.
   Originality/value - This article contributes to the literature on responsible leadership within the context of crisis management.
C1 [Pounder, Paul] St Georges Univ, Dept Business & Management, St Georges, Grenada.
RP Pounder, P (corresponding author), St Georges Univ, Dept Business & Management, St Georges, Grenada.
EM pp95ae@gmail.com
CR Anadol Y, 2020, CROSS CULT STRATEG M, V27, P645, DOI 10.1108/CCSM-01-2020-0023
   Austin, 2020, ROYAL CARIBBEAN CRUI
   Avolio BJ, 2005, LEADERSHIP QUART, V16, P315, DOI 10.1016/j.leaqua.2005.03.001
   Bao GX, 2013, ADMIN SOC, V45, P443, DOI 10.1177/0095399712464952
   Barbados Today Barbados Today, 2020, BARBADOS TODAY
   Bass B., 2008, BASS HDB LEADERSHIP
   BGIS, 2020, AID PERL SAYS THANK
   Boerner S., 2013, J IND MANAGEMENT DAT, V114, P1270
   Boin A., 2017, POLITICS CRISIS MANA, V2nd edition
   Bowen GA, 2009, QUAL RES J, V9, P27, DOI 10.3316/QRJ0902027
   Brashen Henry., 2018, J INSTRUCTIONAL RES, V7, P80, DOI [10.9743/JIR.2018.7, DOI 10.9743/JIR.2018.7]
   Chen CY, 2012, J BUS ETHICS, V105, P107, DOI 10.1007/s10551-011-0953-3
   Ciulla JB, 2005, ELGAR ORIG REF, P159
   Dent EB, 2005, LEADERSHIP QUART, V16, P625, DOI 10.1016/j.leaqua.2005.07.002
   Denton K.D., 2008, ORGAN DEV J, V26, P55
   Doh JP, 2005, ELGAR ORIG REF, P1
   Fedynich, 2018, J ARTS HUMANITIES, V8, P20, DOI [10.18533/journal.v8i2.1582, DOI 10.18533/JOURNAL.V8I2.1582]
   Fiaz M., 2017, J DEV AREAS, V51, P143, DOI DOI 10.1353/jda.2017.0093
   Fiedler F.E., 1978, ADV EXP SOC PSYCHOL, V11, P59, DOI 10.1016/S0065-2601(08)60005-2
   Forde-Craigg, 2020, GAIA WORKING PROTECT
   Freeman RE, 2011, J BUS ETHICS, V98, P15, DOI 10.1007/s10551-011-1022-7
   Fry LW, 2005, LEADERSHIP QUART, V16, P619, DOI 10.1016/j.leaqua.2005.07.001
   Fry LW, 2003, LEADERSHIP QUART, V14, P693, DOI 10.1016/j.leaqua.2003.09.001
   Gove, 2020, BARBADOS TAKES HUMAN
   Graham K., 2020, NATION NEWS     0322
   Henry A., 2020, BARBADOS TODAY
   Hittle B, 2011, MANAGE DECIS, V49, P1182, DOI 10.1108/00251741111151208
   Huston, 2009, NURSING THEORY APPL
   Johnson C.E., 2001, M ETH CHALL LEAD CAS
   Kettl DF, 2006, ANN AM ACAD POLIT SS, V604, P273, DOI 10.1177/0002716205285981
   King A. S., 1990, VIKALPA, V15, P43
   Kirkpatick S.A., 1991, ACAD MANAGEMENT EXEC, V5, P48, DOI DOI 10.5465/AME.1991.4274679
   Kouzes J.M., 2007, LEADERSHIP CHALLENGE
   Lamb R., 2013, CAN MANAGERS USE PAR
   Lubart, 2001, IMAGINATION COGNITIO, V20, P217, DOI [DOI 10.2190/34QQ-EX6N-TF8V-7U3N, 10.2190/34qq-ex6n-tf8v-7u3n]
   Maak T, 2006, J BUS ETHICS, V66, P99, DOI 10.1007/s10551-006-9047-z
   McCallum Shelly, 2009, Leadership & Organization Development Journal, V30, P152, DOI 10.1108/01437730910935756
   Mele D., 2016, HUMANISTIC MANAGEMEN, V1, P33, DOI DOI 10.1007/S41463-016-0011-5
   Mihalic T., 2014, TOURISM DEV CONCEPTS
   Miles K., 2020, JAMAICA OBSERVER
   Miska C, 2014, J BUS ETHICS, V125, P349, DOI 10.1007/s10551-013-1923-8
   Muijs D, 2011, INT J EDUC MANAG, V25, P45, DOI 10.1108/09513541111100116
   Naylor J., 1999, MANAGEMENT
   Noftle EE, 2006, J RES PERS, V40, P179, DOI 10.1016/j.jrp.2004.11.003
   Northouse, 2004, LEADERSHIP THEORY PR
   Nurse M., 2020, CARICOM TODAY 0605
   O'Leary Z., 2014, ESSENTIAL GUIDE DOIN, V2nd
   Oppmann, 2020, CNN             0316
   Oxford Business Group, 2019, REP GHAN 2020
   Pearson CM, 1998, ACAD MANAGE REV, V23, P59, DOI 10.2307/259099
   Pilgrim T., 2020, PUNCHING ITS WEIGHT
   Pirson MA, 2010, J BUS ETHICS, V93, P553, DOI 10.1007/s10551-009-0239-1
   Pisapia J., 2009, STRATEGIC LEADER NEW
   Pless, 2007, RESPONSIBLE LEADERSH, P68
   Pounder P, 2020, INT J PUBLIV LEADERS, V16, P125, DOI 10.1108/IJPL-01-2019-0001
   Sayegh L., 2004, HUM RESOUR MANAG REV, V14, P179, DOI [https://doi.org/10.1016/j.hrmr.2004.05.002, DOI 10.1016/J.HRMR.2004.05.002]
   Schraagen JanMaarten., 2008, J COGN ENG DECIS MAK, V2, P311, DOI 10.1518/155534308X377801
   Smith C., 2020, PM E SO CARIBBEAN PR
   Sommer A, 2007, TECHNOL FORECAST SOC, V74, P1234, DOI 10.1016/j.techfore.2006.10.006
   Taylor TZ, 2015, LEADERSHIP ORG DEV J, V36, P120, DOI 10.1108/LODJ-01-2013-0008
   Thakkar E., 2020, CRUISE HIVE
   The Maritime Executive, 2020, BARB PORT ASS CREW R
   Thornhill, 2020, WORKING CRUISE TOURI
   Tribe J., 2005, EC RECREATION LEISUR
   van Vugt M, 2014, ORGAN PSYCHOL REV, V4, P74, DOI 10.1177/2041386613493635
   Verkerk P.J., 1990, FIEDLERS CONTINGENCY, V9002
   Waldman DA, 2008, LEADERSHIP QUART, V19, P117, DOI 10.1016/j.leaqua.2007.12.008
   Woiceshyn J, 2011, J BUS ETHICS, V104, P311, DOI 10.1007/s10551-011-0910-1
   World Health Organization (WHO), 2020, DASHBOARD
NR 69
TC 4
Z9 4
U1 9
U2 17
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2056-4929
EI 2042-8642
J9 INT J PUBLIV LEADERS
JI Int. J. Public Leadersh.
PD FEB 5
PY 2021
VL 17
IS 1
SI SI
BP 118
EP 131
DI 10.1108/IJPL-08-2020-0085
EA JAN 2021
PG 14
WC Public Administration
WE Emerging Sources Citation Index (ESCI)
SC Public Administration
GA QG2BP
UT WOS:000613491100001
OA Bronze
DA 2022-04-20
ER

PT C
AU Novotna, L
AF Novotna, Lucie
BE Maci, J
   Maresova, P
   Firlej, K
   Soukal, I
TI Business Networking as a Tool of the Information and Knowledge
   Management of the Owners of Small and Middle Enterprises - Case of Study
SO HRADEC ECONOMIC DAYS, VOL 11(1)
SE Hradec Economic Days
LA English
DT Proceedings Paper
CT 19th International Scientific Conference on Hradec Economic Days
CY MAR 25-26, 2021
CL Hradec Kralove, CZECH REPUBLIC
SP Univ Hardec Kralove, Fac Informat & Management, Wroclaw Univ Econ, Cracow Univ Econ, Univ S Bohemia, Off Transfer Technologies
DE business networking; information and knowledge management; expert
   interview; COVID-19; small and middle-sized entrepreneurs
AB This article sums up the results of my research and qualitative expert interviews with owners of small and medium-sized enterprises active in the Czech Republic. The qualitative sample of these interviews includes respondents through the whole field spectrum of entrepreneurial activities, which are enabled by the Trade Licencing Office of the Czech Republic and are classified in the CZ-NACE database. This research took place during the world COVID-19 pandemic when the strictest measures were adopted in the Czech Republic concerning grouping, entrepreneurship, and movement. The research also sums up the short-term and the long-term change ratio of offline and online networking and information tools, which occurred in individual companies because of these measurements. The research shows an interconnection of the management discipline of information and knowledge management and networking as tools of marketing, HR, business, and building of client-supplier networks, which create sources for companies, enhance their competitiveness and lower the risk of company closures in the time of economic boom as well as crisis.
C1 [Novotna, Lucie] Univ Hradec Kralove, Hradec Kralove, Czech Republic.
RP Novotna, L (corresponding author), Univ Hradec Kralove, Hradec Kralove, Czech Republic.
FU internal project "SPEV -Economic Impacts under the Industry 4.0/Society
   5.0 Concept"; University of Hradec Kralove, Faculty of Informatics and
   Management, Czech Republic
FX The work was supported by the internal project "SPEV -Economic Impacts
   under the Industry 4.0/Society 5.0 Concept", 2021, University of Hradec
   Kralove, Faculty of Informatics and Management, Czech Republic.
CR [Anonymous], 2021, PRISMA TRANSPARENT R
   BURES V, 2007, ZNALOSTNI MANAGEMENT
   Faroque AR, 2017, J BUS IND MARK, V32, P864, DOI 10.1108/JBIM-06-2015-0113
   Ford D, 2013, IND MARKET MANAG, V42, P433, DOI 10.1016/j.indmarman.2013.02.012
   Hardwick Jialin, 2012, Journal of Business Strategy, V33, P51, DOI 10.1108/02756661211282795
   Henneberg SC, 2010, IND MARKET MANAG, V39, P355, DOI 10.1016/j.indmarman.2009.03.011
   Ivanova-Gongne M, 2018, J BUS IND MARK, V33, P638, DOI 10.1108/JBIM-07-2016-0154
   Kubberod E, 2019, J SMALL BUS ENTERP D, V26, P747, DOI 10.1108/JSBED-06-2019-0199
   Petrash G., 1996, EUR MANAG J, V14, P365
   Schoonjans B, 2013, SMALL BUS ECON, V41, P169, DOI 10.1007/s11187-011-9408-6
   Sunassee Nakkiran N., 2002, P SAICSIT BOARDW PO, P235
   Tallinn University, 2021, DEV INF KNOWL MAN DEV INF KNOWL MAN
NR 12
TC 0
Z9 0
U1 4
U2 4
PU UNIV HRADEC KRALOVE
PI HRADEC KRALOVE 3
PA ROKITANSKEHO 62, HRADEC KRALOVE 3, 500 03, CZECH REPUBLIC
SN 2464-6059
EI 2464-6067
BN 978-80-7435-822-7
J9 HRADEC ECON DAYS
PY 2021
VL 11
BP 611
EP 619
DI 10.36689/uhk/hed/2021-01-060
PN 1
PG 9
WC Business; Economics
WE Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Business & Economics
GA BR8BA
UT WOS:000670596900060
OA hybrid
DA 2022-04-20
ER

PT J
AU Chakawata, W
AF Chakawata, Webster
TI Africa's response to COVID-19: a governmentality in disguise
   masterclass?
SO INTERNATIONAL REVIEW OF SOCIOLOGY-REVUE INTERNATIONALE DE SOCIOLOGIE
LA English
DT Article; Early Access
DE Africa; COVID-19; Foucault; governmentality; disciplinary power
ID POWER
AB At the risk of oversimplification, virtually all research that scrutinizes COVID-19 is propelled by identical points of departures which chief in their assessment, portray how the pandemic accentuates the likelihood of illiberal or autocratic regimes tightening restrictions upon civil liberties. This paper is no different as it is predicated along this initial starting point but is also carrying an ambition to bring to light how the pandemic context, perhaps counterintuitively has also provided authoritarian governments with the platform to uptake provisions that bring about a veneer of civil rights and the potential which this vacillation between increasingly authoritarian and considerably liberal approaches in handling the virus generates. This paper is offset by Foucault's theorizing on Governmentality and illuminates on how African governments have responded to the virus in the textbook manner Foucault envisages. In so doing, it challenges the generally advanced idea that Governmentality is only applicable in Western liberal contexts by looking at African countries response to the COVID-19 pandemic that has enlisted classic Governmentality techniques such as disciplinary power, surveillance and power/knowledge monopoly by African states.
C1 [Chakawata, Webster] Univ Zimbabwe, Sociol, Harare, Zimbabwe.
   [Chakawata, Webster] Coll Europe, European Interdisciplinary Studies, Warsaw, Poland.
   [Chakawata, Webster] Pan African Univ, Sport Management & Policy Dev, Ibadan, Nigeria.
RP Chakawata, W (corresponding author), 40 Eves Crescent,Ashdown Pk, Harare, Zimbabwe.
EM webster.chakawata@coleurope.eu
CR Abebe A.K, 2020, COMMENTARY ETHIOPIAS
   African Union, 2015, SIL GUNS OWN FUT REA
   African Union, 2020, AFR UN CONV CYB PERS
   Agamben G., 2000, MEANS END NOTES POLI
   Agamben G., 2005, STATE EXCEPTION
   [Anonymous], 2020, ECONOMIST
   [Anonymous], 2020, BBC NEWS
   Appiagyei-Atua K, 2020, CONVERSATION
   Bourdieu P., 1986, DISTINCTION SOCIAL C, P241
   Bradlow D, 2020, CONVERSATION
   Burchell G., 1991, DISCIPLINE PUNISH BI
   Buzan Barry, 1998, SECURITY NEW FRAMEWO
   Cheeseman N, 2019, CONVERSATION
   Committee to Protection Journalists, 2020, JOURN KAK TOUD MAM G
   Cormacain R, 2020, THEORY PRACT LEGIS, V8, P245, DOI 10.1080/20508840.2020.1786272
   Dunne T., 2013, INT RELATIONS THEORI
   ENGELSTEIN L, 1993, AM HIST REV, V98, P338, DOI 10.2307/2166836
   Falana F, 2020, VANGUARD
   FOUCAULT M, 1982, CRIT INQUIRY, V8, P777, DOI 10.1086/448181
   Foucault M., 2004, SECURITE TERRITOIRE
   Foucault M, 1981, UNTYING TEXT POSTSTR, P48
   Foucault M., 2004, SOC MUST BE DEFENDED
   Foucault M., 1980, HIST SEXUALITY, V1
   Foucault M., 1975, DISCIPLINE PUNISH BI
   Funk A., 2020, PROTECT BOTH PUBLIC
   Gakpo J.O, 2020, AFRICAN GOVT MOBILIZ
   Ghoshal N., 2020, UGANDA LGBT SHELTER
   Grothe C., 2021, COVID 19 PANDEMIC IN
   Habermas Jurgen, 1962, STRUCTURAL TRANSFORM
   Hanefeld J, 2015, INT J HEALTH POLICY, V4, P119, DOI 10.15171/ijhpm.2015.25
   Hernandez S., 2021, THE CNN
   Hindess B, 1996, DISCOURSES POWER HOB
   Hobbes Thomas., 1998, LEVIATHAN-J MELVILLE
   Hurley M, 1978, HIST SEXUALITY, V1
   International Labour Office, 2018, WOM MEN INF EC STAT, VThird
   International Labour Organization, 2020, COVID 19 CRIS INF EC
   Jerving S, 2020, S AFRICA DATA SHOWS
   Joseph J, 2010, EUR J INT RELAT, V16, P223, DOI 10.1177/1354066109346886
   Kiersey NJ, 2009, GLOB SOC, V23, P353, DOI 10.1080/13600820903198602
   Latour B, 2021, CRIT INQUIRY, V47, pS25, DOI 10.1086/711428
   Lemke T, 2001, ECON SOC, V30, P190, DOI 10.1080/03085140120042271
   Lemke T., 2002, RETHINK MARXISM, V14, P49, DOI DOI 10.1080/089356902101242288
   Li TM., 2007, ANTHROPOLOGICA, V49, P275
   Lilja M, 2014, J POLITICAL POWER, V7, P107, DOI 10.1080/2158379X.2014.889403
   Makinda SM, 2008, GLOB INST, P1
   Morayef H., 2020, ALGERIA END REPRESSI
   Munishi D., 2020, AFRICAN ARGUMENTS
   Mutsaka F, 2020, NBC MONTANA
   Narayan T., 2020, MATHEMATICA
   Patton Cindy, 2011, ECON POLIT WEEKLY, V46, P103
   Pigou P, 2019, REVOLT REPRESSION ZI
   Plamper J, 2002, KRITIKA, V3, P255, DOI 10.1353/kri.2002.0027
   Reporters Without Borders, 2020, FAKE NEWS BILL WILL
   Rhodes N., 2020, CORRUPTION CORONAVIR
   Ritzer G., 2001, HDB SOCIAL THEORY
   Ritzer G., 2007, BLACKWELL ENCY SOCIO
   Scholte J. A., 2005, GLOBALIZATION CRITIC
   Signe L, 2019, QUARTZ AFRICA
   Smith StevenB., 1989, HEGELS CRITIQUE LIBE
   Statista, 2021, TOT NUMB COR COVID 1
   Taye B., 2020, ACCESS NOW
   United Nations Human Rights Office of the High Commissioner, 2020, COVID 19 GOVT MUST P
   Woodhams S, 2020, DTSCH WELLE
   World Health Organization, 2021, WHO COR DIS DASHB
NR 64
TC 0
Z9 0
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0390-6701
EI 1469-9273
J9 INT REV SOCIOL
JI Int. Rev. Sociol.
DI 10.1080/03906701.2022.2028403
EA JAN 2022
PG 27
WC Sociology
WE Emerging Sources Citation Index (ESCI)
SC Sociology
GA YR5ZN
UT WOS:000750073500001
DA 2022-04-20
ER

PT J
AU Peng, JY
   Zhang, M
   Yao, GQ
   Kwok, LY
   Zhang, WY
AF Peng, Jiangying
   Zhang, Meng
   Yao, Guoqiang
   Kwok, Lai-Yu
   Zhang, Wenyi
TI Probiotics as Adjunctive Treatment for Patients Contracted COVID-19:
   Current Understanding and Future Needs
SO FRONTIERS IN NUTRITION
LA English
DT Review
DE COVID-19; SARS-CoV-2; acute respiratory disease; pneumonia; probiotics;
   adjunctive treatment; gut-lung axis
ID GUT-LUNG AXIS; CORONAVIRUS; MICROBIOME; INFLAMMATION; PREBIOTICS; IMPACT
AB The coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which rages all over the world and seriously threatens human life and health. Currently, there is no optimal treatment for COVID-19, and emerging evidence found that COVID-19 infection results in gut microbiota dysbiosis. The intestinal microbial richness of patients of COVID-19 does not return to normal levels even six months after recovery, but probiotic adjunctive treatment has been found to restore gut homeostasis. An updated PubMed search returned four finished clinical trials that supported the use of probiotics as adjunctive treatment for COVID-19, while at least six clinical trials aiming to investigate beneficial effects of probiotic intake in managing COVID-19 are currently in progress worldwide. Here in we tentatively summarized the understanding of the actions and potential mechanisms of probiotics in the management of COVID-19. We also highlighted some future needs for probiotic researchers in the field. The success in using probiotics as adjunctive treatment for COVID-19 has expanded the scope of application of probiotics, meanwhile deepening our knowledge in the physiological function of probiotics in modulating the gut-lung axis.
C1 [Peng, Jiangying; Zhang, Meng; Yao, Guoqiang; Kwok, Lai-Yu; Zhang, Wenyi] Inner Mongolia Agr Univ, Minist Educ, Key Lab Dairy Biotechnol & Engn, Hohhot, Peoples R China.
   [Peng, Jiangying; Zhang, Meng; Yao, Guoqiang; Kwok, Lai-Yu; Zhang, Wenyi] Inner Mongolia Agr Univ, Minist Agr & Rural Affairs, Key Lab Dairy Prod Proc, Hohhot, Peoples R China.
RP Zhang, WY (corresponding author), Inner Mongolia Agr Univ, Minist Educ, Key Lab Dairy Biotechnol & Engn, Hohhot, Peoples R China.; Zhang, WY (corresponding author), Inner Mongolia Agr Univ, Minist Agr & Rural Affairs, Key Lab Dairy Prod Proc, Hohhot, Peoples R China.
EM zhangwenyizi@163.com
OI Zhang, Meng/0000-0001-5841-4079
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [31922071]
FX This research was supported by the National Natural Science Foundation
   of China (Grant No. 31922071).
CR Akour A, 2020, LETT APPL MICROBIOL, V71, P229, DOI 10.1111/lam.13334
   Baindara P, 2021, NEW MICROB NEW INFEC, V40, DOI 10.1016/j.nmni.2021.100837
   Baud D, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00186
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen YF, 2022, GUT, V71, P222, DOI 10.1136/gutjnl-2021-324090
   d'Ettorre G, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00389
   Dickerson F, 2018, BIPOLAR DISORD, V20, P614, DOI 10.1111/bdi.12652
   Dickson RP, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.113, 10.1038/nmicrobiol.2016.113]
   Din AU, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.110947
   Ding RX, 2019, J FOOD DRUG ANAL, V27, P623, DOI 10.1016/j.jfda.2018.12.012
   Duarte R, 2020, ACTA MEDICA PORT, V33, P155, DOI 10.20344/amp.13547
   Ferreira C, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8101514
   Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10
   Giannoni E, 2020, LANCET GASTROENTEROL, V5, P720, DOI 10.1016/S2468-1253(20)30195-3
   Gu SL, 2020, CLIN INFECT DIS, V71, P2669, DOI 10.1093/cid/ciaa709
   Hao QK, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006895.pub2
   Hiippala K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080988
   Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hu JL, 2021, TRENDS FOOD SCI TECH, V108, P187, DOI 10.1016/j.tifs.2020.12.009
   Kang HJ, 2015, J NUTR SCI VITAMINOL, V61, pS103, DOI 10.3177/jnsv.61.S103
   Koopmans T, 2021, STEEL RES INT, V92, DOI 10.1002/srin.202100290
   Lahti L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5344
   Lee IC, 2020, J CHIN MED ASSOC, V83, P521, DOI 10.1097/JCMA.0000000000000319
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Mak JWY, 2020, LANCET GASTROENTEROL, V5, P644, DOI 10.1016/S2468-1253(20)30122-9
   Marsland BJ, 2015, ANN AM THORAC SOC, V12, pS150, DOI 10.1513/AnnalsATS.201503-133AW
   Sheng W., 2021, RES SQ, V0, P1, DOI [10.21203/rs.3.rs-72753/v1, DOI 10.21203/RS.3.RS-72753/V1]
   Stavropoulou E, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.614986
   Sundararaman A, 2020, APPL MICROBIOL BIOT, V104, P8089, DOI 10.1007/s00253-020-10832-4
   Suvorov Alexander, 2013, Biosci Microbiota Food Health, V32, P81, DOI 10.12938/bmfh.32.81
   Sybesma W, 2013, APPL ENVIRON MICROB, V79, P2233, DOI 10.1128/AEM.03566-12
   de Oliveira GLV, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.635471
   Walton GE, 2021, BRIT J NUTR, V126, P219, DOI 10.1017/S0007114520003980
   Wang YZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004509
   Xu Kaijin, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P147, DOI 10.3785/j.issn.1008-9292.2020.02.02
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Ya T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-68
   Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d
   Yang Q, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020381
   Yeoh YK, 2021, GUT, V70, P698, DOI 10.1136/gutjnl-2020-323020
   Yu Linda Chia-Hui, 2012, World J Gastrointest Pathophysiol, V3, P27, DOI 10.4291/wjgp.v3.i1.27
   Zhang Q, 2021, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.595157
   Zhao W, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.643420
   Zhao W, 2020, FOOD BIOSCI, V36, DOI 10.1016/j.fbio.2020.100656
   Zuo T, 2021, GUT, V70, P276, DOI 10.1136/gutjnl-2020-322294
NR 48
TC 7
Z9 7
U1 10
U2 19
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD JUN 10
PY 2021
VL 8
AR 669808
DI 10.3389/fnut.2021.669808
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA SW8BJ
UT WOS:000664739600001
PM 34179059
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Rosenberg, S
   Mendoza, J
   Tabatabaei-Jafari, H
   Salvador-Carulla, L
AF Rosenberg, Sebastian
   Mendoza, John
   Tabatabaei-Jafari, Hossein
   Salvador-Carulla, Luis
CA Pandemic Mental Hlth
TI International experiences of the active period of COVID-19-Mental health
   care
SO HEALTH POLICY AND TECHNOLOGY
LA English
DT Article
DE COVID-19; Mental health; Health planning; Health systems research
ID SYSTEMS
AB Aim: To summarise commonalities and variations in the mental health response to COVID-19 across different sites and countries, with a view to better understanding key steps not only in crisis management, but for future systemic reform of mental health care.
   Method: We conducted a Rapid Synthesis and Translation Process of lessons learned from an international panel of experts, collecting on the ground experiences of the pandemic as it evolved in real time. Digital conferencing and individual interviews were used to rapidly acquire knowledge on the COVID-19 outbreak across 16 locations in Australia, Denmark, Italy, Spain, Taiwan, the UK, and the USA.
   Results: COVID-19 has had massive impacts on mental health care internationally. Most systems were under-resourced and under-prepared, struggling to manage both existing and new clients. There were significant differences between sites, depending on the explosivity the pandemic and the readiness of the mental health system. Integrated, community mental health systems exhibited greater adaptability in contrast to services which depended on face-to-face and hospital-based care. COVID-19 has demonstrated the need for a new approach to rapid response to crisis in mental health. New decision support system tools are necessary to ensure local decision-makers can effectively respond to the enormous practical challenges posed in these circumstances.
   Conclusions: The process we have undertaken has generated clear lessons for mental health policymakers worldwide, beyond pandemic planning and response to guide next steps in systemic mental health reform. Key here is achieving some balance between national leadership and local context adaptation of evidence. (c) 2020 Fellowship of Postgraduate Medicine. Published by Elsevier Ltd. All rights reserved.
C1 [Rosenberg, Sebastian; Tabatabaei-Jafari, Hossein; Salvador-Carulla, Luis; Pandemic Mental Hlth] Australian Natl Univ, ANU Coll Hlth & Med, Res Sch Populat Hlth, Mental Hlth Res Ctr, 63 Eggleston Rd, Acton, ACT 2601, Australia.
   [Rosenberg, Sebastian] Univ Sydney, Brain & Mind Ctr, Mental Hlth Policy Unit, Sydney, NSW, Australia.
   [Mendoza, John] Univ Sydney, Fac Med, Sydney, NSW, Australia.
   [Mendoza, John] Adelaide Local Hlth Network, Mental Hlth Ctr, Adelaide, SA, Australia.
RP Tabatabaei-Jafari, H (corresponding author), Australian Natl Univ, ANU Coll Hlth & Med, Res Sch Populat Hlth, Mental Hlth Res Ctr, 63 Eggleston Rd, Acton, ACT 2601, Australia.
EM hossein.tabatabaei@anu.edu.au
RI Rosenberg, Sebastian/AAJ-3998-2021; Tabatabaei-Jafari,
   Hossein/Q-8709-2019; Bertelli, Marco O/U-4862-2017; PRISMA,
   Grupo/AAI-6753-2021; Salvador-Carulla, Luis/K-6512-2013
OI Bertelli, Marco O/0000-0002-4228-9338; Dalton,
   Hazel/0000-0002-5816-4548; Tabatabaei-Jafari,
   Hossein/0000-0003-4871-1226; Rosenberg, Sebastian/0000-0002-3374-8694;
   Reis, AlessanRSS/0000-0001-8486-7469; Mendoza, john/0000-0001-7231-1826;
   Dudgeon, Pat/0000-0003-2799-5709; Salvador-Carulla,
   Luis/0000-0002-5742-9866; Perkins, David/0000-0001-9739-7339
CR Alvarez-Galvez J, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1013-3
   Anmella G, 2020, J AFFECT DISORD
   [Anonymous], 2020, COVID 19 GREAT PROT
   [Anonymous], 2021, COR DIS COVID 19 PAN, DOI DOI 11/44679/INDEX.HTM
   [Anonymous], 2020, IND ORG GEST SERV SA
   Barbato A, 2014, ACCESS MENTAL HLTH C
   Bertelli M.O., 2020, ADVICE MANAGING COVI
   Bhugra D, 2017, LANCET PSYCHIAT, V4, P775, DOI 10.1016/S2215-0366(17)30333-4
   Castelletti S, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2007028
   Chiolero A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m764
   Colizzi M, 2020, BRAIN SCI, V10
   Curnow S., 2020, CORONAVIRUS SHUTDOWN
   de Girolamo G, 2020, JAMA PSYCHIAT
   De Leo D, 2020, INT PSYCHOGERIATR, V32, P1161, DOI 10.1017/S1041610220000630
   DELEEUW E, 2001, GLOBAL CHANGE HUMAN, V2, P34, DOI DOI 10.1023/A:1011991014805
   Department of Health, 2020, NAT MENT HLTH WELLB
   Dom G, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010122
   Druss B.G., 2020, JAMA PSYCHIAT, DOI 10.1001/jamapsychiatry.2020.0894
   European Union, 2020, EUR CTR DIS PREV CON
   Fisher JR, 2020, MED J AUST, V10
   Govindarajan A., 2020, SAFEGUARDING OUR LIV
   Hartzband P, 2020, N ENGL J MED
   Kawohl W, 2020, LANCET PSYCHIAT, V7, P389, DOI 10.1016/S2215-0366(20)30141-3
   Kirzinger A., 2020, KFF HLTH TRACKING PO
   Kohn R, 2018, REV PANAM SALUD PUBL, V42, DOI 10.26633/RPSP.2018.165
   Lesser R., 2020, Leading out Adversity
   McElroy N., 2020, ABC NEWS
   Medhora S, 2020, YOUNG PEOPLE ARE EXP
   Molloy S., 2020, SILENT DEATH TOLL CO
   Montemurro N., 2020, BRAIN BEHAV IMMUN
   National Healthcare Safety Network, 2020, COVID 19 MOD
   Newnham EA, 2020, LANCET PLANET HEALTH, V4, pE89, DOI 10.1016/S2542-5196(20)30036-X
   Nicaise P, 2014, HEALTH POLICY, V115, P120, DOI 10.1016/j.healthpol.2014.02.007
   Patel V, 2018, LANCET, V392, P1553, DOI 10.1016/S0140-6736(18)31612-X
   Pineda VS, 2020, J URBAN HEALTH, V97, P336, DOI 10.1007/s11524-020-00437-7
   Priego A., 2020, COVID 19 RADIOGRAFIA
   Reger MA, 2020, JAMA PSYCHIAT
   Rentero D, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113097
   Research School of Population Health, 2020, GLOB IMP COVID 19 ME
   Research school of Population Health, 2019, INT ATL MENT HLTH CA
   Rosen A, 2020, CURR OPIN PSYCHIATR, V33, P375, DOI 10.1097/YCO.0000000000000620
   Rosenberg SP, 2019, MED J AUSTRALIA, V210, P299, DOI 10.5694/mja2.50068
   Salvador-Carulla L., 2013, EVALUATION INTEGRATE
   Salvador-Carulla L., 2020, NEW FRAMEWORK RAPID
   Sheridan Rains L., 2020, EARLY IMPACTS COVID
   Sneader K., 2020, RETURNING RESILIENCE
   Thigpen S, 2012, AM J COMMUN PSYCHOL, V50, P285, DOI 10.1007/s10464-012-9537-3
   Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212
   United Nations, 2020, POL BRIEF COVID 19 N
   Vieta E, 2020, REV PSIQUIATRIA SALU
   World Health Organization, 2020, WHO MENT HLTH PSYCH
   Wright L, 2020, J EPIDEMIOL COMMUNIT
   Yu-Tao Xiang, 2020, JAMA PSYCHIAT
NR 53
TC 15
Z9 15
U1 11
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2211-8837
J9 HEALTH POLICY TECHN
JI Health Policy Technol.
PD DEC
PY 2020
VL 9
IS 4
BP 503
EP 509
DI 10.1016/j.hlpt.2020.08.016
PG 7
WC Health Policy & Services
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA OX7TZ
UT WOS:000593763800009
PM 32874855
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Lin, CL
   Chen, JKC
   Ho, HH
AF Lin, Chih-Lung
   Chen, James K. C.
   Ho, Han-Hsi
TI BIM for Smart Hospital Management during COVID-19 Using MCDM
SO SUSTAINABILITY
LA English
DT Article
DE smart hospital; building information modeling (BIM); Internet of Things
   (IoT); cyber physical system (CPS); service technology innovation
ID CYBER-PHYSICAL SYSTEMS; INFORMATION-SYSTEMS; FUZZY AHP; INTERNET;
   THINGS; TECHNOLOGY; DELPHI; MODEL
AB In context of the recent COVID-19 pandemic, smart hospitals' contributions to pre-medical, remote diagnosis, and social distancing has been further vetted. Smart hospital management evolves with new technology and knowledge management, which needs an evaluation system to prioritize its associated criteria and sub-criteria. The global effect of the COVID-19 pandemic further necessitates a comprehensive research of smart hospital management. This paper will utilize Analytical Hierarchy Process (AHP) within Multiple Criteria Decision Making (MCDM) to establish a smart hospital evaluation system with evaluation criteria and sub-criteria, which were then further prioritized and mapped to BIM-related alternatives to inform asset information management (AIM) practices. This context of this study included the expert opinions of six professionals in the smart hospital field and collected 113 responses from hospital-related personnel. The results indicated that functionalities connected to end users are critical, in particular IoT's Network Core Functionalities, AI's Deep Learning and CPS's Special Network Technologies. Furthermore, BIM's capability to contribute to the lifecycle management of assets can relate and contribute to the asset-intensive physical criteria of smart hospitals, in particular IoT, service technology innovations and their sub-criteria.
C1 [Lin, Chih-Lung] Asia Univ Hosp, Dept Neurosurg, Taichung 413, Taiwan.
   [Chen, James K. C.; Ho, Han-Hsi] Asia Univ, Dept Business Adm, Taichung 413, Taiwan.
RP Chen, JKC; Ho, HH (corresponding author), Asia Univ, Dept Business Adm, Taichung 413, Taiwan.
EM jefflin0529@gmail.com; kcchen@asia.edu.tw; hhh@hanhsiho.com
OI Ho, Han-Hsi/0000-0001-7609-1613
FU Asia University Hospital [ASIA-107-AUH-04]; Asia University R&D
   department office; Asia University RD Office
FX This research was funded by Asia University R&D Office and Asia
   University Hospital (Project No. "ASIA-107-AUH-04"). We are thankful for
   Asia University R&D department office's fellowship and full support for
   this research.
CR Aceto G, 2020, J IND INF INTEGR, V18, DOI 10.1016/j.jii.2020.100129
   Al-Turjman F, 2020, COMPUT COMMUN, V150, P644, DOI 10.1016/j.comcom.2019.12.030
   Alcacer V, 2019, ENG SCI TECHNOL, V22, P899, DOI 10.1016/j.jestch.2019.01.006
   Allan M, 2020, BRIT J SURG, V107, pE538, DOI 10.1002/bjs.12015
   Aman AHM, 2021, J NETW COMPUT APPL, V174, DOI 10.1016/j.jnca.2020.102886
   Aquilani B, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12218943
   Ashton K., 2009, RFID J, V22, P97, DOI DOI 10.1145/2967977
   Baladron C, 2021, REV ESP CARDIOL, V74, P81, DOI [10.1016/j.recesp.2020.06.017, 10.1016/j.rec.2020.06.036]
   BEAUMONT JR, 1988, FUTURES, V20, P69, DOI 10.1016/0016-3287(88)90044-4
   Biesinger F, 2019, PROC CIRP, V79, P355, DOI 10.1016/j.procir.2019.02.087
   Brandtner Michal, 2020, IOP Conference Series: Earth and Environmental Science, V609, DOI 10.1088/1755-1315/609/1/012048
   British Standards Institution, 2019, 196503 BS EN ISO BRI
   Calabrese A, 2013, EXPERT SYST APPL, V40, P3747, DOI 10.1016/j.eswa.2012.12.081
   Chang WH, 2020, TAIWAN J OBSTET GYNE, V59, P821, DOI 10.1016/j.tjog.2020.09.007
   Chen C.-W., 2019, P 36 INT S AUT ROB C, P897
   ENISA, 2016, SMART HOSP SEC RES S
   Falak J, 2020, MATER TODAY-PROC, V22, P1295
   Fiaidhi J, 2021, COMPUT COMMUN, V170, P84, DOI 10.1016/j.comcom.2021.01.029
   Gebre-Mariam M, 2019, INFORM ORGAN-UK, V29, P1, DOI 10.1016/j.infoandorg.2018.12.002
   German Federal Government, 2011, IND 4 0 BMBF
   Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1
   Gu DX, 2019, INFORM MANAGE-AMSTER, V56, DOI 10.1016/j.im.2019.04.005
   Hamam H, 2019, ADV METHODOLOGIES TE, P23
   Haruna A, 2021, AIN SHAMS ENG J, V12, P293, DOI 10.1016/j.asej.2020.06.006
   Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x
   Ho, 2019, P ANN INT C ARCH CIV
   Humphrey-Murto S, 2017, ACAD MED, V92, P1491, DOI 10.1097/ACM.0000000000001812
   Isikdag U, 2012, AUTOMAT CONSTR, V25, P59, DOI 10.1016/j.autcon.2012.04.013
   Jackson P., 1998, INTRO EXPERT SYSTEMS
   Jamaludin J, 2018, 2018 INTERNATIONAL CONFERENCE ON COMPUTING, ELECTRONIC AND ELECTRICAL ENGINEERING (ICE CUBE)
   Jamil F, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8050505
   Jin TX, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102446
   Johns Hopkins Coronavirus Resource Center, 2021, TAIW COVID 19 OV J H
   Juyal S, 2021, MATER TODAY-PROC, V46, P10539, DOI 10.1016/j.matpr.2021.01.074
   Kayleigh, 2020, WHAT IS SMART HOSP H
   Koksalan M., 2011, MULTIPLE CRITERIA DE
   Kumar S, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0268-2
   Kumar S, 2020, INT J HEALTHCARE MAN, V13, P337, DOI 10.1080/20479700.2020.1810453
   Labib, 2009, OR INSIGHT, V22, P201, DOI [10.1057/ori.2009.10, DOI 10.1057/ORI.2009.10]
   Lee SH, 2010, EXPERT SYST APPL, V37, P4941, DOI 10.1016/j.eswa.2009.12.020
   Lei Y, 2020, J IND INF INTEGR, V20, DOI 10.1016/j.jii.2020.100171
   Li J, 2016, IND BIG DATA INT TRA, P90
   Li L, 2018, TECHNOL FORECAST SOC, V135, P66, DOI 10.1016/j.techfore.2017.05.028
   Liang CY, 2017, INFORM MANAGE-AMSTER, V54, P57, DOI 10.1016/j.im.2016.03.010
   Min-Fang T, 2019, COMPUT STAND INTER, V66, DOI 10.1016/j.csi.2019.04.001
   Nair MM, 2019, PROCEDIA COMPUT SCI, V165, P647, DOI 10.1016/j.procs.2020.01.059
   NHSScotland, 2016, IMPL PRACT US NHS SC
   Numbeo, 2021, HLTH CAR IND COUNTR
   Panetta K, 2021, SMARTNER GART
   Patel K.K., 2016, INT J ENG SCI COMPUT, V6, P1
   Pereira A.G., 2020, INT J RECENT TECHNOL, V8, P3305
   Pivoto DGS, 2021, J MANUF SYST, V58, P176, DOI 10.1016/j.jmsy.2020.11.017
   Ploskas N, 2018, MULTIPLE CRITERIA DE, P109
   Poole D., 1998, COMPUTATIONAL INTELL
   Qadri YA, 2020, IEEE COMMUN SURV TUT, V22, P1121, DOI 10.1109/COMST.2020.2973314
   Rabiser R, 2021, PROCEDIA COMPUT SCI, V180, P50, DOI 10.1016/j.procs.2021.01.128
   Ray PP, 2020, COMPUT COMMUN, V160, P111, DOI 10.1016/j.comcom.2020.05.029
   Rong G, 2020, ENGINEERING-PRC, V6, P291, DOI 10.1016/j.eng.2019.08.015
   Russell S, 2020, ARTIFICIAL INTELLIGE, V4th
   Russo RDSM, 2015, PROCEDIA COMPUT SCI, V55, P1123, DOI 10.1016/j.procs.2015.07.081
   SAATY RW, 1987, MATH MODELLING, V9, P161, DOI 10.1016/0270-0255(87)90473-8
   Sacks R, 2018, BIM HDB GUIDE BUILDI
   Scully P., 2020, TOP 10 IOT APPL 2020
   Shorabeh SN, 2021, J CLEAN PROD, V295, DOI 10.1016/j.jclepro.2021.126318
   Sica F, 2019, VALUES FUNCTIONS FUT, P201
   Singh, 2015, PROJECT MANAGEMENT A
   Stevenson AG, 2021, SEMIN FETAL NEONAT M, V26, DOI 10.1016/j.siny.2021.101204
   Tan T, 2021, AUTOMAT CONSTR, V121, DOI 10.1016/j.autcon.2020.103451
   Thakare V, 2014, PROC ECON FINANC, V11, P583, DOI 10.1016/S2212-5671(14)00223-8
   The British Standard Institution, 2020, BSI KIT BIM ASS MAN
   Trawinski B, 2016, COMPUTATIONAL COLLEC, P434
   Vargas L.G, 2015, DECISION MAKING ANAL
   Warkentin M, 2015, FT PRESS ANAL
   WOOLDRIDGE M, 1995, KNOWL ENG REV, V10, P115, DOI 10.1017/S0269888900008122
   Yang G, 2020, IEEE J BIOMED HEALTH, V24, P2535, DOI 10.1109/JBHI.2020.2990529
   Yang HZ, 2021, INFORM PROCESS MANAG, V58, DOI 10.1016/j.ipm.2020.102461
   Zikria YB, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20082334
   Zolbanin HM., 2020, INFORM MANAGE, DOI [10.1016/j.im.2020.103282, DOI 10.1016/J.IM.2020.103282]
NR 78
TC 2
Z9 2
U1 12
U2 20
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD JUN
PY 2021
VL 13
IS 11
AR 6181
DI 10.3390/su13116181
PG 18
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA SQ9VS
UT WOS:000660696000001
OA gold
DA 2022-04-20
ER

PT J
AU Alsofayan, YM
   Althunayyan, SM
   Khan, AA
   Hakawi, AM
   Assiri, AM
AF Alsofayan, Yousef M.
   Althunayyan, Saqer M.
   Khan, Anas A.
   Hakawi, Ahmed M.
   Assiri, Abdullah M.
TI Clinical characteristics of COVID-19 in Saudi Arabia: A national
   retrospective study
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; Coronavirus; Saudi Arabia; Clinical characteristics; Outbreak
ID CORONAVIRUS; PNEUMONIA; WUHAN
AB Background: The global battle to contain the novel coronavirus disease 2019 (COVID-19) pandemic rages on. Previous studies described the clinical characteristics of COVID-19, but knowledge gaps remain in the Middle East region. Identifying these features will help in mapping the disease and guiding pandemic management. A multi-center, retrospective cross-sectional study was initiated to describe the demographic data, clinical characteristics, and outcomes of COVID-19 cases across all the regions of Saudi Arabia.
   Methods: The analysis included all laboratory-confirmed positive COVID-19 patients from the 1st of March 2020 to 31st of March 2020 across all regions of Saudi Arabia. Demographic data, clinical characteristics, incubation periods, laboratory findings, and patient outcomes data were retrieved from 1519 cases in the Health Electronic Surveillance Network Database.
   Results: The median age was 36 years and 54.3% (n = 825) of the patients were men. Patients working in health care facilities represented 12.5% of the cases (n = 190) and 9.3% of cases were asymptomatic. The median incubation period was 6 days. The most common symptoms were cough (89.4%), fever (85.6%), and sore throat (81.6%); 20.1% of the patients had underlying comorbidities. Hypertension was seen in 8.8% and diabetes in 7.6% of all the cases. The percentage of cases with temperatures >38 (sic)C was 20.3% (n = 129), and 1.6% of patients had heart rates >= 125 beats/min and 4.7% of them had respiratory rates of >24 breaths/min. Lymphocytopenia occurred in 37.5% of cases. Overall, 71.6% of patients were admitted to hospitals and 4.7% required ICU treatment. We could not completely assess the clinical courses or final outcomes of COVID-19 patients.
   Conclusion: In this multi-center retrospective study, fever and cough were common symptoms. Special attention should be addressed toward asymptomatic carriers and workers in health care facilities as they play a key role in disease transmission. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Alsofayan, Yousef M.] Minist Hlth, Global Ctr Mass Gatherings Med, POB 11461, Riyadh 11176, Saudi Arabia.
   [Althunayyan, Saqer M.] King Saud Univ, Prince Sultan Bin Abdulaziz Coll Emergency Med Se, Dept Accid & Trauma, Riyadh, Saudi Arabia.
   [Khan, Anas A.] King Saud Univ, Dept Emergency Med, Coll Med, Global Ctr Mass Gatherings Med,Minist Hlth, Riyadh, Saudi Arabia.
   [Hakawi, Ahmed M.] Minist Hlth, Gen Directorate Infect Dis Control, Riyadh, Saudi Arabia.
   [Assiri, Abdullah M.] Minist Hlth, Riyadh, Saudi Arabia.
RP Alsofayan, YM (corresponding author), Minist Hlth, Global Ctr Mass Gatherings Med, POB 11461, Riyadh 11176, Saudi Arabia.
EM ymalsofayan@hotmail.com; salthunayyan@ksu.edu.sa; khanaa@moh.gov.sa;
   ahakawi@moh.gov.sa; AbdullahM.Asiri@moh.gov.sa
RI assiri, abdullah/AAF-5665-2021; AlSofayan, Yousef/AAT-2998-2020; Khan,
   Anas/Q-7349-2017
OI assiri, abdullah/0000-0002-5605-2876; AlSofayan,
   Yousef/0000-0001-7028-7930; , saqer/0000-0001-7994-3412; Khan,
   Anas/0000-0001-5075-7392
CR Al Kahlout RA, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/1386740
   [Anonymous], 2020, MOH NEWS         MAR
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Black J, 2020, LANCET, DOI [10.1016/S0140-6736(20)30917-X.3099(20)30086-4, DOI 10.1016/S0140-6736(20)30917-X.3099(20)30086-4]
   Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 1
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Muller MA, 2015, LANCET INFECT DIS, V15, P559, DOI 10.1016/S1473-3099(15)70090-3
   Pan T, 2020, SCAND J GASTROENTERO, V55, P123, DOI 10.1080/00365521.2019.1707275
   Petrosillo N, 2020, CLIN MICROBIOL INFEC, DOI [10.10161j.cm42020,03,026., DOI 10.10168/J.CM42020.03.026]
   Severance EG, 2008, CLIN VACCINE IMMUNOL, V15, P1805, DOI 10.1128/CVI.00124-08
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   WHO China, 2020, REP WHO CHIN JOINT M, DOI DOI 10.1186/S40249-020-00650-1
   World Health Organization, 2020, COR DIS COVID 19 TEC
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 26
TC 122
Z9 124
U1 1
U2 4
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JUL
PY 2020
VL 13
IS 7
BP 920
EP 925
DI 10.1016/j.jiph.2020.05.026
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA MG5EJ
UT WOS:000546054800004
PM 32534945
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ning, LW
   Niu, JY
   Bi, XJ
   Yang, C
   Liu, Z
   Wu, QH
   Ning, N
   Liang, LB
   Liu, AS
   Hao, YH
   Gao, LJ
   Liu, CJ
AF Ning, Liangwen
   Niu, Jinyu
   Bi, Xuejing
   Yang, Chao
   Liu, Ze
   Wu, Qunhong
   Ning, Ning
   Liang, Libo
   Liu, Aishu
   Hao, Yanhua
   Gao, Lijun
   Liu, Chaojie
TI The impacts of knowledge, risk perception, emotion and information on
   citizens' protective behaviors during the outbreak of COVID-19: a
   cross-sectional study in China
SO BMC PUBLIC HEALTH
LA English
DT Article
DE COVID-19; China; Behavior; Public health; Perception
ID PSYCHOLOGICAL RESPONSES; RESPIRATORY SYNDROME; HEALTH INFORMATION;
   INFLUENZA; EPIDEMIC; FLU; CORONAVIRUS; SINGAPORE; MEDIA; TRUST
AB BackgroundIndividual protective behaviors play an important role in the control of the spread of infectious diseases. This study aimed to investigate the adoption of protective behaviors by Chinese citizens amid the COVID-19 outbreak and its associated factors.MethodsAn online cross-sectional survey was conducted from 22 January to 14 February 2020 through Wenjuanxing platform, measuring their knowledge, risk perception, negative emotion, response to official communication, and protective behaviors in relation to COVID-19. A total of 3008 people completed the questionnaire, of which 2845 were valid questionnaires.ResultsOn average, 71% of respondents embraced protective behaviors. Those who made no error in the knowledge test (AOR=1.77, p<0.001) perceived the high severity of the epidemic (AOR=1.90, p<0.001), had high negative emotion (AOR=1.36, p=0.005), reported good health (AOR=1.94, p<0.001), paid high attention to the governmental media (AOR=4.16, p<0.001) and trusted the governmental media (AOR=1.97, p<0.001) were more likely to embrace protective behaviors after adjustments for variations in potential confounding factors. Women and older people were also more likely to embrace protective behaviors. No regional or educational differences were found in the adoption of protective behaviors.ConclusionThe majority of Chinese citizens embraced protective behaviors. Higher levels of protective behaviors are associated with higher knowledge, perceived severity, negative emotion, and attention to and trust in the official governmental media. Official governmental communication is the largest single predictor of protective behaviors.
C1 [Ning, Liangwen; Niu, Jinyu; Bi, Xuejing; Liu, Ze; Wu, Qunhong; Ning, Ning; Liang, Libo; Hao, Yanhua; Gao, Lijun] Harbin Med Univ, Sch Hlth Management, Harbin, Peoples R China.
   [Yang, Chao] Harbin Ctr Dis Control & Prevent, Harbin, Peoples R China.
   [Liu, Aishu] Harbin Normal Univ, Sch Educ Sci, Harbin, Peoples R China.
   [Liu, Chaojie] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic 3086, Australia.
RP Hao, YH; Gao, LJ (corresponding author), Harbin Med Univ, Sch Hlth Management, Harbin, Peoples R China.
EM hyhyjw@126.com; gg73@163.com
FU National Natural Scientific Fund of ChinaNational Natural Science
   Foundation of China (NSFC) [71673072, 72042001]
FX This study was funded by the National Natural Scientific Fund of China
   (71673072, 72042001). Funding body had no influence on study design,
   data collection, data analysis, data interpretation or writing the
   manuscript.
CR Ahmed F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5446-1
   Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103577
   Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42
   Barr M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-117
   Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826
   Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]
   Cho J, 2006, J BUS RES, V59, P112, DOI 10.1016/j.jbusres.2005.03.006
   Choi JS, 2016, NURS EDUC TODAY, V40, P168, DOI 10.1016/j.nedt.2016.03.006
   Dai Y.J., 2020, CHIN J PUBLIC HLTH, V36, P227
   Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021
   Elledge BL, 2008, HEALTH PROMOT PRACT, V9, p54S, DOI 10.1177/1524839908319089
   Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x
   Everett J. A., 2020, EFFECTIVENESS MORAL, DOI [10.31234/osf.io/9yqs8, DOI 10.31234/OSF.IO/9YQS8]
   Frijda N. H., 1986, EMOTIONS STUDIES EMO
   Fung ICH, 2006, TROP MED INT HEALTH, V11, P1749, DOI 10.1111/j.1365-3156.2006.01734.x
   GAO JL, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0231924, DOI 10.1371/JOURNAL.PONE.0231924]
   Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128
   Harper CA, 2020, INT J MENT HEALTH AD, DOI [DOI 10.1007/s11469-020-00281-5, 10.1007/s11469-020-00281-5]
   Ho SS, 2012, MASS COMMUN SOC, V15, P695, DOI 10.1080/15205436.2011.616275
   Howard JR, 2020, SUNY Series Afr Amer, P1
   Jang WM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122161
   Janis II, 1967, ADV EXPT SOCIAL PSYC, P166, DOI [10.1016/S0065-2601(08)60344-5., DOI 10.1016/S0065-2601(08)60344-5]
   JANISZEWSKI C, 1993, J CONSUM RES, V20, P376, DOI 10.1086/209356
   KASPERSON RE, 1992, J SOC ISSUES, V48, P161, DOI 10.1111/j.1540-4560.1992.tb01950.x
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Kellens W, 2013, RISK ANAL, V33, P24, DOI 10.1111/j.1539-6924.2012.01844.x
   Kim Chanwon, 2017, Crisisonomy, V13, P85, DOI 10.14251/crisisonomy.2017.13.6.85
   Kim Y, 2015, DISASTER MED PUBLIC, V9, P145, DOI 10.1017/dmp.2014.87
   Kwok KO, 2020, EMERG INFECT DIS, V26, P1575, DOI 10.3201/eid2607.200500
   Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037
   Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864
   Launiala A, 2009, ANTHR MATTERS, V11
   Le HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124377
   Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857
   Li JB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134820
   Menon KU, 2005, J COMMUN MANAG, V9, P375, DOI 10.1108/13632540510621614
   Qian M, 2020, PSYCHOL RESPONSES BE, DOI [DOI 10.1101/2020.02.18.20024448, 10.1101/2020.02.18.20024448.]
   Seo M, 2021, J MASS COMMUN Q, V98, P221, DOI 10.1177/1077699019857693
   Setbon M, 2011, PREV MED, V52, P178, DOI 10.1016/j.ypmed.2010.11.010
   Slovic P, 1999, RISK ANAL, V19, P689, DOI 10.1111/j.1539-6924.1999.tb00439.x
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   Tee ML, 2020, J AFFECT DISORDERS, V277, P379, DOI 10.1016/j.jad.2020.08.043
   Tenkorang EY, 2018, INT HEALTH, V10, P202, DOI 10.1093/inthealth/ihy009
   Wachinger G, 2013, RISK ANAL, V33, P1049, DOI 10.1111/j.1539-6924.2012.01942.x
   Walpole HD, 2021, J RISK RES, V24, P135, DOI 10.1080/13669877.2020.1749874
   Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   WHO-World Health Organization, 2018, MAN EP KEY FACTS MAJ
   Williams L, 2012, PSYCHOL HEALTH MED, V17, P383, DOI 10.1080/13548506.2011.626564
   Wise T, 2020, PSYARXIV, DOI [10.31234/osf.io/dz428, DOI 10.31234/OSF.I0/DZ428]
   World Health Organisation W, 2020, COR DIS COVID 19 ADV
   World Health Organization (WHO), 2020, ROLLING UPDATES CORO
   Wray RJ, 2008, AM J PUBLIC HEALTH, V98, P2214, DOI 10.2105/AJPH.2006.107102
   Yang JZ, 2018, J RISK RES, V21, P834, DOI 10.1080/13669877.2016.1247378
   Zeng JJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051750
   Zettler I., 2020, INDIVIDUAL DIFFERENC, DOI 10.31234/osf.io/pkm2a
   Zhang Ll, 2015, ATL J COMMUN, V23, P67, DOI 10.1080/15456870.2015.1013101
   Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221
NR 59
TC 37
Z9 38
U1 19
U2 33
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD NOV 23
PY 2020
VL 20
IS 1
AR 1751
DI 10.1186/s12889-020-09892-y
PG 12
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA PA7EQ
UT WOS:000595794400002
PM 33225934
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Chamakiotis, P
   Panteli, N
   Davison, RM
AF Chamakiotis, Petros
   Panteli, Niki
   Davison, Robert M.
TI Reimagining e-leadership for reconfigured virtual teams due to Covid-19
SO INTERNATIONAL JOURNAL OF INFORMATION MANAGEMENT
LA English
DT Review
DE Virtual teams; e-Leadership; e-Leaders; New normal; New ways of working;
   Remote working; Covid-19; Work reconfiguration
ID TRUST; TECHNOLOGY; COMMUNICATION; WORK; PERFORMANCE; ORGANIZATIONS;
   INFORMATION; CREATIVITY; BOUNDARIES; DISPERSION
AB Driven by an unexpected transition into virtual working worldwide as a result of the Coronavirus disease 2019 (Covid-19) pandemic, in this paper, we examine the extent to which existing knowledge from the literature on virtual teams (VTs) spanning two decades can be used to inform how leadership can be exercised in the Covid-19 'new normal', involving 'reconfigured' VTs which have both similarities with, and differences from, earlier VTs. Drawing on existing literature on VTs pre-Covid-19, we explore what current (and future) VTs might look like and what this means for leadership in this new context with an emphasis on how leadership, or e-leadership, can be exercised to help the leaders of traditional, physically collocated teams that had to transition into VTs. These new e-leaders need to come to grips with a variety of new challenges in order to create high-performing and sustainable VTs. Following a semi-systematic, state-of-the-art literature review, we: (a) identify key themes and explain with a theoretical model how existing knowledge can lead to new insights for newly transitioned eleaders; (b) discuss what future information systems (IS) researchers should focus on given the reconfiguration and new characteristics of VTs in the Covid-19 context; and (c) 'translate' the findings of our synthesis of the existing literature into prescriptive advice that can be used to inform practitioners.
C1 [Chamakiotis, Petros] ESCP Business Sch, Dept Management, C Arroyofresno 1, Madrid 28035, Spain.
   [Panteli, Niki] Royal Holloway Univ London, Sch Business & Management, Egham TW20 0EX, Surrey, England.
   [Davison, Robert M.] City Univ Hong Kong, Dept Informat Syst, Kowloon Tong, Kowloon, 83 Tat Chee Ave, Hong Kong, Peoples R China.
RP Chamakiotis, P (corresponding author), ESCP Business Sch, Dept Management, C Arroyofresno 1, Madrid 28035, Spain.
EM pchamakiotis@escp.eu; Niki.Panteli@rhul.ac.uk; isrobert@cityu.edu.hk
RI Chamakiotis, Petros/C-8844-2012; Davison, Robert M/E-4383-2013
OI Chamakiotis, Petros/0000-0001-7109-310X; Davison, Robert
   M/0000-0002-7243-3521
CR Adamovic M, 2018, INT J HUM RESOUR MAN, V29, P2159, DOI 10.1080/09585192.2017.1323227
   Agerfalk PJ, 2020, EUR J INFORM SYST, V29, P203, DOI 10.1080/0960085X.2020.1771968
   Ancona D, 2020, J MANAGE STUD, DOI 10.1111/joms.12651
   Asatiani A, 2021, INFORM SYST J, V31, P62, DOI 10.1111/isj.12293
   Ashforth BE, 2000, ACAD MANAGE REV, V25, P472, DOI 10.2307/259305
   Australian Psychological Society, 2020, MAINT EMPL ENG COVID, P1
   Axford AT, 2002, J TELEMED TELECARE, V8, P3, DOI 10.1258/135763302320301795
   Bailey K, 2021, INT J MANAG REV, V23, P3, DOI 10.1111/ijmr.12237
   Bakker A. B., 2007, J MANAGERIAL PSYCHOL, V22, P309, DOI DOI 10.1108/02683940710733115
   Barlow JB, 2016, J MANAGE INFORM SYST, V33, P684, DOI 10.1080/07421222.2016.1243944
   Barnes SJ, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102175
   Bass B.M., 1985, LEADERSHIP PERFORMAN
   Bell BS, 2002, GROUP ORGAN MANAGE, V27, P14, DOI 10.1177/1059601102027001003
   Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]
   Buono, 2004, SAM ADV MANAGE J, V69, P4
   Carnevale JB, 2020, J BUS RES, V116, P183, DOI 10.1016/j.jbusres.2020.05.037
   Carroll N, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102186
   Carson JB, 2007, ACAD MANAGE J, V50, P1217, DOI 10.2307/20159921
   Chamakiotis, LSE BUSINESS REV
   Chamakiotis P., 2020, AGILE WORKING WELL B, P133, DOI [10.1007/978-3-030-60283-3_10, DOI 10.1007/978-3-030-60283-3_10]
   Chamakiotis P, 2020, INT J INFORM MANAGE, V50, P182, DOI 10.1016/j.ijinfomgt.2019.04.015
   Chamakiotis P, 2017, NEW TECH WORK EMPLOY, V32, P28, DOI 10.1111/ntwe.12081
   Chamakiotis P, 2013, CREAT INNOV MANAG, V22, P265, DOI 10.1111/caim.12039
   Charlier SD, 2016, LEADERSHIP QUART, V27, P745, DOI 10.1016/j.leaqua.2016.05.002
   Chen CC, 2004, ORGAN SCI, V15, P200, DOI 10.1287/orsc.1030.0047
   Chen CC, 2013, MANAGE ORGAN REV, V9, P167, DOI 10.1111/more.12010
   Collins AL, 2013, J ORGAN BEHAV, V34, pS43, DOI 10.1002/job.1887
   Comella-Dorda S., 2020, REVISITING AGILE TEA
   Contreras F, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.590271
   Crisp CB, 2013, J PERS PSYCHOL, V12, P45, DOI 10.1027/1866-5888/a000075
   Davison R, 2003, GROUP DECIS NEGOT, V12, P517, DOI 10.1023/B:GRUP.0000004256.03294.e3
   Davison RM, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102149
   Deloitte, 2020, LEAD VIRT TEAMS 8 PR
   DeLuca D., 2006, Information Technology & People, V19, P323, DOI 10.1108/09593840610718027
   Dennis AR, 2008, MIS QUART, V32, P575
   DeRosa DM, 2004, HUM RESOUR MANAGE-US, V43, P219, DOI 10.1002/hrm.20016
   Dixon KR, 2010, HUM RELAT, V63, P1177, DOI 10.1177/0018726709354784
   Ebrahim N.A., 2009, AUST J BASIC APPL SC, V3, P2653, DOI DOI 10.6084/M9.FIGSHARE.103369
   Feitosa J, 2021, ORGAN DYN, V50, DOI 10.1016/j.orgdyn.2020.100777
   Fletcher G, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102185
   Fuller MA, 2006, J MANAGE INFORM SYST, V23, P209, DOI 10.2753/MIS0742-1222230308
   Germain ML, 2014, ADV DEV HUM RESOUR, V16, P356, DOI 10.1177/1523422314532097
   GERSICK CJG, 1991, ACAD MANAGE REV, V16, P10, DOI 10.2307/258605
   Gibbs JL, 2021, EUR J WORK ORGAN PSY, V30, P653, DOI 10.1080/1359432X.2020.1844796
   Gibson CB, 2006, ADMIN SCI QUART, V51, P451, DOI 10.2189/asqu.51.3.451
   Gibson CB, 2014, ANNU REV ORGAN PSYCH, V1, P217, DOI 10.1146/annurev-orgpsych-031413-091240
   Gilson LL, 2015, J MANAGE, V41, P1313, DOI 10.1177/0149206314559946
   Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x
   Griffith TL, 2003, MIS QUART, V27, P265
   Hacker J, 2019, AUSTRALAS J INF SYST, V23
   HANDY C, 1995, HARVARD BUS REV, V73, P40
   Hardin AM, 2007, SMALL GR RES, V38, P130, DOI 10.1177/1046496406297041
   Hendrickson, 1993, ACAD MANAGE EXEC, V12, P17
   Igbaria M, 1999, COMMUN ACM, V42, P64, DOI 10.1145/322796.322812
   Jarvenpaa S. L., 1998, Journal of Management Information Systems, V14, P29
   Jarvenpaa SL, 1999, ORGAN SCI, V10, P791, DOI 10.1287/orsc.10.6.791
   Jasper J., 2020, GUARDIAN 0627
   Jimenez A, 2017, J INT MANAG, V23, P341, DOI 10.1016/j.intman.2017.05.001
   Kayworth TR, 2001, J MANAGE INFORM SYST, V18, P7, DOI 10.1080/07421222.2002.11045697
   Kratzer J, 2006, TECHNOVATION, V26, P42, DOI 10.1016/j.technovation.2004.07.016
   Larson L, 2020, LEADERSHIP QUART, V31, DOI 10.1016/j.leaqua.2019.101377
   London Chamber of Commerce and Industry, 2020, LCCI POLL SHOWS COV
   Majchrzak A, 2000, MIS QUART, V24, P569, DOI 10.2307/3250948
   Malhotra A, 2007, ACAD MANAGE PERSPECT, V21, P60, DOI 10.5465/AMP.2007.24286164
   Meinert, 2019, COLLABORATION DIGITA, P121
   Mustafa M, 2013, HUM RESOUR MANAG J, V23, P413, DOI 10.1111/1748-8583.12009
   NippertEng C, 1996, SOCIOL FORUM, V11, P563, DOI 10.1007/BF02408393
   Ocker RJ, 2005, IEEE T PROF COMMUN, V48, P22, DOI 10.1109/TPC.2004.843294
   Oppenheim Maya, 2020, INDEPENDENT
   Ou CXJ, 2016, J ASSOC INF SCI TECH, V67, P1153, DOI 10.1002/asi.23447
   Panteli N., 2004, Information Technology & People, V17, P423, DOI 10.1108/09593840410570276
   Panteli N, 2019, INFORM TECHNOL PEOPL, V32, P2, DOI 10.1108/ITP-04-2017-0133
   Panteli N, 2009, COMMUN ACM, V52, P113, DOI 10.1145/1610252.1610282
   Papagiannidis S, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102166
   Powell A., 2004, Data Base for Advances in Information Systems, V35, P6
   Powell GN, 2020, GEND MANAG, V35, P639, DOI 10.1108/GM-05-2020-0148
   Purvanova RK, 2009, LEADERSHIP QUART, V20, P343, DOI 10.1016/j.leaqua.2009.03.004
   Richter A, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102157
   Ruggieri S, 2009, SOC BEHAV PERSONAL, V37, P1017, DOI 10.2224/sbp.2009.37.8.1017
   Russell E., 2020, 202025EN ESCP ERIM
   Russon M. -A., 2020, BBC NEWS 0721
   Sanghvi A., 2020, REIMAGINING OFFICE W
   Sarker S, 2004, EUR J INFORM SYST, V13, P3, DOI 10.1057/palgrave.ejis.3000485
   Schlachter S, 2018, INT J MANAG REV, V20, P825, DOI 10.1111/ijmr.12165
   Shachaf P, 2008, INFORM MANAGE-AMSTER, V45, P131, DOI 10.1016/j.im.2007.12.003
   Sivunen A, 2006, IEEE T PROF COMMUN, V49, P57, DOI 10.1109/TPC.2006.870458
   Snyder H, 2019, J BUS RES, V104, P333, DOI 10.1016/j.jbusres.2019.07.039
   Sugden J., 2020, WALL STR J
   Tarafdar M, 2015, INFORM SYST J, V25, P103, DOI 10.1111/isj.12042
   Torres-Coronas T., 2007, HIGHER CREATIVITY VI, P98
   Tremaine M., 2005, P 38 HAW INT C SYST
   Venkatesh V, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102197
   Waizenegger L, 2020, EUR J INFORM SYST, V29, P429, DOI 10.1080/0960085X.2020.1800417
   Wang YY, 2018, INT J INFORM MANAGE, V41, P65, DOI 10.1016/j.ijinfomgt.2018.04.001
   Watson-Manheim M. B., 2002, Information Technology & People, V15, P191, DOI 10.1108/09593840210444746
   Whiting R, 2020, WORK EMPLOY SOC, V34, P1079, DOI 10.1177/0950017020916192
   Zander L, 2013, ORGAN DYN, V42, P228, DOI 10.1016/j.orgdyn.2013.06.008
   Zander L, 2012, J WORLD BUS, V47, P592, DOI 10.1016/j.jwb.2012.01.012
   Zhong XP, 2012, INT J INFORM MANAGE, V32, P209, DOI 10.1016/j.ijinfomgt.2011.11.001
   Zimmermann A, 2011, INT J MANAG REV, V13, P59, DOI 10.1111/j.1468-2370.2010.00284.x
NR 100
TC 5
Z9 5
U1 42
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0268-4012
EI 1873-4707
J9 INT J INFORM MANAGE
JI Int. J. Inf. Manage.
PD OCT
PY 2021
VL 60
AR 102381
DI 10.1016/j.ijinfomgt.2021.102381
EA JUN 2021
PG 11
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA TZ1EV
UT WOS:000684219400004
PM 34934257
OA Green Published
DA 2022-04-20
ER

PT J
AU Patterson, A
   Mar, MA
AF Patterson, Amy
   Mar, Mary A.
TI COVID-19 and Power in Global Health
SO INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT
LA English
DT Editorial Material
DE pandemic power shape COVID-19; Power Relations; Issue Framing; Pandemic
   Response; Health Disparities
ID MORAL CLAIMS; KNOWLEDGE; EXERCISE; POLITICS
AB Political scientists bring important tools to the analysis of the coronavirus disease 2019 (COVID-19) pandemic, particularly a focus on the crucial role of power in global health politics. We delineate different kinds of power at play during the COVID-19 crisis, showing how a dearth of compulsory, institutional, and epistemic power undermined global cooperation and fueled the pandemic, with its significant loss to human life and huge economic toll. Through the pandemic response, productive and structural power became apparent, as issue frames stressing security and then preserving livelihoods overwhelmed public health and human rights considerations. Structural power rooted in economic inequalities between and within countries conditioned responses and shaped vulnerabilities, as the crisis threatened to deepen power imbalances along multiple lines. Calls for global health security will surely take on a new urgency in the aftermath of the pandemic and the forms of power delineated here will shape their outcome.
C1 [Patterson, Amy] Univ South, Dept Polit, Sewanee, TN 37375 USA.
   [Mar, Mary A.] Tulane Univ, Dept Polit Sci, New Orleans, LA 70118 USA.
RP Patterson, A (corresponding author), Univ South, Dept Polit, Sewanee, TN 37375 USA.
EM aspatter@sewanee.edu
OI Clark, Mary/0000-0002-3058-2916
CR Benatar S, 2016, INT J HEALTH POLICY, V5, P599, DOI 10.15171/ijhpm.2016.101
   Bernhard A., 2020, BBC FUTURES     0430
   Brooks RA, 2020, NATL GEOGRAPHIC 0424
   Brown GW, 2015, INT J HEALTH POLICY, V4, P111, DOI 10.15171/ijhpm.2015.20
   Bump JB, 2015, INT J HEALTH POLICY, V4, P395, DOI 10.15171/ijhpm.2015.63
   DAHL RA, 1957, BEHAV SCI, V2, P201, DOI 10.1002/bs.3830020303
   Davies S., 2015, DIS DIPLOMACY
   De Sousa A, 2020, BLOOMBERG       0406
   Grepin KA, 2015, INT J HEALTH POLICY, V4, P321, DOI 10.15171/ijhpm.2015.48
   Hanefeld J, 2015, INT J HEALTH POLICY, V4, P119, DOI 10.15171/ijhpm.2015.25
   Lukes S, 2018, J POLITICAL POWER, V11, P46, DOI 10.1080/2158379X.2018.1433755
   Patterson AS, 2020, GLOB PUBLIC HEALTH, V15, P805, DOI 10.1080/17441692.2020.1724315
   Rushton S, 2015, INT J HEALTH POLICY, V4, P311, DOI 10.15171/ijhpm.2015.47
   Shiffman J, 2018, INT J HEALTH POLICY, V7, P879, DOI 10.15171/ijhpm.2018.71
   Shiffman J, 2014, INT J HEALTH POLICY, V3, P297, DOI 10.15171/ijhpm.2014.120
   Silverman R., 2020, SHOULD SCH REOPEN
   Tharoor I., 2020, WASHINGTON POST 0419
   Tooze A., 2020, FOREIGN POLICY  0417
NR 18
TC 2
Z9 2
U1 2
U2 8
PU KERMAN UNIV MEDICAL SCIENCES
PI KERMAN
PA JAHAD BLVD, KERMAN, 7619813159, IRAN
EI 2322-5939
J9 INT J HEALTH POLICY
JI Int. J. Health Policy Manag.
PD OCT
PY 2020
VL 9
IS 10
BP 429
EP 431
DI 10.34172/ijhpm.2020.72
PG 3
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA NU7XE
UT WOS:000573852000005
PM 32610732
OA gold, Green Accepted, Green Published
DA 2022-04-20
ER

PT J
AU Zaki, BL
   George, B
AF Zaki, Bishoy Louis
   George, Bert
TI New development: Policy learning and public management-a match made in
   crisis
SO PUBLIC MONEY & MANAGEMENT
LA English
DT Article
DE Covid-19; crisis governance; epistemic learning; policy learning; public
   management
ID COVID-19
AB IMPACT Policy-makers face significant challenges responding to technically complex, multidimensional, large-scale, and socially-embedded crises such as Covid-19. In this article, the authors call for policy-makers to expand the horizon on expertise at the policy design table. This is by including public management experts and practitioners as policy co-designers. With their in-field experience, situated knowledge of social contexts and public administration capacities, public management experts can provide critical insights into the design of crisis policy responses. This approach entails setting management and co-ordination frameworks that ensure the functional integration of insights from a range of multi-disciplinary experts into the policy learning process.
C1 [Zaki, Bishoy Louis; George, Bert] Univ Ghent, Ghent, Belgium.
RP Zaki, BL (corresponding author), Univ Ghent, Ghent, Belgium.
RI Zaki, Bishoy Louis/ABC-9322-2020
OI Zaki, Bishoy Louis/0000-0001-7962-6812; George, Bert/0000-0001-7175-7885
CR Benton JE, 2020, AM REV PUBLIC ADM, V50, DOI 10.1177/0275074020941698
   Bradley, 2020, ENGLANDS WORLD BEATI
   Bryson J. M., 2004, PUBLIC MANAG REV, V6, P21, DOI [DOI 10.1080/14719030410001675722, 10.1080/14719030410001675722]
   Cao C, 2020, INT J SOCIOL SOC POL, V40, P939, DOI 10.1108/IJSSP-07-2020-0334
   Dunlop CA, 2013, POLIT STUD-LONDON, V61, P599, DOI 10.1111/j.1467-9248.2012.00982.x
   Dzigbede KD, 2020, PUBLIC ADMIN REV, V80, P634, DOI 10.1111/puar.13249
   Feldstein, 2020, COMMUNITY CLOSE CONT, DOI [10.15585/mmwr.mm6936a5, DOI 10.15585/mmwr.mm6936a5]
   Funtowicz S., 2003, SCI PUBL POLICY, V30, P146, DOI DOI 10.3152/147154303781780551
   George B, 2020, PUBLIC ADMIN REV, V80, P696, DOI 10.1111/puar.13255
   Halliday, 2020, 4 KEY FAILINGS ENGLA
   Hartley K, 2020, POLICY SOC, V39, P403, DOI 10.1080/14494035.2020.1783791
   Head BW, 2015, ADMIN SOC, V47, P711, DOI 10.1177/0095399713481601
   Kahneman D., 2011, THINKING FAST SLOW
   Lee S, 2015, INT J EMERG MANAG, V11, P343
   Li Y, 2021, LANCET INFECT DIS, V21, P193, DOI 10.1016/S1473-3099(20)30785-4
   Maxmen A., 2020, 1000 CORONAVIRUS TES
   Moon MJ, 2020, PUBLIC ADMIN REV, V80, P651, DOI 10.1111/puar.13214
   Moore M., 1995, CREATING PUBLIC VALU
   Parker, 2020, US HAS MORE COVID 19
   Scally G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1932
   Trivedi P, 2020, AM REV PUBLIC ADM, V50, P725, DOI 10.1177/0275074020942411
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   Yang H, 2020, J CHIN GOV, V5, P234, DOI 10.1080/23812346.2020.1745411
   Young SL, 2020, AM REV PUBLIC ADM, V50, P480, DOI 10.1177/0275074020941669
   Zaki BL, 2021, POLICY DES PRACT, V4, P15, DOI 10.1080/25741292.2020.1843249
NR 25
TC 4
Z9 4
U1 6
U2 12
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0954-0962
EI 1467-9302
J9 PUBLIC MONEY MANAGE
JI Public Money Manage.
PD FEB 17
PY 2022
VL 42
IS 2
BP 129
EP 132
DI 10.1080/09540962.2021.1956212
EA JUL 2021
PG 4
WC Public Administration
WE Social Science Citation Index (SSCI)
SC Public Administration
GA XW1BW
UT WOS:000680374600001
DA 2022-04-20
ER

PT J
AU Webb, A
   McQuaid, RW
   Webster, CWR
AF Webb, Aleksandra
   McQuaid, Ronald William
   Webster, C. William R.
TI Moving learning online and the COVID-19 pandemic: a university response
SO WORLD JOURNAL OF SCIENCE TECHNOLOGY AND SUSTAINABLE DEVELOPMENT
LA English
DT Article
DE University; Online teaching; Digitalisation; COVID-19; Pandemic
AB Purpose This article investigates some ongoing issues faced by higher education institutions (HEIs) having to rapidly move their teaching online during the early stages of the coronavirus (COVID-19) pandemic. Design/methodology/approach The article incorporates a review of academic and policy literature concerning digitalisation and online learning in universities and qualitative interviews with staff involved in online teaching and learning at a university in Scotland. Findings For most HEIs and organisations across the globe, the COVID-19 pandemic has accelerated the speed at which digitalisation and digital ways of working have been embedded in organisational life and service delivery including new ways of learning and working. This has led to a recognition of the need for practically focused, effective inclusive digital interventions. A range of initiatives that have been developed or accelerated in response to the pandemic are discussed. These should be explicitly designed and implemented to also reach individuals from disadvantaged backgrounds, including those with low-skill levels or qualifications and older age groups. Effort is also needed by policymakers and HEIs to better understand the challenges and unintended consequences that digital learning and working poses. Research limitations/implications More research is needed into the methods and implications of increased online teaching. The range of interviewees is limited to one main organisation. A wider range of staff, students, HEIs and other types of organisation would add additional insights. Practical implications Insights from interviews highlight a number of institutional responses to digitalisation, which were accelerated by the COVID-19 pandemic. These identify learning and reflection points for HEIs moving to enhanced online teaching provision. Originality/value This article provides an analysis of the processes, issues and impacts associated with the rapid shift to digitisation in HEIs at a point in time shortly following the onset of the COVID-19 pandemic in 2020. It raises issues around inclusivity of online learning, pedagogy, unintended consequences of digitalisation and privacy, when moving to online teaching that are relevant both during the pandemic and in the longer term.
C1 [Webb, Aleksandra; McQuaid, Ronald William] Univ Stirling, Stirling Management Sch, Stirling, Scotland.
   [Webster, C. William R.] Univ Stirling, Stirling Management Sch, Publ Policy & Management, Stirling, Scotland.
RP Webb, A (corresponding author), Univ Stirling, Stirling Management Sch, Stirling, Scotland.
EM a.k.webb@stir.ac.uk; ronald.mcquaid@stir.ac.uk;
   william.webster@stir.ac.uk
RI McQuaid, Ronald/K-6219-2012
OI McQuaid, Ronald/0000-0002-5342-7097; Webb,
   Aleksandra/0000-0002-7672-3411
FU EU ERASMUSthornKA2 [2019-1-RO01-KA203063214]
FX The work for this article was part-funded by the EU ERASMUSthornKA2,
   project no. 2019-1-RO01-KA203063214, entitled ESCALATE
   (https://escalate.projects.uvt.ro/).The authors are extremely grateful
   to the authors'project partners and to local experts and colleagues at
   the case study university, who shared their knowledge of policy and
   practice concerning digitalisation and employability in HEIs. The
   authors also wish to thank anonymous referees for their comments.
CR Ali W., 2020, HIGH ED STUD, V10, P16, DOI [10.5539/hes.v10n3p16, DOI 10.5539/HES.V10N3P16]
   Anasi SN, 2018, WORLD J SCI TECHNOL, V15, P13, DOI 10.1108/WJSTSD-11-2016-0059
   [Anonymous], 2020, PUBL CONS NEW DIG ED
   Aristovnik A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208438
   Beetham H, 2018, DIGITAL EXPERIENCE I
   Berriman R., 2017, UK EC OUTLOOK, P30
   Bolton P., 2019, POST 18 ED REV AUG R
   Bughin J., 2018, SKILL SHIFT AUTOMATI
   Butcher, 2020, 124 HEPI
   CEBR (Centre for Economics and Business Research), 2018, EC IMP DIG INCL UK
   Clarke M., 2019, UNDERSTANDING EFFECT
   Commission of the European Community (ECC), 2020, DIG ED ACT PLAN 2021
   Cormier D., 2008, INNOVATE, V4
   Dean, 2018, DEV SKILLS CHANG WOR, P241
   Department for Digital Culture Media and Sport (DCMS), 2020, CYB SEC SKILLS UK LA
   Department for Education, 2019, GUID ESS DIG SKILLS
   Digital Economy and Society Index (DESI), 2020, 2020 COUNTR REP UK
   Frey CB, 2017, TECHNOL FORECAST SOC, V114, P254, DOI 10.1016/j.techfore.2016.08.019
   Gunson R., 2017, SCOTLAND SKILLS 2030
   House of Commons, 2018, DIG CONN SCOTL
   JISC, 2016, JISC NUS BENCHM TOOL
   JISC, 2015, DEV DIG LIT
   JISC, 2018, EV INF DIG TRANSF
   Manyika J., 2017, JOBS LOST JOBS GAINE
   McMurray S, 2016, EDUC TRAIN, V58, P112, DOI 10.1108/ET-02-2014-0017
   McQuaid R., 2020, CIPD APPL RES C 2020
   McQuaid RW, 2005, URBAN STUD, V42, P191, DOI 10.1080/0042098042000316092
   Nania J., 2019, NO LONGER OPTIONAL E
   National Records of Scotland (NRS), 2020, POP SCOTL
   Office for National Statistics (ONS), 2019, WHICH OCC ARE HIGHT
   Osborne M., 2015, CREATIVITY VERSUS RO
   Prensky M., 2001, HORIZON, V9, P1, DOI [10.1108/10748120110424816, 10.1108/10748120110424816(, https://doi.org/10.1108/10748120110424816, DOI 10.1108/10748120110424816]
   PwC, 2015, 2018 DIG U STAYING R
   PwC, 2015, 2018 U MAK RIGHT CHO
   Quality Assurance Agency for Higher Education (QAA), 2020, STRATEGY
   Scottish Council for Development and Industry (SCDI), 2016, DIG SOL PROD PUZZ WH
   Scottish Council for Development and Industry (SCDI), 2019, BUILD WORLD LEAD AI
   Scottish Funding Council (SFC), 2020, U HIGH ED I WE FUND
   Scottish Government, 2017, REAL SCOTL FULL POT
   Scottish Government, 2018, SAF SEC PROSP CYB RE
   Servoz M, 2019, FUTURE WORK WORK FUT, V44, P160
   Siemens G, 2005, INT J INSTR TECHNOL, V2, P1
   Skills Commission, 2014, STILL TUN SKILLS SYS
   Sun J, 2016, COMPUT EDUC, V101, P102, DOI 10.1016/j.compedu.2016.06.003
   The Open University, 2019, BRIDG DIG DIV
   Tucker, 2016, ED LEADERS REPORT, V4
   UK Commission for Employment and Skills (UKCES), 2014, FORG FUT BUILD HIGH
   Universities UK (UUK), 2018, EC CAS FLEX LEARN MA, P6
   Warhurst C., 2019, JRC117404 EUR COMM
   Webb A., 2020, STATE ART REV HIGH E
   Webb A, 2020, INT J SOCIOL SOC POL, V40, P1005, DOI 10.1108/IJSSP-08-2020-0371
   Weller S., 2016, ACAD PRACTICE DEV PR
   Williamson, 2020, AUTOMATIC U REV DATA
   Williamson B., 2017, BIG DATA ED DIGITAL
   Zierahn U, 2016, OECD SOCIAL EMPLOYME, V189
NR 55
TC 5
Z9 5
U1 9
U2 41
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2042-5953
EI 2042-5945
J9 WORLD J SCI TECHNOL
JI World J. Sci. Technol. Sustain. Dev.
PD MAR 16
PY 2021
VL 18
IS 1
BP 1
EP 19
DI 10.1108/WJSTSD-11-2020-0090
EA MAR 2021
PG 19
WC Green & Sustainable Science & Technology
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics
GA QX8LU
UT WOS:000624755600001
OA Bronze, Green Accepted
DA 2022-04-20
ER

PT J
AU Mahmood, M
   Ilyas, NUA
   Khan, MF
   Hasrat, MN
   Richwagen, N
AF Mahmood, Majid
   Ilyas, Noor-Ul-Ain
   Khan, Muhammad Faraz
   Hasrat, Muhammad Naseem
   Richwagen, Nicholas
TI Transmission frequency of COVID-19 through pre-symptomatic and
   asymptomatic patients in AJK: a report of 201 cases
SO VIROLOGY JOURNAL
LA English
DT Article
DE COVID-19; COVID-19 transmission; COVID-19 patients; Pre-symptomatic;
   Asymptomatic; AJK; Pakistan
ID SARS-COV-2
AB BackgroundThe COVID-19 pandemic is a catastrophic global phenomenon, affecting human life in a way unseen since the 1918 influenza pandemic. Effective management of this threat requires halting transmission, a strategy requiring accurate knowledge of SARS-CoV-2 transmission patterns. MethodsThis was a retrospective contact study aiming to estimate the transmission rate of COVID-19 by tracing contacts in symptomatic, pre-symptomatic, and asymptomatic patients. History of patients' contacts during 24 h before appearance of symptoms or infection confirmation was traced for disease transmission.ResultsOverall, a total of 201 COVID-19 patients had contact with 7168 people in 24 h with an average of 35.66 contacts per patient, ranging from a minimum of 4 to maximum of 87 contacts (meetings). Out of 7168 persons met, infection was detected in 64 (0.89%). For the 155 symptomatic patients, a total of 5611 contacted persons were traced before appearance of symptoms (pre-symptomatic) in last 24 h with an average of 36.20 meetings per patient. The infection was transmitted in 63 (1.12%) people with 5548 (98.88%) remaining uninfected. Out of the 63 transmissions, 62 (98.4%) were traced within 6 h before symptom onset, while only 1 was identified in the 6-12 h timeframe before symptoms. A total of 1557 persons were traced having meeting/contacts with asymptomatic cases in last 24 h before infection confirmation. Out of these 1557 persons, only 1 was found to be infected and the infection rate was calculated to be 0.06%. Statistically, the transmission rate by pre-symptomatic patients was found to be significantly higher than the transmission rate by asymptomatic individuals (P<0.05).ConclusionIn the studied population, the risk of pre-symptomatic and asymptomatic transmission of COVID-19 was low, with transmission risks of 1.12% and 0.06% respectively. Pre-symptomatic infection becomes very rare in contacts made longer than 6 h before onset of symptoms. The infection transmission is traced as long as about 9 h before the appearance of clear symptoms in the patients, but the incidence rate was as low as about 0.02% of the total contacts in that period.
C1 [Mahmood, Majid; Ilyas, Noor-Ul-Ain] Univ Poonch Rawalakot, Dept Zool, Rawalakot, Ajk, Pakistan.
   [Khan, Muhammad Faraz] Univ Poonch Rawalakot, Dept Bot, Rawalakot, Ajk, Pakistan.
   [Hasrat, Muhammad Naseem] Sheikh Khalifa Bin Zayd Al Nahyan DHQ Hosp, Rawalakot, Ajk, Pakistan.
   [Richwagen, Nicholas] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA.
RP Mahmood, M (corresponding author), Univ Poonch Rawalakot, Dept Zool, Rawalakot, Ajk, Pakistan.
EM drmajid@upr.edu.pk
OI Khan, Faraz/0000-0003-1525-003X; Mahmood, Majid/0000-0001-6680-3541
CR Al-Sadeq DW, 2020, INT J INFECT DIS, V98, P372, DOI 10.1016/j.ijid.2020.06.098
   Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI 10.1001/jama.2020.2565
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chang L, 2020, EMERG INFECT DIS, V26, P1631, DOI 10.3201/eid2607.200839
   Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
   Furukawa Nathan W, 2020, Emerg Infect Dis, V26, DOI 10.3201/eid2607.201595
   Gallagher J, BBC NEWS, P2021
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762
   Hassoun, SCI AM, P2021
   Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4
   Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154
   Li CY, 2020, EMERG INFECT DIS, V26, P1626, DOI 10.3201/eid2607.200718
   Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180
   Molina MJ., IDENTIFYING AIRBORNE
   Ng OT, 2020, NEW ENGL J MED, V382, P1476, DOI 10.1056/NEJMc2003100
   Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6
   Qian GQ, 2020, CLIN INFECT DIS, V71, P861, DOI 10.1093/cid/ciaa316
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Roxby AC, 2020, MMWR-MORBID MORTAL W, V69, P416, DOI 10.15585/mmwr.mm6914e2
   Temkin E, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.09.040
   Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018
   Tong ZD, 2020, EMERG INFECT DIS, V26, P1052, DOI 10.3201/eid2605.200198
   Wang YR, 2020, J INFECT DIS, V221, P1770, DOI 10.1093/infdis/jiaa119
   Ye F, 2020, INT J INFECT DIS, V94, P133, DOI 10.1016/j.ijid.2020.03.042
   Yu P, 2020, J INFECT DIS, V221, P1757, DOI 10.1093/infdis/jiaa077
   Zhang JJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2817-7
NR 26
TC 1
Z9 1
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD JUL 3
PY 2021
VL 18
IS 1
AR 138
DI 10.1186/s12985-021-01609-w
PG 8
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Virology
GA TH1QH
UT WOS:000671868900003
PM 34217301
OA Green Published, gold, Green Submitted
DA 2022-04-20
ER

PT C
AU Klimova, B
AF Klimova, Blanka
BE Watrobski, J
   Salabun, W
   Toro, C
   Zanni-Merk, C
   Howlett, RJ
   Jain, LC
TI An Insight into Online Foreign Language Learning and Teaching in the Era
   of COVID-19 Pandemic
SO KNOWLEDGE-BASED AND INTELLIGENT INFORMATION & ENGINEERING SYSTEMS (KSE
   2021)
SE Procedia Computer Science
LA English
DT Proceedings Paper
CT 25th KES International Conference on Knowledge-Based and Intelligent
   Information & Engineering Systems (KES)
CY SEP 08-10, 2021
CL Szczecin, POLAND
SP KES Int
DE Foreign language learning; online teaching; COVID-19 pandemic
ID EDUCATION
AB The COVID-19 pandemic has completely changed and transformed the traditional educational setting. Both teaching and learning have been transformed to online settings at all educational levels. The purpose of this article is to discuss students' perception of and attitudes to online foreign language learning in the COVID-19 pandemic at the Faculty of Informatics and Management of the University of Hradec Kralove, Czech Republic. The key method was a questionnaire survey, which was conducted among the third-year distant students. The results, based on five constructs/variables, i.e. language skills, learning materials, students' motivation to study online, preparedness for online teaching and learning, and effectiveness of foreign online teaching, reveal that students do not feel that they have improved their language skills by studying purely online. The results also demonstrate students' preference for printed materials because they are more suitable for taking notes and retaining new words and phrases, especially when students can highlight them. In addition, the findings confirm that both teachers and students are well prepared for performing their online instruction. Although students feel motivated to study online, these students experience social distance as those who are not stimulated to learn online. Moreover, the results confirm that students consider the online language classes effective, but face-to-face classes cannot be replaced. In this respect teacher's role is irreplaceable. Therefore, educational institutions should invest in supporting them technically, mentally, as well as financially, in this difficult period in order to ensure and provide quality teaching for future generations. (C) 2021 The Authors. Published by Elsevier B.V.
C1 [Klimova, Blanka] Univ Hradec Kralove, Rokitanskeho 62, Hradec Kralove 50003, Czech Republic.
RP Klimova, B (corresponding author), Univ Hradec Kralove, Rokitanskeho 62, Hradec Kralove 50003, Czech Republic.
EM blanka.klimova@uhk.cz
FU SPEV project 2021 at the Faculty of Informatics and Management,
   University of Hradec Kralove, Czech Republic
FX This article is supported by the SPEV project 2021, run at the Faculty
   of Informatics and Management, University of Hradec Kralove, Czech
   Republic. The author thanks Ales Berger for his help with the data
   collection.
CR Adnan, 2020, J PEDAGOGICAL SOCIOL, V1, P45, DOI [10.33902/jpsp.2020261309, DOI 10.33902/JPSP.2020261309]
   Almekhlafy Sultan Saleh Ahmed, 2020, ONLINE LEARNING ENGL, DOI [10.1108/PRR-08-2020-0026/full/html#sec012, DOI 10.1108/PRR-08-2020-0026/FULL/HTML#SEC012]
   Arif Nugroho, 2020, METATHESIS J ENGLISH, V4, P277
   Badger Ian, 2003, COMMUNICATION
   Consilz Tan, 2020, ASIAN ED DEV STUDIES, V10, P308
   Darancik Y., 2018, INT ED STUDIES, V11, P166, DOI DOI 10.5539/IES.V11N7P166
   Hopp H, 2020, FRONT EDUC, V5, DOI 10.3389/feduc.2020.601017
   Jay Bonk Curtis, 2006, HDB BLENDED LEARNING
   Klimova BF, 2014, PROCD SOC BEHV, V112, P147, DOI 10.1016/j.sbspro.2014.01.1149
   Klimova BF, 2011, PROCEDIA COMPUT SCI, V3, P1485, DOI 10.1016/j.procs.2011.01.036
   Panda DS, 2020, PHARM EDUC, V20, P297, DOI 10.46542/pe.2020.202.297301
   Plak S., 2020, COLL STUDENTS MOTIVA
   Polakova P, 2021, EDUC SCI, V11, DOI 10.3390/educsci11020081
   Poluekhtova IA, 2020, PSYCHOL RUSS, V13, P26, DOI 10.11621/pir.2020.0402
   Sevencan Seda, 2021, LANGUAGE TEACHING SH
   Vilar Polona, 2016, P ISIC INF BEH C 1
   Xingzhen Gao Lori, 2020, FRONT PSYCHOL, V11
NR 17
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-0509
J9 PROCEDIA COMPUT SCI
PY 2021
VL 192
BP 1787
EP 1794
DI 10.1016/j.procs.2021.08.183
PG 8
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Computer Science, Information Systems; Computer Science, Theory &
   Methods; Engineering, Electrical & Electronic; Mathematics, Applied
WE Conference Proceedings Citation Index - Science (CPCI-S)
SC Automation & Control Systems; Computer Science; Engineering; Mathematics
GA BS4LU
UT WOS:000720289001085
PM 34630743
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Cegarra-Navarro, JG
   Vatamanescu, EM
   Martinez-Martinez, A
AF Cegarra-Navarro, Juan-Gabriel
   Vatamanescu, Elena-Madalina
   Martinez-Martinez, Aurora
TI A context-driven approach on coping with COVID-19: From hiding knowledge
   toward citizen engagement
SO KNOWLEDGE AND PROCESS MANAGEMENT
LA English
DT Article
AB The current study sets out to investigate the relationships among three interconnected dimensions, that is hiding knowledge by the Government, the realized absorptive capacity (RACAP) and citizen engagement, giving way to a context-driven approach. Emphasis is laid on the effects engendered by the lack of official information transparency in the critical context of COVID-19 outbreak at the global level, through the lens of the Spanish example. The relationships among the variables are analyzed by means of an empirical study conducted with 151 Spanish subjects with a view to identify whether the impact of knowledge hiding by the Government on citizen engagement can be mitigated and to acknowledge how the presence of RACAP impacts citizens in limiting the spread of COVID-19 information disorders.
C1 [Cegarra-Navarro, Juan-Gabriel; Martinez-Martinez, Aurora] Univ Politecn Cartagena, Fac Business Sci, Cartagena, Spain.
   [Vatamanescu, Elena-Madalina] SNSPA, Fac Management, Bucharest, Romania.
RP Martinez-Martinez, A (corresponding author), Univ Politecn Cartagena, Fac Business Sci, Cartagena, Spain.
EM aurora.martinez@upct.es
RI Martínez-Martínez, Aurora/Y-1510-2018; Vatamanescu,
   Elena-Madalina/F-4872-2017; , Juan Gabriel/L-2291-2014
OI Martínez-Martínez, Aurora/0000-0001-5579-8142; Vatamanescu,
   Elena-Madalina/0000-0002-9397-0385; , Juan Gabriel/0000-0003-3371-5670
FU European Union FEDEREuropean Commission [ECO2017-88987-R]
FX (INECO/FEDER;UE), cofinanced from the European Union FEDER, Grant/Award
   Number: ECO2017-88987-R
CR Allcott H, 2019, RES POLITICS, V6, DOI 10.1177/2053168019848554
   ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783
   Bratianu C, 2021, MANAGE DECIS, V59, P306, DOI 10.1108/MD-05-2019-0559
   Bratianu C, 2020, KYBERNETES, V49, P6, DOI 10.1108/K-02-2019-0122
   Bratianu C, 2019, SYSTEMS-BASEL, V7, DOI 10.3390/systems7020020
   Brennen JS., 2020, TYPES SOURCES CLAIMS
   Carpini MXD, 2000, POLIT COMMUN, V17, P341, DOI 10.1080/10584600050178942
   Cegarra-Navarro JG, 2021, KNOWL PROCESS MANAG, V28, P134, DOI 10.1002/kpm.1662
   Cegarra-Navarro JG, 2014, EUR MANAG J, V32, P165, DOI 10.1016/j.emj.2013.05.005
   Cerne M, 2014, ACAD MANAGE J, V57, P172, DOI 10.5465/amj.2012.0122
   Connelly CE, 2015, EUR J WORK ORGAN PSY, V24, P479, DOI 10.1080/1359432X.2014.931325
   Connelly CE, 2012, J ORGAN BEHAV, V33, P64, DOI 10.1002/job.737
   Delfs A., 2020, MERKEL QUARANTINE PU
   Dijkstra TK, 2015, COMPUT STAT DATA AN, V81, P10, DOI 10.1016/j.csda.2014.07.008
   Edmondson A.C., 2020, HARVARD BUSINESS REV
   Edwards B, 2001, CONTEMP SOCIOL, V30, P227, DOI 10.2307/3089235
   Escribano A, 2009, RES POLICY, V38, P96, DOI 10.1016/j.respol.2008.10.022
   Cegarra-Navarro JG, 2017, J TECHNOL TRANSFER, V42, P302, DOI 10.1007/s10961-016-9506-3
   Gaventa J, 2012, WORLD DEV, V40, P2399, DOI 10.1016/j.worlddev.2012.05.014
   Haynes K, 2019, INT INTERACT, V45, P421, DOI 10.1080/03050629.2019.1554572
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Henseler J, 2014, ORGAN RES METHODS, V17, P182, DOI 10.1177/1094428114526928
   Hofmeister W., 2020, CORONAVIRUS ERSCHUTT
   Imai H, 2020, PSYCHIAT CLIN NEUROS, V74, P329, DOI 10.1111/pcn.12995
   Jiang Z, 2019, J ORGAN BEHAV, V40, P800, DOI 10.1002/job.2358
   Kassen M, 2013, GOV INFORM Q, V30, P508, DOI 10.1016/j.giq.2013.05.012
   Leung CC, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30520-1
   McGoey L, 2012, ECON SOC, V41, P1, DOI 10.1080/03085147.2011.637330
   Noonan W.R., 2007, DISCUSSING UNDISCUSS
   OECD, 2020, TRANSP COMM TRUST RO
   Peng GZ, 2018, IEEE T SERV COMPUT, V11, P306, DOI 10.1109/TSC.2016.2518161
   Porumbescu GA, 2020, GOV INFORM Q, V37, DOI 10.1016/j.giq.2019.101451
   Richter NF, 2016, EUR MANAG J, V34, P589, DOI 10.1016/j.emj.2016.08.001
   Sevillano, 2020, COVID 19 SPAIN UNREL
   Siddiqui MYA, 2020, AM J TROP MED HYG, V103, P920, DOI 10.4269/ajtmh.20-0592
   Taylor SN, 2011, J APPL BEHAV SCI, V47, P432, DOI 10.1177/0021886311408724
   Tiefenh?ler A., 2020, NEW YORK TIMES UNPRO
   Tremlett G., 2020, WORLD NEWS
   Vatamanescu EM, 2018, INFORM TECHNOL PEOPL, V31, P84, DOI 10.1108/ITP-06-2016-0135
   Wang L, 2019, J APPL PSYCHOL, V104, P229, DOI 10.1037/apl0000337
   Wang S, 2010, HUM RESOUR MANAGE R, V20, P115, DOI 10.1016/j.hrmr.2009.10.001
   Warren AM, 2014, GOV INFORM Q, V31, P291, DOI 10.1016/j.giq.2013.11.007
   Wijnhoven F, 2015, GOV INFORM Q, V32, P30, DOI 10.1016/j.giq.2014.10.002
   World Health Organization, 2020, 13 WHO
   Yuan J, 2020, INT J INFECT DIS, V95, P311, DOI 10.1016/j.ijid.2020.03.050
   Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.2307/4134351
NR 46
TC 11
Z9 11
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1092-4604
EI 1099-1441
J9 KNOWL PROCESS MANAG
JI Knowl. Process Manag.
PD APR
PY 2021
VL 28
IS 2
BP 134
EP 140
DI 10.1002/kpm.1662
EA MAR 2021
PG 7
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA SB9TZ
UT WOS:000630295800001
OA Bronze
DA 2022-04-20
ER

PT J
AU Dunn, M
   Munoz, I
   Sawyer, S
AF Dunn, Michael
   Munoz, Isabel
   Sawyer, Steve
TI Gender Differences and Lost Flexibility in Online Freelancing During the
   COVID-19 Pandemic
SO FRONTIERS IN SOCIOLOGY
LA English
DT Article
DE online labor market; freelance work; precarity; COVID-19; gender;
   knowledge work
ID GIG ECONOMY; FLEXIBLE WORK; AUTONOMY; TIME; SCHEDULES; LABOR; JOBS;
   LIFE; WORKPLACE; ALWAYS
AB We report findings from an ongoing panel study of 68 U.S.-based online freelancers, focusing here on their experiences both pre- and in-pandemic. We see online freelancing as providing a window into one future of work: collaborative knowledge work that is paid by the project and mediated by a digital labor platform. The study's purposive sampling provides for both empirical and conceptual insights into the occupational differences and career plans of freelance workers. The timing of the 2020 data collection provides insight into household changes as a result of the COVID-19 pandemic. Findings make clear these workers are facing diminished work flexibility and increased earning uncertainty. And, data show women are more likely than men to reduce working hours to help absorb the increased share of caregiving and other domestic responsibilities. This raises questions of online freelancing as a viable career path or sustainable source of work.
C1 [Dunn, Michael] Skidmore Coll, Dept Management & Business, Saratoga Springs, NY 12866 USA.
   [Munoz, Isabel; Sawyer, Steve] Syracuse Univ, Sch Informat Studies, Syracuse, NY USA.
RP Dunn, M (corresponding author), Skidmore Coll, Dept Management & Business, Saratoga Springs, NY 12866 USA.
EM mdunn@skidmore.edu
OI Munoz, Imelda/0000-0003-1672-2860
FU Syracuse Universitys office of the Vice President of Research and
   SOURCE; U.S. National Science FoundationNational Science Foundation
   (NSF) [1665386, 2121624, 2121638]
FX This material is supported in part by grants from Syracuse Universitys
   office of the Vice President of Research and SOURCE, and the U.S.
   National Science Foundation under Grant Nos. 1665386, 2121624 and
   2121638. Any opinions, findings, and conclusions or recommendations
   expressed in this material are those of the author(s) and do not
   necessarily reflect the views of the National Science Foundation,
   Syracuse University or Skidmore College.
CR Aroles J, 2019, NEW TECH WORK EMPLOY, V34, P285, DOI 10.1111/ntwe.12146
   Atkeson A., 2020, WHAT WILL BE EC IMPA
   Balka E, 2021, COMPUT SUPP COOP W J, V30, P251, DOI 10.1007/s10606-020-09387-9
   Baltes BB, 1999, J APPL PSYCHOL, V84, P496, DOI 10.1037/0021-9010.84.4.496
   Barbulescu R, 2013, ORGAN SCI, V24, P737, DOI 10.1287/orsc.1120.0757
   Bardzell S, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1301
   Barley S.R., 2011, GURUS HIRED GUNS WAR, DOI [10.1515/9781400841271, DOI 10.1515/9781400841271]
   Berdahl TA, 2021, J GEN INTERN MED, V36, P1997, DOI 10.1007/s11606-021-06700-0
   Chung H, 2020, SOC INDIC RES, V151, P365, DOI 10.1007/s11205-018-2025-x
   Ciolfi L, 2018, COMPUT SUPP COOP W J, V27, P803, DOI 10.1007/s10606-018-9315-3
   Collins C, 2021, GENDER WORK ORGAN, V28, P101, DOI 10.1111/gwao.12506
   Cousins K, 2015, INFORM TECHNOL PEOPL, V28, P34, DOI 10.1108/ITP-08-2013-0155
   Czarniawska B, 2014, COMPUT SUPP COOP W J, V23, P205, DOI 10.1007/s10606-013-9189-3
   Dunn M., 2017, AM J MANAG, V17, P10
   Erickson I, 2019, COMPUT SUPP COOP W J, V28, P627, DOI 10.1007/s10606-019-09360-1
   Erickson I, 2016, ACM CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW 2016), P1323, DOI 10.1145/2818048.2820015
   Foong E., 2018, P ACM HUM COMP INT N, V2, P1
   Fraser J, 2001, WORK EMPLOY SOC, V15, P679, DOI 10.1017/S0950017001006791
   Gerstel N., 2000, QUAL SOCIOL, V23, P467
   Gold M, 2013, NEW TECH WORK EMPLOY, V28, P197, DOI 10.1111/ntwe.12017
   Gomez-Herrera E., 2019, EVID, V250, P19
   Gray ML., 2019, GHOST WORK STOP SILI
   Hannak A, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P1914, DOI 10.1145/2998181.2998327
   Henly JR, 2006, SOC SERV REV, V80, P609, DOI 10.1086/508478
   Hochschild A.R., 1989, 2 SHIFT WORKING FAMI
   Horton JJ, 2010, LECT NOTES COMPUT SC, V6484, P515, DOI 10.1007/978-3-642-17572-5_45
   Howcroft D, 2019, WORK EMPLOY SOC, V33, P21, DOI 10.1177/0950017018760136
   Humphry J, 2014, COMPUT SUPP COOP W J, V23, P185, DOI 10.1007/s10606-013-9197-3
   Hyman J, 2005, WORK EMPLOY SOC, V19, P705, DOI 10.1177/0950017005058055
   Institute for Fiscal Studies, 2020, PAR ESP MOTH PAYING
   International Labour Organization, 2016, NONST EMPL WORLD UND
   Jarrahi MH, 2020, COMPUT SUPP COOP W J, V29, P153, DOI 10.1007/s10606-019-09368-7
   Johns T, 2013, HARVARD BUS REV, V91, P66
   Kahn L.M., 2016, 21913 NAT BUR EC RES, DOI DOI 10.3386/W21913
   Kalenkoski C., 2020, DIFFERENTIAL INITIAL
   Kalleberg A.L., 2016, LERA FOR LIB, V20, P10
   Kalleberg AL, 2003, WORK OCCUPATION, V30, P154, DOI 10.1177/0730888403251683
   Kassi O, 2018, TECHNOL FORECAST SOC, V137, P241, DOI 10.1016/j.techfore.2018.07.056
   Kochhar R, 2020, UNEMPLOYMENT RATE IS
   Lambert SJ, 2012, COMMIMITY WORK FAM, V15, P293, DOI 10.1080/13668803.2012.662803
   Lehdonvirta V, 2018, NEW TECH WORK EMPLOY, V33, P13, DOI 10.1111/ntwe.12102
   Malone T. W., 2004, FUTURE WORK NEW ORDE
   McKayPollack C.E., 2019, AUTOMATION CHANGING
   McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796
   Moreira da Silva J., 2019, WHY YOU SHOULD CARE
   Morini C, 2007, FEMINIST REV, P40, DOI 10.1057/palgrave.fr.9400367
   O'Farrell R, 2020, NEW TECH WORK EMPLOY, V35, P130, DOI 10.1111/ntwe.12155
   Office of Congresswoman Katie Porter, 2020, BURD COVID 19 PAND W
   Pichault F, 2019, NEW TECH WORK EMPLOY, V34, P59, DOI 10.1111/ntwe.12132
   Reichelt M, 2021, EUR SOC, V23, pS228, DOI 10.1080/14616696.2020.1823010
   Shevchuk A, 2021, NEW TECH WORK EMPLOY, V36, P94, DOI 10.1111/ntwe.12191
   Shevchuk A, 2019, ILR REV, V72, P75, DOI 10.1177/0019793918767114
   Shockley KM, 2007, J VOCAT BEHAV, V71, P479, DOI 10.1016/j.jvb.2007.08.006
   SILVER H, 1994, SOC FORCES, V72, P1103, DOI 10.2307/2580294
   Singh, 2015, GLOBAL OPPORTUNITY O
   Six Silberman M., 2019, COMPUT SUPP COOP W J, V28, P911
   Stephany F., 2021, ARXIV PREPRINT ARXIV
   Stephany F, 2020, TIJDSCHR ECON SOC GE, V111, P561, DOI 10.1111/tesg.12455
   Sundararajan A, 2016, SHARING ECONOMY: THE END OF EMPLOYMENT AND THE RISE OF CROWD-BASED CAPITALISM, P1
   Sutherland Will, 2017, Proceedings of the ACM on Human-Computer Interaction, V1, DOI 10.1145/3134732
   The Freelance Creative, 2016, PRET YOUR WHIT MAL F
   Vallas S, 2020, ANNU REV SOCIOL, V46, P273, DOI 10.1146/annurev-soc-121919-054857
   Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2
   Wiswall M, 2018, Q J ECON, V133, P457, DOI 10.1093/qje/qjx035
   Wood AJ, 2019, SOCIOLOGY, V53, P931, DOI 10.1177/0038038519828906
   Wood AJ, 2019, WORK EMPLOY SOC, V33, P56, DOI 10.1177/0950017018785616
   Wood AJ, 2016, HUM RELAT, V69, P1989, DOI 10.1177/0018726716631396
NR 67
TC 1
Z9 1
U1 16
U2 17
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2297-7775
J9 FRONT SOCIOL
JI Front. Sociol.
PD AUG 31
PY 2021
VL 6
AR 738024
DI 10.3389/fsoc.2021.738024
PG 7
WC Sociology
WE Emerging Sources Citation Index (ESCI)
SC Sociology
GA UT2LA
UT WOS:000697951400001
PM 34532354
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Akter, S
   Hakim, SS
   Rahman, MS
AF Akter, Salma
   Hakim, Sheikh Serajul
   Rahman, Md. Saydur
TI Planning for pandemic resilience: COVID-19 experience from urban slums
   in Khulna, Bangladesh
SO JOURNAL OF URBAN MANAGEMENT
LA English
DT Article
DE COVID-19; Pandemic; Vulnerability/adaptation; Resilience; Urban slums;
   Khulna
ID COMMUNITY RESILIENCE; VULNERABILITY; FRAMEWORK; LESSONS; RISK; HOME
AB COVID-19 worsened urban slum dwellers' pre-existing vulnerabilities. Maintaining WHO-suggested physical distancing/isolation made planning more challenging in slums. The scenarios hint at the urgency to investigate whether these resource-scarce communities - already susceptible to climate change, poverty, health services, infrastructure, and space constraints, could build resilience against COVID-19. What lack of resources/assets made communities vulnerable there, and what adaptation measures were taken? What planning/management practices were adopted there, and to what extent could WHO's IPC guidelines (on transmission prevention and control) be followed? Findings show that pre-COVID economic, infrastructural, and health-related issues had affected slum dwellers' COVID-time vulnerabilities. While poor infrastructure and sanitation, informal employment, livelihood diversity, superstition, and comorbidities remained the key 'internal' issues, lack of institutional preparedness and safety-net programs, discontinued municipal services and inaccessible/untrustworthy healthcare services and corruption/bias/non-coordination in beneficiary selection remained the key `external' issues. Information sharing, openness to pandemic knowledge, and active participation in awareness/training programs have been the most adopted measures. Aid schemes, despite criticisms, saved dwellers from starvation. Therefore, this proved to be a critical coping element. However, NGOs systematic monetary aid gave dwellers the most flexibility in spending. On top, NGOs proved to be the most vital external stakeholder in all sectors except for built environment/planning. To increase adaptive capacity, scopes remain in maximizing the use of community infrastructure in future events. Simultaneously, spatial aspects, alongside the non-spatial, seemed crucial in tackling complex poverty profiles, resource-scarcity, and vulnerabilities of slums. Findings are based on NGO BRAC's existing dataset and fieldwork between April-August 2020 on 29 slums in Khulna, Bangladesh, using a qualitative methodology. The study contributes to a growing body of knowledge and practice on resilient planning for COVID-19 (and similar future pandemics), especially for slums, while addressing its overlooked spatial dimensions.
C1 [Akter, Salma] Premier Univ, Architecture Dept, Chittagong, Bangladesh.
   [Hakim, Sheikh Serajul] Khulna Univ, Architecture Discipline, Khulna, Bangladesh.
   [Rahman, Md. Saydur] BRAC, Urban Dev Program, Khulna, Bangladesh.
RP Akter, S (corresponding author), Premier Univ, Architecture Dept, Chittagong, Bangladesh.
EM surma.arch@puc.ac.bd; serajulhakim@arch.ku.ac.bd;
   saidurlushan44@gmail.com
OI Hakim, Dr. Sheikh Serajul/0000-0003-0608-0913; Akter,
   Salma/0000-0002-9991-6021
CR Abuya T., 2020, COVID 19 RELATED KNO
   Adger WN, 2000, PROG HUM GEOG, V24, P347, DOI 10.1191/030913200701540465
   Ahmed I., 2020, BUSINESS STANDARD, V31
   Ahmed SAKS, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003042
   Akter S., 2021, J MIGRATION HLTH, V4
   Aldrich DP, 2015, AM BEHAV SCI, V59, P254, DOI 10.1177/0002764214550299
   Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154
   Asadzadeh A., 2015, STAKEHOLDERS PARTICI
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Barouki R, 2021, ENVIRON INT, V146, DOI 10.1016/j.envint.2020.106272
   BBS, 2015, CENS SLUM AR FLOAT P
   Bene C., 2012, IDS WORKING PAPERS, V2012, P1, DOI [10.1111/j.2040-0209.2012.00405.x, DOI 10.1111/J.2040-0209.2012.00405.X]
   Berkes F, 2013, SOC NATUR RESOUR, V26, P5, DOI 10.1080/08941920.2012.736605
   BRAC U. S. M., 2020, URB SLUM MAP BRAC
   Brown D. D., 1996, CONCEPTS RESILIENCY, V4, P29
   Caruso BA, 2020, LANCET PLANET HEALTH, V4, pE173, DOI 10.1016/S2542-5196(20)30086-3
   Collins A, 2020, J RISK RES, V23, P1073, DOI 10.1080/13669877.2020.1760332
   Corburn J, 2020, J URBAN HEALTH, V97, P348, DOI 10.1007/s11524-020-00438-6
   Cutter SL, 2006, ENVIRONMENT, V48, P8, DOI 10.3200/ENVT.48.2.8-20
   Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013
   de Paz C., 2020, GENDER DIMENSIONS CO
   Dhar B, 2020, DHAKATRIBUNE
   Dhar TK, 2017, URBAN CLIM, V19, P72, DOI 10.1016/j.uclim.2016.12.004
   Dhaval DD, 2020, ORF OCCASIONAL PAPER, V244, P1
   Dianati K, 2019, SCI TOTAL ENVIRON, V660, P1108, DOI 10.1016/j.scitotenv.2018.12.430
   economicsbd, 2011, SLUM BANGL OV
   Gallopin GC, 2006, GLOBAL ENVIRON CHANG, V16, P293, DOI 10.1016/j.gloenvcha.2006.02.004
   Garrett T.A, 2007, EC EFFECTS 1918 INFL
   Ghosh S., 2020, SOCIAL SCI HUMANITIE, V2
   Guillard-Goncalves C, 2018, GEOSCIENCES, V8, DOI 10.3390/geosciences8080294
   Guizani N., 2020, IEEE NETWORK, P1, DOI DOI 10.1101/2020.04.08.20058164
   Gurwitch, 2008, HDB INJURY VIOLENCE, P347
   HAKIM S. S., 2013, CONTROL NEG FORM OF
   Handmer J.W., 1996, IND ENV CRISIS Q, V9, P482, DOI DOI 10.1177/108602669600900403
   Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4
   Haque A, 2020, J HEALTH RES, V34, P563, DOI 10.1108/JHR-07-2020-0279
   Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245
   Hung LS, 2003, J ROY SOC MED, V96, P374, DOI 10.1258/jrsm.96.8.374
   Islam MS, 2021, J PUBLIC HEALTH-UK, V43, P13, DOI 10.1093/pubmed/fdaa182
   Jackson J, 2006, PHILOS T R SOC A, V364, P1911, DOI 10.1098/rsta.2006.1805
   JHU (John Hopkins University), 2021, COVID 19 DASHB CTR S
   Kangwana, 2020, COVID 19 RELATED KNO
   Kao C.-L., 2012, EMERGED HA NA MUTANT
   Kulig JC, 2013, J COMMUNITY PSYCHOL, V41, P758, DOI 10.1002/jcop.21569
   Lau LS, 2020, NAT MED, V26, P647, DOI 10.1038/s41591-020-0851-2
   Leach K, 2013, LOCAL ECON, V28, P927, DOI 10.1177/0269094213500912
   Leykin D, 2016, INT J DISAST RISK RE, V15, P125, DOI 10.1016/j.ijdrr.2016.01.008
   Longstaff FA, 2005, J FINANC, V60, P2213, DOI 10.1111/j.1540-6261.2005.00797.x
   Mamun MA, 2020, BRAIN BEHAV IMMUN, V87, P163, DOI 10.1016/j.bbi.2020.05.028
   Manyena SB, 2006, DISASTERS, V30, P433
   Mathavarajah S, 2021, SCI TOTAL ENVIRON, V760, DOI 10.1016/j.scitotenv.2020.143346
   Maxwell JA, 2010, QUAL INQ, V16, P475, DOI 10.1177/1077800410364740
   Mesfin D, 2020, CLIMATE, V8, DOI 10.3390/cli8100106
   Minor OM, 2017, ANTHROPOL ACTION, V24, P25, DOI 10.3167/aia.2017.240204
   Mishra SV, 2020, HABITAT INT, V103, DOI 10.1016/j.habitatint.2020.102230
   Moser C, 2010, 54947GLB INT BANK RE
   Nahiduzzaman KM, 2020, J URBAN MANAG, V9, P261, DOI 10.1016/j.jum.2020.08.004
   Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6
   Opiyo FEO, 2014, PASTORALISM, V4, DOI 10.1186/s13570-014-0010-9
   Pachauri R.K., 2014, CLIMATE CHANGE 2014
   Pal R, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108344
   Panday P. K., 2020, FACE URBANIZATION UR, P57
   Paul JN, 2020, AWARENESS PERCEPTION
   Pelling M, 2015, CLIMATIC CHANGE, V133, P113, DOI 10.1007/s10584-014-1303-0
   Rahaman KR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186439
   Rahman MR, 2021, MODEL EARTH SYST ENV, V7, P2059, DOI 10.1007/s40808-020-00962-z
   Roy S., 2018, BANGLADESH NATL URBA
   Scherzer S, 2019, INT J DISAST RISK RE, V36, DOI 10.1016/j.ijdrr.2019.101107
   Schwandt TA., 2014, SAGE DICT QUALITATIV
   Scolobig A, 2015, INT J DISAST RISK RE, V12, P202, DOI 10.1016/j.ijdrr.2015.01.006
   Smit W, 2016, HEALTH PLACE, V39, P196, DOI 10.1016/j.healthplace.2016.04.006
   Snyder RE, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2030047
   Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100
   Van Belle S, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01198-0
   Waller MA, 2001, AM J ORTHOPSYCHIAT, V71, P290, DOI 10.1037/0002-9432.71.3.290
   Wilkinson A., 2020, CITIES HLTH, P1
   Wilkinson A., 2020, KEY CONSIDERATIONS C
   Wilkinson A, 2020, ENVIRON URBAN, V32, P503, DOI 10.1177/0956247820922843
   Woolf S, 2016, INT J DISAST RISK RE, V19, P280, DOI 10.1016/j.ijdrr.2016.08.003
   World Meter, COVID 19 COR PAND
   Younus MAF, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10114286
   Zimmerer KS, 2020, FOOD SECUR, V12, P891, DOI 10.1007/s12571-020-01088-x
   Zipfel, 2020, EC IMPACT COVID 19 L
NR 83
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2226-5856
EI 2589-0360
J9 J URBAN MANAG
JI J. Urban Manag.
PD DEC
PY 2021
VL 10
IS 4
BP 325
EP 344
DI 10.1016/j.jum.2021.08.003
EA NOV 2021
PG 20
WC Urban Studies
WE Emerging Sources Citation Index (ESCI)
SC Urban Studies
GA YV0EV
UT WOS:000752407200003
OA gold
DA 2022-04-20
ER

PT J
AU Gallo, CG
   Fiorino, S
   Posabella, G
   Antonacci, D
   Tropeano, A
   Pausini, E
   Pausini, C
   Guarniero, T
   Hong, WD
   Giampieri, E
   Corazza, I
   Federico, L
   de Biase, D
   Zippi, M
   Zancanaro, M
AF Gallo, Claudio G.
   Fiorino, Sirio
   Posabella, Giovanni
   Antonacci, Donato
   Tropeano, Antonio
   Pausini, Emanuele
   Pausini, Carlotta
   Guarniero, Tommaso
   Hong, Wandong
   Giampieri, Enrico
   Corazza, Ivan
   Federico, Lari
   de Biase, Dario
   Zippi, Maddalena
   Zancanaro, Marco
TI COVID-19, what could sepsis, severe acute pancreatitis, gender
   differences, and aging teach us?
SO CYTOKINE
LA English
DT Review
DE CoV-2; Covid-19; Sepsis; Acute pancreatitis; Aging
ID CD8(+) T-CELLS; INTERNATIONAL CONSENSUS DEFINITIONS; NLRP3 INFLAMMASOME
   ACTIVATION; RESPIRATORY-DISTRESS-SYNDROME; NECROSIS-FACTOR-ALPHA;
   CONVERTING ENZYME 2; ACUTE LUNG INJURY; COMPLEMENT ACTIVATION;
   SUPPRESSOR-CELLS; CYTOKINE STORM
AB Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a potentially life-threatening disease, defined as Coronavirus Disease 19 (COVID-19). The most common signs and symptoms of this pathological condition include cough, fever, shortness of breath, and sudden onset of anosmia, ageusia, or dysgeusia. The course of COVID-19 is mild or moderate in more than 80% of cases, but it is severe or critical in about 14% and 5% of infected subjects respectively, with a significant risk of mortality. SARS-CoV-2 related infection is characterized by some pathogenetic events, resembling those detectable in other pathological conditions, such as sepsis and severe acute pancreatitis. All these syndromes are characterized by some similar features, including the coexistence of an exuberant inflammatory-as well as an anti-inflammatory-response with immune depression. Based on current knowledge concerning the onset and the development of acute pancreatitis and sepsis, we have considered these syndromes as a very interesting paradigm for improving our understanding of pathogenetic events detectable in patients with COVID-19. The aim of our review is: 1)to examine the pathogenetic mechanisms acting during the emergence of inflammatory and antiinflammatory processes in human pathology; 2)to examine inflammatory and anti-inflammatory events in sepsis, acute pancreatitis, and SARS-CoV-2 infection and clinical manifestations detectable in patients suffering from these syndromes also according to the age and gender of these individuals; as well as to analyze the possible common and different features among these pathological conditions; 3)to obtain insights into our knowledge concerning COVID-19 pathogenesis. This approach may improve the management of patients suffering from this disease and it may suggest more effective diagnostic approaches and schedules of therapy, depending on the different phases and/or on the severity of SARS-CoV-2 infection.
C1 [Gallo, Claudio G.] Emilian Physiolaser Therapy Ctr, Bologna, Italy.
   [Fiorino, Sirio; Federico, Lari] Budrio Hosp Azienda USL, Internal Med Unit, Bologna, Italy.
   [Posabella, Giovanni; Tropeano, Antonio; Pausini, Emanuele; Pausini, Carlotta; Guarniero, Tommaso; Zancanaro, Marco] Comune Bologna, Bologna, Italy.
   [Antonacci, Donato] Casa Sollievo Sofferenza Hosp, Med Sci Dept, San Giovanni Rotondo, FG, Italy.
   [Hong, Wandong] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Wenzhou, Zhejiang, Peoples R China.
   [Giampieri, Enrico; Corazza, Ivan] Univ Bologna, Expt Diagnost & Specialty Med Dept, Bologna, Italy.
   [de Biase, Dario] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.
   [Zippi, Maddalena] Sandro Pertini Hosp, Unit Gastroenterol & Digest Endoscopy, Rome, Italy.
RP Gallo, CG (corresponding author), Emilian Physiolaser Therapy Ctr, Bologna, Italy.
EM galclaudio@libero.it
RI Corazza, Ivan/AAY-8566-2021; de Biase, Dario/B-9274-2012; Giampieri,
   Enrico/AAC-7354-2022; Zippi, Maddalena/R-4837-2019
OI Corazza, Ivan/0000-0003-2078-1978; de Biase, Dario/0000-0002-0609-8817;
   Giampieri, Enrico/0000-0003-2269-2338; Zippi,
   Maddalena/0000-0001-5876-3199; Guarniero, Tommaso/0000-0003-3929-9022
CR Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Adib-Conquy M, 2000, AM J RESP CRIT CARE, V162, P1877, DOI 10.1164/ajrccm.162.5.2003058
   Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421
   Afshar-Kharghan V, 2017, BLOOD, V129, P2214, DOI 10.1182/blood-2017-03-771501
   Aghbash PS, 2021, LIFE SCI, V270, DOI 10.1016/j.lfs.2021.119124
   Agrawal P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01117
   Ahmed F, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.586765
   Ahn E, 2018, P NATL ACAD SCI USA, V115, P4749, DOI 10.1073/pnas.1718217115
   Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678
   Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6
   Annweiler Cedric, 2020, J Steroid Biochem Mol Biol, V204, P105771, DOI 10.1016/j.jsbmb.2020.105771
   Annweiler G, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113377
   Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006
   Aygun H, 2020, N-S ARCH PHARMACOL, V393, P1157, DOI 10.1007/s00210-020-01911-4
   Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0
   Banu N, 2020, LIFE SCI, V256, DOI 10.1016/j.lfs.2020.117905
   Bao JF, 2020, CLIN CHIM ACTA, V509, P180, DOI 10.1016/j.cca.2020.06.009
   Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585
   Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z
   Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536
   Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051
   Berner R, 1998, PEDIATR RES, V44, P469, DOI 10.1203/00006450-199810000-00002
   Bettoni S, 2017, J IMMUNOL, V199, P1021, DOI 10.4049/jimmunol.1601121
   Bexelius TS, 2009, PANCREATOLOGY, V9, P786, DOI 10.1159/000225906
   Bhatia, 2006, J ORGAN DYSFUNCTION, P80, DOI DOI 10.1080/17471060500435662
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Biran N, 2020, LANCET RHEUMATOL, V2, pE603, DOI 10.1016/S2665-9913(20)30277-0
   Biron BM, 2015, BIOMARK INSIGHTS, V10, P7, DOI 10.4137/BMI.S29519
   Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009
   Bitker L, 2019, CRIT CARE CLIN, V35, P213, DOI 10.1016/j.ccc.2018.11.002
   Blackwell TS, 1996, BRIT J ANAESTH, V77, P110, DOI 10.1093/bja/77.1.110
   Bloch MJ, 2020, J AM COLL CARDIOL, V76, P277, DOI 10.1016/j.jacc.2020.06.003
   Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877
   BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644
   Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829
   Boontham P, 2003, SURG-J R COLL SURG E, V1, P187, DOI 10.1016/S1479-666X(03)80018-5
   Brehm TT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85081-0
   Brenner EJ, 2020, GASTROENTEROLOGY, V159, P481, DOI 10.1053/j.gastro.2020.05.032
   Bronte V, 2020, J CLIN INVEST, V130, P6409, DOI 10.1172/JCI141772
   Buscher K, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00080
   Camicia G, 2014, SHOCK, V42, P286, DOI 10.1097/SHK.0000000000000221
   Cantini F, 2020, J INFECTION, V81, P318, DOI 10.1016/j.jinf.2020.04.017
   Cao Yang, 2020, J Allergy Clin Immunol, V146, P137, DOI 10.1016/j.jaci.2020.05.019
   Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
   Carvelli J, 2020, NATURE, V588, P146, DOI 10.1038/s41586-020-2600-6
   Cauchois R, 2020, P NATL ACAD SCI USA, V117, P18951, DOI 10.1073/pnas.2009017117
   Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055
   Cavalli G, 2021, LANCET RESP MED, V9, P223, DOI 10.1016/S2213-2600(21)00035-7
   Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2
   Chan YC, 2011, REGUL PEPTIDES, V166, P128, DOI 10.1016/j.regpep.2010.10.006
   Chan YC, 2009, J PHARMACOL EXP THER, V329, P450, DOI 10.1124/jpet.108.148353
   Chang, 2021, J INFECT DIS
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Charchaflieh J, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/382463
   Charchaflieh J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/407324
   Chen WJ, 2021, BIOL PROCED ONLINE, V23, DOI 10.1186/s12575-021-00142-y
   Chen XH, 2020, CLIN INFECT DIS, V71, P1937, DOI 10.1093/cid/ciaa449
   Cheng H, 2020, J MED VIROL, V92, P726, DOI 10.1002/jmv.25785
   Cheng ZKJ, 2020, INFECTION, V48, P155, DOI 10.1007/s15010-020-01401-y
   Chimen M, 2017, J IMMUNOL, V198, P2834, DOI 10.4049/jimmunol.1601281
   Choi ST, 2016, YONSEI MED J, V57, P1139, DOI 10.3349/ymj.2016.57.5.1139
   Chousterman BG, 2017, SEMIN IMMUNOPATHOL, V39, P517, DOI 10.1007/s00281-017-0639-8
   Chu KL, 2020, J IMMUNOL, V204, P477, DOI 10.4049/jimmunol.1901046
   Ciccullo A, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106017
   Clere-Jehl R, 2020, TRENDS MOL MED, V26, P987, DOI 10.1016/j.molmed.2020.06.007
   Conti P, 2020, J BIOL REG HOMEOS AG, V34, P1971, DOI 10.23812/20-1-E
   Conway EM, 2015, J THROMB HAEMOST, V13, pS121, DOI 10.1111/jth.12950
   Coomes EA, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2141
   Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003
   Correa TD, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0802-3
   Cugno M, 2020, J ALLERGY CLIN IMMUN, V146, P215, DOI 10.1016/j.jaci.2020.05.006
   Danikas DD, 2008, CLIN EXP IMMUNOL, V154, P87, DOI 10.1111/j.1365-2249.2008.03737.x
   de Bont CM, 2019, CELL MOL IMMUNOL, V16, P19, DOI 10.1038/s41423-018-0024-0
   del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350
   Del Valle Diane Marie, 2020, medRxiv, DOI 10.1101/2020.05.28.20115758
   Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503
   Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827
   Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005
   Diurno F, 2020, EUR REV MED PHARMACO, V24, P4040, DOI 10.26355/eurrev_202004_20875
   Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1
   Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234
   Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345
   Eskier D, 2020, PEERJ, V8, DOI 10.7717/peerj.10181
   Falck-Jones S, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI144734
   Feng SJ, 2015, BLOOD, V125, P1034, DOI 10.1182/blood-2014-06-585430
   FIEREN MWJA, 1990, EUR J CLIN INVEST, V20, P453, DOI 10.1111/j.1365-2362.1990.tb01883.x
   Fiorino S, 2020, AGING CLIN EXP RES, V32, P2115, DOI 10.1007/s40520-020-01669-y
   Fiorino S, 2021, BRIT J NUTR, V125, P275, DOI 10.1017/S0007114520002913
   Foley JH, 2016, CIRC RES, V118, P1392, DOI 10.1161/CIRCRESAHA.116.306853
   Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836
   Fraga-Silva RA, 2010, MOL MED, V16, P210, DOI 10.2119/molmed.2009.00160
   Frankenberger M, 1996, BLOOD, V87, P373
   Franzetti M, 2021, J IMMUNOL, V206, P1569, DOI 10.4049/jimmunol.2001126
   Frediansyah A, 2021, CLIN EPIDEMIOL GLOB, V9, P90, DOI 10.1016/j.cegh.2020.07.006
   Fu Q, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1294951
   Gabrial S, 2020, NEW ENGL J MED, V383, P397, DOI 10.1056/NEJMc2005396
   Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506
   Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025
   Galani IE, 2021, NAT IMMUNOL, V22, P32, DOI 10.1038/s41590-020-00840-x
   Ganter MT, 2007, SHOCK, V28, P29, DOI 10.1097/shk.0b013e3180342439
   Gautier J., 2020, MONOCYTE CLASS SWITC
   Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000
   Ghebrehiwet B, 2020, J CLIN INVEST, V130, P5674, DOI 10.1172/JCI142780
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Glynn PC, 2001, EUR RESPIR J, V18, P522, DOI 10.1183/09031936.01.00057901
   Gong ZZ, 2015, MOL NUTR FOOD RES, V59, P2132, DOI 10.1002/mnfr.201500316
   Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18
   Grant RA, 2021, NATURE, V590, P635, DOI 10.1038/s41586-020-03148-w
   Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003
   Guaraldi G, 2020, LANCET RHEUMATOL, V2, pE474, DOI 10.1016/S2665-9913(20)30173-9
   Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712
   Gustine JN, 2021, AM J PATHOL, V191, P4, DOI 10.1016/j.ajpath.2020.08.009
   Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105
   Hammaren HM, 2019, CYTOKINE, V118, P48, DOI 10.1016/j.cyto.2018.03.041
   Hamming I, 2007, J PATHOL, V212, P1, DOI 10.1002/path.2162
   Harbour SN, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaw2262
   Hardy RS, 2020, NAT REV RHEUMATOL, V16, P133, DOI 10.1038/s41584-020-0371-y
   HATTORI R, 1989, J BIOL CHEM, V264, P9053
   Hegyi P, 2020, GASTROENTEROLOGY, V159, P824, DOI 10.1053/j.gastro.2020.07.014
   Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820
   Herold T, 2020, J ALLERGY CLIN IMMUN, V146, P128, DOI 10.1016/j.jaci.2020.05.008
   Hijdra D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00339
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Holter JC, 2020, P NATL ACAD SCI USA, V117, P25018, DOI 10.1073/pnas.2010540117
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hotchkiss RS, 2019, CRIT CARE MED, V47, P632, DOI 10.1097/CCM.0000000000003685
   Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45
   Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552
   Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419
   Hussain N, 2021, EXPERT REV ANTI-INFE, V19, P473, DOI 10.1080/14787210.2021.1823832
   Imran MM, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13698
   JACOBS RF, 1989, AM REV RESPIR DIS, V140, P1686, DOI 10.1164/ajrccm/140.6.1686
   Jatiani Shashidhar S, 2010, Genes Cancer, V1, P979, DOI 10.1177/1947601910397187
   Java A, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140711
   Jiang YT, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010039
   Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152
   Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95
   Jorgensen SCJ, 2020, PHARMACOTHERAPY, V40, P843, DOI 10.1002/phar.2438
   Kapoor S, 2018, THROMB RES, V170, P87, DOI 10.1016/j.thromres.2018.08.005
   Kato H, 2020, J INFECT CHEMOTHER, V26, P865, DOI 10.1016/j.jiac.2020.05.005
   Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328
   Keshari RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048111
   Khan A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1823-x
   Khanna A, 2017, NEW ENGL J MED, V377, P419, DOI 10.1056/NEJMoa1704154
   Kim Tae-Shin, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-019-0316-1
   Kimball AS, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00236
   Kimmig Lucas M, 2020, medRxiv, DOI 10.1101/2020.05.15.20103531
   Kittana N, 2018, FUND CLIN PHARMACOL, V32, P14, DOI 10.1111/fcp.12318
   Kleczko EK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00954
   Konno Y, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108185
   Kotyla PJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052449
   Krautz C, 2018, J CRIT CARE, V45, P71, DOI 10.1016/j.jcrc.2018.01.013
   Krishnamurthy S, 2021, AM J PHYSIOL-CELL PH, V320, pC279, DOI 10.1152/ajpcell.00478.2020
   Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976
   Kumar V, 2018, J INFLAMM RES, V11, P477, DOI 10.2147/JIR.S178084
   Kvedaraite E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018587118
   Lee HW, 2021, KOREAN J INTERN MED, V36, P371, DOI 10.3904/kjim.2019.262
   Lee KG, 2012, XENOTRANSPLANTATION, V19, P186, DOI 10.1111/j.1399-3089.2012.00704.x
   Lehmann, 2013, ADV BIOSCI BIOTECHNO, V4, P860, DOI DOI 10.4236/ABB.2013.49114
   LEHMANN AK, 1995, INFECT IMMUN, V63, P2109, DOI 10.1128/IAI.63.6.2109-2112.1995
   Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9
   Leisman DE, 2020, LANCET RESP MED, V8, P1233, DOI 10.1016/S2213-2600(20)30404-5
   Leisman Daniel E, 2020, Crit Care Explor, V2, pe0230, DOI 10.1097/CCE.0000000000000230
   Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951
   Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097
   Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B
   Li H, 2020, LANCET, V395, P1517, DOI 10.1016/S0140-6736(20)30920-X
   Li LL, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/4235909
   Li MY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.580237
   Li Y, 2020, INT J INFECT DIS, V98, P80, DOI 10.1016/j.ijid.2020.06.026
   Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9
   Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812
   Liu NY, 2021, INT J INFECT DIS, V104, P58, DOI 10.1016/j.ijid.2020.12.077
   Liu RX, 2014, EXP PHYSIOL, V99, P651, DOI 10.1113/expphysiol.2013.074815
   Liu X, 2014, VIRUS RES, V185, P64, DOI 10.1016/j.virusres.2014.03.010
   Lo MW, 2020, J IMMUNOL, V205, P1488, DOI 10.4049/jimmunol.2000644
   Long HB, 2016, AM J EMERG MED, V34, P772, DOI 10.1016/j.ajem.2015.12.075
   Rodriguez-Garcia JL, 2021, RHEUMATOLOGY, V60, P399, DOI 10.1093/rheumatology/keaa587
   Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315
   Luo YP, 2014, INT IMMUNOPHARMACOL, V20, P24, DOI 10.1016/j.intimp.2014.02.017
   Lupu F, 2014, THROMB RES, V133, pS28, DOI 10.1016/j.thromres.2014.03.014
   Lusyati S, 2013, J Neonatal Perinatal Med, V6, P153, DOI 10.3233/NPM-1364112
   Machado JR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/269681
   Maeda K, 2005, BLOOD, V106, P879, DOI 10.1182/blood-2005-02-0456
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269
   Mahdavi AM, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2119
   Manjuck J, 2000, J LAB CLIN MED, V135, P153, DOI 10.1067/mlc.2000.104306
   Manson JJ, 2020, LANCET RHEUMATOL, V2, pE594, DOI 10.1016/S2665-9913(20)30275-7
   MARCHANT A, 1994, LANCET, V343, P707, DOI 10.1016/S0140-6736(94)91584-9
   Mariette X, 2021, LANCET RESP MED, V9, P295, DOI 10.1016/S2213-2600(20)30556-7
   Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x
   Martin SJ, 2016, FEBS J, V283, P2599, DOI 10.1111/febs.13775
   MATHISON JC, 1990, J CLIN INVEST, V85, P1108, DOI 10.1172/JCI114542
   MCCALL CE, 1993, J CLIN INVEST, V91, P853, DOI 10.1172/JCI116306
   McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318
   Meckiff Benjamin J, 2020, SSRN, P3641939, DOI [10.1101/2020.06.12.148916, 10.2139/ssrn.3641939]
   Mehanic Snjezana, 2013, Mater Sociomed, V25, P277, DOI 10.5455/msm.2013.25.277-281
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Meng YF, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008520
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Miller AJ, 2019, CLIN AUTON RES, V29, P231, DOI 10.1007/s10286-018-0572-5
   Miller A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89957-z
   Miller EJ, 1996, CRIT CARE MED, V24, P1448, DOI 10.1097/00003246-199609000-00004
   Mira JC, 2017, CRIT CARE MED, V45, P253, DOI [10.1097/CCM.0000000000002074, 10.1097/ccm.0000000000002074]
   Mofidi R, 2006, BRIT J SURG, V93, P738, DOI 10.1002/bjs.5290
   Mollnes TE, 2020, FEBS LETT, V594, P2621, DOI 10.1002/1873-3468.13881
   Monk PD, 2021, LANCET RESP MED, V9, P196, DOI 10.1016/S2213-2600(20)30511-7
   Monneret G, 2004, IMMUNOL LETT, V95, P193, DOI 10.1016/j.imlet.2004.07.009
   Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f
   Mukherjee R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13886
   Noris M, 2020, KIDNEY INT, V98, P314, DOI 10.1016/j.kint.2020.05.013
   O'Shea JJ, 2013, ANN RHEUM DIS, V72, P111, DOI 10.1136/annrheumdis-2012-202576
   Ogando NS, 2020, J VIROL, V94, DOI 10.1128/JVI.01246-20
   Ong SM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0327-1
   Pandian SRK, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-02464-2
   Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005
   Patel S, 2017, BIOMED PHARMACOTHER, V94, P317, DOI 10.1016/j.biopha.2017.07.091
   Peerschke EIB, 2008, ADV EXP MED BIOL, V632, P81, DOI 10.1007/978-0-387-78952-1_7
   Pence BD, 2020, GEROSCIENCE, V42, P1051, DOI 10.1007/s11357-020-00213-0
   Pillai S., 2021, CELLS LUNGS SEVERE C
   Pinto LC, 2020, ARCH ENDOCRIN METAB, V64, P199, DOI 10.20945/2359-3997000000256
   Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]
   Rabaan AA, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050436
   Raghunandan S, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.616731
   Rahmani H, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106903
   Raiden S, 2002, J PHARMACOL EXP THER, V303, P45, DOI 10.1124/jpet.102.037382
   Rajasimhan S, 2020, DRUG AGING, V37, P551, DOI 10.1007/s40266-020-00775-w
   Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873
   Reis ES, 2019, NAT REV IMMUNOL, V19, P503, DOI 10.1038/s41577-019-0168-x
   Remy KE, 2020, LANCET RESP MED, V8, P946, DOI 10.1016/S2213-2600(20)30217-4
   Ricklin Daniel, 2019, Nat Rev Drug Discov, DOI 10.1038/s41573-019-0055-y
   Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794
   Rittirsch D, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/962927
   Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9
   Ruiz-Limon P, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00634-1
   Sacchi A, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03125-1
   Salvarani C, 2021, JAMA INTERN MED, V181, P24, DOI 10.1001/jamainternmed.2020.6615
   Sanchez-Cerrillo I, 2020, J CLIN INVEST, V130, P6290, DOI 10.1172/JCI140335
   Schrijver IT, 2019, FRONT IMMUNOL, V10, DOI [10.1155/2014/598654, 10.3389/fimmu.2019.00327]
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Scott IC, 2018, DRUG SAFETY, V41, P645, DOI 10.1007/s40264-018-0651-5
   Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017
   Semeraro N, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.024
   Sendler M, 2020, GASTROENTEROLOGY, V158, P253, DOI 10.1053/j.gastro.2019.09.040
   Sendler M, 2016, J BIOL CHEM, V291, P14717, DOI 10.1074/jbc.M116.718999
   Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288
   Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289
   Shen B, 2020, CELL, V182, P59, DOI 10.1016/j.cell.2020.05.032
   Shen LH, 2009, SHOCK, V31, P500, DOI 10.1097/SHK.0b013e318189017a
   Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9
   Shin EC, 2016, NAT REV IMMUNOL, V16, P509, DOI 10.1038/nri.2016.69
   Silva ACSE, 2013, BRIT J PHARMACOL, V169, P477, DOI 10.1111/bph.12159
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Singh VK, 2009, CLIN GASTROENTEROL H, V7, P1247, DOI 10.1016/j.cgh.2009.08.012
   Siqueira-Batista, 2015, BIOL SYST OPEN ACCES, V5, P1
   Skendros P, 2020, J CLIN INVEST, V130, P6151, DOI 10.1172/JCI141374
   Somers EC, 2021, CLIN INFECT DIS, V73, pE445, DOI [10.1093/cid/ciaa954, 10.1101/2020.05.29.20117358]
   Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029
   Stakos D, 2020, THROMB HAEMOSTASIS, V120, P373, DOI 10.1055/s-0039-3402731
   Stansfield BK, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0040-3
   Steinhagen F, 2016, EUR J IMMUNOL, V46, P647, DOI 10.1002/eji.201545911
   STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C
   Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836
   Sun HY, 2020, J AM GERIATR SOC, V68, pE19, DOI 10.1111/jgs.16533
   Sunzini F, 2020, THER ADV MUSCULOSKEL, V12, DOI 10.1177/1759720X20936059
   Surbatovic M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11355
   Suzuki T, 2006, CYTOKINE, V34, P76, DOI 10.1016/j.cyto.2006.04.007
   Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414
   Tamayo E, 2011, EUR CYTOKINE NETW, V22, P82, DOI 10.1684/ecn.2011.0281
   Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392
   Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0
   Thakur V, 2021, J CLIN MED, V10, DOI 10.3390/jcm10030446
   Tizabi, J MED VIROL, V2021
   Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947
   van de Veerdonk FL, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03166-0
   van Dijk SM, 2017, GUT, V66, P2024, DOI 10.1136/gutjnl-2016-313595
   van Dissel JT, 1998, LANCET, V351, P950, DOI 10.1016/S0140-6736(05)60606-X
   van Vollenhoven R, 2019, ARTHRITIS RHEUMATOL, V71, P685, DOI 10.1002/art.40780
   Vandenborre K, 1999, IMMUNOLOGY, V98, P413, DOI 10.1046/j.1365-2567.1999.00888.x
   VANDEUREN M, 1995, J INFECT DIS, V172, P433, DOI 10.1093/infdis/172.2.433
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422
   Verden A, 2018, DRUG SAFETY, V41, P357, DOI 10.1007/s40264-017-0622-2
   Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751
   Vivarelli S, 2021, INT J ONCOL, V58, P145, DOI 10.3892/ijo.2020.5159
   Wang N, 2020, CELL HOST MICROBE, V28, P455, DOI 10.1016/j.chom.2020.07.005
   Wang Y, 2012, PANCREATOLOGY, V12, P451, DOI 10.1016/j.pan.2012.07.017
   Webster NR, 2009, BRIT J ANAESTH, V103, P70, DOI 10.1093/bja/aep128
   WIEDMER T, 1986, BLOOD, V68, P875
   Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]
   Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548
   Winthrop KL, 2020, ANN RHEUM DIS, V79, P1290, DOI 10.1136/annrheumdis-2019-216852
   Wojta J, 2002, BLOOD, V100, P517, DOI 10.1182/blood.V100.2.517
   Wolf Y, 2020, NAT REV IMMUNOL, V20, P173, DOI 10.1038/s41577-019-0224-6
   Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xia HJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108234
   Xia L, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa786
   Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Yang JX, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.610696
   Yang PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07027
   Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8
   Zahorec R, 2020, BRATISL MED J, V121, P466, DOI 10.4149/BLL_2020_077
   Zangrillo A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02928-0
   Zelek WM, 2019, MOL IMMUNOL, V114, P341, DOI 10.1016/j.molimm.2019.07.030
   Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954
   Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570
   Zhang W, 2014, EXP THER MED, V7, P1342, DOI 10.3892/etm.2014.1566
   Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13
   Zippi Maddalena, 2020, Infez Med, V28, P507
   Zucoloto AZ, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00085
NR 316
TC 1
Z9 1
U1 10
U2 10
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD DEC
PY 2021
VL 148
AR 155628
DI 10.1016/j.cyto.2021.155628
EA AUG 2021
PG 21
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA UY8WP
UT WOS:000701797900011
PM 34411989
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Chen, HY
   Huang, XY
   Chen, SY
   Zhu, WJ
   Huang, WT
   Chen, K
AF Chen, Hongyan
   Huang, Xiaoyi
   Chen, Siyi
   Zhu, Wenjing
   Huang, Wentao
   Chen, Ken
TI Coronavirus Disease 2019 (COVID-19) Mechanical Ventilation Research
   Theme Analysis: Co-word Cluster Analysis
SO JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN
LA English
DT Review
DE Coronavirus disease 2019 (COVID-19); Mechanical ventilation; Research
   hotspot; VOSviewer; Visual analysis
AB The objective of this analysis was to explore the research hotspot of coronavirus disease 2019 (COVID-19) mechanical ventilation. The literature related to COVID-19 mechanical ventilation on PubMed and CNKI database of core journals was retrieved with the keyword of COVID-19 mechanical ventilation. The visualisation software of VOS (visualisation of similarities) viewer performed by the authors and high-frequency keywords. A total of 524 English language articles from PubMed and 81 Chinese literature from China National Knowledge Infrastructure (CNKI) of core journals are included in this paper. The two databases produced six research fields, among which much attention was paid to the prevention of nosocomial infection and antiviral agents in the treatment of mechanical ventilation. The literature yeilded by PubMed paid attention to the factors affecting the poor prognosis of mechanically ventilated patients, the management and research and development of medical data during COVID-19's pandemic, the mechanical ventilation treatment of COVID-19 pregnant women, the mechanical ventilation treatment and nursing in the field of CNKI literature research, and the nutritional treatment of severe pneumonia patients with mechanical ventilation. The current COVID-19 researches, focused on the prevention of nosocomial infection and antiviral drugs in the process of mechanical ventilation, are a new hotspot in the world.
C1 [Chen, Hongyan; Huang, Xiaoyi; Chen, Siyi; Zhu, Wenjing; Huang, Wentao; Chen, Ken] Guangdong Pharmaceut Univ, Sch Nursing, 283 Jianghai Ave, Guangzhou 510000, Peoples R China.
RP Chen, K (corresponding author), Guangdong Pharmaceut Univ, Sch Nursing, 283 Jianghai Ave, Guangzhou 510000, Peoples R China.
EM cc673626220@163.com
RI huang, wentau/AAD-3487-2022
OI huang, wentau/0000-0002-9114-0898
CR Antinori S, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104899
   Begley JL, 2020, ANAESTHESIA, V75, P1014, DOI 10.1111/anae.15115
   Blaser AR, 2017, INTENS CARE MED, V43, P380, DOI 10.1007/s00134-016-4665-0
   Cai QX, 2020, ENGINEERING-PRC, V6, P1192, DOI 10.1016/j.eng.2020.03.007
   Chahar Praveen, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc033
   Cook TM, 2020, ANAESTHESIA, V75, P785, DOI 10.1111/anae.15054
   Dalli J, 2020, BRIT J ANAESTH, V125, pE293, DOI 10.1016/j.bja.2020.05.006
   Deng LS, 2020, J INFECTION, V81, pE1, DOI 10.1016/j.jinf.2020.03.002
   Doggrell SA, 2020, EXPERT OPIN INV DRUG, V29, P793, DOI 10.1080/13543784.2020.1777277
   Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC
   El-Atab N, 2020, ACS NANO, V14, P7659, DOI 10.1021/acsnano.0c03976
   Endersby RVW, 2020, BRIT J ANAESTH, V125, pE191, DOI 10.1016/j.bja.2020.04.062
   Feldman O, 2020, JAMA-J AM MED ASSOC, V323, P2091, DOI 10.1001/jama.2020.6633
   Feng Y, 2020, AM J RESP CRIT CARE, V201, P1380, DOI 10.1164/rccm.202002-0445OC
   Ferrazzi E, 2020, BJOG-INT J OBSTET GY, V127, P1116, DOI 10.1111/1471-0528.16278
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Gondal KM, 2020, JCPSP-J COLL PHYSICI, V30, P349, DOI [10.29271/jcpsp.2020.4.349, 10.29271/jcpsp.2020.04.349]
   Helmy YA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041225
   Ho KF, 2020, SCI TOTAL ENVIRON, V735, DOI 10.1016/j.scitotenv.2020.139510
   Hong L, 2020, J CLIN CARDIOL CHINA, V3, P400, DOI [10.13201/ j. iss- n.1001-1439.2020.05.001., DOI 10.13201/J.ISS-N.1001-1439.2020.05.001]
   Kambhampati Srinivas B S, 2020, J Clin Orthop Trauma, V11, pS304, DOI 10.1016/j.jcot.2020.04.030
   Khoury T, 2020, OTOLARYNG HEAD NECK, V163, P151, DOI 10.1177/0194599820929275
   Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252
   Liu X, 2020, CHIN NURS RES, V34, P1469
   Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Parush A, J MED INTERNET RES, DOI [10.2196/19947, DOI 10.2196/19947.]
   Pierce Williams RAM, 2020, J OBSTET GYNECOL MFM, V2, DOI [10. 1016/j.ajogmf.2020.100134., DOI 10.1016/J.AJOGMF.2020.100134]
   Sankar J, 2020, INDIAN J PEDIATR, V87, P433, DOI 10.1007/s12098-020-03292-1
   Shalish W, 2020, AM J PERINAT, V37, P780, DOI 10.1055/s-0040-1710522
   Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037
   Sommer DD, 2020, J OTOLARYNGOL-HEAD N, V49, DOI 10.1186/s40463-020-00414-9
   [孙雪平 Sun Xueping], 2020, [护理学杂志, Journal of Nursing Science], V35, P20
   Tao ZB, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.04.26
   Wang Jiafang, 2020, Nan Fang Yi Ke Da Xue Xue Bao, V40, P337, DOI 10.12122/j.issn.1673-4254.2020.03.07
   Wang Y, CHINESE J HOSP PHARM
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Whittle JS, 2020, J AM COLL EMERG PHYS, DOI [10.1002/emp2, DOI 10.1002/EMP2.]
   World Health Organization, 2020, 116 WHO
   Yinying Z, 2020, NURS INTEG TRADIT CH, V6, P196, DOI [10.11997/nitcwm202003063, DOI 10.11997/NITCWM202003063]
   [余增渊 Yu Zengyuan], 2020, [中国循证儿科杂志, Chinese Journal of Evidence Based Pediatrics], V15, P37
   Zhai F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113766
   Zhang Y, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104854
   Zhong H, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104872
   Zhong H, 2020, ACS NANO, V14, P6213, DOI 10.1021/acsnano.0c02250
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu Z, 2020, J INFECTION, V81, pE21, DOI 10.1016/j.jinf.2020.03.060
NR 47
TC 1
Z9 1
U1 6
U2 10
PU COLL PHYSICIANS & SURGEONS PAKISTAN
PI KARACHI
PA SEVENTH CENTRAL ST, DEFENCE HOUSING AUTHORITY, KARACHI, 75500, PAKISTAN
SN 1022-386X
EI 1681-7168
J9 JCPSP-J COLL PHYSICI
JI JCPSP-J. Coll. Physicians Surg.
PD OCT
PY 2020
VL 30
IS 10
SU 2
BP S94
EP S100
DI 10.29271/jcpsp.2020.Supp2.S94
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PL4BT
UT WOS:000603070100002
DA 2022-04-20
ER

PT J
AU Hashemian, SM
   Farhadi, T
   Velayati, AA
AF Hashemian, Seyed MohammadReza
   Farhadi, Tayebeh
   Velayati, Ali Akbar
TI A Review on Remdesivir: A Possible Promising Agent for the Treatment of
   COVID-19
SO DRUG DESIGN DEVELOPMENT AND THERAPY
LA English
DT Review
DE remdesivir; COVID-19; SARS-CoV-2; RNA-dependent RNA polymerase
ID GS-5734; CORONAVIRUS; INHIBIT; EBOLA
AB The novel coronavirus 2019 (2019-nCoV), formally named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel human infectious coronavirus. The disease caused by SARS-CoV-2 is named COVID-19. Development and manufacturing of specific therapeutics and vaccines to treat COVID-19 are time-consuming processes. At this time, using available conventional therapeutics along with other treatment options may be useful to fight COVID-19. In different clinical trials, efficacy of remdesivir (GS-5734) against Ebola virus has been demonstrated. Moreover, remdesivir may be an effective therapy in vitro and in animal models infected by SARS and MERS coronaviruses. Hence, the drug may be theoretically effective against SARS-CoV-2. Remdesivir is a phosphoramidate prodrug of an adenosine C-nucleoside. By entrance into respiratory epithelial cells in human, the prodrug is metabolized to a nucleoside triphosphate as the active form. The nucleoside analog inhibits the viral RNA-dependent RNA polymerase (RdRp) by competing with the usual counterpart adenosine triphosphate (ATP). The nucleoside analog is incorporated into the generating RNA strand and causes a delayed stop in the viral replication process. Knowledge about the potential efficacy of remdesivir against coronaviruses has been restricted to in vitro studies and animal models. However, information related to COVID-19 is rapidly growing. Several clinical trials are ongoing for the management of COVID-19 using remdesivir. In this study, characteristics of remdesivir and its usage for treatment of COVID-19 are reviewed based on an electronic search using PubMed and Google Scholar.
C1 [Hashemian, Seyed MohammadReza] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Clin TB & Epidemiol Res Ctr, Tehran, Iran.
   [Hashemian, Seyed MohammadReza; Farhadi, Tayebeh; Velayati, Ali Akbar] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr CRDRC, Tehran, Iran.
RP Farhadi, T (corresponding author), Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr CRDRC, Tehran, Iran.
EM tayebehfarhadi@yahoo.com
RI HASHEMIAN, SEYED MOHAMMAD REZA/C-1224-2018
OI HASHEMIAN, SEYED MOHAMMAD REZA/0000-0002-0768-9168
CR Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Amirian ES, 2020, ONE HEALTH-AMSTERDAM, V9, DOI 10.1016/j.onehlt.2020.100128
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Cao YC, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101647
   Collins JP., 2020, MEDRXIV
   De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Dolin R, 2020, NEW ENGL J MED, V383, P1886, DOI 10.1056/NEJMe2018715
   Eastman RT, 2020, ACS CENTRAL SCI, V6, P672, DOI 10.1021/acscentsci.0c00489
   Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301
   Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   KO WC, 2020, INT J ANTIMICROB AG, V55, DOI [10.1016/j.ijantimicag.2020.105933, DOI 10.1016/J.IJANTIMICAG.2020.105933]
   Lescure Francois-Xavier, 2020, Lancet Infect Dis, V20, P697, DOI 10.1016/S1473-3099(20)30200-0
   Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0
   Lo, 2015, OPEN FORUM INFECT DI, V2, pLB, DOI [10.1093/ofid/ofv130.02, DOI 10.1093/OFID/OFV130.02, 10.1093/OFID/ OFV130.02]
   Lo MK, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau9242
   Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395
   Mehellou Y, 2009, CHEMMEDCHEM, V4, P1779, DOI 10.1002/cmdc.200900289
   Morse JS, 2020, CHEMBIOCHEM, V21, P730, DOI 10.1002/cbic.202000047
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   NIH, 2020, NIH CLIN TRIAL REMD
   Pedersen NC, 2019, J FELINE MED SURG, V21, P271, DOI 10.1177/1098612X19825701
   Seley-Radtke KL, 2018, ANTIVIR RES, V154, P66, DOI 10.1016/j.antiviral.2018.04.004
   Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594
   Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
NR 33
TC 22
Z9 23
U1 4
U2 10
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1177-8881
J9 DRUG DES DEV THER
JI Drug Des. Dev. Ther.
PY 2020
VL 14
BP 3215
EP 3222
DI 10.2147/DDDT.S261154
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA MX0NJ
UT WOS:000557425200001
PM 32821086
OA Green Published
DA 2022-04-20
ER

PT J
AU Riou, B
   Cariou, A
   Duranteau, J
   Langeron, O
   Crestani, B
   Adnet, F
   Raux, M
AF Riou, B.
   Cariou, A.
   Duranteau, J.
   Langeron, O.
   Crestani, B.
   Adnet, F.
   Raux, M.
TI Feedback on Medical Crisis Direction at Assistance publique-Hopitaux de
   Paris during the COVID-19 Crisis
SO ANNALES FRANCAISES DE MEDECINE D URGENCE
LA French
DT Article
DE COVID-19; SARS-CoV2; Health crisis; Pandemic; Management
AB Feedback on the medical crisis management during the first phase of the COVID-19 epidemic was provided to the Assistance publique-Hopitaux de Paris (AP-HP), the largest university hospital center in Europe. The AP-HP has one AP-HP medical crisis director (DMC), 6 hospital group (HG) DMCs, and one DMC for each of the 39 hospital sites. Management was based on daily AP-HP and GH crisis meetings, disciplinary working groups and reliable daily dashboards, which enabled the optimization of actions. Innovative actions have been implemented: regulation units for intensive care unit entries and exits, follow-up of infected patients at home, contact tracing, and inter-regional transfers of critically-ill patients. The key elements of success were the relationship between General management, DMC, the articulation between the central level and those of the GH, the mobilization of all the actors towards a unique identified objective, and the mobilization of all the caregivers, including students. Among the highlighted avenues for improvement, it is worth mentioning the generalization of DMCs outside the AP-HP in accordance with the regulations, the development of knowledge of the crisis operating mode, the anticipation of training in crisis management, the provision of daily information to all those involved in actions carried out in a long-term crisis, and the participation of care-user representatives. The management of research in times of crisis remains to be invented at the national or even European level.
C1 [Riou, B.] Sorbonne Univ, Hop Pitie Salpetriere, AP HP,Inserm, Med Crise,Serv Accueil Urgences,UMR 1166,IHU,ICAN, F-75013 Paris, France.
   [Cariou, A.] Univ Paris, Med Crise GH Paris Ctr, Hop Cochin Port Royal, AP HP,Serv Med Intens & Reanimat, F-75014 Paris, France.
   [Duranteau, J.] Univ Paris Saclay, Hop Bicetre, AP HP, Med Crise GH Saclay,Dept Anesthesie Reanimat, F-94270 Le Kremlin Bicetre, France.
   [Langeron, O.] Univ Paris Est Creteil, Hop Henri Mondor, AP HP, Med Crise GH Henri Mondor,Dept Anesthesie Reanima, F-94010 Creteil, France.
   [Crestani, B.] Univ Paris, Hop Bichat Claude Bernard, AP HP, Med Crise GH Nord,Serv Pneumol, F-75010 Paris, France.
   [Adnet, F.] Univ Paris Nord, Hop Avicenne, AP HP, Med Crise GH Saine St Denis,Serv Urgences, F-93000 Bobigny, France.
   [Raux, M.] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Med Crise GH Sorbonne Univ,Inserm,UMR 1168,Dept A, F-75013 Paris, France.
RP Riou, B (corresponding author), Sorbonne Univ, Hop Pitie Salpetriere, AP HP,Inserm, Med Crise,Serv Accueil Urgences,UMR 1166,IHU,ICAN, F-75013 Paris, France.
EM bruno.riou@aphp.fr
CR Assistance publique.Hopitaux de Paris, 2020, COVID 19 AP HP BAS D
   Carli P, 2017, LANCET, V390, P2735, DOI 10.1016/S0140-6736(17)31590-8
   Collaboration AP-HP/universites/Inserm Covid-19, 2020, ANN FR MED URG, V10, P314
   Costagliola D, 2020, MONDE
   COVID19 APHP Grp, 2020, LANCET, V395, P1760, DOI 10.1016/S0140-6736(20)31210-1
   European Unversity Hospital Alliance, 2020, U HOSP URG CALL MOR
   Gaubert S, 2020, CR ACAD SCI
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hirsch M, 2020, MISSION INFORM COVID
   Lagadec P, 2015, CONTINENT IMPREVUS
   Lagadec P, 2020, PANDEMIE 2020, P798
   Langlois M, 2020, ANN FR MED URGENCE, V10, P327, DOI 10.3166/afmu-2020-0259
   Lapidus N, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00749-6
   Maisonneuve H, 2020, PANDEMIE 2020, P555
   Ministere des Solidarites et de la Sante, 2019, GUID DAID PREP GEST
   Pernet J, 2020, ANN FR MED URGENCE, V10, P306, DOI 10.3166/afmu-2020-0266
   Piarroux R, 2020, MONDE
   Riou B, 2016, ANN FR MED URGENCE, V6, P1, DOI 10.1007/s13341-016-0610-7
   Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517
   Vallet B, 2020, REV PRAT NEWSLETTER
NR 20
TC 3
Z9 3
U1 3
U2 3
PU LAVOISIER
PI CACHAN
PA 14, RUE DE PROVIGNY, 94236 CACHAN, FRANCE
SN 2108-6524
EI 2108-6591
J9 ANN FR MED URGENCE
JI Ann. Fr. Med. Urgence
PD SEP
PY 2020
VL 10
IS 4-5
BP 340
EP 349
DI 10.3166/afmu-2020-0276
PG 10
WC Emergency Medicine
WE Emerging Sources Citation Index (ESCI)
SC Emergency Medicine
GA OG2XY
UT WOS:000581754700021
OA Bronze
DA 2022-04-20
ER

PT J
AU Lolea, IC
   Stamule, S
AF Lolea, Iulian Cornel
   Stamule, Simona
TI Trading using Hidden Markov Models during COVID-19 turbulences
SO MANAGEMENT & MARKETING-CHALLENGES FOR THE KNOWLEDGE SOCIETY
LA English
DT Article
DE COVID-19; Markov chains; financial markets; algorithm; trading;
   volatility
ID TOURISM; MARKETS; TRENDS
AB Obtaining higher than market returns is a difficult goal to achieve, especially in times of turbulence such as the COVID-19 crisis, which tested the resilience of many models and algorithms. We used a Hidden Markov Models (HMM) methodology based on monthly data (DAX returns, VSTOXX index Germany's industrial production and Germany's annual inflation rate) to calibrate a trading strategy in order to obtain higher returns than a buy-and-hold strategy for the DAX index., following Talla (2013) and Nguyen and Nguyen (2015). The stock selection was based on 26 stocks from DAX's composition, which had enough data for this study, aiming to select the 15 best performing. The training period was January 2000 - December 2015, and the out-of-sample January 2016 - August 2021, including the period of high turbulence generated by COVID-19. Fitting the best model revealed that the following regimes are the most suitable: two regimes for DAX returns, two regimes for VSTOXX and three regimes for the inflation rate and for the industrial production, while the posterior transition probabilities were event-depending on the training sample. Furthermore, portfolios built using HMM strategy outperformed the DAX index for the out-of-sample period, both in terms of annualized returns and risk-adjusted returns. The results were in line with expectations and what other researchers like Talla (2013), Nguyen and Nguyen (2015) and Varenius (2020) found out. We managed to highlight that a strategy calibrated based on HMM methodology works well even in periods of extreme volatility such as the one generated in 2020 by COVID-19 pandemic.
C1 [Lolea, Iulian Cornel] Bucharest Univ Econ Studies, Bucharest, Romania.
   [Stamule, Simona] Tech Univ Civil Engn Bucharest, Bucharest, Romania.
RP Lolea, IC (corresponding author), Bucharest Univ Econ Studies, Bucharest, Romania.
EM loleaiulian@gmail.com
CR Burhan HA, 2021, SOSYOEKONOMI, V29, P31, DOI 10.17233/sosyoekonomi.2021.02.02
   Carrasco Sierra A., 2020, INT J ENTREPRENEURIA, V8, P42, DOI 10.37335/ijek.v8i2.116.
   Cepoi CO, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101658
   Chandrika PV, 2020, INT CONF ADVAN COMPU, P1144, DOI 10.1109/ICACCS48705.2020.9074387
   Cuellar Andersson J., 2016, ALGORITHMIC TRADING
   De la Torre OV, 2018, ELECTRON J APPL STAT, V11, P489, DOI 10.1285/i20705948v11n2p489
   Dima AM, 2009, 2009 INTERNATIONAL CONFERENCE ON INFORMATION AND FINANCIAL ENGINEERING, PROCEEDINGS, P94, DOI 10.1109/ICIFE.2009.33
   Fei F, 2017, INT J FORECASTING, V33, P662, DOI 10.1016/j.ijforecast.2017.01.006
   Gavurova B, 2020, J TOUR SERV, V11, P38, DOI 10.29036/jots.v11i21.175
   Hassan MR, 2013, NEUROCOMPUTING, V104, P10, DOI 10.1016/j.neucom.2012.09.017
   Hassan R, 2005, 5TH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND APPLICATIONS, PROCEEDINGS, P192
   He Z, 2018, INT REV FINANC ANAL, V60, P30, DOI 10.1016/j.irfa.2018.08.010
   Jurafsky D., 2021, STANFORD
   Kim EC, 2019, J RISK FINANC MANAG, V12, DOI 10.3390/jrfm12040168
   Korzeb Z, 2020, EQUILIBRIUM, V15, P205, DOI 10.24136/eq.2020.010
   Landmesser J, 2021, OECON COPERNIC, V12, P539, DOI 10.24136/oc.2021.018
   Liu Minghao, 2021, ARXIV PREPRINT ARXIV
   Liu NN, 2021, OECON COPERNIC, V12, P217, DOI 10.24136/oc.2021.009
   Machova R, 2021, J TOUR SERV, V12, P131, DOI 10.29036/jots.v12i22.256
   Marcucci J, 2005, STUD NONLINEAR DYN E, V9
   Nabipour M, 2020, IEEE ACCESS, V8, P150199, DOI 10.1109/ACCESS.2020.3015966
   Nguyen N, 2021, RISKS, V9, DOI 10.3390/risks9010009
   Nguyen N, 2015, RISKS, V3, P455, DOI 10.3390/risks3040455
   Oelschlager L., 2020, ARXIV PREPRINT ARXIV
   Pardal P, 2020, EQUILIBRIUM, V15, P627, DOI 10.24136/eq.2020.027
   RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626
   Ryden T, 1998, J APPL ECONOM, V13, P217, DOI 10.1002/(SICI)1099-1255(199805/06)13:3<217::AID-JAE476>3.0.CO;2-V
   Ryou H, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12177031
   Talla J. T, 2013, IMPACT MACROECONOMIC, P01
   Tudor N. L, 2014, INT C BUS INF SYST, P122
   Uysal A. S., 2021, J FINANCIAL DATA SCI, V3, P87
   Varenius M, 2020, USING HIDDEN MARKOV
   Vieriu RL, 2011, 2011 10TH INTERNATIONAL SYMPOSIUM ON SIGNALS, CIRCUITS AND SYSTEMS (ISSCS)
   Visser I, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i07
   Waduge N, 2018, 2018 3RD INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY RESEARCH (ICITR)
   Waliszewski K, 2021, EQUILIBRIUM, V16, P577, DOI 10.24136/eq.2021.021
   Zhang J, 2021, COMPUT ECON, V57, P1237, DOI 10.1007/s10614-020-10013-5
NR 37
TC 0
Z9 0
U1 1
U2 1
PU SCIENDO
PI WARSAW
PA BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND
SN 1842-0206
EI 2069-8887
J9 MANAG MARK
JI Manag. Mark.
PD DEC 1
PY 2021
VL 16
IS 4
BP 334
EP 351
DI 10.2478/mmcks-2021-0020
PG 18
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA YC8NQ
UT WOS:000739943100002
OA gold
DA 2022-04-20
ER

PT J
AU Coner, A
   Altin, C
AF Coner, Ali
   Altin, Cihan
TI Management of Sacubitril/Valsartan Combination in an End-stage Heart
   Failure Patient Hospitalized for COVID-19 Pneumonia: Should we Withdraw
   Temporarily or Continue?
SO ERCIYES MEDICAL JOURNAL
LA English
DT Article
DE COVID-19 pneumonia; heart failure; neprilysin inhibition; sacubitril;
   valsartan
AB Background: Many factors were blamed for the worse prognosis in COVID-19. Heart failure patients are thought to be under increased risk because of either immune-compromised basal status or possible interaction of viral infection with on-going medications, such as the Renin-Angiotensin-Aldosterone system (RAAS) blockers. Sacubitril is a neprilysin inhibitor and its' combination with valsartan is recommended as a novel medication for heart failure.
   Case Report: A 71 years of age female with end-stage heart failure was hospitalized for COVID-19 pneumonia. She was under sacubitril/valsartan combination for the heart failure, and at the end of the first week of hospitalization, clinical and laboratory parameters recovered uneventfully. Sacubitril/valsartan therapy was continued without complications during the in-hospital course.
   Conclusion: Specific therapies for heart failure should not be withdrawn in COVID-19. To our knowledge, this is the first case report documenting the clinical progress of a COVID-19 pneumonia patient who was already under sacubitril/valsartan treatment.
C1 [Coner, Ali] Baskent Univ Hosp, Dept Cardiol, Alanya Applicat & Res Ctr, Antalya, Turkey.
   [Altin, Cihan] Baskent Univ Hosp, Dept Cardiol, Izmir Zubeyde Hanim Applicat & Res Ctr, Izmir, Turkey.
RP Coner, A (corresponding author), Baskent Univ Hosp, Dept Cardiol, Alanya Applicat & Res Ctr, Antalya, Turkey.
EM conerali@hotmail.com
CR Acanfora D, 2020, EUR HEART J-CARD PHA, V6, P253, DOI 10.1093/ehjcvp/pvaa044
   Acanfora D, 2020, EUR HEART J-CARD PHA, V6, P135, DOI 10.1093/ehjcvp/pvaa028
   Acanfora D, 2020, CLIN DRUG INVEST, V40, P493, DOI 10.1007/s40261-020-00908-4
   Iaccarino G, 2020, HIGH BLOOD PRESS CAR, V27, P105, DOI 10.1007/s40292-020-00380-3
   Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763
   Petramala L, 2020, EUR HEART J-CARD PHA, V6, P252, DOI 10.1093/ehjcvp/pvaa035
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Yang X, 2020, LANCET RESP MED, V8, pE26
   Zhang H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42994-1
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
NR 10
TC 0
Z9 0
U1 1
U2 1
PU ERCIYES UNIV SCH MEDICINE
PI KAYSERI
PA ERCIYES UNIV TIP FAK 38039 MELIKGAZI, KAYSERI, 00000, TURKEY
SN 2149-2247
EI 2149-2549
J9 ERCIYES MED J
JI Erciyes Med. J.
PD NOV
PY 2021
VL 43
IS 6
BP 617
EP 619
DI 10.14744/etd.2020.77010
PG 3
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA WZ9SW
UT WOS:000720300300020
OA gold
DA 2022-04-20
ER

PT J
AU Mejia, E
   Zalewski, J
   Plummer, ST
AF Mejia, Ernesto
   Zalewski, Jodi
   Plummer, Sarah T.
TI Adapting Interstage Home Monitoring with the use of Telemedicine During
   the COVID-19 Pandemic
SO PEDIATRIC CARDIOLOGY
LA English
DT Article; Early Access
DE Single ventricle; COVID-19; Telemedicine; In-home monitoring; Interstage
   outcomes
ID NORWOOD OPERATION; MORTALITY; OUTCOMES
AB Pediatric single ventricle patients have seen dramatic improvements in overall outcomes over the past several decades. This is attributed to the development of home monitoring programs for interstage patients. In today's current COVID-19 pandemic, the use of telemedicine has allowed providers to care for these patients and support their families effectively while minimizing the risk of COVID-19 exposure. Our single-center study reviewed the charts of nine patients followed by our single ventricle team through the COVID-19 pandemic. Patients discharged from the hospital and enrolled in our digital home monitoring program were included. Records were retrospectively reviewed for total number of outpatient visits, adverse events, unplanned hospital readmissions, and unplanned procedures. These results were then compared to outcomes from 2018 to 2019. In-person visits averaged every 6 weeks compared to every 2-3-week pre-pandemic. Zero adverse events reported with the use of telemedicine compared to one adverse event pre-pandemic. There was a 50% decrease in unplanned readmissions and 60% decrease in unplanned procedures during our study period. One patient was diagnosed with acute COVID-19 infection and managed conservatively via telemedicine with full recovery. To our knowledge, this is the only case-control study reporting the use of telemedicine during the COVID-19 pandemic in the interstage population. Although not statistically significant, we report a decrease in total adverse events, unplanned procedures, and unplanned admissions. Telemedicine visits allowed for identification of issues requiring hospital readmission as well as conservative management of one patient with COVID-19.
C1 [Mejia, Ernesto; Zalewski, Jodi; Plummer, Sarah T.] Rainbow Babies & Childrens Hosp, Univ Hosp, 11100 Euclid Ave,Suite 380, Cleveland, OH 44106 USA.
   [Mejia, Ernesto; Zalewski, Jodi; Plummer, Sarah T.] Case Western Reserve Univ, Div Pediat Cardiol, Cleveland, OH 44106 USA.
RP Mejia, E (corresponding author), Rainbow Babies & Childrens Hosp, Univ Hosp, 11100 Euclid Ave,Suite 380, Cleveland, OH 44106 USA.; Mejia, E (corresponding author), Case Western Reserve Univ, Div Pediat Cardiol, Cleveland, OH 44106 USA.
EM Ernesto.Mejia@uhhospitals.org
OI Mejia, Ernesto/0000-0001-7432-8189
CR Ahluwalia Neha, 2020, JACC Case Rep, V2, P1261, DOI 10.1016/j.jaccas.2020.05.013
   Alsaied T, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017224
   Castellanos DA, 2016, PEDIATR CARDIOL, V37, P1575, DOI 10.1007/s00246-016-1472-x
   Chowdhury D, 2020, PEDIATR CARDIOL, V41, P1081, DOI 10.1007/s00246-020-02411-1
   Contreras CM, 2020, J GASTROINTEST SURG, V24, P1692, DOI 10.1007/s11605-020-04623-5
   Foster CC, 2021, PEDIATR CARDIOL, V42, P349, DOI 10.1007/s00246-020-02489-7
   Gardner MM, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010783
   Hansen JH, 2012, EUR J CARDIO-THORAC, V41, P1013, DOI 10.1093/ejcts/ezr190
   Linnane N, 2020, CARDIOL YOUNG, V30, P1350, DOI 10.1017/S1047951120001882
   Ohannessian R, 2020, JMIR PUBLIC HLTH SUR, V6, P121, DOI 10.2196/18810
   Oster ME, 2015, CIRCULATION, V132, P502, DOI 10.1161/CIRCULATIONAHA.114.014107
   Rajasekaran K, 2020, OTOLARYNG HEAD NECK, V163, P104, DOI 10.1177/0194599820925049
   Rudd NA, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014548
   Rudd NA, 2014, J THORAC CARDIOV SUR, V148, P1540, DOI 10.1016/j.jtcvs.2014.02.038
   Sabatino J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061774
   Siehr SL, 2014, J THORAC CARDIOV SUR, V147, P718, DOI 10.1016/j.jtcvs.2013.04.006
   Vergales J, 2020, WORLD J PEDIATR CONG, V11, P753, DOI 10.1177/2150135120945596
   Zhai YS, 2020, PSYCHOTHER PSYCHOSOM, V90, P64, DOI 10.1159/000509000
NR 18
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0172-0643
EI 1432-1971
J9 PEDIATR CARDIOL
JI Pediatr. Cardiol.
DI 10.1007/s00246-022-02835-x
EA FEB 2022
PG 5
WC Cardiac & Cardiovascular Systems; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Pediatrics
GA ZF1NR
UT WOS:000759341100002
PM 35192020
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Meng, Y
   Khan, A
   Bibi, S
   Wu, HY
   Lee, Y
   Chen, WK
AF Meng, Yue
   Khan, Asif
   Bibi, Sughra
   Wu, Haoyue
   Lee, Yao
   Chen, Wenkuan
TI The Effects of COVID-19 Risk Perception on Travel Intention: Evidence
   From Chinese Travelers
SO FRONTIERS IN PSYCHOLOGY
LA English
DT Article
DE COVID-19; risk perception; risk knowledge; travel intention;
   interpersonal and media communication; demographic influence
ID COMMON METHOD VARIANCE; INFORMATION-SEEKING; CONSTRUCT-VALIDITY;
   TOURISM; COMMUNICATION; MEDIA; SARS; BEHAVIOR; CONTAGION; KNOWLEDGE
AB This study attempts to assess the relationship between risk perception, risk knowledge, and travel intentions of Chinese leisure travelers during the COVID-19 pandemic in the framework of social contagion and risk communication theories by analyzing a sample of 1,209 travelers through structural equation modeling (SEM) and path analysis. We used the process macro of Hayes to analyze the moderation effects of age, gender, and education between risk perception, media and interpersonal communication, and risk knowledge. It was found that travelers were more concerned about self-efficacy than severity. Risk perception of travelers predicts the information-seeking process of tourists. This process helps travelers to accumulate risk information that influences their travel intentions. Travelers give more importance to interpersonal (contagion) communication in making a traveling decision. Demographic factors influence traveling decision-making; women travelers were found to be more risk resilient than men. Young travelers seek information at low- and old travelers at high-risk levels. Marketing implications also provided.
C1 [Meng, Yue; Wu, Haoyue; Chen, Wenkuan] Sichuan Agr Univ, Coll Tourism, Chengdu, Peoples R China.
   [Khan, Asif; Lee, Yao] Zhejiang Univ, Sch Management, Dept Tourism & Hotel Management, Hangzhou, Peoples R China.
   [Khan, Asif] Hazara Univ, Dept Tourism & Hospitality, Mansehra, Pakistan.
   [Bibi, Sughra] Zhejiang Univ, Guanghua Law Sch, Hangzhou, Peoples R China.
RP Chen, WK (corresponding author), Sichuan Agr Univ, Coll Tourism, Chengdu, Peoples R China.; Khan, A (corresponding author), Zhejiang Univ, Sch Management, Dept Tourism & Hotel Management, Hangzhou, Peoples R China.; Khan, A (corresponding author), Hazara Univ, Dept Tourism & Hospitality, Mansehra, Pakistan.; Bibi, S (corresponding author), Zhejiang Univ, Guanghua Law Sch, Hangzhou, Peoples R China.
EM asifkhanth@yahoo.com; sughra.fareed@yahoo.com; cwk_academic@sina.com
FU project of Sichuan county economic development research center of
   Sichuan provincial key research base of social sciences [xy2020034];
   social science special research project of Sichuan agricultural
   University [035/03571600]
FX This work is supported by the project of Sichuan county economic
   development research center of Sichuan provincial key research base of
   social sciences, "research on the coordination mechanism of county
   economic, ecological and social coupling development of giant panda
   national park" (xy2020034) and the social science special research
   project of Sichuan agricultural University "research on innovation of
   modern urban agricultural development mode" (035/03571600).
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Aliperti G, 2018, ALMATOURISM, V9, P1, DOI 10.6092/issn.2036-5195/8267
   [Anonymous], 2019, REUTERS
   Atkin T., 2012, WINE EC POLICY, V1, P54, DOI [10.1016/j.wep.2012.08.002, DOI 10.1016/J.WEP.2012.08.002, DOI 10.1016/j.wep.2012.08.002]
   Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003
   BAGOZZI RP, 1991, ADMIN SCI QUART, V36, P421, DOI 10.2307/2393203
   Baker D.M.A., 2015, INT J SAF SECUR TOUR, V1, P1
   Beirman D., 2006, Tourism, security and safety: from theory to practice, P251, DOI 10.1016/B978-0-7506-7898-8.50021-7
   Berman D., 2002, J EXPT ED, V25, P305, DOI DOI 10.1177/105382590202500209
   Bikhchandani S, 2001, IMF STAFF PAPERS, V47, P279
   Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa011
   Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050
   Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7
   Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283
   Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]
   Cahyanto I, 2016, TOUR MANAG PERSPECT, V20, P195, DOI 10.1016/j.tmp.2016.09.004
   Carlsen, 2008, J TRAVEL TOUR MARK, V23, P265, DOI DOI 10.1300/J073V23N02_20
   Chang SJ, 2010, J INT BUS STUD, V41, P178, DOI 10.1057/jibs.2009.88
   Chen CF, 2007, TOURISM MANAGE, V28, P1115, DOI 10.1016/j.tourman.2006.07.007
   Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73
   Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9
   Chien PM, 2017, J TRAVEL RES, V56, P744, DOI 10.1177/0047287516665479
   Cooper M., 2005, Journal of Travel & Tourism Marketing, V19, P117, DOI 10.1300/J073v19n02_10
   Desivilya H, 2015, EUROMED J BUS, V10, P118, DOI 10.1108/EMJB-08-2014-0025
   Dholakia U. M., 2001, EUR J MARKETING, V35, P1340, DOI DOI 10.1108/EUM0000000006479
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Gao S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162856
   Gee Stephanie, 2017, Glob Health Res Policy, V2, P21, DOI 10.1186/s41256-017-0042-y
   Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708
   Griffin RJ, 1999, ENVIRON RES, V80, pS230, DOI 10.1006/enrs.1998.3940
   Griffin RJ, 2004, MEDIA PSYCHOL, V6, P23, DOI 10.1207/s1532785xmep0601_2
   Hair JF, 2017, J ADVERTISING, V46, P163, DOI 10.1080/00913367.2017.1281777
   Hall C. M., 2002, Current Issues in Tourism, V5, P458, DOI 10.1080/13683500208667935
   Ho SS, 2012, MASS COMMUN SOC, V15, P695, DOI 10.1080/15205436.2011.616275
   Hoyle R. H., 1995, STRUCTURAL EQUATION
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Huang S, 2015, J TRAVEL TOUR MARK, V32, P153, DOI 10.1080/10548408.2014.986018
   Jackson M., 2006, THEORIE PARTISANEN Z, P87, DOI [10.4324/9780080457321-17, DOI 10.4324/9780080457321-17]
   Jonas A, 2011, J TRAVEL RES, V50, P87, DOI 10.1177/0047287509355323
   Khan A, 2021, J NAT FIBERS, V18, P1893, DOI 10.1080/15440478.2019.1709110
   Khan A, 2021, CURR ISSUES TOUR, V24, P952, DOI 10.1080/13683500.2020.1850653
   Khan A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12103989
   Khan A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12062533
   Khan A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041618
   Khan AUR, 2021, FRONT MATER SCI, V15, P10, DOI 10.1007/s11706-021-0540-1
   Kim Y, 2015, DISASTER MED PUBLIC, V9, P145, DOI 10.1017/dmp.2014.87
   Kline RB, 2010, PRINCIPLES PRACTICE
   Korstanje ME, 2011, ANATOLIA, V22, P222, DOI 10.1080/13032917.2011.597935
   KUHLTHAU CC, 1991, J AM SOC INFORM SCI, V42, P361, DOI 10.1002/(SICI)1097-4571(199106)42:5<361::AID-ASI6>3.0.CO;2-#
   Kusumi T, 2017, RISK ANAL, V37, P2305, DOI 10.1111/risa.12784
   Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864
   Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170
   Lee CJ, 2010, MASS COMMUN SOC, V13, P48, DOI 10.1080/15205430802694869
   Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8
   Li X, 2010, TOURISM MANAGE, V31, P250, DOI 10.1016/j.tourman.2009.03.001
   Liang HG, 2007, MIS QUART, V31, P59
   Lindell MK, 2001, J APPL PSYCHOL, V86, P114, DOI 10.1037//0021-9010.86.1.114
   McInnes C., 2005, HLTH SECURITY RISK S
   Metaxas T., 2020, INT J ADV RES, V4, P365, DOI [10.21474/IJAR01/10788, DOI 10.21474/IJAR01/10788]
   MILETI DS, 1992, RISK ANAL, V12, P393, DOI 10.1111/j.1539-6924.1992.tb00691.x
   Muter BA, 2013, RISK ANAL, V33, P1489, DOI 10.1111/j.1539-6924.2012.01936.x
   Nurunnabi, 2020, PSU RES REV, DOI [10.1108/PRR-07-2019-0022, DOI 10.1108/PRR-07-2019-0022]
   Pandey Ambarish, 2010, Am J Prev Med, V38, pe1, DOI 10.1016/j.amepre.2009.11.007
   Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452
   Quintal VA, 2010, TOURISM MANAGE, V31, P797, DOI 10.1016/j.tourman.2009.08.006
   Reisinger Y., 2005, Journal of Travel Research, V43, P212, DOI 10.1177/0047287504272017
   Ritchie BW, 2017, J TRAVEL TOUR MARK, V34, P274, DOI 10.1080/10548408.2016.1156616
   Rittichainuwat BN, 2009, TOURISM MANAGE, V30, P410, DOI 10.1016/j.tourman.2008.08.001
   Rosen E., 2018, FORBES
   Sandman P.M, 1993, AIHA J FAIRFAX VA, P1, DOI [10.3320/978-0-932627-51-3, DOI 10.3320/978-0-932627-51-3]
   Sarstedt M, 2019, AUSTRALAS MARK J, V27, P197, DOI 10.1016/j.ausmj.2019.05.003
   Scherer CW, 2003, RISK ANAL, V23, P261, DOI 10.1111/1539-6924.00306
   Schroeder A, 2013, TOURISM MANAGE, V38, P107, DOI 10.1016/j.tourman.2013.03.001
   Shambaugh DavidL., 2013, CHINA GOES GLOBAL PA
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   SNYDER LB, 1995, HEALTH COMMUN, V7, P125, DOI 10.1207/s15327027hc0702_3
   Stryker JE, 2003, J HEALTH COMMUN, V8, P305, DOI 10.1080/10810730305724
   Ter Huurne E, 2008, J RISK RES, V11, P847, DOI 10.1080/13669870701875750
   TimothyCoombs, 2010, HDB CRISIS COMMUNICA, P635, DOI DOI 10.1002/9781444314885.CH31
   United Nations World Tourism Organization (UNWTO), 2018, UNWTO TOUR HIGHL 201
   UNWTO, 2019, GUID SUCC CHIN OUTB
   Wang J, 2019, ANN TOURISM RES, V78, DOI 10.1016/j.annals.2019.102743
   Wen J, 2021, TOUR REV, V76, P74, DOI 10.1108/TR-03-2020-0110
   Wolff K, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102759
   Wooldridge JM, 2009, INTRO ECONOMETRICS M
   Yang ZJ, 2014, J COMMUN, V64, P20, DOI 10.1111/jcom.12071
   Yates M., 2006, TOURISM TURBULENT TI, P263, DOI [10.1016/B978-0-08-044666-0.50026-9, DOI 10.1016/B978-0-08-044666-0.50026-9]
   Ying TY, 2021, TOUR RECREAT RES, V46, P304, DOI 10.1080/02508281.2020.1743048
   Yu M, 2020, CURR ISSUES TOUR, DOI 10.1080/13683500.2020.1733497
NR 92
TC 6
Z9 6
U1 27
U2 72
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-1078
J9 FRONT PSYCHOL
JI Front. Psychol.
PD JUL 16
PY 2021
VL 12
AR 655860
DI 10.3389/fpsyg.2021.655860
PG 16
WC Psychology, Multidisciplinary
WE Social Science Citation Index (SSCI)
SC Psychology
GA TT9VH
UT WOS:000680690800001
PM 34335367
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Tan, KH
   Woods, P
   Azman, H
   Abdullah, IH
   Hashim, RS
   Rahim, HA
   Idrus, MM
   Said, NEM
   Lew, R
   Kosem, I
AF Tan, Kim Hua
   Woods, Peter
   Azman, Hazita
   Abdullah, Imran Ho
   Hashim, Ruzy Suliza
   Rahim, Hajar Abdul
   Idrus, Mohd Muzhafar
   Said, Nur Ehsan Mohd
   Lew, Robert
   Kosem, Iztok
TI COVID-19 INSIGHTS AND LINGUISTIC METHODS
SO 3L-LANGUAGE LINGUISTICS LITERATURE-THE SOUTHEAST ASIAN JOURNAL OF
   ENGLISH LANGUAGE STUDIES
LA English
DT Article
DE COVID-19; corpus-based approach; comparative textual analysis;
   qualitative content analysis; lexical neologism
AB The emergence of COVID-19 affects the world population in many ways, resulting in its own specialised discourse. In addition to providing a source of data for analysis, this discourse has also led to a rethinking of multifarious research methods. This section presents a series of articles by scholars from different parts of the world with macro- and micro-linguistic perspectives, ranging from corpus-based analysis to content analysis studies. At the macro level, these scholars explored ways through which government bodies communicate with the public. Official announcements, parliamentary proceedings and COVID-19-related corpora are examined and a comparative textual analysis between the Malaysian and British governments is provided. At the micro level, the scholars analysed selected corpora with lexical, semantic, and discourse foci and personal posts of short narratives and photos to encapsulate meanings from human life and experience. The main takeaway from these studies is the application of a wide range of methods for different focus and perspectives that may be customised to the researcher's unique context.
C1 [Tan, Kim Hua; Azman, Hazita; Abdullah, Imran Ho; Hashim, Ruzy Suliza] Univ Kebangsaan Malaysia, Fac Social Sci & Humanities, Bangi, Malaysia.
   [Woods, Peter] Multimedia Univ, Fac Creat Multimedia, Knowledge Management Ctr, Cyberjaya, Malaysia.
   [Rahim, Hajar Abdul] Univ Sains Malaysia, Sch Humanities, George Town, Malaysia.
   [Idrus, Mohd Muzhafar] Univ Sains Islam Malaysia, Fac Major Language Studies, Nilai, Negeri Sembilan, Malaysia.
   [Said, Nur Ehsan Mohd] Univ Kebangsan Malaysia, Fac Educ, Bangi, Malaysia.
   [Lew, Robert] Adam Mickiewicz Univ, Fac English, Poznan, Poland.
   [Kosem, Iztok] Jozef Stefan Inst, Ljubljana, Slovenia.
   [Kosem, Iztok] Univ Ljubljana, Ljubljana, Slovenia.
RP Tan, KH (corresponding author), Univ Kebangsaan Malaysia, Fac Social Sci & Humanities, Bangi, Malaysia.
EM drtankimhua@gmail.com; p.woods@mmu.edu.my; hazita@ukm.edu.my;
   imranho@ukm.edu.my; ruzy@ukm.edu.my; hajar@usm.my;
   muzhafaridrus@usim.edu.my; nurehsan@ukm.edu.my; rlew@amu.edu.pl;
   iztok.kosem@ijs.si
RI TAN, Kim Hua/E-9956-2017; Idrus, Mohd Muzhafar/AAI-2007-2021; Lew,
   Robert/E-3198-2010
OI TAN, Kim Hua/0000-0003-3787-5006; Idrus, Mohd
   Muzhafar/0000-0002-4786-3423; Kosem, Iztok/0000-0002-4282-9031; Lew,
   Robert/0000-0002-6772-210X
FU  [FRGS/1/2018/SS09/UKM/02/1]
FX This work was supported by the Research Fund provided by
   FRGS/1/2018/SS09/UKM/02/1.
CR Abdullah Imran Ho, 2017, CULT WORKSH UKM 27 A
   Achrekar H., 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications Workshops, P702, DOI 10.1109/INFCOMW.2011.5928903
   Ahmed S, 2006, GLQ-J LESBIAN GAY ST, V12, P543, DOI 10.1215/10642684-2006-002
   Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668
   Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672
   Byrne J. P., 2012, ENCY BLACK DEATH, pxxi
   Cartier E., 2019, NEOLOGICA, V13, P23
   Chen N., 2020, VIEW MY WINDOW
   Choi C. J., 2018, ANCIENT UNKNOWN STRA
   Cook Paul, 2013, ELECT LEXICOGRAPHY 2, P49
   Davis M, 2020, CORONAVIRUS CORPUS
   Diaz-Aviles E, 2012, PROCEEDINGS OF THE 3RD ANNUAL ACM WEB SCIENCE CONFERENCE, 2012, P82
   Ferguson N. M., 2020, IMPACT NONPHARMACEUT, DOI [10.25561/77482, DOI 10.25561/77482]
   Fiser D, 2019, INT J LEXICOGR, V32, P163, DOI 10.1093/ijl/ecy011
   Hong AL, 2018, 3L-LANG LINGUIST LIT, V24, P82, DOI 10.17576/3L-2018-2402-07
   Hong AL, 2017, 3L-LANG LINGUIST LIT, V23, P115, DOI 10.17576/3L-2017-2301-09
   Hua J., 2020, INT J ENV RES PUB HE, P1
   Idrus MM, 2020, GEMA ONLINE J LANG S, V20, P133, DOI 10.17576/gema-2020-2002-08
   Idrus MM, 2017, INT J ADOLESC YOUTH, V22, P210, DOI 10.1080/02673843.2016.1154876
   Inagaki TK, 2016, PSYCHOSOM MED, V78, P443, DOI 10.1097/PSY.0000000000000302
   Jahanbin K, 2020, ASIAN PAC J TROP MED, V13, P378, DOI 10.4103/1995-7645.279651
   Jeffries L., 2017, KEYWORDS PRESS NEW L
   Kilgarriff A., 2004, P 11 EURALEX INT C, P105
   Kimball W., 2020, GIZMODO
   Langton K, 2020, EXPRESS
   LebdukovuY E., 2019, DISCOURSE ANAL AUSTE, P53
   Lopez C.E., 2020, UNDERSTANDING PERCEP
   Mahbubani R., 2020, BUSINESS INSIDER
   Mertens G, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102258
   Miller ED, 2020, J LOSS TRAUMA, V25, P560, DOI 10.1080/15325024.2020.1759217
   Nor NFM, 2019, GEMA ONLINE J LANG S, V19, P66, DOI 10.17576/gema-2019-1904-04
   Pei Sen, 2020, DIFFERENTIAL EFFECTS
   Pollak S, 2019, INT J LEXICOGR, V32, P184, DOI 10.1093/ijl/ecy026
   Sault Samantha, 2020, WHY LOCKDOWNS CAN HA
   Scucchi J., 2015, THESIS
   Sketch Engine, 2020, CORP 19 CORP
   Trampu s ., 2012, P 15 MULT INF SOC 20, P221
   United Nations Statistics Division, 2020, SYST ENV EC ACC 2012, P1
   Wiederhold BK, 2020, CYBERPSYCH BEH SOC N, V23, P197, DOI 10.1089/cyber.2020.29180.bkw
   Wilson A., 2006, CORPUS LINGUISTICS W
   Yale University, EMERGENCY MANAGEMENT
NR 41
TC 13
Z9 13
U1 4
U2 10
PU PENERBIT UNIV KEBANGSAAN MALAYSIA
PI BANGI
PA PENERBIT UNIV KEBANGSAAN MALAYSIA, FAC ECONOMICS & MANAGEMENT, BANGI,
   SELANGOR 43600, MALAYSIA
SN 0128-5157
EI 2550-2247
J9 3L-LANG LINGUIST LIT
JI 3L-Lang. Ling. Lit.
PY 2020
VL 26
IS 2
BP 1
EP 23
DI 10.17576/3L-2020-2602-01
PG 23
WC Language & Linguistics
WE Emerging Sources Citation Index (ESCI)
SC Linguistics
GA MG6QH
UT WOS:000546153600014
OA Green Accepted
DA 2022-04-20
ER

PT J
AU Li, SJ
   Cui, GH
   Kaminga, AC
   Cheng, SX
   Xu, HL
AF Li, Shaojie
   Cui, Guanghui
   Kaminga, Atipatsa Chiwanda
   Cheng, Sixiang
   Xu, Huilan
TI Associations Between Health Literacy, eHealth Literacy, and
   COVID-19-Related Health Behaviors Among Chinese College Students:
   Cross-sectional Online Study
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE COVID-19; health literacy; eHealth literacy; COVID-19-related health
   behavior questionnaire; Chinese college students
ID ADULTS; SKILLS; FIGHT
AB Background: During the COVID-19 pandemic, the internet has significantly spread information, providing people with knowledge and advice about health protection regarding COVID-19. While a previous study demonstrated that health and eHealth literacy are related to COVID-19 prevention behaviors, few studies have focused on the relationship between health literacy, eHealth literacy, and COVID-19-related health behaviors. The latter includes not only preventative behaviors but also conventional health behaviors.
   Objective: The objective of this study was to develop and verify a COVID-19-related health behavior questionnaire, explore its status and structure, and examine the associations between these behaviors and participants' health literacy and eHealth literacy.
   Methods: A snowball sampling method was adopted to recruit participants to complete anonymous cross-sectional questionnaire surveys online that assessed sociodemographic information, self-reported coronavirus knowledge, health literacy, eHealth literacy, and COVID-19-related health behaviors.
   Results: Of 1873 college students who were recruited, 781 (41.7%) had adequate health literacy; the mean eHealth literacy score was 30.16 (SD 6.31). The COVID-19-related health behavior questionnaire presented a two-factor structure-COVID-19-specific precautionary behaviors and conventional health behaviors-with satisfactory fit indices and internal consistency (Cronbach a=.79). The mean score of COVID-19-related health behaviors was 53.77 (SD 8.03), and scores differed significantly (P<.05) with respect to residence, college year, academic major, family economic level, self-reported health status, having a family member or friend infected with coronavirus, and health literacy level. Linear regression analysis showed that health literacy and eHealth literacy were positively associated with COVID-19-specific precautionary behaviors (beta(health literacy)=.149, beta(eHealth literacy)=.368; P<.001) and conventional health behaviors (beta(health literacy)=.219, beta(eHealth literacy)=.277; P<.001).
   Conclusions: The COVID-19-related health behavior questionnaire was a valid and reliable measure for assessing health behaviors during the pandemic. College students with higher health literacy and eHealth literacy can more actively adopt COVID-19-related health behaviors. Additionally, compared to health literacy, eHealth literacy is more closely related to COVID-19-related health behaviors. Public intervention measures based on health and eHealth literacy are required to promote COVID-19-related health behaviors during the pandemic, which may be helpful to reduce the risk of COVID-19 infection among college students.
C1 [Li, Shaojie; Cheng, Sixiang; Xu, Huilan] Cent South Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, 238 Shangmayuanling Lane, Changsha 410078, Peoples R China.
   [Cui, Guanghui] Shandong Univ Tradit Chinese Med, Sch Acupuncture & Tuina, Jinan, Peoples R China.
   [Kaminga, Atipatsa Chiwanda] Mzuzu Univ, Dept Math & Stat, Luwinga, Malawi.
   [Kaminga, Atipatsa Chiwanda] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Peoples R China.
RP Xu, HL (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, 238 Shangmayuanling Lane, Changsha 410078, Peoples R China.
EM xhl_csu@163.com
OI Li, Shaojie/0000-0003-1366-5813
CR Baines D, 2020, DISCUSSION PAPERS ID
   Barsell DJ, 2018, AM J HEALTH EDUC, V49, P305, DOI 10.1080/19325037.2018.1486758
   Berkman ND, 2010, J HEALTH COMMUN, V15, P9, DOI 10.1080/10810730.2010.499985
   Britt RK, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.3100
   Brors G, 2020, EUR J CARDIOVASC NUR, V19, P458, DOI 10.1177/1474515120941307
   Brown T., 2010, AUSTRALASIAN J PARAM, V8, P1, DOI [10.33151/ajp.8.3.93, DOI 10.33151/AJP.8.3.93]
   Carrion G.C., 2017, MEDIATION ANALYSES P, DOI 10.1007/978-3-319-64069-3_8
   Chen XY, 2020, INT J ENV RES PUB HE, V17, DOI [10.3390/ijerph17082893, 10.3390/ijerph17124437]
   Chinese Center for Disease Control and Prevention, 2020, GUID PUBL PROT PNEUM
   Chong YY, 2020, INT J NURS STUD, V108, DOI 10.1016/j.ijnurstu.2020.103644
   Chou WYS, 2020, HEALTH COMMUN, V35, P1718, DOI 10.1080/10410236.2020.1838096
   Do BN, 2020, J MED INTERNET RES, V22, DOI 10.2196/22894
   Duan TX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103387
   Edwards M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-130
   Greenhalgh T, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1026
   Guo SJ, 2013, CHIN J HLTH ED, V29, P106, DOI DOI 10.16168/J.CNKI.ISSN.1002
   Hamer M, 2020, BRAIN BEHAV IMMUN, V87, P184, DOI 10.1016/j.bbi.2020.05.059
   Hsiang S, 2020, NATURE, V585, pE7, DOI [10.1038/s41586-020-2404-8, 10.1038/s41586-020-2691-0]
   Hu Z, 2020, J MED INTERNET RES, V22, DOI 10.2196/21176
   Klinker CD, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020671
   Li SY, 2020, J MED INTERNET RES, V22, DOI 10.2196/19782
   Li XJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/19684
   Li YH, 2014, CHIN J HLTH ED, V30, P563
   Li YY, 2021, J AFFECT DISORDERS, V281, P597, DOI 10.1016/j.jad.2020.11.109
   Luo HB, 2020, PUBLIC HEALTH REP, V135, P492, DOI 10.1177/0033354920927848
   Neter E, 2019, EUR PSYCHOL, V24, P68, DOI 10.1027/1016-9040/a000350
   Nguyen HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114164
   Nguyen HC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040965
   Nguyen NPT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238830
   Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e27
   Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e9
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Okan O, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155503
   Or PPL, 2020, AM J INFECT CONTROL, V48, P485, DOI 10.1016/j.ajic.2019.12.021
   Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130
   Riiser K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238161
   Schulz Peter Johannes, 2017, J Med Internet Res, V19, pe166, DOI 10.2196/jmir.6317
   Shen MX, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1958-0
   Smirmaul BPC, 2021, AM J LIFESTYLE MED, V15, P60, DOI 10.1177/1559827620950276
   Squiers L, 2012, J HEALTH COMMUN, V17, P30, DOI 10.1080/10810730.2012.713442
   Sun ZG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165889
   Toussaint LL, 2020, ANN BEHAV MED, V54, P619, DOI 10.1093/abm/kaaa064
   Tsukahara S, 2020, J MED INTERNET RES, V22, P1, DOI 10.2196/18155
   Wang WN, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113848
   Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239
   Yang SC, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.5964
   Yuan T, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.925877
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
NR 48
TC 10
Z9 10
U1 16
U2 37
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD MAY 6
PY 2021
VL 23
IS 5
AR e25600
DI 10.2196/25600
PG 13
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Medical Informatics
GA RZ2SF
UT WOS:000648448400005
PM 33822734
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Dar-Odeh, N
   Elsayed, S
   Babkair, H
   Abu-Hammad, S
   Althagafi, N
   Bahabri, R
   Eldeen, YS
   Aljohani, W
   Abu-Hammad, O
AF Dar-Odeh, Najla
   Elsayed, Shadia
   Babkair, Hamzah
   Abu-Hammad, Shaden
   Althagafi, Nebras
   Bahabri, Rayan
   Eldeen, Yasmin Salah
   Aljohani, Wejdan
   Abu-Hammad, Osama
TI What the dental practitioner needs to know about pharmaco-therapeutic
   modalities of COVID-19 treatment: A review
SO JOURNAL OF DENTAL SCIENCES
LA English
DT Review
DE Azithromycin; COVID-19; Dental practice; Ibuprofen; Paracetamol
ID AZITHROMYCIN; PARACETAMOL; CHLOROQUINE; MANAGEMENT; ASPIRIN;
   HYDROXYCHLOROQUINE; GLUCOCORTICOIDS; METRONIDAZOLE; MECHANISM; IBUPROFEN
AB Background/purpose: Several pharmacotherapeutic methods have been used for the treatment of COVID-19 with varying degrees of success. No definitive treatment or vaccine has been officially approved to-date. This review aimed to highlight COVID-19 pharmacotherapeutic agents that are relevant to dental practice in terms of their clinical indications in COVID-19 and dental practice, as well as their adverse effects as they impact the dental patient. Material and methods: Systematic search was performed using the following keywords combinations: Pharmacotherapy AND COVID-19 OR Pharmacotherapy AND SARS-CoV-2 OR Treatment AND COVID-19. Studies were categorized according to the type of pharmacotherapy used. Pharmacotherapeutic agents were extracted and only those relevant to dental practice were included for review. Results: For analysis, a total of 79 clinical trials research articles were included that included COVID-19 pharmacotherapeutic agents relevant to dental practice. Those were analgesics (paracetamol; non-steroidal anti-inflammatory agents); antibiotics (azithromycin, doxycycline, metronidazole); antivirals (penciclovir); and immunomodulatory agents (hydroxychloroquine, corticosteroids). While some COVID-19 drugs are less relevant to dental practice, as antivirals and hydroxychloroquine, their association with long-term adverse effects requires adequate knowledge among dental practitioners.
C1 [Dar-Odeh, Najla; Elsayed, Shadia; Babkair, Hamzah; Althagafi, Nebras; Bahabri, Rayan; Aljohani, Wejdan; Abu-Hammad, Osama] Taibah Univ, Coll Dent, Al Madinah, Al Munawara, Saudi Arabia.
   [Dar-Odeh, Najla; Abu-Hammad, Osama] Univ Jordan, Sch Dent, Amman, Jordan.
   [Elsayed, Shadia] Al Azhar Univ, Fac Dent Med Girls, Cairo, Egypt.
   [Abu-Hammad, Shaden] Queen Alia Mil Hosp, Dent Dept, Amman, Jordan.
   [Eldeen, Yasmin Salah] Nahda Univ, Fac Pharm, Bani Sweif, Egypt.
RP Elsayed, S (corresponding author), Al Azhar Univ, Fac Dent Med Girls, Dept Oral & Maxillofacial Surg, Cairo, Egypt.
EM shadiaelsayed@azhar.edu.eg
RI Elsayed, Shadia Abdelhameed/E-5446-2018; Dar-Odeh, Najla/E-6099-2011
OI Elsayed, Shadia Abdelhameed/0000-0002-3348-3382; Dar-Odeh,
   Najla/0000-0002-6577-2373; Babkair, Hamzah/0000-0001-7079-4684; Salah
   Eldeen, Yasmin/0000-0002-6148-1923
CR Abu-Hammad O, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030216
   Al-Shayyab M H, 2013, INT ARAB J ANTIMICRO, V3, P1, DOI DOI 10.3823/736
   Amici C, 2006, ANTIVIR THER, V11, P1021
   Anderson BJ, 2008, PEDIATR ANESTH, V18, P915, DOI 10.1111/j.1460-9592.2008.02764.x
   [Anonymous], 2020, Med Lett Drugs Ther, V62, P49
   Azzi L, 2019, ORAL DIS, V25, P1465, DOI 10.1111/odi.13001
   Babu KS, 2000, CHEST, V118, P1470, DOI 10.1378/chest.118.5.1470
   Bacharier LB, 2015, JAMA-J AM MED ASSOC, V314, P2034, DOI 10.1001/jama.2015.13896
   Bailey E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004624.pub2
   Becker Daniel E, 2010, Anesth Prog, V57, P67, DOI 10.2344/0003-3006-57.2.67
   Bizjak ED, 1999, PHARMACOTHERAPY, V19, P245, DOI 10.1592/phco.19.3.245.30930
   Bleyzac N, 2020, CLIN DRUG INVEST, V40, P683, DOI 10.1007/s40261-020-00933-3
   Bolfoni MR, 2018, INT ENDOD J, V51, P148, DOI 10.1111/iej.12823
   Brito-Zeron P, 2013, EXPERT OPIN PHARMACO, V14, P279, DOI 10.1517/14656566.2013.767333
   Brotman DJ, 2005, J CLIN ENDOCR METAB, V90, P3202, DOI 10.1210/jc.2004-2379
   Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199
   Chen JH, 2005, J DENT, V33, P3, DOI 10.1016/j.jdent.2004.06.008
   Choi Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1574806
   Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3
   Close R, 2020, ARCH DIS CHILDHOOD-E
   COOPER SA, 1981, ARCH INTERN MED, V141, P282, DOI 10.1001/archinte.141.3.282
   Crimi S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050463
   Cryer B, 2005, CLIN THER, V27, P185, DOI 10.1016/j.clinthera.2005.01.011
   Dar-Odeh N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093151
   Dar-Odeh N, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7020038
   Dar-Odeh NS, 2018, PESQUI BRAS ODONTOPE, V18, DOI 10.4034/PBOCI.2018.181.27
   Davies J E, 2007, OCCUP ENVIRON MED, V64, DOI [10.1136/oem.2007.033902, DOI 10.1136/OEM.2007.033902]
   Day Michael, 2020, BMJ, V368, pm1086, DOI 10.1136/bmj.m1086
   Derry C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004234.pub3
   DIAERESISGLER ASS, 2015, EUR RESPIR J, V45, P428
   Dilly S, 2018, J MED CHEM, V61, P7202, DOI 10.1021/acs.jmedchem.8b00557
   Durkin MJ, 2017, J AM DENT ASSOC, V148, P878, DOI 10.1016/j.adaj.2017.07.019
   Elsayed SA, 2020, J CRANIOFAC SURG, V31, pE643, DOI 10.1097/SCS.0000000000006752
   Elsayed SA, 2020, PESQUI BRAS ODONTOPE, V20, DOI 10.1590/pboci.2020.123
   Fiolet T, 2021, CLIN MICROBIOL INFEC, V27, P19, DOI 10.1016/j.cmi.2020.08.022
   Freeman CD, 1997, DRUGS, V54, P679, DOI 10.2165/00003495-199754050-00003
   Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663
   Gensler LS, 2013, NEUROHOSPITALIST, V3, P92, DOI 10.1177/1941874412458678
   Gharebaghi R, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.645
   Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330
   Golden EB, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2014.12.FOCUS14748
   Goldenberg NA, 2005, ANN INTERN MED, V142, P506, DOI 10.7326/0003-4819-142-7-200504050-00009
   Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019
   HODGE RAV, 1993, ANTIVIR CHEM CHEMOTH, V4, P67, DOI 10.1177/095632029300400201
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horta-Baas G, 2018, REUMATOL CLIN, V14, P177, DOI 10.1016/j.reuma.2017.06.003
   Hyllested M, 2002, BRIT J ANAESTH, V88, P199, DOI 10.1093/bja/88.2.199
   JASANI MK, 1968, ANN RHEUM DIS, V27, P457, DOI 10.1136/ard.27.5.457
   Jia LH, 2017, MOL MED REP, V16, P5779, DOI 10.3892/mmr.2017.7342
   Jozwiak-Bebenista M, 2014, ACTA POL PHARM, V71, P11
   Kaddoura M, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01196
   Kakodkar P, 2020, CUREUS, V12, DOI 10.7759/cureus.11858
   Larsen Marie Kjargaard, 2018, J Oral Maxillofac Res, V9, pe1, DOI 10.5037/jomr.2018.9201
   Legrand E, 2004, EXPERT OPIN PHARMACO, V5, P1347, DOI 10.1517/14656566.5.6.1347
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.02.007]
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Madrid PB, 2015, ACS INFECT DIS, V1, P317, DOI 10.1021/acsinfecdis.5b00030
   Malek AE, 2020, IDCASES, V21, DOI 10.1016/j.idcr.2020.e00864
   Mansour A, 2020, CUREUS, V12, DOI 10.7759/cureus.7520
   Carreras-Presas CM, 2021, ORAL DIS, V27, P710, DOI 10.1111/odi.13382
   Maurya SK, 2020, J RECEPT SIG TRANSD, V40, P605, DOI 10.1080/10799893.2020.1772298
   Meini S, 2020, BMJ OPEN GASTROENTER, V7, DOI 10.1136/bmjgast-2020-000434
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Moraes P C, 2011, Minerva Stomatol, V60, P327
   National Center for Biotechnology Information, 2020, PENC
   Nhan, 2018, J ANTIVIR ANTIRETROV, V10, P6, DOI DOI 10.4172/1948-5964.1000173
   Pasupuleti V, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002733
   PISCITELLI SC, 1992, CLIN PHARMACY, V11, P137
   Ponticelli C, 2017, EXPERT OPIN DRUG SAF, V16, P411, DOI 10.1080/14740338.2017.1269168
   Raborn G Wayne, 2003, J Can Dent Assoc, V69, P498
   Ramadan AM, 2019, PESQUI BRAS ODONTOPE, V19, DOI [10.4034/pboci.2019.191.17, 10.4034/PBOCI.2019.191.17]
   Ravinthar K, 2016, INT J PHARM SCI RES, V7, P5092, DOI 10.13040/IJPSR.0975-8232.7(12).5092-98
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630
   Rothan HA, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0126360
   Rothan HA, 2014, ARCH VIROL, V159, P711, DOI 10.1007/s00705-013-1880-7
   Salman S, 2010, ANTIMICROB AGENTS CH, V54, P360, DOI 10.1128/AAC.00771-09
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Serisier DJ, 2013, LANCET RESP MED, V1, P262, DOI 10.1016/S2213-2600(13)70038-9
   SEYMOUR RA, 1995, J CLIN PERIODONTOL, V22, P22
   Shakir L, 2011, PHARMAZIE, V66, P393, DOI 10.1691/ph.2011.0790
   Shoaei P, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3965-8
   Simsek Yavuz S, 2020, TURK J MED SCI, V50, P611, DOI 10.3906/sag-2004-145
   SLOTS J, 1983, J CLIN PERIODONTOL, V10, P465, DOI 10.1111/j.1600-051X.1983.tb02179.x
   Sodhi M, 2020, CHEST, V158, P55, DOI 10.1016/j.chest.2020.03.040
   Struyf T, 2019, INT DENT J, V69, P480, DOI 10.1111/idj.12512
   Tan SHS, 2020, INT ORTHOP, V44, P1599, DOI 10.1007/s00264-020-04643-5
   Tang JW, 2020, J INFECTION, V80, P350, DOI 10.1016/j.jinf.2020.01.014
   TETT SE, 1989, BRIT J CLIN PHARMACO, V27, P771, DOI 10.1111/j.1365-2125.1989.tb03439.x
   Van Erum J, 2019, NEUROSCI BIOBEHAV R, V105, P72, DOI 10.1016/j.neubiorev.2019.07.019
   Waljee AK, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1415
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wehr C, 2019, DENT J-BASEL, V7, DOI 10.3390/dj7030088
   Weikle B, 2020, CAN BROADCAST CORP, P1
   Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008
   Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237
   Yousefifard M, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13557
   Zhang MD, 2017, CARDIOVASC TOXICOL, V17, P434, DOI 10.1007/s12012-017-9401-7
   Zhang WF, 2020, J PHYS CHEM LETT, V11, P4430, DOI 10.1021/acs.jpclett.0c00571
NR 99
TC 3
Z9 3
U1 2
U2 3
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1991-7902
EI 2213-8862
J9 J DENT SCI
JI J. Dental Sci.
PD JUL
PY 2021
VL 16
IS 3
BP 806
EP 816
DI 10.1016/j.jds.2020.11.007
EA JUN 2021
PG 11
WC Dentistry, Oral Surgery & Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dentistry, Oral Surgery & Medicine
GA SP1YD
UT WOS:000659468400002
PM 33230404
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Yigitcanlar, T
   Kankanamge, N
   Inkinen, T
   Butler, L
   Preston, A
   Rezayee, M
   Gill, P
   Ostadnia, M
   Ioppolo, G
   Senevirathne, M
AF Yigitcanlar, Tan
   Kankanamge, Nayomi
   Inkinen, Tommi
   Butler, Luke
   Preston, Alexander
   Rezayee, Maqsood
   Gill, Palvinderjit
   Ostadnia, Mahsan
   Ioppolo, Giuseppe
   Senevirathne, Mahanama
TI Pandemic vulnerability knowledge visualisation for strategic
   decision-making: a COVID-19 index for government response in Australia
SO MANAGEMENT DECISION
LA English
DT Article
DE Knowledge visualisation; Strategic decision-making; Community
   vulnerability; COVID-19; Government response; Australia
ID SOCIAL VULNERABILITY; MANAGEMENT; COMMUNITY; INFLUENZA
AB Purpose First, the key vulnerability factors from the literature are identified. Second, using the vulnerability factors as indicators, a composite index is developed. Last, from the index values, a set of vulnerability knowledge maps, showing the vulnerability hotspots, are prepared. Design/methodology/approach This study aims to develop a pandemic vulnerability knowledge visualisation index to support the strategic decision-making efforts of authorities. Findings Ten indicators are identified as vulnerability factors that could significantly impact the virus spread risks. Verifying the identified hotspots against the recorded infected cases and deaths has evidenced the usefulness of the index. Determining and visualising the high-vulnerability locations and communities could help in informed strategic decision-making and responses of the authorities to the pandemic. Originality/value The study demonstrates that the developed pandemic vulnerability knowledge visualisation index is particularly appropriate in the context of Australia. Nonetheless, by replicating the methodologic steps of the study, customised versions can be developed for other country contexts.
C1 [Yigitcanlar, Tan; Kankanamge, Nayomi; Butler, Luke; Preston, Alexander; Gill, Palvinderjit] Queensland Univ Technol, Sch Architecture & Built Environm, Brisbane, Qld, Australia.
   [Inkinen, Tommi] Univ Turku, Dept Geog & Geol, Turku, Finland.
   [Rezayee, Maqsood] Nangarhar Univ, Dept Architecture, Jalalabad, Afghanistan.
   [Ostadnia, Mahsan] Islamic Azad Univ, Dept Urban Planning, Tehran, Iran.
   [Ioppolo, Giuseppe] Univ Messina, Dept Econ, Messina, Italy.
   [Senevirathne, Mahanama] Univ Moratuwa, Dept Town & Country Planning, Moratuwa, Sri Lanka.
RP Yigitcanlar, T (corresponding author), Queensland Univ Technol, Sch Architecture & Built Environm, Brisbane, Qld, Australia.
EM tan.yigitcanlar@qut.edu.au
RI Yigitcanlar, Tan/J-1142-2012; Inkinen, Tommi/S-9341-2019
OI Yigitcanlar, Tan/0000-0001-7262-7118; Inkinen,
   Tommi/0000-0001-6682-043X; Butler, Luke/0000-0003-0708-8896; Ostadnia,
   Mahsan/0000-0002-2157-4762; Kankanamge, Nayomi/0000-0002-4529-7042;
   Mahanama, Papola Kankanamge Seneviratne/0000-0002-0833-2128
FU  [1900000214]
FX This research did not receive any specific grant from funding agencies
   in the public, commercial or not-for-profit sectors. The authors declare
   that they have no known competing financial interests or personal
   relationships (or any other conflict of interest) that could have
   appeared to influence the work reported in this paper. Ethical approval
   was obtained from QUT's Human Research Ethics Committee (#1900000214).
   The authors also acknowledge the assistance provided by QUT Digital
   Observatory's data scientist Sam Hames in obtaining the social media
   data used in the study.
CR Aas TH, 2018, INT J INNOV MANAG, V22, DOI 10.1142/S1363919618400029
   Acharya R, 2020, LANCET GLOB HEALTH, V8, pE1142, DOI 10.1016/S2214-109X(20)30300-4
   Alamoodi AH, 2021, EXPERT SYST APPL, V167, DOI 10.1016/j.eswa.2020.114155
   Alomari E, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21092993
   Ammirato S, 2021, KNOWL MAN RES PRACT, V19, P415, DOI 10.1080/14778238.2020.1801364
   Annweiler C, 2021, CLIN INFECT DIS, V72, P490, DOI 10.1093/cid/ciaa792
   Araz OM, 2012, J MED SYST, V36, P1475, DOI 10.1007/s10916-010-9608-7
   Arthur R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189327
   Ballester-Arnal R, 2020, AIDS BEHAV, V24, P2253, DOI 10.1007/s10461-020-02877-3
   Bertuzzo E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18050-2
   Bhadra A, 2021, MODEL EARTH SYST ENV, V7, P623, DOI 10.1007/s40808-020-00984-7
   Bloomer MJ, 2020, COLLEGIAN, V27, P248, DOI 10.1016/j.colegn.2020.05.007
   Bogaert J, 2020, PUBLIC HLTH PRACTICE, V1
   Centers for Disease Control and Prevention (CDC), 2018, SOCIAL VULNERABILITY
   Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Currie CSM, 2020, J SIMUL, V14, P83, DOI 10.1080/17477778.2020.1751570
   Das S, 2021, J HUM BEHAV SOC ENVI, V31, P154, DOI 10.1080/10911359.2020.1781015
   Sola DED, 2020, J MED VIROL, V92, P1460, DOI 10.1002/jmv.25864
   Deliu D., 2020, J EMERG TRENDS MARK, V1, P93
   Diderichsen F, 2019, INT J EPIDEMIOL, V48, P268, DOI 10.1093/ije/dyy167
   Dizdaroglu D, 2012, SMART SUSTAIN BUILT, V1, P291, DOI 10.1108/20466091211287155
   Dollard P, 2020, MMWR-MORBID MORTAL W, V69, P1681, DOI 10.15585/mmwr.mm6945a4
   Dur F, 2015, INT J ENVIRON SCI TE, V12, P803, DOI 10.1007/s13762-013-0476-9
   Eastwood K, 2009, B WORLD HEALTH ORGAN, V87, P588, DOI 10.2471/BLT.08.060772
   Eppler Martin J, 2007, Journal of Knowledge Management, V11, P112, DOI 10.1108/13673270710762756
   Eppler MJ, 2009, LONG RANGE PLANN, V42, P42, DOI 10.1016/j.lrp.2008.11.005
   Fortaleza CMCB, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S095026882000134X
   Franch-Pardo I, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.140033
   Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6
   Gostic K, 2020, ELIFE, V9, DOI 10.7554/eLife.55570
   Honey-Roses J., 2020, CITIES HLTH, P1, DOI DOI 10.1080/23748834.2020.1780074
   Jalali M, 2020, DISABIL SOC, V35, P844, DOI 10.1080/09687599.2020.1754165
   Kankanamge N, 2020, INT J DISAST RISK RE, V48, DOI 10.1016/j.ijdrr.2020.101571
   Kankanamge N, 2020, INT J DISAST RISK RE, V42, DOI 10.1016/j.ijdrr.2019.101360
   Kankanamge N, 2019, INT J DISAST RISK RE, V35, DOI 10.1016/j.ijdrr.2019.101097
   Khademi N, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05908-z
   Khazanchi R, 2020, J GEN INTERN MED, V35, P2784, DOI 10.1007/s11606-020-05882-3
   Khraise WN, 2020, INT J GEN MED, V13, P937, DOI 10.2147/IJGM.S276742
   Kim PS, 2005, PUBLIC ADMIN REV, V65, P646, DOI 10.1111/j.1540-6210.2005.00494.x
   Kuebart A, 2020, TIJDSCHR ECON SOC GE, V111, P482, DOI 10.1111/tesg.12429
   Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007
   Lone SA, 2020, EMERG MICROBES INFEC, V9, P1300, DOI 10.1080/22221751.2020.1775132
   Macharia PM, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003014
   Metaxiotis K., 2010, KNOWLEDGE BASED DEV
   Millar CCJM, 2010, J KNOWL MANAG, V14, P759, DOI 10.1108/13673271011074881
   Moloney K, 2020, PUBLIC ADMIN REV, V80, P671, DOI 10.1111/puar.13224
   Moriarty LF, 2020, MMWR-MORBID MORTAL W, V69, P347, DOI 10.15585/mmwr.mm6912e3
   Morrow BH, 1999, DISASTERS, V23, P1, DOI 10.1111/1467-7717.00102
   Paltiel AD, 2021, ANN INTERN MED, V174, P568, DOI 10.7326/M20-7866
   Rawstorne P, 2020, INT J COMMUNITY WELL, V3, P57, DOI DOI 10.1007/S42413-019-00041-X
   Reshadat S, 2020, J PUBLIC HEALTH-HEID, V28, P693, DOI 10.1007/s10389-019-01086-0
   Roncancio DJ, 2016, NAT HAZARDS, V84, P1367, DOI 10.1007/s11069-016-2491-x
   Rufat S, 2019, ANN AM ASSOC GEOGR, V109, P1131, DOI 10.1080/24694452.2018.1535887
   Smith JA, 2020, HEALTH PROMOT J AUST, V31, P158, DOI 10.1002/hpja.333
   Sparke M, 2020, T I BRIT GEOGR, V45, P498, DOI 10.1111/tran.12389
   Stephenson N, 2014, SOC SCI MED, V102, P10, DOI 10.1016/j.socscimed.2013.11.031
   Surgo Foundation, 2020, COVID 19 COMM VULN I
   van Biljon J, 2020, INFORM TECHNOL DEV, V26, P637, DOI 10.1080/02681102.2020.1821954
   Wang WS, 2021, KAOHSIUNG J MED SCI, V37, P215, DOI 10.1002/kjm2.12322
   Xia Huosong, 2022, Socioecon Plann Sci, V80, P100941, DOI 10.1016/j.seps.2020.100941
   Xie X, 2020, GLOB J ENVIRON SCI M, V6, P107, DOI 10.22034/GJESM.2019.06.SI.10
   Xu SQ, 2020, LANCET, V395, P1321, DOI 10.1016/S0140-6736(20)30845-X
   Xue J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239441
   Yigitcanlar T, 2012, BUILDING PROSPEROUS KNOWLEDGE CITIES: POLICIES, PLANS AND METRICS, P1
   Yigitcanlar T., 2020, J OPEN INNOV TECHNOL, V6, P187, DOI [10.3390/joitmc6040187, DOI 10.3390/JOITMC6040187]
   Yigitcanlar T., 2020, SMART CITIES
   Yigitcanlar T, 2006, URISA J, V18, P7
   Yigitcanlar T, 2020, HEALTH INF SCI SYST, V8, DOI 10.1007/s13755-020-00121-9
   Yigitcanlar T, 2021, J URBAN TECHNOL, V28, P135, DOI 10.1080/10630732.2020.1753483
   Yigitcanlar T, 2015, SUSTAINABILITY-BASEL, V7, P14677, DOI 10.3390/su71114677
   Zhou J., 2021, SN COMPUTER SCI, V2, P1
NR 72
TC 3
Z9 3
U1 4
U2 8
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0025-1747
EI 1758-6070
J9 MANAGE DECIS
JI Manag. Decis.
PD MAR 21
PY 2022
VL 60
IS 4
SI SI
BP 893
EP 915
DI 10.1108/MD-11-2020-1527
EA JUN 2021
PG 23
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA ZY5YK
UT WOS:000658508500001
OA Bronze
DA 2022-04-20
ER

PT J
AU Kayaaslan, B
   Eser, F
   Kalem, AK
   Kaya, G
   Kaplan, B
   Kacar, D
   Hasanoglu, I
   Coskun, B
   Guner, R
AF Kayaaslan, Bircan
   Eser, Fatma
   Kalem, Ayse K.
   Kaya, Gamze
   Kaplan, Betul
   Kacar, Duygu
   Hasanoglu, Imran
   Coskun, Belgin
   Guner, Rahmet
TI Post-COVID syndrome: A single-center questionnaire study on 1007
   participants recovered from COVID-19
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE COVID-19; long-COVID; persistent symptoms; post-COVID; prevalence;
   questionnaire
AB Post recovery manifestations have become another concern in patients who have recovered from coronavirus disease 2019 (COVID-19). Numerous reports have shown that COVID-19 has a variety of long-term effects on almost all systems including respiratory, cardiovascular, gastrointestinal, neurological, psychiatric, and dermatological systems. We aimed to investigate the prevalence and characteristics of the post-COVID syndrome among COVID-19 survivors and to determine the factors associated with persistent symptoms. This prospective study enrolled in patients with COVID-19 followed in hospital or outpatient clinics in Ankara City Hospital. We performed a special questionnaire to inquire about the presence of persistent symptoms beyond 12 weeks from the first diagnosis. Demographic data, comorbid diseases, characteristics of acute COVID-19, presence of persistent symptoms by systems, and knowledge about outpatient clinic visits after recovery were assessed. Of a total of 1007 participants, 39.0% had at least one comorbidity, and 47.5% had persistent symptoms. Fatigue/easy fatigability, myalgia, and loss of weight were the most frequent persistent symptoms (overall 29.3%) followed by respiratory symptoms (25.4%). A total of 235 participants had visited outpatient clinics due to several reasons during the post-COVID-19 period, and 17 of them were hospitalized. Severe acute COVID-19, hospitalization, and presence of comorbidity were independent factors for the development of persistent symptoms. Fully understanding the spectrum of the post-COVID syndrome is essential for appropriate management of all its long-term effects. Our study once again underlined the fact that the prevalence of post-COVID syndrome is higher than expected and concerns many systems, and a multidisciplinary follow-up should be provided to COVID-19 survivors in the post recovery period.
C1 [Kayaaslan, Bircan; Eser, Fatma; Kalem, Ayse K.; Hasanoglu, Imran; Guner, Rahmet] Ankara Yildirim Beyazit Univ, Ankara City Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkey.
   [Kaya, Gamze; Kaplan, Betul; Kacar, Duygu; Coskun, Belgin] Ankara City Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkey.
RP Kayaaslan, B (corresponding author), Ankara Yildirim Beyazit Univ, Ankara City Hosp, Infect Dis & Clin Microbiol, Bilkent St 1, TR-06800 Ankara, Turkey.
EM drbican@gmail.com
CR Ayoubkhani D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n693
   Baig AM, 2021, J MED VIROL, V93, P2555, DOI 10.1002/jmv.26624
   Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603
   Carvalho-Schneider C, 2021, CLIN MICROBIOL INFEC, V27, P258, DOI 10.1016/j.cmi.2020.09.052
   Cenat JM, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113599
   Datta SD, 2020, JAMA-J AM MED ASSOC, V324, P2251, DOI 10.1001/jama.2020.22717
   Fernandez-de-las-Penas C, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052621
   Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029
   Greenhalgh T, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3026
   Kamal M, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13746
   Leth S, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab042
   Mahmud R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249644
   Mazza MG, 2020, BRAIN BEHAV IMMUN, V89, P594, DOI 10.1016/j.bbi.2020.07.037
   Moreno-Perez O, 2021, J INFECTION, V82, P378, DOI 10.1016/j.jinf.2021.01.004
   Osikomaiya B, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-020-05716-x
   Raveendran AV, 2021, DIABETES METAB SYND, V15, P869, DOI 10.1016/j.dsx.2021.04.007
   Sivan M, 2020, ADV CLIN NEUROSCI RE, V19, P14, DOI DOI 10.47795/NELE5960
   Sivan M, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4938
   Sudre CH, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01292-y
   Taquet M, 2021, LANCET PSYCHIAT, V8, P130, DOI 10.1016/S2215-0366(20)30462-4
   Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]
   World Health Organization, INT GUID END IS PREC
   World Health Organization, 2020, CLIN MAN COVID 19 IN
NR 23
TC 5
Z9 5
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD DEC
PY 2021
VL 93
IS 12
BP 6566
EP 6574
DI 10.1002/jmv.27198
EA JUL 2021
PG 9
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Virology
GA WG1VK
UT WOS:000678138400001
PM 34255355
OA Green Published
DA 2022-04-20
ER

PT J
AU Shalneva, KN
   Ugrovatov, MA
   Achmad, H
   Al Audah, N
   Kishkina, MA
   Goncharov, VV
AF Shalneva, Karina Nikolaevna
   Ugrovatov, Mikhail Andreevich
   Achmad, Harun
   Al Audah, Nelly
   Kishkina, Mariya Andreevna
   Goncharov, Vitaly V.
TI Secondary Diseases of Infectious and Non-Infectious Origin in Patients
   Diagnosed with Covid-19
SO INTERNATIONAL JOURNAL OF APPLIED EXERCISE PHYSIOLOGY
LA English
DT Article
DE COVID-19; secondary diseases; infectious and non-infectious genesis;
   disease outcomes
ID CORONAVIRUS
AB The article considers the features of the occurrence and course of secondary diseases of infectious and non-infectious genesis in patients with a diagnosis of COVID-19, and also examines individual clinical cases described in the literature. The author concludes that the results showed that major respiratory diseases, in particular COPD (chronical obstructive pulmonary disease) and smoking, are associated with severe COVID-19 outcomes. These results contribute to a better understanding of risk factors for patients with severe COVID-19, which are important to support the development of preventive interventions and can help improve the assessment and management of risk factors for patients in clinical practice. Future studies should evaluate the association of severe COVID-19 outcomes with the prevalence of other major respiratory diseases other than COPD, as well as explore the potential impact of their immune responses and pharmacological treatment. In addition, the association of severe COVID-19 with all smoking levels and causal mechanisms should be the subject of future research.
   Cardiovascular diseases play an important role in the severity of disease and mortality in patients with COVID-19. Hypertension, acute heart injury, and coronary heart disease in a patient with COVID-19 require careful monitoring and treatment in the case of acute conditions. Other cardiovascular disorders, including arrhythmia and heart failure, must also be considered, as they can be fatal. Therefore, in these patients, careful consideration and treatment of cardiovascular diseases is necessary. The results of this study can help policy makers, doctors and healthcare professionals in the front line to make evidence-based decisions and reduce the mortality and morbidity of this 21st century pandemic.
   Understanding the proportion of COVID-19 patients with acute respiratory bacterial co-infection and pathogens is critical for the treatment of COVID-19 patients and helps ensure responsible use of antibiotics and minimize the negative effects of overuse. In addition, this knowledge may have a significant impact on clarifying recommendations for empirical antibiotic therapy for patients with COVID-19.
C1 [Shalneva, Karina Nikolaevna] St Petersburg State Pediat Med Univ, St Petersburg, Russia.
   [Ugrovatov, Mikhail Andreevich; Kishkina, Mariya Andreevna] Sechenov Univ, Minist Hlth Russian Federat, IM Sechenov Moscow State Med Univ 1, Fed State Autonomous Educ Inst Higher Educ, Moscow, Russia.
   [Achmad, Harun] Hasanuddin Univ, Fac Dent, Dept Pediat Dent, Makassar, Indonesia.
   [Al Audah, Nelly] Lambung Mangkurat Univ, Fac Med, Dept Microbiol & Parasitol, Banjarmasin, South Kalimanta, Indonesia.
   [Goncharov, Vitaly V.] Kuban State Agr Univ, Krasnodar, Russia.
RP Shalneva, KN (corresponding author), St Petersburg State Pediat Med Univ, St Petersburg, Russia.
RI Goncharov, Vitaly Victorovich/C-4842-2017
OI Goncharov, Vitaly Victorovich/0000-0003-3029-4727
CR Achmad H, 2020, J PHARM RES
   Achmad H, 2020, INT J PHARM RES, P830
   Achmad H, 2018, ASIAN J MICROBIOL BI, V20, P18
   Bangalore S, 2020, NEW ENGL J MED, V382, P2478, DOI 10.1056/NEJMc2009020
   Bernet J, 2003, J BIOSCIENCES, V28, P249, DOI 10.1007/BF02970145
   Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753
   Blot SI, 2012, AM J RESP CRIT CARE, V186, P56, DOI 10.1164/rccm.201111-1978OC
   Braiteh N, 2020, AM HEART J, V226, P147, DOI 10.1016/j.ahj.2020.05.009
   Chen N., 2020, SSRN ELECT J, V395, P10223, DOI [10.2139/ssrn.3523861, DOI 10.2139/SSRN.3523861]
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5
   Dolhnikoff M, 2020, J THROMB HAEMOST, V18, P1517, DOI 10.1111/jth.14844
   Dong X, 2020, ALLERGY, V75, P1699, DOI 10.1111/all.14289
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170
   Franchini M, 2020, DIAGNOSIS, V7, P357, DOI 10.1515/dx-2020-0078
   Frieman M, 2008, VIRUS RES, V133, P101, DOI 10.1016/j.virusres.2007.03.015
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   HE YQ, 2020, INFECT CONT HOSP EP, DOI DOI 10.1080/00207454.2020.1750396
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hotez PJ, 2020, MICROBES INFECT, V22, P165, DOI 10.1016/j.micinf.2020.04.005
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang K.J., INTERFERON GAMMA REL
   Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153
   Kapoor A, 2020, INDIAN HEART J, V72, P192, DOI 10.1016/j.ihj.2020.05.017
   Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888
   Keicho N, 2009, HUM IMMUNOL, V70, P527, DOI 10.1016/j.humimm.2009.05.006
   Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685
   Li H, 2020, J INFECTION, V81, P115, DOI 10.1016/j.jinf.2020.04.001
   Li ZQ, 2020, FRONT MED-PRC, V14, P533, DOI 10.1007/s11684-020-0786-5
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   MacIntyre CR, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3548-0
   Mafham MM, 2020, LANCET, V396, P381, DOI 10.1016/S0140-6736(20)31356-8
   Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007
   Memish ZA, 2020, LANCET, V395, P1063, DOI 10.1016/S0140-6736(19)33221-0
   Pagnesi M, 2020, HEART, V106, P1324, DOI 10.1136/heartjnl-2020-317355
   Porfidia A, 2020, THROMB RES, V196, P67, DOI 10.1016/j.thromres.2020.08.020
   Ramadhany, 2020, SYSTEMATIC REV PHARM, V11, P390, DOI [10.31838/srp.2020.4.58, DOI 10.31838/SRP.2020.4.58]
   Reddy ST, 2020, CASE REP NEUROL, V12, P199, DOI 10.1159/000508958
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003
   Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4
   Troyer EA, 2020, BRAIN BEHAV IMMUN, V87, P34, DOI 10.1016/j.bbi.2020.04.027
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Zangrillo A, 2020, CRIT CARE RESUSC, V22, P200
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 50
TC 0
Z9 0
U1 0
U2 1
PU INT JOURNAL APPLIED EXERCISE PHYSIOLOGY
PI MAZANDARAN
PA C/O ALI REZA AMANI, MANAGING ED, SHOMAL UNIV, PO BOX 731, MAZANDARAN,
   46131-46391, IRAN
SN 2322-3537
J9 INT J APPL EXERC PHY
JI Int. J. Appl. Exerc. Physiol.
PD DEC
PY 2020
VL 9
IS 12
BP 145
EP 154
PG 10
WC Sport Sciences
WE Emerging Sources Citation Index (ESCI)
SC Sport Sciences
GA PH6RT
UT WOS:000600538000018
DA 2022-04-20
ER

PT J
AU Wubishet, BL
   Tesfaye, WH
   Khan, MN
   Thomas, J
   Tuffaha, H
   Comans, TA
   Scuffham, P
   Erku, DA
AF Wubishet, Befikadu L.
   Tesfaye, Wubshet H.
   Khan, Md Nuruzzaman
   Thomas, Jackson
   Tuffaha, Haitham
   Comans, Tracy A.
   Scuffham, Paul
   Erku, Daniel A.
TI Public hesitancy to COVID-19 vaccine and the role of pharmacists in
   addressing the problem and improving uptake
SO JOURNAL OF PHARMACY PRACTICE AND RESEARCH
LA English
DT Article
DE clinical pharmacists; COVID-19; pharmacists; pharmacy practice; vaccine
   hesitancy
AB COVID-19 is one of the worst pandemics in recent human history, causing huge health, economic, and psychosocial damage. Since the pandemic hit, several unsubstantiated claims regarding exposure, transmission and management have been disseminated. Misinformation and associated public confusion now extend to the COVID-19 vaccines, spanning from claims based on possible links between some vaccine types and rare blood clots, to baseless claims. As a result, the public's trust in COVID-19 vaccines has been eroded, fuelling an already troubling trend of vaccine hesitancy. As medication experts and the most accessible healthcare providers, pharmacists are well equipped with the required skills and knowledge to improve COVID-19 vaccine uptake by taking roles that range from dispelling myths, to providing reliable evidence-based information, through to vaccine administration. This paper discusses public hesitancy to COVID-19 vaccines, major contributing factors, and the role pharmacists can play in reducing hesitancy and increasing vaccine uptake.
C1 [Wubishet, Befikadu L.; Comans, Tracy A.] Univ Queensland, Ctr Hlth Serv Res, Brisbane, Qld, Australia.
   [Tesfaye, Wubshet H.] Univ Canberra, Hlth Res Inst, Canberra, ACT, Australia.
   [Khan, Md Nuruzzaman] Jatiya Kabi Kazi Nazrul Islam Univ, Dept Populat Sci, Mymensingh, Bangladesh.
   [Thomas, Jackson] Univ Canberra, Fac Hlth, Pharm, Canberra, ACT, Australia.
   [Tuffaha, Haitham] Univ Queensland, Fac Business Econ & Law, Ctr Business & Econ Hlth, Brisbane, Qld, Australia.
   [Tuffaha, Haitham] Univ Queensland, Fac Hlth & Behav Sci, Sch Pharm, Brisbane, Qld, Australia.
   [Scuffham, Paul; Erku, Daniel A.] Griffith Univ, Ctr Appl Hlth Econ, Nathan, Qld, Australia.
   [Scuffham, Paul; Erku, Daniel A.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia.
RP Wubishet, BL (corresponding author), Univ Queensland, Ctr Hlth Serv Res, Brisbane, Qld, Australia.
EM b.wubishet@uq.edu.au
RI Erku, Daniel/AAC-1508-2020; Scuffham, Paul/B-3066-2014
OI Erku, Daniel/0000-0002-8878-0317; Thomas, Jackson/0000-0002-0699-788X;
   Scuffham, Paul/0000-0001-5931-642X
CR [Anonymous], 2021, SYDNEY MORNING HERAL
   Arrizabalaga, 2021, COVID 19 WHY INFECT
   Australia Government Department of Health, 2021, MOR COMM PHARM ADD G
   Business Insider Australia, 2021, SWED JOINS GERM FRAN
   Centers for Disease Control and Prevention, EXC DEATHS ASS COVID
   Cohen, 2021, JOHNSON JOHNSON SAID
   Dorit Rubinstein Reiss, 2021, COVID 19 VACCINE MIS
   Douglas KM, 2021, GROUP PROCESS INTERG, V24, P270, DOI 10.1177/1368430220982068
   Erku DA, 2021, RES SOC ADMIN PHARM, V17, P1954, DOI 10.1016/j.sapharm.2020.04.032
   Georgiou N, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110201
   Goldman RD, 2020, VACCINE, V38, P7668, DOI 10.1016/j.vaccine.2020.09.084
   Haggan M., 2021, PHARM HAVE BECOME IN
   Institute of Global Health Innovation, 2021, COV 19 GLOB ATT COVI
   International Pharmaceutical Federation, 2020, OV PHARM IMP IMM COV
   Isenor Jennifer E, 2016, J Pharm Policy Pract, V9, P32
   Kennedy, 2021, ASTRAZENECA VACCINE
   Kings College London News Centre, 2021, ON 3 PEOPL EXP COV A
   Lin C, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010016
   MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
   Maidment I, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-050043
   McCabe Sean D, 2021, medRxiv, DOI 10.1101/2021.04.05.21254918
   Melbourne Institute, 2021, VACC HES TRACK
   Rutten LJF, 2021, MAYO CLIN PROC, V96, P699, DOI 10.1016/j.mayocp.2020.12.024
   Scott, 2021, TRUST ASTRAZENECA VA
   Smith, 2021, NEW YOUGOV SURVEY SH
   Sollis K., 2021, MEDRXIV2021202120022, DOI [10.1101/2021.02.17.21251957, DOI 10.1101/2021.02.17.21251957]
   Tak CR, 2020, HUM VACC IMMUNOTHER, V16, P70, DOI 10.1080/21645515.2019.1637218
   Tuong W, 2014, J BEHAV MED, V37, P218, DOI 10.1007/s10865-012-9480-7
   Viswanath K, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10862-1
   Wang KL, 2020, VACCINE, V38, P7049, DOI 10.1016/j.vaccine.2020.09.021
   Ward JK, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113414
   William, 2020, CAN WE TRUST WHO
   Worldometers, 2021, COVID 19 COR PAND
   Yemeke TT, 2021, RES SOC ADMIN PHARM, V17, P300, DOI 10.1016/j.sapharm.2020.03.016
NR 34
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1445-937X
EI 2055-2335
J9 J PHARM PRACT RES
JI J. Pharm. Pract. Res.
PD DEC
PY 2021
VL 51
IS 6
BP 494
EP 500
DI 10.1002/jppr.1784
EA DEC 2021
PG 7
WC Pharmacology & Pharmacy
WE Emerging Sources Citation Index (ESCI)
SC Pharmacology & Pharmacy
GA XQ8DH
UT WOS:000726564100001
OA Bronze
DA 2022-04-20
ER

PT J
AU Ladds, E
   Rushforth, A
   Wieringa, S
   Taylor, S
   Rayner, C
   Husain, L
   Greenhalgh, T
AF Ladds, Emma
   Rushforth, Alex
   Wieringa, Sietse
   Taylor, Sharon
   Rayner, Clare
   Husain, Laiba
   Greenhalgh, Trisha
TI Persistent symptoms after Covid-19: qualitative study of 114 "long
   Covid" patients and draft quality principles for services
SO BMC HEALTH SERVICES RESEARCH
LA English
DT Article
DE Post-acute Covid-19; Chronic Covid-19; Long Covid; Qualitative study;
   Quality standards
ID CHRONIC ILLNESS; HEALTH
AB Background Approximately 10% of patients with Covid-19 experience symptoms beyond 3-4 weeks. Patients call this "long Covid". We sought to document such patients' lived experience, including accessing and receiving healthcare and ideas for improving services. Methods We held 55 individual interviews and 8 focus groups (n = 59) with people recruited from UK-based long Covid patient support groups, social media and snowballing. We restricted some focus groups to health professionals since they had already self-organised into online communities. Participants were invited to tell their stories and comment on others' stories. Data were audiotaped, transcribed, anonymised and coded using NVIVO. Analysis incorporated sociological theories of illness, healing, peer support, clinical relationships, access, and service redesign. Results Of 114 participants aged 27-73 years, 80 were female. Eighty-four were White British, 13 Asian, 8 White Other, 5 Black, and 4 mixed ethnicity. Thirty-two were doctors and 19 other health professionals. Thirty-one had attended hospital, of whom 8 had been admitted. Analysis revealed a confusing illness with many, varied and often relapsing-remitting symptoms and uncertain prognosis; a heavy sense of loss and stigma; difficulty accessing and navigating services; difficulty being taken seriously and achieving a diagnosis; disjointed and siloed care (including inability to access specialist services); variation in standards (e.g. inconsistent criteria for seeing, investigating and referring patients); variable quality of the therapeutic relationship (some participants felt well supported while others felt "fobbed off"); and possible critical events (e.g. deterioration after being unable to access services). Emotionally significant aspects of participants' experiences informed ideas for improving services. Conclusion Suggested quality principles for a long Covid service include ensuring access to care, reducing burden of illness, taking clinical responsibility and providing continuity of care, multi-disciplinary rehabilitation, evidence-based investigation and management, and further development of the knowledge base and clinical services.
C1 [Ladds, Emma; Rushforth, Alex; Wieringa, Sietse; Husain, Laiba; Greenhalgh, Trisha] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.
   [Taylor, Sharon] Cent & North West London NHS Fdn Trust, London, England.
   [Taylor, Sharon] Imperial Coll Sch Med, London, England.
RP Greenhalgh, T (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.
EM trish.greenhalgh@phc.ox.ac.uk
RI Greenhalgh, Trisha/B-1825-2015
OI Greenhalgh, Trisha/0000-0003-2369-8088; ladds, emma/0000-0001-9864-7408
FU UK Research and Innovation Covid-19 emergency fund via ESRC;
   NIHRNational Institute for Health Research (NIHR) [ES/V010069/1];
   Wellcome TrustWellcome TrustEuropean Commission [WT104830MA]; National
   Institute for Health Research Oxford Biomedical Research CentreNational
   Institute for Health Research (NIHR) [BRC-1215-20008]; ESRCUK Research &
   Innovation (UKRI)Economic & Social Research Council (ESRC)
   [ES/V010069/1] Funding Source: UKRI
FX This research is funded from the following sources: UK Research and
   Innovation Covid-19 emergency fund via ESRC and NIHR (ES/V010069/1), and
   Wellcome Trust (WT104830MA). TG's salary is also part funded by the
   National Institute for Health Research Oxford Biomedical Research Centre
   (BRC-1215-20008). Funders had no say in the planning, execution or
   writing up of the paper.
CR Alwan N., 2020, BMJ OPINION
   Alwan N, 2020, WELLCOME OPEN RES, V5
   Alwan NA, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3565
   Alwan NA, 2020, LANCET, V396, pE24, DOI 10.1016/S0140-6736(20)31823-7
   [Anonymous], 2020, COVID SYMPT STUD LON
   Anthony K.E., 2020, HDB APPL COMMUNICATI, P765, DOI [10.1002/9781119399926.ch42, DOI 10.1002/9781119399926.CH42]
   Arnold DT, 2020, PATIENT OUTCOMES HOS, DOI 10.1101/2020.08.12.20173526v1.full.pdf
   Assaf G, 2020, PATIENT LED RES
   Barker-Davies RM, 2020, BRIT J SPORT MED, V54, P949, DOI 10.1136/bjsports-2020-102596
   Bate P., 2007, BRINGING USER EXPERI
   Bate P, 2006, QUAL SAF HEALTH CARE, V15, P307, DOI 10.1136/qshc.2005.016527
   British Society for Immunology British Society for Immunology, 2020, LONG TERM IMM HLTH C
   British thoracic society, 2020, COVID 19 INF RESP CO
   Brown P, 2004, SOCIOL HEALTH ILL, V26, P50, DOI 10.1111/j.1467-9566.2004.00378.x
   Bruner J, 1990, ACTS MEANING
   BURY M, 1991, SOCIOL HEALTH ILL, V13, P451, DOI 10.1111/j.1467-9566.1991.tb00522.x
   Callard Felicity, 2020, SOMATOSPHERE 0508
   Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603
   Chase SE., 2018, SAGE HDB QUALITATIVE
   Dhont S, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01462-5
   Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35
   Frank AW., 2013, WOUNDED STORYTELLER
   Frank AW, 1998, FAMILIES SYSTEMS HLT, V16, P197, DOI DOI 10.1037/H0089849
   Garner P., 2020, BMJ BLOG
   Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029
   General Medical Council, 2020, DUT DOCT
   Glaser B., 1975, CHRONIC ILLNESS QUAL
   GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070
   Goertz YMJ, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00542-2020
   Greenhalgh T, 1999, BRIT MED J, V318, P48
   Greenhalgh T, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3026
   Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368
   Heath I., 1998, ANONYMOUS NARRATIVE, P83
   Jones J, 2018, JMIR MED INF, V6, P22, DOI 10.2196/medinform.9162
   Kamberelis G., 2018, SAGE HDB QUALITATIVE, P692
   Kingod N, 2017, QUAL HEALTH RES, V27, P89, DOI 10.1177/1049732316680203
   Kingstone T, 2020, BJGP OPEN
   Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18
   Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623
   Mackenzie M, 2013, SOC POLICY ADMIN, V47, P806, DOI 10.1111/j.1467-9515.2012.00864.x
   May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281
   Mitrani RD, 2020, HEART RHYTHM, V17, P1984, DOI 10.1016/j.hrthm.2020.06.026
   Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375091, 10.1080/13814788.2017.1375092]
   Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X
   NHS England, 2020, CAR NEEDS INP REC CO
   NHS England, 2020, ADV EST REM TOT TRIA
   NHS England, 2020, NHS OFF LONG COV SUF
   Office of National Statistics, 2020, POP EST ETHN GROUP R
   Pallett SJC, 2020, LANCET RESP MED, V8, P885, DOI 10.1016/S2213-2600(20)30315-5
   Phillips M, 2020, REHABILITATION WAKE
   Puntmann V, 2021, JAMA CARDIOL, V6, P244, DOI 10.1001/jamacardio.2020.5285
   Royal College of Occupational Therapists, 2020, CONS YOUR EN PRACT A
   Scambler G, 2009, SOCIOL HEALTH ILL, V31, P441, DOI 10.1111/j.1467-9566.2009.01161.x
   Schei E, 2006, PERSPECT BIOL MED, V49, P393, DOI 10.1353/pbm.2006.0048
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Tenforde M, 2020, MMWR-MORBID MORTAL W, DOI [10.15585/mmwr.mm6930e1external, DOI 10.15585/MMWR.MM6930E1EXTERNAL]
   Vaes AW, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092946
   Wilkerson RG, 2020, AM J EMERG MED, V38
   World Health Organization, REP WHO CHIN JOINT M
NR 59
TC 65
Z9 65
U1 11
U2 25
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6963
J9 BMC HEALTH SERV RES
JI BMC Health Serv. Res.
PD DEC 20
PY 2020
VL 20
IS 1
AR 1144
DI 10.1186/s12913-020-06001-y
PG 13
WC Health Care Sciences & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA PI6QA
UT WOS:000601212000001
PM 33342437
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Govindan, K
   Mina, H
   Alavi, B
AF Govindan, Kannan
   Mina, Hassan
   Alavi, Behrouz
TI A decision support system for demand management in healthcare supply
   chains considering the epidemic outbreaks: A case study of coronavirus
   disease 2019 (COVID-19)
SO TRANSPORTATION RESEARCH PART E-LOGISTICS AND TRANSPORTATION REVIEW
LA English
DT Article
DE Disaster management; Epidemic outbreaks; Healthcare supply chain
   disruption mitigation; Fuzzy inference system; COVID-19
ID MULTISTAGE STOCHASTIC PROGRAM; LOGISTICS MODEL; NETWORK DESIGN; OR/MS
   RESEARCH; RISK; UNCERTAINTY; OPERATIONS; BLOCKCHAIN; INVESTMENT
AB The disasters caused by epidemic outbreaks is different from other disasters due to two specific features: their long-term disruption and their increasing propagation. Not controlling such disasters brings about severe disruptions in the supply chains and communities and, thereby, irreparable losses will come into play. Coronavirus disease 2019 (COVID-19) is one of these disasters that has caused severe disruptions across the world and in many supply chains, particularly in the healthcare supply chain. Therefore, this paper, for the first time, develops a practical decision support system based on physicians' knowledge and fuzzy inference system (FIS) in order to help with the demand management in the healthcare supply chain, to reduce stress in the community, to break down the COVID-19 propagation chain, and, generally, to mitigate the epidemic outbreaks for healthcare supply chain disruptions. This approach first divides community residents into four groups based on the risk level of their immune system (namely, very sensitive, sensitive, slightly sensitive, and normal) and by two indicators of age and pre-existing diseases (such as diabetes, heart problems, or high blood pressure). Then, these individuals are classified and are required to observe the regulations of their class. Finally, the efficiency of the proposed approach was measured in the real world using the information from four users and the results showed the effectiveness and accuracy of the proposed approach.
C1 [Govindan, Kannan] Shanghai Maritime Univ, China Inst FTZ Supply Chain, Shanghai 201306, Peoples R China.
   [Govindan, Kannan] Univ Southern Denmark, Danish Inst Adv Study, Dept Technol & Innovat, Ctr Sustainable Supply Chain Engn, DK-5230 Odense M, Denmark.
   [Mina, Hassan] Univ Tehran, Sch Ind Engn, Coll Engn, Tehran, Iran.
   [Alavi, Behrouz] Sharif Univ Technol, Dept Ind Engn, Tehran, Iran.
RP Govindan, K (corresponding author), Shanghai Maritime Univ, China Inst FTZ Supply Chain, Shanghai 201306, Peoples R China.
EM kgov@iti.sdu.dk
RI Govindan, Kannan/M-5996-2017
OI Govindan, Kannan/0000-0002-6204-1196
CR Acar M, 2019, TRANSPORT RES E-LOG, V130, P273, DOI 10.1016/j.tre.2019.09.007
   Ahmadi M, 2015, TRANSPORT RES E-LOG, V75, P145, DOI 10.1016/j.tre.2015.01.008
   Altay N, 2006, EUR J OPER RES, V175, P475, DOI 10.1016/j.ejor.2005.05.016
   Amindoust A, 2012, APPL SOFT COMPUT, V12, P1668, DOI 10.1016/j.asoc.2012.01.023
   Araz OM, 2020, DECISION SCI, V51, P1316, DOI 10.1111/deci.12443
   Asklany SA, 2011, ATMOS RES, V101, P228, DOI 10.1016/j.atmosres.2011.02.015
   BSI, 2014, SUPPL CHIN IMP 2014
   Buyuktahtakm IE, 2018, EUR J OPER RES, V265, P1046, DOI 10.1016/j.ejor.2017.08.037
   Calnan M, 2018, INT J HEALTH POLICY, V7, P402, DOI 10.15171/ijhpm.2017.104
   Carter WN, 1992, DISASTER MANAGEMENT
   Chai Y., 2009, INT J COMPUT INTELL, V5, P22, DOI [10.1242/jcs.02735, DOI 10.1242/JCS.02735]
   Choi TM, 2020, TRANSPORT RES E-LOG, V140, DOI 10.1016/j.tre.2020.101961
   Choi TM, 2020, EUR J OPER RES, V284, P1031, DOI 10.1016/j.ejor.2020.01.049
   Choi TM, 2020, INT J PROD ECON, V221, DOI 10.1016/j.ijpe.2019.08.008
   Choi TM, 2019, TRANSPORT RES E-LOG, V128, P17, DOI 10.1016/j.tre.2019.05.011
   Choi TM, 2019, TRANSPORT RES E-LOG, V127, P178, DOI 10.1016/j.tre.2019.05.007
   Chou Ji, 2004, ASIAN ECON PAP, V3, P84, DOI DOI 10.1162/1535351041747969
   Chung CJ, 2019, J ENVIRON MANAGE, V246, P808, DOI 10.1016/j.jenvman.2019.06.038
   Fattahi M, 2018, TRANSPORT RES E-LOG, V118, P534, DOI 10.1016/j.tre.2018.08.008
   Fattahi M, 2018, COMPUT OPER RES, V100, P314, DOI 10.1016/j.cor.2017.12.016
   Galindo G, 2013, EUR J OPER RES, V230, P201, DOI 10.1016/j.ejor.2013.01.039
   Goldschmidt KH, 2016, INT J DISAST RISK RE, V20, P1, DOI 10.1016/j.ijdrr.2016.10.001
   Govindan K, 2018, TRANSPORT RES E-LOG, V114, P343, DOI 10.1016/j.tre.2018.03.011
   Govindan K, 2017, EUR J OPER RES, V263, P108, DOI 10.1016/j.ejor.2017.04.009
   Hamdan B, 2020, TRANSPORT RES E-LOG, V134, DOI 10.1016/j.tre.2019.08.005
   He YX, 2015, TRANSPORT RES E-LOG, V79, P178, DOI 10.1016/j.tre.2015.04.007
   Hossain MN, 2018, EARTH SYST ENVIRON, V2, P55, DOI 10.1007/s41748-018-0034-1
   Hosseini-Motlagh SM, 2019, INFORM SCIENCES, V503, P606, DOI 10.1016/j.ins.2019.07.021
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ilbahar E, 2018, SAFETY SCI, V103, P124, DOI 10.1016/j.ssci.2017.10.025
   Ivanov D, 2020, INT J PROD RES, V58, P3252, DOI 10.1080/00207543.2019.1634850
   Jain N, 2020, INT J SUSTAIN ENG, V13, P441, DOI 10.1080/19397038.2020.1737751
   Jain N, 2020, J CLEAN PROD, V248, DOI 10.1016/j.jclepro.2019.119275
   Johanis D., 2007, J BUSINESS CONTINUIT, V1, P356
   Kaur H, 2019, ANN OPER RES, V283, P309, DOI 10.1007/s10479-016-2374-2
   Khajeh A, 2010, EXPERT SYST APPL, V37, P3070, DOI 10.1016/j.eswa.2009.09.023
   Kilci F, 2015, EUR J OPER RES, V243, P323, DOI 10.1016/j.ejor.2014.11.035
   Koh L, 2020, INT J PROD RES, V58, P2054, DOI 10.1080/00207543.2020.1736428
   Lin KP, 2012, COMPUT IND ENG, V62, P1034, DOI 10.1016/j.cie.2011.12.031
   Loree N, 2018, TRANSPORT RES E-LOG, V116, P1, DOI 10.1016/j.tre.2018.05.003
   Mamdani Ebrahim H., 1993, INT J MAN MACH STUD, P283
   Nazari S, 2018, EXPERT SYST APPL, V95, P261, DOI 10.1016/j.eswa.2017.11.001
   Oruc BE, 2018, TRANSPORT RES B-METH, V116, P76, DOI 10.1016/j.trb.2018.08.002
   Pourjavad E, 2019, J INTELL MANUF, V30, P1085, DOI 10.1007/s10845-017-1307-5
   PrasannaVenkatesan S, 2016, TRANSPORT RES E-LOG, V95, P124, DOI 10.1016/j.tre.2016.09.005
   Rezaei-Malek M, 2016, TRANSPORT RES E-LOG, V93, P485, DOI 10.1016/j.tre.2016.07.003
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   Sarma D, 2019, COMPUT IND, V109, P226, DOI 10.1016/j.compind.2019.04.004
   Shahparvari S, 2016, TRANSPORT RES E-LOG, V93, P148, DOI 10.1016/j.tre.2016.05.010
   Shen B, 2019, TECHNOL FORECAST SOC, V144, P412, DOI 10.1016/j.techfore.2017.09.003
   Sheu JB, 2016, TRANSPORT RES E-LOG, V90, P134, DOI 10.1016/j.tre.2015.09.013
   Sugeno M., 1985, IND APPL FUZZY CONTR
   Tavana M, 2019, EVAL PROGRAM PLANN, V77, DOI 10.1016/j.evalprogplan.2019.101703
   Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5
   Tomasini R, 2009, HUMANITARIAN LOGISTI
   United Nations, 2020, WHAT IS COR DIS COVI
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   Wang Y, 2019, TRANSPORT RES E-LOG, V130, P82, DOI 10.1016/j.tre.2019.08.016
   WHO (World Health Organization), 2020, COR DIS COVID 19 OUT
   Yan YZ, 2017, TRANSPORT RES E-LOG, V105, P39, DOI 10.1016/j.tre.2017.07.001
   Zhao TY, 2020, TRANSPORT RES E-LOG, V134, DOI 10.1016/j.tre.2020.101838
NR 61
TC 149
Z9 150
U1 73
U2 202
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1366-5545
EI 1878-5794
J9 TRANSPORT RES E-LOG
JI Transp. Res. Pt. e-Logist. Transp. Rev.
PD JUN
PY 2020
VL 138
AR 101967
DI 10.1016/j.tre.2020.101967
PG 14
WC Economics; Engineering, Civil; Operations Research & Management Science;
   Transportation; Transportation Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Business & Economics; Engineering; Operations Research & Management
   Science; Transportation
GA LT3EM
UT WOS:000536953900003
PM 32382249
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Li, HD
   Dong, SJ
   He, L
   Wang, R
   Long, SY
   He, FM
   Tang, HR
   Feng, L
AF Li, Hongdan
   Dong, Shuju
   He, Li
   Wang, Rui
   Long, Shiyan
   He, Fengming
   Tang, Huairong
   Feng, Ling
TI Nurses' core emergency competencies for COVID-19 in China: A
   cross-sectional study
SO INTERNATIONAL NURSING REVIEW
LA English
DT Article
DE China; COVID-19; emergency competencies; health emergency; health
   policy; nurses
ID PUBLIC-HEALTH; INFECTIOUS-DISEASES; CAPACITY; RISK
AB Aim: To investigate nurses' core emergency competencies for handling the coronavirus disease-19 (COVID-19) and analyse the factors associated with those competencies.
   Background: COVID-19 has become a major global public health event. Nursing staff have played an important role in COVID-19 prevention and control. Understanding their emergency competencies for handling COVID-19, and the potential disadvantages will help governments to develop targeted training policies and improve nurses' capacities in relation to pandemics and emergency preparedness.
   Introduction: COVID-19 is a disastrous infectious disease, but the competencies of nurses in China to handle COVID-19 have not been well documented.
   Methods: We conducted a cross-sectional survey on nurses from 22 provinces of China in February 2020. The scores of self-report questionnaires were used to analyse their competencies for core emergency care, and linear regression analysis was used to explore influential factors.
   Results: A total of 2570 nurses participated. The study revealed that nurses had a good grasp of COVID-19 knowledge, but the majority of nurses lacked experience in isolation ward work and emergency training. We found that age, professional title, work department, major work content, total work time, disaster rescue history, emergency training and infectious disease training were associated with core emergency competencies.
   Conclusions: Chinese nurses were qualified for handling COVID-19 but still need to strengthen the accumulation of practical experience.
   Implications for nursing: Nurses should actively participate in emergencies to strengthen their operational capacity, whether in training or actual practice.
   Implications for nursing/health policy: Managers should improve relevant policies to ensure that nurses have more opportunities to participate in the practical training of health emergencies and explore effective training methods to improve the ability of nurses to respond to these.
C1 [Li, Hongdan; Dong, Shuju; He, Li; Wang, Rui; Long, Shiyan; He, Fengming; Feng, Ling] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Peoples R China.
   [Li, Hongdan; Wang, Rui; Long, Shiyan; He, Fengming; Feng, Ling] Sichuan Univ, West China Sch Nursing, Chengdu, Peoples R China.
   [Tang, Huairong] Sichuan Univ, Dept Hlth Management Ctr, West China Hosp, Chengdu, Peoples R China.
RP Feng, L (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Peoples R China.; Tang, HR (corresponding author), Sichuan Univ, Dept Hlth Management Ctr, West China Hosp, Chengdu, Peoples R China.
EM hx_tanghuairong@163.com; fengling216@163.com
FU National Key R&D Program of China [2017YFC0907504, 2018YFC1311400,
   2018YFC1311401]; Sichuan Science andTechnologyDepartment Project ofChina
   [2020YFS0155]
FX National Key R&D Program of China, Grant/Award Numbers: 2017YFC0907504,
   2018YFC1311400, 2018YFC1311401; Sichuan Science andTechnologyDepartment
   Project ofChina, Grant/Award Number: 2020YFS0155
CR Al Thobaity A, 2016, AUSTRALAS EMERG NURS, V19, P11, DOI 10.1016/j.aenj.2015.12.001
   Al Thobaity A, 2017, INT EMERG NURS, V31, P64, DOI 10.1016/j.ienj.2016.10.003
   Ambat Aishwarya S, 2020, Med J Armed Forces India, DOI 10.1016/j.mjafi.2020.02.007
   Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552
   Catton H, 2020, INT NURS REV, V67, P157, DOI 10.1111/inr.12593
   CNA-Canadian Nurses Association, 2008, ADV NURSING PRACTICE
   Fusco FM, 2020, J HOSP INFECT, V105, P596, DOI 10.1016/j.jhin.2020.06.021
   Gridley-Smith CL, 2017, J PUBLIC HEALTH MAN, V23, P515, DOI 10.1097/PHH.0000000000000646
   Hilts AS, 2016, DISASTER MED PUBLIC, V10, P443, DOI 10.1017/dmp.2016.69
   Horrocks P, 2019, PREHOSP DISASTER MED, V34, P322, DOI 10.1017/S1049023X19004357
   Huang LH, 2020, INT NURS REV, V67, P318, DOI 10.1111/inr.12609
   Johns Hopkins University,, 2020, COVID 19 DASHB CTR S
   Kaba A, 2017, AM J INFECT CONTROL, V45, P200, DOI 10.1016/j.ajic.2016.06.036
   [阚庭 Kan Ting], 2018, [中华护理杂志, Chinese Journal of Nursing], V53, P461
   Kim Dong-Hyun, 2015, J Prev Med Public Health, V48, P265, DOI 10.3961/jpmph.15.066
   Labrague LJ, 2018, INT NURS REV, V65, P41, DOI 10.1111/inr.12369
   Liao KL, 2019, INT J NURS STUD, V91, P70, DOI 10.1016/j.ijnurstu.2018.11.012
   [刘玲玉 Liu Lingyu], 2019, [护理学杂志, Journal of Nursing Science], V34, P75
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7
   Luo Y, 2013, IRAN J PUBLIC HEALTH, V42, P941
   Musau J, 2015, INT NURS REV, V62, P404, DOI 10.1111/inr.12188
   Okeahalam C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042750
   Rosa WE, 2020, INT NURS REV, V67, P160, DOI 10.1111/inr.12592
   Said NB, 2020, INT EMERG NURS, V48, DOI 10.1016/j.ienj.2019.100806
   Sun M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5284-1
   Taskiran G, 2019, INT NURS REV, V66, P165, DOI 10.1111/inr.12501
   Turale S, 2020, INT NURS REV, V67, P164, DOI 10.1111/inr.12598
   Uhm D, 2019, ASIAN NURS RES, V13, P264, DOI 10.1016/j.anr.2019.09.005
   Ulrich CM, 2020, NURS OUTLOOK, V68, P838, DOI 10.1016/j.outlook.2020.08.018
   Veenema TG, 2019, CONFL HEALTH, V13, DOI 10.1186/s13031-019-0197-x
   Wang L, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0486-6
   Wang YL, 2019, EMERG INFECT DIS, V25, P33, DOI 10.3201/eid2501.180178
   Wei PF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5717108
   World Health Organization, 2020, WHO COR DIS COVID 19
   World Health Organization, 2020, STAT WORLDS NURS 202
   Xiao Feng, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P312
   Yang SG, 2017, LANCET INFECT DIS, V17, P716, DOI 10.1016/S1473-3099(17)30227-X
   Yang YS, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102434
   Zhang YY, 2018, J NURS SCHOLARSHIP, V50, P567, DOI 10.1111/jnu.12401
   Zhou ZH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-338
NR 40
TC 1
Z9 1
U1 14
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-8132
EI 1466-7657
J9 INT NURS REV
JI Int. Nurs. Rev.
PD DEC
PY 2021
VL 68
IS 4
BP 524
EP 532
DI 10.1111/inr.12692
EA MAY 2021
PG 9
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA XC9GD
UT WOS:000655189300001
PM 34043839
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Mavri, M
   Mennis, V
AF Mavri, Maria
   Mennis, Vangelis
TI Is COVID-19 the "Catalyst" to Incorporate 3D Printing Technology into
   the Manufacturing Industry?
SO 3D PRINTING AND ADDITIVE MANUFACTURING
LA English
DT Article; Early Access
DE 3D printing; COVID-19; Cloud Factory
ID IMPACT
AB The contribution of the fight against COVID-19 to the incorporation of 3D printing technology into the manufacturing industry is the research question of this study. By observing the structure of initiatives of hobbyists and enterprises in the 3D printing industry that are printing health care equipment for nursing staff, we conclude that 3D printing technology could be used for mass production under a different production model. We propose two different typologies of a factory's structure, calling them "Adjust-Semi Cloud Factory 1" and "Semi-Cloud Factory 2." To measure the effectiveness of these new types of factories, we propose a framework based on characteristics and aspects of knowledge management.
C1 [Mavri, Maria; Mennis, Vangelis] Univ Aegean, Dept Business Adm, Quantitat Methods Lab, 8 Michalon St, Chios 82100, Greece.
RP Mavri, M (corresponding author), Univ Aegean, Dept Business Adm, Quantitat Methods Lab, 8 Michalon St, Chios 82100, Greece.
EM m.mavri@ba.aegean.gr
CR Arbabian ME, 2020, EUR J OPER RES, V285, P538, DOI 10.1016/j.ejor.2020.01.063
   Aydin A, 2021, EMERGENT MATER, V4, P363, DOI 10.1007/s42247-021-00164-y
   Barnatt C., 2013, NEXT IND REVOLUTION
   BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108
   Ben-Ner A, 2017, CALIF MANAGE REV, V59, P5, DOI 10.1177/0008125617695284
   Berman B, 2012, BUS HORIZONS, V55, P155, DOI 10.1016/j.bushor.2011.11.003
   Carl CF, 2003, ORGAN SCI, V14, P686, DOI 10.1287/orsc.14.6.686.24868
   Chan HK, 2018, INT J PROD ECON, V205, P156, DOI 10.1016/j.ijpe.2018.09.009
   Chergui A, 2018, COMPUT IND ENG, V126, P292, DOI 10.1016/j.cie.2018.09.048
   Chua CK, 2017, STANDARDS, QUALITY CONTROL, AND MEASUREMENT SCIENCES IN 3D PRINTING AND ADDITIVE MANUFACTURING, P31, DOI 10.1016/B978-0-12-813489-4.00002-7
   Daoulas T., 2021, ANN 3D PRINT MED, V1, DOI [10.1016/j.stlm.2020.100001, DOI 10.1016/J.STLM.2020.100001]
   Davenport T., 1998, WORKING KNOWLEDGE OR
   de Kok Saswitha, 2016, TURNING ADDITIVE MAN
   Eddy D., 2015, KNOWLEDGE MANAGEMENT, DOI [10.1115/DETC2015-46615, DOI 10.1115/DETC2015-46615]
   Fiday I., 2018, WOHLERS ASSOCIATESRE
   Francois PM, 2021, J STOMATOL ORAL MAXI, V122, P381, DOI 10.1016/j.jormas.2020.06.010
   Godina R., P 20 EUR C KNOWL MAN, P41
   Gold AH, 2001, J MANAGE INFORM SYST, V18, P185, DOI 10.1080/07421222.2001.11045669
   Grunewald SJ., 2014, CHILDREN ADULTS TURN
   Javaid M, 2020, CLIN EPIDEMIOL GLOB, V8, P862, DOI 10.1016/j.cegh.2020.02.014
   Javaid M, 2020, DIABETES METAB SYND, V14, P419, DOI 10.1016/j.dsx.2020.04.032
   Lu Y., P ASME 2018 INT DES
   Martin-Noguerol T, 2021, AM J EMERG MED, V46, P659, DOI 10.1016/j.ajem.2020.08.010
   Mavri M, 2021, INT J TECHNOL ENHANC, V13, P370, DOI 10.1504/IJTEL.2021.118002
   Mavri M, 2015, KNOWL PROCESS MANAG, V22, P141, DOI 10.1002/kpm.1466
   Molitch-Hou M., 2014, TEVIDO EXTENDS BREAS
   Pahl G., 2007, ENG DESIGN SYSTEMATI
   Powell J., 2015, CHANDOS INFORM PROFE, P31
   Rayna T, 2016, TECHNOL FORECAST SOC, V102, P214, DOI 10.1016/j.techfore.2015.07.023
   Sedova M, 2020, BIOINFORMATICS, V36, P4360, DOI 10.1093/bioinformatics/btaa550
   Shree MV, 2020, MATER TODAY-PROC, V21, P958, DOI 10.1016/j.matpr.2019.09.060
   Tareq MS, 2021, J MANUF SYST, V60, P787, DOI 10.1016/j.jmsy.2020.12.021
   Wang YB, 2018, J MECH DESIGN, V140, DOI 10.1115/1.4039201
   Zheng W, 2010, J BUS RES, V63, P763, DOI 10.1016/j.jbusres.2009.06.005
NR 34
TC 0
Z9 0
U1 3
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2329-7662
EI 2329-7670
J9 3D PRINT ADDIT MANUF
JI 3D Print. Addit. Manuf.
DI 10.1089/3dp.2021.0050
EA DEC 2021
PG 10
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Materials Science
GA YB0YB
UT WOS:000738747400001
DA 2022-04-20
ER

PT J
AU Thanh, PT
   Tung, LT
AF Pham Tien Thanh
   Le Thanh Tung
TI Do government activities increase public compliance in the Covid-19
   pandemic? Evidence from Vietnam
SO GLOBAL KNOWLEDGE MEMORY AND COMMUNICATION
LA English
DT Article; Early Access
DE Government communication; Government effort; Public trust; Public
   compliance; Covid-19
ID MENTAL-HEALTH; TRUST; CRISIS; COMMUNICATION; MANAGEMENT; DETERMINANTS;
   PERCEPTIONS; PERFORMANCE; BEHAVIORS; INSIGHTS
AB Purpose - During the COVID-19 pandemic, it has raised an important question of whether government efforts (GEFs), especially communication work, could prevent the outbreak of this pandemic by enhancing public trust and public compliance with the government. This research answers this question by focusing on the case of Vietnam, a low-resource country that gained some achievements during the first pandemic year 2020. In particular, this study aims to investigate the relationship between GEF, public trust and public compliance during the country's first nationwide social distancing.
   Design/methodology/approach - The structural equation modelling is used to analyse data collected from 467 respondents in Vietnam during the nationwide social distancing in 2020.
   Findings - Perceived GEF is positively associated with public compliance with the government directly and indirectly through the mediating role of public trust in government (PTG). The empirical results also reveal the effectiveness of government communication work, one among the government's great efforts, during the COVID-19 pandemic, in terms of intensity and diversity in communication and information channels.
   Practical implications - During a pandemic, the governments must enhance public compliance with public health measures to implement the anti-epidemic missions effectively. Therefore, it is important to raise public perception of GEF and PTG. The study's findings highlight that governments in developing countries should implement relevant responses and policies for the ongoing COVID-19 pandemic and future public health crises, especially in the context that effective vaccines are unavailable or insufficient.
   Originality/value - To the best of the authors' knowledge, this research is among the first attempts that examine the role of GEF, especially public health communication work, in raising public compliance directly and indirectly through the mediating role of public trust. The study carries some important messages for containing a public health crisis like the COVID-19 pandemic.
C1 [Pham Tien Thanh] Ton Duc Thang Univ, Fac Business Adm, Ho Chi Minh City, Vietnam.
   [Le Thanh Tung] Ho Chi Minh City Open Univ, Fac Econ & Publ Management, Ho Chi Minh City, Vietnam.
RP Tung, LT (corresponding author), Ho Chi Minh City Open Univ, Fac Econ & Publ Management, Ho Chi Minh City, Vietnam.
EM phamtienthanh@tdtu.edu.vn; tung.lt@ou.edu.vn
FU Ho Chi Minh City Open University [E2021.09.1]
FX This research is funded by Ho Chi Minh City Open University under grant
   number E2021.09.1.
CR Al-Hasan A, 2020, J MED INTERNET RES, V22, DOI 10.2196/20634
   Ali MY, 2020, ASIA-PAC J PUBLIC HE, V32, P168, DOI 10.1177/1010539520927261
   Ashraf Javid Muhammad, 2021, Transp Res Interdiscip Perspect, V12, P100474, DOI 10.1016/j.trip.2021.100474
   Asl EM, 2021, J EDUC HEALTH PROMOT, V10, DOI 10.4103/jehp.jehp_1580_20
   Bjornskov C, 2007, PUBLIC CHOICE, V130, P1, DOI 10.1007/s11127-006-9069-1
   Boin A, 2015, GEOGR ANN A, V97, P123, DOI 10.1111/geoa.12072
   Bou-Hamad I, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254989
   Briand S, 2020, J COMMUNICATION HEAL, V13, P6
   Britton N.R., 1999, INT J MASS EMERGENCI, V17, P223
   Chan EYY, 2013, NAT GEOSCI, V6, P327, DOI 10.1038/ngeo1815
   Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003
   Dae-Woong Lee，, 2019, International Review of Public Administration, V24, P42, DOI 10.1080/12294659.2019.1645927
   Duong DM, 2020, ASIA-PAC J PUBLIC HE, V32, P161, DOI 10.1177/1010539520927290
   Eriksson K, 2011, POLICY SOC, V30, P89, DOI 10.1016/j.polsoc.2011.03.004
   Eyrich N, 2008, PUBLIC RELAT REV, V34, P412, DOI 10.1016/j.pubrev.2008.09.010
   Cruz MF, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.565503
   Fleming S., 2020, WORLD EC FORUM
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Freberg K, 2013, PUBLIC RELAT REV, V39, P178, DOI 10.1016/j.pubrev.2013.02.007
   Gesser-Edelsburg A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19370
   Gittell RJ, 1996, REG STUD, V30, P477, DOI 10.1080/00343409612331349798
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   Goodwin R, 2011, INT J BEHAV MED, V18, P88, DOI 10.1007/s12529-010-9083-z
   Gozgor G, 2022, APPL RES QUAL LIFE, V17, P559, DOI 10.1007/s11482-020-09902-6
   Guidry JPD, 2017, PUBLIC RELAT REV, V43, P477, DOI 10.1016/j.pubrev.2017.04.009
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Hartley K, 2020, POLICY SOC, V39, P403, DOI 10.1080/14494035.2020.1783791
   Hatcher Abigail M, 2022, Soc Sci Med, V295, P112637, DOI 10.1016/j.socscimed.2019.112637
   Helm L.M., 1981, INFORMING PEOPLE PUB
   Henderson J, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00369
   Hilyard KM, 2010, HEALTH AFFAIR, V29, P2294, DOI 10.1377/hlthaff.2010.0474
   Im T, 2014, J PUBL ADM RES THEOR, V24, P741, DOI 10.1093/jopart/mus037
   Islam Md Saiful, 2020, Addict Behav Rep, V12, P100311, DOI 10.1016/j.abrep.2020.100311
   Jegede A, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.supp.2020.35.23121
   Jimenez P, 2016, ADV ACCOUNT, V34, P17, DOI 10.1016/j.adiac.2016.07.001
   Jin M, 2013, INT J PUBLIC ADMIN, V36, P397, DOI 10.1080/01900692.2013.773038
   Kettl DF, 2018, J PUBLIC AFF EDUC, V24, P295, DOI 10.1080/15236803.2018.1426923
   Khan AH, 2020, J AFFECT DISORDERS, V277, P121, DOI 10.1016/j.jad.2020.07.135
   Lau JTF, 2011, EPIDEMIOL INFECT, V139, P80, DOI 10.1017/S0950268810001925
   Tung LT, 2020, DATA BRIEF, V33, DOI 10.1016/j.dib.2020.106348
   Lee DW, 2019, LOCAL GOV STUD, V45, P803, DOI 10.1080/03003930.2019.1653284
   Lee DW, 2019, INT REV ADM SCI, V85, P337, DOI 10.1177/0020852317702445
   Lee K, 2009, PUBLIC RELAT REV, V35, P74, DOI 10.1016/j.pubrev.2008.06.003
   Lieberoth A, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.200589
   Liu J, 2022, BRIT J MANAGE, V33, P571, DOI 10.1111/1467-8551.12577
   Miller DS, 2016, INT J SOCIOL SOC POL, V36, P410, DOI 10.1108/IJSSP-02-2015-0030
   Ministry of Health of Vietnam, INF PAG COR DIS COVI
   Mirzaei A, 2021, J EDUC HEALTH PROMOT, V10, DOI 10.4103/jehp.jehp_747_20
   Mizrahi S., 2017, PUBLIC POLICY PERFOR, DOI [10.1007/978-3-319-52350-7, DOI 10.1007/978-3-319-52350-7]
   Mizrahi S, 2021, PUBLIC ADMIN REV, V81, P1120, DOI 10.1111/puar.13370
   Morgeson FV, 2011, INT REV ADM SCI, V77, P451, DOI 10.1177/0020852311407278
   Mou Y, 2017, ASIAN J COMMUN, V27, P563, DOI 10.1080/01292986.2017.1371198
   Moynihan DP, 2008, PUBLIC ADMIN REV, V68, P350, DOI 10.1111/j.1540-6210.2007.00867.x
   NEAL DM, 1995, DISASTERS, V19, P327, DOI 10.1111/j.1467-7717.1995.tb00353.x
   Olapegba PO, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105685
   Oliver-Smith Anthony, 1999, ANGRY EARTH DISASTER
   Orfali K, 2021, HASTINGS CENT REP, V51, P16, DOI 10.1002/hast.1206
   Paek HJ, 2008, HEALTH PROMOT PRACT, V9, p60S, DOI 10.1177/1524839908322114
   Park S, 2019, PUBLIC RELAT REV, V45, DOI 10.1016/j.pubrev.2019.05.015
   Pierce M, 2020, LANCET PSYCHIAT, V7, P567, DOI 10.1016/S2215-0366(20)30237-6
   Porumbescu GA, 2016, PUBLIC MANAG REV, V18, P1504, DOI 10.1080/14719037.2015.1122827
   Prati G, 2011, HEALTH EDUC RES, V26, P761, DOI 10.1093/her/cyr035
   Reed J., 2020, FINANC TIMES
   Rockers PC, 2012, J HEALTH POLIT POLIC, V37, P405, DOI 10.1215/03616878-1573076
   Rosenthal U., 1989, COPING CRISIS MANAGE
   Rosenthal U., 1997, J PUBL ADM RES THEOR, V2, P277, DOI DOI 10.1093/oxfordjournals.jpart.a024349
   Saechang O, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9020151
   Salter J., 1997, J CONTING CRISIS MAN, V5, P60, DOI [10.1111/1468-5973.00037, DOI 10.1111/1468-5973.00037]
   Shanka MS, 2022, J BUS RES, V139, P1275, DOI 10.1016/j.jbusres.2021.10.036
   Teasdale E, 2011, PATIENT EDUC COUNS, V85, P413, DOI 10.1016/j.pec.2010.12.026
   Tirkkonen P, 2011, PUBLIC RELAT REV, V37, P172, DOI 10.1016/j.pubrev.2011.01.004
   United Nations, 2020, TRANSCR SECR GEN VIR
   Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2458-11-575, 10.1186/1471-2334-11-37]
   Vogel B, 2020, ENVIRON DEV SUSTAIN, V22, P1633, DOI 10.1007/s10668-018-0242-8
   Wang G, 2020, COMPUT HUM BEHAV, V108, DOI 10.1016/j.chb.2020.106335
   Wang J, 2017, PUBLIC PERFORM MANAG, V40, P701, DOI 10.1080/15309576.2017.1335219
   Woong LD, 2019, INT J DISAST RISK RE, V35, DOI 10.1016/j.ijdrr.2019.101116
   World Health Organization, 2020, WHO DIRECTOR GENERAL
   World Health Organization (WHO), 2020, RISK COMM COMM ENG R
   Wu ZZ, 2017, WASTE MANAGE, V60, P290, DOI 10.1016/j.wasman.2016.09.001
   Zhang LW, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010064
   Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271
NR 82
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2514-9342
EI 2514-9350
J9 GLOB KNOWL MEM COMMU
JI Glob. Knowl. Mem. Commun.
DI 10.1108/GKMC-08-2021-0137
EA MAR 2022
PG 19
WC Information Science & Library Science
WE Emerging Sources Citation Index (ESCI)
SC Information Science & Library Science
GA ZW7OZ
UT WOS:000771399400001
OA Bronze
DA 2022-04-20
ER

PT J
AU Appel, SJ
   Wadas, TM
   Andrabi, MS
AF Appel, Susan J.
   Wadas, Theresa M.
   Andrabi, Mudasir S.
TI Management of Diabetes During a Dual Pandemic
SO JNP-JOURNAL FOR NURSE PRACTITIONERS
LA English
DT Article
DE continuous glucose monitoring; coronavirus disease 2019 (COVID-19);
   COVID-19; diabetes; insulin therapy; new-onset diabetes mellitus
ID SARS CORONAVIRUS; COVID-19; PEOPLE; CONSEQUENCES; INHIBITORS; RECEPTOR
AB The dual pandemics of coronavirus disease-19 (COVID-19) and diabetes among patients are associated with 2-to 3-times higher intensive care admissions and higher mortality rates. Whether sheltering at home, quarantined with a positive COVID-19 test, or hospitalized, the person living with diabetes needs special considerations for successful management. Having diabetes and being COVID-19-positive increases the risk of poor outcomes and death. Providers need to give anticipatory pharmacologic guidance to patients with diabetes during COVID-19 lockdown. Patients with diabetes need to be more observant than others and to use self-protective actions. This review (1) discusses the clinical observations of COVID-19, diabetes and underlying mechanisms, (2) describes special considerations in caring for patients with diabetes in a COVID-19 environment, and (3) reviews clinical implications for the health care provider. This review highlights current evidenced-based knowledge. Additional research regarding clinical management is warranted
   (c) 2021 Elsevier Inc. All rights reserved.
C1 [Appel, Susan J.; Wadas, Theresa M.; Andrabi, Mudasir S.] Univ Alabama, Capstone Coll Nursing, Tuscaloosa, AL 35401 USA.
RP Appel, SJ (corresponding author), Univ Alabama, Capstone Coll Nursing, Tuscaloosa, AL 35401 USA.
EM sjappel@ua.edu
CR Abdi A, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108347
   Agarwal S, 2021, J CLIN ENDOCR METAB, V106, pE377, DOI 10.1210/clinem/dgaa704
   Akinlade KS, 2018, J NATL MED ASSOC, V110, P504, DOI 10.1016/j.jnma.2018.01.003
   American Hospital Association, 2020, COVID 19 CHECKL DISC
   Apicella M, 2020, LANCET DIABETES ENDO, V8, P782, DOI 10.1016/S2213-8587(20)30238-2
   Bellido V, 2020, ENDOCRINOL DIAB NUTR, V67, P355, DOI 10.1016/j.endinu.2020.04.001
   Cai QX, 2020, DIABETES CARE, V43, P1392, DOI 10.2337/dc20-0576
   CARLOU B, 2020, DIABETOLOGIA, V63, P1500, DOI DOI 10.1007/S00125-020-05180-X
   Centers for Disease Control and Prevention, 2020, LIV DIAB MAN SICK DA
   Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023
   Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2
   Cooper M, 2020, EAT DISORD, DOI 10.1080/10640266.2020.1790271
   de Simone G., 2020, EUROPEAN SOC CARDIOL
   Disser NP, 2020, J BONE JOINT SURG AM, V102, P1197, DOI 10.2106/JBJS.20.00847
   Fadini GP, 2020, J ENDOCRINOL INVEST, V43, P867, DOI 10.1007/s40618-020-01236-2
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Gao F, 2020, DIABETES CARE, V43, pE72, DOI 10.2337/dc20-0682
   Gullestad L, 1999, J AM COLL CARDIOL, V34, P2061, DOI 10.1016/S0735-1097(99)00495-7
   Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319
   Hamdy O, 2020, DIABETES CARE, V43, pE81, DOI 10.2337/dc20-0944
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Henry Christopher, 2018, Proc (Bayl Univ Med Cent), V31, P419, DOI 10.1080/08998280.2018.1499293
   Hillson R, 2020, PRACT DIABETES, V37, P101, DOI 10.1002/pdi.2278
   Hu FB, 2015, JAMA-J AM MED ASSOC, V313, P2319, DOI 10.1001/jama.2015.5287
   Iacobellis G, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108125
   International Diabetes Federation, 2019, IDF DIABETES ATLAS, P78
   International Diabetes Federation, 2019, IDF DIABETES ATLAS, P40
   Joensen LE, 2020, DIABETIC MED, V37, P1146, DOI 10.1111/dme.14319
   John Hopkins University & Medicine . Coronavirus Resource Center, COVID 19 DASHB CTR S
   Jones MS, 2020, DIABETES TECHNOL THE, V22, P444, DOI 10.1089/dia.2020.0206
   Knapp S, 2013, GERONTOLOGY, V59, P99, DOI 10.1159/000345107
   Korytkowski M, 2020, J CLIN ENDOCR METAB, V105, P3076, DOI 10.1210/clinem/dgaa342
   Kulcsar KA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131774
   MAAHS DM, 2015, DIABETES CARE, V38, pE15, DOI DOI 10.2337/DC15-1096
   Maugeri G, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04315
   Meyer EJ, 2018, DIABETES CARE, V41, pE47, DOI 10.2337/dc17-1721
   Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006
   National Health Service (NHS) London Clinical Network, OUTP APP PRIOR SPEC
   Petrie JR, 2018, CAN J CARDIOL, V34, P575, DOI 10.1016/j.cjca.2017.12.005
   Potus F, 2020, AM J PHYSIOL-LUNG C, V319, pL277, DOI 10.1152/ajplung.00195.2020
   Rubino F, 2020, NEW ENGL J MED, V383, P789, DOI [10.1056/NEJMc2021832, 10.1056/NEJMc2018688]
   Sardu C, 2020, DIABETES CARE, V43, P1408, DOI 10.2337/dc20-0723
   Shin YH, 2017, HEART VESSELS, V32, P618, DOI 10.1007/s00380-016-0936-5
   Silva-Tinoco R., RESEARCHGATE, DOI [10.24875/RME.20000063, DOI 10.24875/RME.20000063]
   Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2
   Tadic M, 2020, J CLIN HYPERTENS, V22, P943, DOI 10.1111/jch.13912
   The American Journal of Managed Care, TIM COVID 19 DEV 202
   Toniolo A, 2019, REV MED MICROBIOL, V30, P1, DOI 10.1097/MRM.0000000000000155
   U.S. Food and Drug Administration, 2020, FAQS TEST SARS COV 2
   U.S. Food and Drug Administration, 2020, ENF POL NON REM MON
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   Vijayakumar P., 2020, SALIVA IS MORE SENSI, DOI [10.1101/2020.04.16.20067835, DOI 10.1101/2020.04.16.20067835]
   (WHO) WHO, ROLL UPD COR DIS COV
   Wilding J, 2018, DIABETES THER, V9, P1757, DOI 10.1007/s13300-018-0471-8
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Yang WJ, 2016, DIABETES-METAB RES, V32, P391, DOI 10.1002/dmrr.2723
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 59
TC 0
Z9 0
U1 4
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1555-4155
EI 1878-058X
J9 JNP-J NURSE PRACT
JI JNP-J. Nurse Pract.
PD JUN
PY 2021
VL 17
IS 6
BP 680
EP 686
DI 10.1016/j.nurpra.2020.12.021
EA JUN 2021
PG 7
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA SQ1LO
UT WOS:000660121400012
PM 34127911
OA Green Published
DA 2022-04-20
ER

PT J
AU Klumpp, M
   Loske, D
   Bicciato, S
AF Klumpp, Matthias
   Loske, Dominic
   Bicciato, Silvio
TI COVID-19 health policy evaluation: integrating health and economic
   perspectives with a data envelopment analysis approach
SO EUROPEAN JOURNAL OF HEALTH ECONOMICS
LA English
DT Article; Early Access
DE COVID-19; Health policy; Data envelopment analysis; OECD
ID EARLY MEDICAL ABORTION; PRODUCTIVITY ANALYSIS; UNDESIRABLE OUTPUTS; OECD
   COUNTRIES; CARE-SYSTEMS; EFFICIENCY; IMPACT; EPIDEMIC; POPULATION;
   HOSPITALS
AB The COVID-19 pandemic is a global challenge to humankind. To improve the knowledge regarding relevant, efficient and effective COVID-19 measures in health policy, this paper applies a multi-criteria evaluation approach with population, health care, and economic datasets from 19 countries within the OECD. The comparative investigation was based on a Data Envelopment Analysis approach as an efficiency measurement method. Results indicate that on the one hand, factors like population size, population density, and country development stage, did not play a major role in successful pandemic management. On the other hand, pre-pandemic healthcare system policies were decisive. Healthcare systems with a primary care orientation and a high proportion of primary care doctors compared to specialists were found to be more efficient than systems with a medium level of resources that were partly financed through public funding and characterized by a high level of access regulation. Roughly two weeks after the introduction of ad hoc measures, e.g., lockdowns and quarantine policies, we did not observe a direct impact on country-level healthcare efficiency, while delayed lockdowns led to significantly lower efficiency levels during the first COVID-19 wave in 2020. From an economic perspective, strategies without general lockdowns were identified as a more efficient strategy than the full lockdown strategy. Additionally, governmental support of short-term work is promising. Improving the efficiency of COVID-19 countermeasures is crucial in saving as many lives as possible with limited resources.
C1 [Klumpp, Matthias; Loske, Dominic] Georg August Univ Gottingen, Dept Business Adm, Chair Prod & Logist Management, Pl Gottinger Sieben 3, D-37073 Gottingen, Germany.
   [Klumpp, Matthias; Loske, Dominic] FOM Univ Appl Sci Essen, Leimkugelstr 6, D-45141 Essen, Germany.
   [Klumpp, Matthias] Fraunhofer Inst Mat Flow & Logist IML Dortmund, JV Fraunhofer Str 2-4, D-44227 Dortmund, Germany.
   [Bicciato, Silvio] Univ Modena & Reggio Emilia, Interdept Ctr Stem Cells & Regenerat Med CIDSTEM, Dept Life Sci, Via Gottardi 100, I-41125 Modena, Italy.
RP Klumpp, M (corresponding author), Georg August Univ Gottingen, Dept Business Adm, Chair Prod & Logist Management, Pl Gottinger Sieben 3, D-37073 Gottingen, Germany.; Klumpp, M (corresponding author), FOM Univ Appl Sci Essen, Leimkugelstr 6, D-45141 Essen, Germany.
EM matthias.klumpp@uni-goettingen.de
RI Klumpp, Matthias/H-6890-2017
OI Klumpp, Matthias/0000-0002-7543-2751
FU Projekt DEAL
FX Open Access funding enabled and organized by Projekt DEAL.
CR Alberti T, 2020, COMMUN NONLINEAR SCI, V90, DOI 10.1016/j.cnsns.2020.105372
   Benitez MA, 2020, HEALTH POLICY TECHN, V9, P525, DOI 10.1016/j.hlpt.2020.08.014
   Almond D, 2005, AM ECON REV, V95, P258, DOI 10.1257/000282805774669943
   Alonso JM, 2015, HEALTH POLICY, V119, P333, DOI 10.1016/j.healthpol.2014.12.001
   [Anonymous], 1889, PUBLIC HEALTH, V2, P373, DOI [10.1016/S0033-3506(05)80666-3, DOI 10.1016/S0033-3506(05)80666-3]
   Anthun KS, 2017, HEALTH POLICY, V121, P418, DOI 10.1016/j.healthpol.2017.01.006
   Arellanos-Soto D, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90329-w
   Assessment Capacities Project, 2020, COVID 19 GOV MEAS DA
   Attema AE, 2010, HEALTH ECON, V19, P1240, DOI 10.1002/hec.1549
   Austrian Federal Ministry of Social Affairs Health Care and Consumer Protection, 2020, COVID 19 EM MEAS REG
   Bal R, 2020, HEALTH POLICY, V124, P671, DOI 10.1016/j.healthpol.2020.05.010
   Banker RD, 1996, J PROD ANAL, V7, P139, DOI 10.1007/BF00157038
   BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078
   Banker RD, 1997, MANAGE SCI, V43, P1709, DOI 10.1287/mnsc.43.12.1709
   Baser O, 2021, HEALTH POLICY, V125, P148, DOI 10.1016/j.healthpol.2020.10.003
   Battiston P, 2021, HEALTH POLICY, V125, P141, DOI 10.1016/j.healthpol.2020.10.017
   Belgium Government Official Information and Service, 2020, COR VIR STRENGTH MEA
   Beutels P, 2008, HEALTH ECON, V17, P1317, DOI 10.1002/hec.1339
   Bloom DE, 1997, J ECONOMETRICS, V77, P105, DOI 10.1016/S0304-4076(96)01808-8
   Blount S, 1997, APPL MATH COMPUT, V86, P123, DOI 10.1016/S0096-3003(96)00177-4
   Bohm K, 2013, HEALTH POLICY, V113, P258, DOI 10.1016/j.healthpol.2013.09.003
   Bontempi E, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109814
   Braithwaite S, 2013, HEALTH SERV RES, V48, P735, DOI 10.1111/1475-6773.12041
   Cao B, 2017, PHYSICA A, V486, P638, DOI 10.1016/j.physa.2017.05.056
   Castaldo Nadia, 2020, JACC Case Rep, V2, P1307, DOI 10.1016/j.jaccas.2020.04.053
   Cavalieri M, 2017, HEALTH POLICY, V121, P515, DOI 10.1016/j.healthpol.2017.02.011
   Chang JST, 2021, HEALTH CARE MANAG SC, V24, P305, DOI 10.1007/s10729-020-09526-0
   CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8
   Chilton S, 2020, HEALTH ECON, V29, P851, DOI 10.1002/hec.4114
   Cholera THE., 1865, LANCET, V86, P99, DOI [10.1016/S0140-6736(01)44227-9, DOI 10.1016/S0140-6736(01)44227-9]
   Cooper W., 2007, DATA ENVELOPMENT ANA, V2
   da Silva RG, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110027
   Dasaklis TK, 2012, INT J PROD ECON, V139, P393, DOI 10.1016/j.ijpe.2012.05.023
   Dawoud D, 2021, RES SOC ADMIN PHARM, V17, P1950, DOI 10.1016/j.sapharm.2020.05.011
   de Bruin YB, 2020, SAFETY SCI, V128, DOI 10.1016/j.ssci.2020.104773
   Debreu G, 1951, ECONOMETRICA, V19, P273, DOI 10.2307/1906814
   Denburg AE, 2020, HEALTH POLICY, V124, P647, DOI 10.1016/j.healthpol.2020.04.007
   Diaz-Castro L, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052354
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Duarte F, 2017, HEALTH ECON, V26, P1682, DOI 10.1002/hec.3485
   Dyson RG, 2001, EUR J OPER RES, V132, P245, DOI 10.1016/S0377-2217(00)00149-1
   Eberhardt JN, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104382
   Erus B, 2017, HEALTH POLICY, V121, P553, DOI 10.1016/j.healthpol.2017.02.012
   Espinosa-Gonzalez AB, 2021, HEALTH POLICY, V125, P168, DOI 10.1016/j.healthpol.2020.11.008
   Fare, 1991, ACAD EC PAPERS, V19, P329, DOI DOI 10.1016/J.DSS.2009.06.002
   FARE R, 1984, OPER RES LETT, V3, P257, DOI 10.1016/0167-6377(84)90057-9
   Fare R., 2000, SOCIOECONOMIC PLANNI, V34, P35, DOI [10.1016/S0038-0121(99)00012-9, DOI 10.1016/S0038-0121(99)00012-9]
   FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100
   Ferreira DC, 2018, HEALTH POLICY, V122, P1093, DOI 10.1016/j.healthpol.2018.06.009
   Ferreira PL, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3323-3
   Forman R, 2020, HEALTH POLICY, V124, P577, DOI 10.1016/j.healthpol.2020.05.008
   Forslid R, 2015, HEALTH ECON, V24, P726, DOI 10.1002/hec.3057
   French Ministry of Interior, 2020, TRAV TRAV CERT ATT D
   Gabel F, 2020, HEALTH ECON, V29, P475, DOI 10.1002/hec.3997
   Garrafa E, 2020, HEALTH POLICY, V124, P1333, DOI 10.1016/j.healthpol.2020.10.006
   Giokas D, 2015, APPL ECON, V47, P1927, DOI 10.1080/00036846.2014.1002886
   Golany, 1985, ANN OPER RES, V2, P95, DOI [DOI 10.1007/BF01874734, 10.1007/BF01874734]
   Govindan K, 2020, TRANSPORT RES E-LOG, V138, DOI 10.1016/j.tre.2020.101967
   Hailu A, 2001, AM J AGR ECON, V83, P605, DOI 10.1111/0002-9092.00181
   Hale T, 2020, OXFORD COVID 19 GOVT
   Harrington JE, 2010, J HEALTH ECON, V29, P438, DOI 10.1016/j.jhealeco.2010.02.004
   Hatami-Marbini A, 2017, J CLEAN PROD, V142, P2761, DOI 10.1016/j.jclepro.2016.10.192
   Hatswell AJ, 2020, PHARMACOECON-OPEN, V4, P203, DOI 10.1007/s41669-020-00216-9
   Irish Department of Health, 2020, LAT UPD COVID 19 COR
   Italian Ministry of Health, 2020, GOV DEC CLOS NONC ST
   Ivanov D, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101922
   Jain S, 2011, EUR J OPER RES, V214, P616, DOI 10.1016/j.ejor.2011.05.028
   Ji AB, 2019, HEALTH CARE MANAG SC, V22, P560, DOI 10.1007/s10729-019-09477-1
   Kaplan Edward H, 2021, Health Care Manag Sci, V24, P320, DOI 10.1007/s10729-020-09525-1
   Kaplan EH, 2020, HEALTH CARE MANAG SC, V23, P311, DOI 10.1007/s10729-020-09504-6
   Karlsson M, 2014, J HEALTH ECON, V36, P1, DOI 10.1016/j.jhealeco.2014.03.005
   KARTMAN LEO, 1957, EXPTL PARASITOL, V6, P599, DOI 10.1016/0014-4894(57)90043-7
   Kawashima T, 2021, PUBLIC HEALTH, V192, P12, DOI 10.1016/j.puhe.2020.05.018
   Keogh-Brown MR, 2010, HEALTH ECON, V19, P1345, DOI 10.1002/hec.1554
   Kierzkowski A, 2020, J AIR TRANSP MANAG, V88, DOI 10.1016/j.jairtraman.2020.101868
   Kim C, 2019, HEALTH CARE MANAG SC, V22, P534, DOI 10.1007/s10729-019-09471-7
   Knaul F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251722
   Kohl S, 2019, HEALTH CARE MANAG SC, V22, P245, DOI 10.1007/s10729-018-9436-8
   Koon OE, 2020, J PAIN SYMPTOM MANAG, V60, pE90, DOI 10.1016/j.jpainsymman.2020.04.022
   Koopmans T.C., 1951, ACTIVITY ANAL PRODUC, P33
   Kostova D, 2019, HEALTH ECON, V28, P1248, DOI 10.1002/hec.3938
   Lau K, 2019, HEALTH ECON, V28, P175, DOI 10.1002/hec.3834
   Lugner AK, 2010, HEALTH ECON, V19, P518, DOI 10.1002/hec.1485
   Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7
   Matranga D, 2015, HEALTH POLICY, V119, P324, DOI 10.1016/j.healthpol.2014.12.012
   Maurer J, 2016, HEALTH ECON, V25, P1148, DOI 10.1002/hec.3379
   Mauro M, 2021, HEALTH POLICY, V125, P548, DOI 10.1016/j.healthpol.2020.12.015
   Megiddo I, 2019, HEALTH ECON, V28, P556, DOI 10.1002/hec.3867
   Mesnard A, 2009, J PUBLIC ECON, V93, P931, DOI 10.1016/j.jpubeco.2009.05.001
   Middelburg RA, 2020, INT J INFECT DIS, V96, P477, DOI 10.1016/j.ijid.2020.05.066
   Molldrem S, 2021, HEALTH POLICY, V125, P135, DOI 10.1016/j.healthpol.2020.10.015
   Moran V, 2013, HEALTH POLICY, V112, P88, DOI 10.1016/j.healthpol.2013.06.011
   Naevdal E, 2012, HEALTH ECON, V21, P1456, DOI 10.1002/hec.1803
   OCHA, 2020, TOT COVID 19 TESTS P
   OECD, 2020, HLTH RES TOT US DOLL
   OECD, 2020, OECD STAT, DOI 10.1787/16097408
   OECD, 2020, UN RAT
   OECD, 2020, DOCT TOT 1000 INH
   de Oliveira GLA, 2021, ISPRS INT J GEO-INF, V10, DOI 10.3390/ijgi10030121
   Organization for Economic Co-operation and Development (OECD), 2020, HOSP BEDS
   Parsons JA, 2021, HEALTH POLICY, V125, P17, DOI 10.1016/j.healthpol.2020.11.006
   Parsons JA, 2020, HEALTH POLICY, V124, P679, DOI 10.1016/j.healthpol.2020.04.014
   Petrou P, 2018, HEALTH POLICY, V122, P75, DOI 10.1016/j.healthpol.2017.11.004
   Pirozek P, 2015, HEALTH POLICY, V119, P1086, DOI 10.1016/j.healthpol.2015.05.002
   Radcliffe JN., 1862, LANCET, V80, P33, DOI [10.1016/S0140-6736(02)20534-6, DOI 10.1016/S0140-6736(02)20534-6]
   Rassy D, 2013, HEALTH ECON, V22, P824, DOI 10.1002/hec.2862
   Reibling N, 2019, HEALTH POLICY, V123, P611, DOI 10.1016/j.healthpol.2019.05.001
   Rodriguez R, 2021, HEALTH POLICY, V125, P526, DOI 10.1016/j.healthpol.2020.10.012
   Rothgang H., 2005, EUR REV, V13, P187, DOI [10.1017/S1062798705000256, DOI 10.1017/S1062798705000256]
   Sabat I, 2020, HEALTH POLICY, V124, P909, DOI 10.1016/j.healthpol.2020.06.009
   Saez M, 2020, SCI TOTAL ENVIRON, V727, DOI 10.1016/j.scitotenv.2020.138761
   Scheel H, 2001, EUR J OPER RES, V132, P400, DOI 10.1016/S0377-2217(00)00160-0
   Seiford LM, 2002, EUR J OPER RES, V142, P16, DOI 10.1016/S0377-2217(01)00293-4
   Singh RP, 2020, DIABETES METAB SYND, V14, P521, DOI 10.1016/j.dsx.2020.04.041
   Spanish Ministry of Health, 2020, NEW COR DIS ENF NUEV
   Tavakoli M, 2002, Health Care Manag Sci, V5, P5, DOI 10.1023/A:1013269117030
   The German Federal Government, 2020, EXT AD GUID RESTR SO
   The Government of the Republic of Korea The Government of the Republic of Korea, 2020, TACKL COVID 19 HLTH TACKL COVID 19 HLTH
   Thomson B, 2020, CIRCULATION, V142, P14, DOI 10.1161/CIRCULATIONAHA.120.047538
   Tone K, 2009, EUR J OPER RES, V197, P243, DOI 10.1016/j.ejor.2008.05.027
   Toth F, 2016, HEALTH POLICY, V120, P535, DOI 10.1016/j.healthpol.2016.03.011
   U.S. Embassy in the Czech Republic, 2020, COVID 19 INF
   United Nations Development Programme, 2020, 2019 HUM DEV IND RAN
   Valent F, 2021, HEALTH POLICY, V125, P155, DOI 10.1016/j.healthpol.2020.12.009
   Varabyova Y, 2016, HEALTH POLICY, V120, P252, DOI 10.1016/j.healthpol.2015.12.005
   Varabyova Y, 2013, HEALTH POLICY, V112, P70, DOI 10.1016/j.healthpol.2013.03.003
   Vicentini C, 2020, PUBLIC HEALTH, V185, P99, DOI 10.1016/j.puhe.2020.06.028
   Vogler S, 2020, HEALTH POLICY, V124, P1287, DOI 10.1016/j.healthpol.2020.09.001
   Wang D, 2020, ENGINEERING-PRC, V6, P1115, DOI 10.1016/j.eng.2020.05.016
   Wang LQ, 2020, J PSYCHIATR RES, V129, P198, DOI 10.1016/j.jpsychires.2020.07.008
   Wendt C, 2014, SOC POLICY ADMIN, V48, P864, DOI 10.1111/spol.12061
   Wood RM, 2020, HEALTH CARE MANAG SC, V23, P315, DOI 10.1007/s10729-020-09511-7
   Yezli S, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101692
   Yin S, 2020, J IND INF INTEGR, V19, DOI 10.1016/j.jii.2020.100157
   Zare H, 2019, HEALTH CARE MANAG SC, V22, P475, DOI 10.1007/s10729-018-9456-4
   Zhai Pan, 2020, Int J Antimicrob Agents, V55, P105955, DOI 10.1016/j.ijantimicag.2020.105955
NR 136
TC 1
Z9 1
U1 11
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1618-7598
EI 1618-7601
J9 EUR J HEALTH ECON
JI Eur. J. Health Econ.
DI 10.1007/s10198-021-01425-7
EA JAN 2022
PG 23
WC Economics; Health Policy & Services
WE Social Science Citation Index (SSCI)
SC Business & Economics; Health Care Sciences & Services
GA YE6VP
UT WOS:000741261000001
PM 35015167
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Rodriguez-Nakamura, RM
   Gonzalez-Calatayud, M
   Martinez, ARM
AF Rodriguez-Nakamura, Reiko M.
   Gonzalez-Calatayud, Mariel
   Martinez Martinez, Antonio Ramiro
TI Acute mesenteric thrombosis in two patients with COVID-19. Two cases
   report and literature review
SO INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS
LA English
DT Review
DE COVID-19; SARS-CoV-2; Mesenteric ischemia; Thrombosis
AB INTRODUCTION: The coronavirus disease 2019 (COVID-19) affects mainly the respiratory system, other organs may be involved, usually due to coagulation disturbances that lead to a high rate of thrombotic complications.
   CASE PRESENTATION: The first patient is 45 years-old who has been exposed to SARS CoV-2. Upon admission due to acute abdomen evidence surgery is performed in which an intestinal resection with an adequate post-surgical evolution takes place so the patient is discharged after 4 days with a prescription for oral anticoagulants. The second one is 42 years-old and has comorbidities. The patient is admitted upon evidence of COVID-19, after showing signs of vein mesenteric ischemia in a CT scan surgery is performed, however the patient dies 24 h after the intervention.
   DISCUSSION: Within severe cases of patients with COVID-19 the incidence of a symptomatology or gastrointestinal complications is high (39-73.8%). Thromboprophylaxis is recommended to all patients admitted for COVID-19, starting with heparin of low molecular weight as prophylaxis, as well as continuing with oral anticoagulants after being discharged.
   CONCLUSION: Despite the fact that knowledge of the disease is rapidly advancing, all available treatments are still nonspecific to SARS-CoV-2 and the optimal management of COVID-19 remains unclear. An unexplained clinical picture should raise the suspicion for rare conditions such as mesenteric thrombosis. Adequate prophylactic measures should be implemented both during hospitalization and after discharge. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
C1 [Rodriguez-Nakamura, Reiko M.] Hosp Gen Mexico City, Dr Balmis 148, Cdmx 06726, Mexico.
   [Gonzalez-Calatayud, Mariel; Martinez Martinez, Antonio Ramiro] Hosp Gen Mexico City, Mexico City, DF, Mexico.
RP Rodriguez-Nakamura, RM (corresponding author), Hosp Gen Mexico City, Dr Balmis 148, Cdmx 06726, Mexico.
EM dra.reikorod@gmail.com
OI Rodriguez-Nakamura, Reiko/0000-0002-2957-0117
CR Abou-Ismail MY, 2020, THROMB RES, V194, P101, DOI 10.1016/j.thromres.2020.06.029
   Agha RA, 2018, INT J SURG, V60, P132, DOI 10.1016/j.ijsu.2018.10.028
   [Anonymous], 2020, LANCET HAEMATOL, V7, pE425, DOI 10.1016/S2352-3026(20)30151-4
   Azouz E, 2020, INTENS CARE MED, V46, P1464, DOI 10.1007/s00134-020-06079-2
   Cheung S, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.925753
   COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X
   Galanis N, 2020, J SURG CASE REP, DOI 10.1093/jscr/rjaa204
   Goldberg-Stein S, 2020, ABDOM RADIOL, V45, P2613, DOI 10.1007/s00261-020-02669-2
   Gorlinger K., 2020, ANESTH ANALG, DOI [10. 1211/ANE.0000000000005147, DOI 10.1211/ANE.0000000000005147]
   Hatami F, 2020, ANATOL J CARDIOL, V24, P7, DOI 10.14744/AnatolJCardiol.2020.68166
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Hussain P.A., 2020, ACUTE MESENTERIC ISC, V2020, DOI DOI 10.1016/1.ACRA.2020.05.016
   Jam G.F.E., 2020, HIPERCOAGULABILIDAD, V5
   Kunutsor SK, 2020, THROMB RES, V196, P27, DOI 10.1016/j.thromres.2020.08.022
   Marenco de A. Caro, 2019, CIRUGIA ANDALUZA, V30, P57
   Miesbach W, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620938149
   Pons S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03062-7
   Seeliger B, 2020, LANGENBECK ARCH SURG, V405, P861, DOI 10.1007/s00423-020-01948-2
   Simpson D.O.S., 2020, RADIOL CARDIOTHORACI, DOI DOI 10.1148/RYCT.2020200152
   Singhania N, 2020, AM J CARDIOVASC DRUG, V20, P393, DOI 10.1007/s40256-020-00431-z
NR 20
TC 17
Z9 17
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2210-2612
J9 INT J SURG CASE REP
JI Int. J. Surg. Case Rep.
PY 2020
VL 76
BP 409
EP 414
DI 10.1016/j.ijscr.2020.10.040
PG 6
WC Surgery
WE Emerging Sources Citation Index (ESCI)
SC Surgery
GA PT1VG
UT WOS:000608407300095
PM 33083204
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Kutlubay, OC
   Cicek, M
   Yayla, S
AF Kutlubay, Omer Cem
   Cicek, Mesut
   Yayla, Serdar
TI The impact of COVID-19 on online product reviews
SO JOURNAL OF PRODUCT AND BRAND MANAGEMENT
LA English
DT Article; Early Access
DE Mood; Online reviews; Sentiment analysis; Pandemic; COVID-19; Online
   ratings; Mood-as-information theory
ID WORD-OF-MOUTH; CONSUMER-BEHAVIOR; POSITIVE MOOD; EXPERIENCE; SEARCH;
   INFORMATION; EWOM; PERSUASION; EMOTIONS; DYNAMICS
AB Purpose The ongoing COVID-19 pandemic has led to drastic changes in the lives of customers. Social isolation, financial difficulties, fear of being infected and many other factors have caused the psychological well-being of customers to deteriorate. By taking up the role of online reviews in the regulation of consumers' moods, this study aims to examine the changes that have occurred in online product ratings, as well as the negative tone and word counts of product reviews during the COVID-19 pandemic. Design/methodology/approach This study examines the online reviews of 321 products in the pre-COVID, immediate COVID and extended COVID periods. This paper compares the changes that have taken place in product evaluations via various analysis of variance analyses. The authors also test the effect of COVID-related deaths on product evaluations via regression analyses. Findings The results indicate that online product ratings decreased sharply just after the outbreak of COVID-19. The study also found that the tone of reviews was found to be more negative and the length of reviews appeared to be longer in comparison to the pre-COVID-19 period. The results also revealed that the product type (experience vs search) moderated the effect of the pandemic in online reviews and the impact of COVID-19 on online product reviews diminished in the later stages of the ongoing pandemic. Practical implications Managers should be aware of the detrimental impact of pandemics on online product reviews and be more responsive to customer problems during the early stages of pandemics. Originality/value To the best of the authors' knowledge, this is the first study that analyzes the effects of a pandemic on online product ratings and review content. As such, this study offers a timely contribution to the marketing literature.
C1 [Kutlubay, Omer Cem] Univ Arkansas Ft Smith, Coll Business, Ft Smith, AR 72904 USA.
   [Cicek, Mesut] Washington State Univ, Dept Mkt & Int Business, Pullman, WA 99164 USA.
   [Yayla, Serdar] New Jersey City Univ, Mkt Dept, Jersey City, NJ USA.
RP Kutlubay, OC (corresponding author), Univ Arkansas Ft Smith, Coll Business, Ft Smith, AR 72904 USA.
EM omer.kutlubay@uafs.edu
CR Acevedo S., 2017, CLIMATE CHANGE WILL
   Ahmad F, 2021, J PROD BRAND MANAG, V30, P549, DOI 10.1108/JPBM-09-2019-2564
   Ahorsu DK, 2020, INT J MENT HEALTH AD, DOI 10.1007/s11469-020-00270-8
   Bagozzi RP, 1999, J ACAD MARKET SCI, V27, P184, DOI 10.1177/0092070399272005
   Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055
   Bakhshi S, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P443, DOI 10.1145/2566486.2568021
   Bambauer-Sachse S, 2009, J RETAIL CONSUM SERV, V16, P190, DOI 10.1016/j.jretconser.2008.11.013
   BATRA R, 1990, J CONSUM RES, V17, P203, DOI 10.1086/208550
   Beaumont C., 2019, 30 ESSENTIAL ONLINE
   Beedie CJ, 2005, COGNITION EMOTION, V19, P847, DOI 10.1080/02699930541000057
   Berger J, 2020, J MARKETING, V84, P1, DOI 10.1177/0022242919873106
   Bjering E., 2014, ONLINE CONSUMER REV
   Bless H, 1996, J PERS SOC PSYCHOL, V71, P665, DOI 10.1037/0022-3514.71.4.665
   Bodenhausen GV, 2000, PSYCHOL SCI, V11, P320, DOI 10.1111/1467-9280.00263
   Brammer S, 2020, ACAD MANAGE PERSPECT, V34, P493, DOI 10.5465/amp.2019.0053
   Bronner F, 2011, J TRAVEL RES, V50, P15, DOI 10.1177/0047287509355324
   Bronner F, 2010, INT J MARKET RES, V52, P231, DOI 10.2501/S1470785309201193
   Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]
   Chevalier JA, 2006, J MARKETING RES, V43, P345, DOI 10.1509/jmkr.43.3.345
   Clark M. S., 1982, COGNITIVE SOCIAL PSY, DOI DOI 10.2307/3033676
   Clore G. L., 2007, SOCIAL PSYCHOL HDB B
   Cooper, 2001, EMOTIONS WORK THEORY
   Curren M., 1994, PSYCHOL MARKET, V11, P91
   Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008
   Esper TL, 2021, J PUBLIC POLICY MARK, V40, P101, DOI 10.1177/0743915620932150
   Fang JM, 2019, INT J ELECTRON COMM, V23, P557, DOI 10.1080/10864415.2019.1655206
   Fernando AG, 2018, EUR J MARKETING, V52, P1412, DOI 10.1108/EJM-01-2017-0048
   Franke GR, 2004, J ACAD MARKET SCI, V32, P20, DOI 10.1177/0092070303257856
   Godes D, 2012, MARKET SCI, V31, P448, DOI 10.1287/mksc.1110.0653
   Goncalves HM, 2018, PSYCHOL MARKET, V35, P807, DOI 10.1002/mar.21136
   Gorn G. J., 1993, J CONSUM PSYCHOL, V2, P237, DOI DOI 10.1016/S1057-7408(08)80016-2
   Haans RFJ, 2016, STRATEGIC MANAGE J, V37, P1177, DOI 10.1002/smj.2399
   Hamilton R, 2021, J PUBLIC POLICY MARK, V40, P99, DOI 10.1177/0743915620928110
   He HW, 2020, J BUS RES, V116, P176, DOI 10.1016/j.jbusres.2020.05.030
   Hem LE, 2009, INT J MARKET RES, V51, P797, DOI 10.2501/S1470785309200979
   Herhausen D, 2019, J MARKETING, V83, P1, DOI 10.1177/0022242918822300
   Hewett K, 2016, J MARKETING, V80, P1, DOI 10.1509/jm.15.0033
   Hirschman EC, 1998, ADV CONSUM RES, V25, P421
   Huang P, 2009, J MARKETING, V73, P55, DOI 10.1509/jmkg.73.2.55
   IPBES, 2020, IPBES WORKSH BIOD PA
   Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032
   Judge T.A., 2012, ORG BEHAV, P258
   Kaemingk D., 2019, 20 ONLINE REV STATS
   Karakaya F, 2010, J CONSUM MARK, V27, P447, DOI 10.1108/07363761011063349
   Kelley SW, 1997, J RETAILING, V73, P407, DOI 10.1016/S0022-4359(97)90025-7
   Kirk CP, 2020, J BUS RES, V117, P124, DOI 10.1016/j.jbusres.2020.05.028
   Knight AP, 2015, ORGAN SCI, V26, P99, DOI 10.1287/orsc.2013.0866
   Kumar R., 1997, J APPL BEHAV SCI, V33, P84, DOI [10.1177/0021886397331007, DOI 10.1177/0021886397331007]
   Lee AY, 1999, J CONSUM RES, V26, P115, DOI 10.1086/209554
   Li SB, 2021, PSYCHOL MARKET, V38, P2006, DOI 10.1002/mar.21552
   Li XX, 2008, INFORM SYST RES, V19, P456, DOI 10.1287/isre.1070.0154
   Lind JT, 2010, OXFORD B ECON STAT, V72, P109, DOI 10.1111/j.1468-0084.2009.00569.x
   Lis B, 2020, J PROD BRAND MANAG, V29, P637, DOI 10.1108/JPBM-05-2018-1876
   Lis B, 2013, BUS INFORM SYST ENG+, V5, P129, DOI 10.1007/s12599-013-0261-9
   Longstaff PH, 2008, ECOL SOC, V13, DOI 10.5751/ES-02232-130103
   Ludwig S, 2013, J MARKETING, V77, P87, DOI 10.1509/jm.11.0560
   Luo XM, 2009, MARKET SCI, V28, P148, DOI 10.1287/mksc.1080.0389
   Mano H, 1997, PSYCHOL MARKET, V14, P315
   Melumad S, 2019, J MARKETING RES, V56, P259, DOI 10.1177/0022243718815429
   Miniard P. W., 1992, J CONSUM PSYCHOL, V1, P173
   Moe WW, 2011, J MARKETING RES, V48, P444, DOI 10.1509/jmkr.48.3.444
   Moreland A, 2020, MMWR-MORBID MORTAL W, V69, P1198, DOI 10.15585/mmwr.mm6935a2
   Mudambi SM, 2010, MIS QUART, V34, P185
   Naeem M, 2021, J RETAIL CONSUM SERV, V58, DOI 10.1016/j.jretconser.2020.102226
   NELSON P, 1970, J POLIT ECON, V78, P311, DOI 10.1086/259630
   OECD, 2020, E COMM TIM COVID 19
   Ordenes FV, 2017, J CONSUM RES, V43, P875, DOI 10.1093/jcr/ucw070
   Ozuem W, 2021, PSYCHOL MARKET, V38, P1440, DOI 10.1002/mar.21527
   Panchal N., 2021, KFF FILLING NEED TRU
   Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041
   Petty RE, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P41
   PETTY RE, 1993, J PERS SOC PSYCHOL, V64, P5, DOI 10.1037/0022-3514.64.1.5
   Pham M., 1998, SOCIAL PSYCHOL CONSU, P167
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Ransbotham S, 2019, MARKET SCI, V38, P773, DOI 10.1287/mksc.2018.1115
   Restubog SLD, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103440
   Rosselli, 1992, REV PERSONALITY SOCI, V14, P247
   Sakurai M, 2020, EUR J INFORM SYST, V29, P585, DOI 10.1080/0960085X.2020.1814171
   Sar S., 2013, J MARKETING COMMUNIC, V19, P308
   Schoenmueller V, 2020, J MARKETING RES, V57, P853, DOI 10.1177/0022243720941832
   SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513
   Schwarz N, 2003, PSYCHOL INQ, V14, P296, DOI 10.1207/S15327965PLI1403&4_20
   Schwarz N., 1996, PSYCHOL ACTION LINKI, P119
   Schwarz N., 1988, AFFECT COGNITION SOC, P44, DOI DOI 10.2307/3172815
   Schwarz Norbert, 2012, HDB THEORIES SOCIAL, V1, P289, DOI DOI 10.1037/A0030466
   Sheth J, 2020, J BUS RES, V117, P280, DOI 10.1016/j.jbusres.2020.05.059
   Shukla DM, 2020, J BUS RES, V113, P370, DOI 10.1016/j.jbusres.2019.09.032
   Shultz JM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0741-y
   SINCLAIR RC, 1992, CONSTRUCTION OF SOCIAL JUDGMENTS, P165
   SINCLAIR RC, 1995, COGNITION EMOTION, V9, P417, DOI 10.1080/02699939508408974
   Sirakaya E, 2004, ANN TOURISM RES, V31, P517, DOI 10.1016/j.annals.2004.01.009
   Srinivasan SS, 2002, J PRODU BRAND MANAGE, V11, P417, DOI DOI 10.1108/10610420210451616
   Talarico J, 2009, COGNITION EMOTION, V23, P380, DOI 10.1080/02699930801993999
   Tan WQ, 2020, BRAIN BEHAV IMMUN, V87, P84, DOI 10.1016/j.bbi.2020.04.055
   Tang CY, 2015, MARKET LETT, V26, P67, DOI 10.1007/s11002-013-9268-8
   Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676
   Ullah R, 2016, DECIS SUPPORT SYST, V81, P41, DOI 10.1016/j.dss.2015.10.007
   Vastfjall D, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00325
   Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729
   Wang Y, 2018, J MARKETING RES, V55, P163, DOI 10.1509/jmr.15.0511
   Watson D., 1994, NATURE EMOTION FUNDA, P89
   Weathers D, 2007, J RETAILING, V83, P393, DOI 10.1016/j.jretai.2007.03.009
   White K, 2009, J CONSUM PSYCHOL, V19, P526, DOI 10.1016/j.jcps.2009.05.004
   Willemsen LM, 2011, J COMPUT-MEDIAT COMM, V17, P19, DOI 10.1111/j.1083-6101.2011.01551.x
   Woolley K, 2021, J MARKETING RES, V58, P539, DOI 10.1177/00222437211010439
   WRIGHT AA, 1995, J CONSUM RES, V21, P708, DOI 10.1086/209429
   Yang FX, 2017, J HOSP TOUR RES, V41, P93, DOI 10.1177/1096348013515918
   Yoo K. H., 2008, Information Technology and Tourism, V10, P283, DOI 10.3727/109830508788403114
NR 108
TC 0
Z9 0
U1 9
U2 9
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1061-0421
EI 2054-1643
J9 J PROD BRAND MANAG
JI J. Prod. Brand Manag.
DI 10.1108/JPBM-12-2020-3281
EA NOV 2021
PG 13
WC Business; Management
WE Social Science Citation Index (SSCI)
SC Business & Economics
GA XB8DO
UT WOS:000721553900001
OA Bronze
DA 2022-04-20
ER

PT J
AU Vuong, QH
   Le, TT
   La, VP
   Nguyen, HTT
   Ho, MT
   Khuc, QV
   Nguyen, MH
AF Vuong, Quan-Hoang
   Le, Tam-Tri
   La, Viet-Phuong
   Huyen Thanh Thanh Nguyen
   Ho, Manh-Toan
   Quy Van Khuc
   Nguyen, Minh-Hoang
TI Covid-19 vaccines production and societal immunization under the
   serendipity-mindsponge-3D knowledge management theory and conceptual
   framework
SO HUMANITIES & SOCIAL SCIENCES COMMUNICATIONS
LA English
DT Review
ID HEALTH; IMPACT; SCIENCE
AB Since the outbreak of the Coronavirus disease 2019 (Covid-19), tremendous efforts have been made by scientists, health professionals, business people, politicians, and laypeople around the world. Covid-19 vaccines are one of the most crucial innovations that help fight against the virus. This paper attempts to revisit the Covid-19 vaccines production process by employing the serendipity-mindsponge-3D creativity management theory. Vaccine production can be considered an information process and classified into three main stages. The first stage involved the processes of absorbing information (e.g., digital data and open science) and rejecting unhelpful information (e.g., misinformation and fake news) for effectively acquiring useful insights. Useful insights were later employed by experts, enterprises, governments, and international organizations through interdisciplinary coordinated efforts for developing vaccines within a short period. Finally, the appearance of multiple types of vaccines enabled more strategic options for vaccine distribution and administration. Findings from this vaccine creativity management process could be used as critical lessons for further improvements of vaccination programs.
C1 [Vuong, Quan-Hoang; Le, Tam-Tri; La, Viet-Phuong; Huyen Thanh Thanh Nguyen; Ho, Manh-Toan; Nguyen, Minh-Hoang] Phenikaa Univ, Ctr Interdisciplinary Social Res, Hanoi 100803, Vietnam.
   [Le, Tam-Tri; Nguyen, Minh-Hoang] Vuong & Associates, AISDL, Dong Da Hanoi 100000, Vietnam.
   [Quy Van Khuc] Vietnam Natl Univ, VNU Univ Econ & Business, Ctr Econ Dev Studies, Hanoi 100000, Vietnam.
   [Quy Van Khuc] Vietnam Natl Univ, VNU Univ Econ & Business, Fac Polit Econ, Hanoi 100000, Vietnam.
RP Vuong, QH; Nguyen, MH (corresponding author), Phenikaa Univ, Ctr Interdisciplinary Social Res, Hanoi 100803, Vietnam.; Nguyen, MH (corresponding author), Vuong & Associates, AISDL, Dong Da Hanoi 100000, Vietnam.
EM hoang.vuongquan@phenikaauni.edu.vn; hoang.nguyenminh@phenikaa-uni.edu.vn
RI Khuc, Quy/X-2279-2019; Le, Tam-Tri/ABD-1132-2021; Toan, Ho
   Manh/T-5435-2019; Nguyen, Minh-Hoang/N-8135-2019; Vuong,
   Quan-Hoang/F-2115-2010; La, Viet-Phuong/U-7155-2018
OI Khuc, Quy/0000-0001-9516-2413; Toan, Ho Manh/0000-0002-8292-0120;
   Nguyen, Minh-Hoang/0000-0002-7520-3844; Vuong,
   Quan-Hoang/0000-0003-0790-1576; La, Viet-Phuong/0000-0002-4301-9292; Le,
   Tam-Tri/0000-0003-3384-4827; Nguyen, Huyen/0000-0002-5969-5025
CR Al Jazeera, 2020, JAZEERA
   Amaro, 2021, CNBC
   [Anonymous], 2020, NATURE, V586, P169, DOI 10.1038/d41586-020-02797-1
   [Anonymous], 2020, LANCET, V395, P1521, DOI 10.1016/S0140-6736(20)31140-5
   [Anonymous], 2020, FRANCE24
   [Anonymous], REUTERS
   [Anonymous], 2021, EURONEWS
   Bagdasarian N, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01650-6
   Balakrishnan VS, 2020, LANCET INFECT DIS, V20, P1128, DOI 10.1016/S1473-3099(20)30709-X
   Bauchner H, 2020, JAMA-J AM MED ASSOC, V324, P453, DOI 10.1001/jama.2020.11764
   Bauchner H, 2018, JAMA-J AM MED ASSOC, V320, P1985, DOI 10.1001/jama.2018.14350
   Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891
   BioNtech, PROJ LIGHTSP
   Caretaker, 2020, AUSTR 1 VIRT HOSP CO
   CEPI, 2020, CEPI EST GLOB NETW L
   Chan HW, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-021-00781-2
   Chavis AM, 2011, SOC WORK PUBLIC HLTH, V26, P471, DOI 10.1080/19371918.2011.591629
   Chistikova T, 2021, NBC NEWS
   CNBC, 2020, CNBC
   CORD-19, 2020, COVID 19 OP RES DAT
   Dang LNV, 2013, P INT C MAN LEAD GOV
   Diamond D, 2021, WASH POST
   Douglas B., 2020, REUTERS
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   DW, 2021, PUT GETS HIS COVID J
   DW, 2021, FACT CHECK EFF SPUTN
   Else H, 2020, NATURE, V588, P553, DOI 10.1038/d41586-020-03564-y
   Fleming N, 2020, NATURE, V583, P155, DOI 10.1038/d41586-020-01834-3
   Forni G, 2021, CELL DEATH DIFFER, V28, P626, DOI 10.1038/s41418-020-00720-9
   Fraser N, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3000959
   Gallotti R, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-00994-6
   GAVI, COVID 19 VACC RAC
   Germani F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247642
   Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923
   Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8
   Haroon S., 2020, GUARDIAN
   Horbach SPJM, 2020, QUANT SCI STUD, V1, P1056, DOI 10.1162/qss_a_00076
   Hornsey MJ, 2020, J EXP SOC PSYCHOL, V88, DOI 10.1016/j.jesp.2019.103947
   Hotez P, 2021, ECLINICALMEDICINE, V33, DOI 10.1016/j.eclinm.2021.100780
   Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7
   Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812
   Jeffrey M, 2020, SCIENCE
   Jocelyn SM, 2020, MED NEWS TODAY
   Jones I, 2021, LANCET, V397, P642, DOI 10.1016/S0140-6736(21)00191-4
   Kaplan RM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021726118
   Katz IT, 2021, NEW ENGL J MED, V384, P1281, DOI 10.1056/NEJMp2103614
   Khatter A, 2021, BIBLIOMETRIC ANAL HI
   Krause PR, 2021, NEW ENGL J MED, V385, P179, DOI 10.1056/NEJMsr2105280
   Kumar A, 2021, LANCET, V397, P2148, DOI 10.1016/S0140-6736(21)00982-X
   Kwon Diana, 2020, Nature, V581, P130, DOI 10.1038/d41586-020-01394-6
   Le N., 2021, VIETNAM OFFERS BUILD
   Ledford H, 2020, NATURE, V588, P205, DOI 10.1038/d41586-020-03441-8
   Ledford H, 2020, NATURE, V582, P160, DOI 10.1038/d41586-020-01695-w
   Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8
   Logunov DY, 2020, LANCET, V396, P887, DOI 10.1016/S0140-6736(20)31866-3
   Macleod M., 2020, CTV NEWS
   Majumder MS, 2020, LANCET GLOB HEALTH, V8, pE627, DOI 10.1016/S2214-109X(20)30113-3
   Mallapaty Smriti, 2021, Nature, DOI 10.1038/d41586-021-01545-3
   Martins RS, 2020, MAYO CLIN PROC, V95, P2288, DOI 10.1016/j.mayocp.2020.07.026
   Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8
   Maxmen A, 2021, NATURE, V589, P499, DOI 10.1038/d41586-021-00162-4
   McCormick J, 2020, WORLD STREET J
   Mehra MR, 2020, LANCET, V395, P1820, DOI [10.1016/S0140-6736(20)31180-6, 10.1016/S0140-6736(20)31324-6]
   Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621
   Mervis J, 2017, SCIENCE, V357, P959, DOI 10.1126/science.357.6355.959
   Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4
   Napier N.K, 2013, STRATEG MANAG, P175
   National Institutes of Health, COVID 19 CLIN RES
   National Institutes of Health, 2020, TEST OP WARP SPEED R
   National Institutes of Health, ACC COVID 19 THER IN
   Nguyen MH, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073681
   OECD, 2021, ACC COVID 19 VACC GL
   Open COVID Pledge, 2020, MAK PLEDG SHAR YOUR
   Organization WH, 2020, COVID 19 PUBL HLTH E
   Pannett R, 2020, WORLD STREET J
   Pfizer, 2020, PFIZ BIONTECH ANN FU
   Pfizer, 2020, BREAKTHR VACC POT PR
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Vuong QH, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2850-9
   Vuong QH, 2015, INT J INTERCULT REL, V49, P354, DOI 10.1016/j.ijintrel.2015.06.003
   Quan Hoang Vuong, 2014, International Journal of Transitions and Innovation Systems, V3, P294
   Vuong QH, 2020, PALGR COMMUN, V6, DOI 10.1057/s41599-020-0442-3
   Vuong QH, 2019, NAT HUM BEHAV, V3, P1034, DOI 10.1038/s41562-019-0667-6
   Retraction Watch, 2021, RETR COR COVID 19 PA
   Reuters, 2020, REUTERS
   Reuters, 2021, REUTERS
   Reuters (2021b, 2021, REUTERS
   Robertson E, 2021, BRAIN BEHAV IMMUN, V94, P41, DOI 10.1016/j.bbi.2021.03.008
   Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199
   ROSENFIELD PL, 1992, SOC SCI MED, V35, P1343, DOI 10.1016/0277-9536(92)90038-R
   Samantha D., 2020, NEWS DAILY
   Sandmann FG, 2021, LANCET INFECT DIS, V21, P962, DOI 10.1016/S1473-3099(21)00079-7
   Satariano A., 2020, NEW YORK TIMES
   Sawal I, 2021, J MED VIROL, V93, P5228, DOI 10.1002/jmv.27031
   Schell D, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100349
   Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE353, DOI 10.1016/S2468-2667(21)00108-0
   Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494
   Smith D., 2020, GUARDIAN
   Stankiewicz K, 2020, CNBC
   Stolk C.V., 2020, COVID 19 COST VACCIN
   Tahor M., 2021, NAT MED, V27, P1379, DOI [10.1038/s41591-021-01413-7, DOI 10.1038/s41591-021-01413-7]
   Taylor L, 2021, NATURE, V593, P15, DOI 10.1038/d41586-021-01031-w
   Huynh TLD, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104872
   Tollefson J, 2020, NATURE, V586, P190, DOI 10.1038/d41586-020-02800-9
   U.S. Department of Defense, 2020, TRUMP ADM ANN FRAM L
   U.S. Department of Defense, COR OP WARP SPEED
   U.S. Food & Drug Administration, 2021, PFIZ BIONTECH COVID
   U.S. Government Accountability Office, 2021, OP WARP SPEED ACC CO
   Ullah I, 2021, Vacunas, V22, P93, DOI 10.1016/j.vacun.2021.01.001
   UNICEF, 2021, UNICEF SIGNS SUPPL A
   United Nations, 2021, WHO CHIEF TELLS EC S
   Van Bavel J., 2020, NATL IDENTITY PREDIC, DOI DOI 10.31234/OSF.IO/YDT95
   Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z
   Velasquez N., SCI REP 2021, V11, DOI [10.1038/s41598-021-89467-y. 34131158, DOI 10.1038/S41598-021-89467-Y.34131158]
   La VP, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072931
   Vietnam Ministry of Health, 2021, VIET NAM THU NGHIEM
   Vuong Q.H., 2016, GLOBAL MINDSETS EXPL, P109
   Vuong Q.H., 2013, SOCIOL STUDY, V3, P69
   Vuong Q-H, 2017, SCI DATA UPDATES
   Vuong QH, 2021, MINDSPONGE BASED INV
   Vuong QH, 2019, VIETNAMESE SOCIAL SCIENCES AT A FORK IN THE ROAD
   Vuong QH, 2020, NATURE, V582, P149, DOI 10.1038/d41586-020-01694-x
   Vuong QH, 2018, PALGR COMMUN, V4, DOI 10.1057/s41599-018-0189-2
   Vuong QH, 2018, NAT HUM BEHAV, V2, P5, DOI 10.1038/s41562-017-0281-4
   Wellcome, 2020, SHAR RES DAT FIND RE
   Whitehurst L, 2021, AP NEWS
   Whitelaw S, 2020, LANCET DIGIT HEALTH, V2, pE435, DOI 10.1016/S2589-7500(20)30142-4
   WHO, 2021, EST COVID 19 MRNA VA
   WHO, ACC COVID 19 TOOLS A
   WHO, 2021, ACT NOW ACT TOG 2020
   WHO, 2020, COR DIS COVID 19 SOL
   WHO, COVID 19 TECHN ACC P
   Wilson SL, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-004206
   Wolfe D., 2020, THE CNN
   World Health Organization, 2021, WHO SUPP S AFR CONS
   World Health Organization, LETS FLATT INF CURV
   World Health Organization, 2021, COVID 19 VACC TRACK
   World Health Organization, 2021, WHO LISTS ADD COVID
   World Health Organization, 2021, WHO VAL SIN COVID 19
   World Health Organization, 2021, 10 THREATS GLOBAL HL
   World Health Organization, 2021, STAT COVID 19 VACC W
   World Health Organization, EM US LIST
   World Health Organization, 2021, SOC MED COVID 19 GLO
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Zastrow M, 2020, NATURE, V581, P109, DOI 10.1038/d41586-020-01246-3
   Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 147
TC 6
Z9 6
U1 2
U2 2
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2662-9992
J9 HUM SOC SCI COMMUN
JI Hum. Soc. Sci. Commun.
PD JAN 18
PY 2022
VL 9
IS 1
AR 22
DI 10.1057/s41599-022-01034-6
PG 12
WC Humanities, Multidisciplinary; Social Sciences, Interdisciplinary
WE Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)
SC Arts & Humanities - Other Topics; Social Sciences - Other Topics
GA YI5ZD
UT WOS:000743925200002
OA Green Published, gold, Green Submitted
DA 2022-04-20
ER

PT J
AU Teng, YM
   Wu, KS
   Lin, KL
   Xu, D
AF Teng, Yi-Man
   Wu, Kun-Shan
   Lin, Kuan-Ling
   Xu, Dan
TI Mental Health Impact of COVID-19 on Quarantine Hotel Employees in China
SO RISK MANAGEMENT AND HEALTHCARE POLICY
LA English
DT Article
DE COVID-19; quarantine hotel employee; Depression Anxiety and Stress
   Scale; DASS-21; mental health
ID ANXIETY STRESS SCALES; DEPRESSION; WORKERS; KNOWLEDGE; DISTRESS;
   ETHIOPIA; STUDENTS
AB Background: The COVID-19 pandemic has had a far-reaching and unprecedented influence on economies worldwide. It has also impacted on the global population's mental health and caused negative psychosocial effects, which may lead to psychological crises. During the pandemic, the challenges for quarantine hotel employees are not only the increased workloads created by operating a quarantine hotel but also high psychological stress associated with job insecurity, risk of exposure and contagion for themselves, their friends and families. This research attempts to explore COVID-19-related depression, anxiety, and stress among quarantine hotel employees in China. The mental health of quarantine hotel employees, who have faced unprecedented changes, is paramount while they provide hospitality and care for healthcare workers and quarantine guests during mandatory quarantine periods.
   Methods: This is a cross-sectional study that applied convenience sampling to collect questionnaire samples from 170 quarantine hotel employees in Xiamen, Fujian Province, China, during the COVID-19 pandemic, from May 20 to June 10, 2020. The Depression, Anxiety, and Stress Scale (DASS-21) was used to collect data. The study uses descriptive analysis, chi-square test and binary logistic regression to examine the sociodemographic factors associated with depression, anxiety and stress levels during the COVID-19 pandemic.
   Results: The results reveal that 43.5% of respondents report moderate to extremely severe symptoms of depression; 68.2% have moderate to extremely severe anxiety symptoms; and 8.2% indicated moderate to extremely severe stress symptoms. Quarantine hotel employees who have a higher level of education are less likely to experience anxiety, and those with higher incomes are less likely to experience depression.
   Discussion: In order to mitigate the increasing levels of anxiety and depression among their staff, quarantine hoteliers or managers urgently need to implement mental health assistance programs, such as providing extra training in hygiene and knowledge about COVID-19, offering online counseling and psychological support services, training in positive thinking, encouraging staff to keep in touch with their personal support networks, and constructing a resilience model.
C1 [Teng, Yi-Man; Xu, Dan] Yango Univ, Coll Modern Management, Fuzhou 350015, Peoples R China.
   [Wu, Kun-Shan] Tamkang Univ, Dept Business Adm, Taipei, Taiwan.
   [Lin, Kuan-Ling] Yango Univ, Coll Child Dev & Educ, Fuzhou 350015, Peoples R China.
RP Wu, KS (corresponding author), Tamkang Univ, Dept Business Adm, Taipei, Taiwan.
EM kunshan@mail.tku.edu.tw
CR Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7
   Al-Hanawi MK, 2020, RISK MANAG HEALTHC P, V13, P733, DOI 10.2147/RMHP.S264037
   Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176
   Aziznejadroshan P, 2020, RES SQ, DOI [10.21203/rs.3.rs-98099/v113., DOI 10.21203/RS.3.RS-98099/V1]
   Baloran ET, 2020, J LOSS TRAUMA, V25, P635, DOI 10.1080/15325024.2020.1769300
   Chatterjee SS, 2020, INDIAN J PSYCHIAT, V62, P257, DOI 10.4103/psychiatry.IndianJPsychiatry_333_20
   Dong HX, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00751
   Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875
   Girma S, 2020, RISK MANAG HEALTHC P, V13, P1327, DOI 10.2147/RMHP.S267261
   HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941
   Kang LJ, 2020, LANCET PSYCHIAT, V7, pE14, DOI 10.1016/S2215-0366(20)30047-X
   Khan AH, 2020, J AFFECT DISORDERS, V277, P121, DOI 10.1016/j.jad.2020.07.135
   Khattak SR, 2021, J LOSS TRAUMA, V26, P421, DOI 10.1080/15325024.2020.1814580
   Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976
   LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U
   Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Ramaci T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093834
   Ramon-Arbues E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197001
   Rossi R, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00790
   Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083
   Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w
   Tee ML, 2020, J AFFECT DISORDERS, V277, P379, DOI 10.1016/j.jad.2020.08.043
   Teng YM, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02168
   Walton M, 2020, EUR HEART J-ACUTE CA, V9, P241, DOI 10.1177/2048872620922795
   Wang K, 2016, PSYCHOL ASSESSMENT, V28, pE88, DOI 10.1037/pas0000207
   Wang YY, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-2449-0
   Wang ZH, 2020, J AFFECT DISORDERS, V275, P188, DOI 10.1016/j.jad.2020.06.034
   Wong AH, 2020, ANN EMERG MED, V76, P379, DOI 10.1016/j.annemergmed.2020.04.041
   World Health Organization, 2020, MENT HLTH PSYCH CONS
   Yanez JA, 2020, AM J TROP MED HYG, V103, P1614, DOI 10.4269/ajtmh.20-0800
   Yeshaw Y, 2017, NEUROPSYCH DIS TREAT, V13, P2803, DOI 10.2147/NDT.S150444
   Zhao YQ, 2020, J LOSS TRAUMA, V25, P580, DOI 10.1080/15325024.2020.1761592
   Zubayer AA, 2020, HELIYON, V6, DOI [10.1016/j.heli-yon.2020.e0505723., DOI 10.1016/J.HELI-YON.2020.E05057]
NR 34
TC 10
Z9 10
U1 20
U2 33
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-1594
J9 RISK MANAG HEALTHC P
JI RISK MANAG. HEALTHC. POLICY
PY 2020
VL 13
BP 2743
EP 2751
DI 10.2147/RMHP.S286171
PG 9
WC Health Care Sciences & Services; Health Policy & Services
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services
GA PC9JL
UT WOS:000597313500001
PM 33273872
OA Green Published
DA 2022-04-20
ER

PT J
AU Rowaiye, AB
   Okpalefe, OA
   Adejoke, OO
   Ogidigo, JO
   Oladipo, OH
   Ogu, AC
   Oli, AN
   Olofinase, S
   Onyekwere, O
   Abubakar, AR
   Jahan, D
   Islam, S
   Dutta, S
   Haque, M
AF Rowaiye, Adekunle Babajide
   Okpalefe, Okiemute Ajiroghene
   Adejoke, Olukemi Onuh
   Ogidigo, Joyce Oloaigbe
   Oladipo, Oluwakemi Hannah
   Ogu, Amoge Chidinma
   Oli, Angus Nnamdi
   Olofinase, Samson
   Onyekwere, Onyekachi
   Abubakar, Abdullahi Rabiu
   Jahan, Dilshad
   Islam, Salequl
   Dutta, Siddhartha
   Haque, Mainul
TI Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced
   Cytokine Storm and the Implications
SO JOURNAL OF INFLAMMATION RESEARCH
LA English
DT Review
DE COVID-19; SARS-CoV-2; cytokine storm; hyper-inflammation; fatality
ID SPHINGOSINE 1-PHOSPHATE RECEPTOR; C-REACTIVE PROTEIN; INFLAMMATORY
   CYTOKINES; SIGNALING PATHWAYS; OXIDATIVE STRESS; IMMUNE-RESPONSES; CELL
   FUNCTION; LIVER-INJURY; I INTERFERON; HUMAN HEALTH
AB The COVID-19 pandemic constitutes an arduous global health challenge, and the increasing number of fatalities calls for the speedy pursuit of a remedy. This review emphasizes the changing aspects of the COVID-19 disease, featuring the cytokine storm's pathological processes. Furthermore, we briefly reviewed potential therapeutic agents that may modulate and alleviate cytokine storms. The literature exploration was made using PubMed, Embase, MEDLINE, Google scholar, and China National Knowledge Infrastructure databases to retrieve the most recent literature on the etiology, diagnostic markers, and the possible prophylactic and therapeutic options for the management of cytokine storm in patients hospitalized with COVID-19 disease. The causative agent, severe acute respiratory coronavirus-2 (SARS-CoV-2), continually threatens the efficiency of the immune system of the infected individuals. As the first responder, the innate immune system provides primary protection against COVID-19, affecting the disease's progression, clinical outcome, and prognosis. Evidence suggests that the fatalities associated with COVID-19 are primarily due to hyper-inflammation and an aberrant immune function. Accordingly, the magnitude of the release of pro-inflammatory cytokines such as interleukin (IL)-1, (IL-6), and tumor necrosis alpha (TNF-alpha) significantly differentiate between mild and severe cases of COVID-19. The early prediction of a cytokine storm is made possible by several serum chemistry and hematological markers. The prompt use of these markers for diagnosis and the aggressive prevention and management of a cytokine release syndrome is critical in determining the level of morbidity and fatality associated with COVID-19. The prophylaxis and the rapid treatment of cytokine storm by clinicians will significantly enhance the fight against the dreaded COVID-19 disease.
C1 [Rowaiye, Adekunle Babajide; Oli, Angus Nnamdi] Nnamdi Azikiwe Univ, Fac Pharmaceut Sci, Dept Pharmaceut Microbiol & Biotechnol, Awka, Anambra State, Nigeria.
   [Okpalefe, Okiemute Ajiroghene; Olofinase, Samson] Natl Biotechnol Dev Agcy, Dept Genet, Genom, Bioinformat, Abuja, Nigeria.
   [Adejoke, Olukemi Onuh; Ogu, Amoge Chidinma] Natl Biotechnol Dev Agcy, Dept Med Biotechnol, Abuja, Nigeria.
   [Ogidigo, Joyce Oloaigbe] Natl Biotechnol Dev Agcy, Bioresources Dev Ctr, Abuja, Nigeria.
   [Oladipo, Oluwakemi Hannah] Natl Biotechnol Dev Agcy, Bioresources Dev Ctr, Ilorin, Kwara State, Nigeria.
   [Onyekwere, Onyekachi] Natl Biotechnol Dev Agcy, Delta State, Bioresources Dev Ctr, Ubulu Uku, Delta State, Nigeria.
   [Abubakar, Abdullahi Rabiu] Bayero Univ, Fac Pharmaceut Sci, Dept Pharmacol & Therapeut, Kano 700233, Nigeria.
   [Jahan, Dilshad] Asgar Ali Hosp, Dept Hematol, Dhaka 1204, Bangladesh.
   [Islam, Salequl] Jahangirnagar Univ, Dept Microbiol, Dhaka 1342, Bangladesh.
   [Dutta, Siddhartha] All India Inst Med Sci, Dept Pharmacol, Jodhpur, Rajasthan, India.
   [Haque, Mainul] Univ Pertahanan Nas Malaysia, Fac Med & Def Hlth, Unit Pharmacol, Kuala Lumpur 57000, Malaysia.
RP Haque, M (corresponding author), Univ Pertahanan Nas Malaysia, Fac Med & Def Hlth, Unit Pharmacol, Kuala Lumpur 57000, Malaysia.
EM runurono@gmail.com
RI Oli, Angus/AFR-4286-2022
OI Oli, Angus/0000-0001-8519-2555; Rabiu Abubakar,
   Abdullahi/0000-0002-9740-7856
CR Abubakar AR, 2020, INFECT DRUG RESIST, V13, P4673, DOI 10.2147/IDR.S289037
   Al Musawi MS, 2016, LASER MED SCI, V31, P1195, DOI 10.1007/s10103-016-1972-1
   Alattar R, 2020, J MED VIROL, V92, P2042, DOI 10.1002/jmv.25964
   Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200
   Alqahtani SA, 2020, UNITED EUR GASTROENT, V8, P509, DOI 10.1177/2050640620924157
   [Anonymous], 2021, LANCET DIABETES ENDO, V9, P53, DOI 10.1016/S2213-8587(21)00003-6
   [Anonymous], 2020, CHINESE MED J-PEKING, V133, P1087, DOI 10.1097/CM9.0000000000000819
   Aouba A, 2020, ANN RHEUM DIS, V79, P1381, DOI 10.1136/annrheumdis-2020-217706
   Aravindaram K, 2010, PLANTA MED, V76, P1103, DOI 10.1055/s-0030-1249859
   Baddley JW, 2018, CLIN MICROBIOL INFEC, V24, pS10, DOI 10.1016/j.cmi.2017.12.025
   Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585
   Baud D, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00186
   Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1
   Bermejo-Martin JF, 2009, J INFECT DEV COUNTR, V3, P159, DOI 10.3855/jidc.18
   Bertolini A, 2020, HEPATOLOGY, V72, P1864, DOI 10.1002/hep.31480
   Bhaskar S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01648
   Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995
   Boretti A, 2020, PHARMANUTRITION, V12, DOI 10.1016/j.phanu.2020.100190
   Bowie AG, 2000, J IMMUNOL, V165, P7180, DOI 10.4049/jimmunol.165.12.7180
   Briso EM, 2008, J IMMUNOL, V180, P7102, DOI 10.4049/jimmunol.180.11.7102
   Brisse E, 2016, BRIT J HAEMATOL, V174, P203, DOI 10.1111/bjh.14147
   Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545
   Burrage DR, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01844
   Cai QX, 2020, J HEPATOL, V73, P566, DOI 10.1016/j.jhep.2020.04.006
   Calabrese LH, 2014, NAT REV RHEUMATOL, V10, P720, DOI 10.1038/nrrheum.2014.127
   Canna SW, 2012, PEDIATR CLIN N AM, V59, P329, DOI 10.1016/j.pcl.2012.03.002
   Cantini F, 2020, J INFECTION, V81, P318, DOI 10.1016/j.jinf.2020.04.017
   Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1
   Cassandri M, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.71
   Vazquez MIC, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8980506
   Chang SH, 2010, J BIOL CHEM, V285, P38751, DOI 10.1074/jbc.C110.185777
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1
   Chen YY, 2016, J HUM HYPERTENS, V30, P766, DOI 10.1038/jhh.2016.24
   Cheng AY, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106110
   Chhetri S, 2020, IDCASES, V21, DOI 10.1016/j.idcr.2020.e00829
   Chicca A, 2009, INT IMMUNOPHARMACOL, V9, P850, DOI 10.1016/j.intimp.2009.03.006
   Chien JY, 2006, RESPIROLOGY, V11, P715, DOI 10.1111/j.1440-1843.2006.00942.x
   Ciavarella C, 2020, MOLECULES, V25, DOI 10.3390/molecules25092076
   CTI Biopharma, 2020, CTI BIOPH ANN IN PHA
   Das S, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118202
   Davidson S, 2015, J INTERF CYTOK RES, V35, P252, DOI 10.1089/jir.2014.0227
   Del Valle DM, 2020, NAT MED, V26, P1636, DOI 10.1038/s41591-020-1051-9
   Du XR, 2020, J EXP MED, V217, DOI 10.1084/jem.20190969
   Eccleston-Turner M, 2019, NEW ENGL J MED, V381, P2192, DOI 10.1056/NEJMp1905224
   Diaz FE, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1218297
   Fan ZY, 2020, CLIN GASTROENTEROL H, V18, P1561, DOI 10.1016/j.cgh.2020.04.002
   Feld JJ, 2021, LANCET RESP MED, V9, P498, DOI 10.1016/S2213-2600(20)30566-X
   Finzi E, 2020, INT J INFECT DIS, V99, P307, DOI 10.1016/j.ijid.2020.06.006
   Foerch C, 2020, MULT SCLER RELAT DIS, V42, DOI 10.1016/j.msard.2020.102180
   Foster M, 2012, NUTRIENTS, V4, P676, DOI 10.3390/nu4070676
   Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6
   Garcia P, 2020, DRUG SAFETY, V43, P1315, DOI 10.1007/s40264-020-01013-3
   Gasmi A, 2020, CLIN IMMUNOL, V220, DOI 10.1016/j.clim.2020.108545
   Gomez-Pastora J, 2020, CLIN CHIM ACTA, V509, P249, DOI 10.1016/j.cca.2020.06.033
   Grant WB, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040988
   Grifoni E, 2020, J INFECTION, V81, P466, DOI 10.1016/j.jinf.2020.06.008
   Gulen M, 2020, CLIN RES HEPATOL GAS, V44, pE72, DOI 10.1016/j.clinre.2020.05.001
   Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2
   He ZY, 2010, RESPIRATION, V80, P445, DOI 10.1159/000321374
   He ZP, 2005, INT J INFECT DIS, V9, P323, DOI 10.1016/j.ijid.2004.07.014
   Herrero R, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.12.18
   Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hojyo S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6762343
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hottz ED, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00121
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665
   Iwasaki A, 2011, CELL, V146, P861, DOI 10.1016/j.cell.2011.08.027
   Jang IS, 2014, ASIAN AUSTRAL J ANIM, V27, P749, DOI 10.5713/ajas.2013.13852
   Jenkins MR, 2015, J EXP MED, V212, P307, DOI 10.1084/jem.20140964
   Jesenak M, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00364
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Joachimiak MP, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0008895
   Kalil AC, 2021, NEW ENGL J MED, V384, P795, DOI 10.1056/NEJMoa2031994
   Kany S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236008
   Kapugi M, 2019, ORTHOP NURS, V38, P336, DOI 10.1097/NOR.0000000000000595
   Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032
   Kell DB, 2014, METALLOMICS, V6, P748, DOI 10.1039/c3mt00347g
   Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328
   Kernan KF, 2017, INT IMMUNOL, V29, P401, DOI 10.1093/intimm/dxx031
   Khadka RH, 2019, IMMUNOTHERAPY-UK, V11, P851, DOI 10.2217/imt-2019-0074
   Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229
   Kim ES, 2016, J KOREAN MED SCI, V31, P1717, DOI 10.3346/jkms.2016.31.11.1717
   Kim JS, 2021, THERANOSTICS, V11, P316, DOI 10.7150/thno.49713
   Kim PS, 2020, JAMA-J AM MED ASSOC, V324, P2149, DOI 10.1001/jama.2020.22813
   King A, 2020, LANCET RHEUMATOL, V2, pE379, DOI 10.1016/S2665-9913(20)30160-0
   Kong M, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001557
   Kotenko SV, 2017, J BIOL CHEM, V292, P7295, DOI 10.1074/jbc.R117.777102
   Krishnaveni M, 2013, DRUG INVENT TODAY, V5, P153, DOI [DOI 10.1016/J.DIT.2013.04.002, 10.1016/j.dit.2013.04.002]
   Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099
   La Rosee F, 2020, LEUKEMIA, V34, P1805, DOI 10.1038/s41375-020-0891-0
   Lacroix M, 2015, J BIOL CHEM, V290, P26943, DOI 10.1074/jbc.M115.682138
   Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379
   Lane JCE, 2021, RHEUMATOLOGY, V60, P3222, DOI 10.1093/rheumatology/keaa771
   Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Lee AJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01261
   Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729
   Lee K, 2009, GLOB INST, P1
   Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552
   Lewicka A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081958
   Li GH, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-1069-0
   Li SF, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00334-0
   Li X, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2721-8
   Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179
   Liu J, 2020, J ALLERGY CLIN IMMUN, V146, P325, DOI 10.1016/j.jaci.2020.05.021
   Liu L., 2020, N. Engl. J. Med, V382, P1708, DOI 10.1056/NEJMoa2002032
   Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23
   Liu W, 2020, CHINESE MED J-PEKING, V133, P1032, DOI 10.1097/CM9.0000000000000775
   Liuzzo G, 2021, EUR HEART J, V42, P150, DOI 10.1093/eurheartj/ehaa1005
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Maeda K, 2005, BLOOD, V106, P879, DOI 10.1182/blood-2005-02-0456
   Maeda K, 2009, BLOOD, V113, P4534, DOI 10.1182/blood-2008-12-192559
   Maggini S, 2007, BRIT J NUTR, V98, pS29, DOI 10.1017/S0007114507832971
   Magro G, 2020, MED HYPOTHESES, V142, DOI 10.1016/j.mehy.2020.109829
   Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1422
   Mahmudpour M, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155151
   Mandel M, 2020, CYTOKINE, V134, DOI 10.1016/j.cyto.2020.155190
   Mariette X, 2021, LANCET RESP MED, V9, P295, DOI 10.1016/S2213-2600(20)30556-7
   McElvaney OJ, 2020, AM J RESP CRIT CARE, V202, P812, DOI 10.1164/rccm.202005-1583OC
   McGowan EM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197189
   Mehta P, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01919-2020
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Meng WT, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00273
   MORGAN DB, 1977, BMJ-BRIT MED J, V2, P929, DOI 10.1136/bmj.2.6092.929
   Naseri N, 2018, RES PHARM SCI, V13, P73, DOI 10.4103/1735-5362.220970
   Naz F, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01102
   Nile SH, 2020, CYTOKINE GROWTH F R, V53, P66, DOI 10.1016/j.cytogfr.2020.05.002
   Niu WQ, 2007, TRANSL RES, V150, P374, DOI 10.1016/j.trsl.2007.06.002
   Nugraha RV, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/2560645
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   O'Neill CM, 2013, ENDOCRINOLOGY, V154, P3077, DOI 10.1210/en.2012-2138
   Olaimat AN, 2020, NPJ SCI FOOD, V4, DOI 10.1038/s41538-020-00078-9
   Osugi Y, 1997, BLOOD, V89, P4100, DOI 10.1182/blood.V89.11.4100
   Otieno CA, 2020, WORLD J RES REV, V11, P1, DOI [10.31871/WJRR.11.2.4, DOI 10.31871/WJRR.11.2.4]
   Ott LW, 2007, J PROTEOME RES, V6, P2176, DOI 10.1021/pr060665l
   Pagana KD., 2019, MOSBYS DIAGNOSTIC LA, V14th ed
   Parnham MJ, 2005, EUR J PHARMACOL, V517, P132, DOI 10.1016/j.ejphar.2005.05.023
   Patel, 2020, STATPEARLS
   Pathan N, 2004, LANCET, V363, P203, DOI 10.1016/S0140-6736(03)15326-3
   Pau AK, 2021, ANN INTERN MED, V174, P93, DOI 10.7326/M20-6448
   Poggiali E, 2020, CLIN CHIM ACTA, V509, P135, DOI 10.1016/j.cca.2020.06.012
   Potempa LA, 2020, AM J TROP MED HYG, V103, P561, DOI 10.4269/ajtmh.20-0473
   Prasad AS, 2008, MOL MED, V14, P353, DOI 10.2119/2008-00033.Prasad
   Ragab D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01446
   Rahmani H, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106903
   Rayes J, 2020, RES PRACT THROMB HAE, V4, P23, DOI 10.1002/rth2.12266
   Razzaque MS, 2021, COMPUT STRUCT BIOTEC, V19, P1371, DOI 10.1016/j.csbj.2021.02.015
   Razzaque MS, 2020, ADV HUM BIOL, V10, P99, DOI 10.4103/AIHB.AIHB_75_20
   Razzaque MS, 2020, TOHOKU J EXP MED, V251, P175, DOI 10.1620/tjem.251.175
   REITER Z, 1993, J INTERFERON RES, V13, P247, DOI 10.1089/jir.1993.13.247
   Rex J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00117
   Rivera A, 2019, J INTERF CYTOK RES, V39, P609, DOI 10.1089/jir.2019.0036
   Robinson PC, 2020, MED-CAMBRIDGE, V1, P90, DOI 10.1016/j.medj.2020.11.005
   Robinson PC, 2020, LANCET RHEUMATOL, V2, pE653, DOI 10.1016/S2665-9913(20)30309-X
   Rowaiye A. B., 2021, Tropical Journal of Natural Product Research, V5, P145, DOI 10.26538/tjnpr/v5i1.21
   Rowaiye AB, 2020, CURR DRUG TARGETS, V21, P1733, DOI 10.2174/1389450121666200910160929
   Rowaiye AB, 2020, PAN AFR MED J, V36, DOI 10.11604/pamj.2020.36.188.23476
   Rowe CA, 2007, J AM COLL NUTR, V26, P445, DOI 10.1080/07315724.2007.10719634
   Saemann MD, 2000, FASEB J, V14, P2380
   Sahu K, 2020, J FAM MED PRIM CARE, V9, P2149, DOI 10.4103/jfmpc.jfmpc_728_20
   Sallard E, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104791
   Samad N, 2021, J INFLAMM RES, V14, P527, DOI 10.2147/JIR.S295377
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schrezenmeier E, 2020, NAT REV RHEUMATOL, V16, P155, DOI 10.1038/s41584-020-0372-x
   Schulert GS, 2015, ANNU REV MED, V66, P145, DOI 10.1146/annurev-med-061813-012806
   Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397
   Sepulveda FE, 2013, BLOOD, V121, P595, DOI 10.1182/blood-2012-07-440339
   Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294
   Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276
   Shapiro H, 2009, NUTRITION, V25, P981, DOI 10.1016/j.nut.2009.02.010
   Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547
   Shaw TY, 2016, J INVEST MED HIGH IM, V4, DOI 10.1177/2324709616647409
   Sheeja K, 2007, INTEGR CANCER THER, V6, P66, DOI 10.1177/1534735406298975
   Shi L, 2020, AM J CARDIOL, V130, P163, DOI 10.1016/j.amjcard.2020.06.004
   Shibabaw T, 2020, J INFLAMM RES, V13, P507, DOI 10.2147/JIR.S267280
   Shimabukuro-Vornhagen A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0343-9
   Shorr AF, 2002, CHEST, V121, P1262, DOI 10.1378/chest.121.4.1262
   Sieni E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00167
   Soe WM, 2020, J FUNGI, V6, DOI 10.3390/jof6040231
   Soy M, 2020, CLIN RHEUMATOL, V39, P2085, DOI 10.1007/s10067-020-05190-5
   Stackaruk ML, 2013, EXPERT REV VACCINES, V12, P875, DOI 10.1586/14760584.2013.814871
   Stahl EC, 2015, ORGANOGENESIS, V11, P159, DOI 10.1080/15476278.2015.1120046
   Starzonek J, 2019, PEERJ, V7, DOI 10.7717/peerj.8053
   Stebbing J, 2020, LANCET INFECT DIS, V20, P400, DOI 10.1016/S1473-3099(20)30132-8
   Subei AM, 2015, CNS DRUGS, V29, P565, DOI 10.1007/s40263-015-0261-z
   Sun XJ, 2020, CYTOKINE GROWTH F R, V53, P38, DOI 10.1016/j.cytogfr.2020.04.002
   Syedbasha M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00119
   Szabo Z, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00752
   Takada H, 2003, CLIN EXP IMMUNOL, V133, P448, DOI 10.1046/j.1365-2249.2003.02237.x
   Tamura K, 2008, PEDIATR BLOOD CANCER, V51, P662, DOI 10.1002/pbc.21660
   Tan A, 2018, PROSTAG LEUKOTR ESS, V132, P23, DOI 10.1016/j.plefa.2018.03.010
   Tanaka T, 2016, IMMUNOTHERAPY-UK, V8, P959, DOI 10.2217/imt-2016-0020
   Teijaro JR, 2014, P NATL ACAD SCI USA, V111, P3799, DOI 10.1073/pnas.1400593111
   Tian Y, 2020, ALIMENT PHARM THER, V51, P843, DOI 10.1111/apt.15731
   Tishkowski K, 2021, STATPEARLS
   Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11
   Trapani JA, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1036215
   Tsang K, 2003, RESPIROLOGY, V8, pS25, DOI 10.1046/j.1440-1843.2003.00525.x
   Vandenhaute J, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03089
   Vargas-Vargas M, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.72
   Veiga VC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n84
   Velazquez-Salinas L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01057
   Viza D, 2020, FOLIA BIOL-PRAGUE, V66, P86
   Voskoboinik I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00441
   Wang J, 2020, J LEUKOCYTE BIOL, V108, P17, DOI 10.1002/JLB.3COVR0520-272R
   Wang ZG, 2018, BIOMARK RES, V6, DOI 10.1186/s40364-018-0116-0
   Wee JLK, 2011, VET IMMUNOL IMMUNOP, V144, P95, DOI 10.1016/j.vetimm.2011.07.007
   Weitzel LRB, 2009, CURR OPIN ANESTHESIO, V22, P177, DOI 10.1097/ACO.0b013e328328d32f
   Wessels I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01712
   Wool GD, 2021, PATHOBIOLOGY, V88, P15, DOI 10.1159/000512007
   Wrigley BJ, 2011, EUR J HEART FAIL, V13, P1161, DOI 10.1093/eurjhf/hfr122
   Wu DL, 2017, AM J PATHOL, V187, P2620, DOI 10.1016/j.ajpath.2017.08.007
   Wu MY, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01427-8
   Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC
   Wysocki J, 2006, DIABETES, V55, P2132, DOI 10.2337/db06-0033
   Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049
   Xu J., 2020, LANCET, V395, P1517, DOI [10.1016/S0140-6736(20)30920-X, DOI 10.1016/S0140-6736(20)30920-X]
   Xu L, 2020, LIVER INT, V40, P998, DOI 10.1111/liv.14435
   Xu PY, 2020, ANN HEMATOL, V99, P1205, DOI 10.1007/s00277-020-04019-0
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Yang D, 2020, J INFECT DIS, V222, P734, DOI 10.1093/infdis/jiaa356
   Yang J, 2021, AM J EMERG MED, V39, P34, DOI 10.1016/j.ajem.2020.10.013
   Yang L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00243-2
   Yang X, 2020, LANCET RESP MED, V8, pE26
   Yang Y, 2020, J ALLERGY CLIN IMMUN, V146, P119, DOI 10.1016/j.jaci.2020.04.027
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   Yu  BL, 2020, J THROMB THROMBOLYS, V50, P548, DOI 10.1007/s11239-020-02171-y
   Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1
   Zhang LT, 2020, J THROMB HAEMOST, V18, P1324, DOI 10.1111/jth.14859
   Zhao JN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41760-7
   Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zimmermann P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00302
NR 241
TC 15
Z9 15
U1 6
U2 8
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1178-7031
J9 J INFLAMM RES
JI J. Inflamm. Res.
PY 2021
VL 14
BP 1487
EP 1510
DI 10.2147/JIR.S301784
PG 24
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA RP0MG
UT WOS:000641430500001
PM 33889008
OA gold, Green Submitted, Green Published
DA 2022-04-20
ER

PT J
AU Carin, Y
   Desquennes, C
   Jaworski, L
   Andreff, W
AF Carin, Yann
   Desquennes, Cyprien
   Jaworski, Lukas
   Andreff, Wladimir
TI French men's professional basketball under the economic shock of the
   Covid-19
SO SPORT BUSINESS AND MANAGEMENT-AN INTERNATIONAL JOURNAL
LA English
DT Article; Early Access
DE Covid-19; Professional basketball; Financing; Economic and financial
   crisis
ID FOOTBALL; DIVERSIFICATION; VIRUS
AB Purpose The purpose of this paper is to analyse the economic effects of Covid-19 on French men's professional basketball club championships. Three research questions are raised: What are the characteristics of the economic model of French men's professional basketball? Has this economic model changed over the 2008/2009 to 2018/2019 period? What are the economic effects of the Covid-19 crisis on the finance of French men's professional basketball clubs? Design/methodology/approach Relying on a privileged access to the financial data of professional clubs in the two top-tier divisions (456 observations: 222 in Pro A/Jeep Elite and 234 in Pro B), this research focuses on economic models of French men's professional basketball clubs. The breakdown of revenues, expenses and financial performance is examined over the 2008/2009 to 2018/2019 period. The short-term economic effects of Covid-19 are measured over the 2019/2020 and 2020/2021 seasons. Findings The Covid-19 crisis, at least in the short term (2019/2020 season), has affected revenues and expenses. With the closedown of the championship, two out of three main revenue sources have significantly decreased, while two main expense sources have decreased as well. The net incomes of Jeep Elite and Pro B clubs are in the black contrasting with the 2018/2019 season (pre-Covid) owing to clubs having benefited from governmental and federal measures and a stronger support from local authorities and their shareholders. Practical implications Given the financial difficulties that clubs would have faced without governmental support, the federation and leagues would be well advised to develop a real crisis management competence within professional clubs. Owners of French professional men's basketball clubs must increasingly adopt product diversification strategies to be better prepared for future crises. Originality/value Recent research on the economic effects of Covid-19 has focused on professional and amateur football. To the best of our knowledge, one does not avail detailed research on the potential effects of a health crisis fought with containment measures on professional basketball clubs. French professional basketball deserves to be studied because it has the third largest professional league revenue (behind football and rugby) and it is the second most practiced sport in France. Its sources of finance, which are different from those witnessed in football and rugby, also make it an appropriate subject for study.
C1 [Carin, Yann; Desquennes, Cyprien; Jaworski, Lukas] Univ Lille, URePSSS, Lille, France.
   [Andreff, Wladimir] Univ Paris Sorbonne, Paris, France.
RP Carin, Y (corresponding author), Univ Lille, URePSSS, Lille, France.
EM yann.carin@univ-lille.fr
CR Andreff W., 2000, Journal of Sports Economics, V1, P257
   Andreff W, 2007, J SPORT ECON, V8, P652, DOI 10.1177/1527002506297021
   Arrondel L., 2018, ARGENT FOOTBALL EDIT
   Ascari G., 2006, Journal of Sports Economics, V7, P76, DOI 10.1177/1527002505282869
   Barget E., 2015, REFLETS PERSPECTIVES, V54, P71
   Blumberg L, 2016, INT J INFECT DIS, V47, P38, DOI 10.1016/j.ijid.2016.06.011
   Bourg J.F., 2012, THESIS U TOULOUSE
   Carin Y, 2020, STAPS-SCI TECH ACT P, P29, DOI 10.3917/sta.130.0029
   Dermit-Richard N., 2019, REV FRANCAISE GESTIO, V45, P53
   Dermit-Richard N, 2019, SOCCER SOC, V20, P408, DOI 10.1080/14660970.2017.1323740
   Durand C., 2005, BASKET PROFESSIONNEL
   Fuhner J, 2021, EUR SPORT MANAG Q, V21, P350, DOI 10.1080/16184742.2020.1862273
   Gouguet J, 2015, REFLETS PERSPECTIVES, V3, P5
   Hammerschmidt J, 2021, TECHNOL FORECAST SOC, V165, DOI 10.1016/j.techfore.2021.120572
   Holzmayer F, 2020, J BUS RES, V117, P132, DOI 10.1016/j.jbusres.2020.05.044
   Holzmayer F, 2020, SPORT BUS MANAG, V10, P291, DOI 10.1108/SBM-03-2019-0019
   Horky T, 2021, SOCCER SOC, V22, P96, DOI 10.1080/14660970.2020.1790358
   Kornai J, 2003, J ECON LIT, V41, P1095, DOI 10.1257/002205103771799999
   McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9
   Parnell D, 2022, MANAG SPORT LEIS, V27, P72, DOI 10.1080/23750472.2020.1750100
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Ratten V, 2020, INT J ENTREP BEHAV R, V26, P1379, DOI 10.1108/IJEBR-06-2020-0387
   Scelles N, 2013, APPL ECON, V45, P4184, DOI 10.1080/00036846.2013.770124
   Scelles N., 2017, ROUTLEDGE HDB FOOTBA, P60
   Scelles N, 2018, J SPORT ECON, V19, P603, DOI 10.1177/1527002516674510
   Storm R. K., 2009, Soccer and Society, V10, P459, DOI 10.1080/14660970902771506
   Storm RK, 2012, EUR SPORT MANAG Q, V12, P183, DOI 10.1080/16184742.2012.670660
   Szymanski S, 2019, INT J SPORT FINANC, V14, P54, DOI 10.32731/IJSF.141.022019.05
   Szymanski S, 2017, SCOT J POLIT ECON, V64, P419, DOI 10.1111/sjpe.12134
   Terrien M., 2021, MOVEMENT SPORT SCI, V111, P93, DOI [10.1051/sm/2020014, DOI 10.1051/SM/2020014]
NR 30
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2042-678X
EI 2042-6798
J9 SPORT BUS MANAG
JI Sport Bus. Manag.
DI 10.1108/SBM-05-2021-0057
EA DEC 2021
PG 17
WC Hospitality, Leisure, Sport & Tourism
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA XN4DT
UT WOS:000729458000001
OA Bronze
DA 2022-04-20
ER

PT J
AU Eapen, V
   Dadich, A
   Balachandran, S
   Dani, A
   Howari, R
   Sequeria, AZ
   Singer, JD
AF Eapen, Valsamma
   Dadich, Ann
   Balachandran, Srilaxmi
   Dani, Anitha
   Howari, Rasha
   Sequeria, Anupama Zeena
   Singer, Joel D.
TI E-mental health in child psychiatry during COVID-19: an initial
   attitudinal study
SO AUSTRALASIAN PSYCHIATRY
LA English
DT Article
DE COVID-19; e-mental health; child psychiatry services; qualitative;
   lexical analysis; change management; knowledge translation
AB Objective: COVID-19 propelled e-mental health within the Australian health system. It is important to learn from this to inform mental healthcare during future crises.
   Method: A lexical analysis was conducted of clinician reflections during COVID-19 as they delivered psychiatry services to children and families in New South Wales (n = 6) and transitioned to e-mental health.
   Results: E-mental health can extend the reach of, and access to psychiatry services, particularly for individuals disadvantaged by inequity. Yet e-mental health can be problematic. It is partly contingent on technological prowess, equipment, internet access as well as space and privacy. Relatedly, e-mental health can hinder clinician capacity to conduct examinations, monitor child development as well as assess risk and the need for child protection.
   Conclusions: Given the benefits and limitations of e-mental health, a model that supports face-to-face mental healthcare and e-mental health may be of value. This model would require practical, yet flexible policies and protocols that protect the privacy of children and families, safeguard them from harm, and respect the needs and preferences of children, families and clinicians.
C1 [Eapen, Valsamma] Univ New South Wales Sydney UNSW, Acad Unit Child Psychiat AUCS, Sch Psychiat, Ingham Inst Appl Med Res,South West Sydney Local, Sydney, NSW, Australia.
   [Dadich, Ann] Western Sydney Univ, Sch Business, Sydney Partnership Hlth Educ Res & Enterprise SPH, Knowledge Translat Strateg Platform, Penrith, NSW, Australia.
   [Balachandran, Srilaxmi; Dani, Anitha] Univ Newcastle, Sch Med & Publ Hlth, Child & Adolescent Psychiat, Waratah, NSW, Australia.
   [Balachandran, Srilaxmi; Dani, Anitha] Hunter New England Hlth, Waratah, NSW, Australia.
   [Howari, Rasha] Western Sydney Local Hlth Dist & Childrens Hosp W, Child & Adolescent Psychiat, Westmead, NSW, Australia.
   [Sequeria, Anupama Zeena] Headspace, Mt Druitt, NSW, Australia.
   [Singer, Joel D.] Justice Hlth, Child & Adolescent & Forens Psychiat, Malabar, NSW, Australia.
RP Eapen, V (corresponding author), UNSW Sydney, Acad Unit Child Psychiat, South West Sydney AUCS, ICAMHS,L1 MHC,Liverpool Hosp, Elizabeth St, Sydney, NSW 2170, Australia.
EM V.Eapen@unsw.edu.au
RI Eapen, Valsamma/N-9608-2017
OI Eapen, Valsamma/0000-0001-6296-8306
CR Angus-Leppan T, 2010, BUS STRATEG ENVIRON, V19, P230, DOI 10.1002/bse.675
   Braun V., 2019, HDB RES METHODS HLTH, P843, DOI [DOI 10.1007/978-981-10-5251-4_103, 10.1007/978-981-10-5251-4_103, 10.1007/978-981-10-2779-6_103-1]
   Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806
   Dadich A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7494-6
   Fairclough Norman, 1995, CRITICAL DISCOURSE A
   Griffiths K, 2007, AUSTRALAS PSYCHIATRY, V15, P100, DOI 10.1080/10398560601123716
   Guest G., 2012, APPL THEMATIC ANAL
   Haropoulou M., 2013, ORG DECISION MAKING
   Hewett DG, 2009, SOC SCI MED, V69, P1732, DOI 10.1016/j.socscimed.2009.09.048
   Leximancer, 2018, LEX
   Leximancer, 2011, LEX MAN
   Leximancer, 2013, UND DISPL OUTP
   Leximancer, 2018, LEX US GUID REL 4 5
   Leximancer, FAQ
   Masi A, 2021, J PAEDIATR CHILD H, V57, P631, DOI 10.1111/jpc.15285
   Smith AE, 2006, BEHAV RES METHODS, V38, P262, DOI 10.3758/BF03192778
NR 16
TC 0
Z9 0
U1 4
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1039-8562
EI 1440-1665
J9 AUSTRALAS PSYCHIATRY
JI Australas. Psychiatry
PD OCT
PY 2021
VL 29
IS 5
BP 498
EP 503
DI 10.1177/10398562211022748
EA JUN 2021
PG 6
WC Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Psychiatry
GA YU1YX
UT WOS:000667888700001
PM 34126787
OA Bronze
DA 2022-04-20
ER

PT J
AU Camilleri, MA
   Camilleri, AC
AF Camilleri, Mark Anthony
   Camilleri, Adriana Caterina
TI The Acceptance of Learning Management Systems and Video Conferencing
   Technologies: Lessons Learned from COVID-19
SO TECHNOLOGY KNOWLEDGE AND LEARNING
LA English
DT Article; Early Access
DE Perceived usefulness; Perceived interactivity; Facilitating conditions;
   Video conferencing; Learning management systems; SEM-PLS
ID HIGHER-EDUCATION STUDENTS; PRESERVICE TEACHERS; MOBILE DEVICES;
   INFORMATION-TECHNOLOGY; BEHAVIORAL INTENTION; UNIVERSITY-STUDENTS;
   AUGMENTED REALITY; USER ACCEPTANCE; SOCIAL MEDIA; PERFORMANCE
AB During the outbreak of the Coronavirus (COVID-19) pandemic, higher education institutions (HEIs) have shifted from traditional and blended learning approaches to a fully virtual course delivery. This research investigates the students' perceptions on remote learning through asynchronous learning management systems (LMS) and via synchronous video conferencing technologies like Google Meet, Microsoft Teams or Zoom, among others. The data was gathered from a sample of 501 higher education students in a Southern European context. A survey questionnaire included measures that investigated the participants' acceptance of interactive technology to better understand their utilitarian motivations to use them. The findings suggest that the research participants accessed asynchronous content and interacted with online users, including with their course instructor, in real time. While there are a number of theoretical or opinion papers on the impact of COVID-19 on higher education services, currently, there are still a few empirical papers that shed light on the factors that are having an effect on the students' attitudes and intentions to utilize remote learning technologies. This contribution underlines the importance of maintaining ongoing, interactive engagement with students, and of providing them with appropriate facilitating conditions, to continue improving their learning journey.
C1 [Camilleri, Mark Anthony] Univ Malta, Fac Media & Knowledge Management, Dept Corp Commun, MSD-2080 Msida, Malta.
   [Camilleri, Mark Anthony] Univ Edinburgh, Business Sch, Bucchleuch Pl, Edinburgh EH8 9JS, Midlothian, Scotland.
   [Camilleri, Adriana Caterina] Malta Coll Arts Sci & Technol, Curriculum Dept, PLA-9032 Paola, Malta.
RP Camilleri, MA (corresponding author), Univ Malta, Fac Media & Knowledge Management, Dept Corp Commun, MSD-2080 Msida, Malta.; Camilleri, MA (corresponding author), Univ Edinburgh, Business Sch, Bucchleuch Pl, Edinburgh EH8 9JS, Midlothian, Scotland.
EM mark.a.camilleri@um.edu.mt; adriana.camilleri@mcast.edu.mt
RI Camilleri, Mark Anthony/R-4574-2016
OI Camilleri, Mark Anthony/0000-0003-1288-4256; Camilleri, Adriana
   Caterina/0000-0002-5514-2597
CR Agudo-Peregrina AF, 2014, COMPUT HUM BEHAV, V31, P542, DOI 10.1016/j.chb.2013.05.031
   Aguilar SJ, 2020, INFORM LEARN SCI, V121, P285, DOI 10.1108/ILS-04-2020-0084
   Ahmed E, 2016, COMPUT HUM BEHAV, V63, P152, DOI 10.1016/j.chb.2016.05.043
   Ainsworth S, 2006, LEARN INSTR, V16, P183, DOI 10.1016/j.learninstruc.2006.03.001
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Al-Maroof R, 2021, TECHNOL KNOWL LEARN, DOI 10.1007/s10758-021-09519-0
   Al-Rahmi WM, 2018, COMPUT EDUC, V121, P59, DOI 10.1016/j.compedu.2018.02.010
   Gomez-Aguilar DA, 2015, COMPUT HUM BEHAV, V47, P60, DOI 10.1016/j.chb.2014.11.001
   Althunibat A, 2015, COMPUT HUM BEHAV, V52, P65, DOI 10.1016/j.chb.2015.05.046
   Anshari M, 2017, EDUC INF TECHNOL, V22, P3063, DOI 10.1007/s10639-017-9572-7
   Sanchez RA, 2010, COMPUT HUM BEHAV, V26, P1632, DOI 10.1016/j.chb.2010.06.011
   Bao W, 2020, HUM BEHAV EMERG TECH, V2, P113, DOI 10.1002/hbe2.191
   Baturay MH, 2017, INT J TECHNOL ENHANC, V9, P1, DOI 10.1504/IJTEL.2017.10003119
   Bergdahl N, 2021, TECHNOL KNOWL LEARN, V26, P443, DOI 10.1007/s10758-020-09470-6
   Billinghurst M, 2012, COMPUTER, V45, P56, DOI 10.1109/MC.2012.111
   Boelens R, 2018, COMPUT EDUC, V120, P197, DOI 10.1016/j.compedu.2018.02.009
   Bolumole M, 2020, HIGH EDUC RES DEV, V39, P1357, DOI 10.1080/07294360.2020.1825345
   Briz-Ponce L, 2017, COMPUT HUM BEHAV, V72, P612, DOI 10.1016/j.chb.2016.05.027
   Butler A, 2021, STRATEGIC CORPORATE COMMUNICATION IN THE DIGITAL AGE, P115, DOI 10.1108/978-1-80071-264-520211007
   Camilleri M.A., 2021, MANAGE EDUC, V35, P10, DOI [10.1177/0892020620921412, DOI 10.1177/0892020620921412]
   Camilleri MA, 2021, INT J QUAL SERV SCI, V13, P268, DOI 10.1108/IJQSS-03-2020-0034
   Camilleri MA, 2020, 2020 11TH INTERNATIONAL CONFERENCE ON E-EDUCATION, E-BUSINESS, E-MANAGEMENT, AND E-LEARNING (IC4E 2020), P48, DOI 10.1145/3377571.3377574
   Camilleri MA, 2019, INTERACT TECHNOL SMA, V17, P28, DOI 10.1108/ITSE-06-2019-0027
   Camilleri MA, 2017, TECHNOL KNOWL LEARN, V22, P65, DOI 10.1007/s10758-016-9287-7
   Sanchez-Prieto JC, 2017, COMPUT HUM BEHAV, V72, P644, DOI 10.1016/j.chb.2016.09.061
   Cesco S., 2021, INT J HIGHER ED, V10, P285, DOI [10.5430/ijhe.v10n3p285, DOI 10.5430/IJHE.V10N3P285]
   Chattaraman V, 2019, COMPUT HUM BEHAV, V90, P315, DOI 10.1016/j.chb.2018.08.048
   Chen YL, 2014, COMPUT EDUC, V79, P16, DOI 10.1016/j.compedu.2014.07.004
   Cheng MT, 2018, COMPUT EDUC, V120, P241, DOI 10.1016/j.compedu.2018.02.004
   Cheon J, 2012, COMPUT EDUC, V59, P1054, DOI 10.1016/j.compedu.2012.04.015
   Cochrane TD, 2014, BRIT J EDUC TECHNOL, V45, P65, DOI 10.1111/j.1467-8535.2012.01384.x
   Crompton H., 2018, COMPUT EDUC, V123, P53, DOI [10.1016/j.compedu.2018.04.007, DOI 10.1016/j.compedu.2018.04.007]
   Cruz-Benito J, 2015, COMPUT HUM BEHAV, V47, P18, DOI 10.1016/j.chb.2014.11.028
   Dabbagh N, 2012, INTERNET HIGH EDUC, V15, P3, DOI 10.1016/j.iheduc.2011.06.002
   Dalgarno B, 2010, BRIT J EDUC TECHNOL, V41, P10, DOI 10.1111/j.1467-8535.2009.01038.x
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   Araujo FJD, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112977
   Decman M, 2015, COMPUT HUM BEHAV, V49, P272, DOI 10.1016/j.chb.2015.03.022
   Di Mitri D, 2018, J COMPUT ASSIST LEAR, V34, P338, DOI 10.1111/jcal.12288
   Dumpit DZ, 2017, INT J EDUC TECHNOL H, V14, DOI 10.1186/s41239-017-0045-2
   Fiore AM, 2003, INTERNET RES, V13, P38, DOI 10.1108/10662240310458369
   Fitter NT, 2020, IEEE ROBOT AUTOM LET, V5, P2706, DOI 10.1109/LRA.2020.2970939
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fowler C, 2015, BRIT J EDUC TECHNOL, V46, P412, DOI 10.1111/bjet.12135
   Fridin M, 2014, COMPUT EDUC, V70, P53, DOI 10.1016/j.compedu.2013.07.043
   Furio D, 2015, J COMPUT ASSIST LEAR, V31, P189, DOI 10.1111/jcal.12071
   Gangwar H, 2015, J ENTERP INF MANAG, V28, P107, DOI 10.1108/JEIM-08-2013-0065
   Gikandi JW, 2011, COMPUT EDUC, V57, P2333, DOI 10.1016/j.compedu.2011.06.004
   Gonzalez T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239490
   Hair JF, 2020, J BUS RES, V109, P101, DOI 10.1016/j.jbusres.2019.11.069
   Hartshorne Richard, 2009, Journal of Computing in Higher Education, V21, P183, DOI 10.1007/s12528-009-9023-6
   Heilesen SB, 2010, COMPUT EDUC, V55, P1063, DOI 10.1016/j.compedu.2010.05.002
   Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8
   Howley I, 2020, INFORM LEARN SCI, V121, P549, DOI 10.1108/ILS-04-2020-0086
   Hung STA, 2016, COMPUT EDUC, V98, P90, DOI 10.1016/j.compedu.2016.03.009
   Ifenthaler D, 2013, COMPUT HUM BEHAV, V29, P525, DOI 10.1016/j.chb.2012.11.004
   Ifenthaler D, 2012, EDUC TECHNOL SOC, V15, P38
   Jeno LM, 2017, COMPUT EDUC, V107, P1, DOI 10.1016/j.compedu.2016.12.011
   Johnson N, 2020, ONLINE LEARN, V24, P6, DOI 10.24059/olj.v24i2.2285
   Khalifa M, 1999, DECIS SUPPORT SYST, V26, P195, DOI 10.1016/S0167-9236(99)00028-7
   Klasnja-Milicevic A, 2011, COMPUT EDUC, V56, P885, DOI 10.1016/j.compedu.2010.11.001
   Kurucay M, 2017, COMPUT EDUC, V115, P20, DOI 10.1016/j.compedu.2017.06.010
   Lambic D, 2016, COMPUT HUM BEHAV, V61, P313, DOI 10.1016/j.chb.2016.03.052
   Lambropoulos N, 2012, BRIT J EDUC TECHNOL, V43, P295, DOI 10.1111/j.1467-8535.2011.01184.x
   Lee YH, 2011, EDUC TECHNOL SOC, V14, P124
   Lee Y, 2014, COMPUT EDUC, V73, P121, DOI 10.1016/j.compedu.2014.01.001
   Lin SJ, 2013, COMPUT EDUC, V68, P416, DOI 10.1016/j.compedu.2013.06.003
   Liu IF, 2010, COMPUT EDUC, V54, P600, DOI 10.1016/j.compedu.2009.09.009
   Liu YP, 2003, J ADVERTISING RES, V43, P207, DOI 10.2501/JAR-43-2-207-216
   Liyanagunawardena TR, 2013, INT REV RES OPEN DIS, V14, P202, DOI 10.19173/irrodl.v14i3.1455
   MacKenzie SB, 2012, J RETAILING, V88, P542, DOI 10.1016/j.jretai.2012.08.001
   Makransky G, 2019, LEARN INSTR, V60, P225, DOI 10.1016/j.learninstruc.2017.12.007
   McMillan SJ, 2002, J ADVERTISING, V31, P29, DOI 10.1080/00913367.2002.10673674
   McStay A, 2020, LEARN MEDIA TECHNOL, V45, P270, DOI 10.1080/17439884.2020.1686016
   Merhi MI, 2015, COMPUT EDUC, V83, P32, DOI 10.1016/j.compedu.2014.12.014
   Moore JL, 2011, INTERNET HIGH EDUC, V14, P129, DOI 10.1016/j.iheduc.2010.10.001
   Moss ND, 2010, COMPUT HUM BEHAV, V26, P302, DOI 10.1016/j.chb.2009.10.012
   Motiwalla LF, 2007, COMPUT EDUC, V49, P581, DOI 10.1016/j.compedu.2005.10.011
   Ng W, 2012, COMPUT EDUC, V59, P1065, DOI 10.1016/j.compedu.2012.04.016
   Ngai EWT, 2007, COMPUT EDUC, V48, P250, DOI 10.1016/j.compedu.2004.11.007
   Thai NTT, 2017, COMPUT EDUC, V107, P113, DOI 10.1016/j.compedu.2017.01.003
   Nistor N, 2013, COMPUT EDUC, V68, P284, DOI 10.1016/j.compedu.2013.05.016
   Ocak MA, 2011, COMPUT EDUC, V56, P689, DOI 10.1016/j.compedu.2010.10.011
   Ozkan S, 2009, COMPUT EDUC, V53, P1285, DOI 10.1016/j.compedu.2009.06.011
   Park JY, 2015, TECHNOL PEDAGOG EDUC, V24, P389, DOI 10.1080/1475939X.2014.935743
   Park SY, 2012, BRIT J EDUC TECHNOL, V43, P592, DOI 10.1111/j.1467-8535.2011.01229.x
   Patricia Aguilera-Hermida A, 2020, Int J Educ Res Open, V1, P100011, DOI 10.1016/j.ijedro.2020.100011
   Payne K, 2017, COMPUT HUM BEHAV, V77, P95, DOI 10.1016/j.chb.2017.08.029
   Porter WW, 2014, COMPUT EDUC, V75, P185, DOI 10.1016/j.compedu.2014.02.011
   Qimei Chen, 2007, Electronic Commerce Research, V7, P315, DOI 10.1007/s10660-007-9009-2
   Rahiem Maila DH, 2020, INT J LEARNING TEACH, V19, P1, DOI [DOI 10.26803/IJLTER.19.6.1, 10.26803/ijlter.19.6.1]
   Rakes CR, 2020, EDUC RES REV-NETH, V31, DOI 10.1016/j.edurev.2020.100337
   Rana NP, 2019, COMPUT HUM BEHAV, V101, P114, DOI 10.1016/j.chb.2019.07.022
   Rienties B, 2016, COMPUT HUM BEHAV, V60, P333, DOI 10.1016/j.chb.2016.02.074
   Ringle C.M., 2014, ACAD MANAGE REV, V9, P419
   Rodgers, 2006, J INTERACTIVE ADVERT, V6, P5, DOI DOI 10.1080/15252019.2006.10722117
   Sablic M, 2021, TECHNOL KNOWL LEARN, V26, P1061, DOI 10.1007/s10758-020-09455-5
   Sanchez-Franco MJ, 2010, COMPUT EDUC, V54, P37, DOI 10.1016/j.compedu.2009.07.005
   Sanchez-Franco MJ, 2009, COMPUT EDUC, V52, P588, DOI 10.1016/j.compedu.2008.11.006
   Schoonenboom J, 2014, COMPUT EDUC, V71, P247, DOI 10.1016/j.compedu.2013.09.016
   Selwyn N, 2010, J COMPUT ASSIST LEAR, V26, P65, DOI 10.1111/j.1365-2729.2009.00338.x
   Shih HP, 2008, COMPUT EDUC, V50, P327, DOI 10.1016/j.compedu.2006.06.001
   Soflano M, 2015, COMPUT EDUC, V86, P192, DOI 10.1016/j.compedu.2015.03.015
   Sun PC, 2008, COMPUT EDUC, V50, P1183, DOI 10.1016/j.compedu.2006.11.007
   Sung YT, 2016, COMPUT EDUC, V94, P252, DOI 10.1016/j.compedu.2015.11.008
   Sung YT, 2015, EDUC RES REV-NETH, V16, P68, DOI 10.1016/j.edurev.2015.09.001
   Tam M., 2000, Educational Technology & Society, V3
   Tao YH, 2009, COMPUT EDUC, V53, P929, DOI 10.1016/j.compedu.2009.05.009
   Teo T, 2014, J COMPUT HIGH EDUC, V26, P124, DOI 10.1007/s12528-014-9080-3
   Teo T, 2009, COMPUT EDUC, V52, P302, DOI 10.1016/j.compedu.2008.08.006
   Valk JH, 2010, INT REV RES OPEN DIS, V11, P117, DOI 10.19173/irrodl.v11i1.794
   van Raaij EM, 2008, COMPUT EDUC, V50, P838, DOI 10.1016/j.compedu.2006.09.001
   Vanderhoven E, 2015, COMPUT EDUC, V81, P123, DOI 10.1016/j.compedu.2014.10.001
   Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540
   Venkatesh V, 2012, MIS QUART, V36, P157
   Viberg O, 2013, COMPUT EDUC, V69, P169, DOI 10.1016/j.compedu.2013.07.014
   Lopez-Perez MV, 2011, COMPUT EDUC, V56, P818, DOI 10.1016/j.compedu.2010.10.023
   Hoi VN, 2020, COMPUT EDUC, V146, DOI 10.1016/j.compedu.2019.103761
   Wang QY, 2009, COMPUT EDUC, V53, P1138, DOI 10.1016/j.compedu.2009.05.023
   Wang QY, 2009, INTERACT LEARN ENVIR, V17, P95, DOI 10.1080/10494820701706320
   Wang YS, 2009, BRIT J EDUC TECHNOL, V40, P92, DOI 10.1111/j.1467-8535.2007.00809.x
   Wu, 2005, J INTERACT ADVERT, V5, P29, DOI [10.1080/15252019.2005.10722099, DOI 10.1080/15252019.2005.10722099]
   Wu HK, 2013, COMPUT EDUC, V62, P41, DOI 10.1016/j.compedu.2012.10.024
NR 123
TC 3
Z9 3
U1 10
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2211-1662
EI 2211-1670
J9 TECHNOL KNOWL LEARN
JI Technol. Knowl. Learn.
DI 10.1007/s10758-021-09561-y
EA AUG 2021
PG 23
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA TZ5TE
UT WOS:000684533900001
OA Green Submitted, Bronze
DA 2022-04-20
ER

PT J
AU Pang, JJ
   Huang, Y
   Xie, ZZ
   Li, JB
   Cai, ZP
AF Pang, Junjie
   Huang, Yan
   Xie, Zhenzhen
   Li, Jianbo
   Cai, Zhipeng
TI Collaborative City Digital Twin for the COVID-19 Pandemic: A Federated
   Learning Solution
SO TSINGHUA SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Urban areas; COVID-19; Data models; Collaboration; Predictive models;
   Pandemics; Training; COVID-19; Digital Twin (DT); Federated Learning
   (FL); deep learning
ID PRIVACY; FRAMEWORK; INTERNET; CLOUD
AB The novel coronavirus, COVID-19, has caused a crisis that affects all segments of the population. As the knowledge and understanding of COVID-19 evolve, an appropriate response plan for this pandemic is considered one of the most effective methods for controlling the spread of the virus. Recent studies indicate that a city Digital Twin (DT) is beneficial for tackling this health crisis, because it can construct a virtual replica to simulate factors, such as climate conditions, response policies, and people's trajectories, to help plan efficient and inclusive decisions. However, a city DTsystem relies on long-term and high-quality data collection to make appropriate decisions, limiting its advantages when facing urgent crises, such as the COVID-19 pandemic. Federated Learning (FL), in which all clients can learn a shared model while retaining all training data locally, emerges as a promising solution for accumulating the insights from multiple data sources efficiently Furthermore, the enhanced privacy protection settings removing the privacy barriers lie in this collaboration. In this work, we propose a framework that fused city DT with FL to achieve a novel collaborative paradigm that allows multiple city DTs to share the local strategy and status quickly. In particular, an FL central server manages the local updates of multiple collaborators (city DTs), providing a global model that is trained in multiple iterations at different city DT systems until the model gains the correlations between various response plans and infection trends. This approach means a collaborative city DT paradigm fused with FL techniques can obtain knowledge and patterns from multiple DTs and eventually establish a 'global view' of city crisis management. Meanwhile, it also helps improve each city's DT by consolidating other DT's data without violating privacy rules. In this paper, we use the COVID-19 pandemic as the use case of the proposed framework. The experimental results on a real dataset with various response plans validate our proposed solution and demonstrate its superior performance.
C1 [Pang, Junjie; Li, Jianbo] Qingdao Univ, Coll Comp Sci & Technol, Qingdao 266000, Peoples R China.
   [Pang, Junjie] Qingdao Univ, Business Sch, Qingdao 266000, Peoples R China.
   [Huang, Yan] Kennesaw State Univ, Coll Comp & Software Engn, Atlanta, GA 30060 USA.
   [Xie, Zhenzhen] Jilin Univ, Coll Comp Sci & Technol, Changchun 130012, Peoples R China.
   [Cai, Zhipeng] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30303 USA.
RP Li, JB (corresponding author), Qingdao Univ, Coll Comp Sci & Technol, Qingdao 266000, Peoples R China.
EM pangjj18@163.com; yhuang24@kennesaw.edu; xiezz14@mails.jlu.edu.cn;
   lijianbo@188.com; zcai@gsu.edu
OI Cai, Zhipeng/0000-0001-6017-975X
FU National Key Research and Development program of China [2017YFA0604500,
   2018YFB2100303]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China (NSFC) [61701190]; Key Technology
   Innovation Cooperation Project of the Government and University for the
   Entire Industry Demonstration [SXGJSF2017-4]; Program for Innovative
   Postdoctoral Talents in Shandong Province [40618030001]
FX This work was supported in part by the National Key Research and
   Development program of China (Nos. 2017YFA0604500 and 2018YFB2100303),
   in part by the National Natural Science Foundation of China (No.
   61701190), in part by the Key Technology Innovation Cooperation Project
   of the Government and University for the Entire Industry Demonstration
   (No. SXGJSF2017-4), and the Program for Innovative Postdoctoral Talents
   in Shandong Province (No. 40618030001).
CR Abu Basim NM, 2017, 2017 INTERNATIONAL CONFERENCE ON INNOVATIONS IN ELECTRICAL, ELECTRONICS, INSTRUMENTATION AND MEDIA TECHNOLOGY (ICIEEIMT), P1, DOI 10.1109/ICIEEIMT.2017.8116804
   Adhikari B, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P577, DOI 10.1145/3292500.3330917
   Bagaria N., 2020, CONNECTED HLTH SMART, P143
   Bai S., 2018, ARXIV
   Cai ZP, 2019, INT CON DISTR COMP S, P144, DOI 10.1109/ICDCS.2019.00023
   Cai ZP, 2019, IEEE T IND INFORM, V15, P6492, DOI 10.1109/TII.2019.2911697
   Cai ZP, 2020, IEEE T NETW SCI ENG, V7, P766, DOI 10.1109/TNSE.2018.2830307
   Cai ZP, 2018, IEEE T DEPEND SECURE, V15, P577, DOI 10.1109/TDSC.2016.2613521
   Chen HX, 2017, TSINGHUA SCI TECHNOL, V22, P682, DOI 10.23919/TST.2017.8195350
   Chen YQ, 2020, IEEE INTELL SYST, V35, P83, DOI 10.1109/MIS.2020.2988604
   Croatti A, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01623-5
   Dembski F, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12062307
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Fan C, 2020, J MANAGE ENG, V36, DOI 10.1061/(ASCE)ME.1943-5479.0000745
   Fan C, 2021, INT J INFORM MANAGE, V56, DOI 10.1016/j.ijinfomgt.2019.102049
   Francisco A, 2020, J MANAGE ENG, V36, DOI 10.1061/(ASCE)ME.1943-5479.0000741
   Hard A., 2018, ARXIV PREPRINT ARXIV
   He ZB, 2018, TSINGHUA SCI TECHNOL, V23, P389, DOI 10.26599/TST.2018.9010037
   Holstein W. J, 2016, VIRTUAL SINGAPORE CR
   Jianjiang Li, 2020, Big Data Mining and Analytics, V3, P131, DOI 10.26599/BDMA.2019.9020022
   Kumar Sunil, 2019, Big Data Mining and Analytics, V2, P48, DOI 10.26599/BDMA.2018.9020031
   Long G., 2020, FEDERATED LEARNING, P240
   Lu FS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08082-0
   McMahan HB, 2017, PR MACH LEARN RES, V54, P1273
   Nieto-Chaupis H, 2019, 2019 IEEE 9TH ANNUAL COMPUTING AND COMMUNICATION WORKSHOP AND CONFERENCE (CCWC), P654, DOI 10.1109/CCWC.2019.8666474
   Pang JJ, 2021, IEEE INTERNET THINGS, V8, P3088, DOI 10.1109/JIOT.2020.3007662
   Ryffel T, 2018, ARXIV PREPRINT ARXIV
   Shi BY, 2019, 2019 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE (WI 2019), P486, DOI 10.1145/3350546.3360738
   Wang LJ, 2019, THIRTY-THIRD AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTY-FIRST INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / NINTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, P9607
   Wang Z, 2020, TSINGHUA SCI TECHNOL, V25, P161, DOI 10.26599/TST.2018.9010126
   Wei Zhong, 2020, Big Data Mining and Analytics, V3, P181, DOI 10.26599/BDMA.2020.9020003
   Xue F, 2020, ISPRS J PHOTOGRAMM, V167, P418, DOI 10.1016/j.isprsjprs.2020.07.020
   Yang H, 2021, TSINGHUA SCI TECHNOL, V26, P230, DOI 10.26599/TST.2019.9010061
   Yang K, 2021, TSINGHUA SCI TECHNOL, V26, P208, DOI 10.26599/TST.2019.9010059
   Zhao L, 2015, IEEE DATA MINING, P639, DOI 10.1109/ICDM.2015.39
   Zheng X, 2020, IEEE J SEL AREA COMM, V38, P968, DOI 10.1109/JSAC.2020.2980802
   Zheng X, 2018, IEEE COMMUN MAG, V56, P55, DOI 10.1109/MCOM.2018.1701245
   Zhonglin Ye, 2019, Big Data Mining and Analytics, V2, P248, DOI 10.26599/BDMA.2019.9020009
   Zhou YZ, 2017, TSINGHUA SCI TECHNOL, V22, P714, DOI 10.23919/TST.2017.8195353
   Zou B, 2018, WEB CONFERENCE 2018: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW2018), P87, DOI 10.1145/3178876.3186050
NR 40
TC 18
Z9 18
U1 19
U2 55
PU TSINGHUA UNIV PRESS
PI BEIJING
PA B605D, XUE YAN BUILDING, BEIJING, 100084, PEOPLES R CHINA
SN 1007-0214
EI 1878-7606
J9 TSINGHUA SCI TECHNOL
JI Tsinghua Sci. Technol.
PD OCT
PY 2021
VL 26
IS 5
BP 759
EP 771
DI 10.26599/TST.2021.9010026
PG 13
WC Computer Science, Information Systems; Computer Science, Software
   Engineering; Engineering, Electrical & Electronic
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Computer Science; Engineering
GA RT5IV
UT WOS:000644494400014
OA Green Submitted, gold
DA 2022-04-20
ER

PT J
AU Racey, CS
   Donken, R
   Porter, I
   Albert, A
   Bettinger, JA
   Mark, J
   Bonifacio, L
   Dawar, M
   Gagel, M
   Kling, R
   Mema, S
   Mitchell, H
   Roe, I
   Ogilvie, G
   Sadarangani, M
AF Racey, Sarai
   Donken, Robine
   Porter, Imogen
   Albert, Arianne
   Bettinger, Julie A.
   Mark, Jennifer
   Bonifacio, Lizl
   Dawar, Meena
   Gagel, Mike
   Kling, Rakel
   Mema, Silvina
   Mitchell, Hana
   Roe, Ian
   Ogilvie, Gina
   Sadarangani, Manish
TI Intentions of public school teachers in British Columbia, Canada to
   receive a COVID-19 vaccine
SO VACCINE: X
LA English
DT Article
DE Vaccines; COVID-19; Public health; Infectious disease; Health policy
ID HESITANCY
AB Background: To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada.
   Methods: A population-wide cross-sectional online survey from August to November 2020 asked all BC public school teachers with an available email address how likely they were to receive a COVID-19 vaccine. Two multivariable logistic regression models explored separately sociodemographic and vaccine hesitancy predictors for intention to receive a COVID-19 vaccine.
   Results: A total of 5,076 teachers participated. The majority, 89.7%, reported they were likely or very likely to accept a COVID-19 vaccine. In multivariable regression, sociodemographic predictors of intention to be vaccinated included being male, having an educational background in science or engineering, and using reliable information sources on vaccination such as public health and health care providers. Teachers who reported lower levels of vaccine hesitancy, higher general vaccine knowledge, and belief that COVID-19 was a serious illness were more likely to intend to receive a COVID-19 vaccine.
   Conclusion: A high proportion of public-school teachers in BC intend to receive a COVID-19 vaccine. Continued monitoring of vaccine intentions will be important to inform public health vaccine implementation. (C) 2021 The Author(s). Published by Elsevier Ltd.
C1 [Racey, Sarai; Donken, Robine; Dawar, Meena; Mema, Silvina; Ogilvie, Gina] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.
   [Racey, Sarai; Donken, Robine; Albert, Arianne; Ogilvie, Gina] Womens Hlth Res Inst, British Columbia Womens Hosp & Hlth Ctr, Vancouver, BC, Canada.
   [Porter, Imogen; Bettinger, Julie A.; Mark, Jennifer; Bonifacio, Lizl; Sadarangani, Manish] BC Childrens Hosp Res Inst, Vaccine Evaluat Ctr, 950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.
   [Bettinger, Julie A.; Mitchell, Hana; Sadarangani, Manish] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.
   [Dawar, Meena] Vancouver Costal Hlth Author, Vancouver, BC, Canada.
   [Gagel, Mike; Kling, Rakel] Northern Hlth Author, Prince George, BC, Canada.
   [Mema, Silvina] Interior Hlth Author, Kelowna, BC, Canada.
   [Mitchell, Hana] BC Childrens Hosp Res Inst, Vancouver, BC, Canada.
   [Ogilvie, Gina] BC Ctr Dis Control, Vancouver, BC, Canada.
   [Donken, Robine] Vrije Univ Amsterdam, Amsterdam UMC, Dept Epidemiol & Data Sci, Amsterdam, Netherlands.
RP Sadarangani, M (corresponding author), BC Childrens Hosp Res Inst, Vaccine Evaluat Ctr, 950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.
EM msadarangani@bcchr.ubc.ca
OI Bettinger, Julie/0000-0002-2118-4174; Sadarangani,
   Manish/0000-0002-9985-6452; Albert, Arianne/0000-0002-3050-0888; Porter,
   Imogen/0000-0002-9451-8606
FU BC Immunization Committee; Michael Smith Foundation for Health
   ResearchMichael Smith Foundation for Health Research
FX The study was supported by the BC Immunization Committee. We wish to
   thank Kim Marty and Caitlyn Southey for assistance with study and data
   management.; CSR is supported by a fellowship from the Michael Smith
   Foundation for Health Research.
CR Arim R, 2020, STAT CANADA, P1
   BC Centre for Disease Control, BCS PLAN VACC DISTR
   British Columbia Centre for Disease Control and BC Children's Hospital, 2020, IMP SCH CLOS LEARN C
   British Columbia Teachers' Federation, 2018, TEACH BRIT COL FEM W
   DataBC, 2018, BRIT COL PUBL SCH TE
   de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0
   Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y
   Government of British Columbia, BRIT COL POP EST
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Head KJ, 2020, SCI COMMUN, V42, P698, DOI 10.1177/1075547020960463
   Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037
   Lee J, 2020, LANCET CHILD ADOLESC, V4, P421, DOI 10.1016/S2352-4642(20)30109-7
   Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9
   National Advisory Committee on Immunization, 2020, PREL GUID KEY POP EA
   Ogilvie G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000270
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Public Health Agency of Canada, 2020, VACC COV CAN CHILDR
   R Core Team, R PROJECT STAT COMPU
   Rahman M, 2015, CLIN PEDIATR, V54, P371, DOI 10.1177/0009922814551135
   Rhodes A, 2021, LANCET INFECT DIS, V21, pE110, DOI 10.1016/S1473-3099(20)30724-6
   Schaffer DeRoo S, 2020, JAMA-J AM MED ASSOC, V323, P2458, DOI 10.1001/jama.2020.8711
   Shapiro GK, 2018, VACCINE, V36, P660, DOI 10.1016/j.vaccine.2017.12.043
   The American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C, DOI [10.1207/s15327906mbr2501_2, DOI 10.1207/S15327906MBR2501_2]
   Van Lancker W, 2020, LANCET PUBLIC HEALTH, V5, pE243, DOI 10.1016/S2468-2667(20)30084-0
   Wang JH, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030482
   WHO, 2020, DRAFT LANDSC COVID 1
   Wong CA, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-0973
   Xiao, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]
   Zingg A, 2012, VACCINE, V30, P3771, DOI 10.1016/j.vaccine.2012.03.014
NR 30
TC 4
Z9 4
U1 1
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2590-1362
J9 VACCINE-X
JI Vaccine: X
PD AUG
PY 2021
VL 8
AR 100106
DI 10.1016/j.jvacx.2021.100106
EA JUL 2021
PG 7
WC Immunology; Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Immunology; Research & Experimental Medicine
GA WQ3IL
UT WOS:000713712900016
PM 34222854
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Lebel, L
   Navy, H
   Siharath, P
   Long, CTM
   Aung, N
   Lebel, P
   Hoanh, CT
   Lebel, B
AF Lebel, Louis
   Navy, Hap
   Siharath, Phoummixay
   Chau Thi Minh Long
   Aung, Nilar
   Lebel, Phimphakan
   Chu Thai Hoanh
   Lebel, Boripat
TI COVID-19 and household water insecurities in vulnerable communities in
   the Mekong Region
SO ENVIRONMENT DEVELOPMENT AND SUSTAINABILITY
LA English
DT Article; Early Access
DE Water insecurity; COVID-19; Vulnerable groups; Mekong region; SDG 6
AB Access to sufficient clean water is important for reducing the risks from COVID-19. It is unclear, however, what influence COVID-19 has had on water insecurities. The objective of this study was to assess the associations between COVID-19 control measures and household water insecurities. A survey of 1559 individuals living in vulnerable communities in five countries (Cambodia, Laos, Myanmar, Thailand, Vietnam) showed that increased needs for clean water to wash hands or facemasks made it more likely a person was water insecure along those dimensions. Water insecurities with respect to handwashing and drinking, in turn, made adoption of the corresponding good practices less likely, whereas in the case of washing facemasks there was no association. Water system infrastructure, environmental conditions such as floods and droughts, as well as gender norms and knowledge, were also important for water insecurities and the adoption of good practices. As domestic water insecurities and COVID-19 control measures are associated with each other, efforts should therefore be directed at identifying and assisting the water insecure at high risk when COVID-19 reaches their communities.
C1 [Lebel, Louis; Lebel, Phimphakan; Lebel, Boripat] Chiang Mai Univ, Fac Social Sci, Dept Social Sci & Dev, Unit Social & Environm Res, Chiang Mai, Thailand.
   [Navy, Hap] Minist Agr Forestry & Fisheries, Inland Fisheries Res & Dev Inst, Phnom Penh, Cambodia.
   [Siharath, Phoummixay] Natl Univ Laos, Fac Engn, Dept Environm Engn, Viangchan, Laos.
   [Chau Thi Minh Long] Western Highlands Agr & Forestry Sci Inst, Dak Lak, Vietnam.
   [Aung, Nilar] Univ Yangon, Yangon, Myanmar.
   [Chu Thai Hoanh] Int Water Management Inst, Reg Off Southeast Asia, Viangchan, Laos.
RP Lebel, B (corresponding author), Chiang Mai Univ, Fac Social Sci, Dept Social Sci & Dev, Unit Social & Environm Res, Chiang Mai, Thailand.
EM louis@sea-user.org; hapnavy@yahoo.com; phoummixay2011@gmail.com;
   longchau76@yahoo.com; nilaraung1965@gmail.com; phimphakan@sea-user.org;
   boripatlebel@gmail.com
RI Lebel, Louis/D-4130-2014
OI Lebel, Louis/0000-0001-6187-6418
FU Sustainable Mekong Research Network (SUMERNET) [100099231]
FX This study was supported by the Sustainable Mekong Research Network
   (SUMERNET) [Grant No. 100099231].
CR Adams EA., 2021, SUSTAINABILITY SCI P, V17, P86, DOI [10.1080/15487733.2021.1875682, DOI 10.1080/15487733.2021.1875682]
   Amankwaa G., 2020, EXPLORING CORRELATIO, DOI [10.1101/2020.06.08.20125864, DOI 10.1101/2020.06.08.20125864]
   Bauza V, 2021, AM J TROP MED HYG, V104, P2264, DOI 10.4269/ajtmh.21-0087
   Corburn J, 2020, J URBAN HEALTH, V97, P348, DOI 10.1007/s11524-020-00438-6
   Desye B, 2021, ENVIRON HEALTH INSIG, V15, DOI 10.1177/11786302211029447
   Djalante R, 2020, PROG DISASTER SCI, V8, DOI 10.1016/j.pdisas.2020.100129
   Duong MC, 2021, J COMMUN HEALTH, V46, P975, DOI 10.1007/s10900-021-00981-6
   Eichelberger L, 2021, SCI TOTAL ENVIRON, V776, DOI 10.1016/j.scitotenv.2021.145842
   Gupta J, 2020, INT ENVIRON AGREEM-P, V20, P393, DOI 10.1007/s10784-020-09486-4
   Guthrie L., 2020, ASIA PACIFIC COVID 1
   Hannah DM, 2020, NAT SUSTAIN, V3, P773, DOI 10.1038/s41893-020-0593-7
   Hasan SM, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10230-z
   Hosmer DW., 2000, APPL LOGISTIC REGRES, DOI [10.1002/0471722146, DOI 10.1002/0471722146]
   Howard G, 2021, AQUA-UK, V70, P438, DOI 10.2166/aqua.2021.127
   Huong Le Thi Thanh, 2020, AIMS Public Health, V7, P650, DOI 10.3934/publichealth.2020051
   Didar-Ul Islam SM, 2021, ENVIRON DEV SUSTAIN, V23, P11953, DOI 10.1007/s10668-020-01151-9
   Jepson WE, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1214
   Kim T, 2021, ASIA PAC J SOC WORK, V31, P89, DOI 10.1080/02185385.2020.1830299
   Kitchanapaibul S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11145-5
   Lao CK, 2021, CURR PSYCHOL, DOI 10.1007/s12144-021-01985-0
   Lau LS, 2020, NAT MED, V26, P647, DOI 10.1038/s41591-020-0851-2
   MacIntyre CR, 2021, INT J INFECT DIS, V106, P199, DOI 10.1016/j.ijid.2021.03.056
   Maude RR, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10768-y
   Neal MJ, 2020, WATER INT, V45, P435, DOI 10.1080/02508060.2020.1773648
   Paramita W, 2021, GLOB J FLEX SYST MAN, V22, P1, DOI [10.1007/s40171-021-00261-1, DOI 10.1007/S40171-021-00261-1]
   Phonvisay A, 2021, J GLOBAL HLTH SCI, V3, P1, DOI [10.35500/jghs.2021.3.e9, DOI 10.35500/JGHS.2021.3.E9]
   Rafa N, 2020, WATER INT, V45, P710, DOI 10.1080/02508060.2020.1803018
   Sayeed A, 2021, GROUNDWATER SUST DEV, V13, DOI 10.1016/j.gsd.2021.100561
   Scherer N, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-046112
   Sempewo JI, 2021, WATER SUPPLY, V21, P2489, DOI 10.2166/ws.2021.044
   Shao M, 2021, TROP MED HEALTH, V49, DOI 10.1186/s41182-021-00334-y
   Stoler J, 2021, INT J HYG ENVIR HEAL, V234, DOI 10.1016/j.ijheh.2021.113715
   Stoler J, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010355
   Suratana S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252326
   Tortajada C, 2021, INT J WATER RESOUR D, V37, P179, DOI 10.1080/07900627.2021.1877956
   Tsai AC, 2016, J WATER HEALTH, V14, P280, DOI 10.2166/wh.2015.165
   UNESCAP , 2021, SDG 6 COVID 19 ACC P
   Wilkinson A, 2020, ENVIRON URBAN, V32, P503, DOI 10.1177/0956247820922843
   Young SL, 2021, ADV NUTR, V12, P1058, DOI 10.1093/advances/nmab003
   Young SL, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001750
   Zvobgo L, 2020, WATER RES X, V9, DOI 10.1016/j.wroa.2020.100074
NR 41
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-585X
EI 1573-2975
J9 ENVIRON DEV SUSTAIN
JI Environ. Dev. Sustain.
DI 10.1007/s10668-022-02182-0
EA FEB 2022
PG 20
WC Green & Sustainable Science & Technology; Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA ZI7WA
UT WOS:000761825800002
PM 35233185
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Buhagiar, K
   Anand, A
AF Buhagiar, Kristina
   Anand, Amitabh
TI Synergistic triad of crisis management: leadership, knowledge management
   and organizational learning
SO INTERNATIONAL JOURNAL OF ORGANIZATIONAL ANALYSIS
LA English
DT Article; Early Access
DE Crises; Crisis management; Crisis management framework; Knowledge
   management; Organizational learning; Leadership
ID FINANCIAL CRISIS; TRANSFORMATIONAL LEADERSHIP; MEDIATING ROLE; SUPPORT;
   RESILIENCE
AB Purpose The prevalence of instability and crises in organizational ecosystems seems to be on the increase, with an upward trend in the occurrence of, for example, natural disasters, such as tornadoes in America, bushfires in Australia and the widespread outbreak of diseases, e.g., Covid-19. As contexts of crisis increase in frequency, the ability of organizations to adapt and effectively respond to crises has become a key necessity for organizational survival and continuity. The purpose of this paper is to explore how the repercussions of crises may be curtailed through a multidimensional crisis management approach. Design/methodology/approach This paper applies a narrative literature review and concept mapping to synthesize and establish relationships between the literature in the domains of leadership, knowledge management, learning and contexts of crisis. The output of this methodological orientation is the Integrated Crisis Management Framework, presenting a conceptualized overview of the symbiotic and intertwined manner through which leadership, knowledge management and learning contribute towards effective crisis management. Findings According to the analysis and the conceptual underpinnings of this paper, in contexts of crisis, leadership is generally responsible for aggregating crisis management strategies and establishing employee motivation. Knowledge management, on the other hand, provides the infrastructure necessary for calculated yet rapid decision-making. Similarly, in times of crisis, learning is a prerequisite for the development of a "learningful" organization, which contributes towards crisis management by serving as the organization's "memory" - where lessons learned from previous crises suffice to guide future crisis response. Originality/value The literature in crisis management reveals that existing crisis management models and frameworks generally consider crisis from a unidimensional perspective, neglecting to account for the multifaceted nature of crises, and the numerous attributes necessary to overcome contexts of crisis. To address this gap in the literature, this paper proposes a multidimensional conceptualization of crisis management through combining three core elements, including leadership, learning and knowledge management. The novelty of this paper is an Integrated Crisis Management Framework, and eight empirical propositions, which act as an impetus for future research.
C1 [Buhagiar, Kristina] Univ Malta, Edward de Bono Inst Creat Thinking & Innovat, Msida, Malta.
   [Anand, Amitabh] CERIIM, Excelia Business Sch, La Rochelle, France.
RP Anand, A (corresponding author), CERIIM, Excelia Business Sch, La Rochelle, France.
EM kristina.buhagiar@um.edu.mt; enviamit@gmail.com
RI Buhagiar, Kristina/AAA-5246-2021
OI Buhagiar, Kristina/0000-0002-1484-2781
CR Aggarwal I, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00112
   Ananthram S, 2013, PERS REV, V42, P281, DOI 10.1108/00483481311320417
   Antonacopoulou EP, 2014, J MANAGE INQUIRY, V23, P5, DOI 10.1177/1056492612472730
   Barasa E, 2018, INT J HEALTH POLICY, V7, P491, DOI 10.15171/ijhpm.2018.06
   Barton L., 1990, MANAGE DECIS, V28
   BOIN ARJEN, 2013, International Review of Public Administration, V18, P79
   Broekema W, 2017, J CONTING CRISIS MAN, V25, P326, DOI 10.1111/1468-5973.12161
   Brzozowski J., 2016, LEARNING CRISIS SYST
   Bundy J, 2017, J MANAGE, V43, P1661, DOI 10.1177/0149206316680030
   Burnard K, 2018, IEEE T ENG MANAGE, V65, P351, DOI 10.1109/TEM.2018.2796181
   Cania L., 2015, MEDITERRANEAN J SOCI, V6, P548
   Carmeli A, 2008, LONG RANGE PLANN, V41, P177, DOI 10.1016/j.lrp.2008.01.001
   Dorasamy M, 2013, TECHNOL FORECAST SOC, V80, P1834, DOI 10.1016/j.techfore.2012.12.008
   Brandebo MF, 2020, LEADERSHIP ORG DEV J, V41, P567, DOI 10.1108/LODJ-02-2019-0089
   Gilson LL, 2015, GROUP ORGAN MANAGE, V40, P127, DOI 10.1177/1059601115576425
   Gwebu KL, 2018, J MANAGE INFORM SYST, V35, P683, DOI 10.1080/07421222.2018.1451962
   Haddon A, 2015, LEADERSHIP ORG DEV J, V36, P612, DOI 10.1108/LODJ-12-2013-0166
   Hernantes J, 2013, TECHNOL FORECAST SOC, V80, P1742, DOI 10.1016/j.techfore.2013.01.002
   Jamal J, 2017, INT J BUS COMMUN, V54, P369, DOI 10.1177/2329488415572782
   Keszey T, 2018, J KNOWL MANAG, V22, P1061, DOI 10.1108/JKM-01-2017-0033
   Khvatova T, 2016, J KNOWL MANAG, V20, P918, DOI 10.1108/JKM-11-2015-0464
   Kim TY, 2021, J CREATIVE BEHAV, V55, P168, DOI 10.1002/jocb.443
   Lai FY, 2020, SAGE OPEN, V10, DOI 10.1177/2158244019899085
   Lauras M, 2015, DISASTERS, V39, P687, DOI 10.1111/disa.12122
   Lewis MW, 2014, CALIF MANAGE REV, V56, P58, DOI [10.1525/cmr.2013.56.3.58, 10.1525/cmr.2014.56.3.58]
   MARCH JG, 1995, ORGANIZATION, V2, P427, DOI 10.1177/135050849523009
   Morgan L.D., 2008, SAGE ENCY QUALITATIV, P108
   Najafbagy R, 2011, INT J MANAG, V28, P573
   Nonaka I., 2001, MANAGING IND KNOWLED, P1
   Paraskevas A, 2013, ANN TOURISM RES, V41, P130, DOI 10.1016/j.annals.2012.12.005
   Ponis ST, 2012, KNOWL PROCESS MANAG, V19, P148, DOI 10.1002/kpm.1390
   Purvanova RK, 2018, GROUP ORGAN MANAGE, V43, P752, DOI 10.1177/1059601118794102
   Rafailidis A, 2017, TOTAL QUAL MANAG BUS, V28, P1134, DOI 10.1080/14783363.2017.1309122
   Rasli A., 2017, GLOBAL BUSINESS ORG, V36, P54
   Rosing K, 2011, LEADERSHIP QUART, V22, P956, DOI 10.1016/j.leaqua.2011.07.014
   Scheuerlein J, 2018, INT J QUAL RES, V12, P551, DOI 10.18421/IJQR12.03-01
   Senge P.M., 2006, 5 DISCIPLINE ART PRA
   Shaw D, 2007, J ORGAN CHANGE MANAG, V20, P559, DOI 10.1108/09534810710760081
   Smith D., 1990, IND CRISIS Q, V4, P263, DOI DOI 10.1177/108602669000400402
   Veil ShariR., 2011, J BUS COMMUN, V48, P116, DOI [10.1177/0021943610382294, DOI 10.1177/0021943610382294]
   Wang J, 2008, ADV DEV HUM RESOUR, V10, P425, DOI 10.1177/1523422308316464
   Wang WT, 2009, IND MANAGE DATA SYST, V109, P445, DOI 10.1108/02635570910948605
   Wilson S, 2020, LEADERSHIP-LONDON, V16, P279, DOI 10.1177/1742715020929151
   Wisittigars B, 2019, FACILITIES, V37, P881, DOI 10.1108/F-10-2017-0100
   Yao H., 2017, J BUSINESS BEHAV SCI, V29, P3
   Yi L, 2019, SOC BEHAV PERSONAL, V47, DOI 10.2224/sbp.7636
   Zacher H, 2015, LEADERSHIP ORG DEV J, V36, P54, DOI 10.1108/LODJ-11-2012-0141
   Zhang Y, 2015, ACAD MANAGE J, V58, P538, DOI 10.5465/amj.2012.0995
   Zhang Z, 2012, INT J HUM RESOUR MAN, V23, P4085, DOI 10.1080/09585192.2011.639027
   Zouaghi F, 2018, TECHNOL FORECAST SOC, V132, P92, DOI 10.1016/j.techfore.2018.01.011
NR 50
TC 1
Z9 1
U1 30
U2 36
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1934-8835
EI 1758-8561
J9 INT J ORGAN ANAL
JI Int. J. Organ. Anal.
DI 10.1108/IJOA-03-2021-2672
EA AUG 2021
PG 18
WC Management
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA UF3SW
UT WOS:000688497300001
DA 2022-04-20
ER

PT J
AU Carpenter, A
   Chambers, OJ
   El Harchi, A
   Bond, R
   Hanington, O
   Harmer, SC
   Hancox, JC
   James, AF
AF Carpenter, Alexander
   Chambers, Owen J.
   El Harchi, Aziza
   Bond, Richard
   Hanington, Oliver
   Harmer, Stephen C.
   Hancox, Jules C.
   James, Andrew F.
TI COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians
   Treating Patients Affected by SARS-CoV-2
SO FRONTIERS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
DE COVID-19; QT; arrhythmia; hERG; drug safety; QTc
ID DRUGS; PROLONGATION; CHANNEL
AB The COVID-19 pandemic is an unprecedented challenge and will require novel therapeutic strategies. Affected patients are likely to be at risk of arrhythmia due to underlying comorbidities, polypharmacy and the disease process. Importantly, a number of the medications likely to receive significant use can themselves, particularly in combination, be pro-arrhythmic. Drug-induced prolongation of the QT interval is primarily caused by inhibition of the hERG potassium channel either directly and/or by impaired channel trafficking. Concurrent use of multiple hERG-blocking drugs may have a synergistic rather than additive effect which, in addition to any pre-existing polypharmacy, critical illness or electrolyte imbalance, may significantly increase the risk of arrhythmia and Torsades de Pointes. Knowledge of these risks will allow informed decisions regarding appropriate therapeutics and monitoring to keep our patients safe.
C1 [Carpenter, Alexander; El Harchi, Aziza; Hanington, Oliver; Harmer, Stephen C.; Hancox, Jules C.; James, Andrew F.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England.
   [Chambers, Owen J.] Liverpool Heart & Chest Hosp NHS Fdn Trust, Liverpool, Merseyside, England.
   [Bond, Richard] Gloucestershire Hosp NHS Fdn Trust, Gloucester, England.
RP Carpenter, A (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England.
EM alexander.carpenter@bristol.ac.uk
RI Harmer, Stephen/D-5512-2015
OI Harmer, Stephen/0000-0003-3909-6698; Carpenter,
   Alexander/0000-0003-3650-1897
FU MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC)
   [MR/S021299/1]; BHF Clinical Research Training Fellowship
   [FS/19/44/34424]
FX AC receives an MRC Clinical Research Training Fellowship for
   (MR/S021299/1) unrelated work. OH receives a BHF Clinical Research
   Training Fellowship (FS/19/44/34424) for unrelated hERG work.
CR [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], NEWSWEEK
   Aromolaran AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208321
   Badri Marwan, 2015, JACC Clin Electrophysiol, V1, P315, DOI 10.1016/j.jacep.2015.05.008
   Borba MG, 2020, CHLOROQUINE DIPHOSPH, DOI [10.1101/2020.04.07.20056424, DOI 10.1101/2020.04.07.20056424]
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   COLSON P, 2020, INT J ANTIMICROB AG, V55, DOI [10.1016/j.ijantimicag.2020.105932, DOI 10.1016/J.IJANTIMICAG.2020.105932]
   Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005
   Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786
   Dong LY, 2020, DRUG DISCOV THER, V14, P58, DOI 10.5582/ddt.2020.01012
   Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC
   El Harchi A, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14385
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Gibbs C, 2019, EUROPACE, V21, P1254, DOI 10.1093/europace/euz058
   Giudicessi JR, 2020, MAYO CLIN PROC, V95, P1213, DOI 10.1016/j.mayocp.2020.03.024
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hancox JC, 2008, PHARMACOL THERAPEUT, V119, P118, DOI 10.1016/j.pharmthera.2008.05.009
   Heart Rhythm Society, HRS COVID 19 TASK FO
   Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215
   Lazzerini PE, 2020, CIRCULATION, V142, P7, DOI 10.1161/CIRCULATIONAHA.120.047293
   Lazzerini PE, 2019, NAT REV IMMUNOL, V19, P63, DOI 10.1038/s41577-018-0098-z
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Mitra Raman L, 2020, HeartRhythm Case Rep, V6, P244, DOI 10.1016/j.hrcr.2020.03.016
   Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006
   Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
   Peretto G, 2019, HEART RHYTHM, V16, P793, DOI 10.1016/j.hrthm.2018.11.024
   Petrosillo N., 2017, PLOS NEGLECT TROP D, V11, DOI [DOI 10.1371/JOURNAL.PNTD.0006034, 10.1371/journal.pntd.0006034]
   Recanatini M, 2005, MED RES REV, V25, P133, DOI 10.1002/med.20019
   Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426
   Rodriguez-Menchaca AA, 2008, P NATL ACAD SCI USA, V105, P1364, DOI 10.1073/pnas.0708153105
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Shahreyar M, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.12.26
   Taccone FS, 2020, LANCET RESP MED, V8, P539, DOI 10.1016/S2213-2600(20)30172-7
   Tan WY, 2020, INT J CARDIOL, V309, P70, DOI 10.1016/j.ijcard.2020.03.063
   Traebert M, 2004, EUR J PHARMACOL, V484, P41, DOI 10.1016/j.ejphar.2003.11.003
   Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Wisniowska B, 2018, J APPL TOXICOL, V38, P450, DOI 10.1002/jat.3552
   Wu CI, 2020, HEART RHYTHM, V17, P1456, DOI 10.1016/j.hrthm.2020.03.024
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Zeltser D, 2003, MEDICINE, V82, P282, DOI 10.1097/00005792-200307000-00007
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 44
TC 13
Z9 13
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2297-055X
J9 FRONT CARDIOVASC MED
JI Front. Cardiovasc. Med.
PD MAY 5
PY 2020
VL 7
AR 85
DI 10.3389/fcvm.2020.00085
PG 5
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA LS2BU
UT WOS:000536195700001
PM 32432127
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Riswantini, D
   Nugraheni, E
   Arisal, A
   Khotimah, PH
   Munandar, D
   Suwarningsih, W
AF Riswantini, Dianadewi
   Nugraheni, Ekasari
   Arisal, Andria
   Khotimah, Purnomo Husnul
   Munandar, Devi
   Suwarningsih, Wiwin
TI Big Data Research in Fighting COVID-19: Contributions and Techniques
SO BIG DATA AND COGNITIVE COMPUTING
LA English
DT Article
DE Big Data; COVID-19; research contribution area; analytical technique;
   data source; survey
AB The COVID-19 pandemic has induced many problems in various sectors of human life. After more than one year of the pandemic, many studies have been conducted to discover various technological innovations and applications to combat the virus that has claimed many lives. The use of Big Data technology to mitigate the threats of the pandemic has been accelerated. Therefore, this survey aims to explore Big Data technology research in fighting the pandemic. Furthermore, the relevance of Big Data technology was analyzed while technological contributions to five main areas were highlighted. These include healthcare, social life, government policy, business and management, and the environment. The analytical techniques of machine learning, deep learning, statistics, and mathematics were discussed to solve issues regarding the pandemic. The data sources used in previous studies were also presented and they consist of government officials, institutional service, IoT generated, online media, and open data. Therefore, this study presents the role of Big Data technologies in enhancing the research relative to COVID-19 and provides insights into the current state of knowledge within the domain and references for further development or starting new studies are provided.
C1 [Riswantini, Dianadewi; Nugraheni, Ekasari; Arisal, Andria; Khotimah, Purnomo Husnul; Munandar, Devi; Suwarningsih, Wiwin] Indonesian Inst Sci, Res Ctr Informat, Bandung 40135, Indonesia.
RP Riswantini, D (corresponding author), Indonesian Inst Sci, Res Ctr Informat, Bandung 40135, Indonesia.
EM dianadewi.riswantini@lipi.go.id; ekasari.nugraheni@lipi.go.id;
   andria.arisal@lipi.gold; purn001@lipi.go.id; devi.munandar@lipi.go.id;
   wiwin.suwarningsih@lipi.go.id
OI Nugraheni, Ekasari/0000-0002-0132-5865; Munandar,
   Devi/0000-0002-5766-1139; Riswantini, Dianadewi/0000-0001-9968-5924;
   Arisal, Andria/0000-0002-9154-434X
CR Abdallah HS, 2020, CMC-COMPUT MATER CON, V65, P1303, DOI 10.32604/cmc.2020.011313
   Ahir Shiva, 2020, 2020 International Conference on Smart Electronics and Communication (ICOSEC), P113, DOI 10.1109/ICOSEC49089.2020.9215294
   Albaldawi Wafaa S., 2020, IOP Conference Series: Materials Science and Engineering, V928, DOI 10.1088/1757-899X/928/3/032045
   Almaslamani F., 2020, INT J ENG RES TECHNO, V13, P3444, DOI [10.37624/IJERT/13.11.2020.3444-3455, DOI 10.37624/IJERT/13.11.2020.3444-3455]
   Alomari E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010282
   Alwaeli Z.A.A., 2020, 2020 4 INT S MULT ST, P1, DOI 10.1109/ISMSIT50672.2020.9255149
   Arimura Mikiharu, 2020, Transp Res Interdiscip Perspect, V7, P100212, DOI 10.1016/j.trip.2020.100212
   Ashraf M.U., 2020, 2020 INT C EL COMM C, P1, DOI DOI 10.1109/ICECCE49384.2020.9179284
   Atenstaedt R, 2012, BRIT J GEN PRACT, V62, P148, DOI 10.3399/bjgp12X630142
   Batarseh FA, 2020, J BIG DATA-GER, V7, DOI 10.1186/s40537-020-00315-8
   Benreguia B, 2020, IEEE ACCESS, V8, P145242, DOI 10.1109/ACCESS.2020.3015002
   Beria P, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102616
   Bionda E., 2020, P 12 AEIT INT ANN C, P1, DOI [10.23919/AEIT50178.2020.9241083, DOI 10.23919/AEIT50178.2020.9241083]
   Bornmann L, 2019, SCIENTOMETRICS, V120, P419, DOI 10.1007/s11192-019-03018-x
   Bragazzi NL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093176
   Chaves-Maza M, 2020, ENTREP SUSTAIN ISS, V8, P662, DOI 10.9770/jesi.2020.8.2(40)
   Chen CM, 2020, J MED INTERNET RES, V22, DOI 10.2196/19540
   Chen LC, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10165505
   Chi Zhang, 2020, 2020 International Conference on Big Data and Informatization Education (ICBDIE). Proceedings, P346, DOI 10.1109/ICBDIE50010.2020.00087
   ChuanLin Li, 2020, 2020 International Conference on Big Data, Artificial Intelligence and Internet of Things Engineering (ICBAIE), P17, DOI 10.1109/ICBAIE49996.2020.00011
   do Nascimento MG, 2020, IEEE SYMP COMP COMMU, P892
   Doyle R, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102184
   Dsouza J., 2020, P 2020 IEEE 11 INT C, P1, DOI [10.1109/ICCCNT49239.2020.9225621, DOI 10.1109/ICCCNT49239.2020.9225621]
   Dwivedi YK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102211
   Eksinchol I., 2020, P 2020 1 INT C BIG D, P1, DOI [10.1109/IBDAP50342.2020.9245465, DOI 10.1109/IBDAP50342.2020.9245465]
   Fedushko S, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10249112
   Fiaidhi J, 2020, IEEE ACCESS, V8, P114998, DOI 10.1109/ACCESS.2020.2995763
   Gonzalez-Serrano L, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11010256
   Gualtieri G, 2020, ENVIRON POLLUT, V267, DOI 10.1016/j.envpol.2020.115682
   Haupt MR., 2021, ONLINE SOC NET MED, DOI [10.1016/j.osnem.2020.100114, DOI 10.1016/J.OSNEM.2020.100114]
   He HB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207664
   He W, 2021, INT J INFORM MANAGE, V57, DOI 10.1016/j.ijinfomgt.2020.102287
   He YA, 2020, IOP C SER EARTH ENV, V571, DOI 10.1088/1755-1315/571/1/012083
   Hechenbleikner EM, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100377
   Higgins Thomas S, 2020, JMIR Public Health Surveill, V6, pe19702, DOI 10.2196/19702
   Hoosain MS, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su122310143
   Hu SH, 2021, TRANSPORT RES C-EMER, V124, DOI 10.1016/j.trc.2020.102955
   Hua JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072309
   Huang F, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09674-6
   Ibrahim S., 2020, INT J ADV TRENDS COM, V9, P612, DOI [10.30534/ijatcse/2020/8591.42020, DOI 10.30534/IJATCSE/2020/8591.42020]
   Jamshidi MB, 2020, IEEE ACCESS, V8, P109581, DOI 10.1109/ACCESS.2020.3001973
   Jia Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176161
   Jiang P, 2021, J CLEAN PROD, V279, DOI 10.1016/j.jclepro.2020.123673
   Jimenez AJ, 2020, J MED INTERNET RES, V22, DOI 10.2196/23518
   Jing J, 2020, J INTELL FUZZY SYST, V39, P8877, DOI 10.3233/JIFS-189285
   Jung JH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165688
   Kallel A, 2021, SOFTWARE PRACT EXPER, V51, P91, DOI 10.1002/spe.2924
   Katapally TR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19357
   Kim B, 2020, CYBERPSYCH BEH SOC N, V23, P519, DOI 10.1089/cyber.2020.0201
   Kim J, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e232
   Kim TM, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10238575
   Kumar, 2020, ANN DATA SCI, V7, P417, DOI DOI 10.1007/S40745-020-00289-7
   Lee HS, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12166648
   Li G, 2020, J INTELL FUZZY SYST, V39, P8685, DOI 10.3233/JIFS-189264
   Li S, 2020, 2020 INT C HIGH PERF, P1, DOI 10.1109/HPBDIS49115.2020.9130585
   Liampas A, 2021, PAIN THER, V10, P55, DOI 10.1007/s40122-020-00210-3
   Lin CQ, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.140348
   Liu HM, 2020, COMPLEXITY, V2020, DOI 10.1155/2020/8855521
   Liu M, 2020, PUBLIC HEALTH, V183, P76, DOI 10.1016/j.puhe.2020.05.001
   Liu Q, 2020, J INTELL FUZZY SYST, V39, P9085, DOI 10.3233/JIFS-189307
   Liu ZG, 2020, J INTELL FUZZY SYST, V39, P8655, DOI 10.3233/JIFS-189261
   Long ZJ, 2020, IEEE ACCESS, V8, P136046, DOI 10.1109/ACCESS.2020.3011123
   Izquierdo JL, 2020, J MED INTERNET RES, V22, DOI 10.2196/21801
   Mackey Tim, 2020, JMIR Public Health Surveill, V6, pe19509, DOI 10.2196/19509
   Mackey TK, 2020, JMIR PUBLIC HLTH SUR, V6, P360, DOI 10.2196/20794
   Manalu EPS, 2020, PROCEEDINGS OF 2020 INTERNATIONAL CONFERENCE ON INFORMATION MANAGEMENT AND TECHNOLOGY (ICIMTECH), P415, DOI 10.1109/ICIMTech50083.2020.9211290
   Marston HR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218276
   Martinez-Alvarez F, 2020, BIG DATA-US, V8, P308, DOI 10.1089/big.2020.0051
   Mavragani A, 2020, JMIR PUBLIC HLTH SUR, V6, P233, DOI 10.2196/18941
   Melenli S., 2020, TRENDS DATA ENG METH, P1
   Million M, 2020, NEW MICROB NEW INFEC, V38, DOI 10.1016/j.nmni.2020.100709
   Mishra M, 2020, 2020 IEEE SIXTH INTERNATIONAL CONFERENCE ON MULTIMEDIA BIG DATA (BIGMM 2020), P292, DOI 10.1109/BigMM50055.2020.00051
   Cano AM, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12239856
   Ngie H.M., 2020, P 3 AFR C SOFTW ENG, V2689
   Nguyen TT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197032
   Nimpattanavong Chollakorn, 2020, 2020 IEEE 9th Global Conference on Consumer Electronics (GCCE), P215, DOI 10.1109/GCCE50665.2020.9291896
   Pepin JL, 2020, J MED INTERNET RES, V22, DOI 10.2196/19787
   Porter Alan L, 2020, Front Res Metr Anal, V5, P594060, DOI 10.3389/frma.2020.594060
   Prakash A, 2020, 2020 IEEE SIXTH INTERNATIONAL CONFERENCE ON MULTIMEDIA BIG DATA (BIGMM 2020), P356, DOI 10.1109/BigMM50055.2020.00062
   Nguyen QC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176359
   Rivai M.A., 2020, INT J ADV TRENDS COM, V9, P2987, DOI [10.30534/ijatcse/2020/76932020, DOI 10.30534/IJATCSE/2020/76932020]
   Sambhav S., 2020, INT J ADV TRENDS COM, V9, P3338, DOI [10.30534/ijatcse/2020/131932020, DOI 10.30534/IJATCSE/2020/131932020]
   Sari IC, 2020, 2020 5TH INTERNATIONAL WORKSHOP ON BIG DATA AND INFORMATION SECURITY (IWBIS 2020), P25, DOI 10.1109/IWBIS50925.2020.9255531
   Shahbazi Z, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12091566
   Shang WL, 2021, APPL ENERG, V285, DOI 10.1016/j.apenergy.2020.116429
   Shangguan ZH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093279
   Shorten C, 2021, J BIG DATA-GER, V8, DOI 10.1186/s40537-020-00392-9
   Sinha IK, 2020, 2020 IEEE SIXTH INTERNATIONAL CONFERENCE ON MULTIMEDIA BIG DATA (BIGMM 2020), P351, DOI 10.1109/BigMM50055.2020.00061
   Sirinaovakul W., 2020, P 2020 1 INT C BIG D, P1, DOI [10.1109/IBDAP50342.2020.9245459, DOI 10.1109/IBDAP50342.2020.9245459]
   Sun X, 2020, IEEE MULTIMEDIA, V27, P18, DOI 10.1109/MMUL.2020.3025161
   Sung YA, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010310
   Suratnoaji Catur, 2020, The Asian Journal for Public Opinion Research, V8, P393
   Tosi D, 2020, J MED INTERNET RES, V22, DOI 10.2196/21081
   Varotsos CA, 2021, SAFETY SCI, V136, DOI 10.1016/j.ssci.2021.105164
   Villegas-Ch W, 2020, APPL SCI-BASEL, V10, P7016, DOI 10.3390/app10207016
   Wang RR, 2020, P INT COMP SOFTW APP, P1261, DOI 10.1109/COMPSAC48688.2020.00-83
   Wang WS, 2020, J INTELL FUZZY SYST, V39, P9053, DOI 10.3233/JIFS-189304
   Wang YL, 2020, J INTELL FUZZY SYST, V39, P8867, DOI 10.3233/JIFS-189284
   Wang ZP, 2020, J INTELL FUZZY SYST, V39, P8907, DOI 10.3233/JIFS-189288
   WHO, 2020, COR DIS COVID 2019 S
   Wrycza S, 2020, INFORM SYST MANAGE, V37, P288, DOI 10.1080/10580530.2020.1820631
   Wu FR, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187709
   Wu J, 2020, J MED INTERNET RES, V22, DOI 10.2196/21980
   Xue J, 2020, J MED INTERNET RES, V22, DOI 10.2196/24361
   Yan H, 2020, J INTELL FUZZY SYST, V39, P8937, DOI 10.3233/JIFS-189291
   Yang B, 2020, J INTELL FUZZY SYST, V39, P8775, DOI 10.3233/JIFS-189274
   Ye MX, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113517
   Zhang B., 2020, E3S WEB C, V214, P02024, DOI [10.1051/e3sconf/202021402024, DOI 10.1051/E3SCONF/202021402024]
   Zhang XW, 2020, COMPLEXITY, V2020, DOI 10.1155/2020/6688912
   Zhang YN, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003421
   Zhao J, 2021, CMC-COMPUT MATER CON, V67, P965, DOI 10.32604/cmc.2021.014553
   Zheng B, 2020, J INTELL FUZZY SYST, V39, P8917, DOI 10.3233/JIFS-189289
   Zheng Y, 2020, J ADV TRANSPORT, V2020, DOI 10.1155/2020/8898923
NR 113
TC 2
Z9 2
U1 11
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2504-2289
J9 BIG DATA COGN COMPUT
JI Big Data Cogn. Comput.
PD SEP
PY 2021
VL 5
IS 3
AR 30
DI 10.3390/bdcc5030030
PG 20
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Theory & Methods
WE Emerging Sources Citation Index (ESCI)
SC Computer Science
GA UZ6JS
UT WOS:000702310600001
OA gold
DA 2022-04-20
ER

PT J
AU Bolisani, E
   Navarro, JGC
   Garcia-Perez, A
AF Bolisani, Ettore
   Cegarra Navarro, Juan Gabriel
   Garcia-Perez, Alexeis
TI Managing counter-knowledge in the context of a pandemic: challenges for
   scientific institutions and policymakers
SO KNOWLEDGE MANAGEMENT RESEARCH & PRACTICE
LA English
DT Article
DE Counter-knowledge; healthcare sector; public science; knowledge
   management; case-stories; Italy; crisis; pandemic; COVID-19
AB Counter-knowledge comes from unverified sources of information such as hoaxes, rumours or partial lies. It creates an atmosphere of lack of trust that often leads individuals into making risky decisions. In contexts of high uncertainty, the flow of counter-knowledge is likely to increase. Although scientists and scientific institutions can provide knowledge based on evidence and verifiable facts, they may find it difficult to react to the proliferation of counter-knowledge which affects their own credibility. This paper adopts concepts derived from the knowledge management field to shed light on this problem. Examples from the recent history of Italy are discussed. Useful lessons for the public and policymakers are derived. These lessons become particularly relevant in the context of a crisis such as the COVID-19 pandemic, as the world experiences a combination of factors that provide a fertile ground for the emergence of both scientific knowledge and social counter-knowledge.
C1 [Bolisani, Ettore] Univ Padua, DTG Dept Management & Engn, Padua, Italy.
   [Cegarra Navarro, Juan Gabriel] Univ Politecn Cartagena, Fac Ciencias Empresa, Cartagena, Colombia.
   [Garcia-Perez, Alexeis] Coventry Univ, Ctr Business Soc, Coventry, W Midlands, England.
RP Garcia-Perez, A (corresponding author), Coventry Univ, Ctr Business Soc, Coventry, W Midlands, England.
EM alexeis.garcia-perez@coventry.ac.uk
RI , Juan Gabriel/L-2291-2014
OI , Juan Gabriel/0000-0003-3371-5670
CR ADLER PS, 1990, SLOAN MANAGE REV, V32, P25
   Baskerville R., 2006, Knowledge Management Research & Practice, V4, P83, DOI 10.1057/palgrave.kmrp.8500090
   Baumeister RF, 2004, REV GEN PSYCHOL, V8, P111, DOI 10.1037/1089-2680.8.2.111
   Bolisani E., 2018, EMERGENT KNOWLEDGE S
   Bolisani E., 2021, SPRINGER P BUSINESS, DOI 10.1007/978-3-030-59972-0_1
   Bratianu C, 2013, KNOWL MAN RES PRACT, V11, P133, DOI 10.1057/kmrp.2013.11
   Caporale E., 2018, STAMPA, V8
   Cegarra-Navarro JG, 2015, J INTELLECT CAP, V16, P763, DOI 10.1108/JIC-01-2015-0010
   Cegarra-Sanchez J, 2018, VINE J INF KNOWL MAN, V48, P491, DOI 10.1108/VJIKMS-01-2018-0004
   Cerda-Mansilla E, 2021, KNOWL MAN RES PRACT, V19, P445, DOI 10.1080/14778238.2021.1895688
   Coombs C.R., 2013, HEALTH SERV DELIVERY, V1, P2, DOI [10.3310/hsdr01020, DOI 10.3310/HSDR01020]
   Deer B., 2010, SUNDAY TIMES 0124
   Di Grazia S., 2011, DOSSIER BELLA
   Gelfert A, 2018, INFORMAL LOG, V38, P84, DOI 10.22329/il.v38i1.5068
   Greenhill KM, 2017, INT STUD QUART, V61, P660, DOI 10.1093/isq/sqx015
   Hargreaves A, 2005, EXTENDING EDUCATIONAL CHANGE: INTERNATIONAL HANBOOK OF EDUCATIONAL CHANGE, P278, DOI 10.1007/1-4020-4453-4_14
   Hislop D, 2014, MANAGE LEARN, V45, P540, DOI 10.1177/1350507613486423
   Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]
   Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112
   Kirchner K, 2021, KNOWL MAN RES PRACT, V19, P493, DOI 10.1080/14778238.2021.1877579
   Lee JJ, 2004, RES HIGH EDUC, V45, P603, DOI 10.1023/B:RIHE.0000040265.86668.1a
   Lepore F., 2013, LESPRESSO
   Mariano S, 2021, KNOWL MAN RES PRACT, V19, P484, DOI 10.1080/14778238.2020.1866445
   Martelo-Landroguez S, 2019, KNOWL MAN RES PRACT, V17, P203, DOI 10.1080/14778238.2019.1599497
   Martinez-Ortiz PJ, 2017, J PUBLIC AFF, V17, DOI 10.1002/pa.1605
   Mautino B., 2014, STAMINA STORIA SBAGL
   Mazzucco M., 2016, NEXUS EDIZIONI OCT
   Mejova Y., 2020, ARXIV PREPRINT ARXIV
   Minerva D., 1998, CASO BELLA STORIA IT
   Nadeau B., 2002, NEWSWEEK MAGAZI 0428
   Papania MJ, 2013, VACCINES, P1200, DOI DOI 10.1016/B978-1-4557-0090-5.00063
   Pini V., 2013, REPUBBLICA NEWS 0521
   Pistole M.C., 2014, J MENTAL HLTH COUNSE, V36, P345, DOI DOI 10.17744/MEHC.36.4.0402867150372T21
   Repubblica L., 2013, LA REPUBBLICA, P25
   Sanchez-Casado N, 2015, ONLINE INFORM REV, V39, P179, DOI 10.1108/OIR-12-2014-0307
   Spender JC, 1996, STRATEGIC MANAGE J, V17, P45, DOI 10.1002/smj.4250171106
   Tandoc EC, 2018, DIGIT JOURNAL, V6, P137, DOI 10.1080/21670811.2017.1360143
   Thompson D., 2008, COUNTER KNOWLEDGE
   Thompson N., 2017, WIRED MAGAZINE
   Van Beveren J., 2003, Journal of Knowledge Management, V7, P90, DOI 10.1108/13673270310463644
   Vannoni D., 2002, PSICOLOGIA COMUNICAZ
   Vickers AJ, 2001, LANCET ONCOL, V2, P226, DOI 10.1016/S1470-2045(00)00293-X
   Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0
NR 43
TC 5
Z9 5
U1 6
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1477-8238
EI 1477-8246
J9 KNOWL MAN RES PRACT
JI Knowl. Manag. Res. Pract.
PD OCT 2
PY 2021
VL 19
IS 4
BP 517
EP 524
DI 10.1080/14778238.2021.1911606
EA APR 2021
PG 8
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA XR8BJ
UT WOS:000640107700001
OA hybrid
DA 2022-04-20
ER

PT J
AU Soleymani, MR
   Esmaeilzadeh, M
   Taghipour, F
   Ashrafi-rizi, H
AF Soleymani, Mohammad Reza
   Esmaeilzadeh, Maedeh
   Taghipour, Faezeh
   Ashrafi-rizi, Hasan
TI COVID-19 information seeking needs and behaviour among citizens in
   Isfahan, Iran: A qualitative study
SO HEALTH INFORMATION AND LIBRARIES JOURNAL
LA English
DT Article; Early Access
DE COVID-19; information seeking behaviour; misinformation; social media
AB Background Access to reliable and credible health information improves individuals' personal care level in crises, such as the coronavirus disease 2019 (COVID-19) pandemic. It subsequently results in enhancing the community's health and reducing the health system's costs. Objectives This study aimed to investigate the COVID-19 related information seeking behaviour demonstrated by citizens in Isfahan, Iran. Methods This research was conducted in 2020 and employed a qualitative approach using conventional content analysis. The research population was selected from almost different social classes of people in Iran using purposive sampling. The saturation point was reached at 24 semi-structured interviews. The data's soundness was confirmed based on the criteria of credibility, confirmability, dependability and transferability proposed by Guba and Lincoln. Results The findings revealed five subcategories and 25 codes within the information seeking behaviour. The subcategories included attitude towards the COVID-19 crisis, information needs, information resources, information validation and information seeking barriers. Conclusion People seek information from various resources to update their knowledge and become more prepared in the face of COVID-19. The findings can be used to develop policies on informing and preventing the dissemination of false information in crises, such as the COVID-19 crisis.
C1 [Soleymani, Mohammad Reza; Ashrafi-rizi, Hasan] Isfahan Univ Med Sci, Hlth Informat Technol Res Ctr, Esfahan, Iran.
   [Esmaeilzadeh, Maedeh] Isfahan Univ Med Sci, Sch Management & Med Informat Sci, Dept Med Lib & Informat Sci, Esfahan, Iran.
   [Taghipour, Faezeh] Islamic Azad Univ, Dept Management, Khorasgan Branch, Esfahan, Iran.
RP Ashrafi-rizi, H (corresponding author), Isfahan Univ Med Sci, Hlth Informat Technol Res Ctr, Esfahan, Iran.
EM hassanashrafi@mng.mui.ac.ir
FU Research and Technology Deputy of Isfahan University of Medical Sciences
   [198223]
FX This article resulted from research project No 198223 funded by Research
   and Technology Deputy of Isfahan University of Medical Sciences
CR Adekunle AA, 2020, CLEFT PALATE-CRAN J, V57, P444, DOI 10.1177/1055665619884447
   Austrian K, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3576785, DOI 10.2139/SSRN.3576785]
   Bento A.I., 2020, ARXIV PREPRINT ARXIV
   Bigdeli Z., 2016, HUMAN INFO INTERACT, V3, P68
   Dau H, 2020, SUPPORT CARE CANCER, V28, P6011, DOI 10.1007/s00520-020-05446-5
   ELLIS D, 1993, LIBR QUART, V63, P469, DOI 10.1086/602622
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Gutteling JM, 2017, RISK ANAL, V37, P27, DOI 10.1111/risa.12632
   Kalankesh L.R., 2019, FRONT HLTH INF, V8, P13, DOI DOI 10.30699/FHI.V8I1.189
   Khoong EC, 2019, MED CARE, V57, pS176, DOI 10.1097/MLR.0000000000001050
   Kim J, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2143
   KUHLTHAU CC, 1991, J AM SOC INFORM SCI, V42, P361, DOI 10.1002/(SICI)1097-4571(199106)42:5<361::AID-ASI6>3.0.CO;2-#
   Lambert SD, 2007, QUAL HEALTH RES, V17, P1006, DOI 10.1177/1049732307305199
   Latifi M, 2017, HLTH INF MANAGE, V13, P326
   Latifi M., 2019, JPM, V6, P1
   Lincoln Y.S., 1985, NATURALISTIC INQUIRY
   Liu PL, 2020, CYBERPSYCH BEH SOC N, V23, P677, DOI 10.1089/cyber.2020.0250
   Magsamen-Conrad K, 2019, HEALTH COMMUN, V34, P859, DOI 10.1080/10410236.2018.1439265
   Nasrollahzadeh S., 2015, HUMAN INFO INTERACT, V1, P270
   Obasola OI, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016635255
   Russo L., 2020, ONLINE HLTH INFORM S
   Sbaffi L, 2020, J ASSOC INF SCI TECH, V71, P196, DOI 10.1002/asi.24230
   Sulistyawati S, 2021, RISK MANAG HEALTHC P, V14, P163, DOI 10.2147/RMHP.S288579
   Vigso O, 2016, NORD REV, V37, P71, DOI 10.1515/nor-2016-0003
   Wang XH, 2021, HEALTH COMMUN, V36, P1163, DOI 10.1080/10410236.2020.1748829
   Wilson T. D., 2000, Informing Science, V3, P49
   Zamani Maryam, 2014, J Educ Health Promot, V3, P83, DOI 10.4103/2277-9531.139249
NR 27
TC 0
Z9 0
U1 10
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1471-1834
EI 1471-1842
J9 HEALTH INFO LIBR J
JI Heatlth Info. Libr. J.
DI 10.1111/hir.12396
EA SEP 2021
PG 12
WC Information Science & Library Science
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science
GA UN5FN
UT WOS:000694041100001
PM 34490716
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Marin-Garcia, JA
   Ruiz, A
   Maheut, J
   Garcia-Sabater, JP
AF Marin-Garcia, Juan A.
   Ruiz, Angel
   Maheut, Julien
   Garcia-Sabater, Jose P.
TI A data generator for covid-19 patients' care requirements inside
   hospitals
SO WPOM-WORKING PAPERS ON OPERATIONS MANAGEMENT
LA English
DT Article
DE data paper; simulated data set; covid-19; hospital; bed management;
   healthcare; operations management
ID MECHANICAL VENTILATION
AB A Spanish version of the article is provided (see section before references). This paper presents the generation of a plausible data set related to the needs of COVID-19 patients with severe or critical symptoms. Possible illness' stages were proposed within the context of medical knowledge as of January 2021. The parameters chosen in this data set were customized to fit the population data of the Valencia region (Spain) with approximately 2.5 million inhabitants. They were based on the evolution of the pandemic between September 2020 and March 2021, a period that included two complete waves of the pandemic.
   Contrary to expectation and despite the European and national transparency laws (BOE-A2013-12887, 2013; European Parliament and Council of the European Union, 2019), the actual COVID-19 pandemic-related data, at least in Spain, took considerable time to be updated and made available (usually a week or more). Moreover, some relevant data necessary to develop and validate hospital bed management models were not publicly accessible. This was either because these data were not collected, because public agencies failed to make them public (despite having them indexed in their databases), the data were processed within indicators and not shown as raw data, or they simply published the data in a format that was difficult to process (e.g., PDF image documents versus CSV tables). Despite the potential of hospital information systems, there were still data that were not adequately captured within these systems.
   Moreover, the data collected in a hospital depends on the strategies and practices specific to that hospital or health system. This limits the generalization of "real" data, and it encourages working with "realistic" or plausible data that are clean of interactions with local variables or decisions (Gunal, 2012; Marin-Garcia et al., 2020). Besides, one can parameterize the model and define the data structure that would be necessary to run the model without delaying till the real data become available. Conversely, plausible data sets can be generated from publicly available information and, later, when real data become available, the accuracy of the model can be evaluated (Garcia-Sabater and Maheut, 2021).
   This work opens lines of future research, both theoretical and practical. From a theoretical point of view, it would be interesting to develop machine learning tools that, by analyzing specific data samples in real hospitals, can identify the parameters necessary for the automatic prototyping of generators adapted to each hospital. Regarding the lines of research applied, it is evident that the formalism proposed for the generation of sound patients is not limited to patients affected by SARS-CoV- 2 infection. The generation of heterogeneous patients can represent the needs of a specific population and serve as a basis for studying complex health service delivery systems.
C1 [Marin-Garcia, Juan A.; Maheut, Julien; Garcia-Sabater, Jose P.] Univ Politecn Valencia, Dept Org Empresas, ROGLE, Valencia, Spain.
   [Ruiz, Angel] FSA ULaval, Dept Operat & Syst Decis, Quebec City, PQ, Canada.
RP Marin-Garcia, JA (corresponding author), Univ Politecn Valencia, Dept Org Empresas, ROGLE, Valencia, Spain.
EM jamarin@omp.upv.es; Angel.Ruiz@osd.ulaval.ca; juma2@upvnet.upv.es;
   jpgarcia@omp.upv.es
RI Marin-Garcia, Juan A./A-4069-2011; ruiz, angel/P-6960-2015; Maheut,
   Julien/H-6800-2012
OI Marin-Garcia, Juan A./0000-0001-5416-3938; ruiz,
   angel/0000-0002-3151-283X; Maheut, Julien/0000-0002-5796-9053
CR Alexander GL, 2007, STUD HEALTH TECHNOL, V129, P910
   [Anonymous], 2013, BOEA201312887, P1
   [Anonymous], 2020, R LANG ENV STAT COMP, DOI DOI 11/44679/INDEX.HTM
   Belciug S, 2020, ADV ELECTR COMPUT EN, V20, P23, DOI 10.4316/AECE.2020.03003
   Brochard L, 2003, EUR RESPIR J, V22, p31S, DOI 10.1183/09031936.03.00050403
   Casas-Rojo JM, 2020, REV CLIN ESP, V220, P480, DOI 10.1016/j.rce.2020.07.003
   Castelnuovo Filippo, 2020, Infez Med, V28, P539
   Censored D., 2006, RR3857 INRIA
   Claudio, 2021, J IND ENG MANAGEMENT, V14
   Claudio D., 2021, J IND ENG MANAGEMENT, V14
   CNE -Centro Nacional de Epidemiologia, 2020, INF CIENT TECN ENF
   Comtois D., 2021, SUMMARYTOOLS TOOLS Q
   Corbin JM, 1988, UNENDING WORK CARE M
   Daniel P, 2021, AM J EMERG MED, V43, P103, DOI 10.1016/j.ajem.2021.01.068
   Dominguez-Lara S. A., 2018, ED MED, V19, P65, DOI [10.1016/j.edumed.2017.01.008, DOI 10.1016/J.EDUMED.2017.01.008]
   ECDP, 2020, GUID DISCH END IS CO, P1
   Epstein RH, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8501
   European Centre for Disease Prevention and Control, 2020, COR DIS 2019 COVID 1
   Fowler R., 2020, CLIN MANAGEMENT PATI, P1
   Garcia-Martinez JA, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12198180
   Generalitat Valenciana, 2018, MEM GEST CONS SAN U
   Generalitat Valenciana. Conselleria de Sanitat Universal i Salut Publica, 2019, MEM GEST CONS SAN U, P14493
   Gillham M., 2007, CARDIOTHORAC CRIT CA, P419, DOI [10.1016/B978-075067572-7.50032-1, DOI 10.1016/B978-075067572-7.50032-1]
   Godfrey, 2020, EXTDIST EXTENDING RA
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Gunal MM, 2012, HEALTH SYST, V1, P17, DOI 10.1057/hs.2012.8
   Hair JF., 2009, MULTIVARIATE DATA AN
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lagarda-Leyva EA, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11247028
   Maheut J., 2021, RIUNET REPOSITORIO I
   Manninen K., 2020, TYPICAL PROGR COVID
   Marin-Garcia JA, 2020, J IND ENG MANAG-JIEM, V13, P213, DOI 10.3926/jiem.3190
   Marin-Garcia JA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17031048
   Marin-Garcia JA, 2019, WPOM-WORKING PAP OPE, V10, P36, DOI 10.4995/wpom.v10i2.12297
   Marin-Garcia JA, 2015, WPOM-WORKING PAP OPE, V6, P76, DOI 10.4995/wpom.v6i2.4459
   Ministerio De Sanidad Servicios Sociales e Igualdad, 2017, HAB VID INF AN SIST
   Mun, 2008, ADV ANAL MODEL 800 M, P899, DOI [DOI 10.1002/9781119197096.APP03, 10.1002/9781119197096.app03]
   Olivieri A, 2021, INT J INFECT DIS, V102, P363, DOI 10.1016/j.ijid.2020.10.070
   Parlamento Europeo y del Consejo de la Union Europea, 2019, DIR UE 2019 1024 DEL
   Petermann-Rocha F, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01822-4
   Pinaire J, 2017, HEALTH INF SCI SYST, V5, DOI 10.1007/s13755-017-0020-2
   Plaza J., 2021, CIENTIFICO DIVULGATI
   Popat Bhavesh, 2012, Medicine (Abingdon), V40, P298, DOI 10.1016/j.mpmed.2012.03.010
   Posso M, 2020, ARCH BRONCONEUMOL, V56, P756, DOI [10.1016/j.arbres.2020.06.012, 10.1016/j.arbr.2020.06.010]
   Revelle W., 2021, PROCEDURES PSYCHOL
   Roa-Martinez SM, 2017, REV ESP DOC CIENT, V40, DOI 10.3989/redc.2017.1.1375
   RStudio Team, 2020, RSTUDIO INT DEV R
   Rubio-Rivas M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113488
   Ruckdeschel P, 2006, R NEWS, V6, P2
   Ruza, 2008, CUIDADOS INTENSIVOS, V6, P336
   Stang A, 2020, DTSCH ARZTEBL INT, V117, P329, DOI 10.3238/arztebl.2020.0329
   Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007
   Urruela Mora, 2020, MINISTERIO SANIDAD A
   Venables W.N., 2002, MODERN APPL STAT S P
   Walker L., 2020, OPENXLSX READ WRITE
   Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748
   Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01
   Wickham H, 2007, J STAT SOFTW, V21, P1
   Wiersema, 2007, CARDIOTHORACIC CRITI, P410, DOI [10.1016/B978-075067572-7.50031-X, DOI 10.1016/B978-075067572-7.50031-X]
   Winck JC, 2021, PULMONOLOGY, V27, P305, DOI 10.1016/j.pulmoe.2020.12.005
   Wong GN, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.041033
   Xia W, 2013, J IND ENG MANAG-JIEM, V6, P456, DOI 10.3926/jiem.532
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021
NR 64
TC 1
Z9 1
U1 0
U2 0
PU UNIV POLITECNICA VALENCIA, EDITORIAL UPV
PI VALENCIA
PA CAMINO VERA S-N, VALENCIA, 46022, SPAIN
SN 1989-9068
J9 WPOM-WORKING PAP OPE
JI WPOM-Working Pap. Oper. Manag.
PD JAN-JUN
PY 2021
VL 12
IS 1
BP 76
EP 115
DI 10.4995/wpom.15332
PG 40
WC Business
WE Emerging Sources Citation Index (ESCI)
SC Business & Economics
GA SP9WK
UT WOS:000660013200005
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Gao, Y
   Zhong, LLD
   Quach, B
   Davies, B
   Ash, GI
   Lin, ZX
   Feng, YB
   Lau, BWM
   Wagner, PD
   Yang, X
   Guo, YK
   Jia, W
   Bian, ZX
   Baker, JS
AF Gao, Yang
   Zhong, Linda L. D.
   Quach, Binh
   Davies, Bruce
   Ash, Garrett, I
   Lin, Zhi-Xiu
   Feng, Yibin
   Lau, Benson W. M.
   Wagner, Peter D.
   Yang, Xian
   Guo, Yike
   Jia, Wei
   Bian, Zhaoxiang
   Baker, Julien S.
TI COVID-19 Rehabilitation With Herbal Medicine and Cardiorespiratory
   Exercise: Protocol for a Clinical Study
SO JMIR RESEARCH PROTOCOLS
LA English
DT Article
DE COVID-19; rehabilitation; cardiorespiratory exercise; Chinese medicine
ID IMMUNE FUNCTION; PULMONARY; CAPACITY; VALIDITY; IMPROVE; HEALTH
AB Background: Recent studies have revealed that many discharged patients with COVID-19 experience ongoing symptoms months later. Rehabilitation interventions can help address the consequences of COVID-19, including medical, physical, cognitive, and psychological problems. To our knowledge, no studies have investigated the effects of rehabilitation following discharge from hospital for patients with COVID-19.
   Objective: The specific aims of this project are to investigate the effects of a 12-week exercise program on pulmonary fibrosis in patients recovering from COVID-19. A further aim will be to examine how Chinese herbal medicines as well as the gut microbiome and its metabolites regulate immune function and possibly autoimmune deficiency in the rehabilitation process.
   Methods: In this triple-blinded, randomized, parallel-group, controlled clinical trial, we will recruit adult patients with COVID-19 who have been discharged from hospital in Hong Kong and are experiencing impaired lung function and pulmonary function. A total of 172 eligible patients will be randomized into four equal groups: (1) cardiorespiratmy exercise plus Chinese herbal medicines group, (2) cardiorespiratory exercise only group, (3) Chinese herbal medicines only group, and (4) waiting list group (in which participants will receive Chinese herbal medicines after 24 weeks). These treatments will be administered for 12 weeks, with a 12-week follow-up period. Primary outcomes include dyspnea, fatigue, lung function, pulmonary function, blood oxygen levels, immune function, blood coagulation, and related blood biochemistry. Measurements will be recorded prior to initiating the above treatments and repeated at the 13th and 25th weeks of the study. The primary analysis is aimed at comparing the outcomes between groups throughout the study period with an a level of .05 (two-tailed).
   Results: The trial has been approved by the university ethics committee following the Declaration of Helsinki (approval number: REC/19-20/0504) in 2020. The trial has been recruiting patients. The data collection will be completed in 24 months, from January 1, 2021, to December 31, 2022.
   Conclusions: Given that COVID-19 and its sequelae would persist in human populations, important findings from this study would provide valuable insights into the mechanisms and processes of COVID-19 rehabilitation.
C1 [Gao, Yang; Quach, Binh; Baker, Julien S.] Hong Kong Baptist Univ, Ctr Hlth & Exercise Sci Res, Kowloon, Room AAB 926,9-F Acad & Adm Bldg, Hong Kong, Peoples R China.
   [Zhong, Linda L. D.; Jia, Wei; Bian, Zhaoxiang] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China.
   [Zhong, Linda L. D.; Bian, Zhaoxiang] Hong Kong Baptist Univ, Hong Kong Chinese Med Clin Study Ctr, Kowloon, Hong Kong, Peoples R China.
   [Davies, Bruce] Univ South Wales, Neurovasc Res Lab, Pontypridd, M Glam, Wales.
   [Ash, Garrett, I] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA.
   [Ash, Garrett, I] Yale Univ, Ctr Med Informat, New Haven, CT USA.
   [Lin, Zhi-Xiu] Chinese Univ Hong Kong, Fac Med, Sch Chinese Med, Hong Kong, Peoples R China.
   [Feng, Yibin] Univ Hong Kong, Sch Chinese Med, Hong Kong, Peoples R China.
   [Lau, Benson W. M.] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.
   [Wagner, Peter D.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Yang, Xian; Guo, Yike] Hong Kong Baptist Univ, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China.
   [Jia, Wei] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai, Peoples R China.
   [Jia, Wei] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China.
RP Baker, JS (corresponding author), Hong Kong Baptist Univ, Ctr Hlth & Exercise Sci Res, Kowloon, Room AAB 926,9-F Acad & Adm Bldg, Hong Kong, Peoples R China.
EM jsbaker@hkbu.edu.hk
OI Quach, Binh/0000-0002-2500-0301; Ash, Garrett/0000-0002-8655-7525; Yang,
   Xian/0000-0002-1496-8923; Zhong, Linda/0000-0002-3877-1914; Gao, Yang
   (Gemma)/0000-0003-0439-4804; wagner, peter/0000-0001-7957-7432
FU Tsang Shiu Tim Charitable Foundation
FX We are thankful to the participants for their participation. This study
   is supported by the Tsang Shiu Tim Charitable Foundation. The funding
   source played no role in the study design, collection, management,
   analysis, interpretation of data, writing of the report, or decision to
   submit the report for publication.
CR Alison JA, 2014, J THORAC DIS, V6, P1606, DOI 10.3978/j.issn.2072-1439.2014.07.45
   American College of Sports Medicine, 2017, ACSMS GUIDELINES EXE
   Amuasi, WHAT IS RECOVERY RAT, DOI [10.1101/2020.08.26.20180950, DOI 10.1101/2020.08.26.20180950]
   [Anonymous], 2019, SURVEY ELDERLY MENTA
   [Anonymous], 2020, PEDIATR MED RODZ
   [Anonymous], 2007, ANTHR PROC MAN
   [Anonymous], WHO CORONAVIRUS DIS
   [Anonymous], 2019, GUID INF CONTR PRACT
   Bononi A, 2017, CELL DEATH DIFFER, V24, P1694, DOI 10.1038/cdd.2017.95
   Brugliera L, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2678
   Demers C, 2001, AM HEART J, V142, P698, DOI 10.1067/mhj.2001.118468
   Demeyer H, 2017, THORAX, V72, P415, DOI 10.1136/thoraxjnl-2016-209026
   Ekiz T, 2020, HEART LUNG, V49, P853, DOI 10.1016/j.hrtlng.2020.05.011
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Feng WW, 2019, PHARMACOL RES, V142, P176, DOI 10.1016/j.phrs.2019.02.024
   Fischer G, 2014, CLIN J SPORT MED, V24, P69, DOI 10.1097/JSM.0000000000000003
   Gleeson M, 2005, CURR OPIN CLIN NUTR, V8, P511, DOI 10.1097/01.mco.0000170760.63490.95
   Gloeckl R, 2013, EUR RESPIR REV, V22, P178, DOI 10.1183/09059180.00000513
   Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997
   Hacimusalar Y, 2018, NOROPSIKIYATRI ARS, V55, P280, DOI 10.5152/npa.2017.19482
   Hanada M, 2020, J THORAC DIS, V12, P1041, DOI 10.21037/jtd.2019.12.27
   Hu YJ, 2007, PSYCHOL MED, V37, P1005, DOI 10.1017/S0033291707009993
   Huang FF, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104929
   Jiang YY, 2020, J MED INTERNET RES, V22, DOI 10.2196/17089
   Jimenez-Pavon D, 2020, PROG CARDIOVASC DIS, V63, P386, DOI 10.1016/j.pcad.2020.03.009
   Keshavarz M, 2020, CELL MOL BIOL LETT, V25, DOI 10.1186/s11658-020-00211-2
   Kim J, 2014, CLIN ORTHOP SURG, V6, P103, DOI 10.4055/cios.2014.6.1.103
   King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582
   Laoutaris ID, 2018, EUR J PREV CARDIOL, V25, P1257, DOI 10.1177/2047487318776097
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Li LC, 2017, J ETHNOPHARMACOL, V198, P45, DOI 10.1016/j.jep.2016.12.042
   Li TM, 2018, J ETHNOPHARMACOL, V213, P92, DOI 10.1016/j.jep.2017.10.031
   Loeckx M, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9774
   Louvaris Z, 2016, EUR RESPIR J, V48, P567, DOI 10.1183/13993003.00679-2016
   Lovibond S., 1995, MANUAL DEPRESSION AN
   McNamara RJ, 2019, J THORAC DIS, V11, pS2192, DOI 10.21037/jtd.2019.10.29
   Moghadam BH, 2020, J NUTR HEALTH AGING, V24, P796, DOI 10.1007/s12603-020-1431-3
   Mohamed AA, 2020, DIABETES METAB SYND, V14, P489, DOI 10.1016/j.dsx.2020.04.038
   Moussa M.T., 2001, PSYCHOMETRIC PROPERT
   Paglia G, 2012, ANAL BIOANAL CHEM, V402, P1183, DOI 10.1007/s00216-011-5556-4
   Rizzetto L, 2018, J AUTOIMMUN, V92, P12, DOI 10.1016/j.jaut.2018.05.008
   Rochester CL, 2015, AM J RESP CRIT CARE, V192, P1373, DOI 10.1164/rccm.201510-1966ST
   RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472
   Sheehy Lisa Mary, 2020, JMIR Public Health Surveill, V6, pe19462, DOI 10.2196/19462
   Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST
   Sun Y, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09128-z
   Syer T, 2020, THORAX, V75, P503, DOI 10.1136/thoraxjnl-2019-214309
   Vasilopoulou Maroula, 2017, Eur Respir J, V49, DOI 10.1183/13993003.02129-2016
   Wallaert B, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00045-2019
   Walsh NP, 2016, IMMUNOL CELL BIOL, V94, P132, DOI 10.1038/icb.2015.99
   Wang JH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017173
   Wasserman K, 2012, PRINCIPLES EXERCISE, V5
   Yu XQ, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8498603
NR 53
TC 0
Z9 0
U1 5
U2 6
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1929-0748
J9 JMIR RES PROTOC
JI JMIR RES. Protoc.
PD MAY
PY 2021
VL 10
IS 5
AR e25556
DI 10.2196/25556
PG 16
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA SN4JJ
UT WOS:000658257400047
PM 33970864
OA gold, Green Published
DA 2022-04-20
ER

PT J
AU Sohrabi, C
   Alsafi, Z
   O'Neill, N
   Khan, M
   Kerwan, A
   Al-Jabir, A
   Iosifidis, C
   Agha, R
AF Sohrabi, Catrin
   Alsafi, Zaid
   O'Neill, Niamh
   Khan, Mehdi
   Kerwan, Ahmed
   Al-Jabir, Ahmed
   Iosifidis, Christos
   Agha, Riaz
TI World Health Organization declares global emergency: A review of the
   2019 novel coronavirus (COVID-19)
SO INTERNATIONAL JOURNAL OF SURGERY
LA English
DT Review
DE Novel coronavirus; Wuhan; Viral transmission; Global health emergency;
   COVID-19
ID MANAGEMENT; SEPSIS; SARS
AB An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is caused by a betacoronavirus named SARS-CoV-2 that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 90,870 laboratory-confirmed cases and over 3,000 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19.
C1 [Sohrabi, Catrin; O'Neill, Niamh; Iosifidis, Christos] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.
   [Alsafi, Zaid; Khan, Mehdi] UCL, UCL Med Sch, London, England.
   [Kerwan, Ahmed; Al-Jabir, Ahmed] Kings Coll London, GKT Sch Med Educ, London, England.
   [Agha, Riaz] Barts Hlth NHS Trust, London, England.
RP O'Neill, N (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.
EM niamh@ijspg.com
RI Sohrabi, Catrin/AAQ-6271-2020
OI Sohrabi, Catrin/0000-0003-2773-5659; Kerwan, Ahmed/0000-0001-9554-573X;
   Iosifidis, Christos/0000-0002-0148-5674; Al-Jabir,
   Ahmed/0000-0003-3714-211X
CR [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   [Anonymous], 2010, WASHINGTON POST
   [Anonymous], 2018, GLOB MAN SCOR US CO
   [Anonymous], 2020, BLOOMBERG BUSINESSWE
   [Anonymous], 2020, BBC
   [Anonymous], 2020, HARVARD GAZETTE CORO
   [Anonymous], 2020, TIME
   [Anonymous], 2019, BLOOMBERG
   [Anonymous], 2020, FINANCIAL TIMES
   [Anonymous], 2020, NY TIMES, P1
   [Anonymous], 2020, THE GUARDIAN
   Bespoke, 2020, BEB LAUNCH FREE COR
   Center for disease control and Prevention, 2020, NOV COR
   Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Editorial Board of the Wall Street Journal, 2020, WALL STREET J
   European Commission, 2020, COR EU MOB 10 MILL R
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   HM Government, 2020, NOV COR GUID PRIM CA
   HM Government, 2020, 2019 NCOV AC RESP DI
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DSC, 2003, RESPIROLOGY, V8, pS20, DOI 10.1046/j.1440-1843.2003.00520.x
   Info Shengen Visa, 2020, IT SUSP VIS ISS ALL
   Kui L., 2020, CHIN MED J, V1
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Madhav N., 2018, DIS CONTROL PRIORITI, V9, P315
   Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Public Health England, 2020, COR COVID 19 LAT ING
   Reuters, 2020, INST VIEW CHIN EC GR
   Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255
   Rosjo H, 2011, INTENS CARE MED, V37, P77, DOI 10.1007/s00134-010-2051-x
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Schultz MJ, 2017, INTENS CARE MED, V43, P612, DOI 10.1007/s00134-017-4750-z
   Shen L, 2020, J MED ECON, V23, P456, DOI 10.1080/13696998.2020.1717500
   UK Foreign & Commonwealth Office, 2020, TRAV ADV NOV COR
   Verdict Medical Devices, 2020, PRIM LAUNCH MOL TEST
   Verdict Medical Devices, 2020, COD LAUNCH RUO TEST
   Wang D, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2020.1585, DOI 10.1001/JAMA.2020.1585]
   Wang W., 2020, J MED VIROL, P25689
   Wellcome, 2020, WELLCOME SHARING RES
   White House, 2020, PROCL SUSP ENTR IMM
   WHO, 2004, SUMM PROB SARS CAS O
   WHO, 2019, MIDDL E RESP SYNDR C
   WHO, 2020, NOV COR 2019 NCOV SI
   WHO, 2021, STAT 2 M INT HLTH RE
   World Health Organization, 2014, WHO GLOB EP SURV STA
   World Health Organization, 2020, 12 WHO
   World Health Organization, 2020, NOV COR 2019 NCOV AD
   World Health Organization, 2020, 43 WHO
   World Health Organization, 2013, POCK BOOK HOSP CAR C
   World Health Organization, 2020, DIR GEN REM MED BRIE
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 54
TC 2037
Z9 2115
U1 134
U2 461
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1743-9191
EI 1743-9159
J9 INT J SURG
JI Int. J. Surg.
PD APR
PY 2020
VL 76
BP 71
EP 76
DI 10.1016/j.ijsu.2020.02.034
PG 6
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA KY5YP
UT WOS:000522649400028
PM 32112977
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Ltifi, M
   Hichri, A
AF Ltifi, Moez
   Hichri, Abir
TI The effects of corporate governance on the customer's recommendations: a
   study of the banking sector at the time of COVID-19
SO JOURNAL OF KNOWLEDGE MANAGEMENT
LA English
DT Article
DE Brand image; Satisfaction; Corporate governance; COVID-19; Knowledge of
   corporate social responsibility; Identification and recommendation
   behaviour
ID WORD-OF-MOUTH; SOCIAL-RESPONSIBILITY CSR; FINANCIAL PERFORMANCE
   EVIDENCE; SATISFACTION; IMPACT; LOYALTY; KNOWLEDGE; TRUST; IMAGE;
   IDENTIFICATION
AB Purpose This study aims to adopt a mixed-methods approach (accounting and business data) to analyse the effects of the financial institution's governance on both the knowledge of social responsibility and the consumer's attitudes and behaviours, and testing the moderating role of the brand identification in the banking sector during the COVID-19 pandemic. However, this concept has been neglected in previous studies. Design/methodology/approach Data were collected from a sample of 600 respondents in two major Tunisian cities. Participants were selected on the basis of a convenience sampling in which the structural equation modelling method was adopted through SMART PLS 3.0 software. Findings The results showed that good corporate governance has a positive influence on the knowledge of the company's social responsibility, which positively influences its brand image. Therefore, the company's brand image positively influences the customer's satisfaction, which positively influences the recommending behaviour of the financial institutions in the COVID-19 era. However, the brand identification has no moderating effect. Practical implications Managers of financial institutions are advised to pay particular attention to good corporate governance, as it is mandatory for these companies to assume social responsibility and make it known to clients. Therefore, it is obvious to create a good image in the mind of the consumers to satisfy them to recommend the company in question. It is interesting to mobilise the period of health crisis (COVID-19) to create a favourable attitude among the customers because they are sensitive when evaluating and ranking financial institutions according to the relationships that exist especially during this period. Originality/value In fact, there are many studies that dealt with the banking sector. Some of them dealt with the sector through the institutional accounting section while others dealt with the sector through the commercial and marketing section. Therefore, the first contribution of this research is to test a mixed model made up of accounting and commercial data. This model is among the first to determine the effects of the financial institution's governance on the knowledge of social responsibility and on the consumer's attitude and behaviour to test the moderating role of brand identification in the banking sector. The second contribution is to test this model in a period of health crisis (COVID-19). The third contribution is the use of a mixed sample of data collected from two regions. Then, the fourth contribution is the addition of tests for the verification, robustness and validation of the results obtained. Finally, the fifth contribution is the addition of control variables to test their effects on the research model.
C1 [Ltifi, Moez] Shaqra Univ, Coll Sci & Humanities, Dept Business Adm, Al Duwadmi, Saudi Arabia.
   [Ltifi, Moez] Sfax Univ, Higher Business Sch, Sfax, Tunisia.
   [Hichri, Abir] Sfax Univ, Fac Econ Sci & Management, Dept Accounting, Sfax, Tunisia.
RP Ltifi, M (corresponding author), Shaqra Univ, Coll Sci & Humanities, Dept Business Adm, Al Duwadmi, Saudi Arabia.; Ltifi, M (corresponding author), Sfax Univ, Higher Business Sch, Sfax, Tunisia.
EM doctorltyfymoez@gmail.com; abirhichri2016@yahoo.com
RI Ltifi Ph.D, Moez/AAH-8286-2019
OI Ltifi Ph.D, Moez/0000-0003-3210-1845
CR Abdel Razek M, 2014, RES J FINANCE ACCOUN, V5, P2
   Abdelfattah T, 2020, J INT ACCOUNT AUDIT, V38, DOI 10.1016/j.intaccaudtax.2020.100304
   Acharya A, 2021, S ASIAN J BUS STUD, V10, P29, DOI 10.1108/SAJBS-07-2019-0126
   Adnan SM, 2018, J CLEAN PROD, V198, P820, DOI 10.1016/j.jclepro.2018.07.057
   Alexandrov A, 2013, J ACAD MARKET SCI, V41, P531, DOI 10.1007/s11747-012-0323-4
   Arora P, 2011, CORP GOV, V19, P136, DOI 10.1111/j.1467-8683.2010.00843.x
   Ban A.-S, 2018, IMPACT RSE IMAGE MAR, P64
   Bencheikh F, 2017, RES INT BUS FINANC, V42, P874, DOI 10.1016/j.ribaf.2017.07.023
   BenCheikh S., 2008, C INT FISC DROIT GES
   Blazevic V, 2013, J SERV MANAGE, V24, P294, DOI 10.1108/09564231311327003
   Bloemer J., 2002, J CONSUMER SATISF DI, V15, P68
   Bloemer J., 1998, EUR J MARKETING, V32, P499, DOI DOI 10.1108/03090569810216118
   Carroll A.B., 1979, ACAD MANAGE REV, V4, P497, DOI [DOI 10.2307/257850, 10.5465/amr.1979.4498296]
   Chaibi H, 2015, RES INT BUS FINANC, V33, P1, DOI 10.1016/j.ribaf.2014.06.001
   Chang YH, 2017, TRANSPORT POLICY, V59, P38, DOI 10.1016/j.tranpol.2017.07.001
   Choudhury, 2013, IUP J BRAND MANAG, V10, P24
   Cropanzano R, 2005, J MANAGE, V31, P874, DOI 10.1177/0149206305279602
   Danyali AA, 2018, J ORGAN CHANGE MANAG, V31, P1226, DOI 10.1108/JOCM-07-2017-0269
   Davis DF, 2009, INT J LOGIST MANAG, V20, P201, DOI 10.1108/09574090910981297
   de Matos CA, 2008, J ACAD MARKET SCI, V36, P578, DOI 10.1007/s11747-008-0121-1
   Eisingerich AB, 2014, J SERV RES-US, V17, P40, DOI 10.1177/1094670513490836
   Ekta S, 2016, CORP GOV-OXFORD, P978
   El Mehdi, 2013, RECHERCHES SCI GESTI, V97, P163
   Evrard Y., 2003, MARKET ETUDES RECHER, V3eme ed.
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fotios P., 2020, ELECT J, DOI [10.2139/ssrn.3513756, DOI 10.2139/SSRN.3513756]
   Fran?oise A, 2002, ACT 17 C S INT ASS F, P1
   Gangi F, 2019, J KNOWL MANAG, V23, P110, DOI 10.1108/JKM-04-2018-0267
   Garbarino E, 1999, J MARKETING, V63, P70, DOI 10.2307/1251946
   Garcia-Sanchez IM, 2019, J CLEAN PROD, V215, P1288, DOI 10.1016/j.jclepro.2019.01.130
   Sanchez RG, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041549
   Gharbi, 2012, INT J HUMANITIES SOC, V2, P178
   Gharbi J., 2016, REV SCI GESTION, V2, P89
   Grisard C, 2020, ACCOUNT ORG SOC, V82, DOI 10.1016/j.aos.2019.101092
   Grove H, 2011, CORP GOV-OXFORD, V19, P418, DOI 10.1111/j.1467-8683.2011.00882.x
   Guchait P, 2011, J KNOWL MANAG, V15, P513, DOI 10.1108/13673271111137466
   Hair J.F., 2010, MULTIVARIATE DATA AN, V7th
   Haverila M, 2011, YOUNG CONSUM, V12, P310, DOI 10.1108/17473611111185869
   Hikkerova L., 2018, GEST 2000, V35, P101
   Hillebrand B, 2011, J SERV MANAGE, V22, P67, DOI 10.1108/09564231111106929
   Hmissi B, 2017, RES INT BUS FINANC, V42, P1343, DOI 10.1016/j.ribaf.2017.07.071
   Huang CC, 2017, MANAGE DECIS, V55, P915, DOI 10.1108/MD-10-2015-0465
   Huang CJ, 2010, J MANAGE ORGAN, V16, P641, DOI 10.5172/jmo.2010.16.5.641
   Hubbard TD, 2017, STRATEGIC MANAGE J, V38, P2255, DOI 10.1002/smj.2646
   Hussain N, 2018, J BUS ETHICS, V149, P411, DOI 10.1007/s10551-016-3099-5
   Husted K, 2012, J KNOWL MANAG, V16, P754, DOI 10.1108/13673271211262790
   Jallat F, 2002, MARKETING, P1159
   Jolibert, 2005, ACT 21 ME C S AFM MA, P1
   Kang C, 2016, J MARKETING, V80, P59, DOI 10.1509/jm.15.0324
   Kant R, 2017, VISION-INDIA, V21, P76, DOI 10.1177/0972262916681256
   Khan HZ, 2020, CRIT PERSPECT ACCOUN, V71, DOI 10.1016/j.cpa.2019.102096
   Khiari W, 2018, RES INT BUS FINANC, V45, P620, DOI 10.1016/j.ribaf.2017.07.181
   Kim M, 2020, INT J HOSP MANAG, V88, DOI 10.1016/j.ijhm.2020.102520
   Kumar R., 2019, IOSR J BUSINESS MANA, V2, P24
   Lam SK, 2013, J ACAD MARKET SCI, V41, P234, DOI 10.1007/s11747-012-0301-x
   Lam SK, 2012, J INT BUS STUD, V43, P306, DOI 10.1057/jibs.2011.54
   Lee J, 2018, J FASH MARK MANAG, V22, P387, DOI 10.1108/JFMM-08-2017-0087
   Leonidas P, 2012, PROC ECON FINANC, V1, P311, DOI 10.1016/S2212-5671(12)00036-6
   Li ZC, 2014, J BANK FINANC, V45, P255, DOI 10.1016/j.jbankfin.2013.12.008
   Liu Y, 2015, J CORP FINANC, V30, P223, DOI 10.1016/j.jcorpfin.2014.12.004
   Lombart C, 2014, J RETAIL CONSUM SERV, V21, P630, DOI 10.1016/j.jretconser.2013.11.009
   M?sar J., 2012, EKONOMIKA MANAGEMENT, V6, P1
   Mensah L, 2017, RES INT BUS FINANC, V42, P304, DOI 10.1016/j.ribaf.2017.07.141
   Michelon G, 2015, CRIT PERSPECT ACCOUN, V33, P59, DOI 10.1016/j.cpa.2014.10.003
   Minkiewicz J, 2011, J SERV MARK, V25, P190, DOI 10.1108/08876041111129173
   Mitchell RK, 1997, ACAD MANAGE REV, V22, P853, DOI 10.2307/259247
   Mohd Sidek N.Z., 2017, MODERN ORG GOVERNANC, V12, P189
   Molinillo S, 2017, MARK INTELL PLAN, V35, P166, DOI 10.1108/MIP-04-2016-0064
   Molm LD, 2007, SOC PSYCHOL QUART, V70, P199, DOI 10.1177/019027250707000208
   Moorthy K, 2018, INT J LAW MANAG, V60, P934, DOI 10.1108/IJLMA-04-2017-0082
   Mouley S., 2013, ANNUAIRE IEMED MEDIT
   Mukerjee K, 2019, MARK INTELL PLAN, V37, P97, DOI 10.1108/MIP-01-2018-0030
   N'Gobo, 1997, J CONSUMER SATISFACT, V10, P1
   Najjar, 2015, REV GESTION ORG, V7, P116, DOI DOI 10.1016/J.RGO.2015.07.003
   Oliver R.L., 1997, J CONSUMER SATISFACT, V10, P80
   Ortinau, 2008, MARK RES
   Park J, 2014, J BUS RES, V67, P295, DOI 10.1016/j.jbusres.2013.05.016
   Pastrana NA, 2014, PUBLIC RELAT REV, V40, P14, DOI 10.1016/j.pubrev.2013.10.002
   Peng KF, 2014, IND MANAGE DATA SYST, V114, P1131, DOI 10.1108/IMDS-05-2014-0132
   Perez A, 2015, J BUS ETHICS, V129, P571, DOI 10.1007/s10551-014-2177-9
   Perez A, 2015, J SERV MARK, V29, P15, DOI 10.1108/JSM-10-2013-0272
   PETER JP, 1979, J MARKETING RES, V16, P6, DOI 10.2307/3150868
   Pezeshki RE, 2020, INT J EDUC MANAG, V34, P1093, DOI 10.1108/IJEM-11-2018-0378
   Phankasem S., 2016, J BUSINESS RETAIL MA, V10, P126
   Phillips S, 2019, ASIAN J SHIPPING LOG, V35, P30, DOI 10.1016/j.ajsl.2019.03.005
   Plewa C, 2015, J BUS ETHICS, V127, P643, DOI 10.1007/s10551-014-2066-2
   Rached Ben .K, 2018, REV GESTION ORG, V10, P107
   Reb?rioux, 2016, J GOVERNANCE REGULAT, V5, P14
   Reichheld FF, 2003, HARVARD BUS REV, V81, P46
   Resam, 2015, J NEPALESE BUSSINESS, V9, P1
   RING PS, 1994, ACAD MANAGE REV, V19, P90, DOI 10.2307/258836
   Rosario AB, 2016, J MARKETING RES, V53, P297, DOI 10.1509/jmr.14.0380
   Rosenberg L.J., 1973, CONSUMER SATISFACTIO
   Sabadie, 2019, J RETAIL CONSUM SERV, V61, P1
   Sahut JM, 2019, J MANAG GOV, V23, P901, DOI 10.1007/s10997-019-09472-2
   Shumway T, 2001, J BUS, V74, P101, DOI 10.1086/209665
   Srairi S, 2019, BORSA ISTANB REV, V19, pS64, DOI 10.1016/j.bir.2019.02.001
   Srivastava K., 2013, SERVICES MARKETING Q, V34, P274, DOI [https://doi.org/10.1080/15332969.2013.827020, DOI 10.1080/15332969.2013.827020]
   Taghizadeh SK, 2018, J KNOWL MANAG, V22, P162, DOI 10.1108/JKM-12-2016-0548
   Tarchouna A, 2017, RES INT BUS FINANC, V42, P645, DOI 10.1016/j.ribaf.2017.07.008
   Teulon F., 2018, REV MANAG AVENIR, V101, P39, DOI DOI 10.3917/MAV.101.0039
   Valenzuela LM, 2010, J BUS ETHICS, V93, P277, DOI 10.1007/s10551-009-0220-z
   Villaron-Peramato O, 2018, REV MANAG SCI, V12, P27, DOI 10.1007/s11846-016-0212-1
   Walls JL, 2012, STRATEGIC MANAGE J, V33, P885, DOI 10.1002/smj.1952
   Wanvik TI, 2016, EXTRACT IND SOC, V3, P517, DOI 10.1016/j.exis.2016.01.007
   Yin S, 2020, J IND INF INTEGR, V19, DOI 10.1016/j.jii.2020.100157
   Younis RAA, 2021, PERS REV, V50, P244, DOI 10.1108/PR-02-2019-0058
   Yusoff H, 2013, PROC ECON FINANC, V7, P213, DOI 10.1016/S2212-5671(13)00237-2
   Zikmund W. G., 2000, BUSINESS RES METHODS
   Zilakaki E., 2019, INT J EC BUSINESS AD, V3, P433
NR 110
TC 2
Z9 2
U1 9
U2 12
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1367-3270
EI 1758-7484
J9 J KNOWL MANAG
JI J. Knowl. Manag.
PD JAN 6
PY 2022
VL 26
IS 1
BP 165
EP 191
DI 10.1108/JKM-06-2020-0471
EA JUL 2021
PG 27
WC Information Science & Library Science; Management
WE Social Science Citation Index (SSCI)
SC Information Science & Library Science; Business & Economics
GA YC0EX
UT WOS:000677550000001
OA Bronze
DA 2022-04-20
ER

PT J
AU Gotlib, J
   Sobierajski, T
   Jaworski, M
   Wawrzuta, D
   Borowiak, E
   Dobrowolska, B
   Dyk, D
   Gaworska-Krzeminska, A
   Grochans, E
   Kozka, M
   Kulik, H
   Lewko, J
   Nowak-Starz, G
   Wojciechowska, M
   Uchmanowicz, I
   Panczyk, M
AF Gotlib, Joanna
   Sobierajski, Tomasz
   Jaworski, Mariusz
   Wawrzuta, Dominik
   Borowiak, Ewa
   Dobrowolska, Beata
   Dyk, Danuta
   Gaworska-Krzeminska, Aleksandra
   Grochans, Elzbieta
   Kozka, Maria
   Kulik, Halina
   Lewko, Jolanta
   Nowak-Starz, Grazyna
   Wojciechowska, Malgorzata
   Uchmanowicz, Izabella
   Panczyk, Mariusz
TI "Vaccinate, Do Not Hesitate!". Vaccination Readiness against COVID-19
   among Polish Nursing Undergraduate Students: A National Cross-Sectional
   Survey
SO VACCINES
LA English
DT Article
DE COVID-19 vaccine; nursing students; level of knowledge; readiness;
   vaccine hesitancy
ID KNOWLEDGE
AB COVID-19 vaccination raises numerous concerns among the public, and also among medical personnel including nurses. As nurses play a crucial role in the process of vaccination, it is important to recognize the attitudes of students of nursing, nurses in spe, toward COVID-19 vaccination, as well as to define the factors influencing students' pro-vaccine choices. The study was conducted between March and April 2021 at all medical universities in Poland educating nurses in spe. The study included 793 first-degree students from 12 universities. The results revealed that the vast majority of students of nursing (77.2%) were vaccinated against COVID-19, as 61.2% received an mRNA vaccine and 16% a viral vector vaccine. Every other person in the non-vaccinated group declared their intention to get a vaccination. A trend was observed whereby people co-living with persons from the risk group, who are at risk of a severe form of COVID-19, showed greater willingness to get a vaccine. The study results identified the role of universities in increasing the vaccination rate among students, both in terms of education about vaccinations and in shaping pro-vaccine attitudes among students, as well as organizing vaccinations on university campuses to facilitate the process.
C1 [Gotlib, Joanna; Jaworski, Mariusz; Wawrzuta, Dominik; Panczyk, Mariusz] Med Univ Warsaw, Dept Educ & Hlth Sci Res, PL-02091 Warsaw, Poland.
   [Sobierajski, Tomasz] Univ Warsaw, Fac Appl Social Sci & Resocializat, PL-00325 Warsaw, Poland.
   [Borowiak, Ewa] Med Univ Lodz, Dept Conservat Nursing, PL-90926 Lodz, Poland.
   [Dobrowolska, Beata] Med Univ Lublin, Dept Management Nursing, PL-20109 Lublin, Poland.
   [Dyk, Danuta] Med Univ Poznan, Dept Anaesthesiol & Intens Care Nursing, PL-61841 Poznan, Poland.
   [Gaworska-Krzeminska, Aleksandra] Med Univ Gdansk, Dept Nursing Management, PL-80803 Gdansk, Poland.
   [Grochans, Elzbieta] Pomeranian Med Univ, Dept Nursing, PL-70456 Szczecin, Poland.
   [Kozka, Maria] Jagiellonian Univ Med Coll, Dept Clin Nursing, PL-31007 Krakow, Poland.
   [Kulik, Halina] Med Univ Katowice, Dept Propaedeut Nursing, PL-41100 Katowice, Poland.
   [Lewko, Jolanta] Med Univ Bialystok, Fac Hlth Sci, Dept Primary Hlth Care, PL-15950 Bialystok, Poland.
   [Nowak-Starz, Grazyna] Jan Kochanowski Univ Humanities & Sci, Inst Publ Hlth, Med Coll, PL-25406 Kielce, Poland.
   [Wojciechowska, Malgorzata] Univ Phys Educ Warsaw, Dept Nursing, PL-00968 Warsaw, Poland.
   [Uchmanowicz, Izabella] Wroclaw Med Univ, Fac Hlth Sci, PL-50141 Wroclaw, Poland.
RP Wawrzuta, D (corresponding author), Med Univ Warsaw, Dept Educ & Hlth Sci Res, PL-02091 Warsaw, Poland.
EM joanna.gotlib@wum.edu.pl; tomasz.sobierajski@uw.edu.pl;
   mariusz.jaworski@wum.edu.pl; dwawrzuta@wum.edu.pl;
   ewa.borowiak@umed.lodz.pl; beata.dobrowolska@umlub.pl; dyk@ump.edu.pl;
   aleksandra.gaworska-krzeminska@gumed.edu.pl; grochans@pum.edu.pl;
   makozka@cm-uj.krakow.pl; hkulik@sum.edu.pl; jola.lewko@wp.pl;
   gnowakstarz@ujk.edu.pl; malgorzata.wojciechowska@awf.edu.pl;
   izabella.uchmanowicz@umed.wroc.pl; mariusz.panczyk@wum.edu.pl
RI Wawrzuta, Dominik/ABB-1890-2021; Gaworska-Krzemińska,
   Aleksandra/AAL-6720-2020; Dobrowolska, Beata/U-3384-2018; Grochans,
   Elzbieta/M-1593-2014; Panczyk, Mariusz/B-4412-2011; Uchmanowicz,
   Izabella/AAD-2232-2021
OI Gaworska-Krzemińska, Aleksandra/0000-0001-6705-6816; Dobrowolska,
   Beata/0000-0001-9178-9534; Nowak-Starz, Grazyna/0000-0001-7804-2129;
   Wawrzuta, Dominik/0000-0002-0846-8906; Gotlib,
   Joanna/0000-0002-2717-7741; Dyk, Danuta/0000-0003-2435-9424; Kulik,
   Halina/0000-0002-1092-814X; Borowiak, Ewa/0000-0003-1790-3516; Grochans,
   Elzbieta/0000-0002-3679-7002; Panczyk, Mariusz/0000-0003-1830-2114;
   Lewko, Jolanta/0000-0003-3074-1320; Sobierajski,
   Tomasz/0000-0002-6853-9358; Uchmanowicz, Izabella/0000-0001-5452-0210
CR [Anonymous], CBOS NEWS
   Bai W, 2021, INT J BIOL SCI, V17, P1469, DOI 10.7150/ijbs.58835
   Dodd RH, 2021, LANCET INFECT DIS, V21, P161, DOI 10.1016/S1473-3099(20)30926-9
   Evridiki P, 2021, FACTORS INFLUENCING, DOI [10.1101/2021.01.22.21250321, DOI 10.1101/2021.01.22.21250321]
   Galanis PA., 2020, INTENTION HLTH CARE, DOI [10.1101/2020.12.08.20246041, DOI 10.1101/2020.12.08.20246041]
   Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790
   Gohel KH, 2021, CLIN EPIDEMIOL GLOB, V9, P104, DOI 10.1016/j.cegh.2020.07.008
   Hlatshwako TG, 2021, LANCET DIGIT HEALTH, V3, pe76, DOI 10.1016/S2589-7500(21)00002-9
   Ikhlaq A, 2020, PAK J MED SCI, V36, pS32, DOI 10.12669/pjms.36.COVID19-S4.2636
   Kecojevic A, 2021, J COMMUN HEALTH, V46, P1059, DOI 10.1007/s10900-021-00992-3
   Lamb YN, 2021, DRUGS, V81, P495, DOI 10.1007/s40265-021-01480-7
   Lucia VC, 2021, J PUBLIC HEALTH-UK, V43, P445, DOI 10.1093/pubmed/fdaa230
   Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630
   Manning ML, 2021, NURS OUTLOOK, V69, P565, DOI 10.1016/j.outlook.2021.01.019
   Mascarenhas AK, 2021, J DENT EDUC, V85, P1504, DOI 10.1002/jdd.12632
   Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8
   Mojally M, 2020, MED SCI, V24, P2861
   Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9
   Petravic L, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030247
   Porcelli AJ, 2017, CURR OPIN BEHAV SCI, V14, P33, DOI 10.1016/j.cobeha.2016.11.015
   Reyna VF, 2012, JUDGM DECIS MAK, V7, P332
   Romer D, 2021, J MED INTERNET RES, V23, DOI 10.2196/25215
   Rzymski P, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040382
   Saied SM, 2021, J MED VIROL, V93, P4280, DOI 10.1002/jmv.26910
   Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160
   Scholz N., 2021, COVID 19 VACCINATION
   Tempski P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248627
   Wang PW, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040380
   Wawrzuta D, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050481
   World Health Organization, 2021, STAT COVID 19 VACC W
   Yuan T, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.925877
NR 31
TC 2
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD SEP
PY 2021
VL 9
IS 9
AR 1029
DI 10.3390/vaccines9091029
PG 13
WC Immunology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Research & Experimental Medicine
GA UZ2YE
UT WOS:000702075100001
PM 34579265
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ahmad, A
   Jamaludin, A
   Zuraimi, NSM
   Valeri, M
AF Ahmad, Albattat
   Jamaludin, Azizul
   Zuraimi, Nini Shaliza Mohd
   Valeri, Marco
TI Visit intention and destination image in post-Covid-19 crisis recovery
SO CURRENT ISSUES IN TOURISM
LA English
DT Article
DE Crisis recovery; crisis management; change management; destination
   image; travel motivation; visit intention; Covid-19 pandemic
ID TRAVELERS; TOURISM
AB The aim of this research is to analyze the factors influencing visit intention and destination image in post-Covid-19 crisis recovery. In post-crisis recovery, the factors influencing visit intention are physical, socio-psychological and financial factors. A total of 426 respondents were selected and analyzed using correlation and multiple regression analyses. The findings demonstrate that physical factors are the main factors that influence tourists' visit intention. Additionally, destination image significantly affects visit intention and significantly mediates the relationship between the factors and visit intention. All this inevitably affects the organizational structure of the tourist destination.
C1 [Ahmad, Albattat] Management & Sci Univ, Postgrad Ctr, Univ Dr, Shah Alam, Selangor, Malaysia.
   [Jamaludin, Azizul; Zuraimi, Nini Shaliza Mohd] Management & Sci Univ, Sch Hospitality & Creat Arts, Univ Dr, Shah Alam, Selangor, Malaysia.
   [Valeri, Marco] NCI Univ, Knowledge Management, London, England.
   [Valeri, Marco] Niccolo Cusano Univ, Fac Econ, Org Behav, Rome, Italy.
RP Ahmad, A (corresponding author), Management & Sci Univ, Postgrad Ctr, Univ Dr, Shah Alam, Selangor, Malaysia.
EM ahmad_rasmi@msu.edu.my
RI Albattat, Ahmad Rasmi/R-3755-2018
OI Albattat, Ahmad Rasmi/0000-0002-3127-4405; VALERI,
   Marco/0000-0002-9744-506X; Jamaludin, Azizul/0000-0002-8445-3992; Mohd
   Zuraimi, Nini Shaliza/0000-0001-8881-9245
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Arcese G, 2021, J FAM BUS MANAG, V11, P402, DOI 10.1108/JFBM-05-2020-0043
   Baggio R, 2020, J FAM BUS MANAG, DOI 10.1108/JFBM-06-2020-0048
   Bjork P, 2019, TOURISM MANAGE, V71, P466, DOI 10.1016/j.tourman.2018.11.005
   Butowski L., 2017, CURRENT ISSUE TOURIS, V22
   Chemli S, 2022, CURR ISSUES TOUR, V25, P179, DOI 10.1080/13683500.2020.1846502
   ELMO GC, 2020, SUSTAINABILITY BASEL, V12
   Lopes SDF, 2011, PASOS, V9, P305, DOI 10.25145/j.pasos.2011.09.027
   Foo LP, 2021, CURR ISSUES TOUR, V24, P2735, DOI 10.1080/13683500.2020.1777951
   Garg H., 2018, WEALTHY INSIDE WEALT
   Mariani M, 2020, INT J CONTEMP HOSP M, V32, P1643, DOI 10.1108/IJCHM-04-2019-0378
   Masiero L, 2015, INT J HOSP MANAG, V50, P1, DOI 10.1016/j.ijhm.2015.06.009
   Quintal VA, 2010, ASIA PAC J MARKET LO, V22, P554, DOI 10.1108/13555851011090565
   Sigala M, 2020, J BUS RES, V117, P312, DOI 10.1016/j.jbusres.2020.06.015
   Som A, 2015, ROAD TO LUXURY: THE EVOLUTION, MARKETS AND STRATEGIES OF LUXURY BRAND MANAGEMENT, P5
   Stylidis D, 2016, INT J TOUR RES, V18, P129, DOI 10.1002/jtr.2039
   Tavitiyaman P, 2013, J TRAVEL TOUR MARK, V30, P169, DOI 10.1080/10548408.2013.774911
   Valeri M., 2016, Journal of Tourism, Heritage & Services Marketing, V2, P30
   Valeri M., 2020, TOURISM HOSPITALITY
   VALERI M, 2020, INT J ORGAN ANA 0601
   VALERI M, 2020, CURR ISSUES TOU 0612
   Wong IA, 2015, J TRAVEL TOUR MARK, V32, P80, DOI 10.1080/10548408.2014.986014
   Zhang FY, 2018, LECT N MECH ENG, P1, DOI 10.1007/978-981-13-0107-0_1
NR 23
TC 40
Z9 40
U1 24
U2 77
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1368-3500
EI 1747-7603
J9 CURR ISSUES TOUR
JI Curr. Issues Tour.
PD SEP 2
PY 2021
VL 24
IS 17
BP 2392
EP 2397
DI 10.1080/13683500.2020.1842342
EA NOV 2020
PG 6
WC Hospitality, Leisure, Sport & Tourism
WE Social Science Citation Index (SSCI)
SC Social Sciences - Other Topics
GA UC8TG
UT WOS:000588520500001
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Chatterjee, R
   Bajwa, S
   Dwivedi, D
   Kanji, R
   Shaw, MAR
AF Chatterjee, Ranit
   Bajwa, Sukhreet
   Dwivedi, Disha
   Kanji, Repaul
   Shaw, Moniruddin Ahammed Rajib
TI COVID-19 Risk Assessment Tool: Dual application of risk communication
   and risk governance
SO PROGRESS IN DISASTER SCIENCE
LA English
DT Article
DE COVID-19 pandemic; Risk governance; Risk communication; Awareness
   generation; Social behaviour
AB Risk awareness is the best way to prevent and slow-down the transmission of the COVID-19 pandemic. Risk awareness is achieved through communication of risk assessment. Effective risk communication is an important measure to control the infodemic. Most risk assessment tools focus on either tracking the affected patients or diagnosing a probable health condition through symptoms. RIKA India introduces an innovative Risk Assessment Tool which goes beyond the symptom detection and patient tracking. It includes four factors in assessment of risk: Health, Behaviour, Exposure and Social Policy. Each of these four factors have sub-factors which help to assess the overall risk in a more comprehensive way and also present it to the user in a simplified way. The paper discusses the importance of the Risk Assessment Tool for awareness generation and decision making. Further, the datasets generated through the tool have been analysed to understand the key intervention areas for COVID-19 response and management. (C) 2020 The Authors. Published by Elsevier Ltd.
C1 Resilience Innovat Knowledge Acad RIM, Delhi, India.
   KyorD Univ, Kyoto, Japan.
   GO Instinue Disaster Management, Delhi, India.
   Amazon Web Serv, Mumbai, Maharashtra, India.
   Keio Univ, Tokyo, Japan.
RP Shaw, MAR (corresponding author), Resilience Innovat Knowledge Acad RIKA, Delhi, India.
EM shaw@sic.keio.ac.jp
CR Acuto M, 2020, ONE EARTH, V2, P317, DOI 10.1016/j.oneear.2020.04.004
   [Anonymous], 2020, UNDP REPORT
   [Anonymous], INDIAN EXPRESS
   Barry JM, 2009, NATURE, V459, P324, DOI 10.1038/459324a
   Chaturvedi, 2020, TOP 10 POPULAR SMART
   Cheng C, 2006, J APPL SOC PSYCHOL, V36, P222, DOI 10.1111/j.0021-9029.2006.00059.x
   De Bruin YB, 2007, J EXPO SCI ENV EPID, V17, pS55, DOI 10.1038/sj.jes.7500587
   de Bruin YB, 2020, SAFETY SCI, V128, DOI 10.1016/j.ssci.2020.104773
   DeWit A, 2020, ASIA-PAC J-JPN FOCU, V18
   DiClemente R.J., 2017, INT ENCY PUBLIC HLTH, V2nd ed., P378, DOI 10.1016/B978-0-12-803678-5.00389-1
   Divo MJ, 2014, EUR RESPIR J, V44, P1055, DOI 10.1183/09031936.00059814
   ECDC, 2020, COR DIS 2019 COVID 1
   Hua JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072309
   Kennedy RA, 2014, J WOMENS HEALTH, V23, P2014
   Lin YH, 2020, BRAIN BEHAV IMMUN, V87, P30, DOI 10.1016/j.bbi.2020.04.020
   Nebehay S., 2020, WHO OFFICIALS RETHIN
   Pallares S, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02270
   Pearson Correlation Coefficient, STAT SOL
   Ramakrishnan S, 2019, INDIAN HEART J, V71, P309, DOI 10.1016/j.ihj.2019.09.012
   Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090
   Silver L., 2019, MOBILE CONNECTIVITY
   Tashiro A., 2020, J PUBLIC HEALTH POL
   Vaishya R, 2020, DIABETES METAB SYND, V14, P337, DOI 10.1016/j.dsx.2020.04.012
   WHO, EP WIN UPD
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
   Zhang HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103370
NR 26
TC 14
Z9 17
U1 9
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2590-0617
J9 PROG DISASTER SCI
JI Prog. Disaster Sci.
PD OCT
PY 2020
VL 7
AR 100109
DI 10.1016/j.pdisas.2020.100109
PG 11
WC Environmental Sciences; Environmental Studies; Geosciences,
   Multidisciplinary; Public, Environmental & Occupational Health;
   Meteorology & Atmospheric Sciences
WE Emerging Sources Citation Index (ESCI)
SC Environmental Sciences & Ecology; Geology; Public, Environmental &
   Occupational Health; Meteorology & Atmospheric Sciences
GA VK7JH
UT WOS:000748950500021
PM 34171014
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Shahbaz, M
   Sinha, A
   Shah, MI
AF Shahbaz, Muhammad
   Sinha, Avik
   Shah, Muhammad Ibrahim
TI Differential impacts of the US-China trade war and the outbreak of
   COVID-19 on Chinese air quality
SO MANAGEMENT OF ENVIRONMENTAL QUALITY
LA English
DT Article
DE China; Trade war; COVID-19; AQI; Convergence
ID POLLUTION
AB Purpose Over the last couple of years, the Chinese manufacturing sector was affected by the onset of the US-China trade war and the outbreak of coronavirus disease 2019 (COVID-19). In such a scenario air quality in China has encountered a shock, and the impacts of these two incidents are unknown. In this study, the authors analyze the convergence of air quality in China in the presence of multiple structural breaks and how the impacts of these two events are different from each other. Design/methodology/approach In order to assess the nature of shocks in the presence of multiple structural breaks, unit root tests with multiple structural breaks are employed. Findings The results reveal that air quality in China is showing the sign of convergence, and it is consistent across 18 provinces which are worst hit by the outbreak of COVID-19. In the presence of transitory shocks, the impact of COVID-19 outbreak is found to be higher, whereas the impact of the US-China trade war is found to be more persistent. Lastly, the outbreak of COVID-19 has been found to have more impact on pollutants with higher severity of health hazard. Originality/value To the best of the authors' knowledge, this is the first study that contributes to the empirical literature in terms of investigating the convergence of overall air pollution and individual air pollutants taking COVID-19 and the trade war into account.
C1 [Shahbaz, Muhammad] Beijing Inst Technol, Sch Management & Econ, Dept Int Trade & Finance, Beijing, Peoples R China.
   [Shahbaz, Muhammad] Univ Cambridge, Dept Land Econ, Cambridge, England.
   [Sinha, Avik] Goa Inst Management, Ctr Excellence Sustainable Dev, Sattari, Goa, India.
   [Shah, Muhammad Ibrahim] Univ Alberta, Resource Econ & Environm Sociol REES, Edmonton, AB, Canada.
   [Shah, Muhammad Ibrahim] Univ Dhaka, Alma Mater Dept Econ, Dhaka, Bangladesh.
RP Sinha, A (corresponding author), Goa Inst Management, Ctr Excellence Sustainable Dev, Sattari, Goa, India.
EM muhdshahbaz77@gmail.com; f11aviks@iimidr.ac.in; mshah3@ualberta.ca
RI Sinha, Avik/J-3905-2019; Liu, Hai-Ying/P-5557-2014
OI Sinha, Avik/0000-0001-7795-1259; Liu, Hai-Ying/0000-0001-8667-3465;
   Shah, Muhammad Ibrahim/0000-0001-9978-0569
CR Bai J, 2009, REV ECON STUD, V76, P471, DOI 10.1111/j.1467-937X.2008.00530.x
   Clemente J, 1998, ECON LETT, V59, P175, DOI 10.1016/S0165-1765(98)00052-4
   Copeland B.R., 2000, ENVIRON DEV ECON, V5, P405, DOI [10.1017/s1355770x00000255, DOI 10.1017/S1355770X00000255]
   DEVINE G, 1987, AM J AGR ECON, V69, P900
   Elobeid A, 2021, J AGR ECON, V72, P647, DOI 10.1111/1477-9552.12430
   Feng ZZ, 2015, ENVIRON POLLUT, V199, P42, DOI 10.1016/j.envpol.2015.01.016
   Fuchs R, 2019, NATURE, V567, P451, DOI 10.1038/d41586-019-00896-2
   He GJ, 2020, NAT SUSTAIN, V3, DOI 10.1038/s41893-020-0581-y
   He RR, 2019, J CLEAN PROD, V227, P578, DOI 10.1016/j.jclepro.2019.04.192
   Helm D, 2020, ENVIRON RESOUR ECON, V76, P21, DOI 10.1007/s10640-020-00426-z
   Hu M, 2021, ATMOS POLLUT RES, V12, P316, DOI 10.1016/j.apr.2020.11.013
   Le Quere C, 2020, NAT CLIM CHANGE, V10, P647, DOI 10.1038/s41558-020-0797-x
   Liu B., 2020, IMPACT WUHAN COVID 1
   McDonald J., 2020, CHINAS GROWTH CONTIN
   Morrison WM., 2018, CHINAS EC RISE HIST
   Myllyvirta L., 2020, ANAL CORONAVIRUS HAS
   NASA, 2020, AIRB NITR DIOX PLUMM
   National Bureau of Statistics of China, 2020, PURCH MAN IND MARCH
   SARGAN JD, 1983, ECONOMETRICA, V51, P153, DOI 10.2307/1912252
   Schroeter, 2020, WTO STAFF WORKING PA
   Sofia D, 2020, ENVIRON SCI POLLUT R, V27, P19226, DOI 10.1007/s11356-020-08647-x
   Soukup B.J., 2010, BERKELEY J INT LAW, V28, P313
   Struttmann T, 1998, J Am Board Fam Pract, V11, P481
   Swift, 2019, ENV BECOMES TRADE WA
   WADE WA, 1975, JAPCA J AIR WASTE MA, V25, P933, DOI 10.1080/00022470.1975.10468114
   Wang A., 2019, CHINAS AIR POLLUTION
   Wilson WE, 1997, J AIR WASTE MANAGE, V47, P1238, DOI 10.1080/10473289.1997.10464074
   Zhang FQ, 2020, PROD OPER MANAG, V29, P2219, DOI 10.1111/poms.13231
   Zhang JJ, 2019, J ENVIRON SCI, V77, P372, DOI 10.1016/j.jes.2018.09.015
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 30
TC 0
Z9 0
U1 0
U2 0
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1477-7835
EI 1758-6119
J9 MANAG ENVIRON QUAL
JI Manag. Environ. Qual.
PD FEB 21
PY 2022
VL 33
IS 2
BP 353
EP 370
DI 10.1108/MEQ-02-2021-0038
EA NOV 2021
PG 18
WC Environmental Studies
WE Emerging Sources Citation Index (ESCI)
SC Environmental Sciences & Ecology
GA ZH2KV
UT WOS:000713734100001
OA Green Submitted, Bronze
DA 2022-04-20
ER

PT J
AU Yan, QL
   Tang, YL
   Yan, DD
   Wang, JY
   Yang, LQ
   Yang, XP
   Tang, SY
AF Yan, Qinling
   Tang, Yingling
   Yan, Dingding
   Wang, Jiaying
   Yang, Linqian
   Yang, Xinpei
   Tang, Sanyi
TI Impact of media reports on the early spread of COVID-19 epidemic
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE COVID-19; Media report; Individual behaviour change; Correlation
   analysis; SEIR-type model
ID TRANSMISSION; MODELS
AB Media reports can modify people's knowledge of emerging infectious diseases, and thus changing the public attitudes and behaviors. However, how the media reports affect the development of COVID-19 epidemic is a key public health issue. Here the Pearson correlation and cross-correlation analyses are conducted to find the statistically significant correlations between the number of new hospital notifications for COVID-19 and the number of daily news items for twelve major websites in China from January 11th to February 6th 2020. To examine the implication for transmission dynamics of these correlations, we proposed a novel model, which embeds the function of individual behaviour change (media impact) into the intensity of infection. The nonlinear least squares estimation is used to identify the best-fit parameter values in the model from the observed data. To determine impact of key parameters with media impact and control measures for the later outcome of the outbreak, we also carried out the uncertainty and sensitivity analyses. These findings confirm the importance of the responses of individuals to the media reports, and the crucial role of experts and governments in promoting the public under self-quarantine. Therefore, for mitigating epidemic COVID-19, the media publicity should be focused on how to guide people's behavioral changes by experts, and the management departments and designated hospitals of the COVID-19 should take effective quarantined measures, which are critical for the control of the disease. (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Yan, Qinling] Changan Univ, Sch Sci, Xian 710064, Peoples R China.
   [Tang, Yingling; Yan, Dingding; Wang, Jiaying; Yang, Linqian; Yang, Xinpei; Tang, Sanyi] Shaanxi Normal Univ, Coll Math & Informat Sci, Xian 710062, Peoples R China.
RP Tang, SY (corresponding author), Shaanxi Normal Univ, Coll Math & Informat Sci, Xian 710062, Peoples R China.
EM sytang@snnu.edu.cn
FU National Natural Science Foundation of China (NSFCs) [11631012,
   61772017, 11801346]
FX This work was partially supported by the National Natural Science
   Foundation of China (NSFCs: 11631012, 61772017, 11801346).
CR [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003
   Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062
   Benjamin Maie F., 2020, EFFECTIVE CONTAINMEN
   Castillo-Chavez C, 2003, JAMA-J AM MED ASSOC, V290, P2876, DOI 10.1001/jama.290.21.2876
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen Y, 2020, J INVERSE ILL-POSE P, V28, P243, DOI 10.1515/jiip-2020-0010
   Collinson S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-376
   Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0
   de Silva UC, 2009, EUROSURVEILLANCE, V14, P11
   Guan W-J, 2020, CLIN CHARACTERISTICS
   Hellewell J, 2020, FEASIBILITY CONTROLL, DOI [10.1101/2020.02.08.20021162, DOI 10.1101/2020.02.08.20021162]
   Hong L., 2020, EPIDEMIC ANAL COVID, DOI [10.1101/2020.02.16.20023465, DOI 10.1101/2020.02.16.20023465]
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang F., 2011, TIBET MALARIA J, V10, P1
   Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4
   Li J.A., 2020, ROBUST STOCHASTIC ME
   Li Qun, 2020, N Engl J Med, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li YF, 2009, COMMUN NONLINEAR SCI, V14, P2353, DOI 10.1016/j.cnsns.2008.06.024
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Peng L.R., 2020, ARXIV202006563V1
   Sun CJ, 2011, MATH BIOSCI, V230, P87, DOI 10.1016/j.mbs.2011.01.005
   Tang B, 2020, INFECT DIS MODEL, V5, P248, DOI 10.1016/j.idm.2020.02.001
   Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462
   Tang S, 2020, SCI SIN MATH, V50, P1, DOI [10.1360/SSM-2020-0053., DOI 10.1360/SSM-2020-0053]
   TAYLOR R, 1990, J DIAGN MED SONOG, V6, P219, DOI 10.1177/875647939000600404
   Wang Xia, 2020, CHINA SCI MATH, DOI [10.1360 /SSM-2020-0037, DOI 10.1360/SSM-2020-0037]
   William W.S., 2006, TIME SERIES ANAL UNI, P345
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Yan QL, 2018, STAT MED, V37, P948, DOI 10.1002/sim.7548
   Yan QL, 2016, J THEOR BIOL, V390, P1, DOI 10.1016/j.jtbi.2015.11.002
   You C., 2020, ESTIMATION TIME VARY, DOI [10.2139/ssrn.3539694, DOI 10.2139/SSRN.3539694]
   Zeng T., 2020, ARXIV PREPRINT ARXIV
   Zhou C., 2020, EVALUATING NEW EVIDE, DOI [10.1101/2020.02.15.20023440, DOI 10.1101/2020.02.15.20023440]
   Zhu, 2007, COMP MATH MATH PHYS, V8, P153, DOI [10.1080/17486700701425870, DOI 10.1080/17486700701425870]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 35
TC 16
Z9 16
U1 9
U2 128
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD OCT 7
PY 2020
VL 502
AR 110385
DI 10.1016/j.jtbi.2020.110385
PG 13
WC Biology; Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA MO7FQ
UT WOS:000551687300010
PM 32593679
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Cheng, FS
   Yen, YF
   Lin, SY
   Weng, SH
   Chou, YC
   Chu, DC
   Chen, CC
   Hu, HY
AF Cheng, Feng-Shiang
   Yen, Yung-Feng
   Lin, Shu-Yi
   Weng, Shih-Han
   Chou, Yi-Chang
   Chu, Dachen
   Chen, Chu-Chieh
   Hu, Hsiao-Yun
TI Prevalence and Factors Associated with the Reuse of Mask during the
   COVID-19 Pandemic: A Nationwide Survey in Taiwan
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; SARS-CoV-2; reuse of masks; knowledge on usage of masks
ID SURGICAL MASKS; RESPIRATORS; SARS-COV-2; VACCINE; IMPACT
AB Mask usage is an effective measure to prevent severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection; however, mask reuse is not recommended. Studies examining the factors associated with mask reuse during the coronavirus disease (COVID-19) pandemic are limited. This nationwide survey aimed to determine the prevalence and factors associated with mask reuse among Taiwanese citizens during the pandemic. From 18 May through 31 May 2020, a computer-assisted telephone interview system was used to randomly select Taiwanese citizens for interview regarding COVID-19-preventive behaviors and knowledge on mask usage. For a total of 1075 participants, the overall mean age was 57.4 years, and 82.2% of participants reported mask reuse during the COVID-19 pandemic. After controlling for other covariates, participants who had a greater knowledge of mask usage or had a high supply of masks were less likely to reuse masks during the pandemic. Moreover, generalized estimating equations (GEE) analysis showed that, compared with the participants' mask-wearing behaviors before the COVID-19 pandemic, they were more likely to reuse masks during the pandemic. Thus, it is imperative to educate people on the correct usage of masks. Furthermore, the government should provide sufficient masks to the general population to reduce mask reuse.
C1 [Cheng, Feng-Shiang; Yen, Yung-Feng; Lin, Shu-Yi; Weng, Shih-Han; Chou, Yi-Chang; Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei 106, Taiwan.
   [Cheng, Feng-Shiang; Yen, Yung-Feng; Hu, Hsiao-Yun] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei 112, Taiwan.
   [Yen, Yung-Feng] Taipei City Hosp, Yangming Branch, Sect Infect Dis, Taipei 111, Taiwan.
   [Yen, Yung-Feng; Chen, Chu-Chieh] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei 112, Taiwan.
   [Yen, Yung-Feng] Univ Taipei, Dept Psychol & Counseling, Taipei 100, Taiwan.
   [Chu, Dachen; Hu, Hsiao-Yun] Univ Taipei, Dept Hlth & Welf, Taipei 100, Taiwan.
   [Chu, Dachen] Taipei City Hosp, Dept Neurosurg, Taipei 103, Taiwan.
   [Chu, Dachen] Natl Yang Ming Chiao Tung Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan.
RP Hu, HY (corresponding author), Taipei City Hosp, Dept Educ & Res, Taipei 106, Taiwan.; Hu, HY (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei 112, Taiwan.; Hu, HY (corresponding author), Univ Taipei, Dept Hlth & Welf, Taipei 100, Taiwan.
EM A3989@tpech.gov.tw; DAM37@tpech.gov.tw; A3810@tpech.gov.tw;
   A4391@tpech.gov.tw; T0036@tpech.gov.tw; DAD57@tpech.gov.tw;
   chuje@ntunhs.edu.tw; A3547@tpech.gov.tw
OI Chou, Yi-Chang/0000-0002-7478-0105; Hu, Hsiao-Yun/0000-0003-3604-3494
FU Ministry of Science and Technology, TaiwanMinistry of Science and
   Technology, Taiwan [MOST108-2635B-532-001]; Department of Health, Taipei
   City Government, Taiwan [11001-62-030]
FX This study was funded by the Ministry of Science and Technology, Taiwan
   (MOST108-2635B-532-001), and the Department of Health, Taipei City
   Government, Taiwan (11001-62-030).
CR Banerji A, 2021, J ALLER CL IMM-PRACT, V9, P1423, DOI 10.1016/j.jaip.2020.12.047
   Centers for Disease Control (CDC), GUID UNV PEOPL TYP M GUID UNV PEOPL TYP M
   Cheng HY, 2020, J FORMOS MED ASSOC, V119, P771, DOI 10.1016/j.jfma.2020.03.007
   Chiang CH, 2021, INFECT CONT HOSP EP, V42, P244, DOI 10.1017/ice.2020.226
   Chien Li-Chien, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.357
   Cortes MF, 2021, INT J INFECT DIS, V104, P320, DOI 10.1016/j.ijid.2020.12.056
   Dehbandi R, 2020, LANCET MICROBE, V1, pE145, DOI 10.1016/S2666-5247(20)30093-8
   Derraik JGB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176117
   Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X
   Flacco ME, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060628
   Grinshpun SA, 2020, J HOSP INFECT, V105, P608, DOI 10.1016/j.jhin.2020.06.030
   Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8
   Hall VJ, 2021, LANCET, V397, P1725, DOI 10.1016/S0140-6736(21)00790-X
   Huang JH, 2012, EUR J PUBLIC HEALTH, V22, P796, DOI 10.1093/eurpub/ckr167
   Ji Dongxiao, 2020, BMC Mater, V2, P9, DOI 10.1186/s42833-020-00015-w
   Kumar A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243965
   Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002
   Lee LYK, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11346-y
   Li T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237691
   Liu JY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093311
   Miao YY, 2012, TROP MED INT HEALTH, V17, P604, DOI 10.1111/j.1365-3156.2012.02966.x
   Noorimotlagh Z, 2021, ENVIRON SCI POLLUT R, V28, P1, DOI 10.1007/s11356-020-11060-z
   Pellowski JA, 2016, BEHAV MED, V42, P39, DOI 10.1080/08964289.2014.963006
   Pereira-Avila FMV, 2020, REV LAT-AM ENFERM, V28, DOI 10.1590/1518-8345.4604.3360
   Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577
   Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282
   Taiwan Centers for Disease Control and Prevention, SURV COVID 19 SURV COVID 19
   Taiwan Centers for Disease Control (Taiwan CDC), PEOPL MUST WEAR MASK PEOPL MUST WEAR MASK
   Toomey E., 2020, INFECT CONT HOSP EP, V42, P1
   Tsilingiris D, 2020, INTERN EMERG MED, V15, P773, DOI 10.1007/s11739-020-02382-4
   Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151
   Wang J, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115099
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   World Health Organization, COR DIS COVID 19 PAN
NR 34
TC 0
Z9 0
U1 5
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD AUG
PY 2021
VL 18
IS 15
AR 8065
DI 10.3390/ijerph18158065
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA TV8LF
UT WOS:000681967200001
PM 34360358
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Osawa, E
   Okuda, H
   Koto-Shimada, K
   Shibanuma, A
   Saito, T
AF Osawa, Eri
   Okuda, Hiroko
   Koto-Shimada, Kyoko
   Shibanuma, Akira
   Saito, Tomoya
TI The Environment Encouraging COVID-19 Response at Public Health Centers
   and Future Challenges in Japan
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE COVID-19; public health center; public health activity; supportive
   environment; challenge; competency; Japan
AB The coronavirus disease 2019 (COVID-19) pandemic has triggered the implementation of public health measures globally. The health department of local governments has played a critical role in confronting COVID-19. In Japan, public health centers (PHCs) are focal points for COVID-19 response. Understanding the response to COVID-19 in local areas is critical to ensure adequate preparation for future emergencies. Therefore, the purpose of this study is to clarify how the COVID-19 operations by PHCs in Japan were managed and facilitated at the beginning of the infection spread, and their future challenges. We designed a case study that included two PHCs with a population of approximately 400,000 in Japan. Semi-structured focus group interviews with public health nurses from these two PHCs were conducted in September and October 2020. The data were analyzed using chronological time-series analysis. The switch to crisis response was encouraged by the business continuity plan. Their operations for the prevention of COVID-19 in the community were facilitated by the existing network. Further, strengthening the knowledge and skill regarding infectious disease control and management skills during infectious disease-related health emergencies were recommended. It is important to ensure that the environment facilitates emergency response and that people-and-community-centered health promotion activities are conducted, during an emergency situation, with more innovative action and leadership.
C1 [Osawa, Eri] Natl Inst Publ Hlth, Dept Int Hlth & Collaborat, Saitama 3510197, Japan.
   [Okuda, Hiroko] Natl Inst Publ Hlth, Dept Hlth Crisis Management, Saitama 3510197, Japan.
   [Koto-Shimada, Kyoko; Shibanuma, Akira] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo 1130033, Japan.
   [Saito, Tomoya] Natl Inst Infect Dis, Ctr Emergency Preparedness & Response, Tokyo 1628640, Japan.
RP Osawa, E (corresponding author), Natl Inst Publ Hlth, Dept Int Hlth & Collaborat, Saitama 3510197, Japan.
EM osawa.e.aa@niph.go.jp; okuda.h.aa@niph.go.jp; kkoto-shimada@umin.ac.jp;
   shibanuma@m.u-tokyo.ac.jp; saitot16@niid.go.jp
RI Shibanuma, Akira/C-7652-2016
OI Shibanuma, Akira/0000-0003-2058-1722
FU Health Labour Sciences Research Grant, Japan [19HA1003]
FX This research was funded by Health Labour Sciences Research Grant, Japan
   (19HA1003).
CR [Anonymous], 2020, EV BUS WHOL OF SOC A
   Czabanowska K, 2021, INT J HEALTH PLAN M, V36, P14, DOI 10.1002/hpm.3131
   Dutta A, 2021, WORLD DEV, V138, DOI 10.1016/j.worlddev.2020.105234
   Furuse Y, 2020, EMERG INFECT DIS, V26, P2176, DOI 10.3201/eid2609.202272
   Gilmore B, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003188
   Gonah L, 2020, ANN GLOB HEALTH, V86, DOI 10.5334/aogh.3119
   Hatton Tracy, 2016, J Bus Contin Emer Plan, V10, P84
   Honda C, 2022, PUBLIC HEALTH NURS, V39, P161, DOI 10.1111/phn.13011
   Imamura T, 2021, HEALTH SECUR, V19, P229, DOI 10.1089/hs.2020.0159
   Japanese Association of Public Health Center Directors, TRANS NUMB PUBL HLTH
   Lash RR, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.15850
   Lash RR, 2020, MMWR-MORBID MORTAL W, V69, P1360, DOI 10.15585/mmwr.mm6938e3
   Ministry of Health Labour and Welfare, JAP REP COMM HLTH HL
   Ministry of Health Labour and Welfare, JAP REP PNEUM PAT RE
   National Academies of Sciences Engineering and Medicine, 2020, ENC PART COOP CONT T, DOI [10.17226/25916, DOI 10.17226/25916]
   Office for Pandemic Influenza and New Infection Diseases Preparedness and Response, C S NAT ACT PLAN PAN
   Oshitani H, 2020, JPN J INFECT DIS, V73, P491, DOI 10.7883/yoken.JJID.2020.363
   Talabis DAS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11746-0
   Sasaki H, 2020, TOHOKU J EXP MED, V251, P147, DOI 10.1620/tjem.251.147
   Strudsholm Tina, 2021, Healthc Manage Forum, V34, P340, DOI 10.1177/08404704211032710
   Yamada Y, 2021, PUBLIC HLTH NURS HOK, V77, P487
   Yin R.K., 2013, CASE STUDY RES DESIG, V3rd ed.
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 23
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAR
PY 2022
VL 19
IS 6
AR 3343
DI 10.3390/ijerph19063343
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 0C5IF
UT WOS:000775346000001
PM 35329029
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ma, Y
   Faraz, NA
   Ahmed, F
   Iqbal, MK
   Saeed, U
   Mughal, MF
   Raza, A
AF Ma, Ying
   Faraz, Naveed Ahmad
   Ahmed, Fawad
   Iqbal, Muhammad Khalid
   Saeed, Umair
   Mughal, Muhammad Farhan
   Raza, Ali
TI Curbing nurses' burnout during COVID-19: The roles of servant leadership
   and psychological safety
SO JOURNAL OF NURSING MANAGEMENT
LA English
DT Article
DE conservation of resources theory; COVID-19; nurses' burnout;
   psychological safety; servant leadership
ID BEHAVIOR
AB Aims: This study examines the role of servant leadership through the mechanism of psychological safety in curbing nurses' burnout during the COVID-19 pandemic.
   Background: During the COVID-19 pandemic, studies have shown an increased level of stress and burnout among health care workers, especially nurses. This study responds to the call for research to explore the mechanisms of servant leadership in predicting nurses' burnout by employing the perspective of conservation of resources theory.
   Methods: Through a cross-sectional quantitative research design, data were collected in three waves from 443 nurses working in Pakistan's five public sector hospitals. Data were analysed by employing the partial least squares path modelling (PLSPM) technique.
   Results: Servant leadership (beta = -0.318; 95% CI = 0.225, 0.416) and psychological safety (beta = -0.342; CI = 0.143, 0.350) have an inverse relationship with nurses' burnout and explain 63.1% variance.
   Conclusions: Servant leadership significantly reduces nurses' burnout, and psychological safety mediates this relationship.
   Implications for Nursing Management: Human resource management policies in health care must emphasize training nursing leaders in servant leadership behaviour.
C1 [Ma, Ying; Faraz, Naveed Ahmad; Ahmed, Fawad] Wuhan Univ Technol, Sch Management, Wuhan, Peoples R China.
   [Faraz, Naveed Ahmad] Hunan Univ, Sch Business, Changsha, Peoples R China.
   [Ahmed, Fawad] China Univ Min & Technol, Sch Econ & Management, Xuzhou, Jiangsu, Peoples R China.
   [Iqbal, Muhammad Khalid; Raza, Ali] Univ Management & Technol, Knowledge Unit Business Econ Accountancy & Commer, Sialkot Campus, Sialkot, Pakistan.
   [Saeed, Umair] Minist Higher Educ, Coll Sci, Business Adm Dept, Ibri, Oman.
   [Mughal, Muhammad Farhan] Tianjin Univ Finance & Econ, Sch Management Sci, Tianjin, Peoples R China.
RP Faraz, NA (corresponding author), Wuhan Univ Technol, Sch Management, Wuhan, Peoples R China.; Ahmed, F (corresponding author), China Univ Min & Technol, Sch Econ & Management, Xuzhou, Jiangsu, Peoples R China.
EM naveedahmad@whut.edu.cn; fawadahmed1@live.com
RI Faraz, Naveed Ahmad/AAF-7146-2022; Raza, Ali/AAI-8910-2020
OI Raza, Ali/0000-0001-7043-2472; Ahmed, Fawad/0000-0002-3495-7404; Faraz,
   Naveed/0000-0002-4790-9751
FU Wuhan University of Technology [2020IVA079]
FX Wuhan University of Technology, Grant/Award Number: 2020IVA079
CR Ahmed F, 2021, J ADV NURS, V77, P819, DOI 10.1111/jan.14637
   Arnold KA, 2017, J ORGAN BEHAV, V38, P1038, DOI 10.1002/job.2182
   Babakus E., 2010, SERVICES MARKETING Q, V32, P17, DOI [10.1080/15332969.2011.533091, DOI 10.1080/15332969.2011.533091]
   Bakker AB, 2008, WORK STRESS, V22, P187, DOI 10.1080/02678370802393649
   Best C., 2020, PRACTICE NURSING, V31, P128
   Bradley Y., 1999, J CHRISTIAN ED, V2, P43, DOI [10.1177/002196579904200207, DOI 10.1177/002196579904200207]
   Chin WW, 1998, QUANT METH SER, P295
   Chughtai AA, 2016, J PSYCHOL, V150, P866, DOI 10.1080/00223980.2016.1170657
   Coetzer MF, 2017, SA J IND PSYCHOL, V43, DOI [10.4102/ sajip.v43i0.1478, 10.4102/sajip.v43i0.1478]
   Detert JR, 2007, ACAD MANAGE J, V50, P869
   Dirik HF, 2017, J NURS MANAGE, V25, P392, DOI 10.1111/jonm.12480
   Divya S., 2018, International Journal of Business Innovation and Research, V15, P119
   Dominguez-Salas S, 2021, J NURS MANAGE, V29, P1924, DOI 10.1111/jonm.13331
   Edmondson A, 1999, ADMIN SCI QUART, V44, P350, DOI 10.2307/2666999
   Edmondson A., 2014, BUILDING PSYCHOLOGIC
   Edmondson AC, 2014, ANNU REV ORGAN PSYCH, V1, P23, DOI 10.1146/annurev-orgpsych-031413-091305
   Erkutlu H, 2019, INT J WORKPLACE HEAL, V12, P197, DOI 10.1108/IJWHM-12-2018-0154
   Eva N, 2019, LEADERSHIP QUART, V30, P111, DOI 10.1016/j.leaqua.2018.07.004
   Eva N, 2018, PERS REV, V47, P166, DOI 10.1108/PR-03-2016-0064
   Faraz N.A., 2019, INT J MANAGEMENT SCI, V5
   Faraz NA, 2021, CORP SOC RESP ENV MA, V28, P1171, DOI 10.1002/csr.2115
   Garcia-Sierra R, 2016, J NURS MANAGE, V24, P780, DOI 10.1111/jonm.12382
   Greenleaf R.K., 1977, SERVANT LEADERSHIP J, P1
   Hair JF, 2020, J BUS RES, V109, P101, DOI 10.1016/j.jbusres.2019.11.069
   Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203
   Hildenbrand K, 2018, J OCCUP HEALTH PSYCH, V23, P31, DOI 10.1037/ocp0000051
   Hobfoll SE, 2018, ANNU REV ORGAN PSYCH, V5, P103, DOI 10.1146/annurev-orgpsych-032117-104640
   Hunsaker W., 2019, MANAGEMENT SCI LETT, V9, P1257, DOI [10.5267/j.msl.2019.4.016., DOI 10.5267/J.MSL.2019.4.016]
   Iqbal A, 2020, LEADERSHIP ORG DEV J, V41, P813, DOI 10.1108/LODJ-11-2019-0474
   Karatepe OM, 2019, SERV IND J, V39, P86, DOI 10.1080/02642069.2018.1464559
   Laschinger HKS, 2013, J NURS MANAGE, V21, P541, DOI 10.1111/j.1365-2834.2012.01375.x
   Lee A, 2020, J OCCUP ORGAN PSYCH, V93, P1, DOI 10.1111/joop.12265
   Lee HF, 2019, J NURS MANAGE, V27, P52, DOI 10.1111/jonm.12648
   Leiter M.P., 1997, TRUTH BURNOUT ORG CA
   Liden RC, 2008, LEADERSHIP QUART, V19, P161, DOI 10.1016/j.leaqua.2008.01.006
   Liden RC, 2015, LEADERSHIP QUART, V26, P254, DOI 10.1016/j.leaqua.2014.12.002
   Liu Y, 2019, J NURS MANAGE, V27, P1445, DOI 10.1111/jonm.12828
   Martin A.G., 2018, SERVING THOSE WHO SE
   Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452
   Ringle CM, 2020, INT J HUM RESOUR MAN, V31, P1617, DOI 10.1080/09585192.2017.1416655
   Salvarani V, 2019, J NURS MANAGE, V27, P765, DOI 10.1111/jonm.12771
   Schaufeli W.B., 1996, MASLACH BURNOUT INVE, P19
   Schaufeli WB, 2009, CAREER DEV INT, V14, P204, DOI 10.1108/13620430910966406
   Sherman R.O., 2019, CASE SERVANT LEADERS, DOI [10.1016/j.mnl.2018.12.001, DOI 10.1016/J.MNL.2018.12.001]
   Theodosius C, 2021, NURS OPEN, V8, P463, DOI 10.1002/nop2.649
   Usman M, 2020, CAN J ADM SCI, V37, P423, DOI 10.1002/cjas.1568
   Vullinghs JT, 2020, J BUS ETHICS, V165, P719, DOI 10.1007/s10551-018-4084-y
   WHO, 2021, WHO CORONAVIRUS COVI
   World Health Organization, 2020, NURSING MIDWIFERY
   Xie CX, 2021, J NURS MANAGE, V29, P535, DOI 10.1111/jonm.13193
   Zhao FQ, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.584857
   Zhao FQ, 2020, INT J NURS STUD, V110, DOI 10.1016/j.ijnurstu.2020.103725
NR 52
TC 5
Z9 5
U1 22
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0966-0429
EI 1365-2834
J9 J NURS MANAGE
JI J. Nurs. Manag.
PD NOV
PY 2021
VL 29
IS 8
BP 2383
EP 2391
DI 10.1111/jonm.13414
EA AUG 2021
PG 9
WC Management; Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Business & Economics; Nursing
GA WR2JZ
UT WOS:000691401400001
PM 34259372
OA Green Published, Bronze
DA 2022-04-20
ER

PT J
AU Dewanjee, S
   Kandimalla, R
   Kalra, RS
   Valupadas, C
   Vallamkondu, J
   Kolli, V
   Ray, SD
   Reddy, AP
   Reddy, PH
AF Dewanjee, Saikat
   Kandimalla, Ramesh
   Kalra, Rajkumar Singh
   Valupadas, Chandrasekhar
   Vallamkondu, Jayalakshmi
   Kolli, Viswakalyan
   Dey Ray, Sarbani
   Reddy, Arubala P.
   Reddy, P. Hemachandra
TI COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association,
   Therapeutic Options and Challenges
SO CELLS
LA English
DT Article
DE ACE; ACE2; anti-rheumatic drugs; COVID-19; cytokine storm; immune
   response; inflammation; rheumatoid arthritis; SARS-CoV-2; therapeutic
   options
AB Hyperactivation of immune responses resulting in excessive release of pro-inflammatory mediators in alveoli/lung structures is the principal pathological feature of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The cytokine hyperactivation in COVID-19 appears to be similar to those seen in rheumatoid arthritis (RA), an autoimmune disease. Emerging evidence conferred the severity and risk of COVID-19 to RA patients. Amid the evidence of musculoskeletal manifestations involving immune-inflammation-dependent mechanisms and cases of arthralgia and/or myalgia in COVID-19, crosstalk between COVID-19 and RA is often debated. The present article sheds light on the pathological crosstalk between COVID-19 and RA, the risk of RA patients in acquiring SARS-CoV-2 infection, and the aspects of SARS-CoV-2 infection in RA development. We also conferred whether RA can exacerbate COVID-19 outcomes based on available clinical readouts. The mechanistic overlapping in immune-inflammatory features in both COVID-19 and RA was discussed. We showed the emerging links of angiotensin-converting enzyme (ACE)-dependent and macrophage-mediated pathways in both diseases. Moreover, a detailed review of immediate challenges and key recommendations for anti-rheumatic drugs in the COVID-19 setting was presented for better clinical monitoring and management of RA patients. Taken together, the present article summarizes available knowledge on the emerging COVID-19 and RA crosstalk and their mechanistic overlaps, challenges, and therapeutic options.
C1 [Dewanjee, Saikat] Jadavpur Unvers, Dept Pharmaceut Technol, Adv Pharmacognosy Res Lab, Kolkata 700032, India.
   [Kandimalla, Ramesh] CSIR, Indian Inst Technol, Appl Biol, Uppal Rd, Hyderabad 50000, India.
   [Kandimalla, Ramesh] Kakatiya Med Coll, Dept Biochem, Warangal 506007, Andhra Pradesh, India.
   [Kalra, Rajkumar Singh] Natl Inst Adv Ind Sci & Technol, AIST INDIA DAILAB, Higashi 1-1-1, Tsukuba, Ibaraki 3058565, Japan.
   [Valupadas, Chandrasekhar] Mahatma Gandhi Mem Hosp, Dept Med, Warangal 506007, Andhra Pradesh, India.
   [Valupadas, Chandrasekhar] Kakatiya Med Coll Superspecial Hosp, Dept Med, Warangal 506007, Andhra Pradesh, India.
   [Vallamkondu, Jayalakshmi] Natl Inst Technol, Warangal 506004, Andhra Pradesh, India.
   [Kolli, Viswakalyan] GITAM Inst Med Sci & Res, Dept Biochem, Visakhapatnam 530045, Andhra Pradesh, India.
   [Dey Ray, Sarbani] Assam Univ, Dept Pharmaceut Sci, Silchar 788011, India.
   [Reddy, Arubala P.] Texas Tech Univ, Coll Human Sci, Nutr Sci Dept, 1301 Akron Ave, Lubbock, TX 79409 USA.
   [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA.
   [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Neurol, Lubbock, TX 79430 USA.
   [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Grad Sch Biomed Sci, Publ Hlth Dept, Lubbock, TX 79430 USA.
   [Reddy, P. Hemachandra] Texas Tech Univ, Hlth Sci Ctr, Sch Hlth Profess, Dept Speech Language & Hearing Sci, Lubbock, TX 79430 USA.
   [Dewanjee, Saikat] Grad Univ, Okinawa Inst Sci & Technol, Immune Signal Unit, 1919-1 Tancha, Okinawa 9040495, Japan.
RP Reddy, PH (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA.; Reddy, PH (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Neurol, Lubbock, TX 79430 USA.; Reddy, PH (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Grad Sch Biomed Sci, Publ Hlth Dept, Lubbock, TX 79430 USA.; Reddy, PH (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Hlth Profess, Dept Speech Language & Hearing Sci, Lubbock, TX 79430 USA.
EM saikat.dewanjee@jadavpuruniversity.in; ramesh.kandimalla@gmail.com;
   rajkumar-singh@oist.jp; cvalupa-das@gmail.com; vlakshmij@gmail.com;
   kolli.kalyan@gmail.com; sarbanideyray09@gmail.com;
   arubala.reddy@ttu.edu; hemachandra.reddy@ttuhsc.edu
RI Kandimalla, Ramesh/O-4047-2017; Singh, Rajkumar/L-6944-2018
OI Kandimalla, Ramesh/0000-0002-3313-4393; Reddy, P.
   Hemachandra/0000-0002-9560-9948; Dewanjee, Saikat/0000-0001-9085-4226;
   Singh, Rajkumar/0000-0002-8181-457X
FU Council of Scientific and Industrial Research, New Delhi, IndiaCouncil
   of Scientific & Industrial Research (CSIR) - India [02(0275)/16/EMR-II];
   DBT, IndiaDepartment of Biotechnology (DBT) India
   [BT/RLF/Re-entry/22/2016, 102/IFD/SAN/1117/2018-19]; National Institutes
   of Health (NIH), USAUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AG042178, AG047812,
   NS105473, AG060767, AG069333, AG066347, R41 AG060836]; CSIRIICT,
   Hyderabad [IICT/Pubs./2021/099]
FX The authors are thankful to the Council of Scientific and Industrial
   Research, New Delhi, India, for awarding the research project (grant
   number 02(0275)/16/EMR-II) to S.D. The authors sincerely acknowledge
   Jadavpur University, India for providing necessary facilities. R.K.
   acknowledged DBT, India for Ramalingaswami Fellowship (NO.
   BT/RLF/Re-entry/22/2016 and SAN.No. 102/IFD/SAN/1117/2018-19), Kakatiya
   Medical College, Warangal, and CSIRIICT(IICT/Pubs./2021/099), Hyderabad.
   The authors are thankful to the National Institutes of Health (NIH), USA
   AG042178, AG047812, NS105473, AG060767, AG069333, AG066347, and R41
   AG060836 grants to P.H.R. Finally, the authors are exceedingly grateful
   to the editor and reviewers for their serious comments that improved the
   quality of this review.
CR Abu Esba LC, 2021, INFECT DIS THER, V10, P253, DOI 10.1007/s40121-020-00363-w
   Akiyama S, 2021, ANN RHEUM DIS, V80, P384, DOI 10.1136/annrheumdis-2020-218946
   Alivernini S, 2020, NAT MED, V26, P1295, DOI 10.1038/s41591-020-0939-8
   Araki Y, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6290682
   Atzeni F, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040783
   Azkur AK, 2020, ALLERGY, V75, P1564, DOI 10.1111/all.14364
   Brito CA, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-218171
   Calabrese Cassandra, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc018
   Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603
   Casillo GM, 2020, PHARMACOL RES, V156, DOI 10.1016/j.phrs.2020.104791
   Castelnovo L, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000023582
   Chang Y, 2015, CLIN EXP IMMUNOL, V179, P137, DOI 10.1111/cei.12467
   Chen JNS, 2021, J VIROL, V95, DOI 10.1128/JVI.00014-21
   Choudhary S, 2021, MICROB PATHOGENESIS, V150, DOI 10.1016/j.micpath.2020.104673
   Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]
   Conti P, 2020, J BIOL REG HOMEOS AG, V34, P1971, DOI 10.23812/20-1-E
   Costa L, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-217806
   Costela-Ruiz VJ, 2020, CYTOKINE GROWTH F R, V54, P62, DOI 10.1016/j.cytogfr.2020.06.001
   D'Silva KM, 2021, CURR RHEUMATOL REP, V23, DOI 10.1007/s11926-021-00998-9
   D'Silva KM, 2021, CURR OPIN RHEUMATOL, V33, P255, DOI 10.1097/BOR.0000000000000786
   Derksen VFAM, 2021, ANN RHEUM DIS, V80, P1096, DOI 10.1136/annrheumdis-2021-219859
   Dewanjee S, 2021, MOL NEUROBIOL, DOI 10.1007/s12035-021-02450-6
   Disser NP, 2020, J BONE JOINT SURG AM, V102, P1197, DOI 10.2106/JBJS.20.00847
   Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223
   Elemam NM, 2020, IMMUNOTARGETS THER, V9, P43, DOI 10.2147/ITT.S243636
   Fantini J, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105960
   Favalli EG, 2021, EXPERT REV CLIN IMMU, V17, P561, DOI 10.1080/1744666X.2021.1908887
   Favalli EG, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-218068
   Favalli EG, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102523
   Fitzgerald GE, 2021, CURR RHEUMATOL REP, V23, DOI 10.1007/s11926-020-00971-y
   Geng J, 2021, CYTOKINE, V143, DOI 10.1016/j.cyto.2021.155544
   Gianfrancesco M, 2020, ANN RHEUM DIS, V79, P859, DOI 10.1136/annrheumdis-2020-217871
   Gupta L, 2021, ANN RHEUM DIS, V80, DOI 10.1136/annrheumdis-2020-217509
   Haberman RH, 2020, ARTHRITIS RHEUMATOL, V72, P1981, DOI 10.1002/art.41456
   Huang YH, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101606
   Hyrich KL, 2021, NAT REV RHEUMATOL, V17, P71, DOI 10.1038/s41584-020-00562-2
   Hyrich Kimme L, 2020, Ann Rheum Dis, DOI 10.1136/annrheumdis-2020-218910
   Jankelson L, 2020, HEART RHYTHM, V17, P1472, DOI 10.1016/j.hrthm.2020.05.008
   Joo YB, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1977-9
   Kalra RS, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.662786
   Kalra RS, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00470-1
   Kalra RS, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9070546
   Khuroo MS, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106101
   Knudsen LR, 2018, ARTHRIT CARE RES, V70, P1366, DOI 10.1002/acr.23483
   Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379
   Landewe Robert Bm, 2020, Ann Rheum Dis, V79, P851, DOI 10.1136/annrheumdis-2020-217877
   Landi L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78492-y
   Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0
   MacDonald L, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.147413
   Mahil SK, 2021, J ALLERGY CLIN IMMUN, V147, P60, DOI 10.1016/j.jaci.2020.10.007
   Meednu N, 2016, ARTHRITIS RHEUMATOL, V68, P805, DOI 10.1002/art.39489
   Micallef J, 2020, THERAPIE, V75, P355, DOI 10.1016/j.therap.2020.05.003
   Mikuls TR, 2020, ARTHRITIS RHEUMATOL, V72, P1241, DOI 10.1002/art.41301
   Mirastschijski U, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00254
   Mistry J, 2020, RHEUMATOL ADV PRACT, V4, DOI 10.1093/rap/rkaa013
   Monaghesh E, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09301-4
   Monti S, 2020, ANN RHEUM DIS, V79, P667, DOI 10.1136/annrheumdis-2020-217424
   Mukarram Muhammad Shariq, 2021, Case Rep Rheumatol, V2021, P6610340, DOI 10.1155/2021/6610340
   Najafi S, 2020, CLIN RHEUMATOL, V39, P3223, DOI 10.1007/s10067-020-05376-x
   Ni WT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03120-0
   Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9
   Orlov M, 2020, J IMMUNOL, V205, P892, DOI 10.4049/jimmunol.2000554
   Pacha O, 2020, NAT REV IMMUNOL, V20, P345, DOI 10.1038/s41577-020-0328-z
   Parisi S, 2020, LANCET RHEUMATOL, V2, pE655, DOI 10.1016/S2665-9913(20)30348-9
   Pelaia C, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22063059
   Perrot L, 2021, LANCET RHEUMATOL, V3, pE6, DOI 10.1016/S2665-9913(20)30396-9
   Pum A, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11010091
   Ramani SL, 2021, SKELETAL RADIOL, V50, P1763, DOI 10.1007/s00256-021-03734-7
   Ranjbar K, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06045-3
   Ratajczak MZ, 2020, LEUKEMIA, V34, P1726, DOI 10.1038/s41375-020-0887-9
   Reese Justin T, 2021, medRxiv, DOI 10.1101/2021.04.13.21255438
   Rentsch CT, 2021, LANCET RHEUMATOL, V3, pE19, DOI 10.1016/S2665-9913(20)30378-7
   Robinson PC, 2020, MED-CAMBRIDGE, V1, P90, DOI 10.1016/j.medj.2020.11.005
   Rodriguez-Puertas R, 2020, J MED VIROL, V92, P1701, DOI 10.1002/jmv.25992
   Roongta R, 2021, ANN RHEUM DIS, DOI 10.1136/annrheumdis-2021-220479
   Roongta R, 2020, CLIN RHEUMATOL, V39, P3237, DOI 10.1007/s10067-020-05358-z
   Rosas IO, 2021, NEW ENGL J MED, V384, P1503, DOI 10.1056/NEJMoa2028700
   Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2
   Saadoun D, 2021, LANCET RHEUMATOL, V3, pE481, DOI 10.1016/S2665-9913(21)00112-0
   Schett G, 2020, NAT REV RHEUMATOL, V16, P465, DOI 10.1038/s41584-020-0451-z
   Seif F, 2020, INT ARCH ALLERGY IMM, V181, P467, DOI 10.1159/000508247
   Seo MR, 2020, KOREAN J INTERN MED, V35, P1317, DOI 10.3904/kjim.2020.417
   Sepriano A, 2020, ANN RHEUM DIS, V79, P760, DOI 10.1136/annrheumdis-2019-216653
   Shenoy P, 2020, CLIN RHEUMATOL, V39, P2757, DOI 10.1007/s10067-020-05200-6
   Simon D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17703-6
   Steinz MM, 2020, CLIN SCI, V134, P2835, DOI 10.1042/CS20190728
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Strangfeld A, 2021, ANN RHEUM DIS, V80, P930, DOI 10.1136/annrheumdis-2020-219498
   Tang KT, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.645013
   Topless RK, 2021, ACR OPEN RHEUMATOL, V3, P333, DOI 10.1002/acr2.11252
   Vaishya Raju, 2021, J Clin Orthop Trauma, V17, P280, DOI 10.1016/j.jcot.2021.03.002
   Valenzuela R, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.371
   White NJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003252
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   Wong MCS, 2020, ESC HEART FAIL, V7, P3119, DOI 10.1002/ehf2.12952
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Yap HY, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100161
   Zhang B, 2020, J BONE MINER RES, V35, P1828, DOI 10.1002/jbmr.4136
   Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041
   Zhu Z, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05619-x
   Zolk O, 2020, N-S ARCH PHARMACOL, V393, P1131, DOI 10.1007/s00210-020-01890-6
NR 101
TC 2
Z9 2
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD DEC
PY 2021
VL 10
IS 12
AR 3291
DI 10.3390/cells10123291
PG 21
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA XX0WV
UT WOS:000736028400001
PM 34943795
OA gold, Green Published, Green Submitted
DA 2022-04-20
ER

PT J
AU Chatzis, DG
   Magounaki, KT
   Pantazopoulos, IN
   Johnson, EO
   Tsioufis, KP
AF Chatzis, Dimitrios G.
   Magounaki, Kalliopi T.
   Pantazopoulos, Ioannis N.
   Johnson, Elizabeth O.
   Tsioufis, Konstantinos P.
TI COVID-19 pandemic and cardiovascular disease: where do we stand?
SO MINERVA CARDIOANGIOLOGICA
LA English
DT Review
DE Coronavirus; COVID-19; Severe acute respiratory syndrome coronavirus 2;
   Complications; Cardiovascular diseases
AB Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus disease 2019 (COVID-19) which recently has been characterized as a pandemic by the World Health Organization (WHO) having killed almost 250,000 people worldwide as of May 4th, 2020. Despite the fact that SARS-CoV-2 seems to predominantly affect the respiratory system leading to pneumonia and acute respiratory distress syndrome, it is now evident that it may also affect the cardiovascular system in multiple ways. The current paper is a review of the most recent literature regarding SARS-CoV-2 infection and its associated main cardiovascular clinical manifestations. Cardiovascular disease represents a prevalent underlying comorbidity associated with increased mortality rates among COVID-19 affected individuals. In addition, various cardiovascular manifestations have been linked to the viral insult, including among others acute coronary syndromes, myocarditis, acute heart failure, cardiac injury, arrhythmias and acute pulmonary embolism. Further studies are required in order to establish the complicated association between SARS-CoV-2 infection and its effects on the cardiovascular system. Our knowledge regarding diagnostic approaches, therapeutic management and preventive measures is constantly enriched throughout an abundance of ongoing research in the respective fields.
C1 [Chatzis, Dimitrios G.; Magounaki, Kalliopi T.; Pantazopoulos, Ioannis N.; Johnson, Elizabeth O.] European Univ Cyprus, Med Sch, Nicosia, Cyprus.
   [Pantazopoulos, Ioannis N.] Univ Thessaly, Med Sch, Dept Emergency Med, Larisa, Greece.
   [Tsioufis, Konstantinos P.] Natl & Kapodistrian Univ Athens, Med Sch, Dept Cardiol 1, Athens, Greece.
RP Chatzis, DG (corresponding author), European Univ Cyprus, Med Sch, 76 Singrou Ave, Athens 11742, Greece.
EM dimitrioschatzis@yahoo.com
CR Akhmerov A, 2020, CIRC RES, V126, P1443, DOI 10.1161/CIRCRESAHA.120.317055
   American College of Cardiology, 2020, HFSA ACC AHA STAT AD
   Ampel N.M., 2020, NEW ENGL J MED, DOI [10.1056/nejm-jw.NA51172, DOI 10.1056/NEJM-JW.NA51172]
   [Anonymous], 2020, FACT SHEET HLTH CAR
   Atallah B, 2020, EUR HEART J-CARD PHA, V6, P260, DOI 10.1093/ehjcvp/pvaa036
   Baden LR, 2020, NEW ENGL J MED, V382, P1851, DOI 10.1056/NEJMe2005477
   Bangalore S, 2020, NEW ENGL J MED, V382, P1608, DOI 10.1056/NEJMoa1915925
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Biondi Zoccai G, 2020, MINERVA CARDIOANGIOL, V68, P61, DOI 10.23736/S0026-4725.20.05250-0
   Bonow RO, 2020, JAMA CARDIOL, V5, P751, DOI 10.1001/jamacardio.2020.1105
   Brown JD, 2020, LANCET RESP MED
   Canadian Cardiovascular Society, 2020, COVID 19 CONC REG AC
   CHEN J, 2020, DEEP LEARNING BASED, DOI DOI 10.1101/2020.02.25.20021568
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Defilippis M, 2020, CIRCULATION
   Di Napoli R, 2020, FEATURES EVALUATION
   European Centre for Disease Prevention and Control, 2020, COVID 19 SIT UPD WOR
   European Society of cardiology, 2020, ESC GUID DIAGN MAN C, V41, P1798
   European Society of Cardiology, 2020, POS STAT ESC COUNC H
   Fountain JH, 2020, SYSTEM
   Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Hassan SA, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7355
   Hendren NS, 2020, CIRCULATION, V141, P1903, DOI 10.1161/CIRCULATIONAHA.120.047349
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Kreutz R, 2020, CARDIOVASC RES, V116, P1688, DOI 10.1093/cvr/cvaa097
   Li F, 2020, J HEART LUNG TRANSPL, V39, P496, DOI 10.1016/j.healun.2020.03.006
   Li XC, 2017, PHARMACOL RES, V125, P21, DOI 10.1016/j.phrs.2017.06.005
   Liu C, 2020, ACS CENTRAL SCI, V6, P315, DOI 10.1021/acscentsci.0c00272
   Luo P., 2020, J MED VIROL
   Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286
   Mahesh DE, 2020, JACC
   Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923
   Marin Gustavo H., 2020, DRUG DISCOV THER
   Messerli FH, 2020, CIRCULATION, V141, P2042, DOI 10.1161/CIRCULATIONAHA.120.047022
   Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671
   Patel AB, 2020, JAMA-J AM MED ASSOC, V323, P1769, DOI 10.1001/jama.2020.4812
   Rali A.S., 2020, US CARDIOL REV, V14, DOI 10.15420/usc.2020.14
   Rees V., 2020, EUR PHARM REV
   Rismanbaf A, 2020, ARCH ACAD EMERG MED, V8
   Sahin AR, 2020, EURASIAN J MED ONCOL, V4, P1, DOI 10.14744/ejmo.2020.12220
   Sandro G.ViveirosRosa, 2020, REV PANAM SALUD PUBL, V44
   Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950
   Simpson TF, 2020, AM COLL CARDIOL
   Szerlip M, 2020, CATHETER CARDIO INTE, V96, P586, DOI 10.1002/ccd.28887
   Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Welt FGP, 2020, J AM COLL CARDIOL, V75, P2372, DOI 10.1016/j.jacc.2020.03.021
   *WHO, 2020, 63 WHO
   Xiong TY, 2020, EUR HEART J, V41, P1798, DOI 10.1093/eurheartj/ehaa231
   Yang J, 2020, INT J INFECT DIS, DOI 10.1016/j.ijid.2020.03.01732173574
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 55
TC 7
Z9 7
U1 0
U2 0
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0026-4725
EI 1827-1618
J9 MINERVA CARDIOANGIOL
JI Minerva Cardioangiol.
PD AUG
PY 2020
VL 68
IS 4
BP 347
EP 358
DI 10.23736/S0026-4725.20.05298-6
PG 12
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA OH2EZ
UT WOS:000582383900014
PM 32472990
DA 2022-04-20
ER

PT C
AU Alhaider, AA
   Lau, N
AF Alhaider, Abdulrahman A.
   Lau, Nathan
GP IEEE
TI Resilience to the COVID-19 Pandemic: A Distributed Situation Awareness
   Perspective
SO 2020 RESILIENCE WEEK (RWS)
LA English
DT Proceedings Paper
CT Resilience Week (RWS)
CY OCT 19-23, 2020
CL Salt Lake City, UT
DE Pandemic management; Distributed Situation Awareness; COVID-19; command
   center
ID ERGONOMICS; FUTURE
AB Provisionary command centers for containing disease outbreaks can be an effective strategy in coordinating efforts by different government ministries and agencies to provide resilience that limits human and economic losses. This paper applies the Distributed Situation Awareness (DSA) framework to investigate the fundamental design and operational principles of provisionary command centers that contribute to the resilience against disease outbreaks. The investigation involves a case study on modeling the DSA of the Taiwan Central Epidemic Command Center (CECC) that coordinates multiple government ministries and agencies to contain COVID-19. Task, knowledge, and social networks were developed and combined into one DSA network model to depict how the CECC operations in processing and distributing information enhance situation awareness (SA) of all the government agencies and citizens for a coordinated response to the pandemic. The DSA network model illustrates an interorganizational system architecture that can enable graceful extensibility of various government functions and sustained adaptability of the agencies against disease outbreaks.
C1 [Alhaider, Abdulrahman A.; Lau, Nathan] Virginia Tech, Grado Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.
RP Alhaider, AA (corresponding author), Virginia Tech, Grado Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.
EM haider@vt.edu; nathan.lau@vt.edu
OI Lau, Nathan/0000-0003-2235-9527
FU Saudi Arabia Cultural Mission in Washington, DC; Ministry of Higher
   Education, Riyadh, Saudi Arabia
FX A. Alhaider is supported by a scholarship from the Saudi Arabia Cultural
   Mission in Washington, DC and the Ministry of Higher Education, Riyadh,
   Saudi Arabia.
CR Alhaider Abdulrahman A., 2018, Proceedings of the Human Factors and Ergonomics Society Annual Meeting, V62, P563, DOI 10.1177/1541931218621129
   Alhaider A. A., 2020, P INT S HUM FACT ERG, V9, P238, DOI [10.1177/2327857920091000, DOI 10.1177/2327857920091000]
   Alhaider A. A., 2019, P INT S HUM FACT ERG, V8, P273, DOI [10.1177/2327857919081065, DOI 10.1177/2327857919081065]
   Alhaider AA, 2020, ERGONOMICS, V63, P682, DOI 10.1080/00140139.2020.1755061
   Alizargar J, 2020, J FORMOS MED ASSOC, V119, P1236, DOI 10.1016/j.jfma.2020.05.010
   Aspinwall N, 2020, THE DIPLOMAT 05
   Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5
   Candeias V., 2018, WORLD EC FORUM
   CDC, 2020, CECC ORG
   Cheng HY, 2020, J FORMOS MED ASSOC, V119, P771, DOI 10.1016/j.jfma.2020.03.007
   Emanuel Ezekiel., 2020, STAT-US
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Everington Keoni., 2020, TAIWAN NEWS 0429
   Gardner L, 2020, MODELING SPREAD 2019
   Gonzalez RJ, 2020, ANTHROPOL TODAY, V36, P11, DOI 10.1111/1467-8322.12574
   Griffiths J., 2020, THE CNN
   Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3
   Hsieh VCR, 2020, J FORMOS MED ASSOC, V119, P884, DOI 10.1016/j.jfma.2020.03.002
   Huang IYF, 2020, PUBLIC ADMIN REV, V80, P665, DOI 10.1111/puar.13239
   Johns Hopkins, 2020, COVID 19 MAP
   Kao T.-W, 2020, J ASIAN MED STUDENTS, V8
   Kuo S., 2020, TAIWANS AGGRESSIVE E
   Lau N., 2017, HUMAN FACTORS PRACTI, P55, DOI [10.1201/9781315587370-6, DOI 10.1201/9781315587370-6]
   Lee VJ, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa039
   Liu SF, 2020, J MED VIROL, V92, P2011, DOI 10.1002/jmv.25949
   Liu Y.-T., 2012, EPIDEMIOLOGY B, V28, P193, DOI [10.6525/TEB.201207_28(13).0001, DOI 10.6525/TEB.201207_28(13).0001]
   MacIntyre CR, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp3012000
   Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013574
   Pisano G., 2020, LESSONS ITALYS RESPO
   Stanton NA, 2006, ERGONOMICS, V49, P1288, DOI 10.1080/00140130600612762
   Stanton NA, 2006, ERGONOMICS, V49, P1131, DOI 10.1080/00140130600612523
   Su YF, 2017, HEALTH SECUR, V15, P137, DOI 10.1089/hs.2016.0108
   Taiwan Centers for Disease Control (TCDC), 2020, COVID 19 SARS COV2 I
   UN (United Nations), 2020, COVID 19 SLASH GLOB
   Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151
   Watt L, 2020, TIME
   Woods DD, 2015, RELIAB ENG SYST SAFE, V141, P5, DOI 10.1016/j.ress.2015.03.018
   Yaqoob S, 2020, J PURE APPL MICROBIO, V14, P775, DOI 10.22207/JPAM.14.SPL1.15
   Zhang WN, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13030055
NR 39
TC 0
Z9 0
U1 2
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-7281-8693-1
PY 2020
BP 126
EP 132
PG 7
WE Conference Proceedings Citation Index - Science (CPCI-S)
GA BS4FM
UT WOS:000718889600018
OA Bronze
DA 2022-04-20
ER

PT J
AU Bhatta, J
   Sharma, S
   Kandel, S
   Nepal, R
AF Bhatta, Jeevan
   Sharma, Sharmistha
   Kandel, Shashi
   Nepal, Roshan
TI INFODEMIC MONIKERS IN SOCIAL MEDIA DURING COVID-19 PANDEMIC
SO ASIA PACIFIC JOURNAL OF HEALTH MANAGEMENT
LA English
DT Article
DE COVID-19; Pandemic; Infodemic; Social Media
ID ONLINE HEALTH INFORMATION
AB Social media is a common platform that enables its users to share opinions, personal experiences, perspectives with one another instantaneously, globally. It has played a paramount role during pandemics such as COVID-19 and unveiled itself as a crucial means to communicate between the sources and the individuals. However, it also has become a place to disseminate misinformation and fake news rapidly. Infodemic, a plethora of information, some authentic some not makes it even harder to general people to receive factual and trustworthy information when required, has grown to be a major risk to public health and social media is developing as a trendy platform for this infodemic. This commentary aims to explore how social media has affected the current situation. We also aim to share our insight to control this misinformation. This commentary contributes to evolving knowledge to counter fake news or health-related information shared over various social media platforms.
C1 [Bhatta, Jeevan] Nepal Publ Hlth Assoc, Kathmandu, Nepal.
   [Sharma, Sharmistha] Think Aloud P Ltd, Kathmandu, Nepal.
   [Kandel, Shashi] Prince Songkla Univ, Hat Yai, Thailand.
   [Nepal, Roshan] Univ Adelaide, Adelaide, SA, Australia.
RP Bhatta, J (corresponding author), Nepal Publ Hlth Assoc, Kathmandu, Nepal.
EM gwan.ph@gmail.com
RI Bhatta, Jeevan/ABH-6231-2020; Nepal, Roshan/F-3196-2018
OI Bhatta, Jeevan/0000-0003-3953-3982; Nepal, Roshan/0000-0002-5469-3397
CR Abd-Alrazaq A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19016
   Adhanom-Ghebreyesus T, 2020, MUNICH SECURITY C
   [Anonymous], 2020, UN NEWS
   [Anonymous], 2020, THE NEWS MINUTE
   Bento AI, 2020, P NATL ACAD SCI USA, V117, P11220, DOI 10.1073/pnas.2005335117
   Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312
   Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567
   COVID W, 2019, PHEIC GLOB RES INN F
   Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006
   Jones B, 2014, ARE MYTHS MAKING EBO
   Li HOY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002604
   Mitchell A, 2017, AM ENCOUNTER RECALL, P97
   Monitoring BJBT, 2020, MONITORING BJBP, V5, P2020
   Morahan-Martin JM, 2004, CYBERPSYCHOL BEHAV, V7, P497, DOI 10.1089/1094931042403082
   Rovetta A, 2020, GLOBAL INFODEMIOLOGY
   Rovetta A, 2020, JMIR PUBLIC HLTH SUR, V6, DOI 10.2196/19374
   Sharma S, 2020, J HLTH RES
   Tangcharoensathien V, 2020, J MED INTERNET RES, V22, DOI 10.2196/19659
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
NR 19
TC 0
Z9 0
U1 11
U2 19
PU AUSTRALIAN COLL HEALTH SERVICE MANAGEMENT
PI NORTH RYDE
PA PO BOX 341, NORTH RYDE, NSW 1670, AUSTRALIA
SN 1833-3818
J9 ASIA-PAC J HEALTH MA
JI Asia Pac. J. Health Manag.
PY 2021
VL 15
IS 4
BP 95
EP 97
AR 513
DI 10.24083/apjhm.v15i4.513
PG 3
WC Health Policy & Services
WE Emerging Sources Citation Index (ESCI)
SC Health Care Sciences & Services
GA QR4XQ
UT WOS:000625221300011
OA gold
DA 2022-04-20
ER

PT J
AU Sholzberg, M
   da Costa, BR
   Tang, GH
   Rahhal, H
   AlHamzah, M
   Kreuziger, LB
   Ainle, FN
   Almarshoodi, MO
   James, PD
   Lillicrap, D
   Carrier, M
   Beckett, A
   Fralick, M
   Middeldorp, S
   Lee, AYY
   Thorpe, KE
   Negri, EM
   Cushman, M
   Juni, P
AF Sholzberg, Michelle
   da Costa, Bruno R.
   Tang, Grace H.
   Rahhal, Hassan
   AlHamzah, Musaad
   Kreuziger, Lisa Baumann
   Ainle, Fionnuala Ni
   Almarshoodi, Mozah Obaid
   James, Paula D.
   Lillicrap, David
   Carrier, Marc
   Beckett, Andrew
   Fralick, Michael
   Middeldorp, Saskia
   Lee, Agnes Y. Y.
   Thorpe, Kevin E.
   Negri, Elnara Marcia
   Cushman, Mary
   Juni, Peter
CA RAPID Trial Investigators
TI Randomized trials of therapeutic heparin for COVID-19: A meta-analysis
SO RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE anticoagulation; clinical trials; COVID-19; heparin; meta-analysis
ID PROPHYLACTIC ANTICOAGULATION
AB Background: Pulmonary endothelial injury and microcirculatory thromboses likely contribute to hypoxemic respiratory failure, the most common cause of death, in patients with COVID-19. Randomized controlled trials (RCTs) suggest differences in the effect of therapeutic heparin between moderately and severely ill patients with COVID-19. We did a systematic review and meta-analysis of RCTs to determine the effects of therapeutic heparin in hospitalized patients with COVID-19.
   Methods: We searched PubMed, Embase, Web of Science, medRxiv, and medical conference proceedings for RCTs comparing therapeutic heparin with usual care, excluding trials that used oral anticoagulation or intermediate doses of heparin in the experimental arm, Mantel-Haenszel fixed-effect meta-analysis was used to combine odds ratios (ORs).
   Results and Conclusions: There were 3 RCTs that compared therapeutic heparin to lower doses of heparin in 2854 moderately ill ward patients, and 3 RCTs in 1191 severely ill patients receiving critical care. In moderately ill patients, there was a nonsignificant reduction in all-cause death (OR, 0.76; 95% CI, 0.57-1.02), but significant reductions in the composite of death or invasive mechanical ventilation (OR, 0.77; 95% CI, 0.60 0.98), and death or any thrombotic event (OR, 0.58; 95% CI, 0.45-0.77). Organ support-free days alive (OR, 1.29; 95% CI, 1.07-1.57) were significantly increased with therapeutic heparin. There was a nonsignificant increase in major bleeding. In severely ill patients, there was no evidence for benefit of therapeutic heparin, with significant treatment-by-subgroup interactions with illness severity for all-cause death (P = .034). In conclusion, therapeutic heparin is beneficial in moderately ill patients but not in severely ill patients hospitalized with COVID-19.
C1 [Sholzberg, Michelle] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Dept Med, Toronto, ON, Canada.
   [Sholzberg, Michelle] Univ Toronto, Li Ka Shing Knowledge Inst, Dept Lab Med & Pathobiol, St Michaels Hosp, Toronto, ON, Canada.
   [da Costa, Bruno R.] Univ Toronto, Appl Hlth Res Ctr AHRC, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada.
   [da Costa, Bruno R.] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland.
   [Tang, Grace H.] Univ Toronto, Hematol Oncol Clin Res Grp, St Michaels Hosp, Toronto, ON, Canada.
   [Rahhal, Hassan] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Dept Clin Med,Disciplina Emergencias Clin, Sao Paulo, Brazil.
   [AlHamzah, Musaad] King Saud Univ, Coll Med, Dept Surg, Riyadh, Saudi Arabia.
   [AlHamzah, Musaad] King Saud Univ Med City, Div Vasc Surg, Riyadh, Saudi Arabia.
   [Kreuziger, Lisa Baumann] Versiti, Med Coll Wisconsin, Milwaukee, WI USA.
   [Ainle, Fionnuala Ni] Mater Misericordiae Univ Hosp, Dublin, Ireland.
   [Ainle, Fionnuala Ni] Univ Coll Dublin, Sch Med, Dublin, Ireland.
   [Ainle, Fionnuala Ni] Irish Network Venous Thromboembolism Res, Dublin, Ireland.
   [Almarshoodi, Mozah Obaid] Tawam Hosp, SEHA, Al Ain, U Arab Emirates.
   [James, Paula D.] Queens Univ, Dept Med, Kingston, ON, Canada.
   [Lillicrap, David] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.
   [Carrier, Marc] Univ Ottawa, Ottawa Hosp Res Inst, Dept Med, Ottawa, ON, Canada.
   [Beckett, Andrew] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada.
   [Beckett, Andrew] Canadian Forces Hlth Serv, Ottawa, ON, Canada.
   [Fralick, Michael] Univ Toronto, Sinai Hlth, Gen Internal Med, Toronto, ON, Canada.
   [Middeldorp, Saskia] Radboud Univ Nijmegen, Radboud Inst Hlth Sci RIHS, Dept Internal Med, Med Ctr, Nijmegen, Netherlands.
   [Lee, Agnes Y. Y.] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada.
   [Thorpe, Kevin E.] Univ Toronto, Appl Hlth Res Ctr, Dalla Lana Sch Publ Hlth, Li Ka Shing Knowledge Inst,St Michaels Hosp, Toronto, ON, Canada.
   [Negri, Elnara Marcia] Univ Sao Paulo, Dept Patol, Lab Invest Med LIM 59, Biol Celular,Fac Med, Sao Paulo, Brazil.
   [Cushman, Mary] Univ Vermont, Dept Med, Med Ctr, Larner Coll Med, Burlington, VT USA.
   [Juni, Peter] Univ Toronto, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, Dept Med,St Michaels Hosp,Inst Hlth Policy Manage, Toronto, ON, Canada.
RP Sholzberg, M (corresponding author), Univ Toronto, Li Ka Shing Knowledge Inst, Div Hematol Oncol, St Michaels Hosp, 30 Bond St,Room 2-007G Core Lab, Toronto, ON M5B 1W8, Canada.
EM michelle.sholzberg@unityhealth.to
RI Rahhal, Hassan/AFQ-9857-2022
OI Rahhal, Hassan/0000-0001-7841-7322; Baumann Kreuziger,
   Lisa/0000-0002-1171-0548
FU Defense Research Development Canada, Department of National Defense,
   Ottawa, Canada
FX This study was funded by Task 54, Defense Research Development Canada,
   Department of National Defense, Ottawa, Canada. The funders had no role
   in the study design; conduct, collection, management, analysis, or
   interpretation of data; or in preparation or review of the manuscript or
   the approval of the manuscript for submission.
CR Lemos ACB, 2020, THROMB RES, V196, P359, DOI 10.1016/j.thromres.2020.09.026
   Bikdeli B, 2020, THROMB RES, V196, P638, DOI 10.1016/j.thromres.2020.09.033
   Buijsers B, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102969
   Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]
   da Costa BR, 2014, EUR HEART J, V35, P3336, DOI 10.1093/eurheartj/ehu424
   Goldin M, 2021, THROMB HAEMOSTASIS, V121, P1684, DOI 10.1055/a-1475-2351
   Gordon AC, 2021, NEW ENGL J MED, V384, P1491, DOI 10.1056/NEJMoa2100433
   Houston BL, 2020, CLIN TRIALS, V17, P491, DOI 10.1177/1740774520943846
   Iba T, 2020, CRIT CARE MED, V48, P1358, DOI 10.1097/CCM.0000000000004458
   Lawler PR, 2021, NEW ENGL J MED, V385, P790, DOI 10.1056/NEJMoa2105911
   Lopes RD, 2021, LANCET, V397, P2253, DOI 10.1016/S0140-6736(21)01203-4
   McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1
   Mycroft-West CJ, 2020, THROMB HAEMOSTASIS, V120, P1700, DOI 10.1055/s-0040-1721319
   Nopp S, 2020, RES PRACT THROMB HAE, V4, P1178, DOI 10.1002/rth2.12439
   Ortega-Paz L., 2021, EUR HEART J-CARD IMG
   Page Clive, 2013, ISRN Pharmacol, V2013, P910743, DOI 10.1155/2013/910743
   Page MJ, 2021, PLOS MED, V18, DOI [10.1371/journal.pmed.1003583, 10.1016/j.ijsu.2021.105906]
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   Perepu US, 2021, J THROMB HAEMOST, V19, P2225, DOI 10.1111/jth.15450
   Poor HD, 2021, CHEST, V160, P1471, DOI 10.1016/j.chest.2021.06.016
   Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152
   Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x
   Sholzberg M, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2400
   Sholzberg M, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05076-0
   Spyropoulos AC, 2021, JAMA INTERN MED, V181, P1612, DOI 10.1001/jamainternmed.2021.6203
   Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898
   Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817
   ten Cate H, 2021, NEW ENGL J MED, V385, P845, DOI 10.1056/NEJMe2111151
   Tritschler T, 2020, J THROMB HAEMOST, V18, P2958, DOI 10.1111/jth.15094
   WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 31
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2475-0379
J9 RES PRACT THROMB HAE
JI Res. Pract. Thromb. Haemost.
PD DEC
PY 2021
VL 5
IS 8
AR e12638
DI 10.1002/rth2.12638
PG 9
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA ZA9OT
UT WOS:000756485300014
PM 34977448
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Janda, A
   Schuetz, C
   Canna, S
   Gorelik, M
   Heeg, M
   Minden, K
   Hinze, C
   Schulz, A
   Debatin, KM
   Hedrich, CM
   Speth, F
AF Janda, Ales
   Schuetz, Catharina
   Canna, Scott
   Gorelik, Mark
   Heeg, Maximilian
   Minden, Kirsten
   Hinze, Claas
   Schulz, Ansgar
   Debatin, Klaus-Michael
   Hedrich, Christian M.
   Speth, Fabian
TI Therapeutic approaches to pediatric COVID-19: an online survey of
   pediatric rheumatologists
SO RHEUMATOLOGY INTERNATIONAL
LA English
DT Article
DE COVID-19; SARS-CoV-2; Children; Pediatric rheumatology; Autoimmune
   disease; Inflammation; Treatment; Opinion poll
AB Data on therapy of COVID-19 in immunocompetent and immunosuppressed children are scarce. We aimed to explore management strategies of pediatric rheumatologists. All subscribers to international Pediatric Rheumatology Bulletin Board were invited to take part in an online survey on therapeutic approaches to COVID-19 in healthy children and children with autoimmune/inflammatory diseases (AID). Off-label therapies would be considered by 90.3% of the 93 participating respondents. In stable patients with COVID-19 on oxygen supply (stage I), use of remdesivir (48.3%), azithromycin (26.6%), oral corticosteroids (25.4%) and/or hydroxychloroquine (21.9%) would be recommended. In case of early signs of "cytokine storm" (stage II) or in critically ill patients (stage III) (a) anakinra (79.5% stage II; 83.6% stage III) or tocilizumab (58.0% and 87.0%, respectively); (b) corticosteroids (oral 67.2% stage II, intravenously 81.7% stage III); (c) intravenous immunoglobulins (both stages 56.5%); or (d) remdesivir (both stages 46.7%) were considered. In AID, > 94.2% of the respondents would not support a preventive adaptation of the immunomodulating therapy. In case of mild COVID-19, more than 50% of the respondents would continue pre-existing treatment with immunoglobulins (100%), hydroxychloroquine (94.2%), anakinra (79.2%) or canakinumab (72.5%), or tocilizumab (69.8%). Long-term corticosteroids would be reduced by 26.9% (< = 2 mg/kg/d) and 50.0% (> 2 mg/kg/day), respectively, with only 5.8% of respondents voting to discontinue the therapy. Conversely, more than 75% of respondents would refrain from administering cyclophosphamide and anti-CD20-antibodies. As evidence on management of pediatric COVID-19 is incomplete, continuous and critical expert opinion and knowledge exchange is helpful.
C1 [Janda, Ales; Schulz, Ansgar; Debatin, Klaus-Michael] Ulm Univ, Med Ctr, Dept Pediat & Adolescent Med, Eythstr 24, D-89075 Ulm, Germany.
   [Schuetz, Catharina] Tech Univ Dresden, Med Fak Carl Gustav Carus, Dept Pediat, Dresden, Germany.
   [Canna, Scott] Univ Pittsburgh, Pittsburgh, PA USA.
   [Gorelik, Mark] Columbia Univ, Dept Pediat, New York Presbyterian Morgan Stanley Childrens Ho, Div Allergy Immunol & Rheumatol,Irving Med Ctr, New York, NY 10027 USA.
   [Heeg, Maximilian] Univ Freiburg, Fac Med, Ctr Chron Immunodeficiency CCI, Inst Immunodeficiency,Med Ctr, Freiburg, Germany.
   [Minden, Kirsten] Charite Univ Med Berlin, German Rheumatism Res Ctr Berlin, Berlin, Germany.
   [Hinze, Claas] Univ Hosp Munster, Munster, Germany.
   [Hedrich, Christian M.] Univ Liverpool, Inst Life Course & Med Sci, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England.
   [Hedrich, Christian M.] Alder Hey Childrens NHS Fdn Trust Hosp, Dept Paediat Rheumatol, Liverpool, Merseyside, England.
   [Speth, Fabian] Univ Med Ctr Hamburg Eppendorf, Ctr Obstet & Pediat, Pediat Bone Marrow Transplantat & Immunol Unit, Dept Pediat Rheumatol, Hamburg, Germany.
RP Janda, A (corresponding author), Ulm Univ, Med Ctr, Dept Pediat & Adolescent Med, Eythstr 24, D-89075 Ulm, Germany.
EM ales.janda@uniklinik-ulm.de
RI Debatin, Klaus-Michael/J-9704-2014
OI Debatin, Klaus-Michael/0000-0002-8397-1886; Janda,
   Ales/0000-0001-5604-8378
FU Projekt DEAL
FX Open Access funding enabled and organized by Projekt DEAL. No specific
   funding for this study was applied.
CR Alzghari SK, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104380
   American Academy of Pediatrics, 2020, CRITICAL UPDATES COV
   Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585
   Batu ED, 2020, SEMIN ARTHRITIS RHEU, V50, P1262, DOI 10.1016/j.semarthrit.2020.09.008
   Batu ED, 2020, RHEUMATOL INT, V40, P1193, DOI 10.1007/s00296-020-04612-6
   Belot A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.22.2001010
   Bisogno G, 2020, J PEDIAT INF DIS SOC, V9, P530, DOI 10.1093/jpids/piaa088
   Calvo C, 2020, AN PEDIATR, V92, DOI [10.1016/j.anpede.2020.02.002, 10.1016/j.anpedi.2020.02.001]
   Campbell JI, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1081
   Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467
   Centers for Disease Control and Prevention, 2020, COVID 19 INFORM PEDI
   Chen ZM, 2020, WORLD J PEDIATR, V16, P240, DOI 10.1007/s12519-020-00345-5
   Ding YD, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00431
   Diorio C, 2020, J CLIN INVEST, V130, P5967, DOI 10.1172/JCI140970
   Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985
   European Centre for Disease Prevention and Control, 2020, VEKLURY REMDESIVIR D
   Fajgenbaum DC, 2020, INFECT DIS THER, V9, P435, DOI 10.1007/s40121-020-00303-8
   Felsenstein S, 2020, CLIN IMMUNOL, V220, DOI 10.1016/j.clim.2020.108588
   Felsenstein S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108448
   Ferro F, 2020, CLIN EXP RHEUMATOL, V38, P175
   Filocamo G, 2021, J RHEUMATOL, V48, P1343, DOI 10.3899/jrheum.200483
   Franzetti M, 2020, INT J INFECT DIS, V97, P215, DOI 10.1016/j.ijid.2020.05.050
   Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6
   Gao Y, 2020, J INFECTION, V81, pE93, DOI 10.1016/j.jinf.2020.05.017
   Gaur PS, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e398
   Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949
   Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Haslak F, 2020, RHEUMATOL INT, V40, P1423, DOI 10.1007/s00296-020-04645-x
   Hedrich CM, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108420
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Hyrich KL, 2021, NAT REV RHEUMATOL, V17, P71, DOI 10.1038/s41584-020-00562-2
   Janda A, 2020, Z RHEUMATOL, V79, P710, DOI 10.1007/s00393-020-00854-8
   Juul S, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003293
   Knight SR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3339
   Konig MF, 2020, ANN RHEUM DIS, V79, P1386, DOI 10.1136/annrheumdis-2020-217690
   Landewe Robert Bm, 2020, Ann Rheum Dis, V79, P851, DOI 10.1136/annrheumdis-2020-217877
   Marlais M, 2020, LANCET CHILD ADOLESC, V4, pE17, DOI 10.1016/S2352-4642(20)30145-0
   Meyts I, 2021, J ALLERGY CLIN IMMUN, V147, P520, DOI 10.1016/j.jaci.2020.09.010
   Michelena X, 2020, SEMIN ARTHRITIS RHEU, V50, P564, DOI 10.1016/j.semarthrit.2020.05.001
   Minotti C, 2020, J INFECTION, V81, pE61, DOI 10.1016/j.jinf.2020.04.026
   Monti S, 2020, ANN RHEUM DIS, V79, P667, DOI 10.1136/annrheumdis-2020-217424
   Nguyen LS, 2020, CIRCULATION, V142, P303, DOI 10.1161/CIRCULATIONAHA.120.048238
   Ortiz-Alvarez O, 2004, J RHEUMATOL, V31, P2501
   Paediatric Rheumatology European Society, 2020, UPDATED PRES RECOMME
   Pain CE, 2020, LANCET RHEUMATOL, V2, pE376, DOI 10.1016/S2665-9913(20)30137-5
   Pouletty M, 2020, ANN RHEUM DIS, V79, P999, DOI 10.1136/annrheumdis-2020-217960
   Ramirez GA, 2020, SEMIN ARTHRITIS RHEU, V50, P1150, DOI 10.1016/j.semarthrit.2020.06.012
   Ramiro S, 2020, ANN RHEUM DIS, V79, P1143, DOI 10.1136/annrheumdis-2020-218479
   RCPCH Clinical Guidelines, 2020, COVID 19 GUID PAED S
   Romani S, 2021, CTS-CLIN TRANSL SCI, V14, P163, DOI 10.1111/cts.12883
   Shakoory B, 2016, CRIT CARE MED, V44, P275, DOI 10.1097/CCM.0000000000001402
   Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
   Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012
   Singh AK, 2020, DIABETES METAB SYND, V14, P589, DOI 10.1016/j.dsx.2020.05.017
   Speth F, 2013, Z RHEUMATOL, V72, P896, DOI 10.1007/s00393-013-1203-0
   Speth F, 2013, Z RHEUMATOL, V72, P814, DOI 10.1007/s00393-013-1200-3
   Swann OV, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3249
   Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849
   U.S. Food and Drug Administration (FDA), 2020, FDA NEWS RELEASE
   Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
   Wahezi DM, 2020, ARTHRITIS RHEUMATOL, V72, P1809, DOI 10.1002/art.41455
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Welzel T, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040605
   Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570
   Zhang XH, 2020, BLOOD ADV, V4, P1307, DOI 10.1182/bloodadvances.2020001907
NR 66
TC 2
Z9 2
U1 2
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0172-8172
EI 1437-160X
J9 RHEUMATOL INT
JI Rheumatol. Int.
PD MAY
PY 2021
VL 41
IS 5
BP 911
EP 920
DI 10.1007/s00296-021-04824-4
EA MAR 2021
PG 10
WC Rheumatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Rheumatology
GA RH7QC
UT WOS:000626338800001
PM 33683393
OA hybrid, Green Published
DA 2022-04-20
ER

PT J
AU Grandy, G
   Cukier, W
   Gagnon, S
AF Grandy, Gina
   Cukier, Wendy
   Gagnon, Suzanne
TI (In)visibility in the margins: COVID-19, women entrepreneurs and the
   need for inclusive recovery
SO GENDER IN MANAGEMENT
LA English
DT Article
DE Gender; Diversity; intersectionality; Women entrepreneurs; Covid-19
AB Purpose This paper aims to extendLewis and Simpson's (2010)work on the complexity of (in)visibility and explores what it means to women's entrepreneurship in Canada during the COVID-19 pandemic. Design/methodology/approach This piece contributes to the special issue on COVID-19 and the impact on women entrepreneurs. Specifically, it applies an (in)visibility lens to argue that responses to COVID-19 in Canada negatively affect women entrepreneurs disproportionately and that while initiatives such as the Women Entrepreneurship Knowledge Hub (WEKH) are threatened, they can also serve as an agitator during this time to advocate for an inclusive recovery approach. Findings Despite progress through such government funded initiatives as the Women Entrepreneurship Strategy (WES), which is targeting more than $2bn (Cdn) in investments towards women entrepreneurs, structural inequality and the (in)visibility of women's entrepreneurship has been amplified during COVID-19. Through a particular understanding of the (in)visibility vortex notion (Lewis and Simpson, 2010), it is concluded the (in)visibility of women entrepreneurs as deeply embedded and that there is a continued need to advocate for a gender and diversity lens, to ensure inclusive recovery that benefits women and diverse entrepreneurs. Originality/value An (in)visibility lens brings an important addition to the literature on women's entrepreneurship, as well as illuminates the important differences within this broad category, deepening the understanding of these trends and their impact during COVID-19 pandemic. It highlights how the complexities of intersectionality are critical to understand, and their recognition can help to drive a clear evidence base, as well as advocacy. The piece call researchers and practitioners alike to consider the question under COVID-19, will these conditions create a new vortex in this domain, or can the work of organizations and researchers position gender and intersectionality in women entrepreneurship as a disrupter for the future?
C1 [Grandy, Gina] Univ Regina, Hill & Levene Sch Business, Regina, SK, Canada.
   [Cukier, Wendy] Ryerson Univ Ted Rogers, Ted Rogers Sch Business, Toronto, ON, Canada.
   [Gagnon, Suzanne] Univ Manitoba Asper Winnipeg, Sch Business, Winnipeg, MB, Canada.
RP Grandy, G (corresponding author), Univ Regina, Hill & Levene Sch Business, Regina, SK, Canada.
EM gina.grandy@uregina.ca; wcukier@ryerson.ca; Suzanne.Gagnon@umanitoba.ca
CR Ainsworth Susan., 2002, GENDER WORK ORGAN, V9, P579, DOI [10.1111/1468-0432.00176, DOI 10.1111/1468-0432.00176]
   Brush C.G., 2014, WOMEN ENTREPRENEURS
   Criado-Perez Caroline., 2019, INVISIBLE WOMEN DATA
   Cross S., 2002, GENDER WORK ORGAN, V9, P204
   Cukier W., 2020, CONVERSATION
   Cukier W., 2019, STRENGTHENING ECOSYS
   Cukier W, 2020, GEND MANAG, V35, P303, DOI 10.1108/GM-11-2019-0204
   D'Espallier B, 2011, WORLD DEV, V39, P758, DOI 10.1016/j.worlddev.2010.10.008
   Ezzedeen SR, 2012, INT J GEND ENTREP, V4, P44, DOI 10.1108/17566261211202972
   Femmessor, 2020, REG ENTR FEM PER COV REG ENTR FEM PER COV
   Forster V., 2020, FORBES
   Friedman Uri, 2020, ATLANTIC
   Gagnon S., 2020, THINK ENTREPRE UNPUB
   Goodman L., 2016, WOMEN ARE BETTER MEN
   Government of Canada, 2020, WOM ENTR STRAT
   Grekou D., 2018, ENTRY EXIT OUT SELF
   Hearn J, 1996, ORGANIZATION, V3, P611, DOI 10.1177/135050849634017
   ISED, 2018, INN SCI EC DEV CAN
   Kerfoot D, 2010, REVEALING AND CONCEALING GENDER: ISSUES OF VISIBILITY IN ORGANIZATIONS, P100
   Kosny A, 2010, GENDER WORK ORGAN, V17, P359, DOI 10.1111/j.1468-0432.2009.00460.x
   Lewis P, 2006, GENDER WORK ORGAN, V13, P453, DOI 10.1111/j.1468-0432.2006.00317.x
   Lewis P, 2010, REVEALING AND CONCEALING GENDER: ISSUES OF VISIBILITY IN ORGANIZATIONS, P1
   Li G, 2018, GENDER RELATED DIFFE
   Mavin S, 2016, GENDER WORK ORGAN, V23, P379, DOI 10.1111/gwao.12130
   Nelson J.A., 2012, 012 INET, DOI 10.2139/ssrn.2158950
   Neville F, 2018, J MANAGE STUD, V55, P424, DOI 10.1111/joms.12319
   OECD, 2016, POL BRIEF WOM ENTR
   Ozbilgin MF, 2009, EQUALITY, DIVERSITY AND INCLUSION AT WORK: A RESEARCH COMPANION, P1
   Orser B, 2012, ENTREP REGION DEV, V24, P73, DOI 10.1080/08985626.2012.637355
   Orser BJ, 2006, ENTREP THEORY PRACT, V30, P643, DOI 10.1111/j.1540-6520.2006.00140.x
   Osler, 2020, CANADIAN FEDERAL PRO
   Rosa J., 2016, COMP PERFORMANCE FEM
   Rose A., 2019, ALISON ROSE REV FEMA
   Rose A., 2020, ALISON ROSE REV FEMA
   Statistics Canada, 2016, 2016 CENS PUBL US MI
   Statistics Canada, 2019, STUD SELF EMPL CAN W
   Statistics Canada, 2019, LAB FORC SURV LFS PU
   Treasury HM, 2019, AL ROS REV FEM ENTR
   Tsai KH, 2016, INT ENTREP MANAG J, V12, P1127, DOI 10.1007/s11365-016-0383-x
   Unnikrishnan S., 2019, HARVARD BUSINESS REV
   WEKH, 2020, WOM ENTR KNOWL HUB
   WEKH, 2020, IMP COVID 19 WOM ENT
   Yalnizyan A., 2020, CURRENT CBC     0522
NR 43
TC 6
Z9 6
U1 4
U2 15
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1754-2413
EI 1754-2421
J9 GEND MANAG
JI Gend. Manag.
PD DEC 10
PY 2020
VL 35
IS 7-8
SI SI
BP 667
EP 675
DI 10.1108/GM-07-2020-0207
EA SEP 2020
PG 9
WC Business; Management; Women's Studies
WE Social Science Citation Index (SSCI)
SC Business & Economics; Women's Studies
GA PG7RP
UT WOS:000574348300001
DA 2022-04-20
ER

PT J
AU Elmir, S
   Jabi, R
   Noumairi, M
   Gartit, M
   El Bekkaoui, M
   Skiker, I
   Housni, B
   Bouziane, M
   El Oumri, AA
AF Elmir, Siham
   Jabi, Rachid
   Noumairi, Mohammed
   Gartit, Mohammed
   El Bekkaoui, Mehdi
   Skiker, Imane
   Housni, Brahim
   Bouziane, Mohammed
   El Oumri, Ahmed Amine
TI An Exceptional Clinical Presentation associating an occipital stroke, a
   Superior and Inferior Mesenteric Thrombosis following Covid 19 disease,
   case report
SO ANNALS OF MEDICINE AND SURGERY
LA English
DT Article
DE Covid 19; Stroke; Mesenteric thrombosis; Rehabilitation; Anticoagulation
ID REHABILITATION; PROFESSIONALS
AB Introduction: The Covid 19 pandemia since the first reported case in 2019 had a direct socioeconomic impact related to morbi-mortality and indirect in response to protection and isolation strategies. To our knowledge thrombo-embolic complications can be a mode of revelation complicating the management.
   Case presentation: We present an exceptional case of a patient with a history of Covid 19,admitted 21 days later for disturbed consciousness, in whom an ischemic occipital stroke ,intestinal and colonic ishemia had been objectified. Our objective through this presentation is to remind the thrombo-embolic particularity of Covid 19, to take the viral attack as a serious antecedent in the periods following theinfection and to put the point on the primordial place of early rehabilitation in patients with stroke.
   Discussion and Conclusion: We discuss through this report the recommendations of anticoagulation in Covid 19 patients and the place of early rehabilitation in patients with stroke. We also report a new case among the rare cases described in the literature that associates several thrombo-embolic manifestations secondary to Covid 19, in particular the neurological and digestive association.
C1 [Elmir, Siham; Noumairi, Mohammed; Gartit, Mohammed; El Oumri, Ahmed Amine] Univ Mohammed First Oujda, Immunohematol Cellular Therapy Lab Adults & Child, Fac Med & Pharm, Dept Phys Med & Rehabil, Oujda, Morocco.
   [Jabi, Rachid; Bouziane, Mohammed] Mohammed 1st Univ, Lab Anat Microsurg & Surg Expt & Med Simulat LAMC, Fac Med & Pharm, Dept Gen Surg,Mohammed VI Univ Hosp, Oujda, Morocco.
   [El Bekkaoui, Mehdi; Skiker, Imane] Mohammed 1st Univ, Lab Anat Microsurg & Surg Expt & Med Simulat LAMC, Fac Med & Pharm, Dept Radiolgy,Mohammed VI Univ Hosp, Oujda, Morocco.
   [Housni, Brahim] Mohammed 1st Univ, Lab Anat Microsurg & Surg Expt & Med Simulat LAMC, Fac Med & Pharm, Dept Anaesthesia & Intens Care,Mohammed VI Univ H, Oujda, Morocco.
RP Elmir, S (corresponding author), Univ Mohammed First Oujda, Immunohematol Cellular Therapy Lab Adults & Child, Fac Med & Pharm, Dept Phys Med & Rehabil, Oujda, Morocco.
EM sihamelmir144@gmail.com
CR Agha RA, 2018, INT J SURG, V60, P132, DOI 10.1016/j.ijsu.2018.10.028
   Ali I, 2020, HUM VACC IMMUNOTHER, V16, P2594, DOI 10.1080/21645515.2020.1787065
   Almeida Ana, 2021, Cir Esp, DOI 10.1016/j.ciresp.2021.09.013
   Amaravathi U, 2020, J EMERG MED, V60, pE103, DOI 10.1016/j.jemermed.2020.12.016
   Azouz E, 2020, INTENS CARE MED, V46, P1464, DOI 10.1007/s00134-020-06079-2
   Bhayana R, 2020, RADIOLOGY, V297, pE207, DOI 10.1148/radiol.2020201908
   Carda S, 2020, ANN PHYS REHABIL MED, V63, P554, DOI 10.1016/j.rehab.2020.04.001
   Carpenter CR, 2020, ACAD EMERG MED, V27, P653, DOI 10.1111/acem.14048
   Coleman ER, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0686-6
   Mai DT, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.03092
   Gao ZR, 2021, J MICROBIOL IMMUNOL, V54, P12, DOI 10.1016/j.jmii.2020.05.001
   Hadid T, 2021, BLOOD REV, V47, DOI 10.1016/j.blre.2020.100761
   Jin YF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040372
   Lai CC, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106024
   Langer F, 2020, HAMOSTASEOLOGIE, V40, P264, DOI 10.1055/a-1178-3551
   Lew HL, 2020, AM J PHYS MED REHAB, V99, P571, DOI 10.1097/PHM.0000000000001460
   Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869
   McBane RD, 2020, MAYO CLIN PROC, V95, P2467, DOI 10.1016/j.mayocp.2020.08.030
   Miesbach W, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620938149
   Mohamadian M, 2021, J GENE MED, V23, DOI 10.1002/jgm.3303
   Obi AT, 2019, J VASC SURG-VENOUS L, V7, P317, DOI 10.1016/j.jvsv.2018.08.010
   Salzberger B, 2020, INTERNIST, V61, P782, DOI 10.1007/s00108-020-00834-9
   Shahjouei S, 2021, STROKE, V52, pE117, DOI 10.1161/STROKEAHA.120.032927
   Shakoor H, 2021, MATURITAS, V143, P1, DOI 10.1016/j.maturitas.2020.08.003
   Stadler RN, 2021, ANTIMICROB RESIST IN, V10, DOI 10.1186/s13756-021-00912-z
   Tomer V, 2021, MATER TODAY-PROC, V46, P11267, DOI 10.1016/j.matpr.2021.03.486
   Vogrig A, 2021, NEUROSCI LETT, V743, DOI 10.1016/j.neulet.2020.135564
   Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098
NR 28
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2049-0801
J9 ANN MED SURG
JI Ann. Med. Surg.
PD DEC
PY 2021
VL 72
AR 103082
DI 10.1016/j.amsu.2021.103082
EA DEC 2021
PG 5
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA YX8WV
UT WOS:000754377200003
PM 34868574
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Surma, MJ
   Nunes, RJ
   Rook, C
   Loder, A
AF Surma, Martyna Joanna
   Nunes, Richard Joseph
   Rook, Caroline
   Loder, Angela
TI Assessing Employee Engagement in a Post-COVID-19 Workplace Ecosystem
SO SUSTAINABILITY
LA English
DT Article
DE post-COVID-19 workplace ecosystem; employee engagement; physical
   workplace environment; employee engagement metrics; sustainable property
   markets; workplace tools; hybrid work patterns; home office; health and
   well-being
ID WORK ENGAGEMENT; PSYCHOLOGICAL CONDITIONS; THEORETICAL-MODEL; OUTCOMES;
   PRODUCTIVITY; SENSITIVITY; PERFORMANCE
AB This article has aimed to better understand employee engagement in a post-COVID-19 workplace ecosystem. We identified a knowledge gap in the relationship between employee engagement and the physical workplace environment through an interdisciplinary literature review. We subsequently tested this gap by comparing employee engagement metrics proposed by leading academics in the field of organisational psychology with a sample of commonly used real estate industry approaches to monitoring workplace design/management. We focused specifically on industry-projected post-COVID-19 workplace ecosystem scenarios, and the results suggest that traditional employee engagement metrics and industry approaches to monitoring workplace design and management do not fully reflect the recent shift to hybrid work patterns. We shed light on the implications that this can have on our existing knowledge of "sustainable " property markets in a wider city context.
C1 [Surma, Martyna Joanna; Nunes, Richard Joseph] Univ Reading, Henley Business Sch, Dept Real Estate & Planning, Reading RG6 6UD, Berks, England.
   [Rook, Caroline] Univ Reading, Dept Leadership Org & Behav, Henley Business Sch, Reading RG9 2AU, Berks, England.
   [Loder, Angela] Int WELL Bldg Inst, New York, NY 10001 USA.
RP Surma, MJ (corresponding author), Univ Reading, Henley Business Sch, Dept Real Estate & Planning, Reading RG6 6UD, Berks, England.
EM m.j.surma@pgr.reading.ac.uk; r.j.nunes@reading.ac.uk;
   c.rook@henley.ac.uk; angela.loder@wellcertified.com
OI Nunes, Richard J./0000-0003-0829-4130; Surma, Martyna
   Joanna/0000-0003-2335-4859
FU Economic and Social Research Council in the United Kingdom
   [ES/V502133/1]; University of Tokyo
FX The above study was funded by the Accelerating Business Collaboration
   award granted by the Economic and Social Research Council in the United
   Kingdom and delivered via the University of Oxford (grant number:
   ES/V502133/1). The publication fee was financially subsidised by the
   University of Tokyo.
CR Albrecht SL, 2010, NEW HORIZ INNO MANAG, P3
   Altomonte S, 2020, BUILD ENVIRON, V180, DOI 10.1016/j.buildenv.2020.106949
   Angelucci M., REMOTE WORK HETEROGE
   AON, WORK FORM HOM IMPL P
   Appel-Meulenbroek R, 2018, J CORP REAL ESTATE, V20, P56, DOI 10.1108/JCRE-04-2017-0012
   Attridge M, 2009, J WORKPLACE BEHAV HE, V24, P383, DOI 10.1080/15555240903188398
   Augustin S, 2020, P FUT WORKSP
   Bailey C, 2017, INT J MANAG REV, V19, P31, DOI 10.1111/ijmr.12077
   Bloom N, RAISE PRODUCTIVITY L
   Bosti E., 1984, USING OFFICE DESIGN
   BRE, ASS HLTH WELLB BUILD
   Brim B, LONGER WORKERS STAY
   Brinkley I., IS KNOWLEDGE WORK BE
   Brynjolfsson E., COVID 19 REMOTE WORK
   CambridgeDictionary, VIGOUR
   Carmona M., HOME COMFORTS DESIGN
   CBRE, REAL EST STRAT ASS 8
   Chadburn A, 2017, J CORP REAL ESTATE, V19, P66, DOI 10.1108/JCRE-12-2015-0047
   Chan JK, 2007, CALIF MANAGE REV, V49, P6, DOI 10.2307/41166380
   Clements-Croome D.J, 2004, INTELLIGENT BUILDING
   Cooper R., 2014, WELLBEING ENV, V1st
   CushmanWakefield, PURPOSE PLACE HIST F
   CushmanWakefield, FUTURE WORKPLACE WIL
   Day A., 2014, WORKPLACE WELL BEING, P3
   Deloitte, DES AD WORKPL PUBL S
   Deloitte, EL WORKF EXP PHYS LE
   Devlin A. S., 2018, ENV PSYCHOL HUMAN WE
   Dingel JI, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104235
   Dongarwar Deepa, 2020, Int J MCH AIDS, V9, P360, DOI 10.21106/ijma.399
   Duque L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176759
   Eguchi H, 2015, INT ARCH OCC ENV HEA, V88, P651, DOI 10.1007/s00420-014-0995-9
   Feige A, 2013, J CORP REAL ESTATE, V15, P7, DOI 10.1108/JCRE-01-2013-0004
   Gallacher G, 2020, CAN PUBLIC POL, V46, pS44, DOI 10.3138/cpp.2020-026
   Gerards R, 2018, PERS REV, V47, P517, DOI 10.1108/PR-02-2017-0050
   Gillen N., 2021, RETHINK DESIGN GUIDE, V1st
   Harter JK, 2002, J APPL PSYCHOL, V87, P268, DOI 10.1037/0021-9010.87.2.268
   Hickman A., IS WORKING REMOTELY
   Hunter P, 2019, EMBO REP, V20, DOI 10.15252/embr.201847435
   IPUTARUP, RECALIBRATION WORK L
   Isaac F.W., 2016, FULFILLING WORKPLACE, V1st, P321
   IWBI, GLOB RES AG HLTH WEL
   IWBI, PEOPL PLAN APPL BREA
   Jindo T, 2020, PREV MED REP, V17, DOI 10.1016/j.pmedr.2019.101030
   KAHN WA, 1990, ACAD MANAGE J, V33, P692, DOI 10.2307/256287
   Kampf-Dern A., 2020, P TRANSD WORKPL RES
   Kane G.C., 2021, MIT SLOAN MANAGE REV, V62, P12
   Kegel P, 2017, J FACIL MANAG ED RES, V1, P19, DOI [10.22361/jfmer/76637, DOI 10.22361/JFMER/76637]
   Klotz AC, 2020, MIT SLOAN MANAGE REV, V61, P74
   Kniffin KM, 2021, AM PSYCHOL, V76, P63, DOI 10.1037/amp0000716
   Kumar R., 2012, MANAGEMENT LABOUR ST, V37, P31, DOI DOI 10.1177/0258042X1103700104
   Kwallek N, 2007, COLOR RES APPL, V32, P130, DOI 10.1002/col.20298
   Larson B.Z., GUIDE MANAGING YOUR
   Leesman, WORLDS BEST WORKPL 2
   Leesman, WORKPL EXP REV 2
   Leesman, YOUR WORKPLACE FUTUR
   Leesman, HOM WORK IMP COD
   Liu S., 2020, MUNICH PERS REPEC AR, V207
   lodeR A, 2020, SMALL SCALE URBAN GR, DOI [10.4324/9781315642857, DOI 10.4324/9781315642857]
   Love A., 2021, LEAD LEAD, V2021, P32, DOI [10.1002/ltl.20549, DOI 10.1002/LTL.20549]
   Lovelace KJ, 2009, INDOOR WORK AND LIVING ENVIRONMENTS: HEALTH, SAFETY AND PERFORMANCE, P263
   May DR, 2004, J OCCUP ORGAN PSYCH, V77, P11, DOI 10.1348/096317904322915892
   Munir F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1427-9
   Newman SA, 2021, ORGAN DYN, V50, DOI 10.1016/j.orgdyn.2020.100802
   Newsham G.R., IMPROVING ORG PRODUC
   Nishi D, 2017, J OCCUP HEALTH, V59, P17, DOI 10.1539/joh.16-0167-OA
   OLSON MH, 1983, COMMUN ACM, V26, P182, DOI 10.1145/358061.358068
   Osborne S., 2017, INT J APPL MANAG TEC, V16, P4, DOI DOI 10.5590/IJAMT.2017.16.1.04
   Otsuka Sohei, 2020, J Phys Ther Sci, V32, P410, DOI 10.1589/jpts.32.410
   Ramani A., DONUT EFFECT COVID 1
   Rana S, 2014, J WORKPLACE LEARN, V26, P249, DOI 10.1108/JWL-09-2013-0063
   Robertson Ivan T, 2010, Leadership & Organization Development Journal, V31, P324, DOI 10.1108/01437731011043348
   Robinson D., DRIVERS EMPLOYEE ENG
   Roskams M, 2021, FACILITIES, V39, P652, DOI 10.1108/F-07-2020-0090
   Russo D, 2021, EMPIR SOFTW ENG, V26, DOI 10.1007/s10664-021-09945-9
   Saks A.M., 2006, J MANAGE PSYCHOL, V21, P600, DOI [DOI 10.1108/02683940610690169, 10.1108/02683940610690169]
   Schaufeli W., 2014, PEOPLE WORK INTRO CO, P293
   Schaufeli W., 2002, J HAPPINESS STUD, V3, P71, DOI [DOI 10.1023/A:1015630930326, 10.1023/A:1015630930326]
   Schaufeli W.B., 2003, UWES UTRECHT WORK EN
   Schullery NM, 2013, BUS PROF COMMUN Q, V76, P252, DOI 10.1177/1080569913476543
   Seppala P, 2012, J POSIT PSYCHOL, V7, P95, DOI 10.1080/17439760.2011.637342
   Shirom A, 2004, R OCC ST W, V3, P135
   Skarlicki, 2007, RES SOCIAL ISSUES MA, P1051, DOI DOI 10.1080/02678370802393649
   Smith A, 2011, J FACIL MANAG, V9, DOI 10.1108/jfm.2011.30809baa.001
   Sundstrom E., 1986, WORK PLACES PSYCHOL
   Teevan J., NEW FUTURE WORK RES
   Truss C., 2007, WORKING LIFE EMPLOYE
   USGSA, 2006, WORKPL MATT
   Valentin J, 2010, PSYCHOL RES PROG, P1
   Veitch J, 2012, OXFORD HDB ENV CONSE, P248, DOI [10.1093/oxfordhb/9780199733026.013.0014, DOI 10.1093/OXFORDHB/9780199733026.013.0014]
   Veitch JA, 2013, ENVIRON BEHAV, V45, P198, DOI 10.1177/0013916511420560
   Veromaa V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017303
   Vischer JC, 2007, STRESS HEALTH, V23, P175, DOI 10.1002/smi.1134
   Wyon DP, 2004, INDOOR AIR, V14, P92, DOI 10.1111/j.1600-0668.2004.00278.x
NR 93
TC 1
Z9 1
U1 16
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD OCT
PY 2021
VL 13
IS 20
AR 11443
DI 10.3390/su132011443
PG 20
WC Green & Sustainable Science & Technology; Environmental Sciences;
   Environmental Studies
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA WS3VI
UT WOS:000715112300001
OA Green Accepted, gold
DA 2022-04-20
ER

PT J
AU Xu, X
   Li, ZG
   Wang, R
   Zhao, L
AF Xu, Xu
   Li, Zhigang
   Wang, Rui
   Zhao, Li
TI Analysis of the Evolution of User Emotion and Opinion Leaders'
   Information Dissemination Behavior in the Knowledge Q&A Community during
   COVID-19
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE social network analysis; essence posts; knowledge Q&A community;
   information dissemination network; opinion leader; emotional evolution
ID SOCIAL NETWORK ANALYSIS; MENTAL-HEALTH; MEDIA; PERSPECTIVE; ENGAGEMENT;
   MECHANISM; CONSUMERS; FACEBOOK; QUESTION; DEBATE
AB Since its emergence in 2019, COVID-19 has quickly triggered widespread public discussion on social media. From 26 February 2020 to 26 September 2020, this study collected data on COVID-19-related posts in the knowledge Q & A community, identified 220 opinion leaders of this community, and used social network analysis and sentiment analysis to analyze the information exchange behavior and emotional evolution of the opinion leaders during COVID-19. The results show that the COVID-19 topic community could be divided into seven main categories. The information dissemination of opinion leader information dissemination network had low efficiency, multiple paths, and a high degree of control. In addition, the emotional evolution of users showed obvious phased characteristics. User emotion changed from initially strong negative to strong positive over the course of the pandemic and eventually tended to be objective and neutral as time passed and the event stabilized.
C1 [Xu, Xu; Zhao, Li] Southwestern Univ Finance & Econ, Sch Econ Informat Engn, Chengdu 611130, Peoples R China.
   [Li, Zhigang; Wang, Rui] Chengdu Univ Technol, Sch Management Sci, Chengdu 610059, Peoples R China.
RP Li, ZG (corresponding author), Chengdu Univ Technol, Sch Management Sci, Chengdu 610059, Peoples R China.
EM xuxujy@yeah.net; lizhigang@mail.cdut.edu.cn; rwangjy@163.com;
   lizhao@stu.cdut.edu.cn
FU Major Projects of Sichuan Province in the "13th Five-Year Plan for
   Social Sciences in 2020 [SC20YJ002]; Sichuan Regional Public Management
   Information Research Center Fund Project [QGXH18-02]
FX This research was funded by Major Projects of Sichuan Province in the
   "13th Five-Year Plan" for Social Sciences in 2020 (grant number
   SC20YJ002), and Sichuan Regional Public Management Information Research
   Center Fund Project (grant number QGXH18-02).
CR [Anonymous], RECODE YES QUORA STI
   [Anonymous], ZHIHU PRODUCT ANAL R
   Babac MB, 2018, INFORM TECHNOL PEOPL, V31, P327, DOI 10.1108/ITP-08-2016-0200
   Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3
   Bartsch SM, 2020, HEALTH AFFAIR, V39, P927, DOI 10.1377/hlthaff.2020.00426
   Berger J, 2012, J MARKETING RES, V49, P192, DOI 10.1509/jmr.10.0353
   Burhamah W, 2020, J AFFECT DISORDERS, V277, P977, DOI 10.1016/j.jad.2020.09.014
   Burt RS, 2013, ANNU REV PSYCHOL, V64, P527, DOI 10.1146/annurev-psych-113011-143828
   Cerasti Davide, 2020, SN Compr Clin Med, V2, P1213, DOI 10.1007/s42399-020-00388-9
   Chan CH, 2017, J COMPUT-MEDIAT COMM, V22, P266, DOI 10.1111/jcc4.12192
   Chauhan P, 2021, J AMB INTEL HUM COMP, V12, P2601, DOI 10.1007/s12652-020-02423-y
   Chen CM, 2019, BRIT J EDUC TECHNOL, V50, P1846, DOI 10.1111/bjet.12673
   Chen Q, 2020, COMPUT HUM BEHAV, V110, DOI 10.1016/j.chb.2020.106380
   Chen Y, 2021, INT J COMPUT INT SYS, V14, P734, DOI 10.2991/ijcis.d.210203.002
   Cheng X.L., 2019, THESIS CHENGDU U TEC
   de Bruin YB, 2020, SAFETY SCI, V128, DOI 10.1016/j.ssci.2020.104773
   Dong JW, 2021, TOB INDUC DIS, V19, DOI 10.18332/tid/132594
   Feng SH, 2018, DISASTER MED PUBLIC, V12, P26, DOI 10.1017/dmp.2017.29
   File K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030443
   Freeman EE, 2020, J AM ACAD DERMATOL, V82, pE231, DOI 10.1016/j.jaad.2020.04.002
   Gao YK, 2020, JMIR PUBLIC HLTH SUR, V6, P82, DOI 10.2196/21963
   Gazan R, 2010, INFORM PROCESS MANAG, V46, P693, DOI 10.1016/j.ipm.2009.10.007
   Geiger N, 2019, ENVIRON BEHAV, V51, P561, DOI 10.1177/0013916518812925
   Getchell MC, 2016, COMPUT HUM BEHAV, V54, P597, DOI 10.1016/j.chb.2015.06.044
   Grodzinski N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256997
   Gu MY, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9091109
   Guan T, 2018, COMPUT HUM BEHAV, V81, P137, DOI 10.1016/j.chb.2017.12.023
   Farias MGG, 2020, INFORM SOC-ESTUD, V30
   Han Q, 2021, J AFFECT DISORDERS, V284, P247, DOI 10.1016/j.jad.2021.01.049
   He L, 2021, J AM MED INFORM ASSN, V28, P1564, DOI 10.1093/jamia/ocab047
   Jin JH, 2015, INFORM MANAGE-AMSTER, V52, P840, DOI 10.1016/j.im.2015.07.005
   Jin XL, 2013, INT J INFORM MANAGE, V33, P93, DOI 10.1016/j.ijinfomgt.2012.07.007
   Johnson CA, 2007, J AM SOC INF SCI TEC, V58, P883, DOI 10.1002/asi.20561
   Joshi GC, 2020, J INF SCI, V46, P776, DOI 10.1177/0165551519865487
   Kaligotla C, 2020, J SIMUL, DOI 10.1080/17477778.2020.1785345
   Keelan J, 2010, VACCINE, V28, P1535, DOI 10.1016/j.vaccine.2009.11.060
   Kivlighan DM, 2018, COUNS PSYCHOL, V46, P274, DOI 10.1177/0011000018763821
   Li K, 2019, FRONT COMPUT SCI-CHI, V13, P1296, DOI 10.1007/s11704-018-7453-x
   Li YZ, 2020, FUTURE GENER COMP SY, V102, P876, DOI 10.1016/j.future.2019.07.016
   Li ZG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041136
   Lin HC, 2018, INT J HUM-COMPUT INT, V34, P1063, DOI 10.1080/10447318.2017.1413790
   Liu Jun, 2009, OVERALL NETWORK ANAL
   Liu L, 2018, ISPRS INT GEO-INF, V7, DOI 10.3390/ijgi7050189
   Liu Z, 2017, INFORM PROCESS MANAG, V53, P490, DOI 10.1016/j.ipm.2016.05.001
   Lwin May Oo, 2020, JMIR Public Health Surveill, V6, pe19447, DOI 10.2196/19447
   Ma N, 2014, EXPERT SYST APPL, V41, P1357, DOI 10.1016/j.eswa.2013.08.033
   Massey PM, 2020, J MED INTERNET RES, V22, DOI 10.2196/21451
   Mei YL, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11164440
   Meissner N, 2015, CONVERGENCE-US, V21, P450, DOI 10.1177/1354856514546095
   Meng Z., 2005, EMOTIONAL PSYCHOL
   Nip JYM, 2016, INFORM COMMUN SOC, V19, P1127, DOI 10.1080/1369118X.2015.1104372
   Osatuyi B, 2022, COMPUT HUM BEHAV, V126, DOI 10.1016/j.chb.2021.107009
   Park I, 2020, SOC SCI J, DOI 10.1080/03623319.2020.1768485
   Pirri S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155440
   Prasanna PM, 2011, J DIGIT IMAGING, V24, P908, DOI 10.1007/s10278-011-9371-4
   Pulgar J, 2020, PHYS REV PHYS EDUC R, V16, DOI 10.1103/PhysRevPhysEducRes.16.010137
   Rhee June Woong, 2007, [Korean Journal of Journalism & Communication Studies, 한국언론학보], V51, P358
   Rushmore J, 2013, J ANIM ECOL, V82, P976, DOI 10.1111/1365-2656.12088
   Shah C., 2008, P AM SOC INFORM SCI, V45, P1, DOI DOI 10.1002/MEET.2008.1450450279
   Shan SQ, 2017, ENTERP INF SYST-UK, V11, P1462, DOI 10.1080/17517575.2016.1177204
   Shan SQ, 2017, INF DISCOV DELIV, V45, P21, DOI 10.1108/IDD-09-2016-0029
   Sharma C, 2020, ANN RHEUM DIS, V79, P1432, DOI 10.1136/annrheumdis-2020-217333
   Srinivasan S, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-1436-x
   Vo TT, 2019, J BUS ETHICS, V157, P525, DOI 10.1007/s10551-017-3679-z
   Tang WM, 2020, CLIN INFECT DIS, V71, P818, DOI 10.1093/cid/ciaa423
   Tang XN, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2337542.2337558
   Tang ZY, 2018, INFORM TECHNOL PEOPL, V31, P927, DOI 10.1108/ITP-04-2016-0076
   Teasdale Emma, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101084
   Veer M, 2020, CRIT CARE NURS Q, V43, P381, DOI 10.1097/CNQ.0000000000000323
   Vercellone-Smith P, 2012, COMPUT EDUC, V59, P222, DOI 10.1016/j.compedu.2012.01.006
   Wang XH, 2020, INTERNET RES, V30, P1547, DOI 10.1108/INTR-11-2019-0491
   Wang YX, 2019, SOC SCI MED, V240, DOI 10.1016/j.socscimed.2019.112552
   Williams HTP, 2015, GLOBAL ENVIRON CHANG, V32, P126, DOI 10.1016/j.gloenvcha.2015.03.006
   World Health Organization, NOV COR 2019 NCOV SI
   World Health Organization, WHO DIR GEN OP REM M
   Xiong Y, 2018, COMPUT HUM BEHAV, V82, P81, DOI 10.1016/j.chb.2018.01.005
   Xu Junming, 2015, Computer Engineering and Applications, V51, P110, DOI 10.3778/j.issn.1002-8331.1403-0032
   Xu Q, 2018, SCI COMMUN, V40, P691, DOI 10.1177/1075547018806526
   Yang ZW, 2013, PROC INT CONF PARAL, P603, DOI 10.1109/ICPP.2013.74
   Yie KY, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000025016
   Zhang J, 2014, ASLIB J INFORM MANAG, V66, P443, DOI 10.1108/AJIM-01-2014-0008
   Zhang LJ, 2018, CHINA COMMUN, V15, P98, DOI 10.1109/CC.2018.8424607
   Zhang W, 2020, INT J INFORM MANAGE, V50, P498, DOI 10.1016/j.ijinfomgt.2019.04.001
   Zhang WZ, 2014, NEURAL COMPUT APPL, V25, P595, DOI 10.1007/s00521-013-1529-1
   Zhang WZ, 2014, SCI WORLD J, DOI 10.1155/2014/268592
   Zhang YM, 2020, ADV DIFFER EQU-NY, V2020, DOI 10.1186/s13662-020-02774-y
   Zhang YB, 2021, MATH PROBL ENG, V2021, DOI 10.1155/2021/6680303
   Zhao A., 2017, CHINA SCI TECHNOL FO, V11, P149, DOI [10.13580/j.cnki.fstc.2017.11.018, DOI 10.13580/J.CNKI.FSTC.2017.11.018]
   Zhao YX, 2020, J ASSOC INF SCI TECH, V71, P516, DOI 10.1002/asi.24262
NR 89
TC 0
Z9 0
U1 22
U2 22
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD NOV
PY 2021
VL 18
IS 22
AR 12252
DI 10.3390/ijerph182212252
PG 18
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA XK2JF
UT WOS:000727297300001
PM 34832009
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Ortiz, FC
   Matamoros, EP
   Torres, W
   Fischer, R
AF Ortiz, Felipe Chibas
   Matamoros, Efrain Pantaleon
   Torres, Wania
   Fischer, Rachel
TI Science, Innovation, Communication and Ethics in the days of COVID-19 in
   Latin America
SO INTERNATIONAL REVIEW OF INFORMATION ETHICS
LA English
DT Article
DE Covid-19 Pandemic; Digital Literacy; Information Ethics; Innovation
   Manement; Science Communication
AB Two renowned Cuban scientists and professors who arrived in Brazil in the last decade of the last century, completed their doctorates at USP and expanded their professional achievements in the country, share in a relaxed way their knowledge and experiences about Science, Technology, Communication and Ethics in the times of COVID-19 in Latin America. One of them from the Exact Sciences area, Efrain Pantaleon Matamoros; and the other from Social Sciences, Felipe Chibas Ortiz. The views of these two Latin American researchers - who have previously written an article together on Innovation Management - now speak of these themes from the perspectives of different sciences, in an enriching way - relevant to the context of the 'new-normal' during the times of Covid-19. This article, presented as an interview, reflects on what these two experts have to say about Science, Technology, Innovation, Communication and Ethics in the days of COVID-19 in Latin America, from their unique perspectives.
EM chibas_f@yahoo.es; epantaleon@yahoo.com; waniatorres1@gmail.com;
   rachel@3consulting.org
CR Adhanom Tedros, WIKIPEDIA
   ATLAN H, 1989, B MATH BIOL, V51, P247, DOI 10.1007/BF02458445
   BOSTROM N., 2014, SUPERINTELIGENCIA CA
   Brasil, 2012, MIN SAUD CONS NAC SA, P59
   Buckeridge Marcos, ABORDAGEM BRASILEIRA
   Castells Manuel, 1983, CITY GRASSROOTS CROS
   Chibas Ortiz Felipe, 2019, UNESCO WORLD CITIES
   Chibas Ortiz Felipe, 2020, SMART CITIES MIL CIT, P430
   Chonsky N., 2020, BLOG BOI TEMPO
   Criarcom, 2020, THOT CRIARC WEBS ACC
   Grizzle A., 2019, ASSESSING CITIZENS R
   Habermas J., 2020, MONDE
   Helbig J., 2013, SECURING FUTURE GER
   Iribarry Isac Nikos, 2003, Psicol. Reflex. Crit., V16, P483
   Kurzweil R, 2009, ERA MAQUINAS ESPIRIT
   Ma Jack, WIKIPEDIA
   Morin, 2015, INTRO PENSAMENTO COM
   Musk Elon, WIKIPEDIA
   Nissenbaum H, 2004, WASH LAW REV, V79, P119
   Oncubanews,, ONCUBANEWS
   Pantaleon-Matamoros E., 2020, REV PROPRIEDADE IND, V2575, P16
   ROCHA T. A., 2013, HOLOS S L, V3, P15
   Santos Agripino Tecnonatureza, 2020, TRANSUMANISMO POSHUM
   Unesco, 2020, MIL CIT METR
   VALERIO M, 2006, REV IBEROAMERICANA C, V7
   Zizek S, 2020, PANDEMIA COVID19 REI
NR 26
TC 0
Z9 0
U1 0
U2 0
PU INT CENTER INFORMATION ETHICS
PI KARLSRUHE
PA C/O RAFEL CAPURRO, EIC, REDTENBACHERSTR 9, KARLSRUHE, 76133, GERMANY
SN 1614-1687
J9 INT REV INF ETHICS
JI Int. Rev. Inf. Ethics
PD AUG
PY 2021
VL 30
PG 12
WC Ethics
WE Emerging Sources Citation Index (ESCI)
SC Social Sciences - Other Topics
GA YN4US
UT WOS:000747256200003
DA 2022-04-20
ER

PT J
AU Zhang, XL
   Wang, W
   Xiao, Y
AF Zhang, Xiao Lei
   Wang, Wei
   Xiao, Yi
TI Sleep Disordered Breathing Diagnosis and Treatment During the COVID-19
   Pandemic: A Nationwide Survey in China
SO NATURE AND SCIENCE OF SLEEP
LA English
DT Article
DE COVID-19; sleep disordered breathing; polygraphy; surveys and
   questionnaires
ID APNEA; POLYSOMNOGRAPHY; AUTOTITRATION; STROKE
AB Background and Objective: The coronavirus disease 2019 (COVID-19) pandemic has markedly impacted the distribution of medical resources and healthcare delivery systems. The objective of this study was to investigate the influence of the pandemic on the diagnosis and treatment of sleep-disordered breathing (SDB) in China.
   Methods: A retrospective online survey of sleep centers from the assembly of SDB of the Chinese Thoracic Society was conducted from July 1 to July 20, 2020. The questionnaire focused on four main aspects: 1) general information about the centers; 2) changes in SDB management activities, including patient volumes, diagnostic and positive airway pressure (PAP) titration procedures, and follow-up methods, from February to June 2020, compared with before; 3) the application of telemedicine and sleep specialists' self-assessments of knowledge and their perspectives on telemedicine; and 4) changes in medical staff active in sleep services during the pandemic compared with before.
   Results: Fifty-three (96%) of the sleep centers responded to the survey. During the early stage of the outbreak, SDB medical services were dramatically reduced to 5-10% of the pre-epidemic level, and laboratory-based polysomnograms and manual titration were almost cancelled. With the subsidence of COVID-19, SDB medical services gradually resumed to approximately half of the pre-pandemic level by June. However, a second wave of COVID-19 in Beijing significantly reduced the recovery of SDB services. The application of polygraphy has increased significantly. Home-initiated PAP and telemedicine still accounted for a small part of SDB management during the pandemic.
   Conclusion: The COVID-19 pandemic has greatly challenged SDB management in China. Polygraphy played a major role in SDB diagnosis during the pandemic. Home-based SDB management and telemedicine have not been well implemented. The second surge of COVID-19 in Beijing cut back on the recovering SDB service to the early outbreak level, which may give us an impetus to restructure our sleep health service.
C1 [Zhang, Xiao Lei] China Japan Friendship Hosp, Ctr Resp Med, Dept Pulm & Crit Care Med, Beijing, Peoples R China.
   [Zhang, Xiao Lei] Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China.
   [Zhang, Xiao Lei] Chinese Acad Med Sci & Peking Union Med Coll, Grad Sch, Peking Union Med Coll, Beijing, Peoples R China.
   [Zhang, Xiao Lei] Capital Med Univ, Beijing, Peoples R China.
   [Zhang, Xiao Lei] Peking Univ Hlth Sci Ctr, Beijing, Peoples R China.
   [Wang, Wei] Chinese Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Shenyang, Peoples R China.
   [Xiao, Yi] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp Med, 1 Shuaifuyuan St, Beijing 100730, Peoples R China.
RP Xiao, Y (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp Med, 1 Shuaifuyuan St, Beijing 100730, Peoples R China.
EM xiaoyipumch@sina.com
OI , yi/0000-0002-5085-1175
FU National Key Research and Development Project [2018YFC1315103]; Ministry
   of Science and Technology of ChinaMinistry of Science and Technology,
   China
FX This work was supported by research grants from the National Key
   Research and Development Project (2018YFC1315103) from the Ministry of
   Science and Technology of China.
CR Benjafield AV, 2019, LANCET RESP MED, V7, P687, DOI 10.1016/S2213-2600(19)30198-5
   Berry RB, 2008, SLEEP, V31, P1423
   Berry RB, 2014, J CLIN SLEEP MED, V10, P1269, DOI 10.5664/jcsm.4272
   Bruyneel M, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0093-2018
   Chang Y, 2019, J CLIN SLEEP MED, V15, P587, DOI 10.5664/jcsm.7720
   Chen XL, 2015, SLEEP, V38, P877, DOI 10.5665/sleep.4732
   Greiwe J, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-00927-3
   Grigg-Damberger M, 2006, J CLIN NEUROPHYSIOL, V23, P21, DOI 10.1097/01.wnp.0000201077.44102.80
   Grote L, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01323-2020
   Jahrami H, 2021, J CLIN SLEEP MED, V17, P299, DOI 10.5664/jcsm.8930
   Kendzerska T, 2014, SLEEP MED REV, V18, P49, DOI 10.1016/j.smrv.2013.01.003
   Lam B, 2007, INT J TUBERC LUNG D, V11, P2
   Lance Colleen G, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc003
   Miller R, 2020, CLEV CLIN J MED, V87, P384, DOI 10.3949/ccjm.87a.ccc013
   Patel SR, 2020, AM J RESP CRIT CARE, V202, P309, DOI 10.1164/rccm.202005-1546ED
   Pillar G, 2020, SLEEP BREATH, V24, P387, DOI 10.1007/s11325-019-01904-5
   Ramar K, 2020, J CLIN SLEEP MED, V16, P993, DOI 10.5664/jcsm.8580
   Rosen CL, 2012, SLEEP, V35, P757, DOI 10.5665/sleep.1870
   Saletu MT, 2018, J CLIN SLEEP MED, V14, P1495, DOI 10.5664/jcsm.7322
   Wang Q, 2016, Zhonghua Yi Xue Za Zhi, V96, P2380, DOI 10.3760/cma.j.issn.0376-2491.2016.30.004
   World Health Organization, 2020, 51 WHO
   Zhang XL, 2020, ZHONGHUA JIE HE HE H, V43, P490, DOI [10.3760/cma.j.cn112147- 20200309-00283, DOI 10.3760/CMA.J.CN112147-20200309-00283]
   Zinchuk AV, 2018, THORAX, V73, P472, DOI 10.1136/thoraxjnl-2017-210431
NR 23
TC 2
Z9 2
U1 0
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-1608
J9 NAT SCI SLEEP
JI NAT. SCI. SLEEP
PY 2021
VL 13
BP 21
EP 30
DI 10.2147/NSS.S292373
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA PQ4GW
UT WOS:000606504800001
PM 33447115
OA Green Published
DA 2022-04-20
ER

PT J
AU Restar, A
   Garrison-Desany, HM
   Baker, KE
   Adamson, T
   Howell, S
   Baral, SD
   Operario, D
   Beckham, SW
AF Restar, Arjee
   Garrison-Desany, Henri M.
   Baker, Kellan E.
   Adamson, Tyler
   Howell, Sean
   Baral, Stefan David
   Operario, Don
   Beckham, S. Wilson
TI Prevalence and associations of COVID-19 testing in an online sample of
   transgender and non-binary individuals
SO BMJ GLOBAL HEALTH
LA English
DT Article
DE COVID-19; cross-sectional survey; public health
ID HEALTH; CARE; ADULTS
AB Background Testing for COVID-19 and linkage to services is fundamental to successful containment and control of transmission. Yet, knowledge on COVID-19 testing among transgender and non-binary communities remains limited. Methods Between October 2020 and November 2020, we examined the prevalence and associations of COVID-19 testing in an online sample of transgender and non-binary people (n=536). Multivariable hierarchical logistic regression analyses examined associations between COVID-19 testing and participants' sociodemographic, mental health, substance use, gender affirmation, economic changes and healthcare experiences. Results Prevalence of COVID-19 testing in this sample was 35.5% (n=190/536). In the final model, transgender and non-binary participants from upper socioeconomic income background and Europe, who reported having active alcohol use disorder, limited access to gender-affirming surgery, had more than 20% reduction in income, and experienced mistreatment in a health facility due to gender identity had significantly increased odds of COVID-19 testing (all p<0.05); those who reported recent tobacco use had significantly lower odds of COVID-19 testing (p=0.007). Conclusions These findings highlight structural disparities in COVID-19 testing and reinforce the importance of increasing testing strategies for transgender and non-binary populations.
C1 [Restar, Arjee; Garrison-Desany, Henri M.; Baral, Stefan David] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Restar, Arjee; Operario, Don] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA.
   [Baker, Kellan E.; Adamson, Tyler] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA.
   [Howell, Sean] Hornet, San Francisco, CA USA.
   [Beckham, S. Wilson] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA.
RP Restar, A (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.; Restar, A (corresponding author), Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA.
EM arestar1@jhmi.edu
RI Baral, Stefan/AAG-4818-2020
OI Baral, Stefan/0000-0002-5482-2419
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [T32AI102623]; Robert Wood Johnson FoundationRobert Wood Johnson
   Foundation (RWJF); National Institute of Mental HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [K01MH114715]
FX AR is supported by the National Institute of Allergy and Infectious
   Diseases (grant T32AI102623). AR and KEB are supported by the Robert
   Wood Johnson Foundation Health Policy Research Scholar. SWB is supported
   by the National Institute of Mental Health (grant K01MH114715).
CR Behzadifar M, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01181-9
   Brown CS., 2020, INEQUALITY CORONAVIR
   Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789
   Cahill S, 2020, AM J PUBLIC HEALTH, V110, P1360, DOI 10.2105/AJPH.2020.305829
   Calderon C., 2020, LIVES LIVELIHOODS MA
   Cenat JM, 2020, INT J PUBLIC HEALTH, V65, P717, DOI 10.1007/s00038-020-01426-y
   Chatterjee S, 2020, DIABETES METAB SYND, V14, P1757, DOI 10.1016/j.dsx.2020.09.001
   Cheng MP, 2020, ANN INTERN MED, V172, P726, DOI 10.7326/M20-1301
   Chetty R., 2020, EC IMPACTS COVID 19 EC IMPACTS COVID 19
   Chodkiewicz J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134677
   Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2
   Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Drabble LA, 2021, J HOMOSEXUAL, V68, P545, DOI 10.1080/00918369.2020.1868182
   Flaherty AJ, 2020, OTOLARYNG HEAD NECK, V163, P1140, DOI 10.1177/0194599820939072
   Ganson KT, 2021, J ADOLESCENT HEALTH, V68, P53, DOI 10.1016/j.jadohealth.2020.10.008
   Gibb JK, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23499
   Han E, 2020, LANCET, V396, P1525, DOI 10.1016/S0140-6736(20)32007-9
   Hong W, 2021, CYBERPSYCH BEH SOC N, V24, P282, DOI 10.1089/cyber.2020.0387
   Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169
   Hughto JMW, 2015, SOC SCI MED, V147, P222, DOI 10.1016/j.socscimed.2015.11.010
   Hughto JMW, 2016, LGBT HEALTH, V3, P424, DOI 10.1089/lgbt.2016.0044
   Hussain A.H.M., 2020, SSRN ELECT J, DOI DOI 10.2139/SSRN.3586319
   Kcomt L, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100608
   Kim HN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21213
   King WM, 2021, TRANSGENDER HEALTH, V6, P5, DOI 10.1089/trgh.2020.0025
   Lippi G, 2020, EUR J INTERN MED, V75, P107, DOI 10.1016/j.ejim.2020.03.014
   Lo E, 2020, EUR J INTERN MED, V77, P125, DOI 10.1016/j.ejim.2020.05.003
   Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019
   Lyons, 2021, COMPETING HLTH RISKS, DOI [10.1101/2021. 01.07.21249419, DOI 10.1101/2021.01.07.21249419, 10.1101/2021.01.07.21249419]
   Manabe YC, 2020, JAMA-J AM MED ASSOC, V324, P2153, DOI 10.1001/jama.2020.21694
   Operario D, 2014, J COMMUNITY PSYCHOL, V42, P544, DOI 10.1002/jcop.21636
   Raine S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218115
   Reisner SL, 2016, CURR OPIN ENDOCRINOL, V23, P198, DOI 10.1097/MED.0000000000000229
   Rentsch CT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003379
   Restar A., 2020, TRANSGEND HLTH, DOI [10.1089/trgh.2020.0054, DOI 10.1089/TRGH.2020.0054]
   Restar AJ, 2021, TRANSGENDER HEALTH, V6, P1, DOI 10.1089/trgh.2020.0026
   Roberts SA, 2020, J ADOLESCENT HEALTH, V67, P635, DOI 10.1016/j.jadohealth.2020.08.018
   Ruprecht MM, 2021, J URBAN HEALTH, V98, P27, DOI 10.1007/s11524-020-00497-9
   Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w
   Salerno JP, 2020, PSYCHOL TRAUMA-US, V12, pS239, DOI 10.1037/tra0000837
   Sallie SN, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-044276
   Santos GM, 2021, AIDS BEHAV, V25, P311, DOI 10.1007/s10461-020-02969-0
   Schwindt R, 2020, TRANSGENDER HEALTH, V5, P86, DOI 10.1089/trgh.2019.0063
   Seelman Kristie L, 2017, Transgend Health, V2, P17, DOI 10.1089/trgh.2016.0024
   Shadmi E, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01218-z
   Simons D, 2021, ADDICTION, V116, P1319, DOI 10.1111/add.15276
   Tsigaris P, 2020, NICOTINE TOB RES, V22, P1646, DOI 10.1093/ntr/ntaa121
   Wang YY, 2020, LANCET DIABETES ENDO, V8, P564, DOI 10.1016/S2213-8587(20)30182-0
   West CP, 2020, MAYO CLIN PROC, V95, P1127, DOI 10.1016/j.mayocp.2020.04.004
   World Health Organization, 2021, NEW COMM VACC EQUIT
   Wylie K, 2016, LANCET, V388, P401, DOI 10.1016/S0140-6736(16)00682-6
NR 52
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD SEP
PY 2021
VL 6
IS 9
AR e006808
DI 10.1136/bmjgh-2021-006808
PG 14
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA UT0XI
UT WOS:000697848000001
PM 34518208
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU Jarrett, M
   Schultz, S
   Lyall, J
   Wang, JS
   Stier, L
   De Geronimo, M
   Nelson, K
AF Jarrett, Mark
   Schultz, Susanne
   Lyall, Julie
   Wang, Jason
   Stier, Lori
   De Geronimo, Marcella
   Nelson, Karen
TI Clinical Mortality in a Large COVID-19 Cohort: Observational Study
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE COVID-19; mortality; respiratory failure; hypoxemia; observational;
   review; cohort; ICU; intensive care unit
AB Background: Northwell Health, an integrated health system in New York, has treated more than 15,000 inpatients with COVID-19 at the US epicenter of the SARS-CoV-2 pandemic.
   Objective: We describe the demographic characteristics of patients who died of COVID-19, observation of frequent rapid response team/cardiac arrest (RRT/CA) calls for non-intensive care unit (ICU) patients, and factors that contributed to RRT/CA calls.
   Methods: A team of registered nurses reviewed the medical records of inpatients who tested positive for SARS-CoV-2 via polymerase chain reaction before or on admission and who died between March 13 (first Northwell Health inpatient expiration) and April 30, 2020, at 15 Northwell Health hospitals. The findings for these patients were abstracted into a database and statistically analyzed.
   Results: Of 2634 patients who died of COVID-19, 1478 (56.1%) had oxygen saturation levels 90% on presentation and required no respiratory support. At least one RRT/CA was called on 1112/2634 patients (42.2%) at a non-ICU level of care. Before the RRT/CA call, the most recent oxygen saturation levels for 852/1112 (76.6%) of these non-ICU patients were at least 90%. At the time the RRT/CA was called, 479/1112 patients (43.1%) had an oxygen saturation of <80%.
   Conclusions: This study represents one of the largest reviewed cohorts of mortality that also captures data in nonstructured fields. Approximately 50% of deaths occurred at a non-ICU level of care despite admission to the appropriate care setting with normal staffing. The data imply a sudden, unexpected deterioration in respiratory status requiring RRT/CA in a large number of non-ICU patients. Patients admitted at a non-ICU level of care suffered rapid clinical deterioration, often with a sudden decrease in oxygen saturation. These patients could benefit from additional monitoring (eg, continuous central oxygenation saturation), although this approach warrants further study.
C1 [Jarrett, Mark; Wang, Jason] Hofstra Univ, Donald & Barbara Zucker Sch Med Hofstra Northwell, 500 Hofstra Univ, Hempstead, NY 11549 USA.
   [Schultz, Susanne; Lyall, Julie; Stier, Lori; Nelson, Karen] Northwell Hlth, Inst Clin Excellence & Qual Safety, New Hyde Pk, NY USA.
   [De Geronimo, Marcella] Northwell Hlth, Krasnoff Qual Management Inst, New Hyde Pk, NY USA.
RP Jarrett, M (corresponding author), Hofstra Univ, Donald & Barbara Zucker Sch Med Hofstra Northwell, 500 Hofstra Univ, Hempstead, NY 11549 USA.
EM MJarrett@northwell.edu
OI Wang, Jason/0000-0002-6211-2572; Nelson, Karen/0000-0002-8360-1455
FU National Institute on Aging of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute on Aging (NIA) [R24AG064191];
   National Library of Medicine of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM012836]
FX This work was supported by grants R24AG064191 from the National
   Institute on Aging of the National Institutes of Health and R01LM012836
   from the National Library of Medicine of the National Institutes of
   Health. We thank the Northwell Health Institute for Clinical Excellence
   and Quality/Safety: Mary Cama, RN, MSN; Patricia Meo, RN, BSN; Amy
   Logeman, RN, BSN, CPPS; Maureen McCarthy, RN, BSN; Josephine
   Fernandez-Kapilevich, RN, BSN; Theresa A Droluk, RN, BSN; Jessica
   Martin, RN, BSN, RN-BC; Allison Carballo, RN, MBA; and Jimmy Diaz, BS.
   We also thank the Northwell Health Krasnoff Quality Management
   Institute: Alex Ma; Kahliik S Burrell; and Mark P Tursi, MBA. We would
   like to acknowledge the contributions of the Northwell Health COVID-19
   Research Consortium, including Crystal R Herron, PhD, and Jennifer C
   Johnson, MS, for editorial support. We acknowledge and honor all our
   Northwell Health team members who consistently put themselves in harm's
   way during the COVID-19 pandemic. We dedicate this article to them, as
   their vital contribution to knowledge about COVID-19 and sacrifices on
   the behalf of patients made it possible.
CR [Anonymous], COVID 19 TREATM GUID
   Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575
   Center for Systems Science and Engineering, 2020, COVID 19 DASHB
   Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2
   Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   New York State Department of Health, 2020, COVID 19 TRACK
   Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]
   Richardson Safiya, 2020, JAMA, V323, P2052, DOI 10.1001/jama.2020.6775
   Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wortham JM, 2020, MMWR-MORBID MORTAL W, V69, P923, DOI 10.15585/mmwr.mm6928e1
   Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 14
TC 4
Z9 4
U1 1
U2 2
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD SEP 25
PY 2020
VL 22
IS 9
AR e23565
DI 10.2196/23565
PG 16
WC Health Care Sciences & Services; Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Health Care Sciences & Services; Medical Informatics
GA PF8WG
UT WOS:000599327200011
PM 32930099
OA Green Published, gold
DA 2022-04-20
ER

PT J
AU De Los Santos, JSN
   Chavez, VG
AF De Los Santos, Juan Salvador Nambo
   Chavez, Veronica Giles
TI Conceptual Cartography of School Safety: School Experiences in Managing
   the Covid-19 Pandemic in Mexico
SO REVISTA ROMANEASCA PENTRU EDUCATIE MULTIDIMENSIONALA
LA English
DT Article
DE School security; COVID-19; Higher Education; Mexico
AB This article analyses through a conceptual cartography, school safety, and its association with the management of the COVID-19 pandemic in Mexico. The qualitative methodology allowed the identification of a model of safe learning space in Higher Education, which emerges as a proposal to establish safe learning spaces and manage the pandemic. Once this model implemented, it was possible to inform, mobilize, attend to school content and be in confinement, which meant raising awareness of learning in Higher Education in an increasingly changing knowledge society.
C1 [De Los Santos, Juan Salvador Nambo] Ctr Univ CIFE, Cuernavaca, Morelos, Mexico.
   [Chavez, Veronica Giles] Ctr Morelense Desarrollo Ciencia CEM CIENCIA, Jiutepec, Mexico.
RP De Los Santos, JSN (corresponding author), Ctr Univ CIFE, Cuernavaca, Morelos, Mexico.
EM salvadornambo@gmail.com; veronicagicha@gmail.com
CR Global Alliance for Disaster Risk Reduction and Resilience in the Education Sector (GADRRRES), 2017, MARC INT SEG ESC
   González González Gabriela del Carmen, 2011, Comun. soc, P105
   Gonzalez V. R., 2008, INVENTIO GENESIS CUL, V4, P31
   Nambo J., 2018, CRIMINALIDADES VIOLE
   Nambo J., 2019, REV PAZ CONFL, V12, P155
   Ramos C, 2020, SALUD PUBLICA MEXICO, V62, P225, DOI 10.21149/11276
   Rodriguez-Peralta Lourdes, 2015, REV ROMANEASCA PENTR, V7, P47, DOI [10.18662/rrem/2015.0702.04, DOI 10.18662/RREM/2015.0702.04]
   Secretaria de Educacion Publica [Secretariat of Public Education], 2020, LIN ACC COVID 19 I P
   Waver O., 2009, RECONCEPTUALIZAR SEG
NR 9
TC 1
Z9 1
U1 1
U2 3
PU LUMEN PUBLISHING HOUSE
PI IASI
PA TEPES VODA, NO2, IASI, IASI, 00000, ROMANIA
SN 2066-7329
EI 2067-9270
J9 REV ROMANEASCA PENTR
JI Rev. Romaneasca Pentru Educ. Multidimens.
PD AUG
PY 2020
VL 12
IS 2
SU 1
BP 86
EP 92
DI 10.18662/rrem/12.2Sup1/293
PG 7
WC Education & Educational Research
WE Emerging Sources Citation Index (ESCI)
SC Education & Educational Research
GA PE4FY
UT WOS:000598322000010
OA hybrid
DA 2022-04-20
ER

PT J
AU Zebardast, L
   Radaei, M
AF Zebardast, Lobat
   Radaei, Mahjabin
TI The influence of global crises on reshaping pro-environmental behavior,
   case study: the COVID-19 pandemic
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article
DE Pro-environmental behavior; COVID-19; Intention; Theory of Planned
   Behavior
ID PLANNED BEHAVIOR; PERSONAL NORM; KNOWLEDGE; INTENTION; ATTITUDES;
   ADOPTION; DETERMINANTS; MOTIVATION; MANAGEMENT; COMMUNITY
AB As a profound crisis capable of threatening human well-being as well as existence, the COVID-19 pandemic can be considered as an awakening experience which may lead to the promotion of environmentally responsible behaviors in the society. In the present research, an extended form of the Theory of Planned Behavior has been applied to examine the moderating effect of COVID-19 pandemic on pro-environmental behavior mechanism in Iran. To evaluate this effect, a 5-scale Likert questionnaire was designed comprising of 28 questions in 7 sections of information and concerns about COVID-19, environmental knowledge, subjective norm, attitude, intention, perceived behavioral control and pro-environmental behavior. According to the results, the pandemic has led to an increase in people's knowledge about their environment and has positively affected individuals' subjective norms, or the perceived social pressure to get involved in environmentally friendly actions. Individuals' attitude to perform pro-environmental behaviors has also increased as a result of this incident. Moreover, the role of perceived behavioral control over environmental actions has been influenced by the pandemic situation and the COVID-19 crisis has positively influenced the relationship between intention and pro-environmental behavior. (c) 2021 Elsevier B.V. All rights reserved.
C1 [Zebardast, Lobat; Radaei, Mahjabin] Univ Tehran, Coll Engn, Sch Environm, Tehran, Iran.
RP Zebardast, L (corresponding author), Univ Tehran, Coll Engn, Sch Environm, Tehran, Iran.
EM lzebardast@ut.ac.ir
RI Zebardast, Lobat/T-2860-2018
OI Zebardast, Lobat/0000-0001-5660-9665
CR Abdollahzadehgan A., 2013, J INF SYST RES INNOV, P67
   Ahmmadi P, 2021, J CLEAN PROD, V296, DOI 10.1016/j.jclepro.2021.126359
   Ajzen I, 2004, PERS SOC PSYCHOL B, V30, P1108, DOI 10.1177/0146167204264079
   AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Algahtani FD, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030847
   Araghi Y, 2014, TRANSPORT RES D-TR E, V26, P42, DOI 10.1016/j.trd.2013.10.008
   Arcury T.A., 1993, J ENVIRON EDUC, V25, P19
   Attwood S., 2021, BEHAV SCI CAN SUPPOR
   Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42
   Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1
   Bashirian S, 2020, J HOSP INFECT, V105, P430, DOI 10.1016/j.jhin.2020.04.035
   Bayard B, 2007, ECOL ECON, V62, P433, DOI 10.1016/j.ecolecon.2006.07.004
   Boone H.N., 2012, J EXT, V50
   Botetzagias I, 2015, RESOUR CONSERV RECY, V95, P58, DOI 10.1016/j.resconrec.2014.12.004
   Botzen W, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105214
   Bronfman NC, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13105331
   Chanda R., 1999, J ENVIRON EDUC, P31
   Chater N, 2020, NAT HUM BEHAV, V4, P439, DOI 10.1038/s41562-020-0865-2
   Ching J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145167
   Chwialkowska A, 2020, J CLEAN PROD, V268, DOI 10.1016/j.jclepro.2020.122305
   Clark WA, 2007, SOC NATUR RESOUR, V20, P613, DOI 10.1080/08941920701216552
   Daryanto A, 2021, J BUS RES, V123, P208, DOI 10.1016/j.jbusres.2020.09.045
   Davison L, 2014, J AIR TRANSP MANAG, V36, P13, DOI 10.1016/j.jairtraman.2013.12.007
   Deng Y, 2017, SCI TOTAL ENVIRON, V581, P840, DOI 10.1016/j.scitotenv.2017.01.022
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dharmaraj S, 2021, CHEMOSPHERE, V272, DOI 10.1016/j.chemosphere.2021.129601
   Enfield M., 2012, SCI CHILD, V50, P46
   Eriksson L, 2006, J ENVIRON PSYCHOL, V26, P15, DOI 10.1016/j.jenvp.2006.05.003
   Flynn L., 2013, EMERG INFECT DIS, P1
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Frick J, 2004, PERS INDIV DIFFER, V37, P1597, DOI 10.1016/j.paid.2004.02.015
   Gkargkavouzi A, 2019, SOC INDIC RES, V143, P859, DOI 10.1007/s11205-018-1999-8
   Harland P, 2007, BASIC APPL SOC PSYCH, V29, P323, DOI 10.1080/01973530701665058
   He LM, 2020, TOUR MANAG PERSPECT, V35, DOI 10.1016/j.tmp.2020.100716
   Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014
   Hepburn C, 2020, OXFORD REV ECON POL, V36, pS359, DOI 10.1093/oxrep/graa015
   Ho R., 2013, HDB UNIVARIATE MULTI
   Hsu S.J., 1996, J ENVIRON EDUC, V28, P24, DOI [DOI 10.1080/00958964.1996.9942812, 10.1080/00958964.1996.9942812]
   Hu JR, 2021, WASTE MANAGE, V135, P397, DOI 10.1016/j.wasman.2021.09.028
   Hung WS, 2014, TRAVEL MED INFECT DI, V12, P370, DOI 10.1016/j.tmaid.2013.07.001
   Hunter M.R., 2021, J CLEAN PROD, V101
   Ivlevs A, 2019, REV INCOME WEALTH, V65, P293, DOI 10.1111/roiw.12355
   Jans L, 2021, J ENVIRON PSYCHOL, V73, DOI 10.1016/j.jenvp.2020.101531
   Jansson J, 2011, J CONSUM BEHAV, V10, P51, DOI 10.1002/cb.346
   Johnson EJ, 2017, J PUBLIC HEALTH-HEID, V25, P333, DOI 10.1007/s10389-017-0790-7
   Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X
   Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI DOI 10.1080/13504620220145401
   Li D, 2019, RESOUR CONSERV RECY, V146, P28, DOI 10.1016/j.resconrec.2019.03.024
   Likert R., 1932, ARCH PSYCHOL, V22, P5
   Liobikiene G, 2021, RENEW ENERG, V170, P587, DOI 10.1016/j.renene.2021.01.152
   Liu PH, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105162
   Liu ZF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154613
   Lucarelli C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su122410556
   LYNNE GD, 1995, J ECON PSYCHOL, V16, P581, DOI 10.1016/0167-4870(95)00031-6
   LYONS E, 1994, ENVIRON BEHAV, V26, P223, DOI 10.1177/001391659402600205
   Meyer A, 2015, ECOL ECON, V116, P108, DOI 10.1016/j.ecolecon.2015.04.018
   Mi LY, 2021, RESOUR CONSERV RECY, V168, DOI 10.1016/j.resconrec.2021.105467
   Mi LY, 2020, SUSTAIN DEV, V28, P1539, DOI 10.1002/sd.2103
   Mitchener CP, 2012, J SCI TEACH EDUC, V23, P45, DOI 10.1007/s10972-011-9261-0
   Nair D.A., 2020, KERALA J PSYCHIAT, V33, P5
   Onwezen MC, 2013, J ECON PSYCHOL, V39, P141, DOI 10.1016/j.joep.2013.07.005
   Parry N.A., 2020, FOR SCI INT REP
   Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877
   Przybylowski A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010364
   Robinson L., 2020, DEALING UNCERTAINTY
   Roser-Renouf C., 2008, INT J SUSTAIN COMMUN, V3, P37
   Ru XJ, 2018, J CLEAN PROD, V197, P1317, DOI 10.1016/j.jclepro.2018.06.293
   Rulli MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep41613
   Sarstedt M, 2014, J FAM BUS STRATEG, V5, P105, DOI 10.1016/j.jfbs.2014.01.002
   Severo EA, 2021, J CLEAN PROD, V286, DOI 10.1016/j.jclepro.2020.124947
   Singh G, 2021, TECHNOL FORECAST SOC, V173, DOI 10.1016/j.techfore.2021.121094
   Steiger DBM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1675-2
   Stern P.C., 1999, HUMAN ECOLOGY REVIEW, V6, P81, DOI DOI 10.2307/24707060
   Sultan N, 2013, INT J INFORM MANAGE, V33, P160, DOI 10.1016/j.ijinfomgt.2012.08.006
   Sun Y, 2018, URBAN WATER J, V15, P966, DOI 10.1080/1573062X.2019.1581233
   Tal I., 2006, EVOLUTIONARY APPROAC, V7, P7
   Prasetyo YT, 2020, INT J INFECT DIS, V99, P312, DOI 10.1016/j.ijid.2020.07.074
   Trumbo CW, 2005, SOC NATUR RESOUR, V18, P573, DOI 10.1080/08941920590948002
   van Birgelen M, 2011, J AIR TRANSP MANAG, V17, P125, DOI 10.1016/j.jairtraman.2010.12.013
   van der Linden S, 2015, NAT CLIM CHANGE, V5, P612, DOI 10.1038/nclimate2669
   van Dinther M, 2011, EDUC RES REV-NETH, V6, P95, DOI 10.1016/j.edurev.2010.10.003
   Vidal J., 2020, DESTROYED HABITAT CR
   Vlahakis GN, 2014, SCI EDUC-NETHERLANDS, V23, P521, DOI 10.1007/s11191-013-9601-x
   Wallston K., 2001, INT ENCY SOCIAL BEHA, P2724, DOI DOI 10.1016/B0-08-043076-7/03799-2
   Wauters E, 2010, LAND USE POLICY, V27, P86, DOI 10.1016/j.landusepol.2009.02.009
   Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150
   Wilcox B. A., 2006, Unasylva (English ed.), V57, P11
   Wu WH, 2020, J CLEAN PROD, V261, DOI 10.1016/j.jclepro.2020.121163
   Yilmaz F., 2020, ASSESSMENT COVID 19
   Yoon A, 2021, SCI TOTAL ENVIRON, V774, DOI 10.1016/j.scitotenv.2020.144782
   Young W, 2015, BUS STRATEG ENVIRON, V24, P689, DOI 10.1002/bse.1836
   Zhang L, 2021, BUILD ENVIRON, V204, DOI 10.1016/j.buildenv.2021.108136
   Zsoka A, 2013, J CLEAN PROD, V48, P126, DOI 10.1016/j.jclepro.2012.11.030
NR 94
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-9697
EI 1879-1026
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD MAR 10
PY 2022
VL 811
AR 151436
DI 10.1016/j.scitotenv.2021.151436
PG 10
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology
GA ZQ6ZB
UT WOS:000767249700002
PM 34742989
OA Bronze, Green Published
DA 2022-04-20
ER

PT J
AU Raymond, E
   Thieblemont, C
   Alran, S
   Faivre, S
AF Raymond, Eric
   Thieblemont, Catherine
   Alran, Severine
   Faivre, Sandrine
TI Impact of the COVID-19 Outbreak on the Management of Patients with
   Cancer
SO TARGETED ONCOLOGY
LA English
DT Review
AB The coronavirus SARS-CoV-2 (COVID-19) outbreak is having a profound impact on the management of patients with cancer. In this review, we comprehensively investigate the various aspects of cancer care during the pandemic, taking advantage of data generated in Asia and Europe at the frontline of the COVID-19 pandemic spread. Cancer wards have been subjected to several modifications to protect patients and healthcare professionals from COVID-19 infection, while attempting to maintain cancer diagnosis, therapy, and research. In this setting, the management of COVID-19 infected patients with cancer is particularly challenging. We also discuss the direct and potential remote impacts of the global pandemic on the mortality of patients with cancer. As such, the indirect impact of the pandemic on the global economy and the potential consequences in terms of cancer mortality are discussed. As the infection is spreading worldwide, we are obtaining more knowledge on the COVID-19 pandemic consequences that are currently impacting and may continue to further challenge cancer care in several countries.
C1 [Raymond, Eric] Paris St Joseph Hosp Grp, Dept Med Oncol, 185 Rue Raymond Losserand, F-75014 Paris, France.
   [Thieblemont, Catherine] Paris 7 Univ, St Louis Hosp, AP HP, Hematooncol, Paris, France.
   [Alran, Severine] Paris St Joseph Hosp Grp, Dept Gynecol & Mammary Surg, Paris, France.
   [Faivre, Sandrine] Paris 7 Univ, St Louis Hosp, AP HP, Med Oncol, Paris, France.
RP Raymond, E (corresponding author), Paris St Joseph Hosp Grp, Dept Med Oncol, 185 Rue Raymond Losserand, F-75014 Paris, France.
EM eraymond@hpsj.fr
RI Thieblemont, Catherine/AAZ-8423-2020
OI Thieblemont, Catherine/0000-0002-9941-2448; raymond,
   eric/0000-0001-5491-2708
CR Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642
   [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9
   Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Burki TK, 2020, LANCET ONCOL, V21, P629, DOI 10.1016/S1470-2045(20)30217-5
   Cornwall W., 2020, SCIENCE, V10, P13, DOI [10.1126/science.abb9969, DOI 10.1126/SCIENCE.ABB9969, 10.1126/science.abd6018]
   Craven M., 2020, COVID 19 BRIEFING NO
   Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114
   Enserink M, 2020, SCIENCE, V367, P1414, DOI 10.1126/science.367.6485.1414-b
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387
   Filippi AR, 2020, INT J RADIAT ONCOL, V107, P597, DOI 10.1016/j.ijrobp.2020.03.007
   Gomez SL, 2017, CANCER CAUSE CONTROL, V28, P145, DOI 10.1007/s10552-016-0846-y
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI [10.1056/NEJMoa2002032, 10.1056/NEJMc2005203]
   Hanna TP, 2020, NAT REV CLIN ONCOL, V17, P268, DOI 10.1038/s41571-020-0362-6
   Hansen Rikke P, 2011, BMC Health Serv Res, V11, P284, DOI 10.1186/1472-6963-11-284
   Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7
   Johnson HC, 2020, EUROSURVEILLANCE, V25, P8, DOI 10.2807/1560-7917.ES.2020.25.9.2000202
   Lambertini M, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2020-000759
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Maruthappu M, 2016, LANCET, V388, P684, DOI 10.1016/S0140-6736(16)00577-8
   Ngoi N, 2020, ANN ONCOL, V31, P840, DOI 10.1016/j.annonc.2020.03.306
   Oh WK, 2020, ANN ONCOL, VS0923-7534, P36384, DOI [10.1016/j.annonc.2020.03.297, DOI 10.1016/j.annonc.2020.03.297]
   Page KR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005953
   Pons ST, 2017, BRIT J CLIN PHARMACO, V83, P269, DOI 10.1111/bcp.13095
   Porzio G, 2020, J PAIN SYMPTOM MANAG, V60, pE5, DOI 10.1016/j.jpainsymman.2020.03.021
   Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Schwartz J, 2020, CLIN INFECT DIS, V71, P858, DOI 10.1093/cid/ciaa255
   Shankar A, 2020, ASIAN PAC J CANCER P, V21, P569, DOI DOI 10.31557/APJCP.2020.21.3.569
   Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4
   Shuman AG, 2020, ONCOLOGIST, V25, P458, DOI 10.1634/theoncologist.2020-0221
   Ueda M, 2020, J NATL COMPR CANC NE, V18, P366, DOI 10.6004/jnccn.2020.7560
   Vaira LA, 2020, LARYNGOSCOPE, V130, P1787, DOI 10.1002/lary.28692
   Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151
   Wang ZJ, 2020, JAMA ONCOL, V6, P631, DOI 10.1001/jamaoncol.2020.1198
   Ward EM, 2019, JNCI-J NATL CANCER I, V111, P1279, DOI 10.1093/jnci/djz106
   Yu J, 2020, JAMA ONCOL, V6, P1108, DOI 10.1001/jamaoncol.2020.0980
   Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 40
TC 60
Z9 61
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1776-2596
EI 1776-260X
J9 TARGET ONCOL
JI Target. Oncol.
PD JUN
PY 2020
VL 15
IS 3
BP 249
EP 259
DI 10.1007/s11523-020-00721-1
EA MAY 2020
PG 11
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA LZ6PF
UT WOS:000534872900002
PM 32445083
OA Green Published, hybrid
DA 2022-04-20
ER

PT J
AU Mubarak, N
   Safdar, S
   Faiz, S
   Khan, J
   Jaafar, M
AF Mubarak, Namra
   Safdar, Samyia
   Faiz, Shazia
   Khan, Jabran
   Jaafar, Mastura
TI Impact of public health education on undue fear of COVID-19 among
   nurses: The mediating role of psychological capital
SO INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING
LA English
DT Article
DE fear of COVID-19; psychological capital; public health education
ID MODERATING ROLE; MANAGEMENT; PEOPLE; CARE; PERFORMANCE; ENGAGEMENT;
   OUTCOMES
AB This study looked into the mechanism through which health education can reduce the fear of being infected with COVID-19 because health education helps individuals to improve their knowledge and attitudes towards a disease. The spread of COVID-19 has escalated the level of fear among public and nurses. Nevertheless, the mechanism that contributes to minimize the fear towards this pandemic remains unexplored. A cross-sectional survey was adopted to test the relationships among public health education, psychological capital, and fear of COVID-19. In total, 243 responses were obtained via online survey from nurses. The results revealed that public health education can reduce one's fear of COVID-19. Psychological capital emerged as a strong explanatory mechanism for the phenomenon. Drawing on spillover theory, public health education seems to reduce fear of COVID-19 with the mediating role of psychological capital. Limitations and future directions are at the end of this paper. The study outcomes revealed that organizations should focus on educating nursing staff to overcome fear of COVID-19. One way to induce positivity among nursing staff is by holding trainings.
C1 [Mubarak, Namra; Safdar, Samyia; Faiz, Shazia] Capital Univ Sci & Technol, Dept Management & Social Sci, Islamabad, Pakistan.
   [Khan, Jabran; Jaafar, Mastura] Univ Sains Malaysia, Sch Housing Bldg & Planning, George Town 11800, Minden, Malaysia.
RP Mubarak, N (corresponding author), Capital Univ Sci & Technol, Dept Management & Social Sci, Islamabad, Pakistan.
EM namra_mubarakk@yahoo.com
RI jaafar, mastura/A-1747-2012; Safdar, Samyia/ABC-2385-2021; Khan,
   Jabran/E-3370-2018
OI jaafar, mastura/0000-0003-3981-600X; Mubarak, Namra/0000-0002-3006-2013
CR AA (Anadolu Agency), 2020, AS PAC HLTH WORK HIT
   Andriessen D, 2009, PROCEEDINGS OF THE EUROPEAN CON FERENCE ON INTELLECTUAL CAPITAL, P36
   Bandura, 1997, SELF EFFICACY EXERCI
   Bibi I., 2019, HLTH AWARENESS HIGH
   Carmona-Halty M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00306
   Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20
   Dhama K, 2020, HUM VACC IMMUNOTHER, V16, P1232, DOI 10.1080/21645515.2020.1735227
   European Centre for Disease Prevention and Control (ECDC), 2020, COVID 19 SIT UPD WOR
   Freudenberg N, 2005, HEALTH EDUC BEHAV, V32, P298, DOI 10.1177/1090198105275044
   Guo L, 2018, J BUS RES, V92, P219, DOI 10.1016/j.jbusres.2018.07.034
   Haack M, 2020, SUPPORT CARE CANCER, V28, P2283, DOI 10.1007/s00520-019-05052-0
   Han S, 2021, DEVIANT BEHAV, V42, P718, DOI 10.1080/01639625.2020.1789295
   Hernandez-Varas E, 2019, PSICOTHEMA, V31, P277, DOI 10.7334/psicothema2019.22
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Irshad M, 2021, INT J MENT HEALTH NU, V30, P350, DOI 10.1111/inm.12775
   JACOBS JB, 1969, RADIOLOGY, V92, P1372, DOI 10.1148/92.6.1372
   Javadi SMH., 2020, J ARAK U MED SCI, V23, P2
   Jordan JE, 2008, MED J AUSTRALIA, V189, pS9
   Karatepe OM, 2017, J MANAG DEV, V36, P1029, DOI 10.1108/JMD-07-2016-0141
   Kelvin DJ, 2020, J INFECT DEV COUNTR, V14, P1, DOI 10.3855/jidc.12496
   Khan J, 2020, INT J MANAG PROJ BUS, V13, P1077, DOI 10.1108/IJMPB-10-2019-0267
   Lee M, 2020, J NURS RES, V28, DOI 10.1097/JNR.0000000000000372
   Luthans F, 2004, ORGAN DYN, V33, P143, DOI 10.1016/j.orgdyn.2004.01.003
   Luthans F.., 2007, PSYCHOL CAPITAL DEV
   Luthans F, 2007, PERS PSYCHOL, V60, P541, DOI 10.1111/j.1744-6570.2007.00083.x
   Luthans KW, 2019, J MANAG EDUC, V43, P35, DOI 10.1177/1052562918804282
   Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259
   Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002
   Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757
   Pisal H, 2007, J ASSOC NURSE AIDS C, V18, P32, DOI 10.1016/j.jana.2007.06.002
   Preacher K. J., 2005, ASYMPTOTIC RES UNPUB
   Raja U, 2020, J BUS RES, V110, P316, DOI 10.1016/j.jbusres.2020.01.026
   Neto MLR, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112972
   Ruiter RAC, 2001, HEALTH EDUC RES, V16, P307, DOI 10.1093/her/16.3.307
   Satici B, 2021, INT J MENT HEALTH AD, V19, P1980, DOI 10.1007/s11469-020-00294-0
   Sharoni SKA, 2016, INT J OLDER PEOPLE N, V11, P214, DOI 10.1111/opn.12112
   Shaukat N, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00299-5
   Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988
   Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034
   Stolow JA, 2020, HEALTH EDUC BEHAV, V47, P531, DOI 10.1177/1090198120935073
   Wallace CL, 2020, J PAIN SYMPTOM MANAG, V60, pE70, DOI 10.1016/j.jpainsymman.2020.04.012
   WELLS KB, 1995, HEALTH AFFAIR, V14, P78, DOI 10.1377/hlthaff.14.3.78
   Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8
   Yanovitzky I, 2005, EVAL PROGRAM PLANN, V28, P209, DOI 10.1016/j.evalprogplan.2005.01.004
   Yim HY, 2017, ASIAN NURS RES, V11, P6, DOI 10.1016/j.anr.2017.01.002
   Youssef CM, 2007, J MANAGE, V33, P774, DOI 10.1177/0149206307305562
NR 48
TC 5
Z9 6
U1 8
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1445-8330
EI 1447-0349
J9 INT J MENT HEALTH NU
JI Int. J. Ment. Health Nurs.
PD APR
PY 2021
VL 30
IS 2
BP 544
EP 552
DI 10.1111/inm.12819
EA NOV 2020
PG 9
WC Nursing; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing; Psychiatry
GA QV2LS
UT WOS:000591552000001
PM 33230850
OA Bronze, Green Published
DA 2022-04-20
ER

EF
